 |
Life Technologies (India) Pvt Ltd. 306, Agarwal City Mall, opposite M2K Pitampura, Delhi-110034 (India) Tel # +91-11-4220-8000; 4220-8111; 4220-8222 Fax# +91-11-4220-8444, Mobile# +91-98105-21400 Email# customerservice@lifetechindia.com |
| Catalog_No | Product Name | CAS Number | Product type |
|---|---|---|---|
| HY-100001 | SKF-96365 (hydrochloride) | 130495-35-1 | Reference compound |
| HY-100002 | ML162 | 1035072-16-2 | Reference compound |
| HY-100003 | ML-210 | 1360705-96-9 | Reference compound |
| HY-100004 | Fumarate hydratase-IN-1 | 1644060-37-6 | Reference compound |
| HY-100005A | Fumarate hydratase-IN-2 (sodium salt) | 2070009-45-7 | Reference compound |
| HY-100006 | MRT68921 | 1190379-70-4 | Reference compound |
| HY-100006A | MRT68921 (dihydrochloride) | 2080306-21-2 | Reference compound |
| HY-100006B | MRT68921 (hydrochloride) | 2070014-87-6 | Reference compound |
| HY-100007 | Vonoprazan | 881681-00-1 | Reference compound |
| HY-100007A | Vonoprazan (hydrochloride) | 1957202-44-6 | Reference compound |
| HY-100007R | Vonoprazan (Standard) | 881681-00-1 | Reference Standards |
| HY-100008 | Peretinoin | 81485-25-8 | Reference compound |
| HY-100008R | Peretinoin (Standard) | 81485-25-8 | Reference Standards |
| HY-100009 | Ufenamate | 67330-25-0 | Reference compound |
| HY-10001 | Calcipotriol | 112965-21-6 | Reference compound |
| HY-100011 | SR-3029 | 1454585-06-8 | Reference compound |
| HY-100012 | CBR-5884 | 681159-27-3 | Reference compound |
| HY-100013A1 | (1R,2R)-2-PCCA (hydrochloride) | 1609563-71-4 | Reference compound |
| HY-100013B1 | (1S,2S)-2-PCCA (hydrochloride) | 1609563-70-3 | Reference compound |
| HY-100013C | 2-PCCA (hydrochloride) | Reference compound | |
| HY-100014 | KDM5A-IN-1 | 1905481-36-8 | Reference compound |
| HY-100015 | Mivebresib | 1445993-26-9 | Reference compound |
| HY-100015R | Mivebresib (Standard) | 1445993-26-9 | Reference Standards |
| HY-100016 | AZD0156 | 1821428-35-6 | Reference compound |
| HY-100017 | BAY-876 | 1799753-84-6 | Reference compound |
| HY-100018 | BAY1125976 | 1402608-02-9 | Reference compound |
| HY-100019 | Rogaratinib | 1443530-05-9 | Reference compound |
| HY-10001A | Calcipotriol (monohydrate) | 147657-22-5 | Reference compound |
| HY-10001AR | Calcipotriol (monohydrate) (Standard) | 147657-22-5 | Reference Standards |
| HY-10001R | Calcipotriol (Standard) | 112965-21-6 | Reference Standards |
| HY-10002 | Calcitriol | 32222-06-3 | Natural Products |
| HY-100020 | BAY-1436032 | 1803274-65-8 | Reference compound |
| HY-100022 | Tomivosertib | 1849590-01-7 | Reference compound |
| HY-100022A | Tomivosertib (hydrochloride) | 1849590-02-8 | Reference compound |
| HY-100023 | LY3177833 | 1627696-51-8 | Reference compound |
| HY-100023A | LY3177833 (monhydrate) | 1627696-53-0 | Reference compound |
| HY-100024 | NTRC 0066-0 | 1817791-73-3 | Reference compound |
| HY-100025 | HLCL-61 | 586395-74-6 | Reference compound |
| HY-100025A | HLCL-61 (hydrochloride) | 1158279-20-9 | Reference compound |
| HY-100026 | PQR620 | 1927857-56-4 | Reference compound |
| HY-100027A | Ro 41-1049 (hydrochloride) | 127917-66-2 | Reference compound |
| HY-100028 | AT-130 | 211364-06-6 | Reference compound |
| HY-100029 | Bay 41-4109 | 298708-81-3 | Reference compound |
| HY-100029A | Bay 41-4109 (racemate) | 298708-79-9 | Reference compound |
| HY-100029AR | Bay 41-4109 (racemate) (Standard) | 298708-79-9 | Reference Standards |
| HY-100029B | Bay 41-4109 (less active enantiomer) | 476617-51-3 | Reference compound |
| HY-10002A | (1S)-Calcitriol | 61476-45-7 | Reference compound |
| HY-10002B | (1R,5Z)-Calcitriol | 32511-63-0 | Reference compound |
| HY-10002R | Calcitriol (Standard) | 32222-06-3 | Reference Standards |
| HY-10002S | Calcitriol-13C3 | Isotope-Labeled Compounds | |
| HY-10002S1 | Calcitriol-d3 | 128723-16-0 | Isotope-Labeled Compounds |
| HY-10003 | Alfacalcidol | 41294-56-8 | Reference compound |
| HY-100032 | PD 117519 | 96392-15-3 | Reference compound |
| HY-100033 | NSC5844 | 140926-75-6 | Reference compound |
| HY-100034 | NSC 663284 | 383907-43-5 | Reference compound |
| HY-100035 | PT-262 | 86811-36-1 | Reference compound |
| HY-100036 | MK-4101 | 935273-79-3 | Reference compound |
| HY-100037 | NT157 | 1384426-12-3 | Reference compound |
| HY-100039 | YYA-021 | 144217-65-2 | Reference compound |
| HY-10003A | 1α-Hydroxy-3-epi-vitamin D3 | 58028-00-5 | Reference compound |
| HY-10003R | Alfacalcidol (Standard) | 41294-56-8 | Reference Standards |
| HY-10003S | Alfacalcidol-d7 | Isotope-Labeled Compounds | |
| HY-10004 | Faropenem daloxate | 141702-36-5 | Reference compound |
| HY-100040 | Ethyl 1H-pyrazole-4-carboxylate | 37622-90-5 | Biochemical Assay Reagents |
| HY-100041 | Bromobimane | 71418-44-5 | Dye Reagents |
| HY-100043S | 2-Ethyl-3,5-dimethylpyrazine-13C2 | Isotope-Labeled Compounds | |
| HY-100044 | SR 4330 | 20028-80-2 | Reference compound |
| HY-100045 | p-Nitrophenyl phosphorylcholine | 21064-69-7 | Reference compound |
| HY-100046 | Nordoxepin (hydrochloride) | 2887-91-4 | Reference compound |
| HY-100046R | Nordoxepin (hydrochloride) (Standard) | 2887-91-4 | Reference Standards |
| HY-100046S1 | Nordoxepin-d4 (hydrochloride) | 2249819-14-3 | Isotope-Labeled Compounds |
| HY-100047 | Nα,Nα-Bis(carboxymethyl)-L-lysine | 113231-05-3 | Peptides |
| HY-100048S | Acetylisoniazid-d4 | 1330169-81-7 | Isotope-Labeled Compounds |
| HY-10004R | Faropenem daloxate (Standard) | 141702-36-5 | Reference Standards |
| HY-10005 | Flavopiridol | 146426-40-6 | Reference compound |
| HY-100050 | 4-Hydroxymidazolam | 59468-85-8 | Reference compound |
| HY-100052 | 6-Hydroxybentazon | 60374-42-7 | Reference compound |
| HY-100052R | 6-Hydroxybentazon (Standard) | 60374-42-7 | Reference Standards |
| HY-100057 | BMY 28674 | 125481-61-0 | Reference compound |
| HY-100057S | BMY 28674-d8 | 1189644-16-3 | Isotope-Labeled Compounds |
| HY-10006 | Flavopiridol (Hydrochloride) | 131740-09-5 | Reference compound |
| HY-100061 | 2-(Dimethylamino)acetaldehyde | 52334-92-6 | Reference compound |
| HY-100061A | 2-(Dimethylamino)acetaldehyde (hydrochloride) | 125969-54-2 | Reference compound |
| HY-100064 | O-Desmethyl gefitinib | 847949-49-9 | Reference compound |
| HY-100064R | O-Desmethyl gefitinib (Standard) | 847949-49-9 | Reference Standards |
| HY-100064S | O-Desmethyl gefitinib-d8 | Isotope-Labeled Compounds | |
| HY-100064S1 | O-Desmethyl gefitinib-d6 | Isotope-Labeled Compounds | |
| HY-100069 | Fluazinam impurity 1 | 169327-87-1 | Reference compound |
| HY-100069R | Fluazinam impurity 1 (Standard) | 169327-87-1 | Reference Standards |
| HY-10007 | NPS-2143 | 284035-33-2 | Reference compound |
| HY-100072 | (2E,4E,6Z)-Methyl deca-2,4,6-trienoate | 51544-64-0 | Reference compound |
| HY-100079 | 9-Propenyladenine | 1446486-33-4 | Reference compound |
| HY-100079A | (Z)-9-Propenyladenine | 1464851-21-5 | Reference compound |
| HY-100079R | 9-Propenyladenine (Standard) | 1446486-33-4 | Reference Standards |
| HY-10008 | SNS-032 | 345627-80-7 | Reference compound |
| HY-100080 | A-887826 | 1266212-81-0 | Reference compound |
| HY-100083 | Dolutegravir intermediate-1 | 1335210-23-5 | Reference compound |
| HY-100084 | Methyl-3β-hydroxycholenate | 20231-57-6 | Reference compound |
| HY-100085 | 21-Desacetyldeflazacort | 13649-57-5 | Reference compound |
| HY-100085R | 21-Desacetyldeflazacort (Standard) | 13649-57-5 | Reference Standards |
| HY-100085S | 21-Desacetyldeflazacort-d5 | Isotope-Labeled Compounds | |
| HY-100087 | Budesonide impurity C | 1040085-99-1 | Reference compound |
| HY-10008R | SNS-032 (Standard) | 345627-80-7 | Reference Standards |
| HY-10009 | Semagacestat | 425386-60-3 | Reference compound |
| HY-100096 | Emtricitabine S-oxide | 152128-77-3 | Reference compound |
| HY-10009R | Semagacestat (Standard) | 425386-60-3 | Reference Standards |
| HY-10010 | Ko 143 | 461054-93-3 | Reference compound |
| HY-10011 | SCH 563705 | 473728-58-4 | Reference compound |
| HY-100110 | KNK437 | 218924-25-5 | Reference compound |
| HY-100111 | GLX351322 | 835598-94-2 | Reference compound |
| HY-100112 | WEHI-345 analog | 1354825-62-9 | Reference compound |
| HY-100113 | Buloxibutid | 477775-14-7 | Reference compound |
| HY-100114 | TA-01 | 1784751-18-3 | Reference compound |
| HY-100115 | TA-02 | 1784751-19-4 | Reference compound |
| HY-100116A | Mitoquinone (mesylate) | 845959-50-4 | Reference compound |
| HY-100118 | BW-A 78U | 101155-02-6 | Reference compound |
| HY-100119 | Enecadin | 259525-01-4 | Reference compound |
| HY-100119A | Enecadin (hydrochloride) | 178429-67-9 | Reference compound |
| HY-10011A | (S)-SCH 563705 | Reference compound | |
| HY-10011B | (Rac)-SCH 563705 | 2701435-64-3 | Reference compound |
| HY-10012 | AZD-5438 | 602306-29-6 | Reference compound |
| HY-100120 | Pparδ agonist 2 | 870884-12-1 | Reference compound |
| HY-100121 | Vibunazole | 80456-55-9 | Reference compound |
| HY-100122 | Bevenopran | 676500-67-7 | Reference compound |
| HY-100124 | Bamaluzole | 87034-87-5 | Reference compound |
| HY-100125 | Timegadine | 71079-19-1 | Reference compound |
| HY-100125A | Timegadine (hydrochloride) | 71080-06-3 | Reference compound |
| HY-100126 | Tubercidin | 69-33-0 | Natural Products |
| HY-100126R | Tubercidin (Standard) | 69-33-0 | Reference Standards |
| HY-100128 | DM1-SMe | 138148-68-2 | ADC Related |
| HY-100129 | JNJ-17203212 | 821768-06-3 | Reference compound |
| HY-10012R | AZD-5438 (Standard) | 602306-29-6 | Reference Standards |
| HY-10013 | Taranabant | 701977-09-5 | Reference compound |
| HY-100130 | N-[(4-Aminophenyl)methyl]adenosine | 95523-13-0 | Reference compound |
| HY-100131 | GSK481 | 1622849-58-4 | Reference compound |
| HY-100132 | CBP/p300-IN-5 | 1889284-33-6 | Reference compound |
| HY-100133A | DOTA-ADIBO (TFA) | Biochemical Assay Reagents | |
| HY-100138 | 2-Aminoethyl-mono-amide-DOTA-tris(tBu ester) | 173308-19-5 | ADC Related |
| HY-100139 | Diflumidone | 22736-85-2 | Reference compound |
| HY-10013A | Taranabant (racemate) | 701977-00-6 | Reference compound |
| HY-10013B | Taranabant ((1R,2R)stereoisomer) | 701977-08-4 | Reference compound |
| HY-10014 | R547 | 741713-40-6 | Reference compound |
| HY-100140 | Pipequaline | 77472-98-1 | Reference compound |
| HY-100140A | Pipequaline hydrochloride | 80221-58-5 | Reference compound |
| HY-100140R | Pipequaline (Standard) | 77472-98-1 | Reference Standards |
| HY-100141 | Ancarolol | 75748-50-4 | Reference compound |
| HY-100142 | Clozic | 22494-47-9 | Reference compound |
| HY-100143 | Pentiapine | 81382-51-6 | Reference compound |
| HY-100144 | Pirozadil | 54110-25-7 | Reference compound |
| HY-100144R | Pirozadil (Standard) | 54110-25-7 | Reference Standards |
| HY-100145 | Prifuroline | 70833-07-7 | Reference compound |
| HY-100146 | Pirazolac | 71002-09-0 | Reference compound |
| HY-100148 | ICI 211965 | 129424-08-4 | Reference compound |
| HY-10015 | PAP-1 | 870653-45-5 | Reference compound |
| HY-100150 | Mepixanox | 17854-59-0 | Reference compound |
| HY-100151 | RGH-5526 | 69579-13-1 | Reference compound |
| HY-100152 | Beperidium iodide | 86434-57-3 | Reference compound |
| HY-100153 | 48740 RP | 93363-11-2 | Reference compound |
| HY-100154 | Darenzepine | 84629-61-8 | Reference compound |
| HY-100155 | 4-IBP | 155798-08-6 | Reference compound |
| HY-100159 | Ipenoxazone | 104454-71-9 | Reference compound |
| HY-100159A | Ipenoxazone (hydrochloride) | 118635-68-0 | Reference compound |
| HY-10015R | PAP-1 (Standard) | 870653-45-5 | Reference Standards |
| HY-10016 | E 2012 | 870843-42-8 | Reference compound |
| HY-100160 | RP 54275 | 81364-78-5 | Reference compound |
| HY-100161 | CI-943 | 89239-35-0 | Reference compound |
| HY-100162 | TOK-8801 | 105963-46-0 | Reference compound |
| HY-100164 | SDZ-MKS 492 | 114606-56-3 | Reference compound |
| HY-100166 | AP521 | 151227-08-6 | Reference compound |
| HY-100167 | TAK-778 | 180185-61-9 | Reference compound |
| HY-100168 | BAPTA | 85233-19-8 | Biochemical Assay Reagents |
| HY-100168A | BAPTA (tetrasodium) | 126824-24-6 | Reference compound |
| HY-100168AR | BAPTA (tetrasodium) (Standard) | 126824-24-6 | Reference Standards |
| HY-100168B | BAPTA (tetrapotassium) | 73630-08-7 | Biochemical Assay Reagents |
| HY-100168R | BAPTA (Standard) | 85233-19-8 | Reference Standards |
| HY-10017 | SCH 546738 | 906805-42-3 | Reference compound |
| HY-100170 | 5-HT4 antagonist 1 | 261766-73-8 | Reference compound |
| HY-100171 | PRX933 hydrochloride | 639029-42-8 | Reference compound |
| HY-100171A | PRX933 | 313658-33-2 | Reference compound |
| HY-100172 | Proteasome-IN-1 | 374080-21-4 | Reference compound |
| HY-100173 | DW-1350 | 491577-61-8 | Reference compound |
| HY-100174 | W-2429 | 37795-69-0 | Reference compound |
| HY-100176 | PF-4878691 | 532959-63-0 | Reference compound |
| HY-100176R | PF-4878691 (Standard) | 532959-63-0 | Reference Standards |
| HY-100177 | L-Threonine derivative-1 | 852055-88-0 | Reference compound |
| HY-100178 | CX-157 | 205187-53-7 | Reference compound |
| HY-10017A | (R)-SCH 546738 | 2181148-54-7 | Reference compound |
| HY-10018 | Toll-like receptor modulator | 926927-42-6 | Reference compound |
| HY-100180 | Delpazolid | 1219707-39-7 | Reference compound |
| HY-100180R | Delpazolid (Standard) | 1219707-39-7 | Reference Standards |
| HY-100181 | PF-04991532 | 1215197-37-7 | Reference compound |
| HY-100181B | (R)-PF-04991532 | Reference compound | |
| HY-100182 | BACE1-IN-1 | 1310347-50-2 | Reference compound |
| HY-100183 | GSK2239633A | 1240516-71-5 | Reference compound |
| HY-100184 | DSM265 | 1282041-94-4 | Reference compound |
| HY-100186 | GSK-2881078 | 1539314-06-1 | Reference compound |
| HY-100189 | LS2265 | 72678-30-9 | Reference compound |
| HY-10019 | Varenicline | 249296-44-4 | Reference compound |
| HY-100190 | Amphethinile | 91531-98-5 | Reference compound |
| HY-100191 | BMY-25271 | 78441-82-4 | Reference compound |
| HY-100193 | FK-448 Free base | 85858-76-0 | Reference compound |
| HY-100194 | FKK | 78299-79-3 | Reference compound |
| HY-100195 | SAR-020106 | 1184843-57-9 | Reference compound |
| HY-100196 | Pyrroloquinoline quinone | 72909-34-3 | Natural Products |
| HY-100196A | Pyrroloquinoline quinone (disodium salt) | 122628-50-6 | Natural Products |
| HY-100196AR | Pyrroloquinoline quinone (disodium salt) (Standard) | 122628-50-6 | Reference Standards |
| HY-100196R | Pyrroloquinoline quinone (Standard) | 72909-34-3 | Reference Standards |
| HY-100196S1 | Pyrroloquinoline quinone-13C3 (sodium) | Isotope-Labeled Compounds | |
| HY-100197 | Synaptamide | 162758-94-3 | Reference compound |
| HY-100198 | PI4KIIIbeta-IN-10 | 1881233-39-1 | Reference compound |
| HY-100199 | HUHS015 | 1453097-13-6 | Reference compound |
| HY-10019A | Varenicline (dihydrochloride) | 866823-63-4 | Reference compound |
| HY-10019AR | Varenicline (dihydrochloride) (Standard) | 866823-63-4 | Reference Standards |
| HY-10019AS | Varenicline-d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-10019AS1 | Varenicline-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10019R | Varenicline (Standard) | 249296-44-4 | Reference Standards |
| HY-10019S | Varenicline-d4 | 2183239-01-0 | Isotope-Labeled Compounds |
| HY-10019S1 | Varenicline-15N,13C,d2 | Isotope-Labeled Compounds | |
| HY-10019S2 | Varenicline-13C15N | 2140265-12-7 | Isotope-Labeled Compounds |
| HY-10020 | Varenicline (Hydrochloride) | 230615-23-3 | Reference compound |
| HY-100200 | SMER28 | 307538-42-7 | Reference compound |
| HY-100201 | A-196 | 1982372-88-2 | Reference compound |
| HY-100202 | TPEN | 16858-02-9 | Reference compound |
| HY-100206 | 5α-Androstane-3β,5,6β-triol | 4725-51-3 | Reference compound |
| HY-100207 | CP21R7 | 125314-13-8 | Reference compound |
| HY-100208 | HC-067047 | 883031-03-6 | Reference compound |
| HY-100209 | Sufugolix | 308831-61-0 | Reference compound |
| HY-10020R | Varenicline (Hydrochloride) (Standard) | 230615-23-3 | Reference Standards |
| HY-10020S | Varenicline-15N3 (hydrochloride) | 1244134-80-2 | Isotope-Labeled Compounds |
| HY-10021 | Varenicline (Tartrate) | 375815-87-5 | Reference compound |
| HY-100210 | FN-439 | 124168-73-6 | Peptides |
| HY-100210A | FN-439 (TFA) | Reference compound | |
| HY-100211 | TAPI-2 | 187034-31-7 | Reference compound |
| HY-100211A | (R)-TAPI-2 | 689284-12-6 | Reference compound |
| HY-100212 | JE-2147 | 186538-00-1 | Reference compound |
| HY-100213 | EAI045 | 1942114-09-1 | Reference compound |
| HY-100214 | EAI001 | 892772-75-7 | Reference compound |
| HY-100215 | Biotin Hydrazide | 66640-86-6 | Biochemical Assay Reagents |
| HY-100216 | SPDP | 68181-17-9 | ADC Related |
| HY-100217 | DL-3-Indolylglycine | 6747-15-5 | Reference compound |
| HY-100218A | RSL3 | 1219810-16-8 | Reference compound |
| HY-100218B | (1R,3S)-RSL3 | 1219810-13-5 | Reference compound |
| HY-100218C | (1R,3R)-RSL3 | 1219810-15-7 | Reference compound |
| HY-100219 | CB1151 | 182369-28-4 | Reference compound |
| HY-10021R | Varenicline (Tartrate) (Standard) | 375815-87-5 | Reference Standards |
| HY-100220 | GSK6853 | 1910124-24-1 | Reference compound |
| HY-100221 | AM-2394 | 1442684-77-6 | Reference compound |
| HY-100222 | CZ415 | 1429639-50-8 | Reference compound |
| HY-100223 | Calpeptin | 117591-20-5 | Reference compound |
| HY-100223R | Calpeptin (Standard) | 117591-20-5 | Reference Standards |
| HY-100224 | SANT-1 | 304909-07-7 | Reference compound |
| HY-100224G | SANT-1 (GMP) | 304909-07-7 | GMP Small Molecules |
| HY-100225 | ME0328 | 1445251-22-8 | Reference compound |
| HY-100226 | A-205804 | 251992-66-2 | Reference compound |
| HY-100227 | E 64c | 76684-89-4 | Reference compound |
| HY-100228 | SKF 89976A | 85375-85-5 | Reference compound |
| HY-100228A | SKF89976A (hydrochloride) | 85375-15-1 | Reference compound |
| HY-100229 | Aloxistatin | 88321-09-9 | Reference compound |
| HY-100229R | Aloxistatin (Standard) | 88321-09-9 | Reference Standards |
| HY-100230A | ML133 (hydrochloride) | 1222781-70-5 | Reference compound |
| HY-100231 | Cathepsin inhibitor 1 | 225120-65-0 | Reference compound |
| HY-100233 | IQ-1S (free acid) | 23146-22-7 | Reference compound |
| HY-100233A | IQ-1S | 1421610-21-0 | Reference compound |
| HY-100234 | DREADD agonist 21 | 56296-18-5 | Reference compound |
| HY-100234A | DREADD agonist 21 (dihydrochloride) | 2250025-92-2 | Reference compound |
| HY-100235 | GSK591 | 1616391-87-7 | Reference compound |
| HY-100235A | GSK591 (hydrochloride) | 2320953-89-5 | Reference compound |
| HY-100236 | Madrasin | 374913-63-0 | Reference compound |
| HY-100237 | SZL P1-41 | 222716-34-9 | Reference compound |
| HY-100238 | Antihistamine-1 | 1186430-60-3 | Reference compound |
| HY-100239 | ICI 153110 | 87164-90-7 | Reference compound |
| HY-100240 | Lodelaben | 111149-90-7 | Reference compound |
| HY-100241 | Nafocare B1 | 93135-89-8 | Reference compound |
| HY-100242 | Mivotilate | 130112-42-4 | Reference compound |
| HY-100242R | Mivotilate (Standard) | 130112-42-4 | Reference Standards |
| HY-100243 | (+)-Norcisapride | 202590-69-0 | Reference compound |
| HY-100243A | Norcisapride | 83863-69-8 | Reference compound |
| HY-100244 | NS1652 | 1566-81-0 | Reference compound |
| HY-100245 | OM-189 | 55381-18-5 | Reference compound |
| HY-100246 | CI-1044 | 197894-84-1 | Reference compound |
| HY-100248 | Sarmazenil | 78771-13-8 | Reference compound |
| HY-100249 | XEN723 | 1072803-08-7 | Reference compound |
| HY-10025 | (S)-SW IV-52 (hydrochloride) | 845745-37-1 | Reference compound |
| HY-100250 | Spirofylline | 98204-48-9 | Reference compound |
| HY-100253 | TA-7552 | 104756-72-1 | Reference compound |
| HY-100254 | TAK-024 | 186971-69-7 | Reference compound |
| HY-100255 | Tiodazosin | 66969-81-1 | Reference compound |
| HY-100256 | Trifarotene | 895542-09-3 | Reference compound |
| HY-100256R | Trifarotene (Standard) | 895542-09-3 | Reference Standards |
| HY-100257 | Sodium Channel inhibitor 2 | 653573-60-5 | Reference compound |
| HY-100258 | Y-9738 | 59399-41-6 | Reference compound |
| HY-100260 | beta-L-D4A | 7057-48-9 | Reference compound |
| HY-100261 | CCR5 antagonist 1 | 716354-86-8 | Reference compound |
| HY-100262 | Sulfasymazine | 1984-94-7 | Reference compound |
| HY-100263 | Metofenazate | 388-51-2 | Reference compound |
| HY-100263B | Metofenazate (diethanesulfonate) | 1674-48-2 | Reference compound |
| HY-100264 | Uldazepam | 28546-58-9 | Reference compound |
| HY-100265 | Cinperene | 14796-24-8 | Reference compound |
| HY-100266 | Nitromifene | 10448-84-7 | Reference compound |
| HY-100267 | Chlordantoin | 5588-20-5 | Reference compound |
| HY-100268 | Xenalamine | 1174-11-4 | Reference compound |
| HY-100269 | Chymase-IN-1 | 862090-74-2 | Reference compound |
| HY-100270 | Rho-Kinase-IN-1 | 1035094-83-7 | Reference compound |
| HY-100271 | Org41841 | 301847-37-0 | Reference compound |
| HY-100272 | B220 | 112228-65-6 | Reference compound |
| HY-100273 | AGN 194078 | 321995-62-4 | Reference compound |
| HY-100274 | Adenosine antagonist-1 | 431040-19-6 | Reference compound |
| HY-100275 | MK-3328 | 1201323-97-8 | Reference compound |
| HY-100276 | Naminidil | 220641-11-2 | Reference compound |
| HY-100277 | Mifobate | 76541-72-5 | Reference compound |
| HY-100277R | Mifobate (Standard) | 76541-72-5 | Reference Standards |
| HY-100278 | AKP-001 | 897644-83-6 | Reference compound |
| HY-100279 | RMI 10874 | 38020-45-0 | Reference compound |
| HY-100280 | Pirolate | 55149-05-8 | Reference compound |
| HY-100283 | CGS 15435 | 95853-92-2 | Reference compound |
| HY-100284 | Thiazolidinone-Derivatives-1 | 136272-75-8 | Reference compound |
| HY-100285 | RD3-0028 | 3886-39-3 | Reference compound |
| HY-100286 | MDL 19301 | 89388-38-5 | Reference compound |
| HY-100287 | 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide | 137089-36-2 | Reference compound |
| HY-100288 | RP 73163 (Racemate) | 136609-53-5 | Reference compound |
| HY-100289 | MF 5137 | 148927-23-5 | Reference compound |
| HY-10029 | Nutlin-3a | 675576-98-4 | Reference compound |
| HY-100290 | 5-HT1A modulator 1 | 142477-34-7 | Reference compound |
| HY-100291 | SX-3228 | 156364-04-4 | Reference compound |
| HY-100292 | SL910102 | 144756-71-8 | Reference compound |
| HY-100294 | Ruzadolane | 115762-17-9 | Reference compound |
| HY-100295 | (4-Acetamidocyclohexyl) nitrate | 137213-91-3 | Reference compound |
| HY-100296 | Gastrofensin AN 5 free base | 89845-16-9 | Reference compound |
| HY-100297 | MK-447 | 58456-91-0 | Reference compound |
| HY-100298 | Caldaret | 133804-44-1 | Reference compound |
| HY-100299 | RPR107393 free base | 197576-78-6 | Reference compound |
| HY-10029A | (Rac)-Nutlin-3 | 890090-75-2 | Reference compound |
| HY-10030 | Mardepodect (succinate) | 1037309-45-7 | Reference compound |
| HY-100300 | AGN 192836 | 171102-29-7 | Reference compound |
| HY-100301 | FR167344 free base | 215258-13-2 | Reference compound |
| HY-100302 | FR183998 free base | 239440-20-1 | Reference compound |
| HY-100303 | FR194738 free base | 204067-45-8 | Reference compound |
| HY-100303A | FR194738 | 204067-52-7 | Reference compound |
| HY-100304 | KW-8232 free base | 170365-25-0 | Reference compound |
| HY-100304A | KW-8232 | 217813-15-5 | Reference compound |
| HY-100305 | Substituted piperidines-1 | 170842-46-3 | Reference compound |
| HY-100306 | PNU-176798 | 428861-91-0 | Reference compound |
| HY-100308 | SB-568849 | 395679-53-5 | Reference compound |
| HY-100309 | 9-Aminocamptothecin | 91421-43-1 | Natural Products |
| HY-100310 | N-type calcium channel blocker-1 | 241499-17-2 | Reference compound |
| HY-100312 | (±)-WS75624B | 188048-45-5 | Reference compound |
| HY-100313 | YM-53601 free base | 182959-28-0 | Reference compound |
| HY-100313A | YM-53601 | 182959-33-7 | Reference compound |
| HY-100314 | BCR-ABL-IN-1 | 188260-50-6 | Reference compound |
| HY-100315 | XL 999 | 705946-27-6 | Reference compound |
| HY-100316 | CP-96486 | 139401-45-9 | Reference compound |
| HY-100318 | NGD-4715 | 476322-70-0 | Reference compound |
| HY-100319 | UK-157147 | 162704-20-3 | Reference compound |
| HY-10032 | PF 477736 | 952021-60-2 | Reference compound |
| HY-100320 | AVE5688 | 613260-13-2 | Reference compound |
| HY-100321 | MCHR1 antagonist 2 | 863115-70-2 | Reference compound |
| HY-100322 | H100 | 643727-55-3 | Reference compound |
| HY-100325 | NHE3-IN-1 | 632355-68-1 | Reference compound |
| HY-100326 | PDE7-IN-3 | 908570-13-8 | Reference compound |
| HY-100327 | MK-6913 | 1398510-92-3 | Reference compound |
| HY-100328 | CB2R-IN-1 | 1257555-79-5 | Reference compound |
| HY-100329 | CGP 65015 | 189564-33-8 | Reference compound |
| HY-100330 | YM348 | 372163-84-3 | Reference compound |
| HY-100331 | MCH-1 antagonist 1 | 1039825-68-7 | Reference compound |
| HY-100332 | CP 375 | 752186-89-3 | Reference compound |
| HY-100333 | PF-02575799 | 863491-70-7 | Reference compound |
| HY-100334 | Pirinixil | 65089-17-0 | Reference compound |
| HY-100335 | PCI-33380 | 1022899-36-0 | Reference compound |
| HY-100336 | AC260584 | 560083-42-3 | Reference compound |
| HY-100337 | WWL70 | 947669-91-2 | Reference compound |
| HY-100338 | CNX-500 | 1202758-21-1 | Reference compound |
| HY-100339 | GSK583 | 1346547-00-9 | Reference compound |
| HY-100341 | M2I-1 | 312271-03-7 | Reference compound |
| HY-100342 | Ibrutinib-biotin | 1599432-18-4 | Reference compound |
| HY-100343 | GNE-495 | 1449277-10-4 | Reference compound |
| HY-100345 | AMTB (hydrochloride) | 926023-82-7 | Reference compound |
| HY-100346 | PK14105 | 107257-28-3 | Reference compound |
| HY-100347 | SRI-011381 | 1629138-41-5 | Reference compound |
| HY-100347A | SRI-011381 (hydrochloride) | 2070014-88-7 | Reference compound |
| HY-100347S | SRI-011381-d5 | Isotope-Labeled Compounds | |
| HY-100348 | EPI-001 | 227947-06-0 | Reference compound |
| HY-100348R | EPI-001 (Standard) | 227947-06-0 | Reference Standards |
| HY-100349 | SU4312 | 5812-07-7 | Reference compound |
| HY-100349A | cis-SU4312 | 90828-16-3 | Reference compound |
| HY-10035 | TTA-P2 | 1072018-68-8 | Reference compound |
| HY-100350 | CA-074 methyl ester | 147859-80-1 | Reference compound |
| HY-100351 | BI-7273 | 1883429-21-7 | Reference compound |
| HY-100352 | BI-9564 | 1883429-22-8 | Reference compound |
| HY-100353 | C12-Ceramide | 74713-60-3 | Reference compound |
| HY-100353R | C12-Ceramide (Standard) | 74713-60-3 | Reference Standards |
| HY-100354 | C16-Ceramide | 24696-26-2 | Reference compound |
| HY-100354S | C16-Ceramide-13C16 | Isotope-Labeled Compounds | |
| HY-100354S3 | C16-Ceramide-d9 | 2260669-51-8 | Isotope-Labeled Compounds |
| HY-100354S4 | C16-Ceramide-d31 | 852043-41-5 | Isotope-Labeled Compounds |
| HY-100355 | C18-Ceramide | 2304-81-6 | Reference compound |
| HY-100355R | C18-Ceramide (Standard) | 2304-81-6 | Reference Standards |
| HY-100355S | C18-Ceramide-d3 | 2011762-82-4 | Isotope-Labeled Compounds |
| HY-100355S1 | C18-Ceramide-d7 | 1840942-14-4 | Isotope-Labeled Compounds |
| HY-100356 | Aptiganel | 137159-92-3 | Reference compound |
| HY-100358 | AQ-13 dihydrochloride | 169815-40-1 | Reference compound |
| HY-100359 | CL-82198 | 307002-71-7 | Reference compound |
| HY-10035A | (R)-TTA-P2 | Reference compound | |
| HY-10036 | Glucagon receptor antagonist-1 | 503559-84-0 | Reference compound |
| HY-100360 | MS049 | 1502816-23-0 | Reference compound |
| HY-100360A | MS049 (dihydrochloride) | 2095432-59-8 | Reference compound |
| HY-100365 | Remetinostat | 946150-57-8 | Reference compound |
| HY-100366 | Lu AF21934 | 1445605-23-1 | Reference compound |
| HY-100367 | ES 936 | 192820-78-3 | Reference compound |
| HY-100368 | MELK-8a | 1922153-17-0 | Reference compound |
| HY-100368A | MELK-8a (hydrochloride) | 2096992-20-8 | Reference compound |
| HY-100369A | DMCM (hydrochloride) | 1215833-62-7 | Reference compound |
| HY-100369AR | DMCM (hydrochloride) (Standard) | 1215833-62-7 | Reference Standards |
| HY-10037 | Quiflapon | 136668-42-3 | Reference compound |
| HY-100370 | MRK-016 | 342652-67-9 | Reference compound |
| HY-100371 | (RS)-MCPG | 146669-29-6 | Reference compound |
| HY-100371R | (RS)-MCPG (Standard) | 146669-29-6 | Reference Standards |
| HY-100372 | E4CPG | 170846-89-6 | Reference compound |
| HY-100373 | Isavuconazonium (sulfate) | 946075-13-4 | Reference compound |
| HY-100374 | Val-Cit-PAB-MMAE | 644981-35-1 | ADC Related |
| HY-100374G | Val-Cit-PAB-MMAE (GMP) | 644981-35-1 | GMP Small Molecules |
| HY-100375 | Diroximel fumarate | 1577222-14-0 | Reference compound |
| HY-100376 | CPI-1189 | 183619-38-7 | Reference compound |
| HY-100377 | Lvguidingan | 82351-05-1 | Reference compound |
| HY-100379 | Valrocemide | 92262-58-3 | Reference compound |
| HY-10037R | Quiflapon (Standard) | 136668-42-3 | Reference Standards |
| HY-10038 | A 922500 | 959122-11-3 | Reference compound |
| HY-100380 | TPO agonist 1 | 1033040-23-1 | Reference compound |
| HY-100381 | Nigericin (sodium salt) | 28643-80-3 | Natural Products |
| HY-100381R | Nigericin (sodium salt) (Standard) | 28643-80-3 | Reference Standards |
| HY-100382 | FPTQ | 864863-72-9 | Reference compound |
| HY-100383 | BH3I-1 | 300817-68-9 | Reference compound |
| HY-100384 | NKL 22 | 537034-15-4 | Reference compound |
| HY-100385 | Brevianamide F | 38136-70-8 | Natural Products |
| HY-100385R | Brevianamide F (Standard) | 38136-70-8 | Reference Standards |
| HY-100386 | Ticlopidine | 55142-85-3 | Reference compound |
| HY-100386R | Ticlopidine (Standard) | 55142-85-3 | Reference Standards |
| HY-100386S | Ticlopidine-d4 | 1246817-49-1 | Isotope-Labeled Compounds |
| HY-100388 | SHP099 | 1801747-42-1 | Reference compound |
| HY-100388A | SHP099 (monohydrochloride) | 2200214-93-1 | Reference compound |
| HY-100388AR | SHP099 (monohydrochloride) (Standard) | 2200214-93-1 | Reference Standards |
| HY-100388R | SHP099 (Standard) | 1801747-42-1 | Reference Standards |
| HY-100390 | (S)-ML753286 | 1699720-85-8 | Reference compound |
| HY-100394 | NVP-BAW2881 | 861875-60-7 | Reference compound |
| HY-100395 | F16 | 36098-33-6 | Reference compound |
| HY-100396 | SQ22536 | 17318-31-9 | Reference compound |
| HY-100396R | SQ22536 (Standard) | 17318-31-9 | Reference Standards |
| HY-100397 | Elastatinal | 51798-45-9 | Reference compound |
| HY-100397R | Elastatinal (Standard) | 51798-45-9 | Reference Standards |
| HY-100398 | PF-04979064 | 1220699-06-8 | Reference compound |
| HY-100399 | Nevanimibe | 133825-80-6 | Reference compound |
| HY-100399A | Nevanimibe hydrochloride | 133825-81-7 | Reference compound |
| HY-100399AR | Nevanimibe hydrochloride (Standard) | 133825-81-7 | Reference Standards |
| HY-100400A | K-604 (dihydrochloride) | 217094-32-1 | Reference compound |
| HY-100400AR | K-604 (dihydrochloride) (Standard) | 217094-32-1 | Reference Standards |
| HY-100401 | Pactimibe | 189198-30-9 | Reference compound |
| HY-100401A | Pactimibe (sulfate) | 608510-47-0 | Reference compound |
| HY-100402 | CFMTI | 864864-17-5 | Reference compound |
| HY-100403 | Ro 67-7476 | 298690-60-5 | Reference compound |
| HY-100404 | DFMTI | 864864-86-8 | Reference compound |
| HY-100405 | FTIDC | 873551-53-2 | Reference compound |
| HY-100406 | (S)-MCPG | 150145-89-4 | Reference compound |
| HY-100407 | JNJ16259685 | 409345-29-5 | Reference compound |
| HY-100408 | GNF-6231 | 1243245-18-2 | Reference compound |
| HY-100409 | PHCCC | 179068-02-1 | Reference compound |
| HY-100410 | FCCP | 370-86-5 | Reference compound |
| HY-100410R | FCCP (Standard) | 370-86-5 | Reference Standards |
| HY-100411 | MLi-2 | 1627091-47-7 | Reference compound |
| HY-100412 | Linaprazan | 248919-64-4 | Reference compound |
| HY-100412A | Linaprazan (mesylate) | 855998-67-3 | Reference compound |
| HY-100412R | Linaprazan (Standard) | 248919-64-4 | Reference Standards |
| HY-100413 | CS-526 | 313272-12-7 | Reference compound |
| HY-100414 | Soraprazan | 261944-46-1 | Reference compound |
| HY-100415 | UKI-1 | 220355-63-5 | Reference compound |
| HY-100416 | LY2365109 | 868265-28-5 | Reference compound |
| HY-100416A | LY2365109 (hydrochloride) | 1779796-27-8 | Reference compound |
| HY-100418 | SKA-111 | 1369170-24-0 | Reference compound |
| HY-100419 | BFH772 | 890128-81-1 | Reference compound |
| HY-10042 | Odanacatib | 603139-19-1 | Reference compound |
| HY-100421 | CPI-455 | 1628208-23-0 | Reference compound |
| HY-100421A | CPI-455 (hydrochloride) | 2095432-28-1 | Reference compound |
| HY-100422 | KDM5-IN-1 | 1628210-26-3 | Reference compound |
| HY-100423 | Eltanexor | 1642300-52-4 | Reference compound |
| HY-100423A | Eltanexor Z-isomer | 1642300-78-4 | Reference compound |
| HY-100426 | Osemozotan | 137275-81-1 | Reference compound |
| HY-100426A | Osemozotan (hydrochloride) | 137275-80-0 | Reference compound |
| HY-100427 | Imazamox | 114311-32-9 | Reference compound |
| HY-100427R | Imazamox (Standard) | 114311-32-9 | Reference Standards |
| HY-100427S | Imazamox-13C,d3 | Isotope-Labeled Compounds | |
| HY-100428 | Netoglitazone | 161600-01-7 | Reference compound |
| HY-100428R | Netoglitazone (Standard) | 161600-01-7 | Reference Standards |
| HY-100429 | CAN508 | 140651-18-9 | Reference compound |
| HY-10042S | Odanacatib-d4 | Isotope-Labeled Compounds | |
| HY-10043 | gamma-secretase modulator 1 | 1172637-87-4 | Reference compound |
| HY-100430 | CCF642 | 346640-08-2 | Reference compound |
| HY-100431 | IMR-1 | 310456-65-6 | Reference compound |
| HY-100431A | IMR-1A | 331862-41-0 | Reference compound |
| HY-100431AR | IMR-1A (Standard) | 331862-41-0 | Reference Standards |
| HY-100432 | LOC14 | 877963-94-5 | Reference compound |
| HY-100433 | PACMA 31 | 1401089-31-3 | Reference compound |
| HY-100434 | PD-161570 | 192705-80-9 | Reference compound |
| HY-100435 | Oxaquin | 790704-50-6 | Reference compound |
| HY-100436 | Cadazolid | 1025097-10-2 | Reference compound |
| HY-100436R | Cadazolid (Standard) | 1025097-10-2 | Reference Standards |
| HY-100437 | HA15 | 1609402-14-3 | Reference compound |
| HY-100438 | Hydronidone | 851518-71-3 | Reference compound |
| HY-10043A | gamma-secretase modulator 1 (hydrochloride) | 2741571-83-3 | Reference compound |
| HY-10044 | WYE-132 | 1144068-46-1 | Reference compound |
| HY-100441 | Treprostinil | 81846-19-7 | Reference compound |
| HY-100441R | Treprostinil (Standard) | 81846-19-7 | Reference Standards |
| HY-100441S1 | Treprostinil-13C2,d1 | Isotope-Labeled Compounds | |
| HY-100441S2 | Treprostinil-d9 | 2747918-14-3 | Isotope-Labeled Compounds |
| HY-100441S3 | Treprostinil-d7 | Isotope-Labeled Compounds | |
| HY-100442 | Paquinimod | 248282-01-1 | Reference compound |
| HY-100442R | Paquinimod (Standard) | 248282-01-1 | Reference Standards |
| HY-100442S | Paquinimod-d5 | Isotope-Labeled Compounds | |
| HY-100442S1 | Paquinimod-d5-1 | Isotope-Labeled Compounds | |
| HY-100443 | PX20606 | 1268245-19-7 | Reference compound |
| HY-100443A | trans-PX20606 | 1268244-85-4 | Reference compound |
| HY-100443B | (R,R)-PX20606 | 1268244-88-7 | Reference compound |
| HY-100444 | SIS3 (free base) | 521985-36-4 | Reference compound |
| HY-100445 | αvβ1 integrin-IN-1 | 1689540-62-2 | Reference compound |
| HY-100445A | αvβ1 integrin-IN-1 (TFA) | Reference compound | |
| HY-100446 | NTU281 | 815619-12-6 | Reference compound |
| HY-100447 | TM5275 (sodium) | 1103926-82-4 | Reference compound |
| HY-100448A | Butaprost | 69685-22-9 | Reference compound |
| HY-100449 | AL-8810 | 246246-19-5 | Reference compound |
| HY-100449A | (S)-AL-8810 | 1224444-55-6 | Reference compound |
| HY-10045 | AEE788 | 497839-62-0 | Reference compound |
| HY-100450 | BML-111 | 78606-80-1 | Reference compound |
| HY-100452 | TCS-OX2-29 | 372523-75-6 | Reference compound |
| HY-100452A | TCS-OX2-29 (hydrochloride) | 1610882-30-8 | Reference compound |
| HY-100453 | HO-3867 | 1172133-28-6 | Reference compound |
| HY-100454 | CGP 25454A | 104391-26-6 | Reference compound |
| HY-100455 | RK-33 | 1070773-09-9 | Reference compound |
| HY-100456 | ZL006 | 1181226-02-7 | Reference compound |
| HY-100457 | IC87201 | 866927-10-8 | Reference compound |
| HY-100459 | GSK3179106 | 1627856-64-7 | Reference compound |
| HY-10046 | Plerixafor | 110078-46-1 | Reference compound |
| HY-100460 | BIPM | 1070424-33-7 | Reference compound |
| HY-100461 | C29 | 363600-92-4 | Reference compound |
| HY-100462 | PTP1B-IN-2 | 1919853-46-5 | Reference compound |
| HY-100463 | TPI-1 | 79756-69-7 | Reference compound |
| HY-100464 | tBID | 1639895-85-4 | Reference compound |
| HY-100468 | REV7/REV3L-IN-1 | 1979192-13-6 | Reference compound |
| HY-100469 | LXRβ agonist-2 | 1949801-52-8 | Reference compound |
| HY-10046R | Plerixafor (Standard) | 110078-46-1 | Reference Standards |
| HY-10046S | Plerixafor-d4 | 1246819-87-3 | Isotope-Labeled Compounds |
| HY-100470 | NSC781406 | 1676893-24-5 | Reference compound |
| HY-100471 | Esaxerenone | 1632006-28-0 | Reference compound |
| HY-100471R | Esaxerenone (Standard) | 1632006-28-0 | Reference Standards |
| HY-100472 | ZYZ-488 | 1470302-79-4 | Reference compound |
| HY-100474 | Visomitin | 934826-68-3 | Reference compound |
| HY-100475 | KYP-2047 | 796874-99-2 | Reference compound |
| HY-100476 | Mutant IDH1-IN-3 | 1648909-73-2 | Reference compound |
| HY-100481 | RP 72540 | 139088-45-2 | Reference compound |
| HY-100482 | CPI-637 | 1884712-47-3 | Reference compound |
| HY-100483 | A-804598 | 1125758-85-1 | Reference compound |
| HY-100486 | BTTAA | 1334179-85-9 | Reference compound |
| HY-100487 | TAK-243 | 1450833-55-2 | Reference compound |
| HY-100488 | Bay 59-3074 | 406205-74-1 | Reference compound |
| HY-100489 | TBHQ | 1948-33-0 | Reference compound |
| HY-100489R | TBHQ (Standard) | 1948-33-0 | Reference Standards |
| HY-100490 | Rilmenidine | 54187-04-1 | Reference compound |
| HY-100490A | Rilmenidine (hemifumarate) | 207572-68-7 | Reference compound |
| HY-100490AR | Rilmenidine (hemifumarate) (Standard) | 207572-68-7 | Reference Standards |
| HY-100490B | Rilmenidine (phosphate) | 85409-38-7 | Reference compound |
| HY-100490BR | Rilmenidine (phosphate) (Standard) | 85409-38-7 | Reference Standards |
| HY-100490R | Rilmenidine (Standard) | 54187-04-1 | Reference Standards |
| HY-100490S | Rilmenidine-d4 | 85047-14-9 | Isotope-Labeled Compounds |
| HY-100491 | H3B-6527 | 1702259-66-2 | Reference compound |
| HY-100492 | Fisogatinib | 1707289-21-1 | Reference compound |
| HY-100493 | BP-1-102 | 1334493-07-0 | Reference compound |
| HY-100494 | SH5-07 | 1456632-41-9 | Reference compound |
| HY-100495 | FT011 | 1001288-58-9 | Reference compound |
| HY-100496 | Nucleocidin | 24751-69-7 | Natural Products |
| HY-100498 | GSK2256098 | 1224887-10-8 | Reference compound |
| HY-100498A | GSK-2256098 (hydrochloride) | 1416771-10-2 | Reference compound |
| HY-100499 | Tyrphostin AG 528 | 133550-49-9 | Reference compound |
| HY-10049A | CP 122721 (hydrochloride) | 145877-52-7 | Reference compound |
| HY-100500 | Lenampicillin (hydrochloride) | 80734-02-7 | Reference compound |
| HY-100501 | M2698 | 1379545-95-5 | Reference compound |
| HY-100502 | CID5721353 | 301356-95-6 | Reference compound |
| HY-100503 | Maytansinoid DM4 | 799840-96-3 | ADC Related |
| HY-100504 | S-methyl DM1 | 912569-84-7 | ADC Related |
| HY-100506 | GLPG0187 | 1320346-97-1 | Reference compound |
| HY-100507 | Avadomide | 1015474-32-4 | Reference compound |
| HY-100507A | Avadomide (hydrochloride) | 1398053-45-6 | Reference compound |
| HY-100507R | Avadomide (Standard) | 1015474-32-4 | Reference Standards |
| HY-100508 | ITSA-1 | 200626-61-5 | Reference compound |
| HY-100509 | NPS-1034 | 1221713-92-3 | Reference compound |
| HY-10051 | GR203040 | 168398-02-5 | Reference compound |
| HY-100510 | RAF709 | 1628838-42-5 | Reference compound |
| HY-100511 | Benzophenonetetracarboxylic acid | 2479-49-4 | Reference compound |
| HY-100512 | Benzenepentacarboxylic Acid | 1585-40-6 | Dye Reagents |
| HY-100513A | Dehydroaltenusin | 31186-13-7 | Natural Products |
| HY-100514 | GSK484 (hydrochloride) | 1652591-81-5 | Reference compound |
| HY-100515 | Robotnikinin | 1132653-79-2 | Reference compound |
| HY-100516 | Cimicoxib | 265114-23-6 | Reference compound |
| HY-100516R | Cimicoxib (Standard) | 265114-23-6 | Reference Standards |
| HY-100517 | TP-472 | 2079895-62-6 | Reference compound |
| HY-100518 | T-26c | 869296-13-9 | Reference compound |
| HY-100518A | T 26c (sodium) | 869298-22-6 | Reference compound |
| HY-100519 | NVS-PAK1-1 | 1783816-74-9 | Reference compound |
| HY-10052 | Aprepitant | 170729-80-3 | Reference compound |
| HY-100520 | EGFR-IN-2 | 1643497-70-4 | Reference compound |
| HY-100521 | GKI-1 | 2444764-03-6 | Reference compound |
| HY-100522 | FMK 9a | 1955550-51-2 | Reference compound |
| HY-100523 | ML385 | 846557-71-9 | Reference compound |
| HY-100524 | LRE1 | 1252362-53-0 | Reference compound |
| HY-100526 | XMU-MP-1 | 2061980-01-4 | Reference compound |
| HY-100527 | AN2718 | 174672-06-1 | Reference compound |
| HY-100528 | Nanchangmycin | 65101-87-3 | Natural Products |
| HY-100528A | Dianemycin | 35865-33-9 | Natural Products |
| HY-100528AR | Dianemycin (Standard) | 35865-33-9 | Reference Standards |
| HY-100528R | Nanchangmycin (Standard) | 65101-87-3 | Reference Standards |
| HY-100529 | PD150606 | 179528-45-1 | Reference compound |
| HY-10052R | Aprepitant (Standard) | 170729-80-3 | Reference Standards |
| HY-10053 | Maropitant | 147116-67-4 | Reference compound |
| HY-100530 | Rp-cAMPS (triethylammonium salt) | 151837-09-1 | Reference compound |
| HY-100530A | Rp-cAMPS | 73208-40-9 | Reference compound |
| HY-100530B | Sp-cAMPS | 71774-13-5 | Reference compound |
| HY-100530C | Sp-cAMPS (sodium salt) | 142439-95-0 | Reference compound |
| HY-100530D | Rp-cAMPS (sodium salt) | 142439-94-9 | Reference compound |
| HY-100531 | DprE1-IN-2 | 1615713-87-5 | Reference compound |
| HY-100532 | CD437 | 125316-60-1 | Reference compound |
| HY-100532R | CD437 (Standard) | 125316-60-1 | Reference Standards |
| HY-100532S | CD437-13C6 | Isotope-Labeled Compounds | |
| HY-100533 | IDE1 | 1160927-48-9 | Reference compound |
| HY-100534 | IDE 2 | 1136466-93-7 | Reference compound |
| HY-100535 | KAAD-Cyclopamine | 306387-90-6 | Reference compound |
| HY-100536 | IWP-3 | 687561-60-0 | Reference compound |
| HY-100538 | DTP3 | 1809784-29-9 | Peptides |
| HY-100538A | DTP3 (TFA) | 2759216-46-9 | Peptides |
| HY-100539 | PD 128907 | 123594-64-9 | Reference compound |
| HY-100539A | PD 128907 (hydrochloride) | 112960-16-4 | Biochemical Assay Reagents |
| HY-10053B | Maropitant (citrate) | 862543-54-2 | Reference compound |
| HY-10053R | Maropitant (Standard) | 147116-67-4 | Reference Standards |
| HY-10053S | Maropitant-d3 | 2124295-52-7 | Isotope-Labeled Compounds |
| HY-10053S1 | Maropitant-13C,d3 | Isotope-Labeled Compounds | |
| HY-100540 | Golgicide A | 1139889-93-2 | Reference compound |
| HY-100540A | (Rac)-Golgicide A | 1005036-73-6 | Reference compound |
| HY-100540B | Golgicide A-2 | 1394285-50-7 | Reference compound |
| HY-100540C | Golgicide A-1 | 1394285-49-4 | Reference compound |
| HY-100541 | INH6 | 1001753-24-7 | Reference compound |
| HY-100542 | D-α-Hydroxyglutaric acid (disodium) | 103404-90-6 | Reference compound |
| HY-100542R | D-α-Hydroxyglutaric acid (disodium) (Standard) | 103404-90-6 | Reference Standards |
| HY-100543 | Zenidolol | 72795-26-7 | Reference compound |
| HY-100544 | FLLL32 | 1226895-15-3 | Reference compound |
| HY-100545 | BAPTA-AM | 126150-97-8 | Biochemical Assay Reagents |
| HY-100545R | BAPTA-AM (Standard) | 126150-97-8 | Reference Standards |
| HY-100546 | GSK-LSD1 | 1431368-48-7 | Reference compound |
| HY-100546A | GSK-LSD1 (dihydrochloride) | 2102933-95-7 | Reference compound |
| HY-100547 | IEM-1754 | 162831-31-4 | Reference compound |
| HY-100548 | GSK621 | 1346607-05-3 | Reference compound |
| HY-100549 | (S)-Crizotinib | 1374356-45-2 | Reference compound |
| HY-100550 | MSDC 0160 | 146062-49-9 | Reference compound |
| HY-100551 | meso-Erythritol | 149-32-6 | Natural Products |
| HY-100551R | meso-Erythritol (Standard) | 149-32-6 | Reference Standards |
| HY-100552 | VUF10166 | 155584-74-0 | Reference compound |
| HY-100554 | BMY 7378 | 21102-95-4 | Reference compound |
| HY-100555 | CH5138303 | 959763-06-5 | Reference compound |
| HY-100556 | Tie2 kinase inhibitor 1 | 948557-43-5 | Reference compound |
| HY-100557 | Hydroxypropyl Cellulose | 9004-64-2 | Reference compound |
| HY-100557A | Low-Substituted Hydroxypropyl Cellulose | 9004-64-2 | Reference compound |
| HY-100557B | HPC, Viscosity(1%):150-400mPa.s | 9004-64-2 | Biochemical Assay Reagents |
| HY-100557C | HPC, Viscosity(1%):4000-6500mPa.s | 9004-64-2 | Biochemical Assay Reagents |
| HY-100557D | HPC, Viscosity(5%):75-150mPa.s | 9004-64-2 | Biochemical Assay Reagents |
| HY-100557E | HPC, Viscosity(1%):1275-3500mPa.s | 9004-64-2 | Biochemical Assay Reagents |
| HY-100557H | HPC, Viscosity(2%):95000-105000mPa.s | 9004-64-2 | Biochemical Assay Reagents |
| HY-100558 | Bafilomycin A1 | 88899-55-2 | Natural Products |
| HY-100559 | SecinH3 | 853625-60-2 | Reference compound |
| HY-100560 | Abscisic acid | 21293-29-8 | Natural Products |
| HY-100560R | Abscisic acid (Standard) | 21293-29-8 | Reference Standards |
| HY-100560S | Abscisic acid-d6 | 721948-65-8 | Isotope-Labeled Compounds |
| HY-100561 | Tempol | 2226-96-2 | Reference compound |
| HY-100561R | Tempol (Standard) | 2226-96-2 | Reference Standards |
| HY-100561S | Tempol-d17,15N | 90429-66-6 | Isotope-Labeled Compounds |
| HY-100561S1 | Tempol-d17 | 100326-46-3 | Isotope-Labeled Compounds |
| HY-100562 | Flopropione | 2295-58-1 | Natural Products |
| HY-100563 | Cyclo(RGDyK) (trifluoroacetate) | 250612-42-1 | Peptides |
| HY-100563A | Cyclo(RGDyK) | 217099-14-4 | Peptides |
| HY-100564 | 2',3'-cGAMP | 1441190-66-4 | Reference compound |
| HY-100564A | 2',3'-cGAMP (sodium) | 2734858-36-5 | Reference compound |
| HY-100564BS | 2',3'-cGAMP-d8 (ammonium) | Isotope-Labeled Compounds | |
| HY-100565 | SGC2085 | 1821908-48-8 | Reference compound |
| HY-100565A | SGC2085 (hydrochloride) | 1821908-49-9 | Reference compound |
| HY-100566 | SuO-Val-Cit-PAB-MMAE | ADC Related | |
| HY-100567 | MAL-di-EG-Val-Cit-PAB-MMAE | 2746391-62-6 | ADC Related |
| HY-100568 | 3-O-Demethylfortimicin A | 74842-47-0 | Reference compound |
| HY-10057 | AT9283 (hydrochloride) | 896466-61-8 | Reference compound |
| HY-100570 | KF15766 | 124907-44-4 | Reference compound |
| HY-100571 | Cloprostenol isopropyl ester | 157283-66-4 | Reference compound |
| HY-100571A | (+)-5-trans Cloprostenol isopropyl ester | Reference compound | |
| HY-100572 | Nicainoprol | 76252-06-7 | Reference compound |
| HY-100573 | Necrosulfonamide | 1360614-48-7 | Reference compound |
| HY-100573A | (E/Z)-Necrosulfonamide | 432531-71-0 | Reference compound |
| HY-100573S | Necrosulfonamide-d4 | 1795144-22-7 | Isotope-Labeled Compounds |
| HY-100574 | Cl-amidine | 913723-61-2 | Reference compound |
| HY-100574A | Cl-amidine (hydrochloride) | 1373232-26-8 | Reference compound |
| HY-100574B | Cl-amidine (TFA) | 1043444-18-3 | Reference compound |
| HY-100574C | D-Cl-amidine | 1404060-15-6 | Reference compound |
| HY-100574D | D-Cl-amidine (hydrochloride) | 2985338-61-0 | Reference compound |
| HY-100575 | Acriflavine | 8048-52-0 | Dye Reagents |
| HY-100576 | NH125 | 278603-08-0 | Reference compound |
| HY-100577 | Ticarcillin (sodium) | 29457-07-6 | Reference compound |
| HY-100578 | AGK2 | 304896-28-4 | Reference compound |
| HY-100579 | Ferrostatin-1 | 347174-05-4 | Reference compound |
| HY-10058 | AT9283 (lactic acid) | 896466-76-5 | Reference compound |
| HY-100580 | Asaraldehyde | 4460-86-0 | Natural Products |
| HY-100580R | Asaraldehyde (Standard) | 4460-86-0 | Reference Standards |
| HY-100581 | CORM-3 | 475473-26-8 | Reference compound |
| HY-100582 | Ribitol | 488-81-3 | Natural Products |
| HY-100582R | Ribitol (Standard) | 488-81-3 | Reference Standards |
| HY-100582S | Ribitol-1-13C | Isotope-Labeled Compounds | |
| HY-100582S1 | Ribitol-2-13C | Isotope-Labeled Compounds | |
| HY-100582S2 | Ribitol-3-13C | Isotope-Labeled Compounds | |
| HY-100582S3 | Ribitol-5-13C | Isotope-Labeled Compounds | |
| HY-100583 | (-)-(S)-Equol | 531-95-3 | Natural Products |
| HY-100583A | (±)-Equol | 94105-90-5 | Natural Products |
| HY-100583AR | (±)-Equol (Standard) | 94105-90-5 | Reference Standards |
| HY-100583R | (-)-(S)-Equol (Standard) | 531-95-3 | Reference Standards |
| HY-100584 | Davercin | 55224-05-0 | Reference compound |
| HY-100584R | Davercin (Standard) | 55224-05-0 | Reference Standards |
| HY-100585 | Splitomicin | 5690-03-9 | Reference compound |
| HY-100585R | Splitomicin (Standard) | 5690-03-9 | Reference Standards |
| HY-100586 | Ibuprofen (L-lysine) | 57469-77-9 | Reference compound |
| HY-100586R | Ibuprofen (L-lysine) (Standard) | 57469-77-9 | Reference Standards |
| HY-100587 | D-Glutamine | 5959-95-5 | Natural Products |
| HY-100587R | D-Glutamine (Standard) | 5959-95-5 | Reference Standards |
| HY-100588 | VU0364770 | 61350-00-3 | Reference compound |
| HY-100588A | VU0364770 (hydrochloride) | 1414842-70-8 | Reference compound |
| HY-100589 | Isepamicin (sulfate) | 67814-76-0 | Reference compound |
| HY-100590 | FPH1 | 708219-39-0 | Reference compound |
| HY-100591 | SirReal2 | 709002-46-0 | Reference compound |
| HY-100592 | Nicaraven | 79455-30-4 | Reference compound |
| HY-100592R | Nicaraven (Standard) | 79455-30-4 | Reference Standards |
| HY-100593 | Spiramycin | 8025-81-8 | Natural Products |
| HY-100593A | Spiramycin (hexanedioate) | 11034-40-5 | Reference compound |
| HY-100593R | Spiramycin (Standard) | 8025-81-8 | Reference Standards |
| HY-100594 | EUK-134 | 81065-76-1 | Reference compound |
| HY-100595 | Sodium stibogluconate | 16037-91-5 | Reference compound |
| HY-100596 | AS1842856 | 836620-48-5 | Reference compound |
| HY-100597 | Saponins | 8047-15-2 | Natural Products |
| HY-100599 | Urolithin A | 1143-70-0 | Natural Products |
| HY-100599R | Urolithin A (Standard) | 1143-70-0 | Reference Standards |
| HY-100600 | BGG463 | 890129-26-7 | Reference compound |
| HY-100602 | HJC0152 | 1420290-99-8 | Reference compound |
| HY-100603 | GSK-F1 | 1402345-92-9 | Reference compound |
| HY-100603A | (S)-GSK-F1 | 1384097-27-1 | Reference compound |
| HY-100604 | JNJ-40418677 | 1146594-87-7 | Reference compound |
| HY-100604A | (R)-JNJ-40418677 | 1146594-85-5 | Reference compound |
| HY-100605 | VU0483605 | 1623101-11-0 | Reference compound |
| HY-100606 | l-Pindolol | 26328-11-0 | Reference compound |
| HY-100607 | Landiolol | 133242-30-5 | Reference compound |
| HY-100607A | Landiolol (hydrochloride) | 144481-98-1 | Reference compound |
| HY-100607AR | Landiolol (hydrochloride) (Standard) | 144481-98-1 | Reference Standards |
| HY-100608 | BMS453 | 166977-43-1 | Reference compound |
| HY-100609 | 4-P-PDOT | 134865-74-0 | Reference compound |
| HY-100609R | 4-P-PDOT (Standard) | 134865-74-0 | Reference Standards |
| HY-10061 | Lesogaberan | 344413-67-8 | Reference compound |
| HY-100611 | CaCCinh-A01 | 407587-33-1 | Reference compound |
| HY-100612 | T16Ainh-A01 | 552309-42-9 | Reference compound |
| HY-100613 | MONNA | 1572936-83-4 | Reference compound |
| HY-100614 | AS1517499 | 919486-40-1 | Reference compound |
| HY-100615 | Revizinone | 133718-29-3 | Reference compound |
| HY-100615A | R 80123 | 133718-30-6 | Reference compound |
| HY-100616 | cis-ACBD | 73550-55-7 | Reference compound |
| HY-100616A | trans-ACBD | 117488-23-0 | Reference compound |
| HY-100617 | (S)-4CPG | 134052-73-6 | Reference compound |
| HY-100617A | (RS)-4CPG | 7292-81-1 | Reference compound |
| HY-100617B | (R)-4CPG | 134052-68-9 | Reference compound |
| HY-100618 | Hispidin | 555-55-5 | Natural Products |
| HY-100618R | Hispidin (Standard) | 555-55-5 | Reference Standards |
| HY-100619 | BMS-986020 | 1257213-50-5 | Reference compound |
| HY-100619A | BMS-986020 (sodium) | 1380650-53-2 | Reference compound |
| HY-10061A | Lesogaberan (napadisylate) | 477956-38-0 | Reference compound |
| HY-10061B | Lesogaberan (hydrochloride) | 2925644-17-1 | Reference compound |
| HY-100620 | RPR121056 | 181467-56-1 | Reference compound |
| HY-100620R | RPR121056 (Standard) | 181467-56-1 | Reference Standards |
| HY-100621 | MDL 72527 | 93565-01-6 | Reference compound |
| HY-100622 | Ro 20-0657/000 | 29606-06-2 | Reference compound |
| HY-100623 | Dofetilide N-oxide | 144449-71-8 | Reference compound |
| HY-100624 | Ryuvidine | 265312-55-8 | Reference compound |
| HY-100625 | BVT948 | 39674-97-0 | Reference compound |
| HY-100626 | WNK463 | 2012607-27-9 | Reference compound |
| HY-100627 | APS-2-79 | 2002381-25-9 | Reference compound |
| HY-100627A | APS-2-79 (hydrochloride) | 2002381-31-7 | Reference compound |
| HY-10063 | Ispronicline | 252870-53-4 | Reference compound |
| HY-100631 | FGFR4-IN-1 | 1708971-72-5 | Reference compound |
| HY-100633S | N-Demethy Ivabradine-d6 (hydrochloride) | 1346600-74-5 | Isotope-Labeled Compounds |
| HY-100634 | 4-Hydroxypropranolol (hydrochloride) | 14133-90-5 | Reference compound |
| HY-100634R | 4-Hydroxypropranolol (hydrochloride) (Standard) | 14133-90-5 | Reference Standards |
| HY-100634S | 4-Hydroxypropranolol-d7 (hydrochloride) | 1219804-03-1 | Isotope-Labeled Compounds |
| HY-100634SA | 4-Hydroxypropranolol-d7 | 1219908-86-7 | Isotope-Labeled Compounds |
| HY-100635 | Diacetolol | 22568-64-5 | Reference compound |
| HY-100635R | Diacetolol (Standard) | 22568-64-5 | Reference Standards |
| HY-100635S | Diacetolol-d7 | 1346604-19-0 | Isotope-Labeled Compounds |
| HY-100636 | Gefitinib N-oxide | 847949-51-3 | Reference compound |
| HY-100636A | Gefitinib N-oxide (hydrochloride) | Reference compound | |
| HY-100637 | Hydroxybupropion | 92264-81-8 | Reference compound |
| HY-100638 | RPR132595A | 185304-42-1 | Reference compound |
| HY-100638A | RPR132595A (hydrochloride) | Reference compound | |
| HY-100639 | Roflumilast N-oxide | 292135-78-5 | Reference compound |
| HY-100639R | Roflumilast N-oxide (Standard) | 292135-78-5 | Reference Standards |
| HY-10064 | Ticagrelor | 274693-27-5 | Reference compound |
| HY-100640 | Roflumilast Impurity E | 1391052-76-8 | Reference compound |
| HY-100640R | Roflumilast Impurity E (Standard) | 1391052-76-8 | Reference Standards |
| HY-100641 | 4-Hydroxytolbutamide | 5719-85-7 | Reference compound |
| HY-100641S | 4-Hydroxytolbutamide-d9 | 1185112-19-9 | Isotope-Labeled Compounds |
| HY-100642 | 3-O-Methyltolcapone | 134612-80-9 | Reference compound |
| HY-100642R | 3-O-Methyltolcapone (Standard) | 134612-80-9 | Reference Standards |
| HY-100642S | 3-O-Methyltolcapone-d7 | Isotope-Labeled Compounds | |
| HY-100642S1 | 3-O-Methyltolcapone-d4 | 2469274-07-3 | Isotope-Labeled Compounds |
| HY-100644 | Trimethoprim N-oxide | 27653-68-5 | Reference compound |
| HY-100645 | Trimethoprim 3-oxide | 27653-67-4 | Reference compound |
| HY-100646 | (E)-10-Hydroxynortriptyline (maleate) | 74853-74-0 | Reference compound |
| HY-100646A | (Z)-10-Hydroxynortriptyline | 47132-19-4 | Reference compound |
| HY-100646AS | (Z)-10-Hydroxynortriptyline-d3 | Isotope-Labeled Compounds | |
| HY-100647S | N-Desmethyl Nefopam-d4 (hydrochloride) | 2747914-61-8 | Isotope-Labeled Compounds |
| HY-100648 | Keto Ziprasidone | 884305-07-1 | Reference compound |
| HY-100649 | Hydroxy ziprasidone | 884305-08-2 | Reference compound |
| HY-10064R | Ticagrelor (Standard) | 274693-27-5 | Reference Standards |
| HY-10064S | Ticagrelor-d7 | 1265911-55-4 | Isotope-Labeled Compounds |
| HY-10064S1 | Ticagrelor-d4 | 1265911-54-3 | Isotope-Labeled Compounds |
| HY-10065 | Axitinib | 319460-85-0 | Reference compound |
| HY-100650 | Carbodenafil | 944241-52-5 | Reference compound |
| HY-100651 | Desmethylnortriptyline | 4444-42-2 | Reference compound |
| HY-100651R | Desmethylnortriptyline (Standard) | 4444-42-2 | Reference Standards |
| HY-100652A | O-Desmethyl apixaban sulfate (sodium) | Reference compound | |
| HY-100653 | AZD5153 | 1869912-39-9 | Reference compound |
| HY-100653A | AZD5153 (6-Hydroxy-2-naphthoic acid) | 1869912-40-2 | Reference compound |
| HY-100654 | 10-DEBC (hydrochloride) | 925681-41-0 | Reference compound |
| HY-100655 | O-Desmethyl apixaban | 503612-76-8 | Reference compound |
| HY-100655R | O-Desmethyl apixaban (Standard) | 503612-76-8 | Reference Standards |
| HY-100656 | Desmethyl cariprazine | 839712-15-1 | Reference compound |
| HY-100657 | meta-Fexofenadine | 479035-75-1 | Reference compound |
| HY-100657R | meta-Fexofenadine (Standard) | 479035-75-1 | Reference Standards |
| HY-100657S | Meta-Fexofenadine-d6 | Isotope-Labeled Compounds | |
| HY-100658 | Didesmethyl cariprazine | 839712-25-3 | Reference compound |
| HY-100659 | Dihydrodiol-Ibrutinib | 1654820-87-7 | Reference compound |
| HY-100659S | Dihydrodiol-Ibrutinib-d5 | 2068022-09-1 | Isotope-Labeled Compounds |
| HY-10065R | Axitinib (Standard) | 319460-85-0 | Reference Standards |
| HY-10065S | Axitinib-13C,d3 | 1261432-00-1 | Isotope-Labeled Compounds |
| HY-10065S1 | Axitinib-d3 | 1126623-89-9 | Isotope-Labeled Compounds |
| HY-10066 | Nelivaptan | 439687-69-1 | Reference compound |
| HY-100660A | Cetirizine Impurity B (dihydrochloride) | 1000690-91-4 | Reference compound |
| HY-100661 | Cetirizine Impurity D | 346451-15-8 | Reference compound |
| HY-100661R | Cetirizine Impurity D (Standard) | 346451-15-8 | Reference Standards |
| HY-100662 | Didesethyl chloroquine | 4298-14-0 | Reference compound |
| HY-100662S | Didesethyl chloroquine-d4 | 1215797-41-3 | Isotope-Labeled Compounds |
| HY-100663 | Gefitinib impurity 2 | 246512-44-7 | Reference compound |
| HY-100664 | Zopiclone N-oxide | 43200-96-0 | Reference compound |
| HY-100665 | Dehydroaripiprazole | 129722-25-4 | Reference compound |
| HY-100665R | Dehydroaripiprazole (Standard) | 129722-25-4 | Reference Standards |
| HY-100665S | Dehydroaripiprazole-d8 | 2749328-53-6 | Isotope-Labeled Compounds |
| HY-100666 | Fosfluconazole | 194798-83-9 | Reference compound |
| HY-100666R | Fosfluconazole (Standard) | 194798-83-9 | Reference Standards |
| HY-100667 | UBP608 | 2199-87-3 | Reference compound |
| HY-100668 | JYL 1421 | 401907-26-4 | Reference compound |
| HY-100669 | Mycro 3 | 944547-46-0 | Reference compound |
| HY-10067 | Y-33075 | 199433-58-4 | Reference compound |
| HY-100670 | Olinone | 1770789-37-1 | Reference compound |
| HY-100671 | L002 | 321695-57-2 | Reference compound |
| HY-100672 | SR59230A | 174689-39-5 | Reference compound |
| HY-100672B | (2R)-SR59230A | 1932675-95-0 | Reference compound |
| HY-100673 | LM22A-4 | 37988-18-4 | Reference compound |
| HY-100675 | JTE-013 | 383150-41-2 | Reference compound |
| HY-100675R | JTE-013 (Standard) | 383150-41-2 | Reference Standards |
| HY-100676 | GRI977143 | 325850-81-5 | Reference compound |
| HY-100677 | VUF11207 | 1378524-41-4 | Reference compound |
| HY-100678 | CGS 15943 | 104615-18-1 | Reference compound |
| HY-100678R | CGS 15943 (Standard) | 104615-18-1 | Reference Standards |
| HY-100679 | Pirlindole | 60762-57-4 | Reference compound |
| HY-100679A | Pirlindole (mesylate) | 207572-66-5 | Reference compound |
| HY-100679R | Pirlindole (Standard) | 60762-57-4 | Reference Standards |
| HY-100679S | Pirlindole-d4 | 1801646-26-3 | Isotope-Labeled Compounds |
| HY-10068 | Y-33075 (hydrochloride) | 471843-75-1 | Reference compound |
| HY-100681 | GSK2837808A | 1445879-21-9 | Reference compound |
| HY-100682 | T-3256336 | 1266227-69-3 | Reference compound |
| HY-100683 | A12B4C3 | 1005129-80-5 | Reference compound |
| HY-100684 | UAMC-1110 | 1448440-52-5 | Reference compound |
| HY-100685 | MS-444 | 150045-18-4 | Reference compound |
| HY-100686 | U93631 | 152273-12-6 | Reference compound |
| HY-100687 | GNF-PF-3777 | 77603-42-0 | Reference compound |
| HY-100688 | ML390 | 2029049-79-2 | Reference compound |
| HY-100689 | Propyl pyrazole triol | 263717-53-9 | Reference compound |
| HY-100689R | Propyl pyrazole triol (Standard) | 263717-53-9 | Reference Standards |
| HY-10069 | Y-33075 (dihydrochloride) | 173897-44-4 | Reference compound |
| HY-100690 | NSC16168 | 6837-93-0 | Reference compound |
| HY-100691 | NOD-IN-1 | 132819-92-2 | Reference compound |
| HY-100692 | Lin28-let-7a antagonist 1 | 2024548-03-4 | Reference compound |
| HY-100693 | SYP-5 | 1384268-04-5 | Reference compound |
| HY-100694 | GS-9901 | 1640247-87-5 | Reference compound |
| HY-100695 | DDR-TRK-1 | 1934246-19-1 | Reference compound |
| HY-100696 | PNZ5 | 1629277-36-6 | Reference compound |
| HY-100697 | TPOP146 | 2018300-62-2 | Reference compound |
| HY-100699 | Clenproperol | 38339-11-6 | Reference compound |
| HY-100699S | Clenproperol-d7 | 1173021-09-4 | Isotope-Labeled Compounds |
| HY-100701 | Dutacatib | 501000-36-8 | Reference compound |
| HY-100702 | SH-5 | 701976-54-7 | Reference compound |
| HY-100703 | Pipamperone | 1893-33-0 | Reference compound |
| HY-100703A | Pipamperone (dihydrochloride) | 2448-68-2 | Reference compound |
| HY-100703R | Pipamperone (Standard) | 1893-33-0 | Reference Standards |
| HY-100704 | Procaterol (hydrochloride) | 62929-91-3 | Reference compound |
| HY-100704A | (Rac)-Procaterol (hydrochloride) | 59828-07-8 | Reference compound |
| HY-100705 | DMNB | 20357-25-9 | Reference compound |
| HY-100706 | AMA-37 | 404009-46-7 | Reference compound |
| HY-100707 | IC 86621 | 404009-40-1 | Reference compound |
| HY-100708 | NSC632839 | 157654-67-6 | Reference compound |
| HY-100709 | ZPCK | 26049-94-5 | Reference compound |
| HY-10071 | Y-27632 | 146986-50-7 | Reference compound |
| HY-100710 | Epothilone C | 186692-73-9 | Reference compound |
| HY-100711 | Prodigiosin | 82-89-3 | Natural Products |
| HY-100711A | Prodigiosin (hydrochloride) | 56144-17-3 | Natural Products |
| HY-100712 | DPO-1 | 43077-30-1 | Reference compound |
| HY-100713 | Temocapril | 111902-57-9 | Reference compound |
| HY-100713R | Temocapril (Standard) | 111902-57-9 | Reference Standards |
| HY-100713S | Temocapril-d5 | 1356840-03-3 | Isotope-Labeled Compounds |
| HY-100714 | DL-AP5 | 76326-31-3 | Reference compound |
| HY-100714A | D-AP5 | 79055-68-8 | Reference compound |
| HY-100714B | L-AP5 | 79055-67-7 | Reference compound |
| HY-100714C | DL-AP5 (sodium) | 1303993-72-7 | Reference compound |
| HY-100714CR | DL-AP5 (sodium) (Standard) | 1303993-72-7 | Reference Standards |
| HY-100714D | DL-AP5 (lithium) | 125229-62-1 | Reference compound |
| HY-100714R | DL-AP5 (Standard) | 76326-31-3 | Reference Standards |
| HY-100716 | Eganelisib | 1693758-51-8 | Reference compound |
| HY-100717 | HT-2157 | 303149-14-6 | Reference compound |
| HY-100718 | SCH00013 | 217963-18-3 | Reference compound |
| HY-100719 | BRD-6929 | 849234-64-6 | Reference compound |
| HY-10071A | Y-27632 (hydrochloride hydrate) | 331752-47-7 | Reference compound |
| HY-10072 | SPC 839 | 219773-55-4 | Reference compound |
| HY-100720 | GSK2193874 | 1336960-13-4 | Reference compound |
| HY-100721 | GC376 (sodium) | 1416992-39-6 | Reference compound |
| HY-100723 | THK-523 | 1573029-17-0 | Reference compound |
| HY-100724 | YM-17690 | 108806-41-3 | Reference compound |
| HY-100725 | BM212 | 146204-42-4 | Reference compound |
| HY-100725R | BM212 (Standard) | 146204-42-4 | Reference Standards |
| HY-100726 | GNE-272 | 1936428-93-1 | Reference compound |
| HY-100727 | AM-2099 | 1443373-17-8 | Reference compound |
| HY-100728 | BMT-145027 | 2018282-44-3 | Reference compound |
| HY-100729 | GSK9311 | 1923851-49-3 | Reference compound |
| HY-100729A | GSK9311 (hydrochloride) | 2253733-09-2 | Reference compound |
| HY-100731 | Cyclosporin | 79217-60-0 | Natural Products |
| HY-100732 | Cambinol | 14513-15-6 | Reference compound |
| HY-100732R | Cambinol (Standard) | 14513-15-6 | Reference Standards |
| HY-100733 | 4E2RCat | 432499-63-3 | Reference compound |
| HY-100734 | Histone Acetyltransferase Inhibitor II | 932749-62-7 | Reference compound |
| HY-100735 | C 87 | 332420-90-3 | Reference compound |
| HY-100736 | ML348 | 899713-86-1 | Reference compound |
| HY-100737 | ML349 | 890819-86-0 | Reference compound |
| HY-100738 | Ubiquitin Isopeptidase Inhibitor I, G5 | 108477-18-5 | Reference compound |
| HY-100739 | RA190 | 1617495-03-0 | Reference compound |
| HY-10074 | TPCA-1 | 507475-17-4 | Reference compound |
| HY-100740 | Lanabecestat | 1383982-64-6 | Reference compound |
| HY-100740A | Lanabecestat (hydrochloride) | 1383986-31-9 | Reference compound |
| HY-100740B | Lanabecestat (camsylate) | 1522418-41-2 | Reference compound |
| HY-100740C | (1α,1'S,4β)-Lanabecestat | 1384082-96-5 | Reference compound |
| HY-100740R | Lanabecestat (Standard) | 1383982-64-6 | Reference Standards |
| HY-100741 | S63845 | 1799633-27-4 | Reference compound |
| HY-100741A | (S,R)-S63845 | Reference compound | |
| HY-100741C | (R,R)-S63845 | Reference compound | |
| HY-100742 | GNE-140 (racemate) | 1802977-61-2 | Reference compound |
| HY-100742A | (R)-GNE-140 | 2003234-63-5 | Reference compound |
| HY-100742B | (S)-GNE-140 | 2003234-64-6 | Reference compound |
| HY-100743 | DL-AP4 | 6323-99-5 | Reference compound |
| HY-100743R | DL-AP4 (Standard) | 6323-99-5 | Reference Standards |
| HY-100744 | AS8351 | 796-42-9 | Reference compound |
| HY-100746 | STF-62247 | 315702-99-9 | Reference compound |
| HY-100747 | PSB-12379 | 1802226-78-3 | Reference compound |
| HY-100747A | PSB-12379 (disodium) | Reference compound | |
| HY-100748 | Zabadinostat | 934828-12-3 | Reference compound |
| HY-100749 | HeE1-2Tyr | 2245195-67-7 | Reference compound |
| HY-100750 | Norverapamil (hydrochloride) | 67812-42-4 | Reference compound |
| HY-100750R | Norverapamil (hydrochloride) (Standard) | 67812-42-4 | Reference Standards |
| HY-100751 | N-563 | 140686-92-6 | Reference compound |
| HY-100753 | STAT3-IN-1 | 2059952-75-7 | Reference compound |
| HY-100754 | Ritlecitinib | 1792180-81-4 | Reference compound |
| HY-100754A | Ritlecitinib (malonate) | 2140301-97-7 | Reference compound |
| HY-100754B | (2R,5S)-Ritlecitinib | 1792180-79-0 | Reference compound |
| HY-100754C | Ritlecitinib (tosylate) | 2192215-81-7 | Reference compound |
| HY-100755 | KR-33493 | 1021497-97-1 | Reference compound |
| HY-100756 | BAY-826 | 1448316-08-2 | Reference compound |
| HY-100757 | CPUY074020 | 902279-44-1 | Reference compound |
| HY-100758 | FUBP1-IN-1 | 883003-62-1 | Reference compound |
| HY-100759 | JAK2-IN-4 | 1438284-00-4 | Reference compound |
| HY-100760 | Toxoflavin | 84-82-2 | Reference compound |
| HY-100760R | Toxoflavin (Standard) | 84-82-2 | Reference Standards |
| HY-100760S | Toxoflavin-13C4 | 2300178-70-3 | Isotope-Labeled Compounds |
| HY-100761 | SS28 | 141172-08-9 | Reference compound |
| HY-100762 | Mcl1-IN-11 | 2042211-13-0 | Reference compound |
| HY-100763 | Mcl1-IN-12 | 2042211-12-9 | Reference compound |
| HY-100764 | YUKA1 | 708991-09-7 | Reference compound |
| HY-100765 | BI-0252 | 1818291-27-8 | Reference compound |
| HY-100767 | Guanylyl Imidodiphosphate (trisodium) | 148892-91-5 | Biochemical Assay Reagents |
| HY-100768 | HTHQ | 148081-72-5 | Reference compound |
| HY-100768R | HTHQ (Standard) | 148081-72-5 | Reference Standards |
| HY-100769 | Hypidone (hydrochloride) | 1339058-04-6 | Reference compound |
| HY-100771 | PCC0208009 | 1668565-74-9 | Reference compound |
| HY-100775 | Fezagepras (sodium) | 1254472-97-3 | Reference compound |
| HY-100775A | Fezagepras | 1002101-19-0 | Reference compound |
| HY-100775AR | Fezagepras (Standard) | 1002101-19-0 | Reference Standards |
| HY-100775R | Fezagepras (sodium) (Standard) | 1254472-97-3 | Reference Standards |
| HY-100777 | DACA | 89459-25-6 | Reference compound |
| HY-100777R | DACA (Standard) | 89459-25-6 | Reference Standards |
| HY-100778 | SMM-189 | 1054451-07-8 | Reference compound |
| HY-100779 | Rimacalib | 215174-50-8 | Reference compound |
| HY-100781 | D-AP4 | 78739-01-2 | Reference compound |
| HY-100781A | L-AP4 | 23052-81-5 | Reference compound |
| HY-100781B | L-AP4 (monohydrate) | 2247534-79-6 | Reference compound |
| HY-100782 | DL-AP7 | 85797-13-3 | Reference compound |
| HY-100783 | (-)-Bicuculline (methobromide) | 73604-30-5 | Reference compound |
| HY-100783A | (+)-Bicuculline (methochloride) | 53552-05-9 | Reference compound |
| HY-100783B | Bicuculline (methobromide) | 66016-70-4 | Reference compound |
| HY-100784 | Dihydrokainic acid | 52497-36-6 | Reference compound |
| HY-100784R | Dihydrokainic acid (Standard) | 52497-36-6 | Reference Standards |
| HY-100785 | gamma-DGG | 6729-55-1 | Reference compound |
| HY-100785A | gamma-DGG (acetate) | 2935387-13-4 | Reference compound |
| HY-100786 | DL-AP3 | 5652-28-8 | Reference compound |
| HY-100787 | L-Cysteine S-sulfate (sodium) | 7381-67-1 | Reference compound |
| HY-100788 | 2-PMPA | 173039-10-6 | Reference compound |
| HY-100788C | 2-PMPA (sodium) | 373645-42-2 | Reference compound |
| HY-100788R | 2-PMPA (Standard) | 173039-10-6 | Reference Standards |
| HY-100789 | ON1231320 | 1312471-39-8 | Reference compound |
| HY-10079 | CHS-828 | 200484-11-3 | Reference compound |
| HY-100790 | Ciliobrevin A | 302803-72-1 | Reference compound |
| HY-100791 | NSC23005 (sodium) | 1796596-46-7 | Reference compound |
| HY-100792 | URB602 | 565460-15-3 | Reference compound |
| HY-100792R | URB602 (Standard) | 565460-15-3 | Reference Standards |
| HY-100793 | SR12813 | 126411-39-0 | Reference compound |
| HY-100794 | GR127935 (hydrochloride) | 148642-42-6 | Reference compound |
| HY-100795 | Pirmenol | 68252-19-7 | Reference compound |
| HY-100795A | Pirmenol (hydrochloride) | 61477-94-9 | Reference compound |
| HY-100796 | Guanoclor | 5001-32-1 | Reference compound |
| HY-100797 | (RS)-CPP | 100828-16-8 | Reference compound |
| HY-100798 | Phaclofen | 114012-12-3 | Reference compound |
| HY-100799 | ZAPA (sulfate) | 371962-01-5 | Reference compound |
| HY-10079A | CHS-828 (nicotinate) | 1160589-73-0 | Reference compound |
| HY-10079R | CHS-828 (Standard) | 200484-11-3 | Reference Standards |
| HY-10080 | Teglarinad (chloride) | 432037-57-5 | Reference compound |
| HY-100800 | TACA | 38090-53-8 | Reference compound |
| HY-100801 | L-threo-3-Hydroxyaspartic acid | 7298-99-9 | Reference compound |
| HY-100801A | DL-threo-3-Hydroxyaspartic acid | 4294-45-5 | Peptides |
| HY-100801R | L-threo-3-Hydroxyaspartic acid (Standard) | 7298-99-9 | Reference Standards |
| HY-100802 | Homoquinolinic acid | 490-75-5 | Reference compound |
| HY-100803 | Hypotaurine | 300-84-5 | Natural Products |
| HY-100803R | Hypotaurine (Standard) | 300-84-5 | Reference Standards |
| HY-100804 | L-Cysteinesulfinic acid | 1115-65-7 | Natural Products |
| HY-100804R | L-Cysteinesulfinic acid (Standard) | 1115-65-7 | Reference Standards |
| HY-100805 | D-Glutamic acid | 6893-26-1 | Natural Products |
| HY-100805R | D-Glutamic acid (Standard) | 6893-26-1 | Reference Standards |
| HY-100805S | D-Glutamic acid-d5 | 14341-88-9 | Isotope-Labeled Compounds |
| HY-100805S1 | D-Glutamic acid-13C5,15N | 1202063-56-6 | Isotope-Labeled Compounds |
| HY-100805S2 | D-Glutamic acid-13C5 | 1202063-54-4 | Isotope-Labeled Compounds |
| HY-100806 | Kynurenic acid | 492-27-3 | Natural Products |
| HY-100806R | Kynurenic acid (Standard) | 492-27-3 | Reference Standards |
| HY-100806S | Kynurenic acid-d5 | 350820-13-2 | Isotope-Labeled Compounds |
| HY-100807 | Quinolinic acid | 89-00-9 | Natural Products |
| HY-100807R | Quinolinic acid (Standard) | 89-00-9 | Reference Standards |
| HY-100807S | Quinolinic acid-d3 | 138946-42-6 | Isotope-Labeled Compounds |
| HY-100807S1 | Quinolinic acid-13C7 | 1346642-91-8 | Isotope-Labeled Compounds |
| HY-100807S2 | Quinolinic acid-13C4,15N | Isotope-Labeled Compounds | |
| HY-100808 | D-Serine | 312-84-5 | Natural Products |
| HY-100808R | D-Serine (Standard) | 312-84-5 | Reference Standards |
| HY-100808S | D-Serine-d3 | 1414348-52-9 | Isotope-Labeled Compounds |
| HY-100809 | Guvacine hydrochloride | 6027-91-4 | Natural Products |
| HY-10081 | GS-6201 | 752222-83-6 | Reference compound |
| HY-100810 | Isoguvacine (hydrochloride) | 68547-97-7 | Reference compound |
| HY-100811 | 7-Chlorokynurenic acid | 18000-24-3 | Reference compound |
| HY-100811A | 7-Chlorokynurenic acid (sodium salt) | 1263094-00-3 | Reference compound |
| HY-100811AR | 7-Chlorokynurenic acid (sodium salt) (Standard) | 1263094-00-3 | Reference Standards |
| HY-100811R | 7-Chlorokynurenic acid (Standard) | 18000-24-3 | Reference Standards |
| HY-100812 | 2-Hydroxysaclofen | 117354-64-0 | Reference compound |
| HY-100813 | Saclofen | 125464-42-8 | Reference compound |
| HY-100813R | Saclofen (Standard) | 125464-42-8 | Reference Standards |
| HY-100814 | (R)-CPP | 126453-07-4 | Reference compound |
| HY-100815 | (R)-AMPA | 83654-13-1 | Reference compound |
| HY-100815A | (S)-AMPA | 83643-88-3 | Reference compound |
| HY-100815B | (RS)-AMPA | 77521-29-0 | Reference compound |
| HY-100815BR | (RS)-AMPA (Standard) | 77521-29-0 | Reference Standards |
| HY-100815C | (RS)-AMPA (hydrobromide) | 171259-81-7 | Reference compound |
| HY-100815D | (RS)-AMPA (monohydrate) | 76463-67-7 | Reference compound |
| HY-100815E | (RS)-AMPA (hydrochloride) | 2922283-04-1 | Reference compound |
| HY-100816 | Rbin-1 | 328023-11-6 | Reference compound |
| HY-100817 | Rbin-2 | 2032282-97-4 | Reference compound |
| HY-100818 | Futibatinib | 1448169-71-8 | Reference compound |
| HY-100818R | Futibatinib (Standard) | 1448169-71-8 | Reference Standards |
| HY-10082 | Triapine | 143621-35-6 | Reference compound |
| HY-100820 | Sarizotan | 351862-32-3 | Reference compound |
| HY-100820A | Sarizotan (hydrochloride) | 195068-07-6 | Reference compound |
| HY-100820B | Sarizotan (dihydrochloride) | 177976-12-4 | Reference compound |
| HY-100820R | Sarizotan (Standard) | 351862-32-3 | Reference Standards |
| HY-100821 | 2,4-Dihydroxyphenylacetylasparagine | 111872-98-1 | Natural Products |
| HY-100822 | (R)-(+)-HA-966 | 123931-04-4 | Reference compound |
| HY-100822A | (S)-(-)-HA 966 | 111821-58-0 | Reference compound |
| HY-100823 | (1S,3R)-ACPD | 111900-32-4 | Reference compound |
| HY-100824 | PP2 Analog | 309739-67-1 | Reference compound |
| HY-100825 | OABK (hydrochloride) | 1984862-48-7 | Reference compound |
| HY-100826 | TN1 | 289479-94-3 | Reference compound |
| HY-100827 | Safotibant | 633698-99-4 | Reference compound |
| HY-100828 | BGP-15 | 66611-37-8 | Reference compound |
| HY-10082A | (E)-3-AP | 200933-27-3 | Reference compound |
| HY-10082B | Triapine (hydrochloride) | 216240-62-9 | Reference compound |
| HY-10082S1 | Triapine-d3 | Isotope-Labeled Compounds | |
| HY-100830 | NCB-0846 | 1792999-26-8 | Reference compound |
| HY-100830A | NCB-0970 | 2749881-54-5 | Reference compound |
| HY-100831 | YM-58483 | 223499-30-7 | Reference compound |
| HY-100831R | YM-58483 (Standard) | 223499-30-7 | Reference Standards |
| HY-100832 | UNC3866 | 1872382-47-2 | Peptides |
| HY-100832A | UNC3866 (TFA) | 1872382-48-3 | Peptides |
| HY-100833 | Antibiotic-5d | 251349-54-9 | Reference compound |
| HY-100833R | Antibiotic-5d (Standard) | 251349-54-9 | Reference Standards |
| HY-100834 | 5,7-Dichlorokynurenic acid | 131123-76-7 | Reference compound |
| HY-100834A | 5,7-Dichlorokynurenic acid (sodium) | 1184986-70-6 | Reference compound |
| HY-100834R | 5,7-Dichlorokynurenic acid (Standard) | 131123-76-7 | Reference Standards |
| HY-100835 | N-(4-Hydroxyphenylacetyl)spermine | 130210-32-1 | Reference compound |
| HY-100836 | trans-4-Carboxy-L-proline | 64769-66-0 | Natural Products |
| HY-100837 | 5-Iodowillardiine | 140187-25-3 | Reference compound |
| HY-100838 | cis-α-(Carboxycyclopropyl)glycine | 117857-95-1 | Reference compound |
| HY-100838A | L-CCG-I | 117857-93-9 | Reference compound |
| HY-100839 | (RS)-(Tetrazol-5-yl)glycine | 138199-51-6 | Reference compound |
| HY-10084 | CK0106023 | 336115-72-1 | Reference compound |
| HY-100840 | (S)-4C3HPG | 85148-82-9 | Reference compound |
| HY-100840A | (RS)-4C3HPG | 134052-66-7 | Reference compound |
| HY-100841 | (Rac)-3-Hydroxyphenylglycine | 31932-87-3 | Reference compound |
| HY-100841A | (S)-3-Hydroxyphenylglycine | 71301-82-1 | Reference compound |
| HY-100842 | (R)-3C4HPG | 13861-03-5 | Reference compound |
| HY-100842A | (S)-3C4HPG | 55136-48-6 | Reference compound |
| HY-100843 | L-AP6 | 78944-89-5 | Reference compound |
| HY-100844 | GS-444217 | 1262041-49-5 | Reference compound |
| HY-100845 | Salvinorin A | 83729-01-5 | Reference compound |
| HY-100846 | JQEZ5 | 1913252-04-6 | Reference compound |
| HY-100847 | AZ0108 | 1825345-52-5 | Reference compound |
| HY-100848 | TX1-85-1 | 1603845-32-4 | Reference compound |
| HY-100849 | JAK 3i | 1918238-72-8 | Reference compound |
| HY-100850 | Piperoxan (hydrochloride) | 135-87-5 | Reference compound |
| HY-100851 | LY-272015 | 159730-07-1 | Reference compound |
| HY-100851A | LY-272015 (hydrochloride) | 172895-15-7 | Reference compound |
| HY-100852 | ER-000444793 | 792957-74-5 | Reference compound |
| HY-100853 | IWP-O1 | 2074607-48-8 | Reference compound |
| HY-100855 | DC_C66 | 108181-00-6 | Reference compound |
| HY-100856 | PCO371 | 1613373-33-3 | Reference compound |
| HY-100857 | PrPSc-IN-1 | 1315475-30-9 | Dye Reagents |
| HY-100858 | PP7 | 433238-84-7 | Reference compound |
| HY-100859 | LSD1-IN-5 | 2035912-55-9 | Reference compound |
| HY-100860 | LSD1-IN-6 | 2035912-43-5 | Reference compound |
| HY-100861 | C-11 | 2007965-97-9 | ADC Related |
| HY-100862 | BRCA1-IN-2 | 1622262-55-8 | Reference compound |
| HY-100863 | BRCA1-IN-1 | 1622262-74-1 | Reference compound |
| HY-100864 | mPGES1-IN-3 | 1469976-70-2 | Reference compound |
| HY-100865 | BPR1K871 | 2443767-35-7 | Reference compound |
| HY-100866 | F1324 | 2607975-44-8 | Peptides |
| HY-100866A | F1324 (TFA) | Peptides | |
| HY-100866B | F1324 (acetate) | Peptides | |
| HY-100867 | Mivavotinib | 1312691-33-0 | Reference compound |
| HY-100867A | Mivavotinib (monohydrochloride) | 1952251-28-3 | Reference compound |
| HY-100869 | MM-589 | 2097887-20-0 | Reference compound |
| HY-100869A | MM-589 (TFA) | 2253167-09-6 | Reference compound |
| HY-100869B | MM-589 (racemic mixture ) (TFA) | Reference compound | |
| HY-10087 | Navitoclax | 923564-51-6 | Reference compound |
| HY-100870 | Obefazimod | 1258453-75-6 | Reference compound |
| HY-100871 | WT-161 | 1206731-57-8 | Reference compound |
| HY-100872 | KRIBB11 | 342639-96-7 | Reference compound |
| HY-100873 | PF-1355 | 1435467-38-1 | Reference compound |
| HY-100874 | N3-PEG3-vc-PAB-MMAE | ADC Related | |
| HY-100875 | Bisantrene | 78186-34-2 | Reference compound |
| HY-100875A | Bisantrene (dihydrochloride) | 71439-68-4 | Reference compound |
| HY-100875R | Bisantrene (Standard) | 78186-34-2 | Reference Standards |
| HY-100876 | GGTI298 | 180977-44-0 | Reference compound |
| HY-100877 | GCN2-IN-1 | 1448693-69-3 | Reference compound |
| HY-10087A1 | Navitoclax (dihydrochloride) | 1093851-28-5 | Reference compound |
| HY-10087R | Navitoclax (Standard) | 923564-51-6 | Reference Standards |
| HY-10087S | Navitoclax-d8 | 1217620-38-6 | Isotope-Labeled Compounds |
| HY-10088 | Zibotentan | 186497-07-4 | Reference compound |
| HY-100881 | TUG-891 | 1374516-07-0 | Reference compound |
| HY-100881R | TUG-891 (Standard) | 1374516-07-0 | Reference Standards |
| HY-100882 | ONO-7300243 | 638132-34-0 | Reference compound |
| HY-100885 | Acelarin | 840506-29-8 | Reference compound |
| HY-100886 | BAY1082439 | 1375469-38-7 | Reference compound |
| HY-100887 | Piperazine Erastin | 1538593-71-3 | Reference compound |
| HY-100888 | Simurosertib | 1330782-76-7 | Reference compound |
| HY-100888A | (R)-Simurosertib | 1330782-69-8 | Reference compound |
| HY-10088R | Zibotentan (Standard) | 186497-07-4 | Reference Standards |
| HY-100891 | CD80-IN-3 | 486449-65-4 | Reference compound |
| HY-100892 | MX69 | 1005264-47-0 | Reference compound |
| HY-100894 | Biotin-VAD-FMK | 1135688-15-1 | Biochemical Assay Reagents |
| HY-100895 | SAR-20347 | 1450881-55-6 | Reference compound |
| HY-100897 | Sulodexide | 57821-29-1 | Reference compound |
| HY-100898 | OGT 2115 | 853929-59-6 | Reference compound |
| HY-100899 | Heparastatin | 153758-25-9 | Reference compound |
| HY-100900 | ML364 | 1991986-30-1 | Reference compound |
| HY-100901 | CDD3505 | 173865-33-3 | Reference compound |
| HY-100902 | CDD3506 | 197913-15-8 | Reference compound |
| HY-100903 | Norbinaltorphimine dihydrochloride | 113158-34-2 | Reference compound |
| HY-100904 | RX 801077 (hydrochloride) | 89196-95-2 | Reference compound |
| HY-100904A | RX 801077 | 72583-92-7 | Reference compound |
| HY-100906 | 1,1-Dimethyl-4-acetylpiperazinium (iodide) | 75667-84-4 | Reference compound |
| HY-100907 | (±)-Acetylcarnitine (chloride) | 2504-11-2 | Reference compound |
| HY-100908 | N-Acetyltryptamine | 1016-47-3 | Reference compound |
| HY-100908R | N-Acetyltryptamine (Standard) | 1016-47-3 | Reference Standards |
| HY-100910 | W-13 (hydrochloride) | 88519-57-7 | Reference compound |
| HY-100911 | W-5 (hydrochloride) | 61714-25-8 | Reference compound |
| HY-100912 | W-7 (hydrochloride) | 61714-27-0 | Reference compound |
| HY-100913 | W-7 (isomer hydrochloride) | 69762-85-2 | Reference compound |
| HY-100914 | A-7 (hydrochloride) | 79127-24-5 | Reference compound |
| HY-100915 | SKF 97541 | 127729-35-5 | Reference compound |
| HY-100916 | Arecaidine-propargyl ester (tosylate) | 147202-94-6 | Reference compound |
| HY-100919 | Ambenonium (chloride) | 115-79-7 | Reference compound |
| HY-100919R | Ambenonium (chloride) (Standard) | 115-79-7 | Reference Standards |
| HY-100920 | Arcaine (sulfate) | 14923-17-2 | Reference compound |
| HY-100921 | Spaglumic Acid | 3106-85-2 | Natural Products |
| HY-100921A | Spaglumic Acid (trisodium) | 57096-28-3 | Reference compound |
| HY-100921R | Spaglumic Acid (Standard) | 3106-85-2 | Reference Standards |
| HY-100922 | N-Acetylglycyl-D-glutamic acid | 135701-69-8 | Reference compound |
| HY-100923 | H-9 (Dihydrochloride) | 116700-36-8 | Reference compound |
| HY-100924 | β-CCB | 84454-35-3 | Reference compound |
| HY-100925 | Binospirone (hydrochloride) | 102908-60-1 | Reference compound |
| HY-100927 | Ro 20-1724 | 29925-17-5 | Reference compound |
| HY-100927R | Ro 20-1724 (Standard) | 29925-17-5 | Reference Standards |
| HY-100928 | YS 035 (hydrochloride) | 89805-39-0 | Reference compound |
| HY-100929 | GBR-12879 (dihydrochloride) | 67469-45-8 | Reference compound |
| HY-100930 | L-693403 (maleate) | 207455-21-8 | Reference compound |
| HY-100931 | SC-10 | 102649-79-6 | Reference compound |
| HY-100932 | ML-9 | 105637-50-1 | Reference compound |
| HY-100932A | ML-9 (Free Base) | 110448-31-2 | Reference compound |
| HY-100933 | MY-5445 | 78351-75-4 | Reference compound |
| HY-100934 | SC-9 | 102649-78-5 | Reference compound |
| HY-100935 | Cimaterol | 54239-37-1 | Reference compound |
| HY-100935R | Cimaterol (Standard) | 54239-37-1 | Reference Standards |
| HY-100935S | Cimaterol-d7 | 1228182-44-2 | Isotope-Labeled Compounds |
| HY-100936 | Etazolate (hydrochloride) | 35838-58-5 | Reference compound |
| HY-100936R | Etazolate (hydrochloride) (Standard) | 35838-58-5 | Reference Standards |
| HY-100937 | DPCPX | 102146-07-6 | Reference compound |
| HY-100937R | DPCPX (Standard) | 102146-07-6 | Reference Standards |
| HY-100937S | DPCPX-d4 | Isotope-Labeled Compounds | |
| HY-100938 | m-CPBG (hydrochloride) | 2113-05-5 | Reference compound |
| HY-100939 | 4-Chlorophenylguanidine (hydrochloride) | 14279-91-5 | Reference compound |
| HY-100940 | 6-Chloromelatonin | 63762-74-3 | Reference compound |
| HY-100941 | CCCP | 555-60-2 | Reference compound |
| HY-100941R | CCCP (Standard) | 555-60-2 | Reference Standards |
| HY-100942 | 5-Carboxamidotryptamine (maleate) | 74885-72-6 | Reference compound |
| HY-100943 | Cinanserin (hydrochloride) | 54-84-2 | Reference compound |
| HY-100944 | Conduritol B epoxide | 6090-95-5 | Reference compound |
| HY-100945 | Nitrocaramiphen (hydrochloride) | 98636-73-8 | Reference compound |
| HY-100946 | CEP-40783 | 1437321-24-8 | Reference compound |
| HY-100947 | VH-298 | 2097381-85-4 | Reference compound |
| HY-100947A | cis VH-298 | 2097381-86-5 | Reference compound |
| HY-100948 | ATM-3507 | 1861449-70-8 | Reference compound |
| HY-100948B | ATM-3507 (trihydrochloride) | 2438679-30-0 | Reference compound |
| HY-100949 | EC330 | 2016795-77-8 | Reference compound |
| HY-10095 | Olcegepant | 204697-65-4 | Reference compound |
| HY-100950 | ABC1183 | 1042735-18-1 | Reference compound |
| HY-100951 | Beaucage reagent | 66304-01-6 | Reference compound |
| HY-100952 | Nifenalol (hydrochloride) | 5704-60-9 | Reference compound |
| HY-100953 | CYM-5520 | 1449747-00-5 | Reference compound |
| HY-100954 | 2,4-Diamino-6-hydroxypyrimidine | 56-06-4 | Reference compound |
| HY-100954R | 2,4-Diamino-6-hydroxypyrimidine (Standard) | 56-06-4 | Reference Standards |
| HY-100955 | DL-Decanoylcarnitine (chloride) | 18822-87-2 | Reference compound |
| HY-100956 | Flurofamide | 70788-28-2 | Reference compound |
| HY-100957 | Dilazep (dihydrochloride) | 20153-98-4 | Reference compound |
| HY-100957R | Dilazep (dihydrochloride) (Standard) | 20153-98-4 | Reference Standards |
| HY-100958 | 4-DAMP | 1952-15-4 | Reference compound |
| HY-100959 | 3,5-Dinitrocatechol | 7659-29-2 | Reference compound |
| HY-100959R | 3,5-Dinitrocatechol (Standard) | 7659-29-2 | Reference Standards |
| HY-10095A | Olcegepant (hydrochloride) | 586368-06-1 | Reference compound |
| HY-10096 | TCS2002 | 1005201-24-0 | Reference compound |
| HY-100960 | Dioctanoylglycol | 627-86-1 | Reference compound |
| HY-100961 | NPC 200 | 85872-53-3 | Reference compound |
| HY-100962 | (E)-AG 99 | 122520-85-8 | Reference compound |
| HY-100962A | AG 99 | 118409-59-9 | Reference compound |
| HY-100963 | U-54494A | 112465-94-8 | Reference compound |
| HY-100964S | N(1),N(12)-Diethylspermine-d10 (tetrahydrochloride) | Isotope-Labeled Compounds | |
| HY-100965 | Diphenyleneiodonium chloride | 4673-26-1 | Reference compound |
| HY-100966 | BD-1008 (dihydrobromide) | 138356-09-9 | Reference compound |
| HY-100966S | BD-1008-d5 (dihydrobromide) | Isotope-Labeled Compounds | |
| HY-100967 | SKF 91488 (dihydrochloride) | 68941-21-9 | Reference compound |
| HY-100968 | GBR 12783 (dihydrochloride) | 67469-75-4 | Reference compound |
| HY-100969 | EBPC | 4450-98-0 | Reference compound |
| HY-100970 | 4F 4PP (oxalate) | 144734-36-1 | Reference compound |
| HY-100971 | Spiramide | 510-74-7 | Natural Products |
| HY-100972 | ARV-771 | 1949837-12-0 | Reference compound |
| HY-100973 | Adenosine 5′-diphosphoribose | 20762-30-5 | Reference compound |
| HY-100973A | Adenosine 5′-diphosphoribose (sodium) | 68414-18-6 | Reference compound |
| HY-100973AR | Adenosine 5′-diphosphoribose (sodium) (Standard) | 68414-18-6 | Reference Standards |
| HY-100973R | Adenosine 5′-diphosphoribose (Standard) | 20762-30-5 | Reference Standards |
| HY-100975 | TB5 | 948841-07-4 | Reference compound |
| HY-100976 | LUF6283 | 92933-48-7 | Reference compound |
| HY-100977 | Dimethoxycurcumin | 160096-59-3 | Reference compound |
| HY-100977S | Dimethoxycurcumin-d6 | 3006902-95-7 | Isotope-Labeled Compounds |
| HY-100978 | (±)-Hexanoylcarnitine (chloride) | 6920-35-0 | Reference compound |
| HY-100979 | W-84 (dibromide) | 21093-51-6 | Reference compound |
| HY-100980 | HEAT (hydrochloride) | 30007-39-7 | Reference compound |
| HY-100981 | MR-16728 (hydrochloride) | 207403-36-9 | Reference compound |
| HY-100982 | (E)-4-Hydroxycrotonic acid | 24587-49-3 | Reference compound |
| HY-100983 | Protein kinase inhibitor H-7 (dihydrochloride) | 108930-17-2 | Reference compound |
| HY-100983R | Protein kinase inhibitor H-7 (dihydrochloride) (Standard) | 108930-17-2 | Reference Standards |
| HY-100984 | HA-100 | 84468-24-6 | Reference compound |
| HY-100984A | HA-100 (hydrochloride) | 141543-63-7 | Reference compound |
| HY-100985 | IPAG | 193527-91-2 | Reference compound |
| HY-100986 | L-NIO (dihydrochloride) | 159190-44-0 | Reference compound |
| HY-100986B | L-NIO | 36889-13-1 | Reference compound |
| HY-100987 | Lauroylcarnitine (chloride) | 14919-37-0 | Reference compound |
| HY-100990 | MMPX | 78033-08-6 | Reference compound |
| HY-100991 | FG 7142 | 78538-74-6 | Reference compound |
| HY-100991R | FG 7142 (Standard) | 78538-74-6 | Reference Standards |
| HY-100993 | α-Methylserotonin (maleate) | 97469-12-0 | Reference compound |
| HY-100994 | N-Methylquipazine (maleate) | 171205-17-7 | Reference compound |
| HY-100996 | 10074-G5 | 413611-93-5 | Reference compound |
| HY-100997 | Chloroorienticin A | 118395-73-6 | Reference compound |
| HY-100998 | Metaphit | 96316-00-6 | Reference compound |
| HY-100998A | Metaphit (methylsulfate) | 99287-12-4 | Reference compound |
| HY-100999 | (R)-(-)-α-Methylhistamine (dihydrobromide) | 868698-49-1 | Reference compound |
| HY-101000 | Clazuril | 101831-36-1 | Reference compound |
| HY-101000R | Clazuril (Standard) | 101831-36-1 | Reference Standards |
| HY-101002 | Sarcosinamide chloroethylnitrosourea | 81965-43-7 | Reference compound |
| HY-101004 | PCA 4248 | 123875-01-4 | Reference compound |
| HY-101005 | N-Methylhistamine (dihydrochloride) | 16503-22-3 | Reference compound |
| HY-101006 | Methyl 2,5-dihydroxycinnamate | 63177-57-1 | Reference compound |
| HY-101006R | Methyl 2,5-dihydroxycinnamate (Standard) | 63177-57-1 | Reference Standards |
| HY-101007A | (+)-Tyrphostin B44 | 133550-37-5 | Reference compound |
| HY-101009 | Methiothepin (maleate) | 19728-88-2 | Reference compound |
| HY-101010 | Methylfurmethide (iodide) | 1197-60-0 | Reference compound |
| HY-101011 | Naloxonazine (dihydrochloride) | 880759-65-9 | Reference compound |
| HY-101012 | NPPB | 107254-86-4 | Reference compound |
| HY-101012R | NPPB (Standard) | 107254-86-4 | Reference Standards |
| HY-101013 | D-SNAP | 79032-48-7 | Dye Reagents |
| HY-101014 | Octanoylcarnitine (chloride) | 14919-35-8 | Reference compound |
| HY-101015 | (2E)-OBAA | 221632-26-4 | Reference compound |
| HY-101015A | OBAA | 134531-42-3 | Reference compound |
| HY-101016 | 17-ODYA | 34450-18-5 | Reference compound |
| HY-101016R | 17-ODYA (Standard) | 34450-18-5 | Reference Standards |
| HY-101017 | Palmitoylcarnitine (chloride) | 6865-14-1 | Reference compound |
| HY-101017A | D-Palmitoylcarnitine (chloride) | 28330-02-1 | Natural Products |
| HY-101017R | Palmitoylcarnitine (chloride) (Standard) | 6865-14-1 | Reference Standards |
| HY-101018 | Propionyl-DL-carnitine (chloride) | 18828-58-5 | Reference compound |
| HY-101018R | Propionyl-DL-carnitine (chloride) (Standard) | 18828-58-5 | Reference Standards |
| HY-101019 | Ossirene | 106566-58-9 | Reference compound |
| HY-101020 | Picolinamide | 1452-77-3 | Reference compound |
| HY-101020R | Picolinamide (Standard) | 1452-77-3 | Reference Standards |
| HY-101021 | Ascochlorin | 26166-39-2 | Natural Products |
| HY-101022 | CXCR2-IN-1 | 1873376-49-8 | Reference compound |
| HY-101023 | MK-8617 | 1187990-87-9 | Reference compound |
| HY-101024 | PF-06263276 | 1421502-62-6 | Reference compound |
| HY-101025 | Nrf2-IN-1 | 1610022-76-8 | Reference compound |
| HY-101026 | CCT251236 | 1693731-40-6 | Reference compound |
| HY-101027 | GSK 4027 | 2079896-25-4 | Reference compound |
| HY-101027A | GSK4028 | 2079886-19-2 | Reference compound |
| HY-101028 | ZINC13466751 | 117953-17-0 | Reference compound |
| HY-101029 | MBM-55 | 2083622-09-5 | Reference compound |
| HY-101029A | MBM-55S | 2083624-07-9 | Reference compound |
| HY-101030 | MBM-17 | 2083621-90-1 | Reference compound |
| HY-101030A | MBM-17S | 2083621-91-2 | Reference compound |
| HY-101031 | c-Met-IN-1 | 2084836-84-8 | Reference compound |
| HY-101032 | RIPA-56 | 1956370-21-0 | Reference compound |
| HY-101033 | GPR35 agonist 1 | 2079880-92-3 | Reference compound |
| HY-101034 | CHMFL-ABL/KIT-155 | 2081093-21-0 | Reference compound |
| HY-101035 | LOM612 | 2173232-79-4 | Reference compound |
| HY-101036 | Choline (bitartrate) | 87-67-2 | Natural Products |
| HY-101036R | Choline (bitartrate) (Standard) | 87-67-2 | Reference Standards |
| HY-101037 | Sarcosine | 107-97-1 | Natural Products |
| HY-101037R | Sarcosine (Standard) | 107-97-1 | Reference Standards |
| HY-101037S | Sarcosine-15N | Isotope-Labeled Compounds | |
| HY-101037S1 | Sarcosine-d3 | 118685-91-9 | Isotope-Labeled Compounds |
| HY-101038 | ZK 756326 | 874911-96-3 | Reference compound |
| HY-101038A | ZK756326 (dihydrochloride) | 1780259-94-0 | Reference compound |
| HY-101039 | AR-M 1000390 | 209808-01-5 | Reference compound |
| HY-101039A | AR-M 1000390 (hydrochloride) | 209808-47-9 | Reference compound |
| HY-101040 | Telacebec | 1334719-95-7 | Reference compound |
| HY-101040A | Telacebec (ditosylate) | 1566517-83-6 | Reference compound |
| HY-101040R | Telacebec (Standard) | 1334719-95-7 | Reference Standards |
| HY-101041 | (E)-AG 556 | 133550-41-1 | Reference compound |
| HY-101042 | AG-494 | 133550-35-3 | Reference compound |
| HY-101043 | 4-PPBP (maleate) | 201216-39-9 | Reference compound |
| HY-101044 | PPADS (tetrasodium) | 192575-19-2 | Reference compound |
| HY-101045 | AT-112 | 139047-55-5 | Reference compound |
| HY-101046 | Azaperone (dimaleate) | 150323-78-7 | Reference compound |
| HY-101047 | D-erythro-Sphingosine | 123-78-4 | Natural Products |
| HY-101047R | D-erythro-Sphingosine (Standard) | 123-78-4 | Reference Standards |
| HY-101047S | D-erythro-Sphingosine-d7 | 1246304-34-6 | Isotope-Labeled Compounds |
| HY-101047S1 | D-erythro-Sphingosine-13C2,d2 | 2692623-81-5 | Isotope-Labeled Compounds |
| HY-101048 | Synthalin A (sulfate) | 182285-12-7 | Reference compound |
| HY-101049 | CGS 12066 (dimaleate) | 109028-10-6 | Reference compound |
| HY-101050 | Tropanserin | 85181-40-4 | Reference compound |
| HY-101051 | 2-TEDC | 132465-10-2 | Reference compound |
| HY-101052 | HTMT (dimaleate) | 195867-54-0 | Reference compound |
| HY-101053 | Src Inhibitor 1 | 179248-59-0 | Reference compound |
| HY-101054 | NQ301 | 130089-98-4 | Reference compound |
| HY-101055 | Kinetin riboside | 4338-47-0 | Reference compound |
| HY-101055R | Kinetin riboside (Standard) | 4338-47-0 | Reference Standards |
| HY-101055S | Kinetin riboside-d5 | Isotope-Labeled Compounds | |
| HY-101056 | Brensocatib | 1802148-05-5 | Reference compound |
| HY-101058 | PD1-PDL1-IN 1 | 2005454-12-4 | Reference compound |
| HY-101058A | PD1-PDL1-IN 1 (TFA) | Reference compound | |
| HY-101059 | FGIN 1-27 | 142720-24-9 | Reference compound |
| HY-101059R | FGIN 1-27 (Standard) | 142720-24-9 | Reference Standards |
| HY-101060 | FGIN 1-43 | 145040-29-5 | Reference compound |
| HY-101061 | 2-MPMDQ | 149847-77-8 | Reference compound |
| HY-101062 | 3-AQC | 201216-42-4 | Reference compound |
| HY-101063 | Amthamine (dihydrobromide) | 142457-00-9 | Reference compound |
| HY-101064 | Fmoc-leucine | 35661-60-0 | Reference compound |
| HY-101064S | Fmoc-leucine-13C | 202114-53-2 | Isotope-Labeled Compounds |
| HY-101064S1 | Fmoc-leucine-13C6,15N | 1163133-36-5 | Isotope-Labeled Compounds |
| HY-101064S2 | Fmoc-leucine-d3 | 538372-74-6 | Isotope-Labeled Compounds |
| HY-101064S3 | Fmoc-leucine-d10 | 1190594-22-9 | Isotope-Labeled Compounds |
| HY-101064S4 | Fmoc-leucine-15N | 200937-57-1 | Isotope-Labeled Compounds |
| HY-101065 | AJ-76 (hydrochloride) | 85378-82-1 | Reference compound |
| HY-101068 | TOFA | 54857-86-2 | Reference compound |
| HY-101069 | Y-26763 | 127408-31-5 | Reference compound |
| HY-101070 | SMCC-DM1 | 1228105-51-8 | ADC Related |
| HY-101071 | (S)-Monastrol | 254753-54-3 | Reference compound |
| HY-101071A | Monastrol | 329689-23-8 | Reference compound |
| HY-101073 | Salermide | 1105698-15-4 | Reference compound |
| HY-101074 | UCM 608 | 151889-03-1 | Reference compound |
| HY-101075 | L-690330 | 142523-38-4 | Reference compound |
| HY-101075A | L-690330 (hydrate) | 2930564-26-2 | Reference compound |
| HY-101076 | L-690488 | 142523-14-6 | Reference compound |
| HY-101077 | Iso-PPADS (tetrasodium) | 207572-67-6 | Reference compound |
| HY-101078 | (±)-Epibatidine | 148152-66-3 | Reference compound |
| HY-101078A | (±)-Epibatidine (dihydrochloride) | 162885-01-0 | Natural Products |
| HY-101079 | BRL 52537 (hydrochloride) | 112282-24-3 | Reference compound |
| HY-10108 | LY294002 | 154447-36-6 | Reference compound |
| HY-101080 | 3'-Fluorobenzylspiperone (maleate) | 1135278-61-3 | Reference compound |
| HY-101082 | N6,2′-O-Dimethyladenosine | 57817-83-1 | Reference compound |
| HY-101083 | BDA-366 | 1909226-00-1 | Reference compound |
| HY-101083A | (Rac)-BDA-366 | 142645-19-0 | Reference compound |
| HY-101084 | NSC 228155 | 113104-25-9 | Reference compound |
| HY-101085 | SKL2001 | 909089-13-0 | Reference compound |
| HY-101085G | SKL2001 (GMP) | 909089-13-0 | GMP Small Molecules |
| HY-101086 | Acetylcholine (iodide) | 2260-50-6 | Natural Products |
| HY-101086R | Acetylcholine (iodide) (Standard) | 2260-50-6 | Reference Standards |
| HY-101087 | Benzenesulphonamide | 98-10-2 | Reference compound |
| HY-101087R | Benzenesulphonamide (Standard) | 98-10-2 | Reference Standards |
| HY-101088 | CeMMEC13 | 1790895-25-8 | Reference compound |
| HY-101089 | RHPS4 | 390362-78-4 | Reference compound |
| HY-10108A | LY294002 (hydrochloride) | 934389-88-5 | Reference compound |
| HY-10108AR | LY294002 (hydrochloride) (Standard) | 934389-88-5 | Reference Standards |
| HY-10108R | LY294002 (Standard) | 154447-36-6 | Reference Standards |
| HY-10109 | AS-605240 | 648450-29-7 | Reference compound |
| HY-101090 | KYA1797K | 1956356-56-1 | Reference compound |
| HY-101091 | Importazole | 662163-81-7 | Reference compound |
| HY-101092 | QS-21 | 141256-04-4 | Natural Products |
| HY-101093 | CA-170 | 1673534-76-3 | Reference compound |
| HY-101093B | PD-1-IN-20 | Reference compound | |
| HY-101094 | Ocaperidone | 129029-23-8 | Reference compound |
| HY-101096 | Suvecaltamide | 953778-58-0 | Reference compound |
| HY-101097 | PD-1-IN-17 | 1673560-66-1 | Reference compound |
| HY-101097A | PD-1-IN-17 (TFA) | Reference compound | |
| HY-101098 | PD-1-IN-18 | 1673534-97-8 | Reference compound |
| HY-10110 | IC-87114 | 371242-69-2 | Reference compound |
| HY-101100 | Anpirtoline (hydrochloride) | 99201-87-3 | Reference compound |
| HY-101100A | Anpirtoline | 98330-05-3 | Reference compound |
| HY-101101 | L-701252 | 151057-13-5 | Reference compound |
| HY-101102 | 7-Hydroxy-DPAT (hydrobromide) | 76135-30-3 | Reference compound |
| HY-101103 | HP-β-CD | 128446-35-5 | Biochemical Assay Reagents |
| HY-101105 | SB-224289 | 180083-23-2 | Reference compound |
| HY-101105A | SB-224289 (hydrochloride) | 180084-26-8 | Reference compound |
| HY-101106 | AR7 | 80306-38-3 | Reference compound |
| HY-101108 | Tazarotenic acid | 118292-41-4 | Reference compound |
| HY-101108R | Tazarotenic acid (Standard) | 118292-41-4 | Reference Standards |
| HY-101108S | Tazarotenic acid-d6 | 1794760-38-5 | Isotope-Labeled Compounds |
| HY-101108S1 | Tazarotenic acid-13C2,d2 | 1309935-88-3 | Isotope-Labeled Compounds |
| HY-101109 | Sodium ionophore III | 81686-22-8 | Reference compound |
| HY-10110R | IC-87114 (Standard) | 371242-69-2 | Reference Standards |
| HY-10111 | TG100-115 | 677297-51-7 | Reference compound |
| HY-101111 | PF-06840003 | 198474-05-4 | Reference compound |
| HY-101112 | Okicenone | 137018-54-3 | Natural Products |
| HY-101114 | LAS191954 | 1403947-26-1 | Reference compound |
| HY-101115 | PI3K-IN-6 | 1842380-77-1 | Reference compound |
| HY-101116 | GLP-1R Antagonist 1 | 488097-06-9 | Reference compound |
| HY-101117 | EED226 | 2083627-02-3 | Reference compound |
| HY-101119 | GLL398 | 2077980-80-2 | Reference compound |
| HY-101120 | 666-15 | 1433286-70-4 | Reference compound |
| HY-101121 | NI-42 | 1884640-99-6 | Reference compound |
| HY-101122 | LX2761 | 1610954-97-6 | Reference compound |
| HY-101124 | Rodatristat ethyl | 1673571-51-1 | Reference compound |
| HY-101125 | L-Moses | 2079885-05-3 | Reference compound |
| HY-101125A | L-Moses (dihydrochloride) | 2922480-38-2 | Reference compound |
| HY-101125B | D-Moses | 2084850-77-9 | Reference compound |
| HY-101126 | TP-3654 | 1361951-15-6 | Reference compound |
| HY-101127 | SGD-1882 | 1222490-34-7 | ADC Related |
| HY-101128 | Bicyclomycin benzoate | 37134-40-0 | Reference compound |
| HY-101128R | Bicyclomycin benzoate (Standard) | 37134-40-0 | Reference Standards |
| HY-101130 | PNU-74654 | 113906-27-7 | Reference compound |
| HY-101131 | Dansyl glutathione | 75017-02-6 | Reference compound |
| HY-101132 | VB-201 | 630112-41-3 | Reference compound |
| HY-101139 | Xanthine amine congener | 96865-92-8 | Reference compound |
| HY-101139A | Xanthine amine congener (hydrochloride) | 1783977-95-6 | Reference compound |
| HY-101139AR | Xanthine amine congener (hydrochloride) (Standard) | 1783977-95-6 | Reference Standards |
| HY-101139B | Xanthine amine congener (trihydrochloride) | 2459963-12-1 | Reference compound |
| HY-10114 | TGX-221 | 663619-89-4 | Reference compound |
| HY-101140 | KI696 | 1799974-70-1 | Reference compound |
| HY-101140A | KI696 isomer | 1799974-69-8 | Reference compound |
| HY-101141 | sulfo-SPDB-DM4 | 1626359-59-8 | ADC Related |
| HY-101143 | PGMI-004A | 1313738-90-7 | Reference compound |
| HY-101144 | RSM-932A | 850807-63-5 | Reference compound |
| HY-101146 | SF2523 | 1174428-47-7 | Reference compound |
| HY-101147 | YKL-05-099 | 1936529-65-5 | Reference compound |
| HY-10114R | TGX-221 (Standard) | 663619-89-4 | Reference Standards |
| HY-10115 | PI-103 | 371935-74-9 | Reference compound |
| HY-101150 | DGN462 | 1394079-41-4 | ADC Related |
| HY-101150A | sulfo-DGN462 (sodium) | 1401203-09-5 | ADC Related |
| HY-101151 | sulfo-SPDB | 1193111-39-5 | ADC Related |
| HY-101152 | SG3199-Val-Ala-PAB | 1595275-61-8 | ADC Related |
| HY-101153 | MC-Val-Ala-OH | 1342211-31-7 | ADC Related |
| HY-101157 | Propargyl-PEG5-acid | 1245823-51-1 | ADC Related |
| HY-101159 | Mal-amido-PEG8-C2-acid | 1334177-86-4 | ADC Related |
| HY-10115A | PI-103 (Hydrochloride) | 371935-79-4 | Reference compound |
| HY-10115AR | PI-103 (Hydrochloride) (Standard) | 371935-79-4 | Reference Standards |
| HY-10115R | PI-103 (Standard) | 371935-74-9 | Reference Standards |
| HY-10116 | PI-540 | 885616-78-4 | Reference compound |
| HY-101160 | SG2057 | 260417-62-7 | Reference compound |
| HY-101161 | SG3199 | 1595275-71-0 | ADC Related |
| HY-101162 | SGD-1910 | 1342820-51-2 | ADC Related |
| HY-101164 | MAP4 | 157381-42-5 | Reference compound |
| HY-101165 | Cyclothiazide | 2259-96-3 | Reference compound |
| HY-101165R | Cyclothiazide (Standard) | 2259-96-3 | Reference Standards |
| HY-101167 | Aminopotentidine | 140873-26-3 | Reference compound |
| HY-101169 | Tetrindole (mesylate) | 170964-68-8 | Reference compound |
| HY-101170 | BU224 (hydrochloride) | 205437-64-5 | Reference compound |
| HY-101170R | BU224 (hydrochloride) (Standard) | 205437-64-5 | Reference Standards |
| HY-101172 | RS 23597-190 | 149719-06-2 | Reference compound |
| HY-101173 | Imetit (dihydrobromide) | 32385-58-3 | Reference compound |
| HY-101175 | 3-Bromo-7-nitroindazole | 74209-34-0 | Reference compound |
| HY-101176 | 2-Iodomelatonin | 93515-00-5 | Reference compound |
| HY-101176R | 2-Iodomelatonin (Standard) | 93515-00-5 | Reference Standards |
| HY-101178 | L-689560 | 139051-78-8 | Reference compound |
| HY-101179 | Tesmilifene (fumarate) | 1185241-83-1 | Reference compound |
| HY-101179R | Tesmilifene (fumarate) (Standard) | 1185241-83-1 | Reference Standards |
| HY-10118 | Filibuvir | 877130-28-4 | Reference compound |
| HY-101180 | C2 Ceramide | 3102-57-6 | Reference compound |
| HY-101181 | THK-5105 | 1374107-46-6 | Reference compound |
| HY-101182 | THK-5117 | 1374107-54-6 | Reference compound |
| HY-101183 | THK5351 | 1707147-26-9 | Biochemical Assay Reagents |
| HY-101183A | THK5351 (R enantiomer) | 2101218-44-2 | Reference compound |
| HY-101184 | T807 | 1415379-56-4 | Reference compound |
| HY-101184R | T807 (Standard) | 1415379-56-4 | Reference Standards |
| HY-101185 | T808 | 1320211-61-7 | Reference compound |
| HY-101186 | MK-6240 | 1841078-87-2 | Reference compound |
| HY-101188 | INCB38579 | 1246207-65-7 | Reference compound |
| HY-101189 | JNJ-39758979 | 1046447-90-8 | Reference compound |
| HY-101189B | JNJ-39758979 (dihydrochloride) | Reference compound | |
| HY-10119 | Vorapaxar | 618385-01-6 | Reference compound |
| HY-101190 | Volixibat | 1025216-57-2 | Reference compound |
| HY-101191 | Ecteinascidin 770 | 114899-80-8 | Natural Products |
| HY-101192 | GSK682753A | 1334294-76-6 | Reference compound |
| HY-101193 | Zinc Protoporphyrin | 15442-64-5 | Reference compound |
| HY-101193R | Zinc Protoporphyrin (Standard) | 15442-64-5 | Reference Standards |
| HY-101194 | Tin protoporphyrin IX dichloride | 14325-05-4 | Reference compound |
| HY-101195 | DL-erythro-Dihydrosphingosine | 3102-56-5 | Reference compound |
| HY-101196 | PG 9 (maleate) | 155649-00-6 | Reference compound |
| HY-101197 | SM-21 (maleate) | 155059-42-0 | Reference compound |
| HY-101198 | Clobenpropit (dihydrobromide) | 145231-35-2 | Reference compound |
| HY-101199 | N-Benzylnaltrindole (hydrochloride) | 1206487-81-1 | Reference compound |
| HY-10119A | Vorapaxar (sulfate) | 705260-08-8 | Reference compound |
| HY-10119AR | Vorapaxar (sulfate) (Standard) | 705260-08-8 | Reference Standards |
| HY-10119R | Vorapaxar (Standard) | 618385-01-6 | Reference Standards |
| HY-10119S | Vorapaxar-d5 | Isotope-Labeled Compounds | |
| HY-101200 | Linsidomine (hydrochloride) | 16142-27-1 | Reference compound |
| HY-101200R | Linsidomine (hydrochloride) (Standard) | 16142-27-1 | Reference Standards |
| HY-101202 | SNC80 | 156727-74-1 | Reference compound |
| HY-101202A | (Rac)-SNC80 | 1217643-87-2 | Reference compound |
| HY-101203 | GJ103 | 1459687-89-8 | Reference compound |
| HY-101203A | GJ103 (sodium) | 1459687-96-7 | Reference compound |
| HY-101205 | ICI 199441 | 115199-84-3 | Reference compound |
| HY-101207 | NCS-382 | 520505-01-5 | Reference compound |
| HY-101208 | L694247 | 137403-12-4 | Reference compound |
| HY-10121 | Asenapine | 65576-45-6 | Reference compound |
| HY-101212 | Fadraciclib | 1070790-89-4 | Reference compound |
| HY-101213 | OSW-1 | 145075-81-6 | Natural Products |
| HY-101214 | UK-371804 | 256477-09-5 | Reference compound |
| HY-101214A | UK-371804 (hydrochloride) | 256476-36-5 | Reference compound |
| HY-101215 | Evobrutinib | 1415823-73-2 | Reference compound |
| HY-101216 | Org-26576 | 100044-96-0 | Reference compound |
| HY-101217 | BI 689648 | 1633009-87-6 | Reference compound |
| HY-101218 | N-Biotinyl-6-aminohexanoic acid | 72040-64-3 | Reference compound |
| HY-101219 | VEGFR-IN-1 | 269390-69-4 | Reference compound |
| HY-10121B | Asenapine (citrate) | 1411867-74-7 | Reference compound |
| HY-10121R | Asenapine (Standard) | 65576-45-6 | Reference Standards |
| HY-10121S2 | Asenapine-13C,d3 | 2747915-30-4 | Isotope-Labeled Compounds |
| HY-10121S4 | Asenapine-d3,13C | 1217729-73-1 | Isotope-Labeled Compounds |
| HY-10122 | Silodosin | 160970-54-7 | Reference compound |
| HY-101220 | RMI-61140 | 24140-98-5 | Reference compound |
| HY-101222 | SB-203186 (hydrochloride) | 207572-69-8 | Reference compound |
| HY-101223 | DIPPA (hydrochloride) | 155512-52-0 | Reference compound |
| HY-101225 | 8 Hydroxy PIPAT (oxalate) | 1451210-48-2 | Reference compound |
| HY-101226 | MSOP | 66515-29-5 | Reference compound |
| HY-101227 | (±)-threo-3-Methylglutamic acid | 63088-04-0 | Reference compound |
| HY-101229 | (2R,3S)-Chlorpheg | 140924-23-8 | Reference compound |
| HY-10122A | (Rac)-Silodosin | 160970-64-9 | Reference compound |
| HY-10122R | Silodosin (Standard) | 160970-54-7 | Reference Standards |
| HY-10122S | Silodosin-d4 | 1426173-86-5 | Isotope-Labeled Compounds |
| HY-101230 | ICI 174864 | 89352-67-0 | Reference compound |
| HY-101231 | ICI-204448 | 121264-04-8 | Reference compound |
| HY-101232 | Tiotidine | 69014-14-8 | Reference compound |
| HY-101232R | Tiotidine (Standard) | 69014-14-8 | Reference Standards |
| HY-101233 | ICI 154129 | 83420-94-4 | Reference compound |
| HY-101234 | ICI 162846 | 84545-30-2 | Reference compound |
| HY-101236 | ICI 192605 | 117621-64-4 | Reference compound |
| HY-101237 | DHBP (dibromide) | 6159-05-3 | Reference compound |
| HY-101238 | Agmatine (sulfate) | 2482-00-0 | Natural Products |
| HY-101238R | Agmatine (sulfate) (Standard) | 2482-00-0 | Reference Standards |
| HY-101239 | Oxotremorine (sesquifumarate) | 17360-35-9 | Reference compound |
| HY-101240 | Propranolol glycol | 36112-95-5 | Reference compound |
| HY-101240R | Propranolol glycol (Standard) | 36112-95-5 | Reference Standards |
| HY-101240S | Propranolol glycol-d5 | 69533-57-9 | Isotope-Labeled Compounds |
| HY-101241 | MPPG | 169209-65-8 | Reference compound |
| HY-101242 | (±)-α-Methyl-(4-sulfonophenyl)glycine | 169209-64-7 | Peptides |
| HY-101243 | XMD16-5 | 1345098-78-3 | Reference compound |
| HY-101244 | ZINC00881524 | 557782-81-7 | Reference compound |
| HY-101245 | Pilsicainide (hydrochloride) | 88069-49-2 | Reference compound |
| HY-101246 | RPI-1 | 269730-03-2 | Reference compound |
| HY-101247 | MTPG | 169209-66-9 | Reference compound |
| HY-101248 | GR-46611 | 185259-85-2 | Reference compound |
| HY-101249 | L-732138 | 148451-96-1 | Reference compound |
| HY-101250 | Glemanserin | 107703-78-6 | Reference compound |
| HY-101250R | Glemanserin (Standard) | 107703-78-6 | Reference Standards |
| HY-101251 | AMT (hydrochloride) | 21463-31-0 | Reference compound |
| HY-101251R | AMT (hydrochloride) (Standard) | 21463-31-0 | Reference Standards |
| HY-101252 | S-EIT (hydrobromide) | 1071-37-0 | Biochemical Assay Reagents |
| HY-101253 | AM-92016 (hydrochloride) | 133229-11-5 | Reference compound |
| HY-101254 | Luzindole | 117946-91-5 | Reference compound |
| HY-101254R | Luzindole (Standard) | 117946-91-5 | Reference Standards |
| HY-101255 | ODQ | 41443-28-1 | Reference compound |
| HY-101255R | ODQ (Standard) | 41443-28-1 | Reference Standards |
| HY-101256 | ZM226600 | 147695-92-9 | Reference compound |
| HY-101257 | YKL-5-124 | 1957203-01-8 | Reference compound |
| HY-101257A | CDK7-IN-1 | 1957203-02-9 | Reference compound |
| HY-101257B | YKL-5-124 (TFA) | 2748220-93-9 | Reference compound |
| HY-101258 | Cardol triene | 79473-24-8 | Reference compound |
| HY-101259 | BMS-195614 | 182135-66-6 | Reference compound |
| HY-10126 | Barasertib-HQPA | 722544-51-6 | Reference compound |
| HY-101260 | DORA-22 | 1088991-95-0 | Reference compound |
| HY-101261 | ATPA | 140158-50-5 | Reference compound |
| HY-101262 | SB234551 | 188257-69-4 | Reference compound |
| HY-101263 | 2-Thio-PAF | 96801-55-7 | Reference compound |
| HY-101264 | CCR2 antagonist 3 | 1380100-86-6 | Reference compound |
| HY-101265 | Icanbelimod | 1514888-56-2 | Reference compound |
| HY-101266 | Milademetan | 1398568-47-2 | Reference compound |
| HY-101266A | Milademetan (tosylate) | 1398569-75-9 | Reference compound |
| HY-101266B | Milademetan (tosylate hydrate) | 2095625-97-9 | Reference compound |
| HY-101267 | CHMFL-BMX-078 | 1808288-51-8 | Reference compound |
| HY-101268 | CHMFL-ABL-053 | 1808287-83-3 | Reference compound |
| HY-10127 | Barasertib | 722543-31-9 | Reference compound |
| HY-101270 | STK16-IN-1 | 1223001-53-3 | Reference compound |
| HY-101271 | WAY-200070 | 440122-66-7 | Reference compound |
| HY-101272 | GDC-0326 | 1282514-88-8 | Reference compound |
| HY-101273 | BAR502 | 1612191-86-2 | Reference compound |
| HY-101274 | BAR501 | 1632118-69-4 | Reference compound |
| HY-101274A | (3α,5β,6β,7α)-BAR501 | 1632118-70-7 | Reference compound |
| HY-101275 | EMT inhibitor-1 | 1638526-21-2 | Reference compound |
| HY-101277 | Vadadustat | 1000025-07-9 | Reference compound |
| HY-101277S1 | Vadadustat-13C6 | Isotope-Labeled Compounds | |
| HY-101278 | Thiomyristoyl | 1429749-41-6 | Reference compound |
| HY-101279 | ST034307 | 133406-29-8 | Reference compound |
| HY-10127A | Barasertib (dihydrochloride) | 722543-50-2 | Reference compound |
| HY-10127R | Barasertib (Standard) | 722543-31-9 | Reference Standards |
| HY-10128 | ZM-447439 | 331771-20-1 | Reference compound |
| HY-101280 | LB-60-OF61 | 794461-93-1 | Reference compound |
| HY-101280A | LB-60-OF61 (hydrochloride) | 742064-38-6 | Reference compound |
| HY-101281 | VU 6008667 | 2092923-21-0 | Reference compound |
| HY-101281A | (Rac)-VU 6008667 | 2092917-63-8 | Reference compound |
| HY-101281B | (R)-VU 6008667 | 2097818-14-7 | Reference compound |
| HY-101282 | Glutaminyl Cyclase Inhibitor 3 | 2092921-50-9 | Reference compound |
| HY-101283 | HCH6-1 | 1435265-06-7 | Reference compound |
| HY-101284 | DMU2105 | 1821143-79-6 | Reference compound |
| HY-101284A | (E/Z)-DMU2105 | 1031063-36-1 | Reference compound |
| HY-101285 | DMU2139 | 1821143-80-9 | Reference compound |
| HY-101287 | MPT0B392 | 1346169-92-3 | Reference compound |
| HY-10129 | Veliparib | 912444-00-9 | Reference compound |
| HY-101290 | BMT-090605 | 1551403-51-0 | Reference compound |
| HY-101290A | BMT-090605 (hydrochloride) | 2231664-45-0 | Reference compound |
| HY-101291 | Iberdomide | 1323403-33-3 | Reference compound |
| HY-101291R | Iberdomide (Standard) | 1323403-33-3 | Reference Standards |
| HY-101292 | FK614 | 193012-35-0 | Reference compound |
| HY-101293 | VU0359595 | 1246303-14-9 | Reference compound |
| HY-101294 | TPPU | 1222780-33-7 | Reference compound |
| HY-101295 | Pan-RAS-IN-1 | 1835283-94-7 | Reference compound |
| HY-101296 | PD-166866 | 192705-79-6 | Reference compound |
| HY-101297 | Z-IETD-FMK | 210344-98-2 | Reference compound |
| HY-101298 | Paprotrain | 57046-73-8 | Reference compound |
| HY-101299 | (+)-Dihydrexidine (hydrochloride) | 158704-02-0 | Reference compound |
| HY-101299A | Dihydrexidine | 123039-93-0 | Reference compound |
| HY-101299B | Dihydrexidine (hydrochloride) | 137417-08-4 | Reference compound |
| HY-10129R | Veliparib (Standard) | 912444-00-9 | Reference Standards |
| HY-10130 | Veliparib (dihydrochloride) | 912445-05-7 | Reference compound |
| HY-101300 | Cirazoline (hydrochloride) | 40600-13-3 | Reference compound |
| HY-101300R | Cirazoline (hydrochloride) (Standard) | 40600-13-3 | Reference Standards |
| HY-101301A | RS 45041-190 (hydrochloride) | 204274-74-8 | Reference compound |
| HY-101302 | Naltriben (mesylate) | 122517-78-6 | Reference compound |
| HY-101303 | 5-MCA-NAT | 190277-13-5 | Reference compound |
| HY-101304 | S-Isopropylisothiourea (hydrobromide) | 4269-97-0 | Reference compound |
| HY-101306 | Clocinnamox (mesylate) | 117332-69-1 | Reference compound |
| HY-101307 | BNTX (maleate) | 864461-31-4 | Reference compound |
| HY-101308 | MRS2179 (tetrasodium) | 1454889-37-2 | Reference compound |
| HY-101308A | MRS2179 (tetrasodium hydrate) | Reference compound | |
| HY-101309A | 5-(Nonyloxy)tryptamine (oxalate) | 157798-13-5 | Reference compound |
| HY-10131 | Procaspase-3/6 activator 1 | 1100353-03-4 | Reference compound |
| HY-101310 | SYM 2081 | 31137-74-3 | Reference compound |
| HY-101311 | UPF-523 | 168560-79-0 | Reference compound |
| HY-101312 | Cilostamide | 68550-75-4 | Reference compound |
| HY-101312R | Cilostamide (Standard) | 68550-75-4 | Reference Standards |
| HY-101313 | (S)-Remoxipride | 80125-14-0 | Reference compound |
| HY-101313A | (S)-Remoxipride (hydrochloride) | 73220-03-8 | Reference compound |
| HY-101314 | 3-CPMT | 14008-79-8 | Reference compound |
| HY-101315 | AHN 1-055 (hydrochloride) | 202646-03-5 | Reference compound |
| HY-101316 | TRIM | 25371-96-4 | Reference compound |
| HY-101317 | TAN-67 (dihydrobromide) | 1217628-73-3 | Reference compound |
| HY-101317A | TAN-67 | 148545-09-9 | Reference compound |
| HY-101318 | β-Funaltrexamine (hydrochloride) | 72786-10-8 | Reference compound |
| HY-101320 | ZD-7114 | 129689-30-1 | Reference compound |
| HY-101320A | ZD-7114 (hydrochloride) | 129689-28-7 | Reference compound |
| HY-101321 | Immepip | 151070-83-6 | Reference compound |
| HY-101321A | Immepip (dihydrobromide) | 164391-47-3 | Reference compound |
| HY-101321AR | Immepip (dihydrobromide) (Standard) | 164391-47-3 | Reference Standards |
| HY-101322A | MM 77 (dihydrochloride) | 159187-70-9 | Reference compound |
| HY-101323 | Olvanil | 58493-49-5 | Reference compound |
| HY-101323R | Olvanil (Standard) | 58493-49-5 | Reference Standards |
| HY-101324 | MK-212 | 64022-27-1 | Reference compound |
| HY-101324A | MK-212 (monohydrochloride) | 61655-58-1 | Reference compound |
| HY-101324AR | MK-212 (monohydrochloride) (Standard) | 61655-58-1 | Reference Standards |
| HY-101325 | BRL 37344 (sodium) | 127299-93-8 | Reference compound |
| HY-101325A | BRL-37344 | 90730-96-4 | Reference compound |
| HY-101327 | Xamoterol | 81801-12-9 | Reference compound |
| HY-101327A | Xamoterol (hemifumarate) | 73210-73-8 | Reference compound |
| HY-101329 | Anthracene-9-carboxylic acid | 723-62-6 | Reference compound |
| HY-101329R | Anthracene-9-carboxylic acid (Standard) | 723-62-6 | Reference Standards |
| HY-101329S | Anthracene-9-carboxylic acid-d9 | 1219803-78-7 | Isotope-Labeled Compounds |
| HY-10133 | β-Secretase Inhibitor IV | 797035-11-1 | Reference compound |
| HY-101331 | Phenylbiguanide | 102-02-3 | Reference compound |
| HY-101331A | Phenylbiguanide (hydrochloride) | 55-57-2 | Reference compound |
| HY-101331R | Phenylbiguanide (Standard) | 102-02-3 | Reference Standards |
| HY-101332 | EGLU | 170984-72-2 | Reference compound |
| HY-101333 | CPPG | 183364-82-1 | Reference compound |
| HY-101334 | MPDC | 159262-32-5 | Reference compound |
| HY-101334A | MPDC (hydrochloride) | Reference compound | |
| HY-101335 | DCG-IV | 147782-19-2 | Reference compound |
| HY-101336 | RS 17053 hydrochloride | 169505-93-5 | Reference compound |
| HY-101337 | Imiloxan | 81167-16-0 | Reference compound |
| HY-101337A | Imiloxan (hydrochloride) | 81167-22-8 | Reference compound |
| HY-101338 | RS-79948-197 | 186002-54-0 | Reference compound |
| HY-101339 | (R)-RS 56812 | 143137-37-5 | Reference compound |
| HY-101339A | (R)-RS 56812 (hydrochloride) | 143339-12-2 | Reference compound |
| HY-101340 | Luvixasertib | 1610759-22-2 | Reference compound |
| HY-101340A | Luvixasertib (hydrochloride) | 1610677-37-6 | Reference compound |
| HY-101341 | RS 67333 (hydrochloride) | 168986-60-5 | Reference compound |
| HY-101342 | RS 67506 (hydrochloride) | 168986-61-6 | Reference compound |
| HY-101343 | RS 39604 | 167710-87-4 | Reference compound |
| HY-101344 | Cyanopindolol (fumarate) | 69906-86-1 | Reference compound |
| HY-101345 | AH 11110A | 179388-65-9 | Reference compound |
| HY-101346 | ZD7288 | 133059-99-1 | Reference compound |
| HY-101347 | Chlorisondamine (diiodide) | 96750-66-2 | Reference compound |
| HY-101348 | L-741626 | 81226-60-0 | Reference compound |
| HY-101348R | L-741626 (Standard) | 81226-60-0 | Reference Standards |
| HY-101349 | L 741742 | 156337-32-5 | Reference compound |
| HY-101349A | L 741742 (hydrochloride) | 874882-93-6 | Reference compound |
| HY-101350 | QX-314 (bromide) | 24003-58-5 | Reference compound |
| HY-101352 | LY 225910 | 133040-77-4 | Reference compound |
| HY-101353 | LY 235959 | 137433-06-8 | Reference compound |
| HY-101354 | R-IMPP | 2133832-83-2 | Reference compound |
| HY-101355 | CGP 20712 | 137888-49-4 | Reference compound |
| HY-101355A | CGP 20712 (dihydrochloride) | 1216905-73-5 | Reference compound |
| HY-101355AR | CGP 20712 (dihydrochloride) (Standard) | 1216905-73-5 | Reference Standards |
| HY-101355B | CGP 20712 A | 105737-62-0 | Reference compound |
| HY-101355BR | CGP 20712 A (Standard) | 105737-62-0 | Reference Standards |
| HY-101356 | CPCCOEt | 179067-99-3 | Reference compound |
| HY-101357 | CP 93129 | 127792-75-0 | Reference compound |
| HY-101357A | CP 93129 (dihydrochloride) | 879089-64-2 | Reference compound |
| HY-101357AR | CP 93129 (dihydrochloride) (Standard) | 879089-64-2 | Reference Standards |
| HY-101358 | 8-M-PDOT | 134865-70-6 | Reference compound |
| HY-101359 | TPMPA | 182485-36-5 | Reference compound |
| HY-101360 | 1-EBIO | 10045-45-1 | Reference compound |
| HY-101361 | Lidocaine methiodide | 1462-71-1 | Reference compound |
| HY-101362 | QX-222 (chloride) | 5369-00-6 | Reference compound |
| HY-101363 | 1-BCP | 34023-62-6 | Reference compound |
| HY-101363R | 1-BCP (Standard) | 34023-62-6 | Reference Standards |
| HY-101364 | CHPG | 170846-74-9 | Reference compound |
| HY-101364A | CHPG (sodium salt) | 1303993-73-8 | Reference compound |
| HY-101364AR | CHPG (sodium salt) (Standard) | 1303993-73-8 | Reference Standards |
| HY-101365 | RS-102221 | 185376-97-0 | Reference compound |
| HY-101365A | RS-102221 (hydrochloride) | 187397-18-8 | Reference compound |
| HY-101365AR | RS-102221 (hydrochloride) (Standard) | 187397-18-8 | Reference Standards |
| HY-101366 | A-61603 | 107756-30-9 | Reference compound |
| HY-101367A | GR 55562 (dihydrochloride) | 159533-25-2 | Reference compound |
| HY-101368A | WIN 64338 (hydrochloride) | 163727-74-0 | Reference compound |
| HY-101369 | BW-723C86 | 160521-72-2 | Reference compound |
| HY-101370 | 2-Methylthio-ATP (tetrasodium) | 100020-57-3 | Reference compound |
| HY-101371 | Hesperin | 4430-35-7 | Reference compound |
| HY-101372A | Oxotremorine M (iodide) | 3854-04-4 | Reference compound |
| HY-101373A | Zolantidine (dimaleate) | 104076-39-3 | Reference compound |
| HY-101373AR | Zolantidine (dimaleate) (Standard) | 104076-39-3 | Reference Standards |
| HY-101374A | AGN 192403 (hydrochloride) | 1021868-90-5 | Reference compound |
| HY-101375 | (RS)-APICA | 170847-18-4 | Reference compound |
| HY-101376 | (+)-N-Allylnormetazocine (hydrochloride) | 133005-41-1 | Reference compound |
| HY-101377A | R(+)-8-OH-DPAT (hydrobromide) | 78095-19-9 | Reference compound |
| HY-101377B | S(-)-8-OH-DPAT (hydrobromide) | 78095-20-2 | Reference compound |
| HY-101378 | CGP 54626 (hydrochloride) | 149184-21-4 | Reference compound |
| HY-101379A | 8-Bromo-cGMP (sodium) | 51116-01-9 | Reference compound |
| HY-101380A | BU226 (hydrochloride) | 1186195-56-1 | Reference compound |
| HY-101381 | Otenzepad | 102394-31-0 | Reference compound |
| HY-101382 | GR 103691 | 162408-66-4 | Reference compound |
| HY-101383 | PF-01247324 | 875051-72-2 | Reference compound |
| HY-101384A | Ro 10-5824 (dihydrochloride) | 189744-94-3 | Reference compound |
| HY-101385 | L-765314 | 189349-50-6 | Reference compound |
| HY-101386 | PZM21 | 1997387-43-5 | Reference compound |
| HY-101387 | rel-ACPT-I | 194918-76-8 | Reference compound |
| HY-101387A | ACPT-II | 195209-04-2 | Reference compound |
| HY-101388 | AM404 | 183718-77-6 | Reference compound |
| HY-101389 | (R)-Methanandamide | 157182-49-5 | Reference compound |
| HY-101390 | (+)-Niguldipine (hydrochloride) | 113145-69-0 | Reference compound |
| HY-101390A | (-)-Niguldipine (hydrochloride) | 113145-70-3 | Reference compound |
| HY-101390B | Niguldipine (free base) | 102993-22-6 | Reference compound |
| HY-101392 | Harmane | 486-84-0 | Natural Products |
| HY-101392A | Harmane (hydrochloride) | 21655-84-5 | Natural Products |
| HY-101392R | Harmane (Standard) | 486-84-0 | Reference Standards |
| HY-101392S | Harmane-d1 | Isotope-Labeled Compounds | |
| HY-101392S1 | Harmane-d2 | Isotope-Labeled Compounds | |
| HY-101392S2 | Harmane-d4 | 2012598-89-7 | Isotope-Labeled Compounds |
| HY-101393A | CGP 12177 (hydrochloride) | 64208-32-8 | Reference compound |
| HY-101394 | Spermine NONOate | 136587-13-8 | Reference compound |
| HY-101395 | W146 | 909725-61-7 | Reference compound |
| HY-101395A | W146 (TFA) | 909725-62-8 | Reference compound |
| HY-101396 | ICA-069673 | 582323-16-8 | Reference compound |
| HY-101397 | Allopurinol riboside | 16220-07-8 | Natural Products |
| HY-101397R | Allopurinol riboside (Standard) | 16220-07-8 | Reference Standards |
| HY-101398 | Coproporphyrin III | 14643-66-4 | Natural Products |
| HY-101398R | Coproporphyrin III (Standard) | 14643-66-4 | Reference Standards |
| HY-101399 | γ-Glu-Phe | 7432-24-8 | Natural Products |
| HY-101399A | γ-Glu-Phe (TFA) | 2828432-42-2 | Natural Products |
| HY-101399R | γ-Glu-Phe (Standard) | 7432-24-8 | Reference Standards |
| HY-101399S | γ-Glu-(Phe-13C9,15N) | Isotope-Labeled Compounds | |
| HY-101400 | Deoxycytidine triphosphate | 2056-98-6 | Biochemical Assay Reagents |
| HY-101400A | Deoxycytidine triphosphate (trisodium) solution (100mM) | 109909-44-6 | Biochemical Assay Reagents |
| HY-101400S | Deoxycytidine triphosphate-d14 (dilithium) | 2687960-70-7 | Isotope-Labeled Compounds |
| HY-101400S1 | Deoxycytidine triphosphate-15N3,d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-101400S2 | Deoxycytidine triphosphate-13C9,15N3 (dilithium) | Isotope-Labeled Compounds | |
| HY-101400S3 | Deoxycytidine triphosphate-15N3 (dilithium) | Isotope-Labeled Compounds | |
| HY-101400S4 | Deoxycytidine triphosphate-13C9 (dilithium) | Isotope-Labeled Compounds | |
| HY-101401 | 3-(Methylthio)propionic acid | 646-01-5 | Natural Products |
| HY-101401R | 3-(Methylthio)propionic acid (Standard) | 646-01-5 | Reference Standards |
| HY-101402 | Cyclo(his-pro) | 53109-32-3 | Natural Products |
| HY-101402A | Cyclo(his-pro) (TFA) | 936749-56-3 | Natural Products |
| HY-101402AR | Cyclo(his-pro) (TFA) (Standard) | 936749-56-3 | Reference Standards |
| HY-101403 | N-(5-Aminopentyl)acetamide | 32343-73-0 | Natural Products |
| HY-101403A | Monoacetylcadaverine (hydrochloride) | 102029-76-5 | Reference compound |
| HY-101403R | N-(5-Aminopentyl)acetamide (Standard) | 32343-73-0 | Reference Standards |
| HY-101404 | DL-Homocysteine thiolactone (hydrochloride) | 6038-19-3 | Natural Products |
| HY-101404A | L-Homocysteine thiolactone (hydrochloride) | 31828-68-9 | Reference compound |
| HY-101404R | DL-Homocysteine thiolactone (hydrochloride) (Standard) | 6038-19-3 | Reference Standards |
| HY-101404S | DL-Homocysteine thiolactone-d4 (hydrochloride) | 1219805-31-8 | Isotope-Labeled Compounds |
| HY-101405 | Gestrinone | 16320-04-0 | Reference compound |
| HY-101405R | Gestrinone (Standard) | 16320-04-0 | Reference Standards |
| HY-101406 | Thyroxine sulfate | 77074-49-8 | Natural Products |
| HY-101406R | Thyroxine sulfate (Standard) | 77074-49-8 | Reference Standards |
| HY-101407 | Nicotinamide N-oxide | 1986-81-8 | Natural Products |
| HY-101407R | Nicotinamide N-oxide (Standard) | 1986-81-8 | Reference Standards |
| HY-101408 | Docosatrienoic Acid | 28845-86-5 | Natural Products |
| HY-101409 | O-Acetylserine | 5147-00-2 | Natural Products |
| HY-101409A | O-Acetyl-L-serine (hydrochloride) | 66638-22-0 | Natural Products |
| HY-101409AR | O-Acetyl-L-serine (hydrochloride) (Standard) | 66638-22-0 | Reference Standards |
| HY-101409R | O-Acetylserine (Standard) | 5147-00-2 | Reference Standards |
| HY-101410 | SDMA | 30344-00-4 | Natural Products |
| HY-101410A | SDMA (p-hydroxyazobenzene-p′-sulfonate) | 1266235-58-8 | Reference compound |
| HY-101410R | SDMA (Standard) | 30344-00-4 | Reference Standards |
| HY-101410S | SDMA-d6 | 1331888-08-4 | Isotope-Labeled Compounds |
| HY-101411 | 4-Acetamidobutanoic acid | 3025-96-5 | Natural Products |
| HY-101411R | 4-Acetamidobutanoic acid (Standard) | 3025-96-5 | Reference Standards |
| HY-101411S | 4-Acetamidobutanoic acid-d3 | Isotope-Labeled Compounds | |
| HY-101412 | 2-(Methylamino)-1H-purin-6(7H)-one | 10030-78-1 | Natural Products |
| HY-101413 | Iberin | 505-44-2 | Natural Products |
| HY-101414 | L-DABA | 1758-80-1 | Natural Products |
| HY-101414A | L-DABA (hydrobromide) | 73143-97-2 | Reference compound |
| HY-101414R | L-DABA (Standard) | 1758-80-1 | Reference Standards |
| HY-101415 | Coenzyme Q9 | 303-97-9 | Natural Products |
| HY-101415R | Coenzyme Q9 (Standard) | 303-97-9 | Reference Standards |
| HY-101416 | Vanilpyruvic acid | 1081-71-6 | Reference compound |
| HY-101416R | Vanilpyruvic acid (Standard) | 1081-71-6 | Reference Standards |
| HY-101417 | Diethyl phosphate | 598-02-7 | Natural Products |
| HY-101417R | Diethyl phosphate (Standard) | 598-02-7 | Reference Standards |
| HY-101417S1 | Diethyl phosphate-d10-1 | 2483831-48-5 | Isotope-Labeled Compounds |
| HY-101418 | JNJ-47965567 | 1428327-31-4 | Reference compound |
| HY-101419 | CYM-5541 | 945128-26-7 | Reference compound |
| HY-101420 | VUF10460 | 1028327-66-3 | Reference compound |
| HY-101422 | GAL-021 | 1380341-99-0 | Reference compound |
| HY-101422A | GAL-021 (sulfate) | 1380342-00-6 | Reference compound |
| HY-101423 | NIH-12848 | 959551-10-1 | Reference compound |
| HY-101424 | 2-Chloro-N-(2-methyl-4-bromophenyl)acetamide | 96686-51-0 | Reference compound |
| HY-101425 | TCMTB | 21564-17-0 | Reference compound |
| HY-101426 | RG14620 | 136831-49-7 | Reference compound |
| HY-101427 | Bamaquimast | 135779-82-7 | Reference compound |
| HY-101428 | NS-638 | 150493-34-8 | Reference compound |
| HY-101429 | RG13022 | 136831-48-6 | Reference compound |
| HY-101430 | PGD2-IN-1 | 885066-67-1 | Reference compound |
| HY-101432 | Fenclozic acid | 17969-20-9 | Reference compound |
| HY-101433 | N-Acetylprocainamide (hydrochloride) | 34118-92-8 | Reference compound |
| HY-101433R | N-Acetylprocainamide (hydrochloride) (Standard) | 34118-92-8 | Reference Standards |
| HY-101434 | Cetamolol | 34919-98-7 | Reference compound |
| HY-101434A | Cetamolol (hydrochloride) | 77590-95-5 | Reference compound |
| HY-101435 | Centpropazine | 91315-34-3 | Reference compound |
| HY-101436 | Sematilide | 101526-83-4 | Reference compound |
| HY-101436A | Sematilide (hydrochloride) | 101526-62-9 | Reference compound |
| HY-101436AR | Sematilide (hydrochloride) (Standard) | 101526-62-9 | Reference Standards |
| HY-101437 | Ralfinamide | 133865-88-0 | Reference compound |
| HY-101437A | Ralfinamide (mesylate) | 202825-45-4 | Reference compound |
| HY-101437R | Ralfinamide (Standard) | 133865-88-0 | Reference Standards |
| HY-101438 | Darbufelone | 139226-28-1 | Reference compound |
| HY-101438A | Darbufelone (mesylate) | 139340-56-0 | Reference compound |
| HY-101439 | JTT-552 | 888730-46-9 | Reference compound |
| HY-101440A | Indantadol (hydrochloride) | 202914-18-9 | Reference compound |
| HY-101441 | ST-193 | 489416-12-8 | Reference compound |
| HY-101441A | ST-193 (hydrochloride) | 2320274-72-2 | Reference compound |
| HY-101442 | SR9238 | 1416153-62-2 | Reference compound |
| HY-101442R | SR9238 (Standard) | 1416153-62-2 | Reference Standards |
| HY-101443 | ISCK03 | 945526-43-2 | Reference compound |
| HY-101444A | PAβN (dihydrochloride) | 100929-99-5 | Reference compound |
| HY-101445 | Trolox | 53188-07-1 | Reference compound |
| HY-101445A | (R)-Trolox | 53101-49-8 | Reference compound |
| HY-101445AR | (R)-Trolox (Standard) | 53101-49-8 | Reference Standards |
| HY-101445B | (S)-Trolox | 53174-06-4 | Reference compound |
| HY-101445R | Trolox (Standard) | 53188-07-1 | Reference Standards |
| HY-101446 | HIOC | 314054-36-9 | Reference compound |
| HY-101447 | SI-2 | 223788-33-8 | Reference compound |
| HY-101447A | SI-2 (hydrochloride) | 1992052-49-9 | Reference compound |
| HY-101448 | TMI-1 | 287403-39-8 | Reference compound |
| HY-101449 | Adaptaquin | 385786-48-1 | Reference compound |
| HY-101450 | PF-6274484 | 1035638-91-5 | Reference compound |
| HY-101451 | PBIT | 2514-30-9 | Reference compound |
| HY-101453 | Ceefourin 1 | 315702-40-0 | Reference compound |
| HY-101454 | SR0987 | 303126-97-8 | Reference compound |
| HY-101455 | CDN1163 | 892711-75-0 | Reference compound |
| HY-101456 | PCPA methyl ester (hydrochloride) | 14173-40-1 | Reference compound |
| HY-101457 | JZP-430 | 1672691-74-5 | Reference compound |
| HY-101458 | IT1t | 864677-55-4 | Reference compound |
| HY-101458A | IT1t (dihydrochloride) | 1092776-63-0 | Reference compound |
| HY-101459 | RTC13 | 1359825-94-7 | Reference compound |
| HY-101460 | Tz-Thalidomide | 2087490-42-2 | Reference compound |
| HY-101461 | Methyl-β-cyclodextrin | 128446-36-6 | Biochemical Assay Reagents |
| HY-101462 | RAD51 Inhibitor B02 | 1290541-46-6 | Reference compound |
| HY-101464 | ML329 | 19992-50-8 | Reference compound |
| HY-101465 | AK-1 | 330461-64-8 | Reference compound |
| HY-101466 | E7090 | 1622204-21-0 | Reference compound |
| HY-101466A | E7090 (succinate) | 1879965-80-6 | Reference compound |
| HY-101467 | Trilaciclib | 1374743-00-6 | Reference compound |
| HY-101467A | Trilaciclib (hydrochloride) | 1977495-97-8 | Reference compound |
| HY-101467AR | Trilaciclib (hydrochloride) (Standard) | 1977495-97-8 | Reference Standards |
| HY-101472 | Closthioamide | 1227367-59-0 | Natural Products |
| HY-101473 | EMD527040 | 851333-14-7 | Reference compound |
| HY-101474 | (±)-Zanubrutinib | 1633350-06-7 | Reference compound |
| HY-101474A | Zanubrutinib | 1691249-45-2 | Reference compound |
| HY-101474AR | Zanubrutinib (Standard) | 1691249-45-2 | Reference Standards |
| HY-101474B | (R)-Zanubrutinib | 1691249-44-1 | Reference compound |
| HY-101474BS | (R)-Zanubrutinib-d5 | Isotope-Labeled Compounds | |
| HY-101474S | Zanubrutinib-d5 | Isotope-Labeled Compounds | |
| HY-101476 | Emodepside | 155030-63-0 | Reference compound |
| HY-101476R | Emodepside (Standard) | 155030-63-0 | Reference Standards |
| HY-101478 | Fenobam | 57653-26-6 | Reference compound |
| HY-101478A | Fenobam (hydrate) | 63540-28-3 | Reference compound |
| HY-101478R | Fenobam (Standard) | 57653-26-6 | Reference Standards |
| HY-101479 | Iclaprim | 192314-93-5 | Reference compound |
| HY-101479R | Iclaprim (Standard) | 192314-93-5 | Reference Standards |
| HY-101479S | Iclaprim-d6 | 1130072-57-9 | Isotope-Labeled Compounds |
| HY-101480 | Xylamidine | 6443-50-1 | Reference compound |
| HY-101480A | Xylamidine (tosylate) | 6443-40-9 | Reference compound |
| HY-101481 | Flurbiprofen axetil | 91503-79-6 | Reference compound |
| HY-101481R | Flurbiprofen axetil (Standard) | 91503-79-6 | Reference Standards |
| HY-101482 | Ibuprofen piconol | 64622-45-3 | Reference compound |
| HY-101482R | Ibuprofen piconol (Standard) | 64622-45-3 | Reference Standards |
| HY-101483 | Dihydromunduletone | 674786-20-0 | Reference compound |
| HY-101484A | NE-100 (hydrochloride) | 149409-57-4 | Reference compound |
| HY-101484AR | NE-100 (hydrochloride) (Standard) | 149409-57-4 | Reference Standards |
| HY-101485 | AUTEN-99 (hydrobromide) | 1049780-58-6 | Reference compound |
| HY-101486 | LF3 | 664969-54-4 | Reference compound |
| HY-101488 | CC-885 | 1010100-07-8 | Reference compound |
| HY-101489 | GZD856 | 1257628-64-0 | Reference compound |
| HY-101489A | GZD856 (formic) | 2804039-78-7 | Reference compound |
| HY-101490 | PDE1-IN-2 | 1904611-63-7 | Reference compound |
| HY-101491 | SR-18292 | 2095432-55-4 | Reference compound |
| HY-101491S | SR-18292-d9 | Isotope-Labeled Compounds | |
| HY-101492 | GPR120 Agonist 3 | 1599477-75-4 | Reference compound |
| HY-101493 | SUN11602 | 704869-38-5 | Reference compound |
| HY-101494 | Temuterkib | 1951483-29-6 | Reference compound |
| HY-101495 | 18-HEPE | 141110-17-0 | Natural Products |
| HY-101496 | MT-DADMe-ImmA | 653592-04-2 | Reference compound |
| HY-101499 | GKT136901 | 955272-06-7 | Reference compound |
| HY-101499A | GKT136901 (hydrochloride) | 1254507-01-1 | Reference compound |
| HY-101499AR | GKT136901 (hydrochloride) (Standard) | 1254507-01-1 | Reference Standards |
| HY-101499R | GKT136901 (Standard) | 955272-06-7 | Reference Standards |
| HY-101502A | SB290157 (trifluoroacetate) | 1140525-25-2 | Reference compound |
| HY-101503 | HTS01037 | 682741-29-3 | Reference compound |
| HY-101505 | Zinc dethyldithiocarbamate | 14324-55-1 | Biochemical Assay Reagents |
| HY-101506 | 2,4,6-Tribromophenyl caproate | 16732-09-5 | Reference compound |
| HY-101507 | Zerencotrep | 1628287-16-0 | Reference compound |
| HY-101508 | GNA002 | 1385035-79-9 | Reference compound |
| HY-101509 | HSL-IN-1 | 2095156-13-9 | Reference compound |
| HY-101510 | F1063-0967 | 613225-56-2 | Reference compound |
| HY-101511 | TTT-28 | 1609138-51-3 | Reference compound |
| HY-101512 | A-395 | 2089148-72-9 | Reference compound |
| HY-101513 | eIF4A3-IN-1 | 2095486-67-0 | Reference compound |
| HY-101514 | β3-AR agonist 1 | 1283125-73-4 | Reference compound |
| HY-101515 | MELK-IN-1 | 2095596-44-2 | Reference compound |
| HY-101516 | CYP17-IN-1 | 2093317-51-0 | Reference compound |
| HY-101517 | PI3K-IN-2 | 1403458-28-5 | Reference compound |
| HY-101518 | Alrizomadlin | 1818393-16-6 | Reference compound |
| HY-101519 | BETd-260 | 2093388-62-4 | Reference compound |
| HY-101520 | Dot1L-IN-1 | 2088518-50-5 | Reference compound |
| HY-101520A | Dot1L-IN-1 (TFA) | Reference compound | |
| HY-101521 | CHMFL-BTK-01 | 2095280-64-9 | Reference compound |
| HY-101522 | CHMFL-EGFR-202 | 2089381-40-6 | Reference compound |
| HY-101523 | Cdc7-IN-1 | 1402055-25-7 | Reference compound |
| HY-101524 | TC13172 | 2093393-05-4 | Reference compound |
| HY-101525 | MBP146-78 | 188343-77-3 | Reference compound |
| HY-101526 | GENZ-882706 | 2070864-35-4 | Reference compound |
| HY-101526R | GENZ-882706(Raceme) | 2070861-46-8 | Reference compound |
| HY-101527 | 20-HEDE | 240427-90-1 | Reference compound |
| HY-101528 | IDRA 21 | 22503-72-6 | Reference compound |
| HY-101529 | Imanixil | 75689-93-9 | Reference compound |
| HY-101530 | Polyoxyethylene stearate | 9004-99-3 | Reference compound |
| HY-101530A | Polyoxyl 8 stearate | 70802-40-3 | Reference compound |
| HY-101530B | Polyoxyl 40 stearate | 171286-89-8 | Reference compound |
| HY-101530C | Polyoxyl 100 stearate | 9004-99-3 | Reference compound |
| HY-101532 | 6A-Azido-6A-deoxy-β-cyclodextrin | 98169-85-8 | Reference compound |
| HY-101533 | AZD-5991 | 2143061-81-6 | Reference compound |
| HY-101533A | AZD-5991 (Racemate) | 2143010-83-5 | Reference compound |
| HY-101533B | AZD-5991 (S-enantiomer) | 2143061-82-7 | Reference compound |
| HY-101534 | GSK1059865 | 1191044-58-2 | Reference compound |
| HY-101535 | ARP101 | 849773-63-3 | Reference compound |
| HY-101536 | GPR4 antagonist 1 | 1197879-16-5 | Reference compound |
| HY-101540 | NMI 8739 | 129024-87-9 | Reference compound |
| HY-101541 | Docosahexaenoic acid methyl ester | 2566-90-7 | Reference compound |
| HY-101541R | Docosahexaenoic acid methyl ester (Standard) | 2566-90-7 | Reference Standards |
| HY-101541S | Docosahexaenoic acid-d5 methyl ester | 2687960-96-7 | Isotope-Labeled Compounds |
| HY-101541S1 | Docosahexaenoic acid-13C22 methyl ester | Isotope-Labeled Compounds | |
| HY-101542 | Milfasartan | 148564-47-0 | Reference compound |
| HY-101544 | ARQ 069 | 1314021-57-2 | Reference compound |
| HY-101546A | Cavidine | 32728-75-9 | Natural Products |
| HY-101547 | TRPC6-IN-1 | 901715-05-7 | Reference compound |
| HY-101548 | OGT-IN-1 | 371215-02-0 | Reference compound |
| HY-101549 | MRX-2843 | 1429882-07-4 | Reference compound |
| HY-101549A | MRX-2843 (hydrochloride) | 2498541-94-7 | Reference compound |
| HY-101550 | HI-TOPK-032 | 487020-03-1 | Reference compound |
| HY-101552A | L,L-Dityrosine | 63442-81-9 | Reference compound |
| HY-101552B | L,L-Dityrosine (hydrochloride) | 221308-01-6 | Reference compound |
| HY-101552C | Dityrosine (dihydrochloride) | 2716849-01-1 | Reference compound |
| HY-101553 | Triflubazam | 22365-40-8 | Reference compound |
| HY-101554 | Guancydine | 1113-10-6 | Reference compound |
| HY-101556 | Namirotene | 101506-83-6 | Reference compound |
| HY-101558B | Elzasonan (hydrochloride) | 220322-05-4 | Reference compound |
| HY-101559 | 10-Nitrooleic acid | 875685-46-4 | Reference compound |
| HY-101559S | 10-Nitrooleate-d17 (nitrate) | 2749984-40-3 | Isotope-Labeled Compounds |
| HY-101560 | Linrodostat | 1923833-60-6 | Reference compound |
| HY-101560A | Linrodostat (mesylate) | 2221034-29-1 | Reference compound |
| HY-101561 | Avapritinib | 1703793-34-3 | Reference compound |
| HY-101561R | Avapritinib (Standard) | 1703793-34-3 | Reference Standards |
| HY-101562 | Inavolisib | 2060571-02-8 | Reference compound |
| HY-101563 | GSK3326595 | 1616392-22-3 | Reference compound |
| HY-101564 | Onametostat | 2086772-26-9 | Reference compound |
| HY-101565 | Tapotoclax | 1883727-34-1 | Reference compound |
| HY-101566 | Elimusertib | 1876467-74-1 | Reference compound |
| HY-101566A | Elimusertib (hydrochloride) | Reference compound | |
| HY-101566S | Elimusertib-d3 | Isotope-Labeled Compounds | |
| HY-101567 | BMS-986158 | 1800340-40-2 | Reference compound |
| HY-101568 | Roblitinib | 1708971-55-4 | Reference compound |
| HY-101569 | Darovasertib | 1874276-76-2 | Reference compound |
| HY-101570 | Nedisertib | 1637542-33-6 | Reference compound |
| HY-101572 | MHP | 1104874-94-3 | Reference compound |
| HY-101573 | Bencianol | 85443-48-7 | Reference compound |
| HY-101574 | Pratosartan | 153804-05-8 | Reference compound |
| HY-101575 | Acetylazide | 3590-05-4 | Reference compound |
| HY-101576 | RP 70676 | 136609-26-2 | Reference compound |
| HY-101577 | NCX899 | 690655-41-5 | Reference compound |
| HY-101578 | 2614W94 | 205187-35-5 | Reference compound |
| HY-101579 | LY 178002 | 107889-32-7 | Reference compound |
| HY-10158 | Bosutinib | 380843-75-4 | Reference compound |
| HY-101580 | Paliroden | 188396-77-2 | Reference compound |
| HY-101581 | Bucloxic acid | 32808-51-8 | Reference compound |
| HY-101581A | Bucloxic acid (calcium) | 32808-53-0 | Reference compound |
| HY-101582 | ZT 52656A hydrochloride | 115730-24-0 | Reference compound |
| HY-101583 | NEO 376 | 496921-73-4 | Reference compound |
| HY-101585 | Imoxiterol | 88578-07-8 | Reference compound |
| HY-101586 | Alvameline | 120241-31-8 | Reference compound |
| HY-101586A | Alvameline (maleate) | 219581-36-9 | Reference compound |
| HY-101587 | (E)-KME-4 | 102271-49-8 | Reference compound |
| HY-101588 | Gefapixant | 1015787-98-0 | Reference compound |
| HY-101588A | Gefapixant (citrate) | 2310299-91-1 | Reference compound |
| HY-101588R | Gefapixant (Standard) | 1015787-98-0 | Reference Standards |
| HY-101589 | Sotirimod | 227318-75-4 | Reference compound |
| HY-10158A | Bosutinib (hydrate) | 918639-08-4 | Reference compound |
| HY-10158AR | Bosutinib (hydrate) (Standard) | 918639-08-4 | Reference Standards |
| HY-10158S | Bosutinib-d8 | Isotope-Labeled Compounds | |
| HY-10158S1 | Bosutinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-10159 | Nilotinib | 641571-10-0 | Reference compound |
| HY-101590 | Symetine | 15599-45-8 | Reference compound |
| HY-101590A | Symetine (dihydrochloride) | 5585-62-6 | Reference compound |
| HY-101593 | Fibracillin | 51154-48-4 | Reference compound |
| HY-101594 | Tulopafant | 116289-53-3 | Reference compound |
| HY-101595 | RPH-2823 | 96558-24-6 | Reference compound |
| HY-101596 | Ethyl dirazepate | 23980-14-5 | Reference compound |
| HY-101597 | NVX-207 | 745020-66-0 | Reference compound |
| HY-101598 | PD-159020 | 177904-00-6 | Reference compound |
| HY-10159A | Nilotinib (monohydrochloride monohydrate) | 923288-90-8 | Reference compound |
| HY-10159AR | Nilotinib (monohydrochloride monohydrate) (Standard) | 923288-90-8 | Reference Standards |
| HY-10159B | Nilotinib (hydrochloride) | 923288-95-3 | Reference compound |
| HY-10159R | Nilotinib (Standard) | 641571-10-0 | Reference Standards |
| HY-10159S | Nilotinib-d6 | 1268356-17-7 | Isotope-Labeled Compounds |
| HY-10159S1 | Nilotinib-13C,d3 | 1261398-62-2 | Isotope-Labeled Compounds |
| HY-101600 | RPR104632 | 154106-92-0 | Reference compound |
| HY-101601 | Bamirastine | 215529-47-8 | Reference compound |
| HY-101602 | Aligeron | 70713-45-0 | Reference compound |
| HY-101603 | Manitimus | 202057-76-9 | Reference compound |
| HY-101604 | Atrimustine | 75219-46-4 | Reference compound |
| HY-101604R | Atrimustine (Standard) | 75219-46-4 | Reference Standards |
| HY-101605 | Prodipine hydrochloride | 31314-39-3 | Reference compound |
| HY-101606 | Etersalate | 62992-61-4 | Reference compound |
| HY-101607 | KT-362 | 105394-80-7 | Reference compound |
| HY-101607A | KT-362 (free acid) | 93392-97-3 | Reference compound |
| HY-101608 | Ambasilide | 83991-25-7 | Reference compound |
| HY-101609 | Lesopitron (dihydrochloride) | 132449-89-9 | Reference compound |
| HY-10161 | Tozasertib | 639089-54-6 | Reference compound |
| HY-101610 | OPC-28326 | 167626-17-7 | Reference compound |
| HY-101611 | MSC2530818 | 1883423-59-3 | Reference compound |
| HY-101612 | SPD-473 citrate | 161190-26-7 | Reference compound |
| HY-101616 | ABT-639 hydrochloride | 1235560-31-2 | Reference compound |
| HY-101617 | Droxicainide | 78289-26-6 | Reference compound |
| HY-101617A | Droxicainide (hydrochloride) | 149572-05-4 | Reference compound |
| HY-101618 | L162389 | 169281-53-2 | Reference compound |
| HY-101619 | Abaperidone | 183849-43-6 | Reference compound |
| HY-101619A | Abaperidone (hydrochloride) | 183849-45-8 | Reference compound |
| HY-10162 | Olaparib | 763113-22-0 | Reference compound |
| HY-101620 | MRZ 2-514 | 202808-11-5 | Reference compound |
| HY-101621 | Teludipine hydrochloride | 108700-03-4 | Reference compound |
| HY-101621S | Teludipine-d6 | 1246833-02-2 | Isotope-Labeled Compounds |
| HY-101622 | 5-HT6/7 antagonist 1 | 131999-28-5 | Reference compound |
| HY-101625 | Recilisib | 334969-03-8 | Reference compound |
| HY-101625A | Recilisib (sodium) | 922139-31-9 | Reference compound |
| HY-101626 | Sigma-LIGAND-1 | 139652-01-0 | Reference compound |
| HY-101626A | Sigma-LIGAND-1 (hydrochloride) | 139652-86-1 | Reference compound |
| HY-101627 | YM17E | 124900-72-7 | Reference compound |
| HY-101628 | VEGFR-2-IN-9 | 408502-06-7 | Reference compound |
| HY-101629 | (E)-Crotylbarbital | 28360-89-6 | Reference compound |
| HY-10162R | Olaparib (Standard) | 763113-22-0 | Reference Standards |
| HY-10162S | Olaparib-d5 | 2143107-56-4 | Isotope-Labeled Compounds |
| HY-10162S1 | Olaparib-d8 | Isotope-Labeled Compounds | |
| HY-10162S3 | Olaparib-d4-1 | 2143107-55-3 | Isotope-Labeled Compounds |
| HY-10163 | Dabigatran | 211914-51-1 | Reference compound |
| HY-101630 | Deramciclane | 120444-71-5 | Reference compound |
| HY-101630A | Deramciclane (fumarate) | 120444-72-6 | Reference compound |
| HY-101630R | Deramciclane (Standard) | 120444-71-5 | Reference Standards |
| HY-101631 | Levophacetoperane (hydrochloride) | 23257-56-9 | Reference compound |
| HY-101632 | Irindalone | 96478-43-2 | Reference compound |
| HY-101633 | GSK-1004723 | 955359-72-5 | Reference compound |
| HY-101634 | ABT-072 | 1132936-00-5 | Reference compound |
| HY-101634A | ABT-072 (potassium trihydrate) | 1132940-31-8 | Reference compound |
| HY-101635 | Proxibarbal | 2537-29-3 | Reference compound |
| HY-101637 | Reglitazar | 170861-63-9 | Reference compound |
| HY-101638 | (±)-Fabesetron (hydrochloride) | 129299-81-6 | Reference compound |
| HY-101638A | (±)-Fabesetron | 129299-72-5 | Reference compound |
| HY-101639 | CP-409092 | 194098-25-4 | Reference compound |
| HY-101639A | CP-409092 (hydrochloride) | 225240-86-8 | Reference compound |
| HY-10163AS | Dabigatran-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10163AS1 | Dabigatran-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10163R | Dabigatran (Standard) | 211914-51-1 | Reference Standards |
| HY-10163S | Dabigatran-d4 | 1618637-32-3 | Isotope-Labeled Compounds |
| HY-10163S1 | Dabigatran-d3 | 1246817-44-6 | Isotope-Labeled Compounds |
| HY-10163S2 | Dabigatran-13C6 | 1210608-88-0 | Isotope-Labeled Compounds |
| HY-10163S3 | Dabigatran-13C,d3 | Isotope-Labeled Compounds | |
| HY-10164 | E-6123 | 131614-02-3 | Reference compound |
| HY-101640 | TPA 023 | 252977-51-8 | Reference compound |
| HY-101641 | NRA-0160 | 204718-47-8 | Reference compound |
| HY-101642 | Losmiprofen | 74168-08-4 | Reference compound |
| HY-101644 | Saterinone | 102669-89-6 | Reference compound |
| HY-101644A | Saterinone hydrochloride | 102685-83-6 | Reference compound |
| HY-101646 | Saviprazole | 121617-11-6 | Reference compound |
| HY-101647 | Intoplicine | 125974-72-3 | Reference compound |
| HY-101647A | Intoplicine (dimesylate) | 133711-99-6 | Reference compound |
| HY-101648 | ACAT-IN-1 cis isomer | 145961-79-1 | Reference compound |
| HY-101649 | Imiglitazar | 250601-04-8 | Reference compound |
| HY-10165 | PSI-6130 | 817204-33-4 | Reference compound |
| HY-101651 | WQ 2743 | 189280-13-5 | Reference compound |
| HY-101653 | MHP 133 | 147340-43-0 | Reference compound |
| HY-101654 | Rocepafant | 132579-32-9 | Reference compound |
| HY-101655 | COX-2-IN-2 | 134729-13-8 | Reference compound |
| HY-101656 | Medroxalol | 56290-94-9 | Reference compound |
| HY-101656A | Medroxalol (hydrochloride) | 70161-10-3 | Reference compound |
| HY-101657 | Clocoumarol | 35838-63-2 | Reference compound |
| HY-101658 | Pargolol hydrochloride | 36902-82-6 | Reference compound |
| HY-101658A | Pargolol | 47082-97-3 | Reference compound |
| HY-101660 | Nifursemizone | 5579-89-5 | Reference compound |
| HY-101661 | Win 58237 | 158001-76-4 | Reference compound |
| HY-101662 | Pibrentasvir | 1353900-92-1 | Reference compound |
| HY-101663 | Ruzasvir | 1613081-64-3 | Reference compound |
| HY-101664 | Ilaprazole | 172152-36-2 | Reference compound |
| HY-101664R | Ilaprazole (Standard) | 172152-36-2 | Reference Standards |
| HY-101664S | Ilaprazole-d3 | 1070969-17-3 | Isotope-Labeled Compounds |
| HY-101665 | Pagoclone | 133737-32-3 | Reference compound |
| HY-101666 | HBX 41108 | 924296-39-9 | Reference compound |
| HY-101667 | LTURM34 | 1879887-96-3 | Reference compound |
| HY-101668 | Sulamserod | 219757-90-1 | Reference compound |
| HY-101668A | Sulamserod (hydrochloride) | 184159-40-8 | Reference compound |
| HY-101669 | TDN345 | 134069-68-4 | Reference compound |
| HY-10167 | Tecalcet | 148717-54-8 | Reference compound |
| HY-101670 | MTPPA | 70991-61-6 | Reference compound |
| HY-101671 | S-methyl-KE-298 | 143584-75-2 | Reference compound |
| HY-101671R | S-methyl-KE-298 (Standard) | 143584-75-2 | Reference Standards |
| HY-101672 | Deferitazole | 945635-15-4 | Reference compound |
| HY-101674 | Tiapamil hydrochloride | 57010-32-9 | Reference compound |
| HY-101675 | Setipafant | 132418-35-0 | Reference compound |
| HY-101676 | RG-12525 | 120128-20-3 | Reference compound |
| HY-101677 | cPrPMEDAP | 182798-83-0 | Reference compound |
| HY-101679 | YM-58790 | 214558-72-2 | Reference compound |
| HY-101679A | YM-58790 (free base) | 168830-70-4 | Reference compound |
| HY-10167A | Tecalcet (Hydrochloride) | 177172-49-5 | Reference compound |
| HY-101680 | Zolasartan | 145781-32-4 | Reference compound |
| HY-101681 | Utibapril | 109683-61-6 | Reference compound |
| HY-101682 | SCH 42495 | 136511-43-8 | Reference compound |
| HY-101682A | SCH 42495 (racemate) | 145841-10-7 | Reference compound |
| HY-101682B | (R)-SCH 42495 | 156792-25-5 | Reference compound |
| HY-101683 | Deriglidole | 122830-14-2 | Reference compound |
| HY-101684 | Nitroxazepine | 47439-36-1 | Reference compound |
| HY-101684A | Nitroxazepine (hydrochloride) | 16398-39-3 | Reference compound |
| HY-101685 | Iganidipine | 119687-33-1 | Reference compound |
| HY-101685A | Iganidipine di(hydrochloride) | 117241-46-0 | Reference compound |
| HY-101686 | LM-1484 | 197506-02-8 | Reference compound |
| HY-101687 | Nosantine (racemate) | 75166-67-5 | Reference compound |
| HY-101689 | Benzpiperylone | 53-89-4 | Reference compound |
| HY-101690 | QF0301B | 149247-12-1 | Reference compound |
| HY-101691 | Ecastolol | 77695-52-4 | Reference compound |
| HY-101692 | AZ-1355 | 75451-07-9 | Reference compound |
| HY-101693 | Senazodan | 98326-32-0 | Reference compound |
| HY-101693A | Senazodan (hydrochloride) | 98326-33-1 | Reference compound |
| HY-101694 | Siltenzepine | 98374-54-0 | Reference compound |
| HY-101695 | EP1-antagonist-1 | 851204-35-8 | Reference compound |
| HY-101696 | Fluproquazone | 40507-23-1 | Reference compound |
| HY-101698 | Alniditan | 152317-89-0 | Reference compound |
| HY-101698B | Alniditan (dihydrochloride) | 155428-00-5 | Reference compound |
| HY-101699 | AMG-076 (free base) | 693823-79-9 | Reference compound |
| HY-101699A | AMG-076 | 1001438-96-5 | Reference compound |
| HY-101700 | LCB-2853 | 141335-10-6 | Reference compound |
| HY-101701 | Hepronicate | 7237-81-2 | Reference compound |
| HY-101703 | Ro 31-9790 | 145337-55-9 | Reference compound |
| HY-101704 | Y1 receptor antagonist 1 | 221697-09-2 | Reference compound |
| HY-101704A | Y1 receptor antagonist 1 (formic) | Reference compound | |
| HY-101705 | Tibenelast sodium | 105102-18-9 | Reference compound |
| HY-101706 | CGP48369 | 135689-23-5 | Reference compound |
| HY-101707 | UK51656 | 88150-59-8 | Reference compound |
| HY-101708 | N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea | 97627-24-2 | Reference compound |
| HY-101709 | Ricasetron | 117086-68-7 | Reference compound |
| HY-10171 | NPS-2143 (hydrochloride) | 324523-20-8 | Reference compound |
| HY-101710 | Benzgalantamine | 224169-27-1 | Reference compound |
| HY-101712 | TRC051384 | 867164-40-7 | Reference compound |
| HY-101713 | Ilacirnon | 1100318-47-5 | Reference compound |
| HY-101713R | Ilacirnon (Standard) | 1100318-47-5 | Reference Standards |
| HY-101714 | Oxyphenisatin acetate | 115-33-3 | Reference compound |
| HY-101714R | Oxyphenisatin acetate (Standard) | 115-33-3 | Reference Standards |
| HY-101715 | Panidazole | 13752-33-5 | Reference compound |
| HY-101716 | RP-54745 | 135330-08-4 | Reference compound |
| HY-101717 | Indanidine | 85392-79-6 | Reference compound |
| HY-101718 | Aticaprant | 1174130-61-0 | Reference compound |
| HY-101719 | Ketocaine | 1092-46-2 | Reference compound |
| HY-10172 | IMD-0354 | 978-62-1 | Reference compound |
| HY-101720 | Fradafiban | 148396-36-5 | Reference compound |
| HY-101720A | Fradafiban (hydrochloride) | Reference compound | |
| HY-101721 | Ko-3290 | 79848-61-6 | Reference compound |
| HY-101722 | Melinamide | 14417-88-0 | Reference compound |
| HY-101722R | Melinamide (Standard) | 14417-88-0 | Reference Standards |
| HY-101723 | Modecainide | 81329-71-7 | Reference compound |
| HY-101723R | Modecainide (Standard) | 81329-71-7 | Reference Standards |
| HY-101724 | ReN-1869 hydrochloride | 170149-76-5 | Reference compound |
| HY-101725 | Meclonazepam | 58662-84-3 | Reference compound |
| HY-101725A | (R)-Meclonazepam | 86630-81-1 | Reference compound |
| HY-101726 | DuP 105 | 96800-41-8 | Reference compound |
| HY-101727 | Nexopamil (racemate) | 116759-35-4 | Reference compound |
| HY-101729 | Anti-Heart Failure Agent 1 | 142648-47-3 | Reference compound |
| HY-10172R | IMD-0354 (Standard) | 978-62-1 | Reference Standards |
| HY-101730 | Antibacterial compound 2 | 170104-58-2 | Reference compound |
| HY-101731 | CP-96021 (hydrochloride) | 167011-22-5 | Reference compound |
| HY-101733 | Zabicipril (hydrochloride) | 90130-77-1 | Reference compound |
| HY-101734 | Trestolone | 3764-87-2 | Reference compound |
| HY-101735 | (9Z,11E)-Prodlure | 50767-79-8 | Natural Products |
| HY-101735R | (9Z,11E)-Prodlure (Standard) | 50767-79-8 | Reference Standards |
| HY-101736 | AMG9810 | 545395-94-6 | Reference compound |
| HY-101737 | 24-Norursodeoxycholic acid | 99697-24-2 | Reference compound |
| HY-101737R | 24-Norursodeoxycholic acid (Standard) | 99697-24-2 | Reference Standards |
| HY-101738 | Peliglitazar | 331744-64-0 | Reference compound |
| HY-101738A | Peliglitazar (racemate) | 331744-72-0 | Reference compound |
| HY-101739 | Amcinafal | 3924-70-7 | Reference compound |
| HY-10174 | PD184161 | 212631-67-9 | Reference compound |
| HY-101740 | SQ-31765 | 138383-07-0 | Reference compound |
| HY-101743 | Elucaine | 25314-87-8 | Reference compound |
| HY-101744 | Ipsalazide | 82101-17-5 | Reference compound |
| HY-101745 | Rocastine | 91833-49-7 | Reference compound |
| HY-101746 | GSK376501A | 1010412-80-2 | Reference compound |
| HY-101747 | ADR 851 (free base) | 138559-56-5 | Reference compound |
| HY-101747A | ADR 851 | 123805-17-4 | Reference compound |
| HY-101748 | Tegadifur | 62987-05-7 | Reference compound |
| HY-101749 | WAY127093B (racemate) | 145743-63-1 | Reference compound |
| HY-101750 | Arrhythmias-Targeting Compound 1 | 335619-12-0 | Reference compound |
| HY-101751 | Chlorthenoxazine | 132-89-8 | Reference compound |
| HY-101752 | (±)-Befunolol | 39552-01-7 | Reference compound |
| HY-101752A | (±)-Befunolol (hydrochloride) | 39543-79-8 | Reference compound |
| HY-101753 | Cianopramine | 66834-24-0 | Reference compound |
| HY-101753A | Cianopramine (hydrochloride) | 66834-20-6 | Reference compound |
| HY-101754 | Oxyfenamate | 50-19-1 | Reference compound |
| HY-101755 | Tedatioxetine (hydrobromide) | 960151-65-9 | Reference compound |
| HY-101756 | SDZ281-977 | 150779-71-8 | Reference compound |
| HY-101757 | NO-prednisolone | 327610-87-7 | Reference compound |
| HY-101758 | BM-131246 | 103787-97-9 | Reference compound |
| HY-101759 | Isoxsuprine-monoester-1 | 67160-74-1 | Reference compound |
| HY-101760 | GSK2982772 | 1622848-92-3 | Reference compound |
| HY-101761 | TM5441 | 1190221-43-2 | Reference compound |
| HY-101761A | TM5441 (sodium) | 2319722-53-5 | Reference compound |
| HY-101762 | TyK2-IN-2 | 2098466-94-3 | Reference compound |
| HY-101763A | (S,R,S)-AHPC (monohydrochloride) | 1448189-80-7 | Reference compound |
| HY-101763B | (S,R,S)-AHPC (dihydrochloride) | 2137142-47-1 | Reference compound |
| HY-101764 | Lintitript | 136381-85-6 | Reference compound |
| HY-101765 | GW 833972A | 1092502-33-4 | Reference compound |
| HY-101766 | Btk inhibitor 2 | 1558036-85-3 | Reference compound |
| HY-101768 | PRN1371 | 1802929-43-6 | Reference compound |
| HY-101769 | UAMC00039 (dihydrochloride) | 697797-51-6 | Reference compound |
| HY-101770 | BTB-1 | 86030-08-2 | Reference compound |
| HY-101771A | (2-Chloropyridin-4-yl)methanamine hydrochloride | 916210-98-5 | Reference compound |
| HY-101772 | Ziritaxestat | 1628260-79-6 | Reference compound |
| HY-101772R | Ziritaxestat (Standard) | 1628260-79-6 | Reference Standards |
| HY-101773 | c-Met-IN-2 | 1635406-73-3 | Reference compound |
| HY-101774 | CSF1R-IN-1 | 2095849-04-8 | Reference compound |
| HY-101775 | 9-Hydroxyellipticin | 51131-85-2 | Reference compound |
| HY-101775A | 9-Hydroxyellipticine (hydrochloride) | 52238-35-4 | Reference compound |
| HY-101775AR | 9-Hydroxyellipticine (hydrochloride) (Standard) | 52238-35-4 | Reference Standards |
| HY-101776 | Desmethyl-VS-5584 | 1246535-95-4 | Reference compound |
| HY-101776A | Desmethyl-VS-5584 (hydrochloride) | Reference compound | |
| HY-101777 | TC-O 9311 | 444932-31-4 | Reference compound |
| HY-101778 | ML311 | 315698-17-0 | Reference compound |
| HY-101779 | DCG04 | 314263-42-8 | Reference compound |
| HY-101779A | DCG04 isomer-1 | Reference compound | |
| HY-10178 | PHA-680632 | 398493-79-3 | Reference compound |
| HY-101780 | Tinostamustine | 1236199-60-2 | Reference compound |
| HY-101780A | Tinostamustine (hydrochloride) | 1793059-58-1 | Reference compound |
| HY-101782 | HSK0935 | 1638851-44-1 | Reference compound |
| HY-101783 | GNE-955 | 1527523-39-2 | Reference compound |
| HY-101784 | NE 52-QQ57 | 1401728-56-0 | Reference compound |
| HY-101785 | eIF4A3-IN-2 | 2095677-20-4 | Reference compound |
| HY-101786 | KZR-504 | 1629052-78-3 | Reference compound |
| HY-101787 | TP-024 | 1358575-02-6 | Reference compound |
| HY-101788 | Glucokinase activator 1 | 1328987-85-4 | Reference compound |
| HY-101789 | Nav1.7-IN-3 | 1788872-06-9 | Reference compound |
| HY-10179 | Danusertib | 827318-97-8 | Reference compound |
| HY-101790 | ZM223 | 2031177-48-5 | Reference compound |
| HY-101790A | ZM223 (hydrochloride) | 2438679-27-5 | Reference compound |
| HY-101791 | P-gp inhibitor 1 | 2050747-49-2 | Reference compound |
| HY-101792 | RG7800 | 1449598-06-4 | Reference compound |
| HY-101792A | RG7800 (tetrahydrochloride) | Reference compound | |
| HY-101793 | BMS-935177 | 1231889-53-4 | Reference compound |
| HY-101794 | 2-(Pyridyldithio)ethylamine (hydrochloride) | 106139-15-5 | Biochemical Assay Reagents |
| HY-101795 | Larixyl acetate | 4608-49-5 | Natural Products |
| HY-101795R | Larixyl acetate (Standard) | 4608-49-5 | Reference Standards |
| HY-101796 | NSC-70220 | 4551-00-2 | Reference compound |
| HY-101797 | Veralipride | 66644-81-3 | Reference compound |
| HY-101797R | Veralipride (Standard) | 66644-81-3 | Reference Standards |
| HY-101798 | MDVN1003 | 2058116-52-0 | Reference compound |
| HY-101799 | NCGC00244536 | 2003260-55-5 | Reference compound |
| HY-10179R | Danusertib (Standard) | 827318-97-8 | Reference Standards |
| HY-10180 | MLN8054 | 869363-13-3 | Reference compound |
| HY-101800 | Senexin B | 1449228-40-3 | Reference compound |
| HY-101801 | Ac-Gly-BoroPro | 886992-99-0 | Reference compound |
| HY-101802 | Fluzinamide | 76263-13-3 | Reference compound |
| HY-101803 | CP671305 | 445295-04-5 | Reference compound |
| HY-101804 | (E)-Alprenoxime | 125720-84-5 | Reference compound |
| HY-101805 | SK1-IN-1 | 1218816-71-7 | Reference compound |
| HY-101807 | Ro-15-2041 | 77448-87-4 | Reference compound |
| HY-101808 | Doxefazepam | 40762-15-0 | Reference compound |
| HY-101809 | CNS-5161 hydrochloride | 160756-38-7 | Reference compound |
| HY-101809A | CNS 5161 | 160754-76-7 | Reference compound |
| HY-10180A | MLN8054 (sodium) | 869366-15-4 | Reference compound |
| HY-10180R | MLN8054 (Standard) | 869363-13-3 | Reference Standards |
| HY-10181 | Dasatinib | 302962-49-8 | Reference compound |
| HY-101810 | Tazanolast | 82989-25-1 | Reference compound |
| HY-101811 | LAS-31180 | 137338-43-3 | Reference compound |
| HY-101812 | Terbufibrol | 56488-59-6 | Reference compound |
| HY-101813 | Laflunimus | 147076-36-6 | Reference compound |
| HY-101813R | Laflunimus (Standard) | 147076-36-6 | Reference Standards |
| HY-101815 | Lidanserin | 73725-85-6 | Reference compound |
| HY-101817 | Spirendolol | 81840-58-6 | Reference compound |
| HY-101818 | PNU288034 | 383199-88-0 | Reference compound |
| HY-101819 | Antibacterial compound 1 | 232951-56-3 | Reference compound |
| HY-10181A | Dasatinib (hydrochloride) | 854001-07-3 | Reference compound |
| HY-10181AR | Dasatinib (hydrochloride) (Standard) | 854001-07-3 | Reference Standards |
| HY-10181B | Dasatinib (monohydrate) | 863127-77-9 | Reference compound |
| HY-10181BR | Dasatinib (monohydrate) (Standard) | 863127-77-9 | Reference Standards |
| HY-10181G | Dasatinib (GMP) | 302962-49-8 | GMP Small Molecules |
| HY-10181R | Dasatinib (Standard) | 302962-49-8 | Reference Standards |
| HY-10181S | Dasatinib-d8 | 1132093-70-9 | Isotope-Labeled Compounds |
| HY-10181S1 | Dasatinib-d4 | 1160297-08-4 | Isotope-Labeled Compounds |
| HY-10182 | Laduviglusib | 252917-06-9 | Reference compound |
| HY-101820 | Simotinib | 944258-89-3 | Reference compound |
| HY-101820A | Simotinib (hydrochloride) | 1538617-88-7 | Reference compound |
| HY-101820R | Simotinib (Standard) | 944258-89-3 | Reference Standards |
| HY-101822 | Naminterol | 93047-40-6 | Reference compound |
| HY-101823A | A-81282 | 141872-46-0 | Reference compound |
| HY-101826 | ER21355 | 150452-18-9 | Reference compound |
| HY-101826A | ER21355 (hydrochloride) | 150452-21-4 | Reference compound |
| HY-101827 | Citenamide | 10423-37-7 | Reference compound |
| HY-101828 | Guaiapate | 852-42-6 | Reference compound |
| HY-101829 | Sulfaproxiline | 116-42-7 | Reference compound |
| HY-10182A | Laduviglusib (monohydrochloride) | 1797989-42-4 | Reference compound |
| HY-10182AR | Laduviglusib (monohydrochloride) (Standard) | 1797989-42-4 | Reference Standards |
| HY-10182B | Laduviglusib (trihydrochloride) | 1782235-14-6 | Reference compound |
| HY-10182BR | Laduviglusib (trihydrochloride) (Standard) | 1782235-14-6 | Reference Standards |
| HY-10182C | Laduviglusib (dihydrochloride) | 2109414-84-6 | Reference compound |
| HY-10182G | Laduviglusib (GMP) | 252917-06-9 | GMP Small Molecules |
| HY-10182R | Laduviglusib (Standard) | 252917-06-9 | Reference Standards |
| HY-10183 | Go6976 | 136194-77-9 | Reference compound |
| HY-101830 | Wy 49051 | 113418-56-7 | Reference compound |
| HY-101831 | Heterocyclyl carbamate derivative 1 | 168830-01-1 | Reference compound |
| HY-101832 | SBC-110736 | 1629166-02-4 | Reference compound |
| HY-101833 | YM-264 | 131888-54-5 | Reference compound |
| HY-101834 | ACT-462206 | 1361321-96-1 | Reference compound |
| HY-101835 | Decoyinine | 2004-04-8 | Reference compound |
| HY-101836 | DKM 2-93 | 65836-72-8 | Reference compound |
| HY-101837 | CGP 53716 | 152459-94-4 | Reference compound |
| HY-101838 | dBET1 | 1799711-21-9 | Reference compound |
| HY-101839 | ML381 | 1623481-80-0 | Reference compound |
| HY-10184 | TG 100572 | 867334-05-2 | Reference compound |
| HY-101840 | EIPA | 1154-25-2 | Reference compound |
| HY-101840A | EIPA (hydrochloride) | 1345839-28-2 | Reference compound |
| HY-101840AR | EIPA (hydrochloride) (Standard) | 1345839-28-2 | Reference Standards |
| HY-101840R | EIPA (Standard) | 1154-25-2 | Reference Standards |
| HY-101841 | LY 2033298 | 886047-13-8 | Reference compound |
| HY-101842 | ND-646 | 1434639-57-2 | Reference compound |
| HY-101843 | ML213 | 489402-47-3 | Reference compound |
| HY-101844 | ML-18 | 1422269-30-4 | Reference compound |
| HY-101845 | FITM | 932737-65-0 | Reference compound |
| HY-101846 | AX-15836 | 2035509-96-5 | Reference compound |
| HY-101847 | DBHDA | 99584-96-0 | Reference compound |
| HY-101848 | Latrunculin B | 76343-94-7 | Natural Products |
| HY-101848A | 16-epi-Latrunculin B | 444911-05-1 | Reference compound |
| HY-101849 | Fasentin | 392721-37-8 | Reference compound |
| HY-101849R | Fasentin (Standard) | 392721-37-8 | Reference Standards |
| HY-10185 | TG 100572 (Hydrochloride) | 867331-64-4 | Reference compound |
| HY-101850 | MOPSO | 68399-77-9 | Biochemical Assay Reagents |
| HY-101853 | STAT5-IN-1 | 285986-31-4 | Reference compound |
| HY-101854 | N6-(2-Phenylethyl)adenosine | 20125-39-7 | Reference compound |
| HY-101855 | Emrusolmin | 882697-00-9 | Reference compound |
| HY-101856 | BMS-986142 | 1643368-58-4 | Reference compound |
| HY-101857 | TP-020 | 1800025-30-2 | Reference compound |
| HY-101858 | BQCA | 338747-41-4 | Reference compound |
| HY-101859 | NucPE1 | 1404091-23-1 | Dye Reagents |
| HY-10186 | TG 100801 | 867331-82-6 | Reference compound |
| HY-101860 | GIBH-130 | 1252608-59-5 | Reference compound |
| HY-101861 | Miridesap | 224624-80-0 | Reference compound |
| HY-101862 | CB-7921220 | 115453-99-1 | Reference compound |
| HY-101863 | CB-6673567 | 379218-90-3 | Reference compound |
| HY-101864 | Blarcamesine (hydrochloride) | 195615-84-0 | Reference compound |
| HY-101865 | KKL-10 | 952849-76-2 | Reference compound |
| HY-101866 | KKL-35 | 865285-29-6 | Reference compound |
| HY-101867 | AU1235 | 1338780-86-1 | Reference compound |
| HY-101868 | INF39 | 866028-26-4 | Reference compound |
| HY-101869 | MK-0343 | 233275-76-8 | Reference compound |
| HY-101869R | MK-0343 (Standard) | 233275-76-8 | Reference Standards |
| HY-10187 | TG 100801 (Hydrochloride) | 1018069-81-2 | Reference compound |
| HY-101870 | Uzansertib | 1620012-39-6 | Reference compound |
| HY-101870B | Uzansertib (phosphate) | 2088852-47-3 | Reference compound |
| HY-101871 | Trehalose 6-behenate | 66755-19-9 | Reference compound |
| HY-101872 | GSK-872 | 1346546-69-7 | Reference compound |
| HY-101872A | GSK-872 (hydrochloride) | 2703752-81-0 | Reference compound |
| HY-101873 | Atorvastatin lactone | 125995-03-1 | Reference compound |
| HY-101873R | Atorvastatin lactone (Standard) | 125995-03-1 | Reference Standards |
| HY-101873S | Atorvastatin lactone-d5 | Isotope-Labeled Compounds | |
| HY-101876 | Rhodamine 800 | 137993-41-0 | Dye Reagents |
| HY-101877 | Statine | 49642-07-1 | Reference compound |
| HY-101877R | Statine (Standard) | 49642-07-1 | Reference Standards |
| HY-101878 | Texas Red | 60311-02-6 | Dye Reagents |
| HY-101879 | Acridine Orange (hydrochloride) | 65-61-2 | Dye Reagents |
| HY-101880 | ADHP | 119171-73-2 | Dye Reagents |
| HY-101882 | BCECF | 85138-49-4 | Dye Reagents |
| HY-101883 | BCECF-AM | 117464-70-7 | Dye Reagents |
| HY-101884 | Biocytin | 576-19-2 | Reference compound |
| HY-101884A | Biotinylated-D-lysine (TFA) | Reference compound | |
| HY-101884R | Biocytin (Standard) | 576-19-2 | Reference Standards |
| HY-101885 | Biotin LC hydrazide | 109276-34-8 | Biochemical Assay Reagents |
| HY-101886 | 5-BrUTP sodium salt | 161848-60-8 | Biochemical Assay Reagents |
| HY-101887 | Calcein Blue | 54375-47-2 | Dye Reagents |
| HY-101888 | Cresyl Violet (acetate) | 10510-54-0 | Dye Reagents |
| HY-101889 | Cresyl Violet perchlorate | 41830-80-2 | Dye Reagents |
| HY-101890 | Dabsyl chloride | 56512-49-3 | Dye Reagents |
| HY-101891 | Di-8-ANEPPS | 157134-53-7 | Dye Reagents |
| HY-101892 | DiBAC4(3) | 70363-83-6 | Dye Reagents |
| HY-101893 | Dihydrofluorescein diacetate | 35340-49-9 | Dye Reagents |
| HY-101894 | Dihydrorhodamine 123 | 109244-58-8 | Dye Reagents |
| HY-101895 | Fluorescein di(β-D-galactopyranoside) | 17817-20-8 | Dye Reagents |
| HY-101896 | Fluo-4 AM | 273221-67-3 | Dye Reagents |
| HY-101897 | Fura-2 AM | 108964-32-5 | Dye Reagents |
| HY-101898 | Indo-1 AM | 112926-02-0 | Dye Reagents |
| HY-101899 | Monochlorobimane | 76421-73-3 | Dye Reagents |
| HY-101900 | Nile Blue A (sulfate) | 3625-57-8 | Dye Reagents |
| HY-101901 | Oxazine 1 perchlorate | 24796-94-9 | Dye Reagents |
| HY-101902 | Quin-2AM | 83104-85-2 | Dye Reagents |
| HY-101903 | BMS-309403 | 300657-03-8 | Reference compound |
| HY-101903A | BMS-309403 (sodium) | 2802523-05-1 | Reference compound |
| HY-101903AR | BMS-309403 (sodium) (Standard) | 2802523-05-1 | Reference Standards |
| HY-101903R | BMS-309403 (Standard) | 300657-03-8 | Reference Standards |
| HY-101904 | 2-Chloro-2'-deoxycytidine | 10212-19-8 | Reference compound |
| HY-101905 | Moniliformin (sodium salt) | 71376-34-6 | Natural Products |
| HY-101906 | DC260126 | 346692-04-4 | Reference compound |
| HY-101907 | ASP7663 | 1190217-35-6 | Reference compound |
| HY-101908 | BMS CCR2 22 | 445479-97-0 | Reference compound |
| HY-101909 | Val-Cit-PAB-MMAF | 863971-56-6 | ADC Related |
| HY-10191 | Linsitinib | 867160-71-2 | Reference compound |
| HY-101910 | PSB-12062 | 55476-47-6 | Reference compound |
| HY-101911 | 5-BDBD | 768404-03-1 | Reference compound |
| HY-101913 | IL-17A antagonist 1 | 2205034-18-8 | Reference compound |
| HY-101915 | IL-17A antagonist 3 | 2230780-65-9 | Reference compound |
| HY-101916 | Heparan Sulfate | 9050-30-0 | Natural Products |
| HY-101916R | Heparan Sulfate (Standard) | 9050-30-0 | Reference Standards |
| HY-101918 | DS-1040 (Tosylate) | 1335138-89-0 | Reference compound |
| HY-10191R | Linsitinib (Standard) | 867160-71-2 | Reference Standards |
| HY-10192 | NVP-TAE 684 | 761439-42-3 | Reference compound |
| HY-101920 | Autophinib | 1644443-47-9 | Reference compound |
| HY-101921 | PI3Kδ-IN-1 | 1911564-39-0 | Reference compound |
| HY-101922 | IRAK4-IN-1 | 1820787-94-7 | Reference compound |
| HY-101923 | LYN-1604 | 2088939-99-3 | Reference compound |
| HY-101923A | LYN-1604 (hydrochloride) | 2216753-86-3 | Reference compound |
| HY-101923B | LYN-1604 (dihydrochloride) | 2310109-38-5 | Reference compound |
| HY-101924 | AVN-492 | 1220646-23-0 | Reference compound |
| HY-101925 | CM-272 | 1846570-31-7 | Reference compound |
| HY-101928 | KDM4D-IN-1 | 2098902-68-0 | Reference compound |
| HY-101929 | CU-CPT17e | 2109805-75-4 | Reference compound |
| HY-10193 | AZD-1480 | 935666-88-9 | Reference compound |
| HY-101930 | BMS-816336 | 1009583-20-3 | Reference compound |
| HY-101930A | (Rac)-BMS-816336 | 1009365-98-3 | Reference compound |
| HY-101930B | (R)-BMS-816336 | 1009583-83-8 | Reference compound |
| HY-101931 | hVEGF-IN-1 | 1637443-98-1 | Reference compound |
| HY-101932 | TNP-470 | 129298-91-5 | Reference compound |
| HY-101933 | MARK-IN-1 | 1109283-93-3 | Reference compound |
| HY-101934 | MARK-IN-2 | 1314893-26-9 | Reference compound |
| HY-101937 | L-ANAP | 1313516-26-5 | Dye Reagents |
| HY-101937A | (±)-ANAP | 1185251-08-4 | Dye Reagents |
| HY-101937B | L-ANAP (hydrochloride) | Dye Reagents | |
| HY-101937C | (±)-ANAP (hydrochloride) | 2308035-47-2 | Dye Reagents |
| HY-101937D | L-ANAP (TFA) | 2287346-69-2 | Dye Reagents |
| HY-101938 | Sinefungin | 58944-73-3 | Reference compound |
| HY-101939 | RP-001 | 1306761-53-4 | Reference compound |
| HY-101939A | RP-001 (hydrochloride) | 1781880-34-9 | Reference compound |
| HY-10193A | (1R)-AZD-1480 | 935666-99-2 | Reference compound |
| HY-10194 | Sepantronium (bromide) | 781661-94-7 | Reference compound |
| HY-101941 | BTK IN-1 | 1270014-40-8 | Reference compound |
| HY-101942 | Zegocractin | 1713240-67-5 | Reference compound |
| HY-101943 | LY 345899 | 10538-99-5 | Reference compound |
| HY-101944 | Iralukast | 151581-24-7 | Reference compound |
| HY-101945 | A-69412 | 123606-23-5 | Reference compound |
| HY-101946 | AS-35 | 108427-72-1 | Reference compound |
| HY-101947 | SMI-16a | 587852-28-6 | Reference compound |
| HY-10194A | Sepantronium (hydrochloride) | 355406-09-6 | Reference compound |
| HY-10195 | Ruboxistaurin | 169939-94-0 | Reference compound |
| HY-101950 | KIN1148 | 1428729-56-9 | Reference compound |
| HY-101952 | Prostaglandin E2 | 363-24-6 | Natural Products |
| HY-101952G | Prostaglandin E2 (GMP) | 363-24-6 | GMP Small Molecules |
| HY-101952R | Prostaglandin E2 (Standard) | 363-24-6 | Reference Standards |
| HY-101952S | Prostaglandin E2-d4 | 34210-10-1 | Isotope-Labeled Compounds |
| HY-101952S1 | Prostaglandin E2-d9 | 1356347-42-6 | Isotope-Labeled Compounds |
| HY-101953 | β-Apo-13-carotenone | 17974-57-1 | Reference compound |
| HY-101954 | Inarigivir | 475650-36-3 | Reference compound |
| HY-101954A | Inarigivir (ammonium) | 2172788-92-8 | Reference compound |
| HY-101955 | (2S,6S)-Hydroxynorketamine (hydrochloride) | 1430202-70-2 | Reference compound |
| HY-101955A | (2R,6R)-Hydroxynorketamine (hydrochloride) | 1430202-69-9 | Reference compound |
| HY-101957 | AG 1295 | 71897-07-9 | Reference compound |
| HY-101957R | AG 1295 (Standard) | 71897-07-9 | Reference Standards |
| HY-101958 | Tyrphostin 25 | 118409-58-8 | Reference compound |
| HY-101958R | Tyrphostin 25 (Standard) | 118409-58-8 | Reference Standards |
| HY-101959 | Tyrphostin AG213 | 122520-86-9 | Reference compound |
| HY-101959A | Tyrphostin 47 | 118409-60-2 | Reference compound |
| HY-10195A | Ruboxistaurin (mesylate) | 192050-59-2 | Reference compound |
| HY-10195B | Ruboxistaurin (hydrochloride) | 169939-93-9 | Reference compound |
| HY-10195BS | Ruboxistaurin-d6 (hydrochloride) | 1794767-04-6 | Isotope-Labeled Compounds |
| HY-10195R | Ruboxistaurin (Standard) | 169939-94-0 | Reference Standards |
| HY-101960 | (Z)-Tyrphostin A51 | 122520-90-5 | Reference compound |
| HY-101960A | Tyrphostin A51 | 126433-07-6 | Reference compound |
| HY-101961 | Tyrphostin AG 1288 | 116313-73-6 | Reference compound |
| HY-101962 | HNMPA | 132541-52-7 | Reference compound |
| HY-101963 | AD80 | 1384071-99-1 | Reference compound |
| HY-101964 | SPI-112 | 1051387-90-6 | Reference compound |
| HY-101965 | SPI-112Me | 1243685-62-2 | Reference compound |
| HY-101966 | NCT-503 | 1916571-90-8 | Reference compound |
| HY-101967 | GSK299423 | 1352149-24-6 | Reference compound |
| HY-101968 | 2'-Deoxypseudoisocytidine | 65358-18-1 | Oligonucleotides |
| HY-101969 | Pseudothymidine | 65358-15-8 | Oligonucleotides |
| HY-10197 | Wortmannin | 19545-26-7 | Reference compound |
| HY-101970 | Deoxypseudouridine | 39967-60-7 | Oligonucleotides |
| HY-101971 | AZ PFKFB3 26 | 1704740-52-2 | Reference compound |
| HY-101972 | AZ-PFKFB3-67 | 1704741-11-6 | Reference compound |
| HY-101972A | AZ-PFKFB3-67 (quarterhydrate) | Reference compound | |
| HY-101973 | XL041 | 1256918-39-4 | Reference compound |
| HY-101974 | Biotin-PEG3-Bromide | 1041766-91-9 | Reference compound |
| HY-101976 | JAK3-IN-6 | 1443235-95-7 | Reference compound |
| HY-101977 | Selitrectinib | 2097002-61-2 | Reference compound |
| HY-101977B | (3aR)-Selitrectinib | 1350884-56-8 | Reference compound |
| HY-101977R | Selitrectinib (Standard) | 2097002-61-2 | Reference Standards |
| HY-101978 | Ciforadenant | 1202402-40-1 | Reference compound |
| HY-101979 | Numidargistat | 2095732-06-0 | Reference compound |
| HY-101979A | Numidargistat (dihydrochloride) | Reference compound | |
| HY-10197R | Wortmannin (Standard) | 19545-26-7 | Reference Standards |
| HY-10198 | Navarixin | 473727-83-2 | Reference compound |
| HY-101980 | Imaradenant | 1321514-06-0 | Reference compound |
| HY-101981 | Uridine 5'-monophosphate | 58-97-9 | Natural Products |
| HY-101981R | Uridine 5'-monophosphate (Standard) | 58-97-9 | Reference Standards |
| HY-101981S | Uridine 5'-monophosphate-15N2 | Isotope-Labeled Compounds | |
| HY-101981S1 | Uridine 5'-monophosphate-15N2,d11 (dilithium) | Isotope-Labeled Compounds | |
| HY-101981S2 | Uridine 5'-monophosphate-d11 (dilithium) | Isotope-Labeled Compounds | |
| HY-101981S3 | Uridine 5'-monophosphate-13C9,15N2 (dilithium) | 2483830-55-1 | Isotope-Labeled Compounds |
| HY-101981S4 | Uridine 5'-monophosphate-13C9 (dilithium) | Isotope-Labeled Compounds | |
| HY-101981S5 | Uridine 5'-monophosphate-15N2 (dilithium) | Isotope-Labeled Compounds | |
| HY-101982 | Lys-SMCC-DM1 | 1281816-04-3 | ADC Related |
| HY-101982A | (Rac)-Lys-SMCC-DM1 | ADC Related | |
| HY-101984 | N6,N6-Dimethyladenosine | 2620-62-4 | Reference compound |
| HY-101984R | N6,N6-Dimethyladenosine (Standard) | 2620-62-4 | Reference Standards |
| HY-101985 | BV02 | 292870-53-2 | Reference compound |
| HY-101986 | BIIE-0246 | 246146-55-4 | Reference compound |
| HY-101986A | BIIE-0246 (hydrochloride) | Reference compound | |
| HY-101986C | BIIE-0246 (dihydrochloride) | 246146-31-6 | Reference compound |
| HY-101987 | BW 245C | 72814-32-5 | Reference compound |
| HY-101988 | Prostaglandin D2 | 41598-07-6 | Natural Products |
| HY-101988R | Prostaglandin D2 (Standard) | 41598-07-6 | Reference Standards |
| HY-101988S | Prostaglandin D2-d4 | 211105-29-2 | Isotope-Labeled Compounds |
| HY-101988S1 | Prostaglandin D2-d9 | 2254642-52-7 | Isotope-Labeled Compounds |
| HY-101989 | Tubulin polymerization-IN-24 | 564468-51-5 | Reference compound |
| HY-101990 | IMS2186 | 1031206-36-6 | Reference compound |
| HY-101991 | ML291 | 1523437-16-2 | Reference compound |
| HY-101993 | Nap-FF | 946568-62-3 | Reference compound |
| HY-101996 | SMBA1 | 906440-37-7 | Reference compound |
| HY-101997 | BEPP (hydrochloride) | 455311-98-5 | Reference compound |
| HY-101998 | CTP inhibitor | 412940-35-3 | Reference compound |
| HY-101999 | EM20-25 | 141266-44-6 | Reference compound |
| HY-10199A | Ibutamoren | 159634-47-6 | Reference compound |
| HY-10200 | BMS-754807 | 1001350-96-4 | Reference compound |
| HY-102000 | IACS-9571 | 1800477-30-8 | Reference compound |
| HY-102000A | IACS-9571 (TFA) | 1883598-69-3 | Reference compound |
| HY-102000B | IACS-9571 (hydrochloride) | 2319611-93-1 | Reference compound |
| HY-102001 | Tomaymycin DM | 945490-09-5 | ADC Related |
| HY-102003 | Rucaparib (monocamsylate) | 1859053-21-6 | Reference compound |
| HY-102003A | Rucaparib (camsylate) | 1327258-57-0 | Reference compound |
| HY-102004 | Rilapladib | 412950-08-4 | Reference compound |
| HY-102007 | Gamitrinib TPP | 1131626-46-4 | Reference compound |
| HY-102007A | Gamitrinib TPP hexafluorophosphate | 1131626-47-5 | Reference compound |
| HY-102008 | LBM-415 | 478913-91-6 | Reference compound |
| HY-10201 | Sorafenib | 284461-73-0 | Reference compound |
| HY-102010 | Pancratistatin | 96203-70-2 | Natural Products |
| HY-102011 | BMS-1166 | 1818314-88-3 | Reference compound |
| HY-102011A | BMS-1166 (hydrochloride) | 2113650-05-6 | Reference compound |
| HY-102013 | Omilancor | 1912399-75-7 | Reference compound |
| HY-102013R | Omilancor (Standard) | 1912399-75-7 | Reference Standards |
| HY-102014 | RN-18 | 431980-38-0 | Reference compound |
| HY-102015 | 6-Biopterin | 22150-76-1 | Natural Products |
| HY-102015R | 6-Biopterin (Standard) | 22150-76-1 | Reference Standards |
| HY-102015S | 6-Biopterin-d3 | 1217838-71-5 | Isotope-Labeled Compounds |
| HY-102016 | SB756050 | 447410-57-3 | Reference compound |
| HY-102018 | 3'-Deoxy-3'-fluoroadenosine | 75059-22-2 | Reference compound |
| HY-102019 | NSC61610 | 500538-94-3 | Reference compound |
| HY-10201A | Sorafenib (tosylate) | 475207-59-1 | Reference compound |
| HY-10201AR | Sorafenib (tosylate) (Standard) | 475207-59-1 | Reference Standards |
| HY-10201R | Sorafenib (Standard) | 284461-73-0 | Reference Standards |
| HY-10201S | Sorafenib-d3 | 1130115-44-4 | Isotope-Labeled Compounds |
| HY-10201S1 | Sorafenib-d4 | 1207560-07-3 | Isotope-Labeled Compounds |
| HY-10201S2 | Sorafenib-13C,d3 | 1210608-86-8 | Isotope-Labeled Compounds |
| HY-10201S4 | Sorafenib-d3 (tosylate) | 1333386-17-6 | Isotope-Labeled Compounds |
| HY-10202 | Tandutinib | 387867-13-2 | Reference compound |
| HY-102020 | RG3039 | 1005504-62-0 | Reference compound |
| HY-102022 | α-Galactosylceramide | 158021-47-7 | Reference compound |
| HY-102023 | GNF351 | 1227634-69-6 | Reference compound |
| HY-102024 | A2A receptor antagonist 1 | 443103-97-7 | Reference compound |
| HY-102025 | Antifungal agent 1 | 1265166-14-0 | Reference compound |
| HY-102026 | Formycin A | 6742-12-7 | Reference compound |
| HY-102027 | FX1 | 1426138-42-2 | Reference compound |
| HY-102028 | KY1220 | 292168-79-7 | Reference compound |
| HY-102029 | Sarafotoxin S6c | 121695-87-2 | Peptides |
| HY-10202A | Tandutinib (hydrochloride) | 2438900-70-8 | Reference compound |
| HY-10202AR | Tandutinib (hydrochloride) (Standard) | 2438900-70-8 | Reference Standards |
| HY-10202B | Tandutinib (sulfate) | 387867-14-3 | Reference compound |
| HY-10202R | Tandutinib (Standard) | 387867-13-2 | Reference Standards |
| HY-10203 | Vatalanib | 212141-54-3 | Reference compound |
| HY-102031 | Linperlisib | 1702816-75-8 | Reference compound |
| HY-102032 | Butyryltimolol | 106351-79-5 | Reference compound |
| HY-102032A | (RS)-Butyryltimolol | 2320274-78-8 | Reference compound |
| HY-102032AR | (RS)-Butyryltimolol (Standard) | 2320274-78-8 | Reference Standards |
| HY-102033 | Oxamflatin | 151720-43-3 | Reference compound |
| HY-102034 | Complement factor D-IN-1 | 1386455-76-0 | Reference compound |
| HY-102035 | PARP-2-IN-1 | 2115698-83-2 | Reference compound |
| HY-102036 | G-744 | 1346669-54-2 | Reference compound |
| HY-102037 | SSTR5 antagonist 1 | 1628741-91-2 | Reference compound |
| HY-102038 | PC786 | 1902114-15-1 | Reference compound |
| HY-102039 | CDK9-IN-8 | 2105956-51-0 | Reference compound |
| HY-10204 | OSI-930 | 728033-96-3 | Reference compound |
| HY-102040 | Hispidol | 5786-54-9 | Reference compound |
| HY-102040R | Hispidol (Standard) | 5786-54-9 | Reference Standards |
| HY-102041 | SMS2-IN-1 | 2098890-15-2 | Reference compound |
| HY-102044 | BET-IN-2 | 2104688-91-5 | Reference compound |
| HY-102045 | T-3764518 | 1809151-56-1 | Reference compound |
| HY-102046 | FM-381 | 2226521-65-7 | Reference compound |
| HY-102047 | KDOAM-25 | 2230731-99-2 | Reference compound |
| HY-102047A | KDOAM-25 (trihydrochloride) | Reference compound | |
| HY-102047B | KDOAM-25 (citrate) | 2448475-08-7 | Reference compound |
| HY-102048 | STAT5-IN-2 | 2111834-61-6 | Reference compound |
| HY-102049 | IL-15-IN-1 | 1831830-20-6 | Reference compound |
| HY-10205 | Cediranib | 288383-20-0 | Reference compound |
| HY-102050 | PF-05085727 | 1415637-72-7 | Reference compound |
| HY-102051 | XIAP/cIAP1 antagonist-1 | 1403898-55-4 | Reference compound |
| HY-102052 | DCEBIO | 60563-36-2 | Reference compound |
| HY-102053 | Apimostinel | 1421866-48-9 | Reference compound |
| HY-102054 | Acetylhydrolase-IN-1 | 79637-91-5 | Reference compound |
| HY-102055 | JAK2 JH2 Tracer | 2101955-00-2 | Dye Reagents |
| HY-102056 | BAY 59-9435 | 654059-21-9 | Reference compound |
| HY-102057 | Felcisetrag | 916075-84-8 | Reference compound |
| HY-102058 | WM-1119 | 2055397-28-7 | Reference compound |
| HY-102059 | MOZ-IN-2 | 2055397-88-9 | Reference compound |
| HY-10205R | Cediranib (Standard) | 288383-20-0 | Reference Standards |
| HY-10206 | Amuvatinib | 850879-09-3 | Reference compound |
| HY-102060 | WM-8014 | 2055397-18-5 | Reference compound |
| HY-102061 | Naronapride (dihydrochloride) | 860169-57-9 | Reference compound |
| HY-102062 | Nω-Propyl-L-arginine | 137361-05-8 | Reference compound |
| HY-102062A | Nω-Propyl-L-arginine (hydrochloride) | 2321366-46-3 | Reference compound |
| HY-102063 | MRS 2219 | 14141-47-0 | Reference compound |
| HY-102064 | SR 57227A | 77145-61-0 | Reference compound |
| HY-102065 | SC-19220 | 19395-87-0 | Reference compound |
| HY-102066 | Utatrectinib | 1079274-94-4 | Reference compound |
| HY-102067 | 3289-8625 | 294891-81-9 | Reference compound |
| HY-102068 | Clathrin-IN-1 | 1332879-52-3 | Reference compound |
| HY-102069 | 3MB-PP1 | 956025-83-5 | Reference compound |
| HY-10206A | Amuvatinib hydrochloride | 1055986-67-8 | Reference compound |
| HY-10206R | Amuvatinib (Standard) | 850879-09-3 | Reference Standards |
| HY-10207 | Dovitinib (lactate) | 692737-80-7 | Reference compound |
| HY-102070 | NS13001 | 1063331-94-1 | Reference compound |
| HY-102071 | KIN59 | 4152-77-6 | Reference compound |
| HY-102073 | TG53 | 946369-04-6 | Reference compound |
| HY-102074 | ERDRP-0519 | 1374006-96-8 | Reference compound |
| HY-102075A | TMP778 | 1422053-04-0 | Reference compound |
| HY-102075B | TMP780 | 1422053-03-9 | Reference compound |
| HY-102076 | 0990CL | 511514-03-7 | Reference compound |
| HY-102077 | SAMT-247 | 850715-59-2 | Reference compound |
| HY-102078 | ZINC69391 | 303094-67-9 | Reference compound |
| HY-102079 | SAFit1 | 1643125-32-9 | Reference compound |
| HY-10207R | Dovitinib (lactate) (Standard) | 692737-80-7 | Reference Standards |
| HY-10208 | Pazopanib | 444731-52-6 | Reference compound |
| HY-102080 | SAFit2 | 1643125-33-0 | Reference compound |
| HY-102081 | 2OH-BNPP1 | 833481-73-5 | Reference compound |
| HY-102082 | Adenosine N1-oxide | 146-92-9 | Natural Products |
| HY-102083 | BRD4884 | 1404559-91-6 | Reference compound |
| HY-102084 | LMT-28 | 1239600-18-0 | Reference compound |
| HY-102085 | 11-Deoxyglycyrrhetinic acid (sodium) | 1148013-87-9 | Reference compound |
| HY-102086 | MSX3 | 261717-23-1 | Reference compound |
| HY-102087 | JPM-OEt | 262381-84-0 | Reference compound |
| HY-102089 | Fluoroclebopride | 154540-49-5 | Reference compound |
| HY-10208R | Pazopanib (Standard) | 444731-52-6 | Reference Standards |
| HY-10208S | Pazopanib-d6 | 1219592-01-4 | Isotope-Labeled Compounds |
| HY-10208S1 | Pazopanib-13C,d3 | 1261734-88-6 | Isotope-Labeled Compounds |
| HY-10208S2 | Pazopanib-d3 | 1219591-97-5 | Isotope-Labeled Compounds |
| HY-10209 | Masitinib | 790299-79-5 | Reference compound |
| HY-102090 | B7/CD28 interaction inhibitor 1 | 635324-72-0 | Reference compound |
| HY-102091 | (2R,4R)-APDC | 169209-63-6 | Reference compound |
| HY-102091A | (2R,4R)-APDC (hydrate) | Reference compound | |
| HY-102092 | FR139317 | 142375-60-8 | Reference compound |
| HY-102093 | ZD 7155(hydrochloride) | 146709-78-6 | Reference compound |
| HY-102093A | ZD 7155 | 151801-76-2 | Reference compound |
| HY-102093R | ZD 7155(hydrochloride) (Standard) | 146709-78-6 | Reference Standards |
| HY-102094 | (E/Z)-SIB-1893 | 6266-99-5 | Reference compound |
| HY-102095 | SIB-1757 | 31993-01-8 | Reference compound |
| HY-10209A | Masitinib (mesylate) | 1048007-93-7 | Reference compound |
| HY-10209AR | Masitinib (mesylate) (Standard) | 1048007-93-7 | Reference Standards |
| HY-10209R | Masitinib (Standard) | 790299-79-5 | Reference Standards |
| HY-10210 | Retaspimycin (Hydrochloride) | 857402-63-2 | Reference compound |
| HY-10211 | Tanespimycin | 75747-14-7 | Reference compound |
| HY-10211R | Tanespimycin (Standard) | 75747-14-7 | Reference Standards |
| HY-10212 | BIIB021 | 848695-25-0 | Reference compound |
| HY-10212R | BIIB021 (Standard) | 848695-25-0 | Reference Standards |
| HY-10213 | SNX-5422 | 908115-27-5 | Reference compound |
| HY-10213A | SNX-5422 (mesylate) | 1173111-67-5 | Reference compound |
| HY-10214 | SNX-2112 | 908112-43-6 | Reference compound |
| HY-10215 | Luminespib | 747412-49-3 | Reference compound |
| HY-10215R | Luminespib (Standard) | 747412-49-3 | Reference Standards |
| HY-10216 | Refametinib (R enantiomer) | 923032-38-6 | Reference compound |
| HY-10217 | Thrombin Inhibitor 2 | 312904-62-4 | Reference compound |
| HY-10218 | Everolimus | 159351-69-6 | Reference compound |
| HY-10218R | Everolimus (Standard) | 159351-69-6 | Reference Standards |
| HY-10218S | Everolimus-d4 | 1338452-54-2 | Isotope-Labeled Compounds |
| HY-10218S1 | Everolimus-13C2,d4 | 1661009-29-5 | Isotope-Labeled Compounds |
| HY-10219 | Rapamycin | 53123-88-9 | Natural Products |
| HY-10219G | Rapamycin (GMP) | 53123-88-9 | GMP Small Molecules |
| HY-10219GL | Rapamycin (GMP Like) | 53123-88-9 | GMP Small Molecules |
| HY-10219R | Rapamycin (Standard) | 53123-88-9 | Reference Standards |
| HY-10219S | Rapamycin-d3 | 392711-19-2 | Isotope-Labeled Compounds |
| HY-10219S1 | Rapamycin-13C,d3 | Isotope-Labeled Compounds | |
| HY-10220 | SF1126 | 936487-67-1 | Reference compound |
| HY-10221 | Vorinostat | 149647-78-9 | Reference compound |
| HY-10221G | Vorinostat (GMP) | 149647-78-9 | GMP Small Molecules |
| HY-10221R | Vorinostat (Standard) | 149647-78-9 | Reference Standards |
| HY-10222 | Ixabepilone | 219989-84-1 | Reference compound |
| HY-10222R | Ixabepilone (Standard) | 219989-84-1 | Reference Standards |
| HY-10223 | CUDC-101 | 1012054-59-9 | Reference compound |
| HY-10224 | Panobinostat | 404950-80-7 | Reference compound |
| HY-10224A | Panobinostat (lactate) | 960055-56-5 | Reference compound |
| HY-10224R | Panobinostat (Standard) | 404950-80-7 | Reference Standards |
| HY-10224S | Panobinostat-d4 | 1185237-51-7 | Isotope-Labeled Compounds |
| HY-10224S1 | Panobinostat-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10225 | Belinostat | 866323-14-0 | Reference compound |
| HY-10226 | JNJ-16241199 | 604769-01-9 | Reference compound |
| HY-10227 | Bortezomib | 179324-69-7 | Reference compound |
| HY-10227R | Bortezomib (Standard) | 179324-69-7 | Reference Standards |
| HY-10227S | Bortezomib-d8 | Isotope-Labeled Compounds | |
| HY-10228 | Motesanib | 453562-69-1 | Reference compound |
| HY-10228R | Motesanib (Standard) | 453562-69-1 | Reference Standards |
| HY-10229 | Motesanib (Diphosphate) | 857876-30-3 | Reference compound |
| HY-10229R | Motesanib (Diphosphate) (Standard) | 857876-30-3 | Reference Standards |
| HY-10230 | Midostaurin | 120685-11-2 | Reference compound |
| HY-10230R | Midostaurin (Standard) | 120685-11-2 | Reference Standards |
| HY-10230S | Midostaurin-d5 | Isotope-Labeled Compounds | |
| HY-10231 | PX-478 | 685898-44-6 | Reference compound |
| HY-10232 | THIP | 64603-91-4 | Reference compound |
| HY-10232R | THIP (Standard) | 64603-91-4 | Reference Standards |
| HY-10232S | THIP-d4 | 2748778-97-2 | Isotope-Labeled Compounds |
| HY-10233 | Gaboxadol (hydrochloride) | 85118-33-8 | Reference compound |
| HY-10233R | Gaboxadol (hydrochloride) (Standard) | 85118-33-8 | Reference Standards |
| HY-10234 | Saracatinib | 379231-04-6 | Reference compound |
| HY-10234A | Saracatinib (difumarate) | 893428-72-3 | Reference compound |
| HY-10234AR | Saracatinib (difumarate) (Standard) | 893428-72-3 | Reference Standards |
| HY-10234R | Saracatinib (Standard) | 379231-04-6 | Reference Standards |
| HY-10234S | Saracatinib-d3 | 2200301-36-4 | Isotope-Labeled Compounds |
| HY-10235 | Telaprevir | 402957-28-2 | Reference compound |
| HY-10235R | Telaprevir (Standard) | 402957-28-2 | Reference Standards |
| HY-10235S | Telaprevir-d4 | Isotope-Labeled Compounds | |
| HY-10237 | Boceprevir | 394730-60-0 | Reference compound |
| HY-10237R | Boceprevir (Standard) | 394730-60-0 | Reference Standards |
| HY-10237S | Boceprevir-d9 | 1256751-11-7 | Isotope-Labeled Compounds |
| HY-10238 | Danoprevir | 850876-88-9 | Reference compound |
| HY-10239 | Danoprevir (sodium) | 916826-48-7 | Reference compound |
| HY-10240 | Mericitabine | 940908-79-2 | Reference compound |
| HY-10240R | Mericitabine (Standard) | 940908-79-2 | Reference Standards |
| HY-10241 | Simeprevir | 923604-59-5 | Reference compound |
| HY-10241A | Simeprevir (sodium) | 1241946-89-3 | Reference compound |
| HY-10241S | Simeprevir-13C,d3 | Isotope-Labeled Compounds | |
| HY-10242 | Ciluprevir | 300832-84-2 | Reference compound |
| HY-10243 | Vaniprevir | 923590-37-8 | Reference compound |
| HY-10244 | MK-0608 | 443642-29-3 | Reference compound |
| HY-10247 | BRAF inhibitor | 918505-61-0 | Reference compound |
| HY-10248 | RAF265 | 927880-90-8 | Reference compound |
| HY-10249 | GSK-690693 | 937174-76-0 | Reference compound |
| HY-10249A | AKT Kinase Inhibitor | 842148-40-7 | Reference compound |
| HY-10249D | AKT Kinase Inhibitor (hydrochloride) | 3026697-00-4 | Reference compound |
| HY-10250 | Triciribine phosphate | 61966-08-3 | Reference compound |
| HY-10250A | Triciribine phosphate (sodium) | Reference compound | |
| HY-10250S | Triciribine phosphate-13C,d3 | Isotope-Labeled Compounds | |
| HY-10250S1 | Triciribine phosphate-d3 | Isotope-Labeled Compounds | |
| HY-10251 | BMS-599626 | 714971-09-2 | Reference compound |
| HY-10252 | NVP-ADW742 | 475488-23-4 | Reference compound |
| HY-10253 | AG1024 | 65678-07-1 | Reference compound |
| HY-10254 | Mirdametinib | 391210-10-9 | Reference compound |
| HY-10254G | Mirdametinib (GMP) | 391210-10-9 | GMP Small Molecules |
| HY-10255 | Sunitinib (Malate) | 341031-54-7 | Reference compound |
| HY-10255A | Sunitinib | 557795-19-4 | Reference compound |
| HY-10255AR | Sunitinib (Standard) | 557795-19-4 | Reference Standards |
| HY-10255AS | Sunitinib-d10 | 1126721-82-1 | Isotope-Labeled Compounds |
| HY-10255AS1 | Sunitinib-d4 | 1126721-79-6 | Isotope-Labeled Compounds |
| HY-10255R | Sunitinib (Malate) (Standard) | 341031-54-7 | Reference Standards |
| HY-10256 | Adezmapimod | 152121-47-6 | Reference compound |
| HY-10256A | Adezmapimod (hydrochloride) | 869185-85-3 | Reference compound |
| HY-10256AR | Adezmapimod (hydrochloride) (Standard) | 869185-85-3 | Reference Standards |
| HY-10256R | Adezmapimod (Standard) | 152121-47-6 | Reference Standards |
| HY-10257 | BAY 11-7085 | 196309-76-9 | Reference compound |
| HY-10259 | PD 123319 | 130663-39-7 | Reference compound |
| HY-10259A | PD 123319 (ditrifluoroacetate) | 136676-91-0 | Reference compound |
| HY-10260 | Vandetanib | 443913-73-3 | Reference compound |
| HY-10260A | Vandetanib (trifluoroacetate) | 338992-53-3 | Reference compound |
| HY-10260B | Vandetanib (hydrochloride) | 524722-52-9 | Reference compound |
| HY-10260R | Vandetanib (Standard) | 443913-73-3 | Reference Standards |
| HY-10260S | Vandetanib-d6 | 1174683-49-8 | Isotope-Labeled Compounds |
| HY-10260S1 | Vandetanib-d4 | 1215100-18-7 | Isotope-Labeled Compounds |
| HY-10260S2 | Vandetanib-13C6 | 1261397-03-8 | Isotope-Labeled Compounds |
| HY-10261 | Afatinib | 850140-72-6 | Reference compound |
| HY-10261A | Afatinib (dimaleate) | 850140-73-7 | Reference compound |
| HY-10261AR | Afatinib (dimaleate) (Standard) | 850140-73-7 | Reference Standards |
| HY-10261AS | Afatinib-d6 (dimaleate) | Isotope-Labeled Compounds | |
| HY-10261B | (E/Z)-Afatinib | 439081-18-2 | Reference compound |
| HY-10261BR | (E/Z)-Afatinib (Standard) | 439081-18-2 | Reference Standards |
| HY-10261D | Afatinib (oxalate) | 1398312-64-5 | Reference compound |
| HY-10261E | (R)-Afatinib | 439081-17-1 | Reference compound |
| HY-10261R | Afatinib (Standard) | 850140-72-6 | Reference Standards |
| HY-10261S | Afatinib-d6 | 1313874-96-2 | Isotope-Labeled Compounds |
| HY-10261S1 | Afatinib-d4 | Isotope-Labeled Compounds | |
| HY-10262 | BMS-536924 | 468740-43-4 | Reference compound |
| HY-10264 | Edoxaban | 480449-70-5 | Reference compound |
| HY-10264A | Edoxaban (tosylate) | 480449-71-6 | Reference compound |
| HY-10264B | Edoxaban (tosylate monohydrate) | 1229194-11-9 | Reference compound |
| HY-10264C | Edoxaban (hydrochloride) | 480448-29-1 | Reference compound |
| HY-10264R | Edoxaban (Standard) | 480449-70-5 | Reference Standards |
| HY-10264S | Edoxaban-d6 | 1304701-57-2 | Isotope-Labeled Compounds |
| HY-10267 | Eribaxaban | 536748-46-6 | Reference compound |
| HY-10268 | Betrixaban | 330942-05-7 | Reference compound |
| HY-10268A | Betrixaban (maleate) | 936539-80-9 | Reference compound |
| HY-10268B | Betrixaban (hydrochloride) | 2099719-47-6 | Reference compound |
| HY-10268R | Betrixaban (Standard) | 330942-05-7 | Reference Standards |
| HY-10268S | Betrixaban-d6 | 2098655-51-5 | Isotope-Labeled Compounds |
| HY-10268S1 | Betrixaban-d4 | 2098655-55-9 | Isotope-Labeled Compounds |
| HY-10268S2 | Betrixaban-13C6 | Isotope-Labeled Compounds | |
| HY-10269 | LY-517717 | 313489-71-3 | Reference compound |
| HY-10270 | Flovagatran | 871576-03-3 | Reference compound |
| HY-10271 | Flovagatran (sodium) | 871575-98-3 | Reference compound |
| HY-10273 | Atecegatran metoxil | 433937-93-0 | Reference compound |
| HY-10274 | Dabigatran etexilate | 211915-06-9 | Reference compound |
| HY-10274A | Dabigatran etexilate (mesylate) | 872728-81-9 | Reference compound |
| HY-10274AR | Dabigatran etexilate (mesylate) (Standard) | 872728-81-9 | Reference Standards |
| HY-10274R | Dabigatran etexilate (Standard) | 211915-06-9 | Reference Standards |
| HY-10274S | Dabigatran etexilate-d13 | 2749293-92-1 | Isotope-Labeled Compounds |
| HY-10275 | Atecegatran | 433937-74-7 | Reference compound |
| HY-10275A | Atecegatran (TFA) | 433937-75-8 | Reference compound |
| HY-10276 | GW813893 | 478644-12-1 | Reference compound |
| HY-10277 | Odiparcil | 137215-12-4 | Reference compound |
| HY-10278 | Razaxaban | 218298-21-6 | Reference compound |
| HY-10280S | YM-60828-d3 | 1794812-00-2 | Isotope-Labeled Compounds |
| HY-10281 | YM-60828 (methanesulfonate) | 209187-02-0 | Reference compound |
| HY-10282 | Daglutril | 182821-27-8 | Reference compound |
| HY-10284 | Linagliptin | 668270-12-0 | Reference compound |
| HY-10284R | Linagliptin (Standard) | 668270-12-0 | Reference Standards |
| HY-10284S | Linagliptin-d4 | 2140263-92-7 | Isotope-Labeled Compounds |
| HY-10284S1 | Linagliptin-13C,d3 | 1398044-43-3 | Isotope-Labeled Compounds |
| HY-10284S3 | Linagliptin-d3-1 | 1398044-48-8 | Isotope-Labeled Compounds |
| HY-10284S4 | Linagliptin-d5 | Isotope-Labeled Compounds | |
| HY-10284S5 | Linagliptin-d6 | Isotope-Labeled Compounds | |
| HY-10285 | Saxagliptin | 361442-04-8 | Reference compound |
| HY-10285A | Saxagliptin (hydrate) | 945667-22-1 | Reference compound |
| HY-10285AR | Saxagliptin (hydrate) (Standard) | 945667-22-1 | Reference Standards |
| HY-10285R | Saxagliptin (Standard) | 361442-04-8 | Reference Standards |
| HY-10285S | Saxagliptin-15N,d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10285S1 | (rel)-Saxagliptin-13C,d2 (TFA) | 2012595-09-2 | Isotope-Labeled Compounds |
| HY-10285S2 | Saxagliptin-13C2 | Isotope-Labeled Compounds | |
| HY-10286 | Dutogliptin | 852329-66-9 | Reference compound |
| HY-10286A | Dutogliptin (tartrate) | 890402-81-0 | Reference compound |
| HY-10287 | Gosogliptin | 869490-23-3 | Reference compound |
| HY-10289 | Carmegliptin | 813452-18-5 | Reference compound |
| HY-10290 | MK-0674 | 887781-62-6 | Reference compound |
| HY-10291 | Tarenflurbil | 51543-40-9 | Reference compound |
| HY-10291R | Tarenflurbil (Standard) | 51543-40-9 | Reference Standards |
| HY-10293 | Aderbasib | 791828-58-5 | Reference compound |
| HY-10294 | Relacatib | 362505-84-8 | Reference compound |
| HY-10295 | SB 202190 | 152121-30-7 | Reference compound |
| HY-10295A | SB 202190 (hydrochloride) | 350228-36-3 | Reference compound |
| HY-10295AR | SB 202190 (hydrochloride) (Standard) | 350228-36-3 | Reference Standards |
| HY-10295R | SB 202190 (Standard) | 152121-30-7 | Reference Standards |
| HY-10297 | Omipalisib | 1086062-66-9 | Reference compound |
| HY-10299 | GSK-923295 | 1088965-37-0 | Reference compound |
| HY-102998 | Nav1.7-IN-6 | 1788066-71-6 | Reference compound |
| HY-10300 | Narlaprevir | 865466-24-6 | Reference compound |
| HY-103000 | HSF1A | 1196723-93-9 | Reference compound |
| HY-103001 | HMN-154 | 173528-92-2 | Reference compound |
| HY-103002 | SU5408 | 15966-93-5 | Reference compound |
| HY-103005 | Ramelteon metabolite M-II | 896736-21-3 | Reference compound |
| HY-103005R | Ramelteon metabolite M-II (Standard) | 896736-21-3 | Reference Standards |
| HY-103005S | Ramelteon metabolite M-II-d3 | 1246812-22-5 | Isotope-Labeled Compounds |
| HY-103006 | NAI-N3 | 1612756-29-2 | Reference compound |
| HY-103007 | TC-G-1008 | 1621175-65-2 | Reference compound |
| HY-103009 | MSX-127 | 6616-56-4 | Reference compound |
| HY-10300R | Narlaprevir (Standard) | 865466-24-6 | Reference Standards |
| HY-10301 | MK-3207 | 957118-49-9 | Reference compound |
| HY-103010 | MSX-130 | 4051-59-6 | Reference compound |
| HY-103015 | WZ4141 | 1222776-76-2 | Reference compound |
| HY-103016 | WZ4141R | 2319589-98-3 | Reference compound |
| HY-103017 | JH-X-119-01 (hydrochloride) | 2591344-30-6 | Reference compound |
| HY-103017A | JH-X-119-01 | 2227368-54-7 | Reference compound |
| HY-103018 | Gusacitinib | 1425381-60-7 | Reference compound |
| HY-103018A | Gusacitinib (hydrochloride) | 2228989-14-6 | Reference compound |
| HY-103019 | (+)-Enitociclib | 1610358-56-9 | Reference compound |
| HY-103019A | (±)-Enitociclib | 1610358-53-6 | Reference compound |
| HY-103019B | (-)-Enitociclib | 1610358-59-2 | Reference compound |
| HY-103019E | Enitociclib | 1610408-97-3 | Reference compound |
| HY-10302 | MK-3207 (Hydrochloride) | 957116-20-0 | Reference compound |
| HY-103020 | BAY-1816032 | 1891087-61-8 | Reference compound |
| HY-103021 | LY3200882 | 1898283-02-7 | Reference compound |
| HY-103022 | Repotrectinib | 1802220-02-5 | Reference compound |
| HY-103023 | CLP290 | 1181083-81-7 | Reference compound |
| HY-103024 | ICI-63197 | 27277-00-5 | Reference compound |
| HY-103025 | Methylprednisolone aceponate | 86401-95-8 | Reference compound |
| HY-103025R | Methylprednisolone aceponate (Standard) | 86401-95-8 | Reference Standards |
| HY-103028 | GSK962 | 2049872-86-6 | Reference compound |
| HY-103028A | GSK963 | 2049868-46-2 | Reference compound |
| HY-103029 | Bosutinib isomer | 1391063-17-4 | Reference compound |
| HY-10303 | PIK-294 | 900185-02-6 | Reference compound |
| HY-103030 | PI3K-IN-32 | 371934-59-7 | Reference compound |
| HY-103032 | Multi-kinase inhibitor 1 | 778274-97-8 | Reference compound |
| HY-103033 | T.cruzi-IN-1 | 1350920-22-7 | Reference compound |
| HY-103034 | Sipoglitazar | 342026-92-0 | Reference compound |
| HY-103035 | BIO-32546 | 1548743-66-3 | Reference compound |
| HY-103036 | BET bromodomain inhibitor | 1505453-59-7 | Reference compound |
| HY-103038 | ML327 | 1883510-31-3 | Reference compound |
| HY-103039 | TLR7 agonist 2 | 1642857-69-9 | Reference compound |
| HY-10304 | Orbofiban | 163250-90-6 | Reference compound |
| HY-103041 | Brr2-IN-2 | Reference compound | |
| HY-103045 | CMPD101 | 865608-11-3 | Reference compound |
| HY-103045A | CMPD101 (hydrochloride) | 1941168-71-3 | Reference compound |
| HY-103046 | UbcH5c-IN-1 | 2123480-72-6 | Reference compound |
| HY-103048 | PD-1/PD-L1-IN 3 | 1629654-95-0 | Peptides |
| HY-103048A | PD-1/PD-L1-IN 3 (TFA) | Peptides | |
| HY-10304A | Orbofiban (acetate) | 163250-91-7 | Reference compound |
| HY-103050 | ML-030 | 1013750-77-0 | Reference compound |
| HY-103053 | PS121912 | 1529814-60-5 | Reference compound |
| HY-103054 | RO5203648 | 1043491-54-8 | Reference compound |
| HY-103055 | PPTN (mesylate) | 1160271-31-7 | Reference compound |
| HY-103056 | DDD85646 | 1215010-55-1 | Reference compound |
| HY-103058 | GSK199 | 1549811-53-1 | Reference compound |
| HY-103059 | SOICR-IN-1 | 1479049-35-8 | Reference compound |
| HY-10306 | Gantofiban | 183547-57-1 | Reference compound |
| HY-103060 | KLH45 | 1632236-44-2 | Reference compound |
| HY-103061 | Dehydro-ZINC39395747 | 433248-87-4 | Reference compound |
| HY-103064 | 2-Methylthio-AMP (sodium) | 81921-45-1 | Reference compound |
| HY-103066 | Br-PBTC | 1839519-57-1 | Reference compound |
| HY-103067 | A1899 | 498577-46-1 | Reference compound |
| HY-103068 | Diethyl-pythiDC | 1821370-70-0 | Reference compound |
| HY-10307 | Roxifiban | 170902-47-3 | Reference compound |
| HY-103070 | PythiDC | 1821370-71-1 | Reference compound |
| HY-103071 | GSK-5503A | 1253186-46-7 | Reference compound |
| HY-103073 | Mesendogen | 864716-85-8 | Reference compound |
| HY-103074 | GSK2226649A | 1848232-20-1 | Reference compound |
| HY-103076 | EZ-482 | 1016456-76-0 | Reference compound |
| HY-103078 | I-XW-053 | 5496-35-5 | Reference compound |
| HY-103078A | I-XW-053 (sodium) | 1644644-89-2 | Reference compound |
| HY-103079 | PRL-3 Inhibitor 2 | 577962-95-9 | Reference compound |
| HY-10307A | Roxifiban (acetate) | 176022-59-6 | Reference compound |
| HY-10308 | Lefradafiban | 149503-79-7 | Reference compound |
| HY-103080 | CMF019 | 1586787-08-7 | Reference compound |
| HY-103081 | β-Glucuronidase-IN-1 | 484006-66-8 | Reference compound |
| HY-103082 | CLK1-IN-1 | 2123491-32-5 | Reference compound |
| HY-103083 | GPR40 agonist 4 | 2102196-57-4 | Reference compound |
| HY-103085 | T-3775440 hydrochloride | 1422535-52-1 | Reference compound |
| HY-103086 | INU-152 | 1380228-30-7 | Reference compound |
| HY-103087 | FIN56 | 1083162-61-1 | Reference compound |
| HY-103088 | Palupiprant | 1369489-71-3 | Reference compound |
| HY-103089 | LY393558 | 271780-64-4 | Reference compound |
| HY-10309 | Sibrafiban | 172927-65-0 | Reference compound |
| HY-103090 | NPS ALX Compound 4a | 299433-10-6 | Reference compound |
| HY-103090A | NPS ALX Compound 4a (dihydrochloride) | 1781934-44-8 | Reference compound |
| HY-103091 | Donitriptan (hydrochloride) | 170911-68-9 | Reference compound |
| HY-103092 | CP-135807 | 151272-90-1 | Reference compound |
| HY-103093 | Zotepine | 26615-21-4 | Reference compound |
| HY-103093R | Zotepine (Standard) | 26615-21-4 | Reference Standards |
| HY-103094 | LY266097 (hydrochloride) | 172895-39-5 | Reference compound |
| HY-103095 | Enmetazobactam | 1001404-83-6 | Reference compound |
| HY-103095A | Enmetazobactam (iodide) | 1379594-98-5 | Reference compound |
| HY-103096 | R162 | 64302-87-0 | Reference compound |
| HY-103097 | ST271 | 106392-48-7 | Reference compound |
| HY-103098 | EMDT oxalate | 263744-72-5 | Reference compound |
| HY-103099 | SB-399885 hydrochloride | 402713-81-9 | Reference compound |
| HY-10309R | Sibrafiban (Standard) | 172927-65-0 | Reference Standards |
| HY-103100 | SB-699551 | 864741-95-7 | Reference compound |
| HY-103101 | LP44 (hydrochloride) | 824958-12-5 | Reference compound |
| HY-103102 | TCB2 | 912342-28-0 | Reference compound |
| HY-103104 | Fananserin | 127625-29-0 | Reference compound |
| HY-103105 | LP 12 (hydrochloride) | 1185136-22-4 | Reference compound |
| HY-103105A | LP 12 (hydrochloride hydrate) | Reference compound | |
| HY-103106 | 1-Methylpsilocin | 1465-16-3 | Biochemical Assay Reagents |
| HY-103107 | LY334370 | 182563-08-2 | Reference compound |
| HY-103107A | LY334370 (hydrochloride) | 199673-74-0 | Reference compound |
| HY-103107R | LY334370 (Standard) | 182563-08-2 | Reference Standards |
| HY-103108 | CJ033466 | 519148-48-2 | Reference compound |
| HY-103109 | Melperone (hydrochloride) | 1622-79-3 | Reference compound |
| HY-103110 | ST1936 | 1210-81-7 | Reference compound |
| HY-103110A | ST1936 (oxalate) | 1782228-83-4 | Reference compound |
| HY-103111 | MMPIP (hydrochloride) | 1215566-78-1 | Reference compound |
| HY-103112 | SB 243213 (hydrochloride) | 200940-23-4 | Reference compound |
| HY-103112A | SB 243213 (dihydrochloride) | 1780372-25-9 | Reference compound |
| HY-103112B | SB 243213 | 200940-22-3 | Reference compound |
| HY-103113 | MS 245 (oxalate) | 275363-58-1 | Reference compound |
| HY-103114 | AT1015 (hydrochloride) | 190508-50-0 | Reference compound |
| HY-103115 | Pruvanserin (hydrochloride) | 443144-27-2 | Reference compound |
| HY-103116 | DV-7028 (hydrochloride) | 133364-62-2 | Reference compound |
| HY-103117 | S 32212 hydrochloride | 847871-78-7 | Reference compound |
| HY-103118 | PU02 | 313984-77-9 | Reference compound |
| HY-103119 | LP-20 (hydrochloride) | 1386928-34-2 | Reference compound |
| HY-103120 | Org37684 | 213007-95-5 | Reference compound |
| HY-103123 | SB 258719 (hydrochloride) | 1217674-10-6 | Reference compound |
| HY-103124 | DOI (hydrochloride) | 42203-78-1 | Reference compound |
| HY-103126 | DR4485 (hydrochloride) | 402942-53-4 | Reference compound |
| HY-103128 | inS3-54A18 | 328998-53-4 | Reference compound |
| HY-103129 | SB-200646A | 143797-62-0 | Reference compound |
| HY-103129A | SB-200646 | 143797-63-1 | Reference compound |
| HY-103130 | EMD386088 | 1171123-46-8 | Reference compound |
| HY-103131 | PNU-142633 | 187665-65-2 | Reference compound |
| HY-103132 | PNU109291 | 187665-60-7 | Reference compound |
| HY-103133 | WAY208466 (dihydrochloride) | 1207064-61-6 | Reference compound |
| HY-103134 | SB 204070A | 148688-01-1 | Reference compound |
| HY-103135 | SB 206553 (hydrochloride) | 1197334-04-5 | Reference compound |
| HY-103136 | R-96544 | 167144-80-1 | Reference compound |
| HY-103137 | Zacopride (hydrochloride) | 101303-98-4 | Reference compound |
| HY-103137R | Zacopride (hydrochloride) (Standard) | 101303-98-4 | Reference Standards |
| HY-103138 | (Rac)-WAY-161503 (hydrochloride) | 276695-22-8 | Reference compound |
| HY-103138A | (Rac)-WAY-161503 | 75704-24-4 | Reference compound |
| HY-103139 | Altanserin (hydrochloride) | 1135280-78-2 | Reference compound |
| HY-10314 | Lotrafiban | 171049-14-2 | Reference compound |
| HY-103140 | Ro60-0175 (fumarate) | 169675-09-6 | Reference compound |
| HY-103141 | SB-258585 (hydrochloride) | 1216468-02-8 | Reference compound |
| HY-103142 | AS19 | 1000578-26-6 | Reference compound |
| HY-103143 | SDZ 205-557 (hydrochloride) | 1197334-02-3 | Reference compound |
| HY-103143A | SDZ 205-557 | 137196-67-9 | Reference compound |
| HY-103144 | WAY 629 (hydrochloride) | 57756-44-2 | Reference compound |
| HY-103144A | WAY 629 | 57756-45-3 | Reference compound |
| HY-103145 | PNU-22394 (hydrochloride) | 15923-42-9 | Reference compound |
| HY-103146 | GR125487 (sulfamate) | 859502-43-5 | Reference compound |
| HY-103147 | Mesulergine (hydrochloride) | 72786-12-0 | Reference compound |
| HY-103148 | LY215840 | 137328-52-0 | Reference compound |
| HY-103149 | SB-216641A | 193611-67-5 | Reference compound |
| HY-10314A | Lotrafiban (hydrochloride) | 179599-82-7 | Reference compound |
| HY-10315 | Elarofiban | 198958-88-2 | Reference compound |
| HY-103151 | CP94253 (hydrochloride) | 845861-39-4 | Reference compound |
| HY-103151A | CP94253 | 131084-35-0 | Reference compound |
| HY-103152 | GR 113808 | 144625-51-4 | Reference compound |
| HY-103152R | GR 113808 (Standard) | 144625-51-4 | Reference Standards |
| HY-103153 | SB 204741 | 152239-46-8 | Reference compound |
| HY-103153R | SB 204741 (Standard) | 152239-46-8 | Reference Standards |
| HY-103154 | SB228357 | 181629-93-6 | Reference compound |
| HY-103155 | SB-221284 | 196965-14-7 | Reference compound |
| HY-103156 | NAS-181 (dimesylate) | 1217474-40-2 | Reference compound |
| HY-103157 | PD146176 | 4079-26-9 | Reference compound |
| HY-103157R | PD146176 (Standard) | 4079-26-9 | Reference Standards |
| HY-103158 | BW B70C | 134470-38-5 | Reference compound |
| HY-103159 | 1-Deazaadenosine | 14432-09-8 | Reference compound |
| HY-10315A | Elarofiban (diTFA) | 198958-89-3 | Reference compound |
| HY-103160A | EHNA (hydrochloride) | 58337-38-5 | Reference compound |
| HY-103160B | EHNA | 51350-19-7 | Reference compound |
| HY-103161 | ABT-702 dihydrochloride | 1188890-28-9 | Reference compound |
| HY-103162 | ANR94 | 634924-89-3 | Reference compound |
| HY-103163 | (±)-5'-Chloro-5'-deoxy-ENBA | 103626-26-2 | Reference compound |
| HY-103164 | (E)-8-(3-Chlorostyryl)caffeine | 147700-11-6 | Reference compound |
| HY-103164A | 8-(3-Chlorostyryl)caffeine | 148589-13-3 | Reference compound |
| HY-103165 | PSB-0788 | 1027513-54-7 | Reference compound |
| HY-103166 | PSB-603 | 1092351-10-4 | Reference compound |
| HY-103167 | CGH2466 (dihydrochloride) | 1177618-54-0 | Reference compound |
| HY-103168 | XCC | 96865-83-7 | Reference compound |
| HY-103169 | SCH442416 | 316173-57-6 | Reference compound |
| HY-103169R | SCH442416 (Standard) | 316173-57-6 | Reference Standards |
| HY-103170 | LUF5834 | 333962-91-7 | Reference compound |
| HY-103171 | BAY 60-6583 | 910487-58-0 | Reference compound |
| HY-103171R | BAY 60-6583 (Standard) | 910487-58-0 | Reference Standards |
| HY-103172 | 8-Aminoadenine | 28128-33-8 | Reference compound |
| HY-103173 | 5'-N-Ethylcarboxamidoadenosine | 35920-39-9 | Reference compound |
| HY-103173R | 5'-N-Ethylcarboxamidoadenosine (Standard) | 35920-39-9 | Reference Standards |
| HY-103174 | MRS1334 | 192053-05-7 | Reference compound |
| HY-103175 | PSB36 | 524944-72-7 | Reference compound |
| HY-103176 | PSB11 (hydrochloride) | 453591-58-7 | Reference compound |
| HY-103177 | PSB-10 (hydrochloride) | 591771-91-4 | Reference compound |
| HY-103178 | MRE3008F20 | 252979-43-4 | Reference compound |
| HY-103179 | SDZ-WAG994 | 130714-47-5 | Reference compound |
| HY-103180 | 2'-MeCCPA | 205171-12-6 | Reference compound |
| HY-103181 | N6-Cyclopentyladenosine | 41552-82-3 | Reference compound |
| HY-103182 | PSB-1115 | 152529-79-8 | Reference compound |
| HY-103182A | PSB-1115 (potassium salt) | 409344-71-4 | Reference compound |
| HY-103182R | PSB-1115 (Standard) | 152529-79-8 | Reference Standards |
| HY-103183 | CV1808 | 53296-10-9 | Reference compound |
| HY-103183R | CV1808 (Standard) | 53296-10-9 | Reference Standards |
| HY-103185 | CCPA | 37739-05-2 | Reference compound |
| HY-103185A | CCPA (hemihydrate) | 1217443-91-8 | Reference compound |
| HY-103185R | CCPA (Standard) | 37739-05-2 | Reference Standards |
| HY-103186 | MRS-1706 | 264622-53-9 | Reference compound |
| HY-103186R | MRS-1706 (Standard) | 264622-53-9 | Reference Standards |
| HY-103187 | HEMADO | 403842-38-6 | Reference compound |
| HY-103188 | PD81723 | 132861-87-1 | Reference compound |
| HY-103189 | VUF-5574 | 280570-45-8 | Reference compound |
| HY-10319 | BAY-549 | 867017-68-3 | Reference compound |
| HY-103190 | MRS1220 | 183721-15-5 | Reference compound |
| HY-103191 | 1,9-Dideoxyforskolin | 64657-18-7 | Natural Products |
| HY-103192 | MDL12330A | 40297-09-4 | Reference compound |
| HY-103193 | NKH477 | 138605-00-2 | Reference compound |
| HY-103194 | KH7 | 330676-02-3 | Reference compound |
| HY-103195 | NKY80 | 299442-43-6 | Reference compound |
| HY-103196 | Sotalol | 3930-20-9 | Reference compound |
| HY-103197 | 2-Methoxyidazoxan (monohydrochloride) | 109544-45-8 | Reference compound |
| HY-103197R | 2-Methoxyidazoxan (monohydrochloride) (Standard) | 109544-45-8 | Reference Standards |
| HY-103199 | Carpindolol | 39731-05-0 | Reference compound |
| HY-10320 | Doramapimod | 285983-48-4 | Reference compound |
| HY-103200 | SR59230A (hydrochloride) | 1135278-41-9 | Reference compound |
| HY-103201 | A 80426 (mesylate) | 152148-64-6 | Reference compound |
| HY-103202A | SNAP5089 (Free base) | 157066-76-7 | Reference compound |
| HY-103203 | ST91 | 4749-61-5 | Reference compound |
| HY-103204 | RS100329 (hydrochloride) | 1215654-26-4 | Reference compound |
| HY-103207 | Amibegron hydrochloride | 121524-09-2 | Reference compound |
| HY-103208 | Benalfocin (hydrochloride) | 86129-54-6 | Reference compound |
| HY-103209 | Rec 15/2615 (hydrochloride) | 173059-17-1 | Reference compound |
| HY-10320A | Doramapimod (hydrochloride) | 1283526-53-3 | Reference compound |
| HY-10320G | Doramapimod (GMP) | 285983-48-4 | GMP Small Molecules |
| HY-10320R | Doramapimod (Standard) | 285983-48-4 | Reference Standards |
| HY-10321 | PD173074 | 219580-11-7 | Reference compound |
| HY-103210 | DSP-4 (hydrochloride) | 40616-75-9 | Reference compound |
| HY-103211 | L748337 | 244192-94-7 | Reference compound |
| HY-103212 | Azepexole (dihydrochloride) | 36067-72-8 | Reference compound |
| HY-103212A | Azepexole (hydrochloride) | 147663-20-5 | Reference compound |
| HY-103212B | Azepexole | 36067-73-9 | Reference compound |
| HY-103213 | JP1302 dihydrochloride | 1259314-65-2 | Reference compound |
| HY-103213A | JP1302 | 80259-18-3 | Reference compound |
| HY-103213R | JP1302 dihydrochloride (Standard) | 1259314-65-2 | Reference Standards |
| HY-103214 | Bucindolol | 71119-11-4 | Reference compound |
| HY-103214A | Bucindolol (hydrochloride) | 70369-47-0 | Reference compound |
| HY-103214R | Bucindolol (Standard) | 71119-11-4 | Reference Standards |
| HY-103216 | RWJ52353 | 245744-10-9 | Reference compound |
| HY-103216A | RWJ52353 (hydrochloride) | 245744-13-2 | Reference compound |
| HY-103217 | Talopram (hydrochloride) | 7013-41-4 | Reference compound |
| HY-103218 | Talsupram (hydrochloride) | 25487-28-9 | Reference compound |
| HY-10321R | PD173074 (Standard) | 219580-11-7 | Reference Standards |
| HY-10322 | Falnidamol | 196612-93-8 | Reference compound |
| HY-103220 | 6,2',4'-Trimethoxyflavone | 720675-74-1 | Reference compound |
| HY-103221 | MeBIO | 667463-95-8 | Reference compound |
| HY-103222 | DiMNF | 14756-24-2 | Reference compound |
| HY-103223 | Phortress | 328087-38-3 | Reference compound |
| HY-103224 | PIT-1 | 53501-41-0 | Reference compound |
| HY-103224R | PIT-1 (Standard) | 53501-41-0 | Reference Standards |
| HY-103225 | S-8510 (phosphate) | 151466-23-8 | Reference compound |
| HY-103226 | SC-57461A | 423169-68-0 | Reference compound |
| HY-103227 | Desidustat | 1616690-16-4 | Reference compound |
| HY-103227R | Desidustat (Standard) | 1616690-16-4 | Reference Standards |
| HY-103228 | GYKI 53655 (hydrochloride) | 143692-48-2 | Reference compound |
| HY-103229 | Cl-HIBO | 909400-43-7 | Reference compound |
| HY-10322R | Falnidamol (Standard) | 196612-93-8 | Reference Standards |
| HY-103230 | IEM-1460 | 121034-89-7 | Reference compound |
| HY-103232 | IEM-1925 (bromide) | 258282-23-4 | Reference compound |
| HY-103233 | DNQX (disodium salt) | 1312992-24-7 | Reference compound |
| HY-103234 | GYKI 52466 | 102771-26-6 | Reference compound |
| HY-103234A | GYKI 52466 (dihydrochloride) | 2319722-40-0 | Reference compound |
| HY-103234AR | GYKI 52466 (dihydrochloride) (Standard) | 2319722-40-0 | Reference Standards |
| HY-103234B | GYKI 52466 (hydrochloride) | 192065-56-8 | Reference compound |
| HY-103235 | NPEC-caged-(S)-AMPA | 1257323-84-4 | Reference compound |
| HY-103236 | NSC232003 | 1905453-18-0 | Reference compound |
| HY-103237 | L-Adenosine | 3080-29-3 | Oligonucleotides |
| HY-103238 | RSVA405 | 140405-36-3 | Reference compound |
| HY-103239 | PT1 | 331002-70-1 | Reference compound |
| HY-10324 | D4476 | 301836-43-1 | Reference compound |
| HY-103240 | Methoxy-X04 | 863918-78-9 | Dye Reagents |
| HY-103241 | Ro 90-7501 | 293762-45-5 | Reference compound |
| HY-103242 | CRANAD-2 | 1193447-34-5 | Reference compound |
| HY-103243 | TCPOBOP | 76150-91-9 | Reference compound |
| HY-103243R | TCPOBOP (Standard) | 76150-91-9 | Reference Standards |
| HY-103244 | CITCO | 338404-52-7 | Reference compound |
| HY-103245 | Cl-4AS-1 | 188589-66-4 | Reference compound |
| HY-103246 | TFM-4AS-1 | 188589-61-9 | Reference compound |
| HY-103247 | EMD 66684 | 1216884-39-7 | Reference compound |
| HY-103247B | EMD-66684 (potassium salt) | 187683-79-0 | Reference compound |
| HY-103248 | Toyocamycin | 606-58-6 | Natural Products |
| HY-103248R | Toyocamycin (Standard) | 606-58-6 | Reference Standards |
| HY-103249 | Reutericyclin | 303957-69-9 | Natural Products |
| HY-10325 | CL-387785 | 194423-06-8 | Reference compound |
| HY-103250 | PF-945863 | 893556-85-9 | Reference compound |
| HY-103251 | PF-5081090 | 1312473-63-4 | Reference compound |
| HY-103251R | PF-5081090 (Standard) | 1312473-63-4 | Reference Standards |
| HY-103252 | Monomethyl fumarate | 2756-87-8 | Reference compound |
| HY-103252R | Monomethyl fumarate (Standard) | 2756-87-8 | Reference Standards |
| HY-103252S | Monomethyl fumarate-d3 | 1616345-41-5 | Isotope-Labeled Compounds |
| HY-103252S1 | Monomethyl fumarate-d5 | 1616345-45-9 | Isotope-Labeled Compounds |
| HY-103253 | LY231617 | 141545-89-3 | Reference compound |
| HY-103254 | ML221 | 877636-42-5 | Reference compound |
| HY-103255 | CFM-4 | 331458-02-7 | Reference compound |
| HY-103256 | 2,3-DCPE | 418788-90-6 | Reference compound |
| HY-103257 | CHM-1 | 154554-41-3 | Reference compound |
| HY-103258 | TC ASK 10 | 1005775-56-3 | Reference compound |
| HY-103259 | Sodium metatungstate | 12141-67-2 | Reference compound |
| HY-103259A | Sodium metatungstate (hydrate) | 314075-43-9 | Reference compound |
| HY-10326 | GW788388 | 452342-67-5 | Reference compound |
| HY-103261 | SCH28080 | 76081-98-6 | Reference compound |
| HY-103261R | SCH28080 (Standard) | 76081-98-6 | Reference Standards |
| HY-103262 | PSB069 | 78510-31-3 | Reference compound |
| HY-103263 | PSB-06126 | 1052089-16-3 | Reference compound |
| HY-103265 | ARL67156 (trisodium) | 1021868-83-6 | Reference compound |
| HY-103265A | ARL67156 | 160928-38-1 | Reference compound |
| HY-103265B | ARL67156 (trisodium hydrate) | Reference compound | |
| HY-103265D | ARL67156 (triethylamine) | Reference compound | |
| HY-103266 | TC-A 2317 (hydrochloride) | 1245907-03-2 | Reference compound |
| HY-103267 | S32826 (disodium) | 1103672-43-0 | Reference compound |
| HY-103267A | S32826 | 1096770-84-1 | Reference compound |
| HY-103267R | S32826 (disodium) (Standard) | 1103672-43-0 | Reference Standards |
| HY-103268 | (Rac)-AZD3839 | 1227163-56-5 | Reference compound |
| HY-103269 | BAI1 | 335165-68-9 | Reference compound |
| HY-10327 | GW-6604 | 452342-37-9 | Reference compound |
| HY-103271 | Bax inhibitor peptide, negative control | 1315378-74-5 | Reference compound |
| HY-103272 | iMAC2 | 335166-36-4 | Reference compound |
| HY-103273 | Muristerone A | 38778-30-2 | Natural Products |
| HY-103274 | PD180970 | 287204-45-9 | Reference compound |
| HY-103275 | Adaphostin | 241127-58-2 | Reference compound |
| HY-103275R | Adaphostin (Standard) | 241127-58-2 | Reference Standards |
| HY-103276 | Alytesin | 31078-12-3 | Peptides |
| HY-103277 | BIM 23042 | 111857-96-6 | Peptides |
| HY-103277A | BIM 23042 (TFA) | Peptides | |
| HY-10328 | Neflamapimod | 209410-46-8 | Reference compound |
| HY-103280 | LysRs-IN-1 | 281676-77-5 | Reference compound |
| HY-103281 | Litorin | 55749-97-8 | Natural Products |
| HY-103282 | [D-Phe12]-Bombesin | 108437-87-2 | Reference compound |
| HY-103283 | Neuromedin C (porcine) | 81608-30-2 | Peptides |
| HY-103285 | GRP (porcine) | 74815-57-9 | Peptides |
| HY-103286 | PD176252 | 204067-01-6 | Reference compound |
| HY-103287 | [D-Phe12,Leu14]-Bombesin | 108437-88-3 | Reference compound |
| HY-103289 | MEN 11270 | 235082-52-7 | Reference compound |
| HY-10329 | JNJ-7706621 | 443797-96-4 | Reference compound |
| HY-103290 | R715 | 185052-09-9 | Peptides |
| HY-103291 | Sar-[D-Phe8]-des-Arg9-Bradykinin | 126959-88-4 | Reference compound |
| HY-103292 | [Phe8Ψ(CH-NH)Arg9]-Bradykinin | 118122-39-7 | Peptides |
| HY-103293 | Lys-Bradykinin | 342-10-9 | Reference compound |
| HY-103293A | Lys-Bradykinin (TFA) | Reference compound | |
| HY-103293B | Lys-Bradykinin (tetraacetate) | 84640-50-6 | Peptides |
| HY-103294 | R892 | 229030-05-1 | Reference compound |
| HY-103295 | Lys-[Des-Arg9]Bradykinin | 71800-36-7 | Peptides |
| HY-103295A | Lys-[Des-Arg9]Bradykinin (TFA) | 2763588-90-3 | Peptides |
| HY-103296 | Bombinakinin M | 509151-65-9 | Reference compound |
| HY-103297 | OXFBD02 | 1429129-68-9 | Reference compound |
| HY-103298 | MNI-caged kainate | 1315378-75-6 | Reference compound |
| HY-103299 | KG-501 | 18228-17-6 | Reference compound |
| HY-10330 | Toceranib | 356068-94-5 | Reference compound |
| HY-103300 | NPE-caged-proton | 1186195-63-0 | Reference compound |
| HY-103302 | SUN B8155 | 345893-91-6 | Reference compound |
| HY-103303 | CRSP-1 | 697327-12-1 | Peptides |
| HY-103304 | CGRP antagonist 4 | 217438-17-0 | Reference compound |
| HY-103305 | cis-Ned19 | 1137264-00-6 | Reference compound |
| HY-103306 | Ryanodine | 15662-33-6 | Natural Products |
| HY-103307 | FPL64176 | 120934-96-5 | Reference compound |
| HY-103307R | FPL64176 (Standard) | 120934-96-5 | Reference Standards |
| HY-103308 | TRAM-39 | 197525-99-8 | Reference compound |
| HY-103309 | ML218 | 1346233-68-8 | Reference compound |
| HY-103309A | ML218 (hydrochloride) | 2319922-08-0 | Reference compound |
| HY-103309S | ML218-d9 | Isotope-Labeled Compounds | |
| HY-10330A | Toceranib (phosphate) | 874819-74-6 | Reference compound |
| HY-10330S | Toceranib-d8 | 1795134-78-9 | Isotope-Labeled Compounds |
| HY-10331 | Regorafenib | 755037-03-7 | Reference compound |
| HY-103310 | MRS1845 | 544478-19-5 | Reference compound |
| HY-103311 | Ruthenium red | 11103-72-3 | Dye Reagents |
| HY-103312 | Xestospongin C | 88903-69-9 | Natural Products |
| HY-103313 | SR33805 (oxalate) | 121346-33-6 | Reference compound |
| HY-103314 | Gadolinium chloride | 10138-52-0 | Reference compound |
| HY-103315 | Bepridil hydrochloride | 68099-86-5 | Reference compound |
| HY-103315R | Bepridil hydrochloride (Standard) | 68099-86-5 | Reference Standards |
| HY-103315S | Bepridil-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-103316 | trans-Ned 19 | 1354235-96-3 | Reference compound |
| HY-103316A | Ned 19 | 874374-25-1 | Reference compound |
| HY-103317 | NAADP | 5502-96-5 | Reference compound |
| HY-103318 | PD173212 | 217171-01-2 | Reference compound |
| HY-103319 | Calmidazolium (chloride) | 57265-65-3 | Reference compound |
| HY-10331A | Regorafenib (monohydrate) | 1019206-88-2 | Reference compound |
| HY-10331AR | Regorafenib (monohydrate) (Standard) | 1019206-88-2 | Reference Standards |
| HY-10331B | Regorafenib (mesylate) | 835621-08-4 | Reference compound |
| HY-10331R | Regorafenib (Standard) | 755037-03-7 | Reference Standards |
| HY-10331S | Regorafenib-d3 | 1255386-16-3 | Isotope-Labeled Compounds |
| HY-10331S1 | Regorafenib-13C,d3 | Isotope-Labeled Compounds | |
| HY-10332 | (Z)-Semaxanib | 194413-58-6 | Reference compound |
| HY-103320 | Calhex 231 | 652973-93-8 | Reference compound |
| HY-103320A | Calhex 231 (hydrochloride) | 2387505-78-2 | Reference compound |
| HY-103320B | (1R,2R)-Calhex 231 (hydrochloride) | Reference compound | |
| HY-103322 | 6-Bnz-cAMP (sodium salt) | 1135306-29-4 | Reference compound |
| HY-103323 | Fas C-Terminal Tripeptide | 189109-90-8 | Peptides |
| HY-103324 | Palmitoylisopropylamide | 189939-61-5 | Reference compound |
| HY-103325 | JTE-907 | 282089-49-0 | Reference compound |
| HY-103326 | NIDA-41020 | 502486-89-7 | Reference compound |
| HY-103327 | MJ15 | 944154-76-1 | Reference compound |
| HY-103329 | b-AEA | 956605-71-3 | Reference compound |
| HY-10333 | BMS-690514 | 859853-30-8 | Reference compound |
| HY-103330 | TC-C 14G | 656804-72-7 | Reference compound |
| HY-103331 | COR170 | 1048039-15-1 | Reference compound |
| HY-103332 | N-Arachidonylglycine | 179113-91-8 | Reference compound |
| HY-103332R | N-Arachidonylglycine (Standard) | 179113-91-8 | Reference Standards |
| HY-103332S | N-Arachidonylglycine-d8 | 1159908-44-7 | Isotope-Labeled Compounds |
| HY-103333 | Arvanil | 128007-31-8 | Reference compound |
| HY-103334 | MAFP | 188404-10-6 | Reference compound |
| HY-103335 | O1918 | 536697-79-7 | Reference compound |
| HY-103336 | Tocrifluor 1117 | 1186195-59-4 | Reference compound |
| HY-103337 | N-Arachidonoylserotonin | 187947-37-1 | Reference compound |
| HY-103338 | AM1172 | 251908-92-6 | Reference compound |
| HY-103339 | VDM11 | 313998-81-1 | Reference compound |
| HY-103340 | O-2093 | 439080-01-0 | Reference compound |
| HY-103341 | UCM707 | 390824-20-1 | Reference compound |
| HY-103342 | OMDM-2 | 616884-63-0 | Reference compound |
| HY-103344 | ZJ43 | 723331-20-2 | Reference compound |
| HY-103345 | 2-MPPA | 254737-29-6 | Reference compound |
| HY-103345R | 2-MPPA (Standard) | 254737-29-6 | Reference Standards |
| HY-103346 | MMPSI | 220509-74-0 | Reference compound |
| HY-103347 | M50054 | 54135-60-3 | Reference compound |
| HY-103347R | M50054 (Standard) | 54135-60-3 | Reference Standards |
| HY-103348 | Boc-Asp(OMe)-fluoromethyl ketone | 187389-53-3 | Reference compound |
| HY-103349 | PETCM | 10129-56-3 | Reference compound |
| HY-103350 | CA-074 | 134448-10-5 | Reference compound |
| HY-103351 | Cathepsin G Inhibitor I | 429676-93-7 | Reference compound |
| HY-103352 | L-006235 | 294623-49-7 | Reference compound |
| HY-103352R | L-006235 (Standard) | 294623-49-7 | Reference Standards |
| HY-103353 | SID 26681509 | 958772-66-2 | Reference compound |
| HY-103353A | SID 26681509 (quarterhydrate) | Reference compound | |
| HY-103354 | Proglumide (sodium) | 99247-33-3 | Reference compound |
| HY-103354A | Proglumide (hemicalcium) | 85068-56-0 | Reference compound |
| HY-103354R | Proglumide (sodium) (Standard) | 99247-33-3 | Reference Standards |
| HY-103355 | YM022 | 145084-28-2 | Reference compound |
| HY-103357 | LY288513 | 147523-65-7 | Reference compound |
| HY-103357A | LY262691 | 138932-35-1 | Reference compound |
| HY-103358 | KF38789 | 257292-29-8 | Reference compound |
| HY-103359 | Ceranib1 | 328076-61-5 | Reference compound |
| HY-10336 | Brivanib (alaninate) | 649735-63-7 | Reference compound |
| HY-103360 | J-113863 | 353791-85-2 | Reference compound |
| HY-103360A | cis-J-113863 | 202796-41-6 | Reference compound |
| HY-103360B | trans-J-113863 | 202796-42-7 | Reference compound |
| HY-103361 | SB297006 | 58816-69-6 | Reference compound |
| HY-103362 | CCR2 antagonist 4 (hydrochloride) | 1313730-14-1 | Reference compound |
| HY-103363 | SB-328437 | 247580-43-4 | Reference compound |
| HY-103364 | C-021 | 864289-85-0 | Reference compound |
| HY-103364A | C-021 (dihydrochloride) | 1784252-84-1 | Reference compound |
| HY-103364AR | C-021 (dihydrochloride) (Standard) | 1784252-84-1 | Reference Standards |
| HY-103364R | C-021 (Standard) | 864289-85-0 | Reference Standards |
| HY-103365 | BX-513 (hydrochloride) | 1216540-18-9 | Reference compound |
| HY-103366 | NSC 109555 (ditosylate) | 66748-43-4 | Reference compound |
| HY-103367 | CHK1-IN-7 | 838823-31-7 | Reference compound |
| HY-103368 | Eact | 461000-66-8 | Reference compound |
| HY-103369 | PG01 | 853138-65-5 | Reference compound |
| HY-10336R | Brivanib (alaninate) (Standard) | 649735-63-7 | Reference Standards |
| HY-10337 | Brivanib | 649735-46-6 | Reference compound |
| HY-103370 | Talniflumate | 66898-62-2 | Reference compound |
| HY-103370R | Talniflumate (Standard) | 66898-62-2 | Reference Standards |
| HY-103371 | DCPIB | 82749-70-0 | Reference compound |
| HY-103372 | GSK264220A | 685506-42-7 | Reference compound |
| HY-103373 | PE154 | 1192750-33-6 | Dye Reagents |
| HY-103374 | Phenserine | 101246-66-6 | Reference compound |
| HY-103374A | Phenserine (tartrate) | 156910-61-1 | Reference compound |
| HY-103375 | SN003 | 197801-88-0 | Reference compound |
| HY-103376 | NBI-27914 (hydrochloride) | 1215766-76-9 | Reference compound |
| HY-103377 | Antalarmin (hydrochloride) | 220953-69-5 | Reference compound |
| HY-103377R | Antalarmin (hydrochloride) (Standard) | 220953-69-5 | Reference Standards |
| HY-103378 | NBI 35965 (methanesulfonate) | 603151-83-3 | Reference compound |
| HY-103379 | CP 376395 (hydrochloride) | 1013933-37-3 | Reference compound |
| HY-10337R | Brivanib (Standard) | 649735-46-6 | Reference Standards |
| HY-10338 | Foretinib | 849217-64-7 | Reference compound |
| HY-103380 | NSC 625987 | 141992-47-4 | Reference compound |
| HY-103381 | NSC693868 | 40254-90-8 | Reference compound |
| HY-103382 | Arcyriaflavin A | 118458-54-1 | Natural Products |
| HY-103382R | Arcyriaflavin A (Standard) | 118458-54-1 | Reference Standards |
| HY-103383 | (R)-DRF053 (dihydrochloride) | 1241675-76-2 | Reference compound |
| HY-103384 | TMCB | 905105-89-7 | Reference compound |
| HY-103385 | NCX4040 | 287118-97-2 | Reference compound |
| HY-103385R | NCX4040 (Standard) | 287118-97-2 | Reference Standards |
| HY-103386 | FR122047 | 130717-51-0 | Reference compound |
| HY-103387 | DuP-697 | 88149-94-4 | Reference compound |
| HY-103388 | NCX 466 | 1262956-64-8 | Reference compound |
| HY-103389 | 1-Aminobenzotriazole | 1614-12-6 | Reference compound |
| HY-103389R | 1-Aminobenzotriazole (Standard) | 1614-12-6 | Reference Standards |
| HY-10338A | Foretinib (phosphate) | 1226999-07-0 | Reference compound |
| HY-10338R | Foretinib (Standard) | 849217-64-7 | Reference Standards |
| HY-10339 | KW-2449 | 1000669-72-6 | Reference compound |
| HY-103390 | Ro26-4550 (TFA) | 1217448-66-2 | Reference compound |
| HY-103391 | Qc1 | 403718-45-6 | Reference compound |
| HY-103392 | Stiripentol | 49763-96-4 | Reference compound |
| HY-103392S | Stiripentol-d9 | 1185239-64-8 | Isotope-Labeled Compounds |
| HY-103394 | TC HSD 21 | 330203-01-5 | Reference compound |
| HY-103395 | Methylmalonic acid | 516-05-2 | Natural Products |
| HY-103395R | Methylmalonic acid (Standard) | 516-05-2 | Reference Standards |
| HY-103395S | Methylmalonic acid-d3 | 42522-59-8 | Isotope-Labeled Compounds |
| HY-103395S1 | Methylmalonic acid-13C4 | 1173019-21-0 | Isotope-Labeled Compounds |
| HY-103396 | Trimetrexate (glucuronate) | 82952-64-5 | Reference compound |
| HY-103396R | Trimetrexate (glucuronate) (Standard) | 82952-64-5 | Reference Standards |
| HY-103397 | Nanaomycin A | 52934-83-5 | Reference compound |
| HY-103397A | Dihydrokalafungin | 98392-26-8 | Reference compound |
| HY-103397R | Nanaomycin A (Standard) | 52934-83-5 | Reference Standards |
| HY-103398 | Nanaomycin C | 58286-55-8 | Natural Products |
| HY-103399 | Trovafloxacin (mesylate) | 147059-75-4 | Reference compound |
| HY-103399R | Trovafloxacin (mesylate) (Standard) | 147059-75-4 | Reference Standards |
| HY-10340 | Tirbanibulin | 897016-82-9 | Reference compound |
| HY-103400 | 8-Chloroadenosine | 34408-14-5 | Reference compound |
| HY-103400R | 8-Chloroadenosine (Standard) | 34408-14-5 | Reference Standards |
| HY-103403 | (-)-OSU6162 (hydrochloride) | 156907-84-5 | Reference compound |
| HY-103404 | PNU-96415E | 170856-41-4 | Reference compound |
| HY-103405 | NGD94-1 | 178928-68-2 | Reference compound |
| HY-103406 | PNU-177864 | 250266-51-4 | Reference compound |
| HY-103406A | PNU-177864 (hydrochloride) | 1783978-03-9 | Reference compound |
| HY-103407 | PD 168568 | 210688-56-5 | Reference compound |
| HY-103407A | PD 168568 (dihydrochloride) | 1782532-06-2 | Reference compound |
| HY-103408 | PG01037 (dihydrochloride) | 675599-62-9 | Reference compound |
| HY-103409 | ABT-724 (trihydrochloride) | 587870-77-7 | Reference compound |
| HY-10340A | Tirbanibulin (dihydrochloride) | 1038395-65-1 | Reference compound |
| HY-10340AR | Tirbanibulin (dihydrochloride) (Standard) | 1038395-65-1 | Reference Standards |
| HY-10340B | Tirbanibulin (Mesylate) | 1080645-95-9 | Reference compound |
| HY-10340BR | Tirbanibulin (Mesylate) (Standard) | 1080645-95-9 | Reference Standards |
| HY-10340R | Tirbanibulin (Standard) | 897016-82-9 | Reference Standards |
| HY-10341 | Fasudil (Hydrochloride) | 105628-07-7 | Reference compound |
| HY-103410 | Carmoxirole (hydrochloride) | 115092-85-8 | Reference compound |
| HY-103410R | Carmoxirole (hydrochloride) (Standard) | 115092-85-8 | Reference Standards |
| HY-103411 | SKF83822 (hydrobromide) | 74115-10-9 | Reference compound |
| HY-103412 | SKF 83959 (hydrobromide) | 67287-95-0 | Reference compound |
| HY-103413 | Eticlopride (hydrochloride) | 97612-24-3 | Reference compound |
| HY-103414 | Raclopride | 84225-95-6 | Reference compound |
| HY-103414R | Raclopride (Standard) | 84225-95-6 | Reference Standards |
| HY-103414S | Raclopride-d5 (hydrochloride) | 1217623-85-2 | Isotope-Labeled Compounds |
| HY-103415 | Nemonapride | 75272-39-8 | Reference compound |
| HY-103416 | A-77636 (hydrochloride) | 145307-34-2 | Reference compound |
| HY-103417 | SKF 77434 (hydrobromide) | 300561-58-4 | Reference compound |
| HY-103418 | Dopamine D2 receptor agonist-3 | 1257326-24-1 | Reference compound |
| HY-10341A | Fasudil | 103745-39-7 | Reference compound |
| HY-10341B | Fasudil (hydrochloride semihydrate) | 186694-02-0 | Reference compound |
| HY-10341C | Fasudil (dihydrochloride) | 203911-27-7 | Reference compound |
| HY-10341D | Fasudil (mesylate) | 1001206-62-7 | Reference compound |
| HY-10341R | Fasudil (Hydrochloride) (Standard) | 105628-07-7 | Reference Standards |
| HY-10342 | Enzastaurin | 170364-57-5 | Reference compound |
| HY-103423 | PAOPA | 114200-31-6 | Reference compound |
| HY-103424 | A-412997 (dihydrochloride) | 1347744-96-0 | Reference compound |
| HY-103425 | JHW007 (hydrochloride) | 202645-74-7 | Reference compound |
| HY-103427 | NPEC-caged-dopamine | 1257326-23-0 | Reference compound |
| HY-103428 | LE 300 | 274694-98-3 | Reference compound |
| HY-103429 | Quinelorane (dihydrochloride) | 97548-97-5 | Reference compound |
| HY-10342R | Enzastaurin (Standard) | 170364-57-5 | Reference Standards |
| HY-10343 | Sotrastaurin | 425637-18-9 | Reference compound |
| HY-103430 | SKF-83566 (hydrobromide) | 108179-91-5 | Reference compound |
| HY-103430A | SKF-83566 | 99295-33-7 | Reference compound |
| HY-103431 | A68930 (hydrochloride) | 130465-39-3 | Reference compound |
| HY-103432 | DPP4-In | 866396-34-1 | Reference compound |
| HY-103433 | K579 | 440100-64-1 | Reference compound |
| HY-103434 | PK44 | 1017682-65-3 | Reference compound |
| HY-103435 | Vialinin A | 858134-23-3 | Reference compound |
| HY-103436 | NSC624206 | 13116-77-3 | Reference compound |
| HY-103437 | EGFR-IN-80 | 171745-13-4 | Reference compound |
| HY-103438 | BIBU1361 | 793726-84-8 | Reference compound |
| HY-103438A | BIBU1361 (dihydrochloride) | 1643609-75-9 | Reference compound |
| HY-103439 | GW583340 (dihydrochloride) | 1173023-85-2 | Reference compound |
| HY-10343R | Sotrastaurin (Standard) | 425637-18-9 | Reference Standards |
| HY-10344 | AZD 6482 | 1173900-33-8 | Reference compound |
| HY-103440 | EGFR/ErbB-2/ErbB-4 inhibitor-3 | 881001-19-0 | Reference compound |
| HY-103441 | JNJ28871063 (hydrochloride) | 944342-90-9 | Reference compound |
| HY-103442 | CGP52411 | 145915-58-8 | Reference compound |
| HY-103443 | HKI-357 | 848133-17-5 | Reference compound |
| HY-103443A | HKI-357 (dimaleate) | 915942-25-5 | Reference compound |
| HY-103444 | ARP-100 | 704888-90-4 | Reference compound |
| HY-103444R | ARP-100 (Standard) | 704888-90-4 | Reference Standards |
| HY-103445 | SSR69071 | 344930-95-6 | Reference compound |
| HY-103446 | FERb 033 | 1111084-78-6 | Reference compound |
| HY-103447 | Zearalenone | 17924-92-4 | Natural Products |
| HY-103447R | Zearalenone (Standard) | 17924-92-4 | Reference Standards |
| HY-103447S | (Rac)-Zearalenone-d6 | 1185236-04-7 | Isotope-Labeled Compounds |
| HY-103447S1 | Zearalenone-13C18 | 911392-43-3 | Isotope-Labeled Compounds |
| HY-103447S2 | Zearalenone-13C7 | Isotope-Labeled Compounds | |
| HY-103449 | G15 | 1161002-05-6 | Reference compound |
| HY-103450 | G36 | 1392487-51-2 | Reference compound |
| HY-103451 | (R,R)-THC | 221368-54-3 | Reference compound |
| HY-103451A | rel-(R,R)-THC | 138090-06-9 | Reference compound |
| HY-103452 | RU58668 | 151555-47-4 | Reference compound |
| HY-103453 | (R)-DPN | 524047-78-7 | Reference compound |
| HY-103454 | MPP (dihydrochloride) | 911295-24-4 | Reference compound |
| HY-103454B | MPP (hydrochloride) | 2863676-89-3 | Reference compound |
| HY-103455 | ZK164015 | 177583-70-9 | Reference compound |
| HY-103456 | PHTPP | 805239-56-9 | Reference compound |
| HY-103456R | PHTPP (Standard) | 805239-56-9 | Reference Standards |
| HY-103457 | Y134 | 849662-80-2 | Reference compound |
| HY-103458 | BMS 182874 (hydrochloride) | 1215703-04-0 | Reference compound |
| HY-103459 | CI-1020 | 162256-50-0 | Reference compound |
| HY-10346 | AV-412 | 451493-31-5 | Reference compound |
| HY-103460 | IRL 2500 | 169545-27-1 | Reference compound |
| HY-103461 | FAAH-IN-6 | 1143578-94-2 | Reference compound |
| HY-103462 | TC-F2 | 1304778-15-1 | Reference compound |
| HY-103463 | SA57 | 1346169-63-8 | Reference compound |
| HY-103464 | 5'-Fluoroindirubinoxime | 861214-33-7 | Reference compound |
| HY-103465 | FFN511 | 1004548-96-2 | Reference compound |
| HY-103465B | FFN511 (hydrochloride) | 2596358-28-8 | Reference compound |
| HY-103466 | FM4-64 | 162112-35-8 | Dye Reagents |
| HY-103467 | NPE-caged-HPTS (sodium) | 223759-19-1 | Dye Reagents |
| HY-103469 | Peroxy Orange 1 | 1199576-10-7 | Dye Reagents |
| HY-10346A | AV-412 (free base) | 451492-95-8 | Reference compound |
| HY-103470 | K114 | 872201-12-2 | Dye Reagents |
| HY-103471 | Y11 | 1086639-59-9 | Reference compound |
| HY-103472 | FPR-A14 | 329691-12-5 | Reference compound |
| HY-103473 | Boc-MLF | 67247-12-5 | Reference compound |
| HY-103473A | Boc-MLF (TFA) | Reference compound | |
| HY-103474 | Bicuculline methiodide | 40709-69-1 | Reference compound |
| HY-103475 | GS39783 | 39069-52-8 | Reference compound |
| HY-103476 | Ro15-4513 | 91917-65-6 | Reference compound |
| HY-103476R | Ro15-4513 (Standard) | 91917-65-6 | Reference Standards |
| HY-103478 | KHK-IN-2 | 2135304-43-5 | Reference compound |
| HY-103479 | GOAT-IN-1 | 1452473-54-9 | Reference compound |
| HY-103482 | JNJ0966 | 315705-75-0 | Reference compound |
| HY-103483 | MD2-IN-1 | 111797-22-9 | Reference compound |
| HY-103484 | GATA4-NKX2-5-IN-1 | 544681-96-1 | Reference compound |
| HY-103487 | Uprifosbuvir | 1496551-77-9 | Reference compound |
| HY-103489 | PI-273 | 925069-34-7 | Reference compound |
| HY-10349 | WAY-100635 | 162760-96-5 | Reference compound |
| HY-103490 | Takinib | 1111556-37-6 | Reference compound |
| HY-103490R | Takinib (Standard) | 1111556-37-6 | Reference Standards |
| HY-103491 | PF-06462894 | 1622291-66-0 | Reference compound |
| HY-103492 | CDK8-IN-1 | 1629633-48-2 | Reference compound |
| HY-103493 | TAK-915 | 1476727-50-0 | Reference compound |
| HY-103495 | 17-PA | 694438-95-4 | Reference compound |
| HY-103496 | U-90042 | 134516-99-7 | Reference compound |
| HY-103497 | U-89843A (hydrochloride) | 157013-85-9 | Reference compound |
| HY-103498 | Org20599 | 156685-94-8 | Reference compound |
| HY-103499 | ZK 93426 (hydrochloride) | 1216792-30-1 | Reference compound |
| HY-10349A | WAY-100635 (maleate) | 1092679-51-0 | Reference compound |
| HY-10349AR | WAY-100635 (maleate) (Standard) | 1092679-51-0 | Reference Standards |
| HY-10349R | WAY-100635 (Standard) | 162760-96-5 | Reference Standards |
| HY-103500 | Ro19-4603 | 99632-94-7 | Reference compound |
| HY-103501 | SB-205384 | 160296-13-9 | Reference compound |
| HY-103502 | CGP7930 | 57717-80-3 | Reference compound |
| HY-103503 | CGP13501 | 56189-68-5 | Reference compound |
| HY-103504 | (S)-SNAP5114 | 157604-55-2 | Reference compound |
| HY-103505 | CL 218872 | 66548-69-4 | Reference compound |
| HY-103506 | NNC-711 | 145645-62-1 | Reference compound |
| HY-103507 | N-Arachidonyl-GABA | 128201-89-8 | Reference compound |
| HY-103509 | NNC 05-2090 (hydrochloride) | 184845-18-9 | Reference compound |
| HY-10351 | Robalzotan | 169758-66-1 | Reference compound |
| HY-103510 | TB-21007 | 207306-50-1 | Reference compound |
| HY-103511 | TCS1105 | 185391-33-7 | Reference compound |
| HY-103512 | TP003 | 628690-75-5 | Reference compound |
| HY-103513 | GABAA receptor agent 2 | 1236105-75-1 | Reference compound |
| HY-103516 | CGP55845 (hydrochloride) | 149184-22-5 | Reference compound |
| HY-103518 | CGP36216 | 123691-29-2 | Reference compound |
| HY-103518A | CGP36216 (hydrochloride) | 1781834-71-6 | Reference compound |
| HY-103519 | rac-BHFF | 123557-91-5 | Reference compound |
| HY-10351A | Robalzotan (hydrochloride) | 184674-99-5 | Reference compound |
| HY-103520 | DS2 | 374084-31-8 | Reference compound |
| HY-103521 | Anxiolytic/nonsedative agent-1 | 355022-97-8 | Reference compound |
| HY-103522 | AA29504 | 945828-50-2 | Reference compound |
| HY-103524 | Valerenic acid | 3569-10-6 | Reference compound |
| HY-103524R | Valerenic acid (Standard) | 3569-10-6 | Reference Standards |
| HY-103526 | DPNI-GABA | 927866-58-8 | Reference compound |
| HY-103527 | RuBi-GABA | 1028141-88-9 | Reference compound |
| HY-103528 | SCS | 3232-36-8 | Reference compound |
| HY-10353 | Raltegravir | 518048-05-0 | Reference compound |
| HY-103530 | CGP35348 | 123690-79-9 | Reference compound |
| HY-103530R | CGP35348 (Standard) | 123690-79-9 | Reference Standards |
| HY-103531 | CGP52432 | 139667-74-6 | Reference compound |
| HY-103532 | CGP46381 | 123691-14-5 | Reference compound |
| HY-103533 | Gabazine | 104104-50-9 | Reference compound |
| HY-103533R | Gabazine (Standard) | 104104-50-9 | Reference Standards |
| HY-103534 | CI-966 (hydrochloride) | 110283-66-4 | Reference compound |
| HY-103535 | GBLD345 | 122479-08-7 | Reference compound |
| HY-103536 | Galnon | 475115-35-6 | Reference compound |
| HY-103536A | Galnon (TFA) | 1217448-19-5 | Reference compound |
| HY-103537 | (Rac)-BIIB042 | 1257395-14-4 | Reference compound |
| HY-103538 | JLK-6 | 62252-26-0 | Reference compound |
| HY-103539 | 3,5-Bis(4-nitrophenoxy)benzoic acid | 173550-33-9 | Reference compound |
| HY-10353A | Raltegravir (potassium) | 871038-72-1 | Reference compound |
| HY-10353AR | Raltegravir (potassium) (Standard) | 871038-72-1 | Reference Standards |
| HY-10353AS | Raltegravir-d3 (potassium) | 1246816-98-7 | Isotope-Labeled Compounds |
| HY-10353AS1 | Raltegravir-13C,d3 (potassium) | Isotope-Labeled Compounds | |
| HY-10353AS2 | Raltegravir-d4 (potassium) | Isotope-Labeled Compounds | |
| HY-10353B | Raltegravir (sodium) | 1292804-07-9 | Reference compound |
| HY-10353S | Raltegravir-d4 | 2712343-38-7 | Isotope-Labeled Compounds |
| HY-10353S1 | Raltegravir-d6 | 1100750-98-8 | Isotope-Labeled Compounds |
| HY-103540 | Tabimorelin (hemifumarate) | 242143-80-2 | Reference compound |
| HY-103544 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | 96736-12-8 | Peptides |
| HY-103545 | GIP (1-39) | 725474-97-5 | Peptides |
| HY-103546 | BETP | 1371569-69-5 | Reference compound |
| HY-103547 | L-168049 | 191034-25-0 | Reference compound |
| HY-103548 | GSK9027 | 1229096-88-1 | Reference compound |
| HY-103549 | Z-Cyclopentyl-AP4 | 103439-17-4 | Reference compound |
| HY-10355 | AKT inhibitor VIII | 612847-09-3 | Reference compound |
| HY-103550 | A-841720 | 869802-58-4 | Reference compound |
| HY-103551 | (±)-LY395756 | 852679-66-4 | Reference compound |
| HY-103551A | LY 541850 | 852679-76-6 | Reference compound |
| HY-103552 | LY487379 (hydrochloride) | 353229-59-1 | Reference compound |
| HY-103555 | NPEC-caged-(1S,3R)-ACPD | 1315379-60-2 | Reference compound |
| HY-103556 | YM-202074 (fumarate) | 299900-84-8 | Reference compound |
| HY-103557 | Ro 64-5229 | 246852-46-0 | Reference compound |
| HY-103558 | LY379268 | 191471-52-0 | Reference compound |
| HY-103559 | HexylHIBO | 334887-43-3 | Reference compound |
| HY-103560 | (S)-HexylHIBO | 334887-48-8 | Reference compound |
| HY-103561 | DCB | 6971-97-7 | Reference compound |
| HY-103562 | DMeOB | 40252-74-2 | Reference compound |
| HY-103563 | 3-MATIDA | 518357-51-2 | Reference compound |
| HY-103564 | ACDPP | 37804-11-8 | Reference compound |
| HY-103565 | AMN082 | 97075-46-2 | Reference compound |
| HY-103565A | AMN082 (free base) | 83027-13-8 | Reference compound |
| HY-103565AR | AMN082 (free base) (Standard) | 83027-13-8 | Reference Standards |
| HY-103565R | AMN082 (Standard) | 97075-46-2 | Reference Standards |
| HY-103566 | LY456236 | 338736-46-2 | Reference compound |
| HY-103567 | Desmethyl-YM-298198 (hydrochloride) | 1177767-57-5 | Reference compound |
| HY-103567A | Desmethyl-YM-298198 | 299901-57-8 | Reference compound |
| HY-103568 | YM-298198 (hydrochloride) | 1216398-09-2 | Reference compound |
| HY-10357 | MK-2206 (free base) | 1032349-93-1 | Reference compound |
| HY-103570 | MCPG (sodium) | 1303994-09-3 | Reference compound |
| HY-103571 | VU0285683 | 327056-22-4 | Reference compound |
| HY-103572 | MNI137 | 946619-21-2 | Reference compound |
| HY-103573 | VU 0360223 | 1274859-33-4 | Reference compound |
| HY-103574 | Raseglurant (hydrochloride) | 757949-98-7 | Reference compound |
| HY-103575 | MFZ 10-7 | 1224431-15-5 | Reference compound |
| HY-103575A | MFZ 10-7 (hydrochloride) | 1779796-36-9 | Reference compound |
| HY-103576 | LGD-3303 | 917891-35-1 | Reference compound |
| HY-103577 | LG-121071 | 179897-70-2 | Reference compound |
| HY-103578 | S-40503 | 404920-28-1 | Reference compound |
| HY-10358 | MK-2206 (dihydrochloride) | 1032350-13-2 | Reference compound |
| HY-103583 | KDU731 | 1610610-48-4 | Reference compound |
| HY-103586 | GS-441524 | 1191237-69-0 | Reference compound |
| HY-103586A | GS-441524 (hydrochloride) | 2378280-82-9 | Reference compound |
| HY-103591 | DUPA(OtBu)-OH | 1026987-94-9 | Reference compound |
| HY-103592 | ARN14974 | 1644158-57-5 | Reference compound |
| HY-103593 | LCL521 | 1226851-11-1 | Reference compound |
| HY-103593A | LCL521 dihydrochloride | 1226759-47-2 | Reference compound |
| HY-103594 | 2-Aminoacridone | 27918-14-5 | Dye Reagents |
| HY-103595 | Epirizole | 18694-40-1 | Reference compound |
| HY-103595R | Epirizole (Standard) | 18694-40-1 | Reference Standards |
| HY-103596 | Thalidomide-4-OH | 5054-59-1 | Reference compound |
| HY-103597 | Thalidomide-O-COOH | 1061605-21-7 | Reference compound |
| HY-103598 | (S,R,S)-AHPC-PEG3-N3 | 1797406-80-4 | Reference compound |
| HY-103599 | (S,R,S)-AHPC-PEG2-N3 | 2010159-45-0 | Reference compound |
| HY-103600 | (S,R,S)-AHPC-PEG1-N3 | 2101200-09-1 | Reference compound |
| HY-103601 | (S,R,S)-AHPC-PEG4-N3 | 1797406-81-5 | Reference compound |
| HY-103602 | (S,R,S)-AHPC-PEG3-NH2 (hydrochloride) | 2097971-11-2 | Reference compound |
| HY-103602A | (S,R,S)-AHPC-PEG3-NH2 | 2010159-56-3 | Reference compound |
| HY-103602B | (S,R,S)-AHPC-PEG3-NH2 (dihydrochloride) | 2376990-24-6 | Reference compound |
| HY-103603 | (S,R,S)-AHPC-PEG2-NH2 (hydrochloride) | 2097973-72-1 | Reference compound |
| HY-103603A | (S,R,S)-AHPC-PEG2-NH2 | 2010159-60-9 | Reference compound |
| HY-103603B | (S,R,S)-AHPC-PEG2-NH2 (dihydrochloride) | 2341796-76-5 | Reference compound |
| HY-103604 | (S,R,S)-AHPC-PEG4-NH2 (hydrochloride) | 2064292-52-8 | Reference compound |
| HY-103604A | (S,R,S)-AHPC-PEG4-NH2 | 2010159-57-4 | Reference compound |
| HY-103605 | (S,R,S)-AHPC-C6-PEG3-C4-Cl | 1835705-55-9 | Reference compound |
| HY-103606 | (S,R,S)-AHPC-PEG6-C4-Cl | 1835705-59-3 | Reference compound |
| HY-103607 | (S,R,S)-AHPC-PEG2-C4-Cl | 1835705-57-1 | Reference compound |
| HY-103608 | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl | 1835705-61-7 | Reference compound |
| HY-103609 | Pyrene | 129-00-0 | Dye Reagents |
| HY-103609R | Pyrene (Standard) | 129-00-0 | Reference Standards |
| HY-103610 | 4,4'-Dimethoxybenzil | 1226-42-2 | Reference compound |
| HY-103611 | Thalidomide-O-amido-PEG3-C2-NH2 (TFA) | 1957236-21-3 | Reference compound |
| HY-103612 | Thalidomide-O-amido-C3-COOH | 2308035-51-8 | Reference compound |
| HY-103613 | Thalidomide-O-amido-C4-NH2 (TFA) | 1799711-25-3 | Reference compound |
| HY-103614 | Thalidomide-O-amido-C8-NH2 (TFA) | 1950635-16-1 | Reference compound |
| HY-103615 | Thalidomide-O-amido-C4-N3 | 2098488-36-7 | Reference compound |
| HY-103617 | PKM2-IN-1 | 94164-88-2 | Reference compound |
| HY-103618 | THZ531 | 1702809-17-3 | Reference compound |
| HY-103620 | ROCK2-IN-2 | 1995065-79-6 | Reference compound |
| HY-103623 | PF-05241328 | 1387633-03-5 | Reference compound |
| HY-103628 | PROTAC CDK9 Degrader-1 | 2118356-96-8 | Reference compound |
| HY-10363 | AP 24149 | 926922-29-4 | Reference compound |
| HY-103632 | PROTAC BRD9 Degrader-1 | 2097971-01-0 | Reference compound |
| HY-103633 | PROTAC BET Degrader-1 | 2093386-22-0 | Reference compound |
| HY-103634 | dFKBP-1 | 1799711-22-0 | Reference compound |
| HY-103636 | PROTAC Sirt2 Degrader-1 | 2098487-75-1 | Reference compound |
| HY-103637 | Vimirogant | 1802706-04-2 | Reference compound |
| HY-103637A | Vimirogant (hydrochloride) | 1802678-42-7 | Reference compound |
| HY-103638 | 3-Methoxytyramine (hydrochloride) | 1477-68-5 | Natural Products |
| HY-103638A | 3-Methoxytyramine | 554-52-9 | Natural Products |
| HY-103638AR | 3-Methoxytyramine (Standard) | 554-52-9 | Reference Standards |
| HY-103638R | 3-Methoxytyramine (hydrochloride) (Standard) | 1477-68-5 | Reference Standards |
| HY-103638S | 3-Methoxytyramine-d4 (hydrochloride) | 1216788-76-9 | Isotope-Labeled Compounds |
| HY-103639 | M62812 (free base) | 613262-61-6 | Reference compound |
| HY-103639A | M62812 | 613263-00-6 | Reference compound |
| HY-103640 | Amifostine thiol (dihydrochloride) | 14653-77-1 | Reference compound |
| HY-103640R | Amifostine thiol (dihydrochloride) (Standard) | 14653-77-1 | Reference Standards |
| HY-103641 | (2R)-Octyl-α-hydroxyglutarate | 1391194-67-4 | Reference compound |
| HY-103641A | (2S)-Octyl-α-hydroxyglutarate | 1391194-64-1 | Reference compound |
| HY-103641AR | (2S)-Octyl-α-hydroxyglutarate (Standard) | 1391194-64-1 | Reference Standards |
| HY-103641AS1 | (2R)-Octyl-α-hydroxyglutarate-d17 | 2748638-78-8 | Isotope-Labeled Compounds |
| HY-103641B | (2R)-Octyl-α-hydroxyglutarate (sodium) | 1391068-16-8 | Reference compound |
| HY-103641C | Octyl-α-hydroxyglutarate | 2097068-39-6 | Reference compound |
| HY-103641R | (2R)-Octyl-α-hydroxyglutarate (Standard) | 1391194-67-4 | Reference Standards |
| HY-103642 | D-myo-Inositol 1,4,5-trisphosphate (hexapotassium salt) | 103476-24-0 | Reference compound |
| HY-103642A | D-myo-Inositol-1,4,5-triphosphate (trisodium) | 141611-10-1 | Reference compound |
| HY-103643 | Fumagillol | 108102-51-8 | Natural Products |
| HY-103643R | Fumagillol (Standard) | 108102-51-8 | Reference Standards |
| HY-103645 | GW779439X | 551919-98-3 | Reference compound |
| HY-103646 | CK7 | 507487-89-0 | Reference compound |
| HY-103647 | K00546 | 443798-47-8 | Reference compound |
| HY-103649 | OT antagonist 3 | 925703-75-9 | Reference compound |
| HY-103650 | OT antagonist 1 | 479080-38-1 | Reference compound |
| HY-103651 | OT antagonist 1 demethyl derivative | 2763705-17-3 | Reference compound |
| HY-103652 | OT antagonist 3 analog | 2444044-37-3 | Reference compound |
| HY-103656 | Tetraphenylporphyrin | 917-23-7 | Reference compound |
| HY-103658 | Myramistin | 15809-19-5 | Reference compound |
| HY-10366 | BI-78D3 | 883065-90-5 | Reference compound |
| HY-103660 | 18:0 LYSO-PE | 69747-55-3 | Reference compound |
| HY-103661 | BI-6C9 | 791835-21-7 | Reference compound |
| HY-103662 | GW-870086 | 827319-43-7 | Reference compound |
| HY-103663 | MAK683 | 1951408-58-4 | Reference compound |
| HY-103663A | MAK683 (hydrochloride) | 2170606-94-5 | Reference compound |
| HY-103664 | Fmoc-1,6-diaminohexane | 166410-37-3 | Reference compound |
| HY-103664A | Fmoc-1,6-diaminohexane (hydrochloride) | 945923-91-1 | Reference compound |
| HY-103665 | STING agonist-3 | 2138299-29-1 | Reference compound |
| HY-103665A | STING agonist-3 (trihydrochloride) | Reference compound | |
| HY-103666 | CY-09 | 1073612-91-5 | Reference compound |
| HY-103667 | 2-HBA | 131359-24-5 | Reference compound |
| HY-103668A | SSD114 (hydrochloride) | 2319790-02-6 | Reference compound |
| HY-103669 | HAT-IN-1 | 1889281-94-0 | Reference compound |
| HY-10367 | Canertinib | 267243-28-7 | Reference compound |
| HY-103671 | IPN60090 | 1853164-83-6 | Reference compound |
| HY-103671A | IPN60090 (dihydrochloride) | 2102101-72-2 | Reference compound |
| HY-103672 | AZD7624 | 1095004-78-6 | Reference compound |
| HY-103673 | AMPD2 inhibitor 1 | 2139356-35-5 | Reference compound |
| HY-10367A | Canertinib (dihydrochloride) | 289499-45-2 | Reference compound |
| HY-10367AR | Canertinib (dihydrochloride) (Standard) | 289499-45-2 | Reference Standards |
| HY-10367R | Canertinib (Standard) | 267243-28-7 | Reference Standards |
| HY-10368 | EGFR/VEGFR2-IN-4 | 870962-74-6 | Reference compound |
| HY-103682 | PF-06726304 | 1616287-82-1 | Reference compound |
| HY-103682A | PF-06726304 (acetate) | 2080306-28-9 | Reference compound |
| HY-103683 | PF-06409577 | 1467057-23-3 | Reference compound |
| HY-103683R | PF-06409577 (Standard) | 1467057-23-3 | Reference Standards |
| HY-103684 | RT-NH2 | 2321343-06-8 | Dye Reagents |
| HY-103687 | Abiraterone metabolite 1 | 1940176-03-3 | Reference compound |
| HY-103688 | N-Ac-γ-Calicheamicin-AcBut-NHS ester | 174885-02-0 | Reference compound |
| HY-103689 | Cucurbit[8]uril | 259886-51-6 | Reference compound |
| HY-103691 | ARN5187 | 1287451-26-6 | Reference compound |
| HY-103691A | ARN5187 (trihydrochloride) | 1700693-96-4 | Reference compound |
| HY-103692 | STX-0119 | 851095-32-4 | Reference compound |
| HY-103693 | NAZ2329 | 2809469-05-2 | Reference compound |
| HY-103694 | Nebularine | 550-33-4 | Natural Products |
| HY-103695 | CD73-IN-1 | 2132396-40-6 | Reference compound |
| HY-103696 | PTC-028 | 1782970-28-8 | Reference compound |
| HY-103697 | Gardiquimod | 1020412-43-4 | Reference compound |
| HY-103697A | Gardiquimod (diTFA) | 1159840-61-5 | Reference compound |
| HY-103697AR | Gardiquimod (diTFA) (Standard) | 1159840-61-5 | Reference Standards |
| HY-103697B | Gardiquimod (hydrochloride) | 2956183-81-4 | Reference compound |
| HY-103697R | Gardiquimod (Standard) | 1020412-43-4 | Reference Standards |
| HY-103698 | TLR7/8 agonist 1 | 1258457-59-8 | Reference compound |
| HY-103698A | TLR7/8 agonist 1 (dihydrochloride) | 1620278-72-9 | Reference compound |
| HY-103700A | Azide-phenylalanine (hydrochloride) | 1409940-46-0 | Reference compound |
| HY-103700B | (Rac)-Azide-phenylalanine | 1822572-56-4 | Reference compound |
| HY-103701 | L-Ascorbic acid 2-phosphate | 23313-12-4 | Reference compound |
| HY-103701A | L-Ascorbic acid 2-phosphate (magnesium) | 113170-55-1 | Reference compound |
| HY-103701AR | L-Ascorbic acid 2-phosphate (magnesium) (Standard) | 113170-55-1 | Reference Standards |
| HY-103701B | L-Ascorbic acid 2-phosphate (magnesium hydrate) | 1713265-25-8 | Biochemical Assay Reagents |
| HY-103702 | TIP48/49-IN-1 | 1807337-58-1 | Reference compound |
| HY-103703 | DEAE Cross-linked dextran A 25 | 12609-80-2 | Reference compound |
| HY-103704 | LY2562175 | 1103500-20-4 | Reference compound |
| HY-103705 | iCRT3 | 901751-47-1 | Reference compound |
| HY-103706 | ROC-325 | 1859141-26-6 | Reference compound |
| HY-103708 | Nezukone | 13656-81-0 | Reference compound |
| HY-10371 | Pim1/AKK1-IN-1 | 1093222-27-5 | Reference compound |
| HY-103710 | IBR2 | 313526-24-8 | Reference compound |
| HY-103710A | (R)-IBR2 | 952739-54-7 | Reference compound |
| HY-103711 | Estramustine | 2998-57-4 | Reference compound |
| HY-103711R | Estramustine (Standard) | 2998-57-4 | Reference Standards |
| HY-103712 | Samuraciclib | 1805833-75-3 | Reference compound |
| HY-103712A | Samuraciclib (hydrochloride) | 1805789-54-1 | Reference compound |
| HY-103712B | Samuraciclib (hydrochloride dihydrate) | Reference compound | |
| HY-103712C | Samuraciclib (hydrochloride hydrate) | Reference compound | |
| HY-103713 | Seclidemstat | 1423715-37-0 | Reference compound |
| HY-103713A | Seclidemstat (mesylate) | 2044953-70-8 | Reference compound |
| HY-103714 | Ensartinib | 1370651-20-9 | Reference compound |
| HY-103714A | Ensartinib (dihydrochloride) | 2137030-98-7 | Reference compound |
| HY-103715 | NLRP3 modulators 1 | 2143015-87-4 | Reference compound |
| HY-10372 | PP121 | 1092788-83-4 | Reference compound |
| HY-103721 | SIRT6-IN-2 | 891002-11-2 | Reference compound |
| HY-10373 | Trimetrexate | 52128-35-5 | Reference compound |
| HY-10373A | Trimetrexate (trihydrochloride) | 1658520-97-8 | Reference compound |
| HY-10373B | Trimetrexate (isethionate) | 82935-04-4 | Reference compound |
| HY-10374 | Semaxinib | 204005-46-9 | Reference compound |
| HY-10388 | TTA-Q6 | 910484-28-5 | Reference compound |
| HY-10388A | TTA-Q6(isomer) | 910484-32-1 | Reference compound |
| HY-10389 | Alvespimycin | 467214-20-6 | Reference compound |
| HY-10392 | Sutezolid | 168828-58-8 | Reference compound |
| HY-10392R | Sutezolid (Standard) | 168828-58-8 | Reference Standards |
| HY-10392S | Sutezolid-13C4 | Isotope-Labeled Compounds | |
| HY-10393 | Eperezolid | 165800-04-4 | Reference compound |
| HY-10393R | Eperezolid (Standard) | 165800-04-4 | Reference Standards |
| HY-10394 | Linezolid | 165800-03-3 | Reference compound |
| HY-10394R | Linezolid (Standard) | 165800-03-3 | Reference Standards |
| HY-10394S | Linezolid-d3 | 1127120-38-0 | Isotope-Labeled Compounds |
| HY-10394S1 | PNU-100766-d8 | 1032182-14-1 | Isotope-Labeled Compounds |
| HY-10395 | PD173955 | 260415-63-2 | Reference compound |
| HY-10396 | Emricasan | 254750-02-2 | Reference compound |
| HY-10396A | (2R,3S)-Emricasan | 409369-54-6 | Reference compound |
| HY-10396R | Emricasan (Standard) | 254750-02-2 | Reference Standards |
| HY-10397 | EP1013 | 223568-55-6 | Reference compound |
| HY-10397A | MX1013 | 582316-00-5 | Reference compound |
| HY-10398 | CTS-1027 | 193022-04-7 | Reference compound |
| HY-10399 | Ladostigil | 209394-27-4 | Reference compound |
| HY-10399A | Ladostigil (hydrochloride) | 209394-18-3 | Reference compound |
| HY-10399B | (S)-Ladostigil | 209394-29-6 | Reference compound |
| HY-10400 | Ladostigil (hemitartrate) | 209394-46-7 | Reference compound |
| HY-104000 | BAY-320 | 1445830-50-1 | Reference compound |
| HY-104001 | BAY-524 | 1445830-39-6 | Reference compound |
| HY-104003 | S 38093 | 862896-30-8 | Reference compound |
| HY-104003A | S 38093 (hydrochloride) | 1222097-72-4 | Reference compound |
| HY-104004 | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH | 120173-57-1 | Reference compound |
| HY-104004A | Fmoc-Ser(O-β-D-GalNAc(OAc)3)-OH | 160067-63-0 | Peptides |
| HY-104005 | ML335 | 825658-06-8 | Reference compound |
| HY-104006 | CYM51010 | 1069498-96-9 | Reference compound |
| HY-104008 | ACY-957 | 1609389-52-7 | Reference compound |
| HY-104009 | GSK2807 | 2245255-65-4 | Reference compound |
| HY-104009A | GSK2807 (Trifluoroacetate) | 2245255-66-5 | Reference compound |
| HY-10401 | VX-702 | 745833-23-2 | Reference compound |
| HY-104010 | Asciminib | 1492952-76-7 | Reference compound |
| HY-104010A | Asciminib (hydrochloride) | 2119669-71-3 | Reference compound |
| HY-104010R | Asciminib (Standard) | 1492952-76-7 | Reference Standards |
| HY-104012 | Islatravir | 865363-93-5 | Reference compound |
| HY-104013 | Aminopurvalanol A | 220792-57-4 | Reference compound |
| HY-104014 | DMT-2'O-MOE-rG(ib) Phosphoramidite | 251647-55-9 | Reference compound |
| HY-104015 | NecroX-5 | 1383718-29-3 | Reference compound |
| HY-104016 | 2'-O-MOE-5MeU-3'-phosphoramidite | 163878-63-5 | Reference compound |
| HY-104017 | DMT-2'-O-MOE-rA(Bz) phosphoramidite | 251647-53-7 | Reference compound |
| HY-10401R | VX-702 (Standard) | 745833-23-2 | Reference Standards |
| HY-10402 | Losmapimod | 585543-15-3 | Reference compound |
| HY-104020A | Philanthotoxin 74 dihydrochloride | 1227301-51-0 | Reference compound |
| HY-104020B | Philanthotoxin 74 (diTFA) | 401601-12-5 | Reference compound |
| HY-104021 | GSK840 | 2361146-30-5 | Reference compound |
| HY-104025 | SPB | 858128-57-1 | ADC Related |
| HY-104026 | L-Kynurenine | 2922-83-0 | Natural Products |
| HY-104026B | L-Kynurenine (sulfate) | 16055-80-4 | Reference compound |
| HY-104026BS | L-Kynurenine-13C10 (sulfate) | Isotope-Labeled Compounds | |
| HY-104026CS | L-Kynurenine-13C10 (sulfate hemihydrate) | Isotope-Labeled Compounds | |
| HY-104026R | L-Kynurenine (Standard) | 2922-83-0 | Reference Standards |
| HY-104026S | L-Kynurenine-d4 | 2672568-86-2 | Isotope-Labeled Compounds |
| HY-104026S1 | L-Kynurenine-d4-1 | 194546-33-3 | Isotope-Labeled Compounds |
| HY-104026S2 | L-Kynurenine-d4-1 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-104026S3 | L-Kynurenine-13C4,15N-1 | Isotope-Labeled Compounds | |
| HY-104026S5 | L-Kynurenine-13C10 (sulfate hydrate) | Isotope-Labeled Compounds | |
| HY-104027 | ML402 | 298684-44-3 | Reference compound |
| HY-104028 | BAY 73-6691 | 794568-92-6 | Reference compound |
| HY-104028A | BAY 73-6691 (racemate) | 794568-90-4 | Reference compound |
| HY-104028B | (S)-BAY 73-6691 | 794568-91-5 | Reference compound |
| HY-104029 | Olorofim | 1928707-56-5 | Reference compound |
| HY-10402R | Losmapimod (Standard) | 585543-15-3 | Reference Standards |
| HY-10403 | PH-797804 | 586379-66-0 | Reference compound |
| HY-104031 | tCFA15 | 220757-88-0 | Reference compound |
| HY-104031R | tCFA15 (Standard) | 220757-88-0 | Reference Standards |
| HY-104032 | Ac-CoA Synthase Inhibitor1 | 508186-14-9 | Reference compound |
| HY-104035E | Dimethyl silicone oil, viscosity 100 cSt (25 °C) | 63148-62-9 | Biochemical Assay Reagents |
| HY-104035H | Dimethyl silicone oil, viscosity 10 cSt (25 °C) | 63148-62-9 | Biochemical Assay Reagents |
| HY-104036 | IDH-305 | 1628805-46-8 | Reference compound |
| HY-104037 | Cintirorgon | 2055536-64-4 | Reference compound |
| HY-104037A | Cintirorgon (sodium) | 2055538-47-9 | Reference compound |
| HY-104038 | Pariceract | 1919820-28-2 | Reference compound |
| HY-104039 | 2'-Deoxy-5'-O-DMT-5-methylcytidine | 176755-83-2 | Reference compound |
| HY-10403A | (aS)-PH-797804 | 1358027-80-1 | Reference compound |
| HY-10404 | Dilmapimod | 444606-18-2 | Reference compound |
| HY-104040 | MKC8866 | 1338934-59-0 | Reference compound |
| HY-104042 | Vorasidenib | 1644545-52-7 | Reference compound |
| HY-104044 | Pamiparib | 1446261-44-4 | Reference compound |
| HY-104044A | Pamiparib (maleate) | 2086689-94-1 | Reference compound |
| HY-104044R | Pamiparib (Standard) | 1446261-44-4 | Reference Standards |
| HY-104046 | Octaaminocryptand 1 | 135469-17-9 | Reference compound |
| HY-104047 | LM22B-10 | 342777-54-2 | Reference compound |
| HY-104048 | QC6352 | 1851373-36-8 | Reference compound |
| HY-10404A | Dilmapimod (tosylate) | 937169-00-1 | Reference compound |
| HY-10404R | Dilmapimod (Standard) | 444606-18-2 | Reference Standards |
| HY-10405 | Pamapimod | 449811-01-2 | Reference compound |
| HY-104050 | M-31850 | 281224-40-6 | Reference compound |
| HY-104051 | Monacolin J | 79952-42-4 | Reference compound |
| HY-104056 | Fura Red | 149732-62-7 | Dye Reagents |
| HY-104058 | Oregon-BAPTA Green 1AM | 244167-57-5 | Dye Reagents |
| HY-104059 | AMG2850 | 1470018-52-0 | Reference compound |
| HY-10405R | Pamapimod (Standard) | 449811-01-2 | Reference Standards |
| HY-10405S | Pamapimod-d4 | 1246814-57-2 | Isotope-Labeled Compounds |
| HY-10406 | Talmapimod | 309913-83-5 | Reference compound |
| HY-104061 | AMG8788 | 1159996-43-6 | Reference compound |
| HY-104062 | AMG9678 | 1159997-27-9 | Reference compound |
| HY-104064 | 1A-116 | 1430208-73-3 | Reference compound |
| HY-104065 | Pyrotinib | 1269662-73-8 | Reference compound |
| HY-104065A | (Rac)-Pyrotinib | 1246089-97-3 | Reference compound |
| HY-104065B | Pyrotinib dimaleate | 1397922-61-0 | Reference compound |
| HY-104065BR | Pyrotinib dimaleate (Standard) | 1397922-61-0 | Reference Standards |
| HY-104066 | Theliatinib | 1353644-70-8 | Reference compound |
| HY-104066A | Theliatinib (tartrate) | 2413487-72-4 | Reference compound |
| HY-104067 | Naphthol AS-MX phosphate | 1596-56-1 | Reference compound |
| HY-104068 | Naphthol AS-E | 92-78-4 | Reference compound |
| HY-104069 | S1P1 agonist 1 | 1220973-37-4 | Reference compound |
| HY-10406A | Talmapimod (hydrochloride ) | 2387505-88-4 | Reference compound |
| HY-10407 | SU 5402 | 215543-92-3 | Reference compound |
| HY-104070 | LG-100064 | 153559-46-7 | Reference compound |
| HY-104071 | Succinaldehydic acid | 692-29-5 | Natural Products |
| HY-104072 | BRD4-IN-3 | 1380087-86-4 | Reference compound |
| HY-104073 | CAY10602 | 374922-43-7 | Reference compound |
| HY-104074 | Pocapavir | 146949-21-5 | Reference compound |
| HY-104074S | Pocapavir-d3 | Isotope-Labeled Compounds | |
| HY-104075 | R916562 | 1037798-41-6 | Reference compound |
| HY-104076 | β-L-Glucose pentaacetate | 66966-07-2 | Biochemical Assay Reagents |
| HY-104076A | α-L-Glucose pentaacetate | 147648-81-5 | Biochemical Assay Reagents |
| HY-104077 | Remdesivir | 1809249-37-3 | Reference compound |
| HY-104077A | Remdesivir (maleate) | 2250110-53-1 | Reference compound |
| HY-104077R | Remdesivir (Standard) | 1809249-37-3 | Reference Standards |
| HY-104077S | Remdesivir-d5 | Isotope-Labeled Compounds | |
| HY-104077S1 | Remdesivir-d4 | Isotope-Labeled Compounds | |
| HY-104077S2 | Remdesivir impurity 9-d4 | Isotope-Labeled Compounds | |
| HY-10407G | SU 5402 (GMP) | 215543-92-3 | GMP Small Molecules |
| HY-10408 | Ki20227 | 623142-96-1 | Reference compound |
| HY-104081 | Cholestyramine | 11041-12-6 | Reference compound |
| HY-104086 | Cucurbit[7]uril | 259886-50-5 | Biochemical Assay Reagents |
| HY-10409 | Fedratinib | 936091-26-8 | Reference compound |
| HY-10409A | Fedratinib (hydrochloride hydrate) | 1374744-69-0 | Reference compound |
| HY-10409AR | Fedratinib (hydrochloride hydrate) (Standard) | 1374744-69-0 | Reference Standards |
| HY-10409R | Fedratinib (Standard) | 936091-26-8 | Reference Standards |
| HY-10409S | Fedratinib-d9 | Isotope-Labeled Compounds | |
| HY-10410 | TG101209 | 936091-14-4 | Reference compound |
| HY-10411 | AZ960 | 905586-69-8 | Reference compound |
| HY-10412 | CEP-1347 | 156177-65-0 | Reference compound |
| HY-10413 | MK-2894 | 1006036-87-8 | Reference compound |
| HY-10414 | MK-2894 (sodium salt) | 1006036-88-9 | Reference compound |
| HY-10416 | Oxamniquine | 21738-42-1 | Reference compound |
| HY-10418 | AH 6809 | 33458-93-4 | Reference compound |
| HY-10418R | AH 6809 (Standard) | 33458-93-4 | Reference Standards |
| HY-10419A | AH23848 (hemicalcium salt) | 81496-19-7 | Reference compound |
| HY-10421 | Tyrosine kinase inhibitor | 1021950-26-4 | Reference compound |
| HY-10422 | AZD-8055 | 1009298-09-2 | Reference compound |
| HY-10423 | OSI-027 | 936890-98-1 | Reference compound |
| HY-10424 | Milciclib | 802539-81-7 | Reference compound |
| HY-10424A | Milciclib (maleate) | 1253645-38-3 | Reference compound |
| HY-10424R | Milciclib (Standard) | 802539-81-7 | Reference Standards |
| HY-10425 | Rizavasertib | 552325-16-3 | Reference compound |
| HY-10426 | XCT790 | 725247-18-7 | Reference compound |
| HY-10427 | WAY-260022 | 850692-43-2 | Reference compound |
| HY-10431 | SB-431542 | 301836-41-9 | Reference compound |
| HY-10431G | SB-431542 (GMP) | 301836-41-9 | GMP Small Molecules |
| HY-10431R | SB-431542 (Standard) | 301836-41-9 | Reference Standards |
| HY-10432 | A 83-01 | 909910-43-6 | Reference compound |
| HY-10432A | A 83-01 (sodium) | 2828431-89-4 | Reference compound |
| HY-10432G | A 83-01 (GMP) | 909910-43-6 | GMP Small Molecules |
| HY-10432R | A 83-01 (Standard) | 909910-43-6 | Reference Standards |
| HY-10435 | SKF-82958 | 80751-65-1 | Reference compound |
| HY-10435A | SKF-82958 (hydrobromide) | 74115-01-8 | Reference compound |
| HY-10435AR | SKF-82958 (hydrobromide) (Standard) | 74115-01-8 | Reference Standards |
| HY-10437 | Setileuton | 910656-27-8 | Reference compound |
| HY-10437A | Setileuton (tosylate) | 1137737-87-1 | Reference compound |
| HY-10439 | HPGDS inhibitor 1 | 1033836-12-2 | Reference compound |
| HY-10440 | Vismodegib | 879085-55-9 | Reference compound |
| HY-10440R | Vismodegib (Standard) | 879085-55-9 | Reference Standards |
| HY-10442 | 3-Deazaneplanocin A | 102052-95-9 | Reference compound |
| HY-10443 | Balapiravir | 690270-29-2 | Reference compound |
| HY-10443A | Balapiravir (hydrochloride) | 690270-65-6 | Reference compound |
| HY-10443R | Balapiravir (Standard) | 690270-29-2 | Reference Standards |
| HY-10444 | R-1479 | 478182-28-4 | Reference compound |
| HY-10445 | Pramiconazole | 219923-85-0 | Reference compound |
| HY-10446 | Pralatrexate | 146464-95-1 | Reference compound |
| HY-10446R | Pralatrexate (Standard) | 146464-95-1 | Reference Standards |
| HY-10447 | Terameprocol | 24150-24-1 | Reference compound |
| HY-10448 | Capsaicin | 404-86-4 | Natural Products |
| HY-10448A | Capsaicin (Purity 65%) | 404-86-4 | Natural Products |
| HY-10448AR | Capsaicin (Purity 65%) (Standard) | 404-86-4 | Reference Standards |
| HY-10448R | Capsaicin (Standard) | 404-86-4 | Reference Standards |
| HY-10448S | (E/Z)-Capsaicin-d3 | 1185237-43-7 | Isotope-Labeled Compounds |
| HY-10448S1 | Capsaicin-d3 | 1217899-52-9 | Isotope-Labeled Compounds |
| HY-10448S4 | Capsaicin-d7 | Isotope-Labeled Compounds | |
| HY-10449 | Luseogliflozin | 898537-18-3 | Reference compound |
| HY-10449A | Luseogliflozin (hydrate) | 1152425-66-5 | Reference compound |
| HY-10450 | Dapagliflozin | 461432-26-8 | Reference compound |
| HY-10450A | Dapagliflozin ((2S)-1,2-propanediol, hydrate) | 960404-48-2 | Reference compound |
| HY-10450AR | Dapagliflozin ((2S)-1,2-propanediol, hydrate) (Standard) | 960404-48-2 | Reference Standards |
| HY-10450R | Dapagliflozin (Standard) | 461432-26-8 | Reference Standards |
| HY-10450S | Dapagliflozin-d5 | 1204219-80-6 | Isotope-Labeled Compounds |
| HY-10450S2 | Dapagliflozin-d4 | 1224234-25-6 | Isotope-Labeled Compounds |
| HY-10450S3 | Dapagliflozin-13C6 | Isotope-Labeled Compounds | |
| HY-10450S5 | Dapagliflozin-13C6-1 | Isotope-Labeled Compounds | |
| HY-10451 | Canagliflozin | 842133-18-0 | Reference compound |
| HY-10451R | Canagliflozin (Standard) | 842133-18-0 | Reference Standards |
| HY-10451S | Canagliflozin-d4 | 1997338-61-0 | Isotope-Labeled Compounds |
| HY-10451S2 | Canagliflozin-d6 | Isotope-Labeled Compounds | |
| HY-10452 | Ixazomib citrate | 1239908-20-3 | Reference compound |
| HY-10453 | Ixazomib | 1072833-77-2 | Reference compound |
| HY-10453R | Ixazomib (Standard) | 1072833-77-2 | Reference Standards |
| HY-10454 | Delanzomib | 847499-27-8 | Reference compound |
| HY-10455 | Carfilzomib | 868540-17-4 | Reference compound |
| HY-10455R | Carfilzomib (Standard) | 868540-17-4 | Reference Standards |
| HY-10455S | Carfilzomib-d8 | 1537187-53-3 | Isotope-Labeled Compounds |
| HY-10456 | TAK-715 | 303162-79-0 | Reference compound |
| HY-10457 | Velusetrag | 866933-46-2 | Reference compound |
| HY-10457A | Velusetrag (hydrochloride) | 866933-51-9 | Reference compound |
| HY-10458 | PF-562271 (besylate) | 939791-38-5 | Reference compound |
| HY-10459 | PF-562271 | 717907-75-0 | Reference compound |
| HY-10460 | PF-431396 | 717906-29-1 | Reference compound |
| HY-10461 | PF-573228 | 869288-64-2 | Reference compound |
| HY-10461R | PF-573228 (Standard) | 869288-64-2 | Reference Standards |
| HY-10465 | Daclatasvir (dihydrochloride) | 1009119-65-6 | Reference compound |
| HY-10465R | Daclatasvir (dihydrochloride) (Standard) | 1009119-65-6 | Reference Standards |
| HY-10466 | Daclatasvir | 1009119-64-5 | Reference compound |
| HY-10466BS | Daclatasvir-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10466R | Daclatasvir (Standard) | 1009119-64-5 | Reference Standards |
| HY-10466S | Daclatasvir-d6 | 1801709-41-0 | Isotope-Labeled Compounds |
| HY-10466S1 | Daclatasvir-13C2,d6 | Isotope-Labeled Compounds | |
| HY-10466S2 | Daclatasvir-d16 | Isotope-Labeled Compounds | |
| HY-10467 | HCV-796 analog | 691852-36-5 | Reference compound |
| HY-10468 | NM107 | 20724-73-6 | Reference compound |
| HY-10468R | NM107 (Standard) | 20724-73-6 | Reference Standards |
| HY-10469 | GSK256066 | 801312-28-7 | Reference compound |
| HY-10469R | GSK256066 (Standard) | 801312-28-7 | Reference Standards |
| HY-10472 | LY2811376 | 1194044-20-6 | Reference compound |
| HY-10473 | Eprotirome | 355129-15-6 | Reference compound |
| HY-10474 | Torkinib | 1092351-67-1 | Reference compound |
| HY-10474R | Torkinib (Standard) | 1092351-67-1 | Reference Standards |
| HY-10475 | AM580 | 102121-60-8 | Reference compound |
| HY-10475G | AM580 (GMP) | 102121-60-8 | GMP Small Molecules |
| HY-10475R | AM580 (Standard) | 102121-60-8 | Reference Standards |
| HY-10480 | Fasiglifam | 1000413-72-8 | Reference compound |
| HY-10480A | (R)-Fasiglifam | 1234474-57-7 | Reference compound |
| HY-10482 | SCH-1473759 | 1094069-99-4 | Reference compound |
| HY-10483 | SCH-1473759 (hydrochloride) | 1094067-13-6 | Reference compound |
| HY-10484 | Pevonedistat hydrochloride | 1160295-21-5 | Reference compound |
| HY-10486 | JDTic | 361444-66-8 | Reference compound |
| HY-10487 | JDTic (dihydrochloride) | 785835-79-2 | Reference compound |
| HY-10492 | Dinaciclib | 779353-01-4 | Reference compound |
| HY-10493 | Cobicistat | 1004316-88-4 | Reference compound |
| HY-10493R | Cobicistat (Standard) | 1004316-88-4 | Reference Standards |
| HY-10493S | Cobicistat-d8 | 2699607-48-0 | Isotope-Labeled Compounds |
| HY-10496 | SC75741 | 913822-46-5 | Reference compound |
| HY-10497 | BMS-794833 | 1174046-72-0 | Reference compound |
| HY-10498 | Lexibulin | 917111-44-5 | Reference compound |
| HY-10498A | Lexibulin (dihydrochloride) | 917111-49-0 | Reference compound |
| HY-10498R | Lexibulin (Standard) | 917111-44-5 | Reference Standards |
| HY-10499 | PH-064 | 892546-37-1 | Reference compound |
| HY-10499A | PH-064 (tetra(hydrochloride)) | 2489449-03-6 | Reference compound |
| HY-105000S1 | trans-Dihydro Tetrabenazine-d7 | 1217744-19-8 | Isotope-Labeled Compounds |
| HY-105003 | ST 1535 | 496955-42-1 | Reference compound |
| HY-105005 | Crisdesalazine | 927685-43-6 | Reference compound |
| HY-105006 | Spongosine | 24723-77-1 | Reference compound |
| HY-105008 | Secoisolariciresinol diglucoside | 257930-74-8 | Natural Products |
| HY-105008R | Secoisolariciresinol diglucoside (Standard) | 257930-74-8 | Reference Standards |
| HY-10501 | SU14813 | 627908-92-3 | Reference compound |
| HY-105010 | FK-739 (free base) | 133052-30-9 | Reference compound |
| HY-105014 | Tecastemizole | 75970-99-9 | Reference compound |
| HY-105014R | Tecastemizole (Standard) | 75970-99-9 | Reference Standards |
| HY-105017 | Evodenoson | 844873-47-8 | Reference compound |
| HY-105018 | Epelsiban | 872599-83-2 | Reference compound |
| HY-105018A | Epelsiban besylate | 1159097-48-9 | Reference compound |
| HY-105019 | Melflufen | 380449-51-4 | Reference compound |
| HY-105019A | Melflufen (hydrochloride) | 380449-54-7 | Reference compound |
| HY-10501A | SU14813 (maleate) | 849643-15-8 | Reference compound |
| HY-10502 | Tipifarnib | 192185-72-1 | Reference compound |
| HY-105022 | Sabeluzole | 104383-17-7 | Reference compound |
| HY-105022R | Sabeluzole (Standard) | 104383-17-7 | Reference Standards |
| HY-105023 | Cyclosporin G | 74436-00-3 | Reference compound |
| HY-105024 | FPL 62064 | 103141-09-9 | Reference compound |
| HY-105025 | Thymocartin | 85466-18-8 | Peptides |
| HY-105025A | Thymocartin (TFA) | Reference compound | |
| HY-105025B | Thymocartin (acetate) | 85503-03-3 | Reference compound |
| HY-105027 | Sufotidine | 80343-63-1 | Reference compound |
| HY-105028 | Tenidap | 120210-48-2 | Reference compound |
| HY-105028A | Tenidap (sodium) | 119784-94-0 | Reference compound |
| HY-105028R | Tenidap (Standard) | 120210-48-2 | Reference Standards |
| HY-105028S | Tenidap-d3 | 142741-60-4 | Isotope-Labeled Compounds |
| HY-10502A | Tipifarnib (S enantiomer) | 192185-71-0 | Reference compound |
| HY-105033 | Irloxacin | 91524-15-1 | Reference compound |
| HY-105034 | Tiospirone | 87691-91-6 | Reference compound |
| HY-105034A | Tiospirone (hydrochloride) | 87691-92-7 | Reference compound |
| HY-105035 | Rodorubicin | 96497-67-5 | Reference compound |
| HY-105037 | Forigerimod | 497156-60-2 | Peptides |
| HY-105037A | Forigerimod (TFA) | Peptides | |
| HY-105039 | Disomotide | 181477-43-0 | Peptides |
| HY-105040 | Pomaglumetad methionil | 956385-05-0 | Reference compound |
| HY-105040C | Pomaglumetad methionil (hydrochloride) | 635318-26-2 | Reference compound |
| HY-105041 | Tedizolid phosphate (sodium) | 856867-39-5 | Reference compound |
| HY-105042 | Selank | 129954-34-3 | Peptides |
| HY-105042A | Selank (diacetate) | Peptides | |
| HY-105047 | Fluorescein lisicol | 140616-46-2 | Reference compound |
| HY-105048 | Omiganan | 204248-78-2 | Peptides |
| HY-105048A | Omiganan (pentahydrochloride) | 269062-93-3 | Peptides |
| HY-105049 | T-91825 | 189345-04-8 | Reference compound |
| HY-10505 | Orteronel | 566939-85-3 | Reference compound |
| HY-105052 | SC 34301 | 81026-63-3 | Reference compound |
| HY-105055 | Didemnin B | 77327-05-0 | Natural Products |
| HY-105056 | Bretazenil | 84379-13-5 | Reference compound |
| HY-105058A | 14α/β-Vindeburnol | Reference compound | |
| HY-105059 | Denzimol | 73931-96-1 | Reference compound |
| HY-105059A | Denzimol (hydrochloride) | 77234-90-3 | Reference compound |
| HY-105061 | Misonidazole | 13551-87-6 | Reference compound |
| HY-105063 | DiaPep277 | 179822-83-4 | Peptides |
| HY-105064 | Zoniporide | 241800-98-6 | Reference compound |
| HY-105064B | Zoniporide (hydrochloride) | 241800-97-5 | Reference compound |
| HY-105064C | Zoniporide (dihydrochloride) | 241799-10-0 | Reference compound |
| HY-105064D | Zoniporide (hydrochloride hydrate) | 863406-85-3 | Reference compound |
| HY-105064DR | Zoniporide (hydrochloride hydrate) (Standard) | 863406-85-3 | Reference Standards |
| HY-105064R | Zoniporide (Standard) | 241800-98-6 | Reference Standards |
| HY-105066 | Davunetide | 211439-12-2 | Peptides |
| HY-105067A | Tertomotide (hydrochloride) | 922174-60-5 | Peptides |
| HY-105068 | Apadenoson | 250386-15-3 | Reference compound |
| HY-105069A | Rusalatide (acetate) | 875455-82-6 | Peptides |
| HY-105070A | Eritoran (tetrasodium) | 185954-98-7 | Reference compound |
| HY-105074 | Farglitazar | 196808-45-4 | Reference compound |
| HY-105077A | Nemifitide (diTFA) | 204992-09-6 | Peptides |
| HY-10508 | (R)-PD 0325901CL | 1003216-77-0 | Reference compound |
| HY-105082 | Avitriptan | 151140-96-4 | Reference compound |
| HY-105083A | Pumosetrag | 153062-94-3 | Reference compound |
| HY-105084 | Lubeluzole | 144665-07-6 | Reference compound |
| HY-105084A | Lubeluzole (dihydrochloride) | 144665-09-8 | Reference compound |
| HY-105086 | Pamaqueside | 150332-35-7 | Reference compound |
| HY-105088 | Pexiganan | 147664-63-9 | Peptides |
| HY-105088A | Pexiganan (acetate) | 172820-23-4 | Peptides |
| HY-105090 | Lerisetron | 143257-98-1 | Reference compound |
| HY-105090R | Lerisetron (Standard) | 143257-98-1 | Reference Standards |
| HY-105092 | Tetomilast | 145739-56-6 | Reference compound |
| HY-105093 | N 0861 | 141696-90-4 | Reference compound |
| HY-105094 | Leminoprazole | 104340-86-5 | Reference compound |
| HY-105096 | Arofylline | 136145-07-8 | Reference compound |
| HY-105098 | Lobucavir | 127759-89-1 | Reference compound |
| HY-105098B | (±)-Lobucavir | 126062-18-8 | Reference compound |
| HY-105099 | Rifalazil | 129791-92-0 | Reference compound |
| HY-105099R | Rifalazil (Standard) | 129791-92-0 | Reference Standards |
| HY-10510 | BI-D1870 | 501437-28-1 | Reference compound |
| HY-105102 | Netivudine | 84558-93-0 | Reference compound |
| HY-105108 | Cilansetron (hydrochloride hydrate) | 209859-87-0 | Reference compound |
| HY-105109 | Cilansetron | 120635-74-7 | Reference compound |
| HY-105109B | (S)-Cilansetron | 120635-77-0 | Reference compound |
| HY-105110 | SCH 39304 | 120924-80-3 | Reference compound |
| HY-105112 | Carmoxirole | 98323-83-2 | Reference compound |
| HY-105113 | Cefluprenam | 116853-25-9 | Reference compound |
| HY-105114 | Imitrodast | 114686-12-3 | Reference compound |
| HY-105115 | Abecarnil | 111841-85-1 | Reference compound |
| HY-105117 | Fantofarone | 114432-13-2 | Reference compound |
| HY-105117R | Fantofarone (Standard) | 114432-13-2 | Reference Standards |
| HY-105118 | Zaldaride | 109826-26-8 | Reference compound |
| HY-105118A | Zaldaride maleate | 109826-27-9 | Reference compound |
| HY-10512 | AR-A014418 | 487021-52-3 | Reference compound |
| HY-105120 | Vapiprost | 85505-64-2 | Reference compound |
| HY-105120A | Vapiprost (hydrochloride) | 87248-13-3 | Reference compound |
| HY-105122 | Zanoterone | 107000-34-0 | Reference compound |
| HY-105124 | Bufuralol | 54340-62-4 | Reference compound |
| HY-105124A | Bufuralol (hydrochloride) | 60398-91-6 | Reference compound |
| HY-105124AR | Bufuralol (hydrochloride) (Standard) | 60398-91-6 | Reference Standards |
| HY-105124S | Bufuralol-d9 (hydrochloride) | 1173023-51-2 | Isotope-Labeled Compounds |
| HY-105126 | Rioprostil | 77287-05-9 | Reference compound |
| HY-105127 | Brofaromine (hydrochloride) | 63638-90-4 | Reference compound |
| HY-105128 | Epostane | 80471-63-2 | Reference compound |
| HY-105129 | Pimonidazole (hydrochloride) | 70132-51-3 | Reference compound |
| HY-105129A | Pimonidazole | 70132-50-2 | Reference compound |
| HY-105129AR | Pimonidazole (Standard) | 70132-50-2 | Reference Standards |
| HY-105129AS | Pimonidazole-d10 | 2468639-37-2 | Isotope-Labeled Compounds |
| HY-105129R | Pimonidazole (hydrochloride) (Standard) | 70132-51-3 | Reference Standards |
| HY-10512R | AR-A014418 (Standard) | 487021-52-3 | Reference Standards |
| HY-10512S | AR-A014418-d3 | 1216908-63-2 | Isotope-Labeled Compounds |
| HY-105132 | Binodaline | 60662-16-0 | Reference compound |
| HY-105135 | 15-Deoxy-16-hydroxy-16-vinyl-PGE2 Me ester | 73621-92-8 | Reference compound |
| HY-105137 | Lanepitant (dihydrochloride) | 170508-05-1 | Reference compound |
| HY-105138 | Adentri | 166374-48-7 | Reference compound |
| HY-10514 | BX795 | 702675-74-9 | Reference compound |
| HY-105142 | M-5011 | 76604-64-3 | Reference compound |
| HY-10515 | BX-320 | 702676-93-5 | Reference compound |
| HY-105154A | Proxodolol | 152289-59-3 | Reference compound |
| HY-105155 | Lobradimil | 159768-75-9 | Peptides |
| HY-105157 | Icopezil | 145508-78-7 | Reference compound |
| HY-105161 | AP-521 (free base) | 151227-58-6 | Reference compound |
| HY-105163 | Finrozole | 160146-17-8 | Reference compound |
| HY-105164 | Topixantrone | 156090-18-5 | Reference compound |
| HY-105164A | Topixantrone (dihydrochloride) | 2514569-86-7 | Reference compound |
| HY-105165 | Nortopixantrone | 156090-17-4 | Reference compound |
| HY-105165A | Nortopixantrone (dihydrochloride) | 438244-41-8 | Reference compound |
| HY-105168 | TAK 044 | 157380-72-8 | Peptides |
| HY-10517 | Orantinib | 252916-29-3 | Reference compound |
| HY-105170B | ABT-418 (hydrochloride) | 147388-83-8 | Reference compound |
| HY-105172 | TT-232 | 147159-51-1 | Peptides |
| HY-105172A | TT-232 (TFA) | 2703745-48-4 | Reference compound |
| HY-105173 | Teverelix | 151272-78-5 | Peptides |
| HY-105174 | BPC 157 | 137525-51-0 | Peptides |
| HY-105174A | BPC 157 (acetate) | 1628202-19-6 | Peptides |
| HY-105176 | Ontazolast | 147432-77-7 | Reference compound |
| HY-105176A | (R)-Ontazolast | 149106-77-4 | Reference compound |
| HY-105177 | ORG 33628 | 155768-17-5 | Reference compound |
| HY-10517A | (Z)-Orantinib | 210644-62-5 | Reference compound |
| HY-10518 | BMS-345541 (hydrochloride) | 547757-23-3 | Reference compound |
| HY-105180 | Lenapenem | 149951-16-6 | Reference compound |
| HY-105182 | Xanomeline | 131986-45-3 | Reference compound |
| HY-105182A | Xanomeline (tartrate) | 152854-19-8 | Reference compound |
| HY-105182AR | Xanomeline (tartrate) (Standard) | 152854-19-8 | Reference Standards |
| HY-105182R | Xanomeline (Standard) | 131986-45-3 | Reference Standards |
| HY-105182S1 | Xanomeline-d3 | 175615-28-8 | Isotope-Labeled Compounds |
| HY-105183 | PD 145065 | 153049-49-1 | Peptides |
| HY-105184 | YM511 | 148869-05-0 | Reference compound |
| HY-105185 | Fidarestat | 136087-85-9 | Reference compound |
| HY-105185B | (Rac)-Fidarestat | 105300-43-4 | Reference compound |
| HY-10519 | BMS-345541 | 445430-58-0 | Reference compound |
| HY-105191 | Azalanstat | 143393-27-5 | Reference compound |
| HY-105192 | CP-122288 | 143321-74-8 | Reference compound |
| HY-105196 | DAT-582 | 141034-42-6 | Reference compound |
| HY-105198 | Lexipafant | 139133-26-9 | Reference compound |
| HY-10520 | CGP 57380 | 522629-08-9 | Reference compound |
| HY-105201 | Fabesetron | 129300-27-2 | Reference compound |
| HY-105201A | Fabesetron (hydrochloride) | 129299-90-7 | Reference compound |
| HY-105205 | Terlakiren | 119625-78-4 | Reference compound |
| HY-105207 | L 696229 | 135525-71-2 | Reference compound |
| HY-10521 | Darapladib | 356057-34-6 | Reference compound |
| HY-105215 | FK888 | 138449-07-7 | Reference compound |
| HY-105216 | L 697661 | 135525-78-9 | Reference compound |
| HY-105217 | Turosteride | 137099-09-3 | Reference compound |
| HY-105218 | Ifetroban | 143443-90-7 | Reference compound |
| HY-105218A | Ifetroban (sodium) | 156715-37-6 | Reference compound |
| HY-10521R | Darapladib (Standard) | 356057-34-6 | Reference Standards |
| HY-10522 | LEDGIN6 | 957890-42-5 | Reference compound |
| HY-105220 | WY-47766 | 134217-27-9 | Reference compound |
| HY-105221 | Masilukast | 136564-68-6 | Reference compound |
| HY-105226 | CI-988 | 130332-27-3 | Reference compound |
| HY-105226B | CI-988 (hemihydrate) | Reference compound | |
| HY-105231 | Bryostatin 1 | 83314-01-6 | Natural Products |
| HY-105235 | Enadoline | 124378-77-4 | Reference compound |
| HY-105235A | Enadoline (hydrochloride) | 124439-07-2 | Reference compound |
| HY-105236 | (Rac)-Enadoline | 107431-28-7 | Reference compound |
| HY-105237 | Eesperamicin A1 | 99674-26-7 | Reference compound |
| HY-105238 | JHU-75528 | 947696-17-5 | Reference compound |
| HY-105239 | Selepressin | 876296-47-8 | Peptides |
| HY-105239A | Selepressin (acetate) | Peptides | |
| HY-10524 | GSK1904529A | 1089283-49-7 | Reference compound |
| HY-105240 | Delparantag | 872454-31-4 | Peptides |
| HY-105246 | Pracinostat (dihydrochloride) | 929016-98-8 | Reference compound |
| HY-105249 | RDEA 806 | 878670-61-2 | Reference compound |
| HY-105252A | BF 227 | 845647-80-5 | Reference compound |
| HY-105253 | PARP-2/1-IN-2 | 912444-01-0 | Reference compound |
| HY-105257 | Pranazepide | 150408-73-4 | Reference compound |
| HY-105259 | SR 43845 | 114037-60-4 | Reference compound |
| HY-105262 | Galocitabine | 124012-42-6 | Reference compound |
| HY-105263 | EM574 | 110480-13-2 | Reference compound |
| HY-105264 | FK224 | 125787-94-2 | Reference compound |
| HY-105266 | Zabicipril | 83059-56-7 | Reference compound |
| HY-105267 | LY 121019 | 79404-91-4 | Reference compound |
| HY-105268 | AzddMeC | 87190-79-2 | Reference compound |
| HY-10527 | Telatinib | 332012-40-5 | Reference compound |
| HY-105270 | Tallimustine | 115308-98-0 | Reference compound |
| HY-105270A | Tallimustine (hydrochloride) | 118438-45-2 | Reference compound |
| HY-105271 | S-312-d | 120056-57-7 | Reference compound |
| HY-105272 | Loreclezole | 117857-45-1 | Reference compound |
| HY-105272A | Loreclezole (hydrochloride) | 2227372-56-5 | Reference compound |
| HY-105272R | Loreclezole (Standard) | 117857-45-1 | Reference Standards |
| HY-105273 | Erbulozole | 124784-31-2 | Reference compound |
| HY-105275A | FK 453 | 121524-18-3 | Reference compound |
| HY-105279 | α-Trinositol | 28841-62-5 | Reference compound |
| HY-10527C | Telatinib (mesylate) | 332013-26-0 | Reference compound |
| HY-10527CR | Telatinib (mesylate) (Standard) | 332013-26-0 | Reference Standards |
| HY-10527R | Telatinib (Standard) | 332012-40-5 | Reference Standards |
| HY-10528 | Tasquinimod | 254964-60-8 | Reference compound |
| HY-105282 | Eremomycin | 110865-90-2 | Natural Products |
| HY-105283 | PF 04531083 | 1079400-07-9 | Reference compound |
| HY-105284 | Sulopenem | 120788-07-0 | Reference compound |
| HY-105284A | Sulopenem (sodium) | 112294-81-2 | Reference compound |
| HY-105284R | Sulopenem (Standard) | 120788-07-0 | Reference Standards |
| HY-105285 | Piromelatine | 946846-83-9 | Reference compound |
| HY-105285R | Piromelatine (Standard) | 946846-83-9 | Reference Standards |
| HY-105286 | BI-135585 | 1114561-85-1 | Reference compound |
| HY-10528R | Tasquinimod (Standard) | 254964-60-8 | Reference Standards |
| HY-10528S | Tasquinimod-d3 | 1416701-99-9 | Isotope-Labeled Compounds |
| HY-10529 | Betulinic acid | 472-15-1 | Natural Products |
| HY-105294 | FR 64822 | 102671-35-2 | Reference compound |
| HY-105296 | Blarcamesine | 195615-83-9 | Reference compound |
| HY-10529R | Betulinic acid (Standard) | 472-15-1 | Reference Standards |
| HY-10530 | Varlitinib | 845272-21-1 | Reference compound |
| HY-105303 | CEP-9722 | 916574-83-9 | Reference compound |
| HY-105304 | COX-2-IN-36 | 189954-93-6 | Reference compound |
| HY-105309 | GSK-626616 | 1025821-33-3 | Reference compound |
| HY-10530A | Varlitinib (tosylate) | 1146629-86-8 | Reference compound |
| HY-10531 | ARRY-380 (analog) | 937265-83-3 | Reference compound |
| HY-105315 | AFP-07 | 171232-82-9 | Reference compound |
| HY-105318 | LGD-2226 | 328947-93-9 | Biochemical Assay Reagents |
| HY-10532 | SRT 1720 | 925434-55-5 | Reference compound |
| HY-105321 | PBT 1033 | 747408-78-2 | Reference compound |
| HY-105321A | PBT 1033 (hydrochloride) | 648896-70-2 | Reference compound |
| HY-105321R | PBT 1033 (Standard) | 747408-78-2 | Reference Standards |
| HY-105323 | YM758 (phosphate) | 312752-86-6 | Reference compound |
| HY-105327 | P11149 | 164724-79-2 | Reference compound |
| HY-10532A | SRT 1720 (hydrochloride) | 1001645-58-4 | Biochemical Assay Reagents |
| HY-10532R | SRT 1720 (Standard) | 925434-55-5 | Reference Standards |
| HY-10533 | Eniluracil | 59989-18-3 | Reference compound |
| HY-105332 | CRA1000 | 226948-11-4 | Reference compound |
| HY-105336 | 3-Deazauridine | 23205-42-7 | Reference compound |
| HY-10533R | Eniluracil (Standard) | 59989-18-3 | Reference Standards |
| HY-10534 | Voreloxin | 175414-77-4 | Reference compound |
| HY-105343 | BW-180C | 63631-40-3 | Peptides |
| HY-105346 | WIN 51708 | 144177-30-0 | Reference compound |
| HY-105349 | T-0156 | 324572-93-2 | Reference compound |
| HY-10535 | Evofosfamide | 918633-87-1 | Reference compound |
| HY-105350 | Pristinamycin IB | 57206-54-9 | Reference compound |
| HY-105351 | CGS25155 | 150126-87-7 | Reference compound |
| HY-10537 | Laromustine | 173424-77-6 | Reference compound |
| HY-105375 | FR 901537 | 161162-21-6 | Reference compound |
| HY-105387 | Heliquinomycin | 178182-49-5 | Natural Products |
| HY-10539 | Enzastaurin di(hydrochloride) | 365253-37-8 | Reference compound |
| HY-105392 | LB30057 | 184770-78-3 | Reference compound |
| HY-105393 | LB 10517 (sodium) | 175553-22-7 | Reference compound |
| HY-105395 | BCX-1898 | 345267-14-3 | Reference compound |
| HY-105396 | L 670630 | 133174-26-2 | Reference compound |
| HY-10539B | Enzastaurin (hydrochloride) | 359017-79-1 | Reference compound |
| HY-105412A | RU 52583 | 123829-33-4 | Reference compound |
| HY-105414 | Esterbut-3 | 125161-47-9 | Reference compound |
| HY-105416 | Calphostin C | 121263-19-2 | Reference compound |
| HY-10542 | GW 5074 | 220904-83-6 | Reference compound |
| HY-10542A | (Z)-GW 5074 | 1233748-60-1 | Reference compound |
| HY-105435 | FR121196 | 133920-65-7 | Reference compound |
| HY-105436 | FR 113680 | 126088-92-4 | Reference compound |
| HY-10544 | Tegobuvir | 1000787-75-6 | Reference compound |
| HY-105440 | LY 301875 | 154668-27-6 | Reference compound |
| HY-105445 | CP-113818 | 135025-12-6 | Reference compound |
| HY-10545 | Taribavirin | 119567-79-2 | Reference compound |
| HY-105454 | Recainam | 74738-24-2 | Reference compound |
| HY-105454A | Recainam (hydrochloride) | 74752-07-1 | Reference compound |
| HY-105454R | Recainam (Standard) | 74738-24-2 | Reference Standards |
| HY-10545A | Taribavirin (hydrochloride) | 40372-00-7 | Reference compound |
| HY-105460 | TEI-6472 | 151379-49-6 | Reference compound |
| HY-105463 | Saptomycin D | 137714-91-1 | Natural Products |
| HY-10547 | OSU-03012 | 742112-33-0 | Reference compound |
| HY-105477 | Maniwamycin A | 122566-70-5 | Reference compound |
| HY-105484 | U-75302 | 119477-85-9 | Reference compound |
| HY-105485 | FR-62765 | 105346-34-7 | Reference compound |
| HY-10549 | PI3Kγ inhibitor 1 | 1172118-03-4 | Reference compound |
| HY-105495 | Iliparcil | 137214-72-3 | Reference compound |
| HY-10550 | Tariquidar | 206873-63-4 | Reference compound |
| HY-105507 | PF-10040 | 132928-46-2 | Reference compound |
| HY-10550A | Tariquidar (methanesulfonate, hydrate) | 625375-83-9 | Reference compound |
| HY-10550AR | Tariquidar (methanesulfonate, hydrate) (Standard) | 625375-83-9 | Reference Standards |
| HY-10550B | Tariquidar (dimesylate) | 625375-84-0 | Reference compound |
| HY-10550R | Tariquidar (Standard) | 206873-63-4 | Reference Standards |
| HY-105516 | E5090 | 131420-91-2 | Reference compound |
| HY-105521A | Dexnafenodone (hydrochloride) | 94096-42-1 | Reference compound |
| HY-105525A | Sameridine (hydrochloride) | 136483-84-6 | Reference compound |
| HY-105529 | Indicine N-oxide | 41708-76-3 | Natural Products |
| HY-105530 | Zeniplatin | 111490-36-9 | Reference compound |
| HY-105534 | TAK-637 | 217185-75-6 | Reference compound |
| HY-105537 | Ro 70‐0004 | 186386-21-0 | Reference compound |
| HY-105541 | Octotiamine | 137-86-0 | Reference compound |
| HY-105542 | Niaprazine | 27367-90-4 | Reference compound |
| HY-105542R | Niaprazine (Standard) | 27367-90-4 | Reference Standards |
| HY-105544 | Tribehenin | 18641-57-1 | Biochemical Assay Reagents |
| HY-105545 | Dexetimide | 21888-98-2 | Reference compound |
| HY-105545A | Levetimide | 21888-99-3 | Reference compound |
| HY-105545C | Dexetimide (hydrochloride) | 21888-96-0 | Reference compound |
| HY-105549 | Quinacillin | 1596-63-0 | Reference compound |
| HY-10555 | AMG-221 | 1095565-81-3 | Reference compound |
| HY-105556 | Amphetaminil | 17590-01-1 | Reference compound |
| HY-105559 | Viquidil | 84-55-9 | Reference compound |
| HY-105559A | Viquidil (hydrochloride) | 52211-63-9 | Reference compound |
| HY-105562 | Nadoxolol | 54063-51-3 | Reference compound |
| HY-105567A | Carbiphene (hydrochloride) | 467-22-1 | Reference compound |
| HY-105569 | Amphotalide | 1673-06-9 | Reference compound |
| HY-105572 | Moveltipril (calcium) | 85921-53-5 | Reference compound |
| HY-105577 | Picilorex | 62510-56-9 | Reference compound |
| HY-105578A | Letimide (hydrochloride) | 21791-39-9 | Reference compound |
| HY-105579 | Isonixin | 57021-61-1 | Reference compound |
| HY-10558 | CYC-116 | 693228-63-6 | Reference compound |
| HY-105583 | Cloforex | 14261-75-7 | Reference compound |
| HY-105584 | Tolycaine | 3686-58-6 | Reference compound |
| HY-105589 | Liroldine | 105102-20-3 | Reference compound |
| HY-10559 | Nelotanserin | 839713-36-9 | Reference compound |
| HY-10560 | Temanogrel | 887936-68-7 | Reference compound |
| HY-105604 | Anilopam | 53716-46-4 | Reference compound |
| HY-105608 | Narceine | 131-28-2 | Natural Products |
| HY-10560A | Temanogrel (hydrochloride) | 957466-27-2 | Reference compound |
| HY-10560R | Temanogrel (Standard) | 887936-68-7 | Reference Standards |
| HY-10561 | RU 58841 | 154992-24-2 | Reference compound |
| HY-105613 | Metabutoxycaine | 3624-87-1 | Reference compound |
| HY-105616 | Roflurane | 679-90-3 | Reference compound |
| HY-10562 | Ketanserin | 74050-98-9 | Reference compound |
| HY-105627A | Profadol (hydrochloride) | 2324-94-9 | Reference compound |
| HY-105628A | Prodilidine (hydrochloride) | 3734-16-5 | Reference compound |
| HY-10562A | Ketanserin (tartrate) | 83846-83-7 | Reference compound |
| HY-10562AR | Ketanserin (tartrate) (Standard) | 83846-83-7 | Reference Standards |
| HY-10562R | Ketanserin (Standard) | 74050-98-9 | Reference Standards |
| HY-10563 | Sarpogrelate | 125926-17-2 | Reference compound |
| HY-105630 | Pipebuzone | 27315-91-9 | Reference compound |
| HY-105631 | Hydroxytetracaine | 490-98-2 | Reference compound |
| HY-105634 | Nomegestrol | 58691-88-6 | Reference compound |
| HY-105634A | Nomegestrol acetate | 58652-20-3 | Reference compound |
| HY-105634AR | Nomegestrol acetate (Standard) | 58652-20-3 | Reference Standards |
| HY-105637 | Cropropamide | 633-47-6 | Reference compound |
| HY-10564 | Sarpogrelate (hydrochloride) | 135159-51-2 | Reference compound |
| HY-105641 | Morazone | 6536-18-1 | Reference compound |
| HY-105647 | Ambuphylline | 5634-34-4 | Reference compound |
| HY-10564R | Sarpogrelate (hydrochloride) (Standard) | 135159-51-2 | Reference Standards |
| HY-10564S | Sarpogrelate-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10564S1 | Sarpogrelate-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-105651 | Butalamine | 22131-35-7 | Reference compound |
| HY-105651A | Butalamine (hydrochloride) | 56974-46-0 | Reference compound |
| HY-105651AR | Butalamine (hydrochloride) (Standard) | 56974-46-0 | Reference Standards |
| HY-105652 | Ambucetamide | 519-88-0 | Reference compound |
| HY-105656 | Hydrocortisone phosphate (sodium) | 6000-74-4 | Reference compound |
| HY-105661 | IMD-0560 | 439144-66-8 | Reference compound |
| HY-105666 | TGX-155 | 351071-90-4 | Reference compound |
| HY-105668 | Cathepsin S-IN-1 | 537706-31-3 | Reference compound |
| HY-105670 | PHA-543613 | 478149-53-0 | Reference compound |
| HY-105670A | PHA-543613 (hydrochloride) | 1586767-92-1 | Reference compound |
| HY-105670B | PHA-543613 (dihydrochloride) | 478148-58-2 | Reference compound |
| HY-105672 | Cafaminol | 30924-31-3 | Reference compound |
| HY-105674 | Azidamfenicol | 13838-08-9 | Reference compound |
| HY-10568 | TC-E 5005 | 959705-64-7 | Reference compound |
| HY-105685 | SRX246 | 512784-93-9 | Reference compound |
| HY-105686 | FR-229934 | 799841-02-4 | Reference compound |
| HY-105689 | AGN 192870 | 166977-57-7 | Reference compound |
| HY-10569 | Ponesimod | 854107-55-4 | Reference compound |
| HY-105692 | DR2313 | 284028-90-6 | Reference compound |
| HY-105697 | Protoveratrine A | 143-57-7 | Natural Products |
| HY-105698 | Clofexamide | 1223-36-5 | Reference compound |
| HY-105699 | Napamezole | 91524-14-0 | Reference compound |
| HY-10569R | Ponesimod (Standard) | 854107-55-4 | Reference Standards |
| HY-10569S | Ponesimod-d4 | Isotope-Labeled Compounds | |
| HY-10569S1 | Ponesimod-d7 | Isotope-Labeled Compounds | |
| HY-10570 | Nevirapine | 129618-40-2 | Reference compound |
| HY-10570R | Nevirapine (Standard) | 129618-40-2 | Reference Standards |
| HY-10570S | Nevirapine-d4 | 1051418-95-1 | Isotope-Labeled Compounds |
| HY-10570S1 | Nevirapine-d3 | 1051419-24-9 | Isotope-Labeled Compounds |
| HY-10570S2 | Nevirapine-d8 | 1051418-86-0 | Isotope-Labeled Compounds |
| HY-10570S3 | Nevirapine-d5 | 1189717-29-0 | Isotope-Labeled Compounds |
| HY-10571 | Delavirdine | 136817-59-9 | Reference compound |
| HY-105710 | Tropatepine | 27574-24-9 | Reference compound |
| HY-105713 | Sulochrin | 519-57-3 | Natural Products |
| HY-105717 | Meralein (sodium) | 4386-35-0 | Reference compound |
| HY-105718 | Olmidine | 31105-14-3 | Reference compound |
| HY-10571A | Delavirdine (mesylate) | 147221-93-0 | Reference compound |
| HY-10571AR | Delavirdine (mesylate) (Standard) | 147221-93-0 | Reference Standards |
| HY-10571R | Delavirdine (Standard) | 136817-59-9 | Reference Standards |
| HY-10572 | Efavirenz | 154598-52-4 | Reference compound |
| HY-105721 | Aranotin | 19885-51-9 | Reference compound |
| HY-105723 | Duazomycin | 2508-89-6 | Reference compound |
| HY-10572A | (R)-Efavirenz | 154801-74-8 | Reference compound |
| HY-10572B | (Rac)-Efavirenz | 177530-93-7 | Reference compound |
| HY-10572BR | (Rac)-Efavirenz (Standard) | 177530-93-7 | Reference Standards |
| HY-10572BS | (Rac)-Efavirenz-d4 | 1246812-58-7 | Isotope-Labeled Compounds |
| HY-10572BS1 | (Rac)-Efavirenz-d5 | 2749807-27-8 | Isotope-Labeled Compounds |
| HY-10572R | Efavirenz (Standard) | 154598-52-4 | Reference Standards |
| HY-10572S | Efavirenz-d5 | 1132642-95-5 | Isotope-Labeled Compounds |
| HY-10572S1 | Efavirenz-13C6 | 1261394-62-0 | Isotope-Labeled Compounds |
| HY-105733A | Suxemerid (disulfate) | 34144-82-6 | Reference compound |
| HY-105738 | Butaverine | 55837-14-4 | Reference compound |
| HY-10574 | Rilpivirine | 500287-72-9 | Reference compound |
| HY-105740 | Trenimon | 68-76-8 | Reference compound |
| HY-105744 | Leiopyrrole | 5633-16-9 | Reference compound |
| HY-105747A | Guanoxyfen (nitrate) | 860385-36-0 | Reference compound |
| HY-105749 | Pentamethonium (bromide) | 541-20-8 | Reference compound |
| HY-10574A | Rilpivirine (hydrochloride) | 700361-47-3 | Reference compound |
| HY-10574AR | Rilpivirine (hydrochloride) (Standard) | 700361-47-3 | Reference Standards |
| HY-10574AS | Rilpivirine-d6 (hydrochloride) | 2714324-67-9 | Isotope-Labeled Compounds |
| HY-10574R | Rilpivirine (Standard) | 500287-72-9 | Reference Standards |
| HY-10574S | Rilpivirine-d6 | 1312424-26-2 | Isotope-Labeled Compounds |
| HY-10574S1 | Rilpivirine-13C6 | Isotope-Labeled Compounds | |
| HY-105751 | Kalafungin | 11048-15-0 | Natural Products |
| HY-105752 | Loflucarban | 790-69-2 | Reference compound |
| HY-105762 | Etamiphyllin | 314-35-2 | Reference compound |
| HY-105762A | Etamiphyllin (camsylate) | 19326-29-5 | Reference compound |
| HY-105771 | Parapenzolate (bromide) | 5634-41-3 | Reference compound |
| HY-105772A | Lometraline (hydrochloride) | 30060-91-4 | Reference compound |
| HY-10578 | PD 169316 | 152121-53-4 | Reference compound |
| HY-105785 | Clomacran | 5310-55-4 | Reference compound |
| HY-10578R | PD 169316 (Standard) | 152121-53-4 | Reference Standards |
| HY-10579 | Pluripotin | 839707-37-8 | Reference compound |
| HY-105790 | Piperilate | 4546-39-8 | Reference compound |
| HY-105790A | Piperilate (hydrochloride) | 4544-15-4 | Reference compound |
| HY-105791 | Sulazepam | 2898-13-7 | Reference compound |
| HY-105791S | Sulazepam-d5 | Isotope-Labeled Compounds | |
| HY-105793 | Mazaticol | 42024-98-6 | Reference compound |
| HY-105797 | Apoatropine | 500-55-0 | Natural Products |
| HY-105797A | Apoatropine (hydrochloride) | 5978-81-4 | Natural Products |
| HY-105798 | Butanserin | 87051-46-5 | Reference compound |
| HY-10580 | GSK 3 Inhibitor IX | 667463-62-9 | Reference compound |
| HY-105808 | Furobufen | 38873-55-1 | Reference compound |
| HY-105808R | Furobufen (Standard) | 38873-55-1 | Reference Standards |
| HY-10581 | Gatifloxacin | 112811-59-3 | Reference compound |
| HY-105815 | Chlornaphazine | 494-03-1 | Reference compound |
| HY-105818 | Cloticasone propionate | 80486-69-7 | Reference compound |
| HY-10581A | Gatifloxacin (hydrochloride) | 121577-32-0 | Reference compound |
| HY-10581AR | Gatifloxacin (hydrochloride) (Standard) | 121577-32-0 | Reference Standards |
| HY-10581AS | Gatifloxacin-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-10581AS1 | Gatifloxacin-d4 (hydrochloride) | 1189946-71-1 | Isotope-Labeled Compounds |
| HY-10581B | Gatifloxacin (mesylate) | 316819-28-0 | Reference compound |
| HY-10581C | Gatifloxacin (sesquihydrate) | 180200-66-2 | Reference compound |
| HY-10581CR | Gatifloxacin (sesquihydrate) (Standard) | 180200-66-2 | Reference Standards |
| HY-10581R | Gatifloxacin (Standard) | 112811-59-3 | Reference Standards |
| HY-10582 | Flurbiprofen | 5104-49-4 | Reference compound |
| HY-105820 | Algestone | 595-77-7 | Reference compound |
| HY-105825 | Sermetacin | 57645-05-3 | Reference compound |
| HY-105829 | Sulfatroxazole | 23256-23-7 | Reference compound |
| HY-105829S | Sulfatroxazole-d4 | Isotope-Labeled Compounds | |
| HY-10582R | Flurbiprofen (Standard) | 5104-49-4 | Reference Standards |
| HY-10582S | Flurbiprofen-d3 | 1185133-81-6 | Isotope-Labeled Compounds |
| HY-10582S1 | Flurbiprofen-d5 | 215175-76-1 | Isotope-Labeled Compounds |
| HY-10582S2 | Flurbiprofen-13C,d3 | 2747917-55-9 | Isotope-Labeled Compounds |
| HY-10582S3 | Flurbiprofen-d4 | Isotope-Labeled Compounds | |
| HY-10583 | Y-27632 (dihydrochloride) | 129830-38-2 | Reference compound |
| HY-105832 | Fenbenicillin (potassium) | 1177-30-6 | Reference compound |
| HY-105838 | Sulfamethomidine | 3772-76-7 | Reference compound |
| HY-10583G | Y-27632 (dihydrochloride) (GMP) | 129830-38-2 | GMP Small Molecules |
| HY-10583R | Y-27632 (dihydrochloride) (Standard) | 129830-38-2 | Reference Standards |
| HY-105840 | Dichloramine-T | 473-34-7 | Reference compound |
| HY-105841A | Tetronasin (sodium) | 75139-05-8 | Reference compound |
| HY-105844 | Albutoin | 830-89-7 | Reference compound |
| HY-105845 | Phenaglycodol | 79-93-6 | Reference compound |
| HY-105846 | Nogalamycin | 1404-15-5 | Reference compound |
| HY-10585 | Valproic acid | 99-66-1 | Reference compound |
| HY-105852 | Proxazole | 5696-09-3 | Reference compound |
| HY-105853 | Pitofenone | 54063-52-4 | Reference compound |
| HY-105853S | Pitofenone-d4 | Isotope-Labeled Compounds | |
| HY-105855 | Tisocromide | 35423-51-9 | Reference compound |
| HY-105856 | Thozalinone | 655-05-0 | Reference compound |
| HY-105857A | Thiazesim (hydrochloride) | 3122-01-8 | Reference compound |
| HY-105858 | H-Ile-Trp-OH | 13589-06-5 | Reference compound |
| HY-10585A | Valproic acid (sodium) | 1069-66-5 | Reference compound |
| HY-10585AG | Valproic acid (sodium) (GMP) | 1069-66-5 | GMP Small Molecules |
| HY-10585AR | Valproic acid (sodium) (Standard) | 1069-66-5 | Reference Standards |
| HY-10585AS | Valproic acid-d7 (sodium) | 1189994-89-5 | Isotope-Labeled Compounds |
| HY-10585AS1 | Valproic acid-d14 (sodium) | Isotope-Labeled Compounds | |
| HY-10585B | Valproic acid (sodium)(2:1) | 76584-70-8 | Reference compound |
| HY-10585R | Valproic acid (Standard) | 99-66-1 | Reference Standards |
| HY-10585S | Valproic acid-d4 | 87745-17-3 | Isotope-Labeled Compounds |
| HY-10585S1 | Valproic acid-d6 | 87745-18-4 | Isotope-Labeled Compounds |
| HY-10585S2 | Valproic acid-d15 | 362049-65-8 | Isotope-Labeled Compounds |
| HY-10585S3 | Valproic acid-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-10585S4 | Valproic acid-d4-1 | 345909-03-7 | Isotope-Labeled Compounds |
| HY-10586 | 5-Azacytidine | 320-67-2 | Reference compound |
| HY-105860 | Selurampanel | 912574-69-7 | Reference compound |
| HY-10586R | 5-Azacytidine (Standard) | 320-67-2 | Reference Standards |
| HY-10587 | BIX-01294 | 935693-62-2 | Reference compound |
| HY-105872 | Trifenagrel | 84203-09-8 | Reference compound |
| HY-10587A | BIX-01294 (hydrochloride hydrate) | 1808255-64-2 | Reference compound |
| HY-10588 | Bay K 8644 | 71145-03-4 | Reference compound |
| HY-10588R | Bay K 8644 (Standard) | 71145-03-4 | Reference Standards |
| HY-105890 | Spiroplatin | 74790-08-2 | Reference compound |
| HY-105896 | SB399885 | 402713-80-8 | Reference compound |
| HY-10590 | TWS119 | 601514-19-6 | Reference compound |
| HY-105900 | Ro 22-0654 | 81741-99-3 | Reference compound |
| HY-10590R | TWS119 (Standard) | 601514-19-6 | Reference Standards |
| HY-10591 | Neuropathiazol | 880090-88-0 | Reference compound |
| HY-105912 | ONO 1082 | 111111-04-7 | Reference compound |
| HY-105917 | Emidurdar | 265646-85-3 | Reference compound |
| HY-105919 | Naroparcil | 120819-70-7 | Reference compound |
| HY-105925 | Mefenidil | 58261-91-9 | Reference compound |
| HY-105927 | Lycetamine | 60209-20-3 | Reference compound |
| HY-105929 | Lorajmine | 47562-08-3 | Reference compound |
| HY-10593 | IQ 1 | 331001-62-8 | Reference compound |
| HY-105930 | Lobaplatin | 135558-11-1 | Reference compound |
| HY-105932 | Lexithromycin | 53066-26-5 | Reference compound |
| HY-105932R | Lexithromycin (Standard) | 53066-26-5 | Reference Standards |
| HY-105934A | Ketotrexate (sodium) | 52386-42-2 | Reference compound |
| HY-105935 | Keracyanin (chloride) | 18719-76-1 | Natural Products |
| HY-105935R | Keracyanin (chloride) (Standard) | 18719-76-1 | Reference Standards |
| HY-105939 | Isofezolac | 50270-33-2 | Reference compound |
| HY-10594 | Letaxaban | 870262-90-1 | Reference compound |
| HY-105940 | IQB-782 | 40454-21-5 | Reference compound |
| HY-105946 | Hidrosmin | 115960-14-0 | Natural Products |
| HY-105946A | Hidrosmin (mixture) | 115960-14-0 | Reference compound |
| HY-10595 | RO-28-1675 | 300353-13-3 | Reference compound |
| HY-105953 | Froxiprost | 62559-74-4 | Reference compound |
| HY-105955 | FPL 14294 | 154132-95-3 | Reference compound |
| HY-10596 | BMS-688521 | 893397-44-9 | Reference compound |
| HY-105960 | Fenmetozole | 41473-09-0 | Reference compound |
| HY-105960A | Fenmetozole (hydrochloride) | 23712-05-2 | Reference compound |
| HY-105962 | Erizepine | 96645-87-3 | Reference compound |
| HY-105967A | Dicresulene (diammonium) | Reference compound | |
| HY-105969 | Dichloromethotrexate | 528-74-5 | Reference compound |
| HY-105981 | Cefempidone | 103238-57-9 | Reference compound |
| HY-105983A | CBS-1114 (hydrochloride) | 33244-00-7 | Oligonucleotides |
| HY-105997 | AZD 6703 | 851845-37-9 | Reference compound |
| HY-105999 | APC 366 | 158921-85-8 | Reference compound |
| HY-105999A | APC 366 (hydrochloride) | 178925-65-0 | Reference compound |
| HY-105999B | APC 366 (TFA) | 2421110-28-1 | Reference compound |
| HY-106000 | GSK239512 | 720691-69-0 | Reference compound |
| HY-106003 | GSK356278 | 720704-34-7 | Reference compound |
| HY-106004 | Zamicastat | 1080028-80-3 | Reference compound |
| HY-106005 | MMV390048 | 1314883-11-8 | Reference compound |
| HY-106006 | RV-1729 | 1293915-42-0 | Reference compound |
| HY-106007 | Trabodenoson | 871108-05-3 | Reference compound |
| HY-106008 | Avanbulin | 798577-91-0 | Reference compound |
| HY-106009 | VRX0466617 | 926906-64-1 | Reference compound |
| HY-106010 | LBP1 | 1050478-18-6 | Reference compound |
| HY-106011 | SLX-4090 | 913541-47-6 | Reference compound |
| HY-106012 | PI4K-IN-1 | 1800017-49-5 | Reference compound |
| HY-106014 | Tezacitabine | 130306-02-4 | Reference compound |
| HY-106016 | HP 184 | 119229-64-0 | Reference compound |
| HY-106017 | Nerispirdine | 119229-65-1 | Reference compound |
| HY-106018 | Mitemcinal | 154738-42-8 | Reference compound |
| HY-106018A | Mitemcinal (fumarate) | 154802-96-7 | Reference compound |
| HY-106019 | Liarozole | 115575-11-6 | Reference compound |
| HY-106019A | Liarozole (hydrochloride) | 145858-50-0 | Reference compound |
| HY-106019B | Liarozole (fumarate) | 145858-52-2 | Reference compound |
| HY-106019C | Liarozole (dihydrochloride) | 1883548-96-6 | Reference compound |
| HY-106019CR | Liarozole (dihydrochloride) (Standard) | 1883548-96-6 | Reference Standards |
| HY-106019R | Liarozole (Standard) | 115575-11-6 | Reference Standards |
| HY-106024A | Alagebrium (bromide) | 181069-80-7 | Reference compound |
| HY-106024B | Alagebrium chloride | 341028-37-3 | Reference compound |
| HY-106025 | Radequinil | 219846-31-8 | Reference compound |
| HY-106027 | Romazarit | 109543-76-2 | Reference compound |
| HY-106029 | 4α-TPA | 63597-44-4 | Reference compound |
| HY-106031 | F-14512 | 866874-63-7 | Reference compound |
| HY-106033 | Edotreotide | 204318-14-9 | Peptides |
| HY-106035 | Tyroservatide | 154039-16-4 | Reference compound |
| HY-106037 | PGF2α-isopropyl ester | 53764-90-2 | Reference compound |
| HY-106038 | Acopafant | 125372-33-0 | Reference compound |
| HY-106039 | LY 215490 | 150010-68-7 | Reference compound |
| HY-106043 | Lutrelin | 66866-63-5 | Reference compound |
| HY-106045 | Imazodan | 84243-58-3 | Reference compound |
| HY-106045A | Imazodan (hydrochloride) | 89198-09-4 | Reference compound |
| HY-106048 | Bredinin aglycone | 56973-26-3 | Reference compound |
| HY-106048R | Bredinin aglycone (Standard) | 56973-26-3 | Reference Standards |
| HY-106049 | Acrihellin | 67696-82-6 | Reference compound |
| HY-106050 | Tilomisole | 58433-11-7 | Reference compound |
| HY-106052 | Bofumustine | 55102-44-8 | Reference compound |
| HY-106054 | Nocloprost | 79360-43-3 | Reference compound |
| HY-106055 | Murabutide | 74817-61-1 | Reference compound |
| HY-106056 | Zindoxifene | 86111-26-4 | Reference compound |
| HY-106062 | CV 3988 | 85703-73-7 | Reference compound |
| HY-106064A | Piriprost (potassium) | 88851-62-1 | Reference compound |
| HY-106066 | Dazmegrel | 76894-77-4 | Reference compound |
| HY-106067 | Dazoxiben | 78218-09-4 | Reference compound |
| HY-106067A | Dazoxiben (hydrochloride) | 74226-22-5 | Reference compound |
| HY-106067AR | Dazoxiben (hydrochloride) (Standard) | 74226-22-5 | Reference Standards |
| HY-106072 | Vinzolidine | 67699-40-5 | Reference compound |
| HY-106075 | Bromerguride | 83455-48-5 | Reference compound |
| HY-106076 | REV 2871 | 80263-73-6 | Reference compound |
| HY-106077 | Meteneprost | 61263-35-2 | Reference compound |
| HY-106077A | Meteneprost (potassium) | 122576-55-0 | Reference compound |
| HY-106078 | Oxmetidine | 72830-39-8 | Reference compound |
| HY-106079 | Fezolamine | 80410-36-2 | Reference compound |
| HY-106080 | Furegrelate | 85666-24-6 | Reference compound |
| HY-106080A | Furegrelate (sodium) | 85666-17-7 | Reference compound |
| HY-106080AR | Furegrelate (sodium) (Standard) | 85666-17-7 | Reference Standards |
| HY-106083 | Quazolast | 86048-40-0 | Reference compound |
| HY-106084 | Cefteram | 82547-58-8 | Reference compound |
| HY-106087 | IX 207-887 | 98320-39-9 | Reference compound |
| HY-106088 | Tibenelast (free acid) | 97852-72-7 | Reference compound |
| HY-106090A | Teloxantrone (hydrochloride hydrate) | 132937-88-3 | Reference compound |
| HY-106093 | Eltenac | 72895-88-6 | Reference compound |
| HY-106094 | CY 208-243 | 100999-26-6 | Reference compound |
| HY-106098 | Adibendan | 100510-33-6 | Reference compound |
| HY-106100 | Roxindole | 112192-04-8 | Reference compound |
| HY-106100A | Roxindole (hydrochloride) | 108050-82-4 | Reference compound |
| HY-106100AR | Roxindole (hydrochloride) (Standard) | 108050-82-4 | Reference Standards |
| HY-106101 | Echinomycin | 512-64-1 | Reference compound |
| HY-106102 | [Deglycinamide9, Arginine8]-Vasopressin | 37552-33-3 | Peptides |
| HY-106103 | Seglitide | 81377-02-8 | Peptides |
| HY-106103A | Seglitide (acetate) | 99248-33-6 | Peptides |
| HY-106104 | Inocoterone acetate | 83646-86-0 | Reference compound |
| HY-106105 | ONO 3708 | 102191-05-9 | Reference compound |
| HY-106110 | OP-2507 | 101758-79-6 | Reference compound |
| HY-106113 | Ditekiren | 103336-05-6 | Reference compound |
| HY-106115 | Vintoperol | 106498-99-1 | Reference compound |
| HY-106119 | Camonagrel | 105920-77-2 | Reference compound |
| HY-106120 | Adolezesin | 110314-48-2 | Reference compound |
| HY-106123 | Pomisartan | 144702-17-0 | Reference compound |
| HY-106124 | IS-159 | 133790-13-3 | Reference compound |
| HY-106128 | Lagatide | 157476-77-2 | Peptides |
| HY-106129 | Izonsteride | 176975-26-1 | Reference compound |
| HY-106130 | Implitapide | 177469-96-4 | Reference compound |
| HY-106136 | TIK-301 | 118702-11-7 | Reference compound |
| HY-106137 | Tofimilast | 185954-27-2 | Reference compound |
| HY-106138 | Avorelin | 140703-49-7 | Reference compound |
| HY-106139 | Bimosiamose | 187269-40-5 | Reference compound |
| HY-106139A | Bimosiamose (disodium) | 187269-60-9 | Reference compound |
| HY-106139R | Bimosiamose (Standard) | 187269-40-5 | Reference Standards |
| HY-10614 | A-966492 | 934162-61-5 | Reference compound |
| HY-106140A | Asoprisnil ecamate | 222732-94-7 | Reference compound |
| HY-106141 | Albaconazole | 187949-02-6 | Reference compound |
| HY-106141S | Albaconazole-d3 | 1217825-34-7 | Isotope-Labeled Compounds |
| HY-106143 | Belaperidone | 208661-17-0 | Reference compound |
| HY-106146 | Paclitaxel ceribate | 186040-50-6 | Reference compound |
| HY-106147 | Frakefamide | 188196-22-7 | Reference compound |
| HY-106147B | Frakefamide (TFA) | Reference compound | |
| HY-106150 | Eniporide | 176644-21-6 | Biochemical Assay Reagents |
| HY-106150B | Eniporide hydrochloride | 211813-86-4 | Reference compound |
| HY-106155 | Amdoxovir | 145514-04-1 | Reference compound |
| HY-106157 | Donitriptan | 170912-52-4 | Reference compound |
| HY-106157A | Donitriptan (mesylate) | 200615-15-2 | Reference compound |
| HY-106158 | T-1095 | 209746-59-8 | Reference compound |
| HY-106161 | Rupintrivir | 223537-30-2 | Reference compound |
| HY-106161S1 | Rupintrivir-d7 | Isotope-Labeled Compounds | |
| HY-106168 | Thymectacin | 232925-18-7 | Reference compound |
| HY-10617 | Rucaparib (phosphate) | 459868-92-9 | Reference compound |
| HY-106171 | NBI-6024 | 239480-61-6 | Peptides |
| HY-106174 | Lapisteride | 142139-60-4 | Reference compound |
| HY-106175 | Detiviciclovir | 220984-26-9 | Reference compound |
| HY-106178 | PMX-53 | 219639-75-5 | Reference compound |
| HY-106178D | PMX 53 (monoacetate) | 852629-88-0 | Reference compound |
| HY-10617A | Rucaparib | 283173-50-2 | Reference compound |
| HY-10617AR | Rucaparib (Standard) | 283173-50-2 | Reference Standards |
| HY-10617AS | Rucaparib-d8 | Isotope-Labeled Compounds | |
| HY-10617B | Rucaparib (hydrochloride) | 773059-19-1 | Reference compound |
| HY-10617C | Rucaparib (tartrate) | 773059-22-6 | Reference compound |
| HY-10617D | Rucaparib (acetate) | 773059-23-7 | Reference compound |
| HY-10617R | Rucaparib (phosphate) (Standard) | 459868-92-9 | Reference Standards |
| HY-106180 | DTI 0009 | 110299-05-3 | Reference compound |
| HY-106181 | Rivoglitazone | 185428-18-6 | Reference compound |
| HY-106181A | Rivoglitazone (hydrochloride) | 299176-11-7 | Reference compound |
| HY-106182 | TBC3711 | 349453-49-2 | Reference compound |
| HY-106186 | GW-493838 | 253124-46-8 | Reference compound |
| HY-106187 | MART-1 (27-35) (human) | 156251-11-5 | Peptides |
| HY-106188 | L 756423 | 216863-66-0 | Reference compound |
| HY-10619 | Niraparib | 1038915-60-4 | Reference compound |
| HY-106194 | SLV310 | 264869-71-8 | Reference compound |
| HY-106198 | Lidorestat | 245116-90-9 | Reference compound |
| HY-106199 | Adenosine A1 receptor activator T62 | 40312-34-3 | Reference compound |
| HY-10619A | Niraparib (hydrochloride) | 1038915-64-8 | Reference compound |
| HY-10619B | Niraparib (tosylate) | 1038915-73-9 | Reference compound |
| HY-10619D | Niraparib (R-enantiomer) | 1038915-58-0 | Reference compound |
| HY-10619E | Niraparib (tosylate hydrate) | 1613220-15-7 | Reference compound |
| HY-10619R | Niraparib (Standard) | 1038915-60-4 | Reference Standards |
| HY-10620 | PI3K-IN-22 | 1202884-94-3 | Reference compound |
| HY-106200 | CJ-13,610 | 179420-17-8 | Reference compound |
| HY-106200A | CJ-13,610 (hydrochloride) | 179420-27-0 | Reference compound |
| HY-106203 | Crinecerfont | 752253-39-7 | Reference compound |
| HY-106203A | Crinecerfont (hydrochloride) | 321839-75-2 | Reference compound |
| HY-106203B | (R)-Crinecerfont | 2649012-21-3 | Reference compound |
| HY-106203C | Crinecerfont (tosylate) | 2649012-17-7 | Reference compound |
| HY-106204 | Nelipepimut-S | 160212-35-1 | Peptides |
| HY-106206 | AL-6598 | 170291-06-2 | Reference compound |
| HY-106207 | Celivarone | 401925-43-7 | Reference compound |
| HY-106215 | Etiprednol dicloacetate | 199331-40-3 | Reference compound |
| HY-106216 | Tiprelestat | 820211-82-3 | Peptides |
| HY-106218 | Flurocitabine | 37717-21-8 | Reference compound |
| HY-106218A | Flurocitabine (hydrochloride) | 40505-45-1 | Reference compound |
| HY-10622 | PF-00446687 (free base) | 862281-92-3 | Reference compound |
| HY-106224 | Orexin A (human, rat, mouse) | 205640-90-0 | Peptides |
| HY-106224A | Orexin A (human, rat, mouse) (TFA) | Peptides | |
| HY-106224B | Orexin A (human, rat, mouse) (acetate) | Peptides | |
| HY-106225 | Rotigaptide | 355151-12-1 | Reference compound |
| HY-106225R | Rotigaptide (Standard) | 355151-12-1 | Reference Standards |
| HY-106228 | HLF1-11 | 183623-03-2 | Peptides |
| HY-106230A | Dasantafil | 569351-91-3 | Reference compound |
| HY-106231 | Gastrazole (free acid) | 174610-98-1 | Reference compound |
| HY-106233 | Tiviciclovir | 103024-93-7 | Reference compound |
| HY-106233B | Tiviciclovir (hydrochloride) | Reference compound | |
| HY-106234 | ZP 120C | 383123-18-0 | Peptides |
| HY-106235 | LB80317 | 441785-24-6 | Reference compound |
| HY-106239 | Fostedil | 75889-62-2 | Reference compound |
| HY-10624 | THIQ | 312637-48-2 | Reference compound |
| HY-106244 | DOTATATE | 177943-88-3 | Peptides |
| HY-106244A | DOTATATE (acetate) | 177943-89-4 | Peptides |
| HY-106245 | HT-0712 | 617720-02-2 | Reference compound |
| HY-106246 | Pruvanserin | 443144-26-1 | Reference compound |
| HY-106253 | Efipladib | 381683-94-9 | Reference compound |
| HY-106254 | Vapendavir | 439085-51-5 | Reference compound |
| HY-106254A | Vapendavir (diphosphate) | 1198151-75-5 | Reference compound |
| HY-106254S | Vapendavir-d5 | 2738376-73-1 | Isotope-Labeled Compounds |
| HY-106254S1 | Vapendavir-d6 | 2012598-53-5 | Isotope-Labeled Compounds |
| HY-106257A | Ceftolozane (TFA) | 1628046-32-1 | Reference compound |
| HY-106257S | Ceftolozane-d6 (TFA) | Isotope-Labeled Compounds | |
| HY-106258 | Atilmotin | 533927-56-9 | Peptides |
| HY-10626 | T0901317 | 293754-55-9 | Reference compound |
| HY-106262 | Delcasertib | 949100-39-4 | Reference compound |
| HY-106262B | Delcasertib (hydrochloride) | Peptides | |
| HY-106263 | Tyroserleutide | 138168-48-6 | Peptides |
| HY-106263A | Tyroserleutide (TFA) | Peptides | |
| HY-106263B | Tyroserleutide (hydrochloride) | 852982-42-4 | Peptides |
| HY-106265 | 9,10-trans-Dehydroepothilone D | 350493-61-7 | Reference compound |
| HY-106266 | Chiglitazar | 743438-45-1 | Reference compound |
| HY-106266B | Chiglitazar (sodium) | 2390374-10-2 | Reference compound |
| HY-106268 | Larazotide | 258818-34-7 | Peptides |
| HY-106268A | Larazotide (acetate) | 881851-50-9 | Peptides |
| HY-10626R | T0901317 (Standard) | 293754-55-9 | Reference Standards |
| HY-10627 | GW3965 | 405911-09-3 | Reference compound |
| HY-106275 | FX-06 | 88650-17-3 | Peptides |
| HY-106277 | Fasitibant (free base) | 869939-83-3 | Reference compound |
| HY-106277A | Fasitibant (chloride hydrochloride) | 869880-33-1 | Reference compound |
| HY-106278 | GW 590735 | 343321-96-0 | Reference compound |
| HY-106278A | GW 590735 (sodium) | 343322-50-9 | Reference compound |
| HY-106279 | EA-230 | 503844-09-5 | Peptides |
| HY-10627A | GW3965 (hydrochloride) | 405911-17-3 | Reference compound |
| HY-10627AR | GW3965 (hydrochloride) (Standard) | 405911-17-3 | Reference Standards |
| HY-106281 | Bemfivastatin | 805241-79-6 | Reference compound |
| HY-106281A | Bemfivastatin (hemicalcium) | 805241-64-9 | Reference compound |
| HY-106282 | BIT-225 | 917909-71-8 | Reference compound |
| HY-106288 | Human PTHrP-(1-36) | 172867-62-8 | Peptides |
| HY-10629 | LXR-623 | 875787-07-8 | Reference compound |
| HY-106291 | Cefclidin | 105239-91-6 | Reference compound |
| HY-106296 | WIN 54954 | 107355-45-3 | Reference compound |
| HY-106296R | WIN 54954 (Standard) | 107355-45-3 | Reference Standards |
| HY-106297 | Tosagestin | 110072-15-6 | Reference compound |
| HY-106299 | Lilopristone | 97747-88-1 | Reference compound |
| HY-10629R | LXR-623 (Standard) | 875787-07-8 | Reference Standards |
| HY-106300 | AA 193 | 107804-48-8 | Reference compound |
| HY-106301 | Devazepide | 103420-77-5 | Reference compound |
| HY-106301R | Devazepide (Standard) | 103420-77-5 | Reference Standards |
| HY-106302 | Duramycin | 1391-36-2 | Natural Products |
| HY-106303 | YT 146 | 90596-75-1 | Reference compound |
| HY-106305A | Ledoxantrone (trihydrochloride) | 119221-49-7 | Reference compound |
| HY-106306 | Laprafylline | 90749-32-9 | Reference compound |
| HY-106307 | Retelliptine | 72238-02-9 | Reference compound |
| HY-106312 | Viroxime | 63198-97-0 | Reference compound |
| HY-106312A | Enviroxime | 72301-79-2 | Reference compound |
| HY-106316 | CGS 20625 | 111205-55-1 | Reference compound |
| HY-106323 | [Leu13]-Motilin | 59530-69-7 | Peptides |
| HY-106325 | AA 2379 | 103446-98-6 | Reference compound |
| HY-106328 | Fluasterone | 112859-71-9 | Reference compound |
| HY-106328R | Fluasterone (Standard) | 112859-71-9 | Reference Standards |
| HY-10633 | SB-705498 | 501951-42-4 | Reference compound |
| HY-106332A | Sezolamide (hydrochloride) | 119271-78-2 | Reference compound |
| HY-106333 | Irtemazole | 129369-64-8 | Reference compound |
| HY-106334 | Noberastine | 110588-56-2 | Reference compound |
| HY-106338 | Polyketomycin | 200625-47-4 | Natural Products |
| HY-106339 | Lymecycline | 992-21-2 | Reference compound |
| HY-106339R | Lymecycline (Standard) | 992-21-2 | Reference Standards |
| HY-106339S | Lymecycline-d8 | Isotope-Labeled Compounds | |
| HY-10634 | AMG 517 | 659730-32-2 | Reference compound |
| HY-106345 | ILS-920 | 892494-07-4 | Reference compound |
| HY-106347 | Itriglumide | 201605-51-8 | Reference compound |
| HY-106349 | Fosteabine | 73532-83-9 | Reference compound |
| HY-10634R | AMG 517 (Standard) | 659730-32-2 | Reference Standards |
| HY-10635 | ABT-102 | 808756-71-0 | Reference compound |
| HY-106350 | Cefpimizole | 84880-03-5 | Reference compound |
| HY-106350A | Cefpimizole (sodium) | 85287-61-2 | Reference compound |
| HY-106353 | Smilagenin | 126-18-1 | Natural Products |
| HY-106353R | Smilagenin (Standard) | 126-18-1 | Reference Standards |
| HY-106356 | GV-150013 | 167355-22-8 | Reference compound |
| HY-106358 | Andolast (free base) | 132640-22-3 | Reference compound |
| HY-106358A | Andolast | 143330-46-5 | Reference compound |
| HY-106358R | Andolast (free base) (Standard) | 132640-22-3 | Reference Standards |
| HY-106359 | Delmitide | 287096-87-1 | Peptides |
| HY-106359A | Delmitide (acetate) | 501019-16-5 | Peptides |
| HY-10635A | (S)-ABT-102 | 808756-70-9 | Reference compound |
| HY-106361 | Flerobuterol | 82101-10-8 | Reference compound |
| HY-106361A | Flerobuterol (hydrochloride) | 82101-08-4 | Reference compound |
| HY-106364 | Peplomycin | 68247-85-8 | Reference compound |
| HY-106365 | Rofleponide | 144459-70-1 | Reference compound |
| HY-106365A | Rofleponide epimer | 144459-71-2 | Reference compound |
| HY-106368 | Dexamethasone cipecilate | 132245-57-9 | Reference compound |
| HY-106369 | HMR 1556 | 223749-46-0 | Reference compound |
| HY-106371 | Siccanin | 22733-60-4 | Reference compound |
| HY-106372A | Carcainium (chloride) | 1042-42-8 | Reference compound |
| HY-106373 | Adrenocorticotropic hormone | 9002-60-2 | Reference compound |
| HY-106373A | Adrenocorticotropic hormone (TFA) | Reference compound | |
| HY-106374 | Elpamotide | 673478-49-4 | Peptides |
| HY-106376 | DL-Buthionine-(S,R)-sulfoximine | 5072-26-4 | Reference compound |
| HY-106376A | L-Buthionine-(S,R)-sulfoximine | 83730-53-4 | Reference compound |
| HY-106376B | DL-Buthionine-(S,R)-sulfoximine (hydrochloride) | Reference compound | |
| HY-106376BR | DL-Buthionine-(S,R)-sulfoximine (hydrochloride) (Standard) | Reference Standards | |
| HY-106376C | L-Buthionine-(S,R)-sulfoximine (hydrochloride) | Reference compound | |
| HY-106376R | DL-Buthionine-(S,R)-sulfoximine (Standard) | 5072-26-4 | Reference Standards |
| HY-106377A | BIO-11006 (acetate) | Peptides | |
| HY-106379 | Lurosetron | 128486-54-4 | Reference compound |
| HY-10638 | AP23464 | 845895-51-4 | Reference compound |
| HY-106381 | Aurothiomalate (sodium) | 12244-57-4 | Reference compound |
| HY-106381A | Aurothiomalate tetramer (sodium) | Reference compound | |
| HY-106382 | PMEDAP | 113852-41-8 | Reference compound |
| HY-106389 | Onapristone | 96346-61-1 | Reference compound |
| HY-106392 | Lucerastat | 141206-42-0 | Reference compound |
| HY-106392R | Lucerastat (Standard) | 141206-42-0 | Reference Standards |
| HY-106395 | Telinavir | 143224-34-4 | Reference compound |
| HY-106395A | (Rac)-Telinavir | 162679-88-1 | Reference compound |
| HY-106397 | Delucemine | 186495-49-8 | Reference compound |
| HY-106397A | Delucemine (hydrochloride) | 186495-99-8 | Reference compound |
| HY-106399 | Acodazole | 79152-85-5 | Reference compound |
| HY-106399A | Acodazole (hydrochloride) | 55435-65-9 | Reference compound |
| HY-106400 | EGIS 11150 | 494861-87-9 | Reference compound |
| HY-106405 | Nebicapone | 274925-86-9 | Reference compound |
| HY-106405R | Nebicapone (Standard) | 274925-86-9 | Reference Standards |
| HY-106406 | Benzylacyclouridine | 82857-69-0 | Reference compound |
| HY-106406R | Benzylacyclouridine (Standard) | 82857-69-0 | Reference Standards |
| HY-106407 | Beloxepin | 135928-30-2 | Reference compound |
| HY-106408 | Nelonemdaz | 640290-67-1 | Reference compound |
| HY-106408A | Nelonemdaz (potassium) | 916214-57-8 | Reference compound |
| HY-106409 | Tefinostat | 914382-60-8 | Reference compound |
| HY-106410 | Zabofloxacin | 219680-11-2 | Reference compound |
| HY-106410A | Zabofloxacin (hydrochloride) | 623574-00-5 | Reference compound |
| HY-106412 | Stacofylline | 98833-92-2 | Reference compound |
| HY-106415 | Terflavoxate | 86433-40-1 | Reference compound |
| HY-106416 | Neldazosin | 109713-79-3 | Reference compound |
| HY-106420 | 16,16-Dimethyl prostaglandin E2 | 39746-25-3 | Reference compound |
| HY-106424 | Soretolide | 130403-08-6 | Reference compound |
| HY-106425 | Omzotirome | 1092551-88-6 | Reference compound |
| HY-106426 | Gallium maltolate | 108560-70-9 | Reference compound |
| HY-106428 | Icrocaptide | 169543-49-1 | Reference compound |
| HY-106429 | OT-551 (free base) | 627085-11-4 | Reference compound |
| HY-106430 | Piclozotan | 182415-09-4 | Reference compound |
| HY-106431 | Olpadronic acid | 63132-39-8 | Reference compound |
| HY-106431R | Olpadronic acid (Standard) | 63132-39-8 | Reference Standards |
| HY-106432 | Sabcomeline | 159912-53-5 | Reference compound |
| HY-106432A | Sabcomeline (hydrochloride) | 159912-58-0 | Reference compound |
| HY-106434 | Piritrexim | 72732-56-0 | Reference compound |
| HY-106437 | ELB-139 | 188116-08-7 | Reference compound |
| HY-106439 | BTG 1640 | 152538-59-5 | Reference compound |
| HY-10644 | Lck inhibitor 2 | 944795-06-6 | Reference compound |
| HY-106441A | Rislenemdaz | 808732-98-1 | Reference compound |
| HY-106443 | Arimoclomol | 289893-25-0 | Reference compound |
| HY-106443A | Arimoclomol (maleate) | 289893-26-1 | Reference compound |
| HY-106443B | Arimoclomol (citrate) | 368860-21-3 | Reference compound |
| HY-106444 | Fipamezole | 150586-58-6 | Reference compound |
| HY-106444A | Fipamezole (hydrochloride) | 150586-72-4 | Reference compound |
| HY-106445 | Ciamexon | 75985-31-8 | Reference compound |
| HY-106446 | Rentiapril | 80830-42-8 | Reference compound |
| HY-106446R | Rentiapril (Standard) | 80830-42-8 | Reference Standards |
| HY-106447 | Losulazine | 72141-57-2 | Reference compound |
| HY-106448 | Midesteine | 94149-41-4 | Reference compound |
| HY-106449 | Recoflavone | 203191-10-0 | Reference compound |
| HY-106450 | Binodenoson | 144348-08-3 | Reference compound |
| HY-106454 | N-Desalkylflurazepam | 2886-65-9 | Reference compound |
| HY-106454R | N-Desalkylflurazepam (Standard) | 2886-65-9 | Reference Standards |
| HY-106456 | Depramine | 303-54-8 | Reference compound |
| HY-106467 | Caroverine | 23465-76-1 | Reference compound |
| HY-106467B | Caroverine (hydrochloride) | 55750-05-5 | Reference compound |
| HY-106467BR | Caroverine (hydrochloride) (Standard) | 55750-05-5 | Reference Standards |
| HY-106469 | Taltrimide | 81428-04-8 | Reference compound |
| HY-106471 | Pildralazine | 64000-73-3 | Reference compound |
| HY-106472 | Tioxaprofen | 40198-53-6 | Reference compound |
| HY-106473 | Delmetacin | 16401-80-2 | Reference compound |
| HY-106474 | Meribendan | 119322-27-9 | Reference compound |
| HY-106476 | Primidolol | 67227-55-8 | Reference compound |
| HY-106477 | Quazinone | 70018-51-8 | Reference compound |
| HY-106479 | Verofylline | 66172-75-6 | Reference compound |
| HY-106481 | Bufrolin | 54867-56-0 | Reference compound |
| HY-106484 | Tiflucarbine | 89875-86-5 | Reference compound |
| HY-106486A | Butoprozine (hydrochloride) | 62134-34-3 | Reference compound |
| HY-106487 | Pridefine | 5370-41-2 | Reference compound |
| HY-106495 | Vadocaine | 72005-58-4 | Reference compound |
| HY-106499 | Sulfinalol | 66264-77-5 | Reference compound |
| HY-106499A | Sulfinalol (hydrochloride) | 63251-39-8 | Reference compound |
| HY-106504 | Aganodine | 86696-87-9 | Reference compound |
| HY-106506 | Desciclovir | 84408-37-7 | Reference compound |
| HY-106506R | Desciclovir (Standard) | 84408-37-7 | Reference Standards |
| HY-106508 | Fendosal | 53597-27-6 | Reference compound |
| HY-106509 | Velaresol | 77858-21-0 | Reference compound |
| HY-106509R | Velaresol (Standard) | 77858-21-0 | Reference Standards |
| HY-106512 | Cianergoline | 74627-35-3 | Reference compound |
| HY-106514 | Prifelone | 69425-13-4 | Reference compound |
| HY-106515 | Tebuquine | 74129-03-6 | Reference compound |
| HY-106516 | Napactadine (free base) | 76631-45-3 | Reference compound |
| HY-106518 | Adimolol (free base) | 78459-19-5 | Reference compound |
| HY-10652 | JAK-2/3-IN-1 | 1036241-36-7 | Reference compound |
| HY-106523 | Nipradolol | 81486-22-8 | Reference compound |
| HY-106526 | Xibornol | 13741-18-9 | Reference compound |
| HY-106530 | Gitoformate | 10176-39-3 | Reference compound |
| HY-106534 | Gemeprost | 64318-79-2 | Reference compound |
| HY-106535 | Valbilan | 3102-00-9 | Reference compound |
| HY-106537 | W 3699 | 17243-64-0 | Reference compound |
| HY-106538 | Cadralazine | 64241-34-5 | Reference compound |
| HY-106538R | Cadralazine (Standard) | 64241-34-5 | Reference Standards |
| HY-106539 | Colesevelam (hydrochloride) | 182815-44-7 | Reference compound |
| HY-106541 | Neticonazole | 130726-68-0 | Reference compound |
| HY-106541R | Neticonazole (Standard) | 130726-68-0 | Reference Standards |
| HY-106542 | Eberconazole | 128326-82-9 | Reference compound |
| HY-106542A | Eberconazole nitrate | 130104-32-4 | Reference compound |
| HY-106542AR | Eberconazole nitrate (Standard) | 130104-32-4 | Reference Standards |
| HY-106546 | Tolciclate | 50838-36-3 | Reference compound |
| HY-106547 | Rilmazafone | 99593-25-6 | Reference compound |
| HY-10655 | Palosuran | 540769-28-6 | Reference compound |
| HY-106550 | Enprostil | 73121-56-9 | Reference compound |
| HY-106554 | Trimazosin | 35795-16-5 | Reference compound |
| HY-106554A | Trimazosin (hydrochloride hydrate) | 53746-46-6 | Reference compound |
| HY-106555 | Protizinic acid | 13799-03-6 | Reference compound |
| HY-106556 | Zorubicin | 54083-22-6 | Reference compound |
| HY-106559 | Sorbinicate | 6184-06-1 | Reference compound |
| HY-10655A | Palosuran (hydrochloride) | 2469274-58-4 | Reference compound |
| HY-10655AR | Palosuran (hydrochloride) (Standard) | 2469274-58-4 | Reference Standards |
| HY-10655R | Palosuran (Standard) | 540769-28-6 | Reference Standards |
| HY-10656 | SB-657510 | 474960-44-6 | Reference compound |
| HY-106560 | Proglumetacin | 57132-53-3 | Reference compound |
| HY-106561 | Tioclomarol | 22619-35-8 | Reference compound |
| HY-106562 | Dopexamine | 86197-47-9 | Reference compound |
| HY-106564A | Flutropium (bromide) | 63516-07-4 | Reference compound |
| HY-106565 | Meproscillarin | 33396-37-1 | Reference compound |
| HY-106566 | Alclometasone dipropionate | 66734-13-2 | Reference compound |
| HY-106566R | Alclometasone dipropionate (Standard) | 66734-13-2 | Reference Standards |
| HY-106567 | Fluocortin butyl ester | 41767-29-7 | Reference compound |
| HY-10657 | SB-706375 | 733734-61-7 | Reference compound |
| HY-106570 | Tripamide | 73803-48-2 | Reference compound |
| HY-106571 | Cefteram pivoxil | 82547-81-7 | Reference compound |
| HY-106571R | Cefteram pivoxil (Standard) | 82547-81-7 | Reference Standards |
| HY-106572 | Cefbuperazone | 76610-84-9 | Reference compound |
| HY-106572A | Cefbuperazone (sodium) | 76648-01-6 | Reference compound |
| HY-106574 | Ceftobiprole medocaril | 376653-43-9 | Reference compound |
| HY-106574A | Ceftobiprole medocaril (sodium) | 252188-71-9 | Reference compound |
| HY-106575 | Nifurzide | 39978-42-2 | Reference compound |
| HY-106577 | Cibenzoline | 53267-01-9 | Reference compound |
| HY-106577A | (-)-(S)-Cibenzoline | 103419-18-7 | Reference compound |
| HY-106577AS | (-)-(S)-Cibenzoline-d4 | Isotope-Labeled Compounds | |
| HY-106577R | Cibenzoline (Standard) | 53267-01-9 | Reference Standards |
| HY-106577S | Cibenzoline-d4 | Isotope-Labeled Compounds | |
| HY-106577S1 | Cibenzoline-d5 | Isotope-Labeled Compounds | |
| HY-106578 | Quinupramine | 31721-17-2 | Reference compound |
| HY-106579 | Tiaprofenic acid | 33005-95-7 | Reference compound |
| HY-106579R | Tiaprofenic acid (Standard) | 33005-95-7 | Reference Standards |
| HY-106579S | Tiaprofenic acid-d3 | 2740831-64-3 | Isotope-Labeled Compounds |
| HY-10658 | AC-7954 | 477313-09-0 | Reference compound |
| HY-106580 | Plafibride | 63394-05-8 | Reference compound |
| HY-106581 | Pirifibrate | 55285-45-5 | Reference compound |
| HY-106582 | Sobuzoxane | 98631-95-9 | Reference compound |
| HY-106583 | Piroxicam cinnamate | 87234-24-0 | Reference compound |
| HY-106584 | Mosapramine | 89419-40-9 | Reference compound |
| HY-106585 | Cyclobendazole | 31431-43-3 | Reference compound |
| HY-106586 | Ioxaglic acid | 59017-64-0 | Reference compound |
| HY-106586A | Ioxaglate (sodium) | 67992-58-9 | Reference compound |
| HY-106587A | Octoclothepin (maleate salt) | 4789-68-8 | Reference compound |
| HY-106588 | Heptaplatin | 146665-77-2 | Reference compound |
| HY-106590 | Saccharocin | 86630-31-1 | Reference compound |
| HY-106591A | 4-Vinylcyclohexene dioxide | 106-87-6 | Reference compound |
| HY-106592A | U-74389G | 153190-29-5 | Reference compound |
| HY-106594A | Prussian blue insoluble | 14038-43-8 | Reference compound |
| HY-106594B | Prussian blue soluble | 12240-15-2 | Reference compound |
| HY-106597 | Pirlimycin | 79548-73-5 | Reference compound |
| HY-106597A | Pirlimycin (hydrochloride) | 78822-40-9 | Reference compound |
| HY-106597AR | Pirlimycin (hydrochloride) (Standard) | 78822-40-9 | Reference Standards |
| HY-106601 | Picenadol | 79201-85-7 | Reference compound |
| HY-106602 | Gevotroline | 107266-06-8 | Reference compound |
| HY-106605S | Flumezapine-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-106608 | Glutaurine | 56488-60-9 | Reference compound |
| HY-106608A | Glutaurine (TFA) | Reference compound | |
| HY-10661 | FL104 | 885672-81-1 | Reference compound |
| HY-106611 | Brinazarone | 89622-90-2 | Reference compound |
| HY-106612 | Abanoquil | 90402-40-7 | Reference compound |
| HY-106616 | Muzolimine | 55294-15-0 | Reference compound |
| HY-106616R | Muzolimine (Standard) | 55294-15-0 | Reference Standards |
| HY-106617 | Etoperidone | 52942-31-1 | Reference compound |
| HY-106617A | Etoperidone (hydrochloride) | 57775-22-1 | Reference compound |
| HY-106617AS | Etoperidone-d8 (hydrochloride) | 1329796-60-2 | Isotope-Labeled Compounds |
| HY-106618 | Mopidamol | 13665-88-8 | Reference compound |
| HY-106619 | Seprilose | 133692-55-4 | Reference compound |
| HY-106628 | Sudoxicam | 34042-85-8 | Reference compound |
| HY-106628R | Sudoxicam (Standard) | 34042-85-8 | Reference Standards |
| HY-106634 | Mitoguazone | 459-86-9 | Reference compound |
| HY-106634R | Mitoguazone (Standard) | 459-86-9 | Reference Standards |
| HY-106635 | Suriclone | 53813-83-5 | Reference compound |
| HY-106638 | Voclosporin | 515814-01-4 | Reference compound |
| HY-106638R | Voclosporin (Standard) | 515814-01-4 | Reference Standards |
| HY-106638S | Voclosporin-d4 | Isotope-Labeled Compounds | |
| HY-10664 | SB-611812 | 345892-71-9 | Reference compound |
| HY-106644 | Femoxetine | 59859-58-4 | Reference compound |
| HY-106644A | Femoxetine (hydrochloride) | 56222-04-9 | Reference compound |
| HY-106645 | Cloxacepride | 65569-29-1 | Reference compound |
| HY-106647 | Abacavir hydroxyacetate | 1446418-48-9 | Reference compound |
| HY-10664R | SB-611812 (Standard) | 345892-71-9 | Reference Standards |
| HY-106659 | SCH 900978 | 873947-10-5 | Reference compound |
| HY-10666 | SB-436811 | 346729-66-6 | Reference compound |
| HY-106660 | BP 897 (hydrochloride) | 314776-92-6 | Reference compound |
| HY-106662 | Chloroquinoxaline sulfonamide | 97919-22-7 | Reference compound |
| HY-106667 | DL 071IT | 55104-39-7 | Reference compound |
| HY-106668 | Isepamicin | 58152-03-7 | Reference compound |
| HY-106670 | Dulozafone | 75616-02-3 | Reference compound |
| HY-106671 | Spirogermanium | 41992-23-8 | Reference compound |
| HY-106673 | Hydrocortisone buteprate | 72590-77-3 | Reference compound |
| HY-106673R | Hydrocortisone buteprate (Standard) | 72590-77-3 | Reference Standards |
| HY-106681 | Lagosin | 6834-98-6 | Natural Products |
| HY-106682 | Falipamil | 77862-92-1 | Reference compound |
| HY-106684 | Ridazolol | 83395-21-5 | Reference compound |
| HY-106684A | Ridazolol (hydrochloride) | 83394-57-4 | Reference compound |
| HY-106685 | Selenazofurin | 83705-13-9 | Reference compound |
| HY-106688 | Alinidine | 33178-86-8 | Reference compound |
| HY-106688A | Alinidine (hydrobromide) | 71306-36-0 | Reference compound |
| HY-106689 | Dihydro-5-azacytidine | 62488-57-7 | Reference compound |
| HY-106689A | Dihydro-5-azacytidine (acetate) | 2470972-18-8 | Oligonucleotides |
| HY-106690 | Centhaquin | 57961-90-7 | Reference compound |
| HY-106691 | Pirmagrel | 85691-74-3 | Reference compound |
| HY-106697 | Ponalrestat | 72702-95-5 | Reference compound |
| HY-106699 | Taprostene (sodium) | 87440-45-7 | Reference compound |
| HY-106700 | Pentisomide | 78833-03-1 | Reference compound |
| HY-106702 | Fostriecin (sodium) | 87860-39-7 | Natural Products |
| HY-106702A | Fostriecin | 87810-56-8 | Reference compound |
| HY-106714 | Clocortolone pivalate | 34097-16-0 | Reference compound |
| HY-106714R | Clocortolone pivalate (Standard) | 34097-16-0 | Reference Standards |
| HY-106716 | SR 41378 | 93181-85-2 | Reference compound |
| HY-10672 | Urotensin-II receptor antagonist-1 | 1034708-07-0 | Reference compound |
| HY-106720 | Amosulalol | 85320-68-9 | Reference compound |
| HY-106720A | Amosulalol (hydrochloride) | 70958-86-0 | Reference compound |
| HY-106720B | (-)-Amosulalol | 94666-15-6 | Reference compound |
| HY-106720C | (+)-Amosulalol | 94666-17-8 | Reference compound |
| HY-106723 | AMP-PCP | 3469-78-1 | Reference compound |
| HY-106723A | AMP-PCP (disodium) | 7414-56-4 | Reference compound |
| HY-106732 | AT-076 | 1657028-64-2 | Reference compound |
| HY-106735 | Arotinoid | 71441-09-3 | Reference compound |
| HY-106736 | Etilefrine pivalate (hydrochloride) | 42145-91-5 | Reference compound |
| HY-106739 | Motapizone | 90697-57-7 | Reference compound |
| HY-106741 | Bazinaprine | 94011-82-2 | Reference compound |
| HY-106745 | Elziverine | 95520-81-3 | Reference compound |
| HY-106747 | Ralitoline | 93738-40-0 | Reference compound |
| HY-106749 | E-0747 | 99599-78-7 | Reference compound |
| HY-106753 | Tolnapersine | 70312-00-4 | Reference compound |
| HY-106755 | Tucaresol | 84290-27-7 | Reference compound |
| HY-106756 | Spiradoline | 87151-85-7 | Reference compound |
| HY-106758 | Cefuzonam (sodium) | 82219-81-6 | Reference compound |
| HY-106761 | Oxodipine | 90729-41-2 | Reference compound |
| HY-106765 | Thymotrinan | 85465-82-3 | Reference compound |
| HY-106765A | Thymotrinan (TFA) | Reference compound | |
| HY-106766 | DHP-218 | 102097-78-9 | Reference compound |
| HY-106769 | Fluparoxan | 105182-45-4 | Reference compound |
| HY-106769A | (3aR,9aR)-Fluparoxan (hydrochloride) | 105226-30-0 | Reference compound |
| HY-106769B | (3aR,9aR)-Fluparoxan | 105182-47-6 | Reference compound |
| HY-106769C | Fluparoxan (hydrochloride) | 105227-44-9 | Reference compound |
| HY-106770 | Esuprone | 91406-11-0 | Reference compound |
| HY-106774 | R-61837 | 100241-46-1 | Reference compound |
| HY-106777 | Cyclopentenylcytosine | 90597-22-1 | Reference compound |
| HY-106779 | Tamolarizine (hydrochloride) | 93035-33-7 | Reference compound |
| HY-10678 | BMS-687453 | 1000998-59-3 | Reference compound |
| HY-106781A | OPC 4392 (hydrochloride) | 1329509-60-5 | Reference compound |
| HY-106782 | Titanocene dichloride | 1271-19-8 | Biochemical Assay Reagents |
| HY-106783 | Polymyxin B nonapeptide | 86408-36-8 | Peptides |
| HY-106783A | Polymyxin B nonapeptide (TFA) | 2220175-42-6 | Peptides |
| HY-106783AR | Polymyxin B nonapeptide (TFA) (Standard) | 2220175-42-6 | Reference Standards |
| HY-106783R | Polymyxin B nonapeptide (Standard) | 86408-36-8 | Reference Standards |
| HY-106784 | Ajoene | 92285-01-3 | Natural Products |
| HY-106784A | (E)-Ajoene | 92284-99-6 | Natural Products |
| HY-106785 | Pobilukast | 107023-41-6 | Reference compound |
| HY-106789 | Plaunotol | 64218-02-6 | Reference compound |
| HY-10679 | PF-03049423 (free base) | 954138-07-9 | Reference compound |
| HY-10679A | PF-03049423 | 402955-58-2 | Reference compound |
| HY-10680 | MK-6892 | 917910-45-3 | Reference compound |
| HY-106801 | Girolline | 110883-46-0 | Reference compound |
| HY-106805 | ICI 169369 | 85273-96-7 | Reference compound |
| HY-106807 | Litoxetine | 86811-09-8 | Reference compound |
| HY-106808 | Cerebrocrast | 118790-71-9 | Reference compound |
| HY-106809 | BMY-21502 | 123259-91-6 | Reference compound |
| HY-10681 | Gedatolisib | 1197160-78-3 | Reference compound |
| HY-106810 | Naltiazem | 108383-95-5 | Reference compound |
| HY-106810A | Naltiazem (hydrochloride) | 108383-96-6 | Reference compound |
| HY-106816 | Ceronapril | 111223-26-8 | Reference compound |
| HY-106817 | Amitivir | 111393-84-1 | Reference compound |
| HY-106818A | Monatepil (maleate) | 103379-03-9 | Reference compound |
| HY-106822 | Losigamone | 112856-44-7 | Reference compound |
| HY-106823 | Tebufelone | 112018-00-5 | Reference compound |
| HY-106825 | Clanfenur | 51213-99-1 | Reference compound |
| HY-106827 | Trimegestone | 74513-62-5 | Reference compound |
| HY-106827S1 | Trimegestone-13C,d3 | Isotope-Labeled Compounds | |
| HY-106828 | E2-CDS | 103562-82-9 | Reference compound |
| HY-10683 | PKI-402 | 1173204-81-3 | Reference compound |
| HY-106831 | R 56865 | 104606-13-5 | Reference compound |
| HY-106832 | Vatanidipine | 116308-55-5 | Reference compound |
| HY-106832A | Vatanidipine (hydrochloride) | 133743-71-2 | Reference compound |
| HY-106833A | SDZ-62-434 | 115621-95-9 | Reference compound |
| HY-106835 | Flobufen | 112344-52-2 | Reference compound |
| HY-106837 | Israpafant | 117279-73-9 | Reference compound |
| HY-106838A | Org 6906 | 67384-25-2 | Reference compound |
| HY-10684 | Pridopidine | 346688-38-8 | Reference compound |
| HY-106840 | L-365260 | 118101-09-0 | Reference compound |
| HY-106840A | L-365260 (hemihydrate) | Reference compound | |
| HY-106841 | Draflazine | 120770-34-5 | Reference compound |
| HY-106841A | (S)-Draflazine | 138681-29-5 | Reference compound |
| HY-106842 | Nitecapone | 116313-94-1 | Reference compound |
| HY-106844 | EMD 53998 | 120223-04-3 | Reference compound |
| HY-106844A | (+)-EMD 57033 | 147527-31-9 | Reference compound |
| HY-106848 | Arteflene | 123407-36-3 | Reference compound |
| HY-106850 | 3′-Azido-2′,3′-dideoxyuridine | 84472-85-5 | Reference compound |
| HY-106851 | Panadiplon | 124423-84-3 | Reference compound |
| HY-106855 | Almokalant | 123955-10-2 | Reference compound |
| HY-106856 | Dimiracetam | 126100-97-8 | Reference compound |
| HY-106859 | Letrazuril | 103337-74-2 | Reference compound |
| HY-106860 | Gedocarnil | 109623-97-4 | Reference compound |
| HY-106866 | Bulaquine | 79781-00-3 | Reference compound |
| HY-106872 | R82913 | 126347-69-1 | Reference compound |
| HY-106873 | Nepinalone | 22443-11-4 | Reference compound |
| HY-106873A | Nepinalone (hydrochloride) | 22443-55-6 | Reference compound |
| HY-106874 | Delequamine | 119905-05-4 | Reference compound |
| HY-106874A | Delequamine (hydrochloride) | 119942-75-5 | Reference compound |
| HY-106874B | rel-Delequamine | 119813-87-5 | Reference compound |
| HY-106875 | Saripidem | 103844-86-6 | Reference compound |
| HY-106877 | Minalrestat | 129688-50-2 | Reference compound |
| HY-106882 | GE 2270A | 134861-34-0 | Peptides |
| HY-106887 | SCH 32615 | 83861-02-3 | Reference compound |
| HY-106888 | CS-722 (Free base) | 749179-13-3 | Reference compound |
| HY-106888A | CS-722 | 144886-17-9 | Reference compound |
| HY-106889 | Zelandopam (free base) | 139233-53-7 | Reference compound |
| HY-106890 | E4177 | 135070-05-2 | Reference compound |
| HY-106892 | BW 348U87 | 127142-14-7 | Reference compound |
| HY-106895 | Antiarrhythmic agent-1 | 136081-07-7 | Reference compound |
| HY-106897 | BF389 | 127245-22-1 | Reference compound |
| HY-106899A | (rel)-MK 287 | 143445-03-8 | Reference compound |
| HY-106900 | Lifarizine | 119514-66-8 | Reference compound |
| HY-106901A | Asoxime (dichloride) | 34433-31-3 | Reference compound |
| HY-106901AS | Asoxime-d4 (dichloride) | Isotope-Labeled Compounds | |
| HY-106902 | F-1394 | 162490-89-3 | Reference compound |
| HY-106904 | Nexopamil | 136033-49-3 | Reference compound |
| HY-106907 | Furprofen | 66318-17-0 | Reference compound |
| HY-106908 | Filaminast | 141184-34-1 | Reference compound |
| HY-106909A | YM114 | 153608-99-2 | Reference compound |
| HY-106910 | Saredutant | 142001-63-6 | Reference compound |
| HY-106912A | L-706000 (free base) | 161799-18-4 | Reference compound |
| HY-106914 | Sinitrodil | 143248-63-9 | Reference compound |
| HY-106916 | Unoprostone | 120373-36-6 | Reference compound |
| HY-106917 | Lirequinil | 143943-73-1 | Reference compound |
| HY-106918 | Tivirapine | 137332-54-8 | Reference compound |
| HY-106920 | Kynostatin 272 | 147318-81-8 | Reference compound |
| HY-106921 | Bisnafide | 144849-63-8 | Reference compound |
| HY-106921A | Bisnafide (mesylate) | 145124-30-7 | Reference compound |
| HY-106922 | Sanfetrinem | 156769-21-0 | Reference compound |
| HY-106922A | Sanfetrinem (sodium) | 141611-76-9 | Reference compound |
| HY-106924A | Antiallergic agent-3 | 160665-99-6 | Reference compound |
| HY-106925 | Cetefloxacin | 141725-88-4 | Reference compound |
| HY-106927 | Bay Y5959 | 146136-94-9 | Reference compound |
| HY-106929 | Moxilubant | 146978-48-5 | Reference compound |
| HY-106929B | Moxilubant (hydrochloride) | 146957-32-6 | Reference compound |
| HY-106932 | L-734217 | 146144-48-1 | Reference compound |
| HY-106933 | Dabelotine | 118976-38-8 | Reference compound |
| HY-106933A | Dabelotine (methanesulfonate) | 153049-48-0 | Reference compound |
| HY-106934 | Peldesine | 133432-71-0 | Reference compound |
| HY-106934A | Peldesine (dihydrochloride) | 2772702-10-8 | Reference compound |
| HY-106938 | Eldacimibe | 141993-70-6 | Reference compound |
| HY-106945 | Prezatide copper | 130120-56-8 | Peptides |
| HY-106947 | SY-640 | 168705-70-2 | Reference compound |
| HY-106949 | Tazomeline | 131987-54-7 | Reference compound |
| HY-106950 | Fosfructose | 488-69-7 | Natural Products |
| HY-106950A | Fosfructose (trisodium) | 38099-82-0 | Natural Products |
| HY-106950B | D-Fructose 1,6-bisphosphate (tetracyclohexylammonium) | 56594-87-7 | Biochemical Assay Reagents |
| HY-106950CS | Fosfructose-1-13C (sodium) | Isotope-Labeled Compounds | |
| HY-106950CS1 | Fosfructose-2-13C (sodium) | Isotope-Labeled Compounds | |
| HY-106950CS3 | Fosfructose-6-13C (sodium) | Isotope-Labeled Compounds | |
| HY-106950S1 | Fosfructose-13C6 (tetrasodium hydrate) | Isotope-Labeled Compounds | |
| HY-106951 | MK 386 | 158493-17-5 | Reference compound |
| HY-106954 | Upidosin | 152735-23-4 | Reference compound |
| HY-106956 | Lubazodone | 161178-07-0 | Reference compound |
| HY-106957 | Efletirizine | 150756-35-7 | Reference compound |
| HY-106958 | Talviraline | 163451-80-7 | Reference compound |
| HY-106959 | Flurithromycin | 82664-20-8 | Reference compound |
| HY-106961 | ONO 1301 | 176391-41-6 | Reference compound |
| HY-106961A | (Z)-ONO 1301 | 153814-74-5 | Reference compound |
| HY-106963 | ALRT1550 | 178600-20-9 | Reference compound |
| HY-106964A | (Rac)-S 16924 | 734513-52-1 | Reference compound |
| HY-106965 | Org 21465 | 167946-96-5 | Reference compound |
| HY-106968 | ZD-9379 | 170142-20-8 | Reference compound |
| HY-106973A | Nolomirole (hydrochloride) | 138531-51-8 | Reference compound |
| HY-106975 | SCH-42354 | 144505-58-8 | Reference compound |
| HY-106982 | Ezlopitant | 147116-64-1 | Reference compound |
| HY-106991A | Amustaline (dihydrochloride) | 210584-54-6 | Reference compound |
| HY-106992 | S 3304 | 203640-27-1 | Reference compound |
| HY-106993 | Cipralisant | 213027-19-1 | Reference compound |
| HY-106993A | Cipralisant (maleate) | 223420-20-0 | Reference compound |
| HY-106993B | Cipralisant (enantiomer) | 223420-11-9 | Reference compound |
| HY-106994 | Nebentan | 403604-85-3 | Reference compound |
| HY-106994A | Nebentan (potassium) | 342005-82-7 | Reference compound |
| HY-106996 | AWD 12-281 | 257892-33-4 | Reference compound |
| HY-106997 | Icofungipen | 198022-65-0 | Reference compound |
| HY-107001 | DPC 961 | 214287-88-4 | Reference compound |
| HY-107002A | Lergotrile (mesylate) | 51473-23-5 | Reference compound |
| HY-107003 | Opaviraline | 178040-94-3 | Reference compound |
| HY-107004 | Amotosalen | 161262-29-9 | Reference compound |
| HY-107004A | Amotosalen (hydrochloride) | 161262-45-9 | Reference compound |
| HY-107008 | SW 71425 | 155990-20-8 | Reference compound |
| HY-107010 | Esprolol | 396654-09-4 | Reference compound |
| HY-107010A | Esprolol (hydrochloride) | 112805-65-9 | Reference compound |
| HY-107013 | CP-544439 | 230954-09-3 | Reference compound |
| HY-107015A | Prednisolone metazoate (sodium) | 630-67-1 | Reference compound |
| HY-107018 | AR-A 2 | 220051-79-6 | Reference compound |
| HY-107019 | Surinabant | 288104-79-0 | Reference compound |
| HY-107020 | BMS 310705 | 280578-49-6 | Reference compound |
| HY-107022A | BMS-341400 (mesylate) | 296250-54-9 | Reference compound |
| HY-107023 | AZD 9684 | 775274-06-1 | Reference compound |
| HY-107024 | Osteogenic Growth Peptide (10-14) | 105250-85-9 | Peptides |
| HY-107025 | Cf1743 | 319425-66-6 | Reference compound |
| HY-107026 | Lagociclovir valactate | 1001670-19-4 | Reference compound |
| HY-107027 | Polymyxin E2 (sulfate) | 1338055-88-1 | Reference compound |
| HY-107030 | Nitrefazole | 21721-92-6 | Reference compound |
| HY-107031 | Metapramine | 21730-16-5 | Reference compound |
| HY-107032 | Amitriptylinoxide | 4317-14-0 | Reference compound |
| HY-107033 | Tetroxoprim | 53808-87-0 | Reference compound |
| HY-107033R | Tetroxoprim (Standard) | 53808-87-0 | Reference Standards |
| HY-107034 | Moxipraquine | 23790-08-1 | Reference compound |
| HY-107036 | BMS-394136 | 343246-73-1 | Reference compound |
| HY-107037 | Tolmesoxide | 38452-29-8 | Reference compound |
| HY-10704 | PTP1B-IN-1 | 612530-44-6 | Reference compound |
| HY-107040 | Etoxadrol | 28189-85-7 | Reference compound |
| HY-107043 | 7β-Hydroxy-epi-androsterone | 25848-69-5 | Reference compound |
| HY-107045 | CHF 4227 (free base) | 444643-64-5 | Reference compound |
| HY-107046 | UK-432097 | 380221-63-6 | Reference compound |
| HY-107051 | GW 766994 | 408303-43-5 | Reference compound |
| HY-107055 | RTI 336 | 204069-50-1 | Reference compound |
| HY-107063 | AHR-1911 | 22584-04-9 | Reference compound |
| HY-107064 | Cefroxadine | 51762-05-1 | Reference compound |
| HY-107072A | Trantinterol (hydrochloride) | 611234-02-7 | Reference compound |
| HY-107074 | Levovirin valinate (hydrochloride) | 705930-02-5 | Reference compound |
| HY-107085 | Talmetacin | 67489-39-8 | Reference compound |
| HY-107091 | Aspartyl-alanyl-diketopiperazine | 110954-19-3 | Reference compound |
| HY-107093 | MBC-11 | 332863-86-2 | Reference compound |
| HY-107093A | MBC-11 (trisodium) | 387877-45-4 | Reference compound |
| HY-107093B | MBC-11 (triethylamine) | Reference compound | |
| HY-107094 | MT-7716 hydrochloride | 1215859-93-0 | Reference compound |
| HY-107094A | MT-7716 (free base) | 610323-32-5 | Reference compound |
| HY-107095 | JNJ19567470 | 724471-26-5 | Reference compound |
| HY-107096 | CH-0793076 | 534605-78-2 | Reference compound |
| HY-107096B | CH-0793076 (TFA) | 2740278-76-4 | Reference compound |
| HY-107098 | PPL-100 (free acid) | 874339-65-8 | Reference compound |
| HY-107101 | (5R)-5-Hydroxytriptolide | 583028-68-6 | Reference compound |
| HY-107111 | GSK1034702 | 932373-87-0 | Reference compound |
| HY-107111A | GSK1034702 (hydrochloride) | 932373-86-9 | Reference compound |
| HY-107116 | MAP4343 | 511-26-2 | Reference compound |
| HY-107116S | MAP4343-d4 | Isotope-Labeled Compounds | |
| HY-10711A | ALX-5407 (hydrochloride) | 200006-08-2 | Reference compound |
| HY-10712 | Org-24598 | 372198-97-5 | Reference compound |
| HY-107123 | TMC310911 | 1000287-05-7 | Reference compound |
| HY-107124 | BMS-770767 | 1875067-34-7 | Reference compound |
| HY-107125 | AVN-322 | 1194574-68-9 | Reference compound |
| HY-107125A | AVN-322 (free base) | 1194574-33-8 | Reference compound |
| HY-107126 | Ibrexafungerp | 1207753-03-4 | Reference compound |
| HY-107126A | Ibrexafungerp (citrate) | 1965291-08-0 | Reference compound |
| HY-107126B | Ibrexafungerp (phosphate) | 1965291-14-8 | Reference compound |
| HY-107128 | Ampreloxetine (hydrochloride) | 1227056-87-2 | Reference compound |
| HY-107129 | MK-3577 | 1019112-29-8 | Reference compound |
| HY-10713 | Org-24598 (lithium) | 722456-08-8 | Reference compound |
| HY-107130 | Alirinetide | 725715-18-4 | Peptides |
| HY-107133 | Simmitecan (hydrochloride) | 1247847-78-4 | Reference compound |
| HY-107139 | JNJ-10229570 | 524923-88-4 | Reference compound |
| HY-107145 | Ningetinib Tosylate | 1394820-77-9 | Reference compound |
| HY-107145A | Ningetinib | 1394820-69-9 | Reference compound |
| HY-107146 | PZ-128 | 371131-16-7 | Reference compound |
| HY-10715 | SSR504734 | 615571-23-8 | Reference compound |
| HY-107150 | Reproxalap | 916056-79-6 | Reference compound |
| HY-107151 | ABP-700 | 1446482-29-6 | Reference compound |
| HY-10716 | PF-03463275 (hydrochloride) | 1173177-11-1 | Reference compound |
| HY-107164 | Thiomarinol A | 146697-04-3 | Natural Products |
| HY-10716A | PF-03463275 | 1173239-39-8 | Reference compound |
| HY-107176A | Hyzetimibe | 1266548-74-6 | Reference compound |
| HY-107186 | EO-122 | 23581-62-6 | Reference compound |
| HY-107191 | Sildenafil (Mesylate) | 1308285-21-3 | Reference compound |
| HY-107193 | Bacitracin | 1405-87-4 | Natural Products |
| HY-107194 | NSC12 | 102586-30-1 | Reference compound |
| HY-107197 | 8-Prenylchrysin | 34125-75-2 | Reference compound |
| HY-107198 | (2S)-6-Prenylnaringenin | 68236-13-5 | Natural Products |
| HY-107199 | N-Butylthiophosphoric triamide | 94317-64-3 | Reference compound |
| HY-107201 | β-Cyclodextrin | 7585-39-9 | Natural Products |
| HY-107201A | β-Cyclodextrin (hydrate) | 68168-23-0 | Reference compound |
| HY-107202 | Polyinosinic-polycytidylic acid | 24939-03-5 | Reference compound |
| HY-107202A | Poly (I:C):Kanamycin (1:1) | Reference compound | |
| HY-107203 | Propentofylline | 55242-55-2 | Reference compound |
| HY-107204 | Furafylline | 80288-49-9 | Reference compound |
| HY-107204R | Furafylline (Standard) | 80288-49-9 | Reference Standards |
| HY-107205 | Propargyl methacrylate | 13861-22-8 | Reference compound |
| HY-107207 | Kaempferol 3-neohesperidoside | 32602-81-6 | Natural Products |
| HY-107207R | Kaempferol 3-neohesperidoside (Standard) | 32602-81-6 | Reference Standards |
| HY-107208 | Procyanidol B4 | 29106-51-2 | Natural Products |
| HY-107208R | Procyanidol B4 (Standard) | 29106-51-2 | Reference Standards |
| HY-107209 | RKI-1313 | 1342276-76-9 | Reference compound |
| HY-10721 | PF-AKT400 | 1004990-28-6 | Reference compound |
| HY-107210 | Avenasterol | 23290-26-8 | Natural Products |
| HY-107211 | Echinocandin B nucleus | 79411-15-7 | Natural Products |
| HY-107212 | Selamectin | 220119-17-5 | Reference compound |
| HY-107212R | Selamectin (Standard) | 220119-17-5 | Reference Standards |
| HY-107213 | Tulathromycin B | 280755-12-6 | Reference compound |
| HY-107216 | G-1 | 881639-98-1 | Reference compound |
| HY-107217 | Apo-12'-lycopenal | 1071-52-9 | Natural Products |
| HY-107218 | 11-Hydroxysugiol | 88664-08-8 | Natural Products |
| HY-107219 | Jatropholone B | 71386-38-4 | Reference compound |
| HY-10722 | DX-9065a | 155204-81-2 | Reference compound |
| HY-107224 | Levatin | 140670-84-4 | Natural Products |
| HY-107225 | Croverin | 76475-17-7 | Natural Products |
| HY-107226 | Crovatin | 142409-09-4 | Natural Products |
| HY-107227 | 12-O-Tiglylphorbol-13-isobutyrate | 92214-54-5 | Natural Products |
| HY-107231 | Xanthiside | 866366-86-1 | Natural Products |
| HY-107232 | Xanthiazone | 212701-97-8 | Natural Products |
| HY-107233 | Saponin CP4 | 75799-18-7 | Natural Products |
| HY-107235 | Saponin CP6 | 72629-76-6 | Natural Products |
| HY-107236 | Huzhangoside D | 96315-53-6 | Natural Products |
| HY-107237 | Broussonetine A | 173220-07-0 | Natural Products |
| HY-107238 | (3β,24R)-3-(Acetyloxy)eupha-7,25-dien-24-ol | 1352001-09-2 | Natural Products |
| HY-10724 | Fidexaban | 183305-24-0 | Reference compound |
| HY-107242 | Raddeanoside R8 | 124961-61-1 | Natural Products |
| HY-107245 | Segetalin B | 164991-89-3 | Natural Products |
| HY-107246 | Segetalin A | 161875-97-4 | Natural Products |
| HY-107247 | Escin IIb | 158800-83-0 | Natural Products |
| HY-107248 | Escin IIa | 158732-55-9 | Natural Products |
| HY-10725 | Tanogitran | 637328-69-9 | Reference compound |
| HY-107256 | Eupalinilide D | 757202-14-5 | Natural Products |
| HY-107257 | Eupalinilide C | 757202-11-2 | Natural Products |
| HY-107259 | 23S-Hydroxyl-11,15-dioxo-ganoderic acid DM | 1085273-49-9 | Natural Products |
| HY-107260 | Lucidenic acid D | 98665-16-8 | Natural Products |
| HY-107265 | Lucidenic acid E | 98665-17-9 | Natural Products |
| HY-107271 | Imperialine 3-β-D-glucoside | 67968-40-5 | Natural Products |
| HY-107273 | Delavinone | 96997-98-7 | Natural Products |
| HY-107275 | Ebeiedinone | 25650-68-4 | Natural Products |
| HY-107276 | Yubeinine | 157478-01-8 | Natural Products |
| HY-107277 | Hapepunine | 68422-01-5 | Natural Products |
| HY-107284 | Officinalisinin I | 57944-18-0 | Natural Products |
| HY-107295 | Trichilinin B | 117842-13-4 | Natural Products |
| HY-107296 | 1-Acetyltrichilinin | 117842-14-5 | Natural Products |
| HY-107300 | Dehydrosoyasaponin I methyl ester | 117210-13-6 | Natural Products |
| HY-107301 | Dehydrosoyasaponin I | 117210-14-7 | Natural Products |
| HY-107302 | Sandosaponin A | 135272-91-2 | Natural Products |
| HY-107305 | Isosalvianolic acid B | 930573-88-9 | Natural Products |
| HY-107306 | Glycoside O-4 | 94898-61-0 | Natural Products |
| HY-107307 | Ophiopojaponin A | 313054-32-9 | Natural Products |
| HY-107309 | Scabioside C | 17233-22-6 | Natural Products |
| HY-107310 | Cussosaponin C | 366814-42-8 | Natural Products |
| HY-107311 | Hederacholchiside E | 33783-82-3 | Natural Products |
| HY-107313 | Macranthoside A | 128730-82-5 | Natural Products |
| HY-107314 | Pulchinenoside B | 135247-95-9 | Natural Products |
| HY-107315 | Alisol F 24-acetate | 443683-76-9 | Natural Products |
| HY-107318 | Alacepril | 74258-86-9 | Reference compound |
| HY-107319 | Almitrine mesylate | 29608-49-9 | Reference compound |
| HY-107320 | Amtolmetin guacil | 87344-06-7 | Reference compound |
| HY-107321 | Azosemide | 27589-33-9 | Reference compound |
| HY-107322 | Barnidipine (hydrochloride) | 104757-53-1 | Reference compound |
| HY-107322A | Barnidipine | 104713-75-9 | Reference compound |
| HY-107322AS1 | Barnidipine-d5 | 2771469-19-1 | Isotope-Labeled Compounds |
| HY-107322S | Barnidipine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-107323 | Bentazepam | 29462-18-8 | Reference compound |
| HY-107323A | Bentazepam (hydrochloride) | 29462-19-9 | Reference compound |
| HY-107324 | β-Elemene | 515-13-9 | Natural Products |
| HY-107324R | β-Elemene (Standard) | 515-13-9 | Reference Standards |
| HY-107326 | Bunazosin | 80755-51-7 | Reference compound |
| HY-107326A | Bunazosin (hydrochloride) | 52712-76-2 | Reference compound |
| HY-107327 | Carazolol | 57775-29-8 | Reference compound |
| HY-107327R | Carazolol (Standard) | 57775-29-8 | Reference Standards |
| HY-107327S | Carazolol-d7 | 1173021-02-7 | Isotope-Labeled Compounds |
| HY-107327S1 | Carazolol-d7 (hydrochloride) | 1276197-44-4 | Isotope-Labeled Compounds |
| HY-107328 | Carumonam (disodium) | 86832-68-0 | Reference compound |
| HY-107329 | Cefathiamidine | 33075-00-2 | Reference compound |
| HY-107329R | Cefathiamidine (Standard) | 33075-00-2 | Reference Standards |
| HY-107330 | (6R,7S)-Cefminox (sodium heptahydrate) | 92636-39-0 | Reference compound |
| HY-107330R | (6R,7S)-Cefminox (sodium heptahydrate) (Standard) | 92636-39-0 | Reference Standards |
| HY-107333 | Cinoxate | 104-28-9 | Reference compound |
| HY-107333S | Cinoxate-d3 | Isotope-Labeled Compounds | |
| HY-107335 | Aplodan | 6903-79-3 | Reference compound |
| HY-107336 | Cyclovalone | 579-23-7 | Reference compound |
| HY-107337 | Delapril (hydrochloride) | 83435-67-0 | Reference compound |
| HY-107337S | Delapril-d3 (hydrochloride) | 2714473-25-1 | Isotope-Labeled Compounds |
| HY-107338 | Denotivir | 51287-57-1 | Reference compound |
| HY-107339 | Deserpidine | 131-01-1 | Natural Products |
| HY-107339A | Deserpidine (hydrochloride) | 6033-69-8 | Reference compound |
| HY-107339R | Deserpidine (Standard) | 131-01-1 | Reference Standards |
| HY-107340 | Diftalone | 21626-89-1 | Reference compound |
| HY-107343 | Docosahexaenoic acid ethyl ester | 81926-94-5 | Reference compound |
| HY-107343R | Docosahexaenoic acid ethyl ester (Standard) | 81926-94-5 | Reference Standards |
| HY-107343S | Docosahexaenoic acid ethyl ester-d5 | 2692624-15-8 | Isotope-Labeled Compounds |
| HY-107343S1 | Docosahexaenoic acid ethyl ester-d5-1 | 159146-01-7 | Isotope-Labeled Compounds |
| HY-107345 | Droxicam | 90101-16-9 | Reference compound |
| HY-107346 | Enbucrilate | 6606-65-1 | Biochemical Assay Reagents |
| HY-107348 | Etofylline clofibrate | 54504-70-0 | Reference compound |
| HY-107349 | Fenoverine | 37561-27-6 | Reference compound |
| HY-107349R | Fenoverine (Standard) | 37561-27-6 | Reference Standards |
| HY-107349S | Fenoverine-d8 | Isotope-Labeled Compounds | |
| HY-107351 | Fluorocholine (chloride) | 459424-38-5 | Biochemical Assay Reagents |
| HY-107352 | Fosfenopril | 95399-71-6 | Reference compound |
| HY-107352R | Fosfenopril (Standard) | 95399-71-6 | Reference Standards |
| HY-107352S | Fosfenopril-d7 | 1279220-43-7 | Isotope-Labeled Compounds |
| HY-107353 | Gadopentetic acid | 80529-93-7 | Reference compound |
| HY-107353R | Gadopentetic acid (Standard) | 80529-93-7 | Reference Standards |
| HY-107354 | Gepefrine | 18840-47-6 | Reference compound |
| HY-107355 | Letosteine | 53943-88-7 | Reference compound |
| HY-107358 | Lidamidine | 66871-56-5 | Reference compound |
| HY-107358A | Lidamidine (hydrochloride) | 65009-35-0 | Reference compound |
| HY-107360 | Lobenzarit (disodium) | 64808-48-6 | Reference compound |
| HY-107361 | Golidocitinib | 2091134-68-6 | Reference compound |
| HY-107362 | CH7057288 | 2095616-82-1 | Reference compound |
| HY-107363 | FT-1518 | 1313026-58-2 | Reference compound |
| HY-107364 | MTX-211 | 1952236-05-3 | Reference compound |
| HY-107365 | PQR530 | 1927857-61-1 | Reference compound |
| HY-107366 | SGN-2FF | 2089647-47-0 | Reference compound |
| HY-107367 | Epertinib | 908305-13-5 | Reference compound |
| HY-107367A | Epertinib (hydrochloride) | 2071195-74-7 | Reference compound |
| HY-107368 | Sulcotrione | 99105-77-8 | Reference compound |
| HY-107368R | Sulcotrione (Standard) | 99105-77-8 | Reference Standards |
| HY-107369 | 4-Butylresorcinol | 18979-61-8 | Reference compound |
| HY-107369R | 4-Butylresorcinol (Standard) | 18979-61-8 | Reference Standards |
| HY-107370 | Atomoxetine | 83015-26-3 | Reference compound |
| HY-107370AS | (Rac)-Atomoxetine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-107370AS1 | (Rac)-Atomoxetine-d5 (hydrochloride) | 1398065-95-6 | Isotope-Labeled Compounds |
| HY-107370S | Atomoxetine-d7 | 919104-07-7 | Isotope-Labeled Compounds |
| HY-107370S1 | Atomoxetine-d5 | 1129478-03-0 | Isotope-Labeled Compounds |
| HY-107371 | 6-Bromo-2-hydroxy-3-methoxybenzaldehyde | 20035-41-0 | Reference compound |
| HY-107372 | Uridine triphosphate | 63-39-8 | Natural Products |
| HY-107372A | Uridine triphosphate (trisodium dihydrate) | 116295-90-0 | Biochemical Assay Reagents |
| HY-107372S | Uridine triphosphate-13C9,15N2 (sodium) | 285978-18-9 | Isotope-Labeled Compounds |
| HY-107372S2 | Uridine triphosphate-13C9 (dilithium) | Isotope-Labeled Compounds | |
| HY-107372S3 | Uridine triphosphate-d13 (dilithium) | Isotope-Labeled Compounds | |
| HY-107372S4 | Uridine triphosphate-15N2 (dilithium) | Isotope-Labeled Compounds | |
| HY-107373 | β-Chloro-L-alanine | 2731-73-9 | Reference compound |
| HY-107373A | 3-Chloro-L-alanine Hydrochloride | 51887-89-9 | Reference compound |
| HY-107377 | Benzo[a]pyrene | 50-32-8 | Natural Products |
| HY-107377R | Benzo[a]pyrene (Standard) | 50-32-8 | Reference Standards |
| HY-107377S | Benzo[a]pyrene-d12 | 63466-71-7 | Isotope-Labeled Compounds |
| HY-107378 | L-Valyl-L-phenylalanine | 3918-92-1 | Reference compound |
| HY-107379 | AKR1C3-IN-1 | 327092-81-9 | Reference compound |
| HY-107380A | PGlu-3-methyl-His-Pro-NH2 (TFA) | Peptides | |
| HY-107381 | (+)-Cloprostenol | 54276-21-0 | Reference compound |
| HY-107381A | (+)-Cloprostenol (sodium) | 62561-03-9 | Reference compound |
| HY-107381R | (+)-Cloprostenol (Standard) | 54276-21-0 | Reference Standards |
| HY-107382 | RF9 | 876310-60-0 | Reference compound |
| HY-107382A | RF9 (hydrochloride) | Reference compound | |
| HY-107383 | Tetrahydrobiopterin | 17528-72-2 | Natural Products |
| HY-107384 | Asimadoline | 153205-46-0 | Reference compound |
| HY-107384A | Asimadoline (hydrochloride) | 185951-07-9 | Reference compound |
| HY-107385 | Epristeride | 119169-78-7 | Reference compound |
| HY-107385R | Epristeride (Standard) | 119169-78-7 | Reference Standards |
| HY-107390 | AX-024 | 1370544-73-2 | Reference compound |
| HY-107390A | AX-024 (hydrochloride) | 1704801-24-0 | Reference compound |
| HY-107393 | LY-311727 | 164083-84-5 | Reference compound |
| HY-107394 | UK 356618 | 230961-08-7 | Reference compound |
| HY-107395 | BMS 753 | 215307-86-1 | Reference compound |
| HY-107396 | YM-750 | 138046-43-2 | Reference compound |
| HY-107397 | Ch55 | 110368-33-7 | Reference compound |
| HY-107398 | 1-(2,3-Dichlorophenyl)ethanamine (hydrochloride) | 39959-66-5 | Reference compound |
| HY-107399 | CD3254 | 196961-43-0 | Reference compound |
| HY-107400 | B I09 | 1607803-67-7 | Reference compound |
| HY-107404 | SID 7969543 | 868224-64-0 | Reference compound |
| HY-107405 | TC-N 1752 | 1211866-85-1 | Reference compound |
| HY-107405S | TC-N 1752-d5 | Isotope-Labeled Compounds | |
| HY-107407 | SB-218078 | 135897-06-2 | Reference compound |
| HY-107408 | SANT 2 | 329196-48-7 | Reference compound |
| HY-107409 | GNE 5729 | 2026635-66-3 | Reference compound |
| HY-107409B | (S,S)-GNE 5729 | 2026636-06-4 | Reference compound |
| HY-107410 | SC-26196 | 218136-59-5 | Reference compound |
| HY-107411 | Bromoenol lactone | 88070-98-8 | Reference compound |
| HY-107412 | Proteasome inhibitor IX | 856849-35-9 | Reference compound |
| HY-107413 | SR11237 | 146670-40-8 | Reference compound |
| HY-107414 | SKA-121 | 1820708-73-3 | Reference compound |
| HY-107415 | PLX7922 | 1638772-61-8 | Reference compound |
| HY-107416 | RHC 80267 | 83654-05-1 | Reference compound |
| HY-107417 | Hypothemycin | 76958-67-3 | Natural Products |
| HY-107418 | Tropifexor | 1383816-29-2 | Reference compound |
| HY-107419 | NU6140 | 444723-13-1 | Reference compound |
| HY-107420 | AY 9944 | 366-93-8 | Reference compound |
| HY-107421 | Prostratin | 60857-08-1 | Natural Products |
| HY-107422 | Lenumlostat | 2007885-39-2 | Reference compound |
| HY-107422A | Lenumlostat (hydrochloride) | 2098884-53-6 | Reference compound |
| HY-107423 | GNE 6901 | 1698900-69-4 | Reference compound |
| HY-107424 | BAY-299 | 2080306-23-4 | Reference compound |
| HY-107425 | MZ 1 | 1797406-69-9 | Reference compound |
| HY-107425A | cis-MZ 1 | 1797406-72-4 | Reference compound |
| HY-107425B | cis-MZ 1 (hydrate) | Reference compound | |
| HY-107426 | Verrucarin A | 3148-09-2 | Reference compound |
| HY-107427 | PF-3644022 | 1276121-88-0 | Reference compound |
| HY-107428 | PD-166793 | 199850-67-4 | Reference compound |
| HY-107429 | Abrocitinib | 1622902-68-4 | Reference compound |
| HY-107429R | Abrocitinib (Standard) | 1622902-68-4 | Reference Standards |
| HY-107430 | Oxythiamine | 136-16-3 | Reference compound |
| HY-107430A | Oxythiamine (chloride hydrochloride) | 614-05-1 | Reference compound |
| HY-107430B | Oxythiamine (chloride) | 582-36-5 | Reference compound |
| HY-107430R | Oxythiamine (Standard) | 136-16-3 | Reference Standards |
| HY-107431 | Diphenylpyraline | 147-20-6 | Reference compound |
| HY-107431R | Diphenylpyraline (Standard) | 147-20-6 | Reference Standards |
| HY-107433 | U18666A | 3039-71-2 | Reference compound |
| HY-107434 | Molindone | 7416-34-4 | Reference compound |
| HY-107434S | Molindone-d8 | 1189805-13-7 | Isotope-Labeled Compounds |
| HY-107436 | LE135 | 155877-83-1 | Reference compound |
| HY-107437 | CD2665 | 170355-78-9 | Reference compound |
| HY-107438 | Thalidomide-O-amido-C4-NH2 | 1799711-24-2 | Reference compound |
| HY-107438A | Thalidomide-O-amido-C4-NH2 (hydrochloride) | 2245697-86-1 | Reference compound |
| HY-107439 | Thalidomide-O-amido-C8-NH2 | 1950635-15-0 | Reference compound |
| HY-107439A | Thalidomide-O-amido-C8-NH2 (hydrochloride) | 2415263-07-7 | Reference compound |
| HY-107440 | Thalidomide-O-amido-PEG3-C2-NH2 | 1957236-20-2 | Reference compound |
| HY-107440A | Thalidomide-O-amido-PEG3-C2-NH2 (hydrochloride) | 2245697-84-9 | Reference compound |
| HY-107442 | PROTAC BRD4-binding moiety 1 | 2101200-10-4 | Reference compound |
| HY-107443 | I-BET762 carboxylic acid | 1300019-38-8 | Reference compound |
| HY-107443A | (R)-I-BET762 carboxylic acid | 1786401-70-4 | Reference compound |
| HY-107444 | PROTAC Her3-binding moiety 1 | 1603845-36-8 | Reference compound |
| HY-107445 | PROTAC BRD9-binding moiety 1 | 2097512-23-5 | Reference compound |
| HY-107445A | PROTAC BRD9-binding moiety 1 (hydrochloride) | 2448414-41-1 | Reference compound |
| HY-107447 | N-Deshydroxyethyl Dasatinib | 910297-51-7 | Reference compound |
| HY-107447R | N-Deshydroxyethyl Dasatinib (Standard) | 910297-51-7 | Reference Standards |
| HY-107447S | N-Deshydroxyethyl Dasatinib-d8 | 1189998-96-6 | Isotope-Labeled Compounds |
| HY-107451 | PROTAC BET-binding moiety 1 | 2093387-77-8 | Reference compound |
| HY-107452 | SLF-amido-C2-COOH | 1092369-24-8 | Reference compound |
| HY-107453 | SirReal1-O-propargyl | 1862237-99-7 | Reference compound |
| HY-107454 | OSS_128167 | 887686-02-4 | Reference compound |
| HY-107455 | A-485 | 1889279-16-6 | Reference compound |
| HY-107456 | E6130 | 1427058-33-0 | Reference compound |
| HY-107457 | AZD-8529 | 1092453-15-0 | Reference compound |
| HY-107457A | AZD-8529 (mesylate) | 1314217-69-0 | Reference compound |
| HY-107458 | AP23848 | 834894-21-2 | Reference compound |
| HY-107459 | (E/Z)-AG490 | 134036-52-5 | Reference compound |
| HY-107460 | LDN-211904 (oxalate) | 1198408-78-4 | Reference compound |
| HY-107461 | LY2623091 | 1162264-07-4 | Reference compound |
| HY-107462 | 17α-Hydroxydigitoxigenin | 26629-41-4 | Reference compound |
| HY-107466 | WK298 | 1067654-70-9 | Reference compound |
| HY-107468 | PL-100 | 612547-11-2 | Reference compound |
| HY-107469 | Pyridoxal | 66-72-8 | Natural Products |
| HY-107469R | Pyridoxal (Standard) | 66-72-8 | Reference Standards |
| HY-107469S | Pyridoxal-d3 (hydrochloride) | 1173023-49-8 | Isotope-Labeled Compounds |
| HY-107469S1 | Pyridoxal-d3 | 1173148-04-3 | Isotope-Labeled Compounds |
| HY-107470 | Antitumor agent-21 | 1256037-58-7 | Reference compound |
| HY-107471 | CB2 receptor agonist 3 | 919077-81-9 | Reference compound |
| HY-107477 | GSK8573 | 1693766-04-9 | Reference compound |
| HY-107479 | (R)-JNJ-31020028 | 1094873-17-2 | Reference compound |
| HY-107480 | YK11 | 1370003-76-1 | Reference compound |
| HY-107480R | YK11 (Standard) | 1370003-76-1 | Reference Standards |
| HY-107481 | Fasoracetam | 110958-19-5 | Reference compound |
| HY-107482 | Picamilon | 34562-97-5 | Reference compound |
| HY-107482A | Picamilon (sodium) | 62936-56-5 | Reference compound |
| HY-107483 | Cambendazole | 26097-80-3 | Reference compound |
| HY-107483R | Cambendazole (Standard) | 26097-80-3 | Reference Standards |
| HY-107483S | Cambendazole-d7 | 1228182-48-6 | Isotope-Labeled Compounds |
| HY-107485 | HIV-1 integrase inhibitor 8 | 1568-80-5 | Reference compound |
| HY-107486 | Nosiheptide | 56377-79-8 | Natural Products |
| HY-107486R | Nosiheptide (Standard) | 56377-79-8 | Reference Standards |
| HY-107489 | RO 4938581 | 883093-10-5 | Reference compound |
| HY-107492 | Ethaboxam | 162650-77-3 | Reference compound |
| HY-107494 | 13-cis-4-Oxoretinoic acid | 71748-58-8 | Reference compound |
| HY-107494A | all-trans-4-Oxoretinoic acid | 38030-57-8 | Natural Products |
| HY-107494AR | all-trans-4-Oxoretinoic acid (Standard) | 38030-57-8 | Reference Standards |
| HY-107494S2 | 4-Oxoretinoic acid-d3 | 1346606-26-5 | Isotope-Labeled Compounds |
| HY-107495 | Betahistine EP Impurity C | 5452-87-9 | Reference compound |
| HY-107496 | Imidocarb (dipropionate) | 55750-06-6 | Reference compound |
| HY-107496R | Imidocarb (dipropionate) (Standard) | 55750-06-6 | Reference Standards |
| HY-107497 | 1-Methyl-3-amino-4-cyanopyrazole | 21230-50-2 | Reference compound |
| HY-107498 | GNE-8324 | 1698901-76-6 | Reference compound |
| HY-107500 | UVI 3003 | 847239-17-2 | Reference compound |
| HY-107501 | (Rac)-1-Oleoyl lysophosphatidic acid (sodium) | 22556-62-3 | Reference compound |
| HY-107502 | Cryptophycin analog 1 | 1260431-28-4 | Reference compound |
| HY-107503 | MMPIP | 479077-02-6 | Reference compound |
| HY-107504 | VU0360172 (hydrochloride) | 1309976-62-2 | Reference compound |
| HY-107505 | CBiPES (hydrochloride) | 856702-40-4 | Reference compound |
| HY-107505A | CBiPES | 353235-01-5 | Reference compound |
| HY-107506 | Ro 67-4853 | 302841-89-0 | Reference compound |
| HY-107507 | Ro 01-6128 | 302841-86-7 | Reference compound |
| HY-107508 | VU-29 | 890764-36-0 | Reference compound |
| HY-107509 | LY2389575 (hydrochloride) | 885104-09-6 | Reference compound |
| HY-107510 | YM-230888 | 446257-23-4 | Reference compound |
| HY-107512 | Kynurenic acid (sodium) | 2439-02-3 | Reference compound |
| HY-107513 | BAY 36-7620 | 232605-26-4 | Reference compound |
| HY-107514 | (RS)-PPG | 120667-15-4 | Reference compound |
| HY-107515 | LY367385 | 198419-91-9 | Reference compound |
| HY-107515A | LY367385 (hydrochloride) | 2829282-00-8 | Reference compound |
| HY-107516 | (S)-3,4-DCPG | 201730-11-2 | Reference compound |
| HY-107517 | UBP 1112 | 339526-74-8 | Reference compound |
| HY-107518 | (R,S)-3,4-Dicarboxyphenylglycine | 176796-64-8 | Reference compound |
| HY-107519 | (R)-3,4-DCPG | 201730-10-1 | Reference compound |
| HY-107520 | MNI-caged-L-glutamate | 295325-62-1 | Reference compound |
| HY-107520A | MNI-caged-L-glutamate (TFA) | 2226362-29-2 | Reference compound |
| HY-107521 | TFB-TBOA | 480439-73-4 | Reference compound |
| HY-107522 | DL-TBOA | 205309-81-5 | Reference compound |
| HY-107522B | DL-TBOA (ammonium) | 2093503-71-8 | Reference compound |
| HY-107523 | WAY-213613 | 868359-05-1 | Reference compound |
| HY-107523A | WAY-213613 (hydrochloride) | 2450268-84-3 | Reference compound |
| HY-107524 | (±)-HIP-B | 227619-65-0 | Reference compound |
| HY-107525 | (±)-HIP-A | 227619-64-9 | Reference compound |
| HY-107526 | (Rac)-ALX 5407 | 405225-21-0 | Reference compound |
| HY-107527 | Org 25543 (hydrochloride) | 495076-64-7 | Reference compound |
| HY-107527A | Org 25543 | 363628-88-0 | Reference compound |
| HY-107528 | FRATtide | 251087-38-4 | Reference compound |
| HY-107529 | TC-G 24 | 1257256-44-2 | Reference compound |
| HY-107530 | 3F8 | 159109-11-2 | Reference compound |
| HY-107531 | A 1070722 | 1384424-80-9 | Reference compound |
| HY-107532 | N-Nonyldeoxynojirimycin | 81117-35-3 | Peptides |
| HY-107533 | T-98475 | 199119-18-1 | Reference compound |
| HY-107534 | AG-045572 | 263847-55-8 | Reference compound |
| HY-107535 | AS1269574 | 330981-72-1 | Reference compound |
| HY-107536 | ML 145 | 1164500-72-4 | Reference compound |
| HY-107537 | CID 2745687 | 264233-05-8 | Reference compound |
| HY-107538 | YE120 | 383124-82-1 | Reference compound |
| HY-107539 | GPR35 agonist 4 | 871085-49-3 | Reference compound |
| HY-107541 | O-1602 | 317321-41-8 | Reference compound |
| HY-107541R | O-1602 (Standard) | 317321-41-8 | Reference Standards |
| HY-107542 | Oleoylethanolamide | 111-58-0 | Natural Products |
| HY-107542R | Oleoylethanolamide (Standard) | 111-58-0 | Reference Standards |
| HY-107542S | Oleoylethanolamide-d4 | 946524-36-3 | Isotope-Labeled Compounds |
| HY-107542S2 | Oleoylethanolamide-d2 | 1245477-09-1 | Isotope-Labeled Compounds |
| HY-107543 | 8-CPT-2Me-cAMP (sodium) | 634207-53-7 | Reference compound |
| HY-107544 | 8-pCPT-2'-O-Me-cAMP-AM | 1152197-23-3 | Reference compound |
| HY-107545 | Dynole 34-2 | 1128165-88-7 | Reference compound |
| HY-107546 | CFM 1571 (hydrochloride) | 1215548-30-3 | Reference compound |
| HY-107547 | BPIPP | 325746-94-9 | Reference compound |
| HY-107548 | A-350619 (hydrochloride) | 1217201-17-6 | Reference compound |
| HY-107549 | KD 5170 | 940943-37-3 | Reference compound |
| HY-107550 | HDAC6-IN-7 | 956154-63-5 | Reference compound |
| HY-107551 | GLI antagonist-1 | 599150-20-6 | Reference compound |
| HY-107553 | Chetomin | 1403-36-7 | Reference compound |
| HY-107554 | Methimepip (dihydrobromide) | 817636-54-7 | Reference compound |
| HY-107555 | VUF 8430 (dihydrobromide) | 100130-32-3 | Reference compound |
| HY-107556 | VUF 5681 (dihydrobromide) | 639089-06-8 | Reference compound |
| HY-107557 | Proxyfan | 177708-09-7 | Reference compound |
| HY-107557A | Proxyfan (Oxalate) | 1620017-81-3 | Reference compound |
| HY-107558 | JNJ10191584 (maleate) | 869497-75-6 | Reference compound |
| HY-107559 | GT-2016 | 152241-24-2 | Reference compound |
| HY-10756 | BMS-740808 | 280118-23-2 | Reference compound |
| HY-107560 | 4-Methylhistamine (dihydrochloride) | 36376-47-3 | Reference compound |
| HY-107561 | A-943931 (hydrochloride) | 1227675-50-4 | Reference compound |
| HY-107562 | JNJ 10181457 dihydrochloride | 544707-20-2 | Reference compound |
| HY-107562A | JNJ-10181457 | 544707-19-9 | Reference compound |
| HY-107563 | ROS 234 | 184576-87-2 | Reference compound |
| HY-107563A | ROS 234 (dioxalate) | 1781941-93-2 | Reference compound |
| HY-107564 | Impentamine (dihydrobromide) | 149629-70-9 | Reference compound |
| HY-107565 | 2-Pyridylethylamine (hydrochloride) | 3343-39-3 | Reference compound |
| HY-107566 | Conessine | 546-06-5 | Natural Products |
| HY-107566A | Conessine (dihydrobromide) | 5913-82-6 | Natural Products |
| HY-107567 | Carcinine | 56897-53-1 | Reference compound |
| HY-107567B | Carcinine (dihydrochloride) | 57022-38-5 | Reference compound |
| HY-107568 | Iodophenpropit (dihydrobromide) | 145196-87-8 | Reference compound |
| HY-107569 | Garcinol | 78824-30-3 | Natural Products |
| HY-107570 | IWP-12 | 688353-45-9 | Reference compound |
| HY-107571 | VULM 1457 | 228544-65-8 | Reference compound |
| HY-107572 | PD 128042 | 114289-47-3 | Reference compound |
| HY-107573 | KDM2/7-IN-1 | 1453071-47-0 | Reference compound |
| HY-107574 | TC-E 5003 | 17328-16-4 | Reference compound |
| HY-107575 | TLR4-IN-C34 | 40592-88-9 | Reference compound |
| HY-107577 | Gedunin | 2753-30-2 | Natural Products |
| HY-107578 | Macbecin | 73341-72-7 | Reference compound |
| HY-107579 | Acifran | 72420-38-3 | Reference compound |
| HY-107579R | Acifran (Standard) | 72420-38-3 | Reference Standards |
| HY-10758 | FXa-IN-1 | 441328-10-5 | Reference compound |
| HY-107580 | GPR109 receptor agonist-1 | 306935-41-1 | Reference compound |
| HY-107581 | MK-1903 | 1268882-43-4 | Reference compound |
| HY-107582 | JW480 | 1354359-53-7 | Reference compound |
| HY-107584 | BYK 191023 (dihydrochloride) | 1216722-25-6 | Reference compound |
| HY-107586 | Demethylasterriquinone B1 | 78860-34-1 | Natural Products |
| HY-107587 | A-286982 | 280749-17-9 | Reference compound |
| HY-107588 | TC-I 15 | 916734-43-5 | Reference compound |
| HY-107589 | BIO5192 | 327613-57-0 | Reference compound |
| HY-107589A | BIO5192 (hydrate) | Reference compound | |
| HY-107590 | GR144053 (trihydrochloride) | 1215333-48-4 | Reference compound |
| HY-107591 | (Rac)-PF-184 | 1187460-81-6 | Reference compound |
| HY-107591A | (Rac)-PF-184 (hydrate) | Reference compound | |
| HY-107591B | PF-184 | Reference compound | |
| HY-107592 | ACHP | 406208-42-2 | Reference compound |
| HY-107593 | PS-1145 (dihydrochloride) | 1049743-58-9 | Reference compound |
| HY-107594 | Benzene hexabromide | 1837-91-8 | Reference compound |
| HY-107595 | SD-1008 | 960201-81-4 | Reference compound |
| HY-107596 | SR-3576 | 1164153-22-3 | Reference compound |
| HY-107597 | Halicin | 40045-50-9 | Reference compound |
| HY-107598 | JNK Inhibitor VIII | 894804-07-0 | Reference compound |
| HY-107599 | AEG3482 | 63735-71-7 | Reference compound |
| HY-107600 | IQ-3 | 312538-03-7 | Reference compound |
| HY-107601 | UBP316 | 936095-50-0 | Reference compound |
| HY-107602 | UBP310 | 902464-46-4 | Reference compound |
| HY-107603 | NS3763 | 70553-45-6 | Reference compound |
| HY-107604 | UBP 302 | 745055-91-8 | Reference compound |
| HY-107605 | UBP296 | 745055-86-1 | Reference compound |
| HY-107606 | UBP301 | 569371-10-4 | Reference compound |
| HY-107606A | UBP301 (hydrochloride) | Reference compound | |
| HY-107607 | FPL-55712 (free base) | 40785-97-5 | Reference compound |
| HY-107607A | FPL-55712 | 40786-08-1 | Reference compound |
| HY-107608 | Leukotriene B4 | 71160-24-2 | Natural Products |
| HY-107608A | 5(S),12(S)-Leukotriene B4 | 79056-01-2 | Reference compound |
| HY-107608R | Leukotriene B4 (Standard) | 71160-24-2 | Reference Standards |
| HY-107608S | Leukotriene B4-d4 | 124629-74-9 | Isotope-Labeled Compounds |
| HY-107608S1 | Leukotriene B4-d5 | Isotope-Labeled Compounds | |
| HY-107609 | BAY-u 9773 | 154978-38-8 | Reference compound |
| HY-107610 | SR2640 (hydrochloride) | 146662-42-2 | Reference compound |
| HY-107611 | Ro 24-5913 | 128312-51-6 | Reference compound |
| HY-107612 | GPBAR-A | 877052-79-4 | Reference compound |
| HY-107613 | R 59-022 | 93076-89-2 | Reference compound |
| HY-107613A | R 59-022 (hydrochloride) | 93076-98-3 | Reference compound |
| HY-107614 | 1-Oleoyl lysophosphatidic acid (sodium) | 325465-93-8 | Reference compound |
| HY-107614G | 1-Oleoyl lysophosphatidic acid (sodium) (GMP) | 325465-93-8 | GMP Small Molecules |
| HY-107615 | TC LPA5 4 | 1393814-38-4 | Reference compound |
| HY-107616 | H2L5186303 | 139262-76-3 | Reference compound |
| HY-107617 | PTIQ | 1032822-42-6 | Reference compound |
| HY-107619 | PD-334581 | 548756-68-9 | Reference compound |
| HY-107620 | PD 198306 | 212631-61-3 | Reference compound |
| HY-107621 | U0124 | 108923-79-1 | Reference compound |
| HY-107622 | (E/Z)-BIX02188 | 1094614-84-2 | Reference compound |
| HY-107623 | TC-MCH 7c | 864756-35-4 | Reference compound |
| HY-107624 | ATC0175 | 510733-97-8 | Reference compound |
| HY-107625 | SNAP 94847 | 487051-12-7 | Reference compound |
| HY-107625A | SNAP 94847 (hydrochloride) | 1781934-47-1 | Reference compound |
| HY-107626 | ATC0065 | 510732-84-0 | Reference compound |
| HY-107626A | ATC0065 (free base) | 509145-82-8 | Reference compound |
| HY-107627 | MCL0020 | 475498-26-1 | Peptides |
| HY-107628 | N-Pentanoyl 2-benzyltryptamine | 220339-00-4 | Reference compound |
| HY-107629 | Flutax 1 | 191930-58-2 | Biochemical Assay Reagents |
| HY-107630 | RU 26752 | 76676-33-0 | Reference compound |
| HY-107631 | Oxprenoate (potassium) | 76676-34-1 | Reference compound |
| HY-107632 | GYY4137 | 106740-09-4 | Reference compound |
| HY-107632G | GYY4137 (GMP) | 106740-09-4 | GMP Small Molecules |
| HY-107633 | A 1120 | 1152782-19-8 | Reference compound |
| HY-107634 | CP-20961 | 35607-20-6 | Reference compound |
| HY-107635 | TMN355 | 1186372-20-2 | Reference compound |
| HY-107636 | DC_AC50 | 497061-48-0 | Reference compound |
| HY-107637 | ONO-4817 | 223472-31-9 | Reference compound |
| HY-107639 | UK-370106 | 230961-21-4 | Reference compound |
| HY-107640 | WAY-170523 | 307002-73-9 | Reference compound |
| HY-107641 | α-Cyano-4-hydroxycinnamic acid | 28166-41-8 | Reference compound |
| HY-107642 | MA-2029 | 287206-61-5 | Reference compound |
| HY-107643 | Reversan | 313397-13-6 | Reference compound |
| HY-107644 | AQ-RA 741 | 123548-16-3 | Reference compound |
| HY-107645 | DAU 5884 (hydrochloride) | 131780-48-8 | Reference compound |
| HY-107646 | PD 102807 | 23062-91-1 | Reference compound |
| HY-107647 | (S)-(+)-Dimethindene (maleate) | 136152-65-3 | Reference compound |
| HY-107647A | (R)-(+)-Dimethindene (maleate) | 136152-64-2 | Reference compound |
| HY-107648 | McN-A-343 | 55-45-8 | Reference compound |
| HY-107649 | Zamifenacin (fumarate) | 127308-98-9 | Reference compound |
| HY-107650 | Milameline (hydrochloride) | 139886-04-7 | Reference compound |
| HY-107650A | Milameline (hydroiodide) | Reference compound | |
| HY-107651 | VU 0365114 | 1208222-39-2 | Reference compound |
| HY-107652 | AF-DX 384 | 118290-26-9 | Reference compound |
| HY-107653 | J 104129 (fumarate) | 257603-40-0 | Reference compound |
| HY-107654 | Muscarine (iodide) | 24570-49-8 | Reference compound |
| HY-107654S | Muscarine-d9 (iodide) | Isotope-Labeled Compounds | |
| HY-107655 | Arecaidine but-2-ynyl ester (tosylate) | 119630-77-2 | Reference compound |
| HY-107656 | PTAC (oxalate) | 201939-40-4 | Reference compound |
| HY-107657 | (+)-Blebbistatin | 1177356-70-5 | Reference compound |
| HY-107658 | SN 6 | 415697-08-4 | Reference compound |
| HY-107659 | YM-244769 (hydrochloride) | 837424-39-2 | Reference compound |
| HY-107660 | SIRT2-IN-8 | 115687-05-3 | Reference compound |
| HY-107661 | Arundic Acid | 185517-21-9 | Reference compound |
| HY-107661A | S-(+)-Arundic Acid | 807363-10-6 | Reference compound |
| HY-107661R | Arundic Acid (Standard) | 185517-21-9 | Reference Standards |
| HY-107662 | TCS PrP Inhibitor 13 | 34320-83-7 | Reference compound |
| HY-107663 | MIF-1 | 2002-44-0 | Peptides |
| HY-107663A | MIF-1 (TFA) | 35240-69-8 | Peptides |
| HY-107664 | SR 142948 | 184162-64-9 | Reference compound |
| HY-107664A | SR 142948 (dihydrochloride) | Reference compound | |
| HY-107665 | Ro 106-9920 | 62645-28-7 | Peptides |
| HY-107666 | PHA 568487 | 527680-57-5 | Reference compound |
| HY-107667 | TC-2559 (fumarate) | 212332-35-9 | Reference compound |
| HY-107668 | TC-1698 (dihydrochloride) | 787587-06-8 | Reference compound |
| HY-107668A | TC-1698 | 700834-58-8 | Reference compound |
| HY-107669 | nAChR-IN-1 (hydrochloride) | 849461-91-2 | Reference compound |
| HY-107670 | Dihydro-β-erythroidine (hydrobromide) | 29734-68-7 | Natural Products |
| HY-107671 | DMAB-anabaseine (dihydrochloride) | 154149-38-9 | Reference compound |
| HY-107672 | MG624 | 77257-42-2 | Reference compound |
| HY-107673 | RJR-2429 (dihydrochloride) | 1021418-53-0 | Reference compound |
| HY-107674 | bPiDDB | 525596-66-1 | Reference compound |
| HY-107675 | Desformylflustrabromine hydrochloride | 951322-11-5 | Reference compound |
| HY-107676 | SIB-1553A | 191611-89-9 | Reference compound |
| HY-107676A | SIB-1553A (free base) | 191611-76-4 | Reference compound |
| HY-107677 | A 844606 | 861119-08-6 | Reference compound |
| HY-107678 | SEN12333 | 874450-44-9 | Reference compound |
| HY-107679 | SR 16584 | 1150153-86-8 | Reference compound |
| HY-107680 | 3-Pyr-Cytisine | 948027-43-8 | Reference compound |
| HY-107681 | SIB-1508Y | 192231-16-6 | Reference compound |
| HY-107682 | TQS | 353483-92-8 | Reference compound |
| HY-107683 | LY-2087101 | 913186-74-0 | Reference compound |
| HY-107684 | 3-Bromocytisine | 207390-14-5 | Reference compound |
| HY-107686 | 5-Iodo-A-85380 (dihydrochloride) | 1217837-17-6 | Reference compound |
| HY-107689 | RuBiNic | 1256362-30-7 | Reference compound |
| HY-107690 | DMPO | 3317-61-1 | Reference compound |
| HY-107691 | GR 159897 | 158848-32-9 | Reference compound |
| HY-107692 | SB 218795 | 174635-53-1 | Reference compound |
| HY-107693 | SSR 146977 (hydrochloride) | 264618-38-4 | Reference compound |
| HY-107694 | (Rac)-Dizocilpine | 70449-94-4 | Reference compound |
| HY-107695 | Remacemide (hydrochloride) | 111686-79-4 | Reference compound |
| HY-107696 | Ro 04-5595 (hydrochloride) | 64047-73-0 | Reference compound |
| HY-107697 | N20C (hydrochloride) | 1177583-87-7 | Reference compound |
| HY-107698 | PMPA (NMDA antagonist) | 113919-36-1 | Reference compound |
| HY-107699 | PPPA | 113190-92-4 | Reference compound |
| HY-107700 | Gavestinel (sodium salt) | 153436-38-5 | Reference compound |
| HY-107701 | CGP 78608 (hydrochloride) | 1135278-54-4 | Reference compound |
| HY-107701A | CGP-78608 | 206648-13-7 | Reference compound |
| HY-107702 | CGP 37849 | 127910-31-0 | Reference compound |
| HY-107703 | CGP 39551 | 127910-32-1 | Reference compound |
| HY-107704 | SDZ 220-040 | 174575-40-7 | Reference compound |
| HY-107705 | NMDAR antagonist 4 | 132623-44-0 | Reference compound |
| HY-107706 | Co 101244 (hydrochloride) | 193356-17-1 | Reference compound |
| HY-107707 | TCS 46b | 302799-86-6 | Reference compound |
| HY-107708 | threo-Ifenprodil (hemitartrate) | 1312991-83-5 | Reference compound |
| HY-107709 | MK-4074 | 1039758-22-9 | Reference compound |
| HY-107710 | LY 233053 | 125546-04-5 | Reference compound |
| HY-107711 | DQP-1105 | 380560-89-4 | Reference compound |
| HY-107712 | TCN 213 | 556803-08-8 | Reference compound |
| HY-107713 | PPDA | 684283-16-7 | Reference compound |
| HY-107714 | MNI-D-aspartate | 845555-94-4 | Reference compound |
| HY-107716 | Ro 8-4304 (hydrochloride) | 1312991-77-7 | Reference compound |
| HY-107717 | MNI-caged-NMDA | 1227675-52-6 | Reference compound |
| HY-107718 | Midafotel | 117414-74-1 | Reference compound |
| HY-107719 | D-AP7 | 81338-23-0 | Reference compound |
| HY-107720 | ARL 17477 | 866914-87-6 | Reference compound |
| HY-107721 | (±)-J-113397 | 217461-40-0 | Reference compound |
| HY-107722 | SCH 221510 | 322473-89-2 | Reference compound |
| HY-107723 | CGP71683 hydrochloride | 192322-50-2 | Reference compound |
| HY-107723A | CGP71683 | 192321-23-6 | Reference compound |
| HY-107724 | PD 160170 | 181468-88-2 | Reference compound |
| HY-107725 | BIBO3304 | 191868-14-1 | Reference compound |
| HY-107725A | BIBO3304 (diTFA) | 2310085-85-7 | Reference compound |
| HY-107726 | BIBP3226 (TFA) | 1068148-47-9 | Reference compound |
| HY-107726A | BIBP3226 | 159013-54-4 | Reference compound |
| HY-107727 | BMS-193885 (L-Lactic acid) | 679839-66-8 | Reference compound |
| HY-107728 | S 25585 | 263849-50-9 | Reference compound |
| HY-107729 | Lu AA33810 | 304008-29-5 | Reference compound |
| HY-107730 | NPY5RA-972 | 439861-56-0 | Reference compound |
| HY-107731 | SF 11 | 443292-81-7 | Reference compound |
| HY-107732 | JNJ-5207787 | 683746-68-1 | Reference compound |
| HY-107733 | NTNCB (hydrochloride) | 191931-56-3 | Reference compound |
| HY-107734 | L 152804 | 6508-43-6 | Reference compound |
| HY-107735 | CYM 9484 | 1383478-94-1 | Reference compound |
| HY-107736 | AI-3 | 882288-28-0 | Reference compound |
| HY-107737 | 1,2-DLPC | 18194-25-7 | Reference compound |
| HY-107738 | Guggulsterone | 95975-55-6 | Natural Products |
| HY-107739 | Penciclovir (sodium) | 97845-62-0 | Reference compound |
| HY-107740 | Pseudoisocyanine (iodide) | 977-96-8 | Reference compound |
| HY-107741 | SNC162 | 178803-51-5 | Reference compound |
| HY-107743 | Naloxone benzoylhydrazone | 119630-94-3 | Reference compound |
| HY-107744 | Nalmefene | 55096-26-9 | Reference compound |
| HY-107745 | SDM25N (hydrochloride) | 342884-71-3 | Reference compound |
| HY-107747 | GR 89696 | 126766-32-3 | Reference compound |
| HY-107747A | GR 89696 (free base) | 126766-31-2 | Reference compound |
| HY-107748 | 5'-Guanidinonaltrindole (hydrochloride) | 351183-88-5 | Reference compound |
| HY-107748A | 5'-Guanidinonaltrindole (TFA) | 219655-57-9 | Reference compound |
| HY-107749 | ML 190 | 1355244-02-8 | Reference compound |
| HY-107750 | Cyprodime | 118111-54-9 | Reference compound |
| HY-107750A | Cyprodime (hydrochloride) | 2387505-50-0 | Reference compound |
| HY-107751 | BW373U86 | 155836-50-3 | Reference compound |
| HY-107753 | XRP44X | 729605-21-4 | Reference compound |
| HY-107754 | Cesium chloride | 7647-17-8 | Biochemical Assay Reagents |
| HY-107755 | 3-Azaspiro[5.5]undecane (hydrochloride) | 1125-01-5 | Reference compound |
| HY-107756 | LOE 908 (hydrochloride) | 143482-60-4 | Reference compound |
| HY-107757 | GMQ | 5361-15-9 | Reference compound |
| HY-107758 | Y-29794 (oxalate) | 146794-84-5 | Reference compound |
| HY-107759 | Butabindide (oxalate) | 185213-03-0 | Reference compound |
| HY-107760 | Decanoyl-RVKR-CMK | 150113-99-8 | Peptides |
| HY-107760A | Decanoyl-RVKR-CMK (TFA) | 2098497-25-5 | Peptides |
| HY-107761 | JMV 390-1 | 148473-36-3 | Reference compound |
| HY-107762 | CGS35066 | 261619-50-5 | Reference compound |
| HY-107765 | LY2955303 | 1433497-19-8 | Reference compound |
| HY-107767 | Antibiotic DC 81 | 81307-24-6 | Reference compound |
| HY-107769 | Duocarmycin TM | 157922-77-5 | ADC Related |
| HY-10777 | EMD 495235 | 811811-33-3 | Reference compound |
| HY-107770 | Duocarmycin MB | 1613286-58-0 | ADC Related |
| HY-107771 | Fluensulfone | 318290-98-1 | Reference compound |
| HY-107771R | Fluensulfone (Standard) | 318290-98-1 | Reference Standards |
| HY-107773 | GSK3004774 | 2138814-32-9 | Reference compound |
| HY-107774 | BMS-986163 | 1801151-09-6 | Reference compound |
| HY-107775 | Ganfeborole (hydrochloride) | 2131798-13-3 | Reference compound |
| HY-107777 | LLY-283 | 2040291-27-6 | Reference compound |
| HY-107777A | LLY-284 | 2226515-75-7 | Reference compound |
| HY-107778 | PF-9366 | 72882-78-1 | Reference compound |
| HY-107779 | BI-882370 | 1392429-79-6 | Reference compound |
| HY-107780 | Cyclic-di-GMP | 61093-23-0 | Natural Products |
| HY-107780A | Cyclic-di-GMP (sodium) | Natural Products | |
| HY-107780B | Cyclic-di-GMP (diammonium) | 609343-82-0 | Natural Products |
| HY-107781 | PAT-505 | 1782070-22-7 | Reference compound |
| HY-107782 | Picrotin | 21416-53-5 | Natural Products |
| HY-107782R | Picrotin (Standard) | 21416-53-5 | Reference Standards |
| HY-107783 | Sulfo-GMBS | 185332-92-7 | Reference compound |
| HY-107784 | Ectoine | 96702-03-3 | Natural Products |
| HY-107784R | Ectoine (Standard) | 96702-03-3 | Reference Standards |
| HY-107787 | Dioxopromethazine | 13754-56-8 | Reference compound |
| HY-107787A | Dioxopromethazine hydrochloride | 15374-15-9 | Reference compound |
| HY-107787AR | Dioxopromethazine hydrochloride (Standard) | 15374-15-9 | Reference Standards |
| HY-107789 | Sodium lauryl sulfoacetate | 1847-58-1 | Natural Products |
| HY-107790 | 5-Methoxyflavone | 42079-78-7 | Reference compound |
| HY-107792 | Benurestat | 38274-54-3 | Reference compound |
| HY-107793 | Picosulfate (sodium salt hydrate) | 1307301-38-7 | Reference compound |
| HY-107794 | Clodronate (disodium tetrahydrate) | 88416-50-6 | Reference compound |
| HY-107794R | Clodronate (disodium tetrahydrate) (Standard) | 88416-50-6 | Reference Standards |
| HY-107795 | Benorilate | 5003-48-5 | Reference compound |
| HY-107795R | Benorilate (Standard) | 5003-48-5 | Reference Standards |
| HY-107796 | Metamizole (magnesium) | 63372-86-1 | Reference compound |
| HY-107798 | Potassium guaiacolsulfonate (hemihydrate) | 78247-49-1 | Reference compound |
| HY-107798R | Potassium guaiacolsulfonate (hemihydrate) (Standard) | 78247-49-1 | Reference Standards |
| HY-107799 | Castor oil | 8001-79-4 | Biochemical Assay Reagents |
| HY-10780 | JTV-803 (mesylate) | 247131-79-9 | Reference compound |
| HY-107801 | Inosine pranobex | 36703-88-5 | Reference compound |
| HY-107801R | Inosine pranobex (Standard) | 36703-88-5 | Reference Standards |
| HY-107802 | Breviscapine | 116122-36-2 | Natural Products |
| HY-107803 | Geranium oil | 8000-46-2 | Natural Products |
| HY-107805 | Dihydroactinidiolide | 17092-92-1 | Natural Products |
| HY-107811 | Harmol | 487-03-6 | Natural Products |
| HY-107811A | Harmol (hydrochloride) | 40580-83-4 | Reference compound |
| HY-107811R | Harmol (Standard) | 487-03-6 | Reference Standards |
| HY-107813 | Amikacin (sulfate) | 149022-22-0 | Reference compound |
| HY-107813R | Amikacin (sulfate) (Standard) | 149022-22-0 | Reference Standards |
| HY-107814 | Nicarbazin | 330-95-0 | Reference compound |
| HY-107814R | Nicarbazin (Standard) | 330-95-0 | Reference Standards |
| HY-107814S | Nicarbazin-d8 | Isotope-Labeled Compounds | |
| HY-107815 | CHIR 98024 | 556813-39-9 | Reference compound |
| HY-107818 | 4-Hydroxychalcone | 20426-12-4 | Natural Products |
| HY-107819 | 5α-Cholestan-3β-ol | 80-97-7 | Natural Products |
| HY-107819R | 5α-Cholestan-3β-ol (Standard) | 80-97-7 | Reference Standards |
| HY-107819S | 5α-Cholestan-3β-ol-d5 | 2260669-14-3 | Isotope-Labeled Compounds |
| HY-107820 | Ethylvanillin acetate | 72207-94-4 | Reference compound |
| HY-107823 | Cholesteryl acetate | 604-35-3 | Natural Products |
| HY-107824 | D-Melibiose | 585-99-9 | Natural Products |
| HY-107824A | Allolactose | 28447-39-4 | Natural Products |
| HY-107825 | Flavonol | 577-85-5 | Natural Products |
| HY-107826 | 5α-Cholestan-3-one | 566-88-1 | Natural Products |
| HY-107829 | 3-Aminopropionitrile fumarate (2:1) | 2079-89-2 | Reference compound |
| HY-107830 | Methyl cholate | 1448-36-8 | Natural Products |
| HY-107830R | Methyl cholate (Standard) | 1448-36-8 | Reference Standards |
| HY-107831 | 5-Acetylsalicylic acid | 13110-96-8 | Reference compound |
| HY-107832 | Ketoisophorone | 1125-21-9 | Natural Products |
| HY-107833 | A40926 | 102961-72-8 | Reference compound |
| HY-107834 | PIK-75 | 372196-67-3 | Reference compound |
| HY-107835 | Flumethrin | 69770-45-2 | Reference compound |
| HY-107835R | Flumethrin (Standard) | 69770-45-2 | Reference Standards |
| HY-107836 | Methiothepin (mesylate) | 74611-28-2 | Reference compound |
| HY-107837 | L-Ascorbic acid 2-phosphate (trisodium) | 66170-10-3 | Natural Products |
| HY-107837R | L-Ascorbic acid 2-phosphate (trisodium) (Standard) | 66170-10-3 | Reference Standards |
| HY-107840 | RGW-611 | 6497-78-5 | Reference compound |
| HY-107841 | K-Ras(G12C) inhibitor 6 | 2060530-16-5 | Reference compound |
| HY-107842 | (Z)-JIB-04 | 199596-24-2 | Reference compound |
| HY-107843 | 3',4',5',5,7-Pentamethoxyflavanone | 479672-30-5 | Natural Products |
| HY-107845 | SCR7 pyrazine | 14892-97-8 | Reference compound |
| HY-107846 | Xylan | 9014-63-5 | Natural Products |
| HY-107848 | DL-O-Tyrosine | 2370-61-8 | Peptides |
| HY-107849 | 2-Amino-3,5-dibromobenzaldehyde | 50910-55-9 | Biochemical Assay Reagents |
| HY-107850 | Pregnanediol | 80-92-2 | Natural Products |
| HY-107850A | 5α-Pregnane-3α,20α-diol | 566-58-5 | Reference compound |
| HY-107850S | Pregnanediol-d5 | Isotope-Labeled Compounds | |
| HY-107854 | N-Acetyl-5-hydroxytryptamine | 1210-83-9 | Natural Products |
| HY-107854R | N-Acetyl-5-hydroxytryptamine (Standard) | 1210-83-9 | Reference Standards |
| HY-107854S | N-Acetyl-5-hydroxytryptamine-d3 | 2001098-07-1 | Isotope-Labeled Compounds |
| HY-107855 | DL-Mevalonolactone | 674-26-0 | Reference compound |
| HY-107855S | DL-Mevalonolactone-d7 | 347840-19-1 | Isotope-Labeled Compounds |
| HY-107855S1 | DL-Mevalonolactone-d3 | 61219-76-9 | Isotope-Labeled Compounds |
| HY-107856 | 5-Fluorouridine | 316-46-1 | Reference compound |
| HY-107856R | 5-Fluorouridine (Standard) | 316-46-1 | Reference Standards |
| HY-107857 | 3-Chloropropiophenone | 936-59-4 | Biochemical Assay Reagents |
| HY-107858 | Veratryl alcohol | 93-03-8 | Natural Products |
| HY-107859 | Tris(2-chloroethyl) phosphate | 115-96-8 | Reference compound |
| HY-107859S | Tris(2-chloroethyl)phosphate-d12 | 1276500-47-0 | Isotope-Labeled Compounds |
| HY-107863 | Fructooligosaccharides | 308066-66-2 | Biochemical Assay Reagents |
| HY-107864 | Erythrosine B (free acid) | 15905-32-5 | Dye Reagents |
| HY-107864A | Erythrosine B (aluminum) | 12227-78-0 | Dye Reagents |
| HY-107867 | (±)-Clopidogrel (bisulfate) | 135046-48-9 | Reference compound |
| HY-107867S | Clopidogrel-d4 (sulfate) | 1219274-96-0 | Isotope-Labeled Compounds |
| HY-107867S3 | (Rac)-Clopidogrel-d3 (sulfate) | 2468372-74-7 | Isotope-Labeled Compounds |
| HY-107869 | Isoindigo | 476-34-6 | Natural Products |
| HY-10787 | Ximelagatran | 192939-46-1 | Reference compound |
| HY-107870 | 1,2,4-Triazole-3-carboxylic acid, 97% | 4928-87-4 | Biochemical Assay Reagents |
| HY-10790 | Cilomilast | 153259-65-5 | Reference compound |
| HY-107901 | Pparδ agonist 1 | 1902161-12-9 | Reference compound |
| HY-107902 | RIG-1 modulator 1 | 1428729-63-8 | Reference compound |
| HY-107903 | Thyroglobulin | 9010-34-8 | Biochemical Assay Reagents |
| HY-107906 | Conjugated estrogen (sodium) | 12126-59-9 | Reference compound |
| HY-107909 | Theophylline (sodium glycinate) | 8000-10-0 | Reference compound |
| HY-10791 | Ritanserin | 87051-43-2 | Reference compound |
| HY-107910 | Hyaluronidase, Bovine testes | 37326-33-3 | Reference compound |
| HY-107911 | Protamine sulfate | 9009-65-8 | Biochemical Assay Reagents |
| HY-107915 | Levonordefrin | 829-74-3 | Reference compound |
| HY-107915R | Levonordefrin (Standard) | 829-74-3 | Reference Standards |
| HY-107916 | Thyrotropin | 9002-71-5 | Reference compound |
| HY-107917 | Desoxycorticosterone pivalate | 808-48-0 | Reference compound |
| HY-107917R | Desoxycorticosterone pivalate (Standard) | 808-48-0 | Reference Standards |
| HY-107918 | Alkaloids, Rauwolfia | 8063-17-0 | Reference compound |
| HY-10792 | Eplivanserin | 130579-75-8 | Reference compound |
| HY-107921 | EDTA Calcium disodium,98% | 62-33-9 | Biochemical Assay Reagents |
| HY-107921R | EDTA Calcium disodium,98% (Standard) | 62-33-9 | Reference Standards |
| HY-107922 | Ethopropazine (hydrochloride) | 1094-08-2 | Reference compound |
| HY-107922R | Ethopropazine (hydrochloride) (Standard) | 1094-08-2 | Reference Standards |
| HY-107923 | Sulfisoxazole acetyl | 80-74-0 | Reference compound |
| HY-107925 | Propyliodone | 587-61-1 | Reference compound |
| HY-107928 | Iron dextran | 9004-66-4 | Reference compound |
| HY-107928A | Iron–Dextran(Fe 25-35% w/w) | 9004-66-4 | Biochemical Assay Reagents |
| HY-107928B | Iron–Dextran(Fe 35-40% w/w) | 9004-66-4 | Biochemical Assay Reagents |
| HY-107929 | Calcium polystyrene sulfonate | 37286-92-3 | Reference compound |
| HY-10792A | Eplivanserin (mixture) | 130581-13-4 | Reference compound |
| HY-107931 | Propiolactone | 57-57-8 | Reference compound |
| HY-107935 | 6α-Fluoroprednisolone | 53-34-9 | Reference compound |
| HY-107937 | Acrisorcin | 7527-91-5 | Reference compound |
| HY-107939 | Paramethasone Acetate | 1597-82-6 | Reference compound |
| HY-107939R | Paramethasone Acetate (Standard) | 1597-82-6 | Reference Standards |
| HY-10794 | MF498 | 915191-42-3 | Reference compound |
| HY-107940 | Sutilains | 12211-28-8 | Enzyme |
| HY-107944 | Chlorphenesin carbamate | 886-74-8 | Reference compound |
| HY-107944R | Chlorphenesin carbamate (Standard) | 886-74-8 | Reference Standards |
| HY-107947 | Fluphenazine enanthate | 2746-81-8 | Reference compound |
| HY-107949 | Flumethasone pivalate | 2002-29-1 | Reference compound |
| HY-107949R | Flumethasone pivalate (Standard) | 2002-29-1 | Reference Standards |
| HY-107953 | Chorionic gonadotrophin | 9002-61-3 | Reference compound |
| HY-107956 | Imipramine (pamoate) | 10075-24-8 | Reference compound |
| HY-107957 | Cholebrine | 16034-77-8 | Reference compound |
| HY-107959 | Colestipol (hydrochloride) | 37296-80-3 | Reference compound |
| HY-107961 | Diflorasone diacetate | 33564-31-7 | Reference compound |
| HY-107961R | Diflorasone diacetate (Standard) | 33564-31-7 | Reference Standards |
| HY-107965 | Safflower oil (from Carthamus tinctorius seed) | 8001-23-8 | Biochemical Assay Reagents |
| HY-107966 | Heparin calcium (MW 15000-19000) | 37270-89-6 | Biochemical Assay Reagents |
| HY-107966A | Heparin calcium (MW 3600-5000) | 37270-89-6 | Biochemical Assay Reagents |
| HY-107967 | Isosulfan blue | 68238-36-8 | Dye Reagents |
| HY-107967R | Isosulfan blue (Standard) | 68238-36-8 | Dye Reagents |
| HY-107969 | Haloperidol decanoate | 74050-97-8 | Reference compound |
| HY-107969R | Haloperidol decanoate (Standard) | 74050-97-8 | Reference Standards |
| HY-10797 | CJ-42794 | 847728-01-2 | Reference compound |
| HY-107977 | IDH1 Inhibitor 3 | 2171081-24-4 | Reference compound |
| HY-107978 | RIPK-IN-4 | 2141969-56-2 | Reference compound |
| HY-107980 | DS28120313 | 2146177-09-3 | Reference compound |
| HY-107981 | LSN 3213128 | 1941211-99-9 | Reference compound |
| HY-107982 | VU6005649 | 2137047-43-7 | Reference compound |
| HY-107986 | GNE-6776 | 2009273-71-4 | Reference compound |
| HY-107987 | CXCR7 modulator 1 | 2231812-31-8 | Reference compound |
| HY-107988 | MK-3903 | 1219737-12-8 | Reference compound |
| HY-107989 | Urofollitropin | 97048-13-0 | Peptides |
| HY-10799 | EG00229 (trifluoroacetate) | 1210945-69-9 | Reference compound |
| HY-107992 | Iotrolan | 79770-24-4 | Reference compound |
| HY-107994 | Aminooxyacetic acid (hemihydrochloride) | 2921-14-4 | Reference compound |
| HY-107994A | Aminoxyacetic acid | 645-88-5 | Reference compound |
| HY-107996 | Lapyrium (chloride) | 6272-74-8 | Reference compound |
| HY-107997 | TAP311 | 1149362-88-8 | Reference compound |
| HY-107999 | CADD522 | 199735-88-1 | Reference compound |
| HY-108003 | MM 07 | 1876450-21-3 | Reference compound |
| HY-108004 | Decamethoxine | 38146-42-8 | Reference compound |
| HY-108006 | Mirogabalin besylate | 1138245-21-2 | Reference compound |
| HY-108009 | Rezafungin | 1396640-59-7 | Reference compound |
| HY-108009A | Rezafungin (acetate) | 1631754-41-0 | Reference compound |
| HY-10801 | CAY10650 | 1233706-88-1 | Reference compound |
| HY-108011 | Naftazone | 15687-37-3 | Reference compound |
| HY-108011R | Naftazone (Standard) | 15687-37-3 | Reference Standards |
| HY-108012 | ME1111 | 1391758-52-3 | Reference compound |
| HY-108013 | Armillarisin A | 53696-74-5 | Natural Products |
| HY-108014 | (+)-KDT501 | 1374259-84-3 | Reference compound |
| HY-108015 | RO5263397 | 1357266-05-7 | Reference compound |
| HY-108016 | Peruvoside | 1182-87-2 | Natural Products |
| HY-108017 | Ferric maltol | 33725-54-1 | Reference compound |
| HY-108020 | LY2881835 | 1292290-38-0 | Reference compound |
| HY-108022 | Azemiglitazone | 1133819-87-0 | Reference compound |
| HY-108022A | Azemiglitazone (potassium) | 1314533-27-1 | Reference compound |
| HY-108024 | Ganaplacide | 1261113-96-5 | Reference compound |
| HY-108024A | Ganaplacide (hydrochloride) | 2751586-94-2 | Reference compound |
| HY-108026 | Hapten C | 90579-19-4 | Reference compound |
| HY-108030 | Bencycloquidium bromide | 860804-18-8 | Reference compound |
| HY-108032 | Hydroxyectoin | 165542-15-4 | Natural Products |
| HY-108034 | GET73 | 202402-01-5 | Reference compound |
| HY-108035 | (-)-JM-1232 | 1013427-48-9 | Reference compound |
| HY-108036 | Pro-xylane (30% in water) | 439685-79-7 | Reference compound |
| HY-108036A | (S)-Pro-xylane | 868156-46-1 | Reference compound |
| HY-108038 | ABT-107 | 855291-54-2 | Reference compound |
| HY-108039 | Bezisterim | 1001100-69-1 | Reference compound |
| HY-10804 | CCT 137690 | 1095382-05-0 | Reference compound |
| HY-108040 | NCX-6560 | 803728-45-2 | Reference compound |
| HY-108044 | ONO-5334 | 868273-90-9 | Reference compound |
| HY-108045 | Lodenafil carbonate | 398507-55-6 | Reference compound |
| HY-108045R | Lodenafil carbonate (Standard) | 398507-55-6 | Reference Standards |
| HY-108047 | MK-0873 | 500355-52-2 | Reference compound |
| HY-108048 | Desoxypeganine | 495-59-0 | Natural Products |
| HY-108048A | Desoxypeganine (hydrochloride) | 61939-05-7 | Reference compound |
| HY-10805 | Almorexant | 871224-64-5 | Reference compound |
| HY-108050 | 4-Hydroxyoxyphenbutazone | 55648-39-0 | Reference compound |
| HY-108052 | Delphinidin 3-glucoside (chloride) | 6906-38-3 | Natural Products |
| HY-108052R | Delphinidin 3-glucoside (chloride) (Standard) | 6906-38-3 | Reference Standards |
| HY-108054 | Cindunistat | 364067-22-1 | Reference compound |
| HY-108054A | Cindunistat ((hydrochloride) maleate) | 753491-31-5 | Reference compound |
| HY-108055 | Urantide | 669089-53-6 | Peptides |
| HY-108056 | PF 219061 | 547770-05-8 | Reference compound |
| HY-108057 | Facinicline | 677306-35-3 | Reference compound |
| HY-108057A | Facinicline (hydrochloride) | 677305-02-1 | Reference compound |
| HY-108058A | Immethridine (dihydrobromide) | 699020-93-4 | Reference compound |
| HY-108059 | β-Cryptoxanthin | 472-70-8 | Natural Products |
| HY-10805A | Almorexant (hydrochloride) | 913358-93-7 | Reference compound |
| HY-10805S | Almorexant-13C,d3 | Isotope-Labeled Compounds | |
| HY-10806 | SB-649868 | 380899-24-1 | Reference compound |
| HY-108060 | Valopicitabine | 640281-90-9 | Reference compound |
| HY-108060A | Valopicitabine (dihydrochloride) | 640725-71-9 | Reference compound |
| HY-108062 | BLI-489 | 623564-40-9 | Reference compound |
| HY-108062A | BLI-489 (hydrate) | 2580120-08-5 | Reference compound |
| HY-108065 | 3'-Sialyllactose | 35890-38-1 | Natural Products |
| HY-108065A | 3'-Sialyllactose (sodium) | 128596-80-5 | Natural Products |
| HY-108067 | SAD448 | 581106-09-4 | Reference compound |
| HY-108068 | Alphadolone acetate | 23930-37-2 | Reference compound |
| HY-108069 | Iptakalim (hydrochloride) | 642407-63-4 | Reference compound |
| HY-10809 | Bitopertin | 845614-11-1 | Reference compound |
| HY-10809A | Bitopertin (R enantiomer) | 845614-12-2 | Reference compound |
| HY-10811 | GNE-493 | 1033735-94-2 | Reference compound |
| HY-10812 | GNE-490 | 1033739-92-2 | Reference compound |
| HY-108132 | Ro 23-9358 | 153125-17-8 | Reference compound |
| HY-108136A | Bisindolylmaleimide X (hydrochloride) | 145317-11-9 | Reference compound |
| HY-108137 | Z-LVG-CHN2 | 119670-30-3 | Reference compound |
| HY-108137A | Z-L(D-Val)G-CHN2 | Reference compound | |
| HY-10814 | CP-810123 | 439608-12-5 | Reference compound |
| HY-10815 | σ1 Receptor antagonist-1 | 1204401-49-9 | Reference compound |
| HY-108161 | LF 1695 | 86187-86-2 | Reference compound |
| HY-108162 | Ataquimast (free base) | 586348-21-2 | Reference compound |
| HY-108162A | Ataquimast | 182316-31-0 | Reference compound |
| HY-108163 | SB-237376 (free base) | 179258-59-4 | Reference compound |
| HY-108163A | SB-237376 | 179258-62-9 | Reference compound |
| HY-108164 | Aspidin BB | 584-28-1 | Natural Products |
| HY-108166 | Hydroxystilbamidine | 495-99-8 | Dye Reagents |
| HY-108166A | Hydroxystilbamidine bis(methanesulfonate) | 223769-64-0 | Dye Reagents |
| HY-108170 | Pyrethrin II | 121-29-9 | Natural Products |
| HY-108171A | Hexocyclium (methylsulfate) | 115-63-9 | Reference compound |
| HY-10818 | LY309887 | 127228-54-0 | Reference compound |
| HY-10819 | AG2034 | 177575-17-6 | Reference compound |
| HY-108191 | Paldimycin A | 101411-70-5 | Reference compound |
| HY-108193 | GW 328267 | 210237-78-8 | Reference compound |
| HY-108194 | CGP 46700 | 115900-75-9 | Reference compound |
| HY-108195S | 2,2′,4,5,5′-Pentachlorobiphenyl-3′,4′,6′-d3 | 1219794-68-9 | Isotope-Labeled Compounds |
| HY-108196 | PTP1B-IN-15 | 765317-71-3 | Reference compound |
| HY-10820 | Pemetrexed | 137281-23-3 | Reference compound |
| HY-108204 | AZD 3043 | 579494-66-9 | Reference compound |
| HY-10820A | Pemetrexed (disodium) | 150399-23-8 | Reference compound |
| HY-10820AS | Pemetrexed-d5 (disodium) | Isotope-Labeled Compounds | |
| HY-10820B | Pemetrexed (disodium heptahydrate) | 357166-29-1 | Reference compound |
| HY-10820BR | Pemetrexed (disodium heptahydrate) (Standard) | 357166-29-1 | Reference Standards |
| HY-10820R | Pemetrexed (Standard) | 137281-23-3 | Reference Standards |
| HY-10820S | Pemetrexed-d5 | 1129408-57-6 | Isotope-Labeled Compounds |
| HY-10821 | Raltitrexed | 112887-68-0 | Reference compound |
| HY-108213 | Inosinic acid | 131-99-7 | Natural Products |
| HY-108213A | Inosinic acid (disodium)(hydrate)(1:2:X) | 352195-40-5 | Natural Products |
| HY-108213AR | Inosinic acid (disodium)(hydrate)(1:2:X) (Standard) | 352195-40-5 | Reference Standards |
| HY-108213R | Inosinic acid (Standard) | 131-99-7 | Reference Standards |
| HY-108213S | Inosinic acid-13C10,15N4 (dilithium) | Isotope-Labeled Compounds | |
| HY-108213S1 | Inosinic acid-15N4 (dilithium) | Isotope-Labeled Compounds | |
| HY-10822 | Idetrexed | 501332-69-0 | Reference compound |
| HY-108226 | Regorafenib N-oxide and N-desmethyl (M5) | 835621-12-0 | Reference compound |
| HY-108226S | Regorafenib N-oxide and N-desmethyl (M5)-d3 | Isotope-Labeled Compounds | |
| HY-108226S1 | Regorafenib N-oxide and N-desmethyl (M5)-13C6 | Isotope-Labeled Compounds | |
| HY-108227 | Quetiapine sulfone | 329216-65-1 | Reference compound |
| HY-108228 | Zolpidic acid | 189005-44-5 | Reference compound |
| HY-108229 | 6β-Naltrexol | 49625-89-0 | Reference compound |
| HY-108229S | 6β-Naltrexol-d3 | 1435727-11-9 | Isotope-Labeled Compounds |
| HY-10822A | ONX 0801 (trisodium) | 1097638-00-0 | Reference compound |
| HY-10823 | OSI-7904L | 139987-54-5 | Reference compound |
| HY-108230 | ALK-IN-12 | 1197958-53-4 | Reference compound |
| HY-108232 | MK-2206 | 1032349-77-1 | Reference compound |
| HY-108234 | VU 0255035 | 1135243-19-4 | Reference compound |
| HY-108235 | Lanicemine | 153322-05-5 | Reference compound |
| HY-108235A | Lanicemine (dihydrochloride) | 153322-06-6 | Reference compound |
| HY-108235B | (Rac)-Lanicemine | 61890-25-3 | Reference compound |
| HY-108235C | (R)-Lanicemine | 190581-71-6 | Reference compound |
| HY-108236 | Naxagolide (hydrochloride) | 99705-65-4 | Reference compound |
| HY-108237 | Naxagolide | 88058-88-2 | Reference compound |
| HY-108238 | BSI-401 | 142404-10-2 | Reference compound |
| HY-108239 | BIX-01294 (trihydrochloride) | 1392399-03-9 | Reference compound |
| HY-10824 | Talotrexin | 113857-87-7 | Reference compound |
| HY-108241 | (Z)-PUGNAc | 132489-69-1 | Reference compound |
| HY-108242 | Apomorphine (hydrochloride) | 314-19-2 | Reference compound |
| HY-108243 | AZD5423 | 1034148-04-3 | Reference compound |
| HY-108244 | Balsalazide (disodium) | 213594-60-6 | Reference compound |
| HY-108246 | GlcNAcstatin | 922163-64-2 | Reference compound |
| HY-108247 | Guanethidine (sesquisulfate) | 60-02-6 | Reference compound |
| HY-108248 | KU-32 | 956498-70-7 | Reference compound |
| HY-108249 | Tribenoside | 10310-32-4 | Reference compound |
| HY-108249R | Tribenoside (Standard) | 10310-32-4 | Reference Standards |
| HY-10824A | Talotrexin (monoammonium) | 648420-92-2 | Reference compound |
| HY-10824B | Talotrexin (ammonium) | 678991-55-4 | Reference compound |
| HY-10825 | DG051 | 929915-58-2 | Reference compound |
| HY-108250 | (R)-Bicalutamide | 113299-40-4 | Reference compound |
| HY-108251 | Methotrexate metabolite | 19741-14-1 | Reference compound |
| HY-108251R | Methotrexate metabolite (Standard) | 19741-14-1 | Reference Standards |
| HY-108251S | Methotrexate metabolite-d3 | 1794780-00-9 | Isotope-Labeled Compounds |
| HY-108252 | SB-649915 | 420785-70-2 | Reference compound |
| HY-108254 | Bisindolylmaleimide IV | 119139-23-0 | Reference compound |
| HY-108255 | HIV-1 inhibitor-60 | 1443461-21-9 | Reference compound |
| HY-108256 | Melitracen (hydrochloride) | 10563-70-9 | Reference compound |
| HY-108256R | Melitracen (hydrochloride) (Standard) | 10563-70-9 | Reference Standards |
| HY-108256S | Melitracen-d6 (hydrochloride) | 1189648-08-5 | Isotope-Labeled Compounds |
| HY-108257 | Atorvastatin (sodium) | 134523-01-6 | Reference compound |
| HY-108258 | PSN 375963 | 388575-52-8 | Reference compound |
| HY-108258A | PSN 375963 (hydrochloride) | 1781834-82-9 | Reference compound |
| HY-108259 | HQL-79 | 162641-16-9 | Reference compound |
| HY-10826 | DG051 (free acid) | 929916-05-2 | Reference compound |
| HY-108260 | Deferitrin | 239101-33-8 | Reference compound |
| HY-108261 | Tomeglovir | 233254-24-5 | Reference compound |
| HY-108262 | UCN-02 | 121569-61-7 | Natural Products |
| HY-108263 | 3-Hydroxy Midostaurin | 179237-49-1 | Reference compound |
| HY-108263A | (S)-3-Hydroxy Midostaurin | 945260-14-0 | Reference compound |
| HY-108263B | (R)-3-Hydroxy Midostaurin | 155848-20-7 | Reference compound |
| HY-108263S | 3-Hydroxy Midostaurin-d5 | Isotope-Labeled Compounds | |
| HY-108264 | TCS 21311 | 1260181-14-3 | Reference compound |
| HY-108268 | Cyclocephaloside II | 215776-78-6 | Natural Products |
| HY-10827 | Kelatorphan | 92175-57-0 | Reference compound |
| HY-108271 | Mogroside III-A1 | 88901-42-2 | Natural Products |
| HY-108272 | Mogroside II-A2 | 88901-45-5 | Natural Products |
| HY-108275 | Mogroside VI | 189307-15-1 | Natural Products |
| HY-108277 | Ginsenoside F5 | 189513-26-6 | Natural Products |
| HY-108278 | Zolimidine | 1222-57-7 | Reference compound |
| HY-108279 | Ulifloxacin | 112984-60-8 | Reference compound |
| HY-108279R | Ulifloxacin (Standard) | 112984-60-8 | Reference Standards |
| HY-108279S | Ulifloxacin-d8 | 1246820-95-0 | Isotope-Labeled Compounds |
| HY-108280 | Tropesin | 65189-78-8 | Reference compound |
| HY-108281 | Enfenamic acid | 23049-93-6 | Reference compound |
| HY-108283 | Trepibutone | 41826-92-0 | Reference compound |
| HY-108283R | Trepibutone (Standard) | 41826-92-0 | Reference Standards |
| HY-108285 | (Rac)-Telmesteine | 127657-29-8 | Reference compound |
| HY-108286 | Talinolol | 57460-41-0 | Reference compound |
| HY-108286S | (Rac)-Talinolol-d5 | 1215343-94-4 | Isotope-Labeled Compounds |
| HY-108287 | Trithiozine | 35619-65-9 | Reference compound |
| HY-108288 | Sulbactam pivoxil | 69388-79-0 | Reference compound |
| HY-108288R | Sulbactam pivoxil (Standard) | 69388-79-0 | Reference Standards |
| HY-108290 | Riodoxol | 19403-92-0 | Reference compound |
| HY-108292 | Propacetamol (hydrochloride) | 66532-86-3 | Reference compound |
| HY-108292R | Propacetamol (hydrochloride) (Standard) | 66532-86-3 | Reference Standards |
| HY-108293 | Promestriene | 39219-28-8 | Reference compound |
| HY-108293R | Promestriene (Standard) | 39219-28-8 | Reference Standards |
| HY-108294 | Nonaethylene glycol monododecyl ether | 3055-99-0 | Reference compound |
| HY-108295 | Pivagabine | 69542-93-4 | Reference compound |
| HY-108296 | Pirenoxine | 1043-21-6 | Reference compound |
| HY-108297 | Piketoprofen | 60576-13-8 | Reference compound |
| HY-108297R | Piketoprofen (Standard) | 60576-13-8 | Reference Standards |
| HY-108298 | Perfluorodecalin | 306-94-5 | Reference compound |
| HY-108299 | Perfluamine | 338-83-0 | Biochemical Assay Reagents |
| HY-108300 | Oxyfedrine (hydrochloride) | 16777-42-7 | Reference compound |
| HY-108302 | Nifenalol | 7413-36-7 | Reference compound |
| HY-108304 | Prajmalium (bitartrate) | 2589-47-1 | Reference compound |
| HY-108306 | Moprolol | 5741-22-0 | Reference compound |
| HY-108307 | Micronomicin (sulfate) | 66803-19-8 | Natural Products |
| HY-108308 | Ibuprofen guaiacol ester | 66332-77-2 | Reference compound |
| HY-108309 | Medronic acid | 1984-15-2 | Reference compound |
| HY-108309R | Medronic acid (Standard) | 1984-15-2 | Reference Standards |
| HY-10830A | PBPE (hydrochloride) | 262425-59-2 | Reference compound |
| HY-108312 | AC-VEID-CHO | 319494-39-8 | Peptides |
| HY-108312A | AC-VEID-CHO (TFA) | Peptides | |
| HY-108313 | T-00127_HEV1 | 900874-91-1 | Reference compound |
| HY-108314 | GC-7 | 150333-69-0 | Reference compound |
| HY-108314A | GC7 Sulfate | 150417-90-6 | Reference compound |
| HY-108315 | 6-Aminochrysene | 2642-98-0 | Reference compound |
| HY-108316 | Sultiame | 61-56-3 | Reference compound |
| HY-108316R | Sultiame (Standard) | 61-56-3 | Reference Standards |
| HY-108316S | Sulthiame-d4 | 1795021-05-4 | Isotope-Labeled Compounds |
| HY-108317 | ABL127 | 1073529-41-5 | Reference compound |
| HY-108318 | RK-24466 | 213743-31-8 | Reference compound |
| HY-108319 | DPP-IV-IN-2 | 136259-18-2 | Reference compound |
| HY-108321 | Zofenopril | 81872-10-8 | Reference compound |
| HY-108321S | Zofenopril-d5 | Isotope-Labeled Compounds | |
| HY-108322 | NBTGR | 13153-27-0 | Reference compound |
| HY-108323 | CCR2 antagonist 4 | 226226-39-7 | Reference compound |
| HY-108324 | (Z)-Thiothixene | 3313-26-6 | Reference compound |
| HY-108324A | Thiothixene (hydrochloride) | 49746-04-5 | Reference compound |
| HY-108324R | (Z)-Thiothixene (Standard) | 3313-26-6 | Reference Standards |
| HY-108325 | Brequinar | 96187-53-0 | Reference compound |
| HY-108325A | Brequinar (sodium) | 96201-88-6 | Biochemical Assay Reagents |
| HY-108325S | Brequinar-d3 | Isotope-Labeled Compounds | |
| HY-108327 | PF-05020182 | 1354712-92-7 | Reference compound |
| HY-108328 | Nerigliatin | 1245603-92-2 | Reference compound |
| HY-108329 | AM-0902 | 1883711-97-4 | Reference compound |
| HY-10833 | ROCK-IN-10 | 1038549-25-5 | Reference compound |
| HY-108330 | AG126 | 118409-62-4 | Reference compound |
| HY-108331 | 3-TYP | 120241-79-4 | Reference compound |
| HY-108333 | SB-633825 | 956613-01-7 | Reference compound |
| HY-108335 | Sipatrigine | 130800-90-7 | Reference compound |
| HY-108337 | GNE-0723 | 1883518-31-7 | Reference compound |
| HY-108339 | PF-06471553 | 1808094-07-6 | Reference compound |
| HY-10834 | β-catenin-IN-6 | 1039731-99-1 | Reference compound |
| HY-108340 | PF-06767832 | 1859081-58-5 | Reference compound |
| HY-108341 | PF-06424439 | 1469284-78-3 | Reference compound |
| HY-108341A | PF-06424439 (methanesulfonate) | 1469284-79-4 | Reference compound |
| HY-108342 | PF-00956980 | 1262832-74-5 | Reference compound |
| HY-108343 | WEE1-IN-4 | 622855-37-2 | Reference compound |
| HY-108344 | SNS-314 | 1057249-41-8 | Reference compound |
| HY-108345 | Bleomycin | 11056-06-7 | Reference compound |
| HY-108346 | JX401 | 349087-34-9 | Reference compound |
| HY-108347 | CP-100356 (hydrochloride) | 142715-48-8 | Reference compound |
| HY-108348 | BML-259 | 267654-00-2 | Reference compound |
| HY-10835 | DG-041 | 861238-35-9 | Reference compound |
| HY-108350 | MI-2-2 | 1454920-20-7 | Reference compound |
| HY-108351 | IM-54 | 861891-50-1 | Reference compound |
| HY-108352 | HU 331 | 137252-25-6 | Reference compound |
| HY-108353 | Isoprenaline | 7683-59-2 | Reference compound |
| HY-108353A | Isoprenaline (hemisulfate) | 299-95-6 | Reference compound |
| HY-108353S | Isoprenaline-d7 (acetate) | Isotope-Labeled Compounds | |
| HY-108355 | R59949 | 120166-69-0 | Reference compound |
| HY-108356 | NS3694 | 426834-38-0 | Reference compound |
| HY-108357 | 6-Diazo-5-oxo-L-nor-Leucine | 157-03-9 | Reference compound |
| HY-108357R | 6-Diazo-5-oxo-L-nor-Leucine (Standard) | 157-03-9 | Reference Standards |
| HY-108359 | Alsterpaullone | 237430-03-4 | Reference compound |
| HY-10836 | Cruzain-IN-1 | 1199523-24-4 | Reference compound |
| HY-108360 | PDD 00017273 | 1945950-21-9 | Reference compound |
| HY-108361 | CCG-203971 | 1443437-74-8 | Reference compound |
| HY-108365 | Gamithromycin | 145435-72-9 | Reference compound |
| HY-108368 | Azido-PEG2-CH2COOH | 882518-90-3 | Reference compound |
| HY-108368A | Azido-PEG2-CH2COOH (CHA) | 2098500-94-6 | Reference compound |
| HY-108369 | Azido-PEG1-CH2CO2H | 79598-48-4 | Reference compound |
| HY-108370 | N33-TEG-COOH | 201467-81-4 | Reference compound |
| HY-108371 | Boc-C1-PEG2-C4-Cl | 1835705-53-7 | Reference compound |
| HY-108372 | Boc-C5-O-C5-O-C6-Cl | 1835705-52-6 | Reference compound |
| HY-108374 | 4-Azidobutylamine | 88192-20-5 | Reference compound |
| HY-108379 | Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid | 1610413-97-2 | ADC Related |
| HY-10838 | GW 501516 | 317318-70-0 | Reference compound |
| HY-108381 | Idrocilamide | 6961-46-2 | Reference compound |
| HY-108385 | Ochratoxin A-D4 | 1448049-50-0 | Isotope-Labeled Compounds |
| HY-108387 | Morantel (citrate) | 69525-81-1 | Reference compound |
| HY-108388 | Cloethocarb | 51487-69-5 | Reference compound |
| HY-10838R | GW 501516 (Standard) | 317318-70-0 | Reference Standards |
| HY-108391 | C8-Ceramide | 74713-59-0 | Reference compound |
| HY-108396 | γ-Linolenic acid ethyl ester | 31450-14-3 | Reference compound |
| HY-108398A | Mead acid | 20590-32-3 | Natural Products |
| HY-108398AS | Mead acid-d6 | 2692624-12-5 | Isotope-Labeled Compounds |
| HY-108398B | 11(Z),14(Z),17(Z)-Eicosatrienoic acid | 17046-59-2 | Natural Products |
| HY-108398BR | 11(Z),14(Z),17(Z)-Eicosatrienoic acid (Standard) | 17046-59-2 | Reference Standards |
| HY-108400 | SCH-23390 (maleate) | 87134-87-0 | Reference compound |
| HY-108402 | Cefodizime | 69739-16-8 | Reference compound |
| HY-108402A | Cefodizime (sodium) | 86329-79-5 | Reference compound |
| HY-108402AR | Cefodizime (sodium) (Standard) | 86329-79-5 | Reference Standards |
| HY-108402R | Cefodizime (Standard) | 69739-16-8 | Reference Standards |
| HY-108403 | Phenibut | 1078-21-3 | Reference compound |
| HY-108411 | Emedastine | 87233-61-2 | Reference compound |
| HY-108411R | Emedastine (Standard) | 87233-61-2 | Reference Standards |
| HY-108411S | Emedastine-13C,d3 (fumarate) | Isotope-Labeled Compounds | |
| HY-108413 | Talazoparib tosylate | 1373431-65-2 | Reference compound |
| HY-108414 | (R)-Equol | 221054-79-1 | Reference compound |
| HY-108415 | Cloprostenol sodium salt | 55028-72-3 | Reference compound |
| HY-108415R | Cloprostenol sodium salt (Standard) | 55028-72-3 | Reference Standards |
| HY-108416 | 5,7-Dihydroxy-4-methylphthalide | 27979-57-3 | Reference compound |
| HY-108417 | Debio 0617B | 1332329-27-7 | Reference compound |
| HY-108418 | PI3Kδ-IN-15 | 870281-17-7 | Reference compound |
| HY-108418A | (R)-PI3Kδ-IN-15 | 1707193-37-0 | Reference compound |
| HY-108419 | WHI-P258 | 21561-09-1 | Reference compound |
| HY-108420 | INK4C-IN-2 | 6314-70-1 | Reference compound |
| HY-108421 | Xinjiachalcone A | 151410-32-1 | Natural Products |
| HY-108422 | Benodanil | 15310-01-7 | Reference compound |
| HY-108422R | Benodanil (Standard) | 15310-01-7 | Reference Standards |
| HY-108425 | AMG8379 | 1642112-31-9 | Reference compound |
| HY-108425A | AMG8380 | 1642112-32-0 | Reference compound |
| HY-108425B | (Rac)-AMG8379 | 1641574-26-6 | Reference compound |
| HY-108431 | MN58b | 203192-01-2 | Reference compound |
| HY-108432 | BMS-741672 | 1004757-96-3 | Reference compound |
| HY-108433 | CPT2 | 1670277-66-3 | Enzyme |
| HY-108434 | Ceapin-A7 | 2323027-38-7 | Reference compound |
| HY-108435 | GNE-049 | 1936421-41-8 | Reference compound |
| HY-108436 | Deltazinone 1 | 894554-89-3 | Reference compound |
| HY-108437 | exo-IWR-1 | 1127442-87-8 | Reference compound |
| HY-108438 | TCS 2210 | 1201916-31-5 | Reference compound |
| HY-108439 | Neurodazine | 937807-66-4 | Reference compound |
| HY-10844 | Pretomanid | 187235-37-6 | Reference compound |
| HY-108440 | Shz-1 | 326886-05-9 | Reference compound |
| HY-108441 | CCT031374 (hydrobromide) | 1219184-91-4 | Reference compound |
| HY-108442 | JW67 | 442644-28-2 | Reference compound |
| HY-108443 | DMH4 | 515880-75-8 | Reference compound |
| HY-108444 | (Z)-FeCP-oxindole | 1137967-28-2 | Reference compound |
| HY-108444A | (E)-FeCP-oxindole | 884338-18-5 | Reference compound |
| HY-108446 | GSK 1562590 (hydrochloride) | 1003878-07-6 | Reference compound |
| HY-108447 | BC-11 (hydrobromide) | 443776-49-6 | Reference compound |
| HY-108448 | N-Oleoyldopamine | 105955-11-1 | Reference compound |
| HY-108449 | Acoltremon | 68489-09-8 | Reference compound |
| HY-10844R | Pretomanid (Standard) | 187235-37-6 | Reference Standards |
| HY-10844S | Pretomanid-d4 | 1346617-34-2 | Isotope-Labeled Compounds |
| HY-10844S1 | Pretomanid-d5 | Isotope-Labeled Compounds | |
| HY-10845 | CGI-17341 | 127692-13-1 | Reference compound |
| HY-108450 | Polygodial | 6754-20-7 | Natural Products |
| HY-108451 | Ononetin | 487-49-0 | Natural Products |
| HY-108455 | N-Palmitoyl dopamine | 136181-87-8 | Reference compound |
| HY-108456 | N-Stearoyldopamine | 105955-10-0 | Reference compound |
| HY-108457 | 9-Phenanthrol | 484-17-3 | Reference compound |
| HY-108458 | SB 452533 | 459429-39-1 | Reference compound |
| HY-10846 | Delamanid | 681492-22-8 | Reference compound |
| HY-108460 | A-784168 | 824982-41-4 | Reference compound |
| HY-108461 | TRPM8-IN-1 | 1159996-20-9 | Reference compound |
| HY-108462 | ML-SA1 | 332382-54-4 | Reference compound |
| HY-108463 | A-967079 | 1170613-55-4 | Reference compound |
| HY-108464 | Phenamil | 2038-35-9 | Reference compound |
| HY-108464A | Phenamil (methanesulfonate) | 1161-94-0 | Reference compound |
| HY-108465 | Pyr3 | 1160514-60-2 | Reference compound |
| HY-108466 | Ro 08-2750 | 37854-59-4 | Reference compound |
| HY-108467 | GGsTop | 926281-37-0 | Reference compound |
| HY-108468 | KL001 | 309928-48-1 | Reference compound |
| HY-108469 | BI-6015 | 93987-29-2 | Reference compound |
| HY-10846R | Delamanid (Standard) | 681492-22-8 | Reference Standards |
| HY-10846S | Delamanid-d4 | Isotope-Labeled Compounds | |
| HY-10846S1 | Delamanid-d4-1 | 2673270-27-2 | Isotope-Labeled Compounds |
| HY-10847 | SB-277011 | 215803-78-4 | Reference compound |
| HY-108470 | Ro5-3335 | 30195-30-3 | Reference compound |
| HY-108471 | CU-CPT22 | 1416324-85-0 | Reference compound |
| HY-108472 | Loxoribine | 121288-39-9 | Reference compound |
| HY-108473 | CU-CPT 4a | 1279713-77-7 | Reference compound |
| HY-108474 | Nolatrexed dihydrochloride | 152946-68-4 | Reference compound |
| HY-108475 | ProINDY | 719277-30-2 | Reference compound |
| HY-108476 | INDY | 1169755-45-6 | Reference compound |
| HY-108477 | TMPyP4 tosylate | 36951-72-1 | Reference compound |
| HY-108479 | Nolpitantium | 153050-21-6 | Reference compound |
| HY-10847A | SB-277011 (dihydrochloride) | 1226917-67-4 | Reference compound |
| HY-10847B | SB-277011 (hydrochloride) | 215804-67-4 | Reference compound |
| HY-108480 | SDZ NKT 343 | 180046-99-5 | Reference compound |
| HY-108481 | L-760735 | 188923-01-5 | Reference compound |
| HY-108482 | CP-96,345 | 132746-60-2 | Reference compound |
| HY-108483 | RP 67580 | 135911-02-3 | Reference compound |
| HY-108484 | PP 3 | 5334-30-5 | Reference compound |
| HY-108485 | Damnacanthal | 477-84-9 | Natural Products |
| HY-108486 | Herbimycin A | 70563-58-5 | Natural Products |
| HY-108488 | KB SRC 4 | 1380088-03-8 | Reference compound |
| HY-108489 | ER-27319 (maleate) | 1204480-26-1 | Reference compound |
| HY-108490 | VPC 23019 | 449173-19-7 | Reference compound |
| HY-108491 | N,N-Dimethylsphingosine | 119567-63-4 | Reference compound |
| HY-108492 | TC-SP 14 | 1257093-40-5 | Reference compound |
| HY-108493 | CS-2100 | 913827-99-3 | Reference compound |
| HY-108494 | CYM50260 | 1355026-60-6 | Reference compound |
| HY-108495 | CYM50308 | 1345858-76-5 | Reference compound |
| HY-108496 | Sphingosine-1-phosphate | 26993-30-6 | Natural Products |
| HY-108496S | Sphingosine-1-phosphate-d7 | 2260670-15-1 | Isotope-Labeled Compounds |
| HY-108497 | L-803087 | 217480-26-7 | Reference compound |
| HY-108497A | L-803087 (TFA) | 1786412-46-1 | Reference compound |
| HY-108498 | L-817818 | 217480-27-8 | Reference compound |
| HY-108499 | NNC 26-9100 | 199522-35-5 | Reference compound |
| HY-108501 | (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 | 208706-12-1 | Reference compound |
| HY-108502 | KC 12291 (hydrochloride) | 181936-98-1 | Reference compound |
| HY-108504 | Co 102862 | 181144-66-1 | Reference compound |
| HY-108505 | QX-314 (chloride) | 5369-03-9 | Reference compound |
| HY-108506 | Licarbazepine | 29331-92-8 | Reference compound |
| HY-108506R | Licarbazepine (Standard) | 29331-92-8 | Reference Standards |
| HY-108506S | Licarbazepine-d3 | 1189917-36-9 | Isotope-Labeled Compounds |
| HY-108506S1 | Licarbazepine-d4 | 1020719-39-4 | Isotope-Labeled Compounds |
| HY-108506S2 | Licarbazepine-d4-1 | 1188265-49-7 | Isotope-Labeled Compounds |
| HY-108506S4 | Licarbazepine-d8 | 1261393-17-2 | Isotope-Labeled Compounds |
| HY-108507 | MRT-10 | 330829-30-6 | Reference compound |
| HY-108508 | SMANT (hydrochloride) | 1177600-74-6 | Reference compound |
| HY-108509 | BMY-14802 (hydrochloride) | 105565-55-7 | Reference compound |
| HY-108510 | Rimcazole (dihydrochloride) | 75859-03-9 | Reference compound |
| HY-108511 | PB28 (dihydrochloride) | 172907-03-8 | Reference compound |
| HY-108511A | PB28 | 172906-90-0 | Reference compound |
| HY-108512 | PD 144418 | 154130-99-1 | Reference compound |
| HY-108512A | PD 144418 (oxalate) | 1794760-28-3 | Reference compound |
| HY-108513 | σ1 Receptor antagonist 4 | 362512-81-0 | Reference compound |
| HY-108514 | (±)-PPCC (hemioxalate) | 932736-91-9 | Reference compound |
| HY-108515 | (+)-Igmesine (hydrochloride) | Reference compound | |
| HY-108516 | TC-E 5001 | 865565-29-3 | Reference compound |
| HY-108518 | SB-772077B (dihydrochloride) | 607373-46-6 | Reference compound |
| HY-108519 | AS1892802 | 928320-12-1 | Reference compound |
| HY-10852 | Arterolane | 664338-39-0 | Reference compound |
| HY-108520 | HX630 | 188844-52-2 | Reference compound |
| HY-108521 | HX531 | 188844-34-0 | Reference compound |
| HY-108522 | PA452 | 457657-34-0 | Reference compound |
| HY-108523 | LG100754 | 180713-37-5 | Reference compound |
| HY-108524 | LG101506 | 331248-11-4 | Reference compound |
| HY-108525 | Fluorobexarotene | 1190848-23-7 | Reference compound |
| HY-108526 | AC-55649 | 59662-49-6 | Reference compound |
| HY-108527 | CD1530 | 107430-66-0 | Reference compound |
| HY-108528 | BMS961 | 185629-22-5 | Reference compound |
| HY-108529 | BMS493 | 215030-90-3 | Reference compound |
| HY-10852A | Arterolane (maleate) | 959520-73-1 | Reference compound |
| HY-108530 | MM11253 | 345952-44-5 | Reference compound |
| HY-108531 | ER 50891 | 187400-85-7 | Reference compound |
| HY-108531A | ER 50891 (quarterhydrate) | Reference compound | |
| HY-108532 | AC-261066 | 870773-76-5 | Reference compound |
| HY-108533 | CD2314 | 170355-37-0 | Reference compound |
| HY-108534 | PMX464 | 485842-97-5 | Reference compound |
| HY-108535 | HEPES (sodium) | 75277-39-3 | Biochemical Assay Reagents |
| HY-108536D | Calcium chloride dihydrate, for cell culture, 99% | 10035-04-8 | Biochemical Assay Reagents |
| HY-108537 | L 012 (sodium salt) | 143556-24-5 | Dye Reagents |
| HY-108538 | Ethacrynic acid D5 | 1330052-59-9 | Reference compound |
| HY-108539 | CE3F4 | 143703-25-7 | Reference compound |
| HY-108539A | (R)-CE3F4 | 1593478-56-8 | Reference compound |
| HY-108540 | BCH | 20448-79-7 | Reference compound |
| HY-108541 | N2-Methyl-L-arginine | 2480-28-6 | Reference compound |
| HY-108543 | NSC 95397 | 93718-83-3 | Reference compound |
| HY-108544 | INCA-6 | 3519-82-2 | Reference compound |
| HY-108546 | L-AP3 | 23052-80-4 | Reference compound |
| HY-108547 | Alexidine (dihydrochloride) | 1715-30-6 | Reference compound |
| HY-108548 | Rp-8-Br-PET-cGMPS (sodium) | 185246-32-6 | Reference compound |
| HY-108549 | clasto-Lactacystin β-lactone | 154226-60-5 | Natural Products |
| HY-108551 | MG-262 | 179324-22-2 | Reference compound |
| HY-108552 | MG-115 | 133407-86-0 | Reference compound |
| HY-108553 | Dihydroeponemycin | 126463-64-7 | Reference compound |
| HY-108554 | Q94 (hydrochloride) | 1052076-77-3 | Reference compound |
| HY-108555 | FR-171113 | 173904-50-2 | Reference compound |
| HY-108556 | RWJ-56110 | 252889-88-6 | Reference compound |
| HY-108556A | RWJ-56110 (dihydrochloride) | 2387505-58-8 | Reference compound |
| HY-108557 | TCS 2510 | 346673-06-1 | Reference compound |
| HY-108559 | L-161982 | 147776-06-5 | Reference compound |
| HY-108560 | (+)-Fluprostenol | 54276-17-4 | Reference compound |
| HY-108560A | 15(S)-Fluprostenol | 54276-24-3 | Reference compound |
| HY-108560R | (+)-Fluprostenol (Standard) | 54276-17-4 | Reference Standards |
| HY-108561 | L-670596 | 121083-05-4 | Reference compound |
| HY-108562 | SC-51322 | 146032-79-3 | Reference compound |
| HY-108563 | SC 51089 | 146033-02-5 | Reference compound |
| HY-108563A | SC 51089 (free base) | 146033-03-6 | Reference compound |
| HY-108564 | L 655240 | 103253-15-2 | Reference compound |
| HY-108565 | BMY 45778 | 152575-66-1 | Reference compound |
| HY-108566 | U-46619 | 56985-40-1 | Reference compound |
| HY-108567 | Bisphenol A diglycidyl ether | 1675-54-3 | Biochemical Assay Reagents |
| HY-108567R | Bisphenol A diglycidyl ether (Standard) | 1675-54-3 | Reference Standards |
| HY-108567S1 | 2,2-Bis(4-glycidyloxyphenyl)propane-d6 | 1346600-09-6 | Isotope-Labeled Compounds |
| HY-108568 | 15-Deoxy-Δ-12,14-prostaglandin J2 | 87893-55-8 | Natural Products |
| HY-108568R | 15-Deoxy-Δ-12,14-prostaglandin J2 (Standard) | 87893-55-8 | Reference Standards |
| HY-108568S | 15-Deoxy-Δ-12,14-prostaglandin J2-d4 | 1542166-82-4 | Isotope-Labeled Compounds |
| HY-108569 | nTZDpa | 118414-59-8 | Reference compound |
| HY-10857 | Vipadenant | 442908-10-3 | Reference compound |
| HY-108570 | AUDA | 479413-70-2 | Reference compound |
| HY-108571 | CP-775146 | 702680-17-9 | Reference compound |
| HY-108572 | S26948 | 353280-43-0 | Reference compound |
| HY-108573 | P-1075 | 60559-98-0 | Reference compound |
| HY-108574 | CP 339818 (hydrochloride) | 478341-55-8 | Reference compound |
| HY-108575 | Chromanol 293B | 163163-23-3 | Reference compound |
| HY-108576 | Linopirdine (dihydrochloride) | 113168-57-3 | Reference compound |
| HY-108577 | XE991 dihydrochloride | 122955-13-9 | Reference compound |
| HY-108577A | XE991 | 122955-42-4 | Reference compound |
| HY-108578 | RuBi-4AP | 851956-02-0 | Reference compound |
| HY-108579 | UCL 1684 (dibromide) | 199934-16-2 | Reference compound |
| HY-10858 | WAY 316606 | 915759-45-4 | Reference compound |
| HY-108582 | Y-27152 | 127408-30-4 | Reference compound |
| HY-108583 | Psora-4 | 724709-68-6 | Reference compound |
| HY-108584 | Flindokalner | 187523-35-9 | Reference compound |
| HY-108585 | VU591 hydrochloride | 1315380-70-1 | Reference compound |
| HY-108585A | VU591 | 1222810-74-3 | Reference compound |
| HY-108586 | NS3623 | 343630-41-1 | Reference compound |
| HY-108587 | ICA 110381 | 325457-99-6 | Reference compound |
| HY-108588 | NS5806 | 426834-69-7 | Reference compound |
| HY-108589 | PNU 37883 (hydrochloride) | 57568-80-6 | Reference compound |
| HY-10858A | WAY 316606 (hydrochloride) | 1781835-02-6 | Reference compound |
| HY-108590 | DMP-543 | 160588-45-4 | Reference compound |
| HY-108591 | L-364,373 | 103342-82-1 | Reference compound |
| HY-108592 | UCL 2077 | 918311-87-2 | Reference compound |
| HY-108593 | BMS-191011 | 202821-81-6 | Reference compound |
| HY-108594 | PD-118057 | 313674-97-4 | Reference compound |
| HY-108595 | VU590 | 313505-85-0 | Reference compound |
| HY-108596 | BL-1249 | 18200-13-0 | Reference compound |
| HY-108597 | TC-S 7005 | 1082739-92-1 | Reference compound |
| HY-108599 | DCP-LA | 28399-31-7 | Reference compound |
| HY-108599A | DCPLA-ME | 56687-67-3 | Reference compound |
| HY-108599R | DCP-LA (Standard) | 28399-31-7 | Reference Standards |
| HY-108600 | CGP-53353 | 145915-60-2 | Reference compound |
| HY-108601 | (S)-Ro 32-0432 (free base) | 151342-35-7 | Reference compound |
| HY-108601A | (S)-Ro 32-0432 | 1781828-85-0 | Reference compound |
| HY-108602 | Bryostatin 3 | 143370-84-7 | Reference compound |
| HY-108603 | Bryostatin 2 | 87745-28-6 | Natural Products |
| HY-108604 | Bisindolylmaleimide II | 137592-45-1 | Reference compound |
| HY-108605 | PIM1-IN-2 | 477845-12-8 | Reference compound |
| HY-108606 | PI-828 | 942289-87-4 | Reference compound |
| HY-108607 | PACOCF3 | 141022-99-3 | Reference compound |
| HY-108608 | o-3M3FBS | 313981-55-4 | Reference compound |
| HY-108609 | YM-26734 | 144337-18-8 | Reference compound |
| HY-10861 | D3/5-HT receptor modulator-1 | 898532-85-9 | Reference compound |
| HY-108610 | (R)-Edelfosine | 77286-66-9 | Reference compound |
| HY-108610A | Edelfosine | 70641-51-9 | Reference compound |
| HY-108611 | AACOCF3 | 149301-79-1 | Reference compound |
| HY-108612 | VU0155069 | 1130067-06-9 | Reference compound |
| HY-108612A | VU0155069 (hydrochloride) | 1781834-89-6 | Reference compound |
| HY-108613 | JJKK 048 | 1515855-97-6 | Reference compound |
| HY-108614 | GPi688 | 918902-32-6 | Reference compound |
| HY-108615 | CP-316819 | 186392-43-8 | Reference compound |
| HY-108616 | VU 0364739 (hydrochloride) | 1244640-48-9 | Reference compound |
| HY-108617 | YM976 | 191219-80-4 | Reference compound |
| HY-108618 | BC11-38 | 686770-80-9 | Reference compound |
| HY-108619 | Gisadenafil (besylate) | 334827-98-4 | Reference compound |
| HY-10862 | FAAH inhibitor 1 | 326866-17-5 | Reference compound |
| HY-108620 | CDP-840 | 162542-90-7 | Reference compound |
| HY-108621 | RS-25344 (hydrochloride) | 152815-28-6 | Reference compound |
| HY-108622 | Mesopram | 189940-24-7 | Reference compound |
| HY-108623 | Atizoram | 135637-46-6 | Reference compound |
| HY-108624 | CYM 50769 | 1421365-63-0 | Reference compound |
| HY-108625 | SHA 68 | 847553-89-3 | Reference compound |
| HY-108626 | ML154 | 1345964-89-7 | Reference compound |
| HY-108627 | DMPQ (dihydrochloride) | 1123491-15-5 | Reference compound |
| HY-108628 | SU16f | 251356-45-3 | Reference compound |
| HY-10863 | Anandamide | 94421-68-8 | Natural Products |
| HY-108630 | U-73343 | 142878-12-4 | Reference compound |
| HY-108631 | EB-47 (dihydrochloride) | 1190332-25-2 | Reference compound |
| HY-108632 | BYK204165 | 1104546-89-5 | Reference compound |
| HY-108633 | BYK 49187 | 163120-31-8 | Reference compound |
| HY-108634 | Apafant | 105219-56-5 | Reference compound |
| HY-108635 | C16-PAF | 74389-68-7 | Reference compound |
| HY-108636 | RETRA | 1036069-26-7 | Reference compound |
| HY-108637 | PhiKan 083 | 880813-36-5 | Reference compound |
| HY-108637A | PhiKan 083 hydrochloride | 1050480-30-2 | Reference compound |
| HY-108638 | NSC 146109 (hydrochloride) | 59474-01-0 | Reference compound |
| HY-108639 | MIRA-1 | 72835-26-8 | Reference compound |
| HY-10863S | Anandamide-d8 | 924894-98-4 | Isotope-Labeled Compounds |
| HY-10863S1 | Anandamide-d11 | 2260669-86-9 | Isotope-Labeled Compounds |
| HY-10864 | URB-597 | 546141-08-6 | Reference compound |
| HY-108640 | HLI373 | 502137-98-6 | Reference compound |
| HY-108640A | HLI373 (dihydrochloride) | 1782531-99-0 | Reference compound |
| HY-108641 | SKF-86002 (dihydrochloride) | 116339-68-5 | Reference compound |
| HY-108642 | AMG-548 | 864249-60-5 | Reference compound |
| HY-108642A | AMG-548 (hydrochloride) | 2437438-16-7 | Reference compound |
| HY-108642B | AMG-548 (dihydrochloride) | 2518299-32-4 | Reference compound |
| HY-108643 | CMPD1 | 41179-33-3 | Reference compound |
| HY-108644 | SB 706504 | 911110-38-8 | Reference compound |
| HY-108645 | AL 8697 | 1057394-06-5 | Reference compound |
| HY-108646 | SX 011 | 309913-42-6 | Reference compound |
| HY-108647 | EO 1428 | 321351-00-2 | Reference compound |
| HY-108648 | 2-MeS-ADP (trisodium) | 475193-31-8 | Reference compound |
| HY-108648A | 2-MeSADP | 34983-48-7 | Reference compound |
| HY-108649A | MRS2768 (tetrasodium salt) | 2567869-47-8 | Reference compound |
| HY-10865 | LY2183240 | 874902-19-9 | Reference compound |
| HY-108650 | 2-Thio-UTP (tetrasodium) | 1343364-70-4 | Reference compound |
| HY-108651 | Uridine-5'-O-(3-thiotriphosphate) (trisodium) | 1266569-94-1 | Reference compound |
| HY-108652 | α,β-Methylene-ATP (trisodium) | 1343364-54-4 | Reference compound |
| HY-108654 | PSB 0474 | 917567-60-3 | Reference compound |
| HY-108656 | MRS2365 | 436847-09-5 | Reference compound |
| HY-108656A | MRS2365 (trisodium) | Reference compound | |
| HY-108657 | MRS2279 | 367909-40-8 | Reference compound |
| HY-108657A | MRS2279 (diammonium) | 2387505-47-5 | Reference compound |
| HY-108658 | MRS2500 (tetraammonium) | 630103-23-0 | Reference compound |
| HY-108659 | NF340 | 202982-98-7 | Reference compound |
| HY-108660 | PSB-0739 | 1052087-90-7 | Reference compound |
| HY-108661 | NF546 | 1006028-37-0 | Reference compound |
| HY-108661A | NF546 (hydrate) | Reference compound | |
| HY-108662 | PIT | 56583-49-4 | Reference compound |
| HY-108663 | 5-OMe-UDP | 1207530-98-0 | Reference compound |
| HY-108664 | MRS2957 | 1228271-30-4 | Reference compound |
| HY-108665 | AR-C66096 (tetrasodium) | 145782-74-7 | Reference compound |
| HY-108666 | ATPγS (tetralithium salt) | 93839-89-5 | Reference compound |
| HY-108667 | TNP-ATP (triethylammonium) | 61368-63-6 | Reference compound |
| HY-108668 | TC-P 262 | 873398-67-5 | Reference compound |
| HY-108669 | AZ10606120 (dihydrochloride) | 607378-18-7 | Reference compound |
| HY-10867 | PF-622 | 898235-65-9 | Reference compound |
| HY-108670 | AZ 11645373 | 227088-94-0 | Reference compound |
| HY-108671 | NF110 | 111150-22-2 | Reference compound |
| HY-108672 | NF157 | 104869-26-3 | Reference compound |
| HY-108673 | Ro 0437626 | 134362-79-1 | Reference compound |
| HY-108675 | PPNDS (tetrasodium) | 1021868-77-8 | Reference compound |
| HY-108676 | NF023 (hexasodium) | 104869-31-0 | Reference compound |
| HY-108677 | L-368,899 hydrochloride | 160312-62-9 | Reference compound |
| HY-108678 | TC OT 39 | 479232-57-0 | Reference compound |
| HY-108679 | WAY-267464 (hydrochloride) | 1432043-31-6 | Reference compound |
| HY-108680 | Carbazeran (citrate) | 153473-94-0 | Reference compound |
| HY-108681 | 680C91 | 163239-22-3 | Reference compound |
| HY-108682 | EMPA | 680590-49-2 | Reference compound |
| HY-108683 | ACT-335827 | 1354039-86-3 | Reference compound |
| HY-108685 | Alendronate sodium | 129318-43-0 | Reference compound |
| HY-108685S | Alendronate-d4 (sodium) | 1309283-09-7 | Isotope-Labeled Compounds |
| HY-108688 | GSK2033 | 1221277-90-2 | Reference compound |
| HY-108689 | Broflanilide | 1207727-04-5 | Reference compound |
| HY-108689R | Broflanilide (Standard) | 1207727-04-5 | Reference Standards |
| HY-10869 | OL-135 | 681135-77-3 | Reference compound |
| HY-108690 | Fluxametamide | 928783-29-3 | Reference compound |
| HY-108691 | PF-06465469 | 1407966-77-1 | Reference compound |
| HY-108692 | Enterolactone | 78473-71-9 | Natural Products |
| HY-108692R | Enterolactone (Standard) | 78473-71-9 | Reference Standards |
| HY-108692S | Enterolactone-d6 | 104411-11-2 | Isotope-Labeled Compounds |
| HY-108693 | β-Tocotrienol | 490-23-3 | Reference compound |
| HY-108693R | β-Tocotrienol (Standard) | 490-23-3 | Reference Standards |
| HY-108694 | γ-Tocotrienol | 14101-61-2 | Natural Products |
| HY-108694R | γ-Tocotrienol (Standard) | 14101-61-2 | Reference Standards |
| HY-108695 | Enterodiol | 80226-00-2 | Reference compound |
| HY-108695B | (±)-Enterodiol | 77756-22-0 | Natural Products |
| HY-108695BR | (±)-Enterodiol (Standard) | 77756-22-0 | Reference Standards |
| HY-108696 | GNE-781 | 1936422-33-1 | Reference compound |
| HY-108697 | PT2399 | 1672662-14-4 | Reference compound |
| HY-108697A | (Rac)-PT2399 | 1672662-07-5 | Reference compound |
| HY-108698 | Preclamol (hydrochloride) | 88768-67-6 | Reference compound |
| HY-108698A | (R)-Preclamol (hydrochloride) | 89874-80-6 | Reference compound |
| HY-108699 | TM-N1324 | 1144477-35-9 | Reference compound |
| HY-10870 | RO-9187 | 876708-03-1 | Reference compound |
| HY-108700 | N-3-Oxo-octanoyl-L-homoserine lactone | 147795-39-9 | Reference compound |
| HY-108701 | Nampt-IN-3 | 2121591-52-2 | Reference compound |
| HY-108702 | ML-792 | 1644342-14-2 | Reference compound |
| HY-108703 | Foliglurax | 1883329-51-8 | Reference compound |
| HY-108703A | Foliglurax (monohydrochloride) | 2133294-96-7 | Reference compound |
| HY-108704 | CT-721 | 1388710-60-8 | Reference compound |
| HY-108705 | BI-3802 | 2166387-65-9 | Reference compound |
| HY-108706 | KDM2A/7A-IN-1 | 2169272-46-0 | Reference compound |
| HY-108707 | LY3130481 | 1610802-47-5 | Reference compound |
| HY-108708 | GeA-69 | 2143475-98-1 | Reference compound |
| HY-108709 | CC-671 | 1618658-88-0 | Reference compound |
| HY-10871 | Otenabant | 686344-29-6 | Reference compound |
| HY-108710 | VU0650786 | 1809085-30-0 | Reference compound |
| HY-108711 | GPR120 Agonist 1 | 1628448-77-0 | Reference compound |
| HY-108712 | TDCPP | 13674-87-8 | Reference compound |
| HY-108712R | TDCPP (Standard) | 13674-87-8 | Reference Standards |
| HY-108713 | Famitinib | 1044040-56-3 | Reference compound |
| HY-108713A | Famitinib (malate) | 1256377-67-9 | Reference compound |
| HY-108713R | Famitinib (Standard) | 1044040-56-3 | Reference Standards |
| HY-108714 | NGP555 | 1304630-27-0 | Reference compound |
| HY-108715 | Real Thiol | 2280796-90-7 | Dye Reagents |
| HY-108715A | RT-AM | 2280796-94-1 | Dye Reagents |
| HY-108716 | Felezonexor | 1076235-04-5 | Reference compound |
| HY-108717 | Proteinase K | 39450-01-6 | Reference compound |
| HY-108717A | Recombinant Proteinase K (DNase & RNase free, animal free) | 39450-01-6 | Enzyme |
| HY-108717B | Proteinase K (NGS grade) | 39450-01-6 | Enzyme |
| HY-108718 | G-418 | 49863-47-0 | Reference compound |
| HY-108719 | Insulin glargine | 160337-95-1 | Peptides |
| HY-10871A | Otenabant (Hydrochloride) | 686347-12-6 | Reference compound |
| HY-10873 | N-Desethyl Sunitinib | 356068-97-8 | Reference compound |
| HY-108730 | Avelumab | 1537032-82-8 | Inhibitory Antibodies |
| HY-108730A | Avelumab (anti-PD-L1) | 1537032-82-8 | Inhibitory Antibodies |
| HY-108738 | Daclizumab | 152923-56-3 | Inhibitory Antibodies |
| HY-108739 | Idarucizumab | 1362509-93-0 | Inhibitory Antibodies |
| HY-10873R | N-Desethyl Sunitinib (Standard) | 356068-97-8 | Reference Standards |
| HY-10873S | N-Desethyl Sunitinib-d5 | 1217247-62-5 | Isotope-Labeled Compounds |
| HY-10873S1 | N-Desethyl Sunitinib-d4 (TFA) | 2012601-57-7 | Isotope-Labeled Compounds |
| HY-10873S2 | N-Desethyl Sunitinib-d5 (hydrochloride) | 1261432-14-7 | Isotope-Labeled Compounds |
| HY-108741 | Plecanatide | 467426-54-6 | Peptides |
| HY-108741A | Plecanatide (acetate) | 1075732-84-1 | Peptides |
| HY-108742 | Abaloparatide | 247062-33-5 | Peptides |
| HY-108742A | Abaloparatide (TFA) | Peptides | |
| HY-108743 | Insulin degludec | 844439-96-9 | Peptides |
| HY-108746 | Defibrotide (sodium) | 83712-60-1 | Oligonucleotides |
| HY-108749 | Olive oil | 8001-25-0 | Biochemical Assay Reagents |
| HY-10875 | LRRK2-IN-1 | 1234480-84-2 | Reference compound |
| HY-108750 | Soybean oil | 8001-22-7 | Biochemical Assay Reagents |
| HY-108751 | Aripiprazole Lauroxil | 1259305-29-7 | Reference compound |
| HY-108753 | Eteplirsen | 1173755-55-9 | Oligonucleotides |
| HY-108753A | Eteplirsen (sodium) | Oligonucleotides | |
| HY-108760 | Gadoterate meglumine | 92943-93-6 | Reference compound |
| HY-108764 | Mipomersen (sodium) | 629167-92-6 | Oligonucleotides |
| HY-108765 | Ferric carboxymaltose | 53858-86-9 | Biochemical Assay Reagents |
| HY-108766 | Ponatinib (hydrochloride) | 1114544-31-8 | Reference compound |
| HY-108767 | Insulin aspart | 116094-23-6 | Peptides |
| HY-108768 | Pasireotide (pamoate) | 396091-79-5 | Peptides |
| HY-108772 | Crofelemer | 148465-45-6 | Reference compound |
| HY-108774 | Rosuvastatin zinc salt | 953412-08-3 | Reference compound |
| HY-108775A | Sodium thiosulfate (99%, water≤1.0%) | 7772-98-7 | Biochemical Assay Reagents |
| HY-108776 | (Rac)-sn-Glycerol 3-phosphate (sodium) | 1555-56-2 | Natural Products |
| HY-108786 | Asfotase alfa | 1174277-80-5 | Inhibitory Antibodies |
| HY-108790 | Peginterferon beta-1a | 1211327-92-2 | Reference compound |
| HY-108795 | Albiglutide fragment | 224638-84-0 | Peptides |
| HY-108795A | Albiglutide fragment (TFA) | Peptides | |
| HY-108798 | Ziv-aflibercept | 1609655-49-3 | Inhibitory Antibodies |
| HY-108801 | Aflibercept | 862111-32-8 | Inhibitory Antibodies |
| HY-108801A | Aflibercept (VEGF Trap) | 862111-32-8 | Inhibitory Antibodies |
| HY-108807 | Glucarpidase | 1622456-55-6 | Enzyme |
| HY-108810 | Canakinumab | 914613-48-2 | Inhibitory Antibodies |
| HY-108813 | Belatacept | 706808-37-9 | Inhibitory Antibodies |
| HY-108814 | Ecallantide | 460738-38-9 | Peptides |
| HY-108814A | Ecallantide (TFA) | Peptides | |
| HY-108817 | HIV-1 integrase inhibitor 3 | 1638504-56-9 | Reference compound |
| HY-108818 | XZ426 | 1638504-52-5 | Reference compound |
| HY-10882 | Clotrimazole | 23593-75-1 | Reference compound |
| HY-108820 | HIV-1 integrase inhibitor 4 | 1638504-66-1 | Reference compound |
| HY-108822 | Rilonacept | 501081-76-1 | Inhibitory Antibodies |
| HY-108826 | Iduronate sulfatase | 50936-59-9 | Enzyme |
| HY-108829 | Abatacept | 332348-12-6 | Inhibitory Antibodies |
| HY-108829A | Abatacept (powder) | 332348-12-6 | Inhibitory Antibodies |
| HY-10882R | Clotrimazole (Standard) | 23593-75-1 | Reference Standards |
| HY-10882S | Clotrimazole-d5 | 1185076-41-8 | Isotope-Labeled Compounds |
| HY-10882S1 | Clotrimazole-d10 | Isotope-Labeled Compounds | |
| HY-108830 | Galsulfase | 552858-79-4 | Biochemical Assay Reagents |
| HY-108831 | Natalizumab | 189261-10-7 | Inhibitory Antibodies |
| HY-108831A | Natalizumab (Solution) | 189261-10-7 | Inhibitory Antibodies |
| HY-108841 | Raleukin | 143090-92-0 | Inhibitory Antibodies |
| HY-108844 | Rasburicase | 134774-45-1 | Reference compound |
| HY-108845 | Tenecteplase | 191588-94-0 | Enzyme |
| HY-108847 | Etanercept | 185243-69-0 | Inhibitory Antibodies |
| HY-10885 | A-620223 (succinate) | 943650-25-7 | Reference compound |
| HY-108852 | Basiliximab | 179045-86-4 | Inhibitory Antibodies |
| HY-108858 | Dornase alfa | 143831-71-4 | Enzyme |
| HY-10886 | MCOPPB | 1028969-49-4 | Reference compound |
| HY-108860 | Oncaspar | 130167-69-0 | Inhibitory Antibodies |
| HY-108865 | Alteplase | 105857-23-6 | Enzyme |
| HY-108868 | Mersalyl | 492-18-2 | Reference compound |
| HY-108869 | Fodipir | 118248-91-2 | Reference compound |
| HY-108869R | Fodipir (Standard) | 118248-91-2 | Reference Standards |
| HY-108872S | Water-18O | 14314-42-2 | Isotope-Labeled Compounds |
| HY-108872S1 | Water-17O | 13768-40-6 | Isotope-Labeled Compounds |
| HY-108874 | Candicidin | 1403-17-4 | Natural Products |
| HY-108875 | Erythromycin stearate | 643-22-1 | Reference compound |
| HY-108876 | Daunorubicin (citrate) | 1884557-85-0 | ADC Related |
| HY-108877 | Cefepime (hydrochloride) | 107648-80-6 | Reference compound |
| HY-108879 | Cefotetan (disodium) | 74356-00-6 | Reference compound |
| HY-10888 | Istradefylline | 155270-99-8 | Reference compound |
| HY-108880 | Carindacillin (sodium) | 26605-69-6 | Reference compound |
| HY-108881 | Troleandomycin | 2751-09-9 | Reference compound |
| HY-108881R | Troleandomycin (Standard) | 2751-09-9 | Reference Standards |
| HY-108882 | DNase I, Bovine pancreas | 9003-98-9 | Enzyme |
| HY-108882A | Recombinant DNase I (RNase-free) | 9003-98-9 | Enzyme |
| HY-108882B | DNase I (RNase & Protease free) | 9003-98-9 | Enzyme |
| HY-108882C | DNase I (filtered) | 9003-98-9 | Enzyme |
| HY-108882D | Recombinant DNase I (Protease & RNase free, animal free) | 9003-98-9 | Enzyme |
| HY-108883 | Plasmin, Human plasma | 9001-90-5 | Enzyme |
| HY-108886 | JWG-071 | 2250323-50-1 | Reference compound |
| HY-108887 | Anticancer agent 124 | 1884226-20-3 | Reference compound |
| HY-10888R | Istradefylline (Standard) | 155270-99-8 | Reference Standards |
| HY-10888S | Istradefylline-13C,d3 | 2749234-46-4 | Isotope-Labeled Compounds |
| HY-10889 | Preladenant | 377727-87-2 | Reference compound |
| HY-108896 | Icatibant (acetate) | 138614-30-9 | Peptides |
| HY-108900 | Leu-AMS | 288591-93-5 | Reference compound |
| HY-108900A | Leu-AMS R enantiomer | Reference compound | |
| HY-108901 | Formoterol (hemifumarate hydrate) | 183814-30-4 | Reference compound |
| HY-108901R | Formoterol (hemifumarate hydrate) (Standard) | 183814-30-4 | Reference Standards |
| HY-108903 | Hyaluronidase (human recombinant) | 37326-33-3 | Enzyme |
| HY-108903A | Hyaluronidase, Ovine testes | 37326-33-3 | Enzyme |
| HY-108904 | Urokinase, Human urine | 9039-53-6 | Enzyme |
| HY-108905 | Mecasermin | 68562-41-4 | Peptides |
| HY-108907 | SR-1277 | 1446715-47-4 | Reference compound |
| HY-108908 | (Rac)-Modipafant | 122956-68-7 | Reference compound |
| HY-108908A | Modipafant | 122957-06-6 | Reference compound |
| HY-108909 | Chymopapain | 9001-09-6 | Enzyme |
| HY-10891 | HIV-1 inhibitor-61 | 1114507-62-8 | Reference compound |
| HY-108910 | Chymotrypsin | 9004-07-3 | Enzyme |
| HY-108910A | Chymotrypsin (MS grade) | 9004-07-3 | Enzyme |
| HY-108910B | TLCK-treated Chymotrypsin | 9004-07-3 | Enzyme |
| HY-108910C | Chymotrypsin, Human Pancreas | 9004-07-3 | Enzyme |
| HY-108912 | RO1138452 | 221529-58-4 | Reference compound |
| HY-108913 | Nitrocefin | 41906-86-9 | Reference compound |
| HY-108913R | Nitrocefin (Standard) | 41906-86-9 | Reference Standards |
| HY-108915 | Trimethylamine N-oxide (dihydrate) | 62637-93-8 | Natural Products |
| HY-108917 | Morphothiadin | 1092970-12-1 | Reference compound |
| HY-108917A | Morphothiadin (mesylate) | 1646361-04-7 | Reference compound |
| HY-10892 | HEPT | 123027-56-5 | Reference compound |
| HY-108920 | 4-Chlorokynurenine | 153152-32-0 | Reference compound |
| HY-108922 | Probucol disuccinate | 216168-45-5 | Reference compound |
| HY-108931 | AG 1406 | 71308-34-4 | Reference compound |
| HY-108932 | Gemcitabine monophosphate | 116371-67-6 | Reference compound |
| HY-108932A | Gemcitabine monophosphate (disodium) | 1638288-31-9 | Reference compound |
| HY-108933 | JK-P3 | 942655-44-9 | Reference compound |
| HY-108935 | Lavendustin B | 125697-91-8 | Reference compound |
| HY-108936 | QCC374 | 1356331-63-9 | Reference compound |
| HY-108937 | NSC 15364 | 4550-72-5 | Reference compound |
| HY-108938 | SDZ285428 | 174262-13-6 | Reference compound |
| HY-108939 | Aminoacyl tRNA synthetase-IN-1 | 219931-45-0 | Reference compound |
| HY-108940 | GlyRS-IN-1 | 112921-11-6 | Reference compound |
| HY-108941 | Salicyl-AMS | 863238-55-5 | Reference compound |
| HY-108943 | Sabinene | 3387-41-5 | Natural Products |
| HY-108944 | LYP-IN-1 | 1404436-51-6 | Reference compound |
| HY-10895 | SB-334867 | 249889-64-3 | Reference compound |
| HY-108952 | 17,17-(Ethylenedioxy)androst-4-en-3-one | 1044-89-9 | Reference compound |
| HY-108953 | (S)-Quinolactacine A | 319917-25-4 | Natural Products |
| HY-108954 | A-30912A nucleus (hydrochloride) | 1029890-89-8 | Peptides |
| HY-108958 | (Rac)-AZD8186 | 1296270-45-5 | Reference compound |
| HY-108959 | D-87503 | 800394-83-6 | Reference compound |
| HY-10895A | SB-334867 (free base) | 792173-99-0 | Reference compound |
| HY-10896 | JNJ-10397049 | 708275-58-5 | Reference compound |
| HY-108960 | PPADS | 149017-66-3 | Reference compound |
| HY-108963 | LY 170198 | 99682-33-4 | Reference compound |
| HY-108964 | Carvone | 99-49-0 | Natural Products |
| HY-108964R | Carvone (Standard) | 99-49-0 | Reference Standards |
| HY-108966 | Kushenol C | 99119-73-0 | Natural Products |
| HY-108968 | Alitame (hydrate) | 99016-42-9 | Reference compound |
| HY-108968R | Alitame (hydrate) (Standard) | 99016-42-9 | Reference Standards |
| HY-108969 | Pyrazoloacridine | 99009-20-8 | Reference compound |
| HY-108970 | Bafilomycin D | 98813-13-9 | Natural Products |
| HY-108971 | Demecycline | 987-02-0 | Reference compound |
| HY-108971R | Demecycline (Standard) | 987-02-0 | Reference Standards |
| HY-108972 | SQ 29548 | 98672-91-4 | Reference compound |
| HY-108973 | CGP 15210G | 98518-48-0 | Reference compound |
| HY-108974 | Drotaverine (hydrochloride) | 985-12-6 | Reference compound |
| HY-108974S | Drotaverine-d10 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-108976 | Raclopride (tartrate) | 98185-20-7 | Reference compound |
| HY-108977 | VUF 8430 | 98021-17-1 | Reference compound |
| HY-10898 | SB-674042 | 483313-22-0 | Reference compound |
| HY-108981 | CERM11956 | 97631-49-7 | Reference compound |
| HY-108984 | BBMP | 97120-13-3 | Reference compound |
| HY-108985 | Trazium esilate | 97110-59-3 | Reference compound |
| HY-108986 | JFD00244 | 96969-83-4 | Reference compound |
| HY-108987 | 1-O-hexadecyl-2-O-methyl-sn-glycerol | 96960-92-8 | Biochemical Assay Reagents |
| HY-108988 | Albicidin | 1622253-00-2 | Reference compound |
| HY-108989 | FMDP | 96920-07-9 | Reference compound |
| HY-108991 | T-0509 | 96843-99-1 | Reference compound |
| HY-108992 | Deoxynyboquinone | 96748-86-6 | Reference compound |
| HY-108993 | Fujianmycin B | 130548-09-3 | Reference compound |
| HY-108996 | PD 118879 | 96568-33-1 | Reference compound |
| HY-108997 | Palonidipine | 96515-73-0 | Reference compound |
| HY-108997A | Palonidipine (hydrochloride) | 96515-74-1 | Reference compound |
| HY-108998 | Bisaramil (hydrochloride) | 96480-44-3 | Reference compound |
| HY-108999 | Crisnatol (mesylate) | 96389-69-4 | Reference compound |
| HY-108999A | Crisnatol | 96389-68-3 | Reference compound |
| HY-10900 | TCS 1102 | 916141-36-1 | Reference compound |
| HY-109000 | Afabicin | 1518800-35-5 | Reference compound |
| HY-109000A | Afabicin (disodium) | 1518800-29-7 | Reference compound |
| HY-109001 | Alicapistat | 1254698-46-8 | Reference compound |
| HY-109001A | (1S,2R)-Alicapistat | 2221010-57-5 | Reference compound |
| HY-109002 | Apararenone | 945966-46-1 | Reference compound |
| HY-109004 | Enzaplatovir | 1323077-89-9 | Reference compound |
| HY-109004A | (S)-Enzaplatovir | 1323077-88-8 | Reference compound |
| HY-109006 | Ilmetropium (iodide) | 129109-88-2 | Reference compound |
| HY-109008 | Nacubactam | 1452458-86-4 | Reference compound |
| HY-109009 | Padsevonil | 1294000-61-5 | Reference compound |
| HY-109010 | Poseltinib | 1353552-97-2 | Reference compound |
| HY-109011 | Rosiptor | 782487-28-9 | Reference compound |
| HY-109011A | Rosiptor (acetate) | 782487-29-0 | Reference compound |
| HY-109012 | Seltorexant | 1293281-49-8 | Reference compound |
| HY-109012A | Seltorexant (hydrochloride) | 1293284-49-7 | Reference compound |
| HY-109013 | Sofpironium (bromide) | 1628106-94-4 | Reference compound |
| HY-109014 | Tenofovir exalidex | 911208-73-6 | Reference compound |
| HY-109015 | Tucidinostat | 1616493-44-7 | Reference compound |
| HY-109015S | Tucidinostat-d4 | Isotope-Labeled Compounds | |
| HY-109016 | Valnivudine | 956483-02-6 | Reference compound |
| HY-109017 | Vamorolone | 13209-41-1 | Reference compound |
| HY-109018 | Velagliflozin | 946525-65-1 | Reference compound |
| HY-109018A | Velagliflozin (proline) | 1539295-26-5 | Reference compound |
| HY-109018B | Velagliflozin (proline hydrate) | 1661838-94-3 | Reference compound |
| HY-109019 | Vorolanib | 1013920-15-4 | Reference compound |
| HY-109020 | Acrizanib | 1229453-99-9 | Reference compound |
| HY-109022 | Atogepant | 1374248-81-3 | Reference compound |
| HY-109022A | (3R,5R,6S)-Atogepant | Reference compound | |
| HY-109023 | Azeloprazole | 955095-45-1 | Reference compound |
| HY-109024 | Balovaptan | 1228088-30-9 | Reference compound |
| HY-109025 | Baloxavir marboxil | 1985606-14-1 | Reference compound |
| HY-109025A | Baloxavir | 1985605-59-1 | Reference compound |
| HY-109025AR | Baloxavir (Standard) | 1985605-59-1 | Reference Standards |
| HY-109025AS | Baloxavir-d5 | Isotope-Labeled Compounds | |
| HY-109025R | Baloxavir marboxil (Standard) | 1985606-14-1 | Reference Standards |
| HY-109027 | Cavosonstat | 1371587-51-7 | Reference compound |
| HY-109029 | Dezapelisib | 1262440-25-4 | Reference compound |
| HY-109030 | Dorzagliatin | 1191995-00-2 | Reference compound |
| HY-109030R | Dorzagliatin (Standard) | 1191995-00-2 | Reference Standards |
| HY-109032 | Firuglipel | 1371591-51-3 | Reference compound |
| HY-109033 | Fosmetpantotenate | 1858268-66-2 | Reference compound |
| HY-109035 | Inarigivir soproxil | 942123-43-5 | Reference compound |
| HY-109036 | Landipirdine | 1000308-25-7 | Reference compound |
| HY-109036A | (S)-Landipirdine | 1000308-09-7 | Reference compound |
| HY-109037 | Mavacamten | 1642288-47-8 | Reference compound |
| HY-109037R | Mavacamten (Standard) | 1642288-47-8 | Reference Standards |
| HY-109037S | Mavacamten-d6 | 2453251-18-6 | Isotope-Labeled Compounds |
| HY-109037S2 | Mavacamten-d1 | 2453251-02-8 | Isotope-Labeled Compounds |
| HY-109037S3 | Mavacamten-d5 | 2453251-00-6 | Isotope-Labeled Compounds |
| HY-109037S4 | Mavacamten-d7 | Isotope-Labeled Compounds | |
| HY-109038 | Mocravimod | 509092-16-4 | Reference compound |
| HY-109039 | Praliciguat | 1628730-49-3 | Reference compound |
| HY-109040 | Quilseconazole | 1340593-70-5 | Reference compound |
| HY-109041 | Razuprotafib | 1008510-37-9 | Reference compound |
| HY-109042 | Relacorilant | 1496510-51-0 | Reference compound |
| HY-109044 | Tapinarof | 79338-84-4 | Reference compound |
| HY-109044R | Tapinarof (Standard) | 79338-84-4 | Reference Standards |
| HY-109044S | Tapinarof-d5 | 2748997-80-8 | Isotope-Labeled Compounds |
| HY-109045 | Teslexivir | 1075798-37-6 | Reference compound |
| HY-109045A | Teslexivir (hydrochloride) | 1075281-70-7 | Reference compound |
| HY-109046 | Tulrampator | 1038984-31-4 | Reference compound |
| HY-109047 | Adafosbuvir | 1613589-09-5 | Reference compound |
| HY-109049 | Adavivint | 1467093-03-3 | Reference compound |
| HY-109050 | Alobresib | 1637771-14-2 | Reference compound |
| HY-109051 | Arfolitixorin | 31690-11-6 | Natural Products |
| HY-109051A | Arfolitixorin (calcium) | 1148151-21-6 | Reference compound |
| HY-109051C | Arfolitixorin (sulfate) | 149930-93-8 | Reference compound |
| HY-109052 | Atabecestat | 1200493-78-2 | Reference compound |
| HY-109053 | Delgocitinib | 1263774-59-9 | Reference compound |
| HY-109053A | Delgocitinib (ethanolate) | 2064338-33-4 | Reference compound |
| HY-109054 | O-Demethyltramadol | 80456-81-1 | Reference compound |
| HY-109054A | O-Desmethyltramadol (hydrochloride) | 185453-02-5 | Reference compound |
| HY-109054AS | O-Desmethyltramadol-d6 (hydrochloride) | 1261393-87-6 | Isotope-Labeled Compounds |
| HY-109055 | Elenbecestat | 1388651-30-6 | Reference compound |
| HY-109056 | Elsulfavirine | 868046-19-9 | Reference compound |
| HY-109057 | Enarodustat | 1262132-81-9 | Reference compound |
| HY-109057A | Enarodustat (hydrochloride) | 1262131-60-1 | Reference compound |
| HY-109058 | Firibastat | 648927-86-0 | Reference compound |
| HY-109059 | Fulacimstat | 1488354-15-9 | Reference compound |
| HY-109060 | Garvagliptin | 1601479-87-1 | Reference compound |
| HY-109061 | Lazertinib | 1903008-80-9 | Reference compound |
| HY-109064 | Loxicodegol | 1211231-76-3 | Reference compound |
| HY-109065 | Minesapride | 1184662-54-1 | Reference compound |
| HY-109066 | Olinciguat | 1628732-62-6 | Reference compound |
| HY-109067 | Opiranserin | 1441000-45-8 | Reference compound |
| HY-109067A | Opiranserin (hydrochloride) | 1440796-75-7 | Reference compound |
| HY-109068 | Parsaclisib | 1426698-88-5 | Reference compound |
| HY-109068A | Parsaclisib (hydrochloride) | 1995889-48-9 | Reference compound |
| HY-109069 | Petesicatib | 1252637-35-6 | Reference compound |
| HY-109070 | Ralaniten | 1203490-23-6 | Reference compound |
| HY-109071 | Relmapirazin | 1313706-17-0 | Reference compound |
| HY-109072 | Riamilovir | 123606-06-4 | Reference compound |
| HY-109073 | Rovazolac | 1454288-88-0 | Reference compound |
| HY-109074 | Seliforant | 1164115-89-2 | Reference compound |
| HY-109075 | Tasipimidine | 1465908-70-6 | Reference compound |
| HY-109075A | Tasipimidine (sulfate) | 1465908-73-9 | Reference compound |
| HY-109076 | Tigilanol tiglate | 943001-56-7 | Natural Products |
| HY-109077 | Tigolaner | 1621436-41-6 | Reference compound |
| HY-109077S | Tigolaner-d4 | Isotope-Labeled Compounds | |
| HY-109078 | Vecabrutinib | 1510829-06-7 | Reference compound |
| HY-109079 | Abeprazan | 1902954-60-2 | Reference compound |
| HY-109079A | Abeprazan (hydrochloride) | 1902954-87-3 | Reference compound |
| HY-109080 | Belvarafenib | 1446113-23-0 | Reference compound |
| HY-109080A | Belvarafenib (TFA) | 2443966-84-3 | Reference compound |
| HY-109081 | Cedazuridine | 1141397-80-9 | Reference compound |
| HY-109081A | Cedazuridine (hydrochloride) | Reference compound | |
| HY-109082 | Cevidoplenib | 1703788-21-9 | Reference compound |
| HY-109082A | Cevidoplenib (dimesylate) | 2043659-93-2 | Reference compound |
| HY-109083 | Cilofexor | 1418274-28-8 | Reference compound |
| HY-109083A | Cilofexor (tromethamine) | 2253764-93-9 | Reference compound |
| HY-109084 | Conteltinib | 1384860-29-0 | Reference compound |
| HY-109084A | Conteltinib (tetrahydrochloride) | Reference compound | |
| HY-109085 | Difamilast | 937782-05-3 | Reference compound |
| HY-109085R | Difamilast (Standard) | 937782-05-3 | Reference Standards |
| HY-109086 | Edicotinib | 1142363-52-7 | Reference compound |
| HY-109086A | Edicotinib (hydrochloride) | 1559069-92-9 | Reference compound |
| HY-109087 | Elismetrep | 1400699-64-0 | Reference compound |
| HY-109089 | Epeleuton | 1667760-39-5 | Reference compound |
| HY-109089S | Epeleuton-d5 | Isotope-Labeled Compounds | |
| HY-109091 | Lanraplenib | 1800046-95-0 | Reference compound |
| HY-109091A | Lanraplenib (monosuccinate) | 1800046-97-2 | Reference compound |
| HY-109091B | Lanraplenib (succinate) | 1800047-00-0 | Reference compound |
| HY-109092 | Licogliflozin | 1291094-73-9 | Reference compound |
| HY-109092A | rel-Licogliflozin | 2730989-98-5 | Reference compound |
| HY-109093 | Linzagolix | 935283-04-8 | Reference compound |
| HY-109094 | Mosedipimod | 221139-79-3 | Reference compound |
| HY-109096 | Nidufexor | 1773489-72-7 | Reference compound |
| HY-109097 | Otaplimastat | 1176758-04-5 | Reference compound |
| HY-109098 | Parimifasor | 1796641-10-5 | Reference compound |
| HY-109099 | Pemigatinib | 1513857-77-6 | Reference compound |
| HY-109099R | Pemigatinib (Standard) | 1513857-77-6 | Reference Standards |
| HY-109101 | Risdiplam | 1825352-65-5 | Reference compound |
| HY-109101AS1 | Risdiplam-hydroxylate-d3 | Isotope-Labeled Compounds | |
| HY-109101AS2 | Risdiplam-hydroxylate-d6 | Isotope-Labeled Compounds | |
| HY-109101R | Risdiplam (Standard) | 1825352-65-5 | Reference Standards |
| HY-109101S | Risdiplam-d4 | Isotope-Labeled Compounds | |
| HY-109102 | Setafrastat | 1399715-48-0 | Natural Products |
| HY-109103 | Tegatrabetan | 1227637-23-1 | Reference compound |
| HY-109104 | Telratolimod | 1359993-59-1 | Reference compound |
| HY-109105 | Tepilamide fumarate | 1208229-58-6 | Reference compound |
| HY-109106 | Upacicalcet | 1333218-50-0 | Reference compound |
| HY-109106A | Upacicalcet (sodium) | 2052969-18-1 | Reference compound |
| HY-109106B | (Rac)-Upacicalcet | 2649575-19-7 | Reference compound |
| HY-109108 | Valemetostat | 1809336-39-7 | Reference compound |
| HY-109108A | Valemetostat (tosylate) | 1809336-93-3 | Reference compound |
| HY-109109 | Alteminostat | 1246374-97-9 | Reference compound |
| HY-109110 | Avasopasem manganese | 435327-40-5 | Reference compound |
| HY-109111 | Azelaprag | 2049980-18-7 | Reference compound |
| HY-109112 | Brilaroxazine | 1239729-06-6 | Reference compound |
| HY-109112R | Brilaroxazine (Standard) | 1239729-06-6 | Reference Standards |
| HY-109114 | Dersimelagon | 1835256-48-8 | Reference compound |
| HY-109114A | Dersimelagon (phosphate) | 2490660-87-0 | Reference compound |
| HY-109115 | Fosifloxuridine nafalbenamide | 1332837-31-6 | Reference compound |
| HY-109116 | Hydromethylthionine | 613-11-6 | Reference compound |
| HY-109116A | Hydromethylthionine (dihydrobromide) | 951131-15-0 | Reference compound |
| HY-109117 | Iadademstat | 1431304-21-0 | Reference compound |
| HY-109118 | Masupirdine (free base) | 701205-60-9 | Reference compound |
| HY-109118A | Masupirdine (mesylate) | 1791396-46-7 | Reference compound |
| HY-10912 | Fexaramine | 574013-66-4 | Reference compound |
| HY-109120 | Odevixibat | 501692-44-0 | Reference compound |
| HY-109120S | Odevixibat-d5 | Isotope-Labeled Compounds | |
| HY-109120S1 | Odevixibat-13C6 | Isotope-Labeled Compounds | |
| HY-109121 | Reldesemtiv | 1345410-31-2 | Reference compound |
| HY-109122 | Selatogrel | 1159500-34-1 | Reference compound |
| HY-109123 | Soticlestat | 1429505-03-2 | Reference compound |
| HY-109124 | Taniborbactam | 1613267-49-4 | Reference compound |
| HY-109124A | Taniborbactam (hydrochloride) | 2244235-49-0 | Reference compound |
| HY-109125A | Amcipatricin (L-aspartate) | 143563-20-6 | Reference compound |
| HY-109127 | Berotralstat | 1809010-50-1 | Reference compound |
| HY-109127A | Berotralstat (dihydrochloride) | 1809010-52-3 | Reference compound |
| HY-109127R | Berotralstat (Standard) | 1809010-50-1 | Reference Standards |
| HY-109128 | Danicamtiv | 1970972-74-7 | Reference compound |
| HY-10913 | Danegaptide | 943134-39-2 | Reference compound |
| HY-109131 | Foscarbidopa | 1907685-81-7 | Reference compound |
| HY-109133 | Pecavaptan | 1914998-56-3 | Reference compound |
| HY-109134 | Pizuglanstat | 1244967-98-3 | Reference compound |
| HY-109134A | Pizuglanstat (hydrate) | 1584160-52-0 | Reference compound |
| HY-109136 | Runcaciguat | 1402936-61-1 | Reference compound |
| HY-109137 | Selgantolimod | 2004677-13-6 | Reference compound |
| HY-109139 | Taminadenant | 1337962-47-6 | Reference compound |
| HY-109139A | Taminadenant (mesylate) | 2253894-81-2 | Reference compound |
| HY-10913A | Danegaptide Hydrochloride | 943133-81-1 | Reference compound |
| HY-10913S | Danegaptide-d5 | Isotope-Labeled Compounds | |
| HY-10914 | UCPH-101 | 1118460-77-7 | Reference compound |
| HY-109140 | Tuvatexib | 2055404-90-3 | Reference compound |
| HY-109142 | Ziresovir | 1422500-60-4 | Reference compound |
| HY-109143 | Elsubrutinib | 1643570-24-4 | Reference compound |
| HY-109143B | (R)-Elsubrutinib | 1643570-23-3 | Reference compound |
| HY-109144 | Enavogliflozin | 1415472-28-4 | Reference compound |
| HY-109146 | Imifoplatin | 1339960-28-9 | Reference compound |
| HY-109147 | Imnopitant | 290297-57-3 | Reference compound |
| HY-109147A | Imnopitant (dihydrochloride) | 290296-52-5 | Reference compound |
| HY-109148 | Izencitinib | 2051918-33-1 | Reference compound |
| HY-109149 | Lomardexamfetamine | 1032291-80-7 | Reference compound |
| HY-10915 | LUF6096 | 1116652-18-6 | Reference compound |
| HY-109150 | Mesdopetam | 1403894-72-3 | Reference compound |
| HY-109150A | Mesdopetam (hemitartrate) | 2562346-14-7 | Reference compound |
| HY-109151 | Milategrast | 859217-52-0 | Reference compound |
| HY-109152 | Navocaftor | 2159103-66-7 | Reference compound |
| HY-109153 | Nerindocianine | 748120-01-6 | Reference compound |
| HY-109154 | Obafistat | 2160582-57-8 | Reference compound |
| HY-109156 | Pregabalin arenacarbil | 1174748-30-1 | Reference compound |
| HY-109157 | Ralmitaront | 2133417-13-5 | Reference compound |
| HY-109158 | Rebamipide mofetil | 1527495-76-6 | Reference compound |
| HY-109160 | Rimtuzalcap | 2167246-24-2 | Reference compound |
| HY-109162 | Trazpiroben | 1352993-39-5 | Reference compound |
| HY-109163 | Treprostinil palmitil | 1706528-83-7 | Reference compound |
| HY-109164 | Zelquistinel | 2151842-64-5 | Reference compound |
| HY-109165 | Acoramidis | 1446711-81-4 | Reference compound |
| HY-109165A | Acoramidis (hydrochloride) | 2242751-53-5 | Reference compound |
| HY-109167 | Aramisulpride | 71675-90-6 | Reference compound |
| HY-109168 | Bersacapavir | 1638266-40-6 | Reference compound |
| HY-109169 | Bomedemstat | 1990504-34-1 | Reference compound |
| HY-109169A | Bomedemstat (ditosylate) | 1990504-72-7 | Reference compound |
| HY-109169B | Bomedemstat (hydrochloride) | Reference compound | |
| HY-109169C | Bomedemstat (dihydrochloride) | Reference compound | |
| HY-10917 | GW2580 | 870483-87-7 | Reference compound |
| HY-109170 | Eliapixant | 1948229-21-7 | Reference compound |
| HY-109171 | Elinzanetant | 929046-33-3 | Reference compound |
| HY-109171R | Elinzanetant (Standard) | 929046-33-3 | Reference Standards |
| HY-109171S | Elinzanetant-d3 | Isotope-Labeled Compounds | |
| HY-109173 | Filapixant | 1948232-63-0 | Reference compound |
| HY-109174 | Fosciclopirox | 1380539-06-9 | Reference compound |
| HY-109174A | Fosciclopirox (disodium) | 1380539-08-1 | Reference compound |
| HY-109175 | Fosifidancitinib | 1237168-58-9 | Reference compound |
| HY-109176 | Giredestrant | 1953133-47-5 | Reference compound |
| HY-109177 | Icenticaftor | 1334546-77-8 | Reference compound |
| HY-109178 | Ifidancitinib | 1236667-40-5 | Reference compound |
| HY-109179 | Itacnosertib | 1628870-27-8 | Reference compound |
| HY-109179A | Itacnosertib (hydrocholide) | 2409543-84-4 | Reference compound |
| HY-10917S | GW2580-d6 | 2733770-48-2 | Isotope-Labeled Compounds |
| HY-109181 | Lazuvapagon | 2379889-71-9 | Reference compound |
| HY-109182 | Lorpucitinib | 2230282-02-5 | Reference compound |
| HY-109183 | Luvadaxistat | 1425511-32-5 | Reference compound |
| HY-109184 | Murizatoclax | 2245848-05-7 | Reference compound |
| HY-109185 | Pelcitoclax | 1619923-36-2 | Reference compound |
| HY-109186 | Pexopiprant | 932708-14-0 | Reference compound |
| HY-109187 | Posenacaftor | 2095064-05-2 | Reference compound |
| HY-109187A | Posenacaftor (sodium) | 2095064-06-3 | Reference compound |
| HY-109187B | (R)-Posenacaftor (sodium) | 2095064-09-6 | Reference compound |
| HY-109188 | Relzomostat | 2081078-92-2 | Reference compound |
| HY-109189 | Rezivertinib | 1835667-12-3 | Reference compound |
| HY-10919 | C-1311 | 138154-39-9 | Reference compound |
| HY-109190 | Seralutinib | 1619931-27-9 | Reference compound |
| HY-109191 | Sovesudil | 1333400-14-8 | Reference compound |
| HY-109191A | Sovesudil (hydrochloride) | 2984963-50-8 | Reference compound |
| HY-109192 | Tolebrutinib | 1971920-73-6 | Reference compound |
| HY-109193 | Tovinontrine | 2062661-53-2 | Reference compound |
| HY-109194 | Udonitrectag | 1458063-04-1 | Reference compound |
| HY-109195 | Vebicorvir | 2090064-66-5 | Reference compound |
| HY-109196 | Velufenacin | 1648737-78-3 | Reference compound |
| HY-109197 | Vonafexor | 1192171-69-9 | Reference compound |
| HY-109198 | Zandelisib | 1401436-95-0 | Reference compound |
| HY-10920 | Axitinib analogue 1 | 319463-51-9 | Reference compound |
| HY-10929 | UNC0224 | 1197196-48-7 | Reference compound |
| HY-10930 | UNC0321 | 1238673-32-9 | Reference compound |
| HY-10932 | Aniracetam | 72432-10-1 | Reference compound |
| HY-10932R | Aniracetam (Standard) | 72432-10-1 | Reference Standards |
| HY-10933 | CX516 | 154235-83-3 | Reference compound |
| HY-10933S | CX516-d10 | 1286653-21-1 | Isotope-Labeled Compounds |
| HY-10934 | Mibampator | 375345-95-2 | Reference compound |
| HY-10935 | LY450108 | 376594-67-1 | Reference compound |
| HY-10936 | S 18986 | 175340-20-2 | Reference compound |
| HY-10937 | Farampator | 211735-76-1 | Reference compound |
| HY-10939 | (-)-15-Deoxyspergualin | 89149-10-0 | Reference compound |
| HY-10939A | (-)-15-Deoxyspergualin (trihydrochloride) | 84937-45-1 | Biochemical Assay Reagents |
| HY-10940 | Pifithrin-μ | 64984-31-2 | Reference compound |
| HY-10941 | VER-155008 | 1134156-31-2 | Reference compound |
| HY-10942 | VER-82576 | 847559-80-2 | Reference compound |
| HY-10943 | GNF-7 | 839706-07-9 | Reference compound |
| HY-10949 | SMER3 | 67200-34-4 | Reference compound |
| HY-109500 | Masoprocol | 27686-84-6 | Natural Products |
| HY-109502S | 10-OH-NBP-d4 | Isotope-Labeled Compounds | |
| HY-109506 | DPPC | 63-89-8 | Natural Products |
| HY-109506R | DPPC (Standard) | 63-89-8 | Reference Standards |
| HY-109506S | DPPC-d62 | 25582-63-2 | Isotope-Labeled Compounds |
| HY-109506S1 | DPPC-d9 | Isotope-Labeled Compounds | |
| HY-109506S2 | (Rac)-DPPC-d6 | 82765-17-1 | Isotope-Labeled Compounds |
| HY-109506S3 | DPPC-d9-1 | 77165-56-1 | Isotope-Labeled Compounds |
| HY-109506S4 | DPPC-d4 | 326495-33-4 | Isotope-Labeled Compounds |
| HY-109506S5 | DPPC-d13 | 86531-55-7 | Isotope-Labeled Compounds |
| HY-109506S6 | DPPC-d66 | 326495-34-5 | Isotope-Labeled Compounds |
| HY-109506S7 | DPPC-d71 | 474943-49-2 | Isotope-Labeled Compounds |
| HY-109506S8 | DPPC-d75 | 181041-62-3 | Isotope-Labeled Compounds |
| HY-109506S9 | DPPC-13C2 | 65277-91-0 | Isotope-Labeled Compounds |
| HY-109509 | Enoxaparin | 679809-58-6 | Reference compound |
| HY-109511 | AZD-1678 | 942137-41-9 | Reference compound |
| HY-109513 | Ioxilan | 107793-72-6 | Reference compound |
| HY-109513R | Ioxilan (Standard) | 107793-72-6 | Reference Standards |
| HY-109517 | Calf thymus DNA | 91080-16-9 | Natural Products |
| HY-109519 | Simethicone | 8050-81-5 | Reference compound |
| HY-109520 | Glatiramer (acetate) | 147245-92-9 | Reference compound |
| HY-109521A | Manganese chloride (tetrahydrate), molecular biology grade,≥99.0% (KT) | 13446-34-9 | Biochemical Assay Reagents |
| HY-109523 | Cerivastatin (sodium) | 143201-11-0 | Reference compound |
| HY-109523S | Cerivastatin-d3 (sodium) | 916314-45-9 | Isotope-Labeled Compounds |
| HY-109525 | Sacrosidase | 85897-35-4 | Enzyme |
| HY-109527 | 5-HT7 agonist 1 | 334974-31-1 | Reference compound |
| HY-109528 | Fomivirsen (sodium) | 160369-77-7 | Oligonucleotides |
| HY-109530 | Insulin lispro | 133107-64-9 | Reference compound |
| HY-109532 | Ganirelix (acetate) | 129311-55-3 | Reference compound |
| HY-109534 | Poly(tetrafluoroethylene) | 9002-84-0 | Biochemical Assay Reagents |
| HY-109536B | Ammonium polyphosphate, n90g/100ml | 68333-79-9 | Biochemical Assay Reagents |
| HY-109538 | Secretin (swine) | 17034-35-4 | Peptides |
| HY-109538R | Secretin (swine) (Standard) | 17034-35-4 | Reference Standards |
| HY-109539 | Gemtuzumab ozogamicin | 220578-59-6 | ADC Related |
| HY-109540 | Perfluorohexane | 355-42-0 | Reference compound |
| HY-109541 | Colfosceril miristate | 18194-24-6 | Oligonucleotides |
| HY-109541S | Colfosceril miristate-d58 | 326495-29-8 | Isotope-Labeled Compounds |
| HY-109541S1 | Colfosceril miristate-d4 | 185906-01-8 | Isotope-Labeled Compounds |
| HY-109541S2 | Colfosceril miristate-d9 | 71479-88-4 | Isotope-Labeled Compounds |
| HY-109541S3 | Colfosceril miristate-d13 | 326495-28-7 | Isotope-Labeled Compounds |
| HY-109541S4 | Colfosceril miristate-d63 | 326495-30-1 | Isotope-Labeled Compounds |
| HY-109541S5 | Colfosceril miristate-d67 | 326495-32-3 | Isotope-Labeled Compounds |
| HY-109541S6 | (Rac)-Colfosceril miristate-d72 | 100483-63-4 | Isotope-Labeled Compounds |
| HY-109542 | Cyclopenthiazide | 742-20-1 | Reference compound |
| HY-109542R | Cyclopenthiazide (Standard) | 742-20-1 | Reference Standards |
| HY-109543 | Indisetron | 141549-75-9 | Reference compound |
| HY-109543A | Indisetron (dihydrochloride) | 160472-97-9 | Reference compound |
| HY-109544 | Repirinast | 73080-51-0 | Reference compound |
| HY-109545 | Isopropyl unoprostone | 120373-24-2 | Reference compound |
| HY-109546 | Omeprazole magnesium | 95382-33-5 | Reference compound |
| HY-109547 | Diclofenac epolamine | 119623-66-4 | Reference compound |
| HY-109549 | Desirudin | 120993-53-5 | Inhibitory Antibodies |
| HY-10955 | TTA-P1 | 918333-06-9 | Reference compound |
| HY-109555 | Insulin glulisine | 207748-29-6 | Peptides |
| HY-109556 | Insulin Detemir | 169148-63-4 | Peptides |
| HY-109561 | Pegaptanib (sodium) | 222716-86-1 | Oligonucleotides |
| HY-109562 | CCG258208 | 2055990-90-2 | Reference compound |
| HY-109562A | CCG258208 (hydrochloride) | Reference compound | |
| HY-109564 | 5α-Pregnane-3β,6α-diol-20-one | 21853-11-2 | Natural Products |
| HY-109564R | 5α-Pregnane-3β,6α-diol-20-one (Standard) | 21853-11-2 | Reference Standards |
| HY-109565 | Tolinapant | 1799328-86-1 | Reference compound |
| HY-109566 | AZD1390 | 2089288-03-7 | Reference compound |
| HY-109567 | Gemcabene | 183293-82-5 | Reference compound |
| HY-109567A | Gemcabene (calcium) | 209789-08-2 | Reference compound |
| HY-109568 | Lynestrenol | 52-76-6 | Reference compound |
| HY-109568R | Lynestrenol (Standard) | 52-76-6 | Reference Standards |
| HY-109569 | Vitamin K2 | 11032-49-8 | Natural Products |
| HY-10957 | L-692429 | 145455-23-8 | Reference compound |
| HY-109571 | HZ-1157 | 1009734-33-1 | Reference compound |
| HY-109572 | GABAA receptor modulator-1 | 951654-29-8 | Reference compound |
| HY-109573 | hnps-PLA-IN-1 | 185298-58-2 | Reference compound |
| HY-109574 | Raf inhibitor 2 | 220904-99-4 | Reference compound |
| HY-10957A | L-692429 (hydrochloride) | 169188-19-6 | Reference compound |
| HY-109582 | ADT-OH | 18274-81-2 | Reference compound |
| HY-109583 | 4-Oxofenretinide | 865536-65-8 | Reference compound |
| HY-109583S | 4-Oxofenretinide-d4 | 2991099-34-2 | Isotope-Labeled Compounds |
| HY-109585 | IRAK4-IN-7 | 1801343-74-7 | Reference compound |
| HY-109586 | BRL-50481 | 433695-36-4 | Reference compound |
| HY-109587 | BM635 | 1493762-74-5 | Reference compound |
| HY-109587A | BM635 (hydrochloride) | 2748337-90-6 | Reference compound |
| HY-109587B | BM635 (mesylate) | 2703867-74-5 | Reference compound |
| HY-109588 | NITD-349 | 1473450-62-2 | Reference compound |
| HY-109589A | trans-11-Eicosenoic acid | 62322-84-3 | Biochemical Assay Reagents |
| HY-10959 | RG7112 | 939981-39-2 | Reference compound |
| HY-109590 | Arachidonic acid | 506-32-1 | Natural Products |
| HY-109590A | Arachidonic acid (sodium salt) | 6610-25-9 | Reference compound |
| HY-109590R | Arachidonic acid (Standard) | 506-32-1 | Reference Standards |
| HY-109590S | Arachidonic acid-d8 | 69254-37-1 | Isotope-Labeled Compounds |
| HY-109590S1 | Arachidonic acid-d5 | 123167-26-0 | Isotope-Labeled Compounds |
| HY-109590S2 | Arachidonic acid-d11 | 2692624-11-4 | Isotope-Labeled Compounds |
| HY-109590S3 | Arachidonic acid-13C4 | 2692624-40-9 | Isotope-Labeled Compounds |
| HY-109591 | Oleoyl coenzyme A | 1716-06-9 | Biochemical Assay Reagents |
| HY-109591A | Oleoyl coenzyme A (lithium) | 188824-37-5 | Biochemical Assay Reagents |
| HY-109591B | Oleoyl Coenzyme A (triammonium) | 799812-89-8 | Enzyme |
| HY-109591C | 9(Z)-Octadecenoyl coenzyme A (potassium) | 369657-01-2 | Natural Products |
| HY-109591S | Oleoyl coenzyme A-13C18 (lithium) | Isotope-Labeled Compounds | |
| HY-109592 | Imidaprilate | 89371-44-8 | Reference compound |
| HY-109592S | Imidaprilate-d5 | Isotope-Labeled Compounds | |
| HY-109593 | BMS-813160 | 1286279-29-5 | Reference compound |
| HY-10961 | Momelotinib | 1056634-68-4 | Reference compound |
| HY-109617 | 4-(4-Fluorophenyl)benzoic acid | 5731-10-2 | Reference compound |
| HY-109619 | D4-abiraterone | 154229-21-7 | Reference compound |
| HY-10962 | Momelotinib (sulfate) | 1056636-06-6 | Reference compound |
| HY-10963 | Momelotinib (mesylate) | 1056636-07-7 | Reference compound |
| HY-109633 | PI3K-IN-18 | 371943-05-4 | Reference compound |
| HY-109633A | PI3K-IN-18 (dihydrochloride) | 1188890-32-5 | Reference compound |
| HY-10964 | Vadimezan | 117570-53-3 | Reference compound |
| HY-10965 | Rolofylline | 136199-02-5 | Reference compound |
| HY-109654 | Ensulizole | 27503-81-7 | Reference compound |
| HY-109654R | Ensulizole (Standard) | 27503-81-7 | Reference Standards |
| HY-109655 | Ethylhexyl triazone | 88122-99-0 | Reference compound |
| HY-109655R | Ethylhexyl triazone (Standard) | 88122-99-0 | Reference Standards |
| HY-109656 | Diethylamino hydroxybenzoyl hexyl benzoate | 302776-68-7 | Reference compound |
| HY-109656R | Diethylamino hydroxybenzoyl hexyl benzoate (Standard) | 302776-68-7 | Reference Standards |
| HY-10966 | SB-590885 | 405554-55-4 | Reference compound |
| HY-10966R | SB-590885 (Standard) | 405554-55-4 | Reference Standards |
| HY-10968 | CYM5442 | 1094042-01-9 | Reference compound |
| HY-10968A | CYM5442 (hydrochloride) | 1783987-80-3 | Reference compound |
| HY-10969 | Obatoclax (Mesylate) | 803712-79-0 | Reference compound |
| HY-109690 | 1-(2-Amino-3-hydroxyphenyl)ethanone | 4502-10-7 | Reference compound |
| HY-109692 | GPR120 Agonist 5 | 1079821-35-4 | Reference compound |
| HY-10969A | Obatoclax | 803712-67-6 | Reference compound |
| HY-109706 | (Rac)-CPI-098 | 3967-01-9 | Reference compound |
| HY-10971 | Alisertib | 1028486-01-2 | Reference compound |
| HY-109714 | 3,4-Benzocoumarin | 2005-10-9 | Reference compound |
| HY-109718 | ATL-801 | 1000005-71-9 | Reference compound |
| HY-10971A | Alisertib (sodium) | 1028486-06-7 | Reference compound |
| HY-10974 | MK-0752 | 471905-41-6 | Reference compound |
| HY-109743 | BP14979 | 1000036-77-0 | Reference compound |
| HY-109748 | Mn(III)TMPyP (pentachloride) | 125565-45-9 | Biochemical Assay Reagents |
| HY-10975 | MK-0752 (sodium) | 656810-87-6 | Reference compound |
| HY-109754 | Sulopenem etzadroxil | 1000296-70-7 | Reference compound |
| HY-109755 | PF-04064900 | 1000296-71-8 | Reference compound |
| HY-10976 | Luminespib analog | 747412-64-2 | Reference compound |
| HY-10977 | Tivozanib | 475108-18-0 | Reference compound |
| HY-10977A | Tivozanib (hydrochloride hydrate) | 682745-41-1 | Reference compound |
| HY-10977S | Tivozanib-d6 | 1714998-87-4 | Isotope-Labeled Compounds |
| HY-10978 | Crisaborole | 906673-24-3 | Reference compound |
| HY-109785A | (R)-Gyramide A (hydrochloride) | 1793050-70-0 | Reference compound |
| HY-10978R | Crisaborole (Standard) | 906673-24-3 | Reference Standards |
| HY-10978S | Crisaborole-d4 | 2268785-42-6 | Isotope-Labeled Compounds |
| HY-10979 | AN0128 | 872044-70-7 | Reference compound |
| HY-109796 | NIK250 | 1000817-20-8 | Reference compound |
| HY-10980 | Tavaborole | 174671-46-6 | Reference compound |
| HY-109804 | CORM-401 | 1001015-18-4 | Reference compound |
| HY-10980R | Tavaborole (Standard) | 174671-46-6 | Reference Standards |
| HY-10981 | Lenvatinib | 417716-92-8 | Reference compound |
| HY-10981A | Lenvatinib (mesylate) | 857890-39-2 | Reference compound |
| HY-10981AR | Lenvatinib (mesylate) (Standard) | 857890-39-2 | Reference Standards |
| HY-10981R | Lenvatinib (Standard) | 417716-92-8 | Reference Standards |
| HY-10981S | Lenvatinib-d4 | 2264050-65-7 | Isotope-Labeled Compounds |
| HY-10981S1 | Lenvatinib-d5 | Isotope-Labeled Compounds | |
| HY-10981S2 | Lenvatinib-15N,d4 | Isotope-Labeled Compounds | |
| HY-10982 | Amonafide | 69408-81-7 | Reference compound |
| HY-10982A | Amonafide (dihydrochloride) | 150091-68-2 | Reference compound |
| HY-10984 | Pomalidomide | 19171-19-8 | Reference compound |
| HY-109841 | Oleoyl serotonin | 1002100-44-8 | Reference compound |
| HY-109841S | Oleoyl Serotonin-d17 | 2749980-90-1 | Isotope-Labeled Compounds |
| HY-10984A | (S)-Pomalidomide | 202271-89-4 | Reference compound |
| HY-10984R | Pomalidomide (Standard) | 19171-19-8 | Reference Standards |
| HY-10984S | Pomalidomide-d5 | 1377838-49-7 | Isotope-Labeled Compounds |
| HY-10984S1 | Pomalidomide-d3 | 2093128-28-8 | Isotope-Labeled Compounds |
| HY-10984S2 | Pomalidomide-d4 | 1416575-78-4 | Isotope-Labeled Compounds |
| HY-10984S3 | Pomalidomide-15N,13C5 | Isotope-Labeled Compounds | |
| HY-10984S4 | Pomalidomide-13C5 | 1416575-79-5 | Isotope-Labeled Compounds |
| HY-10985 | Marizomib | 437742-34-2 | Reference compound |
| HY-109854 | (S)-Lisofylline | 100324-80-9 | Reference compound |
| HY-109854A | (R)-Lisofylline | 100324-81-0 | Reference compound |
| HY-109855 | CP-67015 | 100325-51-7 | Reference compound |
| HY-109869 | Photoregulin1 | 1003736-23-9 | Reference compound |
| HY-10987 | ENMD-2076 (Tartrate) | 1453868-32-0 | Reference compound |
| HY-109877 | Ro 22-3581 | 10041-06-2 | Reference compound |
| HY-10987A | ENMD-2076 | 934353-76-1 | Reference compound |
| HY-109887 | 3-Bromoimidazo[1,2-a]pyridine-6-carbaldehyde | 1004550-20-2 | Reference compound |
| HY-109897 | CV-6209 | 100488-87-7 | Reference compound |
| HY-10990 | Abexinostat | 783355-60-2 | Reference compound |
| HY-10991 | MGCD-265 analog | 875337-44-3 | Reference compound |
| HY-10992 | AZD-7762 | 860352-01-8 | Reference compound |
| HY-10992A | AZD-7762 (hydrochloride) | 1246094-78-9 | Reference compound |
| HY-10993 | Adavosertib | 955365-80-7 | Reference compound |
| HY-10993R | Adavosertib (Standard) | 955365-80-7 | Reference Standards |
| HY-10995 | Tozadenant | 870070-55-6 | Reference compound |
| HY-10996 | KHS101 | 1262770-73-9 | Reference compound |
| HY-109963 | PR5-LL-CM01 | 1005307-86-7 | Reference compound |
| HY-109968 | Irdabisant | 1005402-19-6 | Reference compound |
| HY-109968A | Irdabisant (hydrochloride) | 1005398-61-7 | Reference compound |
| HY-109969 | Z060228 | 1005459-82-4 | Reference compound |
| HY-10996A | KHS101 hydrochloride | 1784282-12-7 | Reference compound |
| HY-10997 | Ibrutinib | 936563-96-1 | Reference compound |
| HY-10997A | Ibrutinib (Racemate) | 936563-87-0 | Reference compound |
| HY-10997R | Ibrutinib (Standard) | 936563-96-1 | Reference Standards |
| HY-10997S | Ibrutinib-d5 | 1553977-17-5 | Isotope-Labeled Compounds |
| HY-10998 | Salmefamol | 18910-65-1 | Reference compound |
| HY-109987 | ISPA-28 | 1006335-39-2 | Reference compound |
| HY-10999 | Trametinib | 871700-17-3 | Reference compound |
| HY-109992 | LY 186126 | 100644-00-6 | Reference compound |
| HY-10999A | Trametinib (DMSO solvate) | 1187431-43-1 | Reference compound |
| HY-10999R | Trametinib (Standard) | 871700-17-3 | Reference Standards |
| HY-10999S | Trametinib-d4 | Isotope-Labeled Compounds | |
| HY-10999S1 | Trametinib-13C6 | Isotope-Labeled Compounds | |
| HY-10999S2 | Trametinib-13C,d3 | 2712126-59-3 | Isotope-Labeled Compounds |
| HY-11000 | GSK429286A | 864082-47-3 | Reference compound |
| HY-110000 | (+)-PD 128907 hydrochloride | 300576-59-4 | Reference compound |
| HY-110001 | (S)-WAY 100135 (dihydrochloride) | 149007-54-5 | Reference compound |
| HY-110002 | LFM-A13 | 62004-35-7 | Biochemical Assay Reagents |
| HY-110003 | Arachidonylcyclopropylamide | 229021-64-1 | Reference compound |
| HY-110004 | ACEA | 220556-69-4 | Biochemical Assay Reagents |
| HY-110005 | Sp-cAMPS (triethylamine) | 93602-66-5 | Reference compound |
| HY-11000A | CaMKP inhibitor (sodium) | 52789-62-5 | Reference compound |
| HY-11001 | PHA-793887 | 718630-59-2 | Reference compound |
| HY-110010 | Nafadotride | 149649-22-9 | Reference compound |
| HY-110011 | Cromakalim | 94470-67-4 | Reference compound |
| HY-110012 | SCH-202676 (hydrobromide) | 265980-25-4 | Reference compound |
| HY-110013 | Terreic acid | 121-40-4 | Reference compound |
| HY-110013A | (Rac)-Terreic acid | 15255-24-0 | Reference compound |
| HY-110014 | Noladin ether | 222723-55-9 | Reference compound |
| HY-110015 | (-)-Chromanol 293B | 163163-24-4 | Reference compound |
| HY-110016 | Docosatetraenylethanolamide | 150314-35-5 | Natural Products |
| HY-110018 | N-Arachidonyldopamine | 199875-69-9 | Reference compound |
| HY-110018S | N-Arachidonyldopamine-d8 | 1159908-42-5 | Isotope-Labeled Compounds |
| HY-110019 | Indatraline (hydrochloride) | 96850-13-4 | Reference compound |
| HY-110019A | cis-Indatraline (hydrochloride) | 86939-08-4 | Reference compound |
| HY-11002 | CP-466722 | 1080622-86-1 | Reference compound |
| HY-110020 | rel-O-2050 | 851320-29-1 | Reference compound |
| HY-110021 | Fenoldopam (hydrochloride) | 181217-39-0 | Reference compound |
| HY-110022 | GW1929 (hydrochloride) | 1217466-21-1 | Reference compound |
| HY-110023 | Zimelidine (dihydrochloride) | 60525-15-7 | Reference compound |
| HY-110023R | Zimelidine (dihydrochloride) (Standard) | 60525-15-7 | Reference Standards |
| HY-110024 | S-14506 (hydrochloride) | 286369-38-8 | Reference compound |
| HY-110024A | S-14506 | 135722-25-7 | Reference compound |
| HY-110026 | GTP-14564 | 34823-86-4 | Reference compound |
| HY-110027 | 2,3-DCPE (hydrochloride) | 1009555-55-8 | Reference compound |
| HY-110028 | Leelamine (hydrochloride) | 16496-99-4 | Natural Products |
| HY-110029 | Paroxetine (maleate) | 64006-44-6 | Reference compound |
| HY-11003 | GW843682X | 660868-91-7 | Reference compound |
| HY-110031 | BAI1 (hydrochloride) | 329349-20-4 | Reference compound |
| HY-110032 | Lamotrigine (isethionate) | 113170-86-8 | Reference compound |
| HY-110033 | Ecopipam (hydrobromide) | 2587360-22-1 | Reference compound |
| HY-110034 | Didesmethylsibutramine (hydrochloride) | 84484-78-6 | Reference compound |
| HY-110034R | Didesmethylsibutramine (hydrochloride) (Standard) | 84484-78-6 | Reference Standards |
| HY-110034S | Didesmethylsibutramine-d7 (hydrochloride) | 1188263-87-7 | Isotope-Labeled Compounds |
| HY-110036 | GW-405833 | 180002-83-9 | Reference compound |
| HY-110036A | GW405833 (hydrochloride) | 1202865-22-2 | Reference compound |
| HY-110037 | MRS-3777 (hemioxalate) | 1186195-57-2 | Reference compound |
| HY-110038 | FTI-277 (TFA) | 1217447-06-7 | Reference compound |
| HY-110039 | BIBX 1382 (dihydrochloride) | 1216920-18-1 | Reference compound |
| HY-11004 | AZ 628 | 878739-06-1 | Reference compound |
| HY-110040 | L759633 | 174627-50-0 | Reference compound |
| HY-110042 | CCT018159 | 171009-07-7 | Reference compound |
| HY-110043 | (±)-Clopidogrel (hydrochloride) | 130209-90-4 | Reference compound |
| HY-110044 | MNITMT | 177653-76-8 | Reference compound |
| HY-110045 | ZM-306416 (hydrochloride) | 196603-47-1 | Reference compound |
| HY-110046 | CL-82198 (hydrochloride) | 1188890-36-9 | Reference compound |
| HY-110047 | CB65 | 913534-05-1 | Reference compound |
| HY-110048 | O-2545 (hydrochloride) | 874745-43-4 | Reference compound |
| HY-11005 | BX-912 | 702674-56-4 | Reference compound |
| HY-110050 | GP1a | 511532-96-0 | Reference compound |
| HY-110051 | DPP4-In (hydrochloride) | 866396-70-5 | Reference compound |
| HY-110052 | TBCA | 934358-00-6 | Reference compound |
| HY-110053 | Tandospirone (hydrochloride) | 99095-10-0 | Reference compound |
| HY-110054 | CCG-2046 | 13017-69-1 | Reference compound |
| HY-110056 | NBI 35965 (hydrochloride) | 1782228-59-4 | Reference compound |
| HY-110057 | FR 409 | 138472-01-2 | Reference compound |
| HY-11006 | KU-57788 | 503468-95-9 | Reference compound |
| HY-110060 | NDT 9513727 | 439571-48-9 | Reference compound |
| HY-110063 | 4-IPP | 41270-96-6 | Reference compound |
| HY-110065 | SER-601 | 1048038-90-9 | Reference compound |
| HY-110066 | (Z)-Guggulsterone | 39025-23-5 | Natural Products |
| HY-110066R | (Z)-Guggulsterone (Standard) | 39025-23-5 | Reference Standards |
| HY-110067 | VO-OHPic | 675848-25-6 | Reference compound |
| HY-11007 | GNF-2 | 778270-11-4 | Reference compound |
| HY-110070 | DL-AP4 (sodium) | 1263093-79-3 | Reference compound |
| HY-110071 | APcK110 | 1001083-74-4 | Reference compound |
| HY-110073 | iMAC2 (hydrochloride) | 335166-00-2 | Reference compound |
| HY-110074 | TWS119 (TFA) | 1507095-58-0 | Reference compound |
| HY-110075 | Dexrazoxane (monohydrochloride) | 1263283-43-7 | Reference compound |
| HY-110076 | VU590 (dihydrochloride) | 1783987-83-6 | Reference compound |
| HY-110077 | API-1 | 36707-00-3 | Reference compound |
| HY-110078 | Eeyarestatin I | 412960-54-4 | Reference compound |
| HY-110079 | TNP | 519178-28-0 | Reference compound |
| HY-110080 | Lisuride (maleate) | 19875-60-6 | Reference compound |
| HY-110081S | Doxycycline hyclate-d5 | Isotope-Labeled Compounds | |
| HY-110082 | Quinine (hydrochloride) | 130-89-2 | Reference compound |
| HY-110083 | PK44 (phosphate) | 1017682-66-4 | Reference compound |
| HY-110084 | BTZO-1 | 99420-15-2 | Reference compound |
| HY-110085 | 2,2′-Dihydroxy-6,6′-dinaphthyl disulfide | 6088-51-3 | Reference compound |
| HY-110086 | RWJ 50271 | 162112-37-0 | Reference compound |
| HY-110087 | 4BP-TQS | 360791-49-7 | Reference compound |
| HY-110088 | SCH529074 | 922150-11-6 | Reference compound |
| HY-11009 | CGP60474 | 164658-13-3 | Reference compound |
| HY-110090 | UA62784 | 313367-92-9 | Reference compound |
| HY-110091 | TRPV1 antagonist 9 | 939040-79-6 | Reference compound |
| HY-110092 | PSB-1114 (tetrasodium) | 1657025-60-9 | Reference compound |
| HY-110092A | PSB-1114 (triethylamine) | Reference compound | |
| HY-110093 | UNC0638 (hydrate) | 1255517-77-1 | Reference compound |
| HY-110094 | BIMU 8 | 134296-40-5 | Reference compound |
| HY-110095 | (±)-CPSI-1306 | 1309793-47-2 | Reference compound |
| HY-110096 | A-484954 | 142557-61-7 | Reference compound |
| HY-110097 | Aptiganel (hydrochloride) | 137160-11-3 | Reference compound |
| HY-110098 | Ro 5212773 | 1110781-88-8 | Reference compound |
| HY-110099 | (±)-NBI-74330 | 473722-68-8 | Reference compound |
| HY-11010 | AS601245 | 345987-15-7 | Reference compound |
| HY-110100 | CPYPP | 310460-39-0 | Reference compound |
| HY-110101 | ARN272 | 488793-85-7 | Reference compound |
| HY-110102 | Atiprimod (hydrochloride) | 130065-61-1 | Reference compound |
| HY-110103 | ML3403 | 549505-65-9 | Reference compound |
| HY-110104 | 8MDP | 29491-75-6 | Reference compound |
| HY-110105 | NS8593 (hydrochloride) | 875755-24-1 | Reference compound |
| HY-110106 | I-BET151 (dihydrochloride) | 1883545-47-8 | Reference compound |
| HY-110107 | GW438014A | 469861-49-2 | Reference compound |
| HY-110109 | ETP-45658 | 1198357-79-7 | Reference compound |
| HY-11010A | AS601245 (TFA) | 345987-16-8 | Reference compound |
| HY-11011 | A-770041 | 869748-10-7 | Reference compound |
| HY-110110 | VU0463271 | 1391737-01-1 | Reference compound |
| HY-110110A | VU0463271 (quarterhydrate) | Reference compound | |
| HY-110111 | T2AA | 1380782-27-3 | Reference compound |
| HY-110111A | T2AA (hydrochloride) | 2138331-07-2 | Reference compound |
| HY-110112 | BTT-3033 | 1259028-99-3 | Reference compound |
| HY-110113 | CTA056 | 1265822-30-7 | Reference compound |
| HY-110114 | Gue1654 | 397290-30-1 | Reference compound |
| HY-110115 | TC-Mps1-12 | 1206170-62-8 | Reference compound |
| HY-110116 | SD-2590 (hydrochloride) | 226395-93-3 | Reference compound |
| HY-110117 | BIRT 377 | 213211-10-0 | Reference compound |
| HY-110118 | Edaglitazone | 213411-83-7 | Reference compound |
| HY-110119 | Galloflavin (potassium) | 1780260-20-9 | Reference compound |
| HY-11012 | TDZD-8 | 327036-89-5 | Reference compound |
| HY-110120 | DSR-6434 | 1059070-10-8 | Reference compound |
| HY-110121 | NS3861 (fumarate) | 216853-60-0 | Reference compound |
| HY-110121A | NS3861 | 216853-59-7 | Reference compound |
| HY-110122 | AZ 12216052 | 1290628-31-7 | Reference compound |
| HY-110123 | ML-00253764 (hydrochloride) | 1706524-94-8 | Reference compound |
| HY-110124 | ML202 | 1221186-52-2 | Reference compound |
| HY-110125 | ML-193 | 713121-80-3 | Reference compound |
| HY-110126 | AR-C118925XX | 216657-60-2 | Reference compound |
| HY-110127 | NU9056 | 1450644-28-6 | Reference compound |
| HY-110128 | Sulfidefluor 7-AM | 1416872-50-8 | Dye Reagents |
| HY-110129 | Eplivanserin (hemifumarate) | 130580-02-8 | Reference compound |
| HY-11013 | ZSET1446 | 887603-94-3 | Reference compound |
| HY-110130 | RN-1 (dihydrochloride) | 1781835-13-9 | Reference compound |
| HY-110131 | A 85380 (hydrochloride) | 174740-86-4 | Reference compound |
| HY-110132 | JNJ-27141491 | 871313-59-6 | Reference compound |
| HY-110133 | JTE-607 | 188791-09-5 | Reference compound |
| HY-110133A | JTE-607 (free base) | 188791-71-1 | Reference compound |
| HY-110134 | S07662 | 883226-64-0 | Reference compound |
| HY-110135 | NBI-31772 | 374620-70-9 | Reference compound |
| HY-110135A | NBI-31772 (hydrate) | Reference compound | |
| HY-110136 | PMX 205 | 514814-49-4 | Reference compound |
| HY-110136A | PMX 205 (Trifluoroacetate) | Reference compound | |
| HY-110137 | Furamidine (dihydrochloride) | 55368-40-6 | Reference compound |
| HY-110137A | Furamidine | 73819-26-8 | Reference compound |
| HY-110138 | PDP-EA | 861891-72-7 | Reference compound |
| HY-110139 | Procaspase-IN-5 | 1489285-17-7 | Reference compound |
| HY-110140 | (E)-KN-93 (phosphate) | 1188890-41-6 | Reference compound |
| HY-110141 | ABP688 | 924298-51-1 | Reference compound |
| HY-110142 | Thermopsidine | 492-02-4 | Reference compound |
| HY-110143 | CLP257 | 1181081-71-9 | Reference compound |
| HY-110144 | TC-E 5008 | 50405-58-8 | Reference compound |
| HY-110145 | MRS 1477 | 212200-21-0 | Reference compound |
| HY-110146 | XAP044 | 196928-50-4 | Reference compound |
| HY-110147A | SSM3 (tetraTFA) | 2320930-10-5 | Reference compound |
| HY-110147B | SSM3 (tetraTFA hydrate) | Reference compound | |
| HY-110148 | WWL113 | 947669-86-5 | Reference compound |
| HY-110150 | UNC3230 | 1031602-63-7 | Reference compound |
| HY-110151 | Bengamide B | 104947-69-5 | Natural Products |
| HY-110152 | LSN2463359 | 1401031-52-4 | Reference compound |
| HY-110153 | NS19504 | 327062-46-4 | Reference compound |
| HY-110154 | NSC636819 | 1618672-71-1 | Reference compound |
| HY-110155 | LM11A-31 (dihydrochloride) | 1243259-19-9 | Reference compound |
| HY-110155A | (Rac)-LM11A-31 (dihydrochloride) | 1214672-15-7 | Reference compound |
| HY-110156 | YZ9 | 6093-71-6 | Reference compound |
| HY-110157 | AC-186 | 1421854-16-1 | Reference compound |
| HY-110158 | UNC2327 | 1426152-53-5 | Reference compound |
| HY-110159 | (E/Z)-Teriflunomide | 108605-62-5 | Reference compound |
| HY-110159S | Teriflunomide-d4 | 1185240-22-5 | Isotope-Labeled Compounds |
| HY-110160 | Pozanicline (dihydrochloride) | 161416-61-1 | Reference compound |
| HY-110161 | sst2 Receptor agonist-1 | 1021912-42-4 | Reference compound |
| HY-110162 | QO 58 | 1259536-62-3 | Reference compound |
| HY-110164 | AdipoRon hydrochloride | 1781835-20-8 | Reference compound |
| HY-110165 | hENT4-IN-1 | 949467-71-4 | Reference compound |
| HY-110166 | PD 90780 | 77422-99-2 | Reference compound |
| HY-110167 | TFC 007 | 927878-49-7 | Reference compound |
| HY-110168 | NS 9283 | 913830-15-6 | Reference compound |
| HY-110169 | (E/Z)-3PO | 13309-08-5 | Reference compound |
| HY-11017 | Rivastigmine (tartrate) | 129101-54-8 | Reference compound |
| HY-110170 | Dansyl-NECA | 219982-12-4 | Reference compound |
| HY-110171 | iMDK | 881970-80-5 | Reference compound |
| HY-110171A | iMDK (quarterhydrate) | Reference compound | |
| HY-110172 | PDI-IN-1 | 1461648-55-4 | Reference compound |
| HY-110173 | TC-G 1005 | 1415407-60-1 | Reference compound |
| HY-110174 | NAB2 | 1504588-00-4 | Reference compound |
| HY-110175 | CX614 | 191744-13-5 | Reference compound |
| HY-110176 | ASP2535 | 374886-51-8 | Reference compound |
| HY-110177 | SP-100030 | 154563-54-9 | Reference compound |
| HY-110178 | WWL123 | 1338574-83-6 | Reference compound |
| HY-110179 | PSNCBAM-1 | 877202-74-9 | Reference compound |
| HY-11017AS | (S)-Rivastigmine-d6 (tartrate) | 194930-00-2 | Isotope-Labeled Compounds |
| HY-11017R | Rivastigmine (tartrate) (Standard) | 129101-54-8 | Reference Standards |
| HY-11018 | Risperidone | 106266-06-2 | Reference compound |
| HY-110180 | VU0409106 | 1276617-62-9 | Reference compound |
| HY-110181 | M8-B | 883976-12-3 | Reference compound |
| HY-110182 | SP-141 | 1253491-42-7 | Reference compound |
| HY-110183 | Angiotensin A | 51833-76-2 | Peptides |
| HY-110184 | PK-THPP | 1332454-07-5 | Reference compound |
| HY-110185 | NSC 617145 | 203115-63-3 | Reference compound |
| HY-110186 | PQ-69 | 910045-32-8 | Reference compound |
| HY-110188 | BiP inducer X | 101714-41-4 | Reference compound |
| HY-110189 | Pregnenolone monosulfate (sodium) | 1852-38-6 | Natural Products |
| HY-110189S | Pregnenolone monosulfate (sodium)-13C2,d2 | 2483824-22-0 | Isotope-Labeled Compounds |
| HY-110189S1 | Pregnenolone monosulfate-d4 (sodium) | 1485492-21-4 | Isotope-Labeled Compounds |
| HY-11018A | Risperidone (hydrochloride) | 666179-74-4 | Reference compound |
| HY-11018B | Risperidone (mesylate) | 666179-96-0 | Reference compound |
| HY-11018R | Risperidone (Standard) | 106266-06-2 | Reference Standards |
| HY-11018S1 | Risperidone-d4-1 | Isotope-Labeled Compounds | |
| HY-11018S2 | Risperidone-d6 | 1225444-65-4 | Isotope-Labeled Compounds |
| HY-110190 | VU0422288 | 1630936-95-6 | Reference compound |
| HY-110191 | VU0469650 | 1443748-47-7 | Reference compound |
| HY-110192 | ML 297 | 1443246-62-5 | Reference compound |
| HY-110193 | SPP-86 | 1357349-91-7 | Reference compound |
| HY-110194 | Virodhamine (TFA) | 1415264-56-0 | Reference compound |
| HY-110195 | Smurf1-IN-A01 | 1007647-73-5 | Reference compound |
| HY-110196 | (S)-PFI-2 (hydrochloride) | 1627607-88-8 | Reference compound |
| HY-110197 | 6bK (TFA) | 1774353-12-6 | Reference compound |
| HY-110198 | ONO-8130 | 459841-96-4 | Reference compound |
| HY-110199 | TC-I 2014 | 1221349-53-6 | Reference compound |
| HY-110200 | TC AQP1 1 | 37710-81-9 | Reference compound |
| HY-110201 | Estrogen receptor modulator 1 | 63676-22-2 | Reference compound |
| HY-110202 | MRS5698 | 1377273-00-1 | Reference compound |
| HY-110203 | R-7050 | 303997-35-5 | Reference compound |
| HY-110204 | Heclin | 890605-54-6 | Reference compound |
| HY-110206 | AM6545 | 1245626-05-4 | Reference compound |
| HY-110207 | SM-324405 | 677773-91-0 | Reference compound |
| HY-110208 | BRD9876 | 32703-82-5 | Reference compound |
| HY-110209 | AC4 | 1459809-09-6 | Reference compound |
| HY-11021 | Elinogrel | 936500-94-6 | Reference compound |
| HY-110210 | BODIPY-FL NHS ester | 146616-66-2 | Dye Reagents |
| HY-110211 | BODIPY TMR-X SE | 217190-15-3 | Dye Reagents |
| HY-110212 | BODIPY TR-X | 197306-80-2 | Dye Reagents |
| HY-110213 | BODIPY 630/650X | 380367-48-6 | Dye Reagents |
| HY-110215 | XD14 | 1370888-71-3 | Reference compound |
| HY-110216 | 5J-4 | 827001-82-1 | Reference compound |
| HY-110217 | BMS-566419 | 566161-24-8 | Reference compound |
| HY-110218 | CW 008 | 1134613-19-6 | Reference compound |
| HY-110220 | CIM0216 | 1031496-06-6 | Reference compound |
| HY-110221 | Rp-8-pCPT-cGMPS (sodium) | 208445-07-2 | Reference compound |
| HY-110223 | Atomoxetine-d3 (hydrochloride) | 1217776-38-9 | Reference compound |
| HY-110225 | Levetiracetam-d6 (ring-d6) | 1133229-30-7 | Reference compound |
| HY-110228 | Metformin-d6 (hydrochloride) | 1185166-01-1 | Isotope-Labeled Compounds |
| HY-110230 | Flupirtine-d4 (hydrochloride) | 1324717-75-0 | Reference compound |
| HY-110231 | Simvastatin-d6 | 1002347-71-8 | Isotope-Labeled Compounds |
| HY-110232 | Risperidone-d4 | 1020719-76-9 | Isotope-Labeled Compounds |
| HY-110233S | Acamprosate-d6 (calcium) | 1225580-91-5 | Isotope-Labeled Compounds |
| HY-110234 | Topiramate D12 | 1279037-95-4 | Reference compound |
| HY-110234R | Topiramate D12 (Standard) | 1279037-95-4 | Reference Standards |
| HY-110237 | BX430 | 688309-70-8 | Reference compound |
| HY-110238 | MK6-83 | 1062271-24-2 | Reference compound |
| HY-110239 | Perlapine | 1977-11-3 | Reference compound |
| HY-110240 | IHR-1 | 548779-60-8 | Reference compound |
| HY-110241 | Dianicline (dihydrochloride) | 292634-27-6 | Reference compound |
| HY-110242 | Mps-BAY2a | 1382477-96-4 | Reference compound |
| HY-110243 | CAIX Inhibitor S4 | 1330061-67-0 | Reference compound |
| HY-110244 | Tilfrinib | 1600515-49-8 | Reference compound |
| HY-110245 | DMH2 | 1206711-14-9 | Reference compound |
| HY-110246 | Quin C1 | 786706-21-6 | Reference compound |
| HY-110247 | TRAF-STOP inhibitor 6877002 | 433249-94-6 | Reference compound |
| HY-110248 | MI 14 | 1715934-43-2 | Reference compound |
| HY-110249 | CINPA1 | 102636-74-8 | Reference compound |
| HY-110250 | DFHBI | 1241390-29-3 | Dye Reagents |
| HY-110251 | DFHBI-1T | 1539318-36-9 | Dye Reagents |
| HY-110251A | DFHBI-2T | 1539318-40-5 | Dye Reagents |
| HY-110252 | Salvinorin B | 92545-30-7 | Natural Products |
| HY-110253 | 18A | 331261-50-8 | Reference compound |
| HY-110254 | AZD 9272 | 327056-26-8 | Reference compound |
| HY-110255 | AZD 2066 | 934282-55-0 | Reference compound |
| HY-110255A | AZD 2066 (hydrate) | Reference compound | |
| HY-110255B | AZD-2066 (hydrochloride) | 934338-70-2 | Reference compound |
| HY-110256 | N-Acetylcysteine amide | 38520-57-9 | Reference compound |
| HY-110257 | BDY FL-X, SE | 217190-09-5 | Dye Reagents |
| HY-110258 | ML334 | 1432500-66-7 | Reference compound |
| HY-110258B | (R,S,R)-ML334 | 1432065-33-2 | Reference compound |
| HY-110259 | HFI-142 | 332164-34-8 | Reference compound |
| HY-110260 | LDN-193188 | 1267610-30-9 | Reference compound |
| HY-110261 | GS143 | 916232-21-8 | Reference compound |
| HY-110262 | MSC 2032964A | 1124381-43-6 | Reference compound |
| HY-110263 | EML 425 | 1675821-32-5 | Reference compound |
| HY-110264 | MI-192 | 1415340-63-4 | Reference compound |
| HY-110265 | SAR216471 (hydrochloride) | 1279829-64-9 | Reference compound |
| HY-110266 | GN44028 | 1421448-26-1 | Reference compound |
| HY-110267 | DY268 | 1609564-75-1 | Reference compound |
| HY-110269 | VUF 11222 | 1414376-84-3 | Reference compound |
| HY-11027 | MK-0773 | 606101-58-0 | Reference compound |
| HY-110270 | RN-9893 | 1803003-68-0 | Reference compound |
| HY-110270A | RN-9893 (hydrochloride) | 2109450-40-8 | Reference compound |
| HY-110271 | N-Acetylpuromycin | 22852-13-7 | Reference compound |
| HY-110272 | Vatalanib (succinate) | 212142-18-2 | Reference compound |
| HY-110273 | N106 | 862974-25-2 | Reference compound |
| HY-110274 | IP7e | 500164-74-9 | Reference compound |
| HY-110275 | RA839 | 1832713-02-6 | Reference compound |
| HY-110277 | S2101 | 1239262-36-2 | Reference compound |
| HY-110278 | ADX71743 | 1431641-29-0 | Reference compound |
| HY-110279 | Ogerin | 1309198-71-7 | Reference compound |
| HY-11028 | PF-02413873 | 936345-35-6 | Reference compound |
| HY-110280 | MC1742 | 1776116-74-5 | Reference compound |
| HY-110281 | Dehydroascorbic acid | 490-83-5 | Natural Products |
| HY-110281R | Dehydroascorbic acid (Standard) | 490-83-5 | Reference Standards |
| HY-110282 | S3QEL-2 | 890888-12-7 | Reference compound |
| HY-110284 | BAM 15 | 210302-17-3 | Reference compound |
| HY-110285 | ML382 | 1646499-97-9 | Reference compound |
| HY-110286 | 6-Hydroxy-DOPA | 21373-30-8 | Reference compound |
| HY-110287 | Apcin | 300815-04-7 | Reference compound |
| HY-110288 | 3FAx-Neu5Ac | 117405-58-0 | Reference compound |
| HY-110289 | (R)-Citalopram (oxalate) | 219861-53-7 | Reference compound |
| HY-110289R | (R)-Citalopram (oxalate) (Standard) | 219861-53-7 | Reference Standards |
| HY-110289S1 | (R)-Citalopram-d4 (oxalate) | Isotope-Labeled Compounds | |
| HY-11029 | SNT-207707 | 1064662-40-3 | Reference compound |
| HY-110291 | A-971432 | 1240308-45-5 | Reference compound |
| HY-110292 | A-425619 | 581809-67-8 | Reference compound |
| HY-110293 | CHMFL-FLT3-122 | 1839150-56-9 | Reference compound |
| HY-110294 | CM037 | 896795-60-1 | Reference compound |
| HY-110295 | SPL-334 | 688347-51-5 | Reference compound |
| HY-110296 | EC19 | 1010694-08-2 | Reference compound |
| HY-11030 | SNT-207858 | 1104080-42-3 | Reference compound |
| HY-110302 | 6'-GNTI (dihydrochloride) | 2410327-94-3 | Reference compound |
| HY-110303 | Xanthine amine congener (dihydrochloride) | 1962928-23-9 | Reference compound |
| HY-110304 | NPEC-caged-LY379268 | 1315379-62-4 | Reference compound |
| HY-11030A | SNT-207858 (free base) | 1104662-66-9 | Reference compound |
| HY-110312 | JTV-519 (fumarate) | 1883549-36-7 | Reference compound |
| HY-110313 | SB-747651A (dihydrochloride) | 1781882-72-1 | Reference compound |
| HY-110314 | CYM50358 (hydrochloride) | 1781750-72-8 | Reference compound |
| HY-110315 | Ischemin (sodium) | Reference compound | |
| HY-110318 | VUF11207 (fumarate) | 1785665-61-3 | Reference compound |
| HY-110319 | (E/Z)-Daporinad (hydrochloride) | 1785666-54-7 | Reference compound |
| HY-110320 | LDN-209929 (dihydrochloride) | 1784281-97-5 | Reference compound |
| HY-110322 | PPTN (hydrochloride) | 1992047-65-0 | Reference compound |
| HY-110322A | PPTN | 1160271-30-6 | Reference compound |
| HY-110325 | PF-04885614 | 1480833-70-2 | Reference compound |
| HY-110328 | PKI-166 (hydrochloride) | 2230253-82-2 | Reference compound |
| HY-110329 | ML179 | 1883548-87-5 | Reference compound |
| HY-110331 | CCT241533 (dihydrochloride) | 1962925-28-5 | Reference compound |
| HY-110333 | BMS-599626 (dihydrochloride) | 1781932-33-9 | Reference compound |
| HY-110334 | FFN 206 (dihydrochloride) | 1883548-88-6 | Dye Reagents |
| HY-110335 | OXA-06 (hydrochloride) | 1825455-91-1 | Reference compound |
| HY-110335A | OXA-06 | 944955-32-2 | Reference compound |
| HY-110336 | ETP-45835 (dihydrochloride) | 2136571-30-5 | Reference compound |
| HY-110337 | FFN 102 (mesylate) | 1883548-92-2 | Dye Reagents |
| HY-110339 | RKI-1447 (dihydrochloride) | 1782109-09-4 | Reference compound |
| HY-11034 | CVT-12012 | 1018675-35-8 | Reference compound |
| HY-110341 | MRT 68601 (hydrochloride) | 1962928-25-1 | Reference compound |
| HY-110343 | DBM 1285 (dihydrochloride) | 1782532-29-9 | Reference compound |
| HY-110346 | AZD5582 (dihydrochloride) | 1883545-51-4 | Reference compound |
| HY-110347 | Mps1-IN-1 (dihydrochloride) | 1883548-93-3 | Reference compound |
| HY-11035 | WAY-262611 | 1123231-07-1 | Reference compound |
| HY-110350 | CHR-6494 (TFA) | 1458630-17-5 | Reference compound |
| HY-110351 | BGC-20-1531 (hydrochloride) | 1962928-26-2 | Reference compound |
| HY-110353 | CU-T12-9 | 1821387-73-8 | Reference compound |
| HY-110354 | UCM05 | 1094451-90-7 | Reference compound |
| HY-110354R | UCM05 (Standard) | 1094451-90-7 | Reference Standards |
| HY-110358 | QAQ (dichloride) | Reference compound | |
| HY-110358A | QAQ | 1204416-85-2 | Reference compound |
| HY-110360 | Fenretinide-d4 | 2118244-64-5 | Reference compound |
| HY-110363 | Miglustat-d9 (hydrochloride) | 1883545-57-0 | Isotope-Labeled Compounds |
| HY-110365 | Icerguastat (Carbonate) | 1883549-35-6 | Reference compound |
| HY-110366 | WAY-181187 (oxalate) | 1883548-85-3 | Peptides |
| HY-110367 | LCB 03-0110 (dihydrochloride) | 1962928-28-4 | Reference compound |
| HY-110367A | LCB 03-0110 | 1228102-01-9 | Reference compound |
| HY-110368 | BS-181 (dihydrochloride) | 1883548-83-1 | Reference compound |
| HY-110369 | MRS2905 (trisodium) | 3033550-04-5 | Reference compound |
| HY-110374 | NVS-CECR2-1 | 1992047-61-6 | Reference compound |
| HY-110377 | Tariquidar (dihydrochloride) | 1992047-62-7 | Reference compound |
| HY-110378 | ISOX-DUAL | 1962928-22-8 | Reference compound |
| HY-110379 | M084 (hydrochloride) | 1992047-63-8 | Reference compound |
| HY-11038 | Zelavespib | 873436-91-0 | Reference compound |
| HY-110381 | JNJ-DGAT2-A | 1962931-71-0 | Reference compound |
| HY-110382 | Cyclic-di-GMP (disodium) | 2222132-40-1 | Reference compound |
| HY-110382S | 13C20,15N10-Cyclic di-GMP (sodium) | Isotope-Labeled Compounds | |
| HY-110385 | cGAMP (disodium) | 2407516-83-8 | Natural Products |
| HY-110385A | cGAMP (diammonium) | Natural Products | |
| HY-110387 | IDO-IN-9 | 1888378-12-8 | Reference compound |
| HY-110389 | Pitofenone hydrochloride | 1248-42-6 | Reference compound |
| HY-11038B | Zelavespib (hydrochloride) | 2095432-24-7 | Reference compound |
| HY-11038D | Zelavespib (formic) | Reference compound | |
| HY-11039 | PU24FCl | 422508-46-1 | Reference compound |
| HY-110390 | GR148672X | 263890-70-6 | Reference compound |
| HY-110392 | CMP8 | 851107-28-3 | Reference compound |
| HY-110393 | CLR1501 | 1250963-36-0 | Dye Reagents |
| HY-110397 | KP-457 | 1365803-52-6 | Reference compound |
| HY-110397G | KP-457 (GMP) | 1365803-52-6 | GMP Small Molecules |
| HY-110398 | 5,6,7-Trimethoxyflavone | 973-67-1 | Natural Products |
| HY-110399 | Cirsiliol | 34334-69-5 | Natural Products |
| HY-110402 | (S,R,S)-AHPC (TFA) | 1631137-51-3 | Reference compound |
| HY-110404 | Capzimin | 2084868-04-0 | Reference compound |
| HY-110406 | 13(S)-HPODE | 33964-75-9 | Natural Products |
| HY-110406A | (±)13-HpODE | 23017-93-8 | Reference compound |
| HY-110407 | 2'-O,4'-C-Methyleneadenosine | 206055-70-1 | Oligonucleotides |
| HY-110408 | Flurandrenolone Acetate | 2802-11-1 | Reference compound |
| HY-11041 | LSP1-2111 | 936234-43-4 | Reference compound |
| HY-11042 | GNE-477 | 1032754-81-6 | Reference compound |
| HY-11044 | PF-03654746 (Tosylate) | 1039399-17-1 | Reference compound |
| HY-11045 | PF-03654746 | 935840-31-6 | Reference compound |
| HY-11046A | KRP-109 | 1275996-50-3 | Reference compound |
| HY-11048 | NS11394 | 951650-22-9 | Reference compound |
| HY-11051 | JNJ-20788560 | 825649-28-3 | Reference compound |
| HY-11052A | Trap-101 (hydrochloride) | 1216621-00-9 | Reference compound |
| HY-11053 | S 24795 | 304679-75-2 | Reference compound |
| HY-11054 | TH-237A | 935467-97-3 | Reference compound |
| HY-11055 | KP 544 | 393856-87-6 | Reference compound |
| HY-11058 | BHF177 | 917896-43-6 | Reference compound |
| HY-11059 | KH064 | 393569-31-8 | Reference compound |
| HY-11062 | Icilin | 36945-98-9 | Reference compound |
| HY-11063 | Fingolimod | 162359-55-9 | Reference compound |
| HY-11063R | Fingolimod (Standard) | 162359-55-9 | Reference Standards |
| HY-11063S | Fingolimod-d4 | 1346747-38-3 | Isotope-Labeled Compounds |
| HY-11063S1 | Fingolimod-d4 (hydrochloride) | 1346604-90-7 | Isotope-Labeled Compounds |
| HY-11065A | (iodo-125)-CGP 71872 | 200402-51-3 | Reference compound |
| HY-11067 | WHI-P97 | 211555-05-4 | Reference compound |
| HY-11068 | SB 239063 | 193551-21-2 | Reference compound |
| HY-11070 | MK-0952 | 934995-87-6 | Reference compound |
| HY-11071 | MK-0952 (sodium) | 934995-88-7 | Reference compound |
| HY-11072 | MK-0359 | 346629-30-9 | Reference compound |
| HY-11076 | GI 181771 | 305366-98-7 | Reference compound |
| HY-11077 | SR 146131 | 221671-61-0 | Reference compound |
| HY-11079 | A-803467 | 944261-79-4 | Reference compound |
| HY-11080 | PKI-179 | 1197160-28-3 | Reference compound |
| HY-11080A | PKI-179 (hydrochloride) | 1463510-35-1 | Reference compound |
| HY-11083 | GW-803430 | 515141-51-2 | Reference compound |
| HY-11084 | SNAP-7941 | 387825-78-7 | Reference compound |
| HY-11085 | T-226296 | 331758-35-1 | Reference compound |
| HY-11087 | SD 0006 | 271576-80-8 | Reference compound |
| HY-11090A | DPC423 | 292135-59-2 | Reference compound |
| HY-11091 | Razaxaban (hydrochloride) | 405940-76-3 | Reference compound |
| HY-11092 | BMS-509744 | 439575-02-7 | Reference compound |
| HY-11095 | NPS 2390 | 226878-01-9 | Reference compound |
| HY-11097 | TMC353121 | 857066-90-1 | Reference compound |
| HY-11098 | JNJ 2408068 | 317846-22-3 | Reference compound |
| HY-11100 | Asenapine (maleate) | 85650-56-2 | Reference compound |
| HY-111000 | BNC-1 | 96335-59-0 | Reference compound |
| HY-111002 | Displurigen | 96156-26-2 | Reference compound |
| HY-111003 | Isothiafludine | 960527-22-4 | Reference compound |
| HY-111006 | (+)-UH 232 | 95999-12-5 | Reference compound |
| HY-111007 | CH5015765 | 959766-47-3 | Reference compound |
| HY-111008 | Trimidox | 95933-74-7 | Reference compound |
| HY-111008A | Trimidox (hydrochloride) | 95933-75-8 | Reference compound |
| HY-111009 | Swinholide A | 95927-67-6 | Natural Products |
| HY-11101 | Alendronate (sodium hydrate) | 121268-17-5 | Reference compound |
| HY-111011 | CR 665 (acetate) | 958873-83-1 | Reference compound |
| HY-111012 | DBCO-(PEG)3-VC-PAB-MMAE | 2754384-60-4 | ADC Related |
| HY-111013 | VK-II-86 | 955371-84-3 | Reference compound |
| HY-111014 | VK-II-36 | 955371-66-1 | Reference compound |
| HY-111016 | LJP 1586 | 955037-42-0 | Reference compound |
| HY-111018 | FPL 62129 | 95445-79-7 | Reference compound |
| HY-111019A | SCH 34343 (sodium) | 94392-35-5 | Reference compound |
| HY-11101R | Alendronate (sodium hydrate) (Standard) | 121268-17-5 | Reference Standards |
| HY-11101S | Alendronate-d6 (sodium hydrate) | Isotope-Labeled Compounds | |
| HY-11102 | RO4929097 | 847925-91-1 | Reference compound |
| HY-111021 | ASP-4058 | 952565-91-2 | Reference compound |
| HY-111021A | ASP-4058 (hydrochloride) | 952510-14-4 | Reference compound |
| HY-111022 | Icerguastat | 951441-04-6 | Reference compound |
| HY-111023 | Nemonoxacin (malate) | 951163-60-3 | Reference compound |
| HY-111024 | 2,2,5,7,8-Pentamethyl-6-Chromanol | 950-99-2 | Reference compound |
| HY-111024R | 2,2,5,7,8-Pentamethyl-6-Chromanol (Standard) | 950-99-2 | Reference Standards |
| HY-111025 | Ectylurea | 95-04-5 | Reference compound |
| HY-111026 | PPQ-581 | 950381-32-5 | Reference compound |
| HY-111027 | HDAC8-IN-13 | 949792-00-1 | Reference compound |
| HY-111028 | J1038 | 949727-86-0 | Reference compound |
| HY-111029 | ALX-1393 | 949164-09-4 | Reference compound |
| HY-111029A | ALX-1393 (TFA) | Reference compound | |
| HY-11103 | Sitaxsentan (sodium) | 210421-74-2 | Reference compound |
| HY-111030 | PRMT1-IN-2 | 947508-41-0 | Reference compound |
| HY-111036 | AMG0347 | 946615-43-6 | Reference compound |
| HY-111037 | BMS-457 | 946594-19-0 | Reference compound |
| HY-111038 | Capsiconiate | 946572-73-2 | Natural Products |
| HY-111040 | Hedgehog agonist 1 | 946002-48-8 | Reference compound |
| HY-111044 | (+)-JNJ-37654032 | 944919-15-7 | Reference compound |
| HY-111048 | Corin | 1808113-09-8 | Reference compound |
| HY-111049 | GSK8062 | 943549-47-1 | Reference compound |
| HY-11105 | Pilaralisib analogue | 956958-53-5 | Reference compound |
| HY-111050 | JNJ-38877618 | 943540-74-7 | Reference compound |
| HY-111051 | JN403 | 942606-12-4 | Reference compound |
| HY-111052 | AZD7325 | 942437-37-8 | Reference compound |
| HY-111053 | P11 | 942285-55-4 | Reference compound |
| HY-111054 | N-methyl-N-dithiocarboxyglucamine | 94161-07-6 | Reference compound |
| HY-111054A | N-methyl-N-dithiocarboxyglucamine (sodium) | 91840-27-6 | Reference compound |
| HY-111055 | BIP-135 | 941575-71-9 | Reference compound |
| HY-111056 | UK122 | 940290-58-4 | Reference compound |
| HY-111058 | D-106669 | 938444-93-0 | Reference compound |
| HY-11106 | Nintedanib esylate | 656247-18-6 | Reference compound |
| HY-111061 | GTX-758 | 938067-78-8 | Reference compound |
| HY-111063 | BX048 | 937395-09-0 | Reference compound |
| HY-111064 | BX 667 | 937395-08-9 | Reference compound |
| HY-111065 | OXA-01 | 936889-68-8 | Reference compound |
| HY-111066 | JNJ-37822681 | 935776-74-2 | Reference compound |
| HY-111066A | JNJ-37822681 (dihydrochloride) | 2108806-02-4 | Reference compound |
| HY-111067 | (4S)-(+)-Ascochin | 935699-58-4 | Natural Products |
| HY-111068 | KD-3010 | 934760-92-6 | Reference compound |
| HY-111069 | Nifeviroc | 934740-33-7 | Reference compound |
| HY-11106R | Nintedanib esylate (Standard) | 656247-18-6 | Reference Standards |
| HY-11107 | PHA-665752 | 477575-56-7 | Reference compound |
| HY-111070 | Karavilagenin D | 934739-29-4 | Natural Products |
| HY-111071 | Nilofabicin | 934628-27-0 | Reference compound |
| HY-111071R | Nilofabicin (Standard) | 934628-27-0 | Reference Standards |
| HY-111073 | Bentysrepinine | 934264-38-7 | Reference compound |
| HY-111074 | DB12055 | 934017-32-0 | Reference compound |
| HY-111077 | INCB16562 | 933768-63-9 | Reference compound |
| HY-111079 | HIV-1 inhibitor-70 | 933452-76-7 | Reference compound |
| HY-11108 | R406 (free base) | 841290-80-0 | Reference compound |
| HY-111081 | (±)-PPCC | 932736-90-8 | Reference compound |
| HY-111081C | (±)-PPCC (oxalate) | 1781628-91-8 | Reference compound |
| HY-111082 | ISAM-140 | 932191-62-3 | Reference compound |
| HY-111083 | ML191 | 931695-79-3 | Reference compound |
| HY-111084 | UK 52831 | 93118-77-5 | Reference compound |
| HY-111085 | CPI-905 | 931078-17-0 | Reference compound |
| HY-111086 | DG70 | 930470-97-6 | Reference compound |
| HY-111087 | AZD-7295 | 929890-64-2 | Reference compound |
| HY-111088 | LUF5981 | 929641-63-4 | Reference compound |
| HY-11109 | Resatorvid | 243984-11-4 | Reference compound |
| HY-111093 | Protein kinase inhibitor 8 | 926319-75-7 | Reference compound |
| HY-111094 | NPD7155 | 924764-38-5 | Reference compound |
| HY-111095B | D-(-)-Lactic acid (sodium) | 920-49-0 | Natural Products |
| HY-111095BR | D-(-)-Lactic acid (sodium) (Standard) | 920-49-0 | Reference Standards |
| HY-111095S1 | D-(-)-Lactic acid-13C | 2102426-04-8 | Isotope-Labeled Compounds |
| HY-111095S2 | D-(-)-Lactic acid-13C-1 | 1224440-85-0 | Isotope-Labeled Compounds |
| HY-111095S3A | D-(-)-Lactic acid-13C-2 (sodium) | 1217621-81-2 | Isotope-Labeled Compounds |
| HY-111098 | GSK1702934A | 924377-85-5 | Reference compound |
| HY-111099 | GLPG1837 | 1654725-02-6 | Reference compound |
| HY-111101 | AZ1495 | 2196204-23-4 | Reference compound |
| HY-111102 | FL-411 | 2118944-88-8 | Reference compound |
| HY-111108 | LDH-IN-1 | 1964515-43-2 | Reference compound |
| HY-111109 | EZM 2302 | 1628830-21-6 | Reference compound |
| HY-111110 | Olorinab | 1268881-20-4 | Reference compound |
| HY-111111 | Galicaftor | 1918143-53-9 | Reference compound |
| HY-111112S | ZHC-116-d8 (trihydrochloride) | Isotope-Labeled Compounds | |
| HY-111116 | LY3104607 | 1795232-22-2 | Reference compound |
| HY-111117 | 3-Methyltoxoflavin | 32502-62-8 | Reference compound |
| HY-111121 | cBu-Cit-OH | 1799663-03-8 | Reference compound |
| HY-111125 | AMRI-59 | 923515-92-8 | Reference compound |
| HY-111126 | K67 | 2046250-48-8 | Reference compound |
| HY-111129 | CP-66713 | 91896-57-0 | Reference compound |
| HY-111130 | Methapyrilene | 91-80-5 | Reference compound |
| HY-111131 | RY764 | 491845-95-5 | Reference compound |
| HY-111132 | JT010 | 917562-33-5 | Reference compound |
| HY-111133 | LY 154045 | 91706-86-4 | Reference compound |
| HY-111134 | TAN 420C | 91700-91-3 | Reference compound |
| HY-111135 | IKK2-IN-3 | 916985-21-2 | Reference compound |
| HY-111136 | BL-1020 (mesylate) | 916898-61-8 | Reference compound |
| HY-111137 | Puquitinib | 916890-10-3 | Reference compound |
| HY-111138 | CZC-8004 | 916603-07-1 | Reference compound |
| HY-111139 | MS417 | 916489-36-6 | Reference compound |
| HY-111140 | YS121 | 916482-17-2 | Reference compound |
| HY-111142 | COR 32-24 | 91595-86-7 | Reference compound |
| HY-111143 | SCH-900271 | 915210-50-3 | Reference compound |
| HY-111144 | Abediterol | 915133-65-2 | Reference compound |
| HY-111145 | RD162 | 915087-27-3 | Reference compound |
| HY-111149 | PS372424 | 914291-61-5 | Reference compound |
| HY-111149A | PS372424 (hydrochloride) | 1596362-29-6 | Reference compound |
| HY-111150 | AMG-222 | 913978-37-7 | Reference compound |
| HY-111151 | AR-9281 | 913548-29-5 | Reference compound |
| HY-111152 | ML115 | 912798-42-6 | Reference compound |
| HY-111154 | BPH-608 | 911783-02-3 | Reference compound |
| HY-111155 | RBI-257 (maleate) | 911378-38-6 | Reference compound |
| HY-111156 | NW-1172 (free base) | 911290-20-5 | Reference compound |
| HY-111157 | Dezinamide | 91077-32-6 | Biochemical Assay Reagents |
| HY-111158 | BMS-748730 | 910297-57-3 | Reference compound |
| HY-111160 | SKF 83509 | 90955-43-4 | Reference compound |
| HY-111161 | GSK575594A | 909418-68-4 | Reference compound |
| HY-111162 | GSK494581A | 909416-67-7 | Reference compound |
| HY-111163 | NSC49652 | 908563-68-8 | Reference compound |
| HY-111164 | CBS-3595 | 908380-97-2 | Reference compound |
| HY-111166 | USP7/USP47 inhibitor 1 | 90680-28-7 | Reference compound |
| HY-111172 | Inotilone | 906366-79-8 | Reference compound |
| HY-111173 | Diprotin B | 90614-49-6 | Reference compound |
| HY-111174 | Diprotin A | 90614-48-5 | Peptides |
| HY-111174A | Diprotin A (TFA) | 209248-71-5 | Peptides |
| HY-111174R | Diprotin A (Standard) | 90614-48-5 | Reference Standards |
| HY-111176 | PD 145305 | 90536-15-5 | Reference compound |
| HY-111177 | Pheneturide | 90-49-3 | Reference compound |
| HY-111177R | Pheneturide (Standard) | 90-49-3 | Reference Standards |
| HY-111178 | Lauflumide | 90280-13-0 | Reference compound |
| HY-111179 | ML261 | 902523-58-4 | Reference compound |
| HY-111180 | ML262 | 902502-82-3 | Reference compound |
| HY-111182 | Estrone acetate | 901-93-9 | Reference compound |
| HY-111183 | Neocarzinostatin | 9014-02-2 | Reference compound |
| HY-111184 | PIK-108 | 901398-68-3 | Reference compound |
| HY-111186 | Flocoumafen | 90035-08-8 | Reference compound |
| HY-111186R | Flocoumafen (Standard) | 90035-08-8 | Reference Standards |
| HY-111187 | KX2-361 | 897016-26-1 | Reference compound |
| HY-111188 | A55453 | 89687-06-9 | Reference compound |
| HY-111189 | GSK931145 | 896117-64-9 | Reference compound |
| HY-111190 | Thiotropocin | 89550-93-6 | Natural Products |
| HY-111191 | ONO-2952 | 895169-20-7 | Reference compound |
| HY-111191A | (R)-ONO-2952 | 2988224-39-9 | Reference compound |
| HY-111192 | IPR-803 | 892243-35-5 | Reference compound |
| HY-111193 | Declopramide | 891-60-1 | Reference compound |
| HY-111194 | Ro 22-8515 | 89052-67-5 | Reference compound |
| HY-111197 | LY-2300559 | 889116-06-7 | Reference compound |
| HY-111198 | YM-355179 (fumarate) | 887647-69-0 | Reference compound |
| HY-111199 | JP83 | 887264-44-0 | Reference compound |
| HY-111200 | Vabicaserin hydrochloride | 887258-94-8 | Reference compound |
| HY-111201 | Iodiconazole | 887138-63-8 | Reference compound |
| HY-111202 | Pyributicarb | 88678-67-5 | Reference compound |
| HY-111202R | Pyributicarb (Standard) | 88678-67-5 | Reference Standards |
| HY-111203 | TT-301 | 886208-76-0 | Reference compound |
| HY-111204 | MK3281 | 886041-60-7 | Reference compound |
| HY-111205 | γ-Secretase modulator 16 | 884599-96-6 | Reference compound |
| HY-111206 | β3-AR agonist 3 | 883724-08-1 | Reference compound |
| HY-111207 | CA224 | 883561-04-4 | Reference compound |
| HY-111208 | CCT129957 | 883098-58-6 | Reference compound |
| HY-111209 | Pichromene | 883046-50-2 | Reference compound |
| HY-111210 | Pridopidine (hydrochloride) | 882737-42-0 | Reference compound |
| HY-111212 | Tomelukast | 88107-10-2 | Reference compound |
| HY-111213 | PRMT5-IN-20 | 880813-30-9 | Reference compound |
| HY-111214 | K-14585 | 880546-17-8 | Reference compound |
| HY-111216 | CGP52608 | 87958-67-6 | Reference compound |
| HY-111217 | AKOS-22 | 878983-38-1 | Reference compound |
| HY-111218 | TRPV1 antagonist 5 | 878811-00-8 | Reference compound |
| HY-111219 | Parogrelil (hydrochloride) | 139145-84-9 | Reference compound |
| HY-111220 | AP23846 | 878654-51-4 | Reference compound |
| HY-111221 | PD 113271 | 87860-38-6 | Reference compound |
| HY-111222 | PD 113270 | 87860-37-5 | Reference compound |
| HY-111223 | Tralkoxydim | 87820-88-0 | Reference compound |
| HY-111223R | Tralkoxydim (Standard) | 87820-88-0 | Reference Standards |
| HY-111224 | GSK812397 | 878197-98-9 | Reference compound |
| HY-111226 | GSK5182 | 877387-37-6 | Reference compound |
| HY-111226A | (E/Z)-GSK5182 | 2699724-40-6 | Reference compound |
| HY-111232 | GSK894281 | 874958-63-1 | Reference compound |
| HY-111233 | Disoxaril | 87495-31-6 | Reference compound |
| HY-111234 | IDO-IN-11 | 1888378-32-2 | Reference compound |
| HY-111237 | Butyrolactone I | 87414-49-1 | Reference compound |
| HY-111238 | Butyrolactone II | 87414-44-6 | Natural Products |
| HY-111239 | GSK317354A | 874119-13-8 | Reference compound |
| HY-111241 | SV 293 | 873445-73-9 | Reference compound |
| HY-111242 | SV 156 | 873445-60-4 | Reference compound |
| HY-111243 | Ganoderone A | 873061-79-1 | Natural Products |
| HY-111244 | DCB-3503 | 87302-58-7 | Reference compound |
| HY-111245 | AZD-1305 | 872045-91-5 | Reference compound |
| HY-111246 | MK-3984 | 871325-55-2 | Reference compound |
| HY-111247 | Ro 09-0680 | 87112-49-0 | Natural Products |
| HY-111248 | ABD-295 | 871113-99-4 | Reference compound |
| HY-111249 | TTT 3002 | 871037-95-5 | Reference compound |
| HY-111253 | CYM-5478 | 870762-83-7 | Reference compound |
| HY-111254 | GQ-16 | 870554-67-9 | Reference compound |
| HY-111255 | SPD304 | 869998-49-2 | Reference compound |
| HY-111255A | SPD304 (dihydrochloride) | 1049741-03-8 | Reference compound |
| HY-111256 | A-850002 | 869802-73-3 | Reference compound |
| HY-111258 | GSK345931A | 869499-38-7 | Reference compound |
| HY-111259 | Ro 31-1118 (free base) | 81228-35-5 | Reference compound |
| HY-111260 | R547 (mesylate) | 869369-26-6 | Reference compound |
| HY-111262 | ABT-384 | 868623-40-9 | Reference compound |
| HY-111263 | NIAD-4 | 868592-56-7 | Dye Reagents |
| HY-111264 | Naphthomycin B | 86825-88-9 | Natural Products |
| HY-111266 | Halenaquinone | 86690-14-4 | Natural Products |
| HY-111267 | Aftin-4 | 866893-90-5 | Reference compound |
| HY-111269 | AZD8848 | 866269-28-5 | Reference compound |
| HY-111271 | L 888607 | 860033-06-3 | Reference compound |
| HY-111271A | L 888607 (Racemate) | 1030017-51-6 | Reference compound |
| HY-111271B | (R)-L 888607 | 2446042-90-4 | Reference compound |
| HY-111273 | AR244555 | 858350-62-6 | Reference compound |
| HY-111274 | Indomethacin farnesil | 85801-02-1 | Reference compound |
| HY-111278 | Pyocyanin | 85-66-5 | Reference compound |
| HY-111278R | Pyocyanin (Standard) | 85-66-5 | Reference Standards |
| HY-111279 | Sisapronil | 856225-89-3 | Reference compound |
| HY-111280 | ST 198 | 854924-64-4 | Reference compound |
| HY-111283 | AJ-76 | 85379-09-5 | Reference compound |
| HY-111284 | Kebuzone | 853-34-9 | Reference compound |
| HY-111285 | HAMNO | 138736-73-9 | Reference compound |
| HY-111287 | Autophagonizer | 853136-76-2 | Reference compound |
| HY-111288 | MB-07811 | 852948-13-1 | Reference compound |
| HY-111291 | ICI 169369 (free base) | 85273-95-6 | Reference compound |
| HY-111292 | CYM-5482 | 852230-33-2 | Reference compound |
| HY-111293 | Arachidonamide | 85146-53-8 | Reference compound |
| HY-111295 | LAS38096 | 851371-22-7 | Reference compound |
| HY-111296 | YM 53403 | 851331-05-0 | Reference compound |
| HY-111297 | BMVC4 | 868843-84-9 | Reference compound |
| HY-111298 | TG 41 | 850339-33-2 | Reference compound |
| HY-111299 | Psammaplysene A | 850013-02-4 | Reference compound |
| HY-111301 | FR217840 | 848444-16-6 | Reference compound |
| HY-111302 | Norgestrienone | 848-21-5 | Reference compound |
| HY-111303 | CHIC35 | 848193-72-6 | Reference compound |
| HY-111304 | MF266-1 | 848188-18-1 | Reference compound |
| HY-111306 | ATL-802 | 847612-12-8 | Reference compound |
| HY-111308 | RTI-118 | 847554-50-1 | Reference compound |
| HY-111309 | LGD-2941 | 847235-85-2 | Reference compound |
| HY-111310 | ML351 | 847163-28-4 | Reference compound |
| HY-111313 | JNJ-26070109 | 844645-08-5 | Reference compound |
| HY-111314 | NZ 419 | 84210-26-4 | Reference compound |
| HY-111315 | XEN103 | 840489-44-3 | Reference compound |
| HY-111317 | SIRT1 activator 3 | 839699-72-8 | Reference compound |
| HY-111320 | Chrysomycin B | 83852-56-6 | Reference compound |
| HY-111321 | Fuscin | 83-85-2 | Natural Products |
| HY-111323 | ASN06917370 | 837404-68-9 | Reference compound |
| HY-111325 | Synta66 | 835904-51-3 | Reference compound |
| HY-111326 | Naphazoline | 835-31-4 | Reference compound |
| HY-111326A | Naphazoline (nitrate) | 5144-52-5 | Reference compound |
| HY-111326AR | Naphazoline (nitrate) (Standard) | 5144-52-5 | Reference Standards |
| HY-111326S | Naphazoline-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-111327 | Valibose | 83470-79-5 | Reference compound |
| HY-111329 | JGB1741 | 1256375-38-8 | Reference compound |
| HY-111330 | Hydroxyphenyl Fluorescein | 359010-69-8 | Dye Reagents |
| HY-111331 | Germicidin B | 150973-78-7 | Natural Products |
| HY-111332 | (E)-PHCCC | 177610-87-6 | Reference compound |
| HY-111333 | Pyrroxamycin | 105888-54-8 | Natural Products |
| HY-111334 | Brassinin | 105748-59-2 | Natural Products |
| HY-111335 | Methoxybrassinin | 105748-60-5 | Natural Products |
| HY-111338 | Tacrine | 321-64-2 | Reference compound |
| HY-111341 | AZD5904 | 618913-30-7 | Reference compound |
| HY-111342 | HDAC8-IN-1 | 1417997-93-3 | Reference compound |
| HY-111343 | ONC212 | 1807861-48-8 | Reference compound |
| HY-111345 | Epaminurad | 1198153-15-9 | Reference compound |
| HY-111345A | Epaminurad (hydrochloride) | 1198153-46-6 | Reference compound |
| HY-111346 | 1-Linoleoyl Glycerol | 2277-28-3 | Natural Products |
| HY-111347 | BB-Cl-Amidine | 1802637-39-3 | Reference compound |
| HY-111347A | BB-Cl-Amidine (hydrochloride) | 2436747-41-8 | Reference compound |
| HY-111348 | Lamifiban | 144412-49-7 | Reference compound |
| HY-111348A | Lamifiban (TFA) | 144412-50-0 | Reference compound |
| HY-111351 | MLK-IN-1 | 1627729-62-7 | Reference compound |
| HY-111353 | GPR120 Agonist 2 | 1234844-11-1 | Reference compound |
| HY-111354 | Tinoridine (hydrochloride) | 25913-34-2 | Reference compound |
| HY-111355 | Cholesterol sulfate | 1256-86-6 | Natural Products |
| HY-111355B | Cholesteryl sulfate (sodium) | 2864-50-8 | Natural Products |
| HY-111355S | Cholesterol sulfate-d7 (sodium) | 2687961-01-7 | Isotope-Labeled Compounds |
| HY-111356 | IIIM-290 | 2213468-64-3 | Reference compound |
| HY-111357 | Antifungal agent 2 | 2211060-61-4 | Reference compound |
| HY-111358 | TLR7 agonist 1 | 2178156-33-5 | Reference compound |
| HY-111359 | GPR40 agonist 1 | 1853982-41-8 | Reference compound |
| HY-111360 | SPL-707 | 2195361-33-0 | Reference compound |
| HY-111361 | FN-1501 | 1429515-59-2 | Reference compound |
| HY-111363 | MK8722 | 1394371-71-1 | Reference compound |
| HY-111365 | TES-1025 | 1883602-21-8 | Reference compound |
| HY-111366 | CD12681 | 1952239-59-6 | Reference compound |
| HY-111368 | EBI-1051 | 1801896-05-8 | Reference compound |
| HY-111369 | CHK1-IN-2 | 912367-45-4 | Reference compound |
| HY-111370 | mTOR inhibitor-2 | 2219323-96-1 | Reference compound |
| HY-111371 | PF-05180999 | 1394033-54-5 | Reference compound |
| HY-111372 | Finerenone | 1050477-31-0 | Reference compound |
| HY-111372A | (Rac)-Finerenone | 1050477-27-4 | Reference compound |
| HY-111372R | Finerenone (Standard) | 1050477-31-0 | Reference Standards |
| HY-111372S | Finerenone-d3 | 2917530-37-9 | Isotope-Labeled Compounds |
| HY-111372S1 | Finerenone-d5 | Isotope-Labeled Compounds | |
| HY-111373 | RapaLink-1 | 1887095-82-0 | Reference compound |
| HY-111374 | NMDI14 | 307519-88-6 | Reference compound |
| HY-111375 | Azoxymethane | 25843-45-2 | Reference compound |
| HY-111376 | Pyrrophenone | 341973-06-6 | Reference compound |
| HY-111377 | Amine-PEG3-Biotin | 359860-27-8 | Dye Reagents |
| HY-111378 | Casein Kinase II Inhibitor IV | 863598-09-8 | Reference compound |
| HY-111378A | Casein Kinase II Inhibitor IV (hydrochloride) | 2320347-54-2 | Reference compound |
| HY-111379 | EHT 5372 | 1425945-63-6 | Reference compound |
| HY-111380 | EHT 1610 | 1425945-60-3 | Reference compound |
| HY-111381 | BI-3812 | 2166387-64-8 | Reference compound |
| HY-111382 | Diphenylterazine | 344940-63-2 | Dye Reagents |
| HY-111383 | LX2343 | 333745-53-2 | Reference compound |
| HY-111385 | UNC9994 (hydrochloride) | 2108826-33-9 | Reference compound |
| HY-111386 | E-7386 | 1799824-08-0 | Reference compound |
| HY-111387 | IDF-11774 | 1429054-28-3 | Reference compound |
| HY-111388 | Romaciclib | 1609522-33-9 | Reference compound |
| HY-111388A | Romaciclib (monohydrochloride) | 2443816-41-7 | Reference compound |
| HY-111388B | Romaciclib (hydrochloride) | 1609452-30-3 | Reference compound |
| HY-111389 | FAAH-IN-1 | 1242441-47-9 | Reference compound |
| HY-111390 | Dot1L-IN-2 | 1940206-71-2 | Reference compound |
| HY-111391 | Resazurin (sodium) | 62758-13-8 | Dye Reagents |
| HY-111391A | Resazurin (sodium), indicator | 62758-13-8 | Biochemical Assay Reagents |
| HY-111391R | Resazurin (sodium) (Standard) | 62758-13-8 | Reference Standards |
| HY-111392 | Glucametacine | 52443-21-7 | Reference compound |
| HY-111396 | PC58538 | 434910-94-8 | Reference compound |
| HY-111397 | Bizelesin | 129655-21-6 | Reference compound |
| HY-111398 | ALB-127158(a) | 1173154-32-9 | Reference compound |
| HY-111400 | SR-4370 | 1816294-67-3 | Reference compound |
| HY-111402 | Pyridomycin | 18791-21-4 | Reference compound |
| HY-111405 | Antimicrobial Compound 1 | 15237-83-9 | Reference compound |
| HY-111406 | Omidenepag isopropyl | 1187451-19-9 | Reference compound |
| HY-111407 | MK-8353 | 1184173-73-6 | Reference compound |
| HY-111408 | EOAI3402143 | 1699750-95-2 | Reference compound |
| HY-111409 | RIP1 kinase inhibitor 1 | 2095515-38-9 | Reference compound |
| HY-111410 | ATX inhibitor 1 | 2225892-70-4 | Reference compound |
| HY-111411 | IZCZ-3 | 2223019-53-0 | Reference compound |
| HY-111412 | DAAO inhibitor-1 | 2065250-25-9 | Reference compound |
| HY-111413 | c(phg-isoDGR-(NMe)k) | 1844830-65-4 | Biochemical Assay Reagents |
| HY-111413A | c(phg-isoDGR-(NMe)k) (TFA) | Biochemical Assay Reagents | |
| HY-111414 | Hsp90-Cdc37-IN-1 | 2227303-22-0 | Reference compound |
| HY-111415 | EGFR-IN-5 | 2225887-26-1 | Reference compound |
| HY-111416 | WY-135 | 2163060-83-9 | Reference compound |
| HY-111417 | GSK2973980A | 2219321-25-0 | Reference compound |
| HY-111418 | EBI-2511 | 2098546-05-3 | Reference compound |
| HY-111419 | DSP-1053 | 1176326-76-3 | Reference compound |
| HY-111419A | DSP-1053 (benzenesulfonate) | 1176326-78-5 | Reference compound |
| HY-111420 | CBP/p300-IN-1 | 2443789-32-8 | Reference compound |
| HY-111421 | ODM-204 | 1642818-64-1 | Reference compound |
| HY-111422 | PLX51107 | 1627929-55-8 | Reference compound |
| HY-111423 | BDP8900 | 2226507-05-5 | Reference compound |
| HY-111424 | BDP9066 | 2226507-04-4 | Reference compound |
| HY-111424A | (R)-BDP9066 | 2284549-25-1 | Reference compound |
| HY-111425 | SSE15206 | 1370046-40-4 | Reference compound |
| HY-111427 | CDK8/19-IN-1 | 1818427-07-4 | Reference compound |
| HY-111428 | Phleomycin D1 | 11031-11-1 | Reference compound |
| HY-111429 | YAP/TAZ inhibitor-1 | 2093565-23-0 | Reference compound |
| HY-111430 | 1-Ethynylnaphthalene | 15727-65-8 | Reference compound |
| HY-111431 | p-Cresyl sulfate | 3233-58-7 | Natural Products |
| HY-111431A | p-Cresyl sulfate (potassium) | 91978-69-7 | Reference compound |
| HY-111431AS | p-Cresol sulfate-d7 (potassium) | 2469278-96-2 | Isotope-Labeled Compounds |
| HY-111431R | p-Cresyl sulfate (Standard) | 3233-58-7 | Reference Standards |
| HY-111432 | CCG-232601 | 1922099-21-5 | Reference compound |
| HY-111433 | BRD4 degrader AT1 | 2098836-45-2 | Reference compound |
| HY-111434 | UAA crosslinker 1 | 1167421-25-1 | Reference compound |
| HY-111434A | UAA crosslinker 1 (hydrochloride) | 1994331-17-7 | Reference compound |
| HY-111441 | 1,4-Chrysenequinone | 100900-16-1 | Reference compound |
| HY-111442 | GC 14 | 447415-34-1 | Reference compound |
| HY-111443 | TR antagonist 1 | 500794-88-7 | Reference compound |
| HY-111444 | Auxinole | 86445-22-9 | Reference compound |
| HY-111445 | CeMMEC1 | 440662-09-9 | Reference compound |
| HY-111446 | EPAC 5376753 | 302826-61-5 | Reference compound |
| HY-111447 | VAS 3947 | 869853-70-3 | Reference compound |
| HY-111449 | BAY-218 | 2162982-11-6 | Reference compound |
| HY-111450 | CB7993113 | 819827-50-4 | Reference compound |
| HY-111451 | Tuvusertib | 1613200-51-3 | Reference compound |
| HY-111452 | EGFR-IN-85 | 1956378-29-2 | Reference compound |
| HY-111453 | Velsecorat | 1196509-60-0 | Reference compound |
| HY-111454 | SR17018 | 2134602-45-0 | Reference compound |
| HY-111455 | LP-211 | 1052147-86-0 | Reference compound |
| HY-111456 | DBCO-NHCO-PEG4-NHS ester | 2100306-58-7 | ADC Related |
| HY-111457 | BAY-677 | 2117404-84-7 | Reference compound |
| HY-111457A | BAY-678 | 675103-36-3 | Reference compound |
| HY-111458 | GSK2643943A | 2449301-27-1 | Reference compound |
| HY-111460 | 15-Oxospiramilactone | 1053172-87-4 | Reference compound |
| HY-111463 | CDK8-IN-3 | 1884500-15-5 | Reference compound |
| HY-111465 | CDK8-IN-4 | 1613638-82-6 | Reference compound |
| HY-111467 | Mcl1-IN-4 | 1580484-04-3 | Reference compound |
| HY-111468 | Mcl1-IN-3 | 1814891-79-6 | Reference compound |
| HY-111469 | CPT-157633 | 888213-72-7 | Reference compound |
| HY-111471 | JAK-IN-5 | 2096999-92-5 | Reference compound |
| HY-111471A | JAK-IN-5 (hydrochloride) | 2751323-21-2 | Reference compound |
| HY-111472 | Porcn-IN-1 | 2036044-77-4 | Reference compound |
| HY-111473 | Anti-inflammatory agent 82 | 178408-16-7 | Reference compound |
| HY-111474 | Para-aminoblebbistatin | 2097734-03-5 | Reference compound |
| HY-111475 | Mitochondrial fusion promoter M1 | 219315-22-7 | Reference compound |
| HY-111477 | (E/Z)-Ensifentrine | 298680-25-8 | Reference compound |
| HY-111478 | Tiaprost | 71116-82-0 | Reference compound |
| HY-111479 | Amibegron | 121524-08-1 | Reference compound |
| HY-111480 | Propionylpromazine | 3568-24-9 | Reference compound |
| HY-111481 | Flutazolam | 27060-91-9 | Reference compound |
| HY-111482 | SM 16 | 614749-78-9 | Reference compound |
| HY-111483 | Tizaterkib | 2097416-76-5 | Reference compound |
| HY-111483A | Tizaterkib (hexanedioic acid) | 2097416-93-6 | Reference compound |
| HY-111484 | GDC-0927 | 1642297-01-5 | Reference compound |
| HY-111484A | GDC-0927 (Racemate) | 1443983-36-5 | Reference compound |
| HY-111485 | INCB-057643 | 1820889-23-3 | Reference compound |
| HY-111486 | LSZ-102 | 2135600-76-7 | Reference compound |
| HY-111487 | α-Methylacyl-CoA racemase 1 | Enzyme | |
| HY-111488 | ML 400 | 1908414-42-5 | Reference compound |
| HY-111489 | LMPTP inhibitor 1 | 1908414-82-3 | Reference compound |
| HY-111489A | LMPTP inhibitor 1 (hydrochloride) | 2310135-38-5 | Reference compound |
| HY-111489B | LMPTP inhibitor 1 (dihydrochloride) | 2310135-46-5 | Reference compound |
| HY-111490 | Desisobutyryl-ciclesonide | 161115-59-9 | Reference compound |
| HY-111490R | Desisobutyryl-ciclesonide (Standard) | 161115-59-9 | Reference Standards |
| HY-111491 | Methiothepin | 20229-30-5 | Reference compound |
| HY-111492 | DIM-C-pPhOCH3 | 33985-68-1 | Reference compound |
| HY-111493 | LRRK2 inhibitor 1 | 1802525-61-6 | Reference compound |
| HY-111494 | TRPA1 Antagonist 1 | 1984825-08-2 | Reference compound |
| HY-111496 | Sulfo-NHS-SS-Biotin (sodium) | 325143-98-4 | Dye Reagents |
| HY-111498 | RGX-104 (hydrochloride) | 610318-03-1 | Reference compound |
| HY-111498A | RGX-104 | 610318-54-2 | Reference compound |
| HY-111499 | Emopamil | 78370-13-5 | Reference compound |
| HY-111500 | (Rac)-NMDAR antagonist 1 | 2435557-99-4 | Reference compound |
| HY-111500A | NMDAR antagonist 1 | 2220162-06-9 | Reference compound |
| HY-111501 | H4R antagonist 1 | 1429375-54-1 | Reference compound |
| HY-111502 | Y06036 | 1832671-96-1 | Reference compound |
| HY-111503 | Y06137 | 2226534-49-0 | Reference compound |
| HY-111505 | NAcM-OPT | 2089293-61-6 | Reference compound |
| HY-111505A | NAcM-OPT (hydrochloride) | 2416146-10-4 | Reference compound |
| HY-111506 | Aurora inhibitor 1 | 2227019-45-4 | Reference compound |
| HY-111507 | PDGFRα kinase inhibitor 1 | 2209053-93-8 | Reference compound |
| HY-111508 | PI3K/mTOR Inhibitor-2 | 1848242-58-9 | Reference compound |
| HY-111509 | TAK-828F | 1854901-94-2 | Reference compound |
| HY-111510 | IPI-3063 | 1425043-73-7 | Reference compound |
| HY-111512 | PF-06795071 | 2075629-81-9 | Reference compound |
| HY-111513 | 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine | 566169-98-0 | Reference compound |
| HY-111514 | 4-(6-Bromo-2-benzothiazolyl)benzenamine | 566169-97-9 | Reference compound |
| HY-111515 | BAY-678 (racemate) | 675103-35-2 | Reference compound |
| HY-111516 | MGV354 | Reference compound | |
| HY-111517 | H3B-8800 | 1825302-42-8 | Reference compound |
| HY-111518 | JH-XI-10-02 | 2209085-22-1 | Reference compound |
| HY-111519 | dTRIM24 | 2170695-14-2 | Reference compound |
| HY-111520 | NVS-SM2 | 1562333-92-9 | Reference compound |
| HY-111521 | Meropenem-vaborbactam | 2031124-72-6 | Reference compound |
| HY-111522 | RK-9123016 | 955900-27-3 | Reference compound |
| HY-111523 | Isomahanine | 144606-95-1 | Natural Products |
| HY-111524 | CPUY201112 | 1860793-58-3 | Reference compound |
| HY-111525 | Monactin | 7182-54-9 | Natural Products |
| HY-111527 | PPZ2 | 896203-18-2 | Reference compound |
| HY-111529 | Tafenoquine | 106635-80-7 | Reference compound |
| HY-111529A | Tafenoquine (Succinate) | 106635-81-8 | Reference compound |
| HY-111530 | GSTO1-IN-1 | 568544-03-6 | Reference compound |
| HY-111531 | DMTr-LNA-5MeU-3-CED-phosphoramidite | 206055-75-6 | Oligonucleotides |
| HY-111532 | (3R,4R)-A2-32-01 | 1359752-95-6 | Reference compound |
| HY-111532B | (3S,4S)-A2-32-01 | Reference compound | |
| HY-111533 | Ingenol 3-Hexanoate | 83036-61-7 | Reference compound |
| HY-111534 | SBI-115 | 882366-16-7 | Reference compound |
| HY-111535 | BoNT-IN-2 | 354784-03-5 | Reference compound |
| HY-111536 | Mitochonic acid 5 | 1354707-41-7 | Reference compound |
| HY-111537 | rel-AZ5576 | 1333468-05-5 | Reference compound |
| HY-111538 | MAGL-IN-1 | 2324160-91-8 | Reference compound |
| HY-111539 | BAY-1316957 | 1613264-40-6 | Reference compound |
| HY-111540 | LY-3381916 | 2166616-75-5 | Reference compound |
| HY-111540A | (Rac)-LY-3381916 | 2166616-74-4 | Reference compound |
| HY-111540B | (S)-LY-3381916 | 2166616-76-6 | Reference compound |
| HY-111543 | AN11251 | 2130750-59-1 | Reference compound |
| HY-111544 | EML741 | 2328074-38-8 | Reference compound |
| HY-111545 | BSc5371 | 2286419-03-0 | Reference compound |
| HY-111546 | BI-3663 | 2341740-84-7 | Reference compound |
| HY-111547 | M1001 | 874590-32-6 | Reference compound |
| HY-111548 | Spastazoline | 2351882-11-4 | Reference compound |
| HY-111549 | Bragsin1 | 369631-68-5 | Reference compound |
| HY-111550 | Bragsin2 | 342795-08-8 | Reference compound |
| HY-111551 | FT113 | 1630808-89-7 | Reference compound |
| HY-111552 | PIM1-IN-1 | 1417630-95-5 | Reference compound |
| HY-111553 | TAS0728 | 2088323-16-2 | Reference compound |
| HY-111554 | AcLys-PABC-VC-Aur0101 | 1438851-17-2 | ADC Related |
| HY-111555 | AmPEG6C2-Aur0131 | 1650569-94-0 | ADC Related |
| HY-111556 | BSJ-03-123 | 2361493-16-3 | Reference compound |
| HY-111557 | YM-254890 | 568580-02-9 | Natural Products |
| HY-111558 | Bobcat339 | 2280037-51-4 | Reference compound |
| HY-111558A | Bobcat339 (hydrochloride) | 2436747-44-1 | Reference compound |
| HY-111570 | PI3Kγ inhibitor AZ2 | 2231760-33-9 | Reference compound |
| HY-111573 | KCL-286 | 1952276-71-9 | Reference compound |
| HY-111578 | BDP-13176 | 2290660-61-4 | Reference compound |
| HY-111582 | BBIQ | 1229024-57-0 | Reference compound |
| HY-111582G | BBIQ (GMP) | 1229024-57-0 | GMP Small Molecules |
| HY-111583 | RXFP3/4 agonist 1 | 2351104-40-8 | Reference compound |
| HY-111587 | Ifenprodil glucuronide | 66516-92-5 | Reference compound |
| HY-111588 | Xanthoangelol | 62949-76-2 | Natural Products |
| HY-111589 | EPZ-4777 | 1381761-52-9 | Reference compound |
| HY-111592 | S-(5′-Adenosyl)-L-cysteine | 35899-53-7 | Peptides |
| HY-111593 | Homo-PROTAC pVHL30 degrader 1 | 2244684-49-7 | Reference compound |
| HY-111594 | Homo-PROTAC cereblon degrader 1 | 2244520-98-5 | Reference compound |
| HY-111595 | SAHA chloroalkane T1 | 1613617-05-2 | Reference compound |
| HY-111603 | Calcium dobesilate | 20123-80-2 | Reference compound |
| HY-111603R | Calcium dobesilate (Standard) | 20123-80-2 | Reference Standards |
| HY-111603S | Dobesilate-d6 (calcium) | Isotope-Labeled Compounds | |
| HY-111604 | Turbinaric acid | 56882-00-9 | Natural Products |
| HY-111606 | DUPA | 302941-52-2 | Reference compound |
| HY-111613 | Pinaverium bromide | 53251-94-8 | Reference compound |
| HY-111613R | Pinaverium bromide (Standard) | 53251-94-8 | Reference Standards |
| HY-111613S | Pinaverium bromide-d4 | Isotope-Labeled Compounds | |
| HY-111613S1 | Pinaverium bromide-d4-1 | Isotope-Labeled Compounds | |
| HY-111614 | Melengestrol acetate | 2919-66-6 | Reference compound |
| HY-111614R | Melengestrol acetate (Standard) | 2919-66-6 | Reference Standards |
| HY-111614S | Melengestrol acetate-d6 | Isotope-Labeled Compounds | |
| HY-111614S1 | Melengestrol acetate-d2 | Isotope-Labeled Compounds | |
| HY-111614S2 | Melengestrol acetate-d3 | Isotope-Labeled Compounds | |
| HY-111615 | J-2156 | 848647-56-3 | Peptides |
| HY-111615A | J-2156 (TFA) | 2387505-73-7 | Peptides |
| HY-111616 | GSK1820795A | 2650253-86-2 | Reference compound |
| HY-111617 | BTR-1 | 18331-34-5 | Reference compound |
| HY-111621 | DC661 | 1872387-43-3 | Reference compound |
| HY-111623 | USP30 inhibitor 11 | 2067332-64-1 | Reference compound |
| HY-111627 | 5-Aza-7-deazaguanine | 67410-64-4 | Reference compound |
| HY-111630 | PluriSIn #2 | 56563-17-8 | Reference compound |
| HY-111634 | Epsilon-momfluorothrin | 1065124-65-3 | Reference compound |
| HY-111636 | VSW1198 | Reference compound | |
| HY-111638 | 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine | 206055-67-6 | Oligonucleotides |
| HY-111639 | 2’-O,4’-C-Methyleneuridine | 200435-92-3 | Reference compound |
| HY-111640 | 3'-Azido-3'-deoxy-5-methylcytidine | 1282040-14-5 | Reference compound |
| HY-111641 | 3'-Azido-3'-deoxy-5-fluorocytidine | 2095417-18-6 | Reference compound |
| HY-111642 | 3'-Azido-3'-deoxy-beta-L-uridine | 2095417-28-8 | Reference compound |
| HY-111643 | 6-Amino-5-azacytidine | 105331-00-8 | Reference compound |
| HY-111644 | 6-Methyl-5-azacytidine | 105330-94-7 | Reference compound |
| HY-111645 | 3-Methylcytidine | 2140-64-9 | Reference compound |
| HY-111646 | N6-Etheno 2'-deoxyadenosine | 68498-25-9 | Reference compound |
| HY-111647 | N2-Methylguanosine | 2140-77-4 | Natural Products |
| HY-111647R | N2-Methylguanosine (Standard) | 2140-77-4 | Reference Standards |
| HY-111647S1 | N2-Methylguanosine-d3 | Isotope-Labeled Compounds | |
| HY-111648 | 6-O-Methyl Guanosine | 7803-88-5 | Reference compound |
| HY-111651 | Gboxin | 2101315-36-8 | Reference compound |
| HY-111652 | S-Gboxin | 2101317-21-7 | Reference compound |
| HY-111653 | CycLuc1 | 1247879-16-8 | Dye Reagents |
| HY-111655 | SKA-31 | 40172-65-4 | Reference compound |
| HY-111659 | His-Pro | 20930-58-9 | Peptides |
| HY-111659A | His-Pro (hydrochloride) | 2415727-78-3 | Peptides |
| HY-111660S | 3-Methoxytyramine sulfate-d4 | Isotope-Labeled Compounds | |
| HY-111660S1 | 3-Methoxytyramine sulfate-13C,d3 | Isotope-Labeled Compounds | |
| HY-111661 | 6,7-Dimethyl-8-ribityllumazine | 2535-20-8 | Reference compound |
| HY-111662 | Fc 11a-2 | 960119-75-9 | Reference compound |
| HY-111663 | VL285 | 1448188-57-5 | Reference compound |
| HY-111664 | (R)-(+)-Citronellal | 2385-77-5 | Natural Products |
| HY-111664A | (S)-(-)-Citronellal | 5949-05-3 | Natural Products |
| HY-111669 | CT1812 | 1802632-22-9 | Reference compound |
| HY-111671 | SOS1 activator 1 | 2245237-53-8 | Reference compound |
| HY-111673 | 8-CPT-Cyclic AMP (sodium) | 93882-12-3 | Reference compound |
| HY-111674 | LDC7559 | 2407782-01-6 | Reference compound |
| HY-111675 | Ac-FLTD-CMK | 2376255-48-8 | Reference compound |
| HY-111678 | ML230 | 1776055-05-0 | Reference compound |
| HY-111680 | Nesolicaftor | 1953130-87-4 | Reference compound |
| HY-111741 | M700F048 | 2056235-51-7 | Natural Products |
| HY-111742 | Bifenazate-diazene | 149878-40-0 | Reference compound |
| HY-111744 | Deacetylanisomycin | 27958-06-1 | Reference compound |
| HY-111745 | Tyk2-IN-5 | 1797432-62-2 | Reference compound |
| HY-111746 | CWHM-1008 | 2362539-97-5 | Reference compound |
| HY-111747 | TBAJ-587 | 2252316-16-6 | Reference compound |
| HY-111748 | RORγt Inverse agonist 2 | 1801197-92-1 | Reference compound |
| HY-111749 | JAK-IN-4 | 1400877-37-3 | Reference compound |
| HY-111750 | JAK-IN-3 | 1400876-94-9 | Reference compound |
| HY-111751 | JNJ-61432059 | 2035814-50-5 | Reference compound |
| HY-111752 | EML4-ALK kinase inhibitor 1 | 1373409-08-5 | Reference compound |
| HY-111753 | WDR5-IN-4 | 2407457-36-5 | Reference compound |
| HY-111753A | WDR5-IN-4 (TFA) | 2749300-35-2 | Reference compound |
| HY-111754 | DMX-5804 | 2306178-56-1 | Reference compound |
| HY-111755 | Oral antiplatelet agent 1 | 2299200-91-0 | Reference compound |
| HY-111756 | BLM-IN-1 | 2056014-40-3 | Reference compound |
| HY-111757 | ABBV-4083 | 1809266-03-2 | Reference compound |
| HY-111758 | PROTAC B-Raf degrader 1 | 2364367-27-9 | Reference compound |
| HY-111759 | Jaspamycin | 22242-96-2 | Reference compound |
| HY-111760 | NRX-252262 | 2438637-61-5 | Reference compound |
| HY-111761 | DIQ3 | 2258636-02-9 | Reference compound |
| HY-111763 | GPR40/FFAR1 modulator 1 | 874755-26-7 | Reference compound |
| HY-111766 | YD-3 | 170632-41-4 | Reference compound |
| HY-111767 | BAY-545 | 1699717-32-2 | Reference compound |
| HY-111769 | Taurochenodeoxycholate-3-sulfate | 67030-59-5 | Natural Products |
| HY-111770 | 2-Bromohexadecanoic acid | 18263-25-7 | Reference compound |
| HY-111772 | Elexacaftor | 2216712-66-0 | Reference compound |
| HY-111772A | (R)-Elexacaftor | 2229860-99-3 | Reference compound |
| HY-111772S | Elexacaftor-13C,d3 | Isotope-Labeled Compounds | |
| HY-111772S1 | Elexacaftor-d3 | Isotope-Labeled Compounds | |
| HY-111775 | LJ570 | 2252488-69-8 | Reference compound |
| HY-111777 | FASN-IN-1 | 1808260-84-5 | Reference compound |
| HY-111778 | EHMT2-IN-1 | 2230849-55-3 | Reference compound |
| HY-111781 | Civorebrutinib | 2155853-43-1 | Reference compound |
| HY-111782 | 8-Mercaptoguanosine | 26001-38-7 | Reference compound |
| HY-111783 | AZD-7648 | 2230820-11-6 | Reference compound |
| HY-111784 | Inobrodib | 2222941-37-7 | Reference compound |
| HY-111786 | LHC-165 | 1258595-14-0 | Reference compound |
| HY-111787 | Elzovantinib | 2271119-26-5 | Reference compound |
| HY-111789 | Subasumstat | 1858276-04-6 | Reference compound |
| HY-111789A | (S)-Subasumstat | 1858282-76-4 | Reference compound |
| HY-111790 | M3258 | 2285330-15-4 | Reference compound |
| HY-111791 | ACY-1083 | 1708113-43-2 | Reference compound |
| HY-111792 | GSK1795091 | 1233589-81-5 | Reference compound |
| HY-111793 | NUCC-390 | 1060524-97-1 | Reference compound |
| HY-111793A | NUCC-390 (dihydrochloride) | 2749281-71-6 | Reference compound |
| HY-111798 | Heme Oxygenase-1-IN-1 | 1093058-52-6 | Reference compound |
| HY-111798A | Heme Oxygenase-1-IN-1 (hydrochloride) | 1092851-70-1 | Reference compound |
| HY-111801 | Woodorien | 155112-92-8 | Natural Products |
| HY-111802 | 3,4'-Dihydroxyflavone | 14919-49-4 | Reference compound |
| HY-111803 | 4'-Methoxyflavonol | 6889-78-7 | Reference compound |
| HY-111804 | 3',4'-Dihydroxyflavonol | 6068-78-6 | Reference compound |
| HY-111806 | 3,7,4'-Trihydroxyflavone | 2034-65-3 | Natural Products |
| HY-111807 | Locked nucleic acid 1 | 206055-71-2 | Oligonucleotides |
| HY-111809 | N6-Ethyladenosine | 14357-08-5 | Reference compound |
| HY-111810 | SMYD2-IN-1 | 2023788-96-5 | Reference compound |
| HY-111811 | Homomangiferin | 21794-66-1 | Natural Products |
| HY-111812 | Tricin 7-O-glucuronide | 32769-02-1 | Natural Products |
| HY-111815 | N4-Acetylcytidine triphosphate | 1428903-57-4 | Natural Products |
| HY-111815A | N4-Acetylcytidine triphosphate (sodium) | 2803886-33-9 | Natural Products |
| HY-111815B | N4-Acetylcytidine triphosphate (sodium) (solution) | 2803886-33-9 | Natural Products |
| HY-111817 | ACT-451840 | 1984890-99-4 | Reference compound |
| HY-111817A | (Rac)-ACT-451840 | 1839508-99-4 | Reference compound |
| HY-111818 | TH34 | 2196203-96-8 | Reference compound |
| HY-111820 | CK1-IN-1 | 1784751-20-7 | Reference compound |
| HY-111823 | VH032 thiol | 2098836-54-3 | Reference compound |
| HY-111824 | VH032-thiol-C6-NH2 | 2098836-63-4 | Reference compound |
| HY-111825A | (R)-1-PeCSO | 16718-23-3 | Natural Products |
| HY-111826 | γ-Glutamyl-S-1-propenyl cysteine | 91216-96-5 | Natural Products |
| HY-111827 | S-1-Propenyl-L-cysteine | 52438-09-2 | Natural Products |
| HY-111828 | TTA-A2 | 953778-63-7 | Reference compound |
| HY-111830 | Lignin | 9005-53-2 | Natural Products |
| HY-111832 | 1,2,3,6-Tetragalloylglucose | 79886-50-3 | Natural Products |
| HY-111836 | NRX-252114 | 2763260-39-3 | Reference compound |
| HY-111838 | ZZW-115 | 801991-87-7 | Reference compound |
| HY-111838A | ZZW-115 (hydrochloride) | 10122-45-9 | Reference compound |
| HY-111839 | ATRA-hydroxyimino | 135325-47-2 | Reference compound |
| HY-111840 | PROTAC CRABP-II Degrader-1 | 1225383-40-3 | Reference compound |
| HY-111841 | PROTAC CRABP-II Degrader-2 | 1225383-38-9 | Reference compound |
| HY-111842 | PROTAC CRABP-II Degrader-3 | 1225383-41-4 | Reference compound |
| HY-111843 | Ch55-O-C3-NH2 | 144298-98-6 | Reference compound |
| HY-111844 | PROTAC RAR Degrader-1 | 1351169-27-1 | Reference compound |
| HY-111845 | Estrone-N-O-C1-amido | 138219-84-8 | Reference compound |
| HY-111846 | PROTAC ERα Degrader-2 | 1351169-29-3 | Reference compound |
| HY-111848 | PROTAC AR Degrader-4 | 1351169-31-7 | Reference compound |
| HY-111848A | PROTAC AR Degrader-4 (TFA) | Reference compound | |
| HY-111849 | Imatinib carbaldehyde | 1436868-85-7 | Reference compound |
| HY-111850 | Bestatin-amido-Me | 339186-54-8 | Reference compound |
| HY-111851 | SNIPER(ABL)-049 | Reference compound | |
| HY-111852 | GNF5-amido-Me | 778277-37-5 | Reference compound |
| HY-111853 | MV-1-NH-Me | 2095244-62-3 | Reference compound |
| HY-111854 | SNIPER(ABL)-015 | Reference compound | |
| HY-111855 | HG-7-85-01-Decyclopropane | 2444044-44-2 | Reference compound |
| HY-111857 | Dasatinib carbaldehyde | 2112837-79-1 | Reference compound |
| HY-111858 | SNIPER(ABL)-050 | Reference compound | |
| HY-111859 | SNIPER(ABL)-058 | 2222354-61-0 | Reference compound |
| HY-111860 | SNIPER(ABL)-013 | Reference compound | |
| HY-111861 | SNIPER(ABL)-024 | 2222355-77-1 | Reference compound |
| HY-111862 | SNIPER(ABL)-044 | Reference compound | |
| HY-111863 | SNIPER(ABL)-047 | Reference compound | |
| HY-111866 | PROTAC RIPK degrader-2 | 1801547-16-9 | Reference compound |
| HY-111870 | PROTAC RIPK degrader-6 | 2089205-64-9 | Reference compound |
| HY-111871 | SNIPER(ABL)-033 | 2222354-18-7 | Reference compound |
| HY-111872 | SNIPER(ABL)-020 | Reference compound | |
| HY-111873 | SNIPER(ABL)-019 | Reference compound | |
| HY-111874 | SNIPER(ABL)-039 | 2222354-29-0 | Reference compound |
| HY-111875 | SNIPER(BRD)-1 | 2095244-54-3 | Reference compound |
| HY-111876 | SNIPER(TACC3)-1 | Reference compound | |
| HY-111876A | SNIPER(TACC3)-1 (hydrochloride) | Reference compound | |
| HY-111877 | SNIPER(TACC3)-2 | Reference compound | |
| HY-111877A | SNIPER(TACC3)-2 (hydrochloride) | Reference compound | |
| HY-111878 | BzNH-BS | 2443928-42-3 | Reference compound |
| HY-111879 | Biotin-BS | Reference compound | |
| HY-111880 | γ-Sanshool | 78886-65-4 | Natural Products |
| HY-111887 | Emzadirib | 2301085-04-9 | Reference compound |
| HY-111894 | BACE-IN-3 | 1388149-39-0 | Reference compound |
| HY-111895A | Macropa-NH2 (hydrochloride) | 2443966-86-5 | Reference compound |
| HY-111895B | Macropa-NH2 (TFA) | 2705054-08-4 | Reference compound |
| HY-111896 | 7-Methoxyrosmanol | 113085-62-4 | Natural Products |
| HY-111896A | (-)-7-Methoxyrosmanol | 24703-38-6 | Natural Products |
| HY-111898 | Epirosmanol | 93380-12-2 | Natural Products |
| HY-111899 | 7-Ethoxyrosmanol | 111200-01-2 | Natural Products |
| HY-111900 | Rosmaquinone | 121927-71-7 | Natural Products |
| HY-111902 | MCB-3681 | 790704-42-6 | Reference compound |
| HY-111903 | Levomecol | 118573-58-3 | Natural Products |
| HY-111904 | EHMT2-IN-2 | 2230850-47-0 | Reference compound |
| HY-111905 | BRD7-IN-1 | 2448414-48-8 | Reference compound |
| HY-111905A | BRD7-IN-1 free base | 2305379-66-0 | Reference compound |
| HY-111911 | Xanthocillin X permethyl ether | 4464-33-9 | Natural Products |
| HY-111912 | Tribenuron-methyl | 101200-48-0 | Reference compound |
| HY-111912R | Tribenuron-methyl (Standard) | 101200-48-0 | Reference Standards |
| HY-111914A | Ferroheme | 14875-96-8 | Natural Products |
| HY-111915 | 1,2-Dioleoyl-sn-glycero-3-phosphate, sodium salt | 108392-02-5 | Natural Products |
| HY-111916 | ODM-207 | 1801503-93-4 | Reference compound |
| HY-111918 | A71378 | 127902-33-4 | Reference compound |
| HY-111919 | 3-Nitrocoumarin | 28448-04-6 | Reference compound |
| HY-111922 | H-Gly-Gly-Pro-OH | 14379-76-1 | Peptides |
| HY-111925 | BI-749327 | 2361241-23-6 | Reference compound |
| HY-111926 | N6-Methyladenosine 5'-monophosphate (disodium salt) | 81921-35-9 | Reference compound |
| HY-111927 | Pilloin | 32174-62-2 | Natural Products |
| HY-111928 | 5,7-Dimethoxyluteolin | 90363-40-9 | Natural Products |
| HY-111930 | 5-Iodo-indirubin-3'-monoxime | 331467-03-9 | Reference compound |
| HY-111931 | Indirubin-3'-monoxime-5-sulphonic acid | 331467-05-1 | Reference compound |
| HY-111932 | Indirubin-5-sulfonate | 244021-67-8 | Reference compound |
| HY-111934 | Cymarin | 508-77-0 | Natural Products |
| HY-111935 | 3,3'-Diethyl-9-methylthiacarbocyanine (iodide) | 3065-79-0 | Reference compound |
| HY-111937 | MI-1 | 433311-07-0 | Reference compound |
| HY-111939 | Amiprofos methyl | 36001-88-4 | Reference compound |
| HY-111939R | Amiprofos methyl (Standard) | 36001-88-4 | Reference Standards |
| HY-111940 | LUT014 | 2274819-46-2 | Reference compound |
| HY-111941 | GSK8612 | 2361659-62-1 | Reference compound |
| HY-111945 | Cys modifier 1 | 2374314-08-4 | Reference compound |
| HY-111946 | GSK3145095 | 1622849-43-7 | Reference compound |
| HY-111947 | c-Fms-IN-6 | 1628574-81-1 | Reference compound |
| HY-111948 | c-Fms-IN-7 | 1313408-89-7 | Reference compound |
| HY-111950 | (-)-Ibuprofenamide | 121839-78-9 | Reference compound |
| HY-111951 | D-Panose | 33401-87-5 | Reference compound |
| HY-111951R | D-Panose (Standard) | 33401-87-5 | Reference Standards |
| HY-111952 | SR-4995 | 891509-95-8 | Reference compound |
| HY-111954 | (+)-Erinacin A | 156101-08-5 | Reference compound |
| HY-111956 | D-Ala-Lys-AMCA | 375822-19-8 | Dye Reagents |
| HY-111956A | D-Ala-Lys-AMCA (TFA) | Dye Reagents | |
| HY-111956B | D-Ala-Lys-AMCA (hydrochloride) | 2703746-41-0 | Dye Reagents |
| HY-111957 | Fenquinotrione | 1342891-70-6 | Reference compound |
| HY-111959 | 2-Selenouracil | 16724-03-1 | Reference compound |
| HY-111961 | Epitizide | 1764-85-8 | Reference compound |
| HY-111964 | Lenacapavir | 2189684-44-2 | Reference compound |
| HY-111964A | Lenacapavir (sodium) | 2283356-12-5 | Reference compound |
| HY-111965 | PF-06647263 | 1822383-65-2 | Reference compound |
| HY-111968 | Orysastrobin | 248593-16-0 | Reference compound |
| HY-111968R | Orysastrobin (Standard) | 248593-16-0 | Reference Standards |
| HY-111969 | BT18 | 924811-53-0 | Reference compound |
| HY-111973 | Phaseic acid | 24394-14-7 | Reference compound |
| HY-111973S3 | Phaseic acid-d4 | 721948-57-8 | Isotope-Labeled Compounds |
| HY-111974 | β-D-Glucopyranosyl abscisate | 21414-42-6 | Natural Products |
| HY-111975S1 | 7'-Hydroxy ABA-d2 | 865875-19-0 | Isotope-Labeled Compounds |
| HY-111975S5 | 7'-Hydroxy ABA-d7 | Isotope-Labeled Compounds | |
| HY-111976 | MT1 | 2060573-82-0 | Reference compound |
| HY-111977 | ZEN-3219 | 1952264-34-4 | Reference compound |
| HY-111978 | ZEN-3862 | 1952264-33-3 | Reference compound |
| HY-111979 | ZEN-3411 | 1952264-36-6 | Reference compound |
| HY-111983 | Etiroxate | 17365-01-4 | Reference compound |
| HY-111984A | Quinazosin (dihydrochloride) | 7262-00-2 | Reference compound |
| HY-111985 | Revospirone | 95847-87-3 | Reference compound |
| HY-111986 | Trixolane | 47420-28-0 | Reference compound |
| HY-111988 | Penamecillin | 983-85-7 | Reference compound |
| HY-111990 | Tetrofosmin | 127502-06-1 | Reference compound |
| HY-111991S | Cyhalothrin-d5 | 2411870-79-4 | Isotope-Labeled Compounds |
| HY-111996 | Kv3 modulator 1 | 1380696-64-9 | Reference compound |
| HY-111997 | VH285-PEG4-C4-Cl | 1799506-07-2 | Reference compound |
| HY-111999A | E7766 (diammonium salt) | 2242635-03-4 | Reference compound |
| HY-111999B | E7766 (disodium) | 2242636-28-6 | Reference compound |
| HY-112005 | DOPE | 4004-05-1 | Oligonucleotides |
| HY-112005A | DOPE (Excipient) | 4004-05-1 | Natural Products |
| HY-112006 | (S)-ar-Curcumene | 4176-06-1 | Natural Products |
| HY-112009S | Methiocarb sulfoxide-d3 | Isotope-Labeled Compounds | |
| HY-112015 | Deschlorohaloperidol | 3109-12-4 | Reference compound |
| HY-112016 | C20 Ceramide | 7344-02-7 | Natural Products |
| HY-112016A | Sphingomyelin C20:2 | 123482-93-9 | Natural Products |
| HY-112019 | L-Methionine-34S | 1006386-95-3 | Isotope-Labeled Compounds |
| HY-112023 | Lumisterol 3 (>90%) | 5226-01-7 | Reference compound |
| HY-112026 | 1-Adamantaneethanol | 6240-11-5 | Reference compound |
| HY-112030 | Dipotassium tetrachloroplatinate | 10025-99-7 | Biochemical Assay Reagents |
| HY-112037 | IACS-010759 | 1570496-34-2 | Reference compound |
| HY-112037A | IACS-010759 (hydrochloride) | 1807523-99-4 | Reference compound |
| HY-112038 | GSK2983559 (free acid) | 1579965-12-0 | Reference compound |
| HY-112038A | GSK2983559 | Reference compound | |
| HY-112041 | Unesbulin | 1610964-64-1 | Reference compound |
| HY-112045 | Foscenvivint | 1422253-38-0 | Reference compound |
| HY-112047 | GSK8175 | 1423007-82-2 | Reference compound |
| HY-112050 | CU-CPT-8m | 125079-83-6 | Reference compound |
| HY-112051 | CU-CPT9b | 2162962-69-6 | Reference compound |
| HY-112052 | Aminomalonic acid | 1068-84-4 | Natural Products |
| HY-112052R | Aminomalonic acid (Standard) | 1068-84-4 | Reference Standards |
| HY-112053 | DPPH | 1898-66-4 | Reference compound |
| HY-112053R | DPPH (Standard) | 1898-66-4 | Reference Standards |
| HY-112055 | DIM-C-pPhOH | 151358-47-3 | Reference compound |
| HY-112056 | DIM-C-pPhCO2Me | 151358-48-4 | Reference compound |
| HY-112057 | Pseudoerythromycin A enol ether | 105882-69-7 | Reference compound |
| HY-112060 | Saccharin 1-methylimidazole | 482333-74-4 | Reference compound |
| HY-112061 | 8-OH-DPAT | 78950-78-4 | Reference compound |
| HY-112062 | POL1-IN-1 | 1822358-25-7 | Reference compound |
| HY-112063 | CIL56 | 300802-28-2 | Reference compound |
| HY-112065 | PF-06869206 | 2227425-05-8 | Reference compound |
| HY-112066 | SHIN1 | 2146095-85-2 | Reference compound |
| HY-112066A | (+)-SHIN1 | 2443966-90-1 | Reference compound |
| HY-112066B | (-)-SHIN1 | 2444764-09-2 | Reference compound |
| HY-112067 | Chlorcyclizine | 82-93-9 | Reference compound |
| HY-112067A | Chlorcyclizine (hydrochloride) | 14362-31-3 | Reference compound |
| HY-112068 | DM-NOFD | 865488-53-5 | Reference compound |
| HY-112070 | Oxyfedrine | 15687-41-9 | Reference compound |
| HY-112071 | Prenalterol | 57526-81-5 | Reference compound |
| HY-112071A | Prenalterol (hydrochloride) | 61260-05-7 | Reference compound |
| HY-112074 | Tiamenidine | 31428-61-2 | Reference compound |
| HY-112074A | Tiamenidine (hydrochloride) | 51274-83-0 | Reference compound |
| HY-112075 | Lidoflazine | 3416-26-0 | Reference compound |
| HY-112076 | Atropine methyl (bromide) | 2870-71-5 | Reference compound |
| HY-112076A | Atropine methyl (nitrate) | 52-88-0 | Reference compound |
| HY-112076R | Atropine methyl (bromide) (Standard) | 2870-71-5 | Reference Standards |
| HY-112077 | (Z)-Viaminate | 251441-94-8 | Reference compound |
| HY-112077A | Viaminate | 53839-71-7 | Reference compound |
| HY-112077AR | Viaminate (Standard) | 53839-71-7 | Reference Standards |
| HY-112078 | (S,R,S)-AHPC-Me | 1948273-02-6 | Reference compound |
| HY-112078A | (S,R,S,R)-AHPC-Me | 2055344-67-5 | Reference compound |
| HY-112080 | BAY-6035 | 2247890-13-5 | Reference compound |
| HY-112080A | (R)-BAY-6035 | 2283389-29-5 | Reference compound |
| HY-112081 | BAY-707 | 2109805-96-9 | Reference compound |
| HY-112081A | BAY-707 (acetate) | 2223023-19-4 | Reference compound |
| HY-112082 | BAY885 | 2307249-33-6 | Reference compound |
| HY-112083 | BAY-3827 | 2377576-35-5 | Reference compound |
| HY-112085 | N-Bis(2-hydroxypropyl)nitrosamine | 53609-64-6 | Reference compound |
| HY-112088 | AZD4573 | 2057509-72-3 | Reference compound |
| HY-112089 | Naporafenib | 1800398-38-2 | Reference compound |
| HY-112090 | ABBV-744 | 2138861-99-9 | Reference compound |
| HY-112091 | GSK2200150A | 1443138-53-1 | Reference compound |
| HY-112094 | WNK-IN-11 | 2123489-30-3 | Reference compound |
| HY-112094S | WNK-IN-11-d3 | 2123483-49-6 | Isotope-Labeled Compounds |
| HY-112096 | eCF506 | 1914078-41-3 | Reference compound |
| HY-112096S | eCF506-d5 | Isotope-Labeled Compounds | |
| HY-112097 | E260 | 1241537-79-0 | Reference compound |
| HY-112098 | PROTAC ERα Degrader-1 | 2417369-94-7 | Reference compound |
| HY-112099 | Mc-Val-Cit-PAB-Cl | 1639351-92-0 | ADC Related |
| HY-112100 | PROTAC ERα Degrader-5 | 2158322-33-7 | ADC Related |
| HY-112101 | Prohydrojasmon (racemate) | 158474-72-7 | Reference compound |
| HY-112101R | Prohydrojasmon (racemate) (Standard) | 158474-72-7 | Reference Standards |
| HY-112102 | (22S,23S)-Homobrassinolide | 80483-89-2 | Reference compound |
| HY-112102R | (22S,23S)-Homobrassinolide (Standard) | 80483-89-2 | Reference Standards |
| HY-112103 | 6-(γ,γ-Dimethylallylamino)purine | 2365-40-4 | Natural Products |
| HY-112103R | 6-(γ,γ-Dimethylallylamino)purine (Standard) | 2365-40-4 | Reference Standards |
| HY-112103S | 6-(γ,γ-Dimethylallylamino)purine-d6 | 175733-28-5 | Isotope-Labeled Compounds |
| HY-112104 | Meta-topolin | 75737-38-1 | Reference compound |
| HY-112105 | Prohexadione (calcium) | 127277-53-6 | Reference compound |
| HY-112105A | Prohexadione | 88805-35-0 | Reference compound |
| HY-112105R | Prohexadione (calcium) (Standard) | 127277-53-6 | Reference Standards |
| HY-112106A | Diethyl aminoethyl hexanoate citrate | 220439-24-7 | Reference compound |
| HY-112107 | Folcisteine | 5025-82-1 | Reference compound |
| HY-112108 | Chitosan oligosaccharide | 148411-57-8 | Reference compound |
| HY-112111 | Poly-L-Glutamic acid (MW 700000) | 25513-46-6 | Natural Products |
| HY-112111A | Poly-L-Glutamic acid (MW 100000) | 25513-46-6 | Biochemical Assay Reagents |
| HY-112113 | SLV-2436 | 2095704-43-9 | Reference compound |
| HY-112114 | DTPA-DAB2 | 2437438-20-3 | Reference compound |
| HY-112120 | 2-Amino-6-chloro-9-(3-deoxy-3-fluoro-beta-D-ribofuranosyl)-9H-purine | 1612192-05-8 | Reference compound |
| HY-112125 | KRN2 | 248260-75-5 | Reference compound |
| HY-112125A | KRN2 (bromide) | 1390654-28-0 | Reference compound |
| HY-112126 | KRN5 | 1800465-47-7 | Reference compound |
| HY-112128 | USP7-IN-3 | 2202738-42-7 | Reference compound |
| HY-112129 | AGI-25696 | 2201066-35-3 | Reference compound |
| HY-112130 | AGI-24512 | 2201066-53-5 | Reference compound |
| HY-112131 | MAT2A inhibitor 1 | 2201057-10-3 | Reference compound |
| HY-112132 | Palmitodiolein | 2190-30-9 | Reference compound |
| HY-112134 | CSN5i-3 | 2375740-98-8 | Reference compound |
| HY-112134A | (R)-CSN5i-3 | 2863607-74-1 | Reference compound |
| HY-112136 | TAO Kinase inhibitor 1 | 850467-66-2 | Reference compound |
| HY-112137 | Trehalose-6,6'-dibehenate | 66758-35-8 | Reference compound |
| HY-112139 | 4-(Bromoacetyl)phenoxyacetic acid | 29936-81-0 | Reference compound |
| HY-112140 | JH-VIII-157-02 | 1639422-97-1 | Reference compound |
| HY-112142 | AB-423 | 1572510-80-5 | Reference compound |
| HY-112142A | (Rac)-AB-423 | 422547-55-5 | Reference compound |
| HY-112143 | STOCK2S-26016 | 332922-63-1 | Reference compound |
| HY-112144 | TP0463518 | 1558021-37-6 | Reference compound |
| HY-112145 | FLT3-IN-3 | 2229050-90-0 | Reference compound |
| HY-112146 | MMG-11 | 313254-94-3 | Reference compound |
| HY-112146A | MMG-11 (quarterhydrate) | Reference compound | |
| HY-112147 | IDO1 and HDAC1 Inhibitor | 2227044-16-6 | Reference compound |
| HY-112148 | AKT-IN-2 | 1295514-91-8 | Reference compound |
| HY-112149 | ZL0420 | 2230496-80-5 | Reference compound |
| HY-112149A | (E/Z)-ZL0420 | 2229039-45-4 | Reference compound |
| HY-112150 | ZL0454 | 2229042-77-5 | Reference compound |
| HY-112151 | EG01377 | 2227996-00-9 | Reference compound |
| HY-112151A | EG01377 (dihydrochloride) | 2749438-61-5 | Reference compound |
| HY-112152 | GSK726701A | 945721-87-9 | Reference compound |
| HY-112154 | CXCR7 modulator 2 | 2227426-37-9 | Reference compound |
| HY-112155 | MS4078 | 2229036-62-6 | Reference compound |
| HY-112156 | MS4077 | 2230077-10-6 | Reference compound |
| HY-112157 | PF-06751979 | 1818339-66-0 | Reference compound |
| HY-112158 | NSC139021 | 1147-56-4 | Reference compound |
| HY-112160 | XL-784 (free base) | 1356992-21-6 | Reference compound |
| HY-112161 | Branebrutinib | 1912445-55-6 | Reference compound |
| HY-112162 | BOS-172722 | 1578245-44-9 | Reference compound |
| HY-112163 | Zotatifin | 2098191-53-6 | Reference compound |
| HY-112163A | rel-Zotatifin | 2098191-54-7 | Reference compound |
| HY-112164 | IACS-8968 | 2144425-14-7 | Reference compound |
| HY-112164A | IACS-8968 (R-enantiomer) | 2239305-67-8 | Reference compound |
| HY-112164B | IACS-8968 (S-enantiomer) | 2239305-70-3 | Reference compound |
| HY-112165 | PRMT5-IN-2 | 1989620-04-3 | Reference compound |
| HY-112166 | (E)-Rilzabrutinib | 1575596-29-0 | Reference compound |
| HY-112167 | GDC-0575 | 1196541-47-5 | Reference compound |
| HY-112167A | GDC-0575 (dihydrochloride) | 1657014-42-0 | Reference compound |
| HY-112167B | GDC0575 (hydrochloride) | 1196504-54-7 | Reference compound |
| HY-112169 | 10-Formyltetrahydrofolic acid | 2800-34-2 | Reference compound |
| HY-112169A | 10-Formyltetrahydrofolic acid (disodium) | 914800-65-0 | Reference compound |
| HY-112171 | γ-L-Glutamyl-L-alanine | 5875-41-2 | Reference compound |
| HY-112172 | Tenalisib R Enantiomer | 1639417-54-1 | Reference compound |
| HY-112173 | Prolylleucine | 61596-47-2 | Peptides |
| HY-112174 | UDP-GlcNAc (disodium) | 91183-98-1 | Reference compound |
| HY-112174S | UDP-GlcNAc-13C (disodium) | Isotope-Labeled Compounds | |
| HY-112175 | N-Acetylhistamine | 673-49-4 | Natural Products |
| HY-112175R | N-Acetylhistamine (Standard) | 673-49-4 | Reference Standards |
| HY-112176 | Kanosamine hydrochloride | 57649-10-2 | Reference compound |
| HY-112176R | Kanosamine hydrochloride (Standard) | 57649-10-2 | Reference Standards |
| HY-112177 | Myxothiazol | 76706-55-3 | Natural Products |
| HY-112179 | GSK180 | 1799725-26-0 | Reference compound |
| HY-112180 | Rilematovir | 1383450-81-4 | Reference compound |
| HY-112181 | KO-947 | 1695533-89-1 | Reference compound |
| HY-112182 | UM-164 | 903564-48-7 | Reference compound |
| HY-112185 | Orforglipron | 2212020-52-3 | Reference compound |
| HY-112185A | Orforglipron (hemicalcium hydrate) | 3008544-96-2 | Reference compound |
| HY-112189 | Interferon receptor inducer-1 | 2215120-36-6 | Reference compound |
| HY-112191 | PI3K-IN-10 | 2211922-64-2 | Reference compound |
| HY-112197 | PKG drug G1 | 374703-78-3 | Reference compound |
| HY-112198 | AZ31 | 2088113-98-6 | Reference compound |
| HY-112199 | CP-447697 | 1092847-21-6 | Reference compound |
| HY-112202 | GSK3395879 | 2215852-91-6 | Reference compound |
| HY-112205 | RR-11a | 1361390-56-8 | Reference compound |
| HY-112205A | RR-11a analog | 685543-66-2 | Reference compound |
| HY-112209 | VU0467154 | 1451993-15-9 | Reference compound |
| HY-112210 | Shield-1 | 914805-33-7 | Reference compound |
| HY-112215 | Nemtabrutinib | 2095393-15-8 | Reference compound |
| HY-112217A | PSEM 89S (TFA) | 1336913-03-1 | Reference compound |
| HY-112218 | MIK665 | 1799631-75-6 | Reference compound |
| HY-112218A | (R)-MIK665 | 1799831-02-9 | Reference compound |
| HY-112219 | H3R antagonist 1 | 1448422-61-4 | Reference compound |
| HY-112219A | H3R antagonist 1 (hydrochloride) | 2319790-07-1 | Reference compound |
| HY-112220 | VIT-2763 | 2095668-10-1 | Reference compound |
| HY-112225 | Narasin (sodium) | 58331-17-2 | Reference compound |
| HY-112226 | VRT-043198 | 244133-31-1 | Reference compound |
| HY-112226R | VRT-043198 (Standard) | 244133-31-1 | Reference Standards |
| HY-112233 | O-304 | 1261289-04-6 | Reference compound |
| HY-112234 | L-Sepiapterin | 17094-01-8 | Natural Products |
| HY-112240 | Antibacterial agent 104 | 2095612-29-4 | Reference compound |
| HY-112243 | Cimpuciclib | 2202767-78-8 | Reference compound |
| HY-112243A | Cimpuciclib (tosylate) | 2408872-84-2 | Reference compound |
| HY-112247 | SR 16832 | 2088135-12-8 | Reference compound |
| HY-112248 | (Rac)-HAMI 3379 | 712313-35-4 | Reference compound |
| HY-112248A | HAMI 3379 | 1245653-57-9 | Reference compound |
| HY-112251 | D-Lin-MC3-DMA | 1224606-06-7 | Oligonucleotides |
| HY-112251A | D-Lin-MC3-DMA (Excipient) | 1224606-06-7 | Reference compound |
| HY-112251S | D-Lin-MC3-DMA-13C3 | Isotope-Labeled Compounds | |
| HY-112253 | Fructose 1-phosphate | 15978-08-2 | Natural Products |
| HY-112253A | D-Fructose 1-phosphate (disodium) | 71662-09-4 | Reference compound |
| HY-112254 | ZINC03129319 | 1777807-64-3 | Reference compound |
| HY-112255 | J9 | 947018-15-7 | Reference compound |
| HY-112256 | ACP-105 | 899821-23-9 | Reference compound |
| HY-112257 | S-23 | 1010396-29-8 | Reference compound |
| HY-112258 | IMP-1088 | 2059148-82-0 | Reference compound |
| HY-112261 | CDK12-IN-3 | 2220184-50-7 | Reference compound |
| HY-112262 | CGRP antagonist 1 | 1123757-49-2 | Reference compound |
| HY-112263 | ORL1 antagonist 1 | 1174985-59-1 | Reference compound |
| HY-112264 | ETA antagonist 1 | 161801-60-1 | Reference compound |
| HY-112265 | CRTh2 antagonist 1 | 1379445-54-1 | Reference compound |
| HY-112266 | MARK-IN-4 | 1990492-86-8 | Reference compound |
| HY-112267 | Olacaftor | 1897384-89-2 | Reference compound |
| HY-112267A | (R)-Olacaftor | 1899111-41-1 | Reference compound |
| HY-112269 | Glutaminyl Cyclase Inhibitor 1 | 2110449-60-8 | Reference compound |
| HY-112270 | Glutaminyl Cyclase Inhibitor 2 | 1884546-29-5 | Reference compound |
| HY-112272 | Lerociclib | 1628256-23-4 | Reference compound |
| HY-112272A | Lerociclib (dihydrochloride) | 2097938-59-3 | Reference compound |
| HY-112273 | CD532 | 1639009-81-6 | Reference compound |
| HY-112273A | CD532 (hydrochloride) | 2926498-81-7 | Reference compound |
| HY-112274 | M443 | 1820684-31-8 | Reference compound |
| HY-112275 | TNF-α-IN-1 | 444287-49-4 | Reference compound |
| HY-112276 | Beryllon II | 51550-25-5 | Dye Reagents |
| HY-112277 | NCT-505 | 2231079-74-4 | Reference compound |
| HY-112278 | NCT-506 | 2231098-99-8 | Reference compound |
| HY-112279 | GNE-131 | 1629063-81-5 | Reference compound |
| HY-112280 | Crozbaciclib | 2099128-41-1 | Reference compound |
| HY-112280A | Crozbaciclib (fumarate) | 2567494-39-5 | Reference compound |
| HY-112282 | BI-1408 | 2231075-94-6 | Reference compound |
| HY-112284 | Ebopiprant | 2005486-31-5 | Reference compound |
| HY-112284A | Ebopiprant (hydrochloride) | 2005486-32-6 | Reference compound |
| HY-112285 | FT895 | 2225728-57-2 | Reference compound |
| HY-112286 | PI3Kγ inhibitor 2 | 1315538-79-4 | Reference compound |
| HY-112287 | ERK1/2 inhibitor 1 | 2095719-90-5 | Reference compound |
| HY-112288 | C188-9 | 432001-19-9 | Reference compound |
| HY-112289 | IDH889 | 1429179-07-6 | Reference compound |
| HY-112289B | (1R)-IDH889 | 1429179-08-7 | Reference compound |
| HY-112290 | MK-0736 | 719272-79-4 | Reference compound |
| HY-112290A | MK-0736 (hydrochloride) | 719274-77-8 | Reference compound |
| HY-112291 | SB 220025 | 165806-53-1 | Reference compound |
| HY-112291A | SB 220025 (tri(hydrochloride)) | 197446-75-6 | Reference compound |
| HY-112292 | GW806742X | 579515-63-2 | Reference compound |
| HY-112292A | GW806742X (hydrochloride) | Reference compound | |
| HY-112293 | GW2974 | 202272-68-2 | Reference compound |
| HY-112294 | TIE-2/VEGFR-2 kinase-IN-1 | 453590-24-4 | Reference compound |
| HY-112295 | AzKTB | Reference compound | |
| HY-112296 | T025 | 2407433-00-3 | Reference compound |
| HY-112297 | BACE-1 inhibitor 1 | 1262858-14-9 | Reference compound |
| HY-112298 | DS88790512 | 2231089-95-3 | Reference compound |
| HY-112299 | Zipalertinib | 1661854-97-2 | Reference compound |
| HY-112300 | ERK2 IN-1 | 1093061-47-2 | Reference compound |
| HY-112301 | Pralsetinib | 2097132-94-8 | Reference compound |
| HY-112301A | trans-Pralsetinib | 2097132-93-7 | Reference compound |
| HY-112301R | Pralsetinib (Standard) | 2097132-94-8 | Reference Standards |
| HY-112302 | HC-070 | 1628291-95-1 | Reference compound |
| HY-112304 | NCD38 (TFA) | Reference compound | |
| HY-112304A | (1R,2S)-NCD38 (TFA) | 2078047-42-2 | Reference compound |
| HY-112305 | AZ32 | 2288709-96-4 | Reference compound |
| HY-112306 | Ripretinib | 1442472-39-0 | Reference compound |
| HY-112307A | (Rac)-1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol (sodium) | 124011-52-5 | Reference compound |
| HY-112308 | NCGC00247743 | 1435192-04-3 | Reference compound |
| HY-112314 | AZD0424 | 692054-06-1 | Reference compound |
| HY-112316 | BAY1238097 | 1564268-08-1 | Reference compound |
| HY-112316A | (R)-BAY1238097 | 1564269-85-7 | Reference compound |
| HY-112316B | (Rac)-BAY1238097 | 1564268-19-4 | Reference compound |
| HY-112318 | GSK-2793660 (free base) | 1613458-70-0 | Reference compound |
| HY-112318A | GSK-2793660 | 1613458-78-8 | Reference compound |
| HY-112319 | MK-8457 | 1312518-84-5 | Reference compound |
| HY-112322 | Carbacyclin | 69552-46-1 | Reference compound |
| HY-112324 | Terizidone | 25683-71-0 | Reference compound |
| HY-112328 | Fascaplysin | 114719-57-2 | Natural Products |
| HY-112330 | 4-Cyano-3-methylisoquinoline | 161468-32-2 | Reference compound |
| HY-112331 | SJ000291942 | 425613-09-8 | Reference compound |
| HY-112333 | SC-68376 | 318480-82-9 | Reference compound |
| HY-112335 | Lck Inhibitor III | 1188890-30-3 | Reference compound |
| HY-112336 | Aloisine RP106 | 496864-15-4 | Reference compound |
| HY-112337 | VEGFR-2-IN-44 | 288144-20-7 | Reference compound |
| HY-112338 | C188 | 823828-18-8 | Reference compound |
| HY-112340 | CB1 antagonist 4 | 1253641-65-4 | Reference compound |
| HY-112345 | PD-089828 | 179343-17-0 | Reference compound |
| HY-112346 | RGB-286147 | 784211-09-2 | Reference compound |
| HY-112348 | HA-1004 (hydrochloride) | 92564-34-6 | Reference compound |
| HY-112349 | SB 203580 sulfone | 152121-46-5 | Reference compound |
| HY-112350 | AGL 2043 | 226717-28-8 | Reference compound |
| HY-112352 | SU9518 | 251356-32-8 | Reference compound |
| HY-112353 | NP603 | 949164-80-1 | Reference compound |
| HY-112355 | Aurora kinase inhibitor-2 | 331770-21-9 | Reference compound |
| HY-112356 | Scytonemin | 152075-98-4 | Natural Products |
| HY-112358 | GW8510 | 222036-17-1 | Reference compound |
| HY-112359 | C-82 | 1422253-37-9 | Reference compound |
| HY-112362 | 3-(4-Pyridyl)indole | 7272-84-6 | Reference compound |
| HY-112363 | Aloisine A | 496864-16-5 | Reference compound |
| HY-112367 | SB 202474 | 172747-50-1 | Reference compound |
| HY-112368 | PHPS1 | 314291-83-3 | Reference compound |
| HY-112371 | (S)-CR8 | 1084893-56-0 | Reference compound |
| HY-112373 | Aurora kinase inhibitor-3 | 879127-16-9 | Reference compound |
| HY-112374 | NPAS3-IN-1 | 2207-44-5 | Reference compound |
| HY-112375 | AT6 | 2098836-50-9 | Reference compound |
| HY-112376 | MZP-54 | 2010159-47-2 | Reference compound |
| HY-112377 | MZP-55 | 2010159-48-3 | Reference compound |
| HY-112378 | D-65476 | 249762-74-1 | Reference compound |
| HY-112382 | Iso-Olomoucine | 101622-50-8 | Reference compound |
| HY-112384 | Safingol | 15639-50-6 | Reference compound |
| HY-112384A | Safingol (hydrochloride) | 139755-79-6 | Reference compound |
| HY-112384B | DL-threo-Dihydrosphingosine | 2304-75-8 | Reference compound |
| HY-112386 | OXSI-2 | 622387-85-3 | Reference compound |
| HY-112388 | GSK-3b Inhibitor XI | 626604-39-5 | Reference compound |
| HY-112389 | p38 MAP Kinase Inhibitor III | 581098-48-8 | Reference compound |
| HY-112390 | Syk Inhibitor II (dihydrochloride) | 227449-73-2 | Reference compound |
| HY-112390A | Syk Inhibitor II | 726695-51-8 | Reference compound |
| HY-112390B | Syk Inhibitor II (dihydrochloride dihydrate) | 1965323-05-0 | Reference compound |
| HY-112390C | Syk Inhibitor II (hydrochloride) | 2490508-82-0 | Reference compound |
| HY-112391 | SD-1029 | 118372-34-2 | Reference compound |
| HY-112392 | GSK-3 Inhibitor XIII | 404828-14-4 | Reference compound |
| HY-112393 | TX-1918 | 503473-32-3 | Reference compound |
| HY-112394 | 2-Cyanoethylalsterpaullone | 852527-97-0 | Reference compound |
| HY-112395 | BTO-1 | 40647-02-7 | Reference compound |
| HY-112398 | GSK1379725A | 1802251-00-8 | Reference compound |
| HY-112400 | Bisindolylmaleimide V | 113963-68-1 | Reference compound |
| HY-112401 | p38 MAP Kinase Inhibitor IV | 1638-41-1 | Reference compound |
| HY-112402 | SP 600125, negative control | 54642-23-8 | Reference compound |
| HY-112403 | (S)-Roscovitine | 186692-45-5 | Reference compound |
| HY-112405 | BPIQ-I | 174709-30-9 | Reference compound |
| HY-112409 | WEE1-IN-2 | 622855-50-9 | Reference compound |
| HY-112411 | PD 174265 | 216163-53-0 | Reference compound |
| HY-112412 | PDGFR Tyrosine Kinase Inhibitor III | 205254-94-0 | Reference compound |
| HY-112415 | Lith-O-Asp | 881179-02-8 | Reference compound |
| HY-112416 | AZD4320 | 1357576-48-7 | Reference compound |
| HY-112417 | Ki11502 | 347155-76-4 | Reference compound |
| HY-112418 | CDK4/6-IN-18 | 546102-60-7 | Reference compound |
| HY-112420 | EGFR/ErbB-2/ErbB-4 inhibitor-2 | 179248-61-4 | Reference compound |
| HY-112423 | CE-245677 | 717899-97-3 | Reference compound |
| HY-112424 | Tinodasertib | 1464151-33-4 | Reference compound |
| HY-112426 | LAU159 | 2055050-87-6 | Reference compound |
| HY-112427 | Sirt2-IN-1 | 1862238-00-3 | Reference compound |
| HY-112428 | Sirt2-IN-2 | 1862238-01-4 | Reference compound |
| HY-112429 | HJB97 | 2093391-24-1 | Reference compound |
| HY-112430 | TRPM8 antagonist 2 | 259674-19-6 | Reference compound |
| HY-112431 | Carnostatine | Reference compound | |
| HY-112431A | Carnostatine (hydrochloride) | Reference compound | |
| HY-112432 | GlyT1 Inhibitor 1 | 1820934-93-7 | Reference compound |
| HY-112433 | NIK SMI1 | 1660114-31-7 | Reference compound |
| HY-112433A | (S)-NIK SMI1 | 2984765-48-0 | Reference compound |
| HY-112434 | PF-06733804 | 1873373-33-1 | Reference compound |
| HY-112435 | UCT943 | 1450666-80-4 | Reference compound |
| HY-112436 | PF-6683324 | 1799788-94-5 | Reference compound |
| HY-112436A | (3S,4R)-PF-6683324 | 1799789-00-6 | Reference compound |
| HY-112437 | PF-06737007 | 1863905-38-7 | Reference compound |
| HY-112438 | MF-094 | 2241025-68-1 | Reference compound |
| HY-112438A | rac-MF-094 | 2758431-95-5 | Reference compound |
| HY-112439 | PI3Kdelta inhibitor 1 | 2242109-74-4 | Reference compound |
| HY-112440 | HZX-02-059 | 2240205-30-3 | Reference compound |
| HY-112441 | Prolyl Hydroxylase inhibitor 1 | 2205125-60-4 | Reference compound |
| HY-112442 | AZ-3 | 2228908-91-4 | Reference compound |
| HY-112443 | AZD3458 | 2132961-46-5 | Reference compound |
| HY-112444 | BACE1-IN-2 | 1352416-78-4 | Reference compound |
| HY-112445 | SGC3027 | 2624313-13-7 | Reference compound |
| HY-112446 | ST638 | 107761-24-0 | Reference compound |
| HY-112447 | STAT3-IN-5 | 1041438-68-9 | Reference compound |
| HY-112450 | Olomoucine II | 500735-47-7 | Reference compound |
| HY-112451 | cFMS Receptor Inhibitor II | 959860-85-6 | Reference compound |
| HY-112452 | SU11652 | 326914-10-7 | Reference compound |
| HY-112455 | cFMS Receptor Inhibitor IV | 959626-45-0 | Reference compound |
| HY-112456 | IKK2-IN-4 | 354811-10-2 | Reference compound |
| HY-112457 | MK2-IN-3 (hydrate) | 1186648-22-5 | Reference compound |
| HY-112460 | CDK2-IN-3 | 222035-13-4 | Reference compound |
| HY-112461 | NF449 | 389142-38-5 | Reference compound |
| HY-112461A | NF449 (octasodium) | 627034-85-9 | Reference compound |
| HY-112462 | Cdk1/2 Inhibitor III | 443798-55-8 | Reference compound |
| HY-112463 | CDK1-IN-2 | 220749-41-7 | Reference compound |
| HY-112464 | PKR Inhibitor, negative control | 852547-30-9 | Reference compound |
| HY-112465 | H-8 (dihydrochloride) | 113276-94-1 | Reference compound |
| HY-112466 | p38 MAPK-IN-4 | 219138-24-6 | Reference compound |
| HY-112467 | Tivozanib (hydrate) | 682745-40-0 | Reference compound |
| HY-112468 | PNU112455A (hydrochloride) | 21886-12-4 | Reference compound |
| HY-112469 | ERK Inhibitor II (Negative control) | 1177970-73-8 | Reference compound |
| HY-112472 | S3969 | 1027997-01-8 | Reference compound |
| HY-112473 | NAV-2729 | 419547-11-8 | Reference compound |
| HY-112474 | Tyrphostin AG 112 | 144978-82-5 | Reference compound |
| HY-112475 | Flt-3 Inhibitor III | 852045-46-6 | Reference compound |
| HY-112476 | PRL-3 Inhibitor I | 893449-38-2 | Reference compound |
| HY-112477 | Chk2-IN-1 | 724708-21-8 | Reference compound |
| HY-112478 | PTP Inhibitor IV | 329317-98-8 | Reference compound |
| HY-112482A | ABT-702 (hydrochloride) | 2624336-92-9 | Reference compound |
| HY-112483 | QX77 | 1798331-92-6 | Reference compound |
| HY-112484 | RS-246204 | 878451-87-7 | Reference compound |
| HY-112486 | TA-316 | 1429321-13-0 | Reference compound |
| HY-112486G | TA-316 (GMP) | 1429321-13-0 | GMP Small Molecules |
| HY-112487 | Sandoz 58-035 | 78934-83-5 | Reference compound |
| HY-112489 | FSG67 | 1158383-34-6 | Reference compound |
| HY-112490 | Atorvastatin (calcium hydrate) | 344423-98-9 | Biochemical Assay Reagents |
| HY-112491 | KRas G12C inhibitor 1 | 2158297-28-8 | Reference compound |
| HY-112492 | KRas G12C inhibitor 2 | 2206735-61-5 | Reference compound |
| HY-112493 | KRas G12C inhibitor 3 | 2206735-75-1 | Reference compound |
| HY-112494 | KRas G12C inhibitor 4 | 2206736-07-2 | Reference compound |
| HY-112495 | VH032-PEG5-C6-Cl | 1799506-06-1 | Reference compound |
| HY-112496 | Cl-C6-PEG4-O-CH2COOH | 1799506-30-1 | Reference compound |
| HY-112498 | Cy3 NHS ester | 1393363-07-9 | Dye Reagents |
| HY-112498A | Cy3 NHS ester (bromide) | 2892098-34-7 | Dye Reagents |
| HY-112499 | Menaquinone-7 | 2124-57-4 | Reference compound |
| HY-112499R | Menaquinone-7 (Standard) | 2124-57-4 | Reference Standards |
| HY-112499S | Menaquinone-7-d7 | 1233937-31-9 | Isotope-Labeled Compounds |
| HY-112499S1 | Menaquinone-7-13C6 | Isotope-Labeled Compounds | |
| HY-112501 | Codon readthrough inducer 1 | 1338233-09-2 | Reference compound |
| HY-112502 | MethADP | 3768-14-7 | Reference compound |
| HY-112502A | MethADP (disodium) | 104835-70-3 | Reference compound |
| HY-112502B | MethADP (sodium) | 89016-30-8 | Reference compound |
| HY-112502C | MethADP (triammonium) | Reference compound | |
| HY-112502D | MethADP (trisodium) | 2659222-76-9 | Reference compound |
| HY-112504 | INCB054329 | 1628607-64-6 | Reference compound |
| HY-112504A | INCB054329 (Racemate) | 1628607-62-4 | Reference compound |
| HY-112504D | (R)-INCB054329 | 1628607-63-5 | Reference compound |
| HY-112505 | Efflux inhibitor-1 | 1776055-29-8 | Reference compound |
| HY-112509 | STL427944 | 292028-62-7 | Reference compound |
| HY-112514 | 1,3,6,8-Tetrahydroxynaphthalene | 18512-30-6 | Reference compound |
| HY-112516 | Fmoc-Lys(amino aldehyde)-Boc | 146803-44-3 | Reference compound |
| HY-112522 | HS79 | 2138838-56-7 | Reference compound |
| HY-112522A | HS80 | 2138838-57-8 | Reference compound |
| HY-112523A | DMTAP | 197974-74-6 | Biochemical Assay Reagents |
| HY-112526 | Thiofluor 623 | 1004324-99-5 | Dye Reagents |
| HY-112527 | 7(Z),11(Z)-Heptacosadiene | 100462-58-6 | Natural Products |
| HY-112528 | Glycerophospho-N-palmitoyl ethanolamine | 100575-09-5 | Reference compound |
| HY-112530 | 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine | 1069-79-0 | Natural Products |
| HY-112530S | 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine-d70 | 326495-43-6 | Isotope-Labeled Compounds |
| HY-112531 | Poly(2-hydroxyethyl methacrylate) (Mv 20000) | 25249-16-5 | Reference compound |
| HY-112531A | Poly(2-hydroxyethyl methacrylate) (Mv 1000000) | 25249-16-5 | Reference compound |
| HY-112531B | Poly(2-hydroxyethyl methacrylate) (Mv 300000) | 25249-16-5 | Reference compound |
| HY-112532 | REV 5901 | 101910-24-1 | Reference compound |
| HY-112532A | REV 5901 (hydrochloride) | 92532-23-5 | Reference compound |
| HY-112533 | 11-Deoxy-11-methylene PGD2 | 100648-29-1 | Reference compound |
| HY-112534 | GSTO-IN-2 | 1202710-57-3 | Reference compound |
| HY-112535 | α-2,3-sialyltransferase-IN-1 | 881179-06-2 | Reference compound |
| HY-112537 | D-Glucose 6-phosphate | 56-73-5 | Natural Products |
| HY-112537A | Dipotassium glucose-6-phosphate, 98% | 5996-17-8 | Biochemical Assay Reagents |
| HY-112537B | D-Glucose 6-phosphate (sodium) | 54010-71-8 | Natural Products |
| HY-112537S1 | D-Glucose 6-Phosphate-13C6 (disodium xhydrate) | Isotope-Labeled Compounds | |
| HY-112537S2 | D-Glucose 6-phosphate-13C | Isotope-Labeled Compounds | |
| HY-112538 | 1-(1-Naphthyl)piperazine (hydrochloride) | 104113-71-5 | Reference compound |
| HY-112540 | Acetoacetic acid | 541-50-4 | Natural Products |
| HY-112540A | Acetoacetic acid (lithium) | 3483-11-2 | Natural Products |
| HY-112540B | Acetoacetic acid (sodium) | 623-58-5 | Reference compound |
| HY-112541 | 21-Hydroxyoligomycin A | 102042-09-1 | Natural Products |
| HY-112542 | Nemadectin | 102130-84-7 | Natural Products |
| HY-112542R | Nemadectin (Standard) | 102130-84-7 | Reference Standards |
| HY-112543 | S119-8 | 443639-96-1 | Reference compound |
| HY-112544 | IK1 inhibitor PA-6 | 500715-03-7 | Reference compound |
| HY-112545 | DDR2-IN-1 | 1573053-23-2 | Reference compound |
| HY-112546 | MMP-2 Inhibitor I | 10335-69-0 | Reference compound |
| HY-112547 | CRT5 | 1034297-58-9 | Reference compound |
| HY-112549 | 5-oxo-ETE | 106154-18-1 | Reference compound |
| HY-112549S | 5-OxoETE-d7 | 1881277-29-7 | Isotope-Labeled Compounds |
| HY-112551 | 2′,3′,5′-Triacetyl-5-azacytidine | 10302-78-0 | Reference compound |
| HY-112552 | 1,2-Distearoyl-sn-glycerol | 10567-21-2 | Reference compound |
| HY-112553 | HZ52 | 1077626-51-7 | Reference compound |
| HY-112554 | PDM11 | 1032508-03-4 | Reference compound |
| HY-112555 | PDE7-IN-2 | 107522-19-0 | Reference compound |
| HY-112557 | PROTAC TBK1 degrader-2 | 2052306-13-3 | Reference compound |
| HY-112558 | AZ3451 | 2100284-59-9 | Reference compound |
| HY-112559 | Bis-PEG2-acid | 19364-66-0 | Reference compound |
| HY-112560 | Bis-PEG2-PFP ester | 1314378-18-1 | ADC Related |
| HY-112561 | Bis-PEG1-PFP ester | 1807539-02-1 | ADC Related |
| HY-112562 | GPR84 antagonist 8 | 1445846-30-9 | Reference compound |
| HY-112564 | JNJ-632 | 1572510-42-9 | Reference compound |
| HY-112565 | MBX-4132 | 2286411-30-9 | Reference compound |
| HY-112569 | MAT2A inhibitor 2 | 13299-99-5 | Reference compound |
| HY-112570 | CC-90003 | 1621999-82-3 | Reference compound |
| HY-112573A | Azapentacene (sodium) | 3863-80-7 | Reference compound |
| HY-112575 | Tiazotic acid | 64679-65-8 | Reference compound |
| HY-112579 | Ceftobiprole | 209467-52-7 | Reference compound |
| HY-112580 | SRI-31040 | 1928715-72-3 | Reference compound |
| HY-112581 | 5-Methoxyuridine | 35542-01-9 | Reference compound |
| HY-112581B | 5-Methoxyuridine 5'-triphosphate (trisodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-112582 | N1-Methylpseudouridine | 13860-38-3 | Oligonucleotides |
| HY-112582A | N1-Methylpseudouridine-5′-triphosphate | 1428903-59-6 | Oligonucleotides |
| HY-112582B | N1-Methylpseudouridine-5′-triphosphate (tetralithium) | Reference compound | |
| HY-112582C | N1-Methylpseudouridine-5′-triphosphate (trisodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-112582S | N1-Methylpseudouridine-d3 | Isotope-Labeled Compounds | |
| HY-112583 | MIV-247 | 1352817-76-5 | Reference compound |
| HY-112584 | JBSNF-000088 | 7150-23-4 | Reference compound |
| HY-112585 | Darunavir-d9 | 1133378-37-6 | Reference compound |
| HY-112586 | Sulfaethoxypyridazine | 963-14-4 | Reference compound |
| HY-112586R | Sulfaethoxypyridazine (Standard) | 963-14-4 | Reference Standards |
| HY-112586S1 | Sulfaethoxypyridazine-13C6 | Isotope-Labeled Compounds | |
| HY-112587 | MC3482 | 2922280-86-0 | Reference compound |
| HY-112588 | dBET6 | 1950634-92-0 | Reference compound |
| HY-112589 | BRITE-338733 | 503105-88-2 | Reference compound |
| HY-112591 | NSC260594 | 906718-66-9 | Reference compound |
| HY-112596 | H3B-6545 | 2052130-80-8 | Reference compound |
| HY-112596A | H3B-6545 (hydrochloride) | 2052132-51-9 | Reference compound |
| HY-112597 | Mavodelpar (free acid) | 942594-93-6 | Reference compound |
| HY-112597A | Mavodelpar | 1604815-32-8 | Reference compound |
| HY-112598 | PF-06815345 | 1900686-46-5 | Reference compound |
| HY-112598A | PF-06815345 (hydrochloride) | 2334434-49-8 | Reference compound |
| HY-112599 | Pomalidomide-PEG4-C2-NH2 | 2225940-52-1 | Reference compound |
| HY-112599B | Pomalidomide-PEG4-C2-NH2 (hydrochloride) | 2357105-92-9 | Reference compound |
| HY-112600 | Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 | 2435572-48-6 | Reference compound |
| HY-112600A | Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 (TFA) | 2435572-49-7 | Reference compound |
| HY-112601 | IDH1 Inhibitor 1 | 2234285-81-3 | Reference compound |
| HY-112602 | PI3K/mTOR Inhibitor-1 | 1949802-49-6 | Reference compound |
| HY-112603 | AP5 | 1623194-37-5 | Reference compound |
| HY-112603A | AP5 (sodium) | 1623143-67-8 | Reference compound |
| HY-112604 | MK-8318 | 1416581-40-2 | Reference compound |
| HY-112605 | sPLA2-X Inhibitor 31 | 2241025-50-1 | Reference compound |
| HY-112606 | ML-290 | 1482500-76-4 | Reference compound |
| HY-112607 | Tubulin inhibitor 1 | 2237054-53-2 | Reference compound |
| HY-112608 | CHMFL-PI3KD-317 | 2244992-76-3 | Reference compound |
| HY-112609 | QCA570 | 2207569-08-0 | Reference compound |
| HY-112610 | CF53 | 1808160-52-2 | Reference compound |
| HY-112611 | H3B-5942 | 2052128-15-9 | Reference compound |
| HY-112612 | RTI-13951-33 | 2244884-08-8 | Reference compound |
| HY-112612A | RTI-13951-33 hydrochloride | Reference compound | |
| HY-112613 | UCB9608 | 1616413-96-7 | Reference compound |
| HY-112614 | ATM Inhibitor-1 | 2135639-94-8 | Reference compound |
| HY-112615 | NAMPT inhibitor-linker 1 | 2241019-57-6 | ADC Related |
| HY-112616 | NAMPT inhibitor-linker 2 | 2241014-82-2 | ADC Related |
| HY-112617 | Thalidomide-O-amido-PEG2-C2-NH2 | 1957235-74-3 | Reference compound |
| HY-112617A | Thalidomide-O-amido-PEG2-C2-NH2 (TFA) | 1957235-75-4 | Reference compound |
| HY-112617B | Thalidomide-O-amido-PEG2-C2-NH2 (hydrochloride) | 2376990-30-4 | Reference compound |
| HY-112618 | Thalidomide-O-amido-C6-NH2 | 1950635-13-8 | Reference compound |
| HY-112618A | Thalidomide-O-amido-C6-NH2 (TFA) | 1950635-14-9 | Reference compound |
| HY-112618B | Thalidomide-O-amido-C6-NH2 (hydrochloride) | 2376990-31-5 | Reference compound |
| HY-112619 | TES-991 | 1883602-20-7 | Reference compound |
| HY-112620 | MS21570 | 65373-29-7 | Reference compound |
| HY-112621 | Leukotriene A4 methyl ester | 73466-12-3 | Reference compound |
| HY-112622 | GSK3186899 | 1972617-87-0 | Reference compound |
| HY-112623 | Vafidemstat | 1357362-02-7 | Reference compound |
| HY-112624 | Dextran | 9004-54-0 | Oligonucleotides |
| HY-112624A | Dextran T1 (MW 1,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624B | Dextran T70 (MW 70,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624C | Dextran (MW 40000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624D | Dextran T60 (MW 60,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624E | Dextran T0.8 (MW 800) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624F | CY7-Dextran (MW 4000) | Dye Reagents | |
| HY-112624F1 | CY5-Dextran (MW 4000) | Dye Reagents | |
| HY-112624H | Dextran T2 (MW 2,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624I | Dextran T3 (MW 3,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624J | Dextran T4 (MW 4,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624K | Dextran T5 (MW 5,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624L | Dextran T10 (MW 10,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624M | Dextran T150 (MW 150,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624N | Dextran T200 (MW 200,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624O | Dextran T100 (MW 100,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624P | Dextran T500 (MW 500,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624Q | Dextran T800 (MW 800,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624T | Dextran T7 (MW 7,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112624U | Dextran T20 (MW 20,000) | 9004-54-0 | Biochemical Assay Reagents |
| HY-112626 | CDK12-IN-2 | 2244987-03-7 | Reference compound |
| HY-112627 | CAY 10465 | 688348-33-6 | Reference compound |
| HY-112628 | CAY10464 | 688348-37-0 | Reference compound |
| HY-112629 | PDM2 | 688348-25-6 | Reference compound |
| HY-112633 | SMN-C3 | 1449597-34-5 | Reference compound |
| HY-112634 | SIRT5 inhibitor 1 | 2166487-21-2 | Reference compound |
| HY-112636 | Astrophloxine | 14696-39-0 | Reference compound |
| HY-112639 | Aristeromycin | 19186-33-5 | Natural Products |
| HY-112641 | AkaLumine | 1176235-08-7 | Dye Reagents |
| HY-112641A | AkaLumine (hydrochloride) | 2558205-28-8 | Dye Reagents |
| HY-112642 | 9-Methoxycanthin-6-one | 74991-91-6 | Natural Products |
| HY-112645 | BAY-2402234 | 2225819-06-5 | Reference compound |
| HY-112647 | Stafib-1 | 1688703-26-5 | Reference compound |
| HY-112648 | Stafib-2 | 2097938-74-2 | Reference compound |
| HY-112649 | Pomstafib-2 | 2332841-83-3 | Reference compound |
| HY-112650 | 12-OxoETE | 108437-64-5 | Natural Products |
| HY-112652 | ACS-67 | 1088434-86-9 | Reference compound |
| HY-112653 | 8(S)-HETE | 98462-03-4 | Natural Products |
| HY-112653A | (±)8-HETE | 70968-93-3 | Natural Products |
| HY-112654 | GCN2iB | 2183470-12-2 | Reference compound |
| HY-112654A | GCN2iB (acetate) | 2183470-13-3 | Reference compound |
| HY-112657 | Xanthorrhizol | 30199-26-9 | Natural Products |
| HY-112658 | p-Iodoclonidine (hydrochloride) | 108294-57-1 | Reference compound |
| HY-112659 | Lin28-let-7 antagonist 1 | 108825-65-6 | Reference compound |
| HY-112661 | PC-766B | 108375-77-5 | Reference compound |
| HY-112663 | Monazomycin | 11006-31-8 | Natural Products |
| HY-112665 | Virginiamycin Complex | 11006-76-1 | Reference compound |
| HY-112665R | Virginiamycin Complex (Standard) | 11006-76-1 | Reference Standards |
| HY-112666 | Farnesyl thiosalicylic acid amide | 1092521-74-8 | Reference compound |
| HY-112667 | CU-CPT-9a | 2165340-32-7 | Reference compound |
| HY-112668 | Retagliptin (phosphate) | 1256756-88-3 | Reference compound |
| HY-112668A | Retagliptin | 1174122-54-3 | Reference compound |
| HY-112668B | Retagliptin (hydrochloride) | 1174038-86-8 | Reference compound |
| HY-112669 | 5-Chloro-2'-deoxyuridine | 50-90-8 | Reference compound |
| HY-112670 | Exo1 | 75541-83-2 | Reference compound |
| HY-112671 | CDDO-dhTFEA | 1191265-33-4 | Reference compound |
| HY-112673 | RSV-IN-1 | 861139-16-4 | Reference compound |
| HY-112675 | 4-Octyl itaconate | 3133-16-2 | Reference compound |
| HY-112675R | 4-Octyl itaconate (Standard) | 3133-16-2 | Reference Standards |
| HY-112675S | 4-Octyl itaconate-13C5-1 | Isotope-Labeled Compounds | |
| HY-112678 | TM6008 | 945008-17-3 | Reference compound |
| HY-112679 | GLP-1 receptor agonist 2 | 2230197-64-3 | Reference compound |
| HY-112680 | Carboxypyridostatin | 1417638-60-8 | Reference compound |
| HY-112680A | Carboxy pyridostatin (trifluoroacetate salt) | 2444713-88-4 | Reference compound |
| HY-112681 | PKC-theta inhibitor 2 | 736048-65-0 | Reference compound |
| HY-112681B | PKC-theta inhibitor 2 (hydrochloride) | 2253640-49-0 | Reference compound |
| HY-112683 | V-9302 | 1855871-76-9 | Reference compound |
| HY-112683A | V-9302 (hydrochloride) | 2416138-42-4 | Reference compound |
| HY-112684 | RO-7 | 1370241-45-4 | Reference compound |
| HY-112688 | H-Arg-4MβNA | 60285-94-1 | Reference compound |
| HY-112689 | Androgen receptor antagonist 9 | 915086-32-7 | Reference compound |
| HY-112690 | Pradefovir | 625095-60-5 | Reference compound |
| HY-112690A | Pradefovir mesylate | 625095-61-6 | Reference compound |
| HY-112692 | AT-121 | 2099681-31-7 | Reference compound |
| HY-112692A | AT-121 (hydrochloride) | 2099681-71-5 | Reference compound |
| HY-112693 | H-151 | 941987-60-6 | Reference compound |
| HY-112697 | Rhodamine B isothiocyanate | 36877-69-7 | Dye Reagents |
| HY-112698 | CA-5f | 1370032-19-1 | Reference compound |
| HY-112699 | AMPA receptor modulator-1 | 2036074-41-4 | Reference compound |
| HY-112700 | SHIP2-IN-1 | 2252247-80-4 | Reference compound |
| HY-112701 | CCR6 inhibitor 1 | 2437547-04-9 | Reference compound |
| HY-112702 | CRS400393 | 2253175-64-1 | Reference compound |
| HY-112703 | AMG 333 | 1416799-28-4 | Reference compound |
| HY-112704 | PDE5-IN-2 | 2244517-61-9 | Reference compound |
| HY-112705 | VU0529331 | 1286725-49-2 | Reference compound |
| HY-112706 | PF-06747711 | 1892576-58-7 | Reference compound |
| HY-112707 | AM9405 | 3032946-55-4 | Reference compound |
| HY-112708 | Brepocitinib | 1883299-62-4 | Reference compound |
| HY-112708A | Brepocitinib (P-Tosylate) | 2140301-96-6 | Reference compound |
| HY-112709 | LIT-927 | 2172879-52-4 | Reference compound |
| HY-112710 | ORIC-101 | 2222344-98-9 | Reference compound |
| HY-112711 | LV-320 | 2449093-46-1 | Reference compound |
| HY-112712 | Cyclophilin inhibitor 1 | 1509904-96-4 | Reference compound |
| HY-112713 | SMS2-IN-2 | 2241838-28-6 | Reference compound |
| HY-112714 | GSK3532795 | 1392312-45-6 | Reference compound |
| HY-112714A | GSK3532795 (oxalate) | 2097784-79-5 | Reference compound |
| HY-112714B | GSK3532795 (hydrochloride) | 2023808-13-9 | Reference compound |
| HY-112715 | ATP synthase inhibitor 1 | 1023043-30-2 | Reference compound |
| HY-112716 | N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride | 4272-74-6 | Reference compound |
| HY-112718 | PROTAC BET Degrader-10 | 1957234-97-7 | Reference compound |
| HY-112719 | BRD 4354 | 315698-07-8 | Reference compound |
| HY-112719B | BRD 4354 (ditrifluoroacetate) | Reference compound | |
| HY-112720 | AGL-2263 | 638213-98-6 | Reference compound |
| HY-112721 | FDI-6 | 313380-27-7 | Reference compound |
| HY-112722 | Neurotoxin Inhibitor | 951571-70-3 | Reference compound |
| HY-112723 | Apinocaltamide | 1838651-58-3 | Reference compound |
| HY-112724 | Ivarmacitinib | 1445987-21-2 | Reference compound |
| HY-112724A | Ivarmacitinib (sulfate) | 1639419-51-4 | Reference compound |
| HY-112726 | PXS-4728A | 1478364-68-9 | Reference compound |
| HY-112728 | MMV024101 | 1092565-44-0 | Reference compound |
| HY-112729 | HC-056456 | 7733-96-2 | Reference compound |
| HY-112730 | PEO-IAA | 6266-66-6 | Reference compound |
| HY-112731 | TFAP | 1011244-68-0 | Natural Products |
| HY-112732 | Sparfosic acid | 51321-79-0 | Reference compound |
| HY-112732B | Sparfosic acid (trisodium) | 70962-66-2 | Reference compound |
| HY-112734 | 4'-Methylchrysoeriol | 4712-12-3 | Reference compound |
| HY-112735 | Hexadimethrine bromide | 28728-55-4 | Oligonucleotides |
| HY-112736 | RG 14893 | 141835-49-6 | Reference compound |
| HY-112737 | LY223982 | 117423-74-2 | Reference compound |
| HY-112738 | AX048 | 873079-69-7 | Reference compound |
| HY-112739 | SC-41930 | 120072-59-5 | Reference compound |
| HY-112741 | SB-209247 | 154413-61-3 | Reference compound |
| HY-112742 | CP-195543 | 204981-48-6 | Reference compound |
| HY-112746 | Etacstil | 155701-61-4 | Reference compound |
| HY-112747 | Soy PE | 97281-51-1 | Reference compound |
| HY-112749 | ME-344 | 1374524-68-1 | Reference compound |
| HY-112752 | Gal-C4-Chol | 219850-70-1 | Biochemical Assay Reagents |
| HY-112754A | DOTAP (chloride) | 132172-61-3 | Oligonucleotides |
| HY-112754A1 | DOTAP (chloride) (Excipient) | 132172-61-3 | Reference compound |
| HY-112755 | DODMA | 104162-47-2 | Oligonucleotides |
| HY-112755A | 1,2(R)-Dioleyloxy-3-dimethylamino-propane | 666234-78-2 | Reference compound |
| HY-112756 | PEG2000-DGG | Biochemical Assay Reagents | |
| HY-112757 | DLinDMA | 871258-12-7 | Oligonucleotides |
| HY-112758 | DLin-KC2-DMA | 1190197-97-7 | Oligonucleotides |
| HY-112760 | 18:0 mPEG2000 PE (sodium) | 247925-28-6 | Oligonucleotides |
| HY-112762 | LHF-535 | 1450929-77-7 | Reference compound |
| HY-112762A | (E)-LHF-535 | Reference compound | |
| HY-112763 | CLinDMA | 908860-82-2 | Reference compound |
| HY-112764 | DMG-PEG 2000 | 160743-62-4 | Oligonucleotides |
| HY-112764A | DMG-PEG (Excipient) | 160743-62-4 | Reference compound |
| HY-112766 | DPyPE | 201036-16-0 | Reference compound |
| HY-112768 | PEG2000-DMPE | Reference compound | |
| HY-112769 | EX229 | 1219739-36-2 | Reference compound |
| HY-112772A | 98N12-5 | 917572-74-8 | Oligonucleotides |
| HY-112773 | 1,1′,1′′,1′′′-[1,4-Piperazinediylbis(2,1-ethanediylnitrilo)]tetrakis[2-dodecanol] | 1265904-26-4 | Reference compound |
| HY-112776 | BN82002 | 396073-89-5 | Reference compound |
| HY-112776A | BN82002 (hydrochloride) | 1049740-43-3 | Reference compound |
| HY-112777 | Kinesore | 363571-83-9 | Reference compound |
| HY-112778 | NFAT Transcription Factor Regulator-1 | 245747-71-1 | Reference compound |
| HY-112779 | Pertussis Toxin | 70323-44-3 | Reference compound |
| HY-112780 | UC2288 | 1394011-91-6 | Reference compound |
| HY-112781 | Pesampator | 1258963-59-5 | Reference compound |
| HY-112782 | VTX-27 | 1321924-70-2 | Reference compound |
| HY-112785 | Pyriftalid | 135186-78-6 | Reference compound |
| HY-112785R | Pyriftalid (Standard) | 135186-78-6 | Reference Standards |
| HY-112786 | MC-Val-Cit-PAB-MMAF | 863971-17-9 | ADC Related |
| HY-112788 | ONO-8590580 | 1802661-73-9 | Reference compound |
| HY-112789 | (+)-JQ1 PA | 2115701-93-2 | Reference compound |
| HY-112790 | Adenosylcobalamin | 13870-90-1 | Natural Products |
| HY-112790R | Adenosylcobalamin (Standard) | 13870-90-1 | Reference Standards |
| HY-112792 | CCR2 antagonist 1 | 1683534-96-4 | Reference compound |
| HY-112792A | (1S)-CCR2 antagonist 1 | 1683534-97-5 | Reference compound |
| HY-112793 | 3-O-Benzyl-1,2-O-isopropylidene-α-D-glucofuranose | 22529-61-9 | Biochemical Assay Reagents |
| HY-112794 | Topanol CA | 1843-03-4 | Reference compound |
| HY-112796 | Ethyl 2,3,4,6-tetra-O-benzyl-β-D-thiogalactopyranoside | 125411-99-6 | Biochemical Assay Reagents |
| HY-112797 | Ds-HAPP | 330163-26-3 | Dye Reagents |
| HY-112798 | PH-002 | 1311174-68-1 | Reference compound |
| HY-112799 | DK419 | 2102672-22-8 | Reference compound |
| HY-112800 | cyt-PTPε Inhibitor-1 | 428478-94-8 | Reference compound |
| HY-112801 | F-1 | 2244775-31-1 | Reference compound |
| HY-112802 | Ubavitinib | 2248003-60-1 | Reference compound |
| HY-112802A | Ubavitinib (tosylate) | 2248003-71-4 | Reference compound |
| HY-112803 | GNE-371 | 1926986-36-8 | Dye Reagents |
| HY-112804 | SGC-iMLLT | 2255338-25-9 | Reference compound |
| HY-112805 | ST8154AA1 | 2247025-59-6 | ADC Related |
| HY-112806 | ST8155AA1 | 2247025-63-2 | ADC Related |
| HY-112807 | SGLT inhibitor-1 | 2247314-23-2 | Reference compound |
| HY-112808 | KAN0438757 | 1451255-59-6 | Reference compound |
| HY-112809 | GSK2646264 | 1398695-47-0 | Reference compound |
| HY-112811 | PROTAC CDK9 degrader-2 | 2435721-30-3 | Reference compound |
| HY-112812 | SCD1 inhibitor-1 | 1069094-65-0 | Reference compound |
| HY-112813 | TUG-1375 | 2247372-59-2 | Reference compound |
| HY-112814 | VU6001376 | 1968546-34-0 | Reference compound |
| HY-112815 | ALK2-IN-2 | 2254409-25-9 | Reference compound |
| HY-112816 | MA242 | 1049704-18-8 | Reference compound |
| HY-112816A | MA242 (free base) | 1049704-17-7 | Reference compound |
| HY-112818 | S130 | 1160852-22-1 | Reference compound |
| HY-112819 | Insulin levels modulator | 1019254-94-4 | Reference compound |
| HY-112820 | Chlorantraniliprole | 500008-45-7 | Reference compound |
| HY-112820R | Chlorantraniliprole (Standard) | 500008-45-7 | Reference Standards |
| HY-112821 | IBS008738 | 385425-03-6 | Reference compound |
| HY-112822 | ON-013100 | 865783-95-5 | Reference compound |
| HY-112823 | Almonertinib | 1899921-05-1 | Reference compound |
| HY-112823A | Almonertinib (mesylate) | 2134096-06-1 | Reference compound |
| HY-112823B | Almonertinib (hydrochloride) | 2134096-03-8 | Reference compound |
| HY-112823R | Almonertinib (Standard) | 1899921-05-1 | Reference Standards |
| HY-112824 | L-162313 | 151488-11-8 | Reference compound |
| HY-112825 | TSI-01 | 704878-75-1 | Reference compound |
| HY-112828 | LEI105 | 1800327-36-9 | Reference compound |
| HY-112829 | Denifanstat | 1399177-37-7 | Reference compound |
| HY-112830 | BF-168 | 634911-47-0 | Reference compound |
| HY-112831 | Osoresnontrine | 1189767-28-9 | Reference compound |
| HY-112832 | Lumigen APS-5 | 193884-53-6 | Biochemical Assay Reagents |
| HY-112835 | Ethylidene-4-nitrophenyl-a-D-Maltoheptaoside | 96597-16-9 | Biochemical Assay Reagents |
| HY-112839 | 1-Myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine | 273931-53-6 | Reference compound |
| HY-112840 | ST3932 | 1246018-21-2 | Reference compound |
| HY-112841 | PTZ-343 | 101199-38-6 | Reference compound |
| HY-112842 | MBQ-167 | 2097938-73-1 | Reference compound |
| HY-112843 | CNT2 inhibitor-1 | 880155-70-4 | Reference compound |
| HY-112847 | Sulfosuccinimidyl oleate | 135661-44-8 | Reference compound |
| HY-112847A | Sulfosuccinimidyl oleate (sodium) | Reference compound | |
| HY-112847B | (E/Z)-Sulfosuccinimidyl oleate (sodium) | 1212012-37-7 | Reference compound |
| HY-112851 | Diacylglycerol acyltransferase inhibitor-1 | 1610800-25-3 | Reference compound |
| HY-112852 | TL02-59 | 1315330-17-6 | Reference compound |
| HY-112852A | TL02-59 (dihydrochloride) | 2415263-06-6 | Reference compound |
| HY-112853 | Fosmidomycin sodium salt | 66508-37-0 | Reference compound |
| HY-112855 | PF-06454589 | 1527473-30-8 | Reference compound |
| HY-112858 | dSPACER | 129821-76-7 | Reference compound |
| HY-112859 | VU0661013 | 2131184-57-9 | Reference compound |
| HY-112860 | Asp-AMS | 828288-98-8 | Reference compound |
| HY-112861 | Gln-AMS | 209543-57-7 | Reference compound |
| HY-112861A | Gln-AMS (TFA) | Reference compound | |
| HY-112862 | Arg-AMS | 301351-95-1 | Reference compound |
| HY-112863 | RORγt inhibitor 3 | 1361413-10-6 | Reference compound |
| HY-112864 | TGFβRI-IN-6 | 2072051-04-6 | Reference compound |
| HY-112865 | Octocog alfa | 139076-62-3 | Reference compound |
| HY-112868B | ABH (hydrochloride) | 194656-75-2 | Reference compound |
| HY-112870 | Firmonertinib | 1869057-83-9 | Reference compound |
| HY-112870A | Firmonertinib (mesylate) | 2130958-55-1 | Reference compound |
| HY-112874 | BMS-681 | 847998-92-9 | Reference compound |
| HY-112877 | ALK-5-IN-1 | 1018953-58-6 | Reference compound |
| HY-112879 | Mito-TEMPO | 1334850-99-5 | Reference compound |
| HY-112885 | nor-NOHA | 189302-40-7 | Reference compound |
| HY-112885A | nor-NOHA (acetate) | 1140844-63-8 | Reference compound |
| HY-112885B | nor-NOHA (monoacetate) | 2250019-93-1 | Reference compound |
| HY-112885C | nor-NOHA (dihydrochloride) | 291758-32-2 | Reference compound |
| HY-112889 | Oxythiamine diphosphate | 10497-04-8 | Reference compound |
| HY-112889B | Oxythiamine diphosphate (ammonium) | Reference compound | |
| HY-112894 | ZG-10 | 1408077-04-2 | Reference compound |
| HY-112895 | UT-155 | 2031161-35-8 | Reference compound |
| HY-112895A | (R)-UT-155 | 2031161-54-1 | Reference compound |
| HY-112897 | IITZ-01 | 1807988-47-1 | Reference compound |
| HY-112898 | DC1SMe | 501666-85-9 | ADC Related |
| HY-112899 | DC1 | 169901-27-3 | ADC Related |
| HY-112900 | DC41SMe | 1354787-71-5 | ADC Related |
| HY-112901 | DC41 | 1354787-69-1 | ADC Related |
| HY-112902 | OGG1-IN-08 | 350997-39-6 | Reference compound |
| HY-112903A | YW3-56 (hydrochloride) | 2309756-20-3 | Reference compound |
| HY-112904 | XRK3F2 | 2375193-43-2 | Reference compound |
| HY-112906 | C-176 | 314054-00-7 | Reference compound |
| HY-112907 | RIP2 Kinase Inhibitor 3 | 1398053-50-3 | Reference compound |
| HY-112908 | RTS-V5 | 2285346-31-6 | Reference compound |
| HY-112909 | UAMC-3203 | 2271358-64-4 | Reference compound |
| HY-112909A | UAMC-3203 hydrochloride | 2271358-65-5 | Reference compound |
| HY-112910 | Grp94 Inhibitor-1 | 2234897-35-7 | Reference compound |
| HY-112911 | Endothelial lipase inhibitor-1 | 1466427-02-0 | Reference compound |
| HY-112912 | P-gp modulator 1 | 2249749-39-9 | Reference compound |
| HY-112913 | SOCE inhibitor 1 | 2169316-15-6 | Reference compound |
| HY-112914 | mTOR inhibitor-1 | 468747-17-3 | Reference compound |
| HY-112915 | Eg5 Inhibitor V, trans-24 | 869304-55-2 | Reference compound |
| HY-112920 | TM-25659 | 260553-97-7 | Reference compound |
| HY-112921 | diABZI STING agonist-1 (tautomerism) | 2138498-18-5 | Reference compound |
| HY-112921A | diABZI STING agonist-1 | 2138299-33-7 | Reference compound |
| HY-112921B | diABZI STING agonist-1 (trihydrochloride) | 2138299-34-8 | Reference compound |
| HY-112927 | MU380 | 2109805-78-7 | Reference compound |
| HY-112929 | DT-061 | 1809427-19-7 | Reference compound |
| HY-112929B | (1S,2S,3R)-DT-061 | 1809427-20-0 | Reference compound |
| HY-112935 | Nonacog alfa | 181054-95-5 | Inhibitory Antibodies |
| HY-112937 | GNE-6640 | 2009273-67-8 | Reference compound |
| HY-112939 | Colestilan | 95522-45-5 | Reference compound |
| HY-112942 | CMP-Sialic acid | 3063-71-6 | Reference compound |
| HY-112942A | CMP-Sialic acid (sodium salt) | 1007117-62-5 | Reference compound |
| HY-112945 | MLS0315771 | 727664-91-7 | Reference compound |
| HY-112948 | 2-Methylbutyrylcarnitine | 256928-75-3 | Reference compound |
| HY-112950 | RET-IN-1 | 2222755-14-6 | Reference compound |
| HY-112951 | ChX710 | 2438721-44-7 | Reference compound |
| HY-112958 | Fomivirsen | 144245-52-3 | Reference compound |
| HY-112959 | Telavancin | 372151-71-8 | Reference compound |
| HY-112961 | Patiromer | 1208912-84-8 | Reference compound |
| HY-112968 | Human protein C | 925910-74-3 | Enzyme |
| HY-112968A | Bovine Protein C | Enzyme | |
| HY-112974 | Inotersen | 1492984-65-2 | Reference compound |
| HY-112980 | Nusinersen | 1258984-36-9 | Oligonucleotides |
| HY-112980A | Nusinersen (sodium) | Oligonucleotides | |
| HY-112988 | Perfluoropentane | 678-26-2 | Reference compound |
| HY-112998 | Efmoroctocog alfa | 1270012-79-7 | Inhibitory Antibodies |
| HY-113000 | Cetoleic acid | 1002-96-6 | Natural Products |
| HY-113002A | alpha-D-Glucose 1,6-bisphosphate (cyclohexanamine) | 71662-13-0 | Biochemical Assay Reagents |
| HY-113003 | H-γ-Glu-Gln-OH | 10148-81-9 | Natural Products |
| HY-113004 | 3-Hydroxyvaleric acid | 10237-77-1 | Natural Products |
| HY-113005 | Glutarylcarnitine | 102636-82-8 | Natural Products |
| HY-113005A | Glutarylcarnitine (lithium) | Reference compound | |
| HY-113005S | Glutarylcarnitine-d9 (chloride) | Isotope-Labeled Compounds | |
| HY-113008 | Urocanic acid | 104-98-3 | Natural Products |
| HY-113008A | cis-Urocanic acid | 7699-35-6 | Reference compound |
| HY-113008AS | cis-Urocanic acid-13C3 | Isotope-Labeled Compounds | |
| HY-113008B | trans-Urocanic acid | 3465-72-3 | Reference compound |
| HY-113008R | Urocanic acid (Standard) | 104-98-3 | Reference Standards |
| HY-113008S1 | Urocanic acid-13C3 | 1173097-34-1 | Isotope-Labeled Compounds |
| HY-113010 | 1-Arachidoyl-sn-glycero-3-phosphocholine | 108341-80-6 | Natural Products |
| HY-113010S1 | 1-Arachidoyl-sn-glycero-3-phosphocholine-d4 | 2483831-16-7 | Isotope-Labeled Compounds |
| HY-113011 | Maltotriose | 1109-28-0 | Natural Products |
| HY-113011R | Maltotriose (Standard) | 1109-28-0 | Reference Standards |
| HY-113013 | Hydroxypyruvic acid | 1113-60-6 | Natural Products |
| HY-113013A | Hydroxypyruvic acid (lithium hydrate) | 209728-15-4 | Reference compound |
| HY-113013C | Hydroxypyruvic acid (lithium) | 3369-79-7 | Biochemical Assay Reagents |
| HY-113014 | O-Phospho-L-threonine | 1114-81-4 | Natural Products |
| HY-113015 | Stearoylethanolamide | 111-57-9 | Natural Products |
| HY-113015R | Stearoylethanolamide (Standard) | 111-57-9 | Reference Standards |
| HY-113015S | Stearoylethanolamide-d3 | 2749393-37-9 | Isotope-Labeled Compounds |
| HY-113016 | Elaidic acid | 112-79-8 | Natural Products |
| HY-113016R | Elaidic acid (Standard) | 112-79-8 | Reference Standards |
| HY-113016S | Elaidic acid-d9 | 1809227-37-9 | Isotope-Labeled Compounds |
| HY-113016S1 | Elaidic acid-d17 | Isotope-Labeled Compounds | |
| HY-113018 | Ibuprofen acyl-β-D-glucuronide | 115075-59-7 | Natural Products |
| HY-113018A | (S)-Ibuprofen acyl-β-D-glucuronide | 98649-76-4 | Reference compound |
| HY-113018S | Ibuprofen acyl-β-D-glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-113019 | 3β,7α-Dihydroxycholest-5-enoic acid | 115538-84-6 | Natural Products |
| HY-113019S | 3β,7α-Dihydroxycholest-5-enoic acid-d3 | 2342573-95-7 | Isotope-Labeled Compounds |
| HY-113020 | 21-Hydroxypregnenolone | 1164-98-3 | Natural Products |
| HY-113024 | Pristanic acid | 1189-37-3 | Natural Products |
| HY-113024R | Pristanic acid (Standard) | 1189-37-3 | Reference Standards |
| HY-113024S | Pristanic acid-d3 | 1383920-14-6 | Isotope-Labeled Compounds |
| HY-113025A | L-hydroxylysine (dihydrochloride) | 172213-74-0 | Natural Products |
| HY-113026 | Delta-Tocopherol | 119-13-1 | Natural Products |
| HY-113026R | Delta-Tocopherol (Standard) | 119-13-1 | Reference Standards |
| HY-113026S | (2RS,4R,8R)-δ-Tocopherol-d4 (Mixture of Diastereomers) | 1292815-80-5 | Isotope-Labeled Compounds |
| HY-113027 | p-Hydroxymandelic acid | 1198-84-1 | Natural Products |
| HY-113027R | p-Hydroxymandelic acid (Standard) | 1198-84-1 | Reference Standards |
| HY-113031 | 16a-Hydroxydehydroisoandrosterone | 1232-73-1 | Reference compound |
| HY-113031S | 16α-Hydroxydehydroepiandrosterone-d6 | 97453-29-7 | Isotope-Labeled Compounds |
| HY-113031S1 | 16α-Hydroxydehydroepiandrosterone-d5 | Isotope-Labeled Compounds | |
| HY-113033 | Pentosidine | 124505-87-9 | Natural Products |
| HY-113033A | Pentosidine (TFA) | 225784-09-8 | Reference compound |
| HY-113037 | (E/Z)-Farnesyl pyrophosphate | 13058-04-3 | Reference compound |
| HY-113037B | Farnesyl pyrophosphate | 372-97-4 | Reference compound |
| HY-113037C | Farnesyl pyrophosphate (ammonium) | 116057-57-9 | Reference compound |
| HY-113037S1 | Farnesyl pyrophosphate-d3 | Isotope-Labeled Compounds | |
| HY-113038 | D-α-Hydroxyglutaric acid | 13095-47-1 | Natural Products |
| HY-113038A | α-Hydroxyglutaric acid (disodium) | 40951-21-1 | Natural Products |
| HY-113038AR | α-Hydroxyglutaric acid (disodium) (Standard) | 40951-21-1 | Reference Standards |
| HY-113038AS | α-Hydroxyglutaric acid-13C5 (disodium) | 2482467-23-0 | Isotope-Labeled Compounds |
| HY-113038AS1 | α-Hydroxyglutaric acid-d4 (disodium) | 2483831-91-8 | Isotope-Labeled Compounds |
| HY-113038B | α-Hydroxyglutaric acid | 2889-31-8 | Reference compound |
| HY-113039 | L-2-Hydroxyglutaric acid | 13095-48-2 | Natural Products |
| HY-113039R | L-2-Hydroxyglutaric acid (Standard) | 13095-48-2 | Reference Standards |
| HY-113040A | (17R,18S)-Epoxyeicosatetraenoic acid | 725246-18-4 | Reference compound |
| HY-113041 | Prostaglandin A2 | 13345-50-1 | Reference compound |
| HY-113041S | Prostaglandin A2-d4 | 201608-18-6 | Isotope-Labeled Compounds |
| HY-113042 | Prostaglandin B2 | 13367-85-6 | Natural Products |
| HY-113042S | Prostaglandin B2-d4 | 211105-23-6 | Isotope-Labeled Compounds |
| HY-113043 | Galactonic acid | 13382-27-9 | Reference compound |
| HY-113044 | Uridine diphosphate glucose | 133-89-1 | Natural Products |
| HY-113044R | Uridine diphosphate glucose (Standard) | 133-89-1 | Reference Standards |
| HY-113045 | Aquacobalamin | 13422-52-1 | Reference compound |
| HY-113046 | 5-Methyltetrahydrofolic acid | 134-35-0 | Natural Products |
| HY-113046R | 5-Methyltetrahydrofolic acid (Standard) | 134-35-0 | Reference Standards |
| HY-113046S | 5-Methyltetrahydrofolic acid-13C5 | Isotope-Labeled Compounds | |
| HY-113046S1 | 5-Methyltetrahydrofolic acid-13C6 | 212248-92-5 | Isotope-Labeled Compounds |
| HY-113047 | 5,6-Dihydrouridine | 5627-05-4 | Natural Products |
| HY-113048 | Erythronic acid | 13752-84-6 | Reference compound |
| HY-113048A | Erythronic acid (potassium) | Reference compound | |
| HY-113049 | Phosphoenolpyruvic acid | 138-08-9 | Reference compound |
| HY-113049A | Phosphoenolpyruvic acid (trisodium) | 5541-93-5 | Biochemical Assay Reagents |
| HY-113050 | 2,3-Diphosphoglyceric acid | 138-81-8 | Reference compound |
| HY-113050A | 2,3-Diphosphoglyceric acid (pentasodium) | 1287756-01-7 | Natural Products |
| HY-113050B | 2,3-Diphosphoglyceric acid (pentacyclohexylamine) | 62868-79-5 | Biochemical Assay Reagents |
| HY-113050SA | 2,3-Diphosphoglyceric acid-d3 (ammonium) | 2712139-19-8 | Isotope-Labeled Compounds |
| HY-113053 | Prostaglandin A1 | 14152-28-4 | Natural Products |
| HY-113054 | DL-Glyceraldehyde 3-phosphate | 591-59-3 | Reference compound |
| HY-113056A | N1-Acetylspermidine (hydrochloride) | 34450-16-3 | Reference compound |
| HY-113056AS | N1-Acetylspermidine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-113057 | 3-Hydroxycapric acid | 14292-26-3 | Natural Products |
| HY-113057R | 3-Hydroxycapric acid (Standard) | 14292-26-3 | Reference Standards |
| HY-113058 | 3-Hydroxyoctanoic acid | 14292-27-4 | Biochemical Assay Reagents |
| HY-113061 | Pseudouridine | 1445-07-4 | Natural Products |
| HY-113061R | Pseudouridine (Standard) | 1445-07-4 | Reference Standards |
| HY-113061S | Pseudouridine-O18 | Isotope-Labeled Compounds | |
| HY-113062 | 20α-Dihydroprogesterone | 145-14-2 | Natural Products |
| HY-113062S | 20α-Dihydroprogesterone-13C5 | Isotope-Labeled Compounds | |
| HY-113063 | 3-Methyl-2-oxovaleric acid | 1460-34-0 | Natural Products |
| HY-113063R | 3-Methyl-2-oxovaleric acid (Standard) | 1460-34-0 | Reference Standards |
| HY-113064 | Selenocystine | 2897-21-4 | Peptides |
| HY-113066 | Guanosine 5'-diphosphate | 146-91-8 | Oligonucleotides |
| HY-113066A | Guanosine 5'-diphosphate (disodium salt) | 7415-69-2 | Oligonucleotides |
| HY-113066B | Guanosine 5'-diphosphate (ditromethamine) | 103192-39-8 | Reference compound |
| HY-113066C | Guanosine 5'-diphosphate (sodium), 96% (HPLC) | 43139-22-6 | Biochemical Assay Reagents |
| HY-113066S1 | Guanosine 5'-diphosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-113066S2 | Guanosine 5'-diphosphate-d13 (dilithium) | Isotope-Labeled Compounds | |
| HY-113066S3 | Guanosine 5'-diphosphate-13C10,15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-113067 | Phytanic acid | 14721-66-5 | Reference compound |
| HY-113067S | Phytanic acid-d3 | 1383920-40-8 | Isotope-Labeled Compounds |
| HY-113068 | (rel)-β-Tocopherol | 148-03-8 | Natural Products |
| HY-113068R | (rel)-β-Tocopherol (Standard) | 148-03-8 | Reference Standards |
| HY-113068S | β-Tocopherol-d3 | 936230-75-0 | Isotope-Labeled Compounds |
| HY-113069 | Decanoylcarnitine | 1492-27-9 | Natural Products |
| HY-113070 | Dihomo-γ-Linolenoyl Ethanolamide | 150314-34-4 | Reference compound |
| HY-113071 | Mevalonic acid | 150-97-0 | Natural Products |
| HY-113071A | Mevalonic acid (lithium salt) | 2618458-93-6 | Natural Products |
| HY-113071AR | Mevalonic acid (lithium salt) (Standard) | 2618458-93-6 | Reference Standards |
| HY-113071C | (S)-Mevalonic acid | 32451-23-3 | Reference compound |
| HY-113073 | 2,4-Dihydroxybutanoic acid | 1518-62-3 | Reference compound |
| HY-113074 | Glycolithocholic acid 3-sulfate | 15324-64-8 | Reference compound |
| HY-113074R | Glycolithocholic acid 3-sulfate (Standard) | 15324-64-8 | Reference Standards |
| HY-113075 | 1,5-Anhydrosorbitol | 154-58-5 | Natural Products |
| HY-113075S | 1,5-Anhydrosorbitol-13C | 2709705-29-1 | Isotope-Labeled Compounds |
| HY-113076 | Thiamine pyrophosphate | 154-87-0 | Natural Products |
| HY-113076R | Thiamine pyrophosphate (Standard) | 154-87-0 | Reference Standards |
| HY-113076S | Thiamine pyrophosphate-d3 | 2483831-79-2 | Isotope-Labeled Compounds |
| HY-113077 | 9-Hydroxy-10(E),12(E)-octadecadienoic acid | 115185-06-3 | Natural Products |
| HY-113079 | Argininic acid | 157-07-3 | Natural Products |
| HY-113080 | N-Acetylornithine | 6205-08-9 | Natural Products |
| HY-113080R | N-Acetylornithine (Standard) | 6205-08-9 | Reference Standards |
| HY-113080S | N-Acetylornithine-d2 | Isotope-Labeled Compounds | |
| HY-113081 | 1-Methyladenosine | 15763-06-1 | Natural Products |
| HY-113081AS | 1-Methyladenosine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-113081R | 1-Methyladenosine (Standard) | 15763-06-1 | Reference Standards |
| HY-113081S | 1-Methyladenosine-d3 | Isotope-Labeled Compounds | |
| HY-113081S1 | 1-Methyladenosine-d3 (hydriodide) | Isotope-Labeled Compounds | |
| HY-113082 | L-Thyronine | 1596-67-4 | Reference compound |
| HY-113083 | Acetaminophen glucuronide | 16110-10-4 | Reference compound |
| HY-113083R | Acetaminophen glucuronide (Standard) | 16110-10-4 | Reference Standards |
| HY-113084 | L-Cysteine S-sulfate | 1637-71-4 | Peptides |
| HY-113085 | 3-Hydroxyhippuric acid | 1637-75-8 | Natural Products |
| HY-113085R | 3-Hydroxyhippuric acid (Standard) | 1637-75-8 | Reference Standards |
| HY-113086 | CE(16:1(9Z)) | 16711-66-3 | Reference compound |
| HY-113089 | Epsilon-(gamma-glutamyl)-lysine | 17105-15-6 | Natural Products |
| HY-113089A | Epsilon-(gamma-glutamyl)-lysine (TFA) | Natural Products | |
| HY-113091 | Alpha-Tocotrienol | 1721-51-3 | Natural Products |
| HY-113092 | Propionylcarnitine | 17298-37-2 | Natural Products |
| HY-113093 | Ethyl glucuronide | 17685-04-0 | Natural Products |
| HY-113093S | Ethyl glucuronide-d5 | 1135070-98-2 | Isotope-Labeled Compounds |
| HY-113094 | Paullinic acid | 17735-94-3 | Natural Products |
| HY-113094R | Paullinic acid (Standard) | 17735-94-3 | Reference Standards |
| HY-113095 | γ-CEHC | 178167-75-4 | Natural Products |
| HY-113095R | γ-CEHC (Standard) | 178167-75-4 | Reference Standards |
| HY-113095S | γ-CEHC-d5 | Isotope-Labeled Compounds | |
| HY-113096 | Prostaglandin D1 | 17968-82-0 | Reference compound |
| HY-113096S | Prostaglandin D1-d4 | Isotope-Labeled Compounds | |
| HY-113097 | 3α,7α-Dihydroxycoprostanic acid | 17974-66-2 | Natural Products |
| HY-113097S | 3α,7α-Dihydroxycoprostanic acid-d3 | 338976-76-4 | Isotope-Labeled Compounds |
| HY-113097S1 | 3α,7α-Dihydroxycoprostanic acid-d5 | Isotope-Labeled Compounds | |
| HY-113098 | 2-Oxovaleric acid | 1821-02-9 | Natural Products |
| HY-113098R | 2-Oxovaleric acid (Standard) | 1821-02-9 | Reference Standards |
| HY-113099 | Indolelactic acid | 1821-52-9 | Natural Products |
| HY-113099R | Indolelactic acid (Standard) | 1821-52-9 | Reference Standards |
| HY-113099S | Indolelactic acid-d5 | 2470130-19-7 | Isotope-Labeled Compounds |
| HY-113100 | N-Acetylputrescine hydrochloride | 18233-70-0 | Natural Products |
| HY-113100R | N-Acetylputrescine hydrochloride (Standard) | 18233-70-0 | Reference Standards |
| HY-113101 | 2-Hydroxyadipic acid | 18294-85-4 | Natural Products |
| HY-113101R | 2-Hydroxyadipic acid (Standard) | 18294-85-4 | Reference Standards |
| HY-113102A | 9(E),11(E)-Octadecadienoic acid | 544-71-8 | Reference compound |
| HY-113102B | 9(Z),11(Z)-Octadecadienoic acid | 544-70-7 | Reference compound |
| HY-113104S | Androsterone glucuronide-d4 (sodium) | 2687960-88-7 | Isotope-Labeled Compounds |
| HY-113105 | Estriol 16α-(β-D-glucuronide) | 1852-50-2 | Reference compound |
| HY-113107 | 3-Hydroxydodecanoic acid | 1883-13-2 | Natural Products |
| HY-113107R | 3-Hydroxydodecanoic acid (Standard) | 1883-13-2 | Reference Standards |
| HY-113110 | Cysteinylglycine | 19246-18-5 | Natural Products |
| HY-113110A | Cysteinylglycine (TFA) | 1100364-95-1 | Reference compound |
| HY-113111 | 11,12-DiHETrE | 192461-95-3 | Reference compound |
| HY-113111S | 11,12-DiHETrE-d11 | Isotope-Labeled Compounds | |
| HY-113112 | 8,9-DiHETrE | 192461-96-4 | Natural Products |
| HY-113113 | 13,14-Dihydro PGE1 | 19313-28-1 | Reference compound |
| HY-113113S | 13,14-Dihydro PGE1-d4 | 2705226-66-8 | Isotope-Labeled Compounds |
| HY-113114 | Tetrahydrocortisone | 53-05-4 | Natural Products |
| HY-113114S | Tetrahydrocortisone-d5 | Isotope-Labeled Compounds | |
| HY-113114S1 | Tetrahydrocortisone-d6 | Isotope-Labeled Compounds | |
| HY-113116 | Sphinganine 1-phosphate | 19794-97-9 | Reference compound |
| HY-113116S | Sphinganine 1-phosphate-d7 | 2315262-23-6 | Isotope-Labeled Compounds |
| HY-113118 | AAMU | 19893-78-8 | Natural Products |
| HY-113118S | Acetylamino-6-amino-3-methyluracil-13C4,15N3 | Isotope-Labeled Compounds | |
| HY-113119 | N-Butyrylglycine | 20208-73-5 | Peptides |
| HY-113119S | N-Butyrylglycine-d7 | Isotope-Labeled Compounds | |
| HY-113119S1 | N-Butyrylglycine-d2 | 1219799-10-6 | Isotope-Labeled Compounds |
| HY-113120 | Stearidonic acid | 20290-75-9 | Natural Products |
| HY-113121 | Vanillylmandelic acid | 55-10-7 | Natural Products |
| HY-113121R | Vanillylmandelic acid (Standard) | 55-10-7 | Reference Standards |
| HY-113121S | Vanillylmandelic acid-d3 | 74495-70-8 | Isotope-Labeled Compounds |
| HY-113121S1 | Vanillylmandelic acid-d1 | 53587-34-1 | Isotope-Labeled Compounds |
| HY-113123 | LysoPC(14:0/0:0) | 20559-16-4 | Natural Products |
| HY-113123S1 | LysoPC(14:0/0:0)-d7 | Isotope-Labeled Compounds | |
| HY-113125 | Dolichol-20 | 2067-66-5 | Natural Products |
| HY-113126 | 3-Hydroxyisobutyric acid | 2068-83-9 | Natural Products |
| HY-113126A | 3-Hydroxyisobutyric acid (sodium) | 1219589-99-7 | Reference compound |
| HY-113126B | (R)-3-Hydroxyisobutyric acid (sodium) | 1228078-57-6 | Reference compound |
| HY-113127 | L-Tryptophanamide | 20696-57-5 | Reference compound |
| HY-113128 | sn-Glycerol 3-phosphate | 17989-41-2 | Natural Products |
| HY-113128A | sn-Glycerol 3-phosphate (lithium) | Reference compound | |
| HY-113128B | sn-Glycerol 3-phosphate (biscyclohexylammonium salt) | 29849-82-9 | Natural Products |
| HY-113128C | (Rac)-sn-Glycerol 3-phosphate | 57-03-4 | Reference compound |
| HY-113128S | sn-Glycerol 3-phosphate-13C3 (disodium) | Isotope-Labeled Compounds | |
| HY-113130 | Eicosadienoic acid | 2091-39-6 | Natural Products |
| HY-113131 | Dihydroxyacetone phosphate | 57-04-5 | Natural Products |
| HY-113131A | Dihydroxyacetone phosphate (hemimagnesium hydrate) | Natural Products | |
| HY-113132 | 5,6-DHET | 213382-49-1 | Natural Products |
| HY-113133 | Kojibiose | 2140-29-6 | Reference compound |
| HY-113133R | Kojibiose (Standard) | 2140-29-6 | Reference Standards |
| HY-113134 | 25-Hydroxycholesterol | 2140-46-7 | Natural Products |
| HY-113134S | 25-Hydroxycholesterol-d6 | 88247-69-2 | Isotope-Labeled Compounds |
| HY-113135 | 5-Methylcytidine | 2140-61-6 | Natural Products |
| HY-113135R | 5-Methylcytidine (Standard) | 2140-61-6 | Reference Standards |
| HY-113136 | 1-Methylguanosine | 2140-65-0 | Natural Products |
| HY-113136S | 1-Methylguanosine-d3 | Isotope-Labeled Compounds | |
| HY-113137 | N2,N2-Dimethylguanosine | 2140-67-2 | Natural Products |
| HY-113137R | N2,N2-Dimethylguanosine (Standard) | 2140-67-2 | Reference Standards |
| HY-113138 | 3-Methyluridine | 2140-69-4 | Natural Products |
| HY-113139 | 1-Methylinosine | 2140-73-0 | Natural Products |
| HY-113139S | 1-Methylinosine-d3 | Isotope-Labeled Compounds | |
| HY-113143 | Galactose 1-phosphate | 2255-14-3 | Natural Products |
| HY-113143A | Galactose 1-phosphate Potassium salt | 19046-60-7 | Natural Products |
| HY-113143AS | Galactose 1-phosphate-13C (potassium) | 478518-78-4 | Isotope-Labeled Compounds |
| HY-113143AS1 | Galactose 1-phosphate-13C-1 (potassium) | 478518-80-8 | Isotope-Labeled Compounds |
| HY-113144 | L-Hexanoylcarnitine | 22671-29-0 | Natural Products |
| HY-113144AS | L-Hexanoylcarnitine-d3 (chloride) | 2483831-95-2 | Isotope-Labeled Compounds |
| HY-113144R | L-Hexanoylcarnitine (Standard) | 22671-29-0 | Reference Standards |
| HY-113144S | L-Hexanoylcarnitine-d9 | 2847775-84-0 | Isotope-Labeled Compounds |
| HY-113145 | (Rac)-Salvianic acid A | 23028-17-3 | Natural Products |
| HY-113146 | 2-Octenal | 2363-89-5 | Biochemical Assay Reagents |
| HY-113147 | L-Palmitoylcarnitine | 2364-67-2 | Natural Products |
| HY-113147A | L-Palmitoylcarnitine (chloride) | 18877-64-0 | Reference compound |
| HY-113147AR | L-Palmitoylcarnitine (chloride) (Standard) | 18877-64-0 | Reference Standards |
| HY-113147AS | L-Palmitoylcarnitine-d3 (hydrochloride) | 1334532-26-1 | Isotope-Labeled Compounds |
| HY-113147B | L-Palmitoylcarnitine (TFA) | Natural Products | |
| HY-113147S1 | L-Palmitoylcarnitine-d9 | 2847775-90-8 | Isotope-Labeled Compounds |
| HY-113149 | Argininosuccinic acid | 2387-71-5 | Reference compound |
| HY-113149A | Argininosuccinic acid (disodium) | 918149-29-8 | Reference compound |
| HY-113150 | Hexanoylglycine | 24003-67-6 | Reference compound |
| HY-113150S | Hexanoylglycine-d11 | Isotope-Labeled Compounds | |
| HY-113150S1 | Hexanoylglycine-d2 | 1256842-52-0 | Isotope-Labeled Compounds |
| HY-113151 | 18-Oxocortisol | 2410-60-8 | Natural Products |
| HY-113152 | Hypogeic acid (50mg/ml in ethanol) | 2416-19-5 | Natural Products |
| HY-113157 | Estrone 3-glucuronide | 2479-90-5 | Reference compound |
| HY-113158 | 4-Hydroxyhippuric acid | 2482-25-9 | Reference compound |
| HY-113158R | 4-Hydroxyhippuric acid (Standard) | 2482-25-9 | Reference Standards |
| HY-113159 | Docosapentaenoic acid (22n-3) | 24880-45-3 | Natural Products |
| HY-113159A | Docosapentaenoic acid (22n-3) (sodium) | 2983837-44-9 | Reference compound |
| HY-113161 | L-Octanoylcarnitine | 25243-95-2 | Natural Products |
| HY-113161R | L-Octanoylcarnitine (Standard) | 25243-95-2 | Reference Standards |
| HY-113161S | L-Octanoylcarnitine-d3 | 204259-56-3 | Isotope-Labeled Compounds |
| HY-113161S1 | L-Octanoylcarnitine-d9 | 2847775-88-4 | Isotope-Labeled Compounds |
| HY-113162 | Bovinic acid | 2540-56-9 | Natural Products |
| HY-113162A | Bovinic acid (sodium) | 756499-04-4 | Reference compound |
| HY-113162R | Bovinic acid (Standard) | 2540-56-9 | Reference Standards |
| HY-113164 | Vitamin K1 2,3-epoxide | 25486-55-9 | Reference compound |
| HY-113164S | Vitamin K1 2,3-epoxide-d7 | Isotope-Labeled Compounds | |
| HY-113165 | Isobutyryl-L-carnitine | 25518-49-4 | Natural Products |
| HY-113165A | Isobutyryl-L-carnitine (chloride) | 6920-31-6 | Reference compound |
| HY-113165AS | Isobutyryl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-113166 | Dodecanoylcarnitine | 25518-54-1 | Natural Products |
| HY-113166R | Dodecanoylcarnitine (Standard) | 25518-54-1 | Reference Standards |
| HY-113167 | 2-Phosphoglyceric acid | 2553-59-5 | Reference compound |
| HY-113168 | Butyrylcarnitine | 25576-40-3 | Natural Products |
| HY-113168AS | (±)-Butyrylcarnitine-d9 | 2936622-23-8 | Isotope-Labeled Compounds |
| HY-113168R | Butyrylcarnitine (Standard) | 25576-40-3 | Reference Standards |
| HY-113169 | Estriol 3-glucuronide | 2479-91-6 | Natural Products |
| HY-113170 | CE(20:0) | 2573-03-7 | Natural Products |
| HY-113200 | N1-Acetylspermine | 25593-72-0 | Natural Products |
| HY-113200A | N1-Acetylspermine (trihydrochloride) | 77928-70-2 | Reference compound |
| HY-113201 | Tetradecanoylcarnitine | 25597-07-3 | Natural Products |
| HY-113201R | Tetradecanoylcarnitine (Standard) | 25597-07-3 | Reference Standards |
| HY-113201S | Tetradecanoylcarnitine-d9 | 2245713-18-0 | Isotope-Labeled Compounds |
| HY-113202 | Stearoylcarnitine | 25597-09-5 | Natural Products |
| HY-113202A | DL-Stearoylcarnitine | 1976-27-8 | Reference compound |
| HY-113202S | Stearoyl-L-carnitine-d3 | 1021439-31-5 | Isotope-Labeled Compounds |
| HY-113202S1 | Stearoyl-L-carnitine-d9 (chloride) | 2936622-19-2 | Isotope-Labeled Compounds |
| HY-113204 | N-Oleoyl glycine | 2601-90-3 | Natural Products |
| HY-113204R | N-Oleoyl glycine (Standard) | 2601-90-3 | Reference Standards |
| HY-113205 | 15-keto-Prostaglandin E2 | 26441-05-4 | Natural Products |
| HY-113205S | 15-Keto-prostaglandin E2-d9 | Isotope-Labeled Compounds | |
| HY-113205S1 | 15-Keto-prostaglandin E2-d4 | Isotope-Labeled Compounds | |
| HY-113206 | D-Sedoheptulose 7-phosphate | 2646-35-7 | Natural Products |
| HY-113206A | D-Sedoheptulose-7-phosphate (barium) | 17187-72-3 | Reference compound |
| HY-113208 | 13,14-Dihydro-15-keto Prostaglandin F2α | 27376-76-7 | Natural Products |
| HY-113208A | 11β-13,14-Dihydro-15-keto Prostaglandin F2α | 107615-77-0 | Reference compound |
| HY-113208AS1 | 11β-13,14-Dihydro-15-keto Prostaglandin F2α-d4 | Isotope-Labeled Compounds | |
| HY-113209 | 8-Isoprostaglandin F2α | 27415-26-5 | Natural Products |
| HY-113209A | ent-8-Iso-15(S)-prostaglandin F2α | 214748-66-0 | Reference compound |
| HY-113209R | 8-Isoprostaglandin F2α (Standard) | 27415-26-5 | Reference Standards |
| HY-113209S | 8-Iso-PGF2a-d4 | 211105-40-7 | Isotope-Labeled Compounds |
| HY-113209S1 | 8-iso Prostaglandin F2α-d9 | Isotope-Labeled Compounds | |
| HY-113209S2 | 8-Isoprostaglandin F2α-13C5 | Isotope-Labeled Compounds | |
| HY-113210 | Hydroxyphenylacetylglycine | 28116-23-6 | Natural Products |
| HY-113212 | Ursocholic acid | 2955-27-3 | Natural Products |
| HY-113212R | Ursocholic acid (Standard) | 2955-27-3 | Reference Standards |
| HY-113212S | Ursocholic acid-d4 | Isotope-Labeled Compounds | |
| HY-113214 | 3,5-Diiodo-L-tyrosine | 300-39-0 | Natural Products |
| HY-113214R | 3,5-Diiodo-L-tyrosine (Standard) | 300-39-0 | Reference Standards |
| HY-113215 | Allotetrahydrocortisol | 302-91-0 | Natural Products |
| HY-113215S | Allotetrahydrocortisol-d5 | 2687961-06-2 | Isotope-Labeled Compounds |
| HY-113216 | Asymmetric dimethylarginine | 30315-93-6 | Natural Products |
| HY-113216AS | Asymmetric dimethylarginine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-113216B | Asymmetric dimethylarginine (dihydrochloride) | 220805-22-1 | Reference compound |
| HY-113216BS | Asymmetric-dimethylarginine-d6 (dihydrochloride) | 1313730-20-9 | Isotope-Labeled Compounds |
| HY-113216R | Asymmetric dimethylarginine (Standard) | 30315-93-6 | Reference Standards |
| HY-113216S | Asymmetric dimethylarginine-d7 (hydrochloride hydrate) | Isotope-Labeled Compounds | |
| HY-113217 | Cholesteryl oleate | 303-43-5 | Natural Products |
| HY-113217S | Cholesteryl oleate-d7 | 1416275-35-8 | Isotope-Labeled Compounds |
| HY-113217S1 | Cholesteryl oleate-d7-1 | 2260669-48-3 | Isotope-Labeled Compounds |
| HY-113218 | Acetyl-L-carnitine | 3040-38-8 | Natural Products |
| HY-113218S | Acetyl-L-carnitine-d9 | 203805-90-7 | Isotope-Labeled Compounds |
| HY-113219 | Hydroxyphenyllactic acid | 306-23-0 | Natural Products |
| HY-113219R | Hydroxyphenyllactic acid (Standard) | 306-23-0 | Reference Standards |
| HY-113220 | Monoisobutyl phthalic acid | 30833-53-5 | Natural Products |
| HY-113220S | Monoisobutyl phthalic acid-d4 | 1219802-26-2 | Isotope-Labeled Compounds |
| HY-113221 | Isovalerylcarnitine | 31023-24-2 | Natural Products |
| HY-113221AS | Isovalerylcarnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-113221R | Isovalerylcarnitine (Standard) | 31023-24-2 | Reference Standards |
| HY-113224 | Desmosterol | 313-04-2 | Natural Products |
| HY-113224R | Desmosterol (Standard) | 313-04-2 | Reference Standards |
| HY-113224S | Desmosterol-d6 | 1246298-67-8 | Isotope-Labeled Compounds |
| HY-113225 | Guanosine triphosphate | 86-01-1 | Oligonucleotides |
| HY-113225B | Guanosine triphosphate (tritris) | 103192-46-7 | Reference compound |
| HY-113225S1 | Guanosine triphosphate-13C10,15N5 (tetraammonium) | Isotope-Labeled Compounds | |
| HY-113225S2 | Guanosine triphosphate-13C (dilithium) | Isotope-Labeled Compounds | |
| HY-113225S3 | Guanosine triphosphate-15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-113225S4 | Guanosine triphosphate-15N5,d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-113225S5 | Guanosine triphosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-113226 | Orotidine | 314-50-1 | Natural Products |
| HY-113227 | Oxoadipic acid | 3184-35-8 | Natural Products |
| HY-113227R | Oxoadipic acid (Standard) | 3184-35-8 | Reference Standards |
| HY-113228 | Isocitric acid | 320-77-4 | Natural Products |
| HY-113228R | Isocitric acid (Standard) | 320-77-4 | Reference Standards |
| HY-113230 | Galactosylhydroxylysine | 32448-36-5 | Reference compound |
| HY-113230B | Galactosylhydroxylysine (hydrochloride) | Natural Products | |
| HY-113231 | 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid | 3247-75-4 | Natural Products |
| HY-113232 | 3-Methylcrotonylglycine | 33008-07-0 | Natural Products |
| HY-113232S | 3-Methylcrotonylglycine-d2 | 1276197-31-9 | Isotope-Labeled Compounds |
| HY-113233 | 19-Noretiocholanolone | 33036-33-8 | Natural Products |
| HY-113236 | p-Synephrine | 614-35-7 | Natural Products |
| HY-113238A | Lithocholic acid 3-sulfate (disodium) | 64936-81-8 | Biochemical Assay Reagents |
| HY-113238AS | Lithocholic acid 3-sulfate-d4 (disodium) | Isotope-Labeled Compounds | |
| HY-113238F | FITC-Lithocholic acid 3-sulfate | Dye Reagents | |
| HY-113238S1 | Lithocholic acid 3-sulfate-d4（ sodium salt） | Isotope-Labeled Compounds | |
| HY-113239 | Hydroxycotinine | 34834-67-8 | Natural Products |
| HY-113239S | Hydroxycotinine-d3 | 1311275-10-1 | Isotope-Labeled Compounds |
| HY-113239S1 | rel-Hydroxycotinine-d3 | 159956-78-2 | Isotope-Labeled Compounds |
| HY-113239S2 | (Rac)-Hydroxycotinine-d3 | Isotope-Labeled Compounds | |
| HY-113242 | 5-Nonadecylresorcinol | 35176-46-6 | Natural Products |
| HY-113245 | 3-Indolyl-β-D-glucuronide | 35804-66-1 | Reference compound |
| HY-113246 | 15-keto-Prostaglandin F2a | 35850-13-6 | Reference compound |
| HY-113247 | trans-trans-Muconic acid | 3588-17-8 | Natural Products |
| HY-113247R | trans-trans-Muconic acid (Standard) | 3588-17-8 | Reference Standards |
| HY-113247S | trans-trans-Muconic acid-d4 | 1955496-83-9 | Isotope-Labeled Compounds |
| HY-113247S1 | Muconic acid-d4 | 1185239-59-1 | Isotope-Labeled Compounds |
| HY-113248 | 3-Nitro-L-tyrosine | 621-44-3 | Natural Products |
| HY-113248S | 3-Nitro-L-tyrosine-d3 | 213386-10-8 | Isotope-Labeled Compounds |
| HY-113248S1 | 3-Nitro-L-tyrosine-13C6 | Isotope-Labeled Compounds | |
| HY-113251 | 2-Hydroxyestrone | 362-06-1 | Reference compound |
| HY-113251S | 2-Hydroxyestrone-d4 | 81586-97-2 | Isotope-Labeled Compounds |
| HY-113251S1 | 2-Hydroxyestrone-13C6 | Isotope-Labeled Compounds | |
| HY-113252 | 2-Methoxyestrone | 362-08-3 | Natural Products |
| HY-113252R | 2-Methoxyestrone (Standard) | 362-08-3 | Reference Standards |
| HY-113252S | 2-Methoxyestrone-13C,d3 | 1217460-84-8 | Isotope-Labeled Compounds |
| HY-113252S1 | 2-Methoxyestrone-13C6 | Isotope-Labeled Compounds | |
| HY-113252S2 | 2-Methoxyestrone-d4 | 949885-90-9 | Isotope-Labeled Compounds |
| HY-113253A | N8-Acetylspermidine dihydrochloride | 34450-15-2 | Natural Products |
| HY-113254 | 13,14-Dihydro-15-keto-PGE2 | 363-23-5 | Reference compound |
| HY-113254S | 13,14-Dihydro-15-keto-PGE2-d4 | Isotope-Labeled Compounds | |
| HY-113254S1 | 13,14-Dihydro-15-keto-PGE2-d9 | 2750534-81-5 | Isotope-Labeled Compounds |
| HY-113256 | Linoleyl carnitine | 36816-10-1 | Natural Products |
| HY-113257 | Dopamine 4-sulfate | 38339-02-5 | Natural Products |
| HY-113259 | 7α-Hydroxy-4-cholesten-3-one | 3862-25-7 | Natural Products |
| HY-113259AS | 7β-Hydroxy-4-cholesten-3-one-d7 | 1262046-74-1 | Isotope-Labeled Compounds |
| HY-113259R | 7α-Hydroxy-4-cholesten-3-one (Standard) | 3862-25-7 | Reference Standards |
| HY-113259S | 7α-Hydroxy-4-cholesten-3-one-d7 | 2260669-17-6 | Isotope-Labeled Compounds |
| HY-113261 | Oleoylcarnitine | 38677-66-6 | Natural Products |
| HY-113261A | (Rac)-Oleoylcarnitine | 13962-05-5 | Natural Products |
| HY-113261R | Oleoylcarnitine (Standard) | 38677-66-6 | Reference Standards |
| HY-113261S | Oleoylcarnitine-d9 | 2847775-85-1 | Isotope-Labeled Compounds |
| HY-113262 | 8-Hydroxyguanosine | 3868-31-3 | Natural Products |
| HY-113263 | 17a-Hydroxypregnenolone | 387-79-1 | Natural Products |
| HY-113263R | 17a-Hydroxypregnenolone (Standard) | 387-79-1 | Reference Standards |
| HY-113263S | 17a-Hydroxypregnenolone-d3 | 105078-92-0 | Isotope-Labeled Compounds |
| HY-113263S1 | 17α-Hydroxypregnenolone-13C2,d2 | 2483824-29-7 | Isotope-Labeled Compounds |
| HY-113264 | PGD2 ethanolamide | 398138-28-8 | Reference compound |
| HY-113264S | PGD2 ethanolamide-d4 | 2714417-74-8 | Isotope-Labeled Compounds |
| HY-113266 | Valerylcarnitine | 40225-14-7 | Natural Products |
| HY-113266R | Valerylcarnitine (Standard) | 40225-14-7 | Reference Standards |
| HY-113266S | Valerylcarnitine-d9 | 2847775-89-5 | Isotope-Labeled Compounds |
| HY-113268 | Biotin sulfone | 40720-05-6 | Natural Products |
| HY-113268R | Biotin sulfone (Standard) | 40720-05-6 | Reference Standards |
| HY-113269 | alpha-CEHC | 4072-32-6 | Reference compound |
| HY-113269R | alpha-CEHC (Standard) | 4072-32-6 | Reference Standards |
| HY-113270 | Actinine | 407-64-7 | Natural Products |
| HY-113270A | Actinine (chloride) | 6249-56-5 | Natural Products |
| HY-113270AS | Actinine-d9 (chloride) | 85806-17-3 | Isotope-Labeled Compounds |
| HY-113271 | 5-Androstenetriol | 4150-30-5 | Reference compound |
| HY-113273A | Diadenosine pentaphosphate (pentasodium) | 4097-04-5 | Reference compound |
| HY-113273B | Diadenosine pentaphosphate (pentaammonium) | 102783-61-9 | Reference compound |
| HY-113273C | Diadenosine pentaphosphate (pentalithium) | 94108-02-8 | Reference compound |
| HY-113274 | Pi-Methylimidazoleacetic acid | 4200-48-0 | Natural Products |
| HY-113274A | Pi-Methylimidazoleacetic acid (hydrochloride) | 1071661-55-6 | Reference compound |
| HY-113277 | 3-Methyladipic acid | 3058-01-3 | Natural Products |
| HY-113277R | 3-Methyladipic acid (Standard) | 3058-01-3 | Reference Standards |
| HY-113278 | Leucyl-phenylalanine | 3063-05-6 | Natural Products |
| HY-113279 | 7-Dehydrocholesterol | 434-16-2 | Natural Products |
| HY-113279R | 7-Dehydrocholesterol (Standard) | 434-16-2 | Reference Standards |
| HY-113279S | 7-Dehydrocholesterol-d7 | 388622-58-0 | Isotope-Labeled Compounds |
| HY-113280S | Pyridoxol 5'-phosphate-d3 | Isotope-Labeled Compounds | |
| HY-113283 | Homogentisic acid | 451-13-8 | Natural Products |
| HY-113283R | Homogentisic acid (Standard) | 451-13-8 | Reference Standards |
| HY-113284 | Succinyladenosine | 4542-23-8 | Natural Products |
| HY-113285 | Ureidopropionic acid | 462-88-4 | Natural Products |
| HY-113285F | FITC-Ureidopropionic acid | Dye Reagents | |
| HY-113285R | Ureidopropionic acid (Standard) | 462-88-4 | Reference Standards |
| HY-113286 | 4-Guanidinobutanoic acid | 463-00-3 | Natural Products |
| HY-113286R | 4-Guanidinobutanoic acid (Standard) | 463-00-3 | Reference Standards |
| HY-113288 | Campestanol | 474-60-2 | Natural Products |
| HY-113289 | Brassicasterol | 474-67-9 | Reference compound |
| HY-113289R | Brassicasterol (Standard) | 474-67-9 | Reference Standards |
| HY-113291 | 5'-Deoxyadenosine | 4754-39-6 | Natural Products |
| HY-113291R | 5'-Deoxyadenosine (Standard) | 4754-39-6 | Reference Standards |
| HY-113293 | Estrone sulfate | 481-97-0 | Reference compound |
| HY-113293A | Estrone sulfate (potassium) | 1240-04-6 | Natural Products |
| HY-113293B | Estrone sulfate (sodium) | 438-67-5 | Natural Products |
| HY-113293BS | Estrone sulfate-d5 (sodium) | 2734919-86-7 | Isotope-Labeled Compounds |
| HY-113293BS1 | Estrone sulfate-d4 (sodium) | 285979-80-8 | Isotope-Labeled Compounds |
| HY-113294 | 3-Hydroxykynurenine | 484-78-6 | Reference compound |
| HY-113294R | 3-Hydroxykynurenine (Standard) | 484-78-6 | Reference Standards |
| HY-113294S | 3-Hydroxykynurenine-13C3,15N | 2267306-16-9 | Isotope-Labeled Compounds |
| HY-113295 | Salicyluric acid | 487-54-7 | Natural Products |
| HY-113295R | Salicyluric acid (Standard) | 487-54-7 | Reference Standards |
| HY-113295S | Salicyluric acid-13C2,15N | 1286521-95-6 | Isotope-Labeled Compounds |
| HY-113295S3 | Salicyluric acid-d4 | Isotope-Labeled Compounds | |
| HY-113296S | Indoxyl sulfate-13C6 (potassium) | Isotope-Labeled Compounds | |
| HY-113298 | Citraconic acid | 498-23-7 | Natural Products |
| HY-113298R | Citraconic acid (Standard) | 498-23-7 | Reference Standards |
| HY-113299 | Metanephrine | 5001-33-2 | Reference compound |
| HY-113301 | Hexacosanoic acid | 506-46-7 | Natural Products |
| HY-113301R | Hexacosanoic acid (Standard) | 506-46-7 | Reference Standards |
| HY-113301S | Hexacosanoic acid-d4 | 1208837-79-9 | Isotope-Labeled Compounds |
| HY-113301S1 | Hexacosanoic acid-d4-1 | 1194984-85-4 | Isotope-Labeled Compounds |
| HY-113301S2 | Hexacosanoic acid-d3 | 2692624-17-0 | Isotope-Labeled Compounds |
| HY-113302 | 19-Hydroxyandrost-4-ene-3,17-dione | 510-64-5 | Natural Products |
| HY-113303 | FAPy-adenine | 5122-36-1 | Natural Products |
| HY-113304 | (S)-3,4-Dihydroxybutyric acid | 51267-44-8 | Natural Products |
| HY-113304A | (S)-3,4-Dihydroxybutyric acid (lithium hydrate) | Reference compound | |
| HY-113305 | Dopamine 3-O-sulfate | 51317-41-0 | Natural Products |
| HY-113306 | 1-Methyladenine | 5142-22-3 | Natural Products |
| HY-113308 | Taurolithocholic acid | 516-90-5 | Natural Products |
| HY-113308A | Taurolithocholic acid (sodium salt) | 6042-32-6 | Natural Products |
| HY-113308AS | Taurolithocholic acid-d4 (sodium) | 2410279-97-7 | Isotope-Labeled Compounds |
| HY-113308AS1 | Taurolithocholic Acid-d5 (sodium salt) | 1265476-97-8 | Isotope-Labeled Compounds |
| HY-113308AS2 | Taurolithocholic acid-d4-1 (sodium) | Isotope-Labeled Compounds | |
| HY-113308S | Taurolithocholic acid-d5 | 1265681-64-8 | Isotope-Labeled Compounds |
| HY-113308S1 | Taurolithocholic acid-d4 | 2410279-96-6 | Isotope-Labeled Compounds |
| HY-113313 | Aldosterone | 52-39-1 | Natural Products |
| HY-113313R | Aldosterone (Standard) | 52-39-1 | Reference Standards |
| HY-113313S | Aldosterone-d8 | 1261254-31-2 | Isotope-Labeled Compounds |
| HY-113313S1 | Aldosterone-d7 | Isotope-Labeled Compounds | |
| HY-113313S2 | Aldosterone-d4 | Isotope-Labeled Compounds | |
| HY-113314 | AFMK | 52450-38-1 | Reference compound |
| HY-113315 | 3b-Hydroxy-5-cholenoic acid | 5255-17-4 | Natural Products |
| HY-113315R | 3b-Hydroxy-5-cholenoic acid (Standard) | 5255-17-4 | Reference Standards |
| HY-113315S | 3b-Hydroxy-5-cholenoic acid-d4 | 2770684-32-5 | Isotope-Labeled Compounds |
| HY-113316A | (±)-Salsolinol (hydrochloride) | 79923-51-6 | Natural Products |
| HY-113316B | (S)-Salsolinol | 27740-96-1 | Natural Products |
| HY-113317 | L-Xylulose | 527-50-4 | Reference compound |
| HY-113318 | Coproporphyrin I | 531-14-6 | Reference compound |
| HY-113319 | β-D-Fructose,98%(mixtures) | 53188-23-1 | Biochemical Assay Reagents |
| HY-113320 | Etiocholanolone | 53-42-9 | Natural Products |
| HY-113320R | Etiocholanolone (Standard) | 53-42-9 | Reference Standards |
| HY-113320S | Etiocholanolone-d5 | 1620102-33-1 | Isotope-Labeled Compounds |
| HY-113320S1 | Etiocholanolone-d2 | 2687960-82-1 | Isotope-Labeled Compounds |
| HY-113322 | 3-Hydroxyquinine | 53467-23-5 | Reference compound |
| HY-113322S | (3S)-3-Hydroxy quinidine-vinyl-d3 | Isotope-Labeled Compounds | |
| HY-113323 | 3-Methoxy-4-hydroxyphenylglycol | 534-82-7 | Reference compound |
| HY-113323S | 3-Methoxy-4-hydroxyphenylglycol-d3 | 74495-72-0 | Isotope-Labeled Compounds |
| HY-113324 | NADPH | 53-57-6 | Natural Products |
| HY-113325 | NADP | 53-59-8 | Natural Products |
| HY-113325A | NADP (sodium hydrate) | 698999-85-8 | Reference compound |
| HY-113327 | 1,3,7-Trimethyluric acid | 5415-44-1 | Natural Products |
| HY-113327R | 1,3,7-Trimethyluric acid (Standard) | 5415-44-1 | Reference Standards |
| HY-113327S | 1,3,7-Trimethyluric acid-d9 | 117490-42-3 | Isotope-Labeled Compounds |
| HY-113328 | Aminoadipic acid | 542-32-5 | Natural Products |
| HY-113328R | Aminoadipic acid (Standard) | 542-32-5 | Reference Standards |
| HY-113328S | Aminoadipic acid-d3 | 2483832-01-3 | Isotope-Labeled Compounds |
| HY-113328S1 | Aminoadipic acid-d6 | 2509058-79-9 | Isotope-Labeled Compounds |
| HY-113329 | Guanidinoethyl sulfonate | 543-18-0 | Reference compound |
| HY-113330 | 12S-HHT | 54397-84-1 | Reference compound |
| HY-113331 | Thromboxane B2 | 54397-85-2 | Reference compound |
| HY-113331S | Thromboxane B2-d4 | 1346112-79-5 | Isotope-Labeled Compounds |
| HY-113331S1 | Thromboxane B2-d9 | Isotope-Labeled Compounds | |
| HY-113332 | Myristoleic acid | 544-64-9 | Natural Products |
| HY-113332R | Myristoleic acid (Standard) | 544-64-9 | Reference Standards |
| HY-113334 | Turanose | 547-25-1 | Natural Products |
| HY-113334R | Turanose (Standard) | 547-25-1 | Reference Standards |
| HY-113335 | Trihydroxycholestanoic acid | 547-98-8 | Reference compound |
| HY-113335S | Trihydroxycholestanoic acid-d3 | 338976-79-7 | Isotope-Labeled Compounds |
| HY-113335S1 | Trihydroxycholestanoic acid-d5 | 2936622-49-8 | Isotope-Labeled Compounds |
| HY-113336 | 15(S)-HETE | 54845-95-3 | Natural Products |
| HY-113336A | 15(R)-HETE | 83603-31-0 | Reference compound |
| HY-113336B | (±)15-HETE | 71030-36-9 | Reference compound |
| HY-113336S | 15(S)-HETE-d8 | 84807-87-4 | Isotope-Labeled Compounds |
| HY-113337 | Ap4A | 5542-28-9 | Reference compound |
| HY-113337A | Ap4A (tetraammonium) | 102783-36-8 | Reference compound |
| HY-113338 | 8-Hydroxyguanine | 5614-64-2 | Natural Products |
| HY-113338A | 8-Hydroxyguanine (hydrochloride) | 1246818-54-1 | Reference compound |
| HY-113340 | 2-Furoylglycine | 5657-19-2 | Natural Products |
| HY-113341 | 7β-Hydroxycholesterol | 566-27-8 | Reference compound |
| HY-113341S | 7ß-Hydroxycholesterol-d7 | 349553-97-5 | Isotope-Labeled Compounds |
| HY-113342 | 7-Ketocholesterol | 566-28-9 | Natural Products |
| HY-113342S | 7-Keto Cholesterol-d7 | 127684-08-6 | Isotope-Labeled Compounds |
| HY-113344 | 16α-Hydroxyestrone | 566-76-7 | Reference compound |
| HY-113345 | Zymostenol | 566-97-2 | Reference compound |
| HY-113345R | Zymostenol (Standard) | 566-97-2 | Reference Standards |
| HY-113345S | Zymostenol-d7 | 2260669-19-8 | Isotope-Labeled Compounds |
| HY-113346 | Tetrahydrodeoxycorticosterone | 567-03-3 | Reference compound |
| HY-113346S | Tetrahydrodeoxycorticosterone-d3 | 72205-58-4 | Isotope-Labeled Compounds |
| HY-113347 | cis-5-Tetradecenoic acid | 5684-70-8 | Reference compound |
| HY-113350 | Thromboxane A2 | 57576-52-0 | Reference compound |
| HY-113351 | 11β-Hydroxyandrosterone | 57-61-4 | Natural Products |
| HY-113352 | 7-Methylguanine | 578-76-7 | Natural Products |
| HY-113352R | 7-Methylguanine (Standard) | 578-76-7 | Reference Standards |
| HY-113352S | 7-Methylguanine-d3 | 17829-03-7 | Isotope-Labeled Compounds |
| HY-113353 | Nicotinuric acid | 583-08-4 | Natural Products |
| HY-113353R | Nicotinuric acid (Standard) | 583-08-4 | Reference Standards |
| HY-113353S | Nicotinuric acid-d4 | 1216737-36-8 | Isotope-Labeled Compounds |
| HY-113354 | Anserine | 584-85-0 | Natural Products |
| HY-113354R | Anserine (Standard) | 584-85-0 | Reference Standards |
| HY-113354S | Anserine-d4 | 1201658-81-2 | Isotope-Labeled Compounds |
| HY-113354S1 | Anserine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-113355 | NADH | 58-68-4 | Reference compound |
| HY-113356 | m-Tyramine | 588-05-6 | Natural Products |
| HY-113357 | m-Coumaric acid | 588-30-7 | Natural Products |
| HY-113357R | m-Coumaric acid (Standard) | 588-30-7 | Reference Standards |
| HY-113357S | m-Coumaric acid-13C3 | 1261170-79-9 | Isotope-Labeled Compounds |
| HY-113358 | 6-keto Prostaglandin F1α | 58962-34-8 | Natural Products |
| HY-113358S | 6-keto Prostaglandin F1α-d4 | 82414-64-0 | Isotope-Labeled Compounds |
| HY-113359 | Uridine 5'-diphosphate | 58-98-0 | Reference compound |
| HY-113359AS | Uridine 5'-diphosphate-d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-113359AS1 | Uridine 5'-diphosphate-13C9 (dilithium) | Isotope-Labeled Compounds | |
| HY-113359AS2 | Uridine 5'-diphosphate-13C9,15N2 (dilithium) | Isotope-Labeled Compounds | |
| HY-113359AS3 | Uridine 5'-diphosphate-15N2 (dilithium) | Isotope-Labeled Compounds | |
| HY-113360 | Chenodeoxycholic acid 3-sulfate | 59132-32-0 | Reference compound |
| HY-113362 | Petroselinic acid | 593-39-5 | Natural Products |
| HY-113362R | Petroselinic acid (Standard) | 593-39-5 | Reference Standards |
| HY-113365 | Cholestenone | 601-57-0 | Natural Products |
| HY-113365R | Cholestenone (Standard) | 601-57-0 | Reference Standards |
| HY-113365S | Cholestenone-d5 | 72560-60-2 | Isotope-Labeled Compounds |
| HY-113365S1 | Cholestenone-13C | 68165-57-1 | Isotope-Labeled Compounds |
| HY-113365S2 | Cholestenone-13C2 | 82938-09-8 | Isotope-Labeled Compounds |
| HY-113365S3 | Cholestenone-d7 | 2389048-48-8 | Isotope-Labeled Compounds |
| HY-113366 | Prostaglandin J2 | 60203-57-8 | Reference compound |
| HY-113366S | Prostaglandin J2-d4 | 2738376-80-0 | Isotope-Labeled Compounds |
| HY-113367 | Suberylglycine | 60317-54-6 | Natural Products |
| HY-113367S | Suberylglycine-d4 | 2469259-73-0 | Isotope-Labeled Compounds |
| HY-113367S1 | Suberylglycine-d2 | 1219799-02-6 | Isotope-Labeled Compounds |
| HY-113369 | Cholesteryl arachidonate | 604-34-2 | Natural Products |
| HY-113369S | Cholesteryl arachidonate-d8 | Isotope-Labeled Compounds | |
| HY-113371 | 2-Methylcitric acid | 6061-96-7 | Natural Products |
| HY-113371A | 2-Methylcitric acid (trisodium) | 117041-96-0 | Reference compound |
| HY-113371AS | 2-Methylcitric acid-d3 (trisodium) | 2483831-23-6 | Isotope-Labeled Compounds |
| HY-113371R | 2-Methylcitric acid (Standard) | 6061-96-7 | Reference Standards |
| HY-113371S | 2-Methylcitric acid-d3 | 146764-58-1 | Isotope-Labeled Compounds |
| HY-113373 | Guanidinosuccinic acid | 6133-30-8 | Natural Products |
| HY-113374A | N1,N12-Diacetylspermine (dihydrochloride) | 77928-71-3 | Reference compound |
| HY-113375 | D-Ribofuranose | 613-83-2 | Natural Products |
| HY-113376 | Etiocholanolone glucuronide | 3602-09-3 | Reference compound |
| HY-113377 | L-Glyceric acid | 28305-26-2 | Natural Products |
| HY-113377A | L-Glyceric acid (sodium) | 146298-95-5 | Natural Products |
| HY-113378 | 3-Hydroxybutyric acid | 300-85-6 | Natural Products |
| HY-113378R | 3-Hydroxybutyric acid (Standard) | 300-85-6 | Reference Standards |
| HY-113378S | 3-Hydroxybutyric acid-d4 (sodium) | 1219804-68-8 | Isotope-Labeled Compounds |
| HY-113379 | 2,3-Diaminopropionic acid | 4033-39-0 | Natural Products |
| HY-113380 | (S)-b-aminoisobutyric acid | 4249-19-8 | Natural Products |
| HY-113380R | (S)-b-aminoisobutyric acid (Standard) | 4249-19-8 | Reference Standards |
| HY-113381 | 2-Hydroxybutyric acid | 600-15-7 | Reference compound |
| HY-113381A | (R)-2-Hydroxybutanoic acid | 20016-85-7 | Reference compound |
| HY-113381B | (R)-2-Hydroxybutanoic acid (sodium) | 2307465-23-0 | Reference compound |
| HY-113382 | N-Methylhydantoin | 616-04-6 | Natural Products |
| HY-113382R | N-Methylhydantoin (Standard) | 616-04-6 | Reference Standards |
| HY-113400 | Cytidine 5'-diphosphate | 63-38-7 | Natural Products |
| HY-113400S | Cytidine diphosphate-15N3 (dilithium) | Isotope-Labeled Compounds | |
| HY-113400S1 | Cytidine diphosphate-13C9 (dilithium) | Isotope-Labeled Compounds | |
| HY-113400S2 | Cytidine diphosphate-13C9,15N3 (dilithium) | Isotope-Labeled Compounds | |
| HY-113400S3 | Cytidine diphosphate-d13 (dilithium) | Isotope-Labeled Compounds | |
| HY-113401 | Adenosine 2',3'-cyclic phosphate | 634-01-5 | Natural Products |
| HY-113402 | Gamma-glutamylcysteine | 636-58-8 | Natural Products |
| HY-113402A | Gamma-glutamylcysteine (TFA) | 283159-88-6 | Reference compound |
| HY-113402R | Gamma-glutamylcysteine (Standard) | 636-58-8 | Reference Standards |
| HY-113403 | Pyridinoline | 63800-01-1 | Natural Products |
| HY-113404 | DL-Dopa | 63-84-3 | Natural Products |
| HY-113404S | DL-Dopa-d6 | Isotope-Labeled Compounds | |
| HY-113404S1 | L-Dopa-d3 | 157929-66-3 | Isotope-Labeled Compounds |
| HY-113405 | 21-Deoxycortisol | 641-77-0 | Natural Products |
| HY-113405R | 21-Deoxycortisol (Standard) | 641-77-0 | Reference Standards |
| HY-113405S | 21-Desoxycortisol-d4 | Isotope-Labeled Compounds | |
| HY-113405S1 | 21-Deoxycortisol-d8 | 2479914-04-8 | Isotope-Labeled Compounds |
| HY-113406 | (±)-Hexanoylcarnitine | 6418-78-6 | Natural Products |
| HY-113407 | D-Fructose-6-phosphate | 643-13-0 | Natural Products |
| HY-113407A | D-Fructose-6-phosphate (disodium) | 26177-86-6 | Natural Products |
| HY-113407C | D-Fructose-6-phosphate (disodium monohydrate) | Natural Products | |
| HY-113407CR | D-Fructose-6-phosphate (disodium monohydrate) (Standard) | Reference Standards | |
| HY-113408 | Tiglyl carnitine | 64681-36-3 | Natural Products |
| HY-113408R | Tiglyl carnitine (Standard) | 64681-36-3 | Reference Standards |
| HY-113409 | 3-Hydroxyisovaleric acid | 625-08-1 | Natural Products |
| HY-113409R | 3-Hydroxyisovaleric acid (Standard) | 625-08-1 | Reference Standards |
| HY-113410 | 3-Methylglutaric acid | 626-51-7 | Natural Products |
| HY-113410R | 3-Methylglutaric acid (Standard) | 626-51-7 | Reference Standards |
| HY-113410S | 3-Methylglutaric acid-d4 | 1219798-68-1 | Isotope-Labeled Compounds |
| HY-113411 | 3-Hydroxyglutaric acid | 638-18-6 | Natural Products |
| HY-113411S | 3-Hydroxyglutaric acid-d5 | 1219805-72-7 | Isotope-Labeled Compounds |
| HY-113412A | 3-Methylhistamine (dihydrochloride) | 36475-47-5 | Natural Products |
| HY-113412AR | 3-Methylhistamine (dihydrochloride) (Standard) | 36475-47-5 | Reference Standards |
| HY-113413 | Imidazoleacetic acid | 645-65-8 | Natural Products |
| HY-113413R | Imidazoleacetic acid (Standard) | 645-65-8 | Reference Standards |
| HY-113414 | Deoxycorticosterone | 64-85-7 | Natural Products |
| HY-113414R | Deoxycorticosterone (Standard) | 64-85-7 | Reference Standards |
| HY-113414S | Deoxycorticosterone-d8 | 55487-63-3 | Isotope-Labeled Compounds |
| HY-113415 | Testosterone sulfate | 651-45-6 | Reference compound |
| HY-113415A | Testosterone sulfate (pyridinium) | 34991-10-1 | Reference compound |
| HY-113416 | Dehydroepiandrosterone sulfate | 651-48-9 | Reference compound |
| HY-113416AS | Dehydroepiandrosterone sulfate-d6 (sodium dihydrate) | Isotope-Labeled Compounds | |
| HY-113416R | Dehydroepiandrosterone sulfate (Standard) | 651-48-9 | Reference Standards |
| HY-113418 | Beta-Cortol | 667-65-2 | Reference compound |
| HY-113420 | 11-Dehydro-thromboxane B2 | 67910-12-7 | Natural Products |
| HY-113420S | 11-Dehydro-thromboxane B2-d4 | 1240398-15-5 | Isotope-Labeled Compounds |
| HY-113420S2 | 11-Dehydro-thromboxane B2-13C5 | Isotope-Labeled Compounds | |
| HY-113421 | Linoleoyl ethanolamide | 68171-52-8 | Reference compound |
| HY-113421S | Linoleoyl ethanolamide-d4 | 1451194-69-6 | Isotope-Labeled Compounds |
| HY-113422S | Tetrahydrocorticosterone-d5 | Isotope-Labeled Compounds | |
| HY-113422S1 | Tetrahydrocorticosterone-d3 | Isotope-Labeled Compounds | |
| HY-113423 | Tetrahydro-11-deoxycortisol | 68-60-0 | Reference compound |
| HY-113424A | 1,2-Dioleoyl-sn-glycero-3-phosphocholine | 4235-95-4 | Oligonucleotides |
| HY-113424AS | 1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9 | Isotope-Labeled Compounds | |
| HY-113426 | Nepsilon-Acetyl-L-lysine | 692-04-6 | Natural Products |
| HY-113426S | Nepsilon-acetyl-L-lysine-d8 | Isotope-Labeled Compounds | |
| HY-113427 | trans-Vaccenic acid | 693-72-1 | Natural Products |
| HY-113427A | cis-Vaccenic acid | 506-17-2 | Natural Products |
| HY-113427AR | cis-Vaccenic acid (Standard) | 506-17-2 | Reference Standards |
| HY-113427AS | cis-Vaccenic acid-d13 | Isotope-Labeled Compounds | |
| HY-113427R | trans-Vaccenic acid (Standard) | 693-72-1 | Reference Standards |
| HY-113427S | trans-Vaccenic acid-d13 | Isotope-Labeled Compounds | |
| HY-113430 | 5-n-Heneicosylresorcinol | 70110-59-7 | Natural Products |
| HY-113431 | Arabinosylhypoxanthine | 7013-16-3 | Reference compound |
| HY-113432 | Nudifloramide | 701-44-0 | Natural Products |
| HY-113432R | Nudifloramide (Standard) | 701-44-0 | Reference Standards |
| HY-113432S | Nudifloramide-d3 | 1207384-48-2 | Isotope-Labeled Compounds |
| HY-113432S1 | Nudifloramide-d6 | 2012598-72-8 | Isotope-Labeled Compounds |
| HY-113434 | 5(S)-HETE | 70608-72-9 | Reference compound |
| HY-113434A | 5(R)-HETE | 61641-47-2 | Reference compound |
| HY-113434B | 5-HETE | 71030-39-2 | Reference compound |
| HY-113434S | 5(S)-HETE-d8 | 330796-62-8 | Isotope-Labeled Compounds |
| HY-113435 | 8-Dehydrocholesterol | 70741-38-7 | Natural Products |
| HY-113436 | Cholesteryl 11-eicosenoate | 70832-37-0 | Natural Products |
| HY-113437 | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate | 7091-44-3 | Reference compound |
| HY-113437A | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate (sodium) | 169051-60-9 | Natural Products |
| HY-113437AS | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate-d62 (sodium) | 327179-00-0 | Isotope-Labeled Compounds |
| HY-113438 | 15(S)-HPETE | 70981-96-3 | Reference compound |
| HY-113439 | 12-HETE | 71030-37-0 | Reference compound |
| HY-113439S | 12-HETE-d8 | 2525175-25-9 | Isotope-Labeled Compounds |
| HY-113440 | 5-Methoxytryptophol | 712-09-4 | Natural Products |
| HY-113441 | 4-Hydroxy-3-methoxyphenylglycol sulfate (potassium) | 71324-20-4 | Reference compound |
| HY-113441S | 3-Methoxy-4-Hydroxyphenylglycol sulfate-d3 (potassium) | 474909-54-1 | Isotope-Labeled Compounds |
| HY-113442 | 6-trans-12-epi-Leukotriene B4 | 71548-19-1 | Reference compound |
| HY-113442A | 6-trans-Leukotriene B4 | 71652-82-9 | Reference compound |
| HY-113443 | 12(S)-HPETE | 71774-10-2 | Reference compound |
| HY-113444 | Prostaglandin D3 | 71902-47-1 | Reference compound |
| HY-113445 | Thromboxane B3 | 71953-80-5 | Reference compound |
| HY-113446 | Leukotriene C4 | 72025-60-6 | Reference compound |
| HY-113446R | Leukotriene C4 (Standard) | 72025-60-6 | Reference Standards |
| HY-113446S | Leukotriene C4-d5 | 1441421-73-3 | Isotope-Labeled Compounds |
| HY-113447 | 11-Dehydrocorticosterone | 72-23-1 | Reference compound |
| HY-113448 | CE(20:3(8Z,11Z,14Z)) | 7274-08-0 | Reference compound |
| HY-113449 | Ubiquinone-1 | 727-81-1 | Natural Products |
| HY-113450 | 10Z-Nonadecenoic acid | 73033-09-7 | Natural Products |
| HY-113451 | 3-Hydroxysebacic acid | 73141-46-5 | Reference compound |
| HY-113451R | 3-Hydroxysebacic acid (Standard) | 73141-46-5 | Reference Standards |
| HY-113453 | 11(R)-HETE | 73347-43-0 | Reference compound |
| HY-113453A | 11-S-Hydroxyeicosatetraenoic acid | 54886-50-9 | Natural Products |
| HY-113455 | 9S-HODE | 73543-67-6 | Reference compound |
| HY-113455S | 9S-HODE-d4 | 890955-25-6 | Isotope-Labeled Compounds |
| HY-113455S1 | 9(S)-HODE-13C18 | Isotope-Labeled Compounds | |
| HY-113456 | Leukotriene D4 | 73836-78-9 | Reference compound |
| HY-113456S | Leukotriene D4-d5 | 1240398-17-7 | Isotope-Labeled Compounds |
| HY-113457 | 11-Oxo etiocholanolone | 739-27-5 | Natural Products |
| HY-113457S | 11-Oxo etiocholanolone-d5 | Isotope-Labeled Compounds | |
| HY-113459 | Prostaglandin F1a | 745-62-0 | Reference compound |
| HY-113459S | Prostaglandin F1a-d9 | 1542166-81-3 | Isotope-Labeled Compounds |
| HY-113459S1 | 13,14-Dihydro-15-keto Prostaglandin F2α-d4 | 42932-59-2 | Isotope-Labeled Compounds |
| HY-113460 | 11-trans-Leukotriene C4 | 74841-69-3 | Reference compound |
| HY-113461 | 13,14-Dihydro-15-keto-prostaglandin A2 | 74872-89-2 | Reference compound |
| HY-113462 | α-Carotene | 7488-99-5 | Natural Products |
| HY-113462R | α-Carotene (Standard) | 7488-99-5 | Reference Standards |
| HY-113463 | CE(20:5(5Z,8Z,11Z,14Z,17Z) | 74892-97-0 | Natural Products |
| HY-113465 | Leukotriene E4 | 75715-89-8 | Reference compound |
| HY-113465A | 11-trans Leukotriene E4 | 75715-88-7 | Reference compound |
| HY-113465S | Leukotriene E4-d5 | 1240398-14-4 | Isotope-Labeled Compounds |
| HY-113466 | 4-Hydroxynonenal | 75899-68-2 | Reference compound |
| HY-113466S | 4-Hydroxynonenal-d3 | 148706-06-3 | Isotope-Labeled Compounds |
| HY-113468 | 3-O-Methyl-DL-DOPA | 7636-26-2 | Reference compound |
| HY-113468A | 3-O-Methyldopa | 300-48-1 | Natural Products |
| HY-113468AS | 3-O-Methyldopa-d3 | 586954-09-8 | Isotope-Labeled Compounds |
| HY-113468AS1 | 3-O-Methyldopa-d3 (hydrate) | Isotope-Labeled Compounds | |
| HY-113468R | 3-O-Methyl-DL-DOPA (Standard) | 7636-26-2 | Reference Standards |
| HY-113469 | Cyclic GMP | 7665-99-8 | Natural Products |
| HY-113469A | Cyclic GMP (sodium) | 40732-48-7 | Natural Products |
| HY-113469B | Cyclic GMP (TBAOH) | Oligonucleotides | |
| HY-113469R | Cyclic GMP (Standard) | 7665-99-8 | Reference Standards |
| HY-113470 | LysoPC(16:1(9Z)) | 76790-27-7 | Reference compound |
| HY-113471 | Perillic acid | 7694-45-3 | Reference compound |
| HY-113471A | (S)-(-)-Perillic acid | 23635-14-5 | Natural Products |
| HY-113472 | N-Methyl-4-pyridone-3-carboxamide | 769-49-3 | Natural Products |
| HY-113472R | N-Methyl-4-pyridone-3-carboxamide (Standard) | 769-49-3 | Reference Standards |
| HY-113472S | N-Methyl-4-pyridone-3-carboxamide-d3 | 1207384-47-1 | Isotope-Labeled Compounds |
| HY-113473 | 10-Nitrolinoleic acid | 774603-04-2 | Reference compound |
| HY-113474 | 3,4-Dihydroxymandelic acid | 775-01-9 | Natural Products |
| HY-113474R | 3,4-Dihydroxymandelic acid (Standard) | 775-01-9 | Reference Standards |
| HY-113475A | 8(S),15(S)-DiHETE | 80234-65-7 | Natural Products |
| HY-113477 | CE(20:2(6Z,9Z)) | 77715-45-8 | Natural Products |
| HY-113478 | 3β-Ursodeoxycholic acid | 78919-26-3 | Reference compound |
| HY-113478R | 3β-Ursodeoxycholic acid (Standard) | 78919-26-3 | Reference Standards |
| HY-113478S | Ursodeoxycholic acid-2,2,4,4-d4 | 347841-46-7 | Isotope-Labeled Compounds |
| HY-113479 | 20-Hydroxy-leukotriene B4 | 79516-82-8 | Reference compound |
| HY-113481 | Prostaglandin E3 | 802-31-3 | Natural Products |
| HY-113481A | 17-trans Prostaglandin E3 | 210979-33-2 | Reference compound |
| HY-113482 | 1β-Hydroxydeoxycholic acid | 80434-32-8 | Reference compound |
| HY-113482S | 1β-Hydroxydeoxycholic acid-d5 | Isotope-Labeled Compounds | |
| HY-113483 | 20-Carboxy-Leukotriene B4 | 80434-82-8 | Reference compound |
| HY-113484 | Leukotriene B5 | 80445-66-5 | Reference compound |
| HY-113485 | Melanin | 8049-97-6 | Natural Products |
| HY-113486 | Lathosterol | 80-99-9 | Natural Products |
| HY-113486R | Lathosterol (Standard) | 80-99-9 | Reference Standards |
| HY-113486S | (S)-Lathosterol-d4 | 1182005-25-9 | Isotope-Labeled Compounds |
| HY-113486S1 | lathosterol-d7 | 2260669-10-9 | Isotope-Labeled Compounds |
| HY-113488 | 8,9-Epoxyeicosatrienoic acid | 81246-85-7 | Reference compound |
| HY-113489 | 14,15-Epoxyeicosatrienoic acid | 81276-03-1 | Natural Products |
| HY-113490 | 15-KETE | 81416-72-0 | Natural Products |
| HY-113491 | 3-Phosphoglyceric acid | 820-11-1 | Reference compound |
| HY-113492 | 5(S)15(S)-DiHETE | 82200-87-1 | Reference compound |
| HY-113493 | 4-Pyridoxic acid | 82-82-6 | Natural Products |
| HY-113493R | 4-Pyridoxic acid (Standard) | 82-82-6 | Reference Standards |
| HY-113493S1 | 4-Pyridoxic acid-d3 | 1435934-03-4 | Isotope-Labeled Compounds |
| HY-113494 | Stigmastanol | 83-45-4 | Natural Products |
| HY-113494R | Stigmastanol (Standard) | 83-45-4 | Reference Standards |
| HY-113495 | Deoxypyridinoline | 83462-55-9 | Reference compound |
| HY-113498 | Sphingomyelin | 85187-10-6 | Natural Products |
| HY-113499A | cis-Malonylcarnitine | 910825-21-7 | Natural Products |
| HY-113505 | Delta-12-Prostaglandin J2 | 87893-54-7 | Reference compound |
| HY-113509 | Lipoxin A4 | 89663-86-5 | Natural Products |
| HY-113509A | 6-epi-Lipoxin A4 | 94292-80-5 | Reference compound |
| HY-113509B | 15(R)-Lipoxin A4 | 171030-11-8 | Natural Products |
| HY-113509S | Lipoxin A4-d5 | 1622429-53-1 | Isotope-Labeled Compounds |
| HY-113510 | 9(S)-HOTrE | 89886-42-0 | Natural Products |
| HY-113511 | Glycogen, Mussel | 9005-79-2 | Natural Products |
| HY-113511A | Glycogen, Oysters | 9005-79-2 | Natural Products |
| HY-113511B | Glycogen, from rabbit liver, ≥85% | 9005-79-2 | Biochemical Assay Reagents |
| HY-113511C | Glycogen, from bovine liver, ≥85% | 9005-79-2 | Biochemical Assay Reagents |
| HY-113512 | 17-HDHA | 90780-52-2 | Reference compound |
| HY-113513 | 5-HEPE | 92008-51-0 | Reference compound |
| HY-113514 | 6-Phosphogluconic acid | 921-62-0 | Reference compound |
| HY-113516 | 20-HETE Ethanolamide | 942069-11-6 | Natural Products |
| HY-113517 | Normetanephrine | 97-31-4 | Reference compound |
| HY-113517R | Normetanephrine (Standard) | 97-31-4 | Reference Standards |
| HY-113517S | (Rac)-Normetanephrine-d3 | 1073244-89-9 | Isotope-Labeled Compounds |
| HY-113519 | 14R(15S)-EET | 98103-48-1 | Reference compound |
| HY-113524 | N-Acetyl-L-aspartic acid | 997-55-7 | Natural Products |
| HY-113524R | N-Acetyl-L-aspartic acid (Standard) | 997-55-7 | Reference Standards |
| HY-113524S | N-Acetyl-L-aspartic acid-d3 | 284665-15-2 | Isotope-Labeled Compounds |
| HY-113527 | TRIA-662 | 1005-24-9 | Natural Products |
| HY-113527R | TRIA-662 (Standard) | 1005-24-9 | Reference Standards |
| HY-113527S | TRIA-662-d3 | 1218993-18-0 | Isotope-Labeled Compounds |
| HY-113529 | Stachyose (tetrahydrate) | 10094-58-3 | Natural Products |
| HY-113531 | ZK 95962 | 101071-43-6 | Reference compound |
| HY-113533 | Resolvin D4 | 1025684-60-9 | Reference compound |
| HY-113533A | 17(R)-Resolvin D4 | 528583-89-3 | Reference compound |
| HY-113534 | MV1 | 1001600-54-9 | Reference compound |
| HY-113537 | Demegestone | 10116-22-0 | Reference compound |
| HY-113542 | Blasticidin A | 100513-53-9 | Natural Products |
| HY-113543S | Desmetryn-d3 | Isotope-Labeled Compounds | |
| HY-113545 | 9(R)-HODE | 10075-11-3 | Natural Products |
| HY-113545A | (±)9-HODE | 98524-19-7 | Reference compound |
| HY-113547 | Nanterinone | 102791-47-9 | Reference compound |
| HY-113549 | Erbstatin | 100827-28-9 | Reference compound |
| HY-113553 | 4-Aminophenylphosphorylcholine | 102185-28-4 | Reference compound |
| HY-113555 | DORA 42 | 1030377-48-0 | Reference compound |
| HY-113556 | Sappanone A | 102067-84-5 | Natural Products |
| HY-113557 | DNAC-1 | 1006021-30-2 | Reference compound |
| HY-113560 | Plipastatin B1 | 103955-73-3 | Peptides |
| HY-113561 | Biphenomycin A | 100296-21-7 | Natural Products |
| HY-113562 | Laidlomycin phenylcarbamate | 101191-83-7 | Reference compound |
| HY-113567 | GSK2324 | 1020567-30-9 | Reference compound |
| HY-113568 | CAY10581 | 1018340-07-2 | Reference compound |
| HY-113569 | Armentomycin | 10139-00-1 | Reference compound |
| HY-113571 | Tie2 kinase inhibitor 2 | 1020412-97-8 | Reference compound |
| HY-113572 | PX-866-17OH | 1012327-63-7 | Reference compound |
| HY-113573 | Protosappanin A | 102036-28-2 | Natural Products |
| HY-113574 | HSP90-IN-29 | 1012788-65-6 | Reference compound |
| HY-113575 | Dehydroaripiprazole (hydrochloride) | 1008531-60-9 | Reference compound |
| HY-113575S | Dehydro Aripiprazole-d8 (hydrochloride) | 1215383-78-0 | Isotope-Labeled Compounds |
| HY-113578 | PD 116152 | 101708-64-9 | Reference compound |
| HY-113582 | Albothricin | 103867-06-7 | Natural Products |
| HY-113585 | 1,4-Dideoxy-1,4-imino-D-arabinitol (hydrochloride) | 100991-92-2 | Reference compound |
| HY-113586 | Besifovir Dipivoxil | 441785-26-8 | Reference compound |
| HY-113587 | Nicoclonate (hydrochloride) | 10400-20-1 | Reference compound |
| HY-113590 | FR295389 | 1019207-72-7 | Reference compound |
| HY-113591 | CB2 receptor agonist 10 | 1046140-32-2 | Reference compound |
| HY-113592 | ERK-IN-4 | 1049738-54-6 | Reference compound |
| HY-113593 | GSK1360707 | 1013098-04-8 | Reference compound |
| HY-113594 | ICI 200355 | 105080-32-8 | Reference compound |
| HY-113595 | Temafloxacin (hydrochloride) | 105784-61-0 | Reference compound |
| HY-113596 | Acetyl Coenzyme A (trisodium) | 102029-73-2 | Reference compound |
| HY-113596A | Acetyl coenzyme A (lithium) | 32140-51-5 | Biochemical Assay Reagents |
| HY-113596R | Acetyl Coenzyme A (trisodium) (Standard) | 102029-73-2 | Reference Standards |
| HY-113599 | Isoprocurcumenol | 102130-90-5 | Natural Products |
| HY-113600 | H-0106 (dihydrochloride) | 1011465-90-9 | Reference compound |
| HY-113601 | Linatine | 10139-06-7 | Reference compound |
| HY-113602 | Paldimycin B | 101411-71-6 | Reference compound |
| HY-113603 | Tildacerfont | 1014983-00-6 | Reference compound |
| HY-113604 | Pentabromopseudilin | 10245-81-5 | Natural Products |
| HY-113605 | Runanine | 100485-12-9 | Natural Products |
| HY-113606 | Adenosine 5'-phosphosulfate (disodium) | 102029-95-8 | Reference compound |
| HY-113608 | VCP171 | 1018830-99-3 | Reference compound |
| HY-113612 | Cytostatin | 682329-63-1 | Natural Products |
| HY-113612A | Cytostatin (sodium) | 457070-06-3 | Reference compound |
| HY-113613 | ETB067 | 1000995-79-8 | Reference compound |
| HY-113614 | Tetrahydrobostrycin | 1072119-07-3 | Natural Products |
| HY-113616 | VU0364572 | 1240514-87-7 | Reference compound |
| HY-113616A | VU0364572 (TFA) | 1240514-89-9 | Reference compound |
| HY-113618A | RO2959 (hydrochloride) | 1219927-22-6 | Reference compound |
| HY-113618B | RO2959 (monohydrochloride) | 2309172-44-7 | Reference compound |
| HY-113621B | Ageladine A (dihydrochloride) | 2757574-06-2 | Natural Products |
| HY-113622 | Cladospirone bisepoxide | 152607-03-9 | Natural Products |
| HY-113623 | Pyrenophorol | 22248-41-5 | Natural Products |
| HY-113626 | (-)-Cyclopenin | 20007-87-8 | Natural Products |
| HY-113626A | Cyclopenin | 19553-26-5 | Reference compound |
| HY-113627 | Undecylprodigiosin | 52340-48-4 | Natural Products |
| HY-113627A | Undecylprodigiosin (hydrochloride) | 56247-02-0 | Reference compound |
| HY-113628 | ABT-080 | 189498-57-5 | Reference compound |
| HY-113629 | 2-Keto-D-Glucose | 1854-25-7 | Natural Products |
| HY-113629R | 2-Keto-D-Glucose (Standard) | 1854-25-7 | Reference Standards |
| HY-113630A | 20β-22-Azacholesterol | 40521-33-3 | Natural Products |
| HY-113631 | Amorfrutin B | 78916-42-4 | Natural Products |
| HY-113632 | Debromohymenialdisine | 75593-17-8 | Natural Products |
| HY-113635 | ONO-6240 | 99659-62-8 | Reference compound |
| HY-113636 | Kazinol A | 99624-28-9 | Natural Products |
| HY-113637 | Galbonolide A | 100227-57-4 | Reference compound |
| HY-113638 | CVT-11127 | 1018674-83-3 | Peptides |
| HY-113639 | A-933548 | 1037826-43-9 | Reference compound |
| HY-113640 | BC-7013 | 1028291-66-8 | Reference compound |
| HY-113641 | ROCK-IN-32 | 1013117-40-2 | Reference compound |
| HY-113642 | CP-67804 | 103978-08-1 | Reference compound |
| HY-113643 | Levemopamil (hydrochloride) | 101238-54-4 | Reference compound |
| HY-113646 | Shield-2 | 1013621-70-9 | Reference compound |
| HY-113648 | LP10 | 1025400-45-6 | Reference compound |
| HY-113649 | AKB-6899 | 1007377-55-0 | Reference compound |
| HY-113653 | GSK2041706A | 1032824-43-3 | Reference compound |
| HY-113654 | AMG 7905 | 1026876-55-0 | Reference compound |
| HY-113655 | AD-5075 | 103788-05-2 | Reference compound |
| HY-113658 | ts-SA | 100715-13-7 | Reference compound |
| HY-113659 | 3',5'-O-Bis(isobutiryl)-4'-azido-2'-β-C-methyl-2'-deoxycytidine | 1019639-33-8 | Reference compound |
| HY-113662 | CLB-016 | 1005636-29-2 | Reference compound |
| HY-113667 | ASN04885796 | 1032892-26-4 | Reference compound |
| HY-113669 | A-940894 | 1027330-82-0 | Reference compound |
| HY-113670 | CLK1/2-IN-2 | 1005776-20-4 | Reference compound |
| HY-113671 | Belfosdil | 103486-79-9 | Reference compound |
| HY-113673 | A-935142 | 1031335-85-9 | Reference compound |
| HY-113678 | Colistin | 1066-17-7 | Reference compound |
| HY-113679 | Ceramides Mixture | 100403-19-8 | Reference compound |
| HY-113680 | KY1022 | 1029721-36-5 | Reference compound |
| HY-113681 | REV 5975 | 101820-46-6 | Reference compound |
| HY-113683 | AZ 12488024 | 1018988-00-5 | Reference compound |
| HY-113687 | T145 | 1021186-98-0 | Reference compound |
| HY-113689 | GAT211 | 102704-40-5 | Reference compound |
| HY-113690 | AHN 086 | 103625-22-5 | Reference compound |
| HY-113691 | (E)-L-652343 | 102565-09-3 | Reference compound |
| HY-113692 | AZD-9164 (bromide) | 1034916-72-7 | Reference compound |
| HY-113693 | ONO-RS-347 | 103176-67-6 | Reference compound |
| HY-113695 | BW A575C | 103221-88-1 | Reference compound |
| HY-113697 | Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD | 1037589-69-7 | Reference compound |
| HY-113700 | PD 116779 | 102674-89-5 | Reference compound |
| HY-113702 | PD 113413 | 103733-50-2 | Reference compound |
| HY-113703 | PD117588 | 99734-97-1 | Reference compound |
| HY-113704 | BKM1740 | 1070966-97-0 | Reference compound |
| HY-113711 | 15-OxoEDE | 105835-44-7 | Natural Products |
| HY-113713 | CH-38083 | 104786-63-2 | Reference compound |
| HY-113714 | C562-1101 | 1094693-07-8 | Reference compound |
| HY-113715 | Niclofolan | 10331-57-4 | Reference compound |
| HY-113716 | Adecypenol | 104493-13-2 | Reference compound |
| HY-113717 | ICL-SIRT078 | 1060430-64-9 | Reference compound |
| HY-113719 | VM4-037 | 1071470-72-8 | Reference compound |
| HY-113721 | BML-244 | 104062-70-6 | Reference compound |
| HY-113722 | DAT1 | 107401-70-7 | Reference compound |
| HY-113723 | MRS2298 | 491611-43-9 | Reference compound |
| HY-113725 | L 668411 | 112965-15-8 | Reference compound |
| HY-113726 | Nerisopam | 102771-12-0 | Reference compound |
| HY-113729 | B 746 | 103051-26-9 | Reference compound |
| HY-113730 | VUF5834 | 860002-95-5 | Reference compound |
| HY-113732 | Kazinol F | 104494-35-1 | Reference compound |
| HY-113733 | ICI-195739 | 103961-78-0 | Reference compound |
| HY-113734 | CM026 | 851941-94-1 | Reference compound |
| HY-113735 | Cephapirin Benzathine | 97468-37-6 | Reference compound |
| HY-113736 | Glycyllysine | 997-62-6 | Peptides |
| HY-113739 | Desmethylcitalopram (hydrochloride) | 97743-99-2 | Reference compound |
| HY-113739A | (S)-Desmethylcitalopram | 144025-14-9 | Reference compound |
| HY-113739S | Desmethylcitalopram-d3 (hydrochloride) | 1189650-18-7 | Isotope-Labeled Compounds |
| HY-113739S1 | Desmethylcitalopram-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-113743 | Ecomustine | 98383-18-7 | Reference compound |
| HY-113745 | LX-6171 | 914808-66-5 | Reference compound |
| HY-113748 | Rev 6207 (free base) | 98056-23-6 | Reference compound |
| HY-113749 | L-Mabuterol (hydrochloride) | 95656-55-6 | Reference compound |
| HY-113751 | JNJ-39393406 | 953428-73-4 | Reference compound |
| HY-113752 | MMV019313 | 902630-14-2 | Reference compound |
| HY-113753 | PDF-IN-1 | 900783-19-9 | Reference compound |
| HY-113755 | AA-1777 | 90316-11-3 | Reference compound |
| HY-113756 | trans-Latanoprost acid | 903549-49-5 | Reference compound |
| HY-113756A | Latanoprost acid | 41639-83-2 | Reference compound |
| HY-113756AR | Latanoprost acid (Standard) | 41639-83-2 | Reference Standards |
| HY-113757 | Picrasidine M | 99964-79-1 | Natural Products |
| HY-113758 | LY 163443 | 97581-70-9 | Reference compound |
| HY-113759 | Saquayamycin A | 99260-65-8 | Reference compound |
| HY-113761 | ASN03576800 | 957513-35-8 | Reference compound |
| HY-113763 | TWEAK-Fn14-IN-1 | 951612-19-4 | Reference compound |
| HY-113764 | N-Butanoyl-DL-homoserine lactone | 98426-48-3 | Reference compound |
| HY-113767 | Momordin II | 95851-41-5 | Natural Products |
| HY-113771 | Saquayamycin C | 99260-70-5 | Reference compound |
| HY-113772 | Inflachromene | 908568-01-4 | Reference compound |
| HY-113775 | Octadecanoyl-L-threo-sphingosine | 95037-06-2 | Natural Products |
| HY-113776 | 15(S)-HETRE | 92693-02-2 | Natural Products |
| HY-113777 | 22-HDHA | 90780-46-4 | Reference compound |
| HY-113778 | 15-keto-17-phenyl trinor Prostaglandin F2α | 949564-89-0 | Reference compound |
| HY-113781 | Ractopamine | 97825-25-7 | Reference compound |
| HY-113783 | Halobetasol | 98651-66-2 | Reference compound |
| HY-113783R | Halobetasol (Standard) | 98651-66-2 | Reference Standards |
| HY-113784 | Thiocarlide | 910-86-1 | Reference compound |
| HY-113784R | Thiocarlide (Standard) | 910-86-1 | Reference Standards |
| HY-113786 | EZH2-IN-21 | 923894-97-7 | Reference compound |
| HY-113787 | (R)-9b | 1655527-68-6 | Reference compound |
| HY-113790 | ISX-1 | 909207-35-8 | Reference compound |
| HY-113791 | Decuroside I | 96638-79-8 | Natural Products |
| HY-113793 | BPH-742 | 1059677-12-1 | Reference compound |
| HY-113794 | DSHS00884 | 675104-49-1 | Reference compound |
| HY-113795 | Aldgamycin E | 11011-06-6 | Natural Products |
| HY-113796 | Kopsoffinol | 96935-25-0 | Natural Products |
| HY-113797 | RS-52367 | 62435-92-1 | Reference compound |
| HY-113799 | Echinosporin | 79127-35-8 | Reference compound |
| HY-113801 | N-(3-Oxooctanoyl)-DL-homoserine lactone | 106983-27-1 | Natural Products |
| HY-113801R | N-(3-Oxooctanoyl)-DL-homoserine lactone (Standard) | 106983-27-1 | Reference Standards |
| HY-113802 | VUF 8328 | 102203-17-8 | Reference compound |
| HY-113803 | 4-Hydroxynonenal alkyne | 1011268-23-7 | Reference compound |
| HY-113805 | MC70 | 1031367-64-2 | Reference compound |
| HY-113806 | (±)-Trolline | 1021950-79-7 | Natural Products |
| HY-113807 | ZLJ-6 | 1051931-39-5 | Reference compound |
| HY-113811 | Diisopropyl xanthogen disulfide | 105-65-7 | Reference compound |
| HY-113812 | ZK110841 | 105595-17-3 | Reference compound |
| HY-113813 | SQ 28853 | 107550-68-5 | Reference compound |
| HY-113816 | Radicinin | 10088-95-6 | Natural Products |
| HY-113817 | SHIP1 activator 1 | 1000010-33-2 | Reference compound |
| HY-113818 | Kadsuracoccinic acid A | 1016260-22-2 | Natural Products |
| HY-113820 | AZD4619 | 1067247-60-2 | Reference compound |
| HY-113821 | 1-Naphthyl phosphate (potassium salt) | 100929-85-9 | Reference compound |
| HY-113823 | Naphthol AS-G | 91-96-3 | Reference compound |
| HY-113824 | RID-F | 1020853-03-5 | Reference compound |
| HY-113825 | CLK1/2-IN-1 | 1005784-23-5 | Reference compound |
| HY-113826 | L-656224 | 102612-16-8 | Reference compound |
| HY-113827 | THPN | 100079-26-3 | Reference compound |
| HY-113828 | Biotin-PEG2-C4-alkyne | 1011268-28-2 | Reference compound |
| HY-113829 | Valnemulin | 101312-92-9 | Reference compound |
| HY-113831 | CLK1/2-IN-3 | 1005784-60-0 | Reference compound |
| HY-113833 | N-Methylindan-2-amine (hydrochloride) | 10408-85-2 | Reference compound |
| HY-113834 | (R,R)-Ethambutol | 10054-05-4 | Reference compound |
| HY-113836 | 3-Hydroxyhexanoic acid | 10191-24-9 | Natural Products |
| HY-113840 | Sumarotene | 105687-93-2 | Reference compound |
| HY-113841 | RS-87337 | 107707-38-0 | Reference compound |
| HY-113843 | RETRA (hydrobromide) | 1035875-01-4 | Reference compound |
| HY-113844 | Ac-Gly-Lys-OMe | 10236-44-9 | Peptides |
| HY-113844A | Ac-Gly-Lys-OMe (acetate) | 14752-92-2 | Reference compound |
| HY-113845 | (+)-Intermedine | 10285-06-0 | Natural Products |
| HY-113845R | (+)-Intermedine (Standard) | 10285-06-0 | Reference Standards |
| HY-113846 | CMP-5 (hydrochloride) | 1030021-40-9 | Reference compound |
| HY-113846A | CMP-5 (dihydrochloride) | 2309409-79-6 | Reference compound |
| HY-113847 | Nanterinone (mesylate) | 102791-74-2 | Reference compound |
| HY-113848 | AEM1 | 1030123-90-0 | Reference compound |
| HY-113849 | MLS-573151 | 10179-57-4 | Reference compound |
| HY-113850 | CPSA | 1038713-54-0 | Reference compound |
| HY-113851 | BH-IAA | 1020201-82-4 | Reference compound |
| HY-113852 | K-259-2 | 102819-46-5 | Natural Products |
| HY-113853 | WF-10129 | 109075-64-1 | Natural Products |
| HY-113854 | AZD2906 | 1034148-15-6 | Reference compound |
| HY-113857 | RAD-243 | 103825-20-3 | Reference compound |
| HY-113858 | Brefonalol | 103880-26-8 | Reference compound |
| HY-113860 | Antiviral agent 52 | 101784-44-5 | Reference compound |
| HY-113861 | Propioxatin A | 102962-94-7 | Natural Products |
| HY-113862 | PHOME | 1028430-42-3 | Dye Reagents |
| HY-113863 | Rilopirox | 104153-37-9 | Reference compound |
| HY-113864 | Diisobutyl carbinol | 108-82-7 | Reference compound |
| HY-113866 | E-55888 | 1034142-33-0 | Reference compound |
| HY-113869 | BPH-628 | 1059677-40-5 | Reference compound |
| HY-113870 | 6-NBDG | 108708-22-1 | Dye Reagents |
| HY-113871 | R-PEP-27 | 103122-78-7 | Reference compound |
| HY-113873 | 10-Thiastearic acid | 105099-89-6 | Reference compound |
| HY-113874 | Picrasidine N | 101219-62-9 | Natural Products |
| HY-113876 | 2-Methyl-3-phenylquinoxaline | 10130-23-1 | Reference compound |
| HY-113877 | 3-Amino benzamidoxime | 100524-07-0 | Reference compound |
| HY-113878 | 12-OAHSA | 101901-73-9 | Reference compound |
| HY-113878S | 12-OAHSA-d17 | Isotope-Labeled Compounds | |
| HY-113879 | 18-Carboxy dinor Leukotriene B4 | 102674-12-4 | Reference compound |
| HY-113884 | (R)-Coriolic acid | 10219-69-9 | Reference compound |
| HY-113884A | (±)-Coriolic acid | 18104-45-5 | Reference compound |
| HY-113884B | (S)-Coriolic acid | 29623-28-7 | Reference compound |
| HY-113885 | MDA77 | 1103774-21-5 | Reference compound |
| HY-113887 | Prostaglandin F1β | 10164-73-5 | Reference compound |
| HY-113887A | 11β-Prostaglandin F1β | 37785-86-7 | Reference compound |
| HY-113887S | Prostaglandin F1β-d9 | 2389048-37-5 | Isotope-Labeled Compounds |
| HY-113889 | ZK112993 | 105114-63-4 | Reference compound |
| HY-113890 | Halofenozide | 112226-61-6 | Reference compound |
| HY-113891 | JX040 | 1089596-75-7 | Reference compound |
| HY-113892 | Leniquinsin | 10351-50-5 | Reference compound |
| HY-113893 | β-Interleukin I (163-171), human | 106021-96-9 | Peptides |
| HY-113894 | Retreversine | 1028332-91-3 | Reference compound |
| HY-113896 | U-67827E | 103494-23-1 | Reference compound |
| HY-113897 | Chloramphenicol 3-acetate | 10318-16-8 | Reference compound |
| HY-113898 | Ganoderic acid K | 104700-95-0 | Natural Products |
| HY-113899 | Biotin 4-amidobenzoic acid (sodium) | 102418-74-6 | Biochemical Assay Reagents |
| HY-113903 | (+)-Isopulegol | 104870-56-6 | Natural Products |
| HY-113904S | (Rac)-Tenofovir-d6 | 1020719-94-1 | Isotope-Labeled Compounds |
| HY-113904S1 | (Rac)-Tenofovir-d7 | 2747914-59-4 | Isotope-Labeled Compounds |
| HY-113906 | GSK1614343 | 1092076-04-4 | Reference compound |
| HY-113906A | (αR,8aS)-GSK1614343 | 1092476-84-0 | Reference compound |
| HY-113907 | SDZ-285604 | 1033846-45-5 | Reference compound |
| HY-113908 | (1S,3S)-3-Aminomethyl-cyclopentanol | 1007306-62-8 | Reference compound |
| HY-113909 | Dinoprost (methoxyamine) | 101913-98-8 | Reference compound |
| HY-113913 | 12(S)-HPEPE | 103239-14-1 | Reference compound |
| HY-113914 | 9-ING-41 | 1034895-42-5 | Reference compound |
| HY-113915 | Kuguaglycoside C | 1041631-93-9 | Natural Products |
| HY-113916 | Onalespib (lactate) | 1019889-35-0 | Reference compound |
| HY-113919 | Nothofagin | 11023-94-2 | Natural Products |
| HY-113920 | Azumolene (sodium) | 105336-14-9 | Reference compound |
| HY-113920A | Azumolene | 64748-79-4 | Reference compound |
| HY-113921 | m-PEG4-propargyl | 1101668-39-6 | Reference compound |
| HY-113924 | Tri(t-butoxycarbonylethoxymethyl) ethanol | 1027581-61-8 | Reference compound |
| HY-113925 | 1,2-Dilauroyl-sn-glycero-3-phosphate (sodium) | 108321-06-8 | Biochemical Assay Reagents |
| HY-113926 | BAY 60-2770 | 1027642-43-8 | Reference compound |
| HY-113929 | Loperamide oxide | 106900-12-3 | Reference compound |
| HY-113929R | Loperamide oxide (Standard) | 106900-12-3 | Reference Standards |
| HY-113930 | 3-[2-N-(Biotinyl)aminoethyldithio]propanoic acid | 104582-29-8 | Reference compound |
| HY-113931 | Aminooxy-PEG2-azide | 1043426-13-6 | ADC Related |
| HY-113932 | Trolamine salicylate ester | 10377-95-4 | Reference compound |
| HY-113933 | NE11808 | 105462-22-4 | Reference compound |
| HY-113934 | L-threo Lysosphingomyelin (d18:1) | 105615-55-2 | Reference compound |
| HY-113936 | A-943931 | 1027330-97-7 | Reference compound |
| HY-113938 | AZD4694 | 1054629-49-0 | Reference compound |
| HY-113942 | Cycloate | 1134-23-2 | Reference compound |
| HY-113942R | Cycloate (Standard) | 1134-23-2 | Reference Standards |
| HY-113943 | 9(S)-HETE | 107656-13-3 | Reference compound |
| HY-113943A | 9-HETE | 70968-92-2 | Reference compound |
| HY-113943AS | 9-HETE-d8 | Isotope-Labeled Compounds | |
| HY-113943S | 9(S)-HETE-d8 | Isotope-Labeled Compounds | |
| HY-113945 | Abbeymycin | 108073-64-9 | Natural Products |
| HY-113948 | 2-Deoxy-3,5-di-O-p-toluoyl-α-L-ribofuranosyl chloride | 141846-57-3 | Biochemical Assay Reagents |
| HY-113949 | Methyl 2,3-O-Isopropylidene-β-D-ribofuranoside | 4099-85-8 | Reference compound |
| HY-113949A | Methyl 2,3-O-Isopropylidene-β-L-ribofuranoside | 20672-63-3 | Reference compound |
| HY-113950 | Dichlorophenyl-ABA | 18201-65-5 | Reference compound |
| HY-113951 | Prolyl Endopeptidase Inhibitor 1 | 86925-97-5 | Reference compound |
| HY-113952 | Actinonin | 13434-13-4 | Natural Products |
| HY-113952R | Actinonin (Standard) | 13434-13-4 | Reference Standards |
| HY-113953 | Z-Asp-CH2-DCB | 153088-73-4 | Reference compound |
| HY-113955 | CP-346086 | 186390-48-7 | Reference compound |
| HY-113955A | CP-346086 (dihydrate) | 1262769-98-1 | Reference compound |
| HY-113957 | MPI_5a | 1259296-46-2 | Reference compound |
| HY-113958 | Difethialone | 104653-34-1 | Reference compound |
| HY-113958R | Difethialone (Standard) | 104653-34-1 | Reference Standards |
| HY-113960 | ERRα antagonist-1 | 1072145-33-5 | Reference compound |
| HY-113962 | 7α,25-Dihydroxycholesterol | 64907-22-8 | Natural Products |
| HY-113962S | 7α,25-Dihydroxycholesterol-d6 | 2260669-11-0 | Isotope-Labeled Compounds |
| HY-113963 | Ac-IETD-CHO | 191338-86-0 | Peptides |
| HY-113965 | CUR61414 | 334998-36-6 | Reference compound |
| HY-113967 | PF-04859989 | 34783-48-7 | Reference compound |
| HY-113969 | 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline | 61563-24-4 | Reference compound |
| HY-113970A | Nebracetam (hydrochloride) | 1177279-49-0 | Reference compound |
| HY-113972 | Methyl mycophenolate | 31858-66-9 | Natural Products |
| HY-113972A | (E/Z)-Methyl mycophenolate | 24243-40-1 | Reference compound |
| HY-113972R | Methyl mycophenolate (Standard) | 31858-66-9 | Reference Standards |
| HY-113973 | LPA2 antagonist 2 | 36840-10-5 | Reference compound |
| HY-113974 | trans-AUCB | 885012-33-9 | Reference compound |
| HY-113976A | Endothall | 145-73-3 | Reference compound |
| HY-113976AR | Endothall (Standard) | 145-73-3 | Reference Standards |
| HY-113978 | 6-Formylpterin | 712-30-1 | Reference compound |
| HY-113985 | Cirazoline | 59939-16-1 | Reference compound |
| HY-113986 | Dexfadrostat | 102676-87-9 | Reference compound |
| HY-113986B | (S)-Dexfadrostat | 102676-86-8 | Reference compound |
| HY-113995 | (-)-Vesamicol | 112709-59-8 | Reference compound |
| HY-114002 | Anticancer agent 129 | 135882-37-0 | Reference compound |
| HY-114005 | SB-734117 | 607368-97-8 | Reference compound |
| HY-114009 | AKR1C1-IN-1 | 4906-68-7 | Reference compound |
| HY-114011 | AMG7703 | 1103523-24-5 | Reference compound |
| HY-114015 | APC-6860 | 154628-42-9 | Reference compound |
| HY-114017 | Libvatrep | 871814-52-7 | Reference compound |
| HY-114023 | BML-288 | 851681-89-5 | Reference compound |
| HY-114025 | H4 Receptor antagonist 1 | 848217-00-5 | Reference compound |
| HY-114029 | Ep vinyl quinidine | 101143-87-7 | Reference compound |
| HY-114038 | SB-747651A | 607372-46-3 | Reference compound |
| HY-114040 | NO-711 | 159094-94-7 | Reference compound |
| HY-114041 | Resolvin E1 | 552830-51-0 | Natural Products |
| HY-114041S | Resolvin E1-d4 | Isotope-Labeled Compounds | |
| HY-114041S1 | Resolvin E1-d4-1 | 2714040-94-3 | Isotope-Labeled Compounds |
| HY-114043 | NCGC00092410 | 442898-34-2 | Reference compound |
| HY-114056 | AS115 | 926657-43-4 | Reference compound |
| HY-114060 | CFMB | 1208552-99-1 | Reference compound |
| HY-114061 | (R)-FTY 720P | 402616-23-3 | Reference compound |
| HY-114071 | BMS270394 | 262433-54-5 | Reference compound |
| HY-114072 | J-113397 | 256640-45-6 | Reference compound |
| HY-114072A | (S,S)-J-113397 | 256640-46-7 | Reference compound |
| HY-114076 | CGP55845 | 150175-54-5 | Reference compound |
| HY-114080 | Patamostat | 114568-26-2 | Reference compound |
| HY-114080A | Patamostat (mesylate) | 114568-32-0 | Reference compound |
| HY-114080B | Patamostat (hydrochloride) | 3031765-17-7 | Reference compound |
| HY-114081A | Hemicholinium (chloride) | 18997-39-2 | Reference compound |
| HY-114085 | BP 897 | 192384-87-5 | Reference compound |
| HY-114086 | ML359 | 1069858-99-6 | Reference compound |
| HY-114091 | PF-00356231 (hydrochloride) | 820223-77-6 | Reference compound |
| HY-114091A | PF-00356231 | 766536-21-4 | Reference compound |
| HY-114095 | BML-280 | 1158347-73-9 | Reference compound |
| HY-114097A | CCR1 antagonist 11 (hydrochloride) | Reference compound | |
| HY-114100 | Metesind | 138384-68-6 | Reference compound |
| HY-114116 | ML-109 | 1186649-91-1 | Reference compound |
| HY-114117 | Tyclopyrazoflor | 1477919-27-9 | Reference compound |
| HY-114118 | Semaglutide | 910463-68-2 | Reference compound |
| HY-114118A | Semaglutide (TFA) | Reference compound | |
| HY-114118B | Semaglutide (acetate) | 1997361-85-9 | Reference compound |
| HY-114118F | Semaglutide, FITC labeled | Dye Reagents | |
| HY-114118S3 | Semaglutide-13C6,15N (TFA) | Isotope-Labeled Compounds | |
| HY-114128 | Turoctocog alfa | 1192451-26-5 | Reference compound |
| HY-114133 | Depreotide | 161982-62-3 | Peptides |
| HY-114134 | Epoetin beta | 122312-54-3 | Inhibitory Antibodies |
| HY-114141 | BI-671800 | 1093108-50-9 | Reference compound |
| HY-114146 | CID 1375606 | 313493-80-0 | Reference compound |
| HY-114147 | Tuberculosis inhibitor 3 | 2219325-28-5 | Reference compound |
| HY-114150 | D-Val-Leu-Arg-pNA | 64816-14-4 | Peptides |
| HY-114150D | D-Val-Leu-Arg-pNA (acetate) | 162303-66-4 | Peptides |
| HY-114153 | PLX5622 | 1303420-67-8 | Reference compound |
| HY-114153A | PLX5622 (hemifumarate) | Reference compound | |
| HY-114154 | AL-438 | 239066-73-0 | Reference compound |
| HY-114157 | DO-264 | 2301866-59-9 | Reference compound |
| HY-114158 | Pronase E (Activity ≥ 7000 U/g) | 9036-06-0 | Natural Products |
| HY-114158A | Pronase E (Activity ≥ 4000 U/mg) | 9036-06-0 | Natural Products |
| HY-114161 | H-Val-Pro-Pro-OH | 58872-39-2 | Peptides |
| HY-114161A | H-Val-Pro-Pro-OH (TFA) | 2828433-08-3 | Peptides |
| HY-114162 | VTP50469 | 2169916-18-9 | Reference compound |
| HY-114162A | VTP50469 (fumarate) | 2169919-29-1 | Reference compound |
| HY-114162B | VTP50469 (mesylate) | 2169919-27-9 | Reference compound |
| HY-114164 | Thrombin (MW 37kDa) | 9002-04-4 | Reference compound |
| HY-114164A | Human α-Thrombin | 9002-04-4 | Enzyme |
| HY-114164B | Human γ-Thrombin | 9002-04-4 | Enzyme |
| HY-114164C | Thrombin, Pig blood | 9002-04-4 | Enzyme |
| HY-114164D | Rat Thrombin | 9002-04-4 | Enzyme |
| HY-114164E | Rabbit Thrombin | 9002-04-4 | Enzyme |
| HY-114164F | Canine Thrombin | 9002-04-4 | Enzyme |
| HY-114164G | Murine Thrombin | 9002-04-4 | Enzyme |
| HY-114165 | DJ-V-159 | 2253744-53-3 | Reference compound |
| HY-114166 | 2-D08 | 144707-18-6 | Reference compound |
| HY-114168 | KRAS G12C inhibitor 5 | 2158297-63-1 | Reference compound |
| HY-114169 | WRG-28 | 1913291-02-7 | Reference compound |
| HY-114169S | WRG-28-d5 | Isotope-Labeled Compounds | |
| HY-114170 | ML604440 | 1140517-08-3 | Reference compound |
| HY-114173 | DDR1-IN-4 | 2125676-13-1 | Reference compound |
| HY-114174 | Fmoc-Ala-Glu-Asn-Lys-NH2 | 220701-06-4 | Peptides |
| HY-114175 | Adenosine deaminase, microorganism | 9026-93-1 | Enzyme |
| HY-114175A | Adenosine deaminase, Calf Spleen | 9026-93-1 | Enzyme |
| HY-114176 | (S,R,S)-AHPC-C4-NH2 (hydrochloride) | 2245697-83-8 | Reference compound |
| HY-114176A | (S,R,S)-AHPC-C4-NH2 | 2138439-53-7 | Reference compound |
| HY-114176B | (S,R,S)-AHPC-C4-NH2 (dihydrochloride) | 2341796-78-7 | Reference compound |
| HY-114177 | Ebvaciclib | 2185857-97-8 | Reference compound |
| HY-114177A | (S)-Ebvaciclib | 2185859-59-8 | Reference compound |
| HY-114180 | RU.521 | 2262452-06-0 | Reference compound |
| HY-114181 | IRAK4-IN-4 | 1850276-58-2 | Reference compound |
| HY-114182 | PF-06928215 | 2378173-15-8 | Reference compound |
| HY-114184 | MK-8245 analog | 1030612-87-3 | Reference compound |
| HY-114189 | GW284543 | 790186-68-4 | Reference compound |
| HY-114189A | GW284543 (hydrochloride) | 179246-08-3 | Reference compound |
| HY-114191 | SSTR5 antagonist 2 | 1254730-81-8 | Reference compound |
| HY-114191A | SSTR5 antagonist 2 (TFA) | 1254733-98-6 | Reference compound |
| HY-114191B | SSTR5 antagonist 2 (hydrochloride) | 2988224-31-1 | Reference compound |
| HY-114192 | TGFβRI-IN-1 | 1950628-94-0 | Reference compound |
| HY-114193 | CCR1 antagonist 6 | 2436773-01-0 | Reference compound |
| HY-114194 | CCR1 antagonist 7 | 2446154-74-9 | Reference compound |
| HY-114196 | Aclimostat | 2082752-83-6 | Reference compound |
| HY-114197 | Antimalarial agent 14 | 1150-59-0 | Reference compound |
| HY-114198 | Tenovin-2 | 666211-30-9 | Reference compound |
| HY-114199 | Eph inhibitor 1 | 861249-77-6 | Reference compound |
| HY-114200 | Imrecoxib | 395683-14-4 | Reference compound |
| HY-114200R | Imrecoxib (Standard) | 395683-14-4 | Reference Standards |
| HY-114202 | delta-Valerobetaine | 6778-33-2 | Natural Products |
| HY-114202S | delta-Valerobetaine-d9 (chloride) | 85806-18-4 | Isotope-Labeled Compounds |
| HY-114203 | Eckol | 88798-74-7 | Natural Products |
| HY-114204 | GSK8814 | 1997369-78-4 | Reference compound |
| HY-114205 | TP-238 | 2415263-04-4 | Reference compound |
| HY-114205A | TP-238 (hydrochloride) | 2415263-05-5 | Reference compound |
| HY-114206 | SKI-73 | 2206744-61-6 | Reference compound |
| HY-114207 | VinSpinIn | 2380021-98-5 | Reference compound |
| HY-114208 | BI-9321 | 2387510-86-1 | Reference compound |
| HY-114208A | BI-9321 (trihydrochloride) | 2387510-87-2 | Reference compound |
| HY-114209 | MRK-740 | 2387510-80-5 | Reference compound |
| HY-114211 | SGC8158 | Reference compound | |
| HY-114214 | CKD-712 | 626252-75-3 | Reference compound |
| HY-114215 | DSM-421 | 2011769-21-2 | Reference compound |
| HY-114216 | DBPR110 | 1310694-75-7 | Reference compound |
| HY-114220 | T-2307 | 873546-31-7 | Reference compound |
| HY-114221 | Org 48762-0 | 755753-89-0 | Reference compound |
| HY-114224 | TP-271 | 1207284-17-0 | Reference compound |
| HY-114226 | Olutasidenib | 1887014-12-1 | Reference compound |
| HY-114227 | Hexidium (iodide) | 211566-66-4 | Reference compound |
| HY-114228 | PROTAC BET degrader-2 | 2093388-33-9 | Reference compound |
| HY-114229 | PROTAC BET degrader-3 | 3031993-61-7 | Reference compound |
| HY-114231 | Exaluren | 1375073-93-0 | Reference compound |
| HY-114231B | Exaluren (disulfate) | 2244622-33-9 | Reference compound |
| HY-114231C | Exaluren (sulfate) | 1375073-94-1 | Reference compound |
| HY-114233 | MC-GGFG-Exatecan | 1600418-29-8 | ADC Related |
| HY-114234A | TAK-070 (Free base) | 212571-56-7 | Reference compound |
| HY-114237 | GDC-0276 | 1494581-70-2 | Reference compound |
| HY-114240 | 5'-Cholesteryl-TEG phosphoramidite | 1325147-19-0 | Reference compound |
| HY-114243 | DpC | 1382469-39-7 | Reference compound |
| HY-114244 | USL311 | 1373268-67-7 | Reference compound |
| HY-114245 | Se-Methylselenocysteine | 26046-90-2 | Natural Products |
| HY-114245B | Se-Methylselenocysteine (hydrochloride) | 863394-07-4 | Reference compound |
| HY-114245R | Se-Methylselenocysteine (Standard) | 26046-90-2 | Reference Standards |
| HY-114246 | ONC1-13B | 1351185-54-0 | Reference compound |
| HY-114247 | FMAU | 69256-17-3 | Reference compound |
| HY-114250 | Cantrixil | 2135511-22-5 | Reference compound |
| HY-114252 | Strophanthidin | 66-28-4 | Natural Products |
| HY-114252R | Strophanthidin (Standard) | 66-28-4 | Reference Standards |
| HY-114256 | EC1169 | 1610413-96-1 | Reference compound |
| HY-114258 | LY3295668 | 1919888-06-4 | Reference compound |
| HY-114263 | NXT629 | 1454925-59-7 | Reference compound |
| HY-114266 | UC-1728 | 948304-40-3 | Reference compound |
| HY-114267 | Cbz-B3A | 1884710-81-9 | Reference compound |
| HY-114268 | BRD-K98645985 | 1357647-78-9 | Reference compound |
| HY-114269 | (-)-(S)-B-973B | 2244989-34-0 | Reference compound |
| HY-114271A | T3-ATA (S-isomer) | 2438721-48-1 | Reference compound |
| HY-114272A | T4-ATA (S-isomer) | 2448470-97-9 | Reference compound |
| HY-114275 | Justicidin B | 17951-19-8 | Natural Products |
| HY-114277 | Sotorasib | 2296729-00-3 | Reference compound |
| HY-114277A | Sotorasib (racemate) | 2252403-56-6 | Reference compound |
| HY-114277B | Sotorasib isomer | Reference compound | |
| HY-114277S | Sotorasib-d7 | Isotope-Labeled Compounds | |
| HY-114277S2 | Sotorasib-d3 | Isotope-Labeled Compounds | |
| HY-114286 | PXS-5153A | 2125956-82-1 | Reference compound |
| HY-114286A | PXS-5153A (monohydrochloride) | Reference compound | |
| HY-114289 | 6-HEX | 155911-16-3 | Dye Reagents |
| HY-114292A | (E)-tri-Pcoumaroylspermidine | 131086-78-7 | Natural Products |
| HY-114293 | Acetyl coenzyme A | 72-89-9 | Reference compound |
| HY-114293A | Acetyl coenzyme A (trilithium) | 75520-41-1 | Biochemical Assay Reagents |
| HY-114293S | Acetyl coenzyme A-13C2 (lithium) | Isotope-Labeled Compounds | |
| HY-114294A | DL-3-Hydroxy-3-methylglutaryl coenzyme A (disodium hydrate) | 103476-21-7 | Biochemical Assay Reagents |
| HY-114295 | Geranyl diphosphate | 763-10-0 | Reference compound |
| HY-114295A | Geranyl diphosphate (triammonium) | 116057-55-7 | Reference compound |
| HY-114296 | 2,3-Oxidosqualene | 7200-26-2 | Reference compound |
| HY-114297 | Zymosterol | 128-33-6 | Natural Products |
| HY-114297S | Zymosterol-d5 | 1246298-29-2 | Isotope-Labeled Compounds |
| HY-114299 | Salcaprozate (sodium) | 203787-91-1 | Reference compound |
| HY-114299R | Salcaprozate (sodium) (Standard) | 203787-91-1 | Reference Standards |
| HY-114299S | Salcaprozate-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-114300 | DSP-0565 | 1226855-28-2 | Reference compound |
| HY-114301 | PF-06305591 | 1449473-97-5 | Reference compound |
| HY-114301A | PF-06305591 (dihydrate) | 2703582-76-5 | Reference compound |
| HY-114302 | CCB02 | 2100864-57-9 | Reference compound |
| HY-114303 | CM-675 | 1872466-47-1 | Reference compound |
| HY-114304 | COH000 | 1534358-79-6 | Reference compound |
| HY-114305 | A1874 | 2064292-12-0 | Reference compound |
| HY-114306 | EC0489 | 1096702-14-5 | Reference compound |
| HY-114307 | Ly93 | 1883528-69-5 | Reference compound |
| HY-114308 | SGL5213 | 1240305-17-2 | Reference compound |
| HY-114309 | URAT1 inhibitor 1 | 2268720-62-1 | Reference compound |
| HY-114310 | VDR agonist 1 | 2269494-43-9 | Reference compound |
| HY-114311 | FGFR1/DDR2 inhibitor 1 | 2308497-58-5 | Reference compound |
| HY-114312 | MD-224 | 2136247-12-4 | Reference compound |
| HY-114313 | Microtubule inhibitor 1 | 2305668-80-6 | Reference compound |
| HY-114314 | BA-53038B | 2306195-65-1 | Reference compound |
| HY-114315 | NQO1 substrate | 2304503-05-5 | Reference compound |
| HY-114316 | HMG499 | 2416941-68-7 | Reference compound |
| HY-114317 | MARK4 inhibitor 1 | 2271081-58-2 | Reference compound |
| HY-114318 | Bz-DL-Arg-βNA (hydrochloride) | 913-04-2 | Reference compound |
| HY-114319 | β-Cembrenediol | 57605-81-9 | Natural Products |
| HY-114320 | BuChE-IN-TM-10 | 2313524-95-5 | Reference compound |
| HY-114321 | Wnt/β-catenin agonist 1 | 2305372-67-0 | Reference compound |
| HY-114322 | VZ185 | 2306193-61-1 | Reference compound |
| HY-114322A | cis-VZ185 | 2306193-98-4 | Reference compound |
| HY-114323 | PROTAC FLT-3 degrader 1 | 2230826-81-8 | Reference compound |
| HY-114324 | PROTAC PARP1 degrader | 2369022-68-2 | Reference compound |
| HY-114324A | rel-PROTAC PARP1 degrader | Reference compound | |
| HY-114325 | AcLysValCit-PABC-DMAE-SW-163D | 2411007-69-5 | ADC Related |
| HY-114327 | D-Ribose 1,5-diphosphate | 14689-84-0 | Reference compound |
| HY-114330 | ZK824859 | 2271122-53-1 | Reference compound |
| HY-114330A | ZK824859 (hydrochloride) | 2436760-76-6 | Reference compound |
| HY-114331 | DLK-IN-1 | 1620574-24-4 | Reference compound |
| HY-114332 | GNE-8505 | 1620573-48-9 | Reference compound |
| HY-114333 | Octyl-α-ketoglutarate | 876150-14-0 | Reference compound |
| HY-114334 | Glutaminase-IN-1 | 2247127-79-1 | Reference compound |
| HY-114335 | Triphala | 857906-76-4 | Natural Products |
| HY-114336 | Enocyanin | 11029-12-2 | Natural Products |
| HY-114338 | Dalpiciclib | 1637781-04-4 | Reference compound |
| HY-114338A | Dalpiciclib (hydrochloride) | 2891598-76-6 | Reference compound |
| HY-114339 | CDK4/6-IN-2 | 1800506-48-2 | Reference compound |
| HY-114340 | LEM-14 | 1814881-70-3 | Reference compound |
| HY-114346A | BODIPY FL EDA (free base) | 220524-70-9 | Dye Reagents |
| HY-114347 | 6,3'-Dimethoxyflavone | 79786-40-6 | Reference compound |
| HY-114348 | N,N'-Diacetyl-L-cystine | 5545-17-5 | Reference compound |
| HY-114348R | N,N'-Diacetyl-L-cystine (Standard) | 5545-17-5 | Reference Standards |
| HY-114349 | HS-1371 | 2158197-70-5 | Reference compound |
| HY-114350 | BDP FL maleimide | 773859-49-7 | Dye Reagents |
| HY-114351 | BODIPY FL hydrazide | 178388-71-1 | Dye Reagents |
| HY-114352 | BODIPY FL-X | 217190-07-3 | Dye Reagents |
| HY-114353 | BDP FL azide | 1379771-95-5 | Dye Reagents |
| HY-114354 | BODIPY FL alkyne | 302795-84-2 | Dye Reagents |
| HY-114356 | BPI-9016M | 1528546-94-2 | Reference compound |
| HY-114357A | DS-1205b (free base) | 1855860-24-0 | Reference compound |
| HY-114358 | Tamnorzatinib | 1646839-59-9 | Reference compound |
| HY-114360 | Taurohyodeoxycholic acid | 2958-04-5 | Natural Products |
| HY-114360A | Taurohyodeoxycholic acid (sodium) | 38411-85-7 | Biochemical Assay Reagents |
| HY-114360AS1 | Taurohyodeoxycholic acid-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-114361 | OSMI-4 | 2260791-14-6 | Reference compound |
| HY-114362 | DL-alpha-Tocopherol methoxypolyethylene glycol succinate | 1309573-60-1 | Reference compound |
| HY-114363A | SRI 31215 (TFA) | 1832686-44-8 | Reference compound |
| HY-114364 | UDP-Galactose (disodium) | 137868-52-1 | Biochemical Assay Reagents |
| HY-114364S | UDP-α-D-Galactose-13C (disodium) | Isotope-Labeled Compounds | |
| HY-114365 | UDP-GalNAc (disodium) | 108320-87-2 | Biochemical Assay Reagents |
| HY-114366 | BC-1485 | 2035085-19-7 | Reference compound |
| HY-114367 | Delphinidin 3-rutinoside (chloride) | 15674-58-5 | Natural Products |
| HY-114368 | Kira8 | 1630086-20-2 | Reference compound |
| HY-114368A | Kira8 (Hydrochloride) | 2250019-92-0 | Reference compound |
| HY-114370 | Selpercatinib | 2152628-33-4 | Reference compound |
| HY-114370R | Selpercatinib (Standard) | 2152628-33-4 | Reference Standards |
| HY-114370S | Selpercatinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-114371 | Eclitasertib | 2125450-76-0 | Reference compound |
| HY-114372 | Lycopodine | 466-61-5 | Reference compound |
| HY-114373 | Calarene | 17334-55-3 | Natural Products |
| HY-114374 | RO5461111 | 1252637-46-9 | Reference compound |
| HY-114377 | p-SCN-Bn-DOTA | 127985-74-4 | Reference compound |
| HY-114379 | AS2717638 | 2148339-28-8 | Reference compound |
| HY-114380 | Radioprotectin-1 | 1622006-09-0 | Reference compound |
| HY-114381 | GT 949 | 460330-27-2 | Reference compound |
| HY-114383 | ST-539 | 1040754-67-3 | Reference compound |
| HY-114384 | NV-5138 | 2095886-80-7 | Reference compound |
| HY-114384B | NV-5138 (hydrochloride) | 2639392-70-2 | Reference compound |
| HY-114385 | 13,14-epoxy Travoprost | 2557327-99-6 | Reference compound |
| HY-114388 | QM385 | 2093421-02-2 | Reference compound |
| HY-114392 | Gly-β-MCA | 66225-78-3 | Reference compound |
| HY-114392R | Gly-β-MCA (Standard) | 66225-78-3 | Reference Standards |
| HY-114395 | NVS-ZP7-4 | 2349367-89-9 | Reference compound |
| HY-114395A | (R)-NVS-ZP7-4 | 2517682-14-1 | Reference compound |
| HY-114396 | BR351 | 960113-85-3 | Reference compound |
| HY-114397 | SHP394 | 2055757-40-7 | Reference compound |
| HY-114398 | BAY-293 | 2244904-70-7 | Reference compound |
| HY-114398A | (S)-BAY-293 | 2244904-69-4 | Reference compound |
| HY-114399 | STING ligand-1 | 2365039-41-2 | Reference compound |
| HY-114400 | TRPV4 agonist-1 (free base) | 2314467-59-7 | Reference compound |
| HY-114400A | TRPV4 agonist-1 | 2314467-60-0 | Reference compound |
| HY-114402 | ARD-69 | 2316837-10-0 | Reference compound |
| HY-114403 | VU6012962 | 2313526-86-0 | Reference compound |
| HY-114404 | SJFα | 2254609-27-1 | Reference compound |
| HY-114405 | SJFδ | 2254609-23-7 | Reference compound |
| HY-114406 | TD-106 | 2250288-69-6 | Reference compound |
| HY-114407 | TD-428 | 2334525-50-5 | Reference compound |
| HY-114409 | GB1107 | 1978336-61-6 | Reference compound |
| HY-114410 | CCI-006 | 292053-42-0 | Reference compound |
| HY-114411 | ERRγ inverse agonist 1 | 2316832-86-5 | Reference compound |
| HY-114412 | TD-0212 | 1073549-10-6 | Reference compound |
| HY-114412A | TD-0212 (TFA) | 1073549-11-7 | Reference compound |
| HY-114413 | YZ129 | 1643120-60-8 | Reference compound |
| HY-114414 | HDACs/mTOR Inhibitor 1 | 2271413-06-8 | Reference compound |
| HY-114415 | AWZ1066S | 2239272-16-1 | Reference compound |
| HY-114416 | GS-626510 | 1637770-13-8 | Reference compound |
| HY-114418 | MMP3 inhibitor 1 | 312930-75-9 | Reference compound |
| HY-114419 | Zetomipzomib | 1629677-75-3 | Reference compound |
| HY-114419A | Zetomipzomib (maleate) | 2170983-62-5 | Reference compound |
| HY-114420 | AP1867-2-(carboxymethoxy) | 2230613-03-1 | Reference compound |
| HY-114421 | FKBP12 PROTAC dTAG-13 | 2064175-41-1 | Reference compound |
| HY-114423 | p38α inhibitor 1 | 1034189-82-6 | Reference compound |
| HY-114424 | H-Ile-Pro-Pro-OH | 26001-32-1 | Peptides |
| HY-114424A | H-Ile-Pro-Pro-OH (hydrochloride) | 1208862-61-6 | Peptides |
| HY-114426 | AT-1002 | 835872-35-0 | Reference compound |
| HY-114426A | AT-1002 (TFA) | Reference compound | |
| HY-114427 | NS-102 | 136623-01-3 | Reference compound |
| HY-114428 | P110δ-IN-1 | 1595129-71-7 | Reference compound |
| HY-114429 | CB-6644 | 2316817-88-4 | Reference compound |
| HY-114430 | Fmoc-Phe-Lys(Boc)-PAB-PNP | 1646299-50-4 | ADC Related |
| HY-114434 | AP1867 | 195514-23-9 | Reference compound |
| HY-114436 | MRTX-1257 | 2206736-04-9 | Reference compound |
| HY-114436S | MRTX-1257-d6 | 2639608-44-7 | Isotope-Labeled Compounds |
| HY-114437 | Fusion Inhibitory Peptide | 75539-79-6 | Peptides |
| HY-114439 | MtbHU-IN-1 | 59736-84-4 | Reference compound |
| HY-114440 | Belapectin | 1980787-47-0 | Reference compound |
| HY-114452 | LY2940094 | 1307245-86-8 | Reference compound |
| HY-114452A | LY2940094 (tartrate) | 1307245-87-9 | Reference compound |
| HY-114453 | SHP389 | 2235394-90-6 | Reference compound |
| HY-114454 | INH14 | 200134-22-1 | Reference compound |
| HY-114456 | Ganglioside GM3 | 124579-05-1 | Reference compound |
| HY-114456AS | Ganglioside GM3-d5 (Bovine Milk ammonium salt) | 2260669-91-6 | Isotope-Labeled Compounds |
| HY-114456S | Ganglioside GM3-d7 | Isotope-Labeled Compounds | |
| HY-114457 | Phosphatidylinositol 4,5-bisphosphate | 245126-95-8 | Natural Products |
| HY-114458 | Monooctyl succinate | 74295-86-6 | Reference compound |
| HY-114459 | Mutant IDH1-IN-4 | 1416270-18-2 | Reference compound |
| HY-114460 | SHP2-IN-1 | 1801764-90-8 | Reference compound |
| HY-114461B | (3S,17S)-FD-895 | 2598242-04-5 | Reference compound |
| HY-114464 | 11-Beta-hydroxyandrostenedione | 382-44-5 | Natural Products |
| HY-114464S | 11-Beta-hydroxyandrostenedione-d4 | 2687960-98-9 | Isotope-Labeled Compounds |
| HY-114464S1 | 11-Beta-hydroxyandrostenedione-d7 | 2331287-27-3 | Isotope-Labeled Compounds |
| HY-114481 | Imidazole ketone erastin | 1801530-11-9 | Reference compound |
| HY-114483 | AES-135 | 2361659-61-0 | Reference compound |
| HY-114489A | Haemanthamine | 466-75-1 | Natural Products |
| HY-114489B | Haemanthamine (hydrochloride) | Natural Products | |
| HY-114490 | ULK-101 | 2443816-45-1 | Reference compound |
| HY-114491 | Rineterkib | 1715025-32-3 | Dye Reagents |
| HY-114491A | Rineterkib (hydrochloride) | 1715025-34-5 | Reference compound |
| HY-114492 | GSK547 | 2226735-55-1 | Reference compound |
| HY-114492A | (Rac)-GSK547 | Reference compound | |
| HY-114495 | Caerulomycin A | 21802-37-9 | Natural Products |
| HY-114501 | Z3-Dodecenyl E2-butenoate | 104086-73-9 | Reference compound |
| HY-114502 | Chrysanthemic acid | 10453-89-1 | Reference compound |
| HY-114503 | NSAH | 1099592-35-4 | Reference compound |
| HY-114503A | (E/Z)-NSAH | 54009-54-0 | Reference compound |
| HY-114504 | RVX-297 | 1044871-04-6 | Reference compound |
| HY-114505 | 3-Hydroxypentadecane-4-one | 1046789-93-8 | Reference compound |
| HY-114507 | Flumioxazin | 103361-09-7 | Reference compound |
| HY-114507R | Flumioxazin (Standard) | 103361-09-7 | Reference Standards |
| HY-114508 | Dihydrochalcone | 1083-30-3 | Reference compound |
| HY-114509 | Anilazine | 101-05-3 | Reference compound |
| HY-114509R | Anilazine (Standard) | 101-05-3 | Reference Standards |
| HY-114509S | Anilazine-d4 | 1219802-20-6 | Isotope-Labeled Compounds |
| HY-114511 | BMS-593214 | 1004551-40-9 | Reference compound |
| HY-114512 | m-PEG1-NHS ester | 1027371-75-0 | Reference compound |
| HY-114514 | R 47 243 | 104383-18-8 | Reference compound |
| HY-114516 | Fructosylvaline | 10003-64-2 | Reference compound |
| HY-114517 | 3-Acetyl-2,5-dimethylfuran | 10599-70-9 | Reference compound |
| HY-114518 | Butenafine | 101828-21-1 | Reference compound |
| HY-114518S2 | Butenafine-d4 | 1653964-70-5 | Isotope-Labeled Compounds |
| HY-114519 | Helenalin acetate | 10180-86-6 | Reference compound |
| HY-114520 | TT01001 | 1022367-69-6 | Reference compound |
| HY-114521 | 5-(4-Methoxyphenyl)oxazole | 1011-51-4 | Reference compound |
| HY-114522 | X-alpha-Gal | 107021-38-5 | Reference compound |
| HY-114524 | (E)-4-Oxo-2-nonenal | 103560-62-9 | Reference compound |
| HY-114524S | (E)-4-Oxo-2-nonenal-d3 | 1313400-91-7 | Isotope-Labeled Compounds |
| HY-114525 | Chlorbenside | 103-17-3 | Reference compound |
| HY-114525R | Chlorbenside (Standard) | 103-17-3 | Reference Standards |
| HY-114527 | TPMP-I-2 | 102660-13-9 | Reference compound |
| HY-114529 | Yuanhunine | 104387-15-7 | Natural Products |
| HY-114530 | LY2452473 | 1029692-15-6 | Reference compound |
| HY-114531 | Lomifylline | 10226-54-7 | Reference compound |
| HY-114535 | Jaceidin | 10173-01-0 | Natural Products |
| HY-114536 | Mitolactol | 10318-26-0 | Reference compound |
| HY-114538 | Asobamast | 104777-03-9 | Reference compound |
| HY-114539 | L-750667 (triHydrochloride) | 1021868-80-3 | Reference compound |
| HY-114540 | CP-339818 | 185855-91-8 | Reference compound |
| HY-114541 | Coumarin-7-pinacolboronate | 190788-61-5 | Dye Reagents |
| HY-114542 | LY 201409 | 109306-94-7 | Reference compound |
| HY-114544A | N-3-oxo-dodecanoyl-L-homoserine lactone | 168982-69-2 | Reference compound |
| HY-114545 | 5HPP-33 | 105624-86-0 | Reference compound |
| HY-114547 | PD 109488 | 103733-49-9 | Reference compound |
| HY-114547R | PD 109488 (Standard) | 103733-49-9 | Reference Standards |
| HY-114548 | Ebselen oxide | 104473-83-8 | Reference compound |
| HY-114550 | LY339434 | 219566-62-8 | Reference compound |
| HY-114551 | Streptothricin E | 3776-38-3 | Reference compound |
| HY-114552 | (S)-Dabelotine | 152985-35-8 | Reference compound |
| HY-114553 | 5-Fluoro PB-22 3-carboxyindole metabolite | 1432794-98-3 | Reference compound |
| HY-114553S | 1-(5-Fluoropentyl)-1H-indole-3-carboxylic acid-d5 | 2703812-55-7 | Isotope-Labeled Compounds |
| HY-114557 | NSC 90469 | 1041-01-6 | Natural Products |
| HY-114557R | NSC 90469 (Standard) | 1041-01-6 | Reference Standards |
| HY-114558 | Resmethrin | 10453-86-8 | Reference compound |
| HY-114559 | DNJNAc | 105265-96-1 | Reference compound |
| HY-114561 | LY 97119 | 72456-59-8 | Reference compound |
| HY-114564 | Satigrel | 111753-73-2 | Reference compound |
| HY-114565 | LY221068 | 132392-39-3 | Reference compound |
| HY-114566 | SPV106 | 1036939-38-4 | Reference compound |
| HY-114568 | AMC-01 | 1047978-71-1 | Reference compound |
| HY-114569 | 6-CEPN | 1054549-73-3 | Reference compound |
| HY-114569A | DH-8P-DB | 1054549-71-1 | Reference compound |
| HY-114570 | Tiazofurin | 60084-10-8 | Reference compound |
| HY-114571 | cis-Lomibuvir | 1026785-59-0 | Reference compound |
| HY-114573 | TNF-α-IN-19 | 338773-13-0 | Reference compound |
| HY-114575 | Cycloxydim | 101205-02-1 | Reference compound |
| HY-114577 | Palifosfamide (tromethamine) | 1070409-31-2 | Reference compound |
| HY-114578 | PD 118717 | 104229-37-0 | Reference compound |
| HY-114581 | U27391 | 106314-87-8 | Reference compound |
| HY-114582 | Lexitropsin | 110124-49-7 | Reference compound |
| HY-114584 | A-953227 | 1037826-77-9 | Reference compound |
| HY-114585 | Sperabillin A | 111337-86-1 | Natural Products |
| HY-114585A | Sperabillin A (dihydrochloride) | 111337-87-2 | Reference compound |
| HY-114586 | L-158809 | 133240-46-7 | Reference compound |
| HY-114588 | Tafetinib analogue 1 | 1032265-67-0 | Reference compound |
| HY-114589 | VU0240382 | 1092550-36-1 | Reference compound |
| HY-114591 | Spiromesifen | 283594-90-1 | Reference compound |
| HY-114591R | Spiromesifen (Standard) | 283594-90-1 | Reference Standards |
| HY-114591S | Spiromesifen-d9 | 2470126-90-8 | Isotope-Labeled Compounds |
| HY-114592 | M199 | 1051933-86-8 | Reference compound |
| HY-114593 | ent-8-iso Prostaglandin F2α | 159812-83-6 | Reference compound |
| HY-114594 | Khusimol | 16223-63-5 | Natural Products |
| HY-114595 | Hemigossypol | 40817-07-0 | Natural Products |
| HY-114597 | PKF050-638 | 528893-52-9 | Reference compound |
| HY-114599 | 8-iso Prostaglandin A1 | 211186-29-7 | Reference compound |
| HY-114602 | AR-C117977 | 216685-07-3 | Reference compound |
| HY-114603 | Efegatran | 105806-65-3 | Reference compound |
| HY-114603A | Efegatran (sulfate) | 126721-07-1 | Reference compound |
| HY-114603B | Efegatran di(hydrochloride) | 173006-83-2 | Reference compound |
| HY-114604 | Propioxatin B | 102962-95-8 | Natural Products |
| HY-114608 | RY785 | 1393748-80-5 | Reference compound |
| HY-114610 | 13Z,16Z-Docosadienoic acid | 17735-98-7 | Reference compound |
| HY-114611 | BDM44768 | 2011754-00-8 | Reference compound |
| HY-114612 | 11-Ketotestosterone | 564-35-2 | Reference compound |
| HY-114614 | Clenpirin | 27050-41-5 | Reference compound |
| HY-114615 | AMP-Deoxynojirimycin | 216758-20-2 | Reference compound |
| HY-114616 | PBB3 | 1565796-97-5 | Reference compound |
| HY-114618 | S33084 | 273203-30-8 | Reference compound |
| HY-114619 | Oleyl anilide | 5429-85-6 | Reference compound |
| HY-114621 | DB772 | 1451058-50-6 | Reference compound |
| HY-114621A | DB772 (hydrate) | Reference compound | |
| HY-114621B | DB772 (free base) | 433735-90-1 | Reference compound |
| HY-114622 | AFN-1252 (tosylate) | 1047981-31-6 | Reference compound |
| HY-114623 | Prostaglandin D2 methyl ester | 49852-81-5 | Reference compound |
| HY-114626 | L-Lysine thioctate | 20902-53-8 | Reference compound |
| HY-114627 | Valone | 83-28-3 | Reference compound |
| HY-114628 | MS012 | 2089617-83-2 | Reference compound |
| HY-114630 | Protokylol | 136-70-9 | Reference compound |
| HY-114631 | EM-800 | 182167-03-9 | Reference compound |
| HY-114632 | Oxeglitazar | 280585-34-4 | Reference compound |
| HY-114633 | VU625 | 901008-62-6 | Reference compound |
| HY-114634 | Mesoxalate | 473-90-5 | Reference compound |
| HY-114635 | Dexecadotril | 112573-72-5 | Reference compound |
| HY-114636 | RG-102240 | 162326-49-0 | Reference compound |
| HY-114638 | Diproteverine | 69373-95-1 | Reference compound |
| HY-114638A | Diproteverine (hydrochloride) | 69373-88-2 | Reference compound |
| HY-114639 | Maritinone | 33927-59-2 | Natural Products |
| HY-114641 | BIIL-260 | 204974-93-6 | Reference compound |
| HY-114641A | BIIL-260 (hydrochloride) | 192581-24-1 | Reference compound |
| HY-114643 | (Rac)-Tovinontrine | 1430840-90-6 | Reference compound |
| HY-114644 | Galangal acetate | 52946-22-2 | Natural Products |
| HY-114645 | PDK1-IN-RS2 | 1643958-89-7 | Reference compound |
| HY-114646 | TMC-205 | 403646-00-4 | Natural Products |
| HY-114649 | 19-Hydroxy cholesterol | 561-63-7 | Natural Products |
| HY-114651 | Phenazoviridin | 155233-15-1 | Natural Products |
| HY-114652 | AalphaC | 26148-68-5 | Reference compound |
| HY-114653 | SRPIN803 | 380572-02-1 | Reference compound |
| HY-114656 | Dihydro-PGF1α | 20592-20-5 | Reference compound |
| HY-114657 | Benproperine | 2156-27-6 | Reference compound |
| HY-114657A | Benproperine (phosphate) | 19428-14-9 | Reference compound |
| HY-114658 | Daunomycinone | 21794-55-8 | Reference compound |
| HY-114658R | Daunomycinone (Standard) | 21794-55-8 | Reference Standards |
| HY-114661 | m-PEG4-Tos | 62921-76-0 | Reference compound |
| HY-114662 | Methyl 13-methylpentadecanoate | 5487-50-3 | Natural Products |
| HY-114663 | FDU-PB-22 | 1883284-94-3 | Reference compound |
| HY-114664 | KNK423 | 1859-42-3 | Reference compound |
| HY-114666 | Trimoxamine (hydrochloride) | 7082-27-1 | Reference compound |
| HY-114667 | Lavendustin C6 | 144676-04-0 | Reference compound |
| HY-114668 | Camptothecin-20(S)-O-propionate | 194414-69-2 | Reference compound |
| HY-114668A | Camptothecin-20(S)-O-propionate (hydrate) | 1147090-70-7 | Reference compound |
| HY-114670 | Propargyl-PEG4-amine | 1013921-36-2 | Reference compound |
| HY-114671 | Taprostene | 108945-35-3 | Reference compound |
| HY-114672 | MBCQ | 150450-53-6 | Reference compound |
| HY-114673 | Benzomalvin B | 157047-97-7 | Natural Products |
| HY-114674 | A-127722 | 195704-72-4 | Reference compound |
| HY-114674A | Atrasentan (sodium) | 178738-96-0 | Reference compound |
| HY-114678 | LY302148 | 182564-47-2 | Reference compound |
| HY-114680 | ACD-10284 | 16231-76-8 | Reference compound |
| HY-114682 | Lenperone | 24678-13-5 | Reference compound |
| HY-114682A | Lenperone (hydrochloride) | 24677-86-9 | Reference compound |
| HY-114683 | KS370G | 105955-01-9 | Reference compound |
| HY-114684 | A20832 | 40526-96-3 | Reference compound |
| HY-114685 | S-8510 (free base) | 151224-83-8 | Reference compound |
| HY-114686 | (R)-γ-Valerolactone | 58917-25-2 | Reference compound |
| HY-114687 | 5,7-Dihydroxy-11-ketotetranorprostanoic acid | 24379-94-0 | Reference compound |
| HY-114688 | BITC-SG | 62959-30-2 | Reference compound |
| HY-114689 | Diclofenac methyl ester | 15307-78-5 | Reference compound |
| HY-114690 | PNU-140975 | 179474-69-2 | Reference compound |
| HY-114691 | R 59494 | 104588-44-5 | Reference compound |
| HY-114692 | Eterobarb | 27511-99-5 | Reference compound |
| HY-114695 | Prostaglandin F2α-1-glyceryl ester | 43042-79-1 | Reference compound |
| HY-114695S | Prostaglandin F2α-1-glyceryl ester-d5 | Isotope-Labeled Compounds | |
| HY-114696 | Prehispanolone | 132922-55-5 | Natural Products |
| HY-114697 | DSG Crosslinker | 79642-50-5 | ADC Related |
| HY-114697S | DSG Crosslinker-d4 | 2242802-40-8 | Isotope-Labeled Compounds |
| HY-114698 | Retro-2 cycl | 1429192-00-6 | Reference compound |
| HY-114699 | DC_YM21 | 2001072-35-9 | Reference compound |
| HY-114700 | ZINC08438472 | 443872-20-6 | Reference compound |
| HY-114702 | M77976 | 394237-61-7 | Reference compound |
| HY-114703 | Eslicarbazepine | 104746-04-5 | Reference compound |
| HY-114703S1 | Eslicarbazepine-d4 | Isotope-Labeled Compounds | |
| HY-114705 | Ameltolide | 787-93-9 | Reference compound |
| HY-114706 | Suritozole | 110623-33-1 | Reference compound |
| HY-114707 | Threonyl-seryl-lysine | 71730-64-8 | Peptides |
| HY-114711 | Barbigerone | 75425-27-3 | Natural Products |
| HY-114712 | SJ572403 | 19970-45-7 | Reference compound |
| HY-114713 | POBN | 66893-81-0 | Reference compound |
| HY-114716 | Jacareubin | 3811-29-8 | Natural Products |
| HY-114717 | Pterophyllin 2 | 210231-09-7 | Reference compound |
| HY-114719 | A 854777 | 117009-82-2 | Reference compound |
| HY-114720 | Laureatin | 18762-30-6 | Natural Products |
| HY-114721 | BTA-9881 | 1646857-24-0 | Reference compound |
| HY-114723 | NPD9948 | 59856-85-8 | Reference compound |
| HY-114724 | HSR-609 | 161522-25-4 | Reference compound |
| HY-114725 | VRT-532 | 38214-71-0 | Reference compound |
| HY-114727 | PDE7-IN-4 | 18741-24-7 | Reference compound |
| HY-114729 | Leucylproline | 6403-35-6 | Reference compound |
| HY-114730 | CGA-JK3 | 1621626-06-9 | Reference compound |
| HY-114731 | Adenallene | 114987-18-7 | Reference compound |
| HY-114732 | Procaterol | 72332-33-3 | Reference compound |
| HY-114735 | Mandelonitrile benzoate | 4242-46-0 | Reference compound |
| HY-114736 | Hydroxy Varenicline | 357424-21-6 | Reference compound |
| HY-114737 | L-573655 | 112507-21-8 | Reference compound |
| HY-114738 | Rubilactone | 142182-54-5 | Natural Products |
| HY-114739 | MA-0204 | 2095128-17-7 | Reference compound |
| HY-114740 | β-Naphthoflavone | 6051-87-2 | Reference compound |
| HY-114743 | GS 283 | 149440-36-8 | Reference compound |
| HY-114744 | 6α-Hydroxy metandienone | 55720-48-4 | Reference compound |
| HY-114745 | MoTP | 57055-82-0 | Reference compound |
| HY-114746 | 25H-NBOMe imine analog | 1566571-78-5 | Reference compound |
| HY-114747 | 1-(Adamantan-1-yl)-3-propylthiourea | 25444-85-3 | Reference compound |
| HY-114748 | AHU1 | 216774-38-8 | Reference compound |
| HY-114749 | LL-C 10037α | 93752-54-6 | Natural Products |
| HY-114750 | Mebendazole-amine | 52329-60-9 | Reference compound |
| HY-114750R | Mebendazole-amine (Standard) | 52329-60-9 | Reference Standards |
| HY-114750S | Mebendazole-amine-13C6 | Isotope-Labeled Compounds | |
| HY-114751 | 16,16-Dimethylprostaglandin E1 | 41692-15-3 | Reference compound |
| HY-114753 | Neboglamine | 163000-63-3 | Reference compound |
| HY-114753A | Neboglamine (hydrochloride) | 2759182-59-5 | Reference compound |
| HY-114754 | BemPPOX | 1998101-23-7 | Reference compound |
| HY-114756 | 2-(2-Pyridyl)-4-methyl-thiazole-5-carboxylic acid | 34418-48-9 | Reference compound |
| HY-114757 | 2-Hydroxydecanoic acid | 5393-81-7 | Biochemical Assay Reagents |
| HY-114758 | Pyridoxal isonicotinoyl hydrazone | 737-86-0 | Reference compound |
| HY-114759 | MS-PPOH | 206052-02-0 | Reference compound |
| HY-114760 | Vanillic acid glucoside | 32142-31-7 | Natural Products |
| HY-114761 | Prostaglandin F2α dimethyl amine | 67508-09-2 | Reference compound |
| HY-114763 | LP8 | 327042-42-2 | Reference compound |
| HY-114766 | Pumafentrine | 207993-12-2 | Reference compound |
| HY-114769 | Beflubutamid | 113614-08-7 | Reference compound |
| HY-114769R | Beflubutamid (Standard) | 113614-08-7 | Reference Standards |
| HY-114770 | (E,E)-GLL398 | 2077980-83-5 | Reference compound |
| HY-114771 | α-Truxillic acid | 490-20-0 | Reference compound |
| HY-114772 | Methyl reserpate | 2901-66-8 | Natural Products |
| HY-114773 | N-Undecanoyl-L-homoserine lactone | 216596-71-3 | Biochemical Assay Reagents |
| HY-114775 | RCGD423 | 108237-91-8 | Reference compound |
| HY-114776 | Biotin-olefin | 92924-45-3 | Dye Reagents |
| HY-114778 | Fluzoparib | 1358715-18-0 | Reference compound |
| HY-114779 | N9-Isopropylolomoucine | 158982-15-1 | Reference compound |
| HY-114780 | Lactivicin | 107167-31-7 | Reference compound |
| HY-114782 | H-Tyr-Tyr-OH | 1050-28-8 | Reference compound |
| HY-114784 | Ingavirin | 219694-63-0 | Reference compound |
| HY-114784S | Ingavirin-d6 | Isotope-Labeled Compounds | |
| HY-114785 | BPHA | 193807-60-2 | Reference compound |
| HY-114788 | Lysylcysteine | 106325-92-2 | Peptides |
| HY-114791 | Lobelanidine | 552-72-7 | Natural Products |
| HY-114792 | 15-Methylprostaglandin E1 | 35700-26-6 | Reference compound |
| HY-114794 | Desglymidodrine | 3600-87-1 | Reference compound |
| HY-114794R | Desglymidodrine (Standard) | 3600-87-1 | Reference Standards |
| HY-114795 | Indomethacin heptyl ester | 282728-47-6 | Reference compound |
| HY-114796 | tHGA | 43230-43-9 | Reference compound |
| HY-114798 | Rabelomycin | 28399-50-0 | Natural Products |
| HY-114799 | 2-(4-Pyridyl)-4-methyl-thiazole-5-carboxylic acid | 144060-98-0 | Reference compound |
| HY-114800 | Soporidine | 1060376-43-3 | Reference compound |
| HY-114803 | Kokusaginine | 484-08-2 | Natural Products |
| HY-114805 | Formothion | 2540-82-1 | Reference compound |
| HY-114806 | Fenclofenac | 34645-84-6 | Reference compound |
| HY-114806R | Fenclofenac (Standard) | 34645-84-6 | Reference Standards |
| HY-114810 | Prostaglandin F2α serinol amide | 1135226-99-1 | Reference compound |
| HY-114812 | Anthrarobin | 577-33-3 | Reference compound |
| HY-114813 | KHG26693 | 1497249-95-2 | Reference compound |
| HY-114814 | ORM-10921 (free base) | 610782-82-6 | Reference compound |
| HY-114814A | (+)-ORM-10921 (free base) | 610782-83-7 | Reference compound |
| HY-114816 | N-Butanoyl-L-homoserine lactone | 67605-85-0 | ADC Related |
| HY-114816R | N-Butanoyl-L-homoserine lactone (Standard) | 67605-85-0 | Reference Standards |
| HY-114816S | N-butyryl-L-Homoserine lactone-d5 | 2701379-46-4 | Isotope-Labeled Compounds |
| HY-114818 | 4-(tert-Butyl)-benzhydroxamic Acid | 62034-73-5 | Reference compound |
| HY-114822 | Prostaglandin A3 | 36614-31-0 | Reference compound |
| HY-114824 | Streptovitacin A | 523-86-4 | Natural Products |
| HY-114826 | Prostaglandin E2-1-glyceryl ester | 37497-47-5 | Reference compound |
| HY-114826S | Prostaglandin E2-1-glyceryl ester-d5 | Isotope-Labeled Compounds | |
| HY-114830 | Fenleuton | 141579-54-6 | Reference compound |
| HY-114832 | OS 1808 | 5675-57-0 | Reference compound |
| HY-114837 | HBED | 35998-29-9 | Reference compound |
| HY-114840 | L 731734 | 149786-89-0 | Reference compound |
| HY-114841 | ONO 207 | 27376-74-5 | Reference compound |
| HY-114842 | TDRL-551 | 1644626-43-6 | Reference compound |
| HY-114843 | Benzyl-PEG1-Tos | 4981-83-3 | Reference compound |
| HY-114846 | Ro 22-9194 | 106134-33-2 | Reference compound |
| HY-114848 | Amiprilose (hydrochloride) | 60414-06-4 | Reference compound |
| HY-114849 | Norflurazon | 27314-13-2 | Reference compound |
| HY-114849R | Norflurazon (Standard) | 27314-13-2 | Reference Standards |
| HY-114850 | 5-trans Prostaglandin F2β | 36150-02-4 | Reference compound |
| HY-114850A | (5R)-Dinoprost (tromethamine) | 89847-02-9 | Reference compound |
| HY-114852 | Pheleuin | 169195-23-7 | Reference compound |
| HY-114853 | BVT.13 | 756813-87-3 | Reference compound |
| HY-114855 | BT2 | 34576-94-8 | Reference compound |
| HY-114856 | DTBT | 165190-76-1 | Reference compound |
| HY-114857 | Clofencet | 129025-54-3 | Reference compound |
| HY-114858 | Epiblastin A | 16470-02-3 | Reference compound |
| HY-114859 | 4-CAB (hydrochloride) | 23292-08-2 | Reference compound |
| HY-114860 | LY 215891 | 68403-79-2 | Reference compound |
| HY-114861 | Nor-6α-Oxycodol | 116499-16-2 | Reference compound |
| HY-114862 | 13,14-dihydro-15(R)-Prostaglandin E1 | 201848-10-4 | Reference compound |
| HY-114863 | PHCCC(4Me) | 1259532-01-8 | Reference compound |
| HY-114865 | BMS-192364 | 202822-21-7 | Reference compound |
| HY-114866 | Eritadenine | 23918-98-1 | Natural Products |
| HY-114867 | (15R)-Bimatoprost | 1163135-92-9 | Reference compound |
| HY-114869 | DPQ | 129075-73-6 | Reference compound |
| HY-114870 | 2-Methyl benzamideoxime | 40312-14-9 | Reference compound |
| HY-114871 | SL651498 | 205881-86-3 | Reference compound |
| HY-114872 | SLF | 195513-96-3 | Reference compound |
| HY-114872A | SLF (TFA) | 2378802-47-0 | Reference compound |
| HY-114873 | LY256548 | 107889-31-6 | Reference compound |
| HY-114876 | Desmethylflunitrazepam | 2558-30-7 | Reference compound |
| HY-114877 | CG-707 | 1443442-61-2 | Reference compound |
| HY-114879 | DDAO | 118290-05-4 | Dye Reagents |
| HY-114880 | AB-FUBINACA 3-fluorobenzyl isomer | 1185282-19-2 | Reference compound |
| HY-114881 | Frequentin | 29119-03-7 | Natural Products |
| HY-114883 | Homocarnosine | 3650-73-5 | Reference compound |
| HY-114883A | Homocarnosine (TFA) | 2991254-59-0 | Reference compound |
| HY-114886 | IGP-5 | 351978-83-1 | Reference compound |
| HY-114887 | Lodenosine | 110143-10-7 | Reference compound |
| HY-114892 | 15-A2t-Isoprostane | 474391-66-7 | Reference compound |
| HY-114895 | SSR504734 (free base) | 742693-38-5 | Reference compound |
| HY-114897 | L-167307 | 188352-45-6 | Reference compound |
| HY-114898 | ML404 | 1826026-00-9 | Reference compound |
| HY-114899 | Azamethiphos | 35575-96-3 | Reference compound |
| HY-114899R | Azamethiphos (Standard) | 35575-96-3 | Reference Standards |
| HY-114899S | Azamethiphos-d6 | 1189894-02-7 | Isotope-Labeled Compounds |
| HY-114902 | Y02224 | 1853988-48-3 | Reference compound |
| HY-114903 | (E/Z)-BIO-acetoxime | 740841-15-0 | Reference compound |
| HY-114906 | SIRT1/2/3-IN-2 | 388086-13-3 | Reference compound |
| HY-114907 | 4',5'-Dibromofluorescein | 596-03-2 | Dye Reagents |
| HY-114909 | TachypleginA | 331839-29-3 | Reference compound |
| HY-114910 | 11-Deoxy Prostaglandin E2 | 35536-53-9 | Reference compound |
| HY-114911 | Feprazone | 30748-29-9 | Reference compound |
| HY-114911R | Feprazone (Standard) | 30748-29-9 | Reference Standards |
| HY-114912 | Benzoadenosine | 60189-62-0 | Reference compound |
| HY-114913 | Fenarimol | 60168-88-9 | Reference compound |
| HY-114914 | 3-Hydroxylidocaine | 34604-55-2 | Reference compound |
| HY-114915 | PSB-1434 | 1619884-65-9 | Reference compound |
| HY-114918 | MS438 | 512840-45-8 | Reference compound |
| HY-114920 | Piprofurol | 40680-87-3 | Reference compound |
| HY-114923 | SU-11752 | 688036-19-3 | Reference compound |
| HY-114924 | LY465608 | 328918-26-9 | Reference compound |
| HY-114925 | AB-BICA | 1969264-37-6 | Reference compound |
| HY-114926 | KT185 | 1472640-86-0 | Reference compound |
| HY-114927 | (±)-Dunnione | 521-49-3 | Reference compound |
| HY-114928 | Deiodoamiodarone | 23551-25-9 | Reference compound |
| HY-114929 | THDP17 | 104741-27-7 | Reference compound |
| HY-114930 | Endopeptidase-IN-1 | 182821-29-0 | Reference compound |
| HY-114932 | Linoleoyl phenylalanine | 2441-64-7 | Peptides |
| HY-114933 | VU0119498 | 79183-37-2 | Reference compound |
| HY-114936 | Piericidin A | 2738-64-9 | Natural Products |
| HY-114937 | (R)-Eslicarbazepine acetate | 186694-45-1 | Reference compound |
| HY-114938 | Fumaramidmycin | 57687-92-0 | Natural Products |
| HY-114939 | Phelorphan | 110871-16-4 | Reference compound |
| HY-114941 | Aladotril | 173429-64-6 | Reference compound |
| HY-114942 | Prostaglandin E1 ethyl ester | 35900-16-4 | Reference compound |
| HY-114945 | CGRP antagonist 2 | 866086-05-7 | Reference compound |
| HY-114946 | N-methyl-4,4-difluoro Modafinil | 1613222-54-0 | Reference compound |
| HY-114947 | 9-deoxy-9-methylene Prostaglandin E2 | 61263-32-9 | Reference compound |
| HY-114950 | EXP3179 | 114798-36-6 | Reference compound |
| HY-114950R | EXP3179 (Standard) | 114798-36-6 | Reference Standards |
| HY-114952 | SM-32504 | 185539-34-8 | Reference compound |
| HY-114953 | BMS-248360 | 254737-87-6 | Reference compound |
| HY-114954 | CID1792197 | 1164479-69-9 | Reference compound |
| HY-114955 | MTTC | 152467-47-5 | Reference compound |
| HY-114958 | RH 421 | 107610-19-5 | Dye Reagents |
| HY-114961 | 15-epi Prostaglandin A1 | 20897-92-1 | Reference compound |
| HY-114962 | S-22153 | 180304-07-8 | Reference compound |
| HY-114965 | TP-064 | 2080306-20-1 | Reference compound |
| HY-114966 | RP73870 | 197012-43-4 | Reference compound |
| HY-114968 | p38 MAPK-IN-5 | 344457-87-0 | Reference compound |
| HY-114969 | Clioxanide | 14437-41-3 | Natural Products |
| HY-114971 | CREBBP-IN-1 | 1801324-41-3 | Reference compound |
| HY-114974 | Rivenprost | 256382-08-8 | Reference compound |
| HY-114976 | S-Allylmercapturic acid | 23127-41-5 | Natural Products |
| HY-114976S | N-Acetyl-S-allyl-L-cysteine-d3 | 1331907-55-1 | Isotope-Labeled Compounds |
| HY-114977 | Avenanthramide A | 108605-70-5 | Natural Products |
| HY-114977R | Avenanthramide A (Standard) | 108605-70-5 | Reference Standards |
| HY-114978 | VU0424465 | 1428630-85-6 | Reference compound |
| HY-114979 | Pyoluteorin | 25683-07-2 | Reference compound |
| HY-114981 | SRTCX1002 | 1203479-63-3 | Reference compound |
| HY-114982 | KEA1-97 | 2138882-71-8 | Reference compound |
| HY-114983 | Chimmitecan | 185425-25-6 | Reference compound |
| HY-114986 | 6-Keto-PGE1 | 67786-53-2 | Reference compound |
| HY-114987 | EMD 21657 | 61711-37-3 | Reference compound |
| HY-114988 | PGE-M | 24769-56-0 | Reference compound |
| HY-114988S | tetranor-PGEM-d6 | 1240398-16-6 | Isotope-Labeled Compounds |
| HY-114989 | Fluorizoline | 1362243-70-6 | Reference compound |
| HY-114990 | EMD 57439 | 148714-88-9 | Reference compound |
| HY-114991 | Leptospermone | 567-75-9 | Natural Products |
| HY-114992 | 2-Propyl-2-pentenoic acid | 60218-41-9 | Reference compound |
| HY-114994 | MS437 | 541535-31-3 | Reference compound |
| HY-114995 | Tr-PEG2-OH | 105589-77-3 | ADC Related |
| HY-114996 | ADAMTS-5 Inhibitor | 929634-33-3 | Reference compound |
| HY-114998 | α-D-Glucosamine pentaacetate | 7784-54-5 | Biochemical Assay Reagents |
| HY-114999 | Methyl-2,3,4,6-tetra-O-benzyl-α-D-galactopyranoside | 53008-63-2 | Biochemical Assay Reagents |
| HY-115004 | MM-433593 | 1006604-91-6 | Reference compound |
| HY-115014 | Cibenzoline (succinate) | 100678-32-8 | Reference compound |
| HY-115038 | ELN484228 | 312-63-0 | Reference compound |
| HY-115051 | 2-Hydroxymethyltetrahydropyran | 100-72-1 | Natural Products |
| HY-115062 | MJ33 (lithium salt) | 1007476-63-2 | Reference compound |
| HY-115066 | GSK1521498 (free base) | 1007573-18-3 | Reference compound |
| HY-115066A | GSK1521498 (free base) (hydrochloride) | 1007578-24-6 | Reference compound |
| HY-115122 | IDO-IN-12 | 1888341-29-4 | Reference compound |
| HY-115127 | 3-Methylanisole | 100-84-5 | Reference compound |
| HY-115127S | 3-Methylanisole-d3 | 20369-34-0 | Isotope-Labeled Compounds |
| HY-115139 | Fenadiazole | 1008-65-7 | Reference compound |
| HY-115159 | Ro 14-9578 | 100891-41-6 | Reference compound |
| HY-115192 | ent-Naxagolide (hydrochloride) | 100935-99-7 | Reference compound |
| HY-115194 | Amastatin (hydrochloride) | 100938-10-1 | Reference compound |
| HY-115213 | SORT-PGRN interaction inhibitor 1 | 100957-85-5 | Reference compound |
| HY-115231 | ci-IP3/PM | 1009832-82-9 | Reference compound |
| HY-115243 | 2-Chloro-1,4-naphthoquinone | 1010-60-2 | Reference compound |
| HY-115249 | Metronidazole acetic acid | 1010-93-1 | Reference compound |
| HY-115249R | Metronidazole acetic acid (Standard) | 1010-93-1 | Reference Standards |
| HY-115272 | GSK894490A | 1012035-06-1 | Reference compound |
| HY-115273 | MRS-2179 | 101204-49-3 | Reference compound |
| HY-115282 | JNJ-63576253 (free base) | 2110426-27-0 | Reference compound |
| HY-115282A | JNJ-63576253 | 2110428-64-1 | Reference compound |
| HY-115292 | Simvastatin hydroxy acid (sodium) | 101314-97-0 | Reference compound |
| HY-115312 | Ro 18-5364 | 101387-98-8 | Reference compound |
| HY-115314 | Mequitamium (iodide) | 101396-42-3 | Reference compound |
| HY-115319 | CP-24879 (hydrochloride) | 10141-51-2 | Reference compound |
| HY-115340 | Decanoic acid (sodium) | 1002-62-6 | Biochemical Assay Reagents |
| HY-115340S | Decanoic acid-d19 (sodium) | 1086096-26-5 | Isotope-Labeled Compounds |
| HY-115349 | Neamine (tetrahydrochloride) | 15446-43-2 | Reference compound |
| HY-115351 | GW-3333 | 212609-68-2 | Reference compound |
| HY-115354 | 4-Hydroxy alprazolam | 30896-57-2 | Reference compound |
| HY-115354S | 4-Hydroxy Alprazolam-d5 | 2747915-82-6 | Isotope-Labeled Compounds |
| HY-115356 | Eoxin E4 | 1000852-57-2 | Reference compound |
| HY-115357 | BMS711939 | 1000998-62-8 | Reference compound |
| HY-115358 | Lignoceroyl Ethanolamide | 10015-68-6 | Reference compound |
| HY-115360 | IND45193 | 10024-04-1 | Reference compound |
| HY-115362 | Methyl palmitelaidate | 10030-74-7 | Biochemical Assay Reagents |
| HY-115363 | Curcumenone | 100347-96-4 | Natural Products |
| HY-115364 | Parbendazole | 14255-87-9 | Reference compound |
| HY-115364R | Parbendazole (Standard) | 14255-87-9 | Reference Standards |
| HY-115364S | Parbendazole-d3 | 1613439-58-9 | Isotope-Labeled Compounds |
| HY-115365 | (3β,20E)-24-Norchola-5,20(22)-diene-3,23-diol | 53495-21-9 | Reference compound |
| HY-115366 | Soluflazine | 112415-83-5 | Reference compound |
| HY-115367 | Aldgamycin G | 107745-56-2 | Natural Products |
| HY-115369 | Methyl (13Z,16Z,19Z)-docosatrienoate | 108698-01-7 | Biochemical Assay Reagents |
| HY-115371 | Butaperazine (dimaleate) | 1063-55-4 | Reference compound |
| HY-115374 | m-PEG6-azide | 1043884-49-6 | ADC Related |
| HY-115375 | R 50595 (hydrochloride) | 104860-61-9 | Reference compound |
| HY-115376 | Z62954982 | 1090893-12-1 | Reference compound |
| HY-115378 | 1-(3,5-Dimethylphenyl)piperazine | 105907-65-1 | Reference compound |
| HY-115379 | Latromotide | 1049674-65-8 | Peptides |
| HY-115381 | Lipoxin A5 | 110657-98-2 | Reference compound |
| HY-115382 | Guanoctine (hydrochloride) | 1070-95-7 | Reference compound |
| HY-115383 | Roflupram | 1093412-18-0 | Reference compound |
| HY-115384 | Amino-PEG5-C2-acid | 1191078-74-6 | ADC Related |
| HY-115385 | Lumichrome | 1086-80-2 | Reference compound |
| HY-115385R | Lumichrome (Standard) | 1086-80-2 | Reference Standards |
| HY-115386 | MitoTEMPOL | 1101113-39-6 | Reference compound |
| HY-115387 | Oleoyl proline | 107432-37-1 | Peptides |
| HY-115390 | 14,15-Dehydro Leukotriene B4 | 114616-11-4 | Reference compound |
| HY-115391 | Boc-LRR-AMC | 109358-46-5 | Peptides |
| HY-115392 | Ms-PEG12-m | 1059604-93-1 | Reference compound |
| HY-115393 | N-Heptanoyl-DL-homoserine lactone | 106983-26-0 | Peptides |
| HY-115393A | N-Heptanoyl-L-homoserine lactone | 177158-20-2 | Reference compound |
| HY-115394 | Soyasaponin IV | 108906-97-4 | Natural Products |
| HY-115397 | Aprepitant-d4 | 1133387-60-6 | Isotope-Labeled Compounds |
| HY-115399A | N-3-Oxo-hexadecanoyl-L-Homoserine lactone | 925448-37-9 | Reference compound |
| HY-115400 | 1V209 | 1062444-54-5 | Reference compound |
| HY-115402 | DAz-1 | 1112977-84-0 | Dye Reagents |
| HY-115403 | FKGK18 | 1071001-09-6 | Reference compound |
| HY-115406A | CPTH6 (hydrobromide) | 2321332-57-2 | Reference compound |
| HY-115407 | Cochliodone A | 1072931-48-6 | Natural Products |
| HY-115408 | 9(R)-HETE | 107656-14-4 | Reference compound |
| HY-115410 | NG-Amino-L-arginine (hydrochloride) | 1031799-40-2 | Reference compound |
| HY-115411 | L-Hydroxy arginine (acetate) | 1140844-61-6 | Peptides |
| HY-115411A | L-Hydroxy arginine (dihydrochloride) | 133565-48-7 | Reference compound |
| HY-115412 | Vorinostat-d5 | 1132749-48-4 | Reference compound |
| HY-115413 | LG50643 | 111372-42-0 | Reference compound |
| HY-115414 | Bis-propargyl-PEG8 | 1092554-87-4 | Reference compound |
| HY-115415 | 1,2-Distearoyl-sn-glycero-3-phosphate (sodium) | 108321-18-2 | Biochemical Assay Reagents |
| HY-115415S | 1,2-Distearoyl-sn-glycero-3-phosphate-d70 (sodium) | 327179-02-2 | Isotope-Labeled Compounds |
| HY-115416 | Pigment Red 49:1 | 1103-38-4 | Dye Reagents |
| HY-115417 | Bosentan-d4 | 1065472-77-6 | Reference compound |
| HY-115419 | 1-Thio-β-D-glucose (sodium) | 10593-29-0 | Reference compound |
| HY-115420 | 1-β-D-Glucosylsphingadienine (d18:2 (4E8E)) | 114200-59-8 | Reference compound |
| HY-115421 | 11(R)-HEPE | 109430-11-7 | Reference compound |
| HY-115421A | 11-HEPE | 99217-78-4 | Reference compound |
| HY-115421B | 11(S)-HEPE | 156473-26-6 | Reference compound |
| HY-115428 | (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide | 220556-74-1 | Reference compound |
| HY-115429 | Calcium dextrofolinate | 115940-48-2 | Reference compound |
| HY-115430 | Tenofovir disoproxil aspartate | 1571075-19-8 | Reference compound |
| HY-115431 | Antho-rwamide I | 114056-25-6 | Peptides |
| HY-115433 | α-Muricholic acid | 2393-58-0 | Natural Products |
| HY-115433R | α-Muricholic acid (Standard) | 2393-58-0 | Reference Standards |
| HY-115433S | α-Muricholic acid-d5 | Isotope-Labeled Compounds | |
| HY-115433S1 | α-Muricholic acid-d4 | Isotope-Labeled Compounds | |
| HY-115434 | 3,5-Diiodothyroacetic acid | 1155-40-4 | Reference compound |
| HY-115435 | 1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine (sodium) | 105405-50-3 | Biochemical Assay Reagents |
| HY-115435S | 1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine-d54 (sodium) | 327178-93-8 | Isotope-Labeled Compounds |
| HY-115436 | LYG-202 | 1175077-25-4 | Reference compound |
| HY-115437 | Methyl all-cis-7,10,13,16,19-docosapentaenoate | 108698-02-8 | Biochemical Assay Reagents |
| HY-115440 | CRS3123 (dihydrochloride) | 1013915-99-5 | Reference compound |
| HY-115440R | CRS3123 (dihydrochloride) (Standard) | 1013915-99-5 | Reference Standards |
| HY-115441 | (Rac)-Luliconazole | 101530-21-6 | Reference compound |
| HY-115445 | LCS-1 | 41931-13-9 | Reference compound |
| HY-115446A | Lenalidomide-C4-NH2 (hydrochloride) | 2435715-90-3 | Reference compound |
| HY-115447 | Clobenpropit | 145231-45-4 | Reference compound |
| HY-115448 | Bio-AMS | 1393881-52-1 | Reference compound |
| HY-115448A | Bio-AMS (TFA) | Reference compound | |
| HY-115449 | Chromeceptin | 331859-86-0 | Reference compound |
| HY-115450 | ONO-0300302 | 856689-51-5 | Reference compound |
| HY-115451 | Photoregulin 3 | 785708-33-0 | Reference compound |
| HY-115452 | G5-7 | 939681-36-4 | Reference compound |
| HY-115453 | UBCS039 | 358721-70-7 | Reference compound |
| HY-115454 | GB111-NH2 | 956479-18-8 | Reference compound |
| HY-115454A | GB111-NH2 (hydrochloride) | Reference compound | |
| HY-115460 | AER-271 | 634913-39-6 | Reference compound |
| HY-115461 | MID-1 | 312608-54-1 | Reference compound |
| HY-115462 | PGN-9856 | 863704-91-0 | Reference compound |
| HY-115463 | EB-3D | 1839150-63-8 | Reference compound |
| HY-115464 | NC1153 | 150661-91-9 | Reference compound |
| HY-115466 | MLT-748 | 1832578-30-9 | Reference compound |
| HY-115467 | MitoBloCK-10 | 394694-98-5 | Reference compound |
| HY-115470 | CLK-IN-T3 | 2109805-56-1 | Reference compound |
| HY-115474 | Cardionogen-2 | 578755-52-9 | Reference compound |
| HY-115475 | SW-100 | 2126744-35-0 | Reference compound |
| HY-115477 | Brilaroxazine (hydrochloride) | 1708960-04-6 | Reference compound |
| HY-115480 | 1,3,5-Trihydroxyxanthone | 6732-85-0 | Natural Products |
| HY-115481 | EphB1-IN-1 | 1980036-18-7 | Reference compound |
| HY-115486 | MPO-IN-28 | 37836-90-1 | Reference compound |
| HY-115487 | MF-766 | 1050656-06-8 | Reference compound |
| HY-115488A | BNM-III-170 | 1859189-55-1 | Reference compound |
| HY-115489 | GGTI-286 | 171744-11-9 | Reference compound |
| HY-115489A | GGTI-286 (TFA) | Reference compound | |
| HY-115492 | NSC668394 | 382605-72-3 | Reference compound |
| HY-115493 | TIQ-15 | 1380336-17-3 | Reference compound |
| HY-115494 | Neladenoson dalanate (hydrochloride) | 1239235-25-6 | Reference compound |
| HY-115495 | 6-Alkynyl fucose | 935658-91-6 | Reference compound |
| HY-115496 | 7-BIA | 1313403-49-4 | Reference compound |
| HY-115497 | BRD5529 | 1358488-78-4 | Reference compound |
| HY-115498 | ARN14494 | 1037837-27-6 | Reference compound |
| HY-115499 | MPC-0767 | 1310540-32-9 | Reference compound |
| HY-115502 | BCI | 1245792-51-1 | Reference compound |
| HY-115502A | BCI (hydrochloride) | 95130-23-7 | Reference compound |
| HY-115506 | PF-05105679 | 1398583-31-7 | Reference compound |
| HY-115510 | SPR inhibitor 3 | 1292285-54-1 | Reference compound |
| HY-115513 | Pitstop 1 | 1332879-51-2 | Reference compound |
| HY-115514A | BRK inhibitor P21d (hydrochloride) | 2250025-98-8 | Reference compound |
| HY-115519 | (E/Z)-GO289 | 694522-87-7 | Reference compound |
| HY-115521 | Jarin-1 | 1212704-51-2 | Reference compound |
| HY-115524 | DBCO-NHS ester 2 | 1384870-47-6 | ADC Related |
| HY-115528 | FF-10502 | 184302-49-6 | Reference compound |
| HY-115529 | (-)BI97D6 | 1430067-36-9 | Reference compound |
| HY-115531 | UNC-2170 | 1648707-58-7 | Reference compound |
| HY-115532 | BCL6-IN-7 | 2097518-46-0 | Reference compound |
| HY-115533 | LBL1 | 1605301-58-3 | Reference compound |
| HY-115537 | NAE-IN-M22 | 864420-54-2 | Reference compound |
| HY-115539 | Windorphen | 19881-70-0 | Reference compound |
| HY-115543 | β-catenin-IN-37 | 1783856-40-5 | Reference compound |
| HY-115545 | DBCO-NHS ester 3 | 1393350-27-0 | ADC Related |
| HY-115550 | Chalcone 4 (hydrate) | 1202866-96-3 | Reference compound |
| HY-115551 | BzDANP | 1994258-88-6 | Reference compound |
| HY-115552 | Simmiparib | 1551355-46-4 | Reference compound |
| HY-115553 | DETQ | 1638667-81-8 | Reference compound |
| HY-115555 | K-Ras-PDEδ-IN-1 | 1841464-21-8 | Reference compound |
| HY-115560 | Thalidomide-O-amido-C3-NH2 | 2022182-57-4 | Reference compound |
| HY-115560A | Thalidomide-O-amido-C3-NH2 (TFA) | 2022182-58-5 | Reference compound |
| HY-115562 | Dorrigocin A | 158446-29-8 | Reference compound |
| HY-115566 | S1PL-IN-1 | 1538574-95-6 | Reference compound |
| HY-115567 | 5-NIdR | 191421-10-0 | Reference compound |
| HY-115568 | BETd-246 | 2140289-17-2 | Reference compound |
| HY-115570 | GW406108X | 1644443-92-4 | Reference compound |
| HY-115570A | (Z/E)-GW406108X | 265098-01-9 | Reference compound |
| HY-115574 | RSV L-protein-IN-1 | 851658-10-1 | Reference compound |
| HY-115575 | tBPC | 1942-71-8 | Reference compound |
| HY-115576 | P62-mediated mitophagy inducer | 1809031-84-2 | Reference compound |
| HY-115577 | Mitochonic acid 35 | 1611470-23-5 | Reference compound |
| HY-115579 | MALAT1-IN-1 | 827327-28-6 | Reference compound |
| HY-115581 | Thymidine 3',5'-disphosphate | 2863-04-9 | Reference compound |
| HY-115581A | Thymidine 3',5'-diphosphate (tetrasodium) | 118675-87-9 | Reference compound |
| HY-115582 | 3,4-DMMA (hydrochloride) | 70932-18-2 | Reference compound |
| HY-115584 | Lufenuron | 103055-07-8 | Reference compound |
| HY-115584B | Lufenuron, (-)- | 130841-26-8 | Reference compound |
| HY-115584R | Lufenuron (Standard) | 103055-07-8 | Reference Standards |
| HY-115584S | Lufenuron-13C6 | Isotope-Labeled Compounds | |
| HY-115589 | YLT-11 | Reference compound | |
| HY-115594 | Erasin | Reference compound | |
| HY-115597 | BTT-266 | 2413939-89-4 | Reference compound |
| HY-115604 | Pitstop 2 | 1419320-73-2 | Reference compound |
| HY-115608 | cis-4P-PDOT | 620170-78-7 | Reference compound |
| HY-115613 | ML-180 | 863588-32-3 | Reference compound |
| HY-115615 | VUF11207 (TFA) | 1492153-74-8 | Reference compound |
| HY-115620 | AQX-016A | 849669-54-1 | Reference compound |
| HY-115625 | AG-205 | 1375078-57-1 | Reference compound |
| HY-115627 | PKUMDL-LC-101-D04 | 2143896-83-5 | Reference compound |
| HY-115630 | cRIPGBM (chloride) | 2361988-77-2 | Reference compound |
| HY-115635 | ABO (hydrochloride) | 2309172-24-3 | Reference compound |
| HY-115640 | TRFS-green | 1513848-14-0 | Reference compound |
| HY-115642 | preQ1 (dihydrochloride) | 86694-45-3 | Reference compound |
| HY-115644 | BMS-470539 (dihydrochloride) | 2341796-82-3 | Reference compound |
| HY-115645 | R121919 (hydrochloride) | 195055-66-4 | Reference compound |
| HY-115650 | TAE-1 | 1414469-59-2 | Reference compound |
| HY-115658 | VU0420373 | 38376-29-3 | Reference compound |
| HY-115661 | Bisdionin C | 74857-22-0 | Reference compound |
| HY-115666 | COH34 analog 1 | 314248-24-3 | Reference compound |
| HY-115669 | Pentachloropseudilin | 69640-38-6 | Reference compound |
| HY-115670 | GW280264X | 866924-39-2 | Reference compound |
| HY-115671 | KLH45b | Reference compound | |
| HY-115672 | KS15 | 1033781-20-2 | Reference compound |
| HY-115673 | LAS17 | 2362527-67-9 | Reference compound |
| HY-115676 | GSK199 analog (hydrochloride) | 2048226-46-4 | Reference compound |
| HY-115677 | ILK-IN-3 | 6975-75-3 | Reference compound |
| HY-115681 | (2R/S)-6-PNG | 68682-01-9 | Reference compound |
| HY-115681R | (2R/S)-6-PNG (Standard) | 68682-01-9 | Reference Standards |
| HY-115682 | (S)-ZINC-3573 | 2095596-11-3 | Reference compound |
| HY-115683 | NUN82647 | 16082-64-7 | Reference compound |
| HY-115684 | 2-Undecanol | 1653-30-1 | Natural Products |
| HY-115684R | 2-Undecanol (Standard) | 1653-30-1 | Reference Standards |
| HY-115685 | 3-Methyl-GABA | 1216629-00-3 | Reference compound |
| HY-115686 | 8-Azaadenosine | 10299-44-2 | Reference compound |
| HY-115687 | PDE4B-IN-2 | 915082-52-9 | Reference compound |
| HY-115688 | TXNIP-IN-1 | 1268955-50-5 | Reference compound |
| HY-115688A | (S)-TXNIP-IN-1 | 1212421-96-9 | Reference compound |
| HY-115689 | Maohuoside B | 849834-04-4 | Natural Products |
| HY-115690 | K-TMZ | 2269482-26-8 | Reference compound |
| HY-115691 | STY-BODIPY | 2383063-37-2 | Dye Reagents |
| HY-115692 | 2-Coumaranone-1-L | 1887057-34-2 | Reference compound |
| HY-115693 | CAP 3 | 2292123-03-4 | Reference compound |
| HY-115701 | 1-Stearoyl-2-15(S)-Hpete-Sn-Glycero-3-Pe | 154436-49-4 | Reference compound |
| HY-115702S | 1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d4 | 211106-54-6 | Isotope-Labeled Compounds |
| HY-115703 | C17 Ceramide (d18:1/17:0) | 67492-16-4 | Natural Products |
| HY-115704 | Butyryl-L-carnitine (chloride) | 162067-50-7 | Reference compound |
| HY-115704S | Butyryl-L-carnitine-d7 (chloride) | Isotope-Labeled Compounds | |
| HY-115704S1 | Butyryl-L-carnitine-d3 (chloride) | 1334532-21-6 | Isotope-Labeled Compounds |
| HY-115705 | 1,2,3-Tri-10(Z)-heptadecenoyl glycerol | 1094209-16-1 | Isotope-Labeled Compounds |
| HY-115705S | 1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol-d5 | Isotope-Labeled Compounds | |
| HY-115706 | 13-Dilignoceroyl glycerol | 120639-92-1 | Isotope-Labeled Compounds |
| HY-115707 | 1-Palmitoyl-3-Linolenoyl-rac-glycerol | 126281-90-1 | Reference compound |
| HY-115708 | C22 Phytoceramide (t18:0/22:0) | 164576-03-8 | Reference compound |
| HY-115708S | C22 Phytoceramide-d3 (t18:0/22:0) | 2011762-87-9 | Isotope-Labeled Compounds |
| HY-115709 | 4,6-O-Benzylidene-D-glucose | 30688-66-5 | Reference compound |
| HY-115711 | Dicrotalic anhydride | 34695-32-4 | Reference compound |
| HY-115712 | DHPS-IN-1 | 2643300-54-1 | Reference compound |
| HY-115713 | Heme Oxygenase-1-IN-2 | 2839158-50-6 | Reference compound |
| HY-115714 | CDK9-IN-12 | 1942843-54-0 | Reference compound |
| HY-115715 | EN219 | 380351-29-1 | Reference compound |
| HY-115715A | EN219-alkyne | Reference compound | |
| HY-115716 | EGFR-IN-17 | 2817679-31-3 | Reference compound |
| HY-115717 | UZH2 | 2756566-45-5 | Reference compound |
| HY-115718 | PZ703b | 2471970-56-4 | Reference compound |
| HY-115718A | PZ703b (TFA) | Reference compound | |
| HY-115718B | PZ703b (hydrochloride) | Reference compound | |
| HY-115719 | CASK-IN-1 | 2755241-73-5 | Reference compound |
| HY-115720 | Betulinic acid derivative-1 | 2708127-92-6 | Reference compound |
| HY-115721 | Antimalarial agent 2 | 2829950-49-2 | Reference compound |
| HY-115722 | (S)-(-)-MRJF22 | 2757301-90-7 | Reference compound |
| HY-115723 | Antiallergic agent-1 | 2839159-12-3 | Reference compound |
| HY-115724 | FPPQ | 1648745-46-3 | Reference compound |
| HY-115725 | Antileishmanial agent-1 | 2454115-43-4 | Reference compound |
| HY-115726 | FRM-024 | 2085780-87-4 | Reference compound |
| HY-115726A | (-)-FRM-024 | 2085780-85-2 | Reference compound |
| HY-115727 | BET-IN-1 | 2727161-43-3 | Reference compound |
| HY-115728 | PROTAC CDK9 degrader-4 | 2411021-01-5 | Reference compound |
| HY-115729 | PROTAC CDK9 ligand-1 | 3031327-95-1 | Reference compound |
| HY-115729A | (R)-PROTAC CDK9 ligand-1 | 2411021-95-7 | Reference compound |
| HY-115730 | RdRP-IN-3 | 2641299-75-2 | Reference compound |
| HY-115731 | Tocol | 119-98-2 | Reference compound |
| HY-115732 | PKA-IN-1 | 179985-52-5 | Reference compound |
| HY-115733 | Cathepsin L-IN-2 | 108005-94-3 | Reference compound |
| HY-115734 | Phenylpyropene C | 419532-92-6 | Reference compound |
| HY-115735 | SKI-I | 306301-68-8 | Reference compound |
| HY-115736 | Xanthosine-5'-Triphosphate | 6253-56-1 | Reference compound |
| HY-115736A | Xanthosine-5'-Triphosphate (trisodium) | 105931-36-0 | Reference compound |
| HY-115737 | L-threo-PPMP | 207278-87-3 | Reference compound |
| HY-115738 | 2-Acetamido-2,4-dideoxy-4-fluoro-α-D-glucopyranose | 129728-87-6 | Reference compound |
| HY-115739 | RTIL 13 | 1009376-10-6 | Reference compound |
| HY-115740 | Cytarabine triphosphate | 13191-15-6 | Reference compound |
| HY-115740A | Cytarabine triphosphate (trisodium) | 1179343-17-9 | Oligonucleotides |
| HY-115741 | 3BrB-PP1 | 956025-99-3 | Reference compound |
| HY-115742 | (Rac)-γ-Tocopherol | 73980-80-0 | Reference compound |
| HY-115743 | TAK1-IN-3 | 494772-87-1 | Reference compound |
| HY-115744 | Mercaptoethylguanidine (MEG) (dihydrobromide) | 32665-11-5 | Reference compound |
| HY-115745 | Calmodulin antagonist-1 | 78957-84-3 | Reference compound |
| HY-115746 | Dimethyl-bisphenol A | 1568-83-8 | Reference compound |
| HY-115747 | Namoline | 342795-11-3 | Reference compound |
| HY-115748 | Mant-GTPγS | 136749-24-1 | Reference compound |
| HY-115748A | Mant-GTPγS (triammonium) | Reference compound | |
| HY-115749 | D-Luciferin 6′-methyl ether | 24404-90-8 | Reference compound |
| HY-115749A | (Rac)-Luciferin 6′-methyl ether (sodium) | 646450-23-9 | Dye Reagents |
| HY-115750 | Nω-allyl-L-arginine | 139461-37-3 | Reference compound |
| HY-115753 | Calpain Inhibitor-1 | 1448429-06-8 | Reference compound |
| HY-115754 | S-(N-PhenethylthiocarbaMoyl)-L-cysteine | 53330-02-2 | Reference compound |
| HY-115755 | Thio-ITP | 27652-34-2 | Reference compound |
| HY-115756 | 4-Maleimidosalicylic acid | 19232-43-0 | Reference compound |
| HY-115758 | PRMT1-IN-1 | 1025948-98-4 | Reference compound |
| HY-115759 | N-Octylmaleimide | 4080-76-6 | Reference compound |
| HY-115760 | Okadaic acid (ammonium salt) | 175522-42-6 | Reference compound |
| HY-115761 | Dihydrochlamydocin | 52574-64-8 | Reference compound |
| HY-115762 | 4-Hydroxytryptamine creatinine sulfate | 55206-11-6 | Reference compound |
| HY-115763 | 3-Aminopropylphosphinic acid | 103680-47-3 | Reference compound |
| HY-115764 | nAChR agonist 2 | 252870-46-5 | Reference compound |
| HY-115765 | N6-Benzyl-5'-ethylcarboxamido adenosine | 152918-32-6 | Reference compound |
| HY-115766 | Anabaseine | 3471-05-4 | Reference compound |
| HY-115767 | (±)-1,2-Diolein | 2442-61-7 | Reference compound |
| HY-115767S | (±)-1,2-Diolein-13C3 | 2692624-38-5 | Isotope-Labeled Compounds |
| HY-115768 | Compound 48/80 | 94724-12-6 | Reference compound |
| HY-115768A | Compound 48/80 (trimer) | Reference compound | |
| HY-115769 | 1,2-Didecanoylglycerol | 17863-69-3 | Reference compound |
| HY-115770 | 8-Methylsulfinyloctyl isothiocyanate | 75272-81-0 | Natural Products |
| HY-115771 | 3-Phenylpropyl isothiocyanate | 2627-27-2 | Reference compound |
| HY-115772 | 4′-Bromoflavone | 20525-20-6 | Reference compound |
| HY-115773 | NMTCA | 103659-08-1 | Reference compound |
| HY-115774 | 5-HT4R agonist-1 | 2231302-46-6 | Reference compound |
| HY-115777 | ARN-6039 | 1675206-11-7 | Reference compound |
| HY-115781 | DN401 | 2135749-60-7 | Reference compound |
| HY-115796 | VU0477886 | 1926222-30-1 | Reference compound |
| HY-115805 | YKL-04-085 | 2120356-29-6 | Reference compound |
| HY-115820 | Cyclo(Pro-Pro) | 6708-06-1 | Natural Products |
| HY-115821 | Ascorutin | 8067-12-7 | Reference compound |
| HY-115822 | α-Fluoromethylhistidine (dihydrochloride) | 81839-27-2 | Reference compound |
| HY-115823 | ztz240 | 325457-98-5 | Reference compound |
| HY-115824 | 7ETMC | 1370702-83-2 | Reference compound |
| HY-115826 | AB-163 | 14984-65-7 | Reference compound |
| HY-115827 | AH22921 | 74480-23-2 | Reference compound |
| HY-115828 | APA-APA-MPO (dihydrochloride) | 1610362-98-5 | Reference compound |
| HY-115829 | APA-H-MPO (hydrochloride) | 1610362-93-0 | Reference compound |
| HY-115831 | SAR247799 | 1315311-14-8 | Reference compound |
| HY-115832 | Ap44mSe | 79514-49-1 | Reference compound |
| HY-115833 | Histamine H4 receptor antagonist-2 | 379247-14-0 | Reference compound |
| HY-115836 | DDPO | 118675-83-5 | Reference compound |
| HY-115837 | DHPCC-9 | 1192248-37-5 | Reference compound |
| HY-115839 | Detajmium | 47719-70-0 | Reference compound |
| HY-115839A | Detajmium (L-tartrate) | 33774-52-6 | Reference compound |
| HY-115840 | ICL-CCIC-0019 | 936498-64-5 | Reference compound |
| HY-115843 | LL-D05139β | 95153-19-8 | Natural Products |
| HY-115844 | LY-99335 | 78738-97-3 | Reference compound |
| HY-115845 | ML366 | 851094-56-9 | Reference compound |
| HY-115848 | Antiviral agent 12 | 314030-54-1 | Reference compound |
| HY-115849 | Nrf2-Activator-12G | 1554271-18-9 | Reference compound |
| HY-115850 | Ornithine-methotrexate | 80407-73-4 | Reference compound |
| HY-115851 | Demethyl PL265 | 1206514-62-6 | Reference compound |
| HY-115853 | Pyclen | 78668-34-5 | Reference compound |
| HY-115854 | Ro 15-1310 | 78756-33-9 | Reference compound |
| HY-115855 | Ro 31-4639 | 125131-65-9 | Reference compound |
| HY-115856 | Sch 50910 | 790633-59-9 | Reference compound |
| HY-115857 | SH-053-S-CH3-2'F | 872874-00-5 | Reference compound |
| HY-115858 | SU-13197 | 12379-49-6 | Reference compound |
| HY-115859 | SCH 25393 | 73212-54-1 | Reference compound |
| HY-115860 | TAS-4 | 794544-99-3 | Reference compound |
| HY-115861 | UCM765 | 944284-77-9 | Reference compound |
| HY-115862 | Benzo[c][1,8]naphthyridin-6(5H)-one | 53439-81-9 | Reference compound |
| HY-115864 | Osavampator | 1358751-06-0 | Reference compound |
| HY-115865 | XIAP degrader-1 | 2803617-91-4 | Reference compound |
| HY-115866 | COX-2-IN-6 | 2756347-91-6 | Reference compound |
| HY-115867 | GSK852 | 2305842-30-0 | Reference compound |
| HY-115867A | (S)-GSK852 | 2305919-51-9 | Reference compound |
| HY-115868 | BMS-911172 | 1644248-18-9 | Reference compound |
| HY-115869 | RMC-4529 | 2250059-27-7 | Reference compound |
| HY-115870 | AZD8154 | 2215022-45-8 | Reference compound |
| HY-115871 | PDE4-IN-4 | 1793069-00-7 | Reference compound |
| HY-115871A | (Rac)-PDE4-IN-4 | Reference compound | |
| HY-115872 | β-Lactamase-IN-6 | 2326468-84-0 | Reference compound |
| HY-115873 | Folate-MS432 | 2769735-56-8 | Reference compound |
| HY-115874 | BMS-753426 | 1004536-52-0 | Reference compound |
| HY-115875 | LDHA-IN-5 | 2776148-90-2 | Reference compound |
| HY-115876 | BTK-IN-5 | 2145152-06-1 | Reference compound |
| HY-115877 | GDC-0334 | 1984824-54-5 | Reference compound |
| HY-115878 | NJH-2-057 | 2858812-70-9 | Reference compound |
| HY-115879 | SHR168442 | 2382961-86-4 | Reference compound |
| HY-115880 | KRAS G12D inhibitor 3 | 2757095-11-5 | Reference compound |
| HY-115880A | KRAS G12D inhibitor 3 (TFA) | 2757095-12-6 | Reference compound |
| HY-115881 | SR-1114 | 2769141-82-2 | Reference compound |
| HY-115882 | PptT-IN-1 | Reference compound | |
| HY-115883 | PptT-IN-2 | 3035894-73-3 | Reference compound |
| HY-115884 | PptT-IN-3 | 3035894-87-9 | Reference compound |
| HY-115885 | XP5 | 2760511-91-7 | Reference compound |
| HY-115887 | R110 | 1985622-33-0 | Reference compound |
| HY-115888 | MIF2-IN-1 | 2917525-79-0 | Reference compound |
| HY-115889 | L-NAPNA | 85697-89-8 | Reference compound |
| HY-115892 | 1,3,9-Trimethyluric acid | 7464-93-9 | Natural Products |
| HY-115893A | P18IN005 (hydrochloride) | 7403-44-3 | Reference compound |
| HY-115894 | DapL-IN-1 | 423732-11-0 | Reference compound |
| HY-115895 | Trebenzomine | 23915-73-3 | Reference compound |
| HY-115896 | Zuclopenthixol decanoate | 64053-00-5 | Reference compound |
| HY-115898 | Decachlorobiphenyl | 2051-24-3 | Reference compound |
| HY-115899 | Malonyl CoA | 524-14-1 | Reference compound |
| HY-115900 | Tuberculosis inhibitor 4 | Reference compound | |
| HY-115901 | 4-PQBH | 2243355-51-1 | Reference compound |
| HY-115902 | FGFR4-IN-7 | 2765046-07-7 | Reference compound |
| HY-115903 | HIF-1α-IN-2 | 2762315-06-8 | Reference compound |
| HY-115903A | HIF-1α-IN-2 (hydrochloride) | Reference compound | |
| HY-115904 | FLT3/CDK4-IN-1 | 2762296-44-4 | Reference compound |
| HY-115905 | Antimalarial agent 9 | 2914224-54-5 | Reference compound |
| HY-115906 | K783-0308 | 422554-29-8 | Reference compound |
| HY-115907 | K20 | Reference compound | |
| HY-115908 | ZDLD13 | 2762278-95-3 | Reference compound |
| HY-115909 | ZDLD20 | 2762279-02-5 | Reference compound |
| HY-115910 | Y13g | 2766380-73-6 | Reference compound |
| HY-115910A | Y13g (dihydrochloride) | Reference compound | |
| HY-115911 | GPVI antagonist 2 | 880399-00-8 | Reference compound |
| HY-115912 | GPVI antagonist 3 | 901654-94-2 | Reference compound |
| HY-115913 | PDE4-IN-6 | Reference compound | |
| HY-115914 | Lipid-lowering agent-1 | 2304859-34-3 | Reference compound |
| HY-115915 | TS010 | Reference compound | |
| HY-115916 | NOS-IN-2 | 2766146-79-4 | Reference compound |
| HY-115917 | NOS-IN-3 | 2761725-68-0 | Reference compound |
| HY-115918 | XA-E | 132998-84-6 | Reference compound |
| HY-115919 | AChE-IN-8 | 2919335-82-1 | Reference compound |
| HY-115920 | Anti-inflammatory agent 8 | 1103920-19-9 | Reference compound |
| HY-115921 | Anti-inflammatory agent 9 | 2910876-54-7 | Reference compound |
| HY-115922 | Anti-inflammatory agent 10 | 2910876-55-8 | Reference compound |
| HY-115923 | Nur77 modulator 2 | 2055829-03-1 | Reference compound |
| HY-115924 | CDK1-IN-1 | 2761858-59-5 | Reference compound |
| HY-115925 | SHP2-IN-9 | 2987135-92-0 | Reference compound |
| HY-115926 | BRD4 Inhibitor-16 | Reference compound | |
| HY-115927 | 8A8 | 2766594-12-9 | Reference compound |
| HY-115928 | M24 | 2761947-05-9 | Reference compound |
| HY-115929 | DENV-IN-4 | 2762302-75-8 | Reference compound |
| HY-115930 | Bim-IN-1 | 2909483-36-7 | Reference compound |
| HY-115932 | Aurora kinase-IN-1 | Reference compound | |
| HY-115933 | EGFR/BRAF-IN-1 | 2906174-89-6 | Reference compound |
| HY-115934 | COX-2-IN-7 | Reference compound | |
| HY-115935 | COX-2-IN-8 | Reference compound | |
| HY-115936 | COX-2-IN-9 | Reference compound | |
| HY-115937 | c-Met-IN-9 | 2760326-29-0 | Reference compound |
| HY-115938 | BEC2 | 1429614-99-2 | Reference compound |
| HY-115939 | Urease-IN-2 | Reference compound | |
| HY-115940 | Aldose reductase-IN-2 | 1687735-82-5 | Reference compound |
| HY-115941 | HDAC-IN-9 | Reference compound | |
| HY-115942 | Anticancer agent 29 | 2907774-89-2 | Reference compound |
| HY-115943 | Anticancer agent 30 | 2907774-88-1 | Reference compound |
| HY-115944 | BTK-IN-9 | 2361192-21-2 | Reference compound |
| HY-115945 | Complex III-IN-1 | Reference compound | |
| HY-115946 | Complex III-IN-2 | Reference compound | |
| HY-115947 | Anticancer agent 33 | Reference compound | |
| HY-115948 | Antitumor agent-46 | 2917547-18-1 | Reference compound |
| HY-115949 | Antitumor agent-47 | 2917547-24-9 | Reference compound |
| HY-115950 | Antitumor agent-48 | 2917547-29-4 | Reference compound |
| HY-115951 | EGFR/HER2-IN-2 | 1215571-02-0 | Reference compound |
| HY-115952 | EGFR/HER2-IN-3 | 1031620-09-3 | Reference compound |
| HY-115953 | Dopamine D3 receptor ligand-1 | 2882828-93-3 | Reference compound |
| HY-115954 | Dopamine D3 receptor ligand-2 | 2882828-95-5 | Reference compound |
| HY-115955 | Dopamine D3 receptor ligand-3 | 2891605-81-3 | Reference compound |
| HY-115956 | Tubulin inhibitor 18 | 2762382-51-2 | Reference compound |
| HY-115957 | Tubulin inhibitor 19 | Reference compound | |
| HY-115958 | Tubulin inhibitor 20 | 860356-56-5 | Reference compound |
| HY-115959 | Anticancer agent 34 | 2379335-06-3 | Reference compound |
| HY-115960 | Anticancer agent 35 | 2902563-75-9 | Reference compound |
| HY-115961 | Anticancer agent 36 | 2902563-76-0 | Reference compound |
| HY-115962 | Anticancer agent 37 | 905783-28-0 | Reference compound |
| HY-115963 | Anticancer agent 38 | 69123-54-2 | Reference compound |
| HY-115964 | VP-4556 | 654633-67-7 | Reference compound |
| HY-115965 | VP-4604 | 64268-93-5 | Reference compound |
| HY-115965R | VP-4604 (Standard) | 64268-93-5 | Reference Standards |
| HY-115966 | COX-1/2-IN-1 | 2358849-47-3 | Reference compound |
| HY-115967 | COX-1/2-IN-2 | 2882832-86-0 | Reference compound |
| HY-115968 | Dopamine D3 receptor ligand-4 | 2376333-77-4 | Reference compound |
| HY-115969 | F-17 | 1572464-22-2 | Reference compound |
| HY-115970 | Tubulin inhibitor 21 | Reference compound | |
| HY-115971 | Anti-Trypanosoma cruzi agent-1 | 2854299-38-8 | Reference compound |
| HY-115972 | Anti-Trypanosoma cruzi agent-2 | 2863602-85-9 | Reference compound |
| HY-115973 | AChE-IN-11 | Reference compound | |
| HY-115974 | GRPR antagonist-1 | 3052544-28-9 | Reference compound |
| HY-115975 | GRPR antagonist-2 | 3052544-42-7 | Reference compound |
| HY-115976 | COX-2-IN-10 | Reference compound | |
| HY-115977 | Aldose reductase-IN-3 | 1390616-76-8 | Reference compound |
| HY-115978 | α-Glucosidase-IN-2 | 2699784-18-2 | Reference compound |
| HY-115979 | Sirt2-IN-5 | 902456-47-7 | Reference compound |
| HY-115981 | NS5A-IN-2 | 2764786-74-3 | Reference compound |
| HY-115982 | NS5A-IN-3 | 2764786-56-1 | Reference compound |
| HY-115983 | DMUP | 2364350-07-0 | Reference compound |
| HY-115986 | MAO-B-IN-5 | 849909-77-9 | Reference compound |
| HY-115987 | MAO-B-IN-6 | 2376198-66-0 | Reference compound |
| HY-115988 | IMB-26 | 1001426-49-8 | Reference compound |
| HY-115989 | HCV-IN-38 | 3035807-39-4 | Reference compound |
| HY-115990 | Topoisomerase IV inhibitor 1 | 2883403-42-5 | Reference compound |
| HY-115991 | Topoisomerase IV inhibitor 2 | 2883403-36-7 | Reference compound |
| HY-115992 | CDK4/6-IN-9 | 2688098-02-2 | Reference compound |
| HY-115993 | CDK4/6-IN-10 | 2688098-11-3 | Reference compound |
| HY-115994 | Carbonic anhydrase inhibitor 10 | 2883453-30-1 | Reference compound |
| HY-115995 | Antitumor agent-50 | 2891985-53-6 | Reference compound |
| HY-115996 | Antitumor agent-51 | 3035774-65-0 | Reference compound |
| HY-115997 | PROTAC HSP90 degrader BP3 | 2669072-88-0 | Reference compound |
| HY-115998 | Carbonic anhydrase inhibitor 11 | 2411059-71-5 | Reference compound |
| HY-115999 | Carbonic anhydrase inhibitor 12 | 2883451-38-3 | Reference compound |
| HY-116000 | Glumetinib | 1642581-63-2 | Reference compound |
| HY-116001 | (+)-Carbovir | 124915-24-8 | Reference compound |
| HY-116001B | (-)-Carbovir | 120443-30-3 | Reference compound |
| HY-116003 | 12,13-DiHOME | 263399-35-5 | Reference compound |
| HY-116004 | Anti-Trypanosoma cruzi agent-5 | 205381-53-9 | Reference compound |
| HY-116005 | A-286501 | 483341-15-7 | Reference compound |
| HY-116006 | Bis-PEG5-acid | 439114-13-3 | Reference compound |
| HY-116007 | Gaxilose | 14087-31-1 | Natural Products |
| HY-116008 | 8-iso Prostaglandin F3α | 7045-31-0 | Reference compound |
| HY-116009 | RMC-4550 | 2172651-73-7 | Reference compound |
| HY-116010 | Oleandomycin | 3922-90-5 | Reference compound |
| HY-116010A | Oleandomycin (phosphate) | 7060-74-4 | Reference compound |
| HY-116010R | Oleandomycin (Standard) | 3922-90-5 | Reference Standards |
| HY-116011 | N,N’-bis-Cbz-β-Alethine | 104071-84-3 | Reference compound |
| HY-116013 | Dodecylphosphocholine | 29557-51-5 | Reference compound |
| HY-116013S | Dodecylphosphocholine-d38 | 130890-78-7 | Isotope-Labeled Compounds |
| HY-116013S1 | Dodecylphosphocholine-d25 | 861924-55-2 | Isotope-Labeled Compounds |
| HY-116015 | Dihomo-γ-Linolenic acid methyl ester | 21061-10-9 | Reference compound |
| HY-116016 | Etilevodopa | 37178-37-3 | Reference compound |
| HY-116016A | Etilevodopa (hydrochloride) | 39740-30-2 | Reference compound |
| HY-116016AR | Etilevodopa (hydrochloride) (Standard) | 39740-30-2 | Reference Standards |
| HY-116016R | Etilevodopa (Standard) | 37178-37-3 | Reference Standards |
| HY-116017 | C10 Ceramide | 111122-57-7 | Natural Products |
| HY-116018 | FKGK11 | 1071000-98-0 | Reference compound |
| HY-116020 | FAUC 365 | 474432-66-1 | Reference compound |
| HY-116021 | Buquinolate | 5486-03-3 | Reference compound |
| HY-116021S | Buquinolate-13C3 | Isotope-Labeled Compounds | |
| HY-116022 | 4-Nitrophenyl phosphate | 330-13-2 | Reference compound |
| HY-116022A | 4-Nitrophenyl phosphate (disodium hexahydrate) | 333338-18-4 | Biochemical Assay Reagents |
| HY-116022B | 4-Nitrophenyl phosphate (ditromethamine) | 68189-42-4 | Biochemical Assay Reagents |
| HY-116022C | 4-Nitrophenyl phosphate (cyclohexylammonium) | 52483-84-8 | Biochemical Assay Reagents |
| HY-116023 | Moveltipril | 85856-54-8 | Reference compound |
| HY-116024 | Dimefuron | 34205-21-5 | Reference compound |
| HY-116025 | APN-C3-PEG4-alkyne | 2183440-36-8 | Reference compound |
| HY-116026 | 3-Hydroxycarbofuran | 16655-82-6 | Reference compound |
| HY-116026R | 3-Hydroxycarbofuran (Standard) | 16655-82-6 | Reference Standards |
| HY-116026S | 3-Hydroxycarbofuran-d3 | 1794759-59-3 | Isotope-Labeled Compounds |
| HY-116027 | Biotin-PEG3-acid | 252881-76-8 | Reference compound |
| HY-116028 | 15-deoxy-Δ12,14-Prostaglandin D2 | 85235-11-6 | Reference compound |
| HY-116028S1 | 15-deoxy-Δ12,14-Prostaglandin D2-d4 | Isotope-Labeled Compounds | |
| HY-116029 | Tolmetin β-D-Glucuronide | 71595-19-2 | Reference compound |
| HY-116030 | JNJ-26076713 | 669076-03-3 | Reference compound |
| HY-116031 | ATC0175 (free base) | 509118-03-0 | Reference compound |
| HY-116033 | BMS-363131 | 384829-65-6 | Reference compound |
| HY-116034 | Arasertaconazole | 583057-48-1 | Reference compound |
| HY-116035 | Nimbolide | 25990-37-8 | Natural Products |
| HY-116037 | cis-10-Heptadecenoic acid | 29743-97-3 | Biochemical Assay Reagents |
| HY-116037A | trans-10-Heptadecenoic acid | 126761-43-1 | Natural Products |
| HY-116038 | Kulinone | 21688-61-9 | Natural Products |
| HY-116039 | Epiroprim | 73090-70-7 | Reference compound |
| HY-116042 | FSCPX | 156547-56-7 | Reference compound |
| HY-116043 | Prodiamine | 29091-21-2 | Reference compound |
| HY-116044 | BCATc Inhibitor 2 | 406191-34-2 | Reference compound |
| HY-116045 | PDEB1-IN-1 | 1622300-88-2 | Reference compound |
| HY-116046 | GR 196429 | 170729-12-1 | Reference compound |
| HY-116047 | Anisylacetone | 104-20-1 | Natural Products |
| HY-116047R | Anisylacetone (Standard) | 104-20-1 | Reference Standards |
| HY-116047S | Anisylacetone-d5 | 2676886-20-5 | Isotope-Labeled Compounds |
| HY-116050 | 17(S)-HETE | 183509-25-3 | Reference compound |
| HY-116050A | 17(R)-HETE | 183509-24-2 | Reference compound |
| HY-116051 | 16,16-Dimethylprostaglandin F2α | 39746-23-1 | Reference compound |
| HY-116051A | 16,16-Dimethylprostaglandin F2β | 59769-89-0 | Reference compound |
| HY-116052 | p53-MDM2-IN-2 | 1542066-69-2 | Reference compound |
| HY-116055 | (2R)-Glycerol-O-β-D-galactopyranoside | 16232-91-0 | Reference compound |
| HY-116056 | 16-O-Methylcafestol | 108214-28-4 | Natural Products |
| HY-116057 | Stemazole | 317337-07-8 | Reference compound |
| HY-116060 | RK-286D | 140429-37-4 | Reference compound |
| HY-116062 | JNJ-7925476 (hydrochloride) | 109085-56-5 | Reference compound |
| HY-116062A | JNJ-7925476 | 129540-12-1 | Reference compound |
| HY-116063 | Doxorubicin-SMCC | 400647-59-8 | ADC Related |
| HY-116065 | CUMI-101 | 179756-61-7 | Reference compound |
| HY-116066 | YM471 (free base) | 183173-00-4 | Reference compound |
| HY-116067 | VU0404251 | 1276013-77-4 | Reference compound |
| HY-116069 | Propargyl-PEG1-NH2 | 122116-12-5 | Reference compound |
| HY-116070 | Iodoantipyrine | 129-81-7 | Reference compound |
| HY-116071 | Autophagy-IN-3 | 1227476-98-3 | Reference compound |
| HY-116072 | Antiarrhythmic agent-2 | 105919-73-1 | Reference compound |
| HY-116073 | L-Penicillamine | 1113-41-3 | Peptides |
| HY-116074 | FUB-PB-22 3-carboxyindole metabolite | 226883-79-0 | Reference compound |
| HY-116076 | S-15535 | 146998-34-7 | Reference compound |
| HY-116077 | AB 5046B | 154037-63-5 | Natural Products |
| HY-116078 | CKD-519 | 1402796-27-3 | Reference compound |
| HY-116080 | SB 210661 | 162750-10-9 | Reference compound |
| HY-116081 | LY 221501 | 145512-35-2 | Reference compound |
| HY-116082 | CP 226269 | 220941-93-5 | Reference compound |
| HY-116083 | 13,14-Dihydro-15-keto-tetranor prostaglandin D2 | 1204116-69-7 | Reference compound |
| HY-116084 | Trimethylamine N-oxide | 1184-78-7 | Natural Products |
| HY-116084S | Trimethylamine N-oxide-d9 | 1161070-49-0 | Isotope-Labeled Compounds |
| HY-116084S1 | Trimethylamine-N-oxide-13C3 | Isotope-Labeled Compounds | |
| HY-116087 | SRS11-92 | 1467047-25-1 | Reference compound |
| HY-116088 | W123 | 1345982-24-2 | Reference compound |
| HY-116090 | Conoidin A | 18080-67-6 | Reference compound |
| HY-116095 | CypD-IN-5 | 1572646-93-5 | Reference compound |
| HY-116096 | 15-epi-PGE1 | 20897-91-0 | Reference compound |
| HY-116097 | PSB-1491 | 1619884-67-1 | Reference compound |
| HY-116098 | Anecortave desacetate | 10184-70-0 | Reference compound |
| HY-116099 | ER-819762 | 1155773-15-1 | Reference compound |
| HY-116100 | (E/Z)-HA155 | 1229652-22-5 | Reference compound |
| HY-116100A | HA155 | 1312201-00-5 | Reference compound |
| HY-116102 | Laurinterol | 10539-87-4 | Reference compound |
| HY-116104 | Americanol A | 133838-65-0 | Natural Products |
| HY-116105 | Cyclazodone | 14461-91-7 | Reference compound |
| HY-116105S | Cyclazodone-d5 | 1246817-86-6 | Isotope-Labeled Compounds |
| HY-116107 | AG311 | 1126602-42-3 | Reference compound |
| HY-116108 | Musk tibetene | 145-39-1 | Natural Products |
| HY-116109 | LAS 30538 | 145067-04-5 | Reference compound |
| HY-116111 | AG 370 | 134036-53-6 | Reference compound |
| HY-116114 | 7(Z),11(Z)-Pentacosadiene | 127599-39-7 | Biochemical Assay Reagents |
| HY-116115 | 17-Oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid | 1233715-33-7 | Natural Products |
| HY-116116 | Tafetinib | 1032265-57-8 | Reference compound |
| HY-116117 | Salicylcurcumin | 1236545-54-2 | Natural Products |
| HY-116119 | BDF 9148 | 120838-62-2 | Reference compound |
| HY-116120 | N-Acetyldesloratadine | 117796-52-8 | Reference compound |
| HY-116121 | S-Nitrosohomocysteine | 139427-42-2 | Reference compound |
| HY-116124 | 17(S)-HpDHA | 123673-33-6 | Reference compound |
| HY-116126 | Leuhistin | 129085-76-3 | Natural Products |
| HY-116128 | Brassilexin | 119752-76-0 | Natural Products |
| HY-116129 | BPR1J-340 | 1395051-72-5 | Reference compound |
| HY-116131 | DAC-2-25 | 1675245-09-6 | Reference compound |
| HY-116132 | Kotanin | 27909-08-6 | Natural Products |
| HY-116133 | 3-Hydroxystearic acid | 17773-30-7 | Natural Products |
| HY-116136 | Acanthoic acid | 119290-87-8 | Natural Products |
| HY-116137 | Nav1.7-IN-17 | 1235403-87-8 | Reference compound |
| HY-116138 | RG-14467 | 137515-05-0 | Reference compound |
| HY-116139 | Isoxaflutole | 141112-29-0 | Reference compound |
| HY-116139R | Isoxaflutole (Standard) | 141112-29-0 | Reference Standards |
| HY-116141 | 7-Hydroxycoumarinyl arachidonate | 161180-11-6 | Reference compound |
| HY-116143 | MAGL-IN-12 | 1352011-38-1 | Reference compound |
| HY-116144 | Picaridin | 119515-38-7 | Reference compound |
| HY-116144R | Picaridin (Standard) | 119515-38-7 | Reference Standards |
| HY-116145 | MHY884 | 1393371-35-1 | Reference compound |
| HY-116146 | CYM50179 | 1355026-47-9 | Reference compound |
| HY-116147 | Ceranib-2 | 1402830-75-4 | Reference compound |
| HY-116148 | AHR-11797 | 125992-09-8 | Reference compound |
| HY-116149 | A-424274 | 1335145-56-6 | Reference compound |
| HY-116150 | Xymedon | 14716-32-6 | Reference compound |
| HY-116151B | Phloxine B | 18472-87-2 | Dye Reagents |
| HY-116152 | Cipepofol | 1637741-58-2 | Reference compound |
| HY-116152A | (S)-Cipepofol | 1637741-59-3 | Reference compound |
| HY-116152S | Cipepofol-d6 | 2677052-88-7 | Isotope-Labeled Compounds |
| HY-116152S2 | Cipepofol-d6-2 | 2677052-87-6 | Isotope-Labeled Compounds |
| HY-116153 | HUHS2002 | 1393102-59-4 | Reference compound |
| HY-116154 | Metacavir | 120503-45-9 | Reference compound |
| HY-116157 | Pyranthrone | 128-70-1 | Dye Reagents |
| HY-116158 | Oosponol | 146-04-3 | Natural Products |
| HY-116161 | Bimatoprost isopropyl ester | 130273-87-9 | Reference compound |
| HY-116161A | 17-Phenyl trinor PGF2α isopropyl ester | 130209-76-6 | Reference compound |
| HY-116163 | ML350 | Reference compound | |
| HY-116164 | A-79175 | 141579-87-5 | Reference compound |
| HY-116165 | ML-298 | 1426916-02-0 | Reference compound |
| HY-116166 | Methyl 3-hydroxyundecanoate | 129758-71-0 | Natural Products |
| HY-116167 | RY 024 | 173990-15-3 | Reference compound |
| HY-116168 | Aldecalmycin | 139953-58-5 | Natural Products |
| HY-116169 | KUC-7322 | 255734-04-4 | Reference compound |
| HY-116170 | SN34037 | 1548116-54-6 | Reference compound |
| HY-116171 | (Rac)-Calpain Inhibitor XII | 181769-57-3 | Reference compound |
| HY-116174 | Omaciclovir | 124265-89-0 | Reference compound |
| HY-116175 | BIBB 515 | 156635-05-1 | Reference compound |
| HY-116181 | YQA14 | 1221408-42-9 | Reference compound |
| HY-116182 | RO5487624 | 1399103-28-6 | Reference compound |
| HY-116183 | ITX 4520 | 1392116-37-8 | Reference compound |
| HY-116184 | PF-05387252 | 1604034-71-0 | Reference compound |
| HY-116185 | N-Acetyl-3,4-methylenedioxymethcathinone | 1227293-15-3 | Reference compound |
| HY-116186 | m-PEG5-MS | 130955-38-3 | ADC Related |
| HY-116188 | HX1 | 1520083-61-7 | Reference compound |
| HY-116189 | Julibrine I | 142628-28-2 | Natural Products |
| HY-116191 | WJD008 | 1309087-83-9 | Reference compound |
| HY-116193 | 5-PAHSA | 1481636-41-2 | Reference compound |
| HY-116193S | 5-PAHSA-d31 | 2749807-01-8 | Isotope-Labeled Compounds |
| HY-116194 | NaV1.7 blocker-801 | 1235403-75-4 | Reference compound |
| HY-116195 | L-Linalool | 126-91-0 | Natural Products |
| HY-116195R | L-Linalool (Standard) | 126-91-0 | Reference Standards |
| HY-116196 | 17-HETE | 128914-47-6 | Reference compound |
| HY-116197 | CGP44532 | 133345-68-3 | Reference compound |
| HY-116198 | 15-PGDH-IN-2 | 1221413-57-5 | Reference compound |
| HY-116201 | 1-Methyl-3-BZP | 137539-25-4 | Reference compound |
| HY-116202 | PACA | 1431724-30-9 | Reference compound |
| HY-116203 | BN 50739 | 128672-07-1 | Reference compound |
| HY-116204 | SKLB70326 | 1257317-77-3 | Reference compound |
| HY-116205 | UBP684 | 1357838-47-1 | Reference compound |
| HY-116208 | Dalcotidine | 120958-90-9 | Reference compound |
| HY-116209 | Pyrogallol triacetate | 525-52-0 | Reference compound |
| HY-116210 | Phenylphosphinic acid | 1779-48-2 | Reference compound |
| HY-116211 | Amfonelic acid | 15180-02-6 | Reference compound |
| HY-116212 | JCP-170 | 120218-98-6 | Reference compound |
| HY-116213 | Sparstolonin B | 1259330-61-4 | Reference compound |
| HY-116214 | Cyprodinil | 121552-61-2 | Reference compound |
| HY-116214R | Cyprodinil (Standard) | 121552-61-2 | Reference Standards |
| HY-116214S | Cyprodinil-d5 | 1773496-67-5 | Isotope-Labeled Compounds |
| HY-116214S1 | Cyprodinil-13C6 | 1773496-63-1 | Isotope-Labeled Compounds |
| HY-116215 | 2-NBDG | 186689-07-6 | Dye Reagents |
| HY-116216 | PD 168368 | 204066-82-0 | Reference compound |
| HY-116217 | 5-Fluoro-2'-deoxycytidine | 10356-76-0 | Reference compound |
| HY-116218 | Amelparib | 1227156-72-0 | Reference compound |
| HY-116218C | Amelparib (hydrochloride) | Reference compound | |
| HY-116220 | Mcl1-IN-14 | 2012563-29-8 | Reference compound |
| HY-116222 | A 53693 | 115103-48-5 | Reference compound |
| HY-116223 | Tianagliflozin | 1461750-27-5 | Reference compound |
| HY-116227 | (2S,3R)-LP99 | 1808948-28-8 | Reference compound |
| HY-116228 | Cadrofloxacin | 153808-85-6 | Reference compound |
| HY-116229 | Gemifloxacin | 175463-14-6 | Reference compound |
| HY-116230 | BI-L-45 XX | 111317-77-2 | Reference compound |
| HY-116231 | (S)-Gyramide A | 1000592-48-2 | Reference compound |
| HY-116232 | 2-(3-Pyridyl)-benzimidazole | 1137-67-3 | Reference compound |
| HY-116236 | THIIC | 1204737-09-6 | Reference compound |
| HY-116237 | CREBBP-IN-9 | 1219576-50-7 | Reference compound |
| HY-116238 | ROCK-IN-D2 | 1219721-78-4 | Reference compound |
| HY-116239 | Zenarestat | 112733-06-9 | Reference compound |
| HY-116240 | 2′,3′-Dideoxy-5-ethyluridine | 108895-49-4 | Reference compound |
| HY-116241 | L-157012 | 114801-28-4 | Reference compound |
| HY-116242 | Dioctyl adipate | 123-79-5 | Reference compound |
| HY-116245 | Octanophenone | 1674-37-9 | Reference compound |
| HY-116246 | 5(S)-HETE lactone | 127708-42-3 | Reference compound |
| HY-116247 | ST247 | 1356497-91-0 | Reference compound |
| HY-116248 | Ro 41-5253 | 144092-31-9 | Reference compound |
| HY-116250 | Prostaglandin D2-1-glyceryl ester | 309260-52-4 | Reference compound |
| HY-116251 | CID21480113 | 1648-34-6 | Reference compound |
| HY-116252 | (±)-trans-Lamivudine | 131086-22-1 | Reference compound |
| HY-116254 | L-739750 | 160141-08-2 | Reference compound |
| HY-116255 | MS453 | 2059892-29-2 | Reference compound |
| HY-116257 | GSK-7227 | 1067214-81-6 | Reference compound |
| HY-116258 | C16 Ceramide (d16:1,C16:0) | 123065-37-2 | Reference compound |
| HY-116258S | C16 Ceramide-d7 (d16:1,C16:0) | 1840942-13-3 | Isotope-Labeled Compounds |
| HY-116259 | PT-S58 | 1356497-92-1 | Reference compound |
| HY-116262 | SCH 51866 | 167298-74-0 | Reference compound |
| HY-116263 | CATPB | 1322598-09-3 | Reference compound |
| HY-116264 | CatB-IN-1 | 1417737-67-7 | Reference compound |
| HY-116266 | RS 67333 | 160845-95-4 | Reference compound |
| HY-116269 | AZA197 | 1249398-09-1 | Reference compound |
| HY-116270 | DBCO-Maleimide | 1395786-30-7 | ADC Related |
| HY-116271 | Sperabillin C | 111337-84-9 | Natural Products |
| HY-116272 | A51493A | 121245-06-5 | Reference compound |
| HY-116273 | ML299 | 1426916-00-8 | Reference compound |
| HY-116274 | BMS-8 | 1675201-90-7 | Reference compound |
| HY-116277 | Z118332870 | 1223377-83-0 | Reference compound |
| HY-116278 | HJC0149 | 1430330-65-6 | Reference compound |
| HY-116279 | JG-48 | 1627122-26-2 | Reference compound |
| HY-116280 | Aceratioside | 133084-09-0 | Natural Products |
| HY-116281 | ICI D1542 | 147332-48-7 | Reference compound |
| HY-116282 | Dextran sulfate sodium salt (MW 5000) | 9011-18-1 | Biochemical Assay Reagents |
| HY-116282A | Dextran sulfate sodium salt (MW 4500-5500) | 9011-18-1 | Reference compound |
| HY-116282B | Dextran sulfate sodium salt (MW 16000-24000) | 9011-18-1 | Reference compound |
| HY-116282C | Dextran sulfate sodium salt (MW 35000-45000) | 9011-18-1 | Reference compound |
| HY-116282D | Dextran sulfate sodium salt (MW 450000-550000) | 9011-18-1 | Reference compound |
| HY-116282H | Dextran sulfate sodium salt (MW 9000-20000) | 9011-18-1 | Biochemical Assay Reagents |
| HY-116282I | Dextran sulfate sodium salt (MW>500000) | 9011-18-1 | Biochemical Assay Reagents |
| HY-116282J | Dextran sulfate, low sulfate (MW 5000) | 9011-18-1 | Biochemical Assay Reagents |
| HY-116282M | Dextran sulfate, low sulfate (MW 40000) | 9011-18-1 | Biochemical Assay Reagents |
| HY-116282P | Dextran sulfate, high sulfate (MW 5000) | 9011-18-1 | Biochemical Assay Reagents |
| HY-116282W | Dextran sulfate sodium salt (MW 6500-10000) | 9011-18-1 | Biochemical Assay Reagents |
| HY-116283 | 2,3:5,6-Di-O-isopropylidene-L-gulono-1,4-lactone | 7306-64-1 | Biochemical Assay Reagents |
| HY-116284 | Methyl β-D-glucopyranoside | 709-50-2 | Reference compound |
| HY-116284A | Methyl β-D-glucopyranoside (hemihydrate) | 7000-27-3 | Natural Products |
| HY-116285 | n-Octyl β-D-glucopyranoside | 29836-26-8 | Biochemical Assay Reagents |
| HY-116285S | n-Octyl β-D-glucopyranoside-d24 | 869666-57-9 | Isotope-Labeled Compounds |
| HY-116285S1 | 1-O-n-Octyl-β-D-glucopyranoside-d17 | 129522-81-2 | Isotope-Labeled Compounds |
| HY-116290 | Zaragozic acid A | 142561-96-4 | Natural Products |
| HY-116290A | Zaragozic acid A (trisodium) | 144541-82-2 | Reference compound |
| HY-116291 | 4α-Phorbol 12,13-didecanoate | 27536-56-7 | Reference compound |
| HY-116294A | Methoctramine (tetrahydrochloride) | 104807-46-7 | Reference compound |
| HY-116298 | MRS 2500 | 779323-43-2 | Reference compound |
| HY-116301 | CAY10502 | 888320-29-4 | Reference compound |
| HY-116302 | MMP-9-IN-9 | 206549-55-5 | Reference compound |
| HY-116304 | 1G244 | 847928-32-9 | Reference compound |
| HY-116306 | Probestin | 123652-87-9 | Reference compound |
| HY-116307 | 2-Thio-UTP | 35763-29-2 | Reference compound |
| HY-116309 | SDZ 216-525 | 141533-35-9 | Reference compound |
| HY-116312 | 8-CPT-2'-O-Me-cAMP | 510774-50-2 | Reference compound |
| HY-116325 | 3,5,3'-Triiodo-D-thyronine | 5714-08-9 | Reference compound |
| HY-116326 | BayCysLT2 | 712313-33-2 | Reference compound |
| HY-116330 | Hyperforin | 11079-53-1 | Natural Products |
| HY-116330A | Hyperforin (dicyclohexylammonium salt) | 238074-03-8 | Natural Products |
| HY-116330AR | Hyperforin (dicyclohexylammonium salt) (Standard) | 238074-03-8 | Reference Standards |
| HY-116349 | Bromodomain IN-1 | 1914120-48-1 | Reference compound |
| HY-116364 | AZT triphosphate | 92586-35-1 | Reference compound |
| HY-116364A | AZT triphosphate (TEA) | Reference compound | |
| HY-116364B | AZT triphosphate (tetraammonium) | 106060-92-8 | Reference compound |
| HY-116364C | AZT triphosphate (sodium) | 149022-21-9 | Biochemical Assay Reagents |
| HY-116374 | Glycolithocholic acid | 474-74-8 | Reference compound |
| HY-116374A | Glycolithocholic acid (sodium) | 24404-83-9 | Reference compound |
| HY-116374S | Glycolithocholic acid-d4 | 2044276-16-4 | Isotope-Labeled Compounds |
| HY-116377 | DU-14 | 186303-55-9 | Reference compound |
| HY-116379 | RS-100329 | 232953-52-5 | Reference compound |
| HY-116380 | CB2 receptor antagonist 5 | 1314230-69-7 | Reference compound |
| HY-116386 | GSK334429 | 799557-57-6 | Reference compound |
| HY-116387 | WR99210 | 47326-86-3 | Reference compound |
| HY-116387A | WR99210 (hydrochloride) | 30711-93-4 | Reference compound |
| HY-116392A | (−)-L-threo-PDMP (hydrochloride) | 161491-04-9 | Reference compound |
| HY-116392B | DL-threo-PDMP (hydrochloride) | 80938-69-8 | Reference compound |
| HY-116392D | PDMP (hydrochloride) | 73257-80-4 | Reference compound |
| HY-116392E | D-threo-PDMP | 109836-82-0 | Reference compound |
| HY-116392F | D-threo-PDMP (hydrochloride) | 139889-62-6 | Reference compound |
| HY-116392G | D,L-erythro-PDMP | 109760-77-2 | Reference compound |
| HY-116392H | D,L-erythro-PDMP (hydrochloride) | 80943-40-4 | Reference compound |
| HY-116399 | MMP-2/MMP-9-IN-1 | 193807-58-8 | Reference compound |
| HY-116400 | BN 50341 | 107550-66-3 | Reference compound |
| HY-116408 | Propiverine | 60569-19-9 | Reference compound |
| HY-116408A | Propiverine (hydrochloride) | 54556-98-8 | Reference compound |
| HY-116408AR | Propiverine (hydrochloride) (Standard) | 54556-98-8 | Reference Standards |
| HY-116408AS | Propiverine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-116418 | Virodhamine | 287937-12-6 | Reference compound |
| HY-116420 | ROCK2-IN-8 | 681173-76-2 | Reference compound |
| HY-116422 | N,N-Dimethyl sphinganine | 17267-46-8 | Natural Products |
| HY-116423 | JH295 | 1311143-71-1 | Reference compound |
| HY-116423A | JH295 (hydrate) | 2714087-26-8 | Reference compound |
| HY-116424 | DYn-2 | 1354630-46-8 | Reference compound |
| HY-116425 | N-1-Naphthylphthalamic acid | 132-66-1 | Reference compound |
| HY-116425R | N-1-Naphthylphthalamic acid (Standard) | 132-66-1 | Reference Standards |
| HY-116426 | IDT | 18138-19-7 | Reference compound |
| HY-116427 | Propargyl-PEG4-thiol | 1347750-80-4 | ADC Related |
| HY-116429 | Maresin 1 | 1268720-28-0 | Reference compound |
| HY-116429A | 7(S)-Maresin 1 | 1268720-66-6 | Reference compound |
| HY-116429S | Maresin 1-d5 | Isotope-Labeled Compounds | |
| HY-116431 | I-BOP | 128719-90-4 | Reference compound |
| HY-116432 | Hancolupenone | 132746-04-4 | Natural Products |
| HY-116433 | Nequinate | 13997-19-8 | Reference compound |
| HY-116433R | Nequinate (Standard) | 13997-19-8 | Reference Standards |
| HY-116434 | LY 189332 | 123215-05-4 | Reference compound |
| HY-116436 | Clathrodin | 135383-64-1 | Reference compound |
| HY-116437 | Selatinib | 1275595-86-2 | Reference compound |
| HY-116439 | Diisononyl phthalate | 28553-12-0 | Reference compound |
| HY-116441 | 4-Hydroxy-3-methoxyamphetamine (hydrochloride) | 13062-61-8 | Reference compound |
| HY-116442 | Azapropazone | 13539-59-8 | Reference compound |
| HY-116442R | Azapropazone (Standard) | 13539-59-8 | Reference Standards |
| HY-116443 | 2-Amino-1-phenylbutane (hydrochloride) | 20735-15-3 | Reference compound |
| HY-116444 | 16(S)-HETE | 183509-23-1 | Reference compound |
| HY-116444A | 16-HETE | 128914-46-5 | Reference compound |
| HY-116445 | UNC9975 | 1354030-19-5 | Reference compound |
| HY-116446 | Pironetin | 151519-02-7 | Reference compound |
| HY-116447 | Antitumor agent-159 | 1611446-66-2 | Reference compound |
| HY-116448 | Metaflumizone | 139968-49-3 | Reference compound |
| HY-116448R | Metaflumizone (Standard) | 139968-49-3 | Reference Standards |
| HY-116448S | Metaflumizone-d4 | Isotope-Labeled Compounds | |
| HY-116450 | TISCH | 131615-52-6 | Reference compound |
| HY-116451 | PF-04859989 (hydrochloride) | 177943-33-8 | Reference compound |
| HY-116452 | YLT192 | 1246566-47-1 | Reference compound |
| HY-116453 | RO5527239 | 1354812-99-9 | Reference compound |
| HY-116454 | GSK5750 | 1312345-89-3 | Reference compound |
| HY-116455 | BRD-9526 | 1446352-30-2 | Reference compound |
| HY-116456 | 25T2-NBOMe (hydrochloride) | 1539266-51-7 | Reference compound |
| HY-116457 | Propanidid | 1421-14-3 | Reference compound |
| HY-116459 | trans-Cevimeline (hydrochloride) | 107220-29-1 | Reference compound |
| HY-116460 | N'-(5-Chloro-2-hydroxyphenyl)-N-octylpropanediamide | 1298023-69-4 | Reference compound |
| HY-116461 | ML-184 | 794572-10-4 | Reference compound |
| HY-116462 | ONO-EI-601 | 155023-59-9 | Reference compound |
| HY-116463 | E1R | 1301211-78-8 | Reference compound |
| HY-116463A | (2R,3S)-E1R | 1424832-60-9 | Reference compound |
| HY-116463B | (2S,3S)-E1R | 1424832-57-4 | Reference compound |
| HY-116463C | (2R,3R)-E1R | 1400888-63-2 | Reference compound |
| HY-116463D | (Rac)-E1R | 787623-60-3 | Reference compound |
| HY-116464 | 4-APB (hydrochloride) | 286834-82-0 | Reference compound |
| HY-116468 | PPARγ agonist 11 | 1143573-33-4 | Reference compound |
| HY-116469 | ZP7 | 1188890-60-9 | Reference compound |
| HY-116472 | alpha-RA-F | 1260239-23-3 | Reference compound |
| HY-116473 | CFM-1 | 1380448-60-1 | Reference compound |
| HY-116474 | Viridicatol | 14484-44-7 | Natural Products |
| HY-116474R | Viridicatol (Standard) | 14484-44-7 | Reference Standards |
| HY-116476 | Risotilide | 120688-08-6 | Reference compound |
| HY-116477 | URB937 | 1357160-72-5 | Reference compound |
| HY-116478 | L-3373 | 1951-26-4 | Reference compound |
| HY-116479 | Citromycetin | 478-60-4 | Natural Products |
| HY-116480 | LY593093 | 1108748-12-4 | Reference compound |
| HY-116482 | Desmedipham | 13684-56-5 | Reference compound |
| HY-116482R | Desmedipham (Standard) | 13684-56-5 | Reference Standards |
| HY-116483 | MPX-007 | 1688685-29-1 | Reference compound |
| HY-116486 | Aureusimine B | 170713-71-0 | Natural Products |
| HY-116487 | R-18893 | 147362-54-7 | Reference compound |
| HY-116489 | Pyribenzoxim | 168088-61-7 | Reference compound |
| HY-116490 | Guvacoline (hydrobromide) | 17210-51-4 | Natural Products |
| HY-116494 | ML753286 | 1699720-89-2 | Reference compound |
| HY-116494A | (6R)-ML753286 | Reference compound | |
| HY-116495 | (-)-OSU6162 | 146798-66-5 | Reference compound |
| HY-116496 | 7-Methyladenine | 935-69-3 | Reference compound |
| HY-116497 | PH11 | 1627843-95-1 | Reference compound |
| HY-116498 | Penigequinolone A | 180045-91-4 | Reference compound |
| HY-116500A | AH-1058 | 228123-15-7 | Reference compound |
| HY-116501 | VPC-14449 | 1621375-32-3 | Reference compound |
| HY-116503 | Methyl 3-hydroxytridecanoate | 150024-70-7 | Natural Products |
| HY-116504 | WB-308 | 1373764-87-4 | Reference compound |
| HY-116505 | JAK1-IN-4 | 2091134-35-7 | Reference compound |
| HY-116506 | Bigelovin | 3668-14-2 | Natural Products |
| HY-116507 | AZD0328 | 220099-91-2 | Reference compound |
| HY-116508 | MK 319 | 1462383-00-1 | Reference compound |
| HY-116511 | Benzoximate | 29104-30-1 | Reference compound |
| HY-116512 | Linalyl cinnamate | 78-37-5 | Reference compound |
| HY-116513 | Adrenochrome | 54-06-8 | Reference compound |
| HY-116514 | (S)-(−)-Perillyl alcohol | 18457-55-1 | Natural Products |
| HY-116514R | (S)-(?)-Perillyl alcohol (Standard) | 18457-55-1 | Reference Standards |
| HY-116518 | Piperafizine A | 130603-59-7 | Reference compound |
| HY-116519 | LY173013 | 126165-78-4 | Reference compound |
| HY-116521 | SR2595 | 1415252-61-7 | Reference compound |
| HY-116522 | AR420626 | 1798310-55-0 | Reference compound |
| HY-116524 | PF-04781340 | 1648726-56-0 | Reference compound |
| HY-116525 | Octaethylporphyrin | 2683-82-1 | Reference compound |
| HY-116528 | GCA-186 | 149950-61-8 | Reference compound |
| HY-116529 | Lamellarin E | 115982-19-9 | Natural Products |
| HY-116530 | 9-Cyclopentyladenine (monomethanesulfonate) | 189639-09-6 | Reference compound |
| HY-116532 | YCW-E11 | 1519043-97-0 | Reference compound |
| HY-116533 | RMM-46 | 1307896-46-3 | Reference compound |
| HY-116535 | D-threo-PPMP (hydrochloride) | 139889-65-9 | Reference compound |
| HY-116535A | DL-threo-PPMP (hydrochloride) | 139974-41-7 | Reference compound |
| HY-116535B | DL-threo-PPMP | 149022-18-4 | Reference compound |
| HY-116535C | D-threo-PPMP | 139889-53-5 | Reference compound |
| HY-116536 | N-3-Oxo-tetradecanoyl-L-homoserine lactone | 177158-19-9 | Reference compound |
| HY-116537 | A76889 | 134805-77-9 | Reference compound |
| HY-116538 | (10E,12Z)-Octadeca-10,12-dienoic acid | 2420-56-6 | Biochemical Assay Reagents |
| HY-116540 | L 858051 | 110452-75-0 | Reference compound |
| HY-116541 | Acibenzolar-S-methyl | 135158-54-2 | Reference compound |
| HY-116541R | Acibenzolar-S-methyl (Standard) | 135158-54-2 | Reference Standards |
| HY-116543 | ST362 | 1323359-80-3 | Reference compound |
| HY-116544 | Octan-2-yl 2-cyanoacrylate | 133978-15-1 | Reference compound |
| HY-116546 | Sch 40853 | 129672-23-7 | Reference compound |
| HY-116546S | Sch 40853-d4 | Isotope-Labeled Compounds | |
| HY-116547 | Methylenephenanthrene | 203-64-5 | Reference compound |
| HY-116548 | Nitracaine | 1648893-21-3 | Reference compound |
| HY-116549 | Prostaglandin F2α alcohol | 13261-27-3 | Reference compound |
| HY-116550 | Piroheptine (hydrochloride) | 16378-22-6 | Reference compound |
| HY-116552 | KAR425 | 1809050-49-4 | Reference compound |
| HY-116553 | FzM1 | 1680196-54-6 | Reference compound |
| HY-116554 | GYKI-46903 | 142999-59-5 | Reference compound |
| HY-116556 | Rilmakalim | 132014-21-2 | Reference compound |
| HY-116557 | JCP-265 | 140652-99-9 | Reference compound |
| HY-116559 | TIBI | 1196457-06-3 | Reference compound |
| HY-116560 | ONO-8809 | 123288-47-1 | Reference compound |
| HY-116561 | Adamantylmethamphetamine (hydrochloride) | 19835-42-8 | Reference compound |
| HY-116563 | PI3Kα-IN-24 | 1350960-66-5 | Reference compound |
| HY-116564 | Lotilaner | 1369852-71-0 | Reference compound |
| HY-116565 | Usmarapride | 1428862-33-2 | Reference compound |
| HY-116565A | Usmarapride (free base) | 1428862-32-1 | Reference compound |
| HY-116567 | OPC-51803 | 192514-54-8 | Reference compound |
| HY-116567A | (S)-OPC-51803 | 192514-57-1 | Reference compound |
| HY-116568 | Prothioconazole | 178928-70-6 | Reference compound |
| HY-116568R | Prothioconazole (Standard) | 178928-70-6 | Reference Standards |
| HY-116569 | VU0455691 | 1392443-41-2 | Reference compound |
| HY-116571 | RU44790 | 110012-78-7 | Reference compound |
| HY-116572 | TASIN-1 (hydrochloride) | 1678515-13-3 | Reference compound |
| HY-116572A | TASIN-1 | 792927-06-1 | Reference compound |
| HY-116574 | Leiokinine A | 132587-63-4 | Natural Products |
| HY-116576 | LY219057 | 150351-93-2 | Reference compound |
| HY-116578 | Metopimazine | 14008-44-7 | Reference compound |
| HY-116578S | Metopimazine-d6 | 1215315-86-8 | Isotope-Labeled Compounds |
| HY-116579 | BMS-212122 | 194213-64-4 | Reference compound |
| HY-116580 | AZD-3289 | 1227163-49-6 | Reference compound |
| HY-116582 | 8-Nitroguanine | 168701-80-2 | Reference compound |
| HY-116583 | Resorufin butyrate | 15585-42-9 | Dye Reagents |
| HY-116585 | C6 D-Threo Ceramide (d18:1/6:0) | 189894-79-9 | Reference compound |
| HY-116586 | AF710B | Reference compound | |
| HY-116586A | (Rac)-AF710B | 1235733-73-9 | Reference compound |
| HY-116587 | Halocarban | 369-77-7 | Reference compound |
| HY-116588 | FT001 | 1778655-51-8 | Reference compound |
| HY-116590 | (±)-Glaziovine | 17127-48-9 | Natural Products |
| HY-116591 | 8-Iso-15-keto prostaglandin F2β | 1621482-36-7 | Reference compound |
| HY-116592 | SOMCL-863 | 1452310-87-0 | Reference compound |
| HY-116594 | OPC-14523 (free base) | 145969-30-8 | Reference compound |
| HY-116594A | OPC-14523 (hydrochloride) | 145969-31-9 | Reference compound |
| HY-116597 | L-783483 | 194608-77-0 | Reference compound |
| HY-116598 | Lanopepden (mesylate) | 1441390-17-5 | Reference compound |
| HY-116600 | AL-4114 | 139911-05-0 | Reference compound |
| HY-116601 | 6-Hydroxywarfarin | 17834-02-5 | Reference compound |
| HY-116603 | SB-236057 | 180083-49-2 | Reference compound |
| HY-116604 | RLX | 4425-23-4 | Reference compound |
| HY-116605 | GSK926 | 1346704-13-9 | Reference compound |
| HY-116606 | LY108742 | 150196-69-3 | Reference compound |
| HY-116607 | BAY38-7690 | 246872-58-2 | Reference compound |
| HY-116609 | C6 L-threo Ceramide | 189894-80-2 | Reference compound |
| HY-116610 | L 748780 | 168086-64-4 | Reference compound |
| HY-116613 | FR-181877 | 172936-99-1 | Reference compound |
| HY-116615 | Methyl 2-hydroxytetracosanoate | 2433-95-6 | Biochemical Assay Reagents |
| HY-116617 | 15-Keto Travoprost | 404830-45-1 | Reference compound |
| HY-116617R | 15-Keto Travoprost (Standard) | 404830-45-1 | Reference Standards |
| HY-116619 | (E/Z)-Dacinostat | 591207-53-3 | Reference compound |
| HY-116620 | Benzomalvin C | 157047-98-8 | Reference compound |
| HY-116621 | NU-7163 | 503468-03-9 | Reference compound |
| HY-116622 | α5IA | 215874-86-5 | Reference compound |
| HY-116623 | A-123189 | 255713-53-2 | Reference compound |
| HY-116624 | MAZ51 | 163655-37-6 | Reference compound |
| HY-116625 | PF-04628935 | 1383719-97-8 | Reference compound |
| HY-116626 | SM-7368 | 380623-76-7 | Reference compound |
| HY-116628 | (R)-ADR 882 | 138559-57-6 | Reference compound |
| HY-116629 | Dactylyne | 55306-12-2 | Reference compound |
| HY-116632 | Methyl 3-hydroxyhexanoate | 21188-58-9 | Natural Products |
| HY-116633 | BCM-599 | 1820763-99-2 | Reference compound |
| HY-116637 | Tetrahydromagnolol | 20601-85-8 | Natural Products |
| HY-116638 | AHR-5333 | 60284-71-1 | Reference compound |
| HY-116638A | AHR-5333 (mandelate) | 128766-12-1 | Reference compound |
| HY-116639 | Javanicin | 476-45-9 | Natural Products |
| HY-116643 | SU 10603 | 786-97-0 | Reference compound |
| HY-116649 | CB1 antagonist 2 | 614726-85-1 | Reference compound |
| HY-116653 | Flurtamone | 96525-23-4 | Reference compound |
| HY-116653R | Flurtamone (Standard) | 96525-23-4 | Reference Standards |
| HY-116654 | 2-Methyl-4'-(methylthio)-2-morpholinopropiophenone | 71868-10-5 | Reference compound |
| HY-116655 | Hydroxy-PEG1-acid | 89211-34-7 | ADC Related |
| HY-116655A | Hydroxy-PEG1-acid (sodium salt) | 2855229-28-4 | Reference compound |
| HY-116656 | Oximino oxamyl | 30558-43-1 | Reference compound |
| HY-116658 | Leontine | 6783-60-4 | Natural Products |
| HY-116661 | Cannabigerovarin | 55824-11-8 | Reference compound |
| HY-116662 | CL 232468 | 96555-65-6 | Reference compound |
| HY-116663 | (±)20-HDHA | 90906-41-5 | Natural Products |
| HY-116664 | DPQZ | 1431362-93-4 | Reference compound |
| HY-116666S | (Rac)-Etomidate acid-d5 | Isotope-Labeled Compounds | |
| HY-116671 | Folipastatin | 139959-71-0 | Natural Products |
| HY-116673 | TTK21 | 709676-56-2 | Reference compound |
| HY-116675 | Sulmazole | 73384-60-8 | Reference compound |
| HY-116677 | Tris(benzyltriazolylmethyl)amine | 510758-28-8 | Reference compound |
| HY-116678 | Cloricromen | 68206-94-0 | Reference compound |
| HY-116678A | Cloricromen (hydrochloride) | 74697-28-2 | Reference compound |
| HY-116679 | 17-trifluoromethylphenyl trinor Prostaglandin F2α | 221246-34-0 | Reference compound |
| HY-116680 | LY53857 | 60634-51-7 | Reference compound |
| HY-116681 | Aflavarin | 144429-67-4 | Natural Products |
| HY-116682 | GKA-71 | 863504-35-2 | Reference compound |
| HY-116683 | 116-9e | 831217-43-7 | Reference compound |
| HY-116685 | AF-CX 1325 | 88708-96-7 | Reference compound |
| HY-116686 | Inz-1 | 897776-15-7 | Reference compound |
| HY-116687 | 7-Aminoflunitrazepam | 34084-50-9 | Reference compound |
| HY-116687S | 7-Aminoflunitrazepam-d7 | Isotope-Labeled Compounds | |
| HY-116688 | 2-Hydroxy-4-(methylthio)butyric acid | 583-91-5 | Natural Products |
| HY-116690 | Daimuron | 42609-52-9 | Reference compound |
| HY-116690R | Daimuron (Standard) | 42609-52-9 | Reference Standards |
| HY-116691 | Hydrocortisone aceponate | 74050-20-7 | Reference compound |
| HY-116691R | Hydrocortisone aceponate (Standard) | 74050-20-7 | Reference Standards |
| HY-116692 | Apoptosis inducer 34 | 582314-48-5 | Reference compound |
| HY-116693 | DprE1-IN-12 | 634167-64-9 | Reference compound |
| HY-116694 | Digallic acid | 536-08-3 | Natural Products |
| HY-116699 | CP-868388 (free base) | 702681-67-2 | Reference compound |
| HY-116700 | Hinnuliquinone | 78860-37-4 | Natural Products |
| HY-116701 | A 274 | 77273-75-7 | Reference compound |
| HY-116702 | Flufiprole | 704886-18-0 | Reference compound |
| HY-116703 | L-erythro-Dihydrosphingosine | 6036-76-6 | Natural Products |
| HY-116704 | 11-Deoxyprostaglandin F2α | 37786-06-4 | Reference compound |
| HY-116705 | 2-Deoxy-2-fluoro-L-fucose | 70763-62-1 | Reference compound |
| HY-116706 | Lenacil | 2164-08-1 | Reference compound |
| HY-116706R | Lenacil (Standard) | 2164-08-1 | Reference Standards |
| HY-116708 | DCE_254 | 673443-80-6 | Reference compound |
| HY-116710 | 3-Decyl-5,5'-diphenyl-2-thioxo-4-imidazolidinone | 875014-22-5 | Reference compound |
| HY-116711 | 11-cis-Retinal | 564-87-4 | Natural Products |
| HY-116713 | PfDHODH-IN-3 | 92872-51-0 | Reference compound |
| HY-116714 | Cannabigerorcinic acid | 69734-83-4 | Reference compound |
| HY-116716 | PIN1 inhibitor API-1 | 680622-70-2 | Reference compound |
| HY-116722 | (2E)-4-Hydroperoxy-2-nonenal | 7439-43-2 | Reference compound |
| HY-116723 | CFMMC | 1190598-60-7 | Reference compound |
| HY-116724 | Robenidine | 25875-51-8 | Reference compound |
| HY-116726 | Crambene | 6071-81-4 | Reference compound |
| HY-116727 | RU 24926 | 65934-61-4 | Reference compound |
| HY-116730 | CHS-111 | 886755-63-1 | Reference compound |
| HY-116731 | 2-Hydroxydodecanoic acid | 2984-55-6 | Biochemical Assay Reagents |
| HY-116732 | GW-678248 | 329939-64-2 | Reference compound |
| HY-116733 | Tafluprost ethyl ester | 209860-89-9 | Reference compound |
| HY-116736 | BRD7539 | 2057420-00-3 | Reference compound |
| HY-116738 | Trimecaine | 616-68-2 | Reference compound |
| HY-116739 | 13(E)-Docosenoic acid | 506-33-2 | Natural Products |
| HY-116739R | 13(E)-Docosenoic acid (Standard) | 506-33-2 | Reference Standards |
| HY-116741 | Benzofenap | 82692-44-2 | Reference compound |
| HY-116741R | Benzofenap (Standard) | 82692-44-2 | Reference Standards |
| HY-116746 | Clopimozide | 53179-12-7 | Reference compound |
| HY-116748 | (±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane | 257641-01-3 | Reference compound |
| HY-116749 | Ethaselen | 217798-39-5 | Reference compound |
| HY-116750 | 6-Hydroxykaempferol | 4324-55-4 | Natural Products |
| HY-116752 | Dinor-12-oxo phytodienoic acid | 197247-23-7 | Natural Products |
| HY-116752S | Dinor-12-oxo phytodienoic acid-d5 | Isotope-Labeled Compounds | |
| HY-116753 | (-)Clausenamide | 201529-58-0 | Natural Products |
| HY-116754 | Methyl 2-hydroxydecanoate | 71271-24-4 | Biochemical Assay Reagents |
| HY-116755 | Tiropramide | 55837-29-1 | Reference compound |
| HY-116755S | Tiropramide-d5 | Isotope-Labeled Compounds | |
| HY-116757 | (±)-α-CMBHC | 7083-09-2 | Reference compound |
| HY-116758 | 16,16-Dimethyl prostaglandin A1 | 41692-24-4 | Reference compound |
| HY-116759 | VU0405601 | 712325-30-9 | Reference compound |
| HY-116761 | GSK467 | 1628332-52-4 | Reference compound |
| HY-116762 | N-butyryl-L-Homocysteine thiolactone | 202284-85-3 | Biochemical Assay Reagents |
| HY-116763 | COX-2/5-LOX-IN-4 | 443919-96-8 | Reference compound |
| HY-116765 | MAO-B-IN-35 | 1619884-75-1 | Reference compound |
| HY-116766 | ACEA1011 | 153504-72-4 | Reference compound |
| HY-116767 | BLT-1 | 321673-30-7 | Reference compound |
| HY-116768 | 10(E),12(Z)-Conjugated linoleic acid methyl ester | 21870-97-3 | Reference compound |
| HY-116770 | PFM01 | 1558598-41-6 | Reference compound |
| HY-116771 | CL 316243 (free acid) | 183720-02-7 | Reference compound |
| HY-116771A | CL 316243 | 138908-40-4 | Reference compound |
| HY-116772 | Cyanox CY 1790 | 40601-76-1 | Reference compound |
| HY-116773 | A-69024 | 58939-37-0 | Reference compound |
| HY-116776 | Hexadecatetraenoic acid | 29259-52-7 | Reference compound |
| HY-116776S | Hexadecatetraenoic acid-d5 | 2408811-79-8 | Isotope-Labeled Compounds |
| HY-116777 | Impromidine | 55273-05-7 | Reference compound |
| HY-116777A | Impromidine (hydrochloride) | 65573-02-6 | Reference compound |
| HY-116778 | Prostaglandin G2 | 51982-36-6 | Natural Products |
| HY-116780A | Prothipendyl (hydrochloride) | 1225-65-6 | Reference compound |
| HY-116780S | Prothipendyl-d6 (hydrochloride) | 1346604-67-8 | Isotope-Labeled Compounds |
| HY-116781 | PD 114595 | 94636-28-9 | Reference compound |
| HY-116785 | BRD32048 | 433694-46-3 | Reference compound |
| HY-116786 | 11-Hydroxycanthin-6-one | 75969-83-4 | Natural Products |
| HY-116787 | 5-Hydroxythiabendazole | 948-71-0 | Reference compound |
| HY-116787R | 5-Hydroxythiabendazole (Standard) | 948-71-0 | Reference Standards |
| HY-116788 | Lipofermata | 297180-15-5 | Reference compound |
| HY-116790 | (-)-Penbutolol | 38363-40-5 | Reference compound |
| HY-116790A | (+)-Penbutolol | 38363-41-6 | Reference compound |
| HY-116790B | (±)-Penbutolol | 36507-48-9 | Reference compound |
| HY-116790BS | (±)-Penbutolol-d9 | 1346747-40-7 | Isotope-Labeled Compounds |
| HY-116790BSA | (±)-Penbutolol-d9 (hydrochloride) | 1346605-01-3 | Isotope-Labeled Compounds |
| HY-116791 | Calanolide A | 142632-32-4 | Natural Products |
| HY-116792 | Phenoxyacetone | 621-87-4 | Natural Products |
| HY-116793 | Dimepiperate | 61432-55-1 | Reference compound |
| HY-116793R | Dimepiperate (Standard) | 61432-55-1 | Reference Standards |
| HY-116794 | SF5 | 34634-22-5 | Reference compound |
| HY-116795 | 5-Methoxy-α-ethyltryptamine | 4765-10-0 | Reference compound |
| HY-116797 | MS15203 | 73912-52-4 | Reference compound |
| HY-116799 | NSC 145669 | 31785-60-1 | Reference compound |
| HY-116800 | FR194921 | 202646-80-8 | Reference compound |
| HY-116802 | Bromobutide | 74712-19-9 | Reference compound |
| HY-116804 | ZLD1039 | 1826865-46-6 | Reference compound |
| HY-116806 | AF-2785 | 252025-48-2 | Reference compound |
| HY-116807 | Dihydrolipoic Acid | 462-20-4 | Reference compound |
| HY-116807R | Dihydrolipoic Acid (Standard) | 462-20-4 | Reference Standards |
| HY-116808 | TPN729 | 936951-20-1 | Reference compound |
| HY-116808B | TPN729MA | 1422955-52-9 | Reference compound |
| HY-116809 | Lopirazepam | 42863-81-0 | Reference compound |
| HY-116812 | Sclerotigenin | 65641-84-1 | Reference compound |
| HY-116813 | ZK 93423 | 83910-44-5 | Reference compound |
| HY-116814 | ML401 | 1597489-14-9 | Reference compound |
| HY-116815 | Lalistat 1 | 501104-16-1 | Reference compound |
| HY-116818 | Crebinostat | 1092061-61-4 | Reference compound |
| HY-116819 | VU0453379 | 1638646-27-1 | Reference compound |
| HY-116819A | VU0453379 (hydrochloride) | Reference compound | |
| HY-116820 | OS-3-106 | 1580000-17-4 | Reference compound |
| HY-116822 | SSR 146977 | 264618-44-2 | Reference compound |
| HY-116825 | Jalapinolic acid | 502-75-0 | Reference compound |
| HY-116826 | Buramate | 4663-83-6 | Reference compound |
| HY-116828 | ARI-3531 | 1432499-51-8 | Reference compound |
| HY-116830 | BRD0705 | 2056261-41-5 | Reference compound |
| HY-116830A | (Rac)-BRD0705 | 1597440-03-3 | Reference compound |
| HY-116830B | BRD5648 | 2056261-42-6 | Reference compound |
| HY-116831 | 4′-Dihydrophaseic acid | 41756-77-8 | Natural Products |
| HY-116832 | Retrorsine N-oxide | 15503-86-3 | Natural Products |
| HY-116833 | 4-Chloro-3,5-dimethylphenoxyacetic acid | 19545-95-0 | Reference compound |
| HY-116834 | Vat Blue 4B | 2475-31-2 | Biochemical Assay Reagents |
| HY-116835 | BI-6901 | 2040401-92-9 | Reference compound |
| HY-116836 | p38α inhibitor 7 | 668981-02-0 | Reference compound |
| HY-116837 | LUF5831 | 333963-57-8 | Reference compound |
| HY-116838 | TAM-16 | 2030241-59-7 | Reference compound |
| HY-116843 | (15S)-15-Methylprostaglandin E2 | 35700-27-7 | Reference compound |
| HY-116844 | Glymidine | 339-44-6 | Reference compound |
| HY-116845 | TG3-95-1 | 301322-12-3 | Reference compound |
| HY-116849 | LY 181984 | 3955-50-8 | Reference compound |
| HY-116850 | Oxagrelate | 56611-65-5 | Reference compound |
| HY-116852 | Thiocolchicine | 2730-71-4 | Reference compound |
| HY-116852S | Thiocolchicine-d3 | 1314417-95-2 | Isotope-Labeled Compounds |
| HY-116854 | NNC 92-1687 | 22903-37-3 | Reference compound |
| HY-116855 | TASP0433864 | 1431980-60-7 | Reference compound |
| HY-116856 | SRPKIN-1 | 2089226-94-6 | Reference compound |
| HY-116857 | Ditalimfos | 5131-24-8 | Reference compound |
| HY-116857R | Ditalimfos (Standard) | 5131-24-8 | Reference Standards |
| HY-116859 | Ro 14-7437 | 78756-03-3 | Reference compound |
| HY-116862 | Dibenzylfluorescein | 97744-44-0 | Dye Reagents |
| HY-116863 | KKL-40 | 865285-47-8 | Reference compound |
| HY-116863R | KKL-40 (Standard) | 865285-47-8 | Reference Standards |
| HY-116865 | Equilenin | 517-09-9 | Natural Products |
| HY-116865S | Equilenin-4,16,16-d3 | 56588-54-6 | Isotope-Labeled Compounds |
| HY-116866 | Sclerotiorin | 549-23-5 | Natural Products |
| HY-116868 | Anecortave acetate | 7753-60-8 | Reference compound |
| HY-116870 | Vamidothion | 2275-23-2 | Reference compound |
| HY-116871 | YKL-1-116 | 1957202-71-9 | Reference compound |
| HY-116872 | MAC13772 | 4871-40-3 | Reference compound |
| HY-116874 | SKF 83822 | 74115-08-5 | Reference compound |
| HY-116877 | C2 Ceramide (d14:1/2:0) | 2097561-20-9 | Reference compound |
| HY-116878 | 25B-NBOH (hydrochloride) | 1539266-16-4 | Reference compound |
| HY-116879 | 4-Oxo-2-Nonenal Alkyne | 1680193-58-1 | Reference compound |
| HY-116881 | SCH 57790 | 221660-80-6 | Reference compound |
| HY-116883 | Endothion | 2778-04-3 | Reference compound |
| HY-116885 | Thunalbene | 220862-05-5 | Natural Products |
| HY-116887 | N6-Methyladenine | 443-72-1 | Reference compound |
| HY-116888 | BFE-55 | 21151-91-7 | Reference compound |
| HY-116889 | 15-Keto latanoprost acid | 369585-22-8 | Reference compound |
| HY-116890 | CRTh2 antagonist 4 | 916046-55-4 | Reference compound |
| HY-116893 | Diethyl bipy55'DC | 1762-46-5 | Reference compound |
| HY-116894 | Rotundifuran | 50656-65-0 | Natural Products |
| HY-116895 | JJH260 | 1831135-30-8 | Reference compound |
| HY-116896 | LY117018 | 63676-25-5 | Reference compound |
| HY-116896A | LY117018 (TFA) | 2390041-98-0 | Reference compound |
| HY-116897 | G202-0362 | 868883-12-9 | Reference compound |
| HY-116899 | Nonaethylene glycol | 3386-18-3 | Reference compound |
| HY-116900 | Karsil | 2533-89-3 | Reference compound |
| HY-116903 | Pfn1-IN-2 | 919010-22-3 | Reference compound |
| HY-116904 | Anticancer agent 253 | 1983924-33-9 | Reference compound |
| HY-116908 | SB-272183 | 216058-27-4 | Reference compound |
| HY-116909 | O-Methylsterigmatocystin | 17878-69-2 | Natural Products |
| HY-116910 | CPP-115 | 640897-20-7 | Reference compound |
| HY-116913 | Moxicoumone | 17692-56-7 | Reference compound |
| HY-116915 | Synstab A | 257612-36-5 | Reference compound |
| HY-116916 | Acetophenazine | 2751-68-0 | Reference compound |
| HY-116916S | Acetophenazine-d4 (dimaleate) | Isotope-Labeled Compounds | |
| HY-116917 | G-9791 | 1926204-95-6 | Reference compound |
| HY-116918 | N,N-Diphenylacetamide | 519-87-9 | Reference compound |
| HY-116919 | MLS000536924 | 511306-37-9 | Reference compound |
| HY-116920 | Alyssin | 646-23-1 | Natural Products |
| HY-116920A | (R)-Alyssin | 167963-06-6 | Reference compound |
| HY-116920B | (S)-Alyssin | 167963-04-4 | Reference compound |
| HY-116923 | p18SMI-21 | 20535-76-6 | Reference compound |
| HY-116924 | 1,3-Bis-aminooxy propane | 98627-69-1 | Reference compound |
| HY-116925 | L-767679 | 182198-53-4 | Reference compound |
| HY-116926 | Deoxynybomycin | 27259-98-9 | Reference compound |
| HY-116927 | KW-7158 | 214764-26-8 | Reference compound |
| HY-116930 | S-20928 | 152302-33-5 | Reference compound |
| HY-116931 | Kelletinin I | 87697-99-2 | Natural Products |
| HY-116933 | Murrayanol | 144525-81-5 | Natural Products |
| HY-116934 | 5-Pentadecylresorcinol | 3158-56-3 | Natural Products |
| HY-116934R | 5-Pentadecylresorcinol (Standard) | 3158-56-3 | Reference Standards |
| HY-116938 | Farnesiferol C | 512-17-4 | Reference compound |
| HY-116939 | (E)-Broparestrol | 22393-62-0 | Reference compound |
| HY-116940 | Sm4 | 365542-77-4 | Reference compound |
| HY-116941 | A-381393 | 726174-00-1 | Reference compound |
| HY-116942 | 2002-H20 | 351520-91-7 | Reference compound |
| HY-116943 | MTC420 | 2088930-66-7 | Reference compound |
| HY-116945 | Diphenamid | 957-51-7 | Reference compound |
| HY-116946 | Glucokinase activator 6 | 480463-02-3 | Reference compound |
| HY-116947 | COX-2-IN-5 | 416901-58-1 | Reference compound |
| HY-116948 | Azo-mustard | 4213-40-5 | Reference compound |
| HY-116952 | Xylosucrose | 512-66-3 | Biochemical Assay Reagents |
| HY-116953 | Lipoxin B4 | 98049-69-5 | Reference compound |
| HY-116954 | Metribuzin | 21087-64-9 | Reference compound |
| HY-116954R | Metribuzin (Standard) | 21087-64-9 | Reference Standards |
| HY-116955 | Palmitoleoyl chloride | 40426-22-0 | Reference compound |
| HY-116956 | D-Erythrose | 583-50-6 | Biochemical Assay Reagents |
| HY-116956A | L-Erythrose (solution) (70% in water) | 533-49-3 | Biochemical Assay Reagents |
| HY-116956S | D-Erythrose-1-13C | 70849-19-3 | Isotope-Labeled Compounds |
| HY-116956S1 | D-Erythrose-2-13C | 83434-88-2 | Isotope-Labeled Compounds |
| HY-116956S2 | D-Erythrose-3-13C | Isotope-Labeled Compounds | |
| HY-116956S3 | D-Erythrose-4-13C | 90913-08-9 | Isotope-Labeled Compounds |
| HY-116957 | Bunitrolol (hydrochloride) | 29876-08-2 | Reference compound |
| HY-116958 | SCH 206272 | 226915-43-1 | Reference compound |
| HY-116959 | SM-130686 | 259667-25-9 | Reference compound |
| HY-116960 | FR 76830 | 113243-75-7 | Reference compound |
| HY-116961 | TH1020 | 1841460-82-9 | Reference compound |
| HY-116965 | Tyvelose | 5658-12-8 | Biochemical Assay Reagents |
| HY-116969 | 22(R)-Hydroxycholesterol | 17954-98-2 | Reference compound |
| HY-116969S | 22(R)-Hydroxycholesterol-d7 | 1246302-93-1 | Isotope-Labeled Compounds |
| HY-116970 | L-749372 | 159183-70-7 | Reference compound |
| HY-116971 | DCG066 | 494786-13-9 | Reference compound |
| HY-116972 | Etanidazole | 22668-01-5 | Reference compound |
| HY-116973 | L 738372 | 159565-60-3 | Reference compound |
| HY-116974 | ent-Thiamphenicol | 19934-71-5 | Reference compound |
| HY-116975 | Enoxastrobin | 238410-11-2 | Reference compound |
| HY-116976 | NSC-57969 | 6632-09-3 | Reference compound |
| HY-116977 | Binifibrate | 69047-39-8 | Reference compound |
| HY-116982 | BMY 7378 (free base) | 21102-94-3 | Reference compound |
| HY-116992 | Chloroneb | 2675-77-6 | Reference compound |
| HY-116992R | Chloroneb (Standard) | 2675-77-6 | Reference Standards |
| HY-116993 | N-(Hydroxymethyl)nicotinamide | 3569-99-1 | Reference compound |
| HY-116999 | IR415 | 452967-14-5 | Reference compound |
| HY-117002 | SRI 37892 | 1030769-75-5 | Reference compound |
| HY-117005 | C450-0730 | 1036730-46-7 | Reference compound |
| HY-117006 | E1231 | 1031195-19-3 | Reference compound |
| HY-117008 | CAY10589 | 1077626-52-8 | Reference compound |
| HY-117009 | Bis-PEG9-NHS ester | 1008402-79-6 | ADC Related |
| HY-117010 | Kushenol K | 101236-49-1 | Natural Products |
| HY-117012 | NE58018 | 105462-23-5 | Reference compound |
| HY-117015 | Purfalcamine | 1038620-68-6 | Reference compound |
| HY-117016 | Nonacosadiene | 104410-91-5 | Reference compound |
| HY-117019 | LY150310 (free base) | 103294-47-9 | Reference compound |
| HY-117020 | Methyl (S)-(-)-N-Z-aziridine-2-carboxylate | 104597-98-0 | Reference compound |
| HY-117023 | m-PEG2-4-nitrophenyl carbonate | 105108-59-6 | Reference compound |
| HY-117024 | Abediterol (napadisylate) | 1044516-17-7 | Reference compound |
| HY-117025 | Manzamine A | 104196-68-1 | Natural Products |
| HY-117025A | Manzamine A (hydrochloride) | 104264-80-4 | Natural Products |
| HY-117026 | LKY-047 | 1954681-29-8 | Reference compound |
| HY-117028 | Tos-PEG7-OH | 1028089-05-5 | Reference compound |
| HY-117029 | NAAD (sodium) | 104809-30-5 | Reference compound |
| HY-117031 | m-PEG8-MS | 1059588-19-0 | ADC Related |
| HY-117034 | Rankinidine | 106466-66-4 | Natural Products |
| HY-117037 | FR900359 | 107530-18-7 | Natural Products |
| HY-117038 | Anordiol | 1045-29-0 | Reference compound |
| HY-117040 | nor-Binaltorphimine | 105618-26-6 | Reference compound |
| HY-117041 | m-PEG4-CH2-aldehyde | 1059189-65-9 | Reference compound |
| HY-117042 | Biotin-PEG2-C6-azide | 1011268-29-3 | Reference compound |
| HY-117043 | GRL0617 | 1093070-16-6 | Reference compound |
| HY-117044 | 12(R)-HEPE | 109430-12-8 | Reference compound |
| HY-117044A | (±)12-HEPE | 81187-21-5 | Reference compound |
| HY-117045 | Propargyl-PEG12-OH | 1036204-61-1 | Reference compound |
| HY-117046 | AVN-101 | 1025725-91-0 | Reference compound |
| HY-117046A | AVN-101 (hydrochloride) | 1061354-48-0 | Reference compound |
| HY-117047 | ALC67 | 1044255-57-3 | Reference compound |
| HY-117048 | PF-4191834 | 1029317-21-2 | Reference compound |
| HY-117049 | Leucettine L41 | 1112978-84-3 | Reference compound |
| HY-117050 | PEG12-Tos | 1050500-41-8 | ADC Related |
| HY-117051 | STA-2842 | 1046490-67-8 | Reference compound |
| HY-117052 | Thiophene-2-amidoxime | 108443-93-2 | Reference compound |
| HY-117053 | ZM 253270 | 169340-04-9 | Reference compound |
| HY-117055 | Ro 18-3981 | 103295-92-7 | Reference compound |
| HY-117057 | Hexaenoic acid | 105528-06-1 | Reference compound |
| HY-117057S | Hexaenoic acid-d6 | 2692624-21-6 | Isotope-Labeled Compounds |
| HY-117058 | LY243246 | 106400-18-4 | Reference compound |
| HY-117059 | SK609 (hydrochloride) | 1092797-77-7 | Reference compound |
| HY-117061 | Prostaglandin F2α alcohol methyl ether | 143656-18-2 | Reference compound |
| HY-117063 | LEK 8841 (methanesulfonate) | 145204-80-4 | Reference compound |
| HY-117065 | MAC173979 | 41501-64-8 | Reference compound |
| HY-117066 | CL075 | 256922-53-9 | Reference compound |
| HY-117068 | (R)-Bromoenol lactone | 478288-90-3 | Reference compound |
| HY-117068S | (R)-Bromoenol lactone-d7 | Isotope-Labeled Compounds | |
| HY-117070 | TO-PRO-3 (iodide) | 157199-63-8 | Dye Reagents |
| HY-117071 | Dabuzalgron | 219311-44-1 | Reference compound |
| HY-117071A | Dabuzalgron (hydrochloride) | 219311-43-0 | Reference compound |
| HY-117072 | (E)-2-Hexadecenal alkyne | 1778692-99-1 | Reference compound |
| HY-117073 | ITH12575 | 1802013-08-6 | Reference compound |
| HY-117074 | BMS-247243 | 307316-55-8 | Reference compound |
| HY-117077 | A70450 | 142928-23-2 | Reference compound |
| HY-117078 | Justicidin A | 25001-57-4 | Natural Products |
| HY-117079 | N-Boc-N-bis(PEG2-OH) | 275385-03-0 | ADC Related |
| HY-117080 | Sulfo-EGS | 167410-92-6 | Reference compound |
| HY-117081 | C30(ω-hydroxy) Ceramide (d18:1/30:0) | 457100-08-2 | Natural Products |
| HY-117082 | UTL-5g | 646530-37-2 | Reference compound |
| HY-117083 | Clothiapine | 2058-52-8 | Reference compound |
| HY-117085 | Lobaric acid | 522-53-2 | Reference compound |
| HY-117087 | K103 | 1071544-43-8 | Reference compound |
| HY-117088 | LM11A-31 | 102562-74-3 | Reference compound |
| HY-117089 | Tetraconazole | 112281-77-3 | Reference compound |
| HY-117089R | Tetraconazole (Standard) | 112281-77-3 | Reference Standards |
| HY-117090 | (rac)-AL-37350A | 362603-40-5 | Reference compound |
| HY-117091 | DDD-028 | 1538586-09-2 | Reference compound |
| HY-117093 | H8-A5 | 423731-10-6 | Reference compound |
| HY-117095 | 4-Methylumbelliferyl oleate | 18323-58-5 | Dye Reagents |
| HY-117096 | Piperophos | 24151-93-7 | Reference compound |
| HY-117096R | Piperophos (Standard) | 24151-93-7 | Reference Standards |
| HY-117097 | Bayer 16574 | 3568-51-2 | Reference compound |
| HY-117099 | TMB-8 | 53464-72-5 | Reference compound |
| HY-117100 | Propargyl-PEG14-OH | Reference compound | |
| HY-117102 | ANI-7 | 931417-26-4 | Reference compound |
| HY-117103 | AMG131 | 315224-26-1 | Reference compound |
| HY-117103A | AMG131 (benzenesulfonate) | 849738-78-9 | Reference compound |
| HY-117104 | Hydroxy-PEG4-acid | 937188-59-5 | ADC Related |
| HY-117105 | DAPD-NHc-pr | 280138-71-8 | Reference compound |
| HY-117106 | PNU-107484A | 200266-76-8 | Reference compound |
| HY-117107 | Cheirolin | 505-34-0 | Biochemical Assay Reagents |
| HY-117108 | Nocardicin A | 39391-39-4 | Natural Products |
| HY-117109 | Amino Tadalafil | 385769-84-6 | Reference compound |
| HY-117109R | Amino Tadalafil (Standard) | 385769-84-6 | Reference Standards |
| HY-117110 | Arginylproline | 2418-69-1 | Reference compound |
| HY-117112 | Hexamethoxymethylmelamine | 3089-11-0 | Reference compound |
| HY-117113 | JI051 | 2234281-75-3 | Reference compound |
| HY-117115 | 1,2-Dihexanoyl-sn-glycerol | 30403-47-5 | Biochemical Assay Reagents |
| HY-117118A | AC-90179 | 359878-19-6 | Reference compound |
| HY-117119 | VER-3323 | 259857-99-3 | Reference compound |
| HY-117124 | BMS-337197 | 267645-83-0 | Reference compound |
| HY-117125 | Longifolin | 39007-94-8 | Natural Products |
| HY-117126 | BTZ-N3 | 1839081-05-8 | Reference compound |
| HY-117129 | MK 436 | 33450-08-7 | Reference compound |
| HY-117131 | ZINC17167211 | 592539-21-4 | Reference compound |
| HY-117133 | Nesvategrast | 1621332-91-9 | Reference compound |
| HY-117134 | 2-Ethylhexyl palmitate | 29806-73-3 | Biochemical Assay Reagents |
| HY-117135 | HNS-32 | 186086-10-2 | Reference compound |
| HY-117136 | AN-7 | 213262-83-0 | Reference compound |
| HY-117139 | NESS 0327 | 494844-07-4 | Reference compound |
| HY-117141 | N-Arachidonoyl-3-hydroxy-γ-aminobutyric acid | 959761-62-7 | Peptides |
| HY-117142 | Quizalofop-P | 94051-08-8 | Reference compound |
| HY-117142R | Quizalofop-P (Standard) | 94051-08-8 | Reference Standards |
| HY-117143 | TK05 | 1245734-61-5 | Reference compound |
| HY-117145 | Thiophene-2 | 420089-51-6 | Reference compound |
| HY-117146 | Indoxacarb | 173584-44-6 | Reference compound |
| HY-117147 | GSK2945 | 1438071-12-5 | Reference compound |
| HY-117147A | GSK2945 (hydrochloride) | Reference compound | |
| HY-117149 | MLS000532223 | 16616-39-0 | Reference compound |
| HY-117151 | A-315675 | 335679-69-1 | Reference compound |
| HY-117152 | L-threo-Sphingosine | 25695-95-8 | Reference compound |
| HY-117153 | GW7604 | 361203-06-7 | Reference compound |
| HY-117154 | INH154 | 1587705-63-2 | Reference compound |
| HY-117155 | PKI-166 | 187724-61-4 | Reference compound |
| HY-117158 | SKF 89748 | 81998-18-7 | Reference compound |
| HY-117160 | 4-trans-Hydroxy-glibenclamide | 23155-00-2 | Reference compound |
| HY-117160S1 | 4-trans-Hydroxy glibenclamide-d5 | Isotope-Labeled Compounds | |
| HY-117160S2 | 4-trans-Hydroxy glibenclamide-13C,d4 | Isotope-Labeled Compounds | |
| HY-117161 | ZINC05626394 | 189057-68-9 | Reference compound |
| HY-117162 | S 1432 | 24932-86-3 | Reference compound |
| HY-117163 | FzM1.8 | 2204290-85-5 | Reference compound |
| HY-117164 | Longicautadine | 85335-06-4 | Natural Products |
| HY-117166 | Naftoxate | 28820-28-2 | Reference compound |
| HY-117167 | KB-141 | 219691-94-8 | Reference compound |
| HY-117168 | 1,2-Dilinoleoyl-sn-glycerol | 24529-89-3 | Reference compound |
| HY-117170 | B1912 | 24028-59-9 | Reference compound |
| HY-117171S | Proquinazid-(propoxy-d7) | 2140327-37-1 | Isotope-Labeled Compounds |
| HY-117172 | CP320626 | 186430-23-9 | Reference compound |
| HY-117173 | (Rac)-Rasagiline | 1875-50-9 | Reference compound |
| HY-117175 | Pandamarilactonine A | 303008-80-2 | Natural Products |
| HY-117176 | KRP-199 | 221164-28-9 | Reference compound |
| HY-117178 | TA 0910 acid-type | 103300-77-2 | Reference compound |
| HY-117179 | Endosulfan sulfate | 1031-07-8 | Reference compound |
| HY-117179R | Endosulfan sulfate (Standard) | 1031-07-8 | Reference Standards |
| HY-117180 | Diastovaricin I | 102281-52-7 | Natural Products |
| HY-117181 | UK-1745 | 170684-14-7 | Reference compound |
| HY-117182 | LG190178 | 233268-81-0 | Reference compound |
| HY-117183 | Lankacidinol | 23498-37-5 | Natural Products |
| HY-117184 | MSX-2 | 261717-18-4 | Reference compound |
| HY-117186 | Bis-propargyl-PEG6 | 400775-35-1 | Reference compound |
| HY-117187 | Corr4A | 421580-53-2 | Reference compound |
| HY-117190 | Pseudolycorine | 29429-03-6 | Natural Products |
| HY-117191 | m-PEG3-CH2-alcohol | 100688-48-0 | Reference compound |
| HY-117194 | 18BIOder | 275374-93-1 | Reference compound |
| HY-117195 | Lauroyl lysine | 52315-75-0 | Reference compound |
| HY-117196 | GW 9578 | 247923-29-1 | Reference compound |
| HY-117199 | MCPA-thioethyl | 25319-90-8 | Reference compound |
| HY-117200 | Necrostatin-7 | 351062-08-3 | Reference compound |
| HY-117201 | Methyl 3-hydroxyoctanoate | 7367-87-5 | Natural Products |
| HY-117203A | CDK12-IN-E9 | 2020052-55-3 | Reference compound |
| HY-117204 | AA-57 | 68026-87-9 | Natural Products |
| HY-117209 | Cannabivarin | 33745-21-0 | Natural Products |
| HY-117213 | Ex26 | 1233332-37-0 | Reference compound |
| HY-117215 | β-Ocimene | 13877-91-3 | Biochemical Assay Reagents |
| HY-117215A | trans-β-Ocimene | 3779-61-1 | Natural Products |
| HY-117216 | L-703606 | 144425-84-3 | Reference compound |
| HY-117216A | L-703606 (oxalate) | 351351-06-9 | Reference compound |
| HY-117216B | L-703606 (oxalate hydrate) | Reference compound | |
| HY-117218 | KY-04045 | 1223284-75-0 | Reference compound |
| HY-117219 | SKF 104976 | 136209-43-3 | Reference compound |
| HY-117220 | Aspochalasin M | 1173040-34-0 | Natural Products |
| HY-117223 | GEA 857 | 120493-42-7 | Reference compound |
| HY-117224 | Rhizopterin | 119-20-0 | Natural Products |
| HY-117225 | Pantoprazole sulfone | 127780-16-9 | Reference compound |
| HY-117226 | GSK 690 | 2101305-84-2 | Reference compound |
| HY-117226A | GSK 690 (Hydrochloride) | 2436760-79-9 | Reference compound |
| HY-117229 | Sonidegib metabolite M48 | 1221722-10-6 | Reference compound |
| HY-117230 | Triflusulfuron-methyl | 126535-15-7 | Reference compound |
| HY-117230R | Triflusulfuron-methyl (Standard) | 126535-15-7 | Reference Standards |
| HY-117231 | RM 06 | 126869-52-1 | Reference compound |
| HY-117233 | UU-T02 | 1500080-17-0 | Reference compound |
| HY-117235 | Diallyl Trisulfide | 2050-87-5 | Natural Products |
| HY-117235R | Diallyl Trisulfide (Standard) | 2050-87-5 | Reference Standards |
| HY-117237 | Hisphen | 2764-56-9 | Reference compound |
| HY-117238 | Ketomethylenebestatin | 137028-97-8 | Reference compound |
| HY-117239 | SB-206606 | 116049-78-6 | Reference compound |
| HY-117240 | NCT-502 | 1542213-00-2 | Reference compound |
| HY-117241 | AB 3217-B | 139159-00-5 | Reference compound |
| HY-117243 | GSK329 | 1268490-12-5 | Reference compound |
| HY-117244 | AZD7507 | 1041852-85-0 | Reference compound |
| HY-117245 | Pallidol | 1622292-61-8 | Natural Products |
| HY-117247 | 5,6,7,8-Tetrahydro-8-deazahomofolic acid | 111113-75-8 | Reference compound |
| HY-117248 | SR-3737 | 1164153-37-0 | Reference compound |
| HY-117249 | Sanazole | 104958-90-9 | Reference compound |
| HY-117250 | EcDsbB-IN-10 | 112749-52-7 | Reference compound |
| HY-117251 | LP-403812 | 1142050-84-7 | Reference compound |
| HY-117253 | PHA-782584 | 1126899-61-3 | Reference compound |
| HY-117254 | BAS00127538 | 110673-34-2 | Reference compound |
| HY-117255 | ZM260384 | 161229-62-5 | Reference compound |
| HY-117256 | Gabazine (free base) | 105538-73-6 | Reference compound |
| HY-117257 | PF-0713 | 1083093-47-3 | Reference compound |
| HY-117259 | Valiltramiprosate | 1034190-08-3 | Reference compound |
| HY-117259S | Valiltramiprosate-d6 | Isotope-Labeled Compounds | |
| HY-117260 | Coformycin | 11033-22-0 | Natural Products |
| HY-117262 | Propaquizafop | 111479-05-1 | Reference compound |
| HY-117262R | Propaquizafop (Standard) | 111479-05-1 | Reference Standards |
| HY-117264 | (-)-6-Aminocarbovir | 109881-25-6 | Reference compound |
| HY-117266 | β-D-Galactopyranoside, 98% | 56245-60-4 | Biochemical Assay Reagents |
| HY-117268 | 1,3,4,6-Tetra-O-acetyl-β-D-mannopyranose | 18968-05-3 | Biochemical Assay Reagents |
| HY-117269 | Methyl-D-galactoside | 93302-26-2 | Biochemical Assay Reagents |
| HY-117271 | D-Galactosamine pentaacetate | 76375-60-5 | Biochemical Assay Reagents |
| HY-117272A | (2R,3R)-2,3,4-Trihydroxybutanoic acid | 488-16-4 | Reference compound |
| HY-117273 | AZ304 | 942507-42-8 | Reference compound |
| HY-117275 | Meclofenamic acid | 644-62-2 | Reference compound |
| HY-117275A | Meclofenamic acid (sodium hydrate) | 67254-91-5 | Reference compound |
| HY-117275R | Meclofenamic acid (Standard) | 644-62-2 | Reference Standards |
| HY-117275S | Meclofenamic acid-d4 | 1185072-18-7 | Isotope-Labeled Compounds |
| HY-117275S1 | Meclofenamic acid-13C6 | Isotope-Labeled Compounds | |
| HY-117279 | (S)-Metolachor | 87392-12-9 | Reference compound |
| HY-117279R | (S)-Metolachor (Standard) | 87392-12-9 | Reference Standards |
| HY-117280 | GN25 | 1227401-27-5 | Reference compound |
| HY-117281 | Moexipril | 103775-10-6 | Reference compound |
| HY-117281S | Moexipril-d5 | 1356929-49-1 | Isotope-Labeled Compounds |
| HY-117281S1 | Moexipril-d3 | Isotope-Labeled Compounds | |
| HY-117282 | JG-98 | 1456551-16-8 | Reference compound |
| HY-117283 | rel-Aprikalim | 89544-10-5 | Reference compound |
| HY-117284 | Eucatropine | 100-91-4 | Reference compound |
| HY-117285 | Medermycin | 60227-09-0 | Reference compound |
| HY-117286 | (S)-JQ-35 | 1349719-98-7 | Reference compound |
| HY-117287 | Deucravacitinib | 1609392-27-9 | Isotope-Labeled Compounds |
| HY-117287A | Deucravacitinib (hydrochloride) | 1609392-28-0 | Isotope-Labeled Compounds |
| HY-117288 | S55746 | 1448584-12-0 | Reference compound |
| HY-117288A | S55746 (hydrochloride) | 1448525-91-4 | Reference compound |
| HY-117289 | AKOS B018304 | 6308-22-1 | Reference compound |
| HY-117290 | BMS-962212 | 1430114-34-3 | Reference compound |
| HY-117291 | XMD-17-51 | 1628614-50-5 | Reference compound |
| HY-117291A | XMD-17-51 (TFA) | 2436579-93-8 | Reference compound |
| HY-117292 | DAO-IN-2 | 39793-31-2 | Reference compound |
| HY-117293 | Phenyl sulfamate | 19792-91-7 | Reference compound |
| HY-117295A | 7-Fluorotryptamine (hydrochloride) | 159730-09-3 | Reference compound |
| HY-117311 | Spirotryprostatin A | 182234-25-9 | Natural Products |
| HY-117313 | Fumitremorgin B | 12626-17-4 | Natural Products |
| HY-117314 | CyMe4BTBP | 886970-80-5 | Reference compound |
| HY-117318 | PDE12-IN-1 | 2259620-80-7 | Reference compound |
| HY-117319 | Indolmycin | 21200-24-8 | Reference compound |
| HY-117332 | IQA | 391670-48-7 | Reference compound |
| HY-117348 | NCC-149 | 1316652-41-1 | Reference compound |
| HY-117356A | MRS2693 (ammonium) | 911391-37-2 | Reference compound |
| HY-117356B | MRS2693 (trisodium) | 1448858-83-0 | Reference compound |
| HY-117357 | SI-113 | 1392816-46-4 | Reference compound |
| HY-117358 | KW-5805 | 113302-01-5 | Reference compound |
| HY-117359 | UCD38B (hydrochloride) | 1115177-19-9 | Reference compound |
| HY-117361 | LY207702 | 103828-81-5 | Reference compound |
| HY-117364 | HS148 | 1892595-16-2 | Reference compound |
| HY-117365 | MI-1481 | 1887178-64-4 | Reference compound |
| HY-117366 | PS432 | 2083630-26-4 | Reference compound |
| HY-117368 | AL-8417 | 180472-20-2 | Reference compound |
| HY-117370 | USP25/28 inhibitor AZ1 | 2165322-94-9 | Reference compound |
| HY-117371 | Hemiasterlin | 157207-90-4 | Natural Products |
| HY-117373 | Pelargonidin-3-rutinosid | 33978-17-5 | Reference compound |
| HY-117374 | HDAC3-IN-1 | 2044701-99-5 | Reference compound |
| HY-117375 | Brotianide | 23233-88-7 | Reference compound |
| HY-117376 | (all-E)-UAB30 | 205252-59-1 | Reference compound |
| HY-117378 | N-5984 | 220475-76-3 | Reference compound |
| HY-117378A | N-5984 (hydrochloride) | 185035-23-8 | Reference compound |
| HY-117379 | CHIR-2279 | 158198-45-9 | Reference compound |
| HY-117380 | SB 235375 | 224961-34-6 | Reference compound |
| HY-117381 | γ-secretase-IN-2 | 564462-36-8 | Reference compound |
| HY-117383 | NGI-1 | 790702-57-7 | Reference compound |
| HY-117386 | Methoxyfenozide | 161050-58-4 | Reference compound |
| HY-117386R | Methoxyfenozide (Standard) | 161050-58-4 | Reference Standards |
| HY-117386S | Methoxyfenozide-d9 | 2469014-53-5 | Isotope-Labeled Compounds |
| HY-117387 | BFE-37 | 107572-73-6 | Reference compound |
| HY-117389 | Homocarbonyltopsentin | 172286-77-0 | Reference compound |
| HY-117391 | AZ-Dyrk1B-33 | 1679330-37-0 | Reference compound |
| HY-117393 | Bisindolylmaleimide III | 137592-43-9 | Reference compound |
| HY-117394 | MD 85 | 193551-00-7 | Reference compound |
| HY-117395 | PU-H54 | 1454619-13-6 | Reference compound |
| HY-117396 | Isomahanimbine | 26871-46-5 | Natural Products |
| HY-117397 | Fenazaquin | 120928-09-8 | Reference compound |
| HY-117397R | Fenazaquin (Standard) | 120928-09-8 | Reference Standards |
| HY-117398 | HCI-2184 | 1341200-61-0 | Reference compound |
| HY-117401 | 5-Dodecanoylaminofluorescein | 107827-77-0 | Dye Reagents |
| HY-117403 | AB-FUBICA | 1801338-22-6 | Reference compound |
| HY-117406 | Clencyclohexerol | 157877-79-7 | Reference compound |
| HY-117406R | Clencyclohexerol (Standard) | 157877-79-7 | Reference Standards |
| HY-117407 | ALLO-2 | 1357350-60-7 | Reference compound |
| HY-117408 | VU6004256 | 2011034-33-4 | Reference compound |
| HY-117409 | Aminoethyl-SS-ethylalcohol | 15579-01-8 | ADC Related |
| HY-117410 | Vipivotide tetraxetan | 1702967-37-0 | ADC Related |
| HY-117411 | Coblopasvir | 1312608-46-0 | Reference compound |
| HY-117411A | Coblopasvir (dihydrochloride) | 1966138-53-3 | Reference compound |
| HY-117412 | KCG 1 | 139036-51-4 | Reference compound |
| HY-117413 | SR-17398 | 1496088-76-6 | Reference compound |
| HY-117419 | (-)-Lavandulyl acetate | 20777-39-3 | Natural Products |
| HY-117419A | (±)-Lavandulyl acetate | 25905-14-0 | Natural Products |
| HY-117419AR | (±)-Lavandulyl acetate (Standard) | 25905-14-0 | Reference Standards |
| HY-117420 | CM764 | 1350296-29-5 | Reference compound |
| HY-117421 | CM-579 | 1846570-40-8 | Reference compound |
| HY-117421A | CM-579 trihydrochloride | 2448471-08-5 | Reference compound |
| HY-117422 | CAY10410 | 596104-94-8 | Reference compound |
| HY-117423 | ST7710AA1 | 1542067-20-8 | Reference compound |
| HY-117424 | Inz-4 | 1585213-98-4 | Reference compound |
| HY-117425 | Kigelinone | 149471-08-9 | Natural Products |
| HY-117426 | MO-I-500 | 1585219-04-0 | Reference compound |
| HY-117427 | D5D-IN-326 | 1236767-85-3 | Reference compound |
| HY-117429 | Se-Aspirin | 1850293-95-6 | Reference compound |
| HY-117430 | Hymeglusin | 29066-42-0 | Reference compound |
| HY-117431 | Prostaglandin B3 | 36614-32-1 | Reference compound |
| HY-117432 | JC-171 | 2112809-98-8 | Reference compound |
| HY-117433 | 4-Hydroperoxy cyclophosphamide | 39800-16-3 | Reference compound |
| HY-117433S | 4-Hydroperoxy Cyclophosphamide-d4 | 1246816-71-6 | Isotope-Labeled Compounds |
| HY-117434 | Suberosol | 151368-42-2 | Reference compound |
| HY-117436 | R(+)-6-Bromo-APB (hydrobromide) | 139689-19-3 | Reference compound |
| HY-117437 | Azintamide | 1830-32-6 | Reference compound |
| HY-117439 | (R)-Norverapamil | 123932-43-4 | Reference compound |
| HY-117440 | 4'-Methoxy-S-trityl-L-cysteinol | 1338701-15-7 | Reference compound |
| HY-117441 | 5(S)-HPEPE | 143292-98-2 | Natural Products |
| HY-117442 | A2B57 | 1602733-73-2 | Reference compound |
| HY-117443 | IWP-051 | 1354041-91-0 | Reference compound |
| HY-117444 | ONO-9780307 | 856691-44-6 | Reference compound |
| HY-117445 | Oxazole yellow | 143413-86-9 | Dye Reagents |
| HY-117446 | AS-1669058 | 1395553-32-8 | Reference compound |
| HY-117446A | AS-1669058 (free base) | 1395553-31-7 | Reference compound |
| HY-117447 | LY303336 | 157187-00-3 | Reference compound |
| HY-117450 | VU0415374 | 1266338-03-7 | Reference compound |
| HY-117451 | Dodine | 2439-10-3 | Reference compound |
| HY-117452 | LY-402913 | 334970-65-9 | Reference compound |
| HY-117453 | BMS-901715 | 1699861-37-4 | Reference compound |
| HY-117457 | BPIC | 1444382-92-6 | Reference compound |
| HY-117459 | E-3030 (free acid) | 478926-45-3 | Reference compound |
| HY-117460 | Indanorex | 16112-96-2 | Reference compound |
| HY-117463 | Dexamethasone beloxil | 150587-07-8 | Reference compound |
| HY-117464 | CM-352 | 1664361-37-8 | Reference compound |
| HY-117465 | HAC-Y6 | 1331959-78-4 | Reference compound |
| HY-117466 | FR186054 | 179053-90-8 | Reference compound |
| HY-117467 | BMT-108908 | 1801151-15-4 | Reference compound |
| HY-117468 | Lissamine rhodamine B | 2609-88-3 | Dye Reagents |
| HY-117469 | Triptohypol C | 193957-88-9 | Natural Products |
| HY-117471 | Antiarrhythmic agent-3 | 21236-52-2 | Reference compound |
| HY-117472 | DLC27-14 | 1360869-92-6 | Reference compound |
| HY-117473 | DAT-230 | 1504583-00-9 | Reference compound |
| HY-117474 | MJN110 | 1438416-21-7 | Reference compound |
| HY-117475 | N-Acetylthyroxine | 26041-51-0 | Reference compound |
| HY-117477 | DPC 963 | 214287-90-8 | Reference compound |
| HY-117479 | CL67 | 1401242-86-1 | Reference compound |
| HY-117481 | NSC-639829 | 134742-19-1 | Reference compound |
| HY-117482 | BPN-15606 | 1914989-49-3 | Reference compound |
| HY-117482A | BPN-15606 (besylate) | 2436239-00-6 | Reference compound |
| HY-117483 | Gly-Pro-Glu | 32302-76-4 | Peptides |
| HY-117484 | Rubrosterone | 19466-41-2 | Natural Products |
| HY-117486 | RU 56187 | 143782-25-6 | Reference compound |
| HY-117488 | (S)-Grepafloxacin | 146761-69-5 | Reference compound |
| HY-117489 | Julibrine II | 142628-29-3 | Reference compound |
| HY-117491 | BRD4 Inhibitor-10 | 1660117-38-3 | Reference compound |
| HY-117492 | Aconiazide | 13410-86-1 | Reference compound |
| HY-117496 | Ampelopsin A | 130608-11-6 | Natural Products |
| HY-117497 | Simetride | 154-82-5 | Reference compound |
| HY-117500 | Aplysamine-1 | 159026-30-9 | Natural Products |
| HY-117501 | Dexchlorpheniramine | 25523-97-1 | Reference compound |
| HY-117502 | SL-25.1188 | 185835-97-6 | Reference compound |
| HY-117507 | U92016A (hydrochloride) | 149654-41-1 | Reference compound |
| HY-117508 | JNJ-54175446 | 1627902-21-9 | Reference compound |
| HY-117511 | HJC0123 | 1430420-02-2 | Reference compound |
| HY-117512 | UWA-101 (hydrochloride) | 1431520-52-3 | Reference compound |
| HY-117513 | CEP1612 | 189036-01-9 | Reference compound |
| HY-117514 | 5-LOX-IN-7 | 1272519-89-7 | Reference compound |
| HY-117515 | YLT205 | 1316196-63-0 | Reference compound |
| HY-117516 | SR10067 | 1380548-02-6 | Reference compound |
| HY-117517 | NG-012 | 141731-76-2 | Natural Products |
| HY-117518 | Paranyline | 1729-61-9 | Reference compound |
| HY-117518A | Paranyline (hydrochloride) | 5585-60-4 | Reference compound |
| HY-117519 | Amino-Tri-(carboxyethoxymethyl)-methane | 174362-95-9 | ADC Related |
| HY-117519A | Amino-Tri-(carboxyethoxymethyl)-methane (hydrochloride) | 1416771-72-6 | ADC Related |
| HY-117522 | Sepin-1 | 163126-81-6 | Reference compound |
| HY-117523 | (Z)-RG-13022 | 149286-90-8 | Reference compound |
| HY-117526 | (-)-Mesembrine | 24880-43-1 | Natural Products |
| HY-117528 | WAY-123398 | 138490-53-6 | Reference compound |
| HY-117529 | BMS-351 | 1370001-71-0 | Reference compound |
| HY-117532 | PenCB | 31508-00-6 | Reference compound |
| HY-117533 | UNC0006 | 1354030-14-0 | Reference compound |
| HY-117535 | CDK2-IN-4 | 2079895-42-2 | Reference compound |
| HY-117540 | ZLD10A | 1782064-91-8 | Reference compound |
| HY-117541 | Glycyl-glutamine | 13115-71-4 | Reference compound |
| HY-117542 | D595 | 16740-29-7 | Reference compound |
| HY-117543 | Ethonafide | 160554-87-0 | Reference compound |
| HY-117544 | Porphyrin precursor | 149365-62-8 | Reference compound |
| HY-117547 | Licostinel | 153504-81-5 | Reference compound |
| HY-117548 | UNC1062 | 1350549-36-8 | Reference compound |
| HY-117549 | Ibrolipim | 133208-93-2 | Reference compound |
| HY-117554 | BRD9757 | 1423058-85-8 | Reference compound |
| HY-117556 | U-104489 | 177577-60-5 | Reference compound |
| HY-117557 | LY306669 | 153227-04-4 | Reference compound |
| HY-117558 | (Rac)-L-826141 | 491869-01-3 | Reference compound |
| HY-117561 | DuP 714 | 130982-43-3 | Reference compound |
| HY-117562 | a-FABP-IN-1 | 1310361-52-4 | Reference compound |
| HY-117563 | CAY10621 | 120005-55-2 | Reference compound |
| HY-117566 | RPR 102341 | 149105-53-3 | Reference compound |
| HY-117568 | A-80b | 135561-94-3 | Reference compound |
| HY-117569 | KF24345 (free base) | 178750-21-5 | Reference compound |
| HY-117570 | KSC-34 | 2226201-97-2 | Reference compound |
| HY-117571 | Zatolmilast | 1606974-33-7 | Reference compound |
| HY-117572 | MRS2567 | 15398-83-1 | Reference compound |
| HY-117573 | 1Z105 | 1438280-73-9 | Reference compound |
| HY-117574 | SB 207710 | 148703-08-6 | Reference compound |
| HY-117575 | WAY-100135 | 133025-23-7 | Reference compound |
| HY-117575A | WAY-100135 (dihydrochloride) | 149055-79-8 | Reference compound |
| HY-117578 | KB 5666 | 131916-69-3 | Reference compound |
| HY-117580 | 16α-Hydroxyprednisolone | 13951-70-7 | Reference compound |
| HY-117580R | 16α-Hydroxyprednisolone (Standard) | 13951-70-7 | Reference Standards |
| HY-117580S | 16α-Hydroxyprednisolone-d3 | Isotope-Labeled Compounds | |
| HY-117581 | L-669,262 | 130468-11-0 | Reference compound |
| HY-117582 | Elvucitabine | 181785-84-2 | Oligonucleotides |
| HY-117583 | cis-BG47 | Reference compound | |
| HY-117583A | BG47 | 1628784-54-2 | Reference compound |
| HY-117584 | L-163255 (free base) | 159634-54-5 | Reference compound |
| HY-117585 | Caylin-2 | 1392830-09-9 | Reference compound |
| HY-117586 | 9-PAHPA | 1636134-70-7 | Natural Products |
| HY-117591 | L 684248 | 156728-18-6 | Reference compound |
| HY-117595 | PHM16 | 1448791-29-4 | Reference compound |
| HY-117596 | UNC569 | 1350547-65-7 | Reference compound |
| HY-117597 | YM440 | 163300-58-1 | Reference compound |
| HY-117598 | OXFBD03 | 1429129-71-4 | Reference compound |
| HY-117600 | Tributyl phosphate | 126-73-8 | Natural Products |
| HY-117600S | Tributyl phosphate-D27 | 61196-26-7 | Isotope-Labeled Compounds |
| HY-117601 | 11-Deoxyalisol B | 155073-73-7 | Natural Products |
| HY-117602 | TLR7 agonist 3 | 1229024-78-5 | Reference compound |
| HY-117603 | CM-10-18 | 1159614-57-9 | Reference compound |
| HY-117604 | THPP-1 | 1257051-63-0 | Reference compound |
| HY-117605 | N-Desmethyl Sildenafil | 139755-82-1 | Reference compound |
| HY-117605R | N-Desmethyl Sildenafil (Standard) | 139755-82-1 | Reference Standards |
| HY-117605S | N-Desmethyl Sildenafil-d8 | 1185168-06-2 | Isotope-Labeled Compounds |
| HY-117606 | LY3027788 | 1377615-76-3 | Reference compound |
| HY-117606A | LY3027788 (hydrochloride) | 1377615-55-8 | Reference compound |
| HY-117607 | Alatrioprilat | 135038-59-4 | Reference compound |
| HY-117608 | ML 315 | 1440251-53-5 | Reference compound |
| HY-117608A | ML 315 (hydrochloride) | 2172559-91-8 | Reference compound |
| HY-117609 | UE2343 | 1346013-80-6 | Reference compound |
| HY-117610 | Ro 31-8830 | 131848-98-1 | Reference compound |
| HY-117610A | Bisindolylmaleimide XI (hydrochloride) | 145333-02-4 | Reference compound |
| HY-117611 | GAT107 | 1476807-74-5 | Reference compound |
| HY-117614 | WF-210 | 1242279-00-0 | Reference compound |
| HY-117615 | Rhapontisterone | 137476-71-2 | Natural Products |
| HY-117616 | Laurotetanine | 128-76-7 | Natural Products |
| HY-117617 | CAY10669 | 1243583-88-1 | Reference compound |
| HY-117618 | KF-14124 | 134186-26-8 | Reference compound |
| HY-117621 | PF-04634817 | 1228111-63-4 | Reference compound |
| HY-117621A | PF-04634817 (succinate) | 2140301-98-8 | Reference compound |
| HY-117622 | ND-2110 | 1388894-17-4 | Reference compound |
| HY-117623 | PF-06685249 | 1467059-70-6 | Reference compound |
| HY-117626 | LP-935509 | 1454555-29-3 | Reference compound |
| HY-117627 | L 158338 | 133240-38-7 | Reference compound |
| HY-117630 | RB-6145 | 129448-97-1 | Reference compound |
| HY-117632 | Elcubragistat | 1446817-84-0 | Reference compound |
| HY-117633 | Sultroponium | 15130-91-3 | Reference compound |
| HY-117634 | WS009B | 136286-50-5 | Reference compound |
| HY-117636 | (Rac)-L-659989 | 129314-27-8 | Reference compound |
| HY-117637 | ALS-I-41 | 1369357-99-2 | Reference compound |
| HY-117639 | AUT1 | 1311136-84-1 | Reference compound |
| HY-117644 | L-749329 | 159590-37-1 | Reference compound |
| HY-117646 | FG-5893 | 150527-23-4 | Reference compound |
| HY-117647 | CRA-19156 | 579511-43-6 | Reference compound |
| HY-117649 | RU-39411 | 120382-04-9 | Reference compound |
| HY-117650A | RG7834 | 2072057-17-9 | Reference compound |
| HY-117651 | 2-Fluoropalmitic acid | 16518-94-8 | Reference compound |
| HY-117651R | 2-Fluoropalmitic acid (Standard) | 16518-94-8 | Reference Standards |
| HY-117652 | Lobetyol | 136171-87-4 | Natural Products |
| HY-117656 | ESI-05 | 5184-64-5 | Reference compound |
| HY-117657 | (-)-BO 2367 | 145902-81-4 | Reference compound |
| HY-117658 | GSK-114 | 1301761-96-5 | Reference compound |
| HY-117659 | PGDM | 133161-96-3 | Reference compound |
| HY-117660 | Lincomycin | 154-21-2 | Natural Products |
| HY-117660R | Lincomycin (Standard) | 154-21-2 | Reference Standards |
| HY-117660S | Lincomycin-d3 | Isotope-Labeled Compounds | |
| HY-117661 | SPHINX31 | 1818389-84-2 | Reference compound |
| HY-117664 | PNR-7-02 | 1633660-76-0 | Reference compound |
| HY-117665 | Fimaporfin | 1443547-43-0 | Dye Reagents |
| HY-117666 | NSC668036 | 144678-63-7 | Reference compound |
| HY-117668 | MDL 101146 | 149859-17-6 | Reference compound |
| HY-117669 | VPC-14228 | 19983-28-9 | Reference compound |
| HY-117672 | L-671776 | 134313-74-9 | Natural Products |
| HY-117677 | Cdc7-IN-21 | 1330781-04-8 | Reference compound |
| HY-117678 | TG-2-IN-1 | 135273-74-4 | Reference compound |
| HY-117679 | LY 135114 (free base) | 126254-82-8 | Reference compound |
| HY-117682 | L-(+)-threo-Chloramphenicol | 134-90-7 | Reference compound |
| HY-117683 | BCTP | 464152-46-3 | Reference compound |
| HY-117684 | Cabamiquine | 1469439-69-7 | Reference compound |
| HY-117684A | Cabamiquine (succinate) | 2444781-71-7 | Reference compound |
| HY-117685 | Cefovecin (sodium) | 141195-77-9 | Reference compound |
| HY-117688 | WJ35435 | 1620054-84-3 | Reference compound |
| HY-117690 | dBRD9 | 2170679-45-3 | Reference compound |
| HY-117690A | dBRD9 (dihydrochloride) | 2341840-98-8 | Reference compound |
| HY-117693 | (E/Z)-Mirin | 299953-00-7 | Reference compound |
| HY-117694 | MK-8825 | 1380887-60-4 | Reference compound |
| HY-117695 | AQC | 148757-94-2 | Dye Reagents |
| HY-117697 | Lu AF11205 | 1290133-16-2 | Reference compound |
| HY-117699 | Fluanisone | 1480-19-9 | Reference compound |
| HY-117699R | Fluanisone (Standard) | 1480-19-9 | Reference Standards |
| HY-117700 | TNKS-IN-2 | 1584646-59-2 | Reference compound |
| HY-117702 | RB 101 | 135949-60-9 | Reference compound |
| HY-117703 | CVS 738 | 151275-15-9 | Reference compound |
| HY-117705 | G244-LM | 1563007-08-8 | Reference compound |
| HY-117706 | LY 292728 | 153034-77-6 | Reference compound |
| HY-117707 | EBI-907 | 1581764-31-9 | Reference compound |
| HY-117708 | Antitumor agent-144 | 137346-42-0 | Reference compound |
| HY-117709 | BRD6688 | 1404562-17-9 | Reference compound |
| HY-117712 | LG 6-101 | 132798-26-6 | Reference compound |
| HY-117713 | Cycloechinulin | 143086-29-7 | Natural Products |
| HY-117714 | AZD-3161 | 1369501-46-1 | Reference compound |
| HY-117715 | CK-3197 | 132523-92-3 | Reference compound |
| HY-117717 | (Rac)-SC-31391 | 144730-93-8 | Reference compound |
| HY-117718 | AG957 | 140674-76-6 | Reference compound |
| HY-117720 | OSU-2S | 1351056-65-9 | Reference compound |
| HY-117721 | IHVR-11029 | 1383152-30-4 | Reference compound |
| HY-117722 | JW 618 | 1416133-88-4 | Reference compound |
| HY-117723 | MF-PGDH-008 | 452077-89-3 | Reference compound |
| HY-117724 | AZ3976 | 1418747-15-5 | Reference compound |
| HY-117725 | S-2720 | 146739-86-8 | Reference compound |
| HY-117726 | WAY-169916 | 669764-18-5 | Reference compound |
| HY-117727 | Leriglitazone | 146062-44-4 | Reference compound |
| HY-117727A | Leriglitazone (hydrochloride) | 146062-46-6 | Reference compound |
| HY-117727S | Leriglitazone-d4 | 1188263-49-1 | Isotope-Labeled Compounds |
| HY-117731 | UKH-1114 | 2113664-14-3 | Reference compound |
| HY-117732 | Xanthorin | 17526-15-7 | Natural Products |
| HY-117734 | PYD-106 | 1560894-05-4 | Reference compound |
| HY-117736 | Ro 09-1428 | 134452-47-4 | Reference compound |
| HY-117737A | RRD-251 | 72214-67-6 | Reference compound |
| HY-117738 | Benarthin | 143651-45-0 | Natural Products |
| HY-117739 | BRD1652 | 1597438-92-0 | Reference compound |
| HY-117740 | Heronamide C | 1257083-94-5 | Natural Products |
| HY-117741 | GSK951A | 1403602-33-4 | Reference compound |
| HY-117742 | DA-7867 | 380382-38-7 | Reference compound |
| HY-117743 | Eprosartan | 133040-01-4 | Reference compound |
| HY-117743AS1 | Eprosartan-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-117743R | Eprosartan (Standard) | 133040-01-4 | Reference Standards |
| HY-117743S | Eprosartan-d3 | 1185243-70-2 | Isotope-Labeled Compounds |
| HY-117743S1 | Eprosartan-d6 | Isotope-Labeled Compounds | |
| HY-117746 | KSK120 | 1638100-63-6 | Reference compound |
| HY-117747 | DMP 323 | 151867-81-1 | Reference compound |
| HY-117749 | Bisoxatin (acetate) | 14008-48-1 | Reference compound |
| HY-117754 | PSB-SB1202 | 1399049-60-5 | Reference compound |
| HY-117755 | PF-739 | 1852452-14-2 | Reference compound |
| HY-117756 | Piflufolastat | 1423758-00-2 | Reference compound |
| HY-117757 | Ninopterin | 2179-16-0 | Reference compound |
| HY-117760 | Spirolaxine | 126382-01-2 | Natural Products |
| HY-117761 | MHY908 | 1393371-39-5 | Reference compound |
| HY-117762 | U-83836E | 137018-55-4 | Reference compound |
| HY-117763 | A-39355 | 144092-66-0 | Reference compound |
| HY-117764 | LSP4-2022 | 1413405-33-0 | Reference compound |
| HY-117765 | RS-5773 | 129173-57-5 | Reference compound |
| HY-117766 | PC945 | 1931946-73-4 | Reference compound |
| HY-117769 | GSK837149A | 13616-29-0 | Reference compound |
| HY-117770 | STAT3-IN-30 | 1803281-30-2 | Reference compound |
| HY-117771 | DO34 | 1848233-58-8 | Reference compound |
| HY-117771A | DO34 analog | 2098969-71-0 | Reference compound |
| HY-117772 | FSC231 | 1215849-96-9 | Reference compound |
| HY-117774 | AHR-2244 (hydrochloride) | 24677-84-7 | Reference compound |
| HY-117776 | CAY10677 | 1443253-20-0 | Reference compound |
| HY-117777 | GSK121 | 1652591-80-4 | Reference compound |
| HY-117778 | SF2312 | 107729-45-3 | Reference compound |
| HY-117778B | SF2312 (ammonium) | Reference compound | |
| HY-117779 | DBIBB | 1569309-92-7 | Reference compound |
| HY-117780 | Rawsonol | 125111-69-5 | Natural Products |
| HY-117782 | Anticancer agent 236 | 1356340-69-6 | Reference compound |
| HY-117784 | BI-L-357 | 149539-02-6 | Reference compound |
| HY-117785 | 4’-Methoxy-α-ethylaminovalerophenone (hydrochloride) | 17837-89-7 | Reference compound |
| HY-117786 | Go 7874 | 153207-86-4 | Reference compound |
| HY-117787 | TUG-905 | 1390641-90-3 | Reference compound |
| HY-117789 | Keto-itraconazole | 112560-33-5 | Reference compound |
| HY-117791 | (R)-Pralatrexate | 1320211-70-8 | Reference compound |
| HY-117792 | LY314228 | 182633-54-1 | Reference compound |
| HY-117793 | I-191 | 1690172-25-8 | Reference compound |
| HY-117798 | LY 806303 | 149725-15-5 | Reference compound |
| HY-117799 | LY-426965 | 228418-82-4 | Reference compound |
| HY-117799A | LY-426965 (hydrochloride) | 326821-27-6 | Reference compound |
| HY-117799C | (±)-LY-426965 (dihydrochloride) | 228418-81-3 | Reference compound |
| HY-117800 | BJE6-106 | 1564249-38-2 | Reference compound |
| HY-117803 | CP 461 (free base) | 227619-92-3 | Reference compound |
| HY-117804 | 8-Br-cADPR | 151898-26-9 | Reference compound |
| HY-117805 | UR-7247 | 177847-28-8 | Reference compound |
| HY-117807 | A-176120 | 185049-54-1 | Reference compound |
| HY-117809 | PDK1-IN-2 | 1643958-85-3 | Reference compound |
| HY-117810 | JAK2-IN-1 | 1361415-84-0 | Reference compound |
| HY-117811 | (R,R)-MK 287 | 143490-81-7 | Reference compound |
| HY-117813 | 2-Thiouridine | 20235-78-3 | Biochemical Assay Reagents |
| HY-117817 | Ranelic acid | 135459-90-4 | Reference compound |
| HY-117818 | Sapurimycin | 132609-35-9 | Natural Products |
| HY-117819 | TMP920 | 1421837-45-7 | Reference compound |
| HY-117820 | TASP0390325 | 1642187-96-9 | Reference compound |
| HY-117822 | BRD0209 | 1597439-87-6 | Reference compound |
| HY-117823 | VUF11418 | 1414376-85-4 | Reference compound |
| HY-117824 | L-703014 | 142638-79-7 | Reference compound |
| HY-117825 | RU-TRAAK-2 | 1210538-56-9 | Reference compound |
| HY-117826 | JNJ 28610244 | 1251462-28-8 | Reference compound |
| HY-117829 | UNC9994 | 1354030-51-5 | Reference compound |
| HY-117830 | CX08005 | 1256341-22-6 | Reference compound |
| HY-117831 | NSC-79887 | 19056-78-1 | Reference compound |
| HY-117832 | Pyripyropene A | 147444-03-9 | Natural Products |
| HY-117833 | PXS-4681A | 1478364-87-2 | Reference compound |
| HY-117836 | FAK-IN-16 | 1257994-15-2 | Reference compound |
| HY-117837 | GSK1829820A | 1443138-52-0 | Reference compound |
| HY-117838 | Phosphodiesterase 10-IN-2 | 1257051-56-1 | Reference compound |
| HY-117839 | PD-135666 | 134557-41-8 | Reference compound |
| HY-117840 | Altromycin F | 134887-78-8 | Natural Products |
| HY-117841 | T900607 | 261944-52-9 | Reference compound |
| HY-117842 | KY 234 | 172544-75-1 | Reference compound |
| HY-117843 | Ppc-1 | 1245818-17-0 | Reference compound |
| HY-117845 | Citreamicin alpha | 122535-63-1 | Natural Products |
| HY-117846 | MLAF50 | 1417653-96-3 | Reference compound |
| HY-117848 | PDE8B-IN-1 (hydrochloride) | 1305116-67-9 | Reference compound |
| HY-117849 | Neutramycin | 1404-08-6 | Reference compound |
| HY-117850 | TAK 187 | 155432-64-7 | Reference compound |
| HY-117851 | AC-265347 | 1253901-26-6 | Reference compound |
| HY-117853 | Atreleuton | 154355-76-7 | Reference compound |
| HY-117853S | Atreleuton-d4 | 2012598-86-4 | Isotope-Labeled Compounds |
| HY-117854 | SB 201146 | 141311-11-7 | Reference compound |
| HY-117856 | IND24 | 1426047-44-0 | Reference compound |
| HY-117857 | MRT00033659 | 1401731-54-1 | Reference compound |
| HY-117858 | CL-329167 | 143945-39-5 | Reference compound |
| HY-117860 | Vat Yellow 4 | 128-66-5 | Dye Reagents |
| HY-117861 | ML198 | 1380716-06-2 | Reference compound |
| HY-117862 | TASP0412098 | 1233248-29-7 | Reference compound |
| HY-117865 | GNE-886 | 2101957-05-3 | Reference compound |
| HY-117867A | AVE-8063 (hydrochloride) | 162705-22-8 | Reference compound |
| HY-117868 | NC-174 | 138460-25-0 | Reference compound |
| HY-117869 | AFK-108 | 135330-85-7 | Reference compound |
| HY-117870 | Ro 24-4383 | 135312-05-9 | Reference compound |
| HY-117872 | Sartorypyrone A | 1452396-10-9 | Natural Products |
| HY-117873 | KBP-7018 | 1613437-66-3 | Reference compound |
| HY-117873A | KBP-7018 (hydrochloride) | 1613437-67-4 | Reference compound |
| HY-117878 | ML345 | 1632125-79-1 | Reference compound |
| HY-117880 | Exicorilant | 1781244-77-6 | Reference compound |
| HY-117881 | CJ-15208 | 210236-47-8 | Reference compound |
| HY-117882 | Piperiacetildenafil | 147676-50-4 | Reference compound |
| HY-117883 | GZ-793A | 1356447-90-9 | Reference compound |
| HY-117884 | (Rac)-CCT 250863 | 1364269-06-6 | Reference compound |
| HY-117885 | PF-5177624 | 1350821-45-2 | Reference compound |
| HY-117887 | Fidrisertib | 2141955-96-4 | Reference compound |
| HY-117889 | PARP14 inhibitor H10 | 2084811-68-5 | Reference compound |
| HY-117891 | Davasaicin | 147497-64-1 | Reference compound |
| HY-117896 | SC-50605 | 138828-39-4 | Reference compound |
| HY-117897 | CK-2-68 | 1361004-87-6 | Reference compound |
| HY-117900 | PF-06250112 | 1609465-89-5 | Reference compound |
| HY-117900A | (Rac)-PF-06250112 | 1609465-88-4 | Reference compound |
| HY-117901 | Sandoricin | 133585-55-4 | Natural Products |
| HY-117902 | SRI-31142 | 1940118-04-6 | Reference compound |
| HY-117903A | MRT-92 | 1428315-82-5 | Reference compound |
| HY-117906 | GV196771 | 166974-22-7 | Reference compound |
| HY-117909 | CEP-40125 | 1456608-94-8 | Reference compound |
| HY-117910 | (-)-Lentiginosine | 125279-72-3 | Reference compound |
| HY-117912 | TRC210258 | 1431553-15-9 | Reference compound |
| HY-117913 | ES-8891 | 129445-88-1 | Reference compound |
| HY-117917 | (Rac)-MGV354 | 1852495-86-3 | Reference compound |
| HY-117918 | ST-1892 | 1409411-32-0 | Reference compound |
| HY-117921 | DA-E 5090 | 131420-84-3 | Reference compound |
| HY-117922 | JYL-79 | 289902-64-3 | Reference compound |
| HY-117923 | PF-06465603 | 1431626-44-6 | Reference compound |
| HY-117924 | AUTEN-67 | 1783800-77-0 | Reference compound |
| HY-117925 | Personalised postprandial-targeting | 1529779-90-5 | Reference compound |
| HY-117926 | AGN 191701 | 156691-84-8 | Reference compound |
| HY-117927 | EPZ0025654 | 1888328-89-9 | Reference compound |
| HY-117928 | BRL 55834 | 131899-25-7 | Reference compound |
| HY-117930 | Danicopan | 1903768-17-1 | Reference compound |
| HY-117931 | NS004 | 141797-92-4 | Reference compound |
| HY-117934 | Isokotanin B | 154160-09-5 | Natural Products |
| HY-117935 | GGTI-286 (hydrochloride) | 181141-66-2 | Reference compound |
| HY-117936 | Muscarinic agonist 1 | 168818-83-5 | Reference compound |
| HY-117937 | BC-1215 | 1507370-20-8 | Reference compound |
| HY-117938 | T-3861174 | 2209057-94-1 | Reference compound |
| HY-117939 | GM1489 | 171347-75-4 | Reference compound |
| HY-117943 | (rac)-ONO-2050297 | 1637756-67-2 | Reference compound |
| HY-117947 | (R)-OR-S1 | 1809336-19-3 | Reference compound |
| HY-117948 | ML399 | 1560968-49-1 | Reference compound |
| HY-117951 | ANT431 | 1639972-90-9 | Reference compound |
| HY-117952 | L 743310 | 187724-86-3 | Reference compound |
| HY-117953 | RU 59063 | 155180-53-3 | Reference compound |
| HY-117955 | GMA-839 | 162882-76-0 | Reference compound |
| HY-117957 | BMS-932481 | 1263871-36-8 | Reference compound |
| HY-117958 | HJC0197 | 1383539-73-8 | Reference compound |
| HY-117959 | TAK-615 | 1664335-55-0 | Reference compound |
| HY-117960 | Orismilast | 1353546-86-7 | Reference compound |
| HY-117961 | Candoxatrilat | 123122-54-3 | Reference compound |
| HY-117962 | (Rac)-BI 703704 | 1423067-48-4 | Reference compound |
| HY-117962A | BI 703704 | 2740807-77-4 | Reference compound |
| HY-117963 | Lincosamine | 13006-69-4 | Reference compound |
| HY-117964 | Pigment Red 53 | 2092-56-0 | Reference compound |
| HY-117965 | Miricorilant | 1400902-13-7 | Reference compound |
| HY-117966 | Bibn 140 | 145301-79-7 | Reference compound |
| HY-117967 | MK-6169 | 1620479-63-1 | Reference compound |
| HY-117970 | MMPI-1154 | 1382722-47-5 | Reference compound |
| HY-117971 | BVT173187 | 1374984-75-4 | Reference compound |
| HY-117973 | L 691816 | 150461-07-7 | Reference compound |
| HY-117974 | Durlobactam (sodium) | 1467157-21-6 | Reference compound |
| HY-117977 | FCPR03 | 1917347-65-9 | Reference compound |
| HY-117978 | LY2922083 | 1309435-78-6 | Reference compound |
| HY-117979 | Alphadolone | 14107-37-0 | Reference compound |
| HY-117980 | Meturedepa | 1661-29-6 | Reference compound |
| HY-117981 | OUP-186 | 1480830-24-7 | Reference compound |
| HY-117982 | SKI2496 | 1308378-95-1 | Reference compound |
| HY-117983 | RU-505 | 1314206-29-5 | Reference compound |
| HY-117984 | RU 35929 | 111711-47-8 | Reference compound |
| HY-117985 | Evogliptin | 1222102-29-5 | Reference compound |
| HY-117985A | Evogliptin (hydrochloride) | 1246960-27-9 | Reference compound |
| HY-117985B | Evogliptin (tartrate) | 1222102-51-3 | Reference compound |
| HY-117985S | Evogliptin-d9 | Isotope-Labeled Compounds | |
| HY-117986 | AB 3217-A | 139158-99-9 | Natural Products |
| HY-117987 | CPS-11 | 145945-21-7 | Reference compound |
| HY-117988 | SNX2-1-108 | 1366002-73-4 | Reference compound |
| HY-117990 | GSK572A | 1403602-32-3 | Reference compound |
| HY-117991 | DW10075 | 1804982-31-7 | Reference compound |
| HY-117992 | BR103 | 1434873-26-3 | Reference compound |
| HY-117993 | MIND4 | 1639965-26-6 | Reference compound |
| HY-117996 | KPT-251 | 1388841-50-6 | Reference compound |
| HY-117997 | UMB-32 | 1635437-39-6 | Reference compound |
| HY-117999 | BAY39-5493 | 247037-81-6 | Reference compound |
| HY-118008 | Lesopitron | 132449-46-8 | Reference compound |
| HY-118008A | Lesopitron (hydrochloride) | 132449-88-8 | Reference compound |
| HY-118009 | Azotochelin | 23369-85-9 | Natural Products |
| HY-118010 | Norfenfluramine | 1886-26-6 | Reference compound |
| HY-118010A | (+)-Norfenfluramine (hydrochloride) | 37936-89-3 | Reference compound |
| HY-118012 | Flaviviruses-IN-1 | 392237-10-4 | Reference compound |
| HY-118013 | NDM-1 inhibitor-2 | 665013-76-3 | Reference compound |
| HY-118014 | CAY10535 | 945716-28-9 | Reference compound |
| HY-118019 | Scandenolide | 23758-16-9 | Natural Products |
| HY-118020A | Loliolid | 5989-02-6 | Natural Products |
| HY-118021 | Hatomamicin | 116290-93-8 | Natural Products |
| HY-118022 | VU0361747 | 1309976-66-6 | Reference compound |
| HY-118024 | Littorine | 21956-47-8 | Natural Products |
| HY-118025 | (±)-2-Oxo clopidogrel | 109904-27-0 | Reference compound |
| HY-118025R | (±)-2-Oxo clopidogrel (Standard) | 109904-27-0 | Reference Standards |
| HY-118028 | Leyk | 1950-36-3 | Reference compound |
| HY-118029 | Saroaspidin A | 112663-69-1 | Natural Products |
| HY-118030 | RQ-00311651 | 1257116-00-9 | Reference compound |
| HY-118032 | Bozepinib | 1207993-83-6 | Reference compound |
| HY-118033 | SQ 30774 | 121995-36-6 | Reference compound |
| HY-118034 | MTBT | 1110905-26-4 | Reference compound |
| HY-118036 | ACT-387042 | 1229514-11-7 | Reference compound |
| HY-118037 | VUF10132 | 1037732-88-9 | Reference compound |
| HY-118040 | 3-Oxo-C16:1 | 1269663-80-0 | Reference compound |
| HY-118041 | PMPMEase-IN-1 | 1190196-76-9 | Reference compound |
| HY-118043 | RK-1441B | 132138-94-4 | Reference compound |
| HY-118044 | I-SAP | 133538-58-6 | Reference compound |
| HY-118046 | GSK2163632A | 1123163-20-1 | Reference compound |
| HY-118047 | CI 972 (anhydrous) | 115787-68-3 | Reference compound |
| HY-118048 | NAV 26 | 1198160-14-3 | Reference compound |
| HY-118050 | L589420-0-2 | 1431-30-7 | Reference compound |
| HY-118051 | LY 186826 | 126165-79-5 | Reference compound |
| HY-118052 | BPKDi | 1201673-28-0 | Reference compound |
| HY-118054 | LRH-1 Inhibitor-3 | 1185410-60-9 | Reference compound |
| HY-118055 | 15-Deoxy-Δ12,14-prostaglandin A2 | 112839-31-3 | Reference compound |
| HY-118056 | ABD459 | 1047670-51-8 | Reference compound |
| HY-118057 | L-739594 | 156879-13-9 | Reference compound |
| HY-118060 | Dipeptide 2 | 24587-37-9 | Peptides |
| HY-118061 | VCC234718 | 1278553-16-4 | Reference compound |
| HY-118063 | Fluoroclorgyline | 135062-18-9 | Reference compound |
| HY-118064 | (R)-Thionisoxetine | 163059-33-4 | Reference compound |
| HY-118064A | (R)-Thionisoxetine (hydrochloride) | 222961-65-1 | Reference compound |
| HY-118065 | Fenhexamid | 126833-17-8 | Reference compound |
| HY-118065R | Fenhexamid (Standard) | 126833-17-8 | Reference Standards |
| HY-118068 | Methyl 3-hydroxyoctadecanoate | 2420-36-2 | Natural Products |
| HY-118069 | (R)-ZINC-3573 | 2089389-15-9 | Reference compound |
| HY-118072 | Aspalatone | 147249-33-0 | Reference compound |
| HY-118075 | Coenzyme Q2 | 606-06-4 | Enzyme |
| HY-118077 | RE 11775 | 25474-41-3 | Reference compound |
| HY-118078 | Robenacoxib | 220991-32-2 | Reference compound |
| HY-118078R | Robenacoxib (Standard) | 220991-32-2 | Reference Standards |
| HY-118078S | Robenacoxib-d5 | 2012598-81-9 | Isotope-Labeled Compounds |
| HY-118079 | Drimentine B | 204398-91-4 | Reference compound |
| HY-118081 | inS3-54-A26 | 328998-77-2 | Reference compound |
| HY-118084 | LS-104 | 368836-72-0 | Reference compound |
| HY-118085 | Fluazolate | 174514-07-9 | Reference compound |
| HY-118086 | MRS1067 | 70460-45-6 | Reference compound |
| HY-118090 | L-γ-Glutamyl-L-glutamic acid | 1116-22-9 | Peptides |
| HY-118090A | D-γ-Glutamyl-D-glutamic acid | 4553-17-7 | Peptides |
| HY-118091 | LY191704 | 146117-78-4 | Reference compound |
| HY-118091A | Bexlosteride | 148905-78-6 | Reference compound |
| HY-118091B | LY300503 | 148905-79-7 | Reference compound |
| HY-118093 | N-benzoyl-L-aspartic acid | 4631-12-3 | Reference compound |
| HY-118094 | 8-iso Prostaglandin E1 | 21003-46-3 | Reference compound |
| HY-118095 | A60586 | 146667-75-6 | Reference compound |
| HY-118097 | GW0072 | 321557-86-2 | Reference compound |
| HY-118098 | LY3202626 | 1628690-73-2 | Reference compound |
| HY-118099 | Florfenicol amine (hydrochloride) | 108656-33-3 | Reference compound |
| HY-118099R | Florfenicol amine (hydrochloride) (Standard) | 108656-33-3 | Reference Standards |
| HY-118100 | Cyclo(Tyr-Val) | 21754-25-6 | Reference compound |
| HY-118101 | 15-Deoxy-Δ12,14-prostaglandin A1 | 573951-20-9 | Reference compound |
| HY-118103 | Coprostanol | 360-68-9 | Reference compound |
| HY-118103R | Coprostanol (Standard) | 360-68-9 | Reference Standards |
| HY-118103S | Coprostanol-d5 | Isotope-Labeled Compounds | |
| HY-118105 | RK-20448 | 479501-40-1 | Reference compound |
| HY-118109 | SIRT3-IN-2 | 848688-62-0 | Reference compound |
| HY-118110 | MLS000545091 | 322666-76-2 | Reference compound |
| HY-118112 | 4-N-Maleimidobenzoicacid-NHS | 64191-06-6 | Reference compound |
| HY-118113 | BVT-116429 | 870710-02-4 | Reference compound |
| HY-118115 | Pyrabactin | 419538-69-5 | Reference compound |
| HY-118116 | bicyclo-PGE2 | 109826-53-1 | Reference compound |
| HY-118117 | Rovatirelin | 204386-76-5 | Reference compound |
| HY-118118 | Phlebiakauranol aldehyde | 57743-92-7 | Natural Products |
| HY-118119 | CAY10526 | 938069-71-7 | Reference compound |
| HY-118120 | GEMSA | 77482-44-1 | Reference compound |
| HY-118122 | Fialuridine | 69123-98-4 | Reference compound |
| HY-118124 | 2-Iodoestradiol | 24381-12-2 | Reference compound |
| HY-118126 | Mecoprop | 93-65-2 | Reference compound |
| HY-118126R | Mecoprop (Standard) | 93-65-2 | Reference Standards |
| HY-118126S | Mecoprop-d3 | 352431-15-3 | Isotope-Labeled Compounds |
| HY-118127 | Rilapine | 79781-95-6 | Reference compound |
| HY-118129 | Schisandronic acid | 55511-14-3 | Natural Products |
| HY-118131 | PKR-IN-C51 | 1314594-23-4 | Reference compound |
| HY-118132 | LL-Z1220 | 36431-52-4 | Reference compound |
| HY-118133 | 4'-Hydroxy flurbiprofen | 52807-12-2 | Reference compound |
| HY-118134 | Hepln-13 | 64369-13-7 | Reference compound |
| HY-118135 | 4-Methylumbelliferyl-α-D-galactopyranoside | 38597-12-5 | Dye Reagents |
| HY-118136 | CGP 28392 | 89289-93-0 | Reference compound |
| HY-118138 | NC-182 | 106224-67-3 | Reference compound |
| HY-118139 | Desmethyl Celecoxib | 170569-87-6 | Reference compound |
| HY-118139S | Celecoxib-d4 | 544686-20-6 | Isotope-Labeled Compounds |
| HY-118140 | ZCZ011 | 1998197-39-9 | Reference compound |
| HY-118141 | BMS-194449 | 170686-12-1 | Reference compound |
| HY-118142 | 4-Nitrobenzofuroxan | 18771-85-2 | Reference compound |
| HY-118144 | PD166326 | 185039-91-2 | Reference compound |
| HY-118146 | Cicrotoic acid | 25229-42-9 | Reference compound |
| HY-118147 | ML356 | 1808260-45-8 | Reference compound |
| HY-118148 | UK-66914 | 113049-11-9 | Reference compound |
| HY-118149 | 9(S)-HpODE | 29774-12-7 | Reference compound |
| HY-118149A | (±)9-HpODE | 5502-91-0 | Natural Products |
| HY-118151 | Rho-Kinase-IN-3 | 864082-23-5 | Reference compound |
| HY-118152 | Org-12962 | 132834-56-1 | Reference compound |
| HY-118155 | 9-Amino-6-chloro-2-methoxyacridine | 3548-09-2 | Dye Reagents |
| HY-118156 | L-699333 | 155238-60-1 | Reference compound |
| HY-118157 | 3,5,7-Trimethoxyflavone | 26964-29-4 | Reference compound |
| HY-118158 | FAAH/MAGL-IN-4 | 256383-45-6 | Reference compound |
| HY-118159 | Diphenyl-1-pyrenylphosphine | 110231-30-6 | Dye Reagents |
| HY-118160 | PPM-18 | 65240-86-0 | Reference compound |
| HY-118161 | 1-Adamantylaspartate | 115545-59-0 | Reference compound |
| HY-118163 | tetranor-PGFM | 23109-94-6 | Reference compound |
| HY-118164 | Ro 31-8472 | 144284-57-1 | Reference compound |
| HY-118165 | Phenthoate | 2597-03-7 | Reference compound |
| HY-118165R | Phenthoate (Standard) | 2597-03-7 | Reference Standards |
| HY-118165S | Phenthoate-d6 | Isotope-Labeled Compounds | |
| HY-118166 | Gentisein | 529-49-7 | Natural Products |
| HY-118167 | Monoethylglycinexylidide | 7728-40-7 | Reference compound |
| HY-118167R | Monoethylglycinexylidide (Standard) | 7728-40-7 | Reference Standards |
| HY-118167S | Monoethylglycinexylidide-d6 | 1216698-89-3 | Isotope-Labeled Compounds |
| HY-118167S1 | Monoethylglycinexylidide-d6 (hydrochloride) | 2748541-96-8 | Isotope-Labeled Compounds |
| HY-118168 | A 9387 | 3161-15-7 | Reference compound |
| HY-118169 | A-Factor | 60866-47-9 | Reference compound |
| HY-118170 | T16A(inh)-C01 | 171506-87-9 | Reference compound |
| HY-118172 | PD-307243 | 313533-41-4 | Reference compound |
| HY-118174 | N-(2,4-Dinitrophenyl)glycine | 1084-76-0 | Peptides |
| HY-118175 | RG 14921 | 144909-21-7 | Reference compound |
| HY-118177 | Neutrophil elastase inhibitor 1 | 1448314-31-5 | Reference compound |
| HY-118178 | LY43578 | 26766-35-8 | Reference compound |
| HY-118179 | VU0486321 | 1816301-67-3 | Reference compound |
| HY-118180 | CAY10595 | 916047-16-0 | Reference compound |
| HY-118182 | Tidembersat | 175013-73-7 | Reference compound |
| HY-118184 | AF3485 | 1195786-61-8 | Reference compound |
| HY-118185 | SQ 31844 | 115766-42-2 | Reference compound |
| HY-118189 | Misoprostol acid | 112137-89-0 | Reference compound |
| HY-118189S | Misoprostol acid-d5 | 1337917-44-8 | Isotope-Labeled Compounds |
| HY-118190 | AL 8810 methyl ester | 1176541-11-9 | Reference compound |
| HY-118192 | Kmeriol | 54306-10-4 | Natural Products |
| HY-118194 | A-65186 | 119295-94-2 | Reference compound |
| HY-118196 | L 365031 | 111035-59-7 | Reference compound |
| HY-118197 | L-669083 | 130007-52-2 | Reference compound |
| HY-118198 | NPY Y2 antagonist 1 | 1185845-15-1 | Reference compound |
| HY-118202 | (-)-Gallopamil | 36622-40-9 | Reference compound |
| HY-118202A | (-)-Gallopamil (hydrochloride) | 36622-39-6 | Reference compound |
| HY-118203 | SU4984 | 186610-89-9 | Reference compound |
| HY-118205 | SCH-538415 | 637772-75-9 | Reference compound |
| HY-118207 | LU-32-176B | 770688-66-9 | Reference compound |
| HY-118208 | ML-097 | 743456-83-9 | Reference compound |
| HY-118209 | L 646462 | 89149-85-9 | Reference compound |
| HY-118210 | PHOP | 288862-83-9 | Reference compound |
| HY-118211 | EcDsbB-IN-9 | 41933-33-9 | Reference compound |
| HY-118213 | N-(2-Hydroxyethyl)-1,8-naphthalimide | 5450-40-8 | Dye Reagents |
| HY-118216 | Bitertanol | 55179-31-2 | Reference compound |
| HY-118216R | Bitertanol (Standard) | 55179-31-2 | Reference Standards |
| HY-118217 | Cyclanilide | 113136-77-9 | Reference compound |
| HY-118217R | Cyclanilide (Standard) | 113136-77-9 | Reference Standards |
| HY-118220 | EP 171 | 122089-44-5 | Reference compound |
| HY-118221 | Arizonin A1 | 108890-87-5 | Reference compound |
| HY-118222 | KBR 2822 | 126988-60-1 | Reference compound |
| HY-118224 | BPH-715 | 1059677-23-4 | Reference compound |
| HY-118226 | 5,6,7,8-Tetrahydro-2-naphthoic acid | 1131-63-1 | Reference compound |
| HY-118230 | Kidamycin | 11072-82-5 | Reference compound |
| HY-118232 | VUF8504 | 112575-50-5 | Reference compound |
| HY-118233 | Alilusem (potassium) | 114417-20-8 | Reference compound |
| HY-118234 | (Rac)-PD 138312 | 107334-06-5 | Reference compound |
| HY-118236 | (S)-AZD 6482 | 1173900-37-2 | Reference compound |
| HY-118238 | Remeglurant | 1309783-00-3 | Reference compound |
| HY-118239 | Re 80 | 116193-60-3 | Reference compound |
| HY-118242 | RU 45144 | 119286-92-9 | Reference compound |
| HY-118243 | KMS88009 | 1089681-42-4 | Reference compound |
| HY-118244 | Clathrin-IN-3 | 1419321-16-6 | Reference compound |
| HY-118245 | APP-FUBINACA | 1185282-03-4 | Reference compound |
| HY-118247 | Ro 14-6113 | 110675-48-4 | Reference compound |
| HY-118248 | HW 173 | 110270-70-7 | Reference compound |
| HY-118250 | GSK2245035 | 1207629-49-9 | Reference compound |
| HY-118250A | GSK2245035 (maleate) | 1325212-97-2 | Reference compound |
| HY-118251 | PD130883 | 123685-36-9 | Reference compound |
| HY-118256 | LSN2814617 | 1313498-17-7 | Reference compound |
| HY-118256A | (Rac)-LSN2814617 | 1313498-08-6 | Reference compound |
| HY-118259 | L-663581 | 122384-14-9 | Reference compound |
| HY-118260 | Phendioxan | 130905-04-3 | Reference compound |
| HY-118261 | L 659286 | 119742-06-2 | Reference compound |
| HY-118262 | Resorufin acetate | 1152-14-3 | Dye Reagents |
| HY-118263 | Dacomitinib (hydrate) | 1042385-75-0 | Reference compound |
| HY-118264 | MDL-100240 | 142695-08-7 | Reference compound |
| HY-118265 | N-Acetylglutaminylglutamine amide | 123199-99-5 | Reference compound |
| HY-118266 | BTdCPU | 1257423-87-2 | Reference compound |
| HY-118267 | Lentinellic acid | 115219-90-4 | Natural Products |
| HY-118268 | RG 6866 | 120602-97-3 | Reference compound |
| HY-118269 | OSI-296 | 1175296-94-2 | Reference compound |
| HY-118271 | GNF-8625 | 1196546-33-4 | Reference compound |
| HY-118274 | ADDA | 126456-06-2 | Reference compound |
| HY-118275 | FK960 | 133920-70-4 | Reference compound |
| HY-118276 | Lithocholenic acid | 1053-37-8 | Reference compound |
| HY-118279 | KSCM-1 | 1415247-17-4 | Reference compound |
| HY-118281 | ATD-3169 | 1788105-63-4 | Reference compound |
| HY-118282 | mPGES1-IN-7 | 1268709-57-4 | Reference compound |
| HY-118283 | 5-Hydroxylansoprazole | 131926-98-2 | Reference compound |
| HY-118284 | Vicagrel | 1314081-53-2 | Reference compound |
| HY-118285 | Ro4491533 | 579482-31-8 | Reference compound |
| HY-118288 | Aurachin B | 108354-12-7 | Natural Products |
| HY-118292 | Hydroquinone diacetate | 1205-91-0 | Reference compound |
| HY-118294 | 15-OH Tafluprost | 130209-78-8 | Reference compound |
| HY-118295 | Pyrimidine-indole hybrid | 441742-93-4 | Reference compound |
| HY-118297 | Ac4ManNAz (80% α isomer) | 361154-30-5 | Reference compound |
| HY-118299 | JYL 1511 | 623166-14-3 | Reference compound |
| HY-118300 | Abitesartan | 137882-98-5 | Reference compound |
| HY-118301 | ADX71441 | 1207440-88-7 | Reference compound |
| HY-118304 | AKN-028 | 1175017-90-9 | Reference compound |
| HY-118304A | AKN-028 (TFA) | 1175017-91-0 | Reference compound |
| HY-118304B | AKN-028 (acetate) | Reference compound | |
| HY-118306 | Amphidinolide F | 139594-87-9 | Reference compound |
| HY-118308 | AHN-683 | 143934-15-0 | Reference compound |
| HY-118310 | Xylocydine | 685901-63-7 | Reference compound |
| HY-118311 | (Z)-W 3699 | 63250-48-6 | Reference compound |
| HY-118312 | CAY10657 | 494772-86-0 | Reference compound |
| HY-118314 | CI-1015 | 156672-01-4 | Reference compound |
| HY-118315 | L-012 | 143323-55-1 | Reference compound |
| HY-118316 | GSK223 | 899758-61-3 | Reference compound |
| HY-118317 | Zacopride | 90182-92-6 | Reference compound |
| HY-118319 | MJN228 | 459168-97-9 | Reference compound |
| HY-118320 | Alizarine Yellow R | 2243-76-7 | Dye Reagents |
| HY-118322 | Bayer 30468 | 3186-12-7 | Reference compound |
| HY-118324 | 10-Propoxydecanoic acid | 119290-12-9 | Reference compound |
| HY-118325 | Epibatidine (dihydrochloride) | 166374-43-2 | Reference compound |
| HY-118326 | MRT 68601 | 1190379-37-3 | Reference compound |
| HY-118327 | Maleuric acid | 105-61-3 | Reference compound |
| HY-118328 | Hymenidin | 107019-95-4 | Natural Products |
| HY-118329 | S 135 | 104679-67-6 | Reference compound |
| HY-118330 | Apigeninidin (chloride) | 1151-98-0 | Dye Reagents |
| HY-118331 | Kazusamycin B | 107140-30-7 | Reference compound |
| HY-118332 | 19(R)-HETE | 115461-39-7 | Reference compound |
| HY-118334 | Armillaramide | 111149-09-8 | Natural Products |
| HY-118335 | Prazobind | 107021-36-3 | Reference compound |
| HY-118336 | VUF10497 | 1080623-12-6 | Reference compound |
| HY-118338 | WRR-483 | 1076088-50-0 | Reference compound |
| HY-118339 | PF-4479745 | 1065110-43-1 | Reference compound |
| HY-118341 | Clitocine | 105798-74-1 | Natural Products |
| HY-118341R | Clitocine (Standard) | 105798-74-1 | Reference Standards |
| HY-118342 | PQCA | 1144504-35-7 | Reference compound |
| HY-118343 | AC-93253 | 108527-83-9 | Reference compound |
| HY-118347 | Aspartame acesulfame | 106372-55-8 | Peptides |
| HY-118349 | Dansylphenylalanine | 1104-36-5 | Peptides |
| HY-118350 | FR 75513 | 127975-78-4 | Reference compound |
| HY-118351 | N-Tridecanoyl-L-homserine lactone | 878627-21-5 | Biochemical Assay Reagents |
| HY-118352 | LB-205 | 1113025-86-7 | Reference compound |
| HY-118354 | A 80556 | 114676-82-3 | Reference compound |
| HY-118355 | ALLM | 110115-07-6 | Reference compound |
| HY-118356 | WIN 62,577 | 144177-32-2 | Reference compound |
| HY-118357 | Milbemycin A3 Oxime | 114177-14-9 | Reference compound |
| HY-118358 | C8 L-threo ceramide (d18:1/8:0) | 175892-44-1 | Natural Products |
| HY-118362 | Netzahualcoyonol | 113579-07-0 | Reference compound |
| HY-118364 | AGN 190727 | 115503-91-8 | Reference compound |
| HY-118365 | NSC 140873 | 106410-13-3 | Reference compound |
| HY-118367 | A 80915A | 127875-60-9 | Natural Products |
| HY-118368 | L-742001 (hydrochloride) | 174605-64-2 | Reference compound |
| HY-118370 | MF-592 | 1064195-48-7 | Reference compound |
| HY-118371 | Arginase inhibitor 2 | 1345810-21-0 | Reference compound |
| HY-118374 | AM-9635 | 1338483-10-5 | Reference compound |
| HY-118375 | Phenylbutyl isoselenocyanate | 1072807-15-8 | Reference compound |
| HY-118376 | Nestifylline | 116763-36-1 | Reference compound |
| HY-118378 | ZD6021 | 255049-08-2 | Reference compound |
| HY-118379 | NU/ICRF 500 | 156074-08-7 | Reference compound |
| HY-118380 | p-Nitrobenzyl mesylate | 39628-94-9 | Reference compound |
| HY-118382 | SCH-451659 | 502628-66-2 | Reference compound |
| HY-118383 | Agathisflavone | 28441-98-7 | Reference compound |
| HY-118384 | Sangivamycin | 18417-89-5 | Natural Products |
| HY-118384R | Sangivamycin (Standard) | 18417-89-5 | Reference Standards |
| HY-118386 | H2-005 | 1060478-12-7 | Reference compound |
| HY-118387 | AVE-0118 | 498577-53-0 | Reference compound |
| HY-118388 | AS604872 | 612532-48-6 | Reference compound |
| HY-118391 | Benzoyl-L-phenylalanine | 2566-22-5 | Reference compound |
| HY-118397 | RB394 | 1830320-32-5 | Reference compound |
| HY-118399 | PNU-200579 | 194482-44-5 | Reference compound |
| HY-118402 | PD 119819 | 105277-43-8 | Reference compound |
| HY-118403 | CK2-IN-12 | 300675-28-9 | Reference compound |
| HY-118406 | Ethybenztropine | 524-83-4 | Reference compound |
| HY-118406A | Ethybenztropine (hydrochloride) | 26598-44-7 | Reference compound |
| HY-118406B | Ethybenztropine (hydrobromide) | 24815-25-6 | Reference compound |
| HY-118407 | LY56110 | 26766-37-0 | Reference compound |
| HY-118408 | D-4418 | 257892-34-5 | Reference compound |
| HY-118409 | VPC-3033 | 110763-24-1 | Reference compound |
| HY-118410 | L-738167 | 163212-43-9 | Reference compound |
| HY-118411 | 5-Ethynyl-2'-deoxyuridine | 61135-33-9 | Reference compound |
| HY-118412 | Terallethrin | 15589-31-8 | Reference compound |
| HY-118414 | 20-Ethyl prostaglandin E2 | 37492-24-3 | Reference compound |
| HY-118416 | BMS-986124 | 1447968-71-9 | Reference compound |
| HY-118420 | BMS-185411 | 166977-24-8 | Reference compound |
| HY-118421 | Nullscript | 300816-11-9 | Reference compound |
| HY-118423 | SJ-3366 | 195720-26-4 | Reference compound |
| HY-118424 | JNJ-55511118 | 2036081-86-2 | Reference compound |
| HY-118426 | (Rac)-Tipifarnib | 192185-68-5 | Reference compound |
| HY-118427 | Asterriquinol D dimethyl ether | 287117-66-2 | Natural Products |
| HY-118428 | Fluenetil | 4301-50-2 | Reference compound |
| HY-118431 | DMABA NHS ester | 58068-85-2 | Reference compound |
| HY-118431S | DMABA-d4 NHS ester | 1175002-03-5 | Isotope-Labeled Compounds |
| HY-118431S2 | DMABA-d6 NHS ester | 1175002-04-6 | Isotope-Labeled Compounds |
| HY-118431S3 | DMABA-d10 NHS ester | 1175002-05-7 | Isotope-Labeled Compounds |
| HY-118436 | 3-Methyl-2-quinoxalinone | 14003-34-0 | Reference compound |
| HY-118438 | 10-Cl-BBQ | 23982-76-5 | Reference compound |
| HY-118441 | 25T-NBOMe (hydrochloride) | 1539266-47-1 | Reference compound |
| HY-118442 | Sphingosine (d14:1) | 24558-60-9 | Natural Products |
| HY-118444 | (Rac)-WRC-0571 | 501667-77-2 | Reference compound |
| HY-118448 | 2,4-Diacetylphloroglucinol | 2161-86-6 | Reference compound |
| HY-118448R | 2,4-Diacetylphloroglucinol (Standard) | 2161-86-6 | Reference Standards |
| HY-118450 | FR260010 (free base) | 374555-75-6 | Reference compound |
| HY-118451 | Lanomycin | 141363-91-9 | Reference compound |
| HY-118452 | cis-3,4',5-Trimethoxy-3'-hydroxystilbene | 586410-08-4 | Reference compound |
| HY-118455 | MRS1097 | 185259-16-9 | Reference compound |
| HY-118459 | L 658758 | 116507-04-1 | Reference compound |
| HY-118461 | PD 120697 | 108351-91-3 | Reference compound |
| HY-118462 | Coelenteramine 400a | 70217-82-2 | Dye Reagents |
| HY-118462A | Coelenteramine 400a (hydrochloride) | 2320429-05-6 | Reference compound |
| HY-118463 | Benzomalvin A | 157047-96-6 | Natural Products |
| HY-118464 | AC915 | 259729-84-5 | Reference compound |
| HY-118465 | ent-Prostaglandin E2 | 65085-69-0 | Reference compound |
| HY-118466 | Xanthumin | 580-49-4 | Natural Products |
| HY-118467 | Benzolamide | 3368-13-6 | Reference compound |
| HY-118468 | Azothoate | 5834-96-8 | Reference compound |
| HY-118469 | Phanquinone | 84-12-8 | Reference compound |
| HY-118470 | Butaxamine (hydrochloride) | 5696-15-1 | Reference compound |
| HY-118472 | Benazeprilat | 86541-78-8 | Reference compound |
| HY-118472R | Benazeprilat (Standard) | 86541-78-8 | Reference Standards |
| HY-118472S | Benazeprilat-d5 | 1279033-05-4 | Isotope-Labeled Compounds |
| HY-118473 | AZD6370 | 752239-85-3 | Reference compound |
| HY-118474 | GW 610 | 872726-44-8 | Reference compound |
| HY-118475 | 6-Piperazin-1-yl-isoquinoline (hydrochloride) | 936643-77-5 | Reference compound |
| HY-118478 | Ajugasterone B | 21490-21-1 | Natural Products |
| HY-118480 | 4-MMPB | 928853-86-5 | Reference compound |
| HY-118481 | H-Pro-Glu-OH | 67644-00-2 | Reference compound |
| HY-118482 | Sauristolactam | 128533-02-8 | Natural Products |
| HY-118484 | (RS)-Sakuranetin | 520-29-6 | Reference compound |
| HY-118486 | LDL-IN-1 | 615264-52-3 | Reference compound |
| HY-118487 | OB-24 | 939825-12-4 | Reference compound |
| HY-118487A | OB-24 (free base) | 940061-39-2 | Reference compound |
| HY-118488 | L 640035 | 77167-93-2 | Reference compound |
| HY-118489 | L644711 | 81997-33-3 | Reference compound |
| HY-118490 | T-2000 | 97846-21-4 | Reference compound |
| HY-118492 | Riodipine | 71653-63-9 | Reference compound |
| HY-118494 | Ascaridole | 512-85-6 | Natural Products |
| HY-118495 | Cardol diene | 79473-25-9 | Natural Products |
| HY-118497 | BMS 182874 | 153042-42-3 | Reference compound |
| HY-118499 | Alpiropride | 81982-32-3 | Reference compound |
| HY-118503 | Fexaramate | 592524-75-9 | Reference compound |
| HY-118504 | Sulfoxaflor | 946578-00-3 | Reference compound |
| HY-118504R | Sulfoxaflor (Standard) | 946578-00-3 | Reference Standards |
| HY-118512 | Platencin | 869898-86-2 | Reference compound |
| HY-118514 | CAY10514 | 868526-38-9 | Reference compound |
| HY-118515 | ATM4 4-Acetoxy analog | 91295-74-8 | Reference compound |
| HY-118517 | α-Hydroxytamoxifen | 97151-02-5 | Reference compound |
| HY-118518 | Ronipamil | 85247-77-4 | Reference compound |
| HY-118520 | 16-Phenoxy tetranor prostaglandin F2α methyl ester | 51638-90-5 | Reference compound |
| HY-118521 | AS-041164 | 6318-41-8 | Reference compound |
| HY-118524 | Dipiproverine | 117-30-6 | Reference compound |
| HY-118524A | Dipiproverine (hydrochloride) | 2404-18-4 | Reference compound |
| HY-118525 | AL-9 | 869218-90-6 | Reference compound |
| HY-118527 | Fenirofibrate | 54419-31-7 | Reference compound |
| HY-118527S | Fenirofibrate-d6 | 1189423-29-7 | Isotope-Labeled Compounds |
| HY-118528 | TP0427736 | 864374-00-5 | Reference compound |
| HY-118528A | TP0427736 (hydrochloride) | 2459963-17-6 | Reference compound |
| HY-118529 | JUN-1111 | 874351-38-9 | Reference compound |
| HY-118530 | Bucillamine | 65002-17-7 | Reference compound |
| HY-118530R | Bucillamine (Standard) | 65002-17-7 | Reference Standards |
| HY-118532 | Tyrphostin AG30 | 122520-79-0 | Reference compound |
| HY-118533A | Ambenonium (dichloride tetrahydrate) | 52022-31-8 | Reference compound |
| HY-118534 | Cyclobutyrol | 512-16-3 | Reference compound |
| HY-118534A | Cyclobutyrol (sodium) | 1130-23-0 | Reference compound |
| HY-118535 | N-Oleoyl valine | 60374-41-6 | Peptides |
| HY-118537 | ICI 56780 | 28130-28-1 | Reference compound |
| HY-118538 | Noreximide | 3647-74-3 | Reference compound |
| HY-118539 | NSC12404 | 5411-64-3 | Reference compound |
| HY-118540 | Resazurin | 550-82-3 | Dye Reagents |
| HY-118541 | RH-5849 | 112225-87-3 | Reference compound |
| HY-118542 | Nutlin 1 | 548472-58-8 | Reference compound |
| HY-118543 | TM6089 | 863421-32-3 | Reference compound |
| HY-118544 | Sch 24937 | 75696-17-2 | Reference compound |
| HY-118545 | Butamirate | 18109-80-3 | Reference compound |
| HY-118545A | Butamirate (citrate) | 18109-81-4 | Reference compound |
| HY-118545AR | Butamirate (citrate) (Standard) | 18109-81-4 | Reference Standards |
| HY-118546 | JNJ-17156516 | 649551-06-4 | Reference compound |
| HY-118547 | Clorofene | 120-32-1 | Reference compound |
| HY-118548 | Tetranor-PGAM | 52510-53-9 | Reference compound |
| HY-118551 | Bromperidol decanoate | 75067-66-2 | Reference compound |
| HY-118551R | Bromperidol decanoate (Standard) | 75067-66-2 | Reference Standards |
| HY-118553 | Saframycin D | 66082-30-2 | Reference compound |
| HY-118555 | Vascular disrupting agent 1 | 875468-82-9 | Reference compound |
| HY-118556 | Prostaglandin E2 serinol amide | 951209-67-9 | Reference compound |
| HY-118557 | Iferanserin | 58754-46-4 | Reference compound |
| HY-118557A | Iferanserin (hydrochloride) | 210350-29-1 | Reference compound |
| HY-118560S | Tricyclodecenyl acetate-13C2 | Isotope-Labeled Compounds | |
| HY-118561 | Bermoprofen | 78499-27-1 | Reference compound |
| HY-118562 | Dansylamide | 1431-39-6 | Dye Reagents |
| HY-118563 | Farnesylthioacetic acid | 135784-48-4 | Biochemical Assay Reagents |
| HY-118564 | SB209995 | 146574-41-6 | Reference compound |
| HY-118566 | 5α-Androstenone | 18339-16-7 | Natural Products |
| HY-118566S | 5α-Androstenone-d4 | Isotope-Labeled Compounds | |
| HY-118567 | Bis(maltolato)oxovanadium(IV) | 38213-69-3 | Reference compound |
| HY-118570 | 5-Oxoprolyltryptophan | 35937-24-7 | Reference compound |
| HY-118571 | Benzoin methyl ether | 3524-62-7 | Reference compound |
| HY-118574 | UBP141 | 344768-30-5 | Reference compound |
| HY-118575 | DR-4004 | 201608-41-5 | Reference compound |
| HY-118576 | Histidylprolineamide | 33605-69-5 | Peptides |
| HY-118578 | Furalaxyl | 57646-30-7 | Reference compound |
| HY-118578R | Furalaxyl (Standard) | 57646-30-7 | Reference Standards |
| HY-118580 | RO-09-4609 | 279230-20-5 | Reference compound |
| HY-118581 | Coralyne (chloride) | 38989-38-7 | Reference compound |
| HY-118582 | Jacaranone | 60263-07-2 | Natural Products |
| HY-118583A | 4-Fluoro phenibut (hydrochloride) | 1858241-03-8 | Reference compound |
| HY-118584 | Ro 12-7310 | 65316-65-6 | Reference compound |
| HY-118588 | Diminutol | 361431-33-6 | Reference compound |
| HY-118590 | ICRF-193 | 21416-88-6 | Reference compound |
| HY-118590A | ICRF-196 | 21416-68-2 | Reference compound |
| HY-118593 | A2315A | 58717-24-1 | Reference compound |
| HY-118594 | Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 632-93-9 | Reference compound |
| HY-118599 | Prostaglandin F2α ethyl amide | 54130-36-8 | Reference compound |
| HY-118601S | N-Desmethyl Pirenzepine-d8 | 1189860-05-6 | Isotope-Labeled Compounds |
| HY-118607 | VU041 | 332943-64-3 | Reference compound |
| HY-118608 | 2α-Methyl androsterone | 6961-54-2 | Reference compound |
| HY-118609 | EP4 receptor agonist 2 | 493035-81-7 | Reference compound |
| HY-118612 | RO3201195 | 249937-52-8 | Reference compound |
| HY-118614 | β-Nicotyrine | 487-19-4 | Reference compound |
| HY-118614R | β-Nicotyrine (Standard) | 487-19-4 | Reference Standards |
| HY-118615 | LY2048978 | 676495-11-7 | Reference compound |
| HY-118618 | Eucannabinolide | 38458-58-1 | Natural Products |
| HY-118620 | Nortriptyline | 72-69-5 | Natural Products |
| HY-118620R | Nortriptyline (Standard) | 72-69-5 | Reference Standards |
| HY-118621 | JCP174 | 126062-19-9 | Reference compound |
| HY-118622 | Isogentisin | 491-64-5 | Natural Products |
| HY-118624 | Fluprostenol methyl ester | 73275-76-0 | Reference compound |
| HY-118628 | (E/Z)-BML264 | 110683-10-8 | Reference compound |
| HY-118628A | BML264 | 99196-74-4 | Reference compound |
| HY-118630 | Vacuolin-1 | 351986-85-1 | Reference compound |
| HY-118632 | BILR 355 | 380378-81-4 | Reference compound |
| HY-118633 | Ethamoxytriphetol | 67-98-1 | Reference compound |
| HY-118634 | trans-Resveratrol-4'-O-D-Glucuronide | 387372-20-5 | Reference compound |
| HY-118634S | trans-Resveratrol-4'-O-D-Glucuronide-d4 | 1420291-58-2 | Isotope-Labeled Compounds |
| HY-118635 | Cyprodenate | 15585-86-1 | Reference compound |
| HY-118638 | Corynanthine | 483-10-3 | Natural Products |
| HY-118639 | CP-74006 | 4943-86-6 | Reference compound |
| HY-118641 | Cannabinodiol | 39624-81-2 | Natural Products |
| HY-118642 | D-Ribose-L-cysteine | 232617-15-1 | Reference compound |
| HY-118643 | Cimlanod | 1620330-72-4 | Reference compound |
| HY-118645S | 1'-Hydroxymidazolam-d4 | 1781843-10-4 | Isotope-Labeled Compounds |
| HY-118645S1 | 1'-Hydroxymidazolam-13C3 | 1189677-14-2 | Isotope-Labeled Compounds |
| HY-118648 | Prostaglandin F2α methyl ester | 33854-16-9 | Reference compound |
| HY-118651 | Griseoluteic acid | 489-76-9 | Natural Products |
| HY-118652 | Δ17-6-keto Prostaglandin F1α | 68324-95-8 | Reference compound |
| HY-118653 | SAR629 | 1221418-42-3 | Reference compound |
| HY-118656 | Cannabicitran | 31508-71-1 | Natural Products |
| HY-118657 | Ripazepam | 26308-28-1 | Reference compound |
| HY-118659 | Benzalphthalide | 575-61-1 | Reference compound |
| HY-118660 | Anhydrotetracycline (hydrochloride) | 13803-65-1 | Reference compound |
| HY-118660R | Anhydrotetracycline (hydrochloride) (Standard) | 13803-65-1 | Reference Standards |
| HY-118661 | BDM14471 | 934618-96-9 | Reference compound |
| HY-118665 | L-736380 | 152885-49-9 | Reference compound |
| HY-118667 | Dehydroergosterol | 516-85-8 | Biochemical Assay Reagents |
| HY-118668 | ABD-350 | 1117772-52-7 | Reference compound |
| HY-118670 | 16(S)-Iloprost | 74843-14-4 | Reference compound |
| HY-118670A | 16(R)-Iloprost | 74843-13-3 | Reference compound |
| HY-118672 | HNHA | 926908-04-5 | Reference compound |
| HY-118674 | AK-2-38 | 122508-12-7 | Reference compound |
| HY-118675 | L-erythro-Chloramphenicol | 7384-89-6 | Reference compound |
| HY-118676 | Niceritrol | 5868-05-3 | Biochemical Assay Reagents |
| HY-118678 | MRS1186 | 183721-03-1 | Reference compound |
| HY-118681 | 8-Iso-16-cyclohexyl-tetranor prostaglandin E2 | 53319-30-5 | Reference compound |
| HY-118683 | KR-31378 | 335381-68-5 | Reference compound |
| HY-118687 | 4-Bromoethcathinone (hydrochloride) | 135333-26-5 | Reference compound |
| HY-118689 | RA-2 | 1867107-62-7 | Reference compound |
| HY-118694 | TAPI-0 | 163958-73-4 | Reference compound |
| HY-118695 | IRL-3630 | 173189-01-0 | Reference compound |
| HY-118696 | MGAT2-IN-5 | 1426208-69-6 | Reference compound |
| HY-118697 | N-dodecanoyl-L-Homoserine lactone | 137173-46-7 | Reference compound |
| HY-118697R | N-Dodecanoyl-L-homoserine lactone (Standard) | 137173-46-7 | Reference Standards |
| HY-118699 | Indole-3-thio carboxamide | 59108-90-6 | Reference compound |
| HY-118700 | 2-Iminobiotin | 13395-35-2 | Reference compound |
| HY-118700A | 2-Iminobiotin (hydrobromide) | 76985-52-9 | Reference compound |
| HY-118700AR | 2-Iminobiotin (hydrobromide) (Standard) | 76985-52-9 | Reference Standards |
| HY-118703 | L-Ristosamine nucleoside | 136035-11-5 | Reference compound |
| HY-118704 | P-2281 | 1112994-35-0 | Reference compound |
| HY-118705 | Lagochiline | 23554-81-6 | Natural Products |
| HY-118706 | PD 118440 | 108351-90-2 | Reference compound |
| HY-118708 | WEB2347 | 114800-19-0 | Reference compound |
| HY-118709 | Ro 23-7637 | 107071-66-9 | Reference compound |
| HY-118710 | α-Isopropylaminopentiophenone (hydrochloride) | 18268-14-9 | Reference compound |
| HY-118712 | mTOR inhibitor WYE-23 | 1062169-46-3 | Reference compound |
| HY-118714 | α-Hydroxy alprazolam | 37115-43-8 | Reference compound |
| HY-118714S | α-Hydroxy alprazolam-d5 | 136765-24-7 | Isotope-Labeled Compounds |
| HY-118715 | Setin-1 | 1313802-67-3 | Reference compound |
| HY-118716 | PhIP | 105650-23-5 | Reference compound |
| HY-118717 | mTOR inhibitor WYE-28 | 1062172-60-4 | Reference compound |
| HY-118719 | Esterbut-6 | 125161-48-0 | Reference compound |
| HY-118723 | BMH-22 | 309726-06-5 | Reference compound |
| HY-118724 | Laetrile | 1332-94-1 | Natural Products |
| HY-118725 | Luffariellolide | 111149-87-2 | Natural Products |
| HY-118726 | Luotonin F | 244616-85-1 | Natural Products |
| HY-118727 | 6-APDB (hydrochloride) | 1281872-58-9 | Reference compound |
| HY-118728 | Prostaglandin A2 methyl ester | 31753-19-2 | Reference compound |
| HY-118730 | Flucycloxuron | 113036-88-7 | Reference compound |
| HY-118730R | Flucycloxuron (Standard) | 113036-88-7 | Reference Standards |
| HY-118731 | TNK-6123 | 251481-69-3 | Reference compound |
| HY-118734 | IK-862 | 478911-60-3 | Reference compound |
| HY-118736 | Ganodermic acid S | 112430-63-4 | Natural Products |
| HY-118737 | Isamfazone | 55902-02-8 | Reference compound |
| HY-118740 | L-708906 | 251963-74-3 | Reference compound |
| HY-118742 | Benzobicyclon | 156963-66-5 | Reference compound |
| HY-118742R | Benzobicyclon (Standard) | 156963-66-5 | Reference Standards |
| HY-118745 | A-73209 | 136451-98-4 | Reference compound |
| HY-118747 | Scirpusin A | 69297-51-4 | Natural Products |
| HY-118748 | Suprafenacine | 1477482-50-0 | Reference compound |
| HY-118751 | Bensultap | 17606-31-4 | Reference compound |
| HY-118752 | Fentiazac | 18046-21-4 | Reference compound |
| HY-118754 | 13,14-Dihydro-15-keto PGF1α | 29044-75-5 | Reference compound |
| HY-118755 | Acid violet 43 | 4430-18-6 | Biochemical Assay Reagents |
| HY-118756 | Anirolac | 66635-85-6 | Reference compound |
| HY-118758 | γ-Kainylglutamic acid | 98394-38-8 | Reference compound |
| HY-118759 | DSP Crosslinker | 57757-57-0 | ADC Related |
| HY-118759S | DSP Crosslinker-d8 | 1639836-65-9 | Isotope-Labeled Compounds |
| HY-118761 | 5,6-Epoxyretinoic acid | 13100-69-1 | Reference compound |
| HY-118762 | KGP94 | 1131456-28-4 | Reference compound |
| HY-118764 | Propargyl-PEG2-acid | 1859379-85-3 | ADC Related |
| HY-118765 | Ro 23-3423 | 110996-51-5 | Reference compound |
| HY-118768 | FMS586 (free base) | 302556-51-0 | Reference compound |
| HY-118769 | Japonilure | 64726-91-6 | Reference compound |
| HY-118770 | Nafetolol | 42050-23-7 | Reference compound |
| HY-118772 | 17-Phenyl trinor prostaglandin A2 | 38315-51-4 | Reference compound |
| HY-118773 | MreB Perturbing Compound A22 (hydrochloride) | 22816-60-0 | Reference compound |
| HY-118773R | MreB Perturbing Compound A22 (hydrochloride) (Standard) | 22816-60-0 | Reference Standards |
| HY-118774 | Propofol β-D-glucuronide | 114991-26-3 | Reference compound |
| HY-118774R | Propofol β-D-glucuronide (Standard) | 114991-26-3 | Reference Standards |
| HY-118774S | Propofol-d17 β-D-glucuronide | 1683581-05-6 | Isotope-Labeled Compounds |
| HY-118775 | LEK 8804 | 153415-44-2 | Reference compound |
| HY-118778 | KR-32568 | 852146-73-7 | Reference compound |
| HY-118779 | Rhazimine | 93772-08-8 | Natural Products |
| HY-118780 | CHD-5 | 289494-16-2 | Reference compound |
| HY-118781 | Propargyl-PEG3-azide | 932741-18-9 | Reference compound |
| HY-118782 | Ibuprofen diethylaminoethyl ester | 64622-41-9 | Reference compound |
| HY-118783 | 2-Hexyl-4-pentynoic acid | 96017-59-3 | Reference compound |
| HY-118785 | MSP-3 | 1820968-63-5 | Reference compound |
| HY-118788 | N-Desmethyl rosiglitazone | 257892-31-2 | Reference compound |
| HY-118788S | N-Desmethyl rosiglitazone-d4 | 1215407-67-2 | Isotope-Labeled Compounds |
| HY-118790 | BB-223-carboxyindole metabolite | 858515-71-6 | Reference compound |
| HY-118792 | AHR activator 1 | 352346-46-4 | Reference compound |
| HY-118793 | Inosine oxime | 3414-62-8 | Reference compound |
| HY-118795 | SC-22716 | 262451-89-8 | Reference compound |
| HY-118796 | 4-Hydroxy MET | 77872-41-4 | Reference compound |
| HY-118797 | Malioxamycin | 73020-27-6 | Reference compound |
| HY-118798 | DA 3003-2 | 383907-47-9 | Reference compound |
| HY-118802 | 4-Hydroxy DPT | 63065-88-3 | Reference compound |
| HY-118803 | AS1468240 | 365462-61-9 | Reference compound |
| HY-118806 | AC-42 | 244291-63-2 | Reference compound |
| HY-118806A | AC-42 (hydrochloride) | 447407-36-5 | Reference compound |
| HY-118808 | Propargyl-PEG2-NHBoc | 869310-84-9 | ADC Related |
| HY-118809 | J 2931 | 86071-23-0 | Reference compound |
| HY-118810 | BIO-013077-01 | 746667-48-1 | Reference compound |
| HY-118811 | Napropamide-M | 41643-35-0 | Reference compound |
| HY-118813 | 3-Deoxy-galactosone | 4134-97-8 | Natural Products |
| HY-118814 | YM928 | 190842-36-5 | Reference compound |
| HY-118816 | 11β-Prostaglandin F2α | 714966-38-8 | Reference compound |
| HY-118819 | 5-Bromo-3-phenyl salicylic acid | 99514-99-5 | Reference compound |
| HY-118820 | MB-28767 | 80558-61-8 | Reference compound |
| HY-118821 | JTC-017 | 357330-77-9 | Reference compound |
| HY-118824 | Moschamine | 193224-22-5 | Natural Products |
| HY-118824A | N-Feruloylserotonin | 68573-23-9 | Natural Products |
| HY-118825 | N-butyl Amphetamine (hydrochloride) | 35892-11-6 | Reference compound |
| HY-118827 | Vedaprofen | 71109-09-6 | Reference compound |
| HY-118827R | Vedaprofen (Standard) | 71109-09-6 | Reference Standards |
| HY-118827S | Vedaprofen-d3 | 1185054-34-5 | Isotope-Labeled Compounds |
| HY-118828 | 12-Oxo phytodienoic acid | 85551-10-6 | Reference compound |
| HY-118828A | (9S,13R)-12-Oxo phytodienoic acid | 71606-07-0 | Natural Products |
| HY-118828AS | (9S,13R)-12-Oxo phytodienoic acid-d5 | 2692624-08-9 | Isotope-Labeled Compounds |
| HY-118828B | 12-Oxo phytodienoic acid (≥90%) | 85551-10-6 | Natural Products |
| HY-118829 | 3,4-Methylenedioxy PV9 (hydrochloride) | 24646-40-0 | Reference compound |
| HY-118830 | 13,14-Dihydro-15-keto prostaglandin D2 | 59894-07-4 | Reference compound |
| HY-118830S | 13,14-Dihydro-15-keto prostaglandin D2-d4 | Isotope-Labeled Compounds | |
| HY-118830S1 | 13,14-Dihydro-15-keto prostaglandin D2-d9 | 2738376-77-5 | Isotope-Labeled Compounds |
| HY-118833 | RAC 109 | 25360-99-0 | Reference compound |
| HY-118834 | Teleocidin A1 | 70497-14-2 | Natural Products |
| HY-118835 | Zimelidine | 56775-88-3 | Reference compound |
| HY-118836 | GSK215083 | 607742-80-3 | Reference compound |
| HY-118837 | WF-536 | 539857-64-2 | Reference compound |
| HY-118839 | trans-Phenothrin | 66036-31-5 | Reference compound |
| HY-118840 | 1,4-D-Gulonolactone | 6322-07-2 | Natural Products |
| HY-118842 | Sunepitron (hydrochloride) | 148408-65-5 | Reference compound |
| HY-118843 | Lombazole | 60628-98-0 | Reference compound |
| HY-118844 | Flumazenil acid | 84378-44-9 | Reference compound |
| HY-118844R | Flumazenil acid (Standard) | 84378-44-9 | Reference Standards |
| HY-118847 | Antifungal agent 86 | 327077-97-4 | Reference compound |
| HY-118848 | A63162 | 111525-11-2 | Reference compound |
| HY-118851 | NSC-77053 | 77308-57-7 | Reference compound |
| HY-118852 | Isoxaben | 82558-50-7 | Reference compound |
| HY-118852R | Isoxaben (Standard) | 82558-50-7 | Reference Standards |
| HY-118853 | Dichlofenthion | 97-17-6 | Reference compound |
| HY-118854 | Fepradinol | 36981-91-6 | Reference compound |
| HY-118858 | UCPH-102 | 1229591-56-3 | Reference compound |
| HY-118860 | Corifollitropin alfa | 195962-23-3 | Inhibitory Antibodies |
| HY-118861 | Enclomiphene | 15690-57-0 | Reference compound |
| HY-118861A | Enclomiphene (citrate) | 7599-79-3 | Reference compound |
| HY-118861AS1 | Clomiphene-d5 (citrate) | 1217200-17-3 | Isotope-Labeled Compounds |
| HY-118861B | Enclomiphene (hydrochloride) | 14158-65-7 | Reference compound |
| HY-118861S | Enclomiphene-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-118861S1 | Enclomiphene-d4 | Isotope-Labeled Compounds | |
| HY-118865 | Piperaquine (tetraphosphate) | 911061-10-4 | Reference compound |
| HY-118865S | Piperaquine-d6 (tetraphosphate) | Isotope-Labeled Compounds | |
| HY-118870 | γ-Globulins from human blood | 9007-83-4 | Natural Products |
| HY-118874 | Oblimersen | 190977-41-4 | Oligonucleotides |
| HY-118874A | Oblimersen (sodium) | Oligonucleotides | |
| HY-118877 | Urea-13C | 58069-82-2 | Isotope-Labeled Compounds |
| HY-118893 | Asukamycin | 61116-33-4 | Reference compound |
| HY-118894 | AB182 | 54805-58-2 | Reference compound |
| HY-118895 | L-641953 | 89825-69-4 | Reference compound |
| HY-118896 | Acequinocyl | 57960-19-7 | Reference compound |
| HY-118896R | Acequinocyl (Standard) | 57960-19-7 | Reference Standards |
| HY-118896S | Acequinocyl-d25 | 2469735-25-7 | Isotope-Labeled Compounds |
| HY-118897 | UNC-2170 (maleate) | 2173992-60-2 | Reference compound |
| HY-118899 | XR5944 | 343247-32-5 | Reference compound |
| HY-118901 | Opipramol | 315-72-0 | Reference compound |
| HY-118901A | Opipramol (dihydrochloride) | 909-39-7 | Reference compound |
| HY-118901R | Opipramol (Standard) | 315-72-0 | Reference Standards |
| HY-118901S | Opipramol-d4 | 1215716-70-3 | Isotope-Labeled Compounds |
| HY-118902 | Aloisine B | 496864-14-3 | Reference compound |
| HY-118904 | VL-0395 | 620167-11-5 | Reference compound |
| HY-118906 | BO-1165 | 89426-64-2 | Reference compound |
| HY-118907 | Methyl Orange | 547-58-0 | Dye Reagents |
| HY-118907R | Methyl Orange (Standard) | 547-58-0 | Dye Reagents |
| HY-118910 | AHR-14310C | 119810-68-3 | Reference compound |
| HY-118911 | ATM Inhibitor-10 | 1941214-06-7 | Reference compound |
| HY-118912 | BMH-9 | 457937-39-2 | Reference compound |
| HY-118914 | Glucagon receptor antagonist inactive control | 362482-00-6 | Reference compound |
| HY-118915 | FR 106969 | 50655-20-4 | Natural Products |
| HY-118916 | FTI-2148 | 251577-09-0 | Reference compound |
| HY-118916A | FTI-2148 (diTFA) | 817586-01-9 | Reference compound |
| HY-118918 | YM218 (free base) | 387816-81-1 | Reference compound |
| HY-118919 | CYM5181 | 695155-81-8 | Reference compound |
| HY-118920 | SQ 26655 | 82337-14-2 | Reference compound |
| HY-118921 | Ovatodiolide | 3484-37-5 | Natural Products |
| HY-118922 | IW927 | 389142-48-7 | Reference compound |
| HY-118923 | Saflufenacil | 372137-35-4 | Reference compound |
| HY-118923R | Saflufenacil (Standard) | 372137-35-4 | Reference Standards |
| HY-118924 | IR-825 | 1558079-49-4 | Reference compound |
| HY-118925 | Holothurin A | 38-26-6 | Natural Products |
| HY-118926 | Bioresmethrin | 28434-01-7 | Reference compound |
| HY-118930 | MK-0493 | 455956-93-1 | Reference compound |
| HY-118930A | MK-0493 (hydrochloride) | 455957-71-8 | Reference compound |
| HY-118931 | EF-1502 | 684645-54-3 | Reference compound |
| HY-118932 | HCV-IN-45 | 301211-35-8 | Reference compound |
| HY-118933 | Calpain Inhibitor VI | 190274-53-4 | Reference compound |
| HY-118934 | Novocebrin | 36702-84-8 | Reference compound |
| HY-118935 | NGD9002 (free base) | 666256-06-0 | Reference compound |
| HY-118938 | Hoquizil (hydrochloride) | 23256-28-2 | Reference compound |
| HY-118939 | Acantholide | 72548-16-4 | Natural Products |
| HY-118941 | BAY 73-1449 | 693790-96-4 | Reference compound |
| HY-118942 | Topovale | 500214-53-9 | Reference compound |
| HY-118944 | L-748328 | 244192-93-6 | Reference compound |
| HY-118946 | BPH-1358 | 5352-53-4 | Reference compound |
| HY-118946A | BPH-1358 (free base) | 801985-13-7 | Reference compound |
| HY-118946B | BPH-1358 (mesylate) | Reference compound | |
| HY-118948 | MSN-50 | 1592908-75-2 | Reference compound |
| HY-118949 | LY255582 | 119193-09-8 | Reference compound |
| HY-118950 | J 628 | 65323-80-0 | Reference compound |
| HY-118951 | VU0038882 | 429653-28-1 | Reference compound |
| HY-118952 | PF-06456384 | 1834610-73-9 | Reference compound |
| HY-118952A | PF-06456384 (trihydrochloride) | 1834610-75-1 | Reference compound |
| HY-118955 | Acid red 88 | 1658-56-6 | Biochemical Assay Reagents |
| HY-118956 | Adrogolide (hydrochloride) | 166591-11-3 | Reference compound |
| HY-118958 | Ablukast | 96566-25-5 | Reference compound |
| HY-118959 | S2160 | 54799-93-8 | Reference compound |
| HY-118960 | BMS-199264 (hydrochloride) | 186180-83-6 | Reference compound |
| HY-118961 | SR31527 (chloride) | 311814-78-5 | Reference compound |
| HY-118964 | Tyrphostin AG 568 | 151013-48-8 | Reference compound |
| HY-118965 | Alazopeptin | 1397-84-8 | Reference compound |
| HY-118967 | VUANT1 | 663212-40-6 | Reference compound |
| HY-118969 | BMS-262084 | 253174-92-4 | Reference compound |
| HY-118974 | PD-151307 | 225925-12-2 | Reference compound |
| HY-118978 | PF-00277343 | 332926-04-2 | Reference compound |
| HY-118979 | L-691678 | 144210-49-1 | Reference compound |
| HY-118980 | Sorbitol dehydrogenase-IN-1 | 300551-49-9 | Reference compound |
| HY-118982 | CT-2584 | 166981-13-1 | Reference compound |
| HY-118983 | Pivampicillin (hydrochloride) | 26309-95-5 | Reference compound |
| HY-118984 | CRX-526 | 245515-64-4 | Reference compound |
| HY-118985 | Acifluorfen (sodium) | 62476-59-9 | Reference compound |
| HY-118987 | AT-127 | 2099680-72-3 | Reference compound |
| HY-118988 | CAY10506 | 292615-75-9 | Reference compound |
| HY-118990 | Lobelane (hydrochloride) | 246244-19-9 | Reference compound |
| HY-118992 | Aurodox | 12704-90-4 | Reference compound |
| HY-118994 | ARN19874 | 2190502-57-7 | Reference compound |
| HY-118996A | Isometamidium (chloride) | 34301-55-8 | Reference compound |
| HY-118996B | Isometamidium (chloride hydrochloride) | 6798-24-9 | Reference compound |
| HY-118997 | PD-89211 | 444725-49-9 | Reference compound |
| HY-118998 | TX2-121-1 | 1603845-42-6 | Reference compound |
| HY-119001 | BKM1644 | 1070966-96-9 | Reference compound |
| HY-119002 | BO-1236 | 105358-77-8 | Reference compound |
| HY-119005A | YM-49598 (iodide) | 476494-44-7 | Reference compound |
| HY-119006 | L-640,033 | 115326-36-8 | Reference compound |
| HY-119009 | TM-233 | 1103745-28-3 | Reference compound |
| HY-119010 | UCM 549 | 753502-19-1 | Reference compound |
| HY-119011 | Pivampicillin | 33817-20-8 | Reference compound |
| HY-119012 | L 681217 | 93522-10-2 | Reference compound |
| HY-119013 | VPC32183 | 717110-61-7 | Reference compound |
| HY-119016 | SK1-I | 1072443-89-0 | Reference compound |
| HY-119017 | SB-429201 | 1027971-34-1 | Reference compound |
| HY-119018 | AHR-6293 | 61941-63-7 | Reference compound |
| HY-119019 | ASB14780 | 1069046-00-9 | Reference compound |
| HY-119022 | MAC-0547630 | 950386-41-1 | Reference compound |
| HY-119023 | JNJ-26993135 | 841202-16-2 | Reference compound |
| HY-119024 | BCI-137 | 112170-24-8 | Reference compound |
| HY-119025 | L 681176 | 91386-17-3 | Reference compound |
| HY-119030 | Rubradirin | 11031-38-2 | Reference compound |
| HY-119033 | MGL-IN-1 | 1881244-28-5 | Reference compound |
| HY-119034 | AD-20 | 111542-07-5 | Reference compound |
| HY-119035 | R-75317 | 115406-25-2 | Reference compound |
| HY-119037 | UK-101 | 1000313-40-5 | Reference compound |
| HY-119038 | ML-7 | 109376-83-2 | Reference compound |
| HY-119039 | RU-301 | 1110873-99-8 | Reference compound |
| HY-119046 | SNX-0723 | 1073969-18-2 | Reference compound |
| HY-119053 | MS7972 | 352553-42-5 | Reference compound |
| HY-119054 | DNMT1-IN-4 | 889797-65-3 | Reference compound |
| HY-119055 | Sch 33303 | 89108-58-7 | Reference compound |
| HY-119057 | DSM74 | 898743-92-5 | Reference compound |
| HY-119060 | FP0429 | 870860-41-6 | Reference compound |
| HY-119061 | SB357134 | 219963-52-7 | Reference compound |
| HY-119062 | A-800141 | 681245-85-2 | Reference compound |
| HY-119063 | L-645151 | 86394-94-7 | Reference compound |
| HY-119064 | L-645164 | 85493-98-7 | Reference compound |
| HY-119067 | Aspirochlorine | 59978-04-0 | Natural Products |
| HY-119069 | FAUC 3019 | 387360-48-7 | Reference compound |
| HY-119076 | A31472 | 69319-52-4 | Reference compound |
| HY-119078 | VU0080241 | 393845-24-4 | Reference compound |
| HY-119082 | (E/Z)-VU0029767 | 326001-01-8 | Reference compound |
| HY-119082A | VU0029767 | 1134973-88-8 | Reference compound |
| HY-119086 | L-651392 | 93211-49-5 | Reference compound |
| HY-119087 | JNJ-28583867 | 892407-39-5 | Reference compound |
| HY-119088 | Estrogen receptor modulator 12 | 554431-74-2 | Reference compound |
| HY-119092 | Bisaramil | 89194-77-4 | Reference compound |
| HY-119093 | Halopemide | 59831-65-1 | Reference compound |
| HY-119095 | L-741671 | 187724-85-2 | Reference compound |
| HY-119097 | LY456066 | 338738-66-2 | Reference compound |
| HY-119098 | GSK983 | 827591-02-6 | Reference compound |
| HY-119101 | AZD-5672 | 780750-65-4 | Reference compound |
| HY-119102 | BPU-11 | 909664-41-1 | Reference compound |
| HY-119103 | PF-03246799 | 1065110-62-4 | Reference compound |
| HY-119104 | AZD1940 | 881413-29-2 | Reference compound |
| HY-119105 | LY81067 | 87186-60-5 | Reference compound |
| HY-119108 | Emitefur | 110690-43-2 | Reference compound |
| HY-119109 | Laminaran | 9008-22-4 | Natural Products |
| HY-119110 | LY52 | 769970-91-4 | Reference compound |
| HY-119112A | LY 379196 | Reference compound | |
| HY-119113 | C 175 | 6237-31-6 | Reference compound |
| HY-119120 | JTK-101 | 503048-34-8 | Reference compound |
| HY-119123 | Voxvoganan | 1166254-80-3 | Reference compound |
| HY-119123A | Voxvoganan (trihydrochloride) | Reference compound | |
| HY-119124 | Edoxaban M4 | 834919-19-6 | Reference compound |
| HY-119127 | TP-680 | 176915-07-4 | Reference compound |
| HY-119130 | SQ 28516 | 92121-46-5 | Reference compound |
| HY-119131 | AK 275 | 158798-83-5 | Reference compound |
| HY-119136 | BFF-122 | 1152314-49-2 | Reference compound |
| HY-119137 | AMDE-1 | 478043-30-0 | Reference compound |
| HY-119140 | LY 116467 | 57202-76-3 | Reference compound |
| HY-119141 | RH 3421 | 99832-61-8 | Reference compound |
| HY-119145 | MRS2496 | 491611-67-7 | Reference compound |
| HY-119146 | Zolazepam | 31352-82-6 | Reference compound |
| HY-119148 | SQ 28517 | 92131-67-4 | Reference compound |
| HY-119151 | GS-9191 | 859209-84-0 | Reference compound |
| HY-119152 | CMX-2043 | 910627-26-8 | Peptides |
| HY-119156 | Altanserin | 76330-71-7 | Reference compound |
| HY-119158 | VU0652925 | 1476847-58-1 | Reference compound |
| HY-119160 | TM5007 | 342595-05-5 | Reference compound |
| HY-119163 | L-902688 | 634193-54-7 | Reference compound |
| HY-119165 | GSM-1 | 884600-68-4 | Reference compound |
| HY-119166 | 3,5,4'-Tribromosalicylanilide | 87-10-5 | Reference compound |
| HY-119168 | LP-471756 | 413605-11-5 | Reference compound |
| HY-119169 | Tubulozole | 84697-22-3 | Reference compound |
| HY-119171 | GSK 366 | 1953157-39-5 | Reference compound |
| HY-119172 | NSC-60339 | 70-09-7 | Reference compound |
| HY-119173 | PBD-150 | 790663-33-1 | Reference compound |
| HY-119174 | MK771 | 66537-55-1 | Reference compound |
| HY-119176 | Oxyfluorfen | 42874-03-3 | Reference compound |
| HY-119176R | Oxyfluorfen (Standard) | 42874-03-3 | Reference Standards |
| HY-119177 | PD173956 | 305820-76-2 | Reference compound |
| HY-119179 | UCCF-853 | 625458-06-2 | Reference compound |
| HY-119182 | Mitonafide | 54824-17-8 | Reference compound |
| HY-119183 | A 23887 | 61955-05-3 | Reference compound |
| HY-119185 | AZD-6605 | 893556-15-5 | Reference compound |
| HY-119186 | Axillarin | 5188-73-8 | Natural Products |
| HY-119188 | Saframycin A | 66082-27-7 | Reference compound |
| HY-119190 | PF-06445974 | 2055776-17-3 | Reference compound |
| HY-119191 | KF26777 (free base) | 206129-88-6 | Reference compound |
| HY-119195 | I5B2 | 93768-49-1 | Natural Products |
| HY-119196 | Caprospinol | 4952-56-1 | Reference compound |
| HY-119197 | PPARα/γ/δ agonist 1 | 853652-40-1 | Reference compound |
| HY-119198 | NSC745885 | 4219-52-7 | Reference compound |
| HY-119200 | LY-195448 (hydrochloride) | 111112-18-6 | Reference compound |
| HY-119202 | (S)-BMS-378806 | 357263-14-0 | Reference compound |
| HY-119203 | NNC 38-1049 | 757183-18-9 | Reference compound |
| HY-119206 | Sulbenicillin | 41744-40-5 | Reference compound |
| HY-119208 | VUF11211 | 906556-51-2 | Reference compound |
| HY-119209 | Nefazodone | 83366-66-9 | Reference compound |
| HY-119210 | ZINC04177596 | 364052-84-6 | Reference compound |
| HY-119211 | LY 97241 | 72456-63-4 | Reference compound |
| HY-119213 | BMY-27709 | 99390-76-8 | Reference compound |
| HY-119215 | Antioquine | 93767-27-2 | Reference compound |
| HY-119217 | AZ084 | 929300-19-6 | Reference compound |
| HY-119218 | LH 1 | 67190-52-7 | Reference compound |
| HY-119219 | Detoxin C1 | 74717-53-6 | Natural Products |
| HY-119220 | Granotapide | 594842-13-4 | Reference compound |
| HY-119221 | AUY954 | 820240-77-5 | Reference compound |
| HY-119221A | AUY 954 (hydrochloride) | 820240-78-6 | Reference compound |
| HY-119222 | GSK256073 | 862892-90-8 | Reference compound |
| HY-119222A | GSK256073 (tris) | 1228650-42-7 | Reference compound |
| HY-119223 | Desmethylmirtazapine | 61337-68-6 | Reference compound |
| HY-119223R | Desmethylmirtazapine (Standard) | 61337-68-6 | Reference Standards |
| HY-119224 | BIA 3-335 | 359783-06-5 | Reference compound |
| HY-119226 | VU0152099 | 612514-42-8 | Reference compound |
| HY-119229 | VRT-325 | 815592-21-3 | Reference compound |
| HY-119230 | Kobe2601 | 316151-68-5 | Reference compound |
| HY-119232 | GSK466317A | 864082-48-4 | Reference compound |
| HY-119234 | CX4338 | 41609-06-7 | Reference compound |
| HY-119238 | CRL-42872 | 256385-24-7 | Reference compound |
| HY-119239 | R 28935 | 55806-43-4 | Reference compound |
| HY-119240 | CCT020312 | 324759-76-4 | Reference compound |
| HY-119242 | BTI-A-404 | 537679-57-5 | Reference compound |
| HY-119243 | LY2794193 | 2173037-97-1 | Reference compound |
| HY-119244 | Gly-Pro-pNA (hydrochloride) | 103213-34-9 | Reference compound |
| HY-119245 | Udifitimod | 1883345-06-9 | Reference compound |
| HY-119246 | A-269A | 38621-52-2 | Natural Products |
| HY-119248 | KRP-297 | 213252-19-8 | Reference compound |
| HY-119254 | BAY-850 | 2099142-76-2 | Reference compound |
| HY-119254A | trans-BAY-850 | Reference compound | |
| HY-119256 | COR627 | 329221-34-3 | Reference compound |
| HY-119257 | ABT-100 | 450839-40-4 | Reference compound |
| HY-119259 | AZD8309 | 333742-48-6 | Reference compound |
| HY-119261 | Ruboxyl | 80214-88-6 | Reference compound |
| HY-119264 | PRLX-93936 | 903499-49-0 | Reference compound |
| HY-119264A | PRLX-93936 (dihydrochloride) | 1094210-96-4 | Reference compound |
| HY-119265 | LDL-IN-4 | 615264-62-5 | Reference compound |
| HY-119266 | HTS13517 | 91533-02-7 | Reference compound |
| HY-119268 | Thiosildenafil | 479073-79-5 | Reference compound |
| HY-119268R | Thiosildenafil (Standard) | 479073-79-5 | Reference Standards |
| HY-119270 | PD 130908 | 131505-02-7 | Reference compound |
| HY-119271 | CMLD010509 | 256497-58-2 | Reference compound |
| HY-119271A | (-)-CMLD010509 | 2240186-24-5 | Reference compound |
| HY-119272 | EF24 | 342808-40-6 | Reference compound |
| HY-119274 | BN-82451 (dihydrochloride) | 663172-95-0 | Reference compound |
| HY-119277 | CJB-090 (dihydrochloride) | 595584-40-0 | Reference compound |
| HY-119279 | VUF 10214 | 848837-33-2 | Reference compound |
| HY-119280 | Sch 29482 | 77646-83-4 | Reference compound |
| HY-119282 | AZD6538 | 453566-30-8 | Reference compound |
| HY-119283 | CAY10499 | 359714-55-9 | Reference compound |
| HY-119287 | TSQ | 109628-27-5 | Dye Reagents |
| HY-119288 | BC-23 | 6298-15-3 | Reference compound |
| HY-119291 | RA642 | 54093-30-0 | Reference compound |
| HY-119293 | K777 | 233277-99-1 | Reference compound |
| HY-119293A | K777 (tosylate) | 502960-91-0 | Oligonucleotides |
| HY-119296 | Cloprednol | 5251-34-3 | Reference compound |
| HY-119296R | Cloprednol (Standard) | 5251-34-3 | Reference Standards |
| HY-119304 | GW-406381 | 221148-46-5 | Reference compound |
| HY-119306 | MCC-134 | 181238-67-5 | Reference compound |
| HY-119307 | Apratastat | 287405-51-0 | Reference compound |
| HY-119309 | Sucrose octaacetate | 126-14-7 | Reference compound |
| HY-119309R | Sucrose octaacetate (Standard) | 126-14-7 | Reference Standards |
| HY-119311 | Ketopioglitazone | 146062-45-5 | Reference compound |
| HY-119311S | Ketopioglitazone-d4 | 1215370-26-5 | Isotope-Labeled Compounds |
| HY-119312 | C8 Dihydroceramide | 145774-33-0 | Reference compound |
| HY-119315 | Flucloronide | 3693-39-8 | Reference compound |
| HY-119316A | CM-545 | 1624792-70-6 | Reference compound |
| HY-119319 | LLP6 | 254902-10-8 | Reference compound |
| HY-119320 | Ethimidine | 2482-80-6 | Reference compound |
| HY-119322 | Tifenazoxide | 279215-43-9 | Reference compound |
| HY-119323 | 7-Azido-4-methylcoumarin | 95633-27-5 | Reference compound |
| HY-119324 | Anticancer agent 254 | 1841421-67-7 | Reference compound |
| HY-119325A | Lanperisone (hydrochloride) | 116287-13-9 | Reference compound |
| HY-119326 | N-Formylmethamphetamine | 42932-20-7 | Reference compound |
| HY-119327 | Butylate | 2008-41-5 | Reference compound |
| HY-119327R | Butylate (Standard) | 2008-41-5 | Reference Standards |
| HY-119328 | Pestalotin | 34565-32-7 | Natural Products |
| HY-119329 | Glycidamide | 5694-00-8 | Reference compound |
| HY-119331 | CFM-5 | 639507-03-2 | Reference compound |
| HY-119332 | 3-Keto petromyzonol | 359436-56-9 | Natural Products |
| HY-119333 | NNC 11-1607 | 250649-13-9 | Reference compound |
| HY-119335 | Cyphenothrin | 39515-40-7 | Reference compound |
| HY-119335R | Cyphenothrin (Standard) | 39515-40-7 | Reference Standards |
| HY-119336 | Mebroqualone | 4260-20-2 | Reference compound |
| HY-119337 | CE-2072 | 208840-22-6 | Reference compound |
| HY-119339 | SX-682 | 1648843-04-2 | Reference compound |
| HY-119343 | Biotin-PFP ester | 120550-35-8 | Reference compound |
| HY-119344 | MS37452 | 423748-02-1 | Reference compound |
| HY-119347 | Cirsilineol | 41365-32-6 | Natural Products |
| HY-119347R | Cirsilineol (Standard) | 41365-32-6 | Reference Standards |
| HY-119349 | (±)-Dihydrozeatin | 23599-75-9 | Reference compound |
| HY-119350 | Zalunfiban | 1448313-27-6 | Reference compound |
| HY-119350B | Zalunfiban (dihydrochloride) | 2815778-41-5 | Reference compound |
| HY-119350C | Zalunfiban (acetate) | 2376629-15-9 | Reference compound |
| HY-119351 | BNS | 1417440-37-9 | Reference compound |
| HY-119352 | S-2 Methanandamide | 157182-48-4 | Reference compound |
| HY-119353 | Repromicin | 56689-42-0 | Reference compound |
| HY-119357 | TN-16 | 33016-12-5 | Reference compound |
| HY-119358 | Traumatic Acid | 6402-36-4 | Natural Products |
| HY-119358R | Traumatic Acid (Standard) | 6402-36-4 | Reference Standards |
| HY-119359 | 5,6-Epoxy-13-cis retinoic acid | 81444-57-7 | Reference compound |
| HY-119360 | Lilly 18947 (free base) | 2600-77-3 | Reference compound |
| HY-119361 | (Rac)-Deox B 7,4 | 674786-37-9 | Reference compound |
| HY-119366 | S18-000003 | 2068119-11-7 | Reference compound |
| HY-119367 | ODM-203 | 1430723-35-5 | Reference compound |
| HY-119368 | NPB | 2247491-97-8 | Reference compound |
| HY-119369 | FadD32 Inhibitor-1 | 2081969-24-4 | Reference compound |
| HY-119370 | CHMFL-ABL-121 | 2270879-07-5 | Reference compound |
| HY-119372 | TDP1 Inhibitor-1 | 2248702-80-7 | Reference compound |
| HY-119373 | Cav 2.2 blocker 1 | 1567335-29-8 | Reference compound |
| HY-119374 | BRM/BRG1 ATP Inhibitor-1 | 2270879-17-7 | Reference compound |
| HY-119375 | Syncytial Virus Inhibitor-1 | 1422496-79-4 | Reference compound |
| HY-119377 | UPGL00004 | 1890169-95-5 | Reference compound |
| HY-119378 | AK 295 | 160399-35-9 | Reference compound |
| HY-119379 | Fonsartan (free acid) | 144628-52-4 | Reference compound |
| HY-119381 | Iodofenphos | 18181-70-9 | Reference compound |
| HY-119381R | Iodofenphos (Standard) | 18181-70-9 | Reference Standards |
| HY-119383 | iCRT-5 | 18623-44-4 | Reference compound |
| HY-119384 | Promegestone | 34184-77-5 | Reference compound |
| HY-119385 | Savoxepin (mesylate) | 79262-47-8 | Reference compound |
| HY-119387 | Chevalone B | 1318025-75-0 | Natural Products |
| HY-119389 | RGH-1756 | 207277-37-0 | Reference compound |
| HY-119390 | AA-CW236 | 1869921-96-9 | Reference compound |
| HY-119392 | 16-Hexadecanolide | 109-29-5 | Natural Products |
| HY-119393 | Olanzapine N-oxide | 174794-02-6 | Reference compound |
| HY-119393S | Olanzapine N-Oxide-d3 | 1189732-75-9 | Isotope-Labeled Compounds |
| HY-119395A | Kynuramine (dihydrobromide) | 304-47-2 | Reference compound |
| HY-119395B | Kynuramine (dihydrochloride) | 36681-58-0 | Reference compound |
| HY-119396 | DY3002 | 2020015-37-4 | Reference compound |
| HY-119397 | KDM5-C49 | 1596348-16-1 | Reference compound |
| HY-119397A | KDM5-C49 (hydrochloride) | 3026728-26-4 | Reference compound |
| HY-119398 | Lanuginosine | 23740-25-2 | Reference compound |
| HY-119401 | CAY10444 | 298186-80-8 | Reference compound |
| HY-119402 | TP-021 | 2130878-25-8 | Reference compound |
| HY-119403 | 4-Phenyl-1,2,3-thiadiazole | 25445-77-6 | Reference compound |
| HY-119404 | Diproqualone | 36518-02-2 | Reference compound |
| HY-119405 | Niddamycin | 20283-69-6 | Reference compound |
| HY-119407 | Terpendole E | 167427-23-8 | Natural Products |
| HY-119409 | Levophacetoperane | 24558-01-8 | Reference compound |
| HY-119410 | Linotroban | 120824-08-0 | Reference compound |
| HY-119412 | Biliatresone | 1801433-90-8 | Natural Products |
| HY-119413 | 9-Ethyladenine | 2715-68-6 | Natural Products |
| HY-119413R | 9-Ethyladenine (Standard) | 2715-68-6 | Reference Standards |
| HY-119414 | N,N-Dimethyl-L-valine | 2812-32-0 | Reference compound |
| HY-119415 | Levovirin | 206269-27-4 | Reference compound |
| HY-119417 | Chloramben | 133-90-4 | Reference compound |
| HY-119417A | Chloramben (sodium) | 1954-81-0 | Reference compound |
| HY-119417R | Chloramben (Standard) | 133-90-4 | Reference Standards |
| HY-119418 | Desketoraloxifene | 216570-81-9 | Reference compound |
| HY-119419 | Pirimicarb | 23103-98-2 | Reference compound |
| HY-119419R | Pirimicarb (Standard) | 23103-98-2 | Reference Standards |
| HY-119419S | Pirimicarb-d6 | 1015854-66-6 | Isotope-Labeled Compounds |
| HY-119422 | Melianodiol | 32764-64-0 | Natural Products |
| HY-119423 | MMP Inhibitor II | 203915-59-7 | Reference compound |
| HY-119424 | SP4206 | 515846-21-6 | Reference compound |
| HY-119425 | Razoxane | 21416-67-1 | Reference compound |
| HY-119426 | Dexamisole | 14769-74-5 | Reference compound |
| HY-119427 | Anti-melanoma agent 3 | 1253697-49-2 | Reference compound |
| HY-119429 | Bis-PEG4-acid | 31127-85-2 | Reference compound |
| HY-119433 | Asoprisnil | 199396-76-4 | Reference compound |
| HY-119435 | Triallate | 2303-17-5 | Reference compound |
| HY-119435R | Triallate (Standard) | 2303-17-5 | Reference Standards |
| HY-119437 | FLTX1 | 1481401-71-1 | Reference compound |
| HY-119438 | Aspon | 3244-90-4 | Reference compound |
| HY-119439 | Lignan J1 | 27041-98-1 | Natural Products |
| HY-119440 | Xanthinol | 2530-97-4 | Reference compound |
| HY-119442 | Quininib | 143816-42-6 | Reference compound |
| HY-119443 | Neridronate | 79778-41-9 | Reference compound |
| HY-119445 | Sophorose | 534-46-3 | Biochemical Assay Reagents |
| HY-119445A | Sophorose (monohydrate) | 140686-17-5 | Biochemical Assay Reagents |
| HY-119447 | Mavacoxib | 170569-88-7 | Reference compound |
| HY-119447S | Mavacoxib-d4 | Isotope-Labeled Compounds | |
| HY-119451 | (Z)-8-Dodecenyl acetate | 28079-04-1 | Reference compound |
| HY-119453 | Oxycinchophen | 485-89-2 | Reference compound |
| HY-119454S | Chlomethoxyfen-d3 | Isotope-Labeled Compounds | |
| HY-119456 | Romifidine | 65896-16-4 | Reference compound |
| HY-119456A | Romifidine (hydrochloride) | 65896-14-2 | Reference compound |
| HY-119456AS | Romifidine-d4 (hydrochloride) | 1329834-57-2 | Isotope-Labeled Compounds |
| HY-119458 | Luotonin A | 205989-12-4 | Natural Products |
| HY-119459 | Fluopyram | 658066-35-4 | Reference compound |
| HY-119459R | Fluopyram (Standard) | 658066-35-4 | Reference Standards |
| HY-119460 | Cuspin-1 | 337932-29-3 | Reference compound |
| HY-119461 | Capuride | 5579-13-5 | Reference compound |
| HY-119464 | MRL-871 | 1392809-08-3 | Reference compound |
| HY-119465 | Restricticin | 135357-96-9 | Natural Products |
| HY-119466 | Broperamole | 33144-79-5 | Reference compound |
| HY-119467 | MDK0734 | 1366240-73-4 | Reference compound |
| HY-119468 | Medifoxamine | 32359-34-5 | Reference compound |
| HY-119469 | Aceclofenac ethyl ester | 139272-67-6 | Reference compound |
| HY-119478 | Lophophorine | 17627-78-0 | Natural Products |
| HY-119480 | Megazol | 19622-55-0 | Reference compound |
| HY-119482 | Cymipristone | 329971-40-6 | Reference compound |
| HY-119485 | Dilevalol | 75659-07-3 | Reference compound |
| HY-119485AS | Dilevalol-d3 (hydrochloride) | 2734920-41-1 | Isotope-Labeled Compounds |
| HY-119486 | Tavapadon | 1643489-24-0 | Reference compound |
| HY-119486A | (Rac)-Tavapadon | 1643462-64-9 | Reference compound |
| HY-119487 | MMPP | 1895957-18-2 | Reference compound |
| HY-119490 | UMB-136 | 2109805-83-4 | Reference compound |
| HY-119491 | Ethyl tricosanoate | 18281-07-7 | Biochemical Assay Reagents |
| HY-119493 | MSBN | 135980-66-4 | Reference compound |
| HY-119494 | Commendamide | 193825-78-4 | Reference compound |
| HY-119497 | SB251023 | 208842-53-9 | Reference compound |
| HY-119499 | 6-Thioguanosine | 85-31-4 | Reference compound |
| HY-119500 | Ilimaquinone | 71678-03-0 | Natural Products |
| HY-119502 | Camalexin | 135531-86-1 | Natural Products |
| HY-119502R | Camalexin (Standard) | 135531-86-1 | Reference Standards |
| HY-119505 | Curcuphenol | 69301-27-5 | Reference compound |
| HY-119506 | KL044 | 1801856-93-8 | Reference compound |
| HY-119508 | Propaphos | 7292-16-2 | Reference compound |
| HY-119509 | Cismethrin | 35764-59-1 | Reference compound |
| HY-119513 | Nizofenone | 54533-85-6 | Reference compound |
| HY-119515 | Denopamine | 71771-90-9 | Reference compound |
| HY-119516 | Naftalofos | 1491-41-4 | Reference compound |
| HY-119517 | Seclazone | 29050-11-1 | Reference compound |
| HY-119518 | BMS641 | 369364-50-1 | Reference compound |
| HY-119519 | OB-2 | 300689-25-2 | Reference compound |
| HY-119521 | Mexiletine | 31828-71-4 | Reference compound |
| HY-119521S | Mexiletine-d3 | Isotope-Labeled Compounds | |
| HY-119521S1 | Mexiletine-d6 | 1330267-50-9 | Isotope-Labeled Compounds |
| HY-119523 | Disuccinimidyl sebacate | 23024-29-5 | Reference compound |
| HY-119524 | Clofibride | 26717-47-5 | Reference compound |
| HY-119525 | Propetamphos | 31218-83-4 | Reference compound |
| HY-119525R | Propetamphos (Standard) | 31218-83-4 | Reference Standards |
| HY-119526 | Bismaleimide | 13676-54-5 | Reference compound |
| HY-119527 | Conagenin | 134381-30-9 | Natural Products |
| HY-119528 | Mansonone F | 5090-88-0 | Natural Products |
| HY-119529 | Jineol | 178762-28-2 | Natural Products |
| HY-119530 | Thiamiprine | 5581-52-2 | Reference compound |
| HY-119530R | Thiamiprine (Standard) | 5581-52-2 | Reference Standards |
| HY-119532 | Nordeprenyl | 18913-84-3 | Reference compound |
| HY-119532R | Nordeprenyl (Standard) | 18913-84-3 | Reference Standards |
| HY-119536 | Norsufentanil | 61086-18-8 | Reference compound |
| HY-119536S | Norsufentanil-d3 | 1204688-16-3 | Isotope-Labeled Compounds |
| HY-119537 | Alstonidine | 25394-75-6 | Natural Products |
| HY-119539 | Limocitrin | 489-33-8 | Natural Products |
| HY-119540 | Furametpyr | 123572-88-3 | Reference compound |
| HY-119541 | Ampreloxetine | 1227056-84-9 | Reference compound |
| HY-119541A | Ampreloxetine (TFA) | 1227056-85-0 | Reference compound |
| HY-119543 | O-Succinyl-L-homoserine | 1492-23-5 | Peptides |
| HY-119544 | Ripisartan | 148504-51-2 | Reference compound |
| HY-119545 | PD159790 | 179598-53-9 | Reference compound |
| HY-119546 | Pinolenic acid | 16833-54-8 | Natural Products |
| HY-119548 | Bifidenone | 2078008-57-6 | Reference compound |
| HY-119550 | J1075 | 383892-69-1 | Reference compound |
| HY-119552 | Acetylaszonalenin | 42230-55-7 | Natural Products |
| HY-119554 | Perfluorodecyl bromide | 307-43-7 | Reference compound |
| HY-119556 | Butonate | 126-22-7 | Reference compound |
| HY-119557 | Buthiazide | 2043-38-1 | Reference compound |
| HY-119558 | Bromacil | 314-40-9 | Reference compound |
| HY-119558R | Bromacil (Standard) | 314-40-9 | Reference Standards |
| HY-119560 | Spirgetine | 144-45-6 | Reference compound |
| HY-119572 | Sodium zirconium cyclosilicate | 17141-74-1 | Reference compound |
| HY-119575 | Tetramethyluric acid | 2309-49-1 | Biochemical Assay Reagents |
| HY-119576 | Phox-I2 | 353495-22-4 | Reference compound |
| HY-119577 | Ubretid | 15876-67-2 | Reference compound |
| HY-119577R | Ubretid (Standard) | 15876-67-2 | Reference Standards |
| HY-119580 | Leucocyanidin | 480-17-1 | Natural Products |
| HY-119580B | (+)-Leucocyanidin | 69256-15-1 | Natural Products |
| HY-119580R | Leucocyanidin (Standard) | 480-17-1 | Reference Standards |
| HY-119581 | MBED | 123363-40-6 | Reference compound |
| HY-119582 | Safironil | 134377-69-8 | Reference compound |
| HY-119583 | Furanomycin | 18455-25-9 | Reference compound |
| HY-119586 | LG190119 | 233268-77-4 | Reference compound |
| HY-119587 | Alestramustine | 139402-18-9 | Reference compound |
| HY-119589 | Altersolanol B | 22350-90-9 | Reference compound |
| HY-119591 | BPDBA | 312281-74-6 | Reference compound |
| HY-119592 | Cyclophostin | Natural Products | |
| HY-119593 | α-Homonojirimycin | 119557-99-2 | Natural Products |
| HY-119594 | Melarsoprol | 494-79-1 | Reference compound |
| HY-119595 | Haloperidide | 2924-46-1 | Reference compound |
| HY-119596 | Eupatoriochromene | 19013-03-7 | Natural Products |
| HY-119599 | Linearolactone | 113973-98-1 | Natural Products |
| HY-119602 | Rolziracetam | 18356-28-0 | Reference compound |
| HY-119603 | Regelinol | 109974-22-3 | Natural Products |
| HY-119604 | Cafamycin | 112303-17-0 | Natural Products |
| HY-119605 | DAA-1097 | 220551-79-1 | Reference compound |
| HY-119606 | Bacimethrin | 3690-12-8 | Biochemical Assay Reagents |
| HY-119607 | DYRKi | 1640364-04-0 | Reference compound |
| HY-119608 | GSK854 | 1316059-00-3 | Reference compound |
| HY-119609 | Ilicicolin C | 22562-67-0 | Natural Products |
| HY-119611 | Thioquinapiperifil | 220060-39-9 | Reference compound |
| HY-119611A | Thioquinapiperifil (dihydrochloride) | 204077-66-7 | Reference compound |
| HY-119613 | Clociguanil | 3378-93-6 | Reference compound |
| HY-119614 | Niridazole | 61-57-4 | Reference compound |
| HY-119615 | Mezilamine | 50335-55-2 | Reference compound |
| HY-119616 | Phenamet | 3819-34-9 | Reference compound |
| HY-119617 | 2-(3-Hydroxypicolinamido)acetic acid | 3458-69-3 | Reference compound |
| HY-119618 | R1498 | 303196-31-8 | Reference compound |
| HY-119621 | Aceglatone | 642-83-1 | Reference compound |
| HY-119624 | MOMIPP | 1363421-46-8 | Reference compound |
| HY-119627 | Cajucarinolide | 147742-03-8 | Natural Products |
| HY-119630 | Propineb | 12071-83-9 | Reference compound |
| HY-119630R | Propineb (Standard) | 12071-83-9 | Reference Standards |
| HY-119631 | Nornidulin | 33403-37-1 | Reference compound |
| HY-119632 | Anisopirol | 857-62-5 | Reference compound |
| HY-119635 | Albicanol | 54632-04-1 | Natural Products |
| HY-119637 | Frangufoline | 19526-09-1 | Natural Products |
| HY-119638 | Oxiperomide | 5322-53-2 | Reference compound |
| HY-119640 | Aspercolorin | 29123-52-2 | Natural Products |
| HY-119641 | Apholate | 52-46-0 | Reference compound |
| HY-119642 | Kopsinine | 559-51-3 | Natural Products |
| HY-119646 | Aviglycine | 49669-74-1 | Reference compound |
| HY-119647 | PPOH | 206052-01-9 | Reference compound |
| HY-119648 | CCR-11 | 1287652-03-2 | Reference compound |
| HY-119648A | (E/Z)-CCR-11 | 301687-87-6 | Reference compound |
| HY-119649 | Flonicamid | 158062-67-0 | Reference compound |
| HY-119649R | Flonicamid (Standard) | 158062-67-0 | Reference Standards |
| HY-119649S | Flonicamid-15N,18O | 2483830-60-8 | Isotope-Labeled Compounds |
| HY-119651 | Perthane | 72-56-0 | Reference compound |
| HY-119653 | AZ9482 | 1825345-33-2 | Reference compound |
| HY-119657 | Cellocidin | 543-21-5 | Natural Products |
| HY-119658 | PF-4178903 | 1310796-72-5 | Reference compound |
| HY-119660 | Surgumycin | 51938-50-2 | Reference compound |
| HY-119663 | Averantin | 5803-62-3 | Natural Products |
| HY-119666 | Rooperol | 83644-00-2 | Reference compound |
| HY-119667 | Enrasentan | 167256-08-8 | Reference compound |
| HY-119669 | Furylfuramide | 3688-53-7 | Reference compound |
| HY-119671 | BW 755C | 66000-40-6 | Reference compound |
| HY-119672 | Oct4 inducer-1 | 182564-41-6 | Reference compound |
| HY-119673 | Lincophenicol | 148077-13-8 | Reference compound |
| HY-119674 | Xanthopterin | 119-44-8 | Reference compound |
| HY-119674A | Xanthopterin (hydrate) | 5979-01-1 | Natural Products |
| HY-119675 | Albonoursin | 1222-90-8 | Reference compound |
| HY-119677 | Oxypertine | 153-87-7 | Reference compound |
| HY-119678 | Fortunellin | 20633-93-6 | Natural Products |
| HY-119682 | Bax agonist 1 | 18304-79-5 | Reference compound |
| HY-119683 | Epoxiconazole | 133855-98-8 | Reference compound |
| HY-119683A | (Rac)-Epoxiconazole | 135319-73-2 | Reference compound |
| HY-119683R | Epoxiconazole (Standard) | 133855-98-8 | Reference Standards |
| HY-119683S1 | Epoxiconazole-d4 | 2699607-18-4 | Isotope-Labeled Compounds |
| HY-119684 | Maresin 2 | 1639809-46-3 | Reference compound |
| HY-119684S | Maresin 2-d5 | Isotope-Labeled Compounds | |
| HY-119686 | Miloxacin | 37065-29-5 | Reference compound |
| HY-119686S | Miloxacin-d3 | 1228182-43-1 | Isotope-Labeled Compounds |
| HY-119687 | Bifenazate | 149877-41-8 | Reference compound |
| HY-119687R | Bifenazate (Standard) | 149877-41-8 | Reference Standards |
| HY-119688 | Amabiline | 17958-43-9 | Natural Products |
| HY-119689 | Umibecestat | 1387560-01-1 | Reference compound |
| HY-119690 | T326 | 1451042-19-5 | Reference compound |
| HY-119691 | Alamifovir | 193681-12-8 | Reference compound |
| HY-119692 | Curvulin | 19054-27-4 | Natural Products |
| HY-119694 | Rotenolone | 509-96-6 | Natural Products |
| HY-119695 | Simvastatin acid | 121009-77-6 | Reference compound |
| HY-119695A | Simvastatin acid (ammonium) | 139893-43-9 | Natural Products |
| HY-119695AR | Simvastatin acid (ammonium) (Standard) | 139893-43-9 | Reference Standards |
| HY-119695AS | Simvastatin acid-d6 (ammonium) | Isotope-Labeled Compounds | |
| HY-119695AS1 | Simvastatin acid-d9 (ammonium) | Isotope-Labeled Compounds | |
| HY-119695AS2 | Simvastatin acid-d3 (ammonium) | Isotope-Labeled Compounds | |
| HY-119695B | Simvastatin acid (calcium hydrate) | 530112-57-3 | Reference compound |
| HY-119695S | Simvastatin acid-d6 | 2747915-75-7 | Isotope-Labeled Compounds |
| HY-119696 | MTIC | 3413-72-7 | Reference compound |
| HY-119696R | MTIC (Standard) | 3413-72-7 | Reference Standards |
| HY-119696S | MTIC-d3 | 1185242-69-6 | Isotope-Labeled Compounds |
| HY-119697 | Setosusin | 182926-45-0 | Natural Products |
| HY-119698 | BAP9THP | 2312-73-4 | Reference compound |
| HY-119699 | PV1115 | 1093793-10-2 | Reference compound |
| HY-119700 | Isocil | 314-42-1 | Reference compound |
| HY-119702 | YZ51 | 1835652-66-8 | Reference compound |
| HY-119706 | Barbadin | 356568-70-2 | Reference compound |
| HY-119707 | TDR 32750 | 1428183-45-2 | Reference compound |
| HY-119708 | Ensifentrine | 1884461-72-6 | Reference compound |
| HY-119708S | Ensifentrine-d6 | Isotope-Labeled Compounds | |
| HY-119711 | NNGH | 161314-17-6 | Reference compound |
| HY-119712A | L-Primapterin | 2636-52-4 | Reference compound |
| HY-119713 | Khellinol | 478-42-2 | Natural Products |
| HY-119714 | Ambelline | 3660-62-6 | Reference compound |
| HY-119715 | AG-012986 | 486414-35-1 | Reference compound |
| HY-119720 | Neocryptotanshinone | 109664-02-0 | Natural Products |
| HY-119721 | CP-424174 | 210825-31-3 | Reference compound |
| HY-119722 | Butafosfan | 17316-67-5 | Reference compound |
| HY-119723 | Myristoyl ethanolamide | 142-58-5 | Reference compound |
| HY-119724 | ABCG2-IN-3 | 1942919-63-2 | Reference compound |
| HY-119725 | Tetradifon | 116-29-0 | Reference compound |
| HY-119725R | Tetradifon (Standard) | 116-29-0 | Reference Standards |
| HY-119726 | Fosmanogepix | 2091769-17-2 | Reference compound |
| HY-119726A | Fosmanogepix (tautomerism) | 1169701-00-1 | Reference compound |
| HY-119727 | WNK-IN-1 | 2125724-72-1 | Reference compound |
| HY-119728 | FR198248 | 197316-54-4 | Natural Products |
| HY-119729 | Axinysterol | 151606-24-5 | Natural Products |
| HY-119730 | Tripartin | 1428962-73-5 | Reference compound |
| HY-119731 | Antidesmone | 222629-77-8 | Natural Products |
| HY-119733 | BU09059 | 1541206-05-6 | Reference compound |
| HY-119734 | Gossypolone | 4547-72-2 | Reference compound |
| HY-119735 | Curcolone | 17015-43-9 | Natural Products |
| HY-119736 | Leptolstatin | 149633-91-0 | Natural Products |
| HY-119737 | Chlorsulfuron | 64902-72-3 | Reference compound |
| HY-119737R | Chlorsulfuron (Standard) | 64902-72-3 | Reference Standards |
| HY-119738 | OSMI-1 | 1681056-61-0 | Reference compound |
| HY-119738A | (Rac)-OSMI-1 | 2748153-92-4 | Reference compound |
| HY-119739 | Skyrin | 602-06-2 | Natural Products |
| HY-119741 | Salacinol | 200399-47-9 | Natural Products |
| HY-119744 | BAY 38-7271 | 212188-60-8 | Reference compound |
| HY-119748 | Sageone | 142546-15-4 | Natural Products |
| HY-119749 | Diazaborine | 22959-81-5 | Reference compound |
| HY-119750 | Budralazine | 36798-79-5 | Reference compound |
| HY-119751 | Hematein | 475-25-2 | Reference compound |
| HY-119753 | Disobutamide | 68284-69-5 | Reference compound |
| HY-119755 | Quadrosilan | 4657-20-9 | Reference compound |
| HY-119757 | Tyrphostin AG1433 | 168835-90-3 | Reference compound |
| HY-119757A | Tyrphostin AG1433 (hydrochloride) | 168836-03-1 | Reference compound |
| HY-119759 | Lipoxamycin | 32886-15-0 | Natural Products |
| HY-119759A | Lipoxamycin (hemisulfate) | 11075-87-9 | Reference compound |
| HY-119759AR | Lipoxamycin (hemisulfate) (Standard) | 11075-87-9 | Reference Standards |
| HY-119761 | L-670,548 | 121564-89-4 | Reference compound |
| HY-119762 | Spizofurone | 72492-12-7 | Reference compound |
| HY-119764 | Ikarugamycin | 36531-78-9 | Natural Products |
| HY-119765 | VU0366248 | 1243310-20-4 | Reference compound |
| HY-119766 | Aramite | 140-57-8 | Reference compound |
| HY-119766R | Aramite (Standard) | 140-57-8 | Reference Standards |
| HY-119767 | Jolkinolide A | 37905-07-0 | Natural Products |
| HY-119768 | (±)-BAK2-66 | 1301178-83-5 | Reference compound |
| HY-119769 | XX-650-23 | 117739-40-9 | Reference compound |
| HY-119770 | HDL376 | 147751-31-3 | Reference compound |
| HY-119772 | VU0366369 | 1222834-53-8 | Reference compound |
| HY-119774 | Caroxazone | 18464-39-6 | Reference compound |
| HY-119775 | U92016A | 136924-88-4 | Reference compound |
| HY-119776 | UBP618 | 1333110-86-3 | Reference compound |
| HY-119779 | Pyridalyl | 179101-81-6 | Reference compound |
| HY-119779R | Pyridalyl (Standard) | 179101-81-6 | Reference Standards |
| HY-119780 | BW1370U87 | 134476-36-1 | Reference compound |
| HY-119782 | L-Argininamide | 2788-83-2 | Peptides |
| HY-119784 | Eupenifeldin | 151803-45-1 | Natural Products |
| HY-119788S | Fenitrothion oxon-d6 | 1185155-54-7 | Isotope-Labeled Compounds |
| HY-119789 | Albofungin | 37895-35-5 | Reference compound |
| HY-119790 | Palmitoyllactic acid | 7795-58-6 | Reference compound |
| HY-119791 | NBD-amine | 10199-91-4 | Reference compound |
| HY-119792A | Neostigmine (hydroxide) | 588-17-0 | Reference compound |
| HY-119793 | Tolnidamine | 50454-68-7 | Reference compound |
| HY-119799 | UK-500001 | 582332-31-8 | Reference compound |
| HY-119802 | Practolol | 6673-35-4 | Reference compound |
| HY-119802R | Practolol (Standard) | 6673-35-4 | Reference Standards |
| HY-119802S | Practolol-d7 | 2714414-11-4 | Isotope-Labeled Compounds |
| HY-119804 | Licopyranocoumarin | 117038-80-9 | Natural Products |
| HY-119806 | TMPPAA | 844900-50-1 | Reference compound |
| HY-119807 | Prosultiamine | 59-58-5 | Reference compound |
| HY-119808 | Terrein | 582-46-7 | Reference compound |
| HY-119809 | Violacein | 548-54-9 | Natural Products |
| HY-119810 | Seletracetam | 357336-74-4 | Reference compound |
| HY-119810A | Seletracetam (lithium) | Inhibitory Antibodies | |
| HY-119810B | Seletracetam (lithium bromide) | 2024584-38-9 | Reference compound |
| HY-119812 | Eugenone | 480-27-3 | Natural Products |
| HY-119813 | (S,S)-Sinogliatin | 1191996-10-7 | Reference compound |
| HY-119815 | Tenonitrozole | 3810-35-3 | Reference compound |
| HY-119816 | Piretanide | 55837-27-9 | Reference compound |
| HY-119816R | Piretanide (Standard) | 55837-27-9 | Reference Standards |
| HY-119817 | Flosequinan | 76568-02-0 | Reference compound |
| HY-119818 | Farnesylthiotriazole | 156604-45-4 | Reference compound |
| HY-119819 | Psicofuranine | 1874-54-0 | Reference compound |
| HY-119820 | Xaliproden (free base) | 135354-02-8 | Reference compound |
| HY-119821 | Terphenyllin | 52452-60-5 | Natural Products |
| HY-119821R | Terphenyllin (Standard) | 52452-60-5 | Reference Standards |
| HY-119822 | Texasin | 897-46-1 | Reference compound |
| HY-119823 | PGP-4008 | 365565-02-2 | Reference compound |
| HY-119824 | Trofosfamide | 22089-22-1 | Reference compound |
| HY-119825 | Sarracine | 2492-09-3 | Natural Products |
| HY-119826 | Quinfamide | 62265-68-3 | Reference compound |
| HY-119827 | Moflomycin | 107430-03-5 | Reference compound |
| HY-119830 | Azaconazole | 60207-31-0 | Reference compound |
| HY-119831 | Rohitukine | 71294-60-5 | Reference compound |
| HY-119832 | Setastine | 64294-95-7 | Reference compound |
| HY-119832B | (S)-Setastine | Reference compound | |
| HY-119833 | Rubone | 73694-15-2 | Reference compound |
| HY-119839 | Acediasulfone | 80-03-5 | Reference compound |
| HY-119840 | Anthragallol | 602-64-2 | Reference compound |
| HY-119842 | ALO1567 | 97677-19-5 | Reference compound |
| HY-119843 | Asterric Acid | 577-64-0 | Reference compound |
| HY-119844 | Anidoxime | 34297-34-2 | Reference compound |
| HY-119844A | Anidoxime (hydrochloride) | 31729-11-0 | Reference compound |
| HY-119845 | Agamanone | 143381-59-3 | Natural Products |
| HY-119846 | Afromosin | 550-79-8 | Natural Products |
| HY-119847 | Abafungin | 129639-79-8 | Reference compound |
| HY-119850 | Aladorian | 865433-00-7 | Reference compound |
| HY-119850A | Aladorian (sodium) | 1233219-11-8 | Reference compound |
| HY-119853 | Bayer A 139 | 800-24-8 | Reference compound |
| HY-119855 | Aildenafil | 496835-35-9 | Reference compound |
| HY-119857 | AGK7 | 304896-21-7 | Reference compound |
| HY-119858 | Acetiromate | 2260-08-4 | Reference compound |
| HY-119859 | Cytochlor | 32387-56-7 | Reference compound |
| HY-119860 | Ataprost | 83997-19-7 | Reference compound |
| HY-119862 | Bupicomide | 22632-06-0 | Reference compound |
| HY-119863 | Barthrin | 70-43-9 | Reference compound |
| HY-119864 | Drinidene | 53394-92-6 | Reference compound |
| HY-119866 | β-Alethine | 646-08-2 | Reference compound |
| HY-119868 | Butaxamine | 2922-20-5 | Reference compound |
| HY-119873 | Celiprolol | 56980-93-9 | Reference compound |
| HY-119873S | Celiprolol-d9 (hydrochloride) | 1215535-20-8 | Isotope-Labeled Compounds |
| HY-119874 | Alkannin | 23444-65-7 | Natural Products |
| HY-119878 | Lobuprofen | 98207-12-6 | Reference compound |
| HY-119881 | Alafosfalin | 60668-24-8 | Reference compound |
| HY-119881R | Alafosfalin (Standard) | 60668-24-8 | Reference Standards |
| HY-119883 | A-61603 (free base） | 750531-54-5 | Reference compound |
| HY-119885 | Amiflamine | 77518-07-1 | Reference compound |
| HY-119885A | (±)-Amiflamine | 77502-96-6 | Reference compound |
| HY-119886 | BMS-986169 | 1801151-08-5 | Reference compound |
| HY-119889 | A1B11 | 1602731-56-5 | Reference compound |
| HY-119890 | Isbogrel | 89667-40-3 | Reference compound |
| HY-119892 | Batracylin | 67199-66-0 | Reference compound |
| HY-119893 | Diamfenetide | 36141-82-9 | Reference compound |
| HY-119893R | Diamfenetide (Standard) | 36141-82-9 | Reference Standards |
| HY-119894 | Althiomycin | 12656-40-5 | Reference compound |
| HY-119896 | Clethodim | 99129-21-2 | Reference compound |
| HY-119896R | Clethodim (Standard) | 99129-21-2 | Reference Standards |
| HY-119898 | Alloocimene | 673-84-7 | Natural Products |
| HY-119899 | BO-0742 | 774234-08-1 | Reference compound |
| HY-119900 | Carnidazole | 42116-76-7 | Reference compound |
| HY-119900R | Carnidazole (Standard) | 42116-76-7 | Reference Standards |
| HY-119900S | Carnidazole-d3 | Isotope-Labeled Compounds | |
| HY-119901 | Eupatarone | 17249-61-5 | Natural Products |
| HY-119902 | Bistrifluron | 201593-84-2 | Reference compound |
| HY-119902R | Bistrifluron (Standard) | 201593-84-2 | Reference Standards |
| HY-119904 | Malaoxon | 1634-78-2 | Reference compound |
| HY-119904R | Malaoxon (Standard) | 1634-78-2 | Reference Standards |
| HY-119906 | Conglobatin | 72263-05-9 | Natural Products |
| HY-119908 | Hetramine | 531-08-8 | Reference compound |
| HY-119909 | GNX-865 | 1223568-82-8 | Reference compound |
| HY-119910 | (E)-Aminoquinol | 529507-84-4 | Reference compound |
| HY-119910B | Aminoquinol (phosphate) | 7195-12-2 | Reference compound |
| HY-119910C | Aminoquinol (triphosphate) | 3653-53-0 | Reference compound |
| HY-119913A | Dacemazine (hydrochloride) | 25384-29-6 | Reference compound |
| HY-119914 | Bromadol | 77239-98-6 | Reference compound |
| HY-119915 | Atrolactamide | 2019-68-3 | Reference compound |
| HY-119917 | Gossypetin | 489-35-0 | Natural Products |
| HY-119918 | Cycrimine | 77-39-4 | Reference compound |
| HY-119919 | Clofenamide | 671-95-4 | Reference compound |
| HY-119921 | Indatraline | 86939-10-8 | Reference compound |
| HY-119926 | 13-Hydroxylupanine | 15358-48-2 | Natural Products |
| HY-119926A | 13-Hydroxylupanine (hydrochloride) | 6809-89-8 | Natural Products |
| HY-119929 | B 669 | 78182-92-0 | Reference compound |
| HY-119931 | 2-Hydroxychalcone | 644-78-0 | Natural Products |
| HY-119932 | PROTAC FAK degrader 1 | 2301916-69-6 | Reference compound |
| HY-119933 | RIPK1-IN-7 | 2300982-44-7 | Reference compound |
| HY-119934 | NaV1.7 inhibitor-1 | 1494585-79-3 | Reference compound |
| HY-119935 | JAK3 covalent inhibitor-1 | 2300106-50-5 | Reference compound |
| HY-119936 | GLPG2451 | 2055015-61-5 | Reference compound |
| HY-119937 | ROCK inhibitor-2 | 1127308-52-4 | Reference compound |
| HY-119938 | Tuberculosis inhibitor 1 | 2230810-28-1 | Reference compound |
| HY-119939 | CHDI-390576 | 1629729-98-1 | Reference compound |
| HY-119940 | MC180295 | 2237942-08-2 | Reference compound |
| HY-119941 | VU0652835 | 1848252-81-2 | Reference compound |
| HY-119942 | c-Fms-IN-8 | 1255303-58-2 | Reference compound |
| HY-119943 | PF-06256142 | 1609583-14-3 | Reference compound |
| HY-119943A | (Rac)-PF-06256142 | 1609580-97-3 | Reference compound |
| HY-119943B | (R)-PF-06256142 | 1609583-15-4 | Reference compound |
| HY-119944 | JND3229 | 2260886-64-2 | Reference compound |
| HY-119945 | Brobactam | 26631-90-3 | Reference compound |
| HY-119945A | Brobactam (sodium) | 73335-78-1 | Reference compound |
| HY-119946 | BF-1 | 518980-66-0 | Reference compound |
| HY-119948 | AKCI | 669750-88-3 | Reference compound |
| HY-119950 | ADCI | 124070-15-1 | Reference compound |
| HY-119953 | BIBN-99 | 145301-48-0 | Reference compound |
| HY-119955 | Amflutizole | 82114-19-0 | Reference compound |
| HY-119956 | Biflorin | 89701-85-9 | Natural Products |
| HY-119960 | AHR-10037 | 78281-73-9 | Reference compound |
| HY-119961 | (+)-Mepivacaine | 24358-84-7 | Reference compound |
| HY-119963A | trans-β-Terpineol | 7299-41-4 | Reference compound |
| HY-119964 | Cetaben | 55986-43-1 | Reference compound |
| HY-119966 | CCT036477 | 305372-78-5 | Reference compound |
| HY-119968 | Granaticin | 19879-06-2 | Reference compound |
| HY-119969 | Diaziquone | 57998-68-2 | Reference compound |
| HY-119970 | Helenalin | 6754-13-8 | Natural Products |
| HY-119971 | BIM5078 | 337506-43-1 | Reference compound |
| HY-119972 | Diloxanide | 579-38-4 | Reference compound |
| HY-119973 | CAY10397 | 78028-01-0 | Reference compound |
| HY-119974 | Caracemide | 81424-67-1 | Reference compound |
| HY-119975 | Carazostatin | 126168-32-9 | Reference compound |
| HY-119976 | Boscalid | 188425-85-6 | Biochemical Assay Reagents |
| HY-119976R | Boscalid (Standard) | 188425-85-6 | Reference Standards |
| HY-119976S | Boscalid-d4 | 2468796-76-9 | Isotope-Labeled Compounds |
| HY-119977 | APF | 359010-70-1 | Reference compound |
| HY-119979 | Cardanol monoene | 501-26-8 | Natural Products |
| HY-119980 | Fluphenazine | 69-23-8 | Reference compound |
| HY-119980A | Fluphenazine (dimaleate) | 3093-66-1 | Reference compound |
| HY-119980B | Fluphenazine (hydrochloride) | 1254-47-3 | Reference compound |
| HY-119980BS | Fluphenazine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-119980S | Fluphenazine-d8 | 1323633-98-2 | Isotope-Labeled Compounds |
| HY-119981 | Ani9 | 356102-14-2 | Reference compound |
| HY-119982 | Cyclamide | 664-95-9 | Natural Products |
| HY-119983 | 7H-Dibenzo[c,g]carbazole | 194-59-2 | Reference compound |
| HY-119984 | DNP-INT | 69311-70-2 | Reference compound |
| HY-119985 | Broxaterol | 76596-57-1 | Reference compound |
| HY-119987 | Sudan orange G | 2051-85-6 | Dye Reagents |
| HY-119987R | Sudan orange G (Standard) | 2051-85-6 | Dye Reagents |
| HY-119987S | Sudan Orange G-d5 | Isotope-Labeled Compounds | |
| HY-119989 | Cyclopyrimorate | 499231-24-2 | Reference compound |
| HY-11999 | CGI-1746 | 910232-84-7 | Reference compound |
| HY-119990 | Fotocaine | 1612189-10-2 | Reference compound |
| HY-119991 | AHR-9294 | 84023-64-3 | Reference compound |
| HY-119993 | AR03 | 510721-85-4 | Reference compound |
| HY-119994 | DFPM | 301338-95-4 | Reference compound |
| HY-119995 | Chloropyramine | 59-32-5 | Reference compound |
| HY-119996 | AR-C141990 | 873327-59-4 | Reference compound |
| HY-119996A | AR-C141990 (hydrochloride) | 2250019-94-2 | Reference compound |
| HY-119997 | Disulergine | 59032-40-5 | Reference compound |
| HY-12000 | AG490 | 133550-30-8 | Reference compound |
| HY-120000 | MS402 | 1672684-68-2 | Reference compound |
| HY-120002 | Proclonol | 14088-71-2 | Reference compound |
| HY-120004 | PF-06827443 | 2115022-67-6 | Reference compound |
| HY-120006A | (rel)-AR234960 | 1408311-94-3 | Reference compound |
| HY-120007 | JC124 | 1638611-48-9 | Reference compound |
| HY-120009 | Showdomycin | 16755-07-0 | Natural Products |
| HY-12001 | WZ-3146 | 1214265-56-1 | Reference compound |
| HY-120011 | Ro 24-6392 | 131149-63-8 | Reference compound |
| HY-120012 | Mizacorat | 1893415-00-3 | Reference compound |
| HY-120016 | RU 43044 | 136959-96-1 | Reference compound |
| HY-120017 | Befloxatone | 134564-82-2 | Reference compound |
| HY-120018 | VPC-13566 | 218464-59-6 | Reference compound |
| HY-120019 | Ac-YVAD-CHO | 143313-51-3 | Peptides |
| HY-120019A | Ac-YVAD-CHO (acetate) | Reference compound | |
| HY-120020 | LY-395153 | 211313-51-8 | Reference compound |
| HY-120021 | tert-Butyl 4-(1H-indol-4-yl)piperazine-1-carboxylate | 252978-89-5 | Reference compound |
| HY-120023 | VU0453595 | 1432436-13-9 | Reference compound |
| HY-120024 | BMS-986188 | 1776115-10-6 | Reference compound |
| HY-120025 | CRT0105950 | 1661845-86-8 | Reference compound |
| HY-120026 | KB130015 | 147030-48-6 | Reference compound |
| HY-120027 | Kribb3 | 129414-88-6 | Reference compound |
| HY-120028 | GNE-207 | 2158266-58-9 | Reference compound |
| HY-12003 | SNS-314 (mesylate) | 1146618-41-8 | Reference compound |
| HY-120033 | RY796 | 1393441-53-6 | Reference compound |
| HY-120034 | NCGC 607 | 1462267-07-7 | Reference compound |
| HY-120035 | DD1 | 187585-11-1 | Reference compound |
| HY-120036 | Tyrphostin AG1112 | 153150-84-6 | Reference compound |
| HY-120039 | (R)-MDL-101146 | 163660-53-5 | Reference compound |
| HY-120039A | (S)-MDL-101146 | 163660-59-1 | Reference compound |
| HY-120040 | HS94 | 1892594-93-2 | Reference compound |
| HY-120041 | ND-2158 | 1388896-07-8 | Reference compound |
| HY-120043 | KCO912 | 185695-83-4 | Reference compound |
| HY-120044 | L-739749 | 156511-34-1 | Reference compound |
| HY-120045 | DuP 747 | 142515-44-4 | Reference compound |
| HY-120045A | DuP 747 (hydrochloride) | 115904-74-0 | Reference compound |
| HY-120046 | YF479 | 1803281-22-2 | Reference compound |
| HY-120047 | Rutamarin | 13164-05-1 | Natural Products |
| HY-120048 | NBC19 | 2068818-75-5 | Reference compound |
| HY-120049 | TAK-603 | 158146-85-1 | Reference compound |
| HY-12005 | Fingolimod (hydrochloride) | 162359-56-0 | Reference compound |
| HY-120050 | GK470 | 1621517-53-0 | Reference compound |
| HY-120051 | Afizagabar | 1398496-82-6 | Reference compound |
| HY-120056 | YKL-06-061 | 2172617-15-9 | Reference compound |
| HY-120059 | NS4591 | 273930-52-2 | Reference compound |
| HY-12005R | Fingolimod (hydrochloride) (Standard) | 162359-56-0 | Reference Standards |
| HY-120060 | GNF6702 | 1799329-72-8 | Reference compound |
| HY-120062 | TVB-3664 | 2097262-58-1 | Reference compound |
| HY-120066 | Seriniquinone | 22200-69-7 | Reference compound |
| HY-120068 | VU0418506 | 1330624-42-4 | Reference compound |
| HY-120069 | APX2009 | 1415030-15-7 | Reference compound |
| HY-120072 | PF-3450074 | 1352879-65-2 | Reference compound |
| HY-120074 | UBP512 | 1333112-78-9 | Reference compound |
| HY-120075 | TJ191 | 1522415-97-9 | Reference compound |
| HY-120076 | CP-293019 | 179089-90-8 | Reference compound |
| HY-120077 | LY307452 | 174393-13-6 | Reference compound |
| HY-120078 | AZD2716 | 1845753-81-2 | Reference compound |
| HY-120079 | MSN-125 | 1592908-16-1 | Reference compound |
| HY-12008 | Erlotinib (Hydrochloride) | 183319-69-9 | Reference compound |
| HY-120080 | UR-2922 | 220386-56-1 | Reference compound |
| HY-120081 | Metixene | 4969-02-2 | Reference compound |
| HY-120081A | Metixene (hydrochloride hydrate) | 7081-40-5 | Reference compound |
| HY-120081AR | Metixene (hydrochloride hydrate) (Standard) | 7081-40-5 | Reference Standards |
| HY-120081B | Metixene (hydrochloride) | 1553-34-0 | Reference compound |
| HY-120083 | Rodatristat | 1673568-73-4 | Reference compound |
| HY-120084 | BTX161 | 2052301-24-1 | Reference compound |
| HY-120085 | PFE-360 | 1527475-61-1 | Reference compound |
| HY-120086 | RO-5963 | 1416663-77-8 | Reference compound |
| HY-120087 | KG-548 | 175205-09-1 | Reference compound |
| HY-120088 | PF-06446846 | 1632250-49-7 | Reference compound |
| HY-120088A | PF-06446846 (hydrochloride) | 1632250-50-0 | Reference compound |
| HY-12008A | Erlotinib (mesylate) | 248594-19-6 | Reference compound |
| HY-12008R | Erlotinib (Hydrochloride) (Standard) | 183319-69-9 | Reference Standards |
| HY-12008S | Erlotinib-d6 (hydrochloride) | 1189953-78-3 | Isotope-Labeled Compounds |
| HY-12008S1 | Erlotinib-13C6 (hydrochloride) | 1210610-07-3 | Isotope-Labeled Compounds |
| HY-12009 | Pazopanib (Hydrochloride) | 635702-64-6 | Reference compound |
| HY-120090 | MRS1177 | 183721-13-3 | Reference compound |
| HY-120092 | BMT-046091 | 1551401-20-7 | Reference compound |
| HY-120096 | BIBO3304 (free base) | 191868-13-0 | Reference compound |
| HY-120097 | R-10015 | 2097938-51-5 | Reference compound |
| HY-120098 | Vinleurosine | 23360-92-1 | Natural Products |
| HY-120098A | Vinleurosine (sulfate) | 54081-68-4 | Reference compound |
| HY-12009R | Pazopanib (Hydrochloride) (Standard) | 635702-64-6 | Reference Standards |
| HY-12009S | Pazopanib-13C,d3 (hydrochloride) | 1261398-44-0 | Isotope-Labeled Compounds |
| HY-12010 | BMS-599626 (Hydrochloride) | 873837-23-1 | Reference compound |
| HY-120102 | Emicoron | 1422423-23-1 | Reference compound |
| HY-120103 | PF-06649298 | 1854061-16-7 | Reference compound |
| HY-120104 | Nitidanin | 171674-89-8 | Natural Products |
| HY-120105 | NSC666715 | 170747-33-8 | Reference compound |
| HY-120106 | BG14 | 1628784-50-8 | Reference compound |
| HY-120109 | 13-HODE methyl ester | 109837-85-6 | Natural Products |
| HY-12011 | HA14-1 | 65673-63-4 | Reference compound |
| HY-120110 | IOX4 | 1154097-71-8 | Reference compound |
| HY-120111 | MW-150 | 1628502-91-9 | Reference compound |
| HY-120111A | MW-150 hydrochloride | 1923773-01-6 | Reference compound |
| HY-120111B | MW-150 dihydrochloride dihydrate | 1661020-92-3 | Reference compound |
| HY-120113 | SC-2001 | 1383727-17-0 | Reference compound |
| HY-120115 | PARPi-FL | 1380359-84-1 | Dye Reagents |
| HY-120117 | Rumbrin | 148528-19-2 | Reference compound |
| HY-120118 | Metarrestin | 1443414-10-5 | Reference compound |
| HY-12011A | (Rac)-HA14-1 | 927635-64-1 | Reference compound |
| HY-12012 | SB 216763 | 280744-09-4 | Reference compound |
| HY-120122 | PK7088 | 1446352-67-5 | Reference compound |
| HY-120123 | FR181157 | 171046-15-4 | Reference compound |
| HY-120124 | Samelisant | 1394808-20-8 | Reference compound |
| HY-120128 | MTSEA (hydrobromide) | 16599-33-0 | Reference compound |
| HY-12013 | PD153035 (Hydrochloride) | 183322-45-4 | Reference compound |
| HY-120132 | KNI-102 | 139694-65-8 | Reference compound |
| HY-120135 | LTURM 36 | 1879887-94-1 | Reference compound |
| HY-120137 | CMP-5 | 880813-42-3 | Reference compound |
| HY-120138 | BDM31827 | 1388658-04-5 | Reference compound |
| HY-120139 | KMH-233 | 1941174-13-5 | Reference compound |
| HY-120139A | (R)-KMH-233 | 2994330-89-9 | Reference compound |
| HY-12014 | SU11274 | 658084-23-2 | Reference compound |
| HY-120140 | Ganoderic acid DM | 173075-45-1 | Natural Products |
| HY-120142 | EC359 | 2012591-09-0 | Reference compound |
| HY-120144 | SR-8993 | 1594121-16-0 | Reference compound |
| HY-120145 | MST-312 | 368449-04-1 | Reference compound |
| HY-120146 | NNC 05-2090 | 184845-43-0 | Reference compound |
| HY-120147 | Ethiazide | 1824-58-4 | Reference compound |
| HY-120148 | SM19712 (free acid) | 194542-49-9 | Reference compound |
| HY-120148A | SM19712 | 194542-56-8 | Reference compound |
| HY-120149 | Inotodiol | 35963-37-2 | Natural Products |
| HY-12015 | Iniparib | 160003-66-7 | Reference compound |
| HY-120151 | 3,5-Dinitro-p-toluic acid | 16533-71-4 | Reference compound |
| HY-120152A | SLP7111228 (hydrochloride) | 1449768-48-2 | Reference compound |
| HY-120154 | Palitantin | 15265-28-8 | Natural Products |
| HY-120157 | Vif-ElonginC interaction inhibitor 1 | 374679-27-3 | Reference compound |
| HY-120158 | ZD0947 | 172649-40-0 | Reference compound |
| HY-120159 | GS-493 | 1710337-31-7 | Reference compound |
| HY-12016 | KU-55933 | 587871-26-9 | Reference compound |
| HY-120160 | Darglitazone | 141200-24-0 | Reference compound |
| HY-120160A | Darglitazone (Sodium) | 149904-87-0 | Reference compound |
| HY-120161 | AS6 | 1609660-14-1 | Reference compound |
| HY-120164 | Glycerophospho-N-oleoyl ethanolamine | 201738-24-1 | Reference compound |
| HY-120166 | DiFMUP | 214491-43-7 | Reference compound |
| HY-120167 | YM-44778 | 173941-74-7 | Reference compound |
| HY-12017 | PF-04217903 | 956905-27-4 | Reference compound |
| HY-120170 | BMS-466442 | 1598424-76-0 | Reference compound |
| HY-120171 | DH-376 | 1848233-57-7 | Reference compound |
| HY-120173 | Ro 47-3359 | 155144-64-2 | Reference compound |
| HY-120174 | SU200 | 184003-14-3 | Reference compound |
| HY-120175 | Nonaethylene glycol monomethyl ether | 6048-68-6 | Reference compound |
| HY-120177 | KT182 | 1402612-62-7 | Reference compound |
| HY-120178 | (±)7(8)-DiHDPA | 168111-93-1 | Natural Products |
| HY-120179 | LP-922761 | 1454808-95-7 | Reference compound |
| HY-120179A | LP-922761 (hydrate) | Reference compound | |
| HY-12017A | PF-04217903 (mesylate) | 956906-93-7 | Reference compound |
| HY-12017B | PF-04217903 (phenolsulfonate) | 1159490-85-3 | Reference compound |
| HY-12018 | Vatalanib (dihydrochloride) | 212141-51-0 | Reference compound |
| HY-120180 | BMS-188107 | 139232-80-7 | Reference compound |
| HY-120181 | AGI-14100 | 1448346-43-7 | Reference compound |
| HY-120182 | GR 128107 | 190328-44-0 | Reference compound |
| HY-120183 | Harzianopyridone | 137813-88-8 | Natural Products |
| HY-120184 | VU0467485 | 1451994-10-7 | Reference compound |
| HY-120185 | Saintopin | 131190-63-1 | Reference compound |
| HY-120187 | DDCPPB-Glu | 149325-95-1 | Reference compound |
| HY-120188 | CC618 | 1680204-90-3 | Reference compound |
| HY-120189 | LY 233536 | 136845-59-5 | Reference compound |
| HY-12018A | Vatalanib (hydrochloride) | 212141-52-1 | Reference compound |
| HY-12019 | SGX-523 | 1022150-57-7 | Reference compound |
| HY-120190 | Citreoindole | 138655-14-8 | Reference compound |
| HY-120192 | CGP 62349 | 187608-26-0 | Reference compound |
| HY-120196 | CPI703 | 1904649-00-8 | Reference compound |
| HY-120197 | 17-Phenyl trinor prostaglandin F2α methyl amide | 155206-01-2 | Reference compound |
| HY-120198 | Naftypramide | 1505-95-9 | Reference compound |
| HY-12020 | TW-37 | 877877-35-5 | Reference compound |
| HY-120200 | YF-452 | 1951466-83-3 | Reference compound |
| HY-120201 | 7-Hydroxy coumarin glucuronide (sodium) | 168286-98-4 | Reference compound |
| HY-120201S | 7-Hydroxy Coumarin-d5 β-D-glucuronide (sodium) | Isotope-Labeled Compounds | |
| HY-120203 | DA 1131 | 169285-98-7 | Reference compound |
| HY-120204 | BI8626 | 1875036-75-1 | Reference compound |
| HY-120205 | A-119637 | 255713-47-4 | Reference compound |
| HY-120206 | Brasofensine | 171655-91-7 | Reference compound |
| HY-120206A | Brasofensine (maleate) | 173830-14-3 | Reference compound |
| HY-120206B | Brasofensine (sulfate) | 171655-92-8 | Reference compound |
| HY-120207 | (R)-GDC-0927 | 1642297-53-7 | Reference compound |
| HY-120208 | MK204 | 1959605-73-2 | Reference compound |
| HY-120209 | Pigment Yellow 13 | 5102-83-0 | Reference compound |
| HY-120210 | XY018 | 1873358-87-2 | Reference compound |
| HY-120213 | YH-306 | 1373764-75-0 | Reference compound |
| HY-120214 | TAS05567 | 1429038-15-2 | Reference compound |
| HY-120215 | KT203 | 1402612-64-9 | Reference compound |
| HY-120217 | VH032 | 1448188-62-2 | Reference compound |
| HY-120219 | TU-2100 | 207972-39-2 | Reference compound |
| HY-12022 | 3-Aminobenzamide | 3544-24-9 | Reference compound |
| HY-120220 | Piposulfan | 2608-24-4 | Reference compound |
| HY-120221 | SE 175 | 258278-64-7 | Reference compound |
| HY-120223 | BMS-196085 | 170686-10-9 | Reference compound |
| HY-120225 | NJK14047 | 1800576-41-3 | Reference compound |
| HY-120226A | VU714 (oxalate) | 474625-52-0 | Reference compound |
| HY-120229 | GGTI-2147 | 191102-87-1 | Reference compound |
| HY-12023 | GTx-007 | 401900-40-1 | Reference compound |
| HY-120231 | Z-VRPR-FMK | 1381885-28-4 | Reference compound |
| HY-120232 | ABT-963 | 266320-83-6 | Reference compound |
| HY-120233 | MK-8876 | 1426960-33-9 | Reference compound |
| HY-120234 | Z-LLNle-CHO | 133407-83-7 | Peptides |
| HY-120236 | KSCM-5 | 1415247-18-5 | Reference compound |
| HY-120237 | m-PEG7-Amine | 170572-38-0 | ADC Related |
| HY-120238 | RG 13647 | 145543-03-9 | Reference compound |
| HY-120239 | Ro 63-0563 | 202466-77-1 | Reference compound |
| HY-12024 | Alvespimycin (hydrochloride) | 467214-21-7 | Reference compound |
| HY-120240 | AND-302 | 1380201-88-6 | Reference compound |
| HY-120241 | Reticulol | 26246-41-3 | Natural Products |
| HY-120242 | N-(3-Oxobutanoyl)-L-homoserine lactone | 148433-27-6 | Reference compound |
| HY-120243 | L-Ibotenic acid | 25690-45-3 | Reference compound |
| HY-120245 | GSK-340 | 2222509-79-5 | Reference compound |
| HY-120248 | FR221647 | 256461-28-6 | Reference compound |
| HY-12025 | Serdemetan | 881202-45-5 | Reference compound |
| HY-120251 | Leteprinim | 138117-50-7 | Reference compound |
| HY-120251A | Leteprinim (potassium) | 192564-13-9 | Reference compound |
| HY-120252 | ABC44 | 1831135-46-6 | Reference compound |
| HY-120253 | Spirotetramat | 203313-25-1 | Reference compound |
| HY-120253R | Spirotetramat (Standard) | 203313-25-1 | Reference Standards |
| HY-120255 | 17(R)-HDHA | 155976-53-7 | Reference compound |
| HY-120255A | 17(S)-HDHA | 92693-03-3 | Reference compound |
| HY-120255AS | 17(S)-HDHA-d5 | 2738376-87-7 | Isotope-Labeled Compounds |
| HY-120256 | Corynecin II | 35098-52-3 | Biochemical Assay Reagents |
| HY-120258 | Tr-PEG3-OH | 133699-09-9 | ADC Related |
| HY-12026 | WZ4002 | 1213269-23-8 | Reference compound |
| HY-120261 | GB-88 | 1416435-96-5 | Reference compound |
| HY-120264 | YPC-22026 | 1964457-41-7 | Reference compound |
| HY-120265 | MIPS-9922 | 1416956-33-6 | Reference compound |
| HY-120267 | TID43 | 19231-60-8 | Reference compound |
| HY-120268 | SLM6031434 | 1897379-33-7 | Reference compound |
| HY-120268A | SLM6031434 (hydrochloride) | 1897379-34-8 | Reference compound |
| HY-120269 | CAY10512 | 139141-12-1 | Reference compound |
| HY-120270 | PF-06679142 | 1467059-66-0 | Reference compound |
| HY-120271 | GGTI-297 | 181045-83-0 | Reference compound |
| HY-120272 | SMAP-2 | 1809068-70-9 | Reference compound |
| HY-120273 | Glucocorticoids receptor agonist 3 | 305821-96-9 | Reference compound |
| HY-120274 | Balcinrenone | 1850385-64-6 | Reference compound |
| HY-120275 | CYD-2-11 | 1425944-22-4 | Reference compound |
| HY-120276 | Golexanolone | 2089238-18-4 | Reference compound |
| HY-120277 | TIPP | 146369-65-5 | Reference compound |
| HY-120278 | 4-Ethoxyquinazoline | 16347-96-9 | Reference compound |
| HY-120279A | CFI-400437 | 1169211-37-3 | Reference compound |
| HY-12028 | PD98059 | 167869-21-8 | Reference compound |
| HY-120284 | CCCI-01 | 215778-97-5 | Reference compound |
| HY-120285 | M-0002 (hydrochloride) | 285559-03-7 | Reference compound |
| HY-120286 | K-13 | 108890-90-0 | Natural Products |
| HY-120287 | L-054522 | 214348-67-1 | Reference compound |
| HY-120288 | AM4299B | 160825-49-0 | Reference compound |
| HY-12029 | WZ8040 | 1214265-57-2 | Reference compound |
| HY-120290 | PU141 | 168334-34-7 | Reference compound |
| HY-120293 | CB30900 | 145788-82-5 | Reference compound |
| HY-120294 | Chrysin 6-C-glucoside 8-C-arabinoside | 185145-34-0 | Reference compound |
| HY-120295 | A-192621 | 195529-54-5 | Reference compound |
| HY-120296 | 5-Methylurapidil | 34661-85-3 | Reference compound |
| HY-120297 | S 9788 | 140945-01-3 | Reference compound |
| HY-120298 | LY-510929 | 401789-93-3 | Reference compound |
| HY-120299 | KC01 | 1646795-59-6 | Reference compound |
| HY-12030 | PIK-90 | 677338-12-4 | Reference compound |
| HY-120300 | UCM710 | 213738-77-3 | Reference compound |
| HY-120301 | L-366682 | 127819-96-9 | Reference compound |
| HY-120302 | PD 140376 | 149027-97-4 | Reference compound |
| HY-120303 | LY269415 | 132392-65-5 | Reference compound |
| HY-120306 | HHL-6 | 1215093-76-7 | Reference compound |
| HY-120308 | (R)-Nolpitantium | 154728-59-3 | Reference compound |
| HY-120309 | BMY 42393 | 136451-58-6 | Reference compound |
| HY-12031 | U0126-EtOH | 1173097-76-1 | Reference compound |
| HY-120311 | Benadrostin | 117241-60-8 | Natural Products |
| HY-120312 | PCTR3 | 1810710-69-0 | Reference compound |
| HY-120313 | SN23862 | 142439-61-0 | Reference compound |
| HY-120314 | GEA 3162 | 144576-10-3 | Reference compound |
| HY-120315 | Nyssoside | 182138-70-1 | Natural Products |
| HY-120316 | AB3127-C | 139159-01-6 | Reference compound |
| HY-120317 | CPTH2-Alkyne | 1613116-16-7 | Reference compound |
| HY-120318 | Zeaxanthin | 144-68-3 | Natural Products |
| HY-12031A | U0126 | 109511-58-2 | Reference compound |
| HY-12031B | (2Z,3Z)-U0126 | 218601-62-8 | Reference compound |
| HY-12032 | AG14361 | 328543-09-5 | Reference compound |
| HY-120322 | MK-0969 | 203321-88-4 | Reference compound |
| HY-120323 | DRI-C21045 | 2101765-81-3 | Reference compound |
| HY-120325 | DHMPA | 18684-28-1 | Reference compound |
| HY-120327 | KY-226 | 1621673-53-7 | Reference compound |
| HY-120329 | Lu 26-046 | 143756-51-8 | Reference compound |
| HY-12033 | 2-Methoxyestradiol | 362-07-2 | Natural Products |
| HY-120330 | Nek2-IN-5 | 1507367-00-1 | Reference compound |
| HY-120331 | U-89360E | 161897-65-0 | Reference compound |
| HY-120332 | Sonlicromanol (hydrochloride) | 2162149-24-6 | Reference compound |
| HY-120333 | Antibiotic PF 1052 | 147317-15-5 | Natural Products |
| HY-120337 | V-11-0711 | 1428339-47-2 | Reference compound |
| HY-120338 | RYL-552 | 1801444-56-3 | Reference compound |
| HY-12033S | 2-Methoxyestradiol-13C,d3 | 1217470-09-1 | Isotope-Labeled Compounds |
| HY-12033S1 | 2-Methoxyestradiol-13C6 | Isotope-Labeled Compounds | |
| HY-12033S2 | 2-Methoxyestradiol-d5 | 358731-34-7 | Isotope-Labeled Compounds |
| HY-12034 | WYE-354 | 1062169-56-5 | Reference compound |
| HY-120343 | GSK106 | 1652591-82-6 | Reference compound |
| HY-120346 | PBK-IN-9 | 1338540-55-8 | Reference compound |
| HY-120348 | ML67-33 | 1443290-89-8 | Reference compound |
| HY-120349 | LL-Z1640-4 | 66018-41-5 | Reference compound |
| HY-12035 | AMG-208 | 1002304-34-8 | Reference compound |
| HY-120350 | BI-1347 | 2163056-91-3 | Reference compound |
| HY-120354 | YU142670 | 133847-06-0 | Reference compound |
| HY-120355 | AP14145 | 1446770-54-2 | Reference compound |
| HY-120355A | AP14145 (hydrochloride) | 2387505-59-9 | Reference compound |
| HY-120356 | T-1101 | 1438638-83-5 | Reference compound |
| HY-120356A | T-1101 (tosylate) | 2250404-95-4 | Reference compound |
| HY-120356S1 | T-1101-d7 | Isotope-Labeled Compounds | |
| HY-120357 | Ascrolimus | 148147-65-3 | Reference compound |
| HY-120358 | L-6424 | 147030-50-0 | Reference compound |
| HY-12036 | GSK1059615 | 958852-01-2 | Reference compound |
| HY-120360 | CB-64D | 157752-20-0 | Reference compound |
| HY-120366 | WCK-5153 | 1452460-79-5 | Reference compound |
| HY-120367 | DTP348 | 1383370-92-0 | Reference compound |
| HY-120368 | Fluorescein-PEG4-acid | 1807518-76-8 | Reference compound |
| HY-120369 | URB532 | 195140-79-5 | Reference compound |
| HY-12037 | Rigosertib (sodium) | 592542-60-4 | Reference compound |
| HY-120371 | CPUY192018 | 1567836-15-0 | Reference compound |
| HY-120373 | MB710 | 2230044-57-0 | Reference compound |
| HY-120374 | V-PYRRO/NO | 179344-98-0 | Reference compound |
| HY-120375 | LUF7346 | 1821638-40-7 | Reference compound |
| HY-120376 | XZH-5 | 1360562-98-6 | Reference compound |
| HY-120377 | CYP1A1 inhibitor 8a | 1821136-07-5 | Reference compound |
| HY-12037A | Rigosertib | 592542-59-1 | Reference compound |
| HY-12038 | Ki8751 | 228559-41-9 | Reference compound |
| HY-120380 | FeTMPyP | 133314-07-5 | Reference compound |
| HY-120381 | PD 136450 | 139067-52-0 | Reference compound |
| HY-120382 | LY 215890 | 153502-35-3 | Reference compound |
| HY-120383 | Amicetin | 17650-86-1 | Natural Products |
| HY-120384 | AZD-0284 | 2101291-07-8 | Reference compound |
| HY-120386 | LY382884 | 211566-75-5 | Reference compound |
| HY-120387 | SMU-B | 1253286-90-6 | Reference compound |
| HY-120388 | Irganox 1330 | 1709-70-2 | Reference compound |
| HY-120388R | Irganox 1330 (Standard) | 1709-70-2 | Reference Standards |
| HY-12039 | Lyn-IN-1 | 887650-05-7 | Reference compound |
| HY-120390 | L 694746 | 139934-80-8 | Reference compound |
| HY-120391 | LiLo | 134439-56-8 | Reference compound |
| HY-120394 | TVB-3166 | 1533438-83-3 | Reference compound |
| HY-120395 | UC-514321 | 299420-83-0 | Reference compound |
| HY-120396 | LY 293284 | 141318-62-9 | Reference compound |
| HY-120397 | Bis-propargyl-PEG4 | 159428-42-9 | Reference compound |
| HY-120398 | CH5447240 | 1253919-92-4 | Reference compound |
| HY-12040 | Elesclomol | 488832-69-5 | Reference compound |
| HY-120400 | KDM5-C70 | 1596348-32-1 | Reference compound |
| HY-120401 | Glybuzole | 1492-02-0 | Reference compound |
| HY-120402 | BMS-200 | 1675203-82-3 | Reference compound |
| HY-120405 | RS-12254 | 137550-79-9 | Reference compound |
| HY-120407 | Looplure | 14959-86-5 | Reference compound |
| HY-120408 | (±)-Scopolamine | 138-12-5 | Natural Products |
| HY-12041 | SP600125 | 129-56-6 | Reference compound |
| HY-120411 | Sadopine | 111127-62-9 | Reference compound |
| HY-120415 | RK 397 | 154396-73-3 | Reference compound |
| HY-120417 | JP-153 | 1802937-26-3 | Reference compound |
| HY-120418 | L-687306 | 133444-98-1 | Reference compound |
| HY-120419 | PF9601N | 133845-63-3 | Reference compound |
| HY-12042 | Pimasertib | 1236699-92-5 | Reference compound |
| HY-120420 | N4Py | 167695-87-6 | Reference compound |
| HY-120421 | SW116 (free base) | 1036759-00-8 | Reference compound |
| HY-120422S | N-Desmethyl Regorafenib-d3 | Isotope-Labeled Compounds | |
| HY-120423 | AM-6538 | 1245626-00-9 | Reference compound |
| HY-120425 | Ethiprole | 181587-01-9 | Reference compound |
| HY-120425R | Ethiprole (Standard) | 181587-01-9 | Reference Standards |
| HY-120426 | MMDPPO | 146322-08-9 | Reference compound |
| HY-120427 | Cosalane | 154212-56-3 | Reference compound |
| HY-120428 | VU0410425 | 1341167-72-3 | Reference compound |
| HY-120429 | SKLB-163 | 1255099-06-9 | Reference compound |
| HY-12042A | Pimasertib (hydrochloride) | 1236361-78-6 | Reference compound |
| HY-12043 | SB 525334 | 356559-20-1 | Reference compound |
| HY-120430 | HO-PEG14-OH | 1189112-05-7 | Reference compound |
| HY-120431 | RE 1492 | 112169-14-9 | Reference compound |
| HY-120432 | CaMdr1p-IN-1 | 1257542-38-3 | Reference compound |
| HY-120435 | Tyrothricin | 1404-88-2 | Natural Products |
| HY-120436 | RM 49 | 113785-48-1 | Reference compound |
| HY-120438 | TASP0415914 | 1292300-75-4 | Reference compound |
| HY-12044 | Cabozantinib (S-malate) | 1140909-48-3 | Reference compound |
| HY-120441 | CAY10590 | 1101136-50-8 | Reference compound |
| HY-120442 | (±)16(17)-DiHDPA | 1345275-27-5 | Reference compound |
| HY-120444 | MS0124 | 1197196-63-6 | Reference compound |
| HY-120446 | Thiocystine | 14172-54-4 | Reference compound |
| HY-120448 | QTX125 | 1279698-31-5 | Reference compound |
| HY-120448A | QTX125 (TFA) | 2989537-78-0 | Reference compound |
| HY-120449 | AZ4800 | 1226886-78-7 | Reference compound |
| HY-12044R | Cabozantinib (S-malate) (Standard) | 1140909-48-3 | Reference Standards |
| HY-12045 | HMN-214 | 173529-46-9 | Reference compound |
| HY-120450 | CL-55 | 1370706-59-4 | Reference compound |
| HY-120451 | Salvinone | 124681-15-8 | Natural Products |
| HY-120454 | G-479 | 1168092-22-5 | Reference compound |
| HY-120455 | PD 125967 | 128139-14-0 | Reference compound |
| HY-120456 | SR16835 | 1207195-45-6 | Reference compound |
| HY-120458 | LCAHA | 117094-40-3 | Reference compound |
| HY-120459 | Rs-029 | 110230-95-0 | Reference compound |
| HY-12046 | PIK-93 | 593960-11-3 | Reference compound |
| HY-120460 | 8(R)-HETE | 105500-09-2 | Reference compound |
| HY-120462 | Genz-669178 | 1254834-91-7 | Reference compound |
| HY-120463 | R8605 | 119306-51-3 | Reference compound |
| HY-120464 | PF-05212377 | 1226793-34-5 | Reference compound |
| HY-120465 | ZINC36617540 | 1174905-91-9 | Reference compound |
| HY-120467 | Bima SA | 1175838-84-2 | Reference compound |
| HY-120468 | GSK2263167 | 1165924-28-6 | Reference compound |
| HY-120469 | 2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide | 1258292-64-6 | Reference compound |
| HY-12047 | Ponatinib | 943319-70-8 | Reference compound |
| HY-120471 | AM-0687 | 1259522-94-5 | Reference compound |
| HY-120474 | Ro 23-0364 | 98601-60-6 | Reference compound |
| HY-120475 | PBT434 | 1232841-78-9 | Reference compound |
| HY-120475A | PBT434 (mesylate) | 2387898-69-1 | Reference compound |
| HY-120476 | JNJ-39729209 | 1160606-90-5 | Reference compound |
| HY-120478 | ASP6432 | 1282549-08-9 | Reference compound |
| HY-120479 | Cythioate | 115-93-5 | Reference compound |
| HY-12047R | Ponatinib (Standard) | 943319-70-8 | Reference Standards |
| HY-12047S | Ponatinib-d8 | 1562993-37-6 | Isotope-Labeled Compounds |
| HY-12048 | Chelerythrine (chloride) | 3895-92-9 | Natural Products |
| HY-120481 | JNJ-40413269 | 1184847-16-2 | Reference compound |
| HY-120482 | CHM-1-P-Na | 1207854-61-2 | Reference compound |
| HY-120485 | Raxofelast | 128232-14-4 | Reference compound |
| HY-120486 | LY203647 | 122009-61-4 | Reference compound |
| HY-120487 | VUF8507 | 112575-48-1 | Reference compound |
| HY-120489 | A110 | 1185388-35-5 | Reference compound |
| HY-12048R | Chelerythrine (chloride) (Standard) | 3895-92-9 | Reference Standards |
| HY-12049 | CCT129202 | 942947-93-5 | Reference compound |
| HY-120490 | NMK-TD-100 | 1252802-38-2 | Reference compound |
| HY-120491 | L 722151 | 122841-09-2 | Reference compound |
| HY-120492 | RS-21314 | 125709-03-7 | Reference compound |
| HY-120494 | sEH inhibitor-1 | 1208549-68-1 | Reference compound |
| HY-120495 | EP6 | 1353567-32-4 | Reference compound |
| HY-120496 | Clofutriben | 1204178-50-6 | Reference compound |
| HY-120497 | PKCζ-IN-1 | 1132609-87-0 | Reference compound |
| HY-120498 | RS-64459-193 | 123882-89-3 | Reference compound |
| HY-120499 | AZD8542 | 1126366-36-6 | Reference compound |
| HY-12050 | CP-673451 | 343787-29-1 | Reference compound |
| HY-120500 | 16-[[2-(Methylamino)-2-oxoacetyl]amino]-11Z-hexadecenoic acid | 1235543-17-5 | Reference compound |
| HY-120501 | B022 | 1202764-53-1 | Reference compound |
| HY-120502 | 5-LOX-IN-6 | 1159576-98-3 | Reference compound |
| HY-120504 | N-Acetyltyramine | 1202-66-0 | Reference compound |
| HY-120506 | L-366811 | 127819-95-8 | Reference compound |
| HY-120508 | Pivanex | 122110-53-6 | Reference compound |
| HY-120511 | KNT-127 | 1256921-89-7 | Reference compound |
| HY-120512 | 5-Phenyl-4E-pentenol | 13159-16-5 | Dye Reagents |
| HY-120514 | JNc-440 | 1119503-63-7 | Reference compound |
| HY-120515 | 7-Oxostaurosporine | 125035-83-8 | Reference compound |
| HY-120516 | CDE-096 | 1228357-04-7 | Reference compound |
| HY-120519 | L-665871 | 123788-05-6 | Reference compound |
| HY-120520 | Caylin-1 | 1207480-88-3 | Reference compound |
| HY-120521 | Urodilatin | 115966-23-9 | Peptides |
| HY-120522 | L-659877 | 125989-12-0 | Reference compound |
| HY-120523 | UBP646 | 1333213-35-6 | Reference compound |
| HY-120524 | CGP 31358 | 125652-47-3 | Reference compound |
| HY-120527 | VU0463841 | 1439095-16-5 | Reference compound |
| HY-120528 | GB-110 | 1252806-70-4 | Reference compound |
| HY-120528A | GB-110 (hydrochloride) | Reference compound | |
| HY-120529 | Aciculatin | 134044-97-6 | Natural Products |
| HY-12053 | Vinorelbine | 71486-22-1 | Natural Products |
| HY-120530 | JNJ-46281222 | 1254980-38-5 | Reference compound |
| HY-120531 | UR-PI376 | 1192559-94-6 | Reference compound |
| HY-120533 | Syk-IN-11 | 1194954-83-0 | Reference compound |
| HY-120535 | RS 30026 | 127683-04-9 | Reference compound |
| HY-120536 | HPi1 | 13080-21-2 | Reference compound |
| HY-120537 | m-PEG5-CH2COOH | 16142-03-3 | ADC Related |
| HY-120538 | CPG-52364 | 1093135-60-4 | Reference compound |
| HY-120539 | Enofelast | 125722-16-9 | Reference compound |
| HY-12053A | Vinorelbine (ditartrate) | 125317-39-7 | Natural Products |
| HY-12053AR | Vinorelbine (ditartrate) (Standard) | 125317-39-7 | Reference Standards |
| HY-12053AS | Vinorelbine-d3 (ditartrate) | Isotope-Labeled Compounds | |
| HY-12054 | Hesperadin | 422513-13-1 | Reference compound |
| HY-120541 | ST-1006 | 1196994-11-2 | Reference compound |
| HY-120541A | ST-1006 (Maleate) | 1196994-12-3 | Reference compound |
| HY-120542 | SR 1824 | 1338259-06-5 | Reference compound |
| HY-120544 | BAY-386 | 1256941-06-6 | Reference compound |
| HY-120546 | Ulixacaltamide | 1199236-64-0 | Reference compound |
| HY-120546S | Ulixacaltamide-d9 (hydrochloride) | 1346604-21-4 | Isotope-Labeled Compounds |
| HY-120547 | UCB-11056 | 127390-77-6 | Reference compound |
| HY-120548 | KBU2046 | 1143863-69-7 | Reference compound |
| HY-12054A | Hesperadin (hydrochloride) | Reference compound | |
| HY-12055 | BIX02188 | 334949-59-6 | Reference compound |
| HY-120550 | RS 49676 | 111962-89-1 | Reference compound |
| HY-120551 | Fructigenine A | 144606-96-2 | Natural Products |
| HY-120553 | B-355252 | 1261576-81-1 | Reference compound |
| HY-120555 | Texaline | 115070-72-9 | Reference compound |
| HY-120556 | tetranor-12(R)-HETE | 135271-51-1 | Reference compound |
| HY-120559 | GSK-2250665A | 1246030-96-5 | Reference compound |
| HY-12056 | BIX02189 | 1265916-41-3 | Reference compound |
| HY-120560 | OMDM169 | 130193-44-1 | Reference compound |
| HY-120561 | PC-046 | 1202401-59-9 | Reference compound |
| HY-120563 | LY135305 | 123199-75-7 | Reference compound |
| HY-120564 | BMS-763534 | 1188407-40-0 | Reference compound |
| HY-120565 | WB403 | 1594041-84-5 | Reference compound |
| HY-120566 | PSB-16131 | 1213268-80-4 | Reference compound |
| HY-120567 | VU0400195 | 1309434-83-0 | Reference compound |
| HY-120568 | M4284 | 1373346-85-0 | Reference compound |
| HY-12056A | (E/Z)-BIX02189 | 1094614-85-3 | Biochemical Assay Reagents |
| HY-12057 | Vemurafenib | 918504-65-1 | Reference compound |
| HY-120570 | WN1316 | 1356959-71-1 | Reference compound |
| HY-120571 | L-674573 | 127481-29-2 | Reference compound |
| HY-120572 | PI-091 | 129051-63-4 | Natural Products |
| HY-120574 | TH1338 | 1258494-60-8 | Reference compound |
| HY-120576 | ML169 | 1222878-02-5 | Reference compound |
| HY-120577 | BA 41899 | 166020-57-1 | Reference compound |
| HY-120579 | A 53868A | 116198-48-2 | Reference compound |
| HY-12057R | Vemurafenib (Standard) | 918504-65-1 | Reference Standards |
| HY-12057S | Vemurafenib-d5 | 1365986-90-8 | Isotope-Labeled Compounds |
| HY-12057S1 | Vemurafenib-d7 | 1365986-73-7 | Isotope-Labeled Compounds |
| HY-12058 | AZD8330 | 869357-68-6 | Reference compound |
| HY-120581 | ML388 | 1537192-31-6 | Reference compound |
| HY-120583 | (Rac)-LY 255262 | 106892-82-4 | Reference compound |
| HY-120585 | L-365209 | 122211-30-7 | Reference compound |
| HY-120586 | SC-46944 | 120729-15-9 | Reference compound |
| HY-120587 | Bis-PEG6-acid | 119189-70-7 | Reference compound |
| HY-120588 | BI 639667 | 1295298-26-8 | Reference compound |
| HY-120589 | VU0360172 | 1310012-12-4 | Reference compound |
| HY-12059 | AT7867 | 857531-00-1 | Reference compound |
| HY-120590 | Ruserontinib | 1350544-93-2 | Reference compound |
| HY-120594 | R78206 | 124436-97-1 | Reference compound |
| HY-120595 | JNJ-49095397 | 1220626-82-3 | Reference compound |
| HY-120596 | PPARδ/γ agonist 1 (sodium) | 1258076-66-2 | Reference compound |
| HY-120597 | SAK3 | 1256269-87-0 | Reference compound |
| HY-120598 | ASP7657 (free base) | 1196045-28-9 | Reference compound |
| HY-120599 | Sabizabulin | 1332881-26-1 | Reference compound |
| HY-120599A | Sabizabulin (hydrochloride) | 2635953-17-0 | Reference compound |
| HY-12059A | AT7867 (dihydrochloride) | 1431697-86-7 | Reference compound |
| HY-12059B | AT7867 (hydrochloride) | 2624336-89-4 | Reference compound |
| HY-12060 | KRN-633 | 286370-15-8 | Reference compound |
| HY-120600 | Sibiriline | 1346526-26-8 | Reference compound |
| HY-120601 | Alizarin Red S (sodium) | 130-22-3 | Dye Reagents |
| HY-120601A | Alizarin Red S | 83-61-4 | Reference compound |
| HY-120602 | WWL229 | 1338575-28-2 | Reference compound |
| HY-120604 | BVB808 | 1414587-22-6 | Reference compound |
| HY-120606 | A-78773 | 141579-67-1 | Reference compound |
| HY-120607 | Chevalone C | 1318025-77-2 | Natural Products |
| HY-120608 | BMS-814580 | 1197420-11-3 | Reference compound |
| HY-120609 | BMS-902483 | 1192810-88-0 | Reference compound |
| HY-12061 | KU-60019 | 925701-46-8 | Reference compound |
| HY-120611 | BMS-960 (free base) | 1265321-86-5 | Reference compound |
| HY-120611A | BMS-960 | 1265323-40-7 | Reference compound |
| HY-120613 | BMS-986187 | 684238-37-7 | Reference compound |
| HY-120614 | BMS-186511 | 167467-53-0 | Reference compound |
| HY-120619 | BMS-193885 | 186185-03-5 | Reference compound |
| HY-12062 | PD318088 | 391210-00-7 | Reference compound |
| HY-120620 | BMS-195270 | 202822-23-9 | Reference compound |
| HY-120622 | BMS-243117 | 225521-80-2 | Reference compound |
| HY-120623 | BMS-284640 | 230640-88-7 | Reference compound |
| HY-120625 | BMS-358233 | 601519-75-9 | Reference compound |
| HY-120628 | BMS-587101 | 509083-77-6 | Reference compound |
| HY-120629 | BMS-639623 | 675122-44-8 | Reference compound |
| HY-12063 | PHT-427 | 1191951-57-1 | Reference compound |
| HY-120631A | BMS-538305 (hydrochloride) | 841302-51-0 | Reference compound |
| HY-120632 | BMS-433771 | 543700-68-1 | Reference compound |
| HY-120632A | BMS-433771 (dihydrochloride hydrate) | 543700-67-0 | Reference compound |
| HY-120633 | BMS-986104 | 1622180-31-7 | Reference compound |
| HY-120633A | BMS-986104 (hydrochloride) | 1622180-39-5 | Reference compound |
| HY-120634 | BMS-929075 | 1217338-97-0 | Reference compound |
| HY-120635 | BMS-1001 (hydrochloride) | 2113650-04-5 | Reference compound |
| HY-120636 | P2Y1 antagonist 1 | 1555697-67-0 | Reference compound |
| HY-120637 | BMS-986034 | 1492631-88-5 | Reference compound |
| HY-120638 | BMS-250749 | 406913-72-2 | Reference compound |
| HY-120639 | BMS-663749 lysine | 864953-34-4 | Reference compound |
| HY-120640 | BMS-605541 | 639858-32-5 | Reference compound |
| HY-120643 | BMS-823778 (hydrochloride) | 1140898-87-8 | Reference compound |
| HY-120643A | BMS-823778 | 1140897-32-0 | Reference compound |
| HY-120644 | BMS-919373 | 1272353-82-8 | Reference compound |
| HY-120645 | BMS-986122 | 313669-88-4 | Reference compound |
| HY-120646 | BMS-242 | 1675204-51-9 | Reference compound |
| HY-120647 | BMS-1001 | 2113650-03-4 | Reference compound |
| HY-120648 | CAY 10434 | 769917-29-5 | Reference compound |
| HY-120648A | CAY 10462 (dihydrochloride) | 502656-68-0 | Reference compound |
| HY-120649 | SKM 4-45-1 | 290374-09-3 | Reference compound |
| HY-120650 | CAY10435 | 288862-73-7 | Reference compound |
| HY-120651 | LDL-IN-2 | 778624-05-8 | Reference compound |
| HY-120652 | A3AR antagonist 3 | 863202-33-9 | Reference compound |
| HY-120653 | CB1 antagonist 5 | 878533-35-8 | Reference compound |
| HY-120654 | [1,1′:4′,1′′-Terphenyl]-3,4′′,5-triol | 890854-82-7 | Reference compound |
| HY-120656 | Prostaglandin K2 | 275816-51-8 | Reference compound |
| HY-120657 | 9-PAHSA | 1481636-31-0 | Reference compound |
| HY-120657R | 9-PAHSA (Standard) | 1481636-31-0 | Reference Standards |
| HY-120657S | 9-PAHSA-d4 | 2704278-85-1 | Isotope-Labeled Compounds |
| HY-120657S1 | 9-PAHSA-d31 | Isotope-Labeled Compounds | |
| HY-120658 | (Rac)-LY193239 | 122548-63-4 | Reference compound |
| HY-120659 | Gly-Gly-AMC | 208645-74-3 | Dye Reagents |
| HY-12066 | GSK1292263 | 1032823-75-8 | Reference compound |
| HY-120661 | T-1840383 | 1195779-24-8 | Reference compound |
| HY-120662 | GSK1331268 | 1207197-70-3 | Reference compound |
| HY-120663 | KRCA-0713 | 1884321-89-4 | Reference compound |
| HY-120664 | BRD50837 | 1314295-24-3 | Reference compound |
| HY-120665 | Prostaglandin B1 | 13345-51-2 | Natural Products |
| HY-120666 | TAMRA-PEG4-Alkyne | 1225057-68-0 | Dye Reagents |
| HY-120667 | DS-5272 | 1235575-97-9 | Reference compound |
| HY-120669 | PF-06761281 | 1854061-19-0 | Reference compound |
| HY-12067 | R406 | 841290-81-1 | Reference compound |
| HY-120672 | LG 83-6-05 | 131602-24-9 | Reference compound |
| HY-120673 | SQ 32970 | 122280-12-0 | Reference compound |
| HY-120675 | SSTC3 | 1242422-09-8 | Reference compound |
| HY-120676 | B-Raf IN 18 | 1244644-50-5 | Reference compound |
| HY-120677 | AHR-15010 | 132031-90-4 | Reference compound |
| HY-120678 | DBCO-PEG4-acid | 2110448-99-0 | Reference compound |
| HY-120679 | XK469 | 157435-10-4 | Reference compound |
| HY-12068 | PI3K-IN-1 | 1349796-36-6 | Reference compound |
| HY-120682 | UH-AH 37 | 120382-14-1 | Reference compound |
| HY-120684 | PDE10-IN-6 | 1207549-69-6 | Reference compound |
| HY-120685 | WAY-125971 | 139047-48-6 | Reference compound |
| HY-120686 | S-14671 | 135722-27-9 | Reference compound |
| HY-120687 | A68930 | 130465-45-1 | Reference compound |
| HY-120688 | L-772405 | 177947-03-4 | Reference compound |
| HY-120689 | PF-04745637 | 1917294-46-2 | Reference compound |
| HY-12069 | SB-743921 (hydrochloride) | 940929-33-9 | Reference compound |
| HY-120690 | RO5464466 | 1399767-47-5 | Reference compound |
| HY-120691A | GSK205 | 1263068-83-2 | Reference compound |
| HY-120692 | Cyclanoline (chloride) | 17472-50-3 | Natural Products |
| HY-120695 | Nafiverine | 5061-22-3 | Reference compound |
| HY-120696 | SR9186 | 1361414-26-7 | Reference compound |
| HY-120697 | MSAB | 173436-66-3 | Reference compound |
| HY-120699 | RO5488608 | 1337920-46-3 | Reference compound |
| HY-12070 | DPH | 484049-04-9 | Reference compound |
| HY-120700 | L-682,679 | 126409-24-3 | Reference compound |
| HY-120702 | N-Boc-PEG5-bromide | 1392499-32-9 | ADC Related |
| HY-120703 | RU 58642 | 143782-63-2 | Reference compound |
| HY-120704 | Mps-BAY2b | 1263420-68-3 | Reference compound |
| HY-120709 | GSK2793660 (hydrochloride) | 1613458-79-9 | Reference compound |
| HY-12071 | LDN193189 | 1062368-24-4 | Reference compound |
| HY-120710 | DNS-8254 | 1821107-98-5 | Reference compound |
| HY-120711 | BRD0476 | 1314958-91-2 | Reference compound |
| HY-120712 | Ro 31-8588 | 141979-04-6 | Reference compound |
| HY-120713 | MK-8325 (dihydrochloride) | 1334314-19-0 | Reference compound |
| HY-120714 | Metiazinic acid | 13993-65-2 | Reference compound |
| HY-120715 | 4-Epianhydrochlortetracycline (hydrochloride) | 158018-53-2 | Reference compound |
| HY-120717 | VU6001966 | 2009052-76-8 | Reference compound |
| HY-120719 | SB 201823-A | 141429-64-3 | Reference compound |
| HY-12071A | LDN193189 (Tetrahydrochloride) | 2310134-98-4 | Reference compound |
| HY-12071B | LDN-193189 (dihydrochloride) | 1435934-00-1 | Reference compound |
| HY-12071C | LDN193189 (hydrochloride) | 1062368-62-0 | Biochemical Assay Reagents |
| HY-12071G | LDN193189 (GMP) | 1062368-24-4 | GMP Small Molecules |
| HY-12072 | Lck Inhibitor | 847950-09-8 | Reference compound |
| HY-120720 | Isomitraphylline | 4963-01-3 | Natural Products |
| HY-120721 | Lagunamycin | 150693-65-5 | Natural Products |
| HY-120722 | TCH-165 | 1446350-60-2 | Reference compound |
| HY-120723 | (Rac)-Phox-I1 | 1388151-90-3 | Reference compound |
| HY-120724 | HO-PEG15-OH | 28821-35-4 | Reference compound |
| HY-120726 | BF844 | 1404506-35-9 | Reference compound |
| HY-120727 | VU0364289 | 1242443-29-3 | Reference compound |
| HY-120729 | Pyrazophos | 13457-18-6 | Reference compound |
| HY-120729R | Pyrazophos (Standard) | 13457-18-6 | Reference Standards |
| HY-120730 | DA 1686 | 13071-27-7 | Reference compound |
| HY-120731 | N-Oleoyl leucine | 136560-76-4 | Peptides |
| HY-120733 | Calpinactam | 1205538-83-5 | Natural Products |
| HY-120734 | Quinoxyfen | 124495-18-7 | Reference compound |
| HY-120734R | Quinoxyfen (Standard) | 124495-18-7 | Reference Standards |
| HY-120734S | Quinoxyfen-d4 | Isotope-Labeled Compounds | |
| HY-120735 | Lascivol | 129421-88-1 | Natural Products |
| HY-120736 | MEB55 | 1323359-63-2 | Reference compound |
| HY-120737 | L-702007 | 139547-89-0 | Reference compound |
| HY-120738 | p-MPPI (hydrochloride) | 220643-77-6 | Reference compound |
| HY-12074 | Cazpaullone | 914088-64-5 | Reference compound |
| HY-120740 | 4-Amino-PPHT | 129298-03-9 | Reference compound |
| HY-120741 | PF-04822163 | 1798334-07-2 | Reference compound |
| HY-120742 | MMG-0358 | 1378976-02-3 | Reference compound |
| HY-120743 | Triplin | 1421584-86-2 | Reference compound |
| HY-120744 | LDN-193665 | 1289638-16-9 | Reference compound |
| HY-120747 | A-65282 | 135906-72-8 | Reference compound |
| HY-12075 | LY2109761 | 700874-71-1 | Reference compound |
| HY-120750 | A 62176 (hydrochloride) | 111783-54-1 | Reference compound |
| HY-120751 | TROX-1 | 1309601-26-0 | Reference compound |
| HY-120752 | CAY10509 | 1245699-47-1 | Reference compound |
| HY-120753 | Rimocidin | 1393-12-0 | Reference compound |
| HY-120755 | LY290324 | 146554-87-2 | Reference compound |
| HY-120756 | PD125754 | 124339-32-8 | Reference compound |
| HY-120757 | LP-130 | 153314-49-9 | Reference compound |
| HY-120758 | SEL24-B489 | 1616359-00-2 | Reference compound |
| HY-120759 | 3-Hydroxy carvedilol | 146574-43-8 | Reference compound |
| HY-12076 | BMS 777607 | 1025720-94-8 | Reference compound |
| HY-120760 | L-691831 | 136668-70-7 | Reference compound |
| HY-120761 | Amino-PEG10-OH | 129449-09-8 | ADC Related |
| HY-120763 | LB42908 | 226927-89-5 | Reference compound |
| HY-120764 | PF-46396 | 1207481-21-7 | Reference compound |
| HY-120765 | BRD2879 | 1304750-47-7 | Reference compound |
| HY-120766 | NCDM-32B | 1239468-48-4 | Reference compound |
| HY-120767 | Linzagolix (choline) | 1321816-57-2 | Reference compound |
| HY-120768 | A-30312 | 144092-65-9 | Reference compound |
| HY-120769 | Pimprinine | 13640-26-1 | Reference compound |
| HY-120770 | DBCO-PEG4-Maleimide | 1480516-75-3 | ADC Related |
| HY-120773 | Fmoc-PEG3-C2-NHS ester | 1352827-47-4 | Reference compound |
| HY-120774 | GS-462808 | 1354198-41-6 | Reference compound |
| HY-120775 | Boc-NH-PEG1-CH2CH2COOH | 1260092-44-1 | ADC Related |
| HY-120776 | SC-51316 | 133690-62-7 | Reference compound |
| HY-120777 | GSK729 | 1403602-92-5 | Reference compound |
| HY-120781 | Fluorescein-thiourea-PEG4-azide | 1454662-54-4 | Reference compound |
| HY-120782 | Yhhu-3792 | 2097826-24-7 | Reference compound |
| HY-120782A | Yhhu-3792 (hydrochloride) | 2624336-93-0 | Reference compound |
| HY-120783 | Lu AF58801 | 1531592-40-1 | Reference compound |
| HY-120784 | Hexafluoro-diallylhexaflurobisphenol | 128481-73-2 | Reference compound |
| HY-120785 | SR1555 | 1386439-51-5 | Reference compound |
| HY-120785A | SR1555 (hydrochloride) | 2309312-90-9 | Reference compound |
| HY-120786 | MPT0B014 | 1215208-59-5 | Reference compound |
| HY-120788 | VMAT2-IN-4 | 1436695-49-6 | Reference compound |
| HY-120789 | PF-06648671 | 1587727-31-8 | Reference compound |
| HY-12079 | CP-481715 | 212790-31-3 | Reference compound |
| HY-120791A | L-Lysyl-L-lysine (trihydrochloride) | 73343-51-8 | Reference compound |
| HY-120792 | DAU 5884 | 131780-47-7 | Reference compound |
| HY-120793 | CMC2.24 | 1255639-43-0 | Reference compound |
| HY-120794 | SC-67655 | 182134-00-5 | Reference compound |
| HY-120796 | MW108 (hydrochloride) | 1454658-89-9 | Reference compound |
| HY-120797 | CRT0273750 | 1979939-16-6 | Reference compound |
| HY-120798 | 4-Nitrophenyl phenylphosphonate | 57072-35-2 | Reference compound |
| HY-12080 | BX471 | 217645-70-0 | Reference compound |
| HY-120801 | APX-115 | 1395946-75-4 | Reference compound |
| HY-120801A | APX-115 (free base) | 1270084-92-8 | Reference compound |
| HY-120802 | Navafenterol | 1435519-06-4 | Reference compound |
| HY-120802A | Navafenterol (saccharinate) | 1648550-37-1 | Reference compound |
| HY-120803 | Mefluidide | 53780-34-0 | Reference compound |
| HY-120803R | Mefluidide (Standard) | 53780-34-0 | Reference Standards |
| HY-120805 | Aurofusarin | 13191-64-5 | Natural Products |
| HY-120809 | Spiramycin III | 24916-52-7 | Reference compound |
| HY-12080A | BX471 (hydrochloride) | 288262-96-4 | Reference compound |
| HY-120811 | PF-04701475 | 1488407-52-8 | Reference compound |
| HY-120812 | HIV-IN-11 | 160729-91-9 | Reference compound |
| HY-120813 | ARN 077 | 1373625-34-3 | Reference compound |
| HY-120813A | ARN 077 (enantiomer) | 1439366-88-7 | Reference compound |
| HY-120816 | WU-07047 | 1702378-78-6 | Reference compound |
| HY-120818 | TRPC3/6-IN-3 | 1366234-01-6 | Reference compound |
| HY-120820 | LY320954 | 182633-59-6 | Reference compound |
| HY-120821 | Endosidin-2 | 1839524-44-5 | Reference compound |
| HY-120823 | PF-05381941 | 1474022-02-0 | Reference compound |
| HY-120824 | Mofezolac | 78967-07-4 | Reference compound |
| HY-120826 | A2AAR/hMAO-B-IN-1 | 1439488-21-7 | Reference compound |
| HY-120827 | Allosamidin | 103782-08-7 | Reference compound |
| HY-120828 | Albenatide | 1031700-39-6 | Reference compound |
| HY-120829 | Bisoprolol (fumarate) | 105878-43-1 | Reference compound |
| HY-120829S | Bisoprolol-d5 (hemifumarate) | Isotope-Labeled Compounds | |
| HY-12082A | GSK369796 Dihydrochloride | 1010411-21-8 | Reference compound |
| HY-12083 | PPY-A | 875634-01-8 | Reference compound |
| HY-120831 | Pyridoxylideneglutamic acid | 13934-03-7 | Biochemical Assay Reagents |
| HY-120832 | Azt-pmap | 142629-81-0 | Reference compound |
| HY-120833 | Ac-Ile-Glu-Thr-Asp-pNA | 219138-21-3 | Peptides |
| HY-120835 | SB-202742 | 124576-72-3 | Natural Products |
| HY-120836 | AOH1160 | 2089314-57-6 | Reference compound |
| HY-120837 | PZ-II-029 | 164025-44-9 | Reference compound |
| HY-120838 | Heptelidic acid | 57710-57-3 | Reference compound |
| HY-120840 | GR 100679 | 150351-87-4 | Reference compound |
| HY-120842 | RLH-033 | 157097-10-4 | Reference compound |
| HY-120843 | WS009A | 136286-49-2 | Natural Products |
| HY-120845 | Tr-PEG5-OH | 141282-24-8 | ADC Related |
| HY-120846 | CHIR 4531 | 158198-48-2 | Reference compound |
| HY-12085 | Apremilast | 608141-41-9 | Reference compound |
| HY-120851 | O-7460 | 1572051-31-0 | Reference compound |
| HY-120852 | JG26 | 1464910-32-4 | Reference compound |
| HY-120853 | SR-4326 | 1164153-25-6 | Reference compound |
| HY-120855 | CCG-100602 | 1207113-88-9 | Reference compound |
| HY-120856 | ARN-3236 | 1613710-01-2 | Reference compound |
| HY-120857 | BPIQ-II (hydrochloride) | 171179-37-6 | Reference compound |
| HY-120858 | 25T4-NBOMe (hydrochloride) | 1566571-73-0 | Reference compound |
| HY-120859 | Zidebactam | 1436861-97-0 | Reference compound |
| HY-120859A | Zidebactam sodium salt | 1706777-46-9 | Reference compound |
| HY-12085R | Apremilast (Standard) | 608141-41-9 | Reference Standards |
| HY-12085S | Apremilast-d5 | 1258597-47-5 | Isotope-Labeled Compounds |
| HY-12085S1 | Apremilast-d8 | 1258597-45-3 | Isotope-Labeled Compounds |
| HY-12085S2 | (Rac)-Apremilast-d5 | 1258597-61-3 | Isotope-Labeled Compounds |
| HY-12085S3 | Apremilast-d3 | 1258597-46-4 | Isotope-Labeled Compounds |
| HY-120860 | Sporidesmolide I | 2900-38-1 | Natural Products |
| HY-120861 | Acerinol | 19902-53-5 | Natural Products |
| HY-120862 | L 368935 | 145878-31-5 | Reference compound |
| HY-120863 | (Rac)-PD 135390 | 150351-31-8 | Reference compound |
| HY-120864 | SEN461 | 1287727-28-9 | Reference compound |
| HY-120865 | 1,3-PBIT (dihydrobromide) | 200716-66-1 | Reference compound |
| HY-120867 | TASP0376377 | 1233246-60-0 | Reference compound |
| HY-120868 | TP-004 | 1454299-21-8 | Reference compound |
| HY-120870 | para-Nitroblebbistatin | 1621326-32-6 | Reference compound |
| HY-120872 | AJS1669 (free acid) | 1853130-05-8 | Reference compound |
| HY-120874 | PF-06372865 | 1614245-70-3 | Reference compound |
| HY-120875 | HX600 | 172705-89-4 | Reference compound |
| HY-120876 | L-680833 | 127063-08-5 | Reference compound |
| HY-120877 | MRT199665 | 1456858-57-3 | Reference compound |
| HY-120877A | (R)-MRT199665 | Reference compound | |
| HY-120878 | CXCR2-IN-2 | 1838123-21-9 | Reference compound |
| HY-120878A | (R,R)-CXCR2-IN-2 | 1838123-22-0 | Reference compound |
| HY-120879 | PF2562 | 1609258-91-4 | Reference compound |
| HY-120880 | SKF107457 | 126333-28-6 | Peptides |
| HY-120882 | BM-1197 | 1391107-89-3 | Reference compound |
| HY-120883 | Rhizopodin | 150346-23-9 | Natural Products |
| HY-120884 | InhA-IN-5 | 1854095-63-8 | Reference compound |
| HY-120885 | (+)-Oxanthromicin | 1616622-08-2 | Natural Products |
| HY-120886 | GW 2433 | 227941-61-9 | Reference compound |
| HY-12089 | Torcetrapib | 262352-17-0 | Reference compound |
| HY-120890 | 3,4',5-Trismethoxybenzophenone | 94709-12-3 | Reference compound |
| HY-120891 | trans-EKODE-(E)-Ib | 478931-82-7 | Reference compound |
| HY-120892 | Fluprostenol serinol amide | 1176658-85-7 | Reference compound |
| HY-120893 | trans-4,5-Epoxy-(E)-2-decenal | 134454-31-2 | Reference compound |
| HY-120894 | 16(R)-HETE | 183509-22-0 | Reference compound |
| HY-120896B | Imipramine Blue (chloride) | Reference compound | |
| HY-120897 | NS-3-008 (hydrochloride) | 1172854-54-4 | Reference compound |
| HY-12090 | Anacetrapib | 875446-37-0 | Reference compound |
| HY-120900 | AN-12-H5 | 1193340-31-6 | Reference compound |
| HY-120901 | II-B08 | 1143579-78-5 | Reference compound |
| HY-120902 | GSK-3β inhibitor 8 | 1139875-74-3 | Reference compound |
| HY-120903 | DBCO-C3-Acid | 1207355-31-4 | ADC Related |
| HY-120904 | AMPK-IN-1 | 1219739-95-3 | Reference compound |
| HY-120908 | c-Met-IN-16 | 1208248-23-0 | Reference compound |
| HY-120909 | YK5 | 1268273-23-9 | Reference compound |
| HY-120912 | Gingerenone A | 128700-97-0 | Natural Products |
| HY-120914 | TrxR1-IN-B19 | 170950-29-5 | Reference compound |
| HY-120918 | NH2-PEG7 | 1425973-14-3 | Reference compound |
| HY-120920 | UNC9995 | 1354030-52-6 | Reference compound |
| HY-120921 | Zoxamide | 156052-68-5 | Reference compound |
| HY-120921R | Zoxamide (Standard) | 156052-68-5 | Reference Standards |
| HY-120922 | Spiroakyroside | 139390-87-7 | Natural Products |
| HY-120924 | BRD9185 | 2057420-29-6 | Reference compound |
| HY-120926 | BBR 2160 | 118587-22-7 | Reference compound |
| HY-120927 | Alvimopan metabolite | 156130-41-5 | Reference compound |
| HY-120927A | Alvimopan metabolite (hydrochloride) | 170098-43-8 | Reference compound |
| HY-120927S | Alvimopan metabolite-d5 | 2124272-23-5 | Isotope-Labeled Compounds |
| HY-120928 | S 16474 | 149250-10-2 | Reference compound |
| HY-120929 | BI8622 | 1875036-74-0 | Reference compound |
| HY-12093 | MMP408 | 1025716-81-7 | Reference compound |
| HY-120931 | LY329146 | 191043-78-4 | Reference compound |
| HY-120934 | C25-140 | 1358099-18-9 | Reference compound |
| HY-120935 | (R)-Dabelotine | 152886-02-7 | Reference compound |
| HY-120936 | IACS-4759 | 1884209-99-7 | Reference compound |
| HY-120937 | DC4 Crosslinker | 1374647-94-5 | Reference compound |
| HY-120939 | S14063 | 137289-83-9 | Reference compound |
| HY-120940 | AZ13705339 | 2016806-57-6 | Reference compound |
| HY-120940A | AZ13705339 (hemihydrate) | Reference compound | |
| HY-120941 | LASSBio-1359 | 1396397-19-5 | Reference compound |
| HY-120942 | XIE18-6 | 1286862-52-9 | Reference compound |
| HY-120943 | K-111 | 221564-97-2 | Reference compound |
| HY-120944 | BAY-7598 | 1816257-74-5 | Reference compound |
| HY-120946 | VMY-2-95 | 1434047-61-6 | Reference compound |
| HY-120947 | AV-105 | 1205550-99-7 | Reference compound |
| HY-120948 | RU 45196 | 121548-81-0 | Reference compound |
| HY-120949 | (1R,2R)-U-50488 (hydrochloride) | 109620-49-7 | Reference compound |
| HY-12095 | CB1 inverse agonist 2 | 1019839-52-1 | Reference compound |
| HY-120950 | S-tram,tram-Farnesylated cysteine methyl ester | 125741-64-2 | Reference compound |
| HY-120951 | PFM39 | 1310744-67-2 | Reference compound |
| HY-120953 | GAT228 | 1446648-15-2 | Reference compound |
| HY-120954 | 14,15-EE-5(Z)-E | 519038-92-7 | Reference compound |
| HY-120955 | (+)-5-trans Cloprostenol | 57968-81-7 | Reference compound |
| HY-120956 | Methyl stearidonate | 73097-00-4 | Natural Products |
| HY-120957 | AMC Arachidonoyl Amide | 862913-13-1 | Reference compound |
| HY-120958 | Nisinic acid | 68378-49-4 | Reference compound |
| HY-120959 | DAUDA | 73025-02-2 | Dye Reagents |
| HY-120961 | Oleoyl ethyl amide | 85075-82-7 | Reference compound |
| HY-120962 | N-Arachidonoyl Taurine | 119959-65-8 | Reference compound |
| HY-120962S | N-Arachidonoyl Taurine-d4 | Isotope-Labeled Compounds | |
| HY-120963 | N-Oleoyl Taurine | 52514-04-2 | Natural Products |
| HY-120964 | N-Stearoyl Taurine | 63155-80-6 | Reference compound |
| HY-120965 | N-Palmitoyl Taurine | 83982-06-3 | Reference compound |
| HY-120966 | NCX 2121 | 301838-28-8 | Reference compound |
| HY-120967 | (2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98% | 1217471-69-6 | Biochemical Assay Reagents |
| HY-120967A | (2S)-OMPT | 645408-61-3 | Biochemical Assay Reagents |
| HY-120968 | Arachidoyl ethanolamide | 94421-69-9 | Natural Products |
| HY-120969 | Docosanoyl ethanolamide | 94109-05-4 | Natural Products |
| HY-12096A | WAY-207024 (dihydrochloride) | 872002-73-8 | Reference compound |
| HY-120970 | Bis(7)-tacrine (dihydrochloride) | 224445-12-9 | Reference compound |
| HY-120971 | N-Decanoyl p-Nitroaniline | 72298-63-6 | Reference compound |
| HY-120972 | Pentafluorobenzenesulfonyl fluorescein | 728912-45-6 | Dye Reagents |
| HY-120973 | Butaprost (free acid) | 215168-33-5 | Biochemical Assay Reagents |
| HY-120973A | (S)-Butaprost (free acid) | 433219-55-7 | Reference compound |
| HY-120974 | α-lipoic acid derivative 1 | 691410-93-2 | Reference compound |
| HY-120975 | 2,3-Dinor thromboxane b1 | 196493-76-2 | Reference compound |
| HY-120976 | DEPMPO | 157230-67-6 | Reference compound |
| HY-120977 | Methyl pentacosanoate | 55373-89-2 | Natural Products |
| HY-120978 | Omega-3 arachidonic acid methyl ester | 132712-70-0 | Biochemical Assay Reagents |
| HY-120979 | NO-Losartan A | 791122-48-0 | Reference compound |
| HY-12098 | Verubulin (hydrochloride) | 917369-31-4 | Reference compound |
| HY-120980 | Thromboxane B1 | 64626-32-0 | Reference compound |
| HY-120981S | (±)5-iPF2α-VI-d11 | 936565-17-2 | Isotope-Labeled Compounds |
| HY-120982 | (+)-15-epi Cloprostenol | 54276-22-1 | Reference compound |
| HY-120983 | 2-Hexadecanoylthio-1-ethylphosphorylcholine | 60793-01-3 | Biochemical Assay Reagents |
| HY-120984 | Oleic Acid-2,6-diisopropylanilide | 140112-65-8 | Reference compound |
| HY-120985 | Araguspongin B | 123000-02-2 | Reference compound |
| HY-120986 | (S)-Bromoenol lactone | 478288-94-7 | Reference compound |
| HY-120986S | (S)-Bromoenol lactone-d7 | Isotope-Labeled Compounds | |
| HY-120987 | Ethyl stearidonate | 119798-44-6 | Biochemical Assay Reagents |
| HY-120989 | Methyl 7(Z)-hexadecenoate | 56875-67-3 | Natural Products |
| HY-12099 | A3AR antagonist 2 | 1144161-05-6 | Reference compound |
| HY-120990 | Piloty's acid | 599-71-3 | Reference compound |
| HY-120991 | 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PE | 26662-95-3 | Biochemical Assay Reagents |
| HY-120993 | 1,N6-Ethenoadenosine 5'-monophosphate (sodium) | 885597-18-2 | Dye Reagents |
| HY-120994 | Rp-8-CPT-cAMPS (sodium) | 221905-35-7 | Reference compound |
| HY-120994A | Rp-8-CPT-cAMPS | 129735-01-9 | Reference compound |
| HY-120994B | Sp-8-CPT-cAMPS | 129693-13-6 | Reference compound |
| HY-120996 | 10(E)-Pentadecenoic acid | 321744-58-5 | Reference compound |
| HY-120996B | 10(Z)-Pentadecenoic acid | 84743-29-3 | Reference compound |
| HY-120997 | E6 Berbamine | 114784-59-7 | Reference compound |
| HY-120999 | DL-erythro/threo Sphinganine (d16:0) | 50731-08-3 | Natural Products |
| HY-12100 | Umeclidinium (bromide) | 869113-09-7 | Reference compound |
| HY-121000 | Albocycline | 25129-91-3 | Natural Products |
| HY-121002 | Alstonine | 642-18-2 | Natural Products |
| HY-121003 | Aspyrone | 17398-00-4 | Reference compound |
| HY-121004 | Bikaverin | 33390-21-5 | Natural Products |
| HY-121005 | Bufetolol | 53684-49-4 | Reference compound |
| HY-121006 | Biguanide | 56-03-1 | Reference compound |
| HY-121007 | Bepafant | 114776-28-2 | Reference compound |
| HY-121008 | Brl 20596 | 69082-47-9 | Reference compound |
| HY-12100R | Umeclidinium (bromide) (Standard) | 869113-09-7 | Reference Standards |
| HY-12100S | Umeclidinium-d5 (bromide) | Isotope-Labeled Compounds | |
| HY-12100S1 | Umeclidinium-d10 (bromide) | Isotope-Labeled Compounds | |
| HY-121011 | Cannabigerorcin | 38106-51-3 | Reference compound |
| HY-121012 | (rac)-AG-205 | 442656-02-2 | Reference compound |
| HY-121013 | Bryononic acid | 24480-44-2 | Natural Products |
| HY-121014 | Amphimedine | 86047-14-5 | Natural Products |
| HY-121018 | Daltroban | 79094-20-5 | Reference compound |
| HY-121019 | Flordipine | 77590-96-6 | Reference compound |
| HY-121020 | Arcapillin | 83162-82-7 | Natural Products |
| HY-121021 | BB-78485 | 207732-11-4 | Reference compound |
| HY-121025 | BUR1 | 23000-46-6 | Reference compound |
| HY-121026 | DMNQ | 6956-96-3 | Reference compound |
| HY-121027 | Anagyrine | 486-89-5 | Natural Products |
| HY-121027A | Anagyrine (hydrochloride) | 74195-83-8 | Natural Products |
| HY-121029 | Bisegliptin | 862501-61-9 | Reference compound |
| HY-121030 | DACM | 55145-14-7 | Dye Reagents |
| HY-121034 | Acaterin | 144398-20-9 | Natural Products |
| HY-121035 | 7BIO | 916440-85-2 | Reference compound |
| HY-121037 | Eggmanone | 505068-32-6 | Reference compound |
| HY-121038 | Chamazulene | 529-05-5 | Natural Products |
| HY-121039 | Avenin | 6309-98-4 | Reference compound |
| HY-12104 | PF-514273 | 851728-60-4 | Reference compound |
| HY-121042 | BSBM6 | 1186629-63-9 | Reference compound |
| HY-121043 | AA 497 (free base) | 59605-49-1 | Reference compound |
| HY-121043A | AA 497 | 65860-38-0 | Reference compound |
| HY-121045 | Bunitrolol | 34915-68-9 | Reference compound |
| HY-121046 | Flunixin | 38677-85-9 | Reference compound |
| HY-121046S | Flunixin-d3 | 1015856-60-6 | Isotope-Labeled Compounds |
| HY-121048 | AH 7725 | 33459-28-8 | Reference compound |
| HY-121050 | Ambruticin | 58857-02-6 | Natural Products |
| HY-121051 | Aleurodiscal | 122535-46-0 | Natural Products |
| HY-121053 | Adatanserin | 127266-56-2 | Reference compound |
| HY-121053A | Adatanserin (hydrochloride) | 144966-96-1 | Reference compound |
| HY-121054 | Chalcone | 94-41-7 | Natural Products |
| HY-121057 | 3-Hydroxyflunitrazepam | 67739-71-3 | Reference compound |
| HY-121058 | AD 4743 | 87858-57-9 | Reference compound |
| HY-121060 | Gloxazone | 2507-91-7 | Reference compound |
| HY-121061 | Abikoviromycin | 31774-33-1 | Natural Products |
| HY-121062 | Betamethasone acibutate | 5534-05-4 | Reference compound |
| HY-121065 | BN-82685 | 477603-18-2 | Reference compound |
| HY-121066 | Dehydrorotenone | 3466-09-9 | Natural Products |
| HY-121067 | Carbarsone | 121-59-5 | Reference compound |
| HY-121068 | Bisoxatin | 17692-24-9 | Reference compound |
| HY-121068R | Bisoxatin (Standard) | 17692-24-9 | Reference Standards |
| HY-121069 | Elubiol | 67914-69-6 | Reference compound |
| HY-121070 | AZD1092 | 871656-65-4 | Reference compound |
| HY-121071 | Ascamycin | 91432-48-3 | Natural Products |
| HY-121072 | ASS234 | 1334106-34-1 | Reference compound |
| HY-121075 | Alizarin complexone | 3952-78-1 | Reference compound |
| HY-121076 | Berteroin | 4430-42-6 | Reference compound |
| HY-121079 | Azimsulfuron | 120162-55-2 | Reference compound |
| HY-121079R | Azimsulfuron (Standard) | 120162-55-2 | Reference Standards |
| HY-12108 | S 1360 | 280571-30-4 | Reference compound |
| HY-121080 | AMG8163 | 659731-59-6 | Reference compound |
| HY-121081 | BAY-958 | 1335490-39-5 | Reference compound |
| HY-121082 | (-)-Dihydroalprenolol | 59624-90-7 | Reference compound |
| HY-121083 | Aerugidiol | 116425-35-5 | Natural Products |
| HY-121085 | CID-663143 | 578723-96-3 | Reference compound |
| HY-121086 | BAY-588 | 1799759-24-2 | Reference compound |
| HY-121087 | BCI-215 | 1245792-67-9 | Reference compound |
| HY-121088 | Ceefourin 2 | 348148-51-6 | Reference compound |
| HY-121089 | P300-IN-5 | 163107-37-7 | Reference compound |
| HY-12109 | L-870810 | 410544-95-5 | Reference compound |
| HY-121090 | FAAH-IN-9 | 288862-89-5 | Reference compound |
| HY-121091 | EP2 receptor agonist 4 | 212310-16-2 | Reference compound |
| HY-121092 | CAY10701 | 1616967-52-2 | Reference compound |
| HY-121093 | DC-S239 | 303141-21-1 | Reference compound |
| HY-121094 | Androgen receptor allosteric antagonist 1 | 927819-39-4 | Reference compound |
| HY-121095 | Bizine | 1591932-50-1 | Reference compound |
| HY-121095A | Bizine di(hydrochloride) | 1808112-57-3 | Reference compound |
| HY-121096 | Funalenone | 259728-61-5 | Reference compound |
| HY-121097 | Diapocynin | 29799-22-2 | Natural Products |
| HY-121099 | Cgp 8065 | 62939-04-2 | Reference compound |
| HY-121100 | BZAD-01 | 305339-41-7 | Reference compound |
| HY-121103 | Aclantate | 39633-62-0 | Reference compound |
| HY-121104 | Bactobolin | 72615-20-4 | Natural Products |
| HY-121104A | Bactobolin (hydrochloride) | 73543-68-7 | Natural Products |
| HY-121106 | 9-Deazaguanine | 65996-58-9 | Reference compound |
| HY-121107 | Chrysene | 218-01-9 | Natural Products |
| HY-121107R | Chrysene (Standard) | 218-01-9 | Reference Standards |
| HY-121107S | Chrysene-d12 | 1719-03-5 | Isotope-Labeled Compounds |
| HY-121109 | Benalaxyl | 71626-11-4 | Reference compound |
| HY-121109R | Benalaxyl (Standard) | 71626-11-4 | Reference Standards |
| HY-121109S | Benalaxyl-d5 | 2714421-66-4 | Isotope-Labeled Compounds |
| HY-12111 | BMS-564929 | 627530-84-1 | Reference compound |
| HY-121110 | Fexarene | 574013-68-6 | Reference compound |
| HY-121111 | Agaritine | 2757-90-6 | Natural Products |
| HY-121116 | CGS 8216 | 77779-60-3 | Natural Products |
| HY-121117 | Chloracetophos | 5952-41-0 | Reference compound |
| HY-121118 | Coronaridine | 467-77-6 | Natural Products |
| HY-121119 | MRS 1523 | 212329-37-8 | Reference compound |
| HY-121120 | Isosulfazecin | 77900-75-5 | Natural Products |
| HY-121122 | A778317 | 808756-64-1 | Reference compound |
| HY-121123 | Adamantanine | 42381-05-5 | Reference compound |
| HY-121124 | Fluindione | 957-56-2 | Reference compound |
| HY-121124S | Fluindione-d4 | 1246820-41-6 | Isotope-Labeled Compounds |
| HY-121125 | Aucubigenin | 64274-28-8 | Natural Products |
| HY-121129 | Eticlopride | 84226-12-0 | Reference compound |
| HY-12113 | Oprozomib | 935888-69-0 | Reference compound |
| HY-121130 | Dacuronium | 43021-45-0 | Reference compound |
| HY-121131 | Deacylcortivazol | 4906-84-7 | Reference compound |
| HY-121132 | Butibufen | 55837-18-8 | Reference compound |
| HY-121133 | (-)-Cyclopenol | 20007-85-6 | Natural Products |
| HY-121134 | Decylubiquinone | 55486-00-5 | Reference compound |
| HY-121136 | Chartreusin | 6377-18-0 | Reference compound |
| HY-121136A | Chartreusin (sodium) | 1393-72-2 | Natural Products |
| HY-121137 | BMPO | 387334-31-8 | Reference compound |
| HY-121138 | 1,8-Dihydroxy-4,5-dinitroanthraquinone | 81-55-0 | Reference compound |
| HY-12114 | Serlopitant | 860642-69-9 | Reference compound |
| HY-121140 | AZ1729 | 2016864-46-1 | Reference compound |
| HY-121141 | Adiphenine | 64-95-9 | Reference compound |
| HY-121143 | Bis-Q | 73711-18-9 | Reference compound |
| HY-121144 | Cefazedone | 56187-47-4 | Natural Products |
| HY-121144R | Cefazedone (Standard) | 56187-47-4 | Reference Standards |
| HY-121145 | Abruquinone A | 71593-10-7 | Natural Products |
| HY-121146 | Chinotilin (iodide) | 56583-56-3 | Reference compound |
| HY-121148 | Mutalomycin | 62618-08-0 | Reference compound |
| HY-121149 | Droloxifene | 82413-20-5 | Reference compound |
| HY-121149B | (E/Z)-Droloxifene | 165813-01-4 | Reference compound |
| HY-12115 | NG-nitro-L-arginine | 2149-70-4 | Reference compound |
| HY-121151 | (±)-Methotrexate | 60388-53-6 | Reference compound |
| HY-121151S | Amethopterin-d3 | Isotope-Labeled Compounds | |
| HY-121153 | Altenusin | 31186-12-6 | Natural Products |
| HY-121154 | Hexachloroparaxylene | 68-36-0 | Reference compound |
| HY-121156 | Anatibant | 209733-45-9 | Reference compound |
| HY-121156A | Anatibant (hydrochloride) | 209788-45-4 | Reference compound |
| HY-121157 | Chlorfenson | 80-33-1 | Reference compound |
| HY-121157R | Chlorfenson (Standard) | 80-33-1 | Reference Standards |
| HY-121158 | Butamifos | 36335-67-8 | Reference compound |
| HY-121158R | Butamifos (Standard) | 36335-67-8 | Reference Standards |
| HY-121159 | Alanopine | 19149-54-3 | Reference compound |
| HY-12116 | L-NIL | 53774-63-3 | Reference compound |
| HY-121160 | Amiprilose | 56824-20-5 | Reference compound |
| HY-121161 | (Rac)-Brassinazole | 224047-41-0 | Reference compound |
| HY-121161A | Brassinazole | 280129-83-1 | Reference compound |
| HY-121161B | (2S,3R)-Brassinazole | 259200-31-2 | Reference compound |
| HY-121161C | (2R,3S)-Brassinazole | 259200-30-1 | Reference compound |
| HY-121162 | Mesembrine | 468-53-1 | Natural Products |
| HY-121163 | PF-184563 | 748806-39-5 | Reference compound |
| HY-121165 | Cymiazole | 61676-87-7 | Reference compound |
| HY-121165R | Cymiazole (Standard) | 61676-87-7 | Reference Standards |
| HY-121166 | Levobetaxolol | 93221-48-8 | Reference compound |
| HY-121167 | L-Albizziin | 1483-07-4 | Reference compound |
| HY-121168 | Aprophen | 3563-01-7 | Reference compound |
| HY-121169 | Amorolfine | 78613-35-1 | Reference compound |
| HY-12117 | L-NIL (hydrochloride) | 150403-89-7 | Reference compound |
| HY-121172 | 1,4-DPCA | 331830-20-7 | Reference compound |
| HY-121174 | Alaternin | 39723-40-5 | Natural Products |
| HY-121176 | Asalin | 13425-94-0 | Reference compound |
| HY-121178 | Deoxyviolacein | 5839-61-2 | Reference compound |
| HY-12118 | L-NIL (dihydrochloride) | 159190-45-1 | Reference compound |
| HY-121180 | A-58365B | 87896-53-5 | Reference compound |
| HY-121182 | Chalcomycin | 20283-48-1 | Natural Products |
| HY-121183 | Aprikalim | 132562-26-6 | Reference compound |
| HY-121184 | Epicoccamide | 606139-26-8 | Natural Products |
| HY-121185 | Hexoprenaline | 3215-70-1 | Reference compound |
| HY-121186 | Bevantolol (hydrochloride) | 42864-78-8 | Reference compound |
| HY-121186R | Bevantolol (hydrochloride) (Standard) | 42864-78-8 | Reference Standards |
| HY-121187 | BiPNQ | 313513-16-5 | Reference compound |
| HY-121188 | DDMS | 206052-03-1 | Reference compound |
| HY-12119 | GW274150 | 210354-22-6 | Reference compound |
| HY-121191 | Bisnorcymserine | 219920-81-7 | Reference compound |
| HY-121192 | Capillarisin | 56365-38-9 | Natural Products |
| HY-121195 | Apalcillin | 63469-19-2 | Reference compound |
| HY-121197 | Balanol | 63590-19-2 | Natural Products |
| HY-121198 | Dimestrol | 130-79-0 | Reference compound |
| HY-121199 | Germanicol | 465-02-1 | Natural Products |
| HY-12119A | GW274150 (phosphate) | 438542-15-5 | Reference compound |
| HY-12119B | GW274150 (dihydrochloride) | 438542-17-7 | Reference compound |
| HY-121200 | Azadirone | 30002-86-9 | Reference compound |
| HY-121201 | Amicarbalide | 3459-96-9 | Reference compound |
| HY-121202 | Leucopterin | 492-11-5 | Natural Products |
| HY-121203 | Citalopram | 59729-33-8 | Reference compound |
| HY-121203A | Citalopram (oxalate) | 207559-01-1 | Reference compound |
| HY-121203R | Citalopram (Standard) | 59729-33-8 | Reference Standards |
| HY-121203S | Citalopram-d4 (hydrobromide) | 1219803-58-3 | Isotope-Labeled Compounds |
| HY-121203S1 | Citalopram-d6 (oxalate) | 1246819-94-2 | Isotope-Labeled Compounds |
| HY-121203S3 | Citalopram-d6 | 1190003-26-9 | Isotope-Labeled Compounds |
| HY-121203S4 | Citalopram-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-121204 | Iberverin | 505-79-3 | Natural Products |
| HY-121204R | Iberverin (Standard) | 505-79-3 | Reference Standards |
| HY-121205 | Guineesine | 55038-30-7 | Natural Products |
| HY-121206 | (-)-Isopulegol | 89-79-2 | Reference compound |
| HY-121206R | (-)-Isopulegol (Standard) | 89-79-2 | Reference Standards |
| HY-121207 | Denopterin | 22006-84-4 | Reference compound |
| HY-121208 | Ketanserinol | 76330-73-9 | Reference compound |
| HY-121208R | Ketanserinol (Standard) | 76330-73-9 | Reference Standards |
| HY-121211 | Digitolutein | 477-86-1 | Natural Products |
| HY-121212 | Icosabutate | 1253909-57-7 | Reference compound |
| HY-121212R | Icosabutate (Standard) | 1253909-57-7 | Reference Standards |
| HY-121213 | Erysolin | 504-84-7 | Reference compound |
| HY-121214 | Amisulbrom | 348635-87-0 | Reference compound |
| HY-121214R | Amisulbrom (Standard) | 348635-87-0 | Reference Standards |
| HY-121215 | Chloracyzine | 800-22-6 | Reference compound |
| HY-121219 | (-)-Lupinine | 486-70-4 | Natural Products |
| HY-12122 | AR-C102222 | 253771-21-0 | Reference compound |
| HY-121220 | Carbetamide | 16118-49-3 | Reference compound |
| HY-121220R | Carbetamide (Standard) | 16118-49-3 | Reference Standards |
| HY-121221 | Justiciresinol | 136051-41-7 | Natural Products |
| HY-121222 | alpha-Bisabolol | 515-69-5 | Natural Products |
| HY-121225 | Faradiol | 20554-95-4 | Natural Products |
| HY-121226 | Karakin | 1400-11-9 | Natural Products |
| HY-121227 | Cylindrin | 17904-55-1 | Natural Products |
| HY-121229A | (±)-Coniine | 3238-60-6 | Natural Products |
| HY-12122A | AR-C102222 (hydrochloride) | 1781934-50-6 | Reference compound |
| HY-121231 | trans-Caffeic acid | 501-16-6 | Natural Products |
| HY-121231R | trans-Caffeic acid (Standard) | 501-16-6 | Reference Standards |
| HY-121232 | Delapril | 83435-66-9 | Reference compound |
| HY-121233 | Chloropropylate | 5836-10-2 | Reference compound |
| HY-121234 | Botryodiplodin | 27098-03-9 | Reference compound |
| HY-121235 | Clonixin | 17737-65-4 | Reference compound |
| HY-121235R | Clonixin (Standard) | 17737-65-4 | Reference Standards |
| HY-121236 | Bavachromene | 41743-38-8 | Natural Products |
| HY-121238 | Hyocholic Acid | 547-75-1 | Reference compound |
| HY-121238R | Hyocholic Acid (Standard) | 547-75-1 | Reference Standards |
| HY-121238S | Hyocholic Acid-d4 | Isotope-Labeled Compounds | |
| HY-121238S1 | Hyocholic Acid-d5 | Isotope-Labeled Compounds | |
| HY-121239 | Lemnalol | 82570-34-1 | Natural Products |
| HY-12124 | BBS-4 | 402934-09-2 | Reference compound |
| HY-121240 | Brecanavir | 313682-08-5 | Reference compound |
| HY-121241 | Dehydroemetine | 4914-30-1 | Reference compound |
| HY-121242 | Buthidazole | 55511-98-3 | Reference compound |
| HY-121243 | Halauxifen | 943832-60-8 | Reference compound |
| HY-121244 | Coumafuryl | 117-52-2 | Reference compound |
| HY-121245 | Capoamycin | 97937-29-6 | Natural Products |
| HY-121246 | Fluorofenidone | 848353-85-5 | Reference compound |
| HY-121246S | Fluorofenidone-d3 | Isotope-Labeled Compounds | |
| HY-121247 | Bromotetrandrine | 62067-29-2 | Reference compound |
| HY-121248 | Hydramethylnon | 67485-29-4 | Reference compound |
| HY-121249 | Capeserod (hydrochloride) | 191023-43-5 | Reference compound |
| HY-121250 | Fasnall | 929978-58-5 | Reference compound |
| HY-121251 | BI-167107 | 1202235-68-4 | Reference compound |
| HY-121252 | Dopal | 5707-55-1 | Natural Products |
| HY-121252A | Dopal (purity>80%) | 5707-55-1 | Reference compound |
| HY-121252S | Dopal-d5 | Isotope-Labeled Compounds | |
| HY-121254 | GERI-BP002-A | 119-47-1 | Natural Products |
| HY-121255 | (-)-Cryptopleurine | 482-22-4 | Reference compound |
| HY-121256 | Chlorasquin | 18921-73-8 | Reference compound |
| HY-121259 | Doxorubicinol | 54193-28-1 | Reference compound |
| HY-121259S | Doxorubicinol-13C,d3 (TFA) | Isotope-Labeled Compounds | |
| HY-121261 | Antineoplastic agent-1 | 738-99-8 | Reference compound |
| HY-121262 | Bisabolene | 495-62-5 | Natural Products |
| HY-121263 | Dicyclanil | 112636-83-6 | Reference compound |
| HY-121263R | Dicyclanil (Standard) | 112636-83-6 | Reference Standards |
| HY-121265 | Bendiocarb | 22781-23-3 | Reference compound |
| HY-121265R | Bendiocarb (Standard) | 22781-23-3 | Reference Standards |
| HY-121267 | Dicamba | 1918-00-9 | Biochemical Assay Reagents |
| HY-121267R | Dicamba (Standard) | 1918-00-9 | Reference Standards |
| HY-121267S | Dicamba-13C6 | Isotope-Labeled Compounds | |
| HY-121267S1 | Dicamba-d3 | 349553-95-3 | Isotope-Labeled Compounds |
| HY-121268 | Demeclocycline | 127-33-3 | Reference compound |
| HY-121268A | Demeclocycline (calcium) | 17146-81-5 | Reference compound |
| HY-121268R | Demeclocycline (Standard) | 127-33-3 | Reference Standards |
| HY-12127 | Pexacerfont | 459856-18-9 | Reference compound |
| HY-121271 | Kadsurin | 51670-40-7 | Natural Products |
| HY-121272 | Difloxacin | 98106-17-3 | Reference compound |
| HY-121272AS | Difloxacin-d3 (hydrochloride trihydrate) | Isotope-Labeled Compounds | |
| HY-121272AS1 | Difloxacin-d3 (hydrochloride) | 1173021-89-0 | Isotope-Labeled Compounds |
| HY-121272AS2 | Difloxacin-d3 | 1173147-93-7 | Isotope-Labeled Compounds |
| HY-121272R | Difloxacin (Standard) | 98106-17-3 | Reference Standards |
| HY-121274 | Dicyclonon | 79260-71-2 | Reference compound |
| HY-121275 | Benserazide | 322-35-0 | Reference compound |
| HY-121276 | Benperidol | 2062-84-2 | Reference compound |
| HY-121276R | Benperidol (Standard) | 2062-84-2 | Reference Standards |
| HY-121276S1 | Benperidol-d4 | Isotope-Labeled Compounds | |
| HY-121278 | Benzotript | 39544-74-6 | Reference compound |
| HY-121280 | ERK2-IN-4 | 933786-58-4 | Reference compound |
| HY-121282 | Mepazine | 60-89-9 | Reference compound |
| HY-121282A | Mepazine (hydrochloride) | 2975-36-2 | Reference compound |
| HY-121282B | Mepazine (acetate) | 24360-97-2 | Reference compound |
| HY-121284 | Triazamate | 112143-82-5 | Reference compound |
| HY-121286 | Echinatine | 480-83-1 | Natural Products |
| HY-121287 | Ioxynil | 1689-83-4 | Reference compound |
| HY-121288 | Diisoamylamine | 544-00-3 | Reference compound |
| HY-121289 | Drazoxolon | 5707-69-7 | Reference compound |
| HY-12129 | CP 154526 (hydrochloride) | 257639-98-8 | Reference compound |
| HY-121290 | BPH-651 | 149537-49-5 | Reference compound |
| HY-121291 | Aureothin | 2825-00-5 | Natural Products |
| HY-121292 | Clidanac | 34148-01-1 | Reference compound |
| HY-121294 | Indanomycin | 66513-28-8 | Reference compound |
| HY-121295 | Roseoflavin | 51093-55-1 | Reference compound |
| HY-121299 | m-Chlorophenylbiguanide | 48144-44-1 | Reference compound |
| HY-12130 | CP 154526 | 157286-86-7 | Reference compound |
| HY-121300 | Kendomycin | 183202-73-5 | Reference compound |
| HY-121301 | Amperozide | 75558-90-6 | Reference compound |
| HY-121305 | D-Ribulose | 488-84-6 | Biochemical Assay Reagents |
| HY-121305A | L-Ribulose | 2042-27-5 | Reference compound |
| HY-121306 | Indecainide | 74517-78-5 | Reference compound |
| HY-121307 | Gliamilide | 51876-98-3 | Reference compound |
| HY-121309 | Doxorubicinone | 24385-10-2 | Reference compound |
| HY-121309R | Doxorubicinone (Standard) | 24385-10-2 | Reference Standards |
| HY-121309S | Doxorubicinone-d3 | Isotope-Labeled Compounds | |
| HY-121309S1 | Doxorubicinone-13C,d3 | Isotope-Labeled Compounds | |
| HY-12131 | DMP 696 | 202578-52-7 | Reference compound |
| HY-121310 | Phthalocyanine | 574-93-6 | Biochemical Assay Reagents |
| HY-121311 | Metrenperone | 81043-56-3 | Reference compound |
| HY-121312 | Flutonidine | 28125-87-3 | Reference compound |
| HY-121313 | Embusartan | 156001-18-2 | Reference compound |
| HY-121314 | Cloprostenol | 40665-92-7 | Reference compound |
| HY-121315 | BRD4097 | 1550053-19-4 | Reference compound |
| HY-121317 | Leucinocaine | 92-23-9 | Reference compound |
| HY-121318 | LK 11 | 74143-01-4 | Reference compound |
| HY-121319 | Chloranocryl | 2164-09-2 | Reference compound |
| HY-121320 | Raptinal | 1176-09-6 | Reference compound |
| HY-121322 | Neoagarobiose | 484-58-2 | Natural Products |
| HY-121323 | Erucin | 4430-36-8 | Reference compound |
| HY-121323R | Erucin (Standard) | 4430-36-8 | Reference Standards |
| HY-121324 | Prometryn | 7287-19-6 | Reference compound |
| HY-121324R | Prometryn (Standard) | 7287-19-6 | Reference Standards |
| HY-121324S | Prometryn-d14 | 1202864-57-0 | Isotope-Labeled Compounds |
| HY-121325 | Fervenulin | 483-57-8 | Reference compound |
| HY-121328 | Empenthrin | 54406-48-3 | Reference compound |
| HY-121329 | Carumonam | 87638-04-8 | Reference compound |
| HY-121330 | Convolvine | 537-30-4 | Natural Products |
| HY-121331 | Butralin | 33629-47-9 | Reference compound |
| HY-121331R | Butralin (Standard) | 33629-47-9 | Reference Standards |
| HY-121332 | Cyclopeptine | 50886-63-0 | Reference compound |
| HY-121333 | Dinactin | 20261-85-2 | Natural Products |
| HY-121335 | Chlorthal | 2136-79-0 | Reference compound |
| HY-121337 | Flurochloridone | 61213-25-0 | Reference compound |
| HY-121337R | Flurochloridone (Standard) | 61213-25-0 | Reference Standards |
| HY-121338 | Karbutilate | 4849-32-5 | Reference compound |
| HY-121338R | Karbutilate (Standard) | 4849-32-5 | Reference Standards |
| HY-12134 | Poloxin | 321688-88-4 | Reference compound |
| HY-121340 | Emylcamate | 78-28-4 | Reference compound |
| HY-121341 | Brodimoprim | 56518-41-3 | Reference compound |
| HY-121341R | Brodimoprim (Standard) | 56518-41-3 | Reference Standards |
| HY-121345 | Homobaldrinal | 67910-07-0 | Natural Products |
| HY-121347 | Enterocin | 59678-46-5 | Natural Products |
| HY-121348 | Ficellomycin | 59458-27-4 | Natural Products |
| HY-121349 | Aerothionin | 28714-26-3 | Natural Products |
| HY-12135 | Poloxipan | 1239513-63-3 | Reference compound |
| HY-121350 | Merodantoin | 143413-73-4 | Reference compound |
| HY-121351 | Inokosterone | 15130-85-5 | Natural Products |
| HY-121352 | Kibdelone C | 934464-79-6 | Reference compound |
| HY-121354 | Hydracarbazine | 3614-47-9 | Reference compound |
| HY-121356 | Carebastine | 90729-42-3 | Reference compound |
| HY-121356S | Carebastine-d5 | 1189661-02-6 | Isotope-Labeled Compounds |
| HY-121356S1 | Carebastine-d5 Methyl Ester | 1190019-51-2 | Isotope-Labeled Compounds |
| HY-121358 | Lactiflorasyne | 107259-45-0 | Natural Products |
| HY-12136 | Purpurogallin | 569-77-7 | Natural Products |
| HY-121360 | Cylindrospermopsin | 143545-90-8 | Natural Products |
| HY-121362 | Evernic Acid | 537-09-7 | Natural Products |
| HY-121362R | Evernic Acid (Standard) | 537-09-7 | Reference Standards |
| HY-121364 | Bodilisant | 1416130-06-7 | Dye Reagents |
| HY-121365 | Forphenicinol | 71522-58-2 | Reference compound |
| HY-121366 | Kadethrin | 58769-20-3 | Reference compound |
| HY-121367 | Lythrine | 5286-10-2 | Reference compound |
| HY-121368 | Mahanine | 28360-49-8 | Natural Products |
| HY-12137 | Volasertib | 755038-65-4 | Reference compound |
| HY-121370 | a-D-Galactose | 3646-73-9 | Natural Products |
| HY-121372 | Lactandrate | 43000-65-3 | Reference compound |
| HY-121374 | Cardanol diene | 51546-63-5 | Reference compound |
| HY-121376 | Neoamygdalin | 29883-16-7 | Natural Products |
| HY-121377 | Epiyangambin | 24192-64-1 | Natural Products |
| HY-12137A | Volasertib (trihydrochloride) | 946161-17-7 | Reference compound |
| HY-121380 | Secologanate | 22864-93-3 | Natural Products |
| HY-121381 | Kuraridine | 34981-25-4 | Natural Products |
| HY-121382 | Gypsogenin | 639-14-5 | Natural Products |
| HY-121382R | Gypsogenin (Standard) | 639-14-5 | Reference Standards |
| HY-121383 | Labetalol | 36894-69-6 | Reference compound |
| HY-121383R | Labetalol (Standard) | 36894-69-6 | Reference Standards |
| HY-121385 | Hydroxy bosentan | 253688-60-7 | Reference compound |
| HY-121385S | Hydroxy Bosentan-d6 | 1246817-57-1 | Isotope-Labeled Compounds |
| HY-121385S1 | Hydroxy Bosentan-d4 | 1065472-91-4 | Isotope-Labeled Compounds |
| HY-121386 | Yuanhuanin | 83133-14-6 | Natural Products |
| HY-121387 | Furmecyclox | 60568-05-0 | Reference compound |
| HY-121388 | Ledol | 577-27-5 | Natural Products |
| HY-121389 | Hexadecanamide | 629-54-9 | Natural Products |
| HY-121390 | Lasiocarpine | 303-34-4 | Natural Products |
| HY-121390A | Lasiocarpine (hydrochloride) | 1976-49-4 | Reference compound |
| HY-121391 | Hedonal | 541-95-7 | Reference compound |
| HY-121392 | GR 125743 | 148547-33-5 | Reference compound |
| HY-121393 | Imidazenil | 151271-08-8 | Reference compound |
| HY-121394 | L-659,989 | 113787-28-3 | Reference compound |
| HY-121395 | Lepiochlorin | 71339-41-8 | Natural Products |
| HY-121397 | Phyltetralin | 123048-17-9 | Natural Products |
| HY-121398 | Dipivefrin | 52365-63-6 | Reference compound |
| HY-121399 | Gizzerosine | 89238-78-8 | Reference compound |
| HY-12140 | Vestipitant | 334476-46-9 | Reference compound |
| HY-121400 | Hepaxanthin | 512-39-0 | Reference compound |
| HY-121401 | Myrtenal | 564-94-3 | Natural Products |
| HY-121401A | (−)-Myrtenal | 18486-69-6 | Natural Products |
| HY-121404 | Muscarine | 300-54-9 | Reference compound |
| HY-121404A | Muscarine (chloride) | 2303-35-7 | Reference compound |
| HY-121404B | Muscarine (tosylate) | 82083-43-0 | Reference compound |
| HY-121405 | Malonomicin | 38249-71-7 | Reference compound |
| HY-121406 | (Z)-Lafutidine | 206449-93-6 | Reference compound |
| HY-121407 | Lateritin | 172721-98-1 | Natural Products |
| HY-121408 | Hymexelsin | 117842-09-8 | Natural Products |
| HY-121410 | Narasin | 55134-13-9 | Reference compound |
| HY-121411 | Disparlure | 29804-22-6 | Natural Products |
| HY-121412 | Lankacidin C | 23623-31-6 | Natural Products |
| HY-121413 | Clinolamide | 3207-50-9 | Reference compound |
| HY-121414 | Phenazine oxide | 304-81-4 | Reference compound |
| HY-121415 | Herkinorin | 862073-77-6 | Reference compound |
| HY-121416 | Jurubidine | 6084-44-2 | Natural Products |
| HY-121417 | Laserpitin | 7067-12-1 | Reference compound |
| HY-121418 | Lusianthridin | 87530-30-1 | Natural Products |
| HY-12142 | Vofopitant | 168266-90-8 | Reference compound |
| HY-121421 | Diniprofylline | 17692-30-7 | Reference compound |
| HY-121422 | JZP-361 | 1680193-80-9 | Reference compound |
| HY-121423 | Dimethachlor | 50563-36-5 | Reference compound |
| HY-121423R | Dimethachlor (Standard) | 50563-36-5 | Reference Standards |
| HY-121425 | Dunnione | 33404-57-8 | Natural Products |
| HY-121426 | BPP | 73671-44-0 | Reference compound |
| HY-121427 | Fluazifop | 69335-91-7 | Reference compound |
| HY-121427R | Fluazifop (Standard) | 69335-91-7 | Reference Standards |
| HY-121428 | Fagaramide | 60045-88-7 | Reference compound |
| HY-121429 | Dymanthine | 124-28-7 | Reference compound |
| HY-12142S | rac-Vofopitant-d3 | Isotope-Labeled Compounds | |
| HY-12143 | Vofopitant (dihydrochloride) | 168266-51-1 | Reference compound |
| HY-121430 | Lamellarin H | 115982-22-4 | Natural Products |
| HY-121431 | FR-901235 | 124190-19-8 | Natural Products |
| HY-121432 | Kitol | 4626-00-0 | Reference compound |
| HY-121434 | N-Deacetylcolchicine | 3476-50-4 | Reference compound |
| HY-121435 | K-8012 | 1346513-17-4 | Reference compound |
| HY-121436 | Levoxadrol | 4792-18-1 | Reference compound |
| HY-121441 | Fispemifene | 341524-89-8 | Reference compound |
| HY-121442 | Enpiperate | 3608-67-1 | Reference compound |
| HY-121444 | MYRA-A | 3900-43-4 | Reference compound |
| HY-121447 | Heneicosanoic acid | 2363-71-5 | Natural Products |
| HY-121447R | Heneicosanoic acid (Standard) | 2363-71-5 | Reference Standards |
| HY-121448 | GW409544 | 258345-41-4 | Reference compound |
| HY-12145 | CP-99994 (hydrochloride) | 145148-39-6 | Reference compound |
| HY-121450 | Lavoltidine | 76956-02-0 | Reference compound |
| HY-121451 | Dibenzyl phthalate | 523-31-9 | Reference compound |
| HY-121451S | Dibenzyl Phthalate-d4 | 1015854-62-2 | Isotope-Labeled Compounds |
| HY-121452 | Migrastatin | 314245-65-3 | Natural Products |
| HY-121453 | Bamifylline (hydrochloride) | 20684-06-4 | Reference compound |
| HY-121453R | Bamifylline (hydrochloride) (Standard) | 20684-06-4 | Reference Standards |
| HY-121456 | Salnacedin | 87573-01-1 | Reference compound |
| HY-121457 | 9-Nitrooleate | 875685-44-2 | Reference compound |
| HY-121457S | 9-Nitrooleate-d17 | 2714117-50-5 | Isotope-Labeled Compounds |
| HY-121458 | Nemorosone | 351416-47-2 | Natural Products |
| HY-121459 | Neoantimycin | 22862-63-1 | Reference compound |
| HY-12146 | ELOVL6-IN-2 | 1067647-43-1 | Reference compound |
| HY-121460 | Spiraprilat | 83602-05-5 | Reference compound |
| HY-121461 | A25822B | 50686-98-1 | Reference compound |
| HY-121462 | Cyanine | 523-42-2 | Biochemical Assay Reagents |
| HY-121465 | Stearoyl Serotonin | 67964-87-8 | Reference compound |
| HY-121466 | Ormetoprim | 6981-18-6 | Reference compound |
| HY-121466R | Ormetoprim (Standard) | 6981-18-6 | Reference Standards |
| HY-121467 | Acotiamide | 185106-16-5 | Reference compound |
| HY-121467A | Acotiamide (hydrochloride) | 185104-11-4 | Reference compound |
| HY-121467AS | Acotiamide-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-121467S | Acotiamide-d6 | 2749427-97-0 | Isotope-Labeled Compounds |
| HY-121467S1 | Acotiamide-d4 | Isotope-Labeled Compounds | |
| HY-121469 | Dioxone | 702-54-5 | Reference compound |
| HY-121470 | Vesamicol | 22232-64-0 | Reference compound |
| HY-121471 | Chrysoeriol | 491-71-4 | Natural Products |
| HY-121471R | Chrysoeriol (Standard) | 491-71-4 | Reference Standards |
| HY-121473 | Aklavin | 60504-57-6 | Reference compound |
| HY-121474 | Dactimicin | 73196-97-1 | Natural Products |
| HY-121476 | Arachidonoyl Serinol | 183718-70-9 | Reference compound |
| HY-121477 | Resorantel | 20788-07-2 | Reference compound |
| HY-121477R | Resorantel (Standard) | 20788-07-2 | Reference Standards |
| HY-121478 | Nifoxipam | 74723-10-7 | Reference compound |
| HY-121481 | Cucurbitadienol | 35012-08-9 | Natural Products |
| HY-121482 | (+)-Ochromycinone | 28882-53-3 | Natural Products |
| HY-121483 | Leucinal | 82473-52-7 | Reference compound |
| HY-121488 | GP130 receptor agonist-1 | 339303-87-6 | Reference compound |
| HY-12149 | A-867744 | 1000279-69-5 | Reference compound |
| HY-121490 | IMM-02 | 218929-99-8 | Reference compound |
| HY-121491 | ONO-6126 | 401519-28-6 | Reference compound |
| HY-121493 | TM2-115 | 1197196-47-6 | Reference compound |
| HY-121495 | BKI-1369 | 1951431-22-3 | Reference compound |
| HY-121496 | 3M-011 | 642473-62-9 | Reference compound |
| HY-121497 | 3-Methoxybenzamide | 5813-86-5 | Reference compound |
| HY-12150 | CCMI | 917837-54-8 | Reference compound |
| HY-121503 | FD44 | 68207-21-6 | Reference compound |
| HY-121504A | 4-Methylcathinone (hydrochloride) | 6941-17-9 | Reference compound |
| HY-121507 | Hydroxy-PEG2-C2-sulfonic acid | 112724-27-3 | Reference compound |
| HY-121508 | (E/Z)-IT-603 | 292168-90-2 | Reference compound |
| HY-12151 | NS 1738 | 501684-93-1 | Reference compound |
| HY-121512 | SK-7041 | 617690-98-9 | Reference compound |
| HY-121513 | Torcitabine | 40093-94-5 | Oligonucleotides |
| HY-121514 | Talopeptin | 84235-60-9 | Reference compound |
| HY-121515 | DPM-1001 | 1471172-27-6 | Reference compound |
| HY-121515A | DPM-1001 (trihydrochloride) | Reference compound | |
| HY-121516 | CM-TPMF | 477865-59-1 | Reference compound |
| HY-121517 | URB754 | 86672-58-4 | Reference compound |
| HY-121519 | GSK2332255B | 1366233-41-1 | Reference compound |
| HY-12152 | PNU-120596 | 501925-31-1 | Reference compound |
| HY-121520 | Docosahexaenoyl glycine | 132850-40-9 | Peptides |
| HY-121522 | SD-70 | 332173-89-4 | Reference compound |
| HY-121523 | MIND4-17 | 345989-24-4 | Reference compound |
| HY-121524 | DJ101 | 1803242-21-8 | Reference compound |
| HY-121525 | Biebrich scarlet | 4196-99-0 | Dye Reagents |
| HY-121526 | S-Nitroso-N-acetyl-DL-penicillamine | 67776-06-1 | Reference compound |
| HY-121527 | Amylmetacresol | 1300-94-3 | Reference compound |
| HY-121527R | Amylmetacresol (Standard) | 1300-94-3 | Reference Standards |
| HY-121528 | Nilestriol | 39791-20-3 | Reference compound |
| HY-12153 | JNJ-1930942 | 929562-28-7 | Reference compound |
| HY-121532 | (-)-Rasfonin | 303156-68-5 | Natural Products |
| HY-121535 | Levosemotiadil | 116476-16-5 | Reference compound |
| HY-121537 | CAY10404 | 340267-36-9 | Reference compound |
| HY-121538 | CUDA | 479413-68-8 | Reference compound |
| HY-121538A | CUDA (disodium) | Reference compound | |
| HY-121538S | CUDA-d11 | Isotope-Labeled Compounds | |
| HY-121539 | Supercinnamaldehyde | 70351-51-8 | Reference compound |
| HY-121540 | IWP-2-V2 | 877618-79-6 | Reference compound |
| HY-121541 | CB-25 | 869376-63-6 | Reference compound |
| HY-121542 | PPARδ agonist 10 | 685139-10-0 | Reference compound |
| HY-121543 | Sch 38548 | 107811-54-1 | Reference compound |
| HY-121544 | Methicillin | 61-32-5 | Reference compound |
| HY-121544A | Methicillin (sodium hydrate) | 7246-14-2 | Reference compound |
| HY-121544AR | Methicillin (sodium hydrate) (Standard) | 7246-14-2 | Reference Standards |
| HY-121545 | CB-52 | 869376-90-9 | Reference compound |
| HY-121546 | ALLO-1 | 37468-32-9 | Reference compound |
| HY-121548 | Drimentine A | 204398-90-3 | Reference compound |
| HY-121549 | S-NEPC | 147349-28-8 | Reference compound |
| HY-12155 | JNJ-26990990 | 877316-38-6 | Reference compound |
| HY-121550 | ME3221 | 139958-16-0 | Reference compound |
| HY-121553 | Prenisteine | 5287-46-7 | Reference compound |
| HY-121556 | Rufigallol | 82-12-2 | Reference compound |
| HY-121557 | OMDM-1 | 616884-62-9 | Reference compound |
| HY-121558 | JP104 | 887264-45-1 | Reference compound |
| HY-121560 | L-leucyldoxorubicin | 70774-25-3 | Reference compound |
| HY-121562 | SB 714786 | 584555-10-2 | Reference compound |
| HY-121564 | Radermachol | 95378-00-0 | Dye Reagents |
| HY-121565 | SaRI 59-801 | 80565-58-8 | Reference compound |
| HY-121567 | Metipranolol | 22664-55-7 | Reference compound |
| HY-121567R | Metipranolol (Standard) | 22664-55-7 | Reference Standards |
| HY-121569 | Syntelin | 438481-33-5 | Reference compound |
| HY-12157 | VU 0238429 | 1160247-92-6 | Reference compound |
| HY-121570 | Noxytiolin | 15599-39-0 | Reference compound |
| HY-121573 | α-Acetyldigoxin | 5511-98-8 | Reference compound |
| HY-121575 | Lythridine | 15299-77-1 | Reference compound |
| HY-121576 | Butenachlor | 87310-56-3 | Reference compound |
| HY-121577 | Sonlicromanol | 1541170-75-5 | Reference compound |
| HY-121578 | Agaridoxin | 58298-77-4 | Reference compound |
| HY-121579 | L-764406 | 227002-04-2 | Reference compound |
| HY-12158 | VU0238441 | 85511-68-8 | Reference compound |
| HY-121580 | Tabimorelin | 193079-69-5 | Reference compound |
| HY-121582 | (E)-SI-2 | 380537-35-9 | Reference compound |
| HY-121583 | Gemcadiol | 35449-36-6 | Reference compound |
| HY-121584 | Lycoperodine-1 | 42438-90-4 | Natural Products |
| HY-121585 | CAY10698 | 684236-01-9 | Reference compound |
| HY-121586 | Nafazatrom | 59040-30-1 | Reference compound |
| HY-121587 | Etisazole | 7716-60-1 | Reference compound |
| HY-121588 | IMTPPE | 851688-13-6 | Reference compound |
| HY-12159 | MK-0668 | 865110-07-2 | Reference compound |
| HY-121591 | A-28086B | 58439-94-4 | Natural Products |
| HY-121592 | Yokonoside | 53823-12-4 | Natural Products |
| HY-121593 | Ruizgenin | 41743-71-9 | Reference compound |
| HY-121594 | GSK-269984B | 892664-17-4 | Reference compound |
| HY-121595 | 5,5-Diphenylbarbituric acid | 21914-07-8 | Reference compound |
| HY-121596 | Styramate | 94-35-9 | Reference compound |
| HY-121597 | Yuankanin | 77099-20-8 | Natural Products |
| HY-121598 | Actisomide | 96914-39-5 | Reference compound |
| HY-121599 | CGP 36742 | 123690-78-8 | Reference compound |
| HY-12159A | MK-0668 (mesylate) | 865111-04-2 | Reference compound |
| HY-121600 | GAT229 | 889860-85-9 | Reference compound |
| HY-121601 | Lichesterol | 50657-31-3 | Natural Products |
| HY-121602 | DSP 4 (free base) | 62078-98-2 | Reference compound |
| HY-121603 | Bornaprine | 20448-86-6 | Reference compound |
| HY-121604 | (Rac)-MEM 1003 | 165187-25-7 | Reference compound |
| HY-121605 | RL71 | 1195795-93-7 | Reference compound |
| HY-121607 | INI-43 | 881046-01-1 | Reference compound |
| HY-121608 | Lumiflavin | 1088-56-8 | Dye Reagents |
| HY-121609 | Pholedrine | 370-14-9 | Reference compound |
| HY-121609A | Pholedrine (hydrochloride) | 877-86-1 | Reference compound |
| HY-121610 | FR-202306 | 342785-41-5 | Reference compound |
| HY-121611 | HI-236 | 233271-65-3 | Reference compound |
| HY-121613 | Resistoflavine | 29706-96-5 | Reference compound |
| HY-121614 | Ribocitrin | 77752-20-6 | Reference compound |
| HY-121615 | α-Phellandrene | 99-83-2 | Natural Products |
| HY-121616 | (R)-SLV 319 | 656827-86-0 | Reference compound |
| HY-121617 | Bucainide | 51481-62-0 | Reference compound |
| HY-121618 | α-Thujone | 546-80-5 | Natural Products |
| HY-121619 | Jacaric acid | 28872-28-8 | Natural Products |
| HY-121620 | Monolaurin | 142-18-7 | Reference compound |
| HY-121620S | Monolaurin-d23 | Isotope-Labeled Compounds | |
| HY-121621 | RO5101576 | 1123155-95-2 | Reference compound |
| HY-121623 | VU0359516 | 1220513-59-6 | Reference compound |
| HY-121624 | Anthglutin | 69168-09-8 | Natural Products |
| HY-121626 | SKF 83692 | 99234-87-4 | Reference compound |
| HY-121629 | PS210 | 1221962-86-2 | Reference compound |
| HY-12163 | Entinostat | 209783-80-2 | Reference compound |
| HY-121631 | Yibeissine | 143502-51-6 | Natural Products |
| HY-121632 | Quinoclamine | 2797-51-5 | Reference compound |
| HY-121632R | Quinoclamine (Standard) | 2797-51-5 | Reference Standards |
| HY-121633 | Kayahope | 49828-25-3 | Reference compound |
| HY-121634 | DAP-81 | 794466-17-4 | Reference compound |
| HY-121635 | FOX-7 | 145250-81-3 | Reference compound |
| HY-121636 | Resolvin D2 | 810668-37-2 | Reference compound |
| HY-121636S | Resolvin D2-d5 | 1881277-33-3 | Isotope-Labeled Compounds |
| HY-121637 | IDFP | 615250-02-7 | Reference compound |
| HY-121638 | CU-3 | 2983265-35-4 | Reference compound |
| HY-121638A | (5Z,2E)-CU-3 | 1815598-71-0 | Reference compound |
| HY-121638B | (E/Z)-CU-3 | 861123-84-4 | Reference compound |
| HY-12163S | Entinostat-d4 | Isotope-Labeled Compounds | |
| HY-12164 | Mocetinostat | 726169-73-9 | Reference compound |
| HY-121641 | Nitrosobenzene | 586-96-9 | Reference compound |
| HY-121642 | SL-017 | 1169831-01-9 | Reference compound |
| HY-121644 | Viminol | 21363-18-8 | Reference compound |
| HY-121645 | 2,4-Dibromoestradiol | 19590-55-7 | Reference compound |
| HY-121647 | Nopol | 128-50-7 | Reference compound |
| HY-121648 | PK 130 | 140448-29-9 | Reference compound |
| HY-121649 | AQ4 | 70476-63-0 | Reference compound |
| HY-121650 | ADTN | 53463-78-8 | Reference compound |
| HY-121650A | ADTN (hydrobromide) | 13575-86-5 | Biochemical Assay Reagents |
| HY-121652 | Mefox | 79573-48-1 | Reference compound |
| HY-121653 | Flesinoxan | 98206-10-1 | Reference compound |
| HY-121653B | Flesinoxan (hydrochloride) | 98205-89-1 | Reference compound |
| HY-121654 | L-Iditol | 488-45-9 | Biochemical Assay Reagents |
| HY-121655 | Dansyllysine | 1101-84-4 | Dye Reagents |
| HY-121656 | AKR1C2/3-IN-2 | 56600-73-8 | Reference compound |
| HY-121657 | Ornidazole diol | 62580-80-7 | Reference compound |
| HY-121657R | Ornidazole diol (Standard) | 62580-80-7 | Reference Standards |
| HY-121659 | DCFBC | 564482-79-7 | Reference compound |
| HY-121660 | Hexyl nicotinate | 23597-82-2 | Reference compound |
| HY-121661 | Antibacterial agent 201 | 1666171-29-4 | Reference compound |
| HY-121662 | Lenaldekar | 418800-15-4 | Reference compound |
| HY-121663 | ST-148 | 400863-77-6 | Reference compound |
| HY-121665 | Rosaprostol | 56695-65-9 | Reference compound |
| HY-121667 | Scaff10-8 | 777857-56-4 | Reference compound |
| HY-121670 | Ambenoxan | 2455-84-7 | Reference compound |
| HY-121670A | Ambenoxan (hydrochloride) | 1617-99-8 | Reference compound |
| HY-121671 | TBTC | 213192-26-8 | Reference compound |
| HY-121672 | PI3K-IN-7 | 1502813-63-9 | Reference compound |
| HY-121675 | 2-Bromo-LSD | 478-84-2 | Reference compound |
| HY-121677 | Norgestomet | 25092-41-5 | Reference compound |
| HY-121678 | Tetridamine | 17289-49-5 | Reference compound |
| HY-121679 | COX-2-IN-50 | 1242169-24-9 | Reference compound |
| HY-12168 | Tanomastat | 179545-77-8 | Reference compound |
| HY-121681 | K 308 | 36774-74-0 | Reference compound |
| HY-121683 | (E)-2-Hexadecenal | 22644-96-8 | Reference compound |
| HY-121684 | Ramentaceone | 14787-38-3 | Natural Products |
| HY-121685 | Tipepidine | 5169-78-8 | Reference compound |
| HY-121685A | Tipepidine (hydrochloride) | 1449686-84-3 | Reference compound |
| HY-121687 | HIPP | 3682-17-5 | Natural Products |
| HY-121688 | Sulphenone | 80-00-2 | Reference compound |
| HY-12168B | (Rac)-Tanomastat | 179545-76-7 | Reference compound |
| HY-12169 | Marimastat | 154039-60-8 | Reference compound |
| HY-121690 | Semotiadil | 116476-13-2 | Reference compound |
| HY-121691 | Sugereoside | 41743-57-1 | Natural Products |
| HY-121692 | (S)-Alprenolol | 23846-71-1 | Reference compound |
| HY-121692A | (S)-Alprenolol (L-tartrate) | 16768-36-8 | Reference compound |
| HY-121692B | (S)-Alprenolol (hydrochloride) | 15132-12-4 | Reference compound |
| HY-121693 | DIDS | 53005-05-3 | Reference compound |
| HY-121694 | CENTA | 80072-86-2 | Reference compound |
| HY-121696 | Penicillin N | 525-94-0 | Reference compound |
| HY-121699 | Kibdelone B | 934464-78-5 | Reference compound |
| HY-12170 | Prinomastat | 192329-42-3 | Reference compound |
| HY-121700 | L-751788 | 166174-54-5 | Reference compound |
| HY-121701 | SR33805 (analog) | 121346-32-5 | Reference compound |
| HY-121702 | Dihydrohomofolic acid | 14866-11-6 | Reference compound |
| HY-121703 | Rutacridone | 17948-33-3 | Natural Products |
| HY-121704 | SR 57227A (free base) | 77145-51-8 | Reference compound |
| HY-121705 | Propionyl-L-carnitine | 20064-19-1 | Peptides |
| HY-121708 | KI-328 | 930089-25-1 | Reference compound |
| HY-121709 | 4-Aminopteroylaspartic acid | 25312-31-6 | Reference compound |
| HY-12170A | Prinomastat (hydrochloride) | 1435779-45-5 | Reference compound |
| HY-12170B | (R)-Prinomastat | 207795-16-2 | Reference compound |
| HY-121710 | MonoHER | 23869-24-1 | Reference compound |
| HY-121711 | 5-OH-HxMF | 1176-88-1 | Natural Products |
| HY-121713 | Aniline mustard | 553-27-5 | Reference compound |
| HY-121716 | Pelagiomicin A | 173485-80-8 | Natural Products |
| HY-121718 | DQBS | 372087-80-4 | Reference compound |
| HY-121719 | TIQ-A | 420849-22-5 | Reference compound |
| HY-12172 | MK-8141 | 903579-36-2 | Reference compound |
| HY-121720 | L 657925 | 122757-59-9 | Reference compound |
| HY-121721 | Inz-5 | 1585214-21-6 | Reference compound |
| HY-121722 | Deoxyhypusine | 82543-85-9 | Reference compound |
| HY-121725 | MM-206 | 1809581-87-0 | Reference compound |
| HY-121726 | 3HOI-BA-01 | 355428-84-1 | Reference compound |
| HY-121727 | Triafamone | 874195-61-6 | Reference compound |
| HY-121728 | Langkamide | 1370510-16-9 | Reference compound |
| HY-121731 | Nimbocinone | 105532-11-4 | Natural Products |
| HY-121733 | PHGDH-inactive | 1914971-16-6 | Reference compound |
| HY-121735 | 2α-Mannobiose | 15548-39-7 | Reference compound |
| HY-121736 | AGI-12026 | 1446501-77-4 | Reference compound |
| HY-121738 | TC AC 28 | 1809296-92-1 | Reference compound |
| HY-12174 | Zankiren | 138742-43-5 | Reference compound |
| HY-121740 | FAUC-312 | 562104-72-7 | Reference compound |
| HY-121743 | Ro26-4550 | 193744-04-6 | Reference compound |
| HY-121744 | PS10 | 1564265-82-2 | Reference compound |
| HY-121745 | Phosmet oxon | 3735-33-9 | Reference compound |
| HY-121745R | Phosmet oxon (Standard) | 3735-33-9 | Reference Standards |
| HY-121746 | GW7845 | 196809-22-0 | Reference compound |
| HY-121748 | Erycibelline | 107633-95-4 | Natural Products |
| HY-121750 | CCG-222740 | 1922098-69-8 | Reference compound |
| HY-121751 | A 643C | 65822-42-6 | Reference compound |
| HY-121754 | Daphnecinnamte B | 325148-07-0 | Natural Products |
| HY-121755 | Tibric acid | 37087-94-8 | Reference compound |
| HY-121758 | 2-Hydroxyicosanoic acid | 16742-48-6 | Natural Products |
| HY-12176 | Aliskiren | 173334-57-1 | Reference compound |
| HY-121760 | Liconeolignan | 82209-75-4 | Natural Products |
| HY-121761 | Pyrazolate | 58011-68-0 | Reference compound |
| HY-121762 | NTE-122 (dihydrochloride) | 166967-84-6 | Reference compound |
| HY-121763 | SCH-43478 | 112446-99-8 | Reference compound |
| HY-121764 | MPCI | 884538-31-2 | Reference compound |
| HY-121765 | Dacisteine | 18725-37-6 | Reference compound |
| HY-121765R | Dacisteine (Standard) | 18725-37-6 | Reference Standards |
| HY-121766 | Iprovalicarb | 140923-17-7 | Reference compound |
| HY-121767 | PD 123177 | 114785-12-5 | Reference compound |
| HY-121768 | Trimethacarb | 2686-99-9 | Reference compound |
| HY-121769 | BFE-61 | 39543-80-1 | Reference compound |
| HY-12176A | Aliskiren (hydrochloride) | 173399-03-6 | Reference compound |
| HY-12176AS | Aliskiren-d6 (hydrochloride) | 1246815-96-2 | Isotope-Labeled Compounds |
| HY-12176B | Aliskiren (fumarate) | 1196835-68-3 | Reference compound |
| HY-12176R | Aliskiren (Standard) | 173334-57-1 | Reference Standards |
| HY-12177 | Aliskiren (hemifumarate) | 173334-58-2 | Reference compound |
| HY-121770 | Rutarin | 20320-81-4 | Natural Products |
| HY-121771 | Fenothiocarb | 62850-32-2 | Reference compound |
| HY-121773 | Metoquizine | 7125-67-9 | Reference compound |
| HY-121775 | PF-00217830 | 846032-02-8 | Reference compound |
| HY-121776 | Nicomol | 27959-26-8 | Reference compound |
| HY-121777 | SFOM-0046 | 1383607-61-1 | Reference compound |
| HY-121778 | Melitracen | 5118-29-6 | Reference compound |
| HY-121779 | o,p'-DDE | 3424-82-6 | Reference compound |
| HY-121779S | 2,4’-DDE-d8 | 1402834-57-4 | Isotope-Labeled Compounds |
| HY-12177S | Aliskiren-d6 (hemifumarate) | Isotope-Labeled Compounds | |
| HY-121780 | Aranorosin | 117184-53-9 | Natural Products |
| HY-121782 | A 65281 | 111279-49-3 | Reference compound |
| HY-121783 | BE2254 | 40077-13-2 | Reference compound |
| HY-121784 | Maridomycin | 35775-82-7 | Natural Products |
| HY-121785 | 10-Thiofolic acid | 54931-98-5 | Reference compound |
| HY-121787 | OX1a | 136340-88-0 | Reference compound |
| HY-121789 | Proadifen | 302-33-0 | Reference compound |
| HY-121789S | Proadifen-d2 | 151412-33-8 | Isotope-Labeled Compounds |
| HY-121791S | Fluometuron-d6 | 2030182-29-5 | Isotope-Labeled Compounds |
| HY-121792 | CK2-IN-1 | 51726-83-1 | Reference compound |
| HY-121793 | Roemerine | 548-08-3 | Natural Products |
| HY-121794 | Avarol | 55303-98-5 | Natural Products |
| HY-121795 | Pravastatin lactone | 85956-22-5 | Reference compound |
| HY-121795S | Pravastatin lactone-d3 | 1217769-04-4 | Isotope-Labeled Compounds |
| HY-121796 | Mixanpril | 156039-69-9 | Reference compound |
| HY-121798 | TZD18 | 228577-00-2 | Reference compound |
| HY-121799 | Taurohyocholic acid | 32747-07-2 | Reference compound |
| HY-121799A | Taurohyocholic acid (sodium salt) | 117997-17-8 | Reference compound |
| HY-121799S | Taurohyocholic acid-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-121800 | ML138 | 1355243-24-1 | Reference compound |
| HY-121801 | Zarilamid | 84527-51-5 | Reference compound |
| HY-121802 | Dynarrestin | 2222768-84-3 | Reference compound |
| HY-121804 | SSJ-183 | 1187533-34-1 | Reference compound |
| HY-121805 | DBCO-C6-acid | 1425485-72-8 | ADC Related |
| HY-121806 | VU0486846 | 1788055-11-7 | Reference compound |
| HY-121809S | DL-Methyldopa-d3 | Isotope-Labeled Compounds | |
| HY-121810 | LBT-999 | 877467-20-4 | Reference compound |
| HY-121811 | Pongamol | 484-33-3 | Reference compound |
| HY-121813 | Rimcazole | 75859-04-0 | Reference compound |
| HY-121814 | (S)-Acenocoumarol | 66556-78-3 | Reference compound |
| HY-121814A | (R)-Acenocoumarol | 66556-77-2 | Reference compound |
| HY-121817 | Sulfiram | 95-05-6 | Reference compound |
| HY-121817R | Sulfiram (Standard) | 95-05-6 | Reference Standards |
| HY-121818 | (-)-Tremetone | 4976-25-4 | Natural Products |
| HY-12182 | ONO-8711 | 216158-34-8 | Reference compound |
| HY-121820 | DMJ-I-228 | 1374035-59-2 | Reference compound |
| HY-121825 | U-44069 | 56985-32-1 | Reference compound |
| HY-121826 | Naronapride | 860174-12-5 | Reference compound |
| HY-121827 | LH21 | 611207-11-5 | Reference compound |
| HY-121828 | TX-1123 | 157397-06-3 | Reference compound |
| HY-12182A | ONO-8711 (dicyclohexylamine) | Reference compound | |
| HY-121830 | 5Z,8Z,11Z,14Z-Eicosatetraenoic acid, 3-thienylmethyl ester | 390824-17-6 | Reference compound |
| HY-121832 | DDX3-IN-1 | 1919828-83-3 | Reference compound |
| HY-121833 | Gambogic amide | 286935-60-2 | Reference compound |
| HY-121834 | RNase L-IN-2 | 357618-26-9 | Reference compound |
| HY-121835 | GLP-1R agonist 2 | 281209-71-0 | Reference compound |
| HY-121839 | Manoyl oxide | 596-84-9 | Reference compound |
| HY-12184 | ONO-AE 248 | 211230-67-0 | Reference compound |
| HY-121841 | Cannabidiorcol | 35482-50-9 | Reference compound |
| HY-121843 | Ronactolol | 90895-85-5 | Reference compound |
| HY-121845 | 4-Br-Bnlm | 1654775-71-9 | Reference compound |
| HY-121848 | VU0155094 | 731006-86-3 | Reference compound |
| HY-121849 | KL-1156 | 819868-62-7 | Reference compound |
| HY-12185 | BRD7389 | 376382-11-5 | Reference compound |
| HY-121850 | Rolicyprine | 2829-19-8 | Reference compound |
| HY-121851 | Revaprazan | 199463-33-7 | Reference compound |
| HY-121852 | SCH 336 | 447459-51-0 | Reference compound |
| HY-121854 | Bromadoline | 67579-24-2 | Reference compound |
| HY-121854A | Bromadoline (maleate) | 81447-81-6 | Reference compound |
| HY-121855 | 1-Monoelaidin | 2716-53-2 | Biochemical Assay Reagents |
| HY-121856 | Flumizole | 36740-73-5 | Reference compound |
| HY-121858 | Nicotianamine | 34441-14-0 | Natural Products |
| HY-121859 | RU28362 | 74915-64-3 | Reference compound |
| HY-12186 | 3-Deazaneplanocin A (hydrochloride) | 120964-45-6 | Reference compound |
| HY-121860 | L-Ascorbyl myristate | 33425-76-2 | Reference compound |
| HY-121862 | CM03 | 2101208-44-8 | Reference compound |
| HY-121866 | CP-84364 | 114457-62-4 | Reference compound |
| HY-121867 | KSCM-11 | 1415247-16-3 | Reference compound |
| HY-12186G | 3-Deazaneplanocin A (hydrochloride) (GMP) | 120964-45-6 | GMP Small Molecules |
| HY-121870 | Dimethocaine | 94-15-5 | Reference compound |
| HY-121870A | Dimethocaine (hydrochloride) | 553-63-9 | Reference compound |
| HY-121872 | DP-b99 | 222315-88-0 | Reference compound |
| HY-121873 | Lavendamycin | 81645-09-2 | Natural Products |
| HY-121874 | EP009 | 1462951-30-9 | Reference compound |
| HY-121877 | Valnoctamide | 4171-13-5 | Reference compound |
| HY-121877S | Valnoctamide-d5 | 1190015-82-7 | Isotope-Labeled Compounds |
| HY-121879 | SHP836 | 1957276-35-5 | Reference compound |
| HY-121880 | Difenoxuron | 14214-32-5 | Reference compound |
| HY-121881 | PU3 | 352519-21-2 | Reference compound |
| HY-121883 | Lignoceric acid | 557-59-5 | Natural Products |
| HY-121883R | Lignoceric acid (Standard) | 557-59-5 | Reference Standards |
| HY-121883S | Lignoceric acid-d47 | 68060-00-4 | Isotope-Labeled Compounds |
| HY-121883S1 | Lignoceric acid-d3 | 851073-55-7 | Isotope-Labeled Compounds |
| HY-121883S2 | Lignoceric acid-d4 | 61389-26-2 | Isotope-Labeled Compounds |
| HY-121883S3 | Lignoceric acid-d4-1 | 1219794-59-8 | Isotope-Labeled Compounds |
| HY-121883S4 | Lignoceric acid-d4-2 | 1219794-61-2 | Isotope-Labeled Compounds |
| HY-121883SS5 | Lignoceric acid-d9 | 2415226-90-1 | Isotope-Labeled Compounds |
| HY-121884 | Spiroxamine | 118134-30-8 | Reference compound |
| HY-121884R | Spiroxamine (Standard) | 118134-30-8 | Reference Standards |
| HY-121885 | LMD-009 | 950195-51-4 | Reference compound |
| HY-121886 | Bucricaine | 316-15-4 | Reference compound |
| HY-121888 | 20-HEPE | 116477-57-7 | Reference compound |
| HY-121889 | FQ | 190838-76-7 | Reference compound |
| HY-121890 | Etoxybamide | 66857-17-8 | Reference compound |
| HY-121891 | Rhinocaine | 32066-26-5 | Reference compound |
| HY-121892 | (Z)-KC02 | 1646795-60-9 | Reference compound |
| HY-121893 | p53-MDM2-IN-3 | 1542066-74-9 | Reference compound |
| HY-121895 | BI 831266 | 958227-46-8 | Reference compound |
| HY-121896 | DSHN | 313952-63-5 | Reference compound |
| HY-121898 | Milenperone | 59831-64-0 | Reference compound |
| HY-121899 | 1-Oxo Ibuprofen | 65813-55-0 | Reference compound |
| HY-121899R | 1-Oxo Ibuprofen (Standard) | 65813-55-0 | Reference Standards |
| HY-12190 | JNJ-5207852 | 398473-34-2 | Reference compound |
| HY-121900 | LT175 | 862901-87-9 | Reference compound |
| HY-121902 | Butidrine | 7433-10-5 | Reference compound |
| HY-121906 | DOAM | 63779-90-8 | Reference compound |
| HY-121907 | N-Palmitoyl L-alanine | 56255-31-3 | Reference compound |
| HY-121908 | FCPT | 862250-23-5 | Reference compound |
| HY-121909 | Piperic acid | 5285-18-7 | Reference compound |
| HY-12190A | JNJ-5207852 (dihydrochloride) | 1782228-76-5 | Reference compound |
| HY-12191 | A-331440 | 392338-13-5 | Reference compound |
| HY-121910 | Methyl 2-hydroxytetradecanoate | 56009-40-6 | Natural Products |
| HY-121914 | (2-Chlorophenyl)diphenylmethanol | 66774-02-5 | Reference compound |
| HY-121914R | (2-Chlorophenyl)diphenylmethanol (Standard) | 66774-02-5 | Reference Standards |
| HY-121914S | (2-Chlorophenyl)diphenyl-methanol-d5 | 1219802-30-8 | Isotope-Labeled Compounds |
| HY-121915 | 3-Hydroxyundecanoic acid | 40165-88-6 | Natural Products |
| HY-121917 | Ro 31-7837 | 120280-33-3 | Reference compound |
| HY-121918 | RU 41656 | 134377-22-3 | Reference compound |
| HY-12191A | A 331440 (hydrochloride) | 1049740-32-0 | Reference compound |
| HY-121920 | 25C-NBOH (hydrochloride) | 1539266-20-0 | Reference compound |
| HY-121922 | Dienone B | 17194-81-9 | Natural Products |
| HY-121924 | L-689065 | 146775-25-9 | Reference compound |
| HY-121927 | Mobiletrex | 238074-89-0 | Reference compound |
| HY-12193 | A-349821 | 556835-30-4 | Reference compound |
| HY-121930 | Coumarin 6H | 58336-35-9 | Dye Reagents |
| HY-121931 | AA863 | 80809-95-6 | Reference compound |
| HY-121932 | Naphthol AS-BR | 91-92-9 | Reference compound |
| HY-121933 | IDD388 | 314297-26-2 | Reference compound |
| HY-121934 | BH3I-2' | 315195-18-7 | Reference compound |
| HY-121935 | Tecnazene | 117-18-0 | Reference compound |
| HY-121935R | Tecnazene (Standard) | 117-18-0 | Reference Standards |
| HY-121936 | Yohimbic acid | 522-87-2 | Natural Products |
| HY-121936A | Yohimbic acid (hydrate) | 207801-27-2 | Reference compound |
| HY-121936R | Yohimbic acid (Standard) | 522-87-2 | Reference Standards |
| HY-121939 | 6-Hydroxy-L-DOPA | 27244-64-0 | Reference compound |
| HY-121939R | 6-Hydroxy-L-DOPA (Standard) | 27244-64-0 | Reference Standards |
| HY-121940 | 14-Methylhexadecanoic acid | 5918-29-6 | Biochemical Assay Reagents |
| HY-121941 | Epoxy Fluor 7 | 863223-43-2 | Dye Reagents |
| HY-121943 | 12-Methyltetradecanoic acid | 5502-94-3 | Biochemical Assay Reagents |
| HY-121944 | Ricinine | 524-40-3 | Natural Products |
| HY-121944R | Ricinine (Standard) | 524-40-3 | Reference Standards |
| HY-121944S | Ricinine-d3 | 1313734-77-8 | Isotope-Labeled Compounds |
| HY-121947 | 1'-Naphthoyl-2-methylindole | 80749-33-3 | Reference compound |
| HY-121948 | Sesamex | 51-14-9 | Reference compound |
| HY-121949 | U-0521 | 5466-89-7 | Reference compound |
| HY-12195 | ABT-239 | 460746-46-7 | Reference compound |
| HY-121950 | 18-Methyleicosanoic acid | 36332-93-1 | Reference compound |
| HY-121950S | 18-Methyleicosanoic acid-d3 | 2708278-14-0 | Isotope-Labeled Compounds |
| HY-121951 | N-Methylquipazine | 28614-26-8 | Reference compound |
| HY-121952 | (9E,11E)-9,11-Octadecadienoic acid methyl ester | 13038-47-6 | Reference compound |
| HY-121954 | Necrostatin-1 (inactive control) | 64419-92-7 | Reference compound |
| HY-121955 | FW1256 | 117089-08-4 | Reference compound |
| HY-121957 | BnO-PEG1-CH2COOH | 93206-09-8 | Reference compound |
| HY-121962 | neo-Inositol | 488-54-0 | Natural Products |
| HY-121964 | cis-Piperidine-2,3-dicarboxylic acid | 46026-75-9 | Reference compound |
| HY-121965 | β-D-Glucose | 492-61-5 | Biochemical Assay Reagents |
| HY-121966 | Riparin | 112356-54-4 | Reference compound |
| HY-121969 | DDX3-IN-2 | 1919828-81-1 | Reference compound |
| HY-121970 | iGP-1 | 27031-00-1 | Reference compound |
| HY-121971 | PMPMEase-IN-2 | 1190196-77-0 | Reference compound |
| HY-121973 | Juvocimene II | 75539-63-8 | Natural Products |
| HY-121974 | SR14150 | 709024-69-1 | Reference compound |
| HY-121975 | N-Cyclohexanecarbonylpentadecylamine | 702638-84-4 | Natural Products |
| HY-121977 | IKs124 | 199335-15-4 | Reference compound |
| HY-121978 | Laxifloran | 27973-50-8 | Natural Products |
| HY-121982 | Cyclo(L-Phe-L-Val) | 35590-86-4 | Reference compound |
| HY-121983 | CAY10594 | 1130067-34-3 | Reference compound |
| HY-121985 | Protheobromine | 50-39-5 | Reference compound |
| HY-121986 | Yellow AB | 85-84-7 | Dye Reagents |
| HY-121987 | 15(S)-HEDE | 92693-04-4 | Reference compound |
| HY-121987A | (±)15-HEDE | 77159-57-0 | Reference compound |
| HY-121988 | INF4E | 88039-46-7 | Reference compound |
| HY-121989 | cis-Trismethoxy resveratrol | 94608-23-8 | Reference compound |
| HY-12199 | Pitolisant | 362665-56-3 | Reference compound |
| HY-121991 | N-5-Carboxypentyl-1-deoxynojirimycin | 79206-51-2 | Reference compound |
| HY-121993 | Combretastatin A-1 | 109971-63-3 | Reference compound |
| HY-121995 | (14Z)-14-Eicosenoic acid | 17735-95-4 | Natural Products |
| HY-121996 | Prostaglandin E2 Ethanolamide | 194935-38-1 | Reference compound |
| HY-121996S | Prostaglandin E2 ethanolamide-d4 | 2389048-36-4 | Isotope-Labeled Compounds |
| HY-121998 | Binucleine 2 | 220088-42-6 | Reference compound |
| HY-121999 | (+)-cis-Abienol | 17990-16-8 | Reference compound |
| HY-12199A | Pitolisant (oxalate) | 362665-57-4 | Reference compound |
| HY-12199B | Pitolisant (hydrochloride) | 903576-44-3 | Reference compound |
| HY-12199BS | Pitolisant-d5 (hydrochloride) | 2740634-42-6 | Isotope-Labeled Compounds |
| HY-12199S | Pitolisant-d10 | Isotope-Labeled Compounds | |
| HY-12199S1 | Pitolisant-d6 | 2416991-77-8 | Isotope-Labeled Compounds |
| HY-12200 | GSK189254A (hydrochloride) | 945493-87-8 | Reference compound |
| HY-122001 | PF-05186462 | 1235406-03-7 | Reference compound |
| HY-122005 | AVE-9488 | 291756-32-6 | Reference compound |
| HY-122006 | NPD926 | 384361-79-9 | Reference compound |
| HY-122008 | ORM-3819 | 360794-85-0 | Reference compound |
| HY-122009 | Indican | 487-60-5 | Dye Reagents |
| HY-12201 | TAK-901 | 934541-31-8 | Reference compound |
| HY-122010 | NVP-AAD777 | 300842-59-5 | Reference compound |
| HY-122011 | PF-4950834 | 1256264-62-6 | Reference compound |
| HY-122014 | S 39625 | 536711-20-3 | Reference compound |
| HY-122015 | ASP2905 | 792184-90-8 | Reference compound |
| HY-122016A | BRD-4592 | 2119598-24-0 | Reference compound |
| HY-122017 | Methoxy-SANT-2 | 496793-78-3 | Reference compound |
| HY-122018 | GS-9148 | 875608-25-6 | Reference compound |
| HY-122019 | ABD56 | 521294-19-9 | Reference compound |
| HY-12201A | TAK-901 (hydrochloride) | 934542-50-4 | Reference compound |
| HY-12202 | MEK inhibitor | 334951-92-7 | Reference compound |
| HY-122021 | J-115814 | 329716-61-2 | Reference compound |
| HY-122022 | JR-AB2-011 | 2411853-34-2 | Reference compound |
| HY-122024 | AZSMO-23 | 496793-75-0 | Reference compound |
| HY-122025 | AC-262536 | 870888-46-3 | Reference compound |
| HY-122026 | PF-04802367 | 1962178-27-3 | Reference compound |
| HY-122028 | HSD-016 | 946396-92-5 | Reference compound |
| HY-122029 | BRD6897 | 618395-82-7 | Reference compound |
| HY-12203 | PFK-158 | 1462249-75-7 | Reference compound |
| HY-122030 | Lithooxazoline | 80724-92-1 | Natural Products |
| HY-122032 | A 58365A | 87896-52-4 | Natural Products |
| HY-122035 | Flambalactone | 55729-17-4 | Reference compound |
| HY-122036 | Flumedroxone acetate | 987-18-8 | Reference compound |
| HY-122038 | NU-8165 | 849723-20-2 | Reference compound |
| HY-122039 | Hypusine (dihydrochloride) | 82310-93-8 | Reference compound |
| HY-12204 | PFK-015 | 4382-63-2 | Reference compound |
| HY-122040 | 5-Chloro hydrochlorothiazide | 5233-42-1 | Reference compound |
| HY-122041 | Ethacridine | 442-16-0 | Reference compound |
| HY-122043 | Nimolinone | 106533-51-1 | Reference compound |
| HY-122046 | Amb123203 | 956571-77-0 | Reference compound |
| HY-122047 | SW063058 | 533876-30-1 | Reference compound |
| HY-122048 | AR-C67085 | 164992-25-0 | Reference compound |
| HY-122049 | ENMD-1068 (hydrobromide) | 644961-61-5 | Reference compound |
| HY-122050 | Oe-9000 | 675132-92-0 | Reference compound |
| HY-122051 | AC1903 | 831234-13-0 | Reference compound |
| HY-122052 | UK‑396082 | 400044-47-5 | Reference compound |
| HY-122053 | Amidephrine (hydrochloride) | 58921-07-6 | Reference compound |
| HY-122054 | BPK-29 | 2143467-62-1 | Reference compound |
| HY-122054A | BPK-29 (hydrochloride) | 2444815-73-8 | Reference compound |
| HY-122056 | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine | 39036-04-9 | Biochemical Assay Reagents |
| HY-122057 | Bisdionin F | 917877-86-2 | Reference compound |
| HY-122058 | KRH-3955 | 1097732-62-1 | Reference compound |
| HY-122058A | KRH-3955 (hydrochloride) | 2253744-59-9 | Reference compound |
| HY-12206 | Thioperamide | 106243-16-7 | Reference compound |
| HY-122060 | BYK 191023 | 608880-48-4 | Reference compound |
| HY-122062 | Fenoxycarb | 72490-01-8 | Natural Products |
| HY-122062R | Fenoxycarb (Standard) | 72490-01-8 | Reference Standards |
| HY-122062S | Fenoxycarb-13C6 | Isotope-Labeled Compounds | |
| HY-122063 | FR260330 | 442198-67-6 | Reference compound |
| HY-122064 | FR20 | 570373-45-4 | Reference compound |
| HY-122066 | NSC47924 | 6638-24-0 | Reference compound |
| HY-12206A | Thioperamide (maleate) | 148440-81-7 | Reference compound |
| HY-122070 | Tirilazad (mesylate) | 110101-67-2 | Reference compound |
| HY-122070A | Tirilazad (mesylate hydrate) | 111793-42-1 | Reference compound |
| HY-122071 | Bicyclomycin | 38129-37-2 | Natural Products |
| HY-122073 | Furalazine | 556-12-7 | Reference compound |
| HY-122075 | FR 78844 | 112856-39-0 | Reference compound |
| HY-122076 | A-26771B | 56448-20-5 | Reference compound |
| HY-122077 | NS5818 | 674299-39-9 | Reference compound |
| HY-122078 | FR-190809 | 215589-63-2 | Reference compound |
| HY-122079 | NSC1011 | 5335-97-7 | Reference compound |
| HY-122080 | Memoquin | 616885-87-1 | Reference compound |
| HY-122082 | Methopterin | 2410-93-7 | Reference compound |
| HY-122082R | Methopterin (Standard) | 2410-93-7 | Reference Standards |
| HY-122083 | T2384 | 315222-83-4 | Reference compound |
| HY-122084 | (3β,5α)-Androstan-3-amine (hydrochloride) | 54156-23-9 | Reference compound |
| HY-122086 | Prifinium (bromide) | 4630-95-9 | Reference compound |
| HY-122089 | Lapyrium | 109260-82-4 | Natural Products |
| HY-122094 | Steppogenin | 56486-94-3 | Natural Products |
| HY-122096 | DCLX069 | 792946-69-1 | Reference compound |
| HY-122097 | M7594_0037 | 774551-07-4 | Reference compound |
| HY-122098 | Diaplasinin | 481631-45-2 | Reference compound |
| HY-122099 | Riddelline | 23246-96-0 | Natural Products |
| HY-12210 | (S)-BI-1001 | 957889-73-5 | Reference compound |
| HY-122101 | NSC114792 | 17392-79-9 | Reference compound |
| HY-122104 | UCL-1848 (TFA) | 201147-53-7 | Reference compound |
| HY-122105 | JNJ-40255293 | 1147271-25-7 | Reference compound |
| HY-122106 | RS-104966 | 193022-38-7 | Reference compound |
| HY-122108 | Ilicicolin A | 22581-06-2 | Natural Products |
| HY-122109A | Levonantradol (hydrochloride) | 70222-86-5 | Reference compound |
| HY-122111 | (±)7-HDHA | 90780-55-5 | Natural Products |
| HY-122112 | CM572 | 1121932-91-9 | Reference compound |
| HY-122113 | PD173952 | 305820-75-1 | Reference compound |
| HY-122114 | ICA-27243 | 325457-89-4 | Reference compound |
| HY-122115 | DCE_42 | 669749-45-5 | Reference compound |
| HY-122117 | Haptamide B | 546124-87-2 | Reference compound |
| HY-122118 | Lambast | 845-52-3 | Reference compound |
| HY-12212 | Omaveloxolone | 1474034-05-3 | Reference compound |
| HY-122120 | Rafabegron | 244081-42-3 | Reference compound |
| HY-122122 | ML-60218 | 577784-91-9 | Reference compound |
| HY-122123 | S-6123 | 87508-45-0 | Reference compound |
| HY-122124 | CAY10583 | 862891-27-8 | Reference compound |
| HY-122126 | BN 52111 | 120889-14-7 | Reference compound |
| HY-122127 | Acetobixan | 380201-24-1 | Reference compound |
| HY-122128 | Lilly 51641 | 5388-85-2 | Reference compound |
| HY-122129 | Dotriaconta-14,17,20,23,26,29-hexaenoic acid | 105517-82-6 | Reference compound |
| HY-122129S | Dotriaconta-14,17,20,23,26,29-hexaenoic acid-d6 | 2692624-20-5 | Isotope-Labeled Compounds |
| HY-12213 | CDDO-EA | 932730-51-3 | Reference compound |
| HY-122131 | XTT (sodium) | 111072-31-2 | Reference compound |
| HY-122133 | CI 750 | 47739-68-4 | Reference compound |
| HY-122134 | SC-58272 | 164931-25-3 | Reference compound |
| HY-122135 | A-317567 | 371217-32-2 | Reference compound |
| HY-122136 | S26131 | 296280-56-3 | Reference compound |
| HY-122138 | VU6010572 | 2126784-39-0 | Reference compound |
| HY-122139 | Desethylene Ciprofloxacin (hydrochloride) | 528851-31-2 | Reference compound |
| HY-122139R | Desethylene Ciprofloxacin (hydrochloride) (Standard) | 528851-31-2 | Reference Standards |
| HY-122140 | ACG548B | 795316-16-4 | Reference compound |
| HY-122141 | Glycohyocholic acid | 32747-08-3 | Reference compound |
| HY-122141R | Glycohyocholic acid (Standard) | 32747-08-3 | Reference Standards |
| HY-122141S | Glycohyocholic acid-d4 | Isotope-Labeled Compounds | |
| HY-122142 | Pyr-Pro-Arg-pNA | 72194-57-1 | Peptides |
| HY-122143 | V-06-018 | 299927-26-7 | Reference compound |
| HY-122144 | α-Triglycidyl isocyanurate | 59653-73-5 | Reference compound |
| HY-122146 | Bactobolin B | 74141-68-7 | Reference compound |
| HY-122147 | L-644698 | 72313-41-8 | Reference compound |
| HY-122148 | DA 4626 | 83184-14-9 | Reference compound |
| HY-122149 | L-648051 | 91541-18-3 | Reference compound |
| HY-12214A | NVP-2 | 1263373-43-8 | Reference compound |
| HY-12215 | Lorlatinib | 1454846-35-5 | Reference compound |
| HY-122150 | AMPA receptor modulator-3 | 211311-39-6 | Reference compound |
| HY-122151 | MPT0B002 | 946077-08-3 | Reference compound |
| HY-122152 | Spiclomazine (hydrochloride) | 27007-85-8 | Reference compound |
| HY-122153 | VSN-16 | 863713-78-4 | Reference compound |
| HY-122154 | FR234938 | 256461-79-7 | Reference compound |
| HY-122156 | IMB-301 | 64009-84-3 | Reference compound |
| HY-122158 | CRAC channel inhibitor-1 | 903591-53-7 | Reference compound |
| HY-122159 | MDPD | 693265-89-3 | Reference compound |
| HY-12215R | Lorlatinib (Standard) | 1454846-35-5 | Reference Standards |
| HY-12215S2 | Deulorlatinib | 2131126-33-3 | Isotope-Labeled Compounds |
| HY-12216 | Resmetirom | 920509-32-6 | Reference compound |
| HY-122161 | JNJ-10311795 | 518062-14-1 | Reference compound |
| HY-122164 | LY-503430 | 625820-83-9 | Reference compound |
| HY-122165A | LY-79771 (hydrochloride) | 74248-92-3 | Reference compound |
| HY-122166 | Histamine receptors inhibitor 1 | 744270-00-6 | Reference compound |
| HY-122167 | L-869298 | 362718-73-8 | Reference compound |
| HY-122168 | AAT-008 | 847727-81-5 | Reference compound |
| HY-122170 | RU5135 | 78774-26-2 | Reference compound |
| HY-122171 | A-317920 | 360551-59-3 | Reference compound |
| HY-122172 | GSK3-IN-6 | 681432-85-9 | Reference compound |
| HY-122175 | ZK-158252 | 162362-36-9 | Reference compound |
| HY-122177 | MK181 | 314297-32-0 | Reference compound |
| HY-122178 | 5-trans U-44069 | 330796-57-1 | Reference compound |
| HY-122179 | NUCC-555 | 1060469-90-0 | Reference compound |
| HY-122181 | OTS186935 | 2093400-18-9 | Reference compound |
| HY-122181A | OTS186935 (trihydrochloride) | 2093401-85-3 | Reference compound |
| HY-122181B | OTS186935 (hydrochloride) | Reference compound | |
| HY-122182 | OTS193320 | 2093401-33-1 | Reference compound |
| HY-122184 | PET-16 | 34387-64-9 | Reference compound |
| HY-122185 | Anticancer agent 211 | 314022-97-4 | Reference compound |
| HY-122186 | SGC-GAK-1 | 2226517-76-4 | Reference compound |
| HY-122189 | Akuammine | 3512-87-6 | Reference compound |
| HY-12219 | MSI-1436 | 186139-09-3 | Reference compound |
| HY-122190 | TAK-071 | 1820812-16-5 | Reference compound |
| HY-122191 | AK-Toxin II | 85146-10-7 | Reference compound |
| HY-122192 | ICAM-1988 | 444169-80-6 | Reference compound |
| HY-122196 | TYT-1 | 64803-10-7 | Reference compound |
| HY-122197 | ML339 | 2579689-83-9 | Reference compound |
| HY-122198 | ML367 | 381168-77-0 | Reference compound |
| HY-12219A | MSI-1436 lactate | 1309370-86-2 | Reference compound |
| HY-12219B | MSI-1701 | 390808-64-7 | Reference compound |
| HY-12220 | MM-102 | 1417329-24-8 | Reference compound |
| HY-122200 | Phenamacril | 39491-78-6 | Reference compound |
| HY-122200R | Phenamacril (Standard) | 39491-78-6 | Reference Standards |
| HY-122201 | NSC156529 | 41134-88-7 | Reference compound |
| HY-122203 | PCS1055 (dihydrochloride) | 361979-40-0 | Reference compound |
| HY-122203A | PCS1055 | 357173-55-8 | Reference compound |
| HY-122204 | 5M038 | 338962-32-6 | Reference compound |
| HY-122207 | Erythromycin A enol ether | 33396-29-1 | Reference compound |
| HY-122207R | Erythromycin A enol ether (Standard) | 33396-29-1 | Reference Standards |
| HY-122208 | SGA360 | 680611-86-3 | Reference compound |
| HY-122209 | DVR-01 | 330461-34-2 | Reference compound |
| HY-12220A | MM-102 (TFA) | 1883545-52-5 | Reference compound |
| HY-122210 | T521 | 891020-54-5 | Reference compound |
| HY-122211 | MRS2802 | 1047980-53-9 | Reference compound |
| HY-122212 | PF-9404C | 780825-97-0 | Reference compound |
| HY-122213 | RU-25055 | 67983-56-6 | Reference compound |
| HY-122214 | AC-73 | 775294-71-8 | Reference compound |
| HY-122215 | Tilisolol (hydrochloride) | 62774-96-3 | Reference compound |
| HY-122216 | LY 88329 | 78693-86-4 | Reference compound |
| HY-122217 | Pyridate | 55512-33-9 | Reference compound |
| HY-122217R | Pyridate (Standard) | 55512-33-9 | Reference Standards |
| HY-122217S | Pyridate-d5 | Isotope-Labeled Compounds | |
| HY-122218 | JHU-083 | 1998725-11-3 | Reference compound |
| HY-122219 | R243 | 688352-84-3 | Reference compound |
| HY-12222 | Obeticholic acid | 459789-99-2 | Reference compound |
| HY-122221 | KUM 32 | 28717-34-2 | Reference compound |
| HY-122223 | EPZ030456 | 1808011-23-5 | Reference compound |
| HY-122227 | SMP-797 (hydrochloride) | 259224-95-8 | Reference compound |
| HY-122228 | Cestrin | 671181-94-5 | Reference compound |
| HY-122229 | GS-9822 | 2219362-41-9 | Reference compound |
| HY-12222R | Obeticholic acid (Standard) | 459789-99-2 | Reference Standards |
| HY-12222S | Obeticholic acid-d5 | 1992000-80-2 | Isotope-Labeled Compounds |
| HY-12222S1 | Obeticholic Acid-d4 | Isotope-Labeled Compounds | |
| HY-122230 | UR-3216 | 220386-65-2 | Reference compound |
| HY-122231 | MRS3558 | 793695-40-6 | Reference compound |
| HY-122232 | SW083688 | 422281-45-6 | Reference compound |
| HY-122233 | Dimethrin | 70-38-2 | Reference compound |
| HY-122234 | VPC-18005 | 2242480-48-2 | Reference compound |
| HY-122235 | MRL-24 | 393794-17-7 | Reference compound |
| HY-122236 | UMK57 | 342595-74-8 | Reference compound |
| HY-122237 | ATZ-1993 | 219705-77-8 | Reference compound |
| HY-122240 | AAE871 | 289479-07-8 | Reference compound |
| HY-122241 | MT477 | 328069-91-6 | Reference compound |
| HY-122243 | IU1-47 | 670270-31-2 | Reference compound |
| HY-122245 | Sortin2 | 372972-39-9 | Reference compound |
| HY-122246 | ML192 | 460331-61-7 | Reference compound |
| HY-122247 | PVZB1194 | 1141768-04-8 | Reference compound |
| HY-122248 | Phebestin | 187402-73-9 | Reference compound |
| HY-122249 | MT-7 | 946507-08-0 | Reference compound |
| HY-122250 | LY 288601 | 152920-47-3 | Reference compound |
| HY-122251 | CCG-4986 | 7134-19-2 | Reference compound |
| HY-122255 | LY487379 | 353231-17-1 | Reference compound |
| HY-122258 | NSC-370284 | 116409-29-1 | Reference compound |
| HY-122259 | AMPte-Glu-γ-Glu | 41600-13-9 | Reference compound |
| HY-122260 | S-25932 | 92358-02-6 | Reference compound |
| HY-122261 | Spiroamantadine | 34522-38-8 | Reference compound |
| HY-122266 | Orcein | 1400-62-0 | Dye Reagents |
| HY-122267 | Clovamide | 53755-02-5 | Natural Products |
| HY-122267A | cis-Clovamide | 53755-03-6 | Natural Products |
| HY-122268 | QYL-685 | 210355-14-9 | Reference compound |
| HY-122270 | Kahweol stearate | 108214-31-9 | Natural Products |
| HY-122271 | Safrazine (hydrochloride) | 7296-30-2 | Reference compound |
| HY-122272 | Paroxetine | 61869-08-7 | Reference compound |
| HY-122272S | Paroxetine-d4 | 923932-45-0 | Isotope-Labeled Compounds |
| HY-122272S2 | Paroxetine-d6-1 | 1435728-63-4 | Isotope-Labeled Compounds |
| HY-122273 | Pyrithiamine (hydrobromide) | 534-64-5 | Reference compound |
| HY-122274 | MMV666693 | 312527-99-4 | Reference compound |
| HY-122277 | 1'-Hydroxy bufuralol | 57704-16-2 | Reference compound |
| HY-122277S | 1'-Hydroxy bufuralol-d9 | 1185069-74-2 | Isotope-Labeled Compounds |
| HY-122278 | Melevodopa | 7101-51-1 | Reference compound |
| HY-122280 | Aerobactin | 26198-65-2 | Natural Products |
| HY-122280R | Aerobactin (Standard) | 26198-65-2 | Reference Standards |
| HY-122281 | JTE 7-31 | 194358-72-0 | Reference compound |
| HY-122282 | AZ11657312 | 804561-22-6 | Reference compound |
| HY-122285 | A-25794 | 22198-93-2 | Reference compound |
| HY-122288 | SC 28538 | 64444-68-4 | Reference compound |
| HY-122289 | Metioprim | 68902-57-8 | Reference compound |
| HY-122292 | Celastramycin A | 188988-62-7 | Reference compound |
| HY-122294 | Rociverine | 53716-44-2 | Reference compound |
| HY-122295 | Dehydroleucodine | 36150-07-9 | Natural Products |
| HY-122297 | H-Arg-Phe-OH | 2047-13-4 | Reference compound |
| HY-122298 | Fenpicoxamid | 517875-34-2 | Reference compound |
| HY-122299 | Motretinide | 56281-36-8 | Reference compound |
| HY-122300 | R-(-)-Oxaprotiline (hydrochloride) | 76496-69-0 | Reference compound |
| HY-122300A | Oxaprotiline | 56433-44-4 | Reference compound |
| HY-122300B | R-(-)-Oxaprotiline | 76496-68-9 | Reference compound |
| HY-122300C | Oxaprotiline (hydrochloride) | 39022-39-4 | Reference compound |
| HY-122302 | BU-2313 A | 69774-86-3 | Natural Products |
| HY-122303 | 4-hydroxy DiPT (hydrochloride) | 63065-90-7 | Reference compound |
| HY-122306 | Ansatrienin B | 82189-04-6 | Reference compound |
| HY-122307 | Sulisatin | 54935-03-4 | Reference compound |
| HY-122307A | Sulisatin (disodium) | 54935-04-5 | Reference compound |
| HY-122308 | Militarine | 58139-23-4 | Natural Products |
| HY-122308R | Militarine (Standard) | 58139-23-4 | Reference Standards |
| HY-122309 | A-71497 | 134762-03-1 | Reference compound |
| HY-122311 | Orniplabin | 733805-92-0 | Reference compound |
| HY-122312 | BAY-8002 | 724440-27-1 | Reference compound |
| HY-122315 | Oncrasin-60 | 92407-91-5 | Reference compound |
| HY-122317 | Menthol glucuronide | 79466-08-3 | Reference compound |
| HY-122319 | Oxadiargyl | 39807-15-3 | Reference compound |
| HY-122319R | Oxadiargyl (Standard) | 39807-15-3 | Reference Standards |
| HY-122320 | Phytosterols | 949109-75-5 | Reference compound |
| HY-122323 | L-Leucyl-L-arginine | 26607-15-8 | Reference compound |
| HY-122324 | Tylophorine | 482-20-2 | Natural Products |
| HY-122324A | (-)-Tylophorine | 111408-21-0 | Natural Products |
| HY-122326 | Ioglycamic acid | 2618-25-9 | Reference compound |
| HY-122327 | Nodusmicin | 76265-48-0 | Reference compound |
| HY-122328 | Flambamycin | 42617-24-3 | Natural Products |
| HY-122330 | Dicobalt edetate | 36499-65-7 | Reference compound |
| HY-122331 | Norbormide | 991-42-4 | Reference compound |
| HY-122332 | 2'-Fluoroaminopterin | 85803-29-8 | Reference compound |
| HY-122334 | Myxopyronin A | 88192-98-7 | Natural Products |
| HY-122336 | Asperlicin D | 93413-07-1 | Reference compound |
| HY-122338 | Fexarine | 574013-67-5 | Reference compound |
| HY-122341 | Thrazarine | 120128-14-5 | Natural Products |
| HY-122347 | Orvepitant | 579475-18-6 | Reference compound |
| HY-122347A | Orvepitant (maleate) | 579475-24-4 | Reference compound |
| HY-122349 | Lotrifen | 66535-86-2 | Reference compound |
| HY-12235 | PI-3065 | 955977-50-1 | Reference compound |
| HY-122350 | Dactimicin (sulfate) | 73245-91-7 | Reference compound |
| HY-122351 | Advantame (free acid) | 245650-17-3 | Reference compound |
| HY-122351A | Advantame | 714229-20-6 | Reference compound |
| HY-122351AR | Advantame (Standard) | 714229-20-6 | Reference Standards |
| HY-122353 | Orotirelin | 62305-86-6 | Reference compound |
| HY-122356 | Ambazone (monohydrate) | 6011-12-7 | Reference compound |
| HY-122356A | Ambazone | 539-21-9 | Reference compound |
| HY-122357 | Bestim | 66471-20-3 | Peptides |
| HY-122358 | Neoarsphenamine | 457-60-3 | Reference compound |
| HY-122359 | Levormeloxifene | 78994-23-7 | Reference compound |
| HY-122359A | rel-Levormeloxifene | 31477-60-8 | Reference compound |
| HY-122359B | Levormeloxifene (fumarate) | 199583-01-2 | Reference compound |
| HY-12236 | SKF 81297 (hydrobromide) | 67287-39-2 | Reference compound |
| HY-122364 | Bucumolol (hydrochloride) | 36556-75-9 | Reference compound |
| HY-122365 | Inositol nicotinate | 6556-11-2 | Reference compound |
| HY-122365R | Inositol nicotinate (Standard) | 6556-11-2 | Reference Standards |
| HY-122366 | L-Chlorozotocin | 69839-80-1 | Reference compound |
| HY-122367 | Neoxaline | 909900-78-3 | Natural Products |
| HY-122369 | Histargin | 93361-66-1 | Natural Products |
| HY-12236A | SKF 81297 | 71636-61-8 | Reference compound |
| HY-12236B | (R)-SKF-81297 (hydrobromide) | 253446-15-0 | Reference compound |
| HY-12237 | SKF 38393 (hydrobromide) | 20012-10-6 | Reference compound |
| HY-122370A | Tripolin B | 186611-44-9 | Reference compound |
| HY-122373 | Coprine | 58919-61-2 | Reference compound |
| HY-122375 | Palustrol | 5986-49-2 | Natural Products |
| HY-122376 | S-Bioallethrin | 28434-00-6 | Reference compound |
| HY-122378 | Diopterin | 6807-82-5 | Reference compound |
| HY-122379 | 8-Hydroxypinoresinol | 81426-17-7 | Natural Products |
| HY-12238 | IWR-1 | 1127442-82-3 | Reference compound |
| HY-122380 | Alteconazole | 93479-96-0 | Reference compound |
| HY-122381 | Kyotorphin | 70904-56-2 | Peptides |
| HY-122382 | Levofuraltadone | 3795-88-8 | Reference compound |
| HY-122384 | Alcindoromycin | 72586-21-1 | Natural Products |
| HY-122385 | Dabequin (phosphate) | 56548-51-7 | Reference compound |
| HY-122386 | Kirromycin | 50935-71-2 | Natural Products |
| HY-122389 | Difenzoquat methyl sulfate | 43222-48-6 | Reference compound |
| HY-122389R | Difenzoquat methyl sulfate (Standard) | 43222-48-6 | Reference Standards |
| HY-12239 | CID755673 | 521937-07-5 | Reference compound |
| HY-122394 | Thiolactomycin | 82079-32-1 | Reference compound |
| HY-122395 | Triornicin | 77165-75-4 | Natural Products |
| HY-122397 | Rubrolone | 65445-21-8 | Natural Products |
| HY-122399 | Luprostiol | 67110-79-6 | Reference compound |
| HY-12240 | B32B3 | 294193-86-5 | Reference compound |
| HY-122401 | Daigremontianin | 98205-50-6 | Reference compound |
| HY-122402 | Umirolimus | 851536-75-9 | Reference compound |
| HY-122404 | Xantocillin | 580-74-5 | Natural Products |
| HY-122406 | Thiacetarsamide | 531-72-6 | Reference compound |
| HY-122407 | Hexadecyltrimethylammonium (hydroxide),25% in methanol | 505-86-2 | Biochemical Assay Reagents |
| HY-122409 | Cularine | 479-39-0 | Reference compound |
| HY-12241 | AZ82 | 1449578-65-7 | Reference compound |
| HY-122410 | Dihydrolanosterol | 79-62-9 | Natural Products |
| HY-122410R | Dihydrolanosterol (Standard) | 79-62-9 | Reference Standards |
| HY-122410S | Dihydrolanosterol-d7 | 2260669-12-1 | Isotope-Labeled Compounds |
| HY-122411 | Panomifene | 77599-17-8 | Reference compound |
| HY-122412 | Lenampicillin | 86273-18-9 | Reference compound |
| HY-122413 | m-PEG7-NHS ester | 874208-92-1 | Reference compound |
| HY-122414 | Phosalacine | 92567-89-0 | Natural Products |
| HY-122415 | Tunicamine | 66054-53-3 | Reference compound |
| HY-122416 | 6,8-Diprenylnaringenin | 68236-11-3 | Natural Products |
| HY-12242 | GBR 12935 (dihydrochloride) | 67469-81-2 | Reference compound |
| HY-122422 | Gepirone | 83928-76-1 | Reference compound |
| HY-122422A | Gepirone (hydrochloride) | 83928-66-9 | Reference compound |
| HY-122422R | Gepirone (Standard) | 83928-76-1 | Reference Standards |
| HY-122422S | Gepirone-d8 | 2749331-28-8 | Isotope-Labeled Compounds |
| HY-122423 | Desethylamiodarone | 83409-32-9 | Reference compound |
| HY-122425 | Nylidrin | 447-41-6 | Reference compound |
| HY-122426 | 1-Bromoundecane | 693-67-4 | Reference compound |
| HY-122426S | 1-Bromoundecane-d23 | 349553-92-0 | Isotope-Labeled Compounds |
| HY-122426S1 | 1-Bromoundecane-d3 | 1219805-63-6 | Isotope-Labeled Compounds |
| HY-122426S2 | 1-Bromoundecane-d4 | 1219802-82-0 | Isotope-Labeled Compounds |
| HY-122427 | Xylocytidine | 3530-56-1 | Reference compound |
| HY-122428 | Samandarone | 467-52-7 | Natural Products |
| HY-12242A | GBR 12935 | 76778-22-8 | Reference compound |
| HY-12242B | GBR 12935 (fumarate) | 1349767-56-1 | Reference compound |
| HY-12243 | CID-797718 | 370586-05-3 | Reference compound |
| HY-122430 | Rosaramicin | 35834-26-5 | Reference compound |
| HY-122437 | Quinuronium (disulfate) | 135-14-8 | Reference compound |
| HY-122439 | Lovastatin acid | 75225-51-3 | Reference compound |
| HY-12244 | BB-22 | 1400742-42-8 | Reference compound |
| HY-122440 | Scopoline | 487-27-4 | Natural Products |
| HY-122445 | Resorcinolnaphthalein | 41307-63-5 | Reference compound |
| HY-122447 | Saroaspidin C | 112663-70-4 | Natural Products |
| HY-122448 | (-)-Sativan | 41743-86-6 | Natural Products |
| HY-122448A | (Rac)-Sativan | 71831-00-0 | Natural Products |
| HY-12245 | SB-366791 | 472981-92-3 | Reference compound |
| HY-122451 | Ofurace | 58810-48-3 | Reference compound |
| HY-122451R | Ofurace (Standard) | 58810-48-3 | Reference Standards |
| HY-122453 | Palinavir | 154612-39-2 | Reference compound |
| HY-122456 | Fmoc-PEG4-NHS ester | 1314378-14-7 | Reference compound |
| HY-122457 | Δ2,3-Doramectin | 1987882-63-2 | Reference compound |
| HY-122459 | Fmoc-PEG5-NHS ester | 1402080-11-8 | Reference compound |
| HY-12246 | XEN445 | 1515856-92-4 | Reference compound |
| HY-122461 | Glycobiarsol | 116-49-4 | Reference compound |
| HY-122462 | Ladirubicin | 171047-47-5 | Reference compound |
| HY-122464 | (±)-Jasmonic acid | 77026-92-7 | Reference compound |
| HY-122464A | Jasmonic acid | 6894-38-8 | Natural Products |
| HY-122464B | 7-epi Jasmonic acid | 62653-85-4 | Reference compound |
| HY-122464S1 | Jasmonic acid-d5 | 1821807-88-8 | Isotope-Labeled Compounds |
| HY-122464S2 | (±)-Jasmonic acid-d5 | 2750534-78-0 | Isotope-Labeled Compounds |
| HY-122466 | Lonomycin A | 58785-63-0 | Reference compound |
| HY-122467 | Kumbicin C | 1878151-58-6 | Natural Products |
| HY-122469 | Kurasoin B | 193696-42-3 | Reference compound |
| HY-122470 | Stampidine | 217178-62-6 | Reference compound |
| HY-122471A | Laudexium (methylsulfate) | 3253-60-9 | Reference compound |
| HY-122473 | fluoro-Dapagliflozin | 1181681-43-5 | Reference compound |
| HY-122474 | Acetylaranotin | 20485-01-2 | Natural Products |
| HY-122477 | Zylofuramine | 3563-92-6 | Reference compound |
| HY-12248 | Telaglenastat | 1439399-58-2 | Reference compound |
| HY-122481 | Thaspine (acetate) | 74578-01-1 | Natural Products |
| HY-122482 | β-Rubromycin | 27267-70-5 | Reference compound |
| HY-122483 | Diethyl pyimDC | 1821370-64-2 | Reference compound |
| HY-122485 | α-Copaene | 3856-25-5 | Natural Products |
| HY-122486 | Lophirachalcone | 122585-40-4 | Reference compound |
| HY-122487 | Troriluzole | 1926203-09-9 | Reference compound |
| HY-122487A | Troriluzole (hydrochloride) | 1926204-76-3 | Reference compound |
| HY-122488 | Rinderine | 6029-84-1 | Natural Products |
| HY-122489 | DL-Laudanosine | 1699-51-0 | Natural Products |
| HY-122489A | (S)-Laudanosine | 2688-77-9 | Natural Products |
| HY-122489R | DL-Laudanosine (Standard) | 1699-51-0 | Reference Standards |
| HY-12248A | Telaglenastat (hydrochloride) | 1874231-60-3 | Reference compound |
| HY-122490 | Laidlomycin | 56283-74-0 | Natural Products |
| HY-122491 | Dimethyl-W84 (dibromide) | 402475-33-6 | Reference compound |
| HY-122493 | Illudin M | 1146-04-9 | Natural Products |
| HY-122494 | Bilanafos | 35597-43-4 | Peptides |
| HY-122494A | Bialaphos (sodium) | 71048-99-2 | Reference compound |
| HY-122494AR | Bialaphos (sodium) (Standard) | 71048-99-2 | Reference Standards |
| HY-122495 | rel-Quinpirole (dihydrochloride) | 73625-62-4 | Reference compound |
| HY-122496 | Malvidin (chloride) | 643-84-5 | Natural Products |
| HY-122496R | Malvidin (chloride) (Standard) | 643-84-5 | Reference Standards |
| HY-122499 | Ciprostene (calcium) | 81703-55-1 | Reference compound |
| HY-122500 | Kahukuene A | 146293-93-8 | Natural Products |
| HY-122502 | Pyrazofurin | 30868-30-5 | Reference compound |
| HY-122503 | Guamecycline | 16545-11-2 | Reference compound |
| HY-122504 | Linoleoyl glycine | 2764-03-6 | Reference compound |
| HY-122505 | Cephamycin C | 38429-35-5 | Reference compound |
| HY-122506 | Salviolone | 119400-86-1 | Natural Products |
| HY-122507 | Septamycin | 54927-63-8 | Reference compound |
| HY-122508 | Hydroxyebastine | 210686-41-2 | Reference compound |
| HY-122508S | Hydroxy Ebastine-d5 | 1189954-07-1 | Isotope-Labeled Compounds |
| HY-122509 | Senkirkin | 2318-18-5 | Natural Products |
| HY-122509R | Senkirkin (Standard) | 2318-18-5 | Reference Standards |
| HY-122510 | Atropine oxide | 4438-22-6 | Reference compound |
| HY-122510A | Atropine oxide (hydrochloride) | 4574-60-1 | Reference compound |
| HY-122511 | Darcanolide | 33909-56-7 | Reference compound |
| HY-122515 | Fulvic Acid | 479-66-3 | Natural Products |
| HY-122515R | Fulvic Acid (Standard) | 479-66-3 | Reference Standards |
| HY-122517 | Mirincamycin (hydrochloride) | 8063-91-0 | Reference compound |
| HY-122518 | 8-Deazafolic acid | 51989-25-4 | Reference compound |
| HY-122519 | Trixylyl phosphate | 25155-23-1 | Reference compound |
| HY-122520 | Fentonium (bromide) | 5868-06-4 | Reference compound |
| HY-122521 | Sootepin D | 1154518-97-4 | Natural Products |
| HY-122522 | 2-Methylcardol triene | 50423-15-9 | Reference compound |
| HY-122523 | Tetromycin A | 180027-83-2 | Reference compound |
| HY-122524 | 7-Methylguanosine | 20244-86-4 | Natural Products |
| HY-122524S | 7-Methylguanosine-d3 | Isotope-Labeled Compounds | |
| HY-122525A | Sabiporide (hydrochloride) | 324758-66-9 | Reference compound |
| HY-122525B | Sabiporide (mesylate) | 261505-81-1 | Reference compound |
| HY-122526 | Thialysine (hydrochloride) | 4099-35-8 | Peptides |
| HY-122529 | Almurtide | 61136-12-7 | Reference compound |
| HY-122530 | Juvocimene I | 75539-64-9 | Natural Products |
| HY-122531 | Oleyl myristate | 22393-93-7 | Natural Products |
| HY-122532 | Fagaronine (chloride) | 52259-64-0 | Reference compound |
| HY-122534 | Mensacarcin | 808750-39-2 | ADC Related |
| HY-122536 | Ricinelaidic acid | 540-12-5 | Reference compound |
| HY-122537 | Arotinolol (hydrochloride) | 68377-91-3 | Reference compound |
| HY-122537A | Arotinolol | 68377-92-4 | Reference compound |
| HY-122542 | PPACK | 71142-71-7 | Peptides |
| HY-122542A | PPACK (dihydrochloride) | 82188-90-7 | Peptides |
| HY-122542B | PPACK (TFA) | 157379-44-7 | Peptides |
| HY-122543 | PPACK II (diTFA) | 649748-23-2 | Reference compound |
| HY-122543A | PPACK II | 74392-49-7 | Reference compound |
| HY-122550 | Artemisitene | 101020-89-7 | Natural Products |
| HY-122551 | Chlorfenethol | 80-06-8 | Reference compound |
| HY-122552 | Chrysotobibenzyl | 108853-09-4 | Natural Products |
| HY-122559 | BMS-984923 | 1375752-78-5 | Reference compound |
| HY-122560 | VU0134992 | 755002-90-5 | Reference compound |
| HY-122560A | VU0134992 (hydrochloride) | 1052515-91-9 | Reference compound |
| HY-122562 | MT-802 | 2231744-29-7 | Reference compound |
| HY-122564 | Pyrimidyn 7 | 1440126-94-2 | Reference compound |
| HY-122566 | SMU127 | 903864-87-9 | Reference compound |
| HY-122568 | STING agonist-15 | 875863-22-2 | Reference compound |
| HY-122571 | Retro-2 | 1201652-50-7 | Reference compound |
| HY-122573 | Bromodomain inhibitor-13 | 1914047-59-8 | Reference compound |
| HY-122575 | Aurintricarboxylic acid | 4431-00-9 | Reference compound |
| HY-122577 | EN40 | 2094547-67-6 | Reference compound |
| HY-122578 | P53R3 | 922150-12-7 | Reference compound |
| HY-122579 | IGS-1.76 | 313480-47-6 | Reference compound |
| HY-122582 | TL13-12 | 2229037-04-9 | Reference compound |
| HY-122583 | D-G23 | 1225141-73-0 | Reference compound |
| HY-122585 | proMMP-9 inhibitor-3c | 2138321-18-1 | Reference compound |
| HY-122586 | BRD6989 | 642008-81-9 | Reference compound |
| HY-122587 | AVG-233 | 2151937-80-1 | Reference compound |
| HY-122588 | Negamycin | 33404-78-3 | Natural Products |
| HY-122590 | Glabrescione B | 65893-94-9 | Reference compound |
| HY-122591 | PTUPB | 1287761-01-6 | Reference compound |
| HY-122592 | Zifaxaban | 1378266-98-8 | Reference compound |
| HY-122593 | PI3Kδ-IN-5 | 2088525-31-7 | Reference compound |
| HY-122594 | BNS-22 | 1151668-24-4 | Reference compound |
| HY-122595 | EZH2-IN-1 | 1377997-28-8 | Reference compound |
| HY-122604 | PF-DcpSi | 2092917-19-4 | Reference compound |
| HY-122605 | TRPM4-IN-1 | 351424-20-9 | Reference compound |
| HY-122607 | DPA-714 | 958233-07-3 | Reference compound |
| HY-122608 | Samelisant (free base) | 1394808-82-2 | Reference compound |
| HY-122609 | XO44 | 2088112-70-1 | Reference compound |
| HY-122610 | VUT-MK142 | 1313491-22-3 | Reference compound |
| HY-122611 | CSRM617 | 787504-88-5 | Reference compound |
| HY-122611A | CSRM617 (hydrochloride) | 1353749-74-2 | Reference compound |
| HY-122611R | CSRM617 (Standard) | 787504-88-5 | Reference Standards |
| HY-122612 | SB-258585 | 209480-63-7 | Reference compound |
| HY-122613 | YM543 (free base) | 655237-16-4 | Reference compound |
| HY-122614 | S29434 | 874484-20-5 | Reference compound |
| HY-122615 | SPOP-IN-6b | 2136270-20-5 | Reference compound |
| HY-122615A | SPOP-IN-6b (hydrochloride) | 2136270-68-1 | Reference compound |
| HY-122615B | SPOP-IN-6b (dihydrochloride) | Reference compound | |
| HY-122616 | PF-06273340 | 1402438-74-7 | Reference compound |
| HY-122620 | Rafutrombopag (tautomerism) | 2114365-78-3 | Reference compound |
| HY-122622 | PF-04471141 (hydrochloride) | 1655498-17-1 | Reference compound |
| HY-122623 | DB818 | 790241-43-9 | Reference compound |
| HY-122623A | DB818 (dihydrochloride) | Reference compound | |
| HY-122624 | MMP13-IN-2 | 935759-55-0 | Reference compound |
| HY-122626 | BRPF1B/TRIM24-IN-1 | 1242907-48-7 | Reference compound |
| HY-122627 | CLZ-8 | 678158-55-9 | Reference compound |
| HY-122629 | DRAK2-IN-1 | 871837-60-4 | Reference compound |
| HY-122630 | TH-257 | 2244678-29-1 | Reference compound |
| HY-122631 | TG693 | 885272-55-9 | Reference compound |
| HY-122632 | Ciliobrevin D | 1370554-01-0 | Reference compound |
| HY-122635 | T-448 (free base) | 1597426-52-2 | Reference compound |
| HY-122635A | T-448 | 1597426-53-3 | Reference compound |
| HY-122639 | ZINC05007751 | 591239-68-8 | Reference compound |
| HY-122641 | Deltasonamide 1 | 2088485-33-8 | Reference compound |
| HY-122641A | Deltasonamide 2 | 2088485-34-9 | Reference compound |
| HY-122641B | Deltasonamide 2 (TFA) | 2235358-74-2 | Reference compound |
| HY-122641C | Deltasonamide 2 (hydrochloride) | 2448341-55-5 | Reference compound |
| HY-122641D | Deltasonamide 1 (TFA) | 2235358-73-1 | Reference compound |
| HY-122642 | TAK1-IN-4 | 1570374-32-1 | Reference compound |
| HY-122643 | NITD-916 | 1614262-83-7 | Reference compound |
| HY-122645 | SMARCA2-IN-4 | 1915012-19-9 | Reference compound |
| HY-122646 | USP7-IN-2 | 2196243-57-7 | Reference compound |
| HY-122647 | Valiglurax | 1976050-09-5 | Reference compound |
| HY-122649 | UU-T01 | 1417162-83-4 | Reference compound |
| HY-122650 | PHY34 | 2130033-55-3 | Reference compound |
| HY-122652 | MitoBloCK-6 | 303215-67-0 | Reference compound |
| HY-122653 | CCT367766 | 2229856-58-8 | Reference compound |
| HY-122653A | CCT367766 (formic) | Reference compound | |
| HY-122655 | HMCEF | 2002363-68-8 | Reference compound |
| HY-122657 | AI-10-104 | 1881276-00-1 | Reference compound |
| HY-122661 | Mefuparib (hydrochloride) | 1449746-00-2 | Reference compound |
| HY-122663 | (Rac)-BIO8898 | 402564-79-8 | Reference compound |
| HY-122663A | BIO8898 | Reference compound | |
| HY-122664 | XMU-MP-2 | 2031152-10-8 | Reference compound |
| HY-122665 | HTH-01-091 | 2000209-42-5 | Reference compound |
| HY-122665A | HTH-01-091 (TFA) | Reference compound | |
| HY-122666 | Org 25935 | 949588-40-3 | Reference compound |
| HY-122668 | K22 | 2141978-86-9 | Reference compound |
| HY-122671 | OB-1 | 300803-69-4 | Reference compound |
| HY-122671S | OB-1-d3 | Isotope-Labeled Compounds | |
| HY-122672 | Adhesamine | 462605-73-8 | Reference compound |
| HY-122672A | Adhesamine (diTFA) | 1201698-09-0 | Reference compound |
| HY-122675 | ACG416B | 795316-15-3 | Reference compound |
| HY-122678 | LQZ-7F | 354543-09-2 | Reference compound |
| HY-122681 | SR-16435 | 857262-16-9 | Reference compound |
| HY-122682 | SBI-993 | 2073059-82-0 | Reference compound |
| HY-122683 | sAJM589 | 2089-82-9 | Reference compound |
| HY-122694 | Thalidomide-O-amido-PEG-C2-NH2 | 2022182-59-6 | Reference compound |
| HY-122694A | Thalidomide-O-amido-PEG-C2-NH2 (hydrochloride) | 2204226-02-6 | Reference compound |
| HY-122695 | FEN1-IN-2 | 824983-94-0 | Reference compound |
| HY-122696 | CH2COOH-PEG3-CH2COOH | 32775-08-9 | Reference compound |
| HY-122697 | ML418 | 1928763-08-9 | Reference compound |
| HY-122698 | CCI-007 | 939228-52-1 | Reference compound |
| HY-12270 | T-5224 | 530141-72-1 | Reference compound |
| HY-122700 | Factor D inhibitor 6 | 1386455-51-1 | Reference compound |
| HY-122702 | PEG6-(CH2CO2H)2 | 77855-76-6 | Reference compound |
| HY-122703 | BETi-211 | 1995867-02-1 | Reference compound |
| HY-122704 | Surfen | 3811-56-1 | Reference compound |
| HY-122704A | Surfen (dihydrochloride) | 5424-37-3 | Reference compound |
| HY-122705 | RAD51-IN-1 | 2101739-18-6 | Reference compound |
| HY-122706A | IP6K2-IN-2 | 2967648-66-2 | Reference compound |
| HY-122709 | hTG2 inhibitor VA4 | 2088001-23-2 | Reference compound |
| HY-122710 | Thalidomide-O-amido-PEG4-C2-NH2 | 1957236-22-4 | Reference compound |
| HY-122710A | Thalidomide-O-amido-PEG4-C2-NH2 (hydrochloride) | 2245697-85-0 | Reference compound |
| HY-122714 | SK-216 | 654080-03-2 | Reference compound |
| HY-122716 | PTGR2-IN-1 | 349093-44-3 | Reference compound |
| HY-122720 | SEC inhibitor KL-1 | 900308-84-1 | Reference compound |
| HY-122721 | Mcl1-IN-5 | 2056238-04-9 | Reference compound |
| HY-122723 | GOT1 inhibitor-1 | 732973-87-4 | Reference compound |
| HY-122724 | IQDMA | 401463-02-3 | Reference compound |
| HY-122725A | Lenalidomide-C5-NH2 (TFA) | 2550398-71-3 | Reference compound |
| HY-122725B | Lenalidomide-C5-NH2 (hydrochloride) | 2595367-27-2 | Reference compound |
| HY-122727 | STL127705 | 1326852-06-5 | Reference compound |
| HY-12273 | DMH-1 | 1206711-16-1 | Reference compound |
| HY-122732 | OADS | 5970-15-0 | Reference compound |
| HY-122737 | RORγt Inverse agonist 8 | 2079892-79-6 | Reference compound |
| HY-12273G | DMH-1 (GMP) | 1206711-16-1 | GMP Small Molecules |
| HY-12273R | DMH-1 (Standard) | 1206711-16-1 | Reference Standards |
| HY-12274 | ML347 | 1062368-49-3 | Reference compound |
| HY-122742 | HBT1 | 489408-02-8 | Reference compound |
| HY-122743 | Iperoxo | 247079-84-1 | Reference compound |
| HY-122746 | E67-2 | 1364914-62-4 | Reference compound |
| HY-12275 | FR 180204 | 865362-74-9 | Reference compound |
| HY-122751 | (R)-DNMDP | 1630760-60-9 | Reference compound |
| HY-122753 | SLMP53-1 | 1643469-17-3 | Reference compound |
| HY-12276 | MALT1 inhibitor MI-2 | 1047953-91-2 | Reference compound |
| HY-122760 | Bax activator-1 | 1638526-94-9 | Reference compound |
| HY-122761 | Quifenadine | 10447-39-9 | Reference compound |
| HY-122762 | Cetraxate (hydrochloride) | 27724-96-5 | Reference compound |
| HY-122764 | Acalyphin | 81861-72-5 | Natural Products |
| HY-122765 | Luxabendazole | 90509-02-7 | Reference compound |
| HY-122765S | Luxabendazole-d3 | 1448346-27-7 | Isotope-Labeled Compounds |
| HY-122767 | Romurtide | 78113-36-7 | Peptides |
| HY-122769 | Adapiprazine | 57942-72-0 | Reference compound |
| HY-12277 | AZ191 | 1594092-37-1 | Reference compound |
| HY-122772 | (-)-Integerrimine | 480-79-5 | Natural Products |
| HY-122776 | Deacetylmatricarin | 10180-88-8 | Natural Products |
| HY-122777 | γ-Rubromycin | 27267-71-6 | Natural Products |
| HY-122778 | δ-Tocotrienol | 25612-59-3 | Reference compound |
| HY-122778R | δ-Tocotrienol (Standard) | 25612-59-3 | Reference Standards |
| HY-12278 | K02288 | 1431985-92-0 | Reference compound |
| HY-122782 | Lucidal | 252351-96-5 | Natural Products |
| HY-122783 | Isogambogic acid | 149655-52-7 | Natural Products |
| HY-122785 | Fusapyrone | 156856-31-4 | Reference compound |
| HY-122786 | 3-O-Methylviridicatin | 6152-57-4 | Reference compound |
| HY-122787 | Tylocrebrine | 6879-02-3 | Reference compound |
| HY-122788 | N-Oleoyl serinol | 72809-08-6 | Reference compound |
| HY-12279 | Umbralisib | 1532533-67-7 | Reference compound |
| HY-122790 | 2-Hydroxydocosanoic acid | 13980-14-8 | Natural Products |
| HY-122792 | Phenyramidol (Hydrochloride) | 326-43-2 | Reference compound |
| HY-122792R | Phenyramidol (Hydrochloride) (Standard) | 326-43-2 | Reference Standards |
| HY-122794 | Tyrosylleucine | 17355-10-1 | Peptides |
| HY-122794A | Tyrosylleucine (TFA) | 66852-01-5 | Peptides |
| HY-122795 | Vanoxonin | 86933-99-5 | Natural Products |
| HY-122797 | Oleic anhydride | 24909-72-6 | Biochemical Assay Reagents |
| HY-122798 | Verdantiol | 91-51-0 | Reference compound |
| HY-122799 | Cannabigerovarinic acid | 64924-07-8 | Reference compound |
| HY-12279A | Umbralisib (tosylate) | 1532533-72-4 | Reference compound |
| HY-12279B | Umbralisib (sulfate) | 1532533-75-7 | Reference compound |
| HY-12279C | Umbralisib (hydrochloride) | 1532533-78-0 | Reference compound |
| HY-12279F | Umbralisib R-enantiomer | 1532533-69-9 | Reference compound |
| HY-12280 | THZ2 | 1604810-84-5 | Reference compound |
| HY-122808 | (-)-Camphoric acid | 560-09-8 | Natural Products |
| HY-12281 | FPH2 | 957485-64-2 | Reference compound |
| HY-122811 | Dansyl-L-leucine | 1100-22-7 | Peptides |
| HY-122812 | Maesopsin | 5989-16-2 | Reference compound |
| HY-122813S1 | Dabigatran acyl-β-D-glucuronide-d3 (TFA) | Isotope-Labeled Compounds | |
| HY-122814 | Hedgehog IN-1 | 330796-24-2 | Reference compound |
| HY-122815 | Fusicoccin | 20108-30-9 | Natural Products |
| HY-122816 | HLY78 | 854847-61-3 | Reference compound |
| HY-122817 | FR900098 (sodium) | 73226-73-0 | Reference compound |
| HY-122818 | BpV(phen) (trihydrate) | 171202-16-7 | Reference compound |
| HY-122819 | Calindol (hydrochloride) | 729610-18-8 | Reference compound |
| HY-12282 | GNE-9605 | 1536200-31-3 | Reference compound |
| HY-122825 | SNIPER(ER)-110 | 2241690-03-7 | Reference compound |
| HY-122826 | ZXH-3-26 | 2243076-67-5 | Reference compound |
| HY-122828 | PROTAC BTK Degrader-2 | 2250382-66-0 | Reference compound |
| HY-122829 | BCL6 PROTAC 1 | 2257479-54-0 | Reference compound |
| HY-12283 | Rostafuroxin | 156722-18-8 | Reference compound |
| HY-122830 | DD-03-171 | 2366132-45-6 | Reference compound |
| HY-122832 | ABC99 | 2331255-53-7 | Reference compound |
| HY-12284 | NVP-QAV680 | 872365-16-7 | Reference compound |
| HY-122844 | Ifebemtinib | 1227948-82-4 | Reference compound |
| HY-122844A | Ifebemtinib (hydrochloride) | Reference compound | |
| HY-122848 | DDR1/2 inhibitor-3 | 2241813-33-0 | Reference compound |
| HY-12285 | Serabelisib | 1268454-23-4 | Reference compound |
| HY-122856 | AZ12601011 | 2748337-86-0 | Reference compound |
| HY-122857 | PKCiota-IN-1 | 2230052-97-6 | Reference compound |
| HY-122858 | PKCiota-IN-2 | 2230055-52-2 | Reference compound |
| HY-122858A | PKCiota-IN-2 (formic) | Reference compound | |
| HY-12286 | PI-1840 | 1401223-22-0 | Reference compound |
| HY-122862 | RAS inhibitor Abd-7 | 2351843-48-4 | Reference compound |
| HY-122866 | ZT-12-037-01 | 2328073-61-4 | Reference compound |
| HY-12287 | YH239-EE | 1364488-67-4 | Reference compound |
| HY-122872 | MKK7-COV-9 | 2283355-59-7 | Reference compound |
| HY-122874 | DI-404 | 2187412-79-7 | Reference compound |
| HY-122876 | KUNB31 | 2220263-80-7 | Reference compound |
| HY-122878 | HS-131 | 2084850-40-6 | Dye Reagents |
| HY-12288 | Ozanimod | 1306760-87-1 | Reference compound |
| HY-122881 | HOIPIN-1 | Reference compound | |
| HY-122881A | (E/Z)-HOIPIN-1 | 2470242-33-0 | Reference compound |
| HY-122882 | HOIPIN-8 | 2519537-70-1 | Reference compound |
| HY-122883 | BC-1471 | 896683-84-4 | Reference compound |
| HY-122885 | IU1-248 | 2307472-03-1 | Reference compound |
| HY-122886 | XL 188 | 2305045-76-3 | Reference compound |
| HY-12288A | Ozanimod (hydrochloride) | 1618636-37-5 | Reference compound |
| HY-12288R | Ozanimod (Standard) | 1306760-87-1 | Reference Standards |
| HY-12289 | Defactinib | 1073154-85-4 | Reference compound |
| HY-122891 | SB02024 | 2126737-28-6 | Reference compound |
| HY-122895 | E64FC26 | 2285446-62-8 | Reference compound |
| HY-122895A | (E/Z)-E64FC26 | 2285446-67-3 | Reference compound |
| HY-12289A | Defactinib (hydrochloride) | 1073160-26-5 | Reference compound |
| HY-12289S | Defactinib-d6 | 2384121-03-1 | Isotope-Labeled Compounds |
| HY-12290 | Arg-Gly-Asp-Ser | 91037-65-9 | Peptides |
| HY-122903 | TK216 | 1903783-48-1 | Reference compound |
| HY-122903A | (-)-TK216 | 1903783-78-7 | Reference compound |
| HY-122903B | (+)-TK216 | 1903783-77-6 | Reference compound |
| HY-122906 | JTE-952 | 1255303-54-8 | Reference compound |
| HY-122907 | JNJ4796 | 2241664-16-2 | Reference compound |
| HY-122908 | Atuliflapon | 2041075-86-7 | Reference compound |
| HY-122909 | GSK2593074A | 1337531-06-2 | Reference compound |
| HY-12290A | Arg-Gly-Asp-Ser (TFA) | Peptides | |
| HY-12291 | HG6-64-1 | 1315329-43-1 | Reference compound |
| HY-122910 | RIPGBM | 355406-76-7 | Reference compound |
| HY-122912 | ALDH1A inhibitor 673A | 109437-62-9 | Reference compound |
| HY-122913 | Borussertib | 1800070-77-2 | Reference compound |
| HY-122914 | KRAS inhibitor-3 | 900897-56-5 | Reference compound |
| HY-122915 | Zedoarondiol | 98644-24-7 | Natural Products |
| HY-122916 | 7-Acetyllycopsamine | 73544-48-6 | Natural Products |
| HY-122917 | Danshenol A | 189308-08-5 | Natural Products |
| HY-122918 | Moracin T | 1146113-27-0 | Natural Products |
| HY-122919 | Momordicoside L | 81348-83-6 | Natural Products |
| HY-12292 | IM-12 | 1129669-05-1 | Reference compound |
| HY-122920 | Soyasaponin II | 55319-36-3 | Natural Products |
| HY-122921 | 5-Galloylquinic acid | 53584-43-3 | Natural Products |
| HY-122922 | Valtropine | 495-82-9 | Natural Products |
| HY-122924 | Theogallin | 17365-11-6 | Natural Products |
| HY-122924R | Theogallin (Standard) | 17365-11-6 | Reference Standards |
| HY-122927 | Symphytine | 22571-95-5 | Reference compound |
| HY-12293 | LY2857785 | 1619903-54-6 | Reference compound |
| HY-122930 | Lysicamine | 15444-20-9 | Natural Products |
| HY-122931 | Supinine | 551-58-6 | Natural Products |
| HY-122932 | Neoquassin | 76-77-7 | Natural Products |
| HY-122932R | Neoquassin (Standard) | 76-77-7 | Reference Standards |
| HY-122933 | Kurarinol | 855746-98-4 | Natural Products |
| HY-122934 | 11-Methoxyangonin | 56070-89-4 | Natural Products |
| HY-122935 | Nigranoic acid | 39111-07-4 | Natural Products |
| HY-122936 | Tanshindiol C | 97465-71-9 | Reference compound |
| HY-122938 | Ceplignan | 185244-78-4 | Natural Products |
| HY-122939 | MAIPGG | 161876-61-5 | Reference compound |
| HY-12294 | PEAQX | 459836-30-7 | Reference compound |
| HY-122940 | Precocene II | 644-06-4 | Natural Products |
| HY-122941 | Viscidulin II | 92519-93-2 | Natural Products |
| HY-122942 | Moracin M | 56317-21-6 | Natural Products |
| HY-122943 | Moracin D | 69120-07-6 | Natural Products |
| HY-122944 | 20-Deoxocarnosol | 94529-97-2 | Natural Products |
| HY-122945 | Villosin C | 160927-81-1 | Natural Products |
| HY-122946 | Pterisolic acid B | 1401419-86-0 | Natural Products |
| HY-122948 | Isogambogenic acid | 887923-47-9 | Natural Products |
| HY-122949 | Momordicine I | 91590-76-0 | Natural Products |
| HY-12294A | PEAQX (tetrasodium hydrate) | Reference compound | |
| HY-12294B | (Rac)-PEAQX | 2514919-70-9 | Reference compound |
| HY-122950 | Harzianic acid | 157148-06-6 | Reference compound |
| HY-122951 | Eburicoic acid | 560-66-7 | Natural Products |
| HY-122953 | Daturaolone | 41498-80-0 | Natural Products |
| HY-122954 | Momordicoside K | 81348-84-7 | Natural Products |
| HY-122955 | Xanthobaccin A | 227596-81-8 | Natural Products |
| HY-122957 | Huperzine C | 163089-71-2 | Natural Products |
| HY-122958 | Peucedanocoumarin III | 130464-57-2 | Natural Products |
| HY-122959 | Kihadanin B | 73793-68-7 | Natural Products |
| HY-12296 | Navtemadlin | 1352066-68-2 | Reference compound |
| HY-122960 | Epifriedelanol acetate | 2259-07-6 | Natural Products |
| HY-122961 | Dehydromiltirone | 116064-77-8 | Natural Products |
| HY-122963 | Danshenol B | 189308-09-6 | Natural Products |
| HY-122964 | URB447 | 1132922-57-6 | Reference compound |
| HY-122965 | Batatasin III | 56684-87-8 | Natural Products |
| HY-122966 | Desmethylxanthohumol | 115063-39-3 | Natural Products |
| HY-122967 | Isosalvianolic acid C | 142115-17-1 | Natural Products |
| HY-122968 | Brocresine | 555-65-7 | Reference compound |
| HY-122969 | Anwuweizonic acid | 117020-59-4 | Natural Products |
| HY-12296A | (3S,5S,6R)-Navtemadlin | 2459946-14-4 | Reference compound |
| HY-12296S | Navtemadlin-d7 | Isotope-Labeled Compounds | |
| HY-12297 | Sulfatinib | 1308672-74-3 | Reference compound |
| HY-122970 | 1,2-Dihydrotanshinone | 77769-21-2 | Natural Products |
| HY-122974 | VA-K-14 (hydrochloride) | 1171341-19-7 | Reference compound |
| HY-122975 | Metronidazole Benzoate | 13182-89-3 | Reference compound |
| HY-122975R | Metronidazole Benzoate (Standard) | 13182-89-3 | Reference Standards |
| HY-122979 | (+)-Butaclamol (hydrochloride) | 55528-07-9 | Reference compound |
| HY-12297R | Sulfatinib (Standard) | 1308672-74-3 | Reference Standards |
| HY-12298 | Setanaxib | 1218942-37-0 | Reference compound |
| HY-122980 | Myxochelin A | 120243-02-9 | Reference compound |
| HY-122983 | Diisobutyl adipate | 141-04-8 | Reference compound |
| HY-122984 | Diquat (dibromide) | 85-00-7 | Reference compound |
| HY-122984R | Diquat (dibromide) (Standard) | 85-00-7 | Reference Standards |
| HY-122984S | Diquat-d4 (dibromide) | Isotope-Labeled Compounds | |
| HY-122985 | Graphislactone A | 52179-44-9 | Reference compound |
| HY-122988 | Xenbucin | 959-10-4 | Reference compound |
| HY-122988A | Namoxyrate | 1234-71-5 | Reference compound |
| HY-122989 | Aristolactam BIII | 53948-10-0 | Natural Products |
| HY-12299 | WH-4-023 | 837422-57-8 | Reference compound |
| HY-122991 | Prospasmine (hydrochloride) | 132-45-6 | Reference compound |
| HY-122996 | Nikkomycin M | 77368-62-8 | Reference compound |
| HY-122997 | Acetylaleuritolic acid | 28937-85-1 | Natural Products |
| HY-122998 | Iodoalphionic acid | 577-91-3 | Reference compound |
| HY-12300 | Ocifisertib | 1338806-73-7 | Reference compound |
| HY-123000 | 4-Methylumbelliferyl 2-acetamido-2-deoxy-α-D-galactopyranoside | 124223-99-0 | Biochemical Assay Reagents |
| HY-123001 | Nomelidine | 60324-59-6 | Reference compound |
| HY-123002 | Pyrifenox | 88283-41-4 | Reference compound |
| HY-123002R | Pyrifenox (Standard) | 88283-41-4 | Reference Standards |
| HY-123006 | Aszonalenin | 81797-27-5 | Natural Products |
| HY-123007S | 13(S)-HODE-d4 | 139408-39-2 | Isotope-Labeled Compounds |
| HY-123008 | Reproterol (hydrochloride) | 13055-82-8 | Reference compound |
| HY-123008R | Reproterol (hydrochloride) (Standard) | 13055-82-8 | Reference Standards |
| HY-123009 | KCN1 | 927823-01-6 | Reference compound |
| HY-12300A | Ocifisertib (hydrochloride) | 1338799-83-9 | Reference compound |
| HY-12300B | Ocifisertib (fumarate) | 1616420-30-4 | Reference compound |
| HY-12301 | MK-3697 | 1224846-01-8 | Reference compound |
| HY-123011 | Henagliflozin | 1623804-44-3 | Reference compound |
| HY-123012 | Lubabegron | 391920-32-4 | Reference compound |
| HY-123012A | Lubabegron (fumarate) | 391926-19-5 | Reference compound |
| HY-123013 | Y 9000 | 53944-40-4 | Reference compound |
| HY-123014 | (Rac)-SC-45694 | 120772-66-9 | Reference compound |
| HY-123015 | Tamolarizine | 93035-32-6 | Reference compound |
| HY-123016 | 9(S)-HODE cholesteryl ester | 143442-54-0 | Reference compound |
| HY-123016A | (±)9-HODE cholesteryl ester | 33783-76-5 | Reference compound |
| HY-123019 | RA-263 | 82205-95-6 | Reference compound |
| HY-12302 | Kenpaullone | 142273-20-9 | Reference compound |
| HY-123020 | CYD-2-88 | 1821496-27-8 | Reference compound |
| HY-123022 | Tomopenem | 222400-20-6 | Reference compound |
| HY-123023 | 12(S)-HETE-d8 | 84807-90-9 | Isotope-Labeled Compounds |
| HY-123024 | Cefatrizine | 51627-14-6 | Reference compound |
| HY-123025 | Schizozygine | 2047-63-4 | Natural Products |
| HY-123026 | Salannin | 992-20-1 | Natural Products |
| HY-123028 | RFamide | 34388-59-5 | Reference compound |
| HY-123029 | 5,6,7,8-Tetrahydro-2-quinolone | 54802-19-6 | Reference compound |
| HY-12303 | OAC1 | 300586-90-7 | Reference compound |
| HY-123032 | Sorivudine | 77181-69-2 | Reference compound |
| HY-123033 | Nicotinamide riboside | 1341-23-7 | Natural Products |
| HY-123033A | Nicotinamide riboside (chloride) | 23111-00-4 | Natural Products |
| HY-123033AR | Nicotinamide riboside (chloride) (Standard) | 23111-00-4 | Reference Standards |
| HY-123033B | Nicotinamide riboside (tartrate) | 2415657-86-0 | Reference compound |
| HY-123033C | Nicotinamide riboside (malate) | 2415659-01-5 | Reference compound |
| HY-123033D | Nicotinamide riboside (triflate) | 445489-49-6 | Reference compound |
| HY-123034 | CDKI-83 | 1189558-88-0 | Reference compound |
| HY-123035 | Gamendazole | 877773-32-5 | Reference compound |
| HY-123036 | Renierone | 73777-65-8 | Reference compound |
| HY-123037 | Triadimefon | 43121-43-3 | Reference compound |
| HY-123037R | Triadimefon (Standard) | 43121-43-3 | Reference Standards |
| HY-123038 | CVT-5440 | 531506-64-6 | Reference compound |
| HY-123039 | CP-532623 | 261947-38-0 | Reference compound |
| HY-12304 | IOX1 | 5852-78-8 | Reference compound |
| HY-123040 | ACAT Inhibitor 1 | 142642-31-7 | Reference compound |
| HY-123043 | Afeletecan | 215604-75-4 | Reference compound |
| HY-123044 | Tedatioxetine | 508233-95-2 | Reference compound |
| HY-123045 | PNU-292137 | 326823-27-2 | Reference compound |
| HY-123046 | AS1708727 | 1253226-93-5 | Reference compound |
| HY-123047 | Tibolone | 5630-53-5 | Natural Products |
| HY-123047R | Tibolone (Standard) | 5630-53-5 | Reference Standards |
| HY-123047S | Tibolone-d5 | Isotope-Labeled Compounds | |
| HY-12305 | Q-VD-OPh | 1135695-98-5 | Reference compound |
| HY-123050 | (Rac)-SAR131675 | 1092539-44-0 | Reference compound |
| HY-123051 | Ac-WLA-AMC | 1104011-59-7 | Dye Reagents |
| HY-123052 | Ac-PAL-AMC | 1431362-79-6 | Reference compound |
| HY-123053 | Z-Leu-Leu-Glu-AMC | 348086-66-8 | Peptides |
| HY-123054 | BTSA1 | 314761-14-3 | Reference compound |
| HY-123055 | Adenosine dialdehyde | 34240-05-6 | Reference compound |
| HY-123056 | EAD1 | 1644388-26-0 | Reference compound |
| HY-123056A | EAD1 (TFA) | 2320427-95-8 | Reference compound |
| HY-123058 | Vps34-IN-4 | 1383716-46-8 | Reference compound |
| HY-123059 | (Rac)-ICI-118551 (hydrochloride) | 1217094-53-5 | Reference compound |
| HY-12305A | (R)-Q-VD-OPh | Reference compound | |
| HY-12306 | 8-Bromo-cAMP sodium salt | 76939-46-3 | Reference compound |
| HY-123063 | Petromyzonol | 28979-29-5 | Natural Products |
| HY-123065 | Chromotropic acid (disodium dihydrate) | 5808-22-0 | Biochemical Assay Reagents |
| HY-123067 | NBD-Fructose | 940961-04-6 | Dye Reagents |
| HY-123068 | Captopril disulfide | 64806-05-9 | Reference compound |
| HY-123068R | Captopril disulfide (Standard) | 64806-05-9 | Reference Standards |
| HY-12306A | 8-Bromo-cAMP | 23583-48-4 | Reference compound |
| HY-12307 | (-)-Indolactam V | 90365-57-4 | Reference compound |
| HY-123070 | ONO-RS-082 | 99754-06-0 | Reference compound |
| HY-123071 | Box5 | 1206604-29-6 | Peptides |
| HY-123071A | Box5 (TFA) | Peptides | |
| HY-123075 | Odoroside H | 18810-25-8 | Natural Products |
| HY-123076 | Pifithrin-α, p-Nitro, Cyclic | 60477-38-5 | Reference compound |
| HY-123077 | Norsanguinarine | 522-30-5 | Natural Products |
| HY-12308 | TCS 2314 | 317353-73-4 | Reference compound |
| HY-123080 | Tanshinol B | 189290-30-0 | Natural Products |
| HY-123081 | Eburicol | 6890-88-6 | Natural Products |
| HY-123083 | Javanicin C | 126149-71-1 | Natural Products |
| HY-123085 | Alloxazine | 490-59-5 | Reference compound |
| HY-123087 | N-(3-Hydroxytetradecanoyl)-DL-homoserine lactone | 172670-99-4 | Reference compound |
| HY-12309 | EC23 | 104561-41-3 | Reference compound |
| HY-123090 | 11β-HSD1-IN-12 | 872506-67-7 | Reference compound |
| HY-123091 | Ivangustin | 14164-59-1 | Natural Products |
| HY-123095 | TS 155-2 | 1314486-37-7 | Natural Products |
| HY-123096 | Silthiofam | 175217-20-6 | Reference compound |
| HY-123096R | Silthiofam (Standard) | 175217-20-6 | Reference Standards |
| HY-123098 | Tetrahydromethotrexate | 4299-28-9 | Reference compound |
| HY-123099 | MS-1020 | 1255516-86-9 | Reference compound |
| HY-12310 | RSC133 | 1418131-46-0 | Reference compound |
| HY-123100 | Ganoderic acid N | 110241-19-5 | Natural Products |
| HY-123100R | Ganoderic acid N (Standard) | 110241-19-5 | Reference Standards |
| HY-123103 | Linetastine | 159776-68-8 | Reference compound |
| HY-123106 | MCL-0129 | 768357-45-5 | Reference compound |
| HY-123109 | (S,R,S)-AHPC-Boc | 1448189-98-7 | Reference compound |
| HY-123109A | (S,S,S)-AHPC-Boc | 1797406-74-6 | Reference compound |
| HY-123112 | Hoe 892 | 75111-35-2 | Reference compound |
| HY-123114 | Linamarin | 554-35-8 | Natural Products |
| HY-123115 | Leucrose | 7158-70-5 | Reference compound |
| HY-123117 | VA5 | 2088001-24-3 | Reference compound |
| HY-12312 | TCS 401 | 243966-09-8 | Reference compound |
| HY-123120 | SA-152 | 142450-99-5 | Reference compound |
| HY-123121 | Nargenicin A1 | 70695-02-2 | Reference compound |
| HY-123123 | RS-61756-007 | 121571-14-0 | Reference compound |
| HY-123126 | Cevine | 124-98-1 | Reference compound |
| HY-123127 | CVT-2759 analog | 342419-10-7 | Reference compound |
| HY-123128 | Raphanatin | 38165-56-9 | Reference compound |
| HY-12312A | TCS 401 (free base) | 243967-42-2 | Reference compound |
| HY-123130 | ABT-770 | 220614-50-6 | Reference compound |
| HY-123133 | PKSI-527 | 128837-71-8 | Reference compound |
| HY-123134 | FIIN-4 | 2093088-81-2 | Reference compound |
| HY-123135 | Scirpusin B | 69297-49-0 | Natural Products |
| HY-123137 | Ro 24-6778 | 130838-10-7 | Reference compound |
| HY-123138 | LY206130 (free base) | 127414-58-8 | Reference compound |
| HY-123139 | Flutroline | 70801-02-4 | Reference compound |
| HY-123141 | K00135 | 869650-21-5 | Reference compound |
| HY-123142 | RX809055AX | 122566-12-5 | Reference compound |
| HY-123143 | XR11576 | 346689-77-8 | Reference compound |
| HY-123144 | N-Hydroxymethylsorafenib | 1380310-94-0 | Reference compound |
| HY-123145 | JNJ-10258859 | 374927-03-4 | Reference compound |
| HY-123148 | IMB-808 | 870768-70-0 | Reference compound |
| HY-12315 | N-Oxalylglycine | 5262-39-5 | Reference compound |
| HY-123154 | PDE10A-IN-4 | 898563-49-0 | Reference compound |
| HY-123155 | Pyrimorph | 868390-90-3 | Reference compound |
| HY-123156 | SC-23110 | 60149-28-2 | Reference compound |
| HY-123157 | Methoserpidine | 865-04-3 | Reference compound |
| HY-123158 | Diflufenzopyr | 109293-97-2 | Reference compound |
| HY-123158R | Diflufenzopyr (Standard) | 109293-97-2 | Reference Standards |
| HY-123159 | AKI603 | 1432515-73-5 | Reference compound |
| HY-12316 | 20(S)-Hydroxycholesterol | 516-72-3 | Natural Products |
| HY-123161 | JBIR-15 | 1198588-57-6 | Natural Products |
| HY-123162A | Astromicin (disulfate) | 72275-67-3 | Reference compound |
| HY-123163 | JNJ-1250132 | 240805-96-3 | Reference compound |
| HY-123168 | ZIMET 124/73 | 61930-46-9 | Reference compound |
| HY-12316R | 20(S)-Hydroxycholesterol (Standard) | 516-72-3 | Reference Standards |
| HY-12317 | GSA-10 | 300833-95-8 | Reference compound |
| HY-123170 | PD 099560 | 155758-74-0 | Reference compound |
| HY-123171 | ASP8497 | 651055-26-4 | Reference compound |
| HY-123172 | CEP-2563 | 183488-70-2 | Reference compound |
| HY-123174 | Demethoxyrapamycin | 83482-58-0 | Reference compound |
| HY-123175 | Chinfloxacin | 868208-92-8 | Reference compound |
| HY-123176 | GYKI-13380 | 75614-09-4 | Reference compound |
| HY-123177 | Ratjadone | 163564-92-9 | Reference compound |
| HY-123178 | Fenpropathrin | 39515-41-8 | Reference compound |
| HY-123178R | Fenpropathrin (Standard) | 39515-41-8 | Reference Standards |
| HY-123178S | Fenpropathrin-d5 | Isotope-Labeled Compounds | |
| HY-123179 | Mefruside | 7195-27-9 | Reference compound |
| HY-123179S | Mefruside-d3 | 2468638-25-5 | Isotope-Labeled Compounds |
| HY-12318 | IBMX | 28822-58-4 | Reference compound |
| HY-123180 | Ro 31-2201 | 88851-65-4 | Reference compound |
| HY-123182 | PD-140548 | 140677-01-6 | Reference compound |
| HY-123184 | S 1924 | 111371-30-3 | Reference compound |
| HY-123187 | AS2553627 | 1251906-10-1 | Reference compound |
| HY-123189 | LY 171859 | 89139-28-6 | Reference compound |
| HY-12318G | IBMX (GMP) | 28822-58-4 | GMP Small Molecules |
| HY-12318R | IBMX (Standard) | 28822-58-4 | Reference Standards |
| HY-12319 | Cardiogenol C | 671225-39-1 | Reference compound |
| HY-123190 | Safracin A | 87578-98-1 | Natural Products |
| HY-123191 | CJ-463 | 600142-19-6 | Reference compound |
| HY-123192 | Uredofos | 52406-01-6 | Reference compound |
| HY-123193S | Avizafone-d5 (dihydrobromide) | Isotope-Labeled Compounds | |
| HY-123194 | SIRT2/6-IN-1 | 1214468-35-5 | Reference compound |
| HY-123195 | CK-119 | 197917-10-5 | Reference compound |
| HY-123196 | CVT-2759 | 342419-09-4 | Reference compound |
| HY-123197 | FR-193879 | 194928-82-0 | Reference compound |
| HY-123198 | 4-Hydroxybufuralol | 61470-08-4 | Reference compound |
| HY-123199 | Serotonin azidobenzamidine | 98409-42-8 | Reference compound |
| HY-12319A | Cardiogenol C (hydrochloride) | 1049741-55-0 | Reference compound |
| HY-123201 | KRN383 analog | 919767-02-5 | Reference compound |
| HY-123202 | MRS2603 | 860623-35-4 | Reference compound |
| HY-123203 | CP-608039 | 331727-55-0 | Reference compound |
| HY-123204 | FR182024 | 179034-83-4 | Reference compound |
| HY-123205 | Oxatomide | 60607-34-3 | Reference compound |
| HY-123205R | Oxatomide (Standard) | 60607-34-3 | Reference Standards |
| HY-123206 | R-96544 (free base) | 167144-79-8 | Reference compound |
| HY-123208 | Sulfonterol | 42461-79-0 | Reference compound |
| HY-123210 | Lodenafil | 139755-85-4 | Reference compound |
| HY-123210R | Lodenafil (Standard) | 139755-85-4 | Reference Standards |
| HY-123211 | WAY-150138 | 273388-09-3 | Reference compound |
| HY-123214 | Rifametane | 94168-98-6 | Reference compound |
| HY-123215 | CC-17369 | 1547162-46-8 | Reference compound |
| HY-123216 | Cefmatilen | 140128-74-1 | Reference compound |
| HY-123219 | Salifluor | 78417-90-0 | Reference compound |
| HY-123220 | S 1592 | 25552-58-3 | Reference compound |
| HY-123222 | CGP 56999 | 153994-97-9 | Reference compound |
| HY-123225 | LCRF-0004 | 1229611-73-7 | Reference compound |
| HY-123226 | TA-606 | 190602-72-3 | Reference compound |
| HY-123227 | SQ 27786 | 89813-31-0 | Reference compound |
| HY-123228 | CHF5022 | 749269-77-0 | Reference compound |
| HY-123229 | Ropizine | 3601-19-2 | Reference compound |
| HY-12323 | ISX-9 | 832115-62-5 | Reference compound |
| HY-123230 | Trifloxystrobin | 141517-21-7 | Reference compound |
| HY-123230R | Trifloxystrobin (Standard) | 141517-21-7 | Reference Standards |
| HY-123230S | Trifloxystrobin-d6 | 2470226-50-5 | Isotope-Labeled Compounds |
| HY-123230S1 | Trifloxystrobin-d3 | Isotope-Labeled Compounds | |
| HY-123232 | KU-0058684 | 623578-11-0 | Reference compound |
| HY-123234 | Kolanone | 81827-55-6 | Natural Products |
| HY-123237 | KRC-108 | 1146944-35-5 | Reference compound |
| HY-123239 | KLS-13019 | 1801243-39-9 | Reference compound |
| HY-12323G | ISX-9 (GMP) | 832115-62-5 | GMP Small Molecules |
| HY-12324 | SB269652 | 215802-15-6 | Reference compound |
| HY-123240 | CI-966 | 110283-79-9 | Reference compound |
| HY-123241 | ZINC08792229 | 904514-73-4 | Reference compound |
| HY-123242 | FTI-2153 | 344900-92-1 | Reference compound |
| HY-123242A | FTI-2153 (TFA) | 2820151-01-5 | Reference compound |
| HY-123244 | YC137 | 810659-53-1 | Reference compound |
| HY-123247 | LY113174 | 112959-07-6 | Reference compound |
| HY-123249 | HZ166 | 612527-56-7 | Reference compound |
| HY-12325 | GSK2194069 | 1332331-08-4 | Reference compound |
| HY-123251 | DB-766 | 423165-22-4 | Reference compound |
| HY-123252 | Kurchessine | 6869-45-0 | Natural Products |
| HY-123253 | cis-LY393053 | 394735-81-0 | Reference compound |
| HY-123254 | CCG-224406 | 1870843-22-3 | Reference compound |
| HY-123259 | CB3731 | 80015-07-2 | Reference compound |
| HY-12326 | c-di-AMP | 54447-84-6 | Reference compound |
| HY-123260 | S12340 | 144754-35-8 | Reference compound |
| HY-123264 | RL648_81 | 1919050-87-5 | Reference compound |
| HY-123265 | Luteoreticulin | 22388-89-2 | Reference compound |
| HY-123266 | D011-2120 | 620931-39-7 | Reference compound |
| HY-123268 | Ro 363 | 74513-77-2 | Reference compound |
| HY-123268A | Ro 363 (hydrochloride) | 250580-70-2 | Reference compound |
| HY-123269 | PKUMDL-WQ-2101 | 304481-72-9 | Reference compound |
| HY-12326A | c-di-AMP (disodium) | 2734909-87-4 | Reference compound |
| HY-12326B | c-di-AMP (diammonium) | Reference compound | |
| HY-12327 | Trk-IN-1 | 1402438-37-2 | Reference compound |
| HY-123270 | RP23618 | 207991-30-8 | Reference compound |
| HY-123271 | Ro 23-9424 | 115622-58-7 | Reference compound |
| HY-123272 | E6801 | 528859-04-3 | Reference compound |
| HY-123275 | H-D-Phe-Pip-Arg-pNA | 64815-81-2 | Peptides |
| HY-123275A | H-D-Phe-Pip-Arg-pNA (hydrochloride) | 160192-34-7 | Peptides |
| HY-123275B | H-D-Phe-Pip-Arg-pNA (acetate) | 115388-96-0 | Peptides |
| HY-123275C | H-D-Phe-Pip-Arg-pNA (dihydrochloride) | 62354-65-8 | Peptides |
| HY-123277 | IMB-10 | 307525-40-2 | Reference compound |
| HY-123279 | OM137 | 292170-13-9 | Reference compound |
| HY-123283 | OXi8007 | 288847-41-6 | Reference compound |
| HY-123284 | LY137150 | 86315-69-7 | Reference compound |
| HY-123286 | (E)-Triandrin | 132294-76-9 | Natural Products |
| HY-123287 | Soquinolol | 61563-18-6 | Reference compound |
| HY-123289 | CP-690550A | 1243290-37-0 | Reference compound |
| HY-123290 | KCC009 | 744198-19-4 | Reference compound |
| HY-123291 | SM-276001 | 473930-22-2 | Reference compound |
| HY-123292 | RSU 1164 | 88876-94-2 | Reference compound |
| HY-123293 | UK 34787 | 72818-36-1 | Reference compound |
| HY-123294 | Fentrazamide | 158237-07-1 | Reference compound |
| HY-123294R | Fentrazamide (Standard) | 158237-07-1 | Reference Standards |
| HY-123295 | HDAC3-IN-T247 | 1451042-18-4 | Reference compound |
| HY-123297 | TUG-469 | 1236109-67-3 | Reference compound |
| HY-123298 | Chrysotoxine | 156951-82-5 | Natural Products |
| HY-12330 | AZD8186 | 1627494-13-6 | Reference compound |
| HY-123301 | GABAB receptor antagonist 2 | 200402-50-2 | Reference compound |
| HY-123302 | CID1172084 | 459848-10-3 | Reference compound |
| HY-123304 | MBX2546 | 695160-12-4 | Reference compound |
| HY-123305 | 5-Hydroxymebendazole | 60254-95-7 | Reference compound |
| HY-123305R | 5-Hydroxymebendazole (Standard) | 60254-95-7 | Reference Standards |
| HY-123305S | 5-Hydroxymebendazole-d3 | 1173020-86-4 | Isotope-Labeled Compounds |
| HY-123307 | Quizalofop | 76578-12-6 | Reference compound |
| HY-123308 | VPC13163 | 6637-10-1 | Reference compound |
| HY-12331 | KRCA-0008 | 1472795-20-2 | Reference compound |
| HY-123310 | JNJ-26146900 | 868691-50-3 | Reference compound |
| HY-123311 | CP59430 | 86329-06-8 | Reference compound |
| HY-123312 | CK-548 | 388604-55-5 | Reference compound |
| HY-123314 | Floxacrine | 53966-34-0 | Reference compound |
| HY-123315 | Sulfaperin | 599-88-2 | Reference compound |
| HY-123316 | Iobitridol | 136949-58-1 | Reference compound |
| HY-123319 | Antofloxacin (hydrochloride) | 873888-67-6 | Reference compound |
| HY-123319A | Antofloxacin | 119354-43-7 | Reference compound |
| HY-12332 | JW 642 | 1416133-89-5 | Reference compound |
| HY-123320S | Fluvalinate-d5 | Isotope-Labeled Compounds | |
| HY-123321 | Sakyomicin A | 86413-75-4 | Natural Products |
| HY-123322 | PF-184298 | 813447-40-4 | Reference compound |
| HY-123323 | MK-0434 | 134067-56-4 | Reference compound |
| HY-123324 | Pomalidomide-5-OH | 1547162-41-3 | Reference compound |
| HY-123325 | Kapurimycin A1 | 132412-65-8 | Natural Products |
| HY-123327 | FAUC-113 | 221470-50-4 | Reference compound |
| HY-123328 | AGN 191976 | 159359-94-1 | Reference compound |
| HY-12332R | JW 642 (Standard) | 1416133-89-5 | Reference Standards |
| HY-12333 | Denfivontinib | 1457983-28-6 | Reference compound |
| HY-123330 | GW695634 | 457635-65-3 | Reference compound |
| HY-123331 | S 82-5455 | 90832-34-1 | Reference compound |
| HY-123334 | GNF-1331 | 603101-22-0 | Reference compound |
| HY-123335 | L-796778 | 217480-25-6 | Reference compound |
| HY-123335A | L-796778 (acetate) | 2922280-21-3 | Reference compound |
| HY-123336 | Schisantherin C | 64938-51-8 | Natural Products |
| HY-123337 | Zamifenacin | 127308-82-1 | Reference compound |
| HY-123338 | Dihydroguaiaretic acid | 36469-60-0 | Natural Products |
| HY-123339 | Sannamycin G | 73522-72-2 | Reference compound |
| HY-12334 | HTH-01-015 | 1613724-42-7 | Reference compound |
| HY-123340 | Ozolinone | 56784-39-5 | Reference compound |
| HY-123341 | 9-OxoODE | 54232-59-6 | Reference compound |
| HY-123341S | 9-OxoODE-d3 | 2714198-70-4 | Isotope-Labeled Compounds |
| HY-123345 | CRT 0105446 | 1661846-05-4 | Reference compound |
| HY-123346 | SW155246 | 420092-79-1 | Reference compound |
| HY-123347 | TPU-0037C | 485815-61-0 | Reference compound |
| HY-123348 | Sampatrilat | 129981-36-8 | Reference compound |
| HY-123349 | 5α-Hydroxy-6-keto cholesterol | 13027-33-3 | Reference compound |
| HY-12335 | UNC0379 | 1620401-82-2 | Reference compound |
| HY-123350 | Saroaspidin B | 112663-68-0 | Natural Products |
| HY-123351 | Kievitone | 40105-60-0 | Natural Products |
| HY-123352 | ZK 216348 | 669073-68-1 | Reference compound |
| HY-123352A | (-)-ZK 216348 | Reference compound | |
| HY-123353 | Neladenoson dalanate | 1239309-58-0 | Reference compound |
| HY-123354 | SC 44914 | 115812-74-3 | Reference compound |
| HY-123356 | EMD-503982 | 768370-75-8 | Reference compound |
| HY-123357 | IMM-H004 | 1456807-80-9 | Reference compound |
| HY-123358 | AR-H049020XX | 251454-45-2 | Reference compound |
| HY-123359 | RTC14 | 414909-09-4 | Reference compound |
| HY-12335A | UNC0379 (TFA) | 1620401-83-3 | Reference compound |
| HY-12336 | NIBR189 | 1599432-08-2 | Reference compound |
| HY-123360 | BIBW 22 | 137694-16-7 | Reference compound |
| HY-123361 | LY326325 | 177314-99-7 | Reference compound |
| HY-123363 | Tafluposide | 179067-42-6 | Reference compound |
| HY-123365 | GV2-20 | 346411-65-2 | Reference compound |
| HY-123367 | Rubraxanthone | 65411-01-0 | Reference compound |
| HY-123368 | Zolertine (hydrochloride) | 7241-94-3 | Reference compound |
| HY-123369 | BMI-1026 | 477726-77-5 | Reference compound |
| HY-12337 | GK921 | 1025015-40-0 | Reference compound |
| HY-123370 | FR-167356 | 174185-16-1 | Reference compound |
| HY-123371 | Ro 07-1902 | 68160-71-4 | Reference compound |
| HY-123374 | (Rac)-AMG 628 | 862269-73-6 | Reference compound |
| HY-123375 | Fenethazine | 522-24-7 | Reference compound |
| HY-123376 | FR-190997 | 193344-25-1 | Reference compound |
| HY-123377 | Fotagliptin | 1312954-58-7 | Reference compound |
| HY-123377A | Fotagliptin (benzoate) | 1403496-40-1 | Reference compound |
| HY-123379 | Relomycin | 1404-48-4 | Natural Products |
| HY-12338 | ON 146040 | 1404231-34-0 | Reference compound |
| HY-123380 | Methyl streptonigrin | 3398-48-9 | Reference compound |
| HY-123381 | Gemopatrilat | 160135-92-2 | Reference compound |
| HY-123382 | GSK-1482160 (isomer) | 1695551-19-9 | Reference compound |
| HY-123383 | Renierol | 16795-96-3 | Reference compound |
| HY-123386 | Yakuchinone A | 78954-23-1 | Natural Products |
| HY-123387 | Suksdorfin | 53023-17-9 | Natural Products |
| HY-123388 | SCH 12223 (free base) | 89109-20-6 | Reference compound |
| HY-123389 | MR2034 | 57236-85-8 | Reference compound |
| HY-12339 | NVS-CRF38 | 1207258-55-6 | Reference compound |
| HY-123390 | DB07107 | 552332-71-5 | Reference compound |
| HY-123391 | PD 127443 | 121502-05-4 | Reference compound |
| HY-123392 | Sch 13835 | 150519-34-9 | Reference compound |
| HY-123395 | NSC-84096 | 908813-78-5 | Reference compound |
| HY-123396 | 8-Chloro-cAMP | 41941-56-4 | Reference compound |
| HY-123396A | 8-Chloro-cAMP (sodium) | 124705-03-9 | Reference compound |
| HY-123397 | SCH-44643 | 133330-43-5 | Reference compound |
| HY-123398 | RS-51324 | 69811-30-9 | Reference compound |
| HY-123399 | Ro 19-1400 | 122937-55-7 | Reference compound |
| HY-12340 | ETP-46321 | 1252594-99-2 | Reference compound |
| HY-123400A | iso-Samixogrel | 133276-52-5 | Reference compound |
| HY-123401 | DDRI-18 | 4402-18-0 | Reference compound |
| HY-123402 | GSK3987 | 264206-85-1 | Reference compound |
| HY-123405 | YM-75440 | 780736-74-5 | Reference compound |
| HY-123408 | Umespirone | 107736-98-1 | Reference compound |
| HY-123409 | Nicousamide | 704881-43-6 | Reference compound |
| HY-12341 | ML355 | 1532593-30-8 | Reference compound |
| HY-123410 | KM-233 | 628263-22-9 | Reference compound |
| HY-123411 | MGS0039 | 569686-87-9 | Reference compound |
| HY-123412 | FOL7185 | 5441-46-3 | Reference compound |
| HY-123414 | GX-936 | 1235406-09-3 | Reference compound |
| HY-123415 | PD 134922 | 150351-30-7 | Reference compound |
| HY-123417 | IRC-083864 | 1142057-18-8 | Reference compound |
| HY-123418 | PKUMDL-WQ-2201 | 592474-91-4 | Reference compound |
| HY-123419 | CPI-4203 | 1628214-07-2 | Reference compound |
| HY-12342 | ML216 | 1430213-30-1 | Reference compound |
| HY-123420 | Dinordrin | 64675-08-7 | Reference compound |
| HY-123421 | UK-9040 | 47453-14-5 | Reference compound |
| HY-123422 | GSK360A | 931399-19-8 | Reference compound |
| HY-123424 | Roseofungin | 12687-98-8 | Reference compound |
| HY-123426 | JY-XHe-053 | 612526-36-0 | Reference compound |
| HY-123427 | Transcainide | 88296-62-2 | Reference compound |
| HY-123428 | MSK-195 | 289902-82-5 | Reference compound |
| HY-123429 | CK0683A | 83539-21-3 | Reference compound |
| HY-12343 | ML277 | 1401242-74-7 | Reference compound |
| HY-123432 | AHR-13268D | 130838-11-8 | Reference compound |
| HY-123433 | JNJ-40068782 | 950196-50-6 | Reference compound |
| HY-123434 | PD-149164 | 181941-32-2 | Reference compound |
| HY-123435 | RWJ 22108 | 112769-37-6 | Reference compound |
| HY-123436 | Sarubicin B | 84745-01-7 | Natural Products |
| HY-123437 | WAY-120744 | 127810-07-5 | Reference compound |
| HY-123438 | WAY-151693 | 206551-25-9 | Reference compound |
| HY-123439 | FTY720-C2 | 249289-10-9 | Reference compound |
| HY-12344 | UNC2025 | 1429881-91-3 | Reference compound |
| HY-123440 | S3608 | 57359-17-8 | Reference compound |
| HY-123442 | L 775,606 | 188400-51-3 | Reference compound |
| HY-123444 | Kijimicin | 129297-22-9 | Reference compound |
| HY-123445 | AZD7009 | 864368-79-6 | Reference compound |
| HY-123446 | JNJ-42259152 | 1301167-87-2 | Reference compound |
| HY-123449 | MK-761 (free base) | 65321-41-7 | Reference compound |
| HY-123449A | MK-761 (TFA) | Reference compound | |
| HY-12344A | UNC2025 (hydrochloride) | 2070015-17-5 | Reference compound |
| HY-12345 | ML365 | 947914-18-3 | Reference compound |
| HY-123450 | S116836 | 1257628-57-1 | Reference compound |
| HY-123451 | ACH-702 | 922491-46-1 | Reference compound |
| HY-123452 | SCH 30497 | 83674-78-6 | Reference compound |
| HY-123453 | SM27 | 6266-54-2 | Reference compound |
| HY-123454 | SKF1 | 678997-25-6 | Reference compound |
| HY-123457 | PF-1163A | 258871-59-9 | Reference compound |
| HY-123459 | Garomefrine (hydrochlorid) | 137431-04-0 | Reference compound |
| HY-12346 | FH1 | 2719-05-3 | Reference compound |
| HY-123460 | BN-81674 | 252278-73-2 | Reference compound |
| HY-123461 | Sul-121 (hydrochloride) | 1541170-25-5 | Reference compound |
| HY-123464 | RBC10 | 362503-73-9 | Reference compound |
| HY-123467 | Lasiokaurin | 28957-08-6 | Natural Products |
| HY-123468 | HA-1004 | 91742-10-8 | Reference compound |
| HY-123468A | HA-1004 di(hydrochloride) | 92564-08-4 | Reference compound |
| HY-123469 | RS-0466 | 536993-37-0 | Reference compound |
| HY-12347 | Ro 61-8048 | 199666-03-0 | Reference compound |
| HY-123473 | SB-414796 | 264262-71-7 | Reference compound |
| HY-123474 | PF-1163B | 258871-60-2 | Natural Products |
| HY-123475 | Sisunatovir | 1903763-82-5 | Reference compound |
| HY-123475A | Sisunatovir (hydrochloride) | 1903763-83-6 | Reference compound |
| HY-123478 | Fengabine | 80018-06-0 | Reference compound |
| HY-123479 | CK0492B | 64169-11-5 | Reference compound |
| HY-12348 | LEO 29102 | 1035572-38-3 | Reference compound |
| HY-123480 | EGIS-7625 | 755040-97-2 | Reference compound |
| HY-123481 | JNJ-42253432 | 1428327-35-8 | Reference compound |
| HY-123484 | ROCK-IN-D1 | 1219721-73-9 | Reference compound |
| HY-123485 | PPI-1019 | 290828-45-4 | Reference compound |
| HY-123486 | HS-438 | 1430720-10-7 | Reference compound |
| HY-123487 | Sapintoxin A | 79083-69-5 | Natural Products |
| HY-123489 | 3α,21-Dihydroxy-5α-pregnan-20-one | 567-02-2 | Reference compound |
| HY-123489S | 3α,21-Dihydroxy-5α-pregnan-20-one-d3 | 203805-98-5 | Isotope-Labeled Compounds |
| HY-12349 | H1PVAT | 351438-49-8 | Reference compound |
| HY-123490 | Regrelor (disodium) | 676251-22-2 | Reference compound |
| HY-123492 | Kentsin | 56767-30-7 | Peptides |
| HY-123493 | P552-02 (mesylate) | 587879-54-7 | Reference compound |
| HY-123494 | BRD0418 | 1565827-99-7 | Reference compound |
| HY-123495 | CRANAD-28 | 1623747-97-6 | Dye Reagents |
| HY-123498 | MCI-225 (dehydratase) | 99487-26-0 | Reference compound |
| HY-123499 | SRA880 | 573984-99-3 | Reference compound |
| HY-123501 | MitoE10 | 1810703-64-0 | Reference compound |
| HY-123502 | Ceralasertib (formate) | 1352280-98-8 | Reference compound |
| HY-123503 | Salicortin | 1887055-63-1 | Natural Products |
| HY-123504 | ML344 | 894856-92-9 | Reference compound |
| HY-123505 | Dersalazine (sodium) | 367249-56-7 | Reference compound |
| HY-123506 | Fenlean | 863193-70-8 | Reference compound |
| HY-123510 | NSC-670224 | 1374648-47-1 | Reference compound |
| HY-123512 | OUL35 | 6336-34-1 | Reference compound |
| HY-123515 | Clorobiocin | 39868-96-7 | Reference compound |
| HY-123517 | DC07090 (dihydrochloride) | 1158264-37-9 | Reference compound |
| HY-123517A | DC07090 | 879070-72-1 | Reference compound |
| HY-123519 | 14α-Hydroxy Paspalinine | 151341-77-4 | Natural Products |
| HY-12352 | HJC0416 | 1617518-22-5 | Reference compound |
| HY-123520 | GSK299115A | 864082-35-9 | Reference compound |
| HY-123522 | PAT-048 | 1359983-15-5 | Reference compound |
| HY-123523 | Enocitabine | 55726-47-1 | Reference compound |
| HY-123524 | STAT3-IN-4 | 825611-06-1 | Reference compound |
| HY-123525 | COR628 | 550310-04-8 | Reference compound |
| HY-123526 | NSC265473 | 61786-74-1 | Reference compound |
| HY-123528 | Kahweol oleate | 108214-30-8 | Reference compound |
| HY-123529 | LY389795 | 222529-89-7 | Reference compound |
| HY-12352A | HJC0416 (hydrochloride) | 2415263-08-8 | Reference compound |
| HY-123531 | JNJ 10329670 | 400797-24-2 | Reference compound |
| HY-123532 | JNJ10191584 | 73903-17-0 | Reference compound |
| HY-123533 | Resorufin | 635-78-9 | Dye Reagents |
| HY-123533A | Resorufin sodium salt | 34994-50-8 | Dye Reagents |
| HY-123533S | Resorufin-d6 | 1196157-65-9 | Isotope-Labeled Compounds |
| HY-123534 | CYT-1010 | 213769-33-6 | Reference compound |
| HY-123534A | CYT-1010 (hydrochloride) | 1161517-81-2 | Reference compound |
| HY-123535 | P18IN003 | 71727-40-7 | Reference compound |
| HY-123538 | GRK2 Inhibitor 1 | 24269-96-3 | Reference compound |
| HY-12353A | Pimodivir | 1629869-44-8 | Reference compound |
| HY-12353B | Pimodivir (hydrochlorid hemihydrate) | 1777721-70-6 | Reference compound |
| HY-12354 | SB-3CT | 292605-14-2 | Reference compound |
| HY-123541 | Tec-IN-6 | 923762-87-2 | Reference compound |
| HY-123542 | ONO-3403 | 181586-07-2 | Reference compound |
| HY-123544 | RDR03871 | 286008-51-3 | Reference compound |
| HY-123547 | TLK19781 | 309932-60-3 | Reference compound |
| HY-123548 | ML148 | 451496-96-1 | Reference compound |
| HY-123549 | PSB-6426 | 958459-33-1 | Reference compound |
| HY-12355 | Siponimod | 1230487-00-9 | Reference compound |
| HY-123550 | Rosenonolactone | 508-71-4 | Natural Products |
| HY-123552 | RK-1441A | 132035-29-1 | Natural Products |
| HY-123554 | Flavagline FL3 | 1186012-80-5 | Reference compound |
| HY-123555 | PD 142505-0028 | 161774-09-0 | Reference compound |
| HY-123556 | SZV-558 | 1648929-13-8 | Reference compound |
| HY-123557 | Dasolampanel etibutil | 503291-52-9 | Reference compound |
| HY-123558 | Bactobolin C | 74141-69-8 | Natural Products |
| HY-12355A | Siponimod (hemifumarate) | 1234627-85-0 | Reference compound |
| HY-12355R | Siponimod (Standard) | 1230487-00-9 | Reference Standards |
| HY-12355S | Siponimod-d11 | 2104759-32-0 | Isotope-Labeled Compounds |
| HY-123560 | BKM-570 | 259885-54-6 | Reference compound |
| HY-123561 | MMV008138 | 1679333-73-3 | Reference compound |
| HY-123562 | GNF7686 | 442567-43-3 | Reference compound |
| HY-123563 | Metazosin | 95549-92-1 | Reference compound |
| HY-123564 | Mcl1-IN-7 | 2012563-34-5 | Reference compound |
| HY-123567 | LY86057 | 148966-66-9 | Reference compound |
| HY-123568 | PBI-1393 | 175072-12-5 | Reference compound |
| HY-123569 | ISQ-1 (hydrochloride) | 405165-77-7 | Reference compound |
| HY-12357 | Bempedoic acid | 738606-46-7 | Reference compound |
| HY-123571 | CP-199330 | 158102-92-2 | Reference compound |
| HY-123572 | Bis-T-23 | 171674-76-3 | Reference compound |
| HY-123575 | LY 245769 | 127345-02-2 | Reference compound |
| HY-123578 | NSC689857 | 241127-79-7 | Reference compound |
| HY-12357S | Bempedoic acid-d5 | 2408131-71-3 | Isotope-Labeled Compounds |
| HY-12357S2 | Bempedoic acid-d4 | 2408131-70-2 | Isotope-Labeled Compounds |
| HY-12358 | Tpl2 Kinase Inhibitor 1 | 871307-18-5 | Reference compound |
| HY-123580 | RU26988 | 74915-58-5 | Reference compound |
| HY-123581 | Quinocetone | 81810-66-4 | Reference compound |
| HY-123581R | Quinocetone (Standard) | 81810-66-4 | Reference Standards |
| HY-123582 | CP-866,087 | 519052-02-9 | Reference compound |
| HY-123583 | MitoBADY | 1644119-76-5 | Dye Reagents |
| HY-123587 | PR-924 | 1416709-79-9 | Reference compound |
| HY-123587A | (R)-PR-924 | Reference compound | |
| HY-123589 | Gyramide A | 913509-94-1 | Natural Products |
| HY-12359 | TPPB | 497259-23-1 | Reference compound |
| HY-123590 | BC12-4 | 94212-33-6 | Reference compound |
| HY-123593 | Mozavaptan (hydrochloride) | 138470-70-9 | Reference compound |
| HY-123594 | R-2 Methanandamide | 157182-47-3 | Reference compound |
| HY-123596 | LAS191859 | 1420071-13-1 | Reference compound |
| HY-123597 | NSC 109555 | 15427-93-7 | Reference compound |
| HY-123598 | Corynecin III | 18048-95-8 | Natural Products |
| HY-123600 | SRI-29329 | 2086809-58-5 | Reference compound |
| HY-123601 | DHQZ 36 | 1542098-94-1 | Reference compound |
| HY-123602 | CGP 55802A | 152564-63-1 | Reference compound |
| HY-123604 | TH1834 | 2108830-08-4 | Reference compound |
| HY-123604A | TH1834 (dihydrochloride) | 2108830-09-5 | Reference compound |
| HY-123605 | CAY10406 | 2108603-03-6 | Reference compound |
| HY-123607 | UniPR129 | 1639159-47-9 | Reference compound |
| HY-123608 | JE-2178 | 210181-19-4 | Reference compound |
| HY-123609 | Pyrene-amido-PEG4-azide | 1817735-36-6 | Reference compound |
| HY-12361 | PF 1022A | 133413-70-4 | Natural Products |
| HY-123610 | BRD-7880 | 1456542-69-0 | Reference compound |
| HY-123611 | Supinoxin | 888478-45-3 | Reference compound |
| HY-123614 | PD 140248 (hydrochloride) | 147208-55-7 | Reference compound |
| HY-123615 | SPD-2 | 1643781-40-1 | Reference compound |
| HY-123617 | AZ8838 | 2100285-41-2 | Reference compound |
| HY-12361R | PF 1022A (Standard) | 133413-70-4 | Reference Standards |
| HY-12362 | Val-cit-PAB-OH | 159857-79-1 | ADC Related |
| HY-123621 | GNE-375 | 1926989-06-1 | Reference compound |
| HY-123622 | CYMAL-5, 98% (TLC) | 250692-65-0 | Biochemical Assay Reagents |
| HY-123625 | R-348 (choline) | 1620142-65-5 | Reference compound |
| HY-123626 | BiBET | 2059110-46-0 | Reference compound |
| HY-123628 | 3,4,6-Tri-O-benzyl-β-D-mannopyranose 1,2-(methyl orthoacetate) | 16697-49-7 | Reference compound |
| HY-123629 | TAMRA-PEG3-Azide | 1228100-59-1 | Dye Reagents |
| HY-12362G | Val-cit-PAB-OH (GMP) | 159857-79-1 | GMP Small Molecules |
| HY-12363 | U-69593 | 96744-75-1 | Reference compound |
| HY-123630 | Allura Red AC | 25956-17-6 | Dye Reagents |
| HY-123630R | Allura Red AC (Standard) | 25956-17-6 | Dye Reagents |
| HY-123631 | Phenylbutazone trimethylgallate | 16006-74-9 | Reference compound |
| HY-123632 | (3S,5S)-Atorvastatin (sodium salt) | 1428118-38-0 | Reference compound |
| HY-123633 | 4-Methylumbelliferyl β-D-Glucopyranoside | 18997-57-4 | Reference compound |
| HY-123634 | (S)-3'-Aminoblebbistatin | 2097141-18-7 | Reference compound |
| HY-123635 | Nybomycin | 30408-30-1 | Natural Products |
| HY-123636 | UPCDC-30245 | 1883351-01-6 | Reference compound |
| HY-123637 | Autotaxin-IN-1 | 1619971-30-0 | Reference compound |
| HY-123638 | 6-Hydroxykaempferol 3,6,7-tri-O-β-D-glucoside | 145134-62-9 | Natural Products |
| HY-123639 | LM-4108 | 261766-32-9 | Reference compound |
| HY-12364 | C75 | 218137-86-1 | Reference compound |
| HY-123642 | BLXA-4-ME | 362516-29-8 | Reference compound |
| HY-123643 | Brilliant sulfaflavine | 2391-30-2 | Dye Reagents |
| HY-123645 | Rhodamine B hydrazide | 74317-53-6 | Dye Reagents |
| HY-123646 | RS 2135 | 133775-36-7 | Reference compound |
| HY-123647 | Satratoxin H | 53126-64-0 | Natural Products |
| HY-123648 | Rhizoferrin | 138846-62-5 | Natural Products |
| HY-123649 | MK-4882 | 1246470-32-5 | Reference compound |
| HY-12364A | trans-C75 | 191282-48-1 | Reference compound |
| HY-12364B | (−)-C75 | 1234694-22-4 | Reference compound |
| HY-12364C | (+)-trans-C75 | 1234694-20-2 | Reference compound |
| HY-12365 | Namodenoson | 163042-96-4 | Reference compound |
| HY-123650 | FSBA (hydrochloride) | 78859-42-4 | Reference compound |
| HY-123652 | Etofamide | 25287-60-9 | Reference compound |
| HY-123653 | SirReal-1 | 801227-82-7 | Reference compound |
| HY-123654 | L-796449 | 194608-80-5 | Reference compound |
| HY-123655 | Fenazinel (dihydrochloride) | 685138-02-7 | Reference compound |
| HY-123656 | Antiproliferative agent-61 | 1613078-24-2 | Reference compound |
| HY-123657 | RXP 407 | 237770-41-1 | Reference compound |
| HY-12365R | Namodenoson (Standard) | 163042-96-4 | Reference Standards |
| HY-12365S2 | Namodenoson-d5 | Isotope-Labeled Compounds | |
| HY-12366 | Ubrogepant | 1374248-77-7 | Reference compound |
| HY-123661 | MIPS1455 | 1627580-82-8 | Reference compound |
| HY-123662 | AGN-201904Z | 651728-41-5 | Reference compound |
| HY-123663 | U-101958 (maleate) | 224170-09-6 | Reference compound |
| HY-123664 | Trioxifene (mesylate) | 68307-81-3 | Reference compound |
| HY-123665 | PSB-1410 | 1494477-03-0 | Reference compound |
| HY-123667 | NCFP | 774548-65-1 | Reference compound |
| HY-123668 | KM05382 | 882291-64-7 | Reference compound |
| HY-123669 | R-138727 | 204204-73-9 | Reference compound |
| HY-123669A | trans-R-138727 | 239466-74-1 | Reference compound |
| HY-123669AS | (R)-trans-138727-d4 | 1217222-86-0 | Isotope-Labeled Compounds |
| HY-12366R | Ubrogepant (Standard) | 1374248-77-7 | Reference Standards |
| HY-12366S | Ubrogepant-d5 | Isotope-Labeled Compounds | |
| HY-123671 | CYM2503 | 1308833-36-4 | Reference compound |
| HY-123672 | Lovastatin hydroxy acid (sodium) | 75225-50-2 | Reference compound |
| HY-123672R | Lovastatin hydroxy acid (sodium) (Standard) | 75225-50-2 | Reference Standards |
| HY-123672S | Lovastatin-d3 hydroxy acid (sodium) | 1217528-38-5 | Isotope-Labeled Compounds |
| HY-123673 | MCP110 | 521310-51-0 | Reference compound |
| HY-123675 | CFI-400936 | 1338793-07-9 | Reference compound |
| HY-123676 | Sonepiprazole (mesylate) | 170858-34-1 | Reference compound |
| HY-123677 | E2508 | 685886-34-4 | Reference compound |
| HY-123679 | FR168888 | 168620-46-0 | Reference compound |
| HY-123681 | R 57720 | 98164-11-5 | Reference compound |
| HY-123686 | Ivermectin B1a monosaccharide | 71837-27-9 | Natural Products |
| HY-123687 | DBCO-Sulfo-NHS ester (sodium) | 1400191-52-7 | Dye Reagents |
| HY-123689 | Samidorphan | 852626-89-2 | Reference compound |
| HY-123689A | Samidorphan (hydrochloride) | 2328045-02-7 | Reference compound |
| HY-123689S | Samidorphan-d4 | Isotope-Labeled Compounds | |
| HY-123689S1 | Samidorphan-d5 | Isotope-Labeled Compounds | |
| HY-12369 | GGTI-2133 | 191102-79-1 | Reference compound |
| HY-123690 | Etoposide toniribate | 433304-61-1 | Reference compound |
| HY-123691 | 7-O-Demethyl rapamycin | 151519-50-5 | Reference compound |
| HY-123692 | RHI002-Me | 314261-66-0 | Reference compound |
| HY-123693 | ML358 | 1158607-44-3 | Reference compound |
| HY-123695 | 5-HT4 antagonist 3 | 148702-58-3 | Reference compound |
| HY-123696 | CDy9 | 1800205-57-5 | Dye Reagents |
| HY-123697 | VE-465 | 639089-73-9 | Reference compound |
| HY-123698 | Mebolazine | 3625-07-8 | Reference compound |
| HY-12369A | GGTI-2133 (TFA) | 1217480-14-2 | Reference compound |
| HY-12370 | TY-51469 | 603987-59-3 | Reference compound |
| HY-123700 | Kaikasaponin III | 115330-90-0 | Natural Products |
| HY-123702 | CAP-53194 | 660817-08-3 | Reference compound |
| HY-123704 | CGS-12066 (maleate) | 1350965-83-1 | Reference compound |
| HY-123706 | Salinosporamide C | 863126-96-9 | Natural Products |
| HY-123707 | KPU-300 | 1620692-60-5 | Reference compound |
| HY-123708 | SNAP 398299 | 903878-06-8 | Reference compound |
| HY-12371 | VU0431316 | 1620203-63-5 | Reference compound |
| HY-123710 | GYKI-16084 | 185739-21-3 | Reference compound |
| HY-123711 | PC170942 | 867207-49-6 | Reference compound |
| HY-123712 | 2α,17α-Diethynyl-A-nor-5α-androstane-2β,17β-diol diacetate | 70226-89-0 | Reference compound |
| HY-123714 | TL4-12 | 1620820-12-3 | Reference compound |
| HY-123715 | Anticancer agent 255 | 1983924-20-4 | Reference compound |
| HY-123716 | Rubradirin B | 68833-11-4 | Natural Products |
| HY-123718 | 6-Benzylthioinosine | 6165-03-3 | Reference compound |
| HY-12372 | Sanggenon G | 85698-31-3 | Natural Products |
| HY-123720 | Sch 31828 | 115216-83-6 | Natural Products |
| HY-123721 | Tiracizine (hydrochloride) | 78816-67-8 | Reference compound |
| HY-123723 | Hydroxystreptomycin | 6835-00-3 | Natural Products |
| HY-123724 | Ravidomycin | 74622-75-6 | Natural Products |
| HY-123727 | Acid blue 120 | 3529-01-9 | Dye Reagents |
| HY-123728 | FR-A-19 | 141099-46-9 | Reference compound |
| HY-123733 | MIP-1095 | 949575-22-8 | Reference compound |
| HY-123733A | MIP-1095 (TFA) | Reference compound | |
| HY-123734 | S-75 | 37764-44-6 | Reference compound |
| HY-123736 | Ro 32-7315 | 219613-02-2 | Reference compound |
| HY-123737 | MK-8133 | 1431472-56-8 | Reference compound |
| HY-12374 | KBP-5493 | 1314944-07-4 | Reference compound |
| HY-123740 | Disuccinimidyl sulfoxide | 1351828-03-9 | Reference compound |
| HY-123742 | Estradiol 3-sulfate 17-glucuronide (potassium) | 10392-35-5 | Reference compound |
| HY-123743 | JNJ-42314415 | 1334165-90-0 | Reference compound |
| HY-123744 | PD-156707 | 162412-70-6 | Reference compound |
| HY-123747 | SC-53116 | 141196-99-8 | Reference compound |
| HY-123747A | SC-53116 (hydrochloride) | 879208-42-1 | Reference compound |
| HY-123749 | Tetramethylrhodamine-5-iodoacetamide | 114458-99-0 | Dye Reagents |
| HY-12375 | BMS-903452 | 1339944-47-6 | Reference compound |
| HY-123750 | Zimet 38/74 | 61930-49-2 | Reference compound |
| HY-123751 | Antifolate C1 | 136784-51-5 | Reference compound |
| HY-123752 | MS-0022 | 691392-89-9 | Reference compound |
| HY-123753 | MDL 27399 | 131374-22-6 | Reference compound |
| HY-123754 | AGN-201904 | 651729-53-2 | Reference compound |
| HY-123756 | NBD-10007 | 1375736-65-4 | Reference compound |
| HY-123757 | (Rac)-GR218231 | 175442-95-2 | Reference compound |
| HY-123758 | XDM-CBP | 2138461-99-9 | Reference compound |
| HY-123759 | sEH-IN-12 | 1883803-09-5 | Reference compound |
| HY-12376 | BAY 41-2272 | 256376-24-6 | Reference compound |
| HY-123763 | MLN3126 | 628300-71-0 | Reference compound |
| HY-123766 | EGFR-IN-99 | 2068806-31-3 | Reference compound |
| HY-123767 | HEC72702 | 1793063-59-8 | Reference compound |
| HY-12377 | GSK0660 | 1014691-61-2 | Reference compound |
| HY-123772 | CDK5 inhibitor 20-223 | 865317-30-2 | Reference compound |
| HY-123777 | VT-1598 | 2089320-99-8 | Reference compound |
| HY-123777A | VT-1598 (tosylate) | 2089321-00-4 | Reference compound |
| HY-12378 | BQ-123 | 136553-81-6 | Reference compound |
| HY-123781 | RUSKI-201 | 1458031-48-5 | Reference compound |
| HY-123781A | RUSKI-201 (dihydrochloride) | 2320262-09-5 | Reference compound |
| HY-123782 | (Rac)-UK-414495 | 337962-93-3 | Reference compound |
| HY-123785 | ORM-10962 | 763926-98-3 | Reference compound |
| HY-123786 | NSC745887 | 54490-26-5 | Reference compound |
| HY-123788 | BRD5814 | 1953181-29-7 | Reference compound |
| HY-123789 | T5342126 | 956507-49-6 | Reference compound |
| HY-12378A | BQ-123 (TFA) | Reference compound | |
| HY-12379 | NS-2028 | 204326-43-2 | Reference compound |
| HY-123790 | AS2541019 | 2098906-98-8 | Reference compound |
| HY-123794 | MP07-66 | 1938056-90-6 | Reference compound |
| HY-123797 | KGA-2727 | 666842-36-0 | Reference compound |
| HY-123798 | N,O-Bis(trimethylsilyl)trifluoroacetamide with trimethylchlorosilane | 25561-30-2 | Biochemical Assay Reagents |
| HY-123798R | N,O-Bis(trimethylsilyl)trifluoroacetamide with trimethylchlorosilane (Standard) | 25561-30-2 | Reference Standards |
| HY-12380 | Atipamezole (hydrochloride) | 104075-48-1 | Reference compound |
| HY-123800 | BI 187004 | 1303515-32-3 | Reference compound |
| HY-123801 | MIDD0301 | 2187489-08-1 | Reference compound |
| HY-123801A | MIDD0301 (sodium) | 2593569-36-7 | Reference compound |
| HY-123802 | BIO7662 | 327613-10-5 | Reference compound |
| HY-123805 | KIN1400 | 446826-86-4 | Reference compound |
| HY-12380A | Atipamezole | 104054-27-5 | Reference compound |
| HY-12381 | ML224 | 1338824-21-7 | Reference compound |
| HY-123812 | PF-03654764 | 935840-35-0 | Reference compound |
| HY-123813 | CCX-777 | 1226686-36-7 | Reference compound |
| HY-123814 | 4-CPPC | 29553-70-6 | Reference compound |
| HY-123815 | BRD5459 | 612037-58-8 | Reference compound |
| HY-123819 | KRH-1636 | 568526-77-2 | Reference compound |
| HY-12382 | NMS-P715 | 1202055-32-0 | Reference compound |
| HY-123820 | LY3020371 (hydrochloride) | 1377615-44-5 | Reference compound |
| HY-123823 | Nitroaspirin | 175033-36-0 | Reference compound |
| HY-123824 | GNE-0439 | 1241902-40-8 | Reference compound |
| HY-123825 | GX-674 | 1432913-36-4 | Reference compound |
| HY-123826 | CCT68127 | 660822-23-1 | Reference compound |
| HY-123829 | LY2624803 | 879409-35-5 | Reference compound |
| HY-12383 | Pelubiprofen | 69956-77-0 | Reference compound |
| HY-123833 | PF-05661014 | 2153474-85-0 | Reference compound |
| HY-123834 | FEN1-IN-1 | 824983-91-7 | Reference compound |
| HY-123837 | MLS1082 | 883958-36-9 | Reference compound |
| HY-123838 | Ro60-0175 | 169675-08-5 | Reference compound |
| HY-12383S | Pelubiprofen-13C,d3 | Isotope-Labeled Compounds | |
| HY-12384 | Tenosal | 95232-68-1 | Reference compound |
| HY-123840 | MRK-623 | 461449-78-5 | Reference compound |
| HY-123844 | dBET57 | 1883863-52-2 | Reference compound |
| HY-123846 | MLS-0437605 | 862975-18-6 | Reference compound |
| HY-123847 | KPT-6566 | 881487-77-0 | Reference compound |
| HY-123849 | SN32976 | 1246202-11-8 | Reference compound |
| HY-12385 | Ximoprofen | 56187-89-4 | Reference compound |
| HY-123851 | MSC2504877 | 1460286-21-8 | Reference compound |
| HY-123854 | PF-06426779 | 1817628-40-2 | Reference compound |
| HY-123856 | MY10 | 2204270-73-3 | Reference compound |
| HY-123857 | JNJ-55308942 | 2166558-11-6 | Reference compound |
| HY-123862 | LAS195319 | 1605328-04-8 | Reference compound |
| HY-123863 | SSR411298 | 666860-59-9 | Reference compound |
| HY-123869 | GR127935 | 148672-13-3 | Reference compound |
| HY-123870 | MX107 | 2170102-50-6 | Reference compound |
| HY-123872 | MSC1094308 | 2219320-08-6 | Reference compound |
| HY-123875A | Ralaniten triacetate | 1637573-04-6 | Reference compound |
| HY-123879 | BAA473 | 27240-87-5 | Reference compound |
| HY-12388 | N-Desmethyl clomipramine | 303-48-0 | Natural Products |
| HY-123882 | IRAK4-IN-29 | 1604034-78-7 | Reference compound |
| HY-123885 | NSC243928 (mesylate) | 59988-01-1 | Reference compound |
| HY-123886 | Aranciamycin | 72389-06-1 | Natural Products |
| HY-123887 | Manumycin B | 139023-58-8 | Natural Products |
| HY-123888 | Viomellein | 55625-78-0 | Natural Products |
| HY-12388A | N-Desmethyl clomipramine (hydrochloride) | 29854-14-6 | Reference compound |
| HY-12388AR | N-Desmethyl clomipramine (hydrochloride) (Standard) | 29854-14-6 | Reference Standards |
| HY-12388AS | N-Desmethyl clomipramine-d3 (hydrochloride) | 1189971-04-7 | Isotope-Labeled Compounds |
| HY-12388S | N-Desmethyl clomipramine-d7 | Isotope-Labeled Compounds | |
| HY-12388S1 | N-Desmethyl clomipramine-d6 | Isotope-Labeled Compounds | |
| HY-12389 | 8-Hydroxyamoxapine | 61443-78-5 | Reference compound |
| HY-123891 | NS-062 | 2226257-92-5 | Reference compound |
| HY-123892 | RK-287107 | 2171386-10-8 | Reference compound |
| HY-123894 | Pelargonidin 3,5-diglucoside (chloride) | 17334-58-6 | Natural Products |
| HY-123895 | Tanshindiol A | 97411-46-6 | Natural Products |
| HY-123896 | Calceolarioside A | 84744-28-5 | Natural Products |
| HY-123897 | Chamaejasmenin C | 89595-70-0 | Natural Products |
| HY-123898 | Cepharadione B | 55610-02-1 | Natural Products |
| HY-123899 | Cleomiscosin B | 76985-93-8 | Natural Products |
| HY-12389S | 8-Hydroxy amoxapine-d8 | 1189505-24-5 | Isotope-Labeled Compounds |
| HY-12390 | Lofepramine | 23047-25-8 | Reference compound |
| HY-123900 | AZ12799734 | 1117684-36-2 | Reference compound |
| HY-123901 | Garcinone E | 112649-21-5 | Natural Products |
| HY-123902 | Ophiobolin C | 19022-51-6 | Reference compound |
| HY-123903 | Tanshindiol B | 97465-70-8 | Natural Products |
| HY-123904 | UoS12258 | 875927-64-3 | Reference compound |
| HY-123905 | LIN28 inhibitor LI71 | 1357248-83-9 | Reference compound |
| HY-123905A | LIN28 inhibitor LI71 enantiomer | 956189-58-5 | Reference compound |
| HY-12390A | Lofepramine (hydrochloride) | 26786-32-3 | Reference compound |
| HY-12390S | Lofepramine-d3 | 1185083-78-6 | Isotope-Labeled Compounds |
| HY-123911 | dBET23 | 1957234-83-1 | Reference compound |
| HY-123914 | P516-0475 | 1359627-33-0 | Reference compound |
| HY-123915 | Antimalarial agent 20 | 1422207-75-7 | Reference compound |
| HY-123916 | DBCO-Biotin | 1418217-95-4 | Reference compound |
| HY-123918 | JMS-17-2 | 1380392-05-1 | Reference compound |
| HY-123918A | JMS-17-2 (hydrochloride) | 2341841-07-2 | Reference compound |
| HY-123919 | TL13-112 | 2229037-19-6 | Reference compound |
| HY-12392 | Iprindole | 5560-72-5 | Reference compound |
| HY-123921 | Gefitinib-based PROTAC 3 | 2230821-27-7 | Reference compound |
| HY-123922 | NOSO-502 | 1894081-09-4 | Reference compound |
| HY-123924 | CSLP37 | 2244984-64-1 | Reference compound |
| HY-123927 | UniPR1331 | 1809170-59-9 | Reference compound |
| HY-123929 | PAWI-2 | 1448427-02-8 | Reference compound |
| HY-123931 | ZLDI-8 | 667880-38-8 | Reference compound |
| HY-123934 | VU6007477 | 2220141-46-6 | Reference compound |
| HY-123936 | SR12343 | 2055101-86-3 | Reference compound |
| HY-123937 | THAL-SNS-032 | 2139287-33-3 | Reference compound |
| HY-12394 | Dothiepin | 113-53-1 | Reference compound |
| HY-123940 | SGC-AAK1-1 | 2247894-32-0 | Reference compound |
| HY-123941 | FKBP12 PROTAC dTAG-7 | 2064175-32-0 | Reference compound |
| HY-123942 | Diprovocim | 2170867-89-5 | Reference compound |
| HY-123943 | STING agonist-4 | 2138300-40-8 | Reference compound |
| HY-12394S | Dothiepin-d3 | 136765-31-6 | Isotope-Labeled Compounds |
| HY-12394S1 | Dothiepin-d6 (hydrochloride) | 1276545-35-7 | Isotope-Labeled Compounds |
| HY-12395 | Ecteinascidin-Analog-1 | 874758-58-4 | Reference compound |
| HY-123950 | MMRi64 | 430458-66-5 | Reference compound |
| HY-123952 | RTC-5 | 1423077-49-9 | Reference compound |
| HY-123954 | BTX-A51 | 2079068-74-7 | Reference compound |
| HY-123955 | Casein Kinase inhibitor A86 | 2079069-01-3 | Reference compound |
| HY-123956 | HG-12-6 | 2222354-57-4 | Reference compound |
| HY-12396 | Aminothiazole | 96-50-4 | Reference compound |
| HY-123960 | Raphin1 | 2022961-17-5 | Reference compound |
| HY-123960A | Raphin1 (acetate) | 2242616-04-0 | Reference compound |
| HY-123960B | (E/Z)-Raphin1 | 94023-67-3 | Reference compound |
| HY-123961 | SJF-8240 | 2230821-68-6 | Reference compound |
| HY-123962 | G6PD activator AG1 | 421581-52-4 | Reference compound |
| HY-123963 | C-178 | 329198-87-0 | Reference compound |
| HY-123966 | MY33-3 | 2204280-41-9 | Reference compound |
| HY-123966A | MY33-3 (hydrochloride) | 2204280-42-0 | Reference compound |
| HY-123967 | RNF5 inhibitor inh-02 | 324579-65-9 | Reference compound |
| HY-12397 | ZK159222 | 156965-15-0 | Reference compound |
| HY-123971 | HDAC6 degrader-4 | 2235382-05-3 | Reference compound |
| HY-123972 | SEC inhibitor KL-2 | 900308-51-2 | Reference compound |
| HY-123976 | MPT0G211 | 2151853-97-1 | Reference compound |
| HY-123976A | MPT0G211 (mesylate) | 2151854-33-8 | Reference compound |
| HY-123977 | RasGRP3 ligand 1 | 2229068-13-5 | Reference compound |
| HY-123979 | ζ-Stat | 3316-02-7 | Reference compound |
| HY-123979A | ζ-Stat (trisodium) | 31894-34-5 | Reference compound |
| HY-12398 | TEI-9647 | 173388-20-0 | Reference compound |
| HY-123981 | 5MPN | 47208-82-2 | Reference compound |
| HY-123982 | SOD1-Derlin-1 inhibitor-2 | 2170170-27-9 | Reference compound |
| HY-123983 | HS56 | 922050-57-5 | Reference compound |
| HY-123984 | LTβR-IN-1 | 2189366-77-4 | Reference compound |
| HY-123985 | MFN2 agonist-1 | 2230047-87-5 | Reference compound |
| HY-123986 | CTPI-2 | 68003-38-3 | Reference compound |
| HY-12398A | TEI-9648 | 173388-21-1 | Reference compound |
| HY-12399 | MKC9989 | 1338934-20-5 | Reference compound |
| HY-123994 | Tenovin-D3 (hydrochloride) | 1258283-70-3 | Reference compound |
| HY-123999 | CD38 inhibitor 1 | 1700637-55-3 | Reference compound |
| HY-12400 | GSK3182571 | 2135595-04-7 | Reference compound |
| HY-124001 | N-Docosanoyl taurine | 783284-48-0 | Natural Products |
| HY-124002 | 4-Hydroxyalternariol | 959417-21-1 | Reference compound |
| HY-124003 | Phytomonic acid | 503-06-0 | Natural Products |
| HY-124004 | Acetyl-6-formylpterin | 29769-49-1 | Reference compound |
| HY-124005 | Prolylisoleucine | 51926-51-3 | Reference compound |
| HY-124007 | 4-Iodo-SAHA | 1219807-87-0 | Reference compound |
| HY-124008 | Uniconazole-P | 83657-17-4 | Reference compound |
| HY-124009 | L-Cysteic acid | 498-40-8 | Reference compound |
| HY-124009A | L-Cysteic acid (monohydrate) | 23537-25-9 | Natural Products |
| HY-124009R | L-Cysteic acid (Standard) | 498-40-8 | Reference Standards |
| HY-12401 | Mps1-IN-3 | 1609584-72-6 | Reference compound |
| HY-124011 | m-PEG3-aldehyde | 356066-46-1 | Reference compound |
| HY-124012 | PCNA-I1 | 444930-42-1 | Reference compound |
| HY-124013 | NBDA | 64917-85-7 | Dye Reagents |
| HY-124014 | Methyl 2-hydroxyhexadecanoate | 16742-51-1 | Natural Products |
| HY-124015 | 1,1,1-Trifluoro-10(Z)-nonadecen-2-one | 177987-23-4 | Reference compound |
| HY-124018 | MMV665852 | 4300-43-0 | Reference compound |
| HY-124019 | 4,5-DiHDPA lactone | 845673-68-9 | Reference compound |
| HY-12401A | Mps1-IN-3 (hydrochloride) | 2989453-29-2 | Reference compound |
| HY-12402 | SBC-115076 | 489415-96-5 | Reference compound |
| HY-124020 | ß-pBrPh-Glc | 30572-42-0 | Reference compound |
| HY-124021 | Benzyl 2-naphthyl ether | 613-62-7 | Reference compound |
| HY-124022 | HDAC-IN-69 | 676599-90-9 | Reference compound |
| HY-124029 | BI-4394 | 1222173-37-6 | Reference compound |
| HY-12403 | Talfirastide | 51833-78-4 | Peptides |
| HY-124030 | 3-Hydroxyphenazepam | 70030-11-4 | Reference compound |
| HY-124031 | Lobetyolinin | 142451-48-7 | Natural Products |
| HY-124033 | Aspinonene | 157676-96-5 | Biochemical Assay Reagents |
| HY-124035 | Streptochlorin | 120191-51-7 | Reference compound |
| HY-124036 | DS-7423 | 1222104-37-1 | Reference compound |
| HY-124037 | SRT 1460 | 925432-73-1 | Reference compound |
| HY-12403A | Talfirastide (acetate) | 2855063-75-9 | Peptides |
| HY-12404 | Diminazene (aceturate) | 908-54-3 | Reference compound |
| HY-124040 | BI-1950 | 1159724-42-1 | Reference compound |
| HY-124041 | p-Hydroxybestatin | 70267-76-4 | Reference compound |
| HY-124042 | K6PC-5 | 756875-51-1 | Reference compound |
| HY-124045 | Butyrospermol | 472-28-6 | Natural Products |
| HY-124047 | RX 67668 | 40709-76-0 | Reference compound |
| HY-124049 | Ethyl 4-methyl-2-(2-thienyl)-thiazole-5 carboxylate | 56421-62-6 | Reference compound |
| HY-12404R | Diminazene (aceturate) (Standard) | 908-54-3 | Reference Standards |
| HY-12405 | CGP-42112 | 127060-75-7 | Reference compound |
| HY-124050 | Echimidine | 520-68-3 | Reference compound |
| HY-124051 | BAY-8040 | 1194453-23-0 | Reference compound |
| HY-124052 | AZ-27 | 1516772-44-3 | Reference compound |
| HY-124053 | BRD2492 | 1821669-43-5 | Reference compound |
| HY-124056 | AZ10397767 | 333742-63-5 | Reference compound |
| HY-124058 | Jacobine | 6870-67-3 | Natural Products |
| HY-124059 | SW-034538 | 412919-82-5 | Reference compound |
| HY-12406 | VLX600 | 327031-55-0 | Reference compound |
| HY-124060 | PS423 | 1221964-37-9 | Reference compound |
| HY-124061 | GB83 | 1252806-86-2 | Reference compound |
| HY-124062 | TAS-114 | 1198221-21-4 | Reference compound |
| HY-124063 | BI-1935 | 940954-41-6 | Reference compound |
| HY-124064 | TMP-153 | 128831-46-9 | Reference compound |
| HY-124066 | RU-302 | 1182129-77-6 | Reference compound |
| HY-124068 | LQB-118 | 1219104-20-7 | Reference compound |
| HY-124069 | M-525 | 2173582-08-4 | Reference compound |
| HY-12407 | ZK168281 | 186371-96-0 | Reference compound |
| HY-124071 | ACT-389949 | 1258417-54-7 | Reference compound |
| HY-124072 | HL001 | 1186371-31-2 | Reference compound |
| HY-124073 | Dihydrocapsiate | 205687-03-2 | Natural Products |
| HY-124073R | Dihydrocapsiate (Standard) | 205687-03-2 | Reference Standards |
| HY-124076 | Triphenylbismuth | 603-33-8 | Reference compound |
| HY-124078 | NIC | 114773-20-5 | Reference compound |
| HY-124079 | HIF-1/2α-IN-3 | 1085450-53-8 | Reference compound |
| HY-12408 | 6H05 | 1469338-01-9 | Reference compound |
| HY-124081 | N-Oleoyl-L-serine | 107743-37-3 | Peptides |
| HY-124082 | Dodecyl gallate | 1166-52-5 | Reference compound |
| HY-124082R | Dodecyl gallate (Standard) | 1166-52-5 | Reference Standards |
| HY-124083 | MPT0B214 | 1215208-65-3 | Reference compound |
| HY-124084 | SW203668 | 1673556-40-5 | Reference compound |
| HY-124084A | SW203668 (TFA) | 2117405-48-6 | Reference compound |
| HY-124085 | Prostaglandin F1α alcohol | 13487-47-3 | Reference compound |
| HY-124086 | BHQ-O-5HT | 1417436-52-2 | Reference compound |
| HY-124087 | (±)-2-Propyl-4-pentenoic acid | 1575-72-0 | Reference compound |
| HY-124087R | (±)-2-Propyl-4-pentenoic acid (Standard) | 1575-72-0 | Reference Standards |
| HY-124089 | Eicosapentaenoyl ethanolamide | 109001-03-8 | Reference compound |
| HY-124089S | Eicosapentaenoyl ethanolamide-d4 | 946524-41-0 | Isotope-Labeled Compounds |
| HY-12408A | 6H05 (TFA) | 2061344-88-3 | Reference compound |
| HY-12409 | PFI-3 | 1819363-80-8 | Reference compound |
| HY-124091 | Methyl 2-hydroxytricosanoate | 118745-41-8 | Natural Products |
| HY-124092 | Raluridine | 119644-22-3 | Reference compound |
| HY-124093 | 8-Deazahomofolic acid | 111113-73-6 | Reference compound |
| HY-124095 | Mannosan,95% | 14168-65-1 | Biochemical Assay Reagents |
| HY-124097 | HNMPA-(AM)3 | 120944-03-8 | Reference compound |
| HY-124098 | Lignocaine N-oxide | 2903-45-9 | Reference compound |
| HY-124099 | SCH 40120 | 110545-79-4 | Reference compound |
| HY-12410 | GNE-9822 | 1557232-32-2 | Reference compound |
| HY-124100 | LTB4 antagonist 4 | 117423-95-7 | Reference compound |
| HY-124101 | PDAT | 1226213-83-7 | Reference compound |
| HY-124104 | Aldicarb sulfoxide | 1646-87-3 | Reference compound |
| HY-124104S | Aldicarb sulfoxide-d3 | 1795136-36-5 | Isotope-Labeled Compounds |
| HY-124108 | Eicosatetraynoic acid | 1191-85-1 | Reference compound |
| HY-124109 | TRC051384 (hydrochloride) | 1333327-56-2 | Reference compound |
| HY-12411 | AMG-3969 | 1361224-53-4 | Reference compound |
| HY-124110 | TC299423 | 1975146-56-5 | Reference compound |
| HY-124111 | 10-Deoxymethymycin | 36826-66-1 | Reference compound |
| HY-124112 | PAM 1392 | 13794-65-5 | Reference compound |
| HY-124113 | 4'-Bromo-resveratrol | 1224713-90-9 | Reference compound |
| HY-124114 | 4-Hydroxytoremifene | 110503-62-3 | Reference compound |
| HY-124116 | PD 121373 | 113457-06-0 | Reference compound |
| HY-124117 | LY 278584 | 119193-37-2 | Reference compound |
| HY-124118 | (all-Z)-6,9,12,15,18-Heneicosapentaenoic acid ethyl ester | 131775-86-5 | Natural Products |
| HY-12412 | ML132 | 1230628-71-3 | Reference compound |
| HY-124122 | BPTQ | 1802665-43-5 | Reference compound |
| HY-124123 | Aminooxy-PEG4-alcohol | 106492-60-8 | ADC Related |
| HY-124124 | N-Methylnicotinamide | 114-33-0 | Natural Products |
| HY-124124R | N-Methylnicotinamide (Standard) | 114-33-0 | Reference Standards |
| HY-124124S | N-Methylnicotinamide-d4 | 2708278-64-0 | Isotope-Labeled Compounds |
| HY-124127 | Allylpyrocatechol | 1125-74-2 | Reference compound |
| HY-124129 | 10074-A4 | 312631-87-1 | Reference compound |
| HY-124131 | DS-437 | 1674364-87-4 | Reference compound |
| HY-124132 | Autophagy-IN-4 | 1411646-44-0 | Reference compound |
| HY-124134 | AD-2646 | 366487-89-0 | Reference compound |
| HY-124135 | SB-656104 | 446020-51-5 | Reference compound |
| HY-124136 | WYC-209 | 2131803-90-0 | Reference compound |
| HY-124137 | Runx1-CBFβ interaction inhibitor 1 | 493028-20-9 | Reference compound |
| HY-124138 | Pikromycin | 19721-56-3 | Reference compound |
| HY-12413A | BMS-986118 | 1610562-74-7 | Reference compound |
| HY-124140 | Heliosupine | 32728-78-2 | Natural Products |
| HY-124140R | Heliosupine (Standard) | 32728-78-2 | Reference Standards |
| HY-124141 | Myristelaidic acid | 50286-30-1 | Natural Products |
| HY-124143 | Isoguanine | 3373-53-3 | Natural Products |
| HY-124144 | MMV667492 | 380877-02-1 | Reference compound |
| HY-124145 | Metfendrazine | 3734-26-7 | Reference compound |
| HY-124146 | BI1002494 | 1319738-39-0 | Reference compound |
| HY-124150 | BM567 | 284464-77-3 | Reference compound |
| HY-124151 | Adenosine-2'-monophosphate | 130-49-4 | Natural Products |
| HY-124151R | Adenosine-2'-monophosphate (Standard) | 130-49-4 | Reference Standards |
| HY-124152 | 3,4-Dephostatin | 173043-84-0 | Reference compound |
| HY-124153 | GNE-431 | 1433820-83-7 | Reference compound |
| HY-124154 | Jaconine | 480-75-1 | Natural Products |
| HY-124154A | Jaconine (hydrochloride) | 7251-11-8 | Reference compound |
| HY-124156 | KY-02327 | 2093407-25-9 | Reference compound |
| HY-124156A | KY-02327 (acetate) | 2989396-34-9 | Reference compound |
| HY-124157 | AA41612 | 433690-62-1 | Reference compound |
| HY-124158 | KR-60436 | 220853-65-6 | Reference compound |
| HY-124160 | JNJ-56022486 | 2036082-79-6 | Reference compound |
| HY-124161 | SCH54292 | 188480-51-5 | Reference compound |
| HY-124163 | Epostatin | 181372-99-6 | Reference compound |
| HY-124168 | PF-244 | 33979-27-0 | Reference compound |
| HY-124171 | Zinquin ethyl ester | 181530-09-6 | Dye Reagents |
| HY-124173 | PF-06815189 | 2218484-75-2 | Reference compound |
| HY-124175 | 16-Phenoxy prostaglandin F2α ethyl amide | 951319-59-8 | Reference compound |
| HY-124176 | L-6355 | 85642-08-6 | Reference compound |
| HY-124177 | C14 Ceramide | 34227-72-0 | Natural Products |
| HY-124177A | C14 Ceramide (d18:1/14:0) | 123408-74-2 | Natural Products |
| HY-124178 | (R)-Levrazoxane | 24613-06-7 | Reference compound |
| HY-124179 | IT-901 | 1584121-99-2 | Reference compound |
| HY-12418 | Stenoparib | 1140964-99-3 | Reference compound |
| HY-124181 | SM-1295 | 1562375-46-5 | Reference compound |
| HY-124185 | LC 6 | 66818-22-2 | Reference compound |
| HY-124187 | Pinolenic acid ethyl ester | 493015-74-0 | Biochemical Assay Reagents |
| HY-12419 | BMS-983970 | 1584713-87-0 | Reference compound |
| HY-124190 | Isopropyl myristate | 110-27-0 | Reference compound |
| HY-124190R | Isopropyl myristate (Standard) | 110-27-0 | Reference Standards |
| HY-124191 | Ravidasvir (hydrochloride) | 1303533-81-4 | Reference compound |
| HY-124192 | Amogastrin | 16870-37-4 | Reference compound |
| HY-124197 | Coumarin hydrazine | 113707-87-2 | Dye Reagents |
| HY-124198 | 2,1,3-Benzoselenadiazole | 273-15-4 | Reference compound |
| HY-124199 | Cephalochromin | 25908-26-3 | Natural Products |
| HY-12420 | JNJ-47117096 hydrochloride | 1610536-69-0 | Reference compound |
| HY-124200 | AL 8810 isopropyl ester | 208114-93-6 | Reference compound |
| HY-124202 | SQ 32602 | 169529-81-1 | Reference compound |
| HY-124204 | LY 274614 | 136109-04-1 | Reference compound |
| HY-124205 | Pepticinnamin E | 147317-36-0 | Reference compound |
| HY-124208 | L-770644 | 173901-95-6 | Reference compound |
| HY-124208A | L-770644 (dihydrochloride) | 182251-68-9 | Reference compound |
| HY-124209 | 9-keto Fluprostenol | 156406-33-6 | Reference compound |
| HY-12420A | JNJ-47117096 | 1610586-62-3 | Reference compound |
| HY-12421 | BET-BAY 002 | 1588521-78-1 | Reference compound |
| HY-124210 | Formycin B | 13877-76-4 | Natural Products |
| HY-124211 | Dibenzo(a,i)pyrene | 189-55-9 | Reference compound |
| HY-124211S | Dibenzo(a,i)pyrene-d14 | 158776-07-9 | Isotope-Labeled Compounds |
| HY-124212 | Thaxtomin A | 122380-18-1 | Natural Products |
| HY-124215 | Fenchone | 1195-79-5 | Natural Products |
| HY-124215S1 | Fenchone-d3 | Isotope-Labeled Compounds | |
| HY-124216 | Penasterol | 116424-94-3 | Natural Products |
| HY-124217 | Prolintane (hydrochloride) | 1211-28-5 | Reference compound |
| HY-124218 | S 863390 | 130024-92-9 | Reference compound |
| HY-124219 | 17-Phenoxy trinor prostaglandin F2α ethyl amide | 1421369-12-1 | Reference compound |
| HY-12421B | BET-BAY 002 (S enantiomer) | 2070009-49-1 | Reference compound |
| HY-12422 | Voruciclib | 1000023-04-0 | Reference compound |
| HY-124220 | Karounidiol | 118117-31-0 | Natural Products |
| HY-124221 | Radamide | 1166398-85-1 | Reference compound |
| HY-124223 | AF-DX 384 (methanesulfonate) | 118290-27-0 | Reference compound |
| HY-124225 | RU 33965 | 122321-05-5 | Reference compound |
| HY-124228 | Ethyl glutamate | 1119-33-1 | Reference compound |
| HY-124229 | PD 122860 | 122576-86-7 | Reference compound |
| HY-12422A | Voruciclib (hydrochloride) | 1000023-05-1 | Reference compound |
| HY-12422B | (2S,3R)-Voruciclib (hydrochloride) | 2920469-94-7 | Reference compound |
| HY-12422C | rel-(2S,3R)-Voruciclib | 1253731-24-6 | Reference compound |
| HY-12422E | rel-(2S,3R)-Voruciclib (hydrochloride) | 1253647-46-9 | Reference compound |
| HY-12423 | Pamufetinib | 1190836-34-0 | Reference compound |
| HY-124230 | 15-PGDH-IN-3 | 355827-05-3 | Reference compound |
| HY-124232 | BTG 502 | 99083-11-1 | Reference compound |
| HY-124235 | SK&F 97574 (hydrochloride) | 144453-77-0 | Reference compound |
| HY-124236 | Chrysobactin | 120124-51-8 | Natural Products |
| HY-124237 | N-Octanoyl-DL-homoserine lactone | 106983-30-6 | Peptides |
| HY-124237A | N-Octanoyl-L-homoserine lactone | 147852-84-4 | Reference compound |
| HY-124237AR | N-Octanoyl-L-homoserine lactone (Standard) | 147852-84-4 | Reference Standards |
| HY-12423A | Pamufetinib (mesylate) | 1688673-09-7 | Reference compound |
| HY-12424 | Zotarolimus | 221877-54-9 | Reference compound |
| HY-124240 | SRTCX1003 | 1203480-86-7 | Reference compound |
| HY-124241 | N-Cyclopropyl bimatoprost | 1138395-12-6 | Reference compound |
| HY-124242 | (S)-α-Methylbenzyl ricinoleamide | 1246776-22-6 | Reference compound |
| HY-124243 | N-Cyclopropyl methyl bimatoprost | 1138395-10-4 | Reference compound |
| HY-124244 | DB-959 | 1257641-15-8 | Reference compound |
| HY-124245 | 3-Hydroxy desloratadine | 119410-08-1 | Reference compound |
| HY-124245R | 3-Hydroxy desloratadine (Standard) | 119410-08-1 | Reference Standards |
| HY-124245S | 3-Hydroxy desloratadine-d4 | 1246819-99-7 | Isotope-Labeled Compounds |
| HY-124245S1 | 3-Hydroxy desloratadine-d4 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-124245S2 | 3-Hydroxy desloratadine-d6 | Isotope-Labeled Compounds | |
| HY-12424A | 42-(2-Tetrazolyl)rapamycin | 221877-56-1 | Reference compound |
| HY-12425 | DGAT1-IN-1 | 1449779-49-0 | Reference compound |
| HY-124250 | 9-OxoOTrE | 125559-74-2 | Reference compound |
| HY-124251 | 3-Thiopheneacrylic acid | 1195-52-4 | Reference compound |
| HY-124252 | 5,8,11-Eicosatriynoic acid | 13488-22-7 | Reference compound |
| HY-124254 | C.I. Vat Yellow 2 | 129-09-9 | Dye Reagents |
| HY-124257 | (R)-Citronellol | 1117-61-9 | Natural Products |
| HY-124258 | Valilactone | 113276-96-3 | Natural Products |
| HY-124259 | I-AB-MECA | 152918-27-9 | Reference compound |
| HY-12426 | mAChR-IN-1 | 119391-56-9 | Reference compound |
| HY-124260 | SB-204900 | 173220-67-2 | Natural Products |
| HY-124261 | Sampangine | 116664-93-8 | Natural Products |
| HY-124262 | Saptomycin E | 137714-92-2 | Natural Products |
| HY-124264 | UBP710 | 1333111-40-2 | Reference compound |
| HY-124265 | 4β-Hydroxycholesterol | 17320-10-4 | Reference compound |
| HY-124265S | 4β-Hydroxycholesterol-d7 | 1246302-80-6 | Isotope-Labeled Compounds |
| HY-124265S1 | 4β-Hydroxycholesterol-d5 | Isotope-Labeled Compounds | |
| HY-124265S2 | 4β-Hydroxycholesterol-d4 | 1363529-44-5 | Isotope-Labeled Compounds |
| HY-124267 | Zgwatinib | 1268264-10-3 | Reference compound |
| HY-12426A | mAChR-IN-1 (hydrochloride) | 119391-73-0 | Reference compound |
| HY-124270 | Sibenadet (hydrochloride) | 154189-24-9 | Reference compound |
| HY-124273 | C2 L-threo Ceramide (d18:1/2:0) | 143615-69-4 | Reference compound |
| HY-124279 | 14-Pentadecenoic acid | 17351-34-7 | Natural Products |
| HY-12428 | A-1165442 | 1221443-94-2 | Reference compound |
| HY-124281 | 9(R)-PAHSA | 2097130-84-0 | Reference compound |
| HY-124281A | 9(S)-PAHSA | 2097130-87-3 | Reference compound |
| HY-124282 | 17-Hydroxyheptadecanoic acid | 13099-34-8 | Natural Products |
| HY-124283 | LEI-101 (free base) | 1228660-00-1 | Reference compound |
| HY-124283A | LEI-101 | 2250025-91-1 | Reference compound |
| HY-124284 | Hexamethylene bisacetamide | 3073-59-4 | Reference compound |
| HY-124285 | ATPCA (hydrochloride) | 185444-92-2 | Reference compound |
| HY-124286 | N-cis-Tetradec-9Z-enoyl-L-homoserine lactone | 1675245-06-3 | Reference compound |
| HY-124288 | PDK1/AurA-IN-1 | 1919884-11-9 | Reference compound |
| HY-12429 | Beclabuvir | 958002-33-0 | Reference compound |
| HY-124290 | Carotegrast methyl | 401905-67-7 | Reference compound |
| HY-124290A | Carotegrast methyl (hydrochloride) | 1338380-52-1 | Reference compound |
| HY-124292 | Honokiol DCA | 1620160-42-0 | Reference compound |
| HY-124293 | AA147 | 393121-74-9 | Reference compound |
| HY-124295 | Imofinostat | 1338320-94-7 | Reference compound |
| HY-124296 | 2C-TFM (hydrochloride) | 159277-13-1 | Reference compound |
| HY-124298 | Calcein Blue AM | 168482-84-6 | Dye Reagents |
| HY-12429A | Beclabuvir (hydrochloride) | 958002-36-3 | Reference compound |
| HY-124300 | JNJ-54166060 | 1627900-41-7 | Reference compound |
| HY-124300A | (S)-JNJ-54166060 | 1627900-42-8 | Reference compound |
| HY-124301 | Penicolinate A | 1418291-68-5 | Natural Products |
| HY-124303 | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid | 136156-13-3 | Reference compound |
| HY-124303S | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid-d5 | 2749975-45-7 | Isotope-Labeled Compounds |
| HY-124304 | Pinokalant | 149759-26-2 | Reference compound |
| HY-124305 | ML395 | 1638957-17-1 | Reference compound |
| HY-124306 | ML-099 | 496775-95-2 | Reference compound |
| HY-124308 | PS315 | 1221964-50-6 | Reference compound |
| HY-124309 | NHI-2 | 1269802-97-2 | Reference compound |
| HY-124310 | PDE5-IN-6c | 1448419-13-3 | Reference compound |
| HY-124311 | 20-Hydroxyeicosanoic acid | 62643-46-3 | Natural Products |
| HY-124313 | 1-Methyl-1,4-dihydronicotinamide | 17750-23-1 | Reference compound |
| HY-124314 | LEI-106 | 1620582-23-1 | Reference compound |
| HY-124315 | Ro24-5098 | 127682-75-1 | Reference compound |
| HY-124317 | PF-06649283 | 1621585-17-8 | Reference compound |
| HY-124318 | SMPH Crosslinker | 367927-39-7 | Reference compound |
| HY-12432 | Gilteritinib | 1254053-43-4 | Reference compound |
| HY-124320 | Desmethylene paroxetine (hydrochloride) | 1394861-12-1 | Reference compound |
| HY-124321 | Metralindole (hydrochloride) | 53734-79-5 | Reference compound |
| HY-124322 | NB-360 | 1262857-73-7 | Reference compound |
| HY-124323 | m-PEG4-NHS ester | 622405-78-1 | Reference compound |
| HY-124324 | 4-Nitrophenyl β-D-cellotrioside | 106927-48-4 | Dye Reagents |
| HY-124325 | PIP-199 | 622795-76-0 | Reference compound |
| HY-124329 | BS3 Crosslinker | 82436-77-9 | ADC Related |
| HY-124329A | BS3 Crosslinker (disodium) | 127634-19-9 | ADC Related |
| HY-124329AS | BS3 Crosslinker-d4 (disodium) | 910292-87-4 | Isotope-Labeled Compounds |
| HY-12432A | Gilteritinib hemifumarate | 1254053-84-3 | Reference compound |
| HY-12432R | Gilteritinib (Standard) | 1254053-43-4 | Reference Standards |
| HY-12432S1 | Gilteritinib-d8 | 2377109-74-3 | Isotope-Labeled Compounds |
| HY-12433 | BMS-819881 | 1197420-05-5 | Reference compound |
| HY-124330 | Tripolin A | 1148118-92-6 | Reference compound |
| HY-124332 | 25T7-NBOMe (hydrochloride) | 1539266-55-1 | Reference compound |
| HY-124334 | L-161240 | 183298-68-2 | Reference compound |
| HY-124337 | BG48 | 1628784-53-1 | Reference compound |
| HY-124339 | JNJ525 | 2092913-64-7 | Reference compound |
| HY-12434 | INT-767 | 1000403-03-1 | Reference compound |
| HY-124341 | ND-378 | 1807453-72-0 | Reference compound |
| HY-124343 | Diethylhomospermine | 119422-08-1 | Reference compound |
| HY-124344 | Avenanthramide C | 116764-15-9 | Natural Products |
| HY-124345 | 2-Trifluoromethyl-2'-methoxychalcone | 1309371-03-6 | Reference compound |
| HY-124346 | T-3364366 | 1356354-09-0 | Reference compound |
| HY-124348 | DM-PIT-1 | 701947-53-7 | Reference compound |
| HY-124350 | 10-Formylfolic acid | 134-05-4 | Reference compound |
| HY-124350R | 10-Formylfolic acid (Standard) | 134-05-4 | Reference Standards |
| HY-124350S | 10-Formylfolic acid-d4 | 461426-41-5 | Isotope-Labeled Compounds |
| HY-124351 | 5'-Hydroxy meloxicam | 130262-92-9 | Reference compound |
| HY-124352 | 2-Nonyl-3-hydroxy-4-quinolone | 1259944-03-0 | Reference compound |
| HY-124352S | 2-Nonyl-3-hydroxy-4-quinolone-d4 | Isotope-Labeled Compounds | |
| HY-124353 | 11-Dehydro thromboxane B3 | 129228-55-3 | Reference compound |
| HY-124355 | 4-Hydroxy hexenal | 17427-21-3 | Reference compound |
| HY-124355S | 4-Hydroxy hexenal-d3 | 148706-05-2 | Isotope-Labeled Compounds |
| HY-124356 | Alcaftadine carboxylic acid | 147083-93-0 | Reference compound |
| HY-124356AS | Alcaftadine carboxylic acid-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-124357 | Seproxetine (hydrochloride) | 127685-30-7 | Reference compound |
| HY-12436 | NTRC-824 | 1623002-61-8 | Reference compound |
| HY-124360 | NIT | 299922-10-4 | Reference compound |
| HY-124363 | 5-cis Carbaprostacyclin | 69609-77-4 | Reference compound |
| HY-124364 | RO6889678 | 1578153-27-1 | Reference compound |
| HY-124365 | Rhamnetin tetraacetate | 16280-26-5 | Reference compound |
| HY-124366 | Slingshot inhibitor D3 | 1715076-35-9 | Reference compound |
| HY-124367 | 25B-NBF (hydrochloride) | 1539266-17-5 | Reference compound |
| HY-12437 | BDP5290 | 1817698-21-7 | Reference compound |
| HY-124370 | 9(Z),11(E)-Conjugated linoleic acid methyl ester | 13058-52-1 | Natural Products |
| HY-124371 | Amentoflavone hexaacetate | 17482-37-0 | Natural Products |
| HY-124372 | JNJ-46356479 | 1254979-66-2 | Reference compound |
| HY-124373 | ND-336 | 1807453-83-3 | Reference compound |
| HY-124373A | (R)-ND-336 | 2252493-33-5 | Reference compound |
| HY-124375 | IND81 | 1426047-52-0 | Reference compound |
| HY-124377 | SPDP-C6-NHS ester | 158913-22-5 | Reference compound |
| HY-124378 | MAGL-IN-17 | 1643657-35-5 | Reference compound |
| HY-124379 | TPCK | 402-71-1 | Reference compound |
| HY-12438 | G007-LK | 1380672-07-0 | Reference compound |
| HY-124380 | Hydroxy-PEG2-acid | 1334286-77-9 | Reference compound |
| HY-124381 | ML10375 | 174008-52-7 | Reference compound |
| HY-124382 | AS1928370 | 1345614-89-2 | Reference compound |
| HY-124386 | DBCO-NHCO-PEG4-amine | 1255942-08-5 | ADC Related |
| HY-124388 | PDE4-IN-20 | 1396397-03-7 | Reference compound |
| HY-12439 | ML380 | 1627138-52-6 | Reference compound |
| HY-124391 | L 156373 | 122211-29-4 | Reference compound |
| HY-124392 | AMG580 | 1227067-71-1 | Reference compound |
| HY-124393 | GRN-529 | 1253291-12-1 | Reference compound |
| HY-124395 | MS2126 | 16078-42-5 | Reference compound |
| HY-124396 | Lanceotoxin A | 93771-82-5 | Reference compound |
| HY-124399 | N-Octadecyl-N'-propyl-sulfamide | 925891-74-3 | Reference compound |
| HY-124401 | BT-13 | 924537-98-4 | Reference compound |
| HY-124403 | D 15413 | 83364-03-8 | Reference compound |
| HY-124404 | 12(R)-HETE | 82337-46-0 | Reference compound |
| HY-124404A | 12(S)-HETE | 54397-83-0 | Reference compound |
| HY-124406 | A-794282 | 869802-44-8 | Reference compound |
| HY-124408 | Mepronil | 55814-41-0 | Reference compound |
| HY-124408R | Mepronil (Standard) | 55814-41-0 | Reference Standards |
| HY-124409 | WSP-1 | 1352750-34-5 | Dye Reagents |
| HY-124410 | Mitoquinol | 845959-55-9 | Reference compound |
| HY-124410S | Mitoquinol-d15 | Isotope-Labeled Compounds | |
| HY-124411 | Lobenzarit | 63329-53-3 | Reference compound |
| HY-124412 | Paynantheine | 4697-66-9 | Natural Products |
| HY-124412S | Paynantheine-d3 | Isotope-Labeled Compounds | |
| HY-124413 | Otosenine | 16958-29-5 | Natural Products |
| HY-124414 | 4'-Hydroxytamoxifen | 82413-23-8 | Reference compound |
| HY-124414A | 4'-Hydroxytamoxifen (TFA) | Reference compound | |
| HY-124414AR | 4'-Hydroxytamoxifen (TFA) (Standard) | Reference Standards | |
| HY-124414R | 4'-Hydroxytamoxifen (Standard) | 82413-23-8 | Reference Standards |
| HY-124414S | 4'-Hydroxytamoxifen-d6 (contains up to 10% E isomer) | 1346606-80-1 | Isotope-Labeled Compounds |
| HY-124416 | ML604086 | 850330-18-6 | Reference compound |
| HY-124417 | SBI-477 analog | 2073059-56-8 | Reference compound |
| HY-124418 | SBI-477 | 781628-99-7 | Reference compound |
| HY-124419 | RO0711401 | 714971-87-6 | Reference compound |
| HY-12442 | LY5 | 1436382-03-4 | Reference compound |
| HY-124421 | 5F-203 | 260443-89-8 | Reference compound |
| HY-124422 | Pentacosanoic acid | 506-38-7 | Natural Products |
| HY-124422R | Pentacosanoic acid (Standard) | 506-38-7 | Reference Standards |
| HY-124423 | ReN 1869 | 170149-99-2 | Reference compound |
| HY-124424 | VU0071063 | 333415-38-6 | Reference compound |
| HY-124425 | 5′-Deoxythymidine | 3458-14-8 | Natural Products |
| HY-124425R | 5′-Deoxythymidine (Standard) | 3458-14-8 | Reference Standards |
| HY-124427 | Lithospermidin B | 83415-79-6 | Natural Products |
| HY-124428 | ASP6537 | 524699-72-7 | Reference compound |
| HY-124429 | FQI1 | 599151-35-6 | Reference compound |
| HY-12443 | PF-5006739 | 1293395-67-1 | Reference compound |
| HY-124431 | Kikumycin A | 37913-77-2 | Reference compound |
| HY-124433 | Methyl 11-methyldodecanoate | 5129-57-7 | Biochemical Assay Reagents |
| HY-124434 | Mesembrenone | 468-54-2 | Natural Products |
| HY-124438 | Herbicidin A | 55353-31-6 | Reference compound |
| HY-124439 | Setomimycin | 69431-87-4 | Reference compound |
| HY-12444 | Y15 | 4506-66-5 | Reference compound |
| HY-124445 | APC0576 | 318967-58-7 | Reference compound |
| HY-124447 | BTYNB | 304456-62-0 | Reference compound |
| HY-124448 | Lofemizole | 65571-68-8 | Reference compound |
| HY-124449 | Afidopyropen | 915972-17-7 | Reference compound |
| HY-12445 | Asnuciclib | 1421693-22-2 | Reference compound |
| HY-124451 | 2-Chloronaphthalene | 91-58-7 | Reference compound |
| HY-124451S | 2-Chloronaphthalene-d7 | 93951-84-9 | Isotope-Labeled Compounds |
| HY-124452 | Nocardamine | 26605-16-3 | Biochemical Assay Reagents |
| HY-124454 | JCC76 | 1021926-22-6 | Reference compound |
| HY-124455 | Lunine | 518-60-5 | Natural Products |
| HY-124456 | Unguinol | 36587-59-4 | Reference compound |
| HY-124458 | Morocromen | 35843-07-3 | Reference compound |
| HY-12446 | K-Ras(G12C) inhibitor 9 | 1469337-91-4 | Reference compound |
| HY-124462 | Trifluperidol (hydrochloride) | 2062-77-3 | Reference compound |
| HY-124463 | Epiallopregnanolone | 567-01-1 | Reference compound |
| HY-124463S1 | Epiallopregnanolone-d5 | Isotope-Labeled Compounds | |
| HY-124464 | MD 770222 | 70133-35-6 | Reference compound |
| HY-124466 | Codlemone | 33956-49-9 | Natural Products |
| HY-124467 | Difludiazepam | 39080-67-6 | Reference compound |
| HY-124469 | UM-C162 | 1799734-10-3 | Reference compound |
| HY-12447 | SMK-17 | 765958-29-0 | Reference compound |
| HY-124472 | 2,4-Difluororesorcinol | 195136-71-1 | Reference compound |
| HY-124473 | Naphthofluorescein | 61419-02-1 | Reference compound |
| HY-124474 | Procurcumenol | 21698-40-8 | Natural Products |
| HY-124475 | Antalarmin | 157284-96-3 | Reference compound |
| HY-124476 | Cystamine | 51-85-4 | Reference compound |
| HY-124477 | Stachybotrylactam | 163391-76-2 | Natural Products |
| HY-124478 | Ethyl gentisate | 3943-91-7 | Reference compound |
| HY-124479A | γ-Lumicolchicine | 6901-14-0 | Reference compound |
| HY-12448 | SPDB | 115088-06-7 | ADC Related |
| HY-124480 | Tetrazine-Ph-acid | 1380500-92-4 | Reference compound |
| HY-124481 | Oleocanthal | 289030-99-5 | Natural Products |
| HY-124482 | Mesembrenol | 25516-15-8 | Reference compound |
| HY-124484 | JI130 | 2234271-86-2 | Reference compound |
| HY-124485 | Nitroscanate | 19881-18-6 | Reference compound |
| HY-124489 | 2-Hydroxyestradiol | 362-05-0 | Reference compound |
| HY-124489S | 2-Hydroxyestradiol-13C6 | Isotope-Labeled Compounds | |
| HY-124489S1 | 2-Hydroxyestradiol-d5 | 221093-33-0 | Isotope-Labeled Compounds |
| HY-12449 | Crenigacestat | 1421438-81-4 | Reference compound |
| HY-124491 | Moquizone | 19395-58-5 | Reference compound |
| HY-124493 | Aluminon | 569-58-4 | Biochemical Assay Reagents |
| HY-124495 | Butocarboxim | 34681-10-2 | Reference compound |
| HY-124496 | Piperitenone | 491-09-8 | Natural Products |
| HY-124498 | Oxantel | 36531-26-7 | Reference compound |
| HY-124499 | RUC-1 | 796886-30-1 | Reference compound |
| HY-12450 | Lomofungin | 26786-84-5 | Natural Products |
| HY-124500 | AC-4-130 | 1834571-82-2 | Reference compound |
| HY-124501 | LY 165163 | 1814-64-8 | Reference compound |
| HY-124502 | UNC4203 | 1818234-19-3 | Reference compound |
| HY-124503 | Longanlactone | 1438721-51-7 | Natural Products |
| HY-124504 | Lunularic acid | 23255-59-6 | Natural Products |
| HY-124508 | Lambertellin | 28980-51-0 | Natural Products |
| HY-124509 | Pyrocoll | 484-73-1 | Reference compound |
| HY-12451 | FICZ | 172922-91-7 | Reference compound |
| HY-124512 | Quercetin pentaacetate | 1064-06-8 | Reference compound |
| HY-124514 | UC-857993 | 487001-04-7 | Reference compound |
| HY-124517 | Burimamide | 34970-69-9 | Reference compound |
| HY-124519 | Centmitor-1 | 331749-88-3 | Reference compound |
| HY-12452 | DPN | 1428-67-7 | Reference compound |
| HY-124521 | Quinelorane | 97466-90-5 | Reference compound |
| HY-124526 | Chiauranib | 1256349-48-0 | Reference compound |
| HY-124527 | HET0016 | 339068-25-6 | Reference compound |
| HY-12453 | TBK1/IKKε-IN-2 | 1292310-49-6 | Reference compound |
| HY-124531 | Tetra(cyanoethoxymethyl) methane | 2465-91-0 | Reference compound |
| HY-124533 | Trimethylolmelamine | 1017-56-7 | Reference compound |
| HY-124534 | (1S,3R)-3-Aminocyclopentane carboxylic acid | 71830-07-4 | Reference compound |
| HY-124535 | TGX-115 | 351071-62-0 | Reference compound |
| HY-124537 | (+)-Volkensiflavone | 27542-37-6 | Natural Products |
| HY-124539 | ZK 187638 | 397298-63-4 | Reference compound |
| HY-12454 | DM4 | 796073-69-3 | ADC Related |
| HY-124540 | ABT-202 | 309959-34-0 | Reference compound |
| HY-124540B | (Rac)-ABT-202 (dihydrochloride) | 1258641-38-1 | Reference compound |
| HY-124542 | 5-Hydroxydiclofenac | 69002-84-2 | Reference compound |
| HY-124543 | MRS-1191 | 185222-90-6 | Reference compound |
| HY-124546 | Necrostatin-5 | 337349-54-9 | Reference compound |
| HY-124547 | 2,4-D methyl ester | 1928-38-7 | Reference compound |
| HY-124547R | 2,4-D methyl ester (Standard) | 1928-38-7 | Reference Standards |
| HY-124547S | 2,4-D methyl ester-d3 | 2732917-35-8 | Isotope-Labeled Compounds |
| HY-124547S1 | 2,4-D Methyl ester-d3-1 | 358731-20-1 | Isotope-Labeled Compounds |
| HY-12454S | DM4-d6 | Isotope-Labeled Compounds | |
| HY-12455 | Duocarmycin A | 118292-34-5 | ADC Related |
| HY-124550 | Sarcophine | 55038-27-2 | Natural Products |
| HY-124551 | Viridiol | 23820-80-6 | Natural Products |
| HY-124552 | Epolactaene | 167782-17-4 | Natural Products |
| HY-124555 | Hexamide | 3653-39-2 | Reference compound |
| HY-124556 | Elasnin | 68112-21-0 | Reference compound |
| HY-124557 | Mahanimbine | 21104-28-9 | Natural Products |
| HY-124559 | (Rac)-Nanatinostat | 914937-68-1 | Reference compound |
| HY-12456 | Duocarmycin SA | 130288-24-3 | ADC Related |
| HY-124560 | Lifibrol | 96609-16-4 | Reference compound |
| HY-124564 | Methisazone | 1910-68-5 | Reference compound |
| HY-124569 | NAB-14 | 1237541-73-9 | Reference compound |
| HY-12457 | Rachelmycin | 69866-21-3 | Natural Products |
| HY-124571 | ZQ-16 | 376616-73-8 | Reference compound |
| HY-124573 | OBI-3424 | 2097713-68-1 | Reference compound |
| HY-124576 | ABD-1970 | 2010154-82-0 | Reference compound |
| HY-124577 | MDI-2268 | 1609176-50-2 | Reference compound |
| HY-12458 | Pyrindamycin A | 118292-36-7 | Reference compound |
| HY-124581 | DS-6930 | 1242328-82-0 | Reference compound |
| HY-124582 | NEO214 | 1361198-80-2 | Reference compound |
| HY-124583 | PF-4363467 | 2040055-84-1 | Reference compound |
| HY-124584 | Minnelide | 1254702-87-8 | Reference compound |
| HY-124584A | Minnelide (free base) | 1254885-39-6 | Reference compound |
| HY-124586 | Streptonigrin | 3930-19-6 | Natural Products |
| HY-124587 | MLT-747 | 2097853-86-4 | Reference compound |
| HY-124588 | MC3343 | 1535187-91-7 | Reference compound |
| HY-12459 | Pyrindamycin B | 118292-35-6 | Reference compound |
| HY-124591 | TC-2153 | 1381769-23-8 | Reference compound |
| HY-124592 | BMT-052 | 1628720-84-2 | Isotope-Labeled Compounds |
| HY-124593 | PTC299 | 1256565-36-2 | Reference compound |
| HY-124594 | CA inhibitor 1 | 2189684-45-3 | Reference compound |
| HY-124596 | CD161 | 1627716-22-6 | Reference compound |
| HY-124597 | ARN726 | 1628343-77-0 | Reference compound |
| HY-12460 | SPDB-DM4 | 1626359-62-3 | ADC Related |
| HY-124600 | NVR 3-778 | 1445790-55-5 | Reference compound |
| HY-124602 | DI-591 | 2245887-38-9 | Reference compound |
| HY-124603 | AT791 | 1219962-49-8 | Reference compound |
| HY-124607 | (R)-BRD3731 | 2056262-08-7 | Reference compound |
| HY-124607B | BRD3731 | 2056262-07-6 | Reference compound |
| HY-124609 | CAD031 | 2071209-49-7 | Reference compound |
| HY-12461 | WS6 | 1421227-53-3 | Reference compound |
| HY-124611 | JG-231 | 1627126-59-3 | Reference compound |
| HY-124613 | Pyrazinib | 200417-97-6 | Reference compound |
| HY-124614 | GLP-26 | 2133017-36-2 | Reference compound |
| HY-124617 | AMXT-1501 | 441022-64-6 | Reference compound |
| HY-124617A | AMXT-1501 tetrahydrochloride | 2444815-84-1 | Reference compound |
| HY-124618 | FGI-106 | 501081-38-5 | Reference compound |
| HY-124618A | FGI-106 (tetrahydrochloride) | 1149348-10-6 | Reference compound |
| HY-124619 | GPI-1046 | 186452-09-5 | Reference compound |
| HY-12462 | WS3 | 1421227-52-2 | Reference compound |
| HY-124622 | NNC-0640 | 307986-98-7 | Reference compound |
| HY-124623 | DNDI-8219 | 2222660-40-2 | Reference compound |
| HY-124624 | PBOX-15 | 354759-10-7 | Reference compound |
| HY-124625 | BI-4464 | 1227948-02-8 | Reference compound |
| HY-124626 | (R)-(+)-Mequitazine | 147780-50-5 | Reference compound |
| HY-124628 | IPI-9119 | 1346564-56-4 | Reference compound |
| HY-124629 | DB2313 | 2170606-74-1 | Reference compound |
| HY-124629A | DB2313 (tetrahydrochloride) | 2170606-75-2 | Reference compound |
| HY-12463 | Carmoterol (hydrochloride) | 137888-11-0 | Reference compound |
| HY-124632 | WJ460 | 1415251-36-3 | Reference compound |
| HY-124634 | PZ-2891 | 2170608-82-7 | Reference compound |
| HY-124637 | ALE-0540 | 234779-34-1 | Reference compound |
| HY-124638 | MNK inhibitor 9 | 1889336-59-7 | Reference compound |
| HY-124639 | CDK9 inhibitor HH1 | 204188-41-0 | Reference compound |
| HY-12463A | Carmoterol | 147568-66-9 | Reference compound |
| HY-12464 | Butafenacil | 134605-64-4 | Reference compound |
| HY-124643 | RIPK2-IN-3 | 1290490-78-6 | Reference compound |
| HY-124644 | 1E7-03 | 1565845-92-2 | Reference compound |
| HY-124645 | QL-X-138 | 1469988-63-3 | Reference compound |
| HY-124646 | KIRA-7 | 1937235-76-1 | Reference compound |
| HY-124647 | PI3Kα-IN-1 | 2100855-80-7 | Reference compound |
| HY-124648 | SMN-C2 | 1446311-56-3 | Reference compound |
| HY-12464R | Butafenacil (Standard) | 134605-64-4 | Reference Standards |
| HY-12465 | Z-Ile-Leu-aldehyde | 161710-10-7 | Reference compound |
| HY-124651 | SEMBL | 1443448-82-5 | Reference compound |
| HY-124652 | TBK1/IKKε-IN-4 | 1381930-17-1 | Reference compound |
| HY-124653 | HSP27 inhibitor J2 | 2133499-85-9 | Reference compound |
| HY-124654 | SS148 | 1985669-27-9 | Reference compound |
| HY-124658 | G0507 | 1223998-29-5 | Reference compound |
| HY-12466 | Z-DEVD-FMK | 210344-95-9 | Reference compound |
| HY-124660A | A-395N | 2089056-09-5 | Reference compound |
| HY-124662 | IHVR-19029 | 1447464-73-4 | Reference compound |
| HY-124663 | CBK289001 | 1212663-24-5 | Reference compound |
| HY-124664 | TP0438836 | 957772-01-9 | Reference compound |
| HY-124668 | CCR1 antagonist 12 | 921208-19-7 | Reference compound |
| HY-124669 | RTC-30 | 1423077-95-5 | Reference compound |
| HY-12467 | OTS964 (hydrochloride) | 1338545-07-5 | Reference compound |
| HY-124670 | 1beta-Hydroxyalantolactone | 68776-47-6 | Natural Products |
| HY-124673 | AF40431 | 181125-92-8 | Reference compound |
| HY-124674 | CCT365623 | 2126134-01-6 | Reference compound |
| HY-124674A | CCT365623 (hydrochloride) | 2126136-98-7 | Reference compound |
| HY-124675 | MYCMI-6 | 681282-09-7 | Reference compound |
| HY-124676A | DB2115 (tertahydrochloride) | 1366126-19-3 | Reference compound |
| HY-124679 | DS86760016 | 1853176-89-2 | Reference compound |
| HY-12468 | A-1210477 | 1668553-26-1 | Reference compound |
| HY-124680 | AC-263093 (free base) | 849459-86-5 | Reference compound |
| HY-124681 | NY0116 | 1003000-59-6 | Reference compound |
| HY-124687 | ROMK-IN-32 | 1914944-54-9 | Reference compound |
| HY-124689 | TR-100 | 1128165-86-5 | Reference compound |
| HY-12469 | Decernotinib | 944842-54-0 | Reference compound |
| HY-124691 | D-I03 | 688342-78-1 | Reference compound |
| HY-124696 | PU139 | 158093-65-3 | Reference compound |
| HY-124697 | BMP signaling agonist sb4 | 100874-08-6 | Reference compound |
| HY-124699 | MMSET-IN-1 | 1998139-29-9 | Reference compound |
| HY-12470 | PF-4800567 | 1188296-52-7 | Reference compound |
| HY-124700 | LYPLAL1-IN-1 | 1966129-74-7 | Reference compound |
| HY-124701 | Filastatin | 431996-53-1 | Reference compound |
| HY-124702 | ICA-105574 | 316146-57-3 | Reference compound |
| HY-124703 | Pyrimidinone 8 | 65004-42-4 | Reference compound |
| HY-124704 | Chst15-IN-1 | 2158198-77-5 | Reference compound |
| HY-12470A | PF-4800567 (hydrochloride) | 1391052-28-0 | Reference compound |
| HY-12471 | VLX1570 | 1431280-51-1 | Reference compound |
| HY-124711 | TBOPP | 1996629-79-8 | Reference compound |
| HY-124712 | Divin | 1443321-11-6 | Reference compound |
| HY-124713 | ML372 | 1331745-61-9 | Reference compound |
| HY-124717 | YC-001 | 748778-73-6 | Reference compound |
| HY-124718 | p32 Inhibitor M36 | 802555-85-7 | Reference compound |
| HY-124719 | hSMG-1 inhibitor 11j | 1402452-15-6 | Reference compound |
| HY-12472 | Balipodect | 1238697-26-1 | Reference compound |
| HY-124722 | OHM1 | 1450995-09-1 | Reference compound |
| HY-124723 | Gerfelin | 627545-07-7 | Reference compound |
| HY-124726 | Aumitin | 946293-78-3 | Reference compound |
| HY-124727 | ZT55 | 2138488-38-5 | Reference compound |
| HY-124729 | BL-918 | 2101517-69-3 | Reference compound |
| HY-124729A | (Rac)-BL-918 | 2435589-07-2 | Reference compound |
| HY-12473 | Vps34-IN-2 | 1523404-29-6 | Reference compound |
| HY-124731 | PD-321852 | 622856-21-7 | Reference compound |
| HY-124733 | LIT-001 (free base) | 2245072-20-0 | Reference compound |
| HY-124733A | LIT-001 | 2245072-21-1 | Reference compound |
| HY-124735 | RH01687 | 302901-13-9 | Reference compound |
| HY-124738 | BI 01383298 | 2227549-00-8 | Reference compound |
| HY-124739 | HBX 28258 | 1426544-54-8 | Reference compound |
| HY-124740 | ML00253764 | 681847-92-7 | Reference compound |
| HY-124741 | Jamaicin | 24211-36-7 | Natural Products |
| HY-124744 | ASP 8477 | 906737-25-5 | Reference compound |
| HY-124745 | KY-05009 | 1228280-29-2 | Reference compound |
| HY-124748 | ENMD-1068 | 789488-77-3 | Reference compound |
| HY-124748A | ENMD-1068 (hydrochloride) | 2703451-51-6 | Reference compound |
| HY-12475 | Mutant IDH1-IN-1 | 1355326-21-4 | Reference compound |
| HY-124750 | NecroX-7 | 1120332-55-9 | Reference compound |
| HY-124751 | YTX-465 | 2225824-53-1 | Reference compound |
| HY-124754 | Navacaprant | 2244614-14-8 | Reference compound |
| HY-124756 | SBI-425 | 1451272-71-1 | Reference compound |
| HY-124757 | FiVe1 | 932359-76-7 | Reference compound |
| HY-124758 | SH-BC-893 | 1841409-92-4 | Reference compound |
| HY-124759 | CCR1 antagonist 9 | 1220026-26-5 | Reference compound |
| HY-12476 | SAR156497 | 1256137-14-0 | Reference compound |
| HY-124760 | hSMG-1 inhibitor 11e | 1402452-10-1 | Reference compound |
| HY-124761 | Poloppin | 683808-78-8 | Reference compound |
| HY-124762 | TNIK-IN-1 | 933886-36-3 | Reference compound |
| HY-124764 | KY-04031 | 468056-29-3 | Reference compound |
| HY-124767 | SR 142948A | 184162-21-8 | Reference compound |
| HY-124768 | PDE12-IN-3 | 1803357-22-3 | Reference compound |
| HY-12477 | PF-06447475 | 1527473-33-1 | Reference compound |
| HY-124771 | RH01386 | 301177-36-6 | Reference compound |
| HY-124772 | BI-2545 | 2162961-71-7 | Reference compound |
| HY-124775 | (S)-C33 | 2066488-39-7 | Reference compound |
| HY-124776 | NPD8733 | 696655-62-6 | Reference compound |
| HY-124777 | NPD4456 | 859668-98-7 | Reference compound |
| HY-124778 | SW106065 | 62289-81-0 | Reference compound |
| HY-124779 | (S)-Alaproclate | 66171-75-3 | Reference compound |
| HY-124779A | (S)-Alaproclate (hydrochloride) | 57469-92-8 | Reference compound |
| HY-124780 | HOOCCH2O-PEG4-CH2COOH | 77855-75-5 | Reference compound |
| HY-124781 | ML406 | 774589-47-8 | Reference compound |
| HY-124781R | ML406 (Standard) | 774589-47-8 | Reference Standards |
| HY-124782 | HDAC8-IN-8 | 1884231-52-0 | Reference compound |
| HY-124789 | TBT1 | 52535-76-9 | Reference compound |
| HY-124789R | TBT1 (Standard) | 52535-76-9 | Reference Standards |
| HY-12479 | Epetraborole | 1093643-37-8 | Reference compound |
| HY-124790 | KSP-IA | 639074-49-0 | Reference compound |
| HY-124793 | GAK inhibitor 49 | 319492-82-5 | Reference compound |
| HY-124793A | GAK inhibitor 49 (hydrochloride) | 2930378-91-7 | Reference compound |
| HY-124795 | FPMINT | 924866-33-1 | Reference compound |
| HY-124796 | Qstatin | 902688-24-8 | Reference compound |
| HY-124798 | Rheb inhibitor NR1 | 2216763-38-9 | Reference compound |
| HY-12479A | Epetraborole (hydrochloride) | 1234563-16-6 | Reference compound |
| HY-12479B | Epetraborole (R-mandelate) | 1234563-15-5 | Reference compound |
| HY-12480 | Lanopepden | 1152107-25-9 | Reference compound |
| HY-124801 | ABMA | 332108-65-3 | Reference compound |
| HY-124803 | GPCR modulator-1 | 1407592-99-7 | Reference compound |
| HY-124805 | MAL3-101 | 831217-40-4 | Reference compound |
| HY-124806 | TTP-8307 | 950225-08-8 | Reference compound |
| HY-124808 | IMM-01 | 218795-74-5 | Reference compound |
| HY-12481 | SAR405 | 1523406-39-4 | Reference compound |
| HY-124811 | IRES-C11 | 342416-30-2 | Reference compound |
| HY-124813 | PDZ1i | 2083618-79-3 | Reference compound |
| HY-124814 | C215 | 912780-51-9 | Reference compound |
| HY-124815 | CP-312 | 895470-67-4 | Reference compound |
| HY-124817 | Col003 | 328565-16-8 | Reference compound |
| HY-124819 | D13-9001 | 957471-96-4 | Reference compound |
| HY-12481A | SAR405 R enantiomer | 1946010-79-2 | Reference compound |
| HY-124821 | VA012 | 885898-58-8 | Reference compound |
| HY-124822 | COH-SR4 | 73439-19-7 | Reference compound |
| HY-124823 | Monastroline | 462630-41-7 | Reference compound |
| HY-124824 | Methyl gerfelin | 700870-56-0 | Reference compound |
| HY-124825 | iGOT1-01 | 882256-55-5 | Reference compound |
| HY-124826 | BC21 | 691005-38-6 | Reference compound |
| HY-124827 | Tec-IN-1 | 931664-41-4 | Reference compound |
| HY-124828 | CMLD-2 | 958843-91-9 | Reference compound |
| HY-12483 | SR1664 | 1338259-05-4 | Reference compound |
| HY-124830 | SPA70 | 931314-31-7 | Reference compound |
| HY-124831 | NTRC-844 | 1811503-67-9 | Reference compound |
| HY-124832 | δ-Secretase inhibitor 11 | 842964-18-5 | Reference compound |
| HY-124833 | Quinalizarin | 81-61-8 | Reference compound |
| HY-124834 | Nrf2 activator-10 | 75483-04-4 | Reference compound |
| HY-124838 | EG1 | 693241-54-2 | Reference compound |
| HY-12484 | BMH-21 | 896705-16-1 | Reference compound |
| HY-124843 | LLL3 | 63972-38-3 | Reference compound |
| HY-124844 | Azaphilone-9 | 1448460-87-4 | Reference compound |
| HY-124848 | CMPD167 | 313994-79-5 | Reference compound |
| HY-12485 | TBA-354 | 1257426-19-9 | Reference compound |
| HY-124855 | STD1T | 893075-58-6 | Reference compound |
| HY-124857 | 7DG | 26927-01-5 | Reference compound |
| HY-124858 | SC99 | 882290-02-0 | Reference compound |
| HY-124859 | CeMMEC2 | 902955-25-3 | Reference compound |
| HY-12485R | TBA-354 (Standard) | 1257426-19-9 | Reference Standards |
| HY-12486 | FL118 | 135415-73-5 | Reference compound |
| HY-124861 | Malic enzyme inhibitor ME1 | 522649-59-8 | Reference compound |
| HY-124863A | (R)-AAL | 241476-71-1 | Reference compound |
| HY-124866 | PDI-IN-3 | 922507-80-0 | Reference compound |
| HY-124867 | D3-βArr | 662164-09-2 | Reference compound |
| HY-12487 | NL-103 | 1788896-33-2 | Reference compound |
| HY-124870 | N.41 | 357441-99-7 | Reference compound |
| HY-124871 | LASV inhibitor 3.3 | 554438-52-7 | Reference compound |
| HY-124873 | SERCA2a activator 1 | 2139330-34-8 | Reference compound |
| HY-124874 | (rel)-Asperparaline A | 195966-93-9 | Natural Products |
| HY-124875 | Arylsulfonamide 64B | 1342890-83-8 | Reference compound |
| HY-124876 | SynuClean-D | 685121-45-3 | Reference compound |
| HY-124878S | LY 227942-d5 | Isotope-Labeled Compounds | |
| HY-124879 | MF 961 | 138372-62-0 | Reference compound |
| HY-12488 | LY2510924 | 1088715-84-7 | Reference compound |
| HY-124880 | JNJ-28330835 | 888072-47-7 | Reference compound |
| HY-124881 | Scandoside | 18842-99-4 | Natural Products |
| HY-124882 | Dienestrol diacetate | 84-19-5 | Reference compound |
| HY-124883 | R-(–)-Flecainide | 99495-90-6 | Reference compound |
| HY-124887 | L 651142 | 99046-40-9 | Reference compound |
| HY-124889 | Dimethenamid | 87674-68-8 | Reference compound |
| HY-12489 | Ponceau S | 6226-79-5 | Dye Reagents |
| HY-124890 | Thr101 | 727664-79-1 | Reference compound |
| HY-124891 | 1-Phenylpyrrole | 635-90-5 | Reference compound |
| HY-124891S | 1-Phenylpyrrole-d9 | Isotope-Labeled Compounds | |
| HY-124892A | Acetylethylcholine mustard (hydrochloride) | 103994-00-9 | Reference compound |
| HY-124894 | (+)-Benalaxyl | 97716-85-3 | Reference compound |
| HY-124896 | Bonannione A | 97126-57-3 | Natural Products |
| HY-124899 | Hh-Ag1.5 | 612542-14-0 | Reference compound |
| HY-12489A | Ponceau S, BS | 6226-79-5 | Dye Reagents |
| HY-124901 | Tetrasul | 2227-13-6 | Reference compound |
| HY-124901R | Tetrasul (Standard) | 2227-13-6 | Reference Standards |
| HY-124902 | Valclavam | 98359-78-5 | Natural Products |
| HY-124905 | MCI-176 | 103315-31-7 | Reference compound |
| HY-124906 | JAMI1001A | 1001019-46-0 | Reference compound |
| HY-124908 | HT1042 | 23589-77-7 | Reference compound |
| HY-124909 | (6R)-FR054 | 10378-06-0 | Reference compound |
| HY-124909A | FR054 | 35954-65-5 | Reference compound |
| HY-12491 | PIK-C98 | 691388-62-2 | Reference compound |
| HY-124910 | BU-E-75 | 114667-74-2 | Reference compound |
| HY-124911 | LY53857 (free base) | 32896-53-0 | Reference compound |
| HY-124915 | Netzahualcoyondiol | 113579-08-1 | Natural Products |
| HY-124916 | Lycopsamine | 10285-07-1 | Natural Products |
| HY-124916R | Lycopsamine (Standard) | 10285-07-1 | Reference Standards |
| HY-124918 | Cremastranone | 107585-69-3 | Reference compound |
| HY-124919 | JJO-1 | 16722-44-4 | Reference compound |
| HY-12492 | VER-246608 | 1684386-71-7 | Reference compound |
| HY-124920S | Methiocarb-d3 | 1581694-94-1 | Isotope-Labeled Compounds |
| HY-124923 | Lupulone | 468-28-0 | Natural Products |
| HY-124923R | Lupulone (Standard) | 468-28-0 | Reference Standards |
| HY-124925 | Vincanol | 19877-89-5 | Reference compound |
| HY-124926 | S23757 | 208718-14-3 | Reference compound |
| HY-124927 | ARN14988 | 1502027-70-4 | Reference compound |
| HY-124929 | Mimocin | 76177-28-1 | Reference compound |
| HY-12493 | LY-2584702 (free base) | 1082949-67-4 | Reference compound |
| HY-124938 | ABC-1 | 309735-05-5 | Reference compound |
| HY-124939 | ND-322 (hydrochloride) | 1333379-23-9 | Reference compound |
| HY-12493A | LY-2584702 (tosylate salt) | 1082949-68-5 | Reference compound |
| HY-12493B | LY-2584702 (hydrochloride) | 1082948-81-9 | Reference compound |
| HY-12494 | LDC1267 | 1361030-48-9 | Reference compound |
| HY-124941 | 7-Deacetylgedunin | 10314-90-6 | Reference compound |
| HY-124944 | APS6-45 | 2188236-41-9 | Reference compound |
| HY-124946 | C1A | 1021463-02-4 | Reference compound |
| HY-124947 | PF-4522654 | 1065109-28-5 | Reference compound |
| HY-12495 | ISRIB (trans-isomer) | 1597403-47-8 | Reference compound |
| HY-124950 | Picumeterol | 130641-36-0 | Reference compound |
| HY-124950A | (+)-Picumeterol | 139423-79-3 | Reference compound |
| HY-124951 | Arctiol | 36061-11-7 | Natural Products |
| HY-124952 | iKIX1 | 656222-54-7 | Reference compound |
| HY-124953 | 7,3',4'-Trihydroxyisoflavone | 485-63-2 | Reference compound |
| HY-124954 | MN-25 | 501926-82-5 | Reference compound |
| HY-124955 | proTAME | 1362911-19-0 | Reference compound |
| HY-124956 | GIV3727 | 957136-80-0 | Reference compound |
| HY-124957 | β-NETA | 31059-54-8 | Reference compound |
| HY-124958 | NDMC101 | 1308631-40-4 | Reference compound |
| HY-124959 | Spiradoline (mesylate) | 87173-97-5 | Reference compound |
| HY-12495A | ISRIB | 548470-11-7 | Biochemical Assay Reagents |
| HY-12496 | NS-1619 | 153587-01-0 | Reference compound |
| HY-124960 | CTPB | 586976-24-1 | Reference compound |
| HY-124962 | D-NMAPPD | 35922-06-6 | Reference compound |
| HY-12497 | ANA-12 | 219766-25-3 | Reference compound |
| HY-12498 | GV-58 | 1402821-41-3 | Reference compound |
| HY-124984 | ML353 | 2990506-75-5 | Reference compound |
| HY-124987 | MRS4458 | 2225834-49-9 | Reference compound |
| HY-12499 | (S)-Willardiine | 21416-43-3 | Reference compound |
| HY-124996 | (Rac)-ZLc-002 | Reference compound | |
| HY-125001 | JH-VIII-49 | 2209084-73-9 | Reference compound |
| HY-125006 | TRi-1 | 246020-68-8 | Reference compound |
| HY-12501 | ITI-214 (free base) | 1160521-50-5 | Reference compound |
| HY-125010 | Dicycloplatin | 287402-09-9 | Reference compound |
| HY-125012 | MAP4K4-IN-3 | 1811510-58-3 | Reference compound |
| HY-125016 | TT-10 | 2230640-94-3 | Reference compound |
| HY-125017 | Bozitinib | 1440964-89-5 | Reference compound |
| HY-125018 | QM31 | 937735-00-7 | Reference compound |
| HY-125019 | iJak-381 | 1831144-46-7 | Reference compound |
| HY-12501A | ITI-214 | 1642303-38-5 | Reference compound |
| HY-12502 | Efonidipine | 111011-63-3 | Reference compound |
| HY-125020 | NCGC00135472 | 862811-76-5 | Reference compound |
| HY-125021 | 2BAct | 2143542-28-1 | Reference compound |
| HY-125025 | SMI 6860766 | 433234-16-3 | Reference compound |
| HY-125026 | MyomiRs-IN-1 | 1392224-59-7 | Reference compound |
| HY-125027 | Isobutyl-deoxynyboquinone | 1430798-22-3 | Reference compound |
| HY-125028 | Hck-IN-1 | 1473404-51-1 | Reference compound |
| HY-12502A | Efonidipine (hydrochloride monoethanolate) | 111011-76-8 | Reference compound |
| HY-12502B | Efonidipine (hydrochloride) | 111011-53-1 | Reference compound |
| HY-12503 | CFM-2 | 178616-26-7 | Reference compound |
| HY-125033 | EIDD-1931 | 3258-02-4 | Reference compound |
| HY-125033S1 | EIDD-1931-d2 | 1955549-12-8 | Isotope-Labeled Compounds |
| HY-125035 | LCH-7749944 | 796888-12-5 | Reference compound |
| HY-125036 | MitoBloCK-11 | 413606-16-3 | Reference compound |
| HY-125039 | N-Acetyl lysyltyrosylcysteine amide | 1287585-40-3 | Reference compound |
| HY-12504 | Pyr6 | 245747-08-4 | Reference compound |
| HY-125040 | Isariin C | 80111-96-2 | Reference compound |
| HY-125042 | Sarothralin G | 130756-15-9 | Natural Products |
| HY-125043 | SKF-75670 (hydrobromide) | 62717-63-9 | Reference compound |
| HY-125045 | Kahweol eicosanoate | 108214-32-0 | Natural Products |
| HY-125046 | CYM50374 | 1314212-81-1 | Reference compound |
| HY-125047 | Daledalin tosylate | 23226-37-1 | Reference compound |
| HY-125048 | Racemomycin B | 3776-37-2 | Natural Products |
| HY-125049 | Kijanimicin | 78798-08-0 | Reference compound |
| HY-12505 | CX546 | 215923-54-9 | Reference compound |
| HY-125050 | KCA-1490 | 909719-71-7 | Reference compound |
| HY-125051 | SG3-179 | 1877286-78-6 | Reference compound |
| HY-125053 | Batifiban | 710312-77-9 | Peptides |
| HY-125053A | Batifiban (TFA) | Peptides | |
| HY-125054 | Kelletinin A | 112727-22-7 | Reference compound |
| HY-125058 | Kinamycin C | 35303-08-3 | Natural Products |
| HY-125059 | PTC-510 (free base) | 865531-74-4 | Reference compound |
| HY-12506 | Naspm | 122306-11-0 | Reference compound |
| HY-125060 | Viridicatin | 129-24-8 | Natural Products |
| HY-125061 | Hydroxythiohomosildenafil | 479073-82-0 | Reference compound |
| HY-125062 | Steviolmonoside | 60129-60-4 | Reference compound |
| HY-125064 | AP22408 | 268741-43-1 | Reference compound |
| HY-125065 | MK-4541 | 796885-38-6 | Reference compound |
| HY-125066 | Reveromycin B | 144860-68-4 | Reference compound |
| HY-125067 | Yadanzioside P | 79439-84-2 | Natural Products |
| HY-125068 | RPR203494 | 218160-26-0 | Reference compound |
| HY-12506A | Naspm (trihydrochloride) | 1049731-36-3 | Reference compound |
| HY-12507 | GSK-7975A | 1253186-56-9 | Reference compound |
| HY-125070 | Saframycin C | 66082-29-9 | Natural Products |
| HY-125072 | Arabinose 1,5-diphosphate | 93132-85-5 | Reference compound |
| HY-125074 | PNU 142300 | 368891-69-4 | Reference compound |
| HY-125075 | PD 165929 | 185215-75-2 | Reference compound |
| HY-125079 | DSP-2230 | 1233231-30-5 | Reference compound |
| HY-12508 | CMPDA | 380607-77-2 | Reference compound |
| HY-125080 | BIBS-222 | 142023-57-2 | Reference compound |
| HY-125083 | Lys-D-Pro-Thr | 117027-34-6 | Peptides |
| HY-125084 | NEU617 | 1432450-82-2 | Reference compound |
| HY-125085 | ALDH3A1-IN-3 | 315239-63-5 | Reference compound |
| HY-125086 | Leustroducsin B | 145142-82-1 | Natural Products |
| HY-125087 | A-304121 | 360551-71-9 | Reference compound |
| HY-125088 | Oleoylestrone | 180003-17-2 | Reference compound |
| HY-125088S | Oleoylestrone-d4 | 443791-75-1 | Isotope-Labeled Compounds |
| HY-12509 | PEPA | 141286-78-4 | Reference compound |
| HY-125090 | PHA-680626 | 398493-74-8 | Reference compound |
| HY-125091 | LY2066948 | 648904-56-7 | Reference compound |
| HY-125092 | Drimentine C | 204398-92-5 | Reference compound |
| HY-125095 | Yonkenafil (hydrochloride) | 804519-64-0 | Reference compound |
| HY-125096 | C108297 | 864972-30-5 | Reference compound |
| HY-125097 | 5'-Hydroxy-staurosporine | 308847-74-7 | Reference compound |
| HY-125098 | Illudin S | 1149-99-1 | Natural Products |
| HY-125099 | AFM-30a | 2095107-57-4 | Reference compound |
| HY-125099A | AFM-30a (hydrochloride) | Reference compound | |
| HY-12510 | Methoxy-PEPy | 524924-76-3 | Reference compound |
| HY-125100 | Loroglossin | 58139-22-3 | Natural Products |
| HY-125101A | Rafutrombopag (diolamine) | 1257792-42-9 | Reference compound |
| HY-125102 | AZ12253801 | 851432-37-6 | Reference compound |
| HY-125104 | Mirosamicin | 73684-69-2 | Natural Products |
| HY-125108 | PHPS1 (sodium) | 1177131-02-0 | Reference compound |
| HY-12511 | SKF-86002 | 72873-74-6 | Reference compound |
| HY-125111 | PSB-SB-487 | 1399049-81-0 | Reference compound |
| HY-125112 | Vicenin-1 | 35927-38-9 | Natural Products |
| HY-125114 | Jatrophane 4 | 210108-88-6 | Natural Products |
| HY-125115 | Jatrophane 3 | 210108-87-5 | Natural Products |
| HY-125116 | Jatrophane 2 | 210108-86-4 | Natural Products |
| HY-125117 | Simocyclinone D8 | 301845-97-6 | Natural Products |
| HY-125118 | GSK-A1 | 1416334-69-4 | Reference compound |
| HY-12512 | cGAMP | 849214-04-6 | Reference compound |
| HY-125120 | Kansuiphorin C | 133898-77-8 | Natural Products |
| HY-125121 | Esculentoside C | 65931-92-2 | Natural Products |
| HY-125122 | Mulberrofuran A | 68978-04-1 | Natural Products |
| HY-125123 | Euchrestaflavanone A | 80510-05-0 | Natural Products |
| HY-125124 | Chamaejasmenin D | 865852-47-7 | Natural Products |
| HY-125125 | Danshenxinkun D | 98873-76-8 | Natural Products |
| HY-125127 | Danshenxinkun C | 65907-77-9 | Natural Products |
| HY-125128 | Glp-Pro-Val-pNA | 83329-36-6 | Peptides |
| HY-125129 | Carlinoside | 59952-97-5 | Natural Products |
| HY-12513 | Samotolisib | 1386874-06-1 | Reference compound |
| HY-125130 | Hesperetin 7-O-glucoside | 31712-49-9 | Natural Products |
| HY-125131 | Buddlejasaponin IV | 139523-30-1 | Natural Products |
| HY-125132 | Agelastatin A | 152406-28-5 | Reference compound |
| HY-125134 | Alloaromadendrene | 25246-27-9 | Natural Products |
| HY-125135 | (-)-β-Peltatin | 518-29-6 | Natural Products |
| HY-125138 | ω-Muricholic Acid | 6830-03-1 | Natural Products |
| HY-125138S | ω-Muricholic Acid-d5 | 2725726-64-5 | Isotope-Labeled Compounds |
| HY-125138S1 | ω-Muricholic acid-d4 | Isotope-Labeled Compounds | |
| HY-125139 | omega-3 Arachidonic acid ethyl ester, in ethanol, 98% | 123940-93-2 | Biochemical Assay Reagents |
| HY-12514 | NK3201 | 204460-24-2 | Reference compound |
| HY-125140 | ω-3 Arachidonic acid | 24880-40-8 | Natural Products |
| HY-125140S | ω-3 Arachidonic Acid-d8 | 2692624-30-7 | Isotope-Labeled Compounds |
| HY-125141 | δ-CEHC | 84599-16-6 | Reference compound |
| HY-125143 | ABC34 | 1831135-56-8 | Reference compound |
| HY-125144 | BIIB 513 | 265986-98-9 | Reference compound |
| HY-125145 | AA92593 | 457961-34-1 | Reference compound |
| HY-125146 | BMD4503-2 | 301357-87-9 | Reference compound |
| HY-125147 | A-1293201 | 1375557-33-7 | Reference compound |
| HY-125148 | AQ148 | 178820-70-7 | Reference compound |
| HY-12515 | Nicardipine | 55985-32-5 | Reference compound |
| HY-125150 | AL-3138 | 64603-03-8 | Reference compound |
| HY-125151 | BP-1-108 | 1334492-85-1 | Reference compound |
| HY-125152 | Candicidin D | 39372-30-0 | Reference compound |
| HY-125153 | Bursin | 60267-34-7 | Peptides |
| HY-125153A | Bursin (triacetate) | 136994-55-3 | Reference compound |
| HY-125156 | Dapagliflozin-3-O-β-D-glucuronide | 1351438-75-9 | Reference compound |
| HY-125157 | Me-Indoxam | 172732-62-6 | Reference compound |
| HY-125158 | HOI-07 | 1451013-67-4 | Reference compound |
| HY-125158A | (E/Z)-HOI-07 | 1606160-40-0 | Reference compound |
| HY-125159 | Derquantel | 187865-22-1 | Reference compound |
| HY-12515A | Nicardipine (hydrochloride) | 54527-84-3 | Reference compound |
| HY-12515AR | Nicardipine (hydrochloride) (Standard) | 54527-84-3 | Reference Standards |
| HY-12515AS | Nicardipine-d3 (hydrochloride) | 1432061-50-1 | Isotope-Labeled Compounds |
| HY-12515AS2 | Nicardipine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-12515B | (S)-Nicardipine | 76093-36-2 | Reference compound |
| HY-12515C | (R)-Nicardipine | 76093-35-1 | Reference compound |
| HY-12515CS1 | (R)-Nicardipine-d3 | Isotope-Labeled Compounds | |
| HY-12516 | Desogestrel | 54024-22-5 | Reference compound |
| HY-125161 | MT0703 | 108353-14-6 | Reference compound |
| HY-125163 | MM 47755 | 117620-87-8 | Natural Products |
| HY-125165 | SLC5111312 (hydrochloride) | 1870811-01-0 | Reference compound |
| HY-125166 | DB04760 | 544678-85-5 | Reference compound |
| HY-125167 | WOBE437 | 2108100-73-6 | Reference compound |
| HY-125168 | EGA | 415687-81-9 | Reference compound |
| HY-125169 | NSC 185058 | 39122-38-8 | Reference compound |
| HY-12516R | Desogestrel (Standard) | 54024-22-5 | Reference Standards |
| HY-12517 | GNE-293 | 1354955-67-1 | Reference compound |
| HY-125170 | Galiellalactone | 133613-71-5 | Natural Products |
| HY-125171 | IAXO-102 | 1115270-63-7 | Reference compound |
| HY-125172 | PolyQ aggregation inhibitor C2-8 | 300670-16-0 | Reference compound |
| HY-125176 | G907 | 2244035-16-1 | Reference compound |
| HY-12518 | OF-1 | 919973-83-4 | Reference compound |
| HY-125182 | SMCypI C31 | 2649904-85-6 | Reference compound |
| HY-125183 | BMS-818251 | 2974489-09-1 | Reference compound |
| HY-12519 | Oltipraz | 64224-21-1 | Reference compound |
| HY-125191 | BRD1991 | 2235468-02-5 | Reference compound |
| HY-125197 | BRD5631 | 2446154-91-0 | Reference compound |
| HY-12519G | Oltipraz (GMP) | 64224-21-1 | GMP Small Molecules |
| HY-12519S | Oltipraz-d3 | 2012598-51-3 | Isotope-Labeled Compounds |
| HY-125202 | KuWal151 | 2341841-06-1 | Reference compound |
| HY-125203 | PV-1019 | 1093793-05-5 | Reference compound |
| HY-125209 | TH5427 | 2253744-56-6 | Reference compound |
| HY-125209A | TH5427 (hydrochloride) | 2253744-57-7 | Reference compound |
| HY-12520A | SKF 38393 (hydrochloride) | 62717-42-4 | Reference compound |
| HY-12520B | (R)-SKF 38393 (hydrochloride) | 81702-42-3 | Reference compound |
| HY-12521 | GSK-5498A | 1253186-49-0 | Reference compound |
| HY-125218 | PARP11 inhibitor ITK7 | 2411890-36-1 | Reference compound |
| HY-12522 | PF-06380101 | 1436391-86-4 | ADC Related |
| HY-125221 | DJ4 | 1681020-24-5 | Reference compound |
| HY-125222 | Drp1-IN-1 | 2247733-08-8 | Reference compound |
| HY-12522S | PF-06380101-d8 | Isotope-Labeled Compounds | |
| HY-12523 | Peptide M | 110652-62-5 | Peptides |
| HY-125232 | MS645 | 2250091-96-2 | Reference compound |
| HY-125236 | BET-IN-19 | 1643947-30-1 | Reference compound |
| HY-12524 | Bikinin | 188011-69-0 | Reference compound |
| HY-125244 | LEM-14-1189 | 2987501-17-5 | Reference compound |
| HY-12525 | LGD-6972 | 1207989-09-0 | Reference compound |
| HY-125254 | LEI110 | 2313525-90-3 | Reference compound |
| HY-125257 | SHP2 inhibitor LY6 | 2296718-09-5 | Reference compound |
| HY-125259 | SHP504 | 2222280-83-1 | Reference compound |
| HY-12525A | LGD-6972 (sodium) | 1207989-22-7 | Reference compound |
| HY-125260 | SHP844 | 2222280-82-0 | Reference compound |
| HY-125263 | OP-1074 | 1443752-76-8 | Reference compound |
| HY-125263B | (R)-OP-1074 | 1443752-77-9 | Reference compound |
| HY-125265 | JTP-117968 | 2250132-99-9 | Reference compound |
| HY-125269 | TED-347 | 2378626-29-8 | Reference compound |
| HY-12527 | Pyridoclax | 1651890-44-6 | Reference compound |
| HY-125273 | DNS-pE | 2196245-98-2 | Reference compound |
| HY-125276 | TH5487 | 2304947-71-3 | Reference compound |
| HY-125278 | OGT-IN-4 | 2411972-44-4 | Reference compound |
| HY-125279 | OAT-2068 | 2221950-65-6 | Reference compound |
| HY-12528 | DBPR108 | 1186426-66-3 | Reference compound |
| HY-125283 | IM176OUT05 | 1643659-96-4 | Reference compound |
| HY-125284 | Sphynolactone-7 | 2305752-57-0 | Reference compound |
| HY-125286 | AB-680 | 2105904-82-1 | Reference compound |
| HY-125286A | AB-680 (ammonium) | Reference compound | |
| HY-125287 | (Rac)-Minzasolmin | 1802518-63-3 | Reference compound |
| HY-12529 | Ro-3306 | 872573-93-8 | Reference compound |
| HY-125290 | MU1210 | 2275601-87-9 | Reference compound |
| HY-125292 | NV03 | 2448341-58-8 | Reference compound |
| HY-125295 | Leucokinin I | 104600-89-7 | Peptides |
| HY-125296 | Fipronil sulfone | 120068-36-2 | Reference compound |
| HY-125296R | Fipronil sulfone (Standard) | 120068-36-2 | Reference Standards |
| HY-125296S | Fipronil sulfone-13C6 | Isotope-Labeled Compounds | |
| HY-125298 | Cycloaspeptide A | 109171-13-3 | Natural Products |
| HY-12530 | Velpatasvir | 1377049-84-7 | Reference compound |
| HY-125300 | Oligomycin E | 110231-34-0 | Reference compound |
| HY-125301 | Thymoctonan | 107489-37-2 | Reference compound |
| HY-125304 | L 363851 | 100807-53-2 | Reference compound |
| HY-125305 | Z-AEVD-FMK | 1135688-47-9 | Reference compound |
| HY-125306 | Rotihibin A | 142689-34-7 | Natural Products |
| HY-125309 | ABT-299 | 161395-35-3 | Reference compound |
| HY-12530R | Velpatasvir (Standard) | 1377049-84-7 | Reference Standards |
| HY-12530S1 | Velpatasvir-d3 | Isotope-Labeled Compounds | |
| HY-12530S3 | Velpatasvir-13C,d3 | Isotope-Labeled Compounds | |
| HY-12531 | Encainide (hydrochloride) | 66794-74-9 | Reference compound |
| HY-125311 | Zaragozic acid D | 155179-14-9 | Natural Products |
| HY-125314 | AG-041R | 159883-95-1 | Reference compound |
| HY-125316 | AMG-151 | 1138669-65-4 | Reference compound |
| HY-125319 | Amidepsine A | 169181-28-6 | Natural Products |
| HY-12532 | Astemizole | 68844-77-9 | Reference compound |
| HY-125321 | Lychnostatin 2 | 128700-84-5 | Natural Products |
| HY-125322 | Reveromycin C | 144860-69-5 | Reference compound |
| HY-125323 | 6-Hydroxykaempferol 3,6-diglucoside | 142674-16-6 | Natural Products |
| HY-125324 | Squalestatin 3 | 142505-92-8 | Natural Products |
| HY-125325 | Deoxymulundocandin | 138626-63-8 | Natural Products |
| HY-125326 | Spinosyn D | 131929-63-0 | Reference compound |
| HY-125327 | YM-543 | 1610007-47-0 | Reference compound |
| HY-12532R | Astemizole (Standard) | 68844-77-9 | Reference Standards |
| HY-12533 | Disopyramide | 3737-09-5 | Reference compound |
| HY-125330 | Denagliptin (tosylate) | 811432-66-3 | Reference compound |
| HY-125331 | DRF-1042 | 200619-13-2 | ADC Related |
| HY-125335 | Oligomycin D | 1404-59-7 | Reference compound |
| HY-125338 | Psammaplysene B | 865722-85-6 | Reference compound |
| HY-125339 | Ro 41-0960 | 125628-97-9 | Reference compound |
| HY-12533A | Disopyramide (phosphate) | 22059-60-5 | Reference compound |
| HY-12533B | Disopyramide (hydrochloride) | 54687-36-4 | Reference compound |
| HY-12533R | Disopyramide (Standard) | 3737-09-5 | Reference Standards |
| HY-12534 | Wiskostatin | 253449-04-6 | Reference compound |
| HY-125340 | Sarcinapterin | 89157-12-0 | Natural Products |
| HY-125341 | Microginin 527 | 1135249-50-1 | Reference compound |
| HY-125344 | Fusarisetin A | 1300041-53-5 | Natural Products |
| HY-125346 | Lactoferroxin A | 117667-25-1 | Reference compound |
| HY-125347 | TA-993 | 150591-06-3 | Reference compound |
| HY-125348 | 6α-Hydroxy paclitaxel | 153212-75-0 | Reference compound |
| HY-125348S | 6α-Hydroxy Paclitaxel-d5 | 1315376-90-9 | Isotope-Labeled Compounds |
| HY-125349 | A-83016F | 142435-72-1 | Reference compound |
| HY-12535 | Trichodesmine | 548-90-3 | Natural Products |
| HY-125350 | Entacapone acid | 160391-70-8 | Reference compound |
| HY-125351 | SPT-IN-1 | 1933533-18-6 | Reference compound |
| HY-125354 | Limonin glucoside | 123564-61-4 | Natural Products |
| HY-125355 | SEC | 1802997-81-4 | Reference compound |
| HY-125357 | Ternatin | 148619-41-4 | Reference compound |
| HY-125358 | Dactylfungin B | 146935-36-6 | Natural Products |
| HY-125360 | Mazipredone (free base) | 13085-08-0 | Reference compound |
| HY-125361 | Ganosporeric acid A | 135357-25-4 | Natural Products |
| HY-125365 | Rifamycin S | 13553-79-2 | Natural Products |
| HY-125365R | Rifamycin S (Standard) | 13553-79-2 | Reference Standards |
| HY-125366 | ARI-3099 | 1432499-49-4 | Reference compound |
| HY-125368 | LB30870 | 1583240-63-4 | Reference compound |
| HY-12537 | Peptide 401 | 32908-73-9 | Peptides |
| HY-125370S | Phenylephrine glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-125371 | 2'-C-Methyladenosine | 15397-12-3 | Reference compound |
| HY-125372 | 2-Amino benzamidoxime | 16348-49-5 | Reference compound |
| HY-125374 | Larotaxel | 156294-36-9 | Reference compound |
| HY-125374A | Larotaxel (dihydrate) | 192573-38-9 | Reference compound |
| HY-125375 | L-662583 | 119731-75-8 | Reference compound |
| HY-125376 | PI3Kδ-IN-3 | 1431540-99-6 | Reference compound |
| HY-125377 | Leustroducsin C | 145142-83-2 | Natural Products |
| HY-125378 | SBP-0636457 | 1422180-49-1 | Reference compound |
| HY-125378A | (7R)-SBP-0636457 | 1422180-61-7 | Reference compound |
| HY-12538 | Graveoline | 485-61-0 | Reference compound |
| HY-125381 | CFTR corrector 2 | 1628416-28-3 | Reference compound |
| HY-125382 | L-797591 | 217480-24-5 | Reference compound |
| HY-125383 | ZK118182 Isopropyl ester | 154927-31-8 | Reference compound |
| HY-125384 | ARN14686 | 1628345-10-7 | Reference compound |
| HY-125385 | Sulforhodamine 101 DHPE | 187099-99-6 | Dye Reagents |
| HY-125386 | SQ 32056 | 139113-49-8 | Reference compound |
| HY-125387 | TOP1210 | 1628439-59-7 | Reference compound |
| HY-125388 | Martinomycin | 160791-16-2 | Natural Products |
| HY-12539 | Fluorocurarine (chloride) | 22273-09-2 | Reference compound |
| HY-125390 | SM-360320 | 226907-52-4 | Reference compound |
| HY-125392 | 2-(Biotin-amido)-1,3-bis-(C1-PEG1-acid) | 2086689-02-1 | Reference compound |
| HY-125393 | Leustroducsin A | 145142-81-0 | Natural Products |
| HY-125394 | 9(R)-HODE cholesteryl ester | 330800-93-6 | Reference compound |
| HY-125395 | Altromycin G | 134887-79-9 | Natural Products |
| HY-125396 | 11-Deoxyprostaglandin F2β | 37786-07-5 | Reference compound |
| HY-125399 | PSMA-11 | 1366302-52-4 | Reference compound |
| HY-125400 | Zaragozic acid C | 146389-62-0 | Natural Products |
| HY-125402 | GSK-843 | 1601496-05-2 | Reference compound |
| HY-125407 | Palmitoyl serinol | 126127-31-9 | Reference compound |
| HY-125407S | Palmitoyl serinol-d5 | 946524-35-2 | Isotope-Labeled Compounds |
| HY-125408 | Maresin conjugates in tissue regeneration 1 | 1784701-61-6 | Reference compound |
| HY-125409 | Lysinoalanine | 18810-04-3 | Reference compound |
| HY-125409A | (S,R)-Lysinoalanine | 63121-95-9 | Reference compound |
| HY-125410 | Promothiocin A | 156737-05-2 | Natural Products |
| HY-125411 | Berninamycin D | 161263-50-9 | Natural Products |
| HY-125412 | Fasciculic acid B | 126882-55-1 | Natural Products |
| HY-125414 | Lydicamycin | 133352-27-9 | Natural Products |
| HY-125415 | PF-4693627 | 1312815-93-2 | Reference compound |
| HY-125416 | Streptothricin F | 3808-42-2 | Reference compound |
| HY-125419 | Amythiamicin B | 156620-48-3 | Natural Products |
| HY-12542 | Dantrolene | 7261-97-4 | Reference compound |
| HY-125420 | 5-Deazaisofolic acid | 130327-67-2 | Reference compound |
| HY-125422 | Matlystatin A | 140626-94-4 | Natural Products |
| HY-125424 | AM8191 (hydrochloride) | 1417548-17-4 | Reference compound |
| HY-125427 | SKOG102 | 21062-28-2 | Reference compound |
| HY-125429 | Lokysterolamine B | 159934-15-3 | Natural Products |
| HY-12542A | Dantrolene (sodium hemiheptahydrate) | 24868-20-0 | Reference compound |
| HY-12542AR | Dantrolene (sodium hemiheptahydrate) (Standard) | 24868-20-0 | Reference Standards |
| HY-12542R | Dantrolene (Standard) | 7261-97-4 | Reference Standards |
| HY-12542S | Dantrolene-13C3 | 1185234-99-4 | Isotope-Labeled Compounds |
| HY-125430 | Padanamide A | 1314881-80-5 | Reference compound |
| HY-125432 | Poststatin | 135219-43-1 | Reference compound |
| HY-125433 | A-75925 | 129467-48-7 | Reference compound |
| HY-125434 | Laccaic acid B | 17249-00-2 | Natural Products |
| HY-125437 | 3-Epidehydrotumulosic acid | 167775-54-4 | Natural Products |
| HY-125439 | Squalestatin 2 | 142505-91-7 | Reference compound |
| HY-125441 | L-732531 | 148365-48-4 | Reference compound |
| HY-125443 | Lucialdehyde A | 420781-84-6 | Natural Products |
| HY-125445 | PCTR1 | 1810710-59-8 | Reference compound |
| HY-125446S | 2-Hydroxymethyl olanzapine-d3 | 1190006-36-0 | Isotope-Labeled Compounds |
| HY-125449 | Fasciculic acid C | 126882-56-2 | Reference compound |
| HY-12545 | Brevetoxin-3 | 85079-48-7 | Natural Products |
| HY-125452 | DiSBAC10 | 169211-45-4 | Dye Reagents |
| HY-125453 | Symplostatin 1 | 212007-18-6 | Natural Products |
| HY-125455 | Ro 41-1879 | 141916-35-0 | Reference compound |
| HY-125457 | α-Naphtholbenzein | 145-50-6 | Dye Reagents |
| HY-125458 | Iromycin A | 213137-53-2 | Natural Products |
| HY-12546 | Brevetoxin B | 79580-28-2 | Natural Products |
| HY-125461 | Altersolanol A | 22268-16-2 | Natural Products |
| HY-125463 | ANQ9040 | 142021-80-5 | Reference compound |
| HY-125465 | SLLN-15 | 2403650-93-9 | Reference compound |
| HY-125466 | cRIPGBM | 2361988-76-1 | Reference compound |
| HY-125469 | ICA-105665 | 2694728-63-5 | Reference compound |
| HY-12547 | Betonicine | 515-25-3 | Natural Products |
| HY-125471 | VK-1727 | Reference compound | |
| HY-125473 | IDX375 | 1162665-52-2 | Reference compound |
| HY-125474 | Carrageenan | 9000-07-1 | Biochemical Assay Reagents |
| HY-125475 | Rivipansel | 927881-99-0 | Reference compound |
| HY-125486 | Reversin 121 | 174630-04-7 | Peptides |
| HY-125487 | Appenolide A | 148077-10-5 | Reference compound |
| HY-125488 | Unguisin B | 226956-07-6 | Peptides |
| HY-125490 | Shermilamine B | 122271-41-4 | Natural Products |
| HY-125494 | Droxinavir (hydrochloride) | 155662-50-3 | Reference compound |
| HY-125495 | Telmesteine | 122946-43-4 | Reference compound |
| HY-125496 | A201A | 37305-78-5 | Natural Products |
| HY-12550 | GW542573X | 660846-41-3 | Reference compound |
| HY-125501 | Biotin-XX hydrazide | 211237-33-1 | Biochemical Assay Reagents |
| HY-125505 | BI-11634 | 1622159-00-5 | Reference compound |
| HY-125506 | NP-G2-044 | 1807454-59-6 | Reference compound |
| HY-125508 | CCD-3693 | 162883-07-0 | Reference compound |
| HY-125510 | UNC2541 | 1612782-86-1 | Reference compound |
| HY-125511 | Chaetoviridin A | 128252-98-2 | Natural Products |
| HY-125512 | Saccharocarcin B | 158475-33-3 | Reference compound |
| HY-125515 | Tetrahydroharmine | 17019-01-1 | Natural Products |
| HY-125516 | MCTR3 | 1784701-63-8 | Reference compound |
| HY-125518 | Xanthomegnin | 1685-91-2 | Natural Products |
| HY-125522 | Methyl helicterate | 102637-02-5 | Natural Products |
| HY-125523 | Fumiquinazoline D | 140715-86-2 | Natural Products |
| HY-125524 | Antibacterial agent 199 | 1629166-56-8 | Natural Products |
| HY-125527 | Resolvin D1 | 872993-05-0 | Natural Products |
| HY-125527A | 17(R)-Resolvin D1 | 528583-91-7 | Reference compound |
| HY-125527AS | 17(R)-Resolvin D1-d5 | Isotope-Labeled Compounds | |
| HY-125527S | Resolvin D1-d5 | 1881277-32-2 | Isotope-Labeled Compounds |
| HY-125528 | Ro 09-1679 | 141426-89-3 | Reference compound |
| HY-125529 | DMPAC-Chol | 184582-91-0 | Biochemical Assay Reagents |
| HY-125530 | Platycoside A | 209404-00-2 | Natural Products |
| HY-125531 | Dactylorhin A | 256459-34-4 | Natural Products |
| HY-125532 | 3-O-cis-p-Coumaroyltormentic acid | 121072-40-0 | Natural Products |
| HY-125534 | Tos-PEG9-Boc | 1345337-28-1 | Reference compound |
| HY-125535 | OSU-53 | 1290069-19-0 | Reference compound |
| HY-125538 | Deoxybrevianamide E | 34610-68-9 | Natural Products |
| HY-125539 | Roridin E | 16891-85-3 | Natural Products |
| HY-12554 | Terlipressin | 14636-12-5 | Reference compound |
| HY-125540 | Saussureamine C | 148245-83-4 | Natural Products |
| HY-125541 | DBCO-NHCO-PEG4-acid | 1870899-46-9 | ADC Related |
| HY-125542 | DCZ3301 | 2136278-38-9 | Reference compound |
| HY-125543 | Karsoside | 149155-50-0 | Natural Products |
| HY-125544 | LY 295427 | 152755-31-2 | Reference compound |
| HY-125545 | Cynanester A | 143502-52-7 | Natural Products |
| HY-125546 | Erythromycin C | 1675-02-1 | Natural Products |
| HY-125546R | Erythromycin C (Standard) | 1675-02-1 | Reference Standards |
| HY-125548 | Antradion | 19854-90-1 | Reference compound |
| HY-12554A | Terlipressin (diacetate) | 1884420-36-3 | Reference compound |
| HY-12554B | Terlipressin (acetate) | 914453-96-6 | Reference compound |
| HY-125550 | Doramectin aglycone | 1987883-26-0 | Reference compound |
| HY-125551 | L-687908 | 132565-33-4 | Reference compound |
| HY-125552 | Chlorothricin | 34707-92-1 | Reference compound |
| HY-125553 | Hexapeptide-10 | 146439-94-3 | Peptides |
| HY-125554 | KDdiA-PC | 439904-34-4 | Reference compound |
| HY-125555 | Azosulfamide | 133-60-8 | Reference compound |
| HY-125556 | Tetragastrin | 1947-37-1 | Peptides |
| HY-125557 | Lauroguadine (hydrochloride) | 135-42-2 | Reference compound |
| HY-125558 | PT150 | 189035-07-2 | Reference compound |
| HY-125559 | Jesaconitine | 16298-90-1 | Natural Products |
| HY-125560 | Leucomycin A1 | 16846-34-7 | Reference compound |
| HY-125561 | Josamycin propionate | 31674-19-8 | Reference compound |
| HY-125561R | Josamycin propionate (Standard) | 31674-19-8 | Reference Standards |
| HY-125563 | 13,14-Dehydro-15-cyclohexyl carbaprostacyclin | 145375-81-1 | Reference compound |
| HY-125564 | Acetyltrialanine | 19245-85-3 | Natural Products |
| HY-125567 | Antileukinate | 138559-60-1 | Peptides |
| HY-125568 | Pyridoxatin | 135529-30-5 | Natural Products |
| HY-125569 | Leucomycin A5 | 18361-45-0 | Biochemical Assay Reagents |
| HY-12557 | γ-Glutamylvaline | 2746-34-1 | Natural Products |
| HY-125570 | Ginsenoside Rs3 | 194861-70-6 | Natural Products |
| HY-125571 | A 74704 | 129467-45-4 | Reference compound |
| HY-125572 | Gibberellin A7 | 510-75-8 | Natural Products |
| HY-125575 | FC11409B | 1380411-57-3 | Reference compound |
| HY-125576 | Griselimycin | 26034-16-2 | Reference compound |
| HY-125579 | Ro 25-0534 | 143488-32-8 | Reference compound |
| HY-12558 | LY3009120 | 1454682-72-4 | Reference compound |
| HY-125580 | Makaluvamine A | 146555-78-4 | Reference compound |
| HY-125582 | Enmenol | 28957-06-4 | Natural Products |
| HY-125583 | Ketodieldrin | 21038-31-3 | Reference compound |
| HY-125586 | β-Amanitin | 21150-22-1 | ADC Related |
| HY-125587 | 25-Desacetyl rifampicin | 16783-99-6 | Reference compound |
| HY-125587S | 25-Desacetyl Rifampicin-d3 | 2714485-01-3 | Isotope-Labeled Compounds |
| HY-125587S1 | 25-Desacetyl rifampicin-d4 | 2747918-77-8 | Isotope-Labeled Compounds |
| HY-125588 | Chromium picolinate | 14639-25-9 | Reference compound |
| HY-125588R | Chromium picolinate (Standard) | 14639-25-9 | Reference Standards |
| HY-12559 | Alisporivir | 254435-95-5 | Reference compound |
| HY-125592 | Calyxin H | 202596-22-3 | Natural Products |
| HY-125593 | Dasminapant | 1570231-89-8 | Reference compound |
| HY-125594 | T-1095A | 209746-56-5 | Reference compound |
| HY-125596 | Lachnumon | 150671-02-6 | Reference compound |
| HY-125597 | Glabrocoumarone A | 178330-48-8 | Natural Products |
| HY-125598 | Secologanin | 19351-63-4 | Natural Products |
| HY-12560 | PNU-282987 (free base) | 711085-63-1 | Reference compound |
| HY-125600 | LY219703 | 156281-08-2 | Reference compound |
| HY-125602 | MNI-444 | 1974301-94-4 | Reference compound |
| HY-125603 | Termitomycamide B | 1254277-89-8 | Natural Products |
| HY-125604 | WCK-4234 | 1804915-68-1 | Reference compound |
| HY-125605 | Nannochelin A | 133705-25-6 | Reference compound |
| HY-125606 | Amphocil | 120895-52-5 | Reference compound |
| HY-125608 | Tiacumicin C | 106008-70-2 | Natural Products |
| HY-12560A | PNU-282987 | 123464-89-1 | Reference compound |
| HY-12560C | (S)-PNU-282987 (hydrochloride) | 128311-08-0 | Reference compound |
| HY-12560D | PNU-282987 (S enantiomer free base) | 737727-12-7 | Reference compound |
| HY-125610 | DA-3934 | 183176-50-3 | Reference compound |
| HY-125611 | Fluorogestone acetate | 2529-45-5 | Reference compound |
| HY-125612 | Artonin E | 129683-93-8 | Natural Products |
| HY-125615 | DMP 728 (methanesulfonate) | 155158-97-7 | Reference compound |
| HY-125616 | Biotinoyl tripeptide-1 | 299157-54-3 | Peptides |
| HY-125617 | α-Lipomycin | 51053-40-8 | Natural Products |
| HY-125618 | Lankacidinol A | 23498-36-4 | Reference compound |
| HY-125619 | 1,2-Dioctanoyl-sn-glycero-3-phosphocholine | 19191-91-4 | Biochemical Assay Reagents |
| HY-125620 | Rubiginone D2 | 274913-71-2 | Natural Products |
| HY-125623 | MitoPerOx | 1392820-50-6 | Dye Reagents |
| HY-125625 | ES 6864 | 116326-39-7 | Reference compound |
| HY-125626 | 8-iso-15-keto Prostaglandin F2α | 191919-01-4 | Reference compound |
| HY-125628 | Kahalalide A | 179733-11-0 | Reference compound |
| HY-125629 | Primordazine B | 339337-07-4 | Reference compound |
| HY-125630 | Decacyclene | 191-48-0 | Reference compound |
| HY-125631 | Cyclothialidine | 147214-63-9 | Reference compound |
| HY-125632 | Ro 19-9638 | 116370-29-7 | Reference compound |
| HY-125633 | Kapurimycin A3 | 129966-45-6 | Natural Products |
| HY-125636 | Mycro1 | 313987-85-8 | Reference compound |
| HY-125637 | Venturicidin B | 33538-72-6 | Reference compound |
| HY-125639 | (rac)-AR-13503 | 1254032-16-0 | Reference compound |
| HY-12564 | Phthalazinone pyrazole | 880487-62-7 | Reference compound |
| HY-125641 | AL-34662 | 210580-75-9 | Reference compound |
| HY-125643 | Pitavastatin lactone | 141750-63-2 | Reference compound |
| HY-125643R | Pitavastatin lactone (Standard) | 141750-63-2 | Reference Standards |
| HY-125644 | L-Lombricine | 18416-85-8 | Reference compound |
| HY-125645 | M122 | 2127411-50-9 | Reference compound |
| HY-125647 | 10-Deazaaminopterin | 52454-37-2 | Reference compound |
| HY-125648 | Euphorbadienol | 566-14-3 | Natural Products |
| HY-125649 | Delphinidin 3,5-diglucoside | 17670-06-3 | Natural Products |
| HY-125650 | Pseudouridimycin | 1566586-52-4 | Natural Products |
| HY-125650A | Pseudouridimycin (TFA) | 2760807-99-4 | Reference compound |
| HY-125652 | Macrosphelide A | 172923-77-2 | Natural Products |
| HY-125653 | Kapurimycin A2 | 132412-64-7 | Natural Products |
| HY-125654 | Olanexidine | 146510-36-3 | Reference compound |
| HY-125654A | Olanexidine (hydrochloride) | 146509-94-6 | Reference compound |
| HY-125654B | Olanexidine (hydrochloride semihydrate) | 218282-71-4 | Reference compound |
| HY-125654C | Olanexidine (gluconate) | 799787-53-4 | Reference compound |
| HY-125655 | UNC-4219 (TFA) | 1872382-50-7 | Reference compound |
| HY-125656 | Bostrycin | 21879-81-2 | Natural Products |
| HY-125658 | Biotinyl tyramide | 41994-02-9 | Dye Reagents |
| HY-125658S | Biotinyl tyramide-d4 | Isotope-Labeled Compounds | |
| HY-125660 | Leucettamol A | 151124-32-2 | Reference compound |
| HY-125662A | BMX-001 | 1379783-91-1 | Reference compound |
| HY-125664 | Lucialdehyde B | 480439-84-7 | Natural Products |
| HY-125665 | Pheophorbide A | 15664-29-6 | Natural Products |
| HY-125665R | Pheophorbide A (Standard) | 15664-29-6 | Reference Standards |
| HY-125666 | Agistatin B | 144096-46-8 | Natural Products |
| HY-125667 | PA1 | 1620951-72-5 | Reference compound |
| HY-125668 | Ro 43-5054 | 138107-58-1 | Reference compound |
| HY-125669 | XR 3054 | 247090-97-7 | Reference compound |
| HY-12567 | ML375 | 1488362-55-5 | Reference compound |
| HY-125670 | Lanceolarin | 15914-68-8 | Natural Products |
| HY-125671 | Triarachidin | 620-64-4 | Natural Products |
| HY-125673 | AC-178335 | 212966-15-9 | Reference compound |
| HY-125676 | Thermopterin | 135745-46-9 | Natural Products |
| HY-125677 | SHetA2 | 361483-66-1 | Reference compound |
| HY-125678 | Jasmine lactone | 25524-95-2 | Natural Products |
| HY-125678S | Jasmine lactone-d2 | Isotope-Labeled Compounds | |
| HY-12567A | (R)-ML375 | 1488362-56-6 | Reference compound |
| HY-125682 | Amphotericin A | 1405-32-9 | Reference compound |
| HY-125684 | Trichodecenin I | 141024-74-0 | Natural Products |
| HY-125685 | Germacrene D | 23986-74-5 | Natural Products |
| HY-125686 | Beesioside Q | 261767-91-3 | Natural Products |
| HY-125687 | N,N'-suberoyldiglycylglycine | 143673-93-2 | Reference compound |
| HY-125690 | Thielocin B1 | 144118-26-3 | Reference compound |
| HY-125691 | LY-338979 | 193281-00-4 | Reference compound |
| HY-125692 | L-740093 | 154967-59-6 | Reference compound |
| HY-125693 | L685818 | 143839-74-1 | Reference compound |
| HY-125694 | MFB-1041 | 151856-47-2 | Reference compound |
| HY-125695 | Loxitalamic acid | 28179-44-4 | Reference compound |
| HY-125698 | 3-Deoxyaphidicolin | 85483-00-7 | Natural Products |
| HY-125699 | Ochratoxin C | 4865-85-4 | Natural Products |
| HY-12570 | CK2-IN-9 | 1461658-58-1 | Reference compound |
| HY-125700 | Baogongteng A | 74239-84-2 | Natural Products |
| HY-125701 | A-76154 | 136989-30-5 | Reference compound |
| HY-125702 | Pulsatilloside E | 366814-43-9 | Natural Products |
| HY-125703 | Ferutinin | 41743-44-6 | Natural Products |
| HY-125705 | Herquline A | 71812-08-3 | Natural Products |
| HY-125706 | 1233B | 34668-61-6 | Natural Products |
| HY-125707 | Concanamycin B | 81552-33-2 | Natural Products |
| HY-125712 | CGP 53820 | 149267-24-3 | Reference compound |
| HY-125713 | Ganoderic acid Y | 86377-52-8 | Natural Products |
| HY-125715 | Trigalacturonic acid | 6037-45-2 | Biochemical Assay Reagents |
| HY-125716 | DRF-2519 (free base) | 194713-46-7 | Reference compound |
| HY-125717 | VU0029251 | 330819-85-7 | Reference compound |
| HY-125719 | Clevudine triphosphate | 174625-00-4 | Reference compound |
| HY-12572 | TIE-2/VEGFR-2 kinase-IN-2 | 501693-48-7 | Reference compound |
| HY-125720 | A-39183A | 79426-51-0 | Natural Products |
| HY-125721 | Tetranactin | 33956-61-5 | Natural Products |
| HY-125723 | Echinocandin B | 54651-05-7 | Reference compound |
| HY-125726 | Sulfo galactosylceramide | 151057-28-2 | Reference compound |
| HY-125727 | Globosuxanthone A | 917091-74-8 | Natural Products |
| HY-125728 | Micrococcin P1 | 67401-56-3 | Reference compound |
| HY-125729 | Ivermectin B1b | 70209-81-3 | Natural Products |
| HY-125730 | Kibdelone A | 934464-77-4 | Natural Products |
| HY-125731 | Glycodeoxycholic Acid | 360-65-6 | Natural Products |
| HY-125731R | Glycodeoxycholic Acid (Standard) | 360-65-6 | Reference Standards |
| HY-125731S | Glycodeoxycholic acid-d4 | 1069132-37-1 | Isotope-Labeled Compounds |
| HY-125731S1 | Glycodeoxycholic acid-d6 | 2483831-98-5 | Isotope-Labeled Compounds |
| HY-125732 | Decarestrictine D | 127393-89-9 | Natural Products |
| HY-125733 | Thiocillin I | 59979-01-0 | Reference compound |
| HY-125734 | DMHAPC-Chol | 774598-29-7 | Biochemical Assay Reagents |
| HY-125735 | Sch725674 | 877061-66-0 | Natural Products |
| HY-125737 | 15-deoxy-Δ12,14-Prostaglandin J2 Glutathione | 537695-15-1 | Reference compound |
| HY-125738 | Obscurolide A1 | 144397-99-9 | Reference compound |
| HY-125740 | Malvidin-3-glucoside (chloride) | 7228-78-6 | Natural Products |
| HY-125740R | Malvidin-3-glucoside (chloride) (Standard) | 7228-78-6 | Reference Standards |
| HY-125741 | GW768505A (free base) | 501693-25-0 | Reference compound |
| HY-125743 | S-1 Methanandamide | 157182-50-8 | Reference compound |
| HY-125744 | Palmitoyl thio-PC | 113881-60-0 | Reference compound |
| HY-125745 | Loloatin B 10 | 182422-45-3 | Peptides |
| HY-125746 | BODIPY-Cholesterol | 878557-19-8 | Dye Reagents |
| HY-125747 | Actinomycin X2 | 18865-48-0 | Peptides |
| HY-125748 | CBM-301940 | 902146-11-6 | Reference compound |
| HY-125750 | Coumarin 7 | 27425-55-4 | Dye Reagents |
| HY-125751 | UCSF924 | 1434515-70-4 | Reference compound |
| HY-125759 | 3-Phenyltoxoflavin | 32502-63-9 | Reference compound |
| HY-125762 | Tyrosinase-IN-16 | 126651-85-2 | Reference compound |
| HY-12577 | TNKS1/2-IN-1 | 1498300-31-4 | Reference compound |
| HY-125770 | 5(S)-HPETE | 71774-08-8 | Reference compound |
| HY-125771 | 1-Stearoyl-sn-glycero-3-phosphocholine | 19420-57-6 | Biochemical Assay Reagents |
| HY-125771S | 1-Stearoyl-sn-glycero-3-phosphocholine-d35 | 327178-92-7 | Isotope-Labeled Compounds |
| HY-125772 | Acetyl podocarpic acid anhydride | 344327-48-6 | Reference compound |
| HY-125773 | β-cyano-L-Alanine | 6232-19-5 | Reference compound |
| HY-125774 | Bimatoprost acid | 38344-08-0 | Reference compound |
| HY-125774S | Bimatoprost acid-d4 | 58976-50-4 | Isotope-Labeled Compounds |
| HY-125775 | 12(S)-Hydroxy-16-heptadecynoic acid | 148019-74-3 | Reference compound |
| HY-125776 | Kresoxim-methyl | 143390-89-0 | Reference compound |
| HY-125776R | Kresoxim-methyl (Standard) | 143390-89-0 | Reference Standards |
| HY-125777A | α-Conotoxin Vc1.1 (TFA) | Peptides | |
| HY-125778 | Cochlioquinone B | 32450-26-3 | Reference compound |
| HY-125780 | 5-Phenylhydantoin | 89-24-7 | Reference compound |
| HY-125780R | 5-Phenylhydantoin (Standard) | 89-24-7 | Reference Standards |
| HY-125782 | 15(R)-15-Methyl prostaglandin D2 | 210978-26-0 | Reference compound |
| HY-125783 | 1-Palmitoyl-sn-glycero-3-phosphocholine | 17364-16-8 | Reference compound |
| HY-125783S | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9 | 1872379-72-0 | Isotope-Labeled Compounds |
| HY-125783S1 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d31 | 327178-91-6 | Isotope-Labeled Compounds |
| HY-125783S2 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d49 | 2315262-40-7 | Isotope-Labeled Compounds |
| HY-125783S3 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9-1 | 182257-09-6 | Isotope-Labeled Compounds |
| HY-125784 | Viloxazine (hydrochloride) | 35604-67-2 | Reference compound |
| HY-125784A | (R)-Viloxazine (hydrochloride) | 56287-63-9 | Reference compound |
| HY-125784AS | (R)-Viloxazine-d5 (hydrochloride) | 1246815-04-2 | Isotope-Labeled Compounds |
| HY-125784B | (S)-Viloxazine (hydrochloride) | 56287-61-7 | Reference compound |
| HY-125784BS | (S)-Viloxazine-d5 (hydrochloride) | 1246816-39-6 | Isotope-Labeled Compounds |
| HY-125784S | (rac)-Viloxazine-d5 (hydrochloride) | 1276483-10-3 | Isotope-Labeled Compounds |
| HY-125785A | 2-Mercaptopyridine N-oxide (sodium) | 3811-73-2 | Reference compound |
| HY-125786 | Solvent violet 9 | 467-63-0 | Reference compound |
| HY-125787 | MLS000389544 | 573965-48-7 | Reference compound |
| HY-125789 | PF-04753299 | 1289620-49-0 | Reference compound |
| HY-12579 | RO 2468 | 1360821-21-1 | Reference compound |
| HY-125791 | cis-Epoxysuccinic acid | 16533-72-5 | Reference compound |
| HY-125792 | Nexinhib20 | 331949-35-0 | Reference compound |
| HY-125796 | U-14624 | 14901-16-7 | Reference compound |
| HY-125798 | 2,3-Dehydro-2-deoxy-N-acetylneuraminic acid | 24967-27-9 | Reference compound |
| HY-12580 | RO5353 | 1360821-61-9 | Reference compound |
| HY-125801 | 3-Oxo-5β-cholanoic acid | 1553-56-6 | Reference compound |
| HY-125801R | 3-Oxo-5β-cholanoic acid (Standard) | 1553-56-6 | Reference Standards |
| HY-125802 | Monolauryl phosphate | 2627-35-2 | Biochemical Assay Reagents |
| HY-125809 | 4-(1-Phenylethyl)resorcinol | 85-27-8 | Biochemical Assay Reagents |
| HY-125810 | 4'-Ethynyl-2'-deoxyadenosine | 306305-07-7 | Reference compound |
| HY-125814 | 2-Chloro-N6-furfuryladenine | 101862-47-9 | Reference compound |
| HY-125815 | Reactive Blue 4 | 13324-20-4 | Dye Reagents |
| HY-125817 | BI-3406 | 2230836-55-0 | Reference compound |
| HY-125818 | Cytidine-5'-triphosphate | 65-47-4 | Oligonucleotides |
| HY-125818B | Cytidine-5'-triphosphate (sodium hydrate) | 123334-07-6 | Biochemical Assay Reagents |
| HY-125818C | Cytidine-5'-triphosphate (disodium hydrate) | 652154-13-7 | Reference compound |
| HY-125818S1 | Cytidine-5′-triphosphate-d14 (disodium) | Isotope-Labeled Compounds | |
| HY-125818S2 | Cytidine-5'-triphosphate-13C,d1 (dilithium) | Isotope-Labeled Compounds | |
| HY-125818S3 | Cytidine-5'-triphosphate-13C9 (dilithium) | Isotope-Labeled Compounds | |
| HY-125818S4 | Cytidine-5'-triphosphate-d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-125818S5 | Cytidine-5'-triphosphate-15N3,d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-125818S6 | Cytidine-5'-triphosphate-15N3 (dilithium) | Isotope-Labeled Compounds | |
| HY-125819 | Sigma-1 receptor antagonist 2 | 1639220-15-7 | Reference compound |
| HY-125820 | Sigma-1 receptor antagonist 3 | 1639220-17-9 | Reference compound |
| HY-125821 | Sigma-1 receptor antagonist 1 | 1639220-19-1 | Reference compound |
| HY-125824 | Danuglipron | 2230198-02-2 | Reference compound |
| HY-125824A | Danuglipron (tromethamine) | 2230198-03-3 | Reference compound |
| HY-125825 | Pseudoginsenoside Rh2 | 1370264-16-6 | Reference compound |
| HY-125825A | (Z)-Pseudoginsenoside Rh2 | 1636114-55-0 | Natural Products |
| HY-125826 | Heptasaccharide Glc4Xyl3 | 121591-98-8 | Natural Products |
| HY-125827 | 13-Methylberberine (chloride) | 54260-72-9 | Natural Products |
| HY-125828 | 1-(3,4-Dimethoxycinnamoyl)piperidine | 128261-84-7 | Reference compound |
| HY-12583 | A-366 | 1527503-11-2 | Reference compound |
| HY-125830 | ITIC | 1664293-06-4 | Reference compound |
| HY-125831 | ITIC-4F | 2097998-59-7 | Reference compound |
| HY-125832 | PBDB-T | 1415929-80-4 | Reference compound |
| HY-125833 | Alpha-Naphthoflavone | 604-59-1 | Natural Products |
| HY-125834 | GMB-475 | 2490599-18-1 | Reference compound |
| HY-125835 | CP-10 | 2366268-80-4 | Reference compound |
| HY-125836 | CCR4 antagonist 2 | 2206788-99-8 | Reference compound |
| HY-125837 | MS31 | 2366264-12-0 | Reference compound |
| HY-125837A | MS31 (trihydrochloride) | 2748239-18-9 | Reference compound |
| HY-125838 | J30-8 | 2366255-71-0 | Reference compound |
| HY-125839 | OP-3633 | 2102494-14-2 | Reference compound |
| HY-12584 | PF-5190457 | 1334782-79-4 | Reference compound |
| HY-125840 | Belzutifan | 1672668-24-4 | Reference compound |
| HY-125841 | EGFR mutant-IN-1 | Reference compound | |
| HY-125843 | Pomalidomide-PEG1-C2-N3 | 2271036-44-1 | Reference compound |
| HY-125844 | Tos-PEG1-O-CH2COOH | Reference compound | |
| HY-125845 | (S,R,S)-AHPC | 1448297-52-6 | Reference compound |
| HY-125845A | (S,S,S)-AHPC (hydrochloride) | 2115897-23-7 | Reference compound |
| HY-125846 | (S,R,S)-AHPC-PEG1-OTs | Reference compound | |
| HY-125847 | Salvianolic acid F | 158732-59-3 | Natural Products |
| HY-125848 | Ginsenoside F2 | 62025-49-4 | Natural Products |
| HY-125848R | Ginsenoside F2 (Standard) | 62025-49-4 | Reference Standards |
| HY-125849 | Chrysin 7-O-beta-gentiobioside | 88640-89-5 | Natural Products |
| HY-12585 | AM-4668 | 1011531-27-3 | Reference compound |
| HY-125850 | Berberrubine (chloride) | 15401-69-1 | Natural Products |
| HY-125850R | Berberrubine (chloride) (Standard) | 15401-69-1 | Reference Standards |
| HY-125851 | TP-008 | 1976038-41-1 | Reference compound |
| HY-125853 | Phosphatidylcholines,soya | 97281-47-5 | Oligonucleotides |
| HY-125854 | Phosphatidylcholines, egg | 97281-44-2 | Natural Products |
| HY-125856 | Milvexian | 1802425-99-5 | Reference compound |
| HY-125856A | Milvexian (TFA) | 1802426-00-1 | Reference compound |
| HY-125857 | Cytochrome C | 9007-43-6 | Biochemical Assay Reagents |
| HY-125857A | Cytochrome C (equine heart) | 9007-43-6 | Biochemical Assay Reagents |
| HY-125857B | Cytochrome C (Saccharomyces cerevisiae) | 9007-43-6 | Biochemical Assay Reagents |
| HY-125857C | Cytochrome C (bovine heart) | 9007-43-6 | Biochemical Assay Reagents |
| HY-125858 | MI-1061 | 1410737-34-6 | Reference compound |
| HY-125858A | MI-1061 (TFA) | 1410737-35-7 | Reference compound |
| HY-125858B | (S,R,S)-MI-1061 | 1410738-90-7 | ADC Related |
| HY-125859 | Peroxidase, Horseradish | 9003-99-0 | Enzyme |
| HY-125859A | Myeloperoxidase, human white blood cells | 9003-99-0 | Enzyme |
| HY-125859B | Lactoperoxidase, bovine milk | 9003-99-0 | Enzyme |
| HY-12586 | AZD6564 | 1251841-50-5 | Reference compound |
| HY-125860 | Tyrosinase, Mushroom | 9002-10-2 | Enzyme |
| HY-125861 | Methyl cellulose | 9004-67-5 | Biochemical Assay Reagents |
| HY-125861A | Methyl cellulose(Viscosity:15mPa.s) | 9004-67-5 | Biochemical Assay Reagents |
| HY-125861B | Methyl cellulose(Viscosity:400mPa.s) | 9004-67-5 | Biochemical Assay Reagents |
| HY-125861C | Methyl cellulose(Viscosity:1500mPa.s) | 9004-67-5 | Biochemical Assay Reagents |
| HY-125861D | Methyl cellulose(Viscosity:40000mPa.s) | 9004-67-5 | Reference compound |
| HY-125861E | Methyl cellulose(Viscosity:4000mPa.s) | 9004-67-5 | Biochemical Assay Reagents |
| HY-125861H | Methyl cellulose(Viscosity:25mPa.s) | 9004-67-5 | Biochemical Assay Reagents |
| HY-125862 | Glutathione Reductase, baker's yeast | 9001-48-3 | Enzyme |
| HY-125863 | Glucose-6-phosphate dehydrogenase, Microorganism | 9001-40-5 | Enzyme |
| HY-125863A | Glucose-6-phosphate dehydrogenase (Leuconostoc sp., recombinant) | 9001-40-5 | Enzyme |
| HY-125863B | Glucose 6-phosphate dehydrogenase (yeast, recombinant) | 9001-40-5 | Enzyme |
| HY-125863C | Glucose-6-phosphate dehydrogenase, Bacillus sp. | 9001-40-5 | Enzyme |
| HY-125864 | Fibrinogen (Bovine) | 9001-32-5 | Biochemical Assay Reagents |
| HY-125864A | Canine Fibrinogen | 9001-32-5 | Enzyme |
| HY-125864B | Murine Fibrinogen | 9001-32-5 | Enzyme |
| HY-125864C | Porcine Fibrinogen | 9001-32-5 | Enzyme |
| HY-125864D | Rabbit Fibrinogen | 9001-32-5 | Enzyme |
| HY-125865 | Casein | 9000-71-9 | Biochemical Assay Reagents |
| HY-125868 | Penethamate (hydriodide) | 808-71-9 | Reference compound |
| HY-125870 | Gellan gum, for cell culture | 71010-52-1 | Biochemical Assay Reagents |
| HY-125872 | KRAS G12C inhibitor 14 | 2349393-95-7 | Reference compound |
| HY-125873 | KRAS G12C inhibitor 15 | 2349393-21-9 | Reference compound |
| HY-125874 | KRAS G12C inhibitor 16 | 2349392-79-4 | Reference compound |
| HY-125875 | KRAS G12C inhibitor 17 | 2349393-04-8 | Reference compound |
| HY-125876 | PROTAC Bcl2 degrader-1 | 2378801-85-3 | Reference compound |
| HY-125877 | PROTAC Mcl1 degrader-1 | 2163793-38-0 | Reference compound |
| HY-125878 | PROTAC SGK3 degrader-1 | 2381320-35-8 | Reference compound |
| HY-125879 | DS08210767 | 2376334-75-5 | Reference compound |
| HY-12588 | Thiamet G | 1009816-48-1 | Reference compound |
| HY-125880 | SBI-553 | 1849603-72-0 | Reference compound |
| HY-125881 | ASP1126 | 1228580-11-7 | Reference compound |
| HY-125883 | Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc | 2435720-04-8 | Reference compound |
| HY-125884 | Pomalidomide-amido-C4-amido-C6-NH-Boc | 2435808-02-7 | Reference compound |
| HY-125887 | Boc-NH-PEG2-C2-amido-C4-acid | 1310327-20-8 | Reference compound |
| HY-125888 | Boc-NH-C6-amido-C4-acid | 10436-21-2 | Reference compound |
| HY-12589 | ZM39923 (hydrochloride) | 1021868-92-7 | Reference compound |
| HY-12589A | ZM39923 | 273727-89-2 | Reference compound |
| HY-12590 | Glutathione oxidized (disodium) | 103239-24-3 | Peptides |
| HY-125900 | Neocarzilin A | 124958-29-8 | Natural Products |
| HY-125904 | 4-Hydroxyretinoic acid | 66592-72-1 | Reference compound |
| HY-125905 | VH032-cyclopropane-F | 2306193-99-5 | Reference compound |
| HY-125906 | VHL Ligand-Linker Conjugates 15 | 2375564-62-6 | Reference compound |
| HY-125907 | Dox-Ph-PEG1-Cl | 773095-86-6 | Reference compound |
| HY-125908 | A-1210477-piperazinyl | 2351218-72-7 | Reference compound |
| HY-125909 | Phenolic acid | 29656-58-4 | Reference compound |
| HY-12591 | D-Luciferin (sodium) | 103404-75-7 | Dye Reagents |
| HY-125910 | Cholesteryl Linolenate | 2545-22-4 | Reference compound |
| HY-125911 | Gossypin | 652-78-8 | Natural Products |
| HY-125911R | Gossypin (Standard) | 652-78-8 | Reference Standards |
| HY-125913 | Benzamidine | 618-39-3 | Reference compound |
| HY-125916 | Pseurotin A | 58523-30-1 | Natural Products |
| HY-125918 | Bleomycin A5 (hydrochloride) | 55658-47-4 | Natural Products |
| HY-125919 | Vulpinic acid | 521-52-8 | Natural Products |
| HY-12591A | D-Luciferin | 2591-17-5 | Dye Reagents |
| HY-12591B | D-Luciferin (potassium) | 115144-35-9 | Dye Reagents |
| HY-125920 | Lauroylsarcosine (sodium) | 137-16-6 | Biochemical Assay Reagents |
| HY-125920R | Lauroylsarcosine (sodium) (Standard) | 137-16-6 | Reference Standards |
| HY-125921 | WST-3 | 515111-36-1 | Dye Reagents |
| HY-125922 | (22R)-Budesonide | 51372-29-3 | Reference compound |
| HY-125922S | (22R)-Budesonide-d6 | Isotope-Labeled Compounds | |
| HY-125923 | Djenkolic acid | 498-59-9 | Natural Products |
| HY-125924 | DSPE-PEG-Amine, MW 2000 (ammonium) | 474922-26-4 | Biochemical Assay Reagents |
| HY-125926S | 2-Ketodoxapram-d5 | 2407353-31-3 | Isotope-Labeled Compounds |
| HY-125926S1 | 2-Ketodoxapram-d4 | Isotope-Labeled Compounds | |
| HY-125927 | 8-Aminoadenosine | 3868-33-5 | Reference compound |
| HY-125928 | AA43279 | 354812-16-1 | Reference compound |
| HY-125929 | Murexide | 3051-09-0 | Biochemical Assay Reagents |
| HY-12593 | GS967 | 1262618-39-2 | Reference compound |
| HY-125930 | T-2513 | 288247-87-0 | Reference compound |
| HY-125930A | T-2513 (hydrochloride) | 187793-52-8 | Reference compound |
| HY-125931 | Unifiram | 272786-64-8 | Reference compound |
| HY-125932 | Debilon | 26808-51-5 | Natural Products |
| HY-125932A | 9β-Debilon | Natural Products | |
| HY-125933 | Val-Ala-PAB | 1343476-44-7 | Biochemical Assay Reagents |
| HY-125934 | Allocholic acid | 2464-18-8 | Natural Products |
| HY-125938 | Cycloartenyl ferulate | 21238-33-5 | Natural Products |
| HY-125939 | Bortezomib-pinanediol | 205393-22-2 | Reference compound |
| HY-12594 | Paritaprevir | 1216941-48-8 | Reference compound |
| HY-125940 | DPPG | 200880-41-7 | Oligonucleotides |
| HY-125940S | DPPG-d62 | 326495-46-9 | Isotope-Labeled Compounds |
| HY-125941 | PNU-101603 | 168828-60-2 | Reference compound |
| HY-125944 | MitoTEMPO (hydrate) | 1569257-94-8 | Reference compound |
| HY-125945 | Monosulfuron | 155860-63-2 | Reference compound |
| HY-125945R | Monosulfuron (Standard) | 155860-63-2 | Reference Standards |
| HY-125946 | Latanoprost lactone diol | 145667-75-0 | Reference compound |
| HY-125947 | 4-Epioxytetracycline | 14206-58-7 | Reference compound |
| HY-125947R | 4-Epioxytetracycline (Standard) | 14206-58-7 | Reference Standards |
| HY-125949 | Kanshone H | 1445952-33-9 | Natural Products |
| HY-12594A | Paritaprevir (dihydrate) | 1456607-71-8 | Reference compound |
| HY-125954 | Uridine diphosphate glucuronic acid | 2616-64-0 | Biochemical Assay Reagents |
| HY-125954A | Uridine diphosphate glucuronic acid (ammonium) | 43195-60-4 | Biochemical Assay Reagents |
| HY-125954B | UDP-galacturonic acid (trisodium) | 148407-07-2 | Biochemical Assay Reagents |
| HY-125956 | Aurkin A | 1534060-58-6 | Reference compound |
| HY-125957 | A-3 (hydrochloride) | 78957-85-4 | Reference compound |
| HY-125958 | AA9 | 2134114-20-6 | Reference compound |
| HY-125959 | Ucf-101 | 313649-08-0 | Reference compound |
| HY-12596 | JNJ-26489112 | 871824-55-4 | Reference compound |
| HY-125961 | T3Inh-1 | 50440-30-7 | Reference compound |
| HY-125962 | X-34 | 215294-98-7 | Dye Reagents |
| HY-125964 | LLP-3 | 1453835-43-2 | Reference compound |
| HY-125965 | BioA-IN-13 | 1164475-61-9 | Reference compound |
| HY-125966 | AI-4-57 | 63053-14-5 | Reference compound |
| HY-125967 | AM 374 | 86855-26-7 | Reference compound |
| HY-125969 | Rtt109 inhibitor 1 | 852935-07-0 | Reference compound |
| HY-12597 | Quisqualic acid | 52809-07-1 | Natural Products |
| HY-125970 | CRTh2 antagonist 2 | 780763-95-3 | Reference compound |
| HY-125971 | Xylopropamine (hydrobromide) | 861007-60-5 | Reference compound |
| HY-125972 | zr17-2 | 1263893-98-6 | Reference compound |
| HY-125974 | HM03 | 500565-15-1 | Reference compound |
| HY-125974A | HM03 (trihydrochloride) | 1082532-95-3 | Reference compound |
| HY-125975 | 1-Naphthyl 3,5-dinitrobenzoate | 93261-39-3 | Reference compound |
| HY-125976 | ML233 | 2080311-92-6 | Reference compound |
| HY-125978 | JY-3-094 | 389076-27-1 | Reference compound |
| HY-125979 | TSPC | 882286-32-0 | Reference compound |
| HY-12598 | (S)-3,5-DHPG | 162870-29-3 | Reference compound |
| HY-125980 | LX-3 | 380645-50-1 | Reference compound |
| HY-125982 | VUAA1 | 525582-84-7 | Reference compound |
| HY-125986 | GK187 | 1071001-50-7 | Reference compound |
| HY-125987 | RBC6 | 381186-64-7 | Reference compound |
| HY-125989 | 2-Methylthio-AMP | 22140-20-1 | Reference compound |
| HY-125989B | 2-Methylthio-AMP (diTEA) | 1227193-98-7 | Reference compound |
| HY-12598A | DHPG | 146255-66-5 | Reference compound |
| HY-12599 | URMC-099 | 1229582-33-5 | Reference compound |
| HY-125990 | SLC13A5-IN-1 | 2227548-95-8 | Reference compound |
| HY-125996 | NR1H4 activator 1 | 2242855-68-9 | Reference compound |
| HY-125997 | BTK inhibitor 10 | 2241732-30-7 | Reference compound |
| HY-125999 | EPI-589 | 1147883-03-1 | Reference compound |
| HY-12600 | AZD5582 | 1258392-53-8 | Reference compound |
| HY-126003 | ALDH1A1-IN-2 | 2231081-18-6 | Reference compound |
| HY-126005 | VGSC blocker-1 | 2230472-55-4 | Reference compound |
| HY-12601 | TNKS 22 | 1507362-00-6 | Reference compound |
| HY-126010 | Dooku1 | 2253744-54-4 | Reference compound |
| HY-126015 | P053 | 2748196-63-4 | Reference compound |
| HY-126020 | Bractoppin | 2290527-07-8 | Reference compound |
| HY-126021 | Mobam | 1079-33-0 | Reference compound |
| HY-126025 | α-Phthalimidopropiophenone | 19437-20-8 | Reference compound |
| HY-126026 | NF-κB-IN-17 | 786721-94-6 | Reference compound |
| HY-126027 | (+)-3-Carene | 498-15-7 | Natural Products |
| HY-126028 | (-)-Sotalol | 30236-31-8 | Reference compound |
| HY-126028A | (+)-Sotalol | 30236-32-9 | Reference compound |
| HY-12603 | CCT251455 | 1400284-80-1 | Reference compound |
| HY-126030 | (+)-Syringaresinol | 21453-69-0 | Natural Products |
| HY-126031 | (R)-KT109 | 2055172-60-4 | Reference compound |
| HY-126031A | (S)-KT109 | 2055172-61-5 | Reference compound |
| HY-126032 | Morantel | 20574-50-9 | Reference compound |
| HY-126033 | Sophoranol | 3411-37-8 | Natural Products |
| HY-126034 | 3,4-Dichloroisocoumarin | 51050-59-0 | Reference compound |
| HY-126036 | CH-141 | 78279-88-6 | Reference compound |
| HY-126037 | (±)-ML 209 | 1334526-14-5 | Reference compound |
| HY-126038 | BTS 39542 | 57410-31-8 | Reference compound |
| HY-126039 | L-739758 | 168157-33-3 | Reference compound |
| HY-126041A | (±)10(11)-EpDPA | 895127-65-8 | Natural Products |
| HY-126042 | (±)-Lisofylline | 6493-06-7 | Reference compound |
| HY-126042R | (±)-Lisofylline (Standard) | 6493-06-7 | Reference Standards |
| HY-126042S | (±)-Lisofylline-d6 | 1185995-26-9 | Isotope-Labeled Compounds |
| HY-126042S4 | (±)-Lisofylline-d4 | 1185879-05-3 | Isotope-Labeled Compounds |
| HY-126043 | (R)-Mephenytoin | 71140-51-7 | Reference compound |
| HY-126044 | 6-Hydroxy bexarotene | 368451-07-4 | Reference compound |
| HY-126046 | ACP1b | 1371635-84-5 | Reference compound |
| HY-126047 | (S)-(-)-Anatabine | 581-49-7 | Reference compound |
| HY-126047A | (R,S)-Anatabine | 2743-90-0 | Reference compound |
| HY-126047AR | (R,S)-Anatabine (Standard) | 2743-90-0 | Reference Standards |
| HY-126047AS | (R,S)-Anatabine-d4 | 1020719-11-2 | Isotope-Labeled Compounds |
| HY-126047B | (R)-(+)-Anatabine | 126454-22-6 | Reference compound |
| HY-126048 | JTP-70902 | 871696-49-0 | Reference compound |
| HY-126049 | (S)-Oxiracetam | 88929-35-5 | Reference compound |
| HY-12605 | SAR107375 | 1184300-63-7 | Reference compound |
| HY-126050 | (R)-Pantetheine | 496-65-1 | Reference compound |
| HY-126050R | (R)-Pantetheine (Standard) | 496-65-1 | Reference Standards |
| HY-126050S | (R)-Pantetheine-15N | Isotope-Labeled Compounds | |
| HY-126052 | Gnetol | 86361-55-9 | Natural Products |
| HY-126054 | A1062 | 1821-13-2 | Reference compound |
| HY-126055 | Hadacidin | 689-13-4 | Natural Products |
| HY-126055A | Hadacidin (sodium) | 2618-22-6 | Reference compound |
| HY-126057 | (R)-Praziquantel | 57452-98-9 | Reference compound |
| HY-126057A | (S)-Praziquantel | 57452-97-8 | Reference compound |
| HY-126057AS | (S)-Praziquantel-d11 | Isotope-Labeled Compounds | |
| HY-126057S | (R)-Praziquantel-d11 | 1399880-38-6 | Isotope-Labeled Compounds |
| HY-12605S | SAR107375-d11 (Tartrate) | Isotope-Labeled Compounds | |
| HY-126060 | 9-Ethylguanine | 879-08-3 | Reference compound |
| HY-126061 | 1,7-Dimethyluric acid | 33868-03-0 | Reference compound |
| HY-126061S | 1,7-Dimethyluric acid-d3 | 1189713-08-3 | Isotope-Labeled Compounds |
| HY-126063 | ICI-204448 (free acid) | 125190-72-9 | Reference compound |
| HY-126066 | (-)-Syringaresinol | 6216-81-5 | Natural Products |
| HY-126067 | (-)-Pinoresinol | 81446-29-9 | Natural Products |
| HY-126068 | (S)-Amisulpride | 71675-92-8 | Reference compound |
| HY-126069 | 15(R)-Iloprost | 85026-51-3 | Reference compound |
| HY-12607 | ML251 | 1486482-16-9 | Reference compound |
| HY-126070 | N-Butyl cinnamate | 538-65-8 | Biochemical Assay Reagents |
| HY-126073 | DFP00173 | 672286-03-2 | Reference compound |
| HY-126074 | Z433927330 | 1005883-72-6 | Reference compound |
| HY-126075 | WS-383 (free base) | 2247543-65-1 | Reference compound |
| HY-126075A | WS-383 | 2247544-02-9 | Reference compound |
| HY-126076 | VPC-80051 (racemate) | 877969-69-2 | Reference compound |
| HY-126076A | VPC-80051 | 2410979-04-1 | Reference compound |
| HY-126077 | MTI-31 | 1567915-38-1 | Reference compound |
| HY-12608 | TA-1887 | 1003005-29-5 | Reference compound |
| HY-126081 | (8-epi)-BW 245C | 65705-83-1 | Reference compound |
| HY-126082 | (+)-Carbovir triphosphate | 144606-93-9 | Reference compound |
| HY-126083 | 17β-Hydroxywortmannin | 58053-83-1 | Reference compound |
| HY-126084 | Carbaprostacyclin methyl ester | 69552-55-2 | Reference compound |
| HY-126085 | (±)-Alliin | 17795-26-5 | Natural Products |
| HY-126085R | (±)-Alliin (Standard) | 17795-26-5 | Reference Standards |
| HY-12610 | Carbonic anhydrase inhibitor 27 | 167098-81-9 | Reference compound |
| HY-126106 | (BrMT)2 | 622011-16-9 | Reference compound |
| HY-126107 | (±)-4-Hydroxy propranolol β-D-glucuronide | 94731-13-2 | Reference compound |
| HY-126108 | (±)8-HEPE | 99217-77-3 | Reference compound |
| HY-126108A | 8(S)-HEPE | 118492-81-2 | Reference compound |
| HY-126109 | (±)-8-Prenylnaringenin | 68682-02-0 | Natural Products |
| HY-12611 | Sergliflozin etabonate | 408504-26-7 | Reference compound |
| HY-126110 | (±)11-HDoHE | 87018-59-5 | Natural Products |
| HY-126112 | Mephenoxalone | 70-07-5 | Reference compound |
| HY-126112R | Mephenoxalone (Standard) | 70-07-5 | Reference Standards |
| HY-126113 | KIN101 | 610753-87-2 | Reference compound |
| HY-126114 | Lupeol acetate | 1617-68-1 | Natural Products |
| HY-126115 | 15(S)-Latanoprost | 145773-22-4 | Reference compound |
| HY-126115R | 15(S)-Latanoprost (Standard) | 145773-22-4 | Reference Standards |
| HY-126117 | (+)-Xylariamide A | 852690-88-1 | Reference compound |
| HY-126118 | Dienochlor | 2227-17-0 | Reference compound |
| HY-126119 | 5,10-Dideazafolic acid | 85597-18-8 | Reference compound |
| HY-126121 | 2-Hydroxy Ibuprofen | 51146-55-5 | Natural Products |
| HY-126121R | 2-Hydroxy Ibuprofen (Standard) | 51146-55-5 | Reference Standards |
| HY-126121S | 2-Hydroxy Ibuprofen-d6 | 1217055-71-4 | Isotope-Labeled Compounds |
| HY-126123 | NR2B-selective NMDA receptor antagonist 1 | 457897-92-6 | Reference compound |
| HY-126124 | AP39 | 1429061-80-2 | Reference compound |
| HY-126125 | CHIR-98023 | 252916-76-0 | Reference compound |
| HY-126126 | S-Adenosyl-DL-methionine | 17176-17-9 | Natural Products |
| HY-126127 | BRL 22321 (free base) | 72364-91-1 | Reference compound |
| HY-126128 | Heliotrine | 303-33-3 | Reference compound |
| HY-126129 | Desacetylcefotaxime | 66340-28-1 | Reference compound |
| HY-126129R | Desacetylcefotaxime (Standard) | 66340-28-1 | Reference Standards |
| HY-12613 | 2-C-methylene-myo-inositol oxide | 4068-87-5 | Reference compound |
| HY-126130 | LysRs-IN-2 | 2170696-76-9 | Reference compound |
| HY-126131 | anti-TB agent 1 | 2294013-78-6 | Reference compound |
| HY-126133 | AM-001 | 340817-81-4 | Reference compound |
| HY-126134 | HPGDS inhibitor 2 | 2101626-26-8 | Reference compound |
| HY-126136 | ML303 | 1638211-04-7 | Reference compound |
| HY-126137 | PDE9-IN-1 | 2305087-92-5 | Reference compound |
| HY-12614 | AMG-1694 | 1361217-07-3 | Reference compound |
| HY-126140 | MDRTB-IN-1 | 1973401-05-6 | Reference compound |
| HY-126142 | Top1 inhibitor 1 | 2302772-05-8 | ADC Related |
| HY-126143 | CHMFL-ABL-039 | 2304344-56-5 | Reference compound |
| HY-126144 | GSK-3β inhibitor 1 | 187325-53-7 | Reference compound |
| HY-126144A | (E/Z)-GSK-3β inhibitor 1 | 3367-88-2 | Reference compound |
| HY-126145 | S1PR1 modulator 1 | 2328109-05-1 | Reference compound |
| HY-126146 | PKC-iota inhibitor 1 | 2328094-11-5 | Reference compound |
| HY-126147 | J22352 | 2252395-44-9 | Reference compound |
| HY-126150 | Flucetosulfuron | 412928-75-7 | Reference compound |
| HY-126151 | Heneicomycin | 66170-37-4 | Reference compound |
| HY-126152 | Chlorthiamid | 1918-13-4 | Reference compound |
| HY-126152R | Chlorthiamid (Standard) | 1918-13-4 | Reference Standards |
| HY-126154 | L48H37 | 343307-76-6 | Reference compound |
| HY-126156 | Leucodin | 17946-87-1 | Natural Products |
| HY-126157 | Linearol | 37720-82-4 | Reference compound |
| HY-126158 | SRI-29574 | 1928712-46-2 | Reference compound |
| HY-12616 | ACT-209905 | 1062670-13-6 | Reference compound |
| HY-126160 | CB10-277 | 7203-91-0 | Reference compound |
| HY-126161 | Nonabine | 16985-03-8 | Reference compound |
| HY-126164 | LK 614 | 82461-57-2 | Reference compound |
| HY-126166 | NOC-5 | 146724-82-5 | Reference compound |
| HY-126167 | Deacetylsclerotiorin | 34696-50-9 | Reference compound |
| HY-126169 | L-Glutamine amide | 2013-17-4 | Reference compound |
| HY-126170 | Valanimycin | 101961-60-8 | Natural Products |
| HY-126171 | Hypusine | 34994-11-1 | Reference compound |
| HY-126172 | 9-Anthryldiazomethane | 10401-59-9 | Dye Reagents |
| HY-126175 | Neostigmine (iodide) | 1212-37-9 | Reference compound |
| HY-126176 | Cloransulam-methyl | 147150-35-4 | Reference compound |
| HY-126176R | Cloransulam-methyl (Standard) | 147150-35-4 | Reference Standards |
| HY-126179 | Fenquizone | 20287-37-0 | Reference compound |
| HY-126181 | 5-Formylcytosine | 4425-59-6 | Reference compound |
| HY-126182 | Deacetyldiltiazem | 42399-40-6 | Reference compound |
| HY-126182S | Deacetyldiltiazem-d4 | 112259-40-2 | Isotope-Labeled Compounds |
| HY-126182S3 | Deacetyldiltiazem-d6 (hydrochloride) | 1309283-22-4 | Isotope-Labeled Compounds |
| HY-126182S4 | Desacetyl Diltiazem-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-126184 | Revatropate | 149926-91-0 | Reference compound |
| HY-126185 | Nibroxane | 53983-00-9 | Reference compound |
| HY-12619 | DMT003096 | 912361-26-3 | Reference compound |
| HY-126192 | Pittsburgh Compound B | 566169-93-5 | Reference compound |
| HY-126193 | JS-K | 205432-12-8 | Reference compound |
| HY-126194 | Tolcapone 3-β-D-glucuronide | 204853-33-8 | Natural Products |
| HY-126195 | Fluoflavine | 531-46-4 | Reference compound |
| HY-126198 | Linogliride | 75358-37-1 | Reference compound |
| HY-126198A | Linogliride (fumarate) | 78782-47-5 | Reference compound |
| HY-126199 | Tetrachlorvinphos | 22248-79-9 | Reference compound |
| HY-126199R | Tetrachlorvinphos (Standard) | 22248-79-9 | Reference Standards |
| HY-126200 | Fenpropidin | 67306-00-7 | Reference compound |
| HY-126200R | Fenpropidin (Standard) | 67306-00-7 | Reference Standards |
| HY-126201 | GSK-3 inhibitor 7 | 405221-09-2 | Reference compound |
| HY-126202 | Lachnone A | 903892-99-9 | Natural Products |
| HY-126205 | Deacetyleupaserrin | 38456-39-2 | Natural Products |
| HY-126206 | Quazodine | 4015-32-1 | Reference compound |
| HY-126209 | Isomaltol | 3420-59-5 | Reference compound |
| HY-126210 | GJ072 | 943092-47-5 | Reference compound |
| HY-126211 | KBH-A42 | 798543-50-7 | Reference compound |
| HY-126212 | Isorutarin | 53846-51-8 | Natural Products |
| HY-126213 | 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium) | 326589-90-6 | Reference compound |
| HY-126214 | JH-RE-06 | 1361227-90-8 | Reference compound |
| HY-126214S | JH-RE-06-d6 | Isotope-Labeled Compounds | |
| HY-126216 | TAM-IN-2 | 2135642-56-5 | Reference compound |
| HY-126217 | hGPR91 antagonist 1 | 1314796-00-3 | Reference compound |
| HY-126218 | HSV-TK substrate | 111687-37-7 | Reference compound |
| HY-12622 | HSP70-IN-1 | 1268273-90-0 | Reference compound |
| HY-126220 | KMG-301AM | 1372642-77-7 | Dye Reagents |
| HY-126220A | KMG-301AM (TFA) | 1372642-78-8 | Dye Reagents |
| HY-126221A | (R)-Aminocarnitine | 98063-21-9 | Reference compound |
| HY-126221B | (R)-Aminocarnitine (TFA) | Reference compound | |
| HY-126222 | MitoTam (bromide, hydrobromide) | 1634624-73-9 | Reference compound |
| HY-126222A | MitoTam (iodide, hydriodide) | 1634624-74-0 | Reference compound |
| HY-126224 | Driselase, Basidiomycetes sp | 85186-71-6 | Enzyme |
| HY-126225 | SJA710-6 | 1397255-09-2 | Reference compound |
| HY-126226 | MK-6240 Precursor | 1841444-11-8 | Reference compound |
| HY-126230 | PAT-494 | 1781233-84-8 | Reference compound |
| HY-126230A | (Rac)-PAT-494 | 1781233-72-4 | Reference compound |
| HY-126232 | Verproside | 50932-20-2 | Natural Products |
| HY-126233 | PAT-347 | 1689554-51-5 | Reference compound |
| HY-126236 | 3,5-Diiodothyropropionic acid | 1158-10-7 | Reference compound |
| HY-126237 | Acetyllovastatin | 81189-92-6 | Reference compound |
| HY-12624 | Narazaciclib | 1357470-29-1 | Reference compound |
| HY-126241 | RV01 | 1016897-10-1 | Reference compound |
| HY-126242S | Tyk2-IN-7 | 1609391-90-3 | Isotope-Labeled Compounds |
| HY-126244 | CDK4/6-IN-3 | 2366237-37-6 | Reference compound |
| HY-126246 | CDC25B-IN-1 | 2374831-10-2 | Reference compound |
| HY-126247 | BI-2852 | 2375482-51-0 | Reference compound |
| HY-126247B | (R)-BI-2852 | 2375482-49-6 | Reference compound |
| HY-126248 | Tankyrase-IN-2 | 1588870-36-3 | Reference compound |
| HY-126249 | AAPK-25 | 2247919-28-2 | Reference compound |
| HY-12625 | MIV-6 | 1560968-27-5 | Reference compound |
| HY-126250 | NPD-1335 | 2376326-31-5 | Reference compound |
| HY-126251 | CDK9-IN-7 | 2369981-71-3 | Reference compound |
| HY-126252 | A-9758 | 2055271-22-0 | Reference compound |
| HY-126253 | BI-4916 | 2244451-48-5 | Reference compound |
| HY-126254 | BI-4924 | 2244452-09-1 | Reference compound |
| HY-126255 | SBI-797812 | 2237268-08-3 | Reference compound |
| HY-126256 | PRMT5-IN-1 | 2366149-83-7 | Reference compound |
| HY-126256A | PRMT5-IN-1 (hydrochloride) | Reference compound | |
| HY-126257 | AKT-IN-3 | 2374740-21-1 | Reference compound |
| HY-12625A | MIV-6R | 1560968-55-9 | Reference compound |
| HY-126271 | PYCR1-IN-1 | 709-85-3 | Reference compound |
| HY-126275 | HSD1590 | 2379279-96-4 | Reference compound |
| HY-12628 | GNE-618 | 1362151-42-5 | Reference compound |
| HY-126287 | JND4135 | 2366216-76-2 | Reference compound |
| HY-126288 | ASTX029 | 2095719-92-7 | Reference compound |
| HY-12629 | PF470 | 1539296-45-1 | Reference compound |
| HY-126291 | GNE-616 | 2349371-81-7 | Reference compound |
| HY-126292 | KRAS G12C inhibitor 13 | 2241719-75-3 | Reference compound |
| HY-126293 | Apelin agonist 1 | 2227512-85-6 | Reference compound |
| HY-126294 | Londamocitinib | 2241039-81-4 | Reference compound |
| HY-126295 | Anti-parasitic agent 3 | 2366983-10-8 | Reference compound |
| HY-126296 | RIPK1-IN-3 | 2242677-36-5 | Reference compound |
| HY-126297 | c-Fms-IN-10 | 1527517-50-5 | Reference compound |
| HY-126298 | RAF mutant-IN-1 | 2340020-82-6 | Reference compound |
| HY-126299 | NVS-BPTF-1 | 2662454-54-6 | Reference compound |
| HY-126300 | SGC6870 | 2561471-27-8 | Reference compound |
| HY-126300A | SGC6870N | 2561471-15-4 | Reference compound |
| HY-126301 | DMT1 blocker 1 | 1354790-56-9 | Reference compound |
| HY-126302 | DMT1 blocker 2 | 1062648-63-8 | Reference compound |
| HY-126303 | GS-443902 | 1355149-45-9 | Reference compound |
| HY-126303C | GS-443902 (trisodium) | 1355050-21-3 | Reference compound |
| HY-126304 | β-Glycerophosphate (disodium salt hydrate) | 154804-51-0 | Natural Products |
| HY-126304A | Glycerophosphoric acid (disodium salt hydrate) (α and β mixture) | Reference compound | |
| HY-126306 | Deoxyfuconojirimycin (hydrochloride) | 210174-73-5 | Biochemical Assay Reagents |
| HY-126307 | Urolithin B | 1139-83-9 | Natural Products |
| HY-126308 | (E/Z)-DMU2139 | 104890-70-2 | Reference compound |
| HY-12631 | BMS-654457 | 1004551-41-0 | Reference compound |
| HY-126311 | 4-Hydroxyresveratrol | 331443-00-6 | Reference compound |
| HY-126313 | BnOH-NH-bis-(C2-S)-propane-O-isoprene ester | 2448704-23-0 | Reference compound |
| HY-126316 | Zapalog | 1708091-24-0 | Reference compound |
| HY-126319 | SU5204 | 186611-11-0 | Reference compound |
| HY-12632 | GNE 2861 | 1394121-05-1 | Reference compound |
| HY-126320 | EGFR-IN-8 | 2407957-87-1 | Reference compound |
| HY-126321 | RORγt agonist 1 | 2377378-89-5 | Reference compound |
| HY-126322 | DVD-445 | 2375846-41-4 | Reference compound |
| HY-126323 | TCMDC-135051 | 2413716-15-9 | Reference compound |
| HY-126323A | TCMDC-135051 (TFA) | 2571578-55-5 | Reference compound |
| HY-126323B | TCMDC-135051 (hydrochloride) | 2705545-47-5 | Reference compound |
| HY-126324 | IV-23 | 2326007-49-0 | Reference compound |
| HY-126325 | BY27 | 2247236-59-3 | Reference compound |
| HY-126326 | SWE101 | 2376322-12-0 | Reference compound |
| HY-126327 | UNC4976 | 2920299-34-7 | Reference compound |
| HY-126327A | UNC4976 (TFA) | Reference compound | |
| HY-126328 | PKC-theta inhibitor 1 | 1160501-81-4 | Reference compound |
| HY-126329 | AZD9898 | 2042347-69-1 | Reference compound |
| HY-12633 | GS-6620 | 1350735-70-4 | Reference compound |
| HY-126330 | SS-208 | 2245942-72-5 | Reference compound |
| HY-126332 | NED-3238 | 2389062-09-1 | Reference compound |
| HY-126333 | Topoisomerase II inhibitor 1 | 2375613-31-1 | Reference compound |
| HY-12634 | Deleobuvir | 863884-77-9 | Reference compound |
| HY-126346 | DL-175 | 2487253-25-6 | Reference compound |
| HY-126349 | DTSSP Crosslinker | 81069-02-5 | ADC Related |
| HY-12635 | SP2509 | 1423715-09-6 | Reference compound |
| HY-126350 | CL2-SN-38 | 1036969-20-6 | ADC Related |
| HY-126351 | PROTAC ERRα ligand 2 | 2306388-57-6 | Reference compound |
| HY-126353 | Fmoc-Val-Ala-PAB-OH | 1394238-91-5 | ADC Related |
| HY-126354 | Palmitoyldocosahexaenoyl phosphatidylcholine | 59403-54-2 | Reference compound |
| HY-126355 | 4,7,10,13,16-Docosapentaenoic acid | 2313-14-6 | Reference compound |
| HY-126356 | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine | 35418-59-8 | Reference compound |
| HY-126356S | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine-d11 | Isotope-Labeled Compounds | |
| HY-126357 | Palmitoylcarnitine | 1935-18-8 | Reference compound |
| HY-126358 | Acetylcarnitine | 14992-62-2 | Reference compound |
| HY-126359 | 1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine | 27098-24-4 | Reference compound |
| HY-12636 | INCB3619 | 791826-72-7 | Reference compound |
| HY-126360 | Oxazolone | 15646-46-5 | Reference compound |
| HY-126361 | ZK824190 | 2254001-81-3 | Reference compound |
| HY-126361A | ZK824190 (hydrochloride) | 2629177-12-2 | Reference compound |
| HY-126362 | ML266 | 1462267-08-8 | Reference compound |
| HY-126363 | Ditiocarb | 147-84-2 | Reference compound |
| HY-126363S | Ditiocarb-d10 | 1261734-83-1 | Isotope-Labeled Compounds |
| HY-126364 | Mc-Val-Ala-PAB | 1870916-87-2 | ADC Related |
| HY-126365 | Alisol B acetate | 19865-76-0 | Natural Products |
| HY-126367 | Light green SF yellowish | 5141-20-8 | Dye Reagents |
| HY-126370 | Geranylgeranyl pyrophosphate | 6699-20-3 | Reference compound |
| HY-126370A | Geranylgeranyl pyrophosphate (triammonium) | 313263-08-0 | Reference compound |
| HY-126373 | SN-38 glucuronide | 121080-63-5 | Reference compound |
| HY-126373S1 | SN-38 glucuronide-13C6 | Isotope-Labeled Compounds | |
| HY-126375 | Cbz-Valaciclovir | 124832-31-1 | Reference compound |
| HY-126375R | Cbz-?Valaciclovir (Standard) | 124832-31-1 | Reference Standards |
| HY-126376 | Iso-H7 (dihydrochloride) | 140663-38-3 | Reference compound |
| HY-126377 | Sulfobetaine 10 | 15163-36-7 | Biochemical Assay Reagents |
| HY-126378 | LSP-249 | 1801253-04-2 | Reference compound |
| HY-126379 | CDDO-2P-Im | 1883650-96-1 | Reference compound |
| HY-12638 | Dichlorophen | 97-23-4 | Reference compound |
| HY-126380 | Nardosinonediol | 20489-11-6 | Natural Products |
| HY-126381 | Boc-N-PEG5-C2-NHS ester | 2055040-78-1 | Reference compound |
| HY-126382 | Hesperidin methylchalcone | 24292-52-2 | Natural Products |
| HY-126383 | Spilanthol | 25394-57-4 | Natural Products |
| HY-126386 | Pectinase, aspergillus niger | 9032-75-1 | Enzyme |
| HY-126386A | Pectinase, aspergillus acne | 9032-75-1 | Enzyme |
| HY-126386B | Pectinase, rhizobia | 9032-75-1 | Enzyme |
| HY-126387 | Moenomycin complex | 11015-37-5 | Reference compound |
| HY-126388 | Trypsin Inhibitor, soybean | 9035-81-8 | Biochemical Assay Reagents |
| HY-126389 | Chitin, from crab carapace (powder) | 1398-61-4 | Biochemical Assay Reagents |
| HY-126389A | Chitin, from shrimp shells (powder) | 1398-61-4 | Biochemical Assay Reagents |
| HY-126389B | Chitin, from shrimp shells (chitinase substrate) | 1398-61-4 | Biochemical Assay Reagents |
| HY-12638R | Dichlorophen (Standard) | 97-23-4 | Reference Standards |
| HY-12639 | Bephenium | 7181-73-9 | Reference compound |
| HY-126390 | (E/Z)-BCI | 15982-84-0 | Reference compound |
| HY-126392 | Isonardoperoxide | 205248-65-3 | Natural Products |
| HY-126393 | Carboxymethyl-β-cyclodextrin, 99% | 218269-34-2 | Biochemical Assay Reagents |
| HY-126394 | Bamocaftor | 2204245-48-5 | Reference compound |
| HY-126394B | Bamocaftor (potassium) | 2204245-47-4 | Reference compound |
| HY-126395 | Patent Blue V (calcium salt) | 3536-49-0 | Dye Reagents |
| HY-126395R | Patent Blue V (calcium salt) (Standard) | 3536-49-0 | Dye Reagents |
| HY-126396 | Sordarin (sodium) | 463356-00-5 | Reference compound |
| HY-126397 | MnTBAP (chloride) | 55266-18-7 | Reference compound |
| HY-126399 | Bis-tris propane | 64431-96-5 | Biochemical Assay Reagents |
| HY-12639A | Bephenium (hydroxynaphthoate) | 3818-50-6 | Reference compound |
| HY-12639AR | Bephenium (hydroxynaphthoate) (Standard) | 3818-50-6 | Reference Standards |
| HY-12640 | Pyrantel (pamoate) | 22204-24-6 | Reference compound |
| HY-126400 | Tocopherols | 1406-66-2 | Natural Products |
| HY-126401 | Elgodipine | 119413-55-7 | Reference compound |
| HY-126402 | Arg-Gly-Asp (TFA) | 120103-89-1 | Reference compound |
| HY-126403 | Ethoxylated hydrogenated castor oil | 61788-85-0 | Biochemical Assay Reagents |
| HY-126404 | Casein hydrolysate | 65072-00-6 | Reference compound |
| HY-126405 | SMPT | 112241-19-7 | ADC Related |
| HY-126406 | Tirandamycin A | 34429-70-4 | Natural Products |
| HY-126407 | Secologanin dimethyl acetal | 77988-07-9 | Natural Products |
| HY-126409 | Petunidin-3-O-arabinoside (chloride) | 28500-03-0 | Natural Products |
| HY-12640R | Pyrantel (pamoate) (Standard) | 22204-24-6 | Reference Standards |
| HY-12641 | Pyrantel (tartrate) | 33401-94-4 | Reference compound |
| HY-126410 | Petunidin (chloride) | 1429-30-7 | Natural Products |
| HY-126410R | Petunidin (chloride) (Standard) | 1429-30-7 | Reference Standards |
| HY-126411 | Peonidin-3-O-galactoside (chloride) | 28148-89-2 | Natural Products |
| HY-126412 | Neochamaejasmine A | 90411-13-5 | Natural Products |
| HY-126413 | Peonidin-3-O-arabinoside (chloride) | 524943-91-7 | Natural Products |
| HY-126414 | Methylenedihydrotanshinquinone | 126979-81-5 | Natural Products |
| HY-126415 | Magnesium Lithospermate B | 122021-74-3 | Natural Products |
| HY-126416 | Methyl tanshinonate | 18887-19-9 | Natural Products |
| HY-126417 | Methylenetanshinquinone | 67656-29-5 | Natural Products |
| HY-126418 | Methyl 3-O-feruloylquinate | 154418-15-2 | Natural Products |
| HY-126419 | Kobophenol A | 124027-58-3 | Natural Products |
| HY-12641A | Pyrantel | 15686-83-6 | Reference compound |
| HY-12641R | Pyrantel (tartrate) (Standard) | 33401-94-4 | Reference Standards |
| HY-12642 | Diethylcarbamazine (citrate) | 1642-54-2 | Reference compound |
| HY-126420 | Kansuinine B | 57685-46-8 | Natural Products |
| HY-126421 | Kansuinine A | 57701-86-7 | Natural Products |
| HY-126422 | cis-Tiliroside | 163956-16-9 | Natural Products |
| HY-126423 | Isorhamnetin 3-glucuronide | 36687-76-0 | Natural Products |
| HY-126424 | OptoDArG | 2230617-93-1 | Reference compound |
| HY-126425 | NCGC00262650 | 344359-25-7 | Reference compound |
| HY-126426 | CBHcy | 88096-02-0 | Reference compound |
| HY-126428 | ZL0580 | 2377151-10-3 | Reference compound |
| HY-126429 | Nav1.1 activator 1 | 2332897-85-3 | Reference compound |
| HY-12642A | Diethylcarbamazine | 90-89-1 | Reference compound |
| HY-12642R | Diethylcarbamazine (citrate) (Standard) | 1642-54-2 | Reference Standards |
| HY-12643 | Eprinomectin | 123997-26-2 | Reference compound |
| HY-126432S | (Rac)-BA-1049-d5 | Isotope-Labeled Compounds | |
| HY-126436A | Poly-L-ornithine (hydrobromide) (MW 30000-70000) | 27378-49-0 | Biochemical Assay Reagents |
| HY-126436B | Poly-L-ornithine (hydrobromide) (MW>100000) | 27378-49-0 | Biochemical Assay Reagents |
| HY-126436C | Poly-L-ornithine (hydrobromide) (MW 5000-15000) | 27378-49-0 | Biochemical Assay Reagents |
| HY-126436D | Poly-L-ornithine (hydrochloride) (MW 15000-30000) | 26982-21-8 | Biochemical Assay Reagents |
| HY-126437 | Poly-L-lysine (hydrobromide) (MW 30000-70000) | 25988-63-0 | Oligonucleotides |
| HY-126437A | Poly-L-lysine (hydrochloride) | 26124-78-7 | Oligonucleotides |
| HY-126437B | Poly-L-lysine (hydrobromide) (MW 70000-150000) | 25988-63-0 | Peptides |
| HY-126437C | Poly-L-lysine (hydrobromide) (MW 150000-300000) | 25988-63-0 | Reference compound |
| HY-126437D | Poly-L-lysine (hydrobromide) (MW ＞300000) | 25988-63-0 | Peptides |
| HY-126437E | Poly-L-lysine (hydrobromide) (MW 15000-30000) | 25988-63-0 | Biochemical Assay Reagents |
| HY-126437H | Poly-L-lysine (hydrobromide) (MW 4000-15000) | 25988-63-0 | Biochemical Assay Reagents |
| HY-126437I | Poly-L-lysine (hydrobromide) (MW 1000-5000) | 25988-63-0 | Biochemical Assay Reagents |
| HY-126437J | Poly-L-lysine solution (0.01%, sterile-filtered, MW 150000-300000) | 25988-63-0 | Biochemical Assay Reagents |
| HY-126437K | Poly-L-lysine solution (0.01%, sterile-filtered, MW 70000-150000) | 25988-63-0 | Biochemical Assay Reagents |
| HY-12643R | Eprinomectin (Standard) | 123997-26-2 | Reference Standards |
| HY-12643S | Eprinomectin-d3 | Isotope-Labeled Compounds | |
| HY-12644 | Acalisib | 870281-34-8 | Reference compound |
| HY-12645 | NCL1 | 1196119-03-5 | Reference compound |
| HY-126455 | Penicillide | 55303-92-9 | Natural Products |
| HY-126456 | (S,R,S)-AHPC-propargyl | 2098799-78-9 | Reference compound |
| HY-126457 | Thalidomide-propargyl | 2098487-39-7 | Reference compound |
| HY-126458 | Thalidomide-O-PEG2-propargyl | 2098487-52-4 | Reference compound |
| HY-12646 | Rhosin (hydrochloride) | 1281870-42-5 | Reference compound |
| HY-126460 | Myristoyl glutamic acid | 53576-52-6 | Reference compound |
| HY-126460A | Myristoyl glutamic acid (sodium) | 38517-37-2 | Reference compound |
| HY-126461 | Salazinic acid | 521-39-1 | Natural Products |
| HY-126462 | Lantic acid | 22626-26-2 | Natural Products |
| HY-126463 | LolCDE-IN-4 | 1859918-13-0 | Reference compound |
| HY-126464 | Estromustine | 62899-40-5 | Reference compound |
| HY-126467 | TA-270 | 194037-25-7 | Reference compound |
| HY-126468 | Abieslactone | 33869-93-1 | Natural Products |
| HY-126469 | Janthinocin B | 131086-53-8 | Reference compound |
| HY-12646A | Rhosin | 1173671-63-0 | Reference compound |
| HY-12647 | GPR40 Activator 2 | 1312787-30-6 | Reference compound |
| HY-126474 | MitoB (bromide) | 1247025-84-8 | Reference compound |
| HY-126474S | MitoB-d15 (bromide) | Isotope-Labeled Compounds | |
| HY-126475 | KSK213 | 1876429-73-0 | Reference compound |
| HY-126476 | Justicisaponin I | 79162-16-6 | Natural Products |
| HY-126477 | NNK | 64091-91-4 | Reference compound |
| HY-126477R | NNK (Standard) | 64091-91-4 | Reference Standards |
| HY-126477S | NNK-d4 | 764661-24-7 | Isotope-Labeled Compounds |
| HY-126477S1 | NNK-d3 | 86270-92-0 | Isotope-Labeled Compounds |
| HY-126478 | Quinabactin | 946270-26-4 | Reference compound |
| HY-126479 | Carbomycin B | 21238-30-2 | Natural Products |
| HY-12648 | FASN-IN-4 | 1375105-96-6 | Reference compound |
| HY-126482 | Telomerase-IN-2 | 1610878-54-0 | Reference compound |
| HY-126483 | Telomerase-IN-3 | 150096-77-8 | Reference compound |
| HY-126484 | Eremofortin B | 60048-73-9 | Natural Products |
| HY-126486 | AVE1231 | 767334-89-4 | Reference compound |
| HY-126487 | H-Arg-Lys-OH | 40968-46-5 | Reference compound |
| HY-126487A | H-Arg-Lys-OH (TFA) | Reference compound | |
| HY-126488 | H-Ser-His-OH | 67726-09-4 | Reference compound |
| HY-126489 | Tetromycin B | 180027-84-3 | Reference compound |
| HY-12648A | FASN-IN-4 (tosylate) | 2095432-57-6 | Reference compound |
| HY-12649 | Y16 | 429653-73-6 | Reference compound |
| HY-126490 | Phleomycin | 11006-33-0 | Natural Products |
| HY-126491 | SPP-DM1 | 452072-20-7 | ADC Related |
| HY-126492 | Vat-Cit-PAB-Monomethyl Dolastatin 10 | 1415329-13-3 | ADC Related |
| HY-126493 | DM4-SPDP | ADC Related | |
| HY-126493A | (R)-DM4-SPDP | 2245698-48-8 | Reference compound |
| HY-126494 | DM4-SMCC | 1228105-52-9 | ADC Related |
| HY-126495 | Sulfo-LC-SPDP | 150244-18-1 | ADC Related |
| HY-126495A | Sulfo-LC-SPDP (sodium) | 169751-10-4 | ADC Related |
| HY-126496 | PEG4-SPDP | 1305053-43-3 | ADC Related |
| HY-126497 | LC-PEG8-SPDP | 1252257-56-9 | ADC Related |
| HY-126498 | PDEC-NB | 874302-76-8 | ADC Related |
| HY-12650 | Mirogabalin | 1138245-13-2 | Reference compound |
| HY-126502 | Mal-C2-NHS ester | 103750-03-4 | ADC Related |
| HY-126503 | trans-Sulfo-SMCC | 1286837-77-1 | ADC Related |
| HY-126504 | Mal-PEG2-NHS ester | 1433997-01-3 | ADC Related |
| HY-126505 | Mal-PEG4-NHS ester | 1325208-25-0 | ADC Related |
| HY-126506 | Mal-PEG4-PFP ester | 1415800-42-8 | ADC Related |
| HY-126507 | Mal-amido-PEG1-C2-NHS ester | 1260092-50-9 | ADC Related |
| HY-126508 | Mal-amido-PEG5-C2-NHS ester | 1315355-92-0 | ADC Related |
| HY-126509 | Mal-amido-PEG10-C2-NHS ester | 1137109-22-8 | ADC Related |
| HY-12650A | (rel)-Mirogabalin | 1138244-97-9 | Reference compound |
| HY-12650R | Mirogabalin (Standard) | 1138245-13-2 | Reference Standards |
| HY-12650S | Mirogabalin-13C2,d1 (Mixture of Diastereomers) | Isotope-Labeled Compounds | |
| HY-12650S1 | Mirogabalin-d4 | Isotope-Labeled Compounds | |
| HY-12651 | Primaquine (diphosphate) | 63-45-6 | Reference compound |
| HY-126510 | MC-PEG2-C2-NHS ester | 1263044-56-9 | ADC Related |
| HY-126511 | Propargyl-C1-NHS ester | 132178-37-1 | ADC Related |
| HY-126512 | Propargyl-C2-NHS ester | 906564-59-8 | ADC Related |
| HY-126513 | Propargyl-PEG1-NHS ester | 1174157-65-3 | ADC Related |
| HY-126514 | Propargyl-O-C1-amido-PEG2-C2-NHS ester | 2101206-30-6 | ADC Related |
| HY-126515 | Propargyl-O-C1-amido-PEG4-C2-NHS ester | 2101206-92-0 | ADC Related |
| HY-126516 | Propargyl-PEG4-NHS ester | 1428629-70-2 | ADC Related |
| HY-126517 | Cyclooctyne-O-NHS ester | 1425803-45-7 | ADC Related |
| HY-126518 | Cyclooctyne-O-PFP ester | 886209-60-5 | ADC Related |
| HY-126519 | PDdEC-NB | 1956318-90-3 | ADC Related |
| HY-12651A | Primaquine | 90-34-6 | Reference compound |
| HY-12651AS | Primaquine-13C,d3 | Isotope-Labeled Compounds | |
| HY-12651B | l-Primaquine | 57152-58-6 | Reference compound |
| HY-12651R | Primaquine (diphosphate) (Standard) | 63-45-6 | Reference Standards |
| HY-12651S | Primaquine-d3 (diphosphate) | Isotope-Labeled Compounds | |
| HY-12652 | AZD3147 | 1101810-02-9 | Reference compound |
| HY-126520 | N3-C2-NHS ester | 850180-76-6 | ADC Related |
| HY-126521 | N3-C3-NHS ester | 943858-70-6 | ADC Related |
| HY-126522 | N3-C4-NHS ester | 478801-48-8 | ADC Related |
| HY-126523 | N3-C5-NHS ester | 866363-70-4 | ADC Related |
| HY-126524 | N3-Ph-NHS ester | 53053-08-0 | ADC Related |
| HY-126525 | 4-N3Pfp-NHS ester | 126695-58-7 | ADC Related |
| HY-126526 | N3-PEG2-C2-NHS ester | 1312309-64-0 | ADC Related |
| HY-126527 | N3-PEG2-C2-PFP ester | 1393330-37-4 | ADC Related |
| HY-126528 | N3-PEG3-C2-NHS ester | 1245718-89-1 | ADC Related |
| HY-126529 | N3-PEG3-C2-PFP ester | 1807530-07-9 | ADC Related |
| HY-12653 | LDC4297 | 1453834-21-3 | Reference compound |
| HY-126530 | PPC-NB | 1887040-81-4 | ADC Related |
| HY-126531 | DMAC-PDB | 663599-04-0 | ADC Related |
| HY-126532 | Fmoc-Val-Cit-PAB-Duocarmycin TM | ADC Related | |
| HY-126533 | PDP-C1-Ph-Val-Cit | 1610769-13-5 | ADC Related |
| HY-126534 | Abemaciclib metabolite M18 | 2704316-81-2 | Reference compound |
| HY-126534A | Abemaciclib metabolite M18 (hydrochloride) | 2704316-82-3 | Reference compound |
| HY-126534S | Abemaciclib metabolite M18-d8 | Isotope-Labeled Compounds | |
| HY-126535 | Magnoloside B | 116872-05-0 | Natural Products |
| HY-126536 | ChemR23-IN-1 | 2378640-10-7 | Reference compound |
| HY-126539 | UBE2T/FANCL-IN-1 | 1359415-02-3 | Reference compound |
| HY-12653A | LDC4297 (hydrochloride) | 2319747-14-1 | Reference compound |
| HY-12654 | Molidustat | 1154028-82-6 | Reference compound |
| HY-126542 | VRK-IN-1 | 2378855-09-3 | Reference compound |
| HY-126548 | β-Secretase Inhibitor I | 1818239-19-8 | Reference compound |
| HY-12655 | IDE-IN-1 | 1417537-93-9 | Reference compound |
| HY-126550 | Azidoindolene 1 | 1364933-69-6 | Reference compound |
| HY-126551 | Butenoyl-PAF | 474944-25-7 | Reference compound |
| HY-126555 | OX3a | 329939-05-1 | Reference compound |
| HY-126556 | Cytochalasin J | 53760-20-6 | Natural Products |
| HY-126558 | GA3-AM | 1373154-68-7 | Reference compound |
| HY-126558R | GA3-AM (Standard) | 1373154-68-7 | Reference Standards |
| HY-126559 | Ansatrienin A | 82189-03-5 | Natural Products |
| HY-12656 | SCH 51344 | 171927-40-5 | Reference compound |
| HY-126560 | F-Amidine | 877617-45-3 | Reference compound |
| HY-126560A | F-Amidine (TFA) | 877617-46-4 | Reference compound |
| HY-126561 | Green CMFDA | 136832-63-8 | Dye Reagents |
| HY-126562 | Piperlonguminine | 5950-12-9 | Natural Products |
| HY-126562R | Piperlonguminine (Standard) | 5950-12-9 | Reference Standards |
| HY-126564 | Ebelactone A | 76808-16-7 | Natural Products |
| HY-126565 | Licam-C | 75956-68-2 | Reference compound |
| HY-126566 | Trichostatin C | 68676-88-0 | Reference compound |
| HY-126568 | Naftidrofuryl | 31329-57-4 | Reference compound |
| HY-126568S | Naftidrofuryl-d4 | 1215649-28-7 | Isotope-Labeled Compounds |
| HY-126568S1 | Nafronyl-d4 (oxalate) | Isotope-Labeled Compounds | |
| HY-126569 | Efrotomycin | 56592-32-6 | Reference compound |
| HY-12657 | Syk-IN-1 | 1491150-77-6 | Reference compound |
| HY-126571 | Virustomycin A | 84777-85-5 | Reference compound |
| HY-126573 | Trilaurin | 538-24-9 | Natural Products |
| HY-126573R | Trilaurin (Standard) | 538-24-9 | Reference Standards |
| HY-126573S | Trilaurin-d15 | 1219805-25-0 | Isotope-Labeled Compounds |
| HY-126574 | Pantothenoylcysteine | 13147-34-7 | Reference compound |
| HY-126576 | Dactylocycline A | 125622-12-0 | Natural Products |
| HY-126577 | Dactylocycline B | 125622-13-1 | Natural Products |
| HY-126578 | Dactylocycline D | 146064-00-8 | Reference compound |
| HY-126579 | Dactylocycline E | 146064-01-9 | Reference compound |
| HY-12658 | Mps1-IN-4 | 1263423-94-4 | Reference compound |
| HY-126582 | Reprimun | 41776-67-4 | Reference compound |
| HY-126583 | Nemadipine-A | 54280-71-6 | Reference compound |
| HY-126584 | H-Val-Val-OH | 3918-94-3 | Reference compound |
| HY-126585 | SAICAR | 3031-95-6 | Natural Products |
| HY-126585S | SAICAR-d1 | Isotope-Labeled Compounds | |
| HY-12659 | LX7101 | 1192189-69-7 | Reference compound |
| HY-126591 | Junceellin | 92508-09-3 | Natural Products |
| HY-126593 | Cryosim-3 | 1507344-37-7 | Reference compound |
| HY-126594 | Echinoside B | 75410-52-5 | Natural Products |
| HY-126596 | Angelylalkannin | 69175-72-0 | Natural Products |
| HY-126597 | Chaetoglobosin C | 50645-76-6 | Natural Products |
| HY-126598 | Chaetoglobosin F | 55945-75-0 | Natural Products |
| HY-126599 | Cochlioquinone A | 32450-25-2 | Natural Products |
| HY-12659B | LX7101 (monohydrochloride) | 2319882-48-7 | Reference compound |
| HY-12660 | MPI-0479605 | 1246529-32-7 | Reference compound |
| HY-126601 | Malonganenone A | 882403-69-2 | Natural Products |
| HY-126602 | Kinamycin B | 35303-13-0 | Natural Products |
| HY-126603 | Asperlactone | 76375-62-7 | Natural Products |
| HY-126604 | Pyranonigrin A | 773855-65-5 | Natural Products |
| HY-126605 | Trinactin | 7561-71-9 | Natural Products |
| HY-126606 | Isochlortetracycline | 514-53-4 | Reference compound |
| HY-126607 | Sericic acid | 55306-03-1 | Natural Products |
| HY-126609 | Emorfazone | 38957-41-4 | Reference compound |
| HY-126610 | Dactylfungin A | 146935-35-5 | Natural Products |
| HY-126613 | Laurycolactone A | 85643-76-1 | Natural Products |
| HY-126617 | Duclauxin | 1732-37-2 | Reference compound |
| HY-126618 | Aspochalasin I | 670225-69-1 | Natural Products |
| HY-126619 | Aspochalasin D | 71968-02-0 | Reference compound |
| HY-12661A | AMG PERK 44 | 1883548-84-2 | Reference compound |
| HY-12662 | PE859 | 1402727-29-0 | Reference compound |
| HY-126621 | DC-TEADin02 | 2380228-45-3 | Reference compound |
| HY-126629 | Antibacterial agent 12 | 2382921-99-3 | Reference compound |
| HY-12663 | AS2521780 | 1214726-89-2 | Reference compound |
| HY-126634 | Lyngbyatoxin B | 133084-52-3 | Natural Products |
| HY-126635 | Mafoprazine | 80428-29-1 | Reference compound |
| HY-126635R | Mafoprazine (Standard) | 80428-29-1 | Reference Standards |
| HY-126637 | Marasmic acid | 2212-99-9 | Natural Products |
| HY-126638 | Marcfortine A | 75731-43-0 | Reference compound |
| HY-12664 | AF64394 | 1637300-25-4 | Reference compound |
| HY-126640 | Phomoxanthone A | 359844-69-2 | Natural Products |
| HY-126643 | Wedeloside | 74686-30-9 | Natural Products |
| HY-126644 | Halocyamine B | 122548-04-3 | Natural Products |
| HY-126645 | Atelopidtoxin | 9061-57-8 | Natural Products |
| HY-126646 | Sporeamicin A | 131418-65-0 | Natural Products |
| HY-126649 | Bacillosporin C | 76706-63-3 | Reference compound |
| HY-126651 | Azotomycin | 7644-67-9 | Reference compound |
| HY-126653 | Atpenin A5 | 119509-24-9 | Reference compound |
| HY-126655 | Yunnanxane | 139713-81-8 | Natural Products |
| HY-126657 | Fumigaclavine A | 6879-59-0 | Natural Products |
| HY-126658 | Lycophlegmine | 82841-97-2 | Natural Products |
| HY-126660 | Cinerubin A | 34044-10-5 | Reference compound |
| HY-126662 | Netzahualcoyone | 87686-36-0 | Natural Products |
| HY-126663 | N-Me-L-Ala-maytansinol | 77668-69-0 | ADC Related |
| HY-126664 | Azonafide-PEABA | 2752193-52-3 | ADC Related |
| HY-126665 | DMEA-PNU-159682 | 1799421-48-9 | ADC Related |
| HY-126665A | DMEA-PNU-159682 (dichloroacetate) | 1799421-49-0 | Reference compound |
| HY-126666 | PNU-159682 carboxylic acid | 1204819-92-0 | ADC Related |
| HY-126667 | SC-Val-Cit-PAB | ADC Related | |
| HY-126668 | Mal-PEG4-VC-PAB-DMEA | 1569261-93-3 | ADC Related |
| HY-126668A | Mal-PEG4-VC-PAB-DMEA (TFA) | ADC Related | |
| HY-126669 | Mal-PEG4-VA | 1800456-31-8 | ADC Related |
| HY-126670 | mDPR(Boc)-Val-Cit-PAB | 2281797-55-3 | ADC Related |
| HY-126671 | Mal-Phe-C4-Val-Cit-PAB | ADC Related | |
| HY-126672 | Mal-PEG4-Val-Cit-PAB | 1949793-41-2 | ADC Related |
| HY-126673 | Mal-C2-Gly3-EDA | ADC Related | |
| HY-126674 | Mal-Phe-C4-Val-Cit-PAB-DMEA | ADC Related | |
| HY-126675 | AS2863619 (free base) | 2241300-50-3 | Reference compound |
| HY-126675A | AS2863619 | 2241300-51-4 | Reference compound |
| HY-126676 | DBCO-(PEG2-Val-Cit-PAB)2 | ADC Related | |
| HY-126677 | Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA | ADC Related | |
| HY-126678 | Dimethyl-SGD-1882 | 3026416-27-0 | ADC Related |
| HY-126679 | Apoptolidin | 194874-06-1 | Natural Products |
| HY-126681 | SC-VC-PAB-MMAE | 2259318-46-0 | ADC Related |
| HY-126682 | Mal-VC-PAB-DM1 | 1464051-44-2 | ADC Related |
| HY-126683 | Mal-C6-α-Amanitin | 1578249-76-9 | ADC Related |
| HY-126684 | Mal-PEG4-VC-PAB-DMEA-Seco-Duocarmycin SA | 2259318-49-3 | ADC Related |
| HY-126685 | Mal-PEG4-VA-PBD | 1342820-68-1 | ADC Related |
| HY-126686 | Mal-Phe-C4-VC-PAB-MMAE | 2259318-51-7 | ADC Related |
| HY-126687 | Mal-PEG4-VC-PAB-DMEA-PNU-159682 | 2259318-52-8 | ADC Related |
| HY-126688 | Mal-C2-Gly3-EDA-PNU-159682 | 2259318-53-9 | ADC Related |
| HY-126689 | Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 | 2259318-54-0 | ADC Related |
| HY-126690 | DBCO-(PEG2-VC-PAB-MMAE)2 | 2259318-55-1 | ADC Related |
| HY-126691 | DBCO-PEG4-VC-PAB-DMEA-PNU-159682 | 2259318-56-2 | ADC Related |
| HY-126692 | Mal-VC-PAB-ABAEP-Azonafide | 2259318-48-2 | ADC Related |
| HY-126693 | SC-VC-PAB-DM1 | 2259318-47-1 | ADC Related |
| HY-126695 | Altromycin B | 128461-00-7 | Natural Products |
| HY-126696 | Altromycin D | 128461-01-8 | Natural Products |
| HY-126697 | Eremofortin A | 62445-06-1 | Natural Products |
| HY-126699 | Herbimycin C | 91700-92-4 | Reference compound |
| HY-126703 | Lantanose A | 145204-38-2 | Natural Products |
| HY-126704 | Tedisamil | 90961-53-8 | Reference compound |
| HY-126707 | Aldoifosfamide | 120144-70-9 | Reference compound |
| HY-126708 | Luisol A | 225110-59-8 | Natural Products |
| HY-126710 | OU749 | 519170-13-9 | Reference compound |
| HY-126712 | ROS tracer precursor | 2153480-20-5 | Reference compound |
| HY-126715 | Pimelautide | 78512-63-7 | Reference compound |
| HY-126716 | Leukotriene C4 methyl ester | 73958-10-8 | Reference compound |
| HY-126716S | Leukotriene C4-d5 methyl ester | Isotope-Labeled Compounds | |
| HY-126717 | SPDP-PEG6-NHS ester | 1818294-32-4 | Reference compound |
| HY-126718 | Methylenecyclopropylpyruvate | 5746-24-7 | Reference compound |
| HY-126719 | R-1 Methanandamide Phosphate | 649569-33-5 | Reference compound |
| HY-126720 | N-Lignoceroyl Taurine | 807370-75-8 | Reference compound |
| HY-126721 | Tetralysine | 997-20-6 | Peptides |
| HY-126722 | Lipoxin A4 methyl ester | 97643-35-1 | Reference compound |
| HY-126723 | Proline cetyl ester | 97010-18-9 | Reference compound |
| HY-126724 | Flutianil | 958647-10-4 | Reference compound |
| HY-126724R | Flutianil (Standard) | 958647-10-4 | Reference Standards |
| HY-126725 | Chitinovorin B | 95722-76-2 | Natural Products |
| HY-126726 | KOdiA-PC | 439904-33-3 | Biochemical Assay Reagents |
| HY-126730 | Rubratoxin A | 22467-31-8 | Reference compound |
| HY-126732 | L-640876 | 77527-71-0 | Reference compound |
| HY-126733 | (6R)-Leucovorin | 73951-54-9 | Natural Products |
| HY-126735 | Saquayamycin D | 99260-71-6 | Reference compound |
| HY-126738 | Anacardic acid triene | 103904-73-0 | Natural Products |
| HY-126740 | Anguinomycin A | 111278-01-4 | Reference compound |
| HY-126741 | Azadirachtin | 11141-17-6 | Natural Products |
| HY-126741R | Azadirachtin (Standard) | 11141-17-6 | Reference Standards |
| HY-126742 | MBX-1162 | 1225332-95-5 | Reference compound |
| HY-126743 | JBIR-22 | 1219095-76-7 | Reference compound |
| HY-126744 | Juncin E | 129602-22-8 | Natural Products |
| HY-126745 | Corynecin V | 40958-12-1 | Reference compound |
| HY-126746 | Corynecin I | 4423-58-9 | Natural Products |
| HY-126747 | Corynecin IV | 40958-11-0 | Reference compound |
| HY-126748 | VUF14862 | 2223023-78-5 | Reference compound |
| HY-126749 | VUF14738 | 2223027-70-9 | Reference compound |
| HY-126750 | GNF362 | 1003019-41-7 | Reference compound |
| HY-126752 | Ophthalmic acid | 495-27-2 | Natural Products |
| HY-126753 | Kujimycin A | 33955-27-0 | Natural Products |
| HY-126754 | Archangelicin | 2607-56-9 | Natural Products |
| HY-126758 | Ludartin | 36149-87-8 | Natural Products |
| HY-126760 | Retroisosenine | 62018-78-4 | Natural Products |
| HY-126762 | Fenprostalene | 69381-94-8 | Reference compound |
| HY-126763 | ATI22-107 | 681816-57-9 | Reference compound |
| HY-126765 | Territrem B | 70407-20-4 | Natural Products |
| HY-126770 | Rhizocticin A | 114301-25-6 | Natural Products |
| HY-126771 | Chrysomycin A | 82196-88-1 | Reference compound |
| HY-126772 | Tralomethrin | 66841-25-6 | Reference compound |
| HY-126774 | DAF-FM | 254109-20-1 | Dye Reagents |
| HY-126775 | Xenoclauxin | 7599-61-3 | Natural Products |
| HY-126779 | Stictic acid | 549-06-4 | Reference compound |
| HY-12678 | Entrectinib | 1108743-60-7 | Reference compound |
| HY-126780 | Nikkomycin N | 77368-58-2 | Natural Products |
| HY-126781 | Fozivudine tidoxil | 141790-23-0 | Reference compound |
| HY-126782 | Lexitropsin 1 | 123725-00-8 | Reference compound |
| HY-126783 | Levorin A0 | 77215-53-3 | Natural Products |
| HY-126785 | Suc-AAP-Abu-pNA | 108392-27-4 | Peptides |
| HY-126787 | 17-Hydroxyventuricidin A | 113204-43-6 | Natural Products |
| HY-126788 | Antibiotic DC 102 | 115722-50-4 | Natural Products |
| HY-126789 | DM-Nitrophen | 117367-86-9 | Reference compound |
| HY-126789A | DM-Nitrophen (tertasodium) | 291517-40-3 | Reference compound |
| HY-12678R | Entrectinib (Standard) | 1108743-60-7 | Reference Standards |
| HY-12678S | Entrectinib-d4 | Isotope-Labeled Compounds | |
| HY-12678S1 | Entrectinib-d8 | 2251773-94-9 | Isotope-Labeled Compounds |
| HY-126791 | Methylmalonyl-CoA | 1264-45-5 | Enzyme |
| HY-126791A | Methylmalonyl-CoA (tetralithium) | 104809-02-1 | Enzyme |
| HY-126791B | (2R)-Methylmalonyl-CoA | 73173-92-9 | Enzyme |
| HY-126793 | 2′,7′-Dichlorofluorescein diacetate | 2044-85-1 | Dye Reagents |
| HY-126795 | Aspergillin PZ | 483305-08-4 | Natural Products |
| HY-12680 | PRN694 | 1575818-46-0 | Reference compound |
| HY-126800 | Glycotriosyl glutamine | 83235-86-3 | Reference compound |
| HY-126801 | Sannamycin A | 72503-79-8 | Natural Products |
| HY-126802 | Saquayamycin B1 | 99260-68-1 | Reference compound |
| HY-126803 | Saquayamycin B | 99260-67-0 | Natural Products |
| HY-126804 | Safracin B | 87578-99-2 | Natural Products |
| HY-126806 | Pyrrofolic acid | 88912-57-6 | Reference compound |
| HY-126807 | AS1907417 | 885038-66-4 | Reference compound |
| HY-126809 | Chromozym PK | 58840-30-5 | Peptides |
| HY-12681 | CCT251545 | 1661839-45-7 | Reference compound |
| HY-126810 | NP213 | 942577-31-3 | Peptides |
| HY-126810A | NP213 (TFA) | Peptides | |
| HY-126812 | Longestin | 131774-53-3 | Natural Products |
| HY-126813 | Concanamycin C | 81552-34-3 | Natural Products |
| HY-126816 | Atrazine mercapturate | 138722-96-0 | Reference compound |
| HY-126818 | Desfuroylceftiofur | 120882-22-6 | Reference compound |
| HY-12682 | Glutaminase C-IN-1 | 311795-38-7 | Reference compound |
| HY-126820 | Tolypomycin R | 33889-22-4 | Reference compound |
| HY-126821 | Fluo-3 | 123632-39-3 | Dye Reagents |
| HY-126821A | Fluo-3 (pentaammonium) | 339221-91-9 | Dye Reagents |
| HY-126822 | MDL27324 | 123285-50-7 | Reference compound |
| HY-126823 | Phen Green SK diacetate (5/6-mixture) | 234075-45-7 | Dye Reagents |
| HY-126824 | 5,10-Dideazaaminopterin | 95674-53-6 | Reference compound |
| HY-126825 | NE21650 | 427899-21-6 | Reference compound |
| HY-126826 | Antibiotic K 4 | 84890-90-4 | Reference compound |
| HY-126829 | Coumarin-SAHA | 1260635-77-5 | Reference compound |
| HY-12683 | BPTES | 314045-39-1 | Reference compound |
| HY-126830 | Antifolate C2 | 1286279-90-0 | Reference compound |
| HY-126831 | SBFI-AM | 129423-53-6 | Dye Reagents |
| HY-126833 | Myristoyl coenzyme A | 3130-72-1 | Biochemical Assay Reagents |
| HY-126833A | Myristoyl coenzyme A (lithium) | 187100-75-0 | Reference compound |
| HY-126833B | Myristoyl coenzyme A (triammonium) | 799812-85-4 | Enzyme |
| HY-126835 | A924 | 65132-74-3 | Reference compound |
| HY-126837 | SPM VIII | 133397-76-9 | Reference compound |
| HY-126838 | Lavendofuseomycin | 134965-82-5 | Reference compound |
| HY-126839 | C12FDG | 138777-25-0 | Dye Reagents |
| HY-12684 | CH-223191 | 301326-22-7 | Reference compound |
| HY-126841 | 5-Methoxysterigmatocystin | 22897-08-1 | Natural Products |
| HY-126843 | Chromozym U | 112283-16-6 | Reference compound |
| HY-126845 | 3-cis-Hydroxyglibenclamide | 23074-02-4 | Reference compound |
| HY-126847 | N-Acylkansosamine | 92355-88-9 | Reference compound |
| HY-126848 | Diclofenac acyl glucuronide | 64118-81-6 | Reference compound |
| HY-126849 | 3-Morpholinosydnonimine | 33876-97-0 | Biochemical Assay Reagents |
| HY-12685 | Ceralifimod | 891859-12-4 | Reference compound |
| HY-126850 | 4-Epidoxycycline | 6543-77-7 | Reference compound |
| HY-126851 | Fluorescein-DBCO | 2054339-00-1 | Dye Reagents |
| HY-126852 | 4-Hydroxy Atorvastatin lactone | 163217-70-7 | Reference compound |
| HY-126852S | 4-Hydroxy Atorvastatin lactone-d5 | 265989-49-9 | Isotope-Labeled Compounds |
| HY-126854 | N-Acetyllactosamine | 32181-59-2 | Natural Products |
| HY-126854R | N-Acetyllactosamine (Standard) | 32181-59-2 | Reference Standards |
| HY-126855 | Cholic acid 7-sulfate | 60320-05-0 | Reference compound |
| HY-126856 | HC-Toxin | 83209-65-8 | Natural Products |
| HY-126857 | 5-Hydroxyomeprazole | 92340-57-3 | Reference compound |
| HY-126857A | 5-Hydroxyomeprazole (sodium) | 1215629-45-0 | Reference compound |
| HY-126857AS1 | 5-Hydroxyomeprazole-13C,d2 (sodium) | Isotope-Labeled Compounds | |
| HY-126857R | 5-Hydroxyomeprazole (Standard) | 92340-57-3 | Reference Standards |
| HY-126857S | 5-Hydroxy Omeprazole-d3 | 2748479-83-4 | Isotope-Labeled Compounds |
| HY-126857S3 | 5-Hydroxyomeprazole-d3-1 | 1216667-13-8 | Isotope-Labeled Compounds |
| HY-126858 | Ambuic acid | 340774-69-8 | Natural Products |
| HY-12686 | 5Z-7-Oxozeaenol | 253863-19-3 | Natural Products |
| HY-126861 | 2'-Deoxy-5-formylcytidine | 137017-45-9 | Reference compound |
| HY-126862 | AQ-RA 721 | 139051-89-1 | Reference compound |
| HY-126864 | 11-Oxahomofolic acid | 72254-43-4 | Reference compound |
| HY-126866 | Lankacidin C 8-acetate | 23812-97-7 | Reference compound |
| HY-126867 | Neohydroxyaspergillic acid | 72598-34-6 | Natural Products |
| HY-126869 | Pseudomonic acid D | 85248-93-7 | Natural Products |
| HY-12687 | Tizoxanide | 173903-47-4 | Reference compound |
| HY-126871 | Zaragozic acid D2 | 155179-15-0 | Natural Products |
| HY-126873 | Nikkomycin J | 77368-59-3 | Reference compound |
| HY-126874 | Tyropeptin A-4 | 688737-89-5 | Reference compound |
| HY-126876 | GL-V9 | 1178583-19-1 | Reference compound |
| HY-126877 | 3-Deaza-2'-deoxyadenosine | 78582-17-9 | Reference compound |
| HY-126878 | 11-Oxahomoaminopterin | 78520-72-6 | Reference compound |
| HY-12687R | Tizoxanide (Standard) | 173903-47-4 | Reference Standards |
| HY-12687S | Tizoxanide-d4 | 1246817-56-0 | Isotope-Labeled Compounds |
| HY-12688 | Succinyl phosphonate | 26647-82-5 | Reference compound |
| HY-126880 | Fmoc-NH-PEG8-NHS ester | 1334170-03-4 | Reference compound |
| HY-126881 | Fmoc-PEG2-C2-NHS ester | 1807534-85-5 | Reference compound |
| HY-126882 | Fmoc-PEG6-NHS ester | 1818294-31-3 | Reference compound |
| HY-126883 | Tr-PEG4-OH | 125274-16-0 | Reference compound |
| HY-126884 | DBCO-NHCO-PEG4-NH-Boc | 1255942-12-1 | ADC Related |
| HY-126885 | DBCO-PEG5-NHS ester | 2144395-59-3 | ADC Related |
| HY-126886 | Mal-PEG1-NHS ester | 1807518-72-4 | ADC Related |
| HY-126887 | Mal-PEG8-NHS ester | 2055033-05-9 | Reference compound |
| HY-126888 | Mal-PEG5-NHS ester | 1807537-42-3 | Reference compound |
| HY-126889 | Bis-PEG5-NHS ester | 756526-03-1 | ADC Related |
| HY-12688A | Succinyl phosphonate (trisodium salt) | 864167-45-3 | Reference compound |
| HY-12689 | Mitapivat | 1260075-17-9 | Reference compound |
| HY-126890 | Bis-PEG7-NHS ester | 1334170-02-3 | ADC Related |
| HY-126891 | Bis-PEG3-acid | 96517-92-9 | Reference compound |
| HY-126892 | Bis-PEG7-acid | 94376-75-7 | ADC Related |
| HY-126893 | Bis-PEG8-acid | 1246189-43-4 | ADC Related |
| HY-126894 | Bis-PEG9-acid | 1268488-70-5 | ADC Related |
| HY-126897 | N-Acetylloline | 4914-36-7 | Natural Products |
| HY-126898 | 5-LO/mPGES1-IN-1 | 1492060-44-2 | Reference compound |
| HY-126899 | TPI-287 | 849213-15-6 | Reference compound |
| HY-12689A | Mitapivat (hemisulfate sesquihydrate) | 2151847-10-6 | Reference compound |
| HY-12689B | Mitapivat (hemisulfate) | 2329710-91-8 | Reference compound |
| HY-12689C | Mitapivat (hydrochloride) | 2559738-69-9 | Reference compound |
| HY-12690 | DOTA derivative | 153777-70-9 | Reference compound |
| HY-126900 | HI-253 | 149486-73-7 | Reference compound |
| HY-126904 | ZINC08792355 | 904513-52-6 | Reference compound |
| HY-126905 | ZMC3 | 79514-41-3 | Reference compound |
| HY-126906 | Milbemycin A4 | 51596-11-3 | Reference compound |
| HY-126906R | Milbemycin A4 (Standard) | 51596-11-3 | Reference Standards |
| HY-126907 | A32390A | 61241-59-6 | Reference compound |
| HY-126908 | Tetrazine-Ph-NHS ester | 1616668-55-3 | Reference compound |
| HY-12691 | BFCAs-1 | 585531-74-4 | Reference compound |
| HY-126910 | Mesyl Salvinorin B | 862073-79-8 | Reference compound |
| HY-126911 | 11-keto Fluprostenol | 62145-07-7 | Reference compound |
| HY-126912 | Lauroyl coenzyme A | 6244-92-4 | Natural Products |
| HY-126912A | Lauroyl coenzyme A (lithium) | 190063-12-8 | Biochemical Assay Reagents |
| HY-126913 | Rhodblock 6 | 886625-06-5 | Reference compound |
| HY-126914 | Diacetylcercosporin | 62574-06-5 | Reference compound |
| HY-126915 | CNK-6004 | 96626-42-5 | Reference compound |
| HY-126916 | Tetrahydropyranyldiethyleneglycol | 2163-11-3 | Reference compound |
| HY-126917 | THP-PEG5-OH | 146395-14-4 | Reference compound |
| HY-126918 | THP-PEG6-OH | 42607-87-4 | ADC Related |
| HY-126919 | THP-PEG8-OH | 658858-65-2 | Reference compound |
| HY-12692 | DO3A tert-Butyl ester | 122555-91-3 | Reference compound |
| HY-126920 | AFG206 | 630122-37-1 | Reference compound |
| HY-126921 | Lab 170250F | 88630-25-5 | Reference compound |
| HY-126922 | Pyraflufen-ethyl | 129630-19-9 | Reference compound |
| HY-126922R | Pyraflufen-ethyl (Standard) | 129630-19-9 | Reference Standards |
| HY-126923 | 2,3-Dinor thromboxane B2 | 63250-09-9 | Reference compound |
| HY-126924 | (Rac)-Saphenamycin | 634600-55-8 | Reference compound |
| HY-126927 | TTR stabilizer L6 | 881290-53-5 | Reference compound |
| HY-12693 | R(+)-Methylindazone | 54197-31-8 | Reference compound |
| HY-126931 | Dinophysistoxin 1 | 81720-10-7 | Natural Products |
| HY-126932 | TTC-352 | 1607819-68-0 | Reference compound |
| HY-126935 | Ansatrienin A3 | 85819-31-4 | Natural Products |
| HY-126936 | MSD-D | 182504-18-3 | Reference compound |
| HY-126937 | Ivermectin B1a | 71827-03-7 | Reference compound |
| HY-126938 | 4-Methylumbelliferyl heptanoate | 18319-92-1 | Reference compound |
| HY-12693A | (Rac)-Methylindazone | 53108-00-2 | Reference compound |
| HY-12694 | Prucalopride (succinate) | 179474-85-2 | Reference compound |
| HY-126940 | Furanodiene | 19912-61-9 | Natural Products |
| HY-126941 | Hecogenin acetate | 915-35-5 | Natural Products |
| HY-126942 | Amino-PEG6-alcohol | 39160-70-8 | ADC Related |
| HY-126943 | SAHA-BPyne | 930772-88-6 | Reference compound |
| HY-126944 | 2-Aminobenzanilide | 4424-17-3 | Biochemical Assay Reagents |
| HY-126948 | Aminooxy-PEG1-azide | 2100306-70-3 | Reference compound |
| HY-126949 | Aminooxy-PEG3-azide | 1306615-51-9 | ADC Related |
| HY-12695 | Guanosine 5'-triphosphate (trisodium salt) | 36051-31-7 | Natural Products |
| HY-126950 | Aminooxy-PEG4-azide | 2100306-61-2 | Reference compound |
| HY-126951 | Aminooxy-PEG2-alcohol | 185022-12-2 | ADC Related |
| HY-126954 | 13-Deoxycarminomycin | 76034-18-9 | Reference compound |
| HY-126956 | Porphyra 334 | 70579-26-9 | Natural Products |
| HY-126957 | Biotin-PEG2-azide | 1910803-72-3 | Reference compound |
| HY-126958 | Biotin-PEG2-acid | 1365655-89-5 | ADC Related |
| HY-126959 | Biotin-PEG4-acid | 721431-18-1 | Reference compound |
| HY-12695B | Guanosine 5'-triphosphate (trisodium salt hydrate) | 207300-85-4 | Oligonucleotides |
| HY-126960 | Mal-PEG1-acid | 760952-64-5 | ADC Related |
| HY-126961 | Mal-PEG4-acid | 518044-41-2 | Reference compound |
| HY-126962 | Mal-PEG5-acid | 1286755-26-7 | Reference compound |
| HY-126963 | Mal-PEG6-acid | 518044-42-3 | Reference compound |
| HY-126965 | Lipid Y | 88090-57-7 | Reference compound |
| HY-126967A | 1-Palmitoyl-sn-glycerol 3-phosphate | 7220-34-0 | Reference compound |
| HY-126969 | C333H | 870095-15-1 | Reference compound |
| HY-12697 | NGB 2904 | 189060-98-8 | Reference compound |
| HY-126970 | HBF-0259 | 957011-15-3 | Reference compound |
| HY-126972 | RI(dl)-2 | 1902146-75-1 | Reference compound |
| HY-126972A | RI(dl)-2 (TFA) | Reference compound | |
| HY-126973 | BI-1230 | 849022-32-8 | Reference compound |
| HY-126974 | Propargyl-PEG3-NHS ester | 1428629-71-3 | ADC Related |
| HY-126975 | Propargyl-PEG3-acid | 1347760-82-0 | ADC Related |
| HY-126976 | Propargyl-PEG5-amine | 1589522-46-2 | ADC Related |
| HY-126977 | Propargyl-PEG9-OH | 2055022-35-8 | Reference compound |
| HY-126978 | Lepidimoide | 145039-76-5 | Natural Products |
| HY-126979 | Mycro2 | 314049-21-3 | Reference compound |
| HY-12697A | NGB 2904 (hydrochloride) | 189061-11-8 | Reference compound |
| HY-12698 | NNC 63-0532 | 250685-44-0 | Reference compound |
| HY-126981 | Sarasinoside B1 | 114066-50-1 | Natural Products |
| HY-126982 | ThioD | 2206682-00-8 | Reference compound |
| HY-126983 | 6',7'-Epoxybergamottin | 206978-14-5 | Natural Products |
| HY-126984 | Fanetizole (mesylate) | 79069-95-7 | Reference compound |
| HY-126985 | 4,9-Anhydrotetrodotoxin | 13072-89-4 | Reference compound |
| HY-126986 | Tetranor-PGDM | 70803-91-7 | Reference compound |
| HY-126986S | Tetranor-PGDM-d6 | 1314905-92-4 | Isotope-Labeled Compounds |
| HY-126987 | Mesosulfuron-methyl | 208465-21-8 | Reference compound |
| HY-126987R | Mesosulfuron-methyl (Standard) | 208465-21-8 | Reference Standards |
| HY-126988 | SP-Chymostatin B | 70857-49-7 | Reference compound |
| HY-126989 | 19-O-Acetylchaetoglobosin A | 50939-69-0 | Natural Products |
| HY-12699 | RO5166017 | 1048346-74-2 | Reference compound |
| HY-126991 | Leu-thiorphan | 80970-04-3 | Reference compound |
| HY-126994 | 6′-Amino-D-luciferin | 161055-47-6 | Dye Reagents |
| HY-126995 | Glycohyodeoxycholic acid | 13042-33-6 | Natural Products |
| HY-126995R | Glycohyodeoxycholic acid (Standard) | 13042-33-6 | Reference Standards |
| HY-126996 | Triiodothyronine sulfate | 31135-55-4 | Reference compound |
| HY-126997 | Bis-PEG3-PFP ester | 1314378-13-6 | Reference compound |
| HY-126998 | Bis-PEG4-PFP ester | 1314378-12-5 | Reference compound |
| HY-126999 | Bis-PEG5-PFP ester | 1334177-78-4 | Reference compound |
| HY-12700 | RO5256390 | 1043495-96-0 | Reference compound |
| HY-127000 | Julifloricine | 66771-80-0 | Natural Products |
| HY-127001 | Lycodine | 20316-18-1 | Natural Products |
| HY-127002 | Squarunkin A | 2101958-02-3 | Reference compound |
| HY-127002A | Squarunkin A (hydrochloride) | 2253744-55-5 | Reference compound |
| HY-127004 | Silperisone (hydrochloride) | 140944-30-5 | Reference compound |
| HY-127005 | Ritrosulfan | 4148-16-7 | Reference compound |
| HY-127007 | Okilactomycin | 111367-04-5 | Natural Products |
| HY-127008 | N-Butylfluorescein | 335193-91-4 | Dye Reagents |
| HY-127009 | Levoleucovorin | 68538-85-2 | Natural Products |
| HY-12701 | U-99194 | 82668-33-5 | Reference compound |
| HY-127010 | Arnolol | 87129-71-3 | Reference compound |
| HY-127011 | 7-Acetylintermedine | 74243-01-9 | Natural Products |
| HY-127012 | H-0104 (dihydrochloride) | 913636-88-1 | Reference compound |
| HY-127014 | Julimycin B2 | 18126-05-1 | Reference compound |
| HY-127016 | Manninotrionate (potassium) | 122871-01-6 | Reference compound |
| HY-127017 | Histidinomethylalanine | 88495-09-4 | Reference compound |
| HY-127018 | Maltoheptaose | 34620-78-5 | Reference compound |
| HY-127018A | Maltoheptaose (hydrate) | 331748-09-5 | Reference compound |
| HY-127019 | Nigericin | 28380-24-7 | Reference compound |
| HY-127019R | Nigericin (Standard) | 28380-24-7 | Reference Standards |
| HY-12701A | U-99194 (maleate) | 234757-41-6 | Reference compound |
| HY-12702 | 10058-F4 | 403811-55-2 | Reference compound |
| HY-127020 | Deoxyenterocin | 108605-51-2 | Reference compound |
| HY-127022A | Anisodine (hydrobromide) | 76822-34-9 | Natural Products |
| HY-127023 | Eicosapentaenoyl serotonin | 199875-71-3 | Reference compound |
| HY-127024 | Thyroid hormone receptor antagonist (1-850) | 251310-57-3 | Reference compound |
| HY-127025 | 8-Hydroxy loxapine | 61443-77-4 | Reference compound |
| HY-127026 | Quinaprilat | 82768-85-2 | Reference compound |
| HY-127026A | Quinaprilat (hydrate) | 1435786-09-6 | Reference compound |
| HY-127026B | Quinaprilat (hydrochloride) | 82586-58-1 | Reference compound |
| HY-127026R | Quinaprilat (Standard) | 82768-85-2 | Reference Standards |
| HY-127026S | Quinaprilat-d5 | 1279034-23-9 | Isotope-Labeled Compounds |
| HY-127027 | Acetaldophosphamide | 113341-60-9 | Reference compound |
| HY-127028 | Tripynadine | 81849-98-1 | Reference compound |
| HY-127029A | Umbelliprenin | 23838-17-7 | Natural Products |
| HY-12703 | KSI-3716 | 1151813-61-4 | Reference compound |
| HY-127030 | Zatosetron | 123482-22-4 | Reference compound |
| HY-127032 | Polyquaternium-1 | 75345-27-6 | Reference compound |
| HY-127033 | Santalene | 512-61-8 | Natural Products |
| HY-127034 | Antipain (dihydrochloride) | 37682-72-7 | Reference compound |
| HY-127035 | Tristearin | 555-43-1 | Natural Products |
| HY-127035R | Tristearin (Standard) | 555-43-1 | Reference Standards |
| HY-127035S | Tristearin-d105 | 125941-88-0 | Isotope-Labeled Compounds |
| HY-127035S1 | Tristearin-13C3 | 287100-84-9 | Isotope-Labeled Compounds |
| HY-127035S2 | Tristearin-d40 | 33048-69-0 | Isotope-Labeled Compounds |
| HY-127035S3 | Tristearin-d5 | 55256-03-6 | Isotope-Labeled Compounds |
| HY-127035S4 | Tristearin-d9 | 285979-76-2 | Isotope-Labeled Compounds |
| HY-127036 | Tocamphyl | 5634-42-4 | Reference compound |
| HY-127038 | Diflumidone (sodium) | 22737-01-5 | Reference compound |
| HY-127039 | Antipain | 37691-11-5 | Reference compound |
| HY-12703S | KSI-3716-d4 | Isotope-Labeled Compounds | |
| HY-12704 | ITD-1 | 1099644-42-4 | Reference compound |
| HY-127040 | Talastine (hydrochloride) | 16188-76-4 | Reference compound |
| HY-127041 | Virstatin | 88909-96-0 | Reference compound |
| HY-127042 | 6,7-Epoxy-latrunculin A | 122876-48-6 | Natural Products |
| HY-127043 | Pirbenicillin | 63975-62-2 | Reference compound |
| HY-127048 | Trichodermol | 2198-93-8 | Reference compound |
| HY-127049 | Arachidonic acid-biotin | 1217901-28-4 | Dye Reagents |
| HY-12705 | Bromocriptine | 25614-03-3 | Natural Products |
| HY-127052 | Stearonitrile | 638-65-3 | Natural Products |
| HY-127054 | Netilmicin | 56391-56-1 | Reference compound |
| HY-127056 | Sulfo DBCO-amine | 2028284-70-8 | Reference compound |
| HY-127059 | Clindamycin Sulfoxide | 22431-46-5 | Reference compound |
| HY-12705A | Bromocriptine (mesylate) | 22260-51-1 | Reference compound |
| HY-12705AR | Bromocriptine (mesylate) (Standard) | 22260-51-1 | Reference Standards |
| HY-12705S | Bromocriptine-13C,d3 | Isotope-Labeled Compounds | |
| HY-12706 | Spiroxatrine | 1054-88-2 | Reference compound |
| HY-127061 | Palmitoleoyl ethanolamide | 94421-67-7 | Reference compound |
| HY-127063 | Pseudojervine | 36069-05-3 | Natural Products |
| HY-127067 | Yuanhuadin | 76402-66-9 | Natural Products |
| HY-127069 | Methiomeprazine | 7009-43-0 | Reference compound |
| HY-12707 | Piribedil | 3605-01-4 | Reference compound |
| HY-127072 | Amicoumacin A | 78654-44-1 | Natural Products |
| HY-127074 | Chlorendic acid | 115-28-6 | Reference compound |
| HY-127075 | Alahopcin | 82576-50-9 | Reference compound |
| HY-127078 | Salaspermic acid | 71247-78-4 | Natural Products |
| HY-127079 | Epothilone F | 208518-52-9 | Natural Products |
| HY-12707A | Piribedil (dihydrochloride) | 1451048-94-4 | Reference compound |
| HY-12707B | Piribedil (maleate) | 937719-94-3 | Reference compound |
| HY-12707C | Piribedil (hydrochloride) | 78213-63-5 | Reference compound |
| HY-12707R | Piribedil (Standard) | 3605-01-4 | Reference Standards |
| HY-12707S | Piribedil-d8 | 1398044-45-5 | Isotope-Labeled Compounds |
| HY-12708 | Chlorpromazine | 50-53-3 | Reference compound |
| HY-127085 | Acanthifolicin | 77739-71-0 | Natural Products |
| HY-127086 | Dicarbine | 17411-19-7 | Reference compound |
| HY-127086A | Dicarbine (dihydrochloride) | 33162-17-3 | Reference compound |
| HY-127087 | Isogarcinol | 71117-97-0 | Natural Products |
| HY-12709 | ARC 239 | 67339-62-2 | Reference compound |
| HY-127090 | Muramyl dipeptide | 53678-77-6 | Reference compound |
| HY-127093 | Sedecamycin | 23477-98-7 | Reference compound |
| HY-127098 | Kahweol linoleate | 108214-29-5 | Reference compound |
| HY-12709A | ARC 239 (dihydrochloride) | 55974-42-0 | Reference compound |
| HY-12710 | Rauwolscine | 131-03-3 | Natural Products |
| HY-127102 | GSK3494245 | 2080410-41-7 | Reference compound |
| HY-127103 | FB23-2 | 2243736-45-8 | Reference compound |
| HY-127104 | FMF-04-159-2 | 2364489-81-4 | Reference compound |
| HY-127105 | Iptacopan | 1644670-37-0 | Reference compound |
| HY-127105A | Iptacopan (hydrochloride) | 1646321-63-2 | Reference compound |
| HY-127106 | VU0810464 | 2126040-21-7 | Reference compound |
| HY-127109 | Tisolagiline | 1894207-44-3 | Reference compound |
| HY-127109A | Tisolagiline (methylsulfate) | 1894207-45-4 | Reference compound |
| HY-12710A | Rauwolscine (hydrochloride) | 6211-32-1 | Natural Products |
| HY-12711 | 2-Methoxyidazoxan | 102575-24-6 | Reference compound |
| HY-127110 | AK106-001616 | 590416-75-4 | Reference compound |
| HY-127111 | NDI-091143 | 2375840-87-0 | Reference compound |
| HY-127112 | Oleic acid alkyne | 151333-45-8 | Reference compound |
| HY-127113 | Q8 | 1541762-55-3 | Reference compound |
| HY-127118 | Pteropterin | 89-38-3 | Reference compound |
| HY-127118A | Pteropterin (monohydrate) | 6164-84-7 | Reference compound |
| HY-127119 | Benanserin (hydrochloride) | 525-02-0 | Reference compound |
| HY-127120 | Timiperone | 57648-21-2 | Reference compound |
| HY-127122 | Valtorcitabine (dihydrochloride) | 359689-54-6 | Reference compound |
| HY-127125 | Diclofenac ethyl ester | 15307-77-4 | Reference compound |
| HY-127127 | Deamino-NAD | 1851-07-6 | Reference compound |
| HY-127127A | Deamino-NAD (sodium) | 104809-38-3 | Reference compound |
| HY-127128 | Flestolol (sulfate) | 88844-73-9 | Reference compound |
| HY-12713 | Lisuride | 18016-80-3 | Reference compound |
| HY-127130 | Spicamycin | 87099-85-2 | Reference compound |
| HY-127131 | Leucanicidin | 91021-66-8 | Reference compound |
| HY-127133 | Methylpiperidino pyrazole | 289726-02-9 | Reference compound |
| HY-127135 | B07 | 1260629-43-3 | Reference compound |
| HY-127137 | Adenylosuccinic acid | 19046-78-7 | Natural Products |
| HY-127137A | Adenylosuccinic acid (tetraammonium) | Oligonucleotides | |
| HY-127138 | Arctigenin mustard | 26788-57-8 | Natural Products |
| HY-127139 | Eicosapentaenoyl Chloride | 98770-65-1 | Reference compound |
| HY-12714 | TDHL | 37686-84-3 | Reference compound |
| HY-127140 | Cardanol triene | 79353-39-2 | Reference compound |
| HY-127142 | Cephapirin lactone | 60517-75-1 | Reference compound |
| HY-127143 | Sterculic acid | 738-87-4 | Natural Products |
| HY-127144 | α-Saxitoxinol | 75420-34-7 | Reference compound |
| HY-127146 | Platensimycin | 835876-32-9 | Natural Products |
| HY-127147 | Fazadinium (bromide) | 49564-56-9 | Reference compound |
| HY-127149 | Mofarotene | 125533-88-2 | Reference compound |
| HY-127150 | Clofezone | 17449-96-6 | Reference compound |
| HY-127151 | R-(-)-Phencynonate (hydrochloride) | 861655-73-4 | Reference compound |
| HY-127152 | Hippadine | 52886-06-3 | Natural Products |
| HY-127154 | Carmine (lithium) | 12772-56-4 | Dye Reagents |
| HY-127155 | Kigamicin C | 680571-51-1 | Natural Products |
| HY-127156 | Hikizimycin | 12706-94-4 | Reference compound |
| HY-127157 | Aspterric acid | 67309-95-9 | Natural Products |
| HY-127159 | Laurencin | 3442-58-8 | Reference compound |
| HY-12715S | Yohimbine-13C,d3 | 1261254-59-4 | Isotope-Labeled Compounds |
| HY-12715S1 | Yohimbine-d3 | 133146-00-6 | Isotope-Labeled Compounds |
| HY-12716 | BRL-44408 | 118343-19-4 | Reference compound |
| HY-127160 | Benzoxonium (chloride) | 19379-90-9 | Reference compound |
| HY-127160R | Benzoxonium (chloride) (Standard) | 19379-90-9 | Reference Standards |
| HY-127162 | Prostaglandin K1 | 69413-73-6 | Reference compound |
| HY-127165 | Velnacrine | 124027-47-0 | Reference compound |
| HY-127165S | Velnacrine-d3 | 1219806-47-9 | Isotope-Labeled Compounds |
| HY-127165S1 | Velnacrine-d3 (maleate) | Isotope-Labeled Compounds | |
| HY-127165S2 | Velnacrine-d4 (hydrochloride) | 1246816-08-9 | Isotope-Labeled Compounds |
| HY-127165S3 | Velnacrine-d4 | 1246911-78-3 | Isotope-Labeled Compounds |
| HY-127166 | Colchiceine | 477-27-0 | Natural Products |
| HY-127166R | Colchiceine (Standard) | 477-27-0 | Reference Standards |
| HY-127167 | 3',4'-Dihydroxyflavone | 4143-64-0 | Reference compound |
| HY-127168 | 6,7-Dihydroxyflavone | 38183-04-9 | Natural Products |
| HY-12716A | BRL-44408 (maleate) | 681806-46-2 | Reference compound |
| HY-12717 | Phentolamine | 50-60-2 | Reference compound |
| HY-127170 | 3-Hydroxycoumarin | 939-19-5 | Natural Products |
| HY-127178 | ML120 analog 1 | 445426-74-4 | Reference compound |
| HY-12717A | Phentolamine (hydrochloride) | 73-05-2 | Reference compound |
| HY-12717AS | Phentolamine-d4 (hydrochloride) | 1346599-65-2 | Isotope-Labeled Compounds |
| HY-12717R | Phentolamine (Standard) | 50-60-2 | Reference Standards |
| HY-12718A | (±)-WB 4101 (hydrochloride) | 2170-58-3 | Reference compound |
| HY-12719 | Dexmedetomidine | 113775-47-6 | Reference compound |
| HY-12719R | Dexmedetomidine (Standard) | 113775-47-6 | Reference Standards |
| HY-12720 | Apraclonidine | 66711-21-5 | Reference compound |
| HY-12720A | Apraclonidine (hydrochloride) | 73218-79-8 | Reference compound |
| HY-12720AR | Apraclonidine (hydrochloride) (Standard) | 73218-79-8 | Reference Standards |
| HY-12720B | Apraclonidine (dihydrochloride) | 73217-88-6 | Reference compound |
| HY-12721 | Clonidine | 4205-90-7 | Reference compound |
| HY-12721R | Clonidine (Standard) | 4205-90-7 | Reference Standards |
| HY-12721S | Clonidine-d4 (hydrochloride) | 67151-02-4 | Isotope-Labeled Compounds |
| HY-12723 | Apomorphine | 58-00-4 | Reference compound |
| HY-12724 | Guanabenz | 5051-62-7 | Reference compound |
| HY-12724A | Guanabenz (hydrochloride) | 23113-43-1 | Reference compound |
| HY-12725 | ML324 | 1222800-79-4 | Reference compound |
| HY-12726 | Liproxstatin-1 | 950455-15-9 | Reference compound |
| HY-12726A | Liproxstatin-1 (hydrochloride) | 2250025-95-5 | Reference compound |
| HY-12726S | Liproxstatin-1-13C6 | Isotope-Labeled Compounds | |
| HY-12726S1 | Liproxstatin-1-15N | Isotope-Labeled Compounds | |
| HY-12727 | EPZ015666 | 1616391-65-1 | Reference compound |
| HY-12731 | GSK2236805 | 1256390-53-0 | Reference compound |
| HY-12732 | PTC 725 | 1248581-07-8 | Reference compound |
| HY-12733 | AZD5248 | 1254318-44-9 | Reference compound |
| HY-12734 | AM-8735 | 1429386-01-5 | Reference compound |
| HY-12735 | SCH 900822 | 1220894-09-6 | Reference compound |
| HY-12736 | GSK143 | 1240390-27-5 | Reference compound |
| HY-12736A | GSK143 (dihydrochloride) | 2341796-81-2 | Reference compound |
| HY-12738 | PF-3882845 | 1023650-66-9 | Reference compound |
| HY-12740 | Lotamilast | 947620-48-6 | Reference compound |
| HY-12741 | LDN-212320 | 894002-50-7 | Reference compound |
| HY-12742 | SCR7 | 1533426-72-0 | Reference compound |
| HY-12743 | K-7174 | 191089-59-5 | Reference compound |
| HY-12743A | K-7174 (dihydrochloride) | 191089-60-8 | Reference compound |
| HY-12744 | Genz-123346 (free base) | 491833-30-8 | Reference compound |
| HY-12744A | Genz-123346 | 943344-58-9 | Reference compound |
| HY-12746 | DC-05 | 890643-16-0 | Reference compound |
| HY-12747 | DC_517 | 500017-70-9 | Reference compound |
| HY-12749 | Midodrine | 42794-76-3 | Reference compound |
| HY-12749A | Midodrine (hydrochloride) | 43218-56-0 | Reference compound |
| HY-12749AS | Midodrine-d6 (hydrochloride) | 1188265-43-1 | Isotope-Labeled Compounds |
| HY-12749B | (R)-Midodrine (hydrochloride) | 133163-28-7 | Reference compound |
| HY-12750 | AZD3965 | 1448671-31-5 | Reference compound |
| HY-12751 | Trimethobenzamide | 138-56-7 | Reference compound |
| HY-12751A | Trimethobenzamide (hydrochloride) | 554-92-7 | Reference compound |
| HY-12751AR | Trimethobenzamide (hydrochloride) (Standard) | 554-92-7 | Reference Standards |
| HY-12751S | Trimethobenzamide-d6 | Isotope-Labeled Compounds | |
| HY-12752 | Alimemazine | 84-96-8 | Reference compound |
| HY-12752A | Alimemazine hemitartrate | 4330-99-8 | Reference compound |
| HY-12752AR | Alimemazine hemitartrate (Standard) | 4330-99-8 | Reference Standards |
| HY-12752BS | Alimemazine-d6 (hydrochloride) | 1352792-16-5 | Isotope-Labeled Compounds |
| HY-12752S | Alimemazine-d6 | 1346603-88-0 | Isotope-Labeled Compounds |
| HY-12753A | Debutyldronedarone (hydrochloride) | 197431-02-0 | Reference compound |
| HY-12753AR | Debutyldronedarone (hydrochloride) (Standard) | 197431-02-0 | Reference Standards |
| HY-12753AS | Debutyldronedarone-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-12753S | Debutyldronedarone-d7 | Isotope-Labeled Compounds | |
| HY-12753S1 | Debutyldronedarone-d6 (hydrochloride) | 1346598-70-6 | Isotope-Labeled Compounds |
| HY-12754 | ML228 | 1357171-62-0 | Reference compound |
| HY-12755 | ML141 | 71203-35-5 | Reference compound |
| HY-12756 | E6446 | 1219925-73-1 | Reference compound |
| HY-12756A | E6446 (dihydrochloride) | 1345675-25-3 | Reference compound |
| HY-12757 | YHO-13177 | 912287-56-0 | Reference compound |
| HY-12758 | YHO-13351 | 1346753-00-1 | Reference compound |
| HY-12758A | YHO-13351 (free base) | 912288-64-3 | Reference compound |
| HY-12759 | CARM1-IN-1 | 1020399-49-8 | Reference compound |
| HY-12759A | CARM1-IN-1 (hydrochloride) | 2070018-31-2 | Reference compound |
| HY-12760 | Indoramin | 26844-12-2 | Reference compound |
| HY-12760S | Indoramin-d5 | 57165-41-0 | Isotope-Labeled Compounds |
| HY-12761 | A-836339 | 959746-77-1 | Reference compound |
| HY-12761R | A-836339 (Standard) | 959746-77-1 | Reference Standards |
| HY-12762 | QS11 | 944328-88-5 | Reference compound |
| HY-12763 | GNE-317 | 1394076-92-6 | Reference compound |
| HY-12764 | 6-OAU | 83797-69-7 | Reference compound |
| HY-12764R | 6-OAU (Standard) | 83797-69-7 | Reference Standards |
| HY-12765 | Losartan Carboxylic Acid | 124750-92-1 | Reference compound |
| HY-12765R | Losartan Carboxylic Acid (Standard) | 124750-92-1 | Reference Standards |
| HY-12765S | Losartan-d4 (carboxylic acid) | 1246820-62-1 | Isotope-Labeled Compounds |
| HY-12765S1 | Losartan carboxylic acid-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-12766 | Bupropion morpholinol | 357399-43-0 | Reference compound |
| HY-12766S | Bupropion morpholinol-d6 | 1216893-18-3 | Isotope-Labeled Compounds |
| HY-12767 | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol | 142227-49-4 | Reference compound |
| HY-12767S | 4-Hydroxyphenyl Carvedilol-d5 | 1261395-96-3 | Isotope-Labeled Compounds |
| HY-12767S1 | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol-d4 | Isotope-Labeled Compounds | |
| HY-12767S2 | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol-13C6 | Isotope-Labeled Compounds | |
| HY-12768 | Sotuletinib | 953769-46-5 | Reference compound |
| HY-12768A | Sotuletinib (hydrochloride) | 2222138-31-8 | Reference compound |
| HY-12768B | Sotuletinib (dihydrochloride) | 2222138-40-9 | Reference compound |
| HY-12769 | Mebeverine acid | 475203-77-1 | Reference compound |
| HY-12769R | Mebeverine acid (Standard) | 475203-77-1 | Reference Standards |
| HY-12769S | Mebeverine acid-d5 | 2070015-30-2 | Isotope-Labeled Compounds |
| HY-12769S1 | Mebeverine acid-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-12769S2 | Mebeverine acid-d3 | Isotope-Labeled Compounds | |
| HY-12770 | Mebeverine alcohol | 14367-47-6 | Reference compound |
| HY-12770R | Mebeverine alcohol (Standard) | 14367-47-6 | Reference Standards |
| HY-12770S | Mebeverine alcohol-d5 | 2070015-15-3 | Isotope-Labeled Compounds |
| HY-12770S1 | Mebeverine alcohol-d3 | Isotope-Labeled Compounds | |
| HY-12771 | O-desmethyl Mebeverine acid | 586357-02-0 | Reference compound |
| HY-12771S | O-Desmethyl Mebeverine acid-d5 | 1329488-46-1 | Isotope-Labeled Compounds |
| HY-12771S1 | O-desmethyl Mebeverine acid D5 hydrochloride | Isotope-Labeled Compounds | |
| HY-12771S2 | O-Desmethyl Mebeverine acid-d6 | 1630732-39-6 | Isotope-Labeled Compounds |
| HY-12772 | Hydroxy Itraconazole | 112559-91-8 | Reference compound |
| HY-12772A | rel-Hydroxy Itraconazole | 207970-87-4 | Reference compound |
| HY-12772R | Hydroxy Itraconazole (Standard) | 112559-91-8 | Reference Standards |
| HY-12772S | Hydroxy Itraconazole-d8 | Isotope-Labeled Compounds | |
| HY-12772S1 | (2R,4S)-Hydroxy Itraconazole-d8 | 1217516-26-1 | Isotope-Labeled Compounds |
| HY-12772S2 | (2R,4S)-Hydroxy Itraconazole-d5 | 1217524-77-0 | Isotope-Labeled Compounds |
| HY-12772S3 | Hydroxy Itraconazole-d6 | Isotope-Labeled Compounds | |
| HY-12773AS | 5-Hydroxy Propafenone-d5 (hydrochloride) | 1215370-87-8 | Isotope-Labeled Compounds |
| HY-12773AS1 | 5-Hydroxy Propafenone-d5-1 (hydrochloride) | 1188265-48-6 | Isotope-Labeled Compounds |
| HY-12773AS2 | 5-Hydroxy Propafenone-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-12774 | IC261 | 186611-52-9 | Reference compound |
| HY-12776 | GSK805 | 1426802-50-7 | Reference compound |
| HY-12777 | Asivatrep | 1005168-10-4 | Reference compound |
| HY-12778 | Ivabradine metabolite N-Demethyl Ivabradine (hydrochloride) | 1246638-08-3 | Reference compound |
| HY-12778R | Ivabradine metabolite N-Demethyl Ivabradine (hydrochloride) (Standard) | 1246638-08-3 | Reference Standards |
| HY-12778S | N-Demethyl Ivabradine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-12779 | Cyantraniliprole | 736994-63-1 | Reference compound |
| HY-12779R | Cyantraniliprole (Standard) | 736994-63-1 | Reference Standards |
| HY-12779S | Cyantraniliprole-d3 | 1392493-34-3 | Isotope-Labeled Compounds |
| HY-12781 | Desbutyl Lumefantrine | 355841-11-1 | Reference compound |
| HY-12781S | Desbutyl Lumefantrine-d9 | 1346606-35-6 | Isotope-Labeled Compounds |
| HY-12782T | Iadademstat (dihydrochloride) | 1431303-72-8 | Reference compound |
| HY-12783 | SCH 50911 (hydrochloride) | 160415-07-6 | Reference compound |
| HY-12783A | SCH 50911 | 733717-87-8 | Reference compound |
| HY-12784 | Cycloguanil | 516-21-2 | Reference compound |
| HY-12784A | Cycloguanil (hydrochloride) | 152-53-4 | Reference compound |
| HY-12784AR | Cycloguanil (hydrochloride) (Standard) | 152-53-4 | Reference Standards |
| HY-12784AS | Cycloguanil-d4 (hydrochloride) | 1189427-23-3 | Isotope-Labeled Compounds |
| HY-12784AS1 | Cycloguanil-d6 (hydrochloride) | 2712364-69-5 | Isotope-Labeled Compounds |
| HY-12784S | Cycloguanil-d6 | Isotope-Labeled Compounds | |
| HY-12784S1 | Cycloguanil-d6(nitrate) | Isotope-Labeled Compounds | |
| HY-12785 | Albendazole sulfoxide | 54029-12-8 | Reference compound |
| HY-12785R | Albendazole sulfoxide (Standard) | 54029-12-8 | Reference Standards |
| HY-12785S | Albendazole sulfoxide-d3 | 1448346-38-0 | Isotope-Labeled Compounds |
| HY-12785S1 | Albendazole sulfoxide-d7 | 2469575-37-7 | Isotope-Labeled Compounds |
| HY-12787 | L-779450 | 303727-31-3 | Reference compound |
| HY-12788 | PF-04449613 | 1236858-52-8 | Reference compound |
| HY-12788A | (S)-PF-04449613 | Reference compound | |
| HY-12789 | Etrasimod | 1206123-37-6 | Reference compound |
| HY-12790 | CB1-IN-1 | 1429239-98-4 | Reference compound |
| HY-12791 | hPGDS-IN-1 | 1234708-04-3 | Reference compound |
| HY-12793 | Padnarsertib | 1643913-93-2 | Reference compound |
| HY-12794 | Vps34-PIK-III | 1383716-40-2 | Reference compound |
| HY-12795 | Vps34-IN-1 | 1383716-33-3 | Reference compound |
| HY-12796 | Raxatrigine | 934240-30-9 | Reference compound |
| HY-12796A | Raxatrigine (hydrochloride) | 934240-31-0 | Reference compound |
| HY-12797 | GF 15 | 888042-13-5 | Reference compound |
| HY-12798 | Netarsudil | 1254032-66-0 | Reference compound |
| HY-12798A | Netarsudil (dimesylate) | 1422144-42-0 | Reference compound |
| HY-12798B | Netarsudil (hydrochloride) | 1253952-02-1 | Reference compound |
| HY-12798C | AR-13503 | 2309668-15-1 | Reference compound |
| HY-12798CR | AR-13503 (Standard) | 2309668-15-1 | Reference Standards |
| HY-12798E | (R)-AR-13503 | 2377238-62-3 | Reference compound |
| HY-128000 | ML095 | 1135318-57-8 | Reference compound |
| HY-128004 | ML171 analog 1 | 1730-44-5 | Reference compound |
| HY-12801 | DiZPK | 1337883-32-5 | Reference compound |
| HY-12801A | DiZPK (hydrochloride) | 2349295-23-2 | Reference compound |
| HY-12802 | AF38469 | 1531634-31-7 | Reference compound |
| HY-128024 | VHR-IN-1 | 956189-91-6 | Reference compound |
| HY-128026 | MMP-9/MMP-13 Inhibitor I | 204140-01-2 | Reference compound |
| HY-128027 | eCF309 | 2001571-40-8 | Reference compound |
| HY-128029 | Glycogen phosphorylase-IN-1 | 648926-15-2 | Reference compound |
| HY-128030 | Makisterone A | 20137-14-8 | Natural Products |
| HY-128031 | Resolvin D1 methyl ester | 937738-63-1 | Reference compound |
| HY-128033 | Fenpropimorph | 67564-91-4 | Reference compound |
| HY-128033R | Fenpropimorph (Standard) | 67564-91-4 | Reference Standards |
| HY-128034 | PPIase-Parvulin inhibitor | 64005-90-9 | Reference compound |
| HY-128035 | ML-211 | 2205032-89-7 | Reference compound |
| HY-128036B | ddATP (trisodium) | 72029-21-1 | Reference compound |
| HY-128036C | ddATP (tetrasodium) | Reference compound | |
| HY-128038 | N-Desmethyl-loperamide | 66164-07-6 | Reference compound |
| HY-128038S | N-Desmethyl-loperamide-d3 | 1189488-17-2 | Isotope-Labeled Compounds |
| HY-128039 | 17-Phenyl-ω-trinor-PGE2 | 38315-43-4 | Reference compound |
| HY-12804 | VAS2870 | 722456-31-7 | Reference compound |
| HY-128040 | Virodhamine (hydrochloride) | 443129-35-9 | Reference compound |
| HY-128041 | alpha-Hydroxy farnesyl phosphonic acid | 148796-53-6 | Reference compound |
| HY-128043 | 11-Deoxy prostaglandin E1 | 37786-00-8 | Reference compound |
| HY-128044 | Ftase inhibitor I | 149759-96-6 | Reference compound |
| HY-128045 | Fenoxazoline | 4846-91-7 | Reference compound |
| HY-128047 | GALK1-IN-1 | 669718-48-3 | Reference compound |
| HY-12805 | ML171 | 6631-94-3 | Reference compound |
| HY-128057 | NCRW0005-F05 | 342779-66-2 | Reference compound |
| HY-12806 | AG1557 | 189290-58-2 | Reference compound |
| HY-128060 | PDE5-IN-42 | 936449-28-4 | Reference compound |
| HY-128062 | LIMK1 inhibitor BMS-4 | 905298-84-2 | Reference compound |
| HY-128063 | CXCR3 antagonist 1 | 870998-13-3 | Reference compound |
| HY-128064 | Adenosine amine congener | 96760-69-9 | Reference compound |
| HY-128067 | 5-(N,N-Hexamethylene)-amiloride | 1428-95-1 | Reference compound |
| HY-128068 | DHODH-IN-17 | 16344-26-6 | Reference compound |
| HY-12807 | FIPI | 939055-18-2 | Reference compound |
| HY-128075 | Acifluorfen | 50594-66-6 | Reference compound |
| HY-128075R | Acifluorfen (Standard) | 50594-66-6 | Reference Standards |
| HY-12807A | FIPI (hydrochloride) | 1781834-93-2 | Reference compound |
| HY-12808 | STF-118804 | 894187-61-2 | Reference compound |
| HY-12809 | Optovin | 348575-88-2 | Reference compound |
| HY-128090 | Apstatin | 160470-73-5 | Reference compound |
| HY-128090A | Apstatin (TFA) | Reference compound | |
| HY-12810 | EHop-016 | 1380432-32-5 | Reference compound |
| HY-128103 | Glucagon receptor antagonist-7 | 438618-32-7 | Reference compound |
| HY-128105 | 1,2-Dihydroxynaphthalene | 574-00-5 | Natural Products |
| HY-12811 | PF-04856264 | 1235397-05-3 | Reference compound |
| HY-128111 | ASN02563583 | 483283-39-2 | Reference compound |
| HY-128113 | AG-09/1 | 356776-32-4 | Reference compound |
| HY-12812 | Autotaxin modulator 1 | 1548743-69-6 | Reference compound |
| HY-128121 | MLS1547 | 315698-36-3 | Reference compound |
| HY-128126 | B-TPMF | 477865-65-9 | Reference compound |
| HY-128127 | NAEPA | 24435-25-4 | Reference compound |
| HY-128128 | ASN04421891 | 570365-12-7 | Reference compound |
| HY-128129 | UT-B-IN-1 | 892742-76-6 | Reference compound |
| HY-12813 | PDE10-IN-1 | 1516896-09-5 | Reference compound |
| HY-128131 | UCCF-029 (free base) | 2110-25-0 | Reference compound |
| HY-128132 | C3a receptor agonist 1 | 944997-60-8 | Reference compound |
| HY-128133 | MMP-8 inhibitor-1 | 236403-25-1 | Reference compound |
| HY-128135 | MHY 553 | 6265-56-1 | Reference compound |
| HY-128139 | 2'-C-Methylguanosine | 374750-30-8 | Reference compound |
| HY-12813A | PDE10-IN-2 | 1516895-53-6 | Reference compound |
| HY-12814 | TH588 | 1609960-31-7 | Reference compound |
| HY-128140 | Z-FY-CHO | 167498-29-5 | Reference compound |
| HY-128142 | PKC/PKD-IN-1 | 1071135-06-2 | Reference compound |
| HY-128144 | Lalistat 2 | 1234569-09-5 | Reference compound |
| HY-128145 | HSD17B13-IN-41 | 1122660-25-6 | Reference compound |
| HY-128146 | 2-Nitrophenanthraquinone | 604-95-5 | Reference compound |
| HY-128147 | MetAP-2-IN-6 | 5301-98-4 | Reference compound |
| HY-12814A | TH588 (hydrochloride) | 1640282-30-9 | Reference compound |
| HY-12815 | MCC950 | 210826-40-7 | Reference compound |
| HY-128153 | Thienopyridone | 1018454-97-1 | Reference compound |
| HY-12815A | MCC950 (sodium) | 256373-96-3 | Reference compound |
| HY-128170 | Ebsulfur | 2527-03-9 | Reference compound |
| HY-128171 | Diflapolin | 724453-98-9 | Reference compound |
| HY-128172 | TRPM4-IN-2 | 667411-04-3 | Reference compound |
| HY-128174 | β-CCM | 69954-48-9 | Reference compound |
| HY-128189 | Aminoacyl tRNA synthetase-IN-4 | 342017-94-1 | Reference compound |
| HY-12819 | MK-1421 | 1235995-16-0 | Reference compound |
| HY-12820 | Sibofimloc | 1616113-45-1 | Reference compound |
| HY-128200 | Pseudomonas quinolone signal | 108985-27-9 | Reference compound |
| HY-128204 | AN3661 | 1268335-33-6 | Reference compound |
| HY-128205 | BTD | 896684-04-1 | Reference compound |
| HY-128206 | I3MT-3 | 459420-09-8 | Reference compound |
| HY-128207 | SID7970631 | 868224-75-3 | Reference compound |
| HY-12820R | Sibofimloc (Standard) | 1616113-45-1 | Reference Standards |
| HY-12821 | AEBSF (hydrochloride) | 30827-99-7 | Reference compound |
| HY-128221 | SGK1-IN-5 | 1426214-51-8 | Reference compound |
| HY-128222 | Selenosemicarbazide | 21198-79-8 | Reference compound |
| HY-128224 | Antiproliferative agent-13 | 663214-48-0 | Reference compound |
| HY-128229 | AHR antagonist 6 | 378223-81-5 | Reference compound |
| HY-12823 | BLU9931 | 1538604-68-0 | Reference compound |
| HY-128231 | GRK6-IN-4 | 300731-73-1 | Reference compound |
| HY-128234 | PDE11-IN-1 | 522652-41-1 | Reference compound |
| HY-12824 | RNPA1000 | 359600-10-5 | Reference compound |
| HY-12824R | RNPA1000 (Standard) | 359600-10-5 | Reference Standards |
| HY-12825 | BHPI | 56632-39-4 | Reference compound |
| HY-12826 | IMB-XH1 | 292057-76-2 | Reference compound |
| HY-128268 | PFK-IN-1 | 735303-62-5 | Reference compound |
| HY-12827 | Sortin1 | 503837-98-7 | Reference compound |
| HY-12828 | KH-CB19 | 1354037-26-5 | Reference compound |
| HY-12828A | KH-CB20 | 1354448-60-4 | Reference compound |
| HY-12829 | SR-3306 | 1128096-91-2 | Reference compound |
| HY-12830 | M-110 | 1395048-49-3 | Reference compound |
| HY-12831 | Ampkinone | 1233082-79-5 | Reference compound |
| HY-128311 | GRK6-IN-3 | 499231-87-7 | Reference compound |
| HY-12832 | JNJ-42041935 | 1193383-09-3 | Reference compound |
| HY-12833 | AMZ30 | 1313613-09-0 | Reference compound |
| HY-128333 | PI3K/mTOR Inhibitor-4 | 2361215-32-7 | Reference compound |
| HY-128334 | PCSK9 modulator-2 | 2365416-53-9 | Reference compound |
| HY-128337 | AN7973 | 1620899-32-2 | Reference compound |
| HY-128338 | CETP-IN-3 | 939391-31-8 | Reference compound |
| HY-128339 | Autogramin-1 | 2375541-73-2 | Reference compound |
| HY-12834 | MK2-IN-1 | 1314118-92-7 | Reference compound |
| HY-128340 | Autogramin-2 | 2375541-45-8 | Reference compound |
| HY-128341 | ERK5-IN-2 | 1888305-96-1 | Reference compound |
| HY-128342 | Complement C5-IN-1 | 2365402-67-9 | Reference compound |
| HY-128343 | KDM4-IN-2 | 2369607-62-3 | Reference compound |
| HY-128344 | BR102375 | 2366255-59-4 | Reference compound |
| HY-128345 | UDM-001651 | 1477497-01-0 | Reference compound |
| HY-128346 | PQM130 | 2089415-51-8 | Reference compound |
| HY-128347 | M‑89 | 2363165-42-6 | Reference compound |
| HY-128348 | PK68 | 2173556-69-7 | Reference compound |
| HY-128349 | MT-3014 | 1332727-40-8 | Reference compound |
| HY-12834A | MK2-IN-1 (hydrochloride) | 1314118-94-9 | Reference compound |
| HY-12835 | S1P1 agonist III | 1324003-64-6 | Reference compound |
| HY-128350 | FGTI-2734 | 1247018-19-4 | Reference compound |
| HY-128350A | FGTI-2734 (mesylate) | 2702297-24-1 | Reference compound |
| HY-128351 | SHR1653 | 2231770-73-1 | Reference compound |
| HY-128352 | SMYD3-IN-1 | 2095160-79-3 | Reference compound |
| HY-128353 | ROR agonist-1 | 2361528-74-5 | Reference compound |
| HY-128354 | CWHM-1552 | 2368253-58-9 | Reference compound |
| HY-128355 | IDO/TDO-IN-1 | 2033173-01-0 | Reference compound |
| HY-128355A | (R)-IDO/TDO-IN-1 | 2033173-00-9 | Reference compound |
| HY-128356 | SPL-410 | 2351886-00-3 | Reference compound |
| HY-128357 | Ibezapolstat | 1275582-97-2 | Reference compound |
| HY-128357A | Ibezapolstat (hydrochloride) | 1275582-98-3 | Reference compound |
| HY-128358 | MR-L2 | 2374703-19-0 | Reference compound |
| HY-128359 | ACBI1 | 2375564-55-7 | Reference compound |
| HY-12836 | IFN alpha-IFNAR-IN-1 | 844882-93-5 | Reference compound |
| HY-128360 | dMCL1-2 | 2351218-88-5 | Reference compound |
| HY-128361 | SLC26A3-IN-3 | 2369983-43-5 | Reference compound |
| HY-128362 | Ep300/CREBBP-IN-8 | 2259641-24-0 | Reference compound |
| HY-128363 | Ep300/CREBBP-IN-2 | 2259641-59-1 | Reference compound |
| HY-128364 | Ep300/CREBBP-IN-3 | 2259641-47-7 | Reference compound |
| HY-128365 | Neticonazole (hydrochloride) | 130773-02-3 | Reference compound |
| HY-128366 | Waltonitone | 1252676-55-3 | Natural Products |
| HY-128367 | Ep300/CREBBP-IN-4 | 2259641-42-2 | Reference compound |
| HY-128369 | Acid Yellow 36 | 587-98-4 | Dye Reagents |
| HY-12836A | IFN alpha-IFNAR-IN-1 (hydrochloride) | 2070014-98-9 | Reference compound |
| HY-12837 | EN460 | 496807-64-8 | Reference compound |
| HY-128370 | Calcium trinatrium diethylenetriaminepentaacetic acid (hydrate) | 207226-35-5 | Reference compound |
| HY-128371 | 2-Methylhexanoic acid | 4536-23-6 | Reference compound |
| HY-128371R | 2-?Methylhexanoic acid (Standard) | 4536-23-6 | Reference Standards |
| HY-128374 | D-Glucose 6-phosphate (disodium salt) | 3671-99-6 | Natural Products |
| HY-128374R | D-Glucose 6-phosphate (disodium salt) (Standard) | 3671-99-6 | Reference Standards |
| HY-128378 | 16-Dehydroprogesterone | 1096-38-4 | Natural Products |
| HY-128379 | Labetalone (hydrochloride) | 96441-14-4 | Reference compound |
| HY-128379R | Labetalone (hydrochloride) (Standard) | 96441-14-4 | Reference Standards |
| HY-12838 | RO5454948 | 1386979-55-0 | Reference compound |
| HY-128380 | Dibenamine (hydrochloride) | 55-43-6 | Reference compound |
| HY-128382 | Brilliant Black BN | 2519-30-4 | Dye Reagents |
| HY-128383 | 1-Methylpyrrolidine | 120-94-5 | Reference compound |
| HY-128383S | 1-Methylpyrrolidine-d8 | 131857-29-9 | Isotope-Labeled Compounds |
| HY-128383S1 | 1-Methylpyrrolidine-d3 | 77422-30-1 | Isotope-Labeled Compounds |
| HY-128384 | Benzyldodecyldimethylammonium (chloride dihydrate) | 147228-80-6 | Reference compound |
| HY-128386 | Cinitapride (monotartrate) | 1207859-16-2 | Reference compound |
| HY-128387 | 2,3-Butanediol | 513-85-9 | Natural Products |
| HY-128387R | 2,3-Butanediol (Standard) | 513-85-9 | Reference Standards |
| HY-128387S | 2,3-Butanediol-d6 | Isotope-Labeled Compounds | |
| HY-128387S1 | 2,3-Butanediol-d8 | 347841-77-4 | Isotope-Labeled Compounds |
| HY-128389 | 1-Furfurylpyrrole | 1438-94-4 | Reference compound |
| HY-128389R | 1-?Furfurylpyrrole (Standard) | 1438-94-4 | Reference Standards |
| HY-12839 | p38 MAPK-IN-1 | 1006378-90-0 | Reference compound |
| HY-128393 | Trilinolein | 537-40-6 | Natural Products |
| HY-128393R | Trilinolein (Standard) | 537-40-6 | Reference Standards |
| HY-128393S1 | Trilinolein-13C54 | Isotope-Labeled Compounds | |
| HY-128394 | L-Gulose | 6027-89-0 | Reference compound |
| HY-128394R | L-Gulose (Standard) | 6027-89-0 | Reference Standards |
| HY-128397 | CpCDPK1/TgCDPK1-IN-1 | 1092788-23-2 | Reference compound |
| HY-128398 | CpCDPK1/TgCDPK1-IN-2 | 1236038-23-5 | Reference compound |
| HY-128399 | CpCDPK1/TgCDPK1-IN-3 | 1092788-87-8 | Reference compound |
| HY-12840 | OBA-09 | 856095-68-6 | Reference compound |
| HY-128400 | 4'-Methoxychalcone | 959-23-9 | Natural Products |
| HY-128402 | P2X3-IN-1 | 2823331-49-1 | Reference compound |
| HY-128403 | BTK inhibitor 8 | 2230724-66-8 | Reference compound |
| HY-128407 | 2,2-Dihydroxy-1-phenylethan-1-one | 1075-06-5 | Reference compound |
| HY-12841 | KHK-IN-1 | 1303469-70-6 | Reference compound |
| HY-128410 | 4-Phenyl-7,8-dihydroxycoumarin | 842-01-3 | Reference compound |
| HY-128416 | 6-Chloro-7-hydroxy-4-methylcoumarin | 19492-02-5 | Reference compound |
| HY-128417 | alpha-D-glucose | 492-62-6 | Natural Products |
| HY-128417A | alpha-D-glucose (hydrate) | 14431-43-7 | Biochemical Assay Reagents |
| HY-128417AR | alpha-D-glucose (hydrate) (Standard) | 14431-43-7 | Reference Standards |
| HY-128417R | alpha-D-glucose (Standard) | 492-62-6 | Reference Standards |
| HY-128417S | alpha-D-glucose-d12 | 1379594-94-1 | Isotope-Labeled Compounds |
| HY-128417S1 | Alpha-D-glucose-13C | 287100-64-5 | Isotope-Labeled Compounds |
| HY-128417S3 | alpha-D-glucose-d7 | 23403-54-5 | Isotope-Labeled Compounds |
| HY-128417S4 | alpha-D-glucose-13C6 | 40010-60-4 | Isotope-Labeled Compounds |
| HY-128417S5 | alpha-D-glucose-13C6,d7 | Isotope-Labeled Compounds | |
| HY-128418 | Benzonatate (PEGn) | 32760-16-0 | Reference compound |
| HY-128419 | Biguanidinium-porphyrin | 1014978-87-0 | Reference compound |
| HY-12841A | KHK-IN-1 (hydrochloride) | 1303470-48-5 | Reference compound |
| HY-12842 | UC-112 | 383392-66-3 | Reference compound |
| HY-128420 | Lobeline (sulfate) | 134-64-5 | Natural Products |
| HY-128421 | Tridecanedioic acid | 505-52-2 | Natural Products |
| HY-128421R | Tridecanedioic acid (Standard) | 505-52-2 | Reference Standards |
| HY-128423 | Tylvalosin (tartrate) | 63428-13-7 | Reference compound |
| HY-128423A | Tylvalosin | 63409-12-1 | Reference compound |
| HY-128423AS | Tylvalosin-d9 | Isotope-Labeled Compounds | |
| HY-128423R | Tylvalosin (tartrate) (Standard) | 63428-13-7 | Reference Standards |
| HY-128424 | 4'-Deoxyphlorizin | 4319-68-0 | Reference compound |
| HY-128425 | N-Carbamoyl-DL-aspartic acid | 923-37-5 | Natural Products |
| HY-128425A | N-Carbamoyl-L-aspartic acid | 13184-27-5 | Natural Products |
| HY-128425R | N-?Carbamoyl-?DL-?aspartic acid (Standard) | 923-37-5 | Reference Standards |
| HY-128426 | Trans-2-butene-1,4-dicarboxylic acid | 4436-74-2 | Natural Products |
| HY-128426R | Trans-?2-?butene-?1,?4-?dicarboxylic acid (Standard) | 4436-74-2 | Reference Standards |
| HY-128427 | PLpro-IN-1 | 1093070-10-0 | Reference compound |
| HY-128428 | Carboprost | 35700-23-3 | Reference compound |
| HY-128428R | Carboprost (Standard) | 35700-23-3 | Reference Standards |
| HY-128429 | trans-2-Hexenal | 6728-26-3 | Natural Products |
| HY-128429S | trans-2-Hexenal-d2-1 | 164791-70-2 | Isotope-Labeled Compounds |
| HY-12843 | Bohemine | 189232-42-6 | Reference compound |
| HY-128430 | Farnesyl acetate | 29548-30-9 | Natural Products |
| HY-128431 | Arochlor 1254 | 11097-69-1 | Reference compound |
| HY-128433 | CK1-IN-3 | 349438-74-0 | Reference compound |
| HY-128434 | L-Leucyl-L-alanine | 7298-84-2 | Natural Products |
| HY-128434R | L-?Leucyl-?L-?alanine (Standard) | 7298-84-2 | Reference Standards |
| HY-128435 | 2,4'-Dihydroxybenzophenone-1 | 606-12-2 | Natural Products |
| HY-128436 | KT-531 | 2490284-18-7 | Reference compound |
| HY-128437 | TGFβ-IN-5 | 259870-32-1 | Reference compound |
| HY-128439 | BT173 | 2232180-74-2 | Reference compound |
| HY-12844 | Ro 64-6198 | 280783-56-4 | Reference compound |
| HY-128442 | Phenyl sulfate | 937-34-8 | Reference compound |
| HY-128443 | Benzyldimethylstearylammonium (chloride) | 122-19-0 | Reference compound |
| HY-128443R | Benzyldimethylstearylammonium (chloride) (Standard) | 122-19-0 | Reference Standards |
| HY-128446 | CAY10781 | 1210360-87-4 | Reference compound |
| HY-128447 | Allyl methyl sulfide | 10152-76-8 | Natural Products |
| HY-128447R | Allyl methyl sulfide (Standard) | 10152-76-8 | Reference Standards |
| HY-128448 | Carmoisine | 3567-69-9 | Dye Reagents |
| HY-128448R | Carmoisine (Standard) | 3567-69-9 | Dye Reagents |
| HY-128449 | Cephradine (monohydrate) | 75975-70-1 | Reference compound |
| HY-12845 | UNC2400 | 1433200-49-7 | Reference compound |
| HY-128450 | JAK-STAT-IN-1 | 1236666-76-4 | Reference compound |
| HY-128452 | 2'-Hydroxy-2-methoxychalcone | 42220-77-9 | Reference compound |
| HY-128454 | Dimethyl trisulfide | 3658-80-8 | Natural Products |
| HY-128454R | Dimethyl trisulfide (Standard) | 3658-80-8 | Reference Standards |
| HY-128454S | Dimethyl trisulfide-d6 | 58069-93-5 | Isotope-Labeled Compounds |
| HY-128459 | N-Demethylerythromycin A | 992-62-1 | Reference compound |
| HY-128459R | N-Demethylerythromycin A (Standard) | 992-62-1 | Reference Standards |
| HY-12846 | CCT196969 | 1163719-56-9 | Reference compound |
| HY-128463 | N-tert-Butyl-α-phenylnitrone | 3376-24-7 | Reference compound |
| HY-128463S | N-tert-Butyl-α-phenylnitrone-d14 | 119391-92-3 | Isotope-Labeled Compounds |
| HY-128464 | LL320 | 2672496-32-9 | Reference compound |
| HY-128465 | 1,2-Dilauroyl-sn-glycerol | 60562-15-4 | Reference compound |
| HY-128466 | N-Biotinyl-L-cysteine | 151009-85-7 | Biochemical Assay Reagents |
| HY-128467 | Dehydroacetic acid (sodium) | 4418-26-2 | Reference compound |
| HY-128467R | Dehydroacetic acid (sodium) (Standard) | 4418-26-2 | Reference Standards |
| HY-128468 | 1,2-Dimyristoyl-sn-glycerol | 60562-16-5 | Oligonucleotides |
| HY-128469 | Inaperisone | 99323-21-4 | Reference compound |
| HY-12847 | CCT241161 | 1163719-91-2 | Reference compound |
| HY-128470 | Mitoquidone | 91753-07-0 | Reference compound |
| HY-128473 | Valeryl salicylate | 64206-54-8 | Reference compound |
| HY-128476 | Sodium Tartrate | 868-18-8 | Reference compound |
| HY-128476R | Sodium Tartrate (Standard) | 868-18-8 | Reference Standards |
| HY-128479 | JYL-273 | 1391826-17-7 | Reference compound |
| HY-12848 | SAG | 912545-86-9 | Reference compound |
| HY-128480 | Sulfamidopyrine (sodium salt) | 129-89-5 | Reference compound |
| HY-128481 | SB24011 | 1497415-41-4 | Reference compound |
| HY-128482 | Diazobenzenesulfonic acid | 2154-66-7 | Reference compound |
| HY-128483 | Fusaric acid | 536-69-6 | Natural Products |
| HY-128483R | Fusaric acid (Standard) | 536-69-6 | Reference Standards |
| HY-128487 | H-Trp-Glu-OH | 36099-95-3 | Reference compound |
| HY-128488 | Antibiotic TAN-592B | 99685-75-3 | Natural Products |
| HY-12848A | (Rac)-SAG | 364590-63-6 | Reference compound |
| HY-12848B | SAG (hydrochloride) | 2095432-58-7 | Reference compound |
| HY-12848C | SAG (dihydrochloride) | 2702366-44-5 | Reference compound |
| HY-12848R | SAG (Standard) | 912545-86-9 | Reference Standards |
| HY-12848S | SAG-d3 | Isotope-Labeled Compounds | |
| HY-128490 | 4'-Acetyl-chrysomycin B | 2673269-86-6 | Reference compound |
| HY-128493 | PLK4-IN-4 | 2923999-01-1 | Reference compound |
| HY-128498 | Anticancer agent 182 | 133342-90-2 | Natural Products |
| HY-12850 | Dasotraline | 675126-05-3 | Reference compound |
| HY-128502 | Nifurtoinol | 1088-92-2 | Reference compound |
| HY-128509 | Dioxidine | 17311-31-8 | Reference compound |
| HY-12850A | Dasotraline (hydrochloride) | 675126-08-6 | Reference compound |
| HY-128510 | Colterol | 18866-78-9 | Reference compound |
| HY-128510A | Colterol (hydrochloride) | 52872-37-4 | Reference compound |
| HY-128511 | Piridoxilate | 24340-35-0 | Reference compound |
| HY-128514 | Minimycin | 32388-21-9 | Reference compound |
| HY-128515 | Metaterol | 3571-71-9 | Reference compound |
| HY-12852 | Diclosulam | 145701-21-9 | Reference compound |
| HY-128522 | ARS-1323-alkyne | 2436544-27-1 | Reference compound |
| HY-128523 | Kgp-IN-1 | 2097865-36-4 | Reference compound |
| HY-128523A | Kgp-IN-1 (hydrochloride) | 2097865-47-7 | Reference compound |
| HY-128525 | Enterobactin | 28384-96-5 | Reference compound |
| HY-128525R | Enterobactin (Standard) | 28384-96-5 | Reference Standards |
| HY-128527 | PROTAC ER Degrader-3 | 2158322-29-1 | Reference compound |
| HY-128528 | PROTAC ER Degrader-2 | Reference compound | |
| HY-12853 | Mesotrione | 104206-82-8 | Reference compound |
| HY-128530 | Tetrathiomolybdate | 16330-92-0 | Reference compound |
| HY-128532 | Formononetin 7-O-β-D-glucuronide | 18524-03-3 | Reference compound |
| HY-128536 | KMG-104AM | 2436544-28-2 | Dye Reagents |
| HY-12853R | Mesotrione (Standard) | 104206-82-8 | Reference Standards |
| HY-12854 | Imetelstat | 868169-64-6 | Oligonucleotides |
| HY-128544A | Proroxan (hydrochloride) | 33025-33-1 | Reference compound |
| HY-128545 | Nitrazine yellow | 5423-07-4 | Biochemical Assay Reagents |
| HY-128546 | Flupranone | 21686-10-2 | Reference compound |
| HY-12855 | Lys01 | 1391426-22-4 | Reference compound |
| HY-128550 | Carboprost methyl | 35700-21-1 | Reference compound |
| HY-128551 | Droprenilamine | 57653-27-7 | Reference compound |
| HY-128553 | Antineoplaston A10 | 91531-30-5 | Natural Products |
| HY-128553A | (Rac)-Antineoplaston A10 | 77658-84-5 | Reference compound |
| HY-128554 | N-Desethyl amodiaquine | 79352-78-6 | Reference compound |
| HY-128554A | N-Desethyl amodiaquine dihydrochloride | 79049-30-2 | Reference compound |
| HY-128554AR | N-Desethyl amodiaquine dihydrochloride (Standard) | 79049-30-2 | Reference Standards |
| HY-128554S | N-Desethyl amodiaquine-d5 | 1173023-19-2 | Isotope-Labeled Compounds |
| HY-128554S1 | N-Desethyl amodiaquine-d5 (dihydrochloride) | 1216894-33-5 | Isotope-Labeled Compounds |
| HY-12855A | Lys05 | 1391426-24-6 | Reference compound |
| HY-12856 | GSK503 | 1346572-63-1 | Reference compound |
| HY-128561 | AM12 | 2387510-84-9 | Reference compound |
| HY-128569 | ALK-IN-5 | 2351929-66-1 | Reference compound |
| HY-12857 | Brigatinib | 1197953-54-0 | Reference compound |
| HY-128570 | FD-IN-1 | 1646682-14-5 | Reference compound |
| HY-128571 | FLT3-IN-4 | 2304799-09-3 | Reference compound |
| HY-128572 | FLT3-IN-6 | 2377141-31-4 | Reference compound |
| HY-128573 | RORγt Inverse agonist 3 | 2364429-77-4 | Reference compound |
| HY-128574 | GLUT4 activator 1 | 2253733-37-6 | Reference compound |
| HY-128575 | BNC375 | 1557240-80-8 | Reference compound |
| HY-128576 | DS21360717 | 2304654-43-9 | Reference compound |
| HY-128577 | NIC3 | 494830-67-0 | Reference compound |
| HY-128578 | KPLH1130 | 906669-07-6 | Reference compound |
| HY-128579 | DW14800 | 2243709-60-4 | Reference compound |
| HY-12857S | Brigatinib-13C6 | Isotope-Labeled Compounds | |
| HY-12857S2 | Brigatinib-d11 | 2055306-76-6 | Isotope-Labeled Compounds |
| HY-12858 | Empesertib | 1443763-60-7 | Reference compound |
| HY-128580 | FAK inhibitor 2 | 2354405-14-2 | Reference compound |
| HY-128581 | γ-Secretase modulator 4 | 1420200-82-3 | Reference compound |
| HY-128582 | PI3K/HDAC-IN-1 | 2361418-52-0 | Reference compound |
| HY-128583 | G150 | 2369751-30-2 | Reference compound |
| HY-128584 | VU6005806 | 2180914-37-6 | Reference compound |
| HY-128585 | GNE684 | 2438637-64-8 | Reference compound |
| HY-128586 | TAS4464 | 1848959-10-3 | Reference compound |
| HY-128586A | TAS4464 (hydrochloride) | 1848959-11-4 | Reference compound |
| HY-128587 | Mevociclib | 1816989-16-8 | Reference compound |
| HY-128588 | STAT3-IN-3 | 2361304-26-7 | Reference compound |
| HY-128589 | CHMFL-KIT-033 | 2351801-41-5 | Reference compound |
| HY-12859 | BAY1217389 | 1554458-53-5 | Reference compound |
| HY-128590 | PHT-7.3 | 1614225-93-2 | Reference compound |
| HY-128591 | DIPQUO | 1269365-82-3 | Reference compound |
| HY-128592 | TAB29 | 2361144-71-8 | Reference compound |
| HY-128593 | TPN171 | 1229018-87-4 | Reference compound |
| HY-128594 | BACE1-IN-4 | 2361157-92-6 | Reference compound |
| HY-128595 | MT-4 | 2327925-35-7 | Reference compound |
| HY-128596 | ALK-IN-6 | 2055821-33-3 | Reference compound |
| HY-128597 | BRD-IN-3 | 2351938-32-2 | Reference compound |
| HY-128598 | MD2-TLR4-IN-1 | 2249801-12-3 | Reference compound |
| HY-128599 | NMS-P515 | 1262395-13-0 | Reference compound |
| HY-12860 | BMS-986115 | 1584647-27-7 | Reference compound |
| HY-128600 | ERD-308 | 2320561-35-9 | Reference compound |
| HY-128601 | CHK1-IN-3 | 2097252-39-4 | Reference compound |
| HY-128602 | c-Kit-IN-2 | 2121515-37-3 | Reference compound |
| HY-128604 | XY101 | 2349368-16-5 | Reference compound |
| HY-128605 | PD-1-IN-22 | 2349372-98-9 | Reference compound |
| HY-128606 | Thiamine diphosphate analog 1 | 2606-90-8 | Reference compound |
| HY-128607 | Mcl1-IN-9 | 1810769-31-3 | Reference compound |
| HY-12861 | CB-5083 | 1542705-92-9 | Reference compound |
| HY-128612 | Methylnitronitrosoguanidine | 70-25-7 | Reference compound |
| HY-128617 | Legumain inhibitor 1 | 2361157-34-6 | Reference compound |
| HY-12862 | Mps1-IN-7 | 1578244-34-4 | Reference compound |
| HY-12863 | Pelabresib | 1380087-89-7 | Reference compound |
| HY-128634 | Anticancer agent 164 | 2235393-30-1 | Reference compound |
| HY-12863B | CPI-0610 carboxylic acid | 1380089-81-5 | Reference compound |
| HY-12864 | Brilanestrant | 1365888-06-7 | Reference compound |
| HY-128642 | FAPI-2 | 2370952-98-8 | Reference compound |
| HY-128642A | FAPI-2 (TFA) | Reference compound | |
| HY-128643 | FAPI-4 | 2374782-02-0 | Reference compound |
| HY-128656 | LML134 | 1542135-76-1 | Reference compound |
| HY-12866 | Larotrectinib | 1223403-58-4 | Reference compound |
| HY-128661 | IDH1 Inhibitor 2 | 2244895-42-7 | Reference compound |
| HY-128669 | Abemaciclib metabolite M2 | 1231930-57-6 | Reference compound |
| HY-128669R | Abemaciclib metabolite M2 (Standard) | 1231930-57-6 | Reference Standards |
| HY-128669S | Abemaciclib metabolite M2-d6 | Isotope-Labeled Compounds | |
| HY-12866A | Larotrectinib sulfate | 1223405-08-0 | Reference compound |
| HY-12866B | (R)-Larotrectinib | 1223404-68-9 | Reference compound |
| HY-12866R | Larotrectinib (Standard) | 1223403-58-4 | Reference Standards |
| HY-12867 | PT-2385 | 1672665-49-4 | Reference compound |
| HY-128671 | 6-Thioinosine | 574-25-4 | Reference compound |
| HY-128675 | γ-D-Glutamylaminomethylsulfonic acid | 90237-02-8 | Peptides |
| HY-128676 | N-ε-propargyloxycarbonyl-L-lysine (hydrochloride) | 1428330-91-9 | Reference compound |
| HY-128677 | NCC007 | 2342583-66-6 | Reference compound |
| HY-128678 | ORM-10103 | 488847-28-5 | Reference compound |
| HY-128679 | TBK1/IKKε-IN-5 | 1893397-65-3 | Reference compound |
| HY-12868 | Bimiralisib | 1225037-39-7 | Reference compound |
| HY-128680 | c-Fms-IN-9 | 1628574-50-4 | Reference compound |
| HY-128681 | PGAM1-IN-1 | 2438637-65-9 | Reference compound |
| HY-128682 | PGAM1-IN-2 | 2438637-66-0 | Reference compound |
| HY-128683 | Cycloposine | 23185-94-6 | Natural Products |
| HY-128685 | FD 12-9 | 1451741-22-2 | Reference compound |
| HY-128686 | KAG-308 | 1215192-68-9 | Reference compound |
| HY-128689 | Anticancer agent 3 | 146537-05-5 | Reference compound |
| HY-12869 | AZD-8835 | 1620576-64-8 | Reference compound |
| HY-128692 | Lucifer Yellow CH (dilithium salt) | 67769-47-5 | Dye Reagents |
| HY-128693 | BpV(HOpic) | 722494-26-0 | Reference compound |
| HY-128694 | Foropafant | 136468-36-5 | Reference compound |
| HY-128695 | Oleanolic acid hemiphthalate disodium salt | 168770-31-8 | Reference compound |
| HY-128696 | Amlodipine aspartic acid impurity | 400602-35-9 | Peptides |
| HY-128696R | Amlodipine aspartic acid impurity (Standard) | 400602-35-9 | Reference Standards |
| HY-128699 | D-Desthiobiotin | 533-48-2 | Natural Products |
| HY-12870 | AZD9496 | 1639042-08-2 | Reference compound |
| HY-128700 | Nicotinic acid mononucleotide | 321-02-8 | Natural Products |
| HY-128700A | Nicotinic acid mononucleotide (triethylamine) | Reference compound | |
| HY-128701 | cis-9,trans-12-Tetradecadienyl acetate | 31654-77-0 | Biochemical Assay Reagents |
| HY-128703 | Bromodomain inhibitor-8 | 1300031-70-2 | Reference compound |
| HY-128706 | (+)-Menthofuran | 17957-94-7 | Natural Products |
| HY-128706R | (+)-Menthofuran (Standard) | 17957-94-7 | Reference Standards |
| HY-128707 | Z-LEVD-FMK | 1135688-25-3 | Reference compound |
| HY-128708 | ACPK | 1304056-21-0 | Reference compound |
| HY-12870A | AZD9496 (maleate) | 1639042-28-6 | Reference compound |
| HY-12871 | Atuveciclib (Racemate) | 1414943-88-6 | Reference compound |
| HY-128710 | 2'-Fluorothymidine | 122799-38-6 | Reference compound |
| HY-128711 | MAL-di-EG-Val-Cit-PAB-MMAF | ADC Related | |
| HY-128712 | NCGC00029283 | 714240-31-0 | Reference compound |
| HY-128715 | Fluperlapine | 67121-76-0 | Reference compound |
| HY-128716 | Pomalidomide-PEG3-C2-NH2 | 2093416-31-8 | Reference compound |
| HY-128716A | Pomalidomide-PEG3-C2-NH2 (TFA) | 2414913-97-4 | Reference compound |
| HY-128716B | Pomalidomide-PEG3-C2-NH2 (hydrochloride) | 2446474-09-3 | Reference compound |
| HY-128717 | GSK3368715 | 1629013-22-4 | Reference compound |
| HY-128717A | GSK3368715 (dihydrochloride) | 1628925-77-8 | Reference compound |
| HY-128717B | GSK3368715 (trihydrochloride) | 2227587-26-8 | Reference compound |
| HY-128717C | GSK3368715 (hydrochloride) | 2227587-25-7 | Reference compound |
| HY-128718 | Carbodine | 71184-20-8 | Reference compound |
| HY-12871A | (+)-Atuveciclib | 1414943-94-4 | Reference compound |
| HY-12871B | Atuveciclib | 2923012-24-0 | Reference compound |
| HY-12871C | Atuveciclib S-Enantiomer | 2250279-81-1 | Reference compound |
| HY-12872 | Nazartinib | 1508250-71-2 | Reference compound |
| HY-128720 | Diethyl oxalpropionate | 759-65-9 | Natural Products |
| HY-128721 | KX-01-191 | 2211903-84-1 | Reference compound |
| HY-128722 | HIV-1 inhibitor-3 | 1612841-22-1 | Reference compound |
| HY-128723 | Dapagliflozin impurity | 960404-86-8 | Reference compound |
| HY-128724 | CB-5339 | 1863952-15-1 | Reference compound |
| HY-128726 | ITK inhibitor 2 | 1309784-09-5 | Reference compound |
| HY-128729 | DNA2 inhibitor C5 | 35973-25-2 | Reference compound |
| HY-12872A | Nazartinib mesylate | 1508250-72-3 | Reference compound |
| HY-12872B | Nazartinib S-enantiomer | 1508256-20-9 | Reference compound |
| HY-12873 | RBC8 | 361185-42-4 | Reference compound |
| HY-128730 | Acetyl phosphate (lithium potassium) | 94249-01-1 | Natural Products |
| HY-128731 | 5-Methoxy-DL-tryptophan | 28052-84-8 | Natural Products |
| HY-128732 | rel-(2R,3S)-2,3-Dihydroxysuccinic acid (hydrate) | 5990-63-6 | Natural Products |
| HY-128733 | Phenyl acetate | 122-79-2 | Natural Products |
| HY-128733R | Phenyl acetate (Standard) | 122-79-2 | Reference Standards |
| HY-128733S | Phenyl acetate-d5 | 22705-26-6 | Isotope-Labeled Compounds |
| HY-128734 | Dihydroxyfumaric acid (hydrate) | 199926-38-0 | Natural Products |
| HY-128735 | N-Formylglycine | 2491-15-8 | Natural Products |
| HY-128735S | N-Formylglycine-d2 | Isotope-Labeled Compounds | |
| HY-128736 | L-2-Phosphoglyceric acid | 23295-92-3 | Natural Products |
| HY-128736B | D-2-Phosphoglyceric acid | 3443-57-0 | Reference compound |
| HY-128736C | L-2-Phosphoglyceric acid (sodium hydrate) | Reference compound | |
| HY-128737 | Methyl β-D-Galactopyranoside | 1824-94-8 | Natural Products |
| HY-128738 | Thymidine-5'-monophosphate (disodium) salt | 33430-62-5 | Natural Products |
| HY-128738R | Thymidine-5'-monophosphate (disodium) salt (Standard) | 33430-62-5 | Reference Standards |
| HY-128738S | Thymidine-5'-monophosphate-13C10,15N2 (disodium) | 1485539-28-3 | Isotope-Labeled Compounds |
| HY-128739 | Isomaltulose (hydrate) | 343336-76-5 | Natural Products |
| HY-128739R | Isomaltulose (hydrate) (Standard) | 343336-76-5 | Reference Standards |
| HY-12874 | CASIN | 425399-05-9 | Reference compound |
| HY-128740 | Mesoxalate (sodium) (monohydrate) | 31635-99-1 | Natural Products |
| HY-128741 | D-Allose | 2595-97-3 | Natural Products |
| HY-128741R | D-Allose (Standard) | 2595-97-3 | Reference Standards |
| HY-128741S | D-Allose-13C | 70849-28-4 | Isotope-Labeled Compounds |
| HY-128741S1 | D-Allose-13C-1 | Isotope-Labeled Compounds | |
| HY-128741S2 | D-Allose-13C-2 | Isotope-Labeled Compounds | |
| HY-128742 | Thiamine monophosphate (chloride) (dihydrate) | 273724-21-3 | Natural Products |
| HY-128742R | Thiamine monophosphate (chloride) (dihydrate) (Standard) | 273724-21-3 | Reference Standards |
| HY-128743 | 12-Hydroxydodecanoic acid | 505-95-3 | Natural Products |
| HY-128743R | 12-Hydroxydodecanoic acid (Standard) | 505-95-3 | Reference Standards |
| HY-128744 | Phosphonoacetic acid | 4408-78-0 | Natural Products |
| HY-128744R | Phosphonoacetic acid (Standard) | 4408-78-0 | Reference Standards |
| HY-128745 | D-Glucosamic acid | 3646-68-2 | Natural Products |
| HY-128746 | 2,6-Diaminoheptanedioic acid | 583-93-7 | Natural Products |
| HY-128746R | 2,6-Diaminoheptanedioic acid (Standard) | 583-93-7 | Reference Standards |
| HY-128746S | 2,6-Diaminoheptanedioic acid-13C7,15N2 | Isotope-Labeled Compounds | |
| HY-128746S1 | 2,6-Diaminoheptanedioic acid-15N2 | Isotope-Labeled Compounds | |
| HY-128747 | α-D-Glucose-1-phosphate (disodium) | 56401-20-8 | Natural Products |
| HY-128747A | α-D-Glucose-1-phosphate (disodium hydrate) | 230954-92-4 | Natural Products |
| HY-128747R | α-D-Glucose-1-phosphate (disodium) (Standard) | 56401-20-8 | Reference Standards |
| HY-128748 | DL-Glyceraldehyde | 56-82-6 | Natural Products |
| HY-128748S | DL-Glyceraldehyde-1-13C | 70849-18-2 | Isotope-Labeled Compounds |
| HY-128748S1 | DL-Glyceraldehyde-2-13C | 71122-43-5 | Isotope-Labeled Compounds |
| HY-128748S2 | DL-Glyceraldehyde-13C,d | 72599-69-0 | Isotope-Labeled Compounds |
| HY-128748S4 | DL-Glyceraldehyde-13C3 | 478529-56-5 | Isotope-Labeled Compounds |
| HY-128749 | D-Glucaric acid (potassium) | 576-42-1 | Natural Products |
| HY-128749A | D-Glucaric acid (tetrahydrate) | 5793-89-5 | Reference compound |
| HY-128749AR | D-Glucaric acid (tetrahydrate) (Standard) | 5793-89-5 | Reference Standards |
| HY-12875 | BQU57 | 1637739-82-2 | Reference compound |
| HY-128750 | (Z)-4-Amino-4-oxobut-2-enoic acid | 557-24-4 | Natural Products |
| HY-128752 | Uridine 5'-triphosphate (tris) salt | 108321-53-5 | Natural Products |
| HY-128753 | D-Lyxose | 1114-34-7 | Natural Products |
| HY-128753R | D-Lyxose (Standard) | 1114-34-7 | Reference Standards |
| HY-128753S3 | D-Lyxose-13C-2 | 70849-22-8 | Isotope-Labeled Compounds |
| HY-128753S4 | D-Lyxose-13C-3 | 83379-39-9 | Isotope-Labeled Compounds |
| HY-128753S5 | D-Lyxose-13C-4 | 139657-61-7 | Isotope-Labeled Compounds |
| HY-128753S6 | D-Lyxose-d | 288846-88-8 | Isotope-Labeled Compounds |
| HY-128753S7 | D-Lyxose-d-1 | Isotope-Labeled Compounds | |
| HY-128754 | Monoolein | 111-03-5 | Natural Products |
| HY-128754R | Monoolein (Standard) | 111-03-5 | Reference Standards |
| HY-128754S | Monoolein-d5 | 565183-24-6 | Isotope-Labeled Compounds |
| HY-128754S1 | Monoolein-d7 | 2260669-49-4 | Isotope-Labeled Compounds |
| HY-128756 | SIAIS178 | 2376047-73-1 | Reference compound |
| HY-128757 | Remibrutinib | 1787294-07-8 | Reference compound |
| HY-128758 | DYRKs-IN-1 | 1387090-01-8 | Reference compound |
| HY-128758A | DYRKs-IN-1 (hydrochloride) | 1386980-55-7 | Reference compound |
| HY-128759 | DYRKs-IN-2 | 1386980-04-6 | Reference compound |
| HY-128760 | COH34 | 906439-72-3 | Reference compound |
| HY-128761 | CBP/p300-IN-2 | 2158265-96-2 | Reference compound |
| HY-128763 | HDAC-IN-4 | 1252003-13-6 | Reference compound |
| HY-128766 | CHK1-IN-4 | 2120398-41-4 | Reference compound |
| HY-128766A | CHK1-IN-4 (hydrochloride) | Reference compound | |
| HY-128767 | VH032-PEG3-acetylene | 2098799-80-3 | Reference compound |
| HY-128769 | M2N12 | 2376577-06-7 | Reference compound |
| HY-128770 | LY3154207 | 1638667-79-4 | Reference compound |
| HY-128771 | K-Ras G12C-IN-4 | 2376328-55-9 | Reference compound |
| HY-128772 | XPC-6444 | 2230144-21-3 | Reference compound |
| HY-128773 | MRL-494 | 2434898-43-6 | Reference compound |
| HY-128773A | MRL-494 (hydrochloride) | 2699937-04-5 | Reference compound |
| HY-128774 | AM-6494 | 1874232-80-0 | Reference compound |
| HY-128775 | JHU395 | 2079938-92-2 | Reference compound |
| HY-128776 | Antitumor agent-19 | 2379727-90-7 | Reference compound |
| HY-128777 | WEHI-9625 | 2595314-46-6 | Reference compound |
| HY-128778 | Gozanertinib | 1226549-49-0 | Reference compound |
| HY-128780 | Upleganan | 2407717-17-1 | Reference compound |
| HY-128780B | SPR206 (acetate) | 2408422-41-1 | Reference compound |
| HY-128781 | Glucagon receptor antagonist-5 | 2200274-63-9 | Reference compound |
| HY-128783 | VU0090157 | 312622-77-8 | Reference compound |
| HY-128784 | PK11007 | 874146-69-7 | Reference compound |
| HY-128787 | hDHODH-IN-4 | 1644156-56-8 | Reference compound |
| HY-128788 | ddhCTP | 2279171-34-3 | Reference compound |
| HY-12879 | IWP-4 | 686772-17-8 | Reference compound |
| HY-128790 | 4-Methoxyestrone | 58562-33-7 | Reference compound |
| HY-128790S | 4-Methoxyestrone-13C,d3 | 1217437-34-7 | Isotope-Labeled Compounds |
| HY-128790S1 | 4-Methoxyestrone-13C6 | Isotope-Labeled Compounds | |
| HY-128792 | 1,3-Dipalmitin | 502-52-3 | Natural Products |
| HY-128792S | 1,3-Dipalmitin-d6 | 2692624-34-1 | Isotope-Labeled Compounds |
| HY-128793 | trans-Stilbene | 103-30-0 | Dye Reagents |
| HY-128793S | trans-Stilbene-13C2 | 153610-50-5 | Isotope-Labeled Compounds |
| HY-128793S1 | trans-Stilbene-d12 | 16341-52-9 | Isotope-Labeled Compounds |
| HY-128793S2 | trans-Stilbene-d10 | 20748-24-7 | Isotope-Labeled Compounds |
| HY-128793S3 | trans-Stilbene-d2 | 5284-44-6 | Isotope-Labeled Compounds |
| HY-128794 | PF-05150122 | 1235406-00-4 | Reference compound |
| HY-128798 | Menin-MLL inhibitor 20 | 2448173-47-3 | Reference compound |
| HY-128799 | CL097 | 1026249-18-2 | Reference compound |
| HY-128799A | CL097 (hydrochloride) | 2990770-48-2 | Reference compound |
| HY-12880 | HA-100 (dihydrochloride) | 210297-47-5 | Reference compound |
| HY-128801 | NH2-PEG3-C1-Boc | 189808-70-6 | Reference compound |
| HY-128802 | Tos-PEG3-O-C1-CH3COO | 855120-17-1 | Reference compound |
| HY-128803 | Tos-PEG4-NH-Boc | 1246999-33-6 | Reference compound |
| HY-128804 | PEG3-O-CH2COOH | 51951-05-4 | Reference compound |
| HY-128805 | Tos-PEG3-NH-Boc | 206265-94-3 | Reference compound |
| HY-128806 | E3 ligase Ligand 9 | 87304-15-2 | Reference compound |
| HY-128807 | E3 ligase Ligand 10 | 1073560-68-5 | Reference compound |
| HY-128808 | cIAP1 ligand 1 | 2095244-42-9 | Reference compound |
| HY-128809 | cIAP1 ligand 2 | 2357114-70-4 | Reference compound |
| HY-12881 | Eliprodil | 119431-25-3 | Reference compound |
| HY-128810 | E3 ligase Ligand 13 | 2701565-75-3 | Reference compound |
| HY-128811 | E3 ligase Ligand 14 | 2241489-43-8 | Reference compound |
| HY-128812 | cIAP1 Ligand-Linker Conjugates 11 | 1239943-19-1 | Reference compound |
| HY-128812A | cIAP1 Ligand-Linker Conjugates 11 (Hydrochloride) | 1239866-59-1 | Reference compound |
| HY-128813 | cIAP1 Ligand-Linker Conjugates 15 | 1225433-96-4 | Reference compound |
| HY-128813A | cIAP1 Ligand-Linker Conjugates 15 (hydrochloride) | 1225383-36-7 | Reference compound |
| HY-128814 | cIAP1 Ligand-Linker Conjugates 6 (hydrochloride) | Reference compound | |
| HY-128815 | cIAP1 Ligand-Linker Conjugates 14 | 1351169-40-8 | Reference compound |
| HY-128816 | cIAP1 Ligand-Linker Conjugates 2 | 1312302-14-9 | Reference compound |
| HY-128816A | cIAP1 Ligand-Linker Conjugates 2 (Hydrochloride) | Reference compound | |
| HY-128817 | cIAP1 Ligand-Linker Conjugates 12 | 2095244-52-1 | Reference compound |
| HY-128818 | cIAP1 Ligand-Linker Conjugates 5 | 2113688-20-1 | Reference compound |
| HY-128819 | cIAP1 Ligand-Linker Conjugates 3 | 2222354-20-1 | Reference compound |
| HY-12882 | Ifenprodil | 23210-56-2 | Reference compound |
| HY-128820 | cIAP1 Ligand-Linker Conjugates 1 | 2357114-75-9 | Reference compound |
| HY-128821 | cIAP1 Ligand-Linker Conjugates 4 | Reference compound | |
| HY-128822 | cIAP1 Ligand-Linker Conjugates 13 | Reference compound | |
| HY-128823 | cIAP1 Ligand-Linker Conjugates 7 | Reference compound | |
| HY-128824 | cIAP1 Ligand-Linker Conjugates 9 | Reference compound | |
| HY-128825 | cIAP1 Ligand-Linker Conjugates 8 | Reference compound | |
| HY-128826 | cIAP1 Ligand-Linker Conjugates 10 | Reference compound | |
| HY-128828 | 2-Hydroxy atorvastatin (calcium salt) | 265989-46-6 | Reference compound |
| HY-128829 | Kv3 modulator 2 | 2101321-76-8 | Reference compound |
| HY-12882A | Ifenprodil (tartrate) | 23210-58-4 | Natural Products |
| HY-12883 | PF 05089771 | 1235403-62-9 | Reference compound |
| HY-128830 | Kv3 modulator 3 | 1498186-01-8 | Reference compound |
| HY-128831 | Kv3 modulator 4 | 2173375-10-3 | Reference compound |
| HY-128832 | Nutlin-C1-amido-PEG4-C2-N3 | Reference compound | |
| HY-128833 | Bis-NH2-PEG2 | 929-59-9 | Reference compound |
| HY-128834 | N3-PEG4-C2-NH2 | 951671-92-4 | Reference compound |
| HY-128835 | Phenol-amido-C1-PEG3-N3 | 1096439-18-7 | Reference compound |
| HY-128836 | (4R,5S)-Nutlin carboxylic acid | 2306390-08-7 | Reference compound |
| HY-128837 | Nutlin carboxylic acid | 2249750-27-2 | Reference compound |
| HY-128838 | PROTAC ERRα Degrader-1 | 2306388-84-9 | Reference compound |
| HY-128838A | (rel)-PROTAC ERRα Degrader-1 | Reference compound | |
| HY-128839 | PROTAC ERRα Degrader-2 | 2306388-85-0 | Reference compound |
| HY-12883A | PF-05198007 | 1235406-19-5 | Reference compound |
| HY-12883B | PF 05089771 (tosylate) | 1430806-04-4 | Reference compound |
| HY-12884 | OAC2 | 6019-39-2 | Reference compound |
| HY-128840 | PROTAC MDM2 Degrader-1 | 2249944-98-5 | Reference compound |
| HY-128841 | PROTAC MDM2 Degrader-2 | 2249944-99-6 | Reference compound |
| HY-128842 | PROTAC MDM2 Degrader-3 | 2249750-23-8 | Reference compound |
| HY-128843 | PROTAC MDM2 Degrader-4 | 2249750-24-9 | Reference compound |
| HY-128844 | Bis-NH2-C1-PEG3 | 4246-51-9 | Reference compound |
| HY-128845 | PROTAC CRBN Degrader-1 | 2358775-70-7 | Reference compound |
| HY-128846 | Pomalidomide-C2-NH2 | 1957235-66-3 | Reference compound |
| HY-128846A | Pomalidomide-C2-NH2 (hydrochloride) | 2305369-00-8 | Reference compound |
| HY-128847 | Bis-PEG1-C-PEG1-CH2COOH | 2358775-67-2 | Reference compound |
| HY-128848 | Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH | 2351103-63-2 | Reference compound |
| HY-128849 | Eprodisate | 21668-77-9 | Reference compound |
| HY-12885 | 2’3’-c-di-AM(PS)2 (Rp,Rp) | 1638241-89-0 | Reference compound |
| HY-128850 | N-Acetyl-D-mannosamine | 3615-17-6 | Reference compound |
| HY-128850R | N-Acetyl-D-mannosamine (Standard) | 3615-17-6 | Reference Standards |
| HY-128850S1 | N-Acetyl-D-mannosamine-13C | Isotope-Labeled Compounds | |
| HY-128850S2 | N-Acetyl-D-mannosamine-13C-1 | Isotope-Labeled Compounds | |
| HY-128850S5 | N-Acetyl-D-mannosamine-15N | Isotope-Labeled Compounds | |
| HY-128851 | Coenzyme A | 85-61-0 | Natural Products |
| HY-128851A | Coenzyme A (trilithium) | 18439-24-2 | Biochemical Assay Reagents |
| HY-128851B | Coenzyme A (sodium) | 55672-92-9 | Biochemical Assay Reagents |
| HY-128851R | Coenzyme A (Standard) | 85-61-0 | Reference Standards |
| HY-128852 | N-Acetyl-D-galactosamine, 98% | 14215-68-0 | Biochemical Assay Reagents |
| HY-128853 | Taurodeoxycholate (sodium salt) | 1180-95-6 | Natural Products |
| HY-128853R | Taurodeoxycholate (sodium salt) (Standard) | 1180-95-6 | Reference Standards |
| HY-128853S | Taurodeoxycholate-d6 (sodium salt) | 2687960-92-3 | Isotope-Labeled Compounds |
| HY-128854 | Dimethyl biphenyl-4,4'-dicarboxylate | 792-74-5 | Reference compound |
| HY-128854S | Dimethyl biphenyl-4,4'-dicarboxylate-d8 | 1219803-50-5 | Isotope-Labeled Compounds |
| HY-128855 | Talsaclidine | 147025-53-4 | Reference compound |
| HY-128856 | P7C3-OMe | 313268-18-7 | Reference compound |
| HY-128859 | EMT inhibitor-2 | 2232228-60-1 | Reference compound |
| HY-12885A | 2’3’-c-di-AM(PS)2 (Rp,Rp) (disodium salt) | 1638750-95-4 | Reference compound |
| HY-12885B | 2’3’-c-di-AM(PS)2 (Rp,Rp) (ammonium salt) | 1638750-96-5 | Reference compound |
| HY-12885C | 2’3’-c-di-AM(PS)2 (Rp,Rp) enantiomer (ammonium salt) | Reference compound | |
| HY-12886 | Docebenone | 80809-81-0 | Reference compound |
| HY-128860 | Mutated EGFR-IN-2 | 2050906-97-1 | Reference compound |
| HY-128862 | EGFR-IN-7 | 2267329-76-8 | Reference compound |
| HY-128865 | BPR1M97 | 2059904-66-2 | Reference compound |
| HY-128866 | TBAJ-876 | 2332841-25-3 | Reference compound |
| HY-128866A | (Rac)-TBAJ-876 | 2131784-39-7 | Reference compound |
| HY-128867 | bio-THZ1 | 1604811-14-4 | Reference compound |
| HY-128868 | FITC-Dextran (MW 10000) | 60842-46-8 | Dye Reagents |
| HY-128868A | FITC-Dextran (MW 4000) | 60842-46-8 | Dye Reagents |
| HY-128868B | FITC-Dextran (MW 3000-5000) | 60842-46-8 | Dye Reagents |
| HY-128868C | FITC-Dextran (MW 20000) | 60842-46-8 | Dye Reagents |
| HY-128868D | FITC-Dextran (MW 40000) | 60842-46-8 | Dye Reagents |
| HY-128868E | FITC-Dextran (MW 70000) | 60842-46-8 | Dye Reagents |
| HY-128868F | FITC-Dextran (MW 110000) | 60842-46-8 | Dye Reagents |
| HY-128868G | FITC-Dextran (MW 150000) | 60842-46-8 | Dye Reagents |
| HY-128868H | FITC-Dextran (MW 500000) | 60842-46-8 | Dye Reagents |
| HY-128868I | FITC-Dextran (MW 2000000) | 60842-46-8 | Dye Reagents |
| HY-12887 | Piclamilast | 144035-83-6 | Reference compound |
| HY-128870 | Mal-PEG2-VCP-Eribulin | 2130869-18-8 | ADC Related |
| HY-128871 | VCP-Eribulin | 2130869-17-7 | ADC Related |
| HY-128872 | Etrinabdione | 1818428-24-8 | Reference compound |
| HY-128873 | Duocarmycin GA | 1613286-59-1 | ADC Related |
| HY-128875 | CBP/p300-IN-10 | 2259641-71-7 | Reference compound |
| HY-128876 | CBP/p300-IN-3 | 2299226-01-8 | Reference compound |
| HY-128878 | Dexloxiglumide | 119817-90-2 | Reference compound |
| HY-128879 | VP3.15 | 1281681-54-6 | Reference compound |
| HY-128879A | VP3.15 (dihydrobromide) | 1281681-33-1 | Reference compound |
| HY-12887R | Piclamilast (Standard) | 144035-83-6 | Reference Standards |
| HY-12888 | AZD5099 | 907543-25-3 | Reference compound |
| HY-128880 | (+)-CBI-CDPI1 | 128300-14-1 | ADC Related |
| HY-128881 | (+)-CBI-CDPI2 | 128300-15-2 | ADC Related |
| HY-128888 | (R,R)-GSK321 | 1816272-19-1 | Reference compound |
| HY-128888A | (S,S)-GSK321 | 1816272-20-4 | Reference compound |
| HY-128888B | (S,R)-GSK321 | 1816272-18-0 | Reference compound |
| HY-128889 | FXIa-IN-1 | 1803271-50-2 | Reference compound |
| HY-128890 | DOTA-NHS-ester | 170908-81-3 | ADC Related |
| HY-128890A | DOTA-NHS-ester (hexafluorophosphate TFA) | 1823122-52-6 | Biochemical Assay Reagents |
| HY-128890B | DOTA-NHS-ester (TFA) | Reference compound | |
| HY-128891 | Eperisone | 64840-90-0 | Reference compound |
| HY-128892 | EN6 | 1808714-73-9 | Reference compound |
| HY-128893 | MC-Sq-Cit-PAB-Gefitinib | 1941168-63-3 | ADC Related |
| HY-128894 | MC-Sq-Cit-PAB-Dolastatin10 | 1941168-65-5 | ADC Related |
| HY-128895 | KL1333 | 1800405-30-4 | Reference compound |
| HY-128896 | Nitro-PDS-Tubulysin M | 1941168-69-9 | ADC Related |
| HY-128897 | MC-VC-PABC-DNA31 | 1639352-03-6 | ADC Related |
| HY-128899 | MC-Val-Cit-PAB-Auristatin E | 2055896-77-8 | ADC Related |
| HY-128900 | 11-cis-Vaccenyl acetate | 6186-98-7 | Reference compound |
| HY-128901 | F 13714 (fumarate) | 208109-39-1 | Reference compound |
| HY-128902 | MC-Val-Cit-PAB-vinblastine | 2055896-92-7 | ADC Related |
| HY-128903 | MC-Val-Cit-PAB-carfilzomib (iodide) | 2055896-83-6 | ADC Related |
| HY-128904 | MC-Val-Cit-PAB-duocarmycin (chloride) | 2055896-98-3 | ADC Related |
| HY-128905 | MC-Val-Cit-PAB-dimethylDNA31 | 1639352-06-9 | ADC Related |
| HY-128906 | MC-Val-Cit-PAB-Retapamulin | 1639793-15-9 | ADC Related |
| HY-128907 | MC-Val-Cit-PAB-clindamycin | 1639793-13-7 | ADC Related |
| HY-128908 | MC-Val-Cit-PAB-Indibulin | 2055896-95-0 | ADC Related |
| HY-128909 | MC-Val-Cit-PAB-rifabutin | 2055900-34-8 | ADC Related |
| HY-128910 | MC-VC(S)-PABQ-Tubulysin M | 2055896-86-9 | ADC Related |
| HY-128912 | Arborinine | 5489-57-6 | Natural Products |
| HY-128913 | 1,3-Dihydroxy-4-methoxy-10-methylacridin-9(10H)-one | 1189362-86-4 | Natural Products |
| HY-128914 | Tubulysin | 1943604-24-7 | Reference compound |
| HY-128915 | Duocarmycin DM (free base) | 1116745-06-2 | ADC Related |
| HY-128916 | dmDNA31 | 845625-44-7 | Reference compound |
| HY-128917 | DNA31 | 845626-57-5 | Reference compound |
| HY-128918 | SIS17 | 2374313-54-7 | Reference compound |
| HY-128919 | Ac-Lys-AMC | 156661-42-6 | Reference compound |
| HY-12892 | SKI-178 | 1259484-97-3 | Reference compound |
| HY-128920 | Phortress (free base) | 741241-36-1 | Reference compound |
| HY-128921 | Bz-Lys-OMe | 17039-40-6 | Reference compound |
| HY-128922 | Dexamethasone palmitate | 14899-36-6 | Reference compound |
| HY-128922S | Dexamethasone palmitate-d31 | Isotope-Labeled Compounds | |
| HY-128923 | SKF-34288 (hydrochloride) | 320386-54-7 | Reference compound |
| HY-128925 | AMAS | 55750-61-3 | ADC Related |
| HY-128926 | SPP | 341498-08-6 | ADC Related |
| HY-128927 | Mc-Leu-Gly-Arg | "2639874-49-8 " | ADC Related |
| HY-128929 | Fmoc-PEA | 329223-23-6 | ADC Related |
| HY-128930 | 6-O-2-Propyn-1-yl-D-galactose | 881895-59-6 | ADC Related |
| HY-128931 | NH2-Ph-C4-acid-NH2-Me | 1263819-48-2 | Reference compound |
| HY-128932 | Cefminox (sodium) | 75498-96-3 | Reference compound |
| HY-128932R | Cefminox (sodium) (Standard) | 75498-96-3 | Reference Standards |
| HY-128933 | AMP-PNP (tetralithium) | 72957-42-7 | Reference compound |
| HY-128934 | Antitumor agent-2 | 1351163-57-9 | Reference compound |
| HY-128937 | EC1454 | 1602487-15-9 | Reference compound |
| HY-128938 | EC1167 | 1610414-00-0 | ADC Related |
| HY-128938A | EC1167 (hydrochloride) | ADC Related | |
| HY-128939 | EC0488 | 1059477-92-7 | Reference compound |
| HY-128940 | EC089 | 625827-91-0 | ADC Related |
| HY-128941 | CCK2R Ligand-Linker Conjugates 1 | 1452145-13-9 | ADC Related |
| HY-128942 | MAC glucuronide α-hydroxy lactone-linked SN-38 | 2246380-70-9 | ADC Related |
| HY-128943 | MAC glucuronide phenol-linked SN-38 | 2246380-69-6 | ADC Related |
| HY-128945 | CL2A | 2616704-22-2 | ADC Related |
| HY-128945A | CL2A (TFA) | ADC Related | |
| HY-128946 | CL2A-SN-38 | 1279680-68-0 | ADC Related |
| HY-128947 | CL2 Linker | 2270986-66-6 | ADC Related |
| HY-12895 | SKI V | 24418-86-8 | Reference compound |
| HY-128951 | AMCC-DM1 | 1228105-53-0 | ADC Related |
| HY-128952 | Tesirine | 1595275-62-9 | ADC Related |
| HY-128954 | Sulfo-PDBA-DM4 | 1461704-01-7 | ADC Related |
| HY-128955 | MC-VC-PABC-Aur0101 | 1438849-92-3 | ADC Related |
| HY-128957 | Vc-seco-DUBA | 1345681-58-4 | ADC Related |
| HY-128959 | MCC-Modified Daunorubicinol | 721945-30-8 | ADC Related |
| HY-128960 | DBA-DM4 | 905449-84-5 | ADC Related |
| HY-128961 | MC-Alkyl-Hydrazine Modified MMAF | 1404071-64-2 | ADC Related |
| HY-128965 | N-Glycolylneuraminic acid | 1113-83-3 | Reference compound |
| HY-128965R | N-Glycolylneuraminic acid (Standard) | 1113-83-3 | Reference Standards |
| HY-128968 | PEG4-aminooxy-MMAF | 1415246-35-3 | ADC Related |
| HY-128970 | Mp-polymer ester | ADC Related | |
| HY-128971 | LHVS | 170111-28-1 | Reference compound |
| HY-128972 | Purpurin 18 | 25465-77-4 | Reference compound |
| HY-128973 | Pyropheophorbide-a | 24533-72-0 | Reference compound |
| HY-128974 | N-Dodecyl-β-D-maltoside | 69227-93-6 | Reference compound |
| HY-128974S | N-Dodecyl-β-D-maltoside-d25 | 849110-74-3 | Isotope-Labeled Compounds |
| HY-128975 | m-Tyramine (hydrobromide) | 38449-59-1 | Reference compound |
| HY-128976 | 10β,17β-dihydroxyestra-1,4-dien-3-one | 549-02-0 | Reference compound |
| HY-128977 | CD235 | 1627716-57-7 | Reference compound |
| HY-128978 | (E,E)-RAMB4 | 919091-61-5 | Reference compound |
| HY-128979 | Deruxtecan analog 2 | 1599440-10-4 | ADC Related |
| HY-128979B | Deruxtecan analog 2 (monoTFA) | 2758874-59-6 | ADC Related |
| HY-128995AS | Glycyl-Exatecan-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-12900 | RB-005 | 1425049-20-2 | Reference compound |
| HY-129027 | Ac-Leu-Gly-Lys(Ac)MCA | 660847-06-3 | Reference compound |
| HY-129028 | H-Ala-Ala-Tyr-OH | 67131-52-6 | Peptides |
| HY-129028A | H-Ala-Ala-Tyr-OH (TFA) | Peptides | |
| HY-129029 | Bisoprolol | 66722-44-9 | Reference compound |
| HY-129029R | Bisoprolol (Standard) | 66722-44-9 | Reference Standards |
| HY-129029S | Bisoprolol-d5 | 1189881-87-5 | Isotope-Labeled Compounds |
| HY-12903 | Macozinone | 1377239-83-2 | Reference compound |
| HY-129030 | BDZ-g | 732278-52-3 | Reference compound |
| HY-129034 | Ramoplanin | 76168-82-6 | Natural Products |
| HY-129035 | PFI-653 | 2173134-00-2 | Reference compound |
| HY-129037 | BCRP-IN-1 | 765899-28-3 | Reference compound |
| HY-129038 | GR24 | 76974-79-3 | Biochemical Assay Reagents |
| HY-129039 | Butyrolactone 3 | 778649-18-6 | Reference compound |
| HY-12903R | Macozinone (Standard) | 1377239-83-2 | Reference Standards |
| HY-12904 | TCA1 | 864941-32-2 | Reference compound |
| HY-129040A | Iobenguane (sulfate) | 87862-25-7 | Reference compound |
| HY-129040AR | Iobenguane (sulfate) (Standard) | 87862-25-7 | Reference Standards |
| HY-129041 | Procaterol (hydrochloride hemihydrate) | 81262-93-3 | Reference compound |
| HY-129042 | Cibacron Blue 3G-A | 84166-13-2 | Dye Reagents |
| HY-129043 | 3-Formyl rifamycin | 13292-22-3 | Reference compound |
| HY-129043R | 3-Formyl rifamycin (Standard) | 13292-22-3 | Reference Standards |
| HY-129046 | RNase A, Bovine pancreas | 9001-99-4 | Enzyme |
| HY-129046A | RNase A (10mg/mL, DNase free) | Enzyme | |
| HY-129046B | RNase A, Bovine Pancreas (DNase & Protease Free) | 9001-99-4 | Enzyme |
| HY-129046C | RNase B, Bovine Pancreas | Enzyme | |
| HY-129046D | RNase A, Recombinant | 9001-99-4 | Enzyme |
| HY-129046E | RNase A (DNase & Protease Free), Recombinant | 9001-99-4 | Enzyme |
| HY-129046H | RNase A, Recombinant (Protease & DNase free, animal free) | 9001-99-4 | Enzyme |
| HY-129046I | RNase A, Recombinant (animal free) | 9001-99-4 | Enzyme |
| HY-129047 | Trypsin | 9002-07-7 | Reference compound |
| HY-129047A | Trypsin (MS grade) | 9002-07-7 | Enzyme |
| HY-129047B | Recombinant Trypsin Solution | 9002-07-7 | Enzyme |
| HY-129047C | TPCK-treated Trypsin | 9002-07-7 | Enzyme |
| HY-129047D | Trypsin, Human Pancreas | 9002-07-7 | Enzyme |
| HY-129048 | Fladrafinil | 90212-80-9 | Reference compound |
| HY-129051 | Amoscanate | 26328-53-0 | Reference compound |
| HY-129055 | Isoeleutherin | 1078723-14-4 | Natural Products |
| HY-129056 | Melagatran | 159776-70-2 | Reference compound |
| HY-129057 | 2',5-Difluoro-2'-deoxycytidine | 581772-30-7 | Reference compound |
| HY-129059 | Odapipam | 131796-63-9 | Reference compound |
| HY-129060 | Flutrimazole | 119006-77-8 | Reference compound |
| HY-129060R | Flutrimazole (Standard) | 119006-77-8 | Reference Standards |
| HY-129064 | Superoxide dismutase, Porcine erythrocytes | 9054-89-1 | Enzyme |
| HY-129064A | Superoxide Dismutase, Human Erythrocyte | Enzyme | |
| HY-129065 | Nourseothricin (sulfate) | 96736-11-7 | Reference compound |
| HY-129067 | Brain natriuretic peptide | 114471-18-0 | Reference compound |
| HY-129071 | Vindesine (sulfate) | 59917-39-4 | Natural Products |
| HY-129071R | Vindesine (sulfate) (Standard) | 59917-39-4 | Reference Standards |
| HY-129072 | Isocyclosporin A | 59865-16-6 | Reference compound |
| HY-129077 | FR179642 | 168110-44-9 | Natural Products |
| HY-129077R | FR179642 (Standard) | 168110-44-9 | Reference Standards |
| HY-129079 | TFMB-(R)-2-HG | 1445700-01-5 | Reference compound |
| HY-129079A | TFMB-(S)-2-HG | 1445703-64-9 | Reference compound |
| HY-12908 | Bcl-xL antagonist 2 | 1235032-75-3 | Reference compound |
| HY-129084 | Propargylcholine (bromide) | 111755-76-1 | Reference compound |
| HY-129086 | BPAM344 | 1204572-55-3 | Reference compound |
| HY-129087 | BC-1258 | 1507370-40-2 | Reference compound |
| HY-129088 | HUP30 | 312747-21-0 | Reference compound |
| HY-12909 | MK-4409 | 1207745-58-1 | Reference compound |
| HY-129090 | CGS-9895 | 77779-50-1 | Reference compound |
| HY-129094 | ICT5040 | 215655-21-3 | Reference compound |
| HY-129096 | IDT307 | 1141-41-9 | Dye Reagents |
| HY-129097 | FFN-102 (trifluoroacetate) | 1234064-11-9 | Dye Reagents |
| HY-129098 | DMHCA | 79066-03-8 | Reference compound |
| HY-129099 | N-Desmethyltamoxifen | 31750-48-8 | Reference compound |
| HY-129099A | N-Desmethyltamoxifen (hydrochloride) | 15917-65-4 | Reference compound |
| HY-129099AR | N-Desmethyltamoxifen (hydrochloride) (Standard) | 15917-65-4 | Reference Standards |
| HY-129101 | (-)-Eseroline (fumarate) | 70310-73-5 | Reference compound |
| HY-129103 | A-412997 | 630116-49-3 | Reference compound |
| HY-129105 | Clomethiazole | 533-45-9 | Reference compound |
| HY-129105A | Chlormethiazole (edisylate) | 1867-58-9 | Reference compound |
| HY-129109 | NBD-Pen | 1955505-54-0 | Dye Reagents |
| HY-129111 | EACC | 864941-31-1 | Reference compound |
| HY-129113 | α-Chaconine | 20562-03-2 | Natural Products |
| HY-129113R | α-?Chaconine (Standard) | 20562-03-2 | Reference Standards |
| HY-129115 | S1QEL1.1 | 897613-29-5 | Reference compound |
| HY-129116 | SSAA09E1 | 433212-75-0 | Reference compound |
| HY-129117 | Arteannuin L | 207446-89-7 | Natural Products |
| HY-129118 | Takeda103A | 865609-72-9 | Reference compound |
| HY-129119 | Akt1/Akt2-IN-2 | 612847-42-4 | Reference compound |
| HY-12912 | KDU691 | 1513879-19-0 | Reference compound |
| HY-129121 | ML-226 | 2055172-43-3 | Reference compound |
| HY-129122 | VBIT-4 | 2086257-77-2 | Reference compound |
| HY-129123 | ML318 | 1610516-67-0 | Reference compound |
| HY-129123R | ML318 (Standard) | 1610516-67-0 | Reference Standards |
| HY-129124 | β-Solamarine | 3671-38-3 | Natural Products |
| HY-129125 | YMU1 | 902589-96-2 | Reference compound |
| HY-129126 | NC9 | 1352090-52-8 | Reference compound |
| HY-12913 | AMG 579 | 1227067-61-9 | Reference compound |
| HY-129130 | Canthin-6-one N-oxide | 60755-87-5 | Natural Products |
| HY-129131 | Chrysin 6-C-arabinoside 8-C-glucoside | 185145-33-9 | Natural Products |
| HY-129133 | cis-Miyabenol C | 168037-22-7 | Natural Products |
| HY-129136 | TUG-1387 | 6319-64-8 | Reference compound |
| HY-129137 | Cyanidin 3-sophoroside (chloride) | 18376-31-3 | Reference compound |
| HY-129138 | Cyanidin 3,5-diglucoside (chloride) | 2611-67-8 | Natural Products |
| HY-129138R | Cyanidin 3,5-diglucoside (chloride) (Standard) | 2611-67-8 | Reference Standards |
| HY-129139 | Cyanidin-3-O-arabinoside | 111613-04-8 | Natural Products |
| HY-12914 | V116517 | 1073616-61-1 | Reference compound |
| HY-129140 | Delphinidin-3-O-arabinoside (chloride) | 171370-55-1 | Natural Products |
| HY-129141 | YKL-06-062 | 2172617-16-0 | Reference compound |
| HY-129143 | Delphinidin-3-sambubioside (chloride) | 53158-73-9 | Natural Products |
| HY-129143R | Delphinidin-3-sambubioside (chloride) (Standard) | 53158-73-9 | Reference Standards |
| HY-129144 | Dihydrodehydrodiconiferyl alcohol | 28199-69-1 | Natural Products |
| HY-129146S | Doxapram-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-129148 | Ganoderic acid AM1 | 149507-55-1 | Natural Products |
| HY-129149 | Ganoderic acid SZ | 865543-37-9 | Natural Products |
| HY-129150 | Ganoderic acid TR | 862893-75-2 | Natural Products |
| HY-129151 | Ganoderic acid C1 | 95311-97-0 | Natural Products |
| HY-129152 | Ganoderic acid T-N | 112430-64-5 | Natural Products |
| HY-129153 | Ganoderic acid ζ | 294674-09-2 | Natural Products |
| HY-129154 | Ganolucidic acid A | 98665-21-5 | Natural Products |
| HY-129155 | (Rac)-Germacrene D | 37839-63-7 | Natural Products |
| HY-129156 | HS-1793 | 927885-00-5 | Reference compound |
| HY-129159 | (-)-Clerosterol | 2364-23-0 | Natural Products |
| HY-129159R | (-)-Clerosterol (Standard) | 2364-23-0 | Reference Standards |
| HY-129160 | Ganoderenic acid H | 120462-48-8 | Natural Products |
| HY-129161 | Alisol O | 928148-51-0 | Natural Products |
| HY-129162 | Alisol A 23-acetate | 19865-75-9 | Natural Products |
| HY-129163 | HJ-PI01 | 6192-43-4 | Reference compound |
| HY-129166 | UCM53 | 2468847-23-4 | Reference compound |
| HY-129167 | Menin-MLL inhibitor 4 | 2169916-13-4 | Reference compound |
| HY-129169 | USP7-IN-6 | 2166586-47-4 | Reference compound |
| HY-129171 | TGFBR1-IN-1 | 2170830-26-7 | Reference compound |
| HY-129172 | PD-1/PD-L1-IN 5 (TFA) | 2170209-52-4 | Reference compound |
| HY-129172A | PD-1/PD-L1-IN 5 | 2170209-51-3 | Reference compound |
| HY-129179 | Lisaftoclax | 2180923-05-9 | Reference compound |
| HY-129179B | (Rac)-Lisaftoclax | 2651980-10-6 | Reference compound |
| HY-129180 | XY028-133 | 2229974-73-4 | Reference compound |
| HY-129181 | FGFR4-IN-4 | 2230973-67-6 | Reference compound |
| HY-129188 | CCT369260 | 2647503-57-7 | Reference compound |
| HY-129189 | RAS GTPase inhibitor 1 | 2252242-32-1 | Reference compound |
| HY-129197 | Stearyldiethanolamine | 10213-78-2 | Reference compound |
| HY-129199 | U-51605 | 64192-56-9 | Reference compound |
| HY-129200 | Aspergillomarasmine A | 3484-65-9 | Reference compound |
| HY-129201 | ZEN-2759 | 1616400-50-0 | Reference compound |
| HY-129206 | Locicortolone | 65049-45-8 | Reference compound |
| HY-129207 | JMV 3002 | 925239-03-8 | Reference compound |
| HY-129208 | Viridicatumtoxin | 39277-41-3 | Natural Products |
| HY-129209 | Myrotoxin B | 99486-49-4 | Natural Products |
| HY-129210 | KMUP-4 | 864873-81-4 | Reference compound |
| HY-129213 | CL-242817 | 86709-48-0 | Reference compound |
| HY-129214 | (2S,3R)-DEPMPO-Biotin | 936224-52-1 | Reference compound |
| HY-129217 | Naringinase | 9068-31-9 | Natural Products |
| HY-129225 | WRR139 | 2138924-36-2 | Reference compound |
| HY-129226 | SHMT-IN-2 | 2102681-49-0 | Reference compound |
| HY-129228 | Lychnopholide | 77448-64-7 | Natural Products |
| HY-129230 | Triletide | 62087-96-1 | Reference compound |
| HY-129231 | Levomoprolol | 77164-20-6 | Reference compound |
| HY-129234 | Mazethramycin | 68373-96-6 | Natural Products |
| HY-129236 | Hellebrin | 13289-18-4 | Reference compound |
| HY-129237 | Azo-enkephalin | 76995-89-6 | Reference compound |
| HY-129239 | Farudodstat | 1035688-66-4 | Reference compound |
| HY-129240S | 13-cis Acitretin-d3 | 1185241-03-5 | Isotope-Labeled Compounds |
| HY-129241 | AGX51 | 330834-54-3 | Reference compound |
| HY-129242 | Tempone | 2896-70-0 | Reference compound |
| HY-129242S | Tempone-15N,d16 | 80404-14-4 | Isotope-Labeled Compounds |
| HY-129242S1 | Tempone-d16 | 36763-53-8 | Isotope-Labeled Compounds |
| HY-129243 | Uredepa | 302-49-8 | Reference compound |
| HY-129244 | Levamlodipine (gentisate) | 856256-16-1 | Reference compound |
| HY-129245 | Razobazam | 78466-98-5 | Reference compound |
| HY-129246 | Cytembena | 21739-91-3 | Reference compound |
| HY-129247 | Versicolorin A | 6807-96-1 | Natural Products |
| HY-129250 | AZD5213 | 1119807-02-1 | Reference compound |
| HY-129252 | Prothracarcin | 81542-99-6 | Natural Products |
| HY-129253 | GSK984 | 827591-04-8 | Reference compound |
| HY-129254 | 5-Hydroxy propranolol | 81907-82-6 | Reference compound |
| HY-129257 | Esfenvalerate | 66230-04-4 | Reference compound |
| HY-129257R | Esfenvalerate (Standard) | 66230-04-4 | Reference Standards |
| HY-129258 | Lycoctonine | 26000-17-9 | Natural Products |
| HY-12926 | ST7612AA1 | 1428535-92-5 | Reference compound |
| HY-129260 | Kanosamine | 576-44-3 | Reference compound |
| HY-129262 | Deoxypheganomycin D | 69280-94-0 | Reference compound |
| HY-129263 | L-Isoleucyl-L-valine | 41017-96-3 | Reference compound |
| HY-129265 | Poloxin-2 | 321695-37-8 | Reference compound |
| HY-129269 | Pacidamycin I | 121264-05-9 | Natural Products |
| HY-12927 | SX-517 | 1240494-13-6 | Reference compound |
| HY-129271 | Deltorphin | 119975-64-3 | Peptides |
| HY-129273 | L-731735 | 149756-20-7 | Reference compound |
| HY-129274 | RO4988546 | 911114-85-7 | Reference compound |
| HY-129276 | N-Retinoyl phenylalanine | 97885-88-6 | Reference compound |
| HY-129278 | Lunarine | 24185-51-1 | Natural Products |
| HY-129279 | Andrastin A | 174232-42-9 | Natural Products |
| HY-12928 | ML336 | 1613465-33-0 | Reference compound |
| HY-129280 | Janthinocin A | 131086-52-7 | Reference compound |
| HY-129281 | Benzedrone (hydrochloride) | 1797979-43-1 | Reference compound |
| HY-129283 | Goralatide | 120081-14-3 | Natural Products |
| HY-129283A | Goralatide (TFA) | 1796568-94-9 | Natural Products |
| HY-129283B | Goralatide (acetate) | Natural Products | |
| HY-129284 | APHS | 209125-28-0 | Reference compound |
| HY-129285 | A83016A | 142383-42-4 | Reference compound |
| HY-129288 | GW837016X | 833473-68-0 | Reference compound |
| HY-12929 | NSC756093 | 1629908-92-4 | Reference compound |
| HY-129290 | Flamprop-methyl | 52756-25-9 | Reference compound |
| HY-129290R | Flamprop-methyl (Standard) | 52756-25-9 | Reference Standards |
| HY-129291 | Reductiomycin | 68748-55-0 | Natural Products |
| HY-129292 | Quinocarcin | 84573-33-1 | Reference compound |
| HY-129293 | AFP-07 (free acid) | 788799-13-3 | Reference compound |
| HY-129295 | Amidepsine D | 79786-34-8 | Reference compound |
| HY-129296 | YM-44781 (free acid) | 173943-29-8 | Reference compound |
| HY-129297 | CMPF | 86879-39-2 | Reference compound |
| HY-129297S | CMPF-d5 | 2749807-07-4 | Isotope-Labeled Compounds |
| HY-129298 | Amastatin | 67655-94-1 | Reference compound |
| HY-12930 | SPR719 | 1384984-18-2 | Reference compound |
| HY-129300 | Prosulfocarb | 52888-80-9 | Reference compound |
| HY-129300R | Prosulfocarb (Standard) | 52888-80-9 | Reference Standards |
| HY-129300S | Prosulfocarb-d7 | Isotope-Labeled Compounds | |
| HY-129301 | CCTA-1523 | 1616271-41-0 | Reference compound |
| HY-129303 | AP219 | 779282-36-9 | Reference compound |
| HY-129304 | (±)-Cannabichromeorcin | 55824-09-4 | Reference compound |
| HY-129305 | Tampramine (fumarate) | 83166-18-1 | Reference compound |
| HY-129306 | Gilvocarcin M | 77879-89-1 | Natural Products |
| HY-129307 | Gilvocarcin V | 77879-90-4 | Natural Products |
| HY-129308 | LS 82-556 | 92751-45-6 | Reference compound |
| HY-129310 | PIN1 inhibitor 5 | 884033-66-3 | Reference compound |
| HY-129311 | Tr-PEG6-OH | 127999-16-0 | ADC Related |
| HY-129312 | Awamycin | 87913-35-7 | Natural Products |
| HY-129313 | LG 6-102 | 132798-30-2 | Reference compound |
| HY-129314 | CM-39 | 361156-54-9 | Reference compound |
| HY-129315 | Deacylketoconazole | 67914-61-8 | Reference compound |
| HY-129316 | Dihydroaeruginoic Acid | 143209-04-5 | Reference compound |
| HY-129317 | A457 | 1233923-95-9 | Reference compound |
| HY-129318 | MBX-1066 | 868971-24-8 | Reference compound |
| HY-129319 | Valinotricin | 94899-85-1 | Natural Products |
| HY-129325 | Cytochalasin H | 53760-19-3 | Natural Products |
| HY-129327 | Isoadiantone | 54352-47-5 | Natural Products |
| HY-129328 | Magnesium glycinate | 14783-68-7 | Reference compound |
| HY-129329 | Lankamycin | 30042-37-6 | Natural Products |
| HY-12933 | BIIB-028 | 911398-13-5 | Reference compound |
| HY-129330 | Sapintoxin D | 80998-07-8 | Natural Products |
| HY-129331 | Neothramycin A | 59593-16-7 | Natural Products |
| HY-129333 | L-364918 | 122211-31-8 | Reference compound |
| HY-129334 | Macrocalin B | 93781-75-0 | Natural Products |
| HY-129336 | Abemaciclib metabolite M20 | 2138499-06-4 | Reference compound |
| HY-129336S | Abemaciclib metabolite M20-d8 | Isotope-Labeled Compounds | |
| HY-129337 | Reveromycin A | 134615-37-5 | Natural Products |
| HY-129338 | CID 7309015 | 1164457-99-1 | Reference compound |
| HY-129339 | Akrobomycin | 89156-94-5 | Natural Products |
| HY-129340 | AS-183 | 147317-12-2 | Natural Products |
| HY-129342 | Lincomycin B | 2520-24-3 | Reference compound |
| HY-129346 | STF-038533 | 423744-59-6 | Reference compound |
| HY-129347 | Lankacyclinol A | 52212-91-6 | Natural Products |
| HY-129348 | IRE1α kinase-IN-10 | 1415050-59-7 | Reference compound |
| HY-129349 | Phe-Lys(Trt)-PAB | 1116085-99-4 | ADC Related |
| HY-129350 | Fmoc-Phe-Lys(Trt)-PAB-PNP | 1116086-09-9 | ADC Related |
| HY-129351 | Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP | 253863-34-2 | ADC Related |
| HY-129352 | Cbz-Phe-(Alloc)Lys-PAB-PNP | 159857-90-6 | ADC Related |
| HY-129353 | Boc-Phe-(Alloc)Lys-PAB-PNP | 1160844-44-9 | ADC Related |
| HY-129355 | Duocarmycin Analog | 372954-15-9 | ADC Related |
| HY-129356 | Seco-Duocarmycin SA | 144667-38-9 | ADC Related |
| HY-129356A | (S)-Seco-Duocarmycin SA | 152785-82-5 | ADC Related |
| HY-129357 | CCK-B Receptor Antagonist 2 | 155412-88-7 | Reference compound |
| HY-129359 | PDP-Pfp | 160580-70-1 | ADC Related |
| HY-12936 | DDD100097 | 1215012-74-0 | Reference compound |
| HY-129360 | Ala-Ala-Asn-PAB | 2149584-00-7 | ADC Related |
| HY-129360A | Ala-Ala-Asn-PAB (TFA) | Peptides | |
| HY-129361 | Fmoc-Ala-Ala-Asn-PABC-PNP | 1834516-06-1 | ADC Related |
| HY-129362 | Phe-Lys(Fmoc)-PAB | 2149584-03-0 | ADC Related |
| HY-129363 | AP1867-3-(aminoethoxy) | 2127390-15-0 | Reference compound |
| HY-129365 | SNPB | 663598-85-4 | ADC Related |
| HY-129366 | PDB-Pfp | 2088570-81-2 | ADC Related |
| HY-129367 | NO2-SPP | 663598-61-6 | ADC Related |
| HY-129368 | SPDMV | 890409-85-5 | ADC Related |
| HY-129369 | SPDMB | 2101206-29-3 | ADC Related |
| HY-129370 | SPDB-sulfo | 1628113-16-5 | ADC Related |
| HY-129371 | SPDV | 317331-86-5 | ADC Related |
| HY-129372 | PDdB-Pfp | 2101206-44-2 | ADC Related |
| HY-129373 | SPDMV-sulfo | 2101206-86-2 | ADC Related |
| HY-129374 | SPDH | 1824718-79-7 | ADC Related |
| HY-129375 | SNPB-sulfo-Me | 890409-86-6 | ADC Related |
| HY-129376 | Sulfo-SNPB | 1193111-37-3 | ADC Related |
| HY-129377 | Sulfo-SPP | 452072-27-4 | ADC Related |
| HY-129377A | Sulfo-SPP (sodium) | 452072-24-1 | ADC Related |
| HY-129378 | NO2-SPP-sulfo-Me | 890409-87-7 | ADC Related |
| HY-129379 | DC0-NH2 | 615538-51-7 | ADC Related |
| HY-12938 | AMG-8718 | 1215868-94-2 | Reference compound |
| HY-129380 | Fructosyl-lysine | 21291-40-7 | Natural Products |
| HY-129380A | Fructosyl-lysine (dihydrochloride) | 96192-35-7 | Reference compound |
| HY-129380R | Fructosyl-lysine (Standard) | 21291-40-7 | Reference Standards |
| HY-129384 | Rubratoxin B | 21794-01-4 | Reference compound |
| HY-129385 | Linustatin | 72229-40-4 | Natural Products |
| HY-129388 | Pulrodemstat (Methylbenzenesulfonate) | 2097523-57-2 | Reference compound |
| HY-129388A | Pulrodemstat | 1821307-10-1 | Reference compound |
| HY-129388B | Pulrodemstat (benzenesulfonate) | 2097523-60-7 | Reference compound |
| HY-129389 | Benzyl-α-GalNAc | 3554-93-6 | Reference compound |
| HY-129390 | Orelabrutinib | 1655504-04-3 | Reference compound |
| HY-129393 | Etrumadenant | 2239273-34-6 | Reference compound |
| HY-129395 | Mezigdomide | 2259648-80-9 | Reference compound |
| HY-129397 | 2,3-Dinor-11beta-prostaglandin F2alpha | 240405-20-3 | Reference compound |
| HY-129397S | 2,3-Dinor-11β-prostaglandin F2α-d9 | 851030-08-5 | Isotope-Labeled Compounds |
| HY-129398 | Formiminoglutamic acid | 816-90-0 | Reference compound |
| HY-12940 | GLPG0974 | 1391076-61-1 | Reference compound |
| HY-129405 | N-(Ketocaproyl)-DL-homoserine lactone | 76924-95-3 | Reference compound |
| HY-129405R | N-(Ketocaproyl)-DL-homoserine lactone (Standard) | 76924-95-3 | Reference Standards |
| HY-129406 | AF 698 | 82958-11-0 | Reference compound |
| HY-129407 | AAF-CMK (TFA) | 184901-82-4 | Peptides |
| HY-129407A | AAF-CMK | 102129-66-8 | Peptides |
| HY-129408 | SGE-516 | 1430064-74-6 | Reference compound |
| HY-129409 | 7,8-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one | 75187-63-2 | Natural Products |
| HY-12940A | (S)-GLPG0974 | 2326220-69-1 | Reference compound |
| HY-12941 | AM-7209 | 1623432-51-8 | Reference compound |
| HY-129410 | ADR-925 | 75459-34-6 | Reference compound |
| HY-129411 | Sinbaglustat | 441061-33-2 | Reference compound |
| HY-129412 | A-74273 | 130316-95-9 | Reference compound |
| HY-129415 | Esaprazole | 64204-55-3 | Reference compound |
| HY-12942 | PF-05175157 | 1301214-47-0 | Reference compound |
| HY-129420 | WSP-5 | 1593024-78-2 | Dye Reagents |
| HY-129421 | PA-9 | 1436004-46-4 | Reference compound |
| HY-129422 | Diallyl G | 127808-81-5 | Reference compound |
| HY-129424 | Mezolidon | 82697-73-2 | Reference compound |
| HY-129426 | PDK1/Akt/Flt dual pathway inhibitor | 331253-86-2 | Reference compound |
| HY-129428 | Fructosyl-methionine | 80860-78-2 | Reference compound |
| HY-129430 | N-Methylprotoporphyrin IX | 79236-56-9 | Reference compound |
| HY-129431 | U-89843A | 157013-32-6 | Reference compound |
| HY-129432 | (-)-Deacetylsclerotiorin | 61248-35-9 | Reference compound |
| HY-129433 | 17β-HSD1-IN-2 | 1318265-18-7 | Reference compound |
| HY-129434 | Nepetalactone | 490-10-8 | Reference compound |
| HY-129434A | 4aα,7α,7aα-Nepetalactone | 21651-62-7 | Natural Products |
| HY-129435 | Altromycin E | 134887-77-7 | Natural Products |
| HY-129436 | (S)-Bucindolol | 91548-61-7 | Reference compound |
| HY-12944 | GSK163929 | 716354-04-0 | Reference compound |
| HY-129440 | N-(p-Coumaroyl) Serotonin | 68573-24-0 | Natural Products |
| HY-129441 | Metoprine | 7761-45-7 | Reference compound |
| HY-129443 | Deacetylcephaloglycin | 3890-34-4 | Reference compound |
| HY-129444 | MD 780236 (free base) | 73423-36-6 | Reference compound |
| HY-129445 | SG-209 | 83440-03-3 | Reference compound |
| HY-129449 | AnnH31 | 241809-12-1 | Reference compound |
| HY-129450 | Ethyl-L-NIO (hydrochloride) | 150403-97-7 | Reference compound |
| HY-129451 | HIE-124 | 805326-00-5 | Reference compound |
| HY-129452 | (S)-3'-Hydroxy blebbistatin | 2097136-42-8 | Reference compound |
| HY-129453 | BOP (sodium) | 1947348-42-6 | Reference compound |
| HY-129454 | TPU-0037A | 485815-59-6 | Reference compound |
| HY-129457 | FINO2 | 869298-31-7 | Reference compound |
| HY-129458 | Cerivastatin | 145599-86-6 | Reference compound |
| HY-129459 | α-Tocotrienol | 58864-81-6 | Reference compound |
| HY-129459R | α-Tocotrienol (Standard) | 58864-81-6 | Reference Standards |
| HY-12946 | BI 653048 | 1198784-72-3 | Reference compound |
| HY-129460 | XJB-5-131 | 866404-31-1 | Reference compound |
| HY-129461 | Dibenzyl trisulfide | 6493-73-8 | Natural Products |
| HY-129462 | O-Isopropyl ethylthiocarbamate | 141-98-0 | Reference compound |
| HY-129464 | NO-711ME | 127586-66-7 | Reference compound |
| HY-129466 | PCTR2 | 1810710-63-4 | Reference compound |
| HY-129467 | (Rac)-Idroxioleic acid | 56472-29-8 | Reference compound |
| HY-129467A | (Rac)-Idroxioleic acid (sodium) | 1229114-68-4 | Reference compound |
| HY-129467R | (Rac)-Idroxioleic acid (Standard) | 56472-29-8 | Reference Standards |
| HY-129468 | Pirimiphos ethyl | 23505-41-1 | Reference compound |
| HY-129468R | Pirimiphos ethyl (Standard) | 23505-41-1 | Reference Standards |
| HY-129469 | Saframycin S | 75425-66-0 | Natural Products |
| HY-12946A | BI 653048 (phosphate) | 1198784-97-2 | Reference compound |
| HY-12947 | GNE-3511 | 1496581-76-0 | Reference compound |
| HY-129471 | Arbaprostil | 55028-70-1 | Reference compound |
| HY-129474 | MP 518 | 122432-93-3 | Reference compound |
| HY-129475 | Mycinamicin I | 73665-15-3 | Reference compound |
| HY-129476 | L-Canaline | 496-93-5 | Natural Products |
| HY-129478 | TC11 | 100823-03-8 | Reference compound |
| HY-129479 | Almoxatone | 84145-89-1 | Reference compound |
| HY-12948 | AMG319 | 1608125-21-8 | Reference compound |
| HY-129480 | Vertilmicin sulfate | 857468-21-4 | Reference compound |
| HY-129482 | Detoxin D1 | 37878-19-6 | Natural Products |
| HY-129484 | Sporidesmolide III | 1803-67-4 | Reference compound |
| HY-129485 | CM304 | 1417742-48-3 | Reference compound |
| HY-129487 | (E/Z)-MC4 | 219140-31-5 | Reference compound |
| HY-12949 | ML204 | 5465-86-1 | Reference compound |
| HY-129490 | Enpp-1-IN-1 | 2289728-58-9 | Reference compound |
| HY-129491 | O-Desmethyl Midostaurin | 740816-86-8 | Reference compound |
| HY-129491S | O-Desmethyl Midostaurin-d5 | 2699608-28-9 | Isotope-Labeled Compounds |
| HY-129492 | GNF4877 | 2041073-22-5 | Reference compound |
| HY-129493 | Lateropyrone | 93752-78-4 | Natural Products |
| HY-129496 | NP-313 | 5397-78-4 | Reference compound |
| HY-12949A | ML204 (hydrochloride) | 2070015-10-8 | Reference compound |
| HY-129500 | Zofenoprilat (arginine) | 81872-09-5 | Reference compound |
| HY-129502 | Fibrostatin C | 91776-47-5 | Natural Products |
| HY-129503 | 2-Heptyl-4-quinolone | 40522-46-1 | Natural Products |
| HY-129503S | 2-Heptyl-4-quinolone-13C6 | Isotope-Labeled Compounds | |
| HY-129503S1 | 2-Heptyl-4-quinolone-15N | Isotope-Labeled Compounds | |
| HY-129507 | Aplindore (fumarate) | 189681-71-8 | Reference compound |
| HY-129508 | Amthamine | 142437-67-0 | Reference compound |
| HY-129509 | Alterporriol B | 88901-69-3 | Natural Products |
| HY-129510 | 4-Methyl erlotinib | 1346601-52-2 | Reference compound |
| HY-129510R | 4-Methyl erlotinib (Standard) | 1346601-52-2 | Reference Standards |
| HY-129511 | Conivaptan-d4 | 1129433-63-1 | Reference compound |
| HY-129513 | SIB-1893 | 7370-21-0 | Reference compound |
| HY-129515 | Trichodecenin II | 140939-04-4 | Natural Products |
| HY-129516 | A-70874 | 131449-37-1 | Reference compound |
| HY-129517 | UBP714 | 773109-55-0 | Reference compound |
| HY-129522 | Sulfo-ara-F-NMN | 1374663-29-2 | Reference compound |
| HY-129523 | PROTAC K-Ras Degrader-1 | 2378258-52-5 | Reference compound |
| HY-129524 | Ethylene dimethanesulfonate | 4672-49-5 | Reference compound |
| HY-129525A | Sulfo-SIAB (sodium) | 144650-93-1 | ADC Related |
| HY-129526 | Mal-PEG3-NHS ester | 1537892-36-6 | ADC Related |
| HY-129527 | GNE-9278 | 2315311-83-0 | Reference compound |
| HY-129529 | 6-Hydroxyluteolin 7-glucoside | 54300-65-1 | Natural Products |
| HY-12953 | R-268712 | 879487-87-3 | Reference compound |
| HY-129531 | MuRF1-IN-1 | 445222-91-3 | Reference compound |
| HY-12954 | PTACH | 848354-66-5 | Reference compound |
| HY-129545 | DS-1001b | 1898207-64-1 | Reference compound |
| HY-129546 | Eprozinol (hydrochloride) | 27588-43-8 | Reference compound |
| HY-129547 | Fluo-3 (pentapotassium) | 853400-67-6 | Dye Reagents |
| HY-129548 | Prumycin | 38819-28-2 | Reference compound |
| HY-129548A | Prumycin di(hydrochloride) | 57420-47-0 | Reference compound |
| HY-129549 | Thiopropamine (hydrochloride) | 53632-92-1 | Reference compound |
| HY-129550 | BI-4020 | 2664214-60-0 | Reference compound |
| HY-129552 | WAY-855 | 482373-29-5 | Reference compound |
| HY-129554 | cis-9,10-Epoxystearic acid | 24560-98-3 | Natural Products |
| HY-129554R | cis-?9,?10-?Epoxystearic acid (Standard) | 24560-98-3 | Reference Standards |
| HY-129555 | Surfactin | 252023-70-4 | Natural Products |
| HY-129556 | Pepstanone A | 38752-31-7 | Natural Products |
| HY-129557 | A-49816 | 78235-72-0 | Reference compound |
| HY-129558 | UK-1 | 151271-53-3 | Reference compound |
| HY-12956 | Dinoprost | 551-11-1 | Natural Products |
| HY-129560 | DNDS (disodium) | 3709-43-1 | Reference compound |
| HY-129562 | Cucumechinoside D | 125640-33-7 | Natural Products |
| HY-129563 | CGP 57813 | 150608-41-6 | Reference compound |
| HY-129564 | Acetomycin | 510-18-9 | Reference compound |
| HY-129566 | Withanolide B | 56973-41-2 | Natural Products |
| HY-129566R | Withanolide B (Standard) | 56973-41-2 | Reference Standards |
| HY-129568 | Tetraphyllicine | 509-38-6 | Natural Products |
| HY-12956A | Dinoprost (tromethamine salt) | 38562-01-5 | Reference compound |
| HY-12956AR | Dinoprost (tromethamine salt) (Standard) | 38562-01-5 | Reference Standards |
| HY-12956B | (5R)-Dinoprost | 4510-16-1 | Reference compound |
| HY-12956R | Dinoprost (Standard) | 551-11-1 | Reference Standards |
| HY-12956S | Dinoprost-d4 | 34210-11-2 | Isotope-Labeled Compounds |
| HY-12956S1 | Dinoprost-d9 | Isotope-Labeled Compounds | |
| HY-12956S2 | Dinoprost-13C5 | Isotope-Labeled Compounds | |
| HY-12957 | NITD008 | 1044589-82-3 | Reference compound |
| HY-129571 | BioE-1115 | 1268863-35-9 | Reference compound |
| HY-129576 | PSB-16133 (sodium) | 2089035-40-3 | Reference compound |
| HY-129577 | Aplysin | 6790-63-2 | Natural Products |
| HY-129578 | Asperphenamate | 63631-36-7 | Natural Products |
| HY-129578R | Asperphenamate (Standard) | 63631-36-7 | Reference Standards |
| HY-129579 | Linadryl | 5928-69-8 | Reference compound |
| HY-129580 | Nannochelin B | 133705-27-8 | Natural Products |
| HY-129581 | Org 27759 | 868273-09-0 | Reference compound |
| HY-129582 | Ribasine | 87099-54-5 | Natural Products |
| HY-129583 | Lepidiline A | 596093-98-0 | Natural Products |
| HY-129584 | Lepidiline B | 596093-97-9 | Natural Products |
| HY-129585 | SM-4470 | 89433-57-8 | Reference compound |
| HY-129586 | Govorestat | 2170729-29-8 | Reference compound |
| HY-129589 | Thailanstatin A | 1426953-21-0 | ADC Related |
| HY-12959 | Repinotan | 144980-29-0 | Reference compound |
| HY-129591 | Paraherquamide A | 77392-58-6 | Natural Products |
| HY-129592 | p-Tolylmaleimide | 1631-28-3 | Reference compound |
| HY-129594 | DANP | 761401-89-2 | Reference compound |
| HY-129594A | DANP (dihydrochloride) | Reference compound | |
| HY-12959A | Repinotan (hydrochloride) | 144980-77-8 | Reference compound |
| HY-12960 | SKLB4771 | 1370256-78-2 | Reference compound |
| HY-129600 | MYCi361 | 2289690-31-7 | Reference compound |
| HY-129602 | SD-36 | 2429877-44-9 | Reference compound |
| HY-129603 | SI-109 | 2429877-30-3 | Reference compound |
| HY-129605 | Ferulenol | 6805-34-1 | Natural Products |
| HY-129607 | A-65317 | 122224-84-4 | Reference compound |
| HY-129608 | Lenalidomide-acetylene-C5-COOH | 2429878-72-6 | Reference compound |
| HY-129610 | KB02-SLF | 2384184-40-9 | Reference compound |
| HY-129611 | Bromelain | 9001-00-7 | Reference compound |
| HY-129613 | Rhizonin A | 85803-92-5 | Peptides |
| HY-129614 | LG 82-4-01 | 91505-19-0 | Reference compound |
| HY-129615 | MIP-1072 | 949575-20-6 | Reference compound |
| HY-129616 | TachypleginA-2 | 296798-88-4 | Reference compound |
| HY-129619 | SNIPER(ER)-87 | 2222354-91-6 | Reference compound |
| HY-12961A | Bretylium (tosylate) | 61-75-6 | Reference compound |
| HY-12961AR | Bretylium (tosylate) (Standard) | 61-75-6 | Reference Standards |
| HY-12962 | NMDA-IN-1 | 700878-19-9 | Reference compound |
| HY-129622 | NH2-PEG5-C6-Cl | 1261238-22-5 | Reference compound |
| HY-129622A | NH2-PEG5-C6-Cl (hydrochloride) | 2241669-16-7 | Reference compound |
| HY-129623 | Ethyl nonanoate | 123-29-5 | Natural Products |
| HY-129623R | Ethyl nonanoate (Standard) | 123-29-5 | Reference Standards |
| HY-129624 | Bisindolylmaleimide VIII | 125313-65-7 | Reference compound |
| HY-129624A | Bisindolylmaleimide VIII (acetate) | 138516-31-1 | Reference compound |
| HY-129629 | Thiomandelic acid | 4695-09-4 | Reference compound |
| HY-12963 | Dubermatinib | 1341200-45-0 | Reference compound |
| HY-129630 | Tetrahydrocortisol | 53-02-1 | Natural Products |
| HY-129630S | Tetrahydrocortisol-d5 | Isotope-Labeled Compounds | |
| HY-129634 | TrkA-IN-1 | 1680179-43-4 | Reference compound |
| HY-129636 | CLH304a | 1611483-29-4 | Reference compound |
| HY-129636A | (E/Z)-CLH304a | 797-17-1 | Reference compound |
| HY-129637 | NH2-PEG5-OH | 34188-11-9 | ADC Related |
| HY-129638 | L-10503 | 55308-37-7 | Reference compound |
| HY-129639 | L11204 | 55308-64-0 | Reference compound |
| HY-12964 | SGI-7079 | 1239875-86-5 | Reference compound |
| HY-129640 | A-130C | 73522-76-6 | Natural Products |
| HY-129641 | KF-392 | 60671-62-7 | Reference compound |
| HY-129642 | Hirsutide | 865368-30-5 | Natural Products |
| HY-129645 | L-647318 | 87770-13-6 | Reference compound |
| HY-129648 | AC-7954 (free base) | 734528-95-1 | Reference compound |
| HY-129649 | Hydro-UCB35625 | 301648-08-8 | Reference compound |
| HY-12965 | S49076 | 1265965-22-7 | Reference compound |
| HY-129650 | Flobetapir | 938435-69-9 | Reference compound |
| HY-129650R | Flobetapir (Standard) | 938435-69-9 | Reference Standards |
| HY-129651 | SHMT-IN-1 | 1508286-18-7 | Reference compound |
| HY-129652 | HaloAUTAC tt15 | 2241668-45-9 | Reference compound |
| HY-129653 | E3 ligase Ligand 18 | 2241669-88-3 | Reference compound |
| HY-129654 | MTSES (sodium) | 184644-83-5 | Reference compound |
| HY-129655 | Sulfo-SMPB (sodium) | 92921-26-1 | ADC Related |
| HY-129656 | GLP-1 receptor agonist 3 | 2230200-09-4 | Reference compound |
| HY-129657 | GLP-1 receptor agonist 4 | 1187061-62-6 | Reference compound |
| HY-129658 | TT-OAD2 (free base) | 1246826-07-2 | Reference compound |
| HY-129658A | TT-OAD2 | 2382719-60-8 | Reference compound |
| HY-12965A | S49076 (hydrochloride) | 1265966-31-1 | Reference compound |
| HY-12965B | (Z)-S49076 (hydrochloride) | 1265965-19-2 | Reference compound |
| HY-12966 | Cetirizine methyl ester | 83881-46-3 | Reference compound |
| HY-129660 | LK 204-545 | 83068-69-3 | Natural Products |
| HY-129661 | AH 7959 | 763023-14-9 | Reference compound |
| HY-129662 | Ro 31-0052 | 82381-67-7 | Reference compound |
| HY-129663 | L-687384 | 95417-67-7 | Reference compound |
| HY-129664 | L 683519 | 132172-14-6 | Reference compound |
| HY-129665 | GS-389 | 41498-37-7 | Natural Products |
| HY-129666 | NSC-65847 | 6949-15-1 | Reference compound |
| HY-129667 | BM 21.1298 | 5218-08-6 | Reference compound |
| HY-129668 | Bremazocine | 75684-07-0 | Reference compound |
| HY-129669 | Landomycin A | 130432-93-8 | Reference compound |
| HY-129670 | KMUP-1 | 81996-46-5 | Reference compound |
| HY-129671 | Polypodine B | 18069-14-2 | Natural Products |
| HY-129672 | Thelenotoside B | 72175-95-2 | Natural Products |
| HY-129673 | Sarubicin A | 75533-14-1 | Natural Products |
| HY-129674 | PHA 568487 (free base) | 527680-56-4 | Reference compound |
| HY-129677 | ORC-13661 (hydrochloride) | 1979935-34-6 | Reference compound |
| HY-129678 | UK-88947 (hydrochloride) | 137015-76-0 | Reference compound |
| HY-129679 | NMS-P953 | 1403679-33-3 | Reference compound |
| HY-129681 | MCL-1/BCL-2-IN-1 | 2493256-46-3 | Reference compound |
| HY-129682 | LY125180 | 74515-39-2 | Reference compound |
| HY-129683 | AM3102 | 213182-22-0 | Reference compound |
| HY-129685 | M79175 | 82319-87-7 | Reference compound |
| HY-129688 | Sut-8701 | 123577-73-1 | Reference compound |
| HY-129691 | Ro 14-1761 | 82502-19-0 | Reference compound |
| HY-129692 | Withanone | 27570-38-3 | Natural Products |
| HY-129692R | Withanone (Standard) | 27570-38-3 | Reference Standards |
| HY-129693 | PBI 51 | 130694-74-5 | Reference compound |
| HY-129694 | Lenoremycin | 51257-84-2 | Natural Products |
| HY-129695 | PD 132002 | 134452-04-3 | Reference compound |
| HY-129697 | 3-Hydroxy Medetomidine | 128366-50-7 | Reference compound |
| HY-129698 | MS-073 | 129716-45-6 | Reference compound |
| HY-129699 | RH01617 | 302333-18-2 | Reference compound |
| HY-12970 | EPZ020411 | 1700663-41-7 | Reference compound |
| HY-129700 | MCL-1/BCL-2-IN-2 | 2163793-44-8 | Reference compound |
| HY-129701 | MCL-1/BCL-2-IN-3 | 2163793-55-1 | Reference compound |
| HY-129702 | MCL-1/BCL-2-IN-4 | 2163793-56-2 | Reference compound |
| HY-129703 | Thalidomide-PEG2-C2-NH2 | 2093416-32-9 | Reference compound |
| HY-129703A | Thalidomide-PEG2-C2-NH2 (TFA) | 2097509-36-7 | Reference compound |
| HY-129703B | Thalidomide-PEG2-C2-NH2 (hydrochloride) | 2245697-87-2 | Reference compound |
| HY-129704 | Thalidomide-NH-C6-NH2 | 2093386-50-4 | Reference compound |
| HY-129704A | Thalidomide-NH-C6-NH2 (TFA) | 2093386-51-5 | Reference compound |
| HY-129704B | Thalidomide-NH-C6-NH2 (hydrochloride) | 2375194-37-7 | Reference compound |
| HY-129706 | LY127210 (free base) | 57184-68-6 | Reference compound |
| HY-129707 | AMG 837 (hemicalcium) | 1291087-14-3 | Reference compound |
| HY-129708 | LU 2443 | 19703-86-7 | Reference compound |
| HY-129709 | DAC 5945 | 124065-13-0 | Reference compound |
| HY-12970A | EPZ020411 (hydrochloride) | 2070015-25-5 | Reference compound |
| HY-12971 | Nampt-IN-1 | 1698878-14-6 | Reference compound |
| HY-129710 | CGP47656 | 133345-73-0 | Reference compound |
| HY-129711 | Pyrolan | 87-47-8 | Reference compound |
| HY-129714 | EMD 52297 | 129049-51-0 | Reference compound |
| HY-129715 | MPI-0441138 | 827030-33-1 | Reference compound |
| HY-129716 | L-693989 | 138661-20-8 | Reference compound |
| HY-129718 | Nafimidone alcohol | 71009-17-1 | Reference compound |
| HY-12972 | Mavelertinib | 1776112-90-3 | Reference compound |
| HY-129721 | Acid Red 26 | 3761-53-3 | Dye Reagents |
| HY-129724 | α-MSH(11-13) | 67727-97-3 | Reference compound |
| HY-129726 | FR-900137 | 73706-58-8 | Reference compound |
| HY-129727 | (E)-MS0019266 | 21945-37-9 | Reference compound |
| HY-129728 | Lienomycin | 12710-02-0 | Natural Products |
| HY-12973 | ALK-IN-13 | 1197953-88-0 | Reference compound |
| HY-129731 | Lappaconine | 23943-93-3 | Natural Products |
| HY-129733 | LND 623 | 90520-42-6 | Reference compound |
| HY-129734 | Aeruginosin B | 6508-65-2 | Natural Products |
| HY-129736 | P32/98 (hemifumarate) | 251572-86-8 | Reference compound |
| HY-129736A | P32/98 | 136259-20-6 | Reference compound |
| HY-129737 | A-62198 | 117978-26-4 | Reference compound |
| HY-129738 | I942 | 868145-09-9 | Reference compound |
| HY-12974 | PRT-060318 | 1194961-19-7 | Reference compound |
| HY-129742 | JTT-010 | 872422-30-5 | Reference compound |
| HY-129746 | Arylquin 1 | 1630743-73-5 | Reference compound |
| HY-129748 | SQ-24798 | 70873-80-2 | Reference compound |
| HY-129749 | IDO-IN-13 | 2291164-02-6 | Reference compound |
| HY-12975 | AZ6102 | 1645286-75-4 | Reference compound |
| HY-129751 | Nitrovin (hydrochloride) | 2315-20-0 | Reference compound |
| HY-129752 | Piperafizine B | 74720-33-5 | Natural Products |
| HY-129754 | Leuseramycin | 73537-10-7 | Natural Products |
| HY-129755 | CK-17 | 86727-00-6 | Reference compound |
| HY-129756 | Thioacetanilide | 637-53-6 | Reference compound |
| HY-129757 | 5-trans-Fluprostenol | 57968-83-9 | Reference compound |
| HY-129759 | KSG-504 (anhydrous) | 137005-17-5 | Reference compound |
| HY-12976 | DS-1558 | 1202575-67-4 | Reference compound |
| HY-129761 | AR 17048 | 65792-35-0 | Reference compound |
| HY-129762 | Yoshi-864 | 3458-22-8 | Reference compound |
| HY-129763 | Di-4-ANEPPS | 90134-00-2 | Dye Reagents |
| HY-129764 | Prostaglandin F3α | 745-64-2 | Reference compound |
| HY-129764A | (17E)-Prostaglandin F3α | 211100-24-2 | Reference compound |
| HY-129765 | Thiobenzanilide 63T | 1270966-08-9 | Reference compound |
| HY-129767 | CMLD012612 | 2368900-35-8 | Reference compound |
| HY-129768 | CMLD012072 | 2368900-33-6 | Reference compound |
| HY-129769 | CMLD012073 | 2368900-32-5 | Reference compound |
| HY-129770 | D-Methionine sulfoxide | 21056-56-4 | Reference compound |
| HY-129770A | D-Methionine sulfoxide (hydrochloride) | Reference compound | |
| HY-129771 | 3-Bromomethcathinone (hydrochloride) | 676487-42-6 | Reference compound |
| HY-129772 | Phthalimide-PEG3-C2-OTs | 382162-12-1 | Reference compound |
| HY-129773 | Phthalimide-PEG4-PDM-OTBS | Reference compound | |
| HY-129774 | Phthalimide-PEG4-MPDM-OH | Reference compound | |
| HY-129775 | K-Ras ligand-Linker Conjugate 1 | 2749492-84-8 | Reference compound |
| HY-129776 | K-Ras ligand-Linker Conjugate 2 | 2741300-61-6 | Reference compound |
| HY-129779 | BTL-104 | 753451-66-0 | Reference compound |
| HY-129780 | BTL-105 | 945007-11-4 | Reference compound |
| HY-129782 | SC-55858 | 179464-49-4 | Reference compound |
| HY-129783 | Phenindamine (tartrate) | 569-59-5 | Reference compound |
| HY-129785 | CP-220629 | 162141-96-0 | Reference compound |
| HY-129786 | LG 82-4-00 | 91505-18-9 | Reference compound |
| HY-129787 | PF-03550096 | 910376-39-5 | Reference compound |
| HY-129788 | Deltamycin A1 | 58880-22-1 | Natural Products |
| HY-129792 | Thiobencarb | 28249-77-6 | Reference compound |
| HY-129792R | Thiobencarb (Standard) | 28249-77-6 | Reference Standards |
| HY-129792S | Thiobencarb-d10 | 1219804-12-2 | Isotope-Labeled Compounds |
| HY-129793 | L-156903 | 116740-51-3 | Reference compound |
| HY-129794 | YM-298198 | 748758-45-4 | Reference compound |
| HY-129796 | 3'-Fluoroaminopterin | 85803-34-5 | Reference compound |
| HY-12980 | Batefenterol | 743461-65-6 | Reference compound |
| HY-129800 | CGP78850 | 258326-83-9 | Reference compound |
| HY-129801 | N-Ethyl Hexylone (hydrochloride) | 27912-41-0 | Reference compound |
| HY-129804 | Ceforanide (lysine) | 63767-79-3 | Reference compound |
| HY-129806 | Rugulosin | 23537-16-8 | Natural Products |
| HY-129808 | VPC12249 | 403520-23-0 | Reference compound |
| HY-12980A | Batefenterol (Succinate) | 945905-37-3 | Reference compound |
| HY-12981 | RG7713 | 920022-47-5 | Reference compound |
| HY-129810 | PD 135158 | 130325-35-8 | Reference compound |
| HY-129811 | Bis-ANS (dipotassium) | 65664-81-5 | Dye Reagents |
| HY-129812 | Borofalan | 80994-59-8 | Isotope-Labeled Compounds |
| HY-129813 | Aspochracin | 22029-09-0 | Natural Products |
| HY-129814 | MM 42842 (free acid) | 113784-28-4 | Reference compound |
| HY-129819 | (Rac)-DNDI-8219 | 1333170-15-2 | Reference compound |
| HY-129821 | PTI-1 | 1400742-46-2 | Reference compound |
| HY-129822 | 5-EAPB (hydrochloride) | 1823776-22-2 | Reference compound |
| HY-129824 | 3-Methyl orsellinic acid | 4707-46-4 | Reference compound |
| HY-129826 | J-104129 | 244277-89-2 | Reference compound |
| HY-12983 | ALS-8112 | 1445379-92-9 | Reference compound |
| HY-129831 | Prostaglandin I3 (sodium) | 68324-96-9 | Reference compound |
| HY-129832 | Biotin-azide | 908007-17-0 | Biochemical Assay Reagents |
| HY-129834 | Bilirubin Conjugate (disodium) | 68683-34-1 | Reference compound |
| HY-129836 | L-Amoxicillin | 26889-93-0 | Reference compound |
| HY-129836R | L-Amoxicillin (Standard) | 26889-93-0 | Reference Standards |
| HY-12983A | Lumicitabine | 1445385-02-3 | Reference compound |
| HY-129841 | Niguldipine (monohydrochloride) | 119934-51-9 | Reference compound |
| HY-129844 | Biphenyl-4-amidoxime | 40019-44-1 | Reference compound |
| HY-129846 | IBTP (iodide) | 159085-21-9 | Reference compound |
| HY-129847 | Alitame | 80863-62-3 | Reference compound |
| HY-129848 | Cucumarioside G1 | 81296-42-6 | Natural Products |
| HY-129850 | 4-Chloromethamphetamine (hydrochloride) | 30572-91-9 | Reference compound |
| HY-129851 | NTP42 | 2055599-51-2 | Reference compound |
| HY-129852 | 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride | 21811-74-5 | Biochemical Assay Reagents |
| HY-129853A | Doxpicomine | 62904-71-6 | Reference compound |
| HY-129855 | DL-Tryptophan octyl ester (hydrochloride) | 6278-90-6 | Reference compound |
| HY-129858 | 5'-(N-Cyclopropyl)carboxamidoadenosine | 50908-62-8 | Reference compound |
| HY-129861 | 5'-Ethynyl-2'-deoxycytidine | 69075-47-4 | Reference compound |
| HY-129862 | Eclanamine (maleate) | 67450-45-7 | Reference compound |
| HY-129864A | 4-APDB (hydrochloride) | 1203342-42-0 | Reference compound |
| HY-129865 | MET (oxalate) | 5599-47-3 | Reference compound |
| HY-129867 | Z-Leu-Leu-Leu-AMC | 152015-61-7 | Peptides |
| HY-12987 | Pimozide | 2062-78-4 | Reference compound |
| HY-129870 | Diazoketone methotrexate | 82972-54-1 | Reference compound |
| HY-129876 | D-NAME (hydrochloride) | 50912-92-0 | Reference compound |
| HY-129878 | N-Trifluoroacetyladriamycin | 26295-56-7 | Reference compound |
| HY-12987R | Pimozide (Standard) | 2062-78-4 | Reference Standards |
| HY-12987S | Pimozide-d4 | 1803193-57-8 | Isotope-Labeled Compounds |
| HY-12987S1 | Pimozide-d5 N-Oxide | 1794795-40-6 | Isotope-Labeled Compounds |
| HY-12987S2 | Pimozide-d4-1 | Isotope-Labeled Compounds | |
| HY-12988 | C527 | 192718-06-2 | Reference compound |
| HY-129880 | Desacetylvinblastine hydrazide | 55383-37-4 | Reference compound |
| HY-129881 | 2-Thiothinone (hydrochloride) | 54817-67-3 | Reference compound |
| HY-129883 | (3R)-Hydroxyquinidine | 60761-51-5 | Reference compound |
| HY-129885 | Ephenidine (hydrochloride) | 6272-97-5 | Reference compound |
| HY-129886 | PKUMDL-LTQ-301 | 728886-01-9 | Reference compound |
| HY-129887 | Fluorescein diphosphate (tetraammonium) | 217305-49-2 | Dye Reagents |
| HY-129889 | Febuxostat acyl glucuronide | 1351692-92-6 | Reference compound |
| HY-12989 | LDN-91946 | 439946-22-2 | Reference compound |
| HY-129890 | 7-Hydroxy-PIPAT | 159559-71-4 | Reference compound |
| HY-129899 | (±)-Equol 4'-sulfate (sodium) | 1189685-28-6 | Reference compound |
| HY-12990 | Spautin-1 | 1262888-28-7 | Reference compound |
| HY-129900 | (-)-Luteoskyrin | 21884-44-6 | Reference compound |
| HY-129901 | 1-Demethyl phenazolam | 919973-69-6 | Reference compound |
| HY-129902 | L-Acosamine nucleoside | 136035-09-1 | Reference compound |
| HY-129903 | N-Desethyl vardenafil | 448184-46-1 | Reference compound |
| HY-129903R | N-Desethyl vardenafil (Standard) | 448184-46-1 | Reference Standards |
| HY-129903S | N-Desethyl Vardenafil-d8 | 1184985-26-9 | Isotope-Labeled Compounds |
| HY-129905 | L-Leucyl-L-Leucine methyl ester (hydrochloride) | 6491-83-4 | Reference compound |
| HY-129905A | L-Leucyl-L-Leucine methyl ester (hydrobromide) | 16689-14-8 | Reference compound |
| HY-129907 | 2-AEMP | 321882-95-5 | Reference compound |
| HY-129909 | Anticancer agent 173 | 177951-34-7 | Reference compound |
| HY-129912 | N1,N8-Diacetylspermidine | 82414-35-5 | Reference compound |
| HY-129912A | N1,N8-Diacetylspermidine (hydrochloride) | 178244-42-3 | Reference compound |
| HY-129914 | Cefcanel daloxate | 97275-40-6 | Reference compound |
| HY-129917 | KB02-JQ1 | 2384184-44-3 | Reference compound |
| HY-12991A | BIX-01338 (hydrate) | 1228184-65-3 | Reference compound |
| HY-129920 | Prostaglandin E2 methyl ester | 31753-17-0 | Reference compound |
| HY-129922 | 16(R)-AFP 07 (free acid) | 773825-80-2 | Reference compound |
| HY-129923 | (R)-Omeprazole (sodium) | 161796-77-6 | Reference compound |
| HY-129923R | (R)-Omeprazole (sodium) (Standard) | 161796-77-6 | Reference Standards |
| HY-129927 | Thiomuscimol | 62020-54-6 | Reference compound |
| HY-12993 | RSV604 | 676128-63-5 | Reference compound |
| HY-129932 | Pyrrolidine ricinoleamide | 1246776-23-7 | Reference compound |
| HY-129933 | (+)-Norpropoxyphene (maleate) | 159208-83-0 | Reference compound |
| HY-129934 | Latanoprost ethyl amide | 607351-44-0 | Reference compound |
| HY-129934S | Latanoprost ethyl amide-d4 | Isotope-Labeled Compounds | |
| HY-129937 | (S)-GNE-987 | 2738533-33-8 | Reference compound |
| HY-129937A | GNE-987 | 2417371-71-0 | Reference compound |
| HY-129938 | PROTAC BRD4 Degrader-24 | 2417370-39-7 | Reference compound |
| HY-129939 | PROTAC BRD4 ligand-1 | 2313230-51-0 | Reference compound |
| HY-12993A | RSV604 (racemate) | 676128-62-4 | Reference compound |
| HY-12993B | RSV604 (R enantiomer) | 932108-20-8 | Reference compound |
| HY-12994 | VP-14637 | 235106-62-4 | Reference compound |
| HY-129941 | (S,R,S)-AHPC-C10-NH2 | 2341796-74-3 | Reference compound |
| HY-129941A | (S,R,S)-AHPC-C10-NH2 (dihydrochloride) | 2341796-75-4 | Reference compound |
| HY-129942 | S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate | 2127875-65-2 | ADC Related |
| HY-129943 | Benzothiohydrazide | 20605-40-7 | Reference compound |
| HY-129944 | MJ33-OH | 199106-13-3 | Reference compound |
| HY-129944A | MJ33-OH (lithium) | 1135306-36-3 | Reference compound |
| HY-129946 | Dopamine D2 receptor antagonist-1 | 1055411-77-2 | Reference compound |
| HY-129947 | (-)-Carveol | 1253216-40-8 | Reference compound |
| HY-129948S | Ipratropium-d3 (iodide) | Isotope-Labeled Compounds | |
| HY-129949 | Aztreonam (lysine) | 827611-49-4 | Reference compound |
| HY-12995 | BI 665915 | 1360550-04-4 | Reference compound |
| HY-129951S | 7-Aminoclonazepam-d4 | 1215070-96-4 | Isotope-Labeled Compounds |
| HY-129952 | Dihydropleuromutilin | 42302-24-9 | Reference compound |
| HY-129953 | 9α,11β-Prostaglandin F2α | 38432-87-0 | Reference compound |
| HY-129953A | 5-trans Prostaglandin F2α | 36150-01-3 | Reference compound |
| HY-129953B | 15(R)-Prostaglandin F2α | 37658-84-7 | Reference compound |
| HY-129953C | 5-trans Prostaglandin F2α (tromethamine) | 330796-56-0 | Reference compound |
| HY-129953S | 9α,11β-Prostaglandin F2α-d4 | Isotope-Labeled Compounds | |
| HY-129953S1 | 9α,11β-Prostaglandin F2α-d9 | 2738376-79-7 | Isotope-Labeled Compounds |
| HY-129954 | 6-EAPB (hydrochloride) | 1823318-37-1 | Reference compound |
| HY-129955 | Carbazochrome (salicylate) | 13051-01-9 | Reference compound |
| HY-129959 | Aluminum phthalocyanine chloride | 14154-42-8 | Reference compound |
| HY-12995A | (S)-BI 665915 | 1360550-05-5 | Reference compound |
| HY-129960 | L-Selenocystine | 29621-88-3 | Peptides |
| HY-129963 | 3'-UMP (disodium) | 35170-03-7 | Reference compound |
| HY-129966 | PROTAC IRAK4 degrader-1 | 2360533-90-8 | Reference compound |
| HY-129967 | PROTAC IRAK4 ligand-1 | 2357108-39-3 | Reference compound |
| HY-129968 | AM-Imidazole-PA-Boc | 2357108-99-5 | Reference compound |
| HY-129969 | AG-1909 | 131927-00-9 | Reference compound |
| HY-129972 | Ribavirin 5'-monophosphate (dilithium) | 66983-94-6 | Reference compound |
| HY-129973 | 4-Chlorophenylurea | 140-38-5 | Reference compound |
| HY-129974 | 3,3'-Diiodo-L-thyronine | 4604-41-5 | Reference compound |
| HY-129974S | 3,3'-Diiodo-L-thyronine-13C6 | 1217459-13-6 | Isotope-Labeled Compounds |
| HY-129976 | Pemetrexed tromethamine (dihydrochloric) (dihydrate) | 1851348-04-3 | Reference compound |
| HY-129977 | 7-Hydroxy coumarin sulfate (potassium) | 1135316-80-1 | Reference compound |
| HY-129980 | NPC-15437 (dihydrochloride) | 141774-20-1 | Reference compound |
| HY-129982 | SC-435 | 289037-67-8 | Reference compound |
| HY-129983 | 5-Hydroxymethyl-2'-deoxyuridine | 5116-24-5 | Reference compound |
| HY-129985 | Clovoxamine | 54739-19-4 | Reference compound |
| HY-129986 | hCAI/II-IN-9 | 175014-68-3 | Reference compound |
| HY-129987 | Estradiol 17-(β-D-Glucuronide) (sodium) | 15087-02-2 | Reference compound |
| HY-129989 | A-130B | 73492-07-6 | Natural Products |
| HY-129990 | Dios-Arg (diTFA) | 1807353-31-6 | Biochemical Assay Reagents |
| HY-129993 | Gemfibrozil 1-O-β-glucuronide | 91683-38-4 | Reference compound |
| HY-129995 | TSHR antagonist S37b | 2143452-22-4 | Reference compound |
| HY-129995A | TSHR antagonist S37a | 2143452-20-2 | Reference compound |
| HY-129997 | Luteolinidin (chloride) | 1154-78-5 | Natural Products |
| HY-130000 | Pirmitegravir | 2245231-10-9 | Reference compound |
| HY-130001 | CDK9-IN-9 | 2246956-84-1 | Reference compound |
| HY-130003 | Hypoglycemic agent 1 | 2253733-57-0 | Reference compound |
| HY-130004 | MsbA-IN-6 | 2909443-13-4 | Reference compound |
| HY-13001 | Quizartinib | 950769-58-1 | Reference compound |
| HY-130011 | CCG-232964 | 2349373-70-0 | Reference compound |
| HY-130012 | CO23 | 1370363-74-8 | Reference compound |
| HY-130013 | HKYellow-AM (6/12-mixture) | 1448821-89-3 | Dye Reagents |
| HY-130015 | HKSOX-1 (5/6-mixture) | Dye Reagents | |
| HY-130017 | HKSOX-1r (5/6-mixture) | Dye Reagents | |
| HY-13001R | Quizartinib (Standard) | 950769-58-1 | Reference Standards |
| HY-13001S | Quizartinib-d8 | 1300734-19-3 | Isotope-Labeled Compounds |
| HY-13002 | Torin 2 | 1223001-51-1 | Reference compound |
| HY-130022 | HKPerox-1 | 2240163-05-5 | Dye Reagents |
| HY-130025 | HKOCl-3 | 2031170-80-4 | Dye Reagents |
| HY-130027 | HKOCl-4 | 2031170-85-9 | Dye Reagents |
| HY-13003 | Torin 1 | 1222998-36-8 | Reference compound |
| HY-13004 | Maraviroc | 376348-65-1 | Reference compound |
| HY-130043 | 11-O-Methylpseurotin A | 956904-34-0 | Natural Products |
| HY-130046 | 16-Epiestriol | 547-81-9 | Reference compound |
| HY-130046R | 16-Epiestriol (Standard) | 547-81-9 | Reference Standards |
| HY-130046S1 | 16β-Hydroxy-17β-estradiol-2,4-d2 | 366495-94-5 | Isotope-Labeled Compounds |
| HY-130047 | Bivittoside A | 77394-03-7 | Natural Products |
| HY-130049 | Lucidin ω-ethyl ether | 17526-17-9 | Natural Products |
| HY-13004R | Maraviroc (Standard) | 376348-65-1 | Reference Standards |
| HY-13004S | Maraviroc-d6 | 1033699-22-7 | Isotope-Labeled Compounds |
| HY-13005 | Fagomine | 53185-12-9 | Natural Products |
| HY-130050 | Luzopeptin A | 75580-37-9 | Natural Products |
| HY-130053 | Nafenopin | 3771-19-5 | Reference compound |
| HY-130055 | HQNO | 341-88-8 | Natural Products |
| HY-130055R | HQNO (Standard) | 341-88-8 | Reference Standards |
| HY-130059 | Guanine-7-oxide | 5227-68-9 | Reference compound |
| HY-130060 | 12(S)-HETrE | 72710-10-2 | Reference compound |
| HY-130061 | Cyclopentyluracil | 59967-83-8 | Reference compound |
| HY-130066 | Fortimicin C | 62874-51-5 | Natural Products |
| HY-130069 | Teicoplanin A2-5 | 91032-38-1 | Natural Products |
| HY-13007 | PF-3758309 | 898044-15-0 | Reference compound |
| HY-130070 | QO-40 | 1259536-70-3 | Reference compound |
| HY-130071 | Iproplatin | 62928-11-4 | Reference compound |
| HY-130072 | Bivittoside B | 77394-04-8 | Natural Products |
| HY-130073 | Amorfrutin A | 80489-90-3 | Natural Products |
| HY-130074 | FEMA 4809 | 1374760-95-8 | Reference compound |
| HY-130076 | MMP-2 Inhibitor II | 869577-51-5 | Reference compound |
| HY-130077 | Fmoc-PEG1-CH2CH2-NHS ester | 1807521-05-6 | Reference compound |
| HY-130078 | Ferrous bisglycinate | 20150-34-9 | Reference compound |
| HY-130079 | Procaine benzylpenicillin | 54-35-3 | Reference compound |
| HY-13007A | PF-3758309 (hydrochloride) | 1279034-84-2 | Reference compound |
| HY-13007B | PF-3758309 (dihydrochloride) | Reference compound | |
| HY-13008 | MK-0354 | 851776-28-8 | Reference compound |
| HY-130080 | DM3 | 796073-54-6 | ADC Related |
| HY-130081 | DM3-SMe | 796073-70-6 | ADC Related |
| HY-130082 | DM4-SMe | 796073-68-2 | ADC Related |
| HY-130083 | Seco-Duocarmycin TM | 236102-87-7 | ADC Related |
| HY-130084 | Mal-PEG2-VCP-NB | 2395887-69-9 | ADC Related |
| HY-130085 | Mal-PEG6-NHS ester | 1599472-25-9 | ADC Related |
| HY-130086 | Bis-PEG4-NHS ester | 1314378-11-4 | ADC Related |
| HY-130087 | Bis-PEG3-NHS ester | 1314378-16-9 | ADC Related |
| HY-130088 | Bis-PEG2-NHS ester | 65869-63-8 | ADC Related |
| HY-130089 | Bis-PEG1-NHS ester | 65869-64-9 | ADC Related |
| HY-13009 | PF-04620110 | 1109276-89-2 | Reference compound |
| HY-130090 | NHPI-PEG4-C2-Pfp ester | 2101206-46-4 | ADC Related |
| HY-130091 | NHPI-PEG4-C2-NHS ester | 1415328-95-8 | ADC Related |
| HY-130092 | NHPI-PEG3-C2-Pfp ester | 2101206-87-3 | ADC Related |
| HY-130093 | NHPI-PEG3-C2-NHS ester | 2101206-14-6 | ADC Related |
| HY-130094 | NHPI-PEG2-C2-Pfp ester | 2101206-47-5 | ADC Related |
| HY-130095 | NHPI-PEG2-C2-NHS ester | 2101206-31-7 | ADC Related |
| HY-130096 | Ald-Ph-amido-C2-nitrate | 141534-26-1 | ADC Related |
| HY-130097 | Ald-Ph-amido-PEG4-C2-acid | 1309460-27-2 | ADC Related |
| HY-130098 | Ald-Ph-amido-PEG3-C-COOH | 1007215-91-9 | ADC Related |
| HY-130099 | Ald-Ph-amido-PEG2 | 1061569-06-9 | ADC Related |
| HY-13010 | Laquinimod | 248281-84-7 | Reference compound |
| HY-130100 | Ald-Ph-amido-PEG3-C1-Boc | 1007215-94-2 | ADC Related |
| HY-130101 | Ald-Ph-amido-PEG4-C2-NHS ester | 1353011-74-1 | ADC Related |
| HY-130102 | Ald-Ph-amido-PEG3-C2-Pfp ester | 2101206-21-5 | ADC Related |
| HY-130103 | Ald-Ph-amido-PEG2-C2-Pfp ester | 2101206-60-2 | ADC Related |
| HY-130104 | Ald-Ph-amido-PEG2-C2-NHS ester | 1807521-07-8 | ADC Related |
| HY-130105 | Ald-Ph-amido-PEG1-C2-Pfp ester | 2101206-67-9 | ADC Related |
| HY-130106 | Ald-Ph-amido-PEG1-C2-NHS ester | 2101206-80-6 | ADC Related |
| HY-130107 | Ald-Ph-NHS ester | 60444-78-2 | ADC Related |
| HY-130108 | N3-PEG4-C2-Pfp ester | 1353012-00-6 | ADC Related |
| HY-130109 | N3-PEG4-C2-NHS ester | 944251-24-5 | ADC Related |
| HY-13010R | Laquinimod (Standard) | 248281-84-7 | Reference Standards |
| HY-13010S | Laquinimod-d5 | 1214267-09-0 | Isotope-Labeled Compounds |
| HY-13011 | Alectinib | 1256580-46-7 | Reference compound |
| HY-130110 | Sulfo-DMAC-SPP | 663599-11-9 | ADC Related |
| HY-130111 | DMAC-SPP | 663599-10-8 | ADC Related |
| HY-130112 | N-Succinimidyloxycarbonylpropyl methanethiosulfonate | 690632-55-4 | ADC Related |
| HY-130115 | IACS-8803 | 2095690-70-1 | Reference compound |
| HY-130115A | IACS-8803 (disodium) | 2243079-36-7 | Reference compound |
| HY-130115B | IACS-8803 (diammonium) | Reference compound | |
| HY-130116 | IACS-8779 | 2243079-26-5 | Reference compound |
| HY-130116A | IACS-8779 (disodium) | 2243079-27-6 | Reference compound |
| HY-130117 | AlbA-DCA | 2413716-79-5 | Reference compound |
| HY-130118 | MRGPRX1 agonist 1 | 2377379-39-8 | Reference compound |
| HY-130119 | Integrin-IN-2 | 2378617-67-3 | Reference compound |
| HY-13011A | Alectinib (Hydrochloride) | 1256589-74-8 | Reference compound |
| HY-13011R | Alectinib (Standard) | 1256580-46-7 | Reference Standards |
| HY-13011S | Alectinib-d8 | 1256585-15-5 | Isotope-Labeled Compounds |
| HY-13011S1 | Alectinib-d6 | 1616374-19-6 | Isotope-Labeled Compounds |
| HY-13012 | RepSox | 446859-33-2 | Reference compound |
| HY-130120 | HWL-088 | 2378617-96-8 | Reference compound |
| HY-130121 | MK-8719 | 1382799-40-7 | Reference compound |
| HY-130122 | MG-277 | 2411085-89-5 | Reference compound |
| HY-130126 | Sucunamostat (hydrate) | Reference compound | |
| HY-13012G | RepSox (GMP) | 446859-33-2 | GMP Small Molecules |
| HY-13013 | SIS3 | 521984-48-5 | Reference compound |
| HY-130136 | TMPRSS6-IN-1 | 2088415-78-3 | Reference compound |
| HY-130136A | TMPRSS6-IN-1 (TFA) | Reference compound | |
| HY-130137 | m-PEG8-C10-phosphonic acid | 2093153-86-5 | Reference compound |
| HY-130138 | (5S,6S)-DiHETE | 82948-87-6 | Reference compound |
| HY-130138A | (5S,6R)-DiHETE | 82948-88-7 | Reference compound |
| HY-130138B | (5S,6R)-DiHETEs | 129263-59-8 | Reference compound |
| HY-130138C | 5,6-DiHETE | 845673-97-4 | Reference compound |
| HY-130139 | 11,12-DiHETE | 867350-92-3 | Reference compound |
| HY-130140 | 8,9-DiHETE | 867350-87-6 | Natural Products |
| HY-130141 | m-PEG6-amino-Mal | 1644231-07-1 | Reference compound |
| HY-130142 | Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) | 1205744-09-7 | Reference compound |
| HY-130142A | Biotinyl-NH-PEG3-C3-amido-C3-COOH | 1202761-21-4 | Reference compound |
| HY-130143 | Biotin-PEG3-azide | 875770-34-6 | Reference compound |
| HY-130144 | Ald-CH2-PEG3-azide | 1002342-83-7 | ADC Related |
| HY-130145 | m-PEG8-CH2COOH | 102013-72-9 | Reference compound |
| HY-130146 | Propargyl-PEG3-phosphonic acid diethyl ester | 1052678-30-4 | Reference compound |
| HY-130147 | Propargyl-PEG5-OH | 1036204-60-0 | Reference compound |
| HY-130148 | m-PEG8-Br | 1056881-04-9 | Reference compound |
| HY-130149 | Adagrasib | 2326521-71-3 | Reference compound |
| HY-130150 | m-PEG5-succinimidyl carbonate | 1058691-00-1 | ADC Related |
| HY-130151 | m-PEG7-CH2CH2COOH | 1093647-41-6 | ADC Related |
| HY-130152 | Ms-PEG7-MS | 109789-41-5 | Reference compound |
| HY-130154 | Ald-Ph-amido-PEG2-C2-acid | 1807534-84-4 | Reference compound |
| HY-130155 | AMPK activator C2 | 1428422-55-2 | Reference compound |
| HY-130157 | 3-(2-Pyridyldithio)propanoic Acid | 68617-64-1 | Reference compound |
| HY-130158 | Tos-PEG1-CH2-Boc | 1643957-24-7 | Reference compound |
| HY-130159 | Hydroxy-PEG12-t-butyl ester | 1186025-29-5 | Reference compound |
| HY-13016 | Cabozantinib | 849217-68-1 | Reference compound |
| HY-130160 | Fluorescein-thiourea-PEG2-azide | 1146195-72-3 | Reference compound |
| HY-130161 | m-PEG4-Br | 110429-45-3 | ADC Related |
| HY-130162 | Tos-PEG2-O-Propargyl | 1119249-30-7 | Reference compound |
| HY-130163 | Bromo-PEG1-CH2COOH | 1135131-50-8 | Reference compound |
| HY-130164 | Bromo-PEG3-C2-phosphonic acid | 1148026-99-6 | Reference compound |
| HY-130165 | Tr-PEG8-OH | 1144113-16-5 | ADC Related |
| HY-130166 | Amino-PEG9-acid | 1191079-83-0 | ADC Related |
| HY-130167 | Fmoc-NH-PEG9-CH2CH2COOH | 1191064-81-9 | ADC Related |
| HY-130168 | m-PEG5-azide | 1202681-04-6 | Reference compound |
| HY-130169 | Azido-PEG9-amine | 1207714-69-9 | ADC Related |
| HY-13016A | Cabozantinib (hydrochloride) | 1817759-42-4 | Reference compound |
| HY-13016R | Cabozantinib (Standard) | 849217-68-1 | Reference Standards |
| HY-13016S | Cabozantinib-d6 | 1802168-46-2 | Isotope-Labeled Compounds |
| HY-13016S1 | Cabozantinib-d4 | 1802168-53-1 | Isotope-Labeled Compounds |
| HY-13017 | Ivacaftor | 873054-44-5 | Reference compound |
| HY-130170 | Disuccinimidyl tartrate | 62069-75-4 | Reference compound |
| HY-130172 | Benzyl-PEG2-CH2-Boc | 1643957-26-9 | Reference compound |
| HY-130173 | Bafilomycin C1 | 88979-61-7 | Natural Products |
| HY-130174 | Ald-Ph-amido-PEG3-C2-NH2 | 1404111-56-3 | Reference compound |
| HY-130175 | Fmoc-NH-PEG4-CH2COOH | 437655-95-3 | ADC Related |
| HY-130176 | UFP-512 | 480446-44-4 | Reference compound |
| HY-130178 | CL-385319 | 1210501-46-4 | Reference compound |
| HY-130179 | RC-33 (hydrochloride) | 1346016-43-0 | Reference compound |
| HY-13017A | Ivacaftor (benzenesulfonate) | 1134822-09-5 | Reference compound |
| HY-13017B | Ivacaftor (hydrate) | 1134822-07-3 | Reference compound |
| HY-13017S | Ivacaftor-d9 | 1413431-07-8 | Isotope-Labeled Compounds |
| HY-13017S1 | Ivacaftor-d19 | 1413431-22-7 | Isotope-Labeled Compounds |
| HY-13017S2 | Ivacaftor-d18 | 1413431-05-6 | Isotope-Labeled Compounds |
| HY-13017S3 | Ivacaftor-d4 | Isotope-Labeled Compounds | |
| HY-13017S4 | Ivacaftor-13C6 | Isotope-Labeled Compounds | |
| HY-13018 | MRT67307 | 1190378-57-4 | Reference compound |
| HY-130180 | Propargyl-PEG6-NH2 | 1198080-04-4 | Reference compound |
| HY-130181 | m-PEG4-amino-Mal | 1263044-81-0 | Reference compound |
| HY-130182 | Propargyl-PEG8-NH2 | 1196732-52-1 | ADC Related |
| HY-130183 | Propargyl-PEG6-N3 | 1198080-03-3 | Reference compound |
| HY-130184 | Azido-PEG8-NHS ester | 1204834-00-3 | ADC Related |
| HY-130185 | m-PEG7-CH2CH2CHO | 1234369-95-9 | ADC Related |
| HY-130186 | Methyl propionate-PEG12 | 1239588-11-4 | Reference compound |
| HY-130187 | Sapienic acid | 17004-51-2 | Reference compound |
| HY-130187A | Sapienic acid (sodium) | 217477-25-3 | Reference compound |
| HY-130187S | Sapienic acid-d19 | 2692623-89-3 | Isotope-Labeled Compounds |
| HY-130188 | Benzyl-PEG2-azide | 1260001-87-3 | Reference compound |
| HY-130189 | S-Phenylmercapturic acid | 4775-80-8 | Peptides |
| HY-130189R | S-Phenylmercapturic acid (Standard) | 4775-80-8 | Reference Standards |
| HY-13018A | MRT67307 (hydrochloride) | 2095432-39-4 | Reference compound |
| HY-13018B | MRT67307 (dihydrochloride) | 1781882-89-0 | Reference compound |
| HY-13019 | BI605906 | 960293-88-3 | Reference compound |
| HY-130192 | Cbz-NH-PEG8-C2-acid | 1334177-87-5 | Reference compound |
| HY-130193 | Mal-PEG2-NH-Boc | 660843-21-0 | Reference compound |
| HY-130194 | Azido-PEG5-CH2CO2H | 217180-81-9 | ADC Related |
| HY-130195 | SPDP-PEG4-NHS ester | 1334177-95-5 | Reference compound |
| HY-130197 | Lipoamido-PEG4-azide | 890016-39-4 | Reference compound |
| HY-130198 | DNP-PEG4-acid | 858126-76-8 | Reference compound |
| HY-130199 | Psoromic acid | 7299-11-8 | Natural Products |
| HY-13020 | GSK1838705A | 1116235-97-2 | Reference compound |
| HY-130200 | NH2-PEG8-OH | 352439-37-3 | Reference compound |
| HY-130201 | Deacetylsaptomycin D | 138370-82-8 | Reference compound |
| HY-130202 | Ald-Ph-amido-PEG2-C2-Boc | 1807521-09-0 | Reference compound |
| HY-130204 | m-PEG8-azide | 869718-80-9 | Reference compound |
| HY-130205 | Milacemide (hydrochloride) | 76990-85-7 | Reference compound |
| HY-130207 | Oncrasin-72 | 92407-90-4 | Reference compound |
| HY-130208 | Thiodigalactoside | 51555-87-4 | Reference compound |
| HY-130209 | S-Acetyl-PEG8-OH | 1334177-81-9 | Reference compound |
| HY-13021 | SRT3190 | 1204707-73-2 | Reference compound |
| HY-130210 | Oxonol V | 61389-30-8 | Dye Reagents |
| HY-130211 | Azido-PEG5-alcohol | 86770-68-5 | ADC Related |
| HY-130212 | Amobam | 3566-10-7 | Reference compound |
| HY-130212R | Amobam (Standard) | 3566-10-7 | Reference Standards |
| HY-130213 | Thiol-PEG4-acid | 749247-06-1 | Reference compound |
| HY-130214 | 7-Hydroxypestalotin | 41164-59-4 | Natural Products |
| HY-130216 | THP-PEG3-OH | 60221-37-6 | Reference compound |
| HY-130219 | 18-HETE | 133268-58-3 | Reference compound |
| HY-13022 | CC-401 (hydrochloride) | 1438391-30-0 | Reference compound |
| HY-130220 | (±)5-HETE lactone | 81517-87-5 | Reference compound |
| HY-130221 | (25S)-Δ7-Dafachronic acid | 949004-12-0 | Reference compound |
| HY-130222 | Mal-PEG2-Val-Cit-PAB-OH | 2055041-38-6 | ADC Related |
| HY-130223 | 11β-Prostaglandin E2 | 38310-90-6 | Reference compound |
| HY-130224 | Altromycin C | 128439-48-5 | Natural Products |
| HY-130225 | Cannabichromevarin | 41408-19-9 | Natural Products |
| HY-130226 | 11-epi-PGE1 | 24570-01-2 | Reference compound |
| HY-130228 | N3-PEG8-CH2COOH | 1343472-07-0 | Reference compound |
| HY-130229 | (±)5,6-DHET lactone | 213126-92-2 | Reference compound |
| HY-13022A | CC-401 | 395104-30-0 | Reference compound |
| HY-13022B | CC-401 (dihydrochloride) | 2319601-04-0 | Reference compound |
| HY-13023 | AMG-Tie2-1 | 870223-96-4 | Reference compound |
| HY-130230 | THP-PEG4-OH | 128660-97-9 | Reference compound |
| HY-130231 | m-PEG2-acid | 149577-05-9 | Reference compound |
| HY-130232 | Mal-amido-PEG2-TFP ester | 1431291-44-9 | Reference compound |
| HY-130233 | S516 | 1016543-77-3 | Reference compound |
| HY-130235 | Naprodoxime (hydrochloride) | 58033-22-0 | Reference compound |
| HY-130237 | Cinnamtannin B-1 | 88082-60-4 | Natural Products |
| HY-130237R | Cinnamtannin B-1 (Standard) | 88082-60-4 | Reference Standards |
| HY-130238 | (±)8-HDHA | 90780-54-4 | Reference compound |
| HY-130239 | 14(S)-HDHA | 119433-37-3 | Reference compound |
| HY-130239A | (±)14-HDHA | 87042-40-8 | Reference compound |
| HY-130239S | 14(S)-HDHA-d5 | Isotope-Labeled Compounds | |
| HY-13024 | Rebastinib | 1020172-07-9 | Reference compound |
| HY-130240 | GCN2-IN-6 | 2183470-09-7 | Reference compound |
| HY-130241 | Reverse transcriptase-IN-1 | 2380001-43-2 | Reference compound |
| HY-130242 | PXS-5120A | 2125955-70-4 | Reference compound |
| HY-130243 | RORγt Inverse agonist 6 | 1887161-80-9 | Reference compound |
| HY-130244 | BACE1-IN-5 | 2581114-83-0 | Reference compound |
| HY-130245 | PCSK9 degrader 1 | Reference compound | |
| HY-130245A | (R,R)-PCSK9 degrader 1 | 2216703-12-5 | Reference compound |
| HY-130246 | NF-56-EJ40 | 2380230-73-7 | Reference compound |
| HY-130246A | NF-56-EJ40 (hydrochloride) | 2728500-80-7 | Reference compound |
| HY-130247 | Flonoltinib | 2387765-27-5 | Reference compound |
| HY-130247A | Flonoltinib (TFA) | 2928093-29-0 | Reference compound |
| HY-130247B | Flonoltinib (monomaleate) | Reference compound | |
| HY-130247C | Flonoltinib (sulfate) | 2568842-57-7 | Reference compound |
| HY-130248 | BAY-899 | 2471967-92-5 | Reference compound |
| HY-130248B | (R)-BAY-899 | 2988191-40-6 | Reference compound |
| HY-130249 | BAY-298 | 2471978-97-7 | Reference compound |
| HY-13025 | HIV-1 integrase inhibitor | 544467-07-4 | Reference compound |
| HY-130250 | SR-4835 | 2387704-62-1 | Reference compound |
| HY-130251 | DS18561882 | 2227149-22-4 | Reference compound |
| HY-130252 | YQ128 | 2454246-18-3 | Reference compound |
| HY-130253 | IRAK4-IN-6 | 2454244-02-9 | Reference compound |
| HY-130254 | CSK-IN-1 | 2380027-49-4 | Reference compound |
| HY-130255 | BTK inhibitor 13 | 2376726-26-8 | Reference compound |
| HY-130256 | β-NF-JQ1 | 2380000-55-3 | Reference compound |
| HY-130257 | CP5V | 2509359-75-3 | Reference compound |
| HY-130258 | LC3-mHTT-IN-AN1 | 486443-73-6 | Reference compound |
| HY-130259 | LC3-mHTT-IN-AN2 | 7758-73-8 | Natural Products |
| HY-13026 | Idelalisib | 870281-82-6 | Reference compound |
| HY-130260 | KRAS inhibitor-4 | 2374152-69-7 | Reference compound |
| HY-130261 | Mcl-1 antagonist 1 | 2376775-05-0 | Reference compound |
| HY-130262 | PDE1-IN-3 | 2370966-46-2 | Reference compound |
| HY-130264 | HIF-2α-IN-2 | 1672666-82-8 | Reference compound |
| HY-130269 | β-Naphthoflavone-CH2-OH | 2752755-32-9 | Reference compound |
| HY-13026S | Idelalisib-d5 | 1830330-31-8 | Isotope-Labeled Compounds |
| HY-13027 | DAPT | 208255-80-5 | Reference compound |
| HY-130270 | AhR Ligand-Linker Conjugates 1 | 2380012-98-4 | Reference compound |
| HY-130271 | (S,R,S)-AHPC-PEG5-COOH | 2172820-14-1 | Reference compound |
| HY-130272 | Anti-MI/R injury agent 1 | 2387506-35-4 | Reference compound |
| HY-130278 | MitoPQ | 1821370-28-8 | Reference compound |
| HY-13027G | DAPT (GMP) | 208255-80-5 | GMP Small Molecules |
| HY-130280 | Ianthelliformisamine A (TFA) | 1643593-28-5 | Reference compound |
| HY-130281 | Ianthelliformisamine B (diTFA) | 1643593-29-6 | Natural Products |
| HY-130282 | Ianthelliformisamine C (ditrifluoroacetate) | 1643593-30-9 | Reference compound |
| HY-130283 | Methyltetrazine-Ph-NHS ester | 1644644-96-1 | Reference compound |
| HY-130284 | NF864 | 69606-09-3 | Reference compound |
| HY-130285 | 10(S),17(S)-DiHDHA | 871826-47-0 | Reference compound |
| HY-130286 | 10-Hydroxy-4(Z),7(Z),11(E),13(Z),16(Z),19(Z)-docosahexaenoic acid | 90780-50-0 | Natural Products |
| HY-130287 | (±)16-HDHA | 90780-51-1 | Natural Products |
| HY-130288 | (±)13-HDHA | 90780-53-3 | Reference compound |
| HY-130289 | (±)4-HDHA | 90906-40-4 | Reference compound |
| HY-130290 | Biotin-PEG4-OH | 1217609-84-1 | Reference compound |
| HY-130291 | Biotin-PEG3-NHS ester | 1253286-56-4 | Reference compound |
| HY-130292 | m-PEG-acid | 125220-94-2 | Reference compound |
| HY-130293 | Propargyl-PEG4-CH2CH2-Boc | 1245823-50-0 | ADC Related |
| HY-130294 | Pyracrenic acid | 80832-44-6 | Natural Products |
| HY-130295 | Pomalidomide-PEG2-Tos | 2599846-07-6 | Reference compound |
| HY-130296 | Palbociclib-propargyl | 2366269-23-8 | Reference compound |
| HY-130297 | PROTAC BCR-ABL1 ligand 1 | 2489876-34-6 | Reference compound |
| HY-130298 | Amino-PEG11-OH | 15332-94-2 | ADC Related |
| HY-13030 | (+)-JQ-1 | 1268524-70-4 | Reference compound |
| HY-130302 | Integracin A | 224186-03-2 | Natural Products |
| HY-130304 | 8-Isoprostaglandin E2 | 27415-25-4 | Reference compound |
| HY-130304S | 8-Isoprostaglandin E2-d4 | Isotope-Labeled Compounds | |
| HY-130307 | Rubrofusarin | 3567-00-8 | Natural Products |
| HY-130309 | (±)8(9)-EpETE | 851378-93-3 | Reference compound |
| HY-13030A | (R)-(-)-JQ1 Enantiomer | 1268524-71-5 | Reference compound |
| HY-13031 | GW 841819X | 146135-18-4 | Reference compound |
| HY-130310 | 11(R)-HEDE | 330800-88-9 | Reference compound |
| HY-130310A | 11(S)-HEDE | 330800-90-3 | Reference compound |
| HY-130310B | (±)11-HEDE | 5598-37-8 | Reference compound |
| HY-130311 | 2-Linoleoyl glycerol | 3443-82-1 | Reference compound |
| HY-130312 | N-(Azido-PEG4)-N-Boc-PEG4-NHS ester | 2112731-96-9 | Reference compound |
| HY-130313 | Sodium lauroyl glutamate | 29923-31-7 | Reference compound |
| HY-130313R | Sodium lauroyl glutamate (Standard) | 29923-31-7 | Reference Standards |
| HY-130314 | PPHP | 87864-20-8 | Reference compound |
| HY-130315 | Br-PEG4-C2-Boc | 564476-32-0 | ADC Related |
| HY-130317 | trans-11-Methyl-2-dodecenic acid | 677354-24-4 | Reference compound |
| HY-130318 | Quinidine N-oxide | 70116-00-6 | Reference compound |
| HY-130319 | 9(S)-HEPE | 141545-44-0 | Reference compound |
| HY-130319A | 9-HEPE | 286390-03-2 | Reference compound |
| HY-13032 | Molibresib | 1260907-17-2 | Reference compound |
| HY-130320 | Monophosphoryl lipid A | 1246298-63-4 | Reference compound |
| HY-130320A | Monophosphoryl lipid A (free acid) | 960324-04-3 | Reference compound |
| HY-130320B | Monophosphoryl lipid A (Triethylamine) | Reference compound | |
| HY-130321 | Lauroyl-L-carnitine (chloride) | 6919-91-1 | Reference compound |
| HY-130321S | Lauroyl-L-carnitine-d3 (chloride) | 2687960-76-3 | Isotope-Labeled Compounds |
| HY-130321S1 | Lauroyl-L-carnitine-d9 (chloride) | 2245711-25-3 | Isotope-Labeled Compounds |
| HY-130322 | Maresin Conjugates in Tissue Regeneration 2 | 1784701-62-7 | Reference compound |
| HY-130323 | 13-HPOT | 67597-26-6 | Reference compound |
| HY-130324 | Azido-PEG7-amine | 1333154-77-0 | ADC Related |
| HY-130325 | α-Guanidinoglutaric acid | 73477-53-9 | Reference compound |
| HY-130326 | RAPTA-C | 372948-28-2 | Reference compound |
| HY-130328 | NH-bis-PEG2 | 54384-47-3 | ADC Related |
| HY-13032A | GSK 525768A | 1260530-25-3 | Reference compound |
| HY-13032B | Molibresib (besylate) | 1895049-20-3 | Reference compound |
| HY-13033 | CDK-IN-2 | 1269815-17-9 | Reference compound |
| HY-130330 | Ald-CH2-PEG5-Boc | 1446282-23-0 | Reference compound |
| HY-130332 | Mitomycin A | 4055-39-4 | Reference compound |
| HY-130333 | Tetrahydrohomofolic acid | 5786-82-3 | Reference compound |
| HY-130334 | Mal-PEG8-acid | 1818294-46-0 | Reference compound |
| HY-130335 | Encainide | 66778-36-7 | Reference compound |
| HY-130336 | m-PEG6-Tos | 155887-96-0 | Reference compound |
| HY-130337 | Teicoplanin A2-2 | 91032-26-7 | Reference compound |
| HY-130338 | Teicoplanin A2-3 | 91032-36-9 | Reference compound |
| HY-130339 | Teicoplanin A2-4 | 91032-37-0 | Reference compound |
| HY-13034 | Gandotinib | 1229236-86-5 | Reference compound |
| HY-130340 | Teicoplanin A3-1 | 93616-27-4 | Reference compound |
| HY-130342 | HO-PEG11-OH | 6809-70-7 | Reference compound |
| HY-130343 | 5-Methylmellein | 7734-92-1 | Biochemical Assay Reagents |
| HY-130344 | SKF 83959 | 80751-85-5 | Reference compound |
| HY-130345 | PAF (C18) | 74389-69-8 | Biochemical Assay Reagents |
| HY-130345S | C18-PAF-d4 | Isotope-Labeled Compounds | |
| HY-130346 | DBCO-PEG4-DBCO | 2182601-68-7 | ADC Related |
| HY-130347 | H2S Donor 5a | 134861-13-5 | Reference compound |
| HY-130348 | OPSS-PEG8-COOH | 1334177-96-6 | Reference compound |
| HY-130349 | Emamectin B1a | 121124-29-6 | Reference compound |
| HY-130350 | DNP-PEG3-DNP | 1365655-92-0 | Reference compound |
| HY-130351 | 25H-NBOMe (hydrochloride) | 1566571-52-5 | Reference compound |
| HY-130352 | 9-SAHSA | 1895916-79-6 | Reference compound |
| HY-130353 | Desethylamiodarone (hydrochloride) | 96027-74-6 | Reference compound |
| HY-130353R | Desethylamiodarone (hydrochloride) (Standard) | 96027-74-6 | Reference Standards |
| HY-130353S | Desethyl Amiodarone-d4 (hydrochloride) | 1189960-80-2 | Isotope-Labeled Compounds |
| HY-130354 | Dibutyryl-cGMP (sodium) | 51116-00-8 | Reference compound |
| HY-130356 | 5-trans U-46619 | 330796-58-2 | Reference compound |
| HY-130357 | 15(S)-HETE Ethanolamide | 161744-53-2 | Reference compound |
| HY-130358 | PDDHV | 179469-40-0 | Reference compound |
| HY-13036 | (Rac)-IBT6A | 1412418-47-3 | Reference compound |
| HY-130361 | Isoxadifen-ethyl | 163520-33-0 | Reference compound |
| HY-130361R | Isoxadifen-ethyl (Standard) | 163520-33-0 | Reference Standards |
| HY-130364 | Fmoc-NH-PEG6-CH2COOH | 437655-96-4 | ADC Related |
| HY-130365 | Tixocortol pivalate | 55560-96-8 | Reference compound |
| HY-130366 | JG-365 | 132748-20-0 | Reference compound |
| HY-130367 | U-48520 | 67579-11-7 | Reference compound |
| HY-130368 | W-7 | 65595-90-6 | Reference compound |
| HY-130369 | NSC10010 (hydrochloride) | 6286-09-5 | Reference compound |
| HY-13036A | IBT6A | 1022150-12-4 | Reference compound |
| HY-13036B | IBT6A (hydrochloride) | 1553977-42-6 | Reference compound |
| HY-13036C | (Rac)-IBT6A (hydrochloride) | 1807619-60-8 | Reference compound |
| HY-130372 | Propargyl-PEG9-bromide | 2055042-83-4 | ADC Related |
| HY-130373 | Propargyl-PEG9-amine | 2093153-98-9 | Reference compound |
| HY-130374 | Propargyl-PEG8-OH | 1351556-81-4 | Reference compound |
| HY-130375 | Propargyl-PEG8-Boc | 2055014-96-3 | Reference compound |
| HY-130376 | Propargyl-PEG8-NHS ester | 2182601-74-5 | ADC Related |
| HY-130377 | Propargyl-PEG8-bromide | 2055046-25-6 | ADC Related |
| HY-130378 | Propargyl-PEG7-alcohol | 1422023-54-8 | Reference compound |
| HY-130379 | Propargyl-PEG8-acid | 2055014-94-1 | ADC Related |
| HY-13038 | Fostamatinib Disodium | 1025687-58-4 | Reference compound |
| HY-130380 | Propargyl-PEG7-Boc | 1818294-29-9 | Reference compound |
| HY-130381 | Propargyl-PEG7-NHS ester | 2093152-77-1 | ADC Related |
| HY-130382 | Propargyl-PEG6-alcohol | 944560-99-0 | Reference compound |
| HY-130383 | Propargyl-PEG7-acid | 2093154-00-6 | ADC Related |
| HY-130384 | Propargyl-PEG6-Boc | 1355197-95-3 | Reference compound |
| HY-130385 | Propargyl-PEG6-NHS ester | 2093153-99-0 | ADC Related |
| HY-130386 | Propargyl-PEG6-acid | 1951438-84-8 | ADC Related |
| HY-130387 | Propargyl-PEG4-Tos | 875770-32-4 | ADC Related |
| HY-130388 | Propargyl-PEG5-NHS ester | 1393330-40-9 | ADC Related |
| HY-130389 | Propargyl-PEG4-O-C1-Boc | 2098489-63-3 | Reference compound |
| HY-13038A | Fostamatinib | 901119-35-5 | Reference compound |
| HY-13038AR | Fostamatinib (Standard) | 901119-35-5 | Reference Standards |
| HY-13038B | Fostamatinib (disodium hexahydrate) | 914295-16-2 | Reference compound |
| HY-13039 | (2S,3R,4R)-2,3,5-Tris(benzyloxy)-4-hydroxypentanal | 7597-81-1 | Biochemical Assay Reagents |
| HY-130390 | Propargyl-PEG4-O-C1-NHS ester | 1161883-51-7 | Reference compound |
| HY-130391 | MMP12-IN-3 | 208663-26-7 | Reference compound |
| HY-130392 | Wofapyrin | 8066-94-2 | Reference compound |
| HY-130393 | 3C-B-FLY (hydrochloride) | 178557-19-2 | Reference compound |
| HY-130394 | 2C-B-FLY (hydrochloride) | 178557-21-6 | Reference compound |
| HY-130395 | 15-Keto latanoprost | 135646-98-9 | Reference compound |
| HY-130396 | DBCO-PEG4-C2-acid | 1537170-85-6 | Reference compound |
| HY-130397 | Pyrene-amido-PEG4-CH2CH2COOH | 1817735-34-4 | Reference compound |
| HY-130398 | Aerophobin-2 | 87075-23-8 | Natural Products |
| HY-130399 | Mal-amido-PEG6-acid | 1334177-79-5 | Reference compound |
| HY-13040 | N-Benzoyl-5'-O-dmtr-2'-O-(2-methoxyethyl)-adenosine | 251647-48-0 | Reference compound |
| HY-130402A | Propamidine (isethionate) | 140-63-6 | Reference compound |
| HY-130402B | Propamidine | 104-32-5 | Reference compound |
| HY-130403 | Leptocarpin acetate | 73522-57-3 | Natural Products |
| HY-130404 | m-PEG3-Boc | 1778219-81-0 | Reference compound |
| HY-130405 | PtdIns-(1,2-dipalmitoyl) (ammonium) | 34290-57-8 | Reference compound |
| HY-130406 | Benthiavalicarb isopropyl | 177406-68-7 | Reference compound |
| HY-130407 | Lipoamido-PEG3-OH | 1342764-64-0 | Reference compound |
| HY-130408 | m-PEG6-Amine | 184357-46-8 | ADC Related |
| HY-130409 | Kelevan | 4234-79-1 | Reference compound |
| HY-13041 | LX-1031 | 945976-76-1 | Reference compound |
| HY-130410 | Bis-PEG6-NHS ester | 1526718-98-8 | ADC Related |
| HY-130411 | Amino-PEG11-amine | 479200-82-3 | Reference compound |
| HY-130412 | FlAsH-EDT2 | 212118-77-9 | Dye Reagents |
| HY-130413 | Protectin D1 | 660430-03-5 | Reference compound |
| HY-130414 | Mal-amido-PEG4-acid | 1263045-16-4 | Reference compound |
| HY-130415 | Tos-PEG2-CH2COOH | 1807537-35-4 | Reference compound |
| HY-130416 | Mal-PEG2-PFP ester | 1807512-47-5 | Reference compound |
| HY-130417 | Tos-PEG4-acid | 1453117-42-4 | Reference compound |
| HY-130418 | (-)-Domesticine | 54325-07-4 | Reference compound |
| HY-130419 | (±)13(14)-EpDPA | 895127-64-7 | Reference compound |
| HY-130420 | Azido-PEG5-PFP ester | 1818294-48-2 | Reference compound |
| HY-130422 | Tos-PEG4-t-butyl ester | 217817-01-1 | Reference compound |
| HY-130423 | Milbemycin A3 | 51596-10-2 | Reference compound |
| HY-130423R | Milbemycin A3 (Standard) | 51596-10-2 | Reference Standards |
| HY-130424 | m-PEG10-azide | 2112738-12-0 | Reference compound |
| HY-130425 | Bromo-PEG1-acid | 1393330-33-0 | Reference compound |
| HY-130426 | Maleimido-tri(ethylene glycol)-propionic acid | 518044-40-1 | ADC Related |
| HY-130429 | 14,15-Leukotriene C4 | 75290-60-7 | Natural Products |
| HY-130430 | Neplanocin A | 72877-50-0 | Natural Products |
| HY-130431 | Vinclozolin M2 | 83792-61-4 | Reference compound |
| HY-130432 | DBO-83 (dihydrochloride) | 195211-53-1 | Reference compound |
| HY-130433 | NBD Sphingosine | 1449370-25-5 | Dye Reagents |
| HY-130434 | 12-SAHSA | 51350-61-9 | Reference compound |
| HY-130435 | DBCO-PEG4-amine | 1840886-10-3 | ADC Related |
| HY-130436 | Acid-C2-PEG4-C2-NHS ester | 1343476-41-4 | Reference compound |
| HY-130437 | p-nitro-Pifithrin-α | 389850-21-9 | Reference compound |
| HY-130438 | EUK-118 | 186299-34-3 | Reference compound |
| HY-130439 | EUK-124 | 186299-35-4 | Reference compound |
| HY-13044 | ADL-5859 (hydrochloride) | 850173-95-4 | Reference compound |
| HY-130440 | Leukotriene F4 | 83851-42-7 | Reference compound |
| HY-130441 | Leukotriene B3 | 88099-35-8 | Natural Products |
| HY-130442 | Mal-PEG2-acid | 1374666-32-6 | ADC Related |
| HY-130443 | Cbz-NH-PEG6-C2-acid | 1334177-80-8 | Reference compound |
| HY-130444 | PTA2 | 71111-01-8 | Biochemical Assay Reagents |
| HY-130445 | m-PEG3-CH2COOH | 16024-60-5 | Reference compound |
| HY-130446 | m-PEG9-NHS ester | 1316189-13-5 | Reference compound |
| HY-130447 | Amino-PEG5-amine | 72236-26-1 | Reference compound |
| HY-130448 | 8-iso Prostaglandin F1β | 26771-95-9 | Reference compound |
| HY-130449 | N-Boc-N-bis(PEG4-OH) | 2093154-01-7 | ADC Related |
| HY-130452 | NOS1-IN-1 | 357965-99-2 | Reference compound |
| HY-130454 | Mal-PEG6-PFP ester | 1599486-33-5 | Reference compound |
| HY-130456 | AHR 10718 | 96436-73-6 | Reference compound |
| HY-130457 | m-PEG4-MS | 130955-37-2 | ADC Related |
| HY-130458 | EGNHS | 70539-42-3 | Reference compound |
| HY-130462 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC | 26853-31-6 | Natural Products |
| HY-130462R | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC (Standard) | 26853-31-6 | Reference Standards |
| HY-130462S | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 | 179093-76-6 | Isotope-Labeled Compounds |
| HY-130462S1 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82 | 2260669-94-9 | Isotope-Labeled Compounds |
| HY-130462S2 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-13C16 | 2692624-41-0 | Isotope-Labeled Compounds |
| HY-130462S3 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64 | 2921921-66-4 | Isotope-Labeled Compounds |
| HY-130463 | POPG (sodium salt) | 268550-95-4 | Reference compound |
| HY-130465 | 7α-Thiospironolactone | 38753-76-3 | Reference compound |
| HY-130466 | Stearoyl-L-carnitine (chloride) | 32350-57-5 | Reference compound |
| HY-130466S | Stearoyl-L-carnitine-d3 (chloride) | 2245711-27-5 | Isotope-Labeled Compounds |
| HY-130467 | DNP-NH-PEG2-C2-acid | 1353011-89-8 | Reference compound |
| HY-130468 | Leptosin J | 160550-15-2 | Reference compound |
| HY-130469 | Mal-PEG4-Boc | 518044-36-5 | Reference compound |
| HY-13047 | S-(+)-Mecamylamine (hydrochloride) | 107596-30-5 | Reference compound |
| HY-130470 | Chloroacetamido-PEG4-C2-Boc | 1365655-90-8 | Reference compound |
| HY-130471 | Sannamycin C | 73522-71-1 | Reference compound |
| HY-130473 | Tos-PEG4-CH2COOH | 2028284-73-1 | Reference compound |
| HY-130474 | Azido-PEG6-NHS ester | 2055014-64-5 | ADC Related |
| HY-130475 | Azido-PEG9-acid | 1670249-37-2 | ADC Related |
| HY-130476 | Satratoxin G | 53126-63-9 | Natural Products |
| HY-130477 | Fmoc-Lys (biotin-PEG4)-OH | 1334172-64-3 | Reference compound |
| HY-130478 | m-PEG4-CH2COOH | 16024-66-1 | Reference compound |
| HY-130479 | AdipoR agonist 1 | 949745-75-9 | Reference compound |
| HY-13047A | rel-S-(+)-Mecamylamine (hydrochloride) | 110691-49-1 | Reference compound |
| HY-130480 | Fructose-arginine | 25020-14-8 | Reference compound |
| HY-130481 | Propargyl-PEG4-acid | 1415800-32-6 | Reference compound |
| HY-130482 | Salvinorin A carbamate | 858345-57-0 | Reference compound |
| HY-130483 | Br-PEG3-C2-Boc | 782475-37-0 | Reference compound |
| HY-130484 | 2,3-Dehydro-3,4-dihydro ivermectin | 1135339-49-9 | Reference compound |
| HY-130485 | Bromo-PEG2-C2-azide | 530151-56-5 | ADC Related |
| HY-130486 | NH2-PEG6-Boc | 1286281-32-0 | ADC Related |
| HY-130487 | miR-21-IN-2 | 304880-74-8 | Reference compound |
| HY-130488 | Hydroxy-PEG2-C2-PFP ester | 1820673-42-4 | Reference compound |
| HY-130489 | Bromo-PEG5-C2-acid | 1817735-27-5 | Reference compound |
| HY-13049 | Cediranib (maleate) | 857036-77-2 | Reference compound |
| HY-130490 | Biotin-bis-amido-SS-NHS | 142439-92-7 | Reference compound |
| HY-130491 | DNP-NH-PEG4-C2-Boc | 1817735-31-1 | Reference compound |
| HY-130492 | ARCC-4 | 1973403-00-7 | Reference compound |
| HY-130493 | HPB | 1800066-24-3 | Reference compound |
| HY-130494 | (±)11(12)-EET | 87173-81-7 | Reference compound |
| HY-130494S | (±)11(12)-EET-d11 | 2699607-19-5 | Isotope-Labeled Compounds |
| HY-130495 | CDDO-TFEA | 932730-52-4 | Reference compound |
| HY-130496 | Ald-Ph-PEG6-acid | 2055013-55-1 | Reference compound |
| HY-130497 | 12-Oxo-leukotriene B4 | 136696-10-1 | Reference compound |
| HY-130499 | ERRα Ligand-Linker Conjugates 1 | Reference compound | |
| HY-13050 | Sapitinib | 848942-61-0 | Reference compound |
| HY-130500 | Br-PEG3-CH2COOH | 1346502-15-5 | Reference compound |
| HY-130502 | 5β,6β-epoxycholestanol | 4025-59-6 | Biochemical Assay Reagents |
| HY-130503 | N-Boc-PEG1-bromide | 164332-88-1 | ADC Related |
| HY-130504 | Propargyl-PEG1-acid | 55683-37-9 | Reference compound |
| HY-130505 | N-Boc-PEG7-alcohol | 1292268-13-3 | ADC Related |
| HY-130506 | Glutamic acid diethyl ester | 16450-41-2 | Reference compound |
| HY-130507 | Aminooxy-PEG5-azide | 1919045-02-5 | Reference compound |
| HY-130508 | Methyltetrazine-Ph-PEG4-azide | 1802908-04-8 | Reference compound |
| HY-130509 | MTSSL | 81213-52-7 | Reference compound |
| HY-13050A | Sapitinib (fumarate) | 1196531-39-1 | Reference compound |
| HY-130511 | FCE 22250 | 86737-06-6 | Reference compound |
| HY-130512 | Br-PEG4-OH | 85141-94-2 | Reference compound |
| HY-130513 | m-PEG7-Boc | 874208-90-9 | Reference compound |
| HY-130514 | SMAPP1 | 327081-00-5 | Reference compound |
| HY-130515 | Cdc7-IN-3 | 1402057-87-7 | Reference compound |
| HY-130516 | Cdc7-IN-4 | 1402059-21-5 | Reference compound |
| HY-130517 | Cdc7-IN-5 | 1402057-86-6 | Reference compound |
| HY-130519 | Cdc7-IN-7 | 1402059-17-9 | Reference compound |
| HY-13052 | SB-737050A | 583045-76-5 | Reference compound |
| HY-130520 | Bromoacetamido-PEG4-C2-Boc | 1807521-00-1 | Reference compound |
| HY-130521 | Pomalidomide-amido-PEG3-C2-NH2 | 2328070-52-4 | Reference compound |
| HY-130522 | 6β-Prostaglandin I1 | 62770-50-7 | Reference compound |
| HY-130523 | Tos-PEG5-Boc | 581065-94-3 | Reference compound |
| HY-130524 | Amino-PEG4-CH2COOH | 195071-49-9 | ADC Related |
| HY-130525 | Iodo-PEG3-N3 | 936917-36-1 | Reference compound |
| HY-130526 | Tos-PEG6-CH2-Boc | 1530777-90-2 | Reference compound |
| HY-130527 | Ald-Ph-PEG4-NH-Boc | 2110449-01-7 | Reference compound |
| HY-130528 | m-PEG7-MS | 477775-57-8 | ADC Related |
| HY-130529 | OH-α-PVP (TFA) | 1797986-63-0 | Reference compound |
| HY-13053 | Depulfavirine | 867365-76-2 | Reference compound |
| HY-130530 | AP-C5 | 2234272-10-5 | Reference compound |
| HY-130531 | NH-bis(C2-PEG2-NH-Boc) | 2182601-69-8 | Reference compound |
| HY-130532 | Tos-PEG2-CH2-Boc | 882518-89-0 | Reference compound |
| HY-130533 | ReAsH-EDT2 | 438226-89-2 | Dye Reagents |
| HY-130534 | Tos-PEG2-Boc | 1309666-78-1 | Reference compound |
| HY-130536 | Br-PEG4-CH2-Boc | 1807505-29-8 | Reference compound |
| HY-130537 | Azido-PEG6-alcohol | 86770-69-6 | ADC Related |
| HY-130538 | 1-Naphthohydroxamic acid | 6953-61-3 | Reference compound |
| HY-130541 | Propargyl-PEG2-OH | 7218-43-1 | Reference compound |
| HY-130542 | Thiol-PEG8-acid | 866889-02-3 | Reference compound |
| HY-130543 | 1,1,1-Trifluoroethyl-PEG4-azide | 1817735-35-5 | Reference compound |
| HY-130544 | 5-Azidopentanoic acid | 79583-98-5 | Reference compound |
| HY-130545 | 3-(Pyridin-2-yldisulfanyl)propanehydrazide | 115616-51-8 | Reference compound |
| HY-130546 | Hydroxy-PEG3-SS-PEG3-alcohol | 5662-81-7 | ADC Related |
| HY-130547 | BS2G Crosslinker (disodium) | 881415-72-1 | ADC Related |
| HY-130547A | BS2G Crosslinker | 215597-83-4 | Reference compound |
| HY-130547S | BS2G Crosslinker-d4 (disodium) | 910292-86-3 | Isotope-Labeled Compounds |
| HY-130548 | m-PEG6-2-methylacrylate | 90784-86-4 | Reference compound |
| HY-130549 | Acid-PEG3-C2-Boc | 1807539-06-5 | Reference compound |
| HY-13055 | Telotristat etiprate | 1137608-69-5 | Reference compound |
| HY-130550 | (±)7(8)-EpDPA | 895127-66-9 | Natural Products |
| HY-130551 | Tetrazine-Ph-PEG5-NHS ester | 1682653-80-0 | Reference compound |
| HY-130553 | β-Spaglumic acid | 4910-46-7 | Reference compound |
| HY-130554 | m-PEG9-phosphonic acid | 2055016-25-4 | Reference compound |
| HY-130555 | PEG8-Tos | 886469-23-4 | Reference compound |
| HY-130557 | endo-BCN-PEG2-acid | 1993134-72-7 | Reference compound |
| HY-13055A | Telotristat ethyl | 1033805-22-9 | Reference compound |
| HY-13055B | Telotristat | 1033805-28-5 | Reference compound |
| HY-13055BR | Telotristat (Standard) | 1033805-28-5 | Reference Standards |
| HY-13055E | Telotristat (besilate) | 1374745-52-4 | Reference compound |
| HY-13056 | SMND-309 | 1065559-56-9 | Reference compound |
| HY-130560 | Biotin-PEG3-propionic hydrazide | 1381861-94-4 | Reference compound |
| HY-130561 | m-PEG7-azide | 208987-04-6 | Reference compound |
| HY-130563 | Propargyl-PEG3-CH2COOH | 1694731-93-5 | Reference compound |
| HY-130564 | Didemnin C | 77327-06-1 | Reference compound |
| HY-130567 | 1-Monoarachidin | 35474-99-8 | Reference compound |
| HY-130567S | 1-Arachidonoylglycerol-d8 | 2692624-29-4 | Isotope-Labeled Compounds |
| HY-130568 | Mal-PEG1-PFP ester | 1807530-08-0 | Reference compound |
| HY-130569 | 7-Hydroxymethotrexate | 5939-37-7 | Reference compound |
| HY-130569S | 7-Hydroxymethotrexate-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-130569S1 | 7-Hydroxymethotrexate-d3 | 432545-62-5 | Isotope-Labeled Compounds |
| HY-130569S2 | 7-Hydroxymethotrexate-d3 (ammonium) | Isotope-Labeled Compounds | |
| HY-13056R | SMND-309 (Standard) | 1065559-56-9 | Reference Standards |
| HY-13057 | O6BTG-octylglucoside | 382607-78-5 | Reference compound |
| HY-130570 | β-Gal-NONOate | 357192-77-9 | Reference compound |
| HY-130571 | m-PEG9-Amine | 211859-73-3 | ADC Related |
| HY-130572 | Azido-PEG5-acid | 1425973-16-5 | ADC Related |
| HY-130573 | DMAPP | 358-72-5 | Natural Products |
| HY-130573A | DMAPP (triammonium) | 1186-30-7 | Reference compound |
| HY-130574 | MnTE-2-PyP (chloride) | 219818-60-7 | Reference compound |
| HY-130575 | Fura-FF AM | 348079-12-9 | Dye Reagents |
| HY-130576 | POVPC | 121324-31-0 | Reference compound |
| HY-130577 | Amino-PEG5-CH2COOH | 141282-35-1 | Reference compound |
| HY-130578 | m-PEG2-azide | 215181-61-6 | Reference compound |
| HY-130579 | Vinyl-L-NIO (hydrochloride) | 728944-69-2 | Reference compound |
| HY-13058 | ADX-47273 | 851881-60-2 | Reference compound |
| HY-130580 | Thiol-PEG6-alcohol | 194425-46-2 | Reference compound |
| HY-130581 | Lipid X | 86559-73-1 | Reference compound |
| HY-130584 | Propargyl-PEG2-MS | 943726-01-0 | Reference compound |
| HY-130585S | Estradiol undecylate-13C3 | 2482467-27-4 | Isotope-Labeled Compounds |
| HY-130586 | Mal-PEG3-PFP ester | 1807534-78-6 | Reference compound |
| HY-130587 | Sultosilic acid (piperazine salt) | 57775-27-6 | Reference compound |
| HY-130588 | Glutathione arsenoxide | 1271726-51-2 | Reference compound |
| HY-130588A | Glutathione arsenoxide (TFA) | Reference compound | |
| HY-130589 | Bromo-PEG2-bromide | 31255-10-4 | Reference compound |
| HY-13058B | (R)-ADX-47273 | 851881-59-9 | Reference compound |
| HY-13059 | SDZ 220-581 | 174575-17-8 | Reference compound |
| HY-130591 | Propargyl-PEG4-Br | 1308299-09-3 | ADC Related |
| HY-130592 | Compound 48/80 (trihydrochloride) | 848035-21-2 | Reference compound |
| HY-130594 | 6α-Prostaglandin I1 | 62777-90-6 | Reference compound |
| HY-130595 | Benzyl-PEG4-acid | 127457-64-1 | Reference compound |
| HY-130596 | DC-86-M | 94448-15-4 | Natural Products |
| HY-130597 | Propargyl-PEG2-Boc | 1807503-80-5 | Reference compound |
| HY-130598 | N-(Azido-PEG3)-N-Boc-PEG4-acid | 2112731-95-8 | Reference compound |
| HY-130599 | Hydroxy-PEG2-CH2-Boc | 149299-82-1 | Reference compound |
| HY-13059A | SDZ 220-581 (Ammonium salt) | 179411-94-0 | Reference compound |
| HY-13059B | SDZ 220-581 (hydrochloride) | 179411-93-9 | Reference compound |
| HY-13060 | ACHP (Hydrochloride) | 406209-26-5 | Reference compound |
| HY-130600 | HO-PEG17-OH | 351342-04-6 | Reference compound |
| HY-130601 | Thiol-PEG5-thiol | 89141-22-0 | Biochemical Assay Reagents |
| HY-130602 | MS432 | 2672512-44-4 | Reference compound |
| HY-130603 | DCZ0415 | 2242470-43-3 | Reference compound |
| HY-130604 | DT2216 | 2365172-42-3 | Reference compound |
| HY-130605 | BAY-1797 | 2055602-83-8 | Reference compound |
| HY-130606 | Nampt-IN-5 | 2380013-17-0 | Reference compound |
| HY-130607 | IDO1-IN-2 | 2346614-58-0 | Reference compound |
| HY-130608 | Mutated EGFR-IN-3 | 2375107-27-8 | Reference compound |
| HY-130609 | Aβ42-IN-1 | 2582757-69-3 | Reference compound |
| HY-130609A | Aβ42-IN-1 (free base) | 2434633-17-5 | Reference compound |
| HY-13061 | Daun02 | 290304-24-4 | ADC Related |
| HY-130612 | PROTAC BRD2/BRD4 degrader-1 | 2570470-42-5 | Reference compound |
| HY-130613 | MAC-545496 | 838810-96-1 | Reference compound |
| HY-130614 | PROTAC EED degrader-1 | 2639882-72-5 | Reference compound |
| HY-130615 | PROTAC EED degrader-2 | 2639882-69-0 | Reference compound |
| HY-130616 | EGFR-IN-11 | 2463200-44-2 | Reference compound |
| HY-130617 | Pomalidomide-amido-C1-Br | 2351106-38-0 | Reference compound |
| HY-130618 | Boc-C1-PEG3-C4-OH | 2376724-97-7 | Reference compound |
| HY-130619 | Boc-C1-PEG3-C4-OBn | 2381196-81-0 | Reference compound |
| HY-13062 | Daunorubicin (hydrochloride) | 23541-50-6 | Natural Products |
| HY-130620 | PEG3-C4-OBn | 2381196-79-6 | Reference compound |
| HY-130621 | OTs-C6-OBn | 126519-80-0 | Reference compound |
| HY-130622 | LT052 | 2543545-44-2 | Reference compound |
| HY-130624 | Hsp90-Cdc37-IN-2 | 2413849-81-5 | Reference compound |
| HY-130625 | PD-1/PD-L1-IN 6 | 2393983-76-9 | Reference compound |
| HY-130626 | RSV/IAV-IN-1 | 2395007-77-7 | Reference compound |
| HY-130627 | RSV/IAV-IN-2 | 2395007-75-5 | Reference compound |
| HY-130628 | PAK4-IN-1 | 2396529-58-9 | Reference compound |
| HY-13062A | Daunorubicin | 20830-81-3 | Natural Products |
| HY-13062R | Daunorubicin (hydrochloride) (Standard) | 23541-50-6 | Reference Standards |
| HY-13063 | Sodium formononetin-3'-sulfonate | 949021-68-5 | Reference compound |
| HY-130630 | mGluR2 modulator 1 | 2671063-84-4 | Reference compound |
| HY-130631 | SHP2-IN-5 | 54755-93-0 | Reference compound |
| HY-130637 | Boc-NH-PEG1-Ph-O-CH2COOH | 2361117-22-6 | Reference compound |
| HY-130638 | (S,R,S)-AHPC-O-Ph-PEG1-NH-Boc | 2409007-40-3 | Reference compound |
| HY-130639 | Thalidomide-NH-C4-NH-Boc | 2093388-52-2 | Reference compound |
| HY-13064 | Cobimetinib | 934660-93-2 | Reference compound |
| HY-130640 | (S,R,S)-AHPC-Me-C7 ester | 2639528-48-4 | Reference compound |
| HY-130641 | Br-C10-methyl ester | 6287-90-7 | Reference compound |
| HY-130642 | (S,R,S)-AHPC-Me-C10-Br | 2836297-55-1 | Reference compound |
| HY-130643 | PERK-IN-3 | 1337532-08-7 | Reference compound |
| HY-130644 | iRucaparib-AP6 | 2410557-00-3 | Reference compound |
| HY-130648 | Thalidomide-NH-PEG7 | 2641838-98-2 | ADC Related |
| HY-13064A | Cobimetinib (hemifumarate) | 1369665-02-0 | Reference compound |
| HY-13064S1 | Cobimetinib-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13065 | Isobavachalcone | 20784-50-3 | Natural Products |
| HY-130651 | 5-Hexynal | 29329-03-1 | Reference compound |
| HY-130652 | Pomalidomide 4'-PEG3-azide | 2271036-46-3 | Reference compound |
| HY-130653 | Azido-PEG4-C2-acid | 1257063-35-6 | ADC Related |
| HY-130654 | (S,R,S)-AHPC-C2-PEG4-N3 | 2597167-24-1 | Reference compound |
| HY-130656 | 8(Z)-Eicosenoic acid | 76261-96-6 | Natural Products |
| HY-130656A | 8(E)-Eicosenoic acid | 82683-14-5 | Reference compound |
| HY-130657 | m-PEG5-nitrile | 81836-41-1 | Reference compound |
| HY-130658 | D-NMMA (acetate) | 137694-75-8 | Reference compound |
| HY-130659 | Amino-PEG8-amine | 82209-36-7 | Reference compound |
| HY-13065R | Isobavachalcone (Standard) | 20784-50-3 | Reference Standards |
| HY-130660 | Prostaglandin F2α ethanolamide | 353787-70-9 | Reference compound |
| HY-130662 | Hydroxy-PEG8-Boc | 1334177-84-2 | Reference compound |
| HY-130665 | TL12-186 | 2250025-88-6 | Reference compound |
| HY-130666 | Chlorambucyl-proline | 81050-71-7 | Reference compound |
| HY-130667 | Ald-Ph-amido-C2-PEG3-azide | 1807540-88-0 | Reference compound |
| HY-130668 | Cyanidin arabinoside | 792868-19-0 | Natural Products |
| HY-130669 | Ald-Ph-amido-C2-PEG3-NH-Boc | 1807540-87-9 | Reference compound |
| HY-13067 | Celastrol | 34157-83-0 | Natural Products |
| HY-130670 | CGP 54626A (free base) | 149936-58-3 | Reference compound |
| HY-130671A | L-DPPG | 1190099-61-6 | Reference compound |
| HY-130671B | (S,S)-DPPG | Reference compound | |
| HY-130671S | L-DPPG-d9 (free base) | Isotope-Labeled Compounds | |
| HY-130672 | Hydroxy-PEG3-NHS | 1807518-71-3 | Reference compound |
| HY-130673 | L-NABE | 7672-27-7 | Reference compound |
| HY-130674 | Tos-PEG3-CH2COOH | 1581248-63-6 | Reference compound |
| HY-130675 | (±)15-HEPE | 88852-33-9 | Natural Products |
| HY-130675A | 15(S)-HEPE | 86282-92-0 | Reference compound |
| HY-130675AS | 15(S)-HEPE-d5 | Isotope-Labeled Compounds | |
| HY-130676 | CLK-IN-T3N | 2561494-73-1 | Reference compound |
| HY-13067R | Celastrol (Standard) | 34157-83-0 | Reference Standards |
| HY-13068 | Golvatinib | 928037-13-2 | Reference compound |
| HY-130680 | Syk-IN-3 | 1312534-69-2 | Reference compound |
| HY-130682 | Lenalidomide-propargyl-C2-amido-Ph-NH2 (hydrochloride) | 2748150-20-9 | Reference compound |
| HY-130683 | Lenalidomide-propargyl-C2-NH2 (hydrochloride) | 2489242-23-9 | Reference compound |
| HY-130684 | MDM2-IN-1 | 1410737-09-5 | Reference compound |
| HY-130687 | L-Psicose | 16354-64-6 | Biochemical Assay Reagents |
| HY-130689 | Pinoxepin (hydrochloride) | 14008-46-9 | Reference compound |
| HY-130690 | Propargyl-PEG1-SS-PEG1-C2-Boc | 1807518-78-0 | ADC Related |
| HY-130691 | MitoP (bromide) | 74597-01-6 | Reference compound |
| HY-130691S | MitoP-d15 (bromide) | Isotope-Labeled Compounds | |
| HY-130693 | Azido-PEG5-CH2CO2-PFP | 2144777-92-2 | Reference compound |
| HY-130694 | 15(R)-Prostaglandin E2 | 38873-82-4 | Reference compound |
| HY-130695 | N-(Amino-PEG5)-N-bis(PEG4-acid) | 2093152-86-2 | Reference compound |
| HY-130696 | (+)-U-50488 | 67198-17-8 | Reference compound |
| HY-13070 | MK-8245 | 1030612-90-8 | Reference compound |
| HY-130702 | 24(28)-Dehydroergosterol | 29560-24-5 | Reference compound |
| HY-130703 | 5-Dehydroepisterol | 23582-83-4 | Reference compound |
| HY-130704 | Isotachysterol 3 | 22350-43-2 | Reference compound |
| HY-130705 | Previtamin D3 | 1173-13-3 | Reference compound |
| HY-130705A | Tachysterol 3 | 17592-07-3 | Reference compound |
| HY-130707 | K-Ras ligand-Linker Conjugate 3 | 2378261-87-9 | Reference compound |
| HY-130708 | UNC6852 | 2688842-08-0 | Reference compound |
| HY-130709 | PROTAC CDK2/9 Degrader-1 | 2408641-24-5 | Reference compound |
| HY-13071 | Nestoron | 7759-35-5 | Reference compound |
| HY-130711 | (S,R,S)-AHPC-C3-NH2 | 2361119-88-0 | Reference compound |
| HY-130711A | (S,R,S)-AHPC-C3-NH2 (TFA) | 2688842-02-4 | Reference compound |
| HY-130711B | (S,R,S)-AHPC-C3-NH2 (hydrochloride) | 2940858-65-9 | Reference compound |
| HY-130711C | (S,R,S)-AHPC-C3-NH2 (dihydrochloride) | 2564467-25-8 | Reference compound |
| HY-130712 | NH2-C2-amido-C2-Boc | 1692613-62-9 | Reference compound |
| HY-130713 | Thalidomide-C2-amido-C2-COOH | 2353496-84-9 | Reference compound |
| HY-130714 | TD-165 | 2305936-56-3 | Reference compound |
| HY-130715 | tert-Butyl 11-aminoundecanoate | 220851-29-6 | Reference compound |
| HY-130716 | Thalidomide-NH-C10-COOH | 2428400-33-1 | Reference compound |
| HY-130718 | ThrRS-IN-1 | 2408626-64-0 | Reference compound |
| HY-13072 | Cenisertib | 871357-89-0 | Reference compound |
| HY-130723 | AMPK activator 2 | 2410961-69-0 | Reference compound |
| HY-130723A | AMPK activator 2 (hydrochloride) | Reference compound | |
| HY-13072B | Cenisertib (benzoate) | 1145859-64-8 | Reference compound |
| HY-130735 | Janelia Fluor® 646, SE | 1811539-59-9 | Dye Reagents |
| HY-130736 | Janelia Fluor® 549, SE | 1811539-32-8 | Dye Reagents |
| HY-130737 | Pomalidomide 4'-alkylC5-acid | 2225940-49-6 | Reference compound |
| HY-130738 | Benzyl-PEG3-CH2-Boc | 1443467-88-6 | Reference compound |
| HY-13074 | VO-Ohpic (trihydrate) | 476310-60-8 | Reference compound |
| HY-130742 | Azido-PEG8-Boc | 1623791-99-0 | Reference compound |
| HY-130743 | Dieugenol | 4433-08-3 | Reference compound |
| HY-130748 | K-252d | 105114-22-5 | Natural Products |
| HY-13075 | c-Fms-IN-3 | 885704-21-2 | Reference compound |
| HY-130750 | Phycocyanobilin | 20298-86-6 | Reference compound |
| HY-130751 | DODAP | 127512-29-2 | Oligonucleotides |
| HY-130752 | VNI | 1246770-52-4 | Reference compound |
| HY-130753 | JM 1397 | 121043-78-5 | Reference compound |
| HY-130755 | Cyclohexanoyl coenzyme A | 5960-12-3 | Reference compound |
| HY-130757 | Remisporine B | 571194-06-4 | Natural Products |
| HY-130758 | Ald-PEG1-C2-Boc | 2100306-48-5 | Reference compound |
| HY-13076 | CHIR-98014 | 252935-94-7 | Reference compound |
| HY-130760 | HIV-1 integrase inhibitor 7 | 204268-03-1 | Reference compound |
| HY-130762 | Cinnamic acid (sodium) | 538-42-1 | Reference compound |
| HY-130765 | Ferbam | 14484-64-1 | Reference compound |
| HY-130767 | Naphthol AS-TR phosphate | 2616-72-0 | Biochemical Assay Reagents |
| HY-130767A | Naphthol AS-TR phosphate (disodium) | 4264-93-1 | Biochemical Assay Reagents |
| HY-130768 | N-(Azido-PEG3)-N-Fluorescein-PEG3-acid | 2100306-50-9 | Dye Reagents |
| HY-13077 | MK-8245 (Trifluoroacetate) | 1415559-41-9 | Reference compound |
| HY-130770 | Ald-CH2-PEG3-CH2-Boc | 2100306-54-3 | Reference compound |
| HY-130772 | Filipin II | 38620-77-8 | Natural Products |
| HY-130774 | Ponceau 3R | 3564-09-8 | Dye Reagents |
| HY-130777 | AMP-PNP | 25612-73-1 | Biochemical Assay Reagents |
| HY-130777A | AMP-PNP (lithium hydrate) | Biochemical Assay Reagents | |
| HY-130778 | N,N'-Diacetylchitobiose | 35061-50-8 | Natural Products |
| HY-130778R | N,N'-Diacetylchitobiose (Standard) | 35061-50-8 | Reference Standards |
| HY-13078 | Cobimetinib (racemate) | 934662-91-6 | Reference compound |
| HY-130783 | LysoFP-NO2 | 69408-75-9 | Dye Reagents |
| HY-130784 | Dihydro montelukast | 142147-67-9 | Reference compound |
| HY-130785 | LysoFP-NH2 | 69408-85-1 | Reference compound |
| HY-130786 | Denbufylline | 57076-71-8 | Reference compound |
| HY-130787 | Apterin | 53947-89-0 | Natural Products |
| HY-130789 | Cimigenol-3-one | 31222-32-9 | Natural Products |
| HY-13078S | Cobimetinib-13C6 (racemate) | Isotope-Labeled Compounds | |
| HY-13079 | Cobimetinib (R-enantiomer) | 934660-94-3 | Reference compound |
| HY-130790 | Euparone | 53947-86-7 | Natural Products |
| HY-130791 | Dioctanoin | 36354-80-0 | Reference compound |
| HY-130794 | ALK/ROS1-IN-1 | 2365497-07-8 | Reference compound |
| HY-130795 | GSK-3β inhibitor 2 | 1702428-31-6 | Reference compound |
| HY-130797 | TLR7/8 agonist 3 | 642473-95-8 | Reference compound |
| HY-130798 | (S,R,S)-AHPC-amido-C5-acid | 2162120-87-6 | Reference compound |
| HY-130800 | Eragidomide | 1860875-51-9 | Reference compound |
| HY-130801 | 5-Hydroxy-2'-deoxyuridine | 5168-36-5 | Reference compound |
| HY-130802 | 5-Aminouridine | 2149-76-0 | Reference compound |
| HY-130803 | 5-Methyl-5,6-dihydrouridine | 23067-10-9 | Natural Products |
| HY-130805 | 5-Hydroxyuridine | 957-77-7 | Reference compound |
| HY-130806 | Dihydrodeoxyuridine | 5626-99-3 | Reference compound |
| HY-130807 | 5,6-Dihydrothymidine | 5627-00-9 | Reference compound |
| HY-130809 | DBCO-PEG4-Biotin | 1255942-07-4 | Reference compound |
| HY-130810 | DBCO-Sulfo-Link-biotin | 1363444-70-5 | ADC Related |
| HY-130812 | Gemcitabine-O-Si(di-iso)-O-Mc | ADC Related | |
| HY-130813 | BET-IN-6 | 2570470-39-0 | Reference compound |
| HY-130814 | Thalidomide-NH-C4-NH2 (TFA) | 2093387-50-7 | Reference compound |
| HY-130815 | MAK683-CH2CH2COOH | 2639882-68-9 | Reference compound |
| HY-130815A | MAK683-CH2CH2COOH (hydrochloride) | Reference compound | |
| HY-130816 | (S,R,S)-AHPC-O-Ph-PEG1-NH2 | 2361117-24-8 | Reference compound |
| HY-130818 | N-(5-Hydroxypentyl)maleimide | 180608-78-0 | ADC Related |
| HY-130819 | Tos-PEG4-THP | 86259-89-4 | Reference compound |
| HY-130820 | THP-PEG4-Pyrrolidine(N-Boc)-CH2OH | 2378261-80-2 | Reference compound |
| HY-130821 | THP-PEG4-Pyrrolidine(N-Me)-CH2OH | 2378261-81-3 | Reference compound |
| HY-130822 | K-Ras ligand-Linker Conjugate 4 | 2378261-83-5 | Reference compound |
| HY-130823 | K-Ras ligand-Linker Conjugate 5 | 2378261-85-7 | Reference compound |
| HY-130824 | Bis-PEG10-NHS ester | 2221949-02-4 | ADC Related |
| HY-130825 | Bis-PEG13-NHS ester | 2221949-00-2 | ADC Related |
| HY-130826 | Bis-PEG17-NHS ester | 2221948-93-0 | ADC Related |
| HY-130827 | Bis-PEG21-NHS ester | 2221948-98-5 | ADC Related |
| HY-130828 | Bis-PEG25-NHS ester | 2221948-96-3 | ADC Related |
| HY-130829 | m-PEG15-NHS ester | Reference compound | |
| HY-130830 | m-PEG24-NHS ester | 2395839-96-8 | Reference compound |
| HY-130831 | Hydroxy-PEG12-Boc | 2388521-20-6 | Reference compound |
| HY-130832 | Hydroxy-PEG13-Boc | Reference compound | |
| HY-130833 | Hydroxy-PEG16-Boc | 2592433-80-0 | Reference compound |
| HY-130834 | Hydroxy-PEG24-Boc | 2490419-62-8 | Reference compound |
| HY-130835 | FKBP12 PROTAC RC32 | 2375555-66-9 | Reference compound |
| HY-130836 | LpxH-IN-AZ1 | 901260-40-0 | Reference compound |
| HY-130837 | JH-LPH-28 | 2414592-36-0 | Reference compound |
| HY-130837R | JH-LPH-28 (Standard) | 2414592-36-0 | Reference Standards |
| HY-130838 | JH-LPH-33 | 2414590-04-6 | Reference compound |
| HY-130838R | JH-LPH-33 (Standard) | 2414590-04-6 | Reference Standards |
| HY-130839 | LolCDE-IN-1 | 1639933-78-0 | Reference compound |
| HY-130840 | LolCDE-IN-2 | 2748443-01-6 | Reference compound |
| HY-130841 | Apcin-A | 1683617-62-0 | Reference compound |
| HY-130842 | β-Naphthoflavone-CH2-Br | 1282513-77-2 | Reference compound |
| HY-130845 | AR antagonist 1 | 1818885-54-9 | Reference compound |
| HY-130845A | AR antagonist 1 (hydrochloride) | 1818885-55-0 | Reference compound |
| HY-130846 | Pip-alkyne-Ph-COOCH3 | 2308496-47-9 | Reference compound |
| HY-130847 | (S,R,S)-AHPC-Me-C10-NH2 | 2376139-52-3 | Reference compound |
| HY-130849 | (S,R,S)-AHPC-Me-C5-COOH | 2229976-21-8 | Reference compound |
| HY-130850 | CDK9-IN-10 | 3542-63-0 | Reference compound |
| HY-130851 | HS-27 | 1562024-11-6 | Reference compound |
| HY-130852 | CDK9-IN-11 | 2748368-15-0 | Reference compound |
| HY-130853 | Thalidomide-NH-PEG2-C2-NH-Boc | 2097509-40-3 | Reference compound |
| HY-130854 | Thalidomide-NH-C6-NH-Boc | 2093536-13-9 | Reference compound |
| HY-130855 | Mal-amido-PEG7-acid | 2112731-42-5 | Reference compound |
| HY-130856 | Mal-amido-PEG9-acid | 2112731-43-6 | Reference compound |
| HY-130857 | Mal-PEG24-acid | Reference compound | |
| HY-130858 | Mal-amido-PEG16-acid | Reference compound | |
| HY-130860 | Mal-NH-PEG2-CH2CH2COOPFP ester | 1347750-81-5 | Reference compound |
| HY-130861 | Mal-NH-PEG4-CH2CH2COOPFP ester | 1347750-84-8 | Reference compound |
| HY-130862 | Mal-NH-PEG6-CH2CH2COOPFP ester | 1599432-34-4 | Reference compound |
| HY-130863 | Mal-NH-PEG8-CH2CH2COOPFP ester | 2055023-14-6 | Reference compound |
| HY-130864 | Mal-NH-PEG12-CH2CH2COOPFP ester | 2136296-33-6 | Reference compound |
| HY-130865 | Mal-NH-PEG10-CH2CH2COOPFP ester | Reference compound | |
| HY-130866 | Mal-NH-PEG14-CH2CH2COOPFP ester | Reference compound | |
| HY-130867 | Mal-NH-PEG16-CH2CH2COOPFP ester | Reference compound | |
| HY-130868 | Mal-NH-PEG24-CH2CH2COOPFP ester | Reference compound | |
| HY-130870 | Fmoc-NH-PEG11-CH2CH2COOH | 3076038-46-2 | Reference compound |
| HY-130871 | HS-PEG3-CH2CH2NH2 | 1189760-69-7 | Reference compound |
| HY-130871A | HS-PEG3-CH2CH2NH2 (hydrochloride) | Reference compound | |
| HY-130872 | HS-PEG5-CH2CH2NH2 | 1347750-20-2 | Reference compound |
| HY-130872A | HS-PEG5-CH2CH2NH2 (hydrochloride) | 1446256-16-1 | Reference compound |
| HY-130873 | HS-PEG7-CH2CH2NH2 | Reference compound | |
| HY-130874 | HS-PEG7-CH2CH2COOH | Reference compound | |
| HY-130875 | HS-PEG9-CH2CH2COOH | Reference compound | |
| HY-130876 | HS-PEG10-CH2CH2COOH | Reference compound | |
| HY-130878 | HS-PEG24-CH2CH2COOH | Reference compound | |
| HY-130879 | HS-PEG5-CH2CH2N3 | 1449390-11-7 | Reference compound |
| HY-130880 | HS-PEG11-CH2CH2N3 | 2148986-08-5 | Reference compound |
| HY-130881 | HS-PEG6-CH2CH2-Boc | 1818294-40-4 | Reference compound |
| HY-130882 | HS-PEG7-CH2CH2N3 | 2148986-06-3 | Reference compound |
| HY-130883 | N3-PEG3-Propanehydrazide | Reference compound | |
| HY-130885 | N3-PEG6-Propanehydrazide | Reference compound | |
| HY-130886 | N3-PEG12-Hydrazide | Reference compound | |
| HY-130887 | (+)-Biotin-SLC | 1864003-57-5 | Reference compound |
| HY-130888 | (+)-Biotin-ONP | 33755-53-2 | Reference compound |
| HY-130889 | (+)-Biotin-PEG10-OH | Reference compound | |
| HY-130890 | (+)-Biotin-PEG12-OH | Reference compound | |
| HY-130891 | (+)-Biotin-PEG6-hydrazide | 2601437-70-9 | Reference compound |
| HY-130892 | (+)-Biotin-PEG2-hydrazide | 2413847-26-2 | Reference compound |
| HY-130893 | Biotin-EDA | 111790-37-5 | Reference compound |
| HY-130894 | Propargyl-PEG12-methane | Reference compound | |
| HY-130895 | Bis-Mal-PEG5 | Reference compound | |
| HY-130896 | Bis-Mal-PEG7 | Reference compound | |
| HY-130897 | Boc-NH-PEG11-CH2CH2N3 | 2395004-21-2 | Reference compound |
| HY-130898 | BM-PEG3 | 86099-06-1 | Reference compound |
| HY-130899 | Boc-NH-PEG23-CH2CH2N3 | Reference compound | |
| HY-130900 | Propargyl-PEG3-SH | 1412905-18-0 | Reference compound |
| HY-130901 | m-PEG25-Propargyl | Reference compound | |
| HY-130902 | m-PEG37-Propargyl | Reference compound | |
| HY-130903 | m-PEG49-NHS ester | Reference compound | |
| HY-130904 | DSPE-PEG47-acid | Reference compound | |
| HY-130905 | DSPE-PEG46-NH2 | Reference compound | |
| HY-130906 | DSPE-PEG46-N3 | Reference compound | |
| HY-130907 | Fmoc-N-PEG24-acid | 2170484-59-8 | Reference compound |
| HY-130908 | 11-Maleimidoundecanoic acid | 57079-01-3 | Reference compound |
| HY-130909 | Propargyl-PEG25-acid | Reference compound | |
| HY-130910 | Propargyl-PEG8-SH | 1422540-92-8 | Reference compound |
| HY-130911 | Propargyl-PEG12-SH | Reference compound | |
| HY-130912 | DBCO-NH-(CH2)4COOH | 2375193-74-9 | Reference compound |
| HY-130913 | 5-FAM-Alkyne | 510758-19-7 | Reference compound |
| HY-130922 | BCN-PEG1-Val-Cit-OH | ADC Related | |
| HY-130923 | BCN-PEG1-Val-Cit-PABC-OH | ADC Related | |
| HY-130924 | BCN-PEG3-Biotin | 1263166-92-2 | ADC Related |
| HY-130925 | BCN-PEG4-OH | ADC Related | |
| HY-130926 | BCN-PEG3-oxyamine | ADC Related | |
| HY-130927 | BCN-PEG4-Ts | ADC Related | |
| HY-130928 | Tetrazine-Ph-OPSS | ADC Related | |
| HY-130929 | β-Estradiol-6-CMO-PEG3-biotin | ADC Related | |
| HY-130930 | Acid-propionylamino-Val-Cit-OH | 2098907-84-5 | ADC Related |
| HY-130931 | Propargyl-NH-PEG3-C2-NHS ester | 1214319-94-4 | ADC Related |
| HY-130932 | Boc-Val-Ala-PAB-PNP | 1884578-00-0 | ADC Related |
| HY-130933 | Fmoc-Ala-Ala-Asn(Trt)-OH | 1951424-92-2 | ADC Related |
| HY-130934 | TCO-PEG1-Val-Cit-OH | ADC Related | |
| HY-130935 | DBCO-Val-Cit-OH | ADC Related | |
| HY-130936 | DBCO-Val-Cit-PABC-OH | ADC Related | |
| HY-130937 | DBCO-Val-Cit-PABC-PNP | 2994332-18-0 | ADC Related |
| HY-130938 | m-PEG25-acid | Reference compound | |
| HY-130939 | APN-PEG4-Amine (hydrochloride) | ADC Related | |
| HY-130940 | PTDA-PEG4-azide | 2639395-40-5 | ADC Related |
| HY-130941 | Fmoc-N-bis-PEG3-NH-Boc | ADC Related | |
| HY-130942 | Bromoacetamide-PEG3-propargyl | 932741-11-2 | Reference compound |
| HY-130943 | Methyltetrazine-PEG4-SS-PEG4-methyltetrazine | ADC Related | |
| HY-130944 | Mal-PEG1-Val-Cit-PABC-OH | 2055041-37-5 | ADC Related |
| HY-130945 | Tetrazine-PEG5-SS-amine | ADC Related | |
| HY-130946 | NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 | ADC Related | |
| HY-130947 | Tetrazine-PEG4-SS-Py | ADC Related | |
| HY-130948 | Thalidomide-O-C4-NH2 | 1957235-96-9 | Reference compound |
| HY-130948B | Thalidomide-4-O-C4-NH2 (hydrochloride) | 2376990-29-1 | Reference compound |
| HY-130949 | Thalidomide-4-O-C7-NH2 | 2093536-11-7 | Reference compound |
| HY-130949B | Thalidomide-4-O-C7-NH2 (hydrochloride) | Reference compound | |
| HY-130950 | Thalidomide-O-C4-COOH | 2169266-67-3 | Reference compound |
| HY-130951 | Thalidomide-O-C6-COOH | 2169266-69-5 | Reference compound |
| HY-130952 | Thalidomide-O-C8-COOH | 2225148-51-4 | Reference compound |
| HY-130953 | Mal-PEG4-bis-PEG3-methyltetrazine | ADC Related | |
| HY-130954 | Hynic-PEG3-N3 | ADC Related | |
| HY-130955 | Amino-bis-PEG3-TCO | ADC Related | |
| HY-130956 | Boc-NMe-Val-Val-Dil-Dap-OH | ADC Related | |
| HY-130957 | Amino-PEG6-amido-bis-PEG5-N3 | ADC Related | |
| HY-130958 | Tubulysin IM-1 | ADC Related | |
| HY-130959 | Tubulysin IM-2 | 1032072-50-6 | ADC Related |
| HY-130960 | Tubulysin IM-3 | 1639986-05-2 | ADC Related |
| HY-130961 | Boc-Val-Dil-Dap-OH | 1415246-54-6 | ADC Related |
| HY-130962 | Ald-Ph-amido-PEG23-OPSS | ADC Related | |
| HY-130963 | Thalidomide-4-O-C10-NH2 | 1957236-08-6 | Reference compound |
| HY-130963B | Thalidomide-4-O-C10-NH2 (hydrochloride) | Reference compound | |
| HY-130964B | Thalidomide-PEG4-NH2 (hydrochloride) | 2387510-82-7 | Reference compound |
| HY-130965 | Thalidomide-PEG3-NH2 | 1957236-10-0 | Reference compound |
| HY-130965B | Thalidomide-PEG3-NH2 (hydrochloride) | 2983036-20-8 | Reference compound |
| HY-130966 | TCO-PEG1-Val-Cit-PABC-OH | ADC Related | |
| HY-130967 | Ald-Ph-PEG4-bis-PEG4-propargyl | ADC Related | |
| HY-130968 | Amino-PEG4-bis-PEG3-propargyl | ADC Related | |
| HY-130969 | Ald-Ph-PEG4-bis-PEG3-N3 | ADC Related | |
| HY-130970 | Amino-PEG4-bis-PEG3-methyltetrazine | ADC Related | |
| HY-130971 | Mal-PEG4-bis-PEG3-DBCO | ADC Related | |
| HY-130972 | Amino-bis-PEG3-DBCO | ADC Related | |
| HY-130973 | Mal-PEG4-bis-PEG4-propargyl | ADC Related | |
| HY-130974 | Ald-Ph-PEG4-bis-PEG3-methyltetrazine | ADC Related | |
| HY-130975 | Boc-Val-Dil-Dap-Phe-OMe | 1415246-55-7 | ADC Related |
| HY-130976 | N-Boc-Val-Dil-Dap-Doe | 135383-62-9 | ADC Related |
| HY-130977 | Tetrazine-PEG4-amine (hydrochloride) | 2752945-36-9 | ADC Related |
| HY-130978 | Duocarmycin DM | ADC Related | |
| HY-130979 | EED226-COOH | 2467965-71-3 | Reference compound |
| HY-130981 | FN-1501-propionic acid | 2408642-48-6 | Reference compound |
| HY-130982 | Lenalidomide-PEG3-iodine | 2738934-13-7 | Reference compound |
| HY-130983 | N-piperidine Ibrutinib (hydrochloride) | 2231747-18-3 | Reference compound |
| HY-130984 | Azido-PEG1-CH2COO-Cl | 79598-49-5 | Reference compound |
| HY-130985 | 9-Decyn-1-ol | 17643-36-6 | Reference compound |
| HY-130988 | Ipatasertib-NH2 | 1001382-14-4 | Reference compound |
| HY-130988A | Ipatasertib-NH2 (dihydrochloride) | 1001264-73-8 | Reference compound |
| HY-130989 | SuO-Glu-Val-Cit-PAB-MMAE | 1895916-24-1 | ADC Related |
| HY-130990 | DBCO-PEG4-Val-Cit-PAB-MMAF | 2244602-23-9 | ADC Related |
| HY-130991 | K-Ras ligand-Linker Conjugate 6 | 2378261-89-1 | Reference compound |
| HY-130992 | Androgen receptor antagonist 1 | 1338812-36-4 | Reference compound |
| HY-130993 | Isatropolone A | 2097813-40-4 | Natural Products |
| HY-130995 | Agrochelin | 247115-74-8 | Natural Products |
| HY-130996 | Diacetyl Agrochelin | 247115-75-9 | Natural Products |
| HY-130997 | 17-GMB-APA-GA | 256337-10-7 | ADC Related |
| HY-130999 | Microcolin B | 141205-32-5 | Natural Products |
| HY-13100 | PF 03716556 | 928774-43-0 | Reference compound |
| HY-131001 | DPNB-ABT594 | Reference compound | |
| HY-131002 | DPTIP | 351353-48-5 | Reference compound |
| HY-131002A | DPTIP (hydrochloride) | 2361799-64-4 | Reference compound |
| HY-131003 | Taletrectinib | 1505515-69-4 | Reference compound |
| HY-131003A | Taletrectinib (free base) | 1505514-27-1 | Reference compound |
| HY-131004 | CB2R PAM | 2244579-87-9 | Reference compound |
| HY-131005 | Eph inhibitor 2 | 861249-59-4 | Reference compound |
| HY-131006 | FFN200 (dihydrochloride) | 2080306-27-8 | Reference compound |
| HY-131007 | FFN270 (hydrochloride) | 2341841-05-0 | Reference compound |
| HY-131008 | Fluorescein tyramide | 210236-90-1 | Dye Reagents |
| HY-131009 | Fluorescein-NAD+ | Reference compound | |
| HY-13100A | (S)-PF 03716556 | 928774-44-1 | Reference compound |
| HY-13101 | MCOPPB (trihydrochloride) | 1108147-88-1 | Reference compound |
| HY-131010 | Flutax-2 (5/6-mixture) | Dye Reagents | |
| HY-131011 | Furanone C-30 | 247167-54-0 | Reference compound |
| HY-131012 | GoSlo-SR-5-69 | 1363419-31-1 | Reference compound |
| HY-131013 | GSHtracer | 1479071-34-5 | Reference compound |
| HY-131014 | FM-479 | 2226521-64-6 | Reference compound |
| HY-131015 | HaXS8 | 2080306-25-6 | Reference compound |
| HY-131016 | IHR-Cy3 | Reference compound | |
| HY-131018 | Jedi2 | 651005-90-2 | Reference compound |
| HY-131019 | JF-NP-26 | 2341841-03-8 | Reference compound |
| HY-13101B | (S)-MCOPPB | 1108147-70-1 | Reference compound |
| HY-13102 | UK-383367 | 348622-88-8 | Reference compound |
| HY-131020 | Janelia Fluor® 525, SE | 2975167-21-4 | Dye Reagents |
| HY-131021 | Janelia Fluor® 549, Azide | Dye Reagents | |
| HY-131022 | Janelia Fluor® 549 (TFA) | 2245946-45-4 | Dye Reagents |
| HY-131023 | Janelia Fluor® 549, Maleimide (TFA) | Dye Reagents | |
| HY-131024 | Janelia Fluor® 549, Tetrazine | Dye Reagents | |
| HY-131025 | Janelia Fluor® 585, SE | 1811539-88-4 | Dye Reagents |
| HY-131026 | Janelia Fluor® 635, SE | Dye Reagents | |
| HY-131027 | Janelia Fluor® 646, Azide | Dye Reagents | |
| HY-131028 | Janelia Fluor® 646 (TFA) | Dye Reagents | |
| HY-131029 | Janelia Fluor® 646, Maleimide | Dye Reagents | |
| HY-13103 | NS 11021 | 956014-19-0 | Reference compound |
| HY-131030 | Janelia Fluor® 669, SE | 2127150-20-1 | Dye Reagents |
| HY-131031 | KCC-07 | 315702-75-1 | Reference compound |
| HY-131032 | KI-7 | 1489263-00-4 | Reference compound |
| HY-131033 | L-Azidonorleucine (hydrochloride) | 1454334-76-9 | Reference compound |
| HY-131034 | LP-922056 | 1365060-22-5 | Reference compound |
| HY-131035 | Lys-CoA (TFA) | Reference compound | |
| HY-131036 | MAO-IN-M30 (dihydrochloride) | 64821-19-8 | Reference compound |
| HY-131037 | MB-0223 | 2247732-89-2 | Reference compound |
| HY-131039 | MDNI-caged-L-glutamate | 864085-92-7 | Reference compound |
| HY-13104 | MRS 2578 | 711019-86-2 | Reference compound |
| HY-131040 | NLRP3-IN-NBC6 | 2068818-02-8 | Reference compound |
| HY-131041 | Ned-K | 2250019-90-8 | Reference compound |
| HY-131042 | NNMTi | 42464-96-0 | Reference compound |
| HY-131043 | NVS-PAK1-C | 2250019-95-3 | Reference compound |
| HY-131044 | 5-[(2-Nitrophenyl)methylene]-2,4-thiazolidinedione | 36140-65-5 | Reference compound |
| HY-131045 | HADA (hydrochloride) | 2253733-10-5 | Dye Reagents |
| HY-131048 | Antimicrobial agent-33 | 51244-45-2 | Reference compound |
| HY-131049 | Antimicrobial agent-30 | 24138-83-8 | Reference compound |
| HY-131050 | Aspergillus niger-IN-1 | 6325-94-6 | Reference compound |
| HY-131053 | 4-Chloro-N,N-diisopropylbenzamide | 79606-45-4 | Reference compound |
| HY-131054 | Cinerubin B | 35906-51-5 | Natural Products |
| HY-131055 | Mytoxin B | 105049-15-8 | Natural Products |
| HY-131056 | Gly3-VC-PAB-MMAE | 2684216-48-4 | ADC Related |
| HY-131057 | Mc-VC-PAB-SN38 | 1801838-28-7 | ADC Related |
| HY-131058 | Muscotoxin A | 1653999-47-3 | ADC Related |
| HY-131059 | CBS1117 | 959245-08-0 | Reference compound |
| HY-13106 | Olodanrigan | 1316755-16-4 | Reference compound |
| HY-131060 | CN128 (hydrochloride) | 1335282-05-7 | Reference compound |
| HY-131061 | BET bromodomain inhibitor 1 | 2411226-02-1 | Reference compound |
| HY-131062 | yGsy2p-IN-1 | 2415003-97-1 | Reference compound |
| HY-131063 | CDK6/9-IN-1 | 2414373-55-8 | Reference compound |
| HY-131064 | RIPK3-IN-1 | 2361139-70-8 | Reference compound |
| HY-131065 | MET kinase-IN-2 | 2101241-90-9 | Reference compound |
| HY-131066 | EMI48 | 34564-13-1 | Reference compound |
| HY-131067 | EMI56 | 2414374-41-5 | Reference compound |
| HY-131068 | BACE-1 inhibitor 2 | 2563970-92-1 | Reference compound |
| HY-131069A | MBX2329 | 1438272-42-4 | Reference compound |
| HY-13106A | Olodanrigan (sodium) | 1316755-17-5 | Reference compound |
| HY-13108 | Bz 423 | 216691-95-1 | Reference compound |
| HY-131081 | γ-Amanitin | 21150-23-2 | ADC Related |
| HY-131082 | (R)-8-Azido-2-(Fmoc-amino)octanoic acid | 1191429-18-1 | ADC Related |
| HY-131083 | ε-Amanitin | 21705-02-2 | Natural Products |
| HY-131084 | DMAC-SPDB-sulfo | 663599-07-3 | ADC Related |
| HY-131085 | Desmethyl Vc-seco-DUBA | ADC Related | |
| HY-131086 | Me-triacetyl-β-D-glucopyranuronate-Ph-ald-NO2 | 148579-93-5 | ADC Related |
| HY-131087 | Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc | 894096-02-7 | ADC Related |
| HY-131088 | N3-PEG8-Phe-Lys-PABC-Gefitinib | ADC Related | |
| HY-131089 | MC-VC-PABC-C6-α-Amanitin | 2922514-69-8 | ADC Related |
| HY-131091 | Boc-Glu(OBzl)-OSu | 32886-40-1 | Reference compound |
| HY-131092 | H-Asn-Arg-OH | 2478-01-5 | Reference compound |
| HY-131093 | Enduracidin | 11115-82-5 | Reference compound |
| HY-131094 | H-Gly-D-Tyr-OH | 133706-65-7 | Reference compound |
| HY-131095 | Z-Glu-Tyr-OH | 988-75-0 | Peptides |
| HY-131096 | L-Proline 4-methoxy-β-naphthylamide (hydrochloride) | 100930-07-2 | Reference compound |
| HY-131097 | Malachite green isothiocyanate | 147492-82-8 | Biochemical Assay Reagents |
| HY-131098 | Enduracidin A | 34438-27-2 | Reference compound |
| HY-131099 | Enduracidin B | 34304-21-7 | Reference compound |
| HY-131100 | Homo Sildenafil | 642928-07-2 | Reference compound |
| HY-131100R | Homo Sildenafil (Standard) | 642928-07-2 | Reference Standards |
| HY-131100S | Homo Sildenafil-d5 | 1216711-61-3 | Isotope-Labeled Compounds |
| HY-131101 | Nor-Acetildenafil | 949091-38-7 | Reference compound |
| HY-131101R | Nor-Acetildenafil (Standard) | 949091-38-7 | Reference Standards |
| HY-131102 | Mequindox | 13297-17-1 | Reference compound |
| HY-131102R | Mequindox (Standard) | 13297-17-1 | Reference Standards |
| HY-131103 | Phenylethanolamine A | 1346746-81-3 | Reference compound |
| HY-131103R | Phenylethanolamine A (Standard) | 1346746-81-3 | Reference Standards |
| HY-131103S | Phenylethanolamine A-d3 | 2507994-61-6 | Isotope-Labeled Compounds |
| HY-131104AS | Brombuterol-d9 (hydrochloride) | 1353867-94-3 | Isotope-Labeled Compounds |
| HY-131104S | Brombuterol-d9 | 1353940-55-2 | Isotope-Labeled Compounds |
| HY-131105 | Cimbuterol | 54239-39-3 | Reference compound |
| HY-131105R | Cimbuterol (Standard) | 54239-39-3 | Reference Standards |
| HY-131105S | Cimbuterol-d9 | 1246819-04-4 | Isotope-Labeled Compounds |
| HY-131106S | Clorprenaline-d7 | 2748354-86-9 | Isotope-Labeled Compounds |
| HY-131107 | Cefpodoxime proxetil impurity B | 947692-14-0 | Reference compound |
| HY-131108 | β-Aspartylaspartic acid | 60079-22-3 | Natural Products |
| HY-131108R | β-Aspartylaspartic acid (Standard) | 60079-22-3 | Reference Standards |
| HY-131109 | Cyclo(Gly-Tyr) | 5845-66-9 | Peptides |
| HY-131110 | Cyclo(Ala-Glu) | 16364-36-6 | Peptides |
| HY-131111 | Cyclo(Gly-Gln) | 52662-00-7 | Peptides |
| HY-131112 | N-Pivaloyl-L-tyrosine | 33019-85-1 | Reference compound |
| HY-131113 | N-Nitrosodibutylamine | 924-16-3 | Reference compound |
| HY-131113R | N-Nitrosodibutylamine (Standard) | 924-16-3 | Reference Standards |
| HY-131113S | N-Nitrosodibutylamine-d18 | 1219798-82-9 | Isotope-Labeled Compounds |
| HY-131113S1 | N-Nitrosodibutylamine-d9 | Isotope-Labeled Compounds | |
| HY-131114 | Valiolamine | 83465-22-9 | Reference compound |
| HY-131115 | Cyclo(Tyr-Leu) | 82863-65-8 | Natural Products |
| HY-131116 | Dihydrojasmonic acid | 3572-64-3 | Natural Products |
| HY-131118 | Desmethyl Ketoprofen | 22071-22-3 | Reference compound |
| HY-131119 | Dimethyldioctadecylammonium (bromide) | 3700-67-2 | Biochemical Assay Reagents |
| HY-131119S | Dimethyldioctadecylammonium-d74(bromide) | 1111808-79-7 | Isotope-Labeled Compounds |
| HY-131120 | Bromonitromethane | 563-70-2 | Reference compound |
| HY-131121 | 4-Isobutylbenzoic acid | 38861-88-0 | Reference compound |
| HY-131121R | 4-Isobutylbenzoic acid (Standard) | 38861-88-0 | Reference Standards |
| HY-131122S | 4-Nonylphenol-d5 | 358730-95-7 | Isotope-Labeled Compounds |
| HY-131123 | N-Nitrosomorpholine | 59-89-2 | Reference compound |
| HY-131123R | N-Nitrosomorpholine (Standard) | 59-89-2 | Reference Standards |
| HY-131123S | N-Nitrosomorpholine-d4 | 61578-30-1 | Isotope-Labeled Compounds |
| HY-131123S1 | N-Nitrosomorpholine-d8 | 1219805-76-1 | Isotope-Labeled Compounds |
| HY-131124 | 7-Amino-3-chloro cephalosporanic acid | 53994-69-7 | Reference compound |
| HY-131125 | trans-4-Nitrocinnamoyl chloride | 61921-33-3 | Reference compound |
| HY-131126 | Metolcarb | 1129-41-5 | Reference compound |
| HY-131126R | Metolcarb (Standard) | 1129-41-5 | Reference Standards |
| HY-131126S | Metolcarb-d3 | 1777782-68-9 | Isotope-Labeled Compounds |
| HY-131127 | 7-Acetoxy-1-methylquinolinium (iodide) | 7270-83-9 | Reference compound |
| HY-131130 | Neomycin C | 66-86-4 | Reference compound |
| HY-131131 | 5-CFDA-AM | 124412-00-6 | Dye Reagents |
| HY-131132 | JAB-3068 | 2169223-48-5 | Reference compound |
| HY-131132A | JAB-3068 (hydrochloride) | 2169223-49-6 | Reference compound |
| HY-131134S | Fosetyl-aluminum-d15 | Isotope-Labeled Compounds | |
| HY-131139 | Ganglioside GD3 (disodium salt) | 497932-19-1 | Reference compound |
| HY-131139A | Ganglioside GD3 (diammonium) | Reference compound | |
| HY-131140 | BD750 | 892686-59-8 | Reference compound |
| HY-131142 | Monensin methyl ester | 28636-21-7 | Reference compound |
| HY-131143 | Cadein1 | Reference compound | |
| HY-131144S | AMOZ-d5 | 1017793-94-0 | Isotope-Labeled Compounds |
| HY-131145 | Brombuterol (hydrochloride) | 21912-49-2 | Reference compound |
| HY-131145R | Brombuterol (hydrochloride) (Standard) | 21912-49-2 | Reference Standards |
| HY-131146 | AMOZ | 43056-63-9 | Reference compound |
| HY-131146R | AMOZ (Standard) | 43056-63-9 | Reference Standards |
| HY-131150 | Ristomycin (sulfate) | 11140-99-1 | Natural Products |
| HY-131150R | Ristomycin (sulfate) (Standard) | 11140-99-1 | Reference Standards |
| HY-131152 | Leucinostatin (mixture of A&B) | Natural Products | |
| HY-131156 | Mal-PEG2-Val-Cit-PABA-PNP | 1345681-52-8 | ADC Related |
| HY-131157 | Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 | 1224601-12-0 | ADC Related |
| HY-131159 | Thalidomide-O-C8-Boc | 2225148-52-5 | Reference compound |
| HY-131160 | Nuclease, Serratia marcescens | 9025-65-4 | Enzyme |
| HY-131161 | M-MLV Reverse transcriptase | 9068-38-6 | Enzyme |
| HY-131162 | Chymase | 97501-92-3 | Enzyme |
| HY-131164 | Potassium clavulanate mixture with silicon dioxide (1:1) | Reference compound | |
| HY-131165 | Amoxicillin (trihydrate) mixture with potassium clavulanate (4:1) | Reference compound | |
| HY-131166 | Curdlan | 54724-00-4 | Reference compound |
| HY-131168 | (S,R,S)-AHPC-Boc-trans-3-aminocyclobutanol-Pip-CH2COOH | 2086301-47-3 | Reference compound |
| HY-131171 | 3β,5α-Tetrahydronorethisterone | 6424-05-1 | Reference compound |
| HY-131173 | N-Decanoylglycine | 14305-32-9 | Peptides |
| HY-131174 | 8-Ethyl Irinotecan | 947687-02-7 | Reference compound |
| HY-131177 | yGsy2p-IN-H23 | 1269190-98-8 | Reference compound |
| HY-131178 | HG-7-85-01-NH2 | 1258391-29-5 | Reference compound |
| HY-131179 | Influenza A virus-IN-1 | 2250313-14-3 | Reference compound |
| HY-131180 | BMS-986235 | 2253947-47-4 | Reference compound |
| HY-131181 | LEI-401 | 2393840-15-6 | Reference compound |
| HY-131182 | DS-1971a | 1450595-86-4 | Reference compound |
| HY-131183 | PROTAC PD-1/PD-L1 degrader-1 | 2447066-37-5 | Reference compound |
| HY-131184 | N-Boc-piperazine-C3-COOH | 959053-53-3 | Reference compound |
| HY-131185 | Pomalidomide-amido-C3-COOH | 2162120-77-4 | Reference compound |
| HY-131186 | Pomalidomide-amido-C3-piperazine-N-Boc | Reference compound | |
| HY-131187 | BMS-1166-N-piperidine-COOH | 2447066-00-2 | Reference compound |
| HY-131188 | PROTAC Bcl-xL degrader-1 | 2450351-07-0 | Reference compound |
| HY-131189 | N-Boc-SBP-0636457-OH | 2450350-79-3 | Reference compound |
| HY-131190 | N-Boc-SBP-0636457-O-C3-COOH | 2450350-91-9 | Reference compound |
| HY-131194 | JAK2/STAT3-IN-1 | 2485758-50-5 | Reference compound |
| HY-131203 | PROTAC BRD4 Degrader-6 | 2410947-56-5 | Reference compound |
| HY-131204 | CZL80 | 313482-91-6 | Reference compound |
| HY-131220 | aPKC-IN-1 | 15854-12-3 | Reference compound |
| HY-131223 | NDSB-211 | 38880-58-9 | Biochemical Assay Reagents |
| HY-131230 | Desmorpholinyl Quizartinib-PEG2-COOH | 2292116-14-2 | Reference compound |
| HY-131232 | Desmorpholinyl Navitoclax-NH-Me | 2365172-82-1 | Reference compound |
| HY-131233 | Anti-virus agent 1 | 1911578-83-0 | Reference compound |
| HY-131233R | Anti-virus agent 1 (Standard) | 1911578-83-0 | Reference Standards |
| HY-131236 | EBNA1-IN-SC7 | 324022-08-4 | Reference compound |
| HY-131244 | ALK-IN-9 | 2359662-39-6 | Reference compound |
| HY-131246 | DM-01 | 2355280-00-9 | Reference compound |
| HY-131247 | Bcl-2-IN-2 | 2383085-86-5 | Reference compound |
| HY-131249 | MK2-IN-3 | 724711-21-1 | Reference compound |
| HY-131250 | N-Boc-Sitagliptin | 486460-23-5 | Reference compound |
| HY-131251 | Cetirizine 3-chloro impurity | 1232460-31-9 | Reference compound |
| HY-131252 | Dihydro Donepezil | 120012-04-6 | Reference compound |
| HY-131253 | Febuxostat isopropyl isomer | 144060-52-6 | Reference compound |
| HY-131254 | (S)-O-Desmethyl Venlafaxine N-Oxide | 1021934-03-1 | Reference compound |
| HY-131255 | Ziprasidone amino acid | 1159977-64-6 | Reference compound |
| HY-131256 | Cetirizine Impurity C | 83881-59-8 | Reference compound |
| HY-131256A | Cetirizine Impurity C (dihydrochloride) | 2702511-37-1 | Reference compound |
| HY-131257 | Gefitinib impurity 1 | 675126-26-8 | Reference compound |
| HY-131257R | Gefitinib impurity 1 (Standard) | 675126-26-8 | Reference Standards |
| HY-131258 | Ibuprofen impurity 1 | 3585-47-5 | Reference compound |
| HY-131259 | Ibuprofen Impurity F | 65322-85-2 | Reference compound |
| HY-131259R | Ibuprofen Impurity F (Standard) | 65322-85-2 | Reference Standards |
| HY-131260 | Ibuprofen Impurity K | 43153-07-7 | Reference compound |
| HY-131260R | Ibuprofen Impurity K (Standard) | 43153-07-7 | Reference Standards |
| HY-131261 | Ibuprofen alcohol | 36039-36-8 | Reference compound |
| HY-131261R | Ibuprofen alcohol (Standard) | 36039-36-8 | Reference Standards |
| HY-131262 | Hydroxychloroquine Impurity E | 10500-64-8 | Reference compound |
| HY-131263 | Hydroxychloroquine Impurity F | 6281-58-9 | Reference compound |
| HY-131264 | Olmesartan medoxomil impurity C | 879562-26-2 | Reference compound |
| HY-131265 | Mesalamine impurity P | 887256-40-8 | Reference compound |
| HY-131266 | Febuxostat n-butyl isomer | 1657014-33-9 | Reference compound |
| HY-131266R | Febuxostat n-butyl isomer (Standard) | 1657014-33-9 | Reference Standards |
| HY-131267 | Febuxostat sec-butoxy acid | 1335202-59-9 | Reference compound |
| HY-131268 | O-Desisobutyl-O-n-propyl Febuxostat | 1530308-87-2 | Reference compound |
| HY-131269 | Febuxostat impurity 7 | 1350352-70-3 | Reference compound |
| HY-131269R | Febuxostat impurity 7 (Standard) | 1350352-70-3 | Reference Standards |
| HY-131270 | Febuxostat impurity 8 | 144060-62-8 | Reference compound |
| HY-131270R | Febuxostat impurity 8 (Standard) | 144060-62-8 | Reference Standards |
| HY-131271 | Febuxostat impurity 6 | 1271738-74-9 | Reference compound |
| HY-131272 | Febuxostat dicarboxylic acid impurity | 1239233-87-4 | Reference compound |
| HY-131272R | Febuxostat dicarboxylic acid impurity (Standard) | 1239233-87-4 | Reference Standards |
| HY-131273 | Febuxostat amide impurity | 1239233-86-3 | Reference compound |
| HY-131273R | Febuxostat amide impurity (Standard) | 1239233-86-3 | Reference Standards |
| HY-131274 | Fexofenadine Impurity F | 185066-33-5 | Reference compound |
| HY-131275 | Imatinib Impurity E | 1365802-18-1 | Reference compound |
| HY-131275R | Imatinib Impurity E (Standard) | 1365802-18-1 | Reference Standards |
| HY-131276 | Olmesartan lactone impurity | 849206-43-5 | Reference compound |
| HY-131276R | Olmesartan lactone impurity (Standard) | 849206-43-5 | Reference Standards |
| HY-131277 | Dehydro Olmesartan | 172875-98-8 | Reference compound |
| HY-131278 | Olmesartan methyl ester | 1347262-29-6 | Reference compound |
| HY-131279 | Olmesartan ethyl ester | 144689-23-6 | Reference compound |
| HY-131280 | Devaleryl Valsartan Impurity | 676129-92-3 | Reference compound |
| HY-131280R | Devaleryl Valsartan Impurity (Standard) | 676129-92-3 | Reference Standards |
| HY-131281 | Ivabradine impurity 1 | 1428869-91-3 | Reference compound |
| HY-131282 | Ivabradine impurity 2 | 73954-34-4 | Reference compound |
| HY-131283 | 8-Demethyl Ivabradine | 304464-97-9 | Reference compound |
| HY-131284 | (S)-Dehydro Venlafaxine | 2742899-98-3 | Reference compound |
| HY-131286A | Talaglumetad (hydrochloride) | 441765-97-5 | Reference compound |
| HY-131287 | MGS0028 | 321963-33-1 | Reference compound |
| HY-131289 | LY3020371 | 1377615-75-2 | Reference compound |
| HY-131295 | PD0325901-O-C2-dioxolane | 2581116-22-3 | Reference compound |
| HY-131296 | 5-A-RU-PABC-Val-Cit-Fmoc | 2677841-58-4 | Reference compound |
| HY-131298 | 1-Naphthyl butyrate | 3121-70-8 | Biochemical Assay Reagents |
| HY-131300 | Colchicoside | 477-29-2 | Natural Products |
| HY-131303 | Heptadecanoyl Coenzyme A | 3546-17-6 | Biochemical Assay Reagents |
| HY-131305 | HBDDE | 154675-18-0 | Reference compound |
| HY-131306 | Δ2-cis-Hexadecenoic acid | 2825-68-5 | Reference compound |
| HY-131306A | Δ2-trans-Hexadecenoic acid | 929-79-3 | Natural Products |
| HY-131306B | 2-Hexadecenoic acid | 629-56-1 | Biochemical Assay Reagents |
| HY-131307 | Tigloside | 216590-44-2 | Natural Products |
| HY-131308 | Thalidomide-NH-C2-PEG3-OH | 2140807-23-2 | Reference compound |
| HY-131309 | 12-Doxylstearic acid | 29545-47-9 | Reference compound |
| HY-131310 | 9(S)-HpOTrE | 111004-08-1 | Reference compound |
| HY-131312 | Crelosidenib | 2230263-60-0 | Reference compound |
| HY-131312A | Crelosidenib (gentisate) | 2759438-85-0 | Reference compound |
| HY-131314 | Ibuprofen carboxylic acid | 15935-54-3 | Reference compound |
| HY-131314S | Ibuprofen carboxylic acid-d3 | 1216505-29-1 | Isotope-Labeled Compounds |
| HY-131318 | Lenalidomide-I | 2207541-30-6 | Reference compound |
| HY-131325S | Simeton-d3 | Isotope-Labeled Compounds | |
| HY-131326 | DOTA-tris(tBu)ester NHS ester | 819869-77-7 | Reference compound |
| HY-131327 | Azo-resveratrol | 1393556-48-3 | Reference compound |
| HY-131328 | Pirtobrutinib | 2101700-15-4 | Reference compound |
| HY-131328A | (R)-Pirtobrutinib | 2101700-14-3 | Reference compound |
| HY-131332S1 | N-Desmethyl ulipristal acetate-d3 | Isotope-Labeled Compounds | |
| HY-131334 | AMPK activator 4 | 2493239-46-4 | Reference compound |
| HY-131335 | p38α inhibitor 2 | 1095003-80-7 | Reference compound |
| HY-131336 | MGS0274 | 1501974-69-1 | Reference compound |
| HY-131337 | RhlR antagonist 1 | 2614320-29-3 | Reference compound |
| HY-131338 | RORγt inverse agonist 13 | 2170477-75-3 | Reference compound |
| HY-131339 | SP-96 | 2682114-54-9 | Reference compound |
| HY-131340 | LASSBio-1632 | 3029936-02-2 | Reference compound |
| HY-131341 | Syk-IN-4 | 2932264-95-2 | Reference compound |
| HY-131342 | BIIB068 | 1798787-27-5 | Reference compound |
| HY-131343 | HBV-IN-4 | 2305897-84-9 | Reference compound |
| HY-131344 | mTOR inhibitor-8 | 2489196-70-3 | Reference compound |
| HY-131345 | PI3Kα-IN-4 | 2322293-83-2 | Reference compound |
| HY-131345A | (S)-PI3Kα-IN-4 | 2322293-84-3 | Reference compound |
| HY-131346 | HIF-PHD-IN-1 | 1567657-46-8 | Reference compound |
| HY-131347 | PD-1/PD-L1-IN-NP19 | 2377916-66-8 | Reference compound |
| HY-131349 | CCR4-351 | 2174938-70-4 | Reference compound |
| HY-131349A | CCR4-351 (hydrochloride) | 2174938-71-5 | Reference compound |
| HY-131350 | LXE408 | 1799330-15-6 | Reference compound |
| HY-131364 | Nur77 modulator 1 | 2469975-55-9 | Reference compound |
| HY-131368 | α,α-Trehalose 6-phosphate (potassium) | 136632-28-5 | Reference compound |
| HY-131368A | α,α-Trehalose 6-phosphate | 4484-88-2 | Reference compound |
| HY-131370B | Intralipid 20% | 68890-65-3 | Reference compound |
| HY-131371 | Glucoiberin (potassium) | 15592-34-4 | Reference compound |
| HY-131374 | TN14003 | 368874-31-1 | Peptides |
| HY-131376 | 13-Oxo-ODE | 54739-30-9 | Natural Products |
| HY-131376S | 13-Oxo-ODE-d3 | Isotope-Labeled Compounds | |
| HY-131382 | UTA1inh-C1 | 332144-37-3 | Reference compound |
| HY-131383 | Propoxyphenyl Aildenafil | 1391053-82-9 | Reference compound |
| HY-131384 | 8,11,14-Eicosatriynoic acid | 34262-64-1 | Biochemical Assay Reagents |
| HY-131385 | KB02-COOH | 2375196-30-6 | Reference compound |
| HY-131386 | BMS-1166-N-piperidine-CO-N-piperazine | 2447066-14-8 | Reference compound |
| HY-131386A | BMS-1166-N-piperidine-CO-N-piperazine (dihydrochloride) | 2691796-83-3 | Reference compound |
| HY-131387 | (S,R,S)-AHPC-Me-CO-CH2-PEG3-NH2 | 2409538-69-6 | Reference compound |
| HY-131388 | ABM-14 | 1973408-76-2 | Reference compound |
| HY-131389 | Cholesteryl heptadecanoate | 24365-37-5 | Reference compound |
| HY-131390 | S-Ethylglutathione | 24425-52-3 | Reference compound |
| HY-131391 | m-Isobutyl Ibuprofen | 66622-47-7 | Reference compound |
| HY-131394 | 5-Hydroxymethyl-2’-deoxycytidine | 7226-77-9 | Natural Products |
| HY-131395 | N-Acetyl-Leukotriene E4 | 80115-95-3 | Reference compound |
| HY-131396 | α-Hydroxy Montelukast | 2045402-27-3 | Reference compound |
| HY-131397 | Docosahexaenoyl serotonin | 283601-58-1 | Reference compound |
| HY-131404 | TPBM | 6466-43-9 | Reference compound |
| HY-131405 | β-Eleostearic acid | 544-73-0 | Reference compound |
| HY-131408 | L-Allooctopine | 63358-47-4 | Reference compound |
| HY-131409 | D-Val-Leu-Lys-pNA (dihydrochloride) | 62354-43-2 | Dye Reagents |
| HY-131413 | O-Desmethyl Galanthamine | 60755-80-8 | Natural Products |
| HY-131416 | DD-3305 | 55690-47-6 | Reference compound |
| HY-131417 | cis-ACCP | 777075-44-2 | Reference compound |
| HY-131420 | 12-Methyltridecanoic acid | 2724-57-4 | Biochemical Assay Reagents |
| HY-131421 | 8-PIP-cAMP | 31357-06-9 | Reference compound |
| HY-131422 | (Rac)-8-Hydroxy-efavirenz | 205754-32-1 | Reference compound |
| HY-131422S | (Rac)-8-Hydroxy-efavirenz-d4 | 1246812-30-5 | Isotope-Labeled Compounds |
| HY-131423 | Triarachidonin | 23314-57-0 | Biochemical Assay Reagents |
| HY-131424 | Glycidyl linoleate | 24305-63-3 | Natural Products |
| HY-131433 | Teroxalene (hydrochloride) | 3845-22-5 | Reference compound |
| HY-131435 | CD73-IN-2 | 2452209-05-9 | Reference compound |
| HY-131442 | Alkyne-phenol | 1694495-59-4 | Reference compound |
| HY-131443 | TRC-766 | 1810734-44-1 | Reference compound |
| HY-131445 | RJW100 | 1276664-20-0 | Reference compound |
| HY-131445A | SS-RJW100 | Reference compound | |
| HY-131445B | RR-RJW100 | Reference compound | |
| HY-131446 | Chk1-IN-5 | 2120398-39-0 | Reference compound |
| HY-131447 | KY19382 | 2226664-93-1 | Reference compound |
| HY-131448 | A3334 | 854171-31-6 | Reference compound |
| HY-131449 | Terazosin dimer impurity (dihydrochloride) | 1486464-41-8 | Reference compound |
| HY-131450 | 1α,25-Dihydroxyprevitamin D3 | 57102-09-7 | Reference compound |
| HY-131450A | (E)-1α,25-Dihydroxyprevitamin D3 | 96862-25-8 | Reference compound |
| HY-131451 | Mc-Phe-Lys-PAB-MMAE | 646502-54-7 | Reference compound |
| HY-131452 | 1-Ethynylpyrene | 34993-56-1 | Reference compound |
| HY-131453A | Mitochondrial respiration-IN-1 (hydrobromide) | Reference compound | |
| HY-131454 | SR-717 | 2375421-09-1 | Reference compound |
| HY-131454A | SR-717 (free acid) | 2375420-34-9 | Reference compound |
| HY-131455A | Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 (TFA) | Biochemical Assay Reagents | |
| HY-131459S | N-Methyl Metribuzin-d3 | 1794754-27-0 | Isotope-Labeled Compounds |
| HY-131459S1 | N-Methyl Metribuzin-d3-1 | Isotope-Labeled Compounds | |
| HY-131461 | 6-TET Dipivaloate | 314734-87-7 | Reference compound |
| HY-131466 | N-Methyl Palbociclib | 571189-51-0 | Reference compound |
| HY-131466R | N-Methyl Palbociclib (Standard) | 571189-51-0 | Reference Standards |
| HY-131468 | Picoplatin | 181630-15-9 | Reference compound |
| HY-131471 | Zafirlukast metabolite M1 | 219583-10-5 | Reference compound |
| HY-131473 | Desmethyl thiosildenafil | 479073-86-4 | Reference compound |
| HY-131474 | Naphthol AS-D chloroacetate，98% (TLC) | 35245-26-2 | Biochemical Assay Reagents |
| HY-131475 | Naphthol AS-BI phosphate | 1919-91-1 | Biochemical Assay Reagents |
| HY-131475A | Naphthol AS-BI phosphate (disodium hydrate) | 207569-04-8 | Biochemical Assay Reagents |
| HY-131477A | Sinafloxacin (free base) | 156215-70-2 | Reference compound |
| HY-131479 | Threo-dihydrobupropion (hydrochloride) | 357637-18-4 | Reference compound |
| HY-131479A | Threo-dihydrobupropion | 153365-82-3 | Reference compound |
| HY-131481 | Mnm5s2U | 32860-54-1 | Reference compound |
| HY-131482 | PtdIns-(3)-P1(1,2-dioctanoyl) (sodium) | 299216-98-1 | Biochemical Assay Reagents |
| HY-131485 | 3-Acetylpyridine adenine dinucleotide, 90% | 86-08-8 | Biochemical Assay Reagents |
| HY-131485A | 3-Acetylpyridine adenine dinucleotide, 95% | 86-08-8 | Biochemical Assay Reagents |
| HY-131486 | Digoxigenin bisdigitoxoside | 5297-05-2 | Reference compound |
| HY-131488 | 8-Debenzoylpaeoniflorin | 23532-11-8 | Natural Products |
| HY-131490 | Tetrazolium violet | 1719-71-7 | Biochemical Assay Reagents |
| HY-131492 | Δ4-Dafachronic acid | 23017-97-2 | Reference compound |
| HY-131492S | Δ4-Dafachronic Acid-d3 | Isotope-Labeled Compounds | |
| HY-131493 | PF-06939999 | 2159123-14-3 | Reference compound |
| HY-131495 | (S)-6-O-Desmethylnaproxen | 52079-10-4 | Reference compound |
| HY-131495R | (S)-6-O-Desmethylnaproxen (Standard) | 52079-10-4 | Reference Standards |
| HY-131495S | (Rac)-O-Desmethylnaproxen-d3 | 1122399-99-8 | Isotope-Labeled Compounds |
| HY-131496S | ortho-Topolin riboside-d4 | 74511-48-1 | Isotope-Labeled Compounds |
| HY-131498 | MOCAc-PLGL(Dpa)AR | 140430-53-1 | Dye Reagents |
| HY-131499 | Thyroxine methyl ester | 32180-11-3 | Reference compound |
| HY-131500 | SU-9055 | 653-56-5 | Reference compound |
| HY-131501 | Menaquinone 9 | 523-39-7 | Reference compound |
| HY-131501R | Menaquinone 9 (Standard) | 523-39-7 | Reference Standards |
| HY-131501S | Menaquinone-9-d7 | Isotope-Labeled Compounds | |
| HY-131501S1 | Menaquinone-9-13C6 | Isotope-Labeled Compounds | |
| HY-131502 | Taspine | 602-07-3 | Natural Products |
| HY-131503 | 13-Methyltetradecanoic acid | 2485-71-4 | Natural Products |
| HY-131503S | 13-Methyltetradecanoic acid-d6 | Isotope-Labeled Compounds | |
| HY-131504A | Valienamine | 38231-86-6 | Reference compound |
| HY-131508 | M&B 5124 | 15382-90-8 | Reference compound |
| HY-131510 | Chromoionophore XIII | 135656-96-1 | Dye Reagents |
| HY-131511 | Rovicurt | 55830-67-6 | Reference compound |
| HY-131514 | L-Ornithine 2-oxoglutarate | 5191-97-9 | Reference compound |
| HY-131515 | Tri-Salicylic acid | 85531-17-5 | Reference compound |
| HY-131515R | Tri-Salicylic acid (Standard) | 85531-17-5 | Reference Standards |
| HY-131516 | Tiopronin-cysteine disulfide | 77591-18-5 | Reference compound |
| HY-131520 | (E,E,E)-Farnesyl alcohol azide | 851667-96-4 | Reference compound |
| HY-131521 | Oxalomalic acid (trisodium) | 89304-26-7 | Reference compound |
| HY-131524S | Taurocholic acid 3-sulfate-d4 (disodium) | Isotope-Labeled Compounds | |
| HY-131527 | Wy-45494 (hydrochloride) | 93413-90-2 | Reference compound |
| HY-131527R | Wy-45494 (hydrochloride) (Standard) | 93413-90-2 | Reference Standards |
| HY-131528 | Tenilsetam | 86696-86-8 | Reference compound |
| HY-131542 | APPA | 100750-39-8 | Reference compound |
| HY-131543 | 22-Hydroxy mifepristone | 105012-15-5 | Reference compound |
| HY-131543S | 22-Hydroxy Mifepristone-d6 | Isotope-Labeled Compounds | |
| HY-131545 | Parogrelil | 139145-27-0 | Reference compound |
| HY-131547 | Org OD 02-0 | 13258-85-0 | Reference compound |
| HY-131549A | bpV(bipy) (hydrate) | 1173697-60-3 | Reference compound |
| HY-131551 | Drometrizole | 2440-22-4 | Reference compound |
| HY-131551R | Drometrizole (Standard) | 2440-22-4 | Reference Standards |
| HY-131553 | D-α-Tocopherol Succinate | 4345-03-3 | Biochemical Assay Reagents |
| HY-131553R | D-α-Tocopherol Succinate (Standard) | 4345-03-3 | Reference Standards |
| HY-131554 | Tibezonium (iodide) | 54663-47-7 | Reference compound |
| HY-131555 | p-Decylaminophenol | 23227-12-5 | Reference compound |
| HY-131556 | 4-Iodoamphetamine (hydrochloride) | 21894-58-6 | Reference compound |
| HY-131557 | O-Deacetylravidomycin | 88580-27-2 | Biochemical Assay Reagents |
| HY-131566 | Amiquinsin (hydrochloride monohydrate) | 7125-70-4 | Reference compound |
| HY-131574 | Heliosupine N-oxide | 31701-88-9 | Natural Products |
| HY-131576 | Thymidine 5′-diphosphate | 491-97-4 | Reference compound |
| HY-131576A | Thymidine 5′-diphosphate (sodium) | 108322-12-9 | Reference compound |
| HY-131577 | Neutral protease, Paenibacillus polymyxa | 42613-33-2 | Enzyme |
| HY-131577A | Neutral protease I | 42613-33-2 | Enzyme |
| HY-131578 | Rinderine N-oxide | 137821-16-0 | Natural Products |
| HY-131579 | Deschloro Cetirizine (dihydrochloride) | 83881-54-3 | Reference compound |
| HY-131579R | Deschloro Cetirizine (dihydrochloride) (Standard) | 83881-54-3 | Reference Standards |
| HY-131583 | MP265 | 544-47-8 | Reference compound |
| HY-131586 | 3,7-Dihydroxyflavone | 492-00-2 | Natural Products |
| HY-131587 | Integerrimine N-oxide | 85955-28-8 | Natural Products |
| HY-131589 | Metoprolol acid | 56392-14-4 | Reference compound |
| HY-131589R | Metoprolol acid (Standard) | 56392-14-4 | Reference Standards |
| HY-131591 | Digalacturonic acid | 5894-59-7 | Reference compound |
| HY-131592 | Tricetin | 520-31-0 | Natural Products |
| HY-131596 | Emtricitabine triphosphate | 145819-92-7 | Reference compound |
| HY-131596B | Emtricitabine triphosphate (tetrasodium salt) | 1188407-46-6 | Reference compound |
| HY-131598 | 6-Thio-GTP | 17670-19-8 | Reference compound |
| HY-131603 | Lamivudine triphosphate | 143188-53-8 | Reference compound |
| HY-131605 | Ganciclovir triphosphate | 86761-38-8 | Reference compound |
| HY-131606 | Cidofovir diphosphate | 142276-31-1 | Reference compound |
| HY-131606B | Cidofovir diphosphate tri(triethylamine) | Reference compound | |
| HY-131607 | Carbovir triphosphate | 129941-14-6 | Reference compound |
| HY-131611 | 6-Azuridine | 54-25-1 | Reference compound |
| HY-131614 | TPC2-A1-N | 136186-07-7 | Reference compound |
| HY-131615 | TPC2-A1-P | 2804595-86-4 | Reference compound |
| HY-131616 | Ethyl α-eleostearate | 42021-86-3 | Natural Products |
| HY-131617 | Prostaglandin F2α 1,11-lactone | 62410-84-8 | Reference compound |
| HY-131618 | Hippuryl-Arg | 744-46-7 | Reference compound |
| HY-131619S | 3-Methyl Hippuric acid-d7 | 1216551-07-3 | Isotope-Labeled Compounds |
| HY-131620S | 4-Methylhippuric acid-d7 | 1216588-60-1 | Isotope-Labeled Compounds |
| HY-131622 | 7-Aminoclonazepam | 4959-17-5 | Reference compound |
| HY-131622S | 7-Aminoclonazepam-13C6 | 1538556-05-6 | Isotope-Labeled Compounds |
| HY-131624 | LON 954 | 63504-15-4 | Reference compound |
| HY-131626 | 1a,1b-Dihomo prostaglandin E2 | 26198-80-1 | Reference compound |
| HY-131629 | N-Desmethyl-U-47700 | 67579-73-1 | Reference compound |
| HY-131630 | O-Desmethylmetoprolol | 62572-94-5 | Reference compound |
| HY-131630S | O-Desmethylmetoprolol-d5 | 1189981-81-4 | Isotope-Labeled Compounds |
| HY-131631S | Desmethylcyclobenzaprine-d3 (hydrochloride) | 1784139-98-5 | Isotope-Labeled Compounds |
| HY-131632 | 1a,1b-Dihomo prostaglandin F2α | 57944-39-5 | Reference compound |
| HY-131633A | (+)-JQ-1-aldehyde | 2634778-37-1 | Reference compound |
| HY-131636S | Pergolide sulfoxide-d7 | Isotope-Labeled Compounds | |
| HY-131637 | Desacetyl bisacodyl | 603-41-8 | Reference compound |
| HY-131637R | Desacetyl bisacodyl (Standard) | 603-41-8 | Reference Standards |
| HY-131640 | 1,2-Didecanoyl PC | 3436-44-0 | Reference compound |
| HY-131643 | 3-Hydroxyhexadecanoic acid | 2398-34-7 | Natural Products |
| HY-131646 | Thalidomide-O-amido-C3-PEG3-C1-NH2 | 1799711-29-7 | Reference compound |
| HY-131647 | Pomalidomide 4'-PEG5-acid | 2139348-63-1 | Reference compound |
| HY-131648 | 1-Oleoyl-2-acetyl-sn-glycerol | 86390-77-4 | Reference compound |
| HY-131649 | Compound C108 | 15533-09-2 | Reference compound |
| HY-131651 | Leukotriene B4 ethanolamide | 877459-63-7 | Reference compound |
| HY-131652 | 1,2-Di-O-hexadecyl-sn-glycero-3-phosphocholine | 36314-47-3 | Biochemical Assay Reagents |
| HY-131654 | 16α-Hydroxy progesterone | 438-07-3 | Biochemical Assay Reagents |
| HY-131658 | VEGFR-2-IN-6 | 444731-47-9 | Reference compound |
| HY-131663 | L-Lysinamide | 32388-19-5 | Natural Products |
| HY-131664 | EP3 antagonist 2 | 1952261-87-8 | Reference compound |
| HY-131667 | Hdm2 E3 ligase inhibitor 1 | 414905-09-2 | Reference compound |
| HY-131668 | 9-POHSA | 1481636-43-4 | Reference compound |
| HY-131669 | Dasatinib metabolite M6 | 910297-53-9 | Reference compound |
| HY-131670 | (±)9,10-DiHOME | 263399-34-4 | Reference compound |
| HY-131673 | p-SCN-Bn-TCMC (tetrahydrochloride) | 2153478-57-8 | Reference compound |
| HY-131673A | (S)-p-SCN-Bn-TCMC (hydrochloride) | Biochemical Assay Reagents | |
| HY-131676 | C17 Sphingomyelin (d18:1/17:0) | 121999-64-2 | Reference compound |
| HY-131678 | Palmitoyl serotonin | 212707-51-2 | Reference compound |
| HY-131682 | 3-C6-NBD-cholesterol | 201731-19-3 | Dye Reagents |
| HY-131683 | ES9-17 | 55854-43-8 | Reference compound |
| HY-131688 | 2-Chlorohexadecanoic acid | 19117-92-1 | Reference compound |
| HY-131688R | 2-Chlorohexadecanoic acid (Standard) | 19117-92-1 | Reference Standards |
| HY-131693 | γ-Acetylenic GABA | 57659-38-8 | Reference compound |
| HY-131693A | γ-Acetylenic GABA (hydrochloride) | 103451-26-9 | Reference compound |
| HY-131694 | N-Dodecyllactobionamide | 69313-68-4 | Reference compound |
| HY-131696 | 11-deoxy Prostaglandin F1α | 37785-98-1 | Reference compound |
| HY-131697 | FeTPPS | 90384-82-0 | Reference compound |
| HY-131699 | t-Butyl ester-PEG4-CH2COOH | 929087-83-2 | Reference compound |
| HY-131701 | Lactosyl-C18-sphingosine | 109785-20-8 | Reference compound |
| HY-131701S | Lactosyl-C18-sphingosine-d7 | 2315262-32-7 | Isotope-Labeled Compounds |
| HY-131703 | UGT8-IN-1 | 2414349-93-0 | Reference compound |
| HY-131704 | FGFR4-IN-5 | 1628793-01-0 | Reference compound |
| HY-131705 | BTK inhibitor 17 | 1858206-76-4 | Reference compound |
| HY-131706A | GNF-8625 monopyridin-N-piperazine (hydrochloride) | 2412055-62-8 | Reference compound |
| HY-131707 | LEO 39652 | 1445656-91-6 | Reference compound |
| HY-131708 | FNDR-20123 (free base) | 1267502-34-0 | Reference compound |
| HY-131708A | FNDR-20123 | 2641930-61-0 | Reference compound |
| HY-131710 | PDE5-IN-3 | 2538149-57-2 | Reference compound |
| HY-131717 | Thalidomide-NH-CH2-COOH | 927670-97-1 | Reference compound |
| HY-131717A | Thalidomide-NH-CH2-COOH (TFA) | 2377032-39-6 | Reference compound |
| HY-131718 | (1-Isothiocyanatoethyl)benzene | 4478-92-6 | Reference compound |
| HY-131721 | 14,15-EET-SI | 218461-97-3 | Reference compound |
| HY-131722 | EA4 | 389614-94-2 | Reference compound |
| HY-131723 | Pregnenolone 16α-carbonitrile | 1434-54-4 | Reference compound |
| HY-131724 | 4-(Dodecylamino)phenol | 25848-37-7 | Reference compound |
| HY-131728 | GPR35 agonist 3 | 123021-85-2 | Reference compound |
| HY-131729 | 16-Phenoxy tetranor Prostaglandin A2 | 51639-10-2 | Reference compound |
| HY-131736 | 3'-O-Bn-GTP | 1610778-75-0 | Reference compound |
| HY-131737 | 1-NH2-cGMP | 78033-42-8 | Reference compound |
| HY-131740 | 2'-Deoxytubercidin 5'-triphosphate | 67460-15-5 | Reference compound |
| HY-131740A | 2'-Deoxytubercidin 5'-triphosphate (sodium) | Reference compound | |
| HY-131755 | 2'-Deoxyadenosine 3':5'-cyclic monophosphate (sodium) | 93839-95-3 | Biochemical Assay Reagents |
| HY-131760 | 2'-NH2-ATP | 61468-88-0 | Reference compound |
| HY-131763 | 2'-O-MB-cAMP (sodium) | 55443-13-5 | Reference compound |
| HY-131764 | 2'-O-MB-cGMP (sodium) | 58329-72-9 | Reference compound |
| HY-131766 | 2'-O-Me-cAMP | 40269-29-2 | Reference compound |
| HY-131768 | 2'-O-Succinyl-cAMP | 36940-87-1 | Reference compound |
| HY-131772 | 2-AHA-cAMP | 214276-80-9 | Reference compound |
| HY-131773 | 2-Cl-5'-AMP | 21466-01-3 | Reference compound |
| HY-131776 | 2-Chloro-ADP | 16506-88-0 | Reference compound |
| HY-131776A | 2-Chloro-ADP (sodium) | 82927-78-4 | Reference compound |
| HY-131777 | 2-Cl-cAMP | 39023-65-9 | Reference compound |
| HY-131787A | 2-Amino-ATP (tetrasodium) | Biochemical Assay Reagents | |
| HY-131790 | 3'-Amino-3'-deoxyadenosine | 2504-55-4 | Reference compound |
| HY-131792 | 2-Chloroinosine | 13276-43-2 | Reference compound |
| HY-131795 | 2-Methylthioadenosine | 4105-39-9 | Reference compound |
| HY-131796 | 3'-CMP | 84-52-6 | Reference compound |
| HY-131800 | 3'-Deoxy-3'-amino-ATP | 4209-30-7 | Reference compound |
| HY-131800A | 3'-Deoxy-3'-amino-ATP (tetrasodium) | Biochemical Assay Reagents | |
| HY-131801A | 3'-Amino-3'-dGTP (tetrasodium) | Biochemical Assay Reagents | |
| HY-131802 | 3'-Azido-3'-deoxyadenosine | 58699-62-0 | Reference compound |
| HY-131803 | 3'-Azido-3'-deoxyguanosine | 98870-11-2 | Reference compound |
| HY-131810 | 5'-AMPS | 19341-57-2 | Reference compound |
| HY-131811 | 5'-CMPS | 47151-76-8 | Reference compound |
| HY-131812 | 5'-dAMPS | 64145-26-2 | Reference compound |
| HY-131813 | 5'-dCMPS | 64145-27-3 | Reference compound |
| HY-131814 | 5'-dGMPS | 87358-26-7 | Reference compound |
| HY-131815 | 5'-dIMPS | 771477-45-3 | Reference compound |
| HY-131816 | 5'-dUMPS | 205379-91-5 | Reference compound |
| HY-131817 | 5'-GMPS | 76310-16-2 | Reference compound |
| HY-131818 | 5'-Amino-5'-deoxyadenosine | 14365-44-7 | Reference compound |
| HY-131821 | 5'-TMPS | 15548-51-3 | Reference compound |
| HY-131822 | 5'-UMPS | 15548-52-4 | Reference compound |
| HY-131823 | 5,6-DCl-cBIMP | 129693-10-3 | Reference compound |
| HY-131824 | 5,6-DM-cBIMP | 142754-31-2 | Reference compound |
| HY-131829 | N6-(2-Aminoethyl)-NAD+ | 59587-50-7 | Reference compound |
| HY-131833 | Fmoc-Gly-Gly-Phe-OH | 160036-44-2 | ADC Related |
| HY-131833A | Fmoc-Gly-Gly-D-Phe-OH | 2982232-04-0 | ADC Related |
| HY-131833G | Fmoc-Gly-Gly-Phe-OH (GMP) | 160036-44-2 | GMP Small Molecules |
| HY-131842 | 6-Bn-cAMP | 32115-08-5 | Reference compound |
| HY-131844 | 6-Bnz-5'-AMP | 40871-55-4 | Reference compound |
| HY-131846 | 6-Cl-5'-PuMP | 5843-59-4 | Reference compound |
| HY-131847 | 2,6-Dichloro-2',3',5'-triacetyl-purine riboside | 3056-18-6 | Reference compound |
| HY-131863 | Pomalidomide 4'-alkylC8-acid | 2305936-70-1 | Reference compound |
| HY-131864 | SJF-1528 | 2230821-38-0 | Reference compound |
| HY-131864A | SJF-1528 (hemihydrate) | Reference compound | |
| HY-131865 | SJF-1521 | 2230821-40-4 | Reference compound |
| HY-131866 | (S,R,S)-CO-C2-acid | 2172819-72-4 | Reference compound |
| HY-131867 | Thalidomide-NH-PEG1-NH2 (hydrochloride) | 2154342-56-8 | Reference compound |
| HY-131868 | TRPV3 antagonist 74a | 1432051-63-2 | Reference compound |
| HY-131870 | GX-201 | 1788071-27-1 | Reference compound |
| HY-131871 | Ethyl LipotF | 1808089-27-1 | Reference compound |
| HY-131872 | Pomalidomide-PEG2-COOH | 2140807-17-4 | Reference compound |
| HY-131873 | Dynapyrazole-A | 2226517-75-3 | Reference compound |
| HY-131874 | Thalidomide-O-C7-acid | 2169266-70-8 | Reference compound |
| HY-131875 | Pomalidomide 4'-alkylC3-acid | 2225940-47-4 | Reference compound |
| HY-131876 | Thalidomide-O-C3-acid | 2169266-64-0 | Reference compound |
| HY-131878 | Pomalidomide-C7-NH2 (hydrochloride) | 2446474-05-9 | Reference compound |
| HY-131879 | NS383 | 309711-59-9 | Reference compound |
| HY-131880 | Thalidomide-O-C2-acid | 2369068-42-6 | Reference compound |
| HY-131881 | JHU37160 | 2369979-68-8 | Reference compound |
| HY-131885 | RuBi-Glutamate (hexafluorophosphate sodium) | 2417096-44-5 | Reference compound |
| HY-131886 | Pomalidomide 4'-alkylC4-acid | 2225940-48-5 | Reference compound |
| HY-131887 | Pomalidomide-C6-COOH | 2225940-50-9 | Reference compound |
| HY-131888 | Pomalidomide-C3-NH2 (hydrochloride) | 2154342-45-5 | Reference compound |
| HY-131888A | Pomalidomide-C3-NH2 | 2093388-20-4 | Reference compound |
| HY-131889 | Thalidomide-O-C5-acid | 2087490-48-8 | Reference compound |
| HY-131890 | VH032 amide-PEG1-acid | 2172820-07-2 | Reference compound |
| HY-131891 | JHU37152 | 2369979-67-7 | Reference compound |
| HY-131892 | 2-Deoxy-D-galactose | 1949-89-9 | Reference compound |
| HY-131894 | DL-Serine hydroxamate | 55779-32-3 | Peptides |
| HY-131895 | 5,6-Dehydroarachidonic acid | 58688-54-3 | Reference compound |
| HY-131897 | 1-Stearoyl-2-arachidonoyl-sn-glycerol | 65914-84-3 | Reference compound |
| HY-131897S | 1-Stearoyl-2-Arachidonoyl-d8-sn-Glycerol | 2692624-31-8 | Isotope-Labeled Compounds |
| HY-131898 | PTIO | 18390-00-6 | Reference compound |
| HY-131899 | N-Bromoacetamide | 79-15-2 | Reference compound |
| HY-131900 | Protein kinase inhibitor H-7 | 84477-87-2 | Reference compound |
| HY-131901 | Phenylarsine oxide | 637-03-6 | Reference compound |
| HY-131902 | MLT-231 | 2682102-10-7 | Reference compound |
| HY-131903 | HS271 | 2410393-15-4 | Reference compound |
| HY-131904 | POMHEX | 2004714-34-3 | Reference compound |
| HY-131904A | Hex | 2004714-32-1 | Reference compound |
| HY-131906 | JAK2-IN-7 | 2593402-36-7 | Reference compound |
| HY-131907 | LpxC-IN-5 | 2253951-38-9 | Reference compound |
| HY-131908 | CPL304110 | 1627826-19-0 | Reference compound |
| HY-131909 | CJ-2360 | 2226742-61-4 | Reference compound |
| HY-131910 | IHMT-PI3Kδ-372 | 2429889-61-0 | Reference compound |
| HY-131910A | (R)-IHMT-PI3Kδ-372 | 2429889-62-1 | Reference compound |
| HY-131911 | PROTAC IDO1 Degrader-1 | 2488851-89-2 | Reference compound |
| HY-131912 | Thalidomide-NH-PEG8-Ts | 2488761-07-3 | Reference compound |
| HY-131914 | EST64454 | 1351438-26-0 | Reference compound |
| HY-131914A | EST64454 (hydrochloride) | 1950569-11-5 | Reference compound |
| HY-131914B | EST64454 (maleate) | 2088272-67-5 | Reference compound |
| HY-131920A | Polyuridylic acid (potassium) | Biochemical Assay Reagents | |
| HY-131921 | DL-Glyceraldehyde 3-phosphate diethyl acetal (barium) | 93965-35-6 | Biochemical Assay Reagents |
| HY-131922 | Iso-OMPA | 513-00-8 | Reference compound |
| HY-131923 | DAPM | 208255-51-0 | Peptides |
| HY-131924 | Thionicotinamide adenine dinucleotide | 4090-29-3 | Biochemical Assay Reagents |
| HY-131925 | Diethylamine NONOate (diethylammonium salt) | 372965-00-9 | Reference compound |
| HY-131926 | EDTA (iron sodium) | 15708-41-5 | Biochemical Assay Reagents |
| HY-131926R | EDTA (iron sodium) (Standard) | 15708-41-5 | Reference Standards |
| HY-131927 | 2-Naphthyl acetate | 1523-11-1 | Biochemical Assay Reagents |
| HY-131929 | AE-ITU (dihydrobromide) | 56-10-0 | Reference compound |
| HY-131930 | AH-8533 | 759397-79-0 | Reference compound |
| HY-131931 | Lysoganglioside-GM1 (potassium) | 171483-40-2 | Natural Products |
| HY-131932S | N-Desethyl-dorzolamide-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-131933 | DCP-Bio3 | 1001575-95-6 | Reference compound |
| HY-131934 | 9-OAHSA | 154086-90-5 | Reference compound |
| HY-131940 | 3-O-Methyl-N-acetyl-D-glucosamine | 94825-74-8 | Reference compound |
| HY-131941 | SJM-3 | 1234977-97-9 | Reference compound |
| HY-131942 | sFTX-3.3 | 141997-14-0 | Reference compound |
| HY-131943 | DS44960156 | 2361327-08-2 | Reference compound |
| HY-131944 | S-Acetylglutathione | 3054-47-5 | Reference compound |
| HY-131945 | CU-115 | 2471982-20-2 | Reference compound |
| HY-131946 | Menotropin | 61489-71-2 | Biochemical Assay Reagents |
| HY-131947 | DH97-7 | 343263-95-6 | Reference compound |
| HY-131948 | 3-Chlorodiphenylamine | 101-17-7 | Reference compound |
| HY-131952 | TLR7/8/9-IN-1 | 2180127-82-4 | Reference compound |
| HY-131953 | Androgen receptor-IN-3 | 926228-58-2 | Reference compound |
| HY-131954 | 5-HT3 antagonist 4 | 930478-88-9 | Reference compound |
| HY-131955 | Fmoc-aminooxy-PEG2-NH2 | 190249-87-7 | ADC Related |
| HY-131958 | D942 | 849727-81-7 | Reference compound |
| HY-131959 | (S,R,S)-AHPC-PEG5-Boc | 2923734-82-9 | Reference compound |
| HY-131960 | Sucrose-epichlorohydrin copolymer | 26873-85-8 | Biochemical Assay Reagents |
| HY-131960A | Sucrose-epichlorohydrin copolymer 70 | 26873-85-8 | Biochemical Assay Reagents |
| HY-131961 | Triciferol | 957214-00-5 | Reference compound |
| HY-131962 | PKD-IN-1 | 956121-30-5 | Reference compound |
| HY-131962A | PKD-IN-1 (dihydrochloride) | 2308510-39-4 | Reference compound |
| HY-131964 | Imidacloprid-urea | 120868-66-8 | Reference compound |
| HY-131964R | Imidacloprid-urea (Standard) | 120868-66-8 | Reference Standards |
| HY-131965 | Imidacloprid impurity 1 | 105828-41-9 | Reference compound |
| HY-131967 | CD73-IN-4 | 2216764-29-1 | Reference compound |
| HY-131968 | BMS-986202 | 1771691-34-9 | Isotope-Labeled Compounds |
| HY-131969 | ASK1-IN-2 | 2541792-70-3 | Reference compound |
| HY-131970 | LSD1/HDAC6-IN-1 | 2738306-38-0 | Reference compound |
| HY-131971 | AChE/BChE-IN-1 | 2720624-42-8 | Reference compound |
| HY-131972 | PF-06843195 | 2067281-51-8 | Reference compound |
| HY-131973 | PDE10A-IN-2 (hydrochloride) | Reference compound | |
| HY-131974 | Glucocorticoid receptor agonist-1 | 2166375-82-0 | Reference compound |
| HY-131976 | BVDV-IN-1 | 345651-04-9 | Reference compound |
| HY-131978 | DB18 | 2587177-94-2 | Reference compound |
| HY-131979 | TP-040 | 2757254-99-0 | Reference compound |
| HY-131981 | TP0586532 | 2427584-96-9 | Reference compound |
| HY-131983 | Neuraminidase-IN-2 | 2599015-44-6 | Reference compound |
| HY-131986 | LASSBio-1135 | 852453-71-5 | Reference compound |
| HY-131987S | Ethacizine-d5 | Isotope-Labeled Compounds | |
| HY-131989 | Desacetylcephapirin (sodium) | 104557-24-6 | Reference compound |
| HY-131990 | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH | 1599440-25-1 | ADC Related |
| HY-131990A | MC-Gly-Gly-{D-Phe}-Gly-NH-CH2-O-CH2COOH | 1802520-40-6 | Reference compound |
| HY-131990G | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (GMP) | 1599440-25-1 | GMP Small Molecules |
| HY-131990S | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH-d5 | Isotope-Labeled Compounds | |
| HY-131991 | Benzyl selenocyanate | 4671-93-6 | Reference compound |
| HY-131992 | N-Acetylpsychosine | 35823-61-1 | Reference compound |
| HY-131993 | Resolvin E4 | 1781227-87-9 | Reference compound |
| HY-131994 | STING agonist-16 | 652142-94-4 | Reference compound |
| HY-131995 | O-Arachidonoyl glycidol | 439146-24-4 | Reference compound |
| HY-131996S | N-Despropyl macitentan-d4 | Isotope-Labeled Compounds | |
| HY-131997 | 2'MeO6MF | 89112-85-6 | Reference compound |
| HY-131998 | Thalidomide-NH-PEG4-MS | 2140807-24-3 | Reference compound |
| HY-131999 | 3,4,5-Trihydroxycinnamic acid decyl ester | 1770778-45-4 | Reference compound |
| HY-13200 | BRL-15572 (dihydrochloride) | 193611-72-2 | Reference compound |
| HY-132001 | Ziftomenib | 2134675-36-6 | Reference compound |
| HY-132002 | Dimethylsildenafil | 1416130-63-6 | Reference compound |
| HY-132003 | Wortmannin-Rapamycin Conjugate 1 | 1067892-47-0 | Reference compound |
| HY-132004 | Tos-O-C4-NH-Boc | 180851-50-7 | Reference compound |
| HY-132007 | Propargyl-PEG3-PFP ester | 2148295-91-2 | Reference compound |
| HY-132008 | Benzyl-PEG4-THP | 1027926-86-8 | Reference compound |
| HY-132009 | Benzyl-PEG7-bromide | Reference compound | |
| HY-13200A | BRL-15572 (hydrochloride) | 1173022-77-9 | Reference compound |
| HY-13200B | BRL-15572 | 734517-40-9 | Reference compound |
| HY-13201 | CGS 21680 | 120225-54-9 | Reference compound |
| HY-132010 | Benzyl-PEG8-azide | Reference compound | |
| HY-132011 | Benzyl-PEG13-THP | Reference compound | |
| HY-132012 | Benzyl-PEG9-acid | Reference compound | |
| HY-132013 | Benzyl-PEG8-amine | Reference compound | |
| HY-132014 | THP-PEG11-THP | Reference compound | |
| HY-132015 | Benzyl-PEG8-acid | Reference compound | |
| HY-132016 | Benzyl-PEG8-NHS ester | Reference compound | |
| HY-132017 | Bromo-PEG4-NHS ester | 2148295-98-9 | Reference compound |
| HY-132018 | Bromo-PEG2-NHS ester | 2148295-96-7 | Reference compound |
| HY-132019 | Methylamino-PEG7-benzyl | Reference compound | |
| HY-13201A | CGS 21680 (Hydrochloride) | 124431-80-7 | Reference compound |
| HY-13201C | CGS 21680 (sodium) | 120225-64-1 | Biochemical Assay Reagents |
| HY-13202 | T0070907 | 313516-66-4 | Reference compound |
| HY-132020 | Tos-PEG2-THP | 69502-32-5 | Reference compound |
| HY-132021 | Benzyl-PEG7-NHBoc | Reference compound | |
| HY-132022 | Bis-PEG7-t-butyl ester | 2702251-39-4 | Reference compound |
| HY-132023 | Benzyl-PEG11-MS | Reference compound | |
| HY-132024 | Bromo-PEG4-MS | 2167807-41-0 | Reference compound |
| HY-132025 | Benzyl-PEG7-t-butyl ester | Reference compound | |
| HY-132026 | Benzyl-PEG6-MS | 1262681-32-2 | Reference compound |
| HY-132027 | Benzyl-PEG7-acid | Reference compound | |
| HY-132028 | Benzyl-PEG6-bromide | 1449202-44-1 | Reference compound |
| HY-132029 | Benzyl-PEG6-amine | 86770-78-7 | Reference compound |
| HY-13202S | T0070907-d4 | Isotope-Labeled Compounds | |
| HY-13203 | NVP-TAE 226 | 761437-28-9 | Reference compound |
| HY-132030 | Benzyl-PEG6-NHBoc | 2148295-93-4 | Reference compound |
| HY-132031 | Mal-Val-Ala-PAB(C2-glucuronic acid)-DMEA-PNU-159682 | 2682939-53-1 | Reference compound |
| HY-132033 | Bromo-PEG3-THP | 220568-33-2 | Reference compound |
| HY-132034 | Benzyl-PEG6-t-butyl ester | 2148296-00-6 | Reference compound |
| HY-132035 | Benzyl-PEG13-alcohol | Reference compound | |
| HY-13204 | Biperiden (hydrochloride) | 1235-82-1 | Reference compound |
| HY-132042 | Bromo-PEG2-MS | 1935075-34-5 | Reference compound |
| HY-132043 | Propargyl-PEG5-PFP ester | 2148295-92-3 | Reference compound |
| HY-132044 | Benzyl-PEG8-t-butyl ester | Reference compound | |
| HY-132048 | Benzyl-PEG7-MS | Reference compound | |
| HY-132049 | Benzyl-PEG7-azide | 868594-42-7 | Reference compound |
| HY-13204A | Biperiden | 514-65-8 | Reference compound |
| HY-13204AR | Biperiden (Standard) | 514-65-8 | Reference Standards |
| HY-13204AS | Biperiden-d5 | 2938691-75-7 | Isotope-Labeled Compounds |
| HY-13204B | Biperiden (lactate) | 7085-45-2 | Reference compound |
| HY-13204R | Biperiden (hydrochloride) (Standard) | 1235-82-1 | Reference Standards |
| HY-13204S | Biperiden-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13204S1 | rel-Biperiden-d5 | Isotope-Labeled Compounds | |
| HY-13204S2 | rel-Biperiden EP impurity A-d5 | Isotope-Labeled Compounds | |
| HY-13204S3 | rel-Biperiden EP impurity B-d5 | Isotope-Labeled Compounds | |
| HY-13205 | Belnacasan | 273404-37-8 | Reference compound |
| HY-132050 | Azido-PEG4-propargyl | 1192590-91-2 | Reference compound |
| HY-132051 | Benzyl-PEG14-alcohol | Reference compound | |
| HY-132052 | Benzyl-PEG12-alcohol | 2218463-17-1 | Reference compound |
| HY-132053 | Benzyl-PEG16-alcohol | Reference compound | |
| HY-132054 | Benzyl-PEG17-t-butyl ester | Reference compound | |
| HY-132055 | Azido-PEG8-THP | Reference compound | |
| HY-132056 | Hydroxy-PEG14-t-butyl ester | Reference compound | |
| HY-132057 | Bis-PEG10-t-butyl ester | Reference compound | |
| HY-132058 | THP-PEG16-alcohol | Reference compound | |
| HY-132059 | Azido-PEG13-azide | Reference compound | |
| HY-13206 | MTEP (hydrochloride) | 1186195-60-7 | Reference compound |
| HY-132060 | Azido-PEG7-t-butyl ester | 2596867-40-0 | Reference compound |
| HY-132061 | Azido-PEG14-t-butyl ester | Reference compound | |
| HY-132062 | Azido-PEG11-t-butyl ester | Reference compound | |
| HY-132063 | MS-PEG3-dodecyl | 2148295-99-0 | Reference compound |
| HY-132064 | FmocNH-PEG4-t-butyl ester | 2148295-94-5 | Reference compound |
| HY-132065 | Decaethylene glycol dodecyl ether | 618113-48-7 | Reference compound |
| HY-132066 | Bis-PEG3-t-butyl ester | 1611468-29-1 | Reference compound |
| HY-132067 | Bis-PEG4-t-butyl ester | 2100306-53-2 | Reference compound |
| HY-132068 | THP-PEG7-alcohol | 873110-21-5 | Reference compound |
| HY-13206A | MTEP | 329205-68-7 | Reference compound |
| HY-13207 | ONX-0914 | 960374-59-8 | Reference compound |
| HY-132070 | FA-PEG5-Mal | Reference compound | |
| HY-132071 | Methylamino-PEG3-t-butyl ester | 217817-03-3 | Reference compound |
| HY-132072 | THP-PEG8-THP | Reference compound | |
| HY-132073 | Benzyl-PEG14-t-butyl-ester | Reference compound | |
| HY-132074 | Benzyl-PEG11-alcohol | Reference compound | |
| HY-132075 | Methylamino-PEG3-acid | 2148295-95-6 | Reference compound |
| HY-132076 | Azido-PEG10-azide | 1421783-42-7 | Reference compound |
| HY-132077 | THP-PEG16-THP | Reference compound | |
| HY-132078 | Azido-PEG7-acid | Reference compound | |
| HY-132079 | FmocNH-PEG4-t-butyl acetate | 894427-95-3 | Reference compound |
| HY-13207A | ONX-0914 (TFA) | Reference compound | |
| HY-13208 | Xevinapant (hydrochloride) | 1071992-57-8 | Reference compound |
| HY-132080 | Bis-PEG8-t-butyl ester | Reference compound | |
| HY-132081 | Benzyl-PEG10-t-butyl ester | Reference compound | |
| HY-132082 | Benzyl-PEG13-azide | Reference compound | |
| HY-132083 | Hydroxy-PEG2-CH2CH2COO-PEG2-propionic acid | Reference compound | |
| HY-132084 | Bromoacetamido-PEG8-t-butyl acetate | Reference compound | |
| HY-132085 | Azido-PEG3-chloroacetamide | 604766-23-6 | Reference compound |
| HY-132086 | (2-Pyridyldithio)-PEG6 acid | ADC Related | |
| HY-132087 | Bromo-PEG7-alcohol | 86220-35-1 | Reference compound |
| HY-132088 | N-Boc-PEG-t-butyl ester | 145119-18-2 | Reference compound |
| HY-132089 | N-Boc-PEG3-t-butyl ester | Reference compound | |
| HY-13209 | Ambrisentan | 177036-94-1 | Reference compound |
| HY-132090 | Acid-PEG3-SSPy | 2088570-69-6 | Reference compound |
| HY-132091 | Propargyl-PEG9-acid | 1613752-50-3 | Reference compound |
| HY-132092 | Methyl-PEG3-Ald | 141981-62-6 | Reference compound |
| HY-132093 | Azido-PEG5-S-methyl ethanethioate | 1352221-64-7 | Reference compound |
| HY-132094 | Azido-PEG9-S-methyl ethanethioate | 2148986-33-6 | Reference compound |
| HY-132095 | Methyl-PEG4-acyl chloride | 62124-69-0 | Reference compound |
| HY-132096 | Azido-PEG4-acyl chloride | Reference compound | |
| HY-132097 | Bromo-PEG4-PFP ester | Reference compound | |
| HY-132098 | Bis-propargyl-PEG10 | 1351373-48-2 | Reference compound |
| HY-132099 | Fmoc-N-amido-PEG2-azide | Reference compound | |
| HY-13209BS | (Rac)-Ambrisentan-d3 | 1189479-60-4 | Isotope-Labeled Compounds |
| HY-13209BS1 | (Rac)-Ambrisentan-d5 | 1392210-85-3 | Isotope-Labeled Compounds |
| HY-13209C | Ambrisentan (sodium) | 1386915-48-5 | Reference compound |
| HY-13209R | Ambrisentan (Standard) | 177036-94-1 | Reference Standards |
| HY-13209S | Ambrisentan-d10 | 1046116-27-1 | Isotope-Labeled Compounds |
| HY-13210 | Zanamivir | 139110-80-8 | Reference compound |
| HY-132100 | Thiol-PEG2-t-butyl ester | 1398044-50-2 | Reference compound |
| HY-132101 | Amino-PEG7-t-butyl ester | 2428400-07-9 | Reference compound |
| HY-132102 | Bis-CH2-PEG2-acid | 2250056-38-1 | Reference compound |
| HY-132103 | NHS ester-PEG3-S-methyl ethanethioate | Reference compound | |
| HY-132104 | THP-PEG12-alcohol | Reference compound | |
| HY-132105 | Benzyl-PEG6-THP | 230620-73-2 | Reference compound |
| HY-132106 | Benzyl-PEG7-THP | 230620-75-4 | Reference compound |
| HY-132107 | MS-PEG3-THP | 357204-84-3 | Reference compound |
| HY-132108 | Benzyl-PEG3-MS | 702701-70-0 | Reference compound |
| HY-132109 | MS-PEG4-t-butyl ester | 1024602-74-1 | Reference compound |
| HY-13210A | Zanamivir (hydrate)(5:1) | 171094-50-1 | Reference compound |
| HY-13210R | Zanamivir (Standard) | 139110-80-8 | Reference Standards |
| HY-13211 | (E)-2-Decenoic acid | 334-49-6 | Reference compound |
| HY-132110 | Fmoc-N-amido-PEG3-azide | 1172605-58-1 | Reference compound |
| HY-132111 | Fmoc-N-amido-PEG5-azide | 2924480-17-9 | Reference compound |
| HY-132113 | CH2COOH-PEG12-CH2COOH | 2669737-17-9 | Reference compound |
| HY-132114 | Biotin-PEG3-pyridinrthiol | Reference compound | |
| HY-132115 | Biotin-PEG3-SH | 1244028-52-1 | Reference compound |
| HY-132116 | Biotin-PEG3-methyl ethanethioate | Reference compound | |
| HY-132117 | Bromo-PEG12-t-butyl ester | Reference compound | |
| HY-132118 | Bromo-PEG10-t-butyl ester | Reference compound | |
| HY-132119 | Boc-NHCH2CH2-PEG1-azide | 176220-30-7 | Reference compound |
| HY-13211R | (E)-2-Decenoic acid (Standard) | 334-49-6 | Reference Standards |
| HY-13212 | (Z)-2-Decenoic acid | 15790-91-7 | Natural Products |
| HY-132120 | Amino-PEG2-CH2CH2-SH (hydrochloride) | 3037676-58-4 | Reference compound |
| HY-132126 | SPHINX | 848057-98-7 | Reference compound |
| HY-132127 | Cicloprofen | 36950-96-6 | Reference compound |
| HY-132128 | BRD4 Inhibitor-12 | 328956-24-7 | Reference compound |
| HY-132129 | SOS1-IN-2 | 2359690-13-2 | Reference compound |
| HY-13212R | (Z)-2-Decenoic acid (Standard) | 15790-91-7 | Reference Standards |
| HY-13213 | AM211 | 1175526-27-8 | Reference compound |
| HY-132130 | BRD4 Inhibitor-13 | 218934-50-0 | Reference compound |
| HY-132132 | Neutrophil elastase inhibitor 3 | 1234707-32-4 | Reference compound |
| HY-132133 | Nav1.8-IN-1 | 1026822-49-0 | Reference compound |
| HY-132135 | (1E)-CFI-400437 (dihydrochloride) | 1247000-76-5 | Reference compound |
| HY-132136 | DMT-dU-CE Phosphoramidite | 109389-30-2 | Biochemical Assay Reagents |
| HY-132137 | 5-Propargylamino-3'-azidomethyl-dUTP | 666847-57-0 | Biochemical Assay Reagents |
| HY-132137A | 5-Propargylamino-3'-azidomethyl-dUTP (sodium) | Biochemical Assay Reagents | |
| HY-132137B | 5-Propargylamino-3'-azidomethyl-dUTP (tristriethylamine) | Oligonucleotides | |
| HY-132138 | 5-Propargylamino-3'-azidomethyl-dCTP | 666847-71-8 | Biochemical Assay Reagents |
| HY-132138A | 5-Propargylamino-3'-azidomethyl-dCTP (TEA) | Oligonucleotides | |
| HY-132139 | 7-Deaza-7-propargylamino-3'-azidomethyl-dATP | 666847-93-4 | Biochemical Assay Reagents |
| HY-132139A | 7-Deaza-7-propargylamino-3'-azidomethyl-dATP (triethylamine) | Oligonucleotides | |
| HY-13213A | AM211 (sodium) | 1263077-74-2 | Reference compound |
| HY-132140 | 7-Deaza-7-propargylamino-3'-azidomethyl-dGTP | 666847-81-0 | Biochemical Assay Reagents |
| HY-132140A | 7-Deaza-7-propargylamino-3'-azidomethyl-dGTP (triethylamine) | Oligonucleotides | |
| HY-132141 | 5-PA-dUTP | 179101-49-6 | Biochemical Assay Reagents |
| HY-132142 | 5-Propargylamino-dCTP | 115899-39-3 | Biochemical Assay Reagents |
| HY-132143 | 7-Deaza-7-propargylamino-dATP | 587848-72-4 | Biochemical Assay Reagents |
| HY-132143A | 7-Deaza-7-propargylamino-dATP (tetralithium) | Reference compound | |
| HY-132144 | 7-Deaza-7-propargylamino-dGTP | 587848-73-5 | Biochemical Assay Reagents |
| HY-132144A | 7-Deaza-7-propargylamino-dGTP (sodium) | Biochemical Assay Reagents | |
| HY-132145 | 5-Propargylamino-ddUTP | 114748-59-3 | Biochemical Assay Reagents |
| HY-132145A | 5-Propargylamino-ddUTP (triethylamine) (100mM in water) | Biochemical Assay Reagents | |
| HY-132145B | 5-Propargylamino-ddUTP (sodium) (100mM in water) | Biochemical Assay Reagents | |
| HY-132146 | 5-Propargylamino-ddCTP | 114748-56-0 | Biochemical Assay Reagents |
| HY-132146A | 5-Propargylamino-ddCTP (trisodium) solution (25mM) | Biochemical Assay Reagents | |
| HY-132147 | 7-Deaza-7-propargylamino-ddATP | 114748-69-5 | Biochemical Assay Reagents |
| HY-132148 | 7-Deaza-7-propargylamino-ddGTP | 114748-61-7 | Biochemical Assay Reagents |
| HY-13215 | Avasimibe | 166518-60-1 | Reference compound |
| HY-132150A | HPK1-IN-2 (dihydrochloride) | 2375595-72-3 | Reference compound |
| HY-132155 | Indan-5-sulphonamide | 35203-93-1 | Reference compound |
| HY-132156 | Carbonic anhydrase inhibitor 22 | 146533-50-8 | Reference compound |
| HY-132157 | 8-Chloroquinazolin-4-ol | 101494-95-5 | Reference compound |
| HY-132158 | MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin | 2414594-29-7 | ADC Related |
| HY-132159 | MC-AAA-NHCH2OCH2COOH | 2414594-28-6 | ADC Related |
| HY-13216 | Pyroxamide | 382180-17-8 | Reference compound |
| HY-132160 | 7-Aminomethyl-10-methyl-11-fluoro camptothecin | 2378616-23-8 | ADC Related |
| HY-132160A | 7-Aminomethyl-10-methyl-11-fluoro camptothecin (TFA) | Reference compound | |
| HY-132161 | MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT | 2378428-19-2 | ADC Related |
| HY-132162 | 7-MAD-MDCPT | 765871-81-6 | ADC Related |
| HY-132163 | MP-PEG4-VK(Boc)G-OSu | 2378428-21-6 | ADC Related |
| HY-132164 | Gly-7-MAD-MDCPT | 2378427-68-8 | Reference compound |
| HY-132166 | M4205 | 2590556-80-0 | Reference compound |
| HY-132167 | Saruparib | 2589531-76-8 | Reference compound |
| HY-132168 | RMC-5552 | 2382768-62-7 | Reference compound |
| HY-132169 | HCoV-229E-IN-1 | 2639757-13-2 | Reference compound |
| HY-13217 | Vanoxerine (dihydrochloride) | 67469-78-7 | Reference compound |
| HY-132170 | DSM502 | 2426616-55-7 | Reference compound |
| HY-132171 | DSM705 | 2653225-38-6 | Reference compound |
| HY-132171A | DSM705 (hydrochloride) | 2989908-08-7 | Reference compound |
| HY-132172 | TAK1-IN-2 | 2763213-98-3 | Reference compound |
| HY-132173 | GL0388 | 2886772-68-3 | Reference compound |
| HY-132174 | CHIKV-IN-2 | 2361289-44-1 | Reference compound |
| HY-132175 | CK2 inhibitor 2 | 2641079-92-5 | Reference compound |
| HY-132177 | α-L-Fucosidase, Microorganism | 9037-65-4 | Enzyme |
| HY-132177A | α-1-2 Fucosidase, bifidobacterium longum | 9037-65-4 | Enzyme |
| HY-132177B | α1-2,4,6 Fucosidase O, Omnitrophica bacterium | 9037-65-4 | Enzyme |
| HY-132177C | α1-3,4 Fucosidase, Bifidobacterium bifidum | 9037-65-4 | Enzyme |
| HY-132178 | Cytochrome P450 | 9035-51-2 | Enzyme |
| HY-132179 | Fucoidan | 9072-19-9 | Reference compound |
| HY-13217A | Vanoxerine | 67469-69-6 | Reference compound |
| HY-13218 | Acitazanolast | 114607-46-4 | Reference compound |
| HY-132180 | Seco-DUBA (hydrochloride) | 1795733-93-5 | ADC Related |
| HY-132180A | Seco-DUBA | 1227961-59-2 | ADC Related |
| HY-132181 | Dimethylamiloride (hydrochloride) | 2235-97-4 | Reference compound |
| HY-132182 | HPA-12 | 383418-30-2 | Reference compound |
| HY-132183 | Chloride peroxidase | 9055-20-3 | Enzyme |
| HY-132184 | 5,6-Epoxyeicosatrienoic acid | 87173-80-6 | Reference compound |
| HY-132184S | 5,6-Epoxyeicosatrienoic acid-d11 | 1881277-30-0 | Isotope-Labeled Compounds |
| HY-132186 | Abacavir carboxylate | 384380-52-3 | Reference compound |
| HY-132187 | Sphingosylphosphorylcholine | 1670-26-4 | Natural Products |
| HY-132187S | Sphingosylphosphorylcholine-d9 | 2315262-28-1 | Isotope-Labeled Compounds |
| HY-132187S1 | Sphingosylphosphorylcholine-d7 | 2260670-14-0 | Isotope-Labeled Compounds |
| HY-132188 | Manganese peroxidase | 114995-15-2 | Enzyme |
| HY-132189 | Laniquidar | 197509-46-9 | Reference compound |
| HY-13219 | Tepoxalin | 103475-41-8 | Reference compound |
| HY-132190 | Hexanolamino PAF C-16 | 137566-83-7 | Reference compound |
| HY-132191 | Pradimicin A | 117704-65-1 | Natural Products |
| HY-132192 | PD-1/PD-L1-IN-9 | 2628506-54-5 | Reference compound |
| HY-132192A | PD-1/PD-L1-IN-9 (hydrochloride) | Reference compound | |
| HY-132193 | RET-IN-4 | 2436473-55-9 | Reference compound |
| HY-132194 | ERα degrader-2 | 2235396-63-9 | Reference compound |
| HY-132195 | RORγt inverse agonist 14 | 2672496-70-5 | Reference compound |
| HY-132196 | BTK inhibitor 18 | Reference compound | |
| HY-132197 | CBP/p300-IN-12 | 2738688-57-6 | Reference compound |
| HY-132198 | JMJD7-IN-1 | 311316-96-8 | Reference compound |
| HY-132199 | SJ6986 | 2765625-93-0 | Reference compound |
| HY-132200 | UNC5293 | 2226789-82-6 | Reference compound |
| HY-132201 | MK-8153 | 1548286-45-8 | Reference compound |
| HY-132202 | PD-1/PD-L1-IN-10 | 2487550-41-2 | Reference compound |
| HY-132203 | Necrostatin-34 | 375835-43-1 | Reference compound |
| HY-132205 | DS45500853 | 2735803-28-6 | Reference compound |
| HY-132208 | Pomalidomide 4'-PEG2-azide | 2271036-45-2 | Reference compound |
| HY-13221 | BRL 54443 | 57477-39-1 | Reference compound |
| HY-132210 | rel-(2R,4R)-2,4-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane | 116673-45-1 | Reference compound |
| HY-132211 | 3-Thiatetradecanoic acid | 116296-31-2 | Reference compound |
| HY-132212 | LH1307 | 2375720-38-8 | Reference compound |
| HY-132215 | PF-06284674 | 1434288-24-0 | Reference compound |
| HY-132217 | CB2 receptor agonist 2 | 1314230-75-5 | Reference compound |
| HY-132219 | N,N-Dipropyldopamine (hydrobromide) | 65273-66-7 | Reference compound |
| HY-13221A | BRL 54443 (maleate) | 1197333-54-2 | Reference compound |
| HY-13222 | BAN ORL 24 | 1401463-54-4 | Reference compound |
| HY-132221 | CU-32 | 2400954-16-5 | Reference compound |
| HY-132222 | SET2 | 2313525-20-9 | Reference compound |
| HY-132223 | LH1306 | 2182653-84-3 | Reference compound |
| HY-132225 | SB 206553 | 158942-04-2 | Reference compound |
| HY-132228 | Zelatriazin | 1929519-13-0 | Reference compound |
| HY-132229 | LPM4870108 | 2803679-07-2 | Reference compound |
| HY-13222A | BAN ORL 24 (free base) | 475150-69-7 | Reference compound |
| HY-13223 | Crenolanib | 670220-88-9 | Reference compound |
| HY-132230 | GSK040 | 2752331-09-0 | Reference compound |
| HY-132231 | FD223 | 2050524-24-6 | Reference compound |
| HY-132232 | GSK097 | 2159137-02-5 | Reference compound |
| HY-132233 | DDO-2093 | 2250024-74-7 | Reference compound |
| HY-132233A | DDO-2093 (dihydrochloride) | Reference compound | |
| HY-132234 | M-1211 | 2377337-93-2 | Reference compound |
| HY-132237 | Methyl 3-hydroxyhexadecanoate | 51883-36-4 | Biochemical Assay Reagents |
| HY-132238 | Tetradecylphosphonic acid | 4671-75-4 | Biochemical Assay Reagents |
| HY-132239 | 5-Bromo-6-chloro-3-indolyl β-D-Galactopyranoside (contains ca. 10% Ethyl Acetate) | 93863-88-8 | Biochemical Assay Reagents |
| HY-13223A | Crenolanib (benzenesulfonate) | 670220-93-6 | Reference compound |
| HY-13224 | AZD4877 | 758722-49-5 | Reference compound |
| HY-132240 | SF-22 | 824981-55-7 | Reference compound |
| HY-132242 | DL-Sulforaphane N-acetyl-L-cysteine | 334829-66-2 | Reference compound |
| HY-132242R | DL-Sulforaphane N-acetyl-L-cysteine (Standard) | 334829-66-2 | Reference Standards |
| HY-132243 | NFAT Inhibitor-3 | 841210-82-0 | Reference compound |
| HY-132246 | WWL123 analogue-1 | 1338575-41-9 | Reference compound |
| HY-132247 | ErSO | 2407860-35-7 | Reference compound |
| HY-132247A | (±)-ErSO | 2407860-40-4 | Reference compound |
| HY-132247B | (S)-ErSO | 2407860-34-6 | Reference compound |
| HY-132248 | C5 Lenalidomide | 191732-70-4 | Reference compound |
| HY-13224A | AZD4877 (hydrochloride) | 758722-12-2 | Reference compound |
| HY-13225 | Rivanicline oxalate | 220662-95-3 | Reference compound |
| HY-132250 | MCC-DM1 | 1100692-14-5 | ADC Related |
| HY-132251 | MCC | 104676-09-7 | ADC Related |
| HY-132252 | Mal-PEG8-Val-Ala-PABC | ADC Related | |
| HY-132253 | Polatuzumab vedotin | 1313206-42-6 | ADC Related |
| HY-132253A | Polatuzumab vedotin (solution) | 1313206-42-6 | ADC Related |
| HY-132254 | Sacituzumab govitecan | 1491917-83-9 | ADC Related |
| HY-132254A | Sacituzumab govitecan (solution) | 1491917-83-9 | ADC Related |
| HY-132257 | Rovalpituzumab tesirine | 1613313-09-9 | Reference compound |
| HY-132258A | Mirvetuximab soravtansine (solution) | 1453084-37-1 | Reference compound |
| HY-132259 | Depatuxizumab mafodotin | 1585973-65-4 | Reference compound |
| HY-13225A | Rivanicline | 15585-43-0 | Reference compound |
| HY-13225B | Rivanicline hemioxalate | Reference compound | |
| HY-13225D | Rivanicline (fumarate) | 183288-99-5 | Reference compound |
| HY-13226 | Galunisertib | 700874-72-2 | Reference compound |
| HY-132260 | Naratuximab emtansine | 1607824-64-5 | Reference compound |
| HY-132261 | AcBut | 65623-82-7 | ADC Related |
| HY-132262 | Lorvotuzumab mertansine | 1008106-64-6 | Reference compound |
| HY-132263 | FAM hydrazide,5-isomer | 2183440-64-2 | Reference compound |
| HY-132264 | FAM hydrazide, 6-isomer (hydrochloride) | 2183440-65-3 | Dye Reagents |
| HY-132265 | SCO-267 | 1656261-09-4 | Reference compound |
| HY-132266 | BDP TR carboxylic acid | 150152-64-0 | Dye Reagents |
| HY-132267S | N-Nitrosodibenzylamine-d4 | 20002-23-7 | Isotope-Labeled Compounds |
| HY-132268 | Cav 2.2 blocker 2 | 1204535-44-3 | Reference compound |
| HY-132269 | Isoflupredone | 338-95-4 | Reference compound |
| HY-132269R | Isoflupredone (Standard) | 338-95-4 | Reference Standards |
| HY-132269S | Isoflupredone-d5 | Isotope-Labeled Compounds | |
| HY-13226A | Galunisertib (monohydrate) | 924898-09-9 | Reference compound |
| HY-13227 | SD-208 | 627536-09-8 | Reference compound |
| HY-132270 | FAM amine, 5-isomer | 2183440-41-5 | Reference compound |
| HY-132272 | Alkyne amidite, hydroxyprolinol | 1357289-02-1 | Reference compound |
| HY-132273 | Alkyne Phosphoramidite, 5'-terminal | 1417539-32-2 | Reference compound |
| HY-132274 | DMS(O)MT aminolink C6 | 1173109-53-9 | Reference compound |
| HY-132275 | Long trebler phosphoramidite | 1516489-83-0 | Reference compound |
| HY-132276 | PtdIns-(3,4,5)-P3-biotin (sodium) | 1415684-80-8 | Reference compound |
| HY-132277 | 15-Keto Bimatoprost | 1163135-96-3 | Reference compound |
| HY-132277S | 15-Keto Bimatoprost-d5 | Isotope-Labeled Compounds | |
| HY-132278 | DAz-2 | 1176905-54-6 | Dye Reagents |
| HY-13228 | YM-201636 | 371942-69-7 | Reference compound |
| HY-132280 | Tirilazad | 110101-66-1 | Reference compound |
| HY-132280R | Tirilazad (Standard) | 110101-66-1 | Reference Standards |
| HY-132281 | 16-Oxokahweol | 108664-99-9 | Reference compound |
| HY-132282 | Thiamphenicol glycinate (hydrochloride) | 2611-61-2 | Reference compound |
| HY-132283 | PF-9363 | 2569009-58-9 | Reference compound |
| HY-132286 | 2-PADQZ | 60547-97-9 | Reference compound |
| HY-132288 | Pom-8PEG | 2488761-03-9 | Reference compound |
| HY-132289 | Lipid M | 2089251-57-8 | Biochemical Assay Reagents |
| HY-13229 | BOC-D-FMK | 634911-80-1 | Reference compound |
| HY-132290 | TGFβRI-IN-3 | 2763602-67-9 | Reference compound |
| HY-132291 | HIV-1 inhibitor-8 | 2826996-78-3 | Reference compound |
| HY-132292 | ARD-2128 | 2222111-87-5 | Reference compound |
| HY-132293 | BAY-8400 | 2763602-59-9 | Reference compound |
| HY-132294 | GNE-502 | 1953134-16-1 | Reference compound |
| HY-132294A | (1S,3R)-GNE-502 | 1953134-15-0 | Reference compound |
| HY-132295 | Azenosertib | 2376146-48-2 | Reference compound |
| HY-132296 | GSK215 | 2743427-26-9 | Reference compound |
| HY-132297 | PARP1-IN-5 | 2735645-53-9 | Reference compound |
| HY-132297A | PARP1-IN-5 (dihydrochloride) | 2823308-89-8 | Reference compound |
| HY-132298 | TDI-10229 | 2810887-45-5 | Reference compound |
| HY-132299 | PI3Kγ inhibitor 4 | 1821038-80-5 | Reference compound |
| HY-132300 | ZW4864 | 2632259-93-7 | Reference compound |
| HY-132300A | ZW4864 (free base) | 2632259-92-6 | Reference compound |
| HY-132301 | MSC-4381 | 2445185-57-7 | Reference compound |
| HY-132302 | Hu7691 | 2360523-76-6 | Reference compound |
| HY-132302A | Hu7691 (free base) | 2241232-43-7 | Reference compound |
| HY-132303 | MK-8262 | 1432054-03-9 | Reference compound |
| HY-132304 | CC-90005 | 1799574-70-1 | Reference compound |
| HY-132305 | VEGFR-3-IN-1 | 2756668-73-0 | Reference compound |
| HY-132306 | CCF0058981 | 2708934-53-4 | Reference compound |
| HY-132307 | Mcl-1 inhibitor 6 | 2598978-56-2 | Reference compound |
| HY-132308 | DYRK1-IN-1 | 2814486-79-6 | Reference compound |
| HY-132309 | BRD0639 | 2760881-74-9 | Reference compound |
| HY-13231 | CDK9-IN-1 | 1415559-43-1 | Reference compound |
| HY-132310 | MAGL-IN-4 | 2135785-20-3 | Reference compound |
| HY-132313S | 2-(1-Hydroxyethyl) promazine-d4 Sulfoxide | 1346605-30-8 | Isotope-Labeled Compounds |
| HY-132316S | (rac)-2,4-O-Dimethylzearalenone-d6 | 1246833-55-5 | Isotope-Labeled Compounds |
| HY-13232 | ITK antagonist | 1149753-56-9 | Reference compound |
| HY-132326S | N,N-Didesmethyl trimebutine-d5 (hydrochloride) | 1286624-16-5 | Isotope-Labeled Compounds |
| HY-132329S | 2-Hydroxy imipramine-d6 | 1189880-70-3 | Isotope-Labeled Compounds |
| HY-13233 | Talabostat | 149682-77-9 | Reference compound |
| HY-132330S1 | 4-Hydroxy alverine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-132332S | cis-Hydroxy perhexiline-d11 | 1276018-05-3 | Isotope-Labeled Compounds |
| HY-132334S | 9-cis-Retinoic acid-d5 | Isotope-Labeled Compounds | |
| HY-13233A | Talabostat (mesylate) | 150080-09-4 | Reference compound |
| HY-13233B | Talabostat isomer mesylate | Reference compound | |
| HY-13234 | Rifaximin | 80621-81-4 | Reference compound |
| HY-132344S | N-Desmethyl asenapine-d4 (hydrochloride) | 1246820-54-1 | Isotope-Labeled Compounds |
| HY-132348S | Granisetron-d3 | 1224925-64-7 | Isotope-Labeled Compounds |
| HY-132348S1 | Granisetron-d3 (1-methyl-d3) | 1224925-76-1 | Isotope-Labeled Compounds |
| HY-13234R | Rifaximin (Standard) | 80621-81-4 | Reference Standards |
| HY-13234S | Rifaximin-d6 | 1262992-43-7 | Isotope-Labeled Compounds |
| HY-13235 | I-BET151 | 1300031-49-5 | Reference compound |
| HY-132350S | iso-Nadolol (tert-Butyl-d9) | 1246820-10-9 | Isotope-Labeled Compounds |
| HY-132352S1 | (Rac)-4-Hydroxy Duloxetine-d3 | Isotope-Labeled Compounds | |
| HY-132355S | (E)-Fluvoxamine-d3 (maleate) | 1185245-56-0 | Isotope-Labeled Compounds |
| HY-13236 | LUF6000 | 890087-21-5 | Reference compound |
| HY-132362S | 1-(6-Hydroxy-2-propylheptyl) hydrogen 1,2-benzenedicarboxylate-d4 | 1412411-11-0 | Isotope-Labeled Compounds |
| HY-13237 | GSK2578215A | 1285515-21-0 | Reference compound |
| HY-132370S | 5-Hydroxy dantrolene-d4 | 1217225-15-4 | Isotope-Labeled Compounds |
| HY-132372S | 7-Hydroxy amoxapine-d8 | 1216833-74-7 | Isotope-Labeled Compounds |
| HY-132373S | N-Hydroxy Mexiletine-d6 Oxalate | 1330264-84-0 | Isotope-Labeled Compounds |
| HY-132379S | Hydroxy Pioglitazone-d5 (M-IV) (Mixture of-diastereomers) | 1189445-29-1 | Isotope-Labeled Compounds |
| HY-13238 | Dolutegravir | 1051375-16-6 | Reference compound |
| HY-132380S | 3-epi-Ochratoxin A-d5 | 1177316-02-7 | Isotope-Labeled Compounds |
| HY-132382S | β-Sitosterol-d7 (mixture of diasteromers) | 2260669-28-9 | Isotope-Labeled Compounds |
| HY-132383S | 24,25-Dihydroxy Vitamin D2-d3 | 118584-50-2 | Isotope-Labeled Compounds |
| HY-132384S | 5-(Methyl-d3)tetrahydrofolic Acid | 1356019-97-0 | Isotope-Labeled Compounds |
| HY-132386S | Imatinib-d8 (mesylate) | 1092942-83-0 | Isotope-Labeled Compounds |
| HY-132389S | Vitamin K3-d8 | 478171-80-1 | Isotope-Labeled Compounds |
| HY-13238A | Dolutegravir (sodium) | 1051375-19-9 | Reference compound |
| HY-13238R | Dolutegravir (Standard) | 1051375-16-6 | Reference Standards |
| HY-13238S1 | Dolutegravir-d3 | Isotope-Labeled Compounds | |
| HY-13238S2 | Dolutegravir-d5 | 2249814-82-0 | Isotope-Labeled Compounds |
| HY-13239 | LY2979165 | 1311385-32-6 | Reference compound |
| HY-132390S | Normesuximide-d5 | 1185130-51-1 | Isotope-Labeled Compounds |
| HY-132392S | L-DOPA-2,5,6-d3 | 53587-29-4 | Isotope-Labeled Compounds |
| HY-132394S | Hydroxy Atrazine-d5 | 1276197-25-1 | Isotope-Labeled Compounds |
| HY-132395S | 2-Phenanthrol-d9 | 922510-19-8 | Isotope-Labeled Compounds |
| HY-132397S | Phenylephrone-d3 (hydrochloride) | 1246819-29-3 | Isotope-Labeled Compounds |
| HY-132399S | Methsuximide-d5 | 1189980-63-9 | Isotope-Labeled Compounds |
| HY-13239A | LY2979165 (free base) | 1311385-35-9 | Reference compound |
| HY-13240 | LY2886721 | 1262036-50-9 | Reference compound |
| HY-132402S | N-Propionyl Mesalazine-d3 | 1330265-97-8 | Isotope-Labeled Compounds |
| HY-132404S | (rac)-3-O-Methyl DOPA-d3 | 1219173-95-1 | Isotope-Labeled Compounds |
| HY-132405S | Desmethyl Naproxen-d3 | 1189427-82-4 | Isotope-Labeled Compounds |
| HY-132409S | Monocrotophos-d6 | 1795136-77-4 | Isotope-Labeled Compounds |
| HY-13240A | LY2886721 (hydrochloride) | 1262036-49-6 | Reference compound |
| HY-13241 | Ralimetinib dimesylate | 862507-23-1 | Reference compound |
| HY-132412S | D-erythro-Ritalinic acid-d10 | 1330166-48-7 | Isotope-Labeled Compounds |
| HY-132413S | Octhilinone-d17 | 1185109-79-8 | Isotope-Labeled Compounds |
| HY-132417S | (rac)-N,O-Didesmethyl Tramadol-d3 | 1261398-22-4 | Isotope-Labeled Compounds |
| HY-13241A | Ralimetinib | 862505-00-8 | Reference compound |
| HY-13242 | Taladegib | 1258861-20-9 | Reference compound |
| HY-132421S | (±)-Equol-d4 | 1216469-13-4 | Isotope-Labeled Compounds |
| HY-132422S | Nor Lidocaine-d5 (hydrochloride) | 1329497-00-8 | Isotope-Labeled Compounds |
| HY-132423S | 4-Hydroxy Clonidine-d4 | 1189988-05-3 | Isotope-Labeled Compounds |
| HY-132425S | 6-Hydroxy Melatonin-d4 | 69533-61-5 | Isotope-Labeled Compounds |
| HY-132426S | Thiram-d12 | 69193-86-8 | Isotope-Labeled Compounds |
| HY-132427S | 3-Hydroxy Lidocaine-d5 | 1286482-71-0 | Isotope-Labeled Compounds |
| HY-132428S | O-Desmethyl Tramadol-d6 | 873928-73-5 | Isotope-Labeled Compounds |
| HY-132429S | 3-Indoxyl Sulfate-d5 (potassium) | 1644451-34-2 | Isotope-Labeled Compounds |
| HY-13243 | Alvimopan | 156053-89-3 | Reference compound |
| HY-132431S | Didesmethyl Sibutramine-d6 | 1189727-93-2 | Isotope-Labeled Compounds |
| HY-132436S | 4’-Hydroxy Flurbiprofen-d3 | 1189694-02-7 | Isotope-Labeled Compounds |
| HY-132439S | 4-Hydroxy Mepivacaine-d3 | 1323251-06-4 | Isotope-Labeled Compounds |
| HY-13243S1 | Alvimopan-d7 | 1261396-48-8 | Isotope-Labeled Compounds |
| HY-13244 | Disufenton sodium | 168021-79-2 | Reference compound |
| HY-132440S | Iso Rizatriptan-d6 | 1329834-30-1 | Isotope-Labeled Compounds |
| HY-132441S | (rac)-Mepindolol-d7 | 1794970-97-0 | Isotope-Labeled Compounds |
| HY-132442S | ∆8,9-Dehydro Estrone-d2 | 1219799-27-5 | Isotope-Labeled Compounds |
| HY-132444S | 5-Methoxytryptophol-benzene-d4 | 75238-47-0 | Isotope-Labeled Compounds |
| HY-132446S | Metoprolol Acid-d5 | 1215404-47-9 | Isotope-Labeled Compounds |
| HY-132447S | Nefopam-d3 N-Oxide | 1346603-50-6 | Isotope-Labeled Compounds |
| HY-13245 | PF-4136309 | 1341224-83-6 | Reference compound |
| HY-132451S | (R,S)-4-Hydroxy Cyclophosphamide-d4 Preparation Kit | 1329838-09-6 | Isotope-Labeled Compounds |
| HY-132457S | Fenthion-d6 | 1189662-83-6 | Isotope-Labeled Compounds |
| HY-13245A | (s)-PF-4136309 | 1372407-07-2 | Reference compound |
| HY-13245B | (Rac)-PF-4136309 | 857679-55-1 | Reference compound |
| HY-13246 | Apitolisib | 1032754-93-0 | Reference compound |
| HY-132461S | 2-Hydroxy Desipramine-d3 | 1189998-63-7 | Isotope-Labeled Compounds |
| HY-132461S1 | 2-Hydroxy Desipramine-d6 | 2733014-95-2 | Isotope-Labeled Compounds |
| HY-132464S1 | Esmolol acid-d7 (sodium) | Isotope-Labeled Compounds | |
| HY-132466S | Hydroxy Torsemide-d7 | 1329613-35-5 | Isotope-Labeled Compounds |
| HY-132468S | Keto Pioglitazone-d4 (M-III-d4) | 1185033-84-4 | Isotope-Labeled Compounds |
| HY-13247 | Setrobuvir | 1071517-39-9 | Reference compound |
| HY-132473S | rac Felodipine-(Methoxy-d3) | 1189970-31-7 | Isotope-Labeled Compounds |
| HY-132475S | rac-Duloxetine-d3 (oxalate) | 1346599-22-1 | Isotope-Labeled Compounds |
| HY-132476S | N-Methyl Gatifloxacin-d3 | 1216721-34-4 | Isotope-Labeled Compounds |
| HY-132477S | (Z)-4-Hydroxy Tamoxifen-d5 | 164365-20-2 | Isotope-Labeled Compounds |
| HY-13248 | AR-C155858 | 496791-37-8 | Reference compound |
| HY-132480S | Ciclopirox-d11 β-D-Glucuronide | 1279033-13-4 | Isotope-Labeled Compounds |
| HY-132483S | 7-Hydroxy Prochlorperazine-d8 | 1246819-57-7 | Isotope-Labeled Compounds |
| HY-132484S | 4-Hydroxy Propafenone-d5 (hydrochloride) | 1189863-32-8 | Isotope-Labeled Compounds |
| HY-132486S | Cetalkonium Chloride-d7 | 1998128-85-0 | Isotope-Labeled Compounds |
| HY-13249 | 1alpha-Hydroxy VD4 | 143032-85-3 | Reference compound |
| HY-132490S | 5-Hydroxy Buspirone-d8 | 1330164-16-3 | Isotope-Labeled Compounds |
| HY-132493S | Tiagabine-methyl-d6 (hydrochloride) | 1217808-68-8 | Isotope-Labeled Compounds |
| HY-132494S | Perazine-d8 | 1246815-57-5 | Isotope-Labeled Compounds |
| HY-132496S | 4’-Hydroxyphenyl Carvedilol-d3 | 1189675-28-2 | Isotope-Labeled Compounds |
| HY-13250 | Silvestrol aglycone | 960365-65-5 | Reference compound |
| HY-132504S | Tianeptine Metabolite MC5-d4 (sodium salt) | 1330171-36-2 | Isotope-Labeled Compounds |
| HY-132508S | Etravirine-d8 | 1142096-06-7 | Isotope-Labeled Compounds |
| HY-13250B | Silvestrol aglycone (enantiomer) | 1112993-18-6 | Reference compound |
| HY-13251 | Silvestrol | 697235-38-4 | Natural Products |
| HY-132518S | Pyrazole N-Demethyl Sildenafil-d3 | 1185044-03-4 | Isotope-Labeled Compounds |
| HY-13252 | MK-5108 | 1010085-13-8 | Reference compound |
| HY-132523S | Menaquinone 4-d7 2,3-Epoxide | 1233937-43-3 | Isotope-Labeled Compounds |
| HY-13253 | AMG 900 | 945595-80-2 | Reference compound |
| HY-132530S | NVP-BEZ 235-d3 | 1133206-74-2 | Isotope-Labeled Compounds |
| HY-13254 | A-674563 | 552325-73-2 | Reference compound |
| HY-132549S | Nilotinib-d3 | 1215678-43-5 | Isotope-Labeled Compounds |
| HY-13254A | A-674563 (hydrochloride) | 2070009-66-2 | Reference compound |
| HY-13255 | TAME | 901-47-3 | Reference compound |
| HY-132559S | PD-166285-d4 | 1246814-59-4 | Isotope-Labeled Compounds |
| HY-13255A | TAME hydrochloride | 1784-03-8 | Reference compound |
| HY-13256 | Desmethyl Erlotinib (hydrochloride) | 183320-51-6 | Reference compound |
| HY-13256A | Desmethyl Erlotinib | 183321-86-0 | Reference compound |
| HY-13256AR | Desmethyl Erlotinib (Standard) | 183321-86-0 | Reference Standards |
| HY-13256AS | Desmethyl Erlotinib-d4 | 1216420-11-9 | Isotope-Labeled Compounds |
| HY-13256AS1 | Desmethyl Erlotinib-d4-1 | 2012598-45-5 | Isotope-Labeled Compounds |
| HY-13256R | Desmethyl Erlotinib (hydrochloride) (Standard) | 183320-51-6 | Reference Standards |
| HY-13257 | Thiazovivin | 1226056-71-8 | Reference compound |
| HY-132572 | HIV-1 integrase inhibitor 9 | 2709085-95-8 | Reference compound |
| HY-132578 | M5N36 | 2832887-40-6 | Reference compound |
| HY-132579 | Tominersen | 1709886-74-7 | Oligonucleotides |
| HY-132579A | Tominersen (sodium) | Oligonucleotides | |
| HY-13257G | Thiazovivin (GMP) | 1226056-71-8 | GMP Small Molecules |
| HY-13258 | NVP-BHG712 isomer | 2245892-85-5 | Reference compound |
| HY-132580 | Tofersen | 2088232-70-4 | Oligonucleotides |
| HY-132580A | Tofersen (sodium) | 1898254-60-8 | Oligonucleotides |
| HY-132581 | Tadnersen | 2170507-65-8 | Oligonucleotides |
| HY-132581A | Tadnersen (sodium) | Oligonucleotides | |
| HY-132582 | IONIS-MAPTRx | 2857842-32-9 | Oligonucleotides |
| HY-132582A | Tau ASO-12 (murine) (sodium) | Oligonucleotides | |
| HY-132582C | IONIS-MAPTRx (sodium) | Oligonucleotides | |
| HY-132583 | IONIS-DNM2-2.5Rx | 2857839-05-3 | Oligonucleotides |
| HY-132583A | IONIS-DNM2-2.5Rx (sodium) | Oligonucleotides | |
| HY-132584 | Casimersen | 1422958-19-7 | Oligonucleotides |
| HY-132584A | Casimersen (sodium) | Oligonucleotides | |
| HY-132585A | SRP-5051 (sodium) | Oligonucleotides | |
| HY-132586 | Viltolarsen | 2055732-84-6 | Oligonucleotides |
| HY-132586A | Viltolarsen (sodium) | Oligonucleotides | |
| HY-132587 | Fitusiran | 1499251-18-1 | Oligonucleotides |
| HY-132587A | Fitusiran (sodium) | Oligonucleotides | |
| HY-132588 | Lumasiran | 1834610-13-7 | Oligonucleotides |
| HY-132589 | Vutrisiran | 1867157-35-4 | Oligonucleotides |
| HY-132589A | Vutrisiran (sodium) | Oligonucleotides | |
| HY-13258A | NVP-BHG712 | 940310-85-0 | Reference compound |
| HY-13259 | MG-132 | 133407-82-6 | Reference compound |
| HY-132590 | Revusiran | 1438322-82-7 | Oligonucleotides |
| HY-132590A | Revusiran (sodium) | Oligonucleotides | |
| HY-132591 | Inclisiran | 1639324-58-5 | Oligonucleotides |
| HY-132591A | Inclisiran (sodium) | Oligonucleotides | |
| HY-132592 | Suvodirsen | 2095270-67-8 | Oligonucleotides |
| HY-132592A | Suvodirsen (sodium) | 2142024-01-7 | Oligonucleotides |
| HY-132593 | Rovanersen | 2072901-32-5 | Oligonucleotides |
| HY-132593A | Rovanersen (sodium) | 2231347-41-2 | Oligonucleotides |
| HY-132595 | Teprasiran | 1231737-88-4 | Oligonucleotides |
| HY-132595A | Teprasiran (sodium) | 2169310-72-7 | Oligonucleotides |
| HY-132596 | Tivanisiran | 1848224-71-4 | Oligonucleotides |
| HY-132596A | Tivanisiran (sodium) | 1848239-71-3 | Oligonucleotides |
| HY-132598 | Miravirsen | 1072874-90-8 | Oligonucleotides |
| HY-132598A | Miravirsen (sodium) | Oligonucleotides | |
| HY-13259C | (R)-MG-132 | 1211877-36-9 | Reference compound |
| HY-13259D | MG-132 (negative control) | Reference compound | |
| HY-13260 | CCT128930 | 885499-61-6 | Reference compound |
| HY-132600 | RG-101 | 1929655-04-8 | Oligonucleotides |
| HY-132600A | RG-101 (sodium) | Oligonucleotides | |
| HY-132601 | Cobomarsen | 1848257-52-2 | Oligonucleotides |
| HY-132601A | Cobomarsen (sodium) | 1848257-85-1 | Oligonucleotides |
| HY-132602 | Remlarsen | 1848266-71-6 | Oligonucleotides |
| HY-132602A | Remlarsen (sodium) | Oligonucleotides | |
| HY-132604 | Fazirsiran | 2175009-08-0 | Oligonucleotides |
| HY-132604A | Fazirsiran (sodium) | 2175009-09-1 | Oligonucleotides |
| HY-132606 | Nedosiran | 2266591-83-5 | Oligonucleotides |
| HY-132606A | Nedosiran (sodium) | 2247026-22-6 | Oligonucleotides |
| HY-132607 | MTL-CEBPA | 2862057-05-2 | Oligonucleotides |
| HY-132607A | MTL-CEBPA (sodium) | Oligonucleotides | |
| HY-132608 | Inotersen (sodium) | 1432726-13-0 | Oligonucleotides |
| HY-132609 | Patisiran (sodium) | 1386913-72-9 | Oligonucleotides |
| HY-13260A | CCT128930 (hydrochloride) | 2453324-32-6 | Reference compound |
| HY-13261 | A66 | 1166227-08-2 | Reference compound |
| HY-132610 | Givosiran | 1639325-43-1 | Oligonucleotides |
| HY-132610A | Givosiran (sodium) | 1639325-44-2 | Oligonucleotides |
| HY-132611 | Golodirsen | 1422959-91-8 | Oligonucleotides |
| HY-132611A | Golodirsen (sodium) | Oligonucleotides | |
| HY-132613 | Lumasiran (sodium) | 1834612-06-4 | Oligonucleotides |
| HY-132617S | Carboxy Gliclazide-d4 | 1346602-90-1 | Isotope-Labeled Compounds |
| HY-132618S | N-Acetyltyramine Glucuronide-d3 | 1429623-59-5 | Isotope-Labeled Compounds |
| HY-13262 | Lumacaftor | 936727-05-8 | Reference compound |
| HY-132626S | N-Desmethyl Tamoxifen-d5 | 164365-16-6 | Isotope-Labeled Compounds |
| HY-132628S | (Rac)-trans-N-Methyl Sertraline-d6 (hydrochloride) | 2124272-18-8 | Isotope-Labeled Compounds |
| HY-13262S | Lumacaftor-d4 | 2733561-44-7 | Isotope-Labeled Compounds |
| HY-13263 | CHIR-124 | 405168-58-3 | Reference compound |
| HY-132636S | (Rac)-5-Carboxy Tolterodine-d14 | 1189681-84-2 | Isotope-Labeled Compounds |
| HY-132637S | Chlorfenvinphos-d10(Mixture of cis-trans isomers) | 1346606-54-9 | Isotope-Labeled Compounds |
| HY-13264 | Degrasyn | 856243-80-6 | Reference compound |
| HY-132641S | Equilin 3-Sulfate-d4 (sodium salt) | 285979-81-9 | Isotope-Labeled Compounds |
| HY-132643S | Benzyldimethyltetradecylammonium-d7 (chloride) | 1219178-72-9 | Isotope-Labeled Compounds |
| HY-132644S1 | 3-Demethyl Thiocolchicine--13C2,d6 | Isotope-Labeled Compounds | |
| HY-132645S | (Rac)-Tolterodine-d14 (hydrochloride) | 1246816-99-8 | Isotope-Labeled Compounds |
| HY-132649S | α-Cholestane-d4 | 205529-74-4 | Isotope-Labeled Compounds |
| HY-13265 | AR-42 | 935881-37-1 | Reference compound |
| HY-132651S | Dehydro Mefloquine-d5 | 1246819-32-8 | Isotope-Labeled Compounds |
| HY-132657S | Dehydro Felodipine-d3 | 1189916-52-6 | Isotope-Labeled Compounds |
| HY-13266 | BS-181 | 1092443-52-1 | Reference compound |
| HY-132665S | (R)-(+)-Celiprolol-d9 (hydrochloride) | 1330045-90-3 | Isotope-Labeled Compounds |
| HY-13266A | BS-181 (hydrochloride) | 1397219-81-6 | Reference compound |
| HY-13267 | Droxinostat | 99873-43-5 | Reference compound |
| HY-132670S | (R)-(-)-Felodipine-d5 | 1217744-87-0 | Isotope-Labeled Compounds |
| HY-132674S | Benzylhydrochlorothiazide-d5 | 1185024-05-8 | Isotope-Labeled Compounds |
| HY-132675S | Prochlorperazine Sulfoxide-d3 | 1189943-37-0 | Isotope-Labeled Compounds |
| HY-132676S | Ramiprilat-d5 (Mixture of Diastereomers) | 1356837-92-7 | Isotope-Labeled Compounds |
| HY-132681S | (Rac)-Cinacalcet-d3 (hydrochloride) | 1185097-33-9 | Isotope-Labeled Compounds |
| HY-132685AS | N-Desmethyl Topotecan-d3 (hydrochloride) | 2701830-42-2 | Isotope-Labeled Compounds |
| HY-13269 | BMS-707035 | 729607-74-3 | Reference compound |
| HY-132690S | N-Demethyl Trimebutine-d5 (hydrochloride) | 1286632-72-1 | Isotope-Labeled Compounds |
| HY-132690S1 | N-Demethyl Trimebutine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-132692S | N-Acetyl Norgestimate-d6 | 1263195-02-3 | Isotope-Labeled Compounds |
| HY-13270 | ABT-751 | 141430-65-1 | Reference compound |
| HY-132706S | N-Deformyl Formoterol-d6 Fumarate (Mixture of Diastereomers) | 1795142-59-4 | Isotope-Labeled Compounds |
| HY-132709S | N-Desmethyl-diltiazem-d4 (hydrochloride) | 1217650-51-5 | Isotope-Labeled Compounds |
| HY-13270A | ABT-751 (hydrochloride) | 141450-48-8 | Reference compound |
| HY-13271 | Tubastatin A (Hydrochloride) | 1310693-92-5 | Reference compound |
| HY-132710S | Tris(1,3-dichloro-2-propyl) Phosphate-d15 | 1447569-77-8 | Isotope-Labeled Compounds |
| HY-13271A | Tubastatin A | 1252003-15-8 | Reference compound |
| HY-13271B | Tubastatin A (TFA) | 1239262-52-2 | Reference compound |
| HY-13272 | Dacomitinib | 1110813-31-4 | Reference compound |
| HY-132723AS | 17β-Estradiol-3-β-D-glucuronide-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-132723S | 17β-Estradiol-3-β-D-glucuronide-d3 | 1260231-06-8 | Isotope-Labeled Compounds |
| HY-13272R | Dacomitinib (Standard) | 1110813-31-4 | Reference Standards |
| HY-13272S2 | Dacomitinib-d10 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-13272S3 | Dacomitinib-d10 | Isotope-Labeled Compounds | |
| HY-13273 | Ostarine | 841205-47-8 | Reference compound |
| HY-13273S | Ostarine-d4 | 1202044-20-9 | Isotope-Labeled Compounds |
| HY-13274 | JTC-801 | 244218-51-7 | Reference compound |
| HY-13274A | JTC-801 (free base) | 244218-93-7 | Reference compound |
| HY-13275 | IRAK inhibitor 1 | 1042224-63-4 | Reference compound |
| HY-13276 | IRAK inhibitor 2 | 928333-30-6 | Reference compound |
| HY-13277 | IRAK inhibitor 3 | 1012343-93-9 | Reference compound |
| HY-13278 | IRAK inhibitor 4 | 1012104-68-5 | Reference compound |
| HY-132787S | N-Nitrosodiethanolamine-d8 | 1173019-53-8 | Isotope-Labeled Compounds |
| HY-13278A | IRAK inhibitor 4 (trans) | 2070014-89-8 | Reference compound |
| HY-132795S | Des(1-cyclohexanol) Venlafaxine-d6 | 1330046-00-8 | Isotope-Labeled Compounds |
| HY-132798S | Desethylatrazine-d7 | 1216649-31-8 | Isotope-Labeled Compounds |
| HY-13280 | IRAK inhibitor 6 | 1042672-97-8 | Reference compound |
| HY-132800S | 7-Methyl-3-methyluric acid-d3 | 383160-11-0 | Isotope-Labeled Compounds |
| HY-132804S | 2-Ethyl-2-phenylmalonamide-d5 | 1215398-95-0 | Isotope-Labeled Compounds |
| HY-132805S | N-Acetyl-S-(2-hydroxyethyl)-L-cysteine-d4 (dicyclohexylamine salt) | 1331894-57-5 | Isotope-Labeled Compounds |
| HY-132806 | Alogabat | 2230009-48-8 | Reference compound |
| HY-132807 | Amdizalisib | 1894229-05-0 | Reference compound |
| HY-132808 | Atuzabrutinib | 1581714-49-9 | Reference compound |
| HY-132809 | Baxdrostat | 1428652-17-8 | Reference compound |
| HY-132809A | (S)-Baxdrostat | 1428652-16-7 | Reference compound |
| HY-132809B | (Rac)-Baxdrostat | 1428652-15-6 | Reference compound |
| HY-13281 | PIK-75 (hydrochloride) | 372196-77-5 | Reference compound |
| HY-132810 | Bevurogant | 1817773-66-2 | Reference compound |
| HY-132811 | Dazucorilant | 1496508-34-9 | Reference compound |
| HY-132812 | Emraclidine | 2170722-84-4 | Reference compound |
| HY-132813 | Evifacotrep | 2413739-88-3 | Reference compound |
| HY-132814 | Fosgonimeton | 2093305-05-4 | Reference compound |
| HY-132815 | Fostroxacitabine bralpamide | 2129993-56-0 | Reference compound |
| HY-132817 | Gunagratinib | 2211082-53-8 | Reference compound |
| HY-132818 | Idrevloride | 1416973-63-1 | Reference compound |
| HY-132819 | Ilunocitinib | 1187594-14-4 | Reference compound |
| HY-13282 | GANT 58 | 64048-12-0 | Reference compound |
| HY-132820 | Inaxaplin | 2446816-88-0 | Reference compound |
| HY-132821 | Irsenontrine | 1429509-82-9 | Reference compound |
| HY-132821A | Irsenontrine (maleate) | 1630083-70-3 | Reference compound |
| HY-132821B | (R)-Irsenontrine | 1429509-81-8 | Reference compound |
| HY-132822 | Ivospemin | 748119-79-1 | Reference compound |
| HY-132823 | Ledaborbactam | 1842397-36-7 | Reference compound |
| HY-132824 | Ledaborbactam etzadroxil | 1842399-68-1 | Reference compound |
| HY-132825 | Mivorilaner | 1414642-93-5 | Reference compound |
| HY-132827 | Ocedurenone | 1359969-24-6 | Reference compound |
| HY-132828 | Odatroltide | 1639303-73-3 | Reference compound |
| HY-132829 | Rucosopasem manganese | 2248030-85-3 | Reference compound |
| HY-13283 | MF63 | 892549-43-8 | Reference compound |
| HY-132830 | Sebetralstat | 1933514-13-6 | Reference compound |
| HY-132831 | Selnoflast | 2260969-36-4 | Reference compound |
| HY-132831A | Selnoflast (calcium) | 2887416-19-3 | Reference compound |
| HY-132831B | Selnoflast (potassium) | Reference compound | |
| HY-132832 | Sirpiglenastat | 2079939-05-0 | Reference compound |
| HY-132833S | 1,7-Dimethyl-1H-imidazo[4,5-g]quinoxalin-2-amine-d3 | Isotope-Labeled Compounds | |
| HY-132834S | 5-Carboxy-N-phenyl-2-1H-pyridone-d5 | 1020719-24-7 | Isotope-Labeled Compounds |
| HY-132836S | N2-Lauroyl-L-glutamine-d23 | 1795786-88-7 | Isotope-Labeled Compounds |
| HY-132840 | Sovilnesib | 2410796-79-9 | Reference compound |
| HY-132841 | Sucunamostat | 1802888-04-5 | Reference compound |
| HY-132841A | Sucunamostat (hydrochloride) | Reference compound | |
| HY-132842 | Sunvozertinib | 2370013-12-8 | Reference compound |
| HY-132842A | (S)-Sunvozertinib | 2370013-49-1 | Reference compound |
| HY-132844 | Tunlametinib | 1801756-06-8 | Reference compound |
| HY-132845 | Utreloxastat | 1213269-96-5 | Reference compound |
| HY-132846 | Vepafestinib | 2129515-96-2 | Reference compound |
| HY-132847 | Vibozilimod | 1403232-33-6 | Reference compound |
| HY-132848 | Polyvinylimidazole | 25232-42-2 | Biochemical Assay Reagents |
| HY-132849 | Nezulcitinib | 2412496-23-0 | Reference compound |
| HY-13284S | 7-α-Methylthio Spironolactone-d3 | Isotope-Labeled Compounds | |
| HY-13285 | Ki16425 | 355025-24-0 | Reference compound |
| HY-132850 | Dazcapistat | 2221010-42-8 | Reference compound |
| HY-132851 | Corixetan | 1952359-26-0 | ADC Related |
| HY-132853S | Bis(2-ethoxyethyl) phthalate-3,4,5,6-d4 | 1398066-12-0 | Isotope-Labeled Compounds |
| HY-132854S | Bis(2-butoxyethyl) phthalate-d4 | 1398065-96-7 | Isotope-Labeled Compounds |
| HY-132855S | Bis(4-methyl-2-pentyl) phthalate-d4 | 1398066-13-1 | Isotope-Labeled Compounds |
| HY-132856 | Lenalidomide-C5-amido-Boc | 2138441-25-3 | Reference compound |
| HY-132857 | ZXH-4-130 | 2711006-66-3 | Reference compound |
| HY-132857A | ZXH-4-130 (TFA) | 2711006-67-4 | Reference compound |
| HY-132858 | Thalidomide-4-O-C10-COOH | 2379870-45-6 | Reference compound |
| HY-132859 | Bromo-C10-OBn | 78277-30-2 | Reference compound |
| HY-132860S | Benzo[e]pyrene-d12 | 205440-82-0 | Isotope-Labeled Compounds |
| HY-132862 | ZXH-4-137 | 2711006-74-3 | Reference compound |
| HY-132863 | FTO-IN-2 | 2585198-85-0 | Reference compound |
| HY-132865 | FTO-IN-3 | 2585198-87-2 | Reference compound |
| HY-132866 | YS-370 | 2470908-79-1 | Reference compound |
| HY-132867 | MNK/PIM-IN-1 | 2430792-91-7 | Reference compound |
| HY-132868 | SLK/STK10-IN-1 | 264210-49-3 | Reference compound |
| HY-132869 | MEIS-IN-1 | 2761326-82-1 | Reference compound |
| HY-13286S | N-Hydroxy (E)-2-(4-methoxybenzoxy)-4-methoxy-3-prenylcinnamamide-d6 | Isotope-Labeled Compounds | |
| HY-13287 | SGI-1776 (free base) | 1025065-69-3 | Reference compound |
| HY-132870 | MEIS-IN-2 | 2761326-86-5 | Reference compound |
| HY-132871 | MEIS-IN-3 | 2761326-88-7 | Reference compound |
| HY-132878 | FgGpmk1-IN-1 | 319490-29-4 | Reference compound |
| HY-132879 | TAK-020 | 1627603-21-7 | Reference compound |
| HY-13287A | SGI-1776 | 1173928-26-1 | Reference compound |
| HY-13288 | Org 27569 | 868273-06-7 | Reference compound |
| HY-132880 | GSK251 | 2125968-05-8 | Reference compound |
| HY-132882 | ARN19689 | 2320521-34-2 | Reference compound |
| HY-132883 | EGFR/CSC-IN-1 | 2820447-02-5 | Reference compound |
| HY-132884 | TTK inhibitor 3 | 2820453-41-4 | Reference compound |
| HY-132885 | PARP/EZH2-IN-1 | 2687273-52-3 | Reference compound |
| HY-132886 | SARS-CoV-2-IN-6 | 2725749-22-2 | Reference compound |
| HY-132887 | PDE4-IN-3 | 2755687-49-9 | Reference compound |
| HY-132888 | NCATS-SM4487 | 2733617-81-5 | Reference compound |
| HY-132889 | BPTF-IN-BZ1 | 2766623-38-3 | Reference compound |
| HY-13289 | Nepicastat | 173997-05-2 | Reference compound |
| HY-132891 | RSK4-IN-1 | 2755819-10-2 | Reference compound |
| HY-132891A | RSK4-IN-1 (TFA) | Reference compound | |
| HY-132892 | NLRP3-IN-4 | 2758595-77-4 | Reference compound |
| HY-132893 | AZ14145845 | 2830555-70-7 | Reference compound |
| HY-132894 | Pixavir marboxilo | 2365473-17-0 | Reference compound |
| HY-132895 | JNJ-67569762 | 2380313-26-6 | Reference compound |
| HY-132896 | KDM4-IN-3 | 1068515-53-6 | Reference compound |
| HY-132897 | PCSK9-IN-2 | 2099167-44-7 | Reference compound |
| HY-132898 | PI3K-IN-23 | 2755651-17-1 | Reference compound |
| HY-13289A | Nepicastat (hydrochloride) | 170151-24-3 | Reference compound |
| HY-13289B | (R)-Nepicastat (hydrochloride) | 195881-94-8 | Reference compound |
| HY-13290 | KN-62 | 127191-97-3 | Reference compound |
| HY-132900 | RORγ agonist 1 | 2260631-91-0 | Reference compound |
| HY-132901 | IACS-15414 | 2411321-29-2 | Reference compound |
| HY-132902 | DEPTOR-IN-1 | 2615911-12-9 | Reference compound |
| HY-132903 | eeAChE-IN-1 | 2763366-27-2 | Reference compound |
| HY-132904 | eeAChE-IN-2 | 2763366-33-0 | Reference compound |
| HY-132905 | Antileishmanial agent-2 | 2863687-18-5 | Reference compound |
| HY-132906 | Antimalarial agent 3 | 3033386-12-5 | Reference compound |
| HY-132907 | MAO-B-IN-2 | 1253978-24-3 | Reference compound |
| HY-132908 | Anti-ToCV agent 1 | 2848583-24-2 | Reference compound |
| HY-132909 | Nurr1 inverse agonist-1 | 2758673-07-1 | Reference compound |
| HY-132910 | Antitubercular agent-9 | 2722634-44-6 | Reference compound |
| HY-132911 | Antiviral agent 6 | 2847129-11-5 | Reference compound |
| HY-132912 | Antifungal agent 15 | 2639531-53-4 | Reference compound |
| HY-132913 | Cyclopropenone probe 1 | 2771119-22-1 | Reference compound |
| HY-132914 | CDK/HDAC-IN-1 | 2762181-73-5 | Reference compound |
| HY-132915 | Anti gram-positive/negative bacteria agent 1 | 3031404-92-6 | Reference compound |
| HY-132916 | Antiviral agent 7 | Reference compound | |
| HY-132917 | ADAM8-IN-1 | 2758892-64-5 | Reference compound |
| HY-132918 | Antibacterial agent 30 | 2694867-40-6 | Reference compound |
| HY-13292 | Impurity B of Calcitriol | 66791-71-7 | Reference compound |
| HY-132920 | KRAS mutant protein inhibitor 1 | 2642630-16-6 | Reference compound |
| HY-132922 | EEDi-5273 | 2585648-55-9 | Reference compound |
| HY-132923 | NBTIs-IN-4 | 2758890-16-1 | Reference compound |
| HY-132924 | BMS-963272 | 1441057-15-3 | Reference compound |
| HY-132925 | Antifungal agent 16 | 2762034-41-1 | Reference compound |
| HY-132926 | HPK1-IN-8 | 1214561-09-7 | Reference compound |
| HY-132927 | Salpyran | 2719737-44-5 | Reference compound |
| HY-132927A | Salpyran (hydrochloride) | Reference compound | |
| HY-132927B | Salpyran (dihydrochloride) | Reference compound | |
| HY-132928 | Antitubercular agent-10 | 2679830-78-3 | Reference compound |
| HY-132929 | TCMDC-125431 | 3015474-50-4 | Reference compound |
| HY-13293 | Impurity C of Calcitriol | 86307-44-0 | Reference compound |
| HY-132930 | TCMDC-136230 | 3015474-48-0 | Reference compound |
| HY-132931 | TCMDC-125457 | 872113-12-7 | Reference compound |
| HY-132932 | Cavα2δ-IN-1 | 2416957-09-8 | Reference compound |
| HY-132933 | Fungicide4 | 7412-05-7 | Reference compound |
| HY-132934 | Ac32Az19 | 2760674-72-2 | Reference compound |
| HY-132935 | BPR1R024 | 2503015-75-4 | Reference compound |
| HY-132935A | BPR1R024 (mesylate) | 2763365-40-6 | Reference compound |
| HY-132936 | CXCR4 antagonist 2 | 2243636-57-7 | Reference compound |
| HY-132937 | PRMT5-IN-9 | 2691869-52-8 | Reference compound |
| HY-132938 | (S,R,S)-AHPC-Me-decanedioic acid | 2380273-45-8 | Reference compound |
| HY-132939 | 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-C5-Br | 2411022-24-5 | Reference compound |
| HY-13294 | Impurity C of Alfacalcidol | 82266-85-1 | Reference compound |
| HY-132940 | (+)-Pileamartine A | 2230306-50-8 | Reference compound |
| HY-132941 | CFT-2718 | Reference compound | |
| HY-132942 | PROTAC BRD4 ligand-2 | 2154358-11-7 | Reference compound |
| HY-132942A | PROTAC BRD4 ligand-2 (hydrochloride) | Reference compound | |
| HY-132943 | BRD4 ligand-Linker Conjugate 1 | 2154358-89-9 | Reference compound |
| HY-132943A | BRD4 ligand-Linker Conjugate 1 (TFA) | Reference compound | |
| HY-132944 | (R)-Pomalidomide-pyrrolidine | 2418618-52-5 | Reference compound |
| HY-132947S | Heptadecanoyl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-132948S | 5-(4-Hydroxyphenyl)-5-phenyl hydantoin-15N2,d5 | 369656-71-3 | Isotope-Labeled Compounds |
| HY-132949S | Decanoyl-L-carnitine-d3 (chloride) | 2483831-87-2 | Isotope-Labeled Compounds |
| HY-13295 | Vinpocetine | 42971-09-5 | Natural Products |
| HY-132950S | Acetone 2,4-dinitrophenylhydrazone-d3 | 259824-57-2 | Isotope-Labeled Compounds |
| HY-132951S | D-Glycero-D-guloheptonate-d7 | Isotope-Labeled Compounds | |
| HY-132952S | 3-Methylcrotonyl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-132953S | Formaldehyde 2,4-dinitrophenylhydrazone-d3 | 259824-50-5 | Isotope-Labeled Compounds |
| HY-132954S | 4-Fluorobenzaldehyde 2,4-dinitrophenylhydrazone-d3 | 2734379-03-2 | Isotope-Labeled Compounds |
| HY-132955S | Oleoyl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-132956S | Tigloyl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-132957S | Nonadecanoyl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-132958S | 2-Methylbutyryl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-132959S | 3-Methylbutyryl-DL-carnitine-d9 (hydrochloride) | 2608872-54-2 | Isotope-Labeled Compounds |
| HY-13295R | Vinpocetine (Standard) | 42971-09-5 | Reference Standards |
| HY-13295S | Vinpocetine-d5 | 2734920-39-7 | Isotope-Labeled Compounds |
| HY-13296 | PYR-41 | 418805-02-4 | Reference compound |
| HY-132960S | N-Propionylglycine-2,2-d2 | 1256842-51-9 | Isotope-Labeled Compounds |
| HY-132961S | N-Propionyl-d5-glycine | Isotope-Labeled Compounds | |
| HY-132962S | Pseudooxynicotine-d4 (hydrochloride) | 764661-23-6 | Isotope-Labeled Compounds |
| HY-132963S | 3-Fluorobenzaldehyde 2,4-dinitrophenylhydrazone-d3 | 2734701-43-8 | Isotope-Labeled Compounds |
| HY-132964S | 2,2-Dimethylpropionyl-L-carnitine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-132966 | ASP2453 | 2241719-73-1 | Reference compound |
| HY-132967 | Anti-TSWV agent 1 | 2763371-23-7 | Reference compound |
| HY-132968 | Antifungal agent 20 | 2460281-94-9 | Reference compound |
| HY-132969 | SBP-3264 | 2869148-13-8 | Reference compound |
| HY-13297 | PYZD-4409 | 423148-78-1 | Reference compound |
| HY-132970 | EED ligand 1 | 2762275-20-5 | Reference compound |
| HY-132971 | Thalidomide-piperazine (hydrochloride) | 2228029-82-9 | Reference compound |
| HY-132972 | TrxR-IN-2 | 2866261-50-7 | Reference compound |
| HY-132973 | MC-Val-Cit-PAB-NH-C2-NH-Boc | 1616727-22-0 | ADC Related |
| HY-132975 | PrDiAzK | 2231405-64-2 | Reference compound |
| HY-132977 | BTTAA-OH | 1257633-69-4 | Reference compound |
| HY-132978 | SulfoxFluor | 2143892-50-4 | Reference compound |
| HY-132979 | KRAS G12C inhibitor 18 | 2649788-45-2 | Reference compound |
| HY-13298 | Mps1-IN-1 | 1125593-20-5 | Reference compound |
| HY-132980 | Olomorasib | 2771246-13-8 | Reference compound |
| HY-132981 | Lu AF27139 | 2097117-06-9 | Reference compound |
| HY-132987 | Avibactam tomilopil | 2245880-46-8 | Reference compound |
| HY-132988 | Fmoc-Tyr(3-F,tBu)-OH | 2254698-84-3 | Reference compound |
| HY-132989 | Mal-Deferoxamine | 1638156-31-6 | Reference compound |
| HY-13299 | MK-8033 | 1001917-37-8 | Reference compound |
| HY-132991 | ML 2-14 | Reference compound | |
| HY-132992 | EN219-O-C4-NH2 (TFA) | Reference compound | |
| HY-132993 | Hcyb1 | 2988566-71-6 | Reference compound |
| HY-132994 | TVD-0003510 | 2355276-51-4 | Reference compound |
| HY-132995 | DP-1 | 1472616-61-7 | Reference compound |
| HY-132995A | DP-1 (hydrochloride) | 1472616-35-5 | Reference compound |
| HY-132996 | 4-Isothiocyanatophenyl α-D-Mannopyranoside | 96345-79-8 | Reference compound |
| HY-132997 | PROTAC Bcl-xL degrader-3 | 2471970-60-0 | Reference compound |
| HY-132998 | HDAC6 degrader-1 | 2439058-23-6 | Reference compound |
| HY-13299A | MK-8033 (hydrochloride) | 1283000-43-0 | Reference compound |
| HY-13300 | SR-3677 | 1072959-67-1 | Reference compound |
| HY-133000 | Bis-PEG7-PFP ester | 1334170-01-2 | Reference compound |
| HY-133001 | Dehydrocyclopeptine | 31965-37-4 | Reference compound |
| HY-133002 | Methyl sterculate | 3220-60-8 | Natural Products |
| HY-133003 | L662,025 | 122328-38-5 | Reference compound |
| HY-133004 | Fenbutatin oxide | 13356-08-6 | Reference compound |
| HY-133004R | Fenbutatin oxide (Standard) | 13356-08-6 | Reference Standards |
| HY-133004S | Fenbutatin oxide-d30 | Isotope-Labeled Compounds | |
| HY-133005 | Desacetylvinblastine | 3352-69-0 | Reference compound |
| HY-133006 | Fluorescein-PEG5-acid | 2183440-40-4 | Reference compound |
| HY-133007 | Algestone acetophenide | 24356-94-3 | Reference compound |
| HY-133007R | Algestone acetophenide (Standard) | 24356-94-3 | Reference Standards |
| HY-133008 | endo-BCN-PEG3-acid | 1807501-82-1 | Reference compound |
| HY-133009 | BCN-PEG4-acid | 2226472-38-2 | Reference compound |
| HY-13300A | SR-3677 (dihydrochloride) | 1781628-88-3 | Reference compound |
| HY-13301 | MPC-3100 | 958025-66-6 | Reference compound |
| HY-133010 | Tamoxifen N-oxide | 75504-34-6 | Reference compound |
| HY-133010R | Tamoxifen N-oxide (Standard) | 75504-34-6 | Reference Standards |
| HY-133011 | nAChR agonist 1 | 1394371-75-5 | Reference compound |
| HY-133012 | GFB-8438 | 2304549-73-1 | Reference compound |
| HY-133013 | GLPG-3221 | 2222264-64-2 | Reference compound |
| HY-133014 | RIP2 kinase inhibitor 1 | 2380028-10-2 | Reference compound |
| HY-133015 | Mcl-1 inhibitor 3 | 2376774-73-9 | Reference compound |
| HY-133016 | M8891 | 1464842-09-8 | Reference compound |
| HY-133016A | (R)-M8891 | 2575547-29-2 | Reference compound |
| HY-133017 | Amcenestrant | 2114339-57-8 | Reference compound |
| HY-133018 | HCV-IN-7 | 1449756-86-8 | Reference compound |
| HY-133018A | HCV-IN-7 (hydrochloride) | 1449756-87-9 | Reference compound |
| HY-133019 | ATX inhibitor 5 | 2402772-45-4 | Reference compound |
| HY-13302 | CP-547632 | 252003-65-9 | Reference compound |
| HY-133020 | ARD-266 | 2666951-70-6 | Reference compound |
| HY-133021 | Arazine | 135304-07-3 | Reference compound |
| HY-133022 | trans-2-Undecenoic acid | 15790-94-0 | Reference compound |
| HY-133022R | trans-2-Undecenoic acid (Standard) | 15790-94-0 | Reference Standards |
| HY-133023 | Indium(III) isopropoxide | 38218-24-5 | Reference compound |
| HY-133024 | Flumexadol | 30914-89-7 | Reference compound |
| HY-133025 | FK962 | 283167-06-6 | Reference compound |
| HY-133026 | N-Acetylcarnosine | 56353-15-2 | Peptides |
| HY-133027 | Myristyl nicotinate | 273203-62-6 | Reference compound |
| HY-133028 | CKI-7 (free base) | 120615-25-0 | Reference compound |
| HY-133029 | PI3K-IN-9 | 2360875-63-2 | Reference compound |
| HY-13302B | CP-547632 (hydrochloride) | 252003-71-7 | Reference compound |
| HY-13302C | CP-547632 (TFA) | 2805804-54-8 | Reference compound |
| HY-13303 | RO 4927350 | 876755-27-0 | Reference compound |
| HY-133030 | DNMT-IN-1 | 2396691-28-2 | Reference compound |
| HY-133031 | CSV0C018875 | 442150-41-6 | Reference compound |
| HY-133031A | CSV0C018875 (hydrochloride) | 474084-56-5 | Reference compound |
| HY-133033 | COQ7-IN-1 | 2579696-72-1 | Reference compound |
| HY-133034 | NRP1 antagonist 1 | 2569598-01-0 | Reference compound |
| HY-133036 | APJ receptor agonist 1 | 2287153-38-0 | Reference compound |
| HY-13304 | LY2874455 | 1254473-64-7 | Reference compound |
| HY-133044 | Boc-Pip-alkyne-Ph-COOH | 2581824-70-4 | Reference compound |
| HY-133045 | VHL Ligand 8 | 2701565-76-4 | Reference compound |
| HY-133046 | VHL Ligand-Linker Conjugates 17 | Reference compound | |
| HY-133049 | Propargyl-PEG3-phosphonic acid | 1714139-62-4 | Reference compound |
| HY-13305 | MK-2048 | 869901-69-9 | Reference compound |
| HY-133050 | Hydroxy-PEG6-acid | 1347750-85-9 | Reference compound |
| HY-133051 | Hydroxy-PEG5-acid | 2079768-50-4 | Reference compound |
| HY-133052 | Hydroxy-PEG3-acid | 518044-49-0 | Reference compound |
| HY-133053 | HO-PEG8-CH2CH2COOH | 937188-60-8 | Reference compound |
| HY-133054 | PEG4-sulfonic acid | 173459-90-0 | Reference compound |
| HY-133056 | Pseudomonic acid C | 71980-98-8 | Reference compound |
| HY-133056R | Pseudomonic acid C (Standard) | 71980-98-8 | Reference Standards |
| HY-133057 | m-PEG4-CH2-alcohol | 145526-76-7 | Reference compound |
| HY-133058 | m-PEG7-CH2-OH | 1807512-35-1 | Reference compound |
| HY-133059 | MRZ-8676 | 872122-36-6 | Reference compound |
| HY-13306 | Pyrintegrin | 1228445-38-2 | Reference compound |
| HY-133060 | Sannamycin B | 72503-80-1 | Reference compound |
| HY-133061 | Fluorescein-thiourea-PEG6-acid | 2055014-69-0 | Reference compound |
| HY-133062 | Fmoc-NH-PEG5-CH2COOH | 635287-26-2 | ADC Related |
| HY-133063 | Fmoc-NH-PEG8-CH2COOH | 868594-52-9 | ADC Related |
| HY-133064 | m-PEG3-NHS ester | 876746-59-7 | Reference compound |
| HY-133065 | m-PEG5-NHS ester | 874208-94-3 | Reference compound |
| HY-133066 | m-PEG6-NHS ester | 1449390-12-8 | ADC Related |
| HY-133068 | 5-Hydroxyferulic acid | 1782-55-4 | Natural Products |
| HY-133068A | (E)-5-Hydroxyferulic acid | 110642-42-7 | Reference compound |
| HY-133069 | Tos-PEG2-C2-Boc | 850090-13-0 | Reference compound |
| HY-13307 | JK184 | 315703-52-7 | Reference compound |
| HY-133070 | Tos-PEG5-C2-Boc | 850090-10-7 | Reference compound |
| HY-133071 | Tos-PEG6-C2-Boc | 406213-75-0 | Reference compound |
| HY-133073 | CCR7 Ligand 1 | 681514-83-0 | Reference compound |
| HY-133078 | Thienyldecyl Isothiocyanate | 288323-41-1 | Reference compound |
| HY-133079 | Ascorbyl tetra-2-hexyldecanoate | 183476-82-6 | Reference compound |
| HY-13308 | Regorafenib (Hydrochloride) | 835621-07-3 | Reference compound |
| HY-133080 | BAY-784 | 1631164-24-3 | Reference compound |
| HY-133083 | BAY-474 | 1033767-86-0 | Reference compound |
| HY-133084 | ERK-IN-2 | 2743576-56-7 | Reference compound |
| HY-133084A | ERK-IN-2 (free base) | 2743576-55-6 | Reference compound |
| HY-133085 | Rimsulfuron | 122931-48-0 | Reference compound |
| HY-133085R | Rimsulfuron (Standard) | 122931-48-0 | Reference Standards |
| HY-133085S | Rimsulfuron-d6 | Isotope-Labeled Compounds | |
| HY-133086 | Hydrodolasetron | 127951-99-9 | Reference compound |
| HY-133086S | Hydrodolasetron-d4 | Isotope-Labeled Compounds | |
| HY-133086S1 | Hydrodolasetron-d5 | Isotope-Labeled Compounds | |
| HY-133088 | Curcumaromin A | 1810034-38-8 | Natural Products |
| HY-133089 | Curcumaromin B | 1810034-39-9 | Natural Products |
| HY-133090 | Erythbidin A | 210050-83-2 | Natural Products |
| HY-133091 | 7-Ethoxycoumarin | 31005-02-4 | Natural Products |
| HY-133091S | 7-Ethoxycoumarin-d5 | 1189956-39-5 | Isotope-Labeled Compounds |
| HY-133092 | Perphenazine sulfoxide | 10078-25-8 | Reference compound |
| HY-133092R | Perphenazine sulfoxide (Standard) | 10078-25-8 | Reference Standards |
| HY-133095 | BML-260 | 101439-76-3 | Reference compound |
| HY-133096 | Yadanzioside K | 101559-98-2 | Natural Products |
| HY-133097 | Yadanzioside M | 101559-99-3 | Natural Products |
| HY-133098 | Juncutol | 1021950-14-0 | Natural Products |
| HY-133100 | 5-ALA benzyl ester (hydrochloride) | 163271-32-7 | Reference compound |
| HY-133101 | 14-Norpseurotin | 1031727-34-0 | Natural Products |
| HY-133102 | Dihydronarwedine | 21041-10-1 | Natural Products |
| HY-133103 | Virosine B | 1052228-70-2 | Natural Products |
| HY-133104 | Neocaesalpin O | 1053189-53-9 | Natural Products |
| HY-133105 | Procysteine | 19771-63-2 | Reference compound |
| HY-133108 | Azadirachtin B | 106500-25-8 | Natural Products |
| HY-133109 | Trachelosiaside | 106647-12-5 | Natural Products |
| HY-13311 | Infigratinib | 872511-34-7 | Reference compound |
| HY-133110 | Afatinib N-Oxide | 2413212-11-8 | Reference compound |
| HY-133111 | 3-Hydroxy agomelatine | 166526-99-4 | Reference compound |
| HY-133111S | 3-Hydroxy agomelatine-d3 | 1079774-23-4 | Isotope-Labeled Compounds |
| HY-133112 | 7-Desmethyl-3-hydroxyagomelatine | 166527-00-0 | Reference compound |
| HY-133113 | 7-Desmethyl-agomelatine | 152302-45-9 | Reference compound |
| HY-133113S | 7-Desmethyl-agomelatine-d3 | 2749427-92-5 | Isotope-Labeled Compounds |
| HY-133114 | Ezetimibe ketone | 191330-56-0 | Reference compound |
| HY-133115 | N-Desmethylnefopam | 46868-19-3 | Reference compound |
| HY-133115AS | N-Desmethylnefopam-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-133116 | 4-Hydroxyatomoxetine | 435293-66-6 | Reference compound |
| HY-133116S | 4-Hydroxyatomoxetine-d3 | 1217686-14-0 | Isotope-Labeled Compounds |
| HY-133117 | BAY-985 | 2409479-29-2 | Reference compound |
| HY-133117A | (Rac)-BAY-985 | 2101925-20-4 | Reference compound |
| HY-133118 | 6RK73 | 1895050-66-4 | Reference compound |
| HY-133119 | PK150 | 2165324-62-7 | Reference compound |
| HY-13311A | Infigratinib phosphate | 1310746-10-1 | Reference compound |
| HY-13311S | Infigratinib-d3 | Isotope-Labeled Compounds | |
| HY-133120 | INY-03-041 | 2503017-97-6 | Reference compound |
| HY-133120A | INY-03-041 (trihydrochloride) | Reference compound | |
| HY-133121 | WDR5-IN-1 | 2408842-51-1 | Reference compound |
| HY-133122 | UCB-9260 | 1515888-53-5 | Reference compound |
| HY-133123 | EP4 receptor antagonist 1 | 2287259-07-6 | Reference compound |
| HY-133124 | PARP/PI3K-IN-1 | 2337386-47-5 | Reference compound |
| HY-133125 | ERAP1-IN-1 | 865273-97-8 | Reference compound |
| HY-133126 | hDDAH-1-IN-1 | 1229238-69-0 | Reference compound |
| HY-133126A | hDDAH-1-IN-1 (TFA) | 1229238-70-3 | Reference compound |
| HY-133127 | AR453588 | 1065609-00-8 | Reference compound |
| HY-133127A | AR453588 (hydrochloride) | 1065606-97-4 | Reference compound |
| HY-133128 | FM26 | 2407981-35-3 | Reference compound |
| HY-133129 | MS1943 | 2225938-17-8 | Reference compound |
| HY-13313 | XL888 | 1149705-71-4 | Reference compound |
| HY-133130 | JNJ-42226314 | 1252765-13-1 | Reference compound |
| HY-133131 | PROTAC BRD4 Degrader-1 | 2133360-00-4 | Reference compound |
| HY-133136 | PROTAC BRD4 Degrader-2 | 2185795-53-1 | Reference compound |
| HY-133137 | SJF620 | 2376187-16-3 | Reference compound |
| HY-133137A | SJF620 (hydrochloride) | 2821938-05-8 | Reference compound |
| HY-133138 | Pomalidomide-PEG1-azide | 2133360-04-8 | Reference compound |
| HY-133139 | Lenalidomide-PEG1-azide | 2185795-67-7 | Reference compound |
| HY-13314 | Tesevatinib | 781613-23-8 | Reference compound |
| HY-133141 | DI-87 | 2107280-55-5 | Reference compound |
| HY-133143 | 1,2-Bis(2-iodoethoxy)ethane | 36839-55-1 | Reference compound |
| HY-133144 | Lenalidomide-OH | 1416990-08-3 | Reference compound |
| HY-133145 | hDDAH-1-IN-2 | 2408834-77-3 | Reference compound |
| HY-133145A | hDDAH-1-IN-2 (sulfate) | 2747921-54-4 | Reference compound |
| HY-133146 | DJ001 | 2161305-12-8 | Reference compound |
| HY-133147 | HDAC3/6-IN-2 | 2417510-17-7 | Reference compound |
| HY-133148 | Lp-PLA2-IN-2 | 2071636-15-0 | Reference compound |
| HY-133149 | Lp-PLA2-IN-3 | 2196245-16-4 | Reference compound |
| HY-13314A | Tesevatinib (tosylate) | 1000599-06-3 | Reference compound |
| HY-13315 | Montelukast (sodium) | 151767-02-1 | Reference compound |
| HY-133152 | Brexpiprazole S-oxide | 1191900-51-2 | Reference compound |
| HY-133152S | Brexpiprazole S-oxide-d8 | 2748605-29-8 | Isotope-Labeled Compounds |
| HY-133153S | Fenpiverinium-d3 (bromide) | Isotope-Labeled Compounds | |
| HY-133154 | Carboxyaminoimidazole ribotide | 6001-14-5 | Reference compound |
| HY-133155 | 5-Aminoimidazole ribonucleotide | 25635-88-5 | Reference compound |
| HY-133157 | FAICAR | 13018-54-7 | Reference compound |
| HY-133158S | (S)-Adenosylmethionine decarboxylated-d3 (sulfuric) | Isotope-Labeled Compounds | |
| HY-133159 | Resolvin E2 | 865532-70-3 | Reference compound |
| HY-13315A | Montelukast | 158966-92-8 | Reference compound |
| HY-13315AR | Montelukast (Standard) | 158966-92-8 | Reference Standards |
| HY-13315B | Montelukast (dicyclohexylamine) | 577953-88-9 | Reference compound |
| HY-13315BR | Montelukast (dicyclohexylamine) (Standard) | 577953-88-9 | Reference Standards |
| HY-13315R | Montelukast (sodium) (Standard) | 151767-02-1 | Reference Standards |
| HY-13315S | Montelukast-d6 | 1093746-29-2 | Isotope-Labeled Compounds |
| HY-13315S1 | Montelukast-d6 (sodium) | 2673270-26-1 | Isotope-Labeled Compounds |
| HY-133160 | Valproic acid hydroxamate | 106132-78-9 | Reference compound |
| HY-133162 | Mal-PEG1-Boc | 810677-16-8 | Reference compound |
| HY-133164 | Asebotin | 11075-15-3 | Natural Products |
| HY-133166 | A-889425 | 1072921-02-8 | Reference compound |
| HY-133167 | Clothianidin | 210880-92-5 | Reference compound |
| HY-133167R | Clothianidin (Standard) | 210880-92-5 | Reference Standards |
| HY-133167S | Clothianidin-d3 | 1262776-24-8 | Isotope-Labeled Compounds |
| HY-133168 | Englerin A | 1094250-15-3 | Natural Products |
| HY-133168R | Englerin A (Standard) | 1094250-15-3 | Reference Standards |
| HY-133169 | Topazolin | 109605-79-0 | Natural Products |
| HY-13317 | Oseltamivir | 196618-13-0 | Reference compound |
| HY-133171 | (R)-Norfluoxetine | 130194-43-3 | Reference compound |
| HY-133171A | (S)-Norfluoxetine | 126924-38-7 | Reference compound |
| HY-133171AS3 | (R)-Norfluoxetine-d5 | 1217648-64-0 | Isotope-Labeled Compounds |
| HY-133172 | Zanamivir amine | 130525-62-1 | Biochemical Assay Reagents |
| HY-133174 | Biotin-PEG5-azide | 1163732-89-5 | Reference compound |
| HY-133175 | Biotin-PEG7-azide | 1334172-75-6 | Reference compound |
| HY-133176 | Biotin-PEG6-acid | 1352814-10-8 | Reference compound |
| HY-133178 | Urolithin D | 131086-98-1 | Natural Products |
| HY-133178R | Urolithin D (Standard) | 131086-98-1 | Reference Standards |
| HY-133179 | Wnt/β-catenin-IN-4 | 2131223-69-1 | Reference compound |
| HY-13317R | Oseltamivir (Standard) | 196618-13-0 | Reference Standards |
| HY-13317S | Oseltamivir-d3 | 1093851-61-6 | Isotope-Labeled Compounds |
| HY-13317S1 | Oseltamivir-d3-1 | Isotope-Labeled Compounds | |
| HY-13317S3 | Oseltamivir-d5 | 1093851-63-8 | Isotope-Labeled Compounds |
| HY-13317S4 | Oseltamivir-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13318 | Oseltamivir acid | 187227-45-8 | Reference compound |
| HY-133180 | YW1128 | 2131223-64-6 | Reference compound |
| HY-133181 | Triumbelletin | 131559-54-1 | Natural Products |
| HY-133182 | Chloculol | 131652-35-2 | Natural Products |
| HY-133183 | Urolignoside | 131723-83-6 | Natural Products |
| HY-133185 | Megastigmatrienone (mixed isomers) | 13215-88-8 | Natural Products |
| HY-133186 | Fenamidone | 161326-34-7 | Reference compound |
| HY-133186R | Fenamidone (Standard) | 161326-34-7 | Reference Standards |
| HY-133187S | Blonanserin C-d8 | Isotope-Labeled Compounds | |
| HY-133188 | Imazethapyr | 81335-77-5 | Reference compound |
| HY-133188R | Imazethapyr (Standard) | 81335-77-5 | Reference Standards |
| HY-133189 | Bis-propargyl-PEG9 | 1351373-47-1 | Reference compound |
| HY-13318A | Oseltamivir acid (hydrochloride) | 1415963-60-8 | Reference compound |
| HY-13318R | Oseltamivir acid (Standard) | 187227-45-8 | Reference Standards |
| HY-13318S | Oseltamivir acid-d3 | 1242184-43-5 | Isotope-Labeled Compounds |
| HY-13318S1 | Oseltamivir acid-13C,d3 | Isotope-Labeled Compounds | |
| HY-13319 | JNK-IN-8 | 1410880-22-6 | Reference compound |
| HY-133190 | Bis-propargyl-PEG7 | 1351373-46-0 | Reference compound |
| HY-133191 | Bis-propargyl-PEG2 | 126422-57-9 | Reference compound |
| HY-133192 | Bis-propargyl-PEG3 | 126422-58-0 | Reference compound |
| HY-133193 | Bis-propargyl-PEG5 | 185378-83-0 | Reference compound |
| HY-133194 | Taxinine M | 135730-55-1 | Natural Products |
| HY-133195 | Nefopam | 13669-70-0 | Reference compound |
| HY-133196 | Ustusolate A | 1136611-58-9 | Natural Products |
| HY-133198 | Valeriandoid B | 1380399-57-4 | Natural Products |
| HY-133199 | Benastatin A | 138968-85-1 | Natural Products |
| HY-13319G | JNK-IN-8 (GMP) | 1410880-22-6 | GMP Small Molecules |
| HY-13320 | 2-Keto Crizotinib | 1415558-82-5 | Reference compound |
| HY-133200 | A-85783 | 161395-33-1 | Biochemical Assay Reagents |
| HY-133203 | Minaxin C | 1418150-06-7 | Reference compound |
| HY-133204 | Chlorfluazuron | 71422-67-8 | Reference compound |
| HY-133204R | Chlorfluazuron (Standard) | 71422-67-8 | Reference Standards |
| HY-133205 | Taxumairol B | 142203-64-3 | Natural Products |
| HY-133206A | Fosnetupitant (chloride monohydrochloride ) | 1643757-72-5 | Reference compound |
| HY-133207 | Myoseverin B | 361431-27-8 | Reference compound |
| HY-133209 | Fischeria A | 221456-63-9 | Natural Products |
| HY-13321 | Anguizole | 442666-98-0 | Reference compound |
| HY-133210 | Mal-PEG5-PFP ester | 1807512-46-4 | Reference compound |
| HY-133211 | Mal-PEG6-Boc | 518044-37-6 | Reference compound |
| HY-133212 | Mal-PEG8-Boc | 2055048-43-4 | Reference compound |
| HY-133214 | Cyclazosin (hydrochloride) | 146929-33-1 | Reference compound |
| HY-133215 | Zileuton sulfoxide | 1147524-83-1 | Reference compound |
| HY-133216 | Bupirimate | 41483-43-6 | Reference compound |
| HY-133216R | Bupirimate (Standard) | 41483-43-6 | Reference Standards |
| HY-133219 | Guajadial C | 1529775-02-7 | Natural Products |
| HY-133219A | Guajadial D | 1529775-04-9 | Natural Products |
| HY-13322 | Pracinostat | 929016-96-6 | Reference compound |
| HY-133220 | Guajadial E | 1529775-06-1 | Natural Products |
| HY-133220A | Guajadial F | 1529775-08-3 | Natural Products |
| HY-133221 | Abiesadine N | 1159913-80-0 | Natural Products |
| HY-133222 | STX140 | 401600-86-0 | Reference compound |
| HY-133223 | Hispidanin B | 1616080-84-2 | Natural Products |
| HY-133224 | Caesalpine B | 1616757-60-8 | Natural Products |
| HY-133225 | Caesalpine A | 1616757-59-5 | Natural Products |
| HY-133226 | Erythrinin F | 1616592-60-9 | Natural Products |
| HY-133227 | Erythrinin D | 1616592-59-6 | Natural Products |
| HY-133228 | Erythrinin G | 1616592-61-0 | Natural Products |
| HY-133229 | Propargyl-PEG4-alcohol | 87450-10-0 | Reference compound |
| HY-13323 | CX-5461 | 1138549-36-6 | Reference compound |
| HY-133230 | Propargyl-PEG10-amine | 2112737-25-2 | Reference compound |
| HY-133231 | Bis-PEG10-acid | 2055023-26-0 | Reference compound |
| HY-133232 | Sonnerphenolic B | 1627516-10-2 | Natural Products |
| HY-133233 | Thioetheramide-PC | 116457-99-9 | Reference compound |
| HY-133235 | Baccatin IX | 1623410-12-7 | Natural Products |
| HY-133236 | Baccatin VIII | 1623410-10-5 | Natural Products |
| HY-133237 | Anemarrhenasaponin III | 163047-23-2 | Natural Products |
| HY-13323A | CX-5461 (dihydrochloride) | Reference compound | |
| HY-13323R | CX-5461 (Standard) | 1138549-36-6 | Reference Standards |
| HY-13324 | Bardoxolone methyl | 218600-53-4 | Reference compound |
| HY-133246 | Monodes(N-carboxymethyl)valine Daclatasvir | 1007884-60-7 | Reference compound |
| HY-133246A | Monodes(N-carboxymethyl)valine Daclatasvir (TFA) | Reference compound | |
| HY-133247 | Daclatasvir Impurity B | 2226541-13-3 | Reference compound |
| HY-133248 | Daclatasvir Impurity C | 1256385-55-3 | Reference compound |
| HY-13325 | Aβ42-IN-6 | 71939-12-3 | Reference compound |
| HY-13326 | ASP3026 | 1097917-15-1 | Reference compound |
| HY-133269 | m-PEG11-SH | Reference compound | |
| HY-13327 | Evacetrapib | 1186486-62-3 | Reference compound |
| HY-133270 | m-PEG10-SH | 651042-85-2 | Reference compound |
| HY-133271 | m-PEG4-SH | 52190-55-3 | Reference compound |
| HY-133272 | m-PEG5-SH | 524030-00-0 | Reference compound |
| HY-133273 | m-PEG3-SH | 31521-83-2 | Reference compound |
| HY-133274 | m-PEG16-SH | 874820-38-9 | Reference compound |
| HY-133275 | m-PEG24-SH | Reference compound | |
| HY-133276 | m-PEG7-Br | 104518-25-4 | Reference compound |
| HY-133277 | m-PEG2-Br,98%(stabilized with Na2CO3) | 54149-17-6 | Reference compound |
| HY-133278 | m-PEG10-Br | Reference compound | |
| HY-133279 | m-PEG11-Br | 1258596-39-2 | Reference compound |
| HY-13328 | Sapanisertib | 1224844-38-5 | Reference compound |
| HY-133280 | m-PEG9-SH | 651042-84-1 | Reference compound |
| HY-133281 | m-PEG16-Br | 1238189-11-1 | Reference compound |
| HY-133282 | m-PEG24-Br | Reference compound | |
| HY-133283 | m-PEG36-Br | Reference compound | |
| HY-133284 | m-PEG48-Br | Reference compound | |
| HY-133285 | m-PEG10-CH2COOH | 908258-58-2 | Reference compound |
| HY-133286 | m-PEG9-CH2COOH | 405518-55-0 | Reference compound |
| HY-133287 | m-PEG36-OH | Reference compound | |
| HY-133288 | m-PEG16-NH2 | 907577-50-8 | Reference compound |
| HY-133289 | m-PEG48-OH | Reference compound | |
| HY-13329 | IRAK-1-4 Inhibitor I | 509093-47-4 | Reference compound |
| HY-133290 | Thiol-PEG5-acid | 1449390-67-3 | Reference compound |
| HY-133291 | Thiol-PEG6-acid | 1347750-77-9 | Reference compound |
| HY-133292 | Thiol-PEG4-alcohol | 90952-27-5 | Reference compound |
| HY-133293 | Thiol-PEG5-alcohol | 248582-03-8 | Reference compound |
| HY-133294 | Thiol-PEG8-alcohol | 791620-96-7 | Reference compound |
| HY-133295 | Thiol-PEG10-alcohol | Reference compound | |
| HY-133296 | Thiol-PEG9-alcohol | Reference compound | |
| HY-133297 | Thiol-PEG12-alcohol | Reference compound | |
| HY-133298 | Amino-PEG14-alcohol | 34214-89-6 | Reference compound |
| HY-133299 | Br-PEG7-Br | 177987-04-1 | Reference compound |
| HY-13330 | Fexagratinib | 1035270-39-3 | Reference compound |
| HY-133300 | HO-PEG22-OH | Reference compound | |
| HY-133301 | HO-PEG8-CH2COOH | 780006-30-6 | Reference compound |
| HY-133302 | HO-PEG6-CH2COOH | 120394-66-3 | Reference compound |
| HY-133303 | HO-PEG12-CH2COOH | Reference compound | |
| HY-133304 | HO-PEG10-CH2COOH | 2250056-53-0 | Reference compound |
| HY-133305 | HO-PEG24-CH2COOH | Reference compound | |
| HY-133306 | Hydroxy-PEG12-acid | Reference compound | |
| HY-133307 | Hydroxy-PEG10-acid | 2375611-66-6 | ADC Related |
| HY-133308 | Hydroxy-PEG16-acid | Reference compound | |
| HY-133309 | HO-PEG24-CH2CH2COOH | Reference compound | |
| HY-13330R | Fexagratinib (Standard) | 1035270-39-3 | Reference Standards |
| HY-13331 | Clascoterone | 19608-29-8 | Reference compound |
| HY-133310 | Hydroxy-PEG7-CH2-Boc | 2378049-28-4 | Reference compound |
| HY-133311 | Hydroxy-PEG8-CH2-Boc | 2869101-36-8 | Reference compound |
| HY-133312 | Hydroxy-PEG10-CH2-Boc | Reference compound | |
| HY-133313 | Hydroxy-PEG12-CH2-Boc | Reference compound | |
| HY-133314 | Hydroxy-PEG24-CH2-Boc | Reference compound | |
| HY-133315 | HO-PEG1-benzyl ester | Reference compound | |
| HY-133316 | HO-PEG4-benzyl ester | Reference compound | |
| HY-133317 | Azido-PEG11-acid | Reference compound | |
| HY-133318 | Azido-PEG16-acid | Reference compound | |
| HY-133319 | Azido-PEG24-Boc | Reference compound | |
| HY-13331S1 | Clascoterone-d6 | Isotope-Labeled Compounds | |
| HY-13331S2 | Clascoterone-d5-1 | Isotope-Labeled Compounds | |
| HY-13332 | Calcifediol-d6 | 78782-98-6 | Isotope-Labeled Compounds |
| HY-133320 | N3-PEG16-Hydrazide | Reference compound | |
| HY-133321 | N3-PEG24-Hydrazide | Reference compound | |
| HY-133322 | m-PEG21-acid | Reference compound | |
| HY-133323 | m-PEG24-acid | 2248203-61-2 | Reference compound |
| HY-133324 | m-PEG37-acid | 2924199-92-6 | Reference compound |
| HY-133325 | m-PEG49-acid | Reference compound | |
| HY-133326 | m-PEG16-Mal | Reference compound | |
| HY-133327 | Amino-PEG12-amine | 361543-12-6 | Reference compound |
| HY-133328 | Amino-PEG13-amine | 1228119-65-0 | Reference compound |
| HY-133329 | Amino-PEG15-amine | Reference compound | |
| HY-13333 | NVP-BAG956 | 853910-02-8 | Reference compound |
| HY-133330 | Amino-PEG27-amine | 2252208-09-4 | Reference compound |
| HY-133332 | Amino-PEG11-CH2COOH | Reference compound | |
| HY-133333 | Amino-PEG12-CH2COOH | Reference compound | |
| HY-133334 | Amino-PEG7-acid | 2376111-92-9 | Reference compound |
| HY-133335 | Amino-PEG10-CH2-Boc | Reference compound | |
| HY-133336 | Amino-PEG12-CH2-Boc | Reference compound | |
| HY-133337 | Amino-PEG24-CH2-Boc | Reference compound | |
| HY-133338 | Amino-PEG36-CH2-Boc | Reference compound | |
| HY-133339 | H2N-PEG4-Hydrazide | 1425973-15-4 | Reference compound |
| HY-13334 | BGT226 (maleate) | 1245537-68-1 | Reference compound |
| HY-133340 | H2N-PEG5-Hydrazide | Reference compound | |
| HY-133341 | H2N-PEG6-Hydrazide | Reference compound | |
| HY-133342 | H2N-PEG8-Hydrazide | Reference compound | |
| HY-133343 | H2N-PEG12-Hydrazide | Reference compound | |
| HY-133344 | m-PEG3-Hydrazide | 1442104-10-0 | Reference compound |
| HY-133345 | m-PEG7-Hydrazide | Reference compound | |
| HY-133346 | m-PEG9-Hydrazide | Reference compound | |
| HY-133347 | m-PEG11-Hydrazide | Reference compound | |
| HY-133348 | m-PEG12-Hydrazide | Reference compound | |
| HY-133349 | m-PEG13-Hydrazide | Reference compound | |
| HY-13334A | BGT226 | 915020-55-2 | Reference compound |
| HY-13335 | PKCβ inhibitor 1 | 257879-35-9 | Reference compound |
| HY-133350 | m-PEG17-Hydrazide | Reference compound | |
| HY-133351 | m-PEG25-Hydrazide | Reference compound | |
| HY-133352 | Mal-PEG5-mal | 113387-03-4 | Reference compound |
| HY-133353 | Mal-PEG6-mal | Reference compound | |
| HY-133354 | Mal-PEG11-mal | Reference compound | |
| HY-133355 | Boc-NH-PEG12-NH2 | 1642551-09-4 | Reference compound |
| HY-133356 | Boc-NH-PEG15-azide | Reference compound | |
| HY-133357 | Cbz-NH-PEG10-CH2COOH | Reference compound | |
| HY-133358 | Cbz-NH-PEG12-C2-acid | 1334177-88-6 | Reference compound |
| HY-133359 | Cbz-NH-PEG24-C2-acid | Reference compound | |
| HY-13336 | Imisopasem manganese | 218791-21-0 | Reference compound |
| HY-133360 | Cbz-NH-PEG36-C2-acid | Reference compound | |
| HY-133361 | Fmoc-NH-PEG15-CH2CH2COOH | 2378590-46-4 | Reference compound |
| HY-133362 | Fmoc-NH-PEG16-CH2CH2COOH | Reference compound | |
| HY-133363 | Fmoc-NH-PEG19-CH2CH2COOH | Reference compound | |
| HY-133364 | Fmoc-NH-PEG25-CH2CH2COOH | 1257223-69-0 | Reference compound |
| HY-133365 | Fmoc-NH-PEG30-CH2CH2COOH | Reference compound | |
| HY-133366 | DBCO-NHCO-PEG2-amine | Reference compound | |
| HY-133367 | DBCO-NHCO-PEG6-amine | Reference compound | |
| HY-133368 | DBCO-NHCO-PEG12-amine | Reference compound | |
| HY-133369 | DBCO-NHCO-PEG3-acid | Reference compound | |
| HY-13337 | BMS-986094 | 1234490-83-5 | Reference compound |
| HY-133370 | DBCO-NHCO-PEG7-acid | Reference compound | |
| HY-133371 | DBCO-NHCO-C4-NHS ester | Reference compound | |
| HY-133372 | DBCO-NHCO-PEG2-maleimide | 2698339-31-8 | Reference compound |
| HY-133373 | DBCO-NHCO-PEG6-maleimide | Reference compound | |
| HY-133374 | DBCO-NHCO-PEG12-maleimide | Reference compound | |
| HY-133375 | DBCO-NHCO-PEG2-NHS ester | Reference compound | |
| HY-133376 | DBCO-NHCO-PEG12-biotin | 2621391-31-7 | Dye Reagents |
| HY-133377 | Biotin-PEG24-acid | Reference compound | |
| HY-133378 | Biotin-PEG24-NHS ester | Reference compound | |
| HY-133379 | Biotin-PEG12-Mal | Reference compound | |
| HY-13338 | Mabuterol | 56341-08-3 | Reference compound |
| HY-133380 | DSPE-PEG36-mal | Reference compound | |
| HY-133381 | DSPE-PEG36-DBCO | Reference compound | |
| HY-133382 | DSPE-PEG46-DBCO | Reference compound | |
| HY-133383 | DSPE-PEG46-Folate | Reference compound | |
| HY-133384 | SPDP-PEG5-acid | Reference compound | |
| HY-133385 | SPDP-PEG7-acid | Reference compound | |
| HY-133386 | SPDP-PEG9-acid | Reference compound | |
| HY-133387 | HS-C6-PEG9-acid | Reference compound | |
| HY-133388 | Boc-NH-C12-NH2 | 109792-60-1 | Reference compound |
| HY-133389 | Mal-PEG36-NHS ester | Reference compound | |
| HY-13338A | (S)-Mabuterol | 56707-25-6 | Reference compound |
| HY-13338S | Mabuterol-d9 | 1246819-58-8 | Isotope-Labeled Compounds |
| HY-13339 | Brofaromine | 63638-91-5 | Reference compound |
| HY-133390 | Azido-PEG1-azide | 24345-74-2 | Reference compound |
| HY-133391 | Azido-PEG3-azide | 101187-39-7 | Reference compound |
| HY-133392 | Azido-PEG5-azide | 356046-26-9 | Reference compound |
| HY-133393 | Azido-PEG6-azide | 1243536-56-2 | Reference compound |
| HY-133394 | Azido-PEG7-azide | 225523-86-4 | Reference compound |
| HY-133395 | Azido-PEG9-azide | 1171122-72-7 | Reference compound |
| HY-133396 | Azido-PEG11-azide | 1392284-57-9 | Reference compound |
| HY-133397 | Azido-PEG15-azide | Reference compound | |
| HY-133399 | Alkyne-PEG4-maleimide | 1609651-90-2 | Reference compound |
| HY-13340 | VU0152100 | 409351-28-6 | Reference compound |
| HY-133400 | endo-BCN-PEG3-mal | 2141976-33-0 | Reference compound |
| HY-133401 | endo-BCN-PEG3-NH2 | 1883512-27-3 | Reference compound |
| HY-133402 | BCN-exo-PEG3-NH2 | 1841134-72-2 | Reference compound |
| HY-133403A | Biotin-C1-PEG3-C3-amine (TFA) | 1334172-59-6 | Reference compound |
| HY-133404 | Fmoc-aminooxy-PFP ester | Reference compound | |
| HY-133405 | Boc-NH-O-C1-NHS ester | 80366-85-4 | Reference compound |
| HY-133406 | exo BCN-O-PNB | 1380006-72-3 | Reference compound |
| HY-133407 | β-Estradiol-6-one 6-(O-carboxymethyloxime) | 35048-47-6 | Reference compound |
| HY-133408 | 4-Methyl-4-(methyldisulfanyl)pentanoic acid | 796073-55-7 | ADC Related |
| HY-133409 | 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid | 1537891-69-2 | ADC Related |
| HY-133410 | Mal-C2-cyclohexylcarboxyl-hydrazide (TFA) | 359436-59-2 | Reference compound |
| HY-133410A | Mal-C2-cyclohexylcarboxyl-hydrazide (hydrochloride) | 174422-72-1 | Reference compound |
| HY-133411A | NH2-O-C5-COOH (hydrobromide) | 448954-98-1 | Reference compound |
| HY-133412 | DBCO-NHCO-S-S-NHS ester | ADC Related | |
| HY-133413 | DBCO-CONH-S-S-NHS ester | 1435934-53-4 | ADC Related |
| HY-133424A | Trisulfo-Cy3-acid (disodium) | Dye Reagents | |
| HY-133425 | 2-Phthalimidehydroxy-acetic acid | 134724-87-1 | Reference compound |
| HY-133426 | Ald-Ph-amido-PEG4-propargyl | 1969299-27-1 | ADC Related |
| HY-133427 | Propargyl-PEG4-hydrazide | ADC Related | |
| HY-133428 | DBCO-PEG3-TCO | ADC Related | |
| HY-133429 | DBCO-PEG3-oxyamine | 2748394-67-2 | ADC Related |
| HY-13342AS | Apatinib-d8 (free base) | 2468771-43-7 | Isotope-Labeled Compounds |
| HY-13342S | Apatinib-d8 (hydrochloride) | 2468771-44-8 | Isotope-Labeled Compounds |
| HY-13343 | ZM 336372 | 208260-29-1 | Reference compound |
| HY-133430 | DBCO-PEG4-alkyne | 2741418-16-4 | ADC Related |
| HY-133431 | DBCO-PEG3-SS-NHS ester | ADC Related | |
| HY-133432 | DBCO-PEG4-SS-TCO | ADC Related | |
| HY-133433 | DBCO-PEG4-VA-PBD | 2241644-09-5 | ADC Related |
| HY-133434 | Aminoxyacetamide-PEG3-azide | 1379761-16-6 | ADC Related |
| HY-133435 | Aminooxy-amido-PEG4-propargyl | 2253965-03-4 | ADC Related |
| HY-133436 | Boc-aminooxy-amide-PEG4-propargyl | 2253965-01-2 | ADC Related |
| HY-133437 | BCN-PEG4-alkyne | Reference compound | |
| HY-133438 | BCN-PEG4-hydrazide | Reference compound | |
| HY-133439 | BCN-PEG4-NHS ester | Reference compound | |
| HY-13344 | PF-8380 | 1144035-53-9 | Reference compound |
| HY-13344A | PF-8380 (hydrochloride) | 2070015-01-7 | Reference compound |
| HY-133454 | Mal-PEG2-oxyamine | 1146245-73-9 | Reference compound |
| HY-133454A | Mal-PEG2-oxyamine (TFA) | Isotope-Labeled Compounds | |
| HY-133455 | Benzaldehyde-PEG4-azide | 1151451-77-2 | Reference compound |
| HY-133456 | Biotin-PEG2-aldehyde | Reference compound | |
| HY-133457 | Biotin-PEG2-C1-aldehyde | 2408505-11-1 | Reference compound |
| HY-133458 | Biotin-PEG3-amido-SS-amido-azide | 2866429-93-6 | Reference compound |
| HY-133459 | Mal-PEG1-Val-Cit-OH | ADC Related | |
| HY-133460 | Tetrazine-Ph-NHCO-PEG3-alcohol | Reference compound | |
| HY-133461 | Tetrazine-Ph-NHCO-PEG6-NH-Boc | Reference compound | |
| HY-133462 | Tetrazine-Ph-NHCO-PEG4-NH-Boc | Reference compound | |
| HY-133463 | Tetrazine-Ph-PEG5-Ph-tetrazine | Reference compound | |
| HY-133464 | Tetrazine-Ph-NHCO-PEG4-alkyne | Reference compound | |
| HY-133465 | Tetrazine-Ph-PEG4-Ph-aldehyde | Reference compound | |
| HY-133466 | Methyltetrazine-PEG4-SS-NHS ester | ADC Related | |
| HY-133467 | Methyltetrazine-PEG5-methyltetrazine | Reference compound | |
| HY-133468 | Methyltetrazine-PEG6-maleimide | Reference compound | |
| HY-133469 | Methyltetrazine-PEG8-N3 | Reference compound | |
| HY-133470 | Fmoc-NH-PEG4-alcohol | 868594-41-6 | Reference compound |
| HY-133471 | Fmoc-NH-PEG3-C2-NH2 | 906126-25-8 | Reference compound |
| HY-133472 | DBCO-NHCO-PEG3-Fmoc | Reference compound | |
| HY-133473 | S-acetyl-PEG6-Tos | 1818294-25-5 | Reference compound |
| HY-133474 | TCO-PEG3-oxyamine | Reference compound | |
| HY-133475 | TCO-PEG5-maleimide | Reference compound | |
| HY-133476 | TCO-PEG3-alcohol | 1955497-82-1 | Reference compound |
| HY-133477 | (S)-TCO-PEG3-maleimide | Reference compound | |
| HY-133478 | TCO-PEG11-TCO | Reference compound | |
| HY-133479 | Tetrazine-Ph-NHCO-C3-NHS ester | 1244040-64-9 | Reference compound |
| HY-133480 | Bromoacetyl-PEG3-DBCO | Reference compound | |
| HY-133481 | Iodo-PEG12-acid | Reference compound | |
| HY-133482 | Iodo-PEG12-NHS ester | Reference compound | |
| HY-133484 | Thalidomide-PEG2-NH2 | 1957235-94-7 | Reference compound |
| HY-133484B | Thalidomide-PEG2-NH2 (hydrochloride) | 2891597-17-2 | Reference compound |
| HY-133485 | Thalidomide-4-O-C8-NH2 | 1957235-91-4 | Reference compound |
| HY-133485B | Thalidomide-4-O-C8-NH2 (hydrochloride) | 2636798-38-2 | Reference compound |
| HY-133486 | GABAA receptor agent 1 | 1571-87-5 | Reference compound |
| HY-133487 | (S,R,S)-AHPC-C8-NH2 (dihydrochloride) | 2341796-80-1 | Reference compound |
| HY-133487A | (S,R,S)-AHPC-C8-NH2 (hydrochloride) | 2376139-49-8 | Reference compound |
| HY-133487B | (S,R,S)-AHPC-C8-NH2 | 2341796-79-8 | Reference compound |
| HY-133490A | ST1074 | 1402703-29-0 | Reference compound |
| HY-133492 | DBCO-PEG4-MMAF | 2360411-65-8 | ADC Related |
| HY-133493 | Folate-PEG3-NHS ester | Reference compound | |
| HY-133494 | Folate-PEG1-mal | 2743004-48-8 | Reference compound |
| HY-133495 | Folate-PEG2-amine | 1099829-15-8 | Reference compound |
| HY-133496 | Folate-PEG3-alkyne | 1245285-73-7 | Reference compound |
| HY-133497 | HyNic-PEG2-TCO | Reference compound | |
| HY-133498 | HyNic-PEG2-DBCO | 2741281-12-7 | Reference compound |
| HY-133499 | Boc-HyNic-PEG1-mal | 2743657-82-9 | Reference compound |
| HY-133500 | Boc-HyNic-PEG2-alkyne | Reference compound | |
| HY-133501 | Boc-HyNic-PEG2-N3 | Reference compound | |
| HY-133502 | Boc-HyNic-PEG2-DBCO | Reference compound | |
| HY-133503 | Mal-amide-PEG2-oxyamine-Boc | 2253965-15-8 | Reference compound |
| HY-133504 | Tetrazine-Ph-SS-amine | ADC Related | |
| HY-133505 | Me-Tet-PEG4-NH2 (hydrochloride) | 2656478-51-0 | Reference compound |
| HY-133506 | Bromoacetamide-PEG3-C1-acid | 173323-22-3 | Reference compound |
| HY-133507 | Mal-amide-PEG2-oxyamine | 2253965-09-0 | Reference compound |
| HY-133508 | Methyltetrazine-PEG4-SSPy | Reference compound | |
| HY-133509 | DBCO-C2-SulfoNHS ester | 1803279-86-8 | Reference compound |
| HY-133510 | Bis-BCN-PEG1-diamide | Reference compound | |
| HY-133511 | MLS000544460 | 352336-36-8 | Reference compound |
| HY-133512 | NCGC00249987 | 1384864-80-5 | Reference compound |
| HY-133513 | (±)-H3RESCA-TFP | 1919794-40-3 | Reference compound |
| HY-133527 | OG 488, SE | 198139-51-4 | Dye Reagents |
| HY-133528 | OptoBI-1 | 2415272-11-4 | Reference compound |
| HY-133529 | PA-8 | 878437-15-1 | Reference compound |
| HY-133530 | PDD00017238 | 1952247-05-0 | Reference compound |
| HY-133531 | PDD00017272 | 1945950-20-8 | Reference compound |
| HY-133532 | PB succiniMidyl ester | 215868-33-0 | Dye Reagents |
| HY-133533 | O-2050 | 1883545-42-3 | Reference compound |
| HY-133534 | PA-Nic (TFA) | Reference compound | |
| HY-133535 | PA Janelia Fluor® 646, SE | 2093120-32-0 | Dye Reagents |
| HY-133536 | PA Janelia Fluor® 549, SE | 1811539-42-0 | Dye Reagents |
| HY-133537 | Hygrolidin | 83329-73-1 | Natural Products |
| HY-133538 | 4-Succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene | 160854-54-6 | ADC Related |
| HY-133539 | Propargyl-C8-amido-PEG2-NHS ester | 1006592-59-1 | ADC Related |
| HY-133540 | Maleimide-DOTA | 1006711-90-5 | ADC Related |
| HY-133540G | Maleimide-DOTA (GMP) | 1006711-90-5 | GMP Small Molecules |
| HY-133541 | Glucopiericidin A | 108073-65-0 | Natural Products |
| HY-133542 | Dimethylamine-SPDB | 1193111-73-7 | ADC Related |
| HY-133543 | SPDP-sulfo | 121115-30-8 | ADC Related |
| HY-133544 | Mal-CO-PEG5-NHS ester | 1232769-29-7 | ADC Related |
| HY-133545 | Mal-Ph-CONH-PEG4-NHS ester | 1263044-88-7 | ADC Related |
| HY-133546 | Ald-Ph-amido-PEG11-C2-NH2 | 1337889-01-6 | ADC Related |
| HY-133547 | NO2-SPP-sulfo | 663598-66-1 | ADC Related |
| HY-133548 | NO2-SPDB-sulfo | 663598-89-8 | ADC Related |
| HY-133549 | NO2-SPDMV-sulfo | 663599-00-6 | ADC Related |
| HY-133550 | DMAC-SPDB | 663599-05-1 | ADC Related |
| HY-133551 | WF-47-JS03 | 2561413-77-0 | Reference compound |
| HY-133552 | RORγt Inverse agonist 10 | 2413986-35-1 | Reference compound |
| HY-133553 | RET-IN-3 | 2414374-53-9 | Reference compound |
| HY-133554 | ASK1-IN-1 | 2411382-24-4 | Reference compound |
| HY-133555 | mGluR2 antagonist 1 | 1432728-49-8 | Reference compound |
| HY-133556 | IQZ23 | 2415643-79-5 | Reference compound |
| HY-133557 | XZ739 | 2365172-19-4 | Reference compound |
| HY-133558 | VII-31 | 2305757-96-2 | Reference compound |
| HY-133569 | ARN23765 | 2244458-40-8 | Reference compound |
| HY-133570 | 17-AEP-GA | 75747-23-8 | ADC Related |
| HY-133571 | Aminohexylgeldanamycin | 485395-71-9 | ADC Related |
| HY-133571A | Aminohexylgeldanamycin (hydrochloride) | 1146534-45-3 | ADC Related |
| HY-133572 | Ald-Ph-amido-PEG11-NH-Boc | 1245813-70-0 | ADC Related |
| HY-133573 | Cyclooctyne-O-amido-PEG2-PFP ester | 2101206-61-3 | ADC Related |
| HY-133574 | Mal-amido-PEG3-C1-PFP ester | 2101206-13-5 | ADC Related |
| HY-133575 | Cyclooctyne-O-amido-PEG3-PFP ester | 2101206-33-9 | ADC Related |
| HY-133576 | Cyclooctyne-O-amido-PEG4-PFP ester | ADC Related | |
| HY-133579 | Ald-Ph-amido-PEG3-NHS ester | 2101206-32-8 | ADC Related |
| HY-133581 | Mal-PEG3-C1-NHS ester | 2230016-26-7 | ADC Related |
| HY-133582 | Mal-amido-PEG3-C1-NHS ester | 2101206-45-3 | ADC Related |
| HY-133583 | Propargyl-O-C1-amido-PEG3-C2-NHS ester | 2101206-78-2 | ADC Related |
| HY-133584 | Bis-SS-C3-NHS ester | 98604-88-7 | ADC Related |
| HY-133585 | Bis-SS-C3-sulfo-NHS ester | 98604-89-8 | ADC Related |
| HY-133587 | 1,1,1,3,10,11-Hexachloroundecane | 601523-28-8 | Reference compound |
| HY-133588 | 4-Formylaminoantipyrine | 1672-58-8 | Reference compound |
| HY-133588R | 4-Formylaminoantipyrine (Standard) | 1672-58-8 | Reference Standards |
| HY-133588S | 4-Formylaminoantipyrine-d3 | Isotope-Labeled Compounds | |
| HY-133589 | Fulvine | 6029-87-4 | Reference compound |
| HY-133590 | Heliotrine N-oxide | 6209-65-0 | Reference compound |
| HY-133591 | Senecivernine | 72755-25-0 | Natural Products |
| HY-133592 | Neoabietic acid | 471-77-2 | Reference compound |
| HY-133592R | Neoabietic acid (Standard) | 471-77-2 | Reference Standards |
| HY-133593 | Palustric acid | 1945-53-5 | Natural Products |
| HY-133593R | Palustric acid (Standard) | 1945-53-5 | Reference Standards |
| HY-133594 | Sandaracopimaric acid | 471-74-9 | Natural Products |
| HY-133596 | 12,14-Dichlorodehydroabietic acid | 65281-77-8 | Reference compound |
| HY-133597 | 4-Chlorocatechol | 2138-22-9 | Reference compound |
| HY-133598 | 3,4,5-Trichlorocatechol | 56961-20-7 | Reference compound |
| HY-133599 | 4,5-Dichloroguaiacol | 2460-49-3 | Reference compound |
| HY-133600 | 4,5,6-Trichloroguaiacol | 2668-24-8 | Reference compound |
| HY-133601 | 3,4,5-Trichloroguaiacol | 57057-83-7 | Reference compound |
| HY-133602 | Tetrachloroguaiacol | 2539-17-5 | Reference compound |
| HY-133603 | 4,5-Dichloroveratrole | 2772-46-5 | Reference compound |
| HY-133604 | 3,4,5-Trichloroveratrole | 16766-29-3 | Reference compound |
| HY-133605 | Tetrachloroveratrole | 944-61-6 | Reference compound |
| HY-133606 | 3,4,5-Trichlorosyringol | 2539-26-6 | Reference compound |
| HY-133607 | 5,6-Dichlorovanillin | 18268-69-4 | Reference compound |
| HY-133608 | 4,6-Dichloroguaiacol | 16766-31-7 | Reference compound |
| HY-133609 | 3,5-Dichlorocatechol | 13673-92-2 | Reference compound |
| HY-133610 | 3,4,6-Trichlorocatechol | 32139-72-3 | Reference compound |
| HY-133611 | 3,4-Dichlorocatechol | 3978-67-4 | Reference compound |
| HY-133612 | 3,6-Dichlorocatechol | 3938-16-7 | Reference compound |
| HY-133614 | Dihydroisopimaric acid | 5673-36-9 | Reference compound |
| HY-133618 | Pomalidomide-C3-adavosertib | 2414418-49-6 | Reference compound |
| HY-133620 | 7-Oxodehydroabietic acid | 18684-55-4 | Reference compound |
| HY-133621 | 9,10-Dichlorostearic acid | 5829-48-1 | Reference compound |
| HY-133622 | 1,1-Dibromoacetone | 867-54-9 | Reference compound |
| HY-133623 | 1,1,1-Tribromoacetone | 3770-98-7 | Reference compound |
| HY-133624 | 1,1,3-Tribromoacetone | 3475-39-6 | Reference compound |
| HY-133624R | 1,1,3-Tribromoacetone (Standard) | 3475-39-6 | Reference Standards |
| HY-133625 | 1,1-Dibromo-3-chloroacetone | 1578-18-3 | Reference compound |
| HY-133626 | 1,1-Dibromo-3,3-dichloroacetone | 62874-83-3 | Reference compound |
| HY-133627 | 1,3-Dibromo-1,3-dichloroacetone | 62874-84-4 | Reference compound |
| HY-133628 | 1,1,3-Tribromo-3-chloroacetone | 55716-01-3 | Reference compound |
| HY-133629 | 1,1,1,3-Tetrachloroacetone | 16995-35-0 | Reference compound |
| HY-133630 | 1-Bromo-1,1-dichloroacetone | 1751-16-2 | Reference compound |
| HY-133631 | Chloronitromethane | 1794-84-9 | Reference compound |
| HY-133633 | Bromodichloronitromethane | 918-01-4 | Reference compound |
| HY-133634 | Dibromochloronitromethane | 1184-89-0 | Reference compound |
| HY-133635 | Tribromonitromethane | 464-10-8 | Reference compound |
| HY-133636 | Bromochloronitromethane | 135531-25-8 | Reference compound |
| HY-133641 | Dibromoiodomethane | 593-94-2 | Reference compound |
| HY-133642 | Dichloroiodomethane | 594-04-7 | Reference compound |
| HY-133643 | Bromodichloroacetonitrile | 60523-73-1 | Reference compound |
| HY-133644 | Tribromoacetonitrile | 75519-19-6 | Reference compound |
| HY-133646 | Bromochloroacetonitrile | 83463-62-1 | Reference compound |
| HY-133647 | Dibromoacetaldehyde | 3039-13-2 | Reference compound |
| HY-133649 | Dibromochloroacetaldehyde | 64316-11-6 | Reference compound |
| HY-133651 | 2,2-Dibromopropanoic acid | 594-48-9 | Reference compound |
| HY-133652 | 2,3-Dibromoacrylic acid | 24767-86-0 | Reference compound |
| HY-133653 | 3,3-Dibromopropenoic acid | 1578-21-8 | Reference compound |
| HY-133654 | 2,3,3-Tribromopropenoic acid | 71815-46-8 | Reference compound |
| HY-133655 | (E)-2,3-Dibromo-2-butenedioic acid | 608-38-8 | Reference compound |
| HY-133656 | (Z)-2-Bromo-3-methyl-2-butenedioic acid | 23366-89-4 | Reference compound |
| HY-133657 | Bromoiodoacetic acid | 71815-43-5 | Reference compound |
| HY-133658 | Chloroiodoacetic acid | 53715-09-6 | Reference compound |
| HY-133659 | Diiodoacetic acid | 598-89-0 | Reference compound |
| HY-133664 | Dibromochloroacetamide | 855878-13-6 | Reference compound |
| HY-133665 | 2,2-Dibromoacetamide | 598-70-9 | Reference compound |
| HY-133666 | Diiodoacetamide | 5875-23-0 | Reference compound |
| HY-133667 | Bromoiodoacetamide | 62872-36-0 | Reference compound |
| HY-133668 | Monoethyl phthalate | 2306-33-4 | Reference compound |
| HY-133668R | Monoethyl phthalate (Standard) | 2306-33-4 | Reference Standards |
| HY-133668S | Monoethyl phthalate-d4 | 1219806-03-7 | Isotope-Labeled Compounds |
| HY-133669 | DDR1-IN-5 | 2416022-90-5 | Reference compound |
| HY-133670 | DDR1-IN-6 | 2416021-47-9 | Reference compound |
| HY-133671S | Monooctyl phthalate-d4 | 1398065-74-1 | Isotope-Labeled Compounds |
| HY-133672 | (Rac)-Mono(3,5,5-trimethylhexyl) phthalate | 297182-83-3 | Reference compound |
| HY-133673S | Mono(3-carboxypropyl) phthalate-d4 | 1346600-69-8 | Isotope-Labeled Compounds |
| HY-133675 | Mono(5-carboxy-2-ethylpentyl) phthalate | 40809-41-4 | Reference compound |
| HY-133675S | Mono(5-carboxy-2-ethylpentyl) phthalate-d4 | 866864-06-4 | Isotope-Labeled Compounds |
| HY-133676S | Mono(2-ethyl-5-oxohexyl) phthalate-d4 | 679789-44-7 | Isotope-Labeled Compounds |
| HY-133677 | Mono(2-ethyl-5-hydroxyhexyl) phthalate | 40321-99-1 | Reference compound |
| HY-133677S | Mono(2-ethyl-5-hydroxyhexyl) phthalate-d4 | 679789-43-6 | Isotope-Labeled Compounds |
| HY-133680 | β-Tocopherol | 16698-35-4 | Natural Products |
| HY-133680R | β-Tocopherol (Standard) | 16698-35-4 | Reference Standards |
| HY-133680S | β-Tocopherol-d4 | 2241864-46-8 | Isotope-Labeled Compounds |
| HY-133681 | (±)-2,3-Dibromosuccinic acid | 1114-00-7 | Reference compound |
| HY-133681A | 2,3-Dibromosuccinic acid | 526-78-3 | Reference compound |
| HY-133683 | N-(3-Oxotetradecanoyl)-DL-homoserine lactone | 503610-29-5 | Natural Products |
| HY-133683R | N-(3-Oxotetradecanoyl)-DL-homoserine lactone (Standard) | 503610-29-5 | Reference Standards |
| HY-133684 | N-Tetradecanoyl-L-homoserine lactone | 202284-87-5 | Reference compound |
| HY-133684R | N-Tetradecanoyl-L-homoserine lactone (Standard) | 202284-87-5 | Reference Standards |
| HY-133685 | N-Hexanoyl-L-homoserine lactone | 147852-83-3 | Reference compound |
| HY-133685R | N-Hexanoyl-L-homoserine lactone (Standard) | 147852-83-3 | Reference Standards |
| HY-133685S | N-Hexanoyl-L-Homoserine lactone-d3 | 2705226-73-7 | Isotope-Labeled Compounds |
| HY-133689AS | 3-Nitrophenylhydrazine-13C6 (hydrochloride) | 1977535-33-3 | Isotope-Labeled Compounds |
| HY-133690 | D-myo-Inositol-1,3,4,5-tetraphosphate (sodium) | 210488-61-2 | Reference compound |
| HY-133694 | 2-Aminoflubendazole | 82050-13-3 | Reference compound |
| HY-133694R | 2-Aminoflubendazole (Standard) | 82050-13-3 | Reference Standards |
| HY-133694S | 2-Aminoflubendazole-13C6 | Isotope-Labeled Compounds | |
| HY-133695 | Florfenicol amine | 76639-93-5 | Reference compound |
| HY-133695R | Florfenicol amine (Standard) | 76639-93-5 | Reference Standards |
| HY-133695S | ent-Florfenicol Amine-d3 | 1217625-88-1 | Isotope-Labeled Compounds |
| HY-133699 | Pomalidomide-PEG4-COOH | 2138440-81-8 | Reference compound |
| HY-133702 | Aniline-piperazine-C3-NH-Boc | 643087-19-8 | Reference compound |
| HY-133704 | Pyrrolnitrin | 1018-71-9 | Reference compound |
| HY-133705 | Geldanamycin-FITC | 2969156-01-0 | Dye Reagents |
| HY-133706S | 2-Nitrobenzaldehyde semicarbazone-13C,15N2 | 760179-80-4 | Isotope-Labeled Compounds |
| HY-133707 | β-Muricholic acid | 2393-59-1 | Reference compound |
| HY-133707R | β-Muricholic acid (Standard) | 2393-59-1 | Reference Standards |
| HY-133707S | β-Muricholic acid-d5 | 2725726-62-3 | Isotope-Labeled Compounds |
| HY-133707S1 | β-Muricholic acid-d4 | Isotope-Labeled Compounds | |
| HY-133708 | β-Glucogallin | 13405-60-2 | Natural Products |
| HY-133709 | β-Aflatrem | 144446-23-1 | Natural Products |
| HY-133712 | Yonkenafil | 804518-63-6 | Reference compound |
| HY-133712S | Yonkenafil-d8 | Isotope-Labeled Compounds | |
| HY-133712S1 | Yonkenafil-d7 | Isotope-Labeled Compounds | |
| HY-133715 | Pilsicainide | 88069-67-4 | Reference compound |
| HY-133716 | Pantoprazole N-oxide | 953787-60-5 | Reference compound |
| HY-133717 | Naltriben | 111555-58-9 | Reference compound |
| HY-133718 | Acarviosin | 80943-41-5 | Reference compound |
| HY-133719 | Fenfuram | 24691-80-3 | Reference compound |
| HY-133720 | 4-Demethyltraxillaside | 1691201-82-7 | Natural Products |
| HY-133721 | Chamaechromone | 93413-00-4 | Natural Products |
| HY-133724 | Vardenafil N-oxide | 448184-48-3 | Reference compound |
| HY-133724R | Vardenafil N-oxide (Standard) | 448184-48-3 | Reference Standards |
| HY-133726 | Bixafen | 581809-46-3 | Reference compound |
| HY-133726R | Bixafen (Standard) | 581809-46-3 | Reference Standards |
| HY-133728 | Piribedil N-oxide | 53954-71-5 | Reference compound |
| HY-133732 | Alaproclate (hydrochloride) | 60719-83-7 | Reference compound |
| HY-133735 | GRP-60367 | 1309241-34-6 | Reference compound |
| HY-133735A | GRP-60367 (hydrochloride) | 2803211-60-9 | Reference compound |
| HY-133736 | PROTAC BRD4 Degrader-5-CO-PEG3-N3 | 2704602-92-4 | ADC Related |
| HY-133737 | PROTAC BRD4 Degrader-5 | 2409538-70-9 | Reference compound |
| HY-133738 | M-808 | 2377335-74-3 | Reference compound |
| HY-133739 | NBD-125 | 2367641-24-3 | Reference compound |
| HY-133740 | MS117 | 2702280-86-0 | Reference compound |
| HY-133747 | JAK3-IN-9 | 1430095-30-9 | Reference compound |
| HY-133754 | MI-1063 | 1410737-39-1 | Reference compound |
| HY-133760 | MI-888 | 1303607-59-1 | Reference compound |
| HY-133770 | Seco Rapamycin ethyl ester | Reference compound | |
| HY-133771AS | Nordoxepin-d3 (hydrochloride) | 1331665-54-3 | Isotope-Labeled Compounds |
| HY-133772 | Venetoclax N-oxide | 2469279-00-1 | Reference compound |
| HY-133773 | Desoxochlordiazepoxide | 4393-72-0 | Reference compound |
| HY-133774 | Trityl olmesartan medoxomil impurity III | 1227626-51-8 | Reference compound |
| HY-133775 | Olmesartan impurity | 154709-18-9 | Reference compound |
| HY-133776 | Rivastigmine carbamate impurity | 1346242-31-6 | Reference compound |
| HY-133777 | Ciprofibrate impurity A | 1474058-89-3 | Reference compound |
| HY-133778 | O-Desmethyl mycophenolic acid methyl ester | 33431-38-8 | Reference compound |
| HY-133779 | Gefitinib impurity 5 | 199327-61-2 | Reference compound |
| HY-133779R | Gefitinib impurity 5 (Standard) | 199327-61-2 | Reference Standards |
| HY-133780 | Afatinib impurity 11 | 1402086-20-7 | Reference compound |
| HY-133781 | cis-Clopidogrel-MP derivative | 1122047-98-6 | Reference compound |
| HY-133782 | Fluphenazine-N-2-chloroethane (hydrochloride) | 3892-78-2 | Reference compound |
| HY-133787 | Levofloxacin N-oxide | 117678-38-3 | Reference compound |
| HY-133787R | Levofloxacin N-oxide (Standard) | 117678-38-3 | Reference Standards |
| HY-133790 | Palonosetron N-oxide | 813425-83-1 | Reference compound |
| HY-133794 | Dasatinib N-oxide | 910297-52-8 | Reference compound |
| HY-133794R | Dasatinib N-oxide (Standard) | 910297-52-8 | Reference Standards |
| HY-133794S | Dasatinib N-oxide-d8 | 1189988-36-0 | Isotope-Labeled Compounds |
| HY-133795 | Lucanthone N-oxide | 5615-06-5 | Reference compound |
| HY-133797 | Cyclobenzaprine N-oxide | 6682-26-4 | Reference compound |
| HY-133797S | Cyclobenzaprine N-oxide-d3 | 1189877-07-3 | Isotope-Labeled Compounds |
| HY-133798 | Sorafenib N-oxide | 583840-03-3 | Reference compound |
| HY-133799 | Pomalidomide-C7-COOH | 2225940-51-0 | Reference compound |
| HY-133800 | Volvaltrate B | 1181224-13-4 | Natural Products |
| HY-133801 | Unguisin A | 226956-06-5 | Peptides |
| HY-133803 | Z-Ala-Ala-OH | 16012-70-7 | Reference compound |
| HY-133804 | Arteanoflavone | 68710-17-8 | Natural Products |
| HY-133807 | Benpyrine | 2550398-89-3 | Reference compound |
| HY-133807A | (Rac)-Benpyrine | 1333714-43-4 | Reference compound |
| HY-133807B | (R)-Benpyrine | 2637243-08-2 | Reference compound |
| HY-133813A | Apovincaminic acid (hydrochloride salt) | 72296-47-0 | Reference compound |
| HY-133813AR | Apovincaminic acid (hydrochloride salt) (Standard) | 72296-47-0 | Reference Standards |
| HY-133813S | Apovincaminic acid-d4 | Isotope-Labeled Compounds | |
| HY-133816 | Pomalidomide-amino-PEG5-NH2 (hydrochloride) | 2421217-05-0 | Reference compound |
| HY-133816A | Pomalidomide-amino-PEG5-NH2 | 2421217-04-9 | Reference compound |
| HY-133817 | Pomalidomide-amino-PEG3-NH2 (hydrochloride) | 2380273-75-4 | Reference compound |
| HY-133817A | Pomalidomide-amino-PEG3-NH2 | 2380273-74-3 | Reference compound |
| HY-133821 | N-Methylmesoporphyrin IX | 142234-85-3 | Dye Reagents |
| HY-133823 | 11-Hexadecenoic acid | 2271-34-3 | Natural Products |
| HY-133825 | Cyazofamid | 120116-88-3 | Reference compound |
| HY-133828 | Cinanserin | 1166-34-3 | Reference compound |
| HY-133829 | Zofenoprilat | 75176-37-3 | Reference compound |
| HY-133830 | 7α,24(S)-Dihydroxycholesterol | 245523-67-5 | Reference compound |
| HY-133832 | Elopiprazole | 115464-77-2 | Reference compound |
| HY-133838 | Ilmofosine | 83519-04-4 | Reference compound |
| HY-133839 | Kethoxal | 27762-78-3 | Reference compound |
| HY-133845 | CIL-102 | 479077-76-4 | Reference compound |
| HY-133846 | Iodothiouracil | 5984-97-4 | Reference compound |
| HY-133847 | LAPAO | 61792-31-2 | Reference compound |
| HY-133850 | 10-DEBC | 201788-90-1 | Reference compound |
| HY-133852 | FD-1080 | 1151666-58-8 | Dye Reagents |
| HY-133852A | FD-1080 (free acid) | 1151888-25-3 | Dye Reagents |
| HY-133854 | L 8412 | 50602-48-7 | Reference compound |
| HY-133858 | 25N-NBOMe (hydrochloride) | 1566571-65-0 | Reference compound |
| HY-133859 | M084 | 51314-51-3 | Reference compound |
| HY-133860 | Chrysoobtusin | 70588-06-6 | Natural Products |
| HY-133862 | SCH-202676 | 70375-43-8 | Reference compound |
| HY-133865 | Diacetoxy-6-gingerdiol | 143615-75-2 | Natural Products |
| HY-133869 | cGMP-HTL | Reference compound | |
| HY-133870 | Itaconate-alkyne | 2454181-83-8 | Reference compound |
| HY-133871 | trans-2-Hexadecenoyl-L-carnitine | 26145-55-1 | Reference compound |
| HY-133872 | [(3R)-3-Hydroxydodecanoyl]-L-carnitine | 1469900-99-9 | Reference compound |
| HY-133875 | CE3F4 analog 1 | 2141967-43-1 | Reference compound |
| HY-133876 | 4-Di-16-ASP | 114041-00-8 | Dye Reagents |
| HY-133878 | Octadeca-9,12-dienamide | 3072-13-7 | Reference compound |
| HY-133879 | Calcitriol lactone | 81203-50-1 | Reference compound |
| HY-133883 | Cyanine7.5 amine | 2104005-17-4 | Reference compound |
| HY-133884 | ICG-amine | 1686147-55-6 | Dye Reagents |
| HY-133885 | S-(-)-7-Desmethyl-8-nitro blebbistatin | 856925-75-2 | Reference compound |
| HY-133885A | R-(-)-7-Desmethyl-8-nitro blebbistatin | 1217619-62-9 | Reference compound |
| HY-133887 | Methotrexate α-tert-butyl ester | 79640-70-3 | Reference compound |
| HY-133890 | Tauro-α-muricholic acid | 25613-05-2 | Natural Products |
| HY-133890A | Tauro-α-muricholic acid (sodium) | 2260905-08-4 | Reference compound |
| HY-133890AS | Tauro-α-muricholic acid-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-133894 | Bofutrelvir | 2103278-86-8 | Reference compound |
| HY-133897 | (Rac)-Indoximod | 26988-72-7 | Reference compound |
| HY-133898 | Danavorexton | 2114324-48-8 | Reference compound |
| HY-133900 | Deoxyharringtonine | 36804-95-2 | Natural Products |
| HY-133902 | Neoglucobrassicin | 5187-84-8 | Natural Products |
| HY-133905 | Pandamine | 10233-81-5 | Natural Products |
| HY-133907 | NVS-PI3-4 | 941580-60-5 | Reference compound |
| HY-133910 | Lu AE98134 | 849000-18-6 | Reference compound |
| HY-133916 | G140 | 2369751-07-3 | Reference compound |
| HY-133924 | 18-Deoxyherboxidiene | 1200128-66-0 | Reference compound |
| HY-133925 | 6-O-Desmethyl donepezil | 120013-56-1 | Reference compound |
| HY-133925S | 6-O-Desmethyl donepezil-d5 | 1189443-74-0 | Isotope-Labeled Compounds |
| HY-133925S1 | 6-O-Desmethyl donepezil-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-133925S2 | 6-O-Desmethyl donepezil-d7 | 1261396-76-2 | Isotope-Labeled Compounds |
| HY-133926 | 5-O-Desmethyl donepezil | 120013-57-2 | Reference compound |
| HY-133926S | 5-O-Desmethyl donepezil-d5 | 1189929-21-2 | Isotope-Labeled Compounds |
| HY-133927 | (2E,6E)-3,7-Dimethyltrideca-2,6-dien-12-yn-1-ol | 2361137-98-4 | Reference compound |
| HY-133933 | Maleylsulfathiazole | 515-57-1 | Reference compound |
| HY-133935 | Benaxibine | 27661-27-4 | Reference compound |
| HY-133937 | Sulfametrole | 32909-92-5 | Reference compound |
| HY-133948 | 1-Monopalmitolein | 37515-61-0 | Biochemical Assay Reagents |
| HY-133949 | 8,11-Eicosadiynoic acid | 82073-91-4 | Reference compound |
| HY-133950 | N-Monoacetylcystine | 25779-79-7 | Reference compound |
| HY-133951 | 4',6,7-Trimethoxyisoflavone | 798-61-8 | Natural Products |
| HY-133952 | 7-Oxotridecanedioic acid | 101171-43-1 | Biochemical Assay Reagents |
| HY-133953 | 9-Oxoheptadecanedioic acid | 1502-36-9 | Reference compound |
| HY-133954 | 19-Heptatriacontanol | 872307-34-1 | Reference compound |
| HY-133956 | 3-ATA | 129821-08-5 | Reference compound |
| HY-133957 | Fluoromevalonate | 2822-77-7 | Biochemical Assay Reagents |
| HY-133961 | Cholesterol β-D-glucoside | 7073-61-2 | Reference compound |
| HY-133962 | Cholesteryl erucate | 24516-39-0 | Biochemical Assay Reagents |
| HY-133963 | Cholesteryl lignocerate | 73024-96-1 | Natural Products |
| HY-133965 | Cinchonain IIa | 85081-23-8 | Natural Products |
| HY-133966 | 6α-Hydroxy-5α-cholestane | 41083-73-2 | Reference compound |
| HY-133966S | 6α-Hydroxy-5α-cholestane-d7 | 1246302-83-9 | Isotope-Labeled Compounds |
| HY-133967 | (25R)-26-Hydroxycholest-4-en-3-one | 56792-59-7 | Reference compound |
| HY-133968 | 24-Methylenecholesterol | 474-63-5 | Natural Products |
| HY-133968R | 24-Methylenecholesterol (Standard) | 474-63-5 | Reference Standards |
| HY-133968S1 | 24-Methylenecholesterol-13C | Isotope-Labeled Compounds | |
| HY-133969 | 5β-Cholane | 80373-86-0 | Reference compound |
| HY-133970 | 5α-Cholestane | 481-21-0 | Biochemical Assay Reagents |
| HY-133970R | 5α-Cholestane (Standard) | 481-21-0 | Reference Standards |
| HY-133970S | 5α-Cholestane-d6 | 358731-18-7 | Isotope-Labeled Compounds |
| HY-133970S1 | 5α-Cholestane-d2 | 122241-86-5 | Isotope-Labeled Compounds |
| HY-133971 | Cholesterol 5α,6α-epoxide | 1250-95-9 | Biochemical Assay Reagents |
| HY-133971S | Cholesterol-5α,6α-epoxide-d7 | 127685-38-5 | Isotope-Labeled Compounds |
| HY-133972 | 3β-Hydroxy-5-cholestenoic acid | 6561-58-6 | Biochemical Assay Reagents |
| HY-133972S | 3β-Hydroxy-5-cholestenoic acid-d5 | 1620239-03-3 | Isotope-Labeled Compounds |
| HY-133974 | 7-keto-25-Hydroxycholesterol | 64907-23-9 | Reference compound |
| HY-133975 | Isoleucylcysteine | 117525-90-3 | Reference compound |
| HY-133976 | Aceclofenac methyl ester | 139272-66-5 | Reference compound |
| HY-133980 | O-Demethyl Lenvatinib | 417717-04-5 | Reference compound |
| HY-133980A | O-Demethyl Lenvatinib (hydrochloride) | Reference compound | |
| HY-133980AR | O-Demethyl Lenvatinib (hydrochloride) (Standard) | Reference Standards | |
| HY-133984 | (7Z)-7-Tricosene | 52078-42-9 | Natural Products |
| HY-133985 | 7(Z)-Pentacosene | 63623-49-4 | Natural Products |
| HY-133986 | 6-Methylchrysene | 1705-85-7 | Reference compound |
| HY-133987 | AP-1/NF-κB activation inhibitor 1 | 188936-12-1 | Reference compound |
| HY-133991 | Desethyl sildenafil | 139755-91-2 | Reference compound |
| HY-133994 | Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin | 53784-84-2 | Reference compound |
| HY-133998 | SIRT-IN-3 | 1211-19-4 | Reference compound |
| HY-134000 | Emodic acid | 478-45-5 | Natural Products |
| HY-134001 | CBR-470-2 | 2416095-00-4 | Reference compound |
| HY-134004 | Pentoxyverine | 77-23-6 | Reference compound |
| HY-134004R | Pentoxyverine (Standard) | 77-23-6 | Reference Standards |
| HY-134005 | ISIS 416858 | 1223657-78-0 | Oligonucleotides |
| HY-134006 | Stemoninine | 69772-72-1 | Natural Products |
| HY-134008 | Protoapigenone | 862884-32-0 | Natural Products |
| HY-134009 | (+)-Cloprostenol methyl ester | 56687-85-5 | Reference compound |
| HY-13401 | Sovaprevir | 1001667-23-7 | Reference compound |
| HY-134013 | Piperitenone oxide | 3564-96-3 | Reference compound |
| HY-134017 | Acetyl dipeptide-1 cetyl ester | 196604-48-5 | Peptides |
| HY-134019 | Arachidonoyl p-nitroaniline | 119520-58-0 | Reference compound |
| HY-13402 | Varespladib | 172732-68-2 | Reference compound |
| HY-134021 | Prednisolone valerate acetate | 72064-79-0 | Reference compound |
| HY-13402A | Varespladib (sodium) | 172733-42-5 | Reference compound |
| HY-134031 | Ara-ATP | 3714-60-1 | Reference compound |
| HY-134036 | α-Obscurine | 596-55-4 | Natural Products |
| HY-134038 | Cannabinol methyl ether | 41935-92-6 | Reference compound |
| HY-134039 | 5-Hydroxy-8-methoxypsoralen | 7471-73-0 | Natural Products |
| HY-13404 | Capmatinib | 1029712-80-8 | Reference compound |
| HY-134041 | Phloroglucide | 491-45-2 | Natural Products |
| HY-134043 | Chlorthalidone Impurity G | 16289-13-7 | Reference compound |
| HY-134046 | (-)-Isodocarpin | 10391-08-9 | Natural Products |
| HY-134048 | Erucoylcarnitine | 51267-35-7 | Reference compound |
| HY-13404A | Capmatinib (dihydrochloride) | 1197376-85-4 | Reference compound |
| HY-13404B | Capmatinib (hydrochloride) | 1029714-89-3 | Reference compound |
| HY-13404C | Capmatinib (dihydrochloride hydrate) | 1865733-40-9 | Reference compound |
| HY-13404R | Capmatinib (Standard) | 1029712-80-8 | Reference Standards |
| HY-13405 | Tiaramide (hydrochloride) | 35941-71-0 | Reference compound |
| HY-134050 | Apostatin-1 | 2559703-06-7 | Reference compound |
| HY-134052 | Biliverdin dimethyl ester | 10035-62-8 | Biochemical Assay Reagents |
| HY-134054 | N-Acetylstepharine | 4880-87-9 | Natural Products |
| HY-134055 | Arachidonoyl-N,N-dimethyl amide | 45280-17-9 | Reference compound |
| HY-134056 | cis-13,16-Docosadienoic acid methyl ester | 61012-47-3 | Biochemical Assay Reagents |
| HY-13406 | TAK-779 | 229005-80-5 | Reference compound |
| HY-134061 | Arecaidine propargyl ester (hydrobromide) | 116511-28-5 | Reference compound |
| HY-134062 | 7-Methyl-6-mercaptopurine | 3324-79-6 | Reference compound |
| HY-134068 | Methyl 17-hydroxyheptadecanoate | 94036-00-7 | Natural Products |
| HY-13407 | Gossypol | 303-45-7 | Natural Products |
| HY-134070 | 2-O-Methyl PAF C-16 | 78858-44-3 | Reference compound |
| HY-13407R | Gossypol (Standard) | 303-45-7 | Reference Standards |
| HY-13407S | Gossypol-13C2 | Isotope-Labeled Compounds | |
| HY-13408 | (+)-Apogossypol | 66389-74-0 | Reference compound |
| HY-134080 | 1-O-Hexadecyl-2-O-methylglycerol | 84337-41-7 | Biochemical Assay Reagents |
| HY-134082A | (Z)-Oleyloxyethyl phosphorylcholine | 84601-19-4 | Reference compound |
| HY-134086 | NSD-IN-2 | 2351225-46-0 | Reference compound |
| HY-13409 | SB 242084 | 181632-25-7 | Reference compound |
| HY-134090 | 9-Methylstreptimidone | 51867-94-8 | Reference compound |
| HY-134092 | N-Methyl Leukotriene C4 | 131391-65-6 | Reference compound |
| HY-134094 | Fluridone | 59756-60-4 | Reference compound |
| HY-134094R | Fluridone (Standard) | 59756-60-4 | Reference Standards |
| HY-134095 | Erythromycin A N-oxide | 992-65-4 | Reference compound |
| HY-134098 | Diisopropyl adipate | 6938-94-9 | Reference compound |
| HY-134098R | Diisopropyl adipate (Standard) | 6938-94-9 | Reference Standards |
| HY-13409A | SB 242084 (dihydrochloride) | 1049747-87-6 | Reference compound |
| HY-13409B | SB 242084 (monohydrochloride) | 1260505-34-7 | Reference compound |
| HY-13410 | Xanomeline (oxalate) | 141064-23-5 | Reference compound |
| HY-134101 | 2-O-Ethyl PAF C-16 | 78858-42-1 | Reference compound |
| HY-134103A | ddGTP (trisodium) | Oligonucleotides | |
| HY-134104 | C20-Sphingosine | 6918-49-6 | Natural Products |
| HY-134106 | N-Boc-erythro-sphingosine | 116467-63-1 | Reference compound |
| HY-134107 | Azido-erythro-sphingosine | 103348-49-8 | Reference compound |
| HY-134108 | (3E,13Z)-Octadecadien-1-ol | 66410-28-4 | Natural Products |
| HY-134110 | N-Methylarachidonamide | 156910-29-1 | Reference compound |
| HY-134113 | Z-Gly-Pro-Arg-pNA | 66648-35-9 | Peptides |
| HY-134115 | Flumethasone 21-acetate | 2823-42-9 | Reference compound |
| HY-134116 | Isoflupredone acetate | 338-98-7 | Reference compound |
| HY-134116R | Isoflupredone acetate (Standard) | 338-98-7 | Reference Standards |
| HY-134119 | Ethyl palmitoleate | 56219-10-4 | Biochemical Assay Reagents |
| HY-13412 | Cariporide (mesilate) | 159138-81-5 | Reference compound |
| HY-134120 | 2-Hydroxystearic acid | 629-22-1 | Biochemical Assay Reagents |
| HY-134123 | Lipoxin B4 methyl ester | 97589-07-6 | Reference compound |
| HY-134124 | Glutathione ethyl ester | 92614-59-0 | Peptides |
| HY-134125 | Yohimbic acid ethyl ester | 73840-32-1 | Reference compound |
| HY-134126 | Methyl heneicosanoate | 6064-90-0 | Biochemical Assay Reagents |
| HY-134127 | Methyl hexacosanoate | 5802-82-4 | Biochemical Assay Reagents |
| HY-134127S1 | Methyl hexacosanoate-d4 | 2692624-18-1 | Isotope-Labeled Compounds |
| HY-134127S2 | Hexacosanoic acid methyl ester-d3 | 2743078-84-2 | Isotope-Labeled Compounds |
| HY-134129 | Benzoyl coenzyme A | 6756-74-7 | Reference compound |
| HY-134129A | Benzoyl coenzyme A (trilithium) | 102185-37-5 | Biochemical Assay Reagents |
| HY-13413 | Tofogliflozin (hydrate) | 1201913-82-7 | Reference compound |
| HY-134130 | Integrin modulator 1 | 2023788-32-9 | Reference compound |
| HY-134132 | 15(S)-HETE methyl ester | 70946-44-0 | Reference compound |
| HY-134135 | Prostaglandin A1 methyl ester | 26771-94-8 | Reference compound |
| HY-134136 | Octanoyl Coenzyme A | 1264-52-4 | Biochemical Assay Reagents |
| HY-134136A | Octanoyl coenzyme A (lithium) | 324518-20-9 | Biochemical Assay Reagents |
| HY-134136B | Octanoyl coenzyme A (triammonium) | 799812-82-1 | Enzyme |
| HY-134137 | Donepezil N-oxide | 120013-84-5 | Reference compound |
| HY-134137S | Donepezil N-oxide-d5 | Isotope-Labeled Compounds | |
| HY-134138 | Indomethacin N-octyl amide | 282728-65-8 | Reference compound |
| HY-13414 | Remogliflozin | 329045-45-6 | Reference compound |
| HY-134141 | 5-Octyl hydrogen L-glutamate | 4852-91-9 | Peptides |
| HY-134145 | 1-(Anilinocarbonyl)proline | 73096-22-7 | Reference compound |
| HY-134149 | N-Formyl desloratadine | 117810-61-4 | Reference compound |
| HY-134154 | PAz-PC | 117746-89-1 | Reference compound |
| HY-134156 | Methyl cis-11-octadecenoate | 1937-63-9 | Biochemical Assay Reagents |
| HY-134156A | Methyl vaccenate | 6198-58-9 | Biochemical Assay Reagents |
| HY-134160 | 5,6-Dihydro-5-Fluorouracil | 696-06-0 | Reference compound |
| HY-134161 | DL-α-(Difluoromethyl)arginine | 69955-43-7 | Reference compound |
| HY-134163 | 4-Methylumbelliferyl α-L-arabinopyranoside | 69414-26-2 | Biochemical Assay Reagents |
| HY-134164 | 4-Nitrophenyl α-L-arabinofuranoside | 6892-58-6 | Biochemical Assay Reagents |
| HY-13417 | AICAR | 2627-69-2 | Reference compound |
| HY-134173 | Arachidonoyl ethanolamide phosphate | 183323-26-4 | Natural Products |
| HY-134174 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphate | 62600-81-1 | Biochemical Assay Reagents |
| HY-134174A | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphate (sodium) | 169437-35-8 | Biochemical Assay Reagents |
| HY-134177 | 2,5-Anhydro-D-glucitol-1,6-diphosphate | 4429-47-4 | Reference compound |
| HY-134178S | 5-Fluorouridine 5'-triphosphate-19F | Isotope-Labeled Compounds | |
| HY-134178S1 | 5-Fluorouridine 5'-triphosphate-13C,19F,d1 | Isotope-Labeled Compounds | |
| HY-13417A | AICAR (phosphate) | 681006-28-0 | Natural Products |
| HY-13417R | AICAR (Standard) | 2627-69-2 | Reference Standards |
| HY-13417S | AICAR-13C2,15N | 1609374-70-0 | Isotope-Labeled Compounds |
| HY-13418 | Dorsomorphin (dihydrochloride) | 1219168-18-9 | Reference compound |
| HY-134180 | rel-Carbovir monophosphate | 144490-73-3 | Reference compound |
| HY-134181 | Tremella polysaccharide, MW>1000000, cosmetic grade | 9075-53-0 | Biochemical Assay Reagents |
| HY-134181A | Tremella polysaccharide, MW<1000000, cosmetic grade | 9075-53-0 | Biochemical Assay Reagents |
| HY-134183 | AUTAC1 | 2241669-09-8 | Reference compound |
| HY-134184 | AUTAC2 | 2241669-08-7 | Reference compound |
| HY-134188 | JNJ-54717793 | 1628843-99-1 | Reference compound |
| HY-134189 | EST73502 | 1838622-25-5 | Reference compound |
| HY-134189A | EST73502 (monohydrochloride) | 2535970-65-9 | Reference compound |
| HY-13418A | Dorsomorphin | 866405-64-3 | Reference compound |
| HY-13418G | Dorsomorphin (dihydrochloride) (GMP) | 1219168-18-9 | GMP Small Molecules |
| HY-13419 | U-73122 | 112648-68-7 | Reference compound |
| HY-134194 | KL201 | 302939-48-6 | Reference compound |
| HY-13420 | Zebularine | 3690-10-6 | Reference compound |
| HY-134200 | 1-Palmitoyl-2-oleoyl-sn-glycerol | 29541-66-0 | Reference compound |
| HY-134205A | CBR-470-1 | 2416095-06-0 | Reference compound |
| HY-13421 | SR1001 | 1335106-03-0 | Reference compound |
| HY-134211 | (Z)-2-Octenoic acid | 1577-96-4 | Reference compound |
| HY-134215 | cis-11-Methyl-2-dodecenoic acid | 677354-23-3 | Reference compound |
| HY-134216 | MAHMA NONOate | 146724-86-9 | Reference compound |
| HY-134217 | KYN-101 | 2247950-73-6 | Reference compound |
| HY-134218 | 4-Nitrophenyl-α-D-maltopyranoside | 17400-77-0 | Biochemical Assay Reagents |
| HY-13422 | Zatebradine (hydrochloride) | 91940-87-3 | Reference compound |
| HY-134220 | Doramectin monosaccharide | 165108-44-1 | Reference compound |
| HY-134221 | S-Nitroso-N-acetylcysteine | 56577-02-7 | Reference compound |
| HY-134222A | N-Acetylserine | 16354-58-8 | Reference compound |
| HY-134222AS | Acetylserine-d3 | 2230887-17-7 | Isotope-Labeled Compounds |
| HY-134223 | 1,3-Diarachidoyl glycerol | 59925-28-9 | Reference compound |
| HY-134224 | Arachidonoyl 2'-fluoroethylamide | 166100-37-4 | Reference compound |
| HY-134225 | 1-O-Hexadecyl-2-arachidonoyl-sn-glycero-3-PC | 86288-11-1 | Reference compound |
| HY-134226 | Defluoro Levofloxacin | 117620-85-6 | Biochemical Assay Reagents |
| HY-134226R | Defluoro Levofloxacin (Standard) | 117620-85-6 | Reference Standards |
| HY-134228 | 4-Hydroperoxyifosfamide | 39800-28-7 | Reference compound |
| HY-13422A | Zatebradine | 85175-67-3 | Reference compound |
| HY-13423 | Tenovin-1 | 380315-80-0 | Reference compound |
| HY-134230 | L-2-Aminooxy-3-phenylpropanoic acid | 42990-62-5 | Reference compound |
| HY-134230A | L-2-Aminooxy-3-phenylpropanoic acid (hydrobromide) | 73086-97-2 | Reference compound |
| HY-134234 | Celecoxib carboxylic acid | 170571-01-4 | Reference compound |
| HY-134235 | PAF C-16 carboxylic acid | 129879-41-0 | Reference compound |
| HY-134238 | Cardiolipin (Heart, Bovine) (sodium) | 383907-10-6 | Natural Products |
| HY-13424 | RITA | 213261-59-7 | Reference compound |
| HY-134240 | L-Threonic acid (magnesium) | 778571-57-6 | Reference compound |
| HY-134241 | Altechromone A | 38412-47-4 | Natural Products |
| HY-134242 | 6-T-5'-GMP (disodium) | 74686-78-5 | Reference compound |
| HY-134242A | 6-T-5'-GMP | 15867-02-4 | Reference compound |
| HY-134243 | 6-T-GDP | 16541-19-8 | Reference compound |
| HY-134245 | 7-Deazaadenosine 5'-phosphate | 16719-46-3 | Reference compound |
| HY-134246 | 7-CH-5'-dAMP | 103078-56-4 | Reference compound |
| HY-13425 | Deguelin | 522-17-8 | Natural Products |
| HY-134254 | 8-AHA-cAMP | 39824-30-1 | Reference compound |
| HY-134256 | 8-APT-cGMP | 144509-87-5 | Biochemical Assay Reagents |
| HY-134258 | MEISi-1 | 446306-43-0 | Reference compound |
| HY-134259 | MEISi-2 | 2250156-71-7 | Reference compound |
| HY-13426 | Roxadustat | 808118-40-3 | Reference compound |
| HY-134261 | 8-Br-ADPR | 59259-77-7 | Reference compound |
| HY-134262 | 8-Bromo-ATP | 23567-97-7 | Reference compound |
| HY-134263 | 8-Br-cAMP-AM | 190522-24-8 | Reference compound |
| HY-134264 | 8-Br-2'-O-Me-cAMP | 612513-13-0 | Reference compound |
| HY-134266 | 8-Bromo-AMP | 23567-96-6 | Reference compound |
| HY-134268 | 8-Br-7-CH-ADPR | 1011457-95-6 | Reference compound |
| HY-134269 | 8-Br-7-CH-cADPR | 189876-06-0 | Reference compound |
| HY-13426R | Roxadustat (Standard) | 808118-40-3 | Reference Standards |
| HY-13426S | Roxadustat-d5 | 2043026-13-5 | Isotope-Labeled Compounds |
| HY-13427 | Allitinib tosylate | 1050500-29-2 | Reference compound |
| HY-134271 | 8-Br-cGMP-AM | 272445-71-3 | Reference compound |
| HY-134272A | 8-Bromo-2'-deoxy-ATP (tetrasodium) | 1188369-62-1 | Reference compound |
| HY-134274 | 8-Br-GTP | 23197-98-0 | Reference compound |
| HY-134279 | 8-Br-NAD+ (sodium) | 2022926-16-3 | Reference compound |
| HY-13428 | Tubacin | 537049-40-4 | Reference compound |
| HY-134280 | 8-Br-NHD+ | 477782-33-5 | Reference compound |
| HY-134283 | 8-Benzylthio-cAMP | 50655-17-9 | Reference compound |
| HY-134290 | 8-Chloro-ATP | 185341-71-3 | Reference compound |
| HY-134290A | 8-Chloro-ATP (tetrasodium) | 793671-47-3 | Reference compound |
| HY-134291 | 8-Chloro-2'-deoxyadenosine | 85562-55-6 | Reference compound |
| HY-134294 | 8-Chloroguanosine | 2104-68-9 | Reference compound |
| HY-134295 | 8-Chloroinosine | 116285-77-9 | Reference compound |
| HY-134298 | 8-CPT-6-Phe-cAMP | 72549-36-1 | Reference compound |
| HY-134299 | 8-CPT-cAMP-AM | 663941-66-0 | Reference compound |
| HY-134302 | 8-HA-cAMP | 59212-44-1 | Reference compound |
| HY-134308 | 8-NBD-cAMP (sodium) | 221905-51-7 | Dye Reagents |
| HY-134309 | NSC 288387 | 61369-43-5 | Reference compound |
| HY-13431 | KU-0060648 | 881375-00-4 | Reference compound |
| HY-134311 | 8-NBD-cGMP | 115993-88-9 | Dye Reagents |
| HY-134313 | 8-NH2-ATP | 35874-49-8 | Reference compound |
| HY-134313A | 8-NH2-ATP (tetrasodium) | 35892-97-8 | Reference compound |
| HY-134314 | 8-Nitro-cGMP | 913645-39-3 | Reference compound |
| HY-134315 | 8-Nitroguanosine | 337536-53-5 | Reference compound |
| HY-134317 | 8-Azidoadenosine | 4372-67-2 | Reference compound |
| HY-134318B | 8-Azido-ADP (disodium) | 102185-14-8 | Reference compound |
| HY-13432 | Nanatinostat | 1256448-47-1 | Reference compound |
| HY-134320 | 8-Azido-ATP | 53696-59-6 | Reference compound |
| HY-134320B | 8-Azido-ATP (trisodium) | Reference compound | |
| HY-134321 | 8-Azido-cAMP | 31966-52-6 | Dye Reagents |
| HY-134324 | 8-Hydroxyadenosine | 29851-57-8 | Reference compound |
| HY-134325 | 8-OH-cAMP | 31356-95-3 | Reference compound |
| HY-13432A | Nanatinostat (TFA) | 1256448-48-2 | Reference compound |
| HY-13433 | Thapsigargin | 67526-95-8 | Natural Products |
| HY-134332 | 8-pCPT-5'-AMP | 78710-84-6 | Reference compound |
| HY-134333 | ICCB280 | 2041072-41-5 | Reference compound |
| HY-134334 | C/EBPα inducer 1 | 2374285-52-4 | Reference compound |
| HY-134337 | 5'-O-DMTr-3'-O-methyl uridine-3'-CED-phosphoramidite | 179479-05-1 | Reference compound |
| HY-134338 | Ipflufenoquin | 1314008-27-9 | Reference compound |
| HY-134338R | Ipflufenoquin (Standard) | 1314008-27-9 | Reference Standards |
| HY-13434 | Ionomycin | 56092-81-0 | Natural Products |
| HY-134340 | 8-pMeOPT-2'-O-Me-cAMP | 612513-16-3 | Reference compound |
| HY-134345 | 8-pCPT-cGMP-AM | 272445-72-4 | Reference compound |
| HY-134348 | 8-pHPT-2'-O-Me-cAMP | 612513-15-2 | Reference compound |
| HY-13434A | Ionomycin (calcium) | 56092-82-1 | Natural Products |
| HY-13434AR | Ionomycin (calcium) (Standard) | 56092-82-1 | Reference Standards |
| HY-134351 | AA-dUTP (tetrasodium) | 85280-65-5 | Reference compound |
| HY-134352 | AA-UTP (tetrasodium) | 85280-66-6 | Reference compound |
| HY-134353B | ADP-β-S (trilithium) | 73536-95-5 | Reference compound |
| HY-134354 | pNP-ADPr | 939028-75-8 | Reference compound |
| HY-134354A | pNP-ADPr (disodium) | Reference compound | |
| HY-134355 | ADPRP | 53595-18-9 | Reference compound |
| HY-134356 | AICA-riboside, 5′-phosphate | 3031-94-5 | Reference compound |
| HY-134358 | Ara-F-NAD+ | 133575-27-6 | Reference compound |
| HY-134358A | Ara-F-NAD+ (sodium) | Reference compound | |
| HY-134361 | ATP-γ-S (tetrasodium) | 88453-52-5 | Reference compound |
| HY-134367 | Ap2A (disodium) | 85065-24-3 | Reference compound |
| HY-134368 | Ap3A | 5959-90-0 | Reference compound |
| HY-134369 | Ap4C (tetrasodium) | 1352921-13-1 | Reference compound |
| HY-134370 | Ap4G | 10527-46-5 | Reference compound |
| HY-134371 | IL-17 modulator 2 | 1449208-36-9 | Reference compound |
| HY-134375 | cAIMP | 1507367-51-2 | Reference compound |
| HY-134377 | Bocidelpar | 2095128-20-2 | Reference compound |
| HY-13438 | AZD3839 (free base) | 1227163-84-9 | Reference compound |
| HY-134382 | 7-CH-dADP | 187478-96-2 | Reference compound |
| HY-134385 | 6-PhEt-dATP | 1239610-11-7 | Reference compound |
| HY-134389 | 6-Phe-cAMP | 34051-30-4 | Reference compound |
| HY-13439 | SR144528 | 192703-06-3 | Reference compound |
| HY-134391 | 6-Phe-ADP | 105701-92-6 | Reference compound |
| HY-134393 | 6-Me-ATP | 3130-39-0 | Reference compound |
| HY-134393B | 6-Me-ATP (trisodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-134395 | 6-MB-cAMP | 70253-67-7 | Reference compound |
| HY-134398 | Kinetin triphosphate | 1450894-16-2 | Reference compound |
| HY-134398A | Kinetin triphosphate (tetrasodium) | Reference compound | |
| HY-13440 | AMG 511 | 1253573-53-3 | Reference compound |
| HY-134404 | 6-Cl-PuTP | 55673-61-5 | Reference compound |
| HY-134406 | 6-Cl-cPuMP (sodium) | 94200-58-5 | Reference compound |
| HY-13441 | (-)-Blebbistatin | 856925-71-8 | Reference compound |
| HY-134417 | NSC2805 | 4371-34-0 | Reference compound |
| HY-134418 | NOTA | 56491-86-2 | Reference compound |
| HY-134418A | NOTA (trihydrochloride) | 133256-65-2 | Biochemical Assay Reagents |
| HY-13441G | (-)-Blebbistatin (GMP) | 856925-71-8 | GMP Small Molecules |
| HY-13442 | Eribulin | 253128-41-5 | ADC Related |
| HY-134420 | p-Nitrophenyl α-L-fucoside | 10231-84-2 | Biochemical Assay Reagents |
| HY-134421 | 2-Butenoyl coenzyme A (lithium) | 102680-35-3 | Biochemical Assay Reagents |
| HY-134422 | Isobutyryl coenzyme A (lithium) | 103404-95-1 | Biochemical Assay Reagents |
| HY-134423 | Stearoyl coenzyme A (lithium) | 193402-48-1 | Biochemical Assay Reagents |
| HY-134423S | Stearoyl coenzyme A-13C18 (lithium) | Isotope-Labeled Compounds | |
| HY-134424 | Propionyl coenzyme A (lithium) | 108321-21-7 | Biochemical Assay Reagents |
| HY-134425 | β-Methylcrotonyl coenzyme A (lithium) | 108347-83-7 | Biochemical Assay Reagents |
| HY-134426 | DL-β-Hydroxybutyryl coenzyme A (lithium) | 103404-51-9 | Biochemical Assay Reagents |
| HY-134427 | Palmitoyl coenzyme A (lithium) | 188174-64-3 | Biochemical Assay Reagents |
| HY-134428 | Arachidonoyl coenzyme A (lithium) | 188174-63-2 | Biochemical Assay Reagents |
| HY-134429 | p-Nitrophenyl α-L-arabinopyranoside | 1223-07-0 | Biochemical Assay Reagents |
| HY-13442A | Eribulin (mesylate) | 441045-17-6 | Reference compound |
| HY-13442AS | Eribulin-d3 (mesylate) | Isotope-Labeled Compounds | |
| HY-13442C | Eribulin (mesylate) (purity>99%, single impurity ≤ 0.15%) | 441045-17-6 | Reference compound |
| HY-13443 | Exendin-4 | 141758-74-9 | Peptides |
| HY-134430 | p-Nitrophenyl myristate | 14617-85-7 | Biochemical Assay Reagents |
| HY-134432A | Boc-Gln-Ala-Arg-AMC (hydrochloride) | 201849-55-0 | Reference compound |
| HY-134432B | Boc-Gln-Ala-Arg-AMC (acetate) | Dye Reagents | |
| HY-134433 | GDP-L-fucose | 15839-70-0 | Reference compound |
| HY-134433A | GDP-L-fucose (disodium) | 148296-47-3 | Biochemical Assay Reagents |
| HY-134434 | Z-Arg-Arg-AMC (hydrochloride) | 136132-67-7 | Peptides |
| HY-134435 | Z-Arg-AMC (hydrochloride) | 70375-22-3 | Dye Reagents |
| HY-134438 | Hexanoyl coenzyme A (trilithium) | 103476-19-3 | Biochemical Assay Reagents |
| HY-134439 | 8-Octanoyloxypyrene-1,3,6-trisulfonic acid (trisodium) | 115787-84-3 | Reference compound |
| HY-13443A | Exendin-4 (acetate) | 914454-01-6 | Peptides |
| HY-13443B | Exendin-4-Lys-azide (TFA) | Peptides | |
| HY-13443F | Exendin 4, biotin labeled | Peptides | |
| HY-134440 | α,β-Methylene-ATP (dilithium) | 104809-20-3 | Reference compound |
| HY-134440A | α,β-Methylene-ATP | 7292-42-4 | Reference compound |
| HY-134442 | L-α-Phosphatidylinositol (liver, bovine) (sodium) | 383907-33-3 | Biochemical Assay Reagents |
| HY-134445 | N-Benzoyl-L-tyrosine p-nitroanilide | 6154-45-6 | Peptides |
| HY-134448 | 5-Bromo-4-chloro-3-indolyl β-D-fucopyranoside | 17016-46-5 | Biochemical Assay Reagents |
| HY-134449 | Z-Lys-ONp (hydrochloride) | 2179-15-9 | Peptides |
| HY-134450 | L-Aspartic acid β-hydroxamate | 1955-68-6 | Peptides |
| HY-134451 | Diethylumbelliferyl phosphate | 897-83-6 | Reference compound |
| HY-134452 | MeAIB | 2566-34-9 | Reference compound |
| HY-134453 | L-Idaric acid,1,4-lactone | 80876-59-1 | Biochemical Assay Reagents |
| HY-134453A | D-Saccharic acid 1,4-lactone (hydrate) | 61278-30-6 | Reference compound |
| HY-134454 | Z-Pro-Pro-CHO | 108708-25-4 | Peptides |
| HY-134454A | Z-Pro-prolinal | 88795-32-8 | Reference compound |
| HY-134455 | 4-Nitrophenyl β-D-fucopyranoside | 1226-39-7 | Biochemical Assay Reagents |
| HY-134458A | H-Lys-Tyr-OH (TFA) | Reference compound | |
| HY-134459 | 4-Nitrophenyl Laurate | 1956-11-2 | Reference compound |
| HY-134460 | 4-Methylumbelliferyl α-L-fucopyranoside | 54322-38-2 | Reference compound |
| HY-134463 | NHWD-870 | 2115742-03-3 | Reference compound |
| HY-134467 | Phylloflavan | 98570-83-3 | Natural Products |
| HY-13447 | PF-429242 | 947303-87-9 | Reference compound |
| HY-134471 | TNF-α-IN-2 | 2074702-04-6 | Reference compound |
| HY-134472 | PI3Kδ-IN-8 | 2101518-75-4 | Reference compound |
| HY-134476 | NF-κΒ activator 1 | 2387524-59-4 | Reference compound |
| HY-134477 | NF-κΒ activator 2 | 2375281-44-8 | Reference compound |
| HY-13447A | PF429242 (dihydrochloride) | 2248666-66-0 | Reference compound |
| HY-13448 | Nedocromil | 69049-73-6 | Reference compound |
| HY-134481 | FLT3-IN-10 | 2088735-51-5 | Reference compound |
| HY-134482 | PCSK9-IN-1 | 2730022-10-1 | Reference compound |
| HY-13448R | Nedocromil (Standard) | 69049-73-6 | Reference Standards |
| HY-13449 | TAK-733 | 1035555-63-5 | Reference compound |
| HY-134493 | Butyrate-Vitamin D3 | 31316-20-8 | Natural Products |
| HY-134494 | MS48107 | 2375070-79-2 | Reference compound |
| HY-134495 | N-Acetyl-L-cysteine ethyl ester | 59587-09-6 | Reference compound |
| HY-13450 | ZM 449829 | 4452-06-6 | Reference compound |
| HY-134508 | C24-Ceramide | 34435-05-7 | Reference compound |
| HY-134508A | C24-Ceramide (d18:1/24:0) | 102917-80-6 | Reference compound |
| HY-134508S | C24-Ceramide-d7 | 1840942-15-5 | Isotope-Labeled Compounds |
| HY-13451 | Finafloxacin | 209342-40-5 | Reference compound |
| HY-134511 | 15(S)-HpEPE | 125992-60-1 | Reference compound |
| HY-134512 | Aminooxy-PEG3-C2-thiol | 1200365-63-4 | Reference compound |
| HY-134517 | Fmoc-HoCys(ACM)-OH | 150281-21-3 | Reference compound |
| HY-134518 | Erythromycin oxime | 13127-18-9 | Reference compound |
| HY-13451A | Finafloxacin (hydrochloride) | 209342-41-6 | Reference compound |
| HY-13451AS | Finafloxacin-d4 (hydrochloride) | 2012598-36-4 | Isotope-Labeled Compounds |
| HY-13451R | Finafloxacin (Standard) | 209342-40-5 | Reference Standards |
| HY-13452 | CID-1067700 | 314042-01-8 | Reference compound |
| HY-134520 | 21-Deacetoxy deflazacort | 13649-88-2 | Reference compound |
| HY-134520R | 21-Deacetoxy deflazacort (Standard) | 13649-88-2 | Reference Standards |
| HY-134521 | Diclofenac amide | 15362-40-0 | Reference compound |
| HY-134524 | Isosorbide dimethyl ether | 5306-85-4 | Reference compound |
| HY-134525 | Ro 8-4304 | 195988-65-9 | Reference compound |
| HY-134529 | D-Ribofuranose1-dihydrogenphosphate | 14075-00-4 | Reference compound |
| HY-134529A | D-Ribofuranose1-dihydrogenphosphate (dicyclohexanamine) | 58459-37-3 | Reference compound |
| HY-13453 | BAY 11-7082 | 19542-67-7 | Reference compound |
| HY-134539 | IMT1 | 2304621-31-4 | Reference compound |
| HY-13454 | CID 2011756 | 638156-11-3 | Reference compound |
| HY-134541 | SM-102 | 2089251-47-6 | Oligonucleotides |
| HY-134541A | SM-102 (Excipient) | 2089251-47-6 | Reference compound |
| HY-134542 | CaV1.3 antagonist-1 | 1391385-57-1 | Reference compound |
| HY-134544 | Calendic acid | 5204-87-5 | Natural Products |
| HY-134545 | N-Arachidonoyl-L-alanine | 401941-73-9 | Peptides |
| HY-13455 | LDN-192960 | 184582-62-5 | Reference compound |
| HY-134554 | 5′-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine | 162204-30-0 | Reference compound |
| HY-134555 | A3AR antagonist 4 | 109740-09-2 | Reference compound |
| HY-134556 | 2'-Hydroxyflavanone | 17348-76-4 | Natural Products |
| HY-134557 | GS87 | 919936-70-2 | Reference compound |
| HY-134558 | 5-Methoxyflavanone | 55947-36-9 | Natural Products |
| HY-134559 | TKIM | 326921-25-9 | Reference compound |
| HY-13455A | LDN-192960 (hydrochloride) | 2309172-48-1 | Reference compound |
| HY-13456 | LY-404187 | 211311-95-4 | Reference compound |
| HY-134560 | N-(3-Oxodecanoyl)-L-homoserine lactone | 147795-40-2 | Natural Products |
| HY-134561 | 6-Amino-8-trifluoromethylphenanthridine | 651055-83-3 | Reference compound |
| HY-134562 | PF-06371900 | 1622291-81-9 | Reference compound |
| HY-134563 | Z-Asp(OMe)-Gln-Met-Asp(OMe)-FMK | 767287-99-0 | Reference compound |
| HY-134564 | Fluorescein octadecyl ester | 138833-46-2 | Dye Reagents |
| HY-134566 | NBD-X, SE | 145195-58-0 | Dye Reagents |
| HY-134567 | Ac-VDVAD-CHO | 194022-51-0 | Peptides |
| HY-134567A | Ac-VDVAD-CHO (TFA) | Reference compound | |
| HY-13457 | TCN 201 | 852918-02-6 | Reference compound |
| HY-134570 | ZINC40099027 | 1211825-25-0 | Reference compound |
| HY-134572 | (2S,3S)-Pterosin C | 35938-43-3 | Natural Products |
| HY-134573 | Dihydropashanone | 41997-41-5 | Natural Products |
| HY-134575 | C24:1-Ceramide | 54164-50-0 | Reference compound |
| HY-134575S | C24:1-Ceramide-d7 | 1840942-16-6 | Isotope-Labeled Compounds |
| HY-134577 | Clorprenaline | 3811-25-4 | Reference compound |
| HY-134577R | Clorprenaline (Standard) | 3811-25-4 | Reference Standards |
| HY-134577S | Clorprenaline-d6 | 1648796-40-0 | Isotope-Labeled Compounds |
| HY-134578 | H-Arg-Ser-Arg-OH | 115035-42-2 | Peptides |
| HY-134579 | Chaetomellic acid A | 148796-51-4 | Natural Products |
| HY-13458 | Droxidopa | 23651-95-8 | Reference compound |
| HY-134581 | Enpatoran | 2101938-42-3 | Reference compound |
| HY-134581A | Enpatoran (hydrochloride) | 2101945-93-9 | Reference compound |
| HY-134582 | dCBP-1 | 2484739-25-3 | Reference compound |
| HY-134583 | IDO1-IN-7 | 2351199-98-7 | Reference compound |
| HY-13458A | Droxidopa (hydrochloride) | 1260173-94-1 | Reference compound |
| HY-13458R | Droxidopa (Standard) | 23651-95-8 | Reference Standards |
| HY-13458S1 | Droxidopa-13C2,15N (hydrochloride) | 1329556-63-9 | Isotope-Labeled Compounds |
| HY-13458S2 | Droxidopa-13C6 | 1261397-37-8 | Isotope-Labeled Compounds |
| HY-13459 | PF-5274857 | 1373615-35-0 | Reference compound |
| HY-134591 | Thalidomide-NH-PEG4-COOH | 2412056-48-3 | Reference compound |
| HY-134592 | Piperidine-GNE-049-N-Boc | 1936431-36-5 | Reference compound |
| HY-134594 | SENP1-IN-1 | 2416910-69-3 | Reference compound |
| HY-134595 | SENP1-IN-2 | 2416910-70-6 | Reference compound |
| HY-134596 | SENP1-IN-3 | 2416910-59-1 | Reference compound |
| HY-134597 | SENP1-IN-4 | 2416910-64-8 | Reference compound |
| HY-134598 | 653-47 | 1224678-75-4 | Reference compound |
| HY-134598A | 653-47 (hydrochloride) | 1224567-46-7 | Reference compound |
| HY-134599 | (2E)-TCO-PNB ester | 1580501-97-8 | Reference compound |
| HY-13459A | PF-5274857 (hydrochloride) | 1613439-62-5 | Reference compound |
| HY-134601 | KH-3 | 1215115-03-9 | Reference compound |
| HY-134602 | 5'-Methoxynobiletin | 6965-36-2 | Natural Products |
| HY-134607 | (E)-Benzyl ferulate | 132335-97-8 | Natural Products |
| HY-134608 | Cobalt protoporphyrin IX | 14325-03-2 | Reference compound |
| HY-13461 | PHA-767491 | 845714-00-3 | Reference compound |
| HY-134611 | (2-Hydroxyethoxy)acetic acid | 13382-47-3 | Reference compound |
| HY-134615 | Mead ethanolamide | 169232-04-6 | Reference compound |
| HY-134616 | Ulinastatin | 80449-31-6 | Reference compound |
| HY-13461A | PHA-767491 (hydrochloride) | 942425-68-5 | Reference compound |
| HY-13462 | LY-364947 | 396129-53-6 | Reference compound |
| HY-134620 | Cyanine 5 NHS ester (tetrafluoroborate) | 1263093-76-0 | Dye Reagents |
| HY-134621 | P300-IN-1 | 2488868-36-4 | Reference compound |
| HY-134622 | GSK-3/CDK5/CDK2-IN-1 | 395074-72-3 | Reference compound |
| HY-134628S | (Rac)-8,14-Dihydroxy Efavirenz-d4 | 1189859-26-4 | Isotope-Labeled Compounds |
| HY-13463 | Avatrombopag | 570406-98-3 | Reference compound |
| HY-134633 | Alpha-lipoic acid choline ester (chloride) | 1808266-58-1 | Reference compound |
| HY-134635 | Dehydrozingerone | 1080-12-2 | Reference compound |
| HY-134636 | PAPA NONOate | 146672-58-4 | Reference compound |
| HY-13463A | Avatrombopag (maleate) | 677007-74-8 | Reference compound |
| HY-13463B | Avatrombopag (hydrochloride) | 570403-17-7 | Reference compound |
| HY-13463BS | Avatrombopag-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13463R | Avatrombopag (Standard) | 570406-98-3 | Reference Standards |
| HY-13464 | ALK-IN-1 | 1197958-12-5 | Reference compound |
| HY-134640 | AUTAC4 | 2267315-04-6 | Reference compound |
| HY-134645 | 1-Heneicosanol | 15594-90-8 | Biochemical Assay Reagents |
| HY-134648 | Ganfeborole | 2131798-12-2 | Reference compound |
| HY-13465 | VCH-916 | 1200133-34-1 | Reference compound |
| HY-134650 | (4E)-7-(4-Hydroxyphenyl)-1-phenylhept-4-en-3-one | 100667-52-5 | Natural Products |
| HY-134653 | 5-Ph-IAA | 168649-23-8 | Reference compound |
| HY-134654 | MRTX849 analog 24 | 2490716-96-4 | Reference compound |
| HY-134655 | D75-4590 | 384376-42-5 | Reference compound |
| HY-134656 | BC1618 | 2222094-18-8 | Reference compound |
| HY-134658 | Hentriacontanoic acid | 38232-01-8 | Biochemical Assay Reagents |
| HY-13465A | VCH-916 (free base) | 914778-92-0 | Reference compound |
| HY-13466 | MK-4256 | 1104599-69-0 | Reference compound |
| HY-134661 | (S)-Solangepras | 1799968-74-3 | Reference compound |
| HY-134661A | Solangepras | 2254706-21-1 | Reference compound |
| HY-134663 | 2-O-β-D-Glucosyloxy-4-methoxybenzene propanoic acid | 477873-63-5 | Natural Products |
| HY-134664 | 8α-(2-Methylacryloyloxy)-hirsutinolide-13-O-acetate | 67667-71-4 | Natural Products |
| HY-134665 | NITD-2 | 1197896-79-9 | Reference compound |
| HY-134669 | CypK | 1610703-09-7 | Reference compound |
| HY-13467 | AM-1638 | 1142214-62-7 | Reference compound |
| HY-134670 | a-Hydroxymetoprolol | 56392-16-6 | Reference compound |
| HY-134670R | a-Hydroxymetoprolol (Standard) | 56392-16-6 | Reference Standards |
| HY-134670S | α-Hydroxy Metoprolol-d5 (Mixture of Diastereomers) | 1189934-03-9 | Isotope-Labeled Compounds |
| HY-134670S1 | α-Hydroxymetoprolol-d7 | 1276197-39-7 | Isotope-Labeled Compounds |
| HY-134673 | UZH1 | 2925713-02-4 | Reference compound |
| HY-134673A | UZH1a | 2813577-78-3 | Reference compound |
| HY-134673B | UZH1b | 2814392-17-9 | Reference compound |
| HY-134675 | THP-PEG4-C1-OH | Reference compound | |
| HY-134676 | Propenyl-PEG3-Propenyl | 90736-68-8 | Reference compound |
| HY-134677 | Bromo-PEG7-Boc | 2766000-37-5 | Reference compound |
| HY-134678 | Propanol-PEG5-CH2OH | Reference compound | |
| HY-134679 | N-Boc-C1-PEG5-C3-NH2 | 956472-77-8 | Reference compound |
| HY-13468 | KW-2478 | 819812-04-9 | Reference compound |
| HY-134680 | Ms-PEG3-CH2CH2COOH | 2306832-21-1 | Reference compound |
| HY-134681 | Fmoc-NH-PEG5-NH-Boc | Reference compound | |
| HY-134682 | Fmoc-NH-PEG5-C2-NH2 | 2093277-71-3 | Reference compound |
| HY-134683 | Ms-PEG3-NHS ester | Reference compound | |
| HY-134684 | Mal-PEG3-O-Ac | Reference compound | |
| HY-134685 | Edoxaban impurity 6 | 480452-37-7 | Reference compound |
| HY-134686 | Edoxaban impurity 4 | 480452-36-6 | Reference compound |
| HY-134687 | Iodoacetamide-PEG5-azide | Reference compound | |
| HY-134688 | Iodoacetamide-PEG5-NH2 | Reference compound | |
| HY-134689 | Propanol-PEG3-CH2OH | 112935-57-6 | Reference compound |
| HY-13469 | Debio 0932 | 1061318-81-7 | Reference compound |
| HY-134690 | Propanol-PEG4-CH2OH | 156868-17-6 | Reference compound |
| HY-134691 | Propanol-PEG6-CH2OH | Reference compound | |
| HY-134692 | Azido-C1-PEG3-C3-NH2 | 1162336-72-2 | Reference compound |
| HY-134693 | Azido-C1-PEG4-C3-NH2 | Reference compound | |
| HY-134694 | Bromo-PEG2-NH2 (hydrobromide) | Reference compound | |
| HY-134695 | 5-(Biotinamido)pentylazide | 1349190-76-6 | Reference compound |
| HY-134696 | Azido-PEG6-CH2COOH | 880129-82-8 | Reference compound |
| HY-134697 | Benzyl-PEG15-alcohol | Reference compound | |
| HY-134698 | THP-PEG9-THP | 1809333-14-9 | Reference compound |
| HY-134699 | THP-PEG12-THP | Reference compound | |
| HY-13470 | GSK126 | 1346574-57-9 | Reference compound |
| HY-134700 | DSPE-PEG14-COOH | Reference compound | |
| HY-134701 | Acetamido-PEG2-Br | Reference compound | |
| HY-134702 | Mal-PEG12-CHO | Reference compound | |
| HY-134703 | Acid-PEG12-CHO | Reference compound | |
| HY-134704 | Biotin-PEG4-SH | 2762393-22-4 | Reference compound |
| HY-134705 | m-PEG2-amido-Ph-NH2 | 1284417-66-8 | Reference compound |
| HY-134706 | Acetamido-PEG3-Br | Reference compound | |
| HY-134707 | CHO-PEG12-Boc | Reference compound | |
| HY-134708 | Bromo-PEG3-CO-NH2 | Reference compound | |
| HY-134709 | Boc-NH-PEG5-Cl | Reference compound | |
| HY-134710 | Benzyl-PEG24-alcohol | 2218463-19-3 | Reference compound |
| HY-134711 | Amine-PEG6-thiol | Reference compound | |
| HY-134711A | Amine-PEG6-thiol (hydrochloride) | Reference compound | |
| HY-134712 | Methylacetamide-PEG3-NH2 | Reference compound | |
| HY-134713 | Tos-PEG14-OH | Reference compound | |
| HY-134714 | DBCO-PEG3-amine | 2093409-57-3 | Reference compound |
| HY-134715 | Fmoc-N-amido-PEG4-amine | Reference compound | |
| HY-134716 | Methyl acetate-PEG1-methyl acetate | 54665-51-9 | Reference compound |
| HY-134717 | Benzyl-PEG24-azide | Reference compound | |
| HY-134718 | Glycocholic acid-PEG10-iodoacetamide | Reference compound | |
| HY-134719 | ICG-Sulfo-OSu (sodium) | 190714-28-4 | Reference compound |
| HY-134720 | Amine-PEG4-Desthiobiotin | 2306109-91-9 | Reference compound |
| HY-134721 | Amine-PEG3-Desthiobiotin | 2237234-71-6 | Reference compound |
| HY-134722 | Hydrazide-PEG4-Desthiobiotin | Reference compound | |
| HY-134723 | DBCO-PEG4-GGFG-Dxd | 2694856-51-2 | ADC Related |
| HY-134724 | MTH1 ligand 1 | 2412986-35-5 | Reference compound |
| HY-134725 | MTH1 degrader-1 | 2412987-06-3 | Reference compound |
| HY-134730 | N-Acetylpyrrolidine-PEG2-Br | Reference compound | |
| HY-134731 | N-Ethylacetamide-PEG2-Br | Reference compound | |
| HY-134732 | N-Ethylpropionamide-PEG1-Br | 1539080-27-7 | Reference compound |
| HY-134733 | N-Ethyl-N-methylpropionamide-PEG1-Br | 1695856-63-3 | Reference compound |
| HY-134734 | BCN-exo-PEG7-maleimide | 2143965-47-1 | Reference compound |
| HY-134735 | N-Ethylacetamide-PEG1-Br | Reference compound | |
| HY-134736 | Bromo-PEG1-NH2 (hydrobromide) | 2287287-20-9 | Reference compound |
| HY-134737 | Boc-NH-PEG1-C5-OH | Reference compound | |
| HY-134738 | Iodoacetamide-PEG5-NH-Boc | Reference compound | |
| HY-134739 | N-Ethyl-3,3,3-trifluoro-N-methylpropanamide-PEG2-Br | Reference compound | |
| HY-134740 | Br-PEG2-oxazolidin-2-one | Reference compound | |
| HY-134741 | Benzyl-PEG8-MS | 1330059-91-0 | Reference compound |
| HY-134742 | 3-Aminophenol-PEG4-methyl | 1429340-32-8 | Reference compound |
| HY-134743 | m-PEG21-OH | Reference compound | |
| HY-134744 | Boc-Pyrrolidine-PEG2-COOH | Reference compound | |
| HY-134745 | DSPE-PEG2-mal | 1915739-87-5 | Reference compound |
| HY-134746 | Hexaethylene glycol dimethyl ether | 1072-40-8 | Reference compound |
| HY-134747 | THP-PEG10-THP | 42749-29-1 | Reference compound |
| HY-134748 | HO-PEG7-CH2COOH | 2250056-27-8 | Reference compound |
| HY-134749 | Propargyl-PEG2-urea-C3-triethoxysilane | 1637329-79-3 | Reference compound |
| HY-13475 | mPGES1-IN-8 | 1381846-21-4 | Reference compound |
| HY-134750 | HO-PEG5-CH2COOH | 52026-48-9 | Reference compound |
| HY-134751 | VES-POFP | Reference compound | |
| HY-134752 | Benzyl-PEG9-Boc | Reference compound | |
| HY-134753 | Teriflunomide impurity 3 | 1011244-72-6 | Reference compound |
| HY-134754 | Bromo-PEG12-acid | Reference compound | |
| HY-134755 | Bromo-PEG9-Boc | Reference compound | |
| HY-134757 | Lactate oxidase, Microorganism | 9028-72-2 | Enzyme |
| HY-134761 | EN4 | 1197824-15-9 | Reference compound |
| HY-134769 | OPC-163493 | 1644467-84-4 | Reference compound |
| HY-134771 | YM-341619 | 643082-52-4 | Reference compound |
| HY-134772 | AS1810722 | 909561-15-5 | Reference compound |
| HY-134775 | PLK4-IN-1 | 1247001-12-2 | Reference compound |
| HY-134775A | PLK4-IN-3 | 1247001-86-0 | Reference compound |
| HY-134780 | L-369 | 1443522-24-4 | Reference compound |
| HY-134781 | CKK-E12 | 1432494-65-9 | Oligonucleotides |
| HY-134782 | OF-Deg-Lin | 1853202-95-5 | Oligonucleotides |
| HY-134783 | 1,19-Bis(2-butyloctyl) 10-[[3-(dimethylamino)propyl](1-oxononyl)amino]nonadecanedioate | 2036272-50-9 | Reference compound |
| HY-13479 | EC144 | 911397-80-3 | Reference compound |
| HY-134795 | 5-Carboxymethylaminomethyluridine | 69181-26-6 | Reference compound |
| HY-134797 | p-SCN-Bn-deferoxamine | 1222468-90-7 | Reference compound |
| HY-134801 | CID1231538 | 354126-20-8 | Reference compound |
| HY-134807 | Indophagolin | 1207660-00-1 | Reference compound |
| HY-134809 | Cyclotriazadisulfonamide | 182316-44-5 | Reference compound |
| HY-134809A | Cyclotriazadisulfonamide (hydrochloride) | 392287-03-5 | Reference compound |
| HY-134811 | KRAS G12D inhibitor 1 | 2621928-43-4 | Reference compound |
| HY-134813 | MRTX1133 | 2621928-55-8 | Reference compound |
| HY-134813A | MRTX1133 (formic) | Reference compound | |
| HY-134816 | D-Glucan | 9012-72-0 | Biochemical Assay Reagents |
| HY-134817 | USP7-IN-8 | 2009273-60-1 | Reference compound |
| HY-134818 | ML-SI1 | Reference compound | |
| HY-134819 | (1S,2S)-ML-SI3 | 2563870-87-9 | Reference compound |
| HY-134819A | (1R,2R)-ML-SI3 | 2418594-00-8 | Reference compound |
| HY-134820 | MLT-943 | 1832576-04-1 | Reference compound |
| HY-134823 | MD-222 | 2136246-72-3 | Reference compound |
| HY-134828 | AZ506 | 2043321-54-4 | Reference compound |
| HY-134829 | BMS-986176 | 1815613-42-3 | Reference compound |
| HY-134832 | Mito-LND | 2361564-49-8 | Reference compound |
| HY-134836 | STM2457 | 2499663-01-1 | Reference compound |
| HY-134850 | QC-01–175 | 2267290-96-8 | Reference compound |
| HY-134851 | HIV-1 inhibitor-6 | 1821309-39-0 | Reference compound |
| HY-134852 | Fmoc-Cys(STmp)-OH | 1403834-74-1 | Peptides |
| HY-134853 | 2-(Boc-amino)ethanethiol | 67385-09-5 | Reference compound |
| HY-134858 | A1AT modulator 1 | 2406205-61-4 | Reference compound |
| HY-13486 | TAU-IN-1 | 1383373-65-6 | Reference compound |
| HY-134860 | Prostaglandin D1 alcohol | 1176470-37-3 | Reference compound |
| HY-134863 | A1AT modulator 2 | 2555004-05-0 | Reference compound |
| HY-134864 | GnRH antagonist 2 | 1709823-61-9 | Reference compound |
| HY-13487 | USP7/USP47 inhibitor | 1247825-37-1 | Reference compound |
| HY-134877 | BAY 2476568 | 2311901-93-4 | Reference compound |
| HY-134879 | Tau tracer 1 | 2173353-53-0 | Reference compound |
| HY-13488 | HG-10-102-01 | 1351758-81-0 | Reference compound |
| HY-134880 | Tau tracer 2 | 2173361-80-1 | Reference compound |
| HY-134883 | PRMT5-IN-4 | 152615-84-4 | Reference compound |
| HY-134884 | INCB086550 | 2230911-59-6 | Reference compound |
| HY-134885 | RMC-0331 | 2488788-52-7 | Reference compound |
| HY-134886 | PD-1-IN-24 | 2360909-50-6 | Reference compound |
| HY-134891 | HMBPP (lithium) | 396726-03-7 | Natural Products |
| HY-134894A | Glycerophosphorylethanolamine (sodium) | 883288-78-6 | Reference compound |
| HY-134895 | Gadoleic acid | 29204-02-2 | Biochemical Assay Reagents |
| HY-134899 | CPI-1328 | 2390367-27-6 | Reference compound |
| HY-134900 | Allyl methyl trisulfide | 34135-85-8 | Natural Products |
| HY-134900R | Allyl methyl trisulfide (Standard) | 34135-85-8 | Reference Standards |
| HY-134901 | WM-3835 | 2229025-70-9 | Reference compound |
| HY-134903 | (32-Carbonyl)-RMC-5552 | 2382768-55-8 | Reference compound |
| HY-134904 | RMC-6272 | 2382769-46-0 | Reference compound |
| HY-134909 | AS-136A | 949898-66-2 | Reference compound |
| HY-13491 | GNF-5837 | 1033769-28-6 | Reference compound |
| HY-134910 | SID-852843 | 909859-19-4 | Reference compound |
| HY-134911 | HS-243 | 848249-10-5 | Reference compound |
| HY-134912 | CMPPE | 841253-81-4 | Reference compound |
| HY-134913 | Rhodblock 1a | 701226-08-6 | Reference compound |
| HY-134914 | Fosmidomycin | 66508-53-0 | Natural Products |
| HY-134917 | Aldi-2 | 499997-25-0 | Reference compound |
| HY-134919 | CU-76 | 2400954-58-5 | Reference compound |
| HY-134921 | MI-nc (dihydrochloride) | 1934302-23-4 | Reference compound |
| HY-134922 | NS1-IN-1 | 181373-35-3 | Reference compound |
| HY-134923 | CA77.1 | 2412270-22-3 | Reference compound |
| HY-134924 | Succinyl-β-cycloaltrin | 957494-34-7 | Biochemical Assay Reagents |
| HY-134928 | Pyridinium bisretinoid A2E | 173449-96-2 | Reference compound |
| HY-134928A | Pyridinium bisretinoid A2E (TFA) | 1821308-73-9 | Reference compound |
| HY-134928AS | Pyridinium bisretinoid A2E-d4 (TFA) | Isotope-Labeled Compounds | |
| HY-134929 | Benitrobenrazide | 2454676-05-0 | Reference compound |
| HY-13493 | AC710 | 1351522-04-7 | Reference compound |
| HY-134931 | M090 | 1599466-63-3 | Reference compound |
| HY-134932 | AA74-1 | 1361532-00-4 | Reference compound |
| HY-134935 | L-Proline β-naphthylamide (hydrochloride) | 97216-16-5 | Peptides |
| HY-134937 | BC8-15 | 950385-77-0 | Reference compound |
| HY-134938S | 7-Hydroxywarfarin-d5 | 94820-65-2 | Isotope-Labeled Compounds |
| HY-134939 | thio-Miltefosine | 943022-11-5 | Reference compound |
| HY-13493A | AC710 (Mesylate) | 1351522-05-8 | Reference compound |
| HY-134940 | Quabodepistat | 1883747-71-4 | Reference compound |
| HY-134940S | Quabodepistat-d7 | Isotope-Labeled Compounds | |
| HY-13495 | ML281 | 1404437-62-2 | Reference compound |
| HY-134950 | (E)-C-HDMAPP (ammonium) | 933030-60-5 | Reference compound |
| HY-134952 | Acetylcholine (perchlorate) | 927-86-6 | Biochemical Assay Reagents |
| HY-134953 | Mephetyl tetrazole | 916923-10-9 | Reference compound |
| HY-134954 | Palmitoleoyl 3-carbacyclic phosphatidic acid | 910228-13-6 | Reference compound |
| HY-134955 | VT103 | 2290608-13-6 | Reference compound |
| HY-134956 | VT104 | 2417718-25-1 | Reference compound |
| HY-134956B | (R)-VT104 | 2417718-26-2 | Reference compound |
| HY-134957 | VT107 | 2417718-63-7 | Reference compound |
| HY-134958 | Polyinosinic-polycytidylic acid (potassium) | 31852-29-6 | Reference compound |
| HY-13496 | JNJ-28312141 | 885692-52-4 | Reference compound |
| HY-134960 | 2,3-Indolobetulonic acid | 905837-93-6 | Reference compound |
| HY-134961 | Z-Ala-Arg-Arg-AMC | 90468-18-1 | Peptides |
| HY-134963 | SBI-0087702 | 864431-36-7 | Reference compound |
| HY-134964 | CTB | 451491-47-7 | Reference compound |
| HY-134968 | TTBK1-IN-1 | 2735015-60-6 | Reference compound |
| HY-134968A | (R)-TTBK1-IN-1 | 2735015-59-3 | Reference compound |
| HY-13497 | STK33-IN-1 | 1404437-49-5 | Reference compound |
| HY-134971 | AE9C90CB | 893426-98-7 | Reference compound |
| HY-134975 | NY2267 | 886053-73-2 | Reference compound |
| HY-134976 | Azido-FTY720 | 881914-35-8 | Reference compound |
| HY-134977 | Atrovastatin-PEG3-FITC | 1440755-31-6 | Reference compound |
| HY-134978 | (Rac)-SHIN2 | 2204289-53-0 | Reference compound |
| HY-134978A | (+)SHIN2 | Reference compound | |
| HY-134978B | (-)SHIN2 | Reference compound | |
| HY-13498 | BRD-8899 | 1404437-50-8 | Reference compound |
| HY-134982 | Thalidomide-piperazine-Boc | 2222114-64-7 | Reference compound |
| HY-134983 | Thalidomide-Piperazine 5-fluoride | 2222114-22-7 | Reference compound |
| HY-134984 | Thalidomide-NH-amido-C4-NH2 | 2093388-67-9 | Reference compound |
| HY-134984A | Thalidomide-NH-amido-C4-NH2 (hydrochloride) | Reference compound | |
| HY-134985 | Thalidomide-NH-PEG1-NH2 | 2138439-12-8 | Reference compound |
| HY-134985A | Thalidomide-NH-PEG1-NH2 (diTFA) | 2768514-19-6 | Reference compound |
| HY-134986 | Thalidomide-NH-C5-NH2 | 2093386-39-9 | Reference compound |
| HY-134988 | EDP-305 | 1933507-63-1 | Reference compound |
| HY-13499 | JNJ-41443532 | 1228650-83-6 | Reference compound |
| HY-134990 | Hematoporphyrin monomethyl ether | 148471-91-4 | Reference compound |
| HY-134992 | Vazegepant | 1337918-83-8 | Reference compound |
| HY-134992S | (Rac)-Vazegepant-13C,d3 | Isotope-Labeled Compounds | |
| HY-134996 | N-Acetyl-2-carboxybenzenesulfonamide | 849067-18-1 | Reference compound |
| HY-134997 | 4-Oxo Docosahexaenoic Acid | 845673-74-7 | Reference compound |
| HY-134999 | 10-Hydroxywarfarin | 83219-99-2 | Reference compound |
| HY-13500 | GSK343 | 1346704-33-3 | Reference compound |
| HY-135000 | Decarbamoylsaxitoxin | 58911-04-9 | Natural Products |
| HY-135002 | LDN-209929 | 1233355-57-1 | Reference compound |
| HY-135004 | SU-4029 (dihydrochloride) | 3194-36-3 | Reference compound |
| HY-135005 | Biliverdin (hydrochloride) | 856699-18-8 | Natural Products |
| HY-135005A | Biliverdin | 114-25-0 | Natural Products |
| HY-135006 | Octahydroaminoacridine (succinate) | 866245-79-6 | Reference compound |
| HY-135006A | Octahydroaminoacridine | 13415-07-1 | Reference compound |
| HY-135008 | J14 | 1043854-13-2 | Reference compound |
| HY-135009 | 2-Di-1-ASP | 2156-29-8 | Dye Reagents |
| HY-13501 | Mubritinib | 366017-09-6 | Reference compound |
| HY-135013 | Umbellulone | 546-78-1 | Natural Products |
| HY-135014 | Undecylenoyl phenylalanine | 175357-18-3 | Reference compound |
| HY-135016 | Oleic acid (triethanolamine) | 2717-15-9 | Reference compound |
| HY-135018 | 6-Methoxy DiPT (hydrochloride) | 2426-76-8 | Reference compound |
| HY-13502 | Mitoxantrone | 65271-80-9 | Reference compound |
| HY-135020 | AC-24,055 | 1933-50-2 | Reference compound |
| HY-135021 | 3,4-Dihydro Naratriptan | 121679-20-7 | Reference compound |
| HY-135022 | 3-Bromoamphetamine (hydrochloride) | 1210708-61-4 | Reference compound |
| HY-135023 | 5-trans-PGE2 | 36150-00-2 | Reference compound |
| HY-135023R | 5-trans-PGE2 (Standard) | 36150-00-2 | Reference Standards |
| HY-135024 | Phenylacetyl CoA | 7532-39-0 | Enzyme |
| HY-135024A | Phenylacetyl CoA (lithium) | 108321-26-2 | Enzyme |
| HY-135025 | 5-Fluoro-3,5-ADB-PFUPPYCA | 1969261-68-4 | Reference compound |
| HY-135026 | DL-Norepinephrine (tartrate) | 3414-63-9 | Reference compound |
| HY-135029 | Fmoc-N-PEG3-CH2-NHS ester | 2128735-25-9 | Reference compound |
| HY-13502A | Mitoxantrone (dihydrochloride) | 70476-82-3 | Reference compound |
| HY-13502AR | Mitoxantrone (dihydrochloride) (Standard) | 70476-82-3 | Reference Standards |
| HY-13502AS | Mitoxantrone-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-13502AS1 | Mitoxantrone-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13502B | Mitoxantrone (diacetate) | 70711-41-0 | Reference compound |
| HY-13502R | Mitoxantrone (Standard) | 65271-80-9 | Reference Standards |
| HY-13502S | Mitoxantrone-d8 | 1189974-82-0 | Isotope-Labeled Compounds |
| HY-13503 | Epothilone A | 152044-53-6 | Natural Products |
| HY-135030 | 4-Fluoro BZP (hydrochloride) | 199672-06-5 | Reference compound |
| HY-135032 | Norcarfentanil (hydrochloride) | 61085-87-8 | Reference compound |
| HY-135034 | UMB68 (sodium) | 581099-89-0 | Reference compound |
| HY-135035 | Decanoyl-L-carnitine | 3992-45-8 | Reference compound |
| HY-135035R | Decanoyl-L-carnitine (Standard) | 3992-45-8 | Reference Standards |
| HY-135035S | Decanoyl-L-carnitine-d3 | 1297655-08-3 | Isotope-Labeled Compounds |
| HY-135036 | 4-Methylumbelliferyl butyrate | 17695-46-4 | Dye Reagents |
| HY-135037 | Sempervirine methochloride | 6484-78-2 | Reference compound |
| HY-13503R | Epothilone A (Standard) | 152044-53-6 | Reference Standards |
| HY-13504 | PIK-293 | 900185-01-5 | Reference compound |
| HY-135041 | Totrombopag (choline) | 851606-62-7 | Reference compound |
| HY-135042 | CAY10614 | 1202208-36-3 | Reference compound |
| HY-135043 | S-Aristeromycinyl-L-homocysteine | 57884-84-1 | Reference compound |
| HY-135045 | (S,R,S)-AHPC-C4-COOH | 2172819-74-6 | Reference compound |
| HY-135046 | MTOB (sodium) | 51828-97-8 | Reference compound |
| HY-135048 | Mal-PEG4-OH | 1421933-37-0 | Reference compound |
| HY-135049 | Bromo-PEG6-bromide | 72713-23-6 | Reference compound |
| HY-13505 | AM281 | 202463-68-1 | Reference compound |
| HY-135053 | Autotaxin-IN-3 | 2156655-68-2 | Reference compound |
| HY-135055 | Magnesium lactate | 18917-93-6 | Reference compound |
| HY-135056 | MitoTracker Green FM | 201860-17-5 | Dye Reagents |
| HY-135057 | Lauroylamide propylbetaine (35% in water) | 4292-10-8 | Reference compound |
| HY-13506 | M344 | 251456-60-7 | Reference compound |
| HY-135060 | 3,4-Dichloromethcathinone (hydrochloride) | 15861-85-5 | Reference compound |
| HY-135061 | 20α-Dihydro prednisolone | 15847-24-2 | Reference compound |
| HY-135065 | 3-Iodothyronamine (hydrochloride) | 788824-64-6 | Reference compound |
| HY-135065S | 3-Iodothyronamine-d4 (hydrochloride) | 884320-54-1 | Isotope-Labeled Compounds |
| HY-135066 | Triallyl pentaerythritol | 1471-17-6 | Reference compound |
| HY-13506G | M344 (GMP) | 251456-60-7 | GMP Small Molecules |
| HY-13507 | Lumiracoxib | 220991-20-8 | Reference compound |
| HY-135070 | Ac-RLR-AMC | 929903-87-7 | Peptides |
| HY-135070B | Ac-RLR-AMC (TFA) | Peptides | |
| HY-135072 | N,N',N''-Triacetylchitotriose | 38864-21-0 | Natural Products |
| HY-135072R | N,N',N''-Triacetylchitotriose (Standard) | 38864-21-0 | Reference Standards |
| HY-135073 | PCMPA (hydrochloride) | 1934-63-0 | Reference compound |
| HY-135076 | 2,3-Dimethylmethcathinone (hydrochloride) | 1797981-99-7 | Reference compound |
| HY-135077 | Prostaglandin A1 ethyl ester | 93464-24-5 | Reference compound |
| HY-135078 | 2,5-Deoxyfructosazine | 17460-13-8 | Reference compound |
| HY-13507R | Lumiracoxib (Standard) | 220991-20-8 | Reference Standards |
| HY-13508 | JNJ-7777120 | 459168-41-3 | Reference compound |
| HY-135081 | N-(4-acetamidophenyl)-Indomethacin amide | 261766-23-8 | Reference compound |
| HY-135083 | BDP FL-PEG4-amine | 2183473-14-3 | Reference compound |
| HY-135085 | Thiol-C2-PEG2-OH | 56282-36-1 | Reference compound |
| HY-135087 | Caprylic/Capric Triglyceride | 65381-09-1 | Biochemical Assay Reagents |
| HY-135088 | Autotaxin-IN-4 | 2156655-86-4 | Reference compound |
| HY-135089 | Autotaxin-IN-5 | 2156655-99-9 | Reference compound |
| HY-13509 | CCG-50014 | 883050-24-6 | Reference compound |
| HY-135090 | m-PEG8-Tos | 82217-01-4 | Reference compound |
| HY-135094 | Palmitoyl glutamic acid | 38079-66-2 | Reference compound |
| HY-135094R | Palmitoyl glutamic acid (Standard) | 38079-66-2 | Reference Standards |
| HY-135096 | Amitriptyline-d3 (hydrochloride) | 342611-00-1 | Reference compound |
| HY-13510 | Cutamesine dihydrochloride | 165377-44-6 | Reference compound |
| HY-135101 | Methotrexate γ-Methyl Ester | 67022-39-3 | Reference compound |
| HY-135102 | Laidlomycin propionate (potassium) | 84799-02-0 | Reference compound |
| HY-135103 | Tauro-β-muricholic acid (sodium) | 145022-92-0 | Reference compound |
| HY-135103S | Tauro-β-muricholic acid-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-135107 | (S)-Ademetionine | 78548-84-2 | Reference compound |
| HY-135108 | QWF Peptide | 126088-82-2 | Peptides |
| HY-13511 | Rupatadine | 158876-82-5 | Reference compound |
| HY-135110 | Rp-8-Br-cGMPS (sodium) | 208445-06-1 | Reference compound |
| HY-135110A | Rp-8-Br-cGMPS | 150418-07-8 | Reference compound |
| HY-135111 | 4-Desmethoxy Omeprazole | 110374-16-8 | Reference compound |
| HY-135111R | 4-Desmethoxy Omeprazole (Standard) | 110374-16-8 | Reference Standards |
| HY-135113 | Lanthionine | 922-55-4 | Peptides |
| HY-135114 | Hydroxypropyl-beta-cyclodextrin | 107745-73-3 | Reference compound |
| HY-135115 | Oleuropein Aglycone | 31773-95-2 | Reference compound |
| HY-135119 | Salmeterol-d3 | 497063-94-2 | Isotope-Labeled Compounds |
| HY-13511A | Rupatadine (Fumarate) | 182349-12-8 | Reference compound |
| HY-13511AR | Rupatadine (Fumarate) (Standard) | 182349-12-8 | Reference Standards |
| HY-13511AS | Rupatadine-d4 (fumarate) | 1795153-63-7 | Isotope-Labeled Compounds |
| HY-13511R | Rupatadine (Standard) | 158876-82-5 | Reference Standards |
| HY-13511S | Rupatadine-d6 (D-tartrate) | Isotope-Labeled Compounds | |
| HY-13512 | Camostat (mesylate) | 59721-29-8 | Reference compound |
| HY-135121 | Ethacizine (hydrochloride) | 57530-40-2 | Reference compound |
| HY-135122 | DC10SMe | 2649727-40-0 | ADC Related |
| HY-135123 | DC4SMe | 615538-47-1 | ADC Related |
| HY-135124 | DC44SMe | 1354787-76-0 | ADC Related |
| HY-135125 | DC4 | 615538-48-2 | ADC Related |
| HY-135127 | Dot1L-IN-4 | 2565705-02-2 | Reference compound |
| HY-135128 | Dot1L-IN-5 | 2565705-03-3 | Reference compound |
| HY-135129 | Dot1L-IN-6 | 2565705-01-1 | Reference compound |
| HY-13512R | Camostat (mesylate) (Standard) | 59721-29-8 | Reference Standards |
| HY-13513 | U-104 | 178606-66-1 | Reference compound |
| HY-135130 | Bischloroanthrabenzoxocinone | 866022-28-8 | Natural Products |
| HY-135131 | Synthalin (hydrochloride) | 301-15-5 | Reference compound |
| HY-135133 | S-Phenylsulfonylcysteine | 97512-83-9 | Reference compound |
| HY-135136 | Aldehyde reactive probe (TFA) | 627090-10-2 | Reference compound |
| HY-135137 | Leptosin I | 160472-96-8 | Reference compound |
| HY-135139 | Methylbenzethonium (chloride hydrate) | 1320-44-1 | Reference compound |
| HY-13514 | TG 100713 | 925705-73-3 | Reference compound |
| HY-135140 | Methyltetrazine-amine | 1345955-28-3 | Reference compound |
| HY-135140A | Methyltetrazine-amine (hydrochloride) | 1596117-29-1 | Reference compound |
| HY-135142 | Br-PEG3-OH | 57641-67-5 | Reference compound |
| HY-135145 | Limantrafin | 218457-67-1 | Reference compound |
| HY-135146 | GSK-3484862 | 2170136-65-7 | Reference compound |
| HY-135146A | (Rac)-GSK-3484862 | 2170136-02-2 | Reference compound |
| HY-13515 | Sirtinol | 410536-97-9 | Reference compound |
| HY-135151 | Difluoro atorvastatin | 693794-20-6 | Reference compound |
| HY-135152 | CYPMPO | 934182-09-9 | Reference compound |
| HY-135153 | Methylamino-PEG4-acid | 1283658-71-8 | Reference compound |
| HY-135154 | epi-Aszonalenin A | 908853-14-5 | Natural Products |
| HY-135158 | Prolylvaline | 20488-27-1 | Peptides |
| HY-13516 | Aloperine | 56293-29-9 | Natural Products |
| HY-135161 | EDDP (perchlorate) | 31161-17-8 | Reference compound |
| HY-135163 | trans-Latanoprost | 913258-34-1 | Reference compound |
| HY-135164 | Lonchocarpic acid | 5490-47-1 | Natural Products |
| HY-135165 | Hydrobenzole (hydrochloride) | 37975-24-9 | Reference compound |
| HY-135166 | 2-(1-Hydroxypentyl)benzoic acid | 380905-48-6 | Reference compound |
| HY-135167 | HOCPCA | 867178-11-8 | Reference compound |
| HY-135169 | Mal-PEG3-Boc | 518044-35-4 | Reference compound |
| HY-135170 | Myristoyl-L-carnitine (chloride) | 173686-73-2 | Reference compound |
| HY-135170R | Myristoyl-L-carnitine (chloride) (Standard) | 173686-73-2 | Reference Standards |
| HY-135170S | Myristoyl-L-carnitine-d3 (chloride) | 1334532-25-0 | Isotope-Labeled Compounds |
| HY-135172 | Suc-Leu-Tyr-AMC | 94367-20-1 | Dye Reagents |
| HY-135174 | L-Cysteine-glutathione disulfide | 13081-14-6 | Reference compound |
| HY-135175 | Phenoprolamine (hydrochloride) | 93933-71-2 | Reference compound |
| HY-135176 | 13-Dihydrocarminomycin | 62182-86-9 | Natural Products |
| HY-135179 | Biotin-PEG3-alcohol | 289714-02-9 | Reference compound |
| HY-13518 | Piceatannol | 10083-24-6 | Natural Products |
| HY-135180 | 1H-1-Ethyl Candesartan Cilexetil | 914613-35-7 | Reference compound |
| HY-135180R | 1H-1-Ethyl Candesartan Cilexetil (Standard) | 914613-35-7 | Reference Standards |
| HY-135181 | Daunosamnyl-daunorubicin | 28008-54-0 | Reference compound |
| HY-135184 | Rifaquizinone | 922717-97-3 | Reference compound |
| HY-135186 | L-Monomenthyl glutarate | 220621-22-7 | Reference compound |
| HY-135187 | 8-Isoquinoline methanamine (hydrochloride) | 850734-84-8 | Reference compound |
| HY-135189 | 6-Aminophenanthridine | 832-68-8 | Reference compound |
| HY-13518R | Piceatannol (Standard) | 10083-24-6 | Reference Standards |
| HY-13519 | TRAM-34 | 289905-88-0 | Reference compound |
| HY-135190 | (-)-Cedrene | 469-61-4 | Natural Products |
| HY-135194 | Risperidone E-oxime | 691007-09-7 | Reference compound |
| HY-135194R | Risperidone E-oxime (Standard) | 691007-09-7 | Reference Standards |
| HY-135197 | L-Iduronic acid (sodium salt) | 61199-83-5 | Reference compound |
| HY-135199 | Ubiquitination-IN-1 | 1819330-15-8 | Reference compound |
| HY-13520 | Nocodazole | 31430-18-9 | Reference compound |
| HY-135200 | 4-Amino benzamidoxime | 277319-62-7 | Reference compound |
| HY-135201 | 3,4-Methylenedioxy PV8 (hydrochloride) | 24646-39-7 | Reference compound |
| HY-135202 | Chloromethylketone methotrexate | 83160-47-8 | Reference compound |
| HY-135203 | Cysteinylcysteine | 18048-87-8 | Reference compound |
| HY-135204 | Deschloronorketamine (hydrochloride) | 7015-20-5 | Reference compound |
| HY-135208 | tert-Butyl 2-(5-chloro-2,2'-dioxospiro[indole-3,3'-pyrrolidine]-1-yl)acetate | 916048-02-7 | Reference compound |
| HY-13521 | SB-505124 | 694433-59-5 | Reference compound |
| HY-135211 | Rubomycin H | 38942-79-9 | Natural Products |
| HY-135212 | Hydroxy ipronidazole | 35175-14-5 | Reference compound |
| HY-135212R | Hydroxy ipronidazole (Standard) | 35175-14-5 | Reference Standards |
| HY-135212S | Hydroxy ipronidazole-d3 | 1156508-86-9 | Isotope-Labeled Compounds |
| HY-135214 | GA11 | 851053-64-0 | Reference compound |
| HY-135216 | Antiproliferative agent-54 | 1240322-54-6 | Reference compound |
| HY-135217 | Apiole | 523-80-8 | Natural Products |
| HY-135217R | Apiole (Standard) | 523-80-8 | Reference Standards |
| HY-135218 | AV-153 | 27296-05-5 | Reference compound |
| HY-135218A | AV-153 (free base) | 19350-66-4 | Reference compound |
| HY-13521A | SB-505124 (hydrochloride) | 356559-13-2 | Reference compound |
| HY-13522 | Fimepinostat | 1339928-25-4 | Reference compound |
| HY-135220 | PERK-IN-2 | 1337531-83-5 | Reference compound |
| HY-135221 | Cefcapene pivoxil (hydrochloride) | 147816-23-7 | Reference compound |
| HY-135221A | Cefcapene pivoxil | 105889-45-0 | Reference compound |
| HY-135221R | Cefcapene pivoxil (hydrochloride) (Standard) | 147816-23-7 | Reference Standards |
| HY-135222 | MMAI (hydrochloride) | 132980-17-7 | Reference compound |
| HY-135224 | 1,4-PBIT (dihydrobromide) | 157254-60-9 | Reference compound |
| HY-135226 | PROLI NONOate | 178948-42-0 | Reference compound |
| HY-135228 | GZ4 | 68312-88-9 | Reference compound |
| HY-13523 | PAC-1 | 315183-21-2 | Reference compound |
| HY-135230 | LY2444296 | 1346133-11-6 | Reference compound |
| HY-135231 | NL-1 | 188532-26-5 | Reference compound |
| HY-135232 | MMP-9-IN-1 | 502887-71-0 | Reference compound |
| HY-135233 | N-Succinimidyl-S-acetylthioacetate | 76931-93-6 | Biochemical Assay Reagents |
| HY-135235 | Cysteine thiol probe | 1947408-74-3 | Reference compound |
| HY-135236 | OXFBD04 | 2231747-03-6 | Reference compound |
| HY-135237 | DB04760 analog 1 | 2728373-94-0 | Reference compound |
| HY-135238 | (rel)-RSD 921 | 111728-01-9 | Reference compound |
| HY-135239 | Fura-FF (pentapotassium) | 192140-58-2 | Dye Reagents |
| HY-13524 | AG-1478 | 153436-53-4 | Reference compound |
| HY-135241 | 25I-NBF (hydrochloride) | 1539266-13-1 | Reference compound |
| HY-135242 | LY87130 (free base) | 72877-72-6 | Reference compound |
| HY-135244 | Imazamethabenz-methyl | 81405-85-8 | Reference compound |
| HY-135244R | Imazamethabenz-methyl (Standard) | 81405-85-8 | Reference Standards |
| HY-135245 | Ezetimibe hydroxy glucuronide | 536709-33-8 | Reference compound |
| HY-13524A | AG-1478 (hydrochloride) | 170449-18-0 | Reference compound |
| HY-13525 | CP-91149 | 186392-40-5 | Reference compound |
| HY-135250 | Thalidomide-4-O-C6-NH2 | 1957235-98-1 | Reference compound |
| HY-135250A | Thalidomide-4-O-C6-NH2 (TFA) | 1957235-99-2 | Reference compound |
| HY-135250B | Thalidomide-4-O-C6-NH2 (hydrochloride) | 2245697-88-3 | Reference compound |
| HY-135252 | N-Desbutyroyl acebutolol | 57898-80-3 | Reference compound |
| HY-135253 | GR122222X | 161161-54-2 | Reference compound |
| HY-135254 | CP-46665 (dihydrochloride) | 72618-10-1 | Reference compound |
| HY-135256 | Naphthol yellow S, 98% | 846-70-8 | Biochemical Assay Reagents |
| HY-135258 | Galactinol (dihydrate) | 1217474-91-3 | Reference compound |
| HY-135259 | CAY10580 | 64054-40-6 | Reference compound |
| HY-13526 | YO-01027 | 209984-56-5 | Reference compound |
| HY-135265 | Moclobemide N-Oxide | 64544-24-7 | Reference compound |
| HY-135266 | N-Ethyl Tadalafil | 1609405-34-6 | Reference compound |
| HY-135267 | 5-Fluoropentylindole | 1859218-30-6 | Reference compound |
| HY-135269 | Quin II (potassium) | 73630-23-6 | Dye Reagents |
| HY-13526G | YO-01027 (GMP) | 209984-56-5 | GMP Small Molecules |
| HY-13527 | LY310762 | 192927-92-7 | Reference compound |
| HY-135270 | ADRA1D receptor antagonist 1 | 1191908-14-1 | Reference compound |
| HY-135273 | A-1211212 | 1257044-75-9 | Reference compound |
| HY-135276 | Targaprimir-96 | 1655508-14-7 | Reference compound |
| HY-135276A | Targaprimir-96 (TFA) | Reference compound | |
| HY-135279 | CFTR corrector 4 | 1918142-34-3 | Reference compound |
| HY-13528 | Clinofibrate | 30299-08-2 | Reference compound |
| HY-135280 | MRL-650 | 852315-00-5 | Reference compound |
| HY-135281 | CYP11B2-IN-1 | 1356479-78-1 | Reference compound |
| HY-135282 | DHODH-IN-1 | 1800296-63-2 | Reference compound |
| HY-135283 | ABT-546 | 212481-66-8 | Reference compound |
| HY-135284 | FTY720-Mitoxy | 1604816-11-6 | Reference compound |
| HY-135285 | Rifamexil | 113102-19-5 | Reference compound |
| HY-135286A | (+)-Neomenthol | 2216-52-6 | Natural Products |
| HY-135286AR | (+)-Neomenthol (Standard) | 2216-52-6 | Reference Standards |
| HY-13529 | Globalagliatin | 1234703-40-2 | Reference compound |
| HY-135297 | Mono-and diglycerides | Reference compound | |
| HY-135298 | Soya fatty acids | 68308-53-2 | Reference compound |
| HY-135299 | CH6953755 | 2055918-71-1 | Reference compound |
| HY-13530 | CAY10505 | 1218777-13-9 | Reference compound |
| HY-135301 | Flavanone hydrazone | 1692-46-2 | Reference compound |
| HY-135303 | GLPG1205 | 1445847-37-9 | Reference compound |
| HY-135304 | PAD-IN-2 | 2304852-21-7 | Reference compound |
| HY-135306 | Cl-C6-PEG4-C3-COOH | 2127391-58-4 | Reference compound |
| HY-135307 | SSF-109 | 129586-32-9 | Reference compound |
| HY-135309 | PROTAC ER Degrader-4 | 2361114-15-8 | Reference compound |
| HY-13531 | AS-604850 | 648449-76-7 | Reference compound |
| HY-135312 | AZ'6421 | 2361115-35-5 | Reference compound |
| HY-135317 | Emavusertib | 1801344-14-8 | Reference compound |
| HY-135317B | Emavusertib (hydrochloride) | 2376399-42-5 | Reference compound |
| HY-135317C | Emavusertib (tosylate) | 2376399-41-4 | Reference compound |
| HY-135317D | Emavusertib (mesylate) | 2376399-40-3 | Reference compound |
| HY-135317E | Emavusertib (maleate) | 2376399-39-0 | Reference compound |
| HY-135317F | Emavusertib (phosphate) | 2376399-38-9 | Reference compound |
| HY-135318 | NBDHEX | 787634-60-0 | Reference compound |
| HY-135319 | Strictinin | 517-46-4 | Natural Products |
| HY-13532 | AS-252424 | 900515-16-4 | Reference compound |
| HY-135324 | 4,4'-Iminodiphenol | 1752-24-5 | Reference compound |
| HY-135325 | 4-Hydroxyacetophenone oxime | 34523-34-7 | Reference compound |
| HY-135325R | 4-Hydroxyacetophenone oxime (Standard) | 34523-34-7 | Reference Standards |
| HY-135326 | 4-Propionamidophenol | 1693-37-4 | Reference compound |
| HY-135326R | 4-Propionamidophenol (Standard) | 1693-37-4 | Reference Standards |
| HY-135327 | Amphotericin B methyl ester | 36148-89-7 | Reference compound |
| HY-135327A | Amphotericin B methyl ester (hydrochloride) | 35375-29-2 | Reference compound |
| HY-135328 | Norverapamil | 67018-85-3 | Reference compound |
| HY-135328AS | Norverapamil-d7 (hydrochloride) | 1216413-74-9 | Isotope-Labeled Compounds |
| HY-135328S | Norverapamil-d7 | 263175-44-6 | Isotope-Labeled Compounds |
| HY-135329 | Solifenacin D5 (hydrochloride) | 1426174-05-1 | Reference compound |
| HY-135329S | (1R,3S-)Solifenacin-d5 (hydrochloride) | 1217810-85-9 | Isotope-Labeled Compounds |
| HY-135330 | Lamivudine-13C,15N2 | 1391052-30-4 | Isotope-Labeled Compounds |
| HY-135331 | N-Desmethyl-Apalutamide | 1332391-11-3 | Reference compound |
| HY-135331S | N-Desmethyl-Apalutamide-15N,d4 | Isotope-Labeled Compounds | |
| HY-135334 | ACP-5862 | 2230757-47-6 | Reference compound |
| HY-135334S | ACP-5862-d4 | Isotope-Labeled Compounds | |
| HY-135335 | 3'-Hydroxy Repaglinide | 874908-14-2 | Reference compound |
| HY-135335S | 3'-Hydroxy Repaglinide-d5 | 1352792-15-4 | Isotope-Labeled Compounds |
| HY-135336 | (R)-Verapamil (hydrochloride) | 38176-02-2 | Reference compound |
| HY-135336A | (S)-Verapamil (hydrochloride) | 36622-28-3 | Reference compound |
| HY-135336AS | (S)-Verapamil-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-135336BS | (Rac)-Verapamil-d7 (hydrochloride) | 1188265-55-5 | Isotope-Labeled Compounds |
| HY-135336S | (R)-Verapamil-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-135337 | Ethyl tosylcarbamate | 5577-13-9 | Reference compound |
| HY-135339 | Benzyl-PEG2-CH2COOH | 91842-53-4 | Reference compound |
| HY-13534 | Abarelix | 183552-38-7 | Peptides |
| HY-135345 | PROTAC FKBP Degrader-3 | 2079056-43-0 | Reference compound |
| HY-13534A | Abarelix (Acetate) | 547741-72-0 | Peptides |
| HY-13535 | ATN-161 | 262438-43-7 | Reference compound |
| HY-135356 | m-Nifedipine | 21881-77-6 | Reference compound |
| HY-135356R | m-Nifedipine (Standard) | 21881-77-6 | Reference Standards |
| HY-135357 | Diisohexyl phthalate | 71850-09-4 | Reference compound |
| HY-135358 | (Rac)-5-Keto Fluvastatin | 1160169-39-0 | Reference compound |
| HY-135359 | RP 48497 | 148891-53-6 | Reference compound |
| HY-135359R | RP 48497 (Standard) | 148891-53-6 | Reference Standards |
| HY-13535A | ATN-161 (trifluoroacetate salt) | 904763-27-5 | Reference compound |
| HY-13536 | AZD-2461 | 1174043-16-3 | Reference compound |
| HY-135363 | Valsartan Ethyl Ester | 1111177-30-0 | Reference compound |
| HY-135366 | HPN-01 | 928655-63-4 | Reference compound |
| HY-135367 | pyCTZ | 2125486-34-0 | Dye Reagents |
| HY-135367A | pyCTZ (TFA) | Dye Reagents | |
| HY-135367B | pyCTZ (hydrochloride) | Dye Reagents | |
| HY-135368 | 8pyDTZ | 2351898-91-2 | Dye Reagents |
| HY-13537 | BPR1J-097 | 1327167-19-0 | Reference compound |
| HY-135372 | Descarbamoyl cefuroxime | 56271-94-4 | Reference compound |
| HY-135373 | Desfluoro-atorvastatin | 433289-84-0 | Reference compound |
| HY-135374 | (3R,5S)-Atorvastatin (sodium) | 131275-93-9 | Reference compound |
| HY-135375 | O-Methyl Atorvastatin (calcium) | 887196-29-4 | Reference compound |
| HY-135376 | Atorvastatin methyl ester | 345891-62-5 | Reference compound |
| HY-135377 | Atorvastatin 3-Deoxyhept-2E-Enoic Acid | 1105067-93-3 | Reference compound |
| HY-135378 | Atorvastatin ethyl ester | 1146977-93-6 | Reference compound |
| HY-135379 | Atorvastatin acetonide | 581772-29-4 | Reference compound |
| HY-13537A | BPR1J-097 Hydrochloride | Reference compound | |
| HY-13538 | Gemcitabine elaidate | 210829-30-4 | Reference compound |
| HY-135380 | Atorvastatin acetonide tert-butyl ester | 125971-95-1 | Reference compound |
| HY-135380R | Atorvastatin acetonide tert-butyl ester (Standard) | 125971-95-1 | Reference Standards |
| HY-135381 | 3-Oxo Atorvastatin | 887196-30-7 | Reference compound |
| HY-135382 | PROTAC IRAK4 degrader-2 | 2374122-27-5 | Reference compound |
| HY-135382A | PROTAC IRAK4 degrader-3 | 2374122-43-5 | Reference compound |
| HY-135383 | (3S,5S)-Pitavastatin (calcium) | 254452-92-1 | Reference compound |
| HY-135383A | (3S,5R)-Pitavastatin (calcium) | 254452-88-5 | Reference compound |
| HY-135383B | (Z)-Pitavastatin (calcium) | 1159588-21-2 | Reference compound |
| HY-135384 | tert-Buthyl Pitavastatin | 586966-54-3 | Reference compound |
| HY-135384R | tert-Buthyl Pitavastatin (Standard) | 586966-54-3 | Reference Standards |
| HY-135385 | Dihydro Dutasteride | 164656-22-8 | Reference compound |
| HY-135386 | 5β-Dutasteride | 957229-52-6 | Reference compound |
| HY-135387 | 4-Desmethyl Istradefylline | 160434-48-0 | Reference compound |
| HY-135388 | ent-Ezetimibe | 1376614-99-1 | Reference compound |
| HY-135389 | Desmethyl Levofloxacin | 117707-40-1 | Reference compound |
| HY-135389R | Desmethyl Levofloxacin (Standard) | 117707-40-1 | Reference Standards |
| HY-135389S | Desmethyl Levofloxacin-d8 (hydrochloride) | 1217677-38-7 | Isotope-Labeled Compounds |
| HY-135389S1 | Desmethyl Levofloxacin-d8 | 1217976-18-5 | Isotope-Labeled Compounds |
| HY-13538A | Gemcitabine elaidate (hydrochloride) | 2918768-08-6 | Reference compound |
| HY-135390 | Hydroxy desmethyl Bosentan | 253688-62-9 | Reference compound |
| HY-135391 | Ezetimibe phenoxy glucuronide | 190448-57-8 | Reference compound |
| HY-135391S | Ezetimibe phenoxy glucuronide-d4 | 1426174-41-5 | Isotope-Labeled Compounds |
| HY-135392 | N-Desmethyl Pimavanserin | 639863-77-7 | Reference compound |
| HY-135392R | N-Desmethyl Pimavanserin (Standard) | 639863-77-7 | Reference Standards |
| HY-135392S | N-Desmethyl Pimavanserin-d9 (hydrochloride) | 2712363-60-3 | Isotope-Labeled Compounds |
| HY-135393S | Sulfadimethoxypyrimidine-d4 | 1392211-88-9 | Isotope-Labeled Compounds |
| HY-135394 | 3-Desacetyl Cefotaxime lactone | 66340-33-8 | Reference compound |
| HY-135394R | 3-Desacetyl Cefotaxime lactone (Standard) | 66340-33-8 | Reference Standards |
| HY-135396 | (1S,2S)-Bortezomib | 1132709-14-8 | Reference compound |
| HY-135397 | (R)-Linezolid | 872992-20-6 | Reference compound |
| HY-135397R | (R)-?Linezolid (Standard) | 872992-20-6 | Reference Standards |
| HY-135398 | Decarboxy Moxifloxacin | 1322062-57-6 | Reference compound |
| HY-135399 | Tauro-obeticholic acid | 863239-61-6 | Reference compound |
| HY-135399A | Tauro-obeticholic acid (sodium) | 2278141-79-8 | Reference compound |
| HY-135399S | Tauro-obeticholic acid-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-13540 | E7016 | 902128-92-1 | Reference compound |
| HY-135400 | Glyco-Obeticholic acid | 863239-60-5 | Reference compound |
| HY-135400S | Glyco-obeticholic acid-d5 | Isotope-Labeled Compounds | |
| HY-135401 | VU6015929 | 2442597-56-8 | Reference compound |
| HY-135402 | 2'-Ethyl Simvastatin | 79902-42-4 | Reference compound |
| HY-135404 | Anhydrosimvastatin | 210980-68-0 | Reference compound |
| HY-135404R | Anhydrosimvastatin (Standard) | 210980-68-0 | Reference Standards |
| HY-135405 | 4-Acetylsimvastatin | 145576-25-6 | Reference compound |
| HY-135405R | 4-Acetylsimvastatin (Standard) | 145576-25-6 | Reference Standards |
| HY-135406 | (3R,5R)-Rosuvastatin Lactone | 1422954-11-7 | Reference compound |
| HY-135407S | N-Desethyl Oxybutynin-d5 (hydrochloride) | 1173018-49-9 | Isotope-Labeled Compounds |
| HY-135408 | Trimetazidine-N-oxide | 1644530-89-1 | Reference compound |
| HY-13541 | ADH-1 | 229971-81-7 | Peptides |
| HY-135410 | ABZ-amine | 80983-36-4 | Reference compound |
| HY-135410R | ABZ-amine (Standard) | 80983-36-4 | Reference Standards |
| HY-135412 | N-Methyl Duloxetine (hydrochloride) | 916135-70-1 | Reference compound |
| HY-135413 | MeCY5-NHS ester | 937739-58-7 | Reference compound |
| HY-135413A | Sulfo-CY5-NHS ester (potassium) | 2230212-27-6 | Reference compound |
| HY-135413B | MeCY5-NHS ester (triethylamine) | Reference compound | |
| HY-135414 | Cyanine5 NHS ester (chloride) | 1032678-42-4 | Dye Reagents |
| HY-135414A | Cyanine5 NHS ester (bromide) | 1653991-59-3 | Dye Reagents |
| HY-135414B | Cyanine5 NHS ester (iodide) | Dye Reagents | |
| HY-135415 | Cyanine5.5 NHS ester (chloride) | 1469277-96-0 | Dye Reagents |
| HY-135415A | Cyanine5.5 NHS ester (chloride) (TEA) | Dye Reagents | |
| HY-135416 | Streptolysin O | 98072-47-0 | Natural Products |
| HY-135416A | Streptolysin O (≥1000000 units/mg) | 98072-47-0 | Reference compound |
| HY-135418 | Fmoc-Asp-NH2 | 200335-40-6 | ADC Related |
| HY-135419 | CB2 modulator 1 | 666261-80-9 | Reference compound |
| HY-13541A | ADH-1 (trifluoroacetate) | 1135237-88-5 | Peptides |
| HY-13542 | Guadecitabine | 929901-49-5 | Reference compound |
| HY-135421 | Dehydrobruceantinol | 99132-99-7 | Natural Products |
| HY-135422 | Nidulin | 10089-10-8 | Natural Products |
| HY-135423 | Sprodiamide | 128470-17-7 | Reference compound |
| HY-135425 | 10,12-Tricosadiynoic acid | 66990-30-5 | Reference compound |
| HY-135425R | 10,12-Tricosadiynoic acid (Standard) | 66990-30-5 | Reference Standards |
| HY-13543 | Tretazicar | 21919-05-1 | Reference compound |
| HY-135430 | SRS16-86 | 1793052-96-6 | Reference compound |
| HY-135432 | Etrasimod (arginine) | 1206123-97-8 | Reference compound |
| HY-135433 | MAPTAM | 147504-94-7 | Reference compound |
| HY-135434 | Prerubialatin | 1667718-89-9 | Reference compound |
| HY-135436 | AG 538 | 133550-18-2 | Reference compound |
| HY-135437 | Dodovisone B | 1616683-51-2 | Natural Products |
| HY-135438 | Mollugogenol A | 22550-76-1 | Reference compound |
| HY-135441 | PF-06422913 | 1539296-46-2 | Reference compound |
| HY-135444 | Heliangin | 13323-48-3 | Natural Products |
| HY-135445 | Prolylrapamycin | 156223-31-3 | Natural Products |
| HY-135447 | BM-531 | 284464-46-6 | Biochemical Assay Reagents |
| HY-135448 | 25G-NBOMe (hydrochloride) | 1797132-54-7 | Reference compound |
| HY-13545 | ABT-510 | 251579-55-2 | Peptides |
| HY-135453 | (-)-Pinocembrin | 206660-42-6 | Natural Products |
| HY-135456 | Ro4368554 | 478082-99-4 | Reference compound |
| HY-135457 | JMS-053 | 1954650-11-3 | Reference compound |
| HY-13545B | ABT-510 (acetate) | 442526-87-6 | Peptides |
| HY-13546 | ABT-518 | 286845-00-9 | Reference compound |
| HY-135460 | Milameline | 139886-32-1 | Reference compound |
| HY-135463 | NDSB-221 | 160788-56-7 | Biochemical Assay Reagents |
| HY-135464 | (±)-LY367385 | 198419-90-8 | Reference compound |
| HY-135466 | Profluralin | 26399-36-0 | Reference compound |
| HY-135466R | Profluralin (Standard) | 26399-36-0 | Reference Standards |
| HY-135468 | Boromycin | 34524-20-4 | Natural Products |
| HY-13547 | ADPM06 | 490035-90-0 | Reference compound |
| HY-135470 | Nifurpirinol | 13411-16-0 | Reference compound |
| HY-135470R | Nifurpirinol (Standard) | 13411-16-0 | Reference Standards |
| HY-135472 | Spinosyn A 17-pseudoaglycone | 131929-68-5 | Reference compound |
| HY-135473 | Chlormadinone | 1961-77-9 | Reference compound |
| HY-135473R | Chlormadinone (Standard) | 1961-77-9 | Reference Standards |
| HY-135473S | Chlormadinone-d6 | Isotope-Labeled Compounds | |
| HY-135474 | KM91104 | 304481-60-5 | Reference compound |
| HY-135475 | (R)-Meclizine | 189298-48-4 | Reference compound |
| HY-135476 | Depudecin | 139508-73-9 | Natural Products |
| HY-135478 | LY393615 | 325819-97-4 | Reference compound |
| HY-135478A | LY393615 (free base) | 774528-12-0 | Reference compound |
| HY-135479 | A28695B | 42617-35-6 | Reference compound |
| HY-13548 | DL-Alanosine | 5854-95-5 | Reference compound |
| HY-135480 | Geninthiocin | 158792-27-9 | Natural Products |
| HY-135482 | GABAA receptor agent 2 (TFA) | 1781880-44-1 | Reference compound |
| HY-135483A | AR-R17779 (hydrochloride) | 178419-42-6 | Reference compound |
| HY-135484 | NDSB-195 | 160255-06-1 | Biochemical Assay Reagents |
| HY-135489 | (±)-Reticuline | 1699-46-3 | Reference compound |
| HY-135490 | Reproterol | 54063-54-6 | Reference compound |
| HY-135492 | O-Methylmoschatoline | 5140-38-5 | Natural Products |
| HY-135495 | AM-0466 | 1642113-59-4 | Reference compound |
| HY-135496 | Fluclotizolam | 54123-15-8 | Reference compound |
| HY-135497 | Fallypride | 166173-78-0 | Reference compound |
| HY-135498 | Ferrioxamine E | 20008-20-2 | Reference compound |
| HY-13550 | Ametantrone | 64862-96-0 | Reference compound |
| HY-135500 | ACT-373898 | 1433875-14-9 | Reference compound |
| HY-135501 | Bamifylline | 2016-63-9 | Reference compound |
| HY-135505 | JTP-103237 | 1883864-16-1 | Reference compound |
| HY-135507 | NAS-181 | 205242-62-2 | Reference compound |
| HY-135507A | NAS-181 (free base) | 205242-61-1 | Reference compound |
| HY-135509 | Lorlatinib (acetate) | 1924207-18-0 | Reference compound |
| HY-13550A | Ametantrone (acetate) | 70711-40-9 | Reference compound |
| HY-13551 | Amsacrine | 51264-14-3 | Reference compound |
| HY-135511 | Nor-Cerpegin | 145887-88-3 | Reference compound |
| HY-135514 | Lys-Phe | 6235-35-4 | Reference compound |
| HY-135516 | Dalosirvat | 1360540-81-3 | Reference compound |
| HY-135517 | RXP470.1 | 891198-31-5 | Reference compound |
| HY-135517A | (2R)-RXP470.1 | Reference compound | |
| HY-13551A | Amsacrine (hydrochloride) | 54301-15-4 | Reference compound |
| HY-13551B | Amsacrine (gluconate) | 80277-07-2 | Reference compound |
| HY-13551R | Amsacrine (Standard) | 51264-14-3 | Reference Standards |
| HY-135520 | Trimannosyldilysine | 79390-81-1 | Reference compound |
| HY-135521 | U-49900 | 67579-76-4 | Reference compound |
| HY-135522 | Securinol A | 5008-48-0 | Natural Products |
| HY-135525 | Agroclavine | 548-42-5 | Natural Products |
| HY-135526 | Demethoxyviridiol | 56617-66-4 | Reference compound |
| HY-13553 | Anidulafungin | 166663-25-8 | Reference compound |
| HY-135530 | Chinese gallotannin | 5424-20-4 | Natural Products |
| HY-135531 | Cefuzonam | 82219-78-1 | Reference compound |
| HY-135532 | Amoxicillin-clavulanate (potassium) | 74469-00-4 | Reference compound |
| HY-135533 | Chromomycin A2 | 6992-70-7 | Natural Products |
| HY-135534 | Lysine 4-nitroanilide | 6184-11-8 | Reference compound |
| HY-13553R | Anidulafungin (Standard) | 166663-25-8 | Reference Standards |
| HY-13553S1 | Anidulafungin-13C6 | Isotope-Labeled Compounds | |
| HY-13554 | Annamycin | 92689-49-1 | Reference compound |
| HY-135541 | Darexaban (maleate) | 365462-24-4 | Reference compound |
| HY-135542 | NBI-27914 | 184241-44-9 | Reference compound |
| HY-135543 | Levophencynonate | 230313-75-4 | Reference compound |
| HY-135549 | Fluxapyroxad | 907204-31-3 | Reference compound |
| HY-135549R | Fluxapyroxad (Standard) | 907204-31-3 | Reference Standards |
| HY-13555 | β-Lapachone | 4707-32-8 | Natural Products |
| HY-135551 | Delbonine | 95066-33-4 | Natural Products |
| HY-135552 | Benoxathian (hydrochloride) | 92642-97-2 | Reference compound |
| HY-135555 | 5-Carboxamidotryptamine | 74885-09-9 | Reference compound |
| HY-135556 | Norfluoxetine | 83891-03-6 | Natural Products |
| HY-135556A | Norfluoxetine (oxalate) | 107674-50-0 | Reference compound |
| HY-135556AS | Norfluoxetine-d5 | 1185132-92-6 | Isotope-Labeled Compounds |
| HY-135558 | PROTAC BRD4 Degrader-3 | 2313234-00-1 | Reference compound |
| HY-13556 | Arzoxifene | 182133-25-1 | Reference compound |
| HY-135560 | Nicotelline | 494-04-2 | Reference compound |
| HY-135560S | Nicotelline-d9 | 2469258-18-0 | Isotope-Labeled Compounds |
| HY-135562 | Ascofuranone | 38462-04-3 | Reference compound |
| HY-135563 | Oxoprolintane | 35259-27-9 | Reference compound |
| HY-135564 | RK-682 (hemicalcium) | 332131-32-5 | Reference compound |
| HY-135564A | RK-682 | 150627-37-5 | Reference compound |
| HY-135564B | (Rac)-RK-682 | 154639-24-4 | Reference compound |
| HY-135566S | Clenpenterol-d5 (hydrochloride) | 1794793-20-6 | Isotope-Labeled Compounds |
| HY-135568 | CRL42872 (free base) | 256344-23-7 | Reference compound |
| HY-13556A | Arzoxifene (hydrochloride) | 182133-27-3 | Reference compound |
| HY-13557 | Ascomycin | 104987-12-4 | Natural Products |
| HY-135570 | hDHODH-IN-3 | 1644156-80-8 | Reference compound |
| HY-135571 | VBIT-3 | 2088463-66-3 | Reference compound |
| HY-135572 | TLX agonist 1 | 958323-31-4 | Reference compound |
| HY-135577 | β-Apooxytetracycline | 18751-99-0 | Reference compound |
| HY-135577R | β-Apooxytetracycline (Standard) | 18751-99-0 | Reference Standards |
| HY-135578 | Artelinic acid | 120020-26-0 | Reference compound |
| HY-13557R | Ascomycin (Standard) | 104987-12-4 | Reference Standards |
| HY-135580 | Raloxifene Bismethyl Ether | 84541-38-8 | Reference compound |
| HY-135580A | Raloxifene Bismethyl Ether (hydrochloride) | 84541-36-6 | Reference compound |
| HY-135581 | Raloxifene 6-glucuronide | 174264-50-7 | Reference compound |
| HY-135581S1 | Raloxifene 6-glucuronide-d4 (lithium) | Isotope-Labeled Compounds | |
| HY-135582 | Raloxifene 4'-glucuronide | 182507-22-8 | Reference compound |
| HY-135582S | Raloxifene 4'-glucuronide-d4 | 1279033-52-1 | Isotope-Labeled Compounds |
| HY-135582S1 | Raloxifene 4'-glucuronide-d4 (lithium) | Isotope-Labeled Compounds | |
| HY-135583 | LY88074 Trimethyl ether | 63675-87-6 | Reference compound |
| HY-135584 | Raloxifene 6-Monomethyl Ether | 178451-13-3 | Reference compound |
| HY-135585 | LY88074 | 177744-96-6 | Reference compound |
| HY-135586 | Raloxifene N-Oxide | 195454-31-0 | Reference compound |
| HY-135586R | Raloxifene N-Oxide (Standard) | 195454-31-0 | Reference Standards |
| HY-135587 | 4'-tert-Butyldimethylsilyl-6-hydroxy Raloxifene | 174264-46-1 | Reference compound |
| HY-135588 | Raloxifene 6,4'-Bis-β-D-glucuronide | 182507-20-6 | Reference compound |
| HY-135589 | 7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene | 1159977-58-8 | Reference compound |
| HY-13559 | Atiprimod | 123018-47-3 | Reference compound |
| HY-135590 | Raloxifene 4-Monomethyl Ether | 185415-07-0 | Reference compound |
| HY-135591 | Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate) | 174264-51-8 | Reference compound |
| HY-135592 | LY88074 Methyl ether | 63675-88-7 | Reference compound |
| HY-135593 | LY88074 analog 1 | 183060-99-3 | Reference compound |
| HY-135594 | 4'-Raloxifene-β-D-glucopyranoside | 334758-19-9 | Reference compound |
| HY-135595 | 6-Raloxifene-β-D-glucopyranoside | 334758-18-8 | Reference compound |
| HY-135596 | Raloxifene dimethyl ester (hydrochloride) | 84449-82-1 | Reference compound |
| HY-135597 | N-Acetyl-5-methyl-L-tryptophan | 114872-77-4 | Reference compound |
| HY-135599 | Lysine hydroxamate | 25125-92-2 | Reference compound |
| HY-13559A | Atiprimod (dimaleate) | 183063-72-1 | Reference compound |
| HY-13560 | AVN-944 | 297730-17-7 | Reference compound |
| HY-135601 | Cinacalcet metabolite M4 | 104774-87-0 | Reference compound |
| HY-135604S | Dibutyl phosphate-d18 | 156213-21-7 | Isotope-Labeled Compounds |
| HY-135605 | PNU-145156E | 154788-16-6 | Reference compound |
| HY-135606 | LW479 | 1688677-89-5 | Reference compound |
| HY-135608 | BD-1008 | 138356-08-8 | Reference compound |
| HY-13561 | AZM475271 | 476159-98-5 | Reference compound |
| HY-135611 | Imidocarb | 27885-92-3 | Reference compound |
| HY-135611A | Imidocarb (dihydrochloride monohydrate) | Reference compound | |
| HY-135611R | Imidocarb (Standard) | 27885-92-3 | Reference Standards |
| HY-135613 | LY280748 | 153226-99-4 | Reference compound |
| HY-135614 | (+)-Lunacrine | 204686-65-7 | Natural Products |
| HY-135615 | Desmethyl Sibutramine | 168835-59-4 | Reference compound |
| HY-135615A | Desmethyl Sibutramine (hydrochloride) | 84467-94-7 | Reference compound |
| HY-135615AR | Desmethyl Sibutramine (hydrochloride) (Standard) | 84467-94-7 | Reference Standards |
| HY-135615AS | DesMethyl Sibutramine-d7 (hydrochloride) | 1188265-54-4 | Isotope-Labeled Compounds |
| HY-135618 | DHODH-IN-3 | 1148126-04-8 | Reference compound |
| HY-135619 | DHODH-IN-4 | 1148125-93-2 | Reference compound |
| HY-13562 | Banoxantrone | 136470-65-0 | Reference compound |
| HY-135624 | Neogen | 182295-87-0 | Reference compound |
| HY-135625 | BPH-1218 | 1426824-36-3 | Reference compound |
| HY-135627 | JBP485 | 211868-63-2 | Natural Products |
| HY-135628 | PD-85639 | 149838-21-1 | Reference compound |
| HY-13562A | Banoxantrone (dihydrochloride) | 252979-56-9 | Reference compound |
| HY-13562AS | Banoxantrone-d12 (dihydrochloride) | 1562066-98-1 | Isotope-Labeled Compounds |
| HY-13562S | Banoxantrone-d12 | 1562067-05-3 | Isotope-Labeled Compounds |
| HY-13563 | Batabulin | 195533-53-0 | Reference compound |
| HY-135632 | Hydroxychlorodenafil | 1391054-00-4 | Reference compound |
| HY-135634 | GNF-2-PEG-acid | 2749287-69-0 | Dye Reagents |
| HY-135635 | ABL-001-Amide-PEG3-acid | Dye Reagents | |
| HY-135636 | Ponatinib Acid | 2748500-17-4 | Dye Reagents |
| HY-135637 | Nilotinib Acid | 2748500-05-0 | Dye Reagents |
| HY-135638 | Imatinib Acid | 2741007-77-0 | Dye Reagents |
| HY-135639 | Alkyne-probe 1 | 2752193-03-4 | Dye Reagents |
| HY-13563A | Batabulin (sodium) | 195533-98-3 | Reference compound |
| HY-13564 | Batimastat | 130370-60-4 | Reference compound |
| HY-135640 | TAMRA-probe 1 | Dye Reagents | |
| HY-135641 | Biotin-probe 1 | Dye Reagents | |
| HY-135642 | SMS1-IN-1 | 1807943-38-9 | Reference compound |
| HY-135643 | Sanglifehrin A | 187148-13-6 | Reference compound |
| HY-135644 | Rencofilstat | 1383420-08-3 | Reference compound |
| HY-135646 | Eleutheroside B1 | 16845-16-2 | Natural Products |
| HY-135648 | PfDHODH-IN-1 | 183945-55-3 | Reference compound |
| HY-135649 | Tremorine | 51-73-0 | Reference compound |
| HY-13564A | Batimastat (sodium salt) | 130464-84-5 | Reference compound |
| HY-13565 | Becatecarin | 119673-08-4 | Reference compound |
| HY-135652 | Hexyl gallate | 1087-26-9 | Reference compound |
| HY-135653 | EC5026 | 1809885-32-2 | Reference compound |
| HY-135653A | (Rac)-EC5026 | 1809885-55-9 | Reference compound |
| HY-135654 | hDHODH-IN-2 | 183946-00-1 | Reference compound |
| HY-135655 | Fobrepodacin (disodium) | 1384984-20-6 | Reference compound |
| HY-135655A | Fobrepodacin | 1384984-31-9 | Reference compound |
| HY-135658 | hDHODH-IN-1 | 1173715-42-8 | Reference compound |
| HY-135659 | BSH-IN-1 | 2553217-91-5 | Reference compound |
| HY-13566 | Belotecan | 256411-32-2 | Reference compound |
| HY-135660 | MMAE-SMCC | 2021179-11-1 | ADC Related |
| HY-135663 | Methyl jasmonate | 1211-29-6 | Natural Products |
| HY-135664 | hDHODH-IN-5 | 2029049-77-0 | Reference compound |
| HY-135666 | DHODH-IN-8 | 1148126-03-7 | Reference compound |
| HY-135667 | hDHODH-IN-7 | 1644156-41-1 | Reference compound |
| HY-13566A | Belotecan (hydrochloride) | 213819-48-8 | Reference compound |
| HY-13566AS | Belotecan-d7 (hydrochloride) | 1346598-22-8 | Isotope-Labeled Compounds |
| HY-13567 | Bendamustine | 16506-27-7 | Reference compound |
| HY-135670 | Glycosidase-IN-1 | 170376-12-2 | Reference compound |
| HY-135670A | β-glycosidase-IN-1 | 176485-27-1 | Reference compound |
| HY-135670B | Glycosidase-IN-2 | 476310-39-1 | Reference compound |
| HY-135671 | AhR modulator-1 | 118174-38-2 | Reference compound |
| HY-135674 | SR-318 | 2413286-32-3 | Reference compound |
| HY-135675 | DHODH-IN-11 | 1263303-95-2 | Reference compound |
| HY-135676 | DHODH-IN-12 | 1263303-93-0 | Reference compound |
| HY-135677 | DHODH-IN-13 | 1364791-86-5 | Reference compound |
| HY-135678 | DHODH-IN-14 | 1364791-93-4 | Reference compound |
| HY-135679 | DHODH-IN-15 | 1364791-88-7 | Reference compound |
| HY-13567S | Bendamustine-d4 | Isotope-Labeled Compounds | |
| HY-13567S1 | Bendamustine-d8 | 1134803-33-0 | Isotope-Labeled Compounds |
| HY-13568 | Benoxaprofen | 51234-28-7 | Reference compound |
| HY-135680 | I-OMe-Tyrphostin AG 538 | 1094048-77-7 | Reference compound |
| HY-135682 | Nitrosobiotin | 56859-26-8 | Reference compound |
| HY-13568R | Benoxaprofen (Standard) | 51234-28-7 | Reference Standards |
| HY-135691 | hnRNPK-IN-1 | 2313528-04-8 | Reference compound |
| HY-135699 | TD52 | 1798328-24-1 | Reference compound |
| HY-135699A | TD52 (dihydrochloride) | Reference compound | |
| HY-13569A | Beraprost (sodium) | 496807-11-5 | Reference compound |
| HY-13569AR | Beraprost (sodium) (Standard) | 496807-11-5 | Reference Standards |
| HY-13570 | Betamethasone | 378-44-9 | Reference compound |
| HY-135700 | Mevalonolactone | 19115-49-2 | Natural Products |
| HY-135702 | UBS109 | 1258513-40-4 | Reference compound |
| HY-13570A | Betamethasone (hydrochloride) | 956901-32-9 | Reference compound |
| HY-13570B | Betamethasone acetate | 987-24-6 | Reference compound |
| HY-13570BR | Betamethasone acetate (Standard) | 987-24-6 | Reference Standards |
| HY-13570BS1 | Betamethasone acetate-d5 | Isotope-Labeled Compounds | |
| HY-13570C | Betamethasone disodium phosphate | 151-73-5 | Reference compound |
| HY-13570CR | Betamethasone disodium phosphate (Standard) | 151-73-5 | Reference Standards |
| HY-13570CS | Betamethasone 21-phosphate-d5 | Isotope-Labeled Compounds | |
| HY-13570R | Betamethasone (Standard) | 378-44-9 | Reference Standards |
| HY-13570S | Betamethasone-d5 | Isotope-Labeled Compounds | |
| HY-13570S1 | Betamethasone-d5-1 | 2244574-92-1 | Isotope-Labeled Compounds |
| HY-13571 | Betamethasone dipropionate | 5593-20-4 | Reference compound |
| HY-135710 | ADAMTS-5-IN-2 | 294648-66-1 | Reference compound |
| HY-135711 | PDE8B-IN-1 | 1305116-69-1 | Reference compound |
| HY-135712 | Orange G | 1936-15-8 | Dye Reagents |
| HY-135714 | Bavarostat | 2134109-20-7 | Reference compound |
| HY-135715 | (E)-UK122 (TFA) | 1186653-73-5 | Reference compound |
| HY-135717 | Norbiotinamine | 173401-47-3 | Reference compound |
| HY-135717A | Norbiotinamine (hydrochloride) | 160385-86-4 | Reference compound |
| HY-13571A | Beclometasone dipropionate | 5534-09-8 | Reference compound |
| HY-13571AR | Beclometasone dipropionate (Standard) | 5534-09-8 | Reference Standards |
| HY-13571AS | Beclometasone dipropionate-d6 | Isotope-Labeled Compounds | |
| HY-13571AS1 | Beclometasone dipropionate-d10 | Isotope-Labeled Compounds | |
| HY-13571B | Beclometasone dipropionate (monohydrate) | 77011-63-3 | Reference compound |
| HY-13571R | Betamethasone dipropionate (Standard) | 5593-20-4 | Reference Standards |
| HY-13571S | Betamethasone dipropionate-d10 | 2280940-19-2 | Isotope-Labeled Compounds |
| HY-13571S1 | Betamethasone dipropionate-d5 | Isotope-Labeled Compounds | |
| HY-135725 | D-69491 (hydrochloride) | 346599-65-3 | Reference compound |
| HY-135727 | PF-6422899 | 1621002-23-0 | Reference compound |
| HY-13573 | Biapenem | 120410-24-4 | Reference compound |
| HY-135730 | Aglepristone | 124478-60-0 | Reference compound |
| HY-135731 | 4-Methylamino antipyrine | 519-98-2 | Reference compound |
| HY-135731A | 4-Methylamino antipyrine (hydrochloride) | 856307-27-2 | Reference compound |
| HY-135731AR | 4-Methylamino antipyrine (hydrochloride) (Standard) | 856307-27-2 | Reference Standards |
| HY-135731AS | 4-Methylamino antipyrine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-135731R | 4-Methylamino antipyrine (Standard) | 519-98-2 | Reference Standards |
| HY-135732 | SK33 | 1928724-23-5 | Reference compound |
| HY-135735A | Levomedetomidine (hydrochloride) | 190000-46-5 | Reference compound |
| HY-135735S1 | Levomedetomidine-d8 | Isotope-Labeled Compounds | |
| HY-135737 | Dicaprylyl carbonate | 1680-31-5 | Natural Products |
| HY-135738 | Convicine | 19286-37-4 | Natural Products |
| HY-13573R | Biapenem (Standard) | 120410-24-4 | Reference Standards |
| HY-13574 | Biricodar (dicitrate) | 174254-13-8 | Reference compound |
| HY-135740 | Diphenhydramine N-oxide | 3922-74-5 | Reference compound |
| HY-135741 | NYX-2925 | 2012536-16-0 | Reference compound |
| HY-135742 | Lenvatinib N-oxide | 1788901-86-9 | Reference compound |
| HY-135743 | Apovincamine | 4880-92-6 | Natural Products |
| HY-135745 | Sulfentrazone | 122836-35-5 | Reference compound |
| HY-135745R | Sulfentrazone (Standard) | 122836-35-5 | Reference Standards |
| HY-135746 | OR-1896 | 220246-81-1 | Reference compound |
| HY-135746R | OR-1896 (Standard) | 220246-81-1 | Reference Standards |
| HY-135747 | Gut restricted-7 | 2553218-46-3 | Reference compound |
| HY-135748 | Polyinosinic-polycytidylic acid (sodium) | 42424-50-0 | Reference compound |
| HY-135748A | Poly (I:C):Kanamycin (1:1) (sodium) | Reference compound | |
| HY-135749 | BN201 | 1361200-34-1 | Reference compound |
| HY-13574A | Biricodar | 159997-94-1 | Reference compound |
| HY-13575 | Blonanserin | 132810-10-7 | Reference compound |
| HY-135750 | VAF347 | 574759-62-9 | Reference compound |
| HY-135751 | Holomycin | 488-04-0 | Reference compound |
| HY-135752 | Carbendazim mixture with flusilazole | 99827-19-7 | Reference compound |
| HY-135753 | Sethoxydim | 74051-80-2 | Reference compound |
| HY-135753R | Sethoxydim (Standard) | 74051-80-2 | Reference Standards |
| HY-135759 | Cetraxate | 34675-84-8 | Reference compound |
| HY-13575A | Blonanserin (dihydrochloride) | 132812-45-4 | Reference compound |
| HY-13575R | Blonanserin (Standard) | 132810-10-7 | Reference Standards |
| HY-13575S | Blonanserin-d8 | Isotope-Labeled Compounds | |
| HY-13575S1 | Blonanserin-d5 | 1346599-86-7 | Isotope-Labeled Compounds |
| HY-135761 | Penconazole | 66246-88-6 | Reference compound |
| HY-135761R | Penconazole (Standard) | 66246-88-6 | Reference Standards |
| HY-135761S | Penconazole-d7 | 1628110-84-8 | Isotope-Labeled Compounds |
| HY-135762 | Allylescaline (hydrochloride) | 39201-76-8 | Reference compound |
| HY-135763 | Metabolex-36 | 1224102-50-4 | Reference compound |
| HY-135765 | Micordilin | 61701-92-6 | Natural Products |
| HY-135766 | Colletodiol | 21142-67-6 | Natural Products |
| HY-135767 | Bicyclopyrone | 352010-68-5 | Reference compound |
| HY-135767R | Bicyclopyrone (Standard) | 352010-68-5 | Reference Standards |
| HY-13577 | Oclacitinib | 1208319-26-9 | Reference compound |
| HY-135770 | 9-Dehydroxyeurotinone | 1360606-85-4 | Natural Products |
| HY-135771 | Avarone | 55303-99-6 | Natural Products |
| HY-135772 | 12-Ketodeoxycholic acid | 5130-29-0 | Natural Products |
| HY-135772R | 12-Ketodeoxycholic acid (Standard) | 5130-29-0 | Reference Standards |
| HY-135773 | CRTh2 antagonist 3 | 312928-72-6 | Reference compound |
| HY-135774 | 6-Hydroxybenzbromarone | 152831-00-0 | Reference compound |
| HY-135774R | 6-Hydroxybenzbromarone (Standard) | 152831-00-0 | Reference Standards |
| HY-135775 | BMVC | 627810-06-4 | Reference compound |
| HY-135776 | BMVC2 | 850559-51-2 | Reference compound |
| HY-13577A | Oclacitinib (monomaleate) | 1640292-55-2 | Reference compound |
| HY-13577S | Oclacitinib-13C-d3 | Isotope-Labeled Compounds | |
| HY-13578 | Brivudine | 69304-47-8 | Reference compound |
| HY-135780 | 3'-Deoxyuridine-5'-triphosphate | 69199-40-2 | Reference compound |
| HY-135780A | 3'-Deoxyuridine-5'-triphosphate (trisodium) | Reference compound | |
| HY-135781 | H-Arg(Pbf)-OMe (hydrochloride) | 257288-19-0 | Reference compound |
| HY-135782 | iso-ADP ribose | 15720-01-1 | Dye Reagents |
| HY-135783 | AT 1001 | 1314801-63-2 | Reference compound |
| HY-135784 | OSMI-2 | 2260542-60-5 | Reference compound |
| HY-135785 | OSMI-3 | 2260791-13-5 | Reference compound |
| HY-13578R | Brivudine (Standard) | 69304-47-8 | Reference Standards |
| HY-13578S | Brivudine-13C, 15N2 | Isotope-Labeled Compounds | |
| HY-13579 | BTZ043 | 1161233-85-7 | Reference compound |
| HY-135793 | Macropa-NH2 diester | 2146091-22-5 | Reference compound |
| HY-135794 | 11-Ketodihydrotestosterone | 32694-37-4 | Reference compound |
| HY-135794R | 11-Ketodihydrotestosterone (Standard) | 32694-37-4 | Reference Standards |
| HY-135794S | 11-Ketodihydrotestosterone-d3 | 2479914-02-6 | Isotope-Labeled Compounds |
| HY-135795 | 1-Cyclohexyl-3-dodecyl urea | 402939-18-8 | Reference compound |
| HY-135796 | m-PEG3-OH | 112-35-6 | Reference compound |
| HY-135797 | DB1976 | 1557397-51-9 | Reference compound |
| HY-135797A | DB1976 (dihydrochloride) | 2369663-93-2 | Reference compound |
| HY-135798 | Tos-PEG2-NH-Boc | 192132-77-7 | Reference compound |
| HY-135799 | WH-15 | 1264748-47-1 | Dye Reagents |
| HY-13579A | BTZ043 (Racemate) | 957217-65-1 | Reference compound |
| HY-13579R | BTZ043 (Standard) | 1161233-85-7 | Reference Standards |
| HY-13580 | Budesonide | 51333-22-3 | Reference compound |
| HY-135801 | Arachidonyl alcohol | 13487-46-2 | Reference compound |
| HY-135804 | NH2-PEG3-C2-Boc | 252881-74-6 | Reference compound |
| HY-135805 | JBJ-04-125-02 | 2060610-53-7 | Reference compound |
| HY-135805A | (Rac)-JBJ-04-125-02 | 2140807-05-0 | Reference compound |
| HY-135805B | (Rac)-JBJ-04-125-02 (acetate) | Reference compound | |
| HY-135808 | BIZ 114 | 2099120-74-6 | Reference compound |
| HY-135809 | A2764 (dihydrochloride) | 861038-72-4 | Reference compound |
| HY-13580R | Budesonide (Standard) | 51333-22-3 | Reference Standards |
| HY-13580S | Budesonide-d8 | 1105542-94-6 | Isotope-Labeled Compounds |
| HY-135810 | Cletoquine | 4298-15-1 | Reference compound |
| HY-135810A | Cletoquine (oxalate) | 14142-64-4 | Reference compound |
| HY-135810S | Cletoquine-d4 | 1854126-47-8 | Isotope-Labeled Compounds |
| HY-135810S1 | Cletoquine-d4-1 | 1216461-56-1 | Isotope-Labeled Compounds |
| HY-135811 | Desethyl chloroquine | 1476-52-4 | Reference compound |
| HY-135811A | Desethyl chloroquine (diphosphate) | 247912-76-1 | Reference compound |
| HY-135811R | Desethyl chloroquine (Standard) | 1476-52-4 | Reference Standards |
| HY-135811S | Desethyl chloroquine-d4 | 1189971-72-9 | Isotope-Labeled Compounds |
| HY-135811S1 | Desethyl chloroquine-d5 | 1261392-69-1 | Isotope-Labeled Compounds |
| HY-135813 | LtaS-IN-1 | 877950-01-1 | Reference compound |
| HY-135815 | Mobocertinib | 1847461-43-1 | Reference compound |
| HY-135815A | Mobocertinib (succinate) | 2389149-74-8 | Reference compound |
| HY-135815B | Mobocertinib (mesylate) | 2389149-85-1 | Reference compound |
| HY-135816 | CK2/PIM1-IN-1 | 292640-28-9 | Reference compound |
| HY-135818 | XM462 | 1045857-53-1 | Reference compound |
| HY-135819 | Mal-PEG24-NHS ester | 2226733-37-3 | Reference compound |
| HY-13582 | Carbendazim | 10605-21-7 | Reference compound |
| HY-135820 | m-PEG12-acid | 2135793-73-4 | Reference compound |
| HY-135821 | Fmoc-NH-PEG12-CH2CH2COOH | 1952360-91-6 | Reference compound |
| HY-135823 | Propargyl-PEG12-bromide | 2410937-34-5 | Reference compound |
| HY-135824 | m-PEG12-2-methylacrylate | 2867-46-1 | Reference compound |
| HY-135825 | TFEB activator 1 | 39777-61-2 | Reference compound |
| HY-135826 | Necroptosis-IN-1 | 1391980-92-9 | Reference compound |
| HY-135827 | Roginolisib | 1305267-37-1 | Reference compound |
| HY-135827A | Roginolisib (hemifumarate) | 1621688-31-0 | Reference compound |
| HY-135829 | BAY 2416964 | 2242464-44-2 | Reference compound |
| HY-13582A | Carbendazim (hydrochloride) | 37574-18-8 | Reference compound |
| HY-13582R | Carbendazim (Standard) | 10605-21-7 | Reference Standards |
| HY-13582S | Carbendazim-d4 | 291765-95-2 | Isotope-Labeled Compounds |
| HY-13582S1 | Carbendazimb-d3 | 1255507-88-0 | Isotope-Labeled Compounds |
| HY-135830 | AHR antagonist 4 | 2242465-58-1 | Reference compound |
| HY-135831 | AHR antagonist 2 | 2338747-54-7 | Reference compound |
| HY-135832 | Demethyl-RSL3 | 2375354-13-3 | Reference compound |
| HY-135835 | 6-FAM-PEG3-Azide | 412319-45-0 | Dye Reagents |
| HY-135837 | Fluorescein-diisobutyrate-6-amide | 2375357-99-4 | Reference compound |
| HY-135841 | CM010 | 692269-09-3 | Reference compound |
| HY-135842 | Aspoxicillin | 63358-49-6 | Reference compound |
| HY-135842R | Aspoxicillin (Standard) | 63358-49-6 | Reference Standards |
| HY-135843 | TH-263 | 313520-94-4 | Reference compound |
| HY-135844 | LS-102 | 1456891-34-1 | Reference compound |
| HY-135845 | TP3011 | 534605-74-8 | Reference compound |
| HY-135846 | PDD00031705 | 2032096-45-8 | Reference compound |
| HY-135847 | Desmethyl ferroquine | 903546-18-9 | Reference compound |
| HY-135848 | N-Methylbenzamide | 613-93-4 | Reference compound |
| HY-135849 | Catalase, Aspergillus niger | 9001-05-2 | Enzyme |
| HY-135849A | Catalase, Bovine Liver | 9001-05-2 | Enzyme |
| HY-135849B | Catalase, Human Erythrocyte | Enzyme | |
| HY-135849C | Catalase, trichoderma reesei | 9001-05-2 | Enzyme |
| HY-13585 | Carmustine | 154-93-8 | Reference compound |
| HY-135853 | Molnupiravir | 2492423-29-5 | Reference compound |
| HY-135853R | Molnupiravir (Standard) | 2492423-29-5 | Reference Standards |
| HY-135853S | Molnupiravir-d7 | Isotope-Labeled Compounds | |
| HY-135855 | SARS-CoV-IN-1 | 888958-25-6 | Reference compound |
| HY-135856 | SARS-CoV-IN-2 | 888958-26-7 | Reference compound |
| HY-135858 | SARS-CoV-IN-3 | 888958-27-8 | Reference compound |
| HY-135859 | NH2-MPAA-NODA | ADC Related | |
| HY-13585R | Carmustine (Standard) | 154-93-8 | Reference Standards |
| HY-13585S | Carmustine-d8 | Isotope-Labeled Compounds | |
| HY-135860 | SARS-CoV-2-IN-1 | 2412965-59-2 | Reference compound |
| HY-135862 | Tetraniliprole | 1229654-66-3 | Reference compound |
| HY-135864 | KRAS inhibitor-6 | 2022986-61-2 | Reference compound |
| HY-135865 | KRAS inhibitor-7 | 2022986-68-9 | Reference compound |
| HY-135866 | KRAS inhibitor-8 | 2022986-70-3 | Reference compound |
| HY-135867 | NHC-triphosphate | 34973-27-8 | Reference compound |
| HY-135867A | NHC-triphosphate (tetrasodium) | Reference compound | |
| HY-135867D | NHC-diphosphate | 39023-73-9 | Reference compound |
| HY-135867E | NHC-triphosphate (tetraammonium) | Reference compound | |
| HY-135867F | NHC-diphosphate (triammonium) | Reference compound | |
| HY-135868 | Mito-apocynin (C2) | 1254044-41-1 | Reference compound |
| HY-135869 | Mito-apocynin (C11) | 1254044-38-6 | Reference compound |
| HY-135871 | BMT-124110 | 1679371-59-5 | Reference compound |
| HY-135871A | BMT-124110 (formic) | Reference compound | |
| HY-135878 | 2',5'-Dideoxyadenosine | 6698-26-6 | Reference compound |
| HY-13588 | Cefsulodin (sodium) | 52152-93-9 | Reference compound |
| HY-135880 | OMDM-3 | 616884-64-1 | Reference compound |
| HY-135880A | OMDM-4 | 616884-65-2 | Reference compound |
| HY-135881 | OMDM-5 | 616884-66-3 | Reference compound |
| HY-135882 | OMDM-6 | 616884-67-4 | Reference compound |
| HY-135883 | PKR activator 1 | 2283420-62-0 | Reference compound |
| HY-135884 | Tebapivat | 2283422-04-6 | Reference compound |
| HY-135885 | VBIT-12 | 2089227-65-4 | Reference compound |
| HY-135886 | 2-Nitrophenyl α-D-galactopyranoside | 19887-85-5 | Biochemical Assay Reagents |
| HY-135887 | ZX-29 | 2254805-62-2 | Reference compound |
| HY-135888 | TP748 | 951698-15-0 | Reference compound |
| HY-135889 | CPFX2090 | 1429439-25-7 | Reference compound |
| HY-13588A | Cefsulodin | 62587-73-9 | Reference compound |
| HY-13588B | Cefsulodin (sodium hydrate) | 1426397-23-0 | Reference compound |
| HY-13588R | Cefsulodin (sodium) (Standard) | 52152-93-9 | Reference Standards |
| HY-13589 | Cemadotin | 159776-69-9 | Peptides |
| HY-135890 | CG347B | 1598426-03-9 | Reference compound |
| HY-135891 | AZD2423 | 1229603-37-5 | Reference compound |
| HY-135892 | GNE-1858 | 2680616-96-8 | Reference compound |
| HY-135893 | SGK1-IN-2 | 1426214-64-3 | Reference compound |
| HY-135895 | Detomidine carboxylic acid | 115664-39-6 | Reference compound |
| HY-135897 | Urolithin C | 165393-06-6 | Natural Products |
| HY-135898 | DGK-IN-1 | 2407892-34-4 | Reference compound |
| HY-135899 | SIRT7 inhibitor 97491 | 1807758-81-1 | Reference compound |
| HY-13589A | Cemadotin (hydrochloride) | 172837-41-1 | Reference compound |
| HY-13590 | CEP-7055 | 402857-58-3 | Reference compound |
| HY-135900 | Aniline-MPB-amino-C3-PBD | 2412923-79-4 | ADC Related |
| HY-135901 | Py-MPB-amino-C3-PBD | 2412924-07-1 | ADC Related |
| HY-135902 | Synucleozid | 502139-01-7 | Reference compound |
| HY-135902A | Synucleozid (hydrochloride) | 2741856-68-6 | Reference compound |
| HY-135903 | Giredestrant (tartrate) | 2407529-33-1 | Reference compound |
| HY-135905 | CL264 | 1510712-69-2 | Reference compound |
| HY-135906 | CK2/ERK8-IN-1 | 1085822-09-8 | Reference compound |
| HY-135909 | TH1217 | 1862212-48-3 | Reference compound |
| HY-13591 | Piclidenoson | 152918-18-8 | Reference compound |
| HY-135910 | 3,4-Dehydro Cilostazol | 73963-62-9 | Reference compound |
| HY-135910R | 3,4-Dehydro Cilostazol (Standard) | 73963-62-9 | Reference Standards |
| HY-135910S | 3,4-Dehydro Cilostazol-d11 | 1073608-13-5 | Isotope-Labeled Compounds |
| HY-135911 | Biotin-PEG2-OH | 717119-80-7 | Reference compound |
| HY-135912 | Biotin-PEG2-CH2CH2N3 | 945633-30-7 | Reference compound |
| HY-135913 | Cbz-NH-PEG3-CH2COOH | 462100-05-6 | Reference compound |
| HY-135914 | JBJ-02-112-05 | 2748162-29-8 | Reference compound |
| HY-135915 | Biotin-C5-NHS Ester | 72040-63-2 | Reference compound |
| HY-135916 | Biotin-C5-amino-C5-amino | 89889-51-0 | Reference compound |
| HY-135917 | Propargyl-PEG6-SH | 1422540-91-7 | Reference compound |
| HY-135918 | NH2-PEG6-C1-Boc | 297162-50-6 | Reference compound |
| HY-135919 | Cbz-NH-PEG5-CH2COOH | 1449390-66-2 | Reference compound |
| HY-13592 | HDAC-IN-7 | 743420-02-2 | Reference compound |
| HY-135920 | Biotin-C10-NHS Ester | 887628-40-2 | Reference compound |
| HY-135921 | m-PEG5-Hydrazide | 1449390-65-1 | Reference compound |
| HY-135922 | m-PEG6-Hydrazide | 1449390-64-0 | Reference compound |
| HY-135923 | Cbz-NH-PEG2-CH2COOH | 165454-06-8 | Reference compound |
| HY-135924 | Biotin-PEG3-OH | 1263044-40-1 | Reference compound |
| HY-135925 | Cbz-NH-PEG1-CH2COOH | 1260092-43-0 | Reference compound |
| HY-135926 | Cbz-NH-PEG1-CH2CH2COOH | 1205751-19-4 | Reference compound |
| HY-135927 | H2N-PEG2-CH2COOtBu | 1122484-77-8 | Reference compound |
| HY-135928 | Biotin-C2-S-S-pyridine | 112247-65-1 | Biochemical Assay Reagents |
| HY-13593 | Chlorambucil | 305-03-3 | Reference compound |
| HY-135930 | Boc-NH-PEG10-CH2CH2NH2 | 1347704-59-9 | Reference compound |
| HY-135931 | m-PEG11-C2-NHS Ester | Reference compound | |
| HY-135932 | m-PEG8-O-alkyne | 880081-81-2 | Reference compound |
| HY-135933 | Boc-NH-PEG8-CH2CH2NH2 | 1052207-59-6 | Reference compound |
| HY-135935 | DBCO-NHCO-PEG2-CH2COOH | Reference compound | |
| HY-135936 | m-PEG9-C4-SH | Reference compound | |
| HY-135937 | Biotin-PEG9-CH2CH2COOH | Reference compound | |
| HY-135938 | NH2-PEG5-C1-Boc | 2231845-67-1 | Reference compound |
| HY-135939 | DBCO-NHCO-PEG2-Biotin | Reference compound | |
| HY-13593R | Chlorambucil (Standard) | 305-03-3 | Reference Standards |
| HY-13593S | Chlorambucil-d8 | Isotope-Labeled Compounds | |
| HY-13593S1 | Chlorambucil-d8-1 | Isotope-Labeled Compounds | |
| HY-13594 | Chlorin e6 | 19660-77-6 | Dye Reagents |
| HY-135940 | m-PEG3-Mal | Reference compound | |
| HY-135941 | Biotin-PEG9-NHS Ester | Reference compound | |
| HY-135942 | Cbz-NH-PEG8-CH2COOH | Reference compound | |
| HY-135943 | NH2-PEG8-C1-Boc | Reference compound | |
| HY-135947 | Boc-NH-PEG11-OH | 1556847-53-0 | Reference compound |
| HY-13595 | Chrysophanol | 481-74-3 | Natural Products |
| HY-135953 | CDDO-3P-Im | 1883650-95-0 | Reference compound |
| HY-135954 | PDK4-IN-1 | 2310262-10-1 | Reference compound |
| HY-135954A | PDK4-IN-1 (hydrochloride) | 2310262-11-2 | Reference compound |
| HY-135956 | T3 Acyl glucuronide | 910907-23-2 | Natural Products |
| HY-135957 | 2'-Azido-2'-deoxyuridine | 26929-65-7 | Reference compound |
| HY-135958 | DBCO-NHCO-PEG6-Biotin | Reference compound | |
| HY-135959 | DBCO-NH-PEG7-C2-NHS ester | Reference compound | |
| HY-13595R | Chrysophanol (Standard) | 481-74-3 | Reference Standards |
| HY-13596 | Cisatracurium (besylate) | 96946-42-8 | Reference compound |
| HY-135960 | BO-264 | 2408648-20-2 | Reference compound |
| HY-135961 | PTAD-PEG4-amine | ADC Related | |
| HY-135962 | Boc-Aminooxy-PEG2-bromide | 252378-67-9 | ADC Related |
| HY-135963 | Thiol-PEG3-thiol | 2781-02-4 | Biochemical Assay Reagents |
| HY-135964 | (2-pyridyldithio)-PEG4 acid | 581065-93-2 | ADC Related |
| HY-135966 | Azido-PEG3-SS-NHS | ADC Related | |
| HY-135967 | MTH1-IN-2 | 901044-91-5 | Reference compound |
| HY-135969 | Glycol chitosan | 123938-86-3 | Oligonucleotides |
| HY-13596R | Cisatracurium (besylate) (Standard) | 96946-42-8 | Reference Standards |
| HY-135970 | Alkyne-PEG4-SS-PEG4-alkyne | ADC Related | |
| HY-135971 | endo-BCN-PEG4-acid | 1881221-47-1 | ADC Related |
| HY-135973 | BCN-SS-NHS | ADC Related | |
| HY-135974 | Amino-PEG3-SS-acid | ADC Related | |
| HY-135975 | MC-Val-Ala-PAB-PNP | 1639939-40-4 | ADC Related |
| HY-135976 | P2X3 antagonist 34 | 2417288-67-4 | Reference compound |
| HY-135977 | DBCO-SS-aldehyde | ADC Related | |
| HY-135979 | DBCO-SS-PEG4-Biotin | ADC Related | |
| HY-13598 | Valecobulin | 1188371-47-2 | Reference compound |
| HY-135981 | CMS-121 | 1353224-53-9 | Reference compound |
| HY-135982 | GPR81 agonist 1 | 1620992-67-7 | Reference compound |
| HY-135985 | DCLK1-IN-1 | 2222635-15-4 | Reference compound |
| HY-13598A | Valecobulin (hydrochloride) | 1240321-53-2 | Reference compound |
| HY-13599 | Cladribine | 4291-63-8 | Reference compound |
| HY-135996 | Dilaurylglycerosulfate | 99387-94-7 | Reference compound |
| HY-135996A | Dilaurylglycerosulfate (sodium) | 99388-09-7 | Reference compound |
| HY-13599R | Cladribine (Standard) | 4291-63-8 | Reference Standards |
| HY-13599S | Cladribine-d4 | Isotope-Labeled Compounds | |
| HY-13599S1 | Cladribine-13C5,15N2 | Isotope-Labeled Compounds | |
| HY-13599S2 | Cladribine-15N | 1360874-38-9 | Isotope-Labeled Compounds |
| HY-13600 | Clobetasol propionate | 25122-46-7 | Reference compound |
| HY-136001 | PROTAC α-synuclein degrader 3 | 2412273-77-7 | Reference compound |
| HY-136005 | VH032-C7-COOH | 2172819-77-9 | Reference compound |
| HY-136006 | (S,R,S)-AHPC-C6-NH2 (dihydrochloride) | 2341796-77-6 | Reference compound |
| HY-136006A | (S,R,S)-AHPC-C6-NH2 (hydrochloride) | 2360522-76-3 | Reference compound |
| HY-136006B | (S,R,S)-AHPC-C6-NH2 | 2306389-03-5 | Reference compound |
| HY-136008 | (S,R,S)-AHPC-PEG1-NH2 | 2241641-57-4 | Reference compound |
| HY-136008A | (S,R,S)-AHPC-PEG1-NH2 (dihydrochloride) | 2341796-83-4 | Reference compound |
| HY-13600R | Clobetasol propionate (Standard) | 25122-46-7 | Reference Standards |
| HY-13600S1 | Clobetasol propionate-d5 | 2280940-18-1 | Isotope-Labeled Compounds |
| HY-136010 | RIP2 Kinase Inhibitor 4 | 2126803-41-4 | Reference compound |
| HY-136026 | Camlipixant | 1621164-74-6 | Reference compound |
| HY-13603 | Crolibulin | 1000852-17-4 | Reference compound |
| HY-136030 | APN-PEG4-PFP | Reference compound | |
| HY-136031 | Tetrazine-SS-Biotin | 2123482-78-8 | ADC Related |
| HY-136032 | Tetrazine-SS-NHS | ADC Related | |
| HY-136033 | Methyltetrazine-SS-NHS | ADC Related | |
| HY-136034 | Azido-PEG1-Val-Cit-OH | ADC Related | |
| HY-136035 | Methyltetrazine-SS-PEG4-Biotin | ADC Related | |
| HY-136036 | Tetrazine-SS-PEG4-Biotin | ADC Related | |
| HY-136037 | Boc-amino-PEG3-SS-acid | ADC Related | |
| HY-136038 | Azido-PEG3-SSPy | ADC Related | |
| HY-136039 | TCO-SS-amine | ADC Related | |
| HY-13604 | Cyproterone acetate | 427-51-0 | Reference compound |
| HY-136040 | Tetrazine-PEG4-SS-NHS | ADC Related | |
| HY-136041 | Boc-amino-PEG3-SSPy | ADC Related | |
| HY-136044 | APN-PEG4-BCN | ADC Related | |
| HY-136045 | APN-PEG4-tetrazine | ADC Related | |
| HY-136046 | PTAD-PEG4-alkyne | ADC Related | |
| HY-136047 | Methylcyclopropene-PEG3-amine | ADC Related | |
| HY-136048 | Methylcyclopropene-PEG4-NHS | ADC Related | |
| HY-136049 | APN-PEG4-DBCO | ADC Related | |
| HY-13604R | Cyproterone acetate (Standard) | 427-51-0 | Reference Standards |
| HY-13604S | Cyproterone acetate-d3 | 2376035-90-2 | Isotope-Labeled Compounds |
| HY-13605 | Cytarabine | 147-94-4 | Natural Products |
| HY-136050 | TCO-PEG3-Biotin | ADC Related | |
| HY-136051 | Biotin-PEG3-aldehyde | 889443-90-7 | ADC Related |
| HY-136052 | Tetrazine-PEG4-oxyamine (hydrochloride) | ADC Related | |
| HY-136053 | Tetrazine-PEG4-biotin | ADC Related | |
| HY-136054 | N3-PEG5-aldehyde | 2566404-73-5 | ADC Related |
| HY-136055 | (S,R,S)-AHPC-C5-COOH | 2267282-19-7 | Reference compound |
| HY-136056 | Methyltetrazine-PEG4-oxyamine | ADC Related | |
| HY-136057 | iFSP1 | 150651-39-1 | Reference compound |
| HY-136058 | N3-PEG4-amido-Lys(Fmoc)-acid | ADC Related | |
| HY-136059 | Desfluoro-ezetimibe | 302781-98-2 | Reference compound |
| HY-13605A | Cytarabine (hydrochloride) | 69-74-9 | Reference compound |
| HY-13605R | Cytarabine (Standard) | 147-94-4 | Reference Standards |
| HY-13605S | Cytarabine-d2 | 40632-26-6 | Isotope-Labeled Compounds |
| HY-13606 | Dacinostat | 404951-53-7 | Reference compound |
| HY-136060 | Mal-PEG2-bis-PEG3-BCN | ADC Related | |
| HY-136061 | BCN-PEG4-HyNic | 1507370-54-8 | ADC Related |
| HY-136063 | Mefentrifluconazole | 1417782-03-6 | Reference compound |
| HY-136063R | Mefentrifluconazole (Standard) | 1417782-03-6 | Reference Standards |
| HY-136064 | 4,4'-Dimethoxychalcone | 2373-89-9 | Natural Products |
| HY-136065 | bpV(phen) | 42494-73-5 | Reference compound |
| HY-136066 | Tauro-ω-muricholic acid (sodium) | 2456348-84-6 | Reference compound |
| HY-136067 | DBCO-PEG4-HyNic | ADC Related | |
| HY-136068 | DCAP | 500015-20-3 | Reference compound |
| HY-136068R | DCAP (Standard) | 500015-20-3 | Reference Standards |
| HY-136069 | Xeruborbactam | 2170834-63-4 | Reference compound |
| HY-13607 | BMS-641988 | 1093276-09-5 | Reference compound |
| HY-136070 | QPX7728 bis-acetoxy methyl ester | 2170834-56-5 | Reference compound |
| HY-136071 | QPX7728 methoxy acetoxy methy ester | 2170834-57-6 | Reference compound |
| HY-136072 | Xeruborbactam (disodium) | 2170848-99-2 | Reference compound |
| HY-136072A | (1R,2S)-Xeruborbactam (disodium) | 2170836-14-1 | Reference compound |
| HY-136073 | Wnt pathway activator 2 | 1360540-82-4 | Reference compound |
| HY-136074 | Methyltetrazine-PEG4-aldehyde | ADC Related | |
| HY-136075 | HyNic-PEG4-alkyne | ADC Related | |
| HY-136076 | TCO-PEG3-CH2-aldehyde | ADC Related | |
| HY-136077 | TCO-PEG3-aldehyde | ADC Related | |
| HY-136078 | Tetrazine-diazo-PEG4-biotin | ADC Related | |
| HY-136079 | Methyltetrazine-PEG4-hydrazone-DBCO | ADC Related | |
| HY-13607A | (rel)-BMS-641988 | 573738-99-5 | Reference compound |
| HY-136081 | Hexamidine | 3811-75-4 | Reference compound |
| HY-136081A | Hexamidine (diisethionate) | 659-40-5 | Reference compound |
| HY-136081AS | Hexamidine-d12 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-136084 | Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) | ADC Related | |
| HY-136085 | Amino-bis-PEG3-BCN | ADC Related | |
| HY-136086 | Tetrazine-PEG6-amine (hydrochloride) | ADC Related | |
| HY-136087 | Mal-bis-PEG3-DBCO | ADC Related | |
| HY-136088 | Acid-PEG1-bis-PEG3-BCN | ADC Related | |
| HY-136089 | Aminooxy-PEG2-bis-PEG3-BCN | ADC Related | |
| HY-13609 | Deflazacort | 14484-47-0 | Reference compound |
| HY-136090 | Amino-PEG4-bis-PEG3-N3 | ADC Related | |
| HY-136092 | Androsta-1,4,6-triene-3,17-dione | 633-35-2 | Reference compound |
| HY-136093 | Lixumistat (hydrochloride) | 1422365-52-3 | Reference compound |
| HY-136093A | Lixumistat (acetate) | 1422365-94-3 | Reference compound |
| HY-136093B | Lixumistat | 1422365-93-2 | Reference compound |
| HY-136094 | SRT3657 | 1383551-17-4 | Reference compound |
| HY-136095 | Tetrazine-biotin | 1714123-51-9 | ADC Related |
| HY-136096 | DBCO-PEG3 acetic-EVCit-PAB | 2253947-17-8 | ADC Related |
| HY-136097 | Maleimide-PEG2-hydrazide (TFA) | ADC Related | |
| HY-136098 | DBCO-PEG4-acetic-Val-Cit-PAB | ADC Related | |
| HY-136099 | Bocaminooxyacetamide-PEG2-Azido | ADC Related | |
| HY-13609R | Deflazacort (Standard) | 14484-47-0 | Reference Standards |
| HY-13609S | Deflazacort-d5 | Isotope-Labeled Compounds | |
| HY-13609S1 | Deflazacort-d7 | Isotope-Labeled Compounds | |
| HY-13610 | N1,N11-Diethylnorspermine | 121749-39-1 | Reference compound |
| HY-136100 | TCO-PEG1-Val-Cit-PABC-PNP | ADC Related | |
| HY-136101 | Bocaminooxyacetamide-PEG3-alkyne | ADC Related | |
| HY-136103 | DBCO-PEG4-Propionic-Val-Cit-PAB | ADC Related | |
| HY-136104 | Methyltetrazine-Maleimide | ADC Related | |
| HY-136105 | Azido-PEG1-Val-Cit-PABC-PNP | ADC Related | |
| HY-136106 | Fmoc-Gly3-Val-Cit-PAB | 2647914-09-6 | ADC Related |
| HY-136107 | Fmoc-Phe-Lys(Trt)-PAB | 1116085-98-3 | ADC Related |
| HY-136108 | Fmoc-Gly3-Val-Cit-PAB-PNP | 2647914-16-5 | ADC Related |
| HY-136109 | SEP-363856 (hydrochloride) | 1310422-41-3 | Reference compound |
| HY-136109A | SEP-363856 | 1310426-33-5 | Reference compound |
| HY-136109B | (Rac)-SEP-363856 | 1310426-29-9 | Reference compound |
| HY-136109E | SEP-363856 (mesylate) | 2375116-27-9 | Reference compound |
| HY-13610A | N1,N11-Diethylnorspermine (tetrahydrochloride) | 156886-85-0 | Reference compound |
| HY-13610B | N1,N11-Diethylnorspermine (hydrobromide) | 1384898-58-1 | Reference compound |
| HY-13611 | Diflomotecan | 220997-97-7 | Reference compound |
| HY-136110 | 2-Keto-D-galactose | 54142-77-7 | Reference compound |
| HY-136113 | Ibrutinib dimer | 2031255-23-7 | Reference compound |
| HY-136121 | Tubulin inhibitor 6 | 105925-39-1 | Reference compound |
| HY-136122 | Tubulin inhibitor 7 | 1309925-41-4 | Reference compound |
| HY-136123 | Tubulin inhibitor 8 | 1309925-39-0 | Reference compound |
| HY-136124 | Cetilistat impurity 1 | 890655-08-0 | Reference compound |
| HY-136125 | BCOT-PEF3-OPFP | 2101206-48-6 | ADC Related |
| HY-136127 | ALD-PEG4-OPFP | 1324007-10-4 | ADC Related |
| HY-136128 | H3B-120 | 2194903-42-7 | Reference compound |
| HY-136129 | N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol | ADC Related | |
| HY-13613 | Dutasteride | 164656-23-9 | Reference compound |
| HY-136130 | N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol | ADC Related | |
| HY-136131 | NH2-PEG4-hydrazone-DBCO | ADC Related | |
| HY-136132 | MC-VC-PAB-NH2 | 1616727-20-8 | ADC Related |
| HY-136132A | MC-VC-PAB-NH2 (TFA) | 1616727-21-9 | Reference compound |
| HY-136133 | NHS-PEG2-SS-PEG2-NHS | ADC Related | |
| HY-136134 | SS-bis-amino-PEG4-NHS ester | ADC Related | |
| HY-136135 | (2-pyridyldithio)-PEG1-hydrazine | 111625-28-6 | ADC Related |
| HY-136136 | Fmoc-Val-Ala-PAB-PNP | 1394238-92-6 | ADC Related |
| HY-136137 | Azide-PEG1-Val-Cit-PABC-OH | 2055041-40-0 | ADC Related |
| HY-13613R | Dutasteride (Standard) | 164656-23-9 | Reference Standards |
| HY-13613S | Dutasteride-13C6 | 1217685-27-2 | Isotope-Labeled Compounds |
| HY-13613S2 | Dutasteride-13C,15N,d | Isotope-Labeled Compounds | |
| HY-136140 | Aldehyde-benzyl-PEG5-alkyne | 1378928-83-6 | Reference compound |
| HY-136141 | DBCO-PEG3-propionic EVCit-PAB | ADC Related | |
| HY-136142 | Prasugrel chloride impurity | 1056459-37-0 | Reference compound |
| HY-136143 | (BHQ-3)-OSu (hexafluorophosphate) | 871240-95-8 | Reference compound |
| HY-136144 | FIDAS-5 | 1391934-98-7 | Reference compound |
| HY-136145 | FIDAS-3 | 1266684-01-8 | Reference compound |
| HY-136146 | SUVN-911 | 2414674-71-6 | Reference compound |
| HY-136149 | Mpro inhibitor N3 | 884650-98-0 | Reference compound |
| HY-136149A | Mpro inhibitor N3 (hemihydrate) | Reference compound | |
| HY-13615 | Folate-FITC | 583037-91-6 | Dye Reagents |
| HY-136150 | Methyl carnosate | 82684-06-8 | Natural Products |
| HY-136151 | UNC10217938A | 1347749-97-6 | Reference compound |
| HY-136152 | MCHR1 antagonist 3 | 1069622-60-1 | Reference compound |
| HY-136153 | Amphotericin X1 | 136135-57-4 | Reference compound |
| HY-136154 | Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP | ADC Related | |
| HY-136155 | Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester | ADC Related | |
| HY-136156 | Pomalidomide-PEG6-butyl iodide | 1835705-74-2 | Reference compound |
| HY-136157 | Py-ds-dmBut-amido-PEG4-NHS ester | ADC Related | |
| HY-136158 | 6-Maleimidocaproic acid sulfo-NHS | 103848-61-9 | Reference compound |
| HY-136158A | 6-Maleimidocaproic acid sulfo-NHS (sodium) | 215312-86-0 | Biochemical Assay Reagents |
| HY-136159 | 3-Mercaptopropionic acid NHS ester | 117235-10-6 | Reference compound |
| HY-13615A | EC-17 (disodium salt) | 910661-33-5 | Dye Reagents |
| HY-136160 | Thalidomide 4'-oxyacetamide-alkyl-C2-amine (hydrochloride) | 2341841-02-7 | Reference compound |
| HY-136161 | Pomalidomide-PEG6-NH2 (hydrochloride) | 2341841-01-6 | Reference compound |
| HY-136162 | Thalidomide-4-O-C2-NH2 (hydrochloride) | 2341840-99-9 | Reference compound |
| HY-136162A | Thalidomide-4-O-C2-NH2 | 390367-50-7 | Reference compound |
| HY-136163 | (S,R,S)-AHPC-C2-NH2 (dihydrochloride) | 2341796-73-2 | Reference compound |
| HY-136163A | (S,R,S)-AHPC-C2-NH2 | 2241643-69-4 | Reference compound |
| HY-136164 | VH032-OH | 2244684-42-0 | Reference compound |
| HY-136165 | (S,R,S)-AHPC-PEG3-propionic acid | 2140807-42-5 | Reference compound |
| HY-136166 | Thalidomide-NH-PEG3-propionic acid | 2138440-82-9 | Reference compound |
| HY-136168 | Mal-amino-sulfo | 158018-81-6 | Reference compound |
| HY-13617 | Edatrexate | 80576-83-6 | Reference compound |
| HY-136170 | MC-SN38 | 1473403-87-0 | ADC Related |
| HY-136171 | Antidepressant agent 1 | 67411-41-0 | Reference compound |
| HY-136172 | ESI-08 | 301177-43-5 | Reference compound |
| HY-136173 | Batoprotafib | 1801765-04-7 | Reference compound |
| HY-136174 | RBN-2397 | 2381037-82-5 | Reference compound |
| HY-136175 | Revumenib | 2169919-21-3 | Reference compound |
| HY-136177 | Tris(2,4-di-tert-butylphenyl)phosphate | 95906-11-9 | Natural Products |
| HY-136177R | Tris(2,4-di-tert-butylphenyl)phosphate (Standard) | 95906-11-9 | Reference Standards |
| HY-136179 | ZAP-180013 | 873080-25-2 | Reference compound |
| HY-13618 | Edotecarin | 174402-32-5 | Reference compound |
| HY-136181 | YNT-185 (dihydrochloride) | 1804978-82-2 | Reference compound |
| HY-136181A | YNT-185 | 1804978-81-1 | Reference compound |
| HY-136182 | YM-244769 (dihydrochloride) | 1780390-65-9 | Reference compound |
| HY-136182A | YM-244769 | 838819-70-8 | Reference compound |
| HY-136183 | (S,R,S)-AHPC-phenol-alkylC6-amine (dihydrochloride) | 2376990-28-0 | Reference compound |
| HY-136184 | (S,R,S)-AHPC-phenol-C4-NH2 (dihydrochloride) | 2376990-26-8 | Reference compound |
| HY-136185 | Atorvastatin Epoxy Tetrahydrofuran Impurity | 873950-19-7 | Reference compound |
| HY-136186 | (S,R,S)-AHPC-C7-amine | 2306389-04-6 | Reference compound |
| HY-136186A | (S,R,S)-AHPC-C7-amine (dihydrochloride) | 2415256-17-4 | Reference compound |
| HY-136186B | (S,R,S)-AHPC-C7-amine (hydrochloride) | 2502189-41-3 | Reference compound |
| HY-136187 | (S,R,S)-AHPC-C5-NH2 | 2170695-19-7 | Reference compound |
| HY-136187A | (S,R,S)-AHPC-C5-NH2 (dihydrochloride) | 2415256-20-9 | Reference compound |
| HY-136188 | UNC2399 | 2412791-72-9 | Reference compound |
| HY-136189 | UK-59811 (hydrochloride) | 2250025-89-7 | Reference compound |
| HY-13619 | Efaproxiral | 131179-95-8 | Reference compound |
| HY-136190 | TRPC6-PAM-C20 | 667427-75-0 | Reference compound |
| HY-136192 | TP-472N | 2080306-24-5 | Reference compound |
| HY-136194 | TL13-22 | 2229036-65-9 | Reference compound |
| HY-136195 | TL13-110 | 2229037-09-4 | Reference compound |
| HY-136197 | StRIP16 | 2761279-63-2 | Reference compound |
| HY-136198 | SRX3207 | 2254693-15-5 | Reference compound |
| HY-136199 | SIRT1-IN-1 | 352554-02-0 | Reference compound |
| HY-13619A | Efaproxiral (sodium) | 170787-99-2 | Reference compound |
| HY-13619S | Efaproxiral-d6 | 1246815-16-6 | Isotope-Labeled Compounds |
| HY-13620 | Elinafide | 162706-37-8 | Reference compound |
| HY-136200 | Antitrypanosomal agent 2 | 475626-30-3 | Reference compound |
| HY-136201 | Sodium Glucoheptonate | 31138-65-5 | Reference compound |
| HY-136201R | Sodium Glucoheptonate (Standard) | 31138-65-5 | Reference Standards |
| HY-136203 | Resveratrol analog 1 | 861446-16-4 | Reference compound |
| HY-136204 | Resveratrol analog 2 | 915378-82-4 | Reference compound |
| HY-136205 | IA-Alkyne | 930800-38-7 | Reference compound |
| HY-136207 | TC-2559 (difumarate) | 2454492-41-0 | Reference compound |
| HY-136208 | TAN-452 | 892039-23-5 | Reference compound |
| HY-136209 | SU5208 | 62540-08-3 | Reference compound |
| HY-136211 | Cystathionine-γ-lyase-IN-1 | 2165706-30-7 | Reference compound |
| HY-136213 | Endoplasmic reticulum dye 1 | 1404104-40-0 | Dye Reagents |
| HY-136214 | R-BC154 (acetate) | Reference compound | |
| HY-136217 | PU 23 | 817635-93-1 | Reference compound |
| HY-136219 | Protein kinase affinity probe 1 | 2098621-90-8 | Reference compound |
| HY-13622 | Elomotecan (hydrochloride) | 220997-99-9 | Reference compound |
| HY-136220 | AHR antagonist 5 | 2247953-39-3 | Reference compound |
| HY-136220A | AHR antagonist 5 (hemimaleate) | Reference compound | |
| HY-13622A | Elomotecan | 220998-10-7 | Reference compound |
| HY-13622B | Elomotecan (TFA) | Reference compound | |
| HY-13623 | Entecavir | 142217-69-4 | Reference compound |
| HY-136232 | PSEM 308 (hydrochloride) | Reference compound | |
| HY-136233 | PSB 0777 (ammonium) | 2122196-16-9 | Reference compound |
| HY-136233A | PSB 0777 (ammonium hydrate) | Reference compound | |
| HY-136234 | 9-cis-β-Carotene | 13312-52-2 | Natural Products |
| HY-136237 | Thalidomide-NH-C5-NH2 (hydrochloride) | 2375194-03-7 | Reference compound |
| HY-136238 | PM226 | 1949726-13-9 | Reference compound |
| HY-136239 | Beclomethasone 17-propionate | 5534-18-9 | Reference compound |
| HY-136239R | Beclomethasone 17-propionate (Standard) | 5534-18-9 | Reference Standards |
| HY-13623A | Entecavir (monohydrate) | 209216-23-9 | Reference compound |
| HY-13623AR | Entecavir (monohydrate) (Standard) | 209216-23-9 | Reference Standards |
| HY-13623C | (1R,3S,4R)-ent-Entecavir | 188399-46-4 | Reference compound |
| HY-13623CS | (1R,3S,4R)-ent-Entecavir-13C2,15N | Isotope-Labeled Compounds | |
| HY-13623S | Entecavir-d2 | Isotope-Labeled Compounds | |
| HY-13623S1 | Entecavir-13C2,15N | Isotope-Labeled Compounds | |
| HY-13624 | Epirubicin | 56420-45-2 | Reference compound |
| HY-136240 | Tioxazafen | 330459-31-9 | Reference compound |
| HY-136241 | OT-82 | 1800487-55-1 | Reference compound |
| HY-136242 | UT-34 | 2168525-92-4 | Reference compound |
| HY-136244 | PF-06952229 | 1801333-55-0 | Reference compound |
| HY-136247 | Cyanine 5 Tyramide | 1431148-26-3 | Dye Reagents |
| HY-136247A | Cyanine 5 Tyramide methyl indole | Reference compound | |
| HY-136248 | Cyanine 3 Tyramide | 174961-75-2 | Dye Reagents |
| HY-136248A | Cyanine 3 Tyramide methyl indole | Dye Reagents | |
| HY-13624A | Epirubicin (hydrochloride) | 56390-09-1 | Reference compound |
| HY-13624AR | Epirubicin (hydrochloride) (Standard) | 56390-09-1 | Reference Standards |
| HY-13625 | Ertapenem sodium | 153773-82-1 | Reference compound |
| HY-136250 | BSJ-03-204 | 2349356-09-6 | Reference compound |
| HY-136250A | BSJ-03-204 (triTFA) | Reference compound | |
| HY-136251 | BRD0539 | 1403838-79-8 | Reference compound |
| HY-136252 | BSJ-04-132 | 2349356-39-2 | Reference compound |
| HY-136254 | BzATP (triethylammonium salt) | Reference compound | |
| HY-136255 | Camizestrant | 2222844-89-3 | Reference compound |
| HY-136256 | Vimseltinib | 1628606-05-2 | Reference compound |
| HY-136257 | CMP98 | 2244684-50-0 | Reference compound |
| HY-136258 | nAChR agonist CMPI (hydrochloride) | 2250025-94-4 | Reference compound |
| HY-136259 | ML188 | 1417700-13-0 | Reference compound |
| HY-13625R | Ertapenem sodium (Standard) | 153773-82-1 | Reference Standards |
| HY-13626 | Spisulosine | 196497-48-0 | Natural Products |
| HY-136260 | DBCO-PEG4-Ahx-DM1 | 2479378-44-2 | ADC Related |
| HY-136261 | DM1-PEG4-DBCO | ADC Related | |
| HY-136262 | CRBN-6-5-5-VHL | 2362575-45-7 | Reference compound |
| HY-136265 | BC-LI-0186 | 695207-56-8 | Reference compound |
| HY-136266 | HCV-IN-29 | 1009119-83-8 | Reference compound |
| HY-136267 | HCV-IN-30 | 1007882-23-6 | Reference compound |
| HY-136268 | AQX-435 | 1619983-52-6 | Reference compound |
| HY-136269 | A 410099.1, amine-Boc (hydrochloride) | 2374122-37-7 | Reference compound |
| HY-136269A | A 410099.1, amine-Boc | 1613552-03-6 | Reference compound |
| HY-13626S | Spisulosine-d3 | 1246298-31-6 | Isotope-Labeled Compounds |
| HY-13627 | Estramustine (phosphate sodium) | 52205-73-9 | Reference compound |
| HY-136270 | Gartisertib | 1613191-99-3 | Reference compound |
| HY-136272 | A 410099.1 amide-PEG3-amine-Boc | 2415256-19-6 | Reference compound |
| HY-136273 | A 410099.1 amide-PEG2-amine-Boc | 2415256-16-3 | Reference compound |
| HY-136274 | Boc-A 410099.1 amide-alkylC4-amine | 2415256-18-5 | Reference compound |
| HY-136275 | AMPA receptor modulator-2 | 2034181-36-5 | Reference compound |
| HY-136276 | DMNB-caged-Serine | 780009-55-4 | Reference compound |
| HY-136277 | DFHO | 1420815-34-4 | Dye Reagents |
| HY-136278 | DETA NONOate | 146724-94-9 | Reference compound |
| HY-136279 | TrxR inhibitor D9 | 1527513-89-8 | Reference compound |
| HY-13627A | Estramustine phosphate | 4891-15-0 | Reference compound |
| HY-13628 | Etalocib | 161172-51-6 | Reference compound |
| HY-136280 | Panamesine | 139225-22-2 | Reference compound |
| HY-136281 | DuP 734 | 135135-87-4 | Reference compound |
| HY-136282 | OGT-IN-2 | 442665-87-4 | Reference compound |
| HY-136283 | DMNPE-4 AM-caged-calcium | 2253744-58-8 | Reference compound |
| HY-136284 | XP-59 | 890402-73-0 | Reference compound |
| HY-136285 | CPI-1612 | 2374971-81-8 | Reference compound |
| HY-136285A | (R,R)-CPI-1612 | 2374972-35-5 | Reference compound |
| HY-136286 | MC-DM1 | 1375089-56-7 | ADC Related |
| HY-136287 | DBM-MMAF | 1810001-93-4 | ADC Related |
| HY-136288 | Azide-PEG4-VC-PAB-Doxorubicin | ADC Related | |
| HY-136289 | MB-VC-MGBA | 932744-62-2 | ADC Related |
| HY-13628A | Etalocib (sodium) | 152608-41-8 | Reference compound |
| HY-13629 | Etoposide | 33419-42-0 | Natural Products |
| HY-136291 | Sulfo-SPDB-DGN462 | ADC Related | |
| HY-136293 | Mechercharmycin A | 822520-96-7 | Natural Products |
| HY-136295 | Quinaldopeptin | 130743-07-6 | Reference compound |
| HY-136298 | (Rac)-X77 | 2144491-78-9 | Reference compound |
| HY-136298A | X77 | 2455518-33-7 | Reference compound |
| HY-136299 | Sepimostat | 103926-64-3 | Reference compound |
| HY-136299A | Sepimostat (dimethanesulfonate) | 103926-82-5 | Reference compound |
| HY-13629R | Etoposide (Standard) | 33419-42-0 | Reference Standards |
| HY-13629S | Etoposide-d3 | Isotope-Labeled Compounds | |
| HY-13629S1 | Etoposide-13C,d3 | Isotope-Labeled Compounds | |
| HY-13630 | Etoposide phosphate | 117091-64-2 | Reference compound |
| HY-136300 | PHD-1-IN-1 | 2009343-14-8 | Reference compound |
| HY-136301 | Acid secretion-IN-1 | 161958-62-9 | Reference compound |
| HY-136302 | Karrikinolide | 857054-02-5 | Reference compound |
| HY-136303 | GS-704277 | 1911579-04-8 | Reference compound |
| HY-136304 | NHS-PEG1-SS-PEG1-NHS | 1688598-83-5 | Reference compound |
| HY-136306 | Metallo β-lactamase ligand 1 | 1087784-71-1 | Reference compound |
| HY-136307S | Tizoxanide-d4 glucuronide | Isotope-Labeled Compounds | |
| HY-136309 | Ald-PEG23-SPDP | ADC Related | |
| HY-13630A | Etoposide phosphate (disodium) | 122405-33-8 | Reference compound |
| HY-13630R | Etoposide phosphate (Standard) | 117091-64-2 | Reference Standards |
| HY-13631 | Exatecan | 171335-80-1 | Reference compound |
| HY-136310 | PIP4K-IN-a131 | 2055405-95-1 | Reference compound |
| HY-136311 | NCT-504 | 1222765-97-0 | Reference compound |
| HY-136312 | 17-DMAP-GA | 169521-68-0 | Reference compound |
| HY-136313 | MC-VC-PAB-Tubulysin M | 1639939-56-2 | ADC Related |
| HY-136314 | DBCO-PEG4-VC-PAB-MMAE | 2129164-91-4 | ADC Related |
| HY-136315 | OSu-Glu-VC-PAB-MMAD | ADC Related | |
| HY-136317 | MC-betaglucuronide-MMAE-1 | 1703778-92-0 | ADC Related |
| HY-136318 | β-D-tetraacetylgalactopyranoside-PEG1-N3 | 153252-36-9 | ADC Related |
| HY-13631A | Exatecan (mesylate) | 169869-90-3 | Reference compound |
| HY-13631AG | Exatecan (mesylate) (GMP) | 169869-90-3 | GMP Small Molecules |
| HY-13631AS | Exatecan-d5 (mesylate) | 2819276-88-3 | Isotope-Labeled Compounds |
| HY-13631AS1 | Exatecan-d3 (mesylate) | Isotope-Labeled Compounds | |
| HY-13631D | Dxd | 1599440-33-1 | ADC Related |
| HY-13631DS | Dxd-d5 | Isotope-Labeled Compounds | |
| HY-13631E | Deruxtecan | 1599440-13-7 | ADC Related |
| HY-13631ES | Deruxtecan-d4 | 2760715-91-9 | Isotope-Labeled Compounds |
| HY-13631ES1 | Deruxtecan-d6 | 2760715-89-5 | Isotope-Labeled Compounds |
| HY-13631ES2 | Deruxtecan-d4-1 | 2760715-88-4 | Isotope-Labeled Compounds |
| HY-13631ES3 | Deruxtecan-d2 | 2760715-87-3 | Isotope-Labeled Compounds |
| HY-13631ES4 | Deruxtecan-d5 | Isotope-Labeled Compounds | |
| HY-13631F | Gly-Gly-Phe-Gly-NH-O-CO-Exatecan (hydrochloride) | 3053688-78-8 | ADC Related |
| HY-13631I | (1S,9R)-Exatecan (mesylate) | 2938875-54-6 | Reference compound |
| HY-13631J | (1R,9R)-Exatecan (mesylate) | 2938875-39-7 | Reference compound |
| HY-13631M | Gly-Gly-Phe-Gly-NH-O-CO-Exatecan | 1599440-12-6 | Reference compound |
| HY-13631O | (1R)-Deruxtecan | 2270986-87-1 | Reference compound |
| HY-13631P | Exatecan (mesylate dihydrate) | 197720-53-9 | Reference compound |
| HY-13631R | Exatecan (Standard) | 171335-80-1 | Reference Standards |
| HY-13632 | Exemestane | 107868-30-4 | Reference compound |
| HY-136321 | MC-betaglucuronide-MMAE-2 | 1703778-81-7 | ADC Related |
| HY-136327 | Phenylacetic acid mustard | 10477-72-2 | Reference compound |
| HY-136328 | EZM0414 (TFA) | 2411759-92-5 | Reference compound |
| HY-136329 | β-D-glucuronide-pNP-carbonate | 894095-98-8 | ADC Related |
| HY-13632R | Exemestane (Standard) | 107868-30-4 | Reference Standards |
| HY-13632S | Exemestane-d2 | Isotope-Labeled Compounds | |
| HY-13632S1 | Exemestane-13C3 | Isotope-Labeled Compounds | |
| HY-13632S2 | Exemestane-d3 | Isotope-Labeled Compounds | |
| HY-13632S5 | Exemestane-13C,d2 | Isotope-Labeled Compounds | |
| HY-13632S6 | Exemestane-d4 | Isotope-Labeled Compounds | |
| HY-13633 | Exisulind | 59864-04-9 | Reference compound |
| HY-136330 | Oxazosulfyl | 1616678-32-0 | Reference compound |
| HY-136336 | Tofacitinib metabolite-1 | 1640971-51-2 | Reference compound |
| HY-136338 | Cimetidine sulfoxide | 54237-72-8 | Reference compound |
| HY-136338R | Cimetidine sulfoxide (Standard) | 54237-72-8 | Reference Standards |
| HY-136339 | Cbl-b-IN-1 | 2368841-84-1 | Reference compound |
| HY-13634 | Ezatiostat (hydrochloride) | 286942-97-0 | Peptides |
| HY-136340 | 21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione | 37413-91-5 | Reference compound |
| HY-136341 | 7,8-Dihydroneopterin | 1218-98-0 | Natural Products |
| HY-136341R | 7,8-Dihydroneopterin (Standard) | 1218-98-0 | Reference Standards |
| HY-136342 | Antitumor agent-23 | 2355185-12-3 | Reference compound |
| HY-136344 | Simvastatin Acyl-β-D-glucuronide | 463962-56-3 | Reference compound |
| HY-136345 | (Rac)-3′-Hydroxy simvastatin | 126313-98-2 | Reference compound |
| HY-136346 | 2-Hydroxy atorvastatin lactone | 163217-74-1 | Reference compound |
| HY-136346S | Ortho-hydroxy atorvastatin lactone-d5 | 265989-50-2 | Isotope-Labeled Compounds |
| HY-136347 | 3α-Hydroxy pravastatin (sodium) | 81093-43-8 | Reference compound |
| HY-136347R | 3α-Hydroxy pravastatin (sodium) (Standard) | 81093-43-8 | Reference Standards |
| HY-136348 | ML338 | 1630160-25-6 | Reference compound |
| HY-13634A | Ezatiostat | 168682-53-9 | Peptides |
| HY-13634B | TLK117 | 152684-53-2 | Peptides |
| HY-13635 | Finasteride | 98319-26-7 | Reference compound |
| HY-136350 | BRD9500 | 1630760-75-6 | Reference compound |
| HY-136350B | (S)-BRD9500 | 1630760-76-7 | Reference compound |
| HY-136351 | THZ-P1-2 | 2058075-45-7 | Reference compound |
| HY-136352 | Adenosine 5'-succinate | 102029-71-0 | Reference compound |
| HY-136355 | Picoxystrobin | 117428-22-5 | Reference compound |
| HY-136355R | Picoxystrobin (Standard) | 117428-22-5 | Reference Standards |
| HY-136355S | Picoxystrobin-d3 | Isotope-Labeled Compounds | |
| HY-136356 | Triclopyricarb | 902760-40-1 | Reference compound |
| HY-136357 | Tribenuron | 106040-48-6 | Reference compound |
| HY-136358 | LDN-211904 | 1198408-39-7 | Reference compound |
| HY-13635A | Finasteride (acetate) | 222989-99-3 | Reference compound |
| HY-13635R | Finasteride (Standard) | 98319-26-7 | Reference Standards |
| HY-13635S | Finasteride-d9 | 1131342-85-2 | Isotope-Labeled Compounds |
| HY-13636 | Fulvestrant | 129453-61-8 | Reference compound |
| HY-136360 | MI-3454 | 2134169-43-8 | Reference compound |
| HY-136362 | ARRY-382 | 1313407-95-2 | Reference compound |
| HY-136363 | MDR-652 | 1933528-96-1 | Reference compound |
| HY-136367 | Diclofop-methyl | 51338-27-3 | Reference compound |
| HY-136367R | Diclofop-methyl (Standard) | 51338-27-3 | Reference Standards |
| HY-136369 | Ethofumesate | 26225-79-6 | Reference compound |
| HY-136369R | Ethofumesate (Standard) | 26225-79-6 | Reference Standards |
| HY-13636A | Fulvestrant (S enantiomer) | 1316849-17-8 | Reference compound |
| HY-13636B | Fulvestrant (R enantiomer) | 1807900-80-6 | Reference compound |
| HY-13636R | Fulvestrant (Standard) | 129453-61-8 | Reference Standards |
| HY-13636S | Fulvestrant-d3 | Isotope-Labeled Compounds | |
| HY-13636S1 | Fulvestrant-d5 | Isotope-Labeled Compounds | |
| HY-13637 | Ganciclovir | 82410-32-0 | Reference compound |
| HY-136370 | Bromoxynil octanoate | 1689-99-2 | Reference compound |
| HY-136370R | Bromoxynil octanoate (Standard) | 1689-99-2 | Reference Standards |
| HY-136371 | Fluroxypyr-meptyl | 81406-37-3 | Reference compound |
| HY-136371R | Fluroxypyr-meptyl (Standard) | 81406-37-3 | Reference Standards |
| HY-136372 | Diquat (dibromide hydrate) | 6385-62-2 | Reference compound |
| HY-136372R | Diquat (dibromide hydrate) (Standard) | 6385-62-2 | Reference Standards |
| HY-136373 | Metazachlor | 67129-08-2 | Reference compound |
| HY-136373R | Metazachlor (Standard) | 67129-08-2 | Reference Standards |
| HY-136374 | Haloxyfop-P-methyl | 72619-32-0 | Reference compound |
| HY-136374R | Haloxyfop-P-methyl (Standard) | 72619-32-0 | Reference Standards |
| HY-136375 | Cyanazine | 21725-46-2 | Reference compound |
| HY-136375R | Cyanazine (Standard) | 21725-46-2 | Reference Standards |
| HY-136375S | Cyanazine-d5 | 1190003-29-2 | Isotope-Labeled Compounds |
| HY-136376 | Mefenpyr-diethyl | 135590-91-9 | Reference compound |
| HY-136376R | Mefenpyr-diethyl (Standard) | 135590-91-9 | Reference Standards |
| HY-136377 | Fluoroglycofen | 77501-60-1 | Reference compound |
| HY-136377R | Fluoroglycofen (Standard) | 77501-60-1 | Reference Standards |
| HY-136379 | CID44216842 | 1222513-26-9 | Reference compound |
| HY-13637A | Ganciclovir (sodium) | 107910-75-8 | Reference compound |
| HY-13637AR | Ganciclovir (sodium) (Standard) | 107910-75-8 | Reference Standards |
| HY-13637B | Ganciclovir (hydrate) | 1359968-33-4 | Reference compound |
| HY-13637R | Ganciclovir (Standard) | 82410-32-0 | Reference Standards |
| HY-13637S | Ganciclovir-d5 | 1189966-73-1 | Isotope-Labeled Compounds |
| HY-13638 | GDC-0152 | 873652-48-3 | Reference compound |
| HY-136380 | Clodinafop-propargyl | 105512-06-9 | Reference compound |
| HY-136380R | Clodinafop-propargyl (Standard) | 105512-06-9 | Reference Standards |
| HY-136380S | Clodinafop-propargyl-13C6 | Isotope-Labeled Compounds | |
| HY-136381 | N-Nitrosoglyphosate (sodium) | 56516-71-3 | Reference compound |
| HY-136382S | Sulfachloropyridazine-d4 | 1795037-54-5 | Isotope-Labeled Compounds |
| HY-136383 | AZA1 | 1071098-42-4 | Reference compound |
| HY-136384 | Diethofencarb | 87130-20-9 | Reference compound |
| HY-136384R | Diethofencarb (Standard) | 87130-20-9 | Reference Standards |
| HY-136386 | N-Acetyl-D-cysteine | 26117-28-2 | Reference compound |
| HY-136386R | N-Acetyl-D-cysteine (Standard) | 26117-28-2 | Reference Standards |
| HY-136390 | ML417 | 1386162-69-1 | Reference compound |
| HY-136392 | IKK-IN-3 | 615528-53-5 | Reference compound |
| HY-136393 | IKK-IN-4 | 615529-94-7 | Reference compound |
| HY-136394 | Diafenthiuron | 80060-09-9 | Reference compound |
| HY-136394R | Diafenthiuron (Standard) | 80060-09-9 | Reference Standards |
| HY-136395 | Cartap | 15263-53-3 | Reference compound |
| HY-136396 | Chlorempenthrin | 54407-47-5 | Reference compound |
| HY-13640 | Rabacfosadine | 859209-74-8 | Reference compound |
| HY-136403 | TIS108 | 1315459-30-3 | Reference compound |
| HY-136404 | Melanin probe-1 | 1420844-62-7 | Reference compound |
| HY-136405 | Melanin probe-2 | 1285446-04-9 | Reference compound |
| HY-136406 | Bongkrekic acid | 11076-19-0 | Reference compound |
| HY-136406S | Bongkrekic acid-13C28 | Isotope-Labeled Compounds | |
| HY-136408 | Malonyl CoA (lithium) | 108347-84-8 | Reference compound |
| HY-136409 | N-Decanoyl-L-homoserine lactone | 177315-87-6 | Reference compound |
| HY-136409R | N-Decanoyl-L-homoserine lactone (Standard) | 177315-87-6 | Reference Standards |
| HY-13640A | Rabacfosadine (succinate) | 1431856-99-3 | Reference compound |
| HY-13641 | Mitobronitol | 488-41-5 | Reference compound |
| HY-136410 | 4-hydroxy Nonenal Mercapturic Acid | 146764-24-1 | Reference compound |
| HY-136417 | Pd(II)TPBP | 119654-64-7 | Biochemical Assay Reagents |
| HY-13642 | RG108 | 48208-26-0 | Reference compound |
| HY-136420 | SJF-0628 | 2413035-41-1 | Reference compound |
| HY-136424 | GPI-1485 | 186268-78-0 | Reference compound |
| HY-136425 | Fosetyl-aluminum | 39148-24-8 | Reference compound |
| HY-136425R | Fosetyl-aluminum (Standard) | 39148-24-8 | Reference Standards |
| HY-136426 | Trifludimoxazin | 1258836-72-4 | Reference compound |
| HY-136427 | KRM-III | 79220-94-3 | Reference compound |
| HY-136428 | Desoxycarbadox | 55456-55-8 | Reference compound |
| HY-136428R | Desoxycarbadox (Standard) | 55456-55-8 | Reference Standards |
| HY-136428S | Desoxycarbadox-d3 | 1448350-02-4 | Isotope-Labeled Compounds |
| HY-136429 | Ethylhydrocupreine | 522-60-1 | Reference compound |
| HY-136429A | Ethylhydrocupreine (hydrochloride) | 3413-58-9 | Reference compound |
| HY-136429AR | Ethylhydrocupreine (hydrochloride) (Standard) | 3413-58-9 | Reference Standards |
| HY-13643 | Daminozide | 1596-84-5 | Natural Products |
| HY-136430 | JCN037 | 2305154-31-6 | Reference compound |
| HY-136431 | BC-DXI-843 | 2421117-98-6 | Reference compound |
| HY-136432 | Mc-Gly-Gly-Phe-Gly-PAB-OH | 2632342-05-1 | ADC Related |
| HY-136432A | Mc-Gly-Gly-Phe-Gly-PAB-OH (TFA) | ADC Related | |
| HY-136433 | N,N'-Dinitrosopiperazine | 140-79-4 | Reference compound |
| HY-136433S | N,N'-Dinitrosopiperazine-d8 | 69340-07-4 | Isotope-Labeled Compounds |
| HY-136434 | m-Chloramphenicol | 7411-65-6 | Reference compound |
| HY-136435 | Mapenterol (hydrochloride) | 54238-51-6 | Reference compound |
| HY-136435S1 | Mapenterol-d6 (hydrochloride) | 1246816-02-3 | Isotope-Labeled Compounds |
| HY-136436 | Ternidazole (hydrochloride) | 70028-95-4 | Reference compound |
| HY-136436R | Ternidazole (hydrochloride) (Standard) | 70028-95-4 | Reference Standards |
| HY-136436S | Ternidazole-d6 (hydrochloride) | 1346599-62-9 | Isotope-Labeled Compounds |
| HY-136437 | CXCR4 antagonist 1 | 675135-69-0 | Reference compound |
| HY-136438 | Toltrazuril sulfoxide | 69004-15-5 | Reference compound |
| HY-136438R | Toltrazuril sulfoxide (Standard) | 69004-15-5 | Reference Standards |
| HY-136439 | 4-Epianhydrotetracycline (hydrochloride) | 4465-65-0 | Reference compound |
| HY-136439R | 4-Epianhydrotetracycline (hydrochloride) (Standard) | 4465-65-0 | Reference Standards |
| HY-13643R | Daminozide (Standard) | 1596-84-5 | Reference Standards |
| HY-13644 | Gusperimus | 98629-43-7 | Reference compound |
| HY-136440 | Hydroxymetronidazole | 4812-40-2 | Reference compound |
| HY-136440R | Hydroxymetronidazole (Standard) | 4812-40-2 | Reference Standards |
| HY-136440S | Hydroxymetronidazole-d4 | 1215071-08-1 | Isotope-Labeled Compounds |
| HY-136440S1 | Hydroxymetronidazole-d2 | 2196180-19-3 | Isotope-Labeled Compounds |
| HY-136441 | Triclosan-methyl | 4640-01-1 | Reference compound |
| HY-136441S | Triclosan-methyl-d3 | 1020720-00-6 | Isotope-Labeled Compounds |
| HY-136443 | 4-Epitetracycline (hydrochloride) | 23313-80-6 | Reference compound |
| HY-136443R | 4-Epitetracycline (hydrochloride) (Standard) | 23313-80-6 | Reference Standards |
| HY-136444 | 2-NP-AOZ | 19687-73-1 | Reference compound |
| HY-136444R | 2-NP-AOZ (Standard) | 19687-73-1 | Reference Standards |
| HY-136444S | 2-NP-AOZ-d4 | 1007478-57-0 | Isotope-Labeled Compounds |
| HY-136445 | Terbuthylazine-desethyl | 30125-63-4 | Reference compound |
| HY-136445R | Terbuthylazine-desethyl (Standard) | 30125-63-4 | Reference Standards |
| HY-136445S | Terbuthylazine-desethyl-d9 | 1219798-52-3 | Isotope-Labeled Compounds |
| HY-136447 | ASP4132 | 1640294-30-9 | Reference compound |
| HY-136448 | SJ000025081 | 421571-66-6 | Reference compound |
| HY-136449 | Bromchlorbuterol (hydrochloride) | 78982-84-0 | Reference compound |
| HY-13644A | Gusperimus trihydrochloride | 85468-01-5 | Reference compound |
| HY-13645 | Henatinib | 1239269-51-2 | Reference compound |
| HY-136450 | Triclabendazole sulfoxide | 100648-13-3 | Reference compound |
| HY-136450R | Triclabendazole sulfoxide (Standard) | 100648-13-3 | Reference Standards |
| HY-136450S | Triclabendazole sulfoxide-d3 | Isotope-Labeled Compounds | |
| HY-136450S1 | Triclabendazole sulfoxide-13C,d3 | Isotope-Labeled Compounds | |
| HY-136451S | Triclabendazole sulfone-d3 | Isotope-Labeled Compounds | |
| HY-136453 | CR-1-31-B | 1352914-52-3 | Reference compound |
| HY-136453A | CR-1-30-B | 1352914-53-4 | Reference compound |
| HY-136456 | 2-NP-AMOZ | 183193-59-1 | Reference compound |
| HY-136456R | 2-NP-AMOZ (Standard) | 183193-59-1 | Reference Standards |
| HY-136456S | 2-NP-AMOZ-d5 | 1173097-59-0 | Isotope-Labeled Compounds |
| HY-136457 | 2-NP-AHD | 623145-57-3 | Reference compound |
| HY-136457R | 2-NP-AHD (Standard) | 623145-57-3 | Reference Standards |
| HY-136457S | 2-NP-AHD-13C3 | 1007476-86-9 | Isotope-Labeled Compounds |
| HY-136458 | 3-ANOT | 3572-44-9 | Reference compound |
| HY-136458R | 3-ANOT (Standard) | 3572-44-9 | Reference Standards |
| HY-136459 | NMDA receptor antagonist 2 | 875898-41-2 | Reference compound |
| HY-13646 | Encequidar | 849675-66-7 | Reference compound |
| HY-136460 | Calcium ionophore I | 58801-34-6 | Reference compound |
| HY-136461 | Polyoxin D | 22976-86-9 | Reference compound |
| HY-136462 | CYM50358 | 1314212-39-9 | Reference compound |
| HY-136464 | β-catenin-IN-2 | 1458664-10-2 | Reference compound |
| HY-136465 | A2ti-1 | 570390-00-0 | Reference compound |
| HY-136466 | A2ti-2 | 482646-13-9 | Reference compound |
| HY-13646A | Encequidar (mesylate) | 849675-87-2 | Reference compound |
| HY-13646B | Encequidar (hydrochloride) | 849675-88-3 | Reference compound |
| HY-13646C | Encequidar (mesylate hydrochloride) | 2097125-58-9 | Reference compound |
| HY-13647 | HMN-176 | 173529-10-7 | Reference compound |
| HY-136471 | Anticonvulsant agent 6 | 87213-50-1 | Reference compound |
| HY-136473 | CTX-0124143 | 423731-64-0 | Reference compound |
| HY-136474 | Amidephrine | 37571-84-9 | Reference compound |
| HY-136476 | Mg(II) protoporphyrin IX | 14947-11-6 | Reference compound |
| HY-136476A | Mn(II) protoporphyrin IX | 21393-64-6 | Reference compound |
| HY-136476B | Cu(II) protoporphyrin IX | 14494-37-2 | Reference compound |
| HY-136476C | Ni(II) protoporphyrin IX | 15415-30-2 | Reference compound |
| HY-136476D | Ga(III) protoporphyrin IX | 222556-71-0 | Reference compound |
| HY-136476E | Cr(III) protoporphyrin IX | 84640-43-7 | Reference compound |
| HY-136476F | Cd(II) protoporphyrin IX | 80216-25-7 | Reference compound |
| HY-136476G | Pt(II) protoporphyrin IX | 98303-94-7 | Reference compound |
| HY-136477 | Pentagamavunon-1 | 27060-70-4 | Reference compound |
| HY-136479 | F0911-7667 | 361198-09-6 | Reference compound |
| HY-13648 | Incyclinide | 15866-90-7 | Reference compound |
| HY-136480 | Chrysamine G | 6472-91-9 | Reference compound |
| HY-136482 | Nemadipine B | 79925-38-5 | Reference compound |
| HY-136484 | FEN1-IN-3 | 2109805-87-8 | Reference compound |
| HY-136485 | FEN1-IN-4 | 1995893-58-7 | Reference compound |
| HY-136486 | Lasiocarpine N-oxide | 127-30-0 | Natural Products |
| HY-136487 | Buspirone N-oxide | 220747-81-9 | Reference compound |
| HY-136489 | KU-0058948 | 763111-49-5 | Reference compound |
| HY-136489A | KU-0058948 (hydrochloride) | 2108829-86-1 | Reference compound |
| HY-13649 | Indibulin | 204205-90-3 | Reference compound |
| HY-136490 | Psychosine | 2238-90-6 | Reference compound |
| HY-136490S | Psychosine-d5 | 2260670-12-8 | Isotope-Labeled Compounds |
| HY-136490S1 | Psychosine-d7 | 2315262-31-6 | Isotope-Labeled Compounds |
| HY-136492S | Acetylclonidine-d4 | Isotope-Labeled Compounds | |
| HY-136494 | Fluprostenol | 40666-16-8 | Reference compound |
| HY-136497 | Coenzyme FO | 37333-48-5 | Reference compound |
| HY-136498 | T-705RMP | 356783-08-9 | Reference compound |
| HY-136498A | T-705RMP (ammonium) | 2096342-42-4 | Reference compound |
| HY-136498AR | T-705RMP (ammonium) (Standard) | 2096342-42-4 | Reference Standards |
| HY-136499 | DI-82 | 1638148-50-1 | Reference compound |
| HY-13650 | Indisulam | 165668-41-7 | Reference compound |
| HY-136500 | Prostaglandin H2 | 42935-17-1 | Natural Products |
| HY-136501 | MRS2395 | 491611-55-3 | Reference compound |
| HY-136502 | (E)-Aztreonam | 99341-02-3 | Reference compound |
| HY-136504 | Bianthrone | 434-85-5 | Reference compound |
| HY-136506 | NUC-7738 | 2348493-39-8 | Reference compound |
| HY-136509 | CIL62 | 117593-36-9 | Reference compound |
| HY-136511 | Epicaptopril | 63250-36-2 | Reference compound |
| HY-136512 | Streptazolin | 80152-07-4 | Natural Products |
| HY-136513 | Bifenox | 42576-02-3 | Reference compound |
| HY-136513S | Bifenox-d3 | Isotope-Labeled Compounds | |
| HY-136514 | Tampramine | 83166-17-0 | Reference compound |
| HY-136517 | Clenhexerol | 38339-23-0 | Reference compound |
| HY-136520B | Xanthoanthrafil | 1020251-53-9 | Reference compound |
| HY-136521 | AZ13824374 | 3040082-19-4 | Reference compound |
| HY-136522 | S2116 | 2262489-89-2 | Reference compound |
| HY-136523 | S2157 | 2262488-39-9 | Reference compound |
| HY-136526 | BCR-ABL-IN-3 | 2240191-12-0 | Reference compound |
| HY-136527 | BMS-986251 | 2460133-35-9 | Reference compound |
| HY-136528 | RA-9 | 919091-63-7 | Reference compound |
| HY-13653 | (-)-Epigallocatechin Gallate | 989-51-5 | Natural Products |
| HY-136530 | SR18662 | 2505001-62-5 | Reference compound |
| HY-136531 | XMU-MP-3 | 2031152-08-4 | Reference compound |
| HY-136532 | ZT-1a | 212135-62-1 | Reference compound |
| HY-136534 | RET V804M-IN-1 | 2414909-94-5 | Reference compound |
| HY-136535 | Anizatrectinib | 1824664-89-2 | Reference compound |
| HY-136537A | N-β-alanyldopamine (hydrochloride) | 58077-93-3 | Reference compound |
| HY-136538 | LQZ-7I | 195822-23-2 | Reference compound |
| HY-13653R | (-)-Epigallocatechin Gallate (Standard) | 989-51-5 | Reference Standards |
| HY-13653S | (+/-)-Epigallocatechin Gallate-13C3 | Isotope-Labeled Compounds | |
| HY-13653S1 | (-)-Epigallocatechin Gallate-d4 | Isotope-Labeled Compounds | |
| HY-136540 | Resolvin D3 | 916888-47-6 | Reference compound |
| HY-136540S | Resolvin D3-d5 | Isotope-Labeled Compounds | |
| HY-136541 | YB-0158 | 1144043-83-3 | Reference compound |
| HY-136542 | H-β-Ala-AMC (TFA) | 201847-54-3 | Reference compound |
| HY-136546 | Stafia-1 | 2582757-90-0 | Reference compound |
| HY-136547 | Boc-Val-Ala-PAB | 1884577-99-4 | Reference compound |
| HY-136548 | Tenofovir diphosphate | 166403-66-3 | Reference compound |
| HY-136548A | Tenofovir diphosphate (triethylamine) | 2122333-63-3 | Reference compound |
| HY-136548B | Tenofovir diphosphate (disodium) | 2738719-07-6 | Reference compound |
| HY-136552 | β-Bisabolene | 495-61-4 | Natural Products |
| HY-136554 | WYC-210 | 2131803-93-3 | Reference compound |
| HY-136555 | GSK717 | 1595278-21-9 | Reference compound |
| HY-136556 | Factor B-IN-1 | 1481631-75-7 | Reference compound |
| HY-136557 | AFM32a | 2095109-82-1 | Reference compound |
| HY-136557A | AFM32a (hydrochloride) | 2988594-85-8 | Reference compound |
| HY-136559 | 6-Azathymine | 932-53-6 | Reference compound |
| HY-13655A | Isatoribine | 122970-40-5 | Reference compound |
| HY-13656 | Isofludelone | 691868-19-6 | Reference compound |
| HY-136560 | 6-Azathymine acid | 13924-15-7 | Reference compound |
| HY-136561 | GRK5-IN-2 | 1642839-27-7 | Reference compound |
| HY-136562 | N-Arachidonyl maleimide | 876305-42-9 | Reference compound |
| HY-136563 | RA375 | 2649154-57-2 | Peptides |
| HY-136564 | DAD (dichloride) | Reference compound | |
| HY-136564A | DAD | Reference compound | |
| HY-136567 | TBAP-001 | 1777832-90-2 | Reference compound |
| HY-136568 | Stafia-1-dipivaloyloxymethyl ester | 2582755-72-2 | Reference compound |
| HY-136569 | DSR-141562 | 2007975-22-4 | Reference compound |
| HY-136570 | GSK778 | 2451862-42-1 | Reference compound |
| HY-136570A | GSK778 (hydrochloride) | 2863657-79-6 | Reference compound |
| HY-136571 | GSK046 | 2474876-09-8 | Reference compound |
| HY-136572 | CEM114 | 2279062-54-1 | Reference compound |
| HY-136573 | 5-Hydroxytoluene-2,4-disulphonic acid (diammonium) | Reference compound | |
| HY-136574 | 2-Hydroxy-4-methylbenzenesulphonic acid (ammonium) | 79093-71-3 | Reference compound |
| HY-136575 | 4-Hydroxy-2-methylbenzenesulfonic acid (ammonium) | 2742982-16-5 | Reference compound |
| HY-136576 | RP101075 | 1306760-73-5 | Reference compound |
| HY-136577 | RP101442 | 1306761-08-9 | Reference compound |
| HY-136578 | RP101988 | 2990018-57-8 | Reference compound |
| HY-136579 | ASN007 | 2055597-12-9 | Reference compound |
| HY-136579A | ASN007 (benzenesulfonate) | 2055597-39-0 | Reference compound |
| HY-136582 | Masofaniten | 2416716-62-4 | Reference compound |
| HY-136583 | 28-Epirapamycin | 253431-35-5 | Reference compound |
| HY-136584 | 2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid | 413624-71-2 | Reference compound |
| HY-136586 | Loperamide phenyl | 1391052-94-0 | Reference compound |
| HY-136587 | Oxomemazine | 3689-50-7 | Reference compound |
| HY-136587R | Oxomemazine (Standard) | 3689-50-7 | Reference Standards |
| HY-136589 | Verapamil EP Impurity C (hydrochloride) | 51012-67-0 | Reference compound |
| HY-13659 | KRN5500 | 151276-95-8 | Reference compound |
| HY-136590 | 2-Nitrosopyridine | 79917-37-6 | Reference compound |
| HY-136591 | Demoxepam | 963-39-3 | Reference compound |
| HY-136591R | Demoxepam (Standard) | 963-39-3 | Reference Standards |
| HY-136592 | 1-Hydroxy-ibuprofen | 53949-53-4 | Reference compound |
| HY-136593 | (S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid | 23508-35-2 | Reference compound |
| HY-136595 | 3,5-Difluoro-L-tyrosine | 73246-30-7 | Reference compound |
| HY-136596 | Apalutamide-COOH | 1332391-04-4 | Reference compound |
| HY-136596R | Apalutamide-COOH (Standard) | 1332391-04-4 | Reference Standards |
| HY-136597 | Remdesivir O-desphosphate acetonide impurity | 1191237-80-5 | Reference compound |
| HY-13660 | Mocravimod (hydrochloride) | 509088-69-1 | Reference compound |
| HY-136604 | RAD51-IN-3 | 2301084-99-9 | Reference compound |
| HY-136605 | DGY-06-116 | 2556836-50-9 | Reference compound |
| HY-136606 | SARS-CoV MPro-IN-1 | 2413716-71-7 | Reference compound |
| HY-136607 | DiAzK | 2231405-65-3 | Reference compound |
| HY-136608 | 5-AAM-2-CP | 175424-74-5 | Reference compound |
| HY-136609 | 5-AMAM-2-CP | 864628-19-3 | Reference compound |
| HY-13661 | 7-Hydroxystaurosporine | 112953-11-4 | Reference compound |
| HY-136610 | Chlorpyrifos-oxon | 5598-15-2 | Reference compound |
| HY-136610S | Chlorpyrifos-oxon-d10 | 1794779-85-3 | Isotope-Labeled Compounds |
| HY-136611 | ω-Hydroxy-DEET | 72236-22-7 | Reference compound |
| HY-136611R | ω-Hydroxy-DEET (Standard) | 72236-22-7 | Reference Standards |
| HY-136612 | DCBA | 72236-23-8 | Reference compound |
| HY-136612R | DCBA (Standard) | 72236-23-8 | Reference Standards |
| HY-136613 | Demethyl linezolid | 168828-65-7 | Reference compound |
| HY-136614 | H-Val-βNA | 729-24-8 | Reference compound |
| HY-136615 | 5-Hydroxydecanoate (sodium) | 71186-53-3 | Reference compound |
| HY-13662 | Lansoprazole | 103577-45-3 | Reference compound |
| HY-136621 | 5-HT1A modulator 2 (hydrochloride) | 3880-76-0 | Reference compound |
| HY-136622 | A-420983 | 330789-03-2 | Reference compound |
| HY-136623 | BW443C | 88331-14-0 | Reference compound |
| HY-136625 | LY134046 | 71274-97-0 | Reference compound |
| HY-136626 | Z-Ala-Ala-Asn-AMC | 149697-16-5 | Peptides |
| HY-136627 | PGF2α analogue-1 | 291303-34-9 | Reference compound |
| HY-136628 | RU 25434 | 62622-76-8 | Reference compound |
| HY-13662A | Lansoprazole (sodium) | 226904-00-3 | Reference compound |
| HY-13662B | (R)-Lansoprazole | 138530-94-6 | Reference compound |
| HY-13662BR | (R)-Lansoprazole (Standard) | 138530-94-6 | Reference Standards |
| HY-13662BS | (R)-Lansoprazole-d4 | Isotope-Labeled Compounds | |
| HY-13662C | (S)-Lansoprazole | 138530-95-7 | Reference compound |
| HY-13662R | Lansoprazole (Standard) | 103577-45-3 | Reference Standards |
| HY-13662S | Lansoprazole-d4 | 934294-22-1 | Isotope-Labeled Compounds |
| HY-136630 | Felotaxel | 944154-59-0 | Reference compound |
| HY-136631 | PF-04279405 | 955881-01-3 | Reference compound |
| HY-136633 | Pyroxasulfone | 447399-55-5 | Reference compound |
| HY-136633R | Pyroxasulfone (Standard) | 447399-55-5 | Reference Standards |
| HY-136634 | BTM-1042 | 72293-40-4 | Reference compound |
| HY-136637 | NPD-001 | 469863-16-9 | Reference compound |
| HY-136638 | ML328 | 634175-34-1 | Reference compound |
| HY-13664 | Folinic acid (calcium) | 1492-18-8 | Natural Products |
| HY-136640 | BCL6-IN-4 | 2253879-65-9 | Reference compound |
| HY-136641 | NOTA-FAPI | 2374782-03-1 | Reference compound |
| HY-136642 | Fluocinolone | 807-38-5 | Reference compound |
| HY-136644 | PD-217014-methyl ester | 444088-20-4 | Reference compound |
| HY-136644A | PD-217014 | 335458-65-6 | Reference compound |
| HY-136645 | EP4 receptor antagonist 2 | 1965316-82-8 | Reference compound |
| HY-136647 | 8-Bromoadenosine 5'-triphosphate (tetrasodium) | 35892-96-7 | Reference compound |
| HY-136648 | 2'-Deoxyadenosine-5'-triphosphate | 1927-31-7 | Oligonucleotides |
| HY-136648A | 2'-Deoxyadenosine-5'-triphosphate (trisodium) | 54680-12-5 | Biochemical Assay Reagents |
| HY-136648AR | 2'-Deoxyadenosine-5'-triphosphate (trisodium) (Standard) | 54680-12-5 | Reference Standards |
| HY-136648S | 2'-Deoxyadenosine-5'-triphosphate-13C10,15N5 (tetraammonia) | Isotope-Labeled Compounds | |
| HY-136648S1 | 2'-Deoxyadenosine-5'-triphosphate-13C10,15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-136648S2 | 2'-Deoxyadenosine-5'-triphosphate-15N5,d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-136648S3 | 2'-Deoxyadenosine-5'-triphosphate-d14 (dilithium) | 2687960-68-3 | Isotope-Labeled Compounds |
| HY-136648S4 | 2'-Deoxyadenosine-5'-triphosphate-15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-136648S5 | 2'-Deoxyadenosine-5'-triphosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-136649 | 2'-Deoxy-2'-fluoroadenosine 5'-triphosphate (tetralithium) | Oligonucleotides | |
| HY-13664R | Folinic acid (calcium) (Standard) | 1492-18-8 | Reference Standards |
| HY-136650 | Fludarabine triphosphate | 74832-57-8 | Reference compound |
| HY-136650A | Fludarabine triphosphate (trisodium) | Reference compound | |
| HY-136651 | BNTA | 685119-25-9 | Reference compound |
| HY-136653 | Ciramadol | 63269-31-8 | Reference compound |
| HY-136654 | LPK-26 (hydrochloride) | 492451-07-7 | Reference compound |
| HY-136656 | Maltotriitol | 32860-62-1 | Biochemical Assay Reagents |
| HY-136657 | SC-43 | 1400989-25-4 | Reference compound |
| HY-136658 | 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea | 1313019-65-6 | Reference compound |
| HY-136659 | Ro 04-5595 | 194089-07-1 | Reference compound |
| HY-13666 | Levamisole (hydrochloride) | 16595-80-5 | Reference compound |
| HY-136660 | PQR626 | 1927857-98-4 | Reference compound |
| HY-136661 | (-)-N6-Phenylisopropyl adenosine | 38594-96-6 | Reference compound |
| HY-136664A | Neothorin (disodium) | 3547-38-4 | Biochemical Assay Reagents |
| HY-136665 | Boc-D-Phe-Pro-OH | 38675-10-4 | Reference compound |
| HY-136666 | Antibiotic AC4437 | 63487-84-3 | Reference compound |
| HY-13666R | Levamisole (hydrochloride) (Standard) | 16595-80-5 | Reference Standards |
| HY-13666S | Levamisole-d5 (hydrochloride) | 1246819-64-6 | Isotope-Labeled Compounds |
| HY-13667 | Levoleucovorin (Calcium) | 80433-71-2 | Natural Products |
| HY-136672 | (E)-HBT-O | 2056899-56-8 | Dye Reagents |
| HY-136674 | Aftin-5 | 1461717-05-4 | Reference compound |
| HY-136675 | ASMI | 1850419-05-4 | Reference compound |
| HY-136676 | Cgp 38560 (methanesulfonate) | 122088-76-0 | Reference compound |
| HY-136677 | Lnd 796 | 118549-42-1 | Reference compound |
| HY-136678A | SB 258741 (hydrochloride) | Reference compound | |
| HY-136679 | TD114-2 | 436866-52-3 | Reference compound |
| HY-13667R | Levoleucovorin (Calcium) (Standard) | 80433-71-2 | Reference Standards |
| HY-13668 | Lomeguatrib | 192441-08-0 | Reference compound |
| HY-136684 | BrBzGCp2 | 166038-00-2 | Reference compound |
| HY-136686 | IDH-C227 | 1355324-14-9 | Reference compound |
| HY-136688 | MI-389 | 2222635-92-7 | Reference compound |
| HY-136689 | Taxin B | 168109-52-2 | Natural Products |
| HY-13669 | Lomustine | 13010-47-4 | Reference compound |
| HY-136690 | Triasulfuron | 82097-50-5 | Reference compound |
| HY-136690R | Triasulfuron (Standard) | 82097-50-5 | Reference Standards |
| HY-136691 | Episesartemin A | 77449-31-1 | Natural Products |
| HY-136693 | L-654284 | 98719-20-1 | Reference compound |
| HY-136694 | Senkyunolide E | 94530-83-3 | Natural Products |
| HY-136696 | 11-Deoxy-16,16-dimethyl-PGE2 | 53658-98-3 | Reference compound |
| HY-136699 | Excisanin A | 78536-37-5 | Natural Products |
| HY-13669R | Lomustine (Standard) | 13010-47-4 | Reference Standards |
| HY-13670 | Lurtotecan | 149882-10-0 | Reference compound |
| HY-136702 | L-97-1 | 770703-20-3 | Reference compound |
| HY-136703 | Lopinavir Metabolite M-1 | 192725-39-6 | Reference compound |
| HY-136704 | GLS1 Inhibitor-1 | 1832646-52-2 | Reference compound |
| HY-136705 | MeO-Suc-Ala-Ala-Pro-Ala-CMK | 111682-13-4 | Reference compound |
| HY-136706 | Luciferase-IN-1 | 10205-56-8 | Reference compound |
| HY-136707 | DGAT-1 inhibitor 3 | 1231243-91-6 | Reference compound |
| HY-13670A | Lurtotecan (dihydrochloride) | 155773-58-3 | Reference compound |
| HY-13671 | LW6 | 934593-90-5 | Reference compound |
| HY-136711 | CDK7-IN-2 (hydrochloride hydrate) | 2326428-24-2 | Reference compound |
| HY-136714 | Bcl-2-IN-3 | 383860-03-5 | Reference compound |
| HY-136717 | FBPase-1 inhibitor-1 | 883973-99-7 | Reference compound |
| HY-136718 | CLEFMA | 1246964-32-8 | Reference compound |
| HY-13672 | LY2334737 | 892128-60-8 | Reference compound |
| HY-136720 | ZXX2-77 | 304913-22-2 | Reference compound |
| HY-136726 | CGP-82996 | 359886-84-3 | Reference compound |
| HY-136727 | Ac-LEVD-CHO | 402832-01-3 | Peptides |
| HY-136728 | Ac-YVAD-AOM | 154674-81-4 | Peptides |
| HY-13673 | Goserelin | 65807-02-5 | Peptides |
| HY-136731 | APE1-IN-1 | 524708-03-0 | Reference compound |
| HY-136733 | Ac-DNLD-CHO | 775289-20-8 | Peptides |
| HY-136735 | IRE1α kinase-IN-1 | 2328097-41-0 | Reference compound |
| HY-136736 | β-Secretase Inhibitor II | 263563-09-3 | Reference compound |
| HY-13673A | Goserelin (acetate) | 145781-92-6 | Peptides |
| HY-13673S | Goserelin-d10 | Isotope-Labeled Compounds | |
| HY-13673S1 | Goserelin-d7 | Isotope-Labeled Compounds | |
| HY-13673S2 | Goserelin-d7 (TFA) | Isotope-Labeled Compounds | |
| HY-13674 | Maytansine | 35846-53-8 | Natural Products |
| HY-136741 | BOT-64 | 113760-29-5 | Reference compound |
| HY-136742 | BACE2-IN-1 | 1676107-08-6 | Reference compound |
| HY-136744 | Caspase-9 Inhibitor III | 403848-57-7 | Reference compound |
| HY-136747 | Nek2/Hec1-IN-1 | 560103-80-2 | Reference compound |
| HY-136748 | HIF-2α-IN-4 | 882268-69-1 | Reference compound |
| HY-13675 | ME-143 | 852536-39-1 | Reference compound |
| HY-136750 | Z-LLY-FMK | 133410-84-1 | Reference compound |
| HY-136752 | CYP51-IN-2 | 1155361-00-4 | Reference compound |
| HY-136754 | CYP51-IN-4 | 1155361-02-6 | Reference compound |
| HY-136756 | CYP51-IN-6 | 1155361-04-8 | Reference compound |
| HY-136757 | CYP51-IN-7 | 1155361-05-9 | Reference compound |
| HY-136758 | CYP51-IN-8 | 1155361-06-0 | Reference compound |
| HY-136759 | CYP51-IN-9 | 1155361-07-1 | Reference compound |
| HY-13676 | Megestrol acetate | 595-33-5 | Reference compound |
| HY-136762 | CYP51-IN-12 | 1155361-10-6 | Reference compound |
| HY-136763 | CYP51-IN-13 | 1155361-11-7 | Reference compound |
| HY-136764 | CYP51-IN-14 | 1155361-12-8 | Reference compound |
| HY-136765 | PI3K-IN-11 | 884539-95-1 | Reference compound |
| HY-136767 | Cladosporin | 35818-31-6 | Natural Products |
| HY-136769 | Biotin-HPDP | 129179-83-5 | Biochemical Assay Reagents |
| HY-13676R | Megestrol acetate (Standard) | 595-33-5 | Reference Standards |
| HY-13676S | Megestrol acetate-d3 | 162462-72-8 | Isotope-Labeled Compounds |
| HY-13676S1 | Megestrol acetate-d3-1 | Isotope-Labeled Compounds | |
| HY-13677 | 6-Mercaptopurine | 50-44-2 | Reference compound |
| HY-136772 | Pomalidomide-PEG1-NH2 (hydrochloride) | 2380273-67-4 | Reference compound |
| HY-136773 | KER047 | 2248154-85-8 | Reference compound |
| HY-136773A | KER047 (succinate) | 2416307-25-8 | Reference compound |
| HY-136774 | BCL6-IN-5 | 2253878-09-8 | Reference compound |
| HY-13677A | 6-Mercaptopurine hydrate | 6112-76-1 | Reference compound |
| HY-13677AR | 6-Mercaptopurine hydrate (Standard) | 6112-76-1 | Reference Standards |
| HY-13677R | 6-Mercaptopurine (Standard) | 50-44-2 | Reference Standards |
| HY-13677S | 6-Mercaptopurine-d2 | 82677-93-8 | Isotope-Labeled Compounds |
| HY-13677S1 | 6-Mercaptopurine-13C2,15N | 1190008-04-8 | Isotope-Labeled Compounds |
| HY-13678 | Meropenem | 96036-03-2 | Natural Products |
| HY-136780 | SEN177 | 2117405-13-5 | Reference compound |
| HY-136782 | ST-148 (maleate) | 390803-40-4 | Reference compound |
| HY-136784 | Rhod-2 (potassium) | 663625-18-1 | Dye Reagents |
| HY-136788 | ALK4290 | 1251528-23-0 | Reference compound |
| HY-136788A | ALK4290 (dihydrochloride) | 1372127-19-9 | Reference compound |
| HY-136789 | Tuxobertinib | 2414572-47-5 | Reference compound |
| HY-13678A | Meropenem (trihydrate) | 119478-56-7 | Reference compound |
| HY-13678AR | Meropenem (trihydrate) (Standard) | 119478-56-7 | Reference Standards |
| HY-13678S | Meropenem-d6 | 1217976-95-8 | Isotope-Labeled Compounds |
| HY-13678S1 | Meropenem-d6-1 | 1133424-00-6 | Isotope-Labeled Compounds |
| HY-13679 | Sodium 2-mercaptoethanesulfonate | 19767-45-4 | Reference compound |
| HY-136791 | BN52115 | 120908-94-3 | Reference compound |
| HY-136794 | SB-284851-BT | 219769-23-0 | Reference compound |
| HY-136797 | BP13944 | 1622060-51-8 | Reference compound |
| HY-136799 | Rediocide C | 677277-98-4 | Natural Products |
| HY-13679R | Sodium 2-mercaptoethanesulfonate (Standard) | 19767-45-4 | Reference Standards |
| HY-13680 | Meisoindigo | 97207-47-1 | Natural Products |
| HY-136800 | Posatirelin | 78664-73-0 | Reference compound |
| HY-136802 | LolCDE-IN-3 | 1639933-79-1 | Reference compound |
| HY-136804 | CypD-IN-29 | 1115335-95-9 | Reference compound |
| HY-136805 | Kv1.5-IN-1 | 1469902-72-4 | Reference compound |
| HY-136806 | PI3K-IN-12 | 1807551-44-5 | Reference compound |
| HY-136807 | Tpl2-IN-I | 915009-13-1 | Reference compound |
| HY-136808 | Pfn1-IN-1 | 919010-46-1 | Reference compound |
| HY-136809 | PRMT6-IN-2 | 912970-79-7 | Reference compound |
| HY-13681 | Methylprednisolone acetate | 53-36-1 | Reference compound |
| HY-136813 | Multitarget AD inhibitor-1 | 2205015-77-4 | Reference compound |
| HY-136817 | Nanaomycin αA | 58286-56-9 | Natural Products |
| HY-136818 | DA 4643 (dihydrochloride) | 95833-19-5 | Reference compound |
| HY-136819 | Primordazine NC-6364997 | 312532-31-3 | Reference compound |
| HY-13681R | Methylprednisolone acetate (Standard) | 53-36-1 | Reference Standards |
| HY-13681S | Methylprednisolone acetate-d6 | Isotope-Labeled Compounds | |
| HY-13682 | Mifamurtide | 83461-56-7 | Reference compound |
| HY-136820S1 | Taurultam-d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-136821 | Polymyxin D2 | 34167-45-8 | Reference compound |
| HY-136822 | Antibiotic A40104A | 69659-06-9 | Natural Products |
| HY-136824 | Napyradiomycin A1 | 103106-24-7 | Natural Products |
| HY-136828 | LL-BM123α | 52932-62-4 | Reference compound |
| HY-136829 | BPH-675 | 946417-21-6 | Reference compound |
| HY-13682A | Mifamurtide (sodium hydrate) | 838853-48-8 | Reference compound |
| HY-13682B | Mifamurtide (sodium) | 90825-43-7 | Reference compound |
| HY-13682C | Mifamurtide (TFA) | Reference compound | |
| HY-13683 | Mifepristone | 84371-65-3 | Reference compound |
| HY-136830 | ADP-Glucose (disodium) | 102129-65-7 | Biochemical Assay Reagents |
| HY-136831 | SR2640 | 105350-26-3 | Reference compound |
| HY-136832 | Noribogaine (hydrochloride) | 110514-35-7 | Reference compound |
| HY-136833 | X5050 | 2404756-81-4 | Reference compound |
| HY-136835 | GJ071 (oxalate) | 1216676-34-4 | Reference compound |
| HY-136838 | (R)-Donepezil | 142698-19-9 | Reference compound |
| HY-13683R | Mifepristone (Standard) | 84371-65-3 | Reference Standards |
| HY-13683S | Mifepristone-d3 | Isotope-Labeled Compounds | |
| HY-13683S1 | Mifepristone-13C,d3 | Isotope-Labeled Compounds | |
| HY-13683S2 | Mifepristone-d6 | 1228097-18-4 | Isotope-Labeled Compounds |
| HY-136840 | (±)-Apomorphine | 61503-74-0 | Reference compound |
| HY-136841 | SLM6 | 22242-91-7 | Reference compound |
| HY-136842 | Oxetorone (fumarate) | 34522-46-8 | Reference compound |
| HY-136848 | SM1-71 | 2088179-99-9 | Reference compound |
| HY-136849 | TL13-68 | Reference compound | |
| HY-13685 | Miltefosine | 58066-85-6 | Reference compound |
| HY-136855 | MitoPBN | 652968-37-1 | Reference compound |
| HY-136857 | BRD4 degrader-3 | 2413382-30-4 | Reference compound |
| HY-136859 | BATCP | 787549-23-9 | Reference compound |
| HY-13685S1 | Miltefosine-d4 | Isotope-Labeled Compounds | |
| HY-13686 | PQ401 | 196868-63-0 | Reference compound |
| HY-136860 | (R)-Venlafaxine | 93413-46-8 | Reference compound |
| HY-136861 | Antibacterial agent 192 | 387832-36-2 | Reference compound |
| HY-136865 | MeOSuc-AAPV-AMC | 72252-90-5 | Dye Reagents |
| HY-136866 | Aβ42-IN-2 | 1914989-80-2 | Reference compound |
| HY-136868 | Resorufin-β-D-glucopyranoside, 98% | 101490-85-1 | Biochemical Assay Reagents |
| HY-136869 | MHAPC-Chol | 1027801-74-6 | Biochemical Assay Reagents |
| HY-13687 | IKK 16 | 873225-46-8 | Reference compound |
| HY-136870 | Kyoto probe 1 | 2088021-81-0 | Dye Reagents |
| HY-136871 | Decarestrictin A1 | 127393-90-2 | Reference compound |
| HY-136872 | PBFI-AM | 124549-23-1 | Dye Reagents |
| HY-136873 | UCB-J | 2242957-52-2 | Reference compound |
| HY-13687A | IKK 16 (hydrochloride) | 1186195-62-9 | Reference compound |
| HY-13688 | PJ34 (hydrochloride) | 344458-15-7 | Reference compound |
| HY-136880 | Flufylline | 82190-91-8 | Reference compound |
| HY-136882 | TM-1 | 921099-13-0 | Reference compound |
| HY-136883S | Benzophenone-9-d6 | Isotope-Labeled Compounds | |
| HY-136884 | DAR-4M | 339527-79-6 | Reference compound |
| HY-136885 | (S,S)-TAPI-0 | 143457-40-3 | Reference compound |
| HY-136886 | IR-820 | 172616-80-7 | Dye Reagents |
| HY-136887 | Arphamenine B (hemisulfate) | 144110-38-3 | Reference compound |
| HY-136888 | MeOSuc-AAPV-CMK | 65144-34-5 | Peptides |
| HY-13688A | PJ34 | 344458-19-1 | Reference compound |
| HY-13689 | Go 6983 | 133053-19-7 | Reference compound |
| HY-136891 | AHR-16303B | 117023-62-8 | Reference compound |
| HY-136894 | Rhod-5N | 888229-31-0 | Dye Reagents |
| HY-136895 | AZ12672857 | 945396-55-4 | Reference compound |
| HY-136896 | FFA3 agonist 1 | 886358-51-6 | Reference compound |
| HY-136898 | PS-915 (dihydrochloride) | 86356-77-6 | Reference compound |
| HY-13690 | Mitotane | 53-19-0 | Reference compound |
| HY-136901 | Fusarochromanone | 802915-53-3 | Natural Products |
| HY-136905 | AMPA receptor antagonist-2 | 732277-05-3 | Reference compound |
| HY-136907S | (S)-(-)-Verapamil-d3 (hydrochloride) | 1398112-33-8 | Isotope-Labeled Compounds |
| HY-136908 | W140 (TFA) | 909725-64-0 | Biochemical Assay Reagents |
| HY-136909 | SR33805 | 121345-64-0 | Reference compound |
| HY-13690R | Mitotane (Standard) | 53-19-0 | Reference Standards |
| HY-13690S1 | Mitotane-13C6 | 1261396-21-7 | Isotope-Labeled Compounds |
| HY-13690S2 | Mitotane-d8 | 2673270-14-7 | Isotope-Labeled Compounds |
| HY-13690S3 | Mitotane-13C12 | 2483736-36-1 | Isotope-Labeled Compounds |
| HY-13691 | MKC-1 | 125313-92-0 | Reference compound |
| HY-136910 | USP7-797 | 2413944-70-2 | Reference compound |
| HY-136913 | (Rac)-Rhododendrol | 69617-84-1 | Reference compound |
| HY-136915 | Pyrisoxazole | 847749-37-5 | Reference compound |
| HY-136916 | Hydroxythiovardenafil | 912576-30-8 | Reference compound |
| HY-136920 | CBP/p300-IN-8 | 2304416-91-7 | Reference compound |
| HY-136922 | Orexin receptor antagonist 2 | 1457940-75-8 | Reference compound |
| HY-136924 | FP-Biotin | 259270-28-5 | Reference compound |
| HY-136926 | Candicidin A3 | 58591-23-4 | Reference compound |
| HY-136927 | MSA-2 | 129425-81-6 | Reference compound |
| HY-13693 | Mometasone furoate | 83919-23-7 | Reference compound |
| HY-136930 | 6-Iododiosmin | 1431536-92-3 | Reference compound |
| HY-136931 | Picropodophyllol | 3811-15-2 | Natural Products |
| HY-136933 | Gitoxin | 4562-36-1 | Natural Products |
| HY-136933R | Gitoxin (Standard) | 4562-36-1 | Reference Standards |
| HY-136934 | Reversin 205 | 174630-05-8 | Peptides |
| HY-136935 | Alloyohimbine | 522-94-1 | Natural Products |
| HY-136936 | PYBG-BODIPY | 2068027-79-0 | Dye Reagents |
| HY-136937 | PYBG-TMR | 2067339-51-7 | Dye Reagents |
| HY-136938 | NEO2734 | 2081072-29-7 | Reference compound |
| HY-136939 | CFTR corrector 6 | 2226970-01-8 | Reference compound |
| HY-13693R | Mometasone furoate (Standard) | 83919-23-7 | Reference Standards |
| HY-13693S | Mometasone furoate-d3 | Isotope-Labeled Compounds | |
| HY-13693S2 | Mometasone furoate-13C,d6 | Isotope-Labeled Compounds | |
| HY-13694 | Methionine | 348-67-4 | Reference compound |
| HY-136941 | Antioxidant 1024 | 32687-78-8 | Reference compound |
| HY-136941R | Antioxidant 1024 (Standard) | 32687-78-8 | Reference Standards |
| HY-136942 | DS1 | 372497-52-4 | Reference compound |
| HY-136943 | K-41 | 53026-37-2 | Natural Products |
| HY-136945 | StA-IFN-1 | 300839-31-0 | Reference compound |
| HY-136946 | HITCI | 19764-96-6 | Dye Reagents |
| HY-136947 | RJR-2429 | 91556-75-1 | Reference compound |
| HY-13694R | Methionine (Standard) | 348-67-4 | Reference Standards |
| HY-13694S | Methionine-d3 | 284665-18-5 | Isotope-Labeled Compounds |
| HY-13694S1 | Methionine-d4 | Isotope-Labeled Compounds | |
| HY-136951 | cp028 | 347397-83-5 | Reference compound |
| HY-136952 | p-SCN-Bn-HOPO | 1822331-55-4 | Reference compound |
| HY-136953 | LL-BM123γ1 | 60830-76-4 | Reference compound |
| HY-136954 | LL-BM123γ2 | 60830-75-3 | Reference compound |
| HY-136957 | Fluorescein-6-isothiocyanate | 18861-78-4 | Dye Reagents |
| HY-136959 | M133 | 2127411-61-2 | Reference compound |
| HY-13696 | MSX-122 | 897657-95-3 | Reference compound |
| HY-136960 | β2AR antagonist 1 | 2135743-21-2 | Reference compound |
| HY-136961 | NK 1971 | 35020-81-6 | Reference compound |
| HY-136962 | ASB-14 | 216667-08-2 | Biochemical Assay Reagents |
| HY-136964 | Sulfo-NHS-Biotin (sodium) | 194041-65-1 | Reference compound |
| HY-136968 | epi-Doramectin | 1987882-62-1 | Reference compound |
| HY-136969 | RU 752 | 51390-69-3 | Reference compound |
| HY-136972 | (-)-GB-1a | 220611-41-6 | Natural Products |
| HY-136973 | Biliverdin (dihydrochloride) | 55482-27-4 | Biochemical Assay Reagents |
| HY-136975 | Caspase-3-IN-1 | 872254-32-5 | Reference compound |
| HY-136976 | WST-1 | 150849-52-8 | Dye Reagents |
| HY-136977 | EEDi-5285 | 2488952-40-3 | Reference compound |
| HY-136978 | OP-5244 | 2381268-71-7 | Reference compound |
| HY-136978A | OP-5244 (sodium) | Reference compound | |
| HY-136979 | RBN012759 | 2360851-29-0 | Reference compound |
| HY-136980 | Aspartylglutamate | 6157-06-8 | Peptides |
| HY-136986 | Desthiazolylmethyl ritonavir | 256328-82-2 | Reference compound |
| HY-13699 | NBI-42902 | 352290-60-9 | Reference compound |
| HY-136990 | GLPG0259 | 959754-85-9 | Reference compound |
| HY-136991 | Basacv | 95676-71-4 | Reference compound |
| HY-136994 | Sphingolactone-24 | 881177-99-7 | Reference compound |
| HY-136995 | AFD-21 (maleate) | 99465-44-8 | Reference compound |
| HY-136997 | M-5MPEP | 872428-47-2 | Reference compound |
| HY-136998 | 10-Nitro-9-octadecenoic acid | 88127-53-1 | Biochemical Assay Reagents |
| HY-136999 | 7-O-Methyleucomol | 17934-15-5 | Natural Products |
| HY-13700 | Nedaplatin | 95734-82-0 | Reference compound |
| HY-137000 | 4-Prenyloxyresveratrol | 69065-16-3 | Natural Products |
| HY-137002 | Fmoc-N-Me-Arg(Pbf)-OH | 913733-27-4 | Peptides |
| HY-137004 | Indazole-Cl | 848142-62-1 | Reference compound |
| HY-137005 | CS1 | 1448009-94-6 | Reference compound |
| HY-137006 | MTT Formazan | 57360-69-7 | Reference compound |
| HY-137007 | SMA-12b | 1496553-39-9 | Reference compound |
| HY-13701 | Nelarabine | 121032-29-9 | Reference compound |
| HY-137011 | 3,9-Dihydroeucomin | 887375-68-0 | Natural Products |
| HY-137012 | 8-iso Prostaglandin F1α | 26771-96-0 | Reference compound |
| HY-137012S | 8-iso Prostaglandin F1α-d9 | Isotope-Labeled Compounds | |
| HY-137015 | trans-Khellactone | 23458-04-0 | Natural Products |
| HY-137016 | 8-Pcpt-cGMP | 54364-02-2 | Reference compound |
| HY-137016A | 8-Pcpt-cGMP (sodium) | 51239-26-0 | Reference compound |
| HY-137018 | 27-Alkyne cholesterol | 1527467-07-7 | Reference compound |
| HY-13701R | Nelarabine (Standard) | 121032-29-9 | Reference Standards |
| HY-13702 | Nilutamide | 63612-50-0 | Reference compound |
| HY-137020 | 7-Hydroxydichloromethotrexate | 751-75-7 | Reference compound |
| HY-137023 | Sulfo-Cy7 amine | 2236573-39-8 | Reference compound |
| HY-137024 | 15-Keto-PGA1 | 61600-67-7 | Reference compound |
| HY-137025 | (S)-NIFE | 328406-65-1 | Reference compound |
| HY-137028 | 2′-Thioadenosine | 136904-69-3 | Reference compound |
| HY-13702R | Nilutamide (Standard) | 63612-50-0 | Reference Standards |
| HY-13702S | Nilutamide-d6 | 1189477-66-4 | Isotope-Labeled Compounds |
| HY-13703 | Nimustine | 42471-28-3 | Reference compound |
| HY-137030S | 2-Benzotriazol-2-yl-4,6-bis(1-methyl-1-phenylethyl)phenol-d4 (UV-234-d4) | Isotope-Labeled Compounds | |
| HY-137031 | Spinetoram L | 187166-15-0 | Reference compound |
| HY-137034 | (+)-Secolongifolene-diol | 53587-37-4 | Natural Products |
| HY-137037 | Ingenol 20-palmitate | 39071-33-5 | Natural Products |
| HY-137038 | N-alpha-Tosyl-Lys chloromethyl ketone (hydrochloride) | 4238-41-9 | Reference compound |
| HY-13703A | Nimustine (hydrochloride) | 55661-38-6 | Reference compound |
| HY-13704 | SN-38 | 86639-52-3 | Natural Products |
| HY-137040A | Tiemonium (iodide) | 144-12-7 | Reference compound |
| HY-137042 | Cyanine5 alkyne | 1223357-57-0 | Dye Reagents |
| HY-137043 | 9-Keto Travoprost | 1219032-18-4 | Reference compound |
| HY-137045 | Bisindolylmaleimide VII | 137592-47-3 | Reference compound |
| HY-137046 | Nek2-IN-4 | 2225902-88-3 | Reference compound |
| HY-137048 | PF-00835231 | 870153-29-0 | Reference compound |
| HY-137049 | Co 101244 | 193359-26-1 | Reference compound |
| HY-13704R | SN-38 (Standard) | 86639-52-3 | Reference Standards |
| HY-13704S | SN-38-d3 | 718612-49-8 | Isotope-Labeled Compounds |
| HY-13705 | NM-3 | 181427-78-1 | Reference compound |
| HY-137054 | Ukrain | 138069-52-0 | Reference compound |
| HY-137055 | PF-3774076 | 1171824-96-6 | Reference compound |
| HY-137056 | LY164929 | 113573-18-5 | Reference compound |
| HY-13706 | CAY10471 (Racemate) | 844639-57-2 | Reference compound |
| HY-137061 | AZ-GHS-22 | 1143020-91-0 | Reference compound |
| HY-137063 | (+)-ITD-1 | 1409968-46-2 | Reference compound |
| HY-137064 | Memantine lactose adduct | 1159637-28-1 | Reference compound |
| HY-137067 | IMT1B | 2304621-06-3 | Reference compound |
| HY-13706A | CAY10471 | 627865-18-3 | Reference compound |
| HY-13707 | Tin(IV) mesoporphyrin IX (dichloride) | 106344-20-1 | Reference compound |
| HY-137070 | Rivaroxaban diol | 1160170-00-2 | Reference compound |
| HY-137073 | Cy7 alkyne (chloride) | 1998119-13-3 | Reference compound |
| HY-137075 | (±)-JQ1 | 1268524-69-1 | Reference compound |
| HY-137076 | N-Octylnortadalafil | 1173706-35-8 | Reference compound |
| HY-13708 | SUN C5174 | 191592-36-6 | Reference compound |
| HY-137083 | Trifluoperazine N-Glucuronide | 165602-90-4 | Reference compound |
| HY-137083A | Trifluoperazine N-glucuronide (chloride) | 145850-78-8 | Reference compound |
| HY-137083S | Trifluoperazine N-glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-137084 | Antibiotic AB023a | 141443-39-2 | Reference compound |
| HY-137085 | Antibiotic AB023b | 141443-40-5 | Reference compound |
| HY-137088 | Imiclopazine | 7414-95-1 | Reference compound |
| HY-137089 | Azacosterol (dihydrochloride) | 1249-84-9 | Reference compound |
| HY-13709 | Gantacurium (chloride) | 213998-46-0 | Reference compound |
| HY-137092 | IACS-13909 | 2160546-07-4 | Reference compound |
| HY-137093 | Orexin receptor antagonist 3 | 1293282-55-9 | Reference compound |
| HY-137098 | Sulfo-Cy3 maleimide (potassium) | 1656990-68-9 | Dye Reagents |
| HY-137099 | Genistein 7-sulfate | 182322-62-9 | Reference compound |
| HY-137099A | Genistein 7-sulfate (sodium) | Reference compound | |
| HY-13710 | Dimethindene | 5636-83-9 | Reference compound |
| HY-137100 | Cy 5 hydrazide | 1427705-31-4 | Dye Reagents |
| HY-137103 | BTC-AM | 176767-94-5 | Dye Reagents |
| HY-137107 | Radafaxine | 192374-14-4 | Reference compound |
| HY-137108 | Sp-8-pCPT-cGMPS | 160385-87-5 | Reference compound |
| HY-13710A | Dimethindene (maleate) | 3614-69-5 | Reference compound |
| HY-13710AR | Dimethindene (maleate) (Standard) | 3614-69-5 | Reference Standards |
| HY-137110 | Axitinib sulfoxide | 1347304-18-0 | Reference compound |
| HY-137111 | p-MPPF (dihydrochloride) | 223699-41-0 | Reference compound |
| HY-137111A | p-MPPF | 155204-26-5 | Reference compound |
| HY-137115 | BODIPY-Cyclopamine | 334658-24-1 | Dye Reagents |
| HY-137116 | Ser-Tyr β-naphthylamide | 24008-82-0 | Biochemical Assay Reagents |
| HY-137117 | 15-keto-PGE1 | 22973-19-9 | Reference compound |
| HY-137119 | (±)5-iPF2α-VI | 179094-11-2 | Reference compound |
| HY-137119A | 8,12-iso-iPF2α-VI | 1445349-99-4 | Reference compound |
| HY-137119AS | 8,12-iso-iPF2α-VI-d11 | Isotope-Labeled Compounds | |
| HY-137121 | YKAs3003 | 329180-48-5 | Reference compound |
| HY-137122 | 3-Pyridine toxoflavin | 32502-20-8 | Reference compound |
| HY-137124 | BB-F-Yne | 2219331-30-1 | Reference compound |
| HY-137125 | BB-Cl-Yne | 2219324-71-5 | Reference compound |
| HY-137126 | Photosensitizer Pc 4 | 135719-28-7 | Reference compound |
| HY-137128 | BTC (tetrapotassium) | 216453-54-2 | Dye Reagents |
| HY-137129 | 10-Formyl-7,8-dihydrofolic acid | 28459-40-7 | Natural Products |
| HY-13713 | LY377604 | 204592-94-9 | Reference compound |
| HY-137131 | DC-Chol (hydrochloride) | 166023-21-8 | Oligonucleotides |
| HY-137133 | Prostaglandin E1 alcohol | 21562-57-2 | Reference compound |
| HY-137134 | D-Glucuronic acid,2-propen-1-yl ester | 188717-04-6 | Biochemical Assay Reagents |
| HY-137135 | Cantharidic acid | 28874-45-5 | Reference compound |
| HY-137135A | Cantharidic acid (disodium) | 1465-77-6 | Reference compound |
| HY-137139 | 10'-Desmethoxystreptonigrin | 136803-89-9 | Natural Products |
| HY-13714 | Nolatrexed | 147149-76-6 | Reference compound |
| HY-137141 | 16-Keto Aspergillimide | 199784-50-4 | Natural Products |
| HY-137144 | Fulvestrant-3-boronic acid | 1853279-29-4 | Reference compound |
| HY-137145 | galacto-Dapagliflozin | 1408245-02-2 | Reference compound |
| HY-137148 | DIOA | 81166-47-4 | Reference compound |
| HY-137149 | Lonazolac (hemicalcium) | 75821-71-5 | Reference compound |
| HY-13715 | Norepinephrine | 51-41-2 | Natural Products |
| HY-137152 | 8-Aminoclonazolam | 71368-66-6 | Reference compound |
| HY-137153 | Afzelechin 3-O-xyloside | 512781-45-2 | Natural Products |
| HY-137155 | Dapsone hydroxylamine | 32695-27-5 | Reference compound |
| HY-137155S | Dapsone hydroxylamine-d4 | 1330185-26-6 | Isotope-Labeled Compounds |
| HY-137157 | Suprofen (L-lysine) | 69317-48-2 | Reference compound |
| HY-137158 | 16-Phenoxy tetranor Prostaglandin E2 | 54382-74-0 | Reference compound |
| HY-137159 | Bestatin methyl ester | 65322-89-6 | Reference compound |
| HY-13715A | Norepinephrine (hydrochloride) | 329-56-6 | Natural Products |
| HY-13715AR | Norepinephrine (hydrochloride) (Standard) | 329-56-6 | Reference Standards |
| HY-13715B | Norepinephrine (bitartrate monohydrate) | 108341-18-0 | Natural Products |
| HY-13715BR | Norepinephrine (bitartrate monohydrate) (Standard) | 108341-18-0 | Reference Standards |
| HY-13715C | Norepinephrine (tartrate) | 51-40-1 | Natural Products |
| HY-13715R | Norepinephrine (Standard) | 51-41-2 | Reference Standards |
| HY-13715S | (Rac)-Norepinephrine-d3 (formate) | Isotope-Labeled Compounds | |
| HY-13716 | Noscapine | 128-62-1 | Natural Products |
| HY-137160 | (±)-Ketoprofen glucuronide | 76690-94-3 | Reference compound |
| HY-137164 | Ala-Ala-Phe-AMC | 62037-41-6 | Reference compound |
| HY-137164A | Ala-Ala-Phe-AMC (TFA) | 62037-42-7 | Peptides |
| HY-137167 | Guanylyl imidodiphosphate (lithium) | 64564-03-0 | Reference compound |
| HY-137168 | LAB 149202F | 94343-58-5 | Reference compound |
| HY-13716A | Noscapine (hydrochloride) | 912-60-7 | Natural Products |
| HY-13716R | Noscapine (Standard) | 128-62-1 | Reference Standards |
| HY-13716S | Noscapine-13C,d3 | 1217680-57-3 | Isotope-Labeled Compounds |
| HY-13717 | AGN194204 | 220619-73-8 | Reference compound |
| HY-137172 | ETH 157 | 61595-77-5 | Reference compound |
| HY-137173 | Laidlomycin propionate | 78734-47-1 | Reference compound |
| HY-137175 | TMBIM6 antagonist-1 | 123134-61-2 | Reference compound |
| HY-137175A | CDC25B-IN-2 | 134271-74-2 | Reference compound |
| HY-137178 | 20α,22R-Dihydroxycholesterol | 596-94-1 | Reference compound |
| HY-137179 | Glyco-diosgenin | 1402423-29-3 | Reference compound |
| HY-13718 | Oglufanide | 38101-59-6 | Natural Products |
| HY-137180 | Naloxonazine | 82824-01-9 | Reference compound |
| HY-137181 | 9-Carboxymethoxymethylguanine | 80685-22-9 | Reference compound |
| HY-137186 | Suc-Gly-Gly-Phe-pNA | 68982-90-1 | Peptides |
| HY-137187 | FB23 | 2243736-35-6 | Reference compound |
| HY-137188 | Perindopril acyl-β-D-glucuronide | 120398-66-5 | Reference compound |
| HY-13718A | Oglufanide (disodium) | 237068-57-4 | Reference compound |
| HY-13719 | Oleandrin | 465-16-7 | Natural Products |
| HY-137191 | CH7233163 | 2923365-71-1 | Reference compound |
| HY-137193 | 5,6-Dihydroabiraterone | 219843-75-1 | Reference compound |
| HY-137194 | Ethynyl estradiol 3-b-D-glucuronide | 60134-76-1 | Biochemical Assay Reagents |
| HY-137196 | Anhydrochlortetracycline (hydrochloride) | 65490-24-6 | Reference compound |
| HY-137197 | 6β-Hydroxy dexamethasone | 55879-47-5 | Reference compound |
| HY-137198 | 4-Nitrophenyl β-D-maltoside | 56846-39-0 | Biochemical Assay Reagents |
| HY-137199 | Pro-Phe-Arg-AMC | 65147-21-9 | Peptides |
| HY-13719R | Oleandrin (Standard) | 465-16-7 | Reference Standards |
| HY-13720 | Pergolide | 66104-22-1 | Reference compound |
| HY-137200 | N-Desmethyl Bendamustine | 41515-13-3 | Reference compound |
| HY-137201 | 2-Phenylethyl β-D-thiogalactoside | 63407-54-5 | Biochemical Assay Reagents |
| HY-137204 | COR659 | 544450-68-2 | Reference compound |
| HY-137206 | ALV2 | 2438124-95-7 | Reference compound |
| HY-137207 | MK-28 | 864388-65-8 | Reference compound |
| HY-137208 | Chondroitin disaccharide Δdi-0S (sodium) | 136132-69-9 | Reference compound |
| HY-13720A | Pergolide (mesylate) | 66104-23-2 | Reference compound |
| HY-13720AR | Pergolide (mesylate) (Standard) | 66104-23-2 | Reference Standards |
| HY-13720AS | Pergolide-d7 (mesylate) | Isotope-Labeled Compounds | |
| HY-13720S | Pergolide-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13721 | Phenoxodiol | 81267-65-4 | Reference compound |
| HY-137211 | Hydrocortisone-21-lysinate | 95924-98-4 | Reference compound |
| HY-137213 | Fluvastatin lactone | 94061-83-3 | Reference compound |
| HY-137215 | 4'-trans-Hydroxy Cilostazol | 87153-04-6 | Reference compound |
| HY-137215S | 4'-trans-Hydroxy Cilostazol-d5 | Isotope-Labeled Compounds | |
| HY-137215S1 | 4-cis-Hydroxy Cilostazol-d5 | Isotope-Labeled Compounds | |
| HY-137215S2 | 4'-trans-Hydroxy Cilostazol-d4 | Isotope-Labeled Compounds | |
| HY-137217 | α-Artemether | 71939-51-0 | Reference compound |
| HY-137219 | Δ12(E)-Prostaglandin D2 | 64072-89-5 | Reference compound |
| HY-13722 | HPPH | 149402-51-7 | Reference compound |
| HY-137220 | Z-Gly-Pro-pNA | 65022-15-3 | Reference compound |
| HY-137222S | 4',5-Dihydroxy Diclofenac-13C6 | 1309283-30-4 | Isotope-Labeled Compounds |
| HY-137225 | HTS07944 | 706758-28-3 | Reference compound |
| HY-137227 | 15(R)-PTA2 | 71154-83-1 | Reference compound |
| HY-137228 | 4-Nitrophenylmaltohexaoside | 74173-30-1 | Biochemical Assay Reagents |
| HY-137229 | Avermectin B1a monosaccharide | 71831-09-9 | Reference compound |
| HY-13723 | Pimecrolimus | 137071-32-0 | Reference compound |
| HY-137231A | (S)-UFR2709 | 1431628-22-6 | Reference compound |
| HY-137231B | (S)-UFR2709 (hydrochloride) | 2934318-93-9 | Reference compound |
| HY-137232 | 4-Methylumbelliferyl-β-D-lactoside | 84325-23-5 | Biochemical Assay Reagents |
| HY-137234 | DM-β-CD | 51166-71-3 | Biochemical Assay Reagents |
| HY-137236 | 6β-Hydroxy metandienone | 33526-41-9 | Reference compound |
| HY-137238 | Ethyl mycophenolate | 32483-51-5 | Reference compound |
| HY-137239 | 1,4-DPCA ethyl ester | 86443-19-8 | Reference compound |
| HY-13723A | Pimecrolimus (hydrate) | 1000802-56-1 | Reference compound |
| HY-13723R | Pimecrolimus (Standard) | 137071-32-0 | Reference Standards |
| HY-13724 | Pipendoxifene | 198480-55-6 | Reference compound |
| HY-137242 | Ingenol-3-palmitate | 52557-26-3 | Natural Products |
| HY-137243 | Adenosine 3',5'-diphosphate (disodium) | 75431-54-8 | Reference compound |
| HY-137245 | Emlenoflast | 1995067-59-8 | Reference compound |
| HY-137245A | Emlenoflast (sodium) | 2380032-29-9 | Reference compound |
| HY-137246 | CD73-IN-3 | 2375815-63-5 | Reference compound |
| HY-137247 | 16-Mercaptopalmitic acid | 69839-68-5 | Reference compound |
| HY-137249 | Resorufin-β-D-galactopyranoside | 95079-19-9 | Biochemical Assay Reagents |
| HY-13724B | Pipendoxifene hydrochloride | 245124-69-0 | Reference compound |
| HY-13725 | Pirarubicin | 72496-41-4 | Reference compound |
| HY-137251 | Sulfo-MBS (sodium) | 92921-25-0 | Reference compound |
| HY-137252 | 22,23-Dihydroavermectin B1a aglycon | 73162-95-5 | Reference compound |
| HY-137254 | SKF-80723 | 71636-62-9 | Reference compound |
| HY-137255 | Taurolithocholic acid 3-sulfate (disodium) | 64936-83-0 | Biochemical Assay Reagents |
| HY-137255S | Taurolithocholic acid-3-Sulfate-d4 (disodium salt) | Isotope-Labeled Compounds | |
| HY-137257 | Carbamyl-PAF | 91575-58-5 | Reference compound |
| HY-137258 | (±)-N-3-Benzylnirvanol | 93879-40-4 | Reference compound |
| HY-13725A | Pirarubicin (Hydrochloride) | 95343-20-7 | Reference compound |
| HY-13725AR | Pirarubicin (Hydrochloride) (Standard) | 95343-20-7 | Reference Standards |
| HY-13725R | Pirarubicin (Standard) | 72496-41-4 | Reference Standards |
| HY-13726 | Piroxantrone | 91441-23-5 | Reference compound |
| HY-137261 | UDP-β-D-glucose (disodium) | 7333-33-7 | Reference compound |
| HY-137262 | Protein deglycase DJ-1 against-1 | 724737-74-0 | Reference compound |
| HY-137263 | Propionylmaridomycin | 35775-65-6 | Reference compound |
| HY-137265 | Aminomethyltrioxsalen (hydrochloride) | 62442-61-9 | Reference compound |
| HY-137267 | 10-Methyl-10-deazaaminopterin | 80576-77-8 | Reference compound |
| HY-137268 | 2-Nitrophenyl β-D-cellobioside | 70867-33-3 | Biochemical Assay Reagents |
| HY-13727 | Pixantrone (free base) | 144510-96-3 | Reference compound |
| HY-137270 | 16,16-Dimethyl PGA2 | 41691-92-3 | Reference compound |
| HY-137273 | Sucrose octasulfate (sodium) | 74135-10-7 | Reference compound |
| HY-137276 | 5-Bromo-3-indolyl β-D-galactopyranoside | 97753-82-7 | Dye Reagents |
| HY-137279 | Naloxone methiodide | 93302-47-7 | Reference compound |
| HY-13727A | Pixantrone | 144675-97-8 | Reference compound |
| HY-13727AR | Pixantrone (Standard) | 144675-97-8 | Reference Standards |
| HY-13727AS | Pixantrone-d8 | Isotope-Labeled Compounds | |
| HY-13727B | Pixantrone (hydrochloride) | 175989-38-5 | Reference compound |
| HY-13728 | Plevitrexed | 153537-73-6 | Reference compound |
| HY-137281 | HMB-Val-Ser-Leu-VE | 862891-04-1 | Peptides |
| HY-137286 | Z-Leu-Leu-Glu-βNA | 75873-85-7 | Peptides |
| HY-137288 | 17-Phenyl-18,19,20-trinor-PGD2 | 85280-91-7 | Reference compound |
| HY-13728A | (R)-Plevitrexed | 153537-74-7 | Reference compound |
| HY-13728B | (Rac)-Plevitrexed | 153538-08-0 | Reference compound |
| HY-137292 | PTB7-Th | 1469791-66-9 | Reference compound |
| HY-137294 | BTPTT-4F | 2304444-49-1 | Reference compound |
| HY-137295 | Ingenol 3,20-dibenzoate | 59086-90-7 | Natural Products |
| HY-137296 | Lumogallion | 4386-25-8 | Dye Reagents |
| HY-137298 | LYS006 | 1799681-85-8 | Reference compound |
| HY-137298A | LYS006 (hydrochloride) | 2619563-79-8 | Reference compound |
| HY-13730 | Porfiromycin | 801-52-5 | Reference compound |
| HY-137300 | Hydroxy vardenafil | 224785-98-2 | Reference compound |
| HY-137301 | Mycophenolic acid glucuronide | 31528-44-6 | Reference compound |
| HY-137301R | Mycophenolic acid glucuronide (Standard) | 31528-44-6 | Reference Standards |
| HY-137301S | Mycophenolic acid glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-137303 | FA-Gly-Leu-NH2 | 26400-33-9 | Reference compound |
| HY-137304 | 3α-Mannobiose | 23745-85-9 | Biochemical Assay Reagents |
| HY-137305 | O-Acetylgalanthamine | 25650-83-3 | Natural Products |
| HY-137306 | Pergolide sulfone | 72822-03-8 | Reference compound |
| HY-137307 | Cholest-5-ene-3ß,22(S)-diol | 22348-64-7 | Reference compound |
| HY-137307S | Cholest-5-ene-3ß,22(S)-diol-d7 | 1246302-91-9 | Isotope-Labeled Compounds |
| HY-137308 | 15(R)-Prostaglandin D2 | 59894-05-2 | Reference compound |
| HY-137309 | 4-Deoxy-4α-phorbol | 37415-57-9 | Natural Products |
| HY-13731 | PPI-2458 | 431077-35-9 | Reference compound |
| HY-137310 | 4-Hydroxy atorvastatin (hemicalcium) | 265989-44-4 | Reference compound |
| HY-137311A | (S)-Albuterol | 34271-50-6 | Reference compound |
| HY-137312A | Carbuterol (hydrochloride) | 34866-46-1 | Reference compound |
| HY-137313 | Octyl α-D-glucopyranoside | 29781-80-4 | Biochemical Assay Reagents |
| HY-137315 | TML-6 | 1462868-88-7 | Reference compound |
| HY-137315S | TML-6-d3 | 2673270-28-3 | Isotope-Labeled Compounds |
| HY-137316 | Phosphoramide mustard | 10159-53-2 | Reference compound |
| HY-137316A | Phosphoramide mustard (cyclohexanamine) | 1566-15-0 | Reference compound |
| HY-137316AR | Phosphoramide mustard (cyclohexanamine) (Standard) | 1566-15-0 | Reference Standards |
| HY-137318 | BM 15766 (sulfate) | 86621-94-5 | Reference compound |
| HY-13732 | Prednimustine | 29069-24-7 | Reference compound |
| HY-137320 | diABZI-C2-NH2 | 2137975-93-8 | Reference compound |
| HY-137321 | Estriol 3-glucuronide (sodium salt) | 15087-06-6 | Reference compound |
| HY-137322 | THX-B | 1372206-64-8 | Reference compound |
| HY-137323 | Leucinostatin H | 109539-58-4 | Peptides |
| HY-137324 | α-Apooxytetracycline | 18695-01-7 | Reference compound |
| HY-137325 | 2-Chloro-ATP | 49564-60-5 | Reference compound |
| HY-137325A | 2-Chloro-ATP (sodium) | 301334-89-4 | Reference compound |
| HY-13733 | Procarbazine (Hydrochloride) | 366-70-1 | Reference compound |
| HY-137330 | S-(2,4-Dinitrophenyl)glutathione | 26289-39-4 | Peptides |
| HY-137331 | FAPI-46 | 2374782-04-2 | Reference compound |
| HY-137332 | N-Methylspiroperidol | 87539-19-3 | Reference compound |
| HY-137333 | 4-Methylumbelliferyl β-D-cellobioside | 72626-61-0 | Dye Reagents |
| HY-137334 | Neuraminidase-IN-1 | 2379438-80-7 | Reference compound |
| HY-137335 | 6'-Sialyllactose (sodium) | 157574-76-0 | Reference compound |
| HY-137336 | 4-Methylumbelliferyl β-D-fucoside | 55487-93-9 | Biochemical Assay Reagents |
| HY-137337 | Suc-Ala-Ala-Phe-AMC | 71973-79-0 | Dye Reagents |
| HY-137339 | Amitriptyline N-β-D-glucuronide | 112806-33-4 | Reference compound |
| HY-13733A | Procarbazine | 671-16-9 | Reference compound |
| HY-13733R | Procarbazine (Hydrochloride) (Standard) | 366-70-1 | Reference Standards |
| HY-13734 | PX-12 | 141400-58-0 | Reference compound |
| HY-137340 | WH-10417-099 | 2769753-42-4 | Reference compound |
| HY-137341 | SK-3-91 | 2769753-23-1 | Reference compound |
| HY-137342 | SB1-G-187 | 2769753-18-4 | Reference compound |
| HY-137343 | DB-0646 | 2769753-59-3 | Reference compound |
| HY-137344 | dAURK-4 | 2705844-81-9 | Reference compound |
| HY-137344A | dAURK-4 (hydrochloride) | Reference compound | |
| HY-137345 | DB-3-291 | 2769753-64-0 | Reference compound |
| HY-137346 | DD-03-156 | 2769753-69-5 | Reference compound |
| HY-137348 | 10-Pyrene-PC | 95864-17-8 | Biochemical Assay Reagents |
| HY-13735 | Quinacrine | 83-89-6 | Reference compound |
| HY-137350 | 12-epi-LTB4 | 83709-73-3 | Reference compound |
| HY-137355 | 15(S)-15-methyl Prostaglandin D2 | 85280-90-6 | Reference compound |
| HY-137356 | Prochloraz manganese | 75747-77-2 | Reference compound |
| HY-137356R | Prochloraz manganese (Standard) | 75747-77-2 | Reference Standards |
| HY-13735A | Quinacrine (dihydrochloride) | 69-05-6 | Reference compound |
| HY-13735AR | Quinacrine (dihydrochloride) (Standard) | 69-05-6 | Reference Standards |
| HY-13735B | Quinacrine (hydrochloride hydrate) | 6151-30-0 | Reference compound |
| HY-13735C | l-Atabrine dihydrochloride | 56100-42-6 | Reference compound |
| HY-13735D | d-Atabrine dihydrochloride | 56100-41-5 | Reference compound |
| HY-13735E | Quinacrine (methanesulfonate) | 316-05-2 | Reference compound |
| HY-13735H | Quinacrine (acetate) | 78901-94-7 | Reference compound |
| HY-13736 | Quinagolide | 87056-78-8 | Reference compound |
| HY-137360 | Phosphine-biotin | 608514-42-7 | Reference compound |
| HY-137361 | Ramiprilat diketopiperazine | 108736-10-3 | Reference compound |
| HY-137362 | N2-Acetyl acyclovir | 110104-37-5 | Reference compound |
| HY-137362R | N2-Acetyl acyclovir (Standard) | 110104-37-5 | Reference Standards |
| HY-137364 | Disulfamide | 671-88-5 | Reference compound |
| HY-137367 | Z-Val-Val-Arg-AMC | 124485-41-2 | Peptides |
| HY-13736A | Quinagolide (hydrochloride) | 94424-50-7 | Reference compound |
| HY-13737 | R1530 | 882531-87-5 | Reference compound |
| HY-137370 | 2-Hexynyl-5′-N-ethylcarboxamidoadenosine | 141018-30-6 | Reference compound |
| HY-137371 | Lactonic sophorolipid | 148409-20-5 | Reference compound |
| HY-137371R | Lactonic sophorolipid (Standard) | 148409-20-5 | Reference Standards |
| HY-137373 | Rp-8-pCPT-cGMPS | 153660-04-9 | Reference compound |
| HY-137377 | TAS-119 | 1453099-83-6 | Reference compound |
| HY-137378A | 8-Br-PET-cGMP | 144510-04-3 | Reference compound |
| HY-13738 | Raloxifene | 84449-90-1 | Reference compound |
| HY-137381 | 6-Bnz-cAMP | 30275-80-0 | Reference compound |
| HY-137382 | 4-Methylumbelliferyl-N-acetyl-β-D-galactosaminide | 36476-29-6 | Biochemical Assay Reagents |
| HY-137383 | Sulfo-SANPAH | 102568-43-4 | Reference compound |
| HY-137386 | 2-Oxo-3-hydroxy-LSD | 111295-09-1 | Reference compound |
| HY-137387 | Carvedilol Glucuronide | 114869-83-9 | Reference compound |
| HY-137388A | p-F-HHSiD (hydrochloride) | 175615-76-6 | Reference compound |
| HY-137389 | Anhydro abiraterone | 154229-20-6 | Reference compound |
| HY-13738A | Raloxifene (hydrochloride) | 82640-04-8 | Natural Products |
| HY-13738AR | Raloxifene (hydrochloride) (Standard) | 82640-04-8 | Reference Standards |
| HY-13738R | Raloxifene (Standard) | 84449-90-1 | Reference Standards |
| HY-13738S | Raloxifene-d4 | 1185076-44-1 | Isotope-Labeled Compounds |
| HY-13738S2 | Raloxifene-d4 (hydrochloride) | 1188263-47-9 | Isotope-Labeled Compounds |
| HY-13738S3 | Raloxifene-d10 | Isotope-Labeled Compounds | |
| HY-13738S4 | Raloxifene-d10-1 | 2512224-37-0 | Isotope-Labeled Compounds |
| HY-13739 | Ranimustine | 58994-96-0 | Reference compound |
| HY-137390A | (3S,5R)-Fluvastatin (potassium) | 1009811-63-5 | Reference compound |
| HY-137391 | 2-Bromoestradiol | 15833-07-5 | Reference compound |
| HY-137392 | Cathepsin L-IN-4 | 161709-56-4 | Peptides |
| HY-137393 | 3α,5α-Tetrahydronorethisterone | 16392-60-2 | Reference compound |
| HY-137394 | Nicotredole | 29876-14-0 | Reference compound |
| HY-137396 | 6β-Hydroxy Eplerenone | 209253-80-5 | Reference compound |
| HY-137397 | 8-Hydroxyefavirenz | 205754-33-2 | Reference compound |
| HY-13740 | Resiquimod | 144875-48-9 | Reference compound |
| HY-137403 | 4-Methylumbelliferyl β-D-N,N′,N′′-triacetylchitotrioside | 53643-13-3 | Biochemical Assay Reagents |
| HY-137404 | Adenosine 5'-O-thiomonophosphate (dilithium) | 93839-85-1 | Biochemical Assay Reagents |
| HY-137406 | 1,2'-O-Dimethylguanosine | 73667-71-7 | Reference compound |
| HY-137407 | N-Phenylacetyl-L-homoserine lactone | 55154-48-8 | Reference compound |
| HY-137409 | Suc-AAA-pNA | 52299-14-6 | Peptides |
| HY-13740G | Resiquimod (GMP) | 144875-48-9 | GMP Small Molecules |
| HY-13740S | Resiquimod-d5 | 2252319-44-9 | Isotope-Labeled Compounds |
| HY-13741 | RH1 | 221635-42-3 | Reference compound |
| HY-137411 | (E/Z)-Linoleoyl-CoA | 40757-80-0 | Reference compound |
| HY-137412 | PGF2α 1,15-lactone | 55314-49-3 | Reference compound |
| HY-137414 | 20-Hydroxy Prostaglandin E2 | 57930-95-7 | Reference compound |
| HY-137416 | H-Glu(AMC)-OH | 72669-53-5 | Peptides |
| HY-137418 | 2-MeS-ATP | 43170-89-4 | Reference compound |
| HY-13742 | Ropidoxuridine | 93265-81-7 | Reference compound |
| HY-137421 | 4-Nitrophenyl N-acetyl-α-D-glucosaminide | 10139-02-3 | Biochemical Assay Reagents |
| HY-137422 | D-erythro-MAPP | 143492-38-0 | Reference compound |
| HY-137425 | N-Biotinyl-12-aminododecanoic acid | 135447-73-3 | Biochemical Assay Reagents |
| HY-137426 | Phenolphthalein β-D-glucuronide | 15265-26-6 | Biochemical Assay Reagents |
| HY-137426A | Phenolphthalein glucuronide (sodium) | 6820-54-8 | Reference compound |
| HY-137428 | (S,S)-EDDS | 20846-91-7 | Reference compound |
| HY-137429 | Valiloxibic acid | 238401-16-6 | Reference compound |
| HY-13743 | Roquinimex | 84088-42-6 | Reference compound |
| HY-137430 | Aldumastat | 1957278-93-1 | Reference compound |
| HY-137431 | Asundexian | 2064121-65-7 | Reference compound |
| HY-137431A | (R)-Asundexian | 2064124-85-0 | Reference compound |
| HY-137432 | Avotaciclib | 1983983-41-0 | Reference compound |
| HY-137432A | Avotaciclib (trihydrochloride) | 1983984-01-5 | Reference compound |
| HY-137432B | Avotaciclib (hydrochloride) | Reference compound | |
| HY-137432D | Avotaciclib (sulfate) | 1983984-04-8 | Reference compound |
| HY-137433 | Befotertinib | 1835667-63-4 | Reference compound |
| HY-137433A | Befotertinib (mesylate) | 2226167-02-6 | Reference compound |
| HY-137434 | Cedirogant | 2055496-11-0 | Reference compound |
| HY-137435 | Cirtuvivint | 2143917-62-6 | Reference compound |
| HY-137436 | Cotosudil | 1258833-31-6 | Reference compound |
| HY-137438 | Edralbrutinib | 1858206-58-2 | Reference compound |
| HY-137439 | Fanotaprim | 2120282-75-7 | Reference compound |
| HY-13744 | Rubitecan | 91421-42-0 | Natural Products |
| HY-137440 | Firazorexton | 2274802-95-6 | Reference compound |
| HY-137440A | Firazorexton (hydrate) | 2861934-86-1 | Reference compound |
| HY-137440B | (2R,3R)-Firazorexton | 2692692-00-3 | Reference compound |
| HY-137441 | Icapamespib | 1000999-96-1 | Reference compound |
| HY-137441A | Icapamespib (hydrochloride) | 2267287-26-1 | Reference compound |
| HY-137442 | Inupadenant | 2246607-08-7 | Reference compound |
| HY-137442A | Inupadenant (hydrochloride) | 2411004-22-1 | Reference compound |
| HY-137443 | Ipivivint | 1481617-15-5 | Reference compound |
| HY-137444 | Ludaterone | 124548-08-9 | Reference compound |
| HY-137445 | Modoflaner | 1331922-53-2 | Reference compound |
| HY-137446 | Mosliciguat | 2231749-54-3 | Reference compound |
| HY-137447 | Pirepemat | 1227638-29-0 | Reference compound |
| HY-137447A | Pirepemat (fumarate) | 2251806-70-7 | Reference compound |
| HY-137448 | Rezvilutamide | 1572045-62-5 | Reference compound |
| HY-137449 | Rintodestrant | 2088518-51-6 | Reference compound |
| HY-13745 | Sabarubicin | 211100-13-9 | Reference compound |
| HY-137450 | Senaparib | 1401682-78-7 | Reference compound |
| HY-137450A | Senaparib (hydrochloride) | 1401683-39-3 | Reference compound |
| HY-137451 | Sivopixant | 2414285-40-6 | Reference compound |
| HY-137451A | (E/Z)-Sivopixant | 1640808-39-4 | Reference compound |
| HY-137452 | Suntinorexton | 2274802-89-8 | Reference compound |
| HY-137452A | (R,R)-Suntinorexton | Reference compound | |
| HY-137453 | Tenofovir amibufenamide | 1571076-26-0 | Reference compound |
| HY-137453B | (1R)-Tenofovir amibufenamide | 1571076-15-7 | Reference compound |
| HY-137453C | (R,1R)-Tenofovir amibufenamide | 1571076-37-3 | Reference compound |
| HY-137454 | Teplinovivint | 1428064-91-8 | Reference compound |
| HY-137455 | Terevalefim | 1070881-42-3 | Reference compound |
| HY-137456 | Tilpisertib | 2065153-41-3 | Reference compound |
| HY-137457 | Venadaparib | 1681017-83-3 | Reference compound |
| HY-137457A | Venadaparib (hydrochloride) | 1681020-60-9 | Reference compound |
| HY-137458 | Vevorisertib | 1416775-46-6 | Reference compound |
| HY-137458A | Vevorisertib (trihydrochloride) | 1416775-08-0 | Reference compound |
| HY-137459 | Vocacapsaicin | 1931116-86-7 | Reference compound |
| HY-137459A | Vocacapsaicin (hydrochloride) | 1931116-92-5 | Reference compound |
| HY-13746 | Sardomozide | 149400-88-4 | Reference compound |
| HY-137460 | Vodobatinib | 1388803-90-4 | Reference compound |
| HY-137463 | AG-636 | 1623416-31-8 | Reference compound |
| HY-137464A | OATD-01 | 2088453-21-6 | Reference compound |
| HY-137465 | CG428 | 2412055-93-5 | Reference compound |
| HY-137466 | ARN-21934 | 2230854-93-8 | Reference compound |
| HY-13746B | Sardomozide dihydrochloride | 138794-73-7 | Reference compound |
| HY-13747 | Semustine | 13909-09-6 | Reference compound |
| HY-137471 | RBPJ Inhibitor-1 | 2682114-39-0 | Reference compound |
| HY-137472 | SAR502250 | 503860-57-9 | Reference compound |
| HY-137473 | Methyl pyropheophorbide-a | 6453-67-4 | Reference compound |
| HY-137474 | Purpurin 18 methyl ester | 51744-55-9 | Natural Products |
| HY-137475 | Chlorin e6 trimethyl ester | 35038-32-5 | Reference compound |
| HY-137477 | Spiropyran hexyl methacrylate | 2522597-48-2 | Reference compound |
| HY-137478 | KB-0742 | 2416873-83-9 | Reference compound |
| HY-137478A | KB-0742 (dihydrochloride) | 2416874-75-2 | Reference compound |
| HY-137479 | TEAD-IN-1 | 2412761-57-8 | Reference compound |
| HY-13748 | Silybin A | 22888-70-6 | Natural Products |
| HY-137483 | Prostaglandin D2 serinol amide | 851761-42-7 | Reference compound |
| HY-137487 | PROTAC BRAF-V600E degrader-1 | 2417296-84-3 | Reference compound |
| HY-137488 | PROTAC BRAF-V600E degrader-2 | 2417296-82-1 | Reference compound |
| HY-13748R | Silybin A (Standard) | 22888-70-6 | Reference Standards |
| HY-13749 | Sitagliptin | 486460-32-6 | Reference compound |
| HY-137490 | 4-Methylumbelliferyl α-L-arabinofuranoside | 77471-44-4 | Reference compound |
| HY-137492 | 16,16-Dimethyl-PGE2-4-(4-acetamidobenzamido)phenyl ester | 62873-55-6 | Reference compound |
| HY-137493 | 14,15-Leukotriene D4 | 75290-64-1 | Reference compound |
| HY-137494 | Ethyl β-carboline-3-carboxylate | 74214-62-3 | Reference compound |
| HY-137495 | GGACK | 65113-67-9 | Peptides |
| HY-137496 | 4-Methylumbelliferyl β-D-mannopyranoside | 67909-30-2 | Biochemical Assay Reagents |
| HY-137497 | KRAS inhibitor-9 | 300809-71-6 | Reference compound |
| HY-137498 | EBOV/MARV-IN-1 | 2479465-67-1 | Reference compound |
| HY-137499 | NT1-O12B | 2739805-63-9 | Oligonucleotides |
| HY-13749A | Sitagliptin (phosphate) | 654671-78-0 | Reference compound |
| HY-13749AS | Sitagliptin-d4 (phosphate) | 1432063-88-1 | Isotope-Labeled Compounds |
| HY-13749B | Sitagliptin (phosphate monohydrate) | 654671-77-9 | Reference compound |
| HY-13749BR | Sitagliptin (phosphate monohydrate) (Standard) | 654671-77-9 | Reference Standards |
| HY-13749C | (S)-Sitagliptin (phosphate) | 823817-58-9 | Reference compound |
| HY-13749CR | (S)-Sitagliptin (phosphate) (Standard) | 823817-58-9 | Reference Standards |
| HY-13749D | (Rac)-Sitagliptin | 823817-56-7 | Reference compound |
| HY-13749S1 | Sitagliptin-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13749S2 | Sitagliptin-d4 | Isotope-Labeled Compounds | |
| HY-13749S3 | Sitagliptin-d6 | 1133211-99-0 | Isotope-Labeled Compounds |
| HY-13750 | Ebselen | 60940-34-3 | Reference compound |
| HY-137500 | NT1-014B | 2739805-64-0 | Reference compound |
| HY-137501 | 306-O12B-3 | Biochemical Assay Reagents | |
| HY-137502 | ML267 | 1542213-67-1 | Reference compound |
| HY-137504 | 20-ethyl Prostaglandin F2α | 36950-85-3 | Reference compound |
| HY-137506 | XST-14 | 2607143-50-8 | Reference compound |
| HY-13751 | SR-31747 | 132173-07-0 | Reference compound |
| HY-137513 | N-Acetyl-D-glucosamine 6-sulfate (sodium) | 108321-79-5 | Biochemical Assay Reagents |
| HY-137516 | LC-2 | 2502156-03-6 | Reference compound |
| HY-137516A | LC-2 epimer | 2502156-12-7 | Reference compound |
| HY-13751A | SR-31747 (free base) | 132173-06-9 | Reference compound |
| HY-137521 | Z-PDLDA-NHOH | 123984-15-6 | Peptides |
| HY-137522 | Zidovudine O-β-D-glucuronide (sodium) | 133525-01-6 | Reference compound |
| HY-137522A | Zidovudine O-β-D-glucuronide | 117675-21-5 | Reference compound |
| HY-137522AS1 | Zidovudine Glucuronide-13C6 | Isotope-Labeled Compounds | |
| HY-137522S | Zidovudine O-β-D-glucuronide-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-137528 | H-Glu(4MβNA)-OH | 24723-50-0 | Reference compound |
| HY-137529 | Nα-Benzoyl-L-arginine 4-nitroanilide (hydrochloride) | 21653-40-7 | Peptides |
| HY-13753 | Streptozotocin | 18883-66-4 | Natural Products |
| HY-137530 | 8-MA-cAMP | 33823-18-6 | Reference compound |
| HY-137531 | Pomalidomide-PEG1-C2-COOH | 2139348-60-8 | Reference compound |
| HY-137532 | 7-Hydroxyquetiapine | 139079-39-3 | Reference compound |
| HY-137532S | 7-Hydroxy Quetiapine-d8 | 1185098-57-0 | Isotope-Labeled Compounds |
| HY-137532S1 | 7-Hydroxyquetiapine-d4 (hemifumarate) | Isotope-Labeled Compounds | |
| HY-137537 | Pomalidomide-PEG2-azide | 2267306-14-7 | Reference compound |
| HY-137538 | Pomalidomide-PEG3-azide | 2267306-15-8 | Reference compound |
| HY-137540 | Phenyl-1-thio-β-D-glucopyranoside | 2936-70-1 | Biochemical Assay Reagents |
| HY-137541 | 2-Nitro-5-thiocyanatobenzoic acid | 30211-77-9 | Reference compound |
| HY-137543 | Δ8-Tetrahydrocannabivarin | 31262-38-1 | Reference compound |
| HY-137544 | 16-Phenyl tetranor Prostaglandin F2α | 38315-48-9 | Reference compound |
| HY-137546 | Reduced Haloperidol | 34104-67-1 | Reference compound |
| HY-137546S | Reduced Haloperidol-d4 | 1246820-79-0 | Isotope-Labeled Compounds |
| HY-137547 | 20-Hydroxy-PGF2α | 57930-92-4 | Reference compound |
| HY-137548 | 2′,3′-Dideoxy-3′-fluorouridine | 41107-56-6 | Reference compound |
| HY-13755 | Sulforaphane | 4478-93-7 | Natural Products |
| HY-137550 | 4-Nitrophenyl β-D-galactopyranoside | 3150-24-1 | Biochemical Assay Reagents |
| HY-137551 | Tiafenacil | 1220411-29-9 | Reference compound |
| HY-137551R | Tiafenacil (Standard) | 1220411-29-9 | Reference Standards |
| HY-137552 | MKI-1 | 1190277-80-5 | Reference compound |
| HY-137553 | β-Aminoarteether | 133162-24-0 | Reference compound |
| HY-137553A | β-Aminoarteether (maleate) | 133162-25-1 | Reference compound |
| HY-137555 | 11-dehydro-2,3-dinor Thromboxane B2 | 79250-60-5 | Reference compound |
| HY-137557 | Florzolotau | 1565797-16-1 | Reference compound |
| HY-13755A | (R)-Sulforaphane | 142825-10-3 | Natural Products |
| HY-13756 | Tacrolimus | 104987-11-3 | Natural Products |
| HY-137561 | Bexotegrast | 2376257-44-0 | Reference compound |
| HY-137561A | Bexotegrast (hydrochloride) | 2775365-40-5 | Reference compound |
| HY-137563 | A2793 | 88349-90-0 | Reference compound |
| HY-137564 | Desacetylcephalothin (sodium) | 5547-29-5 | Reference compound |
| HY-137565 | Hydroxy ritonavir | 176655-56-4 | Reference compound |
| HY-137566 | Cucumarioside H | 116524-58-4 | Natural Products |
| HY-137567 | Prostaglandin E1 ethanolamide | 210976-81-1 | Reference compound |
| HY-13756A | Tacrolimus (monohydrate) | 109581-93-3 | Natural Products |
| HY-13756R | Tacrolimus (Standard) | 104987-11-3 | Reference Standards |
| HY-13756S | Tacrolimus-13C,d2 | 1356841-89-8 | Isotope-Labeled Compounds |
| HY-13756S2 | Tacrolimus-d3 | Isotope-Labeled Compounds | |
| HY-13757 | Tamoxifen (Citrate) | 54965-24-1 | Reference compound |
| HY-137573 | Trotabresib | 1706738-98-8 | Reference compound |
| HY-137574 | 19(R)-Hydroxy prostaglandin E1 | 64625-55-4 | Reference compound |
| HY-137575 | Terbutalone | 139508-58-0 | Reference compound |
| HY-137575R | Terbutalone (Standard) | 139508-58-0 | Reference Standards |
| HY-137576 | DMT-dI Phosphoramidite | 141684-35-7 | Oligonucleotides |
| HY-13757A | Tamoxifen | 10540-29-1 | Reference compound |
| HY-13757AR | Tamoxifen (Standard) | 10540-29-1 | Reference Standards |
| HY-13757AS | Tamoxifen-d5 | 157698-32-3 | Isotope-Labeled Compounds |
| HY-13757AS1 | Tamoxifen-d3 | 508201-30-7 | Isotope-Labeled Compounds |
| HY-13757R | Tamoxifen (Citrate) (Standard) | 54965-24-1 | Reference Standards |
| HY-13757S | Tamoxifen-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-13758 | TAS-103 | 174634-08-3 | Reference compound |
| HY-137580 | N-Desmethyl Eletriptan | 153525-55-4 | Reference compound |
| HY-137583 | Peltatoside | 23284-18-6 | Natural Products |
| HY-137584 | 1a,1b-Dihomo prostaglandin E1 | 23452-98-4 | Reference compound |
| HY-137585 | 17-Trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α | 294856-01-2 | Reference compound |
| HY-137589 | N6-Dimethyldeoxyadenosine | 35665-58-8 | Reference compound |
| HY-13758A | TAS-103 (dihydrochloride) | 174634-09-4 | Reference compound |
| HY-137591 | 13,14-Dihydro-15-keto-PGE1 | 5094-14-4 | Reference compound |
| HY-137592 | Nicotinamide 1,N6-ethenoadenine dinucleotide | 38806-38-1 | Dye Reagents |
| HY-137592A | Nicotinamide 1,N6-ethenoadenine dinucleotide (sodium) | Reference compound | |
| HY-13760 | Tasidotin hydrochloride | 623174-20-9 | Reference compound |
| HY-137600 | 1,N6-Ethenoadenosine | 39007-51-7 | Reference compound |
| HY-137602 | P1,P2-Diuridine-5’-diphosphate | 26184-65-6 | Reference compound |
| HY-137603 | Uridine-5'-O-(3-thiotriphosphate) | 79049-97-1 | Reference compound |
| HY-137604A | (γ-AmNS)UTP (trisodium) | Reference compound | |
| HY-137605 | WSF1-IN-1 | 2379577-82-7 | Reference compound |
| HY-137606 | Uridine adenosine tetraphosphate | 10527-48-7 | Reference compound |
| HY-137608 | Uridine 5'-O-thiodiphosphate | 221010-51-1 | Reference compound |
| HY-13761 | Teniposide | 29767-20-2 | Reference compound |
| HY-137611A | α,β-MTDP (trisodium) | 71370-60-0 | Reference compound |
| HY-137612 | Sp-UTP-α-S | 71214-29-4 | Reference compound |
| HY-137613 | Sp-TTPαS | 83199-32-0 | Reference compound |
| HY-137614 | Sp-GTPαS | 81570-51-6 | Reference compound |
| HY-137615 | Sp-GDPαS | 71481-45-3 | Reference compound |
| HY-137618 | Sp-dGTPαS | 80902-28-9 | Reference compound |
| HY-137618B | Rp-dGTPαS | 80902-29-0 | Reference compound |
| HY-137619 | Sp-dCTPαS | 80951-75-3 | Reference compound |
| HY-13761R | Teniposide (Standard) | 29767-20-2 | Reference Standards |
| HY-13762 | Tesmilifene | 98774-23-3 | Reference compound |
| HY-137620 | Sp-dATPαS | 80875-87-2 | Reference compound |
| HY-137622 | Sp-cGMPS | 86562-10-9 | Reference compound |
| HY-137623 | Sp-cCMPS | 87063-81-8 | Reference compound |
| HY-137624 | Sp-cAMPS-AM | 1037535-49-1 | Reference compound |
| HY-137626 | Sp-ATPαS | 58976-48-0 | Reference compound |
| HY-137627 | Sp-ADPαS | 59286-20-3 | Reference compound |
| HY-137628 | Sp-8-PIP cAMP | 156816-35-2 | Reference compound |
| HY-137629 | Sp-8-pCPT-PET-cGMPS | 1262749-63-2 | Reference compound |
| HY-13762A | Tesmilifene (hydrochloride) | 92981-78-7 | Reference compound |
| HY-13762AS | Tesmelefine-d4 (hydrochloride) | 1228786-71-7 | Isotope-Labeled Compounds |
| HY-13762S | Tesmilifene-d4 | Isotope-Labeled Compounds | |
| HY-137630 | Sp-8-pCPT-2'-O-Me-cAMPS | 634208-37-0 | Reference compound |
| HY-137632 | Sp-8-Cl-cAMPS | 142754-28-7 | Reference compound |
| HY-137633 | Sp-8-Br-PET-cGMPS | 172806-21-2 | Reference compound |
| HY-137635 | Sp-6-Phe-cAMPS | 169335-92-6 | Reference compound |
| HY-137638 | Sp-5,6-DCl-cBIMPS | 120912-54-1 | Reference compound |
| HY-137638A | Sp-5,6-DCl-cBIMPS (sodium) | 142439-96-1 | Reference compound |
| HY-137639 | Sp-8-Br-cGMPS | 153660-03-8 | Reference compound |
| HY-13764 | Tetrandrine | 518-34-3 | Natural Products |
| HY-137640 | Sp-8-Br-cAMPS | 127634-20-2 | Reference compound |
| HY-137640A | Sp-8-Br-cAMPS (sodium) | 1573115-90-8 | Reference compound |
| HY-137640B | Rp-8-Br-cAMPS | 129735-00-8 | Reference compound |
| HY-137640C | Rp-8-Br-cAMPS (sodium) | 925456-59-3 | Reference compound |
| HY-137641 | Sp-8-Br-2'-O-Me-cAMPS | 634208-34-7 | Reference compound |
| HY-13764R | Tetrandrine (Standard) | 518-34-3 | Reference Standards |
| HY-13765 | 6-Thioguanine | 154-42-7 | Reference compound |
| HY-137655 | BMS-P5 | 1549811-36-0 | Reference compound |
| HY-137655A | BMS-P5 (free base) | 1550371-22-6 | Reference compound |
| HY-137658 | Purine riboside triphosphate | 23197-96-8 | Reference compound |
| HY-137658A | Purine riboside-5'-O-triphosphate (sodium) | 35892-95-6 | Reference compound |
| HY-13765R | 6-Thioguanine (Standard) | 154-42-7 | Reference Standards |
| HY-13766 | Timcodar | 179033-51-3 | Reference compound |
| HY-137660 | pppApG | 68892-47-7 | Reference compound |
| HY-137662 | 5'-Phosphoguanylyl-(3',5')-guanosine | 33008-99-0 | Reference compound |
| HY-137665 | PET-cGMP | 78080-27-0 | Reference compound |
| HY-13766A | Timcodar (mesylate) | 183313-30-6 | Reference compound |
| HY-13767 | Tirapazamine | 27314-97-2 | Reference compound |
| HY-137672A | 2',3'-Cyclic NADP (disodium) | 100929-77-9 | Reference compound |
| HY-137673 | 2'-Deoxy-NAD+ | 6697-37-6 | Reference compound |
| HY-137673A | 2'-Deoxy-NAD+ (sodium) | 1514900-83-4 | Reference compound |
| HY-137677B | GTPγS (tetralithium) | 94825-44-2 | Reference compound |
| HY-13768 | Topotecan | 123948-87-8 | Reference compound |
| HY-137680 | GP4G | 4130-19-2 | Reference compound |
| HY-137683B | Guanosine 5'-O-(2-thiodiphosphate) (trilithium) | 97952-36-8 | Reference compound |
| HY-13768A | Topotecan (hydrochloride) | 119413-54-6 | Natural Products |
| HY-13768AR | Topotecan (hydrochloride) (Standard) | 119413-54-6 | Reference Standards |
| HY-13768C | Topotecan (hydrochloride hydrate) | 1044663-62-8 | Reference compound |
| HY-13768D | Topotecan (acetate) | 123948-88-9 | Reference compound |
| HY-13768S1 | Topotecan-d6 | 1044904-10-0 | Isotope-Labeled Compounds |
| HY-13769 | TPT-260 | 769856-81-7 | Reference compound |
| HY-137693 | ddTTPαS | 158705-77-2 | Reference compound |
| HY-137694B | ddTTP (trisodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-137695 | ddGTPαS | 371195-56-1 | Reference compound |
| HY-137696 | ddCTPαS | 209350-59-4 | Reference compound |
| HY-137697 | ddCTP | 66004-77-1 | Biochemical Assay Reagents |
| HY-137697B | ddCTP (trilithium) | 93939-77-6 | Reference compound |
| HY-137697D | ddCTP (trisodium) | Oligonucleotides | |
| HY-13769A | TPT-260 (Dihydrochloride) | 2076-91-7 | Reference compound |
| HY-13770 | Troxacitabine | 145918-75-8 | Oligonucleotides |
| HY-137701 | ddATPαS | 112820-39-0 | Reference compound |
| HY-137704 | 2′-Deoxy-ADPR | 111864-49-4 | Reference compound |
| HY-137709 | 2'2'-cGAMP | 1465774-27-9 | Reference compound |
| HY-13771 | Ursodeoxycholic acid | 128-13-2 | Natural Products |
| HY-13771A | Ursodeoxycholic acid (sodium) | 2898-95-5 | Natural Products |
| HY-13771R | Ursodeoxycholic acid (Standard) | 128-13-2 | Reference Standards |
| HY-13771S1 | Ursodeoxycholic acid-13C | 63296-46-8 | Isotope-Labeled Compounds |
| HY-13772 | Valrubicin | 56124-62-0 | Reference compound |
| HY-137721 | Cyclic tri-AMP | 54447-85-7 | Reference compound |
| HY-137724 | C-di-IMP | 79940-41-3 | Reference compound |
| HY-137724A | C-di-IMP (disodium) | Reference compound | |
| HY-13772R | Valrubicin (Standard) | 56124-62-0 | Reference Standards |
| HY-13773 | Motolimod | 926927-61-9 | Reference compound |
| HY-137742 | SBP-7455 | 1884222-74-5 | Reference compound |
| HY-13775 | XL019 | 945755-56-6 | Reference compound |
| HY-137756 | JAK2-IN-6 | 353512-04-6 | Reference compound |
| HY-13776 | XR9051 | 762219-35-2 | Reference compound |
| HY-137768 | Captopril EP Impurity B | 80629-35-2 | Reference compound |
| HY-137768R | Captopril EP Impurity B (Standard) | 80629-35-2 | Reference Standards |
| HY-137769 | Captopril EP Impurity C | 26473-47-2 | Reference compound |
| HY-137769R | Captopril EP Impurity C (Standard) | 26473-47-2 | Reference Standards |
| HY-13776A | XR9051 (hydrochloride) | 180422-22-4 | Reference compound |
| HY-13777 | Zoledronic Acid | 118072-93-8 | Reference compound |
| HY-137772 | Captopril EP Impurity E | 23500-15-4 | Reference compound |
| HY-137772R | Captopril EP Impurity E (Standard) | 23500-15-4 | Reference Standards |
| HY-137773 | N-Methyl pemetrexed | 869791-42-4 | Reference compound |
| HY-137774 | Clezutoclax | 1949843-71-3 | Reference compound |
| HY-137776 | Paclitaxel C | 153415-45-3 | Reference compound |
| HY-137776R | Paclitaxel C (Standard) | 153415-45-3 | Reference Standards |
| HY-137778 | 6-Bromo-2-naphthyl β-D-glucopyranoside | 15548-61-5 | Biochemical Assay Reagents |
| HY-137779 | 5-Bromo-4-chloro-3-indolyl β-D-glucopyranoside | 15548-60-4 | Biochemical Assay Reagents |
| HY-13777A | Zoledronic acid (monohydrate) | 165800-06-6 | Reference compound |
| HY-13777AR | Zoledronic acid (monohydrate) (Standard) | 165800-06-6 | Reference Standards |
| HY-13777B | Zoledronic acid (disodium tetrahydrate) | 165800-07-7 | Reference compound |
| HY-13777C | Zoledronate (disodium) | 131654-46-1 | Reference compound |
| HY-13777R | Zoledronic Acid (Standard) | 118072-93-8 | Reference Standards |
| HY-13777S | Zoledronic acid-d5 | Isotope-Labeled Compounds | |
| HY-13777S1 | Zoledronic acid-d3 | 1134798-26-7 | Isotope-Labeled Compounds |
| HY-137781 | Phenyl-β-D-glucuronide | 17685-05-1 | Biochemical Assay Reagents |
| HY-137782 | Palmitoleoyl-CoA | 18198-76-0 | Enzyme |
| HY-137782A | Palmitoleoyl-CoA (triammonium) | 1246304-41-5 | Enzyme |
| HY-137782B | Palmitoleoyl-CoA (lithium) | 324518-22-1 | Enzyme |
| HY-137783 | Resorufin β-D-glucuronide (sodium) | 125440-91-7 | Biochemical Assay Reagents |
| HY-137784 | Boc-Val-Pro-Arg-AMC (hydrochloride) | 70375-24-5 | Dye Reagents |
| HY-137785 | 2-Chloro-4-nitrophenyl-β-D-maltotrioside | 165522-16-7 | Biochemical Assay Reagents |
| HY-137786 | EGFR-IN-16 | 133550-22-8 | Reference compound |
| HY-137787 | Cyanosafracin B | 96996-50-8 | Reference compound |
| HY-137787R | Cyanosafracin B (Standard) | 96996-50-8 | Reference Standards |
| HY-137788 | α-Conotoxin GI | 76862-65-2 | Peptides |
| HY-137789 | Tazofelone | 107902-67-0 | Reference compound |
| HY-13779 | (E/Z)-J147 | 1146963-51-0 | Reference compound |
| HY-137790 | Bicuculline (methochloride) | 38641-83-7 | Reference compound |
| HY-137791 | MMBC | 137350-66-4 | Dye Reagents |
| HY-137793 | Pro-Leu-Gly-NHOH (hydrochloride) | 120928-08-7 | Peptides |
| HY-137794 | Tetramethylkaempferol | 16692-52-7 | Natural Products |
| HY-137798 | Chromozym PL | 88793-79-7 | Peptides |
| HY-137799 | NOBA | 55894-52-5 | Reference compound |
| HY-13779A | J147 | 1807913-16-1 | Reference compound |
| HY-13780 | Vinblastine (sulfate) | 143-67-9 | Natural Products |
| HY-137801 | Sesquicillin A | 51103-58-3 | Natural Products |
| HY-137802 | SAHO2 | 53199-56-7 | Reference compound |
| HY-137805 | Ferrozine | 69898-45-9 | Dye Reagents |
| HY-137806 | Descarbamylnovobiocin | 75057-97-5 | Reference compound |
| HY-137807 | Thymidine 5′-monophosphate p-nitrophenyl ester (sodium) | 98179-10-3 | Reference compound |
| HY-137808 | Succinyl-Coenzyme A (sodium) | 108347-97-3 | Reference compound |
| HY-13780R | Vinblastine (sulfate) (Standard) | 143-67-9 | Reference Standards |
| HY-13781 | Pemetrexed (disodium hemipenta hydrate) | 357166-30-4 | Reference compound |
| HY-137811 | Suc-AAPF-AMC | 88467-45-2 | Peptides |
| HY-137812 | p-Nitrophenyl β-D-lactoside | 4419-94-7 | Biochemical Assay Reagents |
| HY-137813 | PERK-IN-4 | 1337531-89-1 | Reference compound |
| HY-137813S | PERK-IN-4-d3 | Isotope-Labeled Compounds | |
| HY-137814 | 4-Nitrophenyl 4-guanidinobenzoate (hydrochloride) | 19135-17-2 | Reference compound |
| HY-137815 | 4-Nitrophenyl α-L-rhamnopyranoside | 18918-31-5 | Biochemical Assay Reagents |
| HY-137816 | 6-Chloro-3-indolyl-β-D-glucuronide (cyclohexylammonium) | 138182-20-4 | Reference compound |
| HY-137817 | BCH001 | 384859-58-9 | Reference compound |
| HY-137818 | SR19881 | 2213490-89-0 | Reference compound |
| HY-13782 | Tenofovir Disoproxil (fumarate) | 202138-50-9 | Reference compound |
| HY-137820 | Brr2-IN-3 | 2104030-82-0 | Reference compound |
| HY-137822 | p-Nitrophenyl α-D-mannopyranoside | 10357-27-4 | Biochemical Assay Reagents |
| HY-137823 | 4-Nitrophenyl-N-acetyl-β-D-galactosaminide | 14948-96-0 | Reference compound |
| HY-137824 | 4-Methylumbelliferyl-β-D-xylopyranoside | 6734-33-4 | Natural Products |
| HY-137826 | 4-Nitrophenyl β-D-N,N',N''-triacetylchitotriose | 7699-38-9 | Biochemical Assay Reagents |
| HY-137827 | 4-Nitrophenyl β-D-Cellobioside | 3482-57-3 | Dye Reagents |
| HY-137828 | 4-Nitrophenyl N,N′-diacetyl-β-D-chitobioside | 7284-16-4 | Biochemical Assay Reagents |
| HY-137829 | 5-Methyltetrahydrofolic acid (disodium) | 68792-52-9 | Reference compound |
| HY-13782A | Tenofovir Disoproxil | 201341-05-1 | Reference compound |
| HY-13782R | Tenofovir Disoproxil (fumarate) (Standard) | 202138-50-9 | Reference Standards |
| HY-13783 | BIBF0775 | 334951-90-5 | Reference compound |
| HY-137831 | TLBC | 562823-84-1 | Reference compound |
| HY-137833 | Naphthol AS-BI glucuronide | 37-87-6 | Biochemical Assay Reagents |
| HY-137834 | Gly-Pro-AMC (hydrobromide) | 115035-46-6 | Dye Reagents |
| HY-137834A | Gly-Pro-AMC | 67341-40-6 | Peptides |
| HY-137837 | D-Ile-Pro-Arg p-nitroanilide (dihydrochloride) | 96323-41-0 | Reference compound |
| HY-13784 | Pirodavir | 124436-59-5 | Reference compound |
| HY-137840 | Hippuryl-L-phenylalanine | 744-59-2 | Biochemical Assay Reagents |
| HY-137841 | L-Arginine-7-amido-4-methylcoumarin (hydrochloride) | 69304-16-1 | Biochemical Assay Reagents |
| HY-137843 | NSC 80467 | 101982-51-8 | Reference compound |
| HY-137844 | L-Leucine-7-amido-4-methylcoumarin (hydrochloride) | 62480-44-8 | Dye Reagents |
| HY-137845 | 4-Methylumbelliferyl β-D-galactopyranoside | 6160-78-7 | Dye Reagents |
| HY-137847 | 5-Bromo-4-chloro-3-indolyl sulfate (potassium) | 6578-07-0 | Biochemical Assay Reagents |
| HY-137848 | Thymine 1-β-D-arabinofuranoside | 605-23-2 | Reference compound |
| HY-137849 | RK-582 | 2171388-28-4 | Reference compound |
| HY-13785 | ZM 306416 | 690206-97-4 | Reference compound |
| HY-137851 | S-Pyruvylglutathione | 54398-03-7 | Peptides |
| HY-137853 | 4-Methylumbelliferyl-2-acetamido-2-deoxy-β-D-Glucopyranoside | 37067-30-4 | Dye Reagents |
| HY-137854 | Naphthol AS-BI N-acetyl-β-D-glucosaminide | 3395-37-7 | Biochemical Assay Reagents |
| HY-137855 | 4-Methylumbelliferyl sulfate (potassium) | 15220-11-8 | Biochemical Assay Reagents |
| HY-137858 | H-Gly-Arg-pNA (hydrochloride) | 125455-61-0 | Dye Reagents |
| HY-137859 | L-Proline 7-amido-4-methylcoumarin hydrobromide | 115388-93-7 | Biochemical Assay Reagents |
| HY-13786 | O6BTG-C8-αGlu | 793035-88-8 | Reference compound |
| HY-137862 | 1-Oleoyl lysophosphatidic acid | 65528-98-5 | Reference compound |
| HY-137862A | (Rac)-1-Oleoyl lysophosphatidic acid | 22002-87-5 | Reference compound |
| HY-137863 | Pemirolast | 69372-19-6 | Reference compound |
| HY-137864 | Amifostine thiol | 31098-42-7 | Reference compound |
| HY-137866 | Tubulin inhibitor 9 | 1151995-69-5 | Reference compound |
| HY-137868 | Decanoyl coenzyme A | 1264-57-9 | Reference compound |
| HY-137868A | Decanoyl coenzyme A (triammonium) | 799812-83-2 | Enzyme |
| HY-137869 | Magenta-β-D-GlcA | 144110-43-0 | Biochemical Assay Reagents |
| HY-137870 | γ-Glutamyl-β-naphthylamide | 14525-44-1 | Biochemical Assay Reagents |
| HY-137871 | Phenolphthalein monophosphate (dicyclohexylammonium) | 14815-59-9 | Biochemical Assay Reagents |
| HY-137872 | L-Leucyl-4-nitroanilide (hydrochloride) | 16010-98-3 | Biochemical Assay Reagents |
| HY-137873 | 4-Methylumbelliferyl-α-D-Glucopyranoside | 17833-43-1 | Dye Reagents |
| HY-137874 | L-Glutamic γ-monohydroxamate | 1955-67-5 | Peptides |
| HY-137875 | N-Benzoyl-Gly-His-Leu (hydrate) | 207386-83-2 | Peptides |
| HY-137877 | 7-Acetoxy-4-methylcoumarin | 2747-05-9 | Reference compound |
| HY-137878 | 2-O-(p-Nitrophenyl)-α-D-N-acetylneuraminic acid | 26112-88-9 | Reference compound |
| HY-13788 | LY 344864 | 186544-26-3 | Reference compound |
| HY-137881 | MEK-IN-4 | 297744-42-4 | Reference compound |
| HY-137882 | Glucocorticoid receptor agonist-1 Ala-Ala-Mal | 2166376-51-6 | Reference compound |
| HY-137883 | Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br | 2344809-82-9 | Reference compound |
| HY-137884 | 3-Indolyl acetate | 608-08-2 | Biochemical Assay Reagents |
| HY-137887 | Nα-Benzoyl-L-arginine-7-amido-4-methylcoumarin hydrochloride | 83701-04-6 | Biochemical Assay Reagents |
| HY-137888A | Oxidized ATP (trisodium salt) | 71997-40-5 | Reference compound |
| HY-13788A | LY 344864 (S-enantiomer) | 186544-27-4 | Reference compound |
| HY-13788B | LY 344864 hydrochloride | 1217756-94-9 | Reference compound |
| HY-13788C | LY 344864 (racemate) | 186543-64-6 | Reference compound |
| HY-137892 | GSK620 | 2088410-46-0 | Reference compound |
| HY-137894A | Tagtociclib (hydrate) | 2733575-91-0 | Reference compound |
| HY-137895 | L-Arginine p-nitroanilide dihydrochloride, 98% | 40127-11-5 | Biochemical Assay Reagents |
| HY-137896 | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (disodium) | 51023-76-8 | Dye Reagents |
| HY-137898 | Avilamycin A | 69787-79-7 | Natural Products |
| HY-137899 | Dephospho-CoA | 3633-59-8 | Natural Products |
| HY-137901 | L-Alanine 4-nitroanilide hydrochloride, 99% | 31796-55-1 | Biochemical Assay Reagents |
| HY-137902 | L-Arginine β-naphthylamide (hydrochloride) | 18905-73-2 | Biochemical Assay Reagents |
| HY-137905 | Pomalidomide-amido-C5-PEG2-C6-chlorine | 1835705-69-5 | Reference compound |
| HY-137907 | 6"-O-Acetylisoquercitrin | 54542-51-7 | Natural Products |
| HY-137908 | 11β-Misoprostol | 58717-36-5 | Reference compound |
| HY-137909 | Formoterol O-β-D-glucuronide | 615551-59-2 | Reference compound |
| HY-137910 | Tembotrione | 335104-84-2 | Reference compound |
| HY-137910R | Tembotrione (Standard) | 335104-84-2 | Reference Standards |
| HY-137911 | Sparsomycin | 1404-64-4 | Reference compound |
| HY-137912 | trans-Resveratrol-3-O-β-D-Glucuronide | 387372-17-0 | Reference compound |
| HY-137912S1 | Resveratrol-3-O-beta-D-glucuronide-13C6 | Isotope-Labeled Compounds | |
| HY-137916 | L-Histidine 7-amido-4-methylcoumarin | 191723-64-5 | Biochemical Assay Reagents |
| HY-137918 | TGF-βRI inhibitor 3 | 666729-57-3 | Reference compound |
| HY-137919 | Fluticasone 17β-carboxylic acid | 28416-82-2 | Reference compound |
| HY-137920 | Salvinorin A propionate | 689295-71-4 | Reference compound |
| HY-137922 | SHS4121705 | 2379550-82-8 | Reference compound |
| HY-137924 | JA2131 | 6505-99-3 | Reference compound |
| HY-137927 | Benapenem | 1312953-83-5 | Reference compound |
| HY-137928 | H-Ala-4MβNA (hydrochloride) | 3438-14-0 | Dye Reagents |
| HY-137929 | Deoxygerfelin | 36149-01-6 | Reference compound |
| HY-137931 | Testololactone | 4416-57-3 | Reference compound |
| HY-137932 | Resveratrol-3-O-sulfate (sodium) | 858127-11-4 | Reference compound |
| HY-137933 | 5,6,7-Trimethoxycoumarin | 55085-47-7 | Natural Products |
| HY-137934 | Deacetylforskolin | 64657-20-1 | Natural Products |
| HY-137936 | Terrecyclic Acid | 83058-94-0 | Reference compound |
| HY-137938 | Radicinol | 65647-66-7 | Natural Products |
| HY-137940 | β-Gentiobiose | 554-91-6 | Natural Products |
| HY-137941 | Roxatidine | 78273-80-0 | Reference compound |
| HY-137941R | Roxatidine (Standard) | 78273-80-0 | Reference Standards |
| HY-137941S | Roxatidine-d10 (hemioxalate) | Isotope-Labeled Compounds | |
| HY-137942 | 1-Naphthyl phosphate disodium salt, 98% | 2183-17-7 | Biochemical Assay Reagents |
| HY-137944 | 5α-Dihydro levonorgestrel | 78088-19-4 | Reference compound |
| HY-137945 | Phenethicillin (sodium) | 30302-52-4 | Reference compound |
| HY-137945R | Phenethicillin (sodium) (Standard) | 30302-52-4 | Reference Standards |
| HY-137946 | L-Leucine 4-methoxy-β-naphthylamide (hydrochloride) | 4467-68-9 | Peptides |
| HY-137949 | Formoxanthone A | 869880-32-0 | Natural Products |
| HY-137950 | Fmoc-Asp(OtBu)-Osu | 78553-23-8 | Peptides |
| HY-137951 | Metizolam | 40054-68-0 | Reference compound |
| HY-137954 | GRL-0496 | 1087243-14-8 | Reference compound |
| HY-137955 | MRS 2211 (sodium hydrate) | 1197030-56-0 | Reference compound |
| HY-137956 | Previridicatumtoxin | 1379585-81-5 | Reference compound |
| HY-137957 | Longiferone B | 1639810-67-5 | Natural Products |
| HY-137958 | Bemnifosbuvir (hemisulfate) | 2241337-84-6 | Reference compound |
| HY-137958A | Bemnifosbuvir | 1998705-64-8 | Reference compound |
| HY-137959 | Telmisartan acyl-β-D-glucuronide | 250780-40-6 | Biochemical Assay Reagents |
| HY-13796 | IPSU | 1373765-19-5 | Reference compound |
| HY-137960 | O,O-Dimethyl-cannabigerol | 29106-16-9 | Reference compound |
| HY-137961 | Cannabigerol monomethyl ether | 29106-17-0 | Reference compound |
| HY-137963 | Daidzein 4'-β-D-glucuronide | 264236-77-3 | Reference compound |
| HY-137966A | N-Desethyl Brinzolamide (oxalate) | 2775292-24-3 | Reference compound |
| HY-137967 | Genistein 7-β-D-Glucuronide | 38482-81-4 | Reference compound |
| HY-137968 | Avermectin B1a aglycon | 71828-14-3 | Reference compound |
| HY-137970 | Spinosyn D aglycone | 149439-79-2 | Reference compound |
| HY-137974 | 8-Epixanthatin | 30890-35-8 | Reference compound |
| HY-137975 | Exo2 | 304684-77-3 | Reference compound |
| HY-137976 | Penehyclidine (hydrochloride) | 151937-76-7 | Reference compound |
| HY-137977 | DMU-212 | 134029-62-2 | Reference compound |
| HY-137978 | Ezurpimtrostat | 1914148-72-3 | Reference compound |
| HY-137978A | Ezurpimtrostat (hydrochloride) | 1914148-73-4 | Reference compound |
| HY-137979 | Flunitrazolam | 2243815-18-9 | Reference compound |
| HY-137980 | Carbonate ionophore VII | 222310-82-9 | Reference compound |
| HY-137983 | 3-O-Acetylbetulin | 27570-20-3 | Reference compound |
| HY-137984 | Cnicin | 24394-09-0 | Reference compound |
| HY-137985 | Mer-NF5003F | 149598-70-9 | Reference compound |
| HY-137986 | LUF7244 | 1821638-43-0 | Reference compound |
| HY-137988 | Palvanil | 69693-13-6 | Natural Products |
| HY-137989 | Voriconazole N-oxide | 618109-05-0 | Reference compound |
| HY-137989A | Voriconazole N-oxide (hydrochloride) | Reference compound | |
| HY-137989S | Voriconazole N-oxide-d3 | 1217851-84-7 | Isotope-Labeled Compounds |
| HY-137990 | Questin | 3774-64-9 | Natural Products |
| HY-137992 | Aucuparin | 3687-28-3 | Reference compound |
| HY-137994 | Deschloroetizolam | 40054-73-7 | Reference compound |
| HY-137996 | Dehydrovomifoliol | 39763-33-2 | Natural Products |
| HY-138001 | WH-4-025 | 1876463-35-2 | Reference compound |
| HY-138007 | SR-1903 | 1414248-06-8 | Reference compound |
| HY-13801 | Fexinidazole | 59729-37-2 | Reference compound |
| HY-138011 | Dolutegravir O-β-D-glucuronide | 1485692-21-4 | Reference compound |
| HY-138013 | PF-06663195 | 1621585-22-5 | Reference compound |
| HY-138014 | Cinazepam | 172986-25-3 | Reference compound |
| HY-13801R | Fexinidazole (Standard) | 59729-37-2 | Reference Standards |
| HY-13802 | SC-514 | 354812-17-2 | Reference compound |
| HY-138023 | Leucomycin A4 | 18361-46-1 | Natural Products |
| HY-138026 | (3β)-3-Hydroxy-7-oxochol-5-en-24-oic acid | 25218-38-6 | Reference compound |
| HY-13803 | Tazemetostat | 1403254-99-8 | Reference compound |
| HY-138031 | Pteroylhexaglutamate | 35409-55-3 | Reference compound |
| HY-138035 | Tenellin | 53823-15-7 | Reference compound |
| HY-138037 | Aminopeptidase N inhibitor 1 | 596108-59-7 | Reference compound |
| HY-13803R | Tazemetostat (Standard) | 1403254-99-8 | Reference Standards |
| HY-13804 | PP1 | 172889-26-8 | Reference compound |
| HY-138040 | CRBN modulator-1 | 2407829-65-4 | Reference compound |
| HY-13805 | PP2 | 172889-27-9 | Reference compound |
| HY-138050 | Nyasol | 96895-25-9 | Natural Products |
| HY-138051 | TUPS | 950184-27-7 | Reference compound |
| HY-138053 | Ristocetin A (sulfate) | 90831-71-3 | Reference compound |
| HY-138054 | Cjoc42 | 2171519-89-2 | Reference compound |
| HY-138056 | 7-Acetyl paclitaxel | 92950-39-5 | Reference compound |
| HY-138058 | AF-CX 921 | 77946-49-7 | Reference compound |
| HY-138059 | SM-433 | 1071992-81-8 | Reference compound |
| HY-138059A | SM-433 (hydrochloride) | Reference compound | |
| HY-13806 | XL388 | 1251156-08-7 | Reference compound |
| HY-138060 | Moperone (hydrochloride) | 3871-82-7 | Reference compound |
| HY-138061 | DENV-IN-2 | 2253675-62-4 | Reference compound |
| HY-138063 | Siegeskaurolic acid | 52645-97-3 | Natural Products |
| HY-138064 | 4-APC (hydrobromide) | 1076196-38-7 | Reference compound |
| HY-138065 | Iodoacetyl-LC-biotin | 93285-75-7 | Reference compound |
| HY-138067 | SSAA09E2 | 883944-52-3 | Reference compound |
| HY-138068 | L-Tryptophanylglycine | 7360-09-0 | Reference compound |
| HY-13807 | UNC0646 | 1320288-17-2 | Reference compound |
| HY-138071 | 8α-Tigloyloxyhirsutinolide 13-O-acetate | 83182-58-5 | Natural Products |
| HY-138072 | EMI1 | 35773-42-3 | Reference compound |
| HY-138073 | Cryptomoscatone D2 | 276856-55-4 | Reference compound |
| HY-138074 | Milbemycin A4 oxime | 93074-04-5 | Reference compound |
| HY-138075 | Obafluorin | 92121-68-1 | Reference compound |
| HY-138077 | LSM-775 (maleate) | 101896-80-4 | Reference compound |
| HY-138078 | Lufotrelvir | 2468015-78-1 | Reference compound |
| HY-138079 | 2′,3′-cGMP (triethylamine) | 73647-09-3 | Reference compound |
| HY-13808 | UNC 0631 | 1320288-19-4 | Reference compound |
| HY-138081 | Mesulergine | 64795-35-3 | Reference compound |
| HY-138083 | Parvodicin C2 | 110882-85-4 | Natural Products |
| HY-138084 | SIC5-6 | 2410846-16-9 | Reference compound |
| HY-138088 | (+)-Epoxysuberosin | 80368-68-9 | Reference compound |
| HY-138089 | 17β-Hydroxy exemestane | 122370-91-6 | Reference compound |
| HY-138089S | 17β-Hydroxy exemestane-d3 | Isotope-Labeled Compounds | |
| HY-13809 | BMS-833923 | 1059734-66-5 | Reference compound |
| HY-138094 | N-(2-Hydroxyethyl)oxamic acid | 5270-73-5 | Reference compound |
| HY-138095 | ALEPH-4 | 123643-26-5 | Reference compound |
| HY-138096 | Z-LLF-CHO | 133429-58-0 | Peptides |
| HY-138097 | α-NETA | 115066-04-1 | Reference compound |
| HY-138098 | Sartorypyrone B | 1452396-11-0 | Natural Products |
| HY-13810 | PF-04880594 | 1111636-35-1 | Reference compound |
| HY-138100 | Hyalodendrin | 51920-94-6 | Natural Products |
| HY-138102 | SSAA09E3 | 52869-18-8 | Reference compound |
| HY-138104 | SL-164 | 3476-88-8 | Reference compound |
| HY-138106 | Fmoc-D-Cit-OH | 200344-33-8 | Peptides |
| HY-138107 | Arimistane | 1420-49-1 | Reference compound |
| HY-138109 | D-Pro-Phe-Arg-pNA (hydrochloride) | 62354-56-7 | Peptides |
| HY-13811 | NSC697923 | 343351-67-7 | Reference compound |
| HY-138110 | Toladryl | 19804-27-4 | Reference compound |
| HY-138110R | Toladryl (Standard) | 19804-27-4 | Reference Standards |
| HY-138111 | 4-Nitrophenyl β-D-cellotetraoside | 129411-62-7 | Dye Reagents |
| HY-138112S | β-Dihydroequilin-d3 | 350820-03-0 | Isotope-Labeled Compounds |
| HY-138112S1 | β-Dihydroequilin-d5 | Isotope-Labeled Compounds | |
| HY-138112S2 | β-Dihydroequilin-d4 | 350819-99-7 | Isotope-Labeled Compounds |
| HY-138113 | Pyrrothiogatain | 477888-48-5 | Reference compound |
| HY-138115 | 7ß,27-Dihydroxycholesterol | 240129-43-5 | Reference compound |
| HY-138118 | Propyl nicotinate | 7681-15-4 | Reference compound |
| HY-138119 | γ-Glutamylserine | 5875-35-4 | Reference compound |
| HY-138119A | γ-Glutamylserine (TFA) | Peptides | |
| HY-13812 | QNZ | 545380-34-5 | Reference compound |
| HY-138121 | PSB-KD107 | 955121-65-0 | Reference compound |
| HY-138122 | Porphine | 101-60-0 | Reference compound |
| HY-138123 | Fmoc-Glu(OtBu)-OSu | 101214-22-6 | Reference compound |
| HY-138126 | Dansyl-Tyr-Val-Gly | 113527-49-4 | Peptides |
| HY-138126A | Dansyl-Tyr-Val-Gly (TFA) | 350691-68-8 | Reference compound |
| HY-138127 | Gendenafil | 147676-66-2 | Reference compound |
| HY-138128 | Acetaminophen mercapturate | 52372-86-8 | Reference compound |
| HY-13813 | Blebbistatin | 674289-55-5 | Reference compound |
| HY-138130 | L-Guanosine | 26578-09-6 | Oligonucleotides |
| HY-138131 | SOD1-Derlin-1 inhibitor-1 | 840461-03-2 | Reference compound |
| HY-138134 | NOTP | 83834-39-3 | Biochemical Assay Reagents |
| HY-138136 | Ticlatone | 70-10-0 | Reference compound |
| HY-138137 | Menaquinone 6 | 84-81-1 | Natural Products |
| HY-138139A | AXC-715 (hydrochloride) | 2490497-93-1 | Reference compound |
| HY-138139B | AXC-715 (trihydrochloride) | 2479276-17-8 | Reference compound |
| HY-13814 | PR-619 | 2645-32-1 | Reference compound |
| HY-138140 | Desertomycin A | 121820-50-6 | Natural Products |
| HY-138142 | Euphol acetate | 13879-04-4 | Natural Products |
| HY-138143 | N-(p-Tosyl)-GPR-pNA (acetate) | 86890-95-1 | Dye Reagents |
| HY-138144 | Myceliothermophin E | 955083-90-6 | Natural Products |
| HY-138145 | 8-Acetyl-7-hydroxycoumarin | 6748-68-1 | Natural Products |
| HY-138146 | 4-Dehydrowithaferin A | 6850-30-2 | Natural Products |
| HY-138147 | DCP-Rho1 | 1001575-98-9 | Dye Reagents |
| HY-138148 | 13(S)-HPOTrE(γ) | 121107-97-9 | Reference compound |
| HY-138149 | 2-epi-Abamectin | 106434-14-4 | Reference compound |
| HY-13815 | KY02111 | 1118807-13-8 | Reference compound |
| HY-138151 | 3'-Hydroxy stanozolol | 125709-39-9 | Reference compound |
| HY-138152 | Z-D-Arg-Gly-Arg-pNA (dihydrochloride) | 113711-77-6 | Peptides |
| HY-138153 | JKE-1674 | 2421119-60-8 | Reference compound |
| HY-138154 | BLX-3887 | 934758-70-0 | Reference compound |
| HY-138155 | NSC15520 | 730960-98-2 | Reference compound |
| HY-138159 | Boc-Lys(Ac)-AMC | 233691-67-3 | Dye Reagents |
| HY-13816 | NU6027 | 220036-08-8 | Reference compound |
| HY-138161 | JR14a | 2411440-41-8 | Reference compound |
| HY-138162 | 5-Methoxy EiPT | 850032-66-5 | Reference compound |
| HY-138164 | Cafestol palmitate | 81760-46-5 | Reference compound |
| HY-138165 | Ac-Phe-NH2 | 7376-90-1 | Reference compound |
| HY-138166 | Rosuvastatin lactone | 503610-43-3 | Reference compound |
| HY-138166R | Rosuvastatin lactone (Standard) | 503610-43-3 | Reference Standards |
| HY-138166S | Rosuvastatin lactone-d6 | Isotope-Labeled Compounds | |
| HY-13817 | IU1 | 314245-33-5 | Reference compound |
| HY-138170 | ALC-0315 | 2036272-55-4 | Oligonucleotides |
| HY-138170A | ALC-0315 (Excipient) | 2036272-55-4 | Reference compound |
| HY-138171 | Lipid 5 | 2089251-33-0 | Biochemical Assay Reagents |
| HY-138176 | 7-Hydroxyrisperidone | 147663-04-5 | Reference compound |
| HY-138177 | Butyryl-Coenzyme A (sodium) | 125527-24-4 | Enzyme |
| HY-138179 | 7-APRA | 120709-09-3 | Reference compound |
| HY-13818 | Stattic | 19983-44-9 | Reference compound |
| HY-138181 | Contezolid phosphoramidic acid | 1807365-43-0 | Reference compound |
| HY-138185 | Collismycin A | 158792-24-6 | Natural Products |
| HY-138187 | 4-Hydroxy omeprazole sulfide | 103876-98-8 | Reference compound |
| HY-138188 | KRA-533 | 10161-87-2 | Reference compound |
| HY-13819 | MK-8745 | 885325-71-3 | Reference compound |
| HY-138192 | Octyl glucose neopentyl glycol | 1257853-32-9 | Reference compound |
| HY-138193 | Lauryl maltose neopentyl glycol | 1257852-96-2 | Reference compound |
| HY-138194 | Destomycin B | 11005-98-4 | Natural Products |
| HY-138196 | 5-Oxorosuvastatin methyl ester | 147118-39-6 | Reference compound |
| HY-138199S | Omeprazole sulfone N-oxide-13C,d3 | 2740875-18-5 | Isotope-Labeled Compounds |
| HY-138199S1 | Omeprazole sulfone N-oxide-d3 | 2748468-58-6 | Isotope-Labeled Compounds |
| HY-13820 | GSK2656157 | 1337532-29-2 | Reference compound |
| HY-138200 | Cy5 maleimide | 1437796-65-0 | Dye Reagents |
| HY-138201 | IM-93 | 1173657-73-2 | Reference compound |
| HY-138202 | Lck-IN-1 | 923596-52-5 | Reference compound |
| HY-138203 | Z-LE(OMe)TD(OMe)-FMK | 210344-93-7 | Peptides |
| HY-138206 | Prostaglandin E1 isopropyl ester | 217182-28-0 | Reference compound |
| HY-138207 | N-Oleoyl-L-phenylalanine | 136560-78-6 | Peptides |
| HY-138208 | Z-Phe-Tyr(tBu)-diazomethylketone | 114014-15-2 | Reference compound |
| HY-13821 | Epoxomicin | 134381-21-8 | Natural Products |
| HY-138210 | N,O-Diacetyltyramine | 14383-56-3 | Natural Products |
| HY-138211 | BE-26263 | 147716-81-2 | Natural Products |
| HY-138212 | Thiamphenicol palmitate | 52628-58-7 | Biochemical Assay Reagents |
| HY-138213 | Afzelechin-(4α→8)-epiafzelechin | 1383627-30-2 | Natural Products |
| HY-138215 | ADTL-EI1712 | 2414916-45-1 | Reference compound |
| HY-138216 | Despropylene gatifloxacin | 172426-86-7 | Reference compound |
| HY-138217 | Otophylloside B 4'''-O-α-L-cymaropyranoside | 171422-82-5 | Natural Products |
| HY-138218 | ALD-52 | 3270-02-8 | Reference compound |
| HY-13822 | SKI II | 312636-16-1 | Reference compound |
| HY-138222 | JANEX-1 (hydrochloride) | 188829-39-2 | Reference compound |
| HY-138223 | 6-Prenylindole | 23158-16-9 | Natural Products |
| HY-138226 | BODIPY 558/568 C12 | 158757-84-7 | Dye Reagents |
| HY-138227 | 3′-Deoxyadenosine 5′-diphosphate | 13052-95-4 | Reference compound |
| HY-138227A | 3′-Deoxyadenosine 5′-diphosphate (disodium) | 71997-31-4 | Reference compound |
| HY-13823 | C646 | 328968-36-1 | Reference compound |
| HY-138232 | Lys-psi(CH2NH)-Trp(Nps)-OMe | 141365-20-0 | Reference compound |
| HY-138233 | KUS121 | 1357164-52-3 | Reference compound |
| HY-138237 | 25I-NBMD (hydrochloride) | 1539266-14-2 | Reference compound |
| HY-138239 | WEE1-IN-3 | 2272976-28-8 | Reference compound |
| HY-138241 | PBD-BODIPY | 148185-52-8 | Dye Reagents |
| HY-138244 | 8-iso Prostaglandin F2β | 177020-26-7 | Reference compound |
| HY-138246 | Pentynoic acid STP ester (sodium) | 1807530-14-8 | Reference compound |
| HY-138247 | β-Lactamase-IN-2 | 2114651-20-4 | Reference compound |
| HY-138247R | β-Lactamase-IN-2 (Standard) | 2114651-20-4 | Reference Standards |
| HY-138253 | 2′,2′-Difluorodeoxyuridine | 114248-23-6 | Reference compound |
| HY-138253R | 2′,2′-Difluorodeoxyuridine (Standard) | 114248-23-6 | Reference Standards |
| HY-138253S | 2′,2′-Difluorodeoxyuridine-13C,15N2 | 1233921-75-9 | Isotope-Labeled Compounds |
| HY-138257 | (S)-Indeloxazine (benzenesulfonate) | 1214994-13-4 | Reference compound |
| HY-138257A | (R)-Indeloxazine (benzenesulfonate) | 1623762-83-3 | Reference compound |
| HY-138267 | 7-O-Acetylneocaesalpin N | 1309079-08-0 | Natural Products |
| HY-138269 | Barzuxetan | 157380-45-5 | Reference compound |
| HY-138269A | Barzuxetan (hydrochloride) | Biochemical Assay Reagents | |
| HY-13827 | JAK-IN-1 | 1334673-53-8 | Reference compound |
| HY-138270 | Tetrahydropteroylpentaglutamate | 41520-73-4 | Natural Products |
| HY-138271 | LH65.3 | 1494676-74-2 | Reference compound |
| HY-138273 | Sulfosuccinimidyl myristate (sodium) | 162823-01-0 | Reference compound |
| HY-138280 | DTHIB | 897326-30-6 | Reference compound |
| HY-138281 | Complement factor D-IN-2 | 1903742-34-6 | Reference compound |
| HY-138283 | MR837 | 1210906-48-1 | Reference compound |
| HY-138284 | Avenanthramide-C methyl ester | 955382-52-2 | Reference compound |
| HY-138287 | 4'-Aminomethyl-4,5',8-trimethylpsoralen | 64358-50-5 | Reference compound |
| HY-138289 | 4-acetoxy MPT | 2173386-55-3 | Reference compound |
| HY-13829 | BMS-585248 | 619331-12-3 | Reference compound |
| HY-138290 | Diclofenac acyl-β-D-glucuronide allyl ester | 698358-10-0 | Reference compound |
| HY-138291 | Ethoxyquin dimer | 74681-77-9 | Reference compound |
| HY-138293 | SY-5609 | 2417302-07-7 | Reference compound |
| HY-138294 | RAS/RAS-RAF-IN-1 | 2447039-81-6 | Reference compound |
| HY-138295 | KRAS inhibitor-10 | 2578876-75-0 | Reference compound |
| HY-138298 | Trastuzumab deruxtecan (solution) | 1826843-81-5 | ADC Related |
| HY-138298A | Trastuzumab deruxtecan | 1826843-81-5 | ADC Related |
| HY-138300 | ALC-0159 | 1849616-42-7 | Oligonucleotides |
| HY-138300A | ALC-0159 (Excipient) | 1849616-42-7 | Reference compound |
| HY-138301 | Miclxin | 2494198-61-5 | Reference compound |
| HY-138304 | CC-90001 | 1403859-14-2 | Reference compound |
| HY-138305 | HCV-IN-31 | 1998705-62-6 | Reference compound |
| HY-138307 | NH2-PEG-Strt (MW 10000) | Reference compound | |
| HY-138308 | NH2-PEG-Strt (MW 3000) | Reference compound | |
| HY-13831 | BPTU | 870544-59-5 | Reference compound |
| HY-138310 | Thiol-PEG-COOH (MW 5000) | Reference compound | |
| HY-138311 | Boc-NH-PEG-Thiol (MW 10000) | Reference compound | |
| HY-138312 | m-PEG1000-CH2COOH | Reference compound | |
| HY-138314 | m-PEG16-COOH | 2933174-52-6 | Reference compound |
| HY-138315 | Ms-PEG6-THP | 42607-89-6 | Reference compound |
| HY-138316 | THP-PEG10-C2-Boc | Reference compound | |
| HY-138317 | Tyk2-IN-10 | 2368945-72-4 | Reference compound |
| HY-138318 | DBCO-PEG3-amide-N-Fmoc | Reference compound | |
| HY-138319 | Benzyl-PEG25-amine | Reference compound | |
| HY-13832 | Atovaquone | 95233-18-4 | Reference compound |
| HY-138320 | Fmoc-N-amido-PEG36-Boc | Reference compound | |
| HY-138321 | Propargyl-PEG6-Br | 1973383-30-0 | Reference compound |
| HY-138322 | N-trifluoroacetyl-β-alanyl chloride | 87639-76-7 | ADC Related |
| HY-138323 | Benzyl-PEG36-alcohol | Reference compound | |
| HY-138324 | Ms-PEG6-MS | 109789-40-4 | Reference compound |
| HY-138325 | Azido-PEG6-THP | Reference compound | |
| HY-138326 | Bis-PEG18-Boc | Reference compound | |
| HY-138327 | 1,6-Bis(mesyloxy)hexane | 4239-24-1 | ADC Related |
| HY-138328 | Benzyl-PEG18-MS | Reference compound | |
| HY-138329 | THP-PEG24-THP | Reference compound | |
| HY-13832R | Atovaquone (Standard) | 95233-18-4 | Reference Standards |
| HY-13832S | Atovaquone-d4 | 2070015-14-2 | Isotope-Labeled Compounds |
| HY-13832S2 | Atovaquone-d5 | 1329792-63-3 | Isotope-Labeled Compounds |
| HY-13832S3 | cis-Atovaquone-d4 | Isotope-Labeled Compounds | |
| HY-13833 | Endochin | 354155-51-4 | Reference compound |
| HY-138330 | Fmoc-PEG5-NHBoc | Reference compound | |
| HY-138331 | Fmoc-N-amido-PEG6-amine | Reference compound | |
| HY-138332 | Benzyl-PEG24-MS | 2218463-20-6 | Reference compound |
| HY-138333 | Azido-PEG7-PFP ester | Reference compound | |
| HY-138334 | Propargyl-PEG1-THP | 119096-95-6 | Reference compound |
| HY-138335 | Boc-PEG8-Boc | 1432970-18-7 | Reference compound |
| HY-138336 | Br-PEG3-MS | 2702323-73-5 | Reference compound |
| HY-138337 | MS-PEG8-THP | Reference compound | |
| HY-138338 | Benzyl-PEG9-THP | 669556-53-0 | Reference compound |
| HY-138339 | Benzyl-PEG8-Br | Reference compound | |
| HY-13834 | GW844520 | 137735-25-2 | Reference compound |
| HY-138340 | THP-PEG8-Boc | Reference compound | |
| HY-138341 | Benzyl-PEG10-THP | Reference compound | |
| HY-138342 | Benzyl-PEG1-MS | 58841-52-4 | Reference compound |
| HY-138343 | Azido-PEG3-MS | 176520-24-4 | Reference compound |
| HY-138344 | MS-PEG10-THP | 42607-91-0 | Reference compound |
| HY-138345 | Benzyl-PEG11-Boc | Reference compound | |
| HY-138346 | Benzyl-PEG4-Boc | 2484091-04-3 | Reference compound |
| HY-138347 | THP-PEG10-Boc | Reference compound | |
| HY-138348 | THP-PEG2-methyl propionate | Reference compound | |
| HY-138349 | THP-PEG6-C2-Boc | Reference compound | |
| HY-138350 | Azido-PEG10-CH2CO2-NHS | Reference compound | |
| HY-138351 | Propargyl-PEG4-thioacetyl | Reference compound | |
| HY-138352 | THP-PEG4-Boc | Reference compound | |
| HY-138354 | Pyrroline-5-carboxylate | 2139-03-9 | Reference compound |
| HY-138354A | Pyrroline-5-carboxylate (sodium) | 72978-16-6 | Reference compound |
| HY-138355 | CHO-CH2-PEG1-CH2-Boc | 2230956-95-1 | Reference compound |
| HY-138358 | Azido-PEG23-C2-azide | Reference compound | |
| HY-13836 | ELQ-300 | 1354745-52-0 | Reference compound |
| HY-138360 | Benzyl-PEG18-THP | Reference compound | |
| HY-138362 | Br-PEG6-C2-acid | 309916-91-4 | Reference compound |
| HY-138363 | Azido-PEG6-MS | 352439-38-4 | Reference compound |
| HY-138364 | YUM70 | 423145-35-1 | Reference compound |
| HY-138365 | EMAC10101d | 2561476-24-0 | Reference compound |
| HY-138366 | Propargyl-PEG11-alcohol | Reference compound | |
| HY-138367 | Benzyl-PEG3-methyl ester | 127457-61-8 | Reference compound |
| HY-138368 | THP-PEG1-Boc | Reference compound | |
| HY-138369 | Methylamino-PEG3-benzyl | Reference compound | |
| HY-138370 | Boc-NH-PEG4-C2-Boc | 2138484-13-4 | Reference compound |
| HY-138371 | MS-PEG12-THP | 552886-58-5 | Reference compound |
| HY-138372 | Br-PEG4-THP | 1803547-60-5 | Reference compound |
| HY-138373 | Boc-PEG5-methyl ester | 1807530-04-6 | Reference compound |
| HY-138374 | Azido-PEG12-THP | Reference compound | |
| HY-138375 | Mal-PEG5-C2-NH2 (hydrochloride) | 2454216-21-6 | Reference compound |
| HY-138376 | Benzyl-PEG12-MS | Reference compound | |
| HY-138377 | Azido-PEG8-C-Boc | 1984776-39-7 | Reference compound |
| HY-138378 | Benzyl-PEG5-NHBoc | 2064292-55-1 | Reference compound |
| HY-138379 | Boc-PEG4-acid | 2244684-38-4 | Reference compound |
| HY-13838 | PLX647 | 873786-09-5 | Reference compound |
| HY-138380 | Mal-PEG4-C2-NH2 (TFA) | 2512227-13-1 | Reference compound |
| HY-138381 | Br-PEG6-C2-NHBoc | 2688072-13-9 | Reference compound |
| HY-138382 | m-PEG4-PFP ester | 2952895-31-5 | Reference compound |
| HY-138383 | CHO-C-PEG2-C-CHO | 92351-72-9 | Reference compound |
| HY-138384 | Br-PEG9-C2-NHBoc | Reference compound | |
| HY-138385 | MS-PEG5-THP | Reference compound | |
| HY-138386 | endo-BCN-PEG12-NH2 (hydrochloride) | Reference compound | |
| HY-138387 | 6-Azido-hexylamine | 349553-73-7 | ADC Related |
| HY-138388 | Azido-PEG4-formylhydrazine-Boc | Reference compound | |
| HY-138389 | THP-PEG13-OH | Reference compound | |
| HY-13838A | PLX647 (dihydrochloride) | 1779796-38-1 | Reference compound |
| HY-138390 | NH2-PEG10-C2-dimethylamino | Reference compound | |
| HY-138391 | Azido-PEG8-propargyl | 1196733-06-8 | Reference compound |
| HY-138392 | Mal-PEG25-NH2 (hydrochloride) | Reference compound | |
| HY-138393 | Benzyl-PEG6-acid | Reference compound | |
| HY-138395 | DSPE-PEG6-Mal | Reference compound | |
| HY-138396 | Rhodamine B PEG2-NH2 | Reference compound | |
| HY-138397 | Boc-NH-PEG15-C2-acid | Reference compound | |
| HY-138398 | BOC-NH-PEG2-propene | 2410236-85-8 | Reference compound |
| HY-138399 | Boc-NH-PEG22-C2-NH2 | Reference compound | |
| HY-138400 | Me-PEG18-NH2 | Reference compound | |
| HY-138401 | Dimethylamine-PEG19 | Reference compound | |
| HY-138402 | Boc-NH-PEG15-C1-acid | Reference compound | |
| HY-138403 | THP-C1-PEG5 | Reference compound | |
| HY-138404 | THP-PEG2-Mal | Reference compound | |
| HY-138406 | Boc-NH-PEG8-C2-Br | 2688072-12-8 | Reference compound |
| HY-138407 | Evixapodlin | 2374856-75-2 | Reference compound |
| HY-138408 | BocNH-PEG4-CH2CHO | 2708026-80-4 | Reference compound |
| HY-138409 | Dimethylamino-PEG11 | Reference compound | |
| HY-138410 | Boc-NH-PEG11-C2-acid | Reference compound | |
| HY-138411 | Cl-PEG6-acid | 2365309-92-6 | Reference compound |
| HY-138412 | Bromoacetic-PEG2-NHS ester | Reference compound | |
| HY-138413 | THP-PEG10-OH | 42607-90-9 | Reference compound |
| HY-138414 | Bromoacetic-PEG1-CH2-NHS ester | Reference compound | |
| HY-138415 | Azido-PEG11-CH2COOH | 2567584-97-6 | Reference compound |
| HY-138416 | Azido-PEG10-CH2COOH | Reference compound | |
| HY-138417 | Azido-PEG9-CH2COOH | Reference compound | |
| HY-138418 | Azido-PEG7-CH2COOH | 1446411-32-0 | Reference compound |
| HY-138419 | Biotin-PEG6-Silane | Reference compound | |
| HY-13842 | BX517 | 850717-64-5 | Reference compound |
| HY-138420 | m-PEG7-Silane | Reference compound | |
| HY-138421 | Hydroxy-PEG4-methyl acetate | 77303-64-1 | Reference compound |
| HY-138422 | Iodoacetyl-PEG4-NHS ester | 2517899-65-7 | Reference compound |
| HY-138423 | Acryloyl-PEG4-OH | 26150-06-1 | Reference compound |
| HY-138424 | m-PEG15-amine | Reference compound | |
| HY-138425 | Amino-PEG12-C2-azide | Reference compound | |
| HY-138426 | Biotin-PEG4-allyl | 1643661-79-3 | Reference compound |
| HY-138427 | m-PEG18-Mal | Reference compound | |
| HY-138428 | m-PEG9-Mal | Reference compound | |
| HY-138429 | COQ7-IN-2 | 2579696-76-5 | Reference compound |
| HY-138430 | Mal-PEG2-NHS | 329364-72-9 | Reference compound |
| HY-138432 | Boc-NH-PEG26-C2-NH2 | Reference compound | |
| HY-138433 | Benzyl-PEG1-propanol | 131326-24-4 | Reference compound |
| HY-138434 | Fmoc-NH-PEG14-acid | Reference compound | |
| HY-138435 | Azido-PEG13-acid | Reference compound | |
| HY-138436 | PEG2-ethyl acetate | 154773-33-8 | Reference compound |
| HY-138437 | Azido-PEG8-TFP ester | 1818294-49-3 | Reference compound |
| HY-138438 | Azido-PEG3-amino-OPSS | Reference compound | |
| HY-13844 | PDK1-IN-3 | 853909-77-0 | Reference compound |
| HY-138441 | Boc-NH-PEG11-NHS ester | Reference compound | |
| HY-138442 | Benzyl-PEG16-THP | Reference compound | |
| HY-138444 | Benzyl-PEG18-alcohol | Reference compound | |
| HY-138446 | Amino-PEG4-C2-SH (hydrochloride) | Reference compound | |
| HY-138447 | Mal-NH-PEG8-Boc | Reference compound | |
| HY-138448 | m-PEG750-Br | Reference compound | |
| HY-138449 | m-PEG6-Boc | Reference compound | |
| HY-138450 | Br-PEG4-methyl acetate | Reference compound | |
| HY-138451 | Amino-PEG7-C2-SH (hydrochloride) | Reference compound | |
| HY-138453 | ACT-1016-0707 | 2569467-78-1 | Reference compound |
| HY-138454 | MEG (hemisulfate) | 3979-00-8 | Reference compound |
| HY-138455 | Bis-isopropyl-PEG1 | 3944-35-2 | Reference compound |
| HY-138456 | Benzyl-PEG20-alcohol | Reference compound | |
| HY-138457 | Azido-PEG20-Boc | Reference compound | |
| HY-138459 | Propargyl-PEG9-THP | Reference compound | |
| HY-13846 | BM-1074 | 1391108-10-3 | Reference compound |
| HY-138460 | Propargyl-PEG10-alcohol | 2378150-09-3 | Reference compound |
| HY-138461 | Azido-PEG1 | 1517-05-1 | Reference compound |
| HY-138462 | Methyl acetate-PEG2-propanol | Reference compound | |
| HY-138463 | Azido-PEG36-NHS ester | Reference compound | |
| HY-138464 | Br-Boc-C2-azido | 1120364-53-5 | Reference compound |
| HY-138465 | THP-C4-PEG4 | Reference compound | |
| HY-138466 | Azido-PEG3-C6-Cl | 1625717-44-3 | Reference compound |
| HY-138467 | Mal-PFP ester | 138194-55-5 | Reference compound |
| HY-138468 | Boc-PEG25-benzyl | Reference compound | |
| HY-138469 | NH2-PEG3-C6-Cl | 1261350-60-0 | Reference compound |
| HY-13847 | GNE-555 | 1428902-71-9 | Reference compound |
| HY-138470 | Azido-PEG2-C6-Cl | 2568146-55-2 | Reference compound |
| HY-138471 | Azido-PEG2-C6-OH | Reference compound | |
| HY-138472 | Azido-PEG4-THP | 145927-74-8 | Reference compound |
| HY-138473 | Boc-PEG1-Boc | 727729-33-1 | Reference compound |
| HY-138474 | Boc-PEG1-PPG2-C2-azido | Reference compound | |
| HY-138475 | Boc-PEG2-ethoxyethane-PEG2-benzyl | 2111836-22-5 | Reference compound |
| HY-138476 | Benzyl-PEG2-ethoxyethane-PEG2 | 2115897-18-0 | Reference compound |
| HY-138477 | Benzyl-PEG24-THP | Reference compound | |
| HY-138478 | THP-PEG13-Boc | Reference compound | |
| HY-138479 | Benzyl-PEG2-ethanol | 2055300-50-8 | Reference compound |
| HY-13848 | Rugocrixan | 911715-90-7 | Reference compound |
| HY-138480 | Benzyl-PEG13-Boc | Reference compound | |
| HY-138481 | Boc-PEG4-methyl propionate | 2100306-74-7 | Reference compound |
| HY-138482 | MS-PEG1-THP | 1309248-13-2 | Reference compound |
| HY-138483 | THP-PEG9-OH | 669556-83-6 | Reference compound |
| HY-138484 | Folate-PEG3-amine | 710323-40-3 | ADC Related |
| HY-138485 | Boc-PEG1-PPG2-C2-NH2 | Reference compound | |
| HY-138486 | Br-PEG4-acid | 2680525-48-6 | Reference compound |
| HY-138487 | Benzyl-PEG5-acid | 2514948-41-3 | Reference compound |
| HY-138488 | Biotin-PEG4-PFP ester | 1334172-58-5 | ADC Related |
| HY-138489 | TRULI | 1424635-83-5 | Reference compound |
| HY-138490 | Iodoacetyl-PEG8-biotin | Reference compound | |
| HY-138491 | Iodoacetyl-PEG4-biotin | Reference compound | |
| HY-138492 | Boc-NH-PPG2 | 1312905-31-9 | Reference compound |
| HY-138493 | F-PEG2-S-Boc | Reference compound | |
| HY-138494 | Boc-NH-PEG12-NH-Boc | Reference compound | |
| HY-138495 | F-PEG2-SO2-COOH | Reference compound | |
| HY-138496 | F-PEG2-SO-COOH | Reference compound | |
| HY-138497 | F-PEG2-S-COOH | Reference compound | |
| HY-138498 | F-PEG2-COOH | 2383964-72-3 | Reference compound |
| HY-138500 | Mal-PEG12-NH-Boc | 2170654-80-3 | Reference compound |
| HY-138501 | GPR34 receptor antagonist 2 | 907952-06-1 | Reference compound |
| HY-138502 | Melarsomine | 128470-15-5 | Reference compound |
| HY-138502A | Melarsomine (dihydrochloride) | 89141-50-4 | Reference compound |
| HY-138503 | Biotin-PEG3-propargyl | 1421701-68-9 | Reference compound |
| HY-138504 | Bis-PEG2-Boc | 1611468-28-0 | Reference compound |
| HY-138505 | Iodoacetamido-PEG6-acid | Reference compound | |
| HY-138506 | DBCO-S-S-acid | 2749426-25-1 | ADC Related |
| HY-138507 | Desthiobiotin-PEG4-acid | Reference compound | |
| HY-138508 | Biotin-PEG2-methyl ethanethioate | ADC Related | |
| HY-138509 | NHS ester-PEG13-COOH | Reference compound | |
| HY-13851 | PS47 | 1180676-33-8 | Reference compound |
| HY-138511 | NHS ester-PEG7-COOH | Reference compound | |
| HY-138513 | Benzyl-PEG4-acyl chloride | Reference compound | |
| HY-138514 | CH2COOH-PEG9-CH2COOH | 2250056-46-1 | Reference compound |
| HY-138515 | Br-PEG7-NHBoc | Reference compound | |
| HY-138516 | CG-PEG5-azido | Reference compound | |
| HY-138517 | Thiol-C9-PEG7 | 130727-44-5 | Reference compound |
| HY-138518 | Azido-PEG3-aldehyde | 1807530-10-4 | Reference compound |
| HY-138519 | Bis-(Mal-PEG3)-PH-N-succinimidyl acetate | Reference compound | |
| HY-138520 | 5-[Boc(methyl)amino]pentanal | 1620280-47-8 | Reference compound |
| HY-138521 | Azido-C6-OH | 146292-90-2 | ADC Related |
| HY-138522 | NHS-bis-PEG2-amide-Mal | Reference compound | |
| HY-138523 | NH2-PEG3500-NH2 | Reference compound | |
| HY-138524 | Thiol-PEG2-acid | 1379649-73-6 | Reference compound |
| HY-138525 | Azido-PEG4-Thiol | 2720615-82-5 | Reference compound |
| HY-138526 | Thiol-C9-PEG4-acid | 716339-41-2 | Reference compound |
| HY-138527 | Thiol-C9-PEG4 | 130727-41-2 | Reference compound |
| HY-138528 | Thiol-C9-PEG5-acid | Reference compound | |
| HY-138529 | Thiol-C9-PEG5 | 130727-42-3 | Reference compound |
| HY-138530 | Thiol-PEG4-amide-NH2 | Reference compound | |
| HY-138531 | THP-PEG1-THP | 71033-27-7 | Reference compound |
| HY-138532 | m-PEG8-amide-C10-Thiol | Reference compound | |
| HY-138533 | Thiol-C10-amide-PEG8 | 1353948-95-4 | Reference compound |
| HY-138534 | THP-CH3-ethyl propionate | 3539-40-0 | Reference compound |
| HY-138535 | Azide-C2-Azide | 629-13-0 | ADC Related |
| HY-138536 | PROTAC CBP/P300 Degrader-1 | 2484739-48-0 | Reference compound |
| HY-138537 | NF-κB-IN-1 | 1227098-15-8 | Reference compound |
| HY-138538 | 2-Nitrobenzaldehyde Semicarbazone | 16004-43-6 | Reference compound |
| HY-138538R | 2-Nitrobenzaldehyde Semicarbazone (Standard) | 16004-43-6 | Reference Standards |
| HY-138538S | 2-Nitrobenzaldehyde semicarbazone-13C,15N2-1 | 957509-32-9 | Isotope-Labeled Compounds |
| HY-138539 | CBP/p300 ligand 2 | 2484741-78-6 | Reference compound |
| HY-138540 | 1-Dodecylimidazole | 4303-67-7 | Biochemical Assay Reagents |
| HY-138542 | RO0270608 | 220846-33-3 | Reference compound |
| HY-138543 | NITD-688 | 2407227-31-8 | Reference compound |
| HY-138545 | 4-Hydroxy-6-methylcoumarin | 13252-83-0 | Natural Products |
| HY-138546 | Fmoc-Tpi-OH | 204322-23-6 | Reference compound |
| HY-138547 | DHPTA | 3148-72-9 | Reference compound |
| HY-138548 | 4-Ethoxycoumarin | 35817-27-7 | Natural Products |
| HY-138550A | (S,R,S)-AHPC-3-methylbutanyl acetate-methanesulfonothioate-PEG3-NH2 (TFA) | 2417370-48-8 | Reference compound |
| HY-138551A | (S,R,S)-AHPC-3-methylbutanyl acetate-methanesulfonothioate-Me-C10-NH2 (TFA) | 2417370-89-7 | Reference compound |
| HY-138553A | (S,R,S)-AHPC-isobutyl acetate-methanesulfonothioate-Me-C10-NH2 (TFA) | Reference compound | |
| HY-138554 | 3-Acetylcoumarin | 3949-36-8 | Reference compound |
| HY-138555 | PROTAC BRD4 Degrader-8 | 3026420-38-9 | Reference compound |
| HY-138556 | GPX4-IN-2 | 2485005-22-7 | Reference compound |
| HY-138557 | AKR1C3-IN-4 | 1284180-11-5 | Reference compound |
| HY-138558 | PAR-2-IN-1 | 1690176-75-0 | Reference compound |
| HY-138559 | GW604714X | 853953-65-8 | Reference compound |
| HY-13856 | (R)-PS210 | 1410101-89-1 | Reference compound |
| HY-138560 | Cross-linked dextran G 50 | 9048-71-9 | Biochemical Assay Reagents |
| HY-138560A | Cross-linked dextran G 50, medium | 9048-71-9 | Biochemical Assay Reagents |
| HY-138560B | Cross-linked dextran G 50, fine | 9048-71-9 | Biochemical Assay Reagents |
| HY-138561 | EFdA-TP | 950913-56-1 | Reference compound |
| HY-138561A | EFdA-TP (tetraammonium) | Reference compound | |
| HY-138561B | EFdA-TP (tetrasodium) | 2883783-00-2 | Reference compound |
| HY-138561C | EFdA-TP (tetralithium) | Reference compound | |
| HY-138562 | HIV-1 Nef-IN-1 | 13728-56-8 | Reference compound |
| HY-138563 | GSK973 | 2138473-38-6 | Reference compound |
| HY-138563A | (2R,3R)-GSK973 | Reference compound | |
| HY-138564 | NOS-IN-1 | 165383-72-2 | Reference compound |
| HY-138565 | K-975 | 2563855-03-6 | Reference compound |
| HY-138568 | HPK1-IN-3 | 2739844-34-7 | Reference compound |
| HY-138569 | HPK1-IN-4 | 2739844-28-9 | Reference compound |
| HY-138570 | HLE-IN-1 | 13947-21-2 | Reference compound |
| HY-138572 | Fanetizole | 79069-94-6 | Reference compound |
| HY-138573 | N-Acetyl Adamantamine | 880-52-4 | Reference compound |
| HY-138573S | N-Acetyl Adamantamine-d3 | 1217704-63-6 | Isotope-Labeled Compounds |
| HY-138576 | Antifungal agent 6 | 332849-40-8 | Reference compound |
| HY-138577 | 2'-F-Bz-dC Phosphoramidite | 161442-19-9 | Oligonucleotides |
| HY-138578 | 2'-O-Me-C(Bz) Phosphoramidite | 110764-78-8 | Oligonucleotides |
| HY-138579 | 2'-OMe-G(ibu) Phosphoramidite | 150780-67-9 | Oligonucleotides |
| HY-138580 | 2'-OMe-A(Bz) Phosphoramidite | 110782-31-5 | Oligonucleotides |
| HY-138581 | DMT-dA(PAc) Phosphoramidite | 110543-74-3 | Oligonucleotides |
| HY-138582 | N6-Methyl-dA phosphoramidite | 105931-58-6 | Oligonucleotides |
| HY-138583 | Ac-dA Phosphoramidite | 1027734-01-5 | Oligonucleotides |
| HY-138584 | IBU-DC Phosphoramidite | 110522-84-4 | Oligonucleotides |
| HY-138585 | DMT-dG(dmf) Phosphoramidite | 330628-04-1 | Oligonucleotides |
| HY-138586 | DMT-dC(ac) Phosphoramidite | 154110-40-4 | Oligonucleotides |
| HY-138587 | 7-TFA-ap-7-Deaza-ddG | 114748-68-4 | Reference compound |
| HY-138588 | 7-TFA-ap-7-Deaza-ddA | 114748-71-9 | Reference compound |
| HY-138589 | 7-TFA-ap-7-Deaza-dG | 666847-77-4 | Oligonucleotides |
| HY-13858A | Sarecycline (hydrochloride) | 1035979-44-2 | Reference compound |
| HY-13858AR | Sarecycline (hydrochloride) (Standard) | 1035979-44-2 | Reference Standards |
| HY-13859 | Clevudine | 163252-36-6 | Oligonucleotides |
| HY-138590 | 7-TFA-ap-7-Deaza-dA | 178420-75-2 | Oligonucleotides |
| HY-138591 | 7-Deaza-2',3'-dideoxyadenosine | 40627-30-3 | Oligonucleotides |
| HY-138592 | 7-Deaza-2',3'-dideoxyguanosine | 111869-49-9 | Reference compound |
| HY-138593 | 5-O-TBDMS-N4-Benzoyl-2-deoxycytidine | 51549-36-1 | Oligonucleotides |
| HY-138594 | 5'-O-TBDMS-N2-ibu-dG | 85326-10-9 | Oligonucleotides |
| HY-138595 | 5'-O-TBDMS-Bz-dA | 51549-39-4 | Oligonucleotides |
| HY-138596 | 5'-O-TBDMS-dU | 76223-04-6 | Oligonucleotides |
| HY-138597 | 5'-O-TBDMS-dT | 40733-28-6 | Oligonucleotides |
| HY-138598 | 5'-O-TBDMS-dG | 51549-33-8 | Oligonucleotides |
| HY-138599 | 5'-O-TBDMS-dA | 51549-30-5 | Oligonucleotides |
| HY-138600 | 5'-O-DMT-N6-ibu-dA | 190834-10-7 | Oligonucleotides |
| HY-138601 | 5'-O-DMT-N4-Bz-5-Me-dC | 104579-03-5 | Oligonucleotides |
| HY-138602 | 5'-O-DMT-N4-Ac-2'-F-dC | 159414-98-9 | Oligonucleotides |
| HY-138603 | 5'-O-DMT-N4-Bz-2'-F-dC | 146954-77-0 | Oligonucleotides |
| HY-138604 | 5'-O-DMT-N6-Me-2'-dA | 98056-69-0 | Oligonucleotides |
| HY-138605 | 5'-O-DMT-ibu-dC | 100898-62-2 | Oligonucleotides |
| HY-138606 | 5'-O-DMT-PAC-dA | 110522-82-2 | Oligonucleotides |
| HY-138607 | 5'-O-DMT-N2-DMF-dG | 40094-22-2 | Oligonucleotides |
| HY-138608 | 5'-O-DMT-rI | 119898-59-8 | Oligonucleotides |
| HY-138609 | 5'-O-DMT-rU | 81246-79-9 | Oligonucleotides |
| HY-13861 | GW7647 | 265129-71-3 | Reference compound |
| HY-138610 | 5'-O-DMT-Bz-rC | 81246-76-6 | Oligonucleotides |
| HY-138611 | 5'-O-DMT-2'-O-TBDMS-Bz-rC | 81256-87-3 | Oligonucleotides |
| HY-138612 | 5'-O-DMT-3'-O-TBDMS-Ac-rC | 123956-65-0 | Oligonucleotides |
| HY-138613 | 5'-O-DMT-2'-O-TBDMS-rI | 127212-34-4 | Oligonucleotides |
| HY-138614 | 5'-O-DMT-2'-O-TBDMS-Ac-rC | 121058-85-3 | Oligonucleotides |
| HY-138615 | Deoxythymidine-5'-triphosphate | 365-08-2 | Oligonucleotides |
| HY-138615A | Deoxythymidine-5'-triphosphate (sodium hydrate) | Oligonucleotides | |
| HY-138615S1 | Deoxythymidine-5'-triphosphate-15N2 (dilithium) | Isotope-Labeled Compounds | |
| HY-138615S2 | Deoxythymidine-5'-triphosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-138615S3 | Deoxythymidine-5'-triphosphate-15N2,d15 (dilithium) | Isotope-Labeled Compounds | |
| HY-138615S4 | Deoxythymidine-5'-triphosphate-13C10,15N2 (dilithium) | 2483830-18-6 | Isotope-Labeled Compounds |
| HY-138616 | dGTP | 2564-35-4 | Oligonucleotides |
| HY-138616S | dGTP-15N5 (dilithium) | 95648-75-2 | Isotope-Labeled Compounds |
| HY-138616S1 | dGTP-d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-138616S2 | dGTP-15N5,d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-138616S3 | dGTP-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-138616S4 | dGTP-13C10,15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-138617 | AI-10-47 | 1256094-31-1 | Reference compound |
| HY-13862 | AZD1080 | 612487-72-6 | Reference compound |
| HY-138620 | MCU-i4 | 371924-24-2 | Reference compound |
| HY-138621 | Antibacterial agent 19 | 79660-59-6 | Reference compound |
| HY-138622 | 24:0 Lyso PC | 325171-59-3 | Oligonucleotides |
| HY-138622S | 24:0 Lyso PC-13C6 | 2483735-01-7 | Isotope-Labeled Compounds |
| HY-138622S1 | 24:0 Lyso PC-d4 | 2483831-13-4 | Isotope-Labeled Compounds |
| HY-138623 | GSK789 | 2540591-06-6 | Reference compound |
| HY-138625 | LOX-IN-3 | 2409963-83-1 | Reference compound |
| HY-138625A | LOX-IN-3 (dihydrochloride) | 2409964-23-2 | Reference compound |
| HY-138625B | LOX-IN-3 (dihydrochloride monohydrate) | 2414974-55-1 | Reference compound |
| HY-138626 | ACH-000143 | 2225836-30-4 | Reference compound |
| HY-138627 | AST5902 | 2412155-74-7 | Reference compound |
| HY-138627A | AST5902 (trimesylate) | 2929417-90-1 | Reference compound |
| HY-138627AR | AST5902 (trimesylate) (Standard) | 2929417-90-1 | Reference Standards |
| HY-138627B | AST5902 (mesylate) | 2412155-75-8 | Reference compound |
| HY-13863 | Hydroxy-Dynasore | 1256493-34-1 | Reference compound |
| HY-138630 | AG-270 | 2201056-66-6 | Reference compound |
| HY-138632 | PROTAC BRD4 Degrader-9 | 2417370-42-2 | ADC Related |
| HY-138633 | PROTAC BRD4 Degrader-10 | 2417370-49-9 | ADC Related |
| HY-138634 | PROTAC BRD4 Degrader-11 | ADC Related | |
| HY-138635 | PROTAC BRD4 Degrader-12 | 2417370-90-0 | ADC Related |
| HY-138636 | PROTAC BRD4 Degrader-13 | 2417370-71-7 | ADC Related |
| HY-138637 | PROTAC BRD4 Degrader-14 | Reference compound | |
| HY-138638 | Cross-linked dextran LH 20 | 9041-37-6 | Reference compound |
| HY-138639 | PW0787 | 2624131-45-7 | Reference compound |
| HY-13864 | PF-4989216 | 1276553-09-3 | Reference compound |
| HY-138641 | Bavdegalutamide | 2222112-77-6 | Reference compound |
| HY-138642 | Vepdegestrant | 2229711-68-4 | Reference compound |
| HY-138642A | (Rac)-Vepdegestrant | 2229711-08-2 | Reference compound |
| HY-138643 | Cl-NQTrp | 185351-23-9 | Reference compound |
| HY-138645 | 5-Iminodaunorubicin | 72983-78-9 | Reference compound |
| HY-138645A | 5-Iminodaunorubicin (hydrochloride) | 67324-99-6 | Reference compound |
| HY-138646 | Poly(deoxyadenylic-thymidylic) acid (sodium) | 86828-69-5 | Biochemical Assay Reagents |
| HY-138647 | TGP-377/421 | 16752-89-9 | Reference compound |
| HY-138648 | PB1 | 188714-28-5 | Reference compound |
| HY-138649 | PB2 | 914940-24-2 | Reference compound |
| HY-13865 | P 22077 | 1247819-59-5 | Reference compound |
| HY-138650 | Monocaprylin | 26402-26-6 | Reference compound |
| HY-138651 | PAB-Val-Lys-Boc | 1432969-86-2 | ADC Related |
| HY-138652 | L-Histidine benzyl ester (bistosylate) | 24593-59-7 | Reference compound |
| HY-138653 | Lipase Substrate | 195833-46-6 | Reference compound |
| HY-138655 | RapiFluor-MS | 1429047-69-7 | Reference compound |
| HY-138657 | NCGC00378430 | 920650-00-6 | Reference compound |
| HY-138658 | Janelia Fluor® 526, SE | Dye Reagents | |
| HY-138659 | Janelia Fluor® 646, Tetrazine | 2042192-00-5 | Dye Reagents |
| HY-13866 | Ro 31-8220 (mesylate) | 138489-18-6 | Reference compound |
| HY-138660 | HM Janelia Fluor® 526, SE | 2376841-30-2 | Dye Reagents |
| HY-138665 | HHS-0701 | 2851993-91-2 | Reference compound |
| HY-138668 | JW-65 | 2763378-71-6 | Reference compound |
| HY-138669 | C004019 | 2417159-57-8 | Reference compound |
| HY-13866A | Ro 31-8220 | 125314-64-9 | Reference compound |
| HY-13867 | Bisindolylmaleimide I | 133052-90-1 | Reference compound |
| HY-138671 | DprE1-IN-4 | 2419160-96-4 | Reference compound |
| HY-138678 | (R,S,S)-VH032 | 2230826-33-0 | Reference compound |
| HY-138678B | (S,R,R)-VH032 | 2489876-59-5 | Reference compound |
| HY-138679 | Aberrant tau ligand 2 | 2417159-58-9 | Reference compound |
| HY-13867A | Bisindolylmaleimide I (hydrochloride) | 176504-36-2 | Reference compound |
| HY-13868 | SCH-53870 | 188480-50-4 | Reference compound |
| HY-138682 | STING-IN-2 | 346691-38-1 | Reference compound |
| HY-138683 | STING-IN-3 | 2244881-69-2 | Reference compound |
| HY-138684 | MRTX9768 | 2629314-68-5 | Reference compound |
| HY-138684A | MRTX9768 (hydrochloride) | Reference compound | |
| HY-138686 | GPR30 agonist-1 | 415919-74-3 | Reference compound |
| HY-138687 | Nirmatrelvir | 2628280-40-8 | Reference compound |
| HY-138687R | Nirmatrelvir (Standard) | 2628280-40-8 | Reference Standards |
| HY-138687S | Nirmatrelvir-d9 | 2861202-76-6 | Isotope-Labeled Compounds |
| HY-138687S1 | Nirmatrelvir-d6 | 2861202-75-5 | Isotope-Labeled Compounds |
| HY-138688 | Cinnamyl-3,4-dihydroxy-α-cyanocinnamate | 132465-11-3 | Reference compound |
| HY-138690 | Estrogen receptor modulator 6 | 787621-78-7 | Reference compound |
| HY-138691 | JQKD82 | 2410512-38-6 | Reference compound |
| HY-138691A | JQKD82 (trihydrochloride) | 2863676-87-1 | Reference compound |
| HY-138691B | JQKD82 (dihydrochloride) | 2863635-05-4 | Reference compound |
| HY-138692 | Azido-PEG4-azide | 182760-73-2 | Reference compound |
| HY-138694 | 5-Benzyloxygramine | 1453-97-0 | Reference compound |
| HY-138694R | 5-Benzyloxygramine (Standard) | 1453-97-0 | Reference Standards |
| HY-138695 | Orexin 2 Receptor Agonist 2 | 2114324-60-4 | Reference compound |
| HY-138696 | Zanzalintinib | 2367004-54-2 | Reference compound |
| HY-138697 | S65487 | 1644600-79-2 | Reference compound |
| HY-138697A | S65487 (sulfate) | 2416937-01-2 | Reference compound |
| HY-138697B | S65487 (hydrochloride) | 1644543-95-2 | Reference compound |
| HY-138698 | FT206 | 2278274-34-1 | Reference compound |
| HY-138706 | Azido-PEG8-azide | 361543-07-9 | Reference compound |
| HY-138707 | Azido-PEG7-NHS ester | Reference compound | |
| HY-138708 | Azido-PEG8-NHBoc | 2231845-12-6 | Reference compound |
| HY-138709 | Benzyl-PEG6-Ots | 129086-11-9 | Reference compound |
| HY-138710 | Benzyl-PEG7-Ots | Reference compound | |
| HY-138711 | Benzyl-PEG8-Ots | 1144113-17-6 | Reference compound |
| HY-138712 | Benzyl-PEG9-Ots | 393517-91-4 | Reference compound |
| HY-138713 | Benzyl-PEG10-Ots | Reference compound | |
| HY-138714 | Benzyl-PEG12-Ots | Reference compound | |
| HY-138715 | Benzyl-PEG4-Azido | 86770-71-0 | Reference compound |
| HY-138716 | m-PEG9-azide | 1354521-95-1 | Reference compound |
| HY-138717 | m-PEG13-azide | Reference compound | |
| HY-138718 | m-PEG14-NHS ester | Reference compound | |
| HY-138719 | m-PEG5-Propyne | 1101668-41-0 | Reference compound |
| HY-138720 | Fmoc-PEG9-NHS ester | Reference compound | |
| HY-138721 | Fmoc-PEG10-NHS ester | Reference compound | |
| HY-138722 | Mal-PEG10-Boc | Reference compound | |
| HY-138723 | Mal-PEG10-acid | Reference compound | |
| HY-138726 | Mal-PEG10-NHS ester | Reference compound | |
| HY-138727 | Mal-amido-PEG3-acid | 2055353-75-6 | Reference compound |
| HY-138728 | Mal-amido-PEG5-acid | Reference compound | |
| HY-138729 | Mal-amido-PEG3-NHS ester | 2055353-77-8 | Reference compound |
| HY-13873 | IKK-IN-1 | 406211-06-1 | Reference compound |
| HY-138730 | Mal-amido-PEG7-NHS ester | Reference compound | |
| HY-138731 | Mal-amido-PEG9-NHS ester | 2575631-92-2 | Reference compound |
| HY-138732 | m-PEG5-amino-Mal | Reference compound | |
| HY-138733 | Propargyl-PEG13-Boc | Reference compound | |
| HY-138734 | Propargyl-PEG2-NHS ester | 2512228-06-5 | Reference compound |
| HY-138735 | Propargyl-PEG13-OH | Reference compound | |
| HY-138736 | Propargyl-PEG5-Br | 1287660-83-6 | Reference compound |
| HY-138737 | Propargyl-PEG7-Br | Reference compound | |
| HY-138738 | Propargyl-PEG5-azide | 1589522-62-2 | Reference compound |
| HY-138739 | Azido-PEG10-propargyl | Reference compound | |
| HY-138740 | Azido-PEG2-propargyl | 1245006-63-6 | Reference compound |
| HY-138741 | Azido-PEG12-propargyl | 2264091-72-5 | Reference compound |
| HY-138742 | HPK1-IN-7 | 2320462-65-3 | Reference compound |
| HY-138744 | DBCO-PEG13-NHS ester | Reference compound | |
| HY-138745 | Bis-sulfone-PEG3-Azide | 1802908-01-5 | ADC Related |
| HY-138746 | EGFR-IN-15 | 2573869-16-4 | Reference compound |
| HY-138747 | Bis-sulfone-PEG4-Tetrazine | Reference compound | |
| HY-138748 | S-acetyl-PEG5-alcohol | 1000415-61-1 | Reference compound |
| HY-138749 | Biotin alkyne | 773888-45-2 | Reference compound |
| HY-138751 | limertinib | 1934259-00-3 | Reference compound |
| HY-138751A | limertinib (diTFA) | Reference compound | |
| HY-138752 | S-acetyl-PEG4-amine | 1404111-71-2 | Reference compound |
| HY-138752A | S-acetyl-PEG4-amine (TFA) | Reference compound | |
| HY-138755 | S-acetyl-PEG4-NHBoc | 1404111-70-1 | Reference compound |
| HY-138756 | PC DBCO-PEG4-NHS ester | 2055025-02-8 | Reference compound |
| HY-138758 | S-acetyl-PEG4-Thiol | Reference compound | |
| HY-138759 | Thiol-PEG3-NHBoc | 1895922-68-5 | Reference compound |
| HY-138760 | SEluc-2 | 2421112-19-6 | Dye Reagents |
| HY-138763 | Propargyl-PEG11-acid | Reference compound | |
| HY-138764 | Propargyl-PEG12-acid | Reference compound | |
| HY-138765 | Propargyl-PEG7-amine | Reference compound | |
| HY-138766 | Propargyl-PEG11-amine | Reference compound | |
| HY-138767 | AKT-IN-5 | 1402608-05-2 | Reference compound |
| HY-138769 | Azido-PEG12-alcohol | 1111239-69-0 | Reference compound |
| HY-138771 | Thalidomide-NH-PEG3-COOH | 2375283-62-6 | Reference compound |
| HY-138772 | Thalidomide-NH-PEG2-COOH | 2412056-45-0 | Reference compound |
| HY-138773 | Thalidomide-PEG5-COOH | 2688100-28-7 | Reference compound |
| HY-138774 | Thalidomide-PEG4-COOH | 2828438-28-2 | Reference compound |
| HY-138775 | Thalidomide-PEG3-COOH | 2682112-08-7 | Reference compound |
| HY-138776 | Thalidomide-Propargyne-PEG3-COOH | 2797649-54-6 | Reference compound |
| HY-138777 | Thalidomide-Propargyne-PEG2-COOH | 2797619-65-7 | Reference compound |
| HY-138778 | Thalidomide-Propargyne-PEG1-COOH | 2828438-36-2 | Reference compound |
| HY-138779 | ICCB-19 (hydrochloride) | 1803605-68-6 | Reference compound |
| HY-138780 | Thalidomide-Piperazine-PEG3-COOH | 2797619-63-5 | Reference compound |
| HY-138781 | Thalidomide-Piperazine-PEG2-COOH | 2797430-20-5 | Reference compound |
| HY-138782 | Thalidomide-Piperazine-PEG1-COOH | 2731007-11-5 | Reference compound |
| HY-138783 | Thalidomide-Piperazine-Piperidine | 2229716-11-2 | Reference compound |
| HY-138783A | Thalidomide-Piperazine-Piperidine (hydrochloride) | 2599846-44-1 | Reference compound |
| HY-138784 | Thalidomide-PEG5-NH2 | 2460263-40-3 | Reference compound |
| HY-138784A | Thalidomide-PEG5-NH2 (hydrochloride) | 2703775-06-6 | Reference compound |
| HY-138785 | Thalidomide-5-PEG4-NH2 | 2743434-16-2 | Reference compound |
| HY-138785A | Thalidomide-5-PEG4-NH2 (hydrochloride) | 2743434-24-2 | Reference compound |
| HY-138786 | Thalidomide-5-PEG3-NH2 | 2743432-13-3 | Reference compound |
| HY-138786A | Thalidomide-5-PEG3-NH2 (hydrochloride) | 2761385-81-1 | Reference compound |
| HY-138787 | Thalidomide-Piperazine-PEG3-NH2 | 2357113-68-7 | Reference compound |
| HY-138788 | Thalidomide-Piperazine-PEG2-NH2 | 2357110-14-4 | Reference compound |
| HY-138788A | Thalidomide-Piperazine-PEG2-NH2 (diTFA) | Reference compound | |
| HY-138789 | Thalidomide-Piperazine-PEG1-NH2 | 2357111-29-4 | Reference compound |
| HY-138789A | Thalidomide-Piperazine-PEG1-NH2 (diTFA) | Reference compound | |
| HY-138790 | Glutarimide-Isoindolinone-NH-PEG4-COOH | 2927334-86-7 | Reference compound |
| HY-138791 | Glutarimide-Isoindolinone-NH-PEG3-COOH | 2803819-65-8 | Reference compound |
| HY-138792 | Glutarimide-Isoindolinone-NH-PEG2-COOH | 2803827-03-2 | Reference compound |
| HY-138793 | 2-(2,6-Dioxopiperidin-3-yl)phthalimidine | 26581-81-7 | Reference compound |
| HY-138794 | XL177A | 2417089-74-6 | Reference compound |
| HY-138794A | (Rac)-XL177A | 2417089-73-5 | Reference compound |
| HY-138795 | Curcumin-β-D-glucuronide | 227466-72-0 | Reference compound |
| HY-138796 | Griseolutein A | 573-84-2 | Reference compound |
| HY-138797 | Griseolutein B | 2072-68-6 | Reference compound |
| HY-138799 | KA2507 | 1636894-46-6 | Reference compound |
| HY-138799A | KA2507 (monohydrochloride) | 2972712-63-1 | Reference compound |
| HY-138800 | Spinosad | 168316-95-8 | Natural Products |
| HY-138802 | ML089 | 1306638-12-9 | Reference compound |
| HY-138806 | PAQ | 943902-10-1 | Reference compound |
| HY-138809 | FAUC 346 | 474432-65-0 | Reference compound |
| HY-138812 | Antileishmanial agent-28 | 1135272-09-1 | Reference compound |
| HY-138813 | N-Desethyl Sunitinib (hydrochloride) | Reference compound | |
| HY-138813A | (E/Z)-N-Desethylsunitinib (hydrochloride) | 1261432-05-6 | Reference compound |
| HY-138813R | N-Desethyl Sunitinib (hydrochloride) (Standard) | Reference Standards | |
| HY-138815 | (S)-N-(1H-Indole-3-acetyl)tryptophan | 57105-53-0 | Reference compound |
| HY-138815S | (S)-N-(1H-Indole-3-acetyl)tryptophan-d4 | Isotope-Labeled Compounds | |
| HY-138816 | Nav1.7-IN-15 | 1356834-62-2 | Reference compound |
| HY-138818 | N,O-Didesmethylvenlafaxine | 135308-74-6 | Reference compound |
| HY-138819 | IMB5046 | 1001571-08-9 | Reference compound |
| HY-138820 | SW02 | 1010820-68-4 | Reference compound |
| HY-138821 | BCIP (potassium) | 102185-49-9 | Biochemical Assay Reagents |
| HY-138822 | 2,3-Diphospho-D-glyceric acid (pentasodium salt) | 102783-53-9 | Reference compound |
| HY-138825 | NCGC00188636 | 1039980-33-0 | Reference compound |
| HY-138830 | TAK-418 | 1818252-53-7 | Reference compound |
| HY-138830A | (S,S)-TAK-418 | 1818253-48-3 | Reference compound |
| HY-138831 | AES-350 | 847249-57-4 | Reference compound |
| HY-138832 | BM-1244 | 1619923-32-8 | Reference compound |
| HY-138839 | Allyphenyline (oxalate) | 1092984-08-1 | Reference compound |
| HY-138842 | DDN | 118006-14-7 | Reference compound |
| HY-138843 | FTO-IN-1 | 2243944-92-3 | Reference compound |
| HY-138843A | FTO-IN-1 (TFA) | 2797619-81-7 | Reference compound |
| HY-138844 | 3-AP-Me | 1184391-57-8 | Reference compound |
| HY-138845 | Pomalidomide-C4-NH2 | 1957236-34-8 | Reference compound |
| HY-138845A | Pomalidomide-C4-NH2 (hydrochloride) | 2162120-73-0 | Reference compound |
| HY-138846 | Thalidomide-NH-C8-NH2 | 1957236-36-0 | Reference compound |
| HY-138846A | Thalidomide-NH-C8-NH2 (hydrochloride) | 2446474-06-0 | Reference compound |
| HY-138847 | Thalidomide-O-C3-NH2 | 2509360-22-7 | Reference compound |
| HY-138847A | Thalidomide-4-O-C3-NH2 (hydrochloride) | 2913240-95-4 | Reference compound |
| HY-138848 | Thalidomide-4-O-C5-NH2 | 2307477-23-0 | Reference compound |
| HY-138848A | Thalidomide-4-O-C5-NH2 (hydrochloride) | 2419145-66-5 | Reference compound |
| HY-138849 | Thalidomide-NH-amido-C2-NH2 | 2763827-10-5 | Reference compound |
| HY-138849A | Thalidomide-NH-amido-C2-NH2 (hydrochloride) | 2983057-90-3 | Reference compound |
| HY-138850 | Thalidomide-NH-amido-C3-NH2 | 2763827-11-6 | Reference compound |
| HY-138850A | Thalidomide-NH-amido-C3-NH2 (hydrochloride) | Reference compound | |
| HY-138851 | Thalidomide-NH-amido-C5-NH2 | 2763827-12-7 | Reference compound |
| HY-138851A | Thalidomide-NH-amido-C5-NH2 (hydrochloride) | Reference compound | |
| HY-138852 | Thalidomide-NH-amido-C6-NH2 | 2763827-13-8 | Reference compound |
| HY-138852A | Thalidomide-NH-amido-C6-NH2 (hydrochloride) | Reference compound | |
| HY-138853 | Thalidomide-NH-amido-C8-NH2 | 2983057-93-6 | Reference compound |
| HY-138853A | Thalidomide-NH-amido-C8-NH2 (hydrochloride) | 2983057-94-7 | Reference compound |
| HY-138854 | Thalidomide-NH-amido-PEG1-C2-NH2 | 2983036-28-6 | Reference compound |
| HY-138854A | Thalidomide-NH-amido-PEG1-C2-NH2 (hydrochloride) | 2983036-29-7 | Reference compound |
| HY-138855 | Thalidomide-NH-amido-PEG2-C2-NH2 | 2983036-90-2 | Reference compound |
| HY-138855A | Thalidomide-NH-amido-PEG2-C2-NH2 (hydrochloride) | 2983036-91-3 | Reference compound |
| HY-138856 | Thalidomide-NH-amido-PEG3-C2-NH2 | 2983036-98-0 | Reference compound |
| HY-138856A | Thalidomide-NH-amido-PEG3-C2-NH2 (hydrochloride) | 2983036-99-1 | Reference compound |
| HY-138857 | Thalidomide-NH-amido-PEG4-C2-NH2 | 2653336-34-4 | Reference compound |
| HY-138857A | Thalidomide-NH-amido-PEG4-C2-NH2 (hydrochloride) | 2983037-00-7 | Reference compound |
| HY-138858 | Thalidomide-amido-PEG2-NH2 | 2380273-72-1 | Reference compound |
| HY-138858A | Thalidomide-amido-PEG2-NH2 (hydrochloride) | 2380273-73-2 | Reference compound |
| HY-138859 | Pomalidomide-amino-PEG4-NH2 | 2331259-44-8 | Reference compound |
| HY-138859A | Pomalidomide-amino-PEG4-NH2 (hydrochloride) | 2331259-45-9 | Reference compound |
| HY-138860 | Thalidomide-O-C11-acid | 3023879-35-5 | Reference compound |
| HY-138861 | (S,R,S)-AHPC-C1-NH2 | 2010986-20-4 | Reference compound |
| HY-138861A | (S,R,S)-AHPC-C1-NH2 (hydrochloride) | 2361120-26-3 | Reference compound |
| HY-138862 | (S,R,S)-AHPC-C1-Br | 2379404-33-6 | Reference compound |
| HY-138865 | BiCAPPA | 119662-55-4 | Reference compound |
| HY-138866 | Dimethylamiloride | 1214-79-5 | Reference compound |
| HY-138867S | N-Acetyl(mono)desethylchloroquine-d4 | 1216619-20-3 | Isotope-Labeled Compounds |
| HY-138868 | 17-Phenyl trinor prostaglandin E2 ethyl amide | 1219032-20-8 | Reference compound |
| HY-138869 | AubipyOMe | 1221591-26-9 | Reference compound |
| HY-138870 | Enzyme-IN-3 (disodium) | 122855-18-9 | Reference compound |
| HY-138871 | cPLA2α-IN-derivative 1 | 1233706-89-2 | Reference compound |
| HY-138873 | (±)-Threo-Isopropylphenidate (hydrochloride) | 1262795-94-7 | Reference compound |
| HY-138875 | Tetraacetylphytosphingosine | 13018-48-9 | Natural Products |
| HY-138877 | Phosphoglycolic acid | 13147-57-4 | Reference compound |
| HY-138877A | Phosphoglycolic acid (lithium) | Natural Products | |
| HY-138879 | CP-601927 | 357425-02-6 | Reference compound |
| HY-138879A | (Rac)-CP-601927 (hydrochloride) | 230615-01-7 | Reference compound |
| HY-138879B | CP-601932 | 357425-68-4 | Reference compound |
| HY-138880 | 2′,3′-Di-O-acetylguanosine | 42167-65-7 | Oligonucleotides |
| HY-138881 | Lenalidomide-6-F | 2468780-87-0 | Reference compound |
| HY-138882 | Lenalidomide-4-aminomethyl | 790652-68-5 | Reference compound |
| HY-138882A | Lenalidomide-4-aminomethyl (hydrochloride) | 444289-05-8 | Reference compound |
| HY-138885 | Tryptamine guanosine carbamate | 1414808-96-0 | Oligonucleotides |
| HY-138886 | RL5a | 133671-66-6 | Reference compound |
| HY-138887 | Decyl maltose neopentyl glycol | 1257852-99-5 | Reference compound |
| HY-138889 | (8Z,14Z)-Eicosadienoic acid | 135498-07-6 | Reference compound |
| HY-138896 | (9E,11E)-9-Nitro-9,11-octadecadienoic acid | 1417651-32-1 | Reference compound |
| HY-138903 | L-Homocysteic acid | 14857-77-3 | Peptides |
| HY-138905 | S-15176 (difumarate) | 148913-55-7 | Biochemical Assay Reagents |
| HY-138906 | 25C-NBF (hydrochloride) | 1539266-21-1 | Reference compound |
| HY-138912 | Cho-Arg (TFA) | 1609010-56-1 | Biochemical Assay Reagents |
| HY-138913 | 2H-Cho-Arg (TFA) | 1609010-59-4 | Biochemical Assay Reagents |
| HY-138916 | PF-06672131 | 1621002-27-4 | Reference compound |
| HY-13892 | Dovitinib (dilactic acid) | 852433-84-2 | Reference compound |
| HY-138931 | TBK1/IKKε-IN-6 | 2306877-20-1 | Reference compound |
| HY-138933 | (±)-Geosmin | 16423-19-1 | Reference compound |
| HY-138935 | Iclepertin | 1421936-85-7 | Reference compound |
| HY-138936 | SSK1 | 2629250-69-5 | Reference compound |
| HY-138937 | NDB | 1660153-08-1 | Reference compound |
| HY-138939 | 5-LOX-IN-2 | 179691-97-5 | Reference compound |
| HY-13894 | Tyrphostin AG1296 | 146535-11-7 | Reference compound |
| HY-138940 | 3-Methoxy PCE (hydrochloride) | 1797121-52-8 | Reference compound |
| HY-138941 | Octaethylene glycol monododecyl ether | 3055-98-9 | Reference compound |
| HY-138943 | 5-Fluorouridine 5'-O-β-D-galactopyranoside | 149965-92-4 | Reference compound |
| HY-138944 | SGLT1/2-IN-1 | 1673514-65-2 | Reference compound |
| HY-138945 | SYY-B085-1 | 2379416-47-2 | Reference compound |
| HY-138946 | XY028-140 | 2229974-83-6 | Reference compound |
| HY-138947 | KB-R7943 | 182004-64-4 | Reference compound |
| HY-13895 | WHI-P154 | 211555-04-3 | Reference compound |
| HY-138951 | AY77 | 1835734-92-3 | Peptides |
| HY-138953 | Epiboxidine | 188895-96-7 | Reference compound |
| HY-138953A | Epiboxidine (hydrochloride) | 862909-67-9 | Reference compound |
| HY-138956 | MAY0132 | 1895861-88-7 | Reference compound |
| HY-138958 | HT1171 | 192880-96-9 | Reference compound |
| HY-13896 | PD168393 | 194423-15-9 | Reference compound |
| HY-138960 | 6-Chloro-3-indolyl α-D-galactopyranoside | 198402-61-8 | Biochemical Assay Reagents |
| HY-138961 | ER-27319 | 201010-95-9 | Reference compound |
| HY-138962 | κ-Carrageenan | 11114-20-8 | Natural Products |
| HY-138965A | Pomalidomide-5-C2-NH2 (hydrochloride) | Reference compound | |
| HY-138967 | BRF110 | 2095489-35-1 | Reference compound |
| HY-138969 | (±)10(11)-EDP ethanolamide | 2123484-71-7 | Reference compound |
| HY-13897 | CNX-2006 | 1375465-09-0 | Reference compound |
| HY-138970 | (±)19(20)-EDP ethanolamide | 2123485-34-5 | Reference compound |
| HY-138971 | (±)17(18)-EpETE-ethanolamide | 2123491-23-4 | Reference compound |
| HY-138973 | Neramexane | 219810-59-0 | Reference compound |
| HY-138973A | Neramexane (mesylate) | 457068-92-7 | Reference compound |
| HY-138978 | MF-095 | 2241021-89-4 | Reference compound |
| HY-138979 | Lipoxygenin | 2247911-68-6 | Reference compound |
| HY-13898 | Taselisib | 1282512-48-4 | Reference compound |
| HY-138982 | D-2-Thiolhistidine | 1195264-93-7 | Reference compound |
| HY-138984 | GRT2932Q | 228246-34-2 | Reference compound |
| HY-138985 | CAY10568 | 22913-17-3 | Natural Products |
| HY-138989 | 15-LOX-1 inhibitor 1 | 2349374-37-2 | Reference compound |
| HY-138990 | GK563 | 2351820-19-2 | Reference compound |
| HY-138992 | 2,3-Indolobetulin | 2365493-59-8 | Reference compound |
| HY-138993 | NNMT-IN-6 | 2368247-39-4 | Reference compound |
| HY-138993A | NNMT-IN-6 (hydrochloride) | 3031756-18-7 | Reference compound |
| HY-138995 | IMP-1710 | 2383117-96-0 | Reference compound |
| HY-138996 | GLP-1 receptor agonist 8 | 2401892-86-0 | Reference compound |
| HY-138997 | MBX-102 acid | 23953-39-1 | Reference compound |
| HY-139001 | JKE-1716 | 2421118-05-8 | Reference compound |
| HY-139002 | CYP4Z1-IN-2 | 2428734-45-4 | Reference compound |
| HY-139003S | 4'-Hydroxywarfarin-d4 | 94820-63-0 | Isotope-Labeled Compounds |
| HY-139004 | SGC-CK2-1 | 2470424-39-4 | Reference compound |
| HY-139005 | BODIPY aminoacetaldehyde diethyl acetal | 247069-93-8 | Reference compound |
| HY-139006 | N-Oleoyl glutamine | 247150-73-8 | Peptides |
| HY-139007 | BLT-4 | 251917-79-0 | Reference compound |
| HY-139008 | RC363 | 2584411-86-7 | Reference compound |
| HY-139009 | HA15-Biotin | 1965310-52-4 | Reference compound |
| HY-13901 | GANT 61 | 500579-04-4 | Reference compound |
| HY-139010 | Merafloxacin | 91188-00-0 | Reference compound |
| HY-139011 | IV-361 | 2055741-39-2 | Reference compound |
| HY-139012 | RC574 | 2584411-87-8 | Reference compound |
| HY-139014 | N-ε-propargyloxycarbonyl-L-lysine | 1215204-46-8 | Dye Reagents |
| HY-139015 | 5-Aza-4'-thio-2'-deoxycytidine | 169514-76-5 | Reference compound |
| HY-139017 | TLR7/8 agonist 4 | 2388520-33-8 | Reference compound |
| HY-139017A | TLR7/8 agonist 4 (TFA) | 2388520-34-9 | Reference compound |
| HY-139018 | TLR7/8 agonist 4 hydroxy-PEG10-acid | 2388520-17-8 | ADC Related |
| HY-139018A | TLR7/8 agonist 4 hydroxy-PEG10-acid (hydrochloride) | 2388520-36-1 | ADC Related |
| HY-139019 | ACAT-IN-2 | 199984-55-9 | Reference compound |
| HY-13902 | Berzosertib | 1232416-25-9 | Reference compound |
| HY-139020 | ACAT-IN-3 | 454203-25-9 | Reference compound |
| HY-139021 | ACAT-IN-4 | 454203-56-6 | Reference compound |
| HY-139021A | ACAT-IN-4 (hydrochloride) | 199984-46-8 | Reference compound |
| HY-139022 | ACAT-IN-5 | 199983-93-2 | Reference compound |
| HY-139023 | ACAT-IN-6 | 454203-45-3 | Reference compound |
| HY-139024 | ACAT-IN-7 | 199984-38-8 | Reference compound |
| HY-139025 | ACAT-IN-8 | 199984-35-5 | Reference compound |
| HY-139026 | ACAT-IN-9 | 199984-40-2 | Reference compound |
| HY-139027 | ACAT-IN-10 | 454203-40-8 | Reference compound |
| HY-139027A | ACAT-IN-10 (dihydrochloride) | 199983-77-2 | Reference compound |
| HY-139029 | 3-O-Acetylbetulin aldehyde | 27570-21-4 | Natural Products |
| HY-139030 | 28-O-Acetylbetulin | 27686-35-7 | Natural Products |
| HY-139031 | ALDH1A2-IN-1 | 2204229-64-9 | Reference compound |
| HY-139032 | CM121 | 2204230-40-8 | Reference compound |
| HY-139035 | CRHR1 antagonist 1 | 276890-57-4 | Reference compound |
| HY-139036 | Dicyanocobinamide | 27792-36-5 | Reference compound |
| HY-139037 | 8-Aminoguanine | 28128-41-8 | Reference compound |
| HY-139038 | TDRL-X80 | 292065-64-6 | Reference compound |
| HY-139039 | BSJ-4-116 | 2519823-34-6 | Reference compound |
| HY-13904 | Flumatinib | 895519-90-1 | Reference compound |
| HY-139040 | 2-(Tetradecylthio)acetic acid | 2921-20-2 | Reference compound |
| HY-139041 | Palmitoylcholine (chloride) | 2932-74-3 | Reference compound |
| HY-139043 | 6-B345TTQ | 297157-87-0 | Reference compound |
| HY-139044 | VU6000918 | 2101737-32-8 | Reference compound |
| HY-139045 | 2,4-DMA (hydrochloride) | 33189-36-5 | Reference compound |
| HY-139047 | SW157765 | 332063-87-3 | Reference compound |
| HY-139048 | Fluoroethylnormemantine | 1639210-26-6 | Reference compound |
| HY-139048A | Fluoroethylnormemantine (hydrochloride) | 1639210-25-5 | Reference compound |
| HY-13904S | Flumatinib-d3 | Isotope-Labeled Compounds | |
| HY-13905 | Flumatinib (mesylate) | 895519-91-2 | Reference compound |
| HY-139052 | III-31-C | 398515-96-3 | Reference compound |
| HY-139054 | 4'-Methoxyflavone | 4143-74-2 | Natural Products |
| HY-139055 | NCTT-956 | 438575-88-3 | Reference compound |
| HY-139056 | SU0268 | 2210228-45-6 | Reference compound |
| HY-139058 | 23-epi-26-Deoxyactein | 501938-01-8 | Natural Products |
| HY-139058R | 23-epi-26-Deoxyactein (Standard) | 501938-01-8 | Reference Standards |
| HY-139059 | ERD03 | 1377897-01-2 | Reference compound |
| HY-13906 | Largazole | 1009815-87-5 | Natural Products |
| HY-139060 | Bis-PEG12-endo-BCN | Reference compound | |
| HY-139061 | Palmitoyl 3-carbacyclic phosphatidic acid | 476310-22-2 | Reference compound |
| HY-139062 | C6 Urea Ceramide | 486991-52-0 | Reference compound |
| HY-139063 | 16-Phenoxy tetranor prostaglandin F2α | 51705-19-2 | Reference compound |
| HY-139064 | NPBA | 524033-40-7 | Reference compound |
| HY-139065 | AMPC | 2254434-33-6 | Reference compound |
| HY-139066 | Punicic acid | 544-72-9 | Natural Products |
| HY-139067 | 25(S)-27-Hydroxy cholesterol | 56845-83-1 | Reference compound |
| HY-139068 | Ibuprofen arginine | 57469-82-6 | Reference compound |
| HY-139069 | p-Nitrophenyl galacto-N-bioside | 59837-14-8 | Biochemical Assay Reagents |
| HY-13907 | TCS 359 | 301305-73-7 | Reference compound |
| HY-139070 | D-Glyceric acid | 6000-40-4 | Natural Products |
| HY-139070A | D-Glyceric acid (sodium) | 109175-64-6 | Natural Products |
| HY-139071 | Boc-D-Leu-Osu | 60111-76-4 | Reference compound |
| HY-139076 | Menin-MLL inhibitor 19 | 2360487-93-8 | Reference compound |
| HY-139077 | SCD1 inhibitor-3 | 1282606-48-7 | Reference compound |
| HY-139078 | Furosine (dihydrochloride) | 157974-36-2 | Reference compound |
| HY-139081 | GDC-0310 | 1788063-52-4 | Reference compound |
| HY-139084 | XL388-C2-NH2 | 2250061-94-8 | Reference compound |
| HY-139085A | XL388-C2-amide-PEG9-NH2 (hydrochloride) | Reference compound | |
| HY-139085B | XL388-C2-amide-PEG9-NH2 (TFA) | Reference compound | |
| HY-139087 | Erastin2 | 1695533-44-8 | Reference compound |
| HY-139088 | PAD3-IN-1 | 1671088-84-8 | Reference compound |
| HY-139089 | (Z)-Entacapone | 145195-63-7 | Reference compound |
| HY-139089S | (Z)-Entacapone-d10 | Isotope-Labeled Compounds | |
| HY-13909 | RGFP966 | 1357389-11-7 | Reference compound |
| HY-139090 | 3-Oxobetulin acetate | 136587-07-0 | Reference compound |
| HY-139091 | FEMA 4774 | 1359963-68-0 | Reference compound |
| HY-139092 | IL-4-inhibitor-1 | 1332184-63-0 | Reference compound |
| HY-139093 | Paracetamol-cysteine | 53446-10-9 | Peptides |
| HY-139093A | Paracetamol-cysteine (TFA) | 1331891-93-0 | Reference compound |
| HY-139094 | A6770 | 1331754-16-5 | Reference compound |
| HY-139095 | Cipamfylline | 132210-43-6 | Reference compound |
| HY-139096 | 4-Pentadecylbenzylphosphonic acid | 1306684-90-1 | Reference compound |
| HY-139097 | C12-Sphingosine | 128427-86-1 | Reference compound |
| HY-139098 | 7-Methyl-diguanosine triphosphate | 62828-64-2 | Oligonucleotides |
| HY-139099 | Diguanosine 5′-triphosphate | 6674-45-9 | Oligonucleotides |
| HY-139099A | Diguanosine 5′-triphosphate (lithium) | Biochemical Assay Reagents | |
| HY-13910 | Tenofovir | 147127-20-6 | Reference compound |
| HY-139100 | N7-Methyl-guanosine-5'-triphosphate-5'-adenosine | 62828-63-1 | Oligonucleotides |
| HY-139100B | m7G(5')ppp(5')A (diammonium) | 75252-10-7 | Oligonucleotides |
| HY-139101 | Guanosine 5'-triphosphate-5'-adenosine | 10527-47-6 | Oligonucleotides |
| HY-139101A | Guanosine 5'-triphosphate-5'-adenosine (triammonium) | Oligonucleotides | |
| HY-139102 | Thailanstatin B | 1426953-23-2 | Reference compound |
| HY-139103 | Thailanstatin C | 1426953-24-3 | Natural Products |
| HY-139104 | Thailanstatin D | 1609105-89-6 | Natural Products |
| HY-139105 | 20-O-Demethyl-AP3 | 72902-38-6 | Reference compound |
| HY-139106 | N-Demethylansamitocin P-3 | 77353-69-6 | Natural Products |
| HY-139107 | Biotin-PEG4-SS-azide | ADC Related | |
| HY-139108 | DCH36_06 | 593273-05-3 | Reference compound |
| HY-139109 | IR-783 | 115970-66-6 | Dye Reagents |
| HY-13910A | Tenofovir (hydrate) | 206184-49-8 | Reference compound |
| HY-13910AR | Tenofovir (hydrate) (Standard) | 206184-49-8 | Reference Standards |
| HY-13910B | Tenofovir (maleate) | 1236287-04-9 | Reference compound |
| HY-13910R | Tenofovir (Standard) | 147127-20-6 | Reference Standards |
| HY-13911 | Hydroxyfasudil | 105628-72-6 | Reference compound |
| HY-139111 | Oxocarbazate | 1014405-03-8 | Reference compound |
| HY-139112 | Leukotriene B4 dimethyl amide | 83024-92-4 | Reference compound |
| HY-139114 | 20-Carboxyarachidonic acid | 79551-84-1 | Natural Products |
| HY-139116 | Piperidine-4-sulfonic acid | 72450-62-5 | Reference compound |
| HY-139117 | 6,2′,4′-Trimethoxyflavone | 720675-90-1 | Reference compound |
| HY-139118 | NSC308848 | 69408-82-8 | Reference compound |
| HY-139119 | Prostaglandin F2α dimethyl amide | 68192-15-4 | Reference compound |
| HY-13911A | Hydroxyfasudil (hydrochloride) | 155558-32-0 | Reference compound |
| HY-13912 | IWP-2 | 686770-61-6 | Reference compound |
| HY-139120 | 19(R)-hydroxy Prostaglandin E2 | 64625-54-3 | Reference compound |
| HY-139121 | 15(R)-17-Phenyl trinor Prostaglandin F2α | 41639-71-8 | Reference compound |
| HY-139122 | Butyrylhydroxamic acid | 4312-91-8 | Reference compound |
| HY-139124 | 15(R)-15-Methyl Prostaglandin F2α | 35864-81-4 | Reference compound |
| HY-139125 | DCHC | 302953-06-6 | Reference compound |
| HY-139126 | (±)-Muscarine (chloride) | 2936-25-6 | Reference compound |
| HY-139128 | α-Methyl-DL-methionine | 2749-07-7 | Peptides |
| HY-139129 | N-(3-Pyridyl)indomethacinamide | 261766-29-4 | Reference compound |
| HY-13912G | IWP-2 (GMP) | 686770-61-6 | GMP Small Molecules |
| HY-13913 | NS-398 | 123653-11-2 | Reference compound |
| HY-139131 | Australine (hydrochloride) | 186766-07-4 | Reference compound |
| HY-139132 | Met-F-AEA | 166100-39-6 | Reference compound |
| HY-139133 | L-NASPA | 155915-46-1 | Biochemical Assay Reagents |
| HY-139134 | S-2E | 155730-92-0 | Reference compound |
| HY-139135 | Methyl-L-NIO (hydrochloride) | 150403-96-6 | Reference compound |
| HY-139137 | N-Acetyl-S-geranylgeranyl-L-cysteine | 139332-94-8 | Reference compound |
| HY-139138 | Naphthofluorescein di-(β-D-galactopyranoside) | 133551-98-1 | Biochemical Assay Reagents |
| HY-139139 | MAT2A inhibitor 3 | 2439271-82-4 | Reference compound |
| HY-13914 | Roniciclib | 1223498-69-8 | Reference compound |
| HY-139140 | BAY R3401 | 100276-03-7 | Reference compound |
| HY-139142 | Simufilam | 1224591-33-6 | Reference compound |
| HY-139142A | Simufilam (dihydrochloride) | 2480226-06-8 | Reference compound |
| HY-139142B | Simufilam (hydrochloride) | 2480226-07-9 | Reference compound |
| HY-139143 | WWL154 | 1338574-93-8 | Reference compound |
| HY-139144 | YM-08 | 812647-88-4 | Reference compound |
| HY-139145 | Etbicyphat | 1005-93-2 | Reference compound |
| HY-139145S | Etbicyphat-13C3 | Isotope-Labeled Compounds | |
| HY-139147 | iHCK-37 | 516478-09-4 | Reference compound |
| HY-139148 | UMB298 | 2266569-73-5 | Reference compound |
| HY-139149 | NiCur | 2674753-39-8 | Reference compound |
| HY-139149A | (E/Z)-NiCur | 63476-70-0 | Reference compound |
| HY-13915 | NSC348884 | 81624-55-7 | Reference compound |
| HY-139150 | EZH2-IN-4 | 2088132-99-2 | Reference compound |
| HY-139156 | SK-575 | 2523016-96-6 | Reference compound |
| HY-139158 | Ainuovirine | 1097628-00-6 | Reference compound |
| HY-139161 | Penflufen | 494793-67-8 | Reference compound |
| HY-139161R | Penflufen (Standard) | 494793-67-8 | Reference Standards |
| HY-139162 | BGN3 | 1151762-33-2 | Reference compound |
| HY-139163 | BGSN3 | 2996069-91-9 | Reference compound |
| HY-139165 | AT-9010 | 1261253-79-5 | Reference compound |
| HY-139165A | AT-9010 (tetrasodium) | 1621884-18-1 | Reference compound |
| HY-139165B | AT-9010 (triethylamine) | 2648089-95-4 | Reference compound |
| HY-139166 | N-Palmitoyl-L-aspartate | 1782-17-8 | Reference compound |
| HY-139167 | 7-Hydroxywarfarin | 17834-03-6 | Reference compound |
| HY-13917 | PND-1186 | 1061353-68-1 | Reference compound |
| HY-139170 | CAY10746 | 2247240-76-0 | Reference compound |
| HY-139171 | F092 | 2250261-59-5 | Reference compound |
| HY-139172 | MD001 | 2254605-76-8 | Reference compound |
| HY-139175 | ZLY032 | 2314465-67-1 | Reference compound |
| HY-139177 | PPARα agonist 2 | 2376590-40-6 | Reference compound |
| HY-139179 | STING agonist-14 | 2411100-70-2 | Reference compound |
| HY-13917A | PND-1186 (hydrochloride) | 1356154-94-3 | Reference compound |
| HY-13918 | Etimizol | 64-99-3 | Reference compound |
| HY-139180 | PRGL493 | 2479378-45-3 | Reference compound |
| HY-139181 | NR160 | 2484895-50-1 | Reference compound |
| HY-139182 | MAGL-IN-3 | 2514-37-6 | Reference compound |
| HY-139185 | PROTAC ERRα Degrader-3 | 2306388-65-6 | Reference compound |
| HY-139186 | PROTAC KRAS G12C degrader-1 | 2984236-79-3 | Reference compound |
| HY-139188 | CC260 | 2411088-26-9 | Reference compound |
| HY-139189 | DHODH-IN-16 | 2511248-11-4 | Reference compound |
| HY-13919 | Napabucasin | 83280-65-3 | Reference compound |
| HY-139192 | Brophenexin | 2243506-33-2 | Reference compound |
| HY-139192A | Brophenexin (free base) | 1353979-43-7 | Reference compound |
| HY-139193 | TH1760 | 2567914-01-4 | Reference compound |
| HY-139196 | ThioLox | 1202193-89-2 | Reference compound |
| HY-139199 | 4-Hydroxyphenylbutazone | 16860-43-8 | Reference compound |
| HY-139199R | 4-Hydroxyphenylbutazone (Standard) | 16860-43-8 | Reference Standards |
| HY-139200 | DOTMA | 104872-42-6 | Oligonucleotides |
| HY-139201 | Poly-D-lysine hydrobromide (MW 30000-70000) | 27964-99-4 | Reference compound |
| HY-139201A | Poly-D-lysine hydrobromide (MW 70000-150000) | 27964-99-4 | Reference compound |
| HY-139201B | Poly-D-lysine hydrobromide (MW 84000) | 27964-99-4 | Reference compound |
| HY-139201C | Poly-D-lysine hydrobromide (MW 1000-5000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-139201D | Poly-D-lysine hydrobromide (MW 4000-15000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-139201E | Poly-D-lysine hydrobromide (MW 150000-300000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-139201H | Poly-D-lysine hydrobromide (MW ≥300000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-139202 | XVA143 | 264275-77-6 | Reference compound |
| HY-139203 | IL-17 modulator 3 | 2467731-88-8 | Reference compound |
| HY-139204 | BMS-986242 | 1923844-48-7 | Reference compound |
| HY-139205 | BMT-297376 | 2251031-81-7 | Reference compound |
| HY-139206 | LY3509754 | 2452464-73-0 | Reference compound |
| HY-139211 | Difluorinated Curcumin | 1170354-22-9 | Reference compound |
| HY-139212 | IXA6 | 1021106-40-0 | Reference compound |
| HY-139214 | IXA4 | 1185329-96-7 | Reference compound |
| HY-139218 | (S,R,S)-AHPC-Me-C6-NH2 | 2411422-49-4 | Reference compound |
| HY-139223 | pEBOV-IN-1 | 1252187-41-9 | Reference compound |
| HY-139227 | Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine (hydrochloride) | 2564466-93-7 | Reference compound |
| HY-139230 | OLHHA | 1258011-97-0 | Reference compound |
| HY-139231 | 1-Palmitoyl-2-formylyl PC | 2194571-25-8 | Reference compound |
| HY-139232 | 17(R)-Resolvin D3 | 1427475-53-3 | Reference compound |
| HY-139233 | 25P-NBOMe (hydrochloride) | 1539266-43-7 | Reference compound |
| HY-139235S | N-Linolenoylethanolamine-d4 | 1451194-68-5 | Isotope-Labeled Compounds |
| HY-139237 | PCEEA (hydrochloride) | 1798021-89-2 | Reference compound |
| HY-139239 | Bipiperidinyl 4-ANPP | 2515737-24-1 | Reference compound |
| HY-139240 | Cannabidihexol | 2552798-21-5 | Reference compound |
| HY-139244S | Norgestimate-d6 | 1263194-12-2 | Isotope-Labeled Compounds |
| HY-139245 | MC-Ala-Ala-Asn-PAB | 1638970-44-1 | ADC Related |
| HY-139246 | α-Pyrrolidinocyclohexanophenone (hydrochloride) | 1803168-16-2 | Reference compound |
| HY-139247 | pNPS-DHA | 2454246-25-2 | Reference compound |
| HY-139248 | Paclitaxel octadecanedioate | 2089211-45-8 | Reference compound |
| HY-13925 | PD0166285 | 185039-89-8 | Reference compound |
| HY-139250 | 1-Myristin-2-Olein-3-Butyrin | 1122578-93-1 | Reference compound |
| HY-139251 | 1-Myristoyl-2-palmitoyl-3-butyryl-rac-glycerol | 1122578-89-5 | Reference compound |
| HY-139252 | Anticancer agent 225 | 2251753-61-2 | Reference compound |
| HY-139253 | MRIA9 | 2750707-05-0 | Reference compound |
| HY-139254 | Indirubin-3′-oxime | 667463-82-3 | Reference compound |
| HY-13925A | PD0166285 (dihydrochloride) | 212391-63-4 | Reference compound |
| HY-139261 | 1-Deoxysphingosine (m18:1(14Z)) | 2190487-94-4 | Natural Products |
| HY-139262 | FNC-TP | 2457357-99-0 | Reference compound |
| HY-139262A | FNC-TP (trisodium) | Reference compound | |
| HY-139264 | Cloniprazepam | 1998158-84-1 | Reference compound |
| HY-139265 | 3,4-Mdma tert-butyl carbamate | 1228259-70-8 | Reference compound |
| HY-139266 | 7'-Methoxy NABUTIE | 1438278-55-7 | Reference compound |
| HY-139267 | (±)19(20)-EpDTE | 1359721-83-7 | Reference compound |
| HY-139268 | (±)7(8)-EpDTE | 1616607-36-3 | Reference compound |
| HY-13927 | Acetildenafil | 831217-01-7 | Reference compound |
| HY-139272 | Eicosapentaenoyl 1-propanol-2-amide | 1638355-66-4 | Reference compound |
| HY-139276 | Pal-Glu(OSu)-OH | 294855-91-7 | Reference compound |
| HY-139279 | Zotizalkib | 2648641-36-3 | Reference compound |
| HY-13927R | Acetildenafil (Standard) | 831217-01-7 | Reference Standards |
| HY-13928 | GW0742 | 317318-84-6 | Reference compound |
| HY-139282 | C16 1-Deoxyceramide (m18:1/16:0) | 1246298-56-5 | Reference compound |
| HY-139283 | C24:1 1-Deoxyceramide (m18:1/24:1(15Z)) | 1246298-58-7 | Reference compound |
| HY-139284 | C24:1 Dihydro 1-deoxyceramide (m18:0/24:1) | 1246298-60-1 | Reference compound |
| HY-139285 | Arachidonic acid-alkyne | 1219038-32-0 | Reference compound |
| HY-139286 | Photoclick sphingosine | 1823021-14-2 | Reference compound |
| HY-139287 | M1002 | 823830-85-9 | Reference compound |
| HY-139289 | ART812 | 2607138-82-7 | Reference compound |
| HY-139289S | ART899 | 2607139-85-3 | Isotope-Labeled Compounds |
| HY-13929 | Isocarboxazid | 59-63-2 | Reference compound |
| HY-139290 | RGLS4326 | 2229964-07-0 | Oligonucleotides |
| HY-139290A | RGLS4326 (sodium) | Oligonucleotides | |
| HY-139292 | Fmoc-NH-PEG6-alcohol | 1884208-29-0 | Reference compound |
| HY-139293 | PF-07059013 | 2435610-93-6 | Reference compound |
| HY-139294 | PROTAC BRD4 Degrader-15 | 2417370-67-1 | Reference compound |
| HY-139296 | PP2A Cancerous-IN-1 | 1403933-79-8 | Reference compound |
| HY-139297 | SCR130 | 2377858-38-1 | Reference compound |
| HY-139298 | L319 | 1351586-50-9 | Oligonucleotides |
| HY-13929R | Isocarboxazid (Standard) | 59-63-2 | Reference Standards |
| HY-13930 | Miquelianin | 22688-79-5 | Natural Products |
| HY-139300 | Epitinib | 1203902-67-3 | Reference compound |
| HY-139300A | Epitinib (succinate) | 2252334-12-4 | Reference compound |
| HY-139301 | DDO-5936 | 2355377-13-6 | Reference compound |
| HY-139303 | LUF5771 | 1141802-49-4 | Reference compound |
| HY-139304 | PROTAC Bcl-xL ligand-1 | 3029365-95-2 | Reference compound |
| HY-139305 | CL4H6 | 2256087-35-9 | Reference compound |
| HY-139306 | BAMEA-O16B | 2490668-30-7 | Oligonucleotides |
| HY-139307 | MG-2119 | 1065500-40-4 | Reference compound |
| HY-139308 | T0467 | 859518-94-8 | Reference compound |
| HY-139309 | PROTAC Bcl-xL degrader-2 | 2920415-08-1 | Reference compound |
| HY-13930R | Miquelianin (Standard) | 22688-79-5 | Reference Standards |
| HY-139310 | GLPG2938 | 2130996-00-6 | Reference compound |
| HY-139311 | YH-53 | 1471484-62-4 | Reference compound |
| HY-139312 | L-Mannitol | 643-01-6 | Reference compound |
| HY-139312S | L-Mannitol-1-13C | Isotope-Labeled Compounds | |
| HY-139313 | NHE3-IN-2 | 92434-13-4 | Reference compound |
| HY-139314 | A2B receptor antagonist 2 | 784-90-7 | Reference compound |
| HY-139315 | PROTAC IRAK4 degrader-4 | 2360528-45-4 | Reference compound |
| HY-139316 | PROTAC IRAK4 degrader-5 | 2360530-61-4 | Reference compound |
| HY-139317 | PROTAC IRAK4 degrader-6 | 2360530-72-7 | Reference compound |
| HY-139319 | LDHA-IN-3 | 227010-33-5 | Reference compound |
| HY-139322 | PEG-8 laurate | 35179-86-3 | Reference compound |
| HY-139323 | TLR7/8-IN-1 | 2205095-75-4 | Reference compound |
| HY-139324 | Cu(II)GTSM | 68341-14-0 | Reference compound |
| HY-139325 | NHS-Modified MMAF | 1404073-10-4 | Reference compound |
| HY-139325A | NHS-Modified MMAF (TFA) | ADC Related | |
| HY-139326 | NHS-MMAF | 1404073-19-3 | Reference compound |
| HY-139327 | CDK12-IN-4 | 2651196-69-7 | Reference compound |
| HY-139328 | CDK12-IN-5 | 2651200-35-8 | Reference compound |
| HY-139329 | CDK12-IN-6 | 2651196-71-1 | Reference compound |
| HY-139330 | MGH-CP1 | 896657-58-2 | Reference compound |
| HY-139331 | 20S Proteasome-IN-1 | 858557-69-4 | Reference compound |
| HY-139332 | Pomalidomide 4'-PEG6-azide | 2624181-62-8 | Reference compound |
| HY-139333 | Pomalidomide 4'-PEG5-azide | 2624181-61-7 | Reference compound |
| HY-139334 | VH 101 phenol-alkylC6-amine (dihydrochloride) | 2564467-16-7 | Reference compound |
| HY-139335 | VH 101 phenol-alkylC4-amine (dihydrochloride) | 2564467-03-2 | Reference compound |
| HY-139336 | Pomalidomide-C5-azide | 2434629-02-2 | Reference compound |
| HY-139337 | SMCy5.5 | 2417507-09-4 | Dye Reagents |
| HY-139338 | Erlose | 13101-54-7 | Natural Products |
| HY-139339 | Pomalidomide 4'-alkylC6-azide | 2375555-72-7 | Reference compound |
| HY-139340 | Photo-lenalidomide-acid | 2363154-39-4 | Reference compound |
| HY-139341 | Pomalidomide 4'-alkylC3-azide | 2357108-05-3 | Reference compound |
| HY-139342 | CDK7-IN-4 | 2326428-25-3 | Reference compound |
| HY-139343 | Pomalidomide 4'-alkylC2-azide | 2296708-61-5 | Reference compound |
| HY-139344 | FC-11 | 2271035-37-9 | Reference compound |
| HY-139345 | (S,R,S)-AHPC-CO-C9-acid | 2172819-78-0 | Reference compound |
| HY-139346 | VX-150 | 1793080-72-4 | Reference compound |
| HY-139347 | Mazisotine | 1638588-92-7 | Reference compound |
| HY-139347A | Mazisotine (tartrate) | 2919211-45-1 | Reference compound |
| HY-139348 | PFI-90 | 53995-62-3 | Reference compound |
| HY-139349 | Finasteride carboxaldehyde | 154387-61-8 | Reference compound |
| HY-139351 | Gibberellins A4/A7 | 8030-53-3 | Reference compound |
| HY-139352 | Betamethasone 21-valerate | 2240-28-0 | Reference compound |
| HY-139352R | Betamethasone 21-valerate (Standard) | 2240-28-0 | Reference Standards |
| HY-139353 | Fmoc-Phe-Lys(Boc)-PAB | 206133-42-8 | ADC Related |
| HY-139355 | (S)-GS-621763 | 2563617-99-0 | Reference compound |
| HY-139359 | 4-Fluoro pentedrone (hydrochloride) | 2469350-88-5 | Reference compound |
| HY-13936 | 1-Methylimidazoleacetic acid | 2625-49-2 | Natural Products |
| HY-139360 | 3',4'-Methylenedioxy-N-tert-butylcathinone (hydrochloride) | 2469270-98-0 | Reference compound |
| HY-139361 | Sulfopin | 2451481-08-4 | Reference compound |
| HY-139362 | Enpp-1-IN-2 | 2378640-92-5 | Reference compound |
| HY-139363 | AB-FUBINACA isomer 2 | 2365471-64-1 | Reference compound |
| HY-139364 | mPGES1-IN-4 | 2253745-78-5 | Reference compound |
| HY-139365 | mPGES1-IN-5 | 2253745-70-7 | Reference compound |
| HY-139367 | α-Hydroxy flubromazolam | 2204237-96-5 | Reference compound |
| HY-139369 | QD394 | 2132411-21-1 | Reference compound |
| HY-13936S | 2-(1-Methyl-1H-imidazol-4-yl)acetic acid-d3 | 122380-33-0 | Isotope-Labeled Compounds |
| HY-139370 | 4-Fluoro PV9 (hydrochloride) | 2117405-40-8 | Reference compound |
| HY-139371 | 3-Desoxy-3,4-methylenedioxy pyrovalerone (hydrochloride) | 2117405-33-9 | Reference compound |
| HY-139373 | 2-(Aminomethyl)-4-methylphenol (hydrochloride) | 2044714-53-4 | Reference compound |
| HY-139374 | Zabedosertib | 1931994-81-8 | Reference compound |
| HY-139376 | FGFR1 inhibitor-2 | 2410612-08-5 | Reference compound |
| HY-139377 | 4-Methoxy-α-pyrrolidinopropiophenone (hydrochloride) | 1794760-01-2 | Reference compound |
| HY-139378 | 5-IAI (hydrochloride) | 1782044-60-3 | Reference compound |
| HY-13938 | Iretol | 487-71-8 | Reference compound |
| HY-139381 | MitoEbselen-2 (chloride) | 1638973-78-0 | Reference compound |
| HY-139382 | 2-(Isopentylamino)naphthalene-1,4-dione | 1607447-79-9 | Reference compound |
| HY-139384 | FAAH inhibitor 2 | 1450603-63-0 | Reference compound |
| HY-139386 | 15β-Travoprost | 1420791-14-5 | Reference compound |
| HY-139388 | Para-fluoro methylaminorex | 1364933-64-1 | Reference compound |
| HY-139390 | 3,4-Difluoro U-50488 (hydrochloride) | 1339332-99-8 | Reference compound |
| HY-139391 | (±)10(11)-DiHDPA | 1345275-22-0 | Reference compound |
| HY-139392S | Octanoyl-L-carnitine-d3 (chloride) | 1334532-24-9 | Isotope-Labeled Compounds |
| HY-139393 | EOS (d18:1/32:1/18:2) | 1318771-31-1 | Reference compound |
| HY-139394 | Arachidonoyl-1-thio-glycerol | 1309664-54-7 | Reference compound |
| HY-139396 | BMS-986299 | 2242952-69-6 | Reference compound |
| HY-139397 | TJ-M2010-5 | 1357471-57-8 | Reference compound |
| HY-139398 | TBI-223 | 2071265-08-0 | Reference compound |
| HY-139399 | Safimaltib | 2230273-76-2 | Reference compound |
| HY-139400 | Pociredir | 2490676-18-9 | Reference compound |
| HY-139400A | Pociredir (hydrochloride) | 2490676-19-0 | Reference compound |
| HY-139401 | FAPI-34 | 2374782-07-5 | Reference compound |
| HY-139402 | MRTX849 acid | 2561529-96-0 | Reference compound |
| HY-139403 | MRTX849 ethoxypropanoic acid | 2561529-98-2 | Reference compound |
| HY-139404 | C10 AV Ceramide (d18:1/10:0) | 1263052-40-9 | Dye Reagents |
| HY-139406 | 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) (ammonium) | 1246303-11-6 | Reference compound |
| HY-139407 | 3-C12-NBD-cholesterol | 1246303-05-8 | Dye Reagents |
| HY-139408 | 17-Oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-docosahexaenoic acid | 1233715-28-0 | Natural Products |
| HY-139409 | 2-Deoxy-D-glucose 6-phosphate | 3573-50-0 | Reference compound |
| HY-139409A | 2-Deoxy-D-glucose 6-phosphate (disodium) | 33068-19-8 | Reference compound |
| HY-13941 | 1-Naphthyl PP1 | 221243-82-9 | Reference compound |
| HY-139410 | Sodium caseinates | 9005-46-3 | Biochemical Assay Reagents |
| HY-139411 | White mineral oil | 8042-47-5 | Biochemical Assay Reagents |
| HY-139413 | β-D-Glucan | 9041-22-9 | Biochemical Assay Reagents |
| HY-139414 | Lysophosphatidylcholines | 9008-30-4 | Biochemical Assay Reagents |
| HY-139415 | Polyethylene glycol monoisotridecyl ether | 9043-30-5 | Biochemical Assay Reagents |
| HY-139417S | Docosapentaenoic acid-d5 | 1215168-70-9 | Isotope-Labeled Compounds |
| HY-139419 | Bimatoprost grenod | 1194396-71-8 | Reference compound |
| HY-13941B | 1-Naphthyl PP1 (hydrochloride) | 956025-47-1 | Reference compound |
| HY-13942 | 1-NM-PP1 | 221244-14-0 | Reference compound |
| HY-139420 | Tafluprost ethyl amide | 1185851-52-8 | Reference compound |
| HY-139420R | Tafluprost ethyl amide (Standard) | 1185851-52-8 | Reference Standards |
| HY-139421 | (Z)-16-(Ethylcarbamoylamino)hexadec-11-enoic acid | 1184844-74-3 | Reference compound |
| HY-139423 | JAK1-IN-8 | 1973485-18-5 | Reference compound |
| HY-139424 | SQ609 | 627052-25-9 | Reference compound |
| HY-139425 | Cyclo(Pro-Ala) | 65556-33-4 | Reference compound |
| HY-139426 | ML-SI3 | 891016-02-7 | Reference compound |
| HY-139426A | (rel)-ML-SI3 | 2108567-79-7 | Reference compound |
| HY-139427 | 3-Methylglutaconic acid | 5746-90-7 | Reference compound |
| HY-139427S | 3-Methylglutaconic acid-13C3 | 1255644-45-1 | Isotope-Labeled Compounds |
| HY-139428 | Hydroxydehydro Nifedipine Carboxylate | 34783-31-8 | Reference compound |
| HY-139429S | (−)-11-Hydroxy-Δ8-THC-d3 | Isotope-Labeled Compounds | |
| HY-13943 | CNX-774 | 1202759-32-7 | Reference compound |
| HY-139430 | 4-Isopropylcatechol | 2138-43-4 | Reference compound |
| HY-139431 | NAG-thiazoline | 179030-22-9 | Reference compound |
| HY-139432 | 2-(Morpholinothio)benzothiazole | 102-77-2 | Reference compound |
| HY-139433 | 6-Hydroxy etodolac | 101901-06-8 | Reference compound |
| HY-139434 | JMJD6-IN-1 | 899548-78-8 | Reference compound |
| HY-139436 | ARD-2585 | 2757422-79-8 | Reference compound |
| HY-139439 | SBI-581 | Reference compound | |
| HY-139440 | DL-Leucyl-DL-phenylalanine | 56217-82-4 | Reference compound |
| HY-139441 | DM21 | 2243689-80-5 | ADC Related |
| HY-139442 | RdRP-IN-2 | 2863657-16-1 | Reference compound |
| HY-139446 | Trimethylolpropane ethoxylate triacrylate | 28961-43-5 | Biochemical Assay Reagents |
| HY-139449 | CDK4/6-IN-5 | 2380321-50-4 | Reference compound |
| HY-13945 | NVP 231 | 362003-83-6 | Reference compound |
| HY-139451 | ELOVL6-IN-3 | 712346-06-0 | Reference compound |
| HY-139452 | PFB-FDGlu | 209540-62-5 | Reference compound |
| HY-139453 | LP-184 | 924835-67-6 | Reference compound |
| HY-139453A | LP-284 | 2412580-47-1 | Reference compound |
| HY-139458 | MDM2-IN-21 | 939981-88-1 | Reference compound |
| HY-13946 | BML-277 | 516480-79-8 | Reference compound |
| HY-139461S | 5-Acetylamino-6-formylamino-3-methyluracil-d3 | 1216442-68-0 | Isotope-Labeled Compounds |
| HY-139464 | Q134R | 2022949-46-6 | Reference compound |
| HY-139465 | Aficamten | 2364554-48-1 | Reference compound |
| HY-139466 | PF-03622905 | 1072100-15-2 | Reference compound |
| HY-139467 | PF-04577806 | 1072100-81-2 | Reference compound |
| HY-139468 | Ala-Glu-OH | 13187-90-1 | Peptides |
| HY-139474S | N-Acetyl-S-(carbamoylethyl)-L-cysteine-d3 | 1795786-57-0 | Isotope-Labeled Compounds |
| HY-139474S1 | N-Acetyl-S-(carbamoylethyl)-L-cysteine-d4 | 2714331-84-5 | Isotope-Labeled Compounds |
| HY-13948 | Angiotensin II human | 4474-91-3 | Peptides |
| HY-139480 | Poly(ethylene glycol) dithiol (Mn 3400) | 68865-60-1 | Reference compound |
| HY-139480A | Poly(ethylene glycol) dithiol (Mn 1000) | 68865-60-1 | Biochemical Assay Reagents |
| HY-139480B | Poly(ethylene glycol) dithiol (Mn 1500) | 68865-60-1 | Biochemical Assay Reagents |
| HY-139481 | TL-895 | 1415823-49-2 | Reference compound |
| HY-139482 | tri-GalNAc-COOH | 1953146-81-0 | Reference compound |
| HY-139483S | Epinephrine Sulfonic acid-d3 | 1346604-55-4 | Isotope-Labeled Compounds |
| HY-139485 | BMS-986224 | 2055200-88-7 | Reference compound |
| HY-139486 | AM-8123 | 2049973-02-4 | Reference compound |
| HY-13948A | Angiotensin II human (acetate) | 68521-88-0 | Peptides |
| HY-13948B | Angiotensin II human (TFA) | 2761969-44-0 | Peptides |
| HY-13948BS | Angiotensin II human-13C6,15N (TFA) | Isotope-Labeled Compounds | |
| HY-13948F | Biotin-Ahx-Angiotensin II human | 115102-72-2 | Peptides |
| HY-13948F1 | Angiotensin II human, FAM-labeled | Peptides | |
| HY-13949 | SRPIN340 | 218156-96-8 | Reference compound |
| HY-139491S | N-(Acetyl-d3)-S-benzyl-L-cysteine | 201404-15-1 | Isotope-Labeled Compounds |
| HY-13950 | S186 | 97759-16-5 | Reference compound |
| HY-139504 | Gamcemetinib | 1887069-10-4 | Reference compound |
| HY-139505 | N-Acetyl glufosinate-d3 (sodium) | 1356933-74-8 | Isotope-Labeled Compounds |
| HY-139506S | 1-(3-Carboxypropyl)-3,7-dimethylxanthine-d6 | 1246816-64-7 | Isotope-Labeled Compounds |
| HY-139507S | Z,Z-Dienestrol-d6 | 91297-99-3 | Isotope-Labeled Compounds |
| HY-139509S | Capsiamide-d3 | 1795031-33-2 | Isotope-Labeled Compounds |
| HY-13951 | Zenidolol (hydrochloride) | 72795-01-8 | Reference compound |
| HY-139514 | RB-3 | 2396639-11-3 | Reference compound |
| HY-139516 | AZD4694 Precursor | 1211333-20-8 | Reference compound |
| HY-139517S1 | N-Desethyl etifoxine--13C,d3 | 2747914-26-5 | Isotope-Labeled Compounds |
| HY-139519S | N-Desmethyl diphenhydramine-d3 (hydrochloride) | 1794759-12-8 | Isotope-Labeled Compounds |
| HY-13952 | TP-808 | 852821-06-8 | Reference compound |
| HY-13953 | JIB-04 | 199596-05-9 | Reference compound |
| HY-139532S | (S)-Tomoxetine-d3 (hydrochloride) | 1217703-95-1 | Isotope-Labeled Compounds |
| HY-139533 | Phosphatidylinositols, soya, sodium salts | 383907-36-6 | Reference compound |
| HY-139534 | ARI-1 | Reference compound | |
| HY-139534A | (S)-ARI-1 | 2003228-82-6 | Reference compound |
| HY-139535 | Luxeptinib | 1616428-23-9 | Reference compound |
| HY-139536 | MAT2A inhibitor 4 | 1391934-91-0 | Reference compound |
| HY-139539 | Thalidomide-5-COOH | 1216805-11-6 | Reference compound |
| HY-13954 | A 839977 | 870061-27-1 | Reference compound |
| HY-139540 | Pomalidomide-6-OH | 1547162-44-6 | Reference compound |
| HY-139541 | Pomalidomide-5-O-CH3 | 1547163-02-9 | Reference compound |
| HY-139542 | Pomalidomide-6-O-CH3 | 1547163-08-5 | Reference compound |
| HY-139543 | Thalidomide-5-PEG2-Cl | 2230956-57-5 | Reference compound |
| HY-139544 | Thalidomide-5-propoxyethanamine | 2357107-60-7 | Reference compound |
| HY-139545 | Thalidomide-4-C3-NH2 (hydrochloride) | 2357110-84-8 | Reference compound |
| HY-139546 | Thalidomide-5-propargyne-NH2 (hydrochloride) | 2490402-62-3 | Reference compound |
| HY-139547 | Thalidomide-5,6-Cl | 2648939-40-4 | Reference compound |
| HY-139548 | Thalidomide-5-methyl | 40313-92-6 | Reference compound |
| HY-139549 | Thalidomide-benzo | 458151-34-3 | Reference compound |
| HY-13955 | Telmisartan | 144701-48-4 | Reference compound |
| HY-139551 | Guraxetan | Reference compound | |
| HY-139553 | Zunsemetinib | 1640282-42-3 | Reference compound |
| HY-139553A | (R)-Zunsemetinib | 1640282-44-5 | Reference compound |
| HY-139554 | Zifanocycline | 1420294-56-9 | Reference compound |
| HY-139554A | Zifanocycline (TFA) | Reference compound | |
| HY-139554AR | Zifanocycline (TFA) (Standard) | Reference Standards | |
| HY-139555 | Zectivimod | 1623066-63-6 | Reference compound |
| HY-139556 | Zavacorilant | 1781245-13-3 | Reference compound |
| HY-139557 | Zastaprazan | 2133852-18-1 | Reference compound |
| HY-139558 | Zapnometinib | 303175-44-2 | Reference compound |
| HY-139559 | Vornorexant | 1517965-94-4 | Reference compound |
| HY-13955R | Telmisartan (Standard) | 144701-48-4 | Reference Standards |
| HY-13955S | Telmisartan-d3 | 1189889-44-8 | Isotope-Labeled Compounds |
| HY-13955S1 | Telmisartan-d4 | Isotope-Labeled Compounds | |
| HY-13955S2 | Telmisartan-13C,d3 | 1261396-33-1 | Isotope-Labeled Compounds |
| HY-13955S3 | Telmisartan-d7 | 1794754-60-1 | Isotope-Labeled Compounds |
| HY-13956 | Pioglitazone | 111025-46-8 | Reference compound |
| HY-139560 | KDM2B-IN-1 | 1965248-33-2 | Reference compound |
| HY-139561 | KDM2B-IN-2 | 1965248-01-4 | Reference compound |
| HY-139562 | BMS-986318 | 2314378-09-9 | Reference compound |
| HY-139563 | Lenalidomide-C10-OH | 2503018-12-8 | Reference compound |
| HY-139564 | DOTA Zoledronate | 1908409-18-6 | Reference compound |
| HY-139566 | Abrucomstat | 100502-66-7 | Reference compound |
| HY-139567 | Afimetoran | 2171019-55-7 | Reference compound |
| HY-139568 | Deutarserine | 103292-62-2 | Reference compound |
| HY-139569 | Ebaresdax | 1334471-39-4 | Reference compound |
| HY-139569A | Ebaresdax (hydrochloride) | 1334385-87-3 | Reference compound |
| HY-13956A | (R)-Pioglitazone-d1 | 1259828-75-5 | Isotope-Labeled Compounds |
| HY-13956B | Pioglitazone (potassium) | 1266523-09-4 | Reference compound |
| HY-13956C | (R)-Pioglitazone | 959687-65-1 | Reference compound |
| HY-13956R | Pioglitazone (Standard) | 111025-46-8 | Reference Standards |
| HY-13956S | Pioglitazone-d4 | 1134163-29-3 | Isotope-Labeled Compounds |
| HY-13956S1 | Pioglitazone-d4 (alkyl) | 1134163-31-7 | Isotope-Labeled Compounds |
| HY-139570 | Ecubectedin | 2248127-53-7 | Reference compound |
| HY-139571 | Edaxeterkib | 1695534-88-3 | Reference compound |
| HY-139572 | Enuvaptan | 2145062-48-0 | Reference compound |
| HY-139573 | Etavopivat | 2245053-57-8 | Reference compound |
| HY-139573A | (Rac)-Etavopivat | 2622070-93-1 | Reference compound |
| HY-139574 | Firzacorvir | 2243747-96-6 | Reference compound |
| HY-139575 | Guretolimod | 1488364-57-3 | Reference compound |
| HY-139575A | Guretolimod (hydrochloride) | Reference compound | |
| HY-139576 | Larsucosterol | 884905-07-1 | Reference compound |
| HY-139576A | Larsucosterol (sodium) | 1174047-40-5 | Reference compound |
| HY-139576B | Larsucosterol (trimethylamine) | Reference compound | |
| HY-139577 | Ninerafaxstat | 2254741-41-6 | Reference compound |
| HY-139577A | Ninerafaxstat (trihydrochloride) | 2311824-72-1 | Reference compound |
| HY-139578 | Ocarocoxib | 215122-22-8 | Reference compound |
| HY-139579 | Pafolacianine | 1628423-76-6 | Dye Reagents |
| HY-139580 | Plazinemdor | 2378285-59-5 | Reference compound |
| HY-139581 | Ropanicant | 2414674-70-5 | Reference compound |
| HY-139582 | Simpinicline | 753015-44-0 | Reference compound |
| HY-139583 | Sunobinop | 1126793-40-5 | Reference compound |
| HY-139584 | Temgicoluril | 10095-06-4 | Reference compound |
| HY-139585 | Tigulixostat | 1287766-55-5 | Reference compound |
| HY-139586 | Ulevostinag | 2082743-96-0 | Reference compound |
| HY-139586B | Ulevostinag (isomer 2) | 2082743-99-3 | Reference compound |
| HY-139586C | Ulevostinag (isomer 3) | 2082743-98-2 | Reference compound |
| HY-139586D | Ulevostinag (isomer 4) | 2082743-97-1 | Reference compound |
| HY-139587 | Umifoxolaner | 2021230-37-3 | Reference compound |
| HY-139588 | Vemircopan | 2086178-00-7 | Reference compound |
| HY-139589 | Zaloglanstat | 1513852-12-4 | Reference compound |
| HY-13959 | MS436 | 1395084-25-9 | Reference compound |
| HY-139590 | Zeteletinib | 2216753-97-6 | Reference compound |
| HY-139590A | Zeteletinib (hemiadipate) | 2375837-06-0 | Reference compound |
| HY-139593S | Polθ-IN-1-d3 | 2598122-35-9 | Isotope-Labeled Compounds |
| HY-139594 | Polyketide synthase 13-IN-1 | 2345638-96-0 | Reference compound |
| HY-139595 | Polyketide synthase 13-IN-2 | 2219338-48-2 | Reference compound |
| HY-139596 | Polyketide synthase 13-IN-3 | 2221801-50-7 | Reference compound |
| HY-139597 | Temocillin (disodium) | 61545-06-0 | Reference compound |
| HY-139597R | Temocillin (disodium) (Standard) | 61545-06-0 | Reference Standards |
| HY-139598 | LFHP-1c | 2102347-47-5 | Reference compound |
| HY-13960 | GSK1324726A | 1300031-52-0 | Reference compound |
| HY-139600 | KDM2B-IN-3 | 1966933-87-8 | Reference compound |
| HY-139601 | KDM2B-IN-4 | 1966933-85-6 | Reference compound |
| HY-139602 | (+)-JNJ-A07 | 2135640-93-4 | Reference compound |
| HY-139602C | (-)-JNJ-A07 | 2135640-92-3 | Reference compound |
| HY-139603 | MYF-01-37 | 2416417-65-5 | Reference compound |
| HY-139604 | PCC0208017 | 2623158-64-3 | Reference compound |
| HY-139605 | GLUT inhibitor-1 | 2421141-40-2 | Reference compound |
| HY-139606 | VCP/p97 inhibitor-1 | 2630950-38-6 | Reference compound |
| HY-139607 | SSAO inhibitor-1 | 2242883-04-9 | Reference compound |
| HY-139609 | Camonsertib | 2417489-10-0 | Reference compound |
| HY-13961 | GLPG0634 analog | 1206101-20-3 | Reference compound |
| HY-139610S | 3-Sulfo-glycodeoxycholic acid-d4 (disodium) | Isotope-Labeled Compounds | |
| HY-139610S1 | 3-Sulfo-glycodeoxycholic acid-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-139611 | Navlimetostat | 2630904-45-7 | Reference compound |
| HY-139611B | (S)-Navlimetostat | 2630904-44-6 | Reference compound |
| HY-139611C | Navlimetostat (hydrochloride) | Reference compound | |
| HY-139612 | Opnurasib | 2653994-08-0 | Reference compound |
| HY-139612A | (S)-JDQ-443 | 2653994-10-4 | Reference compound |
| HY-139614S | Cholic acid 3-sulfate-d4 (disodium) | Isotope-Labeled Compounds | |
| HY-139615 | Sec61-IN-1 | 2484865-42-9 | Reference compound |
| HY-139616 | Sec61-IN-2 | 2484865-72-5 | Reference compound |
| HY-139617 | Sec61-IN-3 | 2484862-54-4 | Reference compound |
| HY-139618 | Dup-721 | 104421-21-8 | Reference compound |
| HY-139618R | Dup-721 (Standard) | 104421-21-8 | Reference Standards |
| HY-139619 | LT-850-166 | 3031480-22-2 | Reference compound |
| HY-13962 | SGI-1027 | 1020149-73-8 | Reference compound |
| HY-139620 | MS83 | 2762181-19-9 | Reference compound |
| HY-139620A | MS83 epimer 1 | Reference compound | |
| HY-139621 | Colibactin 742 | 2916559-62-9 | Reference compound |
| HY-139622 | DN-F01 | 30388-31-9 | Reference compound |
| HY-139623 | A4B17 | 2759918-91-5 | Reference compound |
| HY-139624 | JNK3 inhibitor-1 | 2622877-97-6 | Reference compound |
| HY-139625 | Dolastatinol | 2759918-83-5 | Reference compound |
| HY-139626 | EPZ-719 | 2697176-16-0 | Reference compound |
| HY-139627 | P2X receptor-1 | 3051864-35-5 | Reference compound |
| HY-139628 | JPD447 | 2883235-86-5 | Reference compound |
| HY-139629 | ANAT inhibitor-1 | 331751-78-1 | Reference compound |
| HY-13963 | ZCL278 | 587841-73-4 | Reference compound |
| HY-139630 | ANAT inhibitor-2 | 1048244-34-3 | Reference compound |
| HY-139631 | HIV-1 inhibitor-9 | 2708201-36-7 | Reference compound |
| HY-139635 | Anticancer agent 11 | 2332936-95-3 | Reference compound |
| HY-139636 | MCA17-1 | 2661480-70-0 | Reference compound |
| HY-139637 | (±)-Silybin | 36804-17-8 | Reference compound |
| HY-139638 | MEK4 inhibitor-1 | 2570386-36-4 | Reference compound |
| HY-139639 | MEK4 inhibitor-2 | 2833643-78-8 | Reference compound |
| HY-13964 | YIL781 | 875258-85-8 | Reference compound |
| HY-139640 | PTP1B-IN-13 | 650621-20-8 | Reference compound |
| HY-139641 | PTP1B-IN-14 | 724451-35-8 | Reference compound |
| HY-139642 | Mal-(CH2)5-Val-Cit-PAB-Eribulin | 2130869-21-3 | ADC Related |
| HY-139643 | CXCR7 antagonist-1 | 1613021-99-0 | Reference compound |
| HY-139643A | CXCR7 antagonist-1 (hydrochloride) | 2990472-61-0 | Reference compound |
| HY-139644 | MIPS521 | 1146188-19-3 | Reference compound |
| HY-139645 | MtDTBS-IN-1 | Reference compound | |
| HY-139646 | KMG-104 | 852057-94-4 | Dye Reagents |
| HY-139647 | (+)-Cinchonaminone | 60305-15-9 | Reference compound |
| HY-139648 | PREP inhibitor-1 | 2760543-16-4 | Reference compound |
| HY-139649 | Ten01 | Reference compound | |
| HY-13964A | YIL781 (hydrochloride) | 1640226-17-0 | Reference compound |
| HY-13965 | Parmodulin 2 | 423735-93-7 | Reference compound |
| HY-139650 | HDAC1/2-IN-3 | 2121516-17-2 | Reference compound |
| HY-139651 | CDK2-IN-7 | 2498658-13-0 | Reference compound |
| HY-139652 | PLK1-IN-2 | 2640254-52-8 | Reference compound |
| HY-139653 | IDO-IN-14 | 2568302-02-1 | Reference compound |
| HY-139654 | α/β-Hydrolase-IN-1 | 2696301-42-3 | Reference compound |
| HY-139655 | cIAP1 Ligand-Linker Conjugates 16 | 2143956-63-0 | Reference compound |
| HY-139656 | cIAP1 ligand 4 | 2891589-73-2 | Reference compound |
| HY-139657 | ThrRS-IN-2 | 468750-19-8 | Reference compound |
| HY-139658 | D-Xylofuranose, 1,2,3,5-tetraacetate | 42927-46-8 | Reference compound |
| HY-139659 | ARD-61 | 2316837-08-6 | Reference compound |
| HY-13966 | 2-Deoxy-D-glucose | 154-17-6 | Natural Products |
| HY-139660 | PROTAC PTK6 ligand-1 | 2408341-98-8 | Reference compound |
| HY-139661 | Boc-bipiperidine-ethynylbenzoic acid | 2308497-81-4 | Reference compound |
| HY-139662 | HB007 | 2387821-46-5 | Reference compound |
| HY-139663 | IHVR-17028 | 1428247-78-2 | Reference compound |
| HY-139664 | GSK-3685032 | 2170137-61-6 | Reference compound |
| HY-139664A | (R)-GSK-3685032 | 2170140-50-6 | Reference compound |
| HY-139664B | (S)-GSK-3685032 | 2170142-58-0 | Reference compound |
| HY-139665 | VB124 | 2230186-18-0 | Reference compound |
| HY-139666 | N-Palmitoyl-L-glutamine | 58725-34-1 | Reference compound |
| HY-139666R | N-Palmitoyl-L-glutamine (Standard) | 58725-34-1 | Reference Standards |
| HY-139667 | PKM2-IN-3 | 2408841-19-8 | Reference compound |
| HY-139668 | VGD071 | 2826992-31-6 | Reference compound |
| HY-139669 | Antifungal agent 13 | 2834776-94-0 | Reference compound |
| HY-13966S | 2-Deoxy-D-glucose-d1 | 188004-07-1 | Isotope-Labeled Compounds |
| HY-13966S2 | 2-Deoxy-D-glucose-13C | 201612-55-7 | Isotope-Labeled Compounds |
| HY-13966S3 | 2-Deoxy-D-glucose-13C6 | 201740-77-4 | Isotope-Labeled Compounds |
| HY-13966S4 | 2-Deoxy-D-glucose-13C-1 | 119897-50-6 | Isotope-Labeled Compounds |
| HY-13967 | AMG 837 | 865231-46-5 | Reference compound |
| HY-139670 | PSMA–DA1 | 2703051-77-6 | Reference compound |
| HY-139671 | Ultrashort α,β-Peptide | 2738334-37-5 | Reference compound |
| HY-139672 | BRD5018 | 2245231-51-8 | Reference compound |
| HY-139673 | BG dimer | 2700187-91-1 | Dye Reagents |
| HY-139675 | GPR84 antagonist 1 | 2762180-28-7 | Reference compound |
| HY-139676 | RMG8-8 | 3030216-89-5 | Reference compound |
| HY-139677 | 5-HT7R antagonist 1 | 2759919-13-4 | Reference compound |
| HY-139677A | 5-HT7R antagonist 1 (free base) | 2337008-64-5 | Reference compound |
| HY-139678 | SC13 | 2839142-69-5 | Reference compound |
| HY-139679 | Antibacterial agent 28 | 2673185-41-4 | Reference compound |
| HY-13967A | AMG 837 (sodium salt) | 865231-45-4 | Reference compound |
| HY-13967B | AMG 837 (calcium hydrate) | 1259389-38-2 | Reference compound |
| HY-13968 | JW 55 | 664993-53-7 | Reference compound |
| HY-139680 | Dopamine D3 receptor antagonist-1 | 3052236-36-6 | Reference compound |
| HY-139681 | Dopamine D3 receptor antagonist-2 | 3052236-39-9 | Reference compound |
| HY-139682 | Dovitinib-RIBOTAC | 2759351-68-1 | Reference compound |
| HY-139682A | Dovitinib-RIBOTAC (TFA) | 2759351-69-2 | Reference compound |
| HY-139683 | Antiviral agent 5 | 2698336-82-0 | Reference compound |
| HY-139684 | MNK1/2-IN-5 | 1426928-20-2 | Reference compound |
| HY-139685 | ABP 25 | 2965359-45-7 | Reference compound |
| HY-139686 | IL-17A inhibitor 2 | 2452464-77-4 | Reference compound |
| HY-139687S | Ractopamine Ketone-d6 (hydrochloride) | 1185012-24-1 | Isotope-Labeled Compounds |
| HY-139688S | (±)-Voriconazole-d3 | Isotope-Labeled Compounds | |
| HY-139689S | rac-trans-N-Desmethyl sertraline-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-139690 | CCG258747 | 2615910-00-2 | Reference compound |
| HY-139691 | SR15006 | 2505001-54-5 | Reference compound |
| HY-139692 | EAAT2 activator 1 | 892415-28-0 | Reference compound |
| HY-139693 | PTPN22-IN-1 | 2580935-57-3 | Reference compound |
| HY-139694 | hA3AR agonist 1 | 2821704-65-6 | Reference compound |
| HY-139695 | Spectinamide 1599 | 1620153-85-6 | Reference compound |
| HY-139696 | AKR1B10-IN-1 | 2136579-33-2 | Reference compound |
| HY-139697 | HAV 3C proteinase-IN-1 | 1626408-58-9 | Reference compound |
| HY-139698 | GT-1 | 1401527-90-9 | Reference compound |
| HY-139699 | GT-055 | 2842084-52-8 | Reference compound |
| HY-139701 | NI-Pano | 2733559-66-3 | Reference compound |
| HY-139702 | α5β1 integrin agonist-1 | 2756557-83-0 | Reference compound |
| HY-139703 | Se-DMC | 2098850-81-6 | Reference compound |
| HY-139704 | Eroonazole | 305376-22-1 | Reference compound |
| HY-139705 | Anticancer agent 12 | 2832055-89-5 | Reference compound |
| HY-139707 | Thalidomide-NH-CBP/p300 ligand 2 | 2484739-21-9 | Reference compound |
| HY-139708 | NMDA receptor antagonist-3 | 2762181-52-0 | Reference compound |
| HY-139709 | Glucocorticoids receptor agonist 1 | 694526-54-0 | Reference compound |
| HY-13971 | GPR40 Activator 1 | 1309435-60-6 | Reference compound |
| HY-139710 | Glucocorticoids receptor agonist 2 | 614761-20-5 | Reference compound |
| HY-139711 | Anticancer agent 13 | 38116-01-7 | Reference compound |
| HY-139712 | PDGFP 1 | Reference compound | |
| HY-139713 | Antifungal agent 14 | 2710259-38-2 | Reference compound |
| HY-139714 | IMD-vanillin | 2928463-38-9 | Reference compound |
| HY-139715 | IMD-ferulic | Reference compound | |
| HY-139716 | IMD-catechol | 2928463-39-0 | Reference compound |
| HY-139717 | IMD-biphenylA | 2928463-40-3 | Reference compound |
| HY-139718 | IMD-biphenylB | 2928463-41-4 | Reference compound |
| HY-139719 | IMD-biphenylC | 2928463-42-5 | Reference compound |
| HY-13972 | Mutant IDH1 inhibitor | 1429180-08-4 | Reference compound |
| HY-139720 | β-Secretase Inhibitor III | 2760674-85-7 | Reference compound |
| HY-139721 | Tenofovir-C3-O-C15-CF3 (ammonium) | 2611373-80-7 | Reference compound |
| HY-139722 | Tenofovir-C3-O-C12-trimethylsilylacetylene (ammonium) | 2611373-74-9 | Reference compound |
| HY-139723 | Antidepressant agent 2 | 2822600-09-7 | Reference compound |
| HY-139725 | CDK5-IN-1 | 2639540-19-3 | Reference compound |
| HY-139726 | Mal-PEG4-Val-Cit-PAB-MMAE | Reference compound | |
| HY-139727 | S(-)-Bisoprolol | 99103-03-4 | Reference compound |
| HY-139727A | S(-)-Bisoprolol (fumarate) | 1426853-23-7 | Reference compound |
| HY-139728 | N,N,N′,N′-Tetracyclohexyl-3-oxapentanediamide | 74267-27-9 | Reference compound |
| HY-139729 | HOPan | 18679-90-8 | Reference compound |
| HY-139730 | c-ABL-IN-1 | 2304918-82-7 | Reference compound |
| HY-139731 | Transketolase-IN-1 | 2763650-87-7 | Reference compound |
| HY-139732 | SARS-CoV-2-IN-8 | Reference compound | |
| HY-139733 | β-N-Acetyl-D-hexosaminidase-IN-1 | 2760672-89-5 | Reference compound |
| HY-139735 | Antitumor agent-29 | 2847856-44-2 | Reference compound |
| HY-139738 | TIM-3-IN-1 | 2883237-04-3 | Reference compound |
| HY-139739 | Antibacterial agent 31 | 2719842-14-3 | Reference compound |
| HY-13973A | GSK-3 inhibitor 1 | 603272-51-1 | Reference compound |
| HY-139740 | Aβ Fibrillization modulator 1 | 2847131-53-5 | Reference compound |
| HY-139741 | cyclo(Phe-Ala-Gly-Arg-Arg-Arg-Gly-AEEAc) | Peptides | |
| HY-139742 | ADTL-SA1215 | 782387-91-1 | Reference compound |
| HY-139743 | Aditoprime | 56066-63-8 | Reference compound |
| HY-139743R | Aditoprime (Standard) | 56066-63-8 | Reference Standards |
| HY-139744 | FPI-1465 | 1452458-70-6 | Reference compound |
| HY-139745 | FPI-1523 (sodium) | 1452459-52-7 | Reference compound |
| HY-139745A | FPI-1523 | 1452459-50-5 | Reference compound |
| HY-139746 | FPI-1602 | 1452460-31-9 | Reference compound |
| HY-139747 | Antibacterial agent 32 | 1436862-65-5 | Reference compound |
| HY-139748 | ETX0462 | Reference compound | |
| HY-139749 | Antibacterial agent 33 | 1426572-59-9 | Reference compound |
| HY-139750 | Antibacterial agent 34 | 1426572-58-8 | Reference compound |
| HY-139751 | β-Lactamase-IN-4 | 1463520-91-3 | Reference compound |
| HY-139752 | Antibacterial agent 35 | 1426572-56-6 | Reference compound |
| HY-139754 | Antibacterial agent 37 | 1452459-04-9 | Reference compound |
| HY-139755 | Antibacterial agent 38 | 1452459-12-9 | Reference compound |
| HY-139756 | Antibacterial agent 39 | 1426572-46-4 | Reference compound |
| HY-139757 | Antibacterial agent 40 | 1817768-97-0 | Reference compound |
| HY-139758 | Antibacterial agent 41 | 1426572-45-3 | Reference compound |
| HY-139759 | Antibacterial agent 42 | 1426572-47-5 | Reference compound |
| HY-139760 | Antibacterial agent 43 | 1426572-48-6 | Reference compound |
| HY-139761 | Antibacterial agent 44 | 1426572-49-7 | Reference compound |
| HY-139762 | Antibacterial agent 45 | 1426572-50-0 | Reference compound |
| HY-139763 | Antibacterial agent 46 | 1426572-51-1 | Reference compound |
| HY-139764 | Antibacterial agent 47 | 1426572-52-2 | Reference compound |
| HY-139765 | Antibacterial agent 48 | 1426572-53-3 | Reference compound |
| HY-139766 | Antibacterial agent 49 | 1426572-54-4 | Reference compound |
| HY-139767 | Antibacterial agent 50 | 1436862-71-3 | Reference compound |
| HY-139768 | Antibacterial agent 51 | 1436862-69-9 | Reference compound |
| HY-139769 | Antibacterial agent 52 | 1426572-60-2 | Reference compound |
| HY-13976A | PRL-8-53 | 51352-87-5 | Reference compound |
| HY-139770 | Antibacterial agent 53 | 1426572-61-3 | Reference compound |
| HY-139771 | Antibacterial agent 54 | 1426572-62-4 | Reference compound |
| HY-139772 | Antibacterial agent 55 | 1426572-63-5 | Reference compound |
| HY-139773 | Antibacterial agent 56 | 1426572-64-6 | Reference compound |
| HY-139774 | Antibacterial agent 57 | 1426572-67-9 | Reference compound |
| HY-139775 | Antibacterial agent 58 | 1426572-65-7 | Reference compound |
| HY-139776 | Antibacterial agent 59 | 1426572-66-8 | Reference compound |
| HY-139777 | Antibacterial agent 60 | 1426572-68-0 | Reference compound |
| HY-139778 | Antibacterial agent 61 | 1426572-69-1 | Reference compound |
| HY-139779 | β-Lactamase-IN-5 | 1463521-39-2 | Reference compound |
| HY-13977A | PKR-IN-C16 | 608512-97-6 | Reference compound |
| HY-139780 | JNJ-61803534 | 1917306-14-9 | Reference compound |
| HY-139781 | PD-L1-IN-1 | 2767424-13-3 | Reference compound |
| HY-139782 | SKLB325 | 66680-03-3 | Reference compound |
| HY-139783 | 3-Campholenyl-2-butanol | 65113-99-7 | Reference compound |
| HY-139784 | Idroxioleic acid | 182370-45-2 | Reference compound |
| HY-139785 | Cavrotolimod | 2378664-12-9 | Reference compound |
| HY-139785A | Cavrotolimod (sodium) | Oligonucleotides | |
| HY-139786 | Cofirasersen | 2247669-96-9 | Reference compound |
| HY-139786A | Cofirasersen (sodium) | Oligonucleotides | |
| HY-139787 | Donidalorsen | 2304692-48-4 | Reference compound |
| HY-139787A | Donidalorsen (sodium) | 2304701-45-7 | Oligonucleotides |
| HY-139788 | Fesomersen | 2380135-03-3 | Oligonucleotides |
| HY-139788A | Fesomersen (sodium) | 2380288-85-5 | Oligonucleotides |
| HY-13979 | DDR1-IN-1 | 1449685-96-4 | Reference compound |
| HY-139791 | Azetukalner | 1009344-33-5 | Reference compound |
| HY-139792 | Besigliptin (tosylate) | 1177460-72-8 | Reference compound |
| HY-139793 | UDP-glucosamine (disodium) | 1355005-51-4 | Reference compound |
| HY-139794 | SDZ283-910 | 164514-54-9 | Reference compound |
| HY-139795 | ZYJ-25e | 1287261-04-4 | Reference compound |
| HY-139796 | ZYJ-34v | 1450662-32-4 | Reference compound |
| HY-139798 | Iboxamycin | 2640000-92-4 | Reference compound |
| HY-139799 | Sch 202596 | 196615-89-1 | Reference compound |
| HY-13979A | DDR1-IN-1 dihydrochloride | 1780303-76-5 | Reference compound |
| HY-13980 | UNC0642 | 1481677-78-4 | Reference compound |
| HY-139800 | (-)-Glycinol | 69393-95-9 | Natural Products |
| HY-139801 | Indolapril (hydrochloride) | 80828-32-6 | Reference compound |
| HY-139802 | L-779976 | 214770-19-1 | Reference compound |
| HY-139803 | SCH-39370 | 115406-23-0 | Reference compound |
| HY-139804 | CTK7A | 1297262-16-8 | Reference compound |
| HY-139805 | Ticarcillin | 34787-01-4 | Reference compound |
| HY-139805A | Ticarcillin (monosodium) | 74682-62-5 | Reference compound |
| HY-139806 | SRA880 (free base) | 187218-90-2 | Reference compound |
| HY-139807 | JAK-IN-14 | 1973485-06-1 | Reference compound |
| HY-139808S | (±)-cis-N-Desmethylsertraline-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-139809S | Cinnarizine-d8 (dihydrochloride) | 1276545-36-8 | Isotope-Labeled Compounds |
| HY-13981 | Ligandrol | 1165910-22-4 | Reference compound |
| HY-139811S | Glimepiride-d4 | Isotope-Labeled Compounds | |
| HY-139813 | Phenanthriplatin | 1416900-51-0 | Reference compound |
| HY-139815 | ZYJ-34c | 1314556-93-8 | Reference compound |
| HY-139816 | BTNPO | 2507992-93-8 | Dye Reagents |
| HY-139817 | Antiviral agent 8 | 2634704-26-8 | Reference compound |
| HY-139818 | Mal-PEG-PLA (PEG MW 3000 & PLA MW 70,000) | Biochemical Assay Reagents | |
| HY-139819 | MPEG-PLA (PEG MW 3000 & PLA MW 50,000) | Reference compound | |
| HY-13982 | JSH-23 | 749886-87-1 | Reference compound |
| HY-139820 | FTO-IN-4 | 2763577-74-6 | Reference compound |
| HY-139821 | FTO-IN-5 | 2763577-75-7 | Reference compound |
| HY-139822 | VEGFR-2-IN-10 | 2760792-40-1 | Reference compound |
| HY-139823 | PRMT5-IN-10 | 2567564-23-0 | Reference compound |
| HY-139823A | PRMT5-IN-11 | 2567564-33-2 | Reference compound |
| HY-139824 | Nitro-coronene | 2842847-23-6 | Reference compound |
| HY-139825 | Indoluidin E | 2763081-76-9 | Reference compound |
| HY-139826 | CuATSP | 68341-12-8 | Reference compound |
| HY-139827 | CuATSM | 68341-09-3 | Reference compound |
| HY-139828 | Anticancer agent 14 | 2762698-14-4 | Reference compound |
| HY-13983 | IDO-IN-7 | 1402836-58-1 | Reference compound |
| HY-139830 | Dyrk1A-IN-1 | 2858696-72-5 | Reference compound |
| HY-139831 | Galectin-8-IN-1 | 3028946-23-5 | Reference compound |
| HY-139832 | MCX 28 | 1414453-58-9 | Reference compound |
| HY-139833 | Anti-inflammatory agent 6 | Reference compound | |
| HY-139834 | Antistaphylococcal agent 1 | 2350182-68-0 | Reference compound |
| HY-139835 | Antistaphylococcal agent 2 | 2350182-67-9 | Reference compound |
| HY-139836 | Antistaphylococcal agent 3 | 2350182-65-7 | Reference compound |
| HY-139837 | GDC-4379 | 2252277-73-7 | Reference compound |
| HY-139838 | Epyrifenacil | 353292-31-6 | Reference compound |
| HY-139839 | Y12196 | 1671025-91-4 | Reference compound |
| HY-13984 | Mutant EGFR inhibitor | 1421373-62-7 | Reference compound |
| HY-139840 | GCPII-IN-1 | 1025796-32-0 | Reference compound |
| HY-139840A | GCPII-IN-1 (TFA) | 1269794-89-9 | Reference compound |
| HY-139842 | Homobrassinolide | 74174-44-0 | Biochemical Assay Reagents |
| HY-139844 | Anti-inflammatory agent 7 | 2759194-24-4 | Reference compound |
| HY-139845 | Antiviral agent 9 | Reference compound | |
| HY-139846 | MK-4688 | 1616428-79-5 | Reference compound |
| HY-139847 | RORγt inverse agonist 23 | 2230779-18-5 | Reference compound |
| HY-139848 | WS-898 | 2891562-77-7 | Reference compound |
| HY-13985 | Nav1.7 inhibitor | 1355631-24-1 | Reference compound |
| HY-139850 | GPS491 | 2655502-29-5 | Reference compound |
| HY-139851 | Fungicide5 | 2344721-61-3 | Reference compound |
| HY-139852 | PLAP-IN-1 | 2857113-78-9 | Reference compound |
| HY-139853 | BMS-986278 | 2170126-74-4 | Reference compound |
| HY-139854 | DNDI-6148 | 2243909-59-1 | Reference compound |
| HY-139855 | ZG-2033 | 2685739-28-8 | Reference compound |
| HY-139856 | Mal-Ala-Ala-PAB-PNP | 2003260-14-6 | ADC Related |
| HY-139857 | Piceid 6″-O-azelaic acid ester | Reference compound | |
| HY-139858 | TGFβR-IN-1 | 2857845-36-2 | Reference compound |
| HY-139859 | APN-PEG36-tetrazine | ADC Related | |
| HY-13986 | Merimepodib | 198821-22-6 | Reference compound |
| HY-139860 | Anticancer agent 15 | 2710312-73-3 | Reference compound |
| HY-139861 | CBP/p300-IN-14 | 2725036-10-0 | Reference compound |
| HY-139862 | Keap1-Nrf2-IN-3 | 2095066-47-8 | Reference compound |
| HY-139863 | Antibacterial agent 62 | 3031364-03-8 | Reference compound |
| HY-139865 | 142I5 | 2865171-75-9 | Reference compound |
| HY-139866 | SARS-CoV-2-IN-9 | 1453052-57-7 | Reference compound |
| HY-139868 | BAY-091 | 2922280-34-8 | Reference compound |
| HY-13986A | (R)-Merimepodib | 2748420-50-8 | Reference compound |
| HY-13987 | (R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid | 103733-65-9 | Reference compound |
| HY-139871 | hTrkA-IN-2 | 2986533-14-4 | Reference compound |
| HY-139872 | eIF4A3-IN-4 | 2861994-92-3 | Reference compound |
| HY-139873 | CXCR2 antagonist 2 | 2647464-91-1 | Reference compound |
| HY-139874 | CXCR2 antagonist 3 | 2647464-92-2 | Reference compound |
| HY-139875 | JH-XVI-178 | 2648453-53-4 | Reference compound |
| HY-139876 | APJ receptor agonist 3 | 2759159-56-1 | Reference compound |
| HY-139877 | OXS007417 | 2761147-94-6 | Reference compound |
| HY-139878 | MLKL-IN-1 | 2837019-30-2 | Reference compound |
| HY-139879 | PARP1-IN-6 | 1654735-36-0 | Reference compound |
| HY-13988 | AT-56 | 162640-98-4 | Reference compound |
| HY-139880 | PI3Kγ inhibitor 5 | 2566569-31-9 | Reference compound |
| HY-139881 | BTK inhibitor 19 | 2557174-19-1 | Reference compound |
| HY-139882 | Anticancer agent 16 | 2761205-38-1 | Reference compound |
| HY-139883 | IDO-IN-15 | 2433886-87-2 | Reference compound |
| HY-139884 | EGFR-IN-18 | 2765573-34-8 | Reference compound |
| HY-139885 | c-Myc inhibitor 4 | 2763366-92-1 | Reference compound |
| HY-139886 | gTPA2-OMe | 2738342-65-7 | Reference compound |
| HY-139887 | Antibacterial agent 63 | 2910919-43-4 | Reference compound |
| HY-139888 | Plasma kallikrein-IN-1 | 2691030-28-9 | Reference compound |
| HY-139889 | DHODH-IN-18 | 2685799-97-5 | Reference compound |
| HY-13989 | b-AP15 | 1009817-63-3 | Reference compound |
| HY-139890 | DC-Srci-6649 | 1037545-61-1 | Reference compound |
| HY-139891 | Trk-IN-6 | 2489327-43-5 | Reference compound |
| HY-139892 | XR8-69 | 2817811-10-0 | Reference compound |
| HY-139893 | ERGi-USU-6 (mesylate) | 2756327-67-8 | Reference compound |
| HY-139894 | KRAS G12D inhibitor 5 | 2621928-53-6 | Reference compound |
| HY-139897 | CX 717 | 867276-98-0 | Reference compound |
| HY-139899 | S6821 | 1119831-25-2 | Reference compound |
| HY-13990 | NVP-TNKS656 | 1419949-20-4 | Reference compound |
| HY-139900 | Benzyl 2-hydroxy-6-methoxybenzoate | 24474-71-3 | Reference compound |
| HY-139901 | Chk1-IN-6 | 2428423-77-0 | Reference compound |
| HY-139902 | Quorum sensing-IN-1 | 2762184-06-3 | Reference compound |
| HY-139903 | Antifungal agent 18 | 2572713-30-3 | Reference compound |
| HY-139904 | TRPA1 Antagonist 3 | 71291-80-0 | Reference compound |
| HY-139905 | Antifungal agent 19 | Reference compound | |
| HY-139906 | CXCL12 ligand 1 | 2045891-59-4 | Reference compound |
| HY-139907 | DG013A | 2007955-07-7 | Reference compound |
| HY-139907A | DG013B | 2758817-06-8 | Reference compound |
| HY-139907B | DG013A (formate) | Reference compound | |
| HY-139907C | DG013B (formate) | Reference compound | |
| HY-139908 | MERS-CoV-IN-1 | 2245697-92-9 | Reference compound |
| HY-139909 | CL2E-SN38 | 1639139-65-3 | ADC Related |
| HY-139909A | CL2E-SN38 (TFA) | ADC Related | |
| HY-13991 | CCG-1423 | 285986-88-1 | Reference compound |
| HY-139910 | KRAS G12D inhibitor 6 | 2648552-32-1 | Reference compound |
| HY-139911 | KRAS G12D inhibitor 7 | 2648552-34-3 | Reference compound |
| HY-139912 | Biotin-aniline | 769933-15-5 | Reference compound |
| HY-139915 | MPO-IN-1 | 2471981-21-0 | Reference compound |
| HY-13991A | (S)-CCG-1423 | 2319939-24-5 | Reference compound |
| HY-13992 | AP20187 | 195514-80-8 | Reference compound |
| HY-139920 | Oritinib | 2035089-28-0 | Reference compound |
| HY-139920A | Oritinib (mesylate) | 2180164-79-6 | Reference compound |
| HY-139924S | 3β-Cholic acid-d4 | Isotope-Labeled Compounds | |
| HY-139926S | PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (trisodium) | Isotope-Labeled Compounds | |
| HY-139928S | Valeryl-L-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-13993 | Ro 25-6981 | 169274-78-6 | Reference compound |
| HY-139931S | 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC | 161922-50-5 | Isotope-Labeled Compounds |
| HY-139937S | (±)14(15)-EET-d11 methyl ester | Isotope-Labeled Compounds | |
| HY-139938S | (±)11(12)-EET methyl ester-d11 | Isotope-Labeled Compounds | |
| HY-139939S | Isovaleryl-DL-carnitine-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-13993A | Ro 25-6981 (Maleate) | 1312991-76-6 | Reference compound |
| HY-13993B | Ro 25-6981 (hydrochloride) | 919289-58-0 | Reference compound |
| HY-13994 | Mps1-IN-2 | 1228817-38-6 | Reference compound |
| HY-139942S | (±)9(10)-EpOME-d4 | 1215168-54-9 | Isotope-Labeled Compounds |
| HY-139945S | (±)15-HETE-d8 | 2525175-31-7 | Isotope-Labeled Compounds |
| HY-13995 | Sevelamer | 52757-95-6 | Reference compound |
| HY-139950 | Rasarfin | 674359-73-0 | Reference compound |
| HY-139951S | 3-Hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium) | Isotope-Labeled Compounds | |
| HY-139952S | Prostaglandin D2 Dopamine-d4 | Isotope-Labeled Compounds | |
| HY-139956 | Mal-amido-PEG9-Val-Ala-PAB-SG3200 | 1817788-75-2 | ADC Related |
| HY-139957 | Mal-amido-PEG8-Val-Ala-PAB-SG3200 | 2025353-40-4 | ADC Related |
| HY-139959S | (±)12(13)-EpOME-d4 | Isotope-Labeled Compounds | |
| HY-13995A | Sevelamer (hydrochloride) | 152751-57-0 | Reference compound |
| HY-13995B | Sevelamer (carbonate) | 845273-93-0 | Reference compound |
| HY-139961S | (±)14(15)-EET-d11 | 2699608-29-0 | Isotope-Labeled Compounds |
| HY-139965S | 4-hydroxy Nonenal Glutathione-d3 (TFA) | Isotope-Labeled Compounds | |
| HY-139967S | PGPC-d6 | Isotope-Labeled Compounds | |
| HY-139968S | 13,14-Dihydro-15(R,S)-hydroxy-16,16-difluoro Prostaglandin E1-d4 | Isotope-Labeled Compounds | |
| HY-139969S | 1-Arachidonoyl-d5-rac-glycerol | 2568492-44-2 | Isotope-Labeled Compounds |
| HY-13997 | Ombitasvir | 1258226-87-7 | Reference compound |
| HY-139970 | VPC-13789 | 2761146-51-2 | Reference compound |
| HY-139971 | Antibacterial agent 64 | 618865-52-4 | Reference compound |
| HY-139972 | PROTAC(H-PGDS)-7 | 2761281-50-7 | Reference compound |
| HY-139973 | OAB-14 | 2140911-49-3 | Reference compound |
| HY-139974 | BChE-IN-2 | Reference compound | |
| HY-139975 | Antitumor agent-31 | 2703000-00-2 | Dye Reagents |
| HY-139976 | 1-SG | 2839421-83-7 | Reference compound |
| HY-139979 | USP5-IN-1 | 2851040-81-6 | Reference compound |
| HY-13998 | Dasabuvir | 1132935-63-7 | Reference compound |
| HY-139980 | CDK9-IN-13 | 2768712-71-4 | Reference compound |
| HY-139981 | Microtubule destabilizing agent-1 | 2850370-28-2 | Reference compound |
| HY-139982 | OX11 | 2414598-74-4 | Reference compound |
| HY-139983 | SDH-IN-1 | 2685795-52-0 | Reference compound |
| HY-139984 | BIIB091 | 2247614-80-6 | Reference compound |
| HY-139985 | NBD-14189 | 2234273-72-2 | Reference compound |
| HY-139986 | CDK7-IN-5 | 1817006-50-0 | Reference compound |
| HY-139987 | LeuRS-IN-1 | 1364914-72-6 | Reference compound |
| HY-139987A | LeuRS-IN-1 (hydrochloride) | 1364683-67-9 | Reference compound |
| HY-139988 | 2-O-DMT-Sulfonyldiethanol phosphoramidite | 108783-02-4 | Reference compound |
| HY-139989 | NBD-14270 | 2411819-82-2 | Reference compound |
| HY-13998A | Dasabuvir (sodium) | 1132940-11-4 | Reference compound |
| HY-13998R | Dasabuvir (Standard) | 1132935-63-7 | Reference Standards |
| HY-13999 | NSI-189 | 1270138-40-3 | Reference compound |
| HY-139990 | CSF1R-IN-3 | 2760584-90-3 | Reference compound |
| HY-139991 | Neuraminidase-IN-3 | 2699874-41-2 | Reference compound |
| HY-139993 | HIF-PHD-IN-2 | 2711720-45-3 | Reference compound |
| HY-139994 | XN methyl pyrazole | 2820169-36-4 | Reference compound |
| HY-139995 | Spermine Prodrug-1 | 2576358-68-2 | Reference compound |
| HY-139996 | Pomalidomide-C5-Dovitinib | 2732969-67-2 | Reference compound |
| HY-139997 | DDC-01-163 | 2140806-84-2 | Reference compound |
| HY-139998 | PCSK9-IN-3 | 2867496-34-0 | Reference compound |
| HY-139999 | LCL-PEG3-N3 | 3033849-90-7 | Reference compound |
| HY-139999A | LCL-PEG3-N3 (hydrochloride) | 3033849-91-8 | Reference compound |
| HY-13999A1 | NSI-189 (phosphate) | 1270138-41-4 | Reference compound |
| HY-140000 | Methylamino-PEG1-acid | 1367918-21-5 | Reference compound |
| HY-140001 | Amino-PEG3-C2-sulfonic acid | 1817735-43-5 | Reference compound |
| HY-140002 | Amino-PEG1-C2-acid | 144942-89-2 | Reference compound |
| HY-140003 | Tetraethyl butane-1,4-diylbis(phosphonate) | 7203-67-0 | Reference compound |
| HY-140004 | Azide-PEG3-Tos | 178685-33-1 | ADC Related |
| HY-140005 | Aminooxy-PEG3-acid | 1807540-79-9 | Reference compound |
| HY-140006 | Diketone-PEG4-PFP ester | 2353409-84-2 | Reference compound |
| HY-140007 | Acrylate-PEG-NH2 (MW 2000) | Reference compound | |
| HY-140008 | DOTA-PEG5-amine | Reference compound | |
| HY-140009 | Azido-PEG1-C2-acid | 1393330-34-1 | Reference compound |
| HY-140010 | N-methyl-N'-(azide-PEG3)-Cy3 | 2107273-16-3 | Reference compound |
| HY-140011 | Acid-C2-PEG3-NHS ester | 1835759-79-9 | Reference compound |
| HY-140012 | Azido-PEG4-beta-D-glucose | 1609083-15-9 | Reference compound |
| HY-140013 | Fmoc-NH-PEG1-C2-acid | 1654740-73-4 | Reference compound |
| HY-140014 | Val-Cit | 159858-33-0 | ADC Related |
| HY-140015 | TCO-PEG3-acid | 2141981-86-2 | Reference compound |
| HY-140015A | (S,E)-TCO2-PEG3-acid | Reference compound | |
| HY-140016 | Bis-(m-PEG4)-amidohexanoic acid | 2353409-74-0 | Reference compound |
| HY-140017 | PEG2-bis(phosphonic acid) | 116604-42-3 | Reference compound |
| HY-140018 | Thiol-PEG3-acid | 1347750-82-6 | Reference compound |
| HY-140019 | Azido-PEG3-amide-C3-triethoxysilane | 2243566-43-8 | Reference compound |
| HY-140020 | Propargyl-PEG10-acid | 2055022-18-7 | Reference compound |
| HY-140021 | Propargyl-PEG13-acid | Reference compound | |
| HY-140022 | Propargyl-PEG14-acid | Reference compound | |
| HY-140023 | Propargyl-PEG4-CH2COOH | 1429934-37-1 | Reference compound |
| HY-140024 | Propargyl-PEG4-CH2-acid | 1872433-74-3 | Reference compound |
| HY-140025 | Propargyl-PEG4-CH2CO2-NHS | 2144777-76-2 | Reference compound |
| HY-140026 | Propargyl-PEG1-Boc | 488150-84-1 | Reference compound |
| HY-140027 | Propargyl-PEG3-Boc | 1374658-84-0 | Reference compound |
| HY-140028 | Propargyl-PEG4-Boc | 1355197-66-8 | Reference compound |
| HY-140029 | Propargyl-PEG10-Boc | 2055022-22-3 | Reference compound |
| HY-140030 | Propargyl-PEG14-Boc | Reference compound | |
| HY-140031 | Propargyl-PEG3-OCH2-Boc | 888010-02-4 | Reference compound |
| HY-140032 | Alkyne-ethyl-PEG1-Boc | 2100306-55-4 | Reference compound |
| HY-140033 | Propargyl-PEG3-amine | 932741-19-0 | Reference compound |
| HY-140034 | Propargyl-PEG12-amine | 2264091-73-6 | Reference compound |
| HY-140035 | Propargyl-PEG24-amine | Reference compound | |
| HY-140036 | Propargyl-PEG3-bromide | 203740-63-0 | Reference compound |
| HY-140037 | Mal-PEG4-propargyl | 1262681-30-0 | Reference compound |
| HY-140038 | Bis-propargyl-PEG1 | 40842-04-4 | Reference compound |
| HY-140039 | Bis-propargyl-PEG11 | 1351373-49-3 | Reference compound |
| HY-140040 | Bis-propargyl-PEG12 | 1351373-50-6 | Reference compound |
| HY-140041 | Bis-propargyl-PEG13 | Reference compound | |
| HY-140042 | Bis-propargyl-O-PEG17 | Reference compound | |
| HY-140043 | N-Me-N-bis(PEG2-propargyl) | 1835759-84-6 | Reference compound |
| HY-140044 | Propargyl-PEG2-methylamine | 1835759-76-6 | Reference compound |
| HY-140045 | Propargyl-PEG4-methylamine | 1807530-11-5 | Reference compound |
| HY-140046 | Propargyl-PEG5-MS | 1036204-62-2 | Reference compound |
| HY-140047 | Propargyl-PEG4-sulfonic acid | 1817735-29-7 | Reference compound |
| HY-140048 | Propargyl-PEG4-5-nitrophenyl carbonate | 1422540-81-5 | Reference compound |
| HY-140049 | Boc-aminooxy-PEG1-propargyl | 1895922-72-1 | Reference compound |
| HY-140050 | Boc-aminooxy-PEG2-propargyl | 1895922-74-3 | Reference compound |
| HY-140051 | N-Boc-aminoxy-PEG3-propargyl | 1951439-46-5 | Reference compound |
| HY-140052 | Boc-aminooxy-PEG4-propargyl | 1895922-77-6 | Reference compound |
| HY-140053 | Boc-aminooxy-PEG5-propargyl | 2086688-98-2 | Reference compound |
| HY-140054 | t-Boc-aminooxy-PEG6-propargyl | 2093152-83-9 | Reference compound |
| HY-140055 | Thalidomide-PEG4-Propargyl | 2098799-77-8 | Reference compound |
| HY-140056 | Aminooxy-PEG1-propargyl | 1895922-69-6 | Reference compound |
| HY-140057 | Aminooxy-PEG3-propargyl | 1807537-27-4 | Reference compound |
| HY-140058 | Aminooxy-PEG4-propargyl | 1835759-78-8 | Reference compound |
| HY-140059 | Propargyl-PEG3-methane | 89635-82-5 | Reference compound |
| HY-140060 | Propargyl-PEG7-methane | 2730134-74-2 | Reference compound |
| HY-140061 | Propargyl-PEG11-methane | 2250411-18-6 | Reference compound |
| HY-140062 | Propargyl-PEG17-methane | 2169967-47-7 | Reference compound |
| HY-140063 | Propargyl-PEG4-CH2-methyl ester | 1872433-63-0 | Reference compound |
| HY-140064 | Propargyl-PEG1-acrylate | 52436-42-7 | Reference compound |
| HY-140065 | endo-BCN-PEG8-acid | 2126805-02-3 | Reference compound |
| HY-140066 | endo-BCN-PEG12-acid | Reference compound | |
| HY-140067 | endo-BCN-PEG2-C2-NHS ester | 2243565-12-8 | Reference compound |
| HY-140068 | endo-BCN-PEG3-NHS ester | 2101206-94-2 | Reference compound |
| HY-140069 | endo-BCN-PEG4-NHS ester | 2252422-32-3 | Reference compound |
| HY-140070 | endo-BCN-PEG8-NHS ester | 1608140-48-2 | Reference compound |
| HY-140072 | endo-BCN-PEG2-PFP ester | 1421932-53-7 | Reference compound |
| HY-140073 | endo-BCN-PEG4-PFP ester | 2904607-26-5 | Reference compound |
| HY-140074 | endo-BCN-PEG4-Boc | 1807501-83-2 | Reference compound |
| HY-140075 | endo-BCN-PEG6-Boc | Reference compound | |
| HY-140076 | endo-BCN-PEG2-alcohol | 1807501-85-4 | Reference compound |
| HY-140077 | endo-BCN-PEG3-NH-Boc | 1807501-84-3 | Reference compound |
| HY-140078 | bis-PEG2-endo-BCN | 1476737-97-9 | ADC Related |
| HY-140079 | Bis-PEG23-endo-BCN | Reference compound | |
| HY-140080 | Gly-PEG3-endo-BCN | 2354291-37-3 | Reference compound |
| HY-140081 | Boc-gly-PEG3-endo-BCN | 2110444-63-6 | ADC Related |
| HY-140082 | Hydroxy-Amino-bis(PEG2-propargyl) | 2100306-77-0 | Reference compound |
| HY-140083 | Propargyl-PEG2-N-bis(PEG2) | 2100306-62-3 | Reference compound |
| HY-140084 | N-(Propargyl-PEG4)-N-bis(PEG4-acid) | 2093153-09-2 | Reference compound |
| HY-140085 | N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) | 2100306-49-6 | Reference compound |
| HY-140086 | N-(Amino-PEG1)-N-bis(PEG2-propargyl) | 2100306-47-4 | Reference compound |
| HY-140087 | N-(Amino-PEG2)-N-bis(PEG3-azide) | 2606952-86-5 | Reference compound |
| HY-140088 | NH-bis(PEG2-propargyl) | 2100306-83-8 | Reference compound |
| HY-140089 | N-Boc-N-bis(PEG2-propargyl) | 2100306-86-1 | Reference compound |
| HY-140090 | N-(Boc-PEG1)-N-bis(PEG2-propargyl) | 2100306-63-4 | Reference compound |
| HY-140091 | N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) | 2112737-71-8 | Reference compound |
| HY-140092 | N-(t-Boc-Aminooxy-PEG2)-N-bis(PEG3-propargyl) | 2112737-60-5 | Reference compound |
| HY-140093 | N-(PEG2-Boc)-N-bis(PEG2-propargyl) | 2100306-69-0 | Reference compound |
| HY-140094 | N-(Propargyl-PEG2)-N-Boc-PEG3-t-butyl ester | 2093152-78-2 | Reference compound |
| HY-140095 | N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) | 2112732-01-9 | Reference compound |
| HY-140096 | Aminoethyl-SS-propionic acid | 15579-00-7 | ADC Related |
| HY-140097 | Amino-SS-PEG12-acid | ADC Related | |
| HY-140098 | Boc-Cystamine | 485800-26-8 | ADC Related |
| HY-140099 | Amino-ethyl-SS-PEG3-NHBoc | 2144777-87-5 | ADC Related |
| HY-140100 | Azidoethyl-SS-propionic acid | 2228857-32-5 | ADC Related |
| HY-140101 | Azido-C2-SS-PEG2-C2-acid | 2144777-72-8 | ADC Related |
| HY-140102 | Azidoethyl-SS-propionic NHS ester | 2243566-44-9 | ADC Related |
| HY-140103 | Azidoethyl-SS-ethylalcohol | 1807540-82-4 | Reference compound |
| HY-140104 | Azidoethyl-SS-ethylamine | 1807512-40-8 | ADC Related |
| HY-140105 | Azidoethyl-SS-ethylazide | 352305-38-5 | ADC Related |
| HY-140106 | Azido-PEG3-SS-PEG3-azide | 1310827-27-0 | Reference compound |
| HY-140107 | Azidoethyl-SS-PEG2-Boc | 2144777-83-1 | Reference compound |
| HY-140108 | Propargyl-PEG1-SS-alcohol | 1391914-41-2 | ADC Related |
| HY-140109 | Propargyl-PEG1-SS-PEG1-acid | 1807503-85-0 | ADC Related |
| HY-140110 | Propargyl-PEG1-SS-PEG1-PFP ester | 1817735-30-0 | ADC Related |
| HY-140111 | Propargyl-PEG1-SS-PEG1-propargyl | 1964503-40-9 | ADC Related |
| HY-140112 | Acid-PEG2-SS-PEG2-acid | 1807539-10-1 | ADC Related |
| HY-140113 | Acid-PEG3-SS-PEG3-acid | 2055014-98-5 | ADC Related |
| HY-140114 | Acid-PEG4-S-S-PEG4-acid | 2055015-40-0 | Reference compound |
| HY-140115 | Bis-(PEG6-acid)-SS | 2055014-97-4 | ADC Related |
| HY-140116 | Boc-NH-ethyl-SS-propionic acid | 485800-27-9 | ADC Related |
| HY-140117 | Boc-aminooxy-ethyl-SS-propanol | 2128735-21-5 | ADC Related |
| HY-140118 | Fmoc-NH-ethyl-SS-propionic acid | 864235-83-6 | ADC Related |
| HY-140119 | Fmoc-NH-ethyl-SS-propionic NHS ester | 2128735-23-7 | ADC Related |
| HY-140120 | Mal-NH-ethyl-SS-propionic acid | 2128735-24-8 | ADC Related |
| HY-140121 | m-PEG6-SS-PEG6-methyl | 1007386-15-3 | ADC Related |
| HY-140122 | THP-SS-alcohol | 877864-04-5 | ADC Related |
| HY-140123 | THP-SS-PEG1-Boc | 1807503-88-3 | ADC Related |
| HY-140124 | THP-SS-PEG1-Tos | 1807512-37-3 | ADC Related |
| HY-140125 | 2-Hydroxyethyl disulfide mono-tosylate | 1807530-16-0 | ADC Related |
| HY-140126 | Bis-Tos-(2-hydroxyethyl disulfide) | 69981-39-1 | ADC Related |
| HY-140127 | Azide-C2-SS-C2-biotin | 1620523-64-9 | ADC Related |
| HY-140128 | DBCO-S-S-PEG3-biotin | 1430408-09-5 | Reference compound |
| HY-140129 | NHS-SS-biotin | 122266-55-1 | ADC Related |
| HY-140130 | PC Biotin-PEG3-alkyne | 1869922-24-6 | ADC Related |
| HY-140131 | Biotin-PEG4-PC-PEG4-alkyne | Reference compound | |
| HY-140132 | PC Biotin-PEG3-azide | 1937270-46-6 | ADC Related |
| HY-140133 | PC-Biotin-PEG4-PEG3-azide | 2055198-04-2 | ADC Related |
| HY-140134 | PC Biotin-PEG3-NHS ester | 2353409-93-3 | ADC Related |
| HY-140135 | PC-Biotin-PEG4-NHS carbonate | 2055198-03-1 | Reference compound |
| HY-140136 | PC DBCO-PEG3-biotin | ADC Related | |
| HY-140137 | WSPC Biotin-PEG3-DBCO | Reference compound | |
| HY-140138 | PC SPDP-NHS carbonate ester | 2279944-61-3 | ADC Related |
| HY-140139 | PC Alkyne-PEG4-NHS ester | 1802907-98-7 | ADC Related |
| HY-140140 | PC Mal-NHS carbonate ester | 1408057-91-9 | ADC Related |
| HY-140141 | PC Methyltetrazine-PEG4-NHS carbonate ester | 2055736-28-0 | Reference compound |
| HY-140142 | PC Azido-PEG11-NHS carbonate ester | Reference compound | |
| HY-140143 | Mal-PEG4-Val-Cit-PAB-OH | 2055041-39-7 | ADC Related |
| HY-140144 | Mal-PEG1-Val-Cit-PAB-PNP | 2249935-92-8 | ADC Related |
| HY-140145 | Mal-PEG4-Val-Cit-PAB-PNP | 2112738-09-5 | ADC Related |
| HY-140146 | Mal-amido-PEG2-Val-Cit-PAB-OH | ADC Related | |
| HY-140147 | Mal-amido-PEG2-Val-Cit-PAB-PNP | 2112738-13-1 | ADC Related |
| HY-140148 | Azido-PEG3-Val-Cit-PAB-OH | 2055024-65-0 | ADC Related |
| HY-140149 | Azido-PEG4-Val-Cit-PAB-OH | 2055024-64-9 | ADC Related |
| HY-140150 | Azido-PEG3-Val-Cit-PAB-PNP | 2055047-18-0 | ADC Related |
| HY-140152 | BCN-PEG3-VC-PFP ester | 2353409-45-5 | ADC Related |
| HY-140153 | Methylamino-PEG2-acid | 1807503-87-2 | Reference compound |
| HY-140154 | Methylamino-PEG1-Boc | 1807521-03-4 | Reference compound |
| HY-140155 | Methylamino-PEG2-Boc | 1807521-04-5 | Reference compound |
| HY-140156 | Methylamino-PEG4-Boc | 1621616-14-5 | Reference compound |
| HY-140157 | N-Me-N-bis(PEG4-C2-Boc) | Reference compound | |
| HY-140158 | Methylamino-PEG3-azide | 1355197-57-7 | Reference compound |
| HY-140159 | Methylamino-PEG5-azide | 2055046-24-5 | Reference compound |
| HY-140161 | PEG3-methylamine | 282551-10-4 | Reference compound |
| HY-140162 | Hydroxy-PEG4-methylamine | 90430-59-4 | Reference compound |
| HY-140163 | N,N'-DME-N-PEG2-Boc | 2279944-69-1 | Reference compound |
| HY-140164 | Azido-PEG2-C2-sulfonic acid | 1817735-39-9 | Reference compound |
| HY-140165 | Bis-PEG3-sulfonic acid | 255831-16-4 | Reference compound |
| HY-140166 | Bis-PEG4-sulfonic acid | 1807539-08-7 | Reference compound |
| HY-140167 | Carboxy-PEG2-sulfonic acid | 1817735-45-7 | Reference compound |
| HY-140168 | Carboxy-PEG4-sulfonic acid | 1817735-25-3 | Reference compound |
| HY-140169 | Carboxy-PEG5-sulfonic acid | 1817735-38-8 | Reference compound |
| HY-140170 | m-PEG4-sulfonic acid | 787524-78-1 | Reference compound |
| HY-140171 | m-PEG5-sulfonic acid | 1807505-35-6 | Reference compound |
| HY-140172 | Boc-NH-PEG3-sulfonic acid | 1817735-32-2 | Reference compound |
| HY-140173 | Boc-PEG2-sulfonic acid | 1817735-40-2 | Reference compound |
| HY-140174 | Boc-PEG4-sulfonic acid | 1817735-26-4 | Reference compound |
| HY-140175 | Butoxycarbonyl-PEG5-sulfonic acid | 1817735-28-6 | Reference compound |
| HY-140176 | Amino-PEG10-acid | 2170987-85-4 | Reference compound |
| HY-140177 | Amino-PEG12-acid | 1415408-69-3 | Reference compound |
| HY-140178 | Amino-PEG14-acid | Reference compound | |
| HY-140179 | Amino-PEG16-acid | 2922656-52-6 | Reference compound |
| HY-140180 | Amino-PEG20-acid | Reference compound | |
| HY-140181 | Amino-PEG23-acid | Reference compound | |
| HY-140182 | Amino-PEG24-acid | 2563873-76-5 | Reference compound |
| HY-140183 | Amino-PEG25-acid | Reference compound | |
| HY-140184 | Amino-PEG28-acid | Reference compound | |
| HY-140185 | Amino-PEG32-acid | Reference compound | |
| HY-140186 | Amino-PEG36-acid | 2241751-76-6 | Reference compound |
| HY-140187 | Amino-PEG36-CONH-PEG36-acid | Reference compound | |
| HY-140188 | Amino-PEG6-amido-C16-COOH | Reference compound | |
| HY-140189 | Amino-PEG3-CH2COOH | 134978-99-7 | Reference compound |
| HY-140190 | Amino-PEG2-(CH2)3COOH | 1263046-77-0 | Reference compound |
| HY-140191 | Amino-PEG4-(CH2)3CO2H | 144598-03-8 | Reference compound |
| HY-140193 | Amino-PEG4-Boc | 581065-95-4 | Reference compound |
| HY-140194 | Amino-PEG5-Boc | 1446282-18-3 | Reference compound |
| HY-140195 | Amino-PEG9-Boc | 1818294-44-8 | Reference compound |
| HY-140196 | Amino-PEG10-Boc | 1818294-42-6 | Reference compound |
| HY-140197 | Amino-PEG12-Boc | 1383814-00-3 | Reference compound |
| HY-140198 | Amino-PEG20-Boc | Reference compound | |
| HY-140199 | Amino-PEG24-Boc | 2170987-96-7 | Reference compound |
| HY-140200 | Amino-PEG36-Boc | Reference compound | |
| HY-140201 | Amino-PEG6-amido-C16-Boc | Reference compound | |
| HY-140202 | Amino-PEG9-amido-C16-Boc | Reference compound | |
| HY-140204 | Amino-PEG9-alcohol | 15332-95-3 | Reference compound |
| HY-140205 | Amino-PEG12-alcohol | 1345681-71-1 | Reference compound |
| HY-140206 | Amino-PEG24-alcohol | 2226726-55-0 | Reference compound |
| HY-140207 | Amino-PEG36-alcohol | 2718868-96-1 | Reference compound |
| HY-140208 | 2,2-Oxybis(ethylamine) | 2752-17-2 | Reference compound |
| HY-140209 | Amino-PEG7-amine | 332941-25-0 | Reference compound |
| HY-140210 | Amino-PEG9-amine | 474082-35-4 | Reference compound |
| HY-140211 | Amino-PEG23-amine | 2673284-93-8 | Reference compound |
| HY-140212 | Azido-PEG1-amine | 464190-91-8 | Reference compound |
| HY-140213 | Azido-PEG2-C2-amine | 166388-57-4 | ADC Related |
| HY-140214 | Azido-PEG5-amine | 516493-93-9 | Reference compound |
| HY-140215 | Azido-PEG6-amine | 957486-82-7 | ADC Related |
| HY-140216 | Azido-PEG8-amine | 857891-82-8 | Reference compound |
| HY-140217 | Azido-PEG10-amine | 912849-73-1 | Reference compound |
| HY-140218 | Azido-PEG11-amine | 1800414-71-4 | Reference compound |
| HY-140219 | Azido-PEG23-amine | 2172677-19-7 | Reference compound |
| HY-140220 | Azido-PEG35-amine | 2301851-71-6 | Reference compound |
| HY-140221 | Azido-PEG1-C2-methylamine | 1835759-88-0 | Reference compound |
| HY-140222 | Amino-PEG2-C2-hydrazide-Boc | 2100306-60-1 | Reference compound |
| HY-140223 | Amino-PEG4-hydrazide-Boc | 1263047-17-1 | Reference compound |
| HY-140224 | Amino-PEG8-hydrazide-Boc | 1334169-96-8 | Reference compound |
| HY-140225 | m-PEG5-NH2 | 5498-83-9 | Reference compound |
| HY-140226 | m-PEG10-amine | 1383658-09-0 | ADC Related |
| HY-140227 | m-PEG12-amine | 1977493-48-3 | ADC Related |
| HY-140228 | m-PEG24-NH2 | 2151823-08-2 | Reference compound |
| HY-140229 | m-PEG36-amine | Reference compound | |
| HY-140230 | m-PEG48-amine | 2416858-25-6 | Reference compound |
| HY-140231 | Boc-NH-PEG6-amine | 1091627-77-8 | Reference compound |
| HY-140232 | Boc-NH-PEG7-NH2 | 206265-98-7 | Reference compound |
| HY-140233 | Boc-amido-PEG9-amine | 890091-43-7 | Reference compound |
| HY-140234 | Boc-NH-PEG11-NH2 | 1233234-77-9 | Reference compound |
| HY-140235 | Boc-NH-PEG15-NH2 | 2222566-55-2 | Reference compound |
| HY-140236 | Boc-NH-PEG23-NH2 | Reference compound | |
| HY-140237 | Boc-Gly-amido-C-PEG3-C3-amine | 525583-49-7 | Reference compound |
| HY-140238 | Cbz-N-PEG15-amine | Reference compound | |
| HY-140239 | Amino-PEG4-benzyl ester | 1351397-21-1 | Reference compound |
| HY-140240 | Amino-PEG6-Thalidomide | Reference compound | |
| HY-140241 | NH2-PEG4-Glu(OH)-NH-m-PEG24 | Reference compound | |
| HY-140242 | NH2-PEG4-Lys(Boc)-NH-(m-PEG24) | ADC Related | |
| HY-140243 | 1,1,1-Trifluoroethyl-PEG4-amine | 1872433-72-1 | Reference compound |
| HY-140244 | Gly-PEG3-amine | 2110448-97-8 | ADC Related |
| HY-140245 | N-(Amino-PEG3)-N-bis(PEG3-acid) | 2055042-59-4 | Reference compound |
| HY-140246 | N-(PEG3-acid)-N-bis(PEG3-amine) | 2183440-35-7 | Reference compound |
| HY-140247 | N-(Azido-PEG3)-N-(PEG2-amine)-PEG3-acid | 2183440-70-0 | Reference compound |
| HY-140248 | N-(Mal-PEG6)-N-bis(PEG3-amine) | 2055040-99-6 | Reference compound |
| HY-140249 | Tri(Amino-PEG3-amide)-amine | 2523025-40-1 | Reference compound |
| HY-140249A | Tri(Amino-PEG3-amide)-amine (TFA) | Reference compound | |
| HY-140250 | Tri(Amino-PEG4-amide)-amine | Reference compound | |
| HY-140250A | Tri(Amino-PEG4-amide)-amine (TFA) | Reference compound | |
| HY-140251 | Tri(Amino-PEG5-amide)-amine | 2055013-52-8 | Reference compound |
| HY-140252 | NH-bis(C1-PEG1-Boc) | 2171072-53-8 | Reference compound |
| HY-140253 | N-(Amino-PEG3)-N-bis(PEG3-Boc) | 2055042-62-9 | Reference compound |
| HY-140254 | N-(Amino-PEG3)-N-bis(PEG4-Boc) | 2353409-57-9 | Reference compound |
| HY-140255 | N-(Amino-PEG4)-N-bis(PEG4-Boc) | 2093153-97-8 | Reference compound |
| HY-140256 | NH-bis(PEG2-C2-Boc) | 1964503-36-3 | Reference compound |
| HY-140257 | NH-bis(PEG3-Boc) | 1814901-03-5 | Reference compound |
| HY-140258 | NH-bis(PEG4-Boc) | 2055041-41-1 | Reference compound |
| HY-140259 | N-(Boc-PEG4)-NH-PEG4-NH-Boc | 2112737-17-2 | Reference compound |
| HY-140260 | NH-bis(PEG3-C2-NH-Boc) | 2055024-51-4 | Reference compound |
| HY-140261 | NH-bis(PEG4-C2-NH-Boc) | 2182601-75-6 | Reference compound |
| HY-140262 | Amino-Tri-(m-PEG4-ethoxymethyl)-methane | 1428661-67-9 | Reference compound |
| HY-140263 | NH-bis(m-PEG4) | 123852-08-4 | Reference compound |
| HY-140264 | NH-bis(m-PEG8) | 2055013-64-2 | Reference compound |
| HY-140265 | DBCO-PEG1-acid | 2228857-38-1 | Reference compound |
| HY-140266 | DBCO-PEG2-acid | 2304558-25-4 | Reference compound |
| HY-140267 | DBCO-PEG5-acid | 2764923-65-9 | Reference compound |
| HY-140268 | DBCO-PEG8-acid | 2765066-35-9 | Reference compound |
| HY-140269 | DBCO-PEG12-acid | 2754384-72-8 | Reference compound |
| HY-140270 | DBCO-NHCO-PEG13-acid | Reference compound | |
| HY-140271 | DBCO-PEG1-NHS ester | 2228857-34-7 | Reference compound |
| HY-140272 | DBCO-PEG4-NHS ester | 1427004-19-0 | Reference compound |
| HY-140273 | DBCO-PEG8-NHS ester | 2553412-88-5 | Reference compound |
| HY-140274 | DBCO-PEG12-NHS ester | 2093934-94-0 | Reference compound |
| HY-140275 | DBCO-NHCO-PEG5-NHS ester | 1378531-80-6 | Reference compound |
| HY-140276 | DBCO-NHCO-PEG13-NHS ester | Reference compound | |
| HY-140277 | DBCO-PEG2-PFP ester | 2304558-23-2 | Reference compound |
| HY-140278 | DBCO-PEG4-PFP ester | Reference compound | |
| HY-140279 | DBCO-PEG4-alcohol | 1416711-60-8 | Reference compound |
| HY-140280 | DBCO-PEG1 | 1839049-33-0 | Reference compound |
| HY-140281 | DBCO-C-PEG1 | 2377004-09-4 | Reference compound |
| HY-140282 | DBCO-PEG1-amine | 2364591-79-5 | Reference compound |
| HY-140283 | DBCO-PEG2-amine | 2250216-96-5 | Reference compound |
| HY-140284 | DBCO-PEG6-amine | 2353409-98-8 | Reference compound |
| HY-140284A | DBCO-PEG6-amine (TFA) | Reference compound | |
| HY-140285 | DBCO-PEG9-amine | 2353409-99-9 | Reference compound |
| HY-140286 | Sulfo DBCO-PEG4-amine | 2055198-05-3 | Reference compound |
| HY-140287 | DBCO-C2-PEG4-amine | Reference compound | |
| HY-140288 | DBCO-C3-PEG4-amine | Reference compound | |
| HY-140289 | DBCO-PEG1-NH-Boc | 2364591-77-3 | Reference compound |
| HY-140290 | DBCO-PEG2-NH-Boc | 2377004-08-3 | Reference compound |
| HY-140291 | DBCO-PEG4-NH-Boc | 2353410-17-8 | Reference compound |
| HY-140292 | DBCO-PEG9-NH-Boc | Reference compound | |
| HY-140293 | DBCO-NH-Boc | 1539290-74-8 | Reference compound |
| HY-140294 | DBCO-C2-PEG4-NH-Boc | Reference compound | |
| HY-140295 | DBCO-C3-PEG4-NH-Boc | Reference compound | |
| HY-140296 | BDP FL DBCO | 2093197-94-3 | Dye Reagents |
| HY-140297 | Carboxyrhodamine 110-PEG4-DBCO | Reference compound | |
| HY-140301 | DBCO-PEG4-Desthiobiotin | 2032788-37-5 | Reference compound |
| HY-140302 | DBCO-PEG5-DBCO | 2363130-04-3 | Reference compound |
| HY-140303 | DBCO-PEG9-DBCO | 2353409-50-2 | Reference compound |
| HY-140304 | DBCO-PEG10-DBCO | Reference compound | |
| HY-140305 | DBCO-PEG13-DBCO | Reference compound | |
| HY-140306 | Mal-Sulfo-DBCO | 2028281-86-7 | ADC Related |
| HY-140307 | Sulfo DBCO-PEG4-Maleimide | 2055198-07-5 | Reference compound |
| HY-140307A | Sulfo DBCO-PEG4-Maleimide (TEA) | Reference compound | |
| HY-140308 | DBCO-PEG4-triethoxysilane | 2353410-02-1 | Reference compound |
| HY-140309 | Gly-Gly-Gly-PEG4-DBCO | 2353409-80-8 | ADC Related |
| HY-140310 | TCO-PEG4-DBCO | 1801863-88-6 | ADC Related |
| HY-140312 | Methyltetrazine-PEG12-DBCO | Reference compound | |
| HY-140313 | Methyltetrazine-DBCO | 1802238-48-7 | ADC Related |
| HY-140314 | DOTA-PEG5-C6-DBCO | Reference compound | |
| HY-140315 | m-PEG4-NH-DBCO | 2228857-36-9 | Reference compound |
| HY-140316 | m-PEG8-DBCO | Reference compound | |
| HY-140317 | m-PEG12-DBCO | Reference compound | |
| HY-140318 | DBCO-mPEG (MW 2kDa) | Reference compound | |
| HY-140319 | DBCO-mPEG (MW 5kDa) | Reference compound | |
| HY-140320 | DBCO-mPEG (MW 10kDa) | Reference compound | |
| HY-140321 | DBCO-mPEG (MW 20kDa) | Reference compound | |
| HY-140322 | DBCO-mPEG (MW 30kDa) | Reference compound | |
| HY-140323 | Tetraethyl heptane-1,7-diylbis(phosphonate) | 5943-17-9 | Reference compound |
| HY-140324 | Tetraethyl octane-1,8-diylbis(phosphonate) | 5943-61-3 | Reference compound |
| HY-140325 | Tetraethyl decane-1,10-diylbis(phosphonate) | 5943-62-4 | Reference compound |
| HY-140326 | Hexane-1,6-diyldiphosphonic acid | 4721-22-6 | Reference compound |
| HY-140327 | [10-(Diethoxy-phosphoryl)-decyl]-phosphonic acid | 1446282-24-1 | Reference compound |
| HY-140328 | 4-Bromobutylphosphonic acid | 1190-14-3 | Reference compound |
| HY-140329 | 6-Bromohexylphosphonic acid | 133345-66-1 | Reference compound |
| HY-140330 | (10-BRomodecyl)phosphonic acid | 934985-98-5 | Reference compound |
| HY-140331 | Diethyl 4-bromobutylphosphonate | 63075-66-1 | Reference compound |
| HY-140332 | Diethyl 8-bromooctylphosphonate | 124939-70-4 | Reference compound |
| HY-140333 | Diethyl 10-bromodecylphosphonate | 272785-01-0 | Reference compound |
| HY-140334 | Diethyl 12-bromododecylphosphonate | 264231-28-9 | Reference compound |
| HY-140335 | Alkynyl myristic acid | 82909-47-5 | Reference compound |
| HY-140336 | C-NH-Boc-C-Bis-(C-PEG1-Boc) | 1807503-91-8 | Reference compound |
| HY-140337 | Ph-Bis(C1-N-(C2-NH-Boc)2) | 1807521-06-7 | Reference compound |
| HY-140338 | Benzenedimethanamine-diethylamine | 71277-17-3 | Reference compound |
| HY-140339 | ANB-NOS | 60117-35-3 | Reference compound |
| HY-140340 | Fmoc-NH-pentanoic acid-NHS-SO3Na | Reference compound | |
| HY-140341 | Sulfo-NHS-Acetate | 152305-87-8 | Reference compound |
| HY-140341A | Sulfo-NHS-Acetate (sodium) | 221222-61-3 | Reference compound |
| HY-140342 | Boc-C16-NHS ester | 843666-34-2 | Reference compound |
| HY-140343 | Ac4GalNAl | 1673590-09-4 | Reference compound |
| HY-140345 | L-Homopropargylglycine | 98891-36-2 | Reference compound |
| HY-140345A | L-Homopropargylglycine (hydrochloride) | 942518-19-6 | Reference compound |
| HY-140346 | L-Azidohomoalanine | 120042-14-0 | Reference compound |
| HY-140346A | L-Azidohomoalanine (hydrochloride) | 942518-29-8 | Reference compound |
| HY-140346AS | L-Azidohomoalanine-1,2,3,4-13C4 (hydrochloride) | 2483829-89-4 | Isotope-Labeled Compounds |
| HY-140347 | APN-C3-NH-Boc | 1539292-60-8 | Reference compound |
| HY-140348 | APN-NH2 | 1539292-61-9 | Reference compound |
| HY-140349 | AZD-CO-C2-Ph-amido-Ph-azide | 1383544-71-5 | Reference compound |
| HY-140350 | 5-endo-BCN-pentanoic acid | 2364591-80-8 | Reference compound |
| HY-140351 | Azide-PEG4-Tos | 168640-82-2 | Reference compound |
| HY-140352 | Azide-PEG5-Tos | 236754-49-7 | ADC Related |
| HY-140353 | Azide-PEG6-Tos | 906007-10-1 | Reference compound |
| HY-140354 | Azide-PEG7-Tos | 1418561-41-7 | Reference compound |
| HY-140355 | Azide-PEG12-Tos | 1821464-56-5 | Reference compound |
| HY-140356 | Tos-PEG6-OH | 42749-28-0 | Reference compound |
| HY-140357 | Tos-PEG9 | 62573-11-9 | Reference compound |
| HY-140358 | PEG20-Tos | 2179113-08-5 | Reference compound |
| HY-140359 | m-PEG7-Tos | 79622-11-0 | Reference compound |
| HY-140360 | m-PEG10-Tos | 211859-75-5 | Reference compound |
| HY-140361 | m-PEG11-Tos | Reference compound | |
| HY-140362 | m-PEG2-MS | 60696-83-5 | Reference compound |
| HY-140363 | m-PEG3-OMs | 74654-05-0 | Reference compound |
| HY-140364 | m-PEG6-MS | 130955-39-4 | Reference compound |
| HY-140365 | Tos-PEG13-Boc | 2820397-84-8 | Reference compound |
| HY-140366 | Tos-PEG5-CH2COOtBu | 1949793-62-7 | Reference compound |
| HY-140367 | Bis-Tos-PEG6 | 42749-27-9 | Reference compound |
| HY-140368 | Bis-Tos-PEG7 | 69502-27-8 | Reference compound |
| HY-140369 | Tos-PEG8-Tos | 57436-38-1 | Reference compound |
| HY-140370 | Tos-PEG9-Tos | 109635-64-5 | Reference compound |
| HY-140371 | Tos-PEG12-Tos | 1456708-45-4 | Reference compound |
| HY-140372 | Tos-PEG20-Tos | Reference compound | |
| HY-140373 | Tos-PEG21-Tos | Reference compound | |
| HY-140374 | Propargyl-PEG2-Tos | 145916-41-2 | Reference compound |
| HY-140375 | Tos-PEG3-C2-methyl ester | 1239588-09-0 | Reference compound |
| HY-140376 | Boc-NH-PEG7-Tos | 1292268-14-4 | Reference compound |
| HY-140377 | Boc-Aminooxy-PEG4-Tos | 1807539-01-0 | Reference compound |
| HY-140378 | t-Boc-Aminooxy-PEG8-MS | Reference compound | |
| HY-140379 | 1,1,1-Trifluoroethyl-PEG4-Tos | 1872433-61-8 | Reference compound |
| HY-140380 | Tos-aminoxy-Boc-PEG4-Tos | 1817735-42-4 | Reference compound |
| HY-140381 | Azide-PEG2-MS | 176520-23-3 | Reference compound |
| HY-140382 | Ms-PEG2-MS | 34604-52-9 | Reference compound |
| HY-140383 | Ms-PEG2-C2-Boc | 1312309-62-8 | Reference compound |
| HY-140384 | Ms-PEG5-t-butyl ester | 870487-48-2 | Reference compound |
| HY-140385 | Ms-PEG8-Boc | 2097604-01-6 | Reference compound |
| HY-140386 | Ms-PEG10-t-butyl ester | Reference compound | |
| HY-140387 | Ms-PEG12-Boc | Reference compound | |
| HY-140388 | PEG4-MS | 65883-12-7 | Reference compound |
| HY-140389 | PEG7-O-MS | 1217601-12-1 | Reference compound |
| HY-140390 | Boc-N-PEG2-MS | 302331-20-0 | Reference compound |
| HY-140391 | Boc-NH-PEG4-MS | 1447797-72-9 | Reference compound |
| HY-140392 | Boc-N-Amido-PEG5-MS | 2128735-28-2 | Reference compound |
| HY-140393 | N-(Tos-PEG4)-N-bis(PEG4-Boc) | 2112737-74-1 | Reference compound |
| HY-140394 | Aminooxy-PEG4-acid | 1807537-38-7 | Reference compound |
| HY-140395 | Aminooxy-PEG8-acid | 2055269-60-6 | Reference compound |
| HY-140396 | Aminooxy-PEG3-bromide | 1895922-73-2 | Reference compound |
| HY-140396A | Aminooxy-PEG3-bromide (hydrochloride) | Reference compound | |
| HY-140396C | Aminooxy-PEG3-bromide (hydrobromide) | Reference compound | |
| HY-140397 | m-PEG2-Amino | 54149-49-4 | Reference compound |
| HY-140398 | m-PEG3-Aminooxy | 248275-10-7 | Reference compound |
| HY-140399 | Aminooxy-PEG7-methane | 1370698-27-3 | Reference compound |
| HY-140400 | Aminooxy-PEG8-methane | 2055024-52-5 | Reference compound |
| HY-140401 | Aminooxy-PEG3-C2-Boc | 1835759-72-2 | Reference compound |
| HY-140402 | Aminooxy-PEG4-C2-Boc | 2100306-82-7 | Reference compound |
| HY-140403 | Aminooxy-PEG4-CH2-Boc | 2062663-62-9 | Reference compound |
| HY-140404 | Aminooxy-PEG3-methyl ester | 2086689-03-2 | Reference compound |
| HY-140405 | 1-(t-Boc-Aminooxy)-3-aminooxy-propane | 1352546-80-5 | Reference compound |
| HY-140406 | Aminooxy-PEG3-C2-NH-Boc | 2062663-65-2 | Reference compound |
| HY-140407 | Bis-aminooxy-PEG1 | 93460-33-4 | Reference compound |
| HY-140408 | Bis-aminooxy-PEG2 | 98627-71-5 | Reference compound |
| HY-140409 | Bis-aminooxy-PEG3 | 98627-70-4 | Reference compound |
| HY-140410 | Bis-aminooxy-PEG4 | 98627-72-6 | Reference compound |
| HY-140411 | Bis-aminooxy-PEG7 | 1383980-52-6 | Reference compound |
| HY-140412 | Boc-Aminooxy-PEG3-acid | 1835759-82-4 | Reference compound |
| HY-140413 | Boc-aminoxy-PEG4-acid | 2062663-68-5 | Reference compound |
| HY-140414 | t-Boc-Aminooxy-PEG12-acid | Reference compound | |
| HY-140415 | Boc-Aminooxy-PEG2-CH2COOH | 2098983-14-1 | Reference compound |
| HY-140416 | Boc-Aminooxy-PEG4-CH2CO2H | 2028281-90-3 | Reference compound |
| HY-140417 | t-Boc-Aminooxy-PEG4-NHS ester | 2401831-99-8 | Reference compound |
| HY-140418 | t-Boc-Aminooxy-PEG12-NHS ester | Reference compound | |
| HY-140419 | t-Boc-Aminooxy-PEG12-Boc | Reference compound | |
| HY-140420 | Boc-Aminooxy-PEG4-CH2-Boc | 2062663-63-0 | Reference compound |
| HY-140421 | Boc-Aminooxy-PEG2 | 1807503-86-1 | Reference compound |
| HY-140422 | t-Boc-Aminooxy-PEG3-alcohol | 252378-66-8 | Reference compound |
| HY-140423 | Boc-Aminoxy-PEG4-OH | 918132-14-6 | Reference compound |
| HY-140424 | t-Boc-Aminooxy-PEG8-alcohol | 2353410-14-5 | Reference compound |
| HY-140425 | Boc-Aminooxy-PEG1-C2-NH2 | 1844894-82-1 | Reference compound |
| HY-140426 | Boc-Aminooxy-PEG2-C2-amine | 252378-69-1 | Reference compound |
| HY-140427 | Boc-Aminooxy-PEG3-C2-NH2 | 1235514-18-7 | Reference compound |
| HY-140428 | Boc-Aminooxy-PEG5-amine | 2250216-94-3 | Reference compound |
| HY-140429 | t-Boc-Aminooxy-PEG7-amine | 2226611-29-4 | Reference compound |
| HY-140430 | Boc-Aminooxy-PEG1-azide | 2100306-67-8 | Reference compound |
| HY-140431 | t-Boc-Aminooxy-PEG2-azide | 252378-68-0 | Reference compound |
| HY-140432 | Boc-Aminooxy-PEG3-azide | 1235514-15-4 | Reference compound |
| HY-140433 | Boc-Aminooxy-PEG4-azide | 2100306-64-5 | Reference compound |
| HY-140434 | t-Boc-Aminooxy-PEG5-azide | 2250216-95-4 | Reference compound |
| HY-140435 | Boc-Aminooxy-PEG3-bromide | 918132-15-7 | Reference compound |
| HY-140436 | t-Boc-Aminooxy-PEG7-bromide | 2353410-15-6 | Reference compound |
| HY-140437 | t-Boc-Aminooxy-PEG7-methane | 2055041-27-3 | Reference compound |
| HY-140438 | Boc-Aminooxy-PEG4-NH2 | 2062663-66-3 | Reference compound |
| HY-140439 | Boc-Aminooxy-PEG3-thiol | 1895922-75-4 | Reference compound |
| HY-140440 | Fmoc-aminooxy-PEG4-acid | 1895922-70-9 | Reference compound |
| HY-140441 | Fmoc-aminooxy-PEG12-acid | Reference compound | |
| HY-140442 | Fmoc-aminooxy-PEG12-NHS ester | Reference compound | |
| HY-140443 | Cbz-aminooxy-PEG8-acid | 2353410-09-8 | Reference compound |
| HY-140444 | Cbz-aminooxy-PEG8-Boc | Reference compound | |
| HY-140445 | 1,1,1-Trifluoroethyl-PEG4-aminooxy | 1895922-78-7 | Reference compound |
| HY-140446 | N-(Aminooxy-PEG3)-N-bis(PEG4-Boc) | 2112737-19-4 | Reference compound |
| HY-140447 | Diketone-PEG11-PFP ester | Reference compound | |
| HY-140448 | Diketone-PEG4-Biotin | 2353409-85-3 | Reference compound |
| HY-140449 | Diketone-PEG12-Biotin | Reference compound | |
| HY-140450 | Diketone-PEG12-DBCO | Reference compound | |
| HY-140451 | Diketone-PEG11-Diketone | Reference compound | |
| HY-140452 | Azido-PEG2-C2-acid | 1312309-63-9 | Reference compound |
| HY-140453 | Azido-PEG6-acid | 361189-66-4 | Reference compound |
| HY-140454 | Azido-PEG8-acid | 1214319-92-2 | ADC Related |
| HY-140455 | Azido-PEG10-acid | 1644163-57-4 | Reference compound |
| HY-140456 | Azido-PEG12-acid | 2152679-71-3 | Reference compound |
| HY-140457 | Azido-PEG24-acid | 2195075-62-6 | Reference compound |
| HY-140458 | Azido-PEG36-acid | Reference compound | |
| HY-140459 | 2-((Azido-PEG8-carbamoyl)methoxy)acetic acid | 846549-37-9 | Reference compound |
| HY-140460 | Fmoc-N-PEG7-acid | 1863885-74-8 | Reference compound |
| HY-140461 | Fmoc-NH-PEG10-acid | 2101563-45-3 | Reference compound |
| HY-140462 | Fmoc-N-PEG20-acid | 1952360-93-8 | Reference compound |
| HY-140463 | Fmoc-N-PEG23-acid | Reference compound | |
| HY-140464 | Fmoc-N-PEG36-acid | 2649489-46-1 | Reference compound |
| HY-140465 | Fmoc-NMe-PEG4-C2-acid | 2170240-98-7 | Reference compound |
| HY-140466 | Fmoc-NH-PEG11-CH2COOH | 2629308-66-1 | Reference compound |
| HY-140467 | Fmoc-NH-PEG12-CH2COOH | 2291257-76-4 | Reference compound |
| HY-140468 | Boc-N-amido-PEG3-acid | 1347750-75-7 | Reference compound |
| HY-140469 | Boc-NH-PEG7-acid | 2055044-68-1 | Reference compound |
| HY-140470 | Boc-NH-PEG8-CH2CH2COOH | 1334169-93-5 | Reference compound |
| HY-140471 | Boc-NH-PEG10-CH2CH2COOH | 2410598-01-3 | Reference compound |
| HY-140472 | Boc-NH-PEG12-CH2CH2COOH | 1415981-79-1 | Reference compound |
| HY-140473 | Boc-NH-PEG20-CH2CH2COOH | 2941512-86-1 | Reference compound |
| HY-140474 | Boc-NH-PEG24-CH2CH2COOH | 2839118-68-0 | Reference compound |
| HY-140475 | Boc-NH-PEG36-CH2CH2COOH | Reference compound | |
| HY-140476 | Boc-NH-PEG1-CH2COOH | 142929-49-5 | Reference compound |
| HY-140477 | Boc-NH-PEG6-CH2COOH | 391684-36-9 | Reference compound |
| HY-140478 | Boc-NH-PEG4-C3-acid | 1416777-48-4 | Reference compound |
| HY-140479 | Acid-PEG1-C2-Boc | 2086689-08-7 | Reference compound |
| HY-140480 | Acid-PEG2-C2-Boc | 2086688-99-3 | Reference compound |
| HY-140481 | Acid-PEG5-C2-Boc | 1309460-29-4 | Reference compound |
| HY-140482 | Acid-PEG6-C2-Boc | 2093153-84-3 | Reference compound |
| HY-140483 | Acid-C1-PEG5-Boc | 2304558-22-1 | Reference compound |
| HY-140484 | Acid-PEG3-mono-methyl ester | 1807505-26-5 | Reference compound |
| HY-140485 | Acid-PEG5-mono-methyl ester | 1309460-30-7 | Reference compound |
| HY-140486 | Acid-PEG6-mono-methyl ester | 1807512-38-4 | Reference compound |
| HY-140487 | Cbz-NH-PEG2-C2-acid | 1347750-76-8 | Reference compound |
| HY-140488 | Cbz-NH-PEG3-C2-acid | 1310327-18-4 | Reference compound |
| HY-140489 | Cbz-NH-PEG5-C2-acid | 1347750-74-6 | Reference compound |
| HY-140490 | Cbz-N-PEG10-acid | Reference compound | |
| HY-140491 | Cbz-N-amido-PEG20-acid | Reference compound | |
| HY-140492 | Biotin-PEG8-acid | 2143964-62-7 | Reference compound |
| HY-140493 | Biotin-PEG12-acid | 1621423-14-0 | Reference compound |
| HY-140494 | Biotin-PEG36-acid | Reference compound | |
| HY-140495 | DNP-PEG6-acid | Reference compound | |
| HY-140496 | DNP-PEG12-acid | Reference compound | |
| HY-140497 | Hydroxy-PEG2-CH2COOH | 51951-04-3 | Reference compound |
| HY-140497A | Hydroxy-PEG2-CH2COONa | 42588-76-1 | Reference compound |
| HY-140498 | Hydroxy-PEG4-CH2COOH | 70678-95-4 | Reference compound |
| HY-140499 | m-PEG9-acid | 2576495-35-5 | Reference compound |
| HY-140500 | m-PEG10-acid | 2409969-94-2 | ADC Related |
| HY-140501 | m-PEG11-acid | 2280998-74-3 | ADC Related |
| HY-140502 | m-PEG17-acid | 2346581-96-0 | Reference compound |
| HY-140503 | m-PEG8-ethoxycarbonyl-propanoic acid | 2353409-75-1 | Reference compound |
| HY-140504 | m-PEG12-COO-propanoic acid | 2168540-50-7 | Reference compound |
| HY-140505 | m-PEG3-Propanoyl chloride | 66722-87-0 | Reference compound |
| HY-140506 | m-PEG6-O-CH2COOH | 75427-75-7 | Reference compound |
| HY-140507 | m-PEG4-CH2-acid | 874208-84-1 | Reference compound |
| HY-140508 | m-PEG12-NH-C2-acid | 1949843-39-3 | Reference compound |
| HY-140509 | TAMRA-PEG4-acid | 1909223-02-4 | Dye Reagents |
| HY-140510 | N-Methyl-N-(t-Boc)-PEG4-acid | 1260431-01-3 | Reference compound |
| HY-140511 | Acid-PEG3-PFP ester | 1835759-67-5 | Reference compound |
| HY-140512 | Acid-PEG5-TEMPO | 2055040-79-2 | Reference compound |
| HY-140513 | Active-mono-sulfone-PEG8-acid | 2055048-45-6 | Reference compound |
| HY-140514 | NH-bis(PEG2-C2-acid) | 1919044-99-7 | Reference compound |
| HY-140515 | NH-bis(PEG3-acid) | 1814901-04-6 | Reference compound |
| HY-140516 | NH-bis(PEG4-acid) | 2055041-59-1 | Reference compound |
| HY-140517 | N-(Azido-PEG3)-N-bis(PEG3-acid) | 2055042-57-2 | Reference compound |
| HY-140518 | N-(Azido-PEG3)-N-bis(PEG4-acid) | 2112731-54-9 | Reference compound |
| HY-140519 | N-(Azido-PEG4)-N-bis(PEG4-acid) | 2093152-80-6 | Reference compound |
| HY-140520 | N-(acid-PEG3)-N-bis(PEG3-azide) | 2182602-17-9 | Reference compound |
| HY-140521 | N-(Acid-PEG2)-N-bis(PEG3-azide) | 2320560-35-6 | Reference compound |
| HY-140522 | 2-(Azido-PEG3-amido)-1,3-bis(carboxylethoxy)propane | 2086689-05-4 | Reference compound |
| HY-140523 | Azido-PEG4-amido-tri-(carboxyethoxymethyl)-methane | 1398044-51-3 | Reference compound |
| HY-140524 | N-(Azido-PEG2)-N-Boc-PEG3-acid | 2086689-01-0 | Reference compound |
| HY-140525 | N-(Azido-PEG2)-N-Boc-PEG4-acid | 2093153-82-1 | Reference compound |
| HY-140526 | N-(Azido-PEG3)-N-Boc-PEG3-acid | 2112731-52-7 | Reference compound |
| HY-140527 | 1,3-bis(carboxyethoxy)-2,2-bis(carboxyethoxy)propane | 35638-19-8 | Reference compound |
| HY-140528 | N-Biotin-N-bis(PEG4-acid) | 1964503-35-2 | Reference compound |
| HY-140529 | N-Mal-N-bis(PEG2-acid) | 2110449-02-8 | Reference compound |
| HY-140530 | Mal-N-bis(PEG4-C2-acid) | 2100306-52-1 | Reference compound |
| HY-140531 | N-(Biotin-PEG4)-N-bis(PEG4-acid) | 2112731-48-1 | Reference compound |
| HY-140531A | N-(Biotin-PEG4)-N-bis(PEG4-acid) (hydrochloride) | 2112731-49-2 | Reference compound |
| HY-140532 | N-(Amino-PEG4)-N-Biotin-PEG4-acid | 2100306-84-9 | Reference compound |
| HY-140533 | N-(Azido-PEG2)-N-biotin-PEG3-acid | 2112731-59-4 | Reference compound |
| HY-140534 | 4-(N-Boc-amino)-1,6-heptanedioic acid | 848242-88-6 | Reference compound |
| HY-140535 | Boc-NH-Bis(acid-PEG1-m) | 1398044-54-6 | Reference compound |
| HY-140536 | N-(Boc-PEG3)-N-bis(PEG3-acid) | 2055042-61-8 | Reference compound |
| HY-140537 | N-(Boc-PEG5)-N-bis(PEG4-acid) | 2093152-87-3 | Reference compound |
| HY-140538 | N-Boc-N-bis(PEG2-acid) | 2054339-01-2 | Reference compound |
| HY-140539 | N-Boc-N-bis(PEG3-acid) | 2055023-35-1 | Reference compound |
| HY-140540 | N-Boc-N-bis(PEG4-acid) | 2093152-88-4 | Reference compound |
| HY-140541 | Tri-(PEG1-C2-acid) | 1381861-95-5 | Reference compound |
| HY-140542 | N-Benzyl-N-bis(PEG3-acid) | 2093154-03-9 | Reference compound |
| HY-140543 | N-DBCO-N-bis(PEG2-C2-acid) | 2110449-00-6 | Reference compound |
| HY-140544 | N-(Azido-PEG2)-N-Fluorescein-PEG3-acid | 2086689-04-3 | Reference compound |
| HY-140545 | N-(Azido-PEG2)-N-fluorescein-PEG4-acid | 2086689-06-5 | Reference compound |
| HY-140546 | N-(Azido-PEG3)-N-Fluorescein-PEG4-acid | 2100306-72-5 | Reference compound |
| HY-140547 | NH-bis-PEG3 | 25743-12-8 | Reference compound |
| HY-140548 | NH-bis-PEG4 | 63721-14-2 | Reference compound |
| HY-140549 | NH-bis-PEG5 | 63721-06-2 | Reference compound |
| HY-140550 | NH-bis(C2-PEG1-azide) | 2100306-81-6 | Reference compound |
| HY-140551 | NH-bis(PEG3-azide) | 1258939-39-7 | Reference compound |
| HY-140552 | N-(Azido-PEG3)-NH-PEG3-acid | 2183440-72-2 | Reference compound |
| HY-140553 | N-Boc-N-bis-PEG5 | 2093154-02-8 | Reference compound |
| HY-140554 | N-Boc-N-bis(C2-PEG1-azide) | 2100306-79-2 | Reference compound |
| HY-140555 | N-Boc-N-bis(PEG3-azide) | 1258939-38-6 | Reference compound |
| HY-140556 | N-Boc-N-bis(PEG4-azide) | 2055041-25-1 | Reference compound |
| HY-140557 | N-Boc-N-bis(PEG3-NHS ester) | 2055042-31-2 | Reference compound |
| HY-140558 | N-Boc-N-bis(PEG4-NHS ester) | 2093153-08-1 | Reference compound |
| HY-140559 | N-(Azido-PEG2)-N-Boc-PEG3-NHS ester | 2093153-85-4 | Reference compound |
| HY-140560 | N-(Azido-PEG2)-N-Boc-PEG4-NHS ester | 2093153-95-6 | Reference compound |
| HY-140561 | N-(Azido-PEG3)-N-Boc-PEG3-NHS ester | 2112731-51-6 | Reference compound |
| HY-140562 | N-(Azido-PEG2)-N-Boc-PEG3-Boc | 2093153-07-0 | Reference compound |
| HY-140563 | N-(Azido-PEG2)-N-Boc-PEG4-Boc | 2093153-83-2 | Reference compound |
| HY-140564 | N-(Azido-PEG3)-N-Boc-PEG3-t-butyl ester | 2112732-03-1 | Reference compound |
| HY-140565 | N-(Azido-PEG3)-N-Boc-PEG4-Boc | 2112731-94-7 | Reference compound |
| HY-140566 | N-Azido-PEG4-N-Boc-N-PEG3-Boc | 2093152-85-1 | Reference compound |
| HY-140567 | N-(Azido-PEG4)-N-Boc-PEG4-Boc | 2112737-20-7 | Reference compound |
| HY-140568 | N-(Hydroxy-PEG3)-N-Boc-PEG4-Boc | Reference compound | |
| HY-140569 | N-(PEG1-OH)-N-Boc-PEG2-propargyl | 2100306-85-0 | Reference compound |
| HY-140570 | N-Mal-N-bis(PEG2-amine) | 2128735-20-4 | Reference compound |
| HY-140571 | N-Mal-N-bis(PEG2-NHS ester) | 2182601-73-4 | Reference compound |
| HY-140572 | N-Mal-N-bis(PEG4-NHS ester) | 2112738-60-8 | Reference compound |
| HY-140573 | N-Mal-N-bis(PEG4-amine) | 2128735-22-6 | Reference compound |
| HY-140574 | N-Mal-N-bis(PEG2-NH-Boc) | 2128735-26-0 | Reference compound |
| HY-140575 | N-Mal-N-bis(PEG4-NH-Boc) | 2128735-27-1 | Reference compound |
| HY-140576 | N-Mal-N-bis(PEG2-C2-Boc) | 2100306-51-0 | Reference compound |
| HY-140577 | N-Me-N-bis-PEG3 | 342818-95-5 | Reference compound |
| HY-140578 | N-Me-N-bis-PEG4 | 2055046-22-3 | Reference compound |
| HY-140579 | N-Me-N-bis(PEG4-acid) | 2055014-77-0 | Reference compound |
| HY-140580 | Bis(m-PEG4)-N-OH | 2182601-79-0 | Reference compound |
| HY-140581 | N-(Azido-PEG3)-N-Biotin-PEG4-methyl ester | 2100306-76-9 | Reference compound |
| HY-140582 | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS | 2353409-72-8 | Reference compound |
| HY-140583 | N-Desthiobiotin-N-bis(PEG4-NHS ester) | 2353409-61-5 | Reference compound |
| HY-140584 | N-Desthiobiotin-N-bis(PEG4-t-butyl ester) | 2353409-60-4 | Reference compound |
| HY-140585 | N-DBCO-N-bis(PEG2-C2-NHS ester) | 2128735-29-3 | Reference compound |
| HY-140586 | N-Benzyl-N-bis-PEG2 | 119580-47-1 | Reference compound |
| HY-140587 | N-Benzyl-N-bis-PEG4 | 1680183-01-0 | Reference compound |
| HY-140588 | Benzyl-N-bis(PEG3-Boc) | Reference compound | |
| HY-140589 | Acid-PEG4-S-PEG4-acid | 2055041-21-7 | Reference compound |
| HY-140590 | Azido-PEG3-S-PEG3-azide | 2055023-77-1 | Reference compound |
| HY-140591 | Azido-PEG3-S-PEG4-propargyl | 2055041-24-0 | Reference compound |
| HY-140592 | Azido-PEG3-S-PEG4-t-butyl ester | 2055041-19-3 | Reference compound |
| HY-140593 | m-PEG3-S-PEG2-OH | 2173095-09-3 | Reference compound |
| HY-140594 | m-PEG3-S-PEG4-propargyl | 2055040-85-0 | Reference compound |
| HY-140595 | m-PEG3-S-PEG1-C2-Boc | 2365419-97-0 | Reference compound |
| HY-140596 | m-PEG3-S-PEG3-Boc | 2055040-96-3 | Reference compound |
| HY-140597 | Propargyl-PEG4-S-PEG4-acid | 2055041-20-6 | Reference compound |
| HY-140598 | Propargyl-PEG4-S-PEG4-propargyl | 2055041-17-1 | Reference compound |
| HY-140599 | Propargyl-PEG4-S-PEG4-Boc | 2055041-18-2 | Reference compound |
| HY-140600 | S-Bis-(PEG4-Boc) | Reference compound | |
| HY-140601 | Sulfone-Bis-PEG4-acid | 2055024-37-6 | Reference compound |
| HY-140602 | Azido-PEG3-Sulfone-PEG4-acid | 2055024-42-3 | Reference compound |
| HY-140603 | Azide-PEG3-Sulfone-PEG3-azide | 2055024-45-6 | Reference compound |
| HY-140604 | Azido-PEG3-Sulfone-PEG4-Boc | 2055023-76-0 | Reference compound |
| HY-140605 | m-PEG3-Sulfone-PEG3-acid | 1919045-04-7 | Reference compound |
| HY-140606 | m-PEG3-Sulfone-PEG3-azide | 1895922-76-5 | Reference compound |
| HY-140607 | m-PEG3-Sulfone-PEG3 | 1919045-00-3 | Reference compound |
| HY-140608 | m-PEG3-Sulfone-PEG4-propargyl | 2055041-02-4 | Reference compound |
| HY-140609 | m-PEG3-Sulfone-PEG3-Boc | 2055041-00-2 | Reference compound |
| HY-140610 | Propargyl-PEG4-Sulfone-PEG4-acid | 2055024-41-2 | Reference compound |
| HY-140611 | Propargyl-peg3-sulfone-peg3-propargyl | 2055024-44-5 | Reference compound |
| HY-140612 | Propargyl-PEG4-Sulfone-PEG4-Boc | 2055024-43-4 | Reference compound |
| HY-140613 | Boc-PEG4-sulfone-PEG4-Boc | Reference compound | |
| HY-140614 | DNP-PEG4-NHS ester | 858126-78-0 | Reference compound |
| HY-140615 | DNP-PEG12-NHS ester | Reference compound | |
| HY-140616 | DNP-PEG6-Boc | Reference compound | |
| HY-140617 | DNP-PEG3-azide | 951671-87-7 | Reference compound |
| HY-140618 | DNP-PEG4-alcohol | 1807520-99-5 | Reference compound |
| HY-140619 | DNP-PEG4-DBCO | 2149585-17-9 | Reference compound |
| HY-140620 | m-PEG4-aldehyde | 197513-96-5 | Reference compound |
| HY-140621 | m-PEG3-0-benzaldehyde | 153364-63-7 | Reference compound |
| HY-140622 | Ald-Ph-amido-PEG24-acid | Reference compound | |
| HY-140623 | Ald-Ph-PEG24-NHS ester | Reference compound | |
| HY-140624 | Ald-Ph-PEG12-TFP ester | Reference compound | |
| HY-140625 | Ald-Ph-PEG24-TFP ester | Reference compound | |
| HY-140626 | Ald-Ph-PEG4-Boc | 1807518-64-4 | Reference compound |
| HY-140627 | Ald-Ph-PEG6-Boc | 2055013-49-3 | Reference compound |
| HY-140628 | Ald-Ph-PEG2-Boc | 2100306-65-6 | Reference compound |
| HY-140629 | Ald-Ph-PEG5-Boc | 1433996-83-8 | Reference compound |
| HY-140630 | Ald-CH2-PEG4-Boc | 1415329-20-2 | Reference compound |
| HY-140631 | Ald-CH2-PEG10-Boc | 2353410-05-4 | Reference compound |
| HY-140632 | Ald-Ph-amido-C2-PEG2-amine | 2055013-56-2 | Reference compound |
| HY-140633 | Ald-C2-PEG4-azide | 2030118-14-8 | Reference compound |
| HY-140634 | Ald-CH2-PEG5-azide | 1446282-38-7 | ADC Related |
| HY-140635 | Ald-CH2-PEG8-azide | 2353410-13-4 | Reference compound |
| HY-140636 | Ald-Ph-PEG2-NH-Boc | 1807503-90-7 | Reference compound |
| HY-140637 | Acrylate-PEG-NH2 (MW 10000) | Reference compound | |
| HY-140638 | Acrylate-PEG-OH (MW 3400) | Reference compound | |
| HY-140639 | Acrylate-PEG-OH (MW 5000) | Reference compound | |
| HY-140640 | Acrylate-PEG-OH (MW 10000) | Reference compound | |
| HY-140641 | HO-PEG-amine (MW 10000) | Reference compound | |
| HY-140642 | Aminooxy-PEG-OH (MW 2000) | Reference compound | |
| HY-140643 | Amine-PEG-CH2COOH (MW 2000) | Reference compound | |
| HY-140644 | Amine-PEG-CH2COOH (MW 3400) | Reference compound | |
| HY-140645 | Amine-PEG-CH2COOH (MW 5000) | Reference compound | |
| HY-140646 | PEG-bis-amine (MW 2000) | 24991-53-5 | Biochemical Assay Reagents |
| HY-140647 | PEG-bis-amine (MW 3400) | 24991-53-5 | Biochemical Assay Reagents |
| HY-140648 | Amine-PEG-amine (MW 5000) | Reference compound | |
| HY-140649 | PEG-bis-amine (MW 20000) | 24991-53-5 | Biochemical Assay Reagents |
| HY-140650 | Amine-PEG-amine (MW 35000) | Reference compound | |
| HY-140651 | Amine-PEG-thiol (MW 2000) | Reference compound | |
| HY-140652 | Amine-PEG-thiol (MW 3400) | Reference compound | |
| HY-140653 | Amine-PEG-thiol (MW 5000) | Reference compound | |
| HY-140654 | Biotin-PEG-amine (MW 2000) | Reference compound | |
| HY-140655 | Biotin-PEG-amine (MW 3400) | Reference compound | |
| HY-140656 | Biotin-PEG-Biotin (MW 1000) | Reference compound | |
| HY-140656A | Biotin-PEG-Biotin | 194920-55-3 | Reference compound |
| HY-140656B | Biotin-PEG-Biotin (MW 2000) | Reference compound | |
| HY-140656C | Biotin-PEG-Biotin (MW 3400) | Reference compound | |
| HY-140656D | Biotin-PEG-Biotin (MW 5000) | Reference compound | |
| HY-140656E | Biotin-PEG-Biotin (MW 10000) | Reference compound | |
| HY-140656F | Biotin-PEG-Biotin (MW 20000) | Dye Reagents | |
| HY-140657 | Biotin-PEG-triethoxysilane (MW 1000) | Reference compound | |
| HY-140658 | Biotin-PEG-triethoxysilane (MW 2000) | Reference compound | |
| HY-140659 | Biotin-PEG-triethoxysilane (MW 5000) | Reference compound | |
| HY-140660 | Azide-PEG-alcohol (MW 2000) | Reference compound | |
| HY-140661 | Azide-PEG-amine (MW 2000) | Reference compound | |
| HY-140662 | Azide-PEG-amine (MW 3500) | Reference compound | |
| HY-140663 | Azide-PEG-amine (MW 5000) | Reference compound | |
| HY-140664 | Azide-PEG-azide (MW 2000) | Reference compound | |
| HY-140665 | Azide-PEG-azide (MW 5000) | Reference compound | |
| HY-140666 | Azide-PEG-azide (MW 10000) | Reference compound | |
| HY-140667 | Azide-PEG-azide (MW 20000) | Reference compound | |
| HY-140668 | Fmoc-N-PEG-CH2COOH (MW 3400) | Reference compound | |
| HY-140669 | Fmoc-N-PEG-CH2COOH (MW 5000) | Reference compound | |
| HY-140670 | m-PEG-acrylate (MW 2000) | Reference compound | |
| HY-140671 | m-PEG-acrylate (MW 10000) | Reference compound | |
| HY-140672 | m-PEG-acrylate (MW 20000) | Reference compound | |
| HY-140673 | m-PEG-acrylate (MW 30000) | Reference compound | |
| HY-140674 | m-PEG-Butyraldehyde (MW 5000) | Reference compound | |
| HY-140675 | mPEG-amine (MW 1000) | 80506-64-5 | Biochemical Assay Reagents |
| HY-140676 | mPEG-amine (MW 2000) | 80506-64-5 | Biochemical Assay Reagents |
| HY-140677 | mPEG-amine (MW 5000) | 80506-64-5 | Biochemical Assay Reagents |
| HY-140678 | mPEG-amine (MW 10000) | 80506-64-5 | Biochemical Assay Reagents |
| HY-140679 | mPEG-amine (MW 20000) | 80506-64-5 | Biochemical Assay Reagents |
| HY-140680 | m-PEG-Lys-NHS ester (MW 20000) | Reference compound | |
| HY-140681 | m-PEG-Lys-NHS ester (MW 40000) | Reference compound | |
| HY-140682 | m-PEG-azide (MW 2000) | Reference compound | |
| HY-140683 | m-PEG-azide (MW 5000) | Reference compound | |
| HY-140684 | m-PEG-azide (MW 10000) | Reference compound | |
| HY-140685 | m-PEG-azide (MW 20000) | Reference compound | |
| HY-140686 | m-PEG-CH2COOH (MW 2000) | Reference compound | |
| HY-140687 | m-PEG-CH2COOH (MW 5000) | Reference compound | |
| HY-140688 | m-PEG-CH2COOH (MW 20000) | Reference compound | |
| HY-140689 | m-PEG-mal (MW 2000) | Reference compound | |
| HY-140691 | m-PEG-mal (MW 10000) | Reference compound | |
| HY-140692 | m-PEG-mal (MW 20000) | Reference compound | |
| HY-140693 | m-PEG-mal (MW 30000) | Reference compound | |
| HY-140694 | m-PEG-NPC (MW 20000) | Reference compound | |
| HY-140695 | m-PEG-Aminooxy (MW 2000) | Reference compound | |
| HY-140696 | m-PEG-OH (MW 2000) | 9004-74-4 | Reference compound |
| HY-140696B | m-PEG-OH (MW 550) | 9004-74-4 | Biochemical Assay Reagents |
| HY-140696C | m-PEG-OH (MW 20000) | 9004-74-4 | Biochemical Assay Reagents |
| HY-140696D | m-PEG-OH (MW 10000) | 9004-74-4 | Biochemical Assay Reagents |
| HY-140696E | m-PEG-OH (MW 1000) | 9004-74-4 | Biochemical Assay Reagents |
| HY-140696H | m-PEG-OH (MW 750) | 9004-74-4 | Biochemical Assay Reagents |
| HY-140697 | m-PEG-OH (MW5000) | 9004-74-4 | Reference compound |
| HY-140698 | m-PEG-NHS ester (MW 5000) | 92451-01-9 | Biochemical Assay Reagents |
| HY-140699 | m-PEG-NHS ester (MW 10000) | 92451-01-9 | Biochemical Assay Reagents |
| HY-140700 | m-PEG-NHS ester (MW 20000) | 92451-01-9 | Biochemical Assay Reagents |
| HY-140701 | m-PEG-Succinimidyl Succinate (MW 5000) | Reference compound | |
| HY-140702 | m-PEG-triethoxysilane (MW 1000) | Reference compound | |
| HY-140703 | m-PEG-triethoxysilane (MW 2000) | Reference compound | |
| HY-140704 | m-PEG-triethoxysilane (MW 5000) | Reference compound | |
| HY-140705 | m-PEG-Tos (MW 2000) | Reference compound | |
| HY-140706 | m-PEG-thiol (MW 2000) | 134874-49-0 | Reference compound |
| HY-140707 | m-PEG-thiol (MW 5000) | Reference compound | |
| HY-140708 | m-PEG-thiol (MW 10000) | Reference compound | |
| HY-140709 | m-PEG-thiol (MW 20000) | Reference compound | |
| HY-140710 | m-PEG-Tresyl (MW 5000) | Reference compound | |
| HY-140711 | HO-PEG-CH2COOH (MW 3400) | Reference compound | |
| HY-140712 | HO-PEG-CH2COOH (MW 5000) | Reference compound | |
| HY-140713 | HO-PEG-amine (MW 1000) | Reference compound | |
| HY-140714 | HO-PEG-amine (MW 2000) | Reference compound | |
| HY-140715 | HO-PEG-amine (MW 3400) | Reference compound | |
| HY-140716 | HO-PEG-amine (MW 5000) | Reference compound | |
| HY-140717 | HO-PEG-mal (MW 3400) | Reference compound | |
| HY-140718 | HO-PEG-mal (MW 5000) | Reference compound | |
| HY-140719 | Mal-PEG-mal (MW 2000) | Reference compound | |
| HY-140720 | Mal-PEG-mal (MW 3400) | Reference compound | |
| HY-140721 | Mal-PEG-mal (MW 5000) | Reference compound | |
| HY-140722 | Mal-PEG-Succinimidyl Valerate (MW 20000) | Reference compound | |
| HY-140723 | Carboxymethyl-PEG-Carboxymethyl (MW 5000) | Reference compound | |
| HY-140724 | Bis-PEG-TFP ester (MW 5000) | Reference compound | |
| HY-140725 | Boc-NH-PEG-amine (MW 2000) | Reference compound | |
| HY-140726 | Boc-NH-PEG-amine (MW 3400) | Reference compound | |
| HY-140727 | Boc-NH-PEG-amine (MW 5000) | Reference compound | |
| HY-140728 | Thiol-PEG-CH2COOH (MW 2000) | Reference compound | |
| HY-140729 | Thiol-PEG-CH2COOH (MW 3400) | Reference compound | |
| HY-140730 | Thiol-PEG-CH2COOH (MW 5000) | Reference compound | |
| HY-140731 | TCO-PEG-TCO (MW 5000) | Reference compound | |
| HY-140732 | Dioxoisoindolin-O-PEG-OH (MW 2000) | Reference compound | |
| HY-140733 | Dioxoisoindolin-O-PEG-OMe (MW 2000) | Reference compound | |
| HY-140734 | DSPE-PEG-Amine, MW 3400 | Reference compound | |
| HY-140735 | DSPE-PEG-Amine, MW 5000 | Reference compound | |
| HY-140736 | DSPE-PEG-Biotin, MW 2000 | 385437-57-0 | Oligonucleotides |
| HY-140736A | DSPE-PEG-Biotin, MW 1000 | 385437-57-0 | Biochemical Assay Reagents |
| HY-140736B | DSPE-PEG-Biotin, MW 5000 | 385437-57-0 | Biochemical Assay Reagents |
| HY-140737 | DSPE-PEG-CH2COOH, MW 2000 | Reference compound | |
| HY-140738 | DSPE-PEG-CH2COOH, MW 5000 | Reference compound | |
| HY-140739 | DSPE-PEG2000-Maleimide | Oligonucleotides | |
| HY-140739A | DSPE-PEG2000-Maleimide (free acid) | 185844-12-6 | Reference compound |
| HY-140740 | DSPE-PEG-Maleimide, MW 5000 | Reference compound | |
| HY-140741 | DSPE-PEG-OH, MW 2000 | Oligonucleotides | |
| HY-140742 | Benzyl-PEG2-amine | 1268135-96-1 | Reference compound |
| HY-140743 | Benzyl-PEG5-amine | 86770-77-6 | Reference compound |
| HY-140744 | Benzyl-PEG5-azide | 86770-72-1 | Reference compound |
| HY-140745 | Benzyloxy carbonyl-PEG3-C2-acid | 2100306-73-6 | Reference compound |
| HY-140746 | Benzyloxy carbonyl-PEG3-NHS ester | 2100306-68-9 | Reference compound |
| HY-140747 | BnO-PEG1-CH2CO2tBu | 1309451-06-6 | Reference compound |
| HY-140748 | BnO-PEG4-Boc | 1807503-89-4 | Reference compound |
| HY-140749 | BnO-PEG5-Boc | 1807537-31-0 | Reference compound |
| HY-140750 | Benzyloxy carbonyl-PEG3-C2-Boc | 1835759-86-8 | Reference compound |
| HY-140751 | Benzyl-PEG5-MS | 1807539-07-6 | Reference compound |
| HY-140752 | DOTA-PEG5-azide | Reference compound | |
| HY-140753 | DOTA-(t-butyl)3-PEG5-azide | Reference compound | |
| HY-140754 | Bromoacetamido-PEG5-DOTA | 2353410-19-0 | Reference compound |
| HY-140755 | Aeide-C1-NHS ester | 824426-32-6 | Reference compound |
| HY-140756 | Azido-PEG1-NHS ester | 1807530-06-8 | Reference compound |
| HY-140757 | Azido-PEG5-NHS ester | 1433996-86-1 | Reference compound |
| HY-140758 | Azido-PEG9-NHS ester | Reference compound | |
| HY-140759 | Azido-PEG10-NHS ester | 2801772-86-9 | Reference compound |
| HY-140760 | Azido-PEG12-NHS ester | 2363756-50-5 | Reference compound |
| HY-140761 | Azido-PEG16-NHS ester | Reference compound | |
| HY-140762 | Azido-PEG24-NHS ester | 2375600-46-5 | Reference compound |
| HY-140763 | Azido-PEG1-CH2CO2-NHS | 1480545-09-2 | Reference compound |
| HY-140764 | Azido-PEG3-NHS ester | 1092654-47-1 | Reference compound |
| HY-140765 | Azido-PEG4-NHS-ester | 1807534-82-2 | Reference compound |
| HY-140766 | Azido-PEG5-CH2CO2-NHS | 2144777-77-3 | Reference compound |
| HY-140767 | Azido-PEG8-C1-NHS ester | 2182601-81-4 | Reference compound |
| HY-140768 | Azido-PEG3-O-NHS ester | 2110448-98-9 | Reference compound |
| HY-140769 | Azido-PEG5-succinimidyl carbonate | 1402411-88-4 | Reference compound |
| HY-140770 | Azido-PEG3-aminoacetic acid-NHS ester | 2170240-91-0 | Reference compound |
| HY-140771 | Azido-PEG1-PFP ester | 1807505-32-3 | Reference compound |
| HY-140772 | Azido-PEG6-PFP ester | 1818294-47-1 | Reference compound |
| HY-140773 | Azido-PEG8-PFP ester | 2055014-62-3 | Reference compound |
| HY-140774 | Azido-PEG8-CH2COO-PFP | 2182601-80-3 | Reference compound |
| HY-140775 | Azido-PEG1-Boc | 1374658-85-1 | Reference compound |
| HY-140776 | Azido-PEG2-C2-Boc | 1271728-79-0 | Reference compound |
| HY-140777 | Azido-PEG4-Boc | 581066-04-8 | Reference compound |
| HY-140778 | Azide-PEG5-Boc | 1415800-41-7 | Reference compound |
| HY-140779 | Azido-PEG6-C2-Boc | 406213-76-1 | Reference compound |
| HY-140780 | Azido-PEG9-Boc | 1818294-43-7 | Reference compound |
| HY-140781 | Azido-PEG10-Boc | 2490419-48-0 | Reference compound |
| HY-140782 | Azido-PEG12-Boc | Reference compound | |
| HY-140783 | Azido-PEG15-t-butyl ester | Reference compound | |
| HY-140784 | Azido-PEG16-Boc | Reference compound | |
| HY-140785 | Azido-PEG36-Boc | Reference compound | |
| HY-140786 | Azido-PEG4-amido-PEG4-Boc | Reference compound | |
| HY-140787 | Azide-PEG6-amido-C16-Boc | Reference compound | |
| HY-140788 | Azide-PEG9-amido-C4-Boc | Reference compound | |
| HY-140789 | Azide-PEG9-amido-C8-Boc | Reference compound | |
| HY-140790 | Azide-PEG9-amido-C12-Boc | Reference compound | |
| HY-140791 | Azide-PEG9-amido-C16-Boc | Reference compound | |
| HY-140792 | Azido-PEG1-C1-Boc | 1820717-35-8 | Reference compound |
| HY-140793 | Azido-PEG2-C1-Boc | 251564-45-1 | Reference compound |
| HY-140794 | Azido-PEG3-C-Boc | 172531-36-1 | Reference compound |
| HY-140795 | Azido-PEG5-Boc | 1448451-72-6 | Reference compound |
| HY-140796 | Azido-PEG6-C1-Boc | 297162-49-3 | Reference compound |
| HY-140797 | Azido-PEG2-alcohol | 139115-90-5 | Reference compound |
| HY-140798 | Azido-PEG7-alcohol | 1274892-60-2 | Reference compound |
| HY-140799 | Azide-PEG8-alcohol | 352439-36-2 | Reference compound |
| HY-140800 | Azido-PEG9-alcohol | 1984776-37-5 | Reference compound |
| HY-140801 | Azido-PEG10-alcohol | 877239-09-3 | Reference compound |
| HY-140802 | Azido-PEG11-alcohol | 2252392-53-1 | Reference compound |
| HY-140803 | Azide-PEG12-alcohol | 1821464-55-4 | Reference compound |
| HY-140804 | Azide-PEG16-alcohol | Reference compound | |
| HY-140805 | Azido-PEG20-alcohol | 1637297-21-2 | Reference compound |
| HY-140806 | Azido-PEG24-alcohol | 2415674-94-9 | Reference compound |
| HY-140807 | Azido-PEG36-alcohol | Reference compound | |
| HY-140808 | Azido-PEG3-C3-OH | 1807512-36-2 | Reference compound |
| HY-140809 | Azido-PEG4-(CH2)3OH | 2028281-87-8 | Reference compound |
| HY-140810 | 3-(Azido-PEG5-amino)propanol | 2228857-31-4 | Reference compound |
| HY-140812 | Azido-PEG3-phosphonic acid | 1964503-38-5 | Reference compound |
| HY-140813 | Azido-PEG3-phosphonic acid ethyl ester | 1337527-24-8 | Reference compound |
| HY-140814 | Azido-PEG4-hydrazide | 2170240-96-5 | Reference compound |
| HY-140815 | Azido-PEG8-hydrazide | 2353410-11-2 | Reference compound |
| HY-140816 | Azido-PEG2-hydrazide-Boc | 2100306-56-5 | Reference compound |
| HY-140817 | Azido-PEG4-hydrazide-Boc | 1919045-01-4 | Reference compound |
| HY-140818 | Azido-PEG8-hydrazide-Boc | 2353410-12-3 | Reference compound |
| HY-140819 | Bromo-PEG1-C2-azide | 1144106-65-9 | Reference compound |
| HY-140820 | Bromo-PEG3-azide | 1446282-43-4 | Reference compound |
| HY-140821 | Bromo-PEG4-azide | 1951439-37-4 | Reference compound |
| HY-140822 | Bromo-PEG5-azide | 1402411-90-8 | Reference compound |
| HY-140823 | Bromo-PEG6-azide | 2062663-64-1 | Reference compound |
| HY-140825 | Bromoacetamido-PEG3-azide | 940005-81-2 | Reference compound |
| HY-140826 | Bromoacetamido-PEG5-azide | 1415800-37-1 | Reference compound |
| HY-140827 | m-PEG3-azide | 74654-06-1 | Reference compound |
| HY-140828 | m-PEG4-azide | 606130-90-9 | Reference compound |
| HY-140829 | m-PEG11-azide | Reference compound | |
| HY-140830 | m-PEG12-azide | 2170098-29-8 | Reference compound |
| HY-140831 | m-PEG16-azide | Reference compound | |
| HY-140832 | m-PEG24-azide | 2563873-82-3 | Reference compound |
| HY-140833 | m-PEG36-azide | Reference compound | |
| HY-140834 | Boc-N-Amido-PEG2-C2-azide | 950683-55-3 | Reference compound |
| HY-140835 | Boc-N-Amido-PEG3-azide | 642091-68-7 | Reference compound |
| HY-140836 | Boc-NH-PEG4-azide | 940951-99-5 | Reference compound |
| HY-140837 | Boc-NH-PEG5-azide | 911209-07-9 | Reference compound |
| HY-140838 | Boc-NH-PEG6-azide | 1292268-15-5 | Reference compound |
| HY-140839 | Boc-NH-PEG7-azide | 206265-96-5 | Reference compound |
| HY-140840 | Boc-NH-PEG9-azide | 2112731-50-5 | Reference compound |
| HY-140841 | APN-C3-PEG4-azide | 2183440-32-4 | Reference compound |
| HY-140842 | Azido-PEG4-nitrile | 2194563-82-9 | Reference compound |
| HY-140843 | 1-Isothiocyanato-PEG3-azide | 1310686-23-7 | Reference compound |
| HY-140844 | Thalidomide-O-PEG4-azide | 2380318-57-8 | Reference compound |
| HY-140845 | 1,1,1-Trifluoroethyl-PEG2-azide | 1835759-68-6 | Reference compound |
| HY-140846 | N-Fmoc-N'-(azido-PEG4)-L-Lysine | Reference compound | |
| HY-140847 | N-Fmoc-N'-(azido-PEG4)-L-Lysine-PFP ester | Reference compound | |
| HY-140848 | Azide-PEG3-L-alanine-Fmoc | 2054345-69-4 | Reference compound |
| HY-140849 | Azido-PEG3-Ala-Boc | 2054345-68-3 | Reference compound |
| HY-140850 | Azide-PEG3-C1-Ala | 2054345-67-2 | Reference compound |
| HY-140851 | Azido-PEG1-methyl ester | 1835759-80-2 | Reference compound |
| HY-140852 | Azido-PEG3-methyl ester | 2086689-07-6 | Reference compound |
| HY-140853 | Azido-PEG3-CH2CO2Me | 1253389-31-9 | Reference compound |
| HY-140854 | Azido-PEG4-(CH2)3-methyl ester | 1835759-71-1 | Reference compound |
| HY-140855 | Azido-PEG4-oxazolidin-2-one | 1919045-03-6 | Reference compound |
| HY-140856 | Azido-PEG5-triethoxysilane | Reference compound | |
| HY-140857 | Iodoacetamide-PEG3-azide | 1594986-04-5 | Reference compound |
| HY-140858 | Azido-PEG4-4-nitrophenyl carbonate | 1422540-98-4 | Reference compound |
| HY-140859 | S-Acetyl-PEG3-azide | 1310827-26-9 | Reference compound |
| HY-140860 | Trityl-PEG8-azide | 1818294-30-2 | Reference compound |
| HY-140861 | Trityl-PEG10-azide | 877239-08-2 | Reference compound |
| HY-140862 | Phthalamide-PEG3-azide | 134179-44-5 | Reference compound |
| HY-140863 | PC-PEG11-Azide | 2353409-89-7 | Reference compound |
| HY-140865 | 2-(Azido-PEG3-amido)-1,3-bis(NHS ester) | 2320560-36-7 | Reference compound |
| HY-140866 | N-(Azido-PEG4)-N-bis(PEG4-NHS ester) | 2353409-90-0 | Reference compound |
| HY-140867 | N-(Azido-PEG2)-N-bis(PEG4-Boc) | 2112731-81-2 | Reference compound |
| HY-140868 | N-(Azido-PEG3)-N-bis(PEG3-Boc) | 2055042-56-1 | Reference compound |
| HY-140869 | N-(Azido-PEG3)-N-bis(PEG4-Boc) | 2353409-58-0 | Reference compound |
| HY-140870 | N-(Azido-PEG4)-N-bis(PEG4-t-butyl ester) | 2093152-79-3 | Reference compound |
| HY-140871 | N-(Boc-PEG3)-N-bis(PEG3-azide) | 2182602-15-7 | Reference compound |
| HY-140872 | N-(Boc-PEG2)-N-bis(PEG3-azide) | 2353409-46-6 | Reference compound |
| HY-140873 | N-(Azido-PEG3)-N-bis(PEG1-t-butyl ester) | 2086689-00-9 | Reference compound |
| HY-140874 | Azido-PEG4-Amido-tri-(t-butoxycarbonylethoxymethyl)-methane | 1421933-29-0 | Reference compound |
| HY-140875 | Propargyl-PEG3-triethoxysilane | 2250216-92-1 | Reference compound |
| HY-140876 | Propargyl-PEG3-methyl ester | 2086689-09-8 | Reference compound |
| HY-140877 | Dde Biotin-PEG4-TAMRA-PEG4 Alkyne | 2353409-55-7 | Dye Reagents |
| HY-140878 | Boc-NH-PEG3-propargyl | 1333880-60-6 | Reference compound |
| HY-140879 | Boc-N-Amido-PEG4-propargyl | 1219810-90-8 | Reference compound |
| HY-140880 | Boc-NH-PEG5-propargyl | 2062663-67-4 | Reference compound |
| HY-140881 | Boc-NH-PEG6-propargyl | 1262991-52-5 | Reference compound |
| HY-140882 | Boc-NH-PEG7-propargyl | 2112737-90-1 | Reference compound |
| HY-140883 | Boc-NH-PEG8-propargyl | 2183440-31-3 | Reference compound |
| HY-140884 | Boc-NH-PEG9-propargyl | Reference compound | |
| HY-140885 | Boc-NH-PEG12-propargyl | Reference compound | |
| HY-140886 | 1,1,1-Trifluoroethyl-PEG2-propargyl | 1835759-73-3 | Reference compound |
| HY-140887 | 1,1,1-Trifluoroethyl-PEG4-propargyl | 1817735-37-7 | Reference compound |
| HY-140888 | Biotin-PEG2-NHS ester | 596820-83-6 | Reference compound |
| HY-140889 | Biotin-PEG4-NHS ester | 459426-22-3 | Reference compound |
| HY-140890 | Biotin-PEG6-NHS ester | 2055045-04-8 | Reference compound |
| HY-140891 | Biotin-PEG8-NHS ester | 2143968-03-8 | Reference compound |
| HY-140892 | Biotin-PEG12-NHS ester | 1934296-88-4 | Reference compound |
| HY-140893 | Biotin-PEG6-alcohol | 906099-89-6 | Reference compound |
| HY-140894 | Biotin-PEG8-alcohol | 2182601-20-1 | Reference compound |
| HY-140895 | Biotin-PEG4-amine | 663171-32-2 | Reference compound |
| HY-140896 | Biotin-PEG5-amine | 113072-75-6 | Reference compound |
| HY-140897 | Biotin-PEG6-amine | 2757573-29-6 | Reference compound |
| HY-140898 | Biotin-PEG7-amine | 1334172-76-7 | Reference compound |
| HY-140899 | Biotin-PEG8-amine | 2183447-27-8 | Reference compound |
| HY-140900 | Biotin-PEG11-amine | 1418022-42-0 | Reference compound |
| HY-140901 | Biotin-PEG23-amine | Reference compound | |
| HY-140902 | rel-Biotin-PEG3-C3-NH2 | 1374658-86-2 | Reference compound |
| HY-140902A | Biotin-PEG3-C3-NH2 | 183896-00-6 | Reference compound |
| HY-140903 | Biotin-PEG4-TFP ester | 2985664-57-9 | Reference compound |
| HY-140904 | Biotin-PEG12-TFP ester | Reference compound | |
| HY-140905 | Biotin-PEG24-TFP ester | Reference compound | |
| HY-140906 | Biotin-PEG36-PFP ester | Reference compound | |
| HY-140907 | Biotin-PEG3-Mal | 1431618-70-0 | Reference compound |
| HY-140908 | Biotin-PEG6-Mal | 1808990-66-0 | Reference compound |
| HY-140909 | Biotin-PEG11-Mal | 1646619-56-8 | Reference compound |
| HY-140910 | Biotin-PEG4-azide | 1309649-57-7 | Reference compound |
| HY-140911 | Biotin-PEG6-azide | 1085938-09-5 | Reference compound |
| HY-140912 | Biotin-PEG11-azide | 2276672-04-7 | Reference compound |
| HY-140913 | Biotin-PEG23-azide | Reference compound | |
| HY-140914 | Biotin-PEG4-Amide-C6-Azide | 1006592-62-6 | Reference compound |
| HY-140915 | Biotin-PEG4-Picolyl azide | 2222687-71-8 | Reference compound |
| HY-140916 | Dde Biotin-PEG4-azide | 1802907-93-2 | Reference compound |
| HY-140917 | Dde Biotin-PEG4-Picolyl azide | 2055048-42-3 | Reference compound |
| HY-140918 | Diazo Biotin-PEG3-azide | 1339202-33-3 | Reference compound |
| HY-140919 | N-(Azido-PEG4)-biocytin | 2055042-70-9 | Reference compound |
| HY-140920 | UV Cleavable Biotin-PEG2-Azide | 1192802-98-4 | Reference compound |
| HY-140921 | Biotin-PEG4-amino-t-Bu-DADPS-C6-azide | 1260247-50-4 | Reference compound |
| HY-140922 | Biotin-PEG4-alkyne | 1458576-00-5 | Reference compound |
| HY-140923 | Biotin-PEG4-amide-Alkyne | 1006592-45-5 | Reference compound |
| HY-140924 | Dde Biotin-PEG4-alkyne | 1802908-00-4 | Reference compound |
| HY-140925 | Diazo Biotin-PEG3-alkyne | 1884349-58-9 | Reference compound |
| HY-140926 | N-(Propargyl-PEG4)-biocytin | 2055042-71-0 | Reference compound |
| HY-140927 | Azido-C3-UV-biotin | Reference compound | |
| HY-140928 | Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne | 2241685-22-1 | Reference compound |
| HY-140929 | Bis-Biotin-PEG23 | 293298-36-9 | Reference compound |
| HY-140930 | Diazo Biotin-PEG3-DBCO | ADC Related | |
| HY-140931 | Dde Biotin-PEG4-DBCO | 1807512-43-1 | Reference compound |
| HY-140932 | Biotin-PEG4-hydrazide | 756525-97-0 | Reference compound |
| HY-140932A | Biotin-PEG4-hydrazide (TFA) | Reference compound | |
| HY-140933 | Biotin-PEG12-hydrazide | Reference compound | |
| HY-140934 | Biotin-PEG2-NH-Boc | 175885-18-4 | Reference compound |
| HY-140935 | Biotin-PEG5-NH-Boc | 189209-28-7 | Reference compound |
| HY-140936 | Biotin-PEG6-Boc | 1352814-07-3 | Reference compound |
| HY-140937 | Biotin-amido-PEG4-PFP ester | Reference compound | |
| HY-140938 | Biotin-PEG3-oxyamine | 1786206-22-1 | Reference compound |
| HY-140939 | Biotin-PEG11-oxyamine | Reference compound | |
| HY-140940 | Biotin-PEG4-methyltetrazine | 1835759-81-3 | Reference compound |
| HY-140941 | Biotin-PEG2-C2-iodoacetamide | 292843-75-5 | Reference compound |
| HY-140942 | Biotin-PEG6-Thalidomide | 2144775-48-2 | Reference compound |
| HY-140943 | Biotin-PEG7-thiourea | 2353409-59-1 | Reference compound |
| HY-140944 | Biotin-PEG3-SS-azide | ADC Related | |
| HY-140945 | Fmoc-Lys (biotin-PEG12)-OH | Reference compound | |
| HY-140946 | TAMRA-PEG3-biotin | 2279944-59-9 | Dye Reagents |
| HY-140947 | TAMRA-Azide-PEG-biotin | 1797415-74-7 | Dye Reagents |
| HY-140948 | (5,6)TAMRA-PEG3-Azide-PEG3-Desthiobiotin | Dye Reagents | |
| HY-140949 | N-(Biotin)-N-bis(PEG1-alcohol) | 2100306-75-8 | Reference compound |
| HY-140950 | m-PEG8-DSPE | Biochemical Assay Reagents | |
| HY-140951 | m-PEG12-DSPE | Reference compound | |
| HY-140952 | m-PEG24-DSPE | Reference compound | |
| HY-140953 | DSPE-PEG4-acid | 2112738-58-4 | Reference compound |
| HY-140954 | DSPE-PEG5-azide | 2112737-73-0 | Reference compound |
| HY-140955 | DSPE-PEG4-DBCO | 2112738-14-2 | Reference compound |
| HY-140956 | DSPE-PEG8-Mal | 2112737-94-5 | Biochemical Assay Reagents |
| HY-140957 | Mal-PEG12-DSPE | Reference compound | |
| HY-140958 | DSPE-PEG5-propargyl | 2112737-93-4 | Reference compound |
| HY-140959 | DSPE-PEG13-TFP ester | Reference compound | |
| HY-140960 | DSPE-PEG-2-Aminoethyl-alpha-mannopyranoside, MW 2000 | Reference compound | |
| HY-140962 | Mal-PEG12-acid | 2445165-75-1 | Reference compound |
| HY-140963 | Mal-PEG12-NHS ester | 2669737-09-9 | Reference compound |
| HY-140964 | Mal-PEG2-C2-Boc | 1374666-31-5 | Reference compound |
| HY-140965 | Mal-PEG5-Boc | 2250216-91-0 | Reference compound |
| HY-140966 | Mal-PEG12-Boc | Reference compound | |
| HY-140967 | Mal-Amido-PEG4-Boc | 1415800-35-9 | Reference compound |
| HY-140968 | Mal-PEG2-alcohol | 34321-81-8 | Reference compound |
| HY-140969 | Mal-PEG3-alcohol | 146551-23-7 | Reference compound |
| HY-140970 | Mal-PEG8-alcohol | 2353409-63-7 | Reference compound |
| HY-140971 | Mal-PEG12-alcohol | Reference compound | |
| HY-140972 | Mal-amido-PEG9-NH-Boc | 2182602-20-4 | Reference compound |
| HY-140973 | Mal-amido-PEG10-acid | 2785355-74-8 | Reference compound |
| HY-140974 | Mal-amido-PEG12-acid | 2378428-27-2 | Reference compound |
| HY-140975 | Mal-amido-PEG24-acid | 2171095-70-6 | Reference compound |
| HY-140976 | Mal-amido-PEG9-amine | 2182602-22-6 | Reference compound |
| HY-140976A | Mal-amido-PEG9-amine (TFA) | 2569576-12-9 | Reference compound |
| HY-140977 | Mal-amido-PEG12-NHS ester | 2101722-60-3 | Reference compound |
| HY-140978 | Mal-amido-PEG4-TFP ester | 1807540-84-6 | Reference compound |
| HY-140979 | Mal-amido-PEG8-TFP ester | 1924596-31-5 | Reference compound |
| HY-140980 | Mal-amido-PEG12-TFP ester | Reference compound | |
| HY-140981 | Mal-amido-PEG24-TFP ester | 2384191-62-0 | Reference compound |
| HY-140982 | m-PEG8-Mal | 1334169-90-2 | Reference compound |
| HY-140983 | m-PEG12-Mal | 2853560-28-6 | Reference compound |
| HY-140984 | m-PEG24-Mal | 2579693-28-8 | Reference compound |
| HY-140985 | m-PEG36-Mal | Reference compound | |
| HY-140986 | m-PEG48-Mal | Reference compound | |
| HY-140987 | 5-Maleimidovaleric acid | 57078-99-6 | ADC Related |
| HY-140988 | Mal-NH2 (TFA) | 146474-00-2 | Reference compound |
| HY-140989 | Mal-PEG1-bromide | 1823885-81-9 | Reference compound |
| HY-140990 | 6-Maleimidocaproic acid-PFP ester | 692739-25-6 | Reference compound |
| HY-140991 | Mal-NH-Boc | 134272-63-2 | Reference compound |
| HY-140992 | Mal-C4-NH-Boc | 124529-64-2 | Reference compound |
| HY-140993 | Bis-Mal-PEG3 | 1008402-47-8 | Reference compound |
| HY-140994 | Bis-Mal-PEG6 | 2458811-07-7 | Reference compound |
| HY-140995 | Bis-Mal-PEG11 | Reference compound | |
| HY-140996 | Bis-Mal-PEG19 | Reference compound | |
| HY-140997 | Mal-PEG4-Glu(OH)-NH-m-PEG24 | 2204309-09-9 | Reference compound |
| HY-140998 | Mal-PEG4-Glu(TFP ester)-NH-m-PEG24 | 2408741-87-5 | Reference compound |
| HY-140999 | Mal-PEG4-Lys(t-Boc)-NH-m-PEG24 | Reference compound | |
| HY-141000 | Mal-PEG4-Lys(TFA)-NH-m-PEG24 | Reference compound | |
| HY-141001 | Bis-Mal-Lysine-PEG4-acid | 1426164-52-4 | Reference compound |
| HY-141002 | Bis-Mal-Lysine-PEG4-TFP ester | 1426164-53-5 | Reference compound |
| HY-141003 | 3,4-Dibromo-Mal-PEG8-acid | Reference compound | |
| HY-141004 | 3,4-Dibromo-Mal-PEG2-amine | 1807534-86-6 | Reference compound |
| HY-141004A | 3,4-Dibromo-Mal-PEG2-amine (TFA) | 2296708-07-9 | Reference compound |
| HY-141005 | 3,4-Dibromo-Mal-PEG2-N-Boc | 1807537-43-4 | Reference compound |
| HY-141006 | 3,4-Dibromo-Mal-PEG4-Boc | 2030168-38-6 | Reference compound |
| HY-141007 | 3,4-Dibromo-Mal-PEG8-Boc | 2055198-02-0 | Reference compound |
| HY-141008 | Tri(Mal-PEG2-amide)-amine | Reference compound | |
| HY-141009 | N-(Mal-PEG6)-N-bis(PEG7-TCO) | 2093152-84-0 | Reference compound |
| HY-141010 | Thalidomide-O-PEG4-amine | 2401832-00-4 | Reference compound |
| HY-141010A | Thalidomide-O-PEG4-amine (hydrochloride) | 2820929-03-9 | Reference compound |
| HY-141010B | Thalidomide-O-PEG4-amine (TFA) | 2934561-88-1 | Reference compound |
| HY-141011 | Thalidomide-O-amido-PEG4-azide | 2411681-89-3 | Reference compound |
| HY-141012 | Thalidomide-O-PEG4-NHS ester | 2411681-88-2 | Reference compound |
| HY-141013 | Thalidomide-O-amido-PEG4-propargyl | 2496687-00-2 | Reference compound |
| HY-141014 | Thalidomide-O-PEG4-Boc | 2411681-87-1 | Reference compound |
| HY-141015 | Pomalidomide-PEG4-azide | 2271036-47-4 | Reference compound |
| HY-141016 | (S,R,S)-AHPC-PEG2-acid | 2172820-09-4 | Reference compound |
| HY-141019 | Bis-PEG11-acid | 2097010-30-3 | Reference compound |
| HY-141020 | Bis-PEG12-acid | 2667583-09-5 | Reference compound |
| HY-141021 | Bis-PEG13-acid | 2225903-66-0 | Reference compound |
| HY-141022 | Bis-PEG14-acid | Reference compound | |
| HY-141023 | Bis-PEG15-acid | Reference compound | |
| HY-141024 | Bis-PEG17-acid | 2226897-74-9 | Reference compound |
| HY-141025 | Bis-PEG21-acid | Reference compound | |
| HY-141026 | Bis-PEG25-acid | 2567200-14-8 | Reference compound |
| HY-141027 | Bis-PEG29-acid | Reference compound | |
| HY-141028 | N,N'-DME-N,N'-Bis-PEG2-acid | 2062663-61-8 | Reference compound |
| HY-141029 | N-Hydroxypropyl-N’-(azide-PEG3)-Cy3 | Reference compound | |
| HY-141030 | N-(m-PEG4)-N'-(azide-PEG4)-Cy3 | 2107273-38-9 | Reference compound |
| HY-141031 | N-Methyl-N'-methyl-O-(m-PEG4)-O'-(azide-PEG4)-Cy3 | 2107273-64-1 | Reference compound |
| HY-141032 | N-methyl-N'-methyl-O-(m-PEG4)-O'-(propargyl-PEG4)-Cy3 | 2107273-62-9 | Reference compound |
| HY-141033 | Cy5-PEG4-acid | Reference compound | |
| HY-141034 | Cy5-PEG6-acid | Reference compound | |
| HY-141035 | N-(m-PEG4)-N'-(PEG2-acid)-Cy5 | 2107273-24-3 | Reference compound |
| HY-141036 | N-(m-PEG4)-N'-(PEG4-acid)-Cy5 | 2107273-32-3 | Reference compound |
| HY-141037 | N-(m-PEG9)-N'-(PEG5-acid)-Cy5 | 2107273-26-5 | Reference compound |
| HY-141038 | N-(m-PEG4)-N'-(Acid-PEG3)-benzothiazole Cy5 | 2107273-80-1 | Reference compound |
| HY-141040 | N-methyl-N'-methyl-O-(m-PEG4)-O'-(acid-PEG5)-Cy5 | Reference compound | |
| HY-141041 | N-(Azide-PEG3)-N'-(PEG4-acid)-Cy5 | 2107273-42-5 | Reference compound |
| HY-141042 | Bis-(N,N'-carboxyl-PEG4)-Cy5 | 2107273-44-7 | Reference compound |
| HY-141043 | N,N'-bis-(Acid-PEG3)-benzothiazole Cy5 | 2107273-82-3 | Reference compound |
| HY-141044 | Cy5-PEG6-NHS ester | Dye Reagents | |
| HY-141045 | N-(m-PEG4)-N'-(PEG2-NHS ester)-Cy5 | 2107273-28-7 | Dye Reagents |
| HY-141046 | N-(m-PEG4)-N'-(PEG4-NHS ester)-Cy5 | 2107273-30-1 | Reference compound |
| HY-141047 | Bis-(N,N'-PEG4-NHS ester)-Cy5 | 2107273-48-1 | Reference compound |
| HY-141048 | N-(Azide-PEG3)-N'-(PEG4-NHS ester)-Cy5 | Reference compound | |
| HY-141049 | N-methyl-N'-(propargyl-PEG4)-Cy5 | 2107273-04-9 | Reference compound |
| HY-141050 | N-PEG3-N'-(propargyl-PEG4)-Cy5 | 2107273-06-1 | Reference compound |
| HY-141051 | N-(m-PEG9)-N'-(propargyl-PEG8)-Cy5 | 2107273-10-7 | Reference compound |
| HY-141052 | N-methyl-N'-methyl-O-(m-PEG4)-O'-(propargyl-PEG4)-Cy5 | 2107273-50-5 | Reference compound |
| HY-141053 | N-(m-PEG4)-N'-(m-PEG4)-O-(m-PEG4)-O'-(propargyl-PEG4)-Cy5 | 2107273-54-9 | Reference compound |
| HY-141054 | N,N'-bis-(propargyl-PEG4)-Cy5 | 2107273-08-3 | Reference compound |
| HY-141055 | Cy5-PEG5-amine (hydrochloride) | Reference compound | |
| HY-141056 | N-(m-PEG4)-N'-(amino-PEG3)-Cy5 | 2107272-96-6 | Reference compound |
| HY-141058 | Cy5-PEG3-azide | Dye Reagents | |
| HY-141059 | Cy5-PEG5-azide (bromide) | Dye Reagents | |
| HY-141061 | N-PEG3-N'-(azide-PEG3)-Cy5 | 2226235-96-5 | Reference compound |
| HY-141062 | N-Methyl-N'-(azido-PEG2-C5)-Cy5 | Reference compound | |
| HY-141063 | N-(m-PEG4)-N'-(azide-PEG3)-Cy5 | 2107273-02-7 | Reference compound |
| HY-141064 | N-(azide-PEG3)-N'-(m-PEG4)-Benzothiazole Cy5 | 2107273-88-9 | Reference compound |
| HY-141065 | N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5 | 2107273-70-9 | Reference compound |
| HY-141067 | N-methyl-N'-methyl-O-(m-PEG4)-O'-(azide-PEG4)-Cy5 | 2107273-56-1 | Reference compound |
| HY-141068 | N-(m-PEG4)-N'-(m-PEG4)-O-(m-PEG4)-O'-(azide-PEG4)-Cy5 | 2107273-58-3 | Reference compound |
| HY-141069 | N-(m-PEG4)-N'-(Biotin-PEG2-amido-PEG4)-Cy5 | 2107273-78-7 | Reference compound |
| HY-141070 | N-(m-PEG4)-N'-(biotin-PEG3)-Cy5 | 2107273-68-5 | Reference compound |
| HY-141071 | N-(m-PEG4)-N'-(DBCO-PEG4)-Cy5 | 2107273-76-5 | Reference compound |
| HY-141072 | N-Methyl-N'-(hydroxy-PEG2)-Cy5 | 2107273-22-1 | Reference compound |
| HY-141073 | N-(m-PEG4)-N'-(hydroxy-PEG2)-Cy5 | 2107273-12-9 | Reference compound |
| HY-141074 | N-(m-PEG4)-N'-hydroxypropyl-Cy5 | 2107273-20-9 | Reference compound |
| HY-141075 | N-(m-PEG4)-N'-(4-Hydroxycyclohexyl-1-amido-PEG4)-Cy5 | 2107273-72-1 | Reference compound |
| HY-141076 | N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 | 2839527-02-3 | Reference compound |
| HY-141077 | N-(Ac-PEG3)-N'-(azide-PEG3)-Cy7 (chloride) | 2107273-00-5 | Reference compound |
| HY-141078 | N-(m-PEG4)-N'-(azide-PEG4)-Cy7 | 2107273-40-3 | Reference compound |
| HY-141079 | N,N'-bis-(azide-PEG3)-chlorocyclohexenyl Cy7 | 2107273-84-5 | Reference compound |
| HY-141080 | Fluorescein-PEG3-amine | 1807539-04-3 | Reference compound |
| HY-141081 | Fluorescein-PEG3-NH-Boc | 1807534-77-5 | Reference compound |
| HY-141082 | Fluorescein-PEG5-NHS ester | 2353409-62-6 | Reference compound |
| HY-141083 | Fluorescein-PEG6-NHS ester | 1818294-35-7 | Reference compound |
| HY-141084 | Fluorescein-PEG6-bis-NHS ester | 2055105-59-2 | Reference compound |
| HY-141085 | Carboxyfluorescein-PEG12-NHS | 2246595-66-2 | Dye Reagents |
| HY-141086 | BDP FL-PEG5-azide | 2093197-91-0 | Reference compound |
| HY-141087 | BDP FL-PEG5-propargyl | 2093197-93-2 | Reference compound |
| HY-141088 | BDP FL-PEG4-TCO | 2183473-16-5 | Reference compound |
| HY-141089 | Carboxyrhodamine 110-PEG4-alkyne | 2055103-66-5 | Reference compound |
| HY-141090 | Carboxyrhodamine 110-PEG3-Azide | 1536327-95-3 | Reference compound |
| HY-141091 | Biotin-PEG4-Dde-TAMRA-PEG3-Azide | 2353409-56-8 | Dye Reagents |
| HY-141092 | Pyrene-PEG2-azide | 2135330-58-2 | Reference compound |
| HY-141093 | Pyrene-PEG5-alcohol | 1817735-44-6 | Reference compound |
| HY-141094 | Pyrene-PEG5-biotin | Reference compound | |
| HY-141095 | Pyrene-PEG5-propargyl | 1817735-33-3 | Reference compound |
| HY-141096 | Acid-PEG9-NHS ester | 1895916-27-4 | Reference compound |
| HY-141097 | Acid-PEG13-NHS ester | 2152679-62-2 | Reference compound |
| HY-141098 | Acid-PEG25-NHS ester | 2563872-17-1 | Reference compound |
| HY-141099 | Di(N-succinimidyl)adipate | 59156-70-6 | Reference compound |
| HY-141100 | Bis-PEG11-NHS ester | Reference compound | |
| HY-141101 | Fmoc-PEG12-NHS ester | 2227246-92-4 | Reference compound |
| HY-141102 | Fmoc-PEG24-NHS ester | Reference compound | |
| HY-141103 | Fmoc-NMe-PEG4-NHS ester | 2228857-30-3 | Reference compound |
| HY-141104 | m-PEG10-NHS ester | 2490419-63-9 | Reference compound |
| HY-141105 | m-PEG11-NHS ester | Reference compound | |
| HY-141106 | m-PEG12-NHS ester | 2207596-93-6 | Reference compound |
| HY-141107 | m-PEG13-NHS ester | Reference compound | |
| HY-141108 | m-PEG17-NHS ester | Reference compound | |
| HY-141109 | m-PEG25-NHS ester | Reference compound | |
| HY-14111 | GSK189254A | 720690-73-3 | Reference compound |
| HY-141110 | m-PEG37-NHS ester | Reference compound | |
| HY-141111 | m-PEG8-ethoxycarbonyl-NHS ester | 2353409-76-2 | Reference compound |
| HY-141112 | m-PEG3-succinimidyl carbonate | 477775-77-2 | Reference compound |
| HY-141113 | m-PEG4-O-NHS ester | 147912-03-6 | Reference compound |
| HY-141114 | m-PEG8-succinimidyl carbonate | 1372860-04-2 | Reference compound |
| HY-141115 | Mal-NO2-Ph-PEG12-NHS | Reference compound | |
| HY-141116 | Boc-N-PEG1-C2-NHS ester | 1260092-55-4 | Reference compound |
| HY-141117 | Boc-NH-PEG2-C2-NHS ester | 2183440-73-3 | Reference compound |
| HY-141118 | Boc-NH-PEG3-NHS ester | 2250216-93-2 | Reference compound |
| HY-141119 | Boc-NH-PEG4-NHS ester | 859230-20-9 | Reference compound |
| HY-141120 | Boc-NH-PEG10-NHS ester | Reference compound | |
| HY-141121 | T-Butoxycarbonyl-PEG1-NHS ester | 2228857-37-0 | Reference compound |
| HY-141122 | Boc-PEG4-C2-NHS ester | 1835759-75-5 | Reference compound |
| HY-141123 | SPDP-C6-Gly-Leu-NHS ester | ADC Related | |
| HY-141124 | NHS-PEG4-(m-PEG4)3-ester | 1333154-70-3 | Reference compound |
| HY-141125 | NHS-PEG4-(m-PEG12)3-ester | Reference compound | |
| HY-141126 | Azido-PEG4-alpha-D-mannose | 1632372-86-1 | Reference compound |
| HY-141127 | Azido-PEG4-tetra-Ac-beta-D-glucose | 153252-44-9 | Reference compound |
| HY-141128 | Ac4GalNAz | 653600-56-7 | Reference compound |
| HY-14113 | 2-Acetyl-4-tetrahydroxybutyl imidazole | 94944-70-4 | Reference compound |
| HY-141130 | LG-PEG10-click-DBCO-Oleic | Reference compound | |
| HY-141131 | Propargyl-PEG2-beta-D-glucose | 2353409-73-9 | Reference compound |
| HY-141132 | Propargyl-PEG4-beta-D-glucose | 1397682-63-1 | Reference compound |
| HY-141133 | Propargyl-PEG4-tetra-Ac-beta-D-glucose | 1360446-31-6 | Reference compound |
| HY-141135 | Propargyl-PEG4-tetra-Ac-beta-D-galactose | 1397682-61-9 | Reference compound |
| HY-141136 | Ac4GlcNAlk | 1361993-37-4 | Reference compound |
| HY-141137 | 2,3,4,6-Tetra-o-acetyl-alpha-galactosylpyranosyl bromide | 529493-92-3 | Reference compound |
| HY-141139 | 1-(Isopropylthio)-2,3,4,6-tetra-o-Ac-beta-D-glucosylpyranose | Reference compound | |
| HY-141140 | 5-Ethynyluridine | 69075-42-9 | Reference compound |
| HY-141141 | Boc-Val-Cit-PAB | 870487-09-5 | ADC Related |
| HY-141142 | Boc-Val-Cit-PAB-PNP | 870487-10-8 | ADC Related |
| HY-141143 | MC(C5)-Val-Cit | 2504147-59-3 | ADC Related |
| HY-141144 | OPSS-Val-Cit-PAB-OH | ADC Related | |
| HY-141145 | OPSS-Val-Cit-PAB-PNP | ADC Related | |
| HY-141146 | Mal-amido-PEG8-val-gly-PAB-OH | 2353409-52-4 | ADC Related |
| HY-141147 | 7-O-(Amino-PEG4)-paclitaxel | Reference compound | |
| HY-141148 | 7-O-(Cbz-N-amido-PEG4)-paclitaxel | Reference compound | |
| HY-141149 | Fmoc-PEG4-Ala-Ala-Asn-PAB | 2055048-57-0 | ADC Related |
| HY-141150 | Azido-PEG5-Ala-Ala-Asn-PAB | 2055048-54-7 | ADC Related |
| HY-141151 | Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB | 2055042-69-6 | ADC Related |
| HY-141152 | Azido-PEG4-Ala-Ala-Asn(Trt)-PAB | 2055042-67-4 | Reference compound |
| HY-141153 | Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP | 2055042-82-3 | Reference compound |
| HY-141154 | Amino-PEG4-Val-Cit-PAB-MMAE | 1492056-71-9 | ADC Related |
| HY-141155 | endo-BCN-PEG4-Val-Cit-PAB-MMAE | 2762519-08-2 | ADC Related |
| HY-141156 | Mal-PEG8-Val-Cit-PAB-MMAE | 2353409-69-3 | ADC Related |
| HY-141158 | N-(Iodoacetamido)-Doxorubicin | 114390-30-6 | ADC Related |
| HY-141159 | TCO-PEG4-acid | 1802913-21-8 | Reference compound |
| HY-141159A | (S)-TCO-PEG4-acid | Reference compound | |
| HY-141159B | (S,E)-TCO2-PEG4-COOH | Reference compound | |
| HY-141160 | TCO-PEG6-acid | 2353409-97-7 | Reference compound |
| HY-141161 | TCO-PEG8-acid | 2353410-03-2 | Reference compound |
| HY-141161A | (S,E)-TCO2-PEG8-acid | Reference compound | |
| HY-141161B | (R,E)-TCO-PEG8-acid | ADC Related | |
| HY-141162 | TCO-PEG12-acid | Reference compound | |
| HY-141163 | TCO-PEG24-acid | Reference compound | |
| HY-141164 | TCO-PEG36-acid | Reference compound | |
| HY-141165 | TCO-NHS ester | 1191901-33-3 | Reference compound |
| HY-141166 | TCO-PEG3-NHS ester | 2141981-88-4 | Reference compound |
| HY-141166A | (S,E)-TCO2-PEG3-NHS ester | Reference compound | |
| HY-141167A | TCO-PEG4-NHS ester | 1621096-79-4 | Reference compound |
| HY-141167B | (S)-TCO-PEG4-NHS ester | ADC Related | |
| HY-141168 | TCO-PEG6-NHS ester | 2353409-96-6 | Reference compound |
| HY-141169 | TCO-PEG8-NHS ester | 2353409-95-5 | Reference compound |
| HY-141169A | (S,E)-TCO2-PEG8-NHS ester | ADC Related | |
| HY-141169B | (R,E)-TCO-PEG8-NHS ester | ADC Related | |
| HY-14117 | Enprofylline | 41078-02-8 | Reference compound |
| HY-141170 | TCO-PEG12-NHS ester | 2185016-39-9 | ADC Related |
| HY-141171 | TCO-PEG24-NHS ester | 2055646-26-7 | Reference compound |
| HY-141172 | TCO-PEG2-Sulfo-NHS ester | 2353409-47-7 | Reference compound |
| HY-141172A | TCO-PEG2-Sulfo-NHS ester (sodium) | Reference compound | |
| HY-141173 | TCO-PEG8-TFP ester | 2353410-06-5 | Reference compound |
| HY-141174 | TCO-PEG12-TFP ester | Reference compound | |
| HY-141175 | TCO-PNB ester | 1438415-89-4 | Reference compound |
| HY-141176 | TCO-amine | 1609736-43-7 | Reference compound |
| HY-141177 | TCO-PEG2-amine | 2141981-87-3 | Reference compound |
| HY-141178 | TCO-PEG3-amine | 1800507-93-0 | Reference compound |
| HY-141178A | (S)-TCO-PEG3-amine | Reference compound | |
| HY-141179 | TCO-PEG4-amine | 2243569-24-4 | Reference compound |
| HY-141180 | TCO-PEG6-amine | 2353409-94-4 | Reference compound |
| HY-141181 | TCO-PEG8-amine | 2353409-92-2 | Reference compound |
| HY-141182 | TCO-C3-PEG3-C3-amine | 2028288-77-7 | Reference compound |
| HY-141183 | TCO-PEG4-biotin | 2183440-30-2 | Reference compound |
| HY-141184 | TCO-PEG9-maleimide | 2183440-37-9 | Reference compound |
| HY-141185 | TCO-PEG3-amide-C3-triethoxysilane | 2250217-32-2 | Reference compound |
| HY-141186 | TCO-OH | 85081-69-2 | Reference compound |
| HY-141186A | (R)-TCO-OH | 39637-78-0 | Reference compound |
| HY-141187 | TCO-PEG3-TCO | 2243569-22-2 | Reference compound |
| HY-141188 | TCO-PEG4-TCO | 2243569-23-3 | Reference compound |
| HY-141189 | TCO-PEG8-TCO | 2353409-67-1 | Reference compound |
| HY-141190 | Gly-Gly-Gly-PEG3-TCO | 2353409-81-9 | ADC Related |
| HY-141191 | N-Boc-PEG5-alcohol | 1404111-67-6 | Reference compound |
| HY-141192 | N-Boc-PEG8-alcohol | 1345337-22-5 | Reference compound |
| HY-141193 | N-Boc-PEG12-alcohol | 2218463-36-4 | Reference compound |
| HY-141194 | N-Boc-PEG16-alcohol | Reference compound | |
| HY-141195 | N-Boc-PEG24-alcohol | Reference compound | |
| HY-141196 | N-Boc-PEG36-alcohol | Reference compound | |
| HY-141197 | N-Boc-PEG23-bromide | 2252157-01-8 | Reference compound |
| HY-141198 | Boc-NH-PEG2-NH-Boc | 475591-59-4 | Reference compound |
| HY-141199 | Bromoacetamido-C2-PEG2-NH-Boc | 182244-33-3 | Reference compound |
| HY-141200 | Bromoacetamido-PEG3-NH-Boc | 1421933-39-2 | Reference compound |
| HY-141201 | m-PEG3-aminooxy-Boc | 1835759-87-9 | Reference compound |
| HY-141202 | Hydroxy-PEG5-Boc | 850090-09-4 | Reference compound |
| HY-141203 | Hydroxy-PEG6-Boc | 361189-64-2 | Reference compound |
| HY-141204 | Hydroxy-PEG7-Boc | 2737223-20-8 | Reference compound |
| HY-141205 | Hydroxy-PEG9-Boc | 2055042-66-3 | Reference compound |
| HY-141206 | Hydroxy-PEG11-Boc | Reference compound | |
| HY-141207 | Hydroxy-PEG20-Boc | Reference compound | |
| HY-141208 | Hydroxy-PEG1-CH2-Boc | 287174-32-7 | Reference compound |
| HY-141209 | Hydroxy-PEG3-CH2-Boc | 518044-31-0 | Reference compound |
| HY-14121 | MRS 1754 | 264622-58-4 | Reference compound |
| HY-141210 | Hydroxy-PEG4-O-Boc | 1807530-05-7 | Reference compound |
| HY-141211 | Hydroxy-PEG6-CH2-Boc | 297162-47-1 | Reference compound |
| HY-141212 | Hydroxy-PEG3-PFP ester | 1807537-40-1 | Reference compound |
| HY-141213 | Bromo-PEG2-alcohol | 57641-66-4 | Reference compound |
| HY-141214 | Bromo-PEG5-alcohol | 957205-14-0 | Reference compound |
| HY-141215 | Bromo-PEG6-alcohol | 136399-05-8 | Reference compound |
| HY-141217 | m-PEG7-alcohol | 4437-01-8 | Reference compound |
| HY-141218 | m-PEG10-alcohol | 27425-92-9 | ADC Related |
| HY-141219 | m-PEG11-OH | 2168540-65-4 | Reference compound |
| HY-141220 | m-PEG12-OH | 2050595-03-2 | ADC Related |
| HY-141221 | m-PEG15-alcohol | 2258654-78-1 | Reference compound |
| HY-141222 | m-PEG16-alcohol | 133604-58-7 | Reference compound |
| HY-141223 | m-PEG19-alcohol | 2412813-38-6 | Reference compound |
| HY-141224 | m-PEG23-alcohol | Reference compound | |
| HY-141225 | m-PEG24-alcohol | 2376450-73-4 | Reference compound |
| HY-141226 | m-PEG36-alcohol | Reference compound | |
| HY-141227 | THP-PEG11-OH | Reference compound | |
| HY-141228 | THP-PEG8-Tos | 669556-37-0 | Reference compound |
| HY-141229 | Methoxy-Tr-NH-PEG7 | 2353409-88-6 | Reference compound |
| HY-141230 | Hexaethylene glycol | 2615-15-8 | Reference compound |
| HY-141231 | Heptaethylene glycol | 5617-32-3 | Reference compound |
| HY-141232 | Decaethylene glycol | 5579-66-8 | Reference compound |
| HY-141233 | Dodecaethylene glycol | 6790-09-6 | Reference compound |
| HY-141234 | HO-PEG13-OH | 17598-96-8 | Reference compound |
| HY-141235 | HO-PEG16-OH | 6812-36-8 | Reference compound |
| HY-141236 | HO-PEG20-OH | 351342-08-0 | Reference compound |
| HY-141237 | HO-PEG21-OH | 928211-42-1 | Reference compound |
| HY-141238 | HO-PEG24-OH | 2243942-52-9 | Reference compound |
| HY-141239 | Hydroxy-PEG1-C2-methyl ester | 93673-82-6 | Reference compound |
| HY-141240 | Hydroxy-PEG2-C2-methyl ester | 457897-73-3 | Reference compound |
| HY-141241 | Hydroxy-PEG3-C2-methyl ester | 2086688-97-1 | Reference compound |
| HY-141242 | Hydroxy-PEG4-C2-methyl ester | 2228857-35-8 | Reference compound |
| HY-141243 | Hydroxy-PEG5-C2-methyl ester | 2100306-80-5 | Reference compound |
| HY-141244 | Hydroxy-PEG3-acrylate | 16695-45-7 | Reference compound |
| HY-141245 | Hydroxy-PEG4-C2-nitrile | 2194563-83-0 | Reference compound |
| HY-141246 | 1-Isothiocyanato-PEG4-alcohol | 1835759-69-7 | Reference compound |
| HY-141247 | 1,1,1-Trifluoroethyl-PEG4-alcohol | 1807512-41-9 | Reference compound |
| HY-141248 | 2-(Azido-PEG2-amido)-1,3-propandiol | 1398044-52-4 | Reference compound |
| HY-141249 | Azido-PEG4-Amido-Tris | 1398044-55-7 | Reference compound |
| HY-141250 | Hydroxy-Amino-bis(PEG1-C2-Boc) | 1415800-34-8 | Reference compound |
| HY-141251 | N-(Hydroxy-PEG3)-N-bis(PEG4-Boc) | 2112734-70-8 | Reference compound |
| HY-141252 | N,N-Diethanol amine-PEG4-Boc | 2279944-66-8 | Reference compound |
| HY-141253 | N-Boc-Tris | 146651-71-0 | Reference compound |
| HY-141254 | N-(Boc-PEG3)-N-bis(PEG2-alcohol) | 2055042-60-7 | Reference compound |
| HY-141255 | Bis-PEG9-PFP ester | 1334170-00-1 | Reference compound |
| HY-141256 | Bis-PEG13-PFP ester | 1383567-59-6 | Reference compound |
| HY-141258 | Bis-PEG25-TFP ester | 2567199-52-2 | Reference compound |
| HY-141259 | C-NH-Boc-C-Bis-(C1-PEG1-PFP) | 1807521-01-2 | Reference compound |
| HY-14126 | BIO-1211 | 187735-94-0 | Peptides |
| HY-141260 | Methyltetrazine-propylamine | 1802978-47-7 | Reference compound |
| HY-141261 | Methyltetrazine-PEG4-amine | 1802908-05-9 | Reference compound |
| HY-141262 | Methyltetrazine-PEG24-amine | 2353410-18-9 | Reference compound |
| HY-141263 | Methyltetrazine-acid | 1380500-88-8 | Reference compound |
| HY-141264 | Methyltetrazine-PEG4-acid | 1802907-91-0 | Reference compound |
| HY-141265 | Methyltetrazine-PEG8-acid | 2183440-33-5 | Reference compound |
| HY-141266 | Methyltetrazine-PEG13-acid | Reference compound | |
| HY-141267 | Methyltetrazine-PEG25-acid | Reference compound | |
| HY-141268 | Methyltetrazine-Sulfo-NHS ester (sodium) | 1821017-46-2 | Reference compound |
| HY-141269 | Methyltetrazine-PEG5-NHS ester | 1802907-92-1 | Reference compound |
| HY-14127 | R121919 | 195055-03-9 | Reference compound |
| HY-141270 | Methyltetrazine-PEG8-NHS ester | 2183440-34-6 | Reference compound |
| HY-141271 | Methyltetrazine-PEG13-NHS ester | Reference compound | |
| HY-141272 | Methyltetrazine-PEG24-NHS ester | Reference compound | |
| HY-141273 | Methyltetrazine-PEG8-PFP ester | 2353409-49-9 | Reference compound |
| HY-141274 | 4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenol | 58884-35-8 | Reference compound |
| HY-141275 | Methyltetrazine-PEG5-alkyne | 1802907-97-6 | Reference compound |
| HY-141276 | Methyltetrazine-amido-PEG5-alkyne | 2322322-23-4 | Reference compound |
| HY-141277 | Methyltetrazine-amido-PEG7-azide | 2112731-46-9 | Reference compound |
| HY-141278 | Methyltetrazine-PEG4-maleimide | 1802908-02-6 | Reference compound |
| HY-141279 | Methyltetrazine-PEG4-NH-Boc | 2194563-84-1 | Reference compound |
| HY-14128 | NBI-34041 | 268545-87-5 | Reference compound |
| HY-141280 | Methyltetrazine-PEG24-NH-Boc | Reference compound | |
| HY-141281 | Methyltetrazine-PEG13-Boc | Reference compound | |
| HY-141282 | Methyltetrazine-PEG24-Boc | Reference compound | |
| HY-141283 | Methyltetrazine-PEG5-triethoxysilane | 2353410-01-0 | Reference compound |
| HY-141284 | Gly-Gly-Gly-PEG4-methyltetrazine | 2353409-82-0 | ADC Related |
| HY-141285 | TAMRA-PEG4-tetrazine | Dye Reagents | |
| HY-141286 | TAMRA-PEG4-methyltetrazine | 2163772-19-6 | Dye Reagents |
| HY-141287 | N-(Azido-PEG3)-N-(PEG2-NH-Boc)-PEG3-acid | 2183440-74-4 | Reference compound |
| HY-141288 | N-(Biotin-PEG4)-N-bis(PEG4-Boc) | 2112730-79-5 | Reference compound |
| HY-141289 | N-(Propanoic acid)-N-bis(m-PEG12) | Reference compound | |
| HY-14129 | CP 316311 | 175139-41-0 | Reference compound |
| HY-141290 | Bis-(m-PEG8-amido)-hexanoic acid | 2353409-77-3 | Reference compound |
| HY-141291 | N'-Boc-N-(Gly-Oleoyl)-Lys | 2353409-71-7 | Reference compound |
| HY-141292 | Oleoyl-Gly-Lys-N-(m-PEG11) | ADC Related | |
| HY-141293 | Oleic-DBCO | 2279951-78-7 | Reference compound |
| HY-141294 | PEG3-bis(phosphonic acid) | 254762-10-2 | Reference compound |
| HY-141295 | PEG3-bis-(ethyl phosphonate) | 160625-24-1 | Reference compound |
| HY-141296 | PEG5-bis-(Ethyl phosphonate) | 1446282-28-5 | Reference compound |
| HY-141297 | Bromo-PEG2-phosphonic acid | 1446282-44-5 | Reference compound |
| HY-141298 | Bromo-PEG5-phosphonic acid | 1446282-37-6 | Reference compound |
| HY-141299 | Bromo-PEG2-phosphonic acid diethyl ester | 1226767-94-7 | Reference compound |
| HY-14130 | CP 376395 | 175140-00-8 | Reference compound |
| HY-141300 | Bromo-PEG3-phosphonic acid diethyl ester | 1148026-98-5 | Reference compound |
| HY-141301 | Bromo-PEG5-phosphonic acid diethyl ester | 1446282-41-2 | Reference compound |
| HY-141302 | Carboxy-PEG4-phosphonic acid | 1623791-69-4 | Reference compound |
| HY-141303 | Carboxy-PEG4-phosphonic acid ethyl ester | 1964503-39-6 | Reference compound |
| HY-141304 | Boc-PEG4-phosphonic acid ethyl ester | 1623791-77-4 | Reference compound |
| HY-141305 | Diethoxy-phosphorylethyl-PEG5-ethylphosphonic acid | 1446282-17-2 | Reference compound |
| HY-141306 | m-PEG2-phosphonic acid | 96962-41-3 | Reference compound |
| HY-141307 | m-PEG4-phosphonic acid | 1872433-62-9 | Reference compound |
| HY-141308 | m-PEG5-phosphonic acid | 1807512-39-5 | Reference compound |
| HY-141309 | m-PEG4-(CH2)6-Phosphonic acid | 2028281-85-6 | Reference compound |
| HY-141310 | m-PEG6-(CH2)6-Phosphonic acid | 2028284-71-9 | Reference compound |
| HY-141311 | m-PEG4-phosphonic acid ethyl ester | 1872433-73-2 | Reference compound |
| HY-141312 | m-PEG5-phosphonic acid ethyl ester | 1807512-42-0 | Reference compound |
| HY-141313 | m-PEG9-phosphonic acid ethyl ester | 2699881-07-5 | Reference compound |
| HY-141314 | m-PEG4-C6-phosphonic acid ethyl ester | 2028281-89-0 | Reference compound |
| HY-141315 | m-PEG6-C6-phosphonic acid ethyl ester | 2028281-88-9 | Reference compound |
| HY-141316 | m-PEG8-(CH2)12-phosphonic acid ethyl ester | 2112737-70-7 | Reference compound |
| HY-141317 | S-acetyl-PEG3-phosphonic acid ethyl ester | 2173125-29-4 | Reference compound |
| HY-141318 | Thiol-PEG3-phosphonic acid | 1360716-36-4 | Reference compound |
| HY-141319 | Thiol-PEG3-phosphonic acid ethyl ester | 1360716-43-3 | Reference compound |
| HY-14132 | BMS-665053 | 1173435-64-7 | Reference compound |
| HY-141320 | PEG2-bis(phosphonic acid diethyl ester) | 500347-73-9 | Reference compound |
| HY-141321 | PEG3-bis(phosphonic acid diethyl ester) | 1807539-03-2 | Reference compound |
| HY-141322 | PEG4-bis(phosphonic acid diethyl ester) | 106338-06-1 | Reference compound |
| HY-141323 | C2-Bis-phosphoramidic acid diethyl ester | 34008-16-7 | Reference compound |
| HY-141324 | Tetraethyl butane-1,4-diylbis(phosphoramidate) | 720707-93-7 | Reference compound |
| HY-141325 | C6-Bis-phosphoramidic acid diethyl ester | 1446282-35-4 | Reference compound |
| HY-141326 | Thiol-PEG12-acid | 2211174-73-9 | Reference compound |
| HY-141327 | Thiol-PEG3-Boc | 1446282-39-8 | Reference compound |
| HY-141328 | Thiol-PEG4-Boc | 564476-33-1 | Reference compound |
| HY-141329 | m-PEG6-thiol | 441771-60-4 | Reference compound |
| HY-141330 | m-PEG8-thiol | 651042-83-0 | Reference compound |
| HY-141331 | m-PEG12-Thiol | 2413368-61-1 | Reference compound |
| HY-141332 | Lipoamido-PEG4-acid | 1314378-10-3 | Reference compound |
| HY-141333 | Lipoamido-PEG8-acid | 1334172-70-1 | Reference compound |
| HY-141334 | Lipoamido-PEG12-acid | 2407442-47-9 | Reference compound |
| HY-141335 | Lipoamido-PEG24-acid | Reference compound | |
| HY-141336 | α-Lipoic acid-NHS | 40846-94-4 | Reference compound |
| HY-141337 | Lipoamido-PEG2-OH | 1674386-82-3 | Reference compound |
| HY-141338 | Lipoamide-PEG3-Mal | 1314378-19-2 | Reference compound |
| HY-141339 | Lipoamide-PEG11-Mal | Reference compound | |
| HY-14134 | BMS-378806 | 357263-13-9 | Reference compound |
| HY-141340 | S-acetyl-PEG3-alcohol | 153870-20-3 | Reference compound |
| HY-141341 | S-acetyl-PEG4-alcohol | 223611-42-5 | Reference compound |
| HY-141342 | S-acetyl-PEG12-alcohol | Reference compound | |
| HY-141343 | S-acetyl-PEG16-alcohol | Reference compound | |
| HY-141344 | S-acetyl-PEG20-alcohol | Reference compound | |
| HY-141345 | S-acetyl-PEG2-Boc | 1820641-93-7 | Reference compound |
| HY-141346 | S-acetyl-PEG3-Boc | 1818294-27-7 | Reference compound |
| HY-141347 | S-acetyl-PEG4-Boc | 1818294-26-6 | Reference compound |
| HY-141348 | S-acetyl-PEG6-Boc | 1818294-39-1 | Reference compound |
| HY-141349 | S-Acetyl-PEG3-C2-acid | 1421933-33-6 | Reference compound |
| HY-14135 | BMS 488043 | 452296-83-2 | Reference compound |
| HY-141350 | S-acetyl-PEG4-propargyl | 1422540-88-2 | Reference compound |
| HY-141351 | m-PEG3-S-Acetyl | 857284-78-7 | Reference compound |
| HY-141352 | SPDP-PEG4-acid | 581065-97-6 | Reference compound |
| HY-141353 | SPDP-PEG12-acid | ADC Related | |
| HY-141354 | SPDP-PEG24-acid | Reference compound | |
| HY-141355 | OPSS-PEG36-acid | ADC Related | |
| HY-141356 | SPDP-PEG12-NHS ester | 2601437-72-1 | Reference compound |
| HY-141357 | SPDP-PEG24-NHS ester | Reference compound | |
| HY-141358 | SPDP-PEG36-NHS ester | ADC Related | |
| HY-141359 | (2-Pyridyldithio)-PEG4-alcohol | 851961-99-4 | Reference compound |
| HY-14136 | Rimonabant | 168273-06-1 | Reference compound |
| HY-141360 | (2-Pyridyldithio)-PEG4-propargyl | 2170240-99-8 | Reference compound |
| HY-141361 | (2-Pyridyldithio)-PEG2-Boc | 2144777-73-9 | Reference compound |
| HY-141362 | Bromo-PEG2-C2-acid | 1807503-92-9 | Reference compound |
| HY-141363 | Bromo-PEG4-acid | 1393330-38-5 | Reference compound |
| HY-141364 | Bromo-PEG1-C2-Boc | 1393330-36-3 | Reference compound |
| HY-141365 | Bromo-PEG2-C2-Boc | 1381861-91-1 | Reference compound |
| HY-141366 | Bromo-PEG5-Boc | 1415800-38-2 | Reference compound |
| HY-141367 | Bromo-PEG6-Boc | 1393330-41-0 | Reference compound |
| HY-141368 | Bromo-PEG8-Boc | 1623792-00-6 | Reference compound |
| HY-141369 | Bromo-PEG24-Boc | Reference compound | |
| HY-14136S | Rimonabant-d10 | 929221-88-5 | Isotope-Labeled Compounds |
| HY-14137 | Rimonabant (Hydrochloride) | 158681-13-1 | Reference compound |
| HY-141370 | Bromo-PEG1-CH2-Boc | 157759-50-7 | Reference compound |
| HY-141371 | Bromo-PEG2-CH2-Boc | 1807518-63-3 | Reference compound |
| HY-141372 | Bromo-PEG3-CH2-Boc | 2100306-71-4 | Reference compound |
| HY-141373 | Bromo-PEG3-bromide | 31255-26-2 | Reference compound |
| HY-141374 | Bromo-PEG5-bromide | 67705-77-5 | Reference compound |
| HY-141375 | m-PEG5-Br | 854601-80-2 | Reference compound |
| HY-141376 | m-PEG6-Br | 125562-29-0 | Reference compound |
| HY-141377 | m-PEG9-Br | 125562-30-3 | Reference compound |
| HY-141378 | m-PEG12-Br | 1620461-89-3 | Reference compound |
| HY-141379 | N-Bromoacetyl-β-alanine | 89520-11-6 | ADC Related |
| HY-14137R | Rimonabant (Hydrochloride) (Standard) | 158681-13-1 | Reference Standards |
| HY-14137S | Rimonabant-d10 (hydrochloride) | 1044909-61-6 | Isotope-Labeled Compounds |
| HY-141380 | Bromoacetamido-PEG2-C2-acid | 1415800-44-0 | Reference compound |
| HY-141381 | Bromoacetamido-PEG3-C2-acid | 1807534-79-7 | Reference compound |
| HY-141382 | Bromoacetamido-PEG4-acid | 1807518-67-7 | ADC Related |
| HY-141383 | Bromoacetamido-PEG8-acid | 1698019-89-4 | Reference compound |
| HY-141384 | 2-Bromo-2,2-dimethyl-acetamido-PEG3-acid | 2279944-67-9 | Reference compound |
| HY-141385 | N-Succinimidyl 3-(Bromoacetamido)propionate | 57159-62-3 | ADC Related |
| HY-141386 | Bromoacetamido-PEG2-C2-NHS ester | 1353011-78-5 | Reference compound |
| HY-141387 | Bromoacetamido-PEG4-NHS ester | 1260139-70-5 | Reference compound |
| HY-141388 | Bromoacetamido-PEG3-C2-Boc | 1807537-33-2 | Reference compound |
| HY-141389 | Bromoacetamido-PEG8-Boc | 2055041-16-0 | Reference compound |
| HY-141390 | Bromoacetamido-PEG9-ethylcarbamoyl-C4-Boc | Reference compound | |
| HY-141391 | Bromoacetamido-PEG9-ethylcarbamoyl-C8-Boc | Reference compound | |
| HY-141392 | Bromoacetamido-PEG9-ethylcarbamoyl-C12-Boc | Reference compound | |
| HY-141393 | Bis-Bromoacetamido-PEG11 | Reference compound | |
| HY-141394 | Chloroacetamido-PEG4-NHS ester | 1353011-95-6 | Reference compound |
| HY-141395 | m-PEG4-Boc | 883554-11-8 | ADC Related |
| HY-141396 | m-PEG5-Boc | 874208-93-2 | Reference compound |
| HY-141397 | m-PEG8-T-Butyl ester | 2768015-32-1 | Reference compound |
| HY-141398 | m-PEG9-t-Butyl ester | 2768015-30-9 | Reference compound |
| HY-141399 | m-PEG10-T-Butyl ester | 2768015-31-0 | Reference compound |
| HY-141400 | m-PEG12-Boc | Reference compound | |
| HY-141401 | m-PEG13-Boc | Reference compound | |
| HY-141402 | m-PEG4-Hydrazide | 1449390-68-4 | Reference compound |
| HY-141403 | m-PEG37-hydrazide | Reference compound | |
| HY-141404 | m-PEG4-CH2-methyl ester | 1920109-55-2 | Reference compound |
| HY-141405 | m-PEG7-4-nitrophenyl carbonate | 678150-56-6 | Reference compound |
| HY-141406 | m-PEG5-2-methylacrylate | 48074-75-5 | Reference compound |
| HY-141407 | m-PEG3-amido-C3-triethoxysilane | 2243566-45-0 | Reference compound |
| HY-141408 | m-PEG5-triethoxysilane | 2243566-42-7 | Reference compound |
| HY-141410 | Fluticasone dimer impurity | 220589-37-7 | Reference compound |
| HY-141411 | (Rac)-Zevaquenabant | 1610420-28-4 | Reference compound |
| HY-141411A | Zevaquenabant | 1998760-00-1 | Reference compound |
| HY-141411B | (R)-Zevaquenabant | Reference compound | |
| HY-141412 | D-(-)-3-Phosphoglyceric acid (disodium) | 80731-10-8 | Reference compound |
| HY-141413 | Benzyl 2,3-Di-O-benzyl-4-O-benzoyl-β-D-galactopyranoside | 57783-81-0 | Biochemical Assay Reagents |
| HY-141415 | Tween 20 | 9005-64-5 | Biochemical Assay Reagents |
| HY-141420 | PtdIns-(3,4,5)-P3(1,2-dihexanoyl) (ammonium) | 799268-62-5 | Biochemical Assay Reagents |
| HY-141422A | 4,4-Diphenylbutylamine (hydrochloride) | 22101-90-2 | Reference compound |
| HY-141423 | Thalidomide-O-amide-C5-NH2 | 2360527-40-6 | Reference compound |
| HY-141423A | Thalidomide-O-amide-C5-NH2 (TFA) | 2748161-83-1 | Reference compound |
| HY-141425 | NSC73306 | 79560-74-0 | Reference compound |
| HY-141426 | MDL-860 | 78940-62-2 | Reference compound |
| HY-141427 | MOCPAC | 787549-26-2 | Reference compound |
| HY-141429 | AS-99 (free base) | 2323623-93-2 | Reference compound |
| HY-141429A | AS-99 (TFA) | Reference compound | |
| HY-141429C | AS-99 | Reference compound | |
| HY-141430 | AS-85 | 2323623-80-7 | Reference compound |
| HY-141431 | Cbl-b-IN-2 | 2503325-21-9 | Reference compound |
| HY-141432 | NX-1607 | 2573775-59-2 | Reference compound |
| HY-141432G | NX-1607 (GMP) | 2573775-59-2 | GMP Small Molecules |
| HY-141434 | 5-OxoETE methyl ester | 74785-00-5 | Reference compound |
| HY-141436 | Sucrosofate (potassium) | 73264-44-5 | Reference compound |
| HY-141436R | Sucrosofate (potassium) (Standard) | 73264-44-5 | Reference Standards |
| HY-141438 | SIM1 | 2719051-84-8 | Reference compound |
| HY-141438A | cis-SIM1 | 2719051-98-4 | Reference compound |
| HY-141439 | TBE 31 | 936475-62-6 | Reference compound |
| HY-14144 | Aclidinium (Bromide) | 320345-99-1 | Reference compound |
| HY-141441 | Novobiocic acid | 485-23-4 | Reference compound |
| HY-141442 | Dihydronovobiocin | 29826-16-2 | Natural Products |
| HY-141445 | MNP-Glc | 70622-80-9 | Biochemical Assay Reagents |
| HY-141447 | Z-LYS-SBZL (monohydrochloride) | 69861-89-8 | Peptides |
| HY-141448 | NRX-2663 | 2763260-34-8 | Reference compound |
| HY-141449 | NRX-103094 | 2763260-36-0 | Reference compound |
| HY-14144R | Aclidinium (Bromide) (Standard) | 320345-99-1 | Reference Standards |
| HY-141450 | NRX-103095 | 2763260-38-2 | Reference compound |
| HY-141453 | Desmethyl-WEHI-345 analog | 1354825-03-8 | Reference compound |
| HY-141454 | TLR8 agonist 2 | 2412937-64-3 | Reference compound |
| HY-141454A | TLR8 agonist 2 (hydrochloride) | 2412937-65-4 | Reference compound |
| HY-141459 | Squamolone | 40451-67-0 | Natural Products |
| HY-141464 | Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH | 131287-39-3 | Reference compound |
| HY-141465 | 3-Hydroxybutyryl-CoA | 2871-66-1 | Enzyme |
| HY-141466 | Crotonyl-CoA | 992-67-6 | Reference compound |
| HY-141466A | Crotonyl-CoA (tetrasodium) | Natural Products | |
| HY-141467 | Propionyl CoA | 317-66-8 | Enzyme |
| HY-141468 | β-Chlornaltrexamine (dihydrochloride) | 67025-98-3 | Reference compound |
| HY-141469 | 6,9,12,15,18-Heneicosapentaenoic acid | 65919-53-1 | Reference compound |
| HY-14147 | Renzapride | 112727-80-7 | Reference compound |
| HY-141472 | 7-Methylguanosine 5'-diphosphate (sodium) | 104809-16-7 | Reference compound |
| HY-141473 | Malonyl CoA (tetralithium) | 116928-84-8 | Enzyme |
| HY-141474 | Glutaryl coenzyme A (lithium) | 103192-48-9 | Biochemical Assay Reagents |
| HY-141475 | Acetoacetyl coenzyme A (sodium) | 102029-52-7 | Reference compound |
| HY-141476 | PI3K/mTOR Inhibitor-3 | 1363338-53-7 | Reference compound |
| HY-141477 | RM-018 | 2641993-55-5 | Reference compound |
| HY-141478 | Antitumor agent-28 | 2097499-67-5 | Reference compound |
| HY-141479A | Butyryl-Coenzyme A (trisodium) | Enzyme | |
| HY-141479B | Butyryl-Coenzyme A (lithium hydrate) | 1107039-35-9 | Enzyme |
| HY-14147A | (S)-Renzapride | Reference compound | |
| HY-14148 | Renzapride (hydrochloride) | 109872-41-5 | Reference compound |
| HY-141480 | GSK-3β inhibitor 3 | 1448990-73-5 | Reference compound |
| HY-141481 | DP-C-4 | Reference compound | |
| HY-141482 | WSB1 Degrader 1 | 2306039-66-5 | Reference compound |
| HY-141483 | DEAE Cross-linked dextran A 50 | 39455-31-7 | Biochemical Assay Reagents |
| HY-141486 | (Rac)-PROTAC PARP/EGFR ligand 1 | 2935073-36-0 | Reference compound |
| HY-141486A | PROTAC PARP/EGFR ligand 1 | 2661609-57-8 | Reference compound |
| HY-141487 | CLP-3094 | 312749-73-8 | Reference compound |
| HY-141488 | Lacto-N-biose I | 50787-09-2 | Natural Products |
| HY-14149 | Cisapride | 81098-60-4 | Reference compound |
| HY-141490 | Beta-D-Glucopyranosyl nitromethane | 81846-60-8 | Reference compound |
| HY-141494 | Pparδ agonist 5 | Reference compound | |
| HY-141495 | (Rac)-Razpipadon | 1643462-93-4 | Reference compound |
| HY-141495A | Razpipadon | 1643489-35-3 | Reference compound |
| HY-141496 | A-77636 | 778546-51-3 | Reference compound |
| HY-14149A | Cisapride (monohydrate) | 260779-88-2 | Reference compound |
| HY-14149R | Cisapride (Standard) | 81098-60-4 | Reference Standards |
| HY-14149S | Cisapride-d6 | 2738376-71-9 | Isotope-Labeled Compounds |
| HY-141508 | Flazin | 100041-05-2 | Natural Products |
| HY-14151 | Prucalopride | 179474-81-8 | Reference compound |
| HY-141510 | myo-Inositol trispyrophosphate (hexasodium) | 23103-35-7 | Reference compound |
| HY-141510A | myo-Inositol trispyrophosphate (hexa-triethylamine) | 851086-77-6 | Reference compound |
| HY-141511 | Coppersensor 1 | 874748-20-6 | Dye Reagents |
| HY-141512 | JB170 | 2705844-82-0 | Reference compound |
| HY-141513 | NH-3 | 447415-26-1 | Reference compound |
| HY-141514 | MSA-2 dimer | 2377881-92-8 | Reference compound |
| HY-141515 | BMS-986121 | 313671-26-0 | Reference compound |
| HY-141519 | PI-55 | 1122579-42-3 | Reference compound |
| HY-14151R | Prucalopride (Standard) | 179474-81-8 | Reference Standards |
| HY-14151S | Prucalopride-13C,d3 | 2140306-00-7 | Isotope-Labeled Compounds |
| HY-14152 | Prucalopride (hydrochloride) | 179474-80-7 | Reference compound |
| HY-141520 | ART558 | 2603528-97-6 | Reference compound |
| HY-141521 | Amelenodor | 2389235-01-0 | Reference compound |
| HY-141522 | Cross-linked dextran G 100 | 9050-94-6 | Biochemical Assay Reagents |
| HY-141522A | Cross-linked dextran G 100, coarse | 9050-94-6 | Biochemical Assay Reagents |
| HY-141523 | Vociprotafib | 2172652-48-9 | Reference compound |
| HY-141524 | RMC-3943 | 1801764-60-2 | Reference compound |
| HY-141525 | SCD1 inhibitor-4 | 1295541-87-5 | Reference compound |
| HY-141526 | O-Methyl-D-tyrosine | 39878-65-4 | Peptides |
| HY-14153 | Tegaserod | 145158-71-0 | Reference compound |
| HY-141530 | Clopidogrel-β-D-glucuronide | 1314116-53-4 | Reference compound |
| HY-141532 | D-Erythritol 4-phosphate | 7183-41-7 | Reference compound |
| HY-141535 | IL-17 modulator 1 | 2446803-85-4 | Reference compound |
| HY-141535A | IL-17 modulator 1 (disodium) | 2446803-91-2 | Reference compound |
| HY-141536 | PSMA-ALB-56 | 2306049-48-7 | ADC Related |
| HY-141537 | ABR-238901 | 1638200-22-2 | Reference compound |
| HY-141539 | SETDB1-TTD-IN-1 | 2755823-12-0 | Reference compound |
| HY-141539A | SETDB1-TTD-IN-1 (TFA) | Reference compound | |
| HY-14153A | Tegaserod (maleate) | 189188-57-6 | Reference compound |
| HY-14153AS | Tegaserod-13C,d3 (maleate) | Isotope-Labeled Compounds | |
| HY-14153S | Tegaserod-d11 | 1134188-56-9 | Isotope-Labeled Compounds |
| HY-14154 | THRX-194556 | 886579-13-1 | Reference compound |
| HY-141540 | Lactyl-CoA | 1926-57-4 | Reference compound |
| HY-141543 | YW2065 | 2131223-85-1 | Reference compound |
| HY-141546 | Pocenbrodib | 2304372-79-8 | Reference compound |
| HY-141547 | Nav1.7-IN-8 | 1432913-44-4 | Reference compound |
| HY-141549 | BPK-21 | 2305052-77-9 | Reference compound |
| HY-14155 | MMP145 | 1025717-75-2 | Reference compound |
| HY-141550 | BPK-25 | 2305052-86-0 | Reference compound |
| HY-141551 | GNE-274 | 2369048-69-9 | Reference compound |
| HY-141551B | (R)-GNE-274 | Reference compound | |
| HY-141552 | FC9402 | 2452401-65-7 | Reference compound |
| HY-141553 | Methyl alpha-eleostearate | 4175-47-7 | Biochemical Assay Reagents |
| HY-141554 | Dihydrotetrabenazine | 3466-75-9 | Reference compound |
| HY-141555 | 5,5′-(1,3-Propanediyl)bis-1,3,4-oxadiazole-2(3H)-thione | 333409-31-7 | Reference compound |
| HY-14156 | 11β-HSD1-IN-15 | 946398-78-3 | Reference compound |
| HY-141566 | EZH2-IN-5 | 1403258-69-4 | Reference compound |
| HY-141567 | Pseudouridine 5'-triphosphate | 1175-34-4 | Oligonucleotides |
| HY-141567A | Pseudouridine 5'-triphosphate (trisodium) solution (100mM) | Oligonucleotides | |
| HY-141569 | Ganglioside GD1a | 12707-58-3 | Natural Products |
| HY-14157 | ADL-5747 | 850176-30-6 | Reference compound |
| HY-141570 | Lyso-PAF C-16 | 52691-62-0 | Reference compound |
| HY-141570S | Lyso-PAF C-16-d4 | 201216-37-7 | Isotope-Labeled Compounds |
| HY-141571 | DOPG (sodium) | 67254-28-8 | Biochemical Assay Reagents |
| HY-141572 | 1,2-Dioleoyl-sn-glycerol | 24529-88-2 | Biochemical Assay Reagents |
| HY-141573 | Oleyl alcohol | 143-28-2 | Reference compound |
| HY-141574 | 1,2-Didecanoyl-Sn-glycerol | 60514-49-0 | Reference compound |
| HY-141575 | C12-NBD-ceramide | 202850-01-9 | Dye Reagents |
| HY-141576 | C6-NBD Sphinganine | 114301-97-2 | Dye Reagents |
| HY-141577 | C12-NBD Sphinganine | 474943-05-0 | Dye Reagents |
| HY-141578 | C18:1-Ceramide | 5966-28-9 | Reference compound |
| HY-141578S | C18:1-Ceramide-13C18 | Isotope-Labeled Compounds | |
| HY-141578S1 | C18:1 Ceramide-d7 | 1942907-50-7 | Isotope-Labeled Compounds |
| HY-141579 | Sphingosine (d17:1) | 6918-48-5 | Natural Products |
| HY-14157A | ADL-5747 (hydrochloride) | 1187653-56-0 | Reference compound |
| HY-141580 | C18 Dihydroceramide | 2304-80-5 | Natural Products |
| HY-141580S | C18 Dihydroceramide-d3 | 2692624-27-2 | Isotope-Labeled Compounds |
| HY-141580S1 | C18 Dihydroceramide-d3-1 | 2699606-99-8 | Isotope-Labeled Compounds |
| HY-141581 | Lyso-PAF C-18 | 74430-89-0 | Reference compound |
| HY-141581S | Lyso-PAF C-18-d4 | Isotope-Labeled Compounds | |
| HY-141582 | Ceramide 3 | 34354-88-6 | Biochemical Assay Reagents |
| HY-141582S | Ceramide 3-d3 | 1354806-91-9 | Isotope-Labeled Compounds |
| HY-141584 | ATSP-7041 | 1451197-99-1 | Peptides |
| HY-141591 | CYT296 | 1799392-31-6 | Reference compound |
| HY-141593 | Modified MMAF-C5-COOH | 1404071-65-3 | ADC Related |
| HY-141594 | Modified MMAF | 1352202-47-1 | Reference compound |
| HY-141596 | Lys-Nε-SPDB-DM4 | 1280215-91-9 | ADC Related |
| HY-141597 | Acid-C3-SSPy | 250266-79-6 | ADC Related |
| HY-141598 | Datopotamab deruxtecan | 2238831-60-0 | ADC Related |
| HY-14160 | CB2 receptor agonist 7 | 871819-90-8 | Reference compound |
| HY-141600 | Aprutumab ixadotin | 1708947-48-1 | Reference compound |
| HY-141601 | Telisotuzumab vedotin | 1714088-51-3 | ADC Related |
| HY-141602 | Pinatuzumab vedotin | 1313706-14-7 | Reference compound |
| HY-141604 | Glembatumumab vedotin | 1182215-65-1 | Reference compound |
| HY-141606 | Anetumab ravtansine | 1375258-01-7 | Reference compound |
| HY-141607 | Indatuximab ravtansine | 1238517-16-2 | ADC Related |
| HY-141609 | IK-175 | 2247950-42-9 | Reference compound |
| HY-141610 | Methyl heptanoate | 106-73-0 | Biochemical Assay Reagents |
| HY-141612 | Pyrrolidino PAF C-16 | 91021-63-5 | Reference compound |
| HY-141613 | 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium) | 90693-88-2 | Oligonucleotides |
| HY-141613A | Dioleyl phosphatidylserine | 6811-55-8 | Reference compound |
| HY-141614 | 1,2-Diarachidoyl-sn-glycero-3-phosphocholine | 61596-53-0 | Biochemical Assay Reagents |
| HY-141615 | 1,2-Dipalmitoyl-sn-glycero-3-phospho-N,N-dimethylethanolamine | 3922-61-0 | Biochemical Assay Reagents |
| HY-141616 | 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine | 50930-23-9 | Natural Products |
| HY-141616S | 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine-d5 | 2342575-12-4 | Isotope-Labeled Compounds |
| HY-141617 | 1-Palmitoyl-2-hydroxy-sn-glycero-3-PE | 53862-35-4 | Reference compound |
| HY-141617S | 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PE | 2747981-09-3 | Isotope-Labeled Compounds |
| HY-141619 | Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:5) | 8064-90-2 | Reference compound |
| HY-141619A | Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:19) | 8064-90-2 | Reference compound |
| HY-14162 | AM103 (free acid) | 936349-47-2 | Reference compound |
| HY-141621 | ACT-606559 | Reference compound | |
| HY-141622 | SDZ 224-015 | 161511-45-1 | Reference compound |
| HY-141623 | SRI-37330 (hydrochloride) | 2322245-49-6 | Reference compound |
| HY-141625 | TRC160334 | 1293289-69-6 | Reference compound |
| HY-141625A | TRC160334 (sodium) | 1293290-41-1 | Reference compound |
| HY-141626S | 6β-Hydroxytestosterone-d7 | Isotope-Labeled Compounds | |
| HY-141627 | Heparin disaccharide I-S (tetrasodium) | 136098-10-7 | Biochemical Assay Reagents |
| HY-141629 | N-Palmitoyl-D-sphingomyelin | 6254-89-3 | Reference compound |
| HY-141629S | N-Palmitoyl-D-sphingomyelin-d31 | 807617-46-5 | Isotope-Labeled Compounds |
| HY-141629S1 | N-Palmitoyl-D-sphingomyelin-13C | 144236-99-7 | Isotope-Labeled Compounds |
| HY-141629S2 | N-Palmitoyl-D-sphingomyelin-d9 | 2415226-88-7 | Isotope-Labeled Compounds |
| HY-14163 | AM103 | 1147872-22-7 | Reference compound |
| HY-141630 | Sphingosine-1-phosphate (d17:1) | 474923-27-8 | Reference compound |
| HY-141631 | Dihomo-γ-Linolenoyl PAF C-16 | 155575-01-2 | Biochemical Assay Reagents |
| HY-141632 | Sphinganine-C17 | 32164-02-6 | Reference compound |
| HY-141633 | Sucrose, monolaurate | 25339-99-5 | Biochemical Assay Reagents |
| HY-141634 | Methyl octacosanoate | 55682-92-3 | Biochemical Assay Reagents |
| HY-141635 | cis-11,14-Eicosadienoic acid methyl ester | 61012-46-2 | Reference compound |
| HY-141636 | 1-PalMitoyl-2-arachidoyllecithin | 35418-58-7 | Biochemical Assay Reagents |
| HY-141636S | 1-PalMitoyl-2-arachidoyllecithin-d9-1 | 1872379-11-7 | Isotope-Labeled Compounds |
| HY-141637 | 2-Deoxy-2-fluoro-D-glucose | 29702-43-0 | Biochemical Assay Reagents |
| HY-141637S | 2-Deoxy-2-fluoro-D-glucose-13C | 478518-95-5 | Isotope-Labeled Compounds |
| HY-141637S1 | 2-Deoxy-2-fluoro-D-glucose-13C,d7 | Isotope-Labeled Compounds | |
| HY-141638 | Me-IQ | 77094-11-2 | Reference compound |
| HY-141639 | 3-Hydroxyheptadecanoic acid | 40165-89-7 | Reference compound |
| HY-14164 | Zileuton | 111406-87-2 | Reference compound |
| HY-141640 | MS154 | 2550393-21-8 | Reference compound |
| HY-141641 | N-(3-Oxopentanoyl)-L-homoserine lactone | 148433-21-0 | Reference compound |
| HY-141642 | Triheptadecanoin | 2438-40-6 | Reference compound |
| HY-141642S | Triheptadecanoin-d5 | 944795-74-8 | Isotope-Labeled Compounds |
| HY-141644 | PY-60 | 2765218-56-0 | Reference compound |
| HY-141645 | IMM-H007 | 1221412-23-2 | Reference compound |
| HY-141646 | MIT-PZR | 2376848-06-3 | Dye Reagents |
| HY-141647 | [18F]-Labeled L-dopa precursor | 1614253-58-5 | Reference compound |
| HY-141648 | Antibacterial agent 219 | 1649473-91-5 | Reference compound |
| HY-141649 | Anticancer agent 251 | 1648546-79-5 | Reference compound |
| HY-14164A | Zileuton (sodium) | 118569-21-4 | Reference compound |
| HY-14164R | Zileuton (Standard) | 111406-87-2 | Reference Standards |
| HY-14164S | Zileuton-d4 | 1189878-76-9 | Isotope-Labeled Compounds |
| HY-14164S1 | Zileuton-13C2,15N | Isotope-Labeled Compounds | |
| HY-14165 | Veliflapon | 128253-31-6 | Reference compound |
| HY-141651 | (S,R,S)-AHPC-C3-COOH | 2172819-73-5 | Reference compound |
| HY-141652 | N-2-Azidoethyl betulonamide | 2055270-64-7 | Reference compound |
| HY-141653 | MK-8666 (tromethamine) | 2056254-98-7 | Reference compound |
| HY-141659 | CMPD-39 | 2242582-40-5 | Reference compound |
| HY-14165A | (S)-Veliflapon | 128253-32-7 | Reference compound |
| HY-14166 | MK-886 | 118414-82-7 | Reference compound |
| HY-141660 | BSc3094 | 946857-84-7 | Reference compound |
| HY-141661 | Aβ/tau aggregation-IN-1 | 2252162-81-3 | Reference compound |
| HY-141662 | 2',3'-cGAMP-C2-PPA | 2586047-11-0 | ADC Related |
| HY-141663 | 2',3'-cGAMP-C2-SH | 2133823-39-7 | ADC Related |
| HY-141664 | PPA | 452072-22-9 | ADC Related |
| HY-141666 | MYC-IN-2 | 2244979-61-9 | Reference compound |
| HY-141667 | MBD | 33984-50-8 | Dye Reagents |
| HY-141668 | BCAT-IN-1 | 1875078-61-7 | Reference compound |
| HY-141669 | BCAT-IN-2 | 1800024-45-6 | Reference compound |
| HY-14166A | MK-886 (sodium salt) | 118427-55-7 | Reference compound |
| HY-14167 | GW842166X | 666260-75-9 | Reference compound |
| HY-141672 | 17β-Estradiol sulfate (sodium) | 4999-79-5 | Reference compound |
| HY-141672S1 | 17β-Estradiol sulfate-d4 (sodium) | 352431-50-6 | Isotope-Labeled Compounds |
| HY-141674 | DMG-PEG | 1397695-86-1 | Biochemical Assay Reagents |
| HY-141675 | Geranyl monophosphate | 1609182-56-0 | Natural Products |
| HY-141676 | HyT36 | 1323151-45-6 | Reference compound |
| HY-141677 | INCB059872 | 1802909-49-4 | Reference compound |
| HY-141677A | INCB059872 (dihydrochloride) | Reference compound | |
| HY-141677B | INCB059872 (tosylate) | 2081940-67-0 | Reference compound |
| HY-141680 | CPS2 | 2756741-90-7 | Reference compound |
| HY-141685 | 3-Methylthienyl-carbonyl-JNJ-7706621 | 443798-09-2 | Reference compound |
| HY-141687 | NSC 107512 | 22242-89-3 | Reference compound |
| HY-141689 | BTK-IN-3 | 1226872-27-0 | Reference compound |
| HY-141690A | PI3K-IN-19 (hydrochloride) | 2132943-80-5 | Reference compound |
| HY-141692 | IL-17 modulator 4 | 2446803-65-0 | Reference compound |
| HY-141692A | IL-17 modulator 4 (sulfate) | 2446806-90-0 | Reference compound |
| HY-141692B | (R)-IL-17 modulator 4 | 2446804-29-9 | Reference compound |
| HY-141696S | 3-Hydroxy Mepivacaine-d3 | 1346597-79-2 | Isotope-Labeled Compounds |
| HY-141699 | FATP1-IN-1 | 1431945-95-7 | Reference compound |
| HY-141700 | FATP1-IN-2 | 2650944-83-3 | Reference compound |
| HY-141701 | mTOR/HDAC-IN-1 | 2815286-02-1 | Reference compound |
| HY-141703 | DC-BPi-11 | 2758411-61-7 | Reference compound |
| HY-141703A | DC-BPi-11 (hydrochloride) | Reference compound | |
| HY-14171 | Bexarotene | 153559-49-0 | Reference compound |
| HY-141711 | VU6028418 | 2649803-05-2 | Reference compound |
| HY-141714 | SBC-115337 | 423148-46-3 | Reference compound |
| HY-141715 | BRD-8000.3 | 2365504-95-4 | Reference compound |
| HY-141716 | SW2_110A | Reference compound | |
| HY-141718S | N-Acetyl-S-(trichlorovinyl)-L-cysteine-d3 | 1346616-95-2 | Isotope-Labeled Compounds |
| HY-14171R | Bexarotene (Standard) | 153559-49-0 | Reference Standards |
| HY-14171S | Bexarotene-d4 | 2182068-00-2 | Isotope-Labeled Compounds |
| HY-14171S2 | Bexarotene-13C6 | Isotope-Labeled Compounds | |
| HY-141720 | 4-(2,4,4-Trimethylpentan-2-yl)benzene-PEG4-OH | 2315-63-1 | Reference compound |
| HY-141720S | N-Acetyl sulfadiazine-d4 | 1219149-66-2 | Isotope-Labeled Compounds |
| HY-141721S | 2-(((7-Methyloctyl)oxy)carbonyl)benzoic acid-d4 | 1332965-96-4 | Isotope-Labeled Compounds |
| HY-141722S | Carboxyphosphamide-d4 | 1246817-74-2 | Isotope-Labeled Compounds |
| HY-141724 | PCSK9 ligand 1 | 2215931-60-3 | Reference compound |
| HY-141725S | N-Acetyl Tizanidine-d4 | 1276602-33-5 | Isotope-Labeled Compounds |
| HY-141728 | Bis(1-chloro-2-propyl) phosphate | 789440-10-4 | Reference compound |
| HY-141729 | Biotin-NH-PSMA-617 | Dye Reagents | |
| HY-141736S | Acetaminophen dimer-d6 | 1794817-30-3 | Isotope-Labeled Compounds |
| HY-141739S | Promethazine sulfoxide-d6 | 1189892-93-0 | Isotope-Labeled Compounds |
| HY-14174 | MRK-560 | 677772-84-8 | Reference compound |
| HY-141740S | Hydroxymethyl Tolperisone-d10 (hydrochloride) | 1346605-29-5 | Isotope-Labeled Compounds |
| HY-141742S | N-Demethyl Promethazine-d3 (hydrochloride) | 1330173-19-7 | Isotope-Labeled Compounds |
| HY-141744S | 4,4'-Dinitrocarbanilide-d8 | 1156508-87-0 | Isotope-Labeled Compounds |
| HY-141745S | 2-(((4-Methyl-7-oxooctyl)oxy)carbonyl)benzoic acid-d4 | 1332966-00-3 | Isotope-Labeled Compounds |
| HY-141749A | Clopidogrel carboxylic acid | 144457-28-3 | Reference compound |
| HY-141749AS | Clopidogrel carboxylic acid-d4 | 1217614-64-6 | Isotope-Labeled Compounds |
| HY-141749B | Clopidogrel carboxylic acid (hydrochloride) | 144750-42-5 | Reference compound |
| HY-141749S | (Rac)-Clopidogrel carboxylic acid-d4 | 1246814-52-7 | Isotope-Labeled Compounds |
| HY-14175 | Begacestat | 769169-27-9 | Reference compound |
| HY-141750S1 | N-Desmethyl Zolmitriptan-d3 | 1217623-11-4 | Isotope-Labeled Compounds |
| HY-141757S | Des-p-fluorobenzyl mosapride-d5 | 1246814-79-8 | Isotope-Labeled Compounds |
| HY-14176 | Compound E | 209986-17-4 | Reference compound |
| HY-141760S | N-Acetyl sulfamethazine-d4 | 1189891-99-3 | Isotope-Labeled Compounds |
| HY-141764S | 2,2-Bis(p-hydroxyphenyl)-1,1,1-trichloroethane-d8 | 1794780-53-2 | Isotope-Labeled Compounds |
| HY-14176A | (1R,3S)-Compound E | 504428-17-5 | Reference compound |
| HY-14176G | Compound E (GMP) | 209986-17-4 | GMP Small Molecules |
| HY-14177 | Raf inhibitor 1 | 1093100-40-3 | Reference compound |
| HY-141771S | Bis(1,3-dichloro-2-propyl) phosphate-d10 | 1477495-19-4 | Isotope-Labeled Compounds |
| HY-141773S | Benzydamine N-oxide-d6 | 1246820-03-0 | Isotope-Labeled Compounds |
| HY-141776S | Omeprazole sulfide-d3 | 922730-98-1 | Isotope-Labeled Compounds |
| HY-141778S | Retinoic acid ethyl ester-d5 | 78995-96-7 | Isotope-Labeled Compounds |
| HY-14177A | Raf inhibitor 1 (dihydrochloride) | 1191385-19-9 | Reference compound |
| HY-14178 | VX-11e | 896720-20-0 | Reference compound |
| HY-141780S | Demethyl Benzydamine-d3 (hydrochloride) | 1246817-08-2 | Isotope-Labeled Compounds |
| HY-141785S | Didesmethylcitalopram-d6 (hydrochloride) | 1189865-88-0 | Isotope-Labeled Compounds |
| HY-141789S | Desethylene Ciprofloxacin-d4 (hydrochloride) | 1330261-13-6 | Isotope-Labeled Compounds |
| HY-14178A | (R)-VX-11e | 1680187-43-2 | Reference compound |
| HY-14179 | PPQ-102 | 931706-15-9 | Reference compound |
| HY-141790S | O-Desmethyl Indomethacin-d4 | 1189916-55-9 | Isotope-Labeled Compounds |
| HY-141793 | ATRA-biotin | 2226143-93-5 | Reference compound |
| HY-141795 | Posovolone | 256955-84-7 | Reference compound |
| HY-141796 | MS67 | 2407452-77-9 | Reference compound |
| HY-141797 | MS33 | 2407449-11-8 | Reference compound |
| HY-141798 | OICR-9429-N-C2-NH2 | 2407457-55-8 | Reference compound |
| HY-141799 | Dimethyl-F-OICR-9429-COOH | 2407458-49-3 | Reference compound |
| HY-14180 | PHA 408 | 503555-55-3 | Reference compound |
| HY-141800 | MurA-IN-1 | 354815-90-0 | Reference compound |
| HY-141804 | ER176 | 1373887-29-6 | Reference compound |
| HY-141805 | MHY-1685 | 27406-31-1 | Reference compound |
| HY-141806 | Urease-IN-1 | 2719841-54-8 | Reference compound |
| HY-141807 | MS21 | 2376137-05-0 | Reference compound |
| HY-141808 | AZD-CO-Ph-PEG4-Ph-CO-AZD | 2569143-72-0 | Reference compound |
| HY-141809 | GPX4-IN-3 | 2761004-85-5 | Reference compound |
| HY-14181 | Cinaciguat | 329773-35-5 | Reference compound |
| HY-141810 | MT-134 | 2968308-52-1 | Reference compound |
| HY-141811 | Antifungal agent 11 | 2966848-10-0 | Reference compound |
| HY-141812 | Antifungal agent 12 | 2966848-11-1 | Reference compound |
| HY-141813 | Autophagy-IN-C1 | 1494665-31-4 | Reference compound |
| HY-141814 | TSWV-IN-1 | Reference compound | |
| HY-14181A | Cinaciguat (hydrochloride) | 646995-35-9 | Reference compound |
| HY-14182 | Vernakalant | 794466-70-9 | Reference compound |
| HY-141828 | Antibacterial agent 26 | 75369-40-3 | Reference compound |
| HY-141829 | Antibacterial agent 27 | 65795-51-9 | Reference compound |
| HY-14182S | Vernakalant-d6 (hydrochloride) | 866455-16-5 | Isotope-Labeled Compounds |
| HY-14183 | Vernakalant (Hydrochloride) | 748810-28-8 | Reference compound |
| HY-141832 | mGluR5 modulator 1 | 1261171-52-1 | Reference compound |
| HY-141833 | Bi-Mc-VC-PAB-MMAE | 1620837-70-8 | ADC Related |
| HY-141834 | Carboxylesterase-IN-1 | 2609018-59-7 | Reference compound |
| HY-141836 | MMV666810 | 1450666-97-3 | Reference compound |
| HY-141837 | MMV674850 | 1820874-51-8 | Reference compound |
| HY-141839 | GLP-1R modulator C16 | 875005-43-9 | Reference compound |
| HY-14184 | Macitentan | 441798-33-0 | Reference compound |
| HY-141840 | GLP-1R modulator C5 | 421578-93-0 | Reference compound |
| HY-141841 | SARS-CoV-2-IN-7 | 2570461-66-2 | Reference compound |
| HY-141842 | GLP-1R modulator L7-028 | 2648317-95-5 | Reference compound |
| HY-141843 | BRD4-IN-2 | 2679925-55-2 | Reference compound |
| HY-141844 | HDAC/BET-IN-1 | 2757573-68-3 | Reference compound |
| HY-141845 | S1P2 antagonist 1 | 2262402-83-3 | Reference compound |
| HY-141846 | Antifungal agent 17 | Reference compound | |
| HY-141848A | (S,S)-BMS-984923 | 1375752-77-4 | Reference compound |
| HY-14184A | Macitentan (n-butyl analogue) | 556797-16-1 | Reference compound |
| HY-14184R | Macitentan (Standard) | 441798-33-0 | Reference Standards |
| HY-14184S | Macitentan-d4 | 1258428-05-5 | Isotope-Labeled Compounds |
| HY-14185 | Lixivaptan | 168079-32-1 | Reference compound |
| HY-141851 | UDP-glucose dehydrogenase | 9028-26-6 | Enzyme |
| HY-141852 | STAMBP-IN-1 | 896683-78-6 | Reference compound |
| HY-141854S | 2-Butanone 2,4-dinitrophenylhydrazone-d3 | 259824-58-3 | Isotope-Labeled Compounds |
| HY-141855S | Acetaldehyde 2,4-Dinitrophenylhydrazone-3,5,6-d3 | 259824-51-6 | Isotope-Labeled Compounds |
| HY-141856S | Acrolein 2,4-dinitrophenylhydrazone-3,5,6-d3 | 259824-62-9 | Isotope-Labeled Compounds |
| HY-141857S | 5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3 | Isotope-Labeled Compounds | |
| HY-141858 | Lynamicin B | 861149-19-1 | Natural Products |
| HY-141859 | PPO-IN-1 | 2763288-69-1 | Reference compound |
| HY-14186 | KVI-020 | 1000306-34-2 | Reference compound |
| HY-141860 | PSMA-Val-Cit-PAB-MMAE | 2748039-79-2 | ADC Related |
| HY-141861 | Anticancer agent 17 | 3031370-98-3 | Reference compound |
| HY-141862 | Zanamivir-Cholesterol Conjugate | 2478446-18-1 | Reference compound |
| HY-141863 | Lepidozin G | 2869125-43-7 | Reference compound |
| HY-141864 | ITK/TRKA-IN-1 | 2655557-54-1 | Reference compound |
| HY-141865 | Adenosine receptor antagonist 1 | 2682930-40-9 | Reference compound |
| HY-141866 | Acid Ceramidase-IN-1 | 2415225-30-6 | Reference compound |
| HY-141867 | Z-FF-FMK | 105608-85-3 | Peptides |
| HY-141868 | SB-682330A | 502498-66-0 | Reference compound |
| HY-14187 | Amiodarone | 1951-25-3 | Reference compound |
| HY-141873 | Wnt/β-catenin agonist 2 | 943820-93-7 | Reference compound |
| HY-141874 | PRMT5-IN-12 | 2568927-94-4 | Reference compound |
| HY-141875 | PRMT5-IN-13 | 2376795-15-0 | Reference compound |
| HY-141876 | PRMT5-IN-14 | 2278356-90-2 | Reference compound |
| HY-141877 | MS4322 | 2375432-47-4 | Reference compound |
| HY-141877B | MS4322 (isomer) | 2601727-80-2 | Reference compound |
| HY-141878 | di-Ellipticine-RIBOTAC | 2767983-76-4 | Reference compound |
| HY-14187S | Amiodarone-d10 (hydrochloride) | 1261393-77-4 | Isotope-Labeled Compounds |
| HY-14187S1 | Amiodarone-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-14188 | Amiodarone (hydrochloride) | 19774-82-4 | Reference compound |
| HY-141881 | PROTAC-O4I2 | 2785323-62-6 | Reference compound |
| HY-141882 | DC-LC3in-D5 | 2868312-73-4 | Reference compound |
| HY-141884 | 2',3'-O-Isopropylidenecytidine | 362-42-5 | Biochemical Assay Reagents |
| HY-141885 | APOL1-IN-1 | 2446817-72-5 | Reference compound |
| HY-141887 | Thalidomide-O-C6-NHBoc | 2509093-23-4 | Reference compound |
| HY-141888S | DL-Dipalmitoylphosphatidylcholine-d62 | 29287-66-9 | Isotope-Labeled Compounds |
| HY-141889 | MLKL-IN-2 | 899759-16-1 | Reference compound |
| HY-14188R | Amiodarone (hydrochloride) (Standard) | 19774-82-4 | Reference Standards |
| HY-14188S | Amiodarone-d4 (hydrochloride) | 1216715-80-8 | Isotope-Labeled Compounds |
| HY-14189 | Valategrast (hydrochloride) | 828271-96-1 | Reference compound |
| HY-141890 | BAZ1A-IN-1 | 941521-45-5 | Reference compound |
| HY-141891 | M435-1279 | 1359431-16-5 | Reference compound |
| HY-141892A | DSPE-PEG Carboxylic acid (sodium), MW 2000 | 1403744-37-5 | Oligonucleotides |
| HY-141893 | 3-Cyanovinylcarbazole phosphoramidite | 1157899-72-3 | Reference compound |
| HY-141894 | 5-Ph-IAA-AM | 2990123-10-7 | Reference compound |
| HY-141895 | Vps34-IN-3 | 2770104-92-0 | Reference compound |
| HY-141896 | RET-IN-7 | 2763386-05-4 | Reference compound |
| HY-141898 | Biotin-4-aminophenol | 901770-40-9 | Dye Reagents |
| HY-14190 | Valategrast | 220847-86-9 | Reference compound |
| HY-141900S | Acetyl-N-deisopropyl-Zilpaterol-d3 | Isotope-Labeled Compounds | |
| HY-141901S | Dehydroepiandrosterone-d6 | 1261254-39-0 | Isotope-Labeled Compounds |
| HY-141901S2 | Dehydroepiandrosterone-13C3 | 2483735-10-8 | Isotope-Labeled Compounds |
| HY-141902S | Fmoc-Glu(OtBu)-OH-13C5,15N | 1261078-12-9 | Isotope-Labeled Compounds |
| HY-141903S | Taurocholic acid-3-o-glucuronide-d4 | Isotope-Labeled Compounds | |
| HY-141905S | Isophorone Diamine-13C,15N2 | Isotope-Labeled Compounds | |
| HY-141907S | 17β-Estradiol-13C3 | 1261254-48-1 | Isotope-Labeled Compounds |
| HY-141909S | 4-Fluoroiodobenzene-13C6 | Isotope-Labeled Compounds | |
| HY-141911S | Tauroursodeoxycholic Acid-3-Sulfate Sodium Salt-d4 | Isotope-Labeled Compounds | |
| HY-141913S | 3-Chlorotyrosine-13C9, 15N (hydrochloride) | Isotope-Labeled Compounds | |
| HY-141914S | Cortisol-21-glucuronide-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-141916S | Taurodeoxycholic Acid-3-Sulfate-d4(Sodium Salt) | Isotope-Labeled Compounds | |
| HY-141917S | 3-Methyluric Acid-13C4,15N3 | 1173019-10-7 | Isotope-Labeled Compounds |
| HY-141918S | Chenodeoxycholic acid 3-sulfate-d4 | Isotope-Labeled Compounds | |
| HY-141919S | 1-Bromo-4-iodobenzene-13C6 | Isotope-Labeled Compounds | |
| HY-141921S | Dehydroepiandrosterone sulfate (sodium)-d6 | 1261254-41-4 | Isotope-Labeled Compounds |
| HY-141923S | Pyridoxamine-d3 (dihydrochloride) | 1173023-45-4 | Isotope-Labeled Compounds |
| HY-141925S | 3-Octanone-13C | Isotope-Labeled Compounds | |
| HY-141926S | Deoxycholic Acid-3-Sulfate Sodium Salt-d4 | Isotope-Labeled Compounds | |
| HY-141928S | 4-Bromoanisole-13C6 | 1538556-42-1 | Isotope-Labeled Compounds |
| HY-141929S | β-aminomethyl-L-alanine-13C,15N2(dihydrochloride) | Isotope-Labeled Compounds | |
| HY-141931S | Glycolithocholic acid 3-sulfate-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-141931S1 | Glycolithocholic acid 3-sulfate-d4 (disodium) | Isotope-Labeled Compounds | |
| HY-141932S | 4,4′-Methylenedianiline-15N2, 13C | 2416442-06-1 | Isotope-Labeled Compounds |
| HY-141933S | 3-Epi-25-Hydroxyvitamin D3-d3 | 2206653-61-2 | Isotope-Labeled Compounds |
| HY-141934S | 2-Methylthiopurine-13C, d3 | Isotope-Labeled Compounds | |
| HY-141936S | Glycochenodeoxychlolic Acid-3-Sulfate-d4(sodium salt) | Isotope-Labeled Compounds | |
| HY-141939S | Triiodothyronine-13C6( hydrochloride) | 1217473-60-3 | Isotope-Labeled Compounds |
| HY-141941S | Triazole Lactic Acid-13C2, 15N3 | Isotope-Labeled Compounds | |
| HY-141943S | Glycocholic Acid-3-Sulfate-d4 (sodium salt) | Isotope-Labeled Compounds | |
| HY-141944S | Cortisol-21-sulfate-d4 (sodium salt) | 2687961-03-9 | Isotope-Labeled Compounds |
| HY-141945S | Taurochenodeoxycholic acid-3-o-glucuronide-d4(disodium salt) | Isotope-Labeled Compounds | |
| HY-141958S | Ciclesonide-d11 | Isotope-Labeled Compounds | |
| HY-14196 | Toloxatone | 29218-27-7 | Reference compound |
| HY-14197 | Clorgyline | 17780-72-2 | Reference compound |
| HY-14197A | Clorgyline hydrochloride | 17780-75-5 | Reference compound |
| HY-14198 | Selegiline | 14611-51-9 | Reference compound |
| HY-141987S1 | 2-Hydroxy atorvastatin sodium salt-d5 | Isotope-Labeled Compounds | |
| HY-14198R | Selegiline (Standard) | 14611-51-9 | Reference Standards |
| HY-14198S | Selegiline-d5 | 1217976-51-6 | Isotope-Labeled Compounds |
| HY-14199 | Selegiline (hydrochloride) | 14611-52-0 | Reference compound |
| HY-14199S | Selegiline-d5 (hydrochloride) | 1217705-21-9 | Isotope-Labeled Compounds |
| HY-14200 | (S)-Rasagiline | 185517-74-2 | Reference compound |
| HY-142003 | 27-O-Demethylrapamycin | 141392-23-6 | Reference compound |
| HY-142006 | (-)-Jasmonoyl-L-isoleucine | 120330-93-0 | Natural Products |
| HY-142009 | Antiviral agent 10 | 312615-62-6 | Reference compound |
| HY-14200A | (S)-Rasagiline mesylate | 202464-88-8 | Reference compound |
| HY-14201 | Lazabemide | 103878-84-8 | Reference compound |
| HY-142013 | Blestriarene B | 127211-03-4 | Natural Products |
| HY-142016 | Retinol, palmitate, 9-cis,13-cis- | 34356-30-4 | Reference compound |
| HY-142019 | Tanshinol borneol ester | 1623012-10-1 | Natural Products |
| HY-14202 | Lazabemide (hydrochloride) | 103878-83-7 | Reference compound |
| HY-142021 | Z-Leu-Arg-AMC | 156192-32-4 | Reference compound |
| HY-142025 | Daumone | 690991-47-0 | Natural Products |
| HY-142026 | Vitisin A | 142449-89-6 | Natural Products |
| HY-142028A | Acyclovir triphosphate (sodium) | 221119-43-3 | Biochemical Assay Reagents |
| HY-14203 | (R)-Safinamide | 174756-44-6 | Reference compound |
| HY-142030 | TRPC5 modulator-1 | 1877343-90-2 | Reference compound |
| HY-142031 | 4-Piperidinecarboxamide | 519034-65-2 | Reference compound |
| HY-142032 | RBM10-8 | 2407372-42-1 | Reference compound |
| HY-142035 | N-Propargylglycine | 58160-95-5 | Reference compound |
| HY-142037 | Geranylacetone | 3796-70-1 | Natural Products |
| HY-142041 | Borocaptate (sodium ) | 144885-51-8 | Reference compound |
| HY-142042 | 3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles | 287196-91-2 | Reference compound |
| HY-14205 | NW-1772 | 911290-35-2 | Reference compound |
| HY-142050 | (R)-IDHP | 950665-05-1 | Natural Products |
| HY-142052 | Anhydrotetracycline | 1665-56-1 | Reference compound |
| HY-142058 | Feudomycin B | 79438-97-4 | Reference compound |
| HY-142059 | PDE5-IN-4 | 224788-36-7 | Reference compound |
| HY-142063 | Petasitenine | 60102-37-6 | Reference compound |
| HY-142066 | 4′-Demethylnobiletin | 34810-62-3 | Reference compound |
| HY-142069 | KB-R7785 | 168158-16-5 | Reference compound |
| HY-142072 | Albomycin | 1414-39-7 | Reference compound |
| HY-142073 | (+)-Dihydrocalanolide A | 183904-53-2 | Reference compound |
| HY-142074 | Inophyllum B | 41135-06-2 | Reference compound |
| HY-142075 | Antibacterial agent 134 | 14474-71-6 | Natural Products |
| HY-142076 | CDK4/6-IN-15 | 2078047-99-9 | Reference compound |
| HY-142076A | CDK4/6-IN-15 (hydrochloride) | Reference compound | |
| HY-142080 | Pimeloyl-CoA | 18907-20-5 | Enzyme |
| HY-142080A | Pimeloyl-CoA (lithium) | Reference compound | |
| HY-142082 | Isohopeaphenol | 197446-77-8 | Natural Products |
| HY-142085 | Antiproliferative agent-20 | 1344715-94-1 | Reference compound |
| HY-142086 | Antitumor agent-40 | 2096500-09-1 | Reference compound |
| HY-142087 | Beauverolide Ja | 76265-41-3 | Reference compound |
| HY-142088 | Beauverolide Ka | 76265-42-4 | Reference compound |
| HY-142090 | Donetidine | 99248-32-5 | Reference compound |
| HY-142093 | NSD3-IN-1 | 347340-51-6 | Reference compound |
| HY-142094 | NSD3-IN-2 | 675190-57-5 | Reference compound |
| HY-142095 | NSD3-IN-3 | 445416-12-6 | Reference compound |
| HY-142096 | Glycyuralin E | 1879910-26-5 | Reference compound |
| HY-142097 | Glicophenone | 303175-66-8 | Reference compound |
| HY-142098 | 3′-Hydroxy-4′-O-methylglabridin | 175554-11-7 | Reference compound |
| HY-142099 | Hispaglabridin A | 68978-03-0 | Reference compound |
| HY-14210 | TNAP-IN-1 | 496014-13-2 | Reference compound |
| HY-142100 | Licoagrochalcone C | 325144-68-1 | Reference compound |
| HY-142101 | 3,4-Didehydroglabridin | 214283-58-6 | Reference compound |
| HY-142101S | 5,6-Orthoquinone Primaquine-d6 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-142102 | T988C | 823802-57-9 | Reference compound |
| HY-142104 | 2-CTC Resin (100-200 mesh,1% DVB,0.4-3.0mmol/g) | 934816-82-7 | Biochemical Assay Reagents |
| HY-142105 | 2-Ethyl-2-hydroxybutanoic acid | 3639-21-2 | Reference compound |
| HY-142105R | 2-Ethyl-2-hydroxybutanoic acid (Standard) | 3639-21-2 | Reference Standards |
| HY-142107S | 9-cis,13-cis-Retinol-d5 | Isotope-Labeled Compounds | |
| HY-142114 | SRI-37330 | 2322245-42-9 | Reference compound |
| HY-142117 | Adenophostin A | 149091-92-9 | Reference compound |
| HY-142117S | 6-Sulfatoxy Melatonin-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-142117S1 | 6-Sulfatoxy Melatonin-d4 | 1309935-98-5 | Isotope-Labeled Compounds |
| HY-142118 | Trabedersen | 925681-61-4 | Oligonucleotides |
| HY-142118A | Trabedersen (sodium) | Oligonucleotides | |
| HY-142119 | Penehyclidine | 87827-02-9 | Reference compound |
| HY-142119S | 5-Hydroxy tryptophol β-D-glucuronide-d4 | Isotope-Labeled Compounds | |
| HY-142121 | Iopentol | 89797-00-2 | Reference compound |
| HY-142121R | Iopentol (Standard) | 89797-00-2 | Reference Standards |
| HY-142122 | Imipramine N-oxide | 6829-98-7 | Reference compound |
| HY-142122R | Imipramine N-oxide (Standard) | 6829-98-7 | Reference Standards |
| HY-142123 | Fluocortolone | 152-97-6 | Reference compound |
| HY-142123R | Fluocortolone (Standard) | 152-97-6 | Reference Standards |
| HY-142124 | Kalimantacin A | 174513-95-2 | Natural Products |
| HY-142125 | Broussochalcone A | 99217-68-2 | Natural Products |
| HY-142125S1 | 7-Hydroxy Granisetron-d3 | 2124272-02-0 | Isotope-Labeled Compounds |
| HY-142127 | Ribostamycin | 25546-65-0 | Natural Products |
| HY-142127S | 2-(α-D-Mannopyranosyl)-L-tryptophan-d4 | 2230887-20-2 | Isotope-Labeled Compounds |
| HY-142128 | Cymal-6 | 228579-27-9 | Reference compound |
| HY-142129 | Pyrocholecalciferol | 10346-43-7 | Reference compound |
| HY-142139S | (S,S)-Iso Valganciclovir-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-142140S | 3-epi-25-Hydroxy Vitamin D3-d6 | 2483831-27-0 | Isotope-Labeled Compounds |
| HY-142159 | FXR/TGR5 agonist 1 | 2677689-72-2 | Reference compound |
| HY-142160 | GNE-9815 | 2729996-45-4 | Reference compound |
| HY-142161 | ABD957 | 3007772-60-0 | Reference compound |
| HY-142162 | LSN3318839 | 2764704-18-7 | Reference compound |
| HY-142162A | (S,R)-LSN3318839 | 2765539-92-0 | Reference compound |
| HY-142163 | S62798 | 2107353-05-7 | Reference compound |
| HY-142165S | (R)-Norverapamil-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-14217 | Quizartinib (dihydrochloride) | 1132827-21-4 | Reference compound |
| HY-14218 | Ditolylguanidine | 97-39-2 | Reference compound |
| HY-142180S | cis (2,3)-Dihydro tetrabenazine-d6 | 1351947-42-6 | Isotope-Labeled Compounds |
| HY-142193S | (-)-Erinacin A-d3 | Isotope-Labeled Compounds | |
| HY-142196S | Betamethasone 17-propionate-d5 | Isotope-Labeled Compounds | |
| HY-14220 | CB-184 | 165307-47-1 | Reference compound |
| HY-142209 | ABBV-167 | 1351456-78-4 | Reference compound |
| HY-14221 | Siramesine | 147817-50-3 | Reference compound |
| HY-142211 | PRMT5-IN-15 | 2410637-87-3 | Reference compound |
| HY-142214 | TRPA1-IN-1 | 2376824-92-7 | Reference compound |
| HY-142217S | Quetiapine dimer impurity-d8 | Isotope-Labeled Compounds | |
| HY-14221A | Siramesine (hydrochloride) | 224177-60-0 | Reference compound |
| HY-14221B | Siramesine (fumarate) | 163630-79-3 | Reference compound |
| HY-14222 | UMB24 | 1033-69-8 | Reference compound |
| HY-142221 | ARB-272572 | 2368182-63-0 | Reference compound |
| HY-14223 | SM-21 | 155058-71-2 | Reference compound |
| HY-142240 | Crisugabalin | 2209104-84-5 | Reference compound |
| HY-142249S | Brexpiprazole-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-14225 | BMS-764459 | 1188407-45-5 | Reference compound |
| HY-142253 | HIV-1 inhibitor-10 | 1449660-81-4 | Reference compound |
| HY-142255S1 | Saroglitazar sulfoxide-d4 | Isotope-Labeled Compounds | |
| HY-142259S | Desisobutyryl ciclesonide-d11 | Isotope-Labeled Compounds | |
| HY-14226 | LIMK-IN-3 | 1116570-97-8 | Reference compound |
| HY-142265 | NVS-BET-1 | 1639115-52-8 | Reference compound |
| HY-142266S | Retigabine N-β-D-glucuronide-d4 | Isotope-Labeled Compounds | |
| HY-14227 | LIMK-IN-1 | 1116571-01-7 | Reference compound |
| HY-142275S | (-)-Nebivolol-d4 (hydrochloride) | 2124271-48-1 | Isotope-Labeled Compounds |
| HY-142279S | 17β-Estradiol 17-acetate 3-β-D-glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-142283 | Dosimertinib | 2403760-70-1 | Isotope-Labeled Compounds |
| HY-142283AS | Dosimertinib (mesylate) | 2403760-72-3 | Isotope-Labeled Compounds |
| HY-142283BS | N-Desmethyl dosimertinib-d5 | 2719691-00-4 | Isotope-Labeled Compounds |
| HY-142283CS | N-Methyl-dosimertinib-d5 | 2719690-98-7 | Isotope-Labeled Compounds |
| HY-142287 | Con B-1 | 2415537-51-6 | Reference compound |
| HY-14229 | TGR5 Receptor Agonist | 1197300-24-5 | Reference compound |
| HY-142295 | GNF2133 | 2561414-56-8 | Reference compound |
| HY-142295A | GNF2133 (hydrochloride) | 2561414-57-9 | Reference compound |
| HY-142296 | RORγt inhibitor 1 | 1561770-72-6 | Reference compound |
| HY-14230 | INCB9471 | 869769-98-2 | Reference compound |
| HY-14231 | CCR5 antagonist 5 | 869725-27-9 | Reference compound |
| HY-142310S | Betamethasone 21-acetate 17-propionate-d3 | Isotope-Labeled Compounds | |
| HY-14232 | TTA-A8 | 1146395-46-1 | Reference compound |
| HY-142328S | Propantheline-d3 (iodide) | Isotope-Labeled Compounds | |
| HY-14233 | Omecamtiv mecarbil | 873697-71-3 | Reference compound |
| HY-142333 | Hexadecanedioic acid mono-L-carnitine ester | 42150-38-9 | Reference compound |
| HY-14233S | Omecamtiv mecarbil-d8 | Isotope-Labeled Compounds | |
| HY-14234 | Glucocorticoid receptor agonist | 1245526-82-2 | Reference compound |
| HY-14240 | PG 116800 | 291533-11-4 | Reference compound |
| HY-142422S | (Rac)-trans-Bifenthrin-d5 | Isotope-Labeled Compounds | |
| HY-14243 | CEP-14083 | 856692-39-2 | Reference compound |
| HY-142433 | ERK1/2 inhibitor 7 | 2648455-13-2 | Reference compound |
| HY-142437 | ERK1/2 inhibitor 8 | 2648368-43-6 | Reference compound |
| HY-142440S | Apatinib 25-N-oxide-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-142441 | THR-β agonist 1 | 2648403-17-0 | Reference compound |
| HY-142444 | SSAO/VAP-1 inhibitor 1 | 2647975-06-0 | Reference compound |
| HY-142448S | Nicotinic acid riboside methyl ester-d4 (triflate) | Isotope-Labeled Compounds | |
| HY-142452 | Pan-RAF kinase inhibitor 1 | 2648838-76-8 | Reference compound |
| HY-142457 | KRAS G12C inhibitor 26 | 2648584-52-3 | Reference compound |
| HY-142458 | KRAS G12C inhibitor 27 | 2648584-51-2 | Reference compound |
| HY-142460 | KRAS G12C inhibitor 28 | 2649004-88-4 | Reference compound |
| HY-142467 | HIV-1 inhibitor-11 | Reference compound | |
| HY-142468 | HIV-1 inhibitor-12 | Reference compound | |
| HY-14247 | Fadrozole (hydrochloride) | 102676-31-3 | Reference compound |
| HY-142471 | ZL-2201 (free base) | 2646592-18-7 | Reference compound |
| HY-142471A | ZL-2201 | 2865115-39-3 | Reference compound |
| HY-142475S | N,N'-Bis(2,6-dimethylphenyl)-1,4-piperazinediacetamide-d8 | 2751283-52-8 | Isotope-Labeled Compounds |
| HY-142478 | KRAS G12C inhibitor 29 | 847337-63-7 | Reference compound |
| HY-14247A | Fadrozole | 102676-47-1 | Reference compound |
| HY-14247B | Fadrozole (hydrochloride hemihydrate) | 176702-70-8 | Reference compound |
| HY-14248 | Letrozole | 112809-51-5 | Natural Products |
| HY-142481 | KRAS G12C inhibitor 30 | 2752352-90-0 | Reference compound |
| HY-142485 | KRAS G12C inhibitor 31 | 2752352-86-4 | Reference compound |
| HY-142487 | KRAS G12C inhibitor 32 | 2756739-00-9 | Reference compound |
| HY-14248R | Letrozole (Standard) | 112809-51-5 | Reference Standards |
| HY-14248S | Letrozole-d4 | 1133712-96-5 | Isotope-Labeled Compounds |
| HY-14249 | Bicalutamide | 90357-06-5 | Reference compound |
| HY-142490 | KRAS G12C inhibitor 33 | 2648985-02-6 | Reference compound |
| HY-14249R | Bicalutamide (Standard) | 90357-06-5 | Reference Standards |
| HY-14249S | Bicalutamide-d4 | 1185035-71-5 | Isotope-Labeled Compounds |
| HY-14249S1 | Bicalutamide-d5 | Isotope-Labeled Compounds | |
| HY-14250 | PF-998425 | 1076225-27-8 | Reference compound |
| HY-14250A | (Rac)-PF-998425 | 1076225-26-7 | Reference compound |
| HY-142511 | KRAS G12C inhibitor 34 | 2749948-26-1 | Reference compound |
| HY-142512 | EGFR-IN-24 | 2757548-54-0 | Reference compound |
| HY-142515S | 7α-Thiomethyl spironolactone-d7 | Isotope-Labeled Compounds | |
| HY-142517 | EGFR-IN-25 | 2749562-63-6 | Reference compound |
| HY-142518 | EGFR-IN-26 | 2375470-64-5 | Reference compound |
| HY-142519 | EGFR-IN-27 | 2752328-62-2 | Reference compound |
| HY-14252 | Milrinone | 78415-72-2 | Reference compound |
| HY-142520 | I-BET567 | 1887237-54-8 | Reference compound |
| HY-142521 | BLT2 probe 1 | 2893803-05-7 | Reference compound |
| HY-142523 | H7 | 2803681-14-1 | Dye Reagents |
| HY-14252A | Milrinone (lactate) | 100286-97-3 | Reference compound |
| HY-14252R | Milrinone (Standard) | 78415-72-2 | Reference Standards |
| HY-14252S | Milrinone-d3 | 2749393-50-6 | Isotope-Labeled Compounds |
| HY-142533 | HL-PEG2k | Reference compound | |
| HY-142537S | p-t-Butylphenyl diphenyl phosphate-d10 | Isotope-Labeled Compounds | |
| HY-14254 | Olprinone (Hydrochloride) | 119615-63-3 | Reference compound |
| HY-142545 | Antibacterial agent 68 | 2887429-54-9 | Reference compound |
| HY-142547S | S 421-d4 | 2714435-90-0 | Isotope-Labeled Compounds |
| HY-14254A | Olprinone | 106730-54-5 | Reference compound |
| HY-14255 | Levcromakalim | 94535-50-9 | Reference compound |
| HY-142555S | Bisphenol A monosulfate-d6 (sodium) | 2733721-65-6 | Isotope-Labeled Compounds |
| HY-14256 | BMS-191095 | 166095-21-2 | Reference compound |
| HY-142566S | Mianserin-d3 (dihydrochloride） | Isotope-Labeled Compounds | |
| HY-142567S | Pregnanetriol-d4 | 2687960-83-2 | Isotope-Labeled Compounds |
| HY-14257 | BMS-191095 (hydrochloride) | 166095-95-0 | Reference compound |
| HY-142578S | Perindoprilat-d4 | 1356841-18-3 | Isotope-Labeled Compounds |
| HY-14258 | Escitalopram | 128196-01-0 | Natural Products |
| HY-142581S | 1-Naphthol β-D-glucuronide-d7 (sodium) | Isotope-Labeled Compounds | |
| HY-14258A | Escitalopram (oxalate) | 219861-08-2 | Reference compound |
| HY-14258AR | Escitalopram (oxalate) (Standard) | 219861-08-2 | Reference Standards |
| HY-14258AS | Escitalopram-d6 (oxalate) | 1217733-09-9 | Isotope-Labeled Compounds |
| HY-14258AS1 | Escitalopram-d4 (oxalate) | Isotope-Labeled Compounds | |
| HY-142592S | Clozapine EP impurity D-d8 | Isotope-Labeled Compounds | |
| HY-142598S | Serotonin-d4 β-D-glucuronide | Isotope-Labeled Compounds | |
| HY-14260 | RS 8359 | 105365-76-2 | Reference compound |
| HY-14261 | Vilazodone (Hydrochloride) | 163521-08-2 | Reference compound |
| HY-142617 | ACT-1004-1239 | 2178049-58-4 | Reference compound |
| HY-142618 | TNF-α-IN-6 | 2699704-20-4 | Reference compound |
| HY-142619 | TP0586352 | 2427626-11-5 | Reference compound |
| HY-14261R | Vilazodone (Hydrochloride) (Standard) | 163521-08-2 | Reference Standards |
| HY-14261S | Vilazodone-d8 | 1794789-93-7 | Isotope-Labeled Compounds |
| HY-14262 | Vilazodone | 163521-12-8 | Reference compound |
| HY-142620 | TRPV4 antagonist 3 | 2681273-35-6 | Reference compound |
| HY-142621 | BCPyr | 2669844-82-8 | Reference compound |
| HY-14262R | Vilazodone (Standard) | 163521-12-8 | Reference Standards |
| HY-14262S1 | Vilazodone-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-14263 | Pericyazine | 2622-26-6 | Reference compound |
| HY-142636S | Propylthiouracil-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-14264 | Cyamemazine | 3546-03-0 | Reference compound |
| HY-142641S | 4-Hydroxy triamterene sulfate-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-142643 | CETP-IN-4 | 1648889-70-6 | Reference compound |
| HY-142644 | ATX inhibitor 7 | 1646784-47-5 | Reference compound |
| HY-142645 | TP0591816 | 2448519-26-2 | Reference compound |
| HY-142646 | PI3Kδ-IN-9 | 2135922-40-4 | Reference compound |
| HY-142647 | EB-42486 | 2390475-81-5 | Reference compound |
| HY-142648 | MLT-985 | 1832576-25-6 | Reference compound |
| HY-142648A | (R)-MLT-985 | 1832577-07-7 | Reference compound |
| HY-14264S | Cyamemazine-d6 | 1216608-24-0 | Isotope-Labeled Compounds |
| HY-142651S | Prochlorperazine-d3 (mesylate) | Isotope-Labeled Compounds | |
| HY-142654 | ATX-002 | 1777792-34-3 | Reference compound |
| HY-142655 | Ftase inhibitor III | 2710375-18-9 | Reference compound |
| HY-142656 | PIM-IN-1 | 2698319-19-4 | Reference compound |
| HY-142657 | PARP1-IN-7 | 2084112-75-2 | Reference compound |
| HY-142658 | BAY-6672 | 2247517-53-7 | Reference compound |
| HY-142658A | BAY-6672 (hydrochloride) | 2247520-31-4 | Reference compound |
| HY-142659 | IRE1α kinase-IN-6 | 2715123-88-7 | Reference compound |
| HY-14266 | Dapivirine | 244767-67-7 | Reference compound |
| HY-142660 | PDE2A-IN-1 | 2648290-28-0 | Reference compound |
| HY-142661 | BAY 1217224 | 1639886-32-0 | Reference compound |
| HY-142662 | PROTAC IRAK3 degrade-1 | 2712600-00-3 | Reference compound |
| HY-142662A | PROTAC IRAK3 degrade-1 (formic) | Reference compound | |
| HY-142663 | OI338 | Reference compound | |
| HY-142669 | Lp-PLA2-IN-4 | 2738877-91-1 | Reference compound |
| HY-14266A | Dapivirine (hydrochloride) | 244768-47-6 | Reference compound |
| HY-14266S | Dapivirine-d11 | 1329613-10-6 | Isotope-Labeled Compounds |
| HY-14266S1 | Dapivirine-d4 | 1309283-15-5 | Isotope-Labeled Compounds |
| HY-14267 | Lersivirine | 473921-12-9 | Reference compound |
| HY-142670 | Lp-PLA2-IN-5 | 2738877-85-3 | Reference compound |
| HY-142671 | ATR-IN-5 | 2601571-19-9 | Reference compound |
| HY-142672 | ATR-IN-6 | 2746446-99-9 | Reference compound |
| HY-142674 | BRD4-BD1/2-IN-1 | 1781219-19-9 | Reference compound |
| HY-142675 | BRD4-BD1/2-IN-2 | 2743464-27-7 | Reference compound |
| HY-142676 | PI3K-IN-26 | 1918151-65-1 | Reference compound |
| HY-142677 | PI3K-IN-27 | 2742654-38-0 | Reference compound |
| HY-142678 | EGFR-IN-21 | 2648206-31-7 | Reference compound |
| HY-142679 | EGFR-IN-22 | 2634646-14-1 | Reference compound |
| HY-14268 | Febuxostat | 144060-53-7 | Reference compound |
| HY-142680 | EGFR-IN-23 | 2747133-37-3 | Reference compound |
| HY-142681 | EGFR-IN-28 | 2754392-31-7 | Reference compound |
| HY-142682 | SCP1-IN-1 | 2764615-55-4 | Reference compound |
| HY-142683 | SCP1-IN-2 | 2764615-56-5 | Reference compound |
| HY-142684 | Pyruvate Carboxylase-IN-1 | 70205-50-4 | Reference compound |
| HY-142686 | SGK1-IN-3 | 2891696-18-5 | Reference compound |
| HY-142686A | SGK1-IN-3 (hydrochloride) | Reference compound | |
| HY-142687 | SGK1-IN-4 | 1628048-93-0 | Reference compound |
| HY-142688 | Carboxylesterase-IN-2 | 2764748-88-9 | Reference compound |
| HY-142689 | Carboxylesterase-IN-3 | 2764748-92-5 | Reference compound |
| HY-14268A | Febuxostat (sodium) | 1140907-13-6 | Reference compound |
| HY-14268R | Febuxostat (Standard) | 144060-53-7 | Reference Standards |
| HY-14268S | Febuxostat-d9 | 1246819-50-0 | Isotope-Labeled Compounds |
| HY-14268S1 | Febuxostat-d7 | 1285539-74-3 | Isotope-Labeled Compounds |
| HY-14268S2 | Febuxostat-d3 | Isotope-Labeled Compounds | |
| HY-14268S3 | Febuxostat-d5 | Isotope-Labeled Compounds | |
| HY-142690 | HDAC-IN-27 | 2763368-89-2 | Reference compound |
| HY-142690A | HDAC-IN-27 (dihydrochloride) | 3069831-25-7 | Reference compound |
| HY-142691 | DCN1-UBC12-IN-1 | 2374827-31-1 | Reference compound |
| HY-142692 | DCN1-UBC12-IN-3 | 2374827-45-7 | Reference compound |
| HY-142693 | Angiogenesis agent 1 | 2765218-28-6 | Reference compound |
| HY-142694 | DCN1-UBC12-IN-2 | 2374827-47-9 | Reference compound |
| HY-142695 | Antibacterial synergist 1 | 2885170-11-4 | Reference compound |
| HY-142696 | CDK6/PIM1-IN-1 | 2677026-14-9 | Reference compound |
| HY-142697 | SGC agonist 1 | 1426309-31-0 | Reference compound |
| HY-142698 | SGC agonist 2 | 2735713-77-4 | Reference compound |
| HY-142699 | SSTR4 agonist 2 | 1638589-52-2 | Reference compound |
| HY-14270 | Lodoxamide | 53882-12-5 | Reference compound |
| HY-142700 | SSTR4 agonist 3 | 2744188-34-7 | Reference compound |
| HY-142701 | SSTR4 agonist 4 | 2747928-27-2 | Reference compound |
| HY-142703 | RORγt inverse agonist 28 | 2741870-21-1 | Reference compound |
| HY-142704 | BRD4 D1-IN-1 | 2863623-98-5 | Reference compound |
| HY-142705 | BRD4 D1-IN-2 | 2863687-22-1 | Reference compound |
| HY-142706 | MAO A/HDAC-IN-1 | 3031466-56-2 | Reference compound |
| HY-142708 | α-Pyridoin | 1141-05-5 | Reference compound |
| HY-14270R | Lodoxamide (Standard) | 53882-12-5 | Reference Standards |
| HY-14271 | Acreozast | 123548-56-1 | Reference compound |
| HY-14272 | Ravuconazole | 182760-06-1 | Reference compound |
| HY-142723 | KCa2 channel modulator 1 | 1019106-73-0 | Reference compound |
| HY-142725S | Melaminsulfone-d3 (sodium) | 2733972-41-1 | Isotope-Labeled Compounds |
| HY-14272R | Ravuconazole (Standard) | 182760-06-1 | Reference Standards |
| HY-14272S | Ravuconazole-d4 | 1329499-27-5 | Isotope-Labeled Compounds |
| HY-14273 | Isavuconazole | 241479-67-4 | Reference compound |
| HY-142735 | KCa2 channel modulator 2 | 2764618-34-8 | Reference compound |
| HY-142738S | Carboxymefloquine-d3 | 2469206-35-5 | Isotope-Labeled Compounds |
| HY-14273R | Isavuconazole (Standard) | 241479-67-4 | Reference Standards |
| HY-14273S | Isavuconazole-d4 | 1346598-58-0 | Isotope-Labeled Compounds |
| HY-14274 | Anastrozole | 120511-73-1 | Reference compound |
| HY-142740 | Rha-PEG3-SMCC | 2794904-62-2 | ADC Related |
| HY-142743 | Y08175 | 2223014-57-9 | Reference compound |
| HY-14274R | Anastrozole (Standard) | 120511-73-1 | Reference Standards |
| HY-14274S | Anastrozole-d12 | 120512-32-5 | Isotope-Labeled Compounds |
| HY-14275 | Verapamil | 52-53-9 | Reference compound |
| HY-142751S | Fenthion sulfone-d6 | 2469195-97-7 | Isotope-Labeled Compounds |
| HY-14275S | Verapamil-d3 | 152561-91-6 | Isotope-Labeled Compounds |
| HY-14275S1 | Verapamil-d7 | 100578-79-8 | Isotope-Labeled Compounds |
| HY-14275S2 | Verapamil-d6 | Isotope-Labeled Compounds | |
| HY-14276 | Gallopamil | 16662-47-8 | Reference compound |
| HY-142768S | Homovanillic acid sulfate-d3 (sodium) | 1189690-01-4 | Isotope-Labeled Compounds |
| HY-14276A | Gallopamil (hydrochloride) | 16662-46-7 | Reference compound |
| HY-14277 | Levocabastine | 79516-68-0 | Reference compound |
| HY-142772 | Y08284 | 2688745-47-1 | Reference compound |
| HY-142774 | Lp-PLA2-IN-6 | 2637485-13-1 | Reference compound |
| HY-142777 | Lp-PLA2-IN-9 | 2637485-12-0 | Reference compound |
| HY-142778 | Lp-PLA2-IN-10 | 2756855-45-3 | Reference compound |
| HY-142779 | Lp-PLA2-IN-11 | 1620680-19-4 | Reference compound |
| HY-14277A | Levocabastine (hydrochloride) | 79547-78-7 | Reference compound |
| HY-14277AR | Levocabastine (hydrochloride) (Standard) | 79547-78-7 | Reference Standards |
| HY-142784S | Isopropyl diphenyl phosphate-d7 | 2469626-65-9 | Isotope-Labeled Compounds |
| HY-142786S | Di-o-tolyl-phosphate-d14 | 2517379-41-6 | Isotope-Labeled Compounds |
| HY-142788S | Tofenacin hydrochloride salt-d4 | Isotope-Labeled Compounds | |
| HY-142798S | 16-Keto 17β-Estradiol-d5 (Major) | Isotope-Labeled Compounds | |
| HY-14280 | Entacapone | 130929-57-6 | Reference compound |
| HY-142805S | 17-Epiestriol-d5 | Isotope-Labeled Compounds | |
| HY-142806 | RORγt inverse agonist 26 | 2738333-10-1 | Reference compound |
| HY-14280A | Entacapone (sodium salt) | 1047659-02-8 | Reference compound |
| HY-14280R | Entacapone (Standard) | 130929-57-6 | Reference Standards |
| HY-14280S | Entacapone-d10 | 1185241-19-3 | Isotope-Labeled Compounds |
| HY-14281 | Trilostane | 13647-35-3 | Reference compound |
| HY-142812 | GRK6-IN-1 | 2677786-61-5 | Reference compound |
| HY-142813S | Procymidox-d5 | Isotope-Labeled Compounds | |
| HY-142817 | GRK6-IN-2 | 2677786-27-3 | Reference compound |
| HY-14281R | Trilostane (Standard) | 13647-35-3 | Reference Standards |
| HY-14281S | Trilostane-d3 | Isotope-Labeled Compounds | |
| HY-14281S2 | Trilostane-d3-1 | 2026644-48-2 | Isotope-Labeled Compounds |
| HY-14282 | Lanoconazole | 101530-10-3 | Reference compound |
| HY-142820 | B-Raf IN 5 | 2648698-30-8 | Reference compound |
| HY-142828S | (Rac)-galaxolidone-d6 | Isotope-Labeled Compounds | |
| HY-14282A | (Z)-Lanoconazole | 101529-65-1 | Reference compound |
| HY-14282R | Lanoconazole (Standard) | 101530-10-3 | Reference Standards |
| HY-14283 | Luliconazole | 187164-19-8 | Reference compound |
| HY-142830 | B-Raf IN 6 | 2648698-34-2 | Reference compound |
| HY-142834 | RORγt/DHODH-IN-2 | 2641758-86-1 | Reference compound |
| HY-14283R | Luliconazole (Standard) | 187164-19-8 | Reference Standards |
| HY-14283S | Luliconazole-13C7 | Isotope-Labeled Compounds | |
| HY-14283S1 | Luliconazole-d3 | Isotope-Labeled Compounds | |
| HY-14284 | Nilvadipine | 75530-68-6 | Reference compound |
| HY-142842S | Carboxy primaquine-d4 | 2469039-32-3 | Isotope-Labeled Compounds |
| HY-142843 | RORγt/DHODH-IN-1 | 2764662-15-7 | Reference compound |
| HY-142847 | RORγt/DHODH-IN-3 | 2764662-16-8 | Reference compound |
| HY-142849 | Carbonic anhydrase inhibitor 2 | 2758231-43-3 | Reference compound |
| HY-14284R | Nilvadipine (Standard) | 75530-68-6 | Reference Standards |
| HY-14284S | Nilvadipine-d4 | Isotope-Labeled Compounds | |
| HY-142853 | Carbonic anhydrase inhibitor 3 | 2758231-56-8 | Reference compound |
| HY-142856S | Methapyrilene-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-142858S | 3-Hydroxychrysene-d11 | 2468771-62-0 | Isotope-Labeled Compounds |
| HY-14286 | Levosimendan | 141505-33-1 | Reference compound |
| HY-142868 | ONO-8713 | 459411-08-6 | Reference compound |
| HY-14286R | Levosimendan (Standard) | 141505-33-1 | Reference Standards |
| HY-142870 | ZY-444 | 1802650-31-2 | Reference compound |
| HY-142876S | Benz[a]anthracen-3-ol-d11 | Isotope-Labeled Compounds | |
| HY-142881 | D-MoDE-A (1) | 2378837-67-1 | Reference compound |
| HY-142885 | M-MoDE-A (2) | 2378837-56-8 | Reference compound |
| HY-142887S | Mono(2-hydroxyisobutyl)phthalate-d4 | 2119597-90-7 | Isotope-Labeled Compounds |
| HY-14289 | Cimetidine | 51481-61-9 | Reference compound |
| HY-14289A | Cimetidine (hydrochloride) | 70059-30-2 | Reference compound |
| HY-14289AR | Cimetidine (hydrochloride) (Standard) | 70059-30-2 | Reference Standards |
| HY-14289R | Cimetidine (Standard) | 51481-61-9 | Reference Standards |
| HY-14289S | Cimetidine-d3 | 1185237-29-9 | Isotope-Labeled Compounds |
| HY-14290 | Pinacidil | 60560-33-0 | Reference compound |
| HY-142907S | (2-Fluoro-4-biphenyl)acetic acid-d5 | 2733149-72-7 | Isotope-Labeled Compounds |
| HY-142908 | Maximiscin | 1612154-44-5 | Reference compound |
| HY-14290A | Pinacidil (monohydrate) | 85371-64-8 | Reference compound |
| HY-14290R | Pinacidil (Standard) | 60560-33-0 | Reference Standards |
| HY-14291 | Vildagliptin | 274901-16-5 | Reference compound |
| HY-142912 | Stemphyperylenol | 102694-33-7 | Reference compound |
| HY-142913 | ABL-L | 1613152-39-8 | Reference compound |
| HY-142914 | Antifungal agent 21 | 1622299-33-5 | Reference compound |
| HY-142916 | Insecticidal agent 1 | Reference compound | |
| HY-142917 | THR-β agonist 4 | 2673409-25-9 | Reference compound |
| HY-142918 | μ opioid receptor agonist 1 | 2667632-83-7 | Reference compound |
| HY-142919 | μ opioid receptor agonist 2 | 2671755-38-5 | Reference compound |
| HY-14291A | Vildagliptin (dihydrate) | 2133364-01-7 | Reference compound |
| HY-14291B | (2R)-Vildagliptin | 1036959-27-9 | Reference compound |
| HY-14291R | Vildagliptin (Standard) | 274901-16-5 | Reference Standards |
| HY-14291S | Vildagliptin-d3 | 1217546-82-1 | Isotope-Labeled Compounds |
| HY-14291S1 | Vildagliptin-d7 | 1133208-42-0 | Isotope-Labeled Compounds |
| HY-14291S2 | Vildagliptin-13C5,15N | 1044741-01-6 | Isotope-Labeled Compounds |
| HY-14291S5 | Vildagliptin-d6 | Isotope-Labeled Compounds | |
| HY-14292 | NVP-DPP728 | 247016-69-9 | Reference compound |
| HY-142920 | LMP7-IN-1 | 2671040-07-4 | Reference compound |
| HY-142921 | FGFR-IN-2 | 2665665-09-6 | Reference compound |
| HY-142922 | BCR-ABL-IN-4 | 2669790-59-2 | Reference compound |
| HY-142923 | AR antagonist 2 | 2275752-15-1 | Reference compound |
| HY-142924 | ATR-IN-8 | 2672511-20-3 | Reference compound |
| HY-142925 | ER degrader 1 | 2667015-33-8 | Reference compound |
| HY-142926 | ER degrader 2 | 2390147-41-6 | Reference compound |
| HY-142927 | ER degrader 3 | 2254818-47-6 | Reference compound |
| HY-142928 | MAT2A-IN-1 | 2667053-18-9 | Reference compound |
| HY-142929 | MAT2A-IN-2 | 2565671-21-6 | Reference compound |
| HY-14293 | NVP-DPP728 (dihydrochloride) | 207556-62-5 | Reference compound |
| HY-142930 | MAT2A-IN-3 | 2377493-28-0 | Reference compound |
| HY-142931 | ATM-IN-1 | 2662761-76-2 | Reference compound |
| HY-142932 | BTK-IN-6 | 2662512-08-3 | Reference compound |
| HY-142933 | IDO-IN-16 | 2663591-36-2 | Reference compound |
| HY-142934 | RORγt inhibitor 2 | 2673278-10-7 | Reference compound |
| HY-142935 | RORγt modulator 2 | 2247083-47-0 | Reference compound |
| HY-142936 | RORγt modulator 3 | 2230877-38-8 | Reference compound |
| HY-142937 | RORγt agonist 2 | 2663787-92-4 | Reference compound |
| HY-142938 | RORγt agonist 3 | 2664106-24-3 | Reference compound |
| HY-142939 | RORγt modulator 4 | 2188177-73-1 | Reference compound |
| HY-14294 | Capravirine | 178979-85-6 | Reference compound |
| HY-142940 | RORγt modulator 5 | 2119042-65-6 | Reference compound |
| HY-142941 | Glucocorticoid receptor-IN-1 | 2662908-25-8 | Reference compound |
| HY-142942 | Glucocorticoid receptor-IN-2 | 2664932-65-2 | Reference compound |
| HY-142943 | DNA-PK-IN-1 | 2663850-40-4 | Reference compound |
| HY-142944 | DNA-PK-IN-2 | 2665720-22-7 | Reference compound |
| HY-142945 | KRAS G12C inhibitor 43 | 2648808-69-7 | Reference compound |
| HY-142946 | KRAS G12C inhibitor 44 | 2927439-07-2 | Reference compound |
| HY-142947 | KRAS G12C inhibitor 45 | 2670380-74-0 | Reference compound |
| HY-142948 | KRAS G12C inhibitor 46 | 2573769-23-8 | Reference compound |
| HY-142949 | ALK5-IN-7 | 2657720-07-3 | Reference compound |
| HY-142950 | ALK5-IN-6 | 2657720-04-0 | Reference compound |
| HY-142952 | UNC6864 (Kei) | Reference compound | |
| HY-142953 | UNC6349 (Ket2) | Reference compound | |
| HY-142954 | UNC6212 (Kme2) | Reference compound | |
| HY-142955 | Dual photoCORM 1 | 2892235-55-9 | Reference compound |
| HY-142956 | ROS-ERS inducer 1 | Reference compound | |
| HY-142957 | NaPi2b-IN-1 | 1453116-06-7 | Reference compound |
| HY-142958 | NF-κB-IN-2 | 1821386-63-3 | Reference compound |
| HY-14296 | PF-610355 | 862541-45-5 | Reference compound |
| HY-142963 | TLR4/NF-κB/MAPK-IN-1 | 2767567-26-8 | Reference compound |
| HY-142965 | HDAC-IN-28 | 1621154-88-8 | Reference compound |
| HY-142967 | TGFβ-IN-1 | 883560-84-7 | Reference compound |
| HY-14297 | Milveterol | 652990-07-3 | Reference compound |
| HY-142971 | 1-Myristoyl-2-Linoleoyl-3-Oleoyl-rac-glycerol | 108961-58-6 | Reference compound |
| HY-142972 | 19(S)-HETE | 115461-40-0 | Reference compound |
| HY-142974 | 1,2-Dioleoyl-3-Docosohexaenoyl-rac-glycerol | 116198-39-1 | Reference compound |
| HY-142975 | N-Pentadecanoyl-psychosine | 112726-51-9 | Reference compound |
| HY-142976 | Tetranor-12(S)-HETE | 121842-79-3 | Reference compound |
| HY-142977 | 6-Oxohexyl 2-hexyldecanoate, 80% (ELSD) | 1849616-54-1 | Biochemical Assay Reagents |
| HY-142978 | 18:0 mPEG2000 PE | 156543-00-9 | Biochemical Assay Reagents |
| HY-142979 | DSPE-PEG 2000 | 892144-24-0 | Biochemical Assay Reagents |
| HY-14298 | Milveterol (hydrochloride) | 804518-03-4 | Reference compound |
| HY-142980 | Dioleoylphosphatidylglycerol | 62700-69-0 | Biochemical Assay Reagents |
| HY-142981 | Dioctadecylamine | 112-99-2 | Biochemical Assay Reagents |
| HY-142982 | Palmitoyloleoylphosphatidylglycerol | 81490-05-3 | Biochemical Assay Reagents |
| HY-142983 | DMPE | 20255-95-2 | Biochemical Assay Reagents |
| HY-142984 | Decanoic acid, 2-hexyl-, 6-oxohexyl ester-1 | 1849616-53-0 | Biochemical Assay Reagents |
| HY-142985 | Oleyl Mesylate | 35709-09-2 | Biochemical Assay Reagents |
| HY-142986 | Dlin-MeOH | 1169768-28-8 | Biochemical Assay Reagents |
| HY-142987 | Linoleyl methane sulfonate | 51154-39-3 | Biochemical Assay Reagents |
| HY-142988 | 1-Stearoyl-2-myristoyl-sn-glycero-3-PC | 20664-02-2 | Biochemical Assay Reagents |
| HY-142989 | 1,2-Didocosahexaenoyl-sn-glycero-3-phosphocholine | 99296-81-8 | Biochemical Assay Reagents |
| HY-14299 | Indacaterol | 312753-06-3 | Reference compound |
| HY-142990 | 1-Oleoyl-2-palmitoyl-sn-glycero-3-PC | 59491-62-2 | Biochemical Assay Reagents |
| HY-142991 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol | 185435-28-3 | Biochemical Assay Reagents |
| HY-142992 | LNP Lipid-2 | 2036272-65-6 | Biochemical Assay Reagents |
| HY-142993 | Dielaidoylphosphatidylethanolamine | 16777-83-6 | Biochemical Assay Reagents |
| HY-142994 | Wybutosine | 55196-46-8 | Biochemical Assay Reagents |
| HY-142995 | DODAP (hydrochloride) | 329009-00-9 | Biochemical Assay Reagents |
| HY-142996 | BGTC | 182056-06-0 | Biochemical Assay Reagents |
| HY-142997 | DOSPA | 282533-23-7 | Biochemical Assay Reagents |
| HY-142998 | Vaxfectin | 370108-99-9 | Biochemical Assay Reagents |
| HY-142999 | DOIC | 1292821-06-7 | Biochemical Assay Reagents |
| HY-14299A | Indacaterol (maleate) | 753498-25-8 | Reference compound |
| HY-14299AR | Indacaterol (maleate) (Standard) | 753498-25-8 | Reference Standards |
| HY-14299B | (S)-Indacaterol | 1235445-80-3 | Reference compound |
| HY-14299C | Indacaterol (xinafoate) | 1000160-97-3 | Reference compound |
| HY-14299D | Indacaterol (acetate) | 1000160-96-2 | Reference compound |
| HY-14299R | Indacaterol (Standard) | 312753-06-3 | Reference Standards |
| HY-14299S | Indacaterol-d3 | 2699828-16-3 | Isotope-Labeled Compounds |
| HY-14300 | Vilanterol | 503068-34-6 | Reference compound |
| HY-14300A | Vilanterol (trifenatate) | 503070-58-4 | Reference compound |
| HY-14300AS | Vilanterol-d4 (trifenatate) | 2021249-10-3 | Isotope-Labeled Compounds |
| HY-14300S2 | Vilanterol-d12 | Isotope-Labeled Compounds | |
| HY-14301 | Olodaterol | 868049-49-4 | Reference compound |
| HY-143017S | 4-Hydroxy Atorvastatin-d5 (disodium) | Isotope-Labeled Compounds | |
| HY-14301A | Olodaterol (hydrochloride) | 869477-96-3 | Reference compound |
| HY-14301AR | Olodaterol (hydrochloride) (Standard) | 869477-96-3 | Reference Standards |
| HY-14302 | Salmeterol | 89365-50-4 | Reference compound |
| HY-143021S | 1,3-Dioleoylglycerol-d5 | 1246523-70-5 | Isotope-Labeled Compounds |
| HY-14302S1 | Salmeterol-d5 | 1093433-84-1 | Isotope-Labeled Compounds |
| HY-14304 | Zinterol | 37000-20-7 | Reference compound |
| HY-14304A | Zinterol (hydrochloride) | 38241-28-0 | Reference compound |
| HY-14305 | BMS-582949 | 623152-17-0 | Reference compound |
| HY-14305A | BMS-582949 (hydrochloride) | 912806-16-7 | Reference compound |
| HY-14307 | Necrocide 1 | 1247028-61-0 | Reference compound |
| HY-14307A | (R)-Necrocide 1 | 1247028-62-1 | Reference compound |
| HY-14308 | GS-9851 | 1064684-44-1 | Reference compound |
| HY-14312 | A 85380 | 161416-98-4 | Reference compound |
| HY-14314 | ABT-418 | 147402-53-7 | Reference compound |
| HY-14316 | Tebanicline | 198283-73-7 | Reference compound |
| HY-14316A | Tebanicline (dihydrochloride) | 209326-19-2 | Reference compound |
| HY-14316B | Tebanicline (hydrochloride) | 203564-54-9 | Reference compound |
| HY-14316C | Tebanicline (tosylate) | 198283-74-8 | Reference compound |
| HY-14319A | Sazetidine A (hydrochloride) | 1197329-42-2 | Reference compound |
| HY-14319B | Sazetidine A (dihydrochloride) | 2455450-63-0 | Reference compound |
| HY-143200 | OSBPL7-IN-1 | 1269826-44-9 | Reference compound |
| HY-143201 | DS20362725 | 2735803-20-8 | Reference compound |
| HY-143202 | DPhPC | 207131-40-6 | Biochemical Assay Reagents |
| HY-143203 | 18:0-18:2 PE | 7266-53-7 | Biochemical Assay Reagents |
| HY-143204 | (Rac)-POPC | 26662-91-9 | Biochemical Assay Reagents |
| HY-143205 | Desthiobiotin polyethyleneoxide iodoacetamide | Reference compound | |
| HY-143206 | Tyrosinase/elastase-IN-1 | Reference compound | |
| HY-143207 | 10-Formyl-5,8-dideazafolic acid | 61038-31-1 | Reference compound |
| HY-143208 | HOE 33187-O-CONH-PEG4-phenol-thiophenone-NHPh-COOEt | 2641500-83-4 | Reference compound |
| HY-143209A | DSPE-PEG1000-OH (sodium) | 871327-06-9 | Natural Products |
| HY-143209B | DSPE-PEG3400 | 145035-96-7 | Biochemical Assay Reagents |
| HY-143210 | Transfectam | 124050-77-7 | Biochemical Assay Reagents |
| HY-143211 | Murapalmitine | 133863-30-6 | Biochemical Assay Reagents |
| HY-143212 | 18:0-22:6 DG | 65886-80-8 | Biochemical Assay Reagents |
| HY-143216 | Ensitrelvir | 2647530-73-0 | Reference compound |
| HY-143216A | Ensitrelvir (fumarate) | 2757470-18-9 | Reference compound |
| HY-143218 | TPE-MI | 1245606-71-6 | Dye Reagents |
| HY-143219 | SS-Inclisiran (sodium) | Oligonucleotides | |
| HY-143220 | SS(no Galnac)-Inclisiran (sodium) | Oligonucleotides | |
| HY-143221 | AS-Inclisiran (sodium) | Oligonucleotides | |
| HY-143224 | NCGC00138783 | Reference compound | |
| HY-143224A | NCGC00138783 (free base) | 896700-07-5 | Reference compound |
| HY-143224B | NCGC00138783 (TFA) | Reference compound | |
| HY-143225 | NCGC00538431 | Reference compound | |
| HY-143226 | DK1 | 1187568-17-7 | Reference compound |
| HY-143227 | DK3 | 1187568-16-6 | Reference compound |
| HY-143228 | SH-42 | 2143952-36-5 | Reference compound |
| HY-143230 | Custirsen | 890056-27-6 | Oligonucleotides |
| HY-143230A | Custirsen (sodium) | Oligonucleotides | |
| HY-143231 | IRAK4-IN-8 | 2033070-97-0 | Reference compound |
| HY-143232 | Antibacterial agent 73 | 414885-92-0 | Reference compound |
| HY-143233 | PIM-1/HDAC-IN-1 | 2897622-19-2 | Reference compound |
| HY-143234 | mIDH1-IN-1 | 2757155-96-5 | Reference compound |
| HY-143235 | BRD4 Inhibitor-15 | 2761366-60-1 | Reference compound |
| HY-143236 | DHFR-IN-1 | 2757991-65-2 | Reference compound |
| HY-143237 | ATX inhibitor 11 | 2485779-27-7 | Reference compound |
| HY-143238 | FY-56 | Reference compound | |
| HY-143239 | PPARα/γ agonist 1 | Reference compound | |
| HY-143241 | HDAC-IN-34 | 2857097-33-5 | Reference compound |
| HY-143242 | Phidianidine B | 1301638-42-5 | Natural Products |
| HY-143243 | Antioxidant agent-5 | 2684291-60-7 | Reference compound |
| HY-143244 | Monoamine Oxidase B inhibitor 1 | 2807477-70-7 | Reference compound |
| HY-143245 | Monoamine Oxidase B inhibitor 2 | 2807477-26-3 | Reference compound |
| HY-143246 | EGFR kinase inhibitor 1 | 2413958-04-8 | Reference compound |
| HY-143247 | Tubulin polymerization-IN-2 | 2873399-22-3 | Reference compound |
| HY-143248 | KR-39038 | 2770300-35-9 | Reference compound |
| HY-143249 | MtMetAP1-IN-1 | Reference compound | |
| HY-14325 | L-745870 | 158985-00-3 | Reference compound |
| HY-143250 | Tubulin inhibitor 12 | 92575-00-3 | Reference compound |
| HY-143251 | Tubulin inhibitor 13 | 2883436-66-4 | Reference compound |
| HY-143252 | CEase-IN-1 | 2985688-68-2 | Reference compound |
| HY-143253 | Estrogen receptor antagonist 7 | 2889371-04-2 | Reference compound |
| HY-143254 | Enpp-1-IN-10 | 2631704-38-4 | Reference compound |
| HY-143255 | Enpp-1-IN-11 | Reference compound | |
| HY-143256 | Enpp-1-IN-12 | 2631703-41-6 | Reference compound |
| HY-143257 | CDK4/6-IN-7 | 2649120-20-5 | Reference compound |
| HY-143258 | CDK4/6-IN-8 | 2649120-22-7 | Reference compound |
| HY-143259 | BE1218 | 2893967-40-1 | Reference compound |
| HY-14325A | L-745870 (trihydrochloride) | 866021-03-6 | Reference compound |
| HY-14325B | L-745870 (hydrochloride) | 1173023-36-3 | Reference compound |
| HY-143260 | GSK-3β inhibitor 6 | Reference compound | |
| HY-143261 | GSK-3β inhibitor 7 | Reference compound | |
| HY-143263 | FAAH/MAGL-IN-1 | Reference compound | |
| HY-143264 | FAAH/MAGL-IN-2 | 2765077-82-3 | Reference compound |
| HY-143265 | Topoisomerase I inhibitor 2 | 2588211-44-1 | Reference compound |
| HY-143266 | Topoisomerase I inhibitor 3 | 2588211-50-9 | Reference compound |
| HY-143267 | Estrogen receptor antagonist 8 | 2889370-92-5 | Reference compound |
| HY-143268 | HPA-IN-1 | Reference compound | |
| HY-143269 | HPA-IN-2 | 2885971-91-3 | Reference compound |
| HY-14327 | FAUC 213 | 337972-47-1 | Reference compound |
| HY-143270 | PROTAC BRD9-binding moiety 5 | 893633-37-9 | Reference compound |
| HY-143271 | RORγt inverse agonist 29 | Reference compound | |
| HY-143272 | FGFR1 inhibitor-6 | Reference compound | |
| HY-143273 | DENV-IN-6 | 2375780-95-1 | Reference compound |
| HY-143274 | DENV-IN-5 | 2375781-06-7 | Reference compound |
| HY-143275 | HL-8 | 2766352-64-9 | Reference compound |
| HY-143276 | (S,S,R)-AHPC-C6-NH2 | 2411422-68-7 | Reference compound |
| HY-143276A | (S,S,R)-AHPC-C6-NH2 (hydrochloride) | Reference compound | |
| HY-143277 | HL-2 | 2766352-49-0 | Reference compound |
| HY-143278 | FLT3-IN-13 | Reference compound | |
| HY-143279 | Topoisomerase II inhibitor 3 | 99140-25-7 | Reference compound |
| HY-14328 | Sonepiprazole | 170858-33-0 | Reference compound |
| HY-143280 | Topoisomerase II inhibitor 4 | 2560590-49-8 | Reference compound |
| HY-143281 | Topoisomerase II inhibitor 5 | Reference compound | |
| HY-143285 | AMC-GlcNAc | Dye Reagents | |
| HY-143286 | PF15 | 2892631-70-6 | Reference compound |
| HY-143286A | PF15 (TFA) | Reference compound | |
| HY-143287 | NTPDase-IN-1 | 2962812-29-7 | Reference compound |
| HY-143288 | NTPDase-IN-2 | 2883147-47-3 | Reference compound |
| HY-143289 | NTPDase-IN-3 | 2883147-45-1 | Reference compound |
| HY-14328A | Sonepiprazole (hydrochloride) | 170857-36-0 | Reference compound |
| HY-143290 | Antibacterial agent 118 | Reference compound | |
| HY-143291 | AChE-IN-9 | Reference compound | |
| HY-143292 | Antibacterial agent 81 | 2873395-27-6 | Reference compound |
| HY-143293 | VEGFR-IN-3 | 2874264-13-6 | Reference compound |
| HY-143294 | sEH inhibitor-2 | 2816102-69-7 | Reference compound |
| HY-143295 | Pim-1 kinase inhibitor 1 | 2803505-57-7 | Reference compound |
| HY-143296 | SphK1-IN-1 | Reference compound | |
| HY-143299 | BRD4-BD1-IN-1 | 2761321-18-8 | Reference compound |
| HY-14330 | ABT-724 | 70006-24-5 | Reference compound |
| HY-143300 | BRD4-BD1-IN-2 | 2761321-26-8 | Reference compound |
| HY-143301 | Topoisomerase I inhibitor 4 | 2485135-31-5 | Reference compound |
| HY-143302 | Anticancer agent 31 | 2222930-72-3 | Reference compound |
| HY-143303 | Anticancer agent 32 | 2222930-76-7 | Reference compound |
| HY-143305 | PD-1/PD-L1-IN-25 | 2768759-52-8 | Reference compound |
| HY-143306 | IDH1 Inhibitor 5 | 1940128-37-9 | Reference compound |
| HY-143312 | V-0219 | 878453-71-5 | Reference compound |
| HY-143312A | V-0219 (hydrochloride) | 2922283-73-4 | Reference compound |
| HY-143312B | (R)-V-0219 | 3031984-80-9 | Reference compound |
| HY-143312C | (S)-V-0219 | 3031984-78-5 | Reference compound |
| HY-143312D | (R)-V-0219 (hydrochloride) | Reference compound | |
| HY-143312E | (S)-V-0219 (hydrochloride) | Reference compound | |
| HY-143313 | Protease-Activated Receptor-1 antagonist 1 | Reference compound | |
| HY-143314 | Protease-Activated Receptor-1 antagonist 2 | 1454588-34-1 | Reference compound |
| HY-143315 | Protease-Activated Receptor-1 antagonist 3 | Reference compound | |
| HY-143316 | NPR-C activator 1 | 2768328-61-4 | Reference compound |
| HY-143317 | XY153 | 2933176-32-8 | Reference compound |
| HY-143319 | SPH5030 | 2364326-23-6 | Reference compound |
| HY-143320 | STING agonist-17 | 2816929-47-0 | Reference compound |
| HY-143321 | STING agonist-13 | 2816929-48-1 | Reference compound |
| HY-143322 | CRK12-IN-2 | 1990479-17-8 | Reference compound |
| HY-143323 | HER2-IN-9 | Reference compound | |
| HY-143324 | A2AAR/HDAC-IN-1 | 2767560-51-8 | Reference compound |
| HY-143325 | A2AAR/HDAC-IN-2 | 2767560-94-9 | Reference compound |
| HY-143326 | Antibacterial agent 83 | 2413865-92-4 | Reference compound |
| HY-143327 | PROTAC BRD4 Degrader-16 | 2585561-36-8 | Reference compound |
| HY-143328 | PROTAC BRD4 Degrader-17 | 2585561-49-3 | Reference compound |
| HY-143329 | MAO-B-IN-3 | Reference compound | |
| HY-143330 | MAO-B-IN-4 | Reference compound | |
| HY-143332 | TRIM24/BRPF1-IN-2 | 3033288-68-2 | Reference compound |
| HY-143333 | Nrf2 activator-3 | 2766570-23-2 | Reference compound |
| HY-143334 | Antifungal agent 84 | 2901064-07-9 | Reference compound |
| HY-143335 | Antifungal agent 52 | 2901064-06-8 | Reference compound |
| HY-143337 | EGFR-IN-47 | 3034649-73-2 | Reference compound |
| HY-143338 | ART-IN-1 | 2418014-98-7 | Reference compound |
| HY-143339 | CBP/p300-IN-15 | 2379409-91-1 | Reference compound |
| HY-14334 | SAM-315 | 744218-85-7 | Reference compound |
| HY-143340 | LEB-03-145 | 2858812-90-3 | Reference compound |
| HY-143342 | LEB-03-144 | 2858812-89-0 | Reference compound |
| HY-143343 | LEB-03-153 | 2858812-88-9 | Reference compound |
| HY-143344 | NJH-2-056 | 2858812-69-6 | Reference compound |
| HY-143345 | EN523 | 2094893-05-5 | Reference compound |
| HY-143346 | CCW16 | 2361138-33-0 | Reference compound |
| HY-143348 | NJH-2-030 | 2709040-02-6 | Reference compound |
| HY-14335 | Ro 04-6790 | 202466-68-0 | Reference compound |
| HY-143355S | Albendazole-2-Aminosulfone-d3 (hydrochloride) | 1435902-07-0 | Isotope-Labeled Compounds |
| HY-143359 | COTI-219 | 1039455-85-0 | Reference compound |
| HY-143359S | COTI-219-d8 | Isotope-Labeled Compounds | |
| HY-14335A | Ro 04-6790 di(hydrochloride) | 1197333-95-1 | Reference compound |
| HY-14336 | SB 271046 | 209481-20-9 | Reference compound |
| HY-143367S | 27-Hydroxy cholesterol-d6 | 1246302-95-3 | Isotope-Labeled Compounds |
| HY-143368S | L-Phenylmercapturic acid-d5 | 1331906-27-4 | Isotope-Labeled Compounds |
| HY-14336A | SB 271046 (Hydrochloride) | 209481-24-3 | Reference compound |
| HY-14337 | MS 245 | 263384-65-2 | Reference compound |
| HY-143377 | Cdc7-IN-8 | 2606780-38-3 | Reference compound |
| HY-14338 | Idalopirdine | 467459-31-0 | Reference compound |
| HY-143380 | Cdc7-IN-9 | 2649407-21-4 | Reference compound |
| HY-143385 | Cdc7-IN-12 | 2764865-33-8 | Reference compound |
| HY-143387 | Cdc7-IN-13 | 2764866-23-9 | Reference compound |
| HY-143389 | Cdc7-IN-14 | 2764866-21-7 | Reference compound |
| HY-14338A | Idalopirdine (hydrochloride) | 467458-02-2 | Reference compound |
| HY-14339 | Intepirdine | 607742-69-8 | Reference compound |
| HY-143390 | NMDA receptor modulator 2 | 2758255-05-7 | Reference compound |
| HY-143391 | NMDA receptor modulator 3 | 2758256-02-7 | Reference compound |
| HY-143393 | NMDA receptor modulator 4 | 2758256-71-0 | Reference compound |
| HY-143396 | NMDA receptor modulator 5 | 2758256-97-0 | Reference compound |
| HY-143397 | NMDA receptor modulator 6 | 2758256-85-6 | Reference compound |
| HY-143398 | PARP10/15-IN-1 | 2892065-01-7 | Reference compound |
| HY-14340 | WAY-181187 | 554403-49-5 | Peptides |
| HY-143400 | HSP70-IN-3 | Reference compound | |
| HY-143401 | Hit 1 | 2785377-42-4 | Reference compound |
| HY-143402 | Topoisomerase I/II inhibitor 2 | 2770804-58-3 | Reference compound |
| HY-143403 | PI3K-IN-31 | 1359956-12-9 | Reference compound |
| HY-143404 | PI3K-IN-30 | 2281803-22-1 | Reference compound |
| HY-143405 | Antifungal agent 24 | 2566522-60-7 | Reference compound |
| HY-143406 | Antifungal agent 25 | 2566522-50-5 | Reference compound |
| HY-143407 | FAK-IN-3 | 2882094-29-1 | Reference compound |
| HY-143408 | OYYF-175 | 65829-22-3 | Reference compound |
| HY-143409 | Antimalarial agent 10 | 2747280-03-9 | Reference compound |
| HY-143410 | Anti-inflammatory agent 16 | Reference compound | |
| HY-143411 | GEM144 | 2487526-28-1 | Reference compound |
| HY-143412 | MIR002 | 2217671-64-0 | Reference compound |
| HY-143413 | BuChE-IN-2 | 2745118-93-6 | Reference compound |
| HY-143414 | Metallo-β-lactamase-IN-6 | 1439899-44-1 | Reference compound |
| HY-143415 | Metallo-β-lactamase-IN-7 | 2752453-58-8 | Reference compound |
| HY-143417 | SARS-CoV-2-IN-16 | 2761911-40-2 | Reference compound |
| HY-143418 | SARS-CoV-2-IN-17 | 2761911-44-6 | Reference compound |
| HY-143419 | ATX inhibitor 14 | 2484811-39-2 | Reference compound |
| HY-14342 | MK-5046 | 1022152-70-0 | Reference compound |
| HY-143420 | ATX inhibitor 15 | 2484811-52-9 | Reference compound |
| HY-143421 | Curcumin monoglucuronide | 2171091-50-0 | Reference compound |
| HY-143422 | MALT1-IN-3 | 2504229-63-2 | Reference compound |
| HY-143422A | (R)-MALT1-IN-3 | 2504229-61-0 | Reference compound |
| HY-143423 | MALT1-IN-5 | 2434602-73-8 | Reference compound |
| HY-143423A | (S)-MALT1-IN-5 | 2434602-25-0 | Reference compound |
| HY-143424 | MALT1-IN-6 | 2254669-07-1 | Reference compound |
| HY-143425 | MALT1-IN-7 | 2178993-11-6 | Reference compound |
| HY-143425A | (R)-MALT1-IN-7 | 2178993-10-5 | Reference compound |
| HY-143426 | MALT1-IN-8 | 2244109-29-1 | Reference compound |
| HY-143427 | MALT1-IN-9 | 2577170-77-3 | Reference compound |
| HY-143429 | Cdc7-IN-15 | 1244027-03-9 | Reference compound |
| HY-14342A | (R)-MK-5046 | 1021736-25-3 | Reference compound |
| HY-143430 | (S)-LY3177833 | 1627696-52-9 | Reference compound |
| HY-143430A | (S)-LY3177833 (hydrate) | 2733342-93-1 | Reference compound |
| HY-143431 | Cdc7-IN-17 | 2253686-94-9 | Reference compound |
| HY-143432 | Cdc7-IN-18 | 2562329-14-8 | Reference compound |
| HY-143432A | (S)-Cdc7-IN-18 | 2562329-13-7 | Reference compound |
| HY-143433 | Cdc7-IN-19 | 2606780-39-4 | Reference compound |
| HY-143434 | FLT3/D835Y-IN-1 | 2648799-49-7 | Reference compound |
| HY-143435 | AG6033 | 329706-62-9 | Reference compound |
| HY-143436 | TNIK-IN-4 | 2754266-04-9 | Reference compound |
| HY-143437 | TNIK-IN-5 | 2754265-66-0 | Reference compound |
| HY-143438 | 2-PAT | 134467-58-6 | Reference compound |
| HY-143439 | LX-039 | 2135341-09-0 | Reference compound |
| HY-143440 | CBP/p300-IN-16 | Reference compound | |
| HY-143441 | CBP/p300-IN-17 | 2259640-87-2 | Reference compound |
| HY-143442 | CBP/p300-IN-18 | 2983027-64-9 | Reference compound |
| HY-143443 | DS17701585 | 2983027-66-1 | Reference compound |
| HY-143444 | JAK-IN-20 | 1654776-91-6 | Reference compound |
| HY-143445 | EGFR-IN-48 | 2882851-77-4 | Reference compound |
| HY-143446 | Tubulin polymerization-IN-7 | 1394017-46-9 | Reference compound |
| HY-143447 | Tubulin polymerization-IN-8 | 2768485-08-9 | Reference compound |
| HY-143448 | Tyrosinase-IN-1 | 1164200-43-4 | Reference compound |
| HY-143449 | Tyrosinase-IN-2 | 180864-33-9 | Reference compound |
| HY-143450 | Tyrosinase-IN-3 | 2409081-40-7 | Reference compound |
| HY-143451 | Tyrosinase-IN-4 | 19275-70-8 | Reference compound |
| HY-143452 | MtTMPK-IN-4 | 2225889-49-4 | Reference compound |
| HY-143454 | Germination-IN-1 | 65384-76-1 | Reference compound |
| HY-143455 | Germination-IN-2 | 89846-43-5 | Reference compound |
| HY-143456 | Anti-inflammatory agent 18 | 2873386-66-2 | Reference compound |
| HY-143457 | Anti-inflammatory agent 19 | 2873386-63-9 | Reference compound |
| HY-143458 | FAK PROTAC B5 | 2471525-44-5 | Reference compound |
| HY-143459 | Tyrosinase-IN-5 | 2525175-90-8 | Reference compound |
| HY-14346 | PD153035 | 153436-54-5 | Reference compound |
| HY-143460 | CAXII-IN-1 | 2479918-59-5 | Reference compound |
| HY-143461 | CK2 inhibitor 3 | Reference compound | |
| HY-143462 | c-Met/HDAC-IN-2 | 2740495-53-6 | Reference compound |
| HY-143463 | AC-386 | 1902910-89-7 | Reference compound |
| HY-143464 | BChE-IN-4 | 2304818-41-3 | Reference compound |
| HY-143465 | BChE-IN-5 | 2983586-25-8 | Reference compound |
| HY-143466 | ULK1-IN-2 | 2497409-01-3 | Reference compound |
| HY-143467 | SARS-CoV-IN-4 | 2445585-37-3 | Reference compound |
| HY-143468 | MEK-IN-5 | 2417022-06-9 | Reference compound |
| HY-143469 | NPP1-IN-1 | 2493063-65-1 | Reference compound |
| HY-14347 | EBE-A22 | 229476-53-3 | Reference compound |
| HY-143470 | SARS-CoV-2-IN-18 | 184904-82-3 | Reference compound |
| HY-143471 | WNY0824 | 2412707-81-2 | Reference compound |
| HY-143472 | PI3Kδ-IN-11 | 2413257-51-7 | Reference compound |
| HY-143473 | FabG1-IN-1 | 1051177-61-7 | Reference compound |
| HY-143474 | POP-IN-3 | 2554621-98-4 | Reference compound |
| HY-143475 | POP-IN-2 | 2743432-81-5 | Reference compound |
| HY-143476 | Plasma kallikrein-IN-2 | Reference compound | |
| HY-143477 | Factor XI-IN-1 | 2720619-72-5 | Reference compound |
| HY-143478 | HIV-IN-1 | 2756837-91-7 | Reference compound |
| HY-143479 | HIV-IN-2 | 2756838-41-0 | Reference compound |
| HY-14348 | GSK163090 | 844903-58-8 | Reference compound |
| HY-143480 | RIPK1-IN-15 | 2755704-34-6 | Reference compound |
| HY-143481 | Nav1.8-IN-2 | 2756250-30-1 | Reference compound |
| HY-143482 | MMV688844 | 2650213-59-3 | Reference compound |
| HY-143483 | NBTIs-IN-5 | 2767443-78-5 | Reference compound |
| HY-143484 | 844-TFM | 2767443-97-8 | Reference compound |
| HY-143485 | IRAK4-IN-9 | 2681278-07-7 | Reference compound |
| HY-143486 | IRAK4-IN-10 | 2681278-09-9 | Reference compound |
| HY-143487 | Antimalarial agent 12 | 2715225-58-2 | Reference compound |
| HY-143488 | Neuraminidase-IN-8 | 2716197-09-8 | Reference compound |
| HY-143490 | PAK4-IN-2 | 2488706-33-6 | Reference compound |
| HY-143491 | VS 8 | 2471865-38-8 | Reference compound |
| HY-143492 | Influenza virus-IN-1 | 108729-21-1 | Reference compound |
| HY-143493 | Influenza virus-IN-2 | 2411584-06-8 | Reference compound |
| HY-143494 | RSV/IAV-IN-3 | 2395007-81-3 | Reference compound |
| HY-143495 | RSV-IN-3 | 862825-90-9 | Reference compound |
| HY-143496 | RSV-IN-4 | 862825-89-6 | Reference compound |
| HY-143497 | HDAC1/2 and CDK2-IN-1 | 2418559-01-8 | Reference compound |
| HY-143498 | ERCC1-XPF-IN-1 | 2411584-25-1 | Reference compound |
| HY-143499 | hMAO-B-IN-3 | 2581113-51-9 | Reference compound |
| HY-14350 | AC-55541 | 916170-19-9 | Reference compound |
| HY-143504S | Mono(3-hydroxybutyl)phthalate-d4 | 2119601-77-1 | Isotope-Labeled Compounds |
| HY-14351 | AC-264613 | 1051487-82-1 | Reference compound |
| HY-143510 | RMC-4627 | 2250059-52-8 | Reference compound |
| HY-143518 | TP-16 | 2332972-26-4 | Reference compound |
| HY-143519S | Isopropyl phenyl-d7 | 2469037-60-1 | Isotope-Labeled Compounds |
| HY-143527S | Clavulanic acid methyl ester-d3 | 1821757-56-5 | Isotope-Labeled Compounds |
| HY-14353 | GSK-9772 | 928035-84-1 | Reference compound |
| HY-143535 | HG122 | 1854976-77-4 | Reference compound |
| HY-143539 | YQ456 | 2093946-08-6 | Reference compound |
| HY-143542S | Nor neostigmine-d6 | 2470126-73-7 | Isotope-Labeled Compounds |
| HY-143545 | RET-IN-8 | 2642164-75-6 | Reference compound |
| HY-143546 | RET-IN-9 | 2649418-11-9 | Reference compound |
| HY-143547S | L-Hercynine-d3 | 1639966-63-4 | Isotope-Labeled Compounds |
| HY-143557 | Trk-IN-7 | 2383011-61-6 | Reference compound |
| HY-14356 | ADL5859 | 850305-06-5 | Reference compound |
| HY-143561 | Trk-IN-8 | 2762200-57-5 | Reference compound |
| HY-143563 | NLRP3 antagonist 1 | 2454017-83-3 | Reference compound |
| HY-143564S | Glycinexylidide-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143568 | P2X3 antagonist 36 | 2310263-59-1 | Reference compound |
| HY-14357 | BMS 695735 | 1054315-48-8 | Reference compound |
| HY-143576 | P2X3 antagonist 37 | 2649318-40-9 | Reference compound |
| HY-143581 | ATX inhibitor 8 | 2156656-37-8 | Reference compound |
| HY-143582 | ATX inhibitor 9 | 2640300-87-2 | Reference compound |
| HY-143583 | ATX inhibitor 10 | 2648969-30-4 | Reference compound |
| HY-143584 | AZ5576 | 2751721-40-9 | Reference compound |
| HY-143585 | CDK9-IN-14 | 2650640-17-6 | Reference compound |
| HY-143586 | CDK7-IN-8 | 2654003-64-0 | Reference compound |
| HY-143587 | CDK7-IN-2 | 2326428-19-5 | Reference compound |
| HY-143588 | KRAS G12C inhibitor 35 | 2650550-87-9 | Reference compound |
| HY-143589 | Glecirasib | 2657613-87-9 | Reference compound |
| HY-143590 | KRAS G12C inhibitor 37 | 2241720-04-5 | Reference compound |
| HY-143591 | KRAS G12C inhibitor 38 | 2660129-56-4 | Reference compound |
| HY-143592 | KRAS G12C inhibitor 39 | 2326522-16-9 | Reference compound |
| HY-143594 | KRAS G12C inhibitor 40 | 2660014-14-0 | Reference compound |
| HY-143596 | KRAS G12C inhibitor 41 | 2660014-65-1 | Reference compound |
| HY-143598 | KRAS G12C inhibitor 42 | 2454488-02-7 | Reference compound |
| HY-143599 | KRAS G12D inhibitor 8 | 2648221-05-8 | Reference compound |
| HY-143602 | KRAS G12D inhibitor 9 | 2648551-39-5 | Reference compound |
| HY-143603 | KRAS G12D inhibitor 10 | 2648551-54-4 | Reference compound |
| HY-143604 | KRAS G12D inhibitor 11 | 2648551-72-6 | Reference compound |
| HY-143606 | KRAS G12D inhibitor 12 | 2648552-54-7 | Reference compound |
| HY-143607 | KRAS G12D inhibitor 13 | 2648552-62-7 | Reference compound |
| HY-14361 | MK-4965 | 920035-77-4 | Reference compound |
| HY-143610 | AKT-IN-7 | 2654025-97-3 | Reference compound |
| HY-143611 | AKT-IN-8 | 2654026-13-6 | Reference compound |
| HY-143613 | THR-β agonist 2 | 2440027-77-8 | Reference compound |
| HY-143613A | THR-β agonist 2 (diacetate) | Reference compound | |
| HY-143614 | THR-β agonist 3 | 2656400-84-7 | Reference compound |
| HY-143615 | RET-IN-10 | 2662622-44-6 | Reference compound |
| HY-143616 | EZH2-IN-7 | 2659225-28-0 | Reference compound |
| HY-143617 | photoCORM-1 | 2892235-56-0 | Reference compound |
| HY-143618 | photoCORM-2 | 2892235-54-8 | Reference compound |
| HY-14362 | GSK-25 | 874119-56-9 | Reference compound |
| HY-143623S | Neo Spiramycin I-d3 | Isotope-Labeled Compounds | |
| HY-14363 | TUG-424 | 1082058-99-8 | Reference compound |
| HY-14364 | A-987306 | 1082954-71-9 | Reference compound |
| HY-143641 | Anticancer agent 25 | 2401013-08-7 | Reference compound |
| HY-143643 | Antibacterial agent 72 | 2412500-67-3 | Reference compound |
| HY-143645S | Glycochenodeoxycholic acid 3-sulfate-d5 (disodium) | Isotope-Labeled Compounds | |
| HY-14365 | TC-G 1004 | 1061747-72-5 | Reference compound |
| HY-143652S | trans-Hydroxy praziquantel-d5 | 1792180-18-7 | Isotope-Labeled Compounds |
| HY-143653 | BCL6-IN-6 | 2408882-54-0 | Reference compound |
| HY-143654 | WW437 | Reference compound | |
| HY-143655 | QW24 | 2416312-06-4 | Reference compound |
| HY-143656 | SH379 | 2338793-00-1 | Reference compound |
| HY-143657 | Myoferlin inhibitor 1 | 2366279-99-2 | Reference compound |
| HY-143658 | SH498 | 2125724-38-9 | Reference compound |
| HY-143659 | QW30 | 1714112-25-0 | Reference compound |
| HY-14366 | Antibiotic A-33853 | 80148-45-4 | Natural Products |
| HY-143660 | LG308 | 1428341-65-4 | Reference compound |
| HY-143662S | (±)12(13)-DiHOME-d4 | Isotope-Labeled Compounds | |
| HY-143664S | (±)14(15)-DiHET-d11 | Isotope-Labeled Compounds | |
| HY-143665S | Nor-W-18-d4 | 2701349-29-1 | Isotope-Labeled Compounds |
| HY-143666S | DPPI-3,4,5-P3-d62 (sodium) | Isotope-Labeled Compounds | |
| HY-14367 | Emicerfont | 786701-13-1 | Reference compound |
| HY-143670S | 1-Palmitoyl-2-arachidonoyl-3-palmitoyl-sn-glycerol-d9 | Isotope-Labeled Compounds | |
| HY-143671S | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-PE-d11 | 2750554-96-0 | Isotope-Labeled Compounds |
| HY-143675S | 1-Palmitoyl-2-palmitoyl-sn-glycero-3-PS-d9 | Isotope-Labeled Compounds | |
| HY-143676S | (1E,4Z,6E)-Curcumin-d6 | 1335198-02-1 | Isotope-Labeled Compounds |
| HY-143677S | (±)11-HETE-d8 | 2750534-80-4 | Isotope-Labeled Compounds |
| HY-143678 | Citrulline-specific probe-biotin | 2468149-70-2 | Reference compound |
| HY-143679S | 4-(3',6'-Dimethyl-3'-heptyl)phenol diethoxylate-13C6 | 1173019-36-7 | Isotope-Labeled Compounds |
| HY-143681S | (Rac)-2-Palmitoyl-3-chloropropanediol-d5 | 1329614-79-0 | Isotope-Labeled Compounds |
| HY-143684S | N-(3-Mercapto-2-methylpropanoyl)glycine-d5 | 1184993-97-2 | Isotope-Labeled Compounds |
| HY-143686 | ImmTher | 143005-30-5 | Biochemical Assay Reagents |
| HY-143688 | EDMPC | 183283-19-4 | Biochemical Assay Reagents |
| HY-143689 | 18:1 Ethylene Glycol | 928-24-5 | Biochemical Assay Reagents |
| HY-14369 | Elagolix sodium | 832720-36-2 | Reference compound |
| HY-143690S | Oxybutynin-10d (hydrochloride) | 120092-65-1 | Isotope-Labeled Compounds |
| HY-143691 | MGlc-DAG | 2021179-21-3 | Biochemical Assay Reagents |
| HY-143692 | SQDG | 123036-44-2 | Biochemical Assay Reagents |
| HY-143693 | DGDG | 63142-69-8 | Biochemical Assay Reagents |
| HY-143695 | 16:0 TAP | 139984-36-4 | Biochemical Assay Reagents |
| HY-143699S | (Rac)-1,2-Bis-palmitol-3-chloropropanediol-d5 | 1185057-55-9 | Isotope-Labeled Compounds |
| HY-14369R | Elagolix sodium (Standard) | 832720-36-2 | Reference Standards |
| HY-14369S | Elagolix-13C,d3 (sodium) | Isotope-Labeled Compounds | |
| HY-14370 | LX2931 | 948840-25-3 | Reference compound |
| HY-143700 | 18:0 DAP | 121315-93-3 | Biochemical Assay Reagents |
| HY-143702 | Fluorescent DOTAP | 1010076-97-7 | Biochemical Assay Reagents |
| HY-143704S | 5-Aminosalicylic acid-13C6 (hydrochloride) | 1261398-47-3 | Isotope-Labeled Compounds |
| HY-143709S | Phthalic acid bis(3,7-dimethyloctyl) ester-d4 | 1398065-81-0 | Isotope-Labeled Compounds |
| HY-143711S | Trimethyllysine-d9 | 1182037-78-0 | Isotope-Labeled Compounds |
| HY-143712 | Allolithocholic acid | 2276-94-0 | Reference compound |
| HY-143712R | Allolithocholic acid (Standard) | 2276-94-0 | Reference Standards |
| HY-143712S1 | Allolithocholic Acid-d4 | Isotope-Labeled Compounds | |
| HY-143713 | Aurora A inhibitor 1 | 2677799-04-9 | Reference compound |
| HY-143714 | Cathepsin K inhibitor 2 | 2672478-52-1 | Reference compound |
| HY-143715 | Cereblon inhibitor 1 | 2672489-14-2 | Reference compound |
| HY-143716 | JAK3/BTK-IN-1 | 2674036-91-8 | Reference compound |
| HY-143717 | JAK3/BTK-IN-2 | 2674036-93-0 | Reference compound |
| HY-143718 | JAK3/BTK-IN-3 | 2674036-98-5 | Reference compound |
| HY-143719 | JAK3/BTK-IN-4 | 2673196-38-6 | Reference compound |
| HY-14372 | BS-194 | 1092443-55-4 | Reference compound |
| HY-143720 | JAK3/BTK-IN-5 | 2673196-75-1 | Reference compound |
| HY-143721 | SSAO inhibitor-2 | 2671028-06-9 | Reference compound |
| HY-143723 | SSAO inhibitor-3 | 2671028-09-2 | Reference compound |
| HY-143726 | RIPK1-IN-8 | 2319663-07-3 | Reference compound |
| HY-143727 | RIPK1-IN-9 | 2682889-57-0 | Reference compound |
| HY-143728 | RIPK1-IN-10 | 2682889-51-4 | Reference compound |
| HY-143729 | EGFR-IN-29 | 2682200-93-5 | Reference compound |
| HY-14373 | CB30865 | 206275-15-2 | Reference compound |
| HY-143730 | BTK inhibitor 20 | 2696450-27-6 | Reference compound |
| HY-143733 | HER2-IN-5 | 2691891-36-6 | Reference compound |
| HY-143734 | HER2-IN-6 | 2691891-38-8 | Reference compound |
| HY-143735 | RAD51-IN-4 | 2267336-26-3 | Reference compound |
| HY-143736 | RAD51-IN-5 | 2690367-19-0 | Reference compound |
| HY-143737 | RAD51-IN-6 | 2690367-57-6 | Reference compound |
| HY-14374 | GPP78 | 1202580-59-3 | Reference compound |
| HY-143741 | RAD51-IN-7 | 2690368-52-4 | Reference compound |
| HY-143743 | Cap-dependent endonuclease-IN-2 | 2303917-78-2 | Reference compound |
| HY-143744 | Suraxavir marboxil | 2364589-86-4 | Reference compound |
| HY-143747 | Cap-dependent endonuclease-IN-5 | 2416258-53-0 | Reference compound |
| HY-143749 | Cap-dependent endonuclease-IN-6 | 2489248-15-7 | Reference compound |
| HY-14375 | CB 300919 | 289715-28-2 | Reference compound |
| HY-143750 | Cap-dependent endonuclease-IN-7 | 2485715-97-5 | Reference compound |
| HY-143752 | Cap-dependent endonuclease-IN-8 | 2454680-16-9 | Reference compound |
| HY-143755 | Cap-dependent endonuclease-IN-9 | 2631005-84-8 | Reference compound |
| HY-143757 | Cap-dependent endonuclease-IN-10 | 2663989-04-4 | Reference compound |
| HY-14376 | Redafamdastat | 1020315-31-4 | Reference compound |
| HY-143762 | Cap-dependent endonuclease-IN-12 | 2460686-97-7 | Reference compound |
| HY-143766 | Cap-dependent endonuclease-IN-13 | 2703046-60-8 | Reference compound |
| HY-143767S | N-Desmethyl Azelastine-d4-1 | Isotope-Labeled Compounds | |
| HY-143768 | Cap-dependent endonuclease-IN-14 | 2740486-73-9 | Reference compound |
| HY-143769 | Cap-dependent endonuclease-IN-15 | 2581298-44-2 | Reference compound |
| HY-143770 | Cap-dependent endonuclease-IN-16 | 2643370-92-5 | Reference compound |
| HY-143771 | Cap-dependent endonuclease-IN-17 | 2649362-71-8 | Reference compound |
| HY-143772S | 4-Hydroxy Aceclofenac-d4 | Isotope-Labeled Compounds | |
| HY-143773S | 5-Hydroxy Imidacloprid-d4 | Isotope-Labeled Compounds | |
| HY-143775 | Cap-dependent endonuclease-IN-20 | 2656435-01-5 | Reference compound |
| HY-143776 | Cap-dependent endonuclease-IN-22 | 2641942-32-5 | Reference compound |
| HY-143777S | (R)-Etodolac-d4 | 1134124-17-6 | Isotope-Labeled Compounds |
| HY-143778S | Clavulanic acid methyl ester-13C,d3 | Isotope-Labeled Compounds | |
| HY-143780S | Oseltamivir-d5 (hydrochloride) | 2140263-19-8 | Isotope-Labeled Compounds |
| HY-143781 | Cap-dependent endonuclease-IN-26 | 1370238-26-8 | Reference compound |
| HY-143782S | Enalaprilat-d5 (maleate) | Isotope-Labeled Compounds | |
| HY-143784S | C14 Benzalkonium-1 acid-13C2,d11 (chloride) | Isotope-Labeled Compounds | |
| HY-143785S | rel-Saxagliptin-15N,d2 (hydrochloride) | 1309934-06-2 | Isotope-Labeled Compounds |
| HY-143786S | Tazobactum ester-13C,d3 | Isotope-Labeled Compounds | |
| HY-143787 | ALOX15-IN-1 | 2764818-24-6 | Reference compound |
| HY-143788S | Pasireotide-d7 (TFA) | Isotope-Labeled Compounds | |
| HY-143789S | Perindopril-d4 | 1356929-58-2 | Isotope-Labeled Compounds |
| HY-143790S | N-2-(Hydroxyethyl)-L-valine-d4 | 120398-50-7 | Isotope-Labeled Compounds |
| HY-143791 | ALOX15-IN-2 | 2764818-23-5 | Reference compound |
| HY-143792 | HTT-D3 | 2254502-89-9 | Reference compound |
| HY-143793 | RBP4 inhibitor 1 | 1198180-03-8 | Reference compound |
| HY-143794S | Levothyroxine-d3 | Isotope-Labeled Compounds | |
| HY-143795S | 1,3-Dinitroglycerin-d5 | 2733972-23-9 | Isotope-Labeled Compounds |
| HY-143796S | (S)-Etodolac-d4 | Isotope-Labeled Compounds | |
| HY-143797S | Almotriptan-d6 (maleate) | Isotope-Labeled Compounds | |
| HY-143798S | R (-) Tolperisone-d10 | 2514950-90-2 | Isotope-Labeled Compounds |
| HY-143799S | 1,2-Dinitroglycerin-d5 | Isotope-Labeled Compounds | |
| HY-14380 | PF-3845 | 1196109-52-0 | Reference compound |
| HY-143800S | S (+) Tolperisone-d10 | Isotope-Labeled Compounds | |
| HY-143801S | N1, N10-Diacetyl triethylenetetramine-d4 | 2733833-08-2 | Isotope-Labeled Compounds |
| HY-143801S1 | N1, N10-Diacetyl triethylenetetramine-d8 | Isotope-Labeled Compounds | |
| HY-143802S | Lovastatin hydroxy-d3 (ammonium) | Isotope-Labeled Compounds | |
| HY-143803S | Oxaflumazine-d8 (disuccinate) | Isotope-Labeled Compounds | |
| HY-143804S | Cefditoren-13C,d3 | Isotope-Labeled Compounds | |
| HY-143805S | (R)-Stiripentol-d9 | Isotope-Labeled Compounds | |
| HY-143807S | (Rac)-Ezetimibe-d4 | Isotope-Labeled Compounds | |
| HY-143808S | (S)-Stiripentol-d9 | Isotope-Labeled Compounds | |
| HY-143809S | Repaglinide M1-d5 | 2519482-60-9 | Isotope-Labeled Compounds |
| HY-143810S | N-Desmethyl Mifepristone-d3 | Isotope-Labeled Compounds | |
| HY-143811S | N-Nitroso-DL-proline-d3 | 65807-08-1 | Isotope-Labeled Compounds |
| HY-143812S | N-Nitroso-3-azabicyclo[3.3.0]octane-d4 | 1346604-35-0 | Isotope-Labeled Compounds |
| HY-143813S | 2-Oxo Prasugrel-d4 (hydrochloride) | 2012598-55-7 | Isotope-Labeled Compounds |
| HY-143815 | m-PEG18-acid | Reference compound | |
| HY-143816S | 4-Hydroxy Atorvastatin-d5 (hemicalcium) | 265989-45-5 | Isotope-Labeled Compounds |
| HY-143817S | Clopidogrel-d3 (hydrochloride) | 2140305-74-2 | Isotope-Labeled Compounds |
| HY-143819 | Propargyl-PEG-amine | 956348-61-1 | Reference compound |
| HY-143820 | Propargyl-PEG-acid | 1421676-62-1 | Reference compound |
| HY-143821 | t-Boc-Aminooxy-PEG4-amine | 2496687-02-4 | Reference compound |
| HY-143822S | N-Methyl-N’-nitrosopiperazine-d4 | 756524-88-6 | Isotope-Labeled Compounds |
| HY-143823S | Pyridoxamine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143824S | Malachite green-d5 (picrate) | 1258668-21-1 | Isotope-Labeled Compounds |
| HY-143825 | t-Boc-Aminooxy-PEG11-amine | 1630094-83-5 | Reference compound |
| HY-143826S | O-Desmethyl Mebeverine alcohol-d5 (citrate) | Isotope-Labeled Compounds | |
| HY-143827 | Biotin-PEG10-amine | Reference compound | |
| HY-143828 | t-Boc-N-amido-PEG10-Br | 2787474-57-9 | Reference compound |
| HY-143829 | t-Boc-N-amido-PEG15-Br | Reference compound | |
| HY-14383 | Vosilasarm | 1182367-47-0 | Reference compound |
| HY-143830 | t-Boc-N-amido-PEG2-C6-Cl | 920264-35-3 | Reference compound |
| HY-143831S | Cefepime-d8 (sulfate) | 131857-33-5 | Isotope-Labeled Compounds |
| HY-143832 | Cbz-PEG5-Br | 2710803-69-1 | Reference compound |
| HY-143833 | Iodo-PEG7-alcohol | Reference compound | |
| HY-143834S | O-Desacetyl-N-desmethyl Diltiazem-d3 | Isotope-Labeled Compounds | |
| HY-143835 | Acid-PEG9-t-butyl ester | Reference compound | |
| HY-143836 | Acid-PEG10-t-butyl ester | Reference compound | |
| HY-143837 | Acid-PEG12-t-butyl ester | Reference compound | |
| HY-143838 | Acid-PEG14-t-butyl ester | Reference compound | |
| HY-143839S | N-Ethyl-N-nitroso-1-propanamine-d4 | 2733722-83-1 | Isotope-Labeled Compounds |
| HY-143840S | 2-Hydroxy Atorvastatin-d5 (disodium) | 1276537-19-9 | Isotope-Labeled Compounds |
| HY-143841 | Mal-amido-PEG15-acid | Reference compound | |
| HY-143842 | Mal-amido-PEG3-alcohol | Reference compound | |
| HY-143843S | Isosorbide-2-mononitrate-13C6 | 1391051-97-0 | Isotope-Labeled Compounds |
| HY-143844 | Bromo-PEG7-amine | Reference compound | |
| HY-143844B | Bromo-PEG7-amine (hydrobromide) | Reference compound | |
| HY-143848S | Tadalafil-13C,d3 | 1261364-86-6 | Isotope-Labeled Compounds |
| HY-143849 | N-bis(t-boc-N-amido-PEG3)-N-(PEG3-acid) (hydrochloride) | Reference compound | |
| HY-143850S | Methyl diethyldithiocarbamate-d3 | 1246816-30-7 | Isotope-Labeled Compounds |
| HY-143851S | N-Nitrosomethylethylamine-d5 | 69278-56-4 | Isotope-Labeled Compounds |
| HY-143852S | N-Nitrosoethylmethylamine-d3 | 69278-54-2 | Isotope-Labeled Compounds |
| HY-143854S | N-Nitroso-N-methyl-4-aminobutyric acid-d3 | 1184996-41-5 | Isotope-Labeled Compounds |
| HY-143855 | Biotin-PEG10-NHS ester | Reference compound | |
| HY-143856S | Loperamide-d6 | 1189574-93-3 | Isotope-Labeled Compounds |
| HY-143857S | 22:0 Lyso PC-13C6 | 2483735-02-8 | Isotope-Labeled Compounds |
| HY-143858S | Nitrosotetracaine-d6 | Isotope-Labeled Compounds | |
| HY-143859S | Metoprolol dimer-d10 | Isotope-Labeled Compounds | |
| HY-143860S | C14 Benzalkonium chloride -1 acid-d5 | Isotope-Labeled Compounds | |
| HY-143861S | Orphenadrine-d3 | 1185011-75-9 | Isotope-Labeled Compounds |
| HY-143862 | Pparδ agonist 7 | 2340432-40-6 | Reference compound |
| HY-143863 | PPARδ agonist 8 | 2697129-55-6 | Reference compound |
| HY-143864 | S1PR1 agonist 1 | 2700209-37-4 | Reference compound |
| HY-143865 | S1PR1 agonist 2 | 2695535-01-2 | Reference compound |
| HY-143866 | Kallikrein-IN-1 | 1933514-53-4 | Reference compound |
| HY-143867 | Kallikrein-IN-2 | 2702983-84-2 | Reference compound |
| HY-143868 | HPK1-IN-27 | 2268794-52-9 | Reference compound |
| HY-143869 | HPK1-IN-28 | 2699603-89-7 | Reference compound |
| HY-143870 | HPK1-IN-29 | 2699604-50-5 | Reference compound |
| HY-143871 | HPK1-IN-30 | 2700292-56-2 | Reference compound |
| HY-143872 | Bcl-2-IN-4 | 2703134-40-9 | Reference compound |
| HY-143873 | Bcl-2-IN-5 | 2728752-20-1 | Reference compound |
| HY-143874 | HER2-IN-7 | 2387574-01-6 | Reference compound |
| HY-143876S | L-Argininosuccinic acid-13C6,15N4 (barium, dihydrate) | 2483829-90-7 | Isotope-Labeled Compounds |
| HY-143877 | NN-390 | 2490284-25-6 | Reference compound |
| HY-143878 | MRGPRX1 agonist 2 | 302952-43-8 | Reference compound |
| HY-143879 | MRGPRX1 agonist 3 | 2764889-51-0 | Reference compound |
| HY-14388 | PF-232798 | 849753-15-7 | Reference compound |
| HY-143880 | MRGPRX1 agonist 4 | 2764889-60-1 | Reference compound |
| HY-143881 | FGFR4-IN-6 | 2760970-10-1 | Reference compound |
| HY-143882 | MS5033 | 2376137-29-8 | Reference compound |
| HY-143883 | MS143 | 2376137-41-4 | Reference compound |
| HY-143884 | JAK2/TYK2-IN-1 | 2613434-12-9 | Reference compound |
| HY-143885 | JAK1/TYK2-IN-3 | 2734918-37-5 | Reference compound |
| HY-143886 | AD011 | 3010931-91-3 | Reference compound |
| HY-143887 | AD012 | 3010931-94-6 | Reference compound |
| HY-143888 | AD013 | 3010931-81-1 | Reference compound |
| HY-143889 | Senexin C | 2375554-02-0 | Reference compound |
| HY-14389 | LP-261 | 915412-67-8 | Reference compound |
| HY-143890 | MRS4738 | 2801625-42-1 | Reference compound |
| HY-143891 | Chromenone 1 | 1639929-29-5 | Reference compound |
| HY-143892 | Keap1-Nrf2-IN-5 | 2696272-70-3 | Reference compound |
| HY-143893 | Keap1-Nrf2-IN-6 | Reference compound | |
| HY-143894 | FLT3-IN-11 | 2499966-50-4 | Reference compound |
| HY-143895 | FLT3-IN-12 | 2499966-67-3 | Reference compound |
| HY-143896 | STING agonist-7 | 2767442-46-4 | Reference compound |
| HY-143897 | PIM1-IN-3 | 2762767-56-4 | Reference compound |
| HY-143898 | PIM1-IN-4 | 2762767-48-4 | Reference compound |
| HY-143899 | FBA-IN-1 | 2605897-57-0 | Reference compound |
| HY-14390 | LAS101057 | 925676-48-8 | Reference compound |
| HY-143900 | BTK-IN-7 | 2952702-39-3 | Reference compound |
| HY-143901 | EGFR-IN-40 | 1466445-39-5 | Reference compound |
| HY-143902 | ZL-Pin01 | 1047464-92-5 | Reference compound |
| HY-143903 | ZL-Pin13 | 2883498-73-3 | Reference compound |
| HY-143904 | PROTAC TTK degrader-1 | 2953426-43-0 | Reference compound |
| HY-143905 | PROTAC TTK degrader-2 | 2953426-48-5 | Reference compound |
| HY-143906 | URAT1 inhibitor 2 | 2803951-18-8 | Reference compound |
| HY-143907S | Atorvastatin EP impurity H-d5 | Isotope-Labeled Compounds | |
| HY-143909S | Di(2-ethylhexyl) azelate-d14 | Isotope-Labeled Compounds | |
| HY-14391 | PSI-353661 | 1231747-08-2 | Reference compound |
| HY-143910S | Azelaic acid 2-ethylhexyl monoester-d14 | Isotope-Labeled Compounds | |
| HY-143911S | Acetaminophen glucuronide-d3 | 1260981-52-9 | Isotope-Labeled Compounds |
| HY-143912S | Aclonifen-d5 | 2469279-06-7 | Isotope-Labeled Compounds |
| HY-143913S | Aripiprazole metabolite-d6 | Isotope-Labeled Compounds | |
| HY-143914S | N-Nitroso-Acebutolol-d7 | Isotope-Labeled Compounds | |
| HY-143915S | Amitriptyline-N-glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-143916S | AMX208-d3 | 2643376-30-9 | Isotope-Labeled Compounds |
| HY-143917S | (Rac)-Aprepitant-d4 | 2748471-42-1 | Isotope-Labeled Compounds |
| HY-143918S | 4'-Hydroxy Atomoxetine-d3 (hemioxalate) | Isotope-Labeled Compounds | |
| HY-143919S | Sulfosate-d9 | Isotope-Labeled Compounds | |
| HY-14392 | 5,6-Dichlorobenzimidazole riboside | 53-85-0 | Oligonucleotides |
| HY-143921S | Almorexant (αS,1S) isomer-13C,d3 | Isotope-Labeled Compounds | |
| HY-143922S | N-Desmethyl Bedaquiline-d6 | 2271264-26-5 | Isotope-Labeled Compounds |
| HY-143923S | Belinostat amide-d5 | Isotope-Labeled Compounds | |
| HY-143924S | Belinostat acid-d5 | 2130853-04-0 | Isotope-Labeled Compounds |
| HY-143925S | Betahistine impurity 5-13C,d3 | Isotope-Labeled Compounds | |
| HY-143926S | Methyl Belinostat-d5 | Isotope-Labeled Compounds | |
| HY-143927S | Belinostat glucuronide-d5 | Isotope-Labeled Compounds | |
| HY-143928S | 4-Hydroxy biphenyl sulfate-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-143929S | Bazedoxifene-5-glucuronide-d4 | Isotope-Labeled Compounds | |
| HY-14393 | Emodin | 518-82-1 | Natural Products |
| HY-143930S | Dihydroxy Bendamustine-d8 | Isotope-Labeled Compounds | |
| HY-143931S | N-Desmethyl citalopram-d4 (oxalate) | 2747915-54-2 | Isotope-Labeled Compounds |
| HY-143932S | Desmethyl Bendamustine-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143933S | Sulfociprofloxacin-d8 (triethylamine) | Isotope-Labeled Compounds | |
| HY-143934S | 4-Oxo cyclophosphamide-d8 | Isotope-Labeled Compounds | |
| HY-143935S | 7-Hydroxycoumarin sulfate-d5 | 1215683-02-5 | Isotope-Labeled Compounds |
| HY-143936S | Chloroxuron-d6 | 2030182-44-4 | Isotope-Labeled Compounds |
| HY-143937S | Carbidopa-d3 | 1276732-89-8 | Isotope-Labeled Compounds |
| HY-143938S | Cyclobenzaprine impurity 2-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143939S | DL-Glutaryl carnitine-13C,d3 | Isotope-Labeled Compounds | |
| HY-14393R | Emodin (Standard) | 518-82-1 | Reference Standards |
| HY-14393S | Emodin-d4 | 132796-52-2 | Isotope-Labeled Compounds |
| HY-14394 | TBB | 17374-26-4 | Reference compound |
| HY-143940S | Cabergoline isomer-d6 | Isotope-Labeled Compounds | |
| HY-143941S | Hydroxychloroquine EP impurity D-d5 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-143942S | Cefditoren-d3 | Isotope-Labeled Compounds | |
| HY-143943S | Felodipine 3,5-dimethyl ester-13C2,d6 | Isotope-Labeled Compounds | |
| HY-143949S | (Rac)-N-desmethyl Dapoxetine-d7 (hydrochloride) | 2747915-74-6 | Isotope-Labeled Compounds |
| HY-143950S | DOTAP-d9 (iodide) | Isotope-Labeled Compounds | |
| HY-143951S | Disulfiram impurity 1-d10 | 2749799-73-1 | Isotope-Labeled Compounds |
| HY-143952S | 9-Dihydroestradiol-d3 | Isotope-Labeled Compounds | |
| HY-143953S | Estrone ß-D-Glucuronide-d4 (lithium) | Isotope-Labeled Compounds | |
| HY-143954S | Epinephrine impurity 19-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143955S | Ebastine-d5 (fumarate) | 1316815-02-7 | Isotope-Labeled Compounds |
| HY-143956S | Fluorofenidone impurity 1-d3 | Isotope-Labeled Compounds | |
| HY-143957S | Fenretinide glucuronide-d4 | 2118244-60-1 | Isotope-Labeled Compounds |
| HY-143958S | 4'-Hydroxy Fenretinide-d4 | 2714413-41-7 | Isotope-Labeled Compounds |
| HY-143959S | Fingolimod Mono-lactate-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143960S | Givinostat impurity 1-d10 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143961S | Givinostat impurity 5-d4 | Isotope-Labeled Compounds | |
| HY-143963S | Irbesartan impurity 20-d4 | Isotope-Labeled Compounds | |
| HY-143964S | Irbesartan impurity 14-d4 | Isotope-Labeled Compounds | |
| HY-143965S | Imidacloprid impurity 2-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143966S | 5-Hydroxy Indapamide-13C,d3 | Isotope-Labeled Compounds | |
| HY-143967S | Iloperidone metabolite P95-13C,d3 | 2747914-96-9 | Isotope-Labeled Compounds |
| HY-143968S | Ketotifen impurity 3-d4 | Isotope-Labeled Compounds | |
| HY-143969S | KL140061A-d4 | Isotope-Labeled Compounds | |
| HY-14397 | Indomethacin | 53-86-1 | Reference compound |
| HY-143970S | Ivabradine impurity 7-d6 | 2733718-12-0 | Isotope-Labeled Compounds |
| HY-143971S | Glycinexylidide-d6 | 1217098-46-8 | Isotope-Labeled Compounds |
| HY-143972S | 7-Hydroxy loxapine-d8 | Isotope-Labeled Compounds | |
| HY-143973S | Iacvita-d10 | Isotope-Labeled Compounds | |
| HY-143974S | Imiquimod impurity 1-d6 | Isotope-Labeled Compounds | |
| HY-143975S | Loxapine impurity 2-d8 | Isotope-Labeled Compounds | |
| HY-143976S | 3-Hydroxy imiquimod-d4 | Isotope-Labeled Compounds | |
| HY-143977S | Loxapine impurity 3-d8 (iodide) | Isotope-Labeled Compounds | |
| HY-143978S | cis-4’-Hydroxy CCNU Lomustine-d4 | Isotope-Labeled Compounds | |
| HY-143979S | 1-(2-Chloroethyl)-3-((1R,4R)-4-hydroxycyclohexyl)-1-nitrosourea-d4 | Isotope-Labeled Compounds | |
| HY-14397A | Indomethacin (sodium hydrate) | 74252-25-8 | Reference compound |
| HY-14397AR | Indomethacin (sodium hydrate) (Standard) | 74252-25-8 | Reference Standards |
| HY-14397G | Indomethacin (GMP) | 53-86-1 | GMP Small Molecules |
| HY-14397R | Indomethacin (Standard) | 53-86-1 | Reference Standards |
| HY-14397S | Indomethacin-d4 | 87377-08-0 | Isotope-Labeled Compounds |
| HY-14397S1 | Indomethacin-d4 Methyl Ester | 1217064-61-3 | Isotope-Labeled Compounds |
| HY-14397S2 | Indometacin-d7 | Isotope-Labeled Compounds | |
| HY-14397S3 | Indomethacin-13C6 | Isotope-Labeled Compounds | |
| HY-14398 | Celecoxib | 169590-42-5 | Reference compound |
| HY-143980S | Losartan impurity 21-d4 | Isotope-Labeled Compounds | |
| HY-143981S | 15-Hydroxy Lubiprostone-d7 | 1217511-55-1 | Isotope-Labeled Compounds |
| HY-143982S | Mianserin EP impurity E-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143983S | Desmethyl Mirtazapine-d4 (hydrochloride) | 1188266-12-7 | Isotope-Labeled Compounds |
| HY-143984S | Minodronic acid impurity 2-d4 | Isotope-Labeled Compounds | |
| HY-143985S | Maytansinoid DM4 impurity 5-d6 | Isotope-Labeled Compounds | |
| HY-143986S | DM50 impurity 1-d9 | Isotope-Labeled Compounds | |
| HY-143986S1 | DM50 impurity 1-d9-1 | Isotope-Labeled Compounds | |
| HY-143987 | DM51 impurity 1 | Reference compound | |
| HY-143987S | DM51 impurity 1-d9 | Isotope-Labeled Compounds | |
| HY-143988S | Nefazodone impurity 3-d6 | Isotope-Labeled Compounds | |
| HY-143989S | N,N-Didesmethyl Mifepristone-d4 | Isotope-Labeled Compounds | |
| HY-14398G | Celecoxib (GMP) | 169590-42-5 | GMP Small Molecules |
| HY-14398GL | Celecoxib (GMP Like) | 169590-42-5 | GMP Small Molecules |
| HY-14398R | Celecoxib (Standard) | 169590-42-5 | Reference Standards |
| HY-14398S | Celecoxib-d7 | 544686-21-7 | Isotope-Labeled Compounds |
| HY-14398S1 | Celecoxib-d3 | 544686-18-2 | Isotope-Labeled Compounds |
| HY-14399 | Itanapraced | 749269-83-8 | Reference compound |
| HY-143990S | Modafinil EP impurity B-d5 | 1329496-95-8 | Isotope-Labeled Compounds |
| HY-143991S | Modafinil acid sulfone-d5 | 2747915-46-2 | Isotope-Labeled Compounds |
| HY-143992S | Maytansinoid DM4 impurity 2-d6 | Isotope-Labeled Compounds | |
| HY-143993S | Maytansinoid DM4 impurity 3-d6 | Isotope-Labeled Compounds | |
| HY-143994S | Metopimazine acid-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143995S | Nuarimol-d4 | Isotope-Labeled Compounds | |
| HY-143996S | Mevalonic acid-13C,d3 (sodium) | 2747918-57-4 | Isotope-Labeled Compounds |
| HY-143997S | (Rac)-Nicotine EP impurity A-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-143999S | Norgestimate-d3 | Isotope-Labeled Compounds | |
| HY-144000 | DSPE-PEG-PDP | 474922-24-2 | Biochemical Assay Reagents |
| HY-144000A | DSPE-PEG2000-PDP | 474922-24-2 | Biochemical Assay Reagents |
| HY-144001 | DSPE-PEG-Carboxylic Acid | 474922-20-8 | Biochemical Assay Reagents |
| HY-144002 | RIBI-529 | 216014-46-9 | Biochemical Assay Reagents |
| HY-144003 | BAY-R 1005 | 294664-93-0 | Biochemical Assay Reagents |
| HY-144004 | DSPE-PEG2000-Mal (ammonium) | 474922-22-0 | Biochemical Assay Reagents |
| HY-144004A | DSPE-PEG5000-Mal (ammonium) | 474922-22-0 | Biochemical Assay Reagents |
| HY-144005 | C16 PEG2000 Ceramide | 212116-78-4 | Biochemical Assay Reagents |
| HY-144005A | C16 PEG750 Ceramide | 212116-78-4 | Biochemical Assay Reagents |
| HY-144005B | C16 PEG5000 Ceramide | 212116-78-4 | Biochemical Assay Reagents |
| HY-144006 | DMPE-PEG2000 | 474922-82-2 | Biochemical Assay Reagents |
| HY-144007 | Chol-PEG | 27321-96-6 | Biochemical Assay Reagents |
| HY-144008 | C8 PEG-Ceramide | 212116-76-2 | Biochemical Assay Reagents |
| HY-144008A | C8 PEG5000 Ceramide | 212116-76-2 | Biochemical Assay Reagents |
| HY-144008B | C8 PEG750 Ceramide | 212116-76-2 | Reference compound |
| HY-144009 | DSPE-PEG-Folate, MW 3350 | 1236288-25-7 | Biochemical Assay Reagents |
| HY-14401 | Encaleret | 787583-71-5 | Reference compound |
| HY-144010 | 18:1 PEG2000 PE | 474922-90-2 | Biochemical Assay Reagents |
| HY-144011 | DSPE-PEG-Cyanur | 1246304-74-4 | Biochemical Assay Reagents |
| HY-144012 | DPPE-PEG2000 | 474922-84-4 | Biochemical Assay Reagents |
| HY-144012A | DPPE-PEG350 | 474922-84-4 | Biochemical Assay Reagents |
| HY-144012B | DPPE-PEG550 | 474922-84-4 | Biochemical Assay Reagents |
| HY-144012C | DPPE-PEG750 | 474922-84-4 | Biochemical Assay Reagents |
| HY-144012D | DPPE-PEG1000 | 474922-84-4 | Biochemical Assay Reagents |
| HY-144012E | DPPE-PEG3000 | 474922-84-4 | Biochemical Assay Reagents |
| HY-144012H | DPPE-PEG5000 | 474922-84-4 | Biochemical Assay Reagents |
| HY-144013 | 18:0 mPEG2000 PE (ammonium) | 474922-77-5 | Biochemical Assay Reagents |
| HY-144013A | 18:0 mPEG350 PE (ammonium) | 474922-77-5 | Biochemical Assay Reagents |
| HY-144013B | 18:0 mPEG550 PE (ammonium) | 474922-77-5 | Biochemical Assay Reagents |
| HY-144013C | 18:0 mPEG750 PE (ammonium) | 474922-77-5 | Biochemical Assay Reagents |
| HY-144013D | 18:0 mPEG1000 PE (ammonium) | 474922-77-5 | Biochemical Assay Reagents |
| HY-144013E | 18:0 mPEG3000 PE (ammonium) | 474922-77-5 | Biochemical Assay Reagents |
| HY-144013H | 18:0 mPEG5000 PE (ammonium) | 474922-77-5 | Biochemical Assay Reagents |
| HY-144014 | MVL5 | 464926-03-2 | Biochemical Assay Reagents |
| HY-144015 | 14:1 EPC (trifluoromethanesulfonate) | 1246304-44-8 | Biochemical Assay Reagents |
| HY-144016 | 16:0 EPC (chloride) | 328250-18-6 | Biochemical Assay Reagents |
| HY-144017 | 12:0 EPC (chloride) | 474945-22-7 | Biochemical Assay Reagents |
| HY-144018 | 18:1 EPC (chloride) | 474945-24-9 | Biochemical Assay Reagents |
| HY-144019 | 18:0 EPC (chloride) | 328268-13-9 | Biochemical Assay Reagents |
| HY-144020 | 14:0 DAP | 72719-84-7 | Biochemical Assay Reagents |
| HY-144021 | 14:0 EPC (chloride) | 186492-53-5 | Biochemical Assay Reagents |
| HY-144022 | 16:0 DAP | 96326-74-8 | Biochemical Assay Reagents |
| HY-144023 | 16:0-18:1 EPC (chloride) | 328250-19-7 | Biochemical Assay Reagents |
| HY-144024S | 5-PAHSA-d9 | 1809226-17-2 | Isotope-Labeled Compounds |
| HY-144025 | DOBAQ | 1360461-69-3 | Biochemical Assay Reagents |
| HY-144026S | 9-PAHSA-d9 | 1809222-43-2 | Isotope-Labeled Compounds |
| HY-144027 | Dolichol (13~21) | 153857-77-3 | Biochemical Assay Reagents |
| HY-144028 | Pan-Trk-IN-2 | 2583778-77-0 | Reference compound |
| HY-144029 | RET-IN-13 | 2684258-54-4 | Reference compound |
| HY-14403 | ERK5-IN-1 | 1234479-76-5 | Reference compound |
| HY-144030 | RET-IN-12 | 2684252-55-7 | Reference compound |
| HY-144031S | Tyk2-IN-8 | 2704587-24-4 | Isotope-Labeled Compounds |
| HY-144032 | Tyk2-IN-9 | 2694816-85-6 | Reference compound |
| HY-144033 | GLP-1R agonist 1 | 2711019-49-5 | Reference compound |
| HY-144034 | GLP-1R agonist 3 | 2428640-18-8 | Reference compound |
| HY-144035 | GLP-1R agonist 4 | 2401894-26-4 | Reference compound |
| HY-144036 | DNA-PK-IN-3 | 2734846-19-4 | Reference compound |
| HY-144037 | DNA-PK-IN-4 | 2722645-10-3 | Reference compound |
| HY-144038 | DNA-PK-IN-5 | 2719736-43-1 | Reference compound |
| HY-144039 | DNA-PK-IN-6 | 2711810-41-0 | Reference compound |
| HY-144040 | CSF1R-IN-4 | 2716185-86-1 | Reference compound |
| HY-144041 | CSF1R-IN-5 | 2716184-93-7 | Reference compound |
| HY-144042 | CSF1R-IN-6 | 2716184-87-9 | Reference compound |
| HY-144043 | ALK5-IN-8 | 2705900-81-6 | Reference compound |
| HY-144044 | EGFR-IN-30 | 2726463-68-7 | Reference compound |
| HY-144045 | HBV-IN-14 | 2712529-19-4 | Reference compound |
| HY-144046 | HBV-IN-15 | 2413192-50-2 | Reference compound |
| HY-144047 | HBV-IN-16 | 2355225-38-4 | Reference compound |
| HY-144048 | EGFR-IN-31 | 2701563-03-1 | Reference compound |
| HY-144049 | EGFR-IN-32 | 2701553-78-6 | Reference compound |
| HY-14405 | Casopitant | 414910-27-3 | Reference compound |
| HY-144050 | EGFR-IN-33 | 2711105-59-6 | Reference compound |
| HY-144051 | EGFR-IN-34 | Reference compound | |
| HY-144052 | EGFR-IN-35 | 2711105-57-4 | Reference compound |
| HY-144053 | EGFR-IN-36 | 2711105-54-1 | Reference compound |
| HY-144054 | EGFR-IN-37 | 2711105-53-0 | Reference compound |
| HY-144055 | EGFR-IN-38 | 2711105-50-7 | Reference compound |
| HY-144056 | EGFR-IN-39 | 2711105-48-3 | Reference compound |
| HY-144057 | JAK-IN-17 | Reference compound | |
| HY-144058 | JAK-IN-18 | 2247925-32-0 | Reference compound |
| HY-144059 | AKT-IN-9 | 2709045-53-2 | Reference compound |
| HY-14405A | Casopitant (mesylate) | 414910-30-8 | Reference compound |
| HY-14405B | (R)-Casopitant | 414910-26-2 | Reference compound |
| HY-144060 | AKT-IN-10 | 2709045-56-5 | Reference compound |
| HY-144061 | INSCoV-601I(1) | 2735704-19-3 | Reference compound |
| HY-144062 | INSCoV-614(1B) | 2735704-33-1 | Reference compound |
| HY-144063 | INSCoV-600K(1) | 2735704-15-9 | Reference compound |
| HY-144064 | Adenosine receptor antagonist 2 | 2703054-47-9 | Reference compound |
| HY-144065 | Cap-dependent endonuclease-IN-19 | 2567929-06-8 | Reference compound |
| HY-144066 | Cap-dependent endonuclease-IN-21 | 2741952-35-0 | Reference compound |
| HY-144067 | Cap-dependent endonuclease-IN-23 | 2741952-36-1 | Reference compound |
| HY-144068 | Cap-dependent endonuclease-IN-25 | 2415788-71-3 | Reference compound |
| HY-144069 | Pan-Trk-IN-3 | 2763637-66-5 | Reference compound |
| HY-14406A | L-733060 (hydrochloride) | 148687-76-7 | Reference compound |
| HY-14407 | Fosaprepitant | 172673-20-0 | Reference compound |
| HY-144070 | ErSO-DFP | 2768139-76-8 | Reference compound |
| HY-144070A | (Rac)-ErSO-DFP | 2768139-73-5 | Reference compound |
| HY-144071 | MurB-IN-1 | 2883232-46-8 | Reference compound |
| HY-144072 | MRS4620 | 2411665-73-9 | Reference compound |
| HY-144073 | HPK1-IN-21 | 2413804-83-6 | Peptides |
| HY-144074 | LRRK2-IN-4 | 2641054-59-1 | Reference compound |
| HY-144075 | JAK-IN-19 | Reference compound | |
| HY-144076 | t-Boc-amido-PEG10-acid | Reference compound | |
| HY-144077 | Bromo-PEG7-CH2COOtBu | Reference compound | |
| HY-144078 | Bromo-PEG8-CH2COOtBu | Reference compound | |
| HY-144079 | Bromo-C4-PEG4-t-butyl ester | Reference compound | |
| HY-14407A | Fosaprepitant (dimeglumine) | 265121-04-8 | Reference compound |
| HY-14407AR | Fosaprepitant (dimeglumine) (Standard) | 265121-04-8 | Reference Standards |
| HY-14407AS | Fosaprepitant-d4 (dimeglumine) | Isotope-Labeled Compounds | |
| HY-14408 | Lu AA47070 | 913842-25-8 | Reference compound |
| HY-144080 | Bromo-PEG5-CH2COOtBu | Reference compound | |
| HY-144081 | HO-PEG18-OH | 4445-03-8 | Reference compound |
| HY-144082 | C18-PEG13-acid | Reference compound | |
| HY-144083S | L-Carnitine(mono)-O-3-dl-hydroxypalmitoyl-d3 (perchlorate) | 2245711-29-7 | Isotope-Labeled Compounds |
| HY-144084S | L-Carnitine(mono)-O-glutaryl-d3 (perchlorate) | 2245711-21-9 | Isotope-Labeled Compounds |
| HY-144085S | D-Fructose-6-phosphate-13C6 (disodium x.hydrate) | Isotope-Labeled Compounds | |
| HY-144086S | 22:0 Lyso-PC-d4 | 2483831-14-5 | Isotope-Labeled Compounds |
| HY-144087 | TYK2-IN-11 | 2757009-40-6 | Reference compound |
| HY-144088 | ZYF0033 | 2380300-79-6 | Reference compound |
| HY-14409 | Lu AA41063 | 851202-49-8 | Reference compound |
| HY-144091 | HPK1-IN-24 | 2294966-07-5 | Reference compound |
| HY-144092 | HPK1-IN-25 | 2403600-50-8 | Reference compound |
| HY-144093 | HPK1-IN-26 | 2229042-24-2 | Reference compound |
| HY-144096 | EZH2-IN-11 | 2387402-80-2 | Reference compound |
| HY-144097 | HER2-IN-8 | 2704630-49-7 | Reference compound |
| HY-144098 | HDAC8-IN-2 | 2824131-20-4 | Reference compound |
| HY-144099 | Keap1-Nrf2-IN-4 | 2851480-01-6 | Reference compound |
| HY-144100 | β-Lactamase-IN-7 | 2419903-21-0 | Reference compound |
| HY-144102 | HDAC-IN-29 | 2695593-95-2 | Reference compound |
| HY-144103 | Neuraminidase-IN-4 | Reference compound | |
| HY-144104 | NSC90616 | Reference compound | |
| HY-144105 | NSC405640 | 1135-99-5 | Reference compound |
| HY-144106 | HCV-IN-33 | 2757963-83-8 | Reference compound |
| HY-144107 | HCV-IN-34 | 2425805-22-5 | Reference compound |
| HY-144108 | HCV-IN-35 | 2757963-82-7 | Reference compound |
| HY-144109 | HCV-IN-36 | 2757963-81-6 | Reference compound |
| HY-14411 | JNK-1-IN-1 | 1262406-02-9 | Reference compound |
| HY-144110 | HCV-IN-37 | 2425804-98-2 | Reference compound |
| HY-144111 | PPARα/δ agonist 1 | 2760128-48-9 | Reference compound |
| HY-144112 | HIV-1 inhibitor-13 | 2761172-60-3 | Reference compound |
| HY-144113 | HIV-1 inhibitor-14 | 2761172-65-8 | Reference compound |
| HY-144115 | A1AR antagonist 1 | 2760128-99-0 | Reference compound |
| HY-144116 | A1AR antagonist 2 | 1441961-74-5 | Reference compound |
| HY-144117 | GFB-12811 | 2775311-17-4 | Reference compound |
| HY-144118 | Cas9-IN-1 | 2866499-55-8 | Reference compound |
| HY-144119 | Cas9-IN-2 | 1030133-34-6 | Reference compound |
| HY-14412 | p38α inhibitor 4 | 1262406-08-5 | Reference compound |
| HY-144120 | αGalCer-RBD | Reference compound | |
| HY-144121 | Ph-Ph+ | Reference compound | |
| HY-144122 | HIV-1 inhibitor-15 | 2757182-99-1 | Reference compound |
| HY-144123 | HIV-1 inhibitor-16 | 2719675-72-4 | Reference compound |
| HY-144124 | 5-C-heptyl-DNJ | 2734265-63-3 | Reference compound |
| HY-144125 | Antitumor agent-41 | Reference compound | |
| HY-144126 | S1P1 agonist 5 | 2760666-20-2 | Reference compound |
| HY-144127 | AR antagonist 3 | 349573-58-6 | Reference compound |
| HY-144128 | hGGPPS-IN-1 | 1429012-38-3 | Reference compound |
| HY-144129 | hGGPPS-IN-2 | 2241547-82-8 | Reference compound |
| HY-14413 | SR3335 | 293753-05-6 | Reference compound |
| HY-144130 | hGGPPS-IN-3 | 2763223-96-5 | Reference compound |
| HY-144131 | RET-IN-11 | 2764891-88-3 | Reference compound |
| HY-144132 | αβ-Tubulin-IN-1 | 2478584-74-4 | Reference compound |
| HY-144133 | GLP-1R agonist 5 | 2749609-30-9 | Reference compound |
| HY-144134 | GLP-1R agonist 6 | 2755653-78-0 | Reference compound |
| HY-144135 | GLP-1R agonist 7 | 2749608-65-7 | Reference compound |
| HY-144136 | GLP-1R agonist 8 | 2736446-82-3 | Reference compound |
| HY-144137 | Estrogen receptor antagonist 1 | 2751609-45-5 | Reference compound |
| HY-144138 | Estrogen receptor antagonist 2 | 2735803-90-2 | Reference compound |
| HY-144139 | Estrogen receptor antagonist 3 | 2730011-50-2 | Reference compound |
| HY-14414 | GSK4112 | 1216744-19-2 | Reference compound |
| HY-144140S | 4-Nitroso hydrochlorothiazide-13C,15N2,d2 | Isotope-Labeled Compounds | |
| HY-144141S | Nortriptyline impurity 3-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144142S | Orphenadrine impurity 6-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144143S | N-Desmethyl Olopatadine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144144S | (E)-N-Desmethyl Olopatadine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144145S | Hydroxy Pioglitazone (M-II)-d4 | 2747917-81-1 | Isotope-Labeled Compounds |
| HY-144146S | Pramipexole impurity 7-d10 | Isotope-Labeled Compounds | |
| HY-144147S | N-Methyl Quinidine-d3 (iodide) | Isotope-Labeled Compounds | |
| HY-144148S | Pyroxsulam-13C,d3 | Isotope-Labeled Compounds | |
| HY-144149S | 3'-p-Hydroxy paclitaxel-d5 | Isotope-Labeled Compounds | |
| HY-14415 | SR8278 | 1254944-66-5 | Reference compound |
| HY-144150S | Pelubiprofen impurity 2-13C2,d6 | Isotope-Labeled Compounds | |
| HY-144151S | Phenylsulfate-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-144152S | Catechol sulfate-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-144153S | S-(1,2-Dichlorovinyl)glutathione-13C2,15N | Isotope-Labeled Compounds | |
| HY-144154S | (Rac)-Rivastigmine-d6 (tartrate) | Isotope-Labeled Compounds | |
| HY-144155S | 5-Hydroxy Rosiglitazone-d4 | 1246817-46-8 | Isotope-Labeled Compounds |
| HY-144155S1 | 5-Hydroxy Rosiglitazone-d4-1 | 1794759-89-9 | Isotope-Labeled Compounds |
| HY-144156S | 7-Hydroxy Ropinirole-d14 | Isotope-Labeled Compounds | |
| HY-144157S | N-Acetyl Retigabine-d3 (dihydrochloride) | 2749395-13-7 | Isotope-Labeled Compounds |
| HY-144158S | Resveratrol 3-sulfate-d4 (triethylamine) | Isotope-Labeled Compounds | |
| HY-144159S | Resveratrol 3,5-diglucuronide-d4 | Isotope-Labeled Compounds | |
| HY-144161S | (Rac)-Ramosetron-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144162S | (Rac)-Selegiline-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144163S | Descarbon Sildenafil-d3 | Isotope-Labeled Compounds | |
| HY-144164S | Sumatriptan-d6 (hemisuccinate) | 1397195-80-0 | Isotope-Labeled Compounds |
| HY-144165S | Silodosin metabolite-d4 | Isotope-Labeled Compounds | |
| HY-144166S | Silodosin glucuronide-d4 (lithium) | Isotope-Labeled Compounds | |
| HY-144167S | Methiocarb sulfone-d3 | 2733969-33-8 | Isotope-Labeled Compounds |
| HY-144168 | STING agonist-8 | 2745723-90-2 | Reference compound |
| HY-144168A | STING agonist-8 (dihydrochloride) | Reference compound | |
| HY-144169 | DHODH-IN-19 | 2742675-85-8 | Reference compound |
| HY-14417 | VU0155041 | 1093757-42-6 | Reference compound |
| HY-144170 | RET-IN-14 | 2755843-62-8 | Reference compound |
| HY-144171S | Meobal-d3 | Isotope-Labeled Compounds | |
| HY-144172S | XMC-d3 | Isotope-Labeled Compounds | |
| HY-144173S | 2,3,5-Trimethacarb-d3 | Isotope-Labeled Compounds | |
| HY-144174S | Methylacifluorfen-d3 | Isotope-Labeled Compounds | |
| HY-144175 | CDK7-IN-12 | 2750638-94-7 | Reference compound |
| HY-144176 | HIF-2α-IN-5 | 2388500-66-9 | Reference compound |
| HY-144177S | Benzthiazuron-d3 | Isotope-Labeled Compounds | |
| HY-144178 | HIF-2α-IN-6 | 2755401-07-9 | Reference compound |
| HY-144179 | MAT2A-IN-4 | 2439272-57-6 | Reference compound |
| HY-14417A | (1R,2S)-VU0155041 | 1263273-14-8 | Reference compound |
| HY-14417B | VU0155041 (sodium) | 1259372-69-4 | Reference compound |
| HY-14418 | VU0361737 | 1161205-04-4 | Reference compound |
| HY-144180S | Fluometuron-desmethyl-d3 | Isotope-Labeled Compounds | |
| HY-144181 | MAT2A-IN-5 | 2756458-55-4 | Reference compound |
| HY-144182S | Metoxuron-monomethyl-d3 | Isotope-Labeled Compounds | |
| HY-144184 | MAT2A-IN-6 | 2756458-72-5 | Reference compound |
| HY-144185 | MAT2A-IN-7 | 2756458-77-0 | Reference compound |
| HY-144186S | Bromuron-d6 | 2030182-53-5 | Isotope-Labeled Compounds |
| HY-144187 | PRMT5-IN-16 | 2755304-16-4 | Reference compound |
| HY-144188 | PRMT5-IN-17 | 2755304-03-9 | Reference compound |
| HY-144189 | PRMT5-IN-18 | 2756849-68-8 | Reference compound |
| HY-14419 | TCN238 | 125404-04-8 | Reference compound |
| HY-144190 | MIF-IN-1 | 851095-20-0 | Reference compound |
| HY-144191S | Dichlorprop-methyl ester-d3 | Isotope-Labeled Compounds | |
| HY-144192S | MCPA methyl ester-d3 | Isotope-Labeled Compounds | |
| HY-144193S | MCPP methyl ester-d3 | Isotope-Labeled Compounds | |
| HY-144194 | MIF-IN-2 | 2756410-57-6 | Reference compound |
| HY-144195 | MIF-IN-3 | 2756410-83-8 | Reference compound |
| HY-144196 | MIF-IN-4 (hydrochloride) | 2489514-05-6 | Reference compound |
| HY-144197 | CCR8 antagonist 1 | 723304-76-5 | Reference compound |
| HY-144198S | Saxagliptin-13C,d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144199S | 5-Hydroxy Saxagliptin-13C,d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144200 | CCR8 antagonist 2 | 2756350-98-6 | Reference compound |
| HY-144201S | Serotonin glucuronide-d4 | 1620326-22-8 | Isotope-Labeled Compounds |
| HY-144202 | Estrogen receptor antagonist 4 | 2730011-45-5 | Reference compound |
| HY-144203S | Trospium EP impurity C-d8 (chloride) | Isotope-Labeled Compounds | |
| HY-144204 | Estrogen receptor antagonist 5 | 2136600-69-4 | Reference compound |
| HY-144205 | TRPC5-IN-2 | 2304552-99-4 | Reference compound |
| HY-144206 | Estrogen receptor antagonist 6 | 2136600-70-7 | Reference compound |
| HY-144207 | SOS1-IN-9 | 2758900-76-2 | Reference compound |
| HY-144208 | TRPC5-IN-3 | 2758126-11-1 | Reference compound |
| HY-144209 | CD73-IN-6 | 2757808-96-9 | Reference compound |
| HY-144210 | SOS1-IN-6 | 2751718-88-2 | Reference compound |
| HY-144211 | SOS1-IN-7 | 2755415-30-4 | Reference compound |
| HY-144212 | SOS1-IN-8 | 2759387-92-1 | Reference compound |
| HY-144213 | SOS1-IN-10 | 2758690-15-0 | Reference compound |
| HY-144214 | ATR-IN-10 | 2713577-93-4 | Reference compound |
| HY-144215 | TLR8 agonist 4 | 2761697-69-0 | Reference compound |
| HY-144216S | (S)-Cetirizine-d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-144217 | SKLB-197 | 2713577-16-1 | Reference compound |
| HY-144219S | Dehydro trospium-d10 (chloride) | Isotope-Labeled Compounds | |
| HY-14422 | SR1078 | 1246525-60-9 | Reference compound |
| HY-144220 | NLRP3/AIM2-IN-1 | Reference compound | |
| HY-144221S | Tiotropium bromide EP impurity A-d6 | Isotope-Labeled Compounds | |
| HY-144222 | NSC 828467 | Reference compound | |
| HY-144223 | NLRP3/AIM2-IN-2 | 791840-86-3 | Reference compound |
| HY-144224S | Tianeptine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144225 | Anticancer agent 26 | Reference compound | |
| HY-144226 | NLRP3/AIM2-IN-3 | 1787787-60-3 | Reference compound |
| HY-144227 | Anticancer agent 27 | 2768083-61-8 | Reference compound |
| HY-144228S | Hydroxy Tipelukast-d6 | 2714417-27-1 | Isotope-Labeled Compounds |
| HY-144228S1 | Hydroxy Tipelukast-d6 (sodium) | 2714473-19-3 | Isotope-Labeled Compounds |
| HY-144229 | trans-Cephalosporin | 2757462-75-0 | Reference compound |
| HY-14423 | Velneperit | 342577-38-2 | Reference compound |
| HY-144230S | Thiorphan methoxyacetophenone-d5 | 1398044-41-1 | Isotope-Labeled Compounds |
| HY-144232 | Anticancer agent 28 | 2768083-57-2 | Reference compound |
| HY-144233S | N1-Acetyl triethylenetetramine-d8 (trihydrochloride) | Isotope-Labeled Compounds | |
| HY-144235S | cis-Dihydro Tetrabenazine-d7 | 1217719-21-5 | Isotope-Labeled Compounds |
| HY-144236 | ZLD2218 | 2713974-32-2 | Reference compound |
| HY-144237 | BRP-201 | 2227434-74-2 | Reference compound |
| HY-144238 | mPGES1-IN-6 | 2914158-00-0 | Reference compound |
| HY-144239S | Venlafaxine N-oxide-d6 | Isotope-Labeled Compounds | |
| HY-144241S | DL-Alpha-tocopherol nicotinate-d9 | Isotope-Labeled Compounds | |
| HY-144242S | Voriconazole EP impurity D-d3 | Isotope-Labeled Compounds | |
| HY-144243S | Vitamin B5-d4 (calcium) | Isotope-Labeled Compounds | |
| HY-144245S | 5-Hydroxyl ZLN005-d13 | Isotope-Labeled Compounds | |
| HY-144246S | Zofenoprilat-NES-d5 | Isotope-Labeled Compounds | |
| HY-144247S | Edaravone glucuronide-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-144248S | Levomedetomidine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-144249S | (S)-Pantoprazole-d6 | Isotope-Labeled Compounds | |
| HY-14425 | Peturadol | 686301-48-4 | Reference compound |
| HY-144250S | Glycyl-L-proline-15N,d2 (trifluoroacetate) | Isotope-Labeled Compounds | |
| HY-144252 | Antibacterial agent 69 | 2915755-61-0 | Reference compound |
| HY-144253 | AKT-IN-11 | Reference compound | |
| HY-144254 | PI3Kδ-IN-10 | 2409725-49-9 | Reference compound |
| HY-144255 | Antibacterial agent 70 | Reference compound | |
| HY-144256 | CHD1Li 6.11 | 2716890-91-2 | Reference compound |
| HY-144258 | PD-1/PD-L1-IN-14 | 2499965-12-5 | Reference compound |
| HY-144259 | Metallo-β-lactamase-IN-2 | 1501705-61-8 | Reference compound |
| HY-14426 | L-655708 | 130477-52-0 | Reference compound |
| HY-144260 | 3CPLro-IN-1 | 2432956-06-2 | Reference compound |
| HY-144261 | Metallo-β-lactamase-IN-3 | 128294-71-3 | Reference compound |
| HY-144262 | Metallo-β-lactamase-IN-4 | 2711044-25-4 | Reference compound |
| HY-144263 | 3CPLro-IN-2 | 2758278-51-0 | Reference compound |
| HY-144264 | hCAII-IN-6 | 3067465-38-4 | Reference compound |
| HY-144265 | PDE4-IN-5 | 2768626-06-6 | Reference compound |
| HY-144266 | TP-060 | 2601393-20-6 | Reference compound |
| HY-144267 | Glucosylceramide synthase-IN-2 | 2597958-02-4 | Reference compound |
| HY-144268 | hCAII-IN-7 | Reference compound | |
| HY-144269 | SHR902275 | 2695506-82-0 | Reference compound |
| HY-14427 | 4E1RCat | 328998-25-0 | Reference compound |
| HY-144270 | Glucosylceramide synthase-IN-3 | 3029827-91-3 | Reference compound |
| HY-144271 | RAF-IN-1 | 2695505-82-7 | Reference compound |
| HY-144272 | AChE-IN-5 | Reference compound | |
| HY-144273 | IDO1-IN-13 | Reference compound | |
| HY-144274 | IDO1-IN-14 | Reference compound | |
| HY-144276 | RIPK1-IN-11 | 2173557-02-1 | Reference compound |
| HY-144277 | RIPK1-IN-12 | 2173556-92-6 | Peptides |
| HY-144278 | Anti-MRSA agent 1 | 2627336-02-9 | Reference compound |
| HY-144279 | MsbA-IN-1 | 2918334-61-7 | Reference compound |
| HY-14428 | ICG-001 | 780757-88-2 | Reference compound |
| HY-144280 | MsbA-IN-2 | 2909443-16-7 | Reference compound |
| HY-144281 | MsbA-IN-3 | 2909443-78-1 | Reference compound |
| HY-144282 | MsbA-IN-4 | 2909443-80-5 | Reference compound |
| HY-144283 | BLK-IN-1 | 1431727-00-2 | Reference compound |
| HY-144284 | MsbA-IN-5 | 2909443-06-5 | Reference compound |
| HY-144285 | CXCR4 antagonist 4 | 2761009-30-5 | Peptides |
| HY-144286 | CXCR4 antagonist 3 | 2761009-43-0 | Reference compound |
| HY-144287 | Glucokinase activator 3 | 1001417-92-0 | Reference compound |
| HY-144288 | BLK-IN-2 | 2694871-86-6 | Reference compound |
| HY-144289 | BMS-820132 | 1001419-18-6 | Reference compound |
| HY-14429 | (-)-Irofulven | 158440-71-2 | Reference compound |
| HY-144290 | ARN25068 | 2649882-80-2 | Reference compound |
| HY-144291 | LY3154885 | 2379422-72-5 | Reference compound |
| HY-144292 | HDAC-IN-30 | 2756809-34-2 | Peptides |
| HY-144293 | HDAC-IN-31 | 1916505-13-9 | Reference compound |
| HY-144294 | Purine phosphoribosyltransferase-IN-1 | 2784631-28-1 | Reference compound |
| HY-144295 | PI3Kα-IN-5 | 2237953-19-2 | Reference compound |
| HY-144296 | Purine phosphoribosyltransferase-IN-2 | 2784631-30-5 | Reference compound |
| HY-144297 | HDAC1-IN-3 | 2482998-35-4 | Reference compound |
| HY-144298 | HDAC1-IN-4 | 2482998-39-8 | Reference compound |
| HY-144299 | Tubulin polymerization-IN-5 | Reference compound | |
| HY-14430 | Cipargamin | 1193314-23-6 | Reference compound |
| HY-144300 | Rifasutenizol | 1001314-13-1 | Reference compound |
| HY-144301 | AAK1-IN-2 | 1802703-21-4 | Reference compound |
| HY-144301A | AAK1-IN-2 (TFA) | 2761587-28-2 | Reference compound |
| HY-144302 | AAK1-IN-3 | 1802703-20-3 | Reference compound |
| HY-144302A | AAK1-IN-3 (TFA) | 2761587-27-1 | Reference compound |
| HY-144303 | Xanthine oxidase-IN-4 | 2642137-96-8 | Reference compound |
| HY-144304 | PROTAC EGFR degrader 2 | 3031336-58-7 | Reference compound |
| HY-144305 | KPH2f | 2760615-09-4 | Reference compound |
| HY-144306 | ERα degrader 4 | Reference compound | |
| HY-144307 | Aurora A/PKC-IN-1 | 3031505-76-4 | Reference compound |
| HY-144308 | RMS-07 | 2645409-78-3 | Reference compound |
| HY-144309 | Cholesterol 24-hydroxylase-IN-1 | 1613480-70-8 | Reference compound |
| HY-14431 | Cerlapirdine | 925448-93-7 | Reference compound |
| HY-144310 | DX3-213B | 2749555-66-4 | Reference compound |
| HY-144311 | OXPHOS-IN-1 | 2749554-48-9 | Reference compound |
| HY-144312 | Thiobis-β-Galactose-propyne | 1989627-40-8 | Reference compound |
| HY-144313 | Galectin-3-IN-2 | 2883648-71-1 | Reference compound |
| HY-144314 | PSDalpha | 2906869-08-5 | Reference compound |
| HY-144315 | CYD19 | 2415281-52-4 | Reference compound |
| HY-144316 | ZLWH-23 | 2765251-12-3 | Reference compound |
| HY-144318 | CREB-IN-1 (TFA) | 2912285-84-6 | Reference compound |
| HY-144319 | SHR5133 | 2270943-23-0 | Reference compound |
| HY-14431A | Cerlapirdine (hydrochloride) | 925447-04-7 | Reference compound |
| HY-14432 | Pavinetant | 941690-55-7 | Reference compound |
| HY-144320 | HBV-IN-17 | 2270943-13-8 | Reference compound |
| HY-144321 | Trk-IN-9 | 2758623-12-8 | Reference compound |
| HY-144322 | HBV-IN-18 | 2766688-73-5 | Reference compound |
| HY-144323 | YF135 | 2913177-53-2 | Reference compound |
| HY-144324 | AChE-IN-6 | 2758788-95-1 | Reference compound |
| HY-144325 | CYP121A1-IN-1 | Reference compound | |
| HY-144326 | Aβ-IN-1 | 2766509-32-2 | Reference compound |
| HY-144327 | Aβ-IN-2 | Reference compound | |
| HY-144328 | STING agonist-10 | 2259308-69-3 | Reference compound |
| HY-144329 | STING agonist-11 | 2259308-68-2 | Reference compound |
| HY-144330 | TDI-6118 | Reference compound | |
| HY-144331 | Antitumor agent-42 | 2763621-91-4 | Reference compound |
| HY-144332 | PHD2/HDACs-IN-1 | 2339867-53-5 | Reference compound |
| HY-144333 | DNA crosslinker 1 (dihydrochloride) | 2761734-27-2 | Reference compound |
| HY-144334 | CHIKV-IN-3 | Peptides | |
| HY-144335 | DNA crosslinker 2 (dihydrochloride) | 2761734-25-0 | Reference compound |
| HY-144336 | DNA crosslinker 3 (dihydrochloride) | 2761734-21-6 | Reference compound |
| HY-144337 | DNA crosslinker 4 (dihydrochloride) | 2761734-23-8 | Reference compound |
| HY-144338 | PARP1/BRD4-IN-1 | 2758117-74-5 | Reference compound |
| HY-144339 | AhR agonist 2 | 2975270-19-8 | Reference compound |
| HY-14434 | Asunaprevir | 630420-16-5 | Reference compound |
| HY-144340 | Antitumor agent-43 | 2766035-37-2 | Reference compound |
| HY-144341 | DprE1-IN-1 | 920459-41-2 | Reference compound |
| HY-144343S | (Rac)-cis-3-hydroxy glyburide-13C,d3 | 1217848-91-3 | Isotope-Labeled Compounds |
| HY-144344S | Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3 | 1217853-98-9 | Isotope-Labeled Compounds |
| HY-144345S | L-γ-Glutamyl-L-cysteinyl-L-lysine-13C5,15N | 1356841-92-3 | Isotope-Labeled Compounds |
| HY-144347 | HF51116 | 2177311-29-2 | Reference compound |
| HY-144348S | N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N | 1391053-26-1 | Isotope-Labeled Compounds |
| HY-14435 | Pyridone 6 | 457081-03-7 | Reference compound |
| HY-144354S | S-Benzyl-DL-cysteine-2,3,3-d3 | 51494-04-3 | Isotope-Labeled Compounds |
| HY-144355S | N-Acetyl-S-propyl-L-cysteine-d7 | 1331909-69-3 | Isotope-Labeled Compounds |
| HY-144359S | 2-(4-Hydroxyphenyl)-L-glycine-d2 | 1213379-02-2 | Isotope-Labeled Compounds |
| HY-144361 | Antitumor agent-44 | 1811548-74-9 | Reference compound |
| HY-144362S | N-Acetyl-S-(2,5-dimethylbenzene)-L-cysteine-d3 | 1331909-07-9 | Isotope-Labeled Compounds |
| HY-144364S | N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 | Isotope-Labeled Compounds | |
| HY-144364S1 | cis-N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 | Isotope-Labeled Compounds | |
| HY-144365S | N-Acetyl-S-(2-hydroxypropyl)cysteine-d3 (dicyclohexylammonium) | 1356934-59-2 | Isotope-Labeled Compounds |
| HY-144366 | P-gp inhibitor 3 | 2766451-11-8 | Reference compound |
| HY-144367S | N-Acetyl-S-(2-hydroxy-3-propionamide)-L-cysteine-d3 (dicyclohexylammonium) | Isotope-Labeled Compounds | |
| HY-144368 | CO delivery molecule 1 | 1972616-04-8 | Reference compound |
| HY-144369 | Proteasome-IN-4 | Reference compound | |
| HY-144371 | DHODH-IN-20 | 2639835-02-0 | Reference compound |
| HY-144372 | TRPV1 antagonist 3 | 2765294-54-8 | Reference compound |
| HY-144373 | IL-17 modulator 6 | 2725869-16-7 | Reference compound |
| HY-144375 | Monoacylglycerol lipase inhibitor 1 | 2714570-98-4 | Reference compound |
| HY-144376 | Carbonic anhydrase inhibitor 4 | 2764889-93-0 | Reference compound |
| HY-144377 | RXR antagonist 1 | 3010910-40-1 | Reference compound |
| HY-144378S | Thiorphan methoxyacetophenone derivative-d7 | 1346603-29-9 | Isotope-Labeled Compounds |
| HY-144381 | Glutamate-5-kinase-IN-1 | Reference compound | |
| HY-144382 | Glutamate-5-kinase-IN-2 | Reference compound | |
| HY-144383 | RXR antagonist 2 | 3010910-41-2 | Reference compound |
| HY-144386S | N-Desmethyl L-ergothioneine methyl ester-d6 | 1795785-97-5 | Isotope-Labeled Compounds |
| HY-144387 | Antibacterial agent 71 | Reference compound | |
| HY-144388 | ChE/Aβ1-42-IN-1 | 2761149-22-6 | Reference compound |
| HY-144389 | hAChE/Aβ1-42-IN-1 | 2761149-17-9 | Reference compound |
| HY-144390 | (S)-S007-1558 | 1327156-14-8 | Reference compound |
| HY-144391 | Chitin synthase inhibitor 1 | 2763387-69-3 | Reference compound |
| HY-144392 | AChE/BuChE-IN-1 | 84212-49-7 | Reference compound |
| HY-144393 | P-gp/BCRP-IN-1 | 2764596-06-5 | Reference compound |
| HY-144394 | Antitumor agent-45 | 2581082-74-6 | Reference compound |
| HY-144395 | HDAC6-IN-4 | 2709103-20-6 | Reference compound |
| HY-144396 | SHP2-IN-8 | 1801692-60-3 | Reference compound |
| HY-144397 | LEO 134310 | 2089130-74-3 | Reference compound |
| HY-144399 | CD33 splicing modulator 1 | 2762547-05-5 | Reference compound |
| HY-144399A | CD33 splicing modulator 1 (hydrochloride) | 2762547-06-6 | Reference compound |
| HY-14440 | MP7 | 1001409-50-2 | Reference compound |
| HY-144401 | DS-3801b | 1369412-66-7 | Reference compound |
| HY-144403S | S-(N-Methylcarbamoyl)glutathione-d3 | 127633-23-2 | Isotope-Labeled Compounds |
| HY-144406S | N-Acetyl-S-(3-hydroxypropyl)cysteine-d3 (dicyclohexylammonium) | Isotope-Labeled Compounds | |
| HY-144407S | N-Acetyl-S-(2-carboxyethyl)-L-cysteine-d3 | 1260619-43-9 | Isotope-Labeled Compounds |
| HY-144408S | N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine-d3 | 131685-10-4 | Isotope-Labeled Compounds |
| HY-144409S | N-Acetyl-S-(2-cyanoethyl)-L-cysteine-d3 | 1260619-59-7 | Isotope-Labeled Compounds |
| HY-14441 | ML 10302 | 148868-55-7 | Reference compound |
| HY-144410S | N-(2-Benzoylmercaptopropionyl)glycine ethyl ester-d3 | 1189930-99-1 | Isotope-Labeled Compounds |
| HY-144414S | N-Acetyl-S-ethyl-L-cysteine-d5 | 1279033-91-8 | Isotope-Labeled Compounds |
| HY-144416S | Diethyl 2-ethyl-2-acetamidomalonate-d3 | 1246820-39-2 | Isotope-Labeled Compounds |
| HY-144418S | DL-2-Amino-3-(hydroxy-amino)propionic acid-15N | 1219426-14-8 | Isotope-Labeled Compounds |
| HY-144419 | Adenosine receptor antagonist 3 | 2400864-80-2 | Reference compound |
| HY-14442 | ML 10302 (hydrochloride) | 186826-17-5 | Reference compound |
| HY-144420 | Neuraminidase-IN-5 | 2473524-63-7 | Reference compound |
| HY-144421S | N-Acetyl-DL-glufosinate-d3 (hydrate) | Isotope-Labeled Compounds | |
| HY-144422 | RET-IN-15 | 2643375-86-2 | Reference compound |
| HY-144423 | Trk-IN-10 | 2700265-61-6 | Reference compound |
| HY-144424 | Trk-IN-11 | 2700265-62-7 | Reference compound |
| HY-144425 | BSc5367 | 3029584-84-4 | Reference compound |
| HY-144426 | Neuraminidase-IN-6 | 2738526-22-0 | Reference compound |
| HY-144427S | Vitamin E-13C2,d6 | 2483824-69-5 | Isotope-Labeled Compounds |
| HY-144428 | Bcl-2/Mcl-1-IN-2 | 2673361-07-2 | Reference compound |
| HY-144429 | TRPC5-IN-4 | 2762315-39-7 | Reference compound |
| HY-14443 | XMD8-92 | 1234480-50-2 | Reference compound |
| HY-144430 | Bcl-2/Mcl-1-IN-1 | 2673361-08-3 | Reference compound |
| HY-144431 | Bcl-2/Mcl-1-IN-3 | 2088981-53-5 | Reference compound |
| HY-144432S | Vitamin B5-13C3,15N (hemicalcium hemihydrate) | 2483830-09-5 | Isotope-Labeled Compounds |
| HY-144433 | DNMT3A-IN-1 | 1403598-56-0 | Reference compound |
| HY-144434 | RSK-IN-1 | 2761698-77-3 | Reference compound |
| HY-144435 | ATR-IN-11 | Reference compound | |
| HY-144436 | ATR-IN-12 | Reference compound | |
| HY-144437 | ALK5-IN-9 | 2489611-06-3 | Reference compound |
| HY-144438 | Aurora/LIM kinase-IN-1 | Reference compound | |
| HY-144439 | HTS07545 | 118666-03-8 | Reference compound |
| HY-14444 | Plinabulin | 714272-27-2 | Reference compound |
| HY-144440 | JAK1-IN-9 | 2875041-96-4 | Reference compound |
| HY-144441 | NSC81111 | 1678-14-4 | Reference compound |
| HY-144442 | PD-1/PD-L1-IN-15 | Reference compound | |
| HY-144443 | PD-1/PD-L1-IN-16 | Reference compound | |
| HY-144444 | NSC381467 | 1033006-96-0 | Reference compound |
| HY-144445 | NSC114126 | 24909-18-0 | Reference compound |
| HY-144446 | BuChE-IN-1 | 2669070-40-8 | Reference compound |
| HY-144447 | PD-1/PD-L1-IN-17 | 2851938-36-6 | Reference compound |
| HY-144448 | FAK-IN-2 | 2872588-02-6 | Reference compound |
| HY-144449 | mTOR/HDAC6-IN-1 | 2986747-52-6 | Reference compound |
| HY-14444S | Plinabulin-d1 | 2054938-28-0 | Isotope-Labeled Compounds |
| HY-14445 | FK 3311 | 116686-15-8 | Reference compound |
| HY-144450 | PI3K-IN-29 | 2768005-77-0 | Reference compound |
| HY-144451 | TRK-IN-12 | 2823342-34-1 | Reference compound |
| HY-144452 | Immunoproteasome inhibitor 1 | 2755772-63-3 | Reference compound |
| HY-144456 | Xanthine oxidase-IN-5 | 2276711-87-4 | Reference compound |
| HY-144464 | SARS-CoV-2 Mpro-IN-1 | 2758359-91-8 | Reference compound |
| HY-144465 | IDO1-IN-15 | 2126853-17-4 | Reference compound |
| HY-144466 | IDO1-IN-16 | 2677054-63-4 | Reference compound |
| HY-144468 | IDO1-IN-17 | 2677054-58-7 | Reference compound |
| HY-14447 | Bilastine | 202189-78-4 | Reference compound |
| HY-14447R | Bilastine (Standard) | 202189-78-4 | Reference Standards |
| HY-14447S | Bilastine-d6 | 1215358-58-9 | Isotope-Labeled Compounds |
| HY-14447S1 | Bilastine-d4 | 2747918-37-0 | Isotope-Labeled Compounds |
| HY-144497 | HE-S2 | 2939851-67-7 | ADC Related |
| HY-14450 | JNJ-31020028 | 1094873-14-9 | Reference compound |
| HY-144501 | D18 | 2230218-36-5 | Reference compound |
| HY-144507S | Methylergonovine-13C,d3 | Isotope-Labeled Compounds | |
| HY-144509S | l-α-tocopherol acetate-13C4,d6 | Isotope-Labeled Compounds | |
| HY-14451 | PF-4778574 | 1219633-99-4 | Reference compound |
| HY-144513 | Stigmastan-3β-ol | 19466-47-8 | Natural Products |
| HY-144513S | Stigmastan-3β-ol-d5 | 2483831-96-3 | Isotope-Labeled Compounds |
| HY-14452 | Fatostatin | 125256-00-0 | Reference compound |
| HY-144524S | Nitroso diisobutylamine-d4 | 1794897-96-3 | Isotope-Labeled Compounds |
| HY-14452A | Fatostatin (hydrobromide) | 298197-04-3 | Reference compound |
| HY-14454 | TPh A | 21306-65-0 | Reference compound |
| HY-144549 | LXR agonist 1 | 1779524-90-1 | Reference compound |
| HY-144554 | Aminooxy CatB-LXR | 1779524-93-4 | ADC Related |
| HY-14456A | MAC13243 | 1071638-38-4 | Reference compound |
| HY-144577S | Ortho-hydroxy atorvastatin-d5 (calcium) | 265989-47-7 | Isotope-Labeled Compounds |
| HY-144584 | AGL-0182-30 | Reference compound | |
| HY-144585 | AGD-0182 | 1835700-14-5 | Reference compound |
| HY-14460 | AM679 | 1206880-66-1 | Reference compound |
| HY-144603 | Neuropeptide Y Y1 receptor antagonist 1 | 2773476-40-5 | Dye Reagents |
| HY-144604 | FPR2 agonist 2 | 2829263-20-7 | Reference compound |
| HY-144605 | PROTAC EGFR degrader 3 | 2768472-28-0 | Reference compound |
| HY-144606 | Mu opioid receptor antagonist 1 | 2767446-03-5 | Reference compound |
| HY-144607 | Mu opioid receptor antagonist 2 | 2773925-64-5 | Reference compound |
| HY-144608 | Mu opioid receptor antagonist 3 | 2773925-66-7 | Reference compound |
| HY-144609 | Mu opioid receptor antagonist 4 | 2773925-74-7 | Reference compound |
| HY-144610 | Mu opioid receptor antagonist 5 | 1124167-61-8 | Reference compound |
| HY-144612 | NS2B/NS3-IN-2 | 3010940-08-3 | Reference compound |
| HY-144614 | JH-XVII-10 | 3034312-17-6 | Reference compound |
| HY-144617 | JH-XIV-68-3 | 2426628-29-5 | Reference compound |
| HY-144618 | Antibacterial agent 74 | 1644387-48-3 | Reference compound |
| HY-144619 | TLR7/8 antagonist 2 | 2769085-03-0 | Reference compound |
| HY-14462 | NP118809 | 41332-24-5 | Reference compound |
| HY-144621 | Antibacterial agent 75 | 2765224-33-5 | Reference compound |
| HY-144623 | Antiviral agent 15 | Reference compound | |
| HY-144624 | PROTAC Axl Degrader 1 | Reference compound | |
| HY-144627 | PROTAC Axl Degrader 2 | Reference compound | |
| HY-144628 | Fmoc-Asn-Pro-Val-PABC-PNP | 2893871-64-0 | Reference compound |
| HY-144629 | Asn-Pro-Val-PABC-MMAE (TFA) | 2893871-67-3 | Reference compound |
| HY-14463 | Onalespib | 912999-49-6 | Reference compound |
| HY-144630 | diSPhMC-Asn-Pro-Val-PABC-MMAE | 2893871-68-4 | Reference compound |
| HY-144632 | Antifungal agent 22 | 2640054-39-1 | Reference compound |
| HY-144634 | DDO-7263 | 2254004-96-9 | Reference compound |
| HY-144635 | Nrf2-ARE/hMAO-B/QR2 modulator 1 | Reference compound | |
| HY-144636 | Atg4B-IN-2 | 2765008-88-4 | Reference compound |
| HY-144637 | Autophagy inducer 2 | 2684238-37-5 | Reference compound |
| HY-144638 | JMX0293 | Reference compound | |
| HY-144639 | Carbonic anhydrase inhibitor 5 | Reference compound | |
| HY-14464 | PF-00489791 | 853003-48-2 | Reference compound |
| HY-144640 | Carbonic anhydrase inhibitor 6 | 1013213-84-7 | Reference compound |
| HY-144641 | Carbonic anhydrase inhibitor 7 | 546105-61-7 | Reference compound |
| HY-144642 | PARP-1-IN-1 | 2763840-83-9 | Reference compound |
| HY-144643 | CYP51/HDAC-IN-1 | 2502095-64-7 | Reference compound |
| HY-144644 | NS2B/NS3-IN-3 | 2832876-90-9 | Reference compound |
| HY-144644A | NS2B/NS3-IN-3 (hydrochloride) | 2832876-91-0 | Reference compound |
| HY-144645 | SP-471P | 2768011-36-3 | Reference compound |
| HY-144646 | SP-471 | 2768010-39-3 | Reference compound |
| HY-144647 | SP inhibitor 1 | 2766185-81-1 | Reference compound |
| HY-144648 | Mpro/PLpro-IN-1 | 2766185-78-6 | Reference compound |
| HY-144649 | PD-1/PD-L1-IN-24 | 2667680-33-1 | Reference compound |
| HY-14465 | PF 02367982 | 913344-84-0 | Reference compound |
| HY-144650 | Hsp90-Cdc37-IN-3 | 2361009-68-7 | Reference compound |
| HY-144651 | IDO1-IN-18 | 2328099-08-5 | Reference compound |
| HY-144652 | IDO1-IN-19 | 2328099-11-0 | Reference compound |
| HY-144653 | PDGFR-IN-1 | 2644673-07-2 | Reference compound |
| HY-144654 | HDAC/Top-IN-1 | 2411379-14-9 | Reference compound |
| HY-144655 | IP2 | 2247640-44-2 | Reference compound |
| HY-144656 | Steroid sulfatase-IN-1 | 2403716-19-6 | Reference compound |
| HY-144657 | (4S)-PROTAC SOS1 degrader-1 | 2913176-81-3 | Reference compound |
| HY-144657A | (4S)-PROTAC SOS1 degrader-1 (diTFA) | Reference compound | |
| HY-144658 | FXIa-IN-8 | 2744293-04-5 | Reference compound |
| HY-144659 | Metallo-β-lactamase-IN-5 | 1417737-65-5 | Reference compound |
| HY-14466 | GW 848687X | 612831-24-0 | Reference compound |
| HY-144660 | AChE-IN-7 | 2699090-78-1 | Reference compound |
| HY-144661 | KRAS G12D inhibitor 14 | 2765254-39-3 | Reference compound |
| HY-144663 | MtTMPK-IN-1 | 2799607-58-0 | Reference compound |
| HY-144664 | MtTMPK-IN-2 | 2799607-71-7 | Reference compound |
| HY-144665 | MtTMPK-IN-3 | 2799607-80-8 | Reference compound |
| HY-144666 | GLS-1-IN-1 | Reference compound | |
| HY-144667 | ALDH1A3-IN-1 | 1695970-90-1 | Reference compound |
| HY-144668 | RdRP-IN-4 | Reference compound | |
| HY-144669 | ALDH1A3-IN-2 | 886502-08-5 | Reference compound |
| HY-14467 | GSK-269984A | 892664-04-9 | Reference compound |
| HY-144670 | ALDH3A1-IN-1 | 1039855-56-5 | Reference compound |
| HY-144671 | ALDH3A1-IN-2 | 374635-48-0 | Reference compound |
| HY-144672 | A2A receptor antagonist 2 | 2767206-20-0 | Reference compound |
| HY-144673 | LSD1-IN-12 | 1228143-76-7 | Reference compound |
| HY-144675 | LSD1-IN-13 | 2170212-33-4 | Reference compound |
| HY-144675A | LSD1-IN-13 (hydrochloride) | 2170347-90-5 | Reference compound |
| HY-144676 | pan-HER-IN-1 | 1639040-94-0 | Reference compound |
| HY-144677 | pan-HER-IN-2 | 1639040-95-1 | Reference compound |
| HY-144680 | BLU-945 | 2660250-10-0 | Reference compound |
| HY-144681 | Ceperognastat | 2241514-56-5 | Reference compound |
| HY-144681A | rel-Ceperognastat | 2241514-58-7 | Reference compound |
| HY-144682 | (2R,4R)-LY3372689 | Reference compound | |
| HY-144683 | PF-07038124 | 2415085-44-6 | Reference compound |
| HY-144683A | PF-07038124 (hydrochloride) | 2415317-57-4 | Reference compound |
| HY-144684 | PDE4-IN-8 | 2415085-45-7 | Reference compound |
| HY-144685 | ATM Inhibitor-2 | 2769140-29-4 | Reference compound |
| HY-144686 | ATM Inhibitor-3 | 2769140-52-3 | Reference compound |
| HY-144687 | ATM Inhibitor-4 | 2769140-74-9 | Reference compound |
| HY-144688 | HIV-1 protease-IN-1 | 2765293-30-7 | Reference compound |
| HY-144689 | BChE-IN-3 | Reference compound | |
| HY-144690 | D5261 | 1574574-57-4 | Reference compound |
| HY-144691 | PP-C8 | 3032108-74-7 | Reference compound |
| HY-144692 | MEK/PI3K-IN-1 | 2281803-28-7 | Reference compound |
| HY-144693 | MEK/PI3K-IN-2 | 2281803-33-4 | Reference compound |
| HY-144694 | HDAC/HSP90-IN-3 | 2700035-54-5 | Reference compound |
| HY-144695 | Dyrk1A/α-synuclein-IN-1 | 2789711-47-1 | Reference compound |
| HY-144696 | Dyrk1A/α-synuclein-IN-2 | 2789711-66-4 | Reference compound |
| HY-144697 | p38 MAPK-IN-3 | Reference compound | |
| HY-144698 | mGlu4 receptor agonist 1 | 1678501-16-0 | Reference compound |
| HY-144699 | ERRα antagonist-2 | 3032965-02-6 | Reference compound |
| HY-144700 | Antileishmanial agent-3 | 2755930-28-8 | Reference compound |
| HY-144701 | SABA1 | 690681-65-3 | Reference compound |
| HY-144701R | SABA1 (Standard) | 690681-65-3 | Reference Standards |
| HY-144705 | GAT564 | 2851895-01-5 | Reference compound |
| HY-144706 | Axl-IN-3 | 2783991-34-2 | Reference compound |
| HY-144707 | AK-778-XXMU | 1227045-76-2 | Reference compound |
| HY-144708 | Axl-IN-4 | 1176456-11-3 | Reference compound |
| HY-144709 | FLT3/ITD-IN-1 | Reference compound | |
| HY-14471 | Cetilistat | 282526-98-1 | Reference compound |
| HY-144710 | FLT3/ITD-IN-2 | 2489446-59-3 | Reference compound |
| HY-144711 | FLT3/ITD-IN-3 | 2489446-47-9 | Reference compound |
| HY-144712 | L5-DA | 2986876-41-7 | Reference compound |
| HY-144713 | PTP1B-IN-16 | 2848581-86-0 | Reference compound |
| HY-144714 | HIV-1 inhibitor-18 | 2764787-56-4 | Reference compound |
| HY-144715 | HIV-1 inhibitor-17 | 2764787-76-8 | Reference compound |
| HY-144716 | PTP1B-IN-19 | 2848581-83-7 | Reference compound |
| HY-144717 | PTP1B-IN-18 | 2848581-84-8 | Reference compound |
| HY-144718 | PTP1B-IN-17 | 2848581-85-9 | Reference compound |
| HY-14471R | Cetilistat (Standard) | 282526-98-1 | Reference Standards |
| HY-14472 | Tesofensine | 195875-84-4 | Reference compound |
| HY-144720 | BRG1-IN-1 | 2616813-99-9 | Reference compound |
| HY-144721 | Antitubercular agent-11 | 3032629-09-4 | Reference compound |
| HY-144722 | Antitubercular agent-12 | 905677-04-5 | Reference compound |
| HY-144723 | Antitubercular agent-13 | 3032629-25-4 | Reference compound |
| HY-144724 | HSP90-IN-10 | 2881071-86-7 | Reference compound |
| HY-144725 | HDAC1/6-IN-1 | 2630989-02-3 | Reference compound |
| HY-144727 | Anti-inflammatory agent 11 | 63932-07-0 | Reference compound |
| HY-144728 | MraY-IN-3 (hydrochloride) | Reference compound | |
| HY-144729 | Antibacterial agent 82 | 3032608-35-5 | Reference compound |
| HY-144730 | gp120-IN-1 | 5948-75-4 | Reference compound |
| HY-144731 | gp120-IN-2 | 123629-42-5 | Reference compound |
| HY-144732 | TRK/ALK-IN-1 | Reference compound | |
| HY-144733 | ERα antagonist 1 | 2762423-09-4 | Reference compound |
| HY-144734 | Pantothenate kinase-IN-1 | 1024168-48-6 | Reference compound |
| HY-144735 | Anti-inflammatory agent 14 | 894496-27-6 | Reference compound |
| HY-144736 | NS2B/NS3-IN-4 | 2910757-30-9 | Reference compound |
| HY-144737 | Anti-inflammatory agent 15 | 474516-87-5 | Reference compound |
| HY-144738 | Dual FAAH/sEH-IN-1 | 2756099-59-7 | Reference compound |
| HY-144739 | BACE1-IN-8 | Reference compound | |
| HY-144740 | NS2B/NS3-IN-5 | 2910757-21-8 | Reference compound |
| HY-144741 | BACE1-IN-9 | 2872604-91-4 | Reference compound |
| HY-144742 | NS2B/NS3-IN-6 | 2459657-57-7 | Reference compound |
| HY-144743 | ATX inhibitor 12 | 2771312-16-2 | Reference compound |
| HY-144744 | NF-κB-IN-3 | 1873311-82-0 | Reference compound |
| HY-144745 | HSR1304 | 2763363-08-0 | Reference compound |
| HY-144746 | PD-1/PD-L1-IN-26 | 2966090-78-6 | Reference compound |
| HY-144747 | Hydroxyethylamine | 1418733-36-4 | Reference compound |
| HY-144748 | Tubulin inhibitor 17 | 2839151-13-0 | Reference compound |
| HY-144749 | AKR1C3-IN-5 | 2839142-93-5 | Reference compound |
| HY-144752 | cSPM | Reference compound | |
| HY-144753 | AChE/BChE-IN-2 | 2761991-42-6 | Reference compound |
| HY-144754 | VEGFR-2-IN-13 | 2839104-01-5 | Reference compound |
| HY-144755 | MC2652 | 2771425-46-6 | Reference compound |
| HY-144756 | LSD1-IN-15 | Reference compound | |
| HY-144757 | LSD1-IN-16 | Reference compound | |
| HY-144758 | LSD1-IN-17 | Reference compound | |
| HY-144759 | FGFR4-IN-9 | Reference compound | |
| HY-144760 | EGFR-IN-3 | 3031812-65-1 | Reference compound |
| HY-144761 | TOPK-p38/JNK-IN-1 | 2745108-35-2 | Reference compound |
| HY-144762 | K027 | 6586-37-4 | Reference compound |
| HY-144763 | XPO1-IN-1 | Reference compound | |
| HY-144764 | 5-HT1A antagonist 1 | Reference compound | |
| HY-144765 | NF-κB-IN-4 | Reference compound | |
| HY-144766 | ATX inhibitor 13 | 2485779-34-6 | Reference compound |
| HY-144767 | PA3552-IN-1 | 1008121-12-7 | Reference compound |
| HY-144768 | (R)-Chol-TPP | Reference compound | |
| HY-144769 | SDOX | 2921601-78-5 | Reference compound |
| HY-14477 | UPF-1035 | 370872-09-6 | Reference compound |
| HY-144770 | SARS-CoV-2-IN-13 | 56961-10-5 | Reference compound |
| HY-144771 | SARS-CoV-2-IN-14 | 22203-98-1 | Reference compound |
| HY-144772 | SARS-CoV-2-IN-15 | 1580-42-3 | Reference compound |
| HY-144773 | Loxoprofenol-SRS | 83648-76-4 | Reference compound |
| HY-144773A | Loxoprofenol-SRS (tromethamine) | 2582872-01-1 | Reference compound |
| HY-144774 | Topoisomerase I inhibitor 5 | 2513461-95-3 | Reference compound |
| HY-144775 | AChE-IN-10 | 2770832-90-9 | Reference compound |
| HY-144776 | NAT | 831243-31-3 | Reference compound |
| HY-144777 | FLT3-IN-14 | 2620551-45-1 | Reference compound |
| HY-144778 | IDO1/TDO-IN-1 | 2379527-72-5 | Reference compound |
| HY-144779 | HDAC10-IN-1 | Reference compound | |
| HY-14478 | UPF 1069 | 1048371-03-4 | Reference compound |
| HY-144780 | CXCR2 antagonist 4 | Reference compound | |
| HY-144781 | CXCR2 antagonist 5 | Reference compound | |
| HY-144782 | HDAC10-IN-2 | Reference compound | |
| HY-144782A | HDAC10-IN-2 (hydrochloride) | Reference compound | |
| HY-144783 | CXCR2 antagonist 6 | Reference compound | |
| HY-144784 | CXCR2 antagonist 7 | Reference compound | |
| HY-144786 | Tubulin polymerization-IN-4 | 2835559-00-5 | Reference compound |
| HY-144790 | AChE-IN-12 | 2764664-52-8 | Reference compound |
| HY-144791 | Bcl-2-IN-6 | 3027734-50-2 | Reference compound |
| HY-144792 | Bcl-2-IN-7 | 3027734-46-6 | Reference compound |
| HY-144793 | Deac-SS-Biotin | Reference compound | |
| HY-144794 | EGFR-IN-46 | 2764772-88-3 | Reference compound |
| HY-144795 | VEGFR-2-IN-14 | Reference compound | |
| HY-144796 | VEGFR-2-IN-15 | 3033033-20-1 | Reference compound |
| HY-144797 | Tubulin inhibitor 22 | 3033038-38-6 | Reference compound |
| HY-144798 | FWM-5 | 2757194-04-8 | Reference compound |
| HY-144799 | FWM-4 | 2757194-03-7 | Reference compound |
| HY-144800 | FWM-1 | Reference compound | |
| HY-144801 | DDO-02005 (free base) | 1186134-30-4 | Reference compound |
| HY-144801A | DDO-02005 | 1186049-44-4 | Reference compound |
| HY-144802 | DDO-02001 | 1186049-49-9 | Reference compound |
| HY-144803 | VEGFR-2-IN-16 | 3033041-36-7 | Reference compound |
| HY-144804 | VEGFR-2-IN-17 | 3033041-34-5 | Reference compound |
| HY-144805 | VEGFR-2-IN-18 | 3033041-38-9 | Reference compound |
| HY-144806 | PI3K/AKT-IN-1 | 3033069-84-7 | Reference compound |
| HY-144807 | Carbonic anhydrase inhibitor 9 | 3033042-50-8 | Reference compound |
| HY-144808 | Anticancer agent 40 | 2760658-33-9 | Reference compound |
| HY-144809 | Pancreatic lipase/Carboxylesterase 1-IN-1 | 194235-21-7 | Reference compound |
| HY-144810 | CDK2-IN-8 | 2919216-36-5 | Reference compound |
| HY-144811 | CDK2-IN-9 | 2919216-33-2 | Reference compound |
| HY-144812 | Gü1303 | 1043922-53-7 | Reference compound |
| HY-144813 | Gü2602 | 1627094-88-5 | Reference compound |
| HY-144817 | Tubulin inhibitor 27 | 184579-57-5 | Reference compound |
| HY-144818 | Tubulin inhibitor 23 | 170488-57-0 | Reference compound |
| HY-144820 | JO146 | 130727-21-8 | Reference compound |
| HY-144822 | Anti-MRSA agent 2 | 2597082-01-2 | Reference compound |
| HY-144823 | Anti-MRSA agent 3 | 2416909-42-5 | Reference compound |
| HY-144824 | Monoamine oxidase/Aromatase-IN-1 | Reference compound | |
| HY-144825 | Chol-CTPP | Reference compound | |
| HY-144826 | ZDWX-25 | 2668297-70-7 | Reference compound |
| HY-144827 | AM8936 | 2820337-96-8 | Reference compound |
| HY-144828 | RIP1/RIP3/MLKL activator 1 | 2682850-41-3 | Reference compound |
| HY-14483 | AF-353 | 865305-30-2 | Reference compound |
| HY-144830 | 6BrCaQ | 954416-67-2 | Reference compound |
| HY-144831 | 6BrCaQ-C10-TPP | Reference compound | |
| HY-144833 | SARS-CoV-2 3CLpro-IN-1 | 2757970-20-8 | Reference compound |
| HY-144835 | Camibirstat | 2671128-05-3 | Reference compound |
| HY-14483A | AF-353 (hydrochloride) | 927887-18-1 | Reference compound |
| HY-144841 | Cemsidomide | 2504235-67-8 | Reference compound |
| HY-144841A | (Rac)-Cemsidomide | 2504233-68-3 | Reference compound |
| HY-14485 | Ro-51 | 1050670-85-3 | Reference compound |
| HY-144856S1 | Sapropterin-d3 | 2747956-15-4 | Isotope-Labeled Compounds |
| HY-144858 | EZM0414 | 2411748-50-8 | Reference compound |
| HY-14486 | Elinogrel (potassium) | 936501-01-8 | Reference compound |
| HY-144863 | BAY 1214784 | 1631164-25-4 | Reference compound |
| HY-144867 | CCT245232 | 1693731-14-4 | Reference compound |
| HY-144868 | Glutathione synthesis-IN-1 | 2632968-72-8 | Reference compound |
| HY-144869 | OTS447 | 1356943-67-3 | Reference compound |
| HY-144870 | STAT3-IN-7 | 2237955-91-6 | Reference compound |
| HY-144871 | STAT3-IN-8 | 2237957-26-3 | Reference compound |
| HY-144872 | RJ-34 | 1170694-29-7 | Reference compound |
| HY-144873 | AVJ16 | 2775241-92-2 | Reference compound |
| HY-144874 | AZ3391 | 2756333-42-1 | Reference compound |
| HY-144875 | CTX-712 | 2144751-78-8 | Reference compound |
| HY-144876 | RIDR-PI-103 | 2581114-71-6 | Reference compound |
| HY-144878 | VPC-70619 | 2361742-30-3 | Reference compound |
| HY-144880 | SC209 | 1977557-86-0 | ADC Related |
| HY-144881 | (S)-HH2853 | 2202678-05-3 | Reference compound |
| HY-144882 | (R)-HH2853 | 2202678-06-4 | Reference compound |
| HY-144893 | OKI-006 | 1315334-23-6 | Reference compound |
| HY-144894 | AM-5308 | 2410796-89-1 | Reference compound |
| HY-144896 | FHT-1015 | 2368903-18-6 | Reference compound |
| HY-144897 | FHT-1204 | 2468048-24-8 | Reference compound |
| HY-144898 | SB-216 | 2756818-39-8 | Reference compound |
| HY-144899 | ASR-490 | 2690312-67-3 | Reference compound |
| HY-144900 | Topramezone | 210631-68-8 | Reference compound |
| HY-144900R | Topramezone (Standard) | 210631-68-8 | Reference Standards |
| HY-144903 | Migoprotafib | 2377352-49-1 | Reference compound |
| HY-144904 | MC4343 | Reference compound | |
| HY-144906 | THP104c | 877792-12-6 | Reference compound |
| HY-144913S | Bempedoic acid impurity 1-d4 | 2408132-01-2 | Isotope-Labeled Compounds |
| HY-144927S | C14 Benzalkonium chloride -1 ketone-d5 | Isotope-Labeled Compounds | |
| HY-144947S | Beclomethasone-17-monopropionate-d3 | Isotope-Labeled Compounds | |
| HY-14495 | BMS-604992 | 674343-47-6 | Reference compound |
| HY-144950S | 3-Hydroxy benzopyrene-d11 | 1246819-35-1 | Isotope-Labeled Compounds |
| HY-14495A | BMS-604992 (free base) | 760944-56-7 | Reference compound |
| HY-14495B | BMS-604992 (dihydrochloride) | 1469750-46-6 | Reference compound |
| HY-144962 | SOS1-IN-11 | 2654741-64-5 | Reference compound |
| HY-144965 | SOS1-IN-12 | 2654741-56-5 | Reference compound |
| HY-144967 | SOS1-IN-13 | 2654741-45-2 | Reference compound |
| HY-144969S | (-)-2-Methyl-isoborneol-d3 | 135441-89-3 | Isotope-Labeled Compounds |
| HY-144971 | dCeMM2 | 296771-07-8 | Reference compound |
| HY-144976 | dCeMM3 | 311787-85-6 | Reference compound |
| HY-144977 | dCeMM4 | 1281683-44-0 | Reference compound |
| HY-144980 | E3 ligase Ligand 21 | 2504233-73-0 | Reference compound |
| HY-144981 | HQ461 | 1226443-41-9 | Reference compound |
| HY-144982 | NRX-1532 | Reference compound | |
| HY-144983 | E3 ligase Ligand 22 | 2377849-57-3 | Reference compound |
| HY-144984 | NRX-1933 | 2763260-30-4 | Reference compound |
| HY-144985 | E3 ligase Ligand 23 | 444287-56-3 | Reference compound |
| HY-144987 | RBN013209 | 2597933-17-8 | Reference compound |
| HY-144988 | CD38 inhibitor 2 | 2597933-78-1 | Reference compound |
| HY-144991 | Aurora kinase inhibitor-8 | 2133001-88-2 | Reference compound |
| HY-144993 | PI3Kδ/γ-IN-1 | 1980884-01-2 | Reference compound |
| HY-144995 | BSJ-02-162 | 2139329-47-6 | Reference compound |
| HY-144998 | NVP-DKY709 | 2291360-73-9 | Reference compound |
| HY-144999 | LEB-03-146 | 2858812-91-4 | Reference compound |
| HY-145000 | N-Desalkyludenafil | 319491-68-4 | Reference compound |
| HY-145001 | 20-HC-Me-Pyrrolidine | Reference compound | |
| HY-145003S | 4(Z),7(Z)-Decadienoic acid-d5 | 2714087-40-6 | Isotope-Labeled Compounds |
| HY-145004S | (±)8,9-DiHETrE-d11 | Isotope-Labeled Compounds | |
| HY-145008S | (±)9(10)-DiHOME-d4 | 1215168-76-5 | Isotope-Labeled Compounds |
| HY-145009 | SN-008 | 2249106-01-0 | Reference compound |
| HY-145010 | SN-011 | 2249435-90-1 | Reference compound |
| HY-145012S | W-19-d4 (hydrochloride) | 2749974-94-3 | Isotope-Labeled Compounds |
| HY-145013 | tri-GalNAc-COOH (acetylation) | 3008204-26-7 | Reference compound |
| HY-145015 | Tuspetinib | 2294874-49-8 | Reference compound |
| HY-145015A | Tuspetinib (hydrate) | 2758339-04-5 | Reference compound |
| HY-145016 | HN37 | 1821222-10-9 | Reference compound |
| HY-145017 | KRAS G12C inhibitor 20 | 2640858-10-0 | Reference compound |
| HY-145018 | KRAS G12C inhibitor 21 | 2737269-61-1 | Reference compound |
| HY-145019 | KRAS G12C inhibitor 22 | 2736599-72-5 | Reference compound |
| HY-145020 | KRAS G12C inhibitor 23 | 2735721-00-1 | Reference compound |
| HY-145022 | KRAS G12C inhibitor 25 | 2734060-73-0 | Reference compound |
| HY-145023 | RET-IN-5 | 2725770-20-5 | Reference compound |
| HY-145024 | RET-IN-6 | 2715208-83-4 | Reference compound |
| HY-145025 | ERK1/2 inhibitor 3 | 2737294-99-2 | Reference compound |
| HY-145026 | ERK1/2 inhibitor 4 | 2490396-99-9 | Reference compound |
| HY-145027 | ERK1/2 inhibitor 5 | 2560552-75-0 | Reference compound |
| HY-145028 | ERK1/2 inhibitor 6 | 2634816-13-8 | Reference compound |
| HY-145029 | SYK/JAK-IN-1 | 2737326-28-0 | Reference compound |
| HY-14503 | MDR-1339 | 1018946-38-7 | Reference compound |
| HY-145033 | VL-6 | 2274813-29-3 | Reference compound |
| HY-145034 | KIF18A-IN-1 | 2600559-12-2 | Reference compound |
| HY-145035 | HPK1-IN-9 | 2734168-78-4 | Reference compound |
| HY-145036 | HPK1-IN-10 | 2734168-69-3 | Reference compound |
| HY-145037 | HPK1-IN-11 | 2734167-68-9 | Reference compound |
| HY-145038 | HPK1-IN-12 | 2734168-51-3 | Reference compound |
| HY-145039 | HPK1-IN-13 | 2734168-30-8 | Reference compound |
| HY-145040 | HPK1-IN-14 | 2734168-45-5 | Reference compound |
| HY-145041 | HPK1-IN-15 | 2201098-03-3 | Reference compound |
| HY-145042 | HPK1-IN-16 | 2294965-95-8 | Reference compound |
| HY-145043 | FGFR-IN-1 | 1513860-41-7 | Reference compound |
| HY-145044 | HPK1-IN-17 | 2403600-07-5 | Reference compound |
| HY-145045 | HPK1-IN-18 | 2403598-42-3 | Reference compound |
| HY-145046 | SOS1-IN-3 | 2359689-76-0 | Reference compound |
| HY-145047 | SOS1-IN-4 | 2738392-83-9 | Reference compound |
| HY-145048 | SOS1-IN-5 | 2716956-47-5 | Reference compound |
| HY-145049 | HBV-IN-6 | 2724224-47-7 | Reference compound |
| HY-145050 | HBV-IN-7 | 2724224-49-9 | Reference compound |
| HY-145051 | HBV-IN-8 | 2724224-57-9 | Reference compound |
| HY-145052 | HBV-IN-9 | 2170998-69-1 | Reference compound |
| HY-145053 | HBV-IN-10 | 2716907-16-1 | Reference compound |
| HY-145053A | (5S,8R)-HBV-IN-10 | 2716907-15-0 | Reference compound |
| HY-145055 | HBV-IN-11 | 2226178-41-0 | Reference compound |
| HY-145056 | ART615 | 3031765-75-7 | Reference compound |
| HY-145057 | PP-biotin | 1801423-93-7 | Reference compound |
| HY-145059 | HBV-IN-12 | 2724229-06-3 | Reference compound |
| HY-145060 | HBV-IN-13 | 2724228-72-0 | Reference compound |
| HY-145061 | ADAMTS-5-IN-3 | 2688733-96-0 | Reference compound |
| HY-145062 | Enpp-1-IN-4 | 2376600-89-2 | Reference compound |
| HY-145063 | Enpp-1-IN-5 | 2230916-95-5 | Reference compound |
| HY-145064 | Enpp-1-IN-6 | 2718971-29-8 | Reference compound |
| HY-145065 | Enpp-1-IN-7 | Reference compound | |
| HY-145066 | Gly-Gly-Gly-PEG4-azide | ADC Related | |
| HY-145069 | Enpp-1-IN-8 | 2718971-08-3 | Reference compound |
| HY-14507 | YK-4-279 | 1037184-44-3 | Reference compound |
| HY-145070 | Enpp-1-IN-9 | 2718970-70-6 | Reference compound |
| HY-145071 | PROTAC ERα Y537S degrader-1 | 2667598-05-0 | Reference compound |
| HY-145072 | BSJ-01-175 | 2227392-55-2 | Reference compound |
| HY-145073 | PROTAC ER Degrader-10 | 2504911-58-2 | Reference compound |
| HY-145078 | PNU-EDA-Gly5 | 1957223-28-7 | ADC Related |
| HY-145079 | Bunamidine (hydrochloride) | 1055-55-6 | Reference compound |
| HY-145080 | Dynole 2−24 | 1416313-72-8 | Reference compound |
| HY-145081 | Pitnot-2 | 1576239-29-6 | Reference compound |
| HY-145082 | 4-Sulfo-N-(4-aminobenzyl)-1,8-naphthalimide (potassium) | 1419320-93-6 | Reference compound |
| HY-145086 | R-PSOP | 1185189-97-2 | Reference compound |
| HY-145087 | NP3-146 | 210826-47-4 | Reference compound |
| HY-145087A | NP3-146 (sodium) | 1995068-96-6 | Reference compound |
| HY-145090 | DBCO-N-bis(PEG4-NHS ester) | 2639395-38-1 | ADC Related |
| HY-145102 | NCT-58 | 2411429-33-7 | Reference compound |
| HY-145103 | UNC6934 | 2561494-77-5 | Reference compound |
| HY-145104 | Antioxidant agent-1 | 136068-43-4 | Reference compound |
| HY-145105 | Inonophenol C | 3017174-74-9 | Reference compound |
| HY-145106 | Histamine H4 receptor antagonist-1 | 1246207-84-0 | Reference compound |
| HY-145107 | HPK1-IN-19 | 2227609-33-6 | Reference compound |
| HY-145108 | FAK-IN-1 | 2553215-22-6 | Reference compound |
| HY-145109 | HPK1-IN-20 | 2561490-78-4 | Reference compound |
| HY-145110 | IGF-1R inhibitor-2 | 1116236-15-7 | Reference compound |
| HY-145111 | TNK2-IN-1 | 2574456-10-1 | Reference compound |
| HY-145112 | AChE-IN-3 | 2713548-95-7 | Reference compound |
| HY-145115 | Adeninobananin | 858956-99-7 | Reference compound |
| HY-145119 | GS-621763 | 2647442-13-3 | Reference compound |
| HY-145119AS | Mindeudesivir (hydrobromide) | 2779498-79-0 | Isotope-Labeled Compounds |
| HY-145119S | Mindeudesivir | 2647442-33-7 | Isotope-Labeled Compounds |
| HY-145120 | RG6344 | 2649372-20-1 | Reference compound |
| HY-145121 | DS96432529 | 2871872-79-4 | Reference compound |
| HY-145122 | ELOVL1-IN-1 | 2227482-41-7 | Reference compound |
| HY-145124 | TRPM8 antagonist 3 | 2102179-29-1 | Reference compound |
| HY-145125 | SJ995973 | 2882065-25-8 | Reference compound |
| HY-145126 | CP-628006 | 305822-08-6 | Reference compound |
| HY-145127 | ETZ | 2989379-61-3 | Dye Reagents |
| HY-145128 | GR103545 | 126766-43-6 | Reference compound |
| HY-145143 | anti-TNBC agent-1 | 2289585-58-4 | Reference compound |
| HY-145147 | AAA-10 | 2758171-70-7 | Reference compound |
| HY-145147A | AAA-10 (formic) | Reference compound | |
| HY-145148 | Hemiasterlin derivative-1 | 1887046-60-7 | ADC Related |
| HY-145149 | Duostatin 5 | 2124210-34-8 | ADC Related |
| HY-145150 | TRPC5-IN-1 | 2265215-18-5 | Reference compound |
| HY-145151 | TRPC6-IN-2 | 2308595-83-5 | Reference compound |
| HY-145152 | Biotin-Thalidomide | 2230857-87-9 | Reference compound |
| HY-145153 | S-777469 | 885496-53-7 | Reference compound |
| HY-145154 | Digoxigenin monodigitoxoside | 5352-63-6 | Reference compound |
| HY-145155 | Calpain-2-IN-1 | 144231-85-6 | Reference compound |
| HY-145157 | Ferric nitrilotriacetate | 16448-54-7 | Reference compound |
| HY-145158 | Temocillin | 66148-78-5 | Reference compound |
| HY-145159 | SHP2 protein degrader-1 | 2624181-69-5 | Reference compound |
| HY-145162 | SHP2-D26 | 2458219-65-1 | Reference compound |
| HY-145169 | AZ194 | 2241651-99-8 | Reference compound |
| HY-14517 | H3R antagonist 5 | 879368-27-1 | Reference compound |
| HY-145177 | Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc | 1799711-31-1 | Reference compound |
| HY-14518 | Aminopterin | 54-62-6 | Reference compound |
| HY-14518A | Aminopterin (sodium) | 58602-66-7 | Reference compound |
| HY-14518R | Aminopterin (Standard) | 54-62-6 | Reference Standards |
| HY-14519 | Methotrexate | 59-05-2 | ADC Related |
| HY-145191 | MrgprX2 antagonist-1 | 2642162-06-7 | Reference compound |
| HY-145192 | MrgprX2 antagonist-2 | 2642346-30-1 | Reference compound |
| HY-145193 | MrgprX2 antagonist-3 | 2642174-19-2 | Reference compound |
| HY-145193A | (R)-MrgprX2 antagonist-3 | 2642174-20-5 | Reference compound |
| HY-145194 | MrgprX2 antagonist-4 | 2641398-04-9 | Reference compound |
| HY-145195 | MrgprX2 antagonist-5 | 2527815-74-1 | Reference compound |
| HY-145196 | RTICBM-189 | 551909-15-0 | Reference compound |
| HY-145197 | MPO-IN-3 | 1435469-45-6 | Reference compound |
| HY-14519A | Methotrexate (disodium) | 7413-34-5 | ADC Related |
| HY-14519B | Methotrexate (hydrate) | 133073-73-1 | Biochemical Assay Reagents |
| HY-14519CS | (R)-Methotrexate-d3 | Isotope-Labeled Compounds | |
| HY-14519D | Methotrexate (monohydrate) | 6745-93-3 | ADC Related |
| HY-14519R | Methotrexate (Standard) | 59-05-2 | Reference Standards |
| HY-14519S | Methotrexate-d3 | 432545-63-6 | Isotope-Labeled Compounds |
| HY-14519S1 | Methotrexate-d3 (diammonium) | Isotope-Labeled Compounds | |
| HY-14520 | Tetrahydrofolic acid | 135-16-0 | Natural Products |
| HY-14520A | (6S)-Tetrahydrofolic acid | 71963-69-4 | Reference compound |
| HY-14520B | Tetrahydrofolic acid (trihydrochloride) | 150731-85-4 | Reference compound |
| HY-14520S | Tetrahydrofolic acid-d4 | 1356841-72-9 | Isotope-Labeled Compounds |
| HY-14520S1 | Tetrahydrofolic acid-13C5 | Isotope-Labeled Compounds | |
| HY-14520S2 | Tetrahydrofolic acid-13C6 | 212248-88-9 | Isotope-Labeled Compounds |
| HY-14521 | Lometrexol | 106400-81-1 | Reference compound |
| HY-14521A | Lometrexol (disodium) | 120408-07-3 | Reference compound |
| HY-14521B | Lometrexol (hydrate) | 1435784-14-7 | Reference compound |
| HY-14522 | LY 222306 | 154446-98-7 | Reference compound |
| HY-145225 | DLin-K-C3-DMA | 1217306-46-1 | Reference compound |
| HY-145226 | XY-06-007 | 2757045-94-4 | Reference compound |
| HY-14523 | LY 254155 | 135503-67-2 | Reference compound |
| HY-145230 | FGFR2-IN-1 | 2677709-76-9 | Reference compound |
| HY-145231 | FGFR2-IN-2 | 2677709-81-6 | Reference compound |
| HY-145232 | PhosTAC7 | 3016307-75-5 | Reference compound |
| HY-145233 | PfPKG-IN-1 | 2866493-89-0 | Reference compound |
| HY-145234 | GPBAR1-IN-3 | 2760546-05-0 | Reference compound |
| HY-145235 | AChE-IN-4 | Reference compound | |
| HY-145236 | Analgesic agent-1 | 2230243-92-0 | Reference compound |
| HY-145237 | BM213 | 2891606-02-1 | Reference compound |
| HY-145238 | FTO-IN-6 | 2968347-63-7 | Reference compound |
| HY-145239 | PD-1/PD-L1-IN-13 | 2865841-81-0 | Reference compound |
| HY-145240 | eIF4E-IN-1 | 2573979-31-2 | Reference compound |
| HY-145241 | TBTDC | 2866214-44-8 | Reference compound |
| HY-145243 | PDPOB | 2351900-45-1 | Reference compound |
| HY-145244 | APN/AKT-IN-1 | 2854340-31-9 | Reference compound |
| HY-145245 | TLR4-IN-C34-C2-amide-C6-OH | Reference compound | |
| HY-145246 | Biotin-PEG8-Vidarabine | Reference compound | |
| HY-145247 | Biotin-PEG7-C2-S-Vidarabine | Reference compound | |
| HY-145248 | Biotin-PEG7-C2-NH-Vidarabine-S-CH3 | Reference compound | |
| HY-145249 | ATP-PEG8-Biotin | Reference compound | |
| HY-145250 | NK1 receptor antagonist 2 | 579475-17-5 | Reference compound |
| HY-145253 | Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH | Reference compound | |
| HY-145254 | Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH | Reference compound | |
| HY-145255 | Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH | 1637413-46-7 | Reference compound |
| HY-145256 | GABAA receptor agent 4 | 2035203-91-7 | Reference compound |
| HY-145257 | GABAA receptor agent 5 | 1808389-92-5 | Reference compound |
| HY-145258 | GABAA receptor agent 6 | 1808463-81-1 | Reference compound |
| HY-145259 | HDAC6-IN-3 | 3023019-99-7 | Reference compound |
| HY-14526 | 5-DACTHF | 118252-44-1 | Reference compound |
| HY-145260 | BRD4/CK2-IN-1 | 2756851-99-5 | Reference compound |
| HY-145261 | hDHODH-IN-8 | 2757405-31-3 | Reference compound |
| HY-145262 | eIF4E-IN-2 | 2575840-38-7 | Reference compound |
| HY-145263 | VD2173 | 2574389-19-6 | Reference compound |
| HY-145263A | VD2173 epimer-1 | Reference compound | |
| HY-145264 | OARV-771 | 2683008-37-7 | Reference compound |
| HY-145265 | Antimicrobial photosensitizer-1 | 2933179-62-3 | Reference compound |
| HY-145266 | OM-1700 | 2406276-78-4 | Reference compound |
| HY-145267 | OM-153 | 2406278-81-5 | Reference compound |
| HY-145268 | SLEC-11 | 863761-17-5 | Reference compound |
| HY-145269 | AL-GDa62 | 2761538-66-1 | Reference compound |
| HY-145270 | ELOVL1-IN-2 | 2761063-79-8 | Reference compound |
| HY-145272 | ELOVL1-IN-3 | 2761063-99-2 | Reference compound |
| HY-145273 | EB-0150 | 2832824-40-3 | Reference compound |
| HY-145274 | EB-0156 | 2832824-43-6 | Reference compound |
| HY-145275 | EB-0176 | 2758314-64-4 | Reference compound |
| HY-145276 | SARS-CoV-2-IN-10 | 2722634-95-7 | Reference compound |
| HY-145277 | SARS-CoV-2-IN-11 | 2722635-28-9 | Reference compound |
| HY-145278 | RXFP3/4 agonist 2 | 2752378-78-0 | Reference compound |
| HY-145279 | RXFP3 agonist 1 | 2752378-24-6 | Reference compound |
| HY-145280 | IDO1/2-IN-1 | 2310286-45-2 | Reference compound |
| HY-145280A | IDO1/2-IN-1 (hydrochloride) | 2310286-60-1 | Reference compound |
| HY-145281 | MS98 | 2376137-31-2 | Reference compound |
| HY-145282 | MS170 | 2376136-61-5 | Reference compound |
| HY-145284 | APJ receptor agonist 4 | 2762567-70-2 | Reference compound |
| HY-145285 | APJ receptor agonist 5 | 2135514-20-2 | Reference compound |
| HY-145286 | IMPDH2-IN-2 | 1434517-02-8 | Reference compound |
| HY-145287 | S-MGB-234 | 1970223-53-0 | Reference compound |
| HY-145287A | S-MGB-234 (TFA) | 1970223-54-1 | Reference compound |
| HY-145288 | Antitumor agent-36 | 3005986-81-9 | Reference compound |
| HY-145289 | Antitumor agent-37 | 3032101-64-4 | Reference compound |
| HY-145290 | CPT-Se3 | 2968315-02-6 | Reference compound |
| HY-145291 | CPT-Se4 | 2968315-03-7 | Reference compound |
| HY-145292 | TNIK-IN-2 | 2754265-76-2 | Reference compound |
| HY-145293 | TNIK-IN-3 | 2754265-25-1 | Reference compound |
| HY-145294 | ROCK2-IN-5 | 3031515-48-4 | Reference compound |
| HY-145295 | Flupyradifurone | 951659-40-8 | Reference compound |
| HY-145295R | Flupyradifurone (Standard) | 951659-40-8 | Reference Standards |
| HY-145296 | Triflumezopyrim | 1263133-33-0 | Reference compound |
| HY-145297 | Flupyrimin | 1689566-03-7 | Reference compound |
| HY-145297R | Flupyrimin (Standard) | 1689566-03-7 | Reference Standards |
| HY-145298 | Dicloromezotiaz | 1263629-39-5 | Reference compound |
| HY-145299 | nAChR modulator-1 | 1902218-84-1 | Reference compound |
| HY-14530 | Pelitrexol | 446022-33-9 | Reference compound |
| HY-145300 | nAChR modulator-2 | 1700657-87-9 | Reference compound |
| HY-145301 | Mycobactin-IN-1 | 65840-95-1 | Reference compound |
| HY-145302 | Mycobactin-IN-2 | 421573-09-3 | Reference compound |
| HY-145303 | DX2-201 | 2749554-00-3 | Reference compound |
| HY-145304 | DX3-235 | 2749555-39-1 | Reference compound |
| HY-145306 | DX3-234 | 2941323-59-5 | Reference compound |
| HY-145307 | DATPT | 2891582-75-3 | Reference compound |
| HY-145308 | Heterobivalent ligand-1 | 2888568-58-7 | Reference compound |
| HY-145309 | eIF4E-IN-3 | 2573979-29-8 | Reference compound |
| HY-14531 | Talarozole | 201410-53-9 | Reference compound |
| HY-145310 | ZL0590 | 2230496-99-6 | Reference compound |
| HY-145311 | Bis-Pro-5FU | 2155827-07-7 | Reference compound |
| HY-145312 | ATR-IN-4 | 2574545-45-0 | Reference compound |
| HY-145313 | TTBK1-IN-2 | 2765453-51-6 | Reference compound |
| HY-145314 | TC113 | Reference compound | |
| HY-145316 | Vanin-1-IN-2 | 2054952-13-3 | Reference compound |
| HY-145317 | LRRK2-IN-2 | 2641059-19-8 | Reference compound |
| HY-145318 | LRRK2-IN-3 | 2641054-60-4 | Reference compound |
| HY-145319 | FPFT-2216 | 2367619-87-0 | Reference compound |
| HY-14532 | Brincidofovir | 444805-28-1 | Reference compound |
| HY-145320 | TMX-4113 | 2766385-92-4 | Reference compound |
| HY-145321 | TMX-4100 | 2367619-63-2 | Reference compound |
| HY-145322 | TMX-4116 | 2766385-56-0 | Reference compound |
| HY-145323 | Mitochondria-Targeted Photoactivatable Prodrug | 2883123-79-1 | Reference compound |
| HY-145324 | Antiviral agent 14 | 2755814-80-1 | Reference compound |
| HY-145325 | Antibacterial agent 66 | Reference compound | |
| HY-145326 | Antibacterial agent 67 | 2488900-01-0 | Reference compound |
| HY-145327 | Antimalarial agent 7 | 2756414-77-2 | Reference compound |
| HY-145328 | PARP-1/2-IN-1 | 1903744-45-5 | Reference compound |
| HY-14533 | K 01-162 | 677746-25-7 | Reference compound |
| HY-145330 | NSC639828 | 134742-26-0 | Reference compound |
| HY-145331 | ARG1-IN-1 | 2376189-62-5 | Reference compound |
| HY-145331A | ARG1-IN-1 (hydrochloride) | Reference compound | |
| HY-145332 | IDO1-IN-11 | 2306411-34-5 | Reference compound |
| HY-145334 | CD73-IN-5 | 2412019-99-7 | Reference compound |
| HY-145335 | GSK2818713 | 1422484-32-9 | Reference compound |
| HY-145336 | JAK1/TYK2-IN-1 | 1883300-48-8 | Reference compound |
| HY-145337 | FT3967385 | Reference compound | |
| HY-145338 | PI3Kβ-IN-1 | 2215098-77-2 | Reference compound |
| HY-145339 | ARN19702 | 1971937-18-4 | Reference compound |
| HY-145340 | 2'-O-Propargyl A(Bz)-3'-phosphoramidite | 171486-59-2 | Reference compound |
| HY-145341 | GNE-149 | 1953132-75-6 | Reference compound |
| HY-145343 | RO7185876 | 2226038-71-5 | Reference compound |
| HY-145343A | (9R)-RO7185876 | 2226077-86-5 | Reference compound |
| HY-145344 | ONO-8430506 | 1354805-08-5 | Reference compound |
| HY-145345 | BACE1-IN-6 | 2079945-75-6 | Reference compound |
| HY-145346 | NLG802 | 2071683-99-1 | Reference compound |
| HY-145347 | GSK232 | 2702984-69-6 | Reference compound |
| HY-145348 | MK-5204 | 1207751-75-4 | Reference compound |
| HY-145349 | FXIa-IN-6 | 1551459-37-0 | Reference compound |
| HY-14535 | SEN-1269 | 956128-01-1 | Reference compound |
| HY-145350 | HDAC-IN-26 | 2410542-97-9 | Reference compound |
| HY-145351 | BAY 1003803 | 1152781-51-5 | Reference compound |
| HY-145352 | ChemR23-IN-2 | 2465086-50-2 | Reference compound |
| HY-145353 | HTL22562 | 2097085-63-5 | Reference compound |
| HY-145354 | FXIa-IN-7 | 2488952-56-1 | Reference compound |
| HY-145355 | IDO1-IN-12 | 2379570-48-4 | Reference compound |
| HY-145356 | HbF inducer-1 | 2987004-95-3 | Reference compound |
| HY-145357 | SGLT1/2-IN-2 | 2387812-73-7 | Reference compound |
| HY-145358 | FAP-PI3KI1 | 2415941-98-7 | Reference compound |
| HY-145359 | eIF4A3-IN-5 | 2100145-31-9 | Reference compound |
| HY-14536 | Methylene Blue | 61-73-4 | Dye Reagents |
| HY-145360 | eIF4A3-IN-6 | 2100133-77-3 | Reference compound |
| HY-145361 | eIF4A3-IN-7 | 2374759-82-5 | Reference compound |
| HY-145362 | S1P1 agonist 4 | 1883345-11-6 | Reference compound |
| HY-145363 | αvβ5 integrin-IN-1 | 2615912-33-7 | Reference compound |
| HY-145364 | Ghrelin receptor full agonist-2 | 2602452-73-1 | Reference compound |
| HY-145365 | DGN549-L | 1884276-68-9 | ADC Related |
| HY-145367 | Ala-CO-amide-C4-Boc | ADC Related | |
| HY-145368 | Tri-GalNAc-NHS ester | 1953146-83-2 | Reference compound |
| HY-145368B | Tri-GalNAc(OAc)3-Perfluorophenyl | Reference compound | |
| HY-145369 | DS34942424 | 2967655-39-4 | Reference compound |
| HY-14536A | Methylene blue (purity≥70%) | 61-73-4 | Reference compound |
| HY-14536R | Methylene Blue (Standard) | 61-73-4 | Reference Standards |
| HY-14537 | Latrepirdine (dihydrochloride) | 97657-92-6 | Reference compound |
| HY-145370 | GluN2B receptor modulator-1 | 2222010-71-9 | Reference compound |
| HY-145371 | ATG7-IN-1 | 2226229-87-2 | Reference compound |
| HY-145372 | γ-Secretase modulator 10 | 2694817-84-8 | Reference compound |
| HY-145373 | BMS-986143 | 1643372-83-1 | Reference compound |
| HY-145374 | AL-611 | 2481279-61-0 | Reference compound |
| HY-145375 | NS5A-IN-1 | Reference compound | |
| HY-145376 | Cholera autoinducer 1 | 1004296-82-5 | Reference compound |
| HY-145379 | Miaosporone A | Reference compound | |
| HY-14538 | Haloperidol | 52-86-8 | Reference compound |
| HY-145381 | 11β-HSD1-IN-6 | 1303515-33-4 | Reference compound |
| HY-145383 | Biotin-PEG4-dialkoxydiphenylsilane-picolyl azide | 2599839-59-3 | Dye Reagents |
| HY-145384 | ROC-0929 | 1048660-43-0 | Reference compound |
| HY-145385 | Coelenteramide | 50611-86-4 | Dye Reagents |
| HY-145386 | (S,S)-CPI-1612 | 2374971-82-9 | Reference compound |
| HY-145387 | MRT-81 | 1263132-08-6 | Reference compound |
| HY-145388 | AU-15330 | 2380274-50-8 | Reference compound |
| HY-145388B | AU-16235 | 2380275-40-9 | Reference compound |
| HY-145389 | SZ-015268 | 2654003-68-4 | Reference compound |
| HY-14538A | Haloperidol (hydrochloride) | 1511-16-6 | Reference compound |
| HY-14538B | Haloperidol (lactate) | 53515-91-6 | Reference compound |
| HY-14538R | Haloperidol (Standard) | 52-86-8 | Reference Standards |
| HY-14538S | Haloperidol-d4 | 1189986-59-1 | Isotope-Labeled Compounds |
| HY-14538S1 | Haloperidol-d4-1 | 136765-35-0 | Isotope-Labeled Compounds |
| HY-14538S2 | Haloperidol-d4 N-Oxide | 1246815-56-4 | Isotope-Labeled Compounds |
| HY-14538S3 | Haloperidol-13C6 | Isotope-Labeled Compounds | |
| HY-14539 | Clozapine | 5786-21-0 | Reference compound |
| HY-145390 | Nrf2 activator-1 | 2230697-41-1 | Reference compound |
| HY-145390A | (R,R)-Nrf2 activator-1 | Reference compound | |
| HY-145391 | Triperiden | 14617-17-5 | Reference compound |
| HY-145392 | ACSS2-IN-1 | 2711039-08-4 | Reference compound |
| HY-145393 | 5-HT2A receptor agonist-1 | 2698331-34-7 | Reference compound |
| HY-145394 | CDK7-IN-6 | 2378710-04-2 | Reference compound |
| HY-145395 | PROTAC BRD9 Degrader-2 | 2633631-78-2 | Reference compound |
| HY-145396 | PLGA-PEG-NH2 | Oligonucleotides | |
| HY-145396A | PLGA20000-PEG1000-NH2 | Biochemical Assay Reagents | |
| HY-145396B | PLGA20000-PEG2000-NH2 | Biochemical Assay Reagents | |
| HY-145396C | PLGA20000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-145396D | PLGA20000-PEG10000-NH2 | Biochemical Assay Reagents | |
| HY-145397 | (4-NH2)-Exatecan | 2495742-21-5 | Reference compound |
| HY-145397A | (R)-(4-NH2)-Exatecan | Reference compound | |
| HY-145397S | (4-NH2)-Exatecan-d5 | Isotope-Labeled Compounds | |
| HY-145399 | AZ14170133 | 2495742-34-0 | ADC Related |
| HY-14539A | Clozapine (hydrochloride) | 54241-01-9 | Reference compound |
| HY-14539B | Clozapine (dihydrochloride) | 2711603-38-0 | Reference compound |
| HY-14539R | Clozapine (Standard) | 5786-21-0 | Reference Standards |
| HY-14539S | Clozapine-d8 | 1185053-50-2 | Isotope-Labeled Compounds |
| HY-14539S2 | Clozapine-d4 | 204395-52-8 | Isotope-Labeled Compounds |
| HY-14539S3 | Clozapine-d3 | 1215691-72-7 | Isotope-Labeled Compounds |
| HY-145400 | PROTAC BRD9 Degrader-3 | 2633632-05-8 | Reference compound |
| HY-145402 | CDK7-IN-7 | 2640208-01-9 | Reference compound |
| HY-145403 | PROTAC BRD9 Degrader-4 | 2633632-34-3 | Reference compound |
| HY-145404 | Mitragynine pseudoindoxyl | 2035457-43-1 | Reference compound |
| HY-145405 | C12-200 | 1220890-25-4 | Oligonucleotides |
| HY-145406 | IHCH-3064 | 2420562-65-6 | Reference compound |
| HY-145407 | 16,17-Dihydroheronamide C | 2698333-36-5 | Reference compound |
| HY-145407A | ent-Heronamide C | Reference compound | |
| HY-145408 | CDK7/9-IN-1 | 2747919-19-1 | Reference compound |
| HY-145409 | SR-0813 | 2597186-19-9 | Reference compound |
| HY-14541 | Olanzapine | 132539-06-1 | Reference compound |
| HY-145411 | PEG2000-C-DMG | Oligonucleotides | |
| HY-145412 | GLP-1 receptor agonist 7 | 2736447-04-2 | Reference compound |
| HY-145413 | BRD2889 | 1415153-39-7 | Reference compound |
| HY-145414 | DYSP-C34 | 2559734-98-2 | Reference compound |
| HY-145415 | W13 | 1060518-03-7 | Reference compound |
| HY-145416 | G247 | Reference compound | |
| HY-145417 | G092 | 2909443-24-7 | Reference compound |
| HY-145418 | IRE1α kinase-IN-3 | 2416223-41-9 | Reference compound |
| HY-145419 | IRE1α kinase-IN-4 | 2771006-45-0 | Reference compound |
| HY-14541A | Olanzapine (hydrochloride) | 783334-36-1 | Reference compound |
| HY-14541R | Olanzapine (Standard) | 132539-06-1 | Reference Standards |
| HY-14541S | Olanzapine-d3 | 786686-79-1 | Isotope-Labeled Compounds |
| HY-14541S1 | Olanzapine-d4 | 1252611-62-3 | Isotope-Labeled Compounds |
| HY-14541S2 | Olanzapine-d8 | 1093380-13-2 | Isotope-Labeled Compounds |
| HY-14542 | Ziprasidone | 146939-27-7 | Reference compound |
| HY-145420 | IRE1α kinase-IN-5 | 2771006-47-2 | Reference compound |
| HY-145422 | KIRA9 | 2922507-65-9 | Reference compound |
| HY-145424 | CDK7-IN-10 | 2588110-62-5 | Reference compound |
| HY-145425 | PAIR2 | 2771006-54-1 | Reference compound |
| HY-145426 | MPT0B390 | 1817802-18-8 | Reference compound |
| HY-145427 | NU5455 | 1257235-99-6 | Reference compound |
| HY-145428 | BT-GSI | Reference compound | |
| HY-145429 | IL-17A modulator-2 | 2748749-47-3 | Reference compound |
| HY-14542A | Ziprasidone (hydrochloride) | 122883-93-6 | Reference compound |
| HY-14542B | Ziprasidone (mesylate trihydrate) | 199191-69-0 | Reference compound |
| HY-14542C | Ziprasidone (mesylate) | 185021-64-1 | Reference compound |
| HY-14542S | Ziprasidone-d8 | 1126745-58-1 | Isotope-Labeled Compounds |
| HY-14543 | Sertindole | 106516-24-9 | Reference compound |
| HY-145430 | IL-17A modulator-1 | 2748749-29-1 | Reference compound |
| HY-145431 | (S)-GSK1379725A | 2359618-49-6 | Reference compound |
| HY-145432 | PI3K-IN-28 | 2747100-02-1 | Reference compound |
| HY-145433 | 17β-HSD1-IN-1 | 2760791-96-4 | Reference compound |
| HY-145434 | IL-17 modulator 5 | 2724206-27-1 | Reference compound |
| HY-145435 | SARS-CoV-2-IN-12 | 2721455-52-1 | Reference compound |
| HY-145436 | KRAS inhibitor-11 | 2761218-40-8 | Reference compound |
| HY-145437 | N'-(2-Fluorophenyl)pyrazine-2-carbohydrazide | 2881111-79-9 | Reference compound |
| HY-145438 | Antitumor agent-38 | 2744193-34-6 | Reference compound |
| HY-145439 | Colistin adjuvant-1 | 2862800-15-3 | Reference compound |
| HY-14543S | Sertindole-d4 | 1794737-42-0 | Isotope-Labeled Compounds |
| HY-14544 | Quetiapine | 111974-69-7 | Reference compound |
| HY-145440 | Colistin adjuvant-2 | 2862800-23-3 | Reference compound |
| HY-145441 | GEM–IB | 2866211-93-8 | Reference compound |
| HY-145442 | 8-Azanebularine | 38874-46-3 | Reference compound |
| HY-145443 | Fludarabine-Cl | 2734853-80-4 | Reference compound |
| HY-145444 | EPZ028862 | 1887082-53-2 | Reference compound |
| HY-145445 | BIOTIN-PEG11-SH | 1650579-23-9 | Dye Reagents |
| HY-145446 | SGC-SMARCA-BRDVIII | 1997319-84-2 | Reference compound |
| HY-145448 | MC-VC-PABC-amide-PEG1-CH2-CC-885 | 2722697-82-5 | Reference compound |
| HY-145449 | CC-885-CH2-PEG1-NH-CH3 | 2722698-03-3 | ADC Related |
| HY-145449A | CC-885-CH2-PEG1-NH-CH3 (TFA) | ADC Related | |
| HY-14544AS | Quetiapine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-14544R | Quetiapine (Standard) | 111974-69-7 | Reference Standards |
| HY-14545 | Amisulpride | 71675-85-9 | Reference compound |
| HY-145450 | ATR-IN-9 | 2417513-43-8 | Reference compound |
| HY-145452 | 5-Octyl-α-ketoglutarate | 1616344-00-3 | Reference compound |
| HY-145453 | Propacetamol | 66532-85-2 | Reference compound |
| HY-145453R | Propacetamol (Standard) | 66532-85-2 | Reference Standards |
| HY-145454 | (R)-Preclamol | 85976-54-1 | Reference compound |
| HY-145454A | Preclamol | 85966-89-8 | Reference compound |
| HY-145455 | Salazopyridazine | 22933-72-8 | Reference compound |
| HY-145456 | Gallium 8-Hydroxyquinolinate | 14642-34-3 | Reference compound |
| HY-145458 | GLP-1 receptor agonist 9 | 2401892-71-3 | Reference compound |
| HY-145459 | N-Boc Ketamine | 1461707-29-8 | Reference compound |
| HY-14545A | Amisulpride (hydrochloride) | 81342-13-4 | Reference compound |
| HY-14545R | Amisulpride (Standard) | 71675-85-9 | Reference Standards |
| HY-14545S | Amisulpride-d5 | 1216626-17-3 | Isotope-Labeled Compounds |
| HY-14545S1 | Amisulpride-d5 N-Oxide | 1794756-15-2 | Isotope-Labeled Compounds |
| HY-14546 | Aripiprazole | 129722-12-9 | Reference compound |
| HY-145461 | Hydroxy lenalidomide | 1421593-78-3 | Reference compound |
| HY-145462 | N-cis-Octadec-9Z-enoyl-L-homoserine lactone | 1400974-23-3 | Reference compound |
| HY-145463 | α-Methylserotonin | 304-52-9 | Reference compound |
| HY-145464 | 4-Propanoyloxy DMT | 1373882-11-1 | Reference compound |
| HY-145466 | EVT-401 | Reference compound | |
| HY-145467 | C16 Ceramide-1-phosphate (d18:1/16:0) (ammonium) | 1246303-22-9 | Natural Products |
| HY-145468 | GPR52 antagonist-1 | 1239987-91-7 | Reference compound |
| HY-145469 | Linoleic acid alkyne | 1219038-31-9 | Natural Products |
| HY-14546A | Aripiprazole (monohydrate) | 851220-85-4 | Reference compound |
| HY-14546R | Aripiprazole (Standard) | 129722-12-9 | Reference Standards |
| HY-14546S | Aripiprazole-d8 | 1089115-06-9 | Isotope-Labeled Compounds |
| HY-14546S1 | Aripiprazole (1,1,2,2,3,3,4,4-d8) | 1089115-04-7 | Isotope-Labeled Compounds |
| HY-14547 | Bifeprunox | 350992-10-8 | Reference compound |
| HY-145471 | KSQ-4279 | 2446480-97-1 | Reference compound |
| HY-145471A | KSQ-4279 (gentisate) | 2938991-80-9 | Reference compound |
| HY-145472 | Sphingosine (d18:1) alkyne | 954096-91-4 | Reference compound |
| HY-145473 | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE | 947381-58-0 | Reference compound |
| HY-145473S | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11 | Isotope-Labeled Compounds | |
| HY-145474 | 17(R)-Resolvin D1 methyl ester | 937738-64-2 | Reference compound |
| HY-145475 | Nervonoyl ethanolamide | 887405-21-2 | Reference compound |
| HY-145476 | N-Nitrosoanatabine | 887407-16-1 | Reference compound |
| HY-145476S | N-Nitrosoanatabine-d4 | 1020719-69-0 | Isotope-Labeled Compounds |
| HY-145477 | 8(R),11(S)-DiHODE | 885215-81-6 | Reference compound |
| HY-145479 | PROTAC AR-V7 degrader-1 | 2767440-24-2 | Reference compound |
| HY-14547A | Bifeprunox (mesylate) | 350992-13-1 | Reference compound |
| HY-145480 | Silodosin Glucuronide (sodium) | 879292-24-7 | Reference compound |
| HY-145481 | 1,3-Olein-2-Lignocerin | 869989-78-6 | Reference compound |
| HY-145482 | W36017 | 21236-54-4 | Reference compound |
| HY-145482R | W36017 (Standard) | 21236-54-4 | Reference Standards |
| HY-145483 | KT-474 | 2432994-31-3 | Reference compound |
| HY-145484 | PROTAC IRAK4 ligand-3 | 2434848-46-9 | Reference compound |
| HY-145485 | HS-PEG-SH (MW 3400) | Reference compound | |
| HY-145486 | 1-Arachidonoyl-sn-glycerol 3-phosphate (ammonium) | 799268-65-8 | Biochemical Assay Reagents |
| HY-145488 | MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D | 2222445-87-4 | ADC Related |
| HY-145489 | Mal-PEG2-Val-Cit-PABA | 1662687-83-3 | ADC Related |
| HY-145490 | trans-Hydroxy Glimepiride | 600177-94-4 | Reference compound |
| HY-145490S1 | trans-Hydroxy Glimepiride-d4 | 2749985-37-1 | Isotope-Labeled Compounds |
| HY-145491 | Resolvin D5 | 578008-43-2 | Natural Products |
| HY-145492 | Δ7(Z)-C14-HSL | 482598-46-9 | Reference compound |
| HY-145493 | C12 NBD Galactosylceramide | 474942-98-8 | Dye Reagents |
| HY-145497 | Dipentamethylenethiuram Tetrasulfide | 120-54-7 | Reference compound |
| HY-145498 | HDMAPP (triammonium) | 443892-56-6 | Reference compound |
| HY-145499 | XTT (sodium hydrate) | 413585-64-5 | Dye Reagents |
| HY-14550 | TP-10 | 898563-00-3 | Reference compound |
| HY-145501A | Sucrose hexasulfate (potassium) | 386229-70-5 | Biochemical Assay Reagents |
| HY-145502 | 1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) (sodium) | 384835-52-3 | Reference compound |
| HY-145503 | Decanoyl-L-carnitine (chloride) | 369651-88-7 | Reference compound |
| HY-145503S | Decanoyl-L-carnitine-d9 (chloride) | 2847775-92-0 | Isotope-Labeled Compounds |
| HY-145504 | 12-Dipalmitoyl-3-Linoelaidoyl-rac-glycerol | 344791-14-6 | Reference compound |
| HY-145505 | 1-Oleoyl-2-hydroxy-sn-glycero-3-PG (sodium) | 326495-24-3 | Biochemical Assay Reagents |
| HY-145506 | 1-Stearoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium) | 326495-23-2 | Biochemical Assay Reagents |
| HY-145507 | 1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium) | 326495-22-1 | Biochemical Assay Reagents |
| HY-145508 | 1,2-Dilauroyl-sn-glycero-3-PG (sodium) | 322647-27-8 | Biochemical Assay Reagents |
| HY-145509 | N-(3-Hydroxy-7-cis tetradecenoyl)-L-Homoserine lactone | 273734-65-9 | Reference compound |
| HY-14550A | PDE10-IN-5 | 898562-99-7 | Reference compound |
| HY-14551 | Osanetant | 160492-56-8 | Reference compound |
| HY-145510 | 1,2-Dipalmitoyl-3-Arachidonoyl-rac-glycerol | 263386-70-5 | Reference compound |
| HY-145511 | 10(S)-HOME | 263023-34-3 | Reference compound |
| HY-145512 | N-(α-Linolenoyl) tyrosine | 259143-19-6 | Peptides |
| HY-145513 | CL2-MMT-SN38 | 1084888-82-3 | Reference compound |
| HY-145514 | dTAGV-1 (TFA) | 2624313-15-9 | Reference compound |
| HY-145514A | dTAGV-1-NEG | 2451573-87-6 | Reference compound |
| HY-145514B | dTAGV-1-NEG (TFA) | Reference compound | |
| HY-145514C | dTAGV-1 (hydrochloride) | 2624313-16-0 | Reference compound |
| HY-145516 | Desmethyl Bosentan | 253688-61-8 | Reference compound |
| HY-145517 | C6-Phytoceramide | 249728-94-7 | Reference compound |
| HY-145519 | Mu-6S-Palm-β-Glc | 229644-17-1 | Dye Reagents |
| HY-14551B | (S)-Osanetant | 182621-58-5 | Reference compound |
| HY-14551C | Osanetant (monohydrochloride) | 173050-51-6 | Reference compound |
| HY-14552 | Talnetant | 174636-32-9 | Reference compound |
| HY-145520 | (±)-2'-hydroxy Ceramide (d18:0/18:0) | 215528-91-9 | Reference compound |
| HY-145521 | 5(S)-HETrE | 195061-94-0 | Reference compound |
| HY-145522 | 13-Dimyristoyl-2-Eicosapentaenoyl Glycerol | 191786-55-7 | Reference compound |
| HY-145523 | OH-Chol | 191173-82-7 | Biochemical Assay Reagents |
| HY-145525 | Linoleoyl-L-carnitine (chloride) | 173686-75-4 | Reference compound |
| HY-145526 | Hydroxy celecoxib | 170571-00-3 | Reference compound |
| HY-145527 | Hexanoyl-L-carnitine (chloride) | 162067-53-0 | Natural Products |
| HY-145528 | Heptanoyl-L-carnitine (chloride) | 162041-08-9 | Reference compound |
| HY-145529 | Valeryl-L-carnitine (chloride) | 162040-64-4 | Natural Products |
| HY-14552A | Talnetant (hydrochloride) | 204519-66-4 | Reference compound |
| HY-145530 | (S)-Hydroxychloroquine (sulfate) | 155204-09-4 | Reference compound |
| HY-145531 | Mirtazapine N-oxide | 155172-12-6 | Reference compound |
| HY-145532 | S-Allylmercaptocysteine | 2281-22-3 | Reference compound |
| HY-145533 | 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid | 153666-19-4 | Reference compound |
| HY-145534 | trans-2-Octenoyl-L-carnitine | 152064-94-3 | Reference compound |
| HY-145535 | Tetracosanoyl-sulfatide | 151122-71-3 | Reference compound |
| HY-145537 | 1,3-Dipalmitoyl-2-eicosapentaenoyl glycerol | 148691-18-3 | Reference compound |
| HY-145538 | 2'-Deoxyguanosine 5'-monophosphate (disodium hydrate) | 146877-98-7 | Reference compound |
| HY-145539 | 12-Dipalmitoyl-sn-glycero-3-PS (sodium salt) | 145849-32-7 | Reference compound |
| HY-145539S | 12-Dipalmitoyl-sn-glycero-3-PS-d62 (sodium salt) | 327178-94-9 | Isotope-Labeled Compounds |
| HY-14554 | Pomaglumetad methionil (anhydrous) | 635318-55-7 | Reference compound |
| HY-145540 | 1,2-Dipalmitoyl-3-Octanoyl-rac-glycerol | 145134-89-0 | Reference compound |
| HY-145541 | 12-Dinonadecanoyl-rac-glycerol | 140456-19-5 | Reference compound |
| HY-145542 | Isovalerylcarnitine (chloride) | 139144-12-0 | Reference compound |
| HY-145542S | Isovalerylcarnitine-d9 (chloride) | 1334532-23-8 | Isotope-Labeled Compounds |
| HY-145543 | 9(S)10(S)13(S)-TriHOME | 135214-44-7 | Natural Products |
| HY-145544 | 1-Lauroyl-2-Elaidoyl-3-Palmitoyl-rac-glycerol | 134907-94-1 | Reference compound |
| HY-145545 | 1-Stearoyl-2-Adrenoyl-sn-glycero-3-PE | 131350-53-3 | Reference compound |
| HY-145546 | 14(15)-EpETE | 131339-24-7 | Reference compound |
| HY-145547 | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine | 123060-40-2 | Biochemical Assay Reagents |
| HY-145548 | cis-4,10,13,16-Docosatetraenoic acid | 122068-08-0 | Reference compound |
| HY-145549 | C20 Sphingomyelin (d18:1/20:0) | 121999-68-6 | Reference compound |
| HY-145550 | Amredobresib | 1610044-98-8 | Reference compound |
| HY-145551 | Atinvicitinib | 2169273-59-8 | Reference compound |
| HY-145552 | Azilsartan mepixetil | 1596357-16-2 | Reference compound |
| HY-145552A | Azilsartan mepixetil (potassium) | 2153458-32-1 | Reference compound |
| HY-145552S | Azilsartan mepixetil-d5 | Isotope-Labeled Compounds | |
| HY-145553 | Azilsartan mopivabil | 2271428-31-8 | Reference compound |
| HY-145554 | Bafrekalant | 2256770-44-0 | Reference compound |
| HY-145555 | Bersiporocin | 2241808-52-4 | Reference compound |
| HY-145556 | Bexirestrant | 2505067-70-7 | Reference compound |
| HY-145557 | Bezuclastinib | 1616385-51-3 | Reference compound |
| HY-145558 | Bliretrigine | 1233229-75-8 | Reference compound |
| HY-145559 | Cemdomespib | 1450642-92-8 | Reference compound |
| HY-145560 | Claficapavir | 2055732-24-4 | Reference compound |
| HY-145561 | Cudetaxestat | 1782070-21-6 | Reference compound |
| HY-145563 | Eciruciclib | 1868086-40-1 | Reference compound |
| HY-145564 | Emprumapimod | 765914-60-1 | Reference compound |
| HY-145564A | Emprumapimod (hydrochloride) | Reference compound | |
| HY-145565 | Enbezotinib | 2359649-81-1 | Reference compound |
| HY-145567 | Fasedienol | 23062-06-8 | Reference compound |
| HY-145568 | Feniralstat | 2166320-76-7 | Reference compound |
| HY-145569 | Fipravirimat | 1818867-24-1 | Reference compound |
| HY-145569A | Fipravirimat (dihydrochloride) | 2442512-14-1 | Reference compound |
| HY-14557 | Pimavanserin | 706779-91-1 | Reference compound |
| HY-145572 | Imlunestrant | 2408840-26-4 | Reference compound |
| HY-145572A | Imlunestrant (tosylate) | 2408840-41-3 | Reference compound |
| HY-145572B | (S)-Imlunestrant (tosylate) | 2408840-43-5 | Reference compound |
| HY-145574 | Iruplinalkib | 1854943-32-0 | Reference compound |
| HY-145575 | Itruvone | 21321-89-1 | Reference compound |
| HY-145576 | 2-Amino-8-oxononanoic acid | 1219456-00-4 | Reference compound |
| HY-145576B | 2-Amino-8-oxononanoic acid (hydrochloride) | 2984160-77-0 | Reference compound |
| HY-145577 | Lafadofensine | 914989-90-5 | Reference compound |
| HY-145577A | Lafadofensine (D-(-)-Mandelic acid) | Reference compound | |
| HY-145578 | Linaprazan glurate | 1228559-81-6 | Reference compound |
| HY-145579 | Linvencorvir | 1808248-05-6 | Reference compound |
| HY-145579R | Linvencorvir (Standard) | 1808248-05-6 | Reference Standards |
| HY-14557A | Pimavanserin (hemitartrate) | 706782-28-7 | Reference compound |
| HY-14557R | Pimavanserin (Standard) | 706779-91-1 | Reference Standards |
| HY-14558 | Tandospirone | 87760-53-0 | Reference compound |
| HY-145580 | Minzasolmin | 1802518-92-8 | Reference compound |
| HY-145580A | (S)-Minzasolmin | 1802518-91-7 | Reference compound |
| HY-145581 | Mitiperstat | 1933460-19-5 | Reference compound |
| HY-145583 | Mufemilast | 1255909-03-5 | Reference compound |
| HY-145584 | Nesuparib | 2055357-64-5 | Reference compound |
| HY-145585 | Onfasprodil | 1892581-29-1 | Reference compound |
| HY-145586 | Onradivir | 2200336-20-3 | Reference compound |
| HY-145586A | Onradivir (monohydrate) | 2375241-19-1 | Reference compound |
| HY-145587 | Paltimatrectinib | 2353522-15-1 | Reference compound |
| HY-145588 | Povorcitinib | 1637677-22-5 | Reference compound |
| HY-145588A | Povorcitinib (phosphate) | 1637677-33-8 | Reference compound |
| HY-145589 | Rafutrombopag | 2600513-51-5 | Reference compound |
| HY-14558R | Tandospirone (Standard) | 87760-53-0 | Reference Standards |
| HY-14558S | Tandospirone-d8 | 1794835-73-6 | Isotope-Labeled Compounds |
| HY-14559 | PRX-07034 (hydrochloride) | 903580-39-2 | Reference compound |
| HY-145590 | Retezorogant | 1950570-48-5 | Reference compound |
| HY-145592 | Ruzotolimod | 1948241-60-8 | Reference compound |
| HY-145593 | Aminooxy-PEG2-BCN | 2253965-14-7 | ADC Related |
| HY-145594 | Safusidenib | 1898206-17-1 | Reference compound |
| HY-145595 | Ferroptosis inducer-1 | 2375357-96-1 | Reference compound |
| HY-145595A | (1R,3R)-Ferroptosis inducer-1 | 2375357-97-2 | Reference compound |
| HY-145596 | Sirpefenicol | 1632310-24-7 | Reference compound |
| HY-145597 | KL-11743 | 1369452-53-8 | Reference compound |
| HY-145598 | Sovleplenib | 1415792-84-5 | Reference compound |
| HY-145599 | Tanuxiciclib | 1983983-64-7 | Reference compound |
| HY-145599A | Tanuxiciclib (trihydrochloride) | 1983984-11-7 | Reference compound |
| HY-14560 | Reboxetine | 71620-89-8 | Reference compound |
| HY-145601 | Tinengotinib | 2230490-29-4 | Reference compound |
| HY-145602 | Tulmimetostat | 2567686-02-4 | Reference compound |
| HY-145603 | Vanzacaftor | 2374124-49-7 | Reference compound |
| HY-145603A | (R)-Vanzacaftor | 2374124-48-6 | Reference compound |
| HY-145603S | Vanzacaftor-d4 | Isotope-Labeled Compounds | |
| HY-145604 | Vicasinabin | 1433361-02-4 | Reference compound |
| HY-145605 | Vutiglabridin | 1800188-47-9 | Reference compound |
| HY-145607 | Zagociguat | 2201048-82-8 | Reference compound |
| HY-145608 | Zilurgisertib | 2173389-57-4 | Reference compound |
| HY-145609 | Debotansine | Reference compound | |
| HY-14560A | (R,R)-Reboxetine (mesylate) | 105017-39-8 | Reference compound |
| HY-14560C | Reboxetine (mesylate) | 98769-84-7 | Reference compound |
| HY-14560CR | Reboxetine (mesylate) (Standard) | 98769-84-7 | Reference Standards |
| HY-14560S | Reboxetine-d5 (mesylate) | 1285918-53-7 | Isotope-Labeled Compounds |
| HY-14561 | Idazoxan | 79944-58-4 | Reference compound |
| HY-145610 | Mepixetil | Reference compound | |
| HY-145611 | Mopivabil | 2988562-84-9 | Reference compound |
| HY-145612 | Sudan red 7B | 6368-72-5 | Reference compound |
| HY-145612S | Sudan red 7B-d5 | Isotope-Labeled Compounds | |
| HY-145613 | 5-Phenylpentan-2-one | 2235-83-8 | Reference compound |
| HY-145614 | Sucistil | Reference compound | |
| HY-145615 | Pomalidomide-C12-NH2 (hydrochloride) | 2862774-02-3 | Reference compound |
| HY-145616 | Sudocetaxel | 1234218-62-2 | Reference compound |
| HY-145618 | Polvitolimod | 2389988-81-0 | Reference compound |
| HY-145619 | Abimtrelvir | 2647530-75-2 | Reference compound |
| HY-14561A | Idazoxan (hydrochloride) | 79944-56-2 | Reference compound |
| HY-14562 | TBPB | 634616-95-8 | Reference compound |
| HY-145620 | Zuvotolimod | 2355262-97-2 | ADC Related |
| HY-145622 | Mecbotamab vedotin | 2460400-64-8 | Reference compound |
| HY-145623 | Mulnitorsen | 2576358-63-7 | Reference compound |
| HY-145624 | Obeversen | 2304711-30-4 | Oligonucleotides |
| HY-145626 | Ozuriftamab | 2460399-44-2 | Inhibitory Antibodies |
| HY-145627 | Ozuriftamab vedotin | 2460400-11-5 | Reference compound |
| HY-145628 | CM398 | 1121931-70-1 | Reference compound |
| HY-145629 | Palsucibep pegol | 2218524-43-5 | Inhibitory Antibodies |
| HY-14563 | VU10010 | 633283-39-3 | Reference compound |
| HY-145632A | Pemvidutide (TFA) | Peptides | |
| HY-145633 | Sozinibercept | 2568358-31-4 | Inhibitory Antibodies |
| HY-145638 | Xalnesiran | 2538784-48-2 | Reference compound |
| HY-145638A | Xalnesiran (sodium) | 2538784-49-3 | Oligonucleotides |
| HY-14564 | GTS-21 | 148372-04-7 | Reference compound |
| HY-145640 | Vimnerixin | 1418112-77-2 | Reference compound |
| HY-145641 | Crexavibart | 2599039-61-7 | Inhibitory Antibodies |
| HY-145642 | Masavibart | 2640223-84-1 | Inhibitory Antibodies |
| HY-145643 | Nepuvibart | 2640224-48-0 | Inhibitory Antibodies |
| HY-145644 | Ogalvibart | 2599039-60-6 | Inhibitory Antibodies |
| HY-145645 | Paridiprubart | 2641646-59-3 | Inhibitory Antibodies |
| HY-14564A | GTS-21 (dihydrochloride) | 156223-05-1 | Reference compound |
| HY-14565 | Pozanicline | 161417-03-4 | Reference compound |
| HY-145651 | Et-29 | 2166487-23-4 | Reference compound |
| HY-145652 | Narmafotinib | 1393653-34-3 | Reference compound |
| HY-145653 | GSK2647544 | 1380426-95-8 | Reference compound |
| HY-145655 | CDK7-IN-11 | 2414896-32-3 | Reference compound |
| HY-145656 | 3-Oxochenodeoxycholic acid | 4185-00-6 | Reference compound |
| HY-145657 | Benzoquinoquinoxaline | 207671-99-6 | Reference compound |
| HY-14566 | Donepezil | 120014-06-4 | Reference compound |
| HY-145663 | HS-(CH2)3CO-L-Ala-D-Ala-L-Ala-NH-CH2-S-(CH2)5-CO-DM | 2243689-64-5 | ADC Related |
| HY-145664 | Myt1-IN-1 | 2719749-02-5 | Reference compound |
| HY-145665 | Myt1-IN-2 | 2719748-43-1 | Reference compound |
| HY-145666 | Myt1-IN-3 | 2719793-54-9 | Reference compound |
| HY-145667 | Biotinylated-JQ1 | 1635437-52-3 | Reference compound |
| HY-145668 | Cyclopentenyl uracil | 90597-20-9 | Reference compound |
| HY-145669 | DIF-3 | 113411-17-9 | Reference compound |
| HY-14566A | (S)-Donepezil | 142057-80-5 | Reference compound |
| HY-14566R | Donepezil (Standard) | 120014-06-4 | Reference Standards |
| HY-14566S | Donepezil-d7 (hydrochloride) | 1261394-20-0 | Isotope-Labeled Compounds |
| HY-14566S1 | Donepezil-d5 | 1128086-25-8 | Isotope-Labeled Compounds |
| HY-14566S3 | Donepezil-d4 | 1219908-72-1 | Isotope-Labeled Compounds |
| HY-14567 | Ciproxifan | 184025-18-1 | Reference compound |
| HY-145670 | cis,trans-Germacrone | 32663-51-7 | Reference compound |
| HY-145671 | 5-(3-hydroxyphenyl)-5-phenylhydantoin | 30074-03-4 | Reference compound |
| HY-145673 | Thiamphenicol glycinate | 2393-92-2 | Reference compound |
| HY-145674 | HDP 30.1699 | 2004724-36-9 | Reference compound |
| HY-145675A | (R)-TCB2 | 912342-36-0 | Reference compound |
| HY-145676 | Sodium phenyl ethylamido hyaluronate（20% substitution） | Reference compound | |
| HY-145676A | Sodium phenyl ethylamido hyaluronate（30% substitution） | Reference compound | |
| HY-145676E | Sodium phenyl ethylamido hyaluronate（10% substitution） | Reference compound | |
| HY-145678 | α-HNJNAc | 1417906-42-3 | Reference compound |
| HY-14567A | Ciproxifan (hydrochloride) | 1049741-81-2 | Reference compound |
| HY-14568 | DCCCyB | 1236046-15-3 | Reference compound |
| HY-145684 | EP2 receptor antagonist-1 | 848920-08-1 | Reference compound |
| HY-145685 | RECQL5-IN-1 | 2718170-45-5 | Reference compound |
| HY-145686 | AV023 | 1107710-62-2 | Reference compound |
| HY-145687 | HDAC-IN-32 | 2766688-17-7 | Reference compound |
| HY-145688 | HDAC-IN-33 | 2766688-19-9 | Reference compound |
| HY-145689 | PI5P4Ks-IN-1 | 959560-36-2 | Reference compound |
| HY-14569 | CDPPB | 781652-57-1 | Reference compound |
| HY-145690 | HP1328 | 2245074-20-6 | Reference compound |
| HY-145691 | HP1142 | 381173-58-6 | Reference compound |
| HY-145692 | Cas9-IN-3 | 2322051-02-3 | Reference compound |
| HY-145693 | CDK5-IN-2 | 2639542-22-4 | Reference compound |
| HY-145694 | CDK5-IN-3 | 2639542-32-6 | Reference compound |
| HY-145695 | Dual AChE-MAO B-IN-1 | Reference compound | |
| HY-145696 | SJ10542 | 2789678-92-6 | Reference compound |
| HY-145697 | GPR84 antagonist 2 | 2244269-74-5 | Reference compound |
| HY-145698 | UCSF678 | 2361697-55-2 | Reference compound |
| HY-145699 | UCSF686 | 2248852-19-7 | Reference compound |
| HY-14570 | Triphen diol | 1213777-80-0 | Reference compound |
| HY-145700 | UCSF648 | 2637090-55-0 | Reference compound |
| HY-145701 | MEK1/2-IN-2 | Reference compound | |
| HY-145702 | MAP855 | 1660107-77-6 | Reference compound |
| HY-145703 | SHP2 protein degrader-2 | 2740582-16-3 | Reference compound |
| HY-145704 | Antimalarial agent 8 | 2715222-97-0 | Reference compound |
| HY-145705 | Pencitabine | 2249843-29-4 | Reference compound |
| HY-145706 | A2A/A1 AR antagonist-1 | 2445615-24-5 | Reference compound |
| HY-145707 | BAY-179 | 2764880-87-5 | Reference compound |
| HY-145708 | Dual AChE-MAO B-IN-2 | 1801157-64-1 | Reference compound |
| HY-145709 | Ar-V7-IN-1 | 2230880-25-6 | Reference compound |
| HY-14571 | E7820 | 289483-69-8 | Reference compound |
| HY-145712 | ElteN378 | 1421366-99-5 | Reference compound |
| HY-145713 | GS-8873 | 2241575-59-5 | Reference compound |
| HY-145713A | GS-8873 (TFA) | 2241575-60-8 | Reference compound |
| HY-145714 | NHS-NH-(diethylamino)ethyl benzoate | 2050902-45-7 | Reference compound |
| HY-145715 | Azido-PEG2-VHL | 2597167-22-9 | Reference compound |
| HY-145716 | Nafoxidine | 1845-11-0 | Reference compound |
| HY-145717 | Deoliosyl-3C-α-L-digitoxosyl-MTM | 1009637-75-5 | Reference compound |
| HY-14572 | PR-104A | 680199-06-8 | Reference compound |
| HY-145720 | Cemdisiran | 1639264-46-2 | Oligonucleotides |
| HY-145720A | Cemdisiran (sodium) | Oligonucleotides | |
| HY-145721 | Mongersen | 1443994-46-4 | Oligonucleotides |
| HY-145721A | Mongersen (sodium) | 1443994-98-6 | Oligonucleotides |
| HY-145722 | Apatorsen (sodium) | 915443-09-3 | Oligonucleotides |
| HY-145722A | Apatorsen | 1002331-21-6 | Oligonucleotides |
| HY-145723 | MAX-40279 | 2070931-57-4 | Reference compound |
| HY-145723A | MAX-40279 (hydrochloride) | 2388506-51-0 | Reference compound |
| HY-145723B | MAX-40279 (hemifumarate) | 2388506-43-0 | Reference compound |
| HY-145723C | MAX-40279 (hemiadipate) | 2388506-44-1 | Reference compound |
| HY-145724 | Drisapersen | 1251830-50-8 | Oligonucleotides |
| HY-145724A | Drisapersen (sodium) | 1181666-20-5 | Oligonucleotides |
| HY-145725 | Baliforsen (sodium) | 1687746-79-7 | Oligonucleotides |
| HY-145725A | Baliforsen | 1698048-23-5 | Oligonucleotides |
| HY-145726 | ISIS 104838 | 250755-32-9 | Oligonucleotides |
| HY-145726A | ISIS 104838 (sodium) | Oligonucleotides | |
| HY-145727 | Volanesorsen | 915430-78-3 | Oligonucleotides |
| HY-145727A | Volanesorsen (sodium) | 1573402-50-2 | Oligonucleotides |
| HY-145728 | Alicaforsen | 185229-68-9 | Oligonucleotides |
| HY-145728A | Alicaforsen (sodium) | 331257-52-4 | Oligonucleotides |
| HY-145728B | (R/S)-Alicaforsen | Oligonucleotides | |
| HY-145729 | Danvatirsen | 1402357-06-5 | Oligonucleotides |
| HY-145729A | Danvatirsen (sodium) | Oligonucleotides | |
| HY-14573 | SJG-136 | 232931-57-6 | ADC Related |
| HY-145731 | Fructose-leucine | 34393-18-5 | Reference compound |
| HY-145733 | DI-1859 | 2247061-09-0 | Reference compound |
| HY-145734 | AMXI-5001 | 2170491-77-5 | Reference compound |
| HY-145734A | AMXI-5001 (hydrochloride) | Reference compound | |
| HY-145735 | Allyl (2-aminoethyl)carbamate | 223741-66-0 | Reference compound |
| HY-145736 | β-Glucuronide-dPBD-PEG5-NH2 | 2246363-68-6 | ADC Related |
| HY-145736A | β-Glucuronide-dPBD-PEG5-NH2 (TFA) | 2246364-63-4 | ADC Related |
| HY-145737 | PROTAC SOS1 degrader-1 | 2913185-35-8 | Reference compound |
| HY-145737A | PROTAC SOS1 degrader-1 (TFA) | Reference compound | |
| HY-145739 | ATX-0114 | 2230647-30-8 | Reference compound |
| HY-14574 | PF-03814735 | 942487-16-3 | Reference compound |
| HY-145741 | MptpB-IN-1 | 2244622-44-2 | Reference compound |
| HY-145742 | 1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol (sodium) | 200880-42-8 | Oligonucleotides |
| HY-145742S | 1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol-d70 (sodium) | 326495-47-0 | Isotope-Labeled Compounds |
| HY-145746 | Sulfo-Cy5 azide | 1782950-80-4 | Dye Reagents |
| HY-145748 | SYUIQ-5 | 188630-47-9 | Reference compound |
| HY-145749 | PARPYnD | 2561483-27-8 | Reference compound |
| HY-14575 | Nastorazepide (hemicalcium) | 343326-69-2 | Reference compound |
| HY-145750 | Trimethylolpropane tris(3-mercaptopropionate) | 33007-83-9 | Biochemical Assay Reagents |
| HY-145751 | 7α-Hydroxy-DHEA | 53-00-9 | Natural Products |
| HY-145752 | HaloPROTAC-E | 2365478-58-4 | Reference compound |
| HY-145755 | Benzyl-piperazine-CO-benzothiazole-4-methylpiperidine | 906258-48-8 | Reference compound |
| HY-145757 | Elevenostat | 1454902-97-6 | Reference compound |
| HY-145758 | FEN1-IN-SC13 | 2098776-03-3 | Reference compound |
| HY-145759 | Mutant p53 modulator-1 | 2746371-35-5 | Reference compound |
| HY-145761 | AMPA-IN-1 | 2097604-91-4 | Reference compound |
| HY-145762 | YM281 | 2230914-84-6 | Reference compound |
| HY-145765 | JQAD1 | 2417097-18-6 | Reference compound |
| HY-145766 | Anisole-piperazine-methanone-benzothiazole-p-methylpiperidine | 906258-69-3 | Reference compound |
| HY-145767A | SN-38-CO-DMEDA (TFA) | 1224601-17-5 | ADC Related |
| HY-145768 | PD-1/PD-L1-IN-18 | 2648851-27-6 | Reference compound |
| HY-145769 | N2S2-CBMBC | 2547100-02-5 | Reference compound |
| HY-145770 | PD-1/PD-L1-IN-19 | 2156651-18-0 | Reference compound |
| HY-145771 | PD-1/PD-L1-IN-20 | 2159138-01-7 | Reference compound |
| HY-145772 | PD-1/PD-L1-IN-21 | 2158336-16-2 | Reference compound |
| HY-145773 | PD-1/PD-L1-IN-22 | 2159063-12-2 | Reference compound |
| HY-145774 | PD-1/PD-L1-IN-23 | 2597056-04-5 | Reference compound |
| HY-145775 | hIgG-hFc receptor-IN-1 | 1425051-22-4 | Reference compound |
| HY-145776 | ALV1 | 2438124-79-7 | Reference compound |
| HY-145777 | AGI-43192 | 2377491-54-6 | Reference compound |
| HY-145778 | AGI-41998 | 2377492-26-5 | Reference compound |
| HY-145779 | H-Glu(Met-OH)-OH | 17663-87-5 | Peptides |
| HY-145779A | H-Glu(Met-OH)-OH (TFA) | Peptides | |
| HY-14578 | Taxiresinol | 40951-69-7 | Natural Products |
| HY-145780 | Cytidine 5′-diphosphoethanolamine | 3036-18-8 | Reference compound |
| HY-145781 | β-L-Fucopyranosyl phosphate | 16562-59-7 | Reference compound |
| HY-145781A | β-L-Fucopyranosyl phosphate (cyclohexanamine) | 40591-57-9 | Biochemical Assay Reagents |
| HY-145782 | Witepsol | 91744-42-2 | Biochemical Assay Reagents |
| HY-145785 | ADH-6 | 2227429-65-2 | Reference compound |
| HY-145785A | ADH-6 (TFA) | 2990065-87-5 | Reference compound |
| HY-145786 | Abiraterone decanoate | 2486052-18-8 | Reference compound |
| HY-145788 | 5-Cyclopropylpentanal | 147159-38-4 | Reference compound |
| HY-145789 | Difluorocyclooctyne-CH2-benzoic acid | 1047997-30-7 | Biochemical Assay Reagents |
| HY-14579 | (+)-Isolariciresinol | 548-29-8 | Natural Products |
| HY-145790 | Difluorocyclooctyne-CH2-COOH | 1047997-31-8 | Biochemical Assay Reagents |
| HY-145791 | Dideoxycytidinene | 7481-88-1 | Reference compound |
| HY-145793 | FTT5 | 2328129-27-5 | Oligonucleotides |
| HY-145794 | ZA3-Ep10 | 2090299-48-0 | Oligonucleotides |
| HY-145795 | OF-02 | 1883431-67-1 | Oligonucleotides |
| HY-145796 | 503O13 | 1566560-20-0 | Biochemical Assay Reagents |
| HY-145797 | L343 | 1443520-22-6 | Biochemical Assay Reagents |
| HY-145798 | N1,N3,N5-Tris(4-dodecylhexadecyl)benzene-1,3,5-tricarboxamide | 2922283-38-1 | Oligonucleotides |
| HY-145799 | 5A2-SC8 | 1857341-90-2 | Oligonucleotides |
| HY-145799A | 5A2-SC8 (TFA) | Reference compound | |
| HY-145800 | GFP150 (TFA) | 2366176-90-9 | Dye Reagents |
| HY-145801 | XT2 | 2582816-37-1 | Reference compound |
| HY-145802 | KIF18A-IN-2 | 2600559-20-2 | Reference compound |
| HY-145803 | KIF18A-IN-3 | 2600577-49-7 | Reference compound |
| HY-145804 | Palacaparib | 2756333-39-6 | Reference compound |
| HY-145806 | 13-cis-Retinyl acetate | 34356-31-5 | Reference compound |
| HY-145809 | FASN-IN-5 | 1309805-49-9 | Reference compound |
| HY-14581 | Palomid 529 | 914913-88-5 | Reference compound |
| HY-145812 | CRK12-IN-1 | 1990479-14-5 | Reference compound |
| HY-145813 | MU1656 | 2766698-38-6 | Reference compound |
| HY-145814 | HSP90-IN-9 | 2765247-36-5 | Reference compound |
| HY-145815 | JPS014 | 2669785-76-4 | Reference compound |
| HY-145815A | JPS014 (TFA) | Reference compound | |
| HY-145816 | JPS016 | 2669785-77-5 | Reference compound |
| HY-145816A | JPS016 (TFA) | Reference compound | |
| HY-145817 | (Rac)-lunresertib | 2719749-28-5 | Reference compound |
| HY-145817A | lunresertib | 2719793-90-3 | Reference compound |
| HY-145817B | (R)-lunresertib | 2719793-91-4 | Reference compound |
| HY-145818 | JPS035 | 2669785-84-4 | Reference compound |
| HY-145819 | JPS036 | 2669785-85-5 | Reference compound |
| HY-145820 | Tubulin inhibitor 14 | 2767446-34-2 | Reference compound |
| HY-145821 | Tubulin inhibitor 15 | 2767446-36-4 | Reference compound |
| HY-145822 | Tubulin inhibitor 16 | 2767446-32-0 | Reference compound |
| HY-145823 | EGFR-IN-42 | 3031307-73-7 | Reference compound |
| HY-145824 | EGFR-IN-43 | 3031307-74-8 | Reference compound |
| HY-145825 | Mcl-1 inhibitor 7 | 2417463-87-5 | Reference compound |
| HY-145825A | (E)-Mcl-1 inhibitor 7 | 2417463-86-4 | Reference compound |
| HY-145826 | Mcl-1 inhibitor 8 | 2388471-31-4 | Reference compound |
| HY-145827 | KIF18A-IN-4 | 1197522-21-6 | Reference compound |
| HY-145828 | Microtubule inhibitor 2 | 3031328-45-4 | Reference compound |
| HY-145829 | Tofacitinib Prodrug-1 | Reference compound | |
| HY-145830 | AC1-IN-1 | 2762422-55-7 | Reference compound |
| HY-145831 | sEH/AChE-IN-1 | 2490589-08-5 | Reference compound |
| HY-145832 | sEH/AChE-IN-2 | 2490589-09-6 | Reference compound |
| HY-145833 | sEH/AChE-IN-3 | 2490589-11-0 | Reference compound |
| HY-145833A | sEH/AChE-IN-4 | 2490589-12-1 | Reference compound |
| HY-145835 | PERK-IN-5 | 2616821-91-9 | Reference compound |
| HY-145835A | (S)-PERK-IN-5 | 2616821-92-0 | Reference compound |
| HY-145836 | FGFR4-IN-8 | 2765240-52-4 | Reference compound |
| HY-145837 | Y1R probe-1 | 2773476-41-6 | Reference compound |
| HY-145838 | AAK1-IN-4 | 1815612-79-3 | Reference compound |
| HY-145839 | AAK1-IN-5 | 1815613-44-5 | Reference compound |
| HY-145840 | Pol I-IN-1 | 2765318-69-0 | Reference compound |
| HY-145841 | 5-HT2A receptor agonist-2 | 528525-37-3 | Reference compound |
| HY-145842 | Encephalitic alphavirus-IN-1 | Reference compound | |
| HY-145843 | c-Myc inhibitor 5 | Reference compound | |
| HY-145844 | EGFR-IN-44 | Reference compound | |
| HY-145845 | HDAC1/MAO-B-IN-1 | 2759855-37-1 | Reference compound |
| HY-145846 | iNOs-IN-1 | Reference compound | |
| HY-145848 | ERRγ agonist-1 | Reference compound | |
| HY-145849 | VEGFR2-IN-1 | 2765224-55-1 | Reference compound |
| HY-14584A | PQ-1 (succinate) | 955995-51-4 | Reference compound |
| HY-14585 | Estrone O-sulfamate | 148672-09-7 | Reference compound |
| HY-145850 | EV-A71-IN-1 | 2413648-96-9 | Reference compound |
| HY-145851 | Top/HDAC-IN-1 | 2775446-49-4 | Reference compound |
| HY-145852 | Top/HDAC-IN-2 | 2775446-64-3 | Reference compound |
| HY-145853 | GA-O-02 | Reference compound | |
| HY-145854 | GA-O-06 | Reference compound | |
| HY-145855 | J-1063 | 2374772-46-8 | Reference compound |
| HY-145856 | VEGFR-2-IN-11 | Reference compound | |
| HY-145857 | GRP78-IN-1 | Reference compound | |
| HY-145858 | Chalcones A-N-5 | 2756846-09-8 | Reference compound |
| HY-145859 | Topo I-IN-1 | 2763655-68-9 | Reference compound |
| HY-14586 | Irosustat | 288628-05-7 | Reference compound |
| HY-145860 | PHGDH-IN-2 | Reference compound | |
| HY-145861 | LSD1-IN-14 | 2698340-11-1 | Reference compound |
| HY-145862 | 5-HT6/5-HT2AR antagonist-1 | 2763654-60-8 | Reference compound |
| HY-145864 | VEGFR-2-IN-12 | Reference compound | |
| HY-145865 | c-Met/MEK1/Flt-3-IN-1 | Reference compound | |
| HY-145866 | Antiproliferative agent-3 | Reference compound | |
| HY-145867 | EGFR-IN-45 | 2765560-03-8 | Reference compound |
| HY-145868 | Tubulin polymerization-IN-3 | Reference compound | |
| HY-145869 | Anti-inflammatory agent 12 | Reference compound | |
| HY-145870 | Anti-inflammatory agent 13 | Reference compound | |
| HY-145871 | BA38017 | 1333905-67-1 | Reference compound |
| HY-145872 | HBV-IN-20 | 2750254-34-1 | Reference compound |
| HY-145873 | BI-10 | 2759037-58-4 | Reference compound |
| HY-145874 | Antibacterial agent 76 | 2902561-25-3 | Reference compound |
| HY-145875 | Antibacterial agent 77 | 2902561-28-6 | Reference compound |
| HY-145876 | Antibacterial agent 78 | 2902561-42-4 | Reference compound |
| HY-145877 | Antibacterial agent 79 | 2902561-44-6 | Reference compound |
| HY-145878 | Antibacterial agent 80 | 2902561-34-4 | Reference compound |
| HY-145879 | Nrf2 activator-2 | 2770448-53-6 | Reference compound |
| HY-14588 | Lopinavir | 192725-17-0 | Reference compound |
| HY-145880 | Elongation factor P-IN-1 | 2906180-02-5 | Reference compound |
| HY-145881 | Elongation factor P-IN-2 | 2906180-05-8 | Reference compound |
| HY-145882 | BOD-NH-NP | 3004972-07-7 | Dye Reagents |
| HY-145884 | BTK-IN-8 | 2824922-28-1 | Reference compound |
| HY-145885 | TLR7/8 agonist 6 | 2115702-83-3 | Reference compound |
| HY-145886 | TLR7/8 antagonist 1 | 2901020-63-9 | Reference compound |
| HY-145887 | BCR-ABL1-IN-1 | 1488090-21-6 | Reference compound |
| HY-145888 | Antioxidant agent-2 | 2250106-92-2 | Reference compound |
| HY-145889 | LC kinetic stabilizer-1 | 2495750-19-9 | Reference compound |
| HY-14588R | Lopinavir (Standard) | 192725-17-0 | Reference Standards |
| HY-14588S | (rel)-Lopinavir-d8 | 1322625-54-6 | Isotope-Labeled Compounds |
| HY-14588S1 | Lopinavir-d8 | 1224729-35-4 | Isotope-Labeled Compounds |
| HY-14588S2 | Lopinavir-d7 | 1432060-78-0 | Isotope-Labeled Compounds |
| HY-14589 | Chrysin | 480-40-0 | Natural Products |
| HY-145890 | LC kinetic stabilizer-2 | 2495750-20-2 | Reference compound |
| HY-145891 | B10-S | 2210238-26-7 | Reference compound |
| HY-145892 | MrgprX2 antagonist-6 | 2902573-97-9 | Reference compound |
| HY-145893 | MrgprX2 antagonist-7 | 2902573-98-0 | Reference compound |
| HY-145894 | NaPi2b-IN-2 | 2227445-31-8 | Reference compound |
| HY-145895 | SNIPER(TACC3)-11 | 2906151-68-4 | Reference compound |
| HY-145896 | Anti-osteoporosis agent-1 | 2761577-50-6 | Reference compound |
| HY-145897 | NMDA-IN-2 | 2761731-14-8 | Reference compound |
| HY-145898 | WBC100 | 2095780-08-6 | Reference compound |
| HY-145899 | PKN1/2-IN-1 | 942425-34-5 | Reference compound |
| HY-14589R | Chrysin (Standard) | 480-40-0 | Reference Standards |
| HY-14590 | Kaempferol | 520-18-3 | Natural Products |
| HY-145900 | S100A2-p53-IN-1 | 2766609-08-7 | Reference compound |
| HY-145902 | PDGFRα/FLT3-ITD-IN-1 | 2761259-05-4 | Reference compound |
| HY-145903 | PDGFRα/FLT3-ITD-IN-2 | 2761259-09-8 | Reference compound |
| HY-145904 | PDGFRα/FLT3-ITD-IN-3 | 2761259-22-5 | Reference compound |
| HY-145905 | D4R antagonist-1 | 2846077-19-6 | Reference compound |
| HY-145906 | D4R antagonis-2 | 2846077-70-9 | Reference compound |
| HY-145907 | p53-HDM2-IN-1 | Reference compound | |
| HY-145908 | Antitumor agent-49 | 2763914-21-0 | Reference compound |
| HY-145909 | BRD4 Inhibitor-17 | 2835555-10-5 | Reference compound |
| HY-14590R | Kaempferol (Standard) | 520-18-3 | Reference Standards |
| HY-145910 | NLRP3-IN-6 | Reference compound | |
| HY-145911 | NLRP3-IN-7 | Reference compound | |
| HY-145912 | RYL-552S | 1801444-69-8 | Reference compound |
| HY-145913 | m7GpppApG | 80010-97-5 | Oligonucleotides |
| HY-145913A | m7GpppApG (triammonium) | Oligonucleotides | |
| HY-145915 | ZINC09659342 | 1668604-47-4 | Reference compound |
| HY-145915A | (E/Z)-ZINC09659342 | 591726-26-0 | Reference compound |
| HY-145917 | SARM1-IN-2 | 2396592-52-0 | Reference compound |
| HY-145918 | MRT-14 | 1263131-83-4 | Reference compound |
| HY-145919 | hGPR91 antagonist 3 | 1314796-31-0 | Reference compound |
| HY-14592 | Tectochrysin | 520-28-5 | Natural Products |
| HY-145921 | ChemR23-IN-3 | 3032433-98-7 | Reference compound |
| HY-145922 | ChemR23 ligand-1 | Reference compound | |
| HY-145923 | Osunprotafib | 2489404-97-7 | Reference compound |
| HY-145924 | BAY 2666605 | 2275774-60-0 | Reference compound |
| HY-145925B | CFT8634 | 2704617-96-7 | Reference compound |
| HY-145925C | (S,R)-CFT8634 | 2704617-95-6 | Reference compound |
| HY-145926 | MRTX0902 | 2654743-22-1 | Reference compound |
| HY-145927 | NXP800 | 1693734-80-3 | Reference compound |
| HY-145928 | Divarasib | 2417987-45-0 | Reference compound |
| HY-145928B | Divarasib (adipate) | 2762240-36-6 | Reference compound |
| HY-145929 | MC-Val-Cit-PAB-Exatecan | 2504068-28-2 | ADC Related |
| HY-14592R | Tectochrysin (Standard) | 520-28-5 | Reference Standards |
| HY-145931 | CC214-2 | 1228012-18-7 | Reference compound |
| HY-145932 | DMA-135 (hydrochloride) | 2237925-62-9 | Reference compound |
| HY-145933 | BJJF078 | 2531244-56-9 | Reference compound |
| HY-145934 | UDP-GalNAz (disodium) | 653600-61-4 | Oligonucleotides |
| HY-145934A | UDP-GlcNAz (disodium) | 1611490-64-2 | Biochemical Assay Reagents |
| HY-145935 | NT219 | 1198078-60-2 | Reference compound |
| HY-145937 | PK9327 | 2413987-20-7 | Reference compound |
| HY-145938 | OncoFAP | 2639365-69-6 | Reference compound |
| HY-145939 | BAY-888 | 2468783-75-5 | Reference compound |
| HY-145940 | BAY-204 | 2468784-57-6 | Reference compound |
| HY-145941 | AETA | 44992-01-0 | Biochemical Assay Reagents |
| HY-145942 | Octenyl succinic anhydride | 26680-54-6 | Biochemical Assay Reagents |
| HY-145943 | MP-PEG8-Val-Lys-Ala-7-MAD-MDCPT | 2639190-44-4 | ADC Related |
| HY-145944 | ASR-488 | 2690312-65-1 | Reference compound |
| HY-145945 | MAGL-IN-6 | 2414320-29-7 | Reference compound |
| HY-145946 | BRM/BRG1 ATP Inhibitor-2 | 2368900-77-8 | Reference compound |
| HY-145947 | PROTAC BRD9 Degrader-5 | 2704616-86-2 | Reference compound |
| HY-145949 | Remdesivir de(ethylbutyl 2-aminopropanoate) | 2607871-93-0 | Reference compound |
| HY-14595 | Biochanin A | 491-80-5 | Natural Products |
| HY-145950 | 2′-Deoxy-5-nitrocytidine | 69100-02-3 | Reference compound |
| HY-145951 | Amidate-VC-PAB-MMAF | 2202782-90-7 | ADC Related |
| HY-145952 | (2E,9Z)-Octadeca-2,9-dienoic acid | 182369-03-5 | Reference compound |
| HY-145953 | VY-3-135 | 1824637-41-3 | Reference compound |
| HY-145954 | NAT2-IN-1 | 856005-97-5 | Reference compound |
| HY-145955 | Stearoyl glutamic acid (sodium) | 38517-23-6 | Reference compound |
| HY-145958 | Sirt2-IN-6 | 2243151-81-5 | Reference compound |
| HY-145959 | AMPA receptor antagonist-3 | 923272-18-8 | Reference compound |
| HY-14595R | Biochanin A (Standard) | 491-80-5 | Reference Standards |
| HY-14596 | Genistein | 446-72-0 | Natural Products |
| HY-145960 | MC-Val-Cit-PAB-Amide-TLR7 agonist 4 | 2413016-49-4 | Reference compound |
| HY-145961 | TLR7 agonist 4 | 2413016-42-7 | Reference compound |
| HY-145962 | MRTX-EX185 | Reference compound | |
| HY-145962A | MRTX-EX185 (formic) | Reference compound | |
| HY-145963 | DRB18 | 2863686-81-9 | Reference compound |
| HY-145964 | INE963 | 2640567-43-5 | Reference compound |
| HY-145965 | Ferroportin-IN-1 | 2443432-65-1 | Reference compound |
| HY-145967 | FT709 | 2413991-74-7 | Reference compound |
| HY-145967A | (R)-FT709 | 2413991-75-8 | Reference compound |
| HY-145969 | β-S-ARCA | 1093268-63-3 | Oligonucleotides |
| HY-145969A | β-S-ARCA (triammonium) | Oligonucleotides | |
| HY-14596R | Genistein (Standard) | 446-72-0 | Reference Standards |
| HY-14596S | Genistein-d4 | 187960-08-3 | Isotope-Labeled Compounds |
| HY-145973 | 3'OMe-m7GpppAmpG | 2089461-55-0 | Oligonucleotides |
| HY-145973A | 3'OMe-m7GpppAmpG (ammonium) solution (100mM) | Oligonucleotides | |
| HY-145974 | m7GpppAmpG | 62858-30-4 | Oligonucleotides |
| HY-145974A | m7GpppAmpG (ammonium) | Oligonucleotides | |
| HY-145975 | m7Gpppm6AmpG | 71340-22-2 | Oligonucleotides |
| HY-145975A | m7Gpppm6AmpG (ammonium) solution (100mM) | Oligonucleotides | |
| HY-145976 | m7GpppGpG | 133608-76-1 | Oligonucleotides |
| HY-145977 | m7GpppGmpG | 1258049-00-1 | Oligonucleotides |
| HY-145977A | m7GpppGmpG (ammonium) | Oligonucleotides | |
| HY-145979 | m7GpppUmpG | 2638447-87-5 | Oligonucleotides |
| HY-14598 | Diethylstilbestrol | 56-53-1 | Reference compound |
| HY-145980 | m7GpppUpG | 2638447-85-3 | Oligonucleotides |
| HY-145981 | m7GpppCpG | 2638447-78-4 | Oligonucleotides |
| HY-145982 | m7GpppCmpG | 2089461-56-1 | Oligonucleotides |
| HY-145983 | Suc-Gly-Pro-AMC | 80049-85-0 | Reference compound |
| HY-145985 | CBR-3465 | 2225883-59-8 | Reference compound |
| HY-145986 | CBR-6672 | 2225885-40-3 | Reference compound |
| HY-145988 | COX-2-IN-11 | 1023741-06-1 | Reference compound |
| HY-145989 | Aminobenzenesulfonic auristatin E | 1800462-99-0 | ADC Related |
| HY-145989A | Aminobenzenesulfonic auristatin E (TFA) | ADC Related | |
| HY-145989S | Aminobenzenesulfonic auristatin E-d8 | Isotope-Labeled Compounds | |
| HY-14598R | Diethylstilbestrol (Standard) | 56-53-1 | Reference Standards |
| HY-14598S | Diethylstilbestrol-d8 | 91318-10-4 | Isotope-Labeled Compounds |
| HY-14598S1 | Diethylstilbestrol-d3 | 58322-36-4 | Isotope-Labeled Compounds |
| HY-145990 | FABPs ligand 6 | 2988135-14-2 | Reference compound |
| HY-145991 | Ribavirin carboxylic acid | 39925-19-4 | Reference compound |
| HY-145991R | Ribavirin carboxylic acid (Standard) | 39925-19-4 | Reference Standards |
| HY-145992 | KCNQ1 activator-1 | 1008671-38-2 | Reference compound |
| HY-145994 | Obeldesivir | 2647441-36-7 | Reference compound |
| HY-145995 | CS12192 | 1888318-68-0 | Reference compound |
| HY-145996 | STC314 | 186295-19-2 | Reference compound |
| HY-145997 | MRGPRX4 modulator-1 | 2492596-61-7 | Reference compound |
| HY-145998 | 2′-O-Methyl-8-methyl guanosine | 2306782-64-7 | Oligonucleotides |
| HY-14600 | Rosiglitazone (maleate) | 155141-29-0 | Reference compound |
| HY-146000 | Influenza virus-IN-3 | 2412451-16-0 | Reference compound |
| HY-146001 | Influenza virus-IN-4 | 2133818-85-4 | Reference compound |
| HY-146002 | IDH2R140Q-IN-1 | 2469044-23-1 | Reference compound |
| HY-146003 | FAAL-IN-1 | 1965250-07-0 | Reference compound |
| HY-146004 | Influenza A virus-IN-4 | 2390067-58-8 | Reference compound |
| HY-146005 | Tau-aggregation and neuroinflammation-IN-1 | 2175953-98-5 | Reference compound |
| HY-146006 | Tubulin/MMP-IN-1 | Reference compound | |
| HY-146007 | hCAIX-IN-17 | Reference compound | |
| HY-146008 | hCAII-IN-3 | 2770927-76-7 | Reference compound |
| HY-146009 | AL-470 | 2671019-15-9 | Reference compound |
| HY-14600R | Rosiglitazone (maleate) (Standard) | 155141-29-0 | Reference Standards |
| HY-14601 | Pioglitazone (hydrochloride) | 112529-15-4 | Reference compound |
| HY-146010 | Carbonic anhydrase inhibitor 13 | 2488872-31-5 | Reference compound |
| HY-146011 | HBV-IN-21 | 2460957-52-0 | Reference compound |
| HY-146012 | HIV-1 protease-IN-4 | Reference compound | |
| HY-146013 | Sirt1/2-IN-1 | 2402779-21-7 | Reference compound |
| HY-146014 | Multi-kinase-IN-1 | 2470807-67-9 | Reference compound |
| HY-146015 | HIV-1 inhibitor-21 | 2554620-04-9 | Reference compound |
| HY-146016 | PI3K/mTOR Inhibitor-5 | 2456295-60-4 | Reference compound |
| HY-146017 | HIV-1 inhibitor-22 | 2554618-33-4 | Reference compound |
| HY-146018 | HIV-1 inhibitor-23 | 2554622-28-3 | Reference compound |
| HY-146019 | HIV-1 inhibitor-24 | 2475658-75-2 | Reference compound |
| HY-146019A | HIV-1 inhibitor-25 | 2475658-74-1 | Reference compound |
| HY-14601R | Pioglitazone (hydrochloride) (Standard) | 112529-15-4 | Reference Standards |
| HY-14602 | Tramiprosate | 3687-18-1 | Natural Products |
| HY-146020 | Topoisomerase IIα-IN-1 | 2407521-87-1 | Reference compound |
| HY-146021 | Topoisomerase IIα-IN-2 | 2407521-90-6 | Reference compound |
| HY-146022 | SIAIS117 | 2353494-84-3 | Reference compound |
| HY-146023 | Antifungal agent 27 | 2987755-90-6 | Reference compound |
| HY-146024 | Antifungal agent 28 | Reference compound | |
| HY-146025 | Antitumor agent-F10 | 2371727-65-8 | Reference compound |
| HY-146026 | Androgen receptor antagonist 3 | 353484-46-5 | Reference compound |
| HY-146027 | Androgen receptor antagonist 4 | 354815-43-3 | Reference compound |
| HY-146029 | Apoptosis inducer 3 | 2420443-14-5 | Reference compound |
| HY-14602R | Tramiprosate (Standard) | 3687-18-1 | Reference Standards |
| HY-14602S | Tramiprosate-d6 | 1131576-06-1 | Isotope-Labeled Compounds |
| HY-14603 | Clioquinol | 130-26-7 | Reference compound |
| HY-146030 | Anticancer agent 46 | 2426686-17-9 | Reference compound |
| HY-146031 | A3N19 | 2249755-49-3 | Reference compound |
| HY-146032 | p38-α MAPK-IN-4 | 2396754-57-5 | Reference compound |
| HY-146033 | HPV18-IN-1 | 331851-78-6 | Reference compound |
| HY-146034 | NOD1/2 antagonist-1 | 2704623-69-6 | Reference compound |
| HY-146035 | AChE-IN-14 | 2390042-05-2 | Reference compound |
| HY-146036 | NADH-IN-1 | 1432445-15-2 | Reference compound |
| HY-146037 | Aurora A inhibitor 2 | 2412144-74-0 | Reference compound |
| HY-146038 | Antitumor agent-55 | 2522594-49-4 | Reference compound |
| HY-146039 | AChE-IN-15 | 2242792-25-0 | Reference compound |
| HY-14603R | Clioquinol (Standard) | 130-26-7 | Reference Standards |
| HY-14604 | Xaliproden (hydrochloride) | 90494-79-4 | Reference compound |
| HY-146040 | Anticancer agent 47 | 2461795-23-1 | Reference compound |
| HY-146041 | Antiparasitic agent-2 | 2494277-80-2 | Reference compound |
| HY-146042 | Antiparasitic agent-4 | 2253996-66-4 | Reference compound |
| HY-146043 | Antiparasitic agent-5 | 2494276-55-8 | Reference compound |
| HY-146044 | Antiparasitic agent-6 | 2253996-73-3 | Reference compound |
| HY-146045 | Antiparasitic agent-7 | 2253996-75-5 | Reference compound |
| HY-146046 | Antitumor agent-56 | 2411579-53-6 | Reference compound |
| HY-146047 | Antibacterial agent 94 | 1666134-58-2 | Reference compound |
| HY-146048 | Antitumor agent-57 | 2432823-48-6 | Reference compound |
| HY-146049 | Antitrypanosomal agent 4 | 2456427-48-6 | Reference compound |
| HY-14605 | Rasagiline (mesylate) | 161735-79-1 | Reference compound |
| HY-146050 | Antitubercular agent-17 | 2328751-33-1 | Reference compound |
| HY-146051 | Antitubercular agent-18 | 1308272-99-2 | Reference compound |
| HY-146052 | Autophagy inducer 3 | 2691054-63-2 | Reference compound |
| HY-146053 | CXCR4 modulator-1 | 1381178-26-2 | Reference compound |
| HY-146054 | CXCR4 modulator-2 | 2488943-55-9 | Reference compound |
| HY-146055 | Antituberculosis agent-1 | 2411740-98-0 | Reference compound |
| HY-146056 | Anabolic agent-1 | 2439179-74-3 | Reference compound |
| HY-146057 | Antituberculosis agent-2 | 2411741-01-8 | Reference compound |
| HY-146058 | NF-κB/PON1-IN-1 | 2419107-97-2 | Reference compound |
| HY-146059 | Antibacterial agent 99 | 2452306-13-5 | Reference compound |
| HY-14605A | Rasagiline | 136236-51-6 | Reference compound |
| HY-14605AR | Rasagiline (Standard) | 136236-51-6 | Reference Standards |
| HY-14605BS | Rasagiline-13C3 (mesylate racemic) | 1216757-55-9 | Isotope-Labeled Compounds |
| HY-14605R | Rasagiline (mesylate) (Standard) | 161735-79-1 | Reference Standards |
| HY-14605S | Rasagiline-13C3 (mesylate) | 1391052-18-8 | Isotope-Labeled Compounds |
| HY-146060 | Antibacterial agent 100 | 2452306-14-6 | Reference compound |
| HY-146061 | KRAS G12C inhibitor 48 | 3033236-94-8 | Reference compound |
| HY-146062 | Antibacterial agent 101 | 2452306-15-7 | Reference compound |
| HY-146063 | Anticancer agent 54 | 2933882-99-4 | Reference compound |
| HY-146064 | OPN expression inhibitor 1 | 2257492-95-6 | Reference compound |
| HY-146065 | FAK-IN-4 | 3032200-62-4 | Reference compound |
| HY-146066 | α7 nAchR-JAK2-STAT3 agonist 1 | 2108714-20-9 | Reference compound |
| HY-146066A | (R)-α7 nAchR-JAK2-STAT3 agonist 1 | Reference compound | |
| HY-146067 | β-Nor-lapachone | 52436-88-1 | Reference compound |
| HY-146068 | AEP-IN-1 | 3032742-75-6 | Reference compound |
| HY-146069 | ABBV-318 | 1802848-94-7 | Reference compound |
| HY-14607 | Besipirdine (hydrochloride) | 130953-69-4 | Reference compound |
| HY-146070 | Elastase-IN-1 | 678152-73-3 | Reference compound |
| HY-146071 | Antitrypanosomal agent 5 | Reference compound | |
| HY-146072 | IRAK4-IN-11 | 3032742-74-5 | Reference compound |
| HY-146073 | IRAK4-IN-12 | Reference compound | |
| HY-146074 | RUVBL1/2 ATPase-IN-1 | 423128-55-6 | Reference compound |
| HY-146075 | β-Lactamase-IN-8 | 1929555-36-1 | Reference compound |
| HY-146076 | 5-HT6/5-HT2A receptor ligand-1 | 2411088-07-6 | Reference compound |
| HY-146077 | 5-HT6/5-HT2A receptor ligand-2 | 2411088-16-7 | Reference compound |
| HY-146078 | Antimicrobial agent-1 | 2579696-45-8 | Reference compound |
| HY-146079 | Antifungal agent 31 | 2077083-94-2 | Reference compound |
| HY-14608 | L-Glutamic acid | 56-86-0 | Natural Products |
| HY-146080 | Antitumor agent-61 | 2408917-12-2 | Reference compound |
| HY-146081 | CD22 ligand-1 | 2493080-27-4 | Reference compound |
| HY-146082 | (Z)-α-Cyanostilbene | 6114-57-4 | Reference compound |
| HY-146083 | (Z)-p-cyano-α-Cyanostilbene | 54676-54-9 | Reference compound |
| HY-146084 | PCSK9 modulator-3 | 2476490-18-1 | Reference compound |
| HY-146085 | PCSK9 modulator-4 | 2476490-20-5 | Reference compound |
| HY-146086 | Nrf2 activator-4 | 2383016-68-8 | Reference compound |
| HY-146087 | Autophagy inducer 4 | 2486455-03-0 | Reference compound |
| HY-146088 | HIV-1 inhibitor-31 | 920036-04-0 | Reference compound |
| HY-146089 | HIV-1 inhibitor-32 | 1033950-94-5 | Reference compound |
| HY-14608A | L-Glutamic acid (monosodium salt) | 142-47-2 | Natural Products |
| HY-14608AR | L-Glutamic acid (monosodium salt) (Standard) | 142-47-2 | Reference Standards |
| HY-14608R | L-Glutamic acid (Standard) | 56-86-0 | Reference Standards |
| HY-14608S | L-Glutamic acid-13C | 115473-51-3 | Isotope-Labeled Compounds |
| HY-14608S1 | L-Glutamic acid-1-13C | 81201-99-2 | Isotope-Labeled Compounds |
| HY-14608S10 | L-Glutamic acid-13C2 | 115473-56-8 | Isotope-Labeled Compounds |
| HY-14608S12 | L-Glutamic acid-14C | 24016-48-6 | Isotope-Labeled Compounds |
| HY-14608S2 | L-Glutamic acid-15N | 21160-87-2 | Isotope-Labeled Compounds |
| HY-14608S3 | L-Glutamic acid-13C5,15N | 202468-31-3 | Isotope-Labeled Compounds |
| HY-14608S4 | L-Glutamic acid-13C5,15N,d5 | 1420815-74-2 | Isotope-Labeled Compounds |
| HY-14608S5 | L-Glutamic acid-13C5 | 55443-55-5 | Isotope-Labeled Compounds |
| HY-14608S6 | L-Glutamic acid-5-13C | 81202-00-8 | Isotope-Labeled Compounds |
| HY-14608S7 | L-Glutamic acid-d5 | 2784-50-1 | Isotope-Labeled Compounds |
| HY-14608S8 | L-Glutamic acid-d3 | 203805-84-9 | Isotope-Labeled Compounds |
| HY-14608S9 | L-Glutamic acid-15N,d5 | Isotope-Labeled Compounds | |
| HY-14609 | MPEP (Hydrochloride) | 219911-35-0 | Reference compound |
| HY-146090 | HIV-1 inhibitor-33 | 2395777-43-0 | Reference compound |
| HY-146091 | HIV-1 inhibitor-34 | 2395777-45-2 | Reference compound |
| HY-146092 | Apoptosis inducer 4 | 2408050-83-7 | Reference compound |
| HY-146093 | Antitumor agent-62 | 2460735-29-7 | Reference compound |
| HY-146094 | Antitumor agent-63 | 1627600-90-1 | Reference compound |
| HY-146095 | p53 Activator 2 | 2338764-89-7 | Reference compound |
| HY-146096 | RMS3 | 2497686-66-3 | Reference compound |
| HY-146097 | RMS5 | 2497686-68-5 | Reference compound |
| HY-146098 | Antibacterial agent 105 | 2364493-24-1 | Reference compound |
| HY-146099 | GABAA receptor agent 7 | 2376841-18-6 | Reference compound |
| HY-14609A | MPEP | 96206-92-7 | Reference compound |
| HY-146100 | GABAA receptor agent 8 | 2376841-54-0 | Reference compound |
| HY-146101 | NMDA receptor antagonist 5 | 2415998-36-4 | Reference compound |
| HY-146102 | M1 ligand 1 | 2479356-53-9 | Reference compound |
| HY-146103 | Antiproliferative agent-7 | 2497687-47-3 | Reference compound |
| HY-146104 | Antimycobacterial agent-1 | 2409926-02-7 | Reference compound |
| HY-146105 | Anticancer agent 65 | 2407861-48-5 | Reference compound |
| HY-146106 | Antitubercular agent-22 | Reference compound | |
| HY-146107 | Antitubercular agent-23 | Reference compound | |
| HY-146108 | RSV-IN-5 | 2415018-86-7 | Reference compound |
| HY-146109 | RyRs activator 1 | 2571579-14-9 | Reference compound |
| HY-14611 | 3,3'-Difluorobenzaldazine | 15332-10-2 | Reference compound |
| HY-146110 | RyRs activator 2 | 2408415-52-9 | Reference compound |
| HY-146111 | IRAK4-IN-13 | 2667681-57-2 | Reference compound |
| HY-146112 | IRAK4-IN-14 | 2667681-71-0 | Reference compound |
| HY-146113 | IRAK4-IN-15 | 2667681-85-6 | Reference compound |
| HY-146114 | Antitumor agent-67 | 2820146-10-7 | Reference compound |
| HY-146115 | TRK-IN-19 | Reference compound | |
| HY-146116 | Antifungal agent 32 | 1809167-48-3 | Reference compound |
| HY-146117 | P-gp modulator 2 | 2987145-05-9 | Reference compound |
| HY-146118 | P-gp modulator 3 | 2987145-15-1 | Reference compound |
| HY-146119 | Antitubercular agent-24 | 1845719-43-8 | Reference compound |
| HY-14612 | CPPHA | 693288-97-0 | Reference compound |
| HY-146120 | Antitubercular agent-25 | 1845719-91-6 | Reference compound |
| HY-146121 | Antitubercular agent-26 | 1845720-46-8 | Reference compound |
| HY-146122 | ATX inhibitor 19 | 2691937-01-4 | Reference compound |
| HY-146123 | ATX inhibitor 20 | 2691937-03-6 | Reference compound |
| HY-146124 | ATX inhibitor 21 | 2691936-89-5 | Reference compound |
| HY-146125 | CGCG/CGG ligand 1 | 2488185-65-3 | Reference compound |
| HY-146126 | NS5A-IN-4 | 2088243-03-0 | Reference compound |
| HY-146127 | Grb2 SH2 domain inhibitor 1 | Reference compound | |
| HY-146127A | Grb2 SH2 domain inhibitor 1 (TFA) | Peptides | |
| HY-146128 | Anti-hyperglycemic agent-1 | 2488372-34-3 | Reference compound |
| HY-146129 | Aldose reductase-IN-5 | 2480090-03-5 | Reference compound |
| HY-146130 | ATG7-IN-2 | 2226227-75-2 | Reference compound |
| HY-146131 | ATG7-IN-3 | 2226229-76-9 | Reference compound |
| HY-146132 | EGFR-IN-55 | 2057423-46-6 | Reference compound |
| HY-146133 | LA-Bac8c | Peptides | |
| HY-146134 | PGN36 | 1564253-75-3 | Reference compound |
| HY-146135 | Tau-aggregation-IN-1 | 1619269-19-0 | Reference compound |
| HY-146136 | EGFR-IN-56 | 2477726-83-1 | Reference compound |
| HY-146137 | Transthyretin-IN-1 | Reference compound | |
| HY-146138 | EGFR-IN-57 | 2492382-37-1 | Reference compound |
| HY-146139 | Aβ-IN-3 | 2477606-87-2 | Reference compound |
| HY-146140 | Aβ-IN-4 | 2477606-97-4 | Reference compound |
| HY-146141 | EphA2 agonist 2 | 2169273-66-7 | Reference compound |
| HY-146142 | AChE/BuChE-IN-2 | 1946008-31-6 | Reference compound |
| HY-146143 | Falcipain-2/3-IN-2 | 946209-23-0 | Reference compound |
| HY-146144 | HIF-IN-1 | 2393928-76-0 | Reference compound |
| HY-146145 | Metyltetraprole | 1472649-01-6 | Reference compound |
| HY-146146 | Kolavenic acid analog | 2379777-37-2 | Reference compound |
| HY-146147 | Influenza virus-IN-5 | 2581825-57-0 | Reference compound |
| HY-146148 | KDM4C-IN-1 | 52348-60-4 | Reference compound |
| HY-146149 | MAO-B-IN-11 | 192383-78-1 | Reference compound |
| HY-14614A | S-Adenosyl-L-methionine (chloride dihydrochloride) | 86867-01-8 | Reference compound |
| HY-14614D | S-Adenosyl-L-methionine (iodide) | 3493-13-8 | Natural Products |
| HY-14615 | [6]-Gingerol | 23513-14-6 | Natural Products |
| HY-146150 | MAO-B-IN-12 | 2394733-97-0 | Reference compound |
| HY-146151 | γ-Secretase modulator 12 | 2204249-82-9 | Reference compound |
| HY-146152 | ASGPR modulator-1 | 2052968-88-2 | Reference compound |
| HY-146153 | HDAC-IN-40 | 2463198-51-6 | Reference compound |
| HY-146154 | EGFR-IN-58 | Reference compound | |
| HY-146155 | TRPC4/5-IN-1 | 3032263-08-1 | Reference compound |
| HY-146156 | α-Glucosidase-IN-7 | Reference compound | |
| HY-146157 | SARS-CoV-2-IN-22 | 2710278-53-6 | Reference compound |
| HY-146158 | Fudapirine | 1859978-72-5 | Reference compound |
| HY-146159 | PI3K/HDAC-IN-2 | 2361418-65-5 | Reference compound |
| HY-14615R | [6]-Gingerol (Standard) | 23513-14-6 | Reference Standards |
| HY-14616 | Shogaol | 555-66-8 | Natural Products |
| HY-146160 | PARP-1/HDAC-IN-1 | 3032621-10-3 | Reference compound |
| HY-146161 | COX-2/NO-IN-1 | 2989882-91-7 | Reference compound |
| HY-146162 | Colletotrichalactones A | 2751633-79-9 | Reference compound |
| HY-146163 | Topoisomerase II inhibitor 7 | 2697171-03-0 | Reference compound |
| HY-146164 | Tubulin polymerization-IN-21 | 2703017-14-3 | Reference compound |
| HY-146165 | Metallo-β-lactamase-IN-8 | 1610537-25-1 | Reference compound |
| HY-146166 | PT4 | 1280738-47-7 | Reference compound |
| HY-146167 | iNOS/PGE2-IN-1 | Reference compound | |
| HY-146168 | Nrf2 activator-5 | 1012860-13-7 | Reference compound |
| HY-146169 | Antitumor agent-68 | 2566497-96-7 | Reference compound |
| HY-14616R | Shogaol (Standard) | 555-66-8 | Reference Standards |
| HY-14617 | Paradol | 27113-22-0 | Natural Products |
| HY-146170 | Anticancer agent 69 | Reference compound | |
| HY-146171 | FabH-IN-1 | 2692652-49-4 | Reference compound |
| HY-146172 | Antioxidant agent-3 | 2710376-48-8 | Reference compound |
| HY-146173 | KCa1.1 channel activator-1 | Reference compound | |
| HY-146174 | KCa1.1 channel activator-2 | Reference compound | |
| HY-146177 | CYP3A4 enzyme-IN-1 | 2531281-25-9 | Reference compound |
| HY-146178 | IMP2-IN-1 | 1480482-51-6 | Reference compound |
| HY-146179 | IMP2-IN-2 | 1448353-39-6 | Reference compound |
| HY-14617R | Paradol (Standard) | 27113-22-0 | Reference Standards |
| HY-14618 | Zingiberene | 495-60-3 | Natural Products |
| HY-146180 | FSDD0I | Reference compound | |
| HY-146181 | FSDD1I | Reference compound | |
| HY-146182 | FSDD3I | Reference compound | |
| HY-146183 | BCL6-IN-9 | 2378852-76-5 | Reference compound |
| HY-146184 | CCT373567 | 2378853-67-7 | Reference compound |
| HY-146185 | CCT373566 | 2378853-66-6 | Reference compound |
| HY-146186 | JAK2 JH2 binder-1 | 2923309-41-3 | Reference compound |
| HY-146187 | Antitumor agent-69 | 2417651-42-2 | Reference compound |
| HY-146188 | Topoisomerase II inhibitor 8 | 2493298-68-1 | Reference compound |
| HY-146189 | Topoisomerase II inhibitor 9 | 2413901-61-6 | Reference compound |
| HY-146190 | Callophycin A | 1345674-93-2 | Reference compound |
| HY-146191 | Zika virus-IN-1 | 2527912-80-5 | Reference compound |
| HY-146192 | Zika virus-IN-2 | 2527912-53-2 | Reference compound |
| HY-146193 | Zika virus-IN-3 | 2527915-11-1 | Reference compound |
| HY-146194 | NHEJ inhibitor-1 | Reference compound | |
| HY-146195 | MAPK-IN-1 | 2470587-69-8 | Reference compound |
| HY-146196 | Anticandidal agent-1 | 2548852-85-1 | Reference compound |
| HY-146197 | Apoptotic agent-1 | 2490538-26-4 | Reference compound |
| HY-146198 | COX-2-IN-19 | 2497530-12-6 | Reference compound |
| HY-146199 | Antibacterial agent 108 | 900784-30-7 | Reference compound |
| HY-146200 | PI3K/mTOR Inhibitor-8 | 2492376-85-7 | Reference compound |
| HY-146201 | PDE4B/7A-IN-1 | 2511632-25-8 | Reference compound |
| HY-146202 | PDE4B/7A-IN-2 | 2511632-55-4 | Reference compound |
| HY-146203 | FAK inhibitor 6 | 2410056-27-6 | Reference compound |
| HY-146204 | HIV-1 capsid inhibitor 1 | 2396382-78-6 | Reference compound |
| HY-146205 | ATX inhibitor 18 | 2402772-30-7 | Reference compound |
| HY-146206 | HCAIX-IN-1 | 2389034-65-3 | Reference compound |
| HY-146207 | HCAIX-IN-2 | 2389034-45-9 | Reference compound |
| HY-146208 | BRD4 Inhibitor-20 | 2490311-14-1 | Reference compound |
| HY-146209 | Tubulin polymerization-IN-13 | 2426665-56-5 | Reference compound |
| HY-14620A | Farnesene (mixture of isomers) | 125037-13-0 | Reference compound |
| HY-14621 | Zingerone | 122-48-5 | Natural Products |
| HY-146210 | EGFR-IN-50 | 2044508-48-5 | Reference compound |
| HY-146211 | Tubulin polymerization-IN-14 | 2417134-05-3 | Reference compound |
| HY-146212 | HDAC/HSP90-IN-4 | Reference compound | |
| HY-146213 | CDK4/6-IN-12 | 2445205-24-1 | Reference compound |
| HY-146214 | CDK4/6-IN-13 | 1908454-70-5 | Reference compound |
| HY-146215 | IDO1-IN-20 | 2415246-15-8 | Reference compound |
| HY-146216 | MMP-9-IN-3 | 2581824-48-6 | Reference compound |
| HY-146217 | MMP-9-IN-4 | 2581824-39-5 | Reference compound |
| HY-146218 | MMP-9-IN-5 | 2581824-80-6 | Reference compound |
| HY-146219 | Biotin-nPEG-amine | 604786-74-5 | Reference compound |
| HY-14621R | Zingerone (Standard) | 122-48-5 | Reference Standards |
| HY-14622 | Necrostatin 2 | 852391-19-6 | Reference compound |
| HY-146220 | MrgprX2 antagonist-8 | 2768216-96-0 | Reference compound |
| HY-146221 | Dyrk1A-IN-5 | 1685235-41-9 | Reference compound |
| HY-146223 | AZD4625 | Reference compound | |
| HY-146223A | (3R,10R,14aS)-AZD4625 | Reference compound | |
| HY-146225 | α-Amylase/α-Glucosidase-IN-2 | 2446063-14-3 | Reference compound |
| HY-146226 | Viral 2C protein inhibitor 1 | 1594427-18-5 | Reference compound |
| HY-146227 | DNA topoisomerase II inhibitor 1 | 2459950-15-1 | Reference compound |
| HY-146228 | HSP90-IN-13 | 2446055-29-2 | Reference compound |
| HY-146229 | VEGFR-2-IN-25 | 2439096-02-1 | Reference compound |
| HY-14622A | Necrostatin 2 (racemate) | 852391-15-2 | Reference compound |
| HY-14622B | Necrostatin 2 (S enantiomer) | 852391-20-9 | Reference compound |
| HY-146230 | VEGFR-2-IN-26 | 2439096-06-5 | Reference compound |
| HY-146231 | SS47 | 2636072-62-1 | Reference compound |
| HY-146231A | SS47 (TFA) | Reference compound | |
| HY-146232 | F 13714 | 208109-38-0 | Reference compound |
| HY-146236 | VEGFR-2-IN-27 | 2439096-14-5 | Reference compound |
| HY-146237 | Golcadomide | 2379572-34-4 | Reference compound |
| HY-146238 | EGFR/HER2/TS-IN-1 | 2444363-11-3 | Reference compound |
| HY-146239 | EGFR/HER2/TS-IN-2 | 2444364-04-7 | Reference compound |
| HY-146240 | ALDH1A1-IN-3 | 2439177-97-4 | Reference compound |
| HY-146241 | SN40 | 2768663-14-3 | Reference compound |
| HY-146241B | SN40 (hydrochloride) | 2768663-15-4 | Reference compound |
| HY-146242 | SN05 | 2768663-51-8 | Reference compound |
| HY-146243 | TH-Z835 | 2766209-50-9 | Reference compound |
| HY-146244 | Agatolimod | 525625-52-9 | Oligonucleotides |
| HY-146244A | Biotin-labeled Agatolimod (sodium) | Oligonucleotides | |
| HY-146244B | FITC-labeled Agatolimod (sodium) | Oligonucleotides | |
| HY-146245 | ODN 1826 | 202668-42-6 | Oligonucleotides |
| HY-146245A | Biotin-labeled ODN 1826 (sodium) | Oligonucleotides | |
| HY-146245B | FITC-labeled ODN 1826 (sodium) | Oligonucleotides | |
| HY-146245C | ODN 1826 (sodium) | Oligonucleotides | |
| HY-146245F | FAM-labeled ODN 1826 (sodium) | Oligonucleotides | |
| HY-146246 | EIDD-2749 | 1613589-24-4 | Reference compound |
| HY-146247A | 4'-Fluorouridine triphosphate (sodium) | Reference compound | |
| HY-146248 | TFMU-ADPr | 2412923-11-4 | Dye Reagents |
| HY-146248A | TFMU-ADPr (triethylamine) | Reference compound | |
| HY-146248B | TFMU-ADPr (diammonium) | Reference compound | |
| HY-146250 | Antitumor agent-71 | 2011756-99-1 | Reference compound |
| HY-146251 | BuChE-IN-6 | 2003213-07-6 | Reference compound |
| HY-146252 | hCAXII-IN-4 | 2414601-79-7 | Reference compound |
| HY-146253 | CDK1/2/4-IN-1 | 2414633-49-9 | Reference compound |
| HY-146254 | hCAIX-IN-12 | 2414598-85-7 | Reference compound |
| HY-146256 | hCAXII-IN-5 | 2414629-92-6 | Reference compound |
| HY-146257 | hCAIX/XII-IN-2 | 2414629-82-4 | Reference compound |
| HY-146258 | hCAIX/XII-IN-3 | 2414629-94-8 | Reference compound |
| HY-146259 | hCAIX/XII-IN-4 | 1119200-33-7 | Reference compound |
| HY-146260 | NVP-CLR457 | 1453082-52-4 | Reference compound |
| HY-146261 | HI5 | 2411548-90-6 | Reference compound |
| HY-146262 | LDC0496 | 2411874-83-2 | Reference compound |
| HY-146263 | ThrRS-IN-3 | 3031483-23-2 | Reference compound |
| HY-146267 | ERα degrader 5 | 2941268-96-6 | Reference compound |
| HY-146268 | CaMKIIα-IN-1 | 3031484-08-6 | Reference compound |
| HY-146269 | 11-Desethyl Irinotecan | 103816-16-6 | Reference compound |
| HY-146270 | pUL89 Endonuclease-IN-1 | 391680-92-5 | Reference compound |
| HY-146271 | pUL89 Endonuclease-IN-2 | 519021-48-8 | Reference compound |
| HY-146272 | Vasopressin V2 receptor antagonist 1 | 2648650-50-2 | Reference compound |
| HY-146273 | Xanthine oxidase-IN-7 | 2411698-59-2 | Reference compound |
| HY-146274 | c-Met-IN-10 | 2415291-03-9 | Reference compound |
| HY-146275 | LXRβ agonist-3 | 2416049-12-0 | Reference compound |
| HY-146276 | CDK/HDAC-IN-2 | 2580938-58-3 | Reference compound |
| HY-146277 | CBP/p300-IN-19 | 2592638-13-4 | Reference compound |
| HY-146277A | CBP/p300-IN-19 (hydrochloride) | 2592638-14-5 | Reference compound |
| HY-146279S | Amino-2-deoxy-D-galactose-15N (hydrochloride) | 478518-55-7 | Isotope-Labeled Compounds |
| HY-146280 | mGAT3/4-IN-1 | 2556833-57-7 | Reference compound |
| HY-146281 | mGAT3/4-IN-2 | 2556833-68-0 | Reference compound |
| HY-146282 | mGAT-IN-1 | 2556833-08-8 | Reference compound |
| HY-146283 | LSD1-IN-18 | 2983011-61-4 | Reference compound |
| HY-146284 | LSD1-IN-19 | 2983011-81-8 | Reference compound |
| HY-146285 | LSD1-IN-20 | 1239589-91-3 | Reference compound |
| HY-146286 | Anticancer agent 44 | 2770943-86-5 | Reference compound |
| HY-146287 | Zn(BQTC) | 2785342-54-1 | Reference compound |
| HY-146288 | LXR agonist 2 | 2978788-07-5 | Reference compound |
| HY-146290 | Anticancer agent 45 | 2770943-87-6 | Reference compound |
| HY-146291 | BET-IN-7 | 303985-05-9 | Reference compound |
| HY-146292 | BET-IN-8 | 2769893-19-6 | Reference compound |
| HY-146293 | HDAC6/HSP90-IN-1 | 2411955-43-4 | Reference compound |
| HY-146294 | COX-2/5-LOX-IN-1 | 2410384-50-6 | Reference compound |
| HY-146295 | COX-2/5-LOX-IN-2 | 2410384-59-5 | Reference compound |
| HY-146296 | Xanthine oxidoreductase-IN-1 | 2396612-00-1 | Reference compound |
| HY-146297 | Xanthine oxidoreductase-IN-2 | 2396612-45-4 | Reference compound |
| HY-146298 | Mt KARI-IN-1 | 2987760-64-3 | Reference compound |
| HY-146299 | Mt KARI-IN-2 | 2413974-52-2 | Reference compound |
| HY-146300 | Mt KARI-IN-4 | 2413974-53-3 | Reference compound |
| HY-146301 | Mt KARI-IN-5 | 2413974-69-1 | Reference compound |
| HY-146302 | 14-3-3η Protein inhibitor 1 | 2770842-10-7 | Reference compound |
| HY-146303 | C-RAF kinase-IN-1 | 2770957-08-7 | Reference compound |
| HY-146304 | YXL-13 | 2415981-79-0 | Reference compound |
| HY-146305 | α-Glucosidase-IN-4 | 2410538-67-7 | Reference compound |
| HY-146306 | Neuraminidase-IN-9 | 2217630-64-1 | Reference compound |
| HY-146307 | TrxR-IN-3 | 2445565-58-0 | Reference compound |
| HY-146308 | HIV-1 inhibitor-26 | 2415504-88-8 | Reference compound |
| HY-146309 | iNOS-IN-2 | 2419891-42-0 | Reference compound |
| HY-146310 | Tubulin polymerization-IN-15 | 2055517-66-1 | Reference compound |
| HY-146311 | Tubulin polymerization-IN-16 | 2296731-38-7 | Reference compound |
| HY-146312 | AChE/BChE/MAO-B-IN-1 | 2416910-82-0 | Reference compound |
| HY-146313 | BChE-IN-7 | 2416910-85-3 | Reference compound |
| HY-146314 | MAO-B-IN-9 | 2416910-88-6 | Reference compound |
| HY-146315 | AChE/BChE-IN-6 | 2416910-94-4 | Reference compound |
| HY-146316 | Topoisomerase II inhibitor 6 | 2987586-62-7 | Reference compound |
| HY-146317 | P1788 | 2554623-76-4 | Reference compound |
| HY-146318 | MIF-IN-5 | 2582755-31-3 | Reference compound |
| HY-146319 | MIF-IN-6 | 2582758-61-8 | Reference compound |
| HY-146320 | ANO1-IN-1 | 407587-01-3 | Reference compound |
| HY-146321 | ANO1-IN-2 | 637314-12-6 | Reference compound |
| HY-146323 | Antitumor agent-58 | Reference compound | |
| HY-146324 | PROTAC eEF2K degrader-1 | 2458170-54-0 | Reference compound |
| HY-146325 | HSP90-IN-11 | 2986564-20-7 | Reference compound |
| HY-146327 | PqsR/LasR-IN-1 | 924818-33-7 | Reference compound |
| HY-146327R | PqsR/LasR-IN-1 (Standard) | 924818-33-7 | Reference Standards |
| HY-146328 | PqsR/LasR-IN-2 | 2071705-93-4 | Reference compound |
| HY-146328R | PqsR/LasR-IN-2 (Standard) | 2071705-93-4 | Reference Standards |
| HY-146329 | PqsR/LasR-IN-3 | 2581109-51-3 | Reference compound |
| HY-146329R | PqsR/LasR-IN-3 (Standard) | 2581109-51-3 | Reference Standards |
| HY-146330 | FtsZ-IN-2 | 2249757-45-5 | Reference compound |
| HY-146331 | PC190723 | 951120-33-5 | Reference compound |
| HY-146332 | Collagen-IN-1 | 104260-73-3 | Reference compound |
| HY-146333 | TRAP-6-IN-1 | 2068737-10-8 | Reference compound |
| HY-146334 | DFBTA | 2966044-07-3 | Reference compound |
| HY-146335 | CLK1/4-IN-1 | 3029431-90-8 | Reference compound |
| HY-146336 | PARP1/2/TNKS1/2-IN-1 | 2243453-32-7 | Reference compound |
| HY-146337 | Dyrk1A/B-IN-1 | 3032401-50-3 | Reference compound |
| HY-146338 | RPR103611 | 150840-75-8 | Reference compound |
| HY-146339 | HIV-1 inhibitor-27 | 2302046-54-2 | Reference compound |
| HY-146341 | FAAH-IN-5 | 1338575-38-4 | Reference compound |
| HY-146342 | FAAH/MAGL-IN-3 | 2848719-34-4 | Reference compound |
| HY-146343 | BMI-Glu | Dye Reagents | |
| HY-146344 | Antiviral agent 17 | 158227-81-7 | Reference compound |
| HY-146344R | Antiviral agent 17 (Standard) | 158227-81-7 | Reference Standards |
| HY-146345 | Antiviral agent 18 | 2170185-97-2 | Reference compound |
| HY-146346 | HD-TAC7 | 2978763-95-8 | Reference compound |
| HY-146347 | MAO-B-IN-10 | 2376710-36-8 | Reference compound |
| HY-146348 | Tuberculosis inhibitor 5 | Reference compound | |
| HY-146349 | PROTAC EGFR degrader 4 | 2882845-50-1 | Reference compound |
| HY-146350 | TrxR-IN-4 | 2414906-32-2 | Reference compound |
| HY-146351 | HDAC-IN-38 | 2408123-36-2 | Reference compound |
| HY-146352 | HIV-1 inhibitor-28 | 2642218-07-1 | Reference compound |
| HY-146353 | HIV-1 inhibitor-29 | 2642217-95-4 | Reference compound |
| HY-146354 | Antiproliferative agent-4 | Reference compound | |
| HY-146355 | hCAII-IN-2 | 2408599-78-8 | Reference compound |
| HY-146356 | Adenylyl cyclase type 2 agonist-1 | 2414908-52-2 | Reference compound |
| HY-146357 | Anticancer agent 48 | 2395009-13-7 | Reference compound |
| HY-146358 | Anticancer agent 49 | 2395009-34-2 | Reference compound |
| HY-146362 | Tubulin polymerization-IN-17 | 2454175-89-2 | Reference compound |
| HY-146363 | HIV-IN-4 | 2408729-03-1 | Reference compound |
| HY-146364 | CI-39 | 2132412-25-8 | Natural Products |
| HY-146365 | HIV-1 inhibitor-30 | 2132412-77-0 | Reference compound |
| HY-146366 | Tubulin inhibitor 26 | 2379241-70-8 | Reference compound |
| HY-146367 | VEGFR-2-IN-19 | 2456315-41-4 | Reference compound |
| HY-146368 | PROTAC VEGFR-2 degrader-1 | 2601594-19-6 | Reference compound |
| HY-146369 | PROTAC VEGFR-2 degrader-2 | 2353417-85-1 | Reference compound |
| HY-146370 | COX-2-IN-12 | 2986222-50-6 | Reference compound |
| HY-146371 | COX-2-IN-13 | 2987588-45-2 | Reference compound |
| HY-146372 | CXCR4 antagonist 5 | 2304749-86-6 | Reference compound |
| HY-146373 | Antibacterial agent 95 | 2413006-48-9 | Reference compound |
| HY-146374 | Antibacterial agent 96 | 2413006-62-7 | Reference compound |
| HY-146375 | UniPR505 | 2938227-14-4 | Reference compound |
| HY-146376 | Tubulin polymerization-IN-18 | 1258011-23-2 | Reference compound |
| HY-146377 | Tubulin polymerization-IN-19 | 2340345-85-7 | Reference compound |
| HY-146378 | Tubulin polymerization-IN-20 | 2410619-45-1 | Reference compound |
| HY-146379 | SARS-CoV-2-IN-19 | 2244991-17-9 | Reference compound |
| HY-146380 | S1427 | 2447061-40-5 | Reference compound |
| HY-146381 | SARS-CoV-2-IN-20 | 1260244-33-4 | Reference compound |
| HY-146382 | WRNA10 | 1174719-68-6 | Reference compound |
| HY-146383 | H3R antagonist 2 | 2970985-05-6 | Reference compound |
| HY-146384 | CRM1 degrader 1 | 2986647-41-8 | Reference compound |
| HY-146385 | hCAI/II-IN-1 | 2422028-82-6 | Reference compound |
| HY-146386 | SIRT5 inhibitor 2 | 340306-87-8 | Reference compound |
| HY-146387 | SIRT5 inhibitor 3 | 2128651-12-5 | Reference compound |
| HY-146388 | Mtb ATP synthase-IN-1 | 2642394-38-3 | Reference compound |
| HY-146389 | Anticancer agent 50 | 2487457-15-6 | Reference compound |
| HY-146390 | Antiproliferative agent-5 | 2459892-41-0 | Reference compound |
| HY-146391 | P-gp inhibitor 4 | 2652001-05-1 | Reference compound |
| HY-146392 | HDAC-IN-39 | 2414046-33-4 | Reference compound |
| HY-146393 | PROTAC CYP1B1 degrader-1 | 2411389-67-6 | Reference compound |
| HY-146394 | HBV-IN-22 | 2338573-94-5 | Reference compound |
| HY-146395 | HBV-IN-23 | 2413649-89-3 | Reference compound |
| HY-146396 | Anticancer agent 51 | 2521777-38-6 | Reference compound |
| HY-146397 | TD-802 | 2760703-21-5 | Reference compound |
| HY-146398 | AMPK activator 6 | 189299-03-4 | Reference compound |
| HY-146399 | AChE/BChE-IN-9 | 2761542-55-4 | Reference compound |
| HY-146400 | Antibacterial agent 97 | 1714961-61-1 | Reference compound |
| HY-146401 | CXCR4 antagonist 6 | 2304750-68-1 | Reference compound |
| HY-146403 | Antibacterial agent 98 | 2408695-41-8 | Reference compound |
| HY-146404 | T761-0184 | 1340907-57-4 | Reference compound |
| HY-146405 | nAChR antagonist 1 | 2987393-37-1 | Reference compound |
| HY-146406 | Anticancer agent 52 | 2388983-64-8 | Reference compound |
| HY-146407 | Anticancer agent 53 | 1926985-18-3 | Reference compound |
| HY-146408 | ALK-IN-21 | 2901889-01-6 | Reference compound |
| HY-146409 | Antitumor agent-59 | 2409952-04-9 | Reference compound |
| HY-146410 | AT2R antagonist 1 | 2709031-17-2 | Reference compound |
| HY-146411 | microRNA-21-IN-1 | 2848720-31-8 | Reference compound |
| HY-146412 | Vanin-1-IN-3 | 2940964-70-3 | Reference compound |
| HY-146413 | HF50731 | 2484771-19-7 | Reference compound |
| HY-146414 | Antitumor photosensitizer-1 | 2344751-89-7 | Reference compound |
| HY-146416 | Antitumor photosensitizer-2 | 2344751-92-2 | Reference compound |
| HY-146417 | Antiviral agent 19 | 1807887-16-6 | Reference compound |
| HY-146418 | Antiviral agent 20 | 2407570-07-2 | Reference compound |
| HY-146419 | Anti-inflammatory agent 20 | 2127403-65-8 | Reference compound |
| HY-146420 | GRP78-IN-2 | 1882875-63-9 | Reference compound |
| HY-146421 | Anti-inflammatory agent 21 | 2408836-40-6 | Reference compound |
| HY-146422 | PROTAC EGFR degrader 5 | 2409793-36-6 | Reference compound |
| HY-146423 | PROTAC EGFR degrader 6 | 2409793-28-6 | Reference compound |
| HY-146424 | OBHS | 870614-18-9 | Reference compound |
| HY-146426 | MraY-IN-2 | Reference compound | |
| HY-146427 | Antifungal agent 29 | Reference compound | |
| HY-146428 | Anti-MRSA agent 4 | Reference compound | |
| HY-146429 | NaPi2b-IN-3 | 2227443-66-3 | Reference compound |
| HY-146431 | AT1R antagonist 1 | 2848719-80-0 | Reference compound |
| HY-146432 | Antitumor agent-60 | 865784-65-2 | Reference compound |
| HY-146433 | Anticancer agent 55 | 2408800-91-7 | Reference compound |
| HY-146434 | TGFβ-IN-2 | 2387678-02-4 | Reference compound |
| HY-146435 | Anti-inflammatory agent 22 | 2721484-76-8 | Reference compound |
| HY-146436 | AT1R antagonist 2 | 2848719-76-4 | Reference compound |
| HY-146437 | Topoisomerase I inhibitor 6 | 2393082-56-7 | Reference compound |
| HY-146438 | PPARγ agonist 3 | 2011801-48-0 | Reference compound |
| HY-146439 | PPARγ agonist 4 | 2380227-06-3 | Reference compound |
| HY-14644 | Apilimod | 541550-19-0 | Reference compound |
| HY-146440 | LSD1/ER-IN-1 | Reference compound | |
| HY-146441 | Prohibitin ligand 1 | Reference compound | |
| HY-146442 | BRAF V600E/CRAF-IN-1 | 2499499-56-6 | Reference compound |
| HY-146443 | BRAF V600E/CRAF-IN-2 | 2499499-62-4 | Reference compound |
| HY-146444 | Anticancer agent 56 | 2241915-59-1 | Reference compound |
| HY-146445 | P300 bromodomain-IN-1 | Reference compound | |
| HY-146446 | PXYC1 | 865098-81-3 | Reference compound |
| HY-146446R | PXYC1 (Standard) | 865098-81-3 | Reference Standards |
| HY-146447 | PXYC13 | 1031940-69-8 | Reference compound |
| HY-146448 | PXYD3 | 2680554-46-3 | Reference compound |
| HY-146449 | PXYD4 | 2712534-78-4 | Reference compound |
| HY-14644A | Apilimod (mesylate) | 870087-36-8 | Reference compound |
| HY-14644B | Apilimod (hydrochloride) | 870087-37-9 | Reference compound |
| HY-14645 | (-)-DHMEQ | 287194-40-5 | Reference compound |
| HY-146450 | PXYC2 | 865101-22-0 | Reference compound |
| HY-146451 | PXYC12 | 1112415-91-4 | Reference compound |
| HY-146452 | Anticancer agent 57 | 2408017-71-8 | Reference compound |
| HY-146453 | TGR5 Receptor Agonist 3 | 2643391-08-4 | Reference compound |
| HY-146454 | Antiproliferative agent-6 | 2389016-82-2 | Reference compound |
| HY-146455 | DPP-4-IN-3 | 2402735-14-0 | Reference compound |
| HY-146456 | A1AR antagonist 3 | 2413257-73-3 | Reference compound |
| HY-146457 | A3AR antagonist 1 | 2413257-74-4 | Reference compound |
| HY-146458 | Antibacterial agent 102 | 2413293-65-7 | Reference compound |
| HY-146459 | Akt1-IN-1 | Reference compound | |
| HY-14645A | (+)-DHMEQ | 287194-41-6 | Reference compound |
| HY-14645B | DHMEQ (racemate) | 287194-38-1 | Reference compound |
| HY-146460 | Antimicrobial agent-2 | 2412592-33-5 | Reference compound |
| HY-146461 | Anticancer agent 58 | Reference compound | |
| HY-146462 | Anticancer agent 59 | 2366170-11-6 | Reference compound |
| HY-146463 | NusB-IN-1 | 2923738-92-3 | Reference compound |
| HY-146464 | Antifungal agent 30 | 2422019-91-6 | Reference compound |
| HY-146465 | Anticancer agent 60 | 2162169-14-2 | Reference compound |
| HY-146466 | Anticancer agent 61 | 2413148-53-3 | Reference compound |
| HY-146467 | Anticancer agent 62 | 2413148-58-8 | Reference compound |
| HY-146468 | DPP-4/GPR119 modulator 1 | 2411099-68-6 | Reference compound |
| HY-146469 | DPP-4/GPR119 modulator 2 | 2010927-65-6 | Reference compound |
| HY-146470 | Antibacterial agent 103 | 2396409-46-2 | Reference compound |
| HY-146471 | EGFR-IN-51 | 2418549-32-1 | Reference compound |
| HY-146472 | EGFR-IN-52 | 454436-75-0 | Reference compound |
| HY-146473 | EGFR-IN-53 | 2418549-33-2 | Reference compound |
| HY-146474 | EGFR-IN-54 | 2418549-30-9 | Reference compound |
| HY-146475 | KRAS inhibitor-17 | 2230873-65-9 | Reference compound |
| HY-146476 | KRAS inhibitor-18 | 2230873-66-0 | Reference compound |
| HY-146477S | Hydroxy Bezafibrate-d6 | 2673270-01-2 | Isotope-Labeled Compounds |
| HY-146478 | A1/A3 AR antagonist 1 | 312929-49-0 | Reference compound |
| HY-146479 | A1/A3 AR antagonist 2 | 2408833-02-1 | Reference compound |
| HY-14648 | Dexamethasone | 50-02-2 | Reference compound |
| HY-146480 | PPARγ agonist 5 | 915124-86-6 | Reference compound |
| HY-146481S | Lansoprazole sulfone N-oxide-d4 | 1190009-70-1 | Isotope-Labeled Compounds |
| HY-146482 | PPARγ agonist 6 | 2428742-08-7 | Reference compound |
| HY-146483 | Anti-Aβ agent 1A | 2313346-53-9 | Reference compound |
| HY-146484S | Flunisolide acetate-d6 | Isotope-Labeled Compounds | |
| HY-146485S | Fulvestrant-9-sulfone-d3 | Isotope-Labeled Compounds | |
| HY-146486 | P2Y2R/GPR17 antagonist 1 | 2395016-49-4 | Reference compound |
| HY-146487 | Anti-infective agent 1 | 2348-77-8 | Reference compound |
| HY-146488 | Anti-infective agent 2 | 2521629-84-3 | Reference compound |
| HY-146489 | Anti-infective agent 3 | 2521629-86-5 | Reference compound |
| HY-14648A | Dexamethasone acetate | 1177-87-3 | Reference compound |
| HY-14648AR | Dexamethasone acetate (Standard) | 1177-87-3 | Reference Standards |
| HY-14648C | Dexamethasone (Water Soluble) | 50-02-2 | Reference compound |
| HY-14648G | Dexamethasone (GMP) | 50-02-2 | GMP Small Molecules |
| HY-14648R | Dexamethasone (Standard) | 50-02-2 | Reference Standards |
| HY-14648S | Dexamethasone-d5 | 358731-91-6 | Isotope-Labeled Compounds |
| HY-14648S1 | Dexamethasone-d5-1 | Isotope-Labeled Compounds | |
| HY-14648S2 | Dexamethasone-d4 | 2305607-27-4 | Isotope-Labeled Compounds |
| HY-14648S3 | Dexamethasone-4,6α,21,21-d4 | 2483831-63-4 | Isotope-Labeled Compounds |
| HY-14648S5 | Dexamethasone-d3-1 | Isotope-Labeled Compounds | |
| HY-14649 | Retinoic acid | 302-79-4 | Natural Products |
| HY-146491 | VEGFR-2/BRAF-IN-1 | Reference compound | |
| HY-146492 | VEGFR-2/BRAF-IN-2 | Reference compound | |
| HY-146494 | Androgen receptor antagonist 5 | 2586195-28-8 | Reference compound |
| HY-146495 | Antitubercular agent-19 | 2248171-05-1 | Reference compound |
| HY-146496 | Antitubercular agent-20 | 2413124-92-0 | Reference compound |
| HY-146497 | Topoisomerase I inhibitor 7 | 2408639-81-4 | Reference compound |
| HY-146498 | Antiplatelet agent 1 | 2493297-12-2 | Reference compound |
| HY-146499 | Antiplatelet agent 2 | 1395047-93-4 | Reference compound |
| HY-14649G | Retinoic acid (GMP) | 302-79-4 | GMP Small Molecules |
| HY-14649R | Retinoic acid (Standard) | 302-79-4 | Reference Standards |
| HY-14649S2 | 11-cis-Retinoic Acid-d5 | Isotope-Labeled Compounds | |
| HY-14649S3 | Retinoic acid-d6 | 2483831-72-5 | Isotope-Labeled Compounds |
| HY-14649S4 | Retinoic acid-d5 | 78996-15-3 | Isotope-Labeled Compounds |
| HY-14649S5 | Retinoic acid-d3 | 154461-49-1 | Isotope-Labeled Compounds |
| HY-14649S6 | Retinoic acid-d3-1 | 3041101-53-2 | Isotope-Labeled Compounds |
| HY-14650 | DHEA | 53-43-0 | Natural Products |
| HY-146501 | PARP10/15-IN-2 | 2892064-99-0 | Reference compound |
| HY-146502 | PARP10/15-IN-3 | 2892064-88-7 | Reference compound |
| HY-146503 | Antibacterial agent 86 | 2807530-12-5 | Reference compound |
| HY-146504 | Topoisomerase I/II inhibitor 3 | 2770804-74-3 | Reference compound |
| HY-146505 | Tubulin polymerization-IN-6 | 2768613-52-9 | Reference compound |
| HY-146506 | isoCA-4 | 1067880-31-2 | Reference compound |
| HY-14650R | DHEA (Standard) | 53-43-0 | Natural Products |
| HY-146511 | Anticancer agent 41 | 1394077-28-1 | Reference compound |
| HY-146516 | Anticancer agent 42 | 2687265-18-3 | Reference compound |
| HY-146517 | Orexin receptor antagonist 4 | 2251017-69-1 | Reference compound |
| HY-146518 | TRK-IN-13 | 1365221-52-8 | Reference compound |
| HY-146519 | TRK-IN-14 | 1365212-84-5 | Reference compound |
| HY-14652 | Tamibarotene | 94497-51-5 | Reference compound |
| HY-146521 | TRK-IN-15 | 1365213-20-2 | Reference compound |
| HY-146522 | TRK-IN-16 | 1365212-81-2 | Reference compound |
| HY-146523 | TRK-IN-17 | 2409544-80-3 | Reference compound |
| HY-146524 | TRK-IN-18 | 2412008-91-2 | Reference compound |
| HY-146525S | Docusate-d34 (sodium) | 175736-89-7 | Isotope-Labeled Compounds |
| HY-146527 | c-ABL-IN-2 | 2574593-54-5 | Reference compound |
| HY-146528 | c-ABL-IN-3 | 2626934-64-1 | Reference compound |
| HY-14653 | Amsilarotene | 125973-56-0 | Reference compound |
| HY-146530 | c-ABL-IN-4 | 2626934-68-5 | Reference compound |
| HY-146533 | KRAS inhibitor-12 | 2230874-00-5 | Reference compound |
| HY-146534S | Diazinon-d10 | 100155-47-3 | Isotope-Labeled Compounds |
| HY-146537 | KRAS G12C inhibitor 47 | 2253119-24-1 | Reference compound |
| HY-146539 | HDAC-IN-35 | Reference compound | |
| HY-14654 | Aspirin | 50-78-2 | Reference compound |
| HY-146540 | GEM-5 | 2233543-49-0 | Reference compound |
| HY-146541 | FGFR4-IN-10 | 2857862-25-8 | Reference compound |
| HY-146543 | KRAS inhibitor-13 | 2230873-96-6 | Reference compound |
| HY-146544 | KRAS inhibitor-14 | 2230873-78-4 | Reference compound |
| HY-146545 | KRAS inhibitor-15 | 2230873-75-1 | Reference compound |
| HY-146546 | KRAS inhibitor-16 | 2230873-67-1 | Reference compound |
| HY-146547 | Anti-inflammatory agent 17 | 2763226-84-0 | Reference compound |
| HY-146548 | Anticancer agent 43 | 2470015-35-9 | Reference compound |
| HY-146549 | RmlA-IN-1 | 1415030-78-2 | Reference compound |
| HY-14654A | Aspirin (lithium) | 552-98-7 | Reference compound |
| HY-14654B | Aspirin (DL-lysine) | 62952-06-1 | Reference compound |
| HY-14654C | Aspirin (calcium) | 69-46-5 | Reference compound |
| HY-14654R | Aspirin (Standard) | 50-78-2 | Reference Standards |
| HY-14654S | Aspirin-d3 | 921943-73-9 | Isotope-Labeled Compounds |
| HY-14654S1 | Aspirin-d4 | 97781-16-3 | Isotope-Labeled Compounds |
| HY-14655 | Sulfasalazine | 599-79-1 | Reference compound |
| HY-146551 | RmlA-IN-2 | 2866140-40-9 | Reference compound |
| HY-146552 | PDHK-IN-4 | Reference compound | |
| HY-146554 | PDHK-IN-5 | Reference compound | |
| HY-146555 | Antitubercular agent-14 | 2408627-49-4 | Reference compound |
| HY-146556 | Antitubercular agent-15 | Reference compound | |
| HY-146557 | Antitubercular agent-16 | Reference compound | |
| HY-14655R | Sulfasalazine (Standard) | 599-79-1 | Reference Standards |
| HY-14655S | Sulfasalazine-d4 | 1346606-50-5 | Isotope-Labeled Compounds |
| HY-14655S1 | Sulfasalazine-d3,15N | Isotope-Labeled Compounds | |
| HY-14656 | Diltiazem (hydrochloride) | 33286-22-5 | Reference compound |
| HY-146560 | Xanthine oxidase-IN-6 | Reference compound | |
| HY-146561 | S-HP210 | Reference compound | |
| HY-146564 | R-HP210 | Reference compound | |
| HY-146564A | HP210 | 728039-52-9 | Reference compound |
| HY-146565 | DNA-PK-IN-8 | 2823369-81-7 | Reference compound |
| HY-146566 | DNA-PK-IN-9 | Reference compound | |
| HY-14656R | Diltiazem (hydrochloride) (Standard) | 33286-22-5 | Reference Standards |
| HY-14656S | Diltiazem-d3 (hydrochloride) | 1217623-80-7 | Isotope-Labeled Compounds |
| HY-14656S1 | Diltiazem-(acetoxy-d3) (hydrochloride) | 1217860-13-3 | Isotope-Labeled Compounds |
| HY-14656S2 | Diltiazem-d6 (hydrochloride) | 1309283-34-8 | Isotope-Labeled Compounds |
| HY-14656S3 | Diltiazem-d5 (hydrochloride) | 2012598-70-6 | Isotope-Labeled Compounds |
| HY-14657 | Dantrolene (sodium) | 14663-23-1 | Reference compound |
| HY-146573 | AKR1C3-IN-6 | 2137881-54-8 | Reference compound |
| HY-146574 | AKR1C3-IN-7 | Reference compound | |
| HY-146575 | AKR1C3-IN-8 | Reference compound | |
| HY-146577 | Keap1-Nrf2-IN-7 | 2769963-42-8 | Reference compound |
| HY-146578 | Keap1-Nrf2-IN-8 | 2769963-54-2 | Reference compound |
| HY-14658 | Thalidomide | 50-35-1 | Reference compound |
| HY-146580 | Cathepsin C-IN-3 | 2825567-71-1 | Reference compound |
| HY-146581 | Cathepsin C-IN-4 | 2825567-86-8 | Reference compound |
| HY-146584 | Cathepsin C-IN-5 | 2825567-97-1 | Reference compound |
| HY-146586 | Haspin-IN-1 | 2768474-30-0 | Reference compound |
| HY-146587 | Haspin-IN-2 | 2768474-47-9 | Reference compound |
| HY-146588 | NMDA receptor antagonist 4 | 1607589-56-9 | Reference compound |
| HY-14658A | (S)-Thalidomide | 841-67-8 | Reference compound |
| HY-14658B | (R)-Thalidomide | 2614-06-4 | Reference compound |
| HY-14658R | Thalidomide (Standard) | 50-35-1 | Reference Standards |
| HY-14658S | Thalidomide-d4 | 1219177-18-0 | Isotope-Labeled Compounds |
| HY-146591 | Antibacterial agent 87 | 2798821-48-2 | Reference compound |
| HY-146593 | Antibacterial agent 88 | 2798821-49-3 | Reference compound |
| HY-146594 | NLRP3-IN-8 | 2768650-56-0 | Reference compound |
| HY-146595 | FtsZ-IN-1 | 2516246-24-3 | Reference compound |
| HY-146596 | Axl-IN-5 | 2642224-24-4 | Reference compound |
| HY-14660 | Dabrafenib | 1195765-45-7 | Reference compound |
| HY-146600S | Hydroxyfenbendazole-d3 | 1596803-40-5 | Isotope-Labeled Compounds |
| HY-146604S | Desisopropylatrazine-d5 | 1189961-78-1 | Isotope-Labeled Compounds |
| HY-14660A | Dabrafenib (Mesylate) | 1195768-06-9 | Reference compound |
| HY-14660R | Dabrafenib (Standard) | 1195765-45-7 | Reference Standards |
| HY-14660S | Dabrafenib-d9 | 1423119-98-5 | Isotope-Labeled Compounds |
| HY-14661 | SB-743921 (free base) | 618430-39-0 | Reference compound |
| HY-146615 | Axl-IN-6 | 2642224-22-2 | Reference compound |
| HY-146616 | GLS1 Inhibitor-3 | 2435781-94-3 | Reference compound |
| HY-146617 | GLS1 Inhibitor-4 | 2768599-97-7 | Reference compound |
| HY-146619 | RAGE/SERT-IN-1 | 2766739-35-7 | Reference compound |
| HY-146626S | 1,3,5(10)-Estratriene-17α-ethyl-3,17β-diol 3-methyl ether-d5 | Isotope-Labeled Compounds | |
| HY-146627S | 5-Cholesten-24(RS)-methyl-3β-ol-d3 | Isotope-Labeled Compounds | |
| HY-146628S | 5-Hydroxy-L-tryptophan-4,6,7-d3 | Isotope-Labeled Compounds | |
| HY-146629S | 4-Methoxy estrone-d4 | Isotope-Labeled Compounds | |
| HY-146630S | 17β-Dihydroequilenin-4,16,16-d3 | 1276056-90-6 | Isotope-Labeled Compounds |
| HY-146631S | 4-Hydroxy-17β-estradiol-1,2,16,16,17-d5 | 221093-38-5 | Isotope-Labeled Compounds |
| HY-146633S | 24(RS)-Hydroxycholesterol-d7 | 144154-78-9 | Isotope-Labeled Compounds |
| HY-146635S | (25RS)-26-Hydroxycholesterol-d4 | Isotope-Labeled Compounds | |
| HY-146636 | Haspin-IN-3 | 2416569-95-2 | Reference compound |
| HY-146637 | VIM-2-IN-1 | 2452118-54-4 | Reference compound |
| HY-146638S | 5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5-d4 | 252976-11-7 | Isotope-Labeled Compounds |
| HY-14664 | Fluvastatin | 93957-54-1 | Reference compound |
| HY-146643 | sEH inhibitor-3 | 1809885-35-5 | Reference compound |
| HY-146646 | Bleomycin A2 | 41432-97-7 | Reference compound |
| HY-146647S | Cholesta-3,5-diene-7-one-25,26,26,26,27,27,27-d7 | Isotope-Labeled Compounds | |
| HY-146648 | Cyclophilin inhibitor 3 | 1676100-30-3 | Reference compound |
| HY-146649 | LmCPB-IN-1 | 2151025-98-6 | Reference compound |
| HY-14664A | Fluvastatin (sodium) | 93957-55-2 | Reference compound |
| HY-14664AR | Fluvastatin (sodium) (Standard) | 93957-55-2 | Reference Standards |
| HY-14664AS | Fluvastatin-d6 (sodium) | Isotope-Labeled Compounds | |
| HY-14664B | (3R,5S)-Fluvastatin | 155229-75-7 | Reference compound |
| HY-14664C | (3S,5R)-Fluvastatin (sodium) | 94061-81-1 | Reference compound |
| HY-14664CS | (3S,5R)-Fluvastatin-d6 (sodium) | 2249799-35-5 | Isotope-Labeled Compounds |
| HY-14664D | Fluvastatin (sodium monohydrate) | 201541-53-9 | Reference compound |
| HY-14664DS | (3S,5R)-Fluvastatin-d6 | 2249799-34-4 | Isotope-Labeled Compounds |
| HY-14664F | (3R,5S)-Fluvastatin (sodium) | 94061-80-0 | Reference compound |
| HY-146650 | LpxC-IN-9 | 2756125-46-7 | Reference compound |
| HY-146651 | MPO-IN-4 | 2088545-68-8 | Reference compound |
| HY-146652 | UGM-IN-3 | 2254751-04-5 | Reference compound |
| HY-146653 | Glyoxalase I inhibitor 1 | 1622952-07-1 | Reference compound |
| HY-146654 | Glyoxalase I inhibitor 2 | 2314467-61-1 | Reference compound |
| HY-146655 | Glyoxalase I inhibitor 3 | 1415388-25-8 | Reference compound |
| HY-146656 | Glyoxalase I inhibitor 4 | 250155-72-7 | Reference compound |
| HY-146656S | S-Sulfo-DL-cysteine-2,3,3-d3 | 2687960-80-9 | Isotope-Labeled Compounds |
| HY-146657 | 4BAB | 828262-76-6 | Reference compound |
| HY-146658 | Glutaminase-IN-4 | 1439390-05-2 | Reference compound |
| HY-146659S | S-Phenyl-DL-cysteine-3,3-d2 | Isotope-Labeled Compounds | |
| HY-146660 | BRD4 Inhibitor-18 | 2451219-73-9 | Reference compound |
| HY-146661 | Aldose reductase-IN-4 | 2446136-17-8 | Reference compound |
| HY-146662 | HPGDS inhibitor 3 | 2255311-93-2 | Reference compound |
| HY-146663 | AChE/BChE-IN-3 | 2410992-65-1 | Reference compound |
| HY-146663A | AChE/BChE-IN-3 (hydrochloride) | 2410992-69-5 | Reference compound |
| HY-146664 | AChE/BChE-IN-4 | 2294963-47-4 | Reference compound |
| HY-146665 | AChE/BChE-IN-5 | 2410992-68-4 | Reference compound |
| HY-146666 | STAT3-IN-9 | 2987726-27-0 | Reference compound |
| HY-146667 | POP-IN-1 | 2743432-99-5 | Reference compound |
| HY-146668 | AChE/BChE-IN-8 | 2421120-96-7 | Reference compound |
| HY-146669 | BChE-IN-6 | 2421121-10-8 | Reference compound |
| HY-14667 | Lomitapide | 182431-12-5 | Reference compound |
| HY-146670 | KDM5B-IN-3 | 1385101-10-9 | Reference compound |
| HY-146671 | ITK inhibitor 5 | 2404603-41-2 | Reference compound |
| HY-146672 | ITK inhibitor 6 | 2404604-06-2 | Reference compound |
| HY-146673 | IDO1/TDO-IN-2 | 5466-47-7 | Reference compound |
| HY-146674 | IDO1/TDO-IN-3 | 2347579-03-5 | Reference compound |
| HY-146676 | UR-MB108 | 2412461-98-2 | Reference compound |
| HY-146677 | 5-HT6R/MAO-B modulator 1 | 2986222-45-9 | Reference compound |
| HY-146678 | HDAC6-IN-5 | 2413603-15-1 | Reference compound |
| HY-146679 | HDAC6-IN-6 | 2413603-10-6 | Reference compound |
| HY-14667S | Lomitapide-d8 | 2459377-96-7 | Isotope-Labeled Compounds |
| HY-14667S1 | Lomitapide-d4 | 857296-42-5 | Isotope-Labeled Compounds |
| HY-14668 | Lomitapide (mesylate) | 202914-84-9 | Reference compound |
| HY-146680 | FLT3/ITD-IN-4 | 2278278-04-7 | Reference compound |
| HY-146681 | PAK1-IN-1 | 2485732-30-5 | Reference compound |
| HY-146682 | KS100 | 2408477-54-1 | Reference compound |
| HY-146683 | KS106 | 2408477-50-7 | Reference compound |
| HY-146684 | HDAC-IN-36 | 2482992-54-9 | Reference compound |
| HY-146686 | BuChE-IN-3 | 2499488-78-5 | Reference compound |
| HY-146687 | BuChE-IN-4 | 2499490-52-5 | Reference compound |
| HY-146688 | SYN20028567 | 1214563-94-6 | Reference compound |
| HY-146689 | SIRT1-IN-2 | 2470969-89-0 | Reference compound |
| HY-14669 | Niraxostat | 206884-98-2 | Reference compound |
| HY-146690 | SIRT1-IN-3 | 2470969-91-4 | Reference compound |
| HY-146691 | hMAO-B-IN-2 | 2454459-87-9 | Reference compound |
| HY-146692 | IQTub4P | 2376321-67-2 | Reference compound |
| HY-146693 | CJJ300 | 1807631-83-9 | Reference compound |
| HY-146694 | RIPK2-IN-1 | 2245820-70-4 | Reference compound |
| HY-146695 | S100P-IN-1 | 690991-06-1 | Reference compound |
| HY-146696 | mEH-IN-1 | 2418576-06-2 | Reference compound |
| HY-146697 | IHMT-TRK-284 | 2416844-79-4 | Reference compound |
| HY-146699 | MtTMPK-IN-5 | 2987763-18-6 | Reference compound |
| HY-14670 | Firocoxib | 189954-96-9 | Reference compound |
| HY-146700 | MtTMPK-IN-6 | 2225885-99-2 | Reference compound |
| HY-146701 | MtTMPK-IN-7 | 2987482-25-5 | Reference compound |
| HY-146702 | MtTMPK-IN-8 | 2990619-92-4 | Reference compound |
| HY-146703 | MtTMPK-IN-9 | 2987299-68-1 | Reference compound |
| HY-146704 | COX-2/sEH-IN-1 | 2474977-38-1 | Reference compound |
| HY-146705 | PqsR-IN-1 | 1333636-58-0 | Reference compound |
| HY-146706 | PqsR-IN-2 | 2982271-63-4 | Reference compound |
| HY-146708S | ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-15N4 (sodium) | 1257650-86-4 | Isotope-Labeled Compounds |
| HY-146709 | BET bromodomain inhibitor 2 | 2414195-69-8 | Reference compound |
| HY-14670R | Firocoxib (Standard) | 189954-96-9 | Reference Standards |
| HY-14670S | Firocoxib-d4 | 1325700-11-5 | Isotope-Labeled Compounds |
| HY-146710 | RET-IN-16 | 2259657-48-0 | Reference compound |
| HY-146711 | Tubulin inhibitor 24 | 2415761-65-6 | Reference compound |
| HY-146712S | N-(4-Hydroxyphenyl)acetamide sulfate-d3 (sodium) | 2733160-80-8 | Isotope-Labeled Compounds |
| HY-146713S | (±)-7-Methyl-nonanoic acid-d3 | 2708280-22-0 | Isotope-Labeled Compounds |
| HY-146715 | IDO/Tubulin-IN-2 | 2409479-24-7 | Reference compound |
| HY-146716S | N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d3 (dicyclohexylamine) | Isotope-Labeled Compounds | |
| HY-146717S | N-Acetyl-S-(3-hydroxypropyl)-L-cysteine-d6 (dicyclohexylamine) | Isotope-Labeled Compounds | |
| HY-146718 | Tubulin polymerization-IN-9 | 2485020-93-5 | Reference compound |
| HY-146719S | Nalpha-Acetyl-DL-glutamine-2,3,3,4,4-d5 | 14341-82-3 | Isotope-Labeled Compounds |
| HY-14672 | Soblidotin | 149606-27-9 | Reference compound |
| HY-146721S | Epicholesterol-2,2,3,4,4,6-d6 | 92543-07-2 | Isotope-Labeled Compounds |
| HY-146722 | Antibacterial agent 89 | 2589639-87-0 | Reference compound |
| HY-146723 | IKKβ-IN-1 | 2410423-31-1 | Reference compound |
| HY-146724 | Dot1L-IN-7 | 2580940-76-5 | Reference compound |
| HY-146725 | FBPase-IN-1 | 20362-54-3 | Reference compound |
| HY-146726S | pentadecanoate-d29 | 352431-43-7 | Isotope-Labeled Compounds |
| HY-146727 | JAK3-IN-11 | 2412734-00-8 | Reference compound |
| HY-146728 | STAT3-IN-10 | 2499491-04-0 | Reference compound |
| HY-146729 | ASK1-IN-3 | 2426705-19-1 | Reference compound |
| HY-146731 | PPARγ agonist 1 | 3032632-09-7 | Reference compound |
| HY-146732S | Acetyl-L-threonine-d5 | Isotope-Labeled Compounds | |
| HY-146733 | PPARα agonist 1 | 3032632-02-0 | Reference compound |
| HY-146734S | 17β-Dihydroequilenin 3-sulfate-4,16,16-d3 (sodium) | 1276056-91-7 | Isotope-Labeled Compounds |
| HY-146735 | MNK1/2-IN-6 | 2771087-94-4 | Reference compound |
| HY-146736S | 17β-Dihydroequilin 3-sulfate-2,4,16,16-d4 (sodium) | 352431-51-7 | Isotope-Labeled Compounds |
| HY-146737S | Tripentadecanoin-d5 | 1219804-57-5 | Isotope-Labeled Compounds |
| HY-146738 | GSD-11 | Reference compound | |
| HY-146739 | BRD4 Inhibitor-19 | 2757865-63-5 | Reference compound |
| HY-14674 | CP-724714 | 383432-38-0 | Reference compound |
| HY-146740 | PD-1/PD-L1-IN-27 | 2891831-47-1 | Reference compound |
| HY-146741 | SDR-04 | 879593-54-1 | Reference compound |
| HY-146742 | PPARγ agonist 2 | 3024531-27-6 | Reference compound |
| HY-146743 | Antitumor agent-53 | 2757145-67-6 | Reference compound |
| HY-146744 | Antileishmanial agent-4 | 2922333-23-9 | Reference compound |
| HY-146745 | Antileishmanial agent-5 | 2922333-29-5 | Reference compound |
| HY-146746 | HIV-1 inhibitor-19 | 2649837-82-9 | Reference compound |
| HY-146747 | Antifungal agent 26 | 2769834-78-6 | Reference compound |
| HY-146748 | Sorbicillin | 79950-85-9 | Reference compound |
| HY-146749 | FLT3/TrKA-IN-1 | Reference compound | |
| HY-146750 | HDAC-IN-37 | 2766466-56-0 | Reference compound |
| HY-146751 | PI3K/Akt/mTOR-IN-2 | 2757804-89-8 | Reference compound |
| HY-146752 | α-Amylase-IN-1 | Reference compound | |
| HY-146753 | HIV-1 inhibitor-20 | 2758387-58-3 | Reference compound |
| HY-146754 | MMP2-IN-1 | 2764598-01-6 | Reference compound |
| HY-146755 | TIY-7 | 2846435-83-2 | Reference compound |
| HY-146756 | 22-((4-Methoxyphenyl)urea-1-yl)-22-deoxypleuromutilin | 2780409-77-8 | Reference compound |
| HY-146757 | RIPK1-IN-13 | 1574547-67-3 | Reference compound |
| HY-146758 | RIPK1-IN-14 | 2919964-79-5 | Reference compound |
| HY-146759 | ZM514 | Reference compound | |
| HY-146760S | C15 Glucosyl(β) ceramide-d7 | 2315262-18-9 | Isotope-Labeled Compounds |
| HY-146761S | 3-O-Sulfo-D-galactosyl-β1-1'-N-tridecanoyl-D-erythro-sphingosine-d7 | 2315262-25-8 | Isotope-Labeled Compounds |
| HY-146762 | MAO-B-IN-7 | 2851012-65-0 | Reference compound |
| HY-146763S | N-Tridecanoyl-D-erythro-sphinganine-d7 | 2315262-21-4 | Isotope-Labeled Compounds |
| HY-146764S | D-Lactosyl-β-1,1'-N-pentadecanoyl-D-erythro-sphingosine-d7 | 2315262-20-3 | Isotope-Labeled Compounds |
| HY-146765 | AMS-17 | 3019885-78-7 | Reference compound |
| HY-146766S | D-Galactosyl-β-1,1'-N-tridecanoyl-D-erythro-sphingosine-d7 | 2315262-19-0 | Isotope-Labeled Compounds |
| HY-146767S | (3β,5α,6β)-3,5,6-Trihydroxycholan-24-oic acid-d4 | Isotope-Labeled Compounds | |
| HY-146768S | 24(R/S),25-Epoxycholesterol-d6 | 1246302-86-2 | Isotope-Labeled Compounds |
| HY-146769 | Antimalarial agent 11 | 1214454-56-4 | Reference compound |
| HY-146770S | Dihydro FF-MAS-d6 | 2315262-47-4 | Isotope-Labeled Compounds |
| HY-146772S | 1-(2-Hydrazinyl-2-oxoethyl)pyridin-1-ium-d5 (bromide) | 1579992-96-3 | Isotope-Labeled Compounds |
| HY-146773S | 7α-Hydroxy-3-oxocholest-4-enoic acid-d3 | 2342573-89-9 | Isotope-Labeled Compounds |
| HY-146774S | 14:1 cholesteryl ester-d7 | 2342574-68-7 | Isotope-Labeled Compounds |
| HY-146775S | Dihydro T-MAS-d6 | 2315262-48-5 | Isotope-Labeled Compounds |
| HY-146776S | 5β,6β-Epoxycholestanol-d7 | 127684-06-4 | Isotope-Labeled Compounds |
| HY-146777S | 14-Demethyl-lanosterol-d6 | 1246298-30-5 | Isotope-Labeled Compounds |
| HY-146778 | Tubulin inhibitor 25 | 2411697-71-5 | Reference compound |
| HY-146779S | 16:1 Cholesteryl ester-d7 | 1416275-33-6 | Isotope-Labeled Compounds |
| HY-146780 | TGFβRI-IN-4 | 2421135-03-5 | Reference compound |
| HY-146781S | 20:3 Cholesteryl ester-d7 | 2342574-76-7 | Isotope-Labeled Compounds |
| HY-146782 | EGFR-IN-49 | 2459932-81-9 | Reference compound |
| HY-146783 | ZINC194100678 | 1995025-05-2 | Reference compound |
| HY-146784S | 7α,24(R/S)-Dihydroxycholesterol-d7 | 2260669-20-1 | Isotope-Labeled Compounds |
| HY-146785S | 1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphate-13C16 (sodium) | 2260669-38-1 | Isotope-Labeled Compounds |
| HY-146786 | ZMF-10 | 2415295-37-1 | Reference compound |
| HY-146787S | 7α,24(R/S)-Dihydroxycholestenone-d7 | 2260669-21-2 | Isotope-Labeled Compounds |
| HY-146788S | 7α,27-Dihydroxycholesterol-d6 | 2260669-25-6 | Isotope-Labeled Compounds |
| HY-146789 | PI3Kδ/γ-IN-2 | 2412195-89-0 | Reference compound |
| HY-14679 | GSK3β inhibitor II | 478482-75-6 | Reference compound |
| HY-146790S | 7ß,27-Dihydroxycholesterol-d6 | 2260669-26-7 | Isotope-Labeled Compounds |
| HY-146791S | 1',3'-Bis[1,2-dilinoleoyl-sn-glycero-3-phospho]-glycerol-d5 (ammonium) | 2315262-46-3 | Isotope-Labeled Compounds |
| HY-146792 | PLK1-IN-4 | 2622273-55-4 | Reference compound |
| HY-146793S | 3β-Hydroxy-7-oxocholest-5-enoic acid-d3 | 2342573-92-4 | Isotope-Labeled Compounds |
| HY-146794S | 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphocholine-d7 | 2097561-16-3 | Isotope-Labeled Compounds |
| HY-146795S | 15:0-18:1 DG-d7 | 2097561-14-1 | Isotope-Labeled Compounds |
| HY-146796S | 15:0 Cholesteryl ester-d7 | 2260669-27-8 | Isotope-Labeled Compounds |
| HY-146797S | Cholesteryldocosa-7,10,13,16-tetraenoate-d7 | 2342574-92-7 | Isotope-Labeled Compounds |
| HY-146798S | 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine-d7 | 2097561-15-2 | Isotope-Labeled Compounds |
| HY-146799S | 15:0-18:1-15:0 TG-d7 | 2097561-17-4 | Isotope-Labeled Compounds |
| HY-146800S | 18:1 SM-d9 | 2260669-50-7 | Isotope-Labeled Compounds |
| HY-146801 | PDHK-IN-3 | Reference compound | |
| HY-146802 | NLRP3-IN-9 | 2768759-64-2 | Reference compound |
| HY-146804 | HIV-1 protease-IN-3 | Reference compound | |
| HY-146805 | EB1 | 42951-68-8 | Reference compound |
| HY-146806 | YL93 | 2771313-42-7 | Reference compound |
| HY-146807 | Type II TRK inhibitor 1 | 2937543-72-9 | Reference compound |
| HY-146808 | Galectin-3 antagonist 1 | 2921603-03-2 | Reference compound |
| HY-146809 | Galectin-3 antagonist 2 | 2921603-02-1 | Reference compound |
| HY-146810 | PRMT4-IN-1 | Reference compound | |
| HY-146811 | HSGN-94 | 2570797-85-0 | Reference compound |
| HY-146812 | DIZ-3 | 2675490-72-7 | Reference compound |
| HY-146813 | EBOV/MARV-IN-2 | 2687244-84-2 | Reference compound |
| HY-146814 | EBOV/MARV-IN-3 | 2687245-05-0 | Reference compound |
| HY-146815 | CP19 | 1018148-68-9 | Reference compound |
| HY-146816 | NBTIs-IN-6 | 2422893-97-6 | Reference compound |
| HY-146817 | Tubulin polymerization-IN-11 | 2470063-59-1 | Reference compound |
| HY-146818 | Tubulin polymerization-IN-12 | 2377301-45-4 | Reference compound |
| HY-146819 | CAIX/CAXII-IN-1 | 2439165-37-2 | Reference compound |
| HY-14682 | GSK319347A | 862812-98-4 | Reference compound |
| HY-146820S | 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phospho-L-serine-d7 (sodium) | 2260669-40-5 | Isotope-Labeled Compounds |
| HY-146821S | 2,3-Dihydroxypropyl ((R)-2-(oleoyloxy)-3-(pentadecanoyloxy)propyl) phosphate-d7 (sodium) | 2260669-42-7 | Isotope-Labeled Compounds |
| HY-146822S | 6αOH Chol ester-d7 | 2260669-30-3 | Isotope-Labeled Compounds |
| HY-146823S | Desmosterol ester-d6 | 2260669-31-4 | Isotope-Labeled Compounds |
| HY-146824S | 17:0-18:1 PI-d5 (ammonium) | 2342575-35-1 | Isotope-Labeled Compounds |
| HY-146825S | 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphoinositol-d7 (ammonium) | 2260669-44-9 | Isotope-Labeled Compounds |
| HY-146826S | 1,3-16:1 DG-d5 | 1246523-68-1 | Isotope-Labeled Compounds |
| HY-146827S | 17:0-20:3 PI-d5 (ammonium) | 2342575-37-3 | Isotope-Labeled Compounds |
| HY-146828S | CER10-d9 | 2260669-52-9 | Isotope-Labeled Compounds |
| HY-146829S | 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphate-d7 (sodium) | 2260669-46-1 | Isotope-Labeled Compounds |
| HY-146830S | 17:0-22:4 PI-d5 (ammonium) | 2342575-39-5 | Isotope-Labeled Compounds |
| HY-146831S | CER3-d9 | 2260669-53-0 | Isotope-Labeled Compounds |
| HY-146832S | 1,3-17:0 DG-d5 | 1246523-65-8 | Isotope-Labeled Compounds |
| HY-146833S | 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphatidylethanolamine-d7 | 2260669-47-2 | Isotope-Labeled Compounds |
| HY-146834S | 1,3-18:0 DG-d5 | 1246523-69-2 | Isotope-Labeled Compounds |
| HY-146835S | (Rac)-16:0PI(3,5)P2-d5 (ammonium) | 2260669-78-9 | Isotope-Labeled Compounds |
| HY-146836S | (Rac)-16:0 PI(5)P-d5 (ammonium) | Isotope-Labeled Compounds | |
| HY-146836S1 | 16:0 PI(5)P-d5 (ammonium) | 2260669-80-3 | Isotope-Labeled Compounds |
| HY-146836S2 | (Rac)-16:0 PI(5)P-d5 (diammonium) | Isotope-Labeled Compounds | |
| HY-146837S | C18(plasm)-18:1 PE-d9 | 2315262-04-3 | Isotope-Labeled Compounds |
| HY-146838S | 17:0-18:1 PC-d5 | 2342575-55-5 | Isotope-Labeled Compounds |
| HY-146839S | 17:0-16:1 PC-d5 | 2342575-79-3 | Isotope-Labeled Compounds |
| HY-146840S | 17:0-14:1 PC-d5 | Isotope-Labeled Compounds | |
| HY-146841S | 19:0 Lyso PC-d5 | 2342575-08-8 | Isotope-Labeled Compounds |
| HY-146842S | 15:0 Lyso PE-d5 | 2342574-96-1 | Isotope-Labeled Compounds |
| HY-146843S | 17:0 Lyso PE-d5 | 2342575-10-2 | Isotope-Labeled Compounds |
| HY-146844S | 19:0 Lyso PE-d5 | 2342575-09-9 | Isotope-Labeled Compounds |
| HY-146845S | 17:0-22:4 PE-d5 | 2342575-44-2 | Isotope-Labeled Compounds |
| HY-146846S | 17:0-20:3 PE-d5 | 2342575-53-3 | Isotope-Labeled Compounds |
| HY-146847S | 17:0-18:1 PE-d5 | 2342575-56-6 | Isotope-Labeled Compounds |
| HY-146848S | C18(plasm)-18:1 PC-d9 | 2315262-03-2 | Isotope-Labeled Compounds |
| HY-146849S | 17:0-22:4 PC-d5 | 2342575-43-1 | Isotope-Labeled Compounds |
| HY-146850S | 17:0-20:3 PC-d5 | 2342575-54-4 | Isotope-Labeled Compounds |
| HY-146851S | 17:0-16:1 PE-d5 | 2342575-77-1 | Isotope-Labeled Compounds |
| HY-146852S | 17:0-14:1 PE-d5 | 2342575-78-2 | Isotope-Labeled Compounds |
| HY-146853S | 17:0-14:1 PG-d5 | 2342575-74-8 | Isotope-Labeled Compounds |
| HY-146854S | 15:0 Lyso PG-d5 | 2342574-98-3 | Isotope-Labeled Compounds |
| HY-146855S | 19:0 Lyso PG-d5 | 2342575-14-6 | Isotope-Labeled Compounds |
| HY-146856S | 17:0 Lyso PG-d5 | 2342575-16-8 | Isotope-Labeled Compounds |
| HY-146857S | 17:0-22:4 PG-d5 | 2342575-46-4 | Isotope-Labeled Compounds |
| HY-146858S | 17:0-20:3 PG-d5 | 2342575-52-2 | Isotope-Labeled Compounds |
| HY-146859S | 17:0-18:1 PG-d5 | 2342575-59-9 | Isotope-Labeled Compounds |
| HY-146860S | 17:0-16:1 PG-d5 | 2342575-72-6 | Isotope-Labeled Compounds |
| HY-146861S | 1-Pentadecanoyl-2-hydroxy-sn-glycero-3-phospho-L-serine-d5 (sodium) | 2342575-00-0 | Isotope-Labeled Compounds |
| HY-146862S | D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxononadecyl)oxy]propyl-1,1,2,3,3-d5 hydrogen phosphate], ammonium salt (1:1) | 2342575-23-7 | Isotope-Labeled Compounds |
| HY-146863 | Tubulin polymerization-IN-10 | 2238784-19-3 | Reference compound |
| HY-146864S | 1-Nonadecanoyl-2-hydroxy-sn-glycero-3-phospho-L-serine-d5 (sodium) | 2342575-18-0 | Isotope-Labeled Compounds |
| HY-146865S | 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phospho-L-serine-d5 (sodium) | 2342575-21-5 | Isotope-Labeled Compounds |
| HY-146866S | 1-Heptadecanoyl-2-docosatetraenoyl-sn-glycero-3-phospho- L-serine-d5 (sodium) | 2342575-48-6 | Isotope-Labeled Compounds |
| HY-146867S | 1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero-3-phospho- L-serine-d5 (sodium) | 2342575-50-0 | Isotope-Labeled Compounds |
| HY-146868S | 1-Heptadecanoyl-2-oleoyl-sn-glycero-3-phospho- L-serine-d5 (sodium) | 2342575-61-3 | Isotope-Labeled Compounds |
| HY-146869S | 1-Heptadecanoyl-2-palmitoleoyl-sn-glycero-3-phospho- L-serine-d5 (sodium) | 2342575-67-9 | Isotope-Labeled Compounds |
| HY-14687 | (rac)-Talazoparib | 1207454-56-5 | Reference compound |
| HY-146870S | 1-Heptadecanoyl-2-myristoleoyl-sn-glycero-3-phospho- L-serine-d5 (sodium) | 2342575-69-1 | Isotope-Labeled Compounds |
| HY-146871S | D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxopentadecyl)oxy]propyl-1,1,2,3,3-d5 hydrogen phosphate], ammonium salt (1:1) | 2342575-02-2 | Isotope-Labeled Compounds |
| HY-146872S | D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxoheptadecyl)oxy]propyl-1,1,2,3,3-d5 hydrogen phosphate], ammonium salt (1:1) | 2342575-26-0 | Isotope-Labeled Compounds |
| HY-146873S | D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-tetradecen-1-yl]oxy]propyl hydrogen phosphate], ammonium salt (1:1) | 2342575-29-3 | Isotope-Labeled Compounds |
| HY-146874S | D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-hexadecen-1-yl]oxy]propyl hydrogen phosphate], ammonium salt (1:1) | 2342575-32-8 | Isotope-Labeled Compounds |
| HY-146875S | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol-d31 (ammonium) | 799812-61-6 | Isotope-Labeled Compounds |
| HY-146876S | C18:0 GM1 Ganglioside-d5 (ammonium) | 2260669-93-8 | Isotope-Labeled Compounds |
| HY-146877S | 16:0-18:1 PG-d31 | 327178-87-0 | Isotope-Labeled Compounds |
| HY-146878S | 16:0-18:1 PG-d5 | 1246298-34-9 | Isotope-Labeled Compounds |
| HY-146879S | 26:0 Lyso PC-d4 | 1246303-15-0 | Isotope-Labeled Compounds |
| HY-14688 | CEP-8983 | 374071-46-2 | Reference compound |
| HY-146880S | 14:0-14:0 PC-d27 | 185906-02-9 | Isotope-Labeled Compounds |
| HY-146881S | 1-Myristoyl-2-myristoyl-sn-glycero-3-phosphocholine-d27 | 185906-03-0 | Isotope-Labeled Compounds |
| HY-146882S | 16:0-18:1 PE-d31 | 326495-44-7 | Isotope-Labeled Compounds |
| HY-146883 | As-358 | 2222042-47-7 | Reference compound |
| HY-146883A | As-358 (hydrochloride) | 2374723-26-7 | Reference compound |
| HY-146884 | MET kinase-IN-3 | 1446324-02-2 | Reference compound |
| HY-146885S | 16:0-18:1 PS-d31 (sodium) | 327178-96-1 | Isotope-Labeled Compounds |
| HY-146886 | FLT3-IN-15 | 2435562-99-3 | Reference compound |
| HY-146887 | USP7-IN-9 | 2444374-01-8 | Reference compound |
| HY-146888 | HIV-1 protease-IN-2 | 2248124-46-9 | Reference compound |
| HY-146889 | ATX inhibitor 16 | 2484811-36-9 | Reference compound |
| HY-14689 | Ecopipam (hydrochloride) | 190133-94-9 | Reference compound |
| HY-146890 | ATX inhibitor 17 | 2750152-64-6 | Reference compound |
| HY-146891S | 16:0-16:0 PC-d31 | 56952-02-4 | Isotope-Labeled Compounds |
| HY-146892S | 1-Palmitoyl-2-palmitoyl-sn-glycero-3-phosphocholine-d31 | 69285-95-6 | Isotope-Labeled Compounds |
| HY-146893S | 18:0-18:0 PC-d35 | 327178-88-1 | Isotope-Labeled Compounds |
| HY-146894S | 1-Stearoyl-2-stearoyl-sn-glycero-3-phosphocholine-d35 | 327178-89-2 | Isotope-Labeled Compounds |
| HY-146895S | 14:0 Lyso PC-d27 | 327178-90-5 | Isotope-Labeled Compounds |
| HY-146896S | 16:0-18:1 PA-d31 (sodium) | 474943-59-4 | Isotope-Labeled Compounds |
| HY-146897S | 1-Deoxy-L-threo-sphinganine-d3 | 1246298-32-7 | Isotope-Labeled Compounds |
| HY-146898S | 1-Desoxymethylsphinganine-d5 | 1246298-43-0 | Isotope-Labeled Compounds |
| HY-146899S | CER6-2’R-d9 | 2260670-10-6 | Isotope-Labeled Compounds |
| HY-14690 | Ecopipam | 112108-01-7 | Reference compound |
| HY-146900S | Lyso GB3-d7 | 2315262-44-1 | Isotope-Labeled Compounds |
| HY-146901S | 15:0 SM (d18:1/15:0)-d9 | 2315262-22-5 | Isotope-Labeled Compounds |
| HY-146902S | C15 Ceramide-1-phosphate-d7 | 2315262-27-0 | Isotope-Labeled Compounds |
| HY-146903S | Lyso iGB3-d7 | 2315262-49-6 | Isotope-Labeled Compounds |
| HY-146904S | 3-Keto sphinganine-d7 | Isotope-Labeled Compounds | |
| HY-146905S | CER6-2’S-d9 | 2260670-11-7 | Isotope-Labeled Compounds |
| HY-146906S | C18 Glucosyl(ß) ceramide-d5 | 2260670-13-9 | Isotope-Labeled Compounds |
| HY-146907S | C18:1 Glucosyl ceramide-d5 | 2260670-16-2 | Isotope-Labeled Compounds |
| HY-146908S | N-Pentadecanoyl-D-erythro-sphingosine-d7 | Isotope-Labeled Compounds | |
| HY-146909S | CER5-2’R-d9 | 2260670-31-1 | Isotope-Labeled Compounds |
| HY-14690B | rel-Ecopipam (hydrobromide) | 1227675-51-5 | Reference compound |
| HY-14690S | Ecopipam-d4 | Isotope-Labeled Compounds | |
| HY-14691 | Refametinib | 923032-37-5 | Reference compound |
| HY-146910S | CER1 (d18:1/26:0/18:1)-d9 | 2260670-32-2 | Isotope-Labeled Compounds |
| HY-146911S | CER9 (t18:0/26:0/18:1)-d9 | 2260670-35-5 | Isotope-Labeled Compounds |
| HY-146912S | 14:0-16:1-14:0 TG-d5 | 944709-23-3 | Isotope-Labeled Compounds |
| HY-146913S | 15:0-18:1-15:0 TG-d5 | 944709-24-4 | Isotope-Labeled Compounds |
| HY-146914S | 16:0-18:0-16:0 TG-d5 | 944709-25-5 | Isotope-Labeled Compounds |
| HY-146915S | 17:0-17:1-17:0 TG-d5 | 958760-74-2 | Isotope-Labeled Compounds |
| HY-146916S | 19:0-12:0-19:0 TG-d5 | 944709-21-1 | Isotope-Labeled Compounds |
| HY-146917S | 20:0-20:1-20:0 TG-d5 | 958764-14-2 | Isotope-Labeled Compounds |
| HY-146918S | 16:0 (Rac)-PtdEG-d71 | 2260670-48-0 | Isotope-Labeled Compounds |
| HY-146919S | 4E,14Z-Sphingadiene-d7 | Isotope-Labeled Compounds | |
| HY-146920S | 3-O-Sulfo-galactosyl(β)sphingosine (d18:1)-d7 (ammonium) | Isotope-Labeled Compounds | |
| HY-146921S | 3-O-Sulfo-D-galactosyl-ß1-1’-N-nervonoyl-D-erythro-sphingosine-d7 (ammonium) | Isotope-Labeled Compounds | |
| HY-146922S | D-Galactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d7 | Isotope-Labeled Compounds | |
| HY-146923S | D-Lactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d7 | Isotope-Labeled Compounds | |
| HY-146924S | 16:0 (Rac)-PC-d80 | 100412-79-1 | Isotope-Labeled Compounds |
| HY-146925S | 15:0 Lyso PC-d5 | 2342574-95-0 | Isotope-Labeled Compounds |
| HY-146926S | 16:0 Coenzyme A-d4 | 2260670-64-0 | Isotope-Labeled Compounds |
| HY-146927S | 24:0 Coenzyme A-d4 | 2260670-66-2 | Isotope-Labeled Compounds |
| HY-146928S | C26 D,L-Carnitine-d9 | 2260670-67-3 | Isotope-Labeled Compounds |
| HY-146929S | 18:1 SM (d18:1/18:1)-d9 | 2342574-42-7 | Isotope-Labeled Compounds |
| HY-146930S | 16:1 SM (d18:1/16:1)-d9 | 2342574-45-0 | Isotope-Labeled Compounds |
| HY-146931S | 20:1 SM (d18:1/20:1)-d9 | 2342574-48-3 | Isotope-Labeled Compounds |
| HY-146932S | 22:1 SM (d18:1/22:1)-d9 | 2342574-51-8 | Isotope-Labeled Compounds |
| HY-146933S | 24:1 SM (d18:1/24:1)-d9 | 2342574-54-1 | Isotope-Labeled Compounds |
| HY-146934S | C22:1 Ceramide-d7 | 2342574-57-4 | Isotope-Labeled Compounds |
| HY-146935S | C20:1 Ceramide-d7 | 2342574-60-9 | Isotope-Labeled Compounds |
| HY-146936S | C16:1 Ceramide-d7 | 1942907-49-4 | Isotope-Labeled Compounds |
| HY-146937S | CER11-2’S-d9 | 2260670-22-0 | Isotope-Labeled Compounds |
| HY-146938S | CER11-2’R-d9 | 2260670-23-1 | Isotope-Labeled Compounds |
| HY-146939S | CER7-2’R,6R-d9 | 2260670-24-2 | Isotope-Labeled Compounds |
| HY-146940S | CER7-2’S,6R-d9 | 2260670-25-3 | Isotope-Labeled Compounds |
| HY-146941S | CER8-d9 | 2260670-29-7 | Isotope-Labeled Compounds |
| HY-146942S | CER5-2’S-d9 | 2260670-30-0 | Isotope-Labeled Compounds |
| HY-146943S | 24:0 L-carnitine-d4 | 2260670-68-4 | Isotope-Labeled Compounds |
| HY-146944S | 12-PAHSA-13C16 | 2342575-05-5 | Isotope-Labeled Compounds |
| HY-146945S | Arachidonoyl LPA-d5 | Isotope-Labeled Compounds | |
| HY-146946S | D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d5 | Isotope-Labeled Compounds | |
| HY-146947S | D-Myo-phosphatidylinositol 4-phosphate diC16-d5 | Isotope-Labeled Compounds | |
| HY-146948S | D-Myo-phosphatidylinositol 4,5-bisphosphate diC16-d5 | Isotope-Labeled Compounds | |
| HY-146949S | D-Myo-phosphatidylinositol diC16-d5 | Isotope-Labeled Compounds | |
| HY-146950S | PAPEth-d5 | Isotope-Labeled Compounds | |
| HY-146951S | PLPEth-d5 | Isotope-Labeled Compounds | |
| HY-146952S | POPEth-d5 | 1612140-92-7 | Isotope-Labeled Compounds |
| HY-146953S | SLPEth-d5 | Isotope-Labeled Compounds | |
| HY-146954S | SOPEth-d5 | Isotope-Labeled Compounds | |
| HY-146955S | Linoleoyl LPA-d5 | Isotope-Labeled Compounds | |
| HY-146956S | Oleoyl LPA-d5 | Isotope-Labeled Compounds | |
| HY-146957 | ZIKV-IN-1 | 2762166-06-1 | Reference compound |
| HY-146958 | MAO-B-IN-8 | 1638956-60-1 | Reference compound |
| HY-146959 | K203 | 955034-69-2 | Reference compound |
| HY-146963S | Amitraz metabolite-d3 | 1255517-75-9 | Isotope-Labeled Compounds |
| HY-146965S | Hydroxytriclabendazole-d3 | Isotope-Labeled Compounds | |
| HY-146966S | 2-NP-DNSAH-13C6 | Isotope-Labeled Compounds | |
| HY-146967S | 4-(3,6-Dimethylhept-3-yl)phenol-13C6 | 1173020-38-6 | Isotope-Labeled Compounds |
| HY-146968S | Alloerythro-Isoxsuprine-13C6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-146969S | Bisdesoxyquinoceton-13C6 | Isotope-Labeled Compounds | |
| HY-146970 | Lankacyclinone C | Reference compound | |
| HY-146971 | Anti-inflammatory agent 38 | 3032633-42-1 | Reference compound |
| HY-146972S | Zearalenone-14-O-β-glucoside-13C6 | Isotope-Labeled Compounds | |
| HY-146973 | HIV-IN-3 | 3032454-77-3 | Reference compound |
| HY-146974 | PDE4-IN-9 | 2519450-32-7 | Reference compound |
| HY-146975S | Descyclopropyl-dicyclanil-15N3 | Isotope-Labeled Compounds | |
| HY-146976S | Nifuraldezone-15N3 | Isotope-Labeled Compounds | |
| HY-146977 | LDHA/PDKs-IN-1 | 2490699-40-4 | Reference compound |
| HY-146978 | LDHA/PDKs-IN-2 | 2490699-44-8 | Reference compound |
| HY-146979 | hA2A/hCA XII modulator 1 | 2548963-55-7 | Reference compound |
| HY-146980 | GLUT4-IN-2 | 2454113-83-6 | Reference compound |
| HY-146981 | α-Glucosidase-IN-3 | 2758286-48-3 | Reference compound |
| HY-146982 | hCAII-IN-1 | 1807520-24-6 | Reference compound |
| HY-146983 | hCAIX-IN-3 | 2375461-31-5 | Reference compound |
| HY-146984 | α-Amylase-IN-2 | 2758286-53-0 | Reference compound |
| HY-146985 | Cathepsin X-IN-1 | 2418577-51-0 | Reference compound |
| HY-146986S1 | N-acetyl-D-talosamine-13C | 875654-29-8 | Isotope-Labeled Compounds |
| HY-146987 | FWM-3 | 714923-33-8 | Reference compound |
| HY-146988 | hCAIX/XII-IN-1 | 3033040-76-2 | Reference compound |
| HY-146989S | 4-O-β-D-Galactopyranosyl-D-mannose-13C | Isotope-Labeled Compounds | |
| HY-146990S | 3-Deoxy-3-fluoro-D-glucose-13C | 478518-97-7 | Isotope-Labeled Compounds |
| HY-146992S | α-D-Glucopyranosyl 1-phosphate-13C (dicyclohexylamine, monohydrate) | 478518-99-9 | Isotope-Labeled Compounds |
| HY-146993S | 3-O-Methyl-D-glucose-13C | 478529-34-9 | Isotope-Labeled Compounds |
| HY-146994S | L-Idose-13C | Isotope-Labeled Compounds | |
| HY-146994S1 | L-Idose-13C-1 | Isotope-Labeled Compounds | |
| HY-146994S2 | L-Idose-13C-2 | 115973-80-3 | Isotope-Labeled Compounds |
| HY-146995S | Glycolaldehyde-1-13C | 71122-42-4 | Isotope-Labeled Compounds |
| HY-146995S1 | Glycolaldehyde-2-13C | 478529-67-8 | Isotope-Labeled Compounds |
| HY-146996S | β-lactosyl-13C | Isotope-Labeled Compounds | |
| HY-146997 | TRβ agonist 1 | 2770681-85-9 | Reference compound |
| HY-146998 | SARS-CoV-2 3CLpro-IN-2 | 2765088-93-3 | Reference compound |
| HY-146999 | YM458 | 2770108-93-3 | Reference compound |
| HY-147000 | DNA Gyrase-IN-1 | 3031486-11-7 | Reference compound |
| HY-147001 | 5-O-Demethyl-28-hydroxy-Avermectin A1a | 96722-46-2 | Reference compound |
| HY-147002 | 7-O-Methyl Ivermectin B1a | Reference compound | |
| HY-147003 | MMV687807 | 1417658-11-7 | Reference compound |
| HY-147004 | A-908292 | 903886-95-3 | Reference compound |
| HY-147005 | piCRAC-1 | 2418049-54-2 | Reference compound |
| HY-147006 | Zovodotin | 1800462-96-7 | Reference compound |
| HY-147007 | β-catenin-IN-3 | 1005288-15-2 | Reference compound |
| HY-147008 | XP-524 | 2344825-52-9 | Reference compound |
| HY-147010 | STING agonist-12 | 2259624-71-8 | Reference compound |
| HY-147011 | FTO-IN-7 | 2243736-37-8 | Reference compound |
| HY-147012 | GalNAc-L96 | 1159408-62-4 | Reference compound |
| HY-147013 | Caprochlorone | 13878-10-9 | Reference compound |
| HY-147014 | Cyclic HPMPC | 127757-45-3 | Reference compound |
| HY-147015 | HOE961 | 152819-48-2 | Reference compound |
| HY-147016 | NIOCH 14 | 1268015-38-8 | Reference compound |
| HY-147017 | GSK2556286 | 1210456-20-4 | Reference compound |
| HY-147018 | 1-Octylnonyl 8-[[8-[(1-ethylnonyl)oxy]-8-oxooctyl](2-hydroxyethyl)amino]octanoate | 2089251-75-0 | Biochemical Assay Reagents |
| HY-147020 | Coronastat | 2922281-15-8 | Reference compound |
| HY-147021 | MC-Val-D-Cit-PAB-PNP | 1350456-66-4 | ADC Related |
| HY-147021A | MC-D-Val-Cit-PAB-PNP | 1350456-64-2 | Reference compound |
| HY-147025 | (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine | 2347517-69-3 | Reference compound |
| HY-147026 | CDK9-IN-15 | 852678-17-2 | Reference compound |
| HY-147027 | PARP-1-IN-2 | 684234-55-7 | Reference compound |
| HY-147028 | M4 mAChR agonist-1 | 785705-53-5 | Reference compound |
| HY-147029 | HIF1-IN-3 | 333314-79-7 | Reference compound |
| HY-147030 | PARP1-IN-8 | 836640-15-4 | Reference compound |
| HY-147031 | JAMM protein inhibitor 2 | 848249-35-4 | Reference compound |
| HY-147032 | USP8-IN-1 | 2477650-96-5 | Reference compound |
| HY-147037 | AMPK activator 7 | 1623138-03-3 | Reference compound |
| HY-147038 | AMPK activator 8 | 1852451-96-7 | Reference compound |
| HY-147039 | BOLD-100 (free base) | 783324-98-1 | Reference compound |
| HY-147040 | ABN401 | 2242563-15-9 | Reference compound |
| HY-147041 | Selvigaltin | 1978336-95-6 | Reference compound |
| HY-147041A | (2S)-Selvigaltin | Reference compound | |
| HY-147045 | UCB-5307 | 1515887-44-1 | Reference compound |
| HY-147046 | ET-JQ1-OH | 2421153-77-5 | Reference compound |
| HY-147047 | InhA-IN-2 | 2428737-43-1 | Reference compound |
| HY-147048 | STAT3 degrader-1 | 2497585-16-5 | Reference compound |
| HY-147049 | PAL-4 | 2609594-35-4 | Reference compound |
| HY-147050 | Ahx-DM1 | 1702356-21-5 | Reference compound |
| HY-147050A | Ahx-DM1 (TFA) | 1702356-22-6 | Reference compound |
| HY-147051 | Nelremagpran | 2492595-24-9 | Reference compound |
| HY-147052 | Boc-Pip-butyn | 1346153-07-8 | Reference compound |
| HY-147053 | 2-(Diethylamino)ethyl (3-(octyloxy)phenyl)carbamate (hydrochloride) | 32223-82-8 | Reference compound |
| HY-147054 | Zedoresertib | 2243882-74-6 | Reference compound |
| HY-147055 | THR-β agonist 5 | 2542029-74-1 | Reference compound |
| HY-147056 | PKRA83 | 1233926-87-8 | Reference compound |
| HY-147057 | Rofapitide tetraxetan | 2581741-18-4 | Reference compound |
| HY-147057A | Rofapitide tetraxetan (acetate) | Reference compound | |
| HY-147058 | SW2_152F | Reference compound | |
| HY-147059 | Dieckol | 88095-77-6 | Natural Products |
| HY-147059R | Dieckol (Standard) | 88095-77-6 | Reference Standards |
| HY-147060 | Dyrk1A-IN-3 | 2493976-27-3 | Reference compound |
| HY-147061 | 2-Deoxyribose 5-phosphate (disodium) | 102916-66-5 | Reference compound |
| HY-147061R | 2-Deoxyribose 5-phosphate (disodium) (Standard) | 102916-66-5 | Reference Standards |
| HY-147062 | N-Acetyl-D-galactosamine-6-phosphate | 18191-20-3 | Reference compound |
| HY-147063 | N-Acetyl-α-D-glucosamine 1-phosphate (disodium) | 31281-59-1 | Reference compound |
| HY-147063R | N-Acetyl-α-D-glucosamine 1-phosphate (disodium) (Standard) | 31281-59-1 | Reference Standards |
| HY-147064 | DL-4-Hydroxy-2-ketoglutarate (lithium) | Reference compound | |
| HY-147064A | DL-4-Hydroxy-2-ketoglutarate | 1187-99-1 | Reference compound |
| HY-147065 | γ-L-Glutamyl-S-allyl-L-cysteine | 1299925-32-8 | Natural Products |
| HY-147066 | Dyrk1A-IN-4 | 2091883-59-7 | Reference compound |
| HY-147067 | 16:0-18:2 PA (sodium) | 322647-59-6 | Biochemical Assay Reagents |
| HY-147071 | 1,2-Diarachidonoyl-sn-glycero-3-phosphoethanolamine | 5634-86-6 | Biochemical Assay Reagents |
| HY-147072 | 1-Stearoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (sodium) | 322647-11-0 | Biochemical Assay Reagents |
| HY-147074 | 18:2 PG | 322729-38-4 | Biochemical Assay Reagents |
| HY-147076 | 20:4 PG (sodium) | 474943-21-0 | Biochemical Assay Reagents |
| HY-147078 | EJMC-1 | 397281-20-8 | Reference compound |
| HY-147079 | Egaptivon pegol | 934868-74-3 | Oligonucleotides |
| HY-147079A | Egaptivon pegol (sodium) | Oligonucleotides | |
| HY-147080 | Avacincaptad pegol sodium | 1491144-00-3 | Oligonucleotides |
| HY-147081 | AS 1411 | 301636-59-9 | Oligonucleotides |
| HY-147081A | AS 1411 (sodium) | Oligonucleotides | |
| HY-147081B | AS 1411 (triethylamine) | Oligonucleotides | |
| HY-147082 | GA-017 | 2351906-74-4 | Reference compound |
| HY-147083 | SGC-AAK1-1N | 2242913-80-8 | Reference compound |
| HY-147084 | KY371 | Reference compound | |
| HY-147085 | Loratadine n-oxide | 165739-62-8 | Reference compound |
| HY-147086 | CAY10789 | 123226-28-8 | Reference compound |
| HY-147087 | YSK 05 | 1318793-78-0 | Reference compound |
| HY-147088 | TEAD-IN-2 | 2563849-97-6 | Reference compound |
| HY-147089 | PRRSV/CD163-IN-1 | 560995-89-3 | Reference compound |
| HY-147090 | Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH | 2750350-39-9 | Reference compound |
| HY-147091 | Tazemetostat de(methyl morpholine)-COOH | 2685873-44-1 | Reference compound |
| HY-147092 | Oryzalin | 19044-88-3 | Reference compound |
| HY-147092R | Oryzalin (Standard) | 19044-88-3 | Reference Standards |
| HY-147093 | vc-PAB-DMEA-PNU159682 | 2227350-96-9 | ADC Related |
| HY-147094 | vc-PABC-DM1 | 1416792-90-9 | Reference compound |
| HY-147095 | Val-Ala-PABC-Exatecan | 2845164-91-0 | Reference compound |
| HY-147095A | Val-Ala-PABC-Exatecan (trifluoroacetate) | 2928571-45-1 | ADC Related |
| HY-147097 | EDA-DA | 87156-00-1 | Reference compound |
| HY-147097A | EDA-DA (TFA) | 87156-01-2 | Reference compound |
| HY-147098 | dTAG-47 | 2265886-81-3 | Reference compound |
| HY-147099 | dTAG-47-NEG | Reference compound | |
| HY-14710 | AZ3146 | 1124329-14-1 | Reference compound |
| HY-147100 | α1A-AR Degrader 9c | 2863635-02-1 | Reference compound |
| HY-147101 | SK-575-NEG | 2523017-04-9 | Reference compound |
| HY-147102 | tri-GalNAc biotin | Reference compound | |
| HY-147104 | Fmoc-Lys(5-FITC)-OH | 1095493-05-2 | Dye Reagents |
| HY-147105 | LRH-1 modulator-1 | 2244781-29-9 | Reference compound |
| HY-147105A | (+)-LRH-1 modulator-1 | Reference compound | |
| HY-147106 | Mrgx2 antagonist-1 | 2767110-35-8 | Reference compound |
| HY-147107 | OfHex1-IN-2 | 58125-33-0 | Reference compound |
| HY-147108 | Mitochondria degrader-1 | 2241669-05-4 | Reference compound |
| HY-14711 | Reversine | 656820-32-5 | Reference compound |
| HY-147110 | APX2039 | 2342606-49-7 | Reference compound |
| HY-147112 | MNP-GAL | 70622-78-5 | Reference compound |
| HY-147113 | 2-Methyl-3-buten-1-ol | 4516-90-9 | Reference compound |
| HY-147114 | 3-Methyl-8-(2'-deoxy-β-D-ribofuranosyl)isoxanthopterin | 170379-51-8 | Dye Reagents |
| HY-147115 | 4-Azidophlorizin | 79541-46-1 | Reference compound |
| HY-147116 | 4-[3-(Trifluoromethyl)diazirin-3-yl] benzoic acid N-hydroxysuccinimide ester | 87736-89-8 | Reference compound |
| HY-147117 | NHS-SS-Ac | 2750799-11-0 | Reference compound |
| HY-147119 | INX-SM-6 | 2734878-16-9 | ADC Related |
| HY-147124 | RIG012 | 2642218-43-5 | Reference compound |
| HY-147131 | CDK9-IN-30 | 748146-89-6 | Reference compound |
| HY-147132 | GluR6 antagonist-1 | 323176-64-3 | Reference compound |
| HY-147133 | VEGFR2-IN-2 | 737818-56-3 | Reference compound |
| HY-147134 | GSK-3β inhibitor 10 | 1198098-03-1 | Reference compound |
| HY-147135 | MYF-03-69 | 2416418-11-4 | Reference compound |
| HY-147136 | MYF-03-176 | 2857937-59-6 | Reference compound |
| HY-14714 | NSC-207895 | 58131-57-0 | Reference compound |
| HY-147140 | BOS-318 | 2387633-15-8 | Reference compound |
| HY-147141 | HS-276 | 2767422-72-8 | Reference compound |
| HY-147149 | BPN-15477 | 1971086-99-3 | Reference compound |
| HY-14715 | CCT241533 | 1262849-73-9 | Reference compound |
| HY-147150 | 8-Azido-cADPR | 150424-94-5 | Reference compound |
| HY-147151 | AMCPy | 439858-38-5 | Reference compound |
| HY-147152 | 1-Myristoyl-3-chloropropanediol | 30557-03-0 | Reference compound |
| HY-147158 | ZXH-1-161 | 2407654-51-5 | Reference compound |
| HY-14715B | CCT241533 (hydrochloride) | 1431697-96-9 | Reference compound |
| HY-14716 | CCT239065 | 1163719-51-4 | Reference compound |
| HY-147164 | MC-Gly-Gly-Phe-Gly-PAB-PNP | 2632342-16-4 | ADC Related |
| HY-147165 | VT02956 | 2999763-09-4 | Reference compound |
| HY-147165A | VT02956 (hydrochloride) | Reference compound | |
| HY-147166 | 2-Carboxyanthracene MTSEA amide | 1159977-18-0 | Reference compound |
| HY-147167 | Bz-D-Arg-pNA (hydrochloride) | 21653-41-8 | Reference compound |
| HY-147168 | Biocytin hydrazide | 102743-85-1 | Reference compound |
| HY-147169 | Biotin-X-NTA | 856661-92-2 | Dye Reagents |
| HY-147170 | (1,1'-Dipyrenyl)dimethyl ether | 74833-81-1 | Dye Reagents |
| HY-147171 | 2,7-Bis(alloxycarbonylamino)-9-chloroacridine | 887353-21-1 | Dye Reagents |
| HY-147172 | Ru(bpy)2(dcbpy)NHS (dihexafluorophosphate) | 160525-49-5 | Dye Reagents |
| HY-147173 | FAPI-74 | 2374782-76-8 | Reference compound |
| HY-147174 | PROTAC_ERRα | 1801547-15-8 | Reference compound |
| HY-147177 | Bodipy 8-chloromethane | 208462-25-3 | Dye Reagents |
| HY-147178 | C-6 NBD-dihydro-Ceramide | 114301-95-0 | Reference compound |
| HY-147179 | INX-SM-56 | 2734878-18-1 | ADC Related |
| HY-14718 | Resminostat | 864814-88-0 | Reference compound |
| HY-147180 | Dansyl-DL-valine (cyclohexylammonium) | 84540-67-0 | Reference compound |
| HY-147181 | 1,3-Di-(2-pyrenyl)propane | 97325-55-8 | Dye Reagents |
| HY-147182 | 3,6-Diamino-9(10H)-acridone | 42832-87-1 | Reference compound |
| HY-147183 | JBJ-09-063 | 2820336-67-0 | Reference compound |
| HY-147183A | JBJ-09-063 (TFA) | Reference compound | |
| HY-147183B | JBJ-09-063 (hydrochloride) | Reference compound | |
| HY-147185 | PRMT7-IN-1 | 2247753-73-5 | Reference compound |
| HY-147186 | 5,5'-Difluoro BAPTA | 156027-00-8 | Reference compound |
| HY-147187 | MNK8 | 2055078-49-2 | Reference compound |
| HY-14718A | Resminostat (hydrochloride) | 1187075-34-8 | Reference compound |
| HY-14719 | RO4987655 | 874101-00-5 | Reference compound |
| HY-147190 | ATR-IN-19 | 2648989-61-9 | Reference compound |
| HY-147192 | (S,R,S)-AHPC-O-PEG1-propargyl | 2098799-79-0 | Reference compound |
| HY-147193 | Nampt-IN-10 (TFA) | 2567724-20-1 | Reference compound |
| HY-147193A | Nampt-IN-10 (trihydrochloride) | Reference compound | |
| HY-147195 | QH536 | 2754254-07-2 | Reference compound |
| HY-147196 | KB03-SLF | 2384184-42-1 | Reference compound |
| HY-147198 | Antimalarial agent 13 | 431884-01-4 | Reference compound |
| HY-14720 | Rabusertib | 911222-45-2 | Reference compound |
| HY-147202 | BRD4 Inhibitor-24 | 309951-18-6 | Reference compound |
| HY-147203 | 5-HT2B antagonist-1 | 393129-91-4 | Reference compound |
| HY-147204 | Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE | 1638970-46-3 | Reference compound |
| HY-147205 | Biotin-PEG-OH (MW 1000) | Reference compound | |
| HY-147205A | Biotin-PEG-OH (MW 2000) | Reference compound | |
| HY-147205B | Biotin-PEG-OH (MW 3400) | Dye Reagents | |
| HY-147205C | Biotin-PEG-OH (MW 5000) | Reference compound | |
| HY-147205D | Biotin-PEG-OH (MW 10000) | Reference compound | |
| HY-147205E | Biotin-PEG-OH (MW 20000) | Dye Reagents | |
| HY-147206 | Biotin-PEG-Alk (MW 600) | Dye Reagents | |
| HY-147206A | Biotin-PEG-Alk (MW 1000) | Dye Reagents | |
| HY-147206B | Biotin-PEG-Alk (MW 2000) | Dye Reagents | |
| HY-147206C | Biotin-PEG-Alk (MW 3400) | Dye Reagents | |
| HY-147206D | Biotin-PEG-Alk (MW 5000) | Reference compound | |
| HY-147206E | Biotin-PEG-Alk (MW 10000) | Dye Reagents | |
| HY-147206F | Biotin-PEG-Alk (MW 20000) | Dye Reagents | |
| HY-147207 | Phospholipid-PEG-Biotin (MW 1000) | Biochemical Assay Reagents | |
| HY-147207A | Phospholipid-PEG-Biotin (MW 2000) | Biochemical Assay Reagents | |
| HY-147207B | Phospholipid-PEG-Biotin (MW 3400) | Biochemical Assay Reagents | |
| HY-147207C | Phospholipid-PEG-Biotin (MW 5000) | Biochemical Assay Reagents | |
| HY-147207D | Phospholipid-PEG-Biotin (MW 10000) | Biochemical Assay Reagents | |
| HY-147207E | Phospholipid-PEG-Biotin (MW 20000) | Biochemical Assay Reagents | |
| HY-147208 | MSC-4106 | 2738542-58-8 | Reference compound |
| HY-14721 | Tepotinib | 1100598-32-0 | Reference compound |
| HY-147214 | GNE-7883 | 2648450-42-2 | Reference compound |
| HY-147215 | UC-1V150 | 927822-45-5 | Reference compound |
| HY-147216 | AXKO-0046 | Reference compound | |
| HY-147216A | AXKO-0046 (dihydrochloride) | Reference compound | |
| HY-147217 | Bepirovirsen | 1403787-62-1 | Oligonucleotides |
| HY-147217A | Bepirovirsen (sodium) | 2563929-84-8 | Oligonucleotides |
| HY-147218 | PF-07265807 | 2412356-57-9 | Reference compound |
| HY-147219 | SIAIS164018 | 2353492-68-7 | Reference compound |
| HY-147219A | SIAIS164018 (hydrochloride) | Reference compound | |
| HY-14721A | Tepotinib (hydrochloride) | 1103508-80-0 | Reference compound |
| HY-14721R | Tepotinib (Standard) | 1100598-32-0 | Reference Standards |
| HY-14722 | NVP-BSK805 | 1092499-93-8 | Reference compound |
| HY-147220 | Dexamethasone oxetanone | 4089-36-5 | Reference compound |
| HY-147222 | SAE-14 | 1241280-25-0 | Reference compound |
| HY-147225 | TSPO Ligand-Linker Conjugates 1 | Reference compound | |
| HY-147226 | EP3 antagonist 3 | 1227827-88-4 | Reference compound |
| HY-147228 | NR2F6 modulator-1 | 904449-84-9 | Reference compound |
| HY-147229 | GDC-6036-NH | 2417918-80-8 | Reference compound |
| HY-14722A | NVP-BSK805 (dihydrochloride) | 1942919-79-0 | Reference compound |
| HY-14722C | NVP-BSK805 (trihydrochloride) | 2320258-95-3 | Reference compound |
| HY-14723 | AMG-458 | 913376-83-7 | Reference compound |
| HY-147230 | EZH2-IN-13 | 1403255-41-3 | Reference compound |
| HY-147231 | SG3400 delate(Mal-amido-PEG8) | 2125685-22-3 | Reference compound |
| HY-147232 | N-Acryloyl-1-pyrenebutylamine | 133399-57-2 | Dye Reagents |
| HY-147233 | MIND4-19 | 129544-85-0 | Reference compound |
| HY-147234 | Sirtuin modulator 2 | 667910-69-2 | Reference compound |
| HY-147235 | RIPK2-IN-2 | 2143956-20-9 | Reference compound |
| HY-147236 | TLR7/8 agonist 7 | 2567953-47-1 | Reference compound |
| HY-147237 | LpxC-IN-10 | 2413574-64-6 | Reference compound |
| HY-147238 | Antifungal agent 35 | 2085274-00-4 | Reference compound |
| HY-147239 | MC-VA-PABC-MMAE | 1818864-51-5 | ADC Related |
| HY-147240 | Acloproxalap | 1824609-67-7 | Reference compound |
| HY-147241 | Alpibectir | 2285440-39-1 | Reference compound |
| HY-147243 | Ansornitinib | 1448874-96-1 | Reference compound |
| HY-147245 | Basroparib | 1858179-75-5 | Reference compound |
| HY-147246 | Berberine ursodeoxycholate | 1868138-66-2 | Reference compound |
| HY-147247 | Fosimdesonide | Reference compound | |
| HY-147248 | Opadotina | Reference compound | |
| HY-147249 | CFTR corrector 8 | 1918142-35-4 | Reference compound |
| HY-147250 | Lirafugratinib | 2549174-42-5 | Reference compound |
| HY-147250A | Lirafugratinib (hydrochloride) | 2688040-45-9 | Reference compound |
| HY-147251 | SRI 6409-94 | 127697-58-9 | Reference compound |
| HY-147252 | Bezeparsen | 2639640-84-7 | Oligonucleotides |
| HY-147252A | Bezeparsen (sodium) | Oligonucleotides | |
| HY-147253 | Brogidirsen | 2409088-11-3 | Oligonucleotides |
| HY-147253A | Brogidirsen (sodium) | Oligonucleotides | |
| HY-147254 | Cadisegliatin | 859525-02-3 | Reference compound |
| HY-147255 | Canocapavir | 2137847-19-7 | Reference compound |
| HY-147255A | (S)-Canocapavir | 2137847-77-7 | Reference compound |
| HY-147256 | Cavutilide | 1276186-19-6 | Reference compound |
| HY-147257 | Cofrogliptin | 1844874-26-5 | Reference compound |
| HY-147259 | Dalmelitinib | 1637658-98-0 | Reference compound |
| HY-147261 | B026 | 2379416-48-3 | Reference compound |
| HY-147263 | Dovramilast | 340019-69-4 | Reference compound |
| HY-147264 | Edecesertib | 2408839-73-4 | Reference compound |
| HY-147265 | Eldocasiran | 2615098-65-0 | Oligonucleotides |
| HY-147265A | Eldocasiran (sodium) | Oligonucleotides | |
| HY-147266 | Elebsiran sodium | Oligonucleotides | |
| HY-147266A | Elebsiran | 2648009-64-5 | Oligonucleotides |
| HY-147267 | Evazarsen | 2589926-22-5 | Oligonucleotides |
| HY-147267A | Evazarsen (sodium) | 2589926-24-7 | Oligonucleotides |
| HY-147268 | Exarafenib | 2639957-39-2 | Reference compound |
| HY-147269 | Fosclevudine alafenamide | 1951476-79-1 | Reference compound |
| HY-147270 | MC-VA-PAB-Exatecan | 2680543-57-9 | ADC Related |
| HY-147271 | Mal-PEG8-Val-Ala-PAB-Exatecan | 2679821-39-5 | ADC Related |
| HY-147273 | Fulimetibant | 2231142-90-6 | Reference compound |
| HY-147274 | Funobactam | 2365454-12-0 | Reference compound |
| HY-147275 | Tazide | Reference compound | |
| HY-147276 | Izuforant | 1429374-83-3 | Reference compound |
| HY-147277 | Lorundrostat | 1820940-17-7 | Reference compound |
| HY-147278 | Manusiran | 2646704-10-9 | Oligonucleotides |
| HY-147278A | Manusiran (sodium) | Oligonucleotides | |
| HY-147279 | Milpocitide | 2643306-81-2 | Reference compound |
| HY-14728 | Aleglitazar | 475479-34-6 | Reference compound |
| HY-147280 | Misetionamide | 856785-75-6 | Reference compound |
| HY-147281 | BAY 1135626 | 1404071-37-9 | ADC Related |
| HY-147282 | Amgen-23 | 1448706-15-7 | Reference compound |
| HY-147283 | MK2-IN-4 | 1105658-32-9 | Reference compound |
| HY-147284 | PI3K-IN-37 | 1257547-40-2 | Reference compound |
| HY-147285 | PI3K/mTOR Inhibitor-9 | 1392421-71-4 | Reference compound |
| HY-147286 | Ac-Lys-Val-Cit-PABC-MMAE | 1650569-89-3 | ADC Related |
| HY-147286A | Ac-Lys-Val-Cit-PABC-MMAE (formic) | ADC Related | |
| HY-147287 | Glu-urea-Glu-NHS ester | 1228927-36-3 | Reference compound |
| HY-147288 | NSC 694621 | 104857-29-6 | Reference compound |
| HY-147289 | NSC 698600 | 908069-17-0 | Reference compound |
| HY-147290 | NSC 694623 | 907957-34-0 | Reference compound |
| HY-147291 | VPC-70063 | 13571-44-3 | Reference compound |
| HY-147292 | Nelutroctiv | 2299177-09-4 | Reference compound |
| HY-147293 | Nenocorilant | 1496509-78-4 | Reference compound |
| HY-147294 | Nivasorexant | 1435480-40-2 | Reference compound |
| HY-147295 | Odetiglucan | 53238-80-5 | Reference compound |
| HY-147296 | Omesdafexor | 2244440-85-3 | Reference compound |
| HY-147297 | Pelecopan | 2378380-49-3 | Reference compound |
| HY-147298 | Plogosertib | 1137212-79-3 | Reference compound |
| HY-147299 | Povafonidine | 177843-85-5 | Reference compound |
| HY-147300 | Puliginurad | 2013582-27-7 | Reference compound |
| HY-147301 | Resomelagon | 1809420-71-0 | Reference compound |
| HY-147301A | Resomelagon (acetate) | 1809420-72-1 | Reference compound |
| HY-147301B | Resomelagon (methanesulfonate) | 2933183-20-9 | Reference compound |
| HY-147303 | Sacibertinib | 1351941-69-9 | Reference compound |
| HY-147304 | BPH-1086 | 1226901-43-4 | Reference compound |
| HY-147306 | ZLc-002 | 1446971-41-0 | Reference compound |
| HY-147306A | (S)-ZLc002 | 308277-46-5 | Reference compound |
| HY-147307 | MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan | 2414393-22-7 | ADC Related |
| HY-147308 | Zelenirstat | 1215011-08-7 | Reference compound |
| HY-147309 | 16-Azidohexadecanoic acid | 112668-54-9 | Reference compound |
| HY-14731 | VE-821 | 1232410-49-9 | Reference compound |
| HY-147310 | CU-CPD107 | 2573912-32-8 | Reference compound |
| HY-147311 | NSC622608 | 2593254-90-9 | Reference compound |
| HY-147312 | GSK-1520489A | 1042433-41-9 | Reference compound |
| HY-147313 | TH10785 | 1002801-51-5 | Reference compound |
| HY-147314 | HIV-IN-6 | 301357-74-4 | Reference compound |
| HY-147315 | CFTR corrector 9 | 909861-78-5 | Reference compound |
| HY-147316 | TP-5801 | 2574474-81-8 | Reference compound |
| HY-147316A | TP-5801 (TFA) | Reference compound | |
| HY-147317 | Epothilone E | 201049-37-8 | Reference compound |
| HY-147318 | PBENZ-DBRMD | 1454662-41-9 | Reference compound |
| HY-147319 | RTI-7470-44 | 825658-63-7 | Reference compound |
| HY-147320 | 3'-DMTr-dG(dmf) | 261728-23-8 | Reference compound |
| HY-147321 | 3'-DMTr-dG(iBu) | 140839-24-3 | Reference compound |
| HY-147322 | YAP/TAZ inhibitor-2 | 2762617-31-0 | Reference compound |
| HY-147323 | Ferulic acid 4-O-sulfate | 86321-29-1 | Reference compound |
| HY-147323R | Ferulic acid 4-O-sulfate (Standard) | 86321-29-1 | Reference Standards |
| HY-147325 | bisSP1 | 2253947-15-6 | ADC Related |
| HY-147327 | N-Formylsarcolysine | 26367-45-3 | Reference compound |
| HY-147328 | LCS3 | 109844-92-0 | Reference compound |
| HY-147329 | RAGE 229 | 2143072-85-7 | Reference compound |
| HY-147330 | SJ1008030 | 2863634-96-0 | Reference compound |
| HY-147330A | SJ1008030 (TFA) | 2863634-97-1 | Reference compound |
| HY-147330B | SJ1008030 (formic) | Reference compound | |
| HY-147331 | Oseltamivir acid methyl ester | 208720-71-2 | Reference compound |
| HY-147331A | Oseltamivir acid methyl ester (hydrochloride) | 208720-78-9 | Reference compound |
| HY-147332 | TCL053 | 2361162-70-9 | Reference compound |
| HY-147333 | Trimipramine N-oxide | 14171-70-1 | Reference compound |
| HY-147335 | 6,9,12,15-Hexadecatetraenoic acid-ethyl ester | 845779-89-7 | Reference compound |
| HY-147336 | Desmethylazelastine | 47491-38-3 | Reference compound |
| HY-147337 | MeTC7 | 1817841-22-7 | Reference compound |
| HY-147338 | 5-Methylcytidine 5′-triphosphate | 327174-86-7 | Reference compound |
| HY-147338A | 5-Methylcytidine 5′-triphosphate (trisodium) | Reference compound | |
| HY-147338S | 5-Methylcytidine 5′-triphosphate-d3 (trisodium) | Isotope-Labeled Compounds | |
| HY-147338S1 | 5-Methylcytidine 5′-triphosphate-15N2,13C (trisodium) | Isotope-Labeled Compounds | |
| HY-147338S2 | 5-Methylcytidine 5′-triphosphate-d8 (trisodium) | Isotope-Labeled Compounds | |
| HY-147339 | M7G(3'-OMe-5')pppA(2'-OMe) | Oligonucleotides | |
| HY-14734 | Anamorelin | 249921-19-5 | Reference compound |
| HY-147342 | β-Benzamide adenine dinucleotide | 156724-91-3 | Reference compound |
| HY-147346 | Zelicapavir | 2070852-76-3 | Reference compound |
| HY-147348 | 4-Formylcolchicine | 2730-82-7 | Reference compound |
| HY-147349 | ANT3310 (sodium) | 2410688-61-6 | Reference compound |
| HY-14734A | Anamorelin (hydrochloride) | 861998-00-7 | Reference compound |
| HY-14734B | Anamorelin (Fumarate) | 339539-92-3 | Reference compound |
| HY-14734R | Anamorelin (Standard) | 249921-19-5 | Reference Standards |
| HY-14735 | Arbaclofen placarbil | 847353-30-4 | Reference compound |
| HY-147351 | GPR40 agonist 6 | 1798751-25-3 | Reference compound |
| HY-147352 | NMDA receptor potentiator-1 | 486427-18-3 | Reference compound |
| HY-147353 | Phenylsulfamide | 15959-53-2 | Reference compound |
| HY-147354 | TriGalNAc CBz | 186613-57-0 | Reference compound |
| HY-147356 | ERCC1-XPF-IN-2 | 1808986-37-9 | Reference compound |
| HY-147357 | TRPC3/6-IN-1 | 736945-96-3 | Reference compound |
| HY-147358 | Yimitasvir (diphosphate) | 1959593-63-5 | Reference compound |
| HY-147358A | Yimitasvir | 1959593-23-7 | Reference compound |
| HY-147358C | (1R,4S)-Yimitasvir (diphosphate) | 2734870-15-4 | Reference compound |
| HY-147359 | Boanmycin | 37293-17-7 | Reference compound |
| HY-14736 | Azilsartan medoxomil | 863031-21-4 | Reference compound |
| HY-147360 | Tribendimidine | 115103-15-6 | Reference compound |
| HY-147361 | LDCA | 349106-80-5 | Reference compound |
| HY-147362 | MAO-B-IN-14 | 1904610-48-5 | Reference compound |
| HY-147363 | DIBAC-GGFG-NH2CH2-Dxd | 2758875-01-1 | Reference compound |
| HY-147364 | 5-(3-Hydroxybenzylidene)-rhodanine | 37530-35-1 | Reference compound |
| HY-147365 | Acifluorfen-methyl | 50594-67-7 | Reference compound |
| HY-147366 | RBP4 ligand-1 | 260553-24-0 | Reference compound |
| HY-147367 | AM-1488 | 2079895-60-4 | Reference compound |
| HY-147368 | PKM2 activator 2 | 1186660-06-9 | Reference compound |
| HY-147369 | NFATc1-IN-1 | 1912422-56-0 | Reference compound |
| HY-14736R | Azilsartan medoxomil (Standard) | 863031-21-4 | Reference Standards |
| HY-14737 | Ceftaroline fosamil | 400827-46-5 | Reference compound |
| HY-147370 | HIV-1 inhibitor-46 | 332947-35-0 | Reference compound |
| HY-147371 | Quinoprazine | 115618-99-0 | Reference compound |
| HY-147372 | SJ000063181 | 945189-68-4 | Reference compound |
| HY-147373 | DA-PROTAC | 2488660-12-2 | Reference compound |
| HY-147374 | Bromodomain inhibitor-9 | 1870849-34-5 | Reference compound |
| HY-147375 | Bromodomain inhibitor-10 | 1870849-58-3 | Reference compound |
| HY-147376 | hACC2-IN-1 | 192323-14-1 | Reference compound |
| HY-147377 | N-Salicyloyltryptamine | 31384-98-2 | Reference compound |
| HY-147379 | Hepcidin antagonist-1 | 338965-09-6 | Reference compound |
| HY-14737A | Ceftaroline fosamil (hydrate) | 400827-55-6 | Reference compound |
| HY-14737R | Ceftaroline fosamil (Standard) | 400827-46-5 | Reference Standards |
| HY-14738 | Ceftaroline fosamil (inner) | 229016-73-3 | Reference compound |
| HY-147381 | MetRS-IN-1 | 24015-12-5 | Reference compound |
| HY-147382 | Neuronotoxicity-IN-1 | 190843-45-9 | Reference compound |
| HY-147383 | NS-8 | 186033-14-7 | Reference compound |
| HY-147384 | CXL-1020 | 950834-06-7 | Reference compound |
| HY-147385 | CCR4 antagonist 3 | 1957-01-3 | Reference compound |
| HY-147386 | CDK-IN-10 | 660822-84-4 | Reference compound |
| HY-147387 | DSS30 | 883027-32-5 | Reference compound |
| HY-147388 | hiCE inhibitor-1 | 2654-68-4 | Reference compound |
| HY-147389 | Enpp-1-IN-14 | 2687222-59-7 | Reference compound |
| HY-14739 | Choline Fenofibrate | 856676-23-8 | Reference compound |
| HY-147390 | MIF098 | 1208448-95-6 | Reference compound |
| HY-147391 | ASIC-IN-1 | 308088-10-0 | Reference compound |
| HY-147392 | CXCR2 antagonist 8 | 182498-30-2 | Reference compound |
| HY-147393 | Factor VII-IN-1 | 244206-28-8 | Reference compound |
| HY-147394 | GPR41 agonist-1 | 506417-09-0 | Reference compound |
| HY-147395 | GPR52 agonist-1 | 1207965-40-9 | Reference compound |
| HY-147397 | PKM2 activator 3 | 1346113-84-5 | Reference compound |
| HY-147398 | Dopamine D4 receptor antagonist-1 | 444724-92-9 | Reference compound |
| HY-147399 | 5-HT7 agonist 2 | 1206846-61-8 | Reference compound |
| HY-14739R | Choline Fenofibrate (Standard) | 856676-23-8 | Reference Standards |
| HY-14740 | Elvitegravir | 697761-98-1 | Reference compound |
| HY-147400 | Sipagladenant | 858979-50-7 | Reference compound |
| HY-147401 | Sitagliptin fenilalanil | 1339955-03-1 | Reference compound |
| HY-147401A | Sitagliptin fenilalanil (hydrochloride) | 1339954-75-4 | Reference compound |
| HY-147402 | Taragarestrant | 2118899-51-5 | Reference compound |
| HY-147402A | Taragarestrant (meglumine) | 2446618-18-2 | Reference compound |
| HY-147404 | Tilpisertib fosmecarbil | 2567459-64-5 | Reference compound |
| HY-147404A | Tilpisertib fosmecarbil (TFA) | 2567459-65-6 | Reference compound |
| HY-147405 | Tinlorafenib | 2573781-75-4 | Reference compound |
| HY-147406 | Tonlamarsen | 2589926-20-3 | Oligonucleotides |
| HY-147406A | Tonlamarsen (sodium) | 2589926-21-4 | Oligonucleotides |
| HY-147407 | Imbotolimod | Reference compound | |
| HY-147408 | Rezetecán | Reference compound | |
| HY-147409 | Ulecaciclib | 2075750-05-7 | Reference compound |
| HY-14740R | Elvitegravir (Standard) | 697761-98-1 | Reference Standards |
| HY-14740S | Elvitegravir-d8 | Isotope-Labeled Compounds | |
| HY-14740S1 | Elvitegravir-d6 | Isotope-Labeled Compounds | |
| HY-14740S2 | Elvitegravir-13C6 | Isotope-Labeled Compounds | |
| HY-14741 | Epetirimod | 227318-71-0 | Reference compound |
| HY-147410 | Ulefnersen | 2589926-25-8 | Oligonucleotides |
| HY-147410A | Ulefnersen (sodium) | 2589926-27-0 | Oligonucleotides |
| HY-147411 | Ulonivirine | 1591823-76-5 | Reference compound |
| HY-147412 | Ultevursen | 2642382-41-8 | Oligonucleotides |
| HY-147412A | Ultevursen (sodium) | Oligonucleotides | |
| HY-147414 | Vamotinib | 1416241-23-0 | Reference compound |
| HY-147416 | Vipoglanstat | 1360622-01-0 | Reference compound |
| HY-147419 | Vulolisib | 2390105-79-8 | Reference compound |
| HY-14742 | Faxeladol | 433265-65-7 | Reference compound |
| HY-147420 | Xelaglifam | 2230597-99-4 | Reference compound |
| HY-147421 | Xilmenolone | 2368807-26-3 | Reference compound |
| HY-147422 | Xininurad | 2365178-28-3 | Reference compound |
| HY-147423 | Zandatrigine | 2154406-04-7 | Reference compound |
| HY-147424 | Zegruvirimat | 2122781-86-4 | Reference compound |
| HY-147425 | Zerlasiran | 2646703-64-0 | Oligonucleotides |
| HY-147425A | Zerlasiran (sodium) | Oligonucleotides | |
| HY-147426 | Zifcasiran | 2437257-11-7 | Oligonucleotides |
| HY-147426A | Zifcasiran (sodium) | 2437257-12-8 | Oligonucleotides |
| HY-147428 | Zolunicant | 188125-42-0 | Reference compound |
| HY-147429 | Zosurabalpin | 2379336-76-0 | Reference compound |
| HY-147429A | Zosurabalpin (TFA) | Reference compound | |
| HY-14743 | Golotimod | 229305-39-9 | Reference compound |
| HY-14743A | Golotimod (TFA) | 2828433-07-2 | Reference compound |
| HY-14743B | Golotimod (hydrochloride) | 1029401-59-9 | Reference compound |
| HY-14744 | Levamlodipine | 103129-82-4 | Reference compound |
| HY-14744A | Levamlodipine (besylate) | 150566-71-5 | Reference compound |
| HY-14744B | Levamlodipine (hydrochloride) | 865430-76-8 | Reference compound |
| HY-14744C | Levamlodipine (hydrobromide) | 865430-78-0 | Reference compound |
| HY-14744D | Levamlodipine (besylate Hemipentahydrate) | 884648-62-8 | Reference compound |
| HY-14744S | Levamlodipine-d4 | 1346617-19-3 | Isotope-Labeled Compounds |
| HY-14747 | Piragliatin | 625114-41-2 | Reference compound |
| HY-14749 | Pyronaridine | 74847-35-1 | Reference compound |
| HY-14749A | Pyronaridine (tetraphosphate) | 76748-86-2 | Reference compound |
| HY-14749AR | Pyronaridine (tetraphosphate) (Standard) | 76748-86-2 | Reference Standards |
| HY-14749AS | Pyronaridine-d4 (tetraphosphate) | 1186026-25-4 | Isotope-Labeled Compounds |
| HY-14750 | Rabeximod | 872178-65-9 | Reference compound |
| HY-147500 | TRβ agonist 2 | 2411099-30-2 | Reference compound |
| HY-147501 | TRβ agonist 3 | 2411099-46-0 | Reference compound |
| HY-147502 | Vin-C01 | 23173-26-4 | Reference compound |
| HY-147503 | Vin-F03 | 2180917-11-5 | Reference compound |
| HY-147504 | Anticancer agent 63 | 2529657-32-5 | Reference compound |
| HY-147505 | Antitubercular agent-21 | 2412142-93-7 | Reference compound |
| HY-147506 | NOD2 antagonist 1 | 2411441-54-6 | Reference compound |
| HY-147507 | SBP-1 | 2451986-45-9 | Dye Reagents |
| HY-147508 | SBP-2 | 2494035-92-4 | Dye Reagents |
| HY-147509 | SBP-3 | 2494035-93-5 | Dye Reagents |
| HY-14751 | Rolapitant | 552292-08-7 | Reference compound |
| HY-147511 | PPARγ agonist 7 | 2569295-93-6 | Reference compound |
| HY-147512 | CB1/2 agonist 1 | 2986688-90-6 | Reference compound |
| HY-147513 | AKT-IN-12 | 2396718-52-6 | Reference compound |
| HY-147514 | Anticancer agent 64 | 2387902-92-1 | Reference compound |
| HY-147515 | FGFR4-IN-11 | 2396664-85-8 | Reference compound |
| HY-147516 | SARS-CoV-2-IN-21 | 89971-88-0 | Reference compound |
| HY-147517 | Keap1-Nrf2-IN-9 | 2769963-24-6 | Reference compound |
| HY-147518 | p38-α MAPK-IN-5 | 1443242-46-3 | Reference compound |
| HY-147519 | ARUK3001185 | 2411969-39-4 | Reference compound |
| HY-14751A | Rolapitant (hydrochloride) | 858102-79-1 | Reference compound |
| HY-14751R | Rolapitant (Standard) | 552292-08-7 | Reference Standards |
| HY-14752 | Ronacaleret | 753449-67-1 | Reference compound |
| HY-147520 | FAK-IN-5 | 2408317-70-2 | Reference compound |
| HY-147521 | Antitumor photosensitizer-3 | Reference compound | |
| HY-147522 | ADG-2e | 2419951-75-8 | Reference compound |
| HY-147525 | PROTAC EZH2 Degrader-1 | 2641601-67-2 | Reference compound |
| HY-147526 | RM-581 | 2086809-59-6 | Reference compound |
| HY-147527 | CDK8-IN-5 | 2855087-10-2 | Reference compound |
| HY-147528 | mGluR2 modulator 2 | 1004614-86-1 | Reference compound |
| HY-147529 | mGluR2 modulator 3 | 1004614-58-7 | Reference compound |
| HY-14753 | Rosonabant | 861151-12-4 | Reference compound |
| HY-147530 | mGluR2 modulator 4 | 2582758-47-0 | Reference compound |
| HY-147531 | Antibacterial agent 106 | 2459657-11-3 | Reference compound |
| HY-147532 | CB2R probe 1 | 2634714-79-5 | Reference compound |
| HY-147533 | RORγt inverse agonist 30 | 1445901-41-6 | Reference compound |
| HY-147534 | Antileishmanial agent-6 | Reference compound | |
| HY-147535 | Antileishmanial agent-7 | 503323-06-6 | Reference compound |
| HY-147536 | Antileishmanial agent-8 | 2477608-96-9 | Reference compound |
| HY-147537 | Antileishmanial agent-9 | 2477608-91-4 | Reference compound |
| HY-147538 | Antitumor agent-64 | 2396562-55-1 | Reference compound |
| HY-147539 | Antitumor agent-65 | 2456288-82-5 | Reference compound |
| HY-14754 | Salirasib | 162520-00-5 | Reference compound |
| HY-147540 | Antitumor agent-66 | 2456288-81-4 | Reference compound |
| HY-147541 | A2A/A3 AR antagonist-1 | 1448221-36-0 | Reference compound |
| HY-147542 | Melatonin receptor agonist 1 | 2411150-76-8 | Reference compound |
| HY-147543 | A1AR antagonist 4 | 1031993-35-7 | Reference compound |
| HY-147544 | A1AR antagonist 5 | 1030509-01-3 | Reference compound |
| HY-147545 | A1AR antagonist 6 | 329693-22-3 | Reference compound |
| HY-147546 | Antibacterial agent 107 | 2454636-44-1 | Reference compound |
| HY-147547 | SV5 | 2581825-37-6 | Reference compound |
| HY-147548 | Keap1-Nrf2-IN-10 | 2445349-54-0 | Reference compound |
| HY-147549 | Antitrypanosomal agent 6 | 2492436-35-6 | Reference compound |
| HY-14754R | Salirasib (Standard) | 162520-00-5 | Reference Standards |
| HY-147550 | Antitrypanosomal agent 7 | 2492436-38-9 | Reference compound |
| HY-147552 | HIV-1 inhibitor-35 | 2416971-32-7 | Reference compound |
| HY-147553 | HIV-1 inhibitor-36 | 2170506-18-8 | Reference compound |
| HY-147554 | HIV-1 inhibitor-37 | 2416971-40-7 | Reference compound |
| HY-147555 | HIV-1 inhibitor-38 | 2416971-48-5 | Reference compound |
| HY-147556 | SK3 Channel-IN-1 | 2396571-04-1 | Reference compound |
| HY-147557 | PAC1R antagonist 1 | 2305204-24-2 | Reference compound |
| HY-147558 | CB1R Allosteric modulator 1 | 2513102-41-3 | Reference compound |
| HY-147559 | CB1R Allosteric modulator 2 | 2513102-64-0 | Reference compound |
| HY-14756 | Totrombopag | 376592-42-6 | Reference compound |
| HY-147560 | σ1 Receptor/μ Opioid receptor modulator 1 | 2412700-00-4 | Reference compound |
| HY-147561 | ALPK1-IN-1 | 2765457-72-3 | Reference compound |
| HY-147562 | ALPK1-IN-2 | 2765633-68-7 | Reference compound |
| HY-147563 | RET-IN-17 | 1885880-08-9 | Reference compound |
| HY-147564 | RET-IN-18 | 2759292-94-7 | Reference compound |
| HY-147565 | ATR-IN-13 | 2758113-84-5 | Reference compound |
| HY-147566 | ATR-IN-14 | 2765785-88-2 | Reference compound |
| HY-147567 | ATR-IN-15 | 2756665-52-6 | Reference compound |
| HY-147568 | ATR-IN-16 | 2756589-62-3 | Reference compound |
| HY-147569 | ATR-IN-17 | 2761194-15-2 | Reference compound |
| HY-14757 | Trelanserin | 189003-92-7 | Reference compound |
| HY-147570 | ATR-IN-18 | 2766407-55-8 | Reference compound |
| HY-147571 | BET-IN-9 | 2758778-88-8 | Reference compound |
| HY-147572 | BET-IN-10 | 2758778-95-7 | Reference compound |
| HY-147573 | BRD4 Inhibitor-23 | 2760307-53-5 | Reference compound |
| HY-147574 | Axl-IN-7 | 1770821-83-4 | Reference compound |
| HY-147575 | Axl-IN-8 | 2231424-62-5 | Reference compound |
| HY-147576 | Axl-IN-9 | 2487649-73-8 | Reference compound |
| HY-147577 | Axl-IN-10 | 2487649-61-4 | Reference compound |
| HY-147578 | Axl-IN-11 | 2758688-17-2 | Reference compound |
| HY-147579 | Axl-IN-12 | 2758062-17-6 | Reference compound |
| HY-14758 | Adipiplon | 840486-93-3 | Reference compound |
| HY-147580 | BTK-IN-10 | 2758596-07-3 | Reference compound |
| HY-147581 | BTK-IN-11 | 2765852-46-6 | Reference compound |
| HY-147582 | BTK-IN-12 | 2762043-53-6 | Reference compound |
| HY-147584 | BTK-IN-14 | 2764674-60-2 | Reference compound |
| HY-147585 | C5aR-IN-1 | 2761048-02-4 | Reference compound |
| HY-147586 | C5aR-IN-2 | 2761048-06-8 | Reference compound |
| HY-147587 | C5aR-IN-3 | 2761048-50-2 | Reference compound |
| HY-147588 | CD73-IN-7 | 2763709-14-2 | Reference compound |
| HY-147589 | CD73-IN-8 | 2763710-08-1 | Reference compound |
| HY-14759 | Aleplasinin | 481629-87-2 | Reference compound |
| HY-147590 | CD73-IN-9 | 2766565-88-0 | Reference compound |
| HY-147591 | CD73-IN-10 | 2766565-91-5 | Reference compound |
| HY-147592 | CD73-IN-11 | 2766566-11-2 | Reference compound |
| HY-147593 | CD73-IN-12 | 2773502-79-5 | Reference compound |
| HY-147594 | CD73-IN-13 | 2773423-69-9 | Reference compound |
| HY-147595 | KRAS G12D inhibitor 15 | 2763155-39-9 | Reference compound |
| HY-147597 | CDK7-IN-13 | 2765676-20-6 | Reference compound |
| HY-147598 | CDK7-IN-14 | 2765676-49-9 | Reference compound |
| HY-147600 | CDK7-IN-15 | 2765676-02-4 | Reference compound |
| HY-147601 | CDK7-IN-16 | 2765676-32-0 | Reference compound |
| HY-147602 | CDK7-IN-17 | 2765676-60-4 | Reference compound |
| HY-147603 | CDK7-IN-18 | 2765676-81-9 | Reference compound |
| HY-147604 | Factor B-IN-2 | 2760669-72-3 | Reference compound |
| HY-147605 | Factor B-IN-3 | 2760669-74-5 | Reference compound |
| HY-147606 | Factor B-IN-4 | 2760669-84-7 | Reference compound |
| HY-147607 | Lanoracopan | 2797066-85-2 | Reference compound |
| HY-147608 | CSF1R-IN-7 | 2738328-56-6 | Reference compound |
| HY-147609 | CSF1R-IN-8 | 2765301-60-6 | Reference compound |
| HY-14761 | Bentamapimod | 848344-36-5 | Reference compound |
| HY-147610 | CSF1R-IN-9 | 2765301-84-4 | Reference compound |
| HY-147611 | CSF1R-IN-10 | 2765301-88-8 | Reference compound |
| HY-147612 | Tyrosine kinase-IN-4 | 765949-21-1 | Reference compound |
| HY-147613 | PI3K/mTOR Inhibitor-6 | 2456295-59-1 | Reference compound |
| HY-147614 | PI3K/mTOR Inhibitor-7 | 2456295-65-9 | Reference compound |
| HY-147615 | CSF1R-IN-12 | 2361556-35-4 | Reference compound |
| HY-147616 | CSF1R-IN-13 | 2361556-61-6 | Reference compound |
| HY-147617 | CSF1R-IN-14 | 2361378-89-2 | Reference compound |
| HY-147619 | FGFR-IN-4 | 2761211-49-6 | Reference compound |
| HY-14762 | Besifloxacin | 141388-76-3 | Reference compound |
| HY-147620 | FGFR-IN-5 | 2762750-70-7 | Reference compound |
| HY-147621 | FGFR-IN-6 | 2762955-18-8 | Reference compound |
| HY-147622 | GLP-1R agonist 9 | 2401894-00-4 | Reference compound |
| HY-147623 | GLP-1R agonist 10 | 2762515-25-1 | Reference compound |
| HY-147625 | GLP-1R agonist 12 | 2765595-19-3 | Reference compound |
| HY-147626 | GLP-1R agonist 13 | 2768016-72-2 | Reference compound |
| HY-147627 | GLP-1R agonist 14 | 2758666-01-0 | Reference compound |
| HY-147628 | GLP-1R agonist 15 | 2763621-11-8 | Reference compound |
| HY-147629 | GLP-1R agonist 16 | 2763329-13-9 | Reference compound |
| HY-14763 | Cariprazine | 839712-12-8 | Reference compound |
| HY-147631 | KRAS G12C inhibitor 50 | 2760354-12-7 | Reference compound |
| HY-147632 | KRAS G12C inhibitor 51 | 2762632-78-8 | Reference compound |
| HY-147633 | KRAS G12C inhibitor 52 | 2761204-87-7 | Reference compound |
| HY-147634 | KRAS G12C inhibitor 53 | 2761968-93-6 | Reference compound |
| HY-147635 | KRAS G12C inhibitor 54 | 2765580-17-2 | Reference compound |
| HY-147636 | KRAS G12C inhibitor 55 | 2508134-76-5 | Reference compound |
| HY-147637 | EphA2 agonist 1 | 2611459-57-3 | Reference compound |
| HY-147638 | MONIRO-1 | 1909225-94-0 | Reference compound |
| HY-147639 | Cav 2.2/3.2 blocker 1 | 2987640-67-3 | Reference compound |
| HY-14763A | Cariprazine (hydrochloride) | 1083076-69-0 | Reference compound |
| HY-14763R | Cariprazine (Standard) | 839712-12-8 | Reference Standards |
| HY-14763S | Cariprazine-d6 | 1308278-67-2 | Isotope-Labeled Compounds |
| HY-14763S1 | Cariprazine-d8 | 1308278-50-3 | Isotope-Labeled Compounds |
| HY-147642 | ChemR23-IN-4 | 2465085-23-6 | Reference compound |
| HY-147643 | Aminoacyl tRNA synthetase-IN-2 | 93218-59-8 | Reference compound |
| HY-147644 | α-Synuclein inhibitor 3 | 2687831-18-9 | Reference compound |
| HY-147645 | FBPase-IN-2 | 127143-25-3 | Reference compound |
| HY-147646 | CDK1/Cyc B-IN-1 | 2459916-56-2 | Reference compound |
| HY-147647 | Glyoxalase I inhibitor 5 | 2455508-17-3 | Reference compound |
| HY-147648 | Glyoxalase I inhibitor 6 | 2455508-19-5 | Reference compound |
| HY-147649 | Glyoxalase I inhibitor 7 | 2455508-31-1 | Reference compound |
| HY-147650 | HIV-1 protease-IN-5 | 2525173-96-8 | Reference compound |
| HY-147651 | β-catenin-IN-4 | 2353536-67-9 | Reference compound |
| HY-147652 | G-quadruplex DNA fluorescence probe 1 | Dye Reagents | |
| HY-147653 | Integrase-LEDGF/p75 allosteric inhibitor 1 | 1431738-14-5 | Reference compound |
| HY-147654 | PROTAC Hemagglutinin Degrader-1 | 3031330-66-9 | Reference compound |
| HY-147655 | CQ211 | 2648986-65-4 | Reference compound |
| HY-147656 | NAMPT degrader-1 | 3011778-39-2 | Reference compound |
| HY-147657 | GABAA receptor modulator-2 | 2413850-54-9 | Reference compound |
| HY-147658 | AChE/BChE/BACE-1-IN-1 | 1321361-13-0 | Reference compound |
| HY-147659 | AChE/BChE/BACE-1-IN-2 | 1877000-20-8 | Reference compound |
| HY-147660 | IMMH001 | 1418093-75-0 | Reference compound |
| HY-147661 | DHFR-IN-2 | 331942-46-2 | Reference compound |
| HY-147662 | hCAIX-IN-5 | 2451479-57-3 | Reference compound |
| HY-147663 | hCAIX-IN-6 | 2451479-86-8 | Reference compound |
| HY-147664 | hCAXII-IN-1 | 2451479-66-4 | Reference compound |
| HY-147665 | hCAIX-IN-7 | 2451479-58-4 | Reference compound |
| HY-147666 | α-Synuclein inhibitor 4 | 2489813-08-1 | Reference compound |
| HY-147667 | α-Synuclein inhibitor 5 | 2489813-11-6 | Reference compound |
| HY-147668 | α-Synuclein inhibitor 6 | 2489813-02-5 | Reference compound |
| HY-147669 | α-Synuclein inhibitor 7 | 2489813-04-7 | Reference compound |
| HY-147670 | TPB15 | 2170347-69-8 | Reference compound |
| HY-147671 | CB 168 | 1241942-59-5 | Reference compound |
| HY-147672 | IleRS-IN-1 | 2502167-19-1 | Reference compound |
| HY-147674 | Isoleucyl tRNA synthetase-IN-2 | 2494195-61-6 | Reference compound |
| HY-147678 | GPR40 agonist 5 | 2443384-60-7 | Reference compound |
| HY-14768 | Favipiravir | 259793-96-9 | Reference compound |
| HY-147681 | SUN13837 | 1080650-67-4 | Reference compound |
| HY-147682 | NF-κB-IN-5 | 2425675-52-9 | Reference compound |
| HY-147683 | FGFR-IN-3 | 2488762-63-4 | Reference compound |
| HY-147684 | FGFR-IN-7 | 2488764-17-4 | Reference compound |
| HY-14768A | Favipiravir (sodium) | 1366418-99-6 | Reference compound |
| HY-14768R | Favipiravir (Standard) | 259793-96-9 | Reference Standards |
| HY-14768S | Favipiravir-13C15N | Isotope-Labeled Compounds | |
| HY-14769 | Folitixorin | 3432-99-3 | Reference compound |
| HY-147690 | Photosensitizer-2 | 2138330-43-3 | Reference compound |
| HY-147691 | MPO-IN-5 | 2476764-11-9 | Reference compound |
| HY-147692 | COX-2-IN-14 | 2428387-48-6 | Reference compound |
| HY-147693 | COX-1/2-IN-3 | 2428387-82-8 | Reference compound |
| HY-147694 | c-Met-IN-11 | 1446324-05-5 | Reference compound |
| HY-147695 | c-Met-IN-12 | 2426675-70-7 | Reference compound |
| HY-147696 | SMTIN-T140 | 2851532-40-4 | Reference compound |
| HY-147697 | LSD1-IN-21 | Reference compound | |
| HY-147698 | ZLHQ-5f | 2851977-85-8 | Reference compound |
| HY-147699 | FRα-IN-1 | 2028296-64-0 | Reference compound |
| HY-14769A | Folitixorin (calcium) | 133978-75-3 | Reference compound |
| HY-14770 | Ibodutant | 522664-63-7 | Reference compound |
| HY-147700 | Antiviral agent 21 | 2420396-84-3 | Reference compound |
| HY-147701 | OfHex1-IN-1 | Reference compound | |
| HY-147702 | BB 0305179 | 2512200-83-6 | Reference compound |
| HY-147703 | Aurora kinase inhibitor-9 | 2419107-09-6 | Reference compound |
| HY-147704 | Antimycobacterial agent-2 | 62670-49-9 | Reference compound |
| HY-147705 | PPARγ phosphorylation inhibitor 1 | 2882975-84-8 | Reference compound |
| HY-147706 | AR524 | 2568148-31-0 | Reference compound |
| HY-147707 | CB2 receptor antagonist 1 | 2772693-05-5 | Reference compound |
| HY-147708 | T-Type calcium channel inhibitor 2 | 2771965-57-0 | Reference compound |
| HY-147709 | Tyrosinase-IN-6 | 2569221-17-4 | Reference compound |
| HY-14771 | Imeglimin | 775351-65-0 | Reference compound |
| HY-147710 | PIN1 inhibitor 2 | 2417101-28-9 | Reference compound |
| HY-147711 | α-Amylase/α-Glucosidase-IN-1 | 329783-03-1 | Reference compound |
| HY-147712 | PKC-IN-4 | 2636771-29-2 | Reference compound |
| HY-147713 | FGFR3-IN-1 | 2428743-04-6 | Reference compound |
| HY-147714 | FGFR3-IN-2 | 2428742-58-7 | Reference compound |
| HY-147715 | FGFR3-IN-3 | 2428738-41-2 | Reference compound |
| HY-147716 | CDK8-IN-6 | 2415156-27-1 | Reference compound |
| HY-147717 | CDK8-IN-7 | 2415156-30-6 | Reference compound |
| HY-147718 | α-Glucosidase-IN-5 | 111316-33-7 | Reference compound |
| HY-147719 | COX-2-IN-16 | 1610894-92-2 | Reference compound |
| HY-14771A | Imeglimin (hydrochloride) | 775351-61-6 | Reference compound |
| HY-14771S | Imeglimin-d3 | Isotope-Labeled Compounds | |
| HY-147720 | γ-Secretase modulator 11 | 2434630-29-0 | Reference compound |
| HY-147720A | γ-Secretase modulator 11 (hydrochloride) | 2434630-30-3 | Reference compound |
| HY-147721 | Dihydropteroate synthase-IN-1 | 2418026-70-5 | Reference compound |
| HY-147722 | hCAIX-IN-8 | 2414633-40-0 | Reference compound |
| HY-147723 | HIV-1 inhibitor-39 | 2414099-82-2 | Reference compound |
| HY-147724 | Microtubule inhibitor 3 | 1236141-96-0 | Reference compound |
| HY-147725 | Microtubule inhibitor 4 | 2411962-64-4 | Reference compound |
| HY-147726 | Microtubule inhibitor 5 | 2416338-55-9 | Reference compound |
| HY-147727 | Microtubule inhibitor 6 | 2416338-64-0 | Reference compound |
| HY-147728 | Microtubule inhibitor 7 | 2416338-65-1 | Reference compound |
| HY-147729 | UIAA-II-232 | 2428407-03-6 | Reference compound |
| HY-14773 | Mirabegron | 223673-61-8 | Reference compound |
| HY-147730 | HDAC6-IN-8 | 2796282-49-8 | Reference compound |
| HY-147731 | HDAC6-IN-9 | 2796282-58-9 | Reference compound |
| HY-147732 | sEH inhibitor-4 | 2851838-08-7 | Reference compound |
| HY-147733 | sEH inhibitor-5 | 2752467-28-8 | Reference compound |
| HY-147734 | Calpain Inhibitor-2 | 2413962-65-7 | Reference compound |
| HY-147735 | GABAA receptor agonist 1 | Reference compound | |
| HY-147736 | GABAA receptor agonist 2 | Reference compound | |
| HY-147737S | Ammonium-15N,d4 (chloride) | 99011-95-7 | Isotope-Labeled Compounds |
| HY-147738 | SQM-NBD | 2786704-34-3 | Dye Reagents |
| HY-14773R | Mirabegron (Standard) | 223673-61-8 | Reference Standards |
| HY-14773S | (Rac)-Mirabegron-d5 | 1215807-38-7 | Isotope-Labeled Compounds |
| HY-14773S1 | Mirabegron-d8 | Isotope-Labeled Compounds | |
| HY-14773S3 | Mirabegron-d5 | 1258889-45-0 | Isotope-Labeled Compounds |
| HY-14774 | Monepantel | 887148-69-8 | Reference compound |
| HY-147740 | WEHI-150 | 70492-21-6 | Reference compound |
| HY-147741 | DPPY | 2095883-62-6 | Reference compound |
| HY-147742 | Thi-DPPY | 2307699-34-7 | Reference compound |
| HY-147743 | SMO-IN-1 | 1126365-66-9 | Reference compound |
| HY-147744 | AZD7254 | 1126366-28-6 | Reference compound |
| HY-147745 | MMP2-IN-2 | 1772-39-0 | Reference compound |
| HY-147746 | MMP2-IN-3 | 897799-81-4 | Reference compound |
| HY-147747 | HSP90-IN-12 | 2408643-60-5 | Reference compound |
| HY-147748 | COX-2-IN-17 | 2411390-10-6 | Reference compound |
| HY-14774R | Monepantel (Standard) | 887148-69-8 | Reference Standards |
| HY-14774S | (Rac)-Monepantel-d5 | 2747918-33-6 | Isotope-Labeled Compounds |
| HY-14774S1 | (Rac)-Monepantel sulfone-d5 | 2747918-68-7 | Isotope-Labeled Compounds |
| HY-14775 | Nesbuvir | 691852-58-1 | Reference compound |
| HY-147750 | TDP1 Inhibitor-2 | 859142-95-3 | Reference compound |
| HY-147751 | APJ receptor agonist 6 | 1965244-85-2 | Reference compound |
| HY-147754 | JAK3/BTK-IN-6 | 2243136-03-8 | Reference compound |
| HY-147755 | C16-K-cBB1 | Reference compound | |
| HY-147756 | Nampt-IN-7 | 1223378-42-4 | Reference compound |
| HY-147757 | PPARγ/δ modulator 1 | 2089159-00-0 | Reference compound |
| HY-147758 | BACE1/2-IN-1 | 2671036-34-1 | Reference compound |
| HY-14776 | Quarfloxin | 865311-47-3 | Reference compound |
| HY-147760 | Dyrk1A-IN-2 | Reference compound | |
| HY-147761 | GAK inhibitor 2 | 2396706-31-1 | Reference compound |
| HY-147762 | NRP1 antagonist 2 | 483289-96-9 | Reference compound |
| HY-147763 | HCV-IN-39 | 2087916-31-0 | Reference compound |
| HY-147764 | HCV-IN-40 | 2087916-66-1 | Reference compound |
| HY-147765 | Anti-Trypanosoma cruzi agent-3 | 2397639-23-3 | Reference compound |
| HY-147766 | Antileishmanial agent-10 | 2397639-33-5 | Reference compound |
| HY-147767 | PI3Kα-IN-6 | 2272894-14-9 | Reference compound |
| HY-147768 | PI3K/AKT-IN-2 | 2684412-41-5 | Reference compound |
| HY-147769 | Anti-inflammatory agent 23 | Reference compound | |
| HY-14777 | Radiprodil | 496054-87-6 | Reference compound |
| HY-147770 | NF-κB-IN-6 | Reference compound | |
| HY-147771 | ZLWT-37 | 2813347-44-1 | Reference compound |
| HY-147772 | ZC0101 | 2541604-52-6 | Reference compound |
| HY-147773 | NAAA-IN-1 | 1439366-66-1 | Reference compound |
| HY-147774 | Cathepsin K inhibitor 6 | 325775-42-6 | Reference compound |
| HY-147775 | NAAA-IN-3 | 1831115-59-3 | Reference compound |
| HY-147776 | Antiproliferative agent-8 | Reference compound | |
| HY-147777 | 14α-Demethylase/DNA Gyrase-IN-2 | 2330812-64-9 | Reference compound |
| HY-147778 | 14α-Demethylase/DNA Gyrase-IN-1 | Reference compound | |
| HY-147779 | VEGFR-2-IN-20 | 2404581-25-3 | Reference compound |
| HY-14778 | Retosiban | 820957-38-8 | Reference compound |
| HY-147780 | Fissitungfine B | 1996671-09-0 | Reference compound |
| HY-147781 | Anticancer agent 66 | 2691895-64-2 | Reference compound |
| HY-147782 | Anticancer agent 67 | 2691895-66-4 | Reference compound |
| HY-147783 | Anticancer agent 68 | 2692652-36-9 | Reference compound |
| HY-147784 | HZ-A-005 | 2041789-14-2 | Reference compound |
| HY-147785 | Pim-1 kinase inhibitor 2 | 2543624-91-3 | Reference compound |
| HY-147786 | TGFβRI-IN-5 | 2541690-15-5 | Reference compound |
| HY-147787 | Urease-IN-3 | 2543651-72-3 | Reference compound |
| HY-147788 | hDHODH-IN-9 | 133676-47-8 | Reference compound |
| HY-147789 | FPDT | Reference compound | |
| HY-14778A | (S)-Retosiban | 2994298-20-1 | Reference compound |
| HY-14779 | Riociguat | 625115-55-1 | Reference compound |
| HY-147790 | MDH1-IN-1 | 2143463-31-2 | Reference compound |
| HY-147791 | MDH1-IN-2 | 2143463-35-6 | Reference compound |
| HY-147792 | WNY1613 | 2650546-39-5 | Reference compound |
| HY-147793 | FGFR4-IN-12 | 2423992-63-4 | Reference compound |
| HY-147794 | COX-2-IN-18 | 1038061-96-9 | Reference compound |
| HY-147795 | Nampt-IN-8 | 2453183-75-8 | Reference compound |
| HY-147796 | EGFR/HER2/CDK9-IN-1 | 879730-44-6 | Reference compound |
| HY-147797 | EGFR/HER2/CDK9-IN-2 | 1180924-34-8 | Reference compound |
| HY-147798 | EGFR/HER2/CDK9-IN-3 | 422276-47-9 | Reference compound |
| HY-147799 | hCA XII/II/IX-IN-1 | Reference compound | |
| HY-14779R | Riociguat (Standard) | 625115-55-1 | Reference Standards |
| HY-14779S | Riociguat-13C,d6 | Isotope-Labeled Compounds | |
| HY-14779S3 | Riociguat-d3 | 1304478-72-5 | Isotope-Labeled Compounds |
| HY-14780 | Viquidacin | 904302-98-3 | Reference compound |
| HY-147800 | VEGFR-2-IN-21 | 2531029-88-4 | Reference compound |
| HY-147801 | Topoisomerase IIα-IN-3 | 2538528-11-7 | Reference compound |
| HY-147802 | EGFR-IN-59 | 2529891-44-7 | Reference compound |
| HY-147803 | TrxR-IN-5 | Reference compound | |
| HY-147804 | SARS-CoV-2 3CLpro-IN-3 | 2505241-13-2 | Reference compound |
| HY-147805 | SARS-CoV-2 3CLpro-IN-4 | 2505241-31-4 | Reference compound |
| HY-147806 | Antiparasitic agent-8 | 2538594-33-9 | Reference compound |
| HY-147807 | HIV-1 inhibitor-40 | 2789676-44-2 | Reference compound |
| HY-147808 | CXCR4 antagonist 7 | 1185451-72-2 | Reference compound |
| HY-147809 | COX-2-IN-20 | 2529451-43-0 | Reference compound |
| HY-14781 | Levomefolic acid | 31690-09-2 | Natural Products |
| HY-147810 | 5-HT7 receptor ligand 1 | 2758571-64-9 | Reference compound |
| HY-147811 | Heterophdoid A | 2756016-53-0 | Natural Products |
| HY-147812 | POLA1 inhibitor 1 | 2217671-41-3 | Reference compound |
| HY-147813 | HIF-1α-IN-3 | 2170715-64-5 | Reference compound |
| HY-147814 | KFU-127 | Reference compound | |
| HY-147815 | COX-2-IN-21 | 2519631-11-7 | Reference compound |
| HY-147816 | Anticancer agent 70 | 2521770-35-2 | Reference compound |
| HY-147817 | Heme Oxygenase-2-IN-1 | 2994198-37-5 | Reference compound |
| HY-147818 | DNA Gyrase-IN-2 | 2522666-80-2 | Reference compound |
| HY-147819 | DNA Gyrase-IN-3 | 2522667-08-7 | Reference compound |
| HY-14781A | Levomefolic acid (magnesium) | 1429498-11-2 | Reference compound |
| HY-14781S1 | Levomefolic acid-13C,d3 | 1356019-94-7 | Isotope-Labeled Compounds |
| HY-14781S2 | Levomefolic acid-13C5 | 2687960-08-1 | Isotope-Labeled Compounds |
| HY-14781S3 | Levomefolic acid-d3 | Isotope-Labeled Compounds | |
| HY-14782 | Adoprazine | 222551-17-9 | Reference compound |
| HY-147820 | AY1511 | 2559709-99-6 | Reference compound |
| HY-147821 | CB1-IN-2 | 2527805-39-4 | Reference compound |
| HY-147822 | Apoptosis inducer 6 | 2529913-90-2 | Reference compound |
| HY-147823 | α-Glucosidase-IN-6 | 2497685-29-5 | Reference compound |
| HY-147824 | Tubulin polymerization-IN-22 | 2493052-22-3 | Reference compound |
| HY-147825 | EGFR/BRAFV600E-IN-1 | 2492429-45-3 | Reference compound |
| HY-147826 | EGFR-IN-60 | 2699877-43-3 | Reference compound |
| HY-147827 | hCAIX-IN-10 | 2497504-72-8 | Reference compound |
| HY-147828 | hCAIX-IN-11 | 2497504-81-9 | Reference compound |
| HY-147829 | hCAXII-IN-2 | 2497504-86-4 | Reference compound |
| HY-14782A | Adoprazine (hydrochloride) | 222551-05-5 | Reference compound |
| HY-14783 | Apricoxib | 197904-84-0 | Reference compound |
| HY-147830 | PDE4B-IN-3 | 2819779-01-4 | Reference compound |
| HY-147831 | EIF2α activator 1 | 2851820-52-3 | Reference compound |
| HY-147832 | EIF2α activator 2 | 1501618-04-7 | Reference compound |
| HY-147833 | ALK-IN-22 | 2468219-09-0 | Reference compound |
| HY-147834 | STING agonist-9 | 2653337-73-4 | Reference compound |
| HY-147835 | Antibacterial agent 109 | 2649396-65-4 | Reference compound |
| HY-147836 | Akt/NF-κB/JNK-IN-1 | Reference compound | |
| HY-147838 | Nampt-IN-9 | 2180973-35-5 | Reference compound |
| HY-147839 | Topoisomerase II inhibitor 10 | 2488208-96-2 | Reference compound |
| HY-14784 | Bederocin | 757942-43-1 | Reference compound |
| HY-147840 | HDAC-IN-41 | 2490309-83-4 | Reference compound |
| HY-147841 | HIV-1 inhibitor-41 | Reference compound | |
| HY-147844 | F8-S43-S3 | 1632320-78-5 | Reference compound |
| HY-147845 | F8-S40 | 301347-96-6 | Reference compound |
| HY-147846 | AChE/PDE4-IN-1 | Reference compound | |
| HY-147848 | Tubulin polymerization-IN-27 | 2462030-32-4 | Reference compound |
| HY-147849 | JMI-105 | 2227315-30-0 | Reference compound |
| HY-14785 | Befiradol | 208110-64-9 | Reference compound |
| HY-147850 | JMI-346 | 2091841-46-0 | Reference compound |
| HY-147851 | BACE1-IN-12 | 2479315-19-8 | Reference compound |
| HY-147852 | B-Raf IN 7 | 2477725-07-6 | Reference compound |
| HY-147853 | B-Raf IN 8 | 1215313-19-1 | Reference compound |
| HY-147854 | B-Raf IN 9 | 2477725-18-9 | Reference compound |
| HY-147855 | ACA-28 | 948044-25-5 | Reference compound |
| HY-147856 | Antileishmanial agent-11 | 2253635-71-9 | Reference compound |
| HY-147857 | Antileishmanial agent-12 | 2482764-71-4 | Reference compound |
| HY-147858 | PROTAC EGFR degrader 7 | Reference compound | |
| HY-147858A | PROTAC EGFR degrader 7 (diTFA) | Reference compound | |
| HY-147859 | BChE-IN-8 | 2653349-78-9 | Reference compound |
| HY-14785A | Befiradol (hydrochloride) | 2436760-81-3 | Reference compound |
| HY-14786 | Darotropium (bromide) | 850607-58-8 | Reference compound |
| HY-147860 | EGFR-IN-61 | 2890261-81-9 | Reference compound |
| HY-147861 | Topoisomerase II inhibitor 11 | 2476559-00-7 | Reference compound |
| HY-147862 | EGFR-IN-62 | 2890261-65-9 | Reference compound |
| HY-147863 | HBV-IN-24 | Reference compound | |
| HY-147864 | c-Fms-IN-12 | 2145102-33-4 | Reference compound |
| HY-147865 | Apoptosis inducer 8 | 2470024-51-0 | Reference compound |
| HY-147866 | Antibacterial agent 110 | Reference compound | |
| HY-147867 | MMP-2/9-IN-1 | 2415311-84-9 | Reference compound |
| HY-147868 | DC-CPin711 | 2447559-21-7 | Reference compound |
| HY-147869 | DC-CPin7 | 893781-17-4 | Reference compound |
| HY-147870 | COX-2-IN-22 | 2447589-08-2 | Reference compound |
| HY-147871 | Antimycobacterial agent-3 | 2469881-50-1 | Reference compound |
| HY-147872 | VEGFR-2-IN-22 | 2447587-73-5 | Reference compound |
| HY-147873 | NMDAR/HDAC-IN-1 | Reference compound | |
| HY-147874 | ANO1-IN-3 | 2494280-04-3 | Reference compound |
| HY-147875 | Aldose reductase-IN-6 | 2470019-41-9 | Reference compound |
| HY-147876 | Antimicrobial agent-3 | 1902712-34-8 | Reference compound |
| HY-147877 | Topoisomerase II inhibitor 12 | 2304527-20-4 | Reference compound |
| HY-147878 | Antibacterial agent 111 | 2448358-84-5 | Reference compound |
| HY-147879 | α-Glucosidase-IN-8 | 2448345-96-6 | Reference compound |
| HY-14788 | Drinabant | 358970-97-5 | Reference compound |
| HY-147880 | BChE-IN-9 | 2468035-31-4 | Reference compound |
| HY-147881 | Anti-Influenza agent 3 | 2481321-20-2 | Reference compound |
| HY-147882 | Anti-MRSA agent 6 | 2452302-73-5 | Reference compound |
| HY-147883 | Antitubercular agent-27 | 2460651-09-4 | Reference compound |
| HY-147884 | Antitubercular agent-28 | 2460651-10-7 | Reference compound |
| HY-147885 | HCV-IN-41 | 2468169-71-1 | Reference compound |
| HY-147886 | PARP1-IN-11 | 2482484-87-5 | Reference compound |
| HY-147887 | Tubulin inhibitor 28 | 71112-91-9 | Reference compound |
| HY-147888 | Tubulin inhibitor 29 | 2905-15-9 | Reference compound |
| HY-147889 | BBR-BODIPY | 2456476-47-2 | Dye Reagents |
| HY-14789 | (R)-Elagolix | 834153-87-6 | Reference compound |
| HY-147890 | Angiogenesis inhibitor 2 | 2151067-32-0 | Reference compound |
| HY-147891 | Angiogenesis inhibitor 3 | 2507759-39-7 | Reference compound |
| HY-147892 | HDAC-IN-42 | 2454024-18-9 | Reference compound |
| HY-147894 | PCAF-IN-1 | 2439194-86-0 | Reference compound |
| HY-147895 | PCAF-IN-2 | 56173-05-8 | Reference compound |
| HY-147896 | Tubulin polymerization-IN-29 | 630058-59-2 | Reference compound |
| HY-147897 | Apoptosis inducer 9 | 2551067-10-6 | Reference compound |
| HY-147898 | PI3K-IN-33 | 2458163-92-1 | Reference compound |
| HY-147899 | PI3K-IN-34 | 2458163-94-3 | Reference compound |
| HY-14790 | Esreboxetine | 98819-76-2 | Reference compound |
| HY-147900 | PI3K-IN-35 | 2458163-99-8 | Reference compound |
| HY-147901 | KDM1/CDK1-IN-1 | 2938990-92-0 | Reference compound |
| HY-147902 | VEGFR-2-IN-24 | 2455414-26-1 | Reference compound |
| HY-147903 | HIV-1 inhibitor-42 | 2459929-46-3 | Reference compound |
| HY-147904 | HIV-IN-5 | 2459929-62-3 | Reference compound |
| HY-147905 | CDK9-IN-18 | 1804127-83-0 | Reference compound |
| HY-147906 | Anticancer agent 71 | 2453228-45-8 | Reference compound |
| HY-147907 | Adenosine receptor inhibitor 1 | 2550400-52-5 | Reference compound |
| HY-147908 | Adenosine receptor inhibitor 2 | 2550401-76-6 | Reference compound |
| HY-147909 | Anticancer agent 72 | 2460167-51-3 | Reference compound |
| HY-14791 | Ibipinabant | 464213-10-3 | Reference compound |
| HY-147910 | Carpro-AM1 | 2499489-76-6 | Reference compound |
| HY-147911 | COX-2/PI3K-IN-1 | Reference compound | |
| HY-147912 | COX-2/PI3K-IN-2 | 2459938-28-2 | Reference compound |
| HY-147913 | PI3K/Akt/mTOR-IN-3 | 2457245-94-0 | Reference compound |
| HY-147914 | NSD2-IN-1 | 2797183-37-8 | Reference compound |
| HY-147915 | Benz-AP | 2416220-53-4 | Reference compound |
| HY-147917 | RNA polymerase II-IN-2 | 2891451-33-3 | Reference compound |
| HY-147918 | Anticancer agent 73 | 124811-87-6 | Reference compound |
| HY-147919 | Antifungal agent 33 | 2445277-57-4 | Reference compound |
| HY-14791A | (±)-Ibipinabant | 362519-49-1 | Reference compound |
| HY-14792 | Inolitazone | 223132-37-4 | Reference compound |
| HY-147920 | PIM1-IN-6 | 2439168-69-9 | Reference compound |
| HY-147921 | PIM1-IN-7 | 2439168-72-4 | Reference compound |
| HY-147922 | hCAI/II-IN-2 | 2480283-75-6 | Reference compound |
| HY-147923 | hCAI/II-IN-3 | 2480283-93-8 | Reference compound |
| HY-147924 | Keap1-Nrf2-IN-11 | 2796292-75-4 | Reference compound |
| HY-147925 | hCAI/II-IN-4 | 2480284-01-1 | Reference compound |
| HY-147926 | VEGFR-2-IN-28 | 2447597-39-7 | Reference compound |
| HY-147927 | Human enteropeptidase-IN-1 | 1802891-20-8 | Reference compound |
| HY-147928 | Apoptotic agent-2 | 2482310-18-7 | Reference compound |
| HY-147929 | Apoptotic agent-3 | 2482310-23-4 | Reference compound |
| HY-14792B | Inolitazone (dihydrochloride) | 223132-38-5 | Reference compound |
| HY-14793 | Lensiprazine | 327026-93-7 | Reference compound |
| HY-147930 | ACC1/2-IN-1 | 2350219-22-4 | Reference compound |
| HY-147931 | Human enteropeptidase-IN-2 | 3031537-31-9 | Reference compound |
| HY-147932 | ACC1/2-IN-2 | 1031411-94-5 | Reference compound |
| HY-147933 | Antitrypanosomal agent 8 | 332376-42-8 | Reference compound |
| HY-147934 | HDAC8-IN-3 | 2432825-93-7 | Reference compound |
| HY-147936 | TP0556351 | 2787582-17-4 | Reference compound |
| HY-147937 | AKT-IN-13 | 2459489-51-9 | Reference compound |
| HY-147938 | AChE-IN-19 | 2742707-36-2 | Reference compound |
| HY-147939 | AChE/BuChE-IN-3 | 2742707-47-5 | Reference compound |
| HY-14794 | Dextromilnacipran | 96847-55-1 | Reference compound |
| HY-147940 | TbPTR1 inhibitor 1 | 2499713-65-2 | Reference compound |
| HY-147941 | MS9427 | 2772613-37-1 | Reference compound |
| HY-147941A | MS9427 (TFA) | Reference compound | |
| HY-147942 | MS9449 | 2772612-96-9 | Reference compound |
| HY-147943 | PROTAC BTK Degrader-1 | 2801715-13-7 | Reference compound |
| HY-147944 | Antimicrobial agent-4 | 2429922-67-6 | Reference compound |
| HY-147945 | DNA gyrase B-IN-1 | Reference compound | |
| HY-147946 | PDE1-IN-4 | 3031349-98-8 | Reference compound |
| HY-147947 | Tubulin polymerization-IN-30 | 2521560-46-1 | Reference compound |
| HY-147948 | DNA Gyrase-IN-4 | 2416400-32-1 | Reference compound |
| HY-147949 | SKLB0565 | 2414607-10-4 | Reference compound |
| HY-14794A | Levomilnacipran | 96847-54-0 | Reference compound |
| HY-14794AS | Levomilnacipran-d10 (hydrochloride) | 2747914-23-2 | Isotope-Labeled Compounds |
| HY-14795 | Mimopezil | 180694-97-7 | Reference compound |
| HY-147950 | PDE4-IN-10 | 2413564-66-4 | Reference compound |
| HY-147951 | COX-2/5-LOX-IN-3 | 2481484-51-7 | Reference compound |
| HY-147952 | AChE-IN-20 | 2428389-65-3 | Reference compound |
| HY-147953 | MAO-B-IN-13 | 2105918-34-9 | Reference compound |
| HY-147954 | α-Glycosidase-IN-1 | 2428389-66-4 | Reference compound |
| HY-147955 | hCAI/II-IN-5 | 2428389-67-5 | Reference compound |
| HY-147956 | hCA VB-IN-1 | Reference compound | |
| HY-147957 | Antibacterial agent 112 | Reference compound | |
| HY-147958 | Antibacterial agent 113 | Reference compound | |
| HY-147959 | Antibacterial agent 114 | 2733391-71-2 | Reference compound |
| HY-14796 | Olesoxime | 22033-87-0 | Reference compound |
| HY-147960 | Glycosyltransferase-IN-1 | Reference compound | |
| HY-147961 | COX-2-IN-23 | 2417995-08-3 | Reference compound |
| HY-147962 | AChE/HDAC-IN-1 | 2414053-06-6 | Reference compound |
| HY-147963 | COX-2-IN-24 | 2417995-10-7 | Reference compound |
| HY-147964 | α-Glucosidase-IN-9 | 735273-33-3 | Reference compound |
| HY-147965 | α-Glucosidase-IN-10 | 2586282-68-8 | Reference compound |
| HY-147966 | HDAC-IN-43 | 1809163-24-3 | Reference compound |
| HY-147967 | EGFR-IN-63 | 2414635-72-4 | Reference compound |
| HY-147968 | Anticancer agent 74 | 2242503-82-6 | Reference compound |
| HY-147969 | Antiangiogenic agent 2 | 2422149-84-4 | Reference compound |
| HY-14797 | Ombrabulin | 181816-48-8 | Reference compound |
| HY-147970 | Antifungal agent 34 | 2036123-97-2 | Reference compound |
| HY-147971 | Anticancer agent 75 | 2414491-13-5 | Reference compound |
| HY-147972 | NF-κB/MAPK-IN-1 | 2413940-56-2 | Reference compound |
| HY-147973 | IZTZ-1 | 2636771-45-2 | Reference compound |
| HY-147974 | HSP90-IN-14 | 1995132-67-6 | Reference compound |
| HY-147975 | JAK3-IN-12 | 1430095-86-5 | Reference compound |
| HY-147976 | Glucocerebrosidase-IN-1 | 2279945-76-3 | Reference compound |
| HY-147976A | Glucocerebrosidase-IN-1 (hydrochloride) | 2279945-77-4 | Reference compound |
| HY-147977 | ALR1/2-IN-1 | 2419233-57-9 | Reference compound |
| HY-147978 | CXCR4 antagonist 8 | 2304750-84-1 | Reference compound |
| HY-147979 | CXCR4 antagonist 9 | 2304750-83-0 | Reference compound |
| HY-14798 | Palifosfamide | 31645-39-3 | Reference compound |
| HY-147980 | Aβ-IN-5 | 2417977-65-0 | Reference compound |
| HY-147981 | Tubulin polymerization-IN-31 | 2421121-79-9 | Reference compound |
| HY-147982 | GABA-AT-IN-1 | 242148-96-5 | Reference compound |
| HY-147983 | PI3Kα-IN-8 | 2315320-24-0 | Reference compound |
| HY-147984 | hCAXII-IN-3 | 2417232-24-5 | Reference compound |
| HY-147985 | hCA I-IN-1 | 2417232-26-7 | Reference compound |
| HY-147986 | hCA I-IN-2 | 2417232-12-1 | Reference compound |
| HY-147987 | FFA1 agonist-1 | 2417231-16-2 | Reference compound |
| HY-147988 | DNA Gyrase-IN-5 | 2417016-23-8 | Reference compound |
| HY-14798R | Palifosfamide (Standard) | 31645-39-3 | Reference Standards |
| HY-14799 | Palovarotene | 410528-02-8 | Reference compound |
| HY-147990 | PDE5-IN-5 | 2414921-33-6 | Reference compound |
| HY-147991 | PDE5/HDAC-IN-1 | 2414921-48-3 | Reference compound |
| HY-147992 | EGFR/HER2-IN-4 | 1879071-89-2 | Reference compound |
| HY-147993 | Aurora kinase inhibitor-10 | 2417228-90-9 | Reference compound |
| HY-147994 | EGFR/HER2-IN-5 | 1879071-97-2 | Reference compound |
| HY-147995 | EGFR-IN-64 | 2416924-93-9 | Reference compound |
| HY-147996 | EGFR-IN-67 | 2416924-99-5 | Reference compound |
| HY-147997 | EGFR-IN-68 | 2416925-03-4 | Reference compound |
| HY-147998 | Enpp-1-IN-13 | 2417022-19-4 | Reference compound |
| HY-147999 | GlcN-6-P Synthase-IN-1 | 2415311-87-2 | Reference compound |
| HY-14800 | Radezolid | 869884-78-6 | Reference compound |
| HY-148000 | sEH inhibitor-6 | 1205963-04-7 | Reference compound |
| HY-148001 | EWP 815 | 20231-01-0 | Reference compound |
| HY-148002 | 1'-Hydroxy Midazolam-β-D-glucuronide | 81256-81-7 | Reference compound |
| HY-148009 | Cardiolipin (16:0/18:1/16:0/18:1) (sodium) | 2260669-35-8 | Reference compound |
| HY-14800R | Radezolid (Standard) | 869884-78-6 | Reference Standards |
| HY-14801 | Sivifene | 2675-35-6 | Reference compound |
| HY-148012 | SOP1812 | 2546091-70-5 | Reference compound |
| HY-148013 | K284-6111 | 702668-62-0 | Reference compound |
| HY-148015 | Enbezotinib (enantiomer) | 2359650-19-2 | Reference compound |
| HY-148016 | I-287 | 2014368-93-3 | Reference compound |
| HY-148019 | 2′-Deoxy-2′-fluoro-N-methyladenosine | 134444-58-9 | Reference compound |
| HY-14802 | Talarozole (R enantiomer) | 870093-23-5 | Reference compound |
| HY-148026 | Sonrotoclax | 2383086-06-2 | Reference compound |
| HY-148029 | Dazostinag (disodium) | 2553413-93-5 | Reference compound |
| HY-14802C | (+)-Talarozole | 201410-66-4 | Reference compound |
| HY-14802D | (-)-Talarozole | 201410-67-5 | Reference compound |
| HY-14803 | Tasimelteon | 609799-22-6 | Reference compound |
| HY-148030 | XL01126 | 3011029-58-3 | Reference compound |
| HY-148031 | MC-Ala-Ala-Asn-PAB-PNP | 1638970-45-2 | ADC Related |
| HY-148033 | Trimethyl chitosan | 52349-26-5 | Reference compound |
| HY-148034 | Plm IV inhibitor-1 | 1539276-41-9 | Reference compound |
| HY-148035 | Plm IV inhibitor-2 | 1539276-38-4 | Reference compound |
| HY-148036 | FLT3-IN-16 | 298207-49-5 | Reference compound |
| HY-148036S | FLT3-IN-16-d1 | Isotope-Labeled Compounds | |
| HY-148037 | Thrombin inhibitor 5 | 328108-09-4 | Reference compound |
| HY-148038 | 5-HT3 antagonist 5 | 901599-43-7 | Reference compound |
| HY-14803R | Tasimelteon (Standard) | 609799-22-6 | Reference Standards |
| HY-14803S | Tasimelteon-d5 | 1962124-51-1 | Isotope-Labeled Compounds |
| HY-14804 | Tasisulam | 519055-62-0 | Reference compound |
| HY-148040 | VEGFR-2-IN-29 | 62802-77-1 | Reference compound |
| HY-148041 | ATPase-IN-2 | 85573-18-8 | Reference compound |
| HY-148042 | HIV-1 inhibitor-47 | 137448-39-6 | Reference compound |
| HY-148043 | Schnurri-3 inhibitor-1 | 736154-60-2 | Reference compound |
| HY-148044 | UNC10201652 | 372495-52-8 | Reference compound |
| HY-148045 | TLR9-IN-1 | 2226366-86-3 | Reference compound |
| HY-148046 | USP15-IN-1 | 2260826-16-0 | Reference compound |
| HY-148049 | TT3 | 1821214-50-9 | Reference compound |
| HY-14804A | Tasisulam (sodium) | 519055-63-1 | Reference compound |
| HY-14805 | Tecovirimat | 869572-92-9 | Reference compound |
| HY-148051 | Ilaprazole sulfone | 172152-37-3 | Reference compound |
| HY-148052 | RIPK3-IN-2 | 2665669-32-7 | Reference compound |
| HY-148053 | Rezivertinib analogue 1 | 2227103-37-7 | Reference compound |
| HY-148053R | Rezivertinib analogue 1 (Standard) | 2227103-37-7 | Reference Standards |
| HY-148054 | Antifungal agent 36 | 34967-98-1 | Reference compound |
| HY-148055 | Wnt/β-catenin agonist 3 | 912790-59-1 | Reference compound |
| HY-148055A | Wnt/β-catenin agonist 3 (hydrochloride) | Reference compound | |
| HY-148057 | TCO-PEG4-VC-PAB-MMAE | 2758671-45-1 | ADC Related |
| HY-148058 | Topoisomerase I inhibitor 8 | 210346-40-0 | Reference compound |
| HY-148059 | Uplarafenib | 1425485-87-5 | Reference compound |
| HY-14805A | Tecovirimat (monohydrate) | 1162664-19-8 | Reference compound |
| HY-14805R | Tecovirimat (Standard) | 869572-92-9 | Reference Standards |
| HY-14805S | Tecovirimat-d4 | Isotope-Labeled Compounds | |
| HY-14806 | Teneligliptin | 760937-92-6 | Reference compound |
| HY-148060 | JAK-IN-21 | 2445499-20-5 | Reference compound |
| HY-148061 | DB1113 | 2769753-53-7 | Reference compound |
| HY-148062 | RSS0680 | 2769753-48-0 | Reference compound |
| HY-148063 | DB0614 | 2769753-47-9 | Reference compound |
| HY-148065 | FMF-06-098-1 | 2769753-07-1 | Reference compound |
| HY-148066 | DB0662 | 2769753-51-5 | Reference compound |
| HY-148067 | XMT-1519 conjugate-1 | 2720500-19-4 | ADC Related |
| HY-148067A | XMT-1519 conjugate-1 (TFA) | ADC Related | |
| HY-148068 | STING agonist-20 | 2591300-72-8 | Reference compound |
| HY-14806A | Teneligliptin (hydrobromide) | 906093-29-6 | Reference compound |
| HY-14806B | Teneligliptin (hydrobromide hydrate) | 1572583-29-9 | Reference compound |
| HY-14806R | Teneligliptin (Standard) | 760937-92-6 | Reference Standards |
| HY-14806S | Teneligliptin-d8 | 1391012-95-5 | Isotope-Labeled Compounds |
| HY-14806S1 | Teneligliptin-d4 | Isotope-Labeled Compounds | |
| HY-14806S2 | Teneligliptin-d5 | Isotope-Labeled Compounds | |
| HY-14807 | Tosedostat | 238750-77-1 | Reference compound |
| HY-148070 | FLT3-IN-17 | 2758999-62-9 | Reference compound |
| HY-148071 | Epocholeone | 162922-31-8 | Reference compound |
| HY-148072 | MM3122 | 2574390-27-3 | Reference compound |
| HY-148073 | MeO-Succ-Arg-Pro-Tyr-AMC | Dye Reagents | |
| HY-148074 | Zelnecirnon | 2366152-15-8 | Reference compound |
| HY-148075 | PI4KIIIbeta-IN-11 | 2365241-79-6 | Reference compound |
| HY-148076 | A2A receptor antagonist 3 | 2738606-83-0 | Reference compound |
| HY-148077 | Phosphoglycolohydroxamic acid | 51528-59-7 | Reference compound |
| HY-148078 | PFM03 | 1558598-48-3 | Reference compound |
| HY-14808 | Adarotene | 496868-77-0 | Reference compound |
| HY-148080 | Indole-C2-amide-C2-NH2 | 215789-29-0 | Reference compound |
| HY-148083 | TBBPA-sulfate | 902525-22-8 | Reference compound |
| HY-148087 | AZD5462 | 2787501-83-9 | Reference compound |
| HY-148088 | M1069 | 3027658-65-4 | Reference compound |
| HY-148088A | M1069 (free base) | 2459881-03-7 | Reference compound |
| HY-148089 | Eplontersen | 1637600-16-8 | Oligonucleotides |
| HY-148089A | Eplontersen (sodium) | 2131025-75-5 | Oligonucleotides |
| HY-14809 | Amenamevir | 841301-32-4 | Reference compound |
| HY-148091 | Duocarmycin analog-2 | 1164275-01-7 | Reference compound |
| HY-148092 | PM-43I | 1637532-77-4 | Reference compound |
| HY-148093 | PM-81I | 1637532-83-2 | Reference compound |
| HY-148096 | STAT6-IN-1 | 1637532-68-3 | Reference compound |
| HY-148098 | Pan KRas-IN-1 | 2791263-84-6 | Reference compound |
| HY-148099 | USP1-IN-2 | 2098212-05-4 | Reference compound |
| HY-14809R | Amenamevir (Standard) | 841301-32-4 | Reference Standards |
| HY-14810 | Atigliflozin | 647834-15-9 | Reference compound |
| HY-148100 | Emapticap pegol | 1390630-22-4 | Oligonucleotides |
| HY-148100A | Emapticap pegol (sodium) | Oligonucleotides | |
| HY-148103 | SR12418 | 1801185-08-9 | Reference compound |
| HY-148104 | ACSS2-IN-2 | 2332820-04-7 | Reference compound |
| HY-148105 | DS12881479 | 2373065-59-7 | Reference compound |
| HY-148106 | MEL23 | 642072-49-9 | Reference compound |
| HY-148108 | AChE-IN-27 | 177028-90-9 | Reference compound |
| HY-148109 | FAK-IN-7 | 19948-85-7 | Reference compound |
| HY-14811 | Beloranib | 251111-30-5 | Reference compound |
| HY-148110 | FAK-IN-8 | 1374959-91-7 | Reference compound |
| HY-148111 | Antitubercular agent-33 | 476317-29-0 | Reference compound |
| HY-148112 | Casein kinase 1δ-IN-1 | 851871-94-8 | Reference compound |
| HY-148113 | PG 34 | 1681056-62-1 | Reference compound |
| HY-148114 | MOPIPP | 1485521-76-3 | Reference compound |
| HY-148115 | S1p receptor agonist 2 | 1354908-17-0 | Reference compound |
| HY-148116 | DN02 | Reference compound | |
| HY-148117 | MD13 | 2758431-97-7 | Reference compound |
| HY-148118 | Tri-GalNAc(OAc)3 | 1159408-64-6 | Reference compound |
| HY-148118A | Tri-GalNAc(OAc)3 (TFA) | 1159408-65-7 | Reference compound |
| HY-14811A | Beloranib (hemioxalate) | 529511-79-3 | Reference compound |
| HY-14812 | Karenitecin | 203923-89-1 | Reference compound |
| HY-148122 | NW 1028 | 2749599-78-6 | Reference compound |
| HY-148123 | Glycerophospholipids, cephalins | 39382-08-6 | Biochemical Assay Reagents |
| HY-148124 | 6-epi Doxycycline | 3219-99-6 | Reference compound |
| HY-148127 | TAM558 | 1802499-21-3 | ADC Related |
| HY-148128 | TAM470 | 1802498-63-0 | ADC Related |
| HY-148129 | TRPC6-IN-3 | 2311863-36-0 | Reference compound |
| HY-14813 | Cutamesine | 165377-43-5 | Reference compound |
| HY-148130 | Rugonersen | 2591587-57-2 | Oligonucleotides |
| HY-148130A | Rugonersen (sodium) | 2591588-58-6 | Oligonucleotides |
| HY-148132 | GSK-3β inhibitor 11 | 536731-65-4 | Reference compound |
| HY-148133 | GSK-3β inhibitor 12 | 784170-07-6 | Reference compound |
| HY-148134 | 5-LOX-IN-1 | 55040-82-9 | Reference compound |
| HY-148135 | hCAI/II-IN-6 | 694466-00-7 | Reference compound |
| HY-148136 | sEH inhibitor-7 | 340221-20-7 | Reference compound |
| HY-148137 | CB1 agonist 1 | 851212-80-1 | Reference compound |
| HY-148138 | Deaminase inhibitor-1 | 397878-17-0 | Reference compound |
| HY-148139 | Cross-linked dextran G 75 | 37224-29-6 | Biochemical Assay Reagents |
| HY-148139A | Cross-linked dextran G 75, coarse | 37224-29-6 | Biochemical Assay Reagents |
| HY-14814 | Delafloxacin | 189279-58-1 | Reference compound |
| HY-148140 | Cross-linked dextran G 25 | 9041-35-4 | Reference compound |
| HY-148140A | Cross-linked dextran G 25, coarse | 9041-35-4 | Biochemical Assay Reagents |
| HY-148140B | Cross-linked dextran G 25, medium | 9041-35-4 | Biochemical Assay Reagents |
| HY-148140C | Cross-linked dextran G 25, fine | 9041-35-4 | Biochemical Assay Reagents |
| HY-148141 | JPE-1375 | 1254036-23-1 | Reference compound |
| HY-148142 | Pomalidomide-C3-NHS ester | 2828476-87-3 | Reference compound |
| HY-148143 | Pomalidomide-C6-NHS ester | 2828476-88-4 | Reference compound |
| HY-148144 | Clobutinol | 14860-49-2 | Reference compound |
| HY-148144A | Clobutinol (hydrochloride) | 1215-83-4 | Reference compound |
| HY-148144AR | Clobutinol (hydrochloride) (Standard) | 1215-83-4 | Reference Standards |
| HY-148145 | Mebanazine | 65-64-5 | Reference compound |
| HY-148146 | Phenoxypropazine | 3818-37-9 | Reference compound |
| HY-148147 | Metamizole | 50567-35-6 | Reference compound |
| HY-14814A | Delafloxacin (meglumine) | 352458-37-8 | Reference compound |
| HY-14814AR | Delafloxacin (meglumine) (Standard) | 352458-37-8 | Reference Standards |
| HY-14814R | Delafloxacin (Standard) | 189279-58-1 | Reference Standards |
| HY-14814S | Delafloxacin-d5 | Isotope-Labeled Compounds | |
| HY-14815 | Fosbretabulin | 222030-63-9 | Reference compound |
| HY-148151 | (-)-5′-Noraristeromycin | 150132-22-2 | Reference compound |
| HY-148152 | PSMA I&S | 2639475-07-1 | Reference compound |
| HY-148152A | PSMA I&S (TFA) | Reference compound | |
| HY-148153 | C6-Amide-(PEG)n-CH3 | Reference compound | |
| HY-148154 | Poly(oxy-1,2-ethanediyl)-propoxy-amide-C6 | Reference compound | |
| HY-148155 | Iotroxic acid | 51022-74-3 | Reference compound |
| HY-148156 | Hydroxydione | 303-01-5 | Reference compound |
| HY-148157 | Amylocaine | 644-26-8 | Reference compound |
| HY-148158 | Pivalylbenzhydrazine | 306-19-4 | Reference compound |
| HY-148159 | Safrazine | 33419-68-0 | Reference compound |
| HY-148160 | Diamthazole | 95-27-2 | Reference compound |
| HY-148160A | Diamthazole (hydrochloride) | 17140-69-1 | Reference compound |
| HY-148161 | L82-G17 | 92285-87-5 | Reference compound |
| HY-148162 | Kayexalate | 37349-16-9 | Reference compound |
| HY-148163 | Polystyrene sulfonic acid (30% in water) | 28210-41-5 | Reference compound |
| HY-148165 | L-Cytidine | 26524-60-7 | Oligonucleotides |
| HY-148166 | L-Inosine | 21138-24-9 | Oligonucleotides |
| HY-148167 | 2'-Deoxy-2'-fluoro-l-uridine | 622785-69-7 | Oligonucleotides |
| HY-148168 | L-5-Methyluridine | 26879-47-0 | Oligonucleotides |
| HY-148169 | 2'-Deoxy-L-guanosine | 22837-44-1 | Oligonucleotides |
| HY-14817 | Indeglitazar | 835619-41-5 | Reference compound |
| HY-148170 | L-I-OddU | 207920-87-4 | Oligonucleotides |
| HY-148171 | L-2'-Fd4C | 221662-50-6 | Oligonucleotides |
| HY-148172 | L-Fd4A | 210474-65-0 | Oligonucleotides |
| HY-148173 | NUCC-0223619 | 1923835-78-2 | Reference compound |
| HY-148174 | JNJ-3790339 | 93076-87-0 | Reference compound |
| HY-148176 | ANEB-001 | 791848-71-0 | Reference compound |
| HY-148177 | Sutidiazine | 1821293-40-6 | Reference compound |
| HY-148178 | MMV688533 | 2260904-47-8 | Reference compound |
| HY-148179 | Neuropeptide Y5 receptor ligand-1 | 322723-35-3 | Reference compound |
| HY-14818 | Laninamivir | 203120-17-6 | Reference compound |
| HY-148180 | Antimycobacterial agent-4 | 476319-66-1 | Reference compound |
| HY-148181 | c-Fms-IN-13 | 885704-58-5 | Reference compound |
| HY-148183 | Homologous recombination-IN-1 | 391889-85-3 | Reference compound |
| HY-148184 | USP1-IN-3 | 2821749-58-8 | Reference compound |
| HY-148185 | T01-1 | 2356229-14-4 | Reference compound |
| HY-148187 | NLRP3-IN-11 | 2769040-91-5 | Reference compound |
| HY-148189 | Aldometanib | 2904601-67-6 | Reference compound |
| HY-14818A | Laninamivir octanoate | 203120-46-1 | Reference compound |
| HY-14818B | Laninamivir (TFA) | 203120-18-7 | Reference compound |
| HY-14818C | Laninamivir octanoate (hydrate) | 1233643-88-3 | Reference compound |
| HY-14818R | Laninamivir (Standard) | 203120-17-6 | Reference Standards |
| HY-14818S1 | Laninamivir-13C,15N2 | Isotope-Labeled Compounds | |
| HY-148190 | Sheng Gelieting | 1152810-23-5 | Reference compound |
| HY-148191 | CL-197 | 1030595-07-3 | Reference compound |
| HY-148193 | Tubulin polymerization-IN-38 | 1005192-31-3 | Reference compound |
| HY-148194 | SC239 | 1977557-97-3 | ADC Related |
| HY-148195 | NNZ 2591 | 847952-38-9 | Peptides |
| HY-148197 | Glutathionylspermidine | 33932-35-3 | Peptides |
| HY-148198 | S1P5 receptor agonist-1 | 2373330-78-8 | Reference compound |
| HY-14820 | Macimorelin | 381231-18-1 | Reference compound |
| HY-148200 | L2H2-6OTD | 1016263-75-4 | Reference compound |
| HY-148200A | L2H2-6OTD (diformic) | Reference compound | |
| HY-148201 | Oleana-2,12-dien-28-oic acid | 272108-04-0 | Reference compound |
| HY-148202 | Influenza antiviral conjugate-1 | 2567770-65-2 | Reference compound |
| HY-148203 | Mcl-1 inhibitor 9 | 1883727-31-8 | Reference compound |
| HY-148204 | Gallichrome | 39000-29-8 | Reference compound |
| HY-148205 | Trypanothione | 96304-42-6 | Reference compound |
| HY-148206 | DMX-129 | 1623123-95-4 | Reference compound |
| HY-148207 | S-Benzylglutathione | 6803-17-4 | Reference compound |
| HY-148208 | S-(p-Nitrobenzyl)glutathione | 6803-19-6 | Reference compound |
| HY-148209 | Balhimycin | 140932-79-2 | Peptides |
| HY-14820A | Macimorelin (acetate) | 945212-59-9 | Reference compound |
| HY-14821 | Namitecan | 372105-27-6 | Reference compound |
| HY-148210 | AMPK activator 9 | 1858204-23-5 | Reference compound |
| HY-148211 | Tetrazine-PEG7-amine (hydrochloride) | ADC Related | |
| HY-148212 | GLP-1R agonist 17 | 2749609-28-5 | Reference compound |
| HY-148213 | CDK2/4/6-IN-1 | 2803837-13-8 | Reference compound |
| HY-148214 | CDK2/4/6-IN-2 | 2531748-80-6 | Reference compound |
| HY-148215 | Hsp90-IN-17 | 1253584-78-9 | Reference compound |
| HY-148215A | Hsp90-IN-17 (hydrochloride) | 1253584-63-2 | Reference compound |
| HY-148216 | HBPC–GSH | 156727-62-7 | Reference compound |
| HY-148217 | DB02307 | 101222-71-3 | Reference compound |
| HY-148218 | N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine | 306748-45-8 | Peptides |
| HY-148223 | Tolindate | 27877-51-6 | Reference compound |
| HY-148224 | Pifoxime | 31224-92-7 | Reference compound |
| HY-148225 | Fulvestrant 3-β-D-Glucuronide | 261506-27-8 | Reference compound |
| HY-148226 | 20-5,14-HEDGE | 1092380-14-7 | Reference compound |
| HY-148228 | ROS kinases-IN-1 | 370096-57-4 | Reference compound |
| HY-14823 | Sobetirome | 211110-63-3 | Reference compound |
| HY-148230 | TFEB Decoy ODN (sodium) | Oligonucleotides | |
| HY-148231 | Dideoxy-amanitin | 58255-46-2 | ADC Related |
| HY-148232 | BAY-3153 | 2771319-69-6 | Reference compound |
| HY-148233S | JNJ-6204 | 2765264-50-2 | Isotope-Labeled Compounds |
| HY-148234 | M4K2234 | 2421141-51-5 | Reference compound |
| HY-148235 | TP-051 | 858097-86-6 | Reference compound |
| HY-148236 | BAY-390 | 2741956-55-6 | Reference compound |
| HY-148237 | JNJ-54119936 | 1599531-55-1 | Reference compound |
| HY-148238 | GNE-2256 | 2102170-43-2 | Reference compound |
| HY-148239 | TP-030-2 | 2095514-84-2 | Reference compound |
| HY-14824 | Sofiniclin | 799279-80-4 | Reference compound |
| HY-148240 | JNJ-65355394 | 2230598-99-7 | Reference compound |
| HY-148241 | A-446 | Reference compound | |
| HY-148242 | BAY-069 | 2639638-66-5 | Reference compound |
| HY-148242A | BAY-252 | 2639638-67-6 | Reference compound |
| HY-148242B | BAY-5000 | 2639435-48-4 | Reference compound |
| HY-148243 | IGUANA-1 (free base) | 2756014-24-9 | Reference compound |
| HY-148244 | MS47134 | Reference compound | |
| HY-148245 | OH-Glu-Val-Cit-PAB-MMAE | 1895916-23-0 | ADC Related |
| HY-148246 | MU1700 | Reference compound | |
| HY-148247 | BI-2081 | 1458656-71-7 | Reference compound |
| HY-148248 | BI-2540 | 875145-22-5 | Reference compound |
| HY-148249 | NVS-MALT1 | 2772439-62-8 | Reference compound |
| HY-14824A | Sofinicline (benzenesulfonate) | 876170-44-4 | Reference compound |
| HY-14825 | Tarafenacin | 385367-47-5 | Reference compound |
| HY-148250 | TP-050 | Reference compound | |
| HY-148251 | MU1742 | Reference compound | |
| HY-148252 | ADRA1D receptor antagonist 1 (free base) | 1191908-24-3 | Reference compound |
| HY-148253 | TP-030-1 | 2095514-75-1 | Reference compound |
| HY-148254 | 8RK64 | 2705841-52-5 | Reference compound |
| HY-148255 | QN523 | 878581-60-3 | Reference compound |
| HY-148258 | GDC-2394 | 2238822-07-4 | Reference compound |
| HY-148259 | SF-1 antagonist-1 | 2842079-86-9 | Reference compound |
| HY-14825A | Tarafenacin (D-tartrate) | 1159101-48-0 | Reference compound |
| HY-148260 | KRAS G12D inhibitor 16 | 2648221-12-7 | Reference compound |
| HY-148261 | KRAS G12C inhibitor 56 | 2749963-77-5 | Reference compound |
| HY-148262 | SphK1-IN-3 | Reference compound | |
| HY-148263 | Biotin-PEG-Thiol (MW 2000) | Dye Reagents | |
| HY-148264 | Imdatifan | 2511247-29-1 | Reference compound |
| HY-148265 | Antiproliferative agent-14 | 1885900-35-5 | Reference compound |
| HY-148266 | UBA5-IN-1 | 1831169-11-9 | Reference compound |
| HY-14827 | Zicronapine | 170381-16-5 | Reference compound |
| HY-148272 | IL-17A modulator-3 | 2467732-95-0 | Reference compound |
| HY-148273 | Setidegrasib | 2821793-99-9 | Reference compound |
| HY-148274 | KTX-582 | 2573298-13-0 | Reference compound |
| HY-148275 | KTX-955 | 2573302-50-6 | Reference compound |
| HY-148276 | KTX-497 | 2432993-46-7 | Reference compound |
| HY-148277 | KTX-612 | 2573298-14-1 | Reference compound |
| HY-148278 | BI-0474 | 2750570-55-7 | Reference compound |
| HY-148279 | c-Met-IN-15 | 330572-32-2 | Reference compound |
| HY-14827A | Zicronapine (fumarate) | 170381-17-6 | Reference compound |
| HY-14828 | Afacifenacin | 877606-63-8 | Reference compound |
| HY-148281 | TMX-2164 | 2418022-85-0 | Reference compound |
| HY-148283 | WAY-309236 | 690697-43-9 | Reference compound |
| HY-148284 | Berbamine acetate | 73885-53-7 | Reference compound |
| HY-148285 | Succinyl CoA | 604-98-8 | Reference compound |
| HY-148286 | Gentamicin C1a | 26098-04-4 | Reference compound |
| HY-148286R | Gentamicin C1a (Standard) | 26098-04-4 | Reference Standards |
| HY-14829 | Afegostat | 169105-89-9 | Reference compound |
| HY-148290 | KTX-951 | 2573298-36-7 | Reference compound |
| HY-148292 | C16-Sphingosine-1-phosphate | 709026-60-8 | Reference compound |
| HY-148294 | Monogalactosyl diglyceride | 41670-62-6 | Reference compound |
| HY-148296 | 4-Methoxyestradiol | 26788-23-8 | Natural Products |
| HY-148297 | Ocadusertib | 2382811-41-6 | Reference compound |
| HY-148298 | CatD-IN-1 | 1628521-28-7 | Reference compound |
| HY-14829A | Afegostat (hydrochloride) | 161302-93-8 | Reference compound |
| HY-14829B | Afegostat (tartrate) | 919364-56-0 | Reference compound |
| HY-14829E | Afegostat (D-Tartrate) | 957230-65-8 | Reference compound |
| HY-14829F | L-Afegostat | 202979-51-9 | Reference compound |
| HY-14829H | Afegostat (TFA) | 1084896-50-3 | Reference compound |
| HY-14830 | SAR 97276 | 321915-72-4 | Reference compound |
| HY-148301 | 6α-Hydroxyestradiol | 1229-24-9 | Reference compound |
| HY-148304 | VU6036720 | 3026597-12-3 | Reference compound |
| HY-148304A | VU6036720 (hydrochloride) | Reference compound | |
| HY-148305 | PD-1/PD-L1-IN-28 | 2499965-07-8 | Reference compound |
| HY-148306 | γ-Secretase modulator 14 | 1420200-85-6 | Reference compound |
| HY-148308 | hRSV-IN-1 | 749868-66-4 | Reference compound |
| HY-148309 | Anti-Influenza agent 4 | 522625-85-0 | Reference compound |
| HY-14831 | Arhalofenate | 24136-23-0 | Reference compound |
| HY-148310 | Flaviviruses-IN-2 | 1009762-84-8 | Reference compound |
| HY-148312 | Sirtuin modulator 4 | 327104-77-8 | Reference compound |
| HY-148313 | PKM2 activator 4 | 781656-66-4 | Reference compound |
| HY-148314 | ROS kinases-IN-2 | 687576-28-9 | Reference compound |
| HY-148315 | GLUT1-IN-2 | 305357-89-5 | Reference compound |
| HY-148316 | hVEGF-IN-2 | 186610-88-8 | Reference compound |
| HY-148317 | PI3Kγ inhibitor 6 | 900515-01-7 | Reference compound |
| HY-148318 | CK2α-IN-1 | 443747-52-2 | Reference compound |
| HY-14832 | Ataluren | 775304-57-9 | Reference compound |
| HY-148322 | Sirtuin modulator 5 | 694469-31-3 | Reference compound |
| HY-148323 | Anti-Trypanosoma cruzi agent-4 | 10001-31-7 | Reference compound |
| HY-148324 | PKM2 activator 5 | 796092-26-7 | Reference compound |
| HY-148325 | α7 Nicotinic receptor agonist-1 | 220100-05-0 | Reference compound |
| HY-148326 | Glu(OtBu)-Val-Cit-PAB-OH | 2757059-05-3 | ADC Related |
| HY-148327 | AK-IN-1 | 378775-98-5 | Reference compound |
| HY-148328 | CK2-IN-4 | 313985-59-0 | Reference compound |
| HY-148329 | GSK3-IN-2 | 380450-97-5 | Reference compound |
| HY-14832R | Ataluren (Standard) | 775304-57-9 | Reference Standards |
| HY-14832S1 | Ataluren-13C6 | Isotope-Labeled Compounds | |
| HY-14833 | Atiratecan | 867063-97-6 | Reference compound |
| HY-148331 | Z-Thioprolyl-Thioproline | 118059-40-8 | Reference compound |
| HY-148332 | Z-Thioprolyl-Thiazolidine | 118059-38-4 | Reference compound |
| HY-148333 | MS177 | 2225938-86-1 | Reference compound |
| HY-148334 | MS8815 | 2855085-25-3 | Reference compound |
| HY-148335 | IRG1-IN-1 | 2407652-42-8 | Reference compound |
| HY-148337 | Thr-Val-Leu | 66317-22-4 | Peptides |
| HY-148338 | TLR8 agonist 5 | 2413016-41-6 | Reference compound |
| HY-148339 | Fmoc-VAP-MMAE | 1912408-91-3 | ADC Related |
| HY-14834 | Budiodarone | 335148-45-3 | Reference compound |
| HY-148340 | 24RBPyBC | 185675-92-7 | Reference compound |
| HY-148346 | STING agonist-20-Ala-amide-PEG2-C2-NH2 | 2720500-49-0 | Reference compound |
| HY-148346A | STING agonist-20-Ala-amide-PEG2-C2-NH2 (TFA) | ADC Related | |
| HY-148348 | AB-836 | 2445597-31-7 | Reference compound |
| HY-148349 | PF-07258669 | 2755890-53-8 | Reference compound |
| HY-148349A | (2R,2R)-PF-07258669 | 2755890-68-5 | Reference compound |
| HY-14834A | Budiodarone (tartrate) | 478941-93-4 | Reference compound |
| HY-14835 | Burapitant | 537034-22-3 | Reference compound |
| HY-148350 | DS69910557 | 3032750-17-4 | Reference compound |
| HY-148351 | BAY-0069 | 420826-65-9 | Reference compound |
| HY-148352 | BAY-4931 | 423150-91-8 | Reference compound |
| HY-148353 | PF-06455943 | 1527474-15-2 | Reference compound |
| HY-148360 | Notum pectinacetylesterase-1 | 460727-10-0 | Reference compound |
| HY-148361 | Fluorogen binding modulator-1 | 510716-65-1 | Reference compound |
| HY-148362 | Pomalidomide-C6-O-C5-O-C4-COOH | 2375774-54-0 | Reference compound |
| HY-148363 | Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate | 2714482-26-3 | Biochemical Assay Reagents |
| HY-148364 | ZINC00784494 | 317328-17-9 | Reference compound |
| HY-148365 | NecroIr1 | Reference compound | |
| HY-148366 | NecroIr2 | Reference compound | |
| HY-148367A | (1s,4s)-Menin-MLL inhibitor-23 | Reference compound | |
| HY-148368 | CYD-4-61 | 1425944-33-7 | Reference compound |
| HY-148369 | U7D-1 | Reference compound | |
| HY-14837 | Amizon | 201349-37-3 | Reference compound |
| HY-148370 | IONIS-FB-LRx | 2272975-74-1 | Oligonucleotides |
| HY-148370A | IONIS-FB-LRx (sodium) | Oligonucleotides | |
| HY-148371 | Glp-Trp-OEt | 87694-58-4 | Reference compound |
| HY-148372 | For-Met-Leu-pNA | 111150-07-3 | Reference compound |
| HY-148373 | BRM/BRG1 ATP Inhibitor-3 | 2368901-31-7 | Reference compound |
| HY-148374 | BRM/BRG1 ATP Inhibitor-4 | 2422030-94-0 | Reference compound |
| HY-148375 | Abiraterone sulfate | 1993430-25-3 | Reference compound |
| HY-148375R | Abiraterone sulfate (Standard) | 1993430-25-3 | Reference Standards |
| HY-148376 | Abiraterone N-oxide | 2378463-76-2 | Reference compound |
| HY-148377 | Abiraterone sulfate N-oxide | 1993430-24-2 | Reference compound |
| HY-148378 | 5β-Dihydrocortisone acetate | 1499-59-8 | Reference compound |
| HY-148379 | Tetrahydrocortisone acetate | 17736-20-8 | Reference compound |
| HY-14838 | Etamicastat | 760173-05-5 | Reference compound |
| HY-148380 | Mal-PEG8-Phe-Lys-PAB-Exatecan | 2679821-44-2 | ADC Related |
| HY-148380A | Mal-PEG8-Phe-Lys-PAB-Exatecan (TFA) | Reference compound | |
| HY-148381 | A947 | 2378056-80-3 | Reference compound |
| HY-148382 | RI-962 | 2763831-53-2 | Reference compound |
| HY-148383 | DP00477 | 169120-56-3 | Reference compound |
| HY-148384 | UHMCP1 | 2103079-87-2 | Reference compound |
| HY-148384A | UHMCP1 (dihydrochloride) | 2925647-93-2 | Reference compound |
| HY-148385 | Ganglioside GM2 | 127663-77-8 | Natural Products |
| HY-148387 | SARS-CoV-2-IN-35 | 2757763-47-4 | Reference compound |
| HY-148388 | N-Stearoylsphingomyelin | 58909-84-5 | Reference compound |
| HY-148389 | Disialo-Asn | 68141-38-8 | Peptides |
| HY-14838A | Etamicastat (hydrochloride) | 677773-32-9 | Reference compound |
| HY-14839 | Evatanepag | 223488-57-1 | Reference compound |
| HY-148390 | Sialylglyco peptide | 67299-24-5 | Reference compound |
| HY-148391 | 23-Oxa-OSW-1 | 790224-37-2 | Reference compound |
| HY-148392 | Neu5Gcα(2-6) N-Glycan-Asn | 82516-83-4 | Reference compound |
| HY-148393 | G0 N-glycan-Asn | 68418-91-7 | Reference compound |
| HY-148394 | UCK2 Inhibitor-1 | 902289-98-9 | Reference compound |
| HY-148395 | UCK2 Inhibitor-2 | 866842-71-9 | Reference compound |
| HY-148396 | UCK2 Inhibitor-3 | 2376687-49-7 | Reference compound |
| HY-148399 | Mal-VC-PAB-PNP-CDN-A | 2640880-35-7 | ADC Related |
| HY-14839A | Evatanepag (sodium) | 223490-49-1 | Reference compound |
| HY-14840 | Phenylpiracetam | 77472-70-9 | Reference compound |
| HY-148402 | p53 Activator 3 | 2636839-90-0 | Reference compound |
| HY-148404 | p53 Activator 5 | 2636840-37-2 | Reference compound |
| HY-148406 | (S,R,S)-AHPC-C10-NHBoc | 2412055-13-9 | Reference compound |
| HY-148407 | lucPpy-IN-1 | 546100-66-7 | Dye Reagents |
| HY-148408 | SIRT2-IN-11 | 1005095-06-6 | Reference compound |
| HY-148409 | MMRi62 | 352693-80-2 | Reference compound |
| HY-14840A | (R)-Phenylpiracetam | 949925-07-9 | Reference compound |
| HY-14841 | Gisadenafil | 334826-98-1 | Reference compound |
| HY-148410 | Zorevunersen | 2415330-04-8 | Oligonucleotides |
| HY-148410A | Zorevunersen (sodium) | 2415330-05-9 | Oligonucleotides |
| HY-148410C | Zorevunensen negative control | Oligonucleotides | |
| HY-148411 | Abetimus | 167362-48-3 | Reference compound |
| HY-148412 | Monarsen | 864021-55-6 | Oligonucleotides |
| HY-148412A | Monarsen (sodium) | Oligonucleotides | |
| HY-148413 | Aprinocarsen (sodium) | 331257-53-5 | Oligonucleotides |
| HY-148415 | Ac-Phe-Gly-pNA | 34336-99-7 | Reference compound |
| HY-148416 | p53 Activator 7 | 2849340-59-4 | Reference compound |
| HY-148417 | ZZL-7 | 99141-91-0 | Reference compound |
| HY-148418 | TUG-499 | 1206629-08-4 | Reference compound |
| HY-148419 | Ralometostat | 2760481-53-4 | Reference compound |
| HY-14842 | Givinostat | 497833-27-9 | Reference compound |
| HY-148420 | CDN-A | 2586047-09-6 | Reference compound |
| HY-148422 | Rohinitib | 1139253-73-8 | Reference compound |
| HY-148423 | Picarbutrazox | 500207-04-5 | Reference compound |
| HY-148424 | PBD dimer-2 | 145325-57-1 | ADC Related |
| HY-148425 | Mal-amide-PEG8-Val-Ala-PAB-PNP | 2210247-59-7 | ADC Related |
| HY-148426 | OSu-PEG4-VC-PAB-MMAE | 2762518-86-3 | ADC Related |
| HY-148429 | Antimalarial agent 17 | 508187-76-6 | Reference compound |
| HY-14842A | Givinostat (hydrochloride) | 199657-29-9 | Reference compound |
| HY-14842B | Givinostat (hydrochloride monohydrate) | 732302-99-7 | Reference compound |
| HY-14843 | Imagabalin | 610300-07-7 | Reference compound |
| HY-148430 | Aromatase-IN-2 | 121768-39-6 | Reference compound |
| HY-148431 | Antimicrobial agent-14 | 380576-68-1 | Reference compound |
| HY-148432 | FGF22-IN-1 | 113143-13-8 | Reference compound |
| HY-148433 | SpdSyn binder-1 | 251106-30-6 | Reference compound |
| HY-148435 | Glucocorticoid receptor agonist-2 | 2166378-92-1 | Reference compound |
| HY-148436 | Glucocorticoid receptor agonist-2 Ala-Ala-Mal | 2166376-64-1 | ADC Related |
| HY-148439 | RMC-6236 | 2765081-21-6 | Reference compound |
| HY-14844 | Lagociclovir | 92562-88-4 | Reference compound |
| HY-148440 | RL-0070933 | 301326-41-0 | Reference compound |
| HY-148441 | NDH-1 inhibitor-1 | 173964-49-3 | Reference compound |
| HY-148442 | ecMetAP-IN-1 | 7471-12-7 | Reference compound |
| HY-148443 | eIF4A3-IN-9 | 1402931-71-8 | Reference compound |
| HY-148444 | eIF4A3-IN-10 | 1402931-72-9 | Reference compound |
| HY-148445 | eIF4A3-IN-11 | 1402931-70-7 | Reference compound |
| HY-148446 | eIF4A3-IN-12 | 1402931-76-3 | Reference compound |
| HY-148447 | eIF4A3-IN-13 | 1402931-85-4 | Reference compound |
| HY-148448 | eIF4A3-IN-14 | 1402931-65-0 | Reference compound |
| HY-148449 | eIF4A3-IN-15 | 1402931-66-1 | Reference compound |
| HY-148450 | eIF4A3-IN-16 | 1402931-74-1 | Reference compound |
| HY-148451 | eIF4A3-IN-17 | 1402931-75-2 | Reference compound |
| HY-148452 | eIF4A3-IN-18 | 1402931-84-3 | Reference compound |
| HY-148453 | Antiproliferative agent-16 | 15641-17-5 | Reference compound |
| HY-148454 | Necroptosis-IN-3 | 547698-18-0 | Reference compound |
| HY-148455 | Casein kinase 1δ-IN-3 | 349438-77-3 | Reference compound |
| HY-148456 | Anti-inflammatory agent 34 | 867301-81-3 | Reference compound |
| HY-148457 | Avacincaptad pegol | 1613641-69-2 | Oligonucleotides |
| HY-148458 | EZH2-IN-14 | 1979157-17-9 | Reference compound |
| HY-148459 | ATAC21 | 2101204-23-1 | ADC Related |
| HY-14846 | Litronesib | 910634-41-2 | Reference compound |
| HY-148461 | Mal-VC-PAB-PNP | 1096584-62-1 | ADC Related |
| HY-148462 | Fmoc-Ala-Ala-PAB | 1384263-83-5 | ADC Related |
| HY-148463 | MP-Ala-Ala-PAB | 1949793-47-8 | ADC Related |
| HY-148464 | MC-Ala-Ala-PAB | 1949793-44-5 | ADC Related |
| HY-148465 | Gadoteric acid | 72573-82-1 | Natural Products |
| HY-148466 | IGUANA-1 | 2756014-25-0 | Reference compound |
| HY-148467 | METTL3-IN-1 | 2648257-77-4 | Reference compound |
| HY-148468 | METTL3-IN-2 | 2767258-88-6 | Reference compound |
| HY-148469 | METTL3-IN-3 | 2767003-71-2 | Reference compound |
| HY-14846A | Litronesib (Racemate) | 546111-97-1 | Reference compound |
| HY-148470A | C4-Amide-C4-NH2 | 1018541-17-7 | Reference compound |
| HY-148471A | C3-Amide-C4-NH2 | 65389-82-4 | Reference compound |
| HY-148472A | C2-Amide-C4-NH2 | 99789-97-6 | Reference compound |
| HY-148475 | (R)-SEMBL | 1443449-07-7 | Reference compound |
| HY-148476 | Tri-GalNAc-DBCO | Reference compound | |
| HY-148478 | MMV688845 | 2208962-35-8 | Reference compound |
| HY-14848 | Naluzotan | 740873-06-7 | Reference compound |
| HY-148480 | Nrf2 activator-6 | 2728780-74-1 | Reference compound |
| HY-148481 | USP7-IN-10 | 2755995-01-6 | Reference compound |
| HY-148481A | USP7-IN-10 (hydrochloride) | Reference compound | |
| HY-148482 | USP7-IN-11 | 2763872-32-6 | Reference compound |
| HY-148484 | Pomalidomide-5'-PEG5-C2-COOH | 2412056-50-7 | Reference compound |
| HY-148488 | A18-Iso5-2DC18 | 2412492-09-0 | Reference compound |
| HY-148489 | CSNK1-IN-1 | 2468784-55-4 | Reference compound |
| HY-14848A | Naluzotan (hydrochloride) | 740873-82-9 | Reference compound |
| HY-14849 | PTZ601 | 426253-04-5 | Reference compound |
| HY-148491 | CSNK1-IN-2 | 2468783-76-6 | Reference compound |
| HY-148492 | Mrgx2 antagonist-2 | 2767111-67-9 | Reference compound |
| HY-148493 | MK-3402 | 2058151-78-1 | Reference compound |
| HY-148494 | Tivumecirnon | 2174938-78-2 | Reference compound |
| HY-148495 | Carnosine conjugated hyalyronate | Reference compound | |
| HY-14850 | Sograzepide | 155488-25-8 | Reference compound |
| HY-148502 | VU6019650 | 2926782-31-0 | Reference compound |
| HY-148503 | 5'-ODMT cEt N-Bz A Phosphoramidite (Amidite) | 1197033-19-4 | Oligonucleotides |
| HY-148504 | 5'-ODMT cEt G Phosphoramidite (Amidite) | 945628-66-0 | Oligonucleotides |
| HY-148505 | 5'-ODMT cEt N-Bzm5 C Phosphoramidite (Amidite) | 1197033-17-2 | Oligonucleotides |
| HY-148506 | 5'-ODMT cEt m5U Phosphoramidite (Amidite) | 1197033-22-9 | Oligonucleotides |
| HY-148507 | GSK1790627 | 871701-87-0 | Reference compound |
| HY-148508 | PhosTAC3 | Reference compound | |
| HY-148509 | PhosTAC5 | Reference compound | |
| HY-14851 | MRE 0094 | 131865-88-8 | Reference compound |
| HY-148510 | HKB99 | 2414908-90-8 | Reference compound |
| HY-148511 | Vidutolimod | 147063-80-7 | Oligonucleotides |
| HY-148511A | Vidutolimod (sodium) | Oligonucleotides | |
| HY-148514 | CT52923 | 205256-55-9 | Reference compound |
| HY-148516 | MPH-220 | 2649776-79-2 | Reference compound |
| HY-148516A | (R)-MPH-220 | Reference compound | |
| HY-148517 | AZD0095 | 2750001-23-9 | Reference compound |
| HY-148518 | MSC-1186 | 2871698-23-4 | Reference compound |
| HY-14852 | Tafamidis | 594839-88-0 | Reference compound |
| HY-148520 | QM295 | 1241046-32-1 | Reference compound |
| HY-148521 | PROTAC FLT3/CDK9 degrader-1 | Reference compound | |
| HY-148522 | FLT3-IN-18 | 752191-77-8 | Reference compound |
| HY-148523 | HQ005 | 2750644-31-4 | Reference compound |
| HY-148524 | β2AR/M-receptor agonist-1 | 2230520-62-2 | Reference compound |
| HY-148525 | PF-4348235 | 1017857-38-3 | Reference compound |
| HY-148526 | β2AR/M3-receptor agonist-1 | 1206887-00-4 | Reference compound |
| HY-148527 | LAS190792 | 1347232-69-2 | Reference compound |
| HY-148528 | SC-VC-PAB-N-Me-L-Ala-Maytansinol | 2226467-76-9 | Reference compound |
| HY-148529 | Midaglizole | 66529-17-7 | Reference compound |
| HY-14852A | Tafamidis meglumine | 951395-08-7 | Reference compound |
| HY-14852S | Tafamidis-d3 | Isotope-Labeled Compounds | |
| HY-14853 | Darexaban | 365462-23-3 | Reference compound |
| HY-148530 | YX-2-107 | 2417408-46-7 | Reference compound |
| HY-148531 | PF-07054894 | 2413693-96-4 | Reference compound |
| HY-148533 | β2AR agonist /M-receptor antagonist-1 | 2772700-36-2 | Reference compound |
| HY-148535 | Calpain Inhibitor XI | 145731-49-3 | Reference compound |
| HY-14854 | Tecarfarin | 867257-26-9 | Reference compound |
| HY-148542 | EpoY | 245660-13-3 | Reference compound |
| HY-148545 | SHMT-IN-3 | 330638-43-2 | Reference compound |
| HY-148546 | STING agonist-21 | 2375419-35-3 | Reference compound |
| HY-148547 | q-FTAA | 1352477-22-5 | Reference compound |
| HY-148548 | p-HTAA | 1175142-38-7 | Reference compound |
| HY-148549 | MC-PEG2-Boc | 640267-55-6 | Reference compound |
| HY-14854A | Tecarfarin (sodium) | 1004551-83-0 | Reference compound |
| HY-14854S | Tecarfarin-13C,d3 | Isotope-Labeled Compounds | |
| HY-14855 | Tedizolid | 856866-72-3 | Reference compound |
| HY-148550 | MC-PEG2-NH2 | 640267-62-5 | Reference compound |
| HY-148552 | Anti-inflammatory agent 35 | 2293951-00-3 | Reference compound |
| HY-148553 | Anti-inflammatory agent 36 | 2293951-01-4 | Reference compound |
| HY-148555 | AXC-879 | 2479277-22-8 | Reference compound |
| HY-148556 | Thalidomide-O-C6-azide | 2411389-65-4 | Reference compound |
| HY-148558 | P2X7 receptor antagonist-3 | 1627900-92-8 | Reference compound |
| HY-148559 | 4A3-SC8 | 1857340-78-3 | Reference compound |
| HY-14855A | (S)-Tedizolid | 1431699-67-0 | Reference compound |
| HY-14855AR | (S)-Tedizolid (Standard) | 1431699-67-0 | Reference Standards |
| HY-14855B | Tedizolid (phosphate) | 856867-55-5 | Reference compound |
| HY-14855BR | Tedizolid (phosphate) (Standard) | 856867-55-5 | Reference Standards |
| HY-14855R | Tedizolid (Standard) | 856866-72-3 | Reference Standards |
| HY-14855S | Tedizolid-13C,d3 | 2931763-72-1 | Isotope-Labeled Compounds |
| HY-14856 | Atagabalin | 223445-75-8 | Reference compound |
| HY-148560 | ccc_R08 | 2919019-72-8 | Reference compound |
| HY-148560A | trans-ccc_R08 | 2413192-49-9 | Reference compound |
| HY-148560B | cis-ccc_R08 | 2413192-48-8 | Reference compound |
| HY-148561 | CDK8-IN-12 | 2613307-67-6 | Reference compound |
| HY-148563 | GPR81 agonist 2 | 1143024-28-5 | Reference compound |
| HY-148564 | TBI-166 | 1353734-12-9 | Reference compound |
| HY-148565 | SERT-IN-2 | 2055228-33-4 | Reference compound |
| HY-148566 | OUL232 | 943119-42-4 | Reference compound |
| HY-148567 | TMV-IN-1 | 2883408-27-1 | Reference compound |
| HY-148568 | TMV-IN-2 | 2883408-32-8 | Reference compound |
| HY-148569 | TMV-IN-3 | 2883408-35-1 | Reference compound |
| HY-14856A | iso-Atagabalin (hydrochloride) | 223445-68-9 | Reference compound |
| HY-14857 | Carotegrast | 401904-75-4 | Reference compound |
| HY-148570 | PHGDH-IN-3 | 2893778-31-7 | Reference compound |
| HY-148571 | TP0597850 | 2642181-22-2 | Reference compound |
| HY-148572 | NAMPT/IDO1-IN-1 | 2247884-06-4 | Reference compound |
| HY-148573 | sEH inhibitor-14 | 2890221-26-6 | Reference compound |
| HY-148574 | MCT1-IN-3 | 2878360-80-4 | Reference compound |
| HY-148575 | α-Glucosidase-IN-23 | 161187-57-1 | Reference compound |
| HY-148576 | Antibacterial agent 136 | Reference compound | |
| HY-148578 | CamA-IN-1 | 2924055-46-7 | Reference compound |
| HY-14858 | Derenofylline | 251945-92-3 | Reference compound |
| HY-148585 | BTK-IN-22 | 2573048-10-7 | Reference compound |
| HY-148586 | β-Estradiol 17-hemisuccinate | 7698-93-3 | Reference compound |
| HY-14859 | Dipraglurant | 872363-17-2 | Reference compound |
| HY-148591 | GSK761 | Reference compound | |
| HY-148592 | Antitumor agent-87 | 1422527-88-5 | Reference compound |
| HY-148594 | BTK-IN-23 | 2573048-11-8 | Reference compound |
| HY-148595 | Antitumor agent-88 | 1422527-87-4 | Reference compound |
| HY-148597 | FGFR-IN-10 | 2847092-41-3 | Reference compound |
| HY-148598 | Curcumin 5-8 | 890984-26-6 | Natural Products |
| HY-14860 | 1-Deoxynojirimycin | 19130-96-2 | Natural Products |
| HY-148601 | 1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol | 217939-97-4 | Biochemical Assay Reagents |
| HY-148602 | KH-4-43 | 2813310-07-3 | Reference compound |
| HY-148606 | STING modulator-3 | 2839639-94-8 | Reference compound |
| HY-148608 | LysoPalloT-NH-amide-C3-ph-m-O-C11 | 1778686-61-5 | Reference compound |
| HY-14860A | 1-Deoxynojirimycin (hydrochloride) | 73285-50-4 | Natural Products |
| HY-14860R | 1-Deoxynojirimycin (Standard) | 19130-96-2 | Reference Standards |
| HY-148610 | LDH-IN-2 | 893739-96-3 | Reference compound |
| HY-148611 | NSC339614 (potassium) | 1135037-53-4 | Reference compound |
| HY-148614 | Isocaproaldehyde | 1119-16-0 | Natural Products |
| HY-148615 | NPD10084 | 1040706-91-9 | Reference compound |
| HY-148616 | α-Pseudouridine | 10017-66-0 | Reference compound |
| HY-148617 | ALDH2 modulator 1 | 1629615-99-1 | Reference compound |
| HY-14862 | Latrepirdine | 3613-73-8 | Reference compound |
| HY-148624 | CHDI-00484077 | 3025894-92-9 | Reference compound |
| HY-148625 | PDE9-IN-2 | 917089-10-2 | Reference compound |
| HY-148626 | CVI-LM001 | Reference compound | |
| HY-148629 | GDC-0134 | 1637394-01-4 | Reference compound |
| HY-14863 | Lunacalcipol | 250384-82-8 | Reference compound |
| HY-14864 | Mapracorat | 887375-26-0 | Reference compound |
| HY-148642 | 12-Hydroxynevirapine | 133627-24-4 | Reference compound |
| HY-148643 | STING modulator-5 | 2305940-22-9 | Reference compound |
| HY-148644 | STING-IN-6 | 2305940-34-3 | Reference compound |
| HY-148645 | STING modulator-4 | 2839639-72-2 | Reference compound |
| HY-148646 | p-NH2-CHX-A"-DTPA | 1105741-38-5 | Reference compound |
| HY-148646A | p-NH2-CHX-A"-DTPA (hydrochloride hydrate) | Biochemical Assay Reagents | |
| HY-148647 | Mipomersen | 1000120-98-8 | Oligonucleotides |
| HY-148648 | Lipid 29 | 2244716-55-8 | Reference compound |
| HY-148649 | Demethyl bleomycin A2 | 41089-03-6 | Reference compound |
| HY-14864A | (S)-Mapracorat | 887375-15-7 | Reference compound |
| HY-14865 | Omadacycline | 389139-89-3 | Reference compound |
| HY-148650 | Sortilin antagonist 1 | 2691846-93-0 | Reference compound |
| HY-148650A | (R)-Sortilin antagonist 1 | 2889422-86-8 | Reference compound |
| HY-148651 | CDK2-IN-15 | 1219915-83-9 | Natural Products |
| HY-148653 | (+)-C-BVDU | 95463-56-2 | Reference compound |
| HY-148656 | PNB-001 | 1528760-09-9 | Reference compound |
| HY-148657 | Aminopterin N-hydroxysuccinimide ester | 98457-88-6 | Reference compound |
| HY-14865A | Omadacycline (mesylate) | 1196800-40-4 | Reference compound |
| HY-14865B | Omadacycline (tosylate) | 1075240-43-5 | Reference compound |
| HY-14865BR | Omadacycline (tosylate) (Standard) | 1075240-43-5 | Reference Standards |
| HY-14865C | Omadacycline (hydrochloride) | 1196800-39-1 | Reference compound |
| HY-14865CR | Omadacycline (hydrochloride) (Standard) | 1196800-39-1 | Reference Standards |
| HY-14865R | Omadacycline (Standard) | 389139-89-3 | Reference Standards |
| HY-14865S | Omadacycline-d9 | 2272886-41-4 | Isotope-Labeled Compounds |
| HY-14866 | Raseglurant | 757950-09-7 | Reference compound |
| HY-148660 | SFI003 | 2361332-90-1 | Reference compound |
| HY-148662 | Pomalidomide-PEG5-C2-NH2 (hydrochloride) | 2357117-23-6 | Reference compound |
| HY-148663 | Mitogenic Pentapeptide | 87173-03-3 | Peptides |
| HY-148664 | eIF4E-IN-4 | 1373822-39-9 | Reference compound |
| HY-148665 | FABP-IN-2 | 1426533-99-4 | Reference compound |
| HY-148666 | H-Gly-Oet | 459-73-4 | Biochemical Assay Reagents |
| HY-148667 | H-Cys(Acm)-OH | 19647-70-2 | Biochemical Assay Reagents |
| HY-148668 | MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan | 2414254-51-4 | Reference compound |
| HY-148668A | MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan | 2414254-52-5 | Reference compound |
| HY-148669 | Bleximenib | 2654081-35-1 | Reference compound |
| HY-148669A | Bleximenib (oxalate) | 2866179-95-3 | Reference compound |
| HY-148669B | (S)-Bleximenib (oxalate) | Reference compound | |
| HY-148670 | Pulmonary arterial hypertension agent-1 | 1201082-00-9 | Reference compound |
| HY-148671 | (S,R,S)-AHPC-amido-C7-acid | 2172819-76-8 | Reference compound |
| HY-148672 | 2-Nitrophenyl a-D-glucopyranoside | 56193-44-3 | Biochemical Assay Reagents |
| HY-148673 | AZD0780 | 2455427-91-3 | Reference compound |
| HY-148674 | PRMT5-IN-25 | 2691869-82-4 | Reference compound |
| HY-148676 | Emilumenib | 2440018-29-9 | Reference compound |
| HY-148677S | 2,3-Dihydroxy-2-methylbutanoic acid-d3 | Isotope-Labeled Compounds | |
| HY-148682 | 18β-Glycyrrhetyl-3-O-sulfate | 10251-38-4 | Reference compound |
| HY-148682R | 18β-Glycyrrhetyl-3-O-sulfate (Standard) | 10251-38-4 | Reference Standards |
| HY-148682S1 | 18β-Glycyrrhetyl-3-O-sulfate-d2 | Isotope-Labeled Compounds | |
| HY-148682S2 | 18β-Glycyrrhetyl-3-O-sulfate-d3 | Isotope-Labeled Compounds | |
| HY-148683 | EG-011 | 2377113-41-0 | Reference compound |
| HY-148684 | AMPK activator 10 | 1914176-03-6 | Reference compound |
| HY-148685 | KM04416 | 26530-26-7 | Reference compound |
| HY-148687 | SPC5001 | Oligonucleotides | |
| HY-148687A | SPC5001 (sodium) | Oligonucleotides | |
| HY-148688 | ASO 556089 sodium | Oligonucleotides | |
| HY-148689 | SPC4061 | 1018108-22-9 | Reference compound |
| HY-148689A | SPC4061 (sodium) | Oligonucleotides | |
| HY-148690 | L18-MDP | 60398-08-5 | Peptides |
| HY-148691 | PROTAC PTPN2 degrader-1 | 2655638-07-4 | Reference compound |
| HY-148692 | OSM-SMI-10B | Reference compound | |
| HY-148692A | (E/Z)-OSM-SMI-10B | 2502294-55-3 | Reference compound |
| HY-148693 | OSM-SMI-8 | 1689690-20-7 | Reference compound |
| HY-148693A | (E/Z)-OSM-SMI-8 | Reference compound | |
| HY-148694 | ISX-3 | 912789-08-3 | Reference compound |
| HY-148695B | ADR58 (sodium) | Oligonucleotides | |
| HY-148695C | Truncated ADR58 (sodium) | Oligonucleotides | |
| HY-148696A | Gly-Cyclopropane-Exatecan | 2414254-49-0 | Reference compound |
| HY-148696B | Gly-(S)-Cyclopropane-Exatecan | Reference compound | |
| HY-148697 | Nigerose | 497-48-3 | Reference compound |
| HY-148698 | 2MD | 213250-70-5 | Reference compound |
| HY-148699 | HRO761 | 2869954-34-5 | Reference compound |
| HY-14870 | Selexipag | 475086-01-2 | Reference compound |
| HY-148700 | Werner syndrome RecQ helicase-IN-2 | 2869954-51-6 | Reference compound |
| HY-148701 | mono-Pal-MTO | 1349197-89-2 | Biochemical Assay Reagents |
| HY-148702 | di-Pal-MTO | 1349197-90-5 | Oligonucleotides |
| HY-148705 | Isomitomycin A | 91917-64-5 | Reference compound |
| HY-148706 | STAT3-IN-17 | 1245814-52-1 | Reference compound |
| HY-148707 | SphK1&2-IN-1 | 1415662-57-5 | Reference compound |
| HY-148708 | Oleoyl-D-lysine | 2240164-55-8 | Reference compound |
| HY-148709 | ARTD10/PARP10-IN-1 | 1708103-76-7 | Reference compound |
| HY-14870R | Selexipag (Standard) | 475086-01-2 | Reference Standards |
| HY-14870S1 | Selexipag-d7 | 1265295-21-3 | Isotope-Labeled Compounds |
| HY-14870S3 | Selexipag-d6 | 1265295-92-8 | Isotope-Labeled Compounds |
| HY-14871 | Tenifatecan | 850728-18-6 | Reference compound |
| HY-148710 | ARTD10/PARP10-IN-2 | 1708103-69-8 | Reference compound |
| HY-148711 | STL1267 | 1429024-58-7 | Reference compound |
| HY-148712 | SIRT6 activator 12q | 2601734-99-8 | Reference compound |
| HY-148713 | Anti-CSCs agent-1 | 2251753-58-7 | Reference compound |
| HY-148717 | NSC363998 (free base) | 159357-82-1 | Reference compound |
| HY-148718 | 4-Chloro Trazodone (hydrochloride) | 1263278-77-8 | Reference compound |
| HY-148718R | 4-Chloro Trazodone (hydrochloride) (Standard) | 1263278-77-8 | Reference Standards |
| HY-148719 | ARN24139 | 2699768-78-8 | Reference compound |
| HY-14872 | Tideglusib | 865854-05-3 | Reference compound |
| HY-14873 | Tonapofylline | 340021-17-2 | Reference compound |
| HY-148730 | BRD7586 | 895460-70-5 | Reference compound |
| HY-148732 | LU-005i | 1620107-33-6 | Reference compound |
| HY-148739 | dBRD 9-A | 2170679-42-0 | Reference compound |
| HY-14874 | Topiroxostat | 577778-58-6 | Reference compound |
| HY-148740 | Werner syndrome RecQ helicase-IN-3 | 2869954-98-1 | Reference compound |
| HY-148741 | Werner syndrome RecQ helicase-IN-4 | 2869954-53-8 | Reference compound |
| HY-148742 | RET-IN-21 | 2414373-42-3 | Reference compound |
| HY-148744 | 3-Deoxy-D-manno-2-octulosonic acid (ammonium), 97% | 103404-70-2 | Biochemical Assay Reagents |
| HY-148745 | JG-258 | 2241517-83-7 | Reference compound |
| HY-148748 | Butyzamide | 1110767-45-7 | Reference compound |
| HY-14874R | Topiroxostat (Standard) | 577778-58-6 | Reference Standards |
| HY-14874S | Topiroxostat-d4 | 2732868-49-2 | Isotope-Labeled Compounds |
| HY-14875 | Verucerfont | 885220-61-1 | Reference compound |
| HY-148751 | TRPV1 activator-1 | 1803181-80-7 | Reference compound |
| HY-148752 | TRPV1 activator-2 | 17514-11-3 | Reference compound |
| HY-148753 | PARP10-IN-2 | 1042780-52-8 | Reference compound |
| HY-148754 | PARP10-IN-3 | 2225800-19-9 | Reference compound |
| HY-148755 | ERX-41 | 2440087-54-5 | Reference compound |
| HY-148756 | NG-497 | 2598242-66-9 | Reference compound |
| HY-148757 | TIM-063 | 2493978-38-2 | Reference compound |
| HY-148758 | PCSK9-IN-13 | 2244129-23-3 | Reference compound |
| HY-148761 | PSMA I&T | 2192281-54-0 | ADC Related |
| HY-148763 | CK2-IN-6 | 1309835-18-4 | Reference compound |
| HY-148764 | M47 | 890808-56-7 | Reference compound |
| HY-148765 | CLK8 | 898920-65-5 | Reference compound |
| HY-148766 | VU661 | 37648-76-3 | Reference compound |
| HY-148767 | MLKL-IN-5 | 2755872-58-1 | Reference compound |
| HY-148768 | AB-506 | 2245020-50-0 | Reference compound |
| HY-148769 | Cefiderocol catechol 3-methoxy | 2243393-93-1 | Reference compound |
| HY-14877 | Anagliptin | 739366-20-2 | Reference compound |
| HY-148771 | MTX-23 | 2488296-74-6 | Reference compound |
| HY-148772 | PTC258 | 2476724-74-8 | Reference compound |
| HY-148773 | MC-Gly-Gly-Phe-Boc | 1599440-14-8 | Reference compound |
| HY-148775 | PLGA-PEG-MAL (60kDA-3.4kDA, LA:GA ratio 75:25) | Oligonucleotides | |
| HY-148775A | mPEG-PLGA (21500-26500) | 743423-15-6 | Oligonucleotides |
| HY-148775B | PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 40:60) | Biochemical Assay Reagents | |
| HY-148776 | PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 50:50) | Reference compound | |
| HY-148777 | A031 | 2682255-44-1 | Reference compound |
| HY-148778 | FGFR3-IN-4 | 2833706-13-9 | Reference compound |
| HY-148779 | FGFR3-IN-5 | 2446664-72-6 | Reference compound |
| HY-14877A | Anagliptin (hydrochloride) | 1359670-56-6 | Reference compound |
| HY-14877S1 | Anagliptin-d7 | Isotope-Labeled Compounds | |
| HY-14878 | (2R)-Atecegatran | 917904-13-3 | Reference compound |
| HY-148780 | HBV-IN-29 | 2413192-59-1 | Reference compound |
| HY-148781 | HBV-IN-30 | 2413192-92-2 | Reference compound |
| HY-148782 | HBV-IN-31 | 2413192-95-5 | Reference compound |
| HY-148783 | HBV-IN-32 | 2413193-04-9 | Reference compound |
| HY-148785 | Nimucitinib | 2740557-24-6 | Reference compound |
| HY-148787 | Oditrasertib | 2252271-93-3 | Reference compound |
| HY-148788 | Osivelotor | 2417955-18-9 | Reference compound |
| HY-148789 | Palazestrant | 2092925-89-6 | Reference compound |
| HY-14879 | Avibactam (free acid) | 1192500-31-4 | Reference compound |
| HY-148790 | Pralurbactam | 2163782-59-8 | Reference compound |
| HY-148791 | Pumecitinib | 2401057-12-1 | Reference compound |
| HY-148792 | Relutrigine | 2392951-29-8 | Reference compound |
| HY-148793 | Resencatinib | 2546117-79-5 | Reference compound |
| HY-148794 | Risvodetinib | 2031185-00-7 | Reference compound |
| HY-148795 | Ritivixibat | 2460667-52-9 | Reference compound |
| HY-148796 | Rizedisben | 1311570-07-6 | Dye Reagents |
| HY-148797 | Rolusafine | 2089153-78-4 | Reference compound |
| HY-148799 | Sevasemten | 2417395-15-2 | Reference compound |
| HY-14879A | Avibactam (sodium) | 1192491-61-4 | Reference compound |
| HY-14879AR | Avibactam (sodium) (Standard) | 1192491-61-4 | Reference Standards |
| HY-14879B | Avibactam (sodium hydrate) | 2938989-90-1 | Reference compound |
| HY-14879BR | Avibactam (sodium hydrate) (Standard) | 2938989-90-1 | Reference Standards |
| HY-14879C | Avibactam (sodium dihydrate) | Reference compound | |
| HY-14879D | ent-Avibactam (sodium) | 396731-20-7 | Reference compound |
| HY-14879R | Avibactam (free acid) (Standard) | 1192500-31-4 | Reference Standards |
| HY-14879S2 | Avibactam sodium salt-13C5 | Isotope-Labeled Compounds | |
| HY-14880 | Bavisant | 929622-08-2 | Reference compound |
| HY-148800 | Suzetrigine | 2649467-58-1 | Reference compound |
| HY-148801 | Tamuzimod | 2097854-81-2 | Reference compound |
| HY-148802 | Taplucainium (chloride) | 2489565-37-7 | Reference compound |
| HY-148803 | Vabametkib | 1571903-56-4 | Reference compound |
| HY-148804 | Vemtoberant | 2169905-68-2 | Reference compound |
| HY-148804A | Vemtoberant (mesylate) | 2169905-97-7 | Reference compound |
| HY-148805 | Vonifimod | 2118903-18-5 | Reference compound |
| HY-148806 | Zatonacaftor | 2301945-38-8 | Reference compound |
| HY-148807 | Zavondemstat | 1851412-93-5 | Reference compound |
| HY-148807A | Zavondemstat (L-lysine) | 2908753-10-4 | Reference compound |
| HY-148807B | (S)-Zavondemstat | Reference compound | |
| HY-148808 | Zelasudil | 2365193-22-0 | Reference compound |
| HY-14880A | Bavisant (dihydrochloride) | 929622-09-3 | Reference compound |
| HY-14880B | Bavisant (dihydrochloride hydrate) | 1103522-80-0 | Reference compound |
| HY-14881 | Bedaquiline | 843663-66-1 | Reference compound |
| HY-148810 | Zongertinib | 2728667-27-2 | Reference compound |
| HY-148811 | Zurletrectinib | 2403703-30-8 | Reference compound |
| HY-148812 | Gly-Mal-Gly-Gly-Phe-Gly-amide-methylcyclopropane-Exatecan | 2766786-76-7 | ADC Related |
| HY-148813 | AK-2292 | 2984506-77-4 | Reference compound |
| HY-148814 | BI-3231 | 2894848-07-6 | Reference compound |
| HY-148815 | Nampt activator-1 | 701929-65-9 | Reference compound |
| HY-148816 | SG-094 | 2922283-37-0 | Reference compound |
| HY-148817 | WDR5-0102 | 824960-50-1 | Reference compound |
| HY-148818 | S-Me-DM4 | 890654-03-2 | Reference compound |
| HY-148819 | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | 2857037-69-3 | Reference compound |
| HY-148819A | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (hydrochloride) | Reference compound | |
| HY-14881A | Bedaquiline (fumarate) | 845533-86-0 | Reference compound |
| HY-14881AR | Bedaquiline (fumarate) (Standard) | 845533-86-0 | Reference Standards |
| HY-14881B | (Rac)-Bedaquiline | 654655-80-8 | Reference compound |
| HY-14881R | Bedaquiline (Standard) | 843663-66-1 | Reference Standards |
| HY-14881S1 | (Rac)-Bedaquiline-d6 | 2517573-53-2 | Isotope-Labeled Compounds |
| HY-14881S2 | Bedaquiline impurity 2-d6 | Isotope-Labeled Compounds | |
| HY-14882 | Cenicriviroc | 497223-25-3 | Reference compound |
| HY-148820 | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | 2857037-70-6 | Reference compound |
| HY-148822 | Nampt activator-2 | 2237268-90-3 | Reference compound |
| HY-148824S | Dimethenamid ESA-d6 | Isotope-Labeled Compounds | |
| HY-148825 | NP10679 | 2914889-88-4 | Reference compound |
| HY-148826 | Rovunaptabin | 145563-68-4 | Oligonucleotides |
| HY-148827 | GEM-231 | 255810-66-3 | Oligonucleotides |
| HY-148827A | GEM-231 (sodium) | Oligonucleotides | |
| HY-148828 | LSP-GR3 | 1235945-37-5 | Oligonucleotides |
| HY-148828A | LSP-GR3 (sodium) | Oligonucleotides | |
| HY-14882A | Cenicriviroc Mesylate | 497223-28-6 | Reference compound |
| HY-148830 | Piperazine-bis(ethyl octadeca-9,12-dienoate) | 2832061-33-1 | Biochemical Assay Reagents |
| HY-148831 | Antibacterial agent 135 | 2233569-54-3 | Reference compound |
| HY-148832 | BTK-IN-20 | 1581714-50-2 | Reference compound |
| HY-148833 | MDM2-p53-IN-16 | 1917350-09-4 | Reference compound |
| HY-148834 | Pomalidomide-piperazine | 2154342-57-9 | Reference compound |
| HY-148835 | AzGGK | 2407768-11-8 | Reference compound |
| HY-148835A | AzGGK (TFA) | Reference compound | |
| HY-148836 | c-Myc inhibitor 6 | 2768765-58-6 | Reference compound |
| HY-148837 | PROTAC c-Myc degrader-1 | 2883535-99-5 | Reference compound |
| HY-148838 | c-Myc inhibitor 8 | 2173505-97-8 | Reference compound |
| HY-148839 | c-Myc inhibitor 9 | 2799717-96-5 | Reference compound |
| HY-148840 | Sulfo DBCO-PEG3-NHS ester | Reference compound | |
| HY-148840A | Sulfo DBCO-PEG3-NHS ester (TEA) | Reference compound | |
| HY-148842 | C14-4 | 2639634-80-1 | Oligonucleotides |
| HY-148844 | GCGR antagonist 2 | 280134-25-0 | Reference compound |
| HY-148846 | Mosapride N-Oxide | 1161443-73-7 | Reference compound |
| HY-148847 | HPK1-IN-32 | 2766481-17-6 | Reference compound |
| HY-14885 | Eliglustat | 491833-29-5 | Reference compound |
| HY-148850 | AZD-2207 | 866598-45-0 | Reference compound |
| HY-148851 | Bacteriochlorophyll a, from Rhodopseudomonas sphaeroides (under argon) | 17499-98-8 | Natural Products |
| HY-148853 | SRI-42127 | 2727872-68-4 | Reference compound |
| HY-148855 | OF-C4-Deg-Lin | 2383003-60-7 | Reference compound |
| HY-148859 | AA-T3A-C12 | 2938207-23-7 | Reference compound |
| HY-14885A | Eliglustat (hemitartrate) | 928659-70-5 | Reference compound |
| HY-14885R | Eliglustat (Standard) | 491833-29-5 | Reference Standards |
| HY-14885S | Eliglustat-d15 (tartrate) | 1884556-84-6 | Isotope-Labeled Compounds |
| HY-14885S1 | Eliglustat-d4 | Isotope-Labeled Compounds | |
| HY-14885S2 | Eliglustat-d15 | 1628700-80-0 | Isotope-Labeled Compounds |
| HY-14886 | Fasitibant (chloride) | 1157852-02-2 | Reference compound |
| HY-148860 | NVP-DFF332 | 2734922-78-0 | Reference compound |
| HY-148862 | Cavα2δ1&NET-IN-1 | 2314361-39-0 | Reference compound |
| HY-148863 | Cavα2δ1&NET-IN-2 | 2143586-17-6 | Reference compound |
| HY-148864 | JQ1-TCO | Reference compound | |
| HY-148864A | (Z)-JQ1-TCO | 2087490-43-3 | Reference compound |
| HY-148865 | Puromycin-bis(PEG2-amide)-Biotin | 2379889-82-2 | Reference compound |
| HY-148866 | Cavα2δ1&NET-IN-3 | 2143584-82-9 | Reference compound |
| HY-148867 | UCM-1306 | 2258608-78-3 | Reference compound |
| HY-148868 | Akt1&PKA-IN-1 | 1334107-58-2 | Reference compound |
| HY-148868A | Akt1&PKA-IN-2 | 1334108-00-7 | Reference compound |
| HY-148869A | Hexanoyl-Coenzyme A (triammonium) | 799812-81-0 | Enzyme |
| HY-14887 | Fedovapagon | 347887-36-9 | Reference compound |
| HY-148870 | Maytansinoid B | 1628543-40-7 | ADC Related |
| HY-148871 | Mc-Val-Cit-PAB-Gefitinib (chloride) | ADC Related | |
| HY-148872 | Thalidomide-5-NH2-C8-NH2 (TFA) | 2097509-49-2 | Reference compound |
| HY-148874 | FXR antagonist 2 | 1660153-21-8 | Reference compound |
| HY-148874A | FXR antagonist 2 (hydrochloride) | Reference compound | |
| HY-148875 | Py-MAA-Val-Cit-PAB-MMAE | 2247398-68-9 | ADC Related |
| HY-148877 | AT-533 | 908112-37-8 | Reference compound |
| HY-148878 | Ras modulator-1 | 623935-08-0 | Reference compound |
| HY-148880 | VHLL-BCN | 2874203-49-1 | Reference compound |
| HY-148896 | (S,R,S)-AHPC-C2-PEG3-BCN | 2876198-36-4 | Reference compound |
| HY-148899 | Mcl-1 inhibitor 10 | 1580484-33-8 | Reference compound |
| HY-148900 | SCFSkp2-IN-2 | 1375060-02-8 | Reference compound |
| HY-148901 | CMB-087229 | 1227692-67-2 | Reference compound |
| HY-148904 | Allylic-SAM | 875155-64-9 | Reference compound |
| HY-148905 | p-Aminophenylmercuric acetate | 6283-24-5 | Biochemical Assay Reagents |
| HY-148906 | Anticancer agent 95 | 853302-91-7 | Reference compound |
| HY-148907 | CS640 | 2388506-83-8 | Reference compound |
| HY-148908 | TNF-α-IN-8 | 444287-85-8 | Reference compound |
| HY-148909 | Isopropyl dodec-11-enylfluorophosphonate | 623114-64-7 | Reference compound |
| HY-14891 | Fosdevirine | 1018450-26-4 | Reference compound |
| HY-148910 | Paromamine | 534-47-4 | Reference compound |
| HY-148913 | CS587 | 2388506-69-0 | Reference compound |
| HY-148918 | E722-2648 | 931963-55-2 | Reference compound |
| HY-148919A | Isopentenyl pyrophosphate (triammonium) | 116057-53-5 | Natural Products |
| HY-148919B | Isopentenyl pyrophosphate (trilithium) | 18687-43-9 | Natural Products |
| HY-14892 | Gemigliptin | 911637-19-9 | Reference compound |
| HY-148921 | SDH-IN-2 | 1823354-06-8 | Reference compound |
| HY-148922 | PPARα/γ agonist 2 | 2213365-56-9 | Reference compound |
| HY-148923 | MC0704 | 3034176-57-0 | Reference compound |
| HY-148925 | α-Amyrenone | 638-96-0 | Natural Products |
| HY-148926 | HSD17B13-IN-1 | 2770246-02-9 | Reference compound |
| HY-14892A | Gemigliptin (tartrate) | 1374639-74-3 | Reference compound |
| HY-148933 | ALKBH5-IN-2 | 1008951-10-7 | Reference compound |
| HY-148937 | Oroselol | 1891-25-4 | Natural Products |
| HY-148939 | MPX-004 | 1688684-07-2 | Reference compound |
| HY-14894 | Ipragliflozin | 761423-87-4 | Reference compound |
| HY-148940 | Docosahexaenoyl glycerol | 140670-40-2 | Reference compound |
| HY-148944 | Didocosahexaenoin | 124538-05-2 | Reference compound |
| HY-148947 | Cy5 Phosphoramidite | 182873-67-2 | Dye Reagents |
| HY-148948 | Nampt activator-3 | 2790481-63-7 | Reference compound |
| HY-148949 | Kallikrein 5-IN-2 | 2361160-57-6 | Reference compound |
| HY-148949A | Kallikrein 5-IN-2 (TFA) | Reference compound | |
| HY-14894A | Ipragliflozin (L-Proline) | 951382-34-6 | Reference compound |
| HY-14894R | Ipragliflozin (Standard) | 761423-87-4 | Reference Standards |
| HY-14894S2 | Pragliflozin-13C6 | 2743031-48-1 | Isotope-Labeled Compounds |
| HY-14895 | Fabomotizole | 173352-21-1 | Reference compound |
| HY-148953 | MTR-106 | 1639357-93-9 | Reference compound |
| HY-148957 | 5-Bromo-2′-deoxy-2′-fluorouridine | 55612-18-5 | Reference compound |
| HY-14895A | Fabomotizole (hydrochloride) | 173352-39-1 | Reference compound |
| HY-14895B | Fabomotizole di(hydrochloride) | 189638-30-0 | Reference compound |
| HY-14895R | Fabomotizole (Standard) | 173352-21-1 | Reference Standards |
| HY-14896 | Opicapone | 923287-50-7 | Reference compound |
| HY-148960 | Bis(diazoacetyl)butane | 1448-16-4 | Reference compound |
| HY-148962 | LY2880070 | 1375637-35-6 | Reference compound |
| HY-148963 | HSP90-IN-20 | 747414-31-9 | Reference compound |
| HY-148964 | Thiotraniliprole | 1442448-92-1 | Reference compound |
| HY-148965S | PtdIns(3)P-d62 (ammonium) | Isotope-Labeled Compounds | |
| HY-148968 | Metham (sodium) | 137-42-8 | Reference compound |
| HY-14896R | Opicapone (Standard) | 923287-50-7 | Reference Standards |
| HY-14897 | Rezatomidine | 847829-38-3 | Reference compound |
| HY-148971A | PtdIns-(345)-P3 (12-dipalmitoyl) (sodium) | 1628353-02-5 | Reference compound |
| HY-148973 | ZW290 | 2411852-67-8 | Reference compound |
| HY-148974 | PLK1-IN-5 | 1001343-34-5 | Reference compound |
| HY-148977 | 18:0,22:6 PS (sodium) | 474943-18-5 | Reference compound |
| HY-148978 | 18:0,18:1 PS (sodium) | 321883-23-2 | Reference compound |
| HY-148978R | 18:0,18:1 PS (sodium) (Standard) | 321883-23-2 | Reference Standards |
| HY-148979 | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphorylethanolamine | 61216-62-4 | Dye Reagents |
| HY-14898 | AGN 210676 | 910562-15-1 | Reference compound |
| HY-148980 | Polyinosinic acid | 30918-54-8 | Reference compound |
| HY-148980A | Polyinosinic acid (sodium) | 33378-44-8 | Reference compound |
| HY-14899 | Taprenepag | 752187-80-7 | Reference compound |
| HY-148992 | APX879 | 1801372-27-9 | Natural Products |
| HY-148994 | Methotrexate-γ-aspartate | 64801-58-7 | Reference compound |
| HY-14900 | Tedalinab | 916591-01-0 | Reference compound |
| HY-149000 | PI3Kα-IN-7 | 2417098-53-2 | Reference compound |
| HY-149001 | PARP1-IN-9 | 2494000-71-2 | Reference compound |
| HY-149002 | Topoisomerase I/II inhibitor 4 | 3031403-77-4 | Reference compound |
| HY-149003 | PARP1-IN-10 | 2494001-21-5 | Reference compound |
| HY-149004 | SLF1081851 | 2763730-97-6 | Reference compound |
| HY-149004A | SLF1081851 (TFA) | 2763730-98-7 | Reference compound |
| HY-149004B | SLF1081851 (hydrochloride) | 2999629-35-3 | Reference compound |
| HY-149005 | PRMT5-IN-19 | 2783961-86-2 | Reference compound |
| HY-149006 | CK156 | 2910938-59-7 | Reference compound |
| HY-149007 | STAT3-IN-11 | 2503096-50-0 | Reference compound |
| HY-149008 | α-Amylase-IN-3 | 93944-58-2 | Reference compound |
| HY-149009 | Bcl-2-IN-9 | 2490542-33-9 | Reference compound |
| HY-14901 | Telapristone | 198414-30-1 | Reference compound |
| HY-149010 | NXPZ-2 | 2254492-08-3 | Reference compound |
| HY-149011 | CA IX-IN-1 | Reference compound | |
| HY-149012 | AChE/hCA I/II-IN-1 | 2049681-10-7 | Reference compound |
| HY-149013 | Anti-MRSA agent 5 | 2490154-44-2 | Reference compound |
| HY-149014 | OX2R-IN-1 | 2639148-08-4 | Reference compound |
| HY-149015 | FTase-IN-1 | 2490538-41-3 | Reference compound |
| HY-149016 | Tubulin polymerization-IN-25 | 2490538-46-8 | Reference compound |
| HY-149017 | Apoptosis inducer 7 | 2252278-57-0 | Reference compound |
| HY-149018 | ATX inhibitor 22 | 2969213-59-8 | Reference compound |
| HY-149019 | Antitumor agent-70 | 2454133-88-9 | Reference compound |
| HY-14902 | Tofogliflozin | 903565-83-3 | Reference compound |
| HY-149020 | Tubulin polymerization-IN-26 | 2490291-68-2 | Reference compound |
| HY-149021 | Tubulin polymerization-IN-28 | 2481404-89-9 | Reference compound |
| HY-149022 | HSV-1/HSV-2-IN-1 | 2490468-31-8 | Reference compound |
| HY-149023 | HSV-1/HSV-2-IN-2 | 2490468-39-6 | Reference compound |
| HY-149024 | VEGFR-2-IN-23 | 2411174-53-1 | Reference compound |
| HY-149025 | DPTIP-prodrug 18 | 2881068-33-1 | Reference compound |
| HY-149026 | GNE-064 | 1997321-20-6 | Reference compound |
| HY-149028 | Mem-C1C18 | Dye Reagents | |
| HY-149029 | TH-6 | 3031349-25-1 | Reference compound |
| HY-14903 | Ulimorelin | 842131-33-3 | Reference compound |
| HY-149030 | DHODH-IN-21 | 2450341-39-4 | Reference compound |
| HY-149031 | DHODH-IN-22 | 2450341-75-8 | Reference compound |
| HY-149032 | Kobusine derivative-1 | Reference compound | |
| HY-149033 | Kobusine derivative-2 | Reference compound | |
| HY-149034 | Influenza A virus-IN-8 | Peptides | |
| HY-149035 | PAA4 | Reference compound | |
| HY-149036 | PAA5 | Reference compound | |
| HY-149037 | GL67 | 179075-30-0 | Biochemical Assay Reagents |
| HY-149037A | GL67 (pentahydrochloride) | Reference compound | |
| HY-149039 | Amine-PEG4-amido-tri-(carboxyethoxymethyl)-methane | 2840751-73-5 | Reference compound |
| HY-14904 | Umifenovir | 131707-25-0 | Reference compound |
| HY-149041 | Coretinphencone | 1631711-77-7 | Natural Products |
| HY-149048 | Adenosylhomocysteinase | 9025-54-1 | Enzyme |
| HY-149049 | Cajaninstilbene acid | 87402-84-4 | Natural Products |
| HY-14904A | Umifenovir (hydrochloride) | 131707-23-8 | Reference compound |
| HY-14904AR | Umifenovir (hydrochloride) (Standard) | 131707-23-8 | Reference Standards |
| HY-14904AS | Umifenovir-d6 (hydrochloride) | 2928218-29-3 | Isotope-Labeled Compounds |
| HY-14904R | Umifenovir (Standard) | 131707-25-0 | Reference Standards |
| HY-14905 | Uridine triacetate | 4105-38-8 | Reference compound |
| HY-149050 | Viral polymerase-IN-1 (hydrochloride) | 2367587-02-6 | Reference compound |
| HY-149051 | BGB-8035 | 2283349-24-4 | Reference compound |
| HY-149052 | SZM-1209 | 2919801-86-6 | Reference compound |
| HY-149053 | OY-101 | 41183-02-2 | Reference compound |
| HY-149053A | (S)-OY-101 | 2924484-79-5 | Reference compound |
| HY-149053B | (R)-OY-101 | 23495-82-1 | Reference compound |
| HY-149054 | GSK-3β inhibitor 13 | 2227316-74-5 | Reference compound |
| HY-149055 | ACT-777991 | 1967811-46-6 | Reference compound |
| HY-149056 | GNE-6893 | 2415374-98-8 | Reference compound |
| HY-149056A | (3S,4R)-GNE-6893 | 2415374-97-7 | Reference compound |
| HY-149057 | Neuraminidase-IN-12 | 2218480-15-8 | Reference compound |
| HY-149058 | Neuraminidase-IN-13 | 2222067-23-2 | Reference compound |
| HY-149059 | Neuraminidase-IN-14 | Reference compound | |
| HY-149060 | Neuraminidase-IN-15 | Reference compound | |
| HY-149061 | Anticancer agent 99 | 2914922-83-9 | Reference compound |
| HY-149062 | Anticancer agent 102 | 2914922-86-2 | Reference compound |
| HY-149063 | Antitumor agent-92 | 2922842-01-9 | Reference compound |
| HY-149064 | Antituberculosis agent-9 | 2998587-72-5 | Reference compound |
| HY-149065 | D-685 | 2893801-00-6 | Reference compound |
| HY-149067 | Antifungal agent 47 | 2719867-46-4 | Reference compound |
| HY-149068 | TSC24 | Reference compound | |
| HY-149069 | TSC25 | Reference compound | |
| HY-14907 | Verubulin | 827031-83-4 | Reference compound |
| HY-149070 | 3′-Azido-2′,3′-dideoxy-5-hydroxyuridine | 111495-90-0 | Oligonucleotides |
| HY-149071 | TLR7 agonist 10 | 2389988-34-3 | Reference compound |
| HY-149072 | TLR7 agonist 11 | 2389988-36-5 | Reference compound |
| HY-149073 | TSC26 | Reference compound | |
| HY-149075 | MR22 | 3027761-24-3 | Reference compound |
| HY-149076 | hGAPDH-IN-1 | Reference compound | |
| HY-149077 | 2′-Deoxy-5-methoxyuridine | 37805-95-1 | Reference compound |
| HY-149078 | Antiparasitic agent-14 | Reference compound | |
| HY-149079 | Antiparasitic agent-15 | Reference compound | |
| HY-14908 | Vidofludimus | 717824-30-1 | Reference compound |
| HY-149080 | Antiparasitic agent-16 | Reference compound | |
| HY-149081 | ERα degrader 6 | 2775441-10-4 | Reference compound |
| HY-149082 | LTB4 antagonist 1 | 2929239-84-7 | Reference compound |
| HY-149083 | LTB4 antagonist 2 | 2929239-85-8 | Reference compound |
| HY-149084 | LTB4 antagonist 3 | 2929239-87-0 | Reference compound |
| HY-149085 | XS-060 | 346721-50-4 | Reference compound |
| HY-149085A | (E)-XS-060 | 2787626-06-4 | Reference compound |
| HY-149086 | BPA-B9 | Reference compound | |
| HY-149087 | MR2938 | 1044870-65-6 | Reference compound |
| HY-149088 | Neuraminidase-IN-16 | Reference compound | |
| HY-149089 | Antibacterial agent 138 | Reference compound | |
| HY-14908A | Vidofludimus (hemicalcium) | 1354012-90-0 | Reference compound |
| HY-14909 | Bardoxolone | 218600-44-3 | Reference compound |
| HY-149090 | AChE/BuChE/MAO-B-IN-2 | Reference compound | |
| HY-149091 | KDM5B-IN-4 | Reference compound | |
| HY-149092 | Anticancer agent 109 | 2097497-16-8 | Reference compound |
| HY-149093 | Antileishmanial agent-14 | 1638956-72-5 | Reference compound |
| HY-149094 | Neuroprotective agent 1 | 2344786-13-4 | Reference compound |
| HY-149095 | Antibacterial agent 139 | Reference compound | |
| HY-149096 | CCR7 antagonist 1 | Reference compound | |
| HY-149097 | ITH12711 | 3042876-07-0 | Reference compound |
| HY-149098 | SJ1461 | 2924546-70-1 | Reference compound |
| HY-149099 | RET-IN-22 | 2918281-79-3 | Reference compound |
| HY-149100 | PLK1-IN-6 | Reference compound | |
| HY-149101 | Riboxin | 86-04-4 | Reference compound |
| HY-149102 | LE 28 | 1416080-97-1 | Dye Reagents |
| HY-149105 | FSH receptor antagonist 1 | 487064-35-7 | Reference compound |
| HY-149117 | AF430 NHS ester | 467233-94-9 | Dye Reagents |
| HY-149120 | ASM-IN-1 | 2913151-46-7 | Reference compound |
| HY-149121 | NLRP3-IN-14 | 2767369-80-0 | Reference compound |
| HY-149122 | NLRP3-IN-15 | 2767369-71-9 | Reference compound |
| HY-149123 | NLRP3-IN-16 | 2906872-59-9 | Reference compound |
| HY-149125 | Globotriaosylceramide (porcine RBC) | 71965-57-6 | Natural Products |
| HY-149127 | Rosolutamide | 1039760-91-2 | Reference compound |
| HY-14913 | Apricitabine | 160707-69-7 | Reference compound |
| HY-149132 | Dendrogenin A | 1191043-85-2 | Biochemical Assay Reagents |
| HY-149136 | MORF-627 | 2412688-16-3 | Reference compound |
| HY-14914 | Azilsartan | 147403-03-0 | Reference compound |
| HY-149143 | JNJ-28583113 | 2765255-93-2 | Reference compound |
| HY-149145 | Ena15 | 956935-02-7 | Reference compound |
| HY-149149 | Incadronic acid | 124351-85-5 | Reference compound |
| HY-14914R | Azilsartan (Standard) | 147403-03-0 | Reference Standards |
| HY-14914S | Azilsartan-d5 | 1346599-45-8 | Isotope-Labeled Compounds |
| HY-14914S1 | Azilsartan-d4 | 1794817-45-0 | Isotope-Labeled Compounds |
| HY-14915 | Bedoradrine | 194785-19-8 | Reference compound |
| HY-149152 | PtdIns-(4,5)-P2 (1,2-dioctanoyl) | 204858-53-7 | Reference compound |
| HY-149154 | (4S,5S,6S,12aS)-Oxytetracycline | 423769-22-6 | Reference compound |
| HY-149155 | o-Cymen-5-ol | 39660-61-2 | Reference compound |
| HY-149156 | Lipid C24 | 2767561-52-2 | Biochemical Assay Reagents |
| HY-149157 | L-Lysine (orotate) | 28003-86-3 | Natural Products |
| HY-14915A | Bedoradrine (sulfate) | 194785-31-4 | Reference compound |
| HY-14916 | Camobucol | 216167-92-9 | Reference compound |
| HY-149160 | 5′-Amino-5′-deoxythymidine | 25152-20-9 | Oligonucleotides |
| HY-149164 | BTB09089 | 245728-44-3 | Reference compound |
| HY-149165 | Glucocorticoid receptor modulator 2 | 2452396-89-1 | Reference compound |
| HY-149167 | ATX-0126 | 2230647-37-5 | Oligonucleotides |
| HY-149169 | Phevamine A | 2280874-34-0 | Natural Products |
| HY-14917 | Capadenoson | 544417-40-5 | Reference compound |
| HY-149170 | FFN246 | 2210244-83-8 | Dye Reagents |
| HY-149173 | CDK-IN-11 | 2376876-87-6 | Reference compound |
| HY-149179 | Polymyxin B | 1404-26-8 | Reference compound |
| HY-149182 | Lucifer yellow iodoacetamide (dipotassium) | 176182-05-1 | Dye Reagents |
| HY-14919 | Denibulin | 284019-34-7 | Reference compound |
| HY-149190 | GPR35 agonist 5 | 2226201-24-5 | Reference compound |
| HY-149199 | Sulfosate | 81591-81-3 | Reference compound |
| HY-14919A | Denibulin (hydrochloride) | 779356-64-8 | Reference compound |
| HY-14920 | Dexelvucitabine | 134379-77-4 | Reference compound |
| HY-149200 | Lysine-methotrexate | 80407-56-3 | Reference compound |
| HY-149202 | UT-11 | Reference compound | |
| HY-149203 | MQA-P | Dye Reagents | |
| HY-149203A | MQA-P (TFA) | Dye Reagents | |
| HY-149204 | SYNTi | Reference compound | |
| HY-149205 | CXJ-2 | 2919976-92-2 | Reference compound |
| HY-149206 | HPK1-IN-33 | 2920000-86-6 | Reference compound |
| HY-149207 | Tyrosinase-IN-11 | 240797-64-2 | Reference compound |
| HY-149208 | HDAC-IN-53 | 2921948-27-6 | Reference compound |
| HY-149209 | LL-K8-22 | Reference compound | |
| HY-14921 | Elsibucol | 216167-95-2 | Reference compound |
| HY-149210 | S1PR1 Radioligand 1 | 2845249-11-6 | Reference compound |
| HY-149211 | AChE/BChE-IN-12 | Reference compound | |
| HY-149212 | SD-6 | 744206-31-3 | Reference compound |
| HY-149213 | LSD1-IN-24 | 4734-59-2 | Reference compound |
| HY-149214 | Anticancer agent 100 | 2914922-73-7 | Reference compound |
| HY-149215 | Anticancer agent 101 | 2914922-80-6 | Reference compound |
| HY-149216 | Anticancer agent 103 | 2914922-78-2 | Reference compound |
| HY-149217 | Antiviral agent 27 | 2270947-36-7 | Reference compound |
| HY-149218 | THR-β agonist 6 | 2791290-58-7 | Reference compound |
| HY-149219 | BIBD-124 | 2716871-93-9 | Reference compound |
| HY-14922 | Fosalvudine tidoxil | 763903-67-9 | Reference compound |
| HY-149220 | 5'-Protected 2,2'-anhydrouridine | 173170-12-2 | Oligonucleotides |
| HY-149221 | Apoptosis inducer 11 | Reference compound | |
| HY-149222 | Apoptosis inducer 12 | 1971096-01-1 | Reference compound |
| HY-149223 | FtsZ-IN-5 | Reference compound | |
| HY-149224 | FtsZ-IN-6 | Reference compound | |
| HY-149225 | FtsZ-IN-7 | Reference compound | |
| HY-149226 | FtsZ-IN-8 | Reference compound | |
| HY-149227 | IDO1-IN-21 | 2892432-98-1 | Reference compound |
| HY-149228 | USP28-IN-2 | 2931509-11-2 | Reference compound |
| HY-149229 | USP28-IN-3 | 2931509-14-5 | Reference compound |
| HY-14923 | Ilepatril | 473289-62-2 | Reference compound |
| HY-149230 | USP28-IN-4 | 2931509-15-6 | Reference compound |
| HY-149231 | Anticancer agent 104 | 3047612-51-8 | Reference compound |
| HY-149232 | HPK1-IN-35 | 2935903-77-6 | Reference compound |
| HY-149233 | hAChE-IN-1 | Reference compound | |
| HY-149234 | MAO-B-IN-18 | Reference compound | |
| HY-149235 | PI3Kδ-IN-12 | Reference compound | |
| HY-149236 | PROTAC GPX4 degrader-1 | 2916433-81-1 | Reference compound |
| HY-149237 | hAChE-IN-2 | Reference compound | |
| HY-149238 | Topo II/HDAC-IN-1 | 2922269-18-7 | Reference compound |
| HY-149239 | Topo II/HDAC-IN-2 | 2922269-24-5 | Reference compound |
| HY-14924 | Inakalant | 335619-18-6 | Reference compound |
| HY-149240 | Anticancer agent 108 | Reference compound | |
| HY-149241 | SHP2-IN-13 | 2951854-02-5 | Reference compound |
| HY-149242 | MAO-B-IN-20 | Reference compound | |
| HY-149243 | BChE-IN-16 | Reference compound | |
| HY-149244 | Nrf2 activator-7 | 2456295-39-7 | Reference compound |
| HY-149245 | Keap1-Nrf2-IN-15 | 2456295-45-5 | Reference compound |
| HY-149246 | Aβ-IN-6 | Reference compound | |
| HY-149247 | Antipsychotic agent-2 | Reference compound | |
| HY-149248 | NF-κB-IN-8 | 2924565-59-1 | Reference compound |
| HY-149249 | MY-943 | Reference compound | |
| HY-14925 | Lapaquistat | 189059-71-0 | Reference compound |
| HY-149250 | MDMX/MDM2-IN-2 | 3043723-74-3 | Reference compound |
| HY-149251 | DENV-IN-10 | Reference compound | |
| HY-149252 | Tubulin inhibitor 32 | 2923531-39-7 | Reference compound |
| HY-149253 | OY-201 | 2962943-05-9 | Reference compound |
| HY-149254 | PTP1B/AKR1B1-IN-1 | Reference compound | |
| HY-149255 | PTP1B/AKR1B1-IN-2 | Reference compound | |
| HY-149256 | PLpro/RBD-IN-1 | 1282451-83-5 | Reference compound |
| HY-149257 | HAT-SIL-TG-1&AT | 2973282-50-5 | Reference compound |
| HY-149258 | KWCN-41 | 2913223-17-1 | Reference compound |
| HY-149259 | FAK-IN-9 | 2911655-93-9 | Reference compound |
| HY-14926 | Levonadifloxacin | 154357-42-3 | Reference compound |
| HY-149260 | HIF-1 inhibitor-5 | Reference compound | |
| HY-149261 | H1k | Reference compound | |
| HY-149262 | CLK1-IN-3 | 2922550-28-3 | Reference compound |
| HY-149263 | HAA-09 | 1422051-33-9 | Reference compound |
| HY-149264 | SARS-CoV-2 3CLpro-IN-13 | 622794-09-6 | Reference compound |
| HY-149265 | ROS-generating agent 1 | 2369030-41-9 | Reference compound |
| HY-149266 | THK01 | 2226941-26-8 | Reference compound |
| HY-149267 | STING agonist-30 | 2951078-67-2 | Reference compound |
| HY-149268 | JNK3 inhibitor-6 | Reference compound | |
| HY-149269 | COX-2-IN-30 | 1160498-08-7 | Reference compound |
| HY-14926A | Levonadifloxacin (arginine) (hydrate) | 627891-34-3 | Reference compound |
| HY-14926B | Levonadifloxacin (arginine) | 306748-89-0 | Reference compound |
| HY-14926R | Levonadifloxacin (Standard) | 154357-42-3 | Reference Standards |
| HY-14927 | Lificiguat | 170632-47-0 | Reference compound |
| HY-149270 | COX-2-IN-31 | Reference compound | |
| HY-149271 | Anti-MRSA agent 7 | Reference compound | |
| HY-149272 | tau/Aβ40 aggregation-IN-1 | 2973377-10-3 | Reference compound |
| HY-149273 | hBChE-IN-1 | 1776948-12-9 | Reference compound |
| HY-149274 | Sigma-1 receptor antagonist 4 | Reference compound | |
| HY-149275 | PKM2/PDK1-IN-1 | 3041957-90-5 | Reference compound |
| HY-149276 | SLC26A3-IN-2 | 950348-60-4 | Reference compound |
| HY-149277 | FM04 | 1807320-40-6 | Reference compound |
| HY-149278 | Complement C1s-IN-1 | 3033831-40-9 | Reference compound |
| HY-149279 | JNK3 inhibitor-7 | 3034676-52-0 | Reference compound |
| HY-14928 | Lobeglitazone | 607723-33-1 | Reference compound |
| HY-149280 | JNK3 inhibitor-8 | 3034676-53-1 | Reference compound |
| HY-149281 | IL-1β-IN-1 | 2780364-50-1 | Reference compound |
| HY-149282 | IL-1β-IN-2 | 2242896-76-8 | Reference compound |
| HY-149283 | JAK/HDAC-IN-2 | 3029138-43-7 | Reference compound |
| HY-149284 | JAK/HDAC-IN-3 | 3029138-70-0 | Reference compound |
| HY-149285 | NT160 | 1418293-40-9 | Reference compound |
| HY-149286 | Antibacterial agent 142 | 3037009-24-5 | Reference compound |
| HY-149287 | hAChE/hBACE-1-IN-1 | Reference compound | |
| HY-149288 | hAChE/hBACE-1-IN-2 | Reference compound | |
| HY-149289 | DNMT-IN-3 | 1683516-27-9 | Reference compound |
| HY-14928A | Lobeglitazone (sulfate) | 763108-62-9 | Reference compound |
| HY-14928S1 | Lobeglitazone-d4 | Isotope-Labeled Compounds | |
| HY-14929 | Migalastat | 108147-54-2 | Reference compound |
| HY-149290 | AMX12006 | 2639775-01-0 | Reference compound |
| HY-149291 | ATM Inhibitor-7 | 3033712-80-7 | Reference compound |
| HY-149292 | SR-4133 | 2999645-23-5 | Reference compound |
| HY-149294 | DNA Gyrase-IN-8 | 2925308-76-3 | Reference compound |
| HY-149295 | PROTAC ERα Degrader-4 | 2521299-80-7 | Reference compound |
| HY-149296 | JAK1-IN-12 | 2945204-95-3 | Reference compound |
| HY-149297 | PSMA-IN-1 | Reference compound | |
| HY-149298 | PSMA-IN-2 | 2946600-14-0 | Reference compound |
| HY-149299 | PYZ18 | 1447578-01-9 | Reference compound |
| HY-14929A | Migalastat (hydrochloride) | 75172-81-5 | Reference compound |
| HY-14930 | Mirodenafil | 862189-95-5 | Reference compound |
| HY-149300 | SB-1436 | 2925298-08-2 | Reference compound |
| HY-149301 | hCAIX-IN-18 | 2925261-76-1 | Reference compound |
| HY-149302 | MC4033 | 28532-21-0 | Reference compound |
| HY-149303 | Potassium tert-butoxide | 865-47-4 | Biochemical Assay Reagents |
| HY-149304 | SARS-CoV-2-IN-40 | 2984557-53-9 | Reference compound |
| HY-149305 | PptT-IN-4 | 2948309-57-5 | Reference compound |
| HY-149306 | MS78 | 3034773-00-4 | Reference compound |
| HY-149307 | CYCA-117-70 | 1958262-04-8 | Reference compound |
| HY-149308 | MKA031 | 2951012-00-1 | Reference compound |
| HY-149309 | Topoisomerase inhibitor 2 | 2713986-17-3 | Reference compound |
| HY-14930A | Mirodenafil (dihydrochloride) | 862189-96-6 | Reference compound |
| HY-14931 | Naproxcinod | 163133-43-5 | Reference compound |
| HY-149310 | Dim16 | 2743448-32-8 | Reference compound |
| HY-149311 | PPO-IN-2 | 1879036-88-0 | Reference compound |
| HY-149312 | PPO-IN-3 | 1879036-82-4 | Reference compound |
| HY-149313 | α‑Amylase-IN-1 | 148404-10-8 | Reference compound |
| HY-149314 | SARS-CoV-2-IN-47 | Reference compound | |
| HY-149315 | SARS-CoV-2-IN-48 | Reference compound | |
| HY-149316 | Smurf1-IN-1 | 1824708-03-3 | Reference compound |
| HY-149317 | ZINC475239213 | 2871002-89-8 | Reference compound |
| HY-149318 | VRT-534 | 926664-32-6 | Reference compound |
| HY-149319 | ZINC61142882 | 3034181-87-5 | Reference compound |
| HY-14932 | Pafuramidine | 186953-56-0 | Reference compound |
| HY-149320 | Acryl42-10 | Reference compound | |
| HY-149321 | SARS-CoV-2 nsp14-IN-3 | 2920574-16-7 | Reference compound |
| HY-149322 | Z795161988 | 3034181-88-6 | Reference compound |
| HY-149323 | SDH-IN-4 | 2982993-88-2 | Reference compound |
| HY-149324 | SP27 | 3034805-75-6 | Reference compound |
| HY-149325 | RPE65-IN-1 | 1141779-07-8 | Reference compound |
| HY-149327 | Anticancer agent 131 | 2864443-47-8 | Reference compound |
| HY-149328 | phoBET1 | 3033545-34-2 | Reference compound |
| HY-149329 | hCAIX/VII-IN-1 | 2990559-21-0 | Reference compound |
| HY-14932A | Pafuramidine (maleate) | 837369-26-3 | Reference compound |
| HY-14932R | Pafuramidine (Standard) | 186953-56-0 | Reference Standards |
| HY-14933 | Prinaberel | 524684-52-4 | Reference compound |
| HY-149330 | HA5 | 2378406-17-6 | Reference compound |
| HY-149331 | TNF-α-IN-11 | 2945197-77-1 | Reference compound |
| HY-149332 | α-Glucosidase-IN-26 | Reference compound | |
| HY-149333 | BO-1 | Reference compound | |
| HY-149334 | ZLD115 | 2980653-93-6 | Reference compound |
| HY-149335 | Sigma-1 receptor antagonist 5 | 2952808-33-0 | Reference compound |
| HY-149336 | D1R antagonist 1 | 2983777-67-7 | Reference compound |
| HY-149337 | D3R ligand 1 | 2983777-91-7 | Reference compound |
| HY-149338 | NNRT-IN-3 | Reference compound | |
| HY-149339 | hnNOS-IN-2 | 2700326-00-5 | Reference compound |
| HY-14934 | Rosabulin | 501948-05-6 | Reference compound |
| HY-149340 | PD07 | Reference compound | |
| HY-149341 | α-Glucosidase-IN-28 | 2949513-10-2 | Reference compound |
| HY-149342 | α-Glucosidase-IN-29 | 2949513-11-3 | Reference compound |
| HY-149343 | Anticancer agent 132 | Reference compound | |
| HY-149344 | Anticancer agent 133 | 2758905-51-8 | Reference compound |
| HY-149345 | IRAK4-IN-24 | 2952533-54-7 | Reference compound |
| HY-149346 | Mtb-IN-2 | 2861190-30-7 | Reference compound |
| HY-149347 | Mtb-IN-3 | 3052302-61-8 | Reference compound |
| HY-149348 | DiPT-4 | 3052259-89-6 | Reference compound |
| HY-149349 | MtUng-IN-1 | 359826-99-6 | Reference compound |
| HY-14935 | Sodelglitazar | 447406-78-2 | Reference compound |
| HY-149350 | HIV-1 inhibitor-57 | 2745197-24-2 | Reference compound |
| HY-149351 | NF-κB-IN-10 | 3052257-09-4 | Reference compound |
| HY-149352 | DG1 | Reference compound | |
| HY-149353 | Antibacterial agent 145 | Reference compound | |
| HY-149354 | Aurora kinase-IN-4 | 2877011-84-0 | Reference compound |
| HY-149355 | COX-2-IN-33 | 3049405-60-6 | Reference compound |
| HY-149356 | PD-1/PD-L1-IN-31 | 3049472-36-5 | Reference compound |
| HY-149357 | Yhhu6669 | 2569526-80-1 | Reference compound |
| HY-149358 | NK3R-IN-1 | 2854331-14-7 | Reference compound |
| HY-149359 | IHMT-IDH1-053 | 3049485-80-2 | Reference compound |
| HY-14936 | Sofigatran | 187602-11-5 | Reference compound |
| HY-149360 | P-gb-IN-1 | 2632874-49-6 | Reference compound |
| HY-149361 | VEGFR2-IN-4 | 3049398-38-8 | Reference compound |
| HY-149362 | MTase-IN-1 | Reference compound | |
| HY-149363 | Tubulin polymerization-IN-43 | 2773345-90-5 | Reference compound |
| HY-149364 | Tubulin inhibitor 34 | 3048497-78-2 | Reference compound |
| HY-149365 | SIKs-IN-1 | 2927557-06-8 | Reference compound |
| HY-149366 | ABCB1-IN-1 | 2986412-70-6 | Reference compound |
| HY-149367 | Anticancer agent 136 | 3049419-74-8 | Reference compound |
| HY-149368 | SARS-CoV-2-IN-51 | 3049478-88-5 | Reference compound |
| HY-149369 | HDAC-IN-59 | 2944459-43-0 | Reference compound |
| HY-14937 | Succinobucol | 216167-82-7 | Reference compound |
| HY-149370 | HDAC-IN-60 | 2944459-58-7 | Reference compound |
| HY-149371 | HDAC6-IN-16 | Reference compound | |
| HY-149372 | HDAC6-IN-17 | Reference compound | |
| HY-149373 | Garcinone B | 76996-28-6 | Natural Products |
| HY-149374 | Tubulin inhibitor 36 | Reference compound | |
| HY-149375 | Tubulin inhibitor 37 | Reference compound | |
| HY-149376 | Tubulin inhibitor 38 | Reference compound | |
| HY-149377 | MMP13-IN-4 | 514855-02-8 | Reference compound |
| HY-149378 | MMP13-IN-5 | Reference compound | |
| HY-149379 | DNA gyrase B-IN-3 | 2412834-56-9 | Reference compound |
| HY-14938 | Tipelukast | 125961-82-2 | Reference compound |
| HY-149380 | Vem-L-Cy5 | Reference compound | |
| HY-149386 | D3R/MOR antagonist 1 | 3033883-15-4 | Reference compound |
| HY-149387 | D3R/MOR antagonist 2 | 3033883-17-6 | Reference compound |
| HY-149388 | Anticancer agent 139 | 2954795-29-8 | Reference compound |
| HY-149389 | PNMT-IN-1 | Reference compound | |
| HY-14939 | Vapitadine | 793655-64-8 | Reference compound |
| HY-149390 | TrxR1-IN-1 | 3052303-04-2 | Reference compound |
| HY-149391 | PROTAC BTK Degrader-6 | 2767204-39-5 | Reference compound |
| HY-149392 | HBV-IN-35 | Reference compound | |
| HY-149393 | RIPK3-IN-3 | 3052303-53-1 | Reference compound |
| HY-149394 | PRDX1-IN-1 | Reference compound | |
| HY-149395 | MmpL3-IN-3 | 1639438-67-7 | Reference compound |
| HY-149396 | FXIIa-IN-1 | 3052551-19-3 | Reference compound |
| HY-149397 | FXIIa-IN-2 | 3052551-17-1 | Reference compound |
| HY-149398 | PARP-1/2-IN-2 | 3052304-23-8 | Reference compound |
| HY-149399 | GABA-IN-1 | Reference compound | |
| HY-14939A | Vapitadine (hydrochloride) | 279253-83-7 | Reference compound |
| HY-14940 | Volinanserin | 139290-65-6 | Reference compound |
| HY-149400 | GABA-IN-2 | 2363715-13-1 | Reference compound |
| HY-149401 | EGFR-IN-82 | 2568086-81-5 | Reference compound |
| HY-149402 | hCA XII-IN-6 | Reference compound | |
| HY-149403 | J-1048 | 2374772-60-6 | Reference compound |
| HY-149404 | Tyrosinase-IN-12 | 1860779-42-5 | Reference compound |
| HY-149405 | Squalene synthase-IN-1 | Reference compound | |
| HY-149406 | AMPK activator 12 | 431920-24-0 | Reference compound |
| HY-149407 | Multi-kinase-IN-4 | Reference compound | |
| HY-149408 | MAOA-IN-1 | Reference compound | |
| HY-149409 | α-Glucosidase-IN-31 | Reference compound | |
| HY-14940A | (S)-Volinanserin | 175673-57-1 | Reference compound |
| HY-14940S | Volinanserin-d4 (hydrochloride) | 1217617-73-6 | Isotope-Labeled Compounds |
| HY-14941 | Elacytarabine | 188181-42-2 | Reference compound |
| HY-149410 | MSN8C | 1314798-31-6 | Reference compound |
| HY-149412 | MHJ-627 | Reference compound | |
| HY-149413 | FHND5071 | 2761152-16-1 | Isotope-Labeled Compounds |
| HY-149414 | MY-673 | 2944459-96-3 | Reference compound |
| HY-149415 | Multi-kinase-IN-5 | Reference compound | |
| HY-149416 | Mal-PEG8-Val-Ala-PAB-SB-743921 | ADC Related | |
| HY-149417 | BChE/HDAC6-IN-1 | 2925457-27-6 | Reference compound |
| HY-149418 | BChE/HDAC6-IN-2 | 2925457-33-4 | Reference compound |
| HY-149419 | GST-IN-1 | 2987870-87-9 | Reference compound |
| HY-14942 | Berubicin | 677017-23-1 | Reference compound |
| HY-149420 | BRD7-IN-2 | 3032601-06-9 | Reference compound |
| HY-149421 | BRD7-IN-3 | 3032601-04-7 | Reference compound |
| HY-149422 | NIR-FP | Dye Reagents | |
| HY-149423 | PI5P4K-β-IN-1 | 332407-28-0 | Reference compound |
| HY-149424 | PI5P4K-β-IN-2 | Reference compound | |
| HY-149425 | SIRT5 inhibitor 6 | 2834736-82-0 | Reference compound |
| HY-149426 | SIRT5 inhibitor 7 | 2951090-00-7 | Reference compound |
| HY-149427 | PI3Kα-IN-12 | 2966861-50-5 | Reference compound |
| HY-149428 | AD4 | 2918262-09-4 | Reference compound |
| HY-149429 | PPARδ agonist 9 | 928023-21-6 | Reference compound |
| HY-14942A | Berubicin (hydrochloride) | 293736-67-1 | Reference compound |
| HY-14943 | Darinaparsin | 69819-86-9 | Reference compound |
| HY-149430 | YIAD-0205 | 2446054-34-6 | Reference compound |
| HY-149431 | NDNA4 | Reference compound | |
| HY-149432 | NDNA3 | Reference compound | |
| HY-149433 | BWA-522 | 3042820-12-9 | Reference compound |
| HY-149434 | PROTAC AR-NTD degrader 1 | 3032601-92-3 | Reference compound |
| HY-149435 | HBV-IN-36 | Reference compound | |
| HY-149436 | CDK2/Bcl2-IN-1 | Reference compound | |
| HY-149439 | COH1 | 20217-22-5 | Reference compound |
| HY-14944 | Homoharringtonine | 26833-87-4 | Natural Products |
| HY-149442 | APE1-IN-3 | 1227098-30-7 | Reference compound |
| HY-149448 | Poly-γ-benzyl-L-glutamate (MW 150000-350000) | 25014-27-1 | Biochemical Assay Reagents |
| HY-149449 | Poly-L-γ-glutamic acid (sodium) | 208106-41-6 | Biochemical Assay Reagents |
| HY-14944R | Homoharringtonine (Standard) | 26833-87-4 | Reference Standards |
| HY-14945 | Remogliflozin etabonate | 442201-24-3 | Reference compound |
| HY-149450 | Aflastatin A | 179729-59-0 | Natural Products |
| HY-149451 | SYHA1815 | 2760195-67-1 | Reference compound |
| HY-149452 | SJ1008066 | 2758867-71-7 | Reference compound |
| HY-149453 | MCUF-651 | 2747162-85-0 | Reference compound |
| HY-149454 | P2Y1/P2Y12 antagonist-1 | 2738381-94-5 | Reference compound |
| HY-149455 | GPX4-IN-8 | 2703776-20-7 | Reference compound |
| HY-149458 | FHT-2344 | 2468058-90-2 | Reference compound |
| HY-149459A | Phototrexate | 2268033-83-4 | Reference compound |
| HY-14946 | Amifampridine | 54-96-6 | Reference compound |
| HY-149460 | Harmaline analog | 2411677-02-4 | Reference compound |
| HY-149461 | KB-05 | 1956368-15-2 | Reference compound |
| HY-149462 | KN1022 | 205255-11-4 | Reference compound |
| HY-149463 | EZH2-IN-16 | 2238820-26-1 | Reference compound |
| HY-149464 | ARN22089 | 2248691-29-2 | Reference compound |
| HY-149468 | Antiviral agent 38 | 2247932-38-1 | Reference compound |
| HY-149469 | 3,7,2',4'-Tetramethoxy-5-hydroxyflavone | 19056-75-8 | Natural Products |
| HY-14946A | Amifampridine (phosphate) | 446254-47-3 | Reference compound |
| HY-14946R | Amifampridine (Standard) | 54-96-6 | Reference Standards |
| HY-14946S | Amifampridine-d3 | 2732980-95-7 | Isotope-Labeled Compounds |
| HY-14947 | Balamapimod | 863029-99-6 | Reference compound |
| HY-149470 | MOZ-IN-3 | Reference compound | |
| HY-149471 | hTYR/AbTYR-IN-1 | 1625821-37-5 | Reference compound |
| HY-149472 | Anti-osteoporosis agent-4 | Reference compound | |
| HY-149473 | AChE-IN-39 | Reference compound | |
| HY-149474 | HDAC-IN-63 | 2920046-95-1 | Reference compound |
| HY-149475 | VEGFR-2-IN-33 | Reference compound | |
| HY-149476 | 5-LOX-IN-5 | Reference compound | |
| HY-149477 | IHC3 | Reference compound | |
| HY-149478 | JT002 | 2238820-43-2 | Reference compound |
| HY-149479 | Quorum sensing-IN-3 | 5005-14-1 | Reference compound |
| HY-14948 | Carisbamate | 194085-75-1 | Reference compound |
| HY-149480 | ERD-3111 | 2832865-25-3 | Reference compound |
| HY-149481 | D4R agonist-1 | "2826198-44-9 " | Reference compound |
| HY-149482 | LN5P45 | Reference compound | |
| HY-149483 | CVN417 | 2919851-73-1 | Reference compound |
| HY-149484 | AChE/BChE-IN-15 | Reference compound | |
| HY-149485 | JNK2-IN-1 | 2998941-15-2 | Reference compound |
| HY-149486 | FGFR1 inhibitor 7 | Reference compound | |
| HY-149487 | FGFR1 inhibitor-8 | Reference compound | |
| HY-149488 | FGFR1 inhibitor-9 | Reference compound | |
| HY-149489 | JH-131e-153 | 742104-91-2 | Reference compound |
| HY-14948A | (R)-Carisbamate | 194085-74-0 | Reference compound |
| HY-14948S | Carisbamate-d4 | 1292841-50-9 | Isotope-Labeled Compounds |
| HY-14948S1 | (R)-Carisbamate-d4 | 1287128-99-7 | Isotope-Labeled Compounds |
| HY-14948S2 | (Rac)-Carisbamate-d4 | 1329808-36-7 | Isotope-Labeled Compounds |
| HY-14949 | Cevipabulin | 849550-05-6 | Reference compound |
| HY-149490 | AJH-836 | 388621-67-8 | Reference compound |
| HY-149491 | HIV-IN-7 | 3032472-86-6 | Natural Products |
| HY-149492 | Phosphatase-IN-1 | 2889356-55-0 | Reference compound |
| HY-149493 | IHMT-PI3K-455 | 3047746-40-4 | Reference compound |
| HY-149495 | CP-07 | Reference compound | |
| HY-149496 | Akt/NF-κB/MAPK-IN-1 | Reference compound | |
| HY-149497 | HDAC6-IN-19 | Reference compound | |
| HY-149498 | Carbonic anhydrase inhibitor 15 | Reference compound | |
| HY-14949C | Cevipabulin fumarate | 849550-67-0 | Reference compound |
| HY-14950 | Dalcetrapib | 211513-37-0 | Reference compound |
| HY-149500 | CITFA | 2379989-52-1 | Reference compound |
| HY-149503 | 4-Hydroxy nebivolol (hydrochloride) | 2717115-85-8 | Reference compound |
| HY-149504 | 3-Hydroxy darifenacin | 206048-82-0 | Reference compound |
| HY-149505 | (±)-10-Hydroxy-12(Z),15(Z)-octadecadienoic acid | 34932-14-4 | Reference compound |
| HY-149506 | 1,3-Didecanoylglycerol | 17598-93-5 | Reference compound |
| HY-149507 | 1,3-Capryloyl-2-oleoylglycerol | 109796-58-9 | Reference compound |
| HY-149508 | Nrf2-IN-3 | 6325-13-9 | Reference compound |
| HY-149509 | α-Synuclein inhibitor 9 | 1510825-03-2 | Reference compound |
| HY-14951 | Firategrast | 402567-16-2 | Reference compound |
| HY-149510 | MET/PDGFRA-IN-1 | Reference compound | |
| HY-149511 | MET/PDGFRA-IN-2 | Reference compound | |
| HY-149512 | FGFR1/VEGFR2-IN-1 | Reference compound | |
| HY-149513 | EP12 | 2882916-73-4 | Reference compound |
| HY-149514 | BC-05 | 2260717-73-3 | Reference compound |
| HY-149515 | MAO-IN-3 | 797805-26-6 | Reference compound |
| HY-149516 | Human enteropeptidase-IN-3 | 1958037-36-9 | Reference compound |
| HY-149517 | EGFR/BRAFV600E-IN-2 | Reference compound | |
| HY-149518 | EGFR/BRAFV600E-IN-3 | Reference compound | |
| HY-149519 | BRD4 Inhibitor-28 | 2468960-80-5 | Reference compound |
| HY-14952 | Giripladib | 865200-20-0 | Reference compound |
| HY-149520 | HPK1-IN-39 | Reference compound | |
| HY-149521 | PI3K-IN-47 | Reference compound | |
| HY-149522 | WK499 | Reference compound | |
| HY-149523 | Anticancer agent 157 | Reference compound | |
| HY-149524 | SIRT5 inhibitor 8 | Reference compound | |
| HY-149525 | SIRT5 inhibitor 9 | Reference compound | |
| HY-149526 | cGAS-IN-1 | 858770-07-7 | Reference compound |
| HY-149527 | MAO-B-IN-23 | 2107978-22-1 | Reference compound |
| HY-149528 | MAO-B-IN-24 | Reference compound | |
| HY-149529 | HDAC8-IN-5 | Reference compound | |
| HY-14953 | Imepitoin | 188116-07-6 | Reference compound |
| HY-149530 | EGFR-IN-86 | 3055550-22-3 | Reference compound |
| HY-149531 | HSP90-IN-25 | Reference compound | |
| HY-149532 | α-Glucosidase-IN-33 | Reference compound | |
| HY-149533 | α-Glucosidase-IN-34 | Reference compound | |
| HY-149534 | DNA Gyrase-IN-9 | Reference compound | |
| HY-149535 | Iscartrelvir | 2921711-74-0 | Reference compound |
| HY-149536 | TWIK-1/TREK-1-IN-1 | 1440532-30-8 | Reference compound |
| HY-149537 | TWIK-1/TREK-1-IN-2 | 1440532-32-0 | Reference compound |
| HY-149538 | TWIK-1/TREK-1-IN-3 | 1440532-33-1 | Reference compound |
| HY-149539 | PLM-101 | Reference compound | |
| HY-149540 | CTL-06 | Reference compound | |
| HY-149541 | CTL-12 | Reference compound | |
| HY-149542 | GSK-3β inhibitor 15 | Reference compound | |
| HY-149545 | 1,3-Palmitin-2-docosahexaenoin | 214038-32-1 | Reference compound |
| HY-149547 | DRF-4015 | 905838-14-4 | Reference compound |
| HY-149548 | 2,3-Dinor-8-iso prostaglandin F1α | 221664-04-6 | Reference compound |
| HY-149549 | 1-Stearoyl-3-Oleoyl-rac-glycerol | 18266-27-8 | Reference compound |
| HY-14955 | Managlinat dialanetil | 280782-97-0 | Reference compound |
| HY-149550 | 1,2-Eucin(13Z)-olein | 675876-04-7 | Natural Products |
| HY-149552 | Ac4-5SGlcNAc | 67561-97-1 | Reference compound |
| HY-149554 | 17-Phenyl trinor Prostaglandin F2α dimethyl amide | 155205-90-6 | Reference compound |
| HY-149555 | DNL343 | 2278265-85-1 | Reference compound |
| HY-149556 | MTX-241F | Reference compound | |
| HY-149557 | α-Amylase/α-Glucosidase-IN-5 | Reference compound | |
| HY-149558 | CXCR4-IN-2 | Reference compound | |
| HY-149559 | Thalidomide-5-O-C2-NH2 (hydrochloride) | 2694727-89-2 | Reference compound |
| HY-14955A | (Rac)-Managlinat dialanetil | 347870-26-2 | Reference compound |
| HY-14956 | Nemonoxacin | 378746-64-6 | Reference compound |
| HY-149560 | Thalidomide-5-O-C3-NH2 (hydrochloride) | 2694727-94-9 | Reference compound |
| HY-149561 | Thalidomide-5-O-C4-NH2 (hydrochloride) | 2694727-93-8 | Reference compound |
| HY-149562 | Thalidomide-5-O-C5-NH2 (hydrochloride) | 2761385-94-6 | Reference compound |
| HY-149563 | Thalidomide-5-O-C6-NH2 (hydrochloride) | 2761398-05-2 | Reference compound |
| HY-149564 | Thalidomide-5-O-C7-NH2 (hydrochloride) | Reference compound | |
| HY-149565 | Thalidomide-5-O-C8-NH2 (hydrochloride) | Reference compound | |
| HY-149566 | Thalidomide-5-O-C9-NH2 (hydrochloride) | Reference compound | |
| HY-149567 | Thalidomide-5-O-C10-NH2 (hydrochloride) | Reference compound | |
| HY-149568 | Thalidomide-5-O-C11-NH2 (hydrochloride) | Reference compound | |
| HY-149569 | Thalidomide-5-O-C12-NH2 (hydrochloride) | Reference compound | |
| HY-14956S | Nemonoxacin-d3 | Isotope-Labeled Compounds | |
| HY-14956S1 | Nemonoxacin-d3-1 | Isotope-Labeled Compounds | |
| HY-14956S2 | Nemonoxacin-d4 | Isotope-Labeled Compounds | |
| HY-14957 | Ozenoxacin | 245765-41-7 | Reference compound |
| HY-149570 | Thalidomide-5-O-C13-NH2 (hydrochloride) | Reference compound | |
| HY-149571 | Thalidomide-5-O-C14-NH2 (hydrochloride) | Reference compound | |
| HY-149572 | Thalidomide-4-O-C9-NH2 (hydrochloride) | Reference compound | |
| HY-149573 | Thalidomide-4-O-C11-NH2 (hydrochloride) | Reference compound | |
| HY-149574 | Thalidomide-4-O-C12-NH2 (hydrochloride) | Reference compound | |
| HY-149575 | Thalidomide-4-O-C13-NH2 (hydrochloride) | Reference compound | |
| HY-149576 | Thalidomide-4-O-C14-NH2 (hydrochloride) | Reference compound | |
| HY-149577 | EBV lytic cycle inducer-1 | 394668-43-0 | Reference compound |
| HY-149578 | Tubulin/HDAC-IN-3 | Reference compound | |
| HY-149579 | α-Glucosidase-IN-36 | 3025234-94-7 | Reference compound |
| HY-14957AS | Ozenoxacin-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-14957R | Ozenoxacin (Standard) | 245765-41-7 | Reference Standards |
| HY-14957S | Ozenoxacin-d3 | Isotope-Labeled Compounds | |
| HY-14958 | Pardoprunox | 269718-84-5 | Reference compound |
| HY-149580 | NF-κB-IN-12 | Reference compound | |
| HY-149581 | DprE1-IN-9 | 2906099-98-5 | Reference compound |
| HY-149582 | Aβ-IN-7 | Reference compound | |
| HY-149583 | Aβ-IN-8 | Reference compound | |
| HY-149584 | CIDD-0149897 | 2862784-20-9 | Reference compound |
| HY-149585 | Chitin synthase inhibitor 14 | 2922114-19-8 | Reference compound |
| HY-149586 | ROS-IN-2 | Reference compound | |
| HY-149587 | Callosobruchusic acid | 87172-91-6 | Reference compound |
| HY-149588 | 17-Trifluoromethylphenyl trinor prostaglandin F2α methyl ester | 195503-20-9 | Reference compound |
| HY-149589 | 11(Z),14(Z)-Eicosadienoic acid | 5598-38-9 | Reference compound |
| HY-14958A | Pardoprunox (hydrochloride) | 269718-83-4 | Reference compound |
| HY-14959 | Ulipristal | 159811-51-5 | Reference compound |
| HY-149594 | CL-Pa | Dye Reagents | |
| HY-149595 | LSD1-UM-109 | 2252446-26-5 | Reference compound |
| HY-149596 | PTZ-LD | 2231747-49-0 | Dye Reagents |
| HY-149597 | Lysyl hydroxylase 2-IN-1 | Reference compound | |
| HY-14959S | Ulipristal-d3 | Isotope-Labeled Compounds | |
| HY-149600 | SDH-IN-7 | 2757173-36-5 | Reference compound |
| HY-149601 | SDH-IN-8 | 2757173-77-4 | Reference compound |
| HY-149602 | Glutaminase C-IN-2 | 3056437-77-2 | Reference compound |
| HY-149603 | Antifungal agent 78 | Reference compound | |
| HY-149604 | NLRP3-IN-21 | 2956791-61-8 | Reference compound |
| HY-149605 | KHK-IN-4 | 3034829-40-5 | Reference compound |
| HY-149606 | TKB245 | 2892688-16-1 | Reference compound |
| HY-149607 | SHP2-IN-22 | 2802453-88-7 | Reference compound |
| HY-149608 | Nurr1 agonist 5 | 3033875-32-7 | Reference compound |
| HY-149609 | Nurr1 agonist 6 | 3033875-47-4 | Reference compound |
| HY-149610 | Antibacterial agent 156 | 3032400-44-2 | Reference compound |
| HY-149611 | Lysyl hydroxylase 2-IN-2 | Reference compound | |
| HY-149614 | Laccase-IN-1 | 2991094-41-6 | Reference compound |
| HY-149615 | Antibacterial agent 157 | 2573134-85-5 | Reference compound |
| HY-149616 | PPM-3 | 3032388-42-1 | Reference compound |
| HY-149617 | CYP51/PD-L1-IN-4 | Reference compound | |
| HY-149618 | Cy5-PEG3-endo-BCN | 1881221-50-6 | Dye Reagents |
| HY-149619 | Cy5-PEG7-endo-BCN | Dye Reagents | |
| HY-149620 | Cy5-PEG2-exo-BCN | Dye Reagents | |
| HY-149622 | Bcl-2-IN-12 | 1383737-59-4 | Reference compound |
| HY-149623 | Bcl-2-IN-13 | 1421687-31-1 | Reference compound |
| HY-149624 | Bcl-2-IN-14 | Reference compound | |
| HY-149625 | Bcl-2-IN-15 | Reference compound | |
| HY-149628 | HM-1228 | Biochemical Assay Reagents | |
| HY-149629S | WD-890 | 2914130-91-7 | Isotope-Labeled Compounds |
| HY-149630 | VEGFR2/HDAC1-IN-1 | 3024922-89-9 | Reference compound |
| HY-149631 | HFY-4A | 2094810-82-7 | Reference compound |
| HY-149632 | EGFR/HER2/DHFR-IN-2 | Reference compound | |
| HY-149633 | EGFR/HER2/DHFR-IN-3 | Reference compound | |
| HY-149634 | PI3Kδ-IN-17 | 2768181-63-9 | Reference compound |
| HY-149635 | HIF-1α-IN-6 | Reference compound | |
| HY-149636 | Multi-target kinase inhibitor 2 | Reference compound | |
| HY-149637 | HSP70/SIRT2-IN-1 | Reference compound | |
| HY-149638 | HSP70/SIRT2-IN-2 | 1796557-72-6 | Reference compound |
| HY-149641 | CDK9-IN-29 | 2737262-24-5 | Reference compound |
| HY-149642 | hDHODH-IN-13 | 3032611-13-2 | Reference compound |
| HY-149644 | CB2R agonist 3 | 444331-43-5 | Reference compound |
| HY-149645 | CB2 receptor antagonist 2 | Reference compound | |
| HY-149646 | HDAC6-IN-24 | Reference compound | |
| HY-149647 | HD-2a | 606148-05-4 | Reference compound |
| HY-149648 | JNJ-8003 | Reference compound | |
| HY-149649 | SARS-CoV-2-IN-64 | Reference compound | |
| HY-149650 | TLR4 agonist-1 | 2374139-51-0 | Reference compound |
| HY-149650A | TLR4 agonist-1 (TEA) | 3020639-70-4 | Reference compound |
| HY-149651 | GPR139 agonist-2 | 2983118-29-0 | Reference compound |
| HY-149652 | IRF5-IN-1 | 689270-18-6 | Reference compound |
| HY-149653 | SDH-IN-10 | Reference compound | |
| HY-149654 | FAAH/cPLA2α-IN-1 | 1696401-38-3 | Reference compound |
| HY-149655 | D1N8 | 2894770-40-0 | Reference compound |
| HY-149656 | D1N52 | 2894770-48-8 | Reference compound |
| HY-149657 | SREBP/SCAP-IN-1 | 2763493-89-4 | Reference compound |
| HY-149658 | SREBP/SCAP-IN-2 | 2763493-94-1 | Reference compound |
| HY-149659 | ARUK2007145 | Reference compound | |
| HY-149661 | PDE5-IN-11 | Reference compound | |
| HY-149662 | TMDJ-035 | 2681302-83-8 | Reference compound |
| HY-149663 | BMS-986172 | 1808258-99-2 | Reference compound |
| HY-149664 | 3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol | 137056-72-5 | Biochemical Assay Reagents |
| HY-149665 | BMS-684 | 313552-29-3 | Reference compound |
| HY-149666 | BMS-496 | 2407854-31-1 | Reference compound |
| HY-149667 | BMS-332 | 2407892-15-1 | Reference compound |
| HY-149668 | α-Glucosidase-IN-41 | 3012673-89-8 | Reference compound |
| HY-149669 | PH14 | Reference compound | |
| HY-14967 | NSC 66811 | 6964-62-1 | Reference compound |
| HY-149670 | Ferroptosis-IN-3 | 3017222-33-9 | Reference compound |
| HY-149671 | Anti-inflammatory agent 63 | 2347694-79-3 | Reference compound |
| HY-149672 | ABBV-467 | 2287186-66-5 | Reference compound |
| HY-149673 | XPW1 | 2700286-66-2 | Reference compound |
| HY-149674 | VEGFR-2/c-Met-IN-1 | 3017162-02-3 | Reference compound |
| HY-149675 | VEGFR-2/c-Met-IN-2 | 3017162-04-5 | Reference compound |
| HY-149676 | α-Glucosidase-IN-42 | Reference compound | |
| HY-149677 | ZK53 | 3031789-26-8 | Reference compound |
| HY-149678 | PROTAC eDHFR Degrader-1 | 2849442-92-6 | Reference compound |
| HY-149679 | PROTAC eDHFR Degrader-2 | 2849442-91-5 | Reference compound |
| HY-149680 | CatD-P1 | Reference compound | |
| HY-149681 | Beclin1-Bcl-2 interaction inhibitor 1 | Reference compound | |
| HY-149682 | WAY-659873 | 868268-81-9 | Reference compound |
| HY-149683 | WAY-639228 | 179051-05-9 | Reference compound |
| HY-149684 | WAY-621924 | 745789-70-2 | Reference compound |
| HY-149685 | WAY-608106 | 685137-44-4 | Reference compound |
| HY-149686 | WAY-299765 | 106578-02-3 | Reference compound |
| HY-149687 | 4-Ketobenzotriazine-CH2-S-(CH2)2-COOH | 170033-08-6 | Reference compound |
| HY-149688 | 4-Ketobenzotriazine-CH2-S-(CH2)5-COOH | 221334-33-4 | Reference compound |
| HY-149689 | 4-Ketobenzotriazine-O-CH2-COOH | 113939-90-5 | Reference compound |
| HY-149690 | O-Phthalimide-C1-S-C1-acid | 221334-38-9 | Reference compound |
| HY-149691 | O-Phthalimide-C1-S-C5-acid | 221334-51-6 | Reference compound |
| HY-149693 | Aurora kinase inhibitor-11 | 923946-98-9 | Reference compound |
| HY-149694 | Aurora kinase inhibitor-12 | Reference compound | |
| HY-149695 | EGFR-IN-91 | 3032113-20-2 | Reference compound |
| HY-149696 | IR-Crizotinib | 2387927-74-2 | Reference compound |
| HY-149697 | Insecticidal agent 6 | 1699760-76-3 | Reference compound |
| HY-149698 | Tyrosinase-IN-17 | 2427043-61-4 | Reference compound |
| HY-149699 | DHFR-IN-12 | Reference compound | |
| HY-149700 | ROCK2-IN-7 | 3000541-95-4 | Reference compound |
| HY-149702 | M1/M4 muscarinic agonist 1 | Reference compound | |
| HY-149703 | M1/M4 muscarinic agonist 2 | Reference compound | |
| HY-149704 | M1/M2/M4 muscarinic agonist 1 | 2640109-42-6 | Reference compound |
| HY-149705 | ICMT-IN-7 | 1313603-21-2 | Reference compound |
| HY-149706 | ICMT-IN-12 | 1313603-25-6 | Reference compound |
| HY-149707 | ICMT-IN-21 | 1310740-69-2 | Reference compound |
| HY-149708 | UCM-13207 | 1621536-10-4 | Reference compound |
| HY-149709 | ICMT-IN-35 | Reference compound | |
| HY-14971 | (E)-Akt inhibitor-IV | 959841-49-7 | Reference compound |
| HY-149710 | POP-3MB | 1144114-27-1 | Reference compound |
| HY-149711 | Farnesylcysteine | 68000-92-0 | Reference compound |
| HY-149712 | Spermatinamine | 1001438-81-8 | Natural Products |
| HY-149713 | J1-1 | 1244769-10-5 | Reference compound |
| HY-149714 | J6-3 | Reference compound | |
| HY-149715 | R1-11 | Reference compound | |
| HY-149716 | MEY-003 | 3047891-88-0 | Reference compound |
| HY-149717 | Antitumor agent-122 | 2378641-43-9 | Reference compound |
| HY-149718 | Antitumor agent-123 | Reference compound | |
| HY-149719 | Ferroptosis-IN-4 | 2798922-35-5 | Reference compound |
| HY-14971A | AKT inhibitor IV | 681281-88-9 | Reference compound |
| HY-149720 | GRL018-21 | Reference compound | |
| HY-149721 | HDAC4-IN-1 | 1418293-39-6 | Reference compound |
| HY-149722 | Antiparasitic agent-20 | Reference compound | |
| HY-149723 | Ferroptosis-IN-5 | 2991058-60-5 | Reference compound |
| HY-149724 | Anti-inflammatory agent 65 | 3035442-58-8 | Reference compound |
| HY-149725 | proMMP-9 selective inhibitor-1 | Reference compound | |
| HY-149726 | EZH2-IN-17 | 2489672-09-3 | Reference compound |
| HY-149727 | β2AR agonist 2 | Reference compound | |
| HY-149728 | β2AR agonist 3 | 2304455-74-9 | Reference compound |
| HY-149729 | ICMT-IN-53 | 1443253-17-5 | Reference compound |
| HY-14973 | Vidupiprant | 1169483-24-2 | Reference compound |
| HY-149730 | ICMT-IN-54 | 908856-14-4 | Reference compound |
| HY-149731 | M1/M2/M4 muscarinic agonist 2 | Reference compound | |
| HY-149732 | M1/M4 muscarinic agonist 3 | 2640109-30-2 | Reference compound |
| HY-149733 | M1/M2/M4 muscarinic agonist 3 | 2640109-28-8 | Reference compound |
| HY-149734 | MA220607 | 2922826-56-8 | Reference compound |
| HY-149735 | BET-IN-20 | 1300735-76-5 | Reference compound |
| HY-149736 | ATP Synthesis-IN-3 | 3032416-36-4 | Reference compound |
| HY-149737 | FXn | Reference compound | |
| HY-149738 | FXh | 2408732-55-6 | Reference compound |
| HY-149739 | WAY-620445 | 728924-73-0 | Reference compound |
| HY-14974 | R 1487 | 449811-92-1 | Reference compound |
| HY-149740 | WAY-354436 | 850023-52-8 | Reference compound |
| HY-149741 | WAY-639872 | 796119-18-1 | Reference compound |
| HY-149742 | WAY-313318 | 351993-88-9 | Reference compound |
| HY-149743 | WAY-606376 | 522639-94-7 | Reference compound |
| HY-149744 | FXb | 2408732-52-3 | Reference compound |
| HY-149745 | 2-Oxabicyclo[3.3.1]non-6-en-8-ol-3,5-COOH | 472960-18-2 | Reference compound |
| HY-149748 | (5α)-Pregnan-20-one-succinic | 2452-44-0 | Reference compound |
| HY-149749 | Methylthiomcresol-C3-COOH | 848486-51-1 | Reference compound |
| HY-14975 | R1487 (Hydrochloride) | 449808-64-4 | Reference compound |
| HY-149750 | Methylthiomcresol-C4-COOH | 848486-53-3 | Reference compound |
| HY-149751 | Methylthiomcresol-C5-COOH | 848486-55-5 | Reference compound |
| HY-149752 | Methylthiomcresol-C1-benzoic acid | 848486-56-6 | Reference compound |
| HY-149753 | Methylthiomcresol-succinaldehydic acid | 848486-57-7 | Reference compound |
| HY-149754 | Ursodeoxycholic acid 7-N-acetylglucosaminide | 145624-10-8 | Reference compound |
| HY-149759 | SHP2-IN-23 | 2415989-91-0 | Reference compound |
| HY-149760 | PVD-06 | 3032975-48-4 | Reference compound |
| HY-149761 | GSK023 | Reference compound | |
| HY-149762 | IMBI | 2785359-14-8 | Reference compound |
| HY-149763 | Aβ42 agonist-1 | 50635-12-6 | Reference compound |
| HY-149764 | Aβ42 agonist-2 | 6314-40-5 | Reference compound |
| HY-149765 | Bone-1064 | 2481214-36-0 | Reference compound |
| HY-149766 | PB94 | 3032970-74-1 | Reference compound |
| HY-149767 | CMX990 | 2882934-64-5 | Reference compound |
| HY-149769 | CP-506 | 2227303-52-6 | Reference compound |
| HY-14977 | CS-0777-P | 840523-39-9 | Reference compound |
| HY-149770 | CYP4A11/CYP4F2-IN-2 | 2280834-99-1 | Reference compound |
| HY-149772 | Ciguatoxin CTX 3C | 148471-85-6 | Reference compound |
| HY-149773S | HPK1-IN-40-d2 | Isotope-Labeled Compounds | |
| HY-149774 | GC-78-HCl | 3022242-53-8 | Reference compound |
| HY-149775 | Urease-IN-10 | 1012205-70-7 | Reference compound |
| HY-149776 | RGH-560 | 2408799-43-7 | Reference compound |
| HY-149777 | B3GNT2-IN-1 | 3033557-95-5 | Reference compound |
| HY-149778 | Antifungal agent 87 | 692730-21-5 | Reference compound |
| HY-149779 | RyR2 stabilizer-1 | 3012675-16-7 | Reference compound |
| HY-149780 | Flavokawain 1i | 1098176-51-2 | Reference compound |
| HY-149781 | STING agonist-34 | 2913152-30-2 | Reference compound |
| HY-149782 | Phosphodiesterase-IN-1 | 521297-42-7 | Reference compound |
| HY-14979 | ML786 | 1237586-97-8 | Reference compound |
| HY-149799 | 28-O-Imidazolyl-azepano-betulin | Reference compound | |
| HY-14979A | ML786 (dihydrochloride) | 1237536-18-3 | Reference compound |
| HY-149800 | PARP-1-IN-3 | 2976342-33-1 | Reference compound |
| HY-149801A | Antibacterial agent 140 (chloride) | Reference compound | |
| HY-149802 | SLC26A3-IN-1 | 307552-53-0 | Reference compound |
| HY-149803 | S1R agonist 1 | 193354-70-0 | Reference compound |
| HY-149803A | S1R agonist 1 (hydrochloride) | 242487-82-7 | Reference compound |
| HY-149804 | S1R agonist 2 | 150085-21-5 | Reference compound |
| HY-149804A | S1R agonist 2 (hydrochloride) | Reference compound | |
| HY-149805 | Anticancer agent 110 | 887349-03-3 | Reference compound |
| HY-149806 | Bromodomain IN-2 | 2445335-77-1 | Reference compound |
| HY-149807 | TGR5 agonist 1 | Reference compound | |
| HY-149808 | TGR5 agonist 2 | Reference compound | |
| HY-149809 | AcrB-IN-1 | 2890177-82-7 | Reference compound |
| HY-14981 | GSK2334470 | 1227911-45-6 | Reference compound |
| HY-149810 | AcrB-IN-2 | 2890177-90-7 | Reference compound |
| HY-149811 | AcrB-IN-3 | 2890177-94-1 | Reference compound |
| HY-149812 | AcrB-IN-4 | 2890177-95-2 | Reference compound |
| HY-149813 | P-gp inhibitor 14 | 2892571-47-8 | Reference compound |
| HY-149814 | PDK-IN-1 | 2897696-10-3 | Reference compound |
| HY-149815 | HBV-IN-33 | Reference compound | |
| HY-149816 | Anti-inflammatory agent 41 | 2896204-90-1 | Reference compound |
| HY-149817 | AChE-IN-29 | Reference compound | |
| HY-149818 | 8BTC | 3064070-24-9 | Reference compound |
| HY-149819 | CDK/HDAC-IN-3 | 2944087-54-9 | Reference compound |
| HY-149820 | MAO-B-IN-22 | 2902600-76-2 | Reference compound |
| HY-149821 | Antifungal agent 50 | 2896209-33-7 | Reference compound |
| HY-149822 | Antifungal agent 51 | 2896209-47-3 | Reference compound |
| HY-149823 | TRPV4 antagonist 4 | 2918803-89-9 | Reference compound |
| HY-149824 | EGFR T790M/L858R-IN-2 | 2955607-40-4 | Reference compound |
| HY-149825 | MTHFD2-IN-1 | Reference compound | |
| HY-149826 | MTHFD2-IN-2 | Reference compound | |
| HY-149827 | MTHFD2-IN-3 | Reference compound | |
| HY-149828 | MTHFD2-IN-4 | Reference compound | |
| HY-149828A | MTHFD2-IN-4 (sodium) | Reference compound | |
| HY-149829 | Antitumor agent-97 | 2654024-16-3 | Reference compound |
| HY-149830 | PD-L1-IN-2 | 2894733-91-4 | Reference compound |
| HY-149831 | ZLY28 | 3004676-77-8 | Reference compound |
| HY-149832 | Anticancer agent 114 | Reference compound | |
| HY-149833 | ERRγ inverse agonist 2 | 324022-01-7 | Reference compound |
| HY-149834 | Antileishmanial agent-18 | 1007567-02-3 | Reference compound |
| HY-149835 | TTX-P | Dye Reagents | |
| HY-149836 | 3-MeOARh-NTR | Dye Reagents | |
| HY-149836A | 3-MeOARh-NTR (chloride) | Dye Reagents | |
| HY-149837 | PRO-F | Dye Reagents | |
| HY-149838 | NF-κB-IN-9 | 3033815-24-3 | Reference compound |
| HY-149839 | Antitumor agent-112 | Reference compound | |
| HY-14984 | N6022 | 1208315-24-5 | Reference compound |
| HY-149840 | Antitumor agent-113 | Reference compound | |
| HY-149841 | AKT-IN-17 | Reference compound | |
| HY-149842 | AKT-IN-18 | Reference compound | |
| HY-149843 | LC-MB12 | 2828438-38-4 | Reference compound |
| HY-149844 | S-F24 | 2946669-78-7 | Reference compound |
| HY-149845 | PROTAC GSK-3β Degrader-1 | Reference compound | |
| HY-149846 | SIQ17 | 2151881-74-0 | Reference compound |
| HY-149847 | JH530 | 2928616-74-2 | Reference compound |
| HY-149848 | MMP-9-IN-6 | 2241964-36-1 | Reference compound |
| HY-149849 | TS-IN-2 | 2945983-00-4 | Reference compound |
| HY-14985 | BAY 61-3606 (dihydrochloride) | 648903-57-5 | Reference compound |
| HY-149850 | p38 Kinase inhibitor 5 | 2929285-29-8 | Reference compound |
| HY-149851 | DNA Gyrase-IN-7 | 2925308-68-3 | Reference compound |
| HY-149852 | Anti-osteoporosis agent-3 | 2944463-16-3 | Reference compound |
| HY-149853 | AD186 | Reference compound | |
| HY-149854 | AB21 | 3026677-23-3 | Reference compound |
| HY-149854A | AB21 (oxalate) | Reference compound | |
| HY-149854B | AB21 (hydrochloride) | 3026677-24-4 | Reference compound |
| HY-149855 | AB10 | Reference compound | |
| HY-149856 | Tubulin inhibitor 33 | 2944462-67-1 | Reference compound |
| HY-149857 | Antitubercular agent-37 | 21696-12-8 | Reference compound |
| HY-149858 | β-catenin-IN-7 | 2952779-17-6 | Reference compound |
| HY-149859 | HDAC-IN-58 | 2071224-39-8 | Reference compound |
| HY-14986 | JAK-IN-32 | 936091-56-4 | Reference compound |
| HY-149860 | FAP-IN-1 | 2956858-96-9 | Reference compound |
| HY-149861 | Mip-IN-1 | 2984599-57-5 | Reference compound |
| HY-149862 | ARD-2051 | 2632305-17-8 | Reference compound |
| HY-149863 | DDO-8926 | 3017181-08-4 | Reference compound |
| HY-149864 | Insecticidal agent 3 | Reference compound | |
| HY-149865 | TPE-1p | Dye Reagents | |
| HY-149866 | HIV-1 inhibitor-58 | 3034064-68-8 | Reference compound |
| HY-149867 | Nurr1 agonist 4 | 87645-58-7 | Reference compound |
| HY-149868 | SARS-CoV-2-IN-42 | Reference compound | |
| HY-149869 | PSMA-IN-3 | 2941187-68-2 | Reference compound |
| HY-14987 | AX20017 | 329221-38-7 | Reference compound |
| HY-149870 | PROTAC CDK9 degrader-8 | 2994191-89-6 | Reference compound |
| HY-149872 | DCA-RMR1 | 3050582-94-7 | Reference compound |
| HY-149873 | Anticancer agent 126 | 3033748-20-5 | Reference compound |
| HY-149874 | BMS-502 | 2407854-18-4 | Reference compound |
| HY-149875 | T3SS-IN-1 | Reference compound | |
| HY-149876 | SDH-IN-5 | 2922765-95-3 | Reference compound |
| HY-149877 | hDHODH-IN-12 | Reference compound | |
| HY-149878 | BD-9136 | 3037514-38-5 | Reference compound |
| HY-149879 | Npx-Au | 3036175-27-3 | Reference compound |
| HY-14988 | I-A09 | 1143579-76-3 | Reference compound |
| HY-149880 | c-Met-IN-18 | 3034863-56-1 | Reference compound |
| HY-149881 | Quorum sensing-IN-2 | 2925926-80-1 | Reference compound |
| HY-149882 | Antimalarial agent 27 | Reference compound | |
| HY-149883 | IZS-L | 1173464-62-4 | Reference compound |
| HY-149884 | IZS-P | 1173464-65-7 | Reference compound |
| HY-149885 | IZS-M | 2950167-07-2 | Reference compound |
| HY-149886 | HIF-2α-IN-9 | 2648334-36-3 | Reference compound |
| HY-149887 | H3B-968 | 2912294-90-5 | Reference compound |
| HY-149888 | AChE-IN-31 | 1325209-07-1 | Reference compound |
| HY-149889 | EGFR-IN-78 | 3042104-73-1 | Reference compound |
| HY-14989 | SQ109 | 502487-67-4 | Reference compound |
| HY-149890 | Anticancer agent 130 | 3038738-52-9 | Reference compound |
| HY-149891 | HSP90-IN-23 | 2944100-30-3 | Reference compound |
| HY-149892S | TYK2 JH2-IN-1-d3 | 2376999-19-6 | Isotope-Labeled Compounds |
| HY-149893 | MGAT2-IN-4 | 1841424-92-7 | Reference compound |
| HY-149894 | MC-1-F2 | 2376894-10-7 | Reference compound |
| HY-149895 | Syk-IN-7 | 3050715-41-5 | Reference compound |
| HY-149896 | Antitumor agent-107 | 3052360-22-9 | Reference compound |
| HY-149897 | HA-CD44 interaction inhibitor 2 | 3009761-01-4 | Reference compound |
| HY-149898 | HA-CD44 interaction inhibitor 1 | 3052354-70-5 | Reference compound |
| HY-149899 | VDR agonist 2 | 3052323-55-1 | Reference compound |
| HY-14989R | SQ109 (Standard) | 502487-67-4 | Reference Standards |
| HY-14990 | Sudoterb | 676266-31-2 | Reference compound |
| HY-149900 | Antiviral agent 33 | 2982270-24-4 | Reference compound |
| HY-149901 | USP8-IN-2 | 2477651-11-7 | Reference compound |
| HY-149902 | USP8-IN-3 | 2477651-10-6 | Reference compound |
| HY-149906 | Trecovirsen | 153021-75-1 | Oligonucleotides |
| HY-149906A | FITC-Trecovirsen (sodium) | Oligonucleotides | |
| HY-149906C | Trecovirsen (sodium) | Oligonucleotides | |
| HY-14990A | Sudoterb (hydrochloride) | 1044503-04-9 | Reference compound |
| HY-149911 | GY1-22 | 326903-84-8 | Reference compound |
| HY-149912 | CZS-241 | 3016297-55-2 | Reference compound |
| HY-149913 | NR2F1 agonist 1 | 374101-64-1 | Reference compound |
| HY-149914 | WCA-814 | 2951858-45-8 | Reference compound |
| HY-149915 | MAT2A-IN-10 | 2924825-23-8 | Reference compound |
| HY-149916 | A2AR-antagonist-1 | 2922920-71-4 | Reference compound |
| HY-149917 | ITK degrader 1 | Reference compound | |
| HY-149918 | Antiproliferative agent-23 | 3049213-47-7 | Reference compound |
| HY-149919 | Antimalarial agent 23 | Reference compound | |
| HY-14992 | Bay 60-7550 | 439083-90-6 | Reference compound |
| HY-149920 | Anticancer agent 98 | 2857070-72-3 | Reference compound |
| HY-149921 | Antiangiogenic agent 3 | Reference compound | |
| HY-149922 | DKI5 | 1101130-96-4 | Reference compound |
| HY-149923 | GPX4-IN-4 | 2920221-53-8 | Reference compound |
| HY-149924 | CST626 | 3033993-13-1 | Reference compound |
| HY-149925 | DNA Gyrase-IN-6 | 3034242-80-0 | Reference compound |
| HY-149926 | Cathepsin Inhibitor 3 | 3026372-49-3 | Reference compound |
| HY-149927 | Antitumor agent-91 | 3035360-70-1 | Reference compound |
| HY-149928 | NNRT-IN-1 | 2925364-09-4 | Reference compound |
| HY-149929 | EBL-3183 | 2872672-18-7 | Reference compound |
| HY-14993 | SCH79797 | 245520-69-8 | Reference compound |
| HY-149930 | YL5084 | 2440199-73-3 | Reference compound |
| HY-149931 | BMV109 | 1458731-58-2 | Dye Reagents |
| HY-149933 | AM841 | 871978-21-1 | Reference compound |
| HY-149934 | DCAF1 binder 1 | 3053860-67-3 | Reference compound |
| HY-149935 | OICR-8268 | 3000549-26-5 | Reference compound |
| HY-149936 | HIV-1 protease-IN-8 | 2925287-55-2 | Reference compound |
| HY-149937 | Antimalarial agent 24 | 2299199-54-3 | Reference compound |
| HY-149938 | Antimalarial agent 25 | 2944456-41-9 | Reference compound |
| HY-149939 | Antimalarial agent 26 | 2299199-56-5 | Reference compound |
| HY-14994 | SCH79797 (dihydrochloride) | 1216720-69-2 | Reference compound |
| HY-149940 | SIMR3030 | 2708270-99-7 | Reference compound |
| HY-149941 | hNTS1R agonist-1 | Reference compound | |
| HY-149942 | PAP-IN-1 | Reference compound | |
| HY-149943 | PAP-IN-2 | Reference compound | |
| HY-149944 | Analgesic agent-2 | 2983892-65-3 | Reference compound |
| HY-149946 | HDAC-IN-57 | 2716217-79-5 | Reference compound |
| HY-149948 | PROTAC BRD3/BRD4-L degrader-2 | Reference compound | |
| HY-149949 | Anticancer agent 105 | 2450987-57-0 | Reference compound |
| HY-149950 | Anticancer agent 106 | 3009090-13-2 | Reference compound |
| HY-149951 | Anticancer agent 107 | 2397573-96-3 | Reference compound |
| HY-149952 | ATR-IN-23 | 2923800-62-6 | Reference compound |
| HY-149953 | FABP4-IN-2 | 2983117-36-6 | Reference compound |
| HY-149954 | SARS-CoV-2-IN-39 | 2882823-03-0 | Reference compound |
| HY-149955 | SARS-CoV-2-IN-38 | 2882823-27-8 | Reference compound |
| HY-149956 | Antileishmanial agent-15 | 2934738-38-0 | Reference compound |
| HY-149957 | Antileishmanial agent-16 | 2934738-41-5 | Reference compound |
| HY-149958 | Antileishmanial agent-17 | 2934738-40-4 | Reference compound |
| HY-149959 | Mps1-IN-6 | 3043761-59-4 | Reference compound |
| HY-149960 | Antiparasitic agent-17 | 3043821-43-5 | Reference compound |
| HY-149961 | Anti-inflammatory agent 40 | 3043821-37-7 | Reference compound |
| HY-149962 | PROTAC CDK9 degrader-5 | 2935587-89-4 | Reference compound |
| HY-149963 | PROTAC CDK9 degrader-6 | 2935587-91-8 | Reference compound |
| HY-149964 | PROTAC CDK9 degrader-7 | 2935587-90-7 | Reference compound |
| HY-149965 | TRK-IN-23 | 2924344-29-4 | Reference compound |
| HY-149966 | PB131 | 2924425-63-6 | Reference compound |
| HY-149967 | GluN2B-NMDAR antagonist-1 | 3043727-74-5 | Reference compound |
| HY-149968 | LSD1-IN-25 | 2911585-60-7 | Reference compound |
| HY-149969 | ER degrader 4 | 2913192-39-7 | Reference compound |
| HY-149970 | ER degrader 5 | 2913192-47-7 | Reference compound |
| HY-149971 | XJ02862-S2 | 3023355-55-4 | Reference compound |
| HY-149972 | Antitumor agent-96 | 3041063-90-2 | Reference compound |
| HY-149973 | α-Amylase-IN-4 | Reference compound | |
| HY-149974 | CDK8-IN-13 | 918523-75-8 | Reference compound |
| HY-149975 | AMPA receptor modulator-4 | 2917551-59-6 | Reference compound |
| HY-149976 | Pim-1 kinase inhibitor 4 | 3026670-71-0 | Reference compound |
| HY-149977 | Anticancer agent 111 | Reference compound | |
| HY-149978 | LSD1-IN-26 | 3041141-72-1 | Reference compound |
| HY-149979 | SLC7A11-IN-1 | 3049302-90-8 | Reference compound |
| HY-14998 | Halofenate | 26718-25-2 | Reference compound |
| HY-149980 | DCN-83 | Reference compound | |
| HY-149981 | P-gp inhibitor 13 | 3041121-57-4 | Reference compound |
| HY-149982 | IDO1-IN-22 | 2126853-16-3 | Reference compound |
| HY-149983 | Antibacterial agent 141 | 2930013-56-0 | Reference compound |
| HY-149984 | MAO-B-IN-21 | 2956426-18-7 | Reference compound |
| HY-149985 | Antitrypanosomal agent 12 | Reference compound | |
| HY-149986 | Antitrypanosomal agent 13 | Reference compound | |
| HY-149987 | LY3522348 | 2568608-48-8 | Reference compound |
| HY-149988 | UNP-6457 | Reference compound | |
| HY-149989 | Ack1 inhibitor 1 | 2924415-92-7 | Reference compound |
| HY-149991 | HIV-1 inhibitor-56 | 2952530-45-7 | Reference compound |
| HY-149992 | MyD88-IN-1 | 2911609-80-6 | Reference compound |
| HY-149993 | hBChE-IN-2 | 2923366-36-1 | Reference compound |
| HY-149994 | DS43260857 | 1612158-07-2 | Reference compound |
| HY-149995 | Pim-1 kinase inhibitor 5 | 2928606-67-9 | Reference compound |
| HY-149996 | Pim-1 kinase inhibitor 6 | 2928606-69-1 | Reference compound |
| HY-149997 | Anticancer agent 120 | 2928614-22-4 | Reference compound |
| HY-149998 | Antimycobacterial agent-5 | Reference compound | |
| HY-149999 | Xeniafaraunol A | 161162-29-4 | Natural Products |
| HY-15000 | EMD534085 | 858668-07-2 | Reference compound |
| HY-150002 | Antibacterial agent 115 | 2259732-60-8 | Reference compound |
| HY-150003 | Aβ1–42 aggregation inhibitor 1 | 2439107-75-0 | Reference compound |
| HY-150004 | c-Met/HDAC-IN-3 | 2439175-23-0 | Reference compound |
| HY-150006 | Pomalidomide-C2-acid | 2225940-46-3 | Reference compound |
| HY-15001 | Stemregenin 1 | 1227633-49-9 | Reference compound |
| HY-150012 | N-Lactoyl-Phenylalanine | 183241-73-8 | Natural Products |
| HY-150012S1 | N-Lactoyl-Phenylalanine-13C6 | Isotope-Labeled Compounds | |
| HY-150013 | H-Met-Met-OH | 7349-78-2 | Reference compound |
| HY-150014 | AMT-NHS | 2925268-86-4 | Reference compound |
| HY-150015 | 4,5'-Dimethylangelicin-NHS | Reference compound | |
| HY-150017 | 2'-O-Methyl-5-methyl-U CEP | 153631-20-0 | Reference compound |
| HY-150019 | PI3K-IN-36 | 1401436-93-8 | Reference compound |
| HY-15001A | Stemregenin 1 (hydrochloride) | 2319882-01-2 | Reference compound |
| HY-15001G | Stemregenin 1 (GMP) | 1227633-49-9 | GMP Small Molecules |
| HY-15002 | AST 487 | 630124-46-8 | Reference compound |
| HY-150021 | GRK5-IN-3 | 2410793-22-3 | Reference compound |
| HY-150022 | GRK5-IN-4 | 2410794-89-5 | Reference compound |
| HY-150023 | BI-1622 | 2681392-19-6 | Reference compound |
| HY-150024 | BI-4142 | 2682003-36-5 | Reference compound |
| HY-150025 | (4aS,8aR)-NPD-001 | 2366272-43-5 | Reference compound |
| HY-150026 | Multi-kinase-IN-2 | 2095628-21-8 | Reference compound |
| HY-150027 | Multi-kinase-IN-3 | 2091950-43-3 | Reference compound |
| HY-150028 | CB1/2 agonist 2 | 2772379-97-0 | Reference compound |
| HY-150029 | CB1/2 agonist 3 | 2772655-86-2 | Reference compound |
| HY-15003 | ATH686 | 853299-52-2 | Reference compound |
| HY-150030 | CB1/2 agonist 4 | 2772949-38-7 | Reference compound |
| HY-150031 | MFI8 | 694488-83-0 | Reference compound |
| HY-150034 | PI3K-IN-38 | 1382979-64-7 | Reference compound |
| HY-150036 | Anthramycin | 4803-27-4 | Reference compound |
| HY-150039 | CCG-271423 | 2750413-88-6 | Reference compound |
| HY-15004 | AUZ 454 | 853299-07-7 | Reference compound |
| HY-150040 | CCG-273463 | 2750413-99-9 | Reference compound |
| HY-150041 | TL4830031 | 2084107-15-1 | Reference compound |
| HY-150042 | TDI-011536 | 2687970-96-1 | Reference compound |
| HY-150043 | MDTF (free acid) | 2102021-49-6 | ADC Related |
| HY-150043A | MDTF | ADC Related | |
| HY-150044 | Type II topoisomerase inhibitor 1 | 2245691-60-3 | Reference compound |
| HY-150045 | TP0480066 | 2245693-15-4 | Reference compound |
| HY-150046 | Nek2-IN-6 | 2410376-96-2 | Reference compound |
| HY-150048 | BK50164 | 2204291-78-9 | Reference compound |
| HY-150049 | γ-Secretase modulator 13 | 1353570-40-7 | Reference compound |
| HY-15005 | Sofosbuvir | 1190307-88-0 | Reference compound |
| HY-150050 | gamma-secretase modulator 5 | 1353570-53-2 | Reference compound |
| HY-150051 | IL-2-IN-1 | 245747-10-8 | Reference compound |
| HY-150052 | Plasma kallikrein-IN-3 | 1357950-47-0 | Reference compound |
| HY-150053 | JNK-IN-11 | 676594-38-0 | Reference compound |
| HY-150055 | iNOs-IN-3 | 2241674-94-0 | Reference compound |
| HY-150056 | CB1R Allosteric modulator 3 | 2633686-36-7 | Reference compound |
| HY-150057 | CB1R Allosteric modulator 4 | 2633686-53-8 | Reference compound |
| HY-150058 | Bocconoline | 32906-88-0 | Natural Products |
| HY-150059 | P2X7 receptor antagonist-2 | 851269-75-5 | Reference compound |
| HY-15005A | PSI-7976 | 1190308-01-0 | Reference compound |
| HY-15005B | Sofosbuvir impurity C | 1496552-28-3 | Reference compound |
| HY-15005C | Sofosbuvir impurity A | 1496552-16-9 | Reference compound |
| HY-15005R | Sofosbuvir (Standard) | 1190307-88-0 | Reference Standards |
| HY-15005S | Sofosbuvir-13C,d3 | Isotope-Labeled Compounds | |
| HY-15005S1 | Sofosbuvir-d6 | 1868135-06-1 | Isotope-Labeled Compounds |
| HY-150060 | PDE4-IN-11 | 524734-30-3 | Reference compound |
| HY-150061 | NVP-BBD130 | 853910-61-9 | Reference compound |
| HY-150062 | SARS-CoV-2 nsp3-IN-1 | 2892105-43-8 | Reference compound |
| HY-150063 | Antibacterial agent 116 | 99330-28-6 | Reference compound |
| HY-150064 | SARS-CoV-2 nsp3-IN-2 | 2038858-11-4 | Reference compound |
| HY-150065 | Antimalarial agent 15 | 956928-33-9 | Reference compound |
| HY-150066 | Antimalarial agent 16 | 2773408-33-4 | Reference compound |
| HY-150067 | CB1R antagonist 1 | 334668-69-8 | Reference compound |
| HY-150068 | EP4 receptor agonist 1 | 691869-12-2 | Reference compound |
| HY-150069 | UBX1325 | 2271269-01-1 | Reference compound |
| HY-15007 | L 366509 | 138382-23-7 | Reference compound |
| HY-150070 | Butabindide | 175553-48-7 | Reference compound |
| HY-150072 | DS89002333 | 2832159-79-0 | Reference compound |
| HY-150072A | (2S,4R)-DS89002333 | Reference compound | |
| HY-150072B | (R)-DS89002333 | Reference compound | |
| HY-150073 | DS01080522 | 2832159-84-7 | Reference compound |
| HY-150074 | STING agonist-18 | 2138299-68-8 | Reference compound |
| HY-150074A | STING agonist-18 (diTFA) | 2138299-69-9 | Reference compound |
| HY-150075 | STING agonist-19 | 2886007-54-9 | Reference compound |
| HY-150076 | BLU2864 | 2810747-89-6 | Reference compound |
| HY-150077 | Utrophin modulator 1 | Reference compound | |
| HY-150078 | OX01914 | 49676-35-9 | Reference compound |
| HY-150079 | HIV-1 integrase inhibitor 10 | Reference compound | |
| HY-15008 | L-368,899 | 148927-60-0 | Reference compound |
| HY-150080 | GSK3739936 | 1803444-21-4 | Reference compound |
| HY-150081 | PRMT5-IN-21 | 2922673-38-7 | Reference compound |
| HY-150082 | CP681301 | 865317-32-4 | Reference compound |
| HY-150084 | (±)14,15-Epoxyeicosatrienoic acid | 197508-62-6 | Natural Products |
| HY-150086 | Copper Fluor-4 | 2365532-64-3 | Dye Reagents |
| HY-150087 | Ctrl-CF4-S2 | 2365532-65-4 | Dye Reagents |
| HY-150089 | SRI-37240 | 883956-47-6 | Reference compound |
| HY-15009 | Fuscoside | 131631-89-5 | Reference compound |
| HY-150090 | SRI-41315 | 1613509-49-1 | Reference compound |
| HY-150091 | 11,12-Epoxyeicosatrienoic acid | 81276-02-0 | Biochemical Assay Reagents |
| HY-150092 | 8(S),9(R)-EET | 123931-39-5 | Natural Products |
| HY-150092S | (2S,3R)-8(9)-EET-d11 | Isotope-Labeled Compounds | |
| HY-150095 | YE6144 | Reference compound | |
| HY-150096 | Zasocitinib | 2272904-53-5 | Reference compound |
| HY-150097 | Recombinant Human Serum Albumin(rHSA) | Biochemical Assay Reagents | |
| HY-15010 | L-371,257 | 162042-44-6 | Reference compound |
| HY-150100 | Tyrosine 3-monooxygenase | 9036-22-0 | Enzyme |
| HY-150102 | EPI-7170 | 2139288-26-7 | Reference compound |
| HY-150105 | BMF-219 | 2448172-22-1 | Reference compound |
| HY-150109 | Purinostat (mesylate) | 2650188-32-0 | Reference compound |
| HY-150109A | Purinostat | 1929583-17-4 | Reference compound |
| HY-15011 | L-372662 | 162045-26-3 | Reference compound |
| HY-150115 | Lipid 10 | 2430034-02-7 | Reference compound |
| HY-150116 | Lipid 1 | 2226547-17-5 | Oligonucleotides |
| HY-150117 | Lipid 6 | 2226547-22-2 | Oligonucleotides |
| HY-150118 | Lipid 8 | 2226547-25-5 | Reference compound |
| HY-150123 | Quinidine methiodide | 42982-87-6 | Reference compound |
| HY-150124 | K34c | 939769-93-4 | Reference compound |
| HY-150124A | K34c (hydrochloride) | 2986315-25-5 | Reference compound |
| HY-150125 | SCD1-IN-1 | 1111078-63-7 | Reference compound |
| HY-150132 | Heptakis(2,3-dimethyl)-β-cyclodextrin | 123155-05-5 | Biochemical Assay Reagents |
| HY-150135B | D-myo-Inositol 1,4,5-trisphosphate (tripotassium) | 141611-11-2 | Reference compound |
| HY-150137 | Iomeprol | 78649-41-9 | Reference compound |
| HY-150138 | Gavestinel | 153436-22-7 | Reference compound |
| HY-150144 | Uracil-m7GpppAmpG (ammonium) | Biochemical Assay Reagents | |
| HY-150145 | Cy5-UTP | Biochemical Assay Reagents | |
| HY-150145A | Cy5-UTP (sodium) (10mM in Water) | Biochemical Assay Reagents | |
| HY-150147 | CAM833 | 2758364-02-0 | Reference compound |
| HY-15015 | OT-R antagonist 1 | 364071-17-0 | Reference compound |
| HY-150150 | SiRNA Negative Control | Oligonucleotides | |
| HY-150156 | Anti-inflammatory agent 32 | 2577388-38-4 | Reference compound |
| HY-150158 | TMX-201 | 1149339-78-5 | Reference compound |
| HY-150159S | Cotinine-d3 N-β-D-Glucuronide | Isotope-Labeled Compounds | |
| HY-15015A | OT-R antagonist 2 | 364071-16-9 | Reference compound |
| HY-150163 | RBM14C12 | 1309763-43-6 | Reference compound |
| HY-150166 | ClpB-IN-1 | 1453172-23-0 | Reference compound |
| HY-150167 | TH-Z93 | 2260887-09-8 | Reference compound |
| HY-150168 | TH-Z145 | 2260887-57-6 | Reference compound |
| HY-150169 | THRX-144644 | 2442519-59-5 | Reference compound |
| HY-150175 | HKSOX-1 | 1786411-17-3 | Dye Reagents |
| HY-150177 | Mannose 6 phosphate | 3672-15-9 | Reference compound |
| HY-150184 | And1-IN-1 | 2451028-69-4 | Reference compound |
| HY-150185 | RXFP2 agonist 1 | 2971704-58-0 | Reference compound |
| HY-150186 | RXFP2 agonist 2 | 2971704-85-3 | Reference compound |
| HY-15018A | SSR126768A (free base) | 785048-28-4 | Reference compound |
| HY-150190 | F5446 | 2304465-89-0 | Reference compound |
| HY-150194S | Fructose-glutamic acid-13C6 | 1083053-45-5 | Isotope-Labeled Compounds |
| HY-150202 | L1-PEG2-TATE | 2794143-66-9 | Reference compound |
| HY-150203 | GLPG3970 | 2403733-82-2 | Reference compound |
| HY-150204 | ONO-0740556 | 2250210-69-4 | Reference compound |
| HY-150205 | Succinate/succinate receptor antagonist 1 | 2361972-29-2 | Reference compound |
| HY-150206 | NLRP3-IN-13 | 1704638-35-6 | Reference compound |
| HY-150207 | RBN-3143 | 2360853-16-1 | Reference compound |
| HY-150209 | MODAG-001 | 2648041-72-7 | Reference compound |
| HY-150210 | FSHR agonist 1 | 1256776-89-2 | Reference compound |
| HY-150211 | DC-BPi-03 | 2758411-46-8 | Reference compound |
| HY-150212 | Tilsotolimod | 1948266-37-2 | Oligonucleotides |
| HY-150212A | Tilsotolimod (sodium) | 2089768-67-0 | Oligonucleotides |
| HY-150213 | ODN BW001 | 886862-38-0 | Oligonucleotides |
| HY-150213A | ODN BW001 (sodium) | Oligonucleotides | |
| HY-150214 | ODN MT01 | 1817821-77-4 | Oligonucleotides |
| HY-150214A | ODN MT 01 (sodium) | Oligonucleotides | |
| HY-150215 | ODN 105870 | 1965342-40-8 | Oligonucleotides |
| HY-150215A | ODN 105870 (sodium) | Oligonucleotides | |
| HY-150217 | CpG ODN 10101 | 1234402-77-7 | Oligonucleotides |
| HY-150217A | CpG ODN 10101 (sodium) | Oligonucleotides | |
| HY-150218 | Agatolimod (sodium) | 541547-35-7 | Oligonucleotides |
| HY-150219 | ODN M326 | 557124-74-0 | Reference compound |
| HY-150219A | ODN M326 (sodium) | Reference compound | |
| HY-150220 | 1,5-Dihexadecyl N-(3-carboxy-1-oxopropyl)-L-glutamate | 125401-63-0 | Reference compound |
| HY-150221 | DB008 | 2991637-98-8 | Reference compound |
| HY-150223 | GalNAc unconjugated/naked Inclisiran | Oligonucleotides | |
| HY-150224 | GalNAc unconjugated/naked Fitusiran (sodium) | Oligonucleotides | |
| HY-150226 | Enzyme-IN-1 | 868540-02-7 | Reference compound |
| HY-150228 | MitoCur-1 | Reference compound | |
| HY-150229 | 306-N16B | 2803699-70-7 | Reference compound |
| HY-15023 | Cligosiban | 900510-03-4 | Reference compound |
| HY-150230 | Desthiobiotin-Iodoacetamide | 2924824-04-2 | Reference compound |
| HY-150231 | SU056 | 2376580-08-2 | Reference compound |
| HY-150232 | MALT1-IN-11 | 2812352-99-9 | Reference compound |
| HY-150233 | Cys-McMMAF | 1160590-05-5 | ADC Related |
| HY-150234 | LabMol-319 | 381188-63-2 | Reference compound |
| HY-150235 | Galectin-8N-IN-1 | 2667628-25-1 | Reference compound |
| HY-150236 | FITC-labeled Tominersen (sodium) | Oligonucleotides | |
| HY-150237 | FITC-labeled Drisapersen (sodium) | Oligonucleotides | |
| HY-150238 | IDH1 Inhibitor 7 | 2135309-56-5 | Reference compound |
| HY-150238S | IDH1 Inhibitor 7-d2 | 2135309-51-0 | Isotope-Labeled Compounds |
| HY-150239 | BAY-364 | 2097610-30-3 | Reference compound |
| HY-150240 | DOPE-GA | 228706-30-7 | Reference compound |
| HY-150241 | DOPE-NHS | 1010188-79-0 | Biochemical Assay Reagents |
| HY-150242A | Cbz-Ala-Ala-Asn (TFA) | Peptides | |
| HY-150245 | mHTT-IN-1 | 2839311-21-4 | Reference compound |
| HY-150246 | RNA splicing modulator 1 | 2726461-38-5 | Reference compound |
| HY-150247 | RNA splicing modulator 2 | 2726461-41-0 | Reference compound |
| HY-150248 | RNA splicing modulator 3 | 2726461-43-2 | Reference compound |
| HY-150249 | GSK3735967 | 2170136-86-2 | Reference compound |
| HY-15025 | Sildenafil | 139755-83-2 | Reference compound |
| HY-150250 | B-Raf IN 13 | 2573782-74-6 | Reference compound |
| HY-150251 | STAT3 degrader-2 | 2497583-03-4 | Reference compound |
| HY-150252 | ATIC-IN-1 | 1402453-15-9 | Reference compound |
| HY-150252A | ATIC-IN-1 (acetate) | Reference compound | |
| HY-150254 | SLB1122168 | 2999629-17-1 | Reference compound |
| HY-150254A | SLB1122168 (formic) | Reference compound | |
| HY-150255 | IMP2-IN-3 | 1448353-63-6 | Reference compound |
| HY-150256 | YTP-17 | Reference compound | |
| HY-150257 | Xanthine oxidase-IN-10 | 851429-65-7 | Reference compound |
| HY-150257A | Xanthine oxidase-IN-11 | Reference compound | |
| HY-150258 | TRK-IN-22 | Reference compound | |
| HY-150259 | MDEG-541 | Reference compound | |
| HY-15025A | Sildenafil (citrate) | 171599-83-0 | Reference compound |
| HY-15025AR | Sildenafil (citrate) (Standard) | 171599-83-0 | Reference Standards |
| HY-15025AS | Sildenafil (citrate)-d8 | 1215071-03-6 | Isotope-Labeled Compounds |
| HY-15025S | Sildenafil-d3 | 1126745-90-1 | Isotope-Labeled Compounds |
| HY-15025S1 | Sildenafil-d8 | 951385-68-5 | Isotope-Labeled Compounds |
| HY-15025S2 | Sildenafil-d3-1 | 1126745-87-6 | Isotope-Labeled Compounds |
| HY-15025S3 | Sildenafil-d5 | 951385-70-9 | Isotope-Labeled Compounds |
| HY-15026 | ATB-429 | 915282-45-0 | Reference compound |
| HY-150260 | SA09-Cu | 155641-16-0 | Reference compound |
| HY-150265 | TNH | 2137895-00-0 | Reference compound |
| HY-150266 | A-1293102 | 1565759-96-7 | Reference compound |
| HY-150268 | BET-IN-16 | 2089390-09-8 | Reference compound |
| HY-150269 | RS5517 | 2227017-46-9 | Reference compound |
| HY-15027 | 5-Aminosalicylic Acid | 89-57-6 | Natural Products |
| HY-150270 | NP-1815-PX | 1239578-79-0 | Reference compound |
| HY-150270A | NP-1815-PX (sodium) | 1239578-80-3 | Reference compound |
| HY-150278 | Peptone from casein | 91079-40-2 | Biochemical Assay Reagents |
| HY-150279 | PolQi2 | 2565638-16-4 | Reference compound |
| HY-15027R | 5-Aminosalicylic Acid (Standard) | 89-57-6 | Reference Standards |
| HY-15027S | 5-Aminosalicylic Acid-d3 (hydrochloride) | 1346601-18-0 | Isotope-Labeled Compounds |
| HY-15027S1 | 5-Aminosalicylic acid-d3 | 1309283-32-6 | Isotope-Labeled Compounds |
| HY-15027S2 | 5-Aminosalicylic acid-13C6 | 1189709-96-3 | Isotope-Labeled Compounds |
| HY-15027S3 | 5-Aminosalicylic acid-d3 (disodium) | Isotope-Labeled Compounds | |
| HY-15027S4 | 5-Aminosalicylic acid-d7 | Isotope-Labeled Compounds | |
| HY-15028 | Otenaproxesul | 1226895-20-0 | Reference compound |
| HY-150287 | Insulin-Transferrin-Selenium, 100X | Biochemical Assay Reagents | |
| HY-150287A | Insulin-Transferrin-Selenium-Ethanolamine | Biochemical Assay Reagents | |
| HY-150287B | Insulin-Transferrin-Selenium-Sodium Pyruvate | Biochemical Assay Reagents | |
| HY-150289 | GNE-235 | Reference compound | |
| HY-15028A | (S)-Otenaproxesul | 1000700-29-7 | Reference compound |
| HY-15029 | (±)-Naproxen | 23981-80-8 | Reference compound |
| HY-150298 | Soquelitinib | 2226636-04-8 | Reference compound |
| HY-15029R | (±)-Naproxen (Standard) | 23981-80-8 | Reference Standards |
| HY-15029S | (±)-Naproxen-d3 | 958293-79-3 | Isotope-Labeled Compounds |
| HY-15029S1 | (±)-Naproxen-d3-1 | 958293-77-1 | Isotope-Labeled Compounds |
| HY-15029S2 | (±)-Naproxen-13C,d3 | 1261392-52-2 | Isotope-Labeled Compounds |
| HY-15030 | Naproxen | 22204-53-1 | Reference compound |
| HY-150306 | IM-250 | 2305750-23-4 | Reference compound |
| HY-150307 | KP-302 | 2082765-42-0 | Reference compound |
| HY-150308 | SR10221 | 1415321-64-0 | Reference compound |
| HY-150309 | PI3K-IN-54 | 1336890-05-1 | Reference compound |
| HY-15030A | Naproxen (sodium) | 26159-34-2 | Reference compound |
| HY-15030AR | Naproxen (sodium) (Standard) | 26159-34-2 | Reference Standards |
| HY-15030R | Naproxen (Standard) | 22204-53-1 | Reference Standards |
| HY-15030S1 | Naproxen-d3 | 1094102-82-5 | Isotope-Labeled Compounds |
| HY-15031 | l-Naproxen | 23979-41-1 | Reference compound |
| HY-150311 | endo-BCN-PEG24-NHS ester | Reference compound | |
| HY-150314 | MCT-IN-1 | 1685273-57-7 | Reference compound |
| HY-15033 | ATB-343 | 1000700-26-4 | Reference compound |
| HY-150330 | DNA ligase-IN-1 | 68302-07-8 | Reference compound |
| HY-150331 | DNA ligase-IN-2 | 635681-64-0 | Oligonucleotides |
| HY-150332 | N-Propionitrile Chlorphine (hydrochloride) | 16145-71-4 | Reference compound |
| HY-150333 | MMB-ICA | 1188516-52-0 | Reference compound |
| HY-150334 | Rilmazolam | 50330-59-1 | Reference compound |
| HY-150335 | Dehydrocannabifuran | 56154-59-7 | Reference compound |
| HY-150337 | Isopropylphenidine (hydrochloride) | 6267-56-7 | Reference compound |
| HY-150338 | N-Propyl Ephenidine (hydrochloride) | 6266-42-8 | Reference compound |
| HY-150339 | AB-INACA | 1887742-41-7 | Reference compound |
| HY-15034 | Indomethacin (sodium) | 7681-54-1 | Reference compound |
| HY-150340 | N-Butyl Pentedrone (hydrochloride) | 18268-13-8 | Reference compound |
| HY-150341 | Ortho-methyl 4-anilino-1-boc-piperidine | 1154101-90-2 | Reference compound |
| HY-150342 | 1-Propinoyl Lysergic acid methylisopropylamide | 3028950-73-1 | Reference compound |
| HY-150343 | (±)-3-Methyl nimetazepam | 89141-65-1 | Reference compound |
| HY-150344 | Abnormal cannabidivarin | 55824-20-9 | Reference compound |
| HY-150345 | Δ8-THC Glucuronide | 62667-60-1 | Reference compound |
| HY-150346 | 1cP-MiPLA | 3028950-74-2 | Reference compound |
| HY-150347 | Cannabigerol diacetate | 1040411-87-7 | Reference compound |
| HY-150348 | Cannabidivarin diacetate | 2552800-24-3 | Reference compound |
| HY-150349 | (±)-3-Methyl nitrazepam | 4928-07-8 | Reference compound |
| HY-15035 | S-Diclofenac | 912758-00-0 | Reference compound |
| HY-150350 | 20mM HEPES, 150 mM NaCl, 240mM Sucrose, pH 7.2 buffer | Biochemical Assay Reagents | |
| HY-15036 | Diclofenac | 15307-86-5 | Reference compound |
| HY-15036A | Diclofenac (diethylamine) | 78213-16-8 | Reference compound |
| HY-15036AR | Diclofenac (diethylamine) (Standard) | 78213-16-8 | Reference Standards |
| HY-15036B | Diclofenac deanol | 81811-14-5 | Reference compound |
| HY-15036R | Diclofenac (Standard) | 15307-86-5 | Reference Standards |
| HY-15036S | Diclofenac-d4 | 153466-65-0 | Isotope-Labeled Compounds |
| HY-15036S1 | Diclofenac-13C6 | 1261393-71-8 | Isotope-Labeled Compounds |
| HY-15037 | Diclofenac (Sodium) | 15307-79-6 | Reference compound |
| HY-15037R | Diclofenac (Sodium) (Standard) | 15307-79-6 | Reference Standards |
| HY-15037S | Diclofenac-13C6 (sodium heminonahydrate) | Isotope-Labeled Compounds | |
| HY-15037S1 | Diclofenac-d4 (sodium) | 154523-54-3 | Isotope-Labeled Compounds |
| HY-15037S2 | Diclofenac-13C6 (sodium) | 1261393-73-0 | Isotope-Labeled Compounds |
| HY-15038 | Diclofenac (potassium) | 15307-81-0 | Reference compound |
| HY-15038R | Diclofenac (potassium) (Standard) | 15307-81-0 | Reference Standards |
| HY-15039 | SSR240612 | 464930-42-5 | Reference compound |
| HY-150400 | XF056-132 (free base) | 2407450-73-9 | Reference compound |
| HY-150400A | XF056-132 | 2694057-55-9 | Reference compound |
| HY-150401 | Exatecan-amide-cyclopropanol | 2414254-34-3 | Reference compound |
| HY-150402 | MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan | 2414254-41-2 | ADC Related |
| HY-150403 | XF067-68 | 2407452-79-1 | Reference compound |
| HY-150407 | TSPO ligand-1 | 4560-08-1 | Reference compound |
| HY-150408 | FBnG-(Cys-acetamide)-CH2-PEG3-CH2-CH2-CH2-NH2 | 2241669-84-9 | Reference compound |
| HY-150409 | TSPO ligand-2 | 1160640-95-8 | Reference compound |
| HY-15041 | NVP-SAA164 | 312722-60-4 | Reference compound |
| HY-150410 | TSPO ligand-3 | 2241669-89-4 | Reference compound |
| HY-150411 | Cys-C-cGMP | 2241669-85-0 | Reference compound |
| HY-150412 | VU0364739 | 1244639-78-8 | Reference compound |
| HY-15042 | MK 0686 | 578727-68-1 | Reference compound |
| HY-15043 | ELN-441958 | 913064-47-8 | Reference compound |
| HY-15044 | NU1025 | 90417-38-2 | Reference compound |
| HY-15045 | INO-1001 | 501364-82-5 | Reference compound |
| HY-15045A | INO-1001 (mesylate) | 501364-91-6 | Reference compound |
| HY-15046 | EB-47 | 366454-36-6 | Reference compound |
| HY-15048 | GPI 15427 | 805242-85-7 | Reference compound |
| HY-15050 | KCL-440 | 651029-09-3 | Reference compound |
| HY-150500 | HDAC-IN-44 | 2414921-46-1 | Reference compound |
| HY-150501 | Diprovocim-X | 3005274-77-8 | Reference compound |
| HY-150502 | Poly(styrenyl acetal trehalose) | Reference compound | |
| HY-150503 | KH-259 | 3023019-93-1 | Reference compound |
| HY-150504 | ERAP2-IN-1 | 2420551-38-6 | Reference compound |
| HY-150505 | DC-U4106 | 2410534-62-0 | Reference compound |
| HY-150506 | SPR7 | 3032859-14-3 | Reference compound |
| HY-150507 | JNJ-4355 | 2697112-33-5 | Reference compound |
| HY-150508 | MK-0159 | 2641484-61-7 | Reference compound |
| HY-150510 | MS8511 | 2866408-21-9 | Reference compound |
| HY-150510A | MS8511 (hydrochloride) | 3031788-28-7 | Reference compound |
| HY-150511 | 3-(3-Phenoxybenzyl)amino-β-carboline | 1327080-54-5 | Reference compound |
| HY-150513 | SLP9101555 | Reference compound | |
| HY-150514 | ARN1468 | 1381459-14-8 | Reference compound |
| HY-150516S | BET-IN-12 | 1800343-11-6 | Isotope-Labeled Compounds |
| HY-150519S | 2-Chloro-2-methylpropane-d9 | 918-20-7 | Isotope-Labeled Compounds |
| HY-150520 | Neomycin | 1404-04-2 | Reference compound |
| HY-150521 | Hispolon | 173933-40-9 | Natural Products |
| HY-150521R | Hispolon (Standard) | 173933-40-9 | Reference Standards |
| HY-150523 | Ristocetin | 1404-55-3 | Reference compound |
| HY-150523S | Sodium borodeuteride-d4 | 15681-89-7 | Isotope-Labeled Compounds |
| HY-150524 | UDP-Galactose | 2956-16-3 | Reference compound |
| HY-150525 | Vitamin B6 | 8059-24-3 | Reference compound |
| HY-150525S | Acetyl-1,2 Coenzyme A-13c2 (Lithium) | Isotope-Labeled Compounds | |
| HY-150526 | EGCG-4″-sulfate | 2708237-76-5 | Reference compound |
| HY-150527S | Drotaveraldine-d10 | Isotope-Labeled Compounds | |
| HY-150528S | rac-Clopidogrel Amide-d4 | 1219423-91-2 | Isotope-Labeled Compounds |
| HY-150531S | Safinamide d3 | 1147299-71-5 | Isotope-Labeled Compounds |
| HY-150532S | (Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N | Isotope-Labeled Compounds | |
| HY-150533S | (E/Z)-Mycophenolic Acid-13C,d3 | 1261432-16-9 | Isotope-Labeled Compounds |
| HY-150534 | Anti-melanoma agent 1 | 2418579-17-4 | Reference compound |
| HY-150535S | Bromoethanol-d4 | 81764-55-8 | Isotope-Labeled Compounds |
| HY-150536 | EP39 | Reference compound | |
| HY-150537 | AChE/GSK-3β-IN-1 | 2412364-73-7 | Reference compound |
| HY-150538 | STAT3-IN-12 | 2980758-31-2 | Reference compound |
| HY-150539 | IAB15 | 2987139-91-1 | Reference compound |
| HY-150540 | Bcl-2-IN-10 | 2773354-28-0 | Reference compound |
| HY-150541 | IAA65 | 2987139-96-6 | Reference compound |
| HY-150542 | Steroid sulfatase-IN-2 | 2413880-39-2 | Reference compound |
| HY-150543 | Steroid sulfatase-IN-3 | 2413880-53-0 | Reference compound |
| HY-150544S | N-Desmethyl selegiline-d5 (hydrochloride) | 1217774-73-6 | Isotope-Labeled Compounds |
| HY-150545 | AChE-IN-21 | 2413656-04-7 | Reference compound |
| HY-150547 | RSV-IN-6 | 2415152-41-7 | Reference compound |
| HY-150548 | COX-2/15-LOX-IN-1 | 2413565-15-6 | Reference compound |
| HY-150549 | HIV-1 protease-IN-6 | 2892016-32-7 | Reference compound |
| HY-150550 | COX-2-IN-26 | 2413565-19-0 | Reference compound |
| HY-150551 | COX-2-IN-27 | 2413565-17-8 | Reference compound |
| HY-150552 | JNK3 inhibitor-2 | 2366264-18-6 | Reference compound |
| HY-150553 | COX-2-IN-28 | 2413565-18-9 | Reference compound |
| HY-150554 | Antitubercular agent-29 | Reference compound | |
| HY-150555 | P-CAB agent 1 | 2374139-68-9 | Reference compound |
| HY-150557 | CYP1B1-IN-1 | 842122-33-2 | Reference compound |
| HY-150558 | CYP1B1-IN-2 | 727730-24-7 | Reference compound |
| HY-150559 | SMS2-IN-3 | 2414240-89-2 | Reference compound |
| HY-15056 | AMG 9090 | 118215-82-0 | Reference compound |
| HY-150560 | α-Glucosidase-IN-11 | 2411744-76-6 | Reference compound |
| HY-150561 | Trk-IN-20 | 2460924-63-2 | Reference compound |
| HY-150562 | CDK9-IN-19 | 2479306-60-8 | Reference compound |
| HY-150563 | Neuroinflammatory-IN-2 | 2361384-14-5 | Reference compound |
| HY-150564 | SMO-IN-2 | 1822355-27-0 | Reference compound |
| HY-150565 | P-gp inhibitor 5 | 2451298-06-7 | Reference compound |
| HY-150566 | BCR-ABL-IN-5 | 1795736-60-5 | Reference compound |
| HY-150567 | SMO-IN-3 | 2376914-71-3 | Reference compound |
| HY-150569 | BCR-ABL-IN-6 | 2499499-26-0 | Reference compound |
| HY-150570 | Carbonic anhydrase inhibitor 14 | 2410402-75-2 | Reference compound |
| HY-150571 | Anticancer agent 76 | 2448091-11-8 | Reference compound |
| HY-150572 | CDK2-IN-11 | 2410402-82-1 | Reference compound |
| HY-150573 | CDK2-IN-12 | 2410402-88-7 | Reference compound |
| HY-150574 | CYP3A4-IN-1 | 2771297-34-6 | Reference compound |
| HY-150576 | c-Met-IN-13 | 2377724-93-9 | Reference compound |
| HY-150577 | HDAC-IN-45 | 2421122-61-2 | Reference compound |
| HY-150578 | Keap1-Nrf2-IN-12 | 2250082-04-1 | Reference compound |
| HY-150579 | Keap1-Nrf2-IN-13 | 2456294-92-9 | Reference compound |
| HY-150580 | CYP3A4-IN-2 | 2562383-94-0 | Reference compound |
| HY-150581 | CYP3A4-IN-3 | 2562384-19-2 | Reference compound |
| HY-150582 | c-Met-IN-14 | 2443380-34-3 | Reference compound |
| HY-150583 | Chitin synthase inhibitor 2 | 2416338-24-2 | Reference compound |
| HY-150584 | Chitin synthase inhibitor 3 | 2416338-26-4 | Reference compound |
| HY-150585 | BuChE-IN-5 | 2402753-39-1 | Reference compound |
| HY-150586 | PTG-0861 | 2494082-34-5 | Reference compound |
| HY-150587 | Anti-inflammatory agent 31 | 3051838-54-8 | Reference compound |
| HY-150588 | InhA-IN-3 | 900701-83-9 | Reference compound |
| HY-150589 | InhA-IN-4 | 894309-72-9 | Reference compound |
| HY-150590 | 20S Proteasome-IN-2 | 2028300-31-2 | Reference compound |
| HY-150591 | 20S Proteasome-IN-3 | 1803040-07-4 | Reference compound |
| HY-150592 | Aurora kinase-IN-2 | 2241914-86-1 | Reference compound |
| HY-150593 | IRAK4-IN-16 | 1812188-83-2 | Reference compound |
| HY-150594 | IRAK4-IN-17 | 2183503-33-3 | Reference compound |
| HY-150595 | HDAC6-IN-10 | 2408286-73-5 | Reference compound |
| HY-150596 | CT1-3 | 2460738-32-1 | Reference compound |
| HY-150597 | HDAC-IN-46 | 2562386-85-8 | Reference compound |
| HY-150598 | CHMFL-PI4K-127 | 2377604-81-2 | Reference compound |
| HY-150599 | HIV-1 inhibitor-43 | 2493426-43-8 | Reference compound |
| HY-150600 | NS2B/NS3-IN-7 | 3035421-16-7 | Reference compound |
| HY-150601 | Estrogen receptor-IN-1 | 74027-99-9 | Reference compound |
| HY-150602 | 20S Proteasome activator 1 | 2761578-18-9 | Reference compound |
| HY-150603 | STAT3-IN-13 | 2248552-86-3 | Reference compound |
| HY-150605 | ERK5-IN-3 | 1888305-85-8 | Reference compound |
| HY-150606 | ERK5-IN-4 | 1888305-17-6 | Reference compound |
| HY-150607 | UNC7467 | 2922283-43-8 | Reference compound |
| HY-150608 | PROTAC STING Degrader-1 | 2762552-74-7 | Reference compound |
| HY-150609 | SHP2/CDK4-IN-1 | 2924036-87-1 | Reference compound |
| HY-150610 | EGFR-IN-69 | 2433837-65-9 | Reference compound |
| HY-150611 | EGFR-IN-70 | 2926716-96-1 | Reference compound |
| HY-150612 | (R)-STU104 | 2767124-77-4 | Reference compound |
| HY-150613 | PARP1/BRD4-IN-2 | 3037993-97-5 | Reference compound |
| HY-150614 | Autotaxin-IN-6 | 2800898-98-8 | Reference compound |
| HY-150615 | SphK1-IN-2 | 3031483-60-7 | Reference compound |
| HY-150616 | SJPYT-195 | 2973762-16-0 | Reference compound |
| HY-150617 | Lartesertib | 2495096-26-7 | Reference compound |
| HY-150617A | (Rac)-Lartesertib | 2020089-41-0 | Reference compound |
| HY-150618 | PI3Kα-IN-9 | 2715287-67-3 | Reference compound |
| HY-150619 | KDM4-IN-4 | 2230475-63-3 | Reference compound |
| HY-150620 | BI-0282 | 1883383-48-9 | Reference compound |
| HY-150621 | AS1134900 | 149760-98-5 | Reference compound |
| HY-150622 | SARS-CoV-2 nsp13-IN-1 | 1005304-44-8 | Reference compound |
| HY-150623 | SARS-CoV-2 nsp13-IN-2 | 522660-61-3 | Reference compound |
| HY-150624 | SARS-CoV-2 nsp13-IN-3 | 1015582-31-6 | Reference compound |
| HY-150625 | SARS-CoV-2 nsp13-IN-4 | 923140-39-0 | Reference compound |
| HY-150626 | SARS-CoV-2 nsp13-IN-5 | 912799-11-2 | Reference compound |
| HY-150627S | Pyrene-d10 | 1718-52-1 | Isotope-Labeled Compounds |
| HY-150628S | 2-Oxobutanoic acid-13C,d1 (sodium hydrate) | 1049741-69-6 | Isotope-Labeled Compounds |
| HY-150629S | 2-Ketobutyric acid-13C4,3,3-d2 sodium salt hydrate | Isotope-Labeled Compounds | |
| HY-150630 | ALR2-IN-1 | 2799695-54-6 | Reference compound |
| HY-150631S | Glutathione-glycine-13C2,15N (trifluoroacetate) | Isotope-Labeled Compounds | |
| HY-150632 | SARS-CoV-2 nsp13-IN-6 | 951588-85-5 | Reference compound |
| HY-150635S | Uridine-5'-monophosphate-15N2 (sodium) | Isotope-Labeled Compounds | |
| HY-150636 | Autophagy-IN-1 | 3031485-19-2 | Reference compound |
| HY-150637 | Mab Aspartate Decarboxylase-IN-1 | 2755712-12-8 | Reference compound |
| HY-150638 | PI3Kδ/γ-IN-3 | 2730151-31-0 | Reference compound |
| HY-150639 | Everafenib | 2923700-82-5 | Reference compound |
| HY-15064 | HC-030031 | 349085-38-7 | Reference compound |
| HY-150640 | Rho-Kinase-IN-2 | 2573071-18-6 | Reference compound |
| HY-150641 | CDK-IN-9 | 3031561-92-6 | Reference compound |
| HY-150642S | Guanosine-5 '- monophosphate-15n5 (sodium) | Isotope-Labeled Compounds | |
| HY-150643 | RSK2-IN-2 | 1637749-78-0 | Reference compound |
| HY-150644 | S07-2010 | 1223194-71-5 | Reference compound |
| HY-150646 | S07-2009 | 1580241-55-9 | Reference compound |
| HY-150648 | S07-2008 | 1090816-80-0 | Reference compound |
| HY-150649 | S07-2005 (racemic) | 1826337-40-9 | Reference compound |
| HY-15065 | Chembridge-5861528 | 332117-28-9 | Reference compound |
| HY-150650 | S07-2001 | 1197904-57-6 | Reference compound |
| HY-150651S | Uridine 5′-monophosphate-15n2 (sodium) | Isotope-Labeled Compounds | |
| HY-150652 | FGFR-IN-8 | 2640217-64-5 | Reference compound |
| HY-150654 | WDR5-IN-5 | 2417012-26-9 | Reference compound |
| HY-150655 | Hsp90-IN-15 | 2252283-32-0 | Reference compound |
| HY-150656S | Adenosine-5′-monophosphate-15N5 (sodium) | Isotope-Labeled Compounds | |
| HY-150658S | DMT-2′O-TBDMS-rA(ac)-1-15N phosphoramidite | Isotope-Labeled Compounds | |
| HY-150659S | Adenosine-5′-triphosphate-d14 (disodium) | Isotope-Labeled Compounds | |
| HY-15066 | CNQX | 115066-14-3 | Reference compound |
| HY-150660S | Ercalcidiol-13C5 | 2785319-25-5 | Isotope-Labeled Compounds |
| HY-150661S | 3-epi-Calcifediol-13C5 | 2482467-12-7 | Isotope-Labeled Compounds |
| HY-150662S | 2-(7-Hydroxycoumarin-4-yl)-propanoic acid methyl ester-d3 | Isotope-Labeled Compounds | |
| HY-150663S | Calcitriol-13C5 | Isotope-Labeled Compounds | |
| HY-150664S | 4-Methoxy-benzoic acid-d3 | 27914-54-1 | Isotope-Labeled Compounds |
| HY-150665S | N-Dansyl-d6 1,4-diaminobutane, 97% (CP) | Isotope-Labeled Compounds | |
| HY-150666S | 1-(3,4-Dimethoxy-d6-benzoyl)piperidine | Isotope-Labeled Compounds | |
| HY-150667S | 2-Amino-6-(3-methoxy-anilino)purine-d3 | Isotope-Labeled Compounds | |
| HY-150668S | Methyl 4-(benzyloxy)-3,5-dimethoxy-benzoate-d6 | Isotope-Labeled Compounds | |
| HY-150669S | HI-P224-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-15066A | CNQX (disodium) | 479347-85-8 | Reference compound |
| HY-15067 | DNQX | 2379-57-9 | Reference compound |
| HY-150670S | Dansyl-2-(2-azidoethoxy)ethanamine-d6 | Isotope-Labeled Compounds | |
| HY-150671S | Methyl suberanilate-d5 | Isotope-Labeled Compounds | |
| HY-150672S | Tetra-O-acetyl-β-D-glucopyranosylvanilin-d3 | Isotope-Labeled Compounds | |
| HY-150673S | Curcumin diglucoside-d6 | Isotope-Labeled Compounds | |
| HY-150674S | Curcumin-diglucoside tetraacetate-d6 | Isotope-Labeled Compounds | |
| HY-150675S | N-Dansyl 6-aminohexanol-d6 | Isotope-Labeled Compounds | |
| HY-150676S | N-Dansyl 1,3-diaminopropane-d6 | Isotope-Labeled Compounds | |
| HY-150677S | Desethylchloroquine-d5 (dioxalate) | Isotope-Labeled Compounds | |
| HY-150678S | Adenosine:H20-13c | Isotope-Labeled Compounds | |
| HY-150679S | Remdesivir-13C6 | Isotope-Labeled Compounds | |
| HY-15068 | NBQX | 118876-58-7 | Reference compound |
| HY-150680 | SARS-CoV-2 nsp14-IN-1 | 2816165-02-1 | Reference compound |
| HY-150681 | SARS-CoV-2 nsp14-IN-2 | 2816165-16-7 | Reference compound |
| HY-150682 | FXIa-IN-9 | 2816108-87-7 | Reference compound |
| HY-150683 | NC-III-49-1 | 3031654-46-0 | Reference compound |
| HY-150684 | GXH-II-052 | 3031654-49-3 | Reference compound |
| HY-150685 | Topo I/COX-2-IN-1 | 3031418-84-2 | Reference compound |
| HY-150686 | Chitin synthase inhibitor 4 | 2755847-31-3 | Reference compound |
| HY-150687 | ZINC12409120 | 1010888-06-8 | Reference compound |
| HY-150688 | JAK3-IN-13 | 2803329-86-2 | Reference compound |
| HY-15068A | NBQX (disodium) | 479347-86-9 | Reference compound |
| HY-15069 | Fanapanel | 161605-73-8 | Reference compound |
| HY-150691 | SARS 3CLpro-IN-1 | 2409178-86-3 | Reference compound |
| HY-150692 | Estrogen receptor α antagonist 1 | 2580941-45-1 | Reference compound |
| HY-150693 | Estrogen receptor β antagonist 2 | 2580941-14-4 | Reference compound |
| HY-150694 | HDAC6-IN-11 | 2409072-27-9 | Reference compound |
| HY-150695 | hCAIX/XII-IN-5 | 2421127-99-1 | Reference compound |
| HY-150696 | Antitumor agent-72 | 2676942-92-8 | Reference compound |
| HY-150697 | HIV-1 inhibitor-44 | Reference compound | |
| HY-150699 | TXA6101 | 1459695-66-9 | Reference compound |
| HY-15069A | Fanapanel (hydrate) | 1255517-78-2 | Reference compound |
| HY-15070 | YM 900 | 143151-35-3 | Reference compound |
| HY-150700 | RLX-33 | 2784577-71-3 | Reference compound |
| HY-150701 | INCB13739 | 869974-19-6 | Reference compound |
| HY-150702 | MAGLi 432 | 2361575-20-2 | Reference compound |
| HY-150703S | DL-4-Methoxyestradiol-13C6 | Isotope-Labeled Compounds | |
| HY-150706S | D-fructose-6-phosphate-13C6 | Isotope-Labeled Compounds | |
| HY-150707S | DL-A-phosphatidylcholine, dipalmitoyl-13C40 | Isotope-Labeled Compounds | |
| HY-150708S | Ethyl 2-hydroxy-2-methyl-3-oxobutanoate-13C | 1225273-82-4 | Isotope-Labeled Compounds |
| HY-150709S | Adenosine 5'-triphosphate-13C10,15N5 (ammonium) | Isotope-Labeled Compounds | |
| HY-150709S1 | Adenosine 5'-triphosphate-13C10,15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-15071 | YM90K | 154164-30-4 | Reference compound |
| HY-150710S | Cytidine 5'-triphosphate-13C9,15N3 (ammonium) | Isotope-Labeled Compounds | |
| HY-150711S | Guanosine-13C10,15N5 (ammonium) | 2483830-19-7 | Isotope-Labeled Compounds |
| HY-150712S | Uridine triphosphate-13C9,15N2 (dilithium) | 2483830-24-4 | Isotope-Labeled Compounds |
| HY-150716S | Iodopropamine-d3 | 1189947-73-6 | Isotope-Labeled Compounds |
| HY-150717 | RSK2-IN-3 | 1627136-54-2 | Reference compound |
| HY-150718S | α-Ketoisohexanoic acid-d3 (sodium) | 172330-01-7 | Isotope-Labeled Compounds |
| HY-150719 | AIMP2-DX2-IN-1 | 848256-17-7 | Reference compound |
| HY-15072 | Zonampanel | 210245-80-0 | Reference compound |
| HY-150720 | TYK2-IN-12 | 2244061-66-1 | Reference compound |
| HY-150721 | COX-2-IN-29 | 3033545-21-7 | Reference compound |
| HY-150722 | HDAC6-IN-12 | 2803866-44-4 | Reference compound |
| HY-150723 | PBI-6DNJ | 2857098-72-5 | Reference compound |
| HY-150724 | ODN 1018 | 937402-51-2 | Oligonucleotides |
| HY-150724A | Biotin-labeled ODN 1018 (sodium) | Oligonucleotides | |
| HY-150724B | FITC-labeled ODN 1018 (sodium) | Oligonucleotides | |
| HY-150724C | ODN 1018 (sodium) | Oligonucleotides | |
| HY-150725 | ODN 1585 | 386832-46-8 | Oligonucleotides |
| HY-150725A | Biotin-labeled ODN 1585 (sodium) | Oligonucleotides | |
| HY-150725B | FITC-labeled ODN 1585 (sodium) | Oligonucleotides | |
| HY-150725C | ODN 1585 (sodium) | Oligonucleotides | |
| HY-150726 | ODN 1668 | 1186063-66-0 | Oligonucleotides |
| HY-150726A | Biotin-labeled ODN 1668 (sodium) | Oligonucleotides | |
| HY-150726B | FITC-labeled ODN 1668 (sodium) | Oligonucleotides | |
| HY-150726C | ODN 1668 (sodium) | Oligonucleotides | |
| HY-150727 | SIRT5 inhibitor 4 | 708992-34-1 | Reference compound |
| HY-150728 | AChE-IN-22 | 3032264-62-0 | Reference compound |
| HY-150729 | ODN 1982 | 207623-15-2 | Oligonucleotides |
| HY-150729A | ODN 1982 (sodium) | Oligonucleotides | |
| HY-15073 | Becampanel | 188696-80-2 | Reference compound |
| HY-150730 | FAK-IN-6 | 3033299-38-3 | Reference compound |
| HY-150731 | Pim-1 kinase inhibitor 3 | 2801695-39-4 | Reference compound |
| HY-150732 | IRAK4-IN-18 | Reference compound | |
| HY-150733 | IRAK4-IN-19 | 3032075-32-1 | Reference compound |
| HY-150734 | ODN 2007 | 455348-63-7 | Oligonucleotides |
| HY-150734A | ODN 2007 (sodium) | Oligonucleotides | |
| HY-150735 | IRAK4-IN-20 | 1931994-80-7 | Reference compound |
| HY-150736 | ODN 20844 | 1964506-29-3 | Oligonucleotides |
| HY-150736A | ODN 20844 (sodium) | Oligonucleotides | |
| HY-150737 | MI-1851 | 2417283-44-2 | Reference compound |
| HY-150738 | ODN 2088 | 1146541-45-8 | Oligonucleotides |
| HY-150738A | Biotin-labeled ODN 2088 (sodium) | Oligonucleotides | |
| HY-150738B | FITC-labeled ODN 2088 (sodium) | Oligonucleotides | |
| HY-150738C | ODN 2088 (sodium) | Oligonucleotides | |
| HY-150739 | ODN 21158 | 1964506-31-7 | Oligonucleotides |
| HY-150739A | ODN 21158 (sodium) | Oligonucleotides | |
| HY-15074 | SPD-502 | 245063-59-6 | Reference compound |
| HY-150740 | ODN 21595 | 1964506-28-2 | Oligonucleotides |
| HY-150740A | ODN 21595 (sodium) | Oligonucleotides | |
| HY-150741 | ODN 2216 | 332437-00-0 | Oligonucleotides |
| HY-150741A | Biotin-labeled ODN 2216 (sodium) | Oligonucleotides | |
| HY-150741B | FITC-labeled ODN 2216 (sodium) | Oligonucleotides | |
| HY-150741C | ODN 2216 (sodium) | Oligonucleotides | |
| HY-150742 | ODN 2336 | 332956-64-6 | Oligonucleotides |
| HY-150742A | ODN 2336 (sodium) | Oligonucleotides | |
| HY-150743 | ODN 2395 | 1254617-22-5 | Oligonucleotides |
| HY-150743A | Biotin-labeled ODN 2395 (sodium) | Oligonucleotides | |
| HY-150743B | FITC-labeled ODN 2395 (sodium) | Oligonucleotides | |
| HY-150743C | ODN 2395 (sodium) | Oligonucleotides | |
| HY-150744 | ODN 24888 | 1964506-30-6 | Oligonucleotides |
| HY-150744A | ODN 24888 (sodium) | Oligonucleotides | |
| HY-150745 | ODN 24987 | 1682661-48-8 | Oligonucleotides |
| HY-150745A | ODN 24987 (sodium) | Oligonucleotides | |
| HY-150746 | ODN 24991 | 1682661-49-9 | Oligonucleotides |
| HY-150746A | ODN 24991 (sodium) | Oligonucleotides | |
| HY-150747 | ODN 6016 | 1271731-64-6 | Oligonucleotides |
| HY-150747A | ODN 6016 (sodium) | Oligonucleotides | |
| HY-150748 | ODN D-SL01 | 1198621-84-9 | Oligonucleotides |
| HY-150748A | ODN D-SL01 (sodium) | Oligonucleotides | |
| HY-150749 | ODN D-SL03 | 1198621-85-0 | Oligonucleotides |
| HY-150749A | ODN D-SL03 (sodium) | Oligonucleotides | |
| HY-150750 | ODN M362 | 934655-87-5 | Oligonucleotides |
| HY-150750A | ODN M362 (sodium) | Oligonucleotides | |
| HY-150751 | ODN TTAGGG | 1801724-76-4 | Oligonucleotides |
| HY-150751A | Biotin-labeled ODN TTAGGG (sodium) | Oligonucleotides | |
| HY-150751B | FITC-labeled ODN TTAGGG (sodium) | Oligonucleotides | |
| HY-150751C | ODN TTAGGG (sodium) | Oligonucleotides | |
| HY-150752 | BTK-IN-15 | 2820426-92-2 | Reference compound |
| HY-150753 | RS6212 | 2097925-52-3 | Reference compound |
| HY-150754 | FtsZ-IN-4 | 2882904-64-3 | Reference compound |
| HY-150755 | Topo I/COX-2-IN-2 | 2841455-91-0 | Reference compound |
| HY-150756 | EBOV-GP-IN-1 | 3032283-85-2 | Reference compound |
| HY-150757 | Autophagy-IN-2 | 2755454-90-9 | Reference compound |
| HY-150758 | NDM-1 inhibitor-3 | Reference compound | |
| HY-150759 | HIV-1 inhibitor-45 | 2677762-43-3 | Reference compound |
| HY-15076 | SPD-502 (sodium) | 205645-02-9 | Reference compound |
| HY-150760 | GSK5852 | 1331942-30-3 | Reference compound |
| HY-150761 | MY-875 | Reference compound | |
| HY-150762S | Adenosine 5'-Triphosphaye (ATP)-d16, ammonium salt-d12(1:4) | 2483831-65-6 | Isotope-Labeled Compounds |
| HY-150763S | Cytidine 5'-Triphosphate (ammonium salt)-d8 | 2483831-66-7 | Isotope-Labeled Compounds |
| HY-150764S | 2-(ethylamino)cyclohexa-2,5-diene-1,4-dione-d5 | Isotope-Labeled Compounds | |
| HY-150765 | PARP1-IN-12 | Reference compound | |
| HY-150766 | KPC-2-IN-1 | 2232877-85-7 | Reference compound |
| HY-150767 | KPC-2-IN-2 | 3034185-71-9 | Reference compound |
| HY-150768S | Guanosine 5'-triphosphate (GTP), ammonium salt-d27 | 2483831-68-9 | Isotope-Labeled Compounds |
| HY-150769 | ZLM-66 | 3033486-43-7 | Reference compound |
| HY-150770S | Adenosine 5'-triphosphate(ATP)-d4 (ammonium salt) | 2483831-82-7 | Isotope-Labeled Compounds |
| HY-150771S | Uridine 5'-triphosphate (ammonium salt)-d8 | 2483831-69-0 | Isotope-Labeled Compounds |
| HY-150772 | Tubulin/HDAC-IN-1 | 2413587-26-3 | Reference compound |
| HY-150773S | Guanosine 5'-triphosphate(GTP)-d4 (ammonium salt) | 2483831-83-8 | Isotope-Labeled Compounds |
| HY-150774 | HDAC6/HSP90-IN-2 | 2803866-22-8 | Reference compound |
| HY-150775 | CYP19A1-IN-2 | 3033282-93-5 | Reference compound |
| HY-150776S | L-carnitine: CLO4, 3-hydroxyisovaleryl-d3 | 2245711-23-1 | Isotope-Labeled Compounds |
| HY-150777S | Cytidine 5'-triphosphate(CTP)-d4 (ammonium salt) | Isotope-Labeled Compounds | |
| HY-150778S | Uridine 5'-triphosphate(UTP)-d4 (ammonium) | Isotope-Labeled Compounds | |
| HY-150779S | Choline-d13 (sulfate) | 2483831-84-9 | Isotope-Labeled Compounds |
| HY-15078 | NS1219 | 233603-81-1 | Reference compound |
| HY-150780S | Cytidine 5'-triphosphate (ammonium salt)-d2 | 2483831-93-0 | Isotope-Labeled Compounds |
| HY-150781 | EGFR-IN-71 | 2676155-98-7 | Reference compound |
| HY-150782 | UNC-CA359 | 2676156-05-9 | Reference compound |
| HY-150783 | SARS-CoV-2-IN-24 | Reference compound | |
| HY-150784 | XR8-89 | 2817811-16-6 | Reference compound |
| HY-150785 | TAS1553 | 2166023-31-8 | Reference compound |
| HY-150786 | PLP_Snyder530 | Reference compound | |
| HY-150787 | BMS-986339 | 2477873-64-4 | Reference compound |
| HY-150789 | SARS-CoV-2-IN-23 | Reference compound | |
| HY-15079 | Talampanel | 161832-65-1 | Reference compound |
| HY-150790 | BMS-986141 | 1478711-48-6 | Reference compound |
| HY-150791 | FLDP-5 | 950665-12-0 | Reference compound |
| HY-150792S | Inosine-15N4 | 204634-01-5 | Isotope-Labeled Compounds |
| HY-150793 | SY-LB-57 | 2253719-35-4 | Reference compound |
| HY-150794 | FLDP-8 | 861968-02-7 | Reference compound |
| HY-150795 | SY-LB-35 | 2603461-70-5 | Reference compound |
| HY-150796S | Guanosine 5'-triphosphate, ammonium salt-15N5 | Isotope-Labeled Compounds | |
| HY-150797 | QA-68 | Reference compound | |
| HY-150798S | Uridine 5'-triphosphate (ammonium salt)-15N2 | Isotope-Labeled Compounds | |
| HY-150799 | CRBN ligand-1 | 3032314-67-0 | Reference compound |
| HY-150803 | VHL Ligand 14 | 2010986-87-3 | Reference compound |
| HY-15082 | Irampanel | 206260-33-5 | Reference compound |
| HY-150839 | E3 ligase Ligand PG | 14149-34-9 | Reference compound |
| HY-15084 | Dizocilpine (maleate) | 77086-22-7 | Reference compound |
| HY-150843S | Adenosine 5'-triphosphate-15N5 (ammonium) | Isotope-Labeled Compounds | |
| HY-150844S | Ethylbenzene-2,3,4,5,6-d5 | 20302-26-5 | Isotope-Labeled Compounds |
| HY-150845S | Bis(2-chloroethoxy)-methane-d8 | 93966-78-0 | Isotope-Labeled Compounds |
| HY-150846S | 1,1,1,2-Tetrachloroethane-d2 | 117164-18-8 | Isotope-Labeled Compounds |
| HY-150847S | 1,2,3,4-Tetramethylbenzene-d14 | 350818-60-9 | Isotope-Labeled Compounds |
| HY-150848S | 2,3,6-Trichloroanisole-d3 | 1219798-64-7 | Isotope-Labeled Compounds |
| HY-150849S | (RS)-S-Adenosyl-L-methionine-d3 (S-methyl-d3) Tri(p-toluenesulfonate) Salt | 349560-27-6 | Isotope-Labeled Compounds |
| HY-15084A | (-)-Dizocilpine (maleate) | 121917-57-5 | Reference compound |
| HY-15084B | Dizocilpine | 77086-21-6 | Reference compound |
| HY-15085 | MDL 105519 | 161230-88-2 | Reference compound |
| HY-150850S | DL-Leucine-N-FMOC-d10 | Isotope-Labeled Compounds | |
| HY-150853S | 3-(Methyl-nitrosoamino)propionitrile-d3 | 1329834-39-0 | Isotope-Labeled Compounds |
| HY-150854S | Bis(8-methyl-1-nonyl) Phthalate-3,4,5,6-d4 | 1346604-79-2 | Isotope-Labeled Compounds |
| HY-150855S | Bis(7-methyl-1-octyl) Phthalate-3,4,5,6-d4 | 1332965-90-8 | Isotope-Labeled Compounds |
| HY-150857S | Thymine-α,α,α,6-d4 Glycol (mixture of diastereomers)-d4 | 132523-94-5 | Isotope-Labeled Compounds |
| HY-150859 | HDAC ligand-1 | 34840-28-3 | Reference compound |
| HY-15085A | (Z)-MDL 105519 | 179105-67-0 | Reference compound |
| HY-15086 | Selfotel | 110347-85-8 | Reference compound |
| HY-150863S | Monononyl phthalate-d4 | 2514564-42-0 | Isotope-Labeled Compounds |
| HY-150864S | Mono-n-Pentyl Phthalate-3,4,5,6-d4 | 1794756-28-7 | Isotope-Labeled Compounds |
| HY-150865S | Mono-n-Propyl Phthalate-3,4,5,6-d4 | 1795020-91-5 | Isotope-Labeled Compounds |
| HY-150871S | Uridine 5'-triphosphate-d7 (ammonium) | Isotope-Labeled Compounds | |
| HY-150873S | Bis(5-methylhexyl) Phthalate-3,4,5,6-d4 | 2708280-88-8 | Isotope-Labeled Compounds |
| HY-150879 | BMS-37 | 1675202-20-6 | Reference compound |
| HY-15087A | Spergualin (trihydrochloride) | 80952-47-2 | Reference compound |
| HY-150885 | BTK ligand 1 | 330785-90-5 | Reference compound |
| HY-150905 | EGFR ligand-2 | 2737283-20-2 | Reference compound |
| HY-15091 | Anisperimus | 170368-04-4 | Reference compound |
| HY-150910 | Brigatinib C | 1197958-75-0 | Reference compound |
| HY-150915S | Uracil 4,5-13c2 | 181517-15-7 | Isotope-Labeled Compounds |
| HY-150918S | 5-Methyl-1H-pyrazole-3-propanoic acid-13C5 | Isotope-Labeled Compounds | |
| HY-150926 | G12Si-1 | 2946593-42-4 | Reference compound |
| HY-150927 | G12Si-2 | 2946593-43-5 | Reference compound |
| HY-150929S | Cytidine 5'-triphosphate (CTP)-d5 (ammonium) | Isotope-Labeled Compounds | |
| HY-150930S | Cytidine 5'-triphosphate-15N3 (ammonium) | Isotope-Labeled Compounds | |
| HY-150931S | Uridine 5'-triphosphate (UTP)-d5 (tetraammonium) | Isotope-Labeled Compounds | |
| HY-150954S | L-Methionine-d3 (S-methyl-d3) Methyl-d3-sulfonium Chloride | Isotope-Labeled Compounds | |
| HY-150958 | RAD51-IN-8 | Reference compound | |
| HY-150959 | α-Glucosidase-IN-12 | 2816072-24-7 | Reference compound |
| HY-15096 | MKT-077 | 147366-41-4 | Dye Reagents |
| HY-150960 | α-Glucosidase-IN-13 | 2816072-18-9 | Reference compound |
| HY-150961 | α-Glucosidase-IN-14 | 2816072-15-6 | Reference compound |
| HY-150962S | 5-Hydroxycytosine-13C,15N2 | 181516-92-7 | Isotope-Labeled Compounds |
| HY-150963 | Renin inhibitor-1 | 1093082-54-2 | Reference compound |
| HY-150964S | S-Adenosyl-L-methionine-d3 (methylbenzenesulfonate) | Isotope-Labeled Compounds | |
| HY-150965 | NDT-30805 | Reference compound | |
| HY-150966 | Antiproliferative agent-10 | Reference compound | |
| HY-150967 | MmpL3-IN-1 | 2290534-93-7 | Reference compound |
| HY-150968 | Antiproliferative agent-11 | Reference compound | |
| HY-150969 | Antiproliferative agent-12 | Reference compound | |
| HY-15097 | Myricetin | 529-44-2 | Natural Products |
| HY-150970 | ICy-OH | 2863682-80-6 | Reference compound |
| HY-150971 | ICy-Q | 2863682-83-9 | Reference compound |
| HY-150972 | P163-0892 | 1574576-45-6 | Reference compound |
| HY-150973 | hCAII-IN-4 | 2816080-18-7 | Reference compound |
| HY-150974 | ROS1-IN-1 | 2883232-34-4 | Reference compound |
| HY-150975 | hCAII-IN-5 | 2816080-16-5 | Reference compound |
| HY-150976 | β-Glucuronidase/hCAII-IN-1 | 2816080-17-6 | Reference compound |
| HY-150977 | β-Glucuronidase/hCAII-IN-2 | 2816080-13-2 | Reference compound |
| HY-150978 | DDAO-C6 | 2102418-90-4 | Dye Reagents |
| HY-150979 | Gd-NMC-3 | 2678579-76-3 | Dye Reagents |
| HY-15097R | Myricetin (Standard) | 529-44-2 | Reference Standards |
| HY-15097S | Myricetin-13C3 | Isotope-Labeled Compounds | |
| HY-15098 | Apoptozole | 1054543-47-3 | Reference compound |
| HY-150980S | 1,2-O-Isopropylidene-β-L-idofuranuronic-6-13C acid γ-lactone | 40010-58-0 | Isotope-Labeled Compounds |
| HY-150981S | 1,2-O-Isopropylidene-a-D-glucofuranuronic-6-13C acid, γ-lactone | 40010-66-0 | Isotope-Labeled Compounds |
| HY-150983 | ATP synthase inhibitor 2 | 2814540-76-4 | Reference compound |
| HY-150983A | ATP synthase inhibitor 2 (TFA) | Reference compound | |
| HY-150985S | 2,2'-Dichloro bisphenol a mono-D-glucuronide-d12 | 2673270-16-9 | Isotope-Labeled Compounds |
| HY-150986S | Dihydrobupropion-d9 | 1215071-07-0 | Isotope-Labeled Compounds |
| HY-150987S | 2,2',6-Trichloro bisphenol A-d11 | Isotope-Labeled Compounds | |
| HY-150988S | 2,2'-Dichloro bisphenol A-d12 | 2748525-32-6 | Isotope-Labeled Compounds |
| HY-150989S | 1,4-Butanediol mononitrate-d8 | 1261398-94-0 | Isotope-Labeled Compounds |
| HY-15099 | NC 2300 | 221144-20-3 | Reference compound |
| HY-150991S | Desmethylsildenafil-d8 (citrate) | 1215071-06-9 | Isotope-Labeled Compounds |
| HY-150992S | 2,6-Dichloro bisphenol A-d12 | 2739737-75-6 | Isotope-Labeled Compounds |
| HY-150993S | Rosiglitazone-d5 (maleate) | 1215168-64-1 | Isotope-Labeled Compounds |
| HY-150994S | 2-Methoxy-3,5-dimethylpyrazine-d3 | 1335402-04-4 | Isotope-Labeled Compounds |
| HY-150997S | Hydroxyalprazolam-d4 | 1420291-59-3 | Isotope-Labeled Compounds |
| HY-150999S | 2,2′,5-Trichlorobiphenyl-3,4,4′,6,6′-d5 | Isotope-Labeled Compounds | |
| HY-15100 | Balicatib | 354813-19-7 | Reference compound |
| HY-151001S | EXP3174-d9 | Isotope-Labeled Compounds | |
| HY-151002S | M8 metabolite of Carvedilol-d5 | 2673270-31-8 | Isotope-Labeled Compounds |
| HY-151003S | D-Panthenol-d4 | 2673270-00-1 | Isotope-Labeled Compounds |
| HY-151017S | Mequitazine-d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-15102 | MK-0429 | 227963-15-7 | Reference compound |
| HY-151027S | Androsterone-d4 glucuronide | 2687960-87-6 | Isotope-Labeled Compounds |
| HY-151029S | Drotavering-d10 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-15103 | AH3960 | 862907-48-0 | Reference compound |
| HY-15104 | Ronacaleret (hydrochloride) | 702686-96-2 | Reference compound |
| HY-151048 | JBJ-07-149 | 2140807-58-3 | Reference compound |
| HY-15105 | SB-423562 | 351490-27-2 | Reference compound |
| HY-15105A | SB-423562 (hydrochloride) | 351490-72-7 | Reference compound |
| HY-15106 | SB-423557 | 351490-26-1 | Reference compound |
| HY-151066 | BMS-1233 | 2447065-99-6 | Reference compound |
| HY-151068S | 2,3′,4′,5-Tetrachlorobiphenyl-3,4,6-d3 | 1219794-77-0 | Isotope-Labeled Compounds |
| HY-151069 | TMX-2039 | 2488892-01-7 | Reference compound |
| HY-151070S | 2,3,4-Trichlorobiphenyl-2′,3′,4′,5′,6′-d5 | Isotope-Labeled Compounds | |
| HY-151071 | TMX-3013 | 2488761-18-6 | Reference compound |
| HY-151073S | 2′,3,4-Trichlorobiphenyl-3′,4′,5′,6′-d4 | Isotope-Labeled Compounds | |
| HY-151074S | 2,2′-Binaphthyl-d14 | 210487-05-1 | Isotope-Labeled Compounds |
| HY-151076S | 2,3,3′,4,5,5′-Hexachlorobiphenyl-2′,4′,6′-d3 | 1219798-69-2 | Isotope-Labeled Compounds |
| HY-151078S | 2,3′,5-Trichlorobiphenyl-2′,3,4,4′,6,6′-d6 | Isotope-Labeled Compounds | |
| HY-151079S | 2,3,4,5,6-Pentachlorobiphenyl-2′,3′,4′,5′,6′-d5 | 1219798-92-1 | Isotope-Labeled Compounds |
| HY-15108 | Purmorphamine | 483367-10-8 | Reference compound |
| HY-151080S | 2,4,5-Trichlorobiphenyl-2′,3′,4′,5′,6′-d5 | 1276197-33-1 | Isotope-Labeled Compounds |
| HY-151081S | 2,5-Dichlorobiphenyl-2′,3′,4′,5′,6′-d5 | 1219804-50-8 | Isotope-Labeled Compounds |
| HY-151082S | 2,2′,3,4,5,5′-Hexachlorobiphenyl-3′,4′,6′-d3 | 1219798-51-2 | Isotope-Labeled Compounds |
| HY-151083S | 2-tert-Butylamino-d9-4-chloro-6-cyclopropylamino-1,3,5-triazine | 1189419-70-2 | Isotope-Labeled Compounds |
| HY-151084S | 3-(3-Ethoxy-4-methoxyphenyl)propionic-2,2,3,3-d4 | 1398065-51-4 | Isotope-Labeled Compounds |
| HY-151085S | 3,4,5-Trichlorobiphenyl-2′,3′,4′,5′,6′-d5 | 93952-22-8 | Isotope-Labeled Compounds |
| HY-151086S | 3-Nitrofluoranthene-d9 | 350820-11-0 | Isotope-Labeled Compounds |
| HY-15108G | Purmorphamine (GMP) | 483367-10-8 | GMP Small Molecules |
| HY-151090S | 3,5-Dichlorobiphenyl-2′,3′,4′,5′,6′-d5 | 1276197-28-4 | Isotope-Labeled Compounds |
| HY-151091S | 6-Nitrochrysene-d11 | 203805-92-9 | Isotope-Labeled Compounds |
| HY-151092 | Anticancer agent 77 | 2787582-75-4 | Reference compound |
| HY-151093 | IDO2-IN-1 | 2803768-09-2 | Reference compound |
| HY-151094 | FTEAA | Reference compound | |
| HY-151095 | Phytoene desaturase-IN-1 | 2765793-54-0 | Reference compound |
| HY-151096 | ACT-660602 | 1646267-59-5 | Reference compound |
| HY-151097S | (±)-Benzfendizone-13C | Isotope-Labeled Compounds | |
| HY-151098S | Chlorpromazine-d6 (oxalate) | 1276197-23-9 | Isotope-Labeled Compounds |
| HY-151100 | GPR84 antagonist 3 | 2815263-05-7 | Reference compound |
| HY-151101 | MS159 | 3031353-59-7 | Reference compound |
| HY-151102 | Fabimycin | 2651965-71-6 | Reference compound |
| HY-151103 | Neuraminidase-IN-10 | 2685786-29-0 | Reference compound |
| HY-151104 | Neuraminidase-IN-11 | 2685786-28-9 | Reference compound |
| HY-151105 | CBR Agonist-1 | Reference compound | |
| HY-151106 | FTO-IN-8 | 2640366-38-5 | Reference compound |
| HY-151107 | CBR Agonist-2 | Reference compound | |
| HY-151108 | IDO1/TDO-IN-4 | 461424-21-5 | Reference compound |
| HY-151109 | IR-990 | Dye Reagents | |
| HY-151110 | PROTAC CDK12/13 Degrader-1 | Reference compound | |
| HY-151110A | PROTAC CDK12/13 Degrader-1 (TFA) | Reference compound | |
| HY-151111 | SPH3127 | 1399849-02-5 | Reference compound |
| HY-151113 | ZINC000104379474 | 1135190-41-8 | Reference compound |
| HY-151115 | JNJ-1289 | 792898-18-1 | Reference compound |
| HY-151116 | HER2-IN-10 | 1059177-03-5 | Reference compound |
| HY-151117S | Methylacetylene-d4 | 6111-63-3 | Isotope-Labeled Compounds |
| HY-151118 | HER2-IN-11 | Reference compound | |
| HY-151119 | Anticancer agent 78 | Reference compound | |
| HY-15112 | JTP-4819 | 162203-65-8 | Reference compound |
| HY-151120 | Anticancer agent 79 | Reference compound | |
| HY-151121 | Anticancer agent 80 | Reference compound | |
| HY-151122S | Methylacetylene-d1 | 7299-37-8 | Isotope-Labeled Compounds |
| HY-151123 | Pelacarsen | 1637637-70-7 | Oligonucleotides |
| HY-151123A | Pelacarsen (sodium) | 2172851-58-8 | Oligonucleotides |
| HY-151124S | n-Tetracontane-d82 | 1219802-99-9 | Isotope-Labeled Compounds |
| HY-151129 | nAChR-IN-1 | 849461-90-1 | Reference compound |
| HY-15113 | Y-29794 | 129184-48-1 | Reference compound |
| HY-151130S | 3′,4′-Dibenzyloxyaceto-phenone-d3 | 344299-53-2 | Isotope-Labeled Compounds |
| HY-151131S | Tri-iso-propyl-d21-phosphine carbon disulfide complex-d21 | 1219798-41-0 | Isotope-Labeled Compounds |
| HY-151132 | Glutaminyl cyclases-IN-1 | 3032400-33-9 | Reference compound |
| HY-151133 | Antiparasitic agent-9 | 2516237-50-4 | Reference compound |
| HY-151134 | HBV-IN-25 | 2161364-69-6 | Reference compound |
| HY-151135 | α-Glucosidase-IN-15 | 2820424-85-7 | Reference compound |
| HY-151136 | DY-46-2 | 1105110-83-5 | Reference compound |
| HY-151137 | HSP90/mTOR-IN-1 | 3033543-67-5 | Reference compound |
| HY-151138 | α-Glucosidase-IN-16 | 1606142-34-0 | Reference compound |
| HY-151139 | LJ-4517 | 2988849-20-1 | Reference compound |
| HY-15113A | Y-29794 (tosylate) | 143984-17-2 | Reference compound |
| HY-15114 | S 17092 | 176797-26-5 | Reference compound |
| HY-151140 | CYP11B1-IN-2 | Reference compound | |
| HY-151141 | α-Glucosidase-IN-17 | 2820424-84-6 | Reference compound |
| HY-151142 | α-Glucosidase-IN-18 | 2820424-81-3 | Reference compound |
| HY-151143 | α-Glucosidase-IN-19 | Reference compound | |
| HY-151144 | α-Glucosidase-IN-20 | 420809-56-9 | Reference compound |
| HY-151145 | α-Glucosidase-IN-21 | 321686-01-5 | Reference compound |
| HY-151146 | (1R,3S)-THCCA-Asn | 1349084-71-4 | Reference compound |
| HY-151148 | Trypanothione synthetase-IN-1 | 2355349-41-4 | Reference compound |
| HY-151149 | Trypanothione synthetase-IN-4 | Reference compound | |
| HY-151150 | Trypanothione synthetase-IN-2 | 3033799-60-6 | Reference compound |
| HY-151151 | Trypanothione synthetase-IN-3 | 1314875-96-1 | Reference compound |
| HY-151152 | AChE-IN-24 | 3033542-32-1 | Reference compound |
| HY-151153 | HDAC1-IN-5 | Reference compound | |
| HY-151154 | EGFR/HER2/DHFR-IN-1 | 2820126-37-0 | Reference compound |
| HY-151155 | ALK-IN-23 | 3033549-18-4 | Reference compound |
| HY-151156 | EGFR/HER2-IN-6 | 2820126-50-7 | Reference compound |
| HY-151158 | EGFR/HER2-IN-7 | 2820126-28-9 | Reference compound |
| HY-151159 | DHFR-IN-4 | 2820126-49-4 | Reference compound |
| HY-15116 | ONO 1603 | 117427-00-6 | Reference compound |
| HY-151160 | LasR-IN-1 | 3033530-75-2 | Reference compound |
| HY-151161 | EGFR/HER2-IN-8 | 2820126-32-5 | Reference compound |
| HY-151162 | HER2-IN-12 | 2820126-51-8 | Reference compound |
| HY-151164 | LasR-IN-2 | 3033530-61-6 | Reference compound |
| HY-151165 | LasR-IN-3 | 2810894-92-7 | Reference compound |
| HY-151165R | LasR-IN-3 (Standard) | 2810894-92-7 | Reference Standards |
| HY-151166 | β-Glucuronidase-IN-2 | Reference compound | |
| HY-151167 | LasR-IN-4 | 183488-96-2 | Reference compound |
| HY-151168 | 3-Chlorogentisyl alcohol | 32744-80-2 | Reference compound |
| HY-151169 | MDM2/4-p53-IN-1 | 3037300-57-2 | Reference compound |
| HY-151170 | MDM2/4-p53-IN-2 | 3037300-49-2 | Reference compound |
| HY-151171 | MDM2/4-p53-IN-3 | Reference compound | |
| HY-151172 | MDM2-p53-IN-15 | Reference compound | |
| HY-151173 | XO/COX/LOX-IN-1 | 2831329-35-0 | Reference compound |
| HY-151174 | PDE4-IN-12 | 2901084-32-8 | Reference compound |
| HY-151175S | (±)-2-Methylbutyryl chloride-d9 | 1219795-10-4 | Isotope-Labeled Compounds |
| HY-151176S | L-Methionine-methyl-sulfonium-d6 (chloride hydrochloride) | 63889-27-0 | Isotope-Labeled Compounds |
| HY-151180S | o-Tolyl-Isocyanated7 | 1219802-73-9 | Isotope-Labeled Compounds |
| HY-151182S | 1,3-Propane-dithiol-d6 | 1219803-51-6 | Isotope-Labeled Compounds |
| HY-151183S | N-Acetyl-S-phenyl-DL-cysteine-3,3-d2 | Isotope-Labeled Compounds | |
| HY-151185 | Sirt2-IN-7 | Reference compound | |
| HY-151186S | 4-n-Octyl-anisole-d17 | 1219794-56-5 | Isotope-Labeled Compounds |
| HY-151187S | 4-n-Butylanisole-2,3,5,6-d4 | 1219804-78-0 | Isotope-Labeled Compounds |
| HY-151188 | DHU-Se1 | Reference compound | |
| HY-151189 | ROCK-IN-4 | 2488395-07-7 | Reference compound |
| HY-151190 | cis-4-Br-2,5-F2-PCPA | 2821068-03-3 | Reference compound |
| HY-151191 | LSD1-IN-22 | 2821068-05-5 | Reference compound |
| HY-151192 | LSD1/2-IN-3 | 2821068-07-7 | Reference compound |
| HY-151193 | NNMT-IN-3 | 3031493-74-7 | Reference compound |
| HY-151194 | LSD1/2-IN-4 | 2821068-09-9 | Reference compound |
| HY-151195 | 20S Proteasome-IN-4 | 2827061-47-0 | Reference compound |
| HY-151196 | FXIa-IN-10 | 2816108-08-2 | Reference compound |
| HY-151197 | HIV protease-IN-1 | 2511547-82-1 | Reference compound |
| HY-151198 | CHF-6366 | 1615208-41-7 | Reference compound |
| HY-151199 | Steroid sulfatase/17β-HSD1-IN-1 | 2990549-70-5 | Reference compound |
| HY-151200 | Steroid sulfatase-IN-4 | 2990549-73-8 | Reference compound |
| HY-151201 | Steroid sulfatase/17β-HSD1-IN-3 | 2990549-76-1 | Reference compound |
| HY-151202 | Steroid sulfatase/17β-HSD1-IN-4 | 2990549-94-3 | Reference compound |
| HY-151203 | PKG1α activator 3 | 2773367-58-9 | Reference compound |
| HY-151204 | PknB-IN-1 | 1447917-39-6 | Reference compound |
| HY-151205 | Antituberculosis agent-3 | 369606-71-3 | Reference compound |
| HY-151206 | PknB-IN-2 | 500015-22-5 | Reference compound |
| HY-151207 | Anticancer agent 81 | 2820286-56-2 | ADC Related |
| HY-151208 | MAO-B-IN-16 | 1021238-13-0 | Reference compound |
| HY-151209 | MAO-B-IN-15 | 2032436-79-4 | Reference compound |
| HY-15121 | L-Theanine | 3081-61-6 | Natural Products |
| HY-151210 | MAO-B-IN-17 | 2890188-81-3 | Reference compound |
| HY-151211 | BTK-IN-16 | 2883232-92-4 | Reference compound |
| HY-151212 | BCP-T.A | 2786829-70-5 | Reference compound |
| HY-151214S | 4-Fluorobenzoyl-2,3,5,6-d4 chloride | 1071809-52-3 | Isotope-Labeled Compounds |
| HY-151215S | S-Sulfo-DL-cysteine-2,3,3-d3-1 | Isotope-Labeled Compounds | |
| HY-151216S | rel-Paroxetine-d4 (hydrochloride) | 1217683-35-6 | Isotope-Labeled Compounds |
| HY-151217 | Ipronidazole | 14885-29-1 | Reference compound |
| HY-151217R | Ipronidazole (Standard) | 14885-29-1 | Reference Standards |
| HY-15121R | L-Theanine (Standard) | 3081-61-6 | Reference Standards |
| HY-15121S | L-Theanine-d5 | 1217451-85-8 | Isotope-Labeled Compounds |
| HY-15121S1 | L-Theanine-13C2,15N2 | Isotope-Labeled Compounds | |
| HY-15122 | Sinomenine | 115-53-7 | Natural Products |
| HY-151220 | Androgen receptor-IN-4 | 2759137-87-4 | Reference compound |
| HY-151221 | CID 697851 | 312508-42-2 | Reference compound |
| HY-151223 | D-Glyceraldehyde 3-phosphate | 591-57-1 | Reference compound |
| HY-151224 | Thermospermine | 70862-11-2 | Reference compound |
| HY-151224R | Thermospermine (Standard) | 70862-11-2 | Reference Standards |
| HY-151226 | Glyceryl monostearate | 31566-31-1 | Reference compound |
| HY-151227 | VL285 Phenol | 1448188-69-9 | Reference compound |
| HY-151229 | S-Methyl-N,N-diethylthiolcarbamate | 686-07-7 | Reference compound |
| HY-15122A | Sinomenine hydrochloride | 6080-33-7 | Natural Products |
| HY-15122AR | Sinomenine hydrochloride (Standard) | 6080-33-7 | Reference Standards |
| HY-15122R | Sinomenine (Standard) | 115-53-7 | Reference Standards |
| HY-15123 | (S)-Flurbiprofen | 51543-39-6 | Reference compound |
| HY-151230 | (-)-Erteberel | 533884-08-1 | Reference compound |
| HY-151231 | 6-Hydroxyluteolin | 18003-33-3 | Natural Products |
| HY-151232 | Rilzabrutinib | 1575591-66-0 | Reference compound |
| HY-151233 | ALK5-IN-10 | 1352608-94-6 | Reference compound |
| HY-151236 | Antitubercular agent-30 | 384857-54-9 | Reference compound |
| HY-151239 | ONT-993 | 937263-81-5 | Reference compound |
| HY-15123R | (S)-Flurbiprofen (Standard) | 51543-39-6 | Reference Standards |
| HY-15124 | (S)-(-)-Bay-K-8644 | 98625-26-4 | Reference compound |
| HY-151240 | Galactosylceramide | 85305-88-0 | Reference compound |
| HY-151241 | Sinomenine N-oxide | 1000026-77-6 | Natural Products |
| HY-151243 | NCATS-SM1441 | 1964517-04-1 | Reference compound |
| HY-151245 | Neolinustatin | 72229-42-6 | Natural Products |
| HY-151247 | GnRH-R antagonist 1 | 2826273-90-7 | Reference compound |
| HY-151248 | HDAC2-IN-1 | 2919691-32-8 | Reference compound |
| HY-15125 | (R)-(+)-Bay-K-8644 | 98791-67-4 | Reference compound |
| HY-151250 | HIV-1 protease-IN-7 | 2916441-36-4 | Peptides |
| HY-151251 | CYP2C9/CYP2C19-IN-1 | 3010895-55-0 | Reference compound |
| HY-151252 | NIC-0102 | 2806031-94-5 | Reference compound |
| HY-151253 | CYP2C1/CYP2C19-IN-2 | 3010895-54-9 | Reference compound |
| HY-151254 | CYP2C19-IN-1 | 3010895-53-8 | Reference compound |
| HY-151255 | CDK8-IN-9 | 2850253-95-9 | Reference compound |
| HY-151256 | JAK-2/3-IN-2 | 2170398-48-6 | Reference compound |
| HY-151257 | IHMT-MST1-58 | 2414484-25-4 | Reference compound |
| HY-151258 | TK4g | 2232890-86-5 | Reference compound |
| HY-151259 | TK4b | 2232890-81-0 | Reference compound |
| HY-151260 | AChE/BACE1/GSK3β-IN-1 | 2866066-81-9 | Reference compound |
| HY-151261 | HDAC6-IN-13 | 2837128-41-1 | Reference compound |
| HY-151262 | JAK-IN-23 | 3031837-35-8 | Reference compound |
| HY-151263 | G4/HDAC-IN-1 | 3031784-60-5 | Reference compound |
| HY-151264 | BSP16 | 2727249-47-8 | Reference compound |
| HY-151265 | MMT5-14 | 2719679-31-7 | Reference compound |
| HY-151266 | AR antagonist 4 | 2883447-45-6 | Reference compound |
| HY-151267 | SARS-CoV-2-IN-25 | Reference compound | |
| HY-151267A | SARS-CoV-2-IN-25 (disodium) | Reference compound | |
| HY-151269 | SARS-CoV-2-IN-26 | Reference compound | |
| HY-151269A | SARS-CoV-2-IN-23 (disodium) | Reference compound | |
| HY-15127 | Isotretinoin | 4759-48-2 | Reference compound |
| HY-151270 | ALK5-IN-25 | 2785430-81-9 | Reference compound |
| HY-151271 | SARS-CoV-2-IN-27 | Reference compound | |
| HY-151271A | SARS-CoV-2-IN-27 (disodium) | Reference compound | |
| HY-151272 | ALK5-IN-26 | 2785430-82-0 | Reference compound |
| HY-151273 | ALK5-IN-27 | 2785430-83-1 | Reference compound |
| HY-151274 | SARS-CoV-2-IN-28 | Reference compound | |
| HY-151274A | SARS-CoV-2-IN-28 (disodium) | Reference compound | |
| HY-151275 | ALK5-IN-28 | 2785430-84-2 | Reference compound |
| HY-151276 | SARS-CoV-2-IN-29 | Reference compound | |
| HY-151276A | SARS-CoV-2-IN-29 (disodium) | Reference compound | |
| HY-151277 | ALK5-IN-29 | 2785430-85-3 | Reference compound |
| HY-151278 | SARS-CoV-2-IN-30 | Reference compound | |
| HY-151278A | SARS-CoV-2-IN-30 (disodium) | Reference compound | |
| HY-151279 | ALK5-IN-30 | 2785430-86-4 | Reference compound |
| HY-15127R | Isotretinoin (Standard) | 4759-48-2 | Reference Standards |
| HY-15127S | Isotretinoin-d5 | Isotope-Labeled Compounds | |
| HY-15128 | 9-cis-Retinoic acid | 5300-03-8 | Reference compound |
| HY-151280 | Antifungal agent 37 | 2833772-92-0 | Reference compound |
| HY-151281 | ALK5-IN-31 | 2785430-87-5 | Reference compound |
| HY-151282 | ALK5-IN-32 | 2785430-88-6 | Reference compound |
| HY-151283 | ALK5-IN-33 | 2785430-89-7 | Reference compound |
| HY-151284 | Antifungal agent 38 | 2833772-94-2 | Reference compound |
| HY-151285 | JAK-2/3-IN-3 | 2242031-31-6 | Reference compound |
| HY-151286 | Antitumor agent-73 | 2812356-72-0 | Reference compound |
| HY-151287 | KRAS inhibitor-20 | 2411786-32-6 | Reference compound |
| HY-151288 | KRAS inhibitor-21 | 2411786-50-8 | Reference compound |
| HY-151289 | ALK5-IN-34 | 2785430-90-0 | Reference compound |
| HY-15128R | 9-cis-Retinoic acid (Standard) | 5300-03-8 | Reference Standards |
| HY-15129 | O-Phospho-L-serine | 407-41-0 | Natural Products |
| HY-151292 | Antitumor agent-74 | 2827065-28-9 | Reference compound |
| HY-151295 | Antitumor agent-75 | 2827065-29-0 | Reference compound |
| HY-15129R | O-Phospho-L-serine (Standard) | 407-41-0 | Reference Standards |
| HY-15129S | O-Phospho-L-serine-13C3,15N | 2734706-69-3 | Isotope-Labeled Compounds |
| HY-15130 | DL-O-Phosphoserine | 17885-08-4 | Natural Products |
| HY-15130R | DL-O-Phosphoserine (Standard) | 17885-08-4 | Reference Standards |
| HY-15131 | PNRI-299 | 550368-41-7 | Reference compound |
| HY-15133 | PTP1B-IN-3 | 809272-64-8 | Reference compound |
| HY-151335 | KU-177 | 1160952-43-1 | Reference compound |
| HY-151337 | Aha1/Hsp90-IN-1 | 2768265-58-1 | Reference compound |
| HY-151338 | AChE-IN-25 | 2835538-69-5 | Reference compound |
| HY-151339 | Antitubercular agent-31 | 2764818-29-1 | Reference compound |
| HY-15133A | PTP1B-IN-3 (diammonium) | 2702673-78-5 | Reference compound |
| HY-15134 | ONT-093 | 216227-54-2 | Reference compound |
| HY-151340 | Antitubercular agent-32 | 2498762-42-6 | Reference compound |
| HY-151341 | HIF-1/2α-IN-1 | 2827693-99-0 | Reference compound |
| HY-151342 | Ser@TPP@CUR | Reference compound | |
| HY-151344 | HIF-1/2α-IN-2 | 862974-22-9 | Reference compound |
| HY-151348 | BACE1-IN-11 | 1803952-77-3 | Reference compound |
| HY-151350 | SphK2-IN-1 | 2927429-64-7 | Reference compound |
| HY-151351 | SphK2-IN-2 | 2927429-60-3 | Reference compound |
| HY-151352 | DHDPS-IN-1 | 1233344-34-7 | Reference compound |
| HY-151354 | Antibacterial agent 121 | 474099-18-8 | Reference compound |
| HY-151356 | Antibacterial agent 122 | 109310-99-8 | Reference compound |
| HY-151357 | MraY-IN-3 | 2851534-52-4 | Reference compound |
| HY-151358 | SENP2-IN-1 | 2986220-46-4 | Reference compound |
| HY-15136 | Lonafarnib | 193275-84-2 | Reference compound |
| HY-151360 | NHE3-IN-3 | 543734-50-5 | Reference compound |
| HY-151361 | AMPK-IN-3 | 2417674-27-0 | Reference compound |
| HY-151362 | Keap1-Nrf2-IN-14 | 1928782-31-3 | Reference compound |
| HY-151363 | IRAK4-IN-21 | 2170694-04-7 | Reference compound |
| HY-151364 | HDAC6/8/BRPF1-IN-1 | 2484255-65-2 | Reference compound |
| HY-151365 | IRAK4-IN-22 | 2170694-05-8 | Reference compound |
| HY-151366 | HDAC8/BRPF1-IN-1 | 2484255-85-6 | Reference compound |
| HY-151367 | SHR2415 | 2494010-42-1 | Reference compound |
| HY-151368 | AChE/BChE-IN-10 | 2924824-48-4 | Reference compound |
| HY-151369 | AV123 | 233605-81-7 | Reference compound |
| HY-15136B | (Rac)-Lonafarnib | 193275-86-4 | Reference compound |
| HY-15136R | Lonafarnib (Standard) | 193275-84-2 | Reference Standards |
| HY-151370 | AChE-IN-26 | 2977170-10-6 | Reference compound |
| HY-151371 | CDK8-IN-10 | 2457317-40-5 | Reference compound |
| HY-151372 | Protein kinase D inhibitor 1 | 2489320-03-6 | Reference compound |
| HY-151373 | MurA-IN-2 | 2164447-18-9 | Reference compound |
| HY-151374 | 3-IN-PP1 | 2227110-54-3 | Reference compound |
| HY-151375 | CDK9/10/GSK3β-IN-1 | 2423045-06-9 | Reference compound |
| HY-151376 | SAP2-IN-1 | 2512847-37-7 | Reference compound |
| HY-151377 | RET-IN-19 | 2484919-71-1 | Reference compound |
| HY-151379 | EM127 | 1886879-71-5 | Reference compound |
| HY-151380 | LANA-DNA-IN-1 | 2512847-06-0 | Reference compound |
| HY-151381 | hDHODH-IN-10 | 3033087-05-4 | Reference compound |
| HY-151382 | CK2-IN-3 | 2969205-85-2 | Reference compound |
| HY-151383 | DPP-4-IN-1 | 2215027-46-4 | Reference compound |
| HY-151384 | DPP-4-IN-2 | 2133900-95-3 | Reference compound |
| HY-151385 | VVD-118313 | 2875046-27-6 | Reference compound |
| HY-151385A | (R,R)-VVD-118313 | 2875046-31-2 | Reference compound |
| HY-151386 | BChE-IN-13 | 2700896-73-5 | Reference compound |
| HY-151387 | A2AAR antagonist 1 | 1784491-64-0 | Reference compound |
| HY-151388 | hMAO-B/MB-COMT-IN-1 | 254974-70-4 | Reference compound |
| HY-151389 | BChE-IN-14 | 2700896-78-0 | Reference compound |
| HY-151390 | hMAO-B/MB-COMT-IN-2 | 3033106-46-3 | Reference compound |
| HY-151391 | LPA5 antagonist 1 | 2839471-45-1 | Reference compound |
| HY-151392 | LPA5 antagonist 2 | 2839471-44-0 | Reference compound |
| HY-151393 | Tubulin polymerization-IN-32 | Reference compound | |
| HY-151394 | Tubulin polymerization-IN-33 | Reference compound | |
| HY-151395 | Tubulin polymerization-IN-34 | Reference compound | |
| HY-151396 | Tubulin polymerization-IN-35 | Reference compound | |
| HY-151397 | Tubulin polymerization-IN-36 | 2011784-91-9 | Reference compound |
| HY-151398 | Tubulin polymerization-IN-37 | 2011784-92-0 | Reference compound |
| HY-151399 | Antimicrobial agent-5 | 2978694-04-9 | Reference compound |
| HY-151400 | Antimicrobial agent-6 | 2978694-10-7 | Reference compound |
| HY-151401 | Antimicrobial agent-7 | Reference compound | |
| HY-151402 | Antimicrobial agent-8 | 2978694-22-1 | Reference compound |
| HY-151403 | Antimicrobial agent-9 | 2978694-25-4 | Reference compound |
| HY-151404 | Antitumor agent-76 | 2787593-12-6 | Reference compound |
| HY-151405 | Z164597606 | 1050587-57-9 | Reference compound |
| HY-151406 | hCAIX-IN-13 | 2813334-66-4 | Reference compound |
| HY-151407 | CDK1-IN-3 | 3032997-12-6 | Reference compound |
| HY-151408 | CDK1-IN-4 | 3032997-16-0 | Reference compound |
| HY-151409 | CDK1-IN-5 | 3032997-20-6 | Reference compound |
| HY-15141 | Staurosporine | 62996-74-1 | Natural Products |
| HY-151410 | Chitin synthase inhibitor 5 | 3033645-28-9 | Reference compound |
| HY-151411 | RUNX1/ETO tetramerization-IN-1 | 88755-39-9 | Reference compound |
| HY-151412 | T-271 | 1005775-58-5 | Reference compound |
| HY-151413 | MEN 10207 | 126050-12-2 | Peptides |
| HY-151414 | 3'-Deoxyinosine | 13146-72-0 | Reference compound |
| HY-151416 | Chitin synthase inhibitor 6 | 3033645-29-0 | Reference compound |
| HY-151417 | Chitin synthase inhibitor 7 | 3033645-30-3 | Reference compound |
| HY-151418 | Chitin synthase inhibitor 8 | 3033645-31-4 | Reference compound |
| HY-151419 | Chitin synthase inhibitor 9 | 2725074-96-2 | Reference compound |
| HY-15141G | Staurosporine (GMP) | 62996-74-1 | GMP Small Molecules |
| HY-15141R | Staurosporine (Standard) | 62996-74-1 | Reference Standards |
| HY-15142 | Doxorubicin (hydrochloride) | 25316-40-9 | Natural Products |
| HY-151420 | Chitin synthase inhibitor 10 | 2725075-01-2 | Reference compound |
| HY-151421 | Chitin synthase inhibitor 11 | 2725075-04-5 | Reference compound |
| HY-151422 | Chitin synthase inhibitor 12 | 2725075-05-6 | Reference compound |
| HY-151423 | Antifungal agent 39 | 2725074-94-0 | Reference compound |
| HY-151424 | Vimentin-IN-1 | 2319587-80-7 | Reference compound |
| HY-151425 | TDO-IN-1 | 2490672-92-7 | Reference compound |
| HY-151426 | Anticancer agent 83 | 904815-29-8 | Reference compound |
| HY-151427 | TGFβ1-IN-1 | 2348795-14-0 | Reference compound |
| HY-151428 | Antitumor agent-78 | 2870703-23-2 | Reference compound |
| HY-151429 | Antitumor agent-77 | 2870703-21-0 | Reference compound |
| HY-15142A | Doxorubicin | 23214-92-8 | Natural Products |
| HY-15142R | Doxorubicin (hydrochloride) (Standard) | 25316-40-9 | Reference Standards |
| HY-151430 | Nrf2/HO-1 activator 1 | 2883506-60-1 | Reference compound |
| HY-151431 | Nrf2/HO-1 activator 2 | 2883506-31-6 | Reference compound |
| HY-151432 | URAT1 inhibitor 3 | 2850331-30-3 | Reference compound |
| HY-151433 | Antiparasitic agent-10 | 2138480-87-0 | Reference compound |
| HY-151434 | GLS1 Inhibitor-6 | 3033615-55-0 | Reference compound |
| HY-151435 | CCR6 antagonist 1 | 588674-64-0 | Reference compound |
| HY-151436 | ZLMT-12 | 2841473-39-8 | Reference compound |
| HY-151437 | Antifungal agent 40 | Reference compound | |
| HY-151439 | Antifungal agent 41 | Reference compound | |
| HY-15144 | Trichostatin A | 58880-19-6 | Natural Products |
| HY-151440 | Antifungal agent 42 | Reference compound | |
| HY-151441 | LRRK2-IN-5 | 2892451-45-3 | Reference compound |
| HY-151442 | Antifungal agent 43 | Reference compound | |
| HY-151443 | HDAC-IN-47 | Reference compound | |
| HY-151444 | LRRK2-IN-6 | 2892451-17-9 | Reference compound |
| HY-151445 | ZIKV-IN-2 | 910582-16-0 | Reference compound |
| HY-151446 | ZIKV-IN-3 | 947699-46-9 | Reference compound |
| HY-151447 | ZIKV-IN-4 | Reference compound | |
| HY-151448 | ZIKV-IN-5 | Reference compound | |
| HY-15144B | (S)-Trichostatin A | 122292-85-7 | Reference compound |
| HY-15145 | SRT 1720 (monohydrochloride) | 2060259-60-9 | Reference compound |
| HY-151450 | Cav 3.2 inhibitor 1 | 2878598-59-3 | Reference compound |
| HY-151451 | Cav 3.2 inhibitor 2 | 2878598-92-4 | Reference compound |
| HY-151452 | Cav 3.2 inhibitor 3 | 2878598-69-5 | Reference compound |
| HY-151453 | Topoisomerase IIα-IN-4 | 2860554-26-1 | Reference compound |
| HY-151454S | N-Formyl palbociclib-d8 | Isotope-Labeled Compounds | |
| HY-151458 | VEGFR-2/DHFR-IN-1 | 2831498-15-6 | Reference compound |
| HY-151459 | VEGFR-2/DHFR-IN-2 | 2831498-09-8 | Reference compound |
| HY-15145A | SRT 1720 (dihydrochloride) | 2468639-77-0 | Reference compound |
| HY-15146 | NSC 74859 | 501919-59-1 | Reference compound |
| HY-151460 | GCN2-IN-7 | 2396465-33-9 | Reference compound |
| HY-151461 | CHNQD-01255 | 2756173-91-6 | Reference compound |
| HY-151462 | RP-6685 | 2832047-80-8 | Reference compound |
| HY-151463 | CDK8-IN-11 | 2839338-28-0 | Reference compound |
| HY-151463A | CDK8-IN-11 (hydrochloride) | Reference compound | |
| HY-151464 | SHP2/HDAC-IN-1 | 2831230-38-5 | Reference compound |
| HY-151465 | HIF-1α-IN-4 | 2826221-23-0 | Reference compound |
| HY-151466 | HIF-1α-IN-5 | 2826221-10-5 | Reference compound |
| HY-151468 | AIE-Cbz-LD-C7 | 2810130-33-5 | Dye Reagents |
| HY-151469 | Chitinase-IN-4 | 2901040-41-1 | Reference compound |
| HY-15147 | XAV-939 | 284028-89-3 | Reference compound |
| HY-151470 | Chitinase-IN-5 | 2901040-47-7 | Reference compound |
| HY-151471 | Anticancer agent 84 | 2714510-72-0 | Reference compound |
| HY-151472 | hCAIX/XII-IN-6 | 3031666-31-3 | Reference compound |
| HY-151473 | PIKfyve-IN-1 | 2857982-26-2 | Reference compound |
| HY-151474 | SARS-CoV-2-IN-31 | 1017691-52-9 | Reference compound |
| HY-151475 | GID4 Ligand 1 | 3031442-96-0 | Reference compound |
| HY-151476 | GID4 Ligand 2 | 3031442-90-4 | Reference compound |
| HY-151477 | SARS-CoV-2-IN-32 | 96068-42-7 | Reference compound |
| HY-151478 | SARS-CoV-2-IN-33 | 299919-79-2 | Reference compound |
| HY-151479 | GID4 Ligand 3 | 340007-39-8 | Reference compound |
| HY-15147G | XAV-939 (GMP) | 284028-89-3 | GMP Small Molecules |
| HY-15148 | Tipranavir | 174484-41-4 | Reference compound |
| HY-151480 | HP590 | 2971855-37-3 | Reference compound |
| HY-151481 | FXR antagonist 1 | 2295804-68-9 | Reference compound |
| HY-151481A | β-FXR antagonist 1 | 2295804-92-9 | Reference compound |
| HY-151482 | SARS-CoV-2 Mpro-IN-2 | 2768834-39-3 | Reference compound |
| HY-151483 | TK-129 | 3031476-73-7 | Reference compound |
| HY-151484 | Anti-infective agent 4 | 2738381-52-5 | Reference compound |
| HY-151485 | Anti-infective agent 5 | 2738381-47-8 | Reference compound |
| HY-151486 | GLUT1-IN-1 | Reference compound | |
| HY-151487 | CypD-IN-3 | 2651994-75-9 | Reference compound |
| HY-151488 | CypD-IN-4 | 3023438-19-6 | Reference compound |
| HY-151489 | CypE-IN-1 | 3023438-33-4 | Reference compound |
| HY-15148R | Tipranavir (Standard) | 174484-41-4 | Reference Standards |
| HY-15148S1 | Tipranavir-d7 | Isotope-Labeled Compounds | |
| HY-15149 | Romidepsin | 128517-07-7 | Reference compound |
| HY-151493 | CAII-IN-1 | Reference compound | |
| HY-151494 | CAII-IN-2 | Reference compound | |
| HY-151495 | CAII-IN-3 | Reference compound | |
| HY-151496 | H-Cys-Val-2-Nal-Met-OH | 158022-12-9 | Reference compound |
| HY-151497 | Antimicrobial agent-10 | Reference compound | |
| HY-151498 | PXS-4787 | 2409963-50-2 | Reference compound |
| HY-151498A | PXS-4787 (hydrochloride) | 2409964-40-3 | Reference compound |
| HY-151499 | PXS-6302 | 2584947-54-4 | Reference compound |
| HY-151499A | PXS-6302 (hydrochloride) | 2584947-79-3 | Reference compound |
| HY-15149S2 | Romidepsin-d7 | Isotope-Labeled Compounds | |
| HY-15150 | Bemcentinib | 1037624-75-1 | Reference compound |
| HY-151500 | JBSNF-000028 (free base) | 3026599-90-3 | Reference compound |
| HY-151500A | JBSNF-000028 (TFA) | Reference compound | |
| HY-151500B | JBSNF-000028 (hydrochloride) | Reference compound | |
| HY-151501 | Antimicrobial agent-11 | Reference compound | |
| HY-151502 | Antimicrobial agent-12 | Reference compound | |
| HY-151503 | MPM-1 | Reference compound | |
| HY-151504 | Engasertib | 1313439-71-2 | Reference compound |
| HY-151505 | CysOx2 | Dye Reagents | |
| HY-151506 | Phospholipid PL1 | 2274812-94-9 | Biochemical Assay Reagents |
| HY-151507 | 306Oi10 | 2322290-93-5 | Oligonucleotides |
| HY-151508 | Diamino lipid DAL4 | 2939000-43-6 | Biochemical Assay Reagents |
| HY-151509 | A2-Iso5-2DC18 | 2412492-07-8 | Reference compound |
| HY-15150G | Bemcentinib (GMP) | 1037624-75-1 | GMP Small Molecules |
| HY-151510 | A2-Iso5-4DC19 | 2412492-19-2 | Biochemical Assay Reagents |
| HY-151511 | A12-Iso5-2DC18 | 2412492-06-7 | Biochemical Assay Reagents |
| HY-151512 | A12-Iso5-4DC19 | 2412492-20-5 | Biochemical Assay Reagents |
| HY-151513 | Iso5-2DC18 | Reference compound | |
| HY-151514 | Antituberculosis agent-5 | 313981-44-1 | Reference compound |
| HY-151515 | Dopamine D2 receptor agonist-2 | 1610591-93-9 | Reference compound |
| HY-151516 | microRNA-21-IN-2 | 303018-40-8 | Reference compound |
| HY-151517 | SOS1-IN-14 | 2793405-20-4 | Reference compound |
| HY-151518 | Aminopeptidase-IN-1 | 374102-08-6 | Reference compound |
| HY-151519 | SIRT2-IN-9 | 522650-91-5 | Reference compound |
| HY-151520 | Wnt/β-catenin agonist 4 | 912784-79-3 | Reference compound |
| HY-151522 | SIRT2-IN-10 | 296793-09-4 | Reference compound |
| HY-151523 | KRas G12R inhibitor 1 | Reference compound | |
| HY-151524 | Cathepsin K inhibitor 3 | 1694638-70-4 | Reference compound |
| HY-151525 | YAP-TEAD-IN-2 | 2714432-83-2 | Reference compound |
| HY-151526 | LabMol-301 | 1360243-08-8 | Reference compound |
| HY-151527 | PI3K/Akt/CREB activator 1 | 2708177-73-3 | Reference compound |
| HY-151528 | PBRM1-BD2-IN-1 | 1915012-21-3 | Reference compound |
| HY-151529 | PBRM1-BD2-IN-2 | 2819989-57-4 | Reference compound |
| HY-151530 | PBRM1-BD2-IN-3 | 2819989-58-5 | Reference compound |
| HY-151531 | PBRM1-BD2-IN-4 | 2819989-60-9 | Reference compound |
| HY-151532 | PBRM1-BD2-IN-5 | 2819989-61-0 | Reference compound |
| HY-151533 | PBRM1-BD2-IN-6 | 2819989-67-6 | Reference compound |
| HY-151534 | PBRM1-BD2-IN-7 | 2819989-68-7 | Reference compound |
| HY-151535 | SARS-CoV-2 3CLpro-IN-5 | 2913186-57-7 | Reference compound |
| HY-151536 | meso-Benzothiazole-BODIPY 505/515 | Dye Reagents | |
| HY-151537 | Gol-NTR | 2968461-58-5 | Dye Reagents |
| HY-151538 | PBRM1-BD2-IN-8 | 2819989-75-6 | Reference compound |
| HY-151539 | TH470 | 2834739-51-2 | Reference compound |
| HY-15154 | NG 52 | 212779-48-1 | Reference compound |
| HY-151540 | MMP-7-IN-1 | 2865097-05-6 | Reference compound |
| HY-151541 | MLKL-IN-3 | 3031406-27-3 | Reference compound |
| HY-151542 | MLKL-IN-4 | 3031406-17-1 | Reference compound |
| HY-151544 | PNE-Lyso | Dye Reagents | |
| HY-151545 | WNK1-IN-1 | 324022-39-1 | Reference compound |
| HY-151546 | MRS4596 | 2840581-38-4 | Reference compound |
| HY-151547 | MRS4719 | 2840581-32-8 | Reference compound |
| HY-151548 | Mtb-cyt-bd oxidase-IN-1 | Reference compound | |
| HY-151549 | Mtb-cyt-bd oxidase-IN-2 | 1463475-67-3 | Reference compound |
| HY-15155 | MLN0905 | 1228960-69-7 | Reference compound |
| HY-151550 | Mtb-cyt-bd oxidase-IN-3 | Reference compound | |
| HY-151551 | Mtb-cyt-bd oxidase-IN-4 | Reference compound | |
| HY-151552 | Mtb-cyt-bd oxidase-IN-5 | Reference compound | |
| HY-151553 | Mtb-cyt-bd oxidase-IN-6 | 1246461-10-8 | Reference compound |
| HY-151554 | SQ-3 | Reference compound | |
| HY-151555 | Antifungal agent 44 | Reference compound | |
| HY-151556 | Antifungal agent 45 | Reference compound | |
| HY-151559 | Zn-DPA-maytansinoid conjugate 1 | 3034629-04-1 | Reference compound |
| HY-15156 | 1alpha, 24, 25-Trihydroxy VD2 | 457048-34-9 | Reference compound |
| HY-151560 | hDHODH-IN-11 | 2396653-34-0 | Reference compound |
| HY-151561 | WM382 | 2606990-92-3 | Reference compound |
| HY-151562 | AChE/BuChE/MAO-B-IN-1 | 2834758-29-9 | Reference compound |
| HY-151563 | OTUB1/USP8-IN-1 | 2858800-98-1 | Reference compound |
| HY-151563A | OTUB1/USP8-IN-1 (TFA) | Reference compound | |
| HY-151564 | Anticancer agent 85 | 2841658-29-3 | Reference compound |
| HY-151565 | Anticancer agent 86 | 2841406-04-8 | Reference compound |
| HY-151566 | Antifungal agent 46 | 2842067-19-8 | Reference compound |
| HY-151567 | Antibacterial agent 123 | 2615254-55-0 | Reference compound |
| HY-151568 | UCB7362 | Reference compound | |
| HY-151569 | SAHA-OH | 2857098-30-5 | Reference compound |
| HY-15157 | Calcitetrol | 72203-93-1 | Reference compound |
| HY-151570 | Anticancer agent 87 | Reference compound | |
| HY-151571 | ZG1077 | 2670380-82-0 | Reference compound |
| HY-151572 | Anticancer agent 88 | Reference compound | |
| HY-151573 | EGFR/CDK2-IN-1 | 2841405-96-5 | Reference compound |
| HY-151574 | PfGSK3/PfPK6-IN-1 | 2797225-49-9 | Reference compound |
| HY-151575 | PfGSK3/PfPK6-IN-2 | 2797225-47-7 | Reference compound |
| HY-151576 | PRMT5:MEP50 PPI | 3031536-71-4 | Reference compound |
| HY-151577 | STAT3-SH2 domain inhibitor 1 | 2816059-41-1 | Reference compound |
| HY-151578 | DPP IV/hCA II-IN-1 | 2836996-95-1 | Reference compound |
| HY-15158 | SBE13 (Hydrochloride) | 1052532-15-6 | Reference compound |
| HY-151580 | CDK2-IN-14 | 2862836-22-2 | Reference compound |
| HY-151580S | CDK2-IN-14-d3 | 2498658-25-4 | Isotope-Labeled Compounds |
| HY-151581 | HCVcc-IN-1 | 2977251-08-2 | Reference compound |
| HY-151587 | Anticancer agent 89 | 2977251-05-9 | Reference compound |
| HY-151588 | Anticancer agent 90 | 2977251-03-7 | Reference compound |
| HY-151589 | HCVcc-IN-2 | 2977251-02-6 | Reference compound |
| HY-15158A | SBE13 | 775294-82-1 | Reference compound |
| HY-15159 | Cyclapolin 9 | 40533-25-3 | Reference compound |
| HY-151590 | DKFZ-748 | 2490709-68-5 | Reference compound |
| HY-151591 | SPAA-52 | 2837000-75-4 | Reference compound |
| HY-151592 | Anticancer agent 91 | 2977251-00-4 | Reference compound |
| HY-151593 | dBRD4-BD1 | 2839318-19-1 | Reference compound |
| HY-151594 | iBRD4-BD1 | 2839318-17-9 | Reference compound |
| HY-151594A | iBRD4-BD1 (diTFA) | 2839318-20-4 | Reference compound |
| HY-151595 | Menin-MLL inhibitor-22 | 2851841-61-5 | Reference compound |
| HY-151596 | MAO-A/5-HT2AR-IN-1 | 2769156-00-3 | Reference compound |
| HY-151598 | Pks13-TE inhibitor 2 | 3031462-75-3 | Reference compound |
| HY-151599 | Pks13-TE inhibitor 3 | 3031462-62-8 | Reference compound |
| HY-15160 | TAK-960 | 1137868-52-0 | Reference compound |
| HY-151600 | Transketolase-IN-2 | 2757552-21-7 | Reference compound |
| HY-151604 | Transketolase-IN-3 | 2757552-03-5 | Reference compound |
| HY-151606 | Akt3 degrader 1 | 2836342-69-7 | Reference compound |
| HY-151608 | SARS-CoV-2 Mpro-IN-3 | 3031351-76-2 | Reference compound |
| HY-151609 | PARP7-IN-12 | 2819700-92-8 | Reference compound |
| HY-15160A | TAK-960 (hydrochloride) | 1137868-96-2 | Reference compound |
| HY-15160B | TAK-960 (dihydrochloride) | Reference compound | |
| HY-15160C | TAK-960 (monohydrochloride) | 2108449-45-0 | Reference compound |
| HY-15161 | Ro3280 | 1062243-51-9 | Reference compound |
| HY-151611 | UAMC-00050 | 2842774-51-8 | Reference compound |
| HY-151612 | Anti-infective agent 6 | 2839192-35-5 | Reference compound |
| HY-151613 | MS15 | 3035638-40-2 | Reference compound |
| HY-151613A | MS15 (TFA) | Reference compound | |
| HY-151614 | Anti-infective agent 7 | 2839192-25-3 | Reference compound |
| HY-151615 | DCI-Br-3 | Dye Reagents | |
| HY-151616 | sEH inhibitor-10 | Reference compound | |
| HY-151617 | sEH inhibitor-11 | Reference compound | |
| HY-151618 | Antitumor agent-79 | 2750233-50-0 | Reference compound |
| HY-151619 | sEH inhibitor-12 | Reference compound | |
| HY-15162 | Monomethyl auristatin E | 474645-27-7 | ADC Related |
| HY-151620 | Antitumor agent-80 | 2758520-84-0 | Reference compound |
| HY-151621 | sEH inhibitor-13 | Reference compound | |
| HY-151622 | PI3K/mTOR Inhibitor-11 | 2845104-25-6 | Reference compound |
| HY-151623 | ACBI2 | 2913161-19-8 | Reference compound |
| HY-151624 | PARP-2-IN-2 | 2915651-00-0 | Reference compound |
| HY-151625 | PARP-2-IN-3 | 2915650-86-9 | Reference compound |
| HY-151626 | MRV03-037 | 2797066-16-9 | Reference compound |
| HY-151627 | 11β-HSD1-IN-11 | 859721-81-6 | Reference compound |
| HY-151628 | MRV03-068 | 2797066-17-0 | Reference compound |
| HY-151629 | MRV03-069 | 2797066-18-1 | Reference compound |
| HY-15162A | MMAE-d8 | 2070009-72-0 | Isotope-Labeled Compounds |
| HY-15162G | Monomethyl auristatin E (GMP) | 474645-27-7 | GMP Small Molecules |
| HY-15162R | Monomethyl auristatin E (Standard) | 474645-27-7 | Reference Standards |
| HY-15163 | Zotiraciclib | 1204918-72-8 | Reference compound |
| HY-151630 | hCAIX-IN-16 | 2849348-38-3 | Reference compound |
| HY-151631 | MRV03-070 | 2797066-20-5 | Reference compound |
| HY-151632 | hCAIX-IN-15 | 2849348-43-0 | Reference compound |
| HY-151633 | hCAIX-IN-14 | 77113-78-1 | Reference compound |
| HY-151634 | Syk-IN-6 | 3018859-95-2 | Reference compound |
| HY-151635 | PI3K/VEGFR2-IN-1 | 2851067-08-6 | Reference compound |
| HY-151636 | 10-Undecynoyl-OSu | 1006592-57-9 | Reference compound |
| HY-151637 | Fmoc-N-propargyl-MPBA | 1009362-00-8 | Reference compound |
| HY-151638 | FMOC-3-azido-D-alanine | 1016163-79-3 | Reference compound |
| HY-151639 | (2S,4R)-H-L-Pro(4-N3)-OH | 1019849-13-8 | Reference compound |
| HY-151639A | (2S,4R)-H-L-Pro(4-N3)-OH (hydrochloride) | Reference compound | |
| HY-15163A | Zotiraciclib (hydrochloride) | 1354567-82-0 | Reference compound |
| HY-15164 | Icotinib (Hydrochloride) | 1204313-51-8 | Reference compound |
| HY-151640 | Fmoc-DAP-N3 | 1021422-85-4 | Reference compound |
| HY-151641 | 3-Azido-L-alanine | 105661-40-3 | Peptides |
| HY-151642 | 3-Azido-D-alanine | 105928-88-9 | Reference compound |
| HY-151642A | 3-Azido-D-alanine (hydrochloride) | 1379690-01-3 | Reference compound |
| HY-151643 | beta-Glc-TEG-Alkyne | 1072903-76-4 | Reference compound |
| HY-151644 | Fluorescein hydrazide | 78044-20-9 | Dye Reagents |
| HY-151645 | Alkyne-SNAP | 1104822-07-2 | Reference compound |
| HY-151646 | Alkyne-PEG5-SNAP | Reference compound | |
| HY-151647 | 3-Azidopropanoic acid-PFP ester | 1240801-10-8 | Reference compound |
| HY-151648 | Bis-propargyl-PEG18 | Reference compound | |
| HY-151649 | Biotin-PEG(4)-SS-Alkyne | 1260247-54-8 | Reference compound |
| HY-15164A | Icotinib | 610798-31-7 | Reference compound |
| HY-15164AR | Icotinib (Standard) | 610798-31-7 | Reference Standards |
| HY-15164AS | Icotinib-d4 | 1567366-82-8 | Isotope-Labeled Compounds |
| HY-151650 | N3-O2Oc-O2Oc-OH | 1254054-60-8 | Reference compound |
| HY-151651 | Hexaethylene glycol phosphoramidite | 125607-09-2 | Reference compound |
| HY-151652 | Boc-L-Cys(Propargyl)-OH | 1260119-25-2 | Reference compound |
| HY-151652A | Boc-L-Cys(Propargyl)-OH (DCHA) | Reference compound | |
| HY-151653 | H-D-Tyr(Propargyl)-OH | 1170674-20-0 | Reference compound |
| HY-151654 | N3-D-Lys(Boc)-OH | 1178899-92-7 | Reference compound |
| HY-151655 | 11-Azidoundecanoic acid | 118162-45-1 | Reference compound |
| HY-151656 | 15-Azido-pentadecanoic acid | 118162-46-2 | Reference compound |
| HY-151657 | Spermine(N3BBB) | 1190203-80-5 | Reference compound |
| HY-151658 | H-L-Lys(N3-Gly)-OH | 1198617-82-1 | Reference compound |
| HY-151658A | H-L-Lys(N3-Gly)-OH (hydrochloride) | Reference compound | |
| HY-151659 | Fmoc-L-Lys(N3-Gly)-OH | 1198617-89-8 | Reference compound |
| HY-15166 | (E/Z)-Zotiraciclib | 937270-47-8 | Reference compound |
| HY-151660 | Fmoc-D-Lys(N3)-OH | 1198791-53-5 | Reference compound |
| HY-151661 | N3-L-Val-OH (CHA) | 1217462-63-9 | Reference compound |
| HY-151662 | 4-Azido-2,3,5,6-tetrafluorobenzoic Acid | 122590-77-6 | Dye Reagents |
| HY-151663 | Fmoc-Abu(3-N3) (2R,3R) | 1229394-75-5 | Reference compound |
| HY-151664 | H-alpha-Prg-D-Ala-OH | 1231709-27-5 | Reference compound |
| HY-151665 | Alkyne-PEG2-iodide | 1234387-33-7 | Reference compound |
| HY-151666 | 6-Azido-D-lysine | 1418009-93-4 | Reference compound |
| HY-151666A | 6-Azido-D-lysine (hydrochloride) | 2098497-01-7 | Reference compound |
| HY-151667 | Biotin-C5-Azide | 1260586-88-6 | Dye Reagents |
| HY-151668 | Z-L-Aha-OH | 1263047-43-3 | Reference compound |
| HY-151668A | Z-L-Aha-OH (DCHA) | 1423018-09-0 | Reference compound |
| HY-151669 | Fmoc-D-Aha-OH | 1263047-53-5 | Reference compound |
| HY-15166A | (E/Z)-Zotiraciclib (hydrochloride) | 1321626-25-8 | Reference compound |
| HY-15166B | (E/Z)-Zotiraciclib (citrate) | 1204918-73-9 | Reference compound |
| HY-15167 | Glyoxalase I inhibitor | 221174-33-0 | Reference compound |
| HY-151670 | Biotin-PEG(4)-SS-Azide | 1260247-52-6 | Reference compound |
| HY-151671 | Fmoc-L-MeLys(N3)-OH | 1263721-14-7 | Reference compound |
| HY-151672 | Biotin-TEG-ATFBA | 1264662-85-2 | Reference compound |
| HY-151673 | Poc-Cystamine | 1266354-28-2 | Reference compound |
| HY-151673A | Poc-Cystamine (hydrochloride) | Reference compound | |
| HY-151674 | N3-L-Cys(Trt)-OH (CHA) | 1286670-90-3 | Reference compound |
| HY-151675 | H-L-Tyr(3-N3)-OH | 129960-90-3 | Reference compound |
| HY-151676 | Boc-L-Tyr(2-azidoethyl)-OH | 1434445-10-9 | Reference compound |
| HY-151677 | (2R,4S)-Boc-D-Pro(4-N3)-OH | 132622-77-6 | Reference compound |
| HY-151677A | (2R,4S)-Boc-D-Pro(4-N3)-OH (DCHA) | Reference compound | |
| HY-151678 | N3-L-Lys(Mtt)-OH | 1333231-26-7 | Reference compound |
| HY-151679 | Fmoc-L-Lys(4-N3-Z)-OH | 1446511-14-3 | Reference compound |
| HY-15167A | Glyoxalase I inhibitor (free base) | 174568-92-4 | Reference compound |
| HY-151680 | TAMRA alkyne, 6-isomer | 1352649-44-5 | Reference compound |
| HY-151681 | (2R,4R)-Fmoc-D-Pro(4-N3)-OH | 1378847-51-8 | Reference compound |
| HY-151682 | H-L-Lys(Norbornene-methoxycarbonyl)-OH | 1378916-76-7 | Reference compound |
| HY-151682A | H-L-Lys(Norbornene-methoxycarbonyl)-OH (hydrochloride) | 2560614-20-0 | Reference compound |
| HY-151683 | H-L-Ser(Propargyl)-OH | 1379150-93-2 | Reference compound |
| HY-151683A | H-L-Ser(Propargyl)-OH (hydrochloride) | 1379006-45-7 | Reference compound |
| HY-151684 | Boc-Ser(O-propargyl)-OH | 145205-94-3 | Reference compound |
| HY-151684A | Boc-Ser(O-propargyl)-OH (DCHA) | Reference compound | |
| HY-151685 | Kdo Azide | 1380099-68-2 | Reference compound |
| HY-151686 | Bz-(Me)Tz-NHS | 1454558-58-7 | Reference compound |
| HY-151687 | Fmoc-L-Tyr(2-azidoethyl)-OH | 1454816-10-4 | Reference compound |
| HY-151688 | 6-O-Propynyl-2'-deoxyguanosine | 1640051-47-3 | ADC Related |
| HY-151689 | (2S,3R)-Fmoc-Abu(3-N3)-OH | 146306-79-8 | Reference compound |
| HY-151690 | FAM hydrazide, 6-isomer | 151890-73-2 | Dye Reagents |
| HY-151691 | Trisulfo-Cy3 Methyltetrazine | 1676067-48-3 | Reference compound |
| HY-151692 | 18-Azido-stearic acid | 1529763-58-3 | Reference compound |
| HY-151693 | H-L-Tyr(2-azidoethyl)-OH (hydrochloride) | 1567845-62-8 | Reference compound |
| HY-151693A | H-L-Tyr(2-azidoethyl)-OH | 1570523-47-5 | Reference compound |
| HY-151694 | H-L-Orn(N3)-OH (hydrochloride) | 1782935-10-7 | Reference compound |
| HY-151695 | Fmoc-L-Lys(Pryoc)-OH | 1584133-25-4 | Reference compound |
| HY-151696 | TCO-PEG3-maleimide | 1809356-72-6 | Reference compound |
| HY-151697 | DACN(Tos2) | 1797508-57-6 | Reference compound |
| HY-151698 | TCO-NHS Ester (axial) | 1610931-22-0 | Reference compound |
| HY-151698A | (S,E)-TCO-NHS Ester | Reference compound | |
| HY-151698B | (R,E)-TCO-NHS Ester | 2829292-74-0 | Reference compound |
| HY-151699 | 6-Azidohexanoyl-Val-Cit-PAB-PNP | 1613321-01-9 | Reference compound |
| HY-151700 | 6-Azidohexanoyl-Val-Cit-PAB | 1613321-02-0 | Reference compound |
| HY-151701 | DiSulfo-Cy5 alkyne | 1617497-19-4 | Dye Reagents |
| HY-151701A | DiSulfo-Cy5 alkyne (TEA) | Dye Reagents | |
| HY-151702 | (2S)-N3-IsoSer | 1620171-65-4 | Oligonucleotides |
| HY-151702A | (2S)-N3-IsoSer (DCHA) | Reference compound | |
| HY-151703 | Boc-D-Lys(N3)-OH | 1620410-04-9 | Reference compound |
| HY-151703A | Boc-D-Lys(N3)-OH (CHA) | 1858224-39-1 | Reference compound |
| HY-151704 | ICG-alkyne | 1622335-41-4 | Reference compound |
| HY-151705 | Alkyne Cholesterol | 1631985-09-5 | Reference compound |
| HY-151706S | Temazepam glucuronide-d5 | Isotope-Labeled Compounds | |
| HY-151707 | DACN(Tos,Ns) | 1797508-58-7 | Reference compound |
| HY-151708 | CalFluor 488 Azide | 1798305-98-2 | Dye Reagents |
| HY-151709 | N3-L-Cit-OH | 1799421-66-1 | Reference compound |
| HY-151709A | N3-L-Cit-OH (DCHA) | 2737202-65-0 | Reference compound |
| HY-151710 | Sulfo-Cy3 Azide | 1801695-56-6 | Dye Reagents |
| HY-151711 | Sulfo-Cy5.5 Azide | 1955527-41-9 | Dye Reagents |
| HY-151712 | Sulfo-Cy5-Methyltetrazine | 1801924-46-8 | Dye Reagents |
| HY-151713 | Sulfo-Cy3-Methyltetrazine | 1801924-47-9 | Dye Reagents |
| HY-151714 | Biotin-MeTz | 1802883-51-7 | Reference compound |
| HY-151715 | N3-D-Dap(Fmoc)-OH | 1807631-13-5 | Reference compound |
| HY-151716 | Halo-DBCO | 1808119-16-5 | Reference compound |
| HY-151717 | N1-Azido-spermine (trihydrochloride) | 1823475-98-4 | Reference compound |
| HY-151718 | Boc-L-Tyr(PEG(3)-N3)-OH | 1831059-64-3 | Reference compound |
| HY-151718A | Boc-L-Tyr(PEG(3)-N3)-OH (DCHA) | Reference compound | |
| HY-151719 | Azidoacetic Acid | 18523-48-3 | Reference compound |
| HY-151720 | Cy5.5 DBCO | 1857352-95-4 | Reference compound |
| HY-151721 | H-D-Orn(N3)-OH (hydrochloride) | 1858224-08-4 | Reference compound |
| HY-151722 | Boc-D-Orn(N3)-OH (CHA) | 1858224-18-6 | Reference compound |
| HY-151723 | H-D-Aha-OH (hydrochloride) | 1858224-26-6 | Reference compound |
| HY-151724 | N3-Pen-Dde | 1867129-38-1 | Reference compound |
| HY-151725 | N3-Pen-Dtpp | 1867129-42-7 | Reference compound |
| HY-151726 | Azido-PEG(4)-Val-Cit-PAB-PNP | 1869126-60-2 | Reference compound |
| HY-151727 | Norbornene-NHS | 1888335-48-5 | Reference compound |
| HY-151728 | Trisulfo-Cy3-Alkyne | 1895849-34-9 | Dye Reagents |
| HY-151729 | N3-D-Dab(Boc)-OH | 1922891-74-4 | Reference compound |
| HY-151730 | (Me)Tz-butanoic acid | 1923268-81-8 | Reference compound |
| HY-151731 | N3-1,4-trans-CHC-OH | 1931895-14-5 | Reference compound |
| HY-151732 | Z-D-Dbu(N3)-OH | 1931958-82-5 | Reference compound |
| HY-151733 | Fmoc-D-Dbu(N3)-OH | 1932023-47-6 | Reference compound |
| HY-151734 | (2R,3S)-Fmoc-Abu(3-N3)-OH | 1932349-21-7 | Reference compound |
| HY-151735 | N3-L-Dab(Boc)-OH | 1932403-71-8 | Reference compound |
| HY-151736 | N3-L-Dap(Boc)-OH | 1932432-15-9 | Reference compound |
| HY-151737 | Z-L-Dbu(N3)-OH | 1932657-23-2 | Reference compound |
| HY-151738 | Fmoc-Aeg(N3)-OH | 1935981-35-3 | Reference compound |
| HY-151739 | 4-Pentynoyl-Val-Ala-PAB | 1956294-75-9 | Reference compound |
| HY-15174 | Dactolisib (Tosylate) | 1028385-32-1 | Reference compound |
| HY-151740 | 4-Pentynoyl-Val-Ala-PAB-PNP | 1956294-76-0 | ADC Related |
| HY-151741 | Biotin-PEG4-MeTz | 1962919-31-8 | Reference compound |
| HY-151742 | Norbornene-methyl-NHS | 1986791-87-0 | Reference compound |
| HY-151743 | N3-Cystamine-Suc-OSu | 1987341-40-1 | Reference compound |
| HY-151744 | N3-TFBA-O2Oc | 1993119-45-1 | Reference compound |
| HY-151745 | N3-TOTA-Suc | 1993176-74-1 | Reference compound |
| HY-151746 | N3-Gly-Gly-Gly-OH | 1993176-75-2 | Reference compound |
| HY-151747 | Chemical phosphorylation amidite | 202284-84-2 | Reference compound |
| HY-151748 | N3-L-Orn(Fmoc)-OH | 1994267-98-9 | Reference compound |
| HY-151749 | N3-D-Lys(Fmoc)-OH | 1994300-35-4 | Reference compound |
| HY-151750 | Pyrene phosphoramidite dU | 199920-17-7 | Dye Reagents |
| HY-151751 | BDP TMR alkyne | 2006345-32-8 | Dye Reagents |
| HY-151752 | Mal-AMCHC-N-Propargylamide | 2027476-42-0 | Reference compound |
| HY-151753 | Trisulfo-Cy5.5-Alkyne | 2055046-12-1 | Dye Reagents |
| HY-151754 | DACN(Tos2,6-OH) | 2109751-74-6 | Reference compound |
| HY-151755 | Sulfo-Cy3-Tetrazine | 2055138-86-6 | Dye Reagents |
| HY-151756 | diSulfo-Cy3 alkyne | 2055138-88-8 | Dye Reagents |
| HY-151757 | Trisulfo-Cy5-Alkyne | 2055138-90-2 | Dye Reagents |
| HY-151758 | Methyltetrazine-PEG12-NHS ester | Reference compound | |
| HY-151759 | Sulfo-Cy5-TCO | 2129525-69-3 | Dye Reagents |
| HY-15176 | Pyridostatin | 1085412-37-8 | Reference compound |
| HY-151760 | (2R,4S)-H-D-Pro(4-N3)-OH | 2137086-50-9 | Reference compound |
| HY-151760A | (2R,4S)-H-D-Pro(4-N3)-OH (hydrochloride) | Reference compound | |
| HY-151761 | H-L-Lys(4-N3-Z)-OH (hydrochloride) | 2084913-49-3 | Reference compound |
| HY-151762 | (2R,4S)-Fmoc-D-Pro(4-N3)-OH | 2137142-63-1 | Reference compound |
| HY-151763 | Boc-L-Aza-OH (CHA) | 2098496-88-7 | Reference compound |
| HY-151764 | N3-D-Orn(Boc)-OH | 2165877-62-1 | ADC Related |
| HY-151764A | N3-D-Orn(Boc)-OH (CHA) | ADC Related | |
| HY-151766 | DACN(Tos,Suc-OH) | 2109751-68-8 | Reference compound |
| HY-151767 | Boc-Cystamine-Poc | 2171512-56-2 | Reference compound |
| HY-151768 | H2N-PEG2-N3 (TosOH) | 2173092-98-1 | Reference compound |
| HY-151769 | TCO-PEG2-Sulfo-NHS ester-EDC Urea | 2353409-48-8 | Reference compound |
| HY-15176A | Pyridostatin (hydrochloride) | 1781882-65-2 | Reference compound |
| HY-15176B | Pyridostatin (TFA) | 1472611-44-1 | Reference compound |
| HY-15177 | PF-04691502 | 1013101-36-4 | Reference compound |
| HY-151771 | DACN(Tos,Mal) | 2411082-28-3 | Reference compound |
| HY-151772 | Methyltetrazine-PEG12-t-butyl ester | Reference compound | |
| HY-151773 | Methyltetrazine-PEG12-acid | Reference compound | |
| HY-151774 | TAMRA hydrazide (6-isomer) | 2183440-67-5 | Dye Reagents |
| HY-151775 | BDP tr azide | 2183473-27-8 | Dye Reagents |
| HY-151776 | Cy3 methyltetrazine | 2183473-57-4 | Dye Reagents |
| HY-151777 | N3-Gly-Gly-Gly-Gly-Gly-OH | 2250433-77-1 | Reference compound |
| HY-151778 | Fmoc-Abg(N3)-OH | 2250433-81-7 | Reference compound |
| HY-151779 | N3-L-Dab(Fmoc)-OH | 2250436-44-1 | Reference compound |
| HY-15178 | Oglemilast | 778576-62-8 | Reference compound |
| HY-151780 | Fmoc-L-Dap(Pentynoyl)-OH | 2250436-47-4 | Reference compound |
| HY-151781 | Fmoc-L-Dap(Poc)-OH | 2250437-44-4 | Reference compound |
| HY-151782 | H-(Gly)3-Lys(N3)-OH | 2250437-45-5 | Reference compound |
| HY-151782A | H-(Gly)3-Lys(N3)-OH (hydrochloride) | 2737202-70-7 | Reference compound |
| HY-151783 | DAPOA | 2389064-43-9 | Reference compound |
| HY-151783A | DAPOA (DCHA) | Reference compound | |
| HY-151784 | Boc-D-Aza-OH | 225780-77-8 | Reference compound |
| HY-151785 | H-L-Dbu(N3)-OH | 2389078-78-6 | Reference compound |
| HY-151785A | H-L-Dbu(N3)-OH (hydrochloride) | Reference compound | |
| HY-151786 | Fmoc-L-Lys(Pentynoyl-DIM)-OH | 2408993-33-7 | Reference compound |
| HY-151787 | Fmoc-L-Lys(N3-Aca-DIM)-OH | 2408993-39-3 | Reference compound |
| HY-151788 | MeO-PEG-alkyne (MW 750Da) | Reference compound | |
| HY-151789 | Sulfo DBCO-TFP Ester | 2268816-76-6 | Reference compound |
| HY-151790 | Alkyne-SS-COOH | 2279938-29-1 | Reference compound |
| HY-151791 | (S,R,S)-AHPC-C6-PEG3-butyl-N3 | 2300155-90-0 | Reference compound |
| HY-151792 | Pomalidomid-C6-PEG3-butyl-N3 | 2300178-66-7 | Reference compound |
| HY-151793 | 2-Azidoethyl β-D-lactoside | 230286-11-0 | Reference compound |
| HY-151794 | DACN(Ms) (hydrochloride) | 2331322-16-6 | Reference compound |
| HY-151795 | DACN(Tos) (hydrochloride) | 2331322-18-8 | Reference compound |
| HY-151796 | DACN(Ms,Ns) | 2411082-25-0 | Reference compound |
| HY-151797 | Ph-HTBA | 2368927-41-5 | Reference compound |
| HY-151798 | TDI-11861 | 2857049-72-8 | Reference compound |
| HY-151799 | P62-RNF168 agonist-1 | 2765180-17-2 | Reference compound |
| HY-15180 | Buparlisib (Hydrochloride) | 1312445-63-8 | Reference compound |
| HY-151800 | MAO-A/B-IN-2 | Reference compound | |
| HY-151801 | DIBA-Cy5 | Dye Reagents | |
| HY-151802 | CPUL1 | 2043660-80-4 | Reference compound |
| HY-151805 | RGT-068A | 2577171-33-4 | Reference compound |
| HY-151806 | HadAB-IN-1 | 1097120-47-2 | Reference compound |
| HY-151807 | 15-PGDH-IN-1 | 2241676-74-2 | Reference compound |
| HY-151808 | JS25 | 2411771-95-2 | Reference compound |
| HY-151809 | CYP4A11/CYP4F2-IN-1 | 502654-40-2 | Reference compound |
| HY-151810 | TP0472993 | 2126874-77-7 | Reference compound |
| HY-151811 | NAQ | Reference compound | |
| HY-151812 | CBP/p300-IN-20 | 2999742-92-4 | Reference compound |
| HY-151813 | NNMT-IN-4 | 2947393-64-6 | Reference compound |
| HY-151814 | (2S,4S)-Fmoc-L-Pro(4-NHPoc)-OH | 2451202-17-6 | Reference compound |
| HY-151815 | beta-Lac-TEG-N3 | 246855-74-3 | Reference compound |
| HY-151816 | alpha-Man-TEG-N3 | 246855-76-5 | Reference compound |
| HY-151817 | 5-Azidomethyl-uridine | 24751-67-5 | Reference compound |
| HY-151818 | 12-Azido-dodecanoyl-OSu | 2489524-00-5 | Reference compound |
| HY-151819 | N3Ac-OPhOMe | 2546513-31-7 | Reference compound |
| HY-15182 | Collagen proline hydroxylase inhibitor-1 | 223663-32-9 | Reference compound |
| HY-151820 | DBCO-PEG24-acid | 2765066-36-0 | Reference compound |
| HY-151821 | Sulfo DBCO-PEG3-acid | 2566404-75-7 | Reference compound |
| HY-151822 | Hydroxy-PEG3-DBCO | 2566404-76-8 | Reference compound |
| HY-151823 | 8-Azido-octanoyl-OSu | 2576471-56-0 | Reference compound |
| HY-151824 | Boc-L-Phe(4-NH-Poc)-OH | 2576508-03-5 | Reference compound |
| HY-151825 | Fmoc-L-Phe(4-NH-Poc)-OH | 2576508-07-9 | Reference compound |
| HY-151826 | Fmoc-D-Lys(pentynoyl)-OH | 2576508-18-2 | Reference compound |
| HY-151827 | DBCO-PEG2-NHS ester | 2585653-12-7 | Reference compound |
| HY-151828 | N3-Gly-Aeg(Fmoc)-OH | 2606227-07-8 | Reference compound |
| HY-151829 | Fmoc-L-Asn(EDA-N3)-OH | 2616562-74-2 | Reference compound |
| HY-15183 | Collagen proline hydroxylase inhibitor | 223666-07-7 | Reference compound |
| HY-151830 | Me-PMeOx(50)-N3 (MW 4.3kDa) | Reference compound | |
| HY-151831 | Me-PMeOx(100)-N3 (MW 8.5kDa) | Reference compound | |
| HY-151833 | Methyltetrazine-amido-N-bis(PEG4-acid) | 2639395-39-2 | Reference compound |
| HY-151834 | DBCO-PEG2-DBCO | 2639395-48-3 | Reference compound |
| HY-151835 | DBCO-PEG24-NHS ester | 2765066-38-2 | Reference compound |
| HY-151836 | (2S,3R)-H-Abu(3-N3)-OH (hydrochloride) | 2737202-63-8 | Reference compound |
| HY-151837 | H-L-Phe(4-NH-Poc)-OH (hydrochloride) | 2737202-66-1 | Reference compound |
| HY-151838 | (2S,3S)-H-Abu(3-N3)-OH (hydrochloride) | 2737202-68-3 | Reference compound |
| HY-151839 | (2R,4R)-H-D-Pro(4-N3)-OH (hydrochloride) | 2737202-69-4 | Reference compound |
| HY-15184 | Elaiophylin | 37318-06-2 | Reference compound |
| HY-151840 | 4-Azidobenzyl alcohol | 31499-54-4 | Reference compound |
| HY-151841 | N3-L-Lys(Boc)-OH | 333366-32-8 | Reference compound |
| HY-151842 | Fmoc-EDA-N3 | 432507-62-5 | Reference compound |
| HY-151843 | N3-L-Lys(Fmoc)-OH | 473430-12-5 | Reference compound |
| HY-151844 | 2-Azido-adenosine | 59587-07-4 | Reference compound |
| HY-151845 | N3-PhAc-OH | 62893-37-2 | Reference compound |
| HY-151846 | Boc-L-Pra-OH (DCHA) | 63039-49-6 | Reference compound |
| HY-151847 | N3-TEMPO | 63697-61-0 | Reference compound |
| HY-151848 | (2R,4R)-Boc-D-Pro(4-N3)-OH | 650601-59-5 | Reference compound |
| HY-151849 | Z-L-Dap(N3)-OH | 684270-44-8 | Reference compound |
| HY-15185 | Nirogacestat | 1290543-63-3 | Reference compound |
| HY-151850 | (2S,4R)-Fmoc-L-Pro(4-N3)-OH | 702679-55-8 | Reference compound |
| HY-151851 | 3-Azidopropanol | 72320-38-8 | Reference compound |
| HY-151852 | 9AzNue5Ac | 76487-51-9 | Reference compound |
| HY-151853A | N3-L-Leu-OH (BHA) | Reference compound | |
| HY-151854 | 4-(Azidomethyl)benzoic acid | 79584-03-5 | Reference compound |
| HY-151855 | Azido Myristic Acid | 80667-36-3 | ADC Related |
| HY-151856 | N3-1,4-cis-CHC-OH | 863222-21-3 | Reference compound |
| HY-151857 | TAMRA azide, 5-isomer | 825651-66-9 | Dye Reagents |
| HY-151858 | Boc-L-Lys(N3)-OH | 846549-33-5 | Reference compound |
| HY-151859 | N3-Gly-Gly-OH | 855750-87-7 | Reference compound |
| HY-151859A | N3-Gly-Gly-OH (DCHA) | 2706488-76-6 | Reference compound |
| HY-15185B | Nirogacestat (dihydrobromide) | 1962925-29-6 | Reference compound |
| HY-15186 | Ipatasertib | 1001264-89-6 | Reference compound |
| HY-151861 | N3-Aca-Aca-OH | 866363-71-5 | Reference compound |
| HY-151862 | 3-Azidopropylamine | 88192-19-2 | Reference compound |
| HY-151863 | alpha-GalNAc-TEG-N3 | 882873-70-3 | Reference compound |
| HY-151864 | DecarboxyBiotin-Alkyne | 887915-53-9 | Reference compound |
| HY-151865 | (2S,4S)-H-L-Pro(4-N3)-OH | 892128-58-4 | Reference compound |
| HY-151865A | (2S,4S)-H-L-Pro(4-N3)-OH (hydrochloride) | Reference compound | |
| HY-151866 | (2S)-N3-HABA | 959148-55-1 | Reference compound |
| HY-151866A | (S)-N3-HABA (DCHA) | Reference compound | |
| HY-151868S | Glycidyl oleate-d5 | 1426395-63-2 | Isotope-Labeled Compounds |
| HY-151869S | Benzenemethanamine,N-(methyl-d3)-,hydrochloride | 122025-10-9 | Isotope-Labeled Compounds |
| HY-15186A | Ipatasertib (dihydrochloride) | 1396257-94-5 | Reference compound |
| HY-15186C | Ipatasertib (tosylate) | 1491138-24-9 | Reference compound |
| HY-15187 | Filanesib | 885060-09-3 | Reference compound |
| HY-151870S | (±)-trans-4-Hydroxy-2-hexenal-5,5,6,6,6-d5 Dimethyl Acetal | 1219806-40-2 | Isotope-Labeled Compounds |
| HY-151871 | ICeD-2 | 3050598-72-3 | Reference compound |
| HY-151872 | HDAC-IN-48 | 3031411-05-6 | Reference compound |
| HY-151873 | SZM679 | 3027645-52-6 | Reference compound |
| HY-151874S | n-Octatriacontane-d78 | 1219803-25-4 | Isotope-Labeled Compounds |
| HY-151875 | MurA-IN-3 | 2866186-38-9 | Reference compound |
| HY-151876 | Glucocorticoid receptor modulator 1 | 2868357-11-1 | Reference compound |
| HY-151877S | Ethyl N-n-Butyl-d9-carbamate | 1276197-24-0 | Isotope-Labeled Compounds |
| HY-151878 | CDK7-IN-20 | 3034210-97-1 | Reference compound |
| HY-151879 | Tubulin inhibitor 30 | 2873383-67-4 | Reference compound |
| HY-15187A | (R)-Filanesib | 885060-08-2 | Reference compound |
| HY-15187B | Filanesib (TFA) | 1781834-99-8 | Reference compound |
| HY-15187C | Filanesib (hydrochloride) | 1385020-40-5 | Reference compound |
| HY-151880 | Antibacterial agent 124 | 2304448-00-6 | Reference compound |
| HY-151881 | SOS1-IN-15 | 2793404-47-2 | Reference compound |
| HY-151882 | EGFR-IN-73 | 2857033-34-0 | Reference compound |
| HY-151883 | APE1-IN-2 | 2923433-95-6 | Reference compound |
| HY-151884 | FUBP1-IN-2 | 1242862-71-0 | Reference compound |
| HY-151885 | Dual AChE-MAO B-IN-3 | Reference compound | |
| HY-151886 | NU223612 | 2759420-43-2 | Reference compound |
| HY-151888 | Anticancer agent 92 | Reference compound | |
| HY-15189 | 17-Aminogeldanamycin | 64202-81-9 | Reference compound |
| HY-151890 | NIR-βgal-2 | Dye Reagents | |
| HY-151891 | TASK-1-IN-1 | 600125-11-9 | Reference compound |
| HY-151892S | Glimepiride-d4(phenylethyl-α,α,β,β-d4)(cis/trans) | 2699607-96-8 | Isotope-Labeled Compounds |
| HY-151893S | 7-Methyl-d3-1-octyl-7,8,8,8-d4 Alcohol | 1794753-02-8 | Isotope-Labeled Compounds |
| HY-151894 | I-BET432 | Reference compound | |
| HY-151895S | (±)-1-Hexadecanoyl-3-chloropropane-d5-diol | 1189718-15-7 | Isotope-Labeled Compounds |
| HY-151896 | HDAC6-IN-14 | 3023019-97-5 | Reference compound |
| HY-151897 | HDAC-IN-49 | Reference compound | |
| HY-151898 | CDK4/6-IN-14 | 2699091-15-9 | Reference compound |
| HY-151899 | A3AR modulator 1 | 2991693-62-8 | Reference compound |
| HY-15190 | NVP-HSP990 | 934343-74-5 | Reference compound |
| HY-151900 | SARS-CoV-2 Mpro-IN-4 | Reference compound | |
| HY-151901 | SARS-CoV-2 Mpro-IN-5 | 3023276-79-8 | Reference compound |
| HY-151902 | SJ988497 | 2595365-41-4 | Reference compound |
| HY-151903S | FGFR2/3-IN-1 | 2640352-86-7 | Isotope-Labeled Compounds |
| HY-151904 | AXL-IN-13 | 2376928-82-2 | Reference compound |
| HY-151905 | D6808 | 3029240-84-1 | Reference compound |
| HY-15191 | Sabutoclax | 1228108-65-3 | Reference compound |
| HY-151910S | (±)-Fluoxetine-d4 Oxalate (trifluoromethylphen-d4-oxy) | 2708283-92-3 | Isotope-Labeled Compounds |
| HY-151910S1 | (±)-Fluoxetine-d5 Oxalate (phenyl-d5) | 1219804-82-6 | Isotope-Labeled Compounds |
| HY-151911S | Mono-Cyclohexyl Phthalate-3,4,5,6-d4 | 1398066-18-6 | Isotope-Labeled Compounds |
| HY-151912S | Picolinafen-d4 (4-Fluorophenyl-d4) | 2469244-77-5 | Isotope-Labeled Compounds |
| HY-151913S | Sebuthylazine-d5 (ethyl-d5) | 1219805-56-7 | Isotope-Labeled Compounds |
| HY-151914 | Antitumor agent-82 | 3037605-45-8 | Reference compound |
| HY-151915 | ATR-IN-20 | 3012609-63-8 | Reference compound |
| HY-151916 | Enpp/Carbonic anhydrase-IN-1 | 2883495-35-8 | Reference compound |
| HY-151917 | Enpp/Carbonic anhydrase-IN-2 | 2883495-39-2 | Reference compound |
| HY-151918 | Antibacterial agent 125 | 1274611-43-6 | Reference compound |
| HY-151919 | FAAH-IN-7 | 3037600-36-2 | Reference compound |
| HY-15191B | (S)-Sabutoclax | 1228178-73-1 | Reference compound |
| HY-15192 | GSK 650394 | 890842-28-1 | Reference compound |
| HY-151920 | BTK-IN-17 | Reference compound | |
| HY-151921 | Anti-inflammatory agent 33 | 2816993-09-4 | Reference compound |
| HY-151923 | ATF3 inducer 1 | 3038756-30-5 | Reference compound |
| HY-151924 | Antiviral agent 23 | 35940-03-5 | Reference compound |
| HY-151925 | Antibacterial agent 126 | Reference compound | |
| HY-151926 | Antiviral agent 24 | 23661-03-2 | Reference compound |
| HY-151927 | AChE-IN-28 | Reference compound | |
| HY-151928 | JNK3 inhibitor-3 | 2873465-25-7 | Reference compound |
| HY-151929 | JNK3 inhibitor-4 | 2409109-65-3 | Reference compound |
| HY-15193 | EMD638683 | 1181770-72-8 | Reference compound |
| HY-151930S | 8′-Hydroxy ABA-d8 | Isotope-Labeled Compounds | |
| HY-151930S1 | 8′-Hydroxy ABA-d2 | Isotope-Labeled Compounds | |
| HY-151931 | JA-ACC | 371778-55-1 | Reference compound |
| HY-151931S | JA-ACC-d3 | Isotope-Labeled Compounds | |
| HY-151932 | FXR agonist 3 | 3037847-72-3 | Reference compound |
| HY-151933 | HIV-1 inhibitor-49 | Reference compound | |
| HY-151934 | ERK-IN-6 | Reference compound | |
| HY-151935 | Antileishmanial agent-13 | 853725-86-7 | Reference compound |
| HY-151936 | LmNADK1-IN-1 | Reference compound | |
| HY-151937 | Antibacterial agent 127 | Reference compound | |
| HY-151938 | Reverse transcriptase-IN-3 | Reference compound | |
| HY-151939 | BLM-IN-2 | 3037604-86-4 | Reference compound |
| HY-15193A | EMD638683 (R-Form) | 1184940-47-3 | Reference compound |
| HY-15193B | EMD638683 (S-Form) | 1184940-46-2 | Reference compound |
| HY-15194 | Dimethylcurcumin | 52328-98-0 | Natural Products |
| HY-151940 | Mal-Pc | 2670367-74-3 | Reference compound |
| HY-151941 | MtInhA-IN-1 | Reference compound | |
| HY-151942 | Antitrypanosomal agent 10 | Reference compound | |
| HY-151943 | Antitrypanosomal agent 11 | Reference compound | |
| HY-151944 | Antibacterial agent 128 | 3059046-75-9 | Reference compound |
| HY-151945 | TRK II-IN-1 | 2904690-41-9 | Reference compound |
| HY-151946 | ALR2-IN-2 | Reference compound | |
| HY-151947 | ALR2-IN-3 | Reference compound | |
| HY-151948 | TrkA-IN-3 | 3026111-73-6 | Reference compound |
| HY-151949 | TrkA-IN-4 | 3026111-74-7 | Reference compound |
| HY-15195 | Avosentan | 290815-26-8 | Reference compound |
| HY-151950 | Antidepressant agent 3 | Reference compound | |
| HY-151951 | Antidepressant agent 4 | Reference compound | |
| HY-151952 | NLRP3-IN-12 | Reference compound | |
| HY-151953 | Antitubulin agent 1 | Reference compound | |
| HY-151954 | TGFβ1-IN-2 | 2883813-66-7 | Reference compound |
| HY-151955 | TGFβ1-IN-3 | 2883813-58-7 | Reference compound |
| HY-151956 | Mtb-cyt-bd oxidase-IN-7 | Reference compound | |
| HY-151957 | Antitubercular agent 34 | 2883173-23-5 | Reference compound |
| HY-151958 | Antitubercular agent-35 | Reference compound | |
| HY-151959 | FXR agonist 4 | 3025841-47-5 | Reference compound |
| HY-15196 | TAK-285 | 871026-44-7 | Reference compound |
| HY-151960 | Antitubercular agent-36 | 2883173-82-6 | Reference compound |
| HY-151961 | RSH-7 | 2764609-97-2 | Reference compound |
| HY-151962 | JNK3 inhibitor-5 | 2911640-63-4 | Reference compound |
| HY-151963 | PPARγ/GR modulator 1 | Reference compound | |
| HY-151965 | Antimalarial agent 18 | Reference compound | |
| HY-151966 | TD1092 | Reference compound | |
| HY-151967 | Anti-IAV agent 1 | Reference compound | |
| HY-151968 | KRAS G12C inhibitor 57 | 2821863-70-9 | Reference compound |
| HY-151969 | VEGFR-2-IN-30 | Reference compound | |
| HY-15197 | ABT-046 | 1031336-60-3 | Reference compound |
| HY-151970 | STING-IN-4 | 2250374-27-5 | Reference compound |
| HY-151971 | Aurora kinase-IN-3 | 2840558-83-8 | Reference compound |
| HY-151972 | BRD4 Inhibitor-25 | Reference compound | |
| HY-151973 | Xanthine oxidoreductase-IN-3 | 651769-78-7 | Reference compound |
| HY-151974 | Xanthine oxidoreductase-IN-4 | 1026587-58-5 | Reference compound |
| HY-151975 | Xanthine oxidoreductase-IN-5 | 1026652-90-3 | Reference compound |
| HY-151976 | STAT3-IN-15 | Reference compound | |
| HY-151977 | Tyrosinase-IN-7 | 2873418-52-9 | Reference compound |
| HY-151978 | ZC0109 | Reference compound | |
| HY-151979 | Tyrosinase-IN-8 | Reference compound | |
| HY-15198 | KG5 | 877874-85-6 | Reference compound |
| HY-151980 | Mps1-IN-5 | 2890819-31-3 | Reference compound |
| HY-151981 | EGFR-IN-74 | Reference compound | |
| HY-151982 | Tubulin polymerization-IN-39 | Reference compound | |
| HY-151983 | Thrombin inhibitor 6 | 1628224-94-1 | Reference compound |
| HY-151984 | CDK9-IN-22 | 2872677-61-5 | Reference compound |
| HY-151985 | TACC3 inhibitor 1 | 3033646-06-6 | Reference compound |
| HY-151986 | FOXM1-IN-1 | 2864407-22-5 | Reference compound |
| HY-151987 | RET-IN-20 | Reference compound | |
| HY-151988 | SARS-CoV-2-IN-36 | Reference compound | |
| HY-15199 | Agerafenib hydrochloride | 1227678-26-3 | Reference compound |
| HY-151990 | SARS-CoV-2/MERS Mpro-IN-1 | Reference compound | |
| HY-151991 | SARS-CoV-2/MERS Mpro-IN-2 | Reference compound | |
| HY-151993S | 2-Hydroxypropane-1,3-diyl distearate-d75 | 2692624-32-9 | Isotope-Labeled Compounds |
| HY-151994S | 1,3-Diolein-d66 | 2692624-33-0 | Isotope-Labeled Compounds |
| HY-151995S | 1,1',1''-(1,2,3-Propanetriyl-1,1,2,3,3-d5) tri-(11Z)-11-heptadecenoate | 2692624-35-2 | Isotope-Labeled Compounds |
| HY-151996 | Tubulin inhibitor 31 | Reference compound | |
| HY-151997S | 1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 | 2692624-36-3 | Isotope-Labeled Compounds |
| HY-151999 | KRAS G12C inhibitor 65 | Reference compound | |
| HY-15200 | Agerafenib | 1188910-76-0 | Reference compound |
| HY-152000S | C18 Ganglioside GM1-d3 (ammonium) | 2692623-83-7 | Isotope-Labeled Compounds |
| HY-152001 | hCAIX-IN-24 | 3038222-64-6 | Reference compound |
| HY-152002S | Ganglioside GM3-d3 (ammonium) | 2692623-85-9 | Isotope-Labeled Compounds |
| HY-152003S | Ganglioside GM2-d3 (ammonium) | 2692623-87-1 | Isotope-Labeled Compounds |
| HY-152005 | SARS-CoV-2 3CLpro-IN-6 | 302821-53-0 | Reference compound |
| HY-152006S | Propionyl-L-carnitine-d3 (hydrochloride) | 2692623-94-0 | Isotope-Labeled Compounds |
| HY-152007S | Butyrylcarnitine-d3 (hydrochloride) | 2692623-96-2 | Isotope-Labeled Compounds |
| HY-152008S | Hexanoyl-L-carnitine-d3 (hydrochloride) | 2692624-43-2 | Isotope-Labeled Compounds |
| HY-152009 | SARS-CoV-2 3CLpro-IN-7 | 1164478-67-4 | Reference compound |
| HY-152010S | L-Octanoylcarnitine-d3 (hydrochloride) | 1297271-48-7 | Isotope-Labeled Compounds |
| HY-152011S | Lauroyl-L-carnitine-d3 (hydrochloride) | 1297271-52-3 | Isotope-Labeled Compounds |
| HY-152012S | Tetradecanoylcarnitine-d3 (hydrochloride) | 1297271-54-5 | Isotope-Labeled Compounds |
| HY-152013S | L-Palmitoylcarnitine-d3-1 (hydrochloride) | 2692623-98-4 | Isotope-Labeled Compounds |
| HY-152014S | Stearoylcarnitine-d3-1 (hydrochloride) | 2692624-00-1 | Isotope-Labeled Compounds |
| HY-152017S | C18 Globotriaosylceramide-d3 | 2692623-80-4 | Isotope-Labeled Compounds |
| HY-152019 | EGFR/C797S-IN-1 | 2378188-21-5 | Reference compound |
| HY-15202 | Binimetinib | 606143-89-9 | Reference compound |
| HY-152020S | Sphingosine-d9 (d18:1) | 2377379-55-8 | Isotope-Labeled Compounds |
| HY-152021S | C18 Ceramide-1-phosphate (d18:1/18:0)-d3 | 2692624-25-0 | Isotope-Labeled Compounds |
| HY-152022S | EOS (d18:1/32:0/18:2)-d9 | 2692624-26-1 | Isotope-Labeled Compounds |
| HY-152023S | (7Z,10Z,13Z)-7,10,13-Hexadecatrienoic-7,8,10,11,13,14-d6 acid | 2692623-88-2 | Isotope-Labeled Compounds |
| HY-152024S | Sebaleic acid-d19 | 2692624-10-3 | Isotope-Labeled Compounds |
| HY-152026 | NADPH oxidase-IN-1 | 2762405-17-2 | Reference compound |
| HY-152027 | HSP90-IN-18 | 2927442-45-1 | Reference compound |
| HY-152028 | HSP90-IN-19 | 2927442-48-4 | Reference compound |
| HY-15202R | Binimetinib (Standard) | 606143-89-9 | Reference Standards |
| HY-15202S1 | Binimetinib-d3 | 2890696-59-8 | Isotope-Labeled Compounds |
| HY-15202S3 | Binimetinib-d4 | 2890696-60-1 | Isotope-Labeled Compounds |
| HY-152030 | Tubulin/MMP-IN-2 | 2734877-51-9 | Reference compound |
| HY-152031 | Glutaminyl Cyclase Inhibitor 5 | 3033553-63-5 | Reference compound |
| HY-152032 | LSD1-IN-23 | 3033660-66-8 | Reference compound |
| HY-152033 | URAT1 inhibitor 4 | 2700292-02-8 | Reference compound |
| HY-152034 | STING-IN-5 | 2920064-17-9 | Reference compound |
| HY-152035 | Mycobacterial Zmp1-IN-1 | 3033421-29-0 | Reference compound |
| HY-152036 | SIAIS100 | 3033463-06-5 | Reference compound |
| HY-152036A | SIAIS100 (TFA) | Reference compound | |
| HY-152037 | AChE/Nrf2 modulator 1 | 2417117-84-9 | Reference compound |
| HY-152038 | SPEN-IN-1 | 2863686-82-0 | Reference compound |
| HY-152039S | 6PPD-quinone-d5 | 2750119-14-1 | Isotope-Labeled Compounds |
| HY-152039S1 | 6PPD-Q-13C6 | Isotope-Labeled Compounds | |
| HY-15204 | Tonabersat | 175013-84-0 | Reference compound |
| HY-152040S | Tenuazonic acid-(acetyl-13C2) (mixture of diastereomers) in methanol | 1486471-66-2 | Isotope-Labeled Compounds |
| HY-152041S | Sudan II-d6 | 1014689-15-6 | Isotope-Labeled Compounds |
| HY-152048S | Methomyl-d3 | 1398109-07-3 | Isotope-Labeled Compounds |
| HY-15204S | Tonabersat-d6 | 1329837-33-3 | Isotope-Labeled Compounds |
| HY-15205 | Ganetespib | 888216-25-9 | Reference compound |
| HY-152051S | Mabuterol-d9 (hydrochloride) | 1353867-83-0 | Isotope-Labeled Compounds |
| HY-152052S | Linalool-d5 | 159592-39-9 | Isotope-Labeled Compounds |
| HY-152055S | Glufosinate-d3 (hydrochloride) | 1323254-05-2 | Isotope-Labeled Compounds |
| HY-152056S | N-Acetyl glufosinate-d3 | 1356992-90-9 | Isotope-Labeled Compounds |
| HY-152057S | beta-Damascenone-d4 | 217482-71-8 | Isotope-Labeled Compounds |
| HY-15206 | Glibenclamide | 10238-21-8 | Reference compound |
| HY-152065S | 6-Octen-1,1-d2-1-ol, 3,7-dimethyl- | 76027-02-6 | Isotope-Labeled Compounds |
| HY-15206A | Glibenclamide (potassium) | 52169-36-5 | Reference compound |
| HY-15206R | Glibenclamide (Standard) | 10238-21-8 | Reference Standards |
| HY-15206S | Glyburide-d11 | 1189985-02-1 | Isotope-Labeled Compounds |
| HY-15206S1 | Glyburide-d3 | 1219803-02-7 | Isotope-Labeled Compounds |
| HY-15206S2 | Glibenclamide-13C6 | Isotope-Labeled Compounds | |
| HY-152070S | Demethylmaprotiline-d2 | Isotope-Labeled Compounds | |
| HY-152070S1 | Demethylmaprotiline-d2-1 | Isotope-Labeled Compounds | |
| HY-152072S | Deoxynivalenol-13C15 | 911392-36-4 | Isotope-Labeled Compounds |
| HY-152073 | BETA-1 | 2924598-24-1 | Dye Reagents |
| HY-152074 | CD73-IN-14 | 2407356-67-4 | Reference compound |
| HY-152075 | AXL-IN-14 | 2947506-65-0 | Reference compound |
| HY-152076 | Telomerase-IN-4 | 2892295-10-0 | Reference compound |
| HY-152077 | Telomerase-IN-5 | 2892295-16-6 | Reference compound |
| HY-152078 | Influenza virus-IN-6 | 2919303-26-5 | Reference compound |
| HY-152079 | CYP1B1-IN-3 | 2872575-51-2 | Reference compound |
| HY-15208 | Clamikalant (sodium) | 261717-22-0 | Reference compound |
| HY-152080 | TUL01101 | 2411222-97-2 | Reference compound |
| HY-152081 | DENV-IN-7 | 2499537-22-1 | Reference compound |
| HY-152082 | DENV-IN-8 | 1809464-07-0 | Reference compound |
| HY-152083 | DENV-IN-9 | 791838-63-6 | Reference compound |
| HY-152084 | Anticancer agent 93 | 94205-22-8 | Reference compound |
| HY-152085 | Anticancer agent 94 | Reference compound | |
| HY-152086 | DRP1i27 | 1453028-33-5 | Reference compound |
| HY-152086A | DRP1i27 (dihydrochloride) | Reference compound | |
| HY-152087 | DCZ19931 | 2789629-84-9 | Reference compound |
| HY-152088 | Neuroinflammatory-IN-3 | 1202404-23-6 | Reference compound |
| HY-152089 | SB26019 | 1233078-90-4 | Reference compound |
| HY-15208A | Clamikalant | 158751-64-5 | Reference compound |
| HY-15209 | Repaglinide | 135062-02-1 | Reference compound |
| HY-152090 | Antiproliferative agent-17 | 2882206-08-6 | Reference compound |
| HY-152091 | Antiproliferative agent-18 | 2882206-14-4 | Reference compound |
| HY-152092 | MMP-1-IN-1 | Reference compound | |
| HY-152093 | YL-939 | 3023925-68-7 | Reference compound |
| HY-152094 | SRD5A1-IN-1 | 2279077-93-7 | Reference compound |
| HY-152095 | PPI-GIT1/β-Pix interaction-IN-1 | 2070916-70-8 | Reference compound |
| HY-152096 | (R)-ZG197 | 2999672-72-7 | Reference compound |
| HY-152097 | (S)-ZG197 | 2999672-66-9 | Reference compound |
| HY-152098 | HX103 | 2566466-98-4 | Reference compound |
| HY-152099 | Antiproliferative agent-19 | Reference compound | |
| HY-15209R | Repaglinide (Standard) | 135062-02-1 | Reference Standards |
| HY-15209S | Repaglinide-d5 | 1217709-85-7 | Isotope-Labeled Compounds |
| HY-152100 | CUR5g | 1370032-20-4 | Reference compound |
| HY-152101 | LY1 | 2883813-32-7 | Reference compound |
| HY-152102 | BTCy | Dye Reagents | |
| HY-152103 | CB2-H | Dye Reagents | |
| HY-152104 | FGFR-IN-9 | 3024090-08-9 | Reference compound |
| HY-152105 | Metallo-β-lactamase-IN-9 | 1802363-75-2 | Reference compound |
| HY-152106 | BAY-7081 | 3036022-06-4 | Reference compound |
| HY-152107 | LRRK2-IN-7 | 2307277-93-4 | Reference compound |
| HY-152107A | (R,R)-LRRK2-IN-7 | 2307277-92-3 | Reference compound |
| HY-152108 | SARS-CoV-2 Mpro-IN-6 | 2768834-48-4 | Reference compound |
| HY-152109 | AChE/MAO-IN-1 | Reference compound | |
| HY-15211 | MRK 003 | 623165-93-5 | Reference compound |
| HY-152110 | AChE/MAO-IN-2 | Reference compound | |
| HY-152111 | AChE/MAO-B-IN-3 | Reference compound | |
| HY-152112 | AChE/BChE/MAO-B-IN-2 | Reference compound | |
| HY-152113 | AChE/BChE/MAO-B-IN-3 | Reference compound | |
| HY-152114 | AChE/BChE/MAO-B-IN-4 | Reference compound | |
| HY-152117 | Acetyl-CoA Carboxylase-IN-1 | 179343-23-8 | Reference compound |
| HY-152118 | CYP1B1-IN-4 | 2685779-55-7 | Reference compound |
| HY-152120 | (±)-Aiphanol | 578020-29-8 | Natural Products |
| HY-152121 | Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal | 2345732-89-8 | Reference compound |
| HY-152131 | CCR5 antagonist 2 | 1800570-93-7 | Reference compound |
| HY-152132 | CCR5 antagonist 3 | 1800570-92-6 | Reference compound |
| HY-152133 | PROTAC HDAC6 degrader 1 | 2785404-76-2 | Reference compound |
| HY-152134 | HDAC6 degrader-3 | 2785404-83-1 | Reference compound |
| HY-152135 | TJ08 | 2924274-19-9 | Reference compound |
| HY-152136 | Antituberculosis agent-6 | 2874263-72-4 | Reference compound |
| HY-152137 | Antituberculosis agent-7 | 2874263-73-5 | Reference compound |
| HY-152138 | Antituberculosis agent-8 | 2874263-74-6 | Reference compound |
| HY-152139 | Antibacterial agent 129 | 2874263-66-6 | Reference compound |
| HY-15214 | CARM1-IN-3 | 912970-67-3 | Reference compound |
| HY-152140 | hCAII-IN-8 | 952306-80-8 | Reference compound |
| HY-152141 | hCAII-IN-9 | 2878477-18-8 | Reference compound |
| HY-152142 | DN-1289 | 3026597-15-6 | Reference compound |
| HY-152143 | Tubulin polymerization-IN-41 | 2804026-81-9 | Reference compound |
| HY-152144 | EGFR-IN-75 | Reference compound | |
| HY-152145 | PROTAC SOS1 degrader-3 | 3029320-99-5 | Reference compound |
| HY-152146 | HDAC-IN-50 | 2653339-26-3 | Reference compound |
| HY-152147 | SZUH280 | 2770263-77-7 | Reference compound |
| HY-152148 | JZP-MA-11 | 1672691-50-7 | Reference compound |
| HY-152149 | CTP Synthetase-IN-1 | 2338811-71-3 | Reference compound |
| HY-15214A | CARM1-IN-3 (dihydrochloride) | Reference compound | |
| HY-152150 | Thrombin inhibitor 7 | 2866508-00-9 | Reference compound |
| HY-152152 | JZP-MA-13 | 3034900-00-7 | Reference compound |
| HY-152153 | GRP78-IN-3 | 2707510-30-1 | Reference compound |
| HY-152154 | Nampt degrader-2 | 3035008-40-0 | Reference compound |
| HY-152155 | ARUK2001607 | 2924824-56-4 | Reference compound |
| HY-152156 | Tubulin inhibitor 11 | 2366260-33-3 | Reference compound |
| HY-152157 | HIV-1 inhibitor-52 | 1818868-23-3 | Reference compound |
| HY-152158 | α-Glucosidase-IN-22 | 2870693-28-8 | Reference compound |
| HY-152159 | CYP4Z1-IN-1 | 2760611-38-7 | Reference compound |
| HY-152160 | HIV-1 inhibitor-50 | 2834087-69-1 | Reference compound |
| HY-152161 | HIV-1 inhibitor-51 | 2834087-82-8 | Reference compound |
| HY-152166 | NaV1.2/1.6 channel blocker-1 | 1199944-04-1 | Reference compound |
| HY-152168 | NSC 295642 | 77111-29-6 | Reference compound |
| HY-152169 | BIHC | 1642826-40-1 | Reference compound |
| HY-15217 | CHR-6494 | 1333377-65-3 | Reference compound |
| HY-152170 | bPiDI | 525596-64-9 | Reference compound |
| HY-152171 | GZ-11608 | 2141974-01-6 | Reference compound |
| HY-152173 | HDAC-IN-51 | 3026728-28-6 | Reference compound |
| HY-152174 | HDAC-IN-52 | 2075787-77-6 | Reference compound |
| HY-152175 | Antibacterial agent 130 | 1502721-60-9 | Reference compound |
| HY-152177 | JS6 | 950244-33-4 | Reference compound |
| HY-152182 | ML-SA5 | 2418670-70-7 | Reference compound |
| HY-152183 | FINDY | 1507367-37-4 | Reference compound |
| HY-152184 | SEW84 | 259089-67-3 | Reference compound |
| HY-152185 | BSJ-04-122 | 2513289-74-0 | Reference compound |
| HY-152187 | Topoisomerase IIα-IN-5 | 3037545-23-3 | Reference compound |
| HY-152188 | AKR1C3-IN-9 | 2924824-43-9 | Reference compound |
| HY-152189 | S19-1035 | 2986319-18-8 | Reference compound |
| HY-152190 | JB002 | 30408-07-2 | Reference compound |
| HY-152191 | ChoKα inhibitor-3 | 2883822-56-6 | Reference compound |
| HY-152193 | ChoKα inhibitor-4 | Reference compound | |
| HY-152194 | Tyrosinase-IN-10 | 2873418-48-3 | Reference compound |
| HY-152195 | ChoKα inhibitor-5 | Reference compound | |
| HY-152196 | CYP1B1-IN-5 | 176442-56-1 | Reference compound |
| HY-152197 | Tankyrase-IN-3 | 938893-79-9 | Reference compound |
| HY-152198 | Tankyrase-IN-4 | Reference compound | |
| HY-152199 | AMPD2 inhibitor 2 | 3026893-31-9 | Reference compound |
| HY-152200 | HIV-1 inhibitor-53 | 2883496-10-2 | Reference compound |
| HY-152201 | BTK-IN-18 | 1374239-71-0 | Reference compound |
| HY-152202 | Mitochondrial respiration-IN-3 | Reference compound | |
| HY-152203 | Mitochondrial respiration-IN-2 | 318498-81-6 | Reference compound |
| HY-152204 | Cathepsin L/S-IN-1 | Reference compound | |
| HY-152205 | JB061 | Reference compound | |
| HY-152206 | JB062 | 2417988-00-0 | Reference compound |
| HY-152207 | LWG-301 | 3038480-88-2 | Reference compound |
| HY-152208 | BPDA2 | 2907659-86-1 | Reference compound |
| HY-152209 | BRD4 Inhibitor-26 | Reference compound | |
| HY-15221 | Methylstat | 1310877-95-2 | Reference compound |
| HY-152210 | ASPER-29 | 2630388-03-1 | Reference compound |
| HY-152212 | BTK-IN-19 | 1374240-01-3 | Reference compound |
| HY-152213 | BET-IN-13 | 2506823-08-9 | Reference compound |
| HY-152214 | SIRT5 inhibitor 5 | 2883730-60-5 | Reference compound |
| HY-152215 | Dynamin IN-1 | 1345853-50-0 | Reference compound |
| HY-152216 | Dynamin IN-2 | 1345853-49-7 | Reference compound |
| HY-152217 | Clathrin-IN-2 | 2650733-69-8 | Reference compound |
| HY-152218 | Clathrin-IN-4 | 762242-59-1 | Reference compound |
| HY-152219 | CLK1-IN-2 | 3029431-68-0 | Reference compound |
| HY-15222 | Menin-MLL inhibitor MI-2 | 1271738-62-5 | Reference compound |
| HY-152220 | SPR39 | Reference compound | |
| HY-152221 | PCSK9-IN-10 | 368434-98-4 | Reference compound |
| HY-152222 | SPR38 | Reference compound | |
| HY-152223 | PCSK9-IN-11 | 2882035-56-3 | Reference compound |
| HY-152224 | SPR41 | Reference compound | |
| HY-152225 | MC2625 | 1776116-75-6 | Reference compound |
| HY-152226 | MC2590 | 2284460-01-9 | Reference compound |
| HY-152227 | PROTAC TYK2 degradation agent1 | 2921556-14-9 | Reference compound |
| HY-152228 | SMYD3-IN-2 | Reference compound | |
| HY-152229 | G0-C14 | 1510653-27-6 | Oligonucleotides |
| HY-15223 | MI-3 | 1271738-59-0 | Reference compound |
| HY-152231 | BODIPY FL thalidomide | 2740620-18-0 | Reference compound |
| HY-152232 | BChE-IN-15 | Reference compound | |
| HY-152233 | Reverse transcriptase-IN-4 | Reference compound | |
| HY-152235 | HDAC6-IN-15 | Reference compound | |
| HY-152236 | PRMT6-IN-3 | 2890765-10-1 | Reference compound |
| HY-152237 | TBK1-IN-1 | Reference compound | |
| HY-152238 | PI3K/mTOR Inhibitor-12 | 2891692-83-2 | Reference compound |
| HY-152239 | RdRP-IN-5 | 2915761-74-7 | Reference compound |
| HY-152239A | cis-RdRP-IN-5 | Reference compound | |
| HY-152239B | trans-RdRP-IN-5 | Reference compound | |
| HY-15224 | PCI-34051 | 950762-95-5 | Reference compound |
| HY-152240 | PD-1/PD-L1-IN-29 | 2665734-13-2 | Reference compound |
| HY-152241 | DS-9300 | 2259641-46-6 | Reference compound |
| HY-152242 | YEATS4-IN-1 | 3034365-92-6 | Reference compound |
| HY-152243 | YEATS4 binder-1 | 3034365-93-7 | Reference compound |
| HY-152245 | Physachenolide C | 791117-61-8 | Natural Products |
| HY-152246 | ZIM | 301298-87-3 | Reference compound |
| HY-152247 | DDO3711 | 2673364-10-6 | Reference compound |
| HY-152248 | ARS-2102 | 2098509-21-6 | Reference compound |
| HY-152249 | Antibacterial agent 131 | Reference compound | |
| HY-152250 | Antibacterial agent 132 | 3026790-18-8 | Reference compound |
| HY-152251 | CB2R/FAAH modulator-1 | 928892-60-8 | Reference compound |
| HY-152252 | Antibacterial agent 133 | Reference compound | |
| HY-152253 | CB2R/FAAH modulator-2 | 2876918-68-0 | Reference compound |
| HY-152254 | CB2R/FAAH modulator-3 | 2876918-67-9 | Reference compound |
| HY-152257 | HPK1-IN-31 | 3003026-16-9 | Reference compound |
| HY-152259 | TMV-IN-4 | 1820823-40-2 | Reference compound |
| HY-15226 | AZ505 | 1035227-43-0 | Reference compound |
| HY-152261 | MS6105 | 2891709-58-1 | Reference compound |
| HY-152263 | HEMTAC CDK4/6 degrader 1 | 2821803-61-4 | Reference compound |
| HY-152264 | CFTR activator 1 | 2768261-09-0 | Reference compound |
| HY-152265 | PARL-IN-1 | Reference compound | |
| HY-152265A | PARL-IN-1 (TFA) | Reference compound | |
| HY-15226A | AZ505 (ditrifluoroacetate) | 1035227-44-1 | Reference compound |
| HY-15227 | EPZ004777 | 1338466-77-5 | Reference compound |
| HY-152270 | Pirnabine | 19825-63-9 | Peptides |
| HY-15227A | EPZ004777 (hydrochloride) | 1380316-03-9 | Reference compound |
| HY-15228 | RX-3117 | 865838-26-2 | Reference compound |
| HY-15229 | Guadecitabine sodium | 929904-85-8 | Reference compound |
| HY-152292 | Zidesamtinib | 2739829-00-4 | Reference compound |
| HY-152293 | EVT801 | 1412453-70-3 | Reference compound |
| HY-152294 | 3′-Deoxy-3′-methyluridine | 444020-64-8 | Reference compound |
| HY-152295 | 3’-Deoxy-2’-thiouridine | 455951-69-6 | Oligonucleotides |
| HY-152296 | 8-Methyladenosine | 56973-12-7 | Oligonucleotides |
| HY-152297 | (1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol | 263701-23-1 | Oligonucleotides |
| HY-152298 | 5-Fluoro-4’-thiouridine | 56527-42-5 | Oligonucleotides |
| HY-152299 | 5-(t-Butyloxycarbonylmethoxy)uridine | Oligonucleotides | |
| HY-15230 | Geldanamycin | 30562-34-6 | Natural Products |
| HY-152300 | N4,N4-Dimethylcytidine | 13007-43-7 | Oligonucleotides |
| HY-152301 | 3’-Deoxy-3’-fluoro-N6-methyladenosine | 122654-27-7 | Oligonucleotides |
| HY-152302 | 3’-Deoxy-3’-fluoro-5-methylcytidine | 847650-07-1 | Oligonucleotides |
| HY-152303 | N6-(4-Methoxybenzyl)adenosine | 23666-24-2 | Oligonucleotides |
| HY-152303S | N6-(4-Methoxybenzyl)adenosine-d3 | Isotope-Labeled Compounds | |
| HY-152304 | N-[(3-Methoxyphenyl)methyl]adenosine | 101565-95-1 | Oligonucleotides |
| HY-152305 | (1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol | 875302-27-5 | Oligonucleotides |
| HY-152306 | N1,N3-Bis(cyanomethyl)pseudouridine | Oligonucleotides | |
| HY-152307 | 2-Chloro-N6-methyladenosine | 13406-50-3 | Oligonucleotides |
| HY-152308 | 3’-Deoxy-3’,5-difluorocytidine | 661470-65-1 | Oligonucleotides |
| HY-152309 | N-(3-Methylbutyl)adenosine | 17659-78-8 | Oligonucleotides |
| HY-15230R | Geldanamycin (Standard) | 30562-34-6 | Reference Standards |
| HY-15231 | PSI-352938 | 1199809-32-9 | Reference compound |
| HY-152310 | N4-(n-Palmitoyl)-4’-azido-2’-deoxy-2’-fluoro-arabinocytidine | Oligonucleotides | |
| HY-152311 | 2-Chloro-N6,N6-dimethyladenosine | 13406-53-6 | Oligonucleotides |
| HY-152312 | 8-Allyloxyadenosine | 2095417-69-7 | Oligonucleotides |
| HY-152313 | 2-Bromoadenosine | 146-76-9 | Oligonucleotides |
| HY-152314 | 2-Cyanoadenosine | 79936-11-1 | Oligonucleotides |
| HY-152315 | 3’-Azido-3’-deoxy-N6-methyladenosine | 889126-08-3 | Oligonucleotides |
| HY-152316 | 2-Chloro-N6-isopropyladenosine | 23541-30-2 | Oligonucleotides |
| HY-152317 | 5-Methyl-2-thio-xylo-uridine | 246857-26-1 | Oligonucleotides |
| HY-152318 | Adenosine-2-carboxamide | 70255-72-0 | Oligonucleotides |
| HY-152319 | 3’-Azido-3’-deoxy-N6,N6-dimethyladenosine | 384334-64-9 | Oligonucleotides |
| HY-15231A | (Rac)-PSI-352938 | 1231747-17-3 | Reference compound |
| HY-15232 | Tenofovir alafenamide | 379270-37-8 | Reference compound |
| HY-152320 | Adenosine-2-carboxy methyl amide | Oligonucleotides | |
| HY-152321 | 5-Hydroxy-arabinouridine | 69321-95-5 | Oligonucleotides |
| HY-152322 | 2-Chloro-N6-iso-pentenyladenosine | 65400-39-7 | Oligonucleotides |
| HY-152323 | N1-Methylsulfonyl pseudouridine | Oligonucleotides | |
| HY-152324 | 2-Chloro-N6-(2-hydroxyethyl)adenosine | 948298-76-8 | Oligonucleotides |
| HY-152325 | N1-(N,N-Dimethylaminocarbonyl)-pseudouridine | Oligonucleotides | |
| HY-152326 | 2’-β-C-Methyl-6-azauridine | 172605-95-7 | Oligonucleotides |
| HY-152327 | 2-Methylthio isopentenyladenosine | 20859-00-1 | Oligonucleotides |
| HY-152328 | 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | 2389988-43-4 | Oligonucleotides |
| HY-152329 | 3’-Deoxy-3’-fluoro-6-azauridine | 439579-23-4 | Oligonucleotides |
| HY-15232A | Tenofovir alafenamide fumarate | 379270-38-9 | Reference compound |
| HY-15232B | Tenofovir alafenamide hemifumarate | 1392275-56-7 | Reference compound |
| HY-15232BR | Tenofovir alafenamide hemifumarate (Standard) | 1392275-56-7 | Reference Standards |
| HY-15232S2 | Tenofovir alafenamide-d6 | Isotope-Labeled Compounds | |
| HY-15233 | Letermovir | 917389-32-3 | Reference compound |
| HY-152330 | 2’-Chloro-N6-(3-methoxy)benzyl adenosine | 722504-73-6 | Oligonucleotides |
| HY-152331 | 7-n-Propyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | 2389988-44-5 | Oligonucleotides |
| HY-152332 | 2’-Chloro-N6-(4-methoxy)benzyl adenosine | 722504-77-0 | Oligonucleotides |
| HY-152333 | 7-n-Butyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | 2389988-45-6 | Oligonucleotides |
| HY-152334 | 2’-Chloro-2’-deoxyadenosine | 2627-62-5 | Oligonucleotides |
| HY-152335 | 2’-Chloro-N6-(3-trifluoromethyl)benzyl adenosine | Oligonucleotides | |
| HY-152336 | N1-(2-Methyl)propyl pseudouridine | Oligonucleotides | |
| HY-152337 | 2’-Chloro-N6-(4-trifluoromethyl)benzyl adenosine | 722515-03-9 | Oligonucleotides |
| HY-152338 | 7-Propargyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | 2389988-31-0 | Oligonucleotides |
| HY-152339 | N4-Amino-2’-β-C-methylcytidine | 622381-10-6 | Oligonucleotides |
| HY-15233R | Letermovir (Standard) | 917389-32-3 | Reference Standards |
| HY-15234 | Fluticasone furoate | 397864-44-7 | Reference compound |
| HY-152340 | 2’-Amino-2’-deoxy-5-fluoro-arabinouridine | 2305415-81-8 | Oligonucleotides |
| HY-152341 | 7-(Butyn-2-yl)-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | 2389988-33-2 | Oligonucleotides |
| HY-152342 | N1-Methoxymethyl pseudouridine | 2131744-33-5 | Oligonucleotides |
| HY-152343 | 1-(β-D-Xylofuranosyl)-2-thiouracil | 2305416-17-3 | Oligonucleotides |
| HY-152344 | 2’-β-C-Methyl inosine | 374750-32-0 | Oligonucleotides |
| HY-152345 | N1-Ethoxymethyl pseudouridine | Oligonucleotides | |
| HY-152346 | N1-Benzoyl pseudouridine | Oligonucleotides | |
| HY-152347 | 1-Amino-3’-deoxy-7,8-dihydro-8-oxoguanosine | 2389988-59-2 | Oligonucleotides |
| HY-152348 | 2’-Deoxy-2’-fluoro-5-methyl-4’-thio-β-D-arabino uridine | 135123-34-1 | Oligonucleotides |
| HY-152349 | 2’-Deoxy-2’-fluoro-β-D-arabino-2-thiouridine | 1006872-85-0 | Oligonucleotides |
| HY-15234R | Fluticasone furoate (Standard) | 397864-44-7 | Reference Standards |
| HY-15234S | Fluticasone furoate-d3 | Isotope-Labeled Compounds | |
| HY-15234S1 | Fluticasone furoate-d5 | Isotope-Labeled Compounds | |
| HY-152350 | 2’-Deoxy-2’-fluoro-4’-thio-β-D-arabinouridine | 941610-00-0 | Oligonucleotides |
| HY-152351 | 8-Bromo-3’-deoxyguanosine | 847649-68-7 | Oligonucleotides |
| HY-152352 | 7,8-Dihydro-8-oxo-7-propargyl guanosine | 2763084-98-4 | Oligonucleotides |
| HY-152353 | 3’-Azido-3’-deoxy-2-thiouridine | 2305416-00-4 | Oligonucleotides |
| HY-152354 | 8-Benzyloxy-3’-deoxyguanosine | 2389988-57-0 | Oligonucleotides |
| HY-152355 | N6-Methyl-xylo-adenosine | 65494-95-3 | Oligonucleotides |
| HY-152356 | 8-Bromo-3’-deoxy-3’-fluoroguanosine | 847649-50-7 | Oligonucleotides |
| HY-152357 | N6,N6-Dimethyl-xylo-adenosine | 669055-52-1 | Oligonucleotides |
| HY-152358 | N3-Methyl-2’-O-methyluridine | 7103-27-7 | Oligonucleotides |
| HY-152359 | 8-Benzyloxy-3’-deoxy-3’-fluoroguanosine | 2389988-61-6 | Oligonucleotides |
| HY-15236 | PSI-6206 | 863329-66-2 | Reference compound |
| HY-152360 | 1-(β-D-Xylofuranosyl)-5-methylcytosine | 18492-10-9 | Oligonucleotides |
| HY-152361 | N6-Methyl-2’-β-C-methyladenosine | 565450-76-2 | Oligonucleotides |
| HY-152362 | 8-Hydroxy-3'-deoxy-3'-fluoroguanosine | Oligonucleotides | |
| HY-152363 | N3-Methyl-2’-O-(2-methoxyethyl)uridine | 2305416-12-8 | Oligonucleotides |
| HY-152364 | 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro guanosine | 2389988-55-8 | Oligonucleotides |
| HY-152365 | N6,N6-Dimethyl-2’-β-C-methyladenosine | 565450-77-3 | Oligonucleotides |
| HY-152366 | 3’-beta-C-Methyladenosine | 15397-13-4 | Oligonucleotides |
| HY-152367 | 8-Hydroxy-3'-deoxyguanosine | Oligonucleotides | |
| HY-152368 | 8-Hydrazinoadenosine | 3868-34-6 | Oligonucleotides |
| HY-152369 | 1,N6-Etheno-ara-adenosine | 2095417-09-5 | Oligonucleotides |
| HY-15236S | PSI-6206-13C,d3 | 1256490-42-2 | Isotope-Labeled Compounds |
| HY-15236S1 | PSI-6206-d1,13C,15N2 | Isotope-Labeled Compounds | |
| HY-15237 | SL 0101-1 | 77307-50-7 | Natural Products |
| HY-152370 | 3’-beta-C-Methyl-N6-methyladenosine | 565450-84-2 | Oligonucleotides |
| HY-152371 | 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine | 2095417-39-1 | Oligonucleotides |
| HY-152372 | Methyl 6-amino-9-β-D-ribofuranosyl-9H-purine-2-carboxylate | 70255-70-8 | Oligonucleotides |
| HY-152373 | 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro-xylo-guanosine | 2389988-56-9 | Oligonucleotides |
| HY-152374 | 3’-Deoxy-3’-fluoro-N6,N6-dimethyladenosine | 122654-28-8 | Oligonucleotides |
| HY-152375 | 8-Hydroxy-xyloguanosine | 2390368-04-2 | Oligonucleotides |
| HY-152376 | N6,N6-Dimethyl-3’-beta-C-methyl-adenosine | 565450-85-3 | Oligonucleotides |
| HY-152377 | 5-Hydroxy-2’-O-methyluridine | 2030403-78-0 | Oligonucleotides |
| HY-152378 | 2’-Deoxy-2’-fluoro-β-D-arabino-6-azauridine | 908129-24-8 | Oligonucleotides |
| HY-152379 | 3’-Deoxy-methyl-2-thiouridine | 2305416-19-5 | Oligonucleotides |
| HY-15238 | ST-836 | 1148156-63-1 | Reference compound |
| HY-152380 | 1,2,4-Triazine-3,5-dione 2-β-D-xylopyranoside | 93060-34-5 | Oligonucleotides |
| HY-152381 | 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one | 10517-16-5 | Oligonucleotides |
| HY-152382 | 3’-O-(2-Methoxyethyl)cytidine | 2305415-84-1 | Oligonucleotides |
| HY-152383 | 5-Difluoromethyluridine | 110483-84-6 | Oligonucleotides |
| HY-152384 | 5’(R)-C-Methyladenosine | 3253-81-4 | Oligonucleotides |
| HY-152385 | 5,6-Dihydro-ara-uridine | 30100-83-5 | Oligonucleotides |
| HY-152387 | 8-Chloro-arabinoadenosine | 769872-68-6 | Oligonucleotides |
| HY-152388 | 3’-beta-C-Methyluridine | 80541-15-7 | Oligonucleotides |
| HY-152389 | 6-Methylpurine-β-D-(3-azido-3-deoxy)riboside | 2095417-25-5 | Oligonucleotides |
| HY-15238A | ST-836 (hydrochloride) | 1415564-68-9 | Reference compound |
| HY-152390 | 2’-Fluoro-2’-deoxy-N6-methylarabinoadenosine | 126502-12-3 | Oligonucleotides |
| HY-152391 | 3’-beta-C-Methyl-5-methyluridine | 934002-35-4 | Oligonucleotides |
| HY-152392 | 2’-Fluoro-2’-deoxy-N6,N6-dimethylarabinoadenosine | 144924-81-2 | Oligonucleotides |
| HY-152393 | 3’-Deoxy-3’-α-C-methyl-5-methyluridine | 847650-50-4 | Oligonucleotides |
| HY-152394 | 3’-beta-C-Methylcytidine | 20724-72-5 | Oligonucleotides |
| HY-152395 | N-[[4-(Trifluoromethyl)phenyl]methyl]adenosine | 722505-71-7 | Oligonucleotides |
| HY-152396 | 1-(β-D-Xylofuranosyl)-N6-(m-methoxybenzyl)adenine | Oligonucleotides | |
| HY-152397 | 3’-Deoxy-N6-isopentenyl adenosine | 1237496-62-6 | Oligonucleotides |
| HY-152398 | 6-Amino-4-methoxy-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine | Oligonucleotides | |
| HY-152399 | 1-(β-D-Xylofuranosyl)-N6-(m-trifluoromethylbenzyl)adenine | Oligonucleotides | |
| HY-15240 | c-Kit-IN-1 | 1225278-16-9 | Reference compound |
| HY-152400 | 8-Bromo-9-(β-D-xylofuranosyl) guanine | 1212650-12-8 | Oligonucleotides |
| HY-152401 | 1-(β-D-Xylofuranosyl)-N6-Isopentenyladenine | Oligonucleotides | |
| HY-152402 | N6-(3-Trifluoromethylbenzyl)-2’-C-methyl adenosine | 2305415-78-3 | Oligonucleotides |
| HY-152403 | 3’-Deoxy-3’-fluoro-xylo-5-methylcytidine | Oligonucleotides | |
| HY-152404 | 3’-Deoxy-3’-fluoro-xylo-N6-(m-methoxybenzyl)adenosine | Oligonucleotides | |
| HY-152405 | 6-Amino-1,2-dihydro-2-β-D-ribofuranosyl-4H-pyrazolo[3,4-d]pyrimidin-4-one | 85426-86-4 | Oligonucleotides |
| HY-152406 | 3’-Beta-C-Methyl-5-methylcytidine | Oligonucleotides | |
| HY-152407 | 7-Allyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine | 2389988-25-2 | Oligonucleotides |
| HY-152408 | 2-β-D-Ribofuranosyl-2H-pyrazolo[3,4-d]pyrimidine-4,6-diamine | 124137-35-5 | Oligonucleotides |
| HY-152409 | N6-Benzyl-2’-C-methyladenosine | 849241-79-8 | Oligonucleotides |
| HY-15241 | NVP-LCQ195 | 902156-99-4 | Reference compound |
| HY-152410 | 6-Amino-4-hydrozino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine | Oligonucleotides | |
| HY-152411 | 3’-Beta-C-Methyl-inosine | Oligonucleotides | |
| HY-152412 | 3’-Deoxy-3’-α-C-methyl-5-fluorouridine | 37731-67-2 | Oligonucleotides |
| HY-152413 | N6-Furfuryl-2’-C-methyladenosine | 1042976-44-2 | Oligonucleotides |
| HY-152414 | 6-Amino-4-hydroxyamino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine | Oligonucleotides | |
| HY-152415 | 3’-Deoxy-3’-α-C-methyladenosine | 26383-05-1 | Oligonucleotides |
| HY-152416 | N6-Isopentenyl-2’-C-methyladenosine | 2305416-13-9 | Oligonucleotides |
| HY-152417 | N3-Ethyl pseudouridine | 2413585-37-0 | Oligonucleotides |
| HY-152418 | 3’-Beta-C-Methyl-N6-(m-methoxybenzyl)adenosine | Oligonucleotides | |
| HY-152419 | N6-(3-Methoxybenzyl)-2’-C-methyl adenosine | 2305415-85-2 | Oligonucleotides |
| HY-15242 | Capromorelin | 193273-66-4 | Reference compound |
| HY-152420 | 2-Trifluoromethyl adenosine | 4627-40-1 | Oligonucleotides |
| HY-152421 | 8-Benzyloxy-9-(β-D-xylofuranosyl)guanine | 2389988-19-4 | Oligonucleotides |
| HY-152422 | 3’-Beta-C-Methyl-N6-(m-trifluoromethylbenzyl)adenosine | Oligonucleotides | |
| HY-152423 | 3’-Deoxy-3’-α-C-methyl-N6,N6-dimethyladenosine | 2095417-44-8 | Oligonucleotides |
| HY-152424 | N6-(4-Methoxybenzyl)-2’-C-methyl adenosine | 2305415-98-7 | Oligonucleotides |
| HY-152425 | 2-Methylamino-N6-methyladenosine | 28360-91-0 | Oligonucleotides |
| HY-152426 | 1-Amino-8-benzyloxy-9-(β-D-xylofuranosyl)guanine | 2389988-20-7 | Oligonucleotides |
| HY-152427 | 3’-Beta-C-Methyl-N6-isopentenyl adenosine | Oligonucleotides | |
| HY-152428 | 3’-Deoxy-3’-α-C-methylguanosine | 444020-69-3 | Oligonucleotides |
| HY-152429 | 3’-Beta-C-ethynyl-5-trifluoromethyluridine | Oligonucleotides | |
| HY-15243 | Capromorelin (Tartrate) | 193273-69-7 | Reference compound |
| HY-152430 | 8-Hydroxymethyl guanosine | 54898-41-8 | Oligonucleotides |
| HY-152431 | 1-Amino-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine | 2389988-21-8 | Oligonucleotides |
| HY-152432 | 1-Amino-7-cyclopropyl methyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | 2389988-22-9 | Oligonucleotides |
| HY-152433 | N1-(1,1-Difluoroethyl)pseudouridine | Oligonucleotides | |
| HY-152434 | 5-Hydroxymethyl-arauridine | 28608-82-4 | Oligonucleotides |
| HY-152435 | 2’-Amino-2’-deoxy-5-methyl uridine | 869729-38-4 | Oligonucleotides |
| HY-152436 | 7-Cyclopropylmethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine | 2389988-23-0 | Oligonucleotides |
| HY-152437 | 3’-Amino-3’-deoxy-5-methyl uridine | 108630-07-5 | Oligonucleotides |
| HY-152438 | 6-Amino-3-ethynyl-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | Oligonucleotides | |
| HY-152439 | 3’-Amino-3’-deoxy-5-fluorouridine | 80955-97-1 | Oligonucleotides |
| HY-15244 | Alpelisib | 1217486-61-7 | Reference compound |
| HY-152440 | 3’-Amino-3’-deoxycytidine | 70580-89-1 | Oligonucleotides |
| HY-152441 | 2-Aminomethyl adenosine | 2305415-79-4 | Oligonucleotides |
| HY-152442 | 3’-beta-C-Ethynyl-3-deazauridine | Oligonucleotides | |
| HY-152443 | 6-Amino-3-(furan-2-yl)-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | Oligonucleotides | |
| HY-152444 | 5-Hydroxymethyl-2’-O-(2-methoxyethyl)uridine | 2095417-51-7 | Oligonucleotides |
| HY-152445 | 3’-Amino-3’-deoxyuridine | 70580-90-4 | Oligonucleotides |
| HY-152446 | N4-Methylarabinocytidine | 13491-42-4 | Oligonucleotides |
| HY-152447 | 3’-beta-C-Ethynyl inosine | Oligonucleotides | |
| HY-152448 | 2’-Azido-2’-deoxycytidine | 51034-68-5 | Oligonucleotides |
| HY-152449 | 3’-Beta-C-ethynyl-N6-(m-trifluoromethyl benzyl)adenosine | Oligonucleotides | |
| HY-15244A | Alpelisib (hydrochloride) | 1584128-91-5 | Reference compound |
| HY-15245 | GSK2636771 | 1372540-25-4 | Reference compound |
| HY-152450 | 5-Hydroxymethyl-2’-β-C-methyluridine | 2305415-92-1 | Oligonucleotides |
| HY-152451 | 3’-Beta-C-ethynyl-N6-(m-methoxybenzyl)adenosine | Oligonucleotides | |
| HY-152452 | 2′-Amino-2′-deoxycytidine | 26889-42-9 | Oligonucleotides |
| HY-152453 | 3’-Beta-C-ethynyl-N6-iso-pentenyl adenosine | Oligonucleotides | |
| HY-152454 | 4’-α-C-Methylcytidine | 153186-29-9 | Oligonucleotides |
| HY-152455 | 3’-Deoxy-N6-(m-methoxy benzyl)adenosine | Oligonucleotides | |
| HY-152456 | 2’-Amino-2’-deoxy-5-methylcytidine | 869729-45-3 | Oligonucleotides |
| HY-152457 | 3’-Deoxy-3’-fluoro-beta-D-xylo-inosine | 171667-46-2 | Oligonucleotides |
| HY-152459 | 2-(n-Propylidene hydrazino) adenosine | 144348-05-0 | Oligonucleotides |
| HY-15246 | Tovorafenib | 1096708-71-2 | Reference compound |
| HY-152460 | 2-Chloro-N6-cyclopentyl-2’-deoxy-2’-fluoro-beta-D-arabinoadenosine | 2216764-33-7 | Oligonucleotides |
| HY-152461 | N6-(3-Trifluoromethylbenzyl)-3’-deoxyadenosine | 2305415-80-7 | Oligonucleotides |
| HY-152462 | 8-Azaguanosine | 2133-80-4 | Oligonucleotides |
| HY-152463 | 4′-C-2-Propen-1-yluridine | 66723-28-2 | Oligonucleotides |
| HY-152464 | N1-Methyl-arabinoadenosine | 685880-77-7 | Oligonucleotides |
| HY-152465 | 5-Carboxymethyl-2-thiouridine | 58479-77-9 | Oligonucleotides |
| HY-152466 | 2’-O-Methyl-N1-methyladenosine | 91101-00-7 | Oligonucleotides |
| HY-152467 | 8-Aza-2’-beta-C-methylguanosine | Oligonucleotides | |
| HY-152468 | Antitumor agent-83 | Reference compound | |
| HY-152469 | Eleven-Nineteen-Leukemia Protein IN-1 | 2894121-68-5 | Reference compound |
| HY-15247 | Vistusertib | 1009298-59-2 | Reference compound |
| HY-152470 | Eleven-Nineteen-Leukemia Protein IN-2 | 2894121-78-7 | Reference compound |
| HY-152471 | Eleven-Nineteen-Leukemia Protein IN-3 | 2894121-83-4 | Reference compound |
| HY-152472 | ENT-C225 | 2919962-53-9 | Reference compound |
| HY-152473 | Topoisomerase IIα-IN-6 | Reference compound | |
| HY-152474 | 2’-β-C-Ethynylcytidine | 188413-99-2 | Oligonucleotides |
| HY-152475 | 2’-β-C-Ethynyladenosine | 640725-76-4 | Oligonucleotides |
| HY-152476 | 3’-β-C-Ethynyluridine | 180300-49-6 | Oligonucleotides |
| HY-152477 | 3’-β-C-Ethynyladenosine | 180300-54-3 | Oligonucleotides |
| HY-152478 | 3’-β-C-Ethynylguanosine | 180300-56-5 | Oligonucleotides |
| HY-152479 | Topoisomerase IIα-IN-7 | Reference compound | |
| HY-15248 | GDC-0349 | 1207360-89-1 | Reference compound |
| HY-152480 | 3’-O-(2-Methoxyethyl)-5-methylcytidine | 2243311-50-2 | Oligonucleotides |
| HY-152481 | N1-Methyl-2’-deoxy-2’-fluoroarabinoadenosine | Oligonucleotides | |
| HY-152482 | 3’-O-(2-Methoxyethyl)-2-thiouridine | 647839-20-1 | Oligonucleotides |
| HY-152483 | N4,N4-Dimethylarabinocytidine | 82855-64-9 | Oligonucleotides |
| HY-152484 | N7-Methyl-2’-deoxy-2’-fluoroarabinoguanosine | Oligonucleotides | |
| HY-152485 | 2-Amino-N6,N6-dimethyl-2’-deoxy-2’-fluoro-beta-D-arabino-adenosine | 2171103-80-1 | Oligonucleotides |
| HY-152486 | N1-Methyl-2’-deoxy-2’-fluoroarabinoguanosine | Oligonucleotides | |
| HY-152487 | 2-Amino-3’-deoxy-3’-fluoroadenosine | 125391-75-5 | Oligonucleotides |
| HY-152488 | 3’-β-C-Ethynyl-5-methyl uridine | 180300-52-1 | Oligonucleotides |
| HY-152489 | 8-Chloro-2’-deoxy-2’-fluoro inosine | Oligonucleotides | |
| HY-15249 | JZL 184 | 1101854-58-3 | Reference compound |
| HY-152490 | 3’-β-C-Ethynyl-N6,N6-dimethyladenosine | 565450-82-0 | Oligonucleotides |
| HY-152491 | 7-Cyclopropyl methyl-7,8-dihydro-8-oxo-9-(β-D-ribofuranosyl)guanine | 2763085-07-8 | Oligonucleotides |
| HY-152492 | 2’-Deoxy-2’-fluoro-N1-methyl inosine | 2376610-64-7 | Oligonucleotides |
| HY-152493 | 3’-O-(2-Methoxyethyl)guanosine | 256224-03-0 | Oligonucleotides |
| HY-152494 | 6-Methyl-9-(β-D-xylofuranosyl)purine | 16006-65-8 | Oligonucleotides |
| HY-152495 | MenA-IN-1 | Reference compound | |
| HY-152496 | 5-Hydroxymethyl xylouridine | 52448-09-6 | Oligonucleotides |
| HY-152497 | 3’-β-C-Methyl-2-thiouridine | Oligonucleotides | |
| HY-152498 | 3’-O-(2-Methoxyethyl)adenosine | 303197-30-0 | Oligonucleotides |
| HY-152499 | 1-Methyl-2'-O-methylinosine | 65150-69-8 | Oligonucleotides |
| HY-15250 | JZL195 | 1210004-12-8 | Reference compound |
| HY-152500 | 4-Deoxy-3’-β-C-methyluridine | 1106013-87-9 | Oligonucleotides |
| HY-152501 | 8-Chloro-2’-O-methyl inosine | Oligonucleotides | |
| HY-152502 | 5-N-Boc-aminomethyluridine | 2305415-73-8 | Oligonucleotides |
| HY-152503 | N6-Benzoyl-3’-O-(2-methoxyethyl)adenosine | 256223-99-1 | Oligonucleotides |
| HY-152504 | 2’-Deoxy-2’-fluoro-N1-methyladensoine | Oligonucleotides | |
| HY-152505 | 5-Methyl-4-thiouridine | 49555-43-3 | Oligonucleotides |
| HY-152506 | Antioxidant agent-8 | Reference compound | |
| HY-152507 | N1-Methyl-2’-beta-C-methyl inosine | Oligonucleotides | |
| HY-152508 | 8-Chloro-2’-beta-C-methyl inosine | 1106012-39-8 | Oligonucleotides |
| HY-152509 | N1-Methyl-2’-beta-C-methyl adenosine | Oligonucleotides | |
| HY-15251 | Reparixin | 266359-83-5 | Reference compound |
| HY-152510 | 5-(Aminomethyl)uridine | 190448-73-8 | Oligonucleotides |
| HY-152511 | 8-Methylthio-adenosine | 29836-01-9 | Oligonucleotides |
| HY-152512 | RLA-4842 | Reference compound | |
| HY-152513 | 2’-O-Methyl-4-thiouridine | 34218-80-9 | Oligonucleotides |
| HY-152514 | 5-Azidomethyl-2’-beta-methyl uridine | 2305415-72-7 | Oligonucleotides |
| HY-152516 | 2’-O-(2-Methoxyethyl) inosine | 545374-76-3 | Oligonucleotides |
| HY-152517 | 8-(Methylthio)guanosine | 2104-66-7 | Oligonucleotides |
| HY-152518 | 2’-O-Methyl-5-methyl-4-thiouridine | 2095417-26-6 | Oligonucleotides |
| HY-152519 | 5-(Aminomethyl)-2-thiouridine | 109666-14-0 | Oligonucleotides |
| HY-15251A | (Rac)-Reparixin | 957407-64-6 | Reference compound |
| HY-15252 | Reparixin (L-lysine salt) | 266359-93-7 | Reference compound |
| HY-152520 | RLA-5331 | Reference compound | |
| HY-152521 | 2-Amino-6-meThythio-9-(β-D-ribofuranosyl)-9H-purine | 4914-73-2 | Oligonucleotides |
| HY-152522 | 5-Fluoro-4’-C-methyluridine | 660845-69-2 | Oligonucleotides |
| HY-152523 | 5-(Azidomethyl) arauridine | 34349-03-6 | Oligonucleotides |
| HY-152524 | Androgen receptor antagonist 7 | 2409791-89-3 | Reference compound |
| HY-152525 | 5-(Azidomethyl)-2’-O-(2-methoxyethyl)uridine | 2305415-77-2 | Oligonucleotides |
| HY-152526 | 5-Fluoro-4’-C-methylcytidine | 791585-24-5 | Oligonucleotides |
| HY-152527 | 2’-Deoxy-2’-fluoro-4-thio-beta-D-arabinouridine | 892145-76-5 | Oligonucleotides |
| HY-152528 | 4’-C-Methyl-5-methylcytidine | 764644-12-4 | Oligonucleotides |
| HY-152529 | 4’-C-Methyl-5-methoxyuridine | 2305415-71-6 | Oligonucleotides |
| HY-15253 | Tiplaxtinin | 393105-53-8 | Reference compound |
| HY-152530 | 2’-beta-C-Methyl-4-thiouridine | 1106032-94-3 | Oligonucleotides |
| HY-152531 | 2-Amino-6-allyl thio-9-(beta-D-ribofuranosyl)-9H-purine | 92104-54-6 | Oligonucleotides |
| HY-152532 | 2’-Deoxy-2’-fluoro-6-S-Methyl-6-thio-ara-guanosine | 109304-11-2 | Oligonucleotides |
| HY-152533 | 5-Ethyl-4-thiouridine | 148744-32-5 | Oligonucleotides |
| HY-152534 | MenA-IN-2 | 3026690-49-0 | Reference compound |
| HY-152535 | ATV041 | 2935937-67-8 | Reference compound |
| HY-152536 | iNOS inhibitor-10 | 2918773-63-2 | Reference compound |
| HY-152537 | Antitumor agent-84 | Reference compound | |
| HY-152538 | Antitumor agent-85 | Reference compound | |
| HY-152539 | HIV-1 inhibitor-54 | 2771211-71-1 | Reference compound |
| HY-15254 | 3-O-(2-Aminoethyl)-25-hydroxyvitamin D3 | 163018-26-6 | Reference compound |
| HY-152540 | 5-Methoxy-4-thiouridine | 37805-89-3 | Oligonucleotides |
| HY-152541 | Adenosine 2-amidine hydrochloride | Oligonucleotides | |
| HY-152542 | 8-Allylthioadenosine | 75059-23-3 | Oligonucleotides |
| HY-152543 | 5-[3-[(Trifluoroacetyl)amino]propyl]uridine | 327623-80-3 | Oligonucleotides |
| HY-152544 | 8-Allylthioguanosine | 126092-30-6 | Oligonucleotides |
| HY-152545 | N1,N2-Dimethyl-2’-O-methylguanosine | 2305416-05-9 | Oligonucleotides |
| HY-152546 | 8-Allyloxyguanosine | 126138-81-6 | Oligonucleotides |
| HY-152547 | N2-[(N,N-Dimethyl amino]methylene-N1-methyl-2’-O-methylguanosine | 2305416-07-1 | Oligonucleotides |
| HY-152548 | 4’-C-Methyl-4-deoxyuridine | 1064364-21-1 | Oligonucleotides |
| HY-152549 | 2’-O-(2-Methoxyethyl)-2-aminoadenosine | 256224-13-2 | Oligonucleotides |
| HY-15255 | Zosuquidar | 167354-41-8 | Reference compound |
| HY-152551 | 4’-C-Methyl-2-thiouridine | 2305415-74-9 | Oligonucleotides |
| HY-152552 | α-Synuclein inhibitor 8 | 2883627-64-1 | Reference compound |
| HY-152553 | 4’-C-Methyl-N6-methyladenosine | 1064364-55-1 | Oligonucleotides |
| HY-152554 | 3’-Deoxy-3’-fluoro-xyloadenosine | 20535-16-4 | Oligonucleotides |
| HY-152555 | 2’-Amino-2’-deoxy-β-D-arabino-5-methyl uridine | 135304-48-2 | Oligonucleotides |
| HY-152556 | 3-Deaza-4’-C-methyluridine | 2305415-96-5 | Oligonucleotides |
| HY-152557 | 5-Methoxymethyluridine | 82448-44-0 | Oligonucleotides |
| HY-152558 | 5’(R)-C-Methyl-N6-methyladenosine | Oligonucleotides | |
| HY-152559 | 5-Ethoxymethyluridine | 95468-92-1 | Oligonucleotides |
| HY-15256 | Faldaprevir | 801283-95-4 | Reference compound |
| HY-152560 | HIV-1 inhibitor-55 | 2771211-73-3 | Reference compound |
| HY-152561 | 5’(R)-C-Methyl-2-thiouridine | 2305416-01-5 | Oligonucleotides |
| HY-152562 | N-Propargyladenosine | 67005-97-4 | Oligonucleotides |
| HY-152563 | N1-Methyl-2’-beta-C-methyl guanosine | Oligonucleotides | |
| HY-152564 | 2-Amino-N-(3-methyl-2-buten-1-yl)adenosine | 16051-64-2 | Oligonucleotides |
| HY-152565 | N6-Aminoadenosine | 5746-27-0 | Oligonucleotides |
| HY-152566 | N7-Methyl-2’-beta-C-methyl guanosine | Oligonucleotides | |
| HY-152567 | N1-Methyl-2’-O-(2-methoxyethyl) guanosine | Oligonucleotides | |
| HY-152568 | N7-Methyl-2’-O-(2-methoxyethyl) guanosine | Oligonucleotides | |
| HY-152569 | N1-Methyl-2’-O-(2-methoxyethyl) adenosine | Oligonucleotides | |
| HY-15256A | Faldaprevir (sodium) | 1215856-44-2 | Reference compound |
| HY-15256S | Faldaprevir-d6 | 2750534-88-2 | Isotope-Labeled Compounds |
| HY-15256S1 | Faldaprevir-d7 | 1613250-18-2 | Isotope-Labeled Compounds |
| HY-15257 | Mavoglurant | 543906-09-8 | Reference compound |
| HY-152570 | N6-Methyl-2’-O-(2-methoxyethyl) adenosine | Oligonucleotides | |
| HY-152571 | N1-Methyl-2’-O-(2-methoxyethyl) inosine | Oligonucleotides | |
| HY-152572 | 6-(4-Morpholinyl)-9-β-D-ribofuranosyl-9H-purine | 52940-48-4 | Oligonucleotides |
| HY-152573 | N1-Methyl-3’-O-(2-methoxyethyl) adenosine | Oligonucleotides | |
| HY-152574 | 5-Amino-2’-deoxy-2’-O-methyluridine hydrochloride | Oligonucleotides | |
| HY-152575 | N6-Methyl-3’-O-(2-methoxyethyl) adenosine | Oligonucleotides | |
| HY-152576 | CB2R agonist 1 | 1817633-49-0 | Reference compound |
| HY-152577 | 3’-O-(2-Methoxyethyl) inosine | Oligonucleotides | |
| HY-152578 | 7-(2,3-Anhydro-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 40627-31-4 | Oligonucleotides |
| HY-152579 | 6-(1-Piperazinyl)-9-β-D-ribofuranosyl-9H-purine | 121370-61-4 | Oligonucleotides |
| HY-15257A | Mavoglurant (racemate) | 1636881-61-2 | Reference compound |
| HY-15258 | Lesinurad | 878672-00-5 | Reference compound |
| HY-152580 | 5-[3-[(2,2,2-Trifluoroacetyl)amino]-1-propyn-1-yl]uridine | 120609-05-4 | Oligonucleotides |
| HY-152581 | CB2R antagonist 3 | Reference compound | |
| HY-152582 | 7-(3-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 40725-89-1 | Oligonucleotides |
| HY-152583 | 3’-Azido-3’-deoxy-5-methyl-beta-L-uridine | 2095417-10-8 | Oligonucleotides |
| HY-152584 | 3’-Deoxy-3’-fluoro-xyloguanosine | 125291-15-8 | Oligonucleotides |
| HY-152585 | 3’-Azido-3’-deoxy-5-fluoro-beta-L-uridine | 2095417-40-4 | Oligonucleotides |
| HY-152586 | 2′,3′-Anhydroadenosine | 2627-64-7 | Oligonucleotides |
| HY-152587 | N1-Methyl-3’-O-(2-methoxyethyl) inosine | Oligonucleotides | |
| HY-152588 | 3’-Deoxy-N1-methyladenosine | 77667-51-7 | Oligonucleotides |
| HY-152589 | Antiviral agent 25 | 2761367-25-1 | Reference compound |
| HY-15258A | Lesinurad (sodium) | 1151516-14-1 | Reference compound |
| HY-15258S1 | Lesinurad-d4 | 1850305-60-0 | Isotope-Labeled Compounds |
| HY-15259 | CP-640186 | 591778-68-6 | Reference compound |
| HY-152590 | 3’-Deoxy-N6-methyladenosine | 3616-27-1 | Oligonucleotides |
| HY-152591 | 4’-Methyl-5-methyluridine | 152540-75-5 | Oligonucleotides |
| HY-152592 | 3’-Azido-3’-deoxy-beta-L-cytidine | 2095417-59-5 | Oligonucleotides |
| HY-152593 | 3’-Deoxy-N1-methylguanosine | Oligonucleotides | |
| HY-152594 | Uridine-5-oxyacetic acid | 28144-25-4 | Oligonucleotides |
| HY-152595 | 3’-Azido-3’-deoxy-5-methyl-beta-L-cytidine | 2095417-52-8 | Oligonucleotides |
| HY-152597 | 3’-Azido-3’-deoxy-5-fluoro-beta-L-cytidine | 2095417-76-6 | Oligonucleotides |
| HY-152598 | N1-Methylxylo-guanosine | Oligonucleotides | |
| HY-152599 | 4’-Methyladenosine | 152540-76-6 | Oligonucleotides |
| HY-15259A | CP-640186 (hydrochloride) | 591778-70-0 | Reference compound |
| HY-15260 | XL413 | 1169558-38-6 | Reference compound |
| HY-152601 | 3’-Azido-3’-deoxy-beta-L-adenosine | 216976-76-0 | Oligonucleotides |
| HY-152602 | 1,3'-Dimethylguanosine | 74466-66-3 | Oligonucleotides |
| HY-152603 | 2-Amino-1-β-D-arabinofuranosyl-5-methyl-4(1H)-pyrimidinone | 10212-31-4 | Oligonucleotides |
| HY-152604 | 3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide | 356782-84-8 | Oligonucleotides |
| HY-152605 | 2’-Deoxy-2’-fluoro-6-S-methyl-6-thio-arabino-inosine | 109304-12-3 | Oligonucleotides |
| HY-152606 | N6-Ethyl-2’-C-methyladenosine | 714250-18-7 | Oligonucleotides |
| HY-152607 | N,N-Dimethyl-2′-O-methyladenosine | 30891-53-3 | Oligonucleotides |
| HY-152608 | N6-iso-Propyladenosine | 17270-23-4 | Oligonucleotides |
| HY-152609 | N1-Cyanomethyl pseudouridine | Oligonucleotides | |
| HY-15260A | XL413 (monohydrochloride) | 2062200-97-7 | Reference compound |
| HY-15260C | XL413 (hydrochloride) | 1169562-71-3 | Reference compound |
| HY-152610 | 3′-C-Methylguanosine | 115303-89-4 | Oligonucleotides |
| HY-152611 | N1-Methyl-5-methyl ara-uridine | 887113-66-8 | Oligonucleotides |
| HY-152612 | 2’-Deoxy-2’-fluoro-5-hydroxymethyl arabinouridine | 94817-51-3 | Oligonucleotides |
| HY-152613 | N2-Ethylguanosine | 77312-39-1 | Oligonucleotides |
| HY-152614 | Antimalarial agent 19 | 2897630-89-4 | Reference compound |
| HY-152615 | 4’-Methylguanosine | 153186-32-4 | Oligonucleotides |
| HY-152616 | 2-Amino-3,7-dihydro-5-iodo-7-β-D-ribofuranosyl-4H-pyrrolo[2,3-d]pyrimidin-4-one | 444020-71-7 | Oligonucleotides |
| HY-152617 | 4’-Thioinosine | 58004-19-6 | Oligonucleotides |
| HY-152618 | 3’-N-Acetyl-3’-amino-3’-deoxyuridine | 2305415-89-6 | Oligonucleotides |
| HY-152619 | N6,N6-Dimethyl-4’-thio-adenosine | 25795-69-1 | Oligonucleotides |
| HY-15262 | SRT 2104 | 1093403-33-8 | Reference compound |
| HY-152620 | 2-(N,N-Dimethylamino)-N6,N6-dimethyladenosine | 2305415-86-3 | Oligonucleotides |
| HY-152621 | N6-Ethyl-4’-thio-adenosine | Oligonucleotides | |
| HY-152622 | 3’-Deoxy-5-methyluridine | 7084-29-9 | Oligonucleotides |
| HY-152623 | 3’-O-Propargyladenosine | 2305416-10-6 | Oligonucleotides |
| HY-152624 | N6-Methyl-4’-thio-adenosine | 900810-24-4 | Oligonucleotides |
| HY-152625 | 2’-Beta-C-Ethynyl inosine | 2183487-92-3 | Oligonucleotides |
| HY-152626 | N6-Ethyl-2’-beta-C-ethynyl adenosine | Oligonucleotides | |
| HY-152627 | N6-Methyl-2’-beta-C-ethynyl adenosine | Oligonucleotides | |
| HY-152628 | 3’-Deoxy-3-deazauridine | 2095417-74-4 | Oligonucleotides |
| HY-152629 | 2’-β-C-Methyl-5-methyluridine | 119410-84-3 | Oligonucleotides |
| HY-15263 | Retaspimycin | 857402-23-4 | Reference compound |
| HY-152630 | 3’-Deoxy-5-fluorouridine | 18829-83-9 | Oligonucleotides |
| HY-152631 | 3’-Deoxy-5-methoxyuridine | 2095417-49-3 | Oligonucleotides |
| HY-152632 | BuChE-IN-7 | Reference compound | |
| HY-152633 | 3’-Deoxy-N6,N6-dimethyladenosine | 3608-59-1 | Oligonucleotides |
| HY-152634 | 8-Chloro-2’-deoxy-2’-fluoro-arabino adenosine | Oligonucleotides | |
| HY-152635 | 8-Chloro-2’-O-methyl adenosine | 634207-55-9 | Oligonucleotides |
| HY-152636 | 2-Cyanomethylthioadenosine | 2095417-67-5 | Oligonucleotides |
| HY-152637 | 2-Benzylthioadenosine | 43157-48-8 | Oligonucleotides |
| HY-152638 | 2-Amino-3’-O-methyladenosine | 80791-88-4 | Oligonucleotides |
| HY-152639 | 2’-Chlorothymidine | 54898-34-9 | Oligonucleotides |
| HY-15264 | MC 1046 | 126860-83-1 | Reference compound |
| HY-152640 | 5-Fluoro-4’-thio-cytidine | Oligonucleotides | |
| HY-152642 | 2’-Azido-2’-deoxy-5-methyl cytidine | 2095417-75-5 | Oligonucleotides |
| HY-152643 | 6-Methylpseudouridine | 1613530-10-1 | Oligonucleotides |
| HY-152644 | 2’-β-C-Methyl-5-methoxyuridine | 2072145-45-8 | Oligonucleotides |
| HY-152645 | 3’-Azido-3’-deoxy-5-methyluridine | 215176-58-2 | Oligonucleotides |
| HY-152646 | 3’-O-(2-Methoxyethyl)-2-aminoadenosine | 256224-02-9 | Oligonucleotides |
| HY-152647 | 6-Methoxypurine-9-beta-D-(3-methoxy riboside) | Oligonucleotides | |
| HY-152648 | N6-Ethyl-2’-O-methyladenosine | 157309-11-0 | Oligonucleotides |
| HY-152649 | N1-Cyclopropylmethylpseudouridine | 1613530-18-9 | Oligonucleotides |
| HY-15265 | Impurity F of Calcipotriol | 112875-61-3 | Reference compound |
| HY-152650 | N6-Methyl-2-methyl thioadenosine | 6741-71-5 | Oligonucleotides |
| HY-152651 | 5’(R)-C-Methyl-3-deazauridine | 2305415-82-9 | Oligonucleotides |
| HY-152652 | 5’(R)-C-Methylguanosine | 85421-89-2 | Oligonucleotides |
| HY-152653 | N6-iso-Propyl-2’-O-methyladenosine | 2803878-84-2 | Oligonucleotides |
| HY-152654 | 4′-Thiocytidine | 93080-09-2 | Oligonucleotides |
| HY-152655 | 6-Ethoxy-9-beta-D-(2-C-methyl-ribofuranosyl)purine | 848750-87-8 | Oligonucleotides |
| HY-152656 | 2-Hydrazinyl-adenosine | 15763-11-8 | Oligonucleotides |
| HY-152657 | N1-Methyl-N3-[(2S)-2-(t-butoxycarbonyl)amino-3-(t-butoxycarbonyl)] propylpseudouridine | 1613530-24-7 | Oligonucleotides |
| HY-152658 | 5-Phenylcytidine | 83866-19-7 | Oligonucleotides |
| HY-152659 | N1-Propargylpseudouridine | 1464021-70-2 | Oligonucleotides |
| HY-15266 | 24R-Calcipotriol | 112827-99-3 | Reference compound |
| HY-152660 | 2-Amino-6-O-methyl-2’-O-methyl purine riboside | Oligonucleotides | |
| HY-152661 | 2-Hydroxy-2’-deoxy-2’-fluoro-beta-D-arabino adenosine | 899827-82-8 | Oligonucleotides |
| HY-152662 | 2’,3’-Dideoxy-5-fluorocytidine | 107036-62-4 | Oligonucleotides |
| HY-152663 | 6-Mthoxy-9-beta-D-(2-C-ethynyl-ribofuranosyl) purine | Oligonucleotides | |
| HY-152664 | 1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine | 136020-18-3 | Oligonucleotides |
| HY-152665 | 1-(β-D-Xylofuranosyl)uracil | 16535-78-7 | Oligonucleotides |
| HY-152666 | 5-Methyl-4’-thiocytidine | 1312295-87-6 | Oligonucleotides |
| HY-152667 | 1-(β-D-Xylofuranosyl)-5-methyluracil | 52486-19-8 | Oligonucleotides |
| HY-152668 | Urease-IN-4 | Reference compound | |
| HY-152669 | Urease-IN-5 | Reference compound | |
| HY-15267 | MC 976 | 129831-99-8 | Reference compound |
| HY-152670 | JC2-11 | 937820-89-8 | Reference compound |
| HY-152671 | hMAO-B-IN-4 | 1666119-75-0 | Reference compound |
| HY-152672 | 9-(β-D-Xylofuranosyl)adenine | 524-69-6 | Oligonucleotides |
| HY-152673 | 9-(β-D-Xylofuranosyl)guanine | 27462-39-1 | Oligonucleotides |
| HY-152674 | 2′-Deoxy-2′-fluoro-5-methoxy-arabinouridine | 2305415-76-1 | Oligonucleotides |
| HY-152675 | 2’-Amino-2’-deoxy-β-D-arabinouridine | 68115-81-1 | Oligonucleotides |
| HY-152676 | 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethyl-2,4(1H,3H)-pyrimidinedione | 83546-42-3 | Oligonucleotides |
| HY-152677 | N3-(2-Methoxy)ethyluridine | Oligonucleotides | |
| HY-152678 | 6-Methoxypurine-9-β-D-5’(R)-C-methylriboside | Oligonucleotides | |
| HY-152679 | 2-Amino-2′-O-(2-methoxy-2-oxoethyl)adenosine | 433288-71-2 | Oligonucleotides |
| HY-15267A | (24R)-MC 976 | 112828-09-8 | Reference compound |
| HY-15267B | (24S)-MC 976 | 112849-14-6 | Reference compound |
| HY-15268 | PP487 | 1092787-12-6 | Reference compound |
| HY-152680 | 4-Amino-5-cyano-1- (β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine | 1704-25-2 | Oligonucleotides |
| HY-152681 | N3-[(Tetrahydro-2-furanyl)methyl]uridine | 122666-26-6 | Oligonucleotides |
| HY-152682 | 5-Ethyluridine | 25110-76-3 | Oligonucleotides |
| HY-152683 | 3-(2-Pyridinylmethyl)uridine | 1427676-15-0 | Oligonucleotides |
| HY-152684 | 2′-O-2-Propyn-1-ylguanosine | 206552-86-5 | Oligonucleotides |
| HY-152685 | 4-Amino-1-(β-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine-5-carboxamide | Oligonucleotides | |
| HY-152686 | 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-methoxy-9H-purine | 758705-70-3 | Oligonucleotides |
| HY-152687 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine | 1612191-99-7 | Oligonucleotides |
| HY-152688 | 3’-Azido-3’-deoxy-5-fluorouridine | 307520-05-4 | Oligonucleotides |
| HY-152689 | 2’-Deoxy-2’-fluoro-N3-(4-nitrobenzyl)-beta-D-arabinouridine | 2072145-77-6 | Oligonucleotides |
| HY-15269 | PP30 | 1092788-09-4 | Reference compound |
| HY-152690 | 2’-Deoxy-2’-fluoro-N3-[(pyrid-2-yl)methyl]-beta-D-arabinouridine | 2072145-51-6 | Oligonucleotides |
| HY-152691 | 2’-Deoxy-2’-fluoro-N3-(n-dodecyl)-beta-D-arabinouridine | 2072145-43-6 | Oligonucleotides |
| HY-152693 | N4-Methyl-2’-O-methyl-cytidine | 13048-95-8 | Oligonucleotides |
| HY-152694 | 5-Vinylcytidine | 1846584-62-0 | Oligonucleotides |
| HY-152695 | 6-Methoxy purine-9-beta-D-(3’-deoxy-3’-fluoro)riboside | 2072145-35-6 | Oligonucleotides |
| HY-152696 | 6-O-Methylinosine | 5746-29-2 | Oligonucleotides |
| HY-152697 | 2-Methyladenosine | 16526-56-0 | Oligonucleotides |
| HY-152698 | 5-Methyl-4’-thiouridine | 13406-51-4 | Oligonucleotides |
| HY-152699 | N6-Methyladenosine N1-oxide | 113509-54-9 | Oligonucleotides |
| HY-15270 | BMS-911543 | 1271022-90-2 | Reference compound |
| HY-152700 | 5-Methoxy-2-thiouridine | 30771-43-8 | Oligonucleotides |
| HY-152701 | 5-Aminocarbonylmethyl-2-thiouridine | 29900-40-1 | Oligonucleotides |
| HY-152702 | 2,8-Dimethyladenosine | 63954-66-5 | Oligonucleotides |
| HY-152703 | 2-Amino-7-cyclopropyl methyl-7,8-dihydro-8-oxo-9-(beta-D-xylo furanosyl)purine | 2389988-30-9 | Oligonucleotides |
| HY-152704 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine | 1612191-98-6 | Oligonucleotides |
| HY-152705 | 5-Bromo-2’-deoxy-2’-fluoro-beta-D-arabinocytidine | 69123-93-9 | Oligonucleotides |
| HY-152706 | 2’-O-Methyl-N2,N2-dimethyl-guanosine | 113886-73-0 | Oligonucleotides |
| HY-152707 | 2-Amino-2′-C-methyladenosine | 640725-73-1 | Oligonucleotides |
| HY-152708 | 3’-Azido-3’-deoxy-5-trifluoromethyluridine | 2095417-62-0 | Oligonucleotides |
| HY-152709 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(5-phenylpyridin-3-yl)purine | 1612191-96-4 | Oligonucleotides |
| HY-15271 | WYE-687 | 1062161-90-3 | Reference compound |
| HY-152710 | 5-Methoxycarbonylmethyl-2-thiouridine | 20299-15-4 | Oligonucleotides |
| HY-152711 | 2-Chloro-2’-β-C-methyl-6-N,N-dimethyladenosine | 2095417-43-7 | Oligonucleotides |
| HY-152712 | 5-Bromo-3’-deoxy-3’-fluorouridine | 439579-22-3 | Oligonucleotides |
| HY-152713 | 3’-Azido-3’-deoxy-5-methoxyuridine | 2095417-70-0 | Oligonucleotides |
| HY-152714 | 5-Formyl-2’-O-methylcytidine | 176858-79-0 | Oligonucleotides |
| HY-152715 | 2’-C-β-Methyl-4-deoxyuridine | 1106032-88-5 | Oligonucleotides |
| HY-152717 | 2’-O-Methyl-2-thiouridine | 113886-72-9 | Oligonucleotides |
| HY-152718 | 4-Amino-1-(2-C-methyl-β-D-ribofuranosyl)-1H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | 847651-51-8 | Oligonucleotides |
| HY-152719 | 8-Benzyloxyadenosine | 131265-29-7 | Oligonucleotides |
| HY-15271A | WYE-687 (dihydrochloride) | 1702364-87-1 | Reference compound |
| HY-15272 | WAY-600 | 1062159-35-6 | Reference compound |
| HY-152720 | 3’-Azido-3’-deoxyuridine | 70580-88-0 | Oligonucleotides |
| HY-152721 | 3’-O-Methyl-4-deoxy uridine | 2095417-12-0 | Oligonucleotides |
| HY-152723 | 2-Amino-N,N-dimethyl-2′-C-methyladenosine | 1336975-57-5 | Oligonucleotides |
| HY-152724 | 3’-Azido-3’-deoxy-5-iodouridine | 2072145-33-4 | Oligonucleotides |
| HY-152725 | N1-Benzyl pseudouridine | 1613530-22-5 | Oligonucleotides |
| HY-152726 | TLR7 agonist 9 | 2389988-38-7 | Reference compound |
| HY-152727 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(naphthalen-1-yl)purine | 1612191-92-0 | Oligonucleotides |
| HY-152728 | 3’-Azido-3’-deoxycytidine | 70580-87-9 | Oligonucleotides |
| HY-152729 | 5-(2-Amino-2-oxoethyl)uridine | 29569-30-0 | Oligonucleotides |
| HY-15273 | UNC0638 | 1255580-76-7 | Reference compound |
| HY-152730 | 3’-Deoxy-3’-fluoroinosine | 117517-20-1 | Oligonucleotides |
| HY-152731 | 3′-Deoxy-3′-methylcytidine | 444020-09-1 | Oligonucleotides |
| HY-152732 | 6-Methyluridine | 16710-13-7 | Oligonucleotides |
| HY-152733 | 8-Aza-7-bromo-7-deazaguanosine | 96555-37-2 | Oligonucleotides |
| HY-152734 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(pyridine-4-yl)purine | 1612191-93-1 | Oligonucleotides |
| HY-152735 | 5-[[Methyl(2,2,2-trifluoroacetyl)amino]methyl]-2-thiouridine | 89128-99-4 | Oligonucleotides |
| HY-152736 | 3’-Deoxy-3’-fluoro-5-methyl-xylo-uridine | 917110-29-3 | Oligonucleotides |
| HY-152737 | 3’-Deoxy-3’-azido-isocytidine | 2095417-77-7 | Oligonucleotides |
| HY-152738 | 2’-β-C-Methyl-3-deazauri dine | 622379-93-5 | Oligonucleotides |
| HY-152739 | 5-(N-Isopentenyl-N-trifluoroacetyl) aminomethyluridine | 1613530-43-0 | Oligonucleotides |
| HY-15274 | L-798106 | 244101-02-8 | Reference compound |
| HY-152740 | 5-Pyrrolidinomethyluridine | 1613530-41-8 | Oligonucleotides |
| HY-152741 | 2’-β-C-Methyl-2-thiouridine | 1678507-60-2 | Oligonucleotides |
| HY-152742 | 8-(N,N-Dimethylaminomethyl)guanosine | Oligonucleotides | |
| HY-152743 | 8-Aza-7-deazguanosine | 85426-74-0 | Oligonucleotides |
| HY-152744 | 2’-O-Propargyladenosine | 151390-97-5 | Oligonucleotides |
| HY-152745 | 2’-β-C-Methyl-5-trifluoromethyluridine | 2072145-39-0 | Oligonucleotides |
| HY-152746 | 2-Amino-6-chloropurine-9-(2’-O-propargyl)riboside | 2095417-35-7 | Oligonucleotides |
| HY-152747 | 5-β-D-Ribofuranosyl-2(1H)-pyridinone | 188871-50-3 | Oligonucleotides |
| HY-152748 | Caspase-3/7 activator 1 | Reference compound | |
| HY-152749 | 2’-β-C-Methyl-5-fluorouridine | 23643-38-1 | Oligonucleotides |
| HY-15275 | BMS-265246 | 582315-72-8 | Reference compound |
| HY-152750 | 2-Amino-N6,N6-dimethyl-2’-O-methyladenosine | 2095417-19-7 | Oligonucleotides |
| HY-152752 | 2’,3’-Dideoxy-3’-fluorocytidine | 51246-79-8 | Oligonucleotides |
| HY-152753 | 3’-Deoxy-3’-fluoro-5-methyluridine | 125217-37-0 | Oligonucleotides |
| HY-152754 | 3’-Deoxy-3’-fluoro-2-thiouridine | 439579-24-5 | Oligonucleotides |
| HY-152755 | 4’-Cyanouridine | 232589-05-8 | Oligonucleotides |
| HY-152756 | Caspase-3/7 activator 2 | Reference compound | |
| HY-152757 | 3’-Deoxy-3’-fluoro-5-trifluoromethyluridine | 439579-21-2 | Oligonucleotides |
| HY-152758 | Caspase-3/7 activator 3 | Reference compound | |
| HY-152759 | 3’-Deoxy-3’-fluoro-xylocytidine | 26563-01-9 | Oligonucleotides |
| HY-15276 | 4-Aminonaphthalimide | 1742-95-6 | Reference compound |
| HY-152760 | 3’-Deoxy-3’-fluoro-5-fluorouridine | 112668-56-1 | Oligonucleotides |
| HY-152761 | 3’-Deoxy-3’-fluoro-5-methoxyluridine | 2072145-76-5 | Oligonucleotides |
| HY-152762 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-phenylpurine | 1612191-91-9 | Oligonucleotides |
| HY-152763 | 2’-Deoxy-2’-fluoro-5-methylcytidine | 182495-80-3 | Oligonucleotides |
| HY-152764 | 4’-α-C-Methyluridine | 153186-26-6 | Oligonucleotides |
| HY-152765 | 3′-Deoxy-3′-fluorouridine | 57944-13-5 | Oligonucleotides |
| HY-152766 | 6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside | 1612191-90-8 | Oligonucleotides |
| HY-152767 | N1-Ethylpseudouridine | 1613529-72-8 | Oligonucleotides |
| HY-152768 | N1-(1,1,1-Trifluoroethyl)pseudouridine | 1613529-80-8 | Oligonucleotides |
| HY-152769 | 2-Methoxy-2’-deoxy-2’-fluoro-beta-D-arabinoadenosine | 1093278-52-4 | Oligonucleotides |
| HY-15277 | AM966 | 1228690-19-4 | Reference compound |
| HY-152770 | 6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-imidazo[1,2-c]pyrimidin-5-one | 2095417-54-0 | Oligonucleotides |
| HY-152771 | 3′-Deoxy-3′-fluorocytidine | 123402-20-0 | Oligonucleotides |
| HY-152772 | 2-Amino-6-chloropurine-9-beta-D-(2’-deoxy-2’-fluoro)-arabinoriboside | 144924-88-9 | Oligonucleotides |
| HY-152773 | 2,6-Diamino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine | 103884-97-5 | Oligonucleotides |
| HY-152774 | Antitumor agent-86 | 2907704-65-6 | Reference compound |
| HY-152775 | RK-701 | 2648855-18-7 | Reference compound |
| HY-152775A | RK-0133114 | Reference compound | |
| HY-152776 | 2-Amino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine | 109304-04-3 | Oligonucleotides |
| HY-152777 | 5’(R)-C-Methyluridine | 72159-54-7 | Oligonucleotides |
| HY-152778 | 2-Chloro-3’-deoxy-3’-fluoroadenosine | 122654-30-2 | Oligonucleotides |
| HY-152779 | 5-Methoxy-5’(R)-C-methyluridine | Oligonucleotides | |
| HY-15278 | Epothilone D | 189453-10-9 | Reference compound |
| HY-152780 | 9-(2’-Deoxy-2’-fluoro-β-D-arabinofuranosyl)-9H-purine | 109304-16-7 | Oligonucleotides |
| HY-152781 | 5’(R)-C-Methyl-5-methyluridine | 129745-35-3 | Oligonucleotides |
| HY-152782 | 4’-Azido-2’-deoxy-2’-fluoro-beta-D-arabinouridine | 173379-73-2 | Oligonucleotides |
| HY-152783 | 5’(R)-C-Methyl-5-fluorouridine | Oligonucleotides | |
| HY-152784 | 5’(R)-C-Methylcytidine | 72159-53-6 | Oligonucleotides |
| HY-152785 | 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-9H-Purine | 124775-29-7 | Oligonucleotides |
| HY-152787 | 5-(3-Azidopropyl)cytidine | Oligonucleotides | |
| HY-152788 | 2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside | 1612192-00-3 | Oligonucleotides |
| HY-152789 | 5-(2-Azidoethyl)cytidine | Oligonucleotides | |
| HY-15278A | (16R)-Epothilone D | Reference compound | |
| HY-15278R | Epothilone D (Standard) | 189453-10-9 | Reference Standards |
| HY-152790 | 5-(2-Hydroxyethyl)uridine | 102691-28-1 | Oligonucleotides |
| HY-152791 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-methyl-9H-purine | 1612191-88-4 | Oligonucleotides |
| HY-152792 | 2’-Deoxy-2’-fluoro-N3-[(pyrid-2-yl)methyl]uridine | Oligonucleotides | |
| HY-152793 | 7-Cyano-7-deazaguanosine | 61210-21-7 | Oligonucleotides |
| HY-152794 | 7-Methyl wyosine | 577773-09-2 | Oligonucleotides |
| HY-152795 | N4-Desmethyl wyosine | 59327-60-5 | Oligonucleotides |
| HY-152796 | 5-Furan-2-yl-2’-O-methyl uridine | 2095417-32-4 | Oligonucleotides |
| HY-152797 | N4-Desmethyl-N5-Methyl wyosine | 59327-63-8 | Oligonucleotides |
| HY-152798 | 5-Iodo-2’-β-C-methyl uridine | 1203461-96-4 | Oligonucleotides |
| HY-152799 | 5-Naphthyl-beta-methylaminocarbony-2’-O-methyluridine | 1675178-56-9 | Oligonucleotides |
| HY-15280 | GSK2292767 | 1254036-66-2 | Reference compound |
| HY-152800 | 7-Deazaguanosine | 62160-23-0 | Oligonucleotides |
| HY-152801 | 5-Naphthyl-β-methylaminocarbony-3’-O-acetyl-2’-O-methyluridine | 2095417-03-9 | Oligonucleotides |
| HY-152802 | 2’-O-(3-Azidopropyl)-5-azacytidine | Oligonucleotides | |
| HY-152803 | 5-Iodo-3’-deoxy-3’-fluorouridine | 2072145-21-0 | Oligonucleotides |
| HY-152804 | 5-Iodo-2’-β-C-methyl cytidine | 2072145-60-7 | Oligonucleotides |
| HY-152805 | 9-(2-β-C-Methyl-β-D-ribofuranosyl)purine | 690269-86-4 | Oligonucleotides |
| HY-152806 | 2-Amino-6-chloro-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine | 640725-74-2 | Oligonucleotides |
| HY-152807 | 4’-Thioadenosine | 2500-80-3 | Oligonucleotides |
| HY-152808 | 6-(2-Furanyl)-9-β-D-ribofuranosyl-9H-purine | 352025-81-1 | Oligonucleotides |
| HY-152809 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(furan-2-yl)purine | 1612191-89-5 | Oligonucleotides |
| HY-15281 | QL-IX-55 | 1223002-54-7 | Reference compound |
| HY-152810 | 2-Amino-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine | 690269-87-5 | Oligonucleotides |
| HY-152811 | 2′-Deoxy-2′-fluoro-5-methyl-arabinocytidine | 78636-53-0 | Oligonucleotides |
| HY-152812 | 2-Chloro-2′-β-C-methyladenosine | 205171-11-5 | Oligonucleotides |
| HY-152813 | 2′-Deoxy-2′-fluoro-4-deoxy-arabinouridine | 136675-88-2 | Oligonucleotides |
| HY-152814 | 2′-β-C-Methyl isoguanosine | 714249-83-9 | Oligonucleotides |
| HY-152815 | 2′-Deoxy-2′-fluoro-3-deaza-arabinouridine | 2095417-48-2 | Oligonucleotides |
| HY-152816 | 2′-β-C-Methyl-2-methoxyadenosine | 1829554-43-9 | Oligonucleotides |
| HY-152817 | 2′-β-C-Methyl-beta-D-6-methylpurine riboside | 2095417-06-2 | Oligonucleotides |
| HY-152818 | 4-Chloro-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine | 443642-33-9 | Oligonucleotides |
| HY-152819 | 4-Amino-5-iodo-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | 847551-49-9 | Oligonucleotides |
| HY-15282 | E-64 | 66701-25-5 | Reference compound |
| HY-152820 | 2'-Deoxy-2'-fluoro-5-trifluoromethyl-arabinouridine | 114652-80-1 | Oligonucleotides |
| HY-152821 | 5-Methoxy-4’-thiouridine | Oligonucleotides | |
| HY-152822 | 5-Iodo-2’-O-methylcytidine | 847650-69-5 | Oligonucleotides |
| HY-152823 | 5-Benzylaminocarbonyl-2’-O-methyluridine | 1648558-95-5 | Oligonucleotides |
| HY-152824 | (R)-N-(2,3-Dihydro-1H-indenyl)-2-amino adenosine | Oligonucleotides | |
| HY-152827 | 4-Methoxy-1-β-D-ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine | 1611486-54-4 | Oligonucleotides |
| HY-152828 | 1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine | 70421-30-6 | Oligonucleotides |
| HY-15283 | Clopidogrel | 113665-84-2 | Reference compound |
| HY-152830 | Adrixetinib | 2394874-66-7 | Reference compound |
| HY-152830A | Adrixetinib (TFA) | Reference compound | |
| HY-152831 | 2-Amino-8-aza-7-deaza-7-iodoguanosine | 1997362-13-6 | Oligonucleotides |
| HY-152834 | 8-Methoxyadenosine | 3969-27-5 | Oligonucleotides |
| HY-152835 | 8-(Methylamino)adenosine | 13389-13-4 | Oligonucleotides |
| HY-152836 | 2’-O-Methyl-5-hydroxymethyluridine | 910050-95-2 | Oligonucleotides |
| HY-152837 | 1,3-Dimethyl pseudouridine | 64272-68-0 | Oligonucleotides |
| HY-152838 | Gemlapodect | 1380329-87-2 | Reference compound |
| HY-152839 | Elenestinib | 2505078-08-8 | Reference compound |
| HY-152839A | Elenestinib (phosphate) | 2832013-93-9 | Reference compound |
| HY-15283AS | (±)-Clopidogrel-d7 (sulfate) | 1346598-07-9 | Isotope-Labeled Compounds |
| HY-15283R | Clopidogrel (Standard) | 113665-84-2 | Reference Standards |
| HY-15284 | Prasugrel | 150322-43-3 | Reference compound |
| HY-152840 | Emzeltrectinib | 2223678-97-3 | Reference compound |
| HY-152843 | Fazamorexant | 1808918-69-5 | Reference compound |
| HY-152844 | Faznolutamide | 1272719-08-0 | Reference compound |
| HY-152845 | Ficonalkib | 2233574-95-1 | Reference compound |
| HY-152846 | Flizasertib | 2268739-68-8 | Reference compound |
| HY-152847 | Foslevcromakalim | 1802655-72-6 | Reference compound |
| HY-152848 | Fulzerasib | 2641747-54-6 | Reference compound |
| HY-152849 | Boditrectinib | 1940165-80-9 | Reference compound |
| HY-152849A | Boditrectinib (oxalate) | 2773577-41-4 | Reference compound |
| HY-15284A | Prasugrel (hydrochloride) | 389574-19-0 | Reference compound |
| HY-15284AR | Prasugrel (hydrochloride) (Standard) | 389574-19-0 | Reference Standards |
| HY-15284B | Prasugrel (Maleic acid) | 389574-20-3 | Reference compound |
| HY-15284R | Prasugrel (Standard) | 150322-43-3 | Reference Standards |
| HY-15284S | Prasugrel-d5 | 1127252-92-9 | Isotope-Labeled Compounds |
| HY-15284S1 | Prasugrel-d3 | 1127253-02-4 | Isotope-Labeled Compounds |
| HY-15284S2 | Prasugrel-d4 | 1189919-49-0 | Isotope-Labeled Compounds |
| HY-15284S3 | Prasugrel-13C6 | 1261394-83-5 | Isotope-Labeled Compounds |
| HY-15285 | Doxercalciferol-d3 | Isotope-Labeled Compounds | |
| HY-152850 | Gumelutamide | 1831085-48-3 | Reference compound |
| HY-152850A | Gumelutamide (monosuccinate) | 2842844-51-1 | Reference compound |
| HY-152851 | Izumerogant | 2299252-72-3 | Reference compound |
| HY-152852 | Mefatinib (free base) | 1639014-72-4 | Reference compound |
| HY-152852A | Mefatinib | 1989592-50-8 | Reference compound |
| HY-152852S | Mefatinib-d6 (free base) | Isotope-Labeled Compounds | |
| HY-152853 | 3-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione | 81691-06-7 | Oligonucleotides |
| HY-152854 | 5-(Hydroxymethyl)cytidine | 19235-17-7 | Oligonucleotides |
| HY-152856 | Merigolix | 1454272-94-6 | Reference compound |
| HY-152857 | Muvalaplin | 2565656-70-2 | Reference compound |
| HY-152858 | 5-Methoxycarbonyl methyl uridine | 29428-50-0 | Oligonucleotides |
| HY-152859 | Brigimadlin | 2095116-40-6 | Reference compound |
| HY-15286 | Sodium 4-pentynoate | 101917-30-0 | Reference compound |
| HY-152860 | Darizmetinib | 2369583-33-3 | Reference compound |
| HY-152861 | Dazostinag | 2553413-86-6 | Reference compound |
| HY-152862 | Dibutepinephrine | 2735735-23-4 | Reference compound |
| HY-152863 | N6-Furfuryl-2-aminoadenosine | 26783-39-1 | Oligonucleotides |
| HY-152864 | 6-Methylpurine-2’-deoxy-2’-fluoro-beta-D-arabinoriboside | 2095417-72-2 | Oligonucleotides |
| HY-152865 | 7-(N-Acetylaminomethyl)-7-deazaguanosine | Oligonucleotides | |
| HY-152866 | N,N-Dimethyl-2'-O-methylcytidine | 34218-81-0 | Oligonucleotides |
| HY-152867 | 5-(Trifluoromethyl)uridine | 21618-67-7 | Oligonucleotides |
| HY-152868 | 3’-O-(2-Azidoethyl)adenosine | Oligonucleotides | |
| HY-152869 | 5-(Trifluoromethyl)cytidine | 76514-02-8 | Oligonucleotides |
| HY-15287 | Nelfinavir | 159989-64-7 | Reference compound |
| HY-152870 | 2’-O-(2-Azidoethyl)adenosine | 2226475-42-7 | Oligonucleotides |
| HY-152871 | Uridine 5-oxyacetic acid methyl ester | 66536-81-0 | Oligonucleotides |
| HY-152872 | Uridine-5-oxo-acetyl-(9-fluorenylmethyl) ester | Oligonucleotides | |
| HY-152873 | Uridine-5-(N-Fmoc-methylamino)-acetyl (9-fluorenylmethyl) ester | Oligonucleotides | |
| HY-152874 | 5-N-(t-Butyloxycarbonylmethyl)-N-trifluoro acetyl-aminomethyl-2’-O-methyluridine | Oligonucleotides | |
| HY-152875 | 5-Carboxymethyluridine | 20964-06-1 | Oligonucleotides |
| HY-152876 | 2′-O-Methyl-2-amino-6-chloropurine riboside | 194034-59-8 | Oligonucleotides |
| HY-152877 | Isocytidine | 489-59-8 | Oligonucleotides |
| HY-152878 | Arabinosylisocytosine | 10212-30-3 | Oligonucleotides |
| HY-152879 | 5-Benzylamino carbonyl-3’-O-acetyl-2’-O-methyluridine | 2095417-64-2 | Oligonucleotides |
| HY-15287A | Nelfinavir (Mesylate) | 159989-65-8 | Reference compound |
| HY-15287R | Nelfinavir (Standard) | 159989-64-7 | Reference Standards |
| HY-15287S | Nelfinavir-d3 | 1217629-70-3 | Isotope-Labeled Compounds |
| HY-15287S1 | Nelfinavir-d4 | Isotope-Labeled Compounds | |
| HY-15288 | PI3kδ inhibitor 1 | 1332075-63-4 | Reference compound |
| HY-152880 | 2’-Deoxy-2’-fluoro-arabino-tubercidine | 169516-61-4 | Oligonucleotides |
| HY-15289 | Ciproxifan (maleate) | 184025-19-2 | Reference compound |
| HY-152896 | Ys-II | 897386-27-5 | Natural Products |
| HY-152898A | Arachidonoyl CoA (triammonium) | 799812-93-4 | Enzyme |
| HY-152899 | Selachyl alcohol | 593-31-7 | Reference compound |
| HY-15290 | AIM-100 | 873305-35-2 | Reference compound |
| HY-152901 | Chol-N3 | 2106868-12-4 | Dye Reagents |
| HY-152903S | Sulfuric-34S acid (disodium) | 225640-22-2 | Isotope-Labeled Compounds |
| HY-152906 | Acid-PEG8-t-butyl ester | 3052794-63-2 | Reference compound |
| HY-152909 | Nystatin A2 | 65086-32-0 | Natural Products |
| HY-15291 | MBX-2982 | 1037792-44-1 | Reference compound |
| HY-152916 | mp-dLAE-PABC-MMAE | 2625616-44-4 | Reference compound |
| HY-152919 | Mal-amide-PEG8-Val-Cit-PAB-OH | 2387738-43-2 | ADC Related |
| HY-15292 | S107 | 927871-76-9 | Reference compound |
| HY-152925 | FA-15 | 4932-15-4 | Reference compound |
| HY-152927 | Hydroxypropylmethyl cellulose acetate succinate (Mw: 20-100k Da) | 71138-97-1 | Reference compound |
| HY-15293 | JTV-519 | 1038410-88-6 | Reference compound |
| HY-15293A | JTV-519 (free base) | 145903-06-6 | Reference compound |
| HY-15293B | JTV-519 (hemifumarate) | 1435938-25-2 | Reference compound |
| HY-15294 | CZC24832 | 1159824-67-5 | Reference compound |
| HY-152943 | MTK458 | 2499962-58-0 | Reference compound |
| HY-152943A | (Rac)-MTK458 | 2499962-44-4 | Reference compound |
| HY-152944 | S6K1-IN-DG2 | 871340-88-4 | Reference compound |
| HY-152945 | Antiproliferative agent-22 | 1374305-45-9 | Reference compound |
| HY-152947 | ELOVL6-IN-4 | 1170321-92-2 | Reference compound |
| HY-152949 | Myosin V-IN-1 | 1259177-59-7 | Reference compound |
| HY-15295 | Vonoprazan (Fumarate) | 881681-01-2 | Reference compound |
| HY-152954 | DRAK1/2-IN-1 | 1629227-34-4 | Reference compound |
| HY-152955 | STING agonist-22 | 2408723-12-4 | Reference compound |
| HY-152956 | STING agonist-23 | 2361570-16-1 | Reference compound |
| HY-152957 | STING agonist-24 | 2408722-91-6 | Reference compound |
| HY-152958 | STING agonist-25 | 2408723-10-2 | Reference compound |
| HY-152959 | STING agonist-26 | 2868261-48-5 | Reference compound |
| HY-15296 | Cabergoline | 81409-90-7 | Reference compound |
| HY-152960 | STING agonist-27 | 2868261-45-2 | Reference compound |
| HY-152961 | STING agonist-28 | 2868261-50-9 | Reference compound |
| HY-152962 | STING agonist-29 | 2868261-51-0 | Reference compound |
| HY-152963 | Tisotumab vedotin | 1418731-10-8 | ADC Related |
| HY-152965 | Biotin-doxorubicin | 3026061-30-0 | Reference compound |
| HY-152968 | 2’-O-t-Butyldimethylsilyladenosine | 69504-13-8 | Oligonucleotides |
| HY-152969 | 6-Chloro-N1-(trimethylsilylethoxymethyl)pseudouridine | Oligonucleotides | |
| HY-15296A | Cabergoline (diphosphate) | 85329-89-1 | Reference compound |
| HY-15296R | Cabergoline (Standard) | 81409-90-7 | Reference Standards |
| HY-15296S | Cabergoline-d5 | 1426173-20-7 | Isotope-Labeled Compounds |
| HY-15296S1 | Cabergoline-d6 | 2738376-76-4 | Isotope-Labeled Compounds |
| HY-15297 | Vesnarinone | 81840-15-5 | Reference compound |
| HY-152970 | 7'-O-DMT-morpholino uracil | 1127343-02-5 | Oligonucleotides |
| HY-152973 | 7'-O-DMT-morpholino thymine | 143485-05-6 | Oligonucleotides |
| HY-152974 | 1-(2,3,5-Tri-O-benzoyl-2-C-β-methyl-β-D-ribofuranosyl)-5-nitropyridine-2(1H)-one | 2072145-38-9 | Oligonucleotides |
| HY-152976 | N4-Benzoyl-7’-O-(4,4’-dimethoxytrityloxy)morpholinocytosine | 2304678-24-6 | Oligonucleotides |
| HY-152977 | 4-Chloro-7-(2-deoxy-3,5-bis-O-(p-toluoyl)-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | Oligonucleotides | |
| HY-152978 | 2'-Deoxy-5'-O-DMT-N4-Fmoc-5-methylcytidine | 176755-86-5 | Oligonucleotides |
| HY-152979 | 2'-Deoxy-5'-O-DMT-N4-Fmoc-5-methylcytidine 3'-CE-phosphoramidite | 176755-87-6 | Oligonucleotides |
| HY-15298 | Grazoprevir | 1350514-68-9 | Reference compound |
| HY-152980 | 4-Chloro-7-(2-deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | 97337-37-6 | Oligonucleotides |
| HY-152981 | Di-O-Toluoyl-1,2-dideoxy-D-ribose-6-chloro-7-iodo-7-deazapurine | Oligonucleotides | |
| HY-152982 | 1-(2-C-β-Methyl-β-D-ribofuranosyl)-5-nitropyridine-2(1H)-one | 2072145-17-4 | Oligonucleotides |
| HY-152983 | 2'-Deoxy-5'-O-DMT-N6-Fmoc-adenosine 3'CE-phosphoramidite | 109420-86-2 | Oligonucleotides |
| HY-152984 | N6-Benzoyl-7'-O-DMT-morpholino adenine | 2243974-77-6 | Oligonucleotides |
| HY-152985 | 3’-Azido-3’-deoxy-4-deoxyuridine | 2095417-07-3 | Oligonucleotides |
| HY-152986 | 4-Chloro-7-(2-deoxy-β-D-erythro-pentofuranosyl)-5-iodo-7H-pyrrolo[2,3-d]pyrimidine | 178995-71-6 | Oligonucleotides |
| HY-152987 | 7-(2-Deoxy-β-D-erythro-pentofuranosyl)-5-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 652965-07-6 | Oligonucleotides |
| HY-152988 | N2-iso-Butyroyl-7'-O-DMT-morpholinoguanine | 2243974-78-7 | Oligonucleotides |
| HY-15298A | Grazoprevir potassium salt | 1206524-86-8 | Reference compound |
| HY-15298B | Grazoprevir hydrate | 1350462-55-3 | Reference compound |
| HY-15298C | Grazoprevir sodium salt | 1425038-27-2 | Reference compound |
| HY-152990 | Methyl 1,2,3,4-tetrahydro-α-hydroxy-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidineacetate | 945684-13-9 | Oligonucleotides |
| HY-152991 | 6-Deoxo-8-oxo-3’-deoxy-guanosine | Oligonucleotides | |
| HY-152992 | 7-Cyano-7-deaza-2'-deoxy guanosine | 199859-58-0 | Oligonucleotides |
| HY-152993 | 2′-Deoxy-N-(2-furanylmethyl)guanosine | 1227069-12-6 | Oligonucleotides |
| HY-152994 | 1,2-Di-O-acetyl-3,5-di-O-benzoyl-D-xylofuranose | 85026-60-4 | Oligonucleotides |
| HY-152995 | Confidential | Oligonucleotides | |
| HY-152996 | 2′-Deoxy-8-(methylthio)adenosine | 29836-02-0 | Oligonucleotides |
| HY-152998 | 2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine | 1613530-52-1 | Oligonucleotides |
| HY-15300 | Skepinone-L | 1221485-83-1 | Reference compound |
| HY-153002 | p38α inhibitor 3 | 260428-69-1 | Reference compound |
| HY-153005 | (2RS)-FPMPA | 135295-27-1 | Reference compound |
| HY-153006 | 2,7-Dichlorodihydrofluorescein | 106070-31-9 | Reference compound |
| HY-153007 | DHFR-IN-5 | 1142407-81-5 | Reference compound |
| HY-153007A | DHFR-IN-5 (hydrochloride) | 1142407-60-0 | Reference compound |
| HY-153008 | BCR-ABL-IN-7 | 688050-42-2 | Reference compound |
| HY-153009 | MMV676584 | 750621-19-3 | Reference compound |
| HY-15301 | CC0651 | 1319207-44-7 | Reference compound |
| HY-153010 | ER proteostasis regulator-1 | 912777-95-8 | Reference compound |
| HY-153011 | ROCK-IN-5 | 692870-25-0 | Reference compound |
| HY-153012 | Axl/Mer/CSF1R-IN-1 | 2394874-60-1 | Reference compound |
| HY-153013 | SN38-COOH | 2170118-23-5 | ADC Related |
| HY-153015 | Zalsupindole | 2481740-94-5 | Reference compound |
| HY-153015A | Zalsupindole (hydrobromide) | 2930845-96-6 | Reference compound |
| HY-153015B | Zalsupindole (hydrochloride) | 2930845-89-7 | Reference compound |
| HY-153015C | Zalsupindole (benzoate) | 2930845-92-2 | Reference compound |
| HY-153015D | Zalsupindole (mesylate) | 2930846-03-8 | Reference compound |
| HY-153016 | HIF-2α agonist 2 | 2750141-15-0 | Reference compound |
| HY-153017 | HIF-1 inhibitor-4 | 333357-56-5 | Reference compound |
| HY-153018 | PTP1B-IN-22 | 86109-60-6 | Reference compound |
| HY-153019 | NUCC-0000323 | 663212-78-0 | Reference compound |
| HY-153020 | HIF-PHD-IN-3 | 794582-71-1 | Reference compound |
| HY-153021 | NMT-IN-1 | 326879-46-3 | Reference compound |
| HY-153023 | PROTAC STAT3 degrader-2 | 2429877-78-9 | Reference compound |
| HY-153027 | Methylergometrine | 113-42-8 | Reference compound |
| HY-15303 | Pritelivir | 348086-71-5 | Reference compound |
| HY-153031 | Val-Cit-PAB-Exatecan | 2227350-99-2 | ADC Related |
| HY-153031A | Val-Cit-PAB-Exatecan (TFA) | 2928571-44-0 | ADC Related |
| HY-153032 | Val-Ala-PAB-MMAE | 1912408-92-4 | ADC Related |
| HY-153034 | LONP1-IN-2 | 2729981-17-1 | Reference compound |
| HY-153039 | Anhydroleucovorin | 7444-29-3 | Reference compound |
| HY-153039R | Anhydroleucovorin (Standard) | 7444-29-3 | Reference Standards |
| HY-15303A | Pritelivir (mesylate) | 1428333-96-3 | Reference compound |
| HY-15303B | Pritelivir (mesylate hydrate) | 1428321-10-1 | Reference compound |
| HY-15303S | Pritelivir-d4-1 | Isotope-Labeled Compounds | |
| HY-15304 | Dynasore | 304448-55-3 | Reference compound |
| HY-153040 | HPPE | 1325721-55-8 | Reference compound |
| HY-153042 | Thalidomide-NH-C2-azaspiro[3.5]nonane (hydrochloride) | 2573304-92-2 | Reference compound |
| HY-153043 | DM-CO-(CH2)5-SMe | 2243689-84-9 | Reference compound |
| HY-153045 | BAY-805 | 2925481-88-3 | Reference compound |
| HY-153045A | BAY-728 | Reference compound | |
| HY-153050 | JAK-IN-24 | 2042629-43-4 | Reference compound |
| HY-153051 | Antitumor agent-90 | 131268-74-1 | Reference compound |
| HY-153056 | BNN3 | 6947-38-2 | Reference compound |
| HY-153057 | PRMT5-IN-46 | 380192-76-7 | Reference compound |
| HY-153058 | LRRK2-IN-8 | 2770269-44-6 | Reference compound |
| HY-153059 | 5-(N-Methyl-N-trifluoroacetyl)aminomethyl uridine | 163496-07-9 | Reference compound |
| HY-15306 | Eltrombopag | 496775-61-2 | Reference compound |
| HY-153060 | β-D-Ribofuranose analogue 1 | 89129-10-2 | Reference compound |
| HY-153061 | 2’-O-Methylisocytidine | 175471-65-5 | Reference compound |
| HY-153062 | 6-Chloro-7-deazapurine-2F-β-D-arabinofuranose | 169516-60-3 | Reference compound |
| HY-153064 | MAX-10181 | 2171558-14-6 | Reference compound |
| HY-153065 | KIF18A-IN-6 | 2914879-10-8 | Reference compound |
| HY-153066 | VLS-1272 | 2914878-00-3 | Reference compound |
| HY-153067 | Mal-cyclohexane-Gly-Gly-Phe-Gly-Exatecan | 2578019-72-2 | Reference compound |
| HY-153068 | CZL55 | 667408-87-9 | Reference compound |
| HY-153069 | GGFG-PAB-Exatecan | 251459-32-2 | Reference compound |
| HY-153069A | GGFG-PAB-Exatecan (TFA) | ADC Related | |
| HY-15306A | Eltrombopag (Olamine) | 496775-62-3 | Reference compound |
| HY-15306AR | Eltrombopag (Olamine) (Standard) | 496775-62-3 | Reference Standards |
| HY-15306R | Eltrombopag (Standard) | 496775-61-2 | Reference Standards |
| HY-15306S | Eltrombopag-13C4 | 1217230-31-3 | Isotope-Labeled Compounds |
| HY-15307 | Belumosudil | 911417-87-3 | Reference compound |
| HY-153070 | TLR7 agonist 5 | 2380231-67-2 | Reference compound |
| HY-153071 | TLR7 agonist 6 | 2380231-86-5 | Reference compound |
| HY-153072 | TLR7 agonist 7 | 2380231-77-4 | Reference compound |
| HY-153073 | TLR7 agonist 8 | 2380231-81-0 | Reference compound |
| HY-153074 | ISR-IN-1 | 1628478-15-8 | Reference compound |
| HY-153075 | ISR-IN-2 | 1628478-12-5 | Reference compound |
| HY-153076 | Flaviviruses-IN-3 | 420090-97-7 | Reference compound |
| HY-153077 | PFKFB3-IN-2 | 794552-84-4 | Reference compound |
| HY-153078 | MRTF/SRF-IN-1 | 1922098-90-5 | Reference compound |
| HY-153079 | eGFP mRNA(N1-Me-Pseudo UTP) | Dye Reagents | |
| HY-15307A | Belumosudil (mesylate) | 2109704-99-4 | Reference compound |
| HY-15307S | Belumosudil-d7 | Isotope-Labeled Compounds | |
| HY-15308 | Avermectin B1a | 65195-55-3 | Reference compound |
| HY-153080 | Firefly Luciferase mRNA(N1-Me-Pseudo UTP) | Oligonucleotides | |
| HY-153081 | eGFP circRNA | Dye Reagents | |
| HY-153082 | Firefly Luciferase circRNA | Dye Reagents | |
| HY-153083 | COVID-19 Spike Protein mRNA(N1-Me-Pseudo UTP) | Oligonucleotides | |
| HY-153084 | CD19 CAR mRNA (Mouse) | Oligonucleotides | |
| HY-153084A | CD19 CAR mRNA (Human) | Oligonucleotides | |
| HY-153085 | CD19 CAR circRNA | Oligonucleotides | |
| HY-153088 | CDK4/6-IN-16 | 1169694-98-7 | Reference compound |
| HY-153089 | GSK3-IN-3 | 331963-27-0 | Reference compound |
| HY-15308R | Avermectin B1a (Standard) | 65195-55-3 | Reference Standards |
| HY-153090 | Transketolase-IN-4 | 419547-73-2 | Reference compound |
| HY-153091 | BMY 14802 | 105565-56-8 | Reference compound |
| HY-153092 | Avenciguat | 1579514-06-9 | Reference compound |
| HY-153093 | MK-8189 | 1424371-93-6 | Reference compound |
| HY-153094 | BDM-2 | 1643876-33-8 | Reference compound |
| HY-153095 | PF-6870961 | 2857112-06-0 | Reference compound |
| HY-153095A | PF-6870961 (hydrochloride) | 2857112-07-1 | Reference compound |
| HY-153096 | OICR12694 | 2360625-97-2 | Reference compound |
| HY-153096A | OICR12694 (TFA) | 2360625-98-3 | Reference compound |
| HY-153098 | ARC186 | Oligonucleotides | |
| HY-153098A | ARC186 (sodium) | Reference compound | |
| HY-15310 | Ivermectin | 70288-86-7 | Natural Products |
| HY-153100 | (R)-mchm5U | 89665-84-9 | Reference compound |
| HY-153100A | (S)-mchm5U | 89665-83-8 | Reference compound |
| HY-153101 | Gal-G2-CNP | 157381-11-8 | Biochemical Assay Reagents |
| HY-153102 | G3-CNP | 118291-90-0 | Biochemical Assay Reagents |
| HY-153103 | LRRK2/NUAK1/TYK2-IN-1 | 2629192-96-5 | Reference compound |
| HY-153104 | CrBKA | 2260810-48-6 | Reference compound |
| HY-153108 | 3'-O-Me-m7G(5')ppp(5')A solution (100mM) | Biochemical Assay Reagents | |
| HY-15310R | Ivermectin (Standard) | 70288-86-7 | Reference Standards |
| HY-15311 | Avermectin B1 | 71751-41-2 | Natural Products |
| HY-153110 | Larotinib | 1438072-11-7 | Reference compound |
| HY-153110A | Larotinib (mesylate hydrate) | 2097129-93-4 | Reference compound |
| HY-153111 | EGFR/HER2-IN-9 | 1637253-79-2 | Reference compound |
| HY-153112 | DHODH-IN-23 | 1346705-53-0 | Reference compound |
| HY-153113 | Rongliflozin | 2648020-91-9 | Reference compound |
| HY-153114 | HEC96719 | 2181834-03-5 | Reference compound |
| HY-153115 | Plasma kallikrein-IN-4 | 1357954-34-7 | Reference compound |
| HY-153117 | Cyclohexyl [3,5-bis(methylthio)-4-isothiazolyl]carbamate | 311334-13-1 | Reference compound |
| HY-153118 | Deoxyribonucleic acid (sodium, from calf thymus, Type I, fibers) | 73049-39-5 | Biochemical Assay Reagents |
| HY-153119 | TMX-4153 | 2867519-91-1 | Reference compound |
| HY-15311R | Avermectin B1 (Standard) | 71751-41-2 | Reference Standards |
| HY-15312 | WP1066 | 857064-38-1 | Reference compound |
| HY-153120 | PI3K/mTOR Inhibitor-13 | 1621718-37-3 | Reference compound |
| HY-153120A | PI3K/mTOR Inhibitor-13 (sodium) | 2361009-23-4 | Reference compound |
| HY-153121 | Leritrelvir | 2923310-64-7 | Reference compound |
| HY-153122 | YCT529 (free acid) | 2863670-66-8 | Reference compound |
| HY-153122A | YCT529 | 2863670-67-9 | Reference compound |
| HY-153124 | β-Cyclodextrin, 2-hydroxyethyl ethers | 128446-32-2 | Biochemical Assay Reagents |
| HY-153125 | DLRIE | 199171-54-5 | Reference compound |
| HY-153126 | Yeast extract | 8013-01-2 | Biochemical Assay Reagents |
| HY-153127 | Florbenazine | 937245-42-6 | Reference compound |
| HY-153128 | DOCK2-IN-1 | 4590-86-7 | Reference compound |
| HY-153129 | EP2 receptor antagonist-2 | 615273-95-5 | Reference compound |
| HY-15313 | CBB1007 | 1379573-92-8 | Reference compound |
| HY-153132 | mGluR3 modulator-1 | 374548-18-2 | Reference compound |
| HY-153133 | CFTR corrector 11 | 688050-45-5 | Reference compound |
| HY-153136 | LNP Lipid-1 | 2089253-13-2 | Biochemical Assay Reagents |
| HY-153137 | Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate | 1566559-80-5 | Biochemical Assay Reagents |
| HY-153138 | FTT5 LLNs | 2803606-43-9 | Biochemical Assay Reagents |
| HY-15313B | CBB1007 (hydrochloride) | 2070014-96-7 | Reference compound |
| HY-15313C | CBB1007 (trihydrochloride) | 2070015-03-9 | Reference compound |
| HY-15314 | Ranirestat | 147254-64-6 | Reference compound |
| HY-15315 | Baricitinib | 1187594-09-7 | Reference compound |
| HY-153151 | Fmoc-DON-Boc | 1998724-98-3 | Reference compound |
| HY-153152 | DPTN (dihydrochloride) | 325767-87-1 | Reference compound |
| HY-153153 | Benzyl-PEG45-alcohol | 26403-74-7 | Reference compound |
| HY-153154 | COMC-6 | 106281-45-2 | Reference compound |
| HY-153158 | VEGFR2-IN-3 | 417717-09-0 | Reference compound |
| HY-153159 | Angiogenesis inhibitor 4 | 417719-77-8 | Reference compound |
| HY-15315A | Baricitinib (phosphate) | 1187595-84-1 | Reference compound |
| HY-15315R | Baricitinib (Standard) | 1187594-09-7 | Reference Standards |
| HY-15315S | Baricitinib-d5 | 1564241-79-7 | Isotope-Labeled Compounds |
| HY-15315S1 | Baricitinib-d3 | 1564242-30-3 | Isotope-Labeled Compounds |
| HY-153160 | PERK-IN-6 | 1337532-14-5 | Reference compound |
| HY-153161 | CASP8-IN-1 | 1956368-39-0 | Reference compound |
| HY-153165 | RXR antagonist 5 | 1807740-94-8 | Reference compound |
| HY-153166 | PT-65 | 2721998-87-2 | Reference compound |
| HY-153168 | Bemoradan | 112018-01-6 | Reference compound |
| HY-153169 | 6PPD-Q | 2754428-18-5 | Reference compound |
| HY-15317 | RI-1 | 415713-60-9 | Reference compound |
| HY-153172 | Phenylbenzothiazole-PEG4-OH | 2274723-90-7 | Reference compound |
| HY-153175 | BT44 | 924759-42-2 | Reference compound |
| HY-153176 | PAT-IN-1 | 2066571-97-7 | Reference compound |
| HY-153177 | PAT-IN-2 | 2066572-01-6 | Reference compound |
| HY-153178 | HECT E3-IN-1 | 1810058-52-6 | Reference compound |
| HY-153179 | Mal-Gly-PAB-Exatecan-D-glucuronic acid | 2763252-25-9 | ADC Related |
| HY-153180 | PB038 | 2851058-71-2 | Reference compound |
| HY-153181 | Trametiglue | 2666940-97-0 | Reference compound |
| HY-153182 | GBT1118 | 1628799-51-8 | Reference compound |
| HY-153183 | Lp-PLA2-IN-12 | 2637485-14-2 | Reference compound |
| HY-153184 | GalNAc-L96 (free base) | 1159408-61-3 | Oligonucleotides |
| HY-153185 | Decyclohexanamine-Exatecan | 2505045-51-0 | Reference compound |
| HY-153186 | LNP Lipid-3 | 2648693-32-5 | Oligonucleotides |
| HY-153187 | LNP Lipid-4 | 2795397-84-9 | Biochemical Assay Reagents |
| HY-153188 | JNJ-1013 | 2597343-08-1 | Reference compound |
| HY-153189 | TrkB-IN-1 | 1609067-49-3 | Reference compound |
| HY-15319 | AMG 487 | 473719-41-4 | Reference compound |
| HY-153190 | W1131 | 2740522-79-4 | Reference compound |
| HY-153190A | W1131 (TFA) | Reference compound | |
| HY-153191 | EZH2-IN-15 | 2098545-98-1 | Reference compound |
| HY-153192 | Nerandomilast | 1423719-30-5 | Reference compound |
| HY-153192A | Nerandomilast (dihydrate) | Reference compound | |
| HY-153193 | LSN3160440 | 2765539-59-9 | Reference compound |
| HY-153195 | Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2OH-Fmoc | 2169723-90-2 | Reference compound |
| HY-153196 | Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2-(4-nitrophenyl)carbonate-Fmoc | 2169723-91-3 | ADC Related |
| HY-153199 | MDM2/XIAP-IN-1 | 359595-95-2 | Reference compound |
| HY-15319A | (±)-AMG 487 | 947536-03-0 | Reference compound |
| HY-15319B | AMG 487 (S-enantiomer) | 473720-30-8 | Reference compound |
| HY-15320 | NBI-74330 | 855527-92-3 | Reference compound |
| HY-153200 | MDM2/XIAP-IN-2 | 2761969-85-9 | Reference compound |
| HY-153202 | SLMP53-2 | 1826116-38-4 | Reference compound |
| HY-153203 | Eicosapentaenoyl-CoA (triammonium) | 1246522-05-3 | Enzyme |
| HY-153204 | Isobutylquinoleine | 65442-31-1 | Natural Products |
| HY-153205 | Aluminum hydroxide adjuvant | Reference compound | |
| HY-153209 | Adjuvant-4 | Reference compound | |
| HY-153209G | Adjuvant-4 (GMP) | GMP Small Molecules | |
| HY-15321 | Etoricoxib | 202409-33-4 | Reference compound |
| HY-153213 | Org 274179-0 | 1421683-12-6 | Reference compound |
| HY-153214 | YW2036 | 2131223-92-0 | Reference compound |
| HY-153215 | MEL24 | 642072-48-8 | Reference compound |
| HY-153219 | P-CAB agent 2 (hydrochloride) | 2209911-80-6 | Reference compound |
| HY-153219A | P-CAB agent 2 | 1978371-23-1 | Reference compound |
| HY-15321A | Etoricoxib (hydrochloride) | 202409-40-3 | Reference compound |
| HY-15321R | Etoricoxib (Standard) | 202409-33-4 | Reference Standards |
| HY-15321S | Etoricoxib-d4 | 1131345-14-6 | Isotope-Labeled Compounds |
| HY-15321S1 | Etoricoxib-13C,d3 | 2748267-73-2 | Isotope-Labeled Compounds |
| HY-15321S2 | Etoricoxib-d3 | 850896-71-8 | Isotope-Labeled Compounds |
| HY-15322 | PRT062607 | 1370261-96-3 | Reference compound |
| HY-153220 | NX-2127 | 2416131-46-7 | Reference compound |
| HY-153220A | (R)-NX-2127 | 3024312-52-2 | Reference compound |
| HY-153221 | QR-6401 | 2845096-18-4 | Reference compound |
| HY-153222 | SEQ-9 | Reference compound | |
| HY-153224 | GLPG2534 | 2095615-97-5 | Reference compound |
| HY-153225 | PYR01 | 2560576-15-8 | Reference compound |
| HY-153226 | BET-IN-14 | 2243669-93-2 | Reference compound |
| HY-153227 | SU 5616 | 186611-58-5 | Reference compound |
| HY-153228 | Pomotrelvir | 2713437-86-4 | Reference compound |
| HY-153229 | Firefly luciferase mRNA-LNP | Biochemical Assay Reagents | |
| HY-15323 | PRT062607 (Hydrochloride) | 1370261-97-4 | Reference compound |
| HY-153230 | Firefly luciferase circRNA-LNP | Biochemical Assay Reagents | |
| HY-153231 | eGFP mRNA-LNP | Biochemical Assay Reagents | |
| HY-153231A | eGFP mRNA-LNP (500 ng/μL) | Biochemical Assay Reagents | |
| HY-153232 | eGFP circRNA-LNP | Biochemical Assay Reagents | |
| HY-153233 | CD19 car mRNA (Mouse)-LNP | Biochemical Assay Reagents | |
| HY-153234 | CD19 car circRNA-LNP | Biochemical Assay Reagents | |
| HY-153235 | COVID-19 Spike Protein mRNA-LNP | Biochemical Assay Reagents | |
| HY-153236 | Py-MAA-Val-Cit-PAB-DX8951 | 2504068-37-3 | ADC Related |
| HY-153238 | AN15368 | 2152662-92-3 | Reference compound |
| HY-153239 | Eltrombopag methyl ester | 1246929-01-0 | Reference compound |
| HY-15324 | PRT062607 (acetate) | 1370261-98-5 | Reference compound |
| HY-153240 | ACT-672125 | 1449367-94-5 | Reference compound |
| HY-153241 | GSK737 | 2748687-95-6 | Reference compound |
| HY-153242 | GSK217 | 2748687-92-3 | Reference compound |
| HY-153243 | IACS-9439 | 2231259-36-0 | Reference compound |
| HY-153244 | MFH290 | 2088715-91-5 | Reference compound |
| HY-153245 | JNJ-64264681 | 2101524-34-7 | Reference compound |
| HY-153246 | ALK2-IN-5 | 2414149-20-3 | Reference compound |
| HY-153247 | GSK3839919A | 2081127-77-5 | Reference compound |
| HY-153248 | PBR28 | 253307-65-2 | Reference compound |
| HY-153249 | DMT-2'-F-Cytidine Phosphoramidite | 200404-36-0 | Oligonucleotides |
| HY-153251 | DMT-2'-O-Methylguanosine phosphoramidite | 1159683-24-5 | Oligonucleotides |
| HY-153253 | DMT-2'-O-Methyladenosine phosphoramidite | 138906-75-9 | Oligonucleotides |
| HY-153254 | BMS905 | 2205846-49-5 | Reference compound |
| HY-153255 | BACE1-IN-13 | 1397683-26-9 | Reference compound |
| HY-153256 | EP3 antagonist 4 | 2408297-80-1 | Reference compound |
| HY-153258 | CaSR antagonist-1 | 1219811-83-2 | Reference compound |
| HY-153259 | TNKS1/2-IN-2 | 1498300-35-8 | Reference compound |
| HY-153260 | TP-1287 | 2044686-42-0 | Reference compound |
| HY-153261 | NLRP3-IN-17 | 2254432-75-0 | Reference compound |
| HY-153262 | KRASG12C IN-2 | 2706637-12-7 | Reference compound |
| HY-153263 | (Aminooxy)acetamide-Val-Cit-PAB-MMAE | 2446645-88-9 | ADC Related |
| HY-153264 | TAS2R14 agonist-1 | 2439115-08-7 | Reference compound |
| HY-153265 | TAS2R14 agonist-2 | 2883007-69-8 | Reference compound |
| HY-153268 | Silevertinib | 2607829-38-7 | Reference compound |
| HY-15327 | 1alpha, 25-Dihydroxy VD2-d6 | 216244-04-1 | Isotope-Labeled Compounds |
| HY-153272 | Antitumor agent-93 | 1681019-44-2 | Reference compound |
| HY-153274 | CWI1-2 | 2408590-36-1 | Reference compound |
| HY-153274A | CWI1-2 (hydrochloride) | 2408590-37-2 | Reference compound |
| HY-153276 | Androgen receptor-IN-5 | 1391944-16-3 | Reference compound |
| HY-153277 | Axl/Mer/CSF1R-IN-2 | 2394874-63-4 | Reference compound |
| HY-153278 | CDK7-IN-21 | 2766124-39-2 | Reference compound |
| HY-153279 | 5-LOX-IN-3 | 1875061-47-4 | Reference compound |
| HY-15328 | 25-Hydroxy VD2-d6 | 1262843-46-8 | Isotope-Labeled Compounds |
| HY-15329 | Maxacalcitol-d6 | Isotope-Labeled Compounds | |
| HY-15330 | Vitamin D2-d3 | 1217448-46-8 | Isotope-Labeled Compounds |
| HY-153306 | RLY-2608 | 2733573-94-7 | Reference compound |
| HY-153306A | (S)-RLY-2608 | 2733573-93-6 | Reference compound |
| HY-15331 | VD3-d6 | 118584-54-6 | Isotope-Labeled Compounds |
| HY-15332 | Alfacalcidol-d6 | 1641940-94-4 | Isotope-Labeled Compounds |
| HY-153320 | AZ-TAK1 | 1413440-36-4 | Reference compound |
| HY-153321 | NX-5948 | 2649400-34-8 | Reference compound |
| HY-153322 | ITK degrader 2 | 2858738-65-3 | Reference compound |
| HY-153324 | PS220 (sodium) | Oligonucleotides | |
| HY-153329 | TNF-α-IN-9 | 2054199-25-4 | Reference compound |
| HY-15333 | ZK-261991 | 886563-25-3 | Reference compound |
| HY-153330 | TNF-α-IN-10 | 2247720-56-3 | Reference compound |
| HY-153331 | DDO-2213 | 2378768-36-4 | Reference compound |
| HY-153332 | Tankyrase-IN-5 | 1460285-69-1 | Reference compound |
| HY-153333 | A1/A3 AR antagonist 3 | 2665804-57-7 | Reference compound |
| HY-153334 | Enpp-1-IN-15 | 2756218-99-0 | Reference compound |
| HY-153335 | Enpp-1-IN-16 | 2289739-47-3 | Reference compound |
| HY-153336 | CDK-IN-12 | 2789680-97-1 | Reference compound |
| HY-153337 | Pomalidomide-C11-NH2 | 2648285-39-4 | Reference compound |
| HY-153337A | Pomalidomide-C11-NH2 (hydrochloride) | 2722611-55-2 | Reference compound |
| HY-153339 | E235 | 891894-69-2 | Reference compound |
| HY-15334 | CEP-5214 | 402857-39-0 | Reference compound |
| HY-153340 | I-152 | 311343-11-0 | Reference compound |
| HY-153341 | CFT1946 | 2882165-79-7 | Reference compound |
| HY-153342 | Luxdegalutamide | 2750830-09-0 | Reference compound |
| HY-153343 | Veludacigib | 2732902-08-6 | Reference compound |
| HY-153343A | (S)-Veludacigib | 2732902-09-7 | Reference compound |
| HY-153344 | FX-909 | 2924573-90-8 | Reference compound |
| HY-153345 | Glucocorticoid receptor agonist-1 phosphate(2,6-difluoro) Ala-Ala-Br | 2345733-40-4 | Reference compound |
| HY-153346 | Elironrasib | 2641998-63-0 | Reference compound |
| HY-153347 | JY-2 | 339103-05-8 | Reference compound |
| HY-153348 | p38 Kinase inhibitor 4 | 13142-47-7 | Reference compound |
| HY-153349 | 2,3-Di(furan-2-yl)quinoxaline | 57490-73-0 | Dye Reagents |
| HY-15335 | Nutlin-3b | 675576-97-3 | Reference compound |
| HY-153350 | ERK-IN-7 | 2494010-63-6 | Reference compound |
| HY-153351 | IpOHA | 132418-03-2 | Reference compound |
| HY-153354 | PKR activator 4 | 2283420-05-1 | Reference compound |
| HY-153356 | MRT-2359 | 2803881-11-8 | Reference compound |
| HY-153357 | NRX-0492 | 2416130-57-7 | Reference compound |
| HY-153358 | TNG260 | 2935964-98-8 | Reference compound |
| HY-153358A | (S)-TNG260 | 2935964-93-3 | Reference compound |
| HY-153359 | M3913 | 2379783-62-5 | Reference compound |
| HY-15336 | AG 555 | 133550-34-2 | Reference compound |
| HY-153360 | MC-GGFG-AM-(10Me-11F-Camptothecin) | 2873460-70-7 | Reference compound |
| HY-153361 | YD23 | 2951015-29-3 | Reference compound |
| HY-153362 | HPK1-IN-34 | 2380300-99-0 | Reference compound |
| HY-153364 | FTX-6746 | 2829349-96-2 | Reference compound |
| HY-153365 | I-138 | 2098211-50-6 | Reference compound |
| HY-153366 | TNG-0746132 | 2821749-57-7 | Reference compound |
| HY-153367 | FHD-609 | 2676211-64-4 | Reference compound |
| HY-153368 | Zomiradomide | 2655656-99-6 | Reference compound |
| HY-153369 | BAY-747 | 1609342-18-8 | Reference compound |
| HY-15337 | Hesperidin | 520-26-3 | Natural Products |
| HY-153370 | DBCO-PEG3-oxyamine-Boc (hydrochloride) | ADC Related | |
| HY-153371 | 50-C2-C9-4tail | 1853203-01-6 | Biochemical Assay Reagents |
| HY-153372 | 93-O17S | 2227008-67-3 | Oligonucleotides |
| HY-153373 | 4A3-Cit | 2768211-13-6 | Biochemical Assay Reagents |
| HY-153375 | LNP Lipid-5 | 2430034-00-5 | Biochemical Assay Reagents |
| HY-153376 | LNP Lipid-6 | 2226547-32-4 | Biochemical Assay Reagents |
| HY-153377 | Lipid 14 | 2430034-05-0 | Oligonucleotides |
| HY-153378 | Lipid 15 | 2588111-36-6 | Oligonucleotides |
| HY-15337R | Hesperidin (Standard) | 520-26-3 | Reference Standards |
| HY-15338 | TG003 | 719277-26-6 | Reference compound |
| HY-153383 | PDCD4-IN-1 | 494763-64-3 | Reference compound |
| HY-153384 | EAPB 02303 | 1958290-51-1 | Reference compound |
| HY-153385 | TMX1 | Reference compound | |
| HY-153386 | CPD-1224 | 2891620-68-9 | Reference compound |
| HY-15338A | (E/Z)-TG003 | 300801-52-9 | Reference compound |
| HY-15339 | CVT-313 | 199986-75-9 | Reference compound |
| HY-153390 | AMG-193 | 2790567-82-5 | Reference compound |
| HY-153390A | (R)-AMG-193 | 2790567-83-6 | Reference compound |
| HY-153391 | PCSK9-IN-14 | 2913198-84-0 | Reference compound |
| HY-153392 | TYA-018 | 2653254-31-8 | Reference compound |
| HY-153393 | ATR-IN-21 | 2905312-17-4 | Reference compound |
| HY-153394 | Aflatoxin Q1 | 52819-96-2 | Natural Products |
| HY-153395 | PH-HG-005-5 | 2810895-93-1 | Reference compound |
| HY-153396 | Acid Ceramidase-IN-2 | 1005497-03-9 | Reference compound |
| HY-153398 | Enpp-1-IN-17 | 2289736-54-3 | Reference compound |
| HY-153399 | Fosigotifator | 2415715-84-1 | Reference compound |
| HY-153399A | ABBV-CLS-7262 | 2945073-88-9 | Reference compound |
| HY-15340 | LG100268 | 153559-76-3 | Reference compound |
| HY-153400 | ATR-IN-22 | 2905312-07-2 | Reference compound |
| HY-153401 | Topoisomerase II inhibitor 13 | 451515-89-2 | Reference compound |
| HY-153402 | Activated EG3 Tail | 1380600-06-5 | Reference compound |
| HY-153403 | Activated A Subunit | 956139-18-7 | Oligonucleotides |
| HY-153404 | Activated C Subunit | 956139-21-2 | Oligonucleotides |
| HY-153405 | Activated DPG Subunit | 1155309-89-9 | Oligonucleotides |
| HY-153406 | Activated T Subunit | 956139-30-3 | Oligonucleotides |
| HY-153407 | NCP2 Anchor | 1380600-13-4 | Reference compound |
| HY-153408 | 4-Hydroxylidocaine | 39942-41-1 | Reference compound |
| HY-153409 | Antifungal agent 48 | 2142003-75-4 | Reference compound |
| HY-15341 | BAM7 | 331244-89-4 | Reference compound |
| HY-153410 | Antifungal agent 49 | 1414861-21-4 | Reference compound |
| HY-153412 | KRAS inhibitor-22 | 2042365-57-9 | Reference compound |
| HY-153413 | Kras4B G12D-IN-1 | 2042365-85-3 | Reference compound |
| HY-153414 | GXF-111 | Reference compound | |
| HY-153415 | PROTAC BCR-ABL Degrader-1 | Reference compound | |
| HY-153416 | QR-0217 | 1027786-12-4 | Reference compound |
| HY-153417 | Anti-amyloid agent-1 | 1396778-73-6 | Reference compound |
| HY-153419 | BTTES | 1334179-86-0 | Reference compound |
| HY-15342 | Timapiprant | 851723-84-7 | Reference compound |
| HY-153421 | PRMT5-IN-28 | 2242753-66-6 | Reference compound |
| HY-153422 | PRMT5-IN-29 | 2242788-69-6 | Reference compound |
| HY-153423 | Mcl-1 inhibitor 12 | 2445466-24-8 | Reference compound |
| HY-153423A | Mcl-1 inhibitor 13 | 2445466-06-6 | Reference compound |
| HY-153424 | PROTAC SMARCA2 degrader-1 | 2892523-73-6 | Reference compound |
| HY-153425 | PROTAC SMARCA2 degrader-2 | 2892523-74-7 | Reference compound |
| HY-153426 | CDK9-IN-23 | 2761572-96-5 | Reference compound |
| HY-153427 | Tau protein aggregation-IN-1 | 916179-45-8 | Reference compound |
| HY-153428 | GGGDTDTC-Mc-vc-PAB-MMAE | ADC Related | |
| HY-153429 | WU-FA-01 | 882429-53-0 | Reference compound |
| HY-15342A | Timapiprant (sodium) | 950688-14-9 | Reference compound |
| HY-15343 | CEP-33779 | 1257704-57-6 | Reference compound |
| HY-153430 | Aβ/tau aggregation-IN-3 | 1210750-32-5 | Reference compound |
| HY-153431 | TRV-1387 | 1569645-63-1 | Reference compound |
| HY-153432 | TRV-7019 | 2598164-15-7 | Reference compound |
| HY-153433 | Serine Hydrolase inhibitor-21 | 366448-34-2 | Reference compound |
| HY-153434 | RIP1 kinase inhibitor 4 | 2919836-00-1 | Reference compound |
| HY-153435 | RIP1 kinase inhibitor 5 | 2428422-17-5 | Reference compound |
| HY-153436 | RIP1 kinase inhibitor 6 | 2428401-62-9 | Reference compound |
| HY-153437 | RIP1 kinase inhibitor 7 | 2428401-23-2 | Reference compound |
| HY-15344 | Ketone monoester | 1208313-97-6 | Reference compound |
| HY-153440 | JAK-IN-25 | 2127110-22-7 | Reference compound |
| HY-153441 | AXL-IN-15 | 1954722-22-5 | Reference compound |
| HY-153443 | CDK4-IN-2 | 2380320-68-1 | Reference compound |
| HY-153444 | Prifetrastat | 2569008-99-5 | Reference compound |
| HY-153445 | MEK-IN-6 | 2845151-86-0 | Reference compound |
| HY-153445A | MEK-IN-6 (hydrate) | 2845153-35-5 | Reference compound |
| HY-153446 | Tegeprotafib | 2407610-46-0 | Reference compound |
| HY-153448 | HPK1-IN-36 | 2738518-06-2 | Reference compound |
| HY-153449 | Decyl α-D-maltopyranoside | 168037-12-5 | Biochemical Assay Reagents |
| HY-15344A | (S,S)-Ketone monoester | 1251829-99-8 | Reference compound |
| HY-15345 | Tetrahydrouridine (dihydrate) | Reference compound | |
| HY-153450 | JBI-589 | 2308504-22-3 | Reference compound |
| HY-153451 | PCSK9-IN-15 | 2455423-94-4 | Reference compound |
| HY-153452 | PCSK9-IN-16 | 2455424-51-6 | Reference compound |
| HY-153453 | PCSK9-IN-17 | 2455424-72-1 | Reference compound |
| HY-153454 | PCSK9-IN-18 | 2455425-15-5 | Reference compound |
| HY-153455 | TRPC3/6-IN-2 | 2387893-55-0 | Reference compound |
| HY-153456 | Hedgehog IN-2 | 1126365-74-9 | Reference compound |
| HY-153457 | Hedgehog IN-3 | 1128191-09-2 | Reference compound |
| HY-153458 | Orexin receptor modulator-1 | 2125735-57-9 | Reference compound |
| HY-153459 | PROTAC BRD4 Degrader-19 | 2684292-71-3 | Reference compound |
| HY-15345A | Tetrahydrouridine | 18771-50-1 | Reference compound |
| HY-15345AS | Tetrahydrouridine-d3 | Isotope-Labeled Compounds | |
| HY-15346 | Copanlisib | 1032568-63-0 | Reference compound |
| HY-153460 | TLR7/8/9 antagonist 2 | 2920729-91-3 | Reference compound |
| HY-153461 | KRAS G12C inhibitor 58 | 2915599-52-7 | Reference compound |
| HY-153462 | ATR-IN-24 | 2370889-43-1 | Reference compound |
| HY-153464 | CXCR4-IN-1 | 2304750-48-7 | Reference compound |
| HY-153468 | ErSO-TFPy | 3035547-78-2 | Reference compound |
| HY-153469 | Benzyl DC-81 | 127810-79-1 | Reference compound |
| HY-15346A | Copanlisib (dihydrochloride) | 1402152-13-9 | Reference compound |
| HY-15346R | Copanlisib (Standard) | 1032568-63-0 | Reference Standards |
| HY-153471 | MOR agonist-1 | 2305781-14-8 | Reference compound |
| HY-153472 | VMAT2-IN-2 (tosylate) | 2608770-12-1 | Reference compound |
| HY-153473 | FLT3-IN-19 | 2237234-48-7 | Reference compound |
| HY-153474 | IRE1α kinase-IN-8 | 1338933-29-1 | Reference compound |
| HY-153475 | IRE1α kinase-IN-9 | 1338933-30-4 | Reference compound |
| HY-153476 | GIP/GLP-1 dual receptor agonist-1 | 2807481-02-1 | Peptides |
| HY-153477 | Thyroid hormone receptor beta agonist-1 | 2140902-80-1 | Reference compound |
| HY-153478 | Estrogen receptor modulator 7 | 2639168-13-9 | Reference compound |
| HY-153479 | Aganirsen | 1146887-67-3 | Oligonucleotides |
| HY-153479A | Aganirsen (sodium) | Oligonucleotides | |
| HY-153480 | ARC19499 | 1350667-54-7 | Oligonucleotides |
| HY-153480A | ARC19499 (sodium) | Oligonucleotides | |
| HY-153481 | ATL 1102 | 350263-41-1 | Oligonucleotides |
| HY-153481A | ATL 1102 (sodium) | Oligonucleotides | |
| HY-153482 | ATU027 | 1415935-22-6 | Oligonucleotides |
| HY-153482A | ATU027 (sodium) | Oligonucleotides | |
| HY-153483 | Bamosiran | 1337968-84-9 | Oligonucleotides |
| HY-153483A | Bamosiran (sodium) | Oligonucleotides | |
| HY-153484 | Bevasiranib | 959961-96-7 | Oligonucleotides |
| HY-153484A | Bevasiranib (sodium) | 849758-52-7 | Oligonucleotides |
| HY-153485 | Cimdelirsen | 2131025-82-4 | Oligonucleotides |
| HY-153485A | Cimdelirsen (sodium) | 2131025-83-5 | Oligonucleotides |
| HY-153486 | N3-VC-PAB-PNP | 2285374-43-6 | Reference compound |
| HY-153488 | ISIS 2503 | 149957-14-2 | Oligonucleotides |
| HY-153488A | ISIS 2503 (sodium) | Oligonucleotides | |
| HY-153489 | ISIS 329993 | 827355-42-0 | Oligonucleotides |
| HY-153489A | ISIS 329993 (sodium) | Oligonucleotides | |
| HY-15349 | Trovirdine | 149488-17-5 | Reference compound |
| HY-153490 | ISIS 5132 | 177075-18-2 | Oligonucleotides |
| HY-153490A | ISIS 5132 (sodium) | Oligonucleotides | |
| HY-153491 | Olezarsen | 2097587-83-0 | Oligonucleotides |
| HY-153491A | Olezarsen (sodium) | 2298451-31-5 | Oligonucleotides |
| HY-153492A | Olpasiran (sodium) | Oligonucleotides | |
| HY-153493 | PF-04523655 | 1420046-64-5 | Oligonucleotides |
| HY-153493A | PF-04523655 (sodium) | Oligonucleotides | |
| HY-153494 | Rosomidnar | 871597-03-4 | Oligonucleotides |
| HY-153494A | Rosomidnar (sodium) | Oligonucleotides | |
| HY-153495 | Prexigebersen | 202484-91-1 | Oligonucleotides |
| HY-153495A | Prexigebersen (sodium) | Oligonucleotides | |
| HY-153496 | Sepofarsen | 2227173-68-2 | Oligonucleotides |
| HY-153496A | Sepofarsen (sodium) | Oligonucleotides | |
| HY-153497 | Vupanorsen | 2097587-62-5 | Oligonucleotides |
| HY-153497A | Vupanorsen (sodium) | 2172852-12-7 | Oligonucleotides |
| HY-153499 | SMO-IN-4 | 1567963-99-8 | Reference compound |
| HY-15350 | Trovirdine (hydrochloride) | 148311-89-1 | Reference compound |
| HY-153508 | ANO1-IN-4 | 2098490-06-1 | Reference compound |
| HY-15351 | UC-781 | 178870-32-1 | Reference compound |
| HY-153511 | Rapamycin analog-2 | 2357217-22-0 | Reference compound |
| HY-153516 | NIK-IN-2 | 1202763-91-4 | Reference compound |
| HY-153519 | WWL0245 | 2869057-11-2 | Reference compound |
| HY-15352 | BMS 561390 | 214287-99-7 | Reference compound |
| HY-153521 | CCT374705 | 2640647-90-9 | Reference compound |
| HY-153523 | Hi 76-0079 | 374567-94-9 | Reference compound |
| HY-153524 | ATTO 425 NHS ester | 892156-28-4 | Dye Reagents |
| HY-153525 | FXR agonist 5 | 2414008-05-0 | Reference compound |
| HY-153526 | PI5P4Ks-IN-2 | 2766854-03-7 | Reference compound |
| HY-153527 | GalNac-L96 analog | 1159408-72-6 | Reference compound |
| HY-153528 | DMAA | 73671-86-0 | Natural Products |
| HY-153529 | PI5P4Ks-IN-3 | 2471969-07-8 | Reference compound |
| HY-15353 | Emivirine | 149950-60-7 | Reference compound |
| HY-153530 | LI-2242 | 2762762-17-2 | Reference compound |
| HY-153531 | PI5P4Kα-IN-1 | 2428737-31-7 | Reference compound |
| HY-153532 | CVM-05-002 | 2428738-43-4 | Reference compound |
| HY-153533 | GRL-1720 | 2835511-03-8 | Reference compound |
| HY-153533A | GRL-1720 (TFA) | Reference compound | |
| HY-153534 | microRNA-21-IN-3 | 2766106-83-4 | Reference compound |
| HY-153535 | THRβ receptor agonist-1 | 2403721-00-4 | Reference compound |
| HY-153536 | PROTAC BTK Degrader-3 | 2563861-90-3 | Reference compound |
| HY-153537 | AP-C1 | 2234280-26-1 | Reference compound |
| HY-153538 | AP-C2 | 682793-07-3 | Reference compound |
| HY-153539 | AP-C3 | 682795-78-4 | Reference compound |
| HY-153540 | AP-C4 | 682794-85-0 | Reference compound |
| HY-153541 | AP-C7 | 2234275-84-2 | Reference compound |
| HY-153542 | AP-C6 | 2234276-60-7 | Reference compound |
| HY-153543 | TLR7/8 agonist 8 | 2649170-16-9 | Reference compound |
| HY-153544 | TLR7/8 agonist 9 | 2649170-17-0 | Reference compound |
| HY-153545 | 9-Amino-NeuAc | 153232-60-1 | Reference compound |
| HY-153546 | STING agonist-31 | 2719001-44-0 | Reference compound |
| HY-153547 | HSP90-IN-21 | 2521791-38-6 | Reference compound |
| HY-153548 | P2X2/3 modulator-1 | 1217483-98-1 | Reference compound |
| HY-153549 | Pentixafor | 1341207-62-2 | Peptides |
| HY-15355 | Loviride | 147362-57-0 | Reference compound |
| HY-153550 | PSMA-1007 | 2226894-58-0 | Peptides |
| HY-153551 | HBED-CC-tris(tert-butyl ester) | 2097123-80-1 | Reference compound |
| HY-153551A | HBED-CC-tris(tert-butyl ester) (TFA) | Reference compound | |
| HY-153552 | NH2-UAMC1110 | 2758337-19-6 | Reference compound |
| HY-153552A | NH2-UAMC1110 (TFA) | 2990021-73-1 | Reference compound |
| HY-153553 | HPK1 antagonist-1 | 2628489-56-3 | Reference compound |
| HY-153554 | NLRP3-IN-18 | 2769040-06-2 | Reference compound |
| HY-153555 | KRAS G12D modulator-1 | 2883034-05-5 | Reference compound |
| HY-153556 | GW297361 | 388627-21-2 | Reference compound |
| HY-153557 | HER2-IN-13 | 2414056-34-9 | Reference compound |
| HY-153557A | HER2-IN-14 | 2414056-35-0 | Reference compound |
| HY-153559 | Lp-PLA2-IN-13 | 2756855-62-4 | Reference compound |
| HY-15356 | BIO-acetoxime | 667463-85-6 | Reference compound |
| HY-153560 | Lp-PLA2-IN-14 | 2756855-66-8 | Reference compound |
| HY-153561 | Lp-PLA2-IN-15 | 1865796-11-7 | Reference compound |
| HY-153561A | Lp-PLA2-IN-16 | 1865780-73-9 | Reference compound |
| HY-153563 | MMP-7-IN-2 | 2848717-49-5 | Reference compound |
| HY-153564 | ROCK-IN-6 | 2489328-74-5 | Reference compound |
| HY-153565 | Immune cell migration-IN-1 | 2316683-71-1 | Reference compound |
| HY-153566 | JAK1-IN-10 | 2416858-88-1 | Reference compound |
| HY-153567 | Immune cell migration-IN-2 | 2260679-24-9 | Reference compound |
| HY-153568 | JAK1-IN-11 | 2427608-43-1 | Reference compound |
| HY-153569 | ROCK-IN-7 | 2376635-95-7 | Reference compound |
| HY-15357 | ALK inhibitor 1 | 761436-81-1 | Reference compound |
| HY-153570 | Influenza virus-IN-7 | 2703046-92-6 | Reference compound |
| HY-153571 | Homo-BacPROTAC6 | Reference compound | |
| HY-153573 | SRG-II-19F | Reference compound | |
| HY-153574 | BI01826025 | Reference compound | |
| HY-153575 | BacPROTAC-1 | Reference compound | |
| HY-153576 | Antibacterial agent 143 | 299405-68-8 | Reference compound |
| HY-153577 | WT-TTR inhibitor 1 | 23983-05-3 | Reference compound |
| HY-153579 | Anti-inflammatory agent 42 | 877468-30-9 | Reference compound |
| HY-15358 | ALK inhibitor 2 | 761438-38-4 | Reference compound |
| HY-153580 | WIC1 | 943083-58-7 | Reference compound |
| HY-153581 | ARTD3/PARP3-IN-1 | 730949-09-4 | Reference compound |
| HY-153582 | ML 2-23 | Reference compound | |
| HY-153583 | HDAC8-IN-4 | 1600528-05-9 | Reference compound |
| HY-153584 | MRK-898 | 461450-30-6 | Reference compound |
| HY-153585 | IK-930 | 2563892-44-2 | Reference compound |
| HY-153588 | HSP90-IN-22 | 442898-75-1 | Reference compound |
| HY-15359 | Episilvestrol | 697235-39-5 | Natural Products |
| HY-153590 | PARP-1-IN-4 | 684234-56-8 | Reference compound |
| HY-153591 | ROS-IN-1 | 298193-11-0 | Reference compound |
| HY-153592 | Therapeutic agent-1 | 850020-01-8 | Reference compound |
| HY-153593 | BET bromodomain inhibitor 3 | 854137-39-6 | Reference compound |
| HY-153594 | Bcl-B inhibitor 1 | 79220-88-5 | Reference compound |
| HY-153595 | DAPK-IN-2 | 304000-05-3 | Reference compound |
| HY-153596 | SNX7 | 685097-43-2 | Reference compound |
| HY-153598 | LD4172 | 2782022-40-4 | Reference compound |
| HY-153600 | GGFG-amide-glycol-amide-Exatecan | 2866301-18-8 | ADC Related |
| HY-153601 | MC-VC-PAB-Cyclohexanediamine-Thailanstatin A | 1609108-96-4 | ADC Related |
| HY-153603 | B-Raf IN 15 | 832107-31-0 | Reference compound |
| HY-153604 | MC4171 | Reference compound | |
| HY-153606 | SOS1 agonist-1 | 2245237-61-8 | Reference compound |
| HY-153607 | HDAC-IN-55 | 1268674-16-3 | Reference compound |
| HY-153608 | JHDM-IN-1 | 1310809-17-6 | Reference compound |
| HY-153609 | AS-Patisiran (sodium) | Oligonucleotides | |
| HY-153610 | ARC7 | 681212-58-8 | Reference compound |
| HY-153611 | ARC12 | 64433-38-1 | Reference compound |
| HY-153612 | MMV009085 | 298217-59-1 | Reference compound |
| HY-153613 | Ac-PLVE-FMK | 2679825-26-2 | Reference compound |
| HY-153614 | Ac-VLPE-FMK | 2679825-27-3 | Reference compound |
| HY-153615 | CVN636 | 2226732-62-1 | Reference compound |
| HY-153617 | FOXO1-IN-3 | 2451093-95-9 | Reference compound |
| HY-153618 | Antifungal agent 53 | 2422019-76-7 | Reference compound |
| HY-153619 | Antifungal agent 54 | 2422019-78-9 | Reference compound |
| HY-153620 | Antifungal agent 55 | 2422019-80-3 | Reference compound |
| HY-153621 | Antifungal agent 56 | 2422019-82-5 | Reference compound |
| HY-153622 | Antifungal agent 57 | 2422019-92-7 | Reference compound |
| HY-153623 | Antifungal agent 58 | 2422019-94-9 | Reference compound |
| HY-153624 | Antifungal agent 59 | 2422019-96-1 | Reference compound |
| HY-153625 | STM2120 | 2762286-04-2 | Reference compound |
| HY-153626 | Chlamydia pneumoniae-IN-1 | 518010-44-1 | Reference compound |
| HY-153627 | GK13S | Reference compound | |
| HY-153628 | GPAT-IN-1 | 1204347-51-2 | Reference compound |
| HY-153629 | FSEN1 | 862808-01-3 | Reference compound |
| HY-153631 | Sulfo-TAG NHS ester (disodium) | 482618-42-8 | lead-like compound library |
| HY-153632 | PROTAC BRD9 Degrader-6 | 2676211-62-2 | Reference compound |
| HY-153637 | THR-β modulator-1 | 2770373-00-5 | Reference compound |
| HY-153638 | PTPN2/1-IN-2 | 2407611-02-1 | Reference compound |
| HY-153640 | AKT-IN-14 | 2781918-35-0 | Reference compound |
| HY-153640A | AKT-IN-14 (free base) | 2781918-27-0 | Reference compound |
| HY-153642 | MMAE-PAB(p-glucuronide)-PEG3-aminooxy | 1835250-20-8 | ADC Related |
| HY-153650 | JS11 | 1394592-04-1 | Reference compound |
| HY-153660 | Bivamelagon | 2641595-54-0 | Reference compound |
| HY-153660A | Bivamelagon (hydrochloride) | 2641595-55-1 | Reference compound |
| HY-153661 | Cereblon inhibitor 2 | 2639380-62-2 | Reference compound |
| HY-153662 | TH-Z816 | 2847881-42-7 | Reference compound |
| HY-153663 | TH-Z827 | 2847881-81-4 | Reference compound |
| HY-153665 | Deg-1 | 2761446-55-1 | Reference compound |
| HY-153668 | Bromodomain inhibitor-12 | 2010124-06-6 | Reference compound |
| HY-153668A | Bromodomain inhibitor-12 (edisylate) | 2010124-27-1 | Reference compound |
| HY-153669 | SB-649701 | 935262-95-6 | Reference compound |
| HY-153670 | IPG7236 | 2756350-91-9 | Reference compound |
| HY-153671 | 4'-Methyl-β-naphthoflavone | 1282513-75-0 | Reference compound |
| HY-153672 | Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 | 2244602-35-3 | ADC Related |
| HY-153673 | PROTAC IRAK4 degrader-8 | 2911615-06-8 | Reference compound |
| HY-153674 | PROTAC SOS1 degrader-4 | Reference compound | |
| HY-153675 | BCPA | 547731-67-9 | Reference compound |
| HY-153676 | RET-IN-23 | 2479961-46-9 | Reference compound |
| HY-153678 | β-Catenin modulator-1 | 1053086-89-7 | Reference compound |
| HY-153679 | β-Catenin modulator-2 | 1015858-71-5 | Reference compound |
| HY-153680 | β-Catenin modulator-3 | 1015858-17-9 | Reference compound |
| HY-153681 | β-Catenin modulator-4 | 901751-85-7 | Reference compound |
| HY-153682 | β-Catenin modulator-5 | 902168-07-4 | Reference compound |
| HY-153686 | BVFP | 357158-20-4 | Reference compound |
| HY-153687 | SORT-PGRN interaction inhibitor 2 | 1008233-79-1 | Reference compound |
| HY-153688 | SORT-PGRN interaction inhibitor 3 | 2691846-87-2 | Reference compound |
| HY-15369 | FPA-124 | 902779-59-3 | Reference compound |
| HY-153690 | Progranulin modulator-1 | 2641013-11-6 | Reference compound |
| HY-153691 | BTB01303 | 652129-89-0 | Reference compound |
| HY-153692 | WRN inhibitor 1 | 2923008-44-8 | Reference compound |
| HY-153692A | (R)-WRN inhibitor 1 | Reference compound | |
| HY-153695 | TXA707 | 1609670-89-4 | Reference compound |
| HY-153697 | FAK-IN-10 | 491839-65-7 | Reference compound |
| HY-153698 | CC-3060 | 444288-86-2 | Reference compound |
| HY-153699 | SHP2-IN-14 | 2673400-91-2 | Reference compound |
| HY-15370 | SB-269970 | 201038-74-6 | Reference compound |
| HY-153700 | Estrogen receptor modulator 8 | 2170766-56-8 | Reference compound |
| HY-153701 | JAK-IN-26 | 2417134-93-9 | Reference compound |
| HY-153701S | Envudeucitinibum | 2417135-66-9 | Isotope-Labeled Compounds |
| HY-153702 | JAK-IN-27 | 2673176-36-6 | Reference compound |
| HY-153703 | PI3Kγ inhibitor 7 | 2575863-25-9 | Reference compound |
| HY-153704 | CDK4/6-IN-17 | 2035069-96-4 | Reference compound |
| HY-153705 | BTK-IN-25 | 2562351-92-0 | Reference compound |
| HY-153706 | URAT1 inhibitor 5 | 2102670-94-8 | Reference compound |
| HY-153708 | SGC-CLK-1 | 748142-15-6 | Reference compound |
| HY-15370A | SB-269970 (hydrochloride) | 261901-57-9 | Reference compound |
| HY-15371 | Forskolin | 66575-29-9 | Natural Products |
| HY-153710 | P2X3 antagonist 38 | 2545974-71-6 | Reference compound |
| HY-153711 | TRPA1-IN-2 | 2415206-22-1 | Reference compound |
| HY-153712 | JAK-IN-28 | 2445500-22-9 | Reference compound |
| HY-153713 | MYC-RIBOTAC | Reference compound | |
| HY-153714 | BN-104 | 2938995-50-5 | Reference compound |
| HY-153715 | NV-354 | 866465-21-6 | Reference compound |
| HY-153717 | LAU-0901 | 727358-25-0 | Reference compound |
| HY-153719 | NSC111552 | 40420-48-2 | Reference compound |
| HY-15371G | Forskolin (GMP) | 66575-29-9 | Reference compound |
| HY-15371R | Forskolin (Standard) | 66575-29-9 | Reference Standards |
| HY-15372 | GW6471 | 880635-03-0 | Reference compound |
| HY-153722 | Dodicin | 6843-97-6 | Reference compound |
| HY-153722A | Dodicin (hydrochloride) | 36895-38-2 | Reference compound |
| HY-153723 | BI-2493 | 2937344-16-4 | Reference compound |
| HY-153724 | BI-2865 | 2937327-93-8 | Reference compound |
| HY-153725 | 17:1 Lyso PC | 1246304-62-0 | Oligonucleotides |
| HY-153728 | WM-586 | 2894832-05-2 | Reference compound |
| HY-153728A | (R)-WM-586 | Reference compound | |
| HY-153729 | ATR-IN-29 | 2761193-67-1 | Reference compound |
| HY-15373 | Fenretinide | 65646-68-6 | Reference compound |
| HY-153730 | Hedgehog IN-5 | 1544681-93-7 | Reference compound |
| HY-153731 | USP1-IN-4 | 2878441-72-4 | Reference compound |
| HY-153732 | Insecticidal agent 2 | 201593-85-3 | Reference compound |
| HY-153733 | PDE5-IN-8 | 1233518-60-9 | Reference compound |
| HY-153734 | Inactive ASO (in vivo) sodium | Oligonucleotides | |
| HY-153735 | ERK-CLIPTAC | 2087490-46-6 | Reference compound |
| HY-153736 | NSC 194308 | 90379-42-3 | Reference compound |
| HY-153737 | 113-N16B | Oligonucleotides | |
| HY-153738 | ERK1/2 inhibitor 9 | 2169302-75-2 | Reference compound |
| HY-153739 | N3-PEG3-VC-PAB-MMAF | 2757277-32-8 | ADC Related |
| HY-15373R | Fenretinide (Standard) | 65646-68-6 | Reference Standards |
| HY-15374 | Frentizole | 26130-02-9 | Reference compound |
| HY-153740 | PF-07284892 | 2498597-94-5 | Reference compound |
| HY-153743 | Protein kinase inhibitor 4 | 2278205-04-0 | Reference compound |
| HY-153744 | JGK-068S | 2490431-16-6 | Reference compound |
| HY-153745 | Protein kinase inhibitor 5 | 2278204-94-5 | Reference compound |
| HY-153745A | Protein kinase inhibitor 5 (sulfate hydrate) | Reference compound | |
| HY-153746 | Kv3 modulator 5 | 1380696-68-3 | Reference compound |
| HY-153747 | Casein kinase 1δ-IN-4 | 851168-98-4 | Reference compound |
| HY-153748 | ML162-yne | 2883115-46-4 | Reference compound |
| HY-153749 | Nek2/Hec1-IN-2 | 544416-00-4 | Reference compound |
| HY-15375 | Allitinib | 897383-62-9 | Reference compound |
| HY-153750 | Wnt pathway inhibitor 3 | 663213-98-7 | Reference compound |
| HY-153751 | BRD4-IN-4 | 304685-40-3 | Reference compound |
| HY-153752 | TAO Kinase inhibitor 2 | 850467-77-5 | Reference compound |
| HY-153753 | Wnt pathway inhibitor 4 | 663214-57-1 | Reference compound |
| HY-153754 | Phosphatidylcholine transfer protein inhibitor-1 | 379723-99-6 | Reference compound |
| HY-153755 | Polθ-IN-7 | 2923356-52-7 | Reference compound |
| HY-153756 | GFP16 | 749212-56-4 | Reference compound |
| HY-153757 | Antioxidant agent-11 | 474379-42-5 | Reference compound |
| HY-153758 | Antiviral agent 30 | 381731-49-3 | Reference compound |
| HY-153759 | CRX000227 | 686769-92-6 | Reference compound |
| HY-15376 | Besipirdine | 119257-34-0 | Reference compound |
| HY-153760 | GSK-3β inhibitor 14 | 863004-48-2 | Reference compound |
| HY-153761 | ASK1-IN-4 | 1427538-26-8 | Reference compound |
| HY-153762 | COX-2-IN-32 | 2725863-08-9 | Reference compound |
| HY-153763 | PROT-IN-1 | 329935-45-7 | Reference compound |
| HY-153764 | IDO-IN-18 | 314027-92-4 | Reference compound |
| HY-153766 | PDE5-IN-9 | 157862-84-5 | Reference compound |
| HY-153767 | PK095 | 380314-37-4 | Reference compound |
| HY-153768 | KAT modulator-1 | 1314006-43-3 | Reference compound |
| HY-15377 | DL-Gabaculine (hydrochloride) | 59556-17-1 | Reference compound |
| HY-153770 | DHPN | 308123-27-5 | Reference compound |
| HY-153771 | Du011 | 890818-51-6 | Reference compound |
| HY-153772 | Androgen receptor antagonist 8 | 1572045-29-4 | Reference compound |
| HY-153773 | Z4P | 2361760-87-2 | Reference compound |
| HY-153775 | UC-764864 | 278806-03-4 | Reference compound |
| HY-15378 | Talibegron (hydrochloride) | 178600-17-4 | Reference compound |
| HY-153780 | Navepdekinra | 2467732-66-5 | Reference compound |
| HY-153782 | GSK878 | 2417048-11-2 | Reference compound |
| HY-153783 | OBI | Dye Reagents | |
| HY-153785 | NH2-C6-ARC186 (sodium) | Oligonucleotides | |
| HY-153787 | ATM Inhibitor-6 | 2765544-85-0 | Reference compound |
| HY-153788 | CK2-IN-7 | 2825012-70-0 | Reference compound |
| HY-153789 | PI5P4Kγ-IN-1 | 2419358-87-3 | Reference compound |
| HY-15379 | Atevirdine | 136816-75-6 | Reference compound |
| HY-153790 | FEN1-IN-5 | 824983-93-9 | Reference compound |
| HY-153791 | FEN1-IN-6 | 824983-84-8 | Reference compound |
| HY-153792 | FEN1-IN-7 | 824983-90-6 | Reference compound |
| HY-153793 | DGKζ-IN-1 | 2660218-70-0 | Reference compound |
| HY-153795 | Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan | 1599439-54-9 | ADC Related |
| HY-153796 | PROTAC Her3 Degrader-8 | 2103331-95-7 | Reference compound |
| HY-153797 | Dox-btn2 | 3026061-31-1 | Reference compound |
| HY-153798 | GLP-1 receptor agonist 10 | 3015555-46-8 | Reference compound |
| HY-15380 | PNU‐142721 | 185220-03-5 | Reference compound |
| HY-153800 | Monlunabant | 2712480-46-9 | Reference compound |
| HY-153800A | (R)-Monlunabant | 2765579-76-6 | Reference compound |
| HY-153802 | Antitumor agent-100 | 2841750-32-9 | Reference compound |
| HY-153802A | Antitumor agent-100 (hydrochloride) | 2841750-53-4 | Reference compound |
| HY-153803 | GBD-9 | 2864408-92-2 | Reference compound |
| HY-153804 | Naphthyridine carbamate dimer | 864627-58-7 | Reference compound |
| HY-153805 | Z-NCTS | 1373391-77-5 | Reference compound |
| HY-153806 | RapaBlock | 2474076-02-1 | Reference compound |
| HY-153807 | αvβ6 integrin inhibitor 2 | 313709-47-6 | Reference compound |
| HY-153808 | Complete Freund's adjuvant (CFA) | 9007-81-2 | Reference compound |
| HY-153808A | Incomplete Freund's adjuvant (IFA) | Reference compound | |
| HY-153808B | Complete Freund's adjuvant (CFA, 1 mg/ml) | 9007-81-2 | Reference compound |
| HY-15381 | Fingolimod phosphate | 402615-91-2 | Reference compound |
| HY-153810 | Mosnodenvir | 2890688-86-3 | Reference compound |
| HY-153811 | IAG933 | 2714434-21-4 | Reference compound |
| HY-153812 | AST 7062601 | 675197-89-4 | Reference compound |
| HY-153813 | Z16078526 | 852222-94-7 | Reference compound |
| HY-153815 | GLP-1 receptor agonist 11 | 2784590-83-4 | Reference compound |
| HY-153816 | GLP-1 receptor agonist 12 | 2775376-50-4 | Reference compound |
| HY-153816A | (1R)-GLP-1 receptor agonist 12 | 2775376-51-5 | Reference compound |
| HY-153817 | FXIa-IN-13 | 2629361-99-3 | Reference compound |
| HY-153818 | Sperm motility agonist-1 | 1796991-30-4 | Reference compound |
| HY-153819 | Sperm motility agonist-2 | 926079-67-6 | Reference compound |
| HY-15381S | Fingolimod phosphate-d4 | 1794828-93-5 | Isotope-Labeled Compounds |
| HY-15382 | FTY720 (S)-Phosphate | 402616-26-6 | Reference compound |
| HY-153820 | PROTAC BRD4 Degrader-20 | 2086300-61-8 | Reference compound |
| HY-153821 | PROTAC KRAS G12C degrader-2 | 2378257-72-6 | Reference compound |
| HY-153822 | JG-23 | 2640819-75-4 | Reference compound |
| HY-153829 | CH3OCO-D-CHA-Gly-Arg-pNA (acetate) | 80895-10-9 | Reference compound |
| HY-15382A | (S)-FTY720-phosphonate | 1142015-10-8 | Reference compound |
| HY-15383 | Glyparamide | 5581-42-0 | Reference compound |
| HY-153830 | LacCer (d18:1/16:0) | 4201-62-1 | Natural Products |
| HY-153831 | c-Met-IN-17 | 3034863-55-0 | Reference compound |
| HY-153832 | MSU-42011 | 2456434-36-7 | Reference compound |
| HY-153833 | PDS-0330 | 2904682-19-3 | Reference compound |
| HY-153834 | GTI 2040 | 236391-66-5 | Oligonucleotides |
| HY-153834A | GTI 2040 (sodium) | Oligonucleotides | |
| HY-153835 | Pegnivacogin | 959716-28-0 | Oligonucleotides |
| HY-153835A | Pegnivacogin (sodium) | Oligonucleotides | |
| HY-153836 | Anivamersen | 959716-29-1 | Oligonucleotides |
| HY-153836A | Anivamersen (sodium) | 959716-31-5 | Oligonucleotides |
| HY-153837 | ISIS 14803 | 223603-41-6 | Oligonucleotides |
| HY-153837A | ISIS 14803 (sodium) | Oligonucleotides | |
| HY-153838 | ODN 5328 | 500239-51-0 | Oligonucleotides |
| HY-153838A | ODN 5328 (sodium) | Oligonucleotides | |
| HY-153839 | ODN 4084-F | 1934318-44-1 | Oligonucleotides |
| HY-153839A | ODN 4084-F (sodium) | Oligonucleotides | |
| HY-15384 | Picoprazole | 78090-11-6 | Reference compound |
| HY-153840 | ODN INH 18 | 1934318-43-0 | Oligonucleotides |
| HY-153840A | ODN INH 18 (sodium) | Oligonucleotides | |
| HY-153840B | ODN INH 18 (triethylamine) | Oligonucleotides | |
| HY-153841 | ODN INH-1 | 1934318-42-9 | Oligonucleotides |
| HY-153841A | ODN INH-1 (sodium) | Oligonucleotides | |
| HY-153843 | RNA Aptamer Corn (sodium) | Oligonucleotides | |
| HY-153845 | RNA Aptamer Broccoli (sodium) | Oligonucleotides | |
| HY-153846 | RNA Aptamer Mango I (sodium) | Oligonucleotides | |
| HY-153847 | RNA Aptamer Mango ΙΙ (sodium) | Oligonucleotides | |
| HY-153848 | RNA Aptamer Mango Ⅳ (sodium) | Oligonucleotides | |
| HY-153849 | RNA Aptamer Mango Ⅲ (sodium) | Oligonucleotides | |
| HY-15385 | Imexon | 59643-91-3 | Reference compound |
| HY-153850 | RNA Aptamer Peach I (sodium) | Oligonucleotides | |
| HY-153851 | RNA Aptamer Peach Ⅱ (sodium) | Oligonucleotides | |
| HY-153852 | LNP Lipid-7 | 1190203-55-4 | Oligonucleotides |
| HY-153855 | Zamaporvint | 1900754-56-4 | Reference compound |
| HY-153856 | TAS2940 | 2451398-65-3 | Reference compound |
| HY-153856A | TAS2940 (fumarate) | 2758034-98-7 | Reference compound |
| HY-153857 | Lasmotinib | 2127107-15-5 | Reference compound |
| HY-153859 | Ser-SNAC (TFA) | 322650-05-5 | Reference compound |
| HY-15386 | Cimoxatone | 73815-11-9 | Reference compound |
| HY-153863 | MS934 | 2756323-15-4 | Reference compound |
| HY-153864 | PROTAC MEK1 Degrader-1 | 2671004-41-2 | Reference compound |
| HY-153865 | Lotiglipron | 2401892-75-7 | Reference compound |
| HY-153866 | CK1-IN-2 | 1383376-92-8 | Reference compound |
| HY-153866A | CK1-IN-2 (hydrochloride) | 1383377-49-8 | Reference compound |
| HY-15387 | Beclobrate | 55937-99-0 | Reference compound |
| HY-153873 | MSU38225 | 1629160-83-3 | Reference compound |
| HY-153878 | BCAT-IN-4 | 406190-85-0 | Reference compound |
| HY-153879 | C12-TLRa | Reference compound | |
| HY-15388 | Tazarotene | 118292-40-3 | Reference compound |
| HY-153880 | KRAS degrader-1 | 2795275-59-9 | Reference compound |
| HY-153881 | KRAS G12C degrader-1 | 2768099-51-8 | Reference compound |
| HY-153882 | 3'-DMTr-dA | 140712-82-9 | Oligonucleotides |
| HY-153886 | Wu-5 | 2630378-05-9 | Reference compound |
| HY-153887 | HyT36(-Cl) | Reference compound | |
| HY-153888 | M351-110 | 1215797-40-2 | Reference compound |
| HY-153889 | BTA-EG4 | 921193-28-4 | Reference compound |
| HY-15388R | Tazarotene (Standard) | 118292-40-3 | Reference Standards |
| HY-15388S | Tazarotene-d8 | Isotope-Labeled Compounds | |
| HY-15388S1 | Tazarotene-13C2,d2 | 2703541-64-2 | Isotope-Labeled Compounds |
| HY-15388S2 | Tazarotene-13C6 | Isotope-Labeled Compounds | |
| HY-15388S3 | Tazarotene-d6 | 1246815-76-8 | Isotope-Labeled Compounds |
| HY-153890 | NVOC cage-TMP-Halo | 2137894-98-3 | Reference compound |
| HY-153891 | Deruxtecan 2-hydroxypropanamide | 2577204-16-9 | Reference compound |
| HY-153891S | Deruxtecan 2-hydroxypropanamide-d5 | Isotope-Labeled Compounds | |
| HY-153892 | Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide | 2750623-07-3 | ADC Related |
| HY-153893 | Magmas-IN-1 | 1251957-89-7 | Reference compound |
| HY-153894 | SRX3177 | 2241237-51-2 | Reference compound |
| HY-153895 | SLU-PP-1072 | 2285432-57-5 | Reference compound |
| HY-153896 | LMTK3-IN-1 | 2764850-23-7 | Reference compound |
| HY-153897 | PSB-1901 | 2332835-02-4 | Reference compound |
| HY-153898 | rTRD01 | 1332175-56-0 | Reference compound |
| HY-153899 | KRAS G12C inhibitor 59 | 2914919-88-1 | Reference compound |
| HY-15390 | Thiambutosine | 500-89-0 | Reference compound |
| HY-153900 | TLR8 agonist 6 | 2616605-55-9 | Reference compound |
| HY-153901 | PROTAC EGFR degrader 8 | 2925923-46-0 | Reference compound |
| HY-153902 | DG-8 | Dye Reagents | |
| HY-153903 | RASP-IN-1 | 916056-81-0 | Reference compound |
| HY-153904 | Casein kinase 1δ-IN-5 | 1579991-10-8 | Reference compound |
| HY-153905 | Casein kinase 1δ-IN-6 | 1579991-01-7 | Reference compound |
| HY-153907 | SMP-88480 | ADC Related | |
| HY-153908 | SMP-93566 | ADC Related | |
| HY-153909 | SMP-33693 | ADC Related | |
| HY-15391 | Lucitanib | 1058137-23-7 | Reference compound |
| HY-153910 | AGPS-IN-1 | 2316782-88-2 | Reference compound |
| HY-153911 | H2-Gamendazole | 877768-84-8 | Reference compound |
| HY-153912 | 5-HT2A receptor agonist-3 | 1391499-52-7 | Reference compound |
| HY-153913 | MMP-9-IN-7 | 333746-76-2 | Reference compound |
| HY-153914 | B-Raf IN 14 | 326918-98-3 | Reference compound |
| HY-153915 | PI3Kα-IN-11 | 300803-79-6 | Reference compound |
| HY-153916 | TCRS-417 | 2032123-28-5 | Reference compound |
| HY-153917 | CRT0063465 | Reference compound | |
| HY-153918 | (R)-SKBG-1 | 2955634-67-8 | Reference compound |
| HY-153918A | (S)-SKBG-1 | 2955618-24-1 | Reference compound |
| HY-15391A | Lucitanib (dihydrochloride) | 2108875-91-6 | Reference compound |
| HY-15392 | Chroman 1 | 1273579-40-0 | Reference compound |
| HY-153920 | Pimicotinib | 2253123-16-7 | Reference compound |
| HY-153920A | Pimicotinib (hydrochloride) | 2866305-19-1 | Reference compound |
| HY-153921 | DEPN-8 | 135822-00-3 | Reference compound |
| HY-15392A | Chroman 1 (dihydrochloride) | Reference compound | |
| HY-15393 | VU 0357121 | 433967-28-3 | Reference compound |
| HY-153930 | h15-LOX-2 inhibitor 1 | 478040-08-3 | Reference compound |
| HY-153932 | NR-7h | 2550399-06-7 | Reference compound |
| HY-153934 | Tetrazole-C15-(N-acetylsulfamoyl)butanoic acid | 873874-16-9 | Reference compound |
| HY-153935 | EP4-IN-1 | 2455480-28-9 | Reference compound |
| HY-153936 | Methyl 12-methyltridecanoate | 5129-58-8 | Reference compound |
| HY-153937 | Skp2 inhibitor 2 | 2760612-77-7 | Reference compound |
| HY-153938 | PROTAC PTPN2 degrader-2 | 2912307-38-9 | Reference compound |
| HY-153938A | PROTAC PTPN2 degrader-2 (TFA) | 2912307-39-0 | Reference compound |
| HY-153939S | Idasanutlin-d3-1 | Isotope-Labeled Compounds | |
| HY-15394 | (Rac)-Rotigotine (hydrochloride) | 102120-99-0 | Reference compound |
| HY-153940 | SOS1/KRAS-IN-1 | 2836330-34-6 | Reference compound |
| HY-153941 | RET-IN-24 | 2583767-68-2 | Reference compound |
| HY-153942 | USP7-IN-12 | 2763698-01-5 | Reference compound |
| HY-153943 | DNA-PK-IN-10 | 2919315-89-0 | Reference compound |
| HY-153944 | KRAS G12C inhibitor 60 | Reference compound | |
| HY-153945 | BET-IN-15 | 2408994-22-7 | Reference compound |
| HY-153947 | PB089 | 2892336-54-6 | ADC Related |
| HY-153948 | CBP-IN-1 | 1936431-44-5 | Reference compound |
| HY-153949 | YK-2-69 | 2619846-89-6 | Reference compound |
| HY-15394A | (Rac)-Rotigotine | 92206-54-7 | Reference compound |
| HY-15394S | (Rac)-Rotigotine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-15394S1 | (Rac)-Rotigotine-d3 (hydrochloride) | 1215846-20-0 | Isotope-Labeled Compounds |
| HY-153950 | CDK7-IN-22 | 2173190-60-6 | Reference compound |
| HY-153951S | BTK-IN-26 | 2762043-61-6 | Isotope-Labeled Compounds |
| HY-153952 | Immuno modulator-1 | 2757469-20-6 | Reference compound |
| HY-153953 | Bcl-2-IN-11 | 2760536-88-5 | Reference compound |
| HY-153958 | PDS-MMAE | 1613113-44-2 | ADC Related |
| HY-153959 | Thalidomide-O-amido-C11-COOH | 2473270-96-9 | Reference compound |
| HY-153962 | SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 | 1373170-36-5 | Reference compound |
| HY-153963 | PF-06655075 | Peptides | |
| HY-153963A | PF-06655075 (TFA) | Peptides | |
| HY-153964 | PF-06478939 | Peptides | |
| HY-153964A | PF-06478939 (TFA) | Peptides | |
| HY-153967 | BLU0588 | 2810747-78-3 | Reference compound |
| HY-153968 | URAT1&XO inhibitor 1 | 2669726-78-5 | Reference compound |
| HY-153969 | URAT1 inhibitor 6 | 2244807-49-4 | Reference compound |
| HY-153970 | URAT1 inhibitor 7 | 1632002-28-8 | Reference compound |
| HY-153971 | URAT1 inhibitor 8 | 1632005-33-4 | Reference compound |
| HY-153972 | URAT1&XO inhibitor 2 | 1239488-96-0 | Reference compound |
| HY-153973 | WRN inhibitor 2 | 2923009-56-5 | Reference compound |
| HY-153976 | Fmoc-Gly3-VC-PAB-MMAE | ADC Related | |
| HY-153977 | GLX481304 | 701224-63-7 | Reference compound |
| HY-153978 | GLX481369 | Reference compound | |
| HY-15398 | Vitamin D3 | 67-97-0 | Natural Products |
| HY-153980 | K-80001 | 242800-40-4 | Reference compound |
| HY-153982 | PPARγ agonist 8 | 1049800-41-0 | Reference compound |
| HY-153986 | AEP-IN-2 | 2565572-83-8 | Reference compound |
| HY-153987 | STING agonist-33 | 2591300-32-0 | Reference compound |
| HY-153989 | SOS1-IN-16 | 2930763-85-0 | Reference compound |
| HY-15398A | 5,6-trans-Vitamin D3 | 22350-41-0 | Reference compound |
| HY-15398AR | 5,6-trans-Vitamin D3 (Standard) | 22350-41-0 | Reference Standards |
| HY-15398C | 3-epi-Vitamin D3 | 57651-82-8 | Reference compound |
| HY-15398R | Vitamin D3 (Standard) | 67-97-0 | Reference Standards |
| HY-15398S | Vitamin D3-d7 | 1627523-19-6 | Isotope-Labeled Compounds |
| HY-15398S1 | Vitamin D3-13C3 | Isotope-Labeled Compounds | |
| HY-15398S3 | Vitamin D3-d3 | 80666-48-4 | Isotope-Labeled Compounds |
| HY-15398S4 | Vitamin D3-13C5 | Isotope-Labeled Compounds | |
| HY-15399 | Vigabatrin | 68506-86-5 | Reference compound |
| HY-153990 | FKBP51F67V-selective antagonist Ligand2 | 1680228-76-5 | Reference compound |
| HY-153991 | STAT6-IN-2 | 1355594-85-2 | Reference compound |
| HY-153992 | STAT6-IN-3 | 371919-80-1 | Reference compound |
| HY-153993 | Pyrocatechol sulfate | 4918-96-1 | Natural Products |
| HY-153995A | D-Ribonic acid | 642-98-8 | Reference compound |
| HY-153996 | CT1113 | 2523435-18-7 | Reference compound |
| HY-153998 | BT100 (sodium) | Oligonucleotides | |
| HY-153999 | BT200 | Oligonucleotides | |
| HY-153999A | BT200 (sodium) | Oligonucleotides | |
| HY-15399R | Vigabatrin (Standard) | 68506-86-5 | Reference Standards |
| HY-15400 | Boc-D-Thr(Bzl)-OH | 69355-99-3 | Peptides |
| HY-154000 | 3,5’-Bis(O-t-butyldimethylsilyl)-2’-O-methyl-5-methyl cytidine | Oligonucleotides | |
| HY-154001 | 2'-Deoxy-8-methylthioguanosine | 157946-92-4 | Oligonucleotides |
| HY-154002 | 4-Amino-5-cyano-1-(2-deoxy-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | Oligonucleotides | |
| HY-154003 | 7-(2-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | 93366-89-3 | Oligonucleotides |
| HY-154005 | 4-Amino-6-bromo-5-cyano-1-(beta-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine | 1203470-58-9 | Oligonucleotides |
| HY-154008 | 6-Amino-4-methoxy-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | 100644-69-7 | Oligonucleotides |
| HY-15401 | WAY 163909 | 428868-32-0 | Reference compound |
| HY-154011 | 8-Amino-2′-deoxyadenosine | 13389-09-8 | Oligonucleotides |
| HY-154012 | 2'-Deoxy-8-methylamino-adenosine | 13389-10-1 | Oligonucleotides |
| HY-154016 | 5'-DMTr-dG(iBu)-Methyl phosphonamidite | 115131-08-3 | Oligonucleotides |
| HY-154017 | 2′-C-Methyl-6-O-methylinosine | 565450-78-4 | Oligonucleotides |
| HY-154018 | N4-Benzoyl-5-methylcytidine | 160107-15-3 | Oligonucleotides |
| HY-154019 | N4-Benzoyl-5'-O-DMT-5-methylcytidine | 160107-17-5 | Oligonucleotides |
| HY-15401A | WAY 163909 (hydrochloride) | 428868-35-3 | Reference compound |
| HY-15402 | Edonentan | 210891-04-6 | Reference compound |
| HY-154021A | 5-Fluoromethylornithine (dihydrochloride) | 124796-41-4 | Reference compound |
| HY-154023 | 5’-O-Benzoyl-2’,3’-di-O-acetyl-4’-C-fluoromethyluridine | Oligonucleotides | |
| HY-154024 | N4-Benzoyl-2’-O-(2-methoxyethyl)cytidine | 2305416-18-4 | Oligonucleotides |
| HY-154025 | 8-Azido-2′-deoxyadenosine | 131265-35-5 | Oligonucleotides |
| HY-154026 | 5-Amino-2'-deoxyuridine (monohydrochloride) | 73446-40-9 | Oligonucleotides |
| HY-154029 | 3-β-D-Ribofuranosyl-6-hydroxymethyl-furano[2,3-d]-pyrimidin-2-one | 1058167-74-0 | Oligonucleotides |
| HY-15402D | Edonentan (hydrate) | 264609-13-4 | Reference compound |
| HY-15403 | Atrasentan | 173937-91-2 | Reference compound |
| HY-154030 | N6-Benzoyl-3'-deoxy-5'-O-DMT-3'-fluoroadenosine | 170871-87-1 | Oligonucleotides |
| HY-154031 | 3'-F-3'-dA(Bz)-2'-Phosphoramidite | 2127174-09-6 | Oligonucleotides |
| HY-154034 | 5'-DMTr-T-Methyl phosphonamidite | 114079-04-8 | Oligonucleotides |
| HY-154035 | N4-Acetyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxycytidine | 121058-82-0 | Oligonucleotides |
| HY-154036 | 5′-DMTr-dC (Ac)-Methylphosphonamidite | 178094-78-5 | Oligonucleotides |
| HY-154037 | N6-Benzoyl-3'-fluoro-2',3'-dideoxyadenosine | 122712-71-4 | Oligonucleotides |
| HY-154038 | 2′,3′-Dideoxy-3′-fluoroadenosine | 87418-35-7 | Oligonucleotides |
| HY-15403A | Atrasentan (hydrochloride) | 195733-43-8 | Reference compound |
| HY-15404 | Darusentan | 171714-84-4 | Reference compound |
| HY-154040 | 5’-O-Benzoyl-3’-O-(4-methoxybenzyl)-2’-O,4’-C-methyleneuridine | Oligonucleotides | |
| HY-154042 | 5’-Azido-5’-deoxy-2’-O,4’-C-methyleneuridine | 2305415-75-0 | Oligonucleotides |
| HY-154044 | 3-Deoxy-1,2-O-isopropylidene-5-p-toluoyl-a-D-glycero-pent-3-enofuranose | 75096-63-8 | Oligonucleotides |
| HY-154045 | 3’-Deoxy-1,2-O-isopropylidene-5-O-(p-toluoyl)-L-arabinofuranose | 2072145-19-6 | Oligonucleotides |
| HY-154046 | 4,6-Diamino-1-(2-deoxy-beta-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | 117818-23-2 | Oligonucleotides |
| HY-154047 | 6-Amino-4-hydrozino-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | Oligonucleotides | |
| HY-15405 | Teriflunomide | 163451-81-8 | Reference compound |
| HY-154050 | 3′-Chloro-3′-deoxy-5′-O-(triphenylmethyl)thymidine | 34627-62-8 | Oligonucleotides |
| HY-154052 | 5′-Amino-2′,5′-dideoxyuridine | 35959-38-7 | Oligonucleotides |
| HY-154054 | 5′-Azido-5′-deoxyadenosine | 737-76-8 | Oligonucleotides |
| HY-154055 | 5′-Azido-2′,5′-dideoxyadenosine | 42204-43-3 | Oligonucleotides |
| HY-154056 | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine | 2072145-54-9 | Oligonucleotides |
| HY-154057 | 5-(2,3,5-Tri-O-benzyl-beta-D-ribofuranosyl)-2(1H)-pyridinone | Oligonucleotides | |
| HY-154058 | 9-(2-Deoxy-β-D-threo-pentofuranosyl)-9H-purin-6-amine | 13276-53-4 | Oligonucleotides |
| HY-154059 | 2’-Deoxy-2’-fluorouridine 5’-monophosphate triethyl ammonium | Oligonucleotides | |
| HY-15405R | Teriflunomide (Standard) | 163451-81-8 | Reference Standards |
| HY-15406 | BNC105P | 945771-96-0 | Reference compound |
| HY-154060 | N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-(2-methoxyethyl)adenosine | 256224-00-7 | Oligonucleotides |
| HY-154061 | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-fluorouridine | 2072145-49-2 | Oligonucleotides |
| HY-154062 | 5'-DMTr-dA(Bz)-Methyl phosphonamidite | 114079-05-9 | Oligonucleotides |
| HY-154064 | 3’-O-MOE-A(Bz)-2’-CED-phosphoramidite | 256224-01-8 | Oligonucleotides |
| HY-154066 | 3’-Deoxy-3’-flluoro-3-deazauridine | 2072145-34-5 | Oligonucleotides |
| HY-15407 | Sacubitril | 149709-62-6 | Reference compound |
| HY-154071 | 2’-O-Acetyl-5’-O-(p-toluoyl)-3’-deoxy-3’-fluoro-5-methyluridine | 2072145-23-2 | Oligonucleotides |
| HY-154072 | 2’-O-Acetyl-5’-O-(p-toluoyl)-3’-deoxy-3’-fluoro-5-trifluoromethyluridine | 2072145-74-3 | Oligonucleotides |
| HY-154077 | N4-Benzoyl-5-methyl-2’-O,4’-C-methylenecytidine | 206055-81-4 | Oligonucleotides |
| HY-154078 | 2’-O-Acetyl-5’-O-(p-toluoyl)-3’-deoxy-3’-fluoro-5-fluorouridine | 2072145-63-0 | Oligonucleotides |
| HY-15407A | Sacubitril hemicalcium salt | 1369773-39-6 | Reference compound |
| HY-15407AS | Sacubitril-13C4 (hemicalcium salt) | Isotope-Labeled Compounds | |
| HY-15407AS1 | Sacubitril-d4 (hemicalcium salt) | Isotope-Labeled Compounds | |
| HY-15407AS2 | Sacubitril-d5 (hemicalcium) | Isotope-Labeled Compounds | |
| HY-15407B | Sacubitril (sodium) | 149690-05-1 | Reference compound |
| HY-15407BR | Sacubitril (sodium) (Standard) | 149690-05-1 | Reference Standards |
| HY-15407S | Sacubitril-d4 | 1884269-07-1 | Isotope-Labeled Compounds |
| HY-15407S3 | Sacubitril-13C4 | Isotope-Labeled Compounds | |
| HY-15408 | Trelagliptin | 865759-25-7 | Reference compound |
| HY-154080 | 5'-O-DMTr-2'-FU-methyl phosphonamidite | Oligonucleotides | |
| HY-154081 | 5’-O-DMTr-2’-OMeU-methyl phosphonamidite | 191786-64-8 | Oligonucleotides |
| HY-154082 | 5-Caroxy uracil-1-yl acetic acid benzyl ester | Oligonucleotides | |
| HY-154083 | 2’-O-Acetyl-5’-O-(p-toluoyl)-3’-deoxy-3’-fluoro-5-methoxyuridine | 2072145-81-2 | Oligonucleotides |
| HY-154085 | (2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid | 174653-39-5 | Oligonucleotides |
| HY-154086 | 5’-O-DMTr-2’,2’-difluoro-dC(Bz)-methyl phosphonamidite | Oligonucleotides | |
| HY-154087 | 3′-Bromo-3′-deoxythymidine | 99785-51-0 | Oligonucleotides |
| HY-154088 | 3′-Deoxy-3′-iodothymidine | 14260-82-3 | Oligonucleotides |
| HY-154089 | 3-Deoxy-1,2:5,6-bis-O-(1-methylethylidene)-α-D-ribo-hexofuranose | 4613-62-1 | Oligonucleotides |
| HY-15408A | Trelagliptin (succinate) | 1029877-94-8 | Reference compound |
| HY-15408AR | Trelagliptin (succinate) (Standard) | 1029877-94-8 | Reference Standards |
| HY-15408S | Trelagliptin-13C,d3 | 2707203-34-5 | Isotope-Labeled Compounds |
| HY-15409 | Empagliflozin | 864070-44-0 | Reference compound |
| HY-15409R | Empagliflozin (Standard) | 864070-44-0 | Reference Standards |
| HY-15409S | Empagliflozin-d4 | 2749293-95-4 | Isotope-Labeled Compounds |
| HY-15409S1 | Empagliflozin-13C6 | Isotope-Labeled Compounds | |
| HY-15409S2 | Empagliflozin-d6 | Isotope-Labeled Compounds | |
| HY-15410 | Gacyclidine | 68134-81-6 | Reference compound |
| HY-154109 | N1-Aminopseudouridine | Oligonucleotides | |
| HY-15410A | Gacyclidine (hydrochloride) | 131774-33-9 | Reference compound |
| HY-15411 | MK-0557 | 328232-95-7 | Reference compound |
| HY-154110 | N3-Aminopseudouridine | Oligonucleotides | |
| HY-154111 | 8-(N-Boc-aminomethyl)guanosine | Oligonucleotides | |
| HY-154112 | 2-Bromo-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine | 40896-58-0 | Oligonucleotides |
| HY-154114 | 2′-Deoxy-2-iodoadenosine | 118706-49-3 | Oligonucleotides |
| HY-154115 | 5’-O-Acetyl-5-acetyloxymethyluridine | 2305416-11-7 | Oligonucleotides |
| HY-154116 | 6-Chloro-2-hydroxy-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine | 161923-50-8 | Oligonucleotides |
| HY-154117 | 2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine | 622379-83-3 | Oligonucleotides |
| HY-154118 | 3',5'-Bis-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabino-6-azidouridine | 1013470-68-2 | Oligonucleotides |
| HY-154119 | 3’-Azido-3’-deoxy-6-azauridine | Oligonucleotides | |
| HY-15412 | HhAntag | 496794-70-8 | Reference compound |
| HY-154120 | 6-Aza-2'-deoxyuridine | 20500-29-2 | Oligonucleotides |
| HY-154121 | 2’-O-(2-Methoxyethyl)guanosine 5’-triphosphate (ammonium) | Oligonucleotides | |
| HY-154122 | 6-Amino-4-methoxy-1-(2-deoxy-a-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | Oligonucleotides | |
| HY-154123 | N6-Benzoyl-2’-chloro-2’-deoxyadenosine | 2095417-58-4 | Oligonucleotides |
| HY-154124 | N6-Benzoyl-2'-chloro-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine | 2243079-24-3 | Oligonucleotides |
| HY-154125 | 6-Chloro-2-fluoropurine-9-b-D-(3,5-bis-O-(p-toluoyl)-2-deoxy)riboside | Oligonucleotides | |
| HY-154126 | 2’,3’,5’-Tri-O-benzoyl-5-hydroxy methyluridine (see GL100342) | 53910-92-2 | Oligonucleotides |
| HY-154127 | 2’,3’,5’-Tri-O-benzoyl-5-difluoromethyluridine | 2305416-06-0 | Oligonucleotides |
| HY-154128 | 1-(b-D-Xylofuranosyl)-5-fluorouracil | Oligonucleotides | |
| HY-154129 | 1-(b-D-Xylofuranosyl)-5-methoxyuracil | Oligonucleotides | |
| HY-15413 | Edivoxetine | 1194508-25-2 | Reference compound |
| HY-154130 | 1-(b-D-Xylofuranosyl)-5-trifluoromethyluracil | Oligonucleotides | |
| HY-154131 | 3-Deaza-xylouridine | Oligonucleotides | |
| HY-154132 | 1-(b-D-Xylofuranosyl)-N6-(p-methoxybenzyl) adenine | Oligonucleotides | |
| HY-154133 | 3’-Deoxy-3’-fluoro-xylo-5-methoxyuridine | Oligonucleotides | |
| HY-154134 | 3’-Deoxy-3’-fluoro-xylo-5-trifluoromethyluridine | Oligonucleotides | |
| HY-154135 | 3’-Deoxy-3’-fluoro-xylo-N6-(p-methoxybenzyl)adenosine | Oligonucleotides | |
| HY-154136 | 5-Fluoro-3’-beta-C-methyluridine | Oligonucleotides | |
| HY-154137 | 3’-Beta-C-Methyl-5-trifluoromethyluridine | Oligonucleotides | |
| HY-154138 | 3’-beta-C-Methyl-5-methoxyuridine | Oligonucleotides | |
| HY-154139 | 3’-Beta-C-Methyl-3-deazauridine | Oligonucleotides | |
| HY-15413A | Edivoxetine (hydrochloride) | 1194374-05-4 | Reference compound |
| HY-15414 | Vortioxetine | 508233-74-7 | Reference compound |
| HY-154140 | 3’-beta-C-Methyl-N6-(p-methoxybenzyl)adenosine | Oligonucleotides | |
| HY-154141 | 3’-Beta-C-Ethynyl-5-fluorouridine | Oligonucleotides | |
| HY-154142 | 3’-Beta-C-Ethynyl-5-methoxyuridine | Oligonucleotides | |
| HY-154143 | 3’-Beta-C-Ethynyl-4-deoxyuridine | Oligonucleotides | |
| HY-154144 | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methyl uridine | 957535-53-4 | Oligonucleotides |
| HY-154145 | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine | 2072145-79-8 | Oligonucleotides |
| HY-154146 | 5-Nitro-1-(3-azido-3-deoxy-β-D-ribofuranosyl)-2(1H)-pyridinone | 2072145-26-5 | Oligonucleotides |
| HY-154147 | 2’-Deoxy-N1-methylguanosine | 5132-79-6 | Oligonucleotides |
| HY-154148 | N6-Isopentenyl-2’-deoxy adenosine, 2’-deoxy riboprine | 25775-85-3 | Oligonucleotides |
| HY-15414A | Vortioxetine (hydrobromide) | 960203-27-4 | Reference compound |
| HY-15414AS | Vortioxetine-d8 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-15414R | Vortioxetine (Standard) | 508233-74-7 | Reference Standards |
| HY-15414S | Vortioxetine-d8 | 2140316-62-5 | Isotope-Labeled Compounds |
| HY-15414S1 | Vortioxetine-d6 | 1629684-23-6 | Isotope-Labeled Compounds |
| HY-15414S2 | Vortioxetine-d4 | Isotope-Labeled Compounds | |
| HY-15415 | KB-R7943 (mesylate) | 182004-65-5 | Reference compound |
| HY-154150 | N-(1-Oxopropyl)cytidine | 60107-04-2 | Oligonucleotides |
| HY-154151 | N4-(3,3,3-Trifluoropropanoyl)cytidine | Oligonucleotides | |
| HY-154153 | 2-Methyl-2’-deoxyadenosine | 110952-90-4 | Oligonucleotides |
| HY-154154 | 3,5-Bis-O-(4-methylbenzoyl)-2-C-methyl-D-ribonic acid gama-lactone | 25137-77-3 | Oligonucleotides |
| HY-154156 | 2’-Deoxy-2’-fluoroadenosine 5’-monophosphate (triethylammonium) | Oligonucleotides | |
| HY-154157 | 2’-O-Methyladenosine 5’-monophosphate triethyl ammonium | Oligonucleotides | |
| HY-154158 | 2’-Deoxy-2’-fluoroguanosine 5’-monophosphate triethyl ammonium | Oligonucleotides | |
| HY-154159 | 2’-O,4’-C-Methyleneadenosine 5’-monophosphate (triethylammonium) | Oligonucleotides | |
| HY-15416 | NS309 | 18711-16-5 | Reference compound |
| HY-154160 | 5-(2-Hydroxyethyl)-2’,3’-di-O-toluoyl-2’-deoxyuridine | Oligonucleotides | |
| HY-154161 | 5-(2-Hydroxyethyl)-2’-deoxy uridine | 90301-60-3 | Oligonucleotides |
| HY-154167 | 5’-O-(4,4’-Dimethoxytrityl)-5-methoxyuridine | 2095417-73-3 | Oligonucleotides |
| HY-15417 | ML-7 (hydrochloride) | 110448-33-4 | Reference compound |
| HY-154170 | 2',3',5'-Tri-O-acetyl-2-thiouridine | 28542-31-6 | Oligonucleotides |
| HY-154171 | Deoxyribosyl dihydropyrimido[4,5-c][1,2]oxazin-7-one | 126128-42-5 | Reference compound |
| HY-154173 | 3’-O-(t-Butyldimethylsilyl)-2’-O-(2-methoxyethyl) uridine | 1345716-52-0 | Oligonucleotides |
| HY-154175 | 1-[6-(Diethoxyphosphinyl)-2-O-(2-methoxyethyl)-β-D-ribo-hexofuranosyl]uracil | Oligonucleotides | |
| HY-15418 | RS 504393 | 300816-15-3 | Reference compound |
| HY-154185 | 3’,5’-Di-O-benzoyl-2’-deoxy-2’-fluoro-5-methyl-β-D-arabino-uridine | 97614-47-6 | Oligonucleotides |
| HY-154186 | N6-Acetyloxymethyladenosine | Oligonucleotides | |
| HY-154187 | N6-Pivaloyloxymethyladenosine | Oligonucleotides | |
| HY-15419 | RS-127445 (hydrochloride) | 199864-86-3 | Reference compound |
| HY-154190 | 2',3',5'-Tri-O-benzoyl-6-azauridine | 1627-29-8 | Oligonucleotides |
| HY-154198 | 5′-O-[Bis(4-methoxyphenyl)phenylmethyl]cytidine | 112897-99-1 | Oligonucleotides |
| HY-15419A | RS-127445 | 199864-87-4 | Reference compound |
| HY-15420 | BML-190 | 2854-32-2 | Reference compound |
| HY-154200 | 3’-Deoxy-5-methycytidine | 7057-38-7 | Oligonucleotides |
| HY-154201 | 3’-Deoxy-O6-methyl inosine | 945215-53-2 | Oligonucleotides |
| HY-154202 | 2’-beta-C-Ethynyl-5-methyluridine | Oligonucleotides | |
| HY-154203 | 4-Deoxy-3’-deoxy-3’-fluoro uridine | Oligonucleotides | |
| HY-154204 | 2'-Deoxy-2'-fluoroarabino inosine | 98983-40-5 | Oligonucleotides |
| HY-154205 | 2’-Deoxy-2’-fluoroarabino-O6-methyl inosine | 109304-06-5 | Oligonucleotides |
| HY-154206 | N4-Benzo yl-5’-O-(4,4’-dimethoxytrityl)-aracytidine | 87418-76-6 | Oligonucleotides |
| HY-154207 | 2’-O-Acetyl-N4-benzoyl-5’-O-DMT arabinocytidine 3’-O-phosphoramidite | 675573-97-4 | Oligonucleotides |
| HY-154210 | DMTr-FNA-C(Bz)Phosphoramidite | 326802-62-4 | Oligonucleotides |
| HY-154211 | 5'-O-DMTr-dU-methyl phosphonamidite | Oligonucleotides | |
| HY-154212 | N4-Acetyl-5’-O-(4,4’-dimethoxytrityl)-5-methyl-2’-deoxycytidine | Oligonucleotides | |
| HY-154213 | 5’-O-DMTr-5-MedC (Ac)-methyl phosphonamidite | Oligonucleotides | |
| HY-154214 | 2-(3-Methyln-propylidene hydrazino) adenosine | Oligonucleotides | |
| HY-154215 | 2-(P-Cyanophenyl methylidene hydrazino) adenosine | Oligonucleotides | |
| HY-154217 | 3′,5′-Bis-O-(triphenylmethyl)uridine | 4710-75-2 | Oligonucleotides |
| HY-154218 | 2-O-Benzoyl-3-O-t-butyldiphenylsilyl-L-threono lactone | 1446785-28-9 | Oligonucleotides |
| HY-15422 | Dye 937 | 195199-04-3 | Dye Reagents |
| HY-154220 | N4-Benzoyl-2’-deoxy-2’,2’-diflurocytidine | 142816-70-4 | Oligonucleotides |
| HY-154221 | N4-Benzoyl-2'-deoxy-5'-O-DMT-2',2'-difluorocytidine | 142808-43-3 | Oligonucleotides |
| HY-154222 | 5’-O-DMTr-2’,2’-difluoro-dC(Bz)-3’-CED-phosphoramidite | 142808-44-4 | Oligonucleotides |
| HY-154223 | 5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyl-2-thiouridine | 302918-83-8 | Oligonucleotides |
| HY-154224 | 2’-O-Me-2-thio-U-3’-phos phoramidite | 302918-84-9 | Oligonucleotides |
| HY-154228 | 3’-O-(4,4’-Dimethoxy trityl)-2’-O-(2-methoxyethyl)-5-methyluridine | Oligonucleotides | |
| HY-154229 | 3’-O-DMT-N2-isobutyryl-2’-O-(2-methoxyethyl)guanosine | Oligonucleotides | |
| HY-154230 | Rev 2’-O-MOE-C(Bz)-5’-amidite | Oligonucleotides | |
| HY-154231 | 2’-Deoxy-2’-fluoro-alpha-D-arabinoguanosine | 2072145-29-8 | Oligonucleotides |
| HY-154232 | 4′,5′-Didehydro-5′-deoxyadenosine | 20535-04-0 | Oligonucleotides |
| HY-154233 | 5’-O-TBDPS-2,2’-anhydrouridine | 175013-46-4 | Oligonucleotides |
| HY-154234 | 5’-O-TBDPS-5-methyl-2,2’-anhydrouridine | 171763-19-2 | Oligonucleotides |
| HY-154235 | N2-iBu-2’,3’-bis-O-TBDMS guanosine | 79974-70-2 | Oligonucleotides |
| HY-154236 | 2’-Deoxy-2’-fluoro-3’,5’-bis-O-TBDMS-uridine | 139878-36-7 | Oligonucleotides |
| HY-154237 | 5’-O-DMTr-3’-deoxyuridine | 86234-42-6 | Oligonucleotides |
| HY-154238 | 5’-O-DMTr-3’-deoxyuridine 2’-CED phosphoramidite | 161503-98-6 | Oligonucleotides |
| HY-154239 | 5’-O-Triphenylmethyl-2’-deoxyuridine | 14270-73-6 | Oligonucleotides |
| HY-15424 | 5-Iodotubercidin | 24386-93-4 | Reference compound |
| HY-154240 | 2-Amino-2’,3’-bis-O-(2-methoxyethyl) adenosine | 847647-19-2 | Oligonucleotides |
| HY-154241 | 8-Methyl-2’-deoxyadenosine | 85562-60-3 | Oligonucleotides |
| HY-154242 | 8-Methylguanosine | 36799-17-4 | Oligonucleotides |
| HY-154243 | 8-Methyl-2’-deoxyguanosine | 85819-69-8 | Oligonucleotides |
| HY-154246 | 2’-Fluoro-2’-deoxy-arabinoadenosine 5’-triphosphate (triethylamine) | Oligonucleotides | |
| HY-154248 | 2’-Deoxy-3’,2-anhydrouridine | 26922-44-1 | Oligonucleotides |
| HY-15425 | PF-543 | 1415562-82-1 | Reference compound |
| HY-154251 | 2-Methoxy-9-β-D-ribofuranosyl-9H-purine | 39638-84-1 | Oligonucleotides |
| HY-154252 | 2’,3’,5’-Tri-O-benzoyl-5-hydroxymethyl-2’-β-C-methyluridine | 2305416-16-2 | Oligonucleotides |
| HY-154253 | 5-Azidomethyl-2'-deoxyuridine | 59090-48-1 | Oligonucleotides |
| HY-154254 | 2-Diethoxymethyl adenosine | Oligonucleotides | |
| HY-154255 | 5-(3-Azidopropyl)uridine | 1354419-08-1 | Oligonucleotides |
| HY-154256 | 5-(2-Azidoethyl)uridine | Oligonucleotides | |
| HY-154257 | N2-iso-Butyryl-8-azaguanosine | 2328168-83-6 | Oligonucleotides |
| HY-154258 | Rev 2’-O-MOE-5MeU-5’-amidite | 1345715-43-6 | Oligonucleotides |
| HY-154259 | Rev 2’-O-MOE-G(iBu)-5’-amidite | 725223-44-9 | Oligonucleotides |
| HY-15425A | PF-543 (Citrate) | 1415562-83-2 | Reference compound |
| HY-15425B | PF-543 (hydrochloride) | 1706522-79-3 | Reference compound |
| HY-15426 | PF-04957325 | 1305115-80-3 | Reference compound |
| HY-154260 | N6-Benzoyl-3'-O-DMT-2'-O-(2-methoxyethyl) adenosine | Oligonucleotides | |
| HY-154261 | Rev 2’-O-MOE-A(Bz)-5’-amidite | Oligonucleotides | |
| HY-154262 | N6-Ethyl-2’-deoxyadenosine | 136050-93-6 | Oligonucleotides |
| HY-154263 | 5’-O-DMTr-N6-ethyl-2’-deoxyadenosine | Oligonucleotides | |
| HY-154264 | 5’-O-DMTr-N6-ethyl-2’-deoxyadenosine 3’-CED phosphoramidite | Oligonucleotides | |
| HY-154265 | 2-Amino-2’-deoxy-N6,N6-dimethyl-2’-adenosine | 83061-20-5 | Oligonucleotides |
| HY-154266 | 2-Amino-2’-deoxy-N6-ethyl-adenosine | Oligonucleotides | |
| HY-154267 | 5'-O-DMT-2-thio-2'-dU-3'-phosphoramidite | 152753-94-1 | Oligonucleotides |
| HY-154268 | Confidential-2 | Oligonucleotides | |
| HY-154269 | Confiden | Oligonucleotides | |
| HY-15427 | GDC-0834 | 1133432-49-1 | Reference compound |
| HY-154270 | Confident | Oligonucleotides | |
| HY-154271 | TLR7 agonist 12 | 2389988-47-8 | Reference compound |
| HY-154273 | 2’,3’,5’-Tri-O-acetyl-5-cyanouridine | 1630743-99-5 | Oligonucleotides |
| HY-154274 | 5-Cyanouridine | 4425-57-4 | Oligonucleotides |
| HY-154275 | 4’-Methylthymidine | 139925-84-1 | Oligonucleotides |
| HY-154276 | 1-O-Acetyl-2-O-benzoyl-3-O-tert-butyldiphenylsilyl-L-threofuranose | 1971879-01-2 | Oligonucleotides |
| HY-15427A | GDC-0834 (Racemate) | 1133432-46-8 | Reference compound |
| HY-15427B | GDC-0834 (S-enantiomer) | 1133432-50-4 | Reference compound |
| HY-154283 | 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)purine | 2389988-53-6 | Oligonucleotides |
| HY-154284 | 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy guanosine | 2389988-54-7 | Oligonucleotides |
| HY-154285 | 3’-O-(2-Methoxyethyl) uridine | 870599-31-8 | Oligonucleotides |
| HY-154286 | 1-O-Acetyl-2,3,5-tri-O-benzoyl-5(R)-C-methyl-D-ribo furanose | 72159-45-6 | Oligonucleotides |
| HY-154288 | 2’,3’,5’-Tri-O-benzoyl-5-iodouridine | 2880-91-3 | Oligonucleotides |
| HY-154289 | 2’,3’-Isopropylidene-5-hydroxyuridine | 20406-82-0 | Oligonucleotides |
| HY-154290 | N3,5-Dimethyl-2’-O-(2-methoxyethyl) uridine | Oligonucleotides | |
| HY-154291 | 3’-Deoxy-3’-fluoro-N1-methyluridine | Oligonucleotides | |
| HY-154292 | 3’-Deoxy-N1-Methyl inosine | Oligonucleotides | |
| HY-154293 | 3’-Deoxy-N6-ethyladenosine | 3608-60-4 | Oligonucleotides |
| HY-154294 | N1-Methyl ara-uridine | 17676-62-9 | Oligonucleotides |
| HY-154295 | 2’-Deoxy-2’-fluoro-N1-methyluridine | Oligonucleotides | |
| HY-154296 | 2'-Deoxy-2'-fluoro-ara-uridine | Oligonucleotides | |
| HY-154297 | N6-Dimethylamino methylidene-2’-deoxyisoguanosine | 146196-17-0 | Oligonucleotides |
| HY-154298 | N-Benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-3′-deoxyadenosine | 84138-86-3 | Oligonucleotides |
| HY-15430 | Encenicline | 550999-75-2 | Reference compound |
| HY-154300 | N-Benzoyl-3′-O-methyladenosine | 85090-30-8 | Oligonucleotides |
| HY-154302 | 5’-O-(4,4’-Dimethoxytrityl)-3’-O-levulinyl-2’-deoxyadenosine | 2072145-67-4 | Oligonucleotides |
| HY-154303 | 3’-O-Levulinyl-2’-deoxyadenosine | 440327-45-7 | Oligonucleotides |
| HY-154304 | 4’,5’-Didehydro-2’,5’-dideoxy-2’-fluorouridine | 1365255-75-9 | Oligonucleotides |
| HY-154305 | 5′-Azido-2′,5′-dideoxy-2′-fluorouridine | 1012080-88-4 | Oligonucleotides |
| HY-154306 | 5’-Deoxy-5’-iodo-2’-O-methyluridine | 194034-84-9 | Oligonucleotides |
| HY-154307 | 4′,5′-Didehydro-5′-deoxy-2′-O-methyluridine | 1848223-48-2 | Oligonucleotides |
| HY-154308 | 5’-Azido-5’-deoxy-2’-O-methyluridine | 194034-68-9 | Oligonucleotides |
| HY-154309 | 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-2'-deoxyadenosine | 89947-86-4 | Oligonucleotides |
| HY-15430A | Encenicline hydrochloride | 550999-74-1 | Reference compound |
| HY-15431 | Capivasertib | 1143532-39-1 | Reference compound |
| HY-154310 | 1,2-Di-O-acetyl-3-azido-3-deoxy-5-O-(4-methyl) benzoyl-L-ribofuranose | Oligonucleotides | |
| HY-154312 | 3,5-Di-O-benzoyl-2-deoxy-2-fluoro-5-trifluoromethyl-arabinouridine | 117311-99-6 | Oligonucleotides |
| HY-154313 | Spiclomazine | 24527-27-3 | Reference compound |
| HY-154314 | N2-(Isopropylphenoxyacetyl)-2’-O-propargylguanosine | 2095417-23-3 | Oligonucleotides |
| HY-154315 | 3',5'-Bis-O-benzoyl-2'-deoxy-2'-fluoro-4-deoxy-arabinouridine | 136675-87-1 | Oligonucleotides |
| HY-154316 | 3’,5’-Di-O-benzoyl-2’-deoxy-2’-fluoro-3-Deaza-arabinouridine | 2095417-46-0 | Oligonucleotides |
| HY-154317 | 2’-O-Methyl-5-methyluridine 5’-triphosphate (triethylammonium) | Oligonucleotides | |
| HY-154318 | 1,2-Di-O-acetyl-3-azido-3-deoxy-5-O-(4-methyl)benzoyl-D-ribofuranose | 120143-22-8 | Oligonucleotides |
| HY-154319 | 1-(3’-O-[4,4’-Dimethoxytrityl]-alpha-L-threofuranosyl)-thymine | 325683-89-4 | Oligonucleotides |
| HY-15431A | (R)-Capivasertib | 1143532-51-7 | Reference compound |
| HY-15432 | (E/Z)-NSC-687852 | 330450-45-8 | Reference compound |
| HY-154320 | 3’-Azido-3’-deoxy-3-deazauridine | 2305416-04-8 | Oligonucleotides |
| HY-154321 | Methyl 2-deoxy-3,5-di-O-benzoyl-2-fluoro-4-thio-D-arabinopentofuranoside | 221552-92-7 | Oligonucleotides |
| HY-154323 | 5’-DMTr-3’dA(Bz)-methylphosphonami dite | Oligonucleotides | |
| HY-154324 | 2′-Deoxy-2-thiouridine | 35059-12-2 | Oligonucleotides |
| HY-154325 | 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-4(1H)-pyrimidinone | 37109-98-1 | Oligonucleotides |
| HY-154326 | 2-Deoxy-2’-deoxy-5’-(4,4’-dimethoxytrityl)uridine | 151503-26-3 | Oligonucleotides |
| HY-154327 | DMTr-dH2U-amidite | 151503-28-5 | Oligonucleotides |
| HY-154328 | 3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine | 2072145-36-7 | Oligonucleotides |
| HY-154329 | 2-Deoxyuridine | 21052-20-0 | Oligonucleotides |
| HY-15433 | Quisinostat | 875320-29-9 | Reference compound |
| HY-154330 | 3'-beta-Azido-2',3'-dideoxyuridine | 101039-96-7 | Oligonucleotides |
| HY-154331 | 1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil | 2072145-82-3 | Oligonucleotides |
| HY-154332 | 8-(Phenylmethoxy)guanosine | 3868-36-8 | Oligonucleotides |
| HY-154333 | 2′-Deoxy-8-(phenylmethoxy)guanosine | 96964-90-8 | Oligonucleotides |
| HY-154334 | 2’-O-Acetyl-3’-azido-5’-O-(4-methylbenzoyl)-3’-deoxyuridine | 256485-42-4 | Oligonucleotides |
| HY-154335 | 1-(3-Deoxy-3-fluoro-β-D-xylofuranosyl)-2,4(1H,3H)-pyrimidinedione | 129885-95-6 | Oligonucleotides |
| HY-154336 | N-[2-[4-(1-Methylethyl)phenoxy]acetyl]guanosine | 937205-20-4 | Oligonucleotides |
| HY-154338 | N-Benzoyl-2′-O-2-propyn-1-yladenosine | 210096-44-9 | Oligonucleotides |
| HY-154339 | N4-Benzoyl-5'-O-DMT-2'-O-propargyl adenosine | 171486-51-4 | Oligonucleotides |
| HY-15433A | Quisinostat (dihydrochloride) | 875320-31-3 | Reference compound |
| HY-15434 | NG25 | 1315355-93-1 | Reference compound |
| HY-154340 | 2,3’-Anhydrothymidine | 15981-92-7 | Oligonucleotides |
| HY-154341 | 9-[2'-O-Acetyl-3'-azido-3'-deoxy-5'-O-toluoyl-b-L-ribofuranosyl)-6-chloropurine | 2095417-30-2 | Oligonucleotides |
| HY-154342 | N1-Ethyl-2’-O-TBDMS-5’-O-DMTr-3’-phosphoramidite | Oligonucleotides | |
| HY-154343 | 3′-Azido-3′-deoxy-5′-O-(triphenylmethyl)thymidine | 29706-84-1 | Oligonucleotides |
| HY-154344 | 5′-Deoxy-5′-iodo-5-methyluridine | 1884334-62-6 | Oligonucleotides |
| HY-154345 | 4′,5′-Didehydro-5′-deoxy-5-methyluridine | 1446748-33-9 | Oligonucleotides |
| HY-154346 | 5’-Azido-5’-deoxy-5-methyluridine | 1187022-65-6 | Oligonucleotides |
| HY-154347 | 5'-Deoxy-5‘-iodothymidine | 25953-14-4 | Oligonucleotides |
| HY-154348 | 4’,5’-Didehydro-5’-deoxy thymidine | 28034-72-2 | Oligonucleotides |
| HY-154349 | N2-iso-Butyroyl-2’-O-propargylguanosine | 2095417-55-1 | Oligonucleotides |
| HY-15434A | NG25 (trihydrochloride) | 2108554-00-1 | Reference compound |
| HY-15435 | CHAPS | 75621-03-3 | Reference compound |
| HY-154350 | 5'-O-DMT-N2-isobutyryl-2'-O-propargylguanosine | 171486-53-6 | Oligonucleotides |
| HY-154351 | N2-iBu-5’-O-DMTr-2’-O-propargylguanosine-3’-CED-phosphoramidite | 171486-61-6 | Oligonucleotides |
| HY-154352 | Methyl 2-deoxy-3,5-di-O-benzoyl-2-fluoro-4-thio-beta-D-arabinopentofuranoside | 197647-15-7 | Oligonucleotides |
| HY-154353 | 5’-O-(4,4’-Dimethoxytrityl)-2’-O-(2-methoxyethyl) adenosine | 1384253-67-1 | Oligonucleotides |
| HY-154354 | Methyl 3’-O-benzyl xyloriboside | 201014-45-1 | Oligonucleotides |
| HY-154355 | 2-Chloro-N6-cyclopentyl 2’-deoxy- adenosine | 215108-39-7 | Oligonucleotides |
| HY-154356 | 1-(alpha-L-Threofuranosyl)cytosine | 2166199-20-6 | Oligonucleotides |
| HY-154357 | 4’-alpha-C-Azido-2’,3’-bis(O-t-butyldimethylsilyl)uridine | Oligonucleotides | |
| HY-154358 | 4’-alpha-C-Allyl-2’,3’-bis(O-t-butyldimethylsilyl) uridine | 512184-18-8 | Oligonucleotides |
| HY-154359 | 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine | 161615-21-0 | Oligonucleotides |
| HY-15435A | CHAPS (hydrate) | 331717-45-4 | Biochemical Assay Reagents |
| HY-154360 | 2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine | 2389988-71-8 | Oligonucleotides |
| HY-154361 | TLR7 agonist 13 | 2389988-70-7 | Reference compound |
| HY-154362 | 1,2-Di-O-acetyl-3-deoxy-3-fluoro-5-O-(4-methyl)benzoyl-D-ribofuranose | 1612192-28-5 | Oligonucleotides |
| HY-154362A | β-D-Ribofuranose, 3-deoxy-3-fluoro-, 1,2-diacetate 5-(4-methylbenzoate) | 1884324-98-4 | Reference compound |
| HY-154363 | 3-Cyanovinyl-9-(5’-O-DMT-2’-deoxyribofuranosyl)carbazole | Oligonucleotides | |
| HY-154364 | 3’-Deoxy-5-trifluoromethyluridine | 35463-35-5 | Oligonucleotides |
| HY-154365 | 5’-O-(4,4’-Dimethoxy trityl)-2’-O-(2-methoxyethyl) inosine | Oligonucleotides | |
| HY-154366 | 5'-DMT-2'-O-TBDMS-N1-Methyl-PseudoUridine-CE-Phosphoramidite | 875302-45-7 | Oligonucleotides |
| HY-154368 | DMTr-MOE-Inosine-3-CED-phosphoramidite | Oligonucleotides | |
| HY-154369 | 1,4-Anhydro-2,3-O-isopropylidene-5-O-t-butyldiphenylsilyl-4-thio-D-ribitol | 1320269-77-9 | Oligonucleotides |
| HY-15437 | SL327 | 305350-87-2 | Reference compound |
| HY-154370 | 2’,3’-Bis-O-(t-butyldimethylsilyl)-N1-methylpseudouridine | Oligonucleotides | |
| HY-154371 | 5’-O-Benzoyl-2’-O,4’-C-methyleneuridine | 293751-31-2 | Oligonucleotides |
| HY-154372 | 2′,5′-Dideoxy-5′-iodouridine | 58510-66-0 | Oligonucleotides |
| HY-154373 | 4′,5′-Didehydro-2′,5′-dideoxyuridine | 58096-66-5 | Oligonucleotides |
| HY-154374 | 5’-Azido-2’,5’-dideoxyuridine | 35959-37-6 | Oligonucleotides |
| HY-154375 | 5’-Deoxy-5’-iodo-2’-O-methyl-5-methyluridine | 187733-72-8 | Oligonucleotides |
| HY-154376 | 4’,5’-Didehydro-2’-O-methyl-5-methyluridine | 2095417-11-9 | Oligonucleotides |
| HY-154377 | 5'-Azido-5'-deoxy-2'-O-methyl-5-methyluridine | 187733-73-9 | Oligonucleotides |
| HY-154379 | 3',5'-Di-O-acetyl-2'-O-methyl-6-chloro-2-aminopurine riboside | 244184-56-3 | Oligonucleotides |
| HY-15438 | SB 415286 | 264218-23-7 | Reference compound |
| HY-154380 | 6-Chloro-9-(3,5-di-O-acetyl-2-O-methyl-β-D-ribofuranosyl)-9H-purine | 194034-61-2 | Oligonucleotides |
| HY-154381 | 5’-Deoxy-5’-iodo-2’-O-(2-methoxyethyl)uridine | 2095417-41-5 | Oligonucleotides |
| HY-154382 | 4’,5’-Didehydro-2’-O-(2-methoxyethyl)uridine | 2095417-78-8 | Oligonucleotides |
| HY-154383 | 5’-Azido-5’-deoxy-2’-O-(2-methoxyethyl)uridine | 2095417-60-8 | Oligonucleotides |
| HY-154384 | 5’-Deoxy-5’-iodo-2’-O-(2-methoxyethyl)-5-methyluridine | 2095417-53-9 | Oligonucleotides |
| HY-154385 | 4’,5’-Didehydro-2’-O-(2-methoxyethyl)-5-methyluridine | 2095417-31-3 | Oligonucleotides |
| HY-154386 | 5’-Azido-5’-deoxy-2’-O-(2-methoxyethyl)-5-methyluridine | 2095417-42-6 | Oligonucleotides |
| HY-154387 | 1-Isopropyltryptophan | 1219485-46-7 | Reference compound |
| HY-15439 | (24S)-24,25-Dihydroxyvitamin D3 | 55700-58-8 | Reference compound |
| HY-154391 | 5-O-(tert-Butyldiphenylsilyl)-2,3-isopropylidene-D-ribonolactone | 130222-84-3 | Oligonucleotides |
| HY-154392 | 2-Chloro-2’-deoxy inosine | 136834-39-4 | Oligonucleotides |
| HY-154393 | 2-Chloro-2'-deoxy-6-O-methylinosine | 146196-07-8 | Oligonucleotides |
| HY-154394 | 2-Chloro-N6-methyl-2’-deoxyadenosine | 146196-08-9 | Oligonucleotides |
| HY-154395 | 2-Chloro-2′-deoxy-N,N-dimethyladenosine | 1858191-70-4 | Oligonucleotides |
| HY-154396 | 8-Chloro-2’-deoxy-2’-fluoroadenosine | Oligonucleotides | |
| HY-154397 | 2',3',5'-Tri-O-benzoyl-5-azacytidine | 28998-36-9 | Oligonucleotides |
| HY-154398 | 5-Aza-xylo-cytidine | Oligonucleotides | |
| HY-154399 | 5-Aza-3’-deoxycytidine | 455951-65-2 | Oligonucleotides |
| HY-15440 | Temsavir | 701213-36-7 | Reference compound |
| HY-154400 | 5-Aza-3’-beta-methylcytidine | Oligonucleotides | |
| HY-154402 | 2′-Azido-2′-deoxy-5-methyluridine | 97748-75-9 | Oligonucleotides |
| HY-154403 | 2’-Azido-2’-deoxy-5’-O-(4,4’-dimethoxytrityl)-5-methyluridine | 2095417-08-4 | Oligonucleotides |
| HY-154404 | 2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine | 267665-69-0 | Oligonucleotides |
| HY-154405 | 5’-Azido-5’-deoxyuridine | 39483-48-2 | Oligonucleotides |
| HY-154406 | 2′-Deoxy-N-methylguanosine | 19916-77-9 | Oligonucleotides |
| HY-154407 | 2’-Deoxy-N2,N2-dimethylguanosine | 88127-22-4 | Oligonucleotides |
| HY-154408 | 2'-O-Me-5-I-U-3'-phosphoramidite | Oligonucleotides | |
| HY-154409 | 2’-Fluoro-2’-deoxy-ara-A(Bz)-3’-phosphoramidite | 329187-86-2 | Oligonucleotides |
| HY-15440A | Fostemsavir | 864953-29-7 | Reference compound |
| HY-15440AR | Fostemsavir (Standard) | 864953-29-7 | Reference Standards |
| HY-15440AS | Fostemsavir-d8 | Isotope-Labeled Compounds | |
| HY-15440B | Fostemsavir Tris | 864953-39-9 | Reference compound |
| HY-15441 | Edelinontrine | 1082744-20-4 | Reference compound |
| HY-154410 | 5’-O-DMT-2’-deoxy-2’-fluoro-β-D-arabinouridine | 144822-63-9 | Oligonucleotides |
| HY-154412 | N4-Benzoyl-2’-deoxy-2’-fluoro-β-D-arabinocytidine | Oligonucleotides | |
| HY-154413 | DMT-2'-F-Bz-dC | 154771-33-2 | Oligonucleotides |
| HY-154414 | 2’-Fluoro-2’-deoxy-ara-C(Bz)-3’-phosphoramidite | 1404463-12-2 | Oligonucleotides |
| HY-154415 | 2’,3’,5’-Tri-O-benzoyl-2-thiouridine | 21052-18-6 | Oligonucleotides |
| HY-154416 | 5-(2,3,5-Tri-O-benzyl-beta-D-ribofuranosyl)-3-methyl-2-benzyloxypyridine | 1846584-69-7 | Oligonucleotides |
| HY-154417 | 2’,3’-Bis(O-t-butyldimethylsilyl)-2-thiouridine | 2305415-97-6 | Oligonucleotides |
| HY-154418 | 2’,3’-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine | 2305415-94-3 | Oligonucleotides |
| HY-154419 | N6-Benzoyl-2'-O-tert-butyldimethylsilyl-3'-O-DMT-adenosine | 1214886-17-5 | Oligonucleotides |
| HY-15442 | Biphenylindanone A | 866823-73-6 | Reference compound |
| HY-154420 | 2’,3’-Bis-(O-t-butyldimethylsilyl)uridine | 69504-12-7 | Oligonucleotides |
| HY-154421 | 2’,5’-Dideoxyuridine | 35959-50-3 | Oligonucleotides |
| HY-154422 | 2’-Amino-2’-deoxy-5’-O-(4,4’-dimethoxytrityl)-5-methyluridine | 158665-47-5 | Oligonucleotides |
| HY-154423 | 2′-Azido-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxyuridine | 177980-10-8 | Oligonucleotides |
| HY-154424 | 2′-Amino-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxyuridine | 174221-86-4 | Oligonucleotides |
| HY-154425 | 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine | 2389988-75-2 | Oligonucleotides |
| HY-154426 | 2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy-3’-fluoroguanosine | 2389988-77-4 | Oligonucleotides |
| HY-154428 | 2'-Deoxy-N2-isopropyl guanosine | 201528-73-6 | Oligonucleotides |
| HY-154429 | 2'-Deoxy-N2,N2-diethyl guanosine | 236389-19-8 | Oligonucleotides |
| HY-15443 | AM251 | 183232-66-8 | Reference compound |
| HY-154430 | 2’-Deoxy-N2-cyclopentyl guanosine | 1353757-90-0 | Oligonucleotides |
| HY-154432 | N1-Methyl-2’-deoxyinosine | 72398-31-3 | Oligonucleotides |
| HY-154434 | 3’-O-(2-Methoxyethyl)-5-methyluridine | 303197-29-7 | Oligonucleotides |
| HY-154436 | Anticonvulsant agent 2 | 75220-84-7 | Reference compound |
| HY-154437 | 3’-β-Amino-2’,3’-dideoxy-5’-O-methoxy trityluridine | 2072145-31-2 | Oligonucleotides |
| HY-154438 | RDR 02308 | 4155-82-2 | Reference compound |
| HY-154439 | 3’-β-Amino-2’,3’-dideoxy-5’-O-trityl-5-methyl uridine | 204688-08-4 | Oligonucleotides |
| HY-15444 | D159687 | 1155877-97-6 | Reference compound |
| HY-154440 | 2-Amino-6-chloro-9-(3’-O-methyl-beta-D-ribofuranosyl)-9H-purine | Oligonucleotides | |
| HY-154441 | N4-Benzoyl-3'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine | Oligonucleotides | |
| HY-154442 | Rev 2’-O-MOE-5MeC(Bz)-5’-amidite | Oligonucleotides | |
| HY-154443 | Rev dC(Bz)-5'-amidite | 140712-83-0 | Oligonucleotides |
| HY-154444 | DMTr-TNA-5MeU-amidite | 325683-94-1 | Oligonucleotides |
| HY-154445 | DMTr-TNA-U-amidite | 325683-95-2 | Oligonucleotides |
| HY-154447 | 5’-O-(p-Toluoyl)-2’-O-acetyl-3’-deoxy-3’-fluoro-6-chloroinosine | 1612192-06-9 | Oligonucleotides |
| HY-154448 | 3,5-Bis-O-(2,4-dichlorobenzyl)guanosine | 2095417-36-8 | Oligonucleotides |
| HY-154449 | N4-Benzoyl-3’-O-(2-methoxyethyl)-5-methylcytidine | Oligonucleotides | |
| HY-15445 | CTEP | 871362-31-1 | Reference compound |
| HY-154450 | N4-Benzoyl-5’-O-DMT-3’-O-(2-methoxyethyl)-5-methylcytidine | 256223-98-0 | Oligonucleotides |
| HY-154452 | 2-Amino-3’,5’-di-O-acetyl-N6,N6-dimethyl-2’-O-methyladenosine | Oligonucleotides | |
| HY-154453 | 4-Deoxy-xylo-uridine | 63527-47-9 | Oligonucleotides |
| HY-154454 | 3’-Deoxy-2’,5’-di-O-acetyl-8-hydroxyguanosine | 2389988-72-9 | Oligonucleotides |
| HY-154456 | 2’-Deoxy-N6-cyclopentyladenosine | 170711-45-2 | Oligonucleotides |
| HY-154457 | 2’-Deoxy-N6-(4-methoxybenzyl)adenosine | 157640-47-6 | Oligonucleotides |
| HY-154458 | 2’-Deoxy-N6-(3-methoxybenzyl)adenosine | 1947400-98-7 | Oligonucleotides |
| HY-154459 | N4-Benzoyl-2’-deoxy-5’-O-DMTr-2’-fluoro- 5-methylcytidine | Oligonucleotides | |
| HY-15446 | Basimglurant | 802906-73-6 | Reference compound |
| HY-154461 | 5-Azidomethyl-2’,3’,5’-tri-O-benzoyl uridine | 1884334-72-8 | Oligonucleotides |
| HY-154462 | 5-Azidomethyl-2’-beta-methyl-2’,3’,5’-tri-O-benzoyluridine | 2305416-08-2 | Oligonucleotides |
| HY-154463 | N2-iso-Butyroyl-3’-deoxy-3’-fluoro guanosine | 2080404-20-0 | Oligonucleotides |
| HY-154464 | N2-iso-Butyroyl-5'-O-DMT-3'-deoxy-3'-fluoroguanosine | 2080404-19-7 | Oligonucleotides |
| HY-154465 | 3’-F-3’-dG(iBu)-2’-phosphoramidite | 2080404-21-1 | Oligonucleotides |
| HY-154466 | 5’-O-(4,4’-Dimethoxytrityl)-3’-O-methyluridine | 127212-40-2 | Oligonucleotides |
| HY-154467 | 2′-Deoxy-6-thioinosine | 2239-64-7 | Oligonucleotides |
| HY-154468 | 6-O-Methyl-2’-O-methylinosine | Oligonucleotides | |
| HY-154469 | 5’-O-DMTr-2’-O-MOE inosine 3’-P-methyl phosphonamidite | Oligonucleotides | |
| HY-154470 | 8-Aza-2’-deoxyguanosine | 4546-73-0 | Oligonucleotides |
| HY-154472 | N4-Ethyl-2’-deoxycytidine | 70465-61-1 | Oligonucleotides |
| HY-154473 | 2’-Deoxy-N4-ethyl-5-methylcytidine | 25406-43-3 | Oligonucleotides |
| HY-154474 | 3’,4-Dideoxyuridine | 2095417-04-0 | Oligonucleotides |
| HY-154475 | 9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine | 1347118-41-5 | Oligonucleotides |
| HY-154477 | 2-Amino-6-chloro-9-(3-deoxy-beta-D-ribofuanosyl)-9H-purine | 1055035-48-7 | Oligonucleotides |
| HY-154478 | 3’-O-Acetyl-N2-iso-Butyroyl-2’-deoxy-guanosine | 74925-81-8 | Oligonucleotides |
| HY-15448 | Tezacaftor | 1152311-62-0 | Reference compound |
| HY-154480 | N4-Benzoyl-3’-O-methylcytidine | 85079-03-4 | Oligonucleotides |
| HY-154481 | 3’-O-Me-C(Bz)-2’-phosphoramidite | 179479-03-9 | Oligonucleotides |
| HY-154482 | N2-iso-Butyroyl-3’-O-methylguanosine | 160107-07-3 | Oligonucleotides |
| HY-154483 | N2-iso-Butyroyl-5’-O-(4,4’-dimethoxytrityl)-3’-O-methylguanosine | 103285-33-2 | Oligonucleotides |
| HY-154484 | 3’-O-Me-G(iBu)-2’-phosphoramidite | 179479-04-0 | Oligonucleotides |
| HY-154485 | 5'-O-DMTr-2'-O-methyl-N6-methyl adenosine 3'-CED phosphoramidite | 2348385-04-4 | Oligonucleotides |
| HY-154486 | 5’-O-DMTr-2’-OMe-5MeU-P-methyl phosphonamidite | Oligonucleotides | |
| HY-154487 | Glycerol dioleate | 25637-84-7 | Reference compound |
| HY-154488 | 3′-O-[(1,1-Dimethylethyl)dimethylsilyl]-2′-O-methyluridine | 171268-84-1 | Oligonucleotides |
| HY-154489 | 5-Bromo-2’-deoxy-2’-fluoro-β-D-arabinouridine | 69123-97-3 | Oligonucleotides |
| HY-15448A | (Rac)-Tezacaftor | 1226709-85-8 | Reference compound |
| HY-15448S | Tezacaftor-d4 | 1961280-24-9 | Isotope-Labeled Compounds |
| HY-15448S1 | Tezacaftor-d6 | 1961280-94-3 | Isotope-Labeled Compounds |
| HY-15449 | Kaempferide | 491-54-3 | Natural Products |
| HY-154490 | 5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-uridine | 2095417-47-1 | Oligonucleotides |
| HY-154491 | 5’-Deoxy-5-methyluridine | 56971-08-5 | Oligonucleotides |
| HY-154492 | 2’,3’-Bis(O-t-butyldimethylsilyl)-4’,5’-didehydro-5’-deoxyuridine | 128070-78-0 | Oligonucleotides |
| HY-154495 | N3-Methyl-5-methyluridine | 3650-91-7 | Oligonucleotides |
| HY-154496 | 2’-Deoxy-N3-methylcytidine | 5040-21-1 | Oligonucleotides |
| HY-154496A | 2’-Deoxy-N3-methylcytidine (hydriodide) | 79043-77-9 | Reference compound |
| HY-154498 | 1,2-Di-O-acetyl-3,5-di-O-benzoyl-3-beta-C-methyl-D-ribofuranose | 22672-43-1 | Oligonucleotides |
| HY-154499 | Methyl 4-C-hydroxymethyl-2,3-O-isopropylidene-beta-D-ribofuranoside | 55797-67-6 | Oligonucleotides |
| HY-15449A | (S)-Kaempferide | Reference compound | |
| HY-15449R | Kaempferide (Standard) | 491-54-3 | Reference Standards |
| HY-15450 | INCB 3284 (dimesylate) | 887401-93-6 | Reference compound |
| HY-154501 | 5-O-Benzoyl-1,2,3-tri-O-acetyl-4-C-methyl-D-ribofuranose | 503543-44-0 | Oligonucleotides |
| HY-154503 | 3-O-(4-Methoxybenzyl)-4-C-hydroxymethyl-1,2-O-isopropylidine-alpha-D-ribofuranose | 225233-47-6 | Oligonucleotides |
| HY-154504 | 5’-O-(4,4’-Dimethoxytrityl)-2’-beta-C-methyl adenosine | 2305415-95-4 | Oligonucleotides |
| HY-154506 | N2-Phenoxyacetylguanosine | 119824-66-7 | Oligonucleotides |
| HY-154507 | N2-Phenoxyacetyl-3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)guanosine | 131474-72-1 | Oligonucleotides |
| HY-154508 | FdUMP (triethylammonium) | 134-46-3 | Oligonucleotides |
| HY-15450A | INCB 3284 | 887401-92-5 | Reference compound |
| HY-15451 | MDA 19 | 1048973-47-2 | Reference compound |
| HY-154510 | 2’-Deoxy-N4-methylcytidine | 22882-02-6 | Oligonucleotides |
| HY-154511 | 2’-Deoxy-N4,N4-dimethylcytidine | 53213-03-9 | Oligonucleotides |
| HY-154512 | 5’-Deoxy-N4,N4-dimethyl-5-fluorocytidine | 933443-84-6 | Oligonucleotides |
| HY-154513 | 2’-Deoxy-5,N4-dimethylcytidine | 25406-44-4 | Oligonucleotides |
| HY-154514 | 2’-Deoxy-5,N4,N4-trimethylcytidine | 25406-45-5 | Oligonucleotides |
| HY-154515 | 2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine | 1260177-41-0 | Oligonucleotides |
| HY-154516 | 2-Chloro-9-(beta-D-ribofuranosyl)purine | 5466-11-5 | Oligonucleotides |
| HY-154517 | N3-Cyanoethyl-5’-O-(4,4’-dimethoxytrityl)-2’-O-methyluridine | Oligonucleotides | |
| HY-15451R | MDA 19 (Standard) | 1048973-47-2 | Reference Standards |
| HY-15452 | Selisistat | 49843-98-3 | Reference compound |
| HY-154520 | 2-Chloro-3′-deoxyadenosine | 115044-75-2 | Oligonucleotides |
| HY-154521 | 2-(4-Methylbenzyl)thioadenosine | 2095417-16-4 | Oligonucleotides |
| HY-154522 | 2-(2,4-Dichlorobenzyl)thioadenosine | 2095417-37-9 | Oligonucleotides |
| HY-154523 | 2-(4-Cyanobenzyl)thioadenosine | 2095417-56-2 | Oligonucleotides |
| HY-154524 | 1-(2-Deoxy-β-D-threo-pentofuranosyl)thymine | 16053-52-4 | Oligonucleotides |
| HY-154525 | 2’-Deoxy-2’-(N-trifluoroacetyl)amino-5’-O-DMTr-uridine 3’-CED phosphoramidite | 126139-44-4 | Oligonucleotides |
| HY-154526 | 1-(3’-O-[4,4’-Dimethoxytrityl]-alpha-L-threofuranosyl)uridine | 325683-90-7 | Oligonucleotides |
| HY-154528 | 2’-O-Phthalimidopropyl cytidine | 165381-50-0 | Oligonucleotides |
| HY-154529 | 5’-O-DMTr-3’-O-phthalimidopropyl cytidine | Oligonucleotides | |
| HY-15452A | (S)-Selisistat | 848193-68-0 | Reference compound |
| HY-15452B | (R)-Selisistat | 848193-69-1 | Reference compound |
| HY-15453 | Devimistat | 95809-78-2 | Reference compound |
| HY-154530 | DMTr-TNA-C(Bz)-amidite | 325683-96-3 | Oligonucleotides |
| HY-154531 | 2′,3′-Dideoxy-3′-fluoro-5-methylcytidine | 115249-95-1 | Oligonucleotides |
| HY-154532 | 9-(5(R)-C-Methyl-2,3,5-tri-O-benzoyl-D-ribofuranosyl)-6-chloropurine | Oligonucleotides | |
| HY-154533 | 3’-O-Acetyl-2’-deoxyuridine | 23197-88-8 | Oligonucleotides |
| HY-154534 | Alpha-Adenosine | 5682-25-7 | Oligonucleotides |
| HY-154535 | Alpha-inosine | 38183-47-0 | Oligonucleotides |
| HY-154536 | Alpha-Guanosine | 15398-66-0 | Oligonucleotides |
| HY-154537 | 3’-O-Methyl inosine | 75479-64-0 | Oligonucleotides |
| HY-15453S | Devimistat-d10 | 2586055-61-8 | Isotope-Labeled Compounds |
| HY-15454 | Xevinapant | 1071992-99-8 | Reference compound |
| HY-154540 | Alpha-5-Methyluridine | 3258-09-1 | Oligonucleotides |
| HY-154541 | N2,N2-Dimethylamino-6-deamino adenosine | 105208-35-3 | Oligonucleotides |
| HY-154542 | 5’-O-Acetyl-2’,3’-dideoxy-2’,3’-didehydro-uridine | 42867-74-3 | Oligonucleotides |
| HY-154543 | 5’-O-(4,4’-Dimethoxytrityl)-3’-O-(2-methoxyethyl) uridine | Oligonucleotides | |
| HY-154544 | 3’-O-MOE-U-2’-phosphoramidite | 1452849-90-9 | Oligonucleotides |
| HY-154545 | 3’-O-MOE-5MeU-2’-phosphoramidite | 256223-93-5 | Oligonucleotides |
| HY-154546 | 3’-O-MOE-5Me-C(Bz)-2’-phosphoramidite | 1098233-10-3 | Oligonucleotides |
| HY-154547 | N2-iso-Butyroyl-3’-O-(methoxyethyl)guanosine | 256224-04-1 | Oligonucleotides |
| HY-154548 | N2-iso-Butyroyl-5’-O-DMT-3’-O-(methoxyethyl)guanosine | 256224-05-2 | Oligonucleotides |
| HY-154549 | 3’-O-MOE-G(iBu)-2’-phosphoramidite | 256224-06-3 | Oligonucleotides |
| HY-15455 | Roflumilast | 162401-32-3 | Reference compound |
| HY-154550 | 2’-O-Acetyl-5’-O-benzoyl-3’-O-methyl-5-methyl uridine | 2305415-91-0 | Oligonucleotides |
| HY-154551 | 3’-O-Methyl-5-methyluridine | 2305415-87-4 | Oligonucleotides |
| HY-154552 | 2’-O-Acetyl-5’-O-benzoyl-3’-O-(2-methoxyethyl) uridine | Oligonucleotides | |
| HY-154553 | 3’,5’-Di-O-acetylthymidine | 6979-97-1 | Oligonucleotides |
| HY-154554 | 3’,5’-Di-O-benzoyl thymidine | 35898-30-7 | Oligonucleotides |
| HY-154555 | 5’-O-Acetyl-2’,3’-dideoxy-2’,3’-didehydro-5-fluoro-uridine | 160203-74-7 | Oligonucleotides |
| HY-154556 | 2′,3′-Dideoxy-5-fluorouridine | 15379-30-3 | Oligonucleotides |
| HY-154557 | 2′,3′-Didehydro-2′,3′-dideoxy-5-fluorouridine | 15379-29-0 | Oligonucleotides |
| HY-154558 | 2′-Deoxy-6-O-methylinosine | 37109-88-9 | Oligonucleotides |
| HY-154559 | 2′-Deoxy-2-hydrazinyladenosine | 1000296-26-3 | Oligonucleotides |
| HY-15455R | Roflumilast (Standard) | 162401-32-3 | Reference Standards |
| HY-15455S | Roflumilast-d4 | 1398065-69-4 | Isotope-Labeled Compounds |
| HY-15455S1 | Roflumilast-d4 N-Oxide | 1794760-31-8 | Isotope-Labeled Compounds |
| HY-15455S2 | Roflumilast-d3 | 1189992-00-4 | Isotope-Labeled Compounds |
| HY-15456 | NVP-BVU972 | 1185763-69-2 | Reference compound |
| HY-154560 | 2’,3’,5’-Tri-O-acetyl-N3-methyluridine | 64623-26-3 | Oligonucleotides |
| HY-154561 | 3’,5’-Di-O-acetyl-2’-deoxy-N3-methyl uridine | 2305416-14-0 | Oligonucleotides |
| HY-154562 | 3’,5’-Di-O-acetyl-2’-deoxy-5,N3-dimethyluridine | 144874-49-7 | Oligonucleotides |
| HY-154563 | 2’,3’,5’-Tri-O-acetyl-5,N3-dimethyluridine | 201421-00-3 | Oligonucleotides |
| HY-154564 | 5’-Deoxy-5’-N-methylaminothymidine | 75191-50-3 | Oligonucleotides |
| HY-154565 | 5’-Deoxy-5’-N,N-dimethylamino thymidine | 162466-79-7 | Oligonucleotides |
| HY-154566 | 5’-Deoxy-5’-N,N-diethylamino thymidine | 2305415-88-5 | Oligonucleotides |
| HY-154567 | 5’-Deoxy-5’-N-(2-chloroethyl)amino thymidine | 2305415-99-8 | Oligonucleotides |
| HY-154568 | 5’-Deoxy-5’-(4-morpholinyl)thymidine | 2305415-93-2 | Oligonucleotides |
| HY-154569 | 5’-Deoxy-5’-furfurylamino thymidine | 2305416-15-1 | Oligonucleotides |
| HY-15457 | Triciribine | 35943-35-2 | Reference compound |
| HY-154570 | 3’-N-Acetyl-3’-amino-3’-deoxy-2’,5’-di-O-acetyluridine | 2305416-09-3 | Oligonucleotides |
| HY-154571 | 2’,3’,5’-Tri-O-acetyl-6-S-methyl-6-thio-guanosine | 80681-58-9 | Oligonucleotides |
| HY-154572 | 9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine | 132370-61-7 | Oligonucleotides |
| HY-154573 | 2’-Deoxy-O6-[2-(4-nitrophenylethyl)]guanosine | 86137-72-6 | Oligonucleotides |
| HY-154575 | 2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine | 882435-02-1 | Oligonucleotides |
| HY-154578 | N1-Methyl-2'-deoxyadenosine | 60192-55-4 | Reference compound |
| HY-154579 | 3’-Azido-N6-benzoyl-3’-deoxyadenosine | 103597-10-0 | Oligonucleotides |
| HY-15458 | SAR131675 | 1433953-83-3 | Reference compound |
| HY-154581 | 5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine | 2095417-02-8 | Oligonucleotides |
| HY-154582 | 5-Naphthyl-beta-methylaminocarbony-3’-O-acetyl-2’-O-methyl-5’-O-DMTr-uridine | 2095417-00-6 | Oligonucleotides |
| HY-154583 | 3’,5’-Bis-O-benzoyl-2’-deoxy-2’-fluoro-β-D-arabinouridine | 128496-10-6 | Oligonucleotides |
| HY-154585 | VP-U-6 | 2361324-80-1 | Oligonucleotides |
| HY-154587 | 1-[6-(Diethoxyphosphinyl)-2-O-methyl-β-D-ribo-hexofuranosyl]uracil | 2095417-38-0 | Oligonucleotides |
| HY-154588 | 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil | 2095417-68-6 | Oligonucleotides |
| HY-154589 | 3',5'-Di-O-benzoyl fialuridine | 97614-45-4 | Oligonucleotides |
| HY-15458A | (S)-SAR131675 | Reference compound | |
| HY-15459 | Cabazitaxel | 183133-96-2 | Natural Products |
| HY-154590 | 2’,3’-Di-O-isopropylidene-4’-alpha-C-azidouridine | 690271-27-3 | Oligonucleotides |
| HY-154592 | DMTr-TNA-G(O6-CONPh2)(N2Ac)-amidite | 325683-97-4 | Oligonucleotides |
| HY-154593 | N4-Benzoyl-5’-O-DMTr-2’-O-(N3-trifluoroacetyl) aminopropyl cytidine | 1053243-01-8 | Oligonucleotides |
| HY-154594 | 5-(Aminomethyl)-2′,3′-O-(1-methylethylidene)-2-thiouridine | 1428903-07-4 | Oligonucleotides |
| HY-154595 | 2’,3’,5’-Tri-O-benzoyl-4-thiouridine | 15049-50-0 | Oligonucleotides |
| HY-154596 | 2,6-Bis(4-morpholinyl)-9-b-D-ribofuranosyl-9H-purine | Oligonucleotides | |
| HY-154597 | 2’-Chloro-N6-benzyl adenosine | 23558-62-5 | Oligonucleotides |
| HY-154599 | 5-Me-3’-dU-2’-phosphoramidite | 142103-12-6 | Oligonucleotides |
| HY-15459R | Cabazitaxel (Standard) | 183133-96-2 | Reference Standards |
| HY-15459S | Cabazitaxel-d6 | 1383561-29-2 | Isotope-Labeled Compounds |
| HY-15459S1 | Cabazitaxel-d9 | 1383572-19-7 | Isotope-Labeled Compounds |
| HY-15460 | CHIR-090 | 728865-23-4 | Reference compound |
| HY-154600 | N4-Benzoyl-3’-deoxycytidine | 161110-00-5 | Oligonucleotides |
| HY-154601 | N4-Benzoyl-5’-O-(4,4-dimethoxytrityl)-3’-deoxy cytidine | 86234-45-9 | Oligonucleotides |
| HY-154602 | 2’-dG (iBu)-2’-phosphoramidite | 157327-97-4 | Oligonucleotides |
| HY-154604 | 1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)thymine 3'-CE phosphoramidite | 208193-48-0 | Oligonucleotides |
| HY-154605 | N2-iso-Butyroyl-2’-fluoro-2’-deoxyarabinoguanosine | 308356-20-9 | Oligonucleotides |
| HY-154606 | 2'-F-2'-ara-N2-ibu-dG Phosphoramidite | 1404463-20-2 | Oligonucleotides |
| HY-154607 | 3’-Deoxy-5’-O-(4,4’-dimethoxytrityl)-3’-fluorouridine | 129015-60-7 | Oligonucleotides |
| HY-154608 | 3'-Deoxy-5'-O-(4,4'-dimethoxytrityl)-3'-fluoro uridine-2'-CED-phosphoramidite | 129015-63-0 | Oligonucleotides |
| HY-154609 | 2’-Bromo-2’-deoxy-5-fluorouridine | 32791-82-5 | Oligonucleotides |
| HY-15460R | CHIR-090 (Standard) | 728865-23-4 | Reference Standards |
| HY-15461 | Ertugliflozin | 1210344-57-2 | Reference compound |
| HY-154610 | 6-Amino-9-[2-deoxy-β-D-ribofuranosyl]-9H-purine | 148171-35-1 | Oligonucleotides |
| HY-154611 | 2’-Deoxy-2’-fluoro-5-methyl-4’-thio-a-D-arabino uridine | 294868-24-9 | Oligonucleotides |
| HY-154612 | 2’-Deoxy-2’-fluoro-4’-thio-a-D-arabinouridine | Oligonucleotides | |
| HY-154613 | (2R-cis)-5-[Tetrahydro-5-(hydroxymethyl)-4-oxo-2-furanyl]-2,4(1H,3H)-pyrimidinedione | 142189-87-5 | Oligonucleotides |
| HY-154614 | 5’-(4,4’-Dimethoxytrityl)-5-methyluridine | 138239-62-0 | Oligonucleotides |
| HY-154615 | N4-Benzoyl-5'-O-DMTr-2'-O-(N3-trifluoroacetyl) aminopropyl cytidine 3'-CED phosphoramidite | 165381-54-4 | Oligonucleotides |
| HY-154616 | 2’-O-Phthalimidopropyl uridine | 165381-44-2 | Oligonucleotides |
| HY-154617 | 6-S-(2-Cyanoethyl)-2’-deoxy-5’-O-DMTr--6-thioguanosine 3’-CED phosphoramidite | Oligonucleotides | |
| HY-154618 | N4-Bz-5'-O-DMTr-3'-deoxy-3'-fluoro-beta-D-xylofuranosyl cytidine-2'-CED-phosphoramidite | 1555759-30-2 | Oligonucleotides |
| HY-15461A | Ertugliflozin L-pyroglutamic acid | 1210344-83-4 | Reference compound |
| HY-15461R | Ertugliflozin (Standard) | 1210344-57-2 | Reference Standards |
| HY-15461S | Ertugliflozin-d5 | 1298086-22-2 | Isotope-Labeled Compounds |
| HY-15461S1 | Ertugliflozin-d9 | Isotope-Labeled Compounds | |
| HY-15462 | SRT3109 | 1204707-71-0 | Reference compound |
| HY-154620 | 2′-O-Hexadecyl-adenosine | 211690-85-6 | Oligonucleotides |
| HY-154621 | 3’-O-Hexadecanyl adenosine | Oligonucleotides | |
| HY-154622 | N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine | 2382942-34-7 | Oligonucleotides |
| HY-154623 | N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine 3’-CED phosphoramidite | 2382942-35-8 | Oligonucleotides |
| HY-154624 | 2’-O-Hexadecanyl-2-aminoadenosine | 2382942-28-9 | Oligonucleotides |
| HY-154625 | 3’-O-Hexadecanyl-2-aminoadenosine | Oligonucleotides | |
| HY-154626 | 2’-O-Hexadecanyl guanosine | 2382942-29-0 | Oligonucleotides |
| HY-154627 | N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine | 2382942-31-4 | Oligonucleotides |
| HY-154628 | N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine 3’-CED phosphoramidite | 2382942-32-5 | Oligonucleotides |
| HY-154629 | Sesame Oil | 8008-74-0 | Reference compound |
| HY-15463 | Imatinib | 152459-95-5 | Reference compound |
| HY-154630 | Polyoxypropylene stearyl ether | 25231-21-4 | Reference compound |
| HY-154631 | Peanut Oil | 8002-03-7 | Reference compound |
| HY-154632 | Omega 3 fatty acid triglycerides | Reference compound | |
| HY-154633 | 3,5-O-[1,1,3,3-Tetrakis(1-methylethyl)-1,3-disiloxanediyl] cytidine | Oligonucleotides | |
| HY-154634 | Cyclomethicone | 69430-24-6 | Reference compound |
| HY-154635 | Oxidized paraffin (calcium) | 68476-81-3 | Reference compound |
| HY-154636 | Liquid Paraffin | 8012-95-1 | Reference compound |
| HY-154636A | Light Liquid Paraffin | 8012-95-1 | Reference compound |
| HY-154637 | Sucrose Stearate | 25168-73-4 | Reference compound |
| HY-154639 | Polyoxyl 20 Cetostearyl Ether | 68439-49-6 | Reference compound |
| HY-15463R | Imatinib (Standard) | 152459-95-5 | Reference Standards |
| HY-15463S | Imatinib-d8 | 1092942-82-9 | Isotope-Labeled Compounds |
| HY-15463S1 | Imatinib-d4 | 1134803-16-9 | Isotope-Labeled Compounds |
| HY-15463S2 | Imatinib-d3 (hydrochloride) | 1134803-18-1 | Isotope-Labeled Compounds |
| HY-15463S3 | Imatinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-15464 | (R)-(-)-Gossypol | 90141-22-3 | Natural Products |
| HY-154640 | 2’,3’,5’-Tri-O-acetyl-5-(trifluoromethyl)uridine | 84500-34-5 | Oligonucleotides |
| HY-154642 | 2’-Bromo-2’-deoxy-5-methyluridine | 95585-76-5 | Oligonucleotides |
| HY-154643 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-9H-purin-2-amine | 1612192-04-7 | Oligonucleotides |
| HY-154644 | Soya Lecithin | 8030-76-0 | Reference compound |
| HY-154644A | Soy lecithin-90 | 8030-76-0 | Biochemical Assay Reagents |
| HY-154644B | Soy lecithin-80 | 8030-76-0 | Biochemical Assay Reagents |
| HY-154646 | 2',3,5'-Tri-O-benzoyl-4'-thiouridine | 2072145-30-1 | Oligonucleotides |
| HY-154647 | N3-(2S)-[2-(tert-Butoxycarbonyl)amino-3-(tert-butoxy carbonyl)]propyluridine | Oligonucleotides | |
| HY-15464A | (R)-(-)-Gossypol acetic acid | 866541-93-7 | Reference compound |
| HY-15464D | (S)-Gossypol (acetic acid) | 1189561-66-7 | Reference compound |
| HY-15465 | KN-93 | 139298-40-1 | Reference compound |
| HY-154652 | 1-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione | 23643-36-9 | Oligonucleotides |
| HY-154653 | 9-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine | 1345969-99-4 | Oligonucleotides |
| HY-154654 | 9-(2-β-C-Methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine | 2095417-45-9 | Oligonucleotides |
| HY-154655 | 6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine | 2095417-61-9 | Oligonucleotides |
| HY-154658 | 2’-Deoxy-2’-fluoro-N3-[(pyrid-4-yl)methyl]-beta-D-arabinouridine | 2072145-47-0 | Oligonucleotides |
| HY-154659 | Polycarbophil | 9003-97-8 | Reference compound |
| HY-15465A | KN-93 (hydrochloride) | 1956426-56-4 | Reference compound |
| HY-15465B | KN-93 (phosphate) | 1913269-12-1 | Reference compound |
| HY-15466 | Izorlisib | 1007207-67-1 | Reference compound |
| HY-154660 | N4-Benzoyl-2’-deoxy-5-iodocytidine | 158042-39-8 | Oligonucleotides |
| HY-154662 | 2’-Deoxy-2’-fluoro-N3-(2S)-(2-amino-3-carbonyl] propyl-beta-D-arabinouridine | 2072145-25-4 | Oligonucleotides |
| HY-154663 | 1-β-D-Arabinofuranosyl-5-bromo-2,4(1H,3H)-pyrimidinedione | 3370-69-2 | Oligonucleotides |
| HY-154665 | N4-Benzoyl-N-DMTr-morpholino-5-methylcytosine-5'-O-phosphoramidite | Oligonucleotides | |
| HY-154666 | 3’-Azido-3’-deoxyinosine | 946497-27-4 | Oligonucleotides |
| HY-154667 | 1,2-Di-O-acetyl-3,5-di-O-benzyl-D-xylofuranose | 146986-45-0 | Oligonucleotides |
| HY-154668 | 5'-Homocytidine | 55085-34-2 | Oligonucleotides |
| HY-154669 | 9-(2,3-Di-O-acetyl-6-O-benzoyl-5-deoxy-D-ribo-exofuranoyl)-6-chloropurine | Oligonucleotides | |
| HY-15467 | ZM323881 | 193001-14-8 | Reference compound |
| HY-154670 | 5’-Homoadenosine | Oligonucleotides | |
| HY-154674 | N1-Allylpseudouridine | 1613530-15-6 | Oligonucleotides |
| HY-154675 | 2-Aminopurine-9-beta-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside | 2095417-63-1 | Oligonucleotides |
| HY-154676 | Purine-9-b-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside | 132723-01-4 | Oligonucleotides |
| HY-154677 | 2-Aminopurine-9-beta-D-(2’-deoxy)riboside | Oligonucleotides | |
| HY-154678 | 4’-Azido-3’-O-benzoyl-5’-O-(m-chlorobenzoyl)-2’-deoxy-2’-fluoro-beta-D-arabinouridine | 1333126-30-9 | Oligonucleotides |
| HY-154679 | 2-Chloro-6-(thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside | 1612192-01-4 | Oligonucleotides |
| HY-15467A | ZM323881 (hydrochloride) | 193000-39-4 | Reference compound |
| HY-15468 | IOX2 | 931398-72-0 | Reference compound |
| HY-154680 | 2’-Deoxy-2’-fluoro-N3-(4-nitrobenzyl)uridine | Oligonucleotides | |
| HY-154681 | 2’-Deoxy-2’-fluoro-N3-[(pyrid-4-yl)methyl]uridine | Oligonucleotides | |
| HY-154682 | 2’-Deoxy-2’-fluoro-N3-(n-dodecyl)uridine | Oligonucleotides | |
| HY-154683 | 3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine | 128495-99-8 | Oligonucleotides |
| HY-154684 | 5-Benzylamino carbonyl-3’-O-acetyl-2’-O-methyl-5’-O-DMTr-uridine | 2095417-22-2 | Oligonucleotides |
| HY-154686 | 1-(3-β-Azido-2,3-dideoxy-5-O-trityl-D-threopenta-furanosyl)thymine | 66503-47-7 | Oligonucleotides |
| HY-154688 | 5’-O-(4,4’-Dimethoxytrityl)-N6-phenoxyacetyl adenosine | 121076-16-2 | Oligonucleotides |
| HY-154689 | N,N-Dibenzoyl-2’-O-methyladdenosine | Oligonucleotides | |
| HY-15468A | IOX2 (sodium) | 2377239-85-3 | Reference compound |
| HY-15469 | GW791343 (dihydrochloride) | 1019779-04-4 | Reference compound |
| HY-154692 | 2′-Deoxy-5-methylisocytidine | 19316-88-2 | Oligonucleotides |
| HY-154696 | Ferric oxide, yellow | 51274-00-1 | Reference compound |
| HY-154696A | Ferric oxide, red | 1309-37-1 | Biochemical Assay Reagents |
| HY-154697 | 3-epi-Azido-3-deoxythymidine | 73971-82-1 | Oligonucleotides |
| HY-154698 | Homouridine | 30685-57-5 | Oligonucleotides |
| HY-154699 | 5-(2-Hydroxyethyl)cytidine | 137248-64-7 | Oligonucleotides |
| HY-15470 | GW791343 (trihydrochloride) | 309712-55-8 | Reference compound |
| HY-154703 | Aluminum magnesium silicate | 12511-31-8 | Reference compound |
| HY-154704 | Calcium carboxymethyl cellulose | 9050-04-8 | Reference compound |
| HY-154705 | N-DMTr-Morpholino-U-5'-O-phosphoramidite | Oligonucleotides | |
| HY-154706 | N-DMTr-Morpholino-T-5'-O-phosphoramidite | Oligonucleotides | |
| HY-154707 | N-DMTr-N4-benzoyl-morpholino-cytosine-5’-O-phosphoramidite | Oligonucleotides | |
| HY-154708 | N-DMTr-N6-Benzoyl-morpholino-A-5'-O-phosphoramidite | Oligonucleotides | |
| HY-154709 | N-DMTr-N2-Isobutyryl-morpholino-G-5'-O-phosphoramidite | Oligonucleotides | |
| HY-154717 | 2-Deoxy-2’-fluoroisocytidine | 1668560-65-3 | Oligonucleotides |
| HY-154718 | 2-Amino-6-chloropurine-3’,5’-di-O-acetyl-2’-deoxyriboside | 69992-11-6 | Oligonucleotides |
| HY-154719 | 5’-O-Benzoylthymidine | 65475-51-6 | Oligonucleotides |
| HY-15472 | PRX-08066 | 866206-54-4 | Reference compound |
| HY-154720 | 3-O-Benzoyl-1,2: 5,6-bis(di-O-isopropylidene)-alpha-D-galactofuranose | 29474-73-5 | Oligonucleotides |
| HY-154721 | 5’-O-DMTr-5-iodo-2’-dU-3’-CED phosphoramidite | 178925-48-9 | Oligonucleotides |
| HY-154722 | N6-Dimethylaminomethylidene isoguanosine | 156706-72-8 | Oligonucleotides |
| HY-154723 | 2’-Deoxy-2’-fluoro-N3-(4-hydroxybenzyl)uridine | Oligonucleotides | |
| HY-154724 | 2’-Deoxy-2’-fluoro-N3-(2S)-[2-(tert-butoxy-carbonyl)-amino-3-carbonyl]propyluridine | Oligonucleotides | |
| HY-154725 | 2’-Deoxy-2’-fluoro-N3-[3-(tert-butoxycarbonyl) amino]propyluridine | Oligonucleotides | |
| HY-154726 | 2’-Deoxy-2’-fluoro- N3-(2S)-(2-amino-3-carbonyl)-propyluridine | Oligonucleotides | |
| HY-154727 | 2’-Deoxy-2’-fluoro-N3-(3-aminopropyl)uridine | Oligonucleotides | |
| HY-154729 | 3’-O-Methyl-2’-O-acetyl-5’-O-benzoyluridine | 2072145-71-0 | Oligonucleotides |
| HY-15472A | PRX-08066 (maleate) | 866206-55-5 | Reference compound |
| HY-15473 | MLN120B | 783348-36-7 | Reference compound |
| HY-154730 | 9-(2’-O-Acetyl-5’-O-benzoyl-3’-O-methyl-beta-D-ribofuranosyl)-6-chloropurine | 2072145-46-9 | Oligonucleotides |
| HY-154731 | 9-(2’-O-Acetyl-5’-O-benzoyl-3’-O-methyl-beta-D-ribofuranosyl)-2,6-dichloropurine | 2072145-40-3 | Oligonucleotides |
| HY-154732 | 2-Thiopseudouridine | 59464-18-5 | Oligonucleotides |
| HY-154733 | 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine | 1612191-95-3 | Oligonucleotides |
| HY-154734 | N3-(4-Nitrobenzyl)uridine | Oligonucleotides | |
| HY-154735 | N3-Allyluridine | 103951-13-9 | Oligonucleotides |
| HY-154736 | N3-(Butyn-3-yl)uridine | Oligonucleotides | |
| HY-154737 | N3-[(Pyrid-4-yl)methyl]uridine | Oligonucleotides | |
| HY-154738 | N3-[3-(tert-Butoxycarbonyl)amino]propyluridine | Oligonucleotides | |
| HY-154739 | Cristobalite | 14464-46-1 | Reference compound |
| HY-154739A | Amorphous silica | 112945-52-5 | Reference compound |
| HY-15473A | MLN120B (dihydrochloride) | 1782573-78-7 | Reference compound |
| HY-154740 | 3′-Chloro-3′-deoxythymidine | 25526-94-7 | Oligonucleotides |
| HY-154740R | 3′-Chloro-3′-deoxythymidine (Standard) | 25526-94-7 | Reference Standards |
| HY-154741S | 6-β-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione-15N2 | Isotope-Labeled Compounds | |
| HY-154743S | 4-Pregnen-11β,21-diol-3,20-dione-d8 | Isotope-Labeled Compounds | |
| HY-154744S | Trimegestone sulfate pyridinium salt-13C,d3 | Isotope-Labeled Compounds | |
| HY-154746S | 3-HPMA Potassium Salt-3-13C3,15N | Isotope-Labeled Compounds | |
| HY-154747S | Carebastine-d6 | Isotope-Labeled Compounds | |
| HY-154749S | Repaglinide M2-d5 | Isotope-Labeled Compounds | |
| HY-15475 | UK-5099 | 56396-35-1 | Reference compound |
| HY-154752S | 8,9-Dehydroestrone-d4 | Isotope-Labeled Compounds | |
| HY-154754S | Saxagliptin Metabolite-15N,d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-154757S | Iloperidone metabolite P88-d3 | Isotope-Labeled Compounds | |
| HY-154758S | 6-Alpha-Methyl-Cortisol-d4 | Isotope-Labeled Compounds | |
| HY-154759S | 6-Alpha-Methyl-Prednisolone-d4 | Isotope-Labeled Compounds | |
| HY-15476 | VU 0364439 | 1246086-78-1 | Reference compound |
| HY-154761S | Clopidogrel-13C,d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-154762S | Acetaminophen glucuronide-d4 | Isotope-Labeled Compounds | |
| HY-154763S | 3-Ethyladenine-d5 (hydroiodide) | Isotope-Labeled Compounds | |
| HY-154768S | Ciprofloxacin-piperazinyl-N-sulfate-d8 | Isotope-Labeled Compounds | |
| HY-154769S | 5-Androsten-3-β-ol-17-one-d6 | Isotope-Labeled Compounds | |
| HY-15477 | YS-49 | 132836-42-1 | Reference compound |
| HY-154771S | Clopidogrelat-13C,d4 | Isotope-Labeled Compounds | |
| HY-154772S | trans-3’-Hydroxycotinine-O-β-glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-154773S | Artesunate-13C4 | Isotope-Labeled Compounds | |
| HY-154774S | Tetrahydro-11-deoxy-Cortisol-d5-21-O-β-Glucuronide | Isotope-Labeled Compounds | |
| HY-154775S | Ethinylestradiol sulfate-d4 | Isotope-Labeled Compounds | |
| HY-154776S | 8,9-Dehydroestrone 2,4,16,16-d4 | Isotope-Labeled Compounds | |
| HY-154777S | l-Gatifloxacin-d4 | Isotope-Labeled Compounds | |
| HY-154778S | Floxuridine-d3 | Isotope-Labeled Compounds | |
| HY-154779 | 5′-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | 910129-15-6 | Oligonucleotides |
| HY-154779R | 5′-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine (Standard) | 910129-15-6 | Reference Standards |
| HY-15477A | YS-49 (monohydrate) | 3028631-24-2 | Reference compound |
| HY-15478 | WZ811 | 55778-02-4 | Reference compound |
| HY-154780S | Desmethylcerivastatin-d7 (sodium) | Isotope-Labeled Compounds | |
| HY-154781S | Hydroxycerivastatin-d3 (sodium) | 1260180-67-3 | Isotope-Labeled Compounds |
| HY-154784S | 6-Hydroxynaloxone-d3 | Isotope-Labeled Compounds | |
| HY-154785S | 6-Naltrexol-d3 | Isotope-Labeled Compounds | |
| HY-154787S | Descarboethoxyloratadine-d6 (diacetate) | Isotope-Labeled Compounds | |
| HY-154788S | Losartan acid-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-154789 | RTIOXA-43 | 2832067-72-6 | Reference compound |
| HY-15479 | TTP 22 | 329907-28-0 | Reference compound |
| HY-154790 | STn/sialyl-Tn | 114661-01-7 | Reference compound |
| HY-154795 | Magnesium isoglycyrrhizinate (hydrate) | 658701-67-8 | Natural Products |
| HY-154796 | 2-Methoxy-2’-deoxyadenosine | 24757-70-8 | Oligonucleotides |
| HY-154796R | 2-Methoxy-2’-deoxyadenosine (Standard) | 24757-70-8 | Reference Standards |
| HY-154797 | N,N-Dimethyldoxorubicin | 70222-95-6 | Reference compound |
| HY-154798 | AMPA receptor modulator-5 | 2034182-22-2 | Reference compound |
| HY-154799 | Anticancer agent 112 | 2495321-37-2 | Reference compound |
| HY-15480 | NSC 42834 | 195371-52-9 | Reference compound |
| HY-154800 | Anticancer agent 113 | 2495323-17-4 | Reference compound |
| HY-154801 | Biotin-PEG3-CONH-Ph-CF3-diazirine | 2845211-64-3 | Reference compound |
| HY-154802 | TCO-GK-PEG4-NHS ester | 2307311-19-7 | ADC Related |
| HY-154803 | DLin-M-K-DMA | 1221271-55-1 | Oligonucleotides |
| HY-154804 | DLin-M-C4-DMA | 1226909-66-5 | Oligonucleotides |
| HY-154807 | DQn-1 | 57343-54-1 | Reference compound |
| HY-154809 | (R)-M3913 | 2379783-61-4 | Reference compound |
| HY-15481 | KU14R | 189224-48-4 | Reference compound |
| HY-154812 | Gintemetostat | 2604513-16-6 | Reference compound |
| HY-154813 | 3′,5′-Di-O-acetyl-2′-deoxy-2′-fluorouridine | 10212-13-2 | Oligonucleotides |
| HY-154814S | Monohydroxy-3-butenyl-mercapturic acid-13C3,15N (sodium) | Isotope-Labeled Compounds | |
| HY-154817 | Metobromuron | 3060-89-7 | Reference compound |
| HY-154817R | Metobromuron (Standard) | 3060-89-7 | Reference Standards |
| HY-154818 | Bovine Serum Albumin, Acetylated | Biochemical Assay Reagents | |
| HY-15482 | D-64131 | 74588-78-6 | Reference compound |
| HY-154821 | DRI-C21041 | 2101765-78-8 | Reference compound |
| HY-154821A | DRI-C21041 (DIEA) | Reference compound | |
| HY-154822 | DRI-C25441 | 2101765-83-5 | Reference compound |
| HY-154823 | Gcase activator 2 | 2759897-35-1 | Reference compound |
| HY-154825 | 20-Hydroxyvitamin D3 | 651734-12-2 | Natural Products |
| HY-154828 | Uridine 3′,5′-diphosphate | 2922-95-4 | Reference compound |
| HY-154829 | AC-099 | 849459-88-7 | Reference compound |
| HY-154829A | AC-099 (hydrochloride) | 849335-07-5 | Reference compound |
| HY-15483 | DY131 | 95167-41-2 | Reference compound |
| HY-154830 | Lysophosphatidylcholine C19:0 | 108273-88-7 | Reference compound |
| HY-154831 | C22-Ceramide | 27888-44-4 | Natural Products |
| HY-154832 | Cav 3.2 inhibitor 4 | 1416984-93-4 | Reference compound |
| HY-154834 | BHQ-1 NHS | 916753-61-2 | Dye Reagents |
| HY-154835 | N6-[[(4-Azidophenyl)methoxy]carbonyl]-L-lysine | 1513855-74-7 | Reference compound |
| HY-154837S | Lu AA39835-d3 | Isotope-Labeled Compounds | |
| HY-154839 | c-Myc inhibitor 10 | 2299227-75-9 | Reference compound |
| HY-15484 | Pifithrin-α (hydrobromide) | 63208-82-2 | Reference compound |
| HY-154840 | 4-Thiouridine 5′-triphosphate (tetralithium) | 20188-72-1 | Reference compound |
| HY-154840A | 4-Thiouridine 5′-triphosphate (tetrasodium) | 68507-49-3 | Reference compound |
| HY-154842 | S-Gem | 2169925-98-6 | Reference compound |
| HY-154843 | C-Gem | 2169926-00-3 | Reference compound |
| HY-154844 | FAP Ligand 1 | 2230625-76-8 | Reference compound |
| HY-154846 | 4'-Aarboxylic acid imrecoxib | 896729-08-1 | Reference compound |
| HY-154847 | WM-662 | 1308257-47-7 | Reference compound |
| HY-154848 | UCL-TRO-1938 | 2919575-27-0 | Reference compound |
| HY-15485 | Zardaverine | 101975-10-4 | Reference compound |
| HY-154850 | F-CRI1 | 2991453-50-8 | Reference compound |
| HY-154851 | GSK-3 inhibitor 3 | 2227279-84-5 | Reference compound |
| HY-154852 | GSK-3 inhibitor 4 | 2227279-83-4 | Reference compound |
| HY-154854 | BBDDL2059 | 2691174-27-1 | Reference compound |
| HY-154855 | HDAC-IN-56 | 2814571-89-4 | Reference compound |
| HY-154857 | 1-Palmitoyl-2-succinyl-sn-glycerophosphorylcholine | 89947-80-8 | Natural Products |
| HY-154858 | C55 Prenol | 50426-50-1 | Natural Products |
| HY-15486 | Salubrinal | 405060-95-9 | Reference compound |
| HY-154860 | PTD10 | 2642231-19-2 | Reference compound |
| HY-154861 | Anticancer agent 118 | 864443-43-6 | Reference compound |
| HY-154862 | Anticancer agent 119 | 2928614-16-6 | Reference compound |
| HY-154864 | Cholesteryl nonadecanoate | 25605-90-7 | Natural Products |
| HY-154865 | Anticancer agent 121 | 2924532-47-6 | Reference compound |
| HY-154866 | Anticancer agent 122 | 2924532-50-1 | Reference compound |
| HY-154867 | DNMT2-IN-1 | Reference compound | |
| HY-154868 | MMP-13-IN-1 | 2925249-49-4 | Reference compound |
| HY-154869 | PD-1/PD-L1-IN-34 | 2924403-17-6 | Reference compound |
| HY-15487 | CE-224535 | 724424-43-5 | Reference compound |
| HY-154871 | α-D-Glucosamine 1-phosphate | 2152-75-2 | Reference compound |
| HY-154878 | Cholera toxin B subunit biotin conjugate | Biochemical Assay Reagents | |
| HY-154878A | Cholera toxin B subunit peroxidase conjugate | Biochemical Assay Reagents | |
| HY-15488 | A 438079 | 899507-36-9 | Reference compound |
| HY-15488A | A 438079 (hydrochloride) | 899431-18-6 | Reference compound |
| HY-15489 | Scriptaid | 287383-59-9 | Reference compound |
| HY-15490 | PF-670462 (dihydrochloride) | 950912-80-8 | Reference compound |
| HY-154909 | 6-Azauridine triphosphate | 6198-30-7 | Reference compound |
| HY-154909A | 6-Azauridine triphosphate (ammonium) | Oligonucleotides | |
| HY-15491 | AG-024322 | 837364-57-5 | Reference compound |
| HY-154910 | CC214-1 | 1021920-32-0 | Reference compound |
| HY-154912 | PAT1inh-B01 | 1775330-54-5 | Reference compound |
| HY-154912A | PAT1inh-B01 (hydrochloride) | Reference compound | |
| HY-154914 | GK16S | Reference compound | |
| HY-154915 | MC-EVCit-PAB-MMAE | 2873452-49-2 | ADC Related |
| HY-154918 | LysoPE(18:2/0:0) | 85046-18-0 | Natural Products |
| HY-154919 | DC-Y13-27 | Reference compound | |
| HY-15492 | AG-13958 | 319460-94-1 | Reference compound |
| HY-154921 | Lactosylceramide (bovine buttermilk) | 4682-48-8 | Biochemical Assay Reagents |
| HY-154921A | Lactosylceramide (porcine RBC) | Biochemical Assay Reagents | |
| HY-154922 | Palmitoyl coenzyme A | 1763-10-6 | Biochemical Assay Reagents |
| HY-154923 | Pentadecanoyl coenzyme A | 24870-39-1 | Biochemical Assay Reagents |
| HY-154924 | Thio-NADP | 19254-05-8 | Biochemical Assay Reagents |
| HY-154925 | Thio-NADH | 1921-48-8 | Biochemical Assay Reagents |
| HY-154927 | DSPE-PEG-Cy5 | 2315262-02-1 | Reference compound |
| HY-154928 | GW6340 | 405910-78-3 | Reference compound |
| HY-15492A | AG-13958 (mono(hydrochloride)) | 319463-49-5 | Reference compound |
| HY-15493 | AN-019 | 879507-25-2 | Reference compound |
| HY-15494 | Picropodophyllin | 477-47-4 | Natural Products |
| HY-154944 | JG-2016 | 2887480-87-5 | Reference compound |
| HY-154945 | N-(5-Amino-1-ribosyl-4-imidazolecarbonyl)-L-aspartic acid | 17388-80-6 | Reference compound |
| HY-154946 | SUCNR1-IN-1 | 2711753-52-3 | Reference compound |
| HY-154949 | WDR5-IN-6 | 326901-92-2 | Reference compound |
| HY-15494S1 | Picropodophyllin-d6 | Isotope-Labeled Compounds | |
| HY-15495 | Tanzisertib | 899805-25-5 | Reference compound |
| HY-154951 | Oct4 inducer-2 | 1494691-70-1 | Reference compound |
| HY-154954 | Ogremorphin | 352563-21-4 | Reference compound |
| HY-154956 | PIKfyve-IN-2 | 2245319-25-7 | Reference compound |
| HY-154957 | mTOR inhibitor-11 | 3033409-32-1 | Reference compound |
| HY-154958 | mTOR inhibitor-12 | 3033409-34-3 | Reference compound |
| HY-154959 | AZD4747 | 2489226-14-2 | Reference compound |
| HY-154959A | (9R,12aR)-AZD4747 | Reference compound | |
| HY-15496 | E6201 | 603987-35-5 | Reference compound |
| HY-154960 | Tubulin/AKT1-IN-1 | 2988927-63-3 | Reference compound |
| HY-154961 | Mcl-1 inhibitor 14 | Reference compound | |
| HY-154962 | Mcl-1 inhibitor 15 | Reference compound | |
| HY-154964 | RSV L-protein-IN-2 | 774130-99-3 | Reference compound |
| HY-154965 | Simnotrelvir | 2920904-06-7 | Reference compound |
| HY-154966 | RSV L-protein-IN-3 | 868860-35-9 | Reference compound |
| HY-154967 | RSV L-protein-IN-4 | 851657-60-8 | Reference compound |
| HY-154968 | RSV L-protein-IN-5 | 851658-28-1 | Reference compound |
| HY-154969 | JAK-IN-29 | Reference compound | |
| HY-15497 | AZD7687 | 1166827-44-6 | Reference compound |
| HY-154970 | BMPR2-IN-1 | Reference compound | |
| HY-154970A | BMPR2-IN-1 (TFA) | Reference compound | |
| HY-154971 | Ara-SH | Reference compound | |
| HY-154972 | α-Amylase/α-Glucosidase-IN-3 | Reference compound | |
| HY-154973 | AMPK activator 11 | 2948304-00-3 | Reference compound |
| HY-154974 | LNP Lipid-8 | 2408140-60-1 | Oligonucleotides |
| HY-154975 | SARS-CoV-2-IN-49 | Reference compound | |
| HY-154976 | SARS-CoV-2-IN-50 | Reference compound | |
| HY-154977 | ETAP | 2575731-47-2 | Reference compound |
| HY-154978 | Cisplatin-resistant cells-IN-1 | Reference compound | |
| HY-154979 | Anti-hepatic fibrosis agent 2 | 2380421-60-1 | Reference compound |
| HY-15498 | Rimegepant | 1289023-67-1 | Reference compound |
| HY-154980 | GPR52 receptor modulator 1 | 2642079-89-6 | Reference compound |
| HY-154981 | Mal-L-Dap(Boc)-OSu | 1703778-79-3 | ADC Related |
| HY-154984 | JET-209 | Reference compound | |
| HY-154985 | DSO-5a | 2195411-63-1 | Reference compound |
| HY-154986 | MARK4 inhibitor 2 | Reference compound | |
| HY-154987 | MARK4 inhibitor 3 | Reference compound | |
| HY-154988 | MARK4 inhibitor 4 | Reference compound | |
| HY-154989 | RdRP-IN-6 | Reference compound | |
| HY-15498A | Rimegepant (sulfate hydrate) | 1374024-48-2 | Reference compound |
| HY-154990 | RdRP-IN-7 | Reference compound | |
| HY-154992 | 2,4-Difluorophenylethynylcobalamin | 2101750-19-8 | Reference compound |
| HY-154993 | Gamma-Glutamyl Transferase-IN-1 | 2956809-71-3 | Reference compound |
| HY-154994 | JAK-IN-30 | 2891469-99-9 | Reference compound |
| HY-154995 | N-4′-(p-Trifluoromethylphenyl)butyl-DAB | 3033570-20-3 | Reference compound |
| HY-154996 | Gamma-Glutamyl Transferase-IN-2 | 2956809-82-6 | Reference compound |
| HY-154997 | 7OQL | Reference compound | |
| HY-154998 | α-Glucosidase-IN-27 | Reference compound | |
| HY-15500 | JM6 | 1008119-83-2 | Reference compound |
| HY-155001 | CSF1R-IN-15 | 2925744-43-8 | Reference compound |
| HY-155002 | hCYP3A4 Fluorogenic substrate 1 | 186299-00-3 | Reference compound |
| HY-155003 | TPEQM-DMA | Dye Reagents | |
| HY-155004 | SDH-IN-3 | 2805297-11-2 | Reference compound |
| HY-155005 | EGFR mutant-IN-2 | 2770009-06-6 | Reference compound |
| HY-155006 | PCSK9-IN-19 | Reference compound | |
| HY-155007 | DNA gyrase B-IN-2 | Reference compound | |
| HY-155008 | PROTAC HK2 Degrader-1 | 3033812-84-6 | Reference compound |
| HY-155009 | PHD2-IN-1 | 2768219-28-7 | Reference compound |
| HY-155010 | Steroid sulfatase/17β-HSD1-IN-5 | Reference compound | |
| HY-155011 | MB076 | 2832966-95-5 | ADC Related |
| HY-155012 | Mcl-1 inhibitor 16 | Reference compound | |
| HY-155013 | SARS-CoV-2-IN-43 | 31356-11-3 | Reference compound |
| HY-155014 | SARS-CoV-2-IN-44 | 1311271-71-2 | Reference compound |
| HY-155015 | SARS-CoV-2-IN-45 | Reference compound | |
| HY-155016 | SARS-CoV-2-IN-46 | Reference compound | |
| HY-155017 | 6-Iodoamiloride | 60398-23-4 | Reference compound |
| HY-155018 | Anticancer agent 127 | 2410953-19-2 | Reference compound |
| HY-155019 | Anticancer agent 128 | 2941243-62-3 | Reference compound |
| HY-15502 | PF-3635659 | 931409-24-4 | Reference compound |
| HY-155020 | Antitumor agent-101 | 2848632-52-8 | Reference compound |
| HY-155021 | PROTAC α-synuclein degrader 5 | 2781922-42-5 | Reference compound |
| HY-155022 | AChE-IN-30 | 2937454-22-1 | Reference compound |
| HY-155023 | Apoptosis inducer 13 | Reference compound | |
| HY-155024 | HAT-IN-8 | Reference compound | |
| HY-155025 | Antitrypanosomal agent 14 | 1447933-37-0 | Reference compound |
| HY-155026 | UPCDC30766 | 2152623-68-0 | Reference compound |
| HY-155027 | DPP-4-IN-8 | Reference compound | |
| HY-155028 | FGFR-IN-11 | 2658488-68-5 | Reference compound |
| HY-155029 | sEH inhibitor-16 | 2999636-75-6 | Reference compound |
| HY-15503 | PHA-690509 | 492445-28-0 | Reference compound |
| HY-155030 | α-Glucosidase-IN-25 | 2941473-92-1 | Reference compound |
| HY-155031 | MCI | Reference compound | |
| HY-155032 | P-gp inhibitor 15 | 2303508-09-8 | Reference compound |
| HY-155033 | SSI-4 | 1875084-68-6 | Reference compound |
| HY-155034 | Antitumor agent-102 | Reference compound | |
| HY-155035 | S07-1066 | 876625-29-5 | Reference compound |
| HY-155036 | Z1078601926 | 1493256-85-1 | Reference compound |
| HY-155037 | VE-PTP-IN-1 | Reference compound | |
| HY-155038 | Antitumor agent-104 | 2245272-16-4 | Reference compound |
| HY-155039 | Antitumor agent-105 | Reference compound | |
| HY-15504 | RGB-286638 | 784210-87-3 | Reference compound |
| HY-155040 | Antitumor agent-106 | Reference compound | |
| HY-155041 | Antihypertensive agent 2 | Reference compound | |
| HY-155042 | Antihypertensive agent 3 | Reference compound | |
| HY-155043 | Tubulin polymerization-IN-42 | 2640220-51-3 | Reference compound |
| HY-155044 | TMV-IN-5 | 1207318-92-0 | Reference compound |
| HY-155045 | TMV-IN-6 | Reference compound | |
| HY-155046 | FGFR4-IN-14 | 3027827-02-4 | Reference compound |
| HY-155047 | BDM91514 | 2892824-90-5 | Reference compound |
| HY-155048 | BDM91270 | 2892824-11-0 | Reference compound |
| HY-155049 | NMDA receptor antagonist 6 | Reference compound | |
| HY-15504A | RGB-286638 (free base) | 784210-88-4 | Reference compound |
| HY-15505 | RWJ-67657 | 215303-72-3 | Reference compound |
| HY-155050 | PRMT5-IN-31 | Reference compound | |
| HY-155051 | Antiproliferative agent-25 | Reference compound | |
| HY-155052 | PAD4-IN-2 | 2642327-52-2 | Reference compound |
| HY-155052A | PAD4-IN-2 (TFA) | Reference compound | |
| HY-155053 | ZIKV-IN-6 | Reference compound | |
| HY-155054 | Cysteine protease inhibitor-3 | Reference compound | |
| HY-155055 | Antiproliferative agent-26 | Reference compound | |
| HY-155056 | SARS-CoV-2 Mpro-IN-7 | Reference compound | |
| HY-155057 | SARS-CoV-2 Mpro-IN-8 | Reference compound | |
| HY-155058 | Nav1.3 channel inhibitor 1 | Reference compound | |
| HY-155059 | Antimycobacterial agent-6 | Reference compound | |
| HY-15506 | TAK-593 | 1005780-62-0 | Reference compound |
| HY-155060 | Antibacterial agent 144 | Reference compound | |
| HY-155061 | hCYP1B1-IN-1 | Reference compound | |
| HY-155062 | IR-251 | Dye Reagents | |
| HY-155063 | TRAP1-IN-1 | 3031102-94-7 | Reference compound |
| HY-155064 | TRAP1-IN-2 | 3031102-92-5 | Reference compound |
| HY-155065 | SB-1295 | Reference compound | |
| HY-155066 | FD274 | 2641899-38-7 | Reference compound |
| HY-155067 | Antitubercular agent-38 | Reference compound | |
| HY-155068 | FC-116 | 2417298-29-2 | Reference compound |
| HY-155069 | Antiproliferative agent-27 | Reference compound | |
| HY-15507 | VGX-1027 | 6501-72-0 | Reference compound |
| HY-155070 | SRE-II | Reference compound | |
| HY-155071 | MmpL3-IN-2 | 2944458-65-3 | Reference compound |
| HY-155072 | PROTAC BTK Degrader-5 | Reference compound | |
| HY-155073 | Tubulin inhibitor 35 | 2247047-77-2 | Reference compound |
| HY-155074 | EGFR-IN-79 | Reference compound | |
| HY-155075 | NC-R17 | 3049087-34-2 | Reference compound |
| HY-155076 | HIV-1 protease-IN-9 | 2925381-27-5 | Reference compound |
| HY-155077 | JNK-IN-12 | Reference compound | |
| HY-155078 | BRD4 Inhibitor-27 | 930039-92-2 | Reference compound |
| HY-155079 | DZD1516 | 2387570-00-3 | Reference compound |
| HY-155079A | (R)-DZD1516 | 2387570-03-6 | Reference compound |
| HY-15508 | JANEX-1 | 202475-60-3 | Reference compound |
| HY-155084 | Antifungal agent 61 | 2982657-98-5 | Reference compound |
| HY-155085 | hAChE-IN-3 | 2983723-56-2 | Reference compound |
| HY-155086 | hAChE-IN-4 | 2983723-58-4 | Reference compound |
| HY-155087 | Anticancer agent 140 | 389571-37-3 | Reference compound |
| HY-155088 | MK-8768 | 1432729-22-0 | Reference compound |
| HY-155089 | IACS-52825 | 2640376-72-1 | Reference compound |
| HY-15509 | Semapimod | 352513-83-8 | Reference compound |
| HY-155090 | ATM Inhibitor-8 | 2956666-60-5 | Reference compound |
| HY-155091 | ATM Inhibitor-9 | 2951007-81-9 | Reference compound |
| HY-155092 | DNA polymerase-IN-2 | 2953023-80-6 | Reference compound |
| HY-155093 | GLUT1-IN-3 | Reference compound | |
| HY-155094 | DNA polymerase-IN-3 | 381689-75-4 | Reference compound |
| HY-155095 | DNA polymerase-IN-4 | 2953023-85-1 | Reference compound |
| HY-155096 | Antibacterial agent 149 | Reference compound | |
| HY-155097 | SARS-CoV-2-IN-53 | Reference compound | |
| HY-155098 | CNBCA | Reference compound | |
| HY-155099 | FGH31 | Reference compound | |
| HY-15509A | Semapimod (tetrahydrochloride) | 164301-51-3 | Reference compound |
| HY-15510 | Tenovin-6 | 1011557-82-6 | Reference compound |
| HY-155100 | BI 7446 | 2767011-00-5 | Reference compound |
| HY-155101 | PD-L1-IN-3 | 2953044-29-4 | Reference compound |
| HY-155102 | PROTAC TG2 degrader-2 | Reference compound | |
| HY-155103 | Antitrypanosomal agent 15 | 2961381-94-0 | Reference compound |
| HY-155104 | MBL-IN-1 | Reference compound | |
| HY-155105 | α-Glucosidase-IN-30 | 2966859-35-6 | Reference compound |
| HY-155106 | SMA4 | Reference compound | |
| HY-155107 | ND-011992 | 2446880-46-0 | Reference compound |
| HY-155108 | OATD-02 | 2146132-73-0 | Reference compound |
| HY-155108B | OATD-02 (hydrochloride) | Reference compound | |
| HY-155109 | Antitumor agent-114 | 2757762-91-5 | Reference compound |
| HY-15510B | Tenovin-6 (Hydrochloride) | 1011301-29-3 | Reference compound |
| HY-15511 | Tyrphostin A9 | 10537-47-0 | Reference compound |
| HY-155110 | Antiviral agent 34 | 945152-88-5 | Reference compound |
| HY-155111 | nSMase2-IN-1 | 2968322-24-7 | Reference compound |
| HY-155112 | Antiproliferative agent-30 | 2713553-88-7 | Reference compound |
| HY-155113 | PROTAC Hsp90α degrader 1 | 3031078-90-4 | Reference compound |
| HY-155114 | HIV-1 inhibitor-59 | Reference compound | |
| HY-155115 | LSD1-IN-27 | 2904571-94-2 | Reference compound |
| HY-155116 | 5-HT6 agonist 1 | Reference compound | |
| HY-155117 | MRS7925 | Reference compound | |
| HY-155118 | EGFR-IN-81 | 2968419-65-8 | Reference compound |
| HY-155119 | SARS-CoV-2-IN-54 | Reference compound | |
| HY-15512 | OTSSP167 | 1431697-89-0 | Reference compound |
| HY-155120 | Cbl-b-IN-5 | 2368835-59-8 | Reference compound |
| HY-155121 | SARS-CoV-2-IN-56 | 3033198-21-6 | Reference compound |
| HY-155122 | PARP-1-IN-13 | 2999661-74-2 | Reference compound |
| HY-155123 | Antioxidant agent-13 | 2966778-87-8 | Reference compound |
| HY-155124 | Antiproliferative agent-32 | 2925814-05-5 | Reference compound |
| HY-155126 | LZWL02003 | 1371564-45-2 | Reference compound |
| HY-155127 | Antiproliferative agent-33 | 477542-73-7 | Reference compound |
| HY-155128 | LANA-DNA-IN-2 | 3033110-75-4 | Reference compound |
| HY-155129 | Antiviral agent 36 | 3033039-89-0 | Reference compound |
| HY-15512A | OTSSP167 (hydrochloride) | 1431698-10-0 | Reference compound |
| HY-15513 | TC-DAPK 6 | 315694-89-4 | Reference compound |
| HY-155130 | Antimalarial agent 31 | 3033682-50-4 | Reference compound |
| HY-155131 | Y18501 | 2410627-32-4 | Reference compound |
| HY-155132 | IRAK4-IN-28 | 2952532-92-0 | Reference compound |
| HY-155133 | COX-2-IN-34 | 2788578-71-0 | Reference compound |
| HY-155134 | Eg5-IN-1 | 3026790-10-0 | Reference compound |
| HY-155135 | HPPD-IN-1 | Reference compound | |
| HY-155136 | NSC89641 | Reference compound | |
| HY-155137 | CHBO4 | 98991-32-3 | Reference compound |
| HY-155138 | GLS1 Inhibitor-7 | Reference compound | |
| HY-155139 | Tubulin polymerization-IN-45 | Reference compound | |
| HY-15514 | Merestinib | 1206799-15-6 | Reference compound |
| HY-155140 | BChE-IN-17 | 2425632-57-9 | Reference compound |
| HY-155141 | hCYP3A4-IN-1 | 3003751-14-9 | Reference compound |
| HY-155142 | CDD-1819 | 2894104-40-4 | Reference compound |
| HY-155143 | CDD-1733 | 2894104-33-5 | Reference compound |
| HY-155144 | CDD-1845 | 2894104-50-6 | Reference compound |
| HY-155146 | Anticancer agent 146 | Reference compound | |
| HY-155147 | GLP-1 receptor agonist 13 | Reference compound | |
| HY-155148 | MAT2A-IN-11 | Reference compound | |
| HY-155149 | MAT2A-IN-12 | 631897-75-1 | Reference compound |
| HY-15514A | Merestinib dihydrochloride | 1206801-37-7 | Reference compound |
| HY-15515 | SEA0400 | 223104-29-8 | Reference compound |
| HY-155150 | JH-XII-03-02 | 2415900-86-4 | Reference compound |
| HY-155151 | RIPK2/3-IN-1 | Reference compound | |
| HY-155152 | P-gp/BCRP-IN-2 | Reference compound | |
| HY-155153 | CDK9-IN-24 | Reference compound | |
| HY-155154 | PRMT4-IN-2 | Reference compound | |
| HY-155154A | PRMT4-IN-3 | Reference compound | |
| HY-155155 | SARS-CoV-2-IN-57 | 1265624-68-7 | Reference compound |
| HY-155156 | PF-07238025 | Reference compound | |
| HY-155157 | PF-07247685 | Reference compound | |
| HY-155158 | Anticancer agent 147 | 2241283-11-2 | Reference compound |
| HY-155159 | COX-2/15-LOX-IN-2 | Reference compound | |
| HY-15516 | Sotagliflozin | 1018899-04-1 | Reference compound |
| HY-155160 | COX-2/15-LOX-IN-3 | Reference compound | |
| HY-155161 | COX-2/15-LOX-IN-4 | Reference compound | |
| HY-155163 | APG-2449 | 2196186-84-0 | Reference compound |
| HY-155164 | WF-3681 | 105364-56-5 | Reference compound |
| HY-155165 | Dazonone | 105622-85-3 | Reference compound |
| HY-155166 | Carbethopendecinium (bromide) | 10567-02-9 | Reference compound |
| HY-155167 | Anticancer agent 151 | 1227476-97-2 | Reference compound |
| HY-155168 | Iso-RJW100 | 1276664-61-9 | Reference compound |
| HY-155169 | hLTA4H/hLTA4S-IN-1 | 128253-12-3 | Reference compound |
| HY-15517 | KN-92 | 176708-42-2 | Reference compound |
| HY-155170 | MTDH-SND1 blocker 1 | 1341030-00-9 | Reference compound |
| HY-155172 | ZX-J-19j | 1352576-02-3 | Reference compound |
| HY-155174 | Antiangiogenic agent 4 | 2974488-31-6 | Reference compound |
| HY-155175 | TIM-3-IN-2 | 1113126-49-0 | Reference compound |
| HY-155176 | SP-2-225 | 2364448-93-9 | Reference compound |
| HY-155177 | CDK9-IN-27 | Reference compound | |
| HY-155178 | Antiproliferative agent-34 | 2910858-34-1 | Reference compound |
| HY-155179 | ZMF-23 | Reference compound | |
| HY-15517A | KN-92 (phosphate) | 1135280-28-2 | Reference compound |
| HY-15517B | KN-92 (hydrochloride) | 1431698-47-3 | Reference compound |
| HY-15518 | LCL161 | 1005342-46-0 | Reference compound |
| HY-155180 | FD2056 | 2685870-87-3 | Reference compound |
| HY-155181 | hCES2-IN-1 | 2994634-52-3 | Reference compound |
| HY-155182 | HDAC-IN-62 | Reference compound | |
| HY-155183 | A3AR agonist 1 | Reference compound | |
| HY-155184 | A3AR agonist 2 | Reference compound | |
| HY-155185 | NMDA receptor antagonist 7 | Reference compound | |
| HY-155185A | NMDA receptor antagonist 8 | Reference compound | |
| HY-155186 | SARS-CoV-2 3CLpro-IN-19 | Reference compound | |
| HY-155187 | SARS-CoV-2 3CLpro-IN-20 | 878985-00-3 | Reference compound |
| HY-155188 | NWP-0476 | 2290611-26-4 | Reference compound |
| HY-155189 | IIIM-8 | 1128053-62-2 | Reference compound |
| HY-15519 | LBW242 | 867324-12-7 | Reference compound |
| HY-155190 | Antitubercular agent-39 | 1357796-08-7 | Reference compound |
| HY-155191 | Galectin-3/galectin-8-IN-1 | Reference compound | |
| HY-155192 | Galectin-3/galectin-8-IN-2 | Reference compound | |
| HY-155193 | XY-52 | Reference compound | |
| HY-155195 | FLT3/CHK1-IN-1 | 2991054-23-8 | Reference compound |
| HY-155196 | ER degrader 6 | 2922929-62-0 | Reference compound |
| HY-155197 | ER degrader 7 | 2922929-63-1 | Reference compound |
| HY-155198 | Antifungal agent 72 | 3032485-62-1 | Reference compound |
| HY-155199 | PDE1-IN-5 | 2982945-34-4 | Reference compound |
| HY-15520 | CGK733 | 905973-89-9 | Reference compound |
| HY-155200 | EGFR-IN-84 | Reference compound | |
| HY-155201 | YJ182 | 3035446-91-1 | Reference compound |
| HY-155202 | YJ196 | 3035447-45-8 | Reference compound |
| HY-155203 | Anticancer agent 154 | Reference compound | |
| HY-155204 | LTB4-IN-2 | Reference compound | |
| HY-155205 | GV150013X | 151386-96-8 | Reference compound |
| HY-155206 | (+)-OSU6162 | 160777-43-5 | Reference compound |
| HY-155207 | Antileishmanial agent-23 | 745033-86-7 | Reference compound |
| HY-155209 | SCD1 inhibitor-5 | 1673558-59-2 | Reference compound |
| HY-15521 | ETP-46464 | 1345675-02-6 | Reference compound |
| HY-155211 | mTOR inhibitor-13 | 1144075-44-4 | Reference compound |
| HY-155215 | Tenilapine | 82650-83-7 | Reference compound |
| HY-155216 | PKM2 activator 10 | 2490276-04-3 | Reference compound |
| HY-155218 | TMX-2172 | 2488892-09-5 | Reference compound |
| HY-155219 | TH9028 | 2379556-15-5 | Reference compound |
| HY-15522 | WAY-267464 | 847375-16-0 | Reference compound |
| HY-155221 | UNC7145 | 2561494-78-6 | Reference compound |
| HY-155222 | TW9 | 2614417-90-0 | Reference compound |
| HY-155224 | Sulpho NONOate | 61142-90-3 | Reference compound |
| HY-155226 | FLT3-IN-21 | Reference compound | |
| HY-155227 | ALK/EGFR-IN-1 | 2730430-08-5 | Reference compound |
| HY-155227A | ALK/EGFR-IN-2 | 2730432-75-2 | Reference compound |
| HY-155227B | ALK/EGFR-IN-3 | 2730432-72-9 | Reference compound |
| HY-155227S | ALK/EGFR-IN-1-d5 | 2730429-93-1 | Reference compound |
| HY-155228 | LK-44 | Reference compound | |
| HY-155229 | CBP/p300-IN-21 | 1065581-69-2 | Reference compound |
| HY-15523 | Braco-19 | 351351-75-2 | Reference compound |
| HY-155230 | T3SS-IN-2 | Reference compound | |
| HY-155231 | Neutrophil elastase inhibitor 4 | Reference compound | |
| HY-155232 | PI3Kδ-IN-16 | 2766437-35-6 | Reference compound |
| HY-155233 | Steroid sulfatase-IN-5 | Reference compound | |
| HY-155234 | Steroid sulfatase-IN-6 | Reference compound | |
| HY-155235 | Steroid sulfatase-IN-7 | Reference compound | |
| HY-155236 | Ancistrotecine B | Natural Products | |
| HY-155237 | LIN28-IN-1 | Reference compound | |
| HY-155238 | E2730 | 1520073-91-9 | Reference compound |
| HY-155239 | VEGFR-2-IN-35 | 2634356-52-6 | Reference compound |
| HY-15523A | Braco-19 (trihydrochloride) | 1177798-88-7 | Reference compound |
| HY-155240 | Tyrosinase-IN-13 | Reference compound | |
| HY-155241 | α-Amylase/α-Glucosidase-IN-4 | Reference compound | |
| HY-155242 | VEGFR-2-IN-36 | Reference compound | |
| HY-155243 | 12R-LOX-IN-1 | 857758-13-5 | Reference compound |
| HY-155244 | 12R-LOX-IN-2 | 3026677-37-9 | Reference compound |
| HY-155245 | A09-003 | 2911646-14-3 | Reference compound |
| HY-155246 | PARP1-IN-15 | Reference compound | |
| HY-155247 | Tyrosinase-IN-14 | Reference compound | |
| HY-155248 | HL23 | 1448355-15-4 | Reference compound |
| HY-155249 | KGP591 | 3018962-69-8 | Reference compound |
| HY-155250 | Antibacterial agent 154 | 2163048-45-9 | Reference compound |
| HY-155251 | anti-TNBC agent-3 | 2422001-25-8 | Reference compound |
| HY-155252 | Spinosyn A aglycone | 149560-97-4 | Reference compound |
| HY-155253 | Sphinganine-1-phosphate (d17:0) | 474923-29-0 | Natural Products |
| HY-155254 | Sodium ionophore VI | 80403-59-4 | Reference compound |
| HY-155255 | Thalidomide-5-PEG2-NH2 (hydrochloride) | 2761406-70-4 | Reference compound |
| HY-155256 | Thalidomide-5-PEG6-NH2 (hydrochloride) | Reference compound | |
| HY-155257 | Thalidomide-5-PEG7-NH2 (hydrochloride) | Reference compound | |
| HY-155258 | Pomalidomide-PEG7-NH2 (hydrochloride) | Reference compound | |
| HY-155259 | Pomalidomide-5-C3-NH2 (hydrochloride) | Reference compound | |
| HY-15526 | PSI-697 | 851546-61-7 | Reference compound |
| HY-155260 | Pomalidomide-5-C4-NH2 (hydrochloride) | Reference compound | |
| HY-155261 | Pomalidomide-5-C5-NH2 (hydrochloride) | 2925306-39-2 | Reference compound |
| HY-155262 | Pomalidomide-5-C6-NH2 (hydrochloride) | 3007650-02-1 | Reference compound |
| HY-155263 | Pomalidomide-5-C7-NH2 (hydrochloride) | 3032282-75-7 | Reference compound |
| HY-155264 | Pomalidomide-5-C8-NH2 (hydrochloride) | 2863635-03-2 | Reference compound |
| HY-155265 | Pomalidomide-5-C9-NH2 (hydrochloride) | 2925306-22-3 | Reference compound |
| HY-155266 | Pomalidomide-5-C10-NH2 (hydrochloride) | 2863635-00-9 | Reference compound |
| HY-155267 | Pomalidomide-5-C11-NH2 (hydrochloride) | Reference compound | |
| HY-155268 | Pomalidomide-5-C12-NH2 (hydrochloride) | Reference compound | |
| HY-155269 | Pomalidomide-5-C13-NH2 (hydrochloride) | Reference compound | |
| HY-15527 | Emapunil | 226954-04-7 | Reference compound |
| HY-155270 | Pomalidomide-5-C14-NH2 (hydrochloride) | Reference compound | |
| HY-155271 | hCAXII-IN-7 | Reference compound | |
| HY-155272 | SHP2-IN-16 | Reference compound | |
| HY-155273 | SHP2-IN-17 | 2941498-93-5 | Reference compound |
| HY-155274 | SHP2-IN-18 | 2941498-87-7 | Reference compound |
| HY-155275 | SHP2-IN-19 | 2941498-84-4 | Reference compound |
| HY-155276 | SHP2-IN-20 | 2941498-94-6 | Reference compound |
| HY-155277 | SHP2-IN-21 | 2941499-08-5 | Reference compound |
| HY-155278 | Anticancer agent 162 | 2761736-66-5 | Reference compound |
| HY-155279 | Antifungal agent 73 | 2923519-78-0 | Reference compound |
| HY-15528 | kb NB 142-70 | 1233533-04-4 | Reference compound |
| HY-155280 | SARS-CoV-2-IN-60 | Reference compound | |
| HY-155281 | Antiparasitic agent-18 | 2821884-59-5 | Reference compound |
| HY-155282 | FASN-IN-6 | 3032387-88-2 | Reference compound |
| HY-155283 | Zndm19 | 364055-05-0 | Reference compound |
| HY-155284 | K1833 | Reference compound | |
| HY-155285 | YS-363 | 2470908-90-6 | Reference compound |
| HY-155286 | (7S,8R,17S)-RCTR1 | 2095607-49-9 | Reference compound |
| HY-155288 | DosatiLink-1 | 2941512-37-2 | Reference compound |
| HY-155289 | DosatiLink-2 | 2941512-38-3 | Reference compound |
| HY-15529 | S0859 | 1019331-10-2 | Reference compound |
| HY-155290 | PonatiLink-1-24 | 2941512-45-2 | Reference compound |
| HY-155291 | 3'-Mant-GDP | 91828-87-4 | Reference compound |
| HY-155295 | Z-CITCO | 2583138-04-7 | Reference compound |
| HY-155297 | Nebidrazine | 55248-23-2 | Reference compound |
| HY-155299 | PITB | Reference compound | |
| HY-15530 | CID-2858522 | 758679-97-9 | Reference compound |
| HY-155300 | BLT2 antagonist-1 | 2069220-61-5 | Reference compound |
| HY-155301 | Antileishmanial agent-24 | 2999670-36-7 | Reference compound |
| HY-155302 | FLT3-IN-22 | Reference compound | |
| HY-155303 | DCLK1-IN-2 | 2978517-43-8 | Reference compound |
| HY-155304 | BuChE-IN-8 | Reference compound | |
| HY-155305 | BuChE-IN-9 | Natural Products | |
| HY-155306 | TGR5 agonist 3 | 2148317-51-3 | Reference compound |
| HY-155307 | TGR5 agonist 4 | Reference compound | |
| HY-155308 | SARS-CoV-2-IN-61 | 3044004-40-9 | Reference compound |
| HY-155309 | LM-41 | 2996821-30-6 | Reference compound |
| HY-15531 | Venetoclax | 1257044-40-8 | Reference compound |
| HY-155310 | AF-2112 | 2996821-62-4 | Reference compound |
| HY-155311 | NKG2D-IN-1 | Reference compound | |
| HY-155312 | NKG2D-IN-2 | Reference compound | |
| HY-155313 | β-Glucuronide-NB-bis[N(Me)-methyl ester]-MMAE | Reference compound | |
| HY-155314 | Tubulin polymerization-IN-50 | 2998928-21-3 | Reference compound |
| HY-155315 | Tubulin polymerization-IN-51 | 2998928-27-9 | Reference compound |
| HY-155316 | 5-HT6R antagonist 2 | 1622175-20-5 | Reference compound |
| HY-155318A | GPR3 agonist-2 | 1983120-51-9 | Reference compound |
| HY-155319 | μ opioid receptor agonist 3 | 2378397-91-0 | Reference compound |
| HY-15531R | Venetoclax (Standard) | 1257044-40-8 | Reference Standards |
| HY-15531S | Venetoclax-d8 | 1257051-06-1 | Isotope-Labeled Compounds |
| HY-15531S1 | Venetoclax-d6 | Isotope-Labeled Compounds | |
| HY-15532 | SCH900776 | 891494-63-6 | Reference compound |
| HY-155320 | Mu opioid receptor antagonist 7 | 2378397-30-7 | Reference compound |
| HY-155321 | NXT-10796 | Reference compound | |
| HY-155322 | Cy3-PEG2-TCO | Dye Reagents | |
| HY-155323 | Cy3-PEG3-TCO | Dye Reagents | |
| HY-155324 | Cy3-PEG7-TCO | Dye Reagents | |
| HY-155325 | Cy3-PEG2-TCO4 | Dye Reagents | |
| HY-155326 | Cy3-PEG3-TCO4 | Dye Reagents | |
| HY-155327 | Cy3-PEG2-endo-BCN | 1663449-60-2 | Dye Reagents |
| HY-155327A | Cy3-PEG2-exo-BCN | Dye Reagents | |
| HY-155327B | Cy3-PEG2-endo-BCN (bromide) | Dye Reagents | |
| HY-155328 | GK444 | 3032392-39-2 | Reference compound |
| HY-155329 | GK718 | 3032392-65-4 | Reference compound |
| HY-15532B | SCH900776 (S-isomer) | 891494-64-7 | Reference compound |
| HY-15533 | LY 3000328 | 1373215-15-6 | Reference compound |
| HY-155330 | PZ-1922 | Reference compound | |
| HY-155330A | PZ-1922 (free base) | 1648745-65-6 | Reference compound |
| HY-155331 | Antifungal agent 77 | 2863678-89-9 | Reference compound |
| HY-155332 | AB131 | 720671-77-2 | Reference compound |
| HY-155333 | Antibiofilm agent-1 | 2001602-10-2 | Reference compound |
| HY-155334 | RyRs activator 4 | 2987900-56-9 | Reference compound |
| HY-155335 | FPR2 agonist 3 | 2829263-19-4 | Reference compound |
| HY-155336 | CB2R agonist 2 | Reference compound | |
| HY-155337 | eIF4E-IN-6 | Reference compound | |
| HY-155338 | SWTX-143 | 2766575-48-6 | Reference compound |
| HY-155339 | Anticancer agent 168 | 207399-56-2 | Reference compound |
| HY-15534 | JC-1 | 3520-43-2 | Dye Reagents |
| HY-155341 | HSK205 | 3022263-37-9 | Reference compound |
| HY-155342 | A3373 | 2324948-66-3 | Reference compound |
| HY-155343 | A4333 | 3025827-56-6 | Reference compound |
| HY-155344 | α-Glucosidase-IN-38 | 2991427-89-3 | Reference compound |
| HY-155345 | AChE-IN-45 | Reference compound | |
| HY-155346 | Free radical scavenger 1 | 2989970-81-0 | Reference compound |
| HY-155348 | Ru3 | Reference compound | |
| HY-155349 | AChE/BuChE-IN-4 | 1997158-25-4 | Reference compound |
| HY-15535 | DMAT | 749234-11-5 | Reference compound |
| HY-155350 | Tubulin polymerization-IN-53 | Reference compound | |
| HY-155351 | PARP7-IN-15 | 2819998-97-3 | Reference compound |
| HY-155352 | mGluR5 antagonist-1 | 2761424-76-2 | Reference compound |
| HY-155354 | Antimalarial agent 33 | Reference compound | |
| HY-155355 | LY836 | Reference compound | |
| HY-155356 | YN14 | Reference compound | |
| HY-155357 | Antibacterial agent 160 | 1854892-66-2 | Reference compound |
| HY-155358 | Os30 | 2998928-68-8 | Reference compound |
| HY-155359 | Tubulin polymerization-IN-55 | 2942396-29-2 | Reference compound |
| HY-15536 | Cebranopadol | 863513-91-1 | Reference compound |
| HY-155360 | MY-1076 | 3008262-76-5 | Reference compound |
| HY-155361 | PROTAC BRD9 Degrader-7 | Reference compound | |
| HY-155362 | Tubulin polymerization-IN-56 | 2966790-98-5 | Reference compound |
| HY-155363 | AMPK activator 13 | Reference compound | |
| HY-155364 | Antimicrobial agent-26 | 3026743-44-9 | Reference compound |
| HY-155365 | hAChE-IN-5 | 3007667-15-1 | Reference compound |
| HY-155366 | hAChE-IN-6 | 3007667-17-3 | Reference compound |
| HY-155367 | mAChR antagonist 1 | 101491-79-6 | Reference compound |
| HY-155368 | BChE-IN-20 | 1428439-79-5 | Reference compound |
| HY-155369 | BChE-IN-21 | Reference compound | |
| HY-15536A | Cebranopadol ((1α,4α)stereoisomer) | 863513-93-3 | Reference compound |
| HY-15536B | Cebranopadol (hemicitrate) | 863513-92-2 | Reference compound |
| HY-15537 | Tilbroquinol | 7175-09-9 | Reference compound |
| HY-155370 | IR808-TZ | Reference compound | |
| HY-155371 | BT-PROTAC | 3032848-64-6 | Reference compound |
| HY-155372 | α-Glucosidase-IN-39 | Reference compound | |
| HY-155373 | Antioxidant agent-16 | Reference compound | |
| HY-155374 | PP5-IN-1 | 1022417-69-1 | Reference compound |
| HY-155375 | AtPCO4-IN-1 | 316134-38-0 | Reference compound |
| HY-155376 | mTOR inhibitor-14 | Reference compound | |
| HY-155377 | PLK1/p38γ-IN-1 | 2418614-81-8 | Reference compound |
| HY-155378 | PZ-1190 | 1852517-78-2 | Reference compound |
| HY-155379 | β-Herpesvirus protease-IN-1 | Reference compound | |
| HY-15538 | Ebrotidine | 100981-43-9 | Reference compound |
| HY-155380 | Antiproliferative agent-41 | 225652-93-7 | Reference compound |
| HY-155381 | APS3 | 1225373-70-5 | Reference compound |
| HY-155382 | Lactate transportor 1 | Reference compound | |
| HY-155383 | TNIR7-1A | 2301931-35-9 | Reference compound |
| HY-155385 | 10-Oxo-12(Z),15(Z)-octadecadienoic acid | 1036406-73-1 | Reference compound |
| HY-155386 | Peroxynitrite (sodium) | 14042-01-4 | Reference compound |
| HY-155387 | ZK-PI-5 | Reference compound | |
| HY-155388 | ZK-PI-9 | Reference compound | |
| HY-155389 | Caspase-3 activator 2 | 2999724-52-4 | Reference compound |
| HY-15539 | Niperotidine | 84845-75-0 | Reference compound |
| HY-155390 | Caspase-3 activator 3 | 2999724-54-6 | Reference compound |
| HY-155391 | hCA/Wnt/β-catenin-IN-1 | 3032826-63-1 | Reference compound |
| HY-155392 | Mz325 | 3032670-12-2 | Reference compound |
| HY-155393 | PROTAC BRD4 Degrader-22 | 3032850-37-3 | Reference compound |
| HY-155394 | RyRs activator 5 | Reference compound | |
| HY-155395 | DDAN-MT | Dye Reagents | |
| HY-155396 | PRO-HD1 | Reference compound | |
| HY-155397 | PRO-HD2 | Reference compound | |
| HY-155398 | PRO-HD3 | Reference compound | |
| HY-155399 | Antitrypanosomal agent 16 | Reference compound | |
| HY-15540 | Metiamide | 34839-70-8 | Reference compound |
| HY-155400 | Antitrypanosomal agent 17 | Reference compound | |
| HY-155401 | Antitrypanosomal agent 18 | Reference compound | |
| HY-155402 | Antiproliferative agent-42 | 3002404-74-9 | Reference compound |
| HY-155403 | SCD1/5-IN-1 | 1241494-17-6 | Reference compound |
| HY-155404 | Adenylyl cyclase-IN-1 | 731827-16-0 | Reference compound |
| HY-155405 | Anti-inflammatory agent 64 | 3016401-76-3 | Reference compound |
| HY-155406 | Estrogen receptor modulator 10 | 2991504-90-4 | Reference compound |
| HY-155407 | ALR-6 | 6621-92-7 | Reference compound |
| HY-155408 | ALR-27 | 903639-13-4 | Reference compound |
| HY-155409 | ALR-38 | 241127-61-7 | Reference compound |
| HY-15541 | Zaltidine | 85604-00-8 | Reference compound |
| HY-155410 | HPSE1-IN-1 | 2876926-29-1 | Reference compound |
| HY-155411 | HPSE1-IN-2 | 2876926-27-9 | Reference compound |
| HY-155412 | PFI-6 | 2675452-91-0 | Reference compound |
| HY-155413 | Antiproliferative agent-43 | Reference compound | |
| HY-155414 | Neutrophil elastase inhibitor 5 | 3020696-44-7 | Reference compound |
| HY-155415 | PCSK9-IN-20 | 2929219-77-0 | Reference compound |
| HY-155416 | M56-S2 (iodide) | 1101867-17-7 | Reference compound |
| HY-155417 | GPR34 receptor antagonist 3 | Reference compound | |
| HY-155418 | ICMT-IN-2 | 1313602-91-3 | Reference compound |
| HY-155419 | ICMT-IN-5 | 1313602-92-4 | Reference compound |
| HY-15541A | Zaltidine (dihydrochloride) | 90274-23-0 | Reference compound |
| HY-155420 | ICMT-IN-9 | 1313602-93-5 | Reference compound |
| HY-155421 | ICMT-IN-11 | 1313602-94-6 | Reference compound |
| HY-155422 | ICMT-IN-13 | 1313602-95-7 | Reference compound |
| HY-155423 | ICMT-IN-14 | 1313602-97-9 | Reference compound |
| HY-155424 | ICMT-IN-15 | 1313602-98-0 | Reference compound |
| HY-155425 | ICMT-IN-17 | 1313602-99-1 | Reference compound |
| HY-155426 | ICMT-IN-19 | 1313603-00-7 | Reference compound |
| HY-155427 | ICMT-IN-20 | 1313603-01-8 | Reference compound |
| HY-155428 | ICMT-IN-22 | 1313603-09-6 | Reference compound |
| HY-155429 | ICMT-IN-24 | 1313603-10-9 | Reference compound |
| HY-15542A | FRAX597 | 1286739-19-2 | Reference compound |
| HY-15542B | FRAX486 | 1232030-35-1 | Reference compound |
| HY-15543 | CP-809101 | 479683-64-2 | Reference compound |
| HY-155430 | ICMT-IN-27 | 1313603-11-0 | Reference compound |
| HY-155431 | ICMT-IN-28 | 1313603-12-1 | Reference compound |
| HY-155432 | ICMT-IN-29 | 1313603-13-2 | Reference compound |
| HY-155433 | ICMT-IN-30 | 1313603-14-3 | Reference compound |
| HY-155434 | ICMT-IN-31 | 1313603-15-4 | Reference compound |
| HY-155435 | ICMT-IN-32 | 1313603-17-6 | Reference compound |
| HY-155436 | ICMT-IN-33 | 1313603-20-1 | Reference compound |
| HY-155437 | NEt-iFQ | 1251538-60-9 | Reference compound |
| HY-155438 | Mal-Cz | 2883232-96-8 | Reference compound |
| HY-155439 | FAK-IN-14 | 2766666-22-0 | Reference compound |
| HY-15543A | CP-809101 (hydrochloride) | 1215721-40-6 | Reference compound |
| HY-15544 | CCR1 antagonist 10 | 1010731-97-1 | Reference compound |
| HY-155440 | FAK-IN-15 | Reference compound | |
| HY-155441 | CDK2-IN-20 | Reference compound | |
| HY-155442 | MIQ-N-succinate | 1511896-15-3 | Reference compound |
| HY-155444 | AG5.0 | Reference compound | |
| HY-155445 | di-DTPA TL | 136687-39-3 | Reference compound |
| HY-155446 | di-DTPA-LTL | Reference compound | |
| HY-155447 | AG3.0 | Reference compound | |
| HY-155448 | GK56 | 250683-14-8 | Reference compound |
| HY-155449 | GK60 | 250683-13-7 | Reference compound |
| HY-15545 | AZD-4818 | 1003566-93-5 | Reference compound |
| HY-155450 | GK81 | 250682-96-3 | Reference compound |
| HY-155451 | GK83 | Reference compound | |
| HY-155452 | SG62 | 250683-07-9 | Reference compound |
| HY-155453 | IB87 | 1251913-63-9 | Reference compound |
| HY-155455 | Dicamba-(CH2)5-acid | 2892008-07-8 | Reference compound |
| HY-155456 | CYP2A6-IN-1 | Reference compound | |
| HY-155457 | Enpp-1-IN-19 | 2738583-25-8 | Reference compound |
| HY-155458 | HYDAMTIQ | 1201832-32-7 | Reference compound |
| HY-155459 | Tubulin polymerization-IN-57 | 95385-38-9 | Reference compound |
| HY-15546 | BMS-817399 | 1202400-18-7 | Reference compound |
| HY-155460 | Pks13-TE inhibitor 4 | 3032947-26-2 | Reference compound |
| HY-155461 | Antibiofilm agent-3 | Reference compound | |
| HY-155462 | hERG-IN-1 | Reference compound | |
| HY-155463 | NLRP3-IN-25 | 2660230-90-8 | Reference compound |
| HY-155464 | VEGFR-2/AURKA-IN-1 | Reference compound | |
| HY-155465 | HPPD-IN-2 | Reference compound | |
| HY-155466 | Boc-MIF-1-Am | Reference compound | |
| HY-155467 | MRS7935 | Reference compound | |
| HY-155468 | AG8.0 | 159173-58-7 | Reference compound |
| HY-155469 | IMP 241 | 391267-27-9 | Reference compound |
| HY-155470 | IMP 243 | 391267-29-1 | Reference compound |
| HY-155471 | IMP 245 | 608489-42-5 | Reference compound |
| HY-155472 | Mcl-1 inhibitor 17 | 892250-00-9 | Reference compound |
| HY-155473 | Phosphatidylcholine transfer protein inhibitor-2 | 379712-59-1 | Reference compound |
| HY-155474 | Me4Phen | Reference compound | |
| HY-155475 | mTORC1-IN-2 | 2974368-96-0 | Reference compound |
| HY-155476 | Influenza virus-IN-8 | 1627115-50-7 | Reference compound |
| HY-155477 | Cbl-b-IN-15 | Reference compound | |
| HY-155478 | Androgen receptor-IN-6 | 3016437-05-8 | Reference compound |
| HY-155479 | PqsR-IN-3 | 3033007-79-0 | Reference compound |
| HY-155480 | PSB-22034 | 2768131-22-0 | Reference compound |
| HY-155481 | CB2 receptor antagonist 3 | Reference compound | |
| HY-155481A | CB2 receptor antagonist 4 | Reference compound | |
| HY-155482 | NA-184 | 2688119-39-1 | Reference compound |
| HY-155483 | PSMA-BCH | 1703768-73-3 | Reference compound |
| HY-155484 | SOMCL-668 | 1422251-09-9 | Reference compound |
| HY-155485 | Abi-DZ-1 | Reference compound | |
| HY-155486 | HCy-AAN-Bio | Reference compound | |
| HY-155487 | JTE-151 | 1404380-58-0 | Reference compound |
| HY-155488 | SHEN26 | 2691076-98-7 | Reference compound |
| HY-155489 | DDO-2728 | 3029515-97-4 | Reference compound |
| HY-155490 | Nur77 antagonist 1 | 2378780-25-5 | Reference compound |
| HY-155491 | Antibacterial agent 166 | Reference compound | |
| HY-155492 | ERα degrader 7 | Reference compound | |
| HY-155493 | CYP19A1/CYP11B2-IN-1 | 183500-36-9 | Reference compound |
| HY-155494 | trans-Stilbene-NHCO-(CH2)3-acid | 316173-40-7 | Reference compound |
| HY-155495 | (±)-Bupropion-(CH2)3-OH (hydrochloride) | 80762-38-5 | Reference compound |
| HY-155498 | TETS-4-Methylaniline | Reference compound | |
| HY-155499 | AMOZ-CHPh-4-acid | 1149378-53-9 | Reference compound |
| HY-15550 | 4'-Hydroxy diclofenac | 64118-84-9 | Reference compound |
| HY-155500 | Digoxigenin NHS ester | 129273-26-3 | Reference compound |
| HY-155502 | AKR1C3-IN-10 | 3028287-43-3 | Reference compound |
| HY-155503 | Antitumor agent-103 | Reference compound | |
| HY-155504 | Metallo-β-lactamase-IN-11 | Reference compound | |
| HY-155505 | AHR agonist 4 | 2953023-30-6 | Reference compound |
| HY-155506 | NAMPT degrader-3 | Reference compound | |
| HY-155507 | c-Myc inhibitor 11 | Reference compound | |
| HY-155508 | c-Myc inhibitor 12 | 3040017-65-7 | Reference compound |
| HY-15550R | 4'-Hydroxy diclofenac (Standard) | 64118-84-9 | Reference Standards |
| HY-15550S | 4'-Hydroxy diclofenac-d4 | 254762-27-1 | Isotope-Labeled Compounds |
| HY-15550S1 | 4'-Hydroxy diclofenac-13C6 | 1189656-64-1 | Isotope-Labeled Compounds |
| HY-15551 | E-4031 | 113559-13-0 | Reference compound |
| HY-155510 | DprE1-IN-5 | Reference compound | |
| HY-155511 | DprE1-IN-6 | Reference compound | |
| HY-155512 | DprE1-IN-7 | Reference compound | |
| HY-155513 | Syk-IN-8 | 2568963-01-7 | Reference compound |
| HY-155514 | HA-IN-1 | Reference compound | |
| HY-155516 | KV1.3-IN-1 | Reference compound | |
| HY-155516A | cis-KV1.3-IN-1 | 3052324-05-4 | Reference compound |
| HY-155517 | INF200 | Reference compound | |
| HY-155518 | IRAK4-IN-25 | 2952533-47-8 | Reference compound |
| HY-155519 | IRAK4-IN-26 | 2952533-49-0 | Reference compound |
| HY-15551A | E-4031 (free base) | 113558-89-7 | Reference compound |
| HY-15552 | Podofilox | 518-28-5 | Natural Products |
| HY-155520 | Antileishmanial agent-19 | Reference compound | |
| HY-155521 | Enzyme-IN-2 | Reference compound | |
| HY-155522 | WES-1 | 2748673-86-9 | Reference compound |
| HY-155523 | Tubulin/HDAC-IN-2 | Reference compound | |
| HY-155524 | Anticancer agent 134 | Reference compound | |
| HY-155525 | Anti-NASH agent 1 | 2409685-41-0 | Reference compound |
| HY-155526 | FY-21 | 3049681-20-8 | Reference compound |
| HY-155527 | SARS-CoV-2 Mpro-IN-9 | 2754370-99-3 | Reference compound |
| HY-155528 | O4I4 | 412008-21-0 | Reference compound |
| HY-155529 | FD1024 | 1422456-47-0 | Reference compound |
| HY-15552R | Podofilox (Standard) | 518-28-5 | Reference Standards |
| HY-15552S | Podofilox-d6 | Isotope-Labeled Compounds | |
| HY-15553 | Mibefradil | 116644-53-2 | Reference compound |
| HY-155530 | PEX5-PEX14 PPI-IN-1 | Reference compound | |
| HY-155531 | PEX5-PEX14 PPI-IN-2 | Reference compound | |
| HY-155532 | 10m/ZS44 | 3008988-49-3 | Reference compound |
| HY-155533 | YF704 | 2956716-97-3 | Reference compound |
| HY-155534 | 17β-HSD10-IN-1 | 2316765-78-1 | Reference compound |
| HY-155535 | 17β-HSD10-IN-2 | 2316765-79-2 | Reference compound |
| HY-155536 | Antimalarial agent 28 | Reference compound | |
| HY-155537 | Pruvonertinib | 2064269-82-3 | Reference compound |
| HY-155538 | Cisd2 agonist 1 | 2916371-54-3 | Reference compound |
| HY-155539 | Cisd2 agonist 2 | 2916371-59-8 | Reference compound |
| HY-15553A | Mibefradil (dihydrochloride) | 116666-63-8 | Reference compound |
| HY-15553B | Mibefradil (dihydrochloride hydrate) | 1049728-52-0 | Reference compound |
| HY-155540 | SARS-CoV-2 3CLpro-IN-14 | 2945139-50-2 | Reference compound |
| HY-155541 | Antitumor agent-110 | 2563879-93-4 | Reference compound |
| HY-155542 | RORγ antagonist 1 | 3049676-15-2 | Reference compound |
| HY-155543 | Anticancer agent 135 | 2957914-60-0 | Reference compound |
| HY-155544 | Antitumor agent-111 | Reference compound | |
| HY-155545 | Antifungal agent 60 | Reference compound | |
| HY-155546 | Antimicrobial agent-22 | 2373339-51-4 | Reference compound |
| HY-155547 | HBV-IN-34 | 2716906-45-3 | Reference compound |
| HY-155548 | RORγt inverse agonist 31 | Reference compound | |
| HY-155549 | Antileishmanial agent-20 | Reference compound | |
| HY-15555 | EPZ005687 | 1396772-26-1 | Reference compound |
| HY-155550 | CSF1R-IN-17 | Reference compound | |
| HY-155551 | Anti-inflammatory agent 46 | 2925586-96-3 | Reference compound |
| HY-155552 | GSPT1 degrader-1 | Reference compound | |
| HY-155553 | GPR119 agonist 2 | 1384951-03-4 | Reference compound |
| HY-155554 | SCAL-255 | 2798953-61-2 | Reference compound |
| HY-155555 | SCAL-266 | 2798953-78-1 | Reference compound |
| HY-155556 | ZG36 | 2999673-34-4 | Reference compound |
| HY-155557 | Anti-inflammatory agent 45 | Reference compound | |
| HY-155558 | MptpB-IN-2 | 3028076-11-8 | Reference compound |
| HY-15556 | GSK269962A | 850664-21-0 | Reference compound |
| HY-155560 | Pomalidomide-C7-NH2 | 2093387-55-2 | Reference compound |
| HY-155568 | Anti-inflammatory agent 47 | 2925288-12-4 | Reference compound |
| HY-155569 | Chitin synthase inhibitor 13 | 2925228-79-9 | Reference compound |
| HY-15556A | GSK269962A (hydrochloride) | 2095432-71-4 | Reference compound |
| HY-15557 | AZ20 | 1233339-22-4 | Reference compound |
| HY-155570 | Anticancer agent 137 | Reference compound | |
| HY-155571 | MDM2/XIAP-IN-3 | 2925583-17-9 | Reference compound |
| HY-155572 | Nrf2 activator-8 | Reference compound | |
| HY-155574 | IRAK4-IN-27 | 2626988-86-9 | Reference compound |
| HY-155577 | MAO A/HSP90-IN-1 | 2927489-95-8 | Reference compound |
| HY-15558 | Hoechst 33258 | 23491-44-3 | Dye Reagents |
| HY-155580 | MAO A/HSP90-IN-2 | 2927489-99-2 | Reference compound |
| HY-155582 | BLK degrader 1 | 3049215-64-4 | Reference compound |
| HY-155583 | RNase L-IN-1 | Reference compound | |
| HY-155583A | RNase L-IN-1 (trihydrochloride) | Reference compound | |
| HY-155587 | Hydroxy-PP | 833481-60-0 | Reference compound |
| HY-15558A | Hoechst 33258 (trihydrochloride) | 23491-45-4 | Dye Reagents |
| HY-15559 | Hoechst 33342 | 23491-52-3 | Dye Reagents |
| HY-155593 | JNK-1-IN-2 | Reference compound | |
| HY-155594 | LT-540-717 | 2143089-35-2 | Reference compound |
| HY-155595 | SNM1A-IN-1 | Reference compound | |
| HY-155596 | h-NTPDase-IN-1 | Reference compound | |
| HY-155597 | h-NTPDase8-IN-1 | 716358-51-9 | Reference compound |
| HY-155599 | HIV-1 protease-IN-10 | 2982527-11-5 | Reference compound |
| HY-15559A | Hoechst 33342 (trihydrochloride) | 875756-97-1 | Dye Reagents |
| HY-15560 | Hoechst 34580 | 23555-00-2 | Dye Reagents |
| HY-155600 | 5′-Guanylyl methylenediphosphonate (sodium) | 10470-57-2 | Reference compound |
| HY-155601 | SARS-CoV-2-IN-52 | 1001242-49-4 | Reference compound |
| HY-155602 | CDK2-IN-18 | 364735-73-9 | Reference compound |
| HY-155609 | VEGFR-2-IN-31 | Reference compound | |
| HY-15560A | Hoechst 34580 (trihydrochloride) | 911004-45-0 | Biochemical Assay Reagents |
| HY-15560B | Hoechst 34580 (tetrahydrochloride) | 2310135-08-9 | Dye Reagents |
| HY-15561 | HOE-S 785026 | 132869-83-1 | Dye Reagents |
| HY-155610 | VEGFR-2-IN-32 | Reference compound | |
| HY-155611 | Cathepsin C-IN-6 | Reference compound | |
| HY-155612 | M826 | 321437-16-5 | Reference compound |
| HY-155612A | (Rac)-M826 | 2649883-37-2 | Reference compound |
| HY-155613 | M867 | 680999-39-7 | Reference compound |
| HY-155614 | KSK68 | 2566715-91-9 | Reference compound |
| HY-155615 | KSK67 | 2566715-93-1 | Reference compound |
| HY-155616 | KSK94 | 2566716-07-0 | Reference compound |
| HY-155619 | Protein kinase inhibitor 7 | 84478-11-5 | Reference compound |
| HY-15561B | HOE-S 785026 (trihydrochloride) | 2320308-12-9 | Dye Reagents |
| HY-15562 | HOE 32021 | 23623-06-5 | Dye Reagents |
| HY-155620 | PD10 | Reference compound | |
| HY-155621 | PD24 | Reference compound | |
| HY-155622 | PD25 | Reference compound | |
| HY-155628 | AMPA receptor modulator-6 | 516491-33-1 | Reference compound |
| HY-15563 | HOE 33187 | 23623-08-7 | Dye Reagents |
| HY-155635 | Nav1.8-IN-4 | 1620846-16-3 | Reference compound |
| HY-155639 | Tyramide alkyne | 2230051-33-7 | Reference compound |
| HY-15564 | AR 231453 | 733750-99-7 | Reference compound |
| HY-155640 | 5-FAM maleimide | 787632-00-2 | Dye Reagents |
| HY-155642 | PU-48 | 335394-78-0 | Reference compound |
| HY-155643 | PROTAC TG2 degrader-1 | 3033465-55-0 | Reference compound |
| HY-155644 | ROS inducer 1 | 2921602-31-3 | Reference compound |
| HY-155645 | Topoisomerase II inhibitor 15 | 451516-79-3 | Reference compound |
| HY-155646 | Anti-inflammatory agent 48 | Reference compound | |
| HY-155647 | Microtubule stabilizing agent-1 | Reference compound | |
| HY-155648 | Tuberculosis inhibitor 6 | 121041-08-5 | Reference compound |
| HY-155649 | Tuberculosis inhibitor 7 | 121041-20-1 | Reference compound |
| HY-15565 | APD668 | 832714-46-2 | Reference compound |
| HY-155650 | Tuberculosis inhibitor 8 | 141353-07-3 | Reference compound |
| HY-155651 | Tuberculosis inhibitor 9 | Reference compound | |
| HY-155652 | ABCG2-IN-1 | 2559759-40-7 | Reference compound |
| HY-155653 | ABCG2-IN-2 | 2559759-59-8 | Reference compound |
| HY-155654 | SARS-CoV-2 Mpro-IN-10 | 2982834-87-5 | Reference compound |
| HY-155655 | JC-229 | 3026716-22-0 | Reference compound |
| HY-155656 | Anti-inflammatory agent 49 | 851471-44-8 | Reference compound |
| HY-155657 | BT424 | 2755180-37-9 | Reference compound |
| HY-155658 | Antifungal agent 62 | Reference compound | |
| HY-155659 | 4A7C-301 | Reference compound | |
| HY-15566 | APD597 | 897732-93-3 | Reference compound |
| HY-155660 | Antifungal agent 63 | Reference compound | |
| HY-155661 | ROS inducer 2 | 2921602-19-7 | Reference compound |
| HY-155662 | ROS inducer 3 | 2921602-09-5 | Reference compound |
| HY-155663 | GPX4-IN-5 | 2922824-09-5 | Reference compound |
| HY-155664 | GPX4-IN-6 | 2922824-07-3 | Reference compound |
| HY-155666 | YXG-158 | 2952994-34-0 | Reference compound |
| HY-155667 | Z-Nle-Lys-Arg-AMC | 1135364-14-5 | Dye Reagents |
| HY-155667A | Z-Nle-Lys-Arg-AMC (acetate) | Reference compound | |
| HY-155668 | HMG-CoA Reductase-IN-1 | Reference compound | |
| HY-155669 | Antifungal agent 64 | Reference compound | |
| HY-155670 | Antifungal agent 65 | 1223550-31-9 | Reference compound |
| HY-155671 | HDAC6-IN-18 | Reference compound | |
| HY-155672 | JPC0323 | 5972-45-2 | Reference compound |
| HY-155673 | SLU-PP-332 | 303760-60-3 | Reference compound |
| HY-155675 | TPPC | Reference compound | |
| HY-155676 | eIF4E-IN-5 | Reference compound | |
| HY-155679 | SARS-CoV-2 nsp14-IN-4 | Reference compound | |
| HY-15568 | A-317491 | 475205-49-3 | Reference compound |
| HY-155680 | BET BD2-IN-1 | 2677039-24-4 | Reference compound |
| HY-155681 | SWS1 | 2922115-32-8 | Reference compound |
| HY-155682 | Antibacterial agent 150 | Reference compound | |
| HY-155684 | SA-PA | Reference compound | |
| HY-155685 | SA-VA | Reference compound | |
| HY-155686 | Tubulin polymerization-IN-44 | Reference compound | |
| HY-155687 | PDE5-IN-10 | Reference compound | |
| HY-155688 | Antimalarial agent 29 | 2821078-81-1 | Reference compound |
| HY-155689 | Antimalarial agent 30 | 1597425-64-3 | Reference compound |
| HY-15568A | A-317491 (sodium salt hydrate) | Reference compound | |
| HY-15569 | NU6102 | 444722-95-6 | Reference compound |
| HY-155690 | HIV-1 protease-IN-11 | 2925287-54-1 | Reference compound |
| HY-155691 | HIV-1 protease-IN-12 | 2925287-59-6 | Reference compound |
| HY-155692 | PDE4-IN-13 | Reference compound | |
| HY-155693 | Topoisomerase II inhibitor 16 | 2403729-27-9 | Reference compound |
| HY-155694 | hCA/VEGFR-2-IN-1 | Reference compound | |
| HY-155695 | HDAC-IN-61 | Reference compound | |
| HY-155697 | SGC-UBD253 | Reference compound | |
| HY-155698 | Mz438 | Dye Reagents | |
| HY-155699 | J27644 | 3033032-03-7 | Reference compound |
| HY-155700 | SDH-IN-6 | 3010257-33-4 | Reference compound |
| HY-155702 | Antifungal agent 66 | 1613152-33-2 | Reference compound |
| HY-155703 | LW3 | 2803367-68-0 | Reference compound |
| HY-155704 | Lyciumamide A | 1647111-40-7 | Natural Products |
| HY-155705 | BMP agonist 1 | Reference compound | |
| HY-155706 | MOR agonist-2 | 2833692-02-5 | Reference compound |
| HY-155707 | MOR agonist-3 | Reference compound | |
| HY-155708 | AChE/BChE-IN-13 | Reference compound | |
| HY-155709 | Antifungal agent 67 | 2925307-52-2 | Reference compound |
| HY-155710 | Antifungal agent 68 | 2925307-53-3 | Reference compound |
| HY-155711 | Antifungal agent 69 | 2925307-56-6 | Reference compound |
| HY-155712 | Antifungal agent 70 | 2925307-57-7 | Reference compound |
| HY-155713 | AChE-IN-34 | Reference compound | |
| HY-155714 | AChE-IN-35 | Reference compound | |
| HY-155715 | G43 | 690693-02-8 | Reference compound |
| HY-155716 | G43-C3-TEG | 2702262-15-3 | Reference compound |
| HY-155717 | NDBM | 2958641-42-2 | Reference compound |
| HY-155718 | fac-[Re(CO)3(L6)(H2O)][NO3] | Reference compound | |
| HY-155719 | fac-[Re(CO)3(L3)(H2O)][NO3] | Reference compound | |
| HY-15571A | VCH-286 | 891824-47-8 | Reference compound |
| HY-155720 | Mtb-IN-4 | 2306039-13-2 | Reference compound |
| HY-155721 | 22-(4′-py)-JA | 1178895-15-2 | Natural Products |
| HY-155722 | Mtb-IN-5 | 2954888-39-0 | Reference compound |
| HY-155723 | Leucettinib-92 | 2732859-57-1 | Reference compound |
| HY-155725 | Z26395438 | 2803-63-6 | Reference compound |
| HY-155726 | Cy-FBP/SBPase-IN-1 | 444792-16-9 | Reference compound |
| HY-155727 | Sirt1/2-IN-2 | 670267-73-9 | Reference compound |
| HY-155728 | Sirt1/2-IN-3 | 301313-42-8 | Reference compound |
| HY-155729 | Sirt1/2-IN-4 | 2999646-13-6 | Reference compound |
| HY-15573 | EI1 | 1418308-27-6 | Reference compound |
| HY-155730 | PI3K-IN-41 | Reference compound | |
| HY-155731 | Antiviral agent 35 | 2760972-52-7 | Reference compound |
| HY-155732 | NPD-2975 | 3032452-65-3 | Reference compound |
| HY-155733 | AChE/Aβ-IN-1 | Reference compound | |
| HY-155734 | SARS-CoV-2-IN-55 | Reference compound | |
| HY-155735 | AChE/Aβ-IN-2 | Reference compound | |
| HY-155736 | MAPK-IN-2 | Reference compound | |
| HY-155737 | ET receptor antagonist 1 | Reference compound | |
| HY-155738 | ET receptor antagonist 2 | Reference compound | |
| HY-155739 | ET receptor antagonist 3 | Reference compound | |
| HY-15574 | Piboserod | 152811-62-6 | Reference compound |
| HY-155740 | PD-1/PD-L1-IN-32 | 2765535-21-3 | Reference compound |
| HY-155741 | CB2 PET Radioligand 1 | Reference compound | |
| HY-155742 | CFTR corrector 12 | 958941-60-1 | Reference compound |
| HY-155743A | ddUTP (lithium), 100mM in H2O | Biochemical Assay Reagents | |
| HY-155744 | Acetylene-PEG3-MMAF-OMe | 1411977-91-7 | Reference compound |
| HY-155745 | Antitumor agent-115 | 2759277-20-6 | Reference compound |
| HY-155746 | JAK2-IN-9 | 2568842-26-0 | Reference compound |
| HY-155747 | FDW028 | 2768426-49-7 | Reference compound |
| HY-155748 | Antitumor agent-116 | Reference compound | |
| HY-155749 | AChE-IN-36 | 2978753-66-9 | Reference compound |
| HY-15574A | Piboserod (hydrochloride) | 178273-87-5 | Reference compound |
| HY-15575 | VcMMAE | 646502-53-6 | ADC Related |
| HY-155750 | AChE-IN-37 | 2978753-64-7 | Reference compound |
| HY-155751 | HMGB1-IN-1 | Reference compound | |
| HY-155752 | 3′-O-Benzoyl-ATP | 288375-18-8 | Reference compound |
| HY-155753 | Anti-inflammatory agent 50 | Reference compound | |
| HY-155754 | 3′-Acetate-ATP | 90290-58-7 | Reference compound |
| HY-155755 | hCES2A-IN-1 | Reference compound | |
| HY-155756 | 3′-Acetate-UTP | 90290-74-7 | Reference compound |
| HY-155757 | 3′-Phenylcarbamate-UTP | 401619-08-7 | Reference compound |
| HY-155758 | hCA/VEGFR-2-IN-2 | 2971782-66-6 | Reference compound |
| HY-155759 | HMGB1-IN-2 | Reference compound | |
| HY-15575G | VcMMAE (GMP) | 646502-53-6 | GMP Small Molecules |
| HY-15575S | VcMMAE-d8 | Isotope-Labeled Compounds | |
| HY-155760 | hCA/VEGFR-2-IN-3 | 2971782-73-5 | Reference compound |
| HY-155761 | Antifungal agent 71 | Reference compound | |
| HY-155762 | Anti-neuroinflammation agent 1 | 2968412-77-1 | Reference compound |
| HY-155763 | hCA/VEGFR-2-IN-4 | 2971782-83-7 | Reference compound |
| HY-155764 | COX-1/2-IN-4 | 2967296-91-7 | Reference compound |
| HY-155765 | Anti-inflammatory agent 51 | 2911610-03-0 | Reference compound |
| HY-155766 | PARP1-IN-14 | 2098639-70-2 | Reference compound |
| HY-155768 | COX-1/2-IN-5 | Reference compound | |
| HY-155769 | Antimicrobial agent-24 | Reference compound | |
| HY-15577 | GSK3787 | 188591-46-0 | Reference compound |
| HY-155770 | FLT3-IN-20 | Reference compound | |
| HY-155771 | 1-DCP | 2964462-17-5 | Reference compound |
| HY-155772 | LUF7690 | 2941609-83-0 | Dye Reagents |
| HY-155773 | VU534 | 923509-20-0 | Reference compound |
| HY-155774 | VU533 | 923417-09-8 | Reference compound |
| HY-15578 | McMMAF | 863971-19-1 | ADC Related |
| HY-155780 | Anti-inflammatory agent 52 | Reference compound | |
| HY-155781 | Anti-inflammatory agent 53 | Reference compound | |
| HY-155782 | Zharp2-1 | 2772600-18-5 | Reference compound |
| HY-155784 | SPC-180002 | 2170274-53-8 | Reference compound |
| HY-155785 | MTP | 2377372-62-6 | Reference compound |
| HY-155786 | 3,7-DMF | 20950-52-1 | Reference compound |
| HY-155787 | SHR5428 | Reference compound | |
| HY-155788 | DSPE-PEG-DBCO (ammonium) | 2052955-83-4 | Reference compound |
| HY-155789 | C17 Globotriaosylceramide (d18:1/17:0) | 536745-81-0 | Reference compound |
| HY-15578G | McMMAF (GMP) | 863971-19-1 | GMP Small Molecules |
| HY-15579 | MMAF | 745017-94-1 | ADC Related |
| HY-155792 | Troglitazone glucuronide | 127040-01-1 | Reference compound |
| HY-15579A | MMAF (hydrochloride) | 1415246-68-2 | ADC Related |
| HY-15579AS | MMAF-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-15579B | MMAF (sodium) | 1799706-65-2 | ADC Related |
| HY-15579BG | MMAF (sodium) (GMP) | 1799706-65-2 | GMP Small Molecules |
| HY-15579G | MMAF (GMP) | 745017-94-1 | GMP Small Molecules |
| HY-15580 | Dolastatin 10 | 110417-88-4 | Natural Products |
| HY-155801 | CRX 527 | 216014-14-1 | Reference compound |
| HY-155804 | RIP1 kinase inhibitor 8 | 2226735-54-0 | Reference compound |
| HY-155805 | CAF-382 | Reference compound | |
| HY-155806 | h-NTPDase-IN-2 | 2939933-03-4 | Reference compound |
| HY-155807 | DPP | 2668267-47-6 | Reference compound |
| HY-155808 | STAT3-IN-18 | 2668267-41-0 | Reference compound |
| HY-155809 | BET-IN-17 | Reference compound | |
| HY-15581 | MMAD | 203849-91-6 | ADC Related |
| HY-155810 | DQP-26 | 1449373-99-2 | Reference compound |
| HY-155811 | DQP-997-74 | 2377187-09-0 | Reference compound |
| HY-155812 | Tyrosine kinase-IN-6 | 2377507-01-0 | Reference compound |
| HY-155813 | MPI60 | 3032440-80-2 | Reference compound |
| HY-155814 | EML734 | 3031795-11-3 | Reference compound |
| HY-155815 | MS9715 | Reference compound | |
| HY-155816 | PROTAC NSD3 degrader-1 | Reference compound | |
| HY-155817 | UNC7096 | Reference compound | |
| HY-155818 | NSD2-IN-4 | 3035028-80-6 | Reference compound |
| HY-155819 | M3/PDE4 modulator-1 | Reference compound | |
| HY-15581S | MMAD-d8 | Isotope-Labeled Compounds | |
| HY-15582 | Auristatin E | 160800-57-7 | ADC Related |
| HY-155820 | Anti-inflammatory agent 54 | 2924156-46-5 | Reference compound |
| HY-155821 | Anti-inflammatory agent 55 | 2924156-51-2 | Reference compound |
| HY-155822 | TZ3O | Reference compound | |
| HY-155823 | TZ4M | Reference compound | |
| HY-155827 | h-NTPDase-IN-3 | 2939933-10-3 | Reference compound |
| HY-155828 | h-NTPDase-IN-4 | 2939933-09-0 | Reference compound |
| HY-155829 | h-NTPDase-IN-5 | 2939932-93-9 | Reference compound |
| HY-15582G | Auristatin E (GMP) | 160800-57-7 | GMP Small Molecules |
| HY-15583 | Auristatin F | 163768-50-1 | ADC Related |
| HY-155830 | PDE4-IN-14 | 2231329-25-0 | Reference compound |
| HY-155831 | HCV-IN-43 | 1850311-28-2 | Reference compound |
| HY-155832 | HCV-IN-44 | 1850311-55-5 | Reference compound |
| HY-155833 | PI3Kδ-IN-13 | 1686137-02-9 | Reference compound |
| HY-155834 | DprE1-IN-8 | 2679830-77-2 | Reference compound |
| HY-155836 | hPL-IN-1 | 2387374-26-5 | Reference compound |
| HY-155837 | hPL-IN-2 | 24900-61-6 | Reference compound |
| HY-15583S | Auristatin F-d8 | Isotope-Labeled Compounds | |
| HY-15584 | Taltobulin | 228266-40-8 | ADC Related |
| HY-155840 | KH16 | 3059680-59-7 | Reference compound |
| HY-155841 | Tubulin polymerization-IN-46 | Reference compound | |
| HY-155842S | 4-Hydroxy AtorvastatinAtorvastatin-d5 (hemicalcium) | Isotope-Labeled Compounds | |
| HY-155843 | CDK9-IN-25 | Reference compound | |
| HY-155844 | CDK9-IN-26 | Reference compound | |
| HY-155845 | Antileishmanial agent-21 | Reference compound | |
| HY-155846 | Antileishmanial agent-22 | Reference compound | |
| HY-155847 | LYP-IN-3 | Reference compound | |
| HY-155848 | LYP-IN-4 | Reference compound | |
| HY-155849 | PKM2-IN-4 | 2996165-24-1 | Reference compound |
| HY-15584A | Taltobulin (trifluoroacetate) | 228266-41-9 | ADC Related |
| HY-15584B | Taltobulin (hydrochloride) | ADC Related | |
| HY-15584C | (R)-Taltobulin | 228266-44-2 | Reference compound |
| HY-155850 | CIAC001 | 2649154-82-3 | Reference compound |
| HY-155851 | Lepadin E | 444914-19-6 | Natural Products |
| HY-155852 | Lepadin H | 412328-25-7 | Natural Products |
| HY-15586 | L67 | 325970-71-6 | Reference compound |
| HY-155863 | AJ2-71 | 2700323-17-5 | Reference compound |
| HY-155864 | AJ2-30 | 2700322-79-6 | Reference compound |
| HY-155868 | 5-Azacytidine 5′-triphosphate | 2226-74-6 | Oligonucleotides |
| HY-155868A | 5-Azacytidine 5′-triphosphate (sodium) | Reference compound | |
| HY-155869 | 5-fluoro-dCTP | 79671-09-3 | Reference compound |
| HY-155869A | 5-fluoro-dCTP (sodium) | Reference compound | |
| HY-15587 | L82 | 329227-30-7 | Reference compound |
| HY-155870 | DL-01 | 2821770-49-2 | ADC Related |
| HY-155870A | DL-01 (formic) | 2964513-44-6 | ADC Related |
| HY-155870B | DL-01 (TFA) | ADC Related | |
| HY-155874 | ZNL-05-044 | Reference compound | |
| HY-155876 | NVP-DFV890 | 2271394-34-2 | Reference compound |
| HY-155878 | 5-Fluoro-2′-deoxy-UTP | 2710-64-7 | Oligonucleotides |
| HY-155878A | 5-Fluoro-2′-deoxy-UTP (sodium) | 1630828-71-5 | Reference compound |
| HY-155879 | (±)-N-Methylcoclaurine | 1472-62-4 | Reference compound |
| HY-15588 | L189 | 64232-83-3 | Reference compound |
| HY-155880 | mPEG-amine (MW 350) | 80506-64-5 | Biochemical Assay Reagents |
| HY-155881 | mPEG-amine (MW 550) | 80506-64-5 | Biochemical Assay Reagents |
| HY-155882 | mPEG-amine (MW 750) | 80506-64-5 | Biochemical Assay Reagents |
| HY-155883 | mPEG-amine (MW 3400) | 80506-64-5 | Biochemical Assay Reagents |
| HY-155884 | mPEG-amine (MW 4000) | 80506-64-5 | Biochemical Assay Reagents |
| HY-155887 | DSPE-PEG-Amine, MW 3400 (ammonium) | 474922-26-4 | Biochemical Assay Reagents |
| HY-155888 | IV-255 | Reference compound | |
| HY-155889 | IV-275 | Reference compound | |
| HY-15589 | GW9508 | 885101-89-3 | Reference compound |
| HY-155890 | Fimepinostat (mesylate) | 1401998-36-4 | Reference compound |
| HY-15590 | AZ-23 | 915720-21-7 | Reference compound |
| HY-155901 | Mal-NH-PEG-NH2 (TFA) (MW 2000) | Biochemical Assay Reagents | |
| HY-155902 | Mal-PEG-OH (MW 5000) | 88504-24-9 | Biochemical Assay Reagents |
| HY-155902A | Mal-PEG-OH (MW 2000) | 88504-24-9 | Biochemical Assay Reagents |
| HY-155902B | Mal-PEG-OH (MW 1000) | 88504-24-9 | Biochemical Assay Reagents |
| HY-155907 | DSPE-PEG-Amine, MW 5000 (ammonium) | 474922-26-4 | Biochemical Assay Reagents |
| HY-155908 | DSPE-PEG-Amine, MW 10000 (ammonium) | 474922-26-4 | Biochemical Assay Reagents |
| HY-155909 | m-PEG-NHS ester (MW 3400) | 92451-01-9 | Biochemical Assay Reagents |
| HY-155909A | m-PEG-NHS ester (MW 1000) | 92451-01-9 | Biochemical Assay Reagents |
| HY-155909B | m-PEG-NHS ester (MW 550) | 92451-01-9 | Biochemical Assay Reagents |
| HY-155909C | m-PEG-NHS ester (MW 350) | 92451-01-9 | Biochemical Assay Reagents |
| HY-15591 | TMC647055 | 1204416-97-6 | Reference compound |
| HY-155912S | 2-Allyl-3-methylpyrazine-d3 | 1335436-12-8 | Isotope-Labeled Compounds |
| HY-155915 | mPEG-CHO (MW 350) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155916 | mPEG-CHO (MW 550) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155917 | mPEG-CHO (MW 750) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155918 | mPEG-CHO (MW 1000) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155919 | mPEG-CHO (MW 2000) | 70086-22-9 | Biochemical Assay Reagents |
| HY-15591A | TMC647055 (Choline salt) | Reference compound | |
| HY-15592 | Cabotegravir | 1051375-10-0 | Reference compound |
| HY-155920 | mPEG-CHO (MW 3400) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155921 | mPEG-CHO (MW 5000) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155922 | mPEG-CHO (MW 10000) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155923 | mPEG-CHO (MW 20000) | 70086-22-5 | Biochemical Assay Reagents |
| HY-155924 | DMPE-PEG350 | 474922-82-2 | Biochemical Assay Reagents |
| HY-155925 | DMPE-PEG550 | 474922-82-2 | Biochemical Assay Reagents |
| HY-155926 | DMPE-PEG750 | 474922-82-2 | Biochemical Assay Reagents |
| HY-155927 | DMPE-PEG1000 | 474922-82-2 | Biochemical Assay Reagents |
| HY-155928 | DMPE-PEG3000 | 474922-82-2 | Biochemical Assay Reagents |
| HY-155929 | DMPE-PEG5000 | 474922-82-2 | Biochemical Assay Reagents |
| HY-15592A | Cabotegravir (sodium) | 1051375-13-3 | Reference compound |
| HY-15592AS | Cabotegravir-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-15592R | Cabotegravir (Standard) | 1051375-10-0 | Reference Standards |
| HY-15592S1 | Cabotegravir-d5 | 2750534-77-9 | Isotope-Labeled Compounds |
| HY-15592S2 | Cabotegravir-d3-1 | Isotope-Labeled Compounds | |
| HY-15593 | Pinometostat | 1380288-87-8 | Reference compound |
| HY-155930 | 18:1 PEG350 PE | 474922-90-2 | Biochemical Assay Reagents |
| HY-155931 | 18:1 PEG550 PE | 474922-90-2 | Biochemical Assay Reagents |
| HY-155932 | 18:1 PEG1000 PE | 474922-90-2 | Biochemical Assay Reagents |
| HY-155933 | 18:1 PEG3000 PE | 474922-90-2 | Biochemical Assay Reagents |
| HY-155934 | 18:1 PEG5000 PE | 474922-90-2 | Biochemical Assay Reagents |
| HY-155935 | N-[2-[(1-Oxohexadecyl)amino]ethyl]octadecanamide | 5136-44-7 | Reference compound |
| HY-155938 | Cyano-myracrylamide | 2801702-34-9 | Reference compound |
| HY-155939 | M4K2163 (dihydrochloride) | 2863635-04-3 | Reference compound |
| HY-15594 | Phen-DC3 | 942936-75-6 | Reference compound |
| HY-155941 | 5-Hydroxydecanoic acid | 624-00-0 | Reference compound |
| HY-155942 | B-Raf IN 19 | 708218-62-6 | Reference compound |
| HY-155943 | AMPK-IN-4 | 873077-70-4 | Reference compound |
| HY-155944 | Isbufylline | 90162-60-0 | Reference compound |
| HY-155945 | Firefly luciferase-IN-1 | 2765796-41-4 | Reference compound |
| HY-155948 | Uricosuric agent-1 | 91627-33-7 | Reference compound |
| HY-15594A | Phen-DC3 Trifluoromethanesulfonate | 929895-45-4 | Reference compound |
| HY-15595 | 360A | 794458-56-3 | Reference compound |
| HY-155950 | TH9619 | 2379556-22-4 | Reference compound |
| HY-155951 | JAK3-IN-14 | 454234-24-3 | Reference compound |
| HY-155952 | LOC1886 | 951948-38-2 | Reference compound |
| HY-155953 | 6-epi-COTC | 959150-61-9 | Reference compound |
| HY-155954 | UCM-1336 | 1621535-90-7 | Reference compound |
| HY-155956 | GM-90257 | 315703-81-2 | Reference compound |
| HY-155958 | Casein kinase 1δ-IN-9 | 854355-54-7 | Reference compound |
| HY-155959 | PD-1/PD-L1-IN-33 | 2975602-78-7 | Reference compound |
| HY-15595A | 360A (iodide) | 737763-37-0 | Reference compound |
| HY-155960 | SH491 | 2975285-28-8 | Reference compound |
| HY-155961 | Antidiabetic agent 2 | Reference compound | |
| HY-155962 | Tubulin polymerization-IN-47 | 2834087-62-4 | Reference compound |
| HY-155963 | Tubulin polymerization-IN-48 | 2982893-22-9 | Reference compound |
| HY-155964 | Anticancer agent 153 | 2982527-32-0 | Reference compound |
| HY-155965 | VEGFR/PARP-IN-1 | 3010256-54-6 | Reference compound |
| HY-155966 | CDK2-IN-19 | Reference compound | |
| HY-155967 | CB1R/AMPK modulator 1 | 2711012-08-5 | Reference compound |
| HY-155968 | HBV-IN-40 | Reference compound | |
| HY-155969 | EGFR-IN-83 | Reference compound | |
| HY-15597 | Salinomycin | 53003-10-4 | Reference compound |
| HY-155970 | Urease-IN-7 | 1129406-54-7 | Reference compound |
| HY-155971 | VISTA-IN-2 | 2614183-36-5 | Reference compound |
| HY-155972 | CRM1-IN-1 | Reference compound | |
| HY-155972A | CRM1-IN-2 | Reference compound | |
| HY-155973 | Urease-IN-8 | 517906-16-0 | Reference compound |
| HY-155974 | MeOIstPyrd | 2308548-54-9 | Reference compound |
| HY-155975 | PI3Kδ-IN-14 | Reference compound | |
| HY-155977 | Anti-osteoporosis agent-5 | 444908-22-9 | Reference compound |
| HY-155978 | RDN2150 | 2839429-51-3 | Reference compound |
| HY-155978A | RDN2150 (TFA) | Reference compound | |
| HY-155979 | SARS-CoV-2 3CLpro-IN-16 | 352659-40-6 | Reference compound |
| HY-15597R | Salinomycin (Standard) | 53003-10-4 | Reference Standards |
| HY-155980 | SARS-CoV-2 3CLpro-IN-17 | 3032604-33-1 | Reference compound |
| HY-155981 | SARS-CoV-2 3CLpro-IN-18 | 3032604-29-5 | Reference compound |
| HY-155982 | STAT3-IN-20 | 2768427-54-7 | Reference compound |
| HY-155983 | E07 aptamer | Reference compound | |
| HY-155985 | Anti-osteoporosis agent-6 | 445231-36-7 | Reference compound |
| HY-155987 | CK2-IN-8 | 442571-27-9 | Reference compound |
| HY-155988 | Sirtuin modulator 6 | 476633-98-4 | Reference compound |
| HY-155989 | GSK3-IN-4 | 748145-19-9 | Reference compound |
| HY-15598S | 20-HETE-d6 | 2548939-89-3 | Isotope-Labeled Compounds |
| HY-15599 | SSR128129E | 848318-25-2 | Reference compound |
| HY-155991 | RUNX-IN-2 | 2893777-88-1 | Reference compound |
| HY-155992 | WLB-89462 | 2849471-75-4 | Reference compound |
| HY-155993 | YCH1899 | 3032451-66-1 | Reference compound |
| HY-155994 | PIK5-12d | Reference compound | |
| HY-155995 | PRO-905 | 2762209-68-5 | Reference compound |
| HY-155996 | FD2157 | Reference compound | |
| HY-155997 | Anti-inflammatory agent 56 | 2413127-32-7 | Reference compound |
| HY-155998 | NF-κB-IN-11 | 2768833-35-6 | Reference compound |
| HY-155999 | MoTPS1-IN-1 | 2991072-02-5 | Reference compound |
| HY-15599A | SSR128129E (free acid) | 848463-13-8 | Reference compound |
| HY-15600 | UPF-648 | 213400-34-1 | Reference compound |
| HY-156001 | DUB-IN-7 | 2894064-79-8 | Reference compound |
| HY-156002 | LUNA18 | 2676177-63-0 | Reference compound |
| HY-156003 | HDAC-IN-64 | Reference compound | |
| HY-156004 | Ziapin 2 | 2399497-60-8 | Reference compound |
| HY-156005 | Antibacterial agent 153 | Reference compound | |
| HY-156007 | SARS-CoV-2 3CLpro-IN-21 | Reference compound | |
| HY-156008 | SARS-CoV-2-IN-58 | Reference compound | |
| HY-156009 | CDFI | 1199797-92-6 | Reference compound |
| HY-15600B | UPF-648 (sodium salt) | 1465017-87-1 | Reference compound |
| HY-15601 | Vesatolimod | 1228585-88-3 | Reference compound |
| HY-156010 | PPARγ-IN-2 | 2682078-97-1 | Reference compound |
| HY-156011 | PSEN1-IN-1 | Reference compound | |
| HY-156012 | PSEN1-IN-2 | Reference compound | |
| HY-156013 | CA inhibitor 2 | Reference compound | |
| HY-156014 | qsl-304 | Reference compound | |
| HY-156016 | HDAC/CD13-IN-1 | Reference compound | |
| HY-156017 | 5-HT6R antagonist 1 | Reference compound | |
| HY-156018 | PI3Kα-IN-13 | 2955529-67-4 | Reference compound |
| HY-156019 | FGFR1 inhibitor-10 | 2426769-76-6 | Reference compound |
| HY-15602 | Ledipasvir | 1256388-51-8 | Reference compound |
| HY-156020 | Glucocerebrosidase-IN-2 | 851185-20-1 | Reference compound |
| HY-156021 | Antitubercular agent-40 | 900314-03-6 | Reference compound |
| HY-156022 | Antitubercular agent-41 | 901032-23-3 | Reference compound |
| HY-156023 | Sirtuin modulator 7 | 863589-52-0 | Reference compound |
| HY-156024 | TEAD-IN-6 | 2821763-12-4 | Reference compound |
| HY-156025 | HCAR2 agonist 1 | 1066676-21-8 | Reference compound |
| HY-156026 | FAK-IN-11 | Reference compound | |
| HY-156027 | SIRT6-IN-3 | 3023471-40-8 | Reference compound |
| HY-156028 | FIKK9.1-IN-1 | 1448523-50-9 | Reference compound |
| HY-156029 | IA1-8H2 | 2755685-19-7 | Reference compound |
| HY-15602A | Ledipasvir (acetone) | 1441674-54-9 | Reference compound |
| HY-15602AS | Ledipasvir-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-15602B | Ledipasvir (D-tartrate) | 1502654-87-6 | Reference compound |
| HY-15602C | Ledipasvir (hydrochloride) | 2128695-48-5 | Reference compound |
| HY-15602D | Ledipasvir (diacetone) | 1502655-48-2 | Reference compound |
| HY-15602S | Ledipasvir-d6 | 2050041-12-6 | Isotope-Labeled Compounds |
| HY-15602S1 | Ledipasvir-d16 | Isotope-Labeled Compounds | |
| HY-15603 | TS-011 | 339071-18-0 | Reference compound |
| HY-156030 | AChE-IN-40 | Reference compound | |
| HY-156031 | BChE-IN-19 | Reference compound | |
| HY-156032 | PIMPC | 2250244-44-9 | Reference compound |
| HY-156033 | EGFR-IN-88 | 2944452-34-8 | Reference compound |
| HY-156034 | JT001 | 2238819-65-1 | Reference compound |
| HY-156034A | JT001 (sodium) | 2238820-09-0 | Reference compound |
| HY-156035 | Bz-DTPA | 102650-30-6 | Reference compound |
| HY-156038 | (S)-p-SCN-Bn-DOTA | 1020407-41-3 | Biochemical Assay Reagents |
| HY-15604 | AZD1208 | 1204144-28-4 | Reference compound |
| HY-156040 | Casein kinase 1δ-IN-10 | 332074-85-8 | Reference compound |
| HY-156041 | Lysophosphatidylethanolamines, egg | 97281-40-8 | Natural Products |
| HY-156045 | Cross-linked dextran G 15 | 11081-40-6 | Biochemical Assay Reagents |
| HY-156045A | Cross-linked dextran G 10 | 9050-68-4 | Biochemical Assay Reagents |
| HY-156045B | Cross-linked dextran G 150 | 12774-36-6 | Biochemical Assay Reagents |
| HY-156045C | Cross-linked dextran G 200 | 9041-36-5 | Biochemical Assay Reagents |
| HY-156048 | Trifluoromethyl-tubercidin | 1854086-05-7 | Reference compound |
| HY-15604A | AZD1208 (hydrochloride) | 1621866-96-3 | Reference compound |
| HY-15605 | Encorafenib | 1269440-17-6 | Reference compound |
| HY-156051 | Tetrazolast | 95104-27-1 | Reference compound |
| HY-156054 | N-Hydroxy riluzole | 179070-90-7 | Reference compound |
| HY-15605R | Encorafenib (Standard) | 1269440-17-6 | Reference Standards |
| HY-15605S | Encorafenib-13C,d3 | Isotope-Labeled Compounds | |
| HY-15606 | Tanaproget | 304853-42-7 | Reference compound |
| HY-156060 | NCI126224 | 65974-52-9 | Reference compound |
| HY-156061 | NAP-1 | 131721-28-3 | Reference compound |
| HY-156063 | (2R,4R)-UCB7362 | 2610631-17-7 | Reference compound |
| HY-156063A | (2R,4R)-UCB7362 (hydrochloride) | 2610631-18-8 | Reference compound |
| HY-156065 | S217879 | 2700303-28-0 | Reference compound |
| HY-156066 | Ferrostatin-1 diyne | 2226204-90-4 | Reference compound |
| HY-156069 | Methylspinazarin | 41768-12-1 | Reference compound |
| HY-15607 | WEHI-539 | 1431866-33-9 | Reference compound |
| HY-156074 | Erythromycin propionate | 134-36-1 | Reference compound |
| HY-156077 | anti-TNBC agent-2 | 2422001-22-5 | Reference compound |
| HY-156078 | α-Glucosidase-IN-32 | Reference compound | |
| HY-156079 | Antidepressant agent 5 | 1071049-42-7 | Reference compound |
| HY-15607A | WEHI-539 hydrochloride | 2070018-33-4 | Reference compound |
| HY-15608 | MPTP (hydrochloride) | 23007-85-4 | Reference compound |
| HY-156080 | PI3K-IN-48 | Reference compound | |
| HY-156081 | Nrf2 activator-9 | Reference compound | |
| HY-156082 | RyRs activator 3 | 2850333-35-4 | Reference compound |
| HY-156083 | CDK9-IN-28 | 3020773-81-0 | Reference compound |
| HY-156084 | LL-K9-3 | 2809353-52-2 | Reference compound |
| HY-156085 | LP23 | 3008239-25-3 | Reference compound |
| HY-156086 | TRK-IN-24 | 2937544-01-7 | Reference compound |
| HY-156087 | Cholicamideβ | Reference compound | |
| HY-156087G | Cholicamideβ (GMP) | GMP Small Molecules | |
| HY-156088 | SSE1806 | 3053861-26-7 | Reference compound |
| HY-156089 | Triptoquinone H | 268541-23-7 | Natural Products |
| HY-15608R | MPTP (hydrochloride) (Standard) | 23007-85-4 | Reference Standards |
| HY-15609 | AZD-3463 | 1356962-20-3 | Reference compound |
| HY-156090 | PK-10 | 3074451-41-2 | Reference compound |
| HY-156091 | PI3Kα/HDAC6-IN-1 | 3007565-26-3 | Reference compound |
| HY-156092 | Antitumor photosensitizer-4 | Reference compound | |
| HY-156093 | TPH1-IN-1 | 3040015-86-6 | Reference compound |
| HY-156094 | JMJD3/HDAC-IN-1 | 2883046-06-6 | ADC Related |
| HY-156095 | F7H | 897109-93-2 | Reference compound |
| HY-156096 | HDAC3-IN-2 | 3033039-28-7 | Reference compound |
| HY-156097 | Anticancer agent 158 | 2978685-72-0 | Reference compound |
| HY-156098 | c-Met-IN-19 | Reference compound | |
| HY-15610 | GDC-0623 | 1168091-68-6 | Reference compound |
| HY-156100 | C12-4 | 2639634-71-0 | Biochemical Assay Reagents |
| HY-156101 | Latanoprost amide | 919281-21-3 | Reference compound |
| HY-156102 | c-ABL-IN-5 | Reference compound | |
| HY-156103 | mHTT-IN-2 | 2743336-70-9 | Reference compound |
| HY-156104 | CaMKIIα-PHOTAC | 2481744-33-4 | Reference compound |
| HY-156105 | 8304-vs | Reference compound | |
| HY-156106 | VHL-IN-1 | 3033117-53-9 | Reference compound |
| HY-156107 | GPR55 agonist 3 | 3006105-44-5 | Reference compound |
| HY-156108 | 2-Chlorophenoxazine | 56821-03-5 | Reference compound |
| HY-156109 | PDK-IN-2 | 3032446-61-7 | Reference compound |
| HY-15611 | KPT-185 | 1333151-73-7 | Reference compound |
| HY-156110 | IGF2BP1-IN-1 | 3029447-08-0 | Reference compound |
| HY-156111 | ARD-1676 | 2632305-36-1 | Reference compound |
| HY-156112 | LM2I | 2055494-50-1 | Reference compound |
| HY-156113 | RET-IN-25 | 2965703-02-8 | Reference compound |
| HY-156114 | EGFR/CDK2-IN-2 | Reference compound | |
| HY-156115 | EGFR/CDK2-IN-3 | Reference compound | |
| HY-156116 | EGFR/CDK2-IN-4 | Reference compound | |
| HY-156117 | LB244 | Reference compound | |
| HY-156119 | MLKL-IN-6 | Reference compound | |
| HY-15612 | CDK4-IN-1 | 1256963-02-6 | Reference compound |
| HY-156120 | CD38 inhibitor 3 | 2857868-82-5 | Reference compound |
| HY-156121 | NLRP3-IN-20 | 2428478-22-0 | Reference compound |
| HY-156122 | DHFR-IN-8 | 3032441-09-8 | Reference compound |
| HY-156123 | DHFR-IN-9 | 3032441-13-4 | Reference compound |
| HY-156124 | Sigma-2 Radioligand 1 | 2860554-32-9 | Reference compound |
| HY-156125 | 14-3-3σ/ERα stabilizer-1 | Reference compound | |
| HY-156126 | Lentztrehalose C | 1808096-68-5 | Natural Products |
| HY-156128 | Imidafenacin Metabolite M4 | 503598-17-2 | Reference compound |
| HY-15613 | Maritoclax | 1227962-62-0 | Reference compound |
| HY-156130 | Menin-MLL inhibitor 29 | Reference compound | |
| HY-156131 | Loperamide | 53179-11-6 | Reference compound |
| HY-156133 | Dihydrospinosyn A aglycone | 727695-12-7 | Reference compound |
| HY-156135 | NSC194598 | 5358-76-9 | Reference compound |
| HY-156136 | 5-n-Heptyl-6-hydroxy-4,7-dioxobenzothiazole | 611207-02-4 | Reference compound |
| HY-156137 | UHDBT | 43152-58-5 | Reference compound |
| HY-156138A | CB-TE2A (tetrahydrochloride) | 1260798-95-5 | Biochemical Assay Reagents |
| HY-15614 | SC144 | 895158-95-9 | Reference compound |
| HY-156140 | Naa50-IN-1 | 2522920-65-4 | Reference compound |
| HY-156144 | p-Diazobenzoyl-biocytin (chloride) | 105319-12-8 | Biochemical Assay Reagents |
| HY-156145 | Biotin N-(bromoacetyl)hydrazide | 57170-18-0 | Biochemical Assay Reagents |
| HY-156146 | N-(4-Azido-2-nitrophenyl)-N''-biotinylnorspemidine | 786609-83-4 | Biochemical Assay Reagents |
| HY-156148 | BCR-ABL-IN-8 | 1808288-49-4 | Reference compound |
| HY-156149 | CYP51/PD-L1-IN-1 | 3032386-49-2 | Reference compound |
| HY-15614A | SC144 (hydrochloride) | 917497-70-2 | Reference compound |
| HY-15615 | TIC10 isomer | 41276-02-2 | Reference compound |
| HY-156150 | CYP51/PD-L1-IN-2 | 3032386-58-3 | Reference compound |
| HY-156151 | CYP51/PD-L1-IN-3 | 3032386-59-4 | Reference compound |
| HY-156152 | CARM1 degrader-1 | 3032785-00-2 | Reference compound |
| HY-156152A | CARM1 degrader-1 (hydrochloride) | Reference compound | |
| HY-156153 | CARM1 degrader-2 | 3032785-06-8 | Reference compound |
| HY-156157 | GPR55 agonist 4 | 3006105-55-8 | Reference compound |
| HY-156158 | IDH2R140Q-IN-2 | 2749568-16-7 | Reference compound |
| HY-156159 | Thalidomide-NH-C9-NH2 (hydrochloride) | 2305936-77-8 | Reference compound |
| HY-15616 | BMS-470539 | 457893-92-4 | Reference compound |
| HY-156160 | Thalidomide-NH-C10-NH2 (hydrochloride) | 2460022-53-9 | Reference compound |
| HY-156161 | Thalidomide-NH-C13-NH2 (hydrochloride) | Reference compound | |
| HY-156162 | Thalidomide-NH-C14-NH2 (hydrochloride) | Reference compound | |
| HY-156163 | Thalidomide-5-NH-PEG1-NH2 (hydrochloride) | 2863634-98-2 | Reference compound |
| HY-156164 | Thalidomide-5-NH-PEG2-NH2 (hydrochloride) | 2357110-58-6 | Reference compound |
| HY-156165 | Thalidomide-5-NH-PEG3-NH2 (hydrochloride) | 2863635-01-0 | Reference compound |
| HY-156166 | Thalidomide-5-NH-PEG4-NH4 (hydrochloride) | Reference compound | |
| HY-156167 | LRRK2-IN-10 | 2704562-80-9 | Reference compound |
| HY-156168 | M190S | 2578300-07-7 | Reference compound |
| HY-156169 | hCAIX/XII-IN-7 | Reference compound | |
| HY-15617 | JNK-IN-7 | 1408064-71-0 | Reference compound |
| HY-156170 | Thalidomide-5-NH-PEG5-NH2 (hydrochloride) | Reference compound | |
| HY-156171 | Thalidomide-5-NH-PEG6-NH2 (hydrochloride) | Reference compound | |
| HY-156172 | Thalidomide-NH-PEG6-NH2 (hydrochloride) | Reference compound | |
| HY-156174 | E104 | 1610431-21-4 | ADC Related |
| HY-156175 | TLR7 agonist 14 | 2832199-45-6 | Reference compound |
| HY-156176 | TLR7 agonist 15 | 2832199-53-6 | Reference compound |
| HY-156177 | TLR7 agonist 16 | 2832199-56-9 | Reference compound |
| HY-156179 | DDC 2′,3′-O-disulfate | Reference compound | |
| HY-15618 | MK-7622 | 1227923-29-6 | Reference compound |
| HY-156180 | DDC 3′-O-β-D glucuronide | Reference compound | |
| HY-156181 | hCAIX/XII-IN-8 | 59994-64-8 | Reference compound |
| HY-156182 | JNK-IN-14 | 2991432-56-3 | Reference compound |
| HY-156183 | Antiproliferative agent-37 | 2989275-31-0 | Reference compound |
| HY-156186 | Anticancer agent 160 | 2983122-03-6 | Natural Products |
| HY-156187 | Anticancer agent 161 | Reference compound | |
| HY-156188 | AChE-IN-41 | 3038811-77-4 | Reference compound |
| HY-156189 | CcpA-IN-1 | 2702277-62-9 | Reference compound |
| HY-15619 | Hoechst S 769121 | 74681-68-8 | Dye Reagents |
| HY-156190 | NR2F2-IN-1 | 1049691-47-5 | Reference compound |
| HY-156190A | NR2F2-IN-1 (free base) | 452087-38-6 | Reference compound |
| HY-156191 | Cholic acid anilide | 6912-96-5 | Reference compound |
| HY-156193 | PF-07208254 | 2573122-40-2 | Reference compound |
| HY-156194 | FLAP-IN-1 | 2041076-43-9 | Reference compound |
| HY-156195 | BHBM | 302807-84-7 | Reference compound |
| HY-156197 | Biotin-cholesterol | 2454045-15-7 | Oligonucleotides |
| HY-156198 | Bottromycin A2 | 15005-62-6 | Natural Products |
| HY-156199 | o-Cresol sulfate | 3233-56-5 | Natural Products |
| HY-15620 | Methylproamine | 188247-01-0 | Biochemical Assay Reagents |
| HY-156202 | Geranylgeranoic acid | 35750-48-2 | Reference compound |
| HY-156205 | CdnP-IN-1 | 691862-35-8 | Reference compound |
| HY-156206 | C24 Dihydro ceramide (d18:0/24:0) | 6063-36-1 | Natural Products |
| HY-156209 | Gb3(d18:1/16:0) | 137896-85-6 | Natural Products |
| HY-156209S | Gb3(d18:1/16:0)-d9 | 2738376-84-4 | Isotope-Labeled Compounds |
| HY-15621 | DMA | 188860-26-6 | Dye Reagents |
| HY-156214 | NICE-01 | 2982819-94-1 | Reference compound |
| HY-156215 | NCI-B16 | 802835-01-4 | Reference compound |
| HY-15621A | DMA (trihydrochloride) | 2095832-33-8 | Dye Reagents |
| HY-15622 | meta-iodoHoechst 33258 | 158013-42-4 | Dye Reagents |
| HY-156225 | MMAF-OtBu | 745017-95-2 | ADC Related |
| HY-156228 | RGB-1 | 930455-91-7 | Reference compound |
| HY-15623 | Hoechst 33258 analog | 258843-62-8 | Dye Reagents |
| HY-156237 | Beclin1-ATG14L interaction inhibitor 1 | 1243063-73-1 | Reference compound |
| HY-156239 | Dopamine D3 receptor ligand-5 | 2899250-94-1 | Reference compound |
| HY-15624 | Hoechst 33258 analog 2 | 23491-54-5 | Dye Reagents |
| HY-156241 | Meliadubin B | Natural Products | |
| HY-156242 | BQZ-485 | 1906915-49-8 | Reference compound |
| HY-156243 | GDI2-IN-1 | Reference compound | |
| HY-156244 | PROTAC GDI2 Degrader-1 | Reference compound | |
| HY-156246S | Desmethylrizatriptan-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-156247 | IVMT-Rx-3 | Reference compound | |
| HY-156248S | Spironolactone-d6 | Isotope-Labeled Compounds | |
| HY-156249 | NMS-P528 | 1466546-45-1 | ADC Related |
| HY-15625 | Hoechst 33258 analog 3 | 23554-98-5 | Dye Reagents |
| HY-156250S | 7α-Methylthiol spironolactone-d5 | Isotope-Labeled Compounds | |
| HY-156251 | Antifungal agent 74 | 2856379-97-8 | Reference compound |
| HY-156252 | Antifungal agent 75 | 3013580-23-6 | Reference compound |
| HY-156253 | Anticancer agent 166 | 6630-80-4 | Reference compound |
| HY-156254 | COX-2-IN-35 | Reference compound | |
| HY-156255 | MAO-B-IN-25 | 2097148-47-3 | Reference compound |
| HY-156256 | Insecticidal agent 4 | 2989908-99-6 | Reference compound |
| HY-156257 | UNC9512 | 3032393-24-8 | Reference compound |
| HY-156258 | HDAC6-IN-21 | 2920929-76-4 | Reference compound |
| HY-156259 | PF-07202954 | 2639372-47-5 | Reference compound |
| HY-15626 | ortho-iodoHoechst 33258 | 158013-41-3 | Dye Reagents |
| HY-156260S | Gamma-6Z-Dodecenolactone-d2 | 1082581-86-9 | Isotope-Labeled Compounds |
| HY-156261 | Beef extract | 68990-09-0 | Biochemical Assay Reagents |
| HY-156262 | DEPC-Treated Water | Biochemical Assay Reagents | |
| HY-156263 | LB Broth Base, powder | Biochemical Assay Reagents | |
| HY-156264 | Augpenin | 86482-18-0 | Biochemical Assay Reagents |
| HY-156266 | Rhizochalinin | 321541-13-3 | Reference compound |
| HY-156267 | PPO-IN-4 | Reference compound | |
| HY-156268S | 2-(2-Furanyl)-5-methylpyrazine-d3 | 1335402-07-7 | Isotope-Labeled Compounds |
| HY-156269S | 2-(2-Furanyl)-6-methylpyrazine-d3 | 1335402-08-8 | Isotope-Labeled Compounds |
| HY-15627 | Hoechst 33342 analog | 178481-68-0 | Dye Reagents |
| HY-156270 | SDH-IN-9 | Reference compound | |
| HY-156271 | Tubulin polymerization-IN-52 | 2108615-05-8 | Reference compound |
| HY-156272 | HBV-IN-41 | 1967002-25-0 | Reference compound |
| HY-156273 | HDAC/JAK/BRD4-IN-1 | 2755325-84-7 | Reference compound |
| HY-156274 | HDAC6-IN-23 | 2991427-09-7 | Reference compound |
| HY-156275 | OSBP-IN-1 | 2890760-43-5 | Reference compound |
| HY-156276 | SP4e | Reference compound | |
| HY-156277 | SP4f | Reference compound | |
| HY-156278 | FB49 | Reference compound | |
| HY-156279 | HDAC6-IN-22 | Reference compound | |
| HY-15627A | Hoechst 33342 analog trihydrochloride | 159277-19-7 | Dye Reagents |
| HY-15628 | Hoechst 33258 analog 5 | 23491-55-6 | Dye Reagents |
| HY-156280 | RARα antagonist 1 | Reference compound | |
| HY-156281 | Antifungal agent 76 | 1615683-57-2 | Reference compound |
| HY-156282 | Antibacterial agent 158 | 2804045-21-2 | Reference compound |
| HY-156283 | Antibacterial agent 159 | 2804044-53-7 | Reference compound |
| HY-156284 | EGFR-IN-89 | 2413029-40-8 | Reference compound |
| HY-156285 | ZZM-1220 | Reference compound | |
| HY-156286 | GPX4-IN-7 | Reference compound | |
| HY-156287 | GCase modulator-1 | 796079-91-9 | Reference compound |
| HY-156288 | Anti-Influenza agent 5 | Reference compound | |
| HY-156289 | Anti-MRSA agent 8 | 3118-36-3 | Reference compound |
| HY-15629 | HOE 32020 | 23554-99-6 | Dye Reagents |
| HY-156290 | SAP-04 | 3053678-30-8 | Reference compound |
| HY-156291 | XSJ2-46 | 2265911-12-2 | Reference compound |
| HY-156292 | IHMT-EZH2-426 | 3018914-66-1 | Reference compound |
| HY-156293 | FPR1 antagonist 1 | Reference compound | |
| HY-156294 | FPR1 antagonist 2 | Reference compound | |
| HY-156296 | CDK9-Cyclin T1 PPI-IN-1 | 2995336-58-6 | Reference compound |
| HY-156297 | β5i-IN-1 | Reference compound | |
| HY-156298 | PARP1-IN-16 | Reference compound | |
| HY-156299 | NMS-P945 | 1466546-35-9 | ADC Related |
| HY-15630 | Hoechst 33342 analog 2 | 106050-84-4 | Dye Reagents |
| HY-156300 | Me-Tet-PEG4-NH2 | 2055646-21-2 | ADC Related |
| HY-156301 | Methyltetrazine-amido-PEG8-amine (Trifluoroacetate) | 2143958-58-9 | Reference compound |
| HY-156301A | Me-Tet-PEG8-NH2 (hydrochloride) | ADC Related | |
| HY-156302 | Coumarin-PEG2-endoBCN | 2488174-18-9 | Dye Reagents |
| HY-156303 | Coumarin-PEG2-TCO | 2488174-19-0 | Dye Reagents |
| HY-156304 | Coumarin-C2-TCO | 2488174-16-7 | Dye Reagents |
| HY-156305 | Coumarin-C2-exo-BCN | 2488174-17-8 | Dye Reagents |
| HY-156306 | Coumarin-PEG3-TCO | 2488319-02-2 | Dye Reagents |
| HY-156307 | Me-Tet-PEG3-Maleimide | 2141976-31-8 | ADC Related |
| HY-156308 | Me-Tet-PEG4-Maleimide | 1715913-76-0 | ADC Related |
| HY-156309 | Coumarin-PEG8-tetrazine | Dye Reagents | |
| HY-15630A | Hoechst 33342 analog 2 (trihydrochloride) | 155815-98-8 | Dye Reagents |
| HY-15631 | Hoechst 33258 analog 6 | 129244-66-2 | Dye Reagents |
| HY-156310 | BCN-endo-PEG7-NH2 | 2143968-34-5 | ADC Related |
| HY-156311 | BCN-endo-PEG2-maleimide | 2675364-08-4 | ADC Related |
| HY-156312 | Me-Tet-PEG8-Maleimide | 2143968-05-0 | ADC Related |
| HY-156313 | Me-Tet-PEG4-NHS | 2143968-22-1 | ADC Related |
| HY-156314 | ASN 07115873 | 626220-97-1 | Reference compound |
| HY-156315 | SCO-PEG2-NH2 | 2141976-34-1 | ADC Related |
| HY-156315A | SCO-PEG2-NH2 (formate) | Reference compound | |
| HY-156316 | SCO-PEG3-NH2 | 2141976-29-4 | ADC Related |
| HY-156316A | SCO-PEG3-NH2 (formate) | Biochemical Assay Reagents | |
| HY-156317 | BCN-endo-PEG7-maleimide | ADC Related | |
| HY-156318 | SCO-PEG3-Maleimide | 2141976-35-2 | ADC Related |
| HY-156319 | BCN-exo-PEG2-NH2 | 1357379-13-5 | ADC Related |
| HY-15632 | para-iodoHoechst 33258 | 158013-43-5 | Dye Reagents |
| HY-156320 | BCN-exo-PEG2-maleimide | 2141976-22-7 | ADC Related |
| HY-156321 | SCO-PEG7-Maleimide | 2143968-81-2 | ADC Related |
| HY-156322 | BCN-exo-PEG3-maleimide | 2919127-00-5 | ADC Related |
| HY-156323 | BCN-exo-PEG4-NHS | ADC Related | |
| HY-156324 | BCN-exo-PEG8-NHS | ADC Related | |
| HY-156325 | SARS-CoV-2-IN-62 | 2350285-18-4 | Reference compound |
| HY-156326S | (3E,5E)-Octadien-2-one-13C2 | Isotope-Labeled Compounds | |
| HY-156326S1 | (3E,5Z)-Octadien-2-one-13C2 | Isotope-Labeled Compounds | |
| HY-156327S | 2-Hexylcinnamyl-alcohol-d5 | Isotope-Labeled Compounds | |
| HY-156328 | NSC 48160 | 6640-90-0 | Reference compound |
| HY-156329 | sEH/FLAP-IN-1 | Reference compound | |
| HY-156330 | HIV-IN-9 | Reference compound | |
| HY-156331 | VU6004909 | 1860797-76-7 | Reference compound |
| HY-156332 | TNKS-2-IN-2 | 2719726-91-5 | Reference compound |
| HY-156333S | S-(2-Furanylmethyl) methanethioate-d2 | Isotope-Labeled Compounds | |
| HY-156334 | FAK-IN-12 | Reference compound | |
| HY-156335 | VU0531245 | 1396749-92-0 | Reference compound |
| HY-156336 | PLK1-IN-7 | 2938910-96-2 | Reference compound |
| HY-156337 | SARS-CoV-2-IN-63 | 2350285-21-9 | Reference compound |
| HY-156338 | Laccase-IN-2 | Reference compound | |
| HY-156339 | GABA receptor Antagonist 1 | Reference compound | |
| HY-156340 | Anti-inflammatory agent 58 | 3032851-09-2 | Reference compound |
| HY-156341S1 | LLIYYTSSLHSGVPSR-(Arg-13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-156342 | Anti-inflammatory agent 59 | 3032851-11-6 | Reference compound |
| HY-156343S1 | SNNYATHYAESVK-(Lys-13C6,15N2) (TFA) | Isotope-Labeled Compounds | |
| HY-156344S1 | GLEWVAEIR-(Arg-13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-156345S1 | LPFTFGQGTK-(Lys-13C6,15N2) (TFA) | Isotope-Labeled Compounds | |
| HY-156346 | HCoV-OC43-IN-1 | 2809363-81-1 | Reference compound |
| HY-156347S | (2-Methyl-3-furanyl)-dithio-2-propanone-d3 | 1335401-41-6 | Isotope-Labeled Compounds |
| HY-156348 | MAO-B-IN-26 | 38470-71-2 | Reference compound |
| HY-156349 | Sec61-IN-4 | Reference compound | |
| HY-156350 | SGC-STK17B-1 | 2650530-00-8 | Reference compound |
| HY-156351S | cis-4-Nonenal-d2 | Isotope-Labeled Compounds | |
| HY-156352S | Ethyl (S)-2-hydroxy-3-methylbutyrate-d5 | Isotope-Labeled Compounds | |
| HY-156354 | GPR61 Inverse agonist 1 | Reference compound | |
| HY-156355 | Sec61-IN-5 | Reference compound | |
| HY-156356 | AChE-IN-42 | Reference compound | |
| HY-156358 | AChE-IN-43 | Reference compound | |
| HY-156359 | Tuberculosis inhibitor 10 | Reference compound | |
| HY-156360 | Xanthine oxidase-IN-12 | 3041062-80-7 | Reference compound |
| HY-156361 | Tuberculosis inhibitor 11 | Reference compound | |
| HY-156363 | K-Ras-IN-2 | 905794-70-9 | Reference compound |
| HY-156366 | SNX7886 | 2924557-42-4 | Reference compound |
| HY-156367 | RIPK1-IN-16 | 2561431-77-2 | Reference compound |
| HY-156368 | RIPK3-IN-4 | 2304617-58-9 | Reference compound |
| HY-156369 | Urease-IN-9 | Reference compound | |
| HY-156370 | Tyrosinase-IN-15 | Reference compound | |
| HY-156371 | MIPS-21335 | 2569296-51-9 | Reference compound |
| HY-156372 | AChE-IN-44 | 2758685-58-2 | Reference compound |
| HY-156373 | MN714 | Reference compound | |
| HY-156374 | D359-0396 | 1031977-31-7 | Reference compound |
| HY-156375 | PKM2 activator 6 | Reference compound | |
| HY-156376 | Cu(II)-Elesclomol | 1224195-72-5 | Reference compound |
| HY-156377 | Biotin-PEG7-Maleimide | 1898221-65-2 | ADC Related |
| HY-156378 | Aurora A inhibitor 3 | Reference compound | |
| HY-156379 | Biotin-PEG8-Alkyne | 2143968-80-1 | Reference compound |
| HY-156380 | α-Amylase/α-Glucosidase-IN-6 | Reference compound | |
| HY-156381 | Biotin-PEG3-CoenzymeA | Reference compound | |
| HY-156382 | SPOP-IN-1 | 2136270-56-7 | Reference compound |
| HY-156383 | SCO-PEG3-NHS | 2141976-25-0 | Reference compound |
| HY-156384 | SCO-PEG4-NHS | 2141976-26-1 | Reference compound |
| HY-156385 | SCO-PEG8-NHS | 2143968-68-5 | Reference compound |
| HY-156386 | SCO-PEG3-COOH | 2141976-36-3 | Reference compound |
| HY-156387 | SCO-PEG4-COOH | 2141976-27-2 | Reference compound |
| HY-156388 | SCO-PEG8-COOH | 2143968-79-8 | Reference compound |
| HY-156389 | (R)-TCO4-PEG2-NH2 | Reference compound | |
| HY-156390 | (R)-TCO4-PEG7-NH2 | Reference compound | |
| HY-156391 | TCO4-PEG2-Maleimide | 2141981-85-1 | Reference compound |
| HY-156391A | (R)-TCO4-PEG2-Maleimide | Reference compound | |
| HY-156392 | TCO4-PEG7-Maleimide | Reference compound | |
| HY-156393 | Laxiflorin B | 165337-71-3 | Natural Products |
| HY-156394 | Laxiflorin B-4 | 2810956-32-0 | Reference compound |
| HY-156395 | MN551 | Reference compound | |
| HY-156397 | HTH-02-006 | Reference compound | |
| HY-156398 | Anti-inflammatory agent 60 | Reference compound | |
| HY-156399 | KR-27425 | Reference compound | |
| HY-15640 | Capsazepine | 138977-28-3 | Reference compound |
| HY-156400 | IDO1-IN-23 | 3007671-44-2 | Reference compound |
| HY-156401 | BRD9 Degrader-1 | Reference compound | |
| HY-156402 | AuM1Gly | Reference compound | |
| HY-156403 | AuM1Phe | Reference compound | |
| HY-156404 | PM-1 | 1449483-78-6 | Dye Reagents |
| HY-156405 | FTO-IN-10 | Reference compound | |
| HY-156406 | PITCOIN4 | Reference compound | |
| HY-156407 | Adam-20-S | 2413880-52-9 | Reference compound |
| HY-156408 | Spns2-IN-1 | Reference compound | |
| HY-156409 | ABBV-712 | 2368945-27-9 | Reference compound |
| HY-15641 | FG-2216 | 223387-75-5 | Reference compound |
| HY-156410 | FLT3-IN-23 | 2489528-97-2 | Reference compound |
| HY-156411 | NR-NO2 | 3033874-97-1 | Reference compound |
| HY-156412 | DHFR-IN-10 | 929484-47-9 | Reference compound |
| HY-156413 | NLRP3 agonist 1 | 2454019-69-1 | Reference compound |
| HY-156414 | DHFR-IN-11 | Reference compound | |
| HY-156415 | NLRP3 agonist 2 | Reference compound | |
| HY-156416 | LtaS-IN-2 | Reference compound | |
| HY-156418 | KY386 | 2787598-01-8 | Reference compound |
| HY-156419 | PARP7-IN-16 | 2435657-10-4 | Reference compound |
| HY-156419A | PARP7-IN-16 (free base) | 2136325-05-6 | Reference compound |
| HY-15642 | TD-198946 | 364762-86-7 | Reference compound |
| HY-156420 | ATUX-1215 | 2910929-53-0 | Reference compound |
| HY-156421 | QST4 | 2991427-35-9 | Reference compound |
| HY-156422 | KPZ560 | 2397562-43-3 | Reference compound |
| HY-156423 | Tubulin/JAK2-IN-1 | 2933938-46-4 | Reference compound |
| HY-156424 | NOX2-IN-1 | 2648709-25-3 | Reference compound |
| HY-156425 | NOX2-IN-2 | 2648709-79-7 | Reference compound |
| HY-156425A | NOX2-IN-2 (diTFA) | 2648709-80-0 | Reference compound |
| HY-156427 | Antileishmanial agent-25 | Reference compound | |
| HY-156429 | MK-1468 | 2769107-89-1 | Reference compound |
| HY-15643 | LY 303511 | 154447-38-8 | Reference compound |
| HY-156430 | MMP-7-IN-3 | 2865097-58-9 | Reference compound |
| HY-156431 | Anti-inflammatory agent 61 | Reference compound | |
| HY-156432 | ALK-IN-26 | 2447607-85-2 | Reference compound |
| HY-156434 | PDE11A4-IN-1 | 3027607-92-4 | Reference compound |
| HY-156435 | tau Protein/α-synuclein-IN-1 | Reference compound | |
| HY-156436 | Anti-inflammatory agent 62 | Reference compound | |
| HY-156437 | NBI-961 | 2225902-98-5 | Reference compound |
| HY-156438 | NT-0796 | 2272917-13-0 | Reference compound |
| HY-156439 | Antibiofilm agent-2 | 2977230-63-8 | Reference compound |
| HY-15643A | LY 303511 (hydrochloride) | 2070014-90-1 | Reference compound |
| HY-15643B | LY 303511 (dihydrochloride) | 854127-90-5 | Reference compound |
| HY-15644 | Tyrphostin 23 | 118409-57-7 | Reference compound |
| HY-156440 | 7-51A | Reference compound | |
| HY-156441 | SARS-CoV-2-IN-65 | Reference compound | |
| HY-156442 | MEDS433 | 2241027-61-0 | Reference compound |
| HY-156443 | YG1702 | 724737-08-0 | Reference compound |
| HY-156444 | HDAC1/CDK7-IN-1 | 2987905-95-1 | Reference compound |
| HY-156445 | PI3K/mTOR Inhibitor-14 | 2919684-77-6 | Reference compound |
| HY-156447 | α-Glucosidase-IN-40 | Reference compound | |
| HY-156448 | 80-O14B | 1624618-01-4 | Oligonucleotides |
| HY-156449 | STING-IN-7 | 899947-07-0 | Reference compound |
| HY-15645 | H4R antagonist 2 | 1148115-99-4 | Reference compound |
| HY-156450 | ERK5-IN-5 | 2318792-30-0 | Reference compound |
| HY-156451 | ERK5-IN-6 | 2734916-64-2 | Reference compound |
| HY-156452 | T-1-MCPAB | Reference compound | |
| HY-156453 | PAK4-IN-3 | Reference compound | |
| HY-156454 | UCB-6876 | 637324-45-9 | Reference compound |
| HY-156455 | SETD7-IN-1 | Reference compound | |
| HY-156456 | Elastase LasB-IN-1 | 2762675-17-0 | Reference compound |
| HY-156457 | EGFR-IN-90 | 3008611-00-2 | Reference compound |
| HY-156458 | SR-29065 | Reference compound | |
| HY-156459 | SARS-CoV-2 Mpro-IN-12 | 370583-15-6 | Reference compound |
| HY-15646 | UNC1999 | 1431612-23-5 | Reference compound |
| HY-156460 | CMKLR1 antagonist 1 | 3033101-08-2 | Reference compound |
| HY-156461S | Myrcenol-d6 | Isotope-Labeled Compounds | |
| HY-156462 | Topoisomerase I inhibitor 9 | 1228150-86-4 | Reference compound |
| HY-156464 | Topoisomerase I inhibitor 10 | Reference compound | |
| HY-156465 | RIOK2-IN-2 | 2648987-17-9 | Reference compound |
| HY-156466 | QL-1200186 | 2848664-42-4 | Reference compound |
| HY-156467 | Neladalkib | 2739866-40-9 | Reference compound |
| HY-156467A | Neladalkib (TFA) | Reference compound | |
| HY-156468 | Antioxidant agent-17 | Reference compound | |
| HY-156469 | NLRP3-IN-22 | 1193329-98-4 | Reference compound |
| HY-15647 | BRD9539 | 1374601-41-8 | Reference compound |
| HY-156470 | Multi-kinase-IN-6 | 3009081-73-3 | Reference compound |
| HY-156471 | RET-IN-26 | Reference compound | |
| HY-156472 | HDAC6-IN-25 | Reference compound | |
| HY-156475 | Me-Tet-PEG2-COOH | 2741759-99-7 | ADC Related |
| HY-156476 | Me-Tet-PEG2-NHS | 2740357-12-2 | ADC Related |
| HY-156477 | Me-Tet-PEG8-NHBoc | 2143968-21-0 | ADC Related |
| HY-156478 | Me-Tet-PEG4-NHBoc | 2143955-71-7 | ADC Related |
| HY-156479 | Me-Tet-PEG3-NHBoc | 2141976-32-9 | ADC Related |
| HY-15648 | GSK-J1 | 1373422-53-7 | Reference compound |
| HY-156480S | 3-Mercaptooctyl-acetate-d5 | Isotope-Labeled Compounds | |
| HY-156481 | SU-8000 | 2126-63-8 | Reference compound |
| HY-156482S | 3-Mercapto-1-octanol-d5 | Isotope-Labeled Compounds | |
| HY-156483 | TT-012 | 1164471-33-3 | Reference compound |
| HY-156485S | β-Thujene-d2 | Isotope-Labeled Compounds | |
| HY-156486S | 3,5-Dimethyl-2E-(propenyl)pyrazine-d3 | 1335436-58-2 | Isotope-Labeled Compounds |
| HY-156488 | TCO-PEG7-Maleimide | Reference compound | |
| HY-156489 | Epigenetic factor-IN-1 | 2640673-56-7 | Reference compound |
| HY-15648A | GSK-J2 | 1394854-52-4 | Reference compound |
| HY-15648B | GSK-J4 | 1373423-53-0 | Reference compound |
| HY-15648C | GSK-J5 | 1394854-51-3 | Reference compound |
| HY-15648D | GSK-J1 (lithium salt) | 2309668-29-7 | Reference compound |
| HY-15648F | GSK-J4 (hydrochloride) | 1797983-09-5 | Reference compound |
| HY-15648G | GSK-J1 (sodium) | 1797832-71-3 | Reference compound |
| HY-15648H | GSK-J5 (hydrochloride) | 1797983-32-4 | Reference compound |
| HY-15648I | GSK-J2 (sodium) | 2108665-15-0 | Reference compound |
| HY-15649 | UNC1215 | 1415800-43-9 | Reference compound |
| HY-156490 | Me-Tet-PEG5-NHS | 2096446-25-0 | ADC Related |
| HY-156491 | Me-Tet-PEG9-NHS | 2143955-78-4 | ADC Related |
| HY-156492 | Me-Tet-PEG4-COOH | 2141976-30-7 | ADC Related |
| HY-156493 | Me-Tet-PEG5-COOH | 2143964-72-9 | ADC Related |
| HY-156494 | Me-Tet-PEG9-COOH | 2143964-70-7 | ADC Related |
| HY-156495 | Biotin-PEG3-Me-Tet | 2143968-06-1 | ADC Related |
| HY-156497 | Biotin-PEG8-Me-Tet | 2143958-82-9 | Reference compound |
| HY-156498 | RMC-7977 | 2765082-12-8 | Reference compound |
| HY-156499 | RNF114 ligand 1 | 900137-36-2 | Reference compound |
| HY-15650 | SGC0946 | 1561178-17-3 | Reference compound |
| HY-156500 | ICMT-IN-1 | 1313603-22-3 | Reference compound |
| HY-156501 | BT101 (sodium) | Oligonucleotides | |
| HY-156502 | TINK-IN-1 | 1417795-25-5 | Reference compound |
| HY-156507 | DBCO-PEG3-NHS ester | 2163772-16-3 | Reference compound |
| HY-156508 | HPK1-IN-37 | 2766481-68-7 | Reference compound |
| HY-156509 | HPK1-IN-38 | 2578802-72-7 | Reference compound |
| HY-15651 | Alvelestat | 848141-11-7 | Reference compound |
| HY-156511 | ETC-168 | 1464150-99-9 | Reference compound |
| HY-156512 | DT-6 | 2414315-95-8 | Reference compound |
| HY-156513 | ZD06519 | 2873460-17-2 | ADC Related |
| HY-156514 | MC-GGFG-AM-(10NH2-11F-Camptothecin) | 2987938-97-4 | ADC Related |
| HY-156515 | MC-GGFG-(7ethanol-10NH2-11F-Camptothecin) | 2987937-38-0 | ADC Related |
| HY-156516 | 10NH2-11F-Camptothecin | 2873460-30-9 | ADC Related |
| HY-156516A | 10NH2-11F-Camptothecin (TFA) | 2873461-64-2 | Reference compound |
| HY-156517 | 7Ethanol-10NH2-11F-Camptothecin | 2873460-31-0 | ADC Related |
| HY-156518 | Glucose-malemide | 2093979-63-4 | Reference compound |
| HY-156519 | ALPK1-IN-3 | 2765633-73-4 | Reference compound |
| HY-15651A | Alvelestat (tosylate) | 1240425-05-1 | Reference compound |
| HY-15651S | Alvelestat-13C,d3 | Isotope-Labeled Compounds | |
| HY-15652 | Freselestat | 208848-19-5 | Reference compound |
| HY-156520 | Immunosuppressant-1 | 1224571-03-2 | Reference compound |
| HY-156521 | αvβ1 integrin-IN-2 | 2234874-68-9 | Reference compound |
| HY-156522 | CRF1 receptor antagonist-1 | 2635364-30-4 | Reference compound |
| HY-156523 | TNIK&MAP4K4-IN-1 | 2478592-86-6 | Reference compound |
| HY-156524 | USP1-IN-5 | 2925547-94-8 | Reference compound |
| HY-156525 | USP1-IN-6 | 2925547-95-9 | Reference compound |
| HY-156526 | PHD-IN-1 | 2924182-31-8 | Reference compound |
| HY-156527 | PHD-IN-2 | 2924182-42-1 | Reference compound |
| HY-156528 | pan-KRAS-IN-4 | 2885961-55-5 | Reference compound |
| HY-156529 | pan-KRAS-IN-2 | 2882825-14-9 | Reference compound |
| HY-15652A | Freselestat (quarterhydrate) | Reference compound | |
| HY-15653 | Filorexant | 1088991-73-4 | Reference compound |
| HY-156530 | CYP11A1-IN-1 | 2744168-51-0 | Reference compound |
| HY-156532 | 5-HT2C agonist-3 | 2104810-18-4 | Reference compound |
| HY-156532A | 5-HT2C agonist-3 (free base) | 2104810-17-3 | Reference compound |
| HY-156532C | (-)-5-HT2C agonist-3 | 2104810-16-2 | Reference compound |
| HY-156533 | 5-HT2 agonist-1 | 2708279-78-9 | Reference compound |
| HY-156533A | 5-HT2 agonist-1 (free base) | 2708279-77-8 | Reference compound |
| HY-156534 | 5-HT2A&5-HT2C agonist-1 | 1640-02-4 | Reference compound |
| HY-156535 | JAK kinase-IN-1 | 2698389-43-2 | Reference compound |
| HY-156536 | RXFP1 receptor agonist-1 | 2924619-64-5 | Reference compound |
| HY-156537 | RXFP1 receptor agonist-2 | 2924460-54-6 | Reference compound |
| HY-156538 | RXFP1 receptor agonist-3 | 2924767-53-1 | Reference compound |
| HY-156539 | RXFP1 receptor agonist-4 | 2941376-76-5 | Reference compound |
| HY-15654 | Sodium 4-phenylbutyrate | 1716-12-7 | Reference compound |
| HY-156540 | RXFP1 receptor agonist-5 | 2941385-36-8 | Reference compound |
| HY-156541 | RXFP1 receptor agonist-6 | 2941346-85-4 | Reference compound |
| HY-156542 | RXFP1 receptor agonist-7 | 2941484-13-3 | Reference compound |
| HY-156543 | RXFP1 receptor agonist-8 | 2941271-76-5 | Reference compound |
| HY-156549 | KRAS G12C inhibitor 61 | 2300967-40-0 | Reference compound |
| HY-15654R | Sodium 4-phenylbutyrate (Standard) | 1716-12-7 | Reference Standards |
| HY-15654S | Phenylbutyrate-d11 (sodium) | 1392208-11-5 | Isotope-Labeled Compounds |
| HY-15655 | GW1929 | 196808-24-9 | Reference compound |
| HY-156550 | ROCK-IN-8 | 1621103-79-4 | Reference compound |
| HY-156551 | Porcn-IN-2 | 1900754-65-5 | Reference compound |
| HY-156552 | DDR1/2 inhibitor-2 | 2908756-11-4 | Reference compound |
| HY-156553 | BTK-IN-27 | 1841502-36-0 | Reference compound |
| HY-156554 | Raf inhibitor 3 | 1662682-11-2 | Reference compound |
| HY-156555 | pan-KRAS-IN-3 | 2875116-29-1 | Reference compound |
| HY-156556 | c-Fms-IN-14 | 1898210-99-5 | Reference compound |
| HY-156558 | SeGalNac | 1365541-49-6 | Reference compound |
| HY-156559 | GlcNAc-SH | 91288-32-3 | Reference compound |
| HY-15656 | Ceritinib | 1032900-25-6 | Reference compound |
| HY-156560 | Z-LVG | 119670-31-4 | Reference compound |
| HY-156562 | 5-PT | 92085-05-7 | Reference compound |
| HY-156562A | 5-PT (formic) | 2906227-87-8 | Reference compound |
| HY-156565 | Sumonerimod | 2433782-42-2 | Reference compound |
| HY-156565A | Sumonerimod (hemicalcium) | 2941310-03-6 | Reference compound |
| HY-156566 | PROTAC BRD4 Degrader-21 | 2503036-46-0 | Reference compound |
| HY-156567 | AMB639752 | 371210-26-3 | Reference compound |
| HY-156568 | SMD-3040 | 3033109-92-8 | Reference compound |
| HY-156568A | SMD-3040 (TFA) | Reference compound | |
| HY-156568B | SMD-3040 formate | Reference compound | |
| HY-156569 | DGKα-IN-2 | 2648556-92-5 | Reference compound |
| HY-15656A | Ceritinib dihydrochloride | 1380575-43-8 | Reference compound |
| HY-15656R | Ceritinib (Standard) | 1032900-25-6 | Reference Standards |
| HY-15656S | Ceritinib-d7 | 1632484-77-5 | Isotope-Labeled Compounds |
| HY-156570 | DGKα-IN-3 | 2648418-86-2 | Reference compound |
| HY-156571 | DGKα-IN-4 | 2648723-43-5 | Reference compound |
| HY-156572 | DGKζ-IN-3 | 2732901-70-9 | Reference compound |
| HY-156573 | DGKα&ζ-IN-1 | 2830643-06-4 | Reference compound |
| HY-156574 | DGKζ-IN-4 | 2778366-77-9 | Reference compound |
| HY-156575S | DGKα-IN-5 | 2886721-97-5 | Isotope-Labeled Compounds |
| HY-156576 | DGKα-IN-6 | 2886734-91-2 | Reference compound |
| HY-156577 | DGKα-IN-7 | 2886092-50-6 | Reference compound |
| HY-156578 | DGKα-IN-8 | 2886717-70-8 | Reference compound |
| HY-156579 | WRN inhibitor 3 | 2923009-48-5 | Reference compound |
| HY-15658 | GSK2801 | 1619994-68-1 | Reference compound |
| HY-156580 | WRN inhibitor 4 | 2923009-45-2 | Reference compound |
| HY-156581 | WRN inhibitor 5 | 2923009-95-2 | Reference compound |
| HY-156584 | ODE-Bn-PMEG | 1626364-18-8 | Reference compound |
| HY-156585 | CNS-11 | 445218-34-8 | Reference compound |
| HY-156586 | Egalognastat | 1884154-02-2 | Reference compound |
| HY-15659 | Wnt-C59 | 1243243-89-1 | Reference compound |
| HY-156590 | B-Raf IN 16 | 2304746-24-3 | Reference compound |
| HY-156591 | PROTAC MLKL Degrader-1 | 3032600-90-8 | Reference compound |
| HY-156592 | ROCK2-IN-6 | 2260506-59-8 | Reference compound |
| HY-156592A | ROCK2-IN-6 (hydrochloride) | 2762238-94-6 | Reference compound |
| HY-156593 | ROCK-IN-9 | 2643334-76-1 | Reference compound |
| HY-156595 | BCL6 ligand-1 | 2230407-20-0 | Reference compound |
| HY-156596 | Aneratrigine | 2097163-74-9 | Reference compound |
| HY-156596A | Aneratrigine (hydrochloride) | 2097163-75-0 | Reference compound |
| HY-156597 | Arbemnifosbuvir | 1998705-63-7 | Reference compound |
| HY-156598 | 1,3-Bis(carboxyphenoxy)propane | 221291-98-1 | Reference compound |
| HY-156599 | Bavtavirine | 1956373-71-9 | Reference compound |
| HY-15659G | Wnt-C59 (GMP) | 1243243-89-1 | GMP Small Molecules |
| HY-15660 | Efinaconazole | 164650-44-6 | Reference compound |
| HY-156601 | Bexicaserin | 2035818-24-5 | Reference compound |
| HY-156601A | (S)-Bexicaserin | 2035818-21-2 | Reference compound |
| HY-156602 | Bocodepsin | 1834513-65-3 | Reference compound |
| HY-156602A | Bocodepsin (hydrochloride) | 1834513-66-4 | Reference compound |
| HY-156603 | Canlitinib | 2222730-78-9 | Reference compound |
| HY-156604 | Cinsebrutinib | 2724962-58-5 | Reference compound |
| HY-156605 | Davelizomib | 2409841-51-4 | Reference compound |
| HY-156606 | Anticancer agent 142 | 2948338-60-9 | Reference compound |
| HY-156607 | Anticancer agent 143 | 2948339-38-4 | Reference compound |
| HY-156608 | Anticancer agent 144 | 2948340-59-6 | Reference compound |
| HY-156609 | FOXM1-IN-2 | 2694866-10-7 | Reference compound |
| HY-15660S | Efinaconazole-d4 | Isotope-Labeled Compounds | |
| HY-156612 | Friluglanstat | 1422203-86-8 | Reference compound |
| HY-156613 | Frunexian | 1803270-60-1 | Reference compound |
| HY-156614 | Icalcaprant | 2227384-17-8 | Reference compound |
| HY-156615 | Igermetostat | 2409538-60-7 | Reference compound |
| HY-156616 | VC1052 | 370108-98-8 | Biochemical Assay Reagents |
| HY-156617 | Cyclopropaneacetamide-Exatecan | 2414254-36-5 | ADC Related |
| HY-156617A | (αR)-Cyclopropaneacetamide-Exatecan | 2414254-37-6 | Reference compound |
| HY-156618 | Irpagratinib | 2230974-62-4 | Reference compound |
| HY-156619 | Labuxtinib | 1426449-01-5 | Reference compound |
| HY-15661A | OSI-413 (free base) | 183320-29-8 | Reference compound |
| HY-15662 | Tulathromycin A | 217500-96-4 | Reference compound |
| HY-156620 | Lacutoclax | 2291166-56-6 | Reference compound |
| HY-156621 | Lepzacitinib | 2321488-47-3 | Reference compound |
| HY-156622 | Leramistat | 1642602-54-7 | Reference compound |
| HY-156623 | Lerzeparib | 2459693-01-5 | Reference compound |
| HY-156624 | Lingdolinurad | 2088176-96-7 | Reference compound |
| HY-156625 | Nedometinib | 2252314-46-6 | Reference compound |
| HY-156626 | Nevadistinel | 2181816-92-0 | Reference compound |
| HY-156628 | Opevesostat | 2231294-96-3 | Reference compound |
| HY-156629 | Orziloben | 1555822-28-0 | Reference compound |
| HY-15662R | Tulathromycin A (Standard) | 217500-96-4 | Reference Standards |
| HY-15662S | Tulathromycin A-d7 | Isotope-Labeled Compounds | |
| HY-15663 | IPA-3 | 42521-82-4 | Reference compound |
| HY-156630 | Ionizable lipid-1 | 2055939-68-7 | Oligonucleotides |
| HY-156630A | Ionizable lipid-1 (hydrochloride) | Biochemical Assay Reagents | |
| HY-156631S | Pozdeutinurad | 2173408-41-6 | Isotope-Labeled Compounds |
| HY-156632 | Resigratinib | 2750709-91-0 | Reference compound |
| HY-156633 | Rezatapopt | 2636846-41-6 | Reference compound |
| HY-156634 | Risevistinel | 2591344-26-0 | Reference compound |
| HY-156635 | TIE-2/VEGFR-2 kinase-IN-3 | 433224-09-0 | Reference compound |
| HY-156637 | TIE-2/VEGFR-2 kinase-IN-4 | 433224-29-4 | Reference compound |
| HY-156638 | TIE-2/VEGFR-2 kinase-IN-5 | 1014407-83-0 | Reference compound |
| HY-156639 | EGFR/ErbB-2 inhibitor-1 | 1135150-79-6 | Reference compound |
| HY-15664 | Bivalirudin (TFA) | 1191386-55-6 | Peptides |
| HY-156640 | Rocbrutinib | 2485861-07-0 | Reference compound |
| HY-156641 | Sontigidomide | 2560577-69-5 | Reference compound |
| HY-156642 | (1-OH)-Exatecan | 2894780-53-9 | Reference compound |
| HY-156643 | Tacaciclib | 2768774-66-7 | Reference compound |
| HY-156645 | Tegomil fumarate | 1817769-42-8 | Reference compound |
| HY-156646 | Tibremciclib | 2397678-18-9 | Reference compound |
| HY-156647 | Usnoflast | 2455519-86-3 | Reference compound |
| HY-156648 | Vamagloxistat | 2408241-62-1 | Reference compound |
| HY-156648A | Vamagloxistat (sodium) | 2667602-26-6 | Reference compound |
| HY-156649 | Vorbipiprant | 1417742-86-9 | Reference compound |
| HY-15665 | XMD17-109 | 1435488-37-1 | Reference compound |
| HY-156650 | Votoplam | 2407849-89-0 | Reference compound |
| HY-156651 | Zevotrelvir | 2773516-53-1 | Reference compound |
| HY-156653S | Deunirmatrelvir | 2861202-79-9 | Isotope-Labeled Compounds |
| HY-156654 | Ibuzatrelvir | 2755812-39-4 | Reference compound |
| HY-156655 | Olgotrelvir | 2763596-71-8 | Reference compound |
| HY-156655A | Olgotrelvir (sodium) | 2763596-72-9 | Reference compound |
| HY-156656 | Tirfipiravir | 2759996-93-3 | Reference compound |
| HY-156659 | NC1 | 445406-82-6 | Reference compound |
| HY-15666 | Olverembatinib | 1257628-77-5 | Reference compound |
| HY-156661 | MurF-IN-1 | 303790-97-8 | Reference compound |
| HY-156662 | Casein kinase 1δ-IN-7 | 764694-25-9 | Reference compound |
| HY-156663 | Calcium Channel antagonist 2 | 874370-15-7 | Reference compound |
| HY-156664 | Calcium Channel antagonist 3 | 687573-14-4 | Reference compound |
| HY-156665 | HBV-IN-37 | 380483-01-2 | Reference compound |
| HY-156666 | Casein kinase 1δ-IN-8 | 851396-73-1 | Reference compound |
| HY-156667 | H4R antagonist 3 | 1003091-20-0 | Reference compound |
| HY-156668 | Rac1-IN-3 | 380470-06-4 | Reference compound |
| HY-156669 | Calcium Channel antagonist 4 | 687574-49-8 | Reference compound |
| HY-15666A | Olverembatinib (dimesylate) | 1421783-64-3 | Reference compound |
| HY-15666R | Olverembatinib (Standard) | 1257628-77-5 | Reference Standards |
| HY-15667 | P005091 | 882257-11-6 | Reference compound |
| HY-156670 | Camptothecin analog-1 | 2873460-51-4 | Reference compound |
| HY-156671 | RMC-4998 | 2642037-07-6 | Reference compound |
| HY-156671A | RMC-4998 (formic) | Reference compound | |
| HY-156672 | S6K2-IN-1 | Reference compound | |
| HY-156673 | m-Se3 | 2829939-44-6 | Reference compound |
| HY-156675 | Plecstatin-1 | 2119725-22-1 | Reference compound |
| HY-156675A | Plecstatin-1 (hydrochloride) | Reference compound | |
| HY-156677 | STC-15 | 2648257-56-9 | Reference compound |
| HY-156679 | VK-0214 | 852949-30-5 | Reference compound |
| HY-156680 | Vopimetostat | 2760483-96-1 | Reference compound |
| HY-156681 | Tersolisib | 2883540-92-7 | Reference compound |
| HY-156681A | (S)-Tersolisib | 2883540-91-6 | Reference compound |
| HY-156682 | JNT-517 | 2837993-05-0 | Reference compound |
| HY-156683 | CHK-336 | 2743436-86-2 | Reference compound |
| HY-156684 | Nedizantrep | 2376824-99-4 | Reference compound |
| HY-156685 | EDI048 | 2767264-57-1 | Reference compound |
| HY-156686 | NH2-methylpropanamide-Exatecan (TFA) | 1817857-35-4 | ADC Related |
| HY-156687 | GGFG-Eribulin | 2841688-66-0 | Reference compound |
| HY-156690 | 2-Quinizarincarboxylic acid | 6416-55-3 | Reference compound |
| HY-156691 | TLR7/8 agonist 4 hydroxy-PEG6-acid | 2388520-23-6 | Reference compound |
| HY-156691A | TLR7/8 agonist 4 hydroxy-PEG6-acid (hydrochloride) | Reference compound | |
| HY-156693 | MTvkPABC-P5 | 3027976-10-6 | Reference compound |
| HY-156693A | MTvkPABC-P5 (TFA) | ADC Related | |
| HY-156694 | Hydroxy-PP-Me | 833481-77-9 | Reference compound |
| HY-156696 | S3226 | 215183-03-2 | Reference compound |
| HY-156698 | HJM-561 | 2570251-68-0 | Reference compound |
| HY-15670 | BMS-906024 | 1401066-79-2 | Reference compound |
| HY-156700 | Lenalidomide-acetylene-Br | 2619512-84-2 | Reference compound |
| HY-156702 | HBV-IN-38 | 1834483-86-1 | Reference compound |
| HY-156703S | HBV-IN-39-d3 | 2173356-23-3 | Isotope-Labeled Compounds |
| HY-156704 | FGFR4-IN-16 | 1970120-44-5 | Reference compound |
| HY-156705 | CDK7-IN-25 | 2009209-60-1 | Reference compound |
| HY-156706 | JAK-IN-31 | 2597016-88-9 | Reference compound |
| HY-15671 | GKA50 | 851884-87-2 | Reference compound |
| HY-156711 | Ternatumoside II | 1473419-87-2 | Natural Products |
| HY-156712 | Depatuxizumab MMAE | ADC Related | |
| HY-156715 | MASTL-IN-1 | 3024916-67-1 | Reference compound |
| HY-156716 | MASTL-IN-2 | 3024916-69-3 | Reference compound |
| HY-156717 | RE-33 | 2923520-98-1 | Reference compound |
| HY-15671A | GKA50 (quarterhydrate) | Reference compound | |
| HY-15672 | FM19G11 | 329932-55-0 | Reference compound |
| HY-156722 | ER-34122 | 179325-62-3 | Reference compound |
| HY-156723 | 9-Chloromethyl-10-hydroxy-11-F-Camptothecin | 2414594-22-0 | Reference compound |
| HY-156726 | Pomalidomide-amino-PEG4-C4-Cl | 2924835-36-7 | Reference compound |
| HY-156727 | Val-Cit-PABC-Ahx-May | 2126749-74-2 | ADC Related |
| HY-156727A | Val-Cit-PABC-Ahx-May (TFA) | 2126749-75-3 | ADC Related |
| HY-15673 | KP372-1 | 1374996-60-7 | Reference compound |
| HY-156730 | KT-333 | 2502186-79-8 | Reference compound |
| HY-156730A | KT-333 (ammonium) | 2839758-34-6 | Reference compound |
| HY-156730B | KT-333 (diammonium) | 2502186-80-1 | Reference compound |
| HY-156731 | (8R,8'R)-Matairesinol 4,4'-di-O-β-D-glucopyranoside | 41948-08-7 | Natural Products |
| HY-156734 | D-4-77 | Reference compound | |
| HY-156735 | HSD17B13-IN-2 | 863564-24-3 | Reference compound |
| HY-156736 | HSD17B13-IN-3 | 313259-88-0 | Reference compound |
| HY-156737 | Tubulin polymerization-IN-49 | Reference compound | |
| HY-156741 | EGFR-IN-87 | 1835666-87-9 | Reference compound |
| HY-156743 | DCAF1 binder 2 | Reference compound | |
| HY-156744 | DBr-1 | Reference compound | |
| HY-156745 | DDa-1 | 3036944-98-3 | Reference compound |
| HY-156746 | DBt-10 | Reference compound | |
| HY-156747 | GSPT1 degrader-2 | 2803879-60-7 | Reference compound |
| HY-156748 | MC-PEG2-VA-PAB-Exatecan | 2845165-13-9 | Reference compound |
| HY-15675 | AZD1656 | 919783-22-5 | Reference compound |
| HY-156750 | (-)-10-epi-α-Cyperone | 2303-31-3 | Biochemical Assay Reagents |
| HY-156751 | (Rac)-GDC-2992 | 2753650-84-7 | Reference compound |
| HY-156751A | GDC-2992 | 2753651-10-2 | Reference compound |
| HY-156752 | Cyclosiversioside F 16,25-diacetate | 452919-90-3 | Reference compound |
| HY-156753 | NorA-IN-1 | 1389310-69-3 | Reference compound |
| HY-156754 | 3β-Hydroxy-lup-20(29)-en-16-one | 65043-60-9 | Reference compound |
| HY-156755 | Propargyl-PEG4-GGFG-DXd | 2762518-94-3 | ADC Related |
| HY-156756 | 7-Hydroxymethyl-10,11-MDCPT | 428816-69-7 | Reference compound |
| HY-156756S | 7-Hydroxymethyl-10,11-MDCPT-d5 | Isotope-Labeled Compounds | |
| HY-156757 | MDL-811 | 2275619-98-0 | Reference compound |
| HY-156758 | Mal-PEG8-Val-Cit-PAB-MMAF | ADC Related | |
| HY-156759 | METTL3-IN-5 | 2965311-25-3 | Reference compound |
| HY-15676 | Idasanutlin | 1229705-06-9 | Reference compound |
| HY-156762 | Cbl-b-IN-6 | 2815221-33-9 | Reference compound |
| HY-156763 | Cbl-b-IN-7 | 2815221-35-1 | Reference compound |
| HY-156764 | Cbl-b-IN-8 | 2815223-33-5 | Reference compound |
| HY-156765 | Cbl-b-IN-9 | 2815223-41-5 | Reference compound |
| HY-156766 | Cbl-b-IN-10 | 2815225-12-6 | Reference compound |
| HY-156767 | Cbl-b-IN-11 | 2815225-15-9 | Reference compound |
| HY-156768 | Cbl-b-IN-12 | 2851871-29-7 | Reference compound |
| HY-156769 | Cbl-b-IN-13 | 2368841-85-2 | Reference compound |
| HY-15676A | Idasanutlin (enantiomer) | Reference compound | |
| HY-15677 | INT-777 | 1199796-29-6 | Reference compound |
| HY-156771 | GPR88-IN-1 | 714265-50-6 | Reference compound |
| HY-156772 | GPR88 agonist 2 | 2821859-71-4 | Reference compound |
| HY-156773 | STM3006 | 2499664-52-5 | Reference compound |
| HY-156774 | CCW 28-3 | 2361142-23-4 | Reference compound |
| HY-156775 | Antitumor agent-119 | 913169-79-6 | Reference compound |
| HY-156776 | HAPSBC | 1376545-81-1 | Reference compound |
| HY-156777 | Antiproliferative agent-36 | 193828-76-1 | Reference compound |
| HY-156778 | Antitumor agent-120 | 948901-10-8 | Reference compound |
| HY-156779 | HSP90-IN-27 | 525577-38-2 | Reference compound |
| HY-15677A | INT-777 (R-enantiomer) | 1198786-98-9 | Reference compound |
| HY-156780 | NSC 689534 | 907958-80-9 | Reference compound |
| HY-156781 | Sirtuin-1 inhibitor 1 | 945114-10-3 | Reference compound |
| HY-156782 | DHX9-IN-1 | 2973747-89-4 | Reference compound |
| HY-156784 | ATX968 | 2973395-71-8 | Reference compound |
| HY-156787 | Porfimer sodium | 87806-31-3 | Reference compound |
| HY-15679 | PI4KIII beta inhibitor 3 | 1245319-54-3 | Reference compound |
| HY-156790 | FGFR3-IN-6 | 2833703-72-1 | Reference compound |
| HY-156791 | FGFR3-IN-7 | 2833703-79-8 | Reference compound |
| HY-156792 | RIOK2-IN-1 | 1088216-72-1 | Reference compound |
| HY-156793 | hRIO2 kinase ligand-1 | 923841-73-0 | Reference compound |
| HY-156794 | Enzomenib | 2412555-70-3 | Reference compound |
| HY-156795 | PROTAC CDK9/CycT1 Degrader-2 | 3020773-91-2 | Reference compound |
| HY-156796 | Akt/ROCK-IN-1 | 2983889-44-5 | Reference compound |
| HY-156798 | ADS032 | 2757333-37-0 | Reference compound |
| HY-156799 | Cholesterol 24-hydroxylase-IN-2 | 1613481-52-9 | Reference compound |
| HY-15680 | O-Propargyl-Puromycin | 1416561-90-4 | Reference compound |
| HY-156800 | PDDC | 2232878-43-0 | Reference compound |
| HY-15681 | Senexin A | 1366002-50-7 | Reference compound |
| HY-156810 | Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz | 2914227-56-6 | ADC Related |
| HY-156813 | Fmoc-Val-Ala-aminomethyl acetate | 2505045-86-1 | ADC Related |
| HY-156814 | HPP-9 | Reference compound | |
| HY-156815 | YL-365 | Reference compound | |
| HY-156816 | ON 108600 | 1585246-23-6 | Reference compound |
| HY-156817 | TNIK-IN-6 | 2375196-40-8 | Reference compound |
| HY-156818 | TNIK-IN-7 | 1417795-24-4 | Reference compound |
| HY-156819 | Zoldonrasib | 2922732-54-3 | Reference compound |
| HY-15681A | Senexin A (hydrochloride) | 1780390-76-2 | Reference compound |
| HY-15682 | TTNPB | 71441-28-6 | Reference compound |
| HY-156820 | HLDA-221 | Reference compound | |
| HY-156825 | Fmoc-Ser-Ribose(diBoc)-5-phosphatediAllyl | 2760364-52-9 | Reference compound |
| HY-156826 | DiBoc-Vidarabine-Ribose(diBoc)-2-cyanoethyl-diisopropylphosphoramidite | 2760364-53-0 | Reference compound |
| HY-156827 | MMH1 | Reference compound | |
| HY-156828 | MMH2 | Reference compound | |
| HY-156829 | PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) | Reference compound | |
| HY-156829A | PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) | Reference compound | |
| HY-15682G | TTNPB (GMP) | 71441-28-6 | GMP Small Molecules |
| HY-15682R | TTNPB (Standard) | 71441-28-6 | Reference Standards |
| HY-15683 | IDO5L | 914471-09-3 | Reference compound |
| HY-156830 | TGR5 Receptor Agonist 4 | 1872436-42-4 | Reference compound |
| HY-156830A | (4′R)-TGR5 Receptor Agonist 4 | 1872436-55-9 | Reference compound |
| HY-156831 | Lixosicone | 1610878-71-1 | Reference compound |
| HY-156832F | 5'6-FAM-GGUGAAAGACGAUGGACAATT,UUGUCCAUCGUCUUUCACCTT | Dye Reagents | |
| HY-156833F | 5'6-FAM-UUCUCCGAACGUGUCACGUTT, ACGUGACACGUUCGGAGAATT | Dye Reagents | |
| HY-156838 | Cyclophellitol aziridine | 136861-97-7 | Reference compound |
| HY-156842 | MCAAD-3 | 1625629-51-7 | Reference compound |
| HY-156843 | Antiproliferative agent-38 | 239-13-4 | Reference compound |
| HY-156846 | O-Benzoylhydroxylamine | 54495-98-6 | Reference compound |
| HY-156848 | Fmoc-GGFG-DXd | 1599440-11-5 | ADC Related |
| HY-156849 | Exatecan-methylacetamide-OH | 2594423-51-3 | ADC Related |
| HY-15685 | Ripasudil | 887375-67-9 | Reference compound |
| HY-156850 | ITF 3756 | 2247608-27-9 | Reference compound |
| HY-156856 | FL118-14-Propanol | 2821768-98-1 | ADC Related |
| HY-156857 | PPZ-A10 | 2941268-67-1 | Oligonucleotides |
| HY-156859 | NSC309401 (dihydrochloride) | 77681-42-6 | Reference compound |
| HY-156859A | NSC309401 | 750522-61-3 | Reference compound |
| HY-15685A | Ripasudil (free base) | 223645-67-8 | Reference compound |
| HY-156860 | WP 1122 | 1204310-73-5 | Reference compound |
| HY-156862 | (+)-Chloroquine | 58175-86-3 | Reference compound |
| HY-156863 | GRK2 Inhibitor 2 | 2592436-21-8 | Reference compound |
| HY-156865 | siFLUC (sodium) | Oligonucleotides | |
| HY-156868 | 22-Hydroxyvitamin D3 | 110927-46-3 | Reference compound |
| HY-15687 | SAR407899 (hydrochloride) | 923262-96-8 | Reference compound |
| HY-156871 | CAMK1D-IN-1 | 404828-08-6 | Reference compound |
| HY-156872 | MTX-216 | 1952236-19-9 | Reference compound |
| HY-156875 | 20-HETE inhibitor-1 | 2472030-28-5 | Reference compound |
| HY-156876 | 20-HETE inhibitor-2 | 2992666-48-3 | Reference compound |
| HY-156878 | Antiproliferative agent-39 | 871837-61-5 | Reference compound |
| HY-156879 | Antiproliferative agent-40 | 871837-59-1 | Reference compound |
| HY-15687A | SAR407899 | 923359-38-0 | Reference compound |
| HY-15688 | 8-OH-DPAT (hydrobromide) | 76135-31-4 | Reference compound |
| HY-156881 | PARG-IN-4 | 2988890-20-4 | Reference compound |
| HY-156882 | Biotin-PEG3-amide-C2-CO-Halofuginone | 2758563-75-4 | Reference compound |
| HY-156883 | Dasatinib analog-1 | 1174416-41-1 | Reference compound |
| HY-156889 | Cav 3.1 blocker 1 | 2158201-04-6 | Reference compound |
| HY-15689 | Epacadostat | 1204669-58-8 | Reference compound |
| HY-156895 | Ile-AMS | 213554-08-6 | Reference compound |
| HY-156895A | Ile-AMS (TFA) | Reference compound | |
| HY-156896 | Val-Cit-amide-Cbz-N(Me)-Maytansine | 1628543-59-8 | ADC Related |
| HY-156897 | Val-Cit-amide-Ph-Maytansine | ADC Related | |
| HY-15689R | Epacadostat (Standard) | 1204669-58-8 | Reference Standards |
| HY-156901 | MNG-14a | 1257853-50-1 | Reference compound |
| HY-156902 | Steroid sulfatase-IN-8 | 345222-92-6 | Reference compound |
| HY-156905 | 6-Azido-N-acetylgalactosamine-UDP | 1202854-87-2 | Reference compound |
| HY-156906 | UNC3474 | 1648707-79-2 | Reference compound |
| HY-156907 | ZINC49534341 | 1274013-03-4 | Reference compound |
| HY-156908 | 3-OH-Kynurenamine | 99362-47-7 | Reference compound |
| HY-156912 | Tyrosine kinase-IN-7 | 345615-74-9 | Reference compound |
| HY-156913 | Casein kinase 1δ-IN-13 | 345616-08-2 | Reference compound |
| HY-156914 | IGF-1R/SRC-IN-1 | 852367-46-5 | Reference compound |
| HY-156915 | Pim-1 kinase inhibitor 13 | 79492-49-2 | Reference compound |
| HY-156919 | p53 Activator 8 | 1426937-93-0 | Reference compound |
| HY-15691A | PF-4455242 (hydrochloride) | 1322001-35-3 | Reference compound |
| HY-15692 | PHD2-IN-3 | 1000025-14-8 | Reference compound |
| HY-156920 | VDX-111 | 158983-23-4 | Reference compound |
| HY-156922 | NPY-5 receptor antagonist-1 | 432506-24-6 | Reference compound |
| HY-156923 | Glucokinase activator 5 | 536736-95-5 | Reference compound |
| HY-156925 | PKA/AKAP-IN-1 | 299934-88-6 | Reference compound |
| HY-156936 | RCB-02-4-8 | 2941228-91-5 | Biochemical Assay Reagents |
| HY-156939 | ZnDTPA | 65229-17-6 | Reference compound |
| HY-15694 | SMIP004 | 143360-00-3 | Reference compound |
| HY-15695 | Puromycin aminonucleoside | 58-60-6 | Reference compound |
| HY-156955 | SUCNR1-IN-2 | 2988733-54-4 | Reference compound |
| HY-156958 | S-72 | 2446799-14-8 | Reference compound |
| HY-156959 | Ovalicin | 19683-98-8 | Reference compound |
| HY-15695R | Puromycin aminonucleoside (Standard) | 58-60-6 | Reference Standards |
| HY-156960 | JNJ-40929837 | 1191044-42-4 | Reference compound |
| HY-156960A | JNJ-40929837 (succinate) | 1191044-47-9 | Reference compound |
| HY-156961 | GLPG3667 | 2308520-97-8 | Reference compound |
| HY-156962 | BFF-816 | 2008006-36-6 | Reference compound |
| HY-156963 | Aderamastat | 877176-23-3 | Reference compound |
| HY-156964 | Benzmalecene | 148-07-2 | Reference compound |
| HY-156965 | BAY-771 | 2771756-82-0 | Reference compound |
| HY-156966 | ATG12-ATG3 inhibitor 1 | 333351-38-5 | Reference compound |
| HY-156967 | BAY 1892005 | 2036352-13-1 | Reference compound |
| HY-156968 | GLP-1 receptor agonist 14 | 3011682-51-9 | Reference compound |
| HY-156969 | Topoisomerase I inhibitor 11 | 2922723-28-0 | Reference compound |
| HY-15697 | TUG-770 | 1402601-82-4 | Reference compound |
| HY-156970 | Phosphatase Binder-1 | 2456385-41-2 | Reference compound |
| HY-156972 | NOP agonist-1 | 2099681-43-1 | Reference compound |
| HY-156973 | Tiopropamine | 39516-21-7 | Reference compound |
| HY-156975 | Sulfatrozole | 13369-07-8 | Reference compound |
| HY-156976 | Sulcardine | 343935-60-4 | Reference compound |
| HY-156976A | Sulcardine (hydrochloride) | 343935-48-8 | Reference compound |
| HY-156977 | Sitofibrate | 55902-94-8 | Reference compound |
| HY-156978 | Ritolukast | 111974-60-8 | Reference compound |
| HY-156979 | RBT-9 | 123307-75-5 | Reference compound |
| HY-15698 | CRT0066101 | 956123-34-5 | Reference compound |
| HY-156980 | Podilfen | 13409-53-5 | Reference compound |
| HY-156981 | Pirdonium (bromide) | 35620-67-8 | Reference compound |
| HY-156982 | Parpi | 1919043-65-4 | Reference compound |
| HY-156983 | MRS 5980 | 1639420-13-5 | Reference compound |
| HY-156984 | Monometacrine | 4757-49-7 | Reference compound |
| HY-156985 | Lipid AX4 | 2735814-23-8 | Biochemical Assay Reagents |
| HY-156986 | ITH15004 | 2600675-12-3 | Reference compound |
| HY-156987 | Iotasul | 71767-13-0 | Reference compound |
| HY-156988 | DPI-287 | 519058-13-0 | Reference compound |
| HY-156989 | Butobendine | 55769-65-8 | Reference compound |
| HY-15698A | CRT0066101 (dihydrochloride) | 1883545-60-5 | Reference compound |
| HY-15698B | CRT0066101 (trihydrochloride) | 1781742-22-0 | Reference compound |
| HY-15699 | SAR7334 | 1333210-07-3 | Reference compound |
| HY-156991 | NODAGA-NHS | 1407166-70-4 | Reference compound |
| HY-156992 | AT-035 | 2099680-55-2 | Reference compound |
| HY-156993 | NOP agonist-2 | 2099680-36-9 | Reference compound |
| HY-156994 | ASGPR ligand-1 | 1426160-58-8 | Reference compound |
| HY-156996 | AGI-134 | 1821461-84-0 | Reference compound |
| HY-156997 | ABX196 | 1161877-58-2 | Reference compound |
| HY-156998 | Troxacitabine triphosphate | 171039-00-2 | Reference compound |
| HY-15699A | SAR7334 (hydrochloride) | 1333207-63-8 | Reference compound |
| HY-15700 | PluriSIn 1 | 91396-88-2 | Reference compound |
| HY-157001 | 7-Deaza-dGTP (tetralithium) | Oligonucleotides | |
| HY-157002 | Prostaglandin E2 isopropyl ester | 71845-66-4 | Reference compound |
| HY-157003 | (S)-TCO-PEG2-NH2 | ADC Related | |
| HY-157006 | (S)-TCO-PEG3-NH2 | ADC Related | |
| HY-157007 | (S)-TCO-PEG7-NH2 | ADC Related | |
| HY-157008 | (S)-TCO-PEG2-Maleimide | ADC Related | |
| HY-15701 | Leukadherin-1 | 344897-95-6 | Reference compound |
| HY-157011 | JAK-IN-33 | 3032404-49-9 | Reference compound |
| HY-157012 | SCO-NHS carbonate | 2925279-71-4 | Reference compound |
| HY-157013 | UR-MB-355 | Reference compound | |
| HY-157014 | TPT-004 | 3032648-15-7 | Reference compound |
| HY-157015 | Antifungal agent 81 | Reference compound | |
| HY-157016 | OfChi-h-IN-1 | 902928-83-0 | Reference compound |
| HY-157018 | Antifungal agent 82 | Reference compound | |
| HY-157019 | UniPR1447 | 1809170-68-0 | Reference compound |
| HY-15701A | (Z)-Leukadherin-1 | 2055362-72-4 | Reference compound |
| HY-15701B | ADH-503 | 2055362-74-6 | Reference compound |
| HY-15702 | HJC0350 | 885434-70-8 | Reference compound |
| HY-157020 | UniPR1449 | Reference compound | |
| HY-157021 | SARS-CoV-2-IN-66 | 1807620-38-7 | Reference compound |
| HY-157022 | SARS-CoV-2-IN-67 | 2997784-47-9 | Reference compound |
| HY-157023 | RCB16007 | 2952530-26-4 | Reference compound |
| HY-157024 | Phytoene desaturase-IN-2 | Reference compound | |
| HY-157025 | Herbicidal agent 1 | Reference compound | |
| HY-157026 | Nurr1 agonist 7 | 228707-95-7 | Reference compound |
| HY-157027 | Antifungal agent 85 | 3017207-42-7 | Reference compound |
| HY-157028 | Antiparasitic agent-19 | 3032412-28-2 | Reference compound |
| HY-157029S | KRASG12D-IN-1 | Isotope-Labeled Compounds | |
| HY-15703 | QNZ46 | 1237744-13-6 | Reference compound |
| HY-157030 | NIEA | 75896-33-2 | Reference compound |
| HY-157031S | KRASG12D-IN-2 | Isotope-Labeled Compounds | |
| HY-157032 | Proteasome-IN-5 | 1613134-34-1 | Reference compound |
| HY-157033 | LMP7-IN-2 | 1613317-24-0 | Reference compound |
| HY-157034 | LU-002i | 1838705-22-8 | Reference compound |
| HY-157034A | LU-002i (TFA) | Reference compound | |
| HY-157035 | Proteasome β2c/i-IN-1 | 2322333-75-3 | Reference compound |
| HY-157036 | INSA | 2962939-33-7 | Dye Reagents |
| HY-157037 | OfChi-h-IN-2 | 902932-91-6 | Reference compound |
| HY-157038 | MAGL-IN-8 | 3017151-71-9 | Reference compound |
| HY-157039 | RIPK1-IN-17 | Reference compound | |
| HY-15704 | LH846 | 639052-78-1 | Reference compound |
| HY-157040 | MAGL-IN-9 | Reference compound | |
| HY-157041 | MAGL-IN-10 | 3017151-83-3 | Reference compound |
| HY-157042 | MAGL-IN-11 | 3017151-84-4 | Reference compound |
| HY-157043 | "Antibacterial agent 161 (trifluoromethanesulfonate )" | Reference compound | |
| HY-157044 | "Antibacterial agent 162 (trifluoromethanesulfonate )" | Reference compound | |
| HY-157045 | ATP Synthesis-IN-1 | Reference compound | |
| HY-157046 | ATP Synthesis-IN-2 | Reference compound | |
| HY-157047 | Anticancer agent 171 | Reference compound | |
| HY-157048 | Anticancer agent 172 | Reference compound | |
| HY-157049 | Caprylocaproyl Macrogolglycerides | Reference compound | |
| HY-15705 | GPR35 agonist 2 | 494191-73-0 | Reference compound |
| HY-157050S | 3-Hydroxygepirone-d8 | Isotope-Labeled Compounds | |
| HY-157051 | [Ru(DIP)2TAP]Cl2 | Reference compound | |
| HY-157052 | exo-BCN-Fmoc-L-Lysine | 1493802-76-8 | Reference compound |
| HY-157053 | [Ru(dppn)2phen](PF6)2 | Reference compound | |
| HY-157054 | endo-BCN-L-Lysine | 1493802-96-2 | Reference compound |
| HY-157054A | (Rac)-BCN-L-Lysine | 1580501-90-1 | Reference compound |
| HY-157055 | PD-1-IN-25 | 2413100-40-8 | Reference compound |
| HY-157056S | 5α-Estran-3β-ol-17-one-d3 | Isotope-Labeled Compounds | |
| HY-157057S | N-Desmethyldiltiazem-d5 (maleate) | Isotope-Labeled Compounds | |
| HY-157058S | 5-Hydroxynepafenac-d5 | 2012598-56-8 | Isotope-Labeled Compounds |
| HY-157059S | 6-O-Desmethylprazosin-d8 (TFA) | Isotope-Labeled Compounds | |
| HY-15706 | H2L 5765834 | 420841-84-5 | Reference compound |
| HY-157060S | 7-Hydroxycannabidivarin-d7 | 2249814-78-4 | Isotope-Labeled Compounds |
| HY-157061S | 7-Nor-7-carboxycannabidiol-d10 | Isotope-Labeled Compounds | |
| HY-157062S | 7-O-Desmethylprazosin-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-157067 | KRAS G12C inhibitor 62 | 2658588-10-2 | Reference compound |
| HY-157068 | icFSP1 | 1115910-36-5 | Reference compound |
| HY-157069S | Prochlorperazine sulfoxide-d8 | 1215350-60-9 | Isotope-Labeled Compounds |
| HY-15707 | NS6180 | 353262-04-1 | Reference compound |
| HY-157070 | SCO-L-Lysine | 1309581-49-4 | Reference compound |
| HY-157071S | Seliciclib Carboxylic Acid-d7 | 849108-26-5 | Isotope-Labeled Compounds |
| HY-157072 | WAY-311474 | 569313-77-5 | Reference compound |
| HY-157073 | WAY-607695 | 380469-52-3 | Reference compound |
| HY-157074S | Tandospirone Acid Metabolite-d6 | 2012598-82-0 | Isotope-Labeled Compounds |
| HY-157075S | (Z)-Rilpivirine-d4 | Isotope-Labeled Compounds | |
| HY-157076S | exo-Hydroxytandospirone-d8 | Isotope-Labeled Compounds | |
| HY-157077S | 5-Hydroxysaxagliptin-13C,d2 (TFA) | 2012595-11-6 | Isotope-Labeled Compounds |
| HY-157078 | Eg5-IN-2 | 1629735-05-2 | ADC Related |
| HY-157079 | LP-6 | 1629736-79-3 | ADC Related |
| HY-15708 | LY2795050 | 1346133-08-1 | Reference compound |
| HY-157080 | Dibromomaleimide-C5-COOH | 1443214-97-8 | ADC Related |
| HY-157082 | ZHSI-1 | 2925912-67-8 | Reference compound |
| HY-157083 | mCMY020 | Reference compound | |
| HY-157084 | HS-291 | Reference compound | |
| HY-157085 | BX-2819 | 1184181-50-7 | Reference compound |
| HY-157086 | IR5790 | 192809-26-0 | Reference compound |
| HY-157087 | AChE/MAO-B-IN-4 | Reference compound | |
| HY-157088 | C105SR | Reference compound | |
| HY-157089 | AChE/MAO-B-IN-5 | Reference compound | |
| HY-15709 | AL 082D06 | 256925-03-8 | Reference compound |
| HY-157090 | AChE/MAO-B-IN-6 | Reference compound | |
| HY-157091 | Uridine, 5'-(P,P',P'',P''-tetrahydrogen imidotriphosphate) | 497064-75-2 | Oligonucleotides |
| HY-157092 | ICMT-IN-3 | 1313602-73-1 | Reference compound |
| HY-157092A | (S)-ICMT-IN-3 | Reference compound | |
| HY-157092B | (R)-ICMT-IN-3 | Reference compound | |
| HY-157093 | Cytidine, 5′-(P,P′,P′′,P′′-tetrahydrogen imidotriphosphate) | 497064-76-3 | Reference compound |
| HY-157094 | ICMT-IN-4 | 1313602-74-2 | Reference compound |
| HY-157095 | ICMT-IN-6 | 1313602-75-3 | Reference compound |
| HY-157096 | ICMT-IN-8 | 1313602-76-4 | Reference compound |
| HY-157097 | ICMT-IN-10 | 1313602-78-6 | Reference compound |
| HY-157098 | ICMT-IN-16 | 1313602-79-7 | Reference compound |
| HY-157099 | ICMT-IN-18 | 1313602-81-1 | Reference compound |
| HY-15710 | Cort108297 | 1018679-79-2 | Reference compound |
| HY-157100 | ICMT-IN-23 | 1313602-82-2 | Reference compound |
| HY-157101 | ICMT-IN-25 | 1313602-83-3 | Reference compound |
| HY-157102 | ICMT-IN-26 | 1313602-84-4 | Reference compound |
| HY-157103 | ICMT-IN-34 | 1313602-85-5 | Reference compound |
| HY-157104 | ICMT-IN-36 | 1313602-86-6 | Reference compound |
| HY-157105 | ICMT-IN-37 | 1313602-87-7 | Reference compound |
| HY-157106 | ICMT-IN-38 | 1313602-88-8 | Reference compound |
| HY-157107 | ICMT-IN-39 | 1313602-64-0 | Reference compound |
| HY-157108 | ICMT-IN-40 | 1313602-65-1 | Reference compound |
| HY-157109 | ICMT-IN-41 | 1313602-66-2 | Reference compound |
| HY-157110 | ICMT-IN-42 | 1313602-67-3 | Reference compound |
| HY-157111 | ICMT-IN-43 | 1313602-68-4 | Reference compound |
| HY-157112 | ICMT-IN-44 | 1313602-69-5 | Reference compound |
| HY-157113 | ICMT-IN-45 | 1313602-70-8 | Reference compound |
| HY-157114 | ICMT-IN-46 | 1313602-71-9 | Reference compound |
| HY-157115 | ICMT-IN-47 | 1313602-72-0 | Reference compound |
| HY-157116 | ICMT-IN-48 | 337486-54-1 | Reference compound |
| HY-157117 | ICMT-IN-49 | 303728-92-9 | Reference compound |
| HY-157118 | ICMT-IN-50 | 371940-21-5 | Reference compound |
| HY-157119 | ICMT-IN-51 | 1313602-89-9 | Reference compound |
| HY-157120 | ICMT-IN-52 | 1313602-90-2 | Reference compound |
| HY-157121 | JAK-IN-34 | 2068766-90-3 | Reference compound |
| HY-157122 | VJDT | 2765319-65-9 | Reference compound |
| HY-157123 | Tyrosinase-IN-18 | Reference compound | |
| HY-157124 | Tyrosinase-IN-19 | Reference compound | |
| HY-157125 | PI3Kα-IN-14 | 3026856-46-9 | Reference compound |
| HY-157126 | Pterostilbene-isothiocyanate | 1616974-29-8 | Reference compound |
| HY-157127 | Ketoprofen L-thyroxine ester | 3032398-41-4 | Reference compound |
| HY-157128 | PI3Kδ-IN-18 | 3019965-38-6 | Reference compound |
| HY-157129 | AMPK-α1β1γ1 activator 1 | 1943510-86-8 | Reference compound |
| HY-15713 | NMS-873 | 1418013-75-8 | Reference compound |
| HY-157130 | T3SS-IN-3 | Reference compound | |
| HY-157131 | TRPV2-selective blocker 1 | 2242724-49-6 | Reference compound |
| HY-157132 | FAAH-IN-8 | 2867633-84-7 | Reference compound |
| HY-157133 | TAS0612 | 2148902-58-1 | Reference compound |
| HY-157134 | Y08262 | 2450965-18-9 | Reference compound |
| HY-157135 | hCAIX-IN-19 | Reference compound | |
| HY-157136 | LFS-1107 | 1799330-91-8 | Reference compound |
| HY-157137 | PARP1-IN-17 | Reference compound | |
| HY-157138 | MMP-9-IN-8 | 2490543-89-8 | Reference compound |
| HY-157139 | ALP/Carbonic anhydrase-IN-1 | 2091887-74-8 | Reference compound |
| HY-15714 | NMS-859 | 1449236-96-7 | Reference compound |
| HY-157140 | HibK | 1644442-22-7 | Reference compound |
| HY-157141 | Antibacterial agent 163 | 16588-39-9 | Reference compound |
| HY-157142 | Antibacterial agent 165 | Reference compound | |
| HY-157143 | Antibacterial agent 164 | Reference compound | |
| HY-157144 | SARS-CoV-2-IN-68 | 2682897-84-1 | Reference compound |
| HY-157145 | SARS-CoV-2-IN-69 | 78471-90-6 | Reference compound |
| HY-157146 | NLRP3-IN-23 | Reference compound | |
| HY-157147 | NLRP3-IN-24 | Reference compound | |
| HY-157148 | 1D228 | 2925447-16-9 | Isotope-Labeled Compounds |
| HY-157149 | DS21150768 | Reference compound | |
| HY-157150 | mAC2-IN-1 | Reference compound | |
| HY-157151 | iPRMT1 | Reference compound | |
| HY-157152 | HDAC-IN-65 | Reference compound | |
| HY-157153 | hDHODH-IN-14 | 881826-17-1 | Reference compound |
| HY-157154 | MAT-POS-e194df51-1 | 2765433-05-2 | Reference compound |
| HY-157157 | PAD4-IN-3 | 2642327-44-2 | Reference compound |
| HY-157158 | TrxR-IN-6 | 3032446-53-7 | Reference compound |
| HY-157159 | BTK-IN-28 | Reference compound | |
| HY-15716 | Kobe0065 | 436133-68-5 | Reference compound |
| HY-157160 | PPO-IN-5 | Reference compound | |
| HY-157161 | 11β-HSD2-IN-1 | Reference compound | |
| HY-157162 | Insecticidal agent 5 | 3021587-00-5 | Reference compound |
| HY-157164 | PROTAC EZH2 Degrader-2 | Reference compound | |
| HY-157165 | Tubulin/PARP-IN-1 | Reference compound | |
| HY-157166 | EGFR kinase inhibitor 2 | Reference compound | |
| HY-157168 | TrkA-IN-6 | Reference compound | |
| HY-157169 | IBL-302 | 1414455-21-2 | Reference compound |
| HY-15717 | Kobe2602 | 454453-49-7 | Reference compound |
| HY-157170 | CYP450-IN-1 | Reference compound | |
| HY-157171 | Ac-YR-NH2 | Reference compound | |
| HY-157172 | MorHap | Reference compound | |
| HY-157173 | Mannosamine-biotin adduct | Reference compound | |
| HY-157174 | Mannosamine–desthiobiotin adduct | Reference compound | |
| HY-157175 | Mannosamine–lipoic acid adduct | Reference compound | |
| HY-157176 | BAX-IN-1 | 331261-91-7 | Reference compound |
| HY-157177 | WAY-322454 | 1008244-02-7 | Reference compound |
| HY-157178 | WAY-359473 | 314248-20-9 | Reference compound |
| HY-157179 | WAY-312491 | 609792-38-3 | Reference compound |
| HY-15718 | Istaroxime | 203737-93-3 | Reference compound |
| HY-157180 | WAY-327131 | 725695-33-0 | Reference compound |
| HY-157181 | Hal-HS | 151749-58-5 | Reference compound |
| HY-157182 | DNP-PEG2-NHCO-C2-DBCO | Reference compound | |
| HY-157183 | HSMO9 | 1313762-77-4 | Reference compound |
| HY-157184 | 1-Deoxydihydroceramide | 2415078-34-9 | Reference compound |
| HY-157185 | Etioporphyrin IV acid | Reference compound | |
| HY-157186 | (22R)-33,34,35-Trinorbacteriohopan-32-oic acid | 74431-96-2 | Reference compound |
| HY-157187 | Fenhexamid-1-pentanoic acid | 2248672-35-5 | Reference compound |
| HY-157188 | Fenhexamid-4-pentanoic acid | 2250414-53-8 | Reference compound |
| HY-157189 | GPR132 antagonist 1 | 898211-21-7 | Reference compound |
| HY-157189A | GPR132 antagonist 1 (dihydrocholide) | Reference compound | |
| HY-15718A | Istaroxime (hydrochloride) | 374559-48-5 | Reference compound |
| HY-15718B | Istaroxime (oxalate) | 203737-94-4 | Reference compound |
| HY-15719 | NU 7026 | 154447-35-5 | Reference compound |
| HY-157190 | Fenhexamid-butyric acid | 1160646-98-9 | Reference compound |
| HY-157191 | Fenhexamid-5-hexenoic acid | 2250414-52-7 | Reference compound |
| HY-157192 | Clothianidin-2-S-propanoic acid | 912270-45-2 | Reference compound |
| HY-157193 | Diacylglyceride | 73566-74-2 | Reference compound |
| HY-157194 | RL-6-Me-7-OH | 2184-54-5 | Reference compound |
| HY-157198 | Dinotefuran-NHCO-propionic acid | Reference compound | |
| HY-15720 | H-1152 | 451462-58-1 | Reference compound |
| HY-157200 | 2,4-DA-6-FP | 4261-17-0 | Reference compound |
| HY-157201 | ZEo | Reference compound | |
| HY-157202 | Zeoh | Reference compound | |
| HY-157203 | Cholic acid-cysteine-cyanuric chloride complex | Reference compound | |
| HY-157204 | ZEp | Reference compound | |
| HY-157205 | Zeph | Reference compound | |
| HY-157206 | ICMT-IN-55 | 1313602-77-5 | Reference compound |
| HY-157207S | N-Desmethyl-Atomoxetine labeled-d5 (hydrochloride) | 2712570-39-1 | Isotope-Labeled Compounds |
| HY-15720A | H-1152 (dihydrochloride) | 871543-07-6 | Reference compound |
| HY-15720B | Glycyl H-1152 (hydrochloride) | 913844-45-8 | Reference compound |
| HY-15721 | FH535 | 108409-83-2 | Reference compound |
| HY-157210 | CDK7-IN-26 | 3024545-79-4 | Reference compound |
| HY-157211 | Anti-inflammatory agent 66 | Reference compound | |
| HY-157212 | PARP-1/Proteasome-IN-1 | Reference compound | |
| HY-157213 | LWY713 | Reference compound | |
| HY-157214 | NVS-STG2 | 3030588-01-0 | Reference compound |
| HY-157215 | HDAC-IN-66 | Reference compound | |
| HY-157216 | HDAC1 Degrader-1 | Reference compound | |
| HY-157217 | Antitumor agent-99 | Reference compound | |
| HY-157218 | PPm | 2101951-47-5 | Reference compound |
| HY-157219 | HDAC6-IN-26 | 2991427-19-9 | Reference compound |
| HY-15722 | SB-222200 | 174635-69-9 | Reference compound |
| HY-157220 | Tolvaptan phosphate ester (sodium) | 942619-79-6 | Reference compound |
| HY-157221 | Biotin-16-dGTP (tetralithium) | Oligonucleotides | |
| HY-157222 | Antitumor agent-125 | Reference compound | |
| HY-157223 | ARN16186 | 2320555-85-7 | Reference compound |
| HY-157224 | Zearalanone carboxymethoxyl oxime | 102570-33-2 | Reference compound |
| HY-157225 | Brazilin-7-acetate | Reference compound | |
| HY-157226 | ORI-TRN-002 | Reference compound | |
| HY-157227 | VPC01091.4 | 945604-76-2 | Reference compound |
| HY-157228 | ACBI3 | 2938169-76-5 | Reference compound |
| HY-157229 | STX-721 | 2765525-82-2 | Reference compound |
| HY-15723 | NSC 23766 | 733767-34-5 | Reference compound |
| HY-157230 | XIAP antagonist 1 | 375835-04-4 | Reference compound |
| HY-157231A | HC-5404-Fu | 3034479-99-4 | Reference compound |
| HY-157232 | AC Antibody purification resin 2 | ADC Related | |
| HY-157233 | AC Antibody purification resin 1 | ADC Related | |
| HY-157234 | AC mAb-X purification resin | ADC Related | |
| HY-157235 | AC Antibody affinity resin | ADC Related | |
| HY-157236 | AEX Anion-exchange resin 1 | ADC Related | |
| HY-157237 | AEX Ion-exchange resin | ADC Related | |
| HY-157238 | AEX Anion-exchange resin 2 | ADC Related | |
| HY-157239 | AEX HQ Anion-exchange resin | ADC Related | |
| HY-15723A | NSC 23766 (trihydrochloride) | 1177865-17-6 | Reference compound |
| HY-15724 | Vercirnon | 698394-73-9 | Reference compound |
| HY-157240 | CEX Ion-exchange resin | ADC Related | |
| HY-157241 | CEX Cation-exchange resin 1 | ADC Related | |
| HY-157242 | CEX Polishing resin | ADC Related | |
| HY-157243 | CEX Cation-exchange resin 2 | ADC Related | |
| HY-157244 | Proteins separation resin | ADC Related | |
| HY-157245 | Hydrophobic polishing resin | ADC Related | |
| HY-157246 | Hydrophobic resin | ADC Related | |
| HY-157247S | Dodecyl N,N-dimethylaminoacetate-d6 | 2705076-41-9 | Isotope-Labeled Compounds |
| HY-157248 | Fmoc-3-Me-Glu(OtBu)-OH | 1429504-34-6 | Peptides |
| HY-157249 | Antiviral agent 43 | 2739990-96-4 | Reference compound |
| HY-15724A | Vercirnon (sodium) | 886214-18-2 | Reference compound |
| HY-15725 | CDDO-Im | 443104-02-7 | Reference compound |
| HY-157250 | BHD | 2749517-98-2 | Reference compound |
| HY-157251 | UNC8153 (TFA) | 2929304-61-8 | Reference compound |
| HY-157251A | UNC8153 | 2929304-60-7 | Reference compound |
| HY-157252 | CL4F8-6 | 2766493-12-1 | Biochemical Assay Reagents |
| HY-157253 | 13(S)-HODE-biotin | 1217458-58-6 | Reference compound |
| HY-157254 | AA10 | 2134106-02-6 | Reference compound |
| HY-157255S | α-Dimethylaminopentiophenone-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-157257 | Trimethoprim fumaric acid | 1546799-45-4 | Reference compound |
| HY-157258 | Trimethoprim pentanoic acid | 78025-89-5 | Reference compound |
| HY-157259 | Trimethoprim propanoic acid | 94236-24-5 | Reference compound |
| HY-15726 | ICI 89406 | 53671-71-9 | Reference compound |
| HY-157260 | Propylbenzene-(CH2)2-COOH | 1057602-98-8 | Reference compound |
| HY-157261 | UNC2383 | 2123481-48-9 | Reference compound |
| HY-157262 | Methyl isonicotinate-(CH2)2-COOH | 2710224-09-0 | Reference compound |
| HY-157269 | J10-1 | 1069110-72-0 | Reference compound |
| HY-15727 | Afuresertib | 1047644-62-1 | Reference compound |
| HY-157270 | 2-Heptylundecanol | 5333-44-8 | Reference compound |
| HY-157275 | Gly-Gly-Gly-PEG2-azide | 2222277-20-3 | ADC Related |
| HY-157277 | AdBeSA | 201480-32-2 | Reference compound |
| HY-15727A | Afuresertib (hydrochloride) | 1047645-82-8 | Reference compound |
| HY-15728 | Radotinib | 926037-48-1 | Reference compound |
| HY-157280 | AdCaPy | 307320-40-7 | ADC Related |
| HY-157281 | Photolumazine III | 23140-55-8 | Reference compound |
| HY-157282 | Photolumazine I | 29161-67-9 | Reference compound |
| HY-157284 | Cys-mc-MMAE | ADC Related | |
| HY-157287 | (S)-Phe-A110/B319 | Reference compound | |
| HY-157288 | (R)-Phe-A110/B319 | Reference compound | |
| HY-15728S | Radotinib-d6 | 2754051-83-5 | Isotope-Labeled Compounds |
| HY-15729 | Rociletinib | 1374640-70-6 | Reference compound |
| HY-157290 | HL403 | Reference compound | |
| HY-157291 | Antiviral agent 44 | 872201-68-8 | Reference compound |
| HY-157292 | 2E-3-F16 | 3002962-69-5 | Reference compound |
| HY-157294 | GSK866 | 1991970-93-4 | Reference compound |
| HY-157294A | (R)-GSK866 | 1094607-80-3 | Reference compound |
| HY-157295 | PI3K/HDAC-IN-3 | 3006905-22-9 | Reference compound |
| HY-157296 | AChE-IN-47 | 3033056-55-9 | Reference compound |
| HY-157297 | CDK-IN-13 | Reference compound | |
| HY-157298 | anti-TNBC agent-4 | 3027501-51-2 | Reference compound |
| HY-157299 | PDK-IN-3 | Reference compound | |
| HY-15729A | Rociletinib hydrobromide | 1446700-26-0 | Reference compound |
| HY-15730 | Poziotinib | 1092364-38-9 | Reference compound |
| HY-157300 | Antifungal agent 88 | Reference compound | |
| HY-157302 | c-Met-IN-21 | 3025958-01-1 | Reference compound |
| HY-157303 | SSTR5 antagonist 3 | 2851454-42-5 | Reference compound |
| HY-157305 | Jun11165 | Reference compound | |
| HY-157306 | HC-1310 | 2101230-88-8 | Reference compound |
| HY-157308 | α-Synuclein inhibitor 10 | 3050715-65-3 | Reference compound |
| HY-157309 | RIPK2-IN-4 | Reference compound | |
| HY-15731 | Estetrol | 15183-37-6 | Natural Products |
| HY-157311 | α-Glucosidase-IN-45 | 3026192-46-8 | Reference compound |
| HY-157312 | TM38837 | 1034264-77-1 | Reference compound |
| HY-157313 | Pancreatic lipase-IN-1 | Reference compound | |
| HY-157314 | HDAC6-IN-27 | 2758023-91-3 | Reference compound |
| HY-157315 | Fabl inhibitor 21272541 | 898527-42-9 | Reference compound |
| HY-157316 | TZ-NBD | Dye Reagents | |
| HY-157317 | Antitumor agent-126 | 3014356-10-3 | Reference compound |
| HY-157318 | PB17-026-01 | Reference compound | |
| HY-157319 | PI3Kα-IN-15 | 2893920-80-2 | Reference compound |
| HY-15731S | Estetrol-d4 | Isotope-Labeled Compounds | |
| HY-15732 | BGB-102 | 807640-87-5 | Reference compound |
| HY-157320 | Tubulin/PARP-IN-2 | Reference compound | |
| HY-157321 | hCAI/II-IN-7 | 14204-32-1 | Reference compound |
| HY-157322 | SAV13 | 423748-49-6 | Reference compound |
| HY-157323 | HDAC6-IN-28 | Reference compound | |
| HY-157324 | EGFR-IN-94 | Reference compound | |
| HY-157325 | RIPK2-IN-5 | 2885227-09-6 | Reference compound |
| HY-157326 | hMAO-B-IN-6 | 2764830-43-3 | Reference compound |
| HY-157327 | AKE-72 | 2566525-18-4 | Reference compound |
| HY-157328 | 7PCGY | 1415888-05-9 | Reference compound |
| HY-157329 | AD16 | 311315-04-5 | Reference compound |
| HY-15733 | Lucidin | 478-08-0 | Natural Products |
| HY-157330 | P-gp inhibitor 16 | Reference compound | |
| HY-157331 | DCZ5418 | 2883709-99-5 | Reference compound |
| HY-157332 | WDR5-IN-7 | 3032761-31-9 | Reference compound |
| HY-157333 | CYP51-IN-15 | 3034186-60-9 | Reference compound |
| HY-157334 | DEG-77 | 3032265-06-5 | Reference compound |
| HY-157335 | Mn(II)-DO3A (sodium) | 120066-53-7 | Reference compound |
| HY-157338 | NHS-Ala-Ala-Asn-active metabolite | 2231135-69-4 | ADC Related |
| HY-157339 | MMT-2'-O-Methyl adenosine (n-bz) CED phosphoramidite | 2645354-88-5 | Reference compound |
| HY-15733R | Lucidin (Standard) | 478-08-0 | Reference Standards |
| HY-15734 | AGI-6780 | 1432660-47-3 | Reference compound |
| HY-157340 | 2',3'-Dibenzoyl-1-methylpseudouridine | Reference compound | |
| HY-157343 | GD3 Ganglioside | 62010-37-1 | Natural Products |
| HY-157343A | GD3 Ganglioside (sodium) | Natural Products | |
| HY-157344 | Nutrient Broth | Biochemical Assay Reagents | |
| HY-157345 | Nutrient Agar | Biochemical Assay Reagents | |
| HY-157346 | LB Nutrient Agar | Biochemical Assay Reagents | |
| HY-157346A | LB Agar | Biochemical Assay Reagents | |
| HY-157347 | Yeast Nitrogen Base Medium | Biochemical Assay Reagents | |
| HY-157347A | Yeast Nitrogen Base Medium without Amino Acids | Biochemical Assay Reagents | |
| HY-157348 | Lauryl Sulfate Tryptose Broth | Biochemical Assay Reagents | |
| HY-157349 | Brilliant Green Lactose Bile Broth | Biochemical Assay Reagents | |
| HY-15735 | c-Met inhibitor 1 | 1357072-61-7 | Reference compound |
| HY-157350 | Violet Red Bile Agar | Biochemical Assay Reagents | |
| HY-157351 | E.Coli Broth | Biochemical Assay Reagents | |
| HY-157352 | Eosin-Methylene Blue Agar | Biochemical Assay Reagents | |
| HY-157353 | MacConkey Agar | Biochemical Assay Reagents | |
| HY-157354 | Urease Agar Base | Biochemical Assay Reagents | |
| HY-157355 | Brain Heart Infusion Broth | Biochemical Assay Reagents | |
| HY-157356 | Violet Red Bile Glucose Agar | Biochemical Assay Reagents | |
| HY-157357 | Fungi Agar Medium | Biochemical Assay Reagents | |
| HY-157358 | Corn Meal Medium | Biochemical Assay Reagents | |
| HY-157359 | Bacterial Organophosphorus Medium | Biochemical Assay Reagents | |
| HY-15736 | Sodium Channel inhibitor 1 | 1198117-23-5 | Reference compound |
| HY-157360 | Acetamide Agar | Biochemical Assay Reagents | |
| HY-157361 | Ethyl Violet Aziode Broth | Biochemical Assay Reagents | |
| HY-157362 | Tryptone Soya Broth | Biochemical Assay Reagents | |
| HY-157363 | Tryptone Soya Agar | Biochemical Assay Reagents | |
| HY-157364 | Levine Eosin-Methylene Blue Agar Medium | Biochemical Assay Reagents | |
| HY-157365 | Anaerobic Agar | Biochemical Assay Reagents | |
| HY-157366 | Sulfite Agar | Biochemical Assay Reagents | |
| HY-157367 | Bismuth Sulfite Agar Medium | Biochemical Assay Reagents | |
| HY-157368 | Bismuth Sulfite Agar | Biochemical Assay Reagents | |
| HY-157369 | Salmonella Arizona Agar | Biochemical Assay Reagents | |
| HY-15737 | DB07268 | 929007-72-7 | Reference compound |
| HY-157370 | Blood Enrichment Medium | Biochemical Assay Reagents | |
| HY-157371 | Blood Agar Base | Biochemical Assay Reagents | |
| HY-157372 | Peptone Bacteriological | Biochemical Assay Reagents | |
| HY-157373 | Bromcresol Purple Broth Base | Biochemical Assay Reagents | |
| HY-157374 | Beef Heart Infusion | Biochemical Assay Reagents | |
| HY-157375 | Brain Heart Infusion Agar | Biochemical Assay Reagents | |
| HY-157376 | Casein Agar | Biochemical Assay Reagents | |
| HY-157377 | Yeast Peptone Dextrose Agar | Biochemical Assay Reagents | |
| HY-157378 | YM11 Agar | Biochemical Assay Reagents | |
| HY-157379 | YM Agar | Biochemical Assay Reagents | |
| HY-15738 | GNF-5 | 778277-15-9 | Reference compound |
| HY-157380 | Salmonella-Shigella Agar | Biochemical Assay Reagents | |
| HY-157381 | China Blue Lactose Agar | Biochemical Assay Reagents | |
| HY-157382 | AChE-IN-51 | Reference compound | |
| HY-157384 | BChE-IN-22 | Reference compound | |
| HY-157385 | HDAC-IN-67 | 2821923-75-3 | Reference compound |
| HY-157386S | 8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2 | Isotope-Labeled Compounds | |
| HY-157387 | c-Met-IN-22 | Reference compound | |
| HY-157388 | CARM1/HDAC2-IN-1 | Reference compound | |
| HY-157389 | AK-HW-90 | Reference compound | |
| HY-15739 | Ansamitocin P-3 | 66584-72-3 | Natural Products |
| HY-157390 | DPP-4-IN-9 | 2906243-39-6 | Reference compound |
| HY-157391 | ALK/ROS1-IN-3 | Reference compound | |
| HY-157392 | hMAO-A-IN-1 | 1039315-88-2 | Reference compound |
| HY-157393 | BET bromodomain inhibitor 4 | 2407658-41-5 | Reference compound |
| HY-157394 | eeAChE/eqBuChE-IN-1 | 2921654-26-2 | Reference compound |
| HY-157395 | malonyl-NAC | 2361327-06-0 | Reference compound |
| HY-157396 | JAB-2485 | 2899209-55-1 | Reference compound |
| HY-157397A | ANAT inhibitor-4 (dilithium) | Reference compound | |
| HY-157398 | EGFR T790M/L858R-IN-3 | Reference compound | |
| HY-157399 | EGFR/HER2-IN-10 | 2931499-82-8 | Reference compound |
| HY-15739R | Ansamitocin P-3 (Standard) | 66584-72-3 | Reference Standards |
| HY-15740 | Mc-MMAD | 1401963-15-2 | ADC Related |
| HY-157400 | hMAO-B-IN-7 | 2955577-14-5 | Reference compound |
| HY-157401 | HDAC6-IN-29 | Reference compound | |
| HY-157402 | Topoisomerase II/EGFR-IN-1 | Reference compound | |
| HY-157403 | Jun12682 | Reference compound | |
| HY-157404 | Pim-1/2 kinase inhibitor 2 | 2918764-16-4 | Reference compound |
| HY-157405 | DENV-IN-11 | Reference compound | |
| HY-157407 | Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan | 2699066-62-9 | ADC Related |
| HY-157408 | KDM4D-IN-3 | Reference compound | |
| HY-15741 | Mc-MMAE | 863971-24-8 | ADC Related |
| HY-157411 | anti-TNBC agent-5 | Reference compound | |
| HY-157412 | CRM1-IN-3 | 1114628-25-9 | Reference compound |
| HY-157413 | YS-67 | 2761327-15-3 | Reference compound |
| HY-157414 | Azide-A-DSBSO crosslinker | 1704097-02-8 | Reference compound |
| HY-157416 | COP1-ATGL modulator 1 | 2946701-09-1 | Reference compound |
| HY-157417 | G-quadruplex ligand 1 | 1023617-96-0 | Reference compound |
| HY-157418 | 1-Deoxy-Cer | 1645269-61-9 | Reference compound |
| HY-157419 | FL77-24 | 2413582-39-3 | Reference compound |
| HY-15742 | Vc-MMAD | 1401963-17-4 | ADC Related |
| HY-157420 | VEGFR-2-IN-38 | 3020790-57-9 | Reference compound |
| HY-157421 | Nampt activator-4 | 2847156-05-0 | Reference compound |
| HY-157422 | CSF1R-IN-19 | 1819989-27-9 | Reference compound |
| HY-157423 | 16:1 (DELTA 9-Cis) PC | 56815-99-7 | Biochemical Assay Reagents |
| HY-157424 | 3′-Phosphoadenosine 5′-phosphosulfate (tetralithium salt) | 102029-54-9 | Biochemical Assay Reagents |
| HY-157425 | 5-HT2CR agonist 1 | 1216074-15-5 | Reference compound |
| HY-157426 | GSPT1 degrader-3 | Reference compound | |
| HY-157428 | USP3 ZnF-UBD ligand-1 | 2419322-41-9 | Reference compound |
| HY-157429 | 25N-N1-Nap | 2865185-31-3 | Reference compound |
| HY-15743 | Birabresib | 202590-98-5 | Reference compound |
| HY-157430 | BET-IN-21 | 3014815-06-3 | Reference compound |
| HY-157431 | Mycobacterium Tuberculosis-IN-2 | 2284580-65-8 | Reference compound |
| HY-157432 | EGFR-IN-97 | 3020681-05-1 | Reference compound |
| HY-157433 | Mab-SaS-IN-1 | 773869-38-8 | Reference compound |
| HY-157434 | PCSK9-IN-23 | 2115700-96-2 | Reference compound |
| HY-157435 | PELI1-IN-1 | Reference compound | |
| HY-157436 | HDAC6-IN-30 | Reference compound | |
| HY-157437 | AChE/BChE-IN-16 | Reference compound | |
| HY-157438 | pppApA | 17730-98-2 | Reference compound |
| HY-157438A | pppApA (sodium) | Reference compound | |
| HY-157439 | SARS-CoV-2-IN-72 | Reference compound | |
| HY-15743A | (R)-Birabresib | 1983196-25-3 | Reference compound |
| HY-15743R | Birabresib (Standard) | 202590-98-5 | Reference Standards |
| HY-15744 | LY255283 | 117690-79-6 | Reference compound |
| HY-157440 | AChE/Aβ-IN-3 | Reference compound | |
| HY-157441 | AChE/Aβ-IN-4 | Reference compound | |
| HY-157442 | GLPG3312 | 2340388-72-7 | Reference compound |
| HY-157443 | Myt1-IN-4 | Reference compound | |
| HY-157444 | 5,3',4',3'',4'',5''-6-O-Ethyl-EGCG | 1613308-63-6 | Reference compound |
| HY-157445 | CBR1-IN-3 | 891101-69-2 | Reference compound |
| HY-157446 | MoTPS1/2-IN-1 | Reference compound | |
| HY-157447 | CBR1-IN-4 | 1798284-64-6 | Reference compound |
| HY-157448 | CBR1-IN-6 | Reference compound | |
| HY-157449 | CBR1-IN-5 | 1798284-62-4 | Reference compound |
| HY-15745 | PSI-7409 | 1015073-42-3 | Reference compound |
| HY-157450 | YF-Mo1 | 1119826-36-6 | Reference compound |
| HY-157451 | CBR1-IN-7 | 1119826-35-5 | Reference compound |
| HY-157452 | (8S)-Methyl zearalenone | 1137720-39-8 | Reference compound |
| HY-157453 | CCR4 antagonist 4 | 668980-17-4 | Reference compound |
| HY-157454 | Antiviral agent 48 | 3032868-59-7 | Reference compound |
| HY-157455 | AR antagonist 5 | 2902679-53-0 | Reference compound |
| HY-157456 | RIPK1-IN-19 | 2763831-43-0 | Reference compound |
| HY-157457 | Z21090 | 2992690-71-6 | Reference compound |
| HY-157458 | PDEδ autophagic degrader 1 | Reference compound | |
| HY-157459 | SDH-IN-11 | 2998946-58-8 | Reference compound |
| HY-15745A | PSI-7409 (tetrasodium) | 1621884-22-7 | Reference compound |
| HY-15746 | Dobutamine (hydrochloride) | 49745-95-1 | Reference compound |
| HY-157460 | BRD4 Inhibitor-29 | 902563-50-2 | Reference compound |
| HY-157461 | Glycation-IN-1 | 3023711-86-3 | Reference compound |
| HY-157462 | FC14-584B | 1358567-64-2 | Reference compound |
| HY-157464 | [Ru(phen)2(4-Me-Sal)]BF4 | Reference compound | |
| HY-157465 | MA-PEG4-VC-PAB-DMEA-duocarmycin DM | ADC Related | |
| HY-157465A | MA-PEG4-VC-PAB-DMEA-duocarmycin DM (TFA) | Reference compound | |
| HY-157466 | Antiparasitic agent-21 | Reference compound | |
| HY-157468 | (R)-ELX-02 | 1375073-95-2 | Reference compound |
| HY-15746A | Dobutamine | 34368-04-2 | Reference compound |
| HY-15746B | Dobutamine (tartrate) | 101626-66-8 | Reference compound |
| HY-15746R | Dobutamine (hydrochloride) (Standard) | 49745-95-1 | Reference Standards |
| HY-15746S | (rac)-Dobutamine-d4 (hydrochloride) | 1246815-74-6 | Isotope-Labeled Compounds |
| HY-15746S1 | (rac)-Dobutamine-d6 (hydrochloride) | 1246818-96-1 | Isotope-Labeled Compounds |
| HY-15747 | Deltarasin | 1440898-61-2 | Reference compound |
| HY-157470 | PPO-IN-6 | 125727-57-3 | Reference compound |
| HY-157471 | PPO-IN-7 | 103361-04-2 | Reference compound |
| HY-157476 | AChE-IN-53 | 2807436-94-6 | Reference compound |
| HY-157477 | SARS-CoV-2 3CLpro-IN-22 | Reference compound | |
| HY-157478 | CSNK2A-IN-1 | 3029550-24-8 | Reference compound |
| HY-157479 | DPI-2016 | 2760731-35-7 | Reference compound |
| HY-15747A | Deltarasin (hydrochloride) | 1613404-76-4 | Reference compound |
| HY-15748 | JNJ-40411813 | 1127498-03-6 | Reference compound |
| HY-157480 | EGFR/AURKB-IN-1 | 3008543-34-5 | Reference compound |
| HY-157481 | HDAC1-IN-6 | Reference compound | |
| HY-157482 | EBP-59 | Reference compound | |
| HY-157483 | P-gp inhibitor 18 | Reference compound | |
| HY-157484 | P-gp inhibitor 19 | Reference compound | |
| HY-157485 | Ebio1 | 339287-36-4 | Reference compound |
| HY-157486 | KMI169 | Reference compound | |
| HY-157487 | Anticancer agent 185 | Reference compound | |
| HY-157488 | α-Glucosidase-IN-46 | Reference compound | |
| HY-157489 | α-Glucosidase-IN-47 | Reference compound | |
| HY-15749 | XL228 | 898280-07-4 | Reference compound |
| HY-157490 | PARP/HDAC-IN-1 | Reference compound | |
| HY-157491 | K2-B4-5e | Reference compound | |
| HY-157492 | RO7075573 | 2097284-11-0 | Reference compound |
| HY-157493 | PR antagonist 1 | 936345-34-5 | Reference compound |
| HY-157494 | EP3 antagonist 5 | 499147-44-3 | Reference compound |
| HY-157495 | EP3 antagonist 6 | 499149-94-9 | Reference compound |
| HY-157496 | EP3 antagonist 7 | 740850-59-3 | Reference compound |
| HY-157497 | DA5-HTL | Reference compound | |
| HY-15750 | Cys-mcMMAD | ADC Related | |
| HY-157502S | Buctopamine-d9 | Isotope-Labeled Compounds | |
| HY-157503 | Photosensitizer-3 | 1928742-39-5 | Reference compound |
| HY-157504 | 2′-O-Methyl-5′-O-phosphonoadenylyl-(3′→5′)-guanosine (TEA) | 2638447-50-2 | Reference compound |
| HY-157507 | JC-010a | 2565765-13-9 | Reference compound |
| HY-157508 | VCP Activator 1 | 3061959-30-3 | Reference compound |
| HY-157510 | Thalidomide-O-C3-azide | 2758432-00-5 | Reference compound |
| HY-157511 | Thalidomide-O-C5-azide | 2411098-96-7 | Reference compound |
| HY-157512 | SJF-0661 | 2413035-43-3 | Reference compound |
| HY-157514 | Thalidomide 4'-ether-PEG1-azide | 2758432-02-7 | Reference compound |
| HY-157515 | Thalidomide 4'-ether-PEG2-azide | 2758431-90-0 | Reference compound |
| HY-157516 | CDK2-IN-22 | Reference compound | |
| HY-157517 | MAO-B-IN-29 | 122823-57-8 | Reference compound |
| HY-157518 | OJT008 | 256370-29-3 | Reference compound |
| HY-157519 | LAH-1 | 3018150-68-7 | Reference compound |
| HY-157520 | BChE-IN-25 | 79183-25-8 | Reference compound |
| HY-157521 | AANAT-IN-1 | 3055162-52-9 | Reference compound |
| HY-157522 | NCI-14465 | 1144534-31-5 | Reference compound |
| HY-157524 | 1,2-O-Dioctadecyl-sn-glycerol | 82188-61-2 | Biochemical Assay Reagents |
| HY-157526 | EGFR-TK-IN-1 | Reference compound | |
| HY-157527 | hAChE-IN-7 | 2978613-03-3 | Reference compound |
| HY-157528 | CJ28 | Natural Products | |
| HY-157529 | IR820-PTX | 2250419-19-1 | Dye Reagents |
| HY-15753 | Ellipticine | 519-23-3 | Natural Products |
| HY-157530 | VAP-1-IN-3 | Reference compound | |
| HY-157532 | AChE-IN-55 | Reference compound | |
| HY-157533 | AcrB-IN-5 | 81050-84-2 | Reference compound |
| HY-157534 | Pancreatic lipase-IN-2 | Reference compound | |
| HY-157535 | SHP2-IN-24 | Reference compound | |
| HY-157536 | SMT-738 | Reference compound | |
| HY-157537 | α-Amylase-IN-5 | 2996821-90-8 | Reference compound |
| HY-157538 | PDK4-IN-2 | 1616752-12-5 | Reference compound |
| HY-157539 | PB49673382 | 2763495-65-2 | Reference compound |
| HY-15753A | Ellipticine (hydrochloride) | 5081-48-1 | Natural Products |
| HY-15754 | CGP37157 | 75450-34-9 | Reference compound |
| HY-157542 | CG428-NEG | 2714560-39-9 | Reference compound |
| HY-157543 | Tubulin polymerization-IN-59 | Reference compound | |
| HY-157544 | PC5-VC-PAB-MMAE | 2922216-98-4 | ADC Related |
| HY-157546 | VEGFR-2-IN-40 | Reference compound | |
| HY-157547 | FXIa-IN-14 | 2423992-72-5 | Reference compound |
| HY-157548 | Antitumor agent-133 | Reference compound | |
| HY-157549 | Brivoligide | 1803075-42-4 | Oligonucleotides |
| HY-15755 | RKI-1447 | 1342278-01-6 | Reference compound |
| HY-157550 | DENV-IN-12 | 2581065-80-5 | Reference compound |
| HY-157553 | FAK-IN-19 | 863599-15-9 | Reference compound |
| HY-157554 | ZM640 | Reference compound | |
| HY-157555 | NLRP3-IN-29 | 2198483-40-6 | Reference compound |
| HY-157556 | BPP-2 | Reference compound | |
| HY-157557 | AP30663 | Reference compound | |
| HY-157558 | KDRLKZ-1 | Reference compound | |
| HY-157559 | KDRLKZ-2 | Reference compound | |
| HY-15756 | PTP1B-IN-4 | 765317-72-4 | Reference compound |
| HY-157560 | KDRLKZ-3 | Reference compound | |
| HY-157561 | K2-B4-3e | Reference compound | |
| HY-157562 | DS68591889 | 2488609-21-6 | Reference compound |
| HY-157563 | Dopamine D4 receptor ligand 2 | 219125-63-0 | Reference compound |
| HY-157564 | Antitumor agent-135 | 2922110-00-5 | Reference compound |
| HY-157565 | Bi Unit | 2306467-24-1 | Reference compound |
| HY-157566 | Lenalidomide 5'-piperazine-4-methylpiperidine (hydrochloride) | 2520105-60-4 | Reference compound |
| HY-157567 | FSI-TN42 | 2445840-25-3 | Reference compound |
| HY-157568S | Budesonide acid-d8 | Isotope-Labeled Compounds | |
| HY-157569 | PD1-PDL1-IN 2 | 2566710-63-0 | Reference compound |
| HY-15757 | SJB2-043 | 63388-44-3 | Reference compound |
| HY-157570 | Anti-inflammatory agent 70 | 2767427-87-0 | Reference compound |
| HY-157571S | N-6-[rel-(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinamine-Sonidegib-d8 | Isotope-Labeled Compounds | |
| HY-157573 | N-Acetylmuramic acid-azide | 2245794-64-1 | Reference compound |
| HY-157574 | TRPV6-IN-1 | 1819366-84-1 | Reference compound |
| HY-157577 | PROTAC(H-PGDS)-8 | 2761281-51-8 | Reference compound |
| HY-157578 | COX-2-IN-38 | 1018480-97-1 | Reference compound |
| HY-157579 | MS154N | 2675490-97-6 | Reference compound |
| HY-15758 | 3,3'-Diindolylmethane | 1968-05-4 | Natural Products |
| HY-157581 | MS39 | 2675490-92-1 | Reference compound |
| HY-157582 | MS39N | 2675490-96-5 | Reference compound |
| HY-157583 | COX-2-IN-39 | 1018480-89-1 | Reference compound |
| HY-157585S | 21-Dehydro Budesonide-d8-1 | Isotope-Labeled Compounds | |
| HY-157586 | 2-Linoleoyl-sn-glycero-3-phosphoethanolamine | 60701-98-6 | Reference compound |
| HY-157587 | E3 ligase Ligand-Linker Conjugate 29 | Reference compound | |
| HY-157588 | (S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH | Reference compound | |
| HY-157589 | E3 ligase Ligand-Linker Conjugate 31 | Reference compound | |
| HY-15758R | 3,3'-Diindolylmethane (Standard) | 1968-05-4 | Reference Standards |
| HY-157590 | E3 ligase Ligand-Linker Conjugate 32 | Reference compound | |
| HY-157591 | MMH1-NR | Reference compound | |
| HY-157592 | MMH2-NR | Reference compound | |
| HY-157593 | E3 ligase Ligand-Linker Conjugate 35 | Reference compound | |
| HY-157594 | E3 ligase Ligand-Linker Conjugate 37 | Reference compound | |
| HY-157595 | E3 ligase Ligand-Linker Conjugate 38 | Reference compound | |
| HY-157596 | E3 ligase Ligand-Linker Conjugate 40 | Reference compound | |
| HY-157597 | E3 ligase Ligand-Linker Conjugate 42 | Reference compound | |
| HY-157598 | E3 ligase Ligand-Linker Conjugate 46 | Reference compound | |
| HY-157599 | E3 ligase Ligand-Linker Conjugate 65 | Reference compound | |
| HY-15759A | Napsagatran hydrate | 159668-20-9 | Reference compound |
| HY-15760 | Necrostatin-1 | 4311-88-0 | Reference compound |
| HY-157600 | E3 ligase Ligand-Linker Conjugate 66 | Reference compound | |
| HY-157601 | HSD17B13-IN-4 | Reference compound | |
| HY-157602 | DHX9-IN-8 | 2973746-64-2 | Reference compound |
| HY-157603 | DHX9-IN-7 | 2973400-87-0 | Reference compound |
| HY-157604 | DHX9-IN-9 | 2973400-46-1 | Reference compound |
| HY-157605 | DHX9-IN-11 | 2973402-91-2 | Reference compound |
| HY-157606 | DHX9-IN-13 | 2973399-28-7 | Reference compound |
| HY-157607 | DHX9-IN-15 | 2973398-27-3 | Reference compound |
| HY-157608 | DHX9-IN-10 | 2973746-79-9 | Reference compound |
| HY-157609 | DHX9-IN-12 | 2973747-13-4 | Reference compound |
| HY-15761 | AZD2858 | 486424-20-8 | Reference compound |
| HY-157610 | DHX9-IN-14 | 2973747-90-7 | Reference compound |
| HY-157611 | DHX9-IN-17 | 2973397-26-9 | Reference compound |
| HY-157612 | DHX9-IN-16 | 2973397-48-5 | Reference compound |
| HY-157613 | HSD17B13-IN-5 | Reference compound | |
| HY-157615 | HSD17B13-IN-6 | 2576696-34-7 | Reference compound |
| HY-157617 | 16:0 Cyclic LPA (ammonium) | 799268-71-6 | Biochemical Assay Reagents |
| HY-157618 | 18:0-18:1 PG (sodium) | 322647-48-3 | Oligonucleotides |
| HY-15762 | Valdecoxib | 181695-72-7 | Reference compound |
| HY-157620 | 18:0 Lyso PS (sodium) | 1246298-16-7 | Oligonucleotides |
| HY-157622 | 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine | 159701-21-0 | Biochemical Assay Reagents |
| HY-157623 | 16:0 Lyso PS | 143077-66-1 | Biochemical Assay Reagents |
| HY-157624 | 1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine | 96998-01-5 | Oligonucleotides |
| HY-157625 | 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine | 96998-00-4 | Biochemical Assay Reagents |
| HY-157627 | HSD17B13-IN-9 | 2576690-78-1 | Reference compound |
| HY-157629 | 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-PE | 70812-59-8 | Oligonucleotides |
| HY-15762R | Valdecoxib (Standard) | 181695-72-7 | Reference Standards |
| HY-15762S | Valdecoxib-d3 | 1219794-90-7 | Isotope-Labeled Compounds |
| HY-15763 | Erastin | 571203-78-6 | Reference compound |
| HY-157630 | HSD17B13-IN-10 | 2576696-23-4 | Reference compound |
| HY-157632 | HSD17B13-IN-13 | 2762668-28-8 | Reference compound |
| HY-157634 | E3 Ligase Ligand-linker Conjugate 91 | 2229713-40-8 | Reference compound |
| HY-157635 | E3 Ligase Ligand-linker Conjugate 92 | Reference compound | |
| HY-157636 | E3 Ligase Ligand-linker Conjugate 93 | Reference compound | |
| HY-157637 | E3 Ligase Ligand-linker Conjugate 94 | Reference compound | |
| HY-157639A | 18:2 Lyso PA (sodium) | Reference compound | |
| HY-15764 | A 419259 | 364042-47-7 | Reference compound |
| HY-157642 | 1-Hexanoyl-2-hydroxy-sn-glycero-3-phosphocholine | 58445-96-8 | Biochemical Assay Reagents |
| HY-157644 | 1-Heptanoyl-2-hydroxy-sn-glycero-3-phosphocholine | 160118-49-0 | Biochemical Assay Reagents |
| HY-157646 | MZ-101 | 2839908-40-4 | Reference compound |
| HY-157647 | 1-Stearoyl-2-Adrenoyl-sn-glycero-3-PC | 137254-39-8 | Reference compound |
| HY-15764A | A 419259 (trihydrochloride) | 1435934-25-0 | Reference compound |
| HY-15764G | A 419259 (GMP) | 364042-47-7 | GMP Small Molecules |
| HY-157650 | HSD17B13-IN-20 | 2919797-59-2 | Reference compound |
| HY-157652 | 18:0-20:4 PI(3,4,5)P3 | 799268-60-3 | Biochemical Assay Reagents |
| HY-157653 | HSD17B13-IN-22 | 2919797-60-5 | Reference compound |
| HY-157654 | HSD17B13-IN-26 | 2919797-61-6 | Reference compound |
| HY-157655 | Cafedrine-theodrenaline | 8004-31-7 | Reference compound |
| HY-157657 | Cardiolipin (16:1/16:1/16:1/16:1) (sodium salt) | 2260669-34-7 | Oligonucleotides |
| HY-157658 | K-8794 | 180577-26-8 | Reference compound |
| HY-157659 | WDR5-MLL1 antagonist 1 | 1422389-91-0 | Reference compound |
| HY-15766 | GNE-617 | 1362154-70-8 | Reference compound |
| HY-157660 | 15(R)-Prostaglandin F1α | 21562-54-9 | Reference compound |
| HY-157661 | 14:0 Cardiolipin (sodium) | 63988-21-6 | Biochemical Assay Reagents |
| HY-157662 | HSD17B13-IN-33 | 2730027-85-5 | Reference compound |
| HY-157663 | HSD17B13-IN-36 | 2730027-86-6 | Reference compound |
| HY-157664 | HSD17B13-IN-38 | 2730022-56-5 | Reference compound |
| HY-157665 | HSD17B13-IN-39 | 2730022-55-4 | Reference compound |
| HY-157666 | 13:0 PC | 71242-28-9 | Oligonucleotides |
| HY-157667 | HSD17B13-IN-44 | 2912452-29-8 | Reference compound |
| HY-157669 | 1-Oleoyl-sn-glycero-2,3-cyclic-phosphate (ammonium) | 799268-72-7 | Biochemical Assay Reagents |
| HY-15766A | GNE-617 (hydrochloride) | 2070014-99-0 | Reference compound |
| HY-15767 | TAK-632 | 1228591-30-7 | Reference compound |
| HY-157671 | HSD17B13-IN-45 | 2912452-50-5 | Reference compound |
| HY-157672 | 18:1-14:0 PC | 95896-56-3 | Oligonucleotides |
| HY-157673 | 1,2-Dipalmitoleoyl-sn-glycero-3-phosphoethanolamine | 61599-23-3 | Biochemical Assay Reagents |
| HY-157674 | HSD17B13-IN-46 | 2912453-90-6 | Reference compound |
| HY-157675 | 1,2-Dinervonoyl-sn-glycero-3-phosphocholine | 51779-96-5 | Oligonucleotides |
| HY-157676 | HSD17B13-IN-47 | 2912455-14-0 | Reference compound |
| HY-157678 | 1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine (sodium) | 321883-39-0 | Oligonucleotides |
| HY-157679 | 1-O-Hexadecyl-2-eicosapentaenoyl-SN-glycero-3-phosphocholine | 132196-28-2 | Oligonucleotides |
| HY-15768 | Ilomastat | 142880-36-2 | Reference compound |
| HY-157681 | 1,2-Dilinolenoyl-sn-glycero-3-phosphocholine | 2701-19-1 | Biochemical Assay Reagents |
| HY-157687 | 18:1 (Δ9-Trans) PC | 56782-46-8 | Oligonucleotides |
| HY-157688 | C18(Plasm) LPE | 174062-73-8 | Oligonucleotides |
| HY-157689 | 1,2-Dieicosenoyl-sn-glycero-3-phosphocholine | 61596-54-1 | Biochemical Assay Reagents |
| HY-15769 | WHI-P180 | 211555-08-7 | Reference compound |
| HY-157690 | 19(S),20(R)-EDP | 2460392-58-7 | Reference compound |
| HY-157690A | 19(R),20(S)-EDP | 2242542-60-3 | Reference compound |
| HY-157692 | 10:0 PS | 321863-22-3 | Biochemical Assay Reagents |
| HY-157693 | C18:1 Cyclic LPA | 799268-69-2 | Oligonucleotides |
| HY-157694 | 09:0 Lyso PC | 253678-66-9 | Oligonucleotides |
| HY-157695 | 1-(1Z-Octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine | 799268-64-7 | Oligonucleotides |
| HY-157696 | 18:0 Diether PC | 1188-85-8 | Biochemical Assay Reagents |
| HY-157697 | 1-1(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-PE | 144371-69-7 | Biochemical Assay Reagents |
| HY-157698 | 1-1(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-PC | 97802-56-7 | Biochemical Assay Reagents |
| HY-157699 | 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) (ammonium) | 1246303-10-5 | Biochemical Assay Reagents |
| HY-15769A | WHI-P180 (hydrochloride) | 153437-55-9 | Reference compound |
| HY-15770 | TR-14035 | 232271-19-1 | Reference compound |
| HY-157700 | Hexadecenyl-2-hydroxy-sn-glycero-3-PC | 97802-53-4 | Oligonucleotides |
| HY-157702 | 1-Heptadecenoyl-2-OH-sn-glycero-3-phosphoethanolamine | 1246298-09-8 | Biochemical Assay Reagents |
| HY-157703 | 18:1 PI(4,5)P2 | 799268-56-7 | Biochemical Assay Reagents |
| HY-157704 | 18:1 PI(3)P | 1246303-09-2 | Biochemical Assay Reagents |
| HY-157706 | PI(3,4)P2 (18:1) (ammonium salt) | 799268-54-5 | Biochemical Assay Reagents |
| HY-157707 | 18:1 PI(3,4,5)P3 | 799268-57-8 | Biochemical Assay Reagents |
| HY-157708 | HSD17B13-IN-67 | 2912457-83-9 | Reference compound |
| HY-15771 | Tirabrutinib | 1351636-18-4 | Reference compound |
| HY-157710 | HSD17B13-IN-68 | 3004660-61-8 | Reference compound |
| HY-157714 | 08:0 PI(3,4)P2 | 852043-35-7 | Biochemical Assay Reagents |
| HY-157715 | 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) (ammonium) | 852043-38-0 | Biochemical Assay Reagents |
| HY-157717 | HSD17B13-IN-70 | 3004660-93-6 | Reference compound |
| HY-157718 | 1,2-Di-O-(9Z-octadecenyl)-sn-glycero-3-phosphocholine | 105370-99-8 | Biochemical Assay Reagents |
| HY-157719 | S-Adenosylhomocysteine sulfoxide | 29907-86-6 | Reference compound |
| HY-15771A | Tirabrutinib (hydrochloride) | 1439901-97-9 | Reference compound |
| HY-15772 | Osimertinib | 1421373-65-0 | Reference compound |
| HY-157720 | HSD17B13-IN-72 | 3004661-16-6 | Reference compound |
| HY-157721 | 1,2-Dibehenoyl-sn-glycero-3-phosphocholine | 17688-29-8 | Oligonucleotides |
| HY-157722 | HSD17B13-IN-73 | 3004661-39-3 | Reference compound |
| HY-157723 | HSD17B13-IN-74 | 2912458-81-0 | Reference compound |
| HY-157724 | HSD17B13-IN-76 | 2912459-00-6 | Reference compound |
| HY-157725 | C18:1 LPA | 799279-68-8 | Oligonucleotides |
| HY-157726 | HSD17B13-IN-77 | 2912459-67-5 | Reference compound |
| HY-157727 | HDHD4-IN-1 | 1447279-68-6 | Reference compound |
| HY-157728 | ML307 | Reference compound | |
| HY-157729 | 1-Undecanoylglycerol | 64633-19-8 | Reference compound |
| HY-15772A | Osimertinib (mesylate) | 1421373-66-1 | Reference compound |
| HY-15772AR | Osimertinib (mesylate) (Standard) | 1421373-66-1 | Reference Standards |
| HY-15772R | Osimertinib (Standard) | 1421373-65-0 | Reference Standards |
| HY-15772S | Osimertinib-d6 | 1638281-44-3 | Isotope-Labeled Compounds |
| HY-15772S1 | Osimertinib-13C,d3 | 2254100-49-5 | Isotope-Labeled Compounds |
| HY-15772S3 | Asandeutertinib | 1638281-46-5 | Isotope-Labeled Compounds |
| HY-15773 | PF-4708671 | 1255517-76-0 | Reference compound |
| HY-157730 | 2-Myristyldistearin | 57396-99-3 | Natural Products |
| HY-157731 | α-Laurodimyristin | 60138-12-7 | Natural Products |
| HY-157732 | 1,2-Dimyristoyl-3-palmitoyl-rac-glycerol | 60138-13-8 | Natural Products |
| HY-157733 | 1,2-Dioleoyl-3-behenoylglycerol | 77145-66-5 | Reference compound |
| HY-157734 | 1,2-Palmitate-3-elaidate | 93452-43-8 | Natural Products |
| HY-157735 | 2-Myristyldipalmitin | 56599-89-4 | Natural Products |
| HY-157736 | Tritetracosanoin | 56983-26-7 | Reference compound |
| HY-157737 | GVSKYG-PEG2-azide (TFA) | Peptides | |
| HY-157737A | GVSKYG-PEG2-azide (hydrochloride) | ADC Related | |
| HY-157738 | 1,2-Dilauroyl-3-myristoyl-rac-glycerol | 60175-30-6 | Reference compound |
| HY-157739 | 1,2-Dioleoyl-3-arachidoylglycerol | 77145-65-4 | Natural Products |
| HY-15774 | CBB1003 | 1379573-88-2 | Reference compound |
| HY-157740 | XSJ-10 | Reference compound | |
| HY-157741 | 1-Myristoyl-2-oleoyl-3-palmitoyl-rac-glycerol | 99131-43-8 | Reference compound |
| HY-157742 | 1,3-Dioleoyl-2-elaidoyl glycerol | 110170-81-5 | Reference compound |
| HY-157743 | SCH 60057 | 203061-35-2 | Natural Products |
| HY-157744 | Coumarin–quinone conjugate | 2741190-31-6 | Reference compound |
| HY-157745 | m-PEG-NHS ester (MW 40000) | 92451-01-9 | Reference compound |
| HY-157746 | CTPS1-IN-1 | 2341943-12-0 | Reference compound |
| HY-157747 | E3 Ligase Ligand-linker Conjugate 99 | Reference compound | |
| HY-157748 | E3 Ligase Ligand-linker Conjugate 100 | Reference compound | |
| HY-157749 | Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 | Reference compound | |
| HY-15774A | CBB1003 (hydrochloride) | 2070015-02-8 | Reference compound |
| HY-15775 | Arginase inhibitor 1 | 1345808-25-4 | Reference compound |
| HY-157750 | MEK1/C-Raf-IN-1 | 946128-76-3 | Reference compound |
| HY-157751 | RIPK1-IN-21 | 3016304-64-3 | Reference compound |
| HY-157752 | E3 Ligase Ligand-linker Conjugate 101 | Reference compound | |
| HY-157753 | E3 Ligase Ligand-linker Conjugate 102 | Reference compound | |
| HY-157754 | E3 Ligase Ligand-linker Conjugate 103 | Reference compound | |
| HY-157756 | E3 Ligase Ligand-linker Conjugate 104 | Reference compound | |
| HY-157757 | E3 Ligase Ligand-linker Conjugate 105 | Reference compound | |
| HY-157758 | (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 | Reference compound | |
| HY-157759 | (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH | Reference compound | |
| HY-15776 | HG-9-91-01 | 1456858-58-4 | Reference compound |
| HY-157760 | (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH | Reference compound | |
| HY-157761 | E3 Ligase Ligand-linker Conjugate 106 | Reference compound | |
| HY-157762 | GPX4-IN-9 | 3032746-99-6 | Reference compound |
| HY-157763 | PROTAC BTK Degrader-8 | Reference compound | |
| HY-157764 | PROTAC ATR degrader-1 | 2925916-30-7 | Reference compound |
| HY-157765 | PROTAC ERα Degrader-6 | Reference compound | |
| HY-157766 | FAAH/TRPV1 blocker-1 | Reference compound | |
| HY-157767 | Abd110 | 3021581-79-0 | Reference compound |
| HY-15777 | Ribociclib | 1211441-98-3 | Reference compound |
| HY-157778 | MK-7845 | 2952554-69-5 | Isotope-Labeled Compounds |
| HY-157779 | TPA-NAC | Reference compound | |
| HY-15777A | Ribociclib hydrochloride | 1211443-80-9 | Reference compound |
| HY-15777AS | Ribociclib-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-15777B | Ribociclib succinate | 1374639-75-4 | Reference compound |
| HY-15777C | Ribociclib succinate hydrate | 1374639-79-8 | Reference compound |
| HY-15777R | Ribociclib (Standard) | 1211441-98-3 | Reference Standards |
| HY-15777S | Ribociclib-d6 | 1328934-40-2 | Isotope-Labeled Compounds |
| HY-15777S1 | Ribociclib-d8 | 2167898-24-8 | Isotope-Labeled Compounds |
| HY-15778 | AVE 0991 | 304462-19-9 | Reference compound |
| HY-157783 | Dencatistat | 2377000-84-3 | Reference compound |
| HY-157784 | XPC-7724 | Reference compound | |
| HY-157786 | XPC-5462 | 2230145-14-7 | Reference compound |
| HY-157787 | Ginkgolic acid 2-phosphate | 2281761-58-6 | Reference compound |
| HY-157788 | ZX703 | Reference compound | |
| HY-15778A | AVE 0991 (sodium salt) | 306288-04-0 | Reference compound |
| HY-15779 | K145 | 1309444-75-4 | Reference compound |
| HY-157792 | Antidepressant agent 6 | Reference compound | |
| HY-157793 | SMU-L11 | Reference compound | |
| HY-157794 | 6-Nitroquinazoline | 7556-95-8 | Reference compound |
| HY-157795 | Exatecan analogue 1 | 2671770-58-2 | ADC Related |
| HY-157796 | β2AR agonist 4 | Reference compound | |
| HY-157797 | SN-38-CM2 | 2376127-86-3 | Reference compound |
| HY-15779A | K145 (hydrochloride) | 1449240-68-9 | Reference compound |
| HY-15780 | Brexpiprazole | 913611-97-9 | Reference compound |
| HY-157800 | Trilexium | 1983180-82-0 | Reference compound |
| HY-157802 | LTGO-33 | 2834106-06-6 | Reference compound |
| HY-157802A | (S)-LTGO-33 | Reference compound | |
| HY-157804 | PROTAC SARS-CoV-2 Mpro degrader-1 | 3029579-46-9 | Reference compound |
| HY-157805 | PROTAC SARS-CoV-2 Mpro degrader-2 | Reference compound | |
| HY-157806 | α-Synuclein inhibitor 12 | Reference compound | |
| HY-157807 | Prostaglandin E2-biotin | 2641624-60-2 | Reference compound |
| HY-157808 | Antibacterial agent 185 | Reference compound | |
| HY-157809 | Anti-inflammatory agent 74 | Reference compound | |
| HY-15780A | Brexpiprazole (hydrochloride) | 913612-38-1 | Reference compound |
| HY-15780R | Brexpiprazole (Standard) | 913611-97-9 | Reference Standards |
| HY-15780S | Brexpiprazole-d8 | 1427049-21-5 | Isotope-Labeled Compounds |
| HY-15780S1 | Brexpiprazole-d8-1 | 1427049-19-1 | Isotope-Labeled Compounds |
| HY-15781 | Morinidazole | 92478-27-8 | Reference compound |
| HY-157810 | AKR1C3-IN-11 | Reference compound | |
| HY-157811 | PD-1/PD-L1-IN-40 | Reference compound | |
| HY-157813 | 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan | 2964536-59-0 | ADC Related |
| HY-157814 | Menin-MLL inhibitor-25 | Reference compound | |
| HY-15781A | (R)-Morinidazole | 898230-59-6 | Reference compound |
| HY-15782 | YH16899 | 1428623-14-6 | Reference compound |
| HY-157820 | Galectin-4-IN-2 | 1044566-28-0 | Reference compound |
| HY-157821 | Galectin-4-IN-3 | 1044566-26-8 | Reference compound |
| HY-157822 | Galectin-8-IN-2 | 1044566-24-6 | Reference compound |
| HY-157824 | 6Lac[6]Met | 1132892-04-6 | Reference compound |
| HY-157829 | (R)-Palmitoyl-(2-methyl)ethanolamide | 179951-56-5 | Reference compound |
| HY-157833 | Heptadecanoyl ethanolamide | 53832-59-0 | Reference compound |
| HY-157838 | HMC-B17 | 2935913-83-8 | Reference compound |
| HY-157839 | PROTAC α-synuclein degrader 6 | 3032208-24-2 | Reference compound |
| HY-15784 | NPPM 6748-481 | 432020-20-7 | Reference compound |
| HY-157840 | Anti-infective agent 9 | 758689-17-7 | Reference compound |
| HY-157844 | NUCC-0226272 | 3004503-12-9 | Reference compound |
| HY-157847 | phospho-STAT3-IN-2 | Reference compound | |
| HY-157848 | SARS-CoV-2-IN-82 | 924058-34-4 | Reference compound |
| HY-15785 | Pimitespib | 1260533-36-5 | Reference compound |
| HY-157850 | BP-M345 | 1360119-00-1 | Reference compound |
| HY-157856 | rel-4(5)-Epdpe methyl ester | 121818-29-9 | Reference compound |
| HY-157856A | (Rac)-rel-4(5)-Epdpe methyl ester | 234087-65-1 | Reference compound |
| HY-15786 | SGE-201 | 35882-85-0 | Reference compound |
| HY-157870 | Mtb-IN-6 | Reference compound | |
| HY-157871 | TAK1-IN-5 | Reference compound | |
| HY-157872 | ALDH1A1-IN-4 | 23982-86-7 | Reference compound |
| HY-157876 | Anticancer agent 191 | Reference compound | |
| HY-157880 | N3-PC | Reference compound | |
| HY-157881 | 2-Mercaptoethanesulfonic acid (ampule,3.0M±0.1M in H2O) | 3375-50-6 | Biochemical Assay Reagents |
| HY-157883 | C7BzO | 565454-39-9 | Biochemical Assay Reagents |
| HY-157886 | TDP1 Inhibitor-3 | Reference compound | |
| HY-157887 | ADT-007 | 1945941-09-2 | Reference compound |
| HY-157888 | SHP2-IN-26 | Reference compound | |
| HY-157889 | ZINC000028464438 | 866123-66-2 | Reference compound |
| HY-15789 | Elbasvir | 1370468-36-2 | Reference compound |
| HY-157891 | JBC117 | 1214531-21-1 | Reference compound |
| HY-157892 | Antimalarial agent 38 | 123580-46-1 | Reference compound |
| HY-15789R | Elbasvir (Standard) | 1370468-36-2 | Reference Standards |
| HY-15790 | Elobixibat | 439087-18-0 | Reference compound |
| HY-157901 | 2,3-Dihydroxybutanoic acid | 3413-97-6 | Reference compound |
| HY-15790A | Elobixibat (hydrate) | 1633824-78-8 | Reference compound |
| HY-15790H | (S)-Elobixibat | 439087-68-0 | Reference compound |
| HY-15790R | Elobixibat (Standard) | 439087-18-0 | Reference Standards |
| HY-15790S | Elobixibat-d5 | Isotope-Labeled Compounds | |
| HY-15791 | FR173657 | 167838-64-4 | Reference compound |
| HY-157910 | (±)17(18)-EpETE methyl ester | 141339-46-0 | Reference compound |
| HY-157912 | EGFR-IN-102 | 2781912-10-3 | Reference compound |
| HY-157913 | PKM2-IN-6 | 771467-00-6 | Reference compound |
| HY-157914 | Dibenzyl-14-crown-4 | 106868-21-7 | Biochemical Assay Reagents |
| HY-157915 | HFPB | 2098575-63-2 | Biochemical Assay Reagents |
| HY-157916 | ARP | 139585-03-8 | Biochemical Assay Reagents |
| HY-157917 | Nitro-PAPS (disodium dihydrate) | Biochemical Assay Reagents | |
| HY-157918 | Carboxy-EG6-hexadecanethiol | 1432697-96-5 | Biochemical Assay Reagents |
| HY-157919 | Biotin-PEAC5-maleimide (hydrochloride) | 2377497-15-7 | Biochemical Assay Reagents |
| HY-15792 | (R)-FL118 | 151636-76-9 | Reference compound |
| HY-157920 | Biotin-PE-maleimide | 374592-99-1 | Biochemical Assay Reagents |
| HY-157921 | Amino-EG6-undecanethiol (hydrochloride) | 1392815-15-4 | Biochemical Assay Reagents |
| HY-157922 | Trehalose C12 | 64622-91-9 | Biochemical Assay Reagents |
| HY-157923 | Trehalose C14 | 64622-92-0 | Biochemical Assay Reagents |
| HY-157924 | Bis(benzo-15-crown-5) | 69271-98-3 | Biochemical Assay Reagents |
| HY-157925 | Bicyclo-PGE1 | 1283861-32-4 | Reference compound |
| HY-157926 | Nitroso-PSAP | 80459-15-0 | Biochemical Assay Reagents |
| HY-157928 | Keap1-Nrf2-IN-18 | Reference compound | |
| HY-157929 | Keap1-Nrf2-IN-19 | Reference compound | |
| HY-15793 | NBI-98782 | 85081-18-1 | Reference compound |
| HY-157930 | TP-2 | Reference compound | |
| HY-157931 | Anticancer agent 192 | Reference compound | |
| HY-157932 | MR24 | Reference compound | |
| HY-157933 | SF-C5-TPP | Reference compound | |
| HY-157934 | MAO-IN-4 | 3023217-85-5 | Reference compound |
| HY-157935 | 17β-HSD10-IN-3 | 2225109-18-0 | Reference compound |
| HY-157936 | GluN2B-NMDAR antagonist-2 | Reference compound | |
| HY-157937 | VISTA-IN-3 | 2994662-45-0 | Reference compound |
| HY-157938S | 6-ECDCA-d4 | 2025364-15-0 | Isotope-Labeled Compounds |
| HY-157939 | GPR183 antagonist-3 | Reference compound | |
| HY-15793A | Trans (2,3)-Dihydrotetrabenazine | 171598-74-6 | Reference compound |
| HY-15794 | Nemorubicin | 108852-90-0 | Reference compound |
| HY-157940 | Methylsolfonyl 25(S)-Δ7-dafachronic acid | Reference compound | |
| HY-157941 | ART0380 | 2267316-76-5 | Reference compound |
| HY-157942 | CYP1B1-IN-7 | 52601-58-8 | Reference compound |
| HY-157943 | Hexyl 5-aminolevulinate | 140898-97-1 | Dye Reagents |
| HY-15794A | Nemorubicin (hydrochloride) | 108943-08-4 | Reference compound |
| HY-15794G | Nemorubicin (GMP) | 108852-90-0 | GMP Small Molecules |
| HY-157950 | DSPE-PEG2000-triGalNAc (ammonium) | 2936651-86-2 | Reference compound |
| HY-157954 | WRN inhibitor 6 | Reference compound | |
| HY-157955 | TAAR1 agonist 1 | Reference compound | |
| HY-157955A | TAAR1 agonist 1 (hydrochloride) | Reference compound | |
| HY-157956 | LASSBio-873 | 873694-54-3 | Reference compound |
| HY-157958 | α7 nAChR Modulator-3 | Reference compound | |
| HY-157959 | Orphenadrine | 83-98-7 | Reference compound |
| HY-15796 | GNE0877 | 1374828-69-9 | Reference compound |
| HY-157960 | VEGFR-2-IN-42 | Reference compound | |
| HY-157963 | RIPK1-IN-23 | 3031534-16-1 | Reference compound |
| HY-157964 | DHC-156 | Reference compound | |
| HY-157965 | ZINC09875266 | 925200-00-6 | Reference compound |
| HY-157966 | SARS-CoV-2 3CLpro-IN-23 | Reference compound | |
| HY-15797 | UNC2250 | 1493694-70-4 | Reference compound |
| HY-157974 | [Ag(2,2′-bipy)(dppe)][CF3SO3] | Reference compound | |
| HY-157975 | LM11 | Reference compound | |
| HY-157976 | Dinorprostaglandin E1 | 7046-40-4 | Reference compound |
| HY-157977 | DOTA-GA-maleimide | 1800229-46-2 | Reference compound |
| HY-157978 | AChE-IN-59 | 2957916-86-6 | Reference compound |
| HY-157979 | AQP3-IN-1 | 198711-19-2 | Reference compound |
| HY-15798 | UNC2881 | 1493764-08-1 | Reference compound |
| HY-157980 | CDK9-IN-32 | Reference compound | |
| HY-157981 | AChE-IN-60 | Reference compound | |
| HY-157982 | BChE-IN-28 | Reference compound | |
| HY-157987 | MBX3135 | 1636878-36-8 | Reference compound |
| HY-15799 | AZD1283 | 919351-41-0 | Reference compound |
| HY-157990 | Wnt/β-catenin-IN-1 | Reference compound | |
| HY-157992 | LM-021 | 1022282-98-9 | Reference compound |
| HY-157993 | SAG-524 | 2246696-89-7 | Reference compound |
| HY-157994 | EGFR WT/T790M-IN-2 | Reference compound | |
| HY-157995 | Dyrk1A-IN-7 | Reference compound | |
| HY-157996 | CSF1R-IN-21 | 2935479-62-0 | Reference compound |
| HY-157997 | MHC02181 | 460999-85-3 | Reference compound |
| HY-157998 | mG2N001 | 2760515-88-4 | Reference compound |
| HY-157999 | SDI-118 | 1651179-19-9 | Reference compound |
| HY-15800 | CZC-25146 (hydrochloride) | 1330003-04-7 | Reference compound |
| HY-158000 | Bile acid probe 1 | 2148335-01-5 | Reference compound |
| HY-158001 | MHC00188 | 1380881-85-5 | Reference compound |
| HY-158002 | IDOR-4 | 2839901-24-3 | Reference compound |
| HY-158003 | COE-PNH2 | Reference compound | |
| HY-158004 | SMU101 | Reference compound | |
| HY-158005 | Anticancer agent 195 | Reference compound | |
| HY-158006 | SDX-7539 | 1631953-52-0 | Reference compound |
| HY-158007 | (RS)-G12Di-1 | Reference compound | |
| HY-158008 | (R)-G12Di-7 | 2946593-60-6 | Reference compound |
| HY-158009 | SGF29-IN-1 | 6638-82-0 | Reference compound |
| HY-15800A | CZC-25146 | 1191911-26-8 | Reference compound |
| HY-15801 | HG-14-10-04 | 1356962-34-9 | Reference compound |
| HY-158010 | FGFR3-IN-8 | Reference compound | |
| HY-158011 | FGFR3-IN-9 | 2446523-17-5 | Reference compound |
| HY-158012 | LY3056480 | 2064292-78-8 | Reference compound |
| HY-158013 | JJC8-088 | 1627576-82-2 | Reference compound |
| HY-158013A | JJC8-088 (dioxalate) | 2068692-71-5 | Reference compound |
| HY-158014 | JJC8-089 | 1627576-64-0 | Reference compound |
| HY-158016 | Antiproliferative agent-49 | Reference compound | |
| HY-158017 | WXM-1-170 | Reference compound | |
| HY-158018 | EGFR-TK-IN-2 | Reference compound | |
| HY-158019 | Anticancer agent 196 | Reference compound | |
| HY-15802 | WZ4003 | 1214265-58-3 | Reference compound |
| HY-158020 | Anticancer agent 197 | Reference compound | |
| HY-158021 | Tyrosinase-IN-26 | Reference compound | |
| HY-158022 | CTSL/CAPN1-IN-1 | Reference compound | |
| HY-158023 | DHODH-IN-26 | Reference compound | |
| HY-158024 | NDT-19795 | 2272917-12-9 | Reference compound |
| HY-158024A | (S)-NDT-19795 | Reference compound | |
| HY-158025 | Anticancer agent 198 | Reference compound | |
| HY-158026 | ALDH1A1-IN-5 | Reference compound | |
| HY-158027 | B-Raf IN 17 | Reference compound | |
| HY-158028 | PAN endonuclease-IN-2 | Reference compound | |
| HY-158029 | PI3Kα-IN-21 | Reference compound | |
| HY-158030 | HDAC6-IN-37 | 2986486-82-0 | Reference compound |
| HY-158031 | PLK1/BRD4-IN-5 | Reference compound | |
| HY-158034S | U-13C Hemicellulose from potato | Isotope-Labeled Compounds | |
| HY-158036 | PROTAC STING Degrader-2 | 3023095-61-3 | Reference compound |
| HY-158037 | α-Glucosidase-IN-55 | Reference compound | |
| HY-158038 | AurkA allosteric-IN-1 | Reference compound | |
| HY-158039 | YCH2823 | Reference compound | |
| HY-158045 | PROTAC PARP1 degrader-1 | Reference compound | |
| HY-158046 | UNC8899 | Reference compound | |
| HY-158047 | UNC8900 | Reference compound | |
| HY-158048 | UNC9036 | Reference compound | |
| HY-158049 | Anticancer agent 199 | 2422001-24-7 | Reference compound |
| HY-15805 | KIN-8194 | 330786-01-1 | Reference compound |
| HY-158050 | PXB17 | Reference compound | |
| HY-158051 | CIDD-0072424 | 1620195-03-0 | Reference compound |
| HY-158052 | PD-1/PD-L1 antagonist 1 | Reference compound | |
| HY-158053 | Antifungal agent 94 | 3030502-21-4 | Reference compound |
| HY-158054 | Antifungal agent 95 | 2883716-51-4 | Reference compound |
| HY-158056 | URAT1/GLUT9-IN-1 | 2883011-18-3 | Reference compound |
| HY-158057 | A2AR/A2BR antagonist 1 | Reference compound | |
| HY-158058 | WYJ-2 | 3029403-05-9 | Reference compound |
| HY-158059 | DS-1-38 | Reference compound | |
| HY-15805A | cis-KIN-8194 | 330792-60-4 | Reference compound |
| HY-158060 | MC2646 | Reference compound | |
| HY-158061 | Topoisomerase II inhibitor 20 | Reference compound | |
| HY-158061A | Topoisomerase II inhibitor 20 (TFA) | Reference compound | |
| HY-158062 | LC-1-40 | Reference compound | |
| HY-158064 | BTK-IN-36 | 2502301-31-5 | Reference compound |
| HY-158065 | Azido-mono-amide-DOTA-tris(t-Bu ester) | 1402795-92-9 | Biochemical Assay Reagents |
| HY-158066 | p-NH2-Bn-NOTA (hydrochloride hydrate) | Biochemical Assay Reagents | |
| HY-158067 | Deferoxamine-DBCO | 2359695-48-8 | Biochemical Assay Reagents |
| HY-158068 | Maleimido-mono-amide-DTPA (TFA) | Biochemical Assay Reagents | |
| HY-158069 | p-NH₂-Bn-DTPA-penta (t-Bu ester) | 205986-41-0 | Biochemical Assay Reagents |
| HY-158070 | Diamsar (hydrochloride) | 139265-92-2 | Biochemical Assay Reagents |
| HY-158071 | p-SCN-Bn-HEHA (hydrochloride) | Biochemical Assay Reagents | |
| HY-158072 | DOTAM-NHS-ester | 2236057-47-7 | Biochemical Assay Reagents |
| HY-158073 | ML2006a4 | 2943213-62-3 | Reference compound |
| HY-158075 | DNMT/HDAC-IN-1 | 2095619-17-1 | Reference compound |
| HY-158076 | S2/IAPinh | Reference compound | |
| HY-158077 | (R)-tetraMe-Tetraxetan | 148408-89-3 | Biochemical Assay Reagents |
| HY-158078 | Carbonic anhydrase inhibitor 21 | Reference compound | |
| HY-158080 | 2-Keto-L-gulonic acid | 526-98-7 | Biochemical Assay Reagents |
| HY-158082 | TRITC-dextran, MW 4000 | Biochemical Assay Reagents | |
| HY-158082A | TRITC-dextran, MW 20000 | Biochemical Assay Reagents | |
| HY-158082B | TRITC-dextran, MW 40000 | Biochemical Assay Reagents | |
| HY-158082C | TRITC-dextran, MW 70000 | Biochemical Assay Reagents | |
| HY-158082D | TRITC-dextran, MW 150000 | Biochemical Assay Reagents | |
| HY-158082E | TRITC-dextran, MW 500000 | Biochemical Assay Reagents | |
| HY-158082H | TRITC-dextran, MW 2000000 | Biochemical Assay Reagents | |
| HY-158084S | N-Nonanoylglycine-d2 | 3008541-78-1 | Isotope-Labeled Compounds |
| HY-158085S | N-Undecanoylglycine-d2 | 3008541-79-2 | Isotope-Labeled Compounds |
| HY-158086S | N-(1-Oxotridecyl)glycine-d2 | 3008541-80-5 | Isotope-Labeled Compounds |
| HY-158087S | N-(1-Oxopentadecyl)glycine-d2 | 3008541-82-7 | Isotope-Labeled Compounds |
| HY-158088S | N-(1-Oxoheptadecyl)glycine-d2 | 3008541-84-9 | Isotope-Labeled Compounds |
| HY-158089 | PLGA-COOH (MW 80000) (LA/GA 50:50) | Oligonucleotides | |
| HY-158090 | Triptolide palmitate | 2126920-51-0 | Reference compound |
| HY-158092 | ChEs/MAOs-IN-2 | 693268-77-8 | Reference compound |
| HY-158093 | NIC-12 | 2409826-23-7 | Reference compound |
| HY-158097 | IAV-IN-2 | Reference compound | |
| HY-158098 | FGFR1 inhibitor-11 | 2157482-40-9 | Reference compound |
| HY-158099 | Biotin-Cel | 2609685-71-2 | Reference compound |
| HY-158100 | SYD5115 | Reference compound | |
| HY-158101 | BMS-986365 | 2446928-30-7 | Reference compound |
| HY-158102 | ORIC-944 | 2369769-29-7 | Reference compound |
| HY-158102A | ORIC-944 (TFA) | Reference compound | |
| HY-158104 | LPPM-8 | Reference compound | |
| HY-158105 | ARV-393 | 2851885-95-3 | Reference compound |
| HY-158106 | AZD8421 | 3047321-53-6 | Reference compound |
| HY-158107 | BBO-8520 | 2893809-51-1 | Reference compound |
| HY-158108 | anti-TNBC agent-6 | Reference compound | |
| HY-158109 | M3554 | ADC Related | |
| HY-15811 | XMD8-87 | 1234480-46-6 | Reference compound |
| HY-158110 | Phenylcapsaicin | 848127-67-3 | Reference compound |
| HY-158111 | NLRP3-IN-34 | 1392502-55-4 | Reference compound |
| HY-158112 | Herbicidal agent 3 | Reference compound | |
| HY-158113 | CBPD-409 | 3037549-86-0 | Reference compound |
| HY-158114 | Pentadecanoic acid chloride | 17746-08-6 | Natural Products |
| HY-158115 | NST-628 | 3002056-30-3 | Reference compound |
| HY-158116 | VVD-214 | 3026500-20-6 | Reference compound |
| HY-158117 | [Cu2Cl2(4'-(4-Methoxy-1-naphthyl)-terpy)2](PF6)2 | Reference compound | |
| HY-158118 | Lys(CO-C3-p-I-Ph)-OMe | 2088426-96-2 | Reference compound |
| HY-158119A | PSMA-trillium | 3036415-37-6 | Reference compound |
| HY-15812 | Aurora kinase-IN-5 | 1234481-08-3 | Reference compound |
| HY-158120 | LasR agonist 1 | Reference compound | |
| HY-158122 | Lys(CO-C3-p-I-Ph)-O-tBu | 2703051-80-1 | Reference compound |
| HY-158123 | PSMA binder-1 | 2170653-14-0 | Reference compound |
| HY-158124 | LasR antagonist 1 | 1421464-74-5 | Reference compound |
| HY-158125 | PSMA binder-2 | 2149567-00-8 | Reference compound |
| HY-158126 | G-quadruplex ligand 2 | Reference compound | |
| HY-158127 | FABP1-IN-1 | 3048021-44-6 | Reference compound |
| HY-158128 | MK-8527 | 1810869-23-8 | Reference compound |
| HY-15813 | FIIN-1 | 1256152-35-8 | Reference compound |
| HY-158130 | FKBP51-Hsp90-IN-1 | 433313-64-5 | Reference compound |
| HY-158131 | FKBP51-Hsp90-IN-2 | 601511-07-3 | Reference compound |
| HY-158135 | Val-Cit-PAB-DEA-COOH | 2270986-50-8 | ADC Related |
| HY-158137 | Val-Cit-PAB-DEA-Dxd | 2964543-53-9 | ADC Related |
| HY-158138 | TOPOI/PARP-1-IN-1 | 2948352-16-5 | Reference compound |
| HY-15814 | HG-7-85-01 | 1258391-13-7 | Reference compound |
| HY-158141 | BRD1401 | Reference compound | |
| HY-158142 | PROTAC TYK2 degrader-1 | 2770470-20-5 | Reference compound |
| HY-158143 | PRMT5-IN-34 | Reference compound | |
| HY-158144 | GLPG2737 | 2093974-63-9 | Reference compound |
| HY-158145 | DS55980254 | 2488609-43-2 | Reference compound |
| HY-158146 | sGC activator 1 | 2101645-33-2 | Reference compound |
| HY-158147 | PI3Kδ-IN-20 | Reference compound | |
| HY-158148 | CSF1R-IN-23 | 2935480-17-2 | Reference compound |
| HY-158149 | T-1-PMPA | 1323883-62-0 | Reference compound |
| HY-15815 | Bromosporine | 1619994-69-2 | Reference compound |
| HY-158150 | 20S Proteasome-IN-5 | Reference compound | |
| HY-158151 | p53 Activator 12 | 2746374-04-7 | Reference compound |
| HY-158152 | PROTAC CRBN ligand-2 | Reference compound | |
| HY-158153 | EGFR-IN-108 | Reference compound | |
| HY-158154 | EGFR-IN-110 | Reference compound | |
| HY-158155 | CVN293 | 2815296-08-1 | Reference compound |
| HY-158156 | NF-κB-IN-16 | Reference compound | |
| HY-158157 | ZL-28-6 | 2739807-18-0 | Reference compound |
| HY-158158 | CARM1-IN-5 | Reference compound | |
| HY-158159 | IL17A-IN-1 | Reference compound | |
| HY-15816 | Ulixertinib | 869886-67-9 | Reference compound |
| HY-158160 | LBA-3 | 2918263-09-7 | Reference compound |
| HY-158161 | SLC6A19-IN-1 | Reference compound | |
| HY-158162 | SIRT3 activator 1 | Reference compound | |
| HY-158163 | Herbicidal agent 4 | Reference compound | |
| HY-158166 | DNA-PK-IN-13 | 3036751-03-5 | Reference compound |
| HY-158167 | AhR agonist 5 | Reference compound | |
| HY-158168 | AhR agonist 6 | 3033281-96-5 | Reference compound |
| HY-158169 | AhR agonist 7 | 3033281-98-7 | Reference compound |
| HY-15816A | Ulixertinib (hydrochloride) | 1956366-10-1 | Reference compound |
| HY-158170 | CDK7-IN-28 | Reference compound | |
| HY-158171 | Cbl-b-IN-17 | Reference compound | |
| HY-158172 | Cbl-b-IN-18 | Reference compound | |
| HY-158173 | Cbl-b-IN-19 | Reference compound | |
| HY-158174 | Cbl-b-IN-20 | Reference compound | |
| HY-158175 | EGFR T790M/L858R-IN-4 | 3032760-34-9 | Reference compound |
| HY-158176 | EGFR T790M/L858R-IN-5 | 3032760-70-3 | Reference compound |
| HY-158177 | EGFR T790M/L858R-IN-6 | 3032760-71-4 | Reference compound |
| HY-158178 | EGFR T790M/L858R-IN-7 | 3032760-90-7 | Reference compound |
| HY-158179 | A3AR agonist 3 | 3032474-53-3 | Reference compound |
| HY-158180 | A3AR agonist 4 | 3032475-23-0 | Reference compound |
| HY-158181 | A3AR agonist 5 | 3032475-38-7 | Reference compound |
| HY-158183 | NMD670 | 2354321-33-6 | Reference compound |
| HY-158185 | Isocycloseram | 2061933-85-3 | Reference compound |
| HY-158186S | Bisoprolol-d6 (hemifumarate) | Isotope-Labeled Compounds | |
| HY-158187S | R-(+)-Cibenzoline-d4 | Isotope-Labeled Compounds | |
| HY-158189 | TPP-Ce6 | 3030629-73-0 | Reference compound |
| HY-158190 | Rose Bengal Chloramphenicol Agar | Biochemical Assay Reagents | |
| HY-158192S | N-Desmethyl diltiazem-d4 | 1217975-79-5 | Isotope-Labeled Compounds |
| HY-158193 | N-Decanoyl cyclopentylamide | 540796-75-6 | Reference compound |
| HY-158194 | α2C adrenoceptor agonist 1 | 928115-79-1 | Reference compound |
| HY-158195 | DPP23 | 1262887-77-3 | Reference compound |
| HY-158196 | PERK/eIF2α activator 1 | 1178583-17-9 | Reference compound |
| HY-158197 | RC-106 | 1346216-50-9 | Reference compound |
| HY-158198 | PRXS571 | 2396759-31-0 | Reference compound |
| HY-158199 | BCN-HS-PEG2-bis(PNP) | 2126749-95-7 | Reference compound |
| HY-158201 | ATF4-IN-1 | 2991057-76-0 | Reference compound |
| HY-158202 | ATF4-IN-2 | 2991057-60-2 | Reference compound |
| HY-158203 | BMP agonist 2 | 1438900-88-9 | Reference compound |
| HY-158204 | CNB-001 | 1019110-87-2 | Reference compound |
| HY-158205 | HPO-DAEE | 1895934-61-8 | Reference compound |
| HY-158207S | (+)-Nebivolol-d4 | 2747915-48-4 | Isotope-Labeled Compounds |
| HY-158208 | PMMB276 | 2209036-28-0 | Reference compound |
| HY-158209 | Block polyoxyethylene-polyoxypropylene | 106392-12-5 | Reference compound |
| HY-158210 | Wnt/β-catenin-IN-3 | 1809413-98-6 | Reference compound |
| HY-158212 | Dyrk1A-IN-8 | 101578-13-6 | Reference compound |
| HY-158217 | GelMA, 30% methacrylation, Green Fluorescent | Biochemical Assay Reagents | |
| HY-158217A | GelMA, 60% methacrylation, Green Fluorescent | Biochemical Assay Reagents | |
| HY-158217B | GelMA, 90% methacrylation, Green Fluorescent | Biochemical Assay Reagents | |
| HY-158218 | GelMA, 30% methacrylation, Red Fluorescent | Biochemical Assay Reagents | |
| HY-158218A | GelMA, 60% methacrylation, red fluorescent | Biochemical Assay Reagents | |
| HY-158218B | GelMA, 90% methacrylation, red fluorescent | Biochemical Assay Reagents | |
| HY-158219 | Gelatin Methacryloyl, 30% methacrylation, blue fluorescent | Biochemical Assay Reagents | |
| HY-158219A | Gelatin Methacryloyl, 60% methacrylation, blue fluorescent | Biochemical Assay Reagents | |
| HY-158219B | Gelatin Methacryloyl, 90% methacrylation, blue fluorescent | Biochemical Assay Reagents | |
| HY-15822 | MF-438 | 921605-87-0 | Reference compound |
| HY-158220 | Hyaluronic acid Methacryloyl (MW 400 kDa) | Biochemical Assay Reagents | |
| HY-158220A | Hyaluronic acid Methacryloyl (MW 150 kDa) | Biochemical Assay Reagents | |
| HY-158220B | Hyaluronic acid methacryloyl (MW 10000) | Biochemical Assay Reagents | |
| HY-158220C | Hyaluronic acid methacryloyl (MW 50000) | Biochemical Assay Reagents | |
| HY-158221 | Chondroitin Sulfate Methacryloyl | Biochemical Assay Reagents | |
| HY-158222 | Alginate Methacryloyl (MW 50000) | Biochemical Assay Reagents | |
| HY-158222A | Alginate Methacryloyl (MW 300000) | Biochemical Assay Reagents | |
| HY-158223 | Carboxymethyl chitosan Methacryloyl | Biochemical Assay Reagents | |
| HY-158224 | Silk Fibroin Methacryloyl | Biochemical Assay Reagents | |
| HY-158225 | Methacrylated Type I collagen | Biochemical Assay Reagents | |
| HY-158226 | Elastin Methacrylated | Biochemical Assay Reagents | |
| HY-158227 | Dextran Methacryloyl (MW 200000) | Biochemical Assay Reagents | |
| HY-158227A | Dextran Methacryloyl (MW 500000) | Biochemical Assay Reagents | |
| HY-158228 | Poly-L-lysine Methacryloyl | Biochemical Assay Reagents | |
| HY-158229 | Heparin Methacrylate | Biochemical Assay Reagents | |
| HY-15823 | CAY10566 | 944808-88-2 | Reference compound |
| HY-158230 | SN-398 | 124623-00-3 | Reference compound |
| HY-158231 | Polyether F127 Diacrylate | Biochemical Assay Reagents | |
| HY-158233 | Apoptotic agent-4 | Reference compound | |
| HY-158235 | Tyrosinase-IN-27 | 2966803-96-1 | Reference compound |
| HY-158236 | ORL1 antagonist 2 | 1169982-72-2 | Reference compound |
| HY-158237 | PDE10A-IN-3 | 1006889-85-5 | Reference compound |
| HY-158238S | Silodosin β-D-glucuronide-d4 | 2851016-14-1 | Isotope-Labeled Compounds |
| HY-158239 | MS181 | Reference compound | |
| HY-158241 | GmhA-IN-1 | 1606387-54-5 | Reference compound |
| HY-158242 | Antibacterial agent 212 | Reference compound | |
| HY-158243 | Fallypride precursor | 166173-74-6 | Reference compound |
| HY-158245 | Herbicide safener-2 | 3027836-84-3 | Reference compound |
| HY-158246 | QPP-I-6 | 2864442-05-5 | Reference compound |
| HY-158248 | FGFR4-IN-19 | Reference compound | |
| HY-15825 | IWP L6 | 1427782-89-5 | Reference compound |
| HY-158251 | BIBD-300 | 3030758-22-3 | Reference compound |
| HY-158252S | Tiagabine-d5 (hydrochloride) | 1253297-72-1 | Isotope-Labeled Compounds |
| HY-158253 | Lectin from Helix pomatia, biotin conjugate | Biochemical Assay Reagents | |
| HY-158254S | (Rac)-Trandolaprilate-d5 | Isotope-Labeled Compounds | |
| HY-158255 | mPEG-PLGA (2000-80000) (LA/GA 50:50) | Reference compound | |
| HY-158255A | mPEG-PLGA (22500-26500) | 743423-15-6 | Reference compound |
| HY-158256 | Luciferase-IN-3 | 690987-97-4 | Dye Reagents |
| HY-158257 | Firefly luciferase-IN-4 | 370587-13-6 | Dye Reagents |
| HY-158258 | Antiviral agent 55 | 371137-60-9 | Reference compound |
| HY-15826 | SGC-CBP30 | 1613695-14-9 | Reference compound |
| HY-158261 | AChE-IN-63 | 876685-78-8 | Reference compound |
| HY-158262 | Bradykinin B1 receptor antagonist 1 | 578727-81-8 | Reference compound |
| HY-158264 | SNRI-IN-1 | 887766-95-2 | Reference compound |
| HY-158265 | FLT3D835Y/F691L-IN-1 | Reference compound | |
| HY-158266 | DOTA-PSMA-EB-01 | Peptides | |
| HY-158267 | Enrofloxacin/OVA | Biochemical Assay Reagents | |
| HY-158268 | 4-Hydroxynonenal/BSA | Biochemical Assay Reagents | |
| HY-158269 | T4-BSA | Biochemical Assay Reagents | |
| HY-15827 | NSC 405020 | 7497-07-6 | Reference compound |
| HY-158270 | Ethambutol-KLH | Biochemical Assay Reagents | |
| HY-158272 | Penicillin/OVA | Biochemical Assay Reagents | |
| HY-158273 | 2,4-D/BSA | Biochemical Assay Reagents | |
| HY-158274 | Gibberellins/BSA | Biochemical Assay Reagents | |
| HY-158275 | Rifampin/BSA | Biochemical Assay Reagents | |
| HY-158276 | Rifampin/KLH | Biochemical Assay Reagents | |
| HY-158277 | Streptomycin/BSA | Biochemical Assay Reagents | |
| HY-158278 | Aflatoxin B1/BSA | Biochemical Assay Reagents | |
| HY-158279 | Gentamicin/OVA | Biochemical Assay Reagents | |
| HY-15828 | Onvansertib | 1034616-18-6 | Reference compound |
| HY-158280 | Streptomycin/KLH | Biochemical Assay Reagents | |
| HY-158281 | Aflatoxin B1/KLH | Biochemical Assay Reagents | |
| HY-158282 | Pyrazinamide-KLH | Biochemical Assay Reagents | |
| HY-158283 | Ethambutol-BSA | Biochemical Assay Reagents | |
| HY-158284 | Penicillin G/BSA | Biochemical Assay Reagents | |
| HY-158285 | 25-OH Vitamin D3/BSA | Biochemical Assay Reagents | |
| HY-158286 | Streptomycin/OVA | Biochemical Assay Reagents | |
| HY-158287 | 2,4-D/KLH | Biochemical Assay Reagents | |
| HY-158288 | Pyrazinamide-BSA | Biochemical Assay Reagents | |
| HY-158289 | Isoniazid-KLH | Biochemical Assay Reagents | |
| HY-158290 | Natrexone/BSA | Biochemical Assay Reagents | |
| HY-158291 | Periplogenin/KLH | Biochemical Assay Reagents | |
| HY-158292 | Digoxin-OVA | Biochemical Assay Reagents | |
| HY-158293 | Toosendanin/OVA | Biochemical Assay Reagents | |
| HY-158294 | Toosendanin/BSA | Biochemical Assay Reagents | |
| HY-158295 | IAA/BSA | Biochemical Assay Reagents | |
| HY-158296 | Tetracycline/OVA | Biochemical Assay Reagents | |
| HY-158297 | Histamine/OVA | Biochemical Assay Reagents | |
| HY-158298 | Penicillin/BSA | Biochemical Assay Reagents | |
| HY-158299 | Periplogenin/BSA | Biochemical Assay Reagents | |
| HY-15830 | 25,26-Dihydroxyvitamin D3 | 29261-12-9 | Natural Products |
| HY-158300 | HCY/BSA | Biochemical Assay Reagents | |
| HY-158301 | MY-1B | 2929308-79-0 | Reference compound |
| HY-158302 | Glutor | 2561471-22-3 | Reference compound |
| HY-158303 | Chk2-IN-2 | 2984543-29-3 | Reference compound |
| HY-158304 | Rac1-IN-4 | 2924486-45-1 | Reference compound |
| HY-158305 | SM51a | 2764770-62-7 | Reference compound |
| HY-158306 | SM45a | 2764770-56-9 | Reference compound |
| HY-158307 | Z-Arg-Arg-βNA (acetate) | 2237216-27-0 | Peptides |
| HY-158308 | HDAC6-IN-41 | Reference compound | |
| HY-158309 | hOAT-IN-1 | 3057092-65-3 | Reference compound |
| HY-15831 | L-838417-d9 | 1213669-91-0 | Isotope-Labeled Compounds |
| HY-158310 | SOS1/EGFR-IN-1 | 2956724-20-0 | Reference compound |
| HY-158311 | Anti-osteoporosis agent-8 | Reference compound | |
| HY-158312 | UH15-38 | 2540881-21-6 | Reference compound |
| HY-158315 | NZ-97 | Reference compound | |
| HY-158316 | BTL-MK | 2758569-43-4 | Reference compound |
| HY-158317 | SFB-AMD3465 | 2416231-90-6 | Reference compound |
| HY-158318 | NUDT5/14 antagonist 1 | Reference compound | |
| HY-158319 | Mutant IDH1/NAMPT-IN-1 | 3040122-14-0 | Reference compound |
| HY-15832 | GSK 2830371 | 1404456-53-6 | Reference compound |
| HY-158320 | T3SS-IN-5 | Reference compound | |
| HY-158321 | SDH-IN-15 | Reference compound | |
| HY-158322 | nsp12-IN-1 | Reference compound | |
| HY-158323 | HGPRT/TBrHGPRT1-IN-1 | Reference compound | |
| HY-158325 | PROTAC FLT-3 degrader 4 | 2956722-48-6 | Reference compound |
| HY-158326 | FAP-IN-4 | Reference compound | |
| HY-158327 | Insecticidal agent 9 | Reference compound | |
| HY-158328A | CA IX/VEGFR-2-IN-2 | Reference compound | |
| HY-158329 | Alloc-DOX | 561022-65-9 | Reference compound |
| HY-15832A | (R)-GSK 2830371 | 2743427-27-0 | Reference compound |
| HY-15833 | Chlorthalidone | 77-36-1 | Reference compound |
| HY-158331 | Gal-ARV-771 | Reference compound | |
| HY-158332 | Sulotroban | 72131-33-0 | Reference compound |
| HY-158333 | Tasuldine | 88579-39-9 | Reference compound |
| HY-158334 | NDs-IN-1 | 3033806-97-9 | Reference compound |
| HY-158335 | DXR-IN-1 | Reference compound | |
| HY-158336 | E/Z-FETPY | 3056250-97-3 | Reference compound |
| HY-158337 | Nesosteine | 84210-62-8 | Reference compound |
| HY-158338 | ABHD antagonist 1 | 3034510-10-3 | Reference compound |
| HY-158339 | ABHD antagonist 2 | 3034510-43-2 | Reference compound |
| HY-15833R | Chlorthalidone (Standard) | 77-36-1 | Reference Standards |
| HY-15833S | Chlorthalidone-d4 | 1794941-44-8 | Isotope-Labeled Compounds |
| HY-158340 | TYK2 ligand 1 | 2770471-05-9 | Reference compound |
| HY-158341 | IOX5 | Reference compound | |
| HY-158342 | PROTAC TEAD degrader-1 | Reference compound | |
| HY-158343 | Thalidomide-NH-PEG2-C2-CH2 | 2064175-30-8 | Reference compound |
| HY-158345 | PROTAC VHL-type degrader-1 | 2821804-13-9 | Reference compound |
| HY-158346 | Polθ-IN-3 | 2922287-81-6 | Reference compound |
| HY-158347 | SARS-CoV-2 Mpro-IN-15 | Reference compound | |
| HY-158348 | m-PEG8-Lys(Mal)-Val-Ala-PAB-Ph-CO-Dazostinag | 2553413-13-9 | Reference compound |
| HY-158349 | Mal-Val-Ala-PAB-4-Abu(Me)-Dazostinag | 2553413-19-5 | ADC Related |
| HY-15834A | Eprosartan (mesylate) | 144143-96-4 | Reference compound |
| HY-15834AR | Eprosartan (mesylate) (Standard) | 144143-96-4 | Reference Standards |
| HY-15835 | CUDC-427 | 1446182-94-0 | Reference compound |
| HY-158351 | Mal-Val-Ala-PAB-NMe-CH2CH2-O-CO-Dazostinag | 2553412-83-0 | ADC Related |
| HY-158359 | 5′-XDP (sodium) | Reference compound | |
| HY-15836 | BAY 87-2243 | 1227158-85-1 | Reference compound |
| HY-158361 | Malt extract | Biochemical Assay Reagents | |
| HY-158362A | Monoglyceride lipase, Bacillus sp. | 9040-75-9 | Enzyme |
| HY-158363 | CSF1R-IN-25 | 2070864-23-0 | Reference compound |
| HY-158364 | NMT-IN-3 | 3061506-36-0 | Reference compound |
| HY-158365 | LRRK2-IN-14 | 2942328-06-3 | Reference compound |
| HY-158368 | PRDX1-IN-2 | 2566976-43-8 | Reference compound |
| HY-158369 | CK2-IN-10 | 831207-32-0 | Reference compound |
| HY-15837 | SAR-260301 | 1260612-13-2 | Reference compound |
| HY-158370 | CK2-IN-11 | 2938991-22-9 | Reference compound |
| HY-158371 | HDAC/CK2-IN-1 | 2599838-15-8 | Reference compound |
| HY-158372 | hCA I-IN-3 | Reference compound | |
| HY-158373 | Anticancer agent 213 | Reference compound | |
| HY-158374 | BIO-8169 | 2792153-06-9 | Reference compound |
| HY-158375 | MBL-IN-4 | Reference compound | |
| HY-158376 | mGluR7-IN-1 | Reference compound | |
| HY-158377 | CDK8/19-IN-2 | 3024381-54-9 | Reference compound |
| HY-158378 | Trivalent hydroxyarsinothricn | Reference compound | |
| HY-158379 | Antiparasitic agent-22 | Reference compound | |
| HY-15838 | ID-8 | 147591-46-6 | Reference compound |
| HY-158380 | UH-NIP-16 | Reference compound | |
| HY-158381 | PROTAC PTP1B degrader 1 | Reference compound | |
| HY-158382 | NH2-C4-PEG4-C5-COOH | Reference compound | |
| HY-158383 | Pomalidomide-CO-C3-PEG4-C6-NH2 | Reference compound | |
| HY-158385 | 5-Azido-PEG4-SS-UTP (tristriethylamine) | Oligonucleotides | |
| HY-158386 | IRE1a-IN-1 | 3033375-01-5 | Reference compound |
| HY-158387 | Anticancer agent 214 | 2916404-95-8 | Reference compound |
| HY-158388 | Anticancer agent 215 | 2916404-93-6 | Reference compound |
| HY-158389 | Anticancer agent 216 | 2916406-02-3 | Reference compound |
| HY-15839 | UNC 669 | 1314241-44-5 | Reference compound |
| HY-158390 | Anticancer agent 217 | 2916406-04-5 | Reference compound |
| HY-158391 | Anticancer agent 218 | 2916406-46-5 | Reference compound |
| HY-158392 | Anticancer agent 219 | 2916407-63-9 | Reference compound |
| HY-158393 | IRE1a-IN-2 | 3033375-24-2 | Reference compound |
| HY-158394 | TEAD-IN-12 | 3034813-66-3 | Reference compound |
| HY-158395 | TEAD-IN-13 | 3034813-74-3 | Reference compound |
| HY-158396 | TEAD-IN-14 | Reference compound | |
| HY-158398 | STAT6-IN-4 | 3033742-14-9 | Reference compound |
| HY-158399 | STAT6-IN-5 | 3033742-22-9 | Reference compound |
| HY-15840 | YLF-466D | 1273323-67-3 | Reference compound |
| HY-158400 | TEAD ligand 1 | 2971850-47-0 | Reference compound |
| HY-158401 | Antibiofilm agent-7 | Reference compound | |
| HY-158402 | Anti-inflammatory agent 84 | Reference compound | |
| HY-158403 | METTL3-IN-7 | Reference compound | |
| HY-158404 | METTL3-IN-8 | 932512-38-4 | Reference compound |
| HY-158405 | PAV-104 | 2923674-83-1 | Reference compound |
| HY-158407 | Anticancer agent 220 | Reference compound | |
| HY-158408 | NZ-66 | 3062992-25-7 | Reference compound |
| HY-158409 | Pan-RAS-IN-2 | 3034673-92-9 | Reference compound |
| HY-15841 | CEP-37440 | 1391712-60-9 | Reference compound |
| HY-158410 | PSA-IN-1 | Reference compound | |
| HY-158412 | BT317 | 38485-94-8 | Reference compound |
| HY-158415 | ATPase-IN-4 | 1219577-48-6 | Reference compound |
| HY-158417 | KSI-6666 | 1807873-14-8 | Reference compound |
| HY-158419 | PB(OH)3 | 1854111-80-0 | Reference compound |
| HY-15842 | SF1670 | 345630-40-2 | Reference compound |
| HY-158420 | STL001 | 3047493-70-6 | Reference compound |
| HY-158421 | MS-L6 | 63498-32-8 | Reference compound |
| HY-158422 | SARS-CoV-2 Mpro-IN-16 | Reference compound | |
| HY-158423 | NPD8790 | 615281-26-0 | Reference compound |
| HY-158424 | LSN3353871 | 2565657-20-5 | Reference compound |
| HY-158425 | Antimicrobial agent-31 | Reference compound | |
| HY-158426 | 2-APQC | 500271-63-6 | Reference compound |
| HY-158429 | PROTAC CYP1B1 degrader-2 | 2836297-26-6 | Reference compound |
| HY-15843 | MIR96-IN-1 | 1311982-88-3 | Reference compound |
| HY-158430 | CYP1B1 ligand 2 | 2836297-58-4 | Reference compound |
| HY-158431 | (S,R,S)-AHPC-Me-8-bromooctanoic acid | 2638512-58-8 | Reference compound |
| HY-158432 | GT-653 | Reference compound | |
| HY-158433 | KDM5B ligand 2 | Reference compound | |
| HY-158434 | IRAK1-IN-1 | Reference compound | |
| HY-158435 | P-gp inhibitor 23 | Reference compound | |
| HY-158436 | Antitumor agent-155 | Reference compound | |
| HY-158438 | MNK1/2-IN-8 | 2430793-35-2 | Reference compound |
| HY-158439 | anti-TNBC agent-7 | Reference compound | |
| HY-15844 | AG-825 | 149092-50-2 | Reference compound |
| HY-158440 | SARS-CoV-2 Mpro-IN-17 | Reference compound | |
| HY-158441 | A2G2S1 glycan (G2S1), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158442 | A2G2 glycan (G2) | Biochemical Assay Reagents | |
| HY-158443 | A2G2S1 glycan (G2S1), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158444 | A2G2 glycan (G2), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158445 | A2G2 glycan (G2), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158446 | A2G2 glycan (G2), APTS labelled | Biochemical Assay Reagents | |
| HY-158447 | A2G2 glycan (G2), procainamide labelled | Biochemical Assay Reagents | |
| HY-158448 | FA2G2 glycan (G2F) | Biochemical Assay Reagents | |
| HY-158449 | FA2G2 glycan (G2F), 2-AA labelled | Biochemical Assay Reagents | |
| HY-15845 | STF-083010 | 307543-71-1 | Reference compound |
| HY-158450 | FA2G2 glycan (G2F), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158451 | FA2G2 glycan (G2F), APTS labelled | Biochemical Assay Reagents | |
| HY-158452 | A3G3 glycan (G3) | Biochemical Assay Reagents | |
| HY-158453 | FA2B glycan (G0B), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158454 | FA2B glycan (G0B), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158455 | FA2[3]BG1 & FA2[6]BG1 glycan (G1B), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158456 | FA2[3]BG1 & FA2[6]BG1 glycan (G1B), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158457 | A2[3]G1 N-glycan | Biochemical Assay Reagents | |
| HY-158458 | A2[3]G1F1(α-1-3) glycan | Biochemical Assay Reagents | |
| HY-158459 | A2G2F2 glycan | Biochemical Assay Reagents | |
| HY-15846 | CPI-203 | 1446144-04-2 | Reference compound |
| HY-158460 | Alpha-Gal | Biochemical Assay Reagents | |
| HY-158461 | Alpha-Gal standard, 2-AA labelled | Biochemical Assay Reagents | |
| HY-158462 | Alpha-Gal standard, 2-AB labelled | Biochemical Assay Reagents | |
| HY-158463 | A2G2S2-KVANKT glycopeptide | Biochemical Assay Reagents | |
| HY-158464 | Fetuin glycoprotein | Biochemical Assay Reagents | |
| HY-158465 | GPEP FA2-KVANKT glycopeptide | Biochemical Assay Reagents | |
| HY-158466 | Human IgG Glycoprotein | Biochemical Assay Reagents | |
| HY-158467 | Core 1 O-glycan (C1), 2AB labelled | Biochemical Assay Reagents | |
| HY-158468 | Sialylated Core 1 O-glycan (C1S(3)1), 2AB labelled | Biochemical Assay Reagents | |
| HY-158469 | Disialylated Core 1 O-glycan (C1S(3,6)2), 2-AB labelled | Biochemical Assay Reagents | |
| HY-15846A | (Rac)-CPI-203 | 202591-23-9 | Reference compound |
| HY-15847 | HS38 | 1030203-81-6 | Reference compound |
| HY-158470 | Disialylated Core 2 O-glycan (C2S(3,3)2), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158471 | Core 1 O-glycan (C1) | Biochemical Assay Reagents | |
| HY-158472 | Sialylated Core 1 O-glycan (C1S(3)1) | Biochemical Assay Reagents | |
| HY-158473 | FA2[3]G1 & FA2[6]G1 glycan (G1F) | Biochemical Assay Reagents | |
| HY-158474 | A2G2S1 glycan (G2S1), APTS labelled | Biochemical Assay Reagents | |
| HY-158475 | A2G2S1 glycan (G2S1) | Biochemical Assay Reagents | |
| HY-158476 | FA2G2S1 glycan (G2FS1), procainamide labelled | Biochemical Assay Reagents | |
| HY-158477 | FA2G2S1 glycan (G2FS1) | Biochemical Assay Reagents | |
| HY-158478 | FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158479 | FA2[3]G1 & FA2[6]G1 glycan (G1F), APTS labelled | Biochemical Assay Reagents | |
| HY-15848 | AdipoRon | 924416-43-3 | Reference compound |
| HY-158480 | FA2[3]G1 & FA2[6]G1 glycan (G1F), procainamide labelled | Biochemical Assay Reagents | |
| HY-158481 | FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158482 | M3 glycan (Man3) | Biochemical Assay Reagents | |
| HY-158483 | M3 glycan (Man3), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158484 | M3 glycan (Man3), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158485 | M5 glycan (Man5) | Biochemical Assay Reagents | |
| HY-158486 | FA2G2S1 glycan (G2FS1), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158487 | A3G3 glycan (G3), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158488 | A3G3 glycan (G3), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158489 | A3G3 glycan (G3), procainamide labelled | Biochemical Assay Reagents | |
| HY-15849 | LP-533401 | 945976-43-2 | Reference compound |
| HY-158490 | A4G4 glycan | Biochemical Assay Reagents | |
| HY-158491 | A4G4 glycan, 2-AA labelled | Biochemical Assay Reagents | |
| HY-158492 | A4G4 glycan, 2-AB labelled | Biochemical Assay Reagents | |
| HY-158493 | A2 glycan (G0), procainamide labelled | Biochemical Assay Reagents | |
| HY-158494 | A2 glycan (G0) | Biochemical Assay Reagents | |
| HY-158495 | A2 glycan (G0), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158496 | A2 glycan (G0), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158497 | A2 glycan (G0), APTS labelled | Biochemical Assay Reagents | |
| HY-158498 | FA2 glycan (G0F) | Biochemical Assay Reagents | |
| HY-158499 | FA2 glycan (G0F), 2-AA labelled | Biochemical Assay Reagents | |
| HY-15849A | LP-533401 hydrochloride | 1040526-12-2 | Reference compound |
| HY-158500 | FA2 glycan (G0F), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158501 | M5 glycan (Man5), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158502 | FA2G2S1 glycan (G2FS1), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158503 | M5 glycan (Man5), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158504 | FA2G2S1 glycan (G2FS1), APTS labelled | Biochemical Assay Reagents | |
| HY-158505 | M5 glycan (Man5), APTS labelled | Biochemical Assay Reagents | |
| HY-158506 | A2G2S2 glycan (G2S2) | Biochemical Assay Reagents | |
| HY-158507 | M5 glycan (Man5), procainamide labelled | Biochemical Assay Reagents | |
| HY-158508 | A2G2S2 glycan (G2S2), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158509 | M6 glycan (Man6) | Biochemical Assay Reagents | |
| HY-15851 | Revefenacin | 864750-70-9 | Reference compound |
| HY-158510 | A2G2S2 glycan (G2S2), APTS labelled | Biochemical Assay Reagents | |
| HY-158511 | M6 glycan (Man6), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158512 | A2G2S2 glycan (G2S2), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158513 | FA2G2S2 glycan (G2FS2) | Biochemical Assay Reagents | |
| HY-158514 | M6 glycan (Man6), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158515 | FA2G2S2 glycan (G2FS2), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158516 | M6 glycan (Man6), procainamide labelled | Biochemical Assay Reagents | |
| HY-158517 | FA2G2S2 glycan (G2FS2), APTS labelled | Biochemical Assay Reagents | |
| HY-158518 | FA2G2S2 glycan (G2FS2), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158519 | M7 glycan (Man7) | Biochemical Assay Reagents | |
| HY-15851R | Revefenacin (Standard) | 864750-70-9 | Reference Standards |
| HY-15851S1 | Revefenacin-d9 | Isotope-Labeled Compounds | |
| HY-15851S2 | Revefenacin-d3 | Isotope-Labeled Compounds | |
| HY-15851S3 | Revefenacin-d4 | Isotope-Labeled Compounds | |
| HY-15852 | THRX-195518 | 909800-36-8 | Reference compound |
| HY-158520 | A2[3]G1 & A2[6]G1 glycan (G1), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158521 | M7 glycan (Man7), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158522 | A2[3]G1 & A2[6]G1 glycan (G1), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158523 | A2[3]G1 & A2[6]G1 glycan (G1) | Biochemical Assay Reagents | |
| HY-158524 | M7 glycan (Man7), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158525 | A3G3S3 glycan | Biochemical Assay Reagents | |
| HY-158526 | M7 glycan (Man7), procainamide labelled | Biochemical Assay Reagents | |
| HY-158527 | FA2 glycan (G0F), APTS labelled | Biochemical Assay Reagents | |
| HY-158528 | A3 glycan | Biochemical Assay Reagents | |
| HY-158529 | A3 glycan, 2-AA labelled | Biochemical Assay Reagents | |
| HY-15853 | MK-7246 | 1218918-62-7 | Reference compound |
| HY-158530 | A3 glycan, 2-AB labelled | Biochemical Assay Reagents | |
| HY-158531 | A3 glycan, procainamide labelled | Biochemical Assay Reagents | |
| HY-158532 | A4 glycan | Biochemical Assay Reagents | |
| HY-158533 | A3G3S3 glycan, 2-AA labelled | Biochemical Assay Reagents | |
| HY-158534 | M8 glycan (Man8) | Biochemical Assay Reagents | |
| HY-158535 | A3G3S3 glycan, 2-AB labelled | Biochemical Assay Reagents | |
| HY-158536 | M8 glycan (Man8), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158537 | A3G3S3 glycan, procainamide labelled | Biochemical Assay Reagents | |
| HY-158538 | M8 glycan (Man8), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158539 | M8 glycan (Man8), procainamide labelled | Biochemical Assay Reagents | |
| HY-15853A | MK-7246 S enantiomer | 2310135-53-4 | Reference compound |
| HY-158540 | A4 glycan, 2-AA labelled | Biochemical Assay Reagents | |
| HY-158541 | A4 glycan, 2-AB labelled | Biochemical Assay Reagents | |
| HY-158542 | A4 glycan, procainamide labelled | Biochemical Assay Reagents | |
| HY-158543 | M9 glycan (Man9) | Biochemical Assay Reagents | |
| HY-158544 | M9 glycan (Man9), 2-AA labelled | Biochemical Assay Reagents | |
| HY-158545 | M9 glycan (Man9), 2-AB labelled | Biochemical Assay Reagents | |
| HY-158546 | M9 glycan (Man9), procainamide labelled | Biochemical Assay Reagents | |
| HY-158547 | Etherolenic acid | 169217-39-4 | Natural Products |
| HY-15855 | Fosbretabulin (tromethamine) | 404886-32-4 | Reference compound |
| HY-158550 | 13(R),14(R)-epoxy Fluprostenol isopropyl ester | 2557329-36-7 | Reference compound |
| HY-158551 | PROTAC BcI-2/BcI-xI Degrader-1 | 3034200-49-9 | Reference compound |
| HY-158552 | 4-Ethylethcathinone hydrochloride | 2446466-62-0 | Reference compound |
| HY-158554 | 2-Ethylethcathinone (hydrochloride) | 2446466-59-5 | Reference compound |
| HY-158555 | 4-Ethyl-N,N-Dimethylcathinone (hydrochloride) | 2702382-98-5 | Reference compound |
| HY-158556 | 2,3-Dimethylethcathinone (hydrochloride) | 2705531-06-0 | Reference compound |
| HY-15856 | cis-(Z)-Flupentixol (dihydrochloride) | 51529-01-2 | Reference compound |
| HY-158569 | SAR114137 | 958853-11-7 | Reference compound |
| HY-15856A | Flupentixol | 2709-56-0 | Reference compound |
| HY-15856B | Flupentixol (dihydrochloride) | 2413-38-9 | Reference compound |
| HY-15856BR | Flupentixol (dihydrochloride) (Standard) | 2413-38-9 | Reference Standards |
| HY-15857 | CW-069 | 1594094-64-0 | Reference compound |
| HY-158570 | (2E)-Eicosenoic acid | 2127095-72-9 | Reference compound |
| HY-158571 | 17-Phenoxy trinor prostaglandin F2α | 2162157-41-5 | Reference compound |
| HY-158575 | all-cis-14,17,20,23,26,29-Dotriacontahexaenol | 2649103-52-4 | Natural Products |
| HY-15858 | AP-III-a4 | 1177827-73-4 | Reference compound |
| HY-158580 | 5-CF3-ddUTP (sodium) | 149208-43-5 | Biochemical Assay Reagents |
| HY-158583 | 13-POHSA | 2126038-97-7 | Reference compound |
| HY-158584 | 13-OAHSA | 1997286-67-5 | Reference compound |
| HY-158586 | 3'-Azido-ddATP sodium solution (100mM) | 1383937-03-8 | Biochemical Assay Reagents |
| HY-158587 | 3′-Azido-ddGTP (sodium) | Biochemical Assay Reagents | |
| HY-158588 | 3′-Azido-ddCTP (sodium) | Biochemical Assay Reagents | |
| HY-15858A | AP-III-a4 (hydrochloride) | 2070014-95-6 | Reference compound |
| HY-15859 | Atglistatin | 1469924-27-3 | Reference compound |
| HY-158594 | Docosahexaenoic acid alkyne | 2692622-57-2 | Reference compound |
| HY-158595 | 15(R),19(R)-Hydroxy prostaglandin F2α | 1224444-23-8 | Reference compound |
| HY-15860 | FLI-06 | 313967-18-9 | Reference compound |
| HY-15861 | Targapremir-210 | 1049722-30-6 | Reference compound |
| HY-158611 | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid methyl ester | 2055816-84-5 | Reference compound |
| HY-158612 | 3-Keto sphinganine (d8:0) (hydrochloride) | 1824382-78-6 | Reference compound |
| HY-158614 | 1-Palmitoyl-2-12-PAHSA-3-oleoyl-sn-glycerol | 2456348-64-2 | Reference compound |
| HY-158615 | STING18 | 2706536-26-5 | Reference compound |
| HY-158616 | 4-Methyl-7-(2-nitrophenoxy)-2H-chromen-2-one | 1286479-53-5 | Reference compound |
| HY-158617 | 4-Methyl-7-(4-nitrophenoxy)-2H-chromen-2-one | 1644277-00-8 | Reference compound |
| HY-158620 | Acyclo-5-Br-UTP (sodium) | Biochemical Assay Reagents | |
| HY-158621 | AcycloCTP (sodium) | Biochemical Assay Reagents | |
| HY-158622 | AcycloATP (sodium) | Biochemical Assay Reagents | |
| HY-158623 | (±)13(14)-DiHDPA | 1345275-24-2 | Natural Products |
| HY-158627 | JPC0323 Oleate | 1612785-68-8 | Reference compound |
| HY-158638 | NBD-FTY720 phenoxy (hydrochloride) | 2319882-09-0 | Dye Reagents |
| HY-158639 | 12-POHSA | 2042646-31-9 | Reference compound |
| HY-158649 | Fasnall (benzenesulfonate) | 2187367-11-7 | Reference compound |
| HY-15865 | FR901463 | 146478-74-2 | Reference compound |
| HY-158650 | 10-OAHSA | 2005487-34-1 | Reference compound |
| HY-158652 | (R)-CCG-1423 | 2309931-09-5 | Reference compound |
| HY-158655 | C17 3'-Sulfo galactosylceramide (d18:1/17:0) | 1071654-84-6 | Reference compound |
| HY-158656 | 3-Keto sphinganine (d6:0) (hydrochloride) | 1824544-52-6 | Reference compound |
| HY-158657 | 3-Keto-C12-dihydrosphingosine (hydrochloride) | 1823032-02-5 | Natural Products |
| HY-15866 | FR901465 | 146478-73-1 | Reference compound |
| HY-158661 | N-Methoxy mephedrone (hydrochloride) | 2703493-29-0 | Reference compound |
| HY-158662 | 3-Me-5-OMe-UTP (sodium) | Biochemical Assay Reagents | |
| HY-158663 | N,N-Dimethyl-ATP (sodium) | Biochemical Assay Reagents | |
| HY-158664 | 2-Amino-ATP (sodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-158665 | 3'-Deoxy-3'-amino-ATP (sodium) | Biochemical Assay Reagents | |
| HY-158666 | 3'-Amino-3'-dGTP (sodium) | Biochemical Assay Reagents | |
| HY-158667 | N4-Me-dCTP (sodium) | Biochemical Assay Reagents | |
| HY-158668 | 3'-Aminoacetyl-GTP (sodium) | Biochemical Assay Reagents | |
| HY-158669 | 3'-NH2-ddATP (sodium) | Biochemical Assay Reagents | |
| HY-158670 | 3'-NH2-ddGTP (sodium) | Biochemical Assay Reagents | |
| HY-158671 | 3'-NH2-ddCTP (sodium) | Biochemical Assay Reagents | |
| HY-158672 | 3′-O-Azidomethyl-dTTP (sodium) | Biochemical Assay Reagents | |
| HY-158673 | 3'-P-dATP (sodium) | Biochemical Assay Reagents | |
| HY-158674 | 3'-P-dGTP (sodium) | Biochemical Assay Reagents | |
| HY-158675 | 3'-P-dCTP (sodium) | Biochemical Assay Reagents | |
| HY-158676 | 3'-P-dTTP (sodium) | Biochemical Assay Reagents | |
| HY-158677 | BcI-2/BcI-xI ligand 1 | 3034202-16-6 | Reference compound |
| HY-158678 | E3 ligase Ligand 27 | 3034204-25-3 | Reference compound |
| HY-158679 | E3 Ligase Ligand-linker Conjugate 110 | Reference compound | |
| HY-15868 | HS-173 | 1276110-06-5 | Reference compound |
| HY-158680 | PARP1-IN-21 | 2855979-51-8 | Reference compound |
| HY-158681 | PARP1-IN-22 | 3033649-17-8 | Reference compound |
| HY-158682 | LpxC-IN-13 | 3033881-14-7 | Reference compound |
| HY-158683 | KIF18A-IN-11 | Reference compound | |
| HY-158684 | YX-02-030 | 3049076-98-1 | Reference compound |
| HY-158685 | RG7112D | 2360561-90-4 | Reference compound |
| HY-158687 | SARS-CoV-2 Mpro-IN-18 | Reference compound | |
| HY-158688 | PI3Kδ-IN-21 | Reference compound | |
| HY-15869 | Inauhzin | 309271-94-1 | Reference compound |
| HY-158690 | DDD00057570 | 338965-07-4 | Reference compound |
| HY-158692 | Tyk2-IN-18 | 3024860-29-2 | Reference compound |
| HY-158693 | WLB-87848 | 2839205-09-1 | Reference compound |
| HY-158694 | TLR7 agonist 20 | 3029695-00-6 | Reference compound |
| HY-158694A | TLR7 agonist 20 (hydrochloride) | Reference compound | |
| HY-158695 | Dual AChE-MAO B-IN-4 | Reference compound | |
| HY-158696 | BChE/MAO-B-IN-1 | Reference compound | |
| HY-158697 | α-Glucosidase-IN-65 | Reference compound | |
| HY-15870 | SR 11302 | 160162-42-5 | Reference compound |
| HY-158700 | DprE1-IN-10 | 1254782-81-4 | Reference compound |
| HY-158701 | KRAS G12D inhibitor 23 | Reference compound | |
| HY-158702 | 5-HTQ (chloride) | 40581-89-3 | Reference compound |
| HY-158703 | KRAS G12D inhibitor 24 | 3033701-29-7 | Reference compound |
| HY-158704 | 3'-NH2-ddTTP (sodium) | Biochemical Assay Reagents | |
| HY-158705 | SAINT-2 | 187587-97-9 | Reference compound |
| HY-158706 | SAE-IN-2 | Reference compound | |
| HY-158707 | dTTPαS (sodium) | 178603-75-3 | Biochemical Assay Reagents |
| HY-158709 | Cho-es-Lys | 1356250-80-0 | Biochemical Assay Reagents |
| HY-15870A | (6E)-SR 11302 | 1386982-70-2 | Reference compound |
| HY-15871 | GGTI298 (Trifluoroacetate) | 1217457-86-7 | Reference compound |
| HY-158711 | STING agonist-38 | 2850251-27-1 | Reference compound |
| HY-158712 | 3'-ONH2-dATP (sodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-158713 | 3'-ONH2-dGTP (sodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-158714 | 3'-ONH2-dCTP (sodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-158715 | 3'-ONH2-dTTP (sodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-158716 | 3'-O-Methylthiomethyl-dTTP (sodium) | Biochemical Assay Reagents | |
| HY-158717 | 3'-O-Methylthiomethyl-dATP (sodium) | Biochemical Assay Reagents | |
| HY-158718 | 3'-O-Methylthiomethyl-dGTP (sodium) | Biochemical Assay Reagents | |
| HY-158719 | 3′-O-Azidomethyl-dATP (sodium) solution (100mM) | Biochemical Assay Reagents | |
| HY-15872 | FTI-277 | 170006-73-2 | Reference compound |
| HY-158722 | Caerulein (acetate) | 2760881-68-1 | Peptides |
| HY-158724 | Calxgluk | 1820596-85-7 | Reference compound |
| HY-158725 | N-Octadecenoyl-(cis-9)-sulfatide | 1292769-40-4 | Natural Products |
| HY-158726 | Complex 3 | 2480150-28-3 | Reference compound |
| HY-158728 | 28-Deoxybetulin methyleneamine | 1025068-94-3 | Reference compound |
| HY-15872A | FTI-277 (hydrochloride) | 180977-34-8 | Reference compound |
| HY-15873 | FTI 276 | 170006-72-1 | Reference compound |
| HY-158730 | N-3-Hydroxybutyryl-L-homoserine lactone | 1325550-06-8 | Reference compound |
| HY-158732 | MAO-B-IN-33 | 2286257-25-6 | Reference compound |
| HY-158733 | HR68 | 2454582-64-8 | Reference compound |
| HY-158734 | Methyl γ-linolenyl fluorophosphonate | 1370451-91-4 | Reference compound |
| HY-158735 | Thioarginine (hydrobromide) | 2108196-23-0 | Reference compound |
| HY-158736 | Lyso-sulfatide (bovine) (ammonium) | 1246681-32-2 | Reference compound |
| HY-158738 | TCEP-biotin | 2227020-26-8 | Reference compound |
| HY-158739 | Rhodamine dithenoyl hydrazide | 2740257-94-5 | Dye Reagents |
| HY-15873A | FTI 276 (TFA) | 1217471-51-6 | Reference compound |
| HY-15874 | Fiboflapon | 936350-00-4 | Reference compound |
| HY-158740 | 1(R)-(Trifluoromethyl)oleyl alcohol | 2644636-20-2 | Reference compound |
| HY-158741 | IPG-2 AM | 1369302-24-8 | Dye Reagents |
| HY-158742 | SBB-Analogue (GL13) Biotin | 2171036-89-6 | Dye Reagents |
| HY-158743 | Indium (III) thiosemicarbazone 5b | 2345755-20-4 | Reference compound |
| HY-158746 | Fluo-2 AM | 1070771-36-6 | Dye Reagents |
| HY-158747 | CBDPA (CRM) | 2718149-62-1 | Reference compound |
| HY-158749 | 1-Oleoyl-2-lauroyl-3-palmitoyl-rac-glycerol | 1183882-29-2 | Natural Products |
| HY-15874A | Fiboflapon sodium | 1196070-26-4 | Reference compound |
| HY-158750 | 1-1(Z)-Octadecenyl-2-adrenoyl-sn-glycero-3-pe | 1390622-95-3 | Reference compound |
| HY-158751 | Jun9-72-2 | 2657659-42-0 | Reference compound |
| HY-158757 | KIF18A-IN-12 | 3033980-95-6 | Reference compound |
| HY-158758 | PROTAC IRAK4 degrader-10 | 3033829-95-4 | Reference compound |
| HY-158759 | Poly(vinyl acetate) | 9003-20-7 | Reference compound |
| HY-15876 | Clopidogrel thiolactone | 1147350-75-1 | Reference compound |
| HY-158760 | PROTAC IRAK4 degrader-11 | Reference compound | |
| HY-158761 | Polyaminopropyl biguanide | 133029-32-0 | Reference compound |
| HY-158762 | TK-642 | 2765183-10-4 | Reference compound |
| HY-158763 | MPI8 | 856242-63-2 | Reference compound |
| HY-158764 | PROTAC BET Degrader-12 | Reference compound | |
| HY-158765 | Leuco ethyl violet | 4865-00-3 | Reference compound |
| HY-158766 | 3-sucCA | 94159-47-4 | Reference compound |
| HY-158767 | Dehydro amlodipine (fumarate) | 2138811-33-1 | Reference compound |
| HY-158767R | Dehydro amlodipine (fumarate) (Standard) | 2138811-33-1 | Reference Standards |
| HY-158768 | Amino-PEG4-GGFG-Dxd | 2879227-88-8 | ADC Related |
| HY-15876R | Clopidogrel thiolactone (Standard) | 1147350-75-1 | Reference Standards |
| HY-15877 | BTB06584 | 219793-45-0 | Reference compound |
| HY-158771 | PRC1 ligand 1 | 2467965-59-7 | Reference compound |
| HY-158772 | m7G(5')ppp(5')(2'OMeA)pU (ammonium) | Oligonucleotides | |
| HY-158774 | TG2-179-1 | 1135023-19-6 | Reference compound |
| HY-158775 | Ferroptocide | 2505218-38-0 | Reference compound |
| HY-158776 | SLU-10482 | 2755451-45-5 | Reference compound |
| HY-158779 | Sulfane sulfur probe 4 | 1810731-98-6 | Dye Reagents |
| HY-15878 | LDC000067 | 1073485-20-7 | Reference compound |
| HY-158783 | SACLAC | 2248703-42-4 | Reference compound |
| HY-158784 | Arachidonoyl m-nitroaniline | 1175954-87-6 | Reference compound |
| HY-15879 | LB42708 | 226929-39-1 | Reference compound |
| HY-158790 | (R)-HTS-3 | 2771208-83-2 | Reference compound |
| HY-158791 | Enpp-1-IN-21 | 2803505-78-2 | Reference compound |
| HY-158792 | GK241 | 1899930-93-8 | Reference compound |
| HY-158793 | Lentztrehalose A | 1609356-99-1 | Reference compound |
| HY-158794 | Lentztrehalose B | 1808096-67-4 | Reference compound |
| HY-158795 | Fz25 | 2762498-70-2 | Reference compound |
| HY-158796 | L202 | 2170488-92-1 | Oligonucleotides |
| HY-158799 | Poly(ADP-ribose) Polymer/pADPr | Reference compound | |
| HY-15880 | CCT007093 | 176957-55-4 | Reference compound |
| HY-158800 | 1-NBD-decanoyl-2-decanoyl-sn-glycerol | 2309189-98-6 | Reference compound |
| HY-158803 | C6 Biotin glucosylceramide (d18:1/6:0) | 2692623-22-4 | Natural Products |
| HY-158805 | 4-Methoxy-α-pyrrolidinopropiophenone (tosylate) | 2748561-60-4 | Reference compound |
| HY-158806 | 3,4-DHMA (TFA) | 2704135-58-8 | Reference compound |
| HY-15881 | TCS JNK 5a | 312917-14-9 | Reference compound |
| HY-158812 | Eicosapentaenoyl-L-carnitine (chloride) | 2133456-02-5 | Reference compound |
| HY-158814 | 2-(2-Chlorophenyl)-1-(1H-indol-3-yl)ethanone | 1096914-22-5 | Reference compound |
| HY-158815 | SM-102 N-Oxide | 2824195-50-6 | Reference compound |
| HY-158818 | DXR-IN-2 | 2260608-07-7 | Reference compound |
| HY-158819 | m7(3'OMeG)(5')ppp(5')m6(2'OMeA)pG (trisodium) | 2956651-00-4 | Oligonucleotides |
| HY-15882 | GNE-783 | 1200127-66-7 | Reference compound |
| HY-158820 | Cosdosiran | 1834560-88-1 | Oligonucleotides |
| HY-158820A | Cosdosiran (sodium) | Oligonucleotides | |
| HY-158821 | ISTH0036 | 2179222-27-4 | Oligonucleotides |
| HY-158821A | ISTH0036 (sodium) | Oligonucleotides | |
| HY-158822 | IMT504 | 1075758-80-3 | Oligonucleotides |
| HY-158822A | IMT504 (sodium) | Oligonucleotides | |
| HY-158823 | GTI-2501 | 236391-67-6 | Oligonucleotides |
| HY-158823A | GTI-2501 (sodium) | Oligonucleotides | |
| HY-158824 | Asvasiran | 870094-26-1 | Oligonucleotides |
| HY-158824A | Asvasiran (sodium) | 1386946-83-3 | Oligonucleotides |
| HY-158825 | Cepadacursen (sodium) | 2252375-14-5 | Oligonucleotides |
| HY-158826 | EZN-2968 | 1098309-50-2 | Oligonucleotides |
| HY-158826A | EZN-2968 (sodium) | Oligonucleotides | |
| HY-158827 | AZD8233 | 2604215-74-7 | Oligonucleotides |
| HY-158827A | AZD8233 (sodium) | Oligonucleotides | |
| HY-158828 | SSO111 (sodium) | Oligonucleotides | |
| HY-158829 | SSOe26 (sodium) | Oligonucleotides | |
| HY-15883 | GNE-900 | 1200126-26-6 | Reference compound |
| HY-158830 | MDM4-targeting ASO (sodium) | Oligonucleotides | |
| HY-158836 | NAPIE | 2748289-69-0 | Reference compound |
| HY-158839 | 4-Ethyl pentedrone (hydrochloride) | 2748592-71-2 | Reference compound |
| HY-15884 | GSK2838232 | 1443460-91-0 | Reference compound |
| HY-158843 | 15(S)-Hete-biotin | 1217461-45-4 | Natural Products |
| HY-158845 | 8Br-HA | 2937864-01-0 | Reference compound |
| HY-15885 | LY2119620 | 886047-22-9 | Reference compound |
| HY-158857 | ortho-CBNQ | 2565592-49-4 | Reference compound |
| HY-15886 | Mdivi-1 | 338967-87-6 | Reference compound |
| HY-158861 | C3-K2-E14 | 2933215-86-0 | Biochemical Assay Reagents |
| HY-158867 | DOSPA (hydrochlorid) | 913194-16-8 | Oligonucleotides |
| HY-15887 | MG 149 | 1243583-85-8 | Reference compound |
| HY-158873 | N,N-Dihexyl sphingosine (d18:1/6:0/6:0) | 2377379-53-6 | Reference compound |
| HY-15888 | PTC-209 | 315704-66-6 | Reference compound |
| HY-158881 | DDG | 2350271-86-0 | Reference compound |
| HY-158882 | FLAC6 | 2820046-26-0 | Reference compound |
| HY-158883 | ODG | 2350271-85-9 | Reference compound |
| HY-158884 | CALXCHOL (sodium) | 2121543-66-4 | Reference compound |
| HY-15888A | PTC-209 (hydrobromide) | 1217022-63-3 | Reference compound |
| HY-15889 | AMG 925 | 1401033-86-0 | Reference compound |
| HY-158899 | 3,4-Ethylenedioxy U-51754 (hydrochloride) | 2748623-92-7 | Reference compound |
| HY-15889A | AMG 925 (HCl) | 1401034-19-2 | Reference compound |
| HY-15890 | C-7280948 | 587850-67-7 | Reference compound |
| HY-158905 | MTDB-Alkyne | 2923694-73-7 | Reference compound |
| HY-15891 | GW311616 | 198062-54-3 | Reference compound |
| HY-158912 | 1-Oleoyl-3-arachidoyl-rac-glycerol | 1427086-85-8 | Reference compound |
| HY-158913 | 4-Methylthio-N-benzylcathinone (hydrochloride) | 2706488-88-0 | Reference compound |
| HY-158918 | 4-CF3-TPP-DC | 2661108-93-4 | Reference compound |
| HY-15891A | GW311616 (hydrochloride) | 197890-44-1 | Reference compound |
| HY-15892 | CK-636 | 442632-72-6 | Reference compound |
| HY-158925 | Conglobatin C1 | 2673270-37-4 | Natural Products |
| HY-158927 | 5-Chloro-2-thiothinone (hydrochloride) | 2903386-66-1 | Reference compound |
| HY-15893 | DMOG | 89464-63-1 | Reference compound |
| HY-158934 | (±)-CBCQ | 2415352-36-0 | Reference compound |
| HY-158935 | Dihydro K22 | 2926907-58-4 | Reference compound |
| HY-158936 | Lumula | 511229-72-4 | Reference compound |
| HY-158937 | 15(R)-15-Methyl prostaglandin F2α methyl ester | 35700-22-2 | Reference compound |
| HY-158938 | 11(Z),14(Z),17(Z)-Eicosatrienoic acid methyl ester | 62472-96-2 | Reference compound |
| HY-158939 | (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid | 339534-01-9 | Reference compound |
| HY-15894 | BQ-788 (sodium salt) | 156161-89-6 | Reference compound |
| HY-158940 | N-Glycine 3'-sulfo galactosylsphingosine | 2620491-81-6 | Reference compound |
| HY-158943 | 2-Fluoro QMPSB | 2707165-48-6 | Reference compound |
| HY-158944 | 1,2-Dipalmitoleoyl-3-11(Z)-octadecenoyl-rac-glycerol | 2692623-04-2 | Reference compound |
| HY-158945 | 1,3-Dipalmitoleoyl-2-11(Z)-octadecenoyl glycerol | 2348469-98-5 | Reference compound |
| HY-158946 | 1,2-Dielaidoyl-3-linoleoyl-rac-glycerol | 2692623-11-1 | Reference compound |
| HY-158947 | 1-1(Z)-Hexadecenyl-2-palmitoyl-sn-glycero-3-PE | 1199257-33-4 | Reference compound |
| HY-158947S | 1-1(Z)-Hexadecenyl-2-Palmitoyl-d9-sn-glycero-3-PE | 2738509-20-9 | Isotope-Labeled Compounds |
| HY-158948 | 1-Palmitoyl-2-11(Z)-octadecenoyl-3-butyroyl-rac-glycerol | 2692623-15-5 | Reference compound |
| HY-158949 | 1-Palmitoyl-2-11(Z)-octadecenoyl-3-oleoyl-rac-glycerol | 2692623-16-6 | Reference compound |
| HY-15894A | BQ-788 | 173326-37-9 | Reference compound |
| HY-15895 | Aprocitentan | 1103522-45-7 | Reference compound |
| HY-158952 | C24 (2'(R)-Hydroxy) dihydro ceramide (d18:0/24:0) | 164989-36-0 | Reference compound |
| HY-158957 | 1,3-Diheptadecanoyl-2-oleoyl glycerol | 869990-15-8 | Reference compound |
| HY-158958 | 1,2-Dilinoleoyl-3-γ-linolenoyl-rac-glycerol | 852369-68-7 | Reference compound |
| HY-158959 | 1,3-Diarachidonoyl-2-oleoyl glycerol | 869990-37-4 | Reference compound |
| HY-15895R | Aprocitentan (Standard) | 1103522-45-7 | Reference Standards |
| HY-15895S | Aprocitentan-d4 | Isotope-Labeled Compounds | |
| HY-158960 | 1,2-Dioleoyl-3-arachidonoyl-rac-glycerol | 91539-55-8 | Reference compound |
| HY-158961 | 1,3-Dielaidoyl-2-oleoyl glycerol | 946577-28-2 | Reference compound |
| HY-158964 | 1-Palmitoyl-2-oleoyl-3-linolenoyl-rac-glycerol | 78144-20-4 | Reference compound |
| HY-158967 | 3,4-Difluoro-N-desmethyl U-47700 (hydrochloride) | 2740551-86-2 | Reference compound |
| HY-158968 | MMs02943764 | 708287-29-0 | Reference compound |
| HY-15897 | LDN-212854 | 1432597-26-6 | Reference compound |
| HY-158970 | Caf1-IN-1 | 1807775-88-7 | Reference compound |
| HY-158973 | bCSE-IN-1 | Reference compound | |
| HY-158974 | YTHDC1-IN-1 | 2995344-53-9 | Reference compound |
| HY-158975 | VRK1/CK1-IN-1 | 3050772-20-5 | Reference compound |
| HY-158976 | Sodium lactate ringer's solution | Biochemical Assay Reagents | |
| HY-158977 | β-Lactamase-IN-9 | Reference compound | |
| HY-158978 | Multitarget AD inhibitor-2 | Reference compound | |
| HY-158979 | Nav1.8-IN-14 | 2417373-18-1 | Reference compound |
| HY-15898 | Y-320 | 288250-47-5 | Reference compound |
| HY-158980 | Antifungal agent 103 | Reference compound | |
| HY-158981 | Herbicide safener-3 | 3029112-55-5 | Reference compound |
| HY-158985 | Amino-PEG3-2G degrader-1 | 2267315-06-8 | Reference compound |
| HY-158985A | Amino-PEG3-2G degrader-1 (hydrochloride) | Reference compound | |
| HY-158987 | Adenosine phosphonobutyric, 2'(3'), 5'-diposphate | 1050202-63-5 | Reference compound |
| HY-15899 | Des(benzylpyridyl) Atazanavir | 1192224-24-0 | Reference compound |
| HY-158990 | GE1111 | 2883669-12-1 | Reference compound |
| HY-158991 | I1421 | Reference compound | |
| HY-158992S | SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT (TFA) | Isotope-Labeled Compounds | |
| HY-158994S | MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS (TFA) | Isotope-Labeled Compounds | |
| HY-158995S | 3-Epiglycyrrhetinic acid-d2 | Isotope-Labeled Compounds | |
| HY-158995S1 | 3-Epiglycyrrhetinic acid-d3 | Isotope-Labeled Compounds | |
| HY-158998 | ALKBH1-IN-2 | Reference compound | |
| HY-158999 | VCPIP1-IN-1 | 3025297-92-8 | Reference compound |
| HY-15900 | Voxtalisib | 934493-76-2 | Reference compound |
| HY-159000 | VCPIP1-IN-2 | 3025298-68-1 | Reference compound |
| HY-159001 | ZCDD083 | 2958659-59-9 | Reference compound |
| HY-159002S | Methyl-warfarin-d3 | Isotope-Labeled Compounds | |
| HY-159004 | Se-DOPE | Reference compound | |
| HY-159005 | TDTM | 1357270-50-8 | Reference compound |
| HY-159006 | CYP1B1 ligand 3 | 65823-65-6 | Reference compound |
| HY-159007 | BD-AcAc2 | 58213-75-5 | Oligonucleotides |
| HY-159008 | NHSF | 2292112-27-5 | Reference compound |
| HY-159009 | MS7 | 1593654-46-6 | Reference compound |
| HY-15901 | LGB321 | 1210417-75-6 | Reference compound |
| HY-159015 | SIAIS630120-NC | Reference compound | |
| HY-159016 | SIAIS630121-NC | Reference compound | |
| HY-159017 | EM-12-Alkyne-C6-OMs | 2570254-42-9 | Reference compound |
| HY-159018 | Alkyne-C6-OMs | 228403-45-0 | Reference compound |
| HY-15901A | LGB321 (monohydrochloride) | 1469925-36-7 | Reference compound |
| HY-15902 | ABTS (diammonium salt) | 30931-67-0 | Dye Reagents |
| HY-15903 | ADOS | 82692-96-4 | Dye Reagents |
| HY-15904 | N-Ethyl-N-(3-sulfopropyl)-m-anisidine (sodium) | 82611-88-9 | Biochemical Assay Reagents |
| HY-159045 | F-SAHA | 149648-08-8 | Reference compound |
| HY-159046S | ASGITFSNSGMHW(Val-13C5,15N)R (TFA) | Isotope-Labeled Compounds | |
| HY-15905 | ALPS | 82611-85-6 | Dye Reagents |
| HY-159051 | Dragendorff reagent | 39775-75-2 | Biochemical Assay Reagents |
| HY-159053 | 2,3,4,6-Tetra-O-acetyl-D-mannopyranose | 140147-37-1 | Biochemical Assay Reagents |
| HY-159057 | Biotin-BMCC | 188682-72-6 | Reference compound |
| HY-159058 | Hericium Erinaceus Extract | Biochemical Assay Reagents | |
| HY-159059 | Ganoderma Lucidum/Reishi Extract | Biochemical Assay Reagents | |
| HY-15906 | AMPPD | 122341-56-4 | Biochemical Assay Reagents |
| HY-159060 | Coriolus Versicolor Extract | Biochemical Assay Reagents | |
| HY-159061 | Antrodia Camphorata Extract | Biochemical Assay Reagents | |
| HY-159062 | Goji Extract | Biochemical Assay Reagents | |
| HY-159063 | Soy Polysaccharides | Biochemical Assay Reagents | |
| HY-159064S | DSPSAPVNVT(Val-13C5,15N)R (TFA) | Isotope-Labeled Compounds | |
| HY-159065S | FIQE(Val-13C5,15N)NTTTR (TFA) | Isotope-Labeled Compounds | |
| HY-159066 | Polysachoride of astragalus mongholicus | Biochemical Assay Reagents | |
| HY-159067 | DEAE-dextran, MW 500000 (hydrochloride) | 9064-91-9 | Biochemical Assay Reagents |
| HY-159068 | Coreopsis tinctoria polysacharide | Biochemical Assay Reagents | |
| HY-159069 | Zymosan (ZM), 95% | 9010-72-4 | Biochemical Assay Reagents |
| HY-15907 | BBD | 18378-20-6 | Dye Reagents |
| HY-159071 | Lichenan, 80% | 1402-10-4 | Biochemical Assay Reagents |
| HY-159072 | Mal-Val-Ala-PAB-N(SO2Me)-Exatecan | 2575682-08-3 | Reference compound |
| HY-159075 | N-Sulfosuccinimidyl iodoacetate (sodium) | Reference compound | |
| HY-159076 | E3 ligase Ligand 7 | 37630-54-9 | Reference compound |
| HY-159077 | H2N-C6-NH-CO-CH2-O-Ph-CH2-NH-Boc | Reference compound | |
| HY-159078 | PolQi1 | 2607139-80-8 | Reference compound |
| HY-15908 | BCA | 979-88-4 | Biochemical Assay Reagents |
| HY-159080 | HgCht2-IN-1 | Reference compound | |
| HY-159081 | AChE/BChE-IN-20 | Reference compound | |
| HY-159082 | E3 ligase Ligand 28 | Reference compound | |
| HY-159083 | DN5355 | 937012-09-4 | Reference compound |
| HY-159085 | P-gp inhibitor 24 | Reference compound | |
| HY-159086 | RGB097 | Reference compound | |
| HY-159087 | RGB110 | Reference compound | |
| HY-159088 | KOR agonist 2 | Reference compound | |
| HY-15909 | BCIP | 6578-06-9 | Dye Reagents |
| HY-159090 | AT1R antagonist 3 | 3053482-15-5 | Reference compound |
| HY-159091 | HIV-1 integrase inhibitor 12 | Reference compound | |
| HY-159092 | HIV-1 integrase inhibitor 13 | Reference compound | |
| HY-159093 | Antitumor agent-178 | Reference compound | |
| HY-159094 | Nav1.8-IN-15 | 524061-69-6 | Reference compound |
| HY-159095 | PKR activator 5 | 2761226-35-9 | Reference compound |
| HY-159096 | Apoptosis inducer 21 | Reference compound | |
| HY-159097 | T.cruzi-IN-4 | Reference compound | |
| HY-159098 | dWIZ-1 | Reference compound | |
| HY-159099 | HbF inducer 2 | 2654011-51-3 | Reference compound |
| HY-15910 | 5-BrdU | 59-14-3 | Oligonucleotides |
| HY-159100 | PVP-037 | 862810-50-2 | Reference compound |
| HY-159101 | EP26 | Reference compound | |
| HY-159102 | PVP-037.2 | Reference compound | |
| HY-159103 | LeuRS-IN-2 | Reference compound | |
| HY-159104 | Cinnamon bark oil, from Cinnamonum zeylanicum Blume | 8015-91-6 | Biochemical Assay Reagents |
| HY-159106 | MeSeI | 2901664-87-5 | Reference compound |
| HY-159107 | 2-MNG | 2101538-28-5 | Reference compound |
| HY-159108 | AZ683 | 953798-95-3 | Reference compound |
| HY-159109 | HDAC6-IN-46 | 3038789-39-5 | Reference compound |
| HY-15911 | CNP-AFU | 157843-41-9 | Biochemical Assay Reagents |
| HY-159110 | ABA-DMNB | 1947375-16-7 | Reference compound |
| HY-159111 | KS124 | Reference compound | |
| HY-159112 | AW01178 | 651293-70-8 | Reference compound |
| HY-159113 | PCC0105003 | Reference compound | |
| HY-159114 | Whole Glucan Particles | Biochemical Assay Reagents | |
| HY-159115 | ART26.12 | 2766800-24-0 | Reference compound |
| HY-159116 | AChE-IN-69 | 2755986-33-3 | Reference compound |
| HY-159118 | PC-Qz1 | Reference compound | |
| HY-159119 | hDHODH-IN-15 | Reference compound | |
| HY-159120 | ZG-2291 | 2962103-40-6 | Reference compound |
| HY-159121 | sEH inhibitor-17 | 2823295-37-8 | Reference compound |
| HY-159122 | CA IX-IN-2 | 3009842-92-3 | Reference compound |
| HY-159123 | KHK-6 | Reference compound | |
| HY-159124 | YZL-51N | 3031072-69-9 | Reference compound |
| HY-159125 | PD-1/PD-L1-IN-47 | 1137341-95-7 | Reference compound |
| HY-159126 | SIRT2-IN-15 | 312275-43-7 | Reference compound |
| HY-159127 | HRS-4642 | 2836263-09-1 | Reference compound |
| HY-159128 | hCAIX-IN-21 | Reference compound | |
| HY-159129 | hCAXII-IN-10 | Reference compound | |
| HY-15913 | DAOS | 83777-30-4 | Biochemical Assay Reagents |
| HY-159130 | AO-022 | Reference compound | |
| HY-159131 | PNSC928 | Reference compound | |
| HY-159132 | CAIX/CAXII-IN-2 | Reference compound | |
| HY-159133 | BuChE-IN-13 | Reference compound | |
| HY-159134 | TRPA1-IN-3 | 92585-24-5 | Reference compound |
| HY-159135 | Fmoc-Thr(OtBu)-OtBu | 129460-13-5 | Reference compound |
| HY-159136 | Fmoc-Ser(tBu)-OtBu | 129460-16-8 | Reference compound |
| HY-15914 | DHBS | 54970-72-8 | Dye Reagents |
| HY-159143 | BChE-IN-33 | Reference compound | |
| HY-159144 | Anti-inflammatory agent 91 | Reference compound | |
| HY-159145 | Lenalidomide-acetylene-C3-MsO | 2138441-31-1 | Reference compound |
| HY-159146 | PPARα agonist 4 | Reference compound | |
| HY-159147 | SIAIS039 | 2570251-69-1 | Reference compound |
| HY-159148 | AChE-IN-70 | Reference compound | |
| HY-159149 | Antitumor agent-182 | Reference compound | |
| HY-15915 | DTNB | 69-78-3 | Biochemical Assay Reagents |
| HY-159150 | HIV-1 inhibitor-71 | 2762922-66-5 | Reference compound |
| HY-159151 | AChE/Aβ-IN-6 | Reference compound | |
| HY-159152 | PQM-164 | 2226535-25-5 | Reference compound |
| HY-159153 | Photosensitizer-4 | Reference compound | |
| HY-159154 | PSS-II | Reference compound | |
| HY-159155 | CDK2/4-IN-1 | Reference compound | |
| HY-159156 | MAT2A inhibitor 6 | 2447686-21-5 | Dye Reagents |
| HY-159157 | Anti-inflammatory agent 92 | 1609387-77-0 | Reference compound |
| HY-159158 | COX-1/2-IN-8 | Reference compound | |
| HY-159159 | MS-II-124 | 3037332-85-4 | Reference compound |
| HY-15916 | DTE | 6892-68-8 | Biochemical Assay Reagents |
| HY-159160 | HBV-IN-46 | 3034992-40-7 | Reference compound |
| HY-159162 | 7-(2-Aminoethyl)camptothecin | 433284-40-3 | ADC Related |
| HY-159162A | 7-(2-Aminoethyl)camptothecin (TFA) | Reference compound | |
| HY-159163 | KRASG12C IN-12 | 2093328-45-9 | Reference compound |
| HY-159164 | PROTAC CRBN ligand-3 | Reference compound | |
| HY-159165 | Pomalidomide-cyclopentane-amide-Alkyne | Reference compound | |
| HY-159169 | 5-LOX/sEH-IN-1 | Reference compound | |
| HY-15917 | DL-dithiothreitol | 3483-12-3 | Biochemical Assay Reagents |
| HY-159170 | Quorum sensing-IN-7 | Reference compound | |
| HY-159171 | sEH/HDAC6-IN-2 | 3009011-58-6 | Reference compound |
| HY-159172 | HDAC3-IN-4 | 2988762-46-3 | Reference compound |
| HY-159173 | AChE-IN-71 | 1708114-58-2 | Reference compound |
| HY-159174 | EPHA2/A4/GAK-IN-1 | Reference compound | |
| HY-159175 | XM-U-14 | Reference compound | |
| HY-159176 | Antitumor agent-183 | 2775428-94-7 | Isotope-Labeled Compounds |
| HY-159177 | M4 mAChR Modulator-1 | Reference compound | |
| HY-159178 | m-AM-BBIQ | 1258457-58-7 | Reference compound |
| HY-159179 | α4 integrin receptor antagonist 3 | 863226-74-8 | Reference compound |
| HY-15917A | L-Dithiothreitol | 16096-97-2 | Biochemical Assay Reagents |
| HY-15917S | DL-dithiothreitol-d10 | 302912-05-6 | Isotope-Labeled Compounds |
| HY-15917S1 | DL-dithiothreitol-d10-1 | 203633-21-0 | Isotope-Labeled Compounds |
| HY-15917S2 | DL-dithiothreitol-d6 | 850153-85-4 | Isotope-Labeled Compounds |
| HY-15918 | HDAOS | 82692-88-4 | Biochemical Assay Reagents |
| HY-159180 | p-NCS-Bz-NODA-GA | 1660127-21-8 | Biochemical Assay Reagents |
| HY-159181 | p-NCS-Bz-DOTA-GA | 2194580-71-5 | Biochemical Assay Reagents |
| HY-159183 | THP-NCS | 1807847-98-8 | Biochemical Assay Reagents |
| HY-159184 | THP-Mal | 1314929-99-1 | Biochemical Assay Reagents |
| HY-15919 | HTBA | 53279-72-4 | Biochemical Assay Reagents |
| HY-159190 | HRX-0233 | 2409140-12-9 | Reference compound |
| HY-159191S | VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI (TFA) | Isotope-Labeled Compounds | |
| HY-159192S | SADDNIKTPAE(Arg-13C6,15N4)LLGPLPPSADDNLKT (TFA) | Isotope-Labeled Compounds | |
| HY-159193S | DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT (TFA) | Isotope-Labeled Compounds | |
| HY-159194 | DSPE-PEG2000-Cy5.5 | Reference compound | |
| HY-15920 | INT | 146-68-9 | Biochemical Assay Reagents |
| HY-159204 | 3'-Amino-Modifier C7 CPG 1000 | Biochemical Assay Reagents | |
| HY-15921 | IPTG | 367-93-1 | Biochemical Assay Reagents |
| HY-15921A | IPTG hemidioxane | 1330286-44-6 | Biochemical Assay Reagents |
| HY-15922 | Luminol | 521-31-3 | Dye Reagents |
| HY-15922A | Luminol (sodium salt) | 20666-12-0 | Dye Reagents |
| HY-15923 | MAOS | 82692-97-5 | Dye Reagents |
| HY-15924 | Thiazolyl Blue | 298-93-1 | Dye Reagents |
| HY-15925 | Nitro blue tetrazolium chloride | 298-83-9 | Dye Reagents |
| HY-15926 | ONPG | 369-07-3 | Biochemical Assay Reagents |
| HY-15926S | ONPG-13C | 864933-71-1 | Isotope-Labeled Compounds |
| HY-15927 | 4-Nitrophenyl β-D-glucopyranoside | 2492-87-7 | Biochemical Assay Reagents |
| HY-15928 | PNPP (disodium) | 4264-83-9 | Dye Reagents |
| HY-15929 | TBHBA | 14348-40-4 | Biochemical Assay Reagents |
| HY-15930 | TMB | 54827-17-7 | Dye Reagents |
| HY-15930A | TMB (dihydrochloride) | 64285-73-0 | Dye Reagents |
| HY-15930B | TMB (dihydrochloride x.hydrate) | 207738-08-7 | Biochemical Assay Reagents |
| HY-15930C | TMB (monosulfate) | 54827-18-8 | Dye Reagents |
| HY-15930R | TMB (Standard) | 54827-17-7 | Dye Reagents |
| HY-15931 | TMB-PS | 102062-36-2 | Dye Reagents |
| HY-15932 | TOOS | 82692-93-1 | Biochemical Assay Reagents |
| HY-15933 | TOPS | 40567-80-4 | Biochemical Assay Reagents |
| HY-15934 | X-GAL | 7240-90-6 | Dye Reagents |
| HY-15934A | 5-Bromo-4-chloro-3-indolyl-α-D-mannopyranoside, 93% | 125229-64-3 | Biochemical Assay Reagents |
| HY-15935 | X-Gluc (Dicyclohexylamine) | 18656-96-7 | Dye Reagents |
| HY-15935B | X-Gluc (cyclohexanamine) | 114162-64-0 | Dye Reagents |
| HY-15935C | X-Gluc (sodium) | 129541-41-9 | Dye Reagents |
| HY-15936 | γ-GT | 63699-78-5 | Biochemical Assay Reagents |
| HY-15937 | 5(6)-FAM SE | 117548-22-8 | Dye Reagents |
| HY-15938 | 5-FAM SE | 92557-80-7 | Dye Reagents |
| HY-15939 | 6-FAM SE | 92557-81-8 | Dye Reagents |
| HY-15940 | 5(6)-Carboxyfluorescein | 72088-94-9 | Dye Reagents |
| HY-15941 | 5(6)-FITC | 27072-45-3 | Dye Reagents |
| HY-15942 | 5-TAMRA | 91809-66-4 | Dye Reagents |
| HY-159422 | S-309309 | 2267352-04-3 | Reference compound |
| HY-15943 | 6-TAMRA | 91809-67-5 | Dye Reagents |
| HY-15944 | 5(6)-TAMRA | 98181-63-6 | Dye Reagents |
| HY-159449 | PROTAC SMARCA2 degrader-5 | 2568277-68-7 | Reference compound |
| HY-15945 | DBeQ | 177355-84-9 | Reference compound |
| HY-159450 | PROTAC SMARCA2 degrader-6 | 2568523-72-6 | Reference compound |
| HY-159451 | PROTAC SMARCA2 degrader-7 | 2568277-71-2 | Reference compound |
| HY-159452 | PROTAC SMARCA2/4-degrader-1 | 2568273-68-5 | Reference compound |
| HY-159453 | PROTAC SMARCA2/4-degrader-2 | 2568277-76-7 | Reference compound |
| HY-159454 | PROTAC SMARCA2/4-degrader-3 | 2568507-10-6 | Reference compound |
| HY-159455 | PROTAC SMARCA2/4-degrader-4 | 2568523-81-7 | Reference compound |
| HY-159456 | PROTAC SMARCA2/4-degrader-5 | 2568277-84-7 | Reference compound |
| HY-159457 | PROTAC SMARCA2/4-degrader-6 | 2568277-87-0 | Reference compound |
| HY-159458 | PROTAC SMARCA2/4-degrader-7 | 2568277-89-2 | Reference compound |
| HY-159459 | PROTAC SMARCA2/4-degrader-32 | 2568273-79-8 | Reference compound |
| HY-159460 | PROTAC SMARCA2/4-degrader-8 | 2568507-14-0 | Reference compound |
| HY-159461 | PROTAC SMARCA2/4-degrader-9 | 2568507-15-1 | Reference compound |
| HY-159462 | PROTAC SMARCA2 degrader-10 | 2568279-34-3 | Reference compound |
| HY-159465 | E3 ligase Ligand 30 | 2725913-42-6 | Reference compound |
| HY-159466 | E3 Ligase Ligand-linker Conjugate 113 | 2378054-01-2 | Reference compound |
| HY-15947 | Ravoxertinib | 1453848-26-4 | Reference compound |
| HY-159470 | Polyprenol (13~21) | 308068-00-0 | Biochemical Assay Reagents |
| HY-159471 | N6-[(6-Aminohexyl)carbamoylmethyl]-ADP | 100826-95-7 | Reference compound |
| HY-159472 | SMARCA2/4-ligand-1 | 2411651-36-8 | Reference compound |
| HY-159473 | K-Ras-IN-3 | 3024991-82-7 | Reference compound |
| HY-159474 | KRAS inhibitor-24 | 3030576-47-4 | Reference compound |
| HY-159475 | KRAS inhibitor-25 | 3030577-05-7 | Reference compound |
| HY-159476 | KRAS inhibitor-26 | 3030576-80-5 | Reference compound |
| HY-159477 | SARS-CoV-2-IN-92 | 2123489-12-1 | Reference compound |
| HY-159478 | CHO-Ph-spiro[3.3]heptane-COOEt | Reference compound | |
| HY-159479 | PfSUB1-IN-1 | Reference compound | |
| HY-15947A | Ravoxertinib hydrochloride | 2070009-58-2 | Reference compound |
| HY-15948 | Kif15-IN-1 | 672926-32-8 | Reference compound |
| HY-159480 | AD1058 | 2907782-78-7 | Reference compound |
| HY-159481 | SDH-IN-17 | Reference compound | |
| HY-159482 | SBN-284 | Reference compound | |
| HY-159483 | SelB-1 | 2674058-66-1 | Reference compound |
| HY-159484 | Hsp110/sGC-modulator-1 | Reference compound | |
| HY-159485 | NFh-ALP | Reference compound | |
| HY-159486 | SDH-IN-18 | 723748-50-3 | Reference compound |
| HY-159487 | (S,R,S)-AHPC-CO-spiro[3.3]heptane-Ph-CHO | Reference compound | |
| HY-159488 | PPO-IN-14 | Reference compound | |
| HY-159489 | SDUY038 | 2892720-11-3 | Reference compound |
| HY-15949 | Kif15-IN-2 | 672926-33-9 | Reference compound |
| HY-159490 | Thalidomide-5-piperazine-C-piperidine-CO-C8-NH2 | Reference compound | |
| HY-159491 | DPP-4-IN-11 | Reference compound | |
| HY-159492 | 5-HT7 receptor ligand 2 | Reference compound | |
| HY-159493 | BI2536-PEG2-Halo | Reference compound | |
| HY-159494 | PROTAC sEH-degrader-1 | Reference compound | |
| HY-159495 | Keap1-Nrf2-IN-21 | Reference compound | |
| HY-159496 | Dyrk1A-IN-10 | 2891824-14-7 | Reference compound |
| HY-15950 | AZD1981 | 802904-66-1 | Reference compound |
| HY-159500 | Zopocianine | 2206660-94-6 | Reference compound |
| HY-159500A | Zopocianine (sodium) | 2206660-95-7 | Reference compound |
| HY-159502 | Surlorian | 1467605-57-7 | Reference compound |
| HY-159503 | Segigratinib | 1882873-93-9 | Reference compound |
| HY-159503A | Segigratinib (hydrochloride) | 2847066-15-1 | Reference compound |
| HY-159504 | Pregabalinum naproxencarbilum | 1221072-91-8 | Reference compound |
| HY-159506 | Bimokalner | 2243284-19-5 | Reference compound |
| HY-159507 | Brezivaptan | 1370444-22-6 | Reference compound |
| HY-159508 | Brimarafenibum | 1643326-82-2 | Reference compound |
| HY-159509 | Claziprotamidum | 2361124-03-8 | Reference compound |
| HY-15951 | ML167 | 1285702-20-6 | Reference compound |
| HY-159510 | VEGFR-2-IN-51 | Reference compound | |
| HY-159511 | Hedgehog IN-7 | Reference compound | |
| HY-159512 | EGFR kinase inhibitor 7 | Reference compound | |
| HY-159513 | Bcl-2/Mcl-1-IN-4 | Reference compound | |
| HY-159514 | Graveolide | 72173-44-5 | Natural Products |
| HY-159515 | PBE-AMF | Reference compound | |
| HY-159516 | Sabialimon P | 2267333-96-8 | Reference compound |
| HY-159517 | PI3K/Akt/mTOR-IN-5 | Reference compound | |
| HY-159518 | ROS inducer 4 | 2959444-40-5 | Reference compound |
| HY-159519 | EGFR/HER2-IN-16 | Reference compound | |
| HY-159520 | Ofirnoflastum | 2731294-23-6 | Reference compound |
| HY-159521 | HN252 | Reference compound | |
| HY-159522 | Odentegravirum | 2495436-99-0 | Reference compound |
| HY-159523 | Nurandociguatum | 2781965-75-9 | Reference compound |
| HY-159524 | Matsupexolum | 1399442-97-7 | Reference compound |
| HY-159525 | Linustedastatum | 2254299-48-2 | Reference compound |
| HY-159526 | Adarulatide tetraxetan | 1246013-02-4 | Peptides |
| HY-159527 | Glovadalenum | 2576359-31-2 | Reference compound |
| HY-159528 | Girocitinibum | 2222137-79-1 | Reference compound |
| HY-159529 | DBCO-PEG4-Eosin 5-isothiocyanate | Dye Reagents | |
| HY-159530 | Darbinuradum | 1877347-38-0 | Reference compound |
| HY-159534 | Flezurafenibum | 2760321-00-2 | Reference compound |
| HY-159535 | Fovinaciclibum | 2146171-49-3 | Reference compound |
| HY-159536 | Frevecitinibum | 1299417-07-4 | Reference compound |
| HY-159537 | (S,R,S)-AHPC-CO-bicyclo[2.2.2]octane-CHO | Reference compound | |
| HY-159538 | COOEt-bicyclo[2.2.2]octane-CHO | 959958-67-9 | Reference compound |
| HY-159539 | COOEt-spiro[3.3]heptane-CHO | 2226571-47-5 | Reference compound |
| HY-15954 | NVP-CGM097 | 1313363-54-0 | Reference compound |
| HY-159540 | (S,R,S)-AHPC-CO-Spiro-CHO | Reference compound | |
| HY-159542 | SMARCA2 ligand-6 | 2408394-89-6 | Reference compound |
| HY-159543 | (S,R,S)-AHPC-CO-Ph-Ph-CHO | Reference compound | |
| HY-159544 | SMARCA2 ligand-7 | 2568281-41-2 | Reference compound |
| HY-159545 | SMARCA2/4-ligand-2 | 2568281-88-7 | Reference compound |
| HY-159546 | (S,R,S)-AHPC-Me-CO-cyclohexene-Bpin | Reference compound | |
| HY-159547 | Cyclopropane-(S,R,S)-AHPC | 2502205-74-3 | Reference compound |
| HY-159548 | Cyclopropane-(S,R,S)-AHPC-CO-cyclohexene-Bpin | Reference compound | |
| HY-159549 | (S,R,S)-AHPC-CO-C-Cyclohexene-Bpin | Reference compound | |
| HY-15954A | NVP-CGM097 (stereoisomer) | 2070009-54-8 | Reference compound |
| HY-15954B | NVP-CGM097 (sulfate) | 1313367-56-4 | Reference compound |
| HY-15954C | (R)-NVP-CGM097 | 2643938-26-3 | Reference compound |
| HY-159550 | (S,R,S)-AHPC-CO-cyclohexene-Bpin | Reference compound | |
| HY-159553 | Ac-NH-(S,R,S)-AHPC | Reference compound | |
| HY-159556 | Dimethylformamide-(S,R,S)-AHPC | Reference compound | |
| HY-159557 | Ethyl-trans-4-benzylcyclohexane-1-carboxylate | 1923826-92-9 | Reference compound |
| HY-159558 | (S,R,S)-AHPC-CO-cyclohexane-C-Ph-pyrimidine-diazabicyclo | Reference compound | |
| HY-159560 | PBA-AMF | Reference compound | |
| HY-159561 | COX-1-IN-2 | Reference compound | |
| HY-159562 | COX-2-IN-46 | Reference compound | |
| HY-159563 | Mal-va-mac-SN38 | 2778229-31-3 | Reference compound |
| HY-159564 | iNOS/COX-2-IN-3 | Reference compound | |
| HY-159565 | VEGFR-2/InhA-IN-1 | Reference compound | |
| HY-159567 | Ferroptosis-IN-11 | 1266755-01-4 | Reference compound |
| HY-159568 | hCAIX-IN-22 | Reference compound | |
| HY-159569 | TfR-1-IN-1 | 1643444-62-5 | Reference compound |
| HY-159570 | XD2-149 | 2710221-08-0 | Reference compound |
| HY-159571 | Thalidomide-NH-C5-azacyclohexane-N-Boc | 2710222-09-4 | Reference compound |
| HY-159572 | NH2-C5-Azacyclohexane-N-Boc | Reference compound | |
| HY-159573 | Napabucasin analogue | 1133287-34-9 | Reference compound |
| HY-159575 | COOEt-cyclohexane-C-Ph-pyrimidine-diazabicyclo | Reference compound | |
| HY-159576 | O-Me Eribulin | 2676196-81-7 | ADC Related |
| HY-159577 | Nic-15 | 2896739-91-4 | Reference compound |
| HY-159578S | VU6036864 | 2746406-36-8 | Isotope-Labeled Compounds |
| HY-159579 | CW-3308 | 3055592-99-6 | Reference compound |
| HY-15958 | VBY-825 | 1310340-58-9 | Reference compound |
| HY-159580 | STAT3-IN-31 | Reference compound | |
| HY-159581 | URAT1&XO inhibitor 3 | 2089040-93-5 | Reference compound |
| HY-159582 | ACKR3 agonist 1 | Reference compound | |
| HY-159583 | FPR2 agonist 4 | 2101188-49-0 | Reference compound |
| HY-159584 | LBG20304 | Reference compound | |
| HY-159585 | CYP51-IN-20 | Reference compound | |
| HY-159586 | Tyrosinase-IN-32 | Reference compound | |
| HY-159587 | P300-IN-4 | Reference compound | |
| HY-159588 | Mcl-1 inhibitor 20 | Reference compound | |
| HY-159589 | BTK-IN-37 | Reference compound | |
| HY-15958A | (S,R,R)-VBY-825 | Reference compound | |
| HY-15959 | Savolitinib | 1313725-88-0 | Reference compound |
| HY-159592 | Piperazine-Pyrimidine-Cyclohexane-COOEt | Reference compound | |
| HY-159593 | Ac-NH-(S,R,S)-AHPC-CO-cyclohexane-pyrimidine-diazabicyclo | Reference compound | |
| HY-159594 | Dimethylformamide-(S,R,S)-AHPC-CO-cyclohexane-pyrimidine-diazabicyclo | Reference compound | |
| HY-159595 | PCSK9-IN-29 | 1233353-86-0 | Reference compound |
| HY-159596 | Naphthyridin-Me-dimethoxybenzene-COOH | Reference compound | |
| HY-159597 | Thalidomide-methylpyrrolidine | 2616540-84-0 | Reference compound |
| HY-159598 | 3-Azaspiro[5.5]undecane-9-methanol | 1784372-01-5 | Reference compound |
| HY-159599 | Thalidomide-pyrrolidine-C-azaspiro | 2832871-47-1 | Reference compound |
| HY-159601 | CSN5-IN-1 | Reference compound | |
| HY-159602 | BET BD2-IN-3 | 2677039-66-4 | Reference compound |
| HY-159603 | S-WJM992 | Reference compound | |
| HY-159604 | METTL3-IN-9 | 295348-36-6 | Reference compound |
| HY-159605 | Autophagy inducer 5 | Reference compound | |
| HY-159606 | MS182 | 3034773-62-8 | Reference compound |
| HY-159607 | PRT3789 | 2755761-78-3 | Reference compound |
| HY-159608 | PROTAC Cbl-b-IN-1 | 3035210-39-7 | Reference compound |
| HY-159609 | PROTAC GSPT1 degrader-1 | 3034310-17-0 | Reference compound |
| HY-15961 | Antitumor agent-3 | 420126-30-3 | Reference compound |
| HY-159610 | PROTAC GSPT1 degrader-2 | 3024909-61-0 | Reference compound |
| HY-159611 | KRAS G12C inhibitor 68 | 3034851-27-6 | Reference compound |
| HY-159612 | PARP1-IN-28 | 2855059-11-7 | Reference compound |
| HY-159613 | PELP1-IN-1 | 946262-80-2 | Reference compound |
| HY-159615 | Cbl-b-IN-21 | 2851878-87-8 | Reference compound |
| HY-159617 | Cbz-Pip-2C-Pip-C-Pip | 3035215-25-6 | Reference compound |
| HY-159618 | (3S)Lenalidomide-5-Pip-C-Pip-2C-Pip | Reference compound | |
| HY-159619 | Boc-azetidine-2C-oxotetrahydropyrimidin-bromophenyl | 3034310-18-1 | Reference compound |
| HY-159620 | Thalidomide 5-azetidine-2C-oxotetrahydropyrimidin-bromophenyl | 3034310-00-1 | Reference compound |
| HY-159621 | Endosidine 5 | 364361-68-2 | Reference compound |
| HY-159622 | Boc-Pip-C-oxotetrahydropyrimidin-bromophenyl | 3024909-51-8 | Reference compound |
| HY-159623 | Thalidomide 5-Pip-C-oxotetrahydropyrimidin-bromophenyl | 3024909-50-7 | Reference compound |
| HY-159624 | KK-92A | Reference compound | |
| HY-159625 | WX8 | 232935-92-1 | Reference compound |
| HY-159627A | Met-AMS (TEA) | 1122489-97-7 | Reference compound |
| HY-159628A | Glu-AMS (TEA) | 1810728-44-9 | Reference compound |
| HY-159632 | PAR4 antagonist 6 | Reference compound | |
| HY-159633 | PLpro-IN-5 | 3009839-42-0 | Reference compound |
| HY-159636 | Lactalbumin | 9013-90-5 | Biochemical Assay Reagents |
| HY-159637 | IWY357 | 3052672-51-9 | Reference compound |
| HY-159638 | Elunonavir | 2242428-57-3 | Reference compound |
| HY-159639 | BAY-2925976 | 2642235-06-9 | Reference compound |
| HY-15964 | Tirasemtiv | 1005491-05-3 | Reference compound |
| HY-159640 | NVP-FVP954 | Reference compound | |
| HY-159641 | VVD-130037 | 3034880-93-5 | Reference compound |
| HY-159642 | TYRA-300 | 2800223-30-5 | Reference compound |
| HY-159642G | TYRA-300 (GMP) | 2800223-30-5 | GMP Small Molecules |
| HY-159643 | NDI-101150 | 2628486-22-4 | Reference compound |
| HY-159644 | Casdatifan | 2709069-30-5 | Reference compound |
| HY-159646 | BMS-986397 | 2564486-44-6 | Reference compound |
| HY-159647 | PLX-4545 | 2892065-45-9 | Reference compound |
| HY-159648 | PF-07328948 | 2936625-34-0 | Reference compound |
| HY-159649 | BMS-986408 | 2618418-12-3 | Reference compound |
| HY-15965 | Uprosertib | 1047634-65-0 | Reference compound |
| HY-159650 | EOS-984 | 2724937-55-5 | Reference compound |
| HY-159651 | PTOTAC HSD17B13 degrader 1 | 3046195-01-8 | Reference compound |
| HY-159652 | KRAS inhibitor-31 | 2920695-77-6 | Reference compound |
| HY-159653 | MASTL-IN-5 | 3024916-78-4 | Reference compound |
| HY-159654 | PDE4-IN-19 | 3042879-82-0 | Reference compound |
| HY-159655 | PLpro-IN-6 | 3041046-04-9 | Reference compound |
| HY-159656 | PNPLA3 modifier 1 | 3036158-95-6 | Reference compound |
| HY-159657 | SIK-IN-4 | 3033846-10-2 | Reference compound |
| HY-159658 | TTR stabilizer 1 | 2778162-15-3 | Reference compound |
| HY-15965A | Uprosertib hydrochloride | 1047635-80-2 | Reference compound |
| HY-15966 | GSK2110183 analog 1 | 1047634-63-8 | Reference compound |
| HY-159660 | E3 ligase Ligand 31 | 2357114-13-5 | Reference compound |
| HY-159661 | E3 Ligase Ligand-linker Conjugate 114 | Reference compound | |
| HY-159662 | HSD17B13 degrader 2 | 3035000-69-9 | Reference compound |
| HY-159665 | CDLI-5 | 3047549-85-6 | Reference compound |
| HY-159666 | Nystatin A1 | 34786-70-4 | Reference compound |
| HY-159668 | DL002 | 3049680-91-0 | ADC Related |
| HY-159669 | Stercobilin hydrochloride (mixture of isomers) | 13129-80-1 | Biochemical Assay Reagents |
| HY-15966A | GSK2110183 analog 1 (hydrochloride) | 2070009-64-0 | Reference compound |
| HY-15967 | PS48 | 1180676-32-7 | Reference compound |
| HY-159670 | Monophosphoryl Lipid A-12 | 1332714-01-8 | Biochemical Assay Reagents |
| HY-159670B | Monophosphoryl Lipid A-12 (triethylamine) | Reference compound | |
| HY-159671 | 3D-Monophosphoryl Lipid (14) | 252042-59-4 | Biochemical Assay Reagents |
| HY-159671A | 3D-Monophosphoryl Lipid (14) (triethylamine) | 252042-60-7 | Reference compound |
| HY-159671B | 3D-Monophosphoryl Lipid (14) (ammonium) | Reference compound | |
| HY-159672 | 3D-Monophosphoryl Lipid (12,16) | Biochemical Assay Reagents | |
| HY-159672A | 3D-Monophosphoryl Lipid (12,16) (free acid) | 220048-49-7 | Reference compound |
| HY-159672B | 3D-Monophosphoryl Lipid (12,16) (triethylamine) | Reference compound | |
| HY-159674 | N-Tetamine-pSar45-Maleimide | Biochemical Assay Reagents | |
| HY-159675 | 1-A-N | Oligonucleotides | |
| HY-159677 | E3 Ligase Ligand-linker Conjugate 115 | 2375564-59-1 | Reference compound |
| HY-159678 | 4-(1,3-Dioxolan-2-yl)phenethyl methanesulfonate | 2369046-75-1 | Reference compound |
| HY-159679 | E3 Ligase Ligand-linker Conjugate 116 | 2409844-90-0 | Reference compound |
| HY-15968 | Entospletinib | 1229208-44-9 | Reference compound |
| HY-159680 | OMs-PEG2-NHAlloc-PEG2-Boc | 2376332-47-5 | Reference compound |
| HY-159681 | AASS-IN-1 | Reference compound | |
| HY-159682 | 3,8-Diazabicyclo[3.2.1]octane-4-pyrimidine-piperidine-cyclohexene-Bpin | Reference compound | |
| HY-159683 | E3 Ligase Ligand-linker Conjugate 117 | Reference compound | |
| HY-159683A | E3 Ligase Ligand-linker Conjugate 119 | Reference compound | |
| HY-159684 | 3,8-Diazabicyclo[3.2.1]octane-pyrimidine-piperidine-cyclohexene-Bpin | Reference compound | |
| HY-159685 | E3 Ligase Ligand-linker Conjugate 118 | Reference compound | |
| HY-159686 | Aclidinium | 727649-81-2 | Reference compound |
| HY-159687 | Nafithromycin | 1691240-78-4 | Reference compound |
| HY-159688 | Cefditoren | 104145-95-1 | Reference compound |
| HY-159689 | Cloroperone | 61764-61-2 | Reference compound |
| HY-15969 | Sal003 | 1164470-53-4 | Reference compound |
| HY-159691 | IONIS-FGFR4Rx | 1416376-17-4 | Oligonucleotides |
| HY-159691A | IONIS-FGFR4Rx (sodium) | Oligonucleotides | |
| HY-159692 | AZD8701 | 2603457-08-3 | Oligonucleotides |
| HY-159692A | AZD8701 (sodium) | Oligonucleotides | |
| HY-159693 | ISIS 626112 | 2091995-55-8 | Oligonucleotides |
| HY-159693A | ISIS 626112 (sodium) | Oligonucleotides | |
| HY-159694 | IONIS PTP1BRx | 1403406-29-0 | Oligonucleotides |
| HY-159694A | IONIS PTP1BRx (sodium) | Oligonucleotides | |
| HY-159695 | IONIS-GCCRRx | 1431900-72-9 | Oligonucleotides |
| HY-159695A | IONIS-GCCRRx (sodium) | Oligonucleotides | |
| HY-159696 | ISIS 449884 | 1428588-67-3 | Oligonucleotides |
| HY-159696A | ISIS 449884 (sodium) | Oligonucleotides | |
| HY-159697 | ISIS 532401 | 1644201-52-4 | Oligonucleotides |
| HY-159697A | ISIS 532401 (sodium) | Oligonucleotides | |
| HY-159698 | IONIS-DGAT 2Rx | 2091332-22-6 | Oligonucleotides |
| HY-159698A | IONIS-DGAT 2Rx (sodium) | Oligonucleotides | |
| HY-159699 | 80-O18 | Oligonucleotides | |
| HY-15970 | Verdinexor | 1392136-43-4 | Reference compound |
| HY-159700 | AA3-DLin | 3027565-91-6 | Oligonucleotides |
| HY-159704 | 9-Keto-latanoprost | 141074-06-8 | Reference compound |
| HY-159706 | S9-A13 | 1223771-84-3 | Reference compound |
| HY-159708 | Ionizable lipid Az1 | Oligonucleotides | |
| HY-159709 | VL-422 | 2765519-47-7 | Oligonucleotides |
| HY-15971 | AMD 3465 (hexahydrobromide) | 185991-07-5 | Reference compound |
| HY-159710 | TNT-b10 | 3037332-26-3 | Oligonucleotides |
| HY-159711 | PPPDA-O16B | Oligonucleotides | |
| HY-159713 | Lipid R6 | Oligonucleotides | |
| HY-159714 | Lipid HTO12 | 3047222-45-4 | Oligonucleotides |
| HY-159715 | Lipid DIM1 | 2820155-36-8 | Oligonucleotides |
| HY-159716 | Lipid 50 | 2440135-57-7 | Oligonucleotides |
| HY-159717 | Lipid 331 | Oligonucleotides | |
| HY-159718 | NLRP3-IN-46 | Reference compound | |
| HY-15971A | AMD 3465 | 185991-24-6 | Reference compound |
| HY-159725 | BAmP-O16B | Oligonucleotides | |
| HY-159726 | C10-200 | Oligonucleotides | |
| HY-159728 | PROTAC PRMT3 degrader 1 | Reference compound | |
| HY-15973 | BSF-466895 | 262442-90-0 | Reference compound |
| HY-159730 | ERG245 | Reference compound | |
| HY-159731 | OX2R agonist 1 | 2648347-78-6 | Reference compound |
| HY-159732 | PRMT3-IN-4 | Reference compound | |
| HY-159733 | E3 Ligase Ligand-linker Conjugate 120 | Reference compound | |
| HY-159734 | TPP-resveratrol | Reference compound | |
| HY-159735 | Lipid 23 | Oligonucleotides | |
| HY-159737 | Rociclovir | 108436-80-2 | Reference compound |
| HY-159738 | N-(2-(Diethylamino)ethyl)-2-iodobenzamide | 170794-62-4 | Reference compound |
| HY-159741 | Minamestane | 105051-87-4 | Reference compound |
| HY-159742 | GP130 modulator-1 | 2375779-31-8 | Reference compound |
| HY-159743 | M101 | Reference compound | |
| HY-159744 | M103 | Reference compound | |
| HY-159745 | M107 | Reference compound | |
| HY-159746 | HS801 | Reference compound | |
| HY-159747 | M401 | Reference compound | |
| HY-159748 | M402 | Reference compound | |
| HY-159749 | M902 | Reference compound | |
| HY-15975 | GNF179 | 1261114-01-5 | Reference compound |
| HY-159750 | M903 | Reference compound | |
| HY-159751 | HS101 | Reference compound | |
| HY-159752 | HS103 | Reference compound | |
| HY-159753 | HS105 | Reference compound | |
| HY-159754 | HS201 | Reference compound | |
| HY-15976 | P7C3 | 301353-96-8 | Reference compound |
| HY-159767A | (S)-DOTAGA.(SA.FAPi)2 | 2417089-06-4 | ADC Related |
| HY-159768A | DOTAGA.Glu.(FAPi)2 | 2882922-68-9 | Reference compound |
| HY-15977 | (S)-P7C3-OMe | 1235481-43-2 | Reference compound |
| HY-159770A | (S)-EB-FAPI-B2 | 2740747-99-1 | ADC Related |
| HY-159772 | 1-(4-(2-Aminoethyl)piperidin-1-yl)-2-azidoethan-1-one | Reference compound | |
| HY-159774 | ADC Control human IgG1-DM1 | ADC Related | |
| HY-159777 | CPI-203-PEG5-Alkyne | Reference compound | |
| HY-159779 | NR-V04 | 2766608-52-8 | Reference compound |
| HY-15978 | P7C3-A20 | 1235481-90-9 | Reference compound |
| HY-159780 | Amino-PEG4-(S,R,S)-AHPC-Me | 2458220-06-7 | Reference compound |
| HY-159783 | Mal-Exatecan | 3028213-52-4 | ADC Related |
| HY-159788 | PROTAC K-Ras Degrader-4 | 2938169-99-2 | Reference compound |
| HY-15979 | H-89 | 127243-85-0 | Reference compound |
| HY-159794 | Azido-methyltetrazine di-arm linker | 2861998-16-3 | ADC Related |
| HY-159795 | Claturafenib | 2754408-94-9 | Reference compound |
| HY-159798 | NR-11c | Reference compound | |
| HY-159799 | p38α inhibitor 5 | 2550397-96-9 | Reference compound |
| HY-15979A | H-89 (dihydrochloride) | 130964-39-5 | Reference compound |
| HY-15980 | GNF179 (Metabolite) | 1310455-86-7 | Reference compound |
| HY-159800 | 6-(4-Azidobutanamido)hexanoic acid | Reference compound | |
| HY-159801 | E3 Ligase Ligand-linker Conjugate 122 | 3033187-29-7 | Reference compound |
| HY-159802 | Tolamolol | 38103-61-6 | Reference compound |
| HY-159803 | IST-622 | 128201-92-3 | Reference compound |
| HY-159805 | CDK2-IN-31 | 2813260-27-2 | Reference compound |
| HY-159806 | UU | 2415-43-2 | Oligonucleotides |
| HY-159807 | UAU | 752-71-6 | Oligonucleotides |
| HY-159809 | Antibacterial agent 249 | 138801-72-6 | Reference compound |
| HY-15981 | Omarigliptin | 1226781-44-7 | Reference compound |
| HY-159811 | Antitumor agent-187 | 2879230-64-3 | Reference compound |
| HY-159817 | Asaretoclax | 2363074-01-3 | Reference compound |
| HY-159818 | Amogammadex | 1309580-40-2 | Reference compound |
| HY-159819 | Vormatrigine | 2392951-18-5 | Reference compound |
| HY-15981R | Omarigliptin (Standard) | 1226781-44-7 | Reference Standards |
| HY-15982 | APY0201 | 1232221-74-7 | Reference compound |
| HY-159820 | Veonetinib | 1210828-09-3 | Reference compound |
| HY-159821 | Ulacamten | 2830607-59-3 | Reference compound |
| HY-159822 | Teprosulvose | 1983131-47-0 | Reference compound |
| HY-159823 | Suricapavir | 2417270-21-2 | Reference compound |
| HY-159824 | Soxataltinib | 2546116-88-3 | Reference compound |
| HY-159825 | Branosotine | 2412849-26-2 | Reference compound |
| HY-159826 | Brexanolone caprilcerbate | 2681264-65-1 | Reference compound |
| HY-159827 | Cenacitinib | 2641636-52-2 | Reference compound |
| HY-159828 | Dezecapavir | 2570323-59-8 | Reference compound |
| HY-159829 | Direclidine | 1803346-98-6 | Reference compound |
| HY-159830 | Rivasterat | 2446590-96-9 | Reference compound |
| HY-159831 | Remlifanserin | 2289704-13-6 | Reference compound |
| HY-159832 | Relicpixant | 2445366-94-7 | Reference compound |
| HY-159833 | Ranosidenib | 2301974-60-5 | Reference compound |
| HY-159834 | Progerinin | 2249696-72-6 | Reference compound |
| HY-159835 | Oveporexton | 2460722-04-5 | Reference compound |
| HY-159836 | Nivegacetor | 2443487-67-8 | Reference compound |
| HY-159837 | Nispomeben | 1443133-41-2 | Reference compound |
| HY-159838 | Enrupatinib | 2222689-47-4 | Reference compound |
| HY-159839 | Evategrel | 2760609-74-1 | Reference compound |
| HY-15984 | VER-50589 | 747413-08-7 | Reference compound |
| HY-159840 | Fanregratinib | 1628537-44-9 | Reference compound |
| HY-159841 | Filricianine | 2140857-94-7 | Reference compound |
| HY-159841A | Filricianine (sodium) | 2140857-96-9 | Dye Reagents |
| HY-159842 | Fosrolapitant | 2573694-38-7 | Reference compound |
| HY-159843 | Glasmacinal | 2097822-02-9 | Reference compound |
| HY-159844 | Gridegalutamide | 2446929-86-6 | Reference compound |
| HY-159845 | Lecufexor | 2247972-61-6 | Reference compound |
| HY-159846 | Luvometinib | 2739690-43-6 | Reference compound |
| HY-159847 | Nacresertib | 2629977-59-7 | Reference compound |
| HY-159848 | Nedemelteon | 1000334-38-2 | Reference compound |
| HY-159849 | Cytidylyl-(3′,5′)-uridine | 2382-64-1 | Oligonucleotides |
| HY-15985 | CTX-0294885 | 1439934-41-4 | Reference compound |
| HY-159850 | CAU | 3022-32-0 | Oligonucleotides |
| HY-159852 | BBO-10203 | 2971769-60-3 | Reference compound |
| HY-159853 | C14-A1 | Reference compound | |
| HY-159854 | C14-O2 | 2639634-77-6 | Oligonucleotides |
| HY-159855 | CAP 2 (hydrochloride) | Reference compound | |
| HY-159856 | 16:0 Cardiolipin | 105380-95-8 | Reference compound |
| HY-159857 | Gp(2′-5′)Ap (sodium) | Oligonucleotides | |
| HY-159858 | Lipid 16 | Oligonucleotides | |
| HY-159859 | IZ-Chol | 191990-35-9 | Reference compound |
| HY-15985A | CTX-0294885 (hydrochloride) | 2319590-02-6 | Reference compound |
| HY-15986 | VER-49009 | 558640-51-0 | Reference compound |
| HY-159860 | IR-117-17 | 2940241-38-1 | Reference compound |
| HY-159861 | Ionizable Lipid 4 | 1799316-81-6 | Reference compound |
| HY-159862 | IM21.7c | 2416939-42-7 | Reference compound |
| HY-159863 | Cholesterol‑undecanoate‑glucose conjugate | Reference compound | |
| HY-159865 | CL15F6 | 2766493-40-5 | Reference compound |
| HY-159866 | mPEG2000-CLS | Reference compound | |
| HY-159868 | SORT1-IN-1 | 2806762-69-4 | Reference compound |
| HY-159869 | G0-C14 analog | 2935435-86-0 | Reference compound |
| HY-159870 | E12CA1A3 | 2778182-26-4 | Reference compound |
| HY-159874 | KRN7000 analog 2 | Reference compound | |
| HY-159875 | SORT1-IN-2 | 2854233-44-4 | Reference compound |
| HY-159876 | SORT1-IN-3 | 2915675-56-6 | Reference compound |
| HY-159877 | SORT1-IN-4 | 2915675-58-8 | Reference compound |
| HY-159878 | SORT1-IN-5 | 3031580-91-0 | Reference compound |
| HY-159879 | AAK1-IN-6 | 3061058-16-7 | Reference compound |
| HY-159880 | AChE/BChE-IN-24 | 3053509-06-8 | Reference compound |
| HY-159881 | SHS206 | Reference compound | |
| HY-159883 | DDHF20 | Reference compound | |
| HY-159884 | MG-T-19 | 328540-44-9 | Reference compound |
| HY-159885 | MG-B-28 | Reference compound | |
| HY-159886 | MG-C-30 | 877164-43-7 | Reference compound |
| HY-159888 | SON38 | 3034673-37-2 | Reference compound |
| HY-159889 | hA3AR agonist 2 | Reference compound | |
| HY-15989 | SM-164 | 957135-43-2 | Reference compound |
| HY-159890 | MTI013 | Reference compound | |
| HY-159891 | Microtubule destabilizing agent-2 | Reference compound | |
| HY-159892 | PD-1/PD-L1-IN-54 | 1393644-68-2 | Reference compound |
| HY-159893 | SMO-IN-5 | Reference compound | |
| HY-159894 | Autophagy-lysosome activator-1 | Reference compound | |
| HY-159895 | PAR4 antagonist 7 | Reference compound | |
| HY-159896 | PAR4 antagonist 8 | Reference compound | |
| HY-159897 | PAK4-IN-5 | Reference compound | |
| HY-159898 | AChE/BChE-IN-23 | Reference compound | |
| HY-159899 | DHFR-IN-22 | 2941327-87-1 | Reference compound |
| HY-15989A | SM-164 (hydrochloride) | 2734174-02-6 | Reference compound |
| HY-15990 | CH5164840 | 1052645-73-4 | Reference compound |
| HY-159900 | Antimalarial agent 46 | 2715225-19-5 | Reference compound |
| HY-159901 | LSD1-IN-37 | Reference compound | |
| HY-159902 | KRN7000 analog 3 | 1384423-78-2 | Reference compound |
| HY-159904 | ChAT IN-1 | Reference compound | |
| HY-159905 | HPK1-IN-54 | 3048537-48-7 | Reference compound |
| HY-159909 | ATMW-2 | Reference compound | |
| HY-15991 | Tenapanor | 1234423-95-0 | Reference compound |
| HY-159910 | LH1513 | Reference compound | |
| HY-159911 | SARS-CoV-2 Mpro-IN-29 | Reference compound | |
| HY-159912 | pan-TEAD-IN-1 | 3027484-09-6 | Reference compound |
| HY-159913 | AYK004-C1 | 3031612-92-4 | Reference compound |
| HY-159914 | AYK004-B1 | 3031612-91-3 | Reference compound |
| HY-159915 | Se2h | Reference compound | |
| HY-159916 | AYK004 | 3031612-90-2 | Reference compound |
| HY-159917 | PPL agonist-1 | 3040997-52-9 | Reference compound |
| HY-159918 | AYK005 | 3031612-93-5 | Reference compound |
| HY-159919 | UM-3006 | 1927013-87-3 | Reference compound |
| HY-15991A | Tenapanor (hydrochloride) | 1234365-97-9 | Reference compound |
| HY-15992 | BIBF 1202 | 894783-71-2 | Reference compound |
| HY-159920 | PSB-22269 | Reference compound | |
| HY-159921 | Tubulin Polymerization-IN-1 prodrug | 3033099-32-7 | Reference compound |
| HY-159922 | AR antagonist 9 | Reference compound | |
| HY-159923 | BPRMU191 | 2131199-52-3 | Reference compound |
| HY-159924 | DBPR116 | 2131200-75-2 | Reference compound |
| HY-159925 | QKY-613 | 2646682-38-2 | Reference compound |
| HY-159926 | Tixanox (sodium) | 40691-57-4 | Reference compound |
| HY-159927 | TAK-661 | 175215-34-6 | Reference compound |
| HY-159928 | Neuroprotective agent 8 | Reference compound | |
| HY-159929 | Antibiotic adjuvant 2 | Reference compound | |
| HY-15992S | BIBF 1202-13C,d3 | Isotope-Labeled Compounds | |
| HY-15993 | Posizolid | 252260-02-9 | Reference compound |
| HY-159930 | Antibiotic adjuvant 3 | 2972593-21-6 | Reference compound |
| HY-159931 | HW161023 | 2920698-73-1 | Reference compound |
| HY-159932 | SARS-CoV-2 Mpro-IN-30 | Reference compound | |
| HY-159933 | SARS-CoV-2-IN-105 | Reference compound | |
| HY-159934 | QI-18 | Reference compound | |
| HY-159935 | Top1-IN-2 | Reference compound | |
| HY-159936 | CS4 | Reference compound | |
| HY-159937 | PKMYT1-IN-7 | 2986404-30-0 | Reference compound |
| HY-159938 | p38α inhibitor 6 | Reference compound | |
| HY-15994 | Citarinostat | 1316215-12-9 | Reference compound |
| HY-159940 | Ferroptosis/apoptosis inducer-2 | 2869886-85-9 | Reference compound |
| HY-159941 | tau-0N4R-IN-1 | 2200453-71-8 | Reference compound |
| HY-159942 | 5-HT7R antagonist 3 | 1887043-58-4 | Reference compound |
| HY-159943 | ROS151 | Reference compound | |
| HY-159944 | PPARγ agonist 14 | 6951-57-1 | Reference compound |
| HY-159945 | tau Protein/α-synuclein-IN-2 | Reference compound | |
| HY-159947 | PROTAC BTK Degrader-11 | 2736508-94-2 | Reference compound |
| HY-159949 | YS10 | 3055427-13-6 | Reference compound |
| HY-15995 | Tubulysin A | 205304-86-5 | ADC Related |
| HY-159952 | ALK5-IN-84 | Reference compound | |
| HY-159953 | IRAK1/4/pan-FLT3 Kinase-IN-1 | 2760328-82-1 | Reference compound |
| HY-159955 | DC-159a | 931411-93-7 | Reference compound |
| HY-159956 | BTK-IN-39 | 2736510-62-4 | Reference compound |
| HY-159957 | BAY-184 | 2520347-03-7 | Reference compound |
| HY-159958 | KNa1.1-IN-2 | 3037315-44-6 | Reference compound |
| HY-159959 | cis-3-Indoleacrylic acid | 29953-72-8 | Reference compound |
| HY-15996 | Seviteronel | 1610537-15-9 | Reference compound |
| HY-159960 | Carbonic anhydrase inhibitor 28 | Reference compound | |
| HY-159961 | SARS-CoV-2 Mpro-IN-34 | Reference compound | |
| HY-159962 | TGase2-IN-1 | 2244702-64-3 | Reference compound |
| HY-159963 | PfCLK3-IN-1 | Reference compound | |
| HY-159964 | USP7-IN-16 | 2166587-77-3 | Reference compound |
| HY-159965 | NOD1-RIPK2-IN-1 | Reference compound | |
| HY-159966 | Top/HDAC-IN-3 | 3059615-90-3 | Reference compound |
| HY-159969 | MLEB-22043 | Reference compound | |
| HY-15996A | Seviteronel (R enantiomer) | 1375603-38-5 | Reference compound |
| HY-15996B | Seviteronel (racemate) | 1375603-36-3 | Reference compound |
| HY-15997 | (-)-U-50488 (hydrochloride) | 114528-79-9 | Reference compound |
| HY-159972 | PKR1 antagonist 1 | 910113-60-9 | Reference compound |
| HY-159973 | Me-SJ46411 | Reference compound | |
| HY-159974 | Me-SJ46411-PEG1-Piperazine-Boc | Reference compound | |
| HY-159977 | 1,2-Didehydrotanshinone IIA | 119963-50-7 | Reference compound |
| HY-15997A | (+)-U-50488 (hydrochloride) | 114528-81-3 | Reference compound |
| HY-15997B | (±)-U-50488 (hydrochloride) | 67197-96-0 | Reference compound |
| HY-15997C | (±)-U-50488 (hydrate hydrochloride) | Reference compound | |
| HY-159982 | SH7s | Reference compound | |
| HY-159983 | GS-2278 | 2750508-72-4 | Reference compound |
| HY-159984 | HIV-1 inhibitor-78 | Reference compound | |
| HY-159985 | Jun13728 | Reference compound | |
| HY-159986 | X-17 | Reference compound | |
| HY-159987 | AB-161 | 2848560-66-5 | Reference compound |
| HY-159989 | UNC10142 | Reference compound | |
| HY-15999 | Cerdulatinib | 1198300-79-6 | Reference compound |
| HY-159990 | GPX4-IN-15 | 3032966-42-7 | Reference compound |
| HY-159993 | MR44397 | Reference compound | |
| HY-159994 | AUPF02 | 904803-58-3 | Reference compound |
| HY-159996 | GRL093-22 | Reference compound | |
| HY-159997 | AD353 | Reference compound | |
| HY-15999A | Cerdulatinib (hydrochloride) | 1369761-01-2 | Reference compound |
| HY-160001 | ZH8659 | 885466-70-6 | Reference compound |
| HY-160002 | MAO-B-IN-27 | 788824-83-9 | Reference compound |
| HY-160003 | PPARγ agonist 9 | 474329-47-0 | Reference compound |
| HY-160004 | PXL770 | 1523493-53-9 | Reference compound |
| HY-160005 | LMP517 | 1883730-99-1 | Reference compound |
| HY-160006 | PIM-IN-2 | 1006699-45-1 | Reference compound |
| HY-160007 | DHX9-IN-3 | 2973401-57-7 | Reference compound |
| HY-160008 | DHX9-IN-4 | 2973401-45-3 | Reference compound |
| HY-160009 | DHX9-IN-5 | 2973398-17-1 | Reference compound |
| HY-160010 | DHX9-IN-6 | 2973401-56-6 | Reference compound |
| HY-160013 | FGFR-IN-12 | 943189-02-4 | Reference compound |
| HY-160015 | CB07-Exatecan | 2879247-31-9 | ADC Related |
| HY-160017 | Pomalidomide-5'-C8-acid | 2682112-09-8 | Reference compound |
| HY-160018 | BAY-155 | 2163769-52-4 | Reference compound |
| HY-160019 | MTX115325 | 2750895-97-5 | Reference compound |
| HY-160020 | ET516 | 2820120-95-2 | Reference compound |
| HY-160021 | RORγt agonist 4 | 2241769-59-3 | Reference compound |
| HY-160022 | XIAP BIR2/BIR2-3 inhibitor-1 | 1609384-59-9 | Reference compound |
| HY-160023 | Elisrasib | 2914919-85-8 | Reference compound |
| HY-160025 | IDO antagonist-1 | 2206797-88-6 | Reference compound |
| HY-160026 | IL-17 modulator 8 | 1608097-49-9 | Reference compound |
| HY-160027 | TNF-alpha-IN-1 | Reference compound | |
| HY-160028 | IL-17 modulator 9 | 1449211-26-0 | Reference compound |
| HY-160029 | PRMT5-IN-32 | 2918815-34-4 | Reference compound |
| HY-160030 | XIAP BIR2/BIR2-3 inhibitor-3 | 1434125-52-6 | Reference compound |
| HY-160031 | GLP-1R agonist 19 | 2765065-09-4 | Reference compound |
| HY-160036 | PCSK9-IN-22 | 2794203-47-5 | Reference compound |
| HY-160037 | SEW06622 | 261349-28-4 | Reference compound |
| HY-160038 | GAC0003A4 | 929492-71-7 | Reference compound |
| HY-160039 | GAC0001E5 | 927969-67-3 | Reference compound |
| HY-160040 | Cobitolimod | 1226822-98-5 | Oligonucleotides |
| HY-160040A | Cobitolimod (sodium) | 1527479-55-5 | Oligonucleotides |
| HY-160041 | Olaptesed pegol | 1390628-22-4 | Oligonucleotides |
| HY-160041A | Olaptesed pegol (sodium) | Oligonucleotides | |
| HY-160042 | AFP aptamer (sodium) | Oligonucleotides | |
| HY-160043 | AL6 aptamer (sodium) | Oligonucleotides | |
| HY-160044 | Apt-M13 aptamer (sodium) | Oligonucleotides | |
| HY-160045 | AP1153 aptamer (sodium) | Oligonucleotides | |
| HY-160046 | AS2 (sodium) | Oligonucleotides | |
| HY-160047 | AX102 (sodium) | Oligonucleotides | |
| HY-160048 | PEG40K unconjugated/naked AX102 (sodium) | Oligonucleotides | |
| HY-160049 | BC15 aptamer (sodium) | Oligonucleotides | |
| HY-160050 | CD63-1 aptamer (sodium) | Oligonucleotides | |
| HY-160051 | CD63-2 aptamer (sodium) | Oligonucleotides | |
| HY-160052 | IL-6 aptamer (sodium) | Oligonucleotides | |
| HY-160053 | Gint4.T aptamer (sodium) | Oligonucleotides | |
| HY-160054 | GMT 3 aptamer (sodium) | Oligonucleotides | |
| HY-160055 | GMT 4 aptamer (sodium) | Oligonucleotides | |
| HY-160056 | GMT 5 aptamer (sodium) | Oligonucleotides | |
| HY-160057 | GMT 8 aptamer (sodium) | Oligonucleotides | |
| HY-160058 | GMT 9 aptamer (sodium) | Oligonucleotides | |
| HY-160059 | JHIT2e aptamer (sodium) | Oligonucleotides | |
| HY-160060 | MA3 aptamer (sodium) | Oligonucleotides | |
| HY-160061 | P12FR2 aptamer (sodium) | Oligonucleotides | |
| HY-160062 | S2.2 aptamer (sodium) | Oligonucleotides | |
| HY-160063 | SW1 aptamer (sodium) | Oligonucleotides | |
| HY-160064 | SW1-A aptamer (sodium) | Oligonucleotides | |
| HY-160065 | sgc8c aptamer (sodium) | Oligonucleotides | |
| HY-160065F | FAM-sgc8c aptamer (sodium) | Dye Reagents | |
| HY-160066 | SYL3C aptamer (sodium) | Oligonucleotides | |
| HY-160067 | T18.3 aptamer (sodium) | Oligonucleotides | |
| HY-160068 | 2-2(t) aptamer (sodium) | Oligonucleotides | |
| HY-160069 | Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH | 2922060-48-6 | Reference compound |
| HY-16007 | (-)-Hydroxycitric acid | 27750-10-3 | Natural Products |
| HY-160070 | Phorbol-12,13-didecanoate | 24928-17-4 | Reference compound |
| HY-160071 | Bis(2,5-dioxopyrrolidin-1-yl) octadecanedioate | 191091-33-5 | Reference compound |
| HY-160072 | Fmoc-NH-PEG2-NHS ester | 1194666-63-1 | Reference compound |
| HY-160073 | Florensocatib | 2762114-61-2 | Reference compound |
| HY-160073A | Florensocatib (hydrate) | 2971064-13-6 | Reference compound |
| HY-160076 | APJ receptor agonist 8 | 2049973-39-7 | Reference compound |
| HY-160077 | Pomalidomide-CO-C5-azide | 2227423-33-6 | Reference compound |
| HY-160078 | Deferiprone O-β-D-glucuronide | 141675-48-1 | Reference compound |
| HY-160079A | 3′-O-Azidomethyl-dCTP (sodium) | Biochemical Assay Reagents | |
| HY-160080 | Creatinol (hemisulfate) | 50648-53-8 | Reference compound |
| HY-160081 | KCC2 Modulator-1 | 2704531-36-0 | Reference compound |
| HY-160082 | KCC2 Modulator-2 | 2704531-37-1 | Reference compound |
| HY-160084 | 2′-Deoxy-4′-thiocytidine | 134111-30-1 | Reference compound |
| HY-16009 | Buntanetap | 116839-68-0 | Reference compound |
| HY-160092 | Martinostat | 1629052-58-9 | Reference compound |
| HY-160092A | Martinostat (hydrochloride) | Reference compound | |
| HY-160093 | SQLE-IN-1 | 1019169-83-5 | Reference compound |
| HY-160094 | BCN-sulfonamide-PEG2-sulfonamide-N-bis(ethanol) | 2126749-81-1 | Reference compound |
| HY-160096 | M3541 | 1360628-91-6 | Reference compound |
| HY-160097 | AXC-666 | 313350-30-0 | Reference compound |
| HY-160099 | 20-5,14-HEDE | 240427-86-5 | Reference compound |
| HY-16009B | Buntanetap (L-Tartrate) | 865795-23-9 | Reference compound |
| HY-160105 | GABAB receptor antagonist 3 | 160415-40-7 | Reference compound |
| HY-160107 | AZ1422 | Reference compound | |
| HY-160108 | Bcl-2-IN-17 | 1321801-22-2 | Reference compound |
| HY-160109 | Ac5GalNTGc | Reference compound | |
| HY-160109A | Ac5GalNTGc epimer | 1334320-77-2 | Reference compound |
| HY-16011 | NE 10790 | 152831-36-2 | Reference compound |
| HY-160111 | PDM-042 | 1404488-48-7 | Reference compound |
| HY-160113 | Sodium phosphate buffer (pH 6.9 0.02 mol/l) | Biochemical Assay Reagents | |
| HY-160114 | Potassium phosphate buffer (pH 6.9 0.1 mol/l) | Biochemical Assay Reagents | |
| HY-160115 | TDP-43 degrader-1 | 2902692-25-3 | Reference compound |
| HY-160116 | α-Synuclein aggregate binder 1 | 1565797-17-2 | Reference compound |
| HY-16012 | Domatinostat (tosylate) | 1186222-89-8 | Reference compound |
| HY-160120 | Disodium carbamyl phosphate | 72461-86-0 | Reference compound |
| HY-160123 | DGKζ-IN-5 | 2951002-04-1 | Reference compound |
| HY-160124 | Infigratinib-Boc | 2504949-83-9 | Reference compound |
| HY-160127 | SerSA | 299437-44-8 | Reference compound |
| HY-160129 | Centanamycin | 413577-16-9 | Reference compound |
| HY-16012A | Domatinostat | 910462-43-0 | Reference compound |
| HY-160131 | Macropa | 1128304-86-8 | Reference compound |
| HY-160132 | TG-2-IN-4 | 2410899-01-1 | Reference compound |
| HY-16014 | A-385358 | 406228-55-5 | Reference compound |
| HY-160141 | Catadegbrutinib | 2736508-60-2 | Reference compound |
| HY-160142 | UBX-382 | 2884554-45-2 | Reference compound |
| HY-160143 | G3-VC-PAB-DMEA-Duocarmycin DM | 2415664-00-3 | ADC Related |
| HY-160144S | Lomedeucitinib | 2328068-29-5 | Isotope-Labeled Compounds |
| HY-160144S1 | (S)-Lomedeucitinib | 2328068-38-6 | Isotope-Labeled Compounds |
| HY-160144S2 | (rac)-Lomedeucitinib | 2328064-33-9 | Isotope-Labeled Compounds |
| HY-160147 | (Z)-Hexadec-9-en-15-ynoicacid | 2231023-75-7 | Reference compound |
| HY-16015 | Opaganib | 915385-81-8 | Reference compound |
| HY-160150 | 2-Hydroxyphytanoyl-CoA | 172787-73-4 | Reference compound |
| HY-160151 | TP1L | Reference compound | |
| HY-160155 | Cholesteryl-Teg azide | 1391826-58-6 | Reference compound |
| HY-160157 | IM-2 | 2813269-89-3 | ADC Related |
| HY-160159 | PPARγ modulator-1 | 1415321-54-8 | Reference compound |
| HY-16015A | Opaganib (hydrochloride) | 1185157-59-8 | Reference compound |
| HY-160160 | BAY-5516 | 2891706-79-7 | Reference compound |
| HY-160161 | BAY-5094 | 2891706-78-6 | Reference compound |
| HY-160162 | SR 11023 | 1820602-13-8 | Reference compound |
| HY-160165 | TRK-IN-25 | 2412309-60-3 | Reference compound |
| HY-160166 | TRK-IN-26 | 2412309-52-3 | Reference compound |
| HY-160167 | Birelentinib | 2662512-15-2 | Reference compound |
| HY-160168 | BTK-IN-31 | 2662512-02-7 | Reference compound |
| HY-160169 | Necrosis inhibitor 2 | 2258671-03-1 | Reference compound |
| HY-160169A | Necrosis inhibitor 2 (hydrocholide) | Reference compound | |
| HY-160170 | Necrosis inhibitor 3 | 2258670-86-7 | Reference compound |
| HY-160171 | CDK9-IN-31 | 2991074-93-0 | Reference compound |
| HY-160171A | CDK9-IN-31 (dimaleate) | Reference compound | |
| HY-160172 | ALK/ROS1-IN-4 | 2649878-59-9 | Reference compound |
| HY-160172A | ALK/ROS1-IN-4 (hydrate) | Reference compound | |
| HY-160173 | LPA receptor antagonist-1 | 1614824-42-8 | Reference compound |
| HY-160174 | BCR-ABL kinase-IN-3 | 2699634-21-2 | Reference compound |
| HY-160174A | BCR-ABL kinase-IN-3 (dihydrocholide) | Reference compound | |
| HY-160176 | SSTR5 antagonist 6 | 1007836-12-5 | Reference compound |
| HY-160177 | Glucocorticoid receptor agonist-3 | 2842165-73-3 | ADC Related |
| HY-160178 | Glucocorticoid receptor agonist-3 Ala-Ala-Mal | 3014393-35-9 | ADC Related |
| HY-160179 | Glucocorticoid receptor agonist-4 | 2842165-72-2 | ADC Related |
| HY-16018 | Ilorasertib | 1227939-82-3 | Reference compound |
| HY-160180 | Glucocorticoid receptor agonist-4 Ala-Ala-Mal | 3014393-37-1 | Reference compound |
| HY-160181 | INX-SM-3 | 2734877-96-2 | ADC Related |
| HY-160182 | INX-P | 2734878-02-3 | ADC Related |
| HY-160183 | LSD1-IN-29 | 1496573-83-1 | Reference compound |
| HY-160186 | 20-SOLA | Reference compound | |
| HY-160187 | AAA | Reference compound | |
| HY-160188 | BAY-9683 | 2891706-83-3 | Reference compound |
| HY-160189 | 3-Ethyl-3-methylthiolan-2-one | 103620-92-4 | Reference compound |
| HY-16018A | Ilorasertib (hydrochloride) | 1847485-91-9 | Reference compound |
| HY-160191 | LSD1-IN-30 | 1289575-45-6 | Reference compound |
| HY-160196 | HC-7366 | 2803470-63-3 | Reference compound |
| HY-160197 | Aluminum phosphate adjuvant | Reference compound | |
| HY-160197G | Aluminum phosphate adjuvant (GMP) | GMP Small Molecules | |
| HY-160198 | Vaccine adjuvant-1 | Reference compound | |
| HY-160198G | Vaccine adjuvant-1 (GMP) | GMP Small Molecules | |
| HY-160199 | 3'-L-Histidyl-AMP | 213206-31-6 | Oligonucleotides |
| HY-160199A | 3'-L-histidyl-AMP (disodium) | Oligonucleotides | |
| HY-16020 | AC-430 (hydrobromide) | 1359828-49-1 | Reference compound |
| HY-160202 | 18:1 Cardiolipin (disodium) | 115404-77-8 | Reference compound |
| HY-160203 | 18:0 Cardiolipin | 64069-64-3 | Oligonucleotides |
| HY-160207 | Elunetirom | 2156649-32-8 | Reference compound |
| HY-160208 | BI-8668 | 2084059-97-0 | Reference compound |
| HY-160209 | KIO-301 | 1643463-61-9 | Reference compound |
| HY-160210 | BAY-6096 | 2313483-41-7 | Reference compound |
| HY-160211 | JA310 | 3022928-90-8 | Reference compound |
| HY-160212 | JP3000 | 3034097-74-7 | Reference compound |
| HY-160213 | JA397 | Reference compound | |
| HY-160214 | Perforin-IN-2 | 1567836-70-7 | Reference compound |
| HY-160215 | TGF-βRI inhibitor 1 | 2169299-67-4 | Reference compound |
| HY-160215A | TGF-βRI inhibitor 1 (methylbenzenesulfonate) | 2345717-52-2 | Reference compound |
| HY-160216 | RIPK1-IN-18 | 2682889-01-4 | Reference compound |
| HY-160216A | RIPK1-IN-18 (sulfate hydrate) | 2897618-64-1 | Reference compound |
| HY-160217 | HPK1-IN-41 | 2828455-23-6 | Reference compound |
| HY-160218 | HPK1-IN-42 | 2848684-50-2 | Reference compound |
| HY-160219S | BTK-IN-33 | 2765854-31-5 | Isotope-Labeled Compounds |
| HY-16022 | Acetyldigitoxin | 1111-39-3 | Natural Products |
| HY-160220S | KRAS inhibitor-23 | 2641747-55-7 | Isotope-Labeled Compounds |
| HY-160221 | PROTAC AR Degrader-7 | 2505495-83-8 | Reference compound |
| HY-160222 | HSV-60mer (sodium) | Oligonucleotides | |
| HY-160223 | ssVACV-70mer (sodium) | Oligonucleotides | |
| HY-160224 | dsVACV-70mer (sodium) | Oligonucleotides | |
| HY-160225 | ISD (sodium) | Oligonucleotides | |
| HY-160226 | ISD Control (sodium) | Oligonucleotides | |
| HY-160227 | ORN 06 | 1116698-32-8 | Oligonucleotides |
| HY-160227A | ORN 06 (sodium) | Oligonucleotides | |
| HY-160228 | ORN 02 | 937769-72-7 | Oligonucleotides |
| HY-160228A | ORN 02 (sodium) | Oligonucleotides | |
| HY-160229 | ssRNA40 (sodium) | Oligonucleotides | |
| HY-16023 | Acolbifene (hydrochloride) | 252555-01-4 | Reference compound |
| HY-160230 | ssRNA41 (sodium) | Oligonucleotides | |
| HY-160231 | ssRNA42 (sodium) | Oligonucleotides | |
| HY-160234 | mc-vc-PAB-PBD | 2088364-36-5 | ADC Related |
| HY-160235 | Pomalidomide-C2-amide-C5-azide | 2732859-29-7 | Reference compound |
| HY-160236 | 3-(3-Sulfooxyphenyl)propanoic acid | 86321-32-6 | Reference compound |
| HY-160237 | HYL001 | 2426547-83-1 | Reference compound |
| HY-160239 | HFI-437 | 1110650-74-2 | Reference compound |
| HY-16023A | Acolbifene | 182167-02-8 | Reference compound |
| HY-16023B | (Rac)-Acolbifene | 151533-34-5 | Reference compound |
| HY-160240 | HPI | 210541-64-3 | Reference compound |
| HY-160241 | Lenalidomide-C5-acid | 2338824-30-7 | Reference compound |
| HY-160244 | Pomalidomide 5'-piperazine-4-methylpiperidine (dihydrochloride) | 2758431-93-3 | Reference compound |
| HY-160245 | QL47R | 1579278-89-9 | Reference compound |
| HY-160246 | QL47B | 1579278-92-4 | Reference compound |
| HY-160246A | QL47B (TFA) | Reference compound | |
| HY-160247 | Boc-Lys-PEG8-N-bis(D-glucose) | 2892350-30-8 | ADC Related |
| HY-16025 | EOC317 | 939805-30-8 | Reference compound |
| HY-160250 | UGT1A1-IN-1 | 2097024-37-6 | Reference compound |
| HY-160251 | 3-HC-Gluc | 132929-88-5 | Reference compound |
| HY-160252 | PHGDH-IN-4 | 2132969-16-3 | Reference compound |
| HY-160255 | N-Cbz-L-Cysteine | 53907-29-2 | Reference compound |
| HY-160255A | N-Cbz-D-Cysteine | 156916-81-3 | Reference compound |
| HY-160256 | DSPE-PEG-BDP FL,MW 2000 | Biochemical Assay Reagents | |
| HY-160257 | DOPE-PEG-BDP FL,MW 5000 | Biochemical Assay Reagents | |
| HY-160258 | GDP-Fucose-Tz | 2762518-76-1 | Reference compound |
| HY-160259 | VEGFR-2-IN-39 | 2353417-86-2 | Reference compound |
| HY-16026 | Ricolinostat | 1316214-52-4 | Reference compound |
| HY-160260 | EP300/CBP-IN-1 | 2638507-71-6 | Reference compound |
| HY-160261S | EP300/CBP-IN-2 | 2379527-49-6 | Isotope-Labeled Compounds |
| HY-160262 | AR/BET protein degrader-1 | 2571123-81-2 | Reference compound |
| HY-160263S | Anticancer agent 186 | 2408740-75-8 | Isotope-Labeled Compounds |
| HY-160264 | PROTAC ER Degrader-12 | Reference compound | |
| HY-160265 | URAT1 inhibitor 9 | 2251727-90-7 | Reference compound |
| HY-160266 | THR-β agonist 7 | 2604229-32-3 | Isotope-Labeled Compounds |
| HY-160267 | iPAF1C | 950403-60-8 | Reference compound |
| HY-160269 | DSPE-PEG-Fluor 488,MW 2000 | Biochemical Assay Reagents | |
| HY-16027 | Acyline | 170157-13-8 | Peptides |
| HY-160270 | DSPE-PEG-Fluor 488,MW 5000 | Biochemical Assay Reagents | |
| HY-160271 | DSPE-CH2-PEG-Fluor 488,MW 2000 | Biochemical Assay Reagents | |
| HY-160272 | DOPE-PEG-Fluor 488,MW 2000 | Biochemical Assay Reagents | |
| HY-160273 | DOPE-PEG-Fluor 488,MW 5000 | Biochemical Assay Reagents | |
| HY-160274 | DSPE-PEG-Fluor 555,MW 2000 | Biochemical Assay Reagents | |
| HY-160275 | DOPE-PEG-Fluor 555,MW 2000 | Biochemical Assay Reagents | |
| HY-160276 | DOPE-PEG-Fluor 555,MW 5000 | Biochemical Assay Reagents | |
| HY-160277 | DSPE-PEG-Fluor 594,MW 2000 | Biochemical Assay Reagents | |
| HY-160278 | DSPE-PEG-Fluor 647,MW 2000 | Biochemical Assay Reagents | |
| HY-160279 | DSPE-PEG-Fluor 647,MW 5000 | Biochemical Assay Reagents | |
| HY-16027A | Acyline (TFA) | Peptides | |
| HY-160280 | DOPE-PEG-Fluor 647,MW 2000 | Biochemical Assay Reagents | |
| HY-160281 | CCD-2 | 2271351-19-8 | Reference compound |
| HY-160282 | PI3K-IN-49 | 2922415-69-6 | Reference compound |
| HY-160283 | PI3K-IN-50 | 3023536-43-5 | Reference compound |
| HY-160284 | CDK12/13-IN-1 | 2407774-31-4 | Reference compound |
| HY-160287 | NVS MLLT-1 | 2561471-13-2 | Reference compound |
| HY-160289 | ARI-3144 | 1426305-25-0 | Reference compound |
| HY-160291 | Trivalent GalNAc-DBCO | 2765060-22-6 | Reference compound |
| HY-160292 | Enoltasosartan | 159237-67-9 | Reference compound |
| HY-160296 | AN-988 | 340304-55-4 | Reference compound |
| HY-160297 | GDP-FAzP4Biotin | 2762518-71-6 | Reference compound |
| HY-16031 | AFP464 (free base) | 468719-52-0 | Reference compound |
| HY-16031B | AFP464 (dihydrochloride) | Reference compound | |
| HY-16032 | Akt1-IN-2 | 473382-39-7 | Reference compound |
| HY-16034 | AKT-IN-20 | 473382-50-2 | Reference compound |
| HY-16035 | Alatrofloxacin | 146961-76-4 | Reference compound |
| HY-16035A | Alatrofloxacin (mesylate) | 146961-77-5 | Reference compound |
| HY-16036A | ALB-109564 (hydrochloride) | 1300114-12-8 | Reference compound |
| HY-16039 | AM095 | 1345614-59-6 | Reference compound |
| HY-16040 | AM095 (free acid) | 1228690-36-5 | Reference compound |
| HY-160406 | SNX281 | 2332803-84-4 | Reference compound |
| HY-160408 | Mal-GGG-Bal-NHS ester | 1193111-65-7 | ADC Related |
| HY-160409 | TopBP1-IN-1 | 1212595-23-7 | Reference compound |
| HY-160410 | Ceramide 3B | 178436-06-1 | Natural Products |
| HY-160412 | Balinatunfib | 2248726-53-4 | Reference compound |
| HY-160414 | TRX-COBI | Reference compound | |
| HY-160415 | WD6305 | Reference compound | |
| HY-160415A | WD6305 (TFA) | Reference compound | |
| HY-160416 | THR-β modulator-2 | 2542029-56-9 | Reference compound |
| HY-160417 | PARP1-IN-19 | 2756337-27-4 | Reference compound |
| HY-160418 | PI3K-IN-51 | 2055765-77-8 | Reference compound |
| HY-160419 | Mps1-IN-8 | 2259843-95-1 | Reference compound |
| HY-160420 | Cinoxolone | 31581-02-9 | Reference compound |
| HY-160421 | TREM2-IN-1 | 2000236-36-0 | Reference compound |
| HY-160424 | DEANO (sodium) | 92382-74-6 | Reference compound |
| HY-160426 | Gcase activator 3 | 2270984-21-7 | Reference compound |
| HY-160428 | DMTr-5-fluoro-2'-deoxycytidine-phosphoramidite | 143774-48-5 | Reference compound |
| HY-160429 | PSAR18-COOH | 2313534-26-6 | Peptides |
| HY-160433 | TNF-α-IN-12 | 364039-56-5 | Reference compound |
| HY-160434 | TNF-α-IN-13 | 364039-48-5 | Reference compound |
| HY-160435 | TNF-α-IN-14 | 364039-54-3 | Reference compound |
| HY-160436 | TNF-α-IN-15 | 364039-58-7 | Reference compound |
| HY-160437 | TNF-α-IN-16 | 364039-60-1 | Reference compound |
| HY-160438 | PBX-7011 | 3003834-30-5 | Reference compound |
| HY-160438A | PBX-7011 (mesylate) | ADC Related | |
| HY-160438B | PBX-7011 (TFA) | Reference compound | |
| HY-160439 | Ionizable lipid-2 | 2763904-72-7 | Oligonucleotides |
| HY-160440 | rel-VU6021625 | 2307718-96-1 | Reference compound |
| HY-160440A | VU6021625 | 2803696-99-1 | Reference compound |
| HY-160441 | MC-Val-Cit-PAB-Ispinesib | 1629737-40-1 | ADC Related |
| HY-160444 | SJ3149 | 3026986-17-1 | Reference compound |
| HY-160445 | KRAS G12D inhibitor 19 | 2833695-47-7 | Reference compound |
| HY-160446 | BET-IN-24 | 2407658-21-1 | Reference compound |
| HY-160447 | FAK/Aurora kinase-IN-1 | 2178117-69-4 | Reference compound |
| HY-160448 | p53 Activator 9 | 2849345-37-3 | Reference compound |
| HY-160449 | p53 Activator 10 | 2849484-29-1 | Reference compound |
| HY-16045 | Hexaminolevulinate (hydrochloride) | 140898-91-5 | Dye Reagents |
| HY-160450 | p53 Activator 11 | 2850211-42-4 | Reference compound |
| HY-160453 | MC-Gly-Gly-Phe-Gly-NH-CH2-O-cyclopropane-CH2COOH | 2922606-39-9 | ADC Related |
| HY-160455 | GSTP1-1 inhibitor 1 | 3829-23-0 | Reference compound |
| HY-160456 | FABP4/5-IN-4 | 2862795-48-8 | Reference compound |
| HY-160457 | FABP4/5-IN-5 | 2862791-11-3 | Reference compound |
| HY-160458 | PI3Kα-IN-17 | 2935973-28-5 | Reference compound |
| HY-16046 | Rimiducid | 195514-63-7 | Reference compound |
| HY-160469 | INY-05-040 | 2503018-29-7 | Reference compound |
| HY-160471S | N-Nitrososertraline-d3 | Isotope-Labeled Compounds | |
| HY-160473 | TAM557 | 1802499-20-2 | ADC Related |
| HY-160473A | TAM557 (TFA) | Reference compound | |
| HY-160477 | DC-SX029 | 300713-88-6 | Reference compound |
| HY-160478 | GNF-6 | 839708-29-1 | Reference compound |
| HY-160481 | MG-1102 | 2567913-75-9 | Reference compound |
| HY-160485 | G-4'G-7S | 1630724-68-3 | Reference compound |
| HY-160487 | KME-2780 | 2968466-26-2 | Reference compound |
| HY-160488 | PTK7/β-catenin-IN-1 | 906147-24-8 | Reference compound |
| HY-160489 | PTK7/β-catenin-IN-2 | 902434-29-1 | Reference compound |
| HY-160493 | PTK7/β-catenin-IN-6 | 1219439-82-3 | Reference compound |
| HY-160496 | STAT3-IN-25 | 2591440-75-2 | Reference compound |
| HY-160497 | MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885 | 2722697-86-9 | Reference compound |
| HY-160498 | Amoitone B | 1257228-26-4 | Reference compound |
| HY-160499 | BRD4 Inhibitor-30 | 1789731-20-9 | Reference compound |
| HY-16050 | Plitidepsin | 137219-37-5 | Natural Products |
| HY-160501 | DS17 | Reference compound | |
| HY-160502 | CST967 | Reference compound | |
| HY-160505 | RO-275 | 2648837-04-9 | Reference compound |
| HY-160506 | PRO-6E | 2353493-69-1 | Reference compound |
| HY-160508 | NCX1-IN-1 | 2754283-55-9 | Reference compound |
| HY-160509 | BTB 06061 | 652967-47-0 | Reference compound |
| HY-16050R | Plitidepsin (Standard) | 137219-37-5 | Reference Standards |
| HY-160512 | Lipid 9 | 2982842-90-8 | Oligonucleotides |
| HY-160514 | LXQ46 | 2097148-94-0 | Reference compound |
| HY-160515 | USP7-IN-13 | 2305046-93-7 | Reference compound |
| HY-160519 | Targocil-II | 955918-74-8 | Reference compound |
| HY-160520 | ALK-IN-28 | 1108743-80-1 | Reference compound |
| HY-160523 | DBCO Ir catayst | 2695594-15-9 | Reference compound |
| HY-160524 | NOX2-IN-3 | 921145-98-4 | Reference compound |
| HY-160525 | CDO1 degrader-1 | Reference compound | |
| HY-160527 | BRD4 degrader-4 | 2851986-83-7 | Reference compound |
| HY-160528 | IBG3 | Reference compound | |
| HY-160529 | α7 nAChR Modulator-2 | Reference compound | |
| HY-160530 | WEE1-IN-6 | 2928524-08-5 | Reference compound |
| HY-160531 | IKZF1-degrader-1 | 2915586-02-4 | Reference compound |
| HY-160532 | CK1α degrader-1 | 2881012-96-8 | Reference compound |
| HY-160533 | IKZF1-degrader-2 | 2915330-86-6 | Reference compound |
| HY-160540 | MRGPRX2 modulator-1 | 2781839-42-5 | Reference compound |
| HY-160542 | Clenhexyl (hydrochloride) | 37162-93-9 | Reference compound |
| HY-160543 | Exatecan-amide-CH2-O-CH2-CH2-OH | 2920907-39-5 | ADC Related |
| HY-160545 | NLRP3-IN-31 | 2769040-08-4 | Reference compound |
| HY-160546 | cGAS-IN-2 | 2765273-11-6 | Reference compound |
| HY-160547 | PROTAC AR Degrader-5 | 2703021-51-4 | Reference compound |
| HY-160548 | mTOR inhibitor-18 | 2170358-67-3 | Reference compound |
| HY-160549 | c-Myc inhibitor 14 | 2581994-88-7 | Reference compound |
| HY-16055 | Silatecan | 220913-32-6 | Reference compound |
| HY-160550 | DPM-1003 | 3018836-86-4 | Reference compound |
| HY-160552 | 244cis | 2956402-64-3 | Biochemical Assay Reagents |
| HY-160553 | 9322-O16B | 2909427-23-0 | Biochemical Assay Reagents |
| HY-160554 | C12-113 | 1220890-27-6 | Biochemical Assay Reagents |
| HY-160555 | (S,R,S)-AHPC-CO-C9-NH2 | 2349429-71-4 | Reference compound |
| HY-160555A | (S,R,S)-AHPC-CO-C9-NH2 (hydrochloride) | 2376139-50-1 | Reference compound |
| HY-160556 | CDK2-IN-26 | 2821777-43-7 | Reference compound |
| HY-160557 | PLK1/BRD4-IN-2 | 2251709-89-2 | Reference compound |
| HY-160558 | PLK1/BRD4-IN-3 | 2251709-91-6 | Reference compound |
| HY-16056 | Arbutamine | 128470-16-6 | Reference compound |
| HY-160562 | PROTAC ERα Degrader-7 | 3025781-93-2 | Reference compound |
| HY-160563 | PROTAC ERα Degrader-8 | 3025533-68-7 | Reference compound |
| HY-160564 | ZNL-0056 | 2767987-38-0 | Reference compound |
| HY-160569 | C14-SPM | 2241864-59-3 | Biochemical Assay Reagents |
| HY-16056A | Arbutamine (hydrochloride) | 125251-66-3 | Reference compound |
| HY-160573 | cKK-E15 | 1432494-71-7 | Biochemical Assay Reagents |
| HY-160576 | DNCA | 2226561-66-4 | Biochemical Assay Reagents |
| HY-160577 | DOG-IM4 | 2758097-38-8 | Biochemical Assay Reagents |
| HY-160578 | Glucosamine Cholesterol | 1257309-90-2 | Biochemical Assay Reagents |
| HY-160579 | MIC5 | 2349307-32-8 | Biochemical Assay Reagents |
| HY-160580 | G1-OC2-K3-E10 | 2933216-12-5 | Biochemical Assay Reagents |
| HY-160581 | OH-C-Chol | 496801-51-5 | Biochemical Assay Reagents |
| HY-160582 | MR-2-93-3 | 2941228-90-4 | Biochemical Assay Reagents |
| HY-160585 | PD-L1/PD-1-IN-1 | 2753642-49-6 | Reference compound |
| HY-160586 | Srpk1-IN-1 | 2408444-93-7 | Reference compound |
| HY-160587 | Antiangiogenic agent 5 | 2095397-52-5 | Reference compound |
| HY-160588 | Nav1.8-IN-7 | 2761181-58-0 | Reference compound |
| HY-160589 | Nav1.8-IN-8 | 2626945-23-9 | Reference compound |
| HY-16059 | Arglabin | 84692-91-1 | Natural Products |
| HY-160591 | Nav1.8-IN-10 | 2664047-95-2 | Reference compound |
| HY-160592 | Nav1.8-IN-11 | 2990578-70-4 | Reference compound |
| HY-160593 | Nav1.8-IN-12 | 3029020-84-3 | Reference compound |
| HY-160596 | 5-Formyl-dCTP | 2409156-19-8 | Reference compound |
| HY-160597 | Exatecan-amide-bicyclo[1.1.1]pentan-1-ol | 2866299-06-9 | ADC Related |
| HY-160598 | Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol | 2891774-71-1 | Reference compound |
| HY-16060 | Apalutamide | 956104-40-8 | Reference compound |
| HY-160602 | CPL207280 | 2361497-72-3 | Reference compound |
| HY-160603 | PF-05214030 | 1669444-50-1 | Reference compound |
| HY-160604 | Remacemide | 128298-28-2 | Reference compound |
| HY-160607 | MMA-NODAGA | 1440903-11-6 | Reference compound |
| HY-16060R | Apalutamide (Standard) | 956104-40-8 | Reference Standards |
| HY-16060S | Apalutamide-d4 | 1638885-65-0 | Isotope-Labeled Compounds |
| HY-16060S1 | Apalutamide-d3 | 1638885-61-6 | Isotope-Labeled Compounds |
| HY-16060S2 | Apalutamide-13C,d3 | Isotope-Labeled Compounds | |
| HY-16060S3 | Apalutamide-d7 | Isotope-Labeled Compounds | |
| HY-160610A | Carbamoyl phosphate (dilithium salt) | 1866-68-8 | Reference compound |
| HY-160611 | TgENR-IN-1 | 1428626-91-8 | Reference compound |
| HY-160612 | Transthyretin-IN-2 | 4664-62-4 | Reference compound |
| HY-160613 | EGFR/HER2-IN-11 | 1346176-20-2 | Reference compound |
| HY-160615 | TP receptor antagonist-1 | 1448452-21-8 | Reference compound |
| HY-160616 | LPA5 antagonist 3 | 1664336-44-0 | Reference compound |
| HY-160617 | SIRT2-IN-14 | 1884571-59-8 | Reference compound |
| HY-160618 | 11β-HSD2-IN-2 | 1834601-37-4 | Reference compound |
| HY-16062 | ARQ 621 | 1095253-39-6 | Reference compound |
| HY-160621 | CXF-009 | 2727084-00-4 | Reference compound |
| HY-160623 | INS018 055 | 2828567-39-9 | Reference compound |
| HY-160624 | CD 10899 | 1331770-20-7 | Reference compound |
| HY-160628 | GPR120 Agonist 4 | 1628641-89-3 | Reference compound |
| HY-16063 | ARQ-736 | 1228237-57-7 | Reference compound |
| HY-160633 | PfFAS-II inhibitor 1 | 1459704-68-7 | Reference compound |
| HY-160634 | BRD4 Inhibitor-31 | 1446233-35-7 | Reference compound |
| HY-160635 | Ack1 inhibitor 2 | 1196392-26-3 | Reference compound |
| HY-160636 | BRD4 Inhibitor-32 | 1445992-86-8 | Reference compound |
| HY-160637 | Lp-PLA2-IN-17 | 1818842-74-8 | Reference compound |
| HY-160638 | NSC-311068 | 73768-68-0 | Reference compound |
| HY-160641 | isoG Nucleoside-1 | 242816-13-3 | Oligonucleotides |
| HY-160642 | isoG Nucleoside-2 | 915098-24-7 | Reference compound |
| HY-160643 | CDK2-IN-27 | 2927473-94-5 | Reference compound |
| HY-160644 | 8PC | 952588-30-6 | Reference compound |
| HY-160645 | P2X4 antagonist-1 | 2055601-42-6 | Reference compound |
| HY-160646 | LTA4H-IN-3 | 2707473-09-2 | Reference compound |
| HY-160647 | CCR8 antagonist 3 | 912463-57-1 | Reference compound |
| HY-160648 | InhA-IN-6 | 1040406-33-4 | Reference compound |
| HY-160649 | MC-Gly-Gly-Phe-Gly-GABA-Exatecan | 1599439-52-7 | ADC Related |
| HY-160652 | 17-Azidoheptadecanoic acid | 1841512-95-5 | Reference compound |
| HY-160653 | JPL | 952588-18-0 | Reference compound |
| HY-160654 | IRAK4 modulator-1 | 1356014-97-5 | Reference compound |
| HY-160655 | SERT-IN-3 | 289717-03-9 | Reference compound |
| HY-160656 | 5-HT/NA Reuptake inhibitor-1 | 844882-78-6 | Reference compound |
| HY-160657 | DC-TEADin04 | 2380228-38-4 | Reference compound |
| HY-160658 | AZ760 | 912461-36-0 | Reference compound |
| HY-160659 | Androgen receptor antagonist 10 | 876759-87-4 | Reference compound |
| HY-160660 | BRD4 Inhibitor-33 | 1445993-17-8 | Reference compound |
| HY-160661 | LPAR1 antagonist 2 | 1664336-46-2 | Reference compound |
| HY-160662 | BRD4-IN-5 | 1445993-41-8 | Reference compound |
| HY-160663 | Nav1.7 blocker 1 | 1426336-36-8 | Reference compound |
| HY-160664 | TP receptor antagonist-2 | 1448452-22-9 | Reference compound |
| HY-160668 | Histamine H3 antagonist-1 | 1000392-25-5 | Reference compound |
| HY-160669 | Antibacterial agent 198 | 1649473-36-8 | Reference compound |
| HY-160670 | BRD4-IN-6 | 1446232-91-2 | Reference compound |
| HY-160671 | BRD4-IN-7 | 1446232-98-9 | Reference compound |
| HY-160672 | BRD4-IN-8 | 1445992-82-4 | Reference compound |
| HY-160675 | TCMDC-137332 | 165119-08-4 | Reference compound |
| HY-160676 | sEH-IN-1 | 1061377-99-8 | Reference compound |
| HY-160677 | P2X4 antagonist-2 | 2055601-24-4 | Reference compound |
| HY-160678 | InhA-IN-7 | 952588-17-9 | Reference compound |
| HY-160679 | BaENR-IN-1 | 1071966-17-0 | Reference compound |
| HY-160680 | AR antagonist 6 | 876760-08-6 | Reference compound |
| HY-160681 | OvCHT1-IN-1 | 1613336-69-8 | Reference compound |
| HY-160682 | EGFR/HER2-IN-12 | 2237230-21-4 | Reference compound |
| HY-160683 | MC-Gly-Gly-Phe-Gly-NH-CH2-O-amide-Eribulin | 2907719-55-3 | ADC Related |
| HY-160684 | GW701427A | 433224-56-7 | Reference compound |
| HY-160685 | GW809897X | 579515-94-9 | Reference compound |
| HY-160686 | GSK248233A | 850665-21-3 | Reference compound |
| HY-160687 | GW549390X | 135307-33-4 | Reference compound |
| HY-160688 | GW759710A | 944795-23-7 | Reference compound |
| HY-160689 | GW694590A | 948313-24-4 | Reference compound |
| HY-16069 | Tucatinib | 937263-43-9 | Reference compound |
| HY-160690 | GW632046X | 681002-67-5 | Reference compound |
| HY-160691 | GW814408X | 886599-05-9 | Reference compound |
| HY-160692 | AR antagonist 7 | 876759-97-6 | Reference compound |
| HY-160693 | 2′-O-Methylguanosine 5′-monophosphate | 24121-01-5 | Reference compound |
| HY-160694 | cBu-Cit-PROTAC BRD4 Degrader-5 | 2417369-73-2 | Reference compound |
| HY-160695 | PT-179 | 2924858-25-1 | Reference compound |
| HY-160696 | ORIC-533 | 2641306-62-7 | Reference compound |
| HY-160698 | SGR-1505 | 2661481-41-8 | Reference compound |
| HY-160699 | DCC-3116 | 2543673-19-2 | Reference compound |
| HY-16069A | Tucatinib (hemiethanolate) | 1429755-56-5 | Reference compound |
| HY-16069S | Tucatinib-d6 | Isotope-Labeled Compounds | |
| HY-160700 | TNG348 | 2839740-79-1 | Reference compound |
| HY-160701 | Cirtociclib | 2888704-84-3 | Reference compound |
| HY-160702 | DMBA-SIL-Mal-MMAE | 2923885-49-6 | ADC Related |
| HY-160703 | DMBA-SIL-PNP | 2923885-47-4 | Reference compound |
| HY-160704 | CMX-521 | 2077178-99-3 | Reference compound |
| HY-160705 | PNI 132 | 2568616-81-7 | Oligonucleotides |
| HY-160706 | HHQ16 | 2620471-66-9 | Oligonucleotides |
| HY-160708 | Tie2 kinase inhibitor 3 | 870225-11-9 | Reference compound |
| HY-160709 | Wnt/β-catenin-IN-2 | 1397006-01-7 | Reference compound |
| HY-16071 | AT13148 | 1056901-62-2 | Reference compound |
| HY-160714 | Fmoc-Ala-Ala-Ala-amide-C-O-C-COOH | 3002986-41-3 | ADC Related |
| HY-160715 | BNT411 | 2296821-50-4 | Reference compound |
| HY-160719 | NHS-activated 2-octynoic acid-BSA | Reference compound | |
| HY-160726 | Polymethacrylate Copolymer (N−C4−52−6.9) | 2315261-99-3 | Biochemical Assay Reagents |
| HY-160728 | 3′-O-N3-dATP | 1048021-78-8 | Oligonucleotides |
| HY-160728A | 3′-O-N3-dATP (trisodium) | Reference compound | |
| HY-160734 | Aleniglipron | 2685823-26-9 | Reference compound |
| HY-16074 | ATN-224 | 649749-10-0 | Reference compound |
| HY-160745 | 2'-O-methyladenosine 5'-phosphate | 24121-00-4 | Oligonucleotides |
| HY-160755 | UM-2 | 349484-08-8 | Oligonucleotides |
| HY-160756A | Val-Cit-Exatecan (TFA) | ADC Related | |
| HY-160758 | J9Z38 | 1414864-34-8 | Reference compound |
| HY-160761 | K-Opioid receptor agonist-1 | 1816990-29-0 | Reference compound |
| HY-160764 | N6-Carboxymethyl-ATP | 55860-25-8 | Reference compound |
| HY-160765 | WNTinib | 2770091-44-4 | Reference compound |
| HY-160768 | OTUB2-IN-1 | Reference compound | |
| HY-160769 | NIBR-LTSi | Reference compound | |
| HY-160773 | DBCO-PEG6-NHS ester | Reference compound | |
| HY-160773A | DBCO-C3-amide-PEG6-NHS ester | Reference compound | |
| HY-160774 | Val-Cit-PABC-DOX | 1022094-34-3 | ADC Related |
| HY-160776 | Diazido-methyltetrazine tri-arm | 2861998-18-5 | ADC Related |
| HY-160777 | VNPP433-3β | 1630820-51-7 | Reference compound |
| HY-160783 | SRI-43265 | 2727872-88-8 | Reference compound |
| HY-160785 | TREX1-IN-1 | 2756594-27-9 | Reference compound |
| HY-160786 | TREX1-IN-3 | 2588445-13-8 | Reference compound |
| HY-160786A | TREX1-IN-4 | 2588445-14-9 | Reference compound |
| HY-160787 | NCGC1481 | 2193085-94-6 | Reference compound |
| HY-160788 | DBCO-β-Glu-PEG12-Exatecan | 3025107-83-6 | Reference compound |
| HY-16079 | AZD3514 | 1240299-33-5 | Reference compound |
| HY-160790 | β-Glu-PNP | 3025520-67-3 | ADC Related |
| HY-160791 | Claramine | 1430194-56-1 | Reference compound |
| HY-160791A | Claramine (TFA) | 3030428-57-7 | Reference compound |
| HY-160793 | NSC80734 | 501950-47-6 | Reference compound |
| HY-160795 | Boc-NMeVal-Val-Dil-Dap | 1369426-99-2 | ADC Related |
| HY-160799 | HA-9104 | 2412367-83-8 | Reference compound |
| HY-160801 | HKYK-0030 | 2923054-94-6 | Reference compound |
| HY-160804 | Desmethyl nevanimibe | 2419904-59-7 | Reference compound |
| HY-160806 | (5-Cl)-Exatecan | 2813268-66-3 | Oligonucleotides |
| HY-160807 | DBM-GGFG-NH-O-CO-Exatecan | 2769152-95-4 | ADC Related |
| HY-160811 | hVEGF-IN-3 | 46739-60-0 | Reference compound |
| HY-160818 | MC3138 | 1844889-12-8 | Reference compound |
| HY-16082 | AZD7545 | 252017-04-2 | Reference compound |
| HY-160821A | N-Acetylmannosamine 6-phosphate (sodium salt) | 335275-62-2 | Reference compound |
| HY-160822 | AGG-523 | 920289-29-8 | Reference compound |
| HY-160831 | PQQ-trimethylester | 74447-88-4 | Reference compound |
| HY-160832 | GC373 | 1429218-54-1 | Reference compound |
| HY-160839 | SPB-PEG4-AAD | 3027246-94-9 | Reference compound |
| HY-160840 | SPB-AAD | 3027246-93-8 | Reference compound |
| HY-160841 | Biotin-16-dCTP | 2567941-52-8 | Reference compound |
| HY-160842 | CSF1R-IN-24 | 3024322-57-1 | Reference compound |
| HY-160843 | NCAO | 20584-81-0 | Reference compound |
| HY-160845 | HDAC6-IN-39 | 2653255-56-0 | Reference compound |
| HY-160846 | HDAC6-IN-40 | 2653254-34-1 | Reference compound |
| HY-160848 | FLT3/ITD-IN-5 | 3023632-62-1 | Reference compound |
| HY-160849 | N-Desmethyl Rilmazolam | 50330-93-3 | Reference compound |
| HY-160850 | C18 Ceramide-1-phosphate (d18:1/18:0) (ammonium salt) | 384835-48-7 | Reference compound |
| HY-160851 | GDC-3280 | 1590403-33-0 | Reference compound |
| HY-160852 | YSK 12C4 | 1829511-70-7 | Reference compound |
| HY-160853 | Tubulin inhibitor 42 | 2135713-96-9 | Reference compound |
| HY-160854 | Tubulin inhibitor 43 | 1541208-02-9 | Reference compound |
| HY-160856 | TOP5300 | 1848981-48-5 | Reference compound |
| HY-160857 | TOP5668 | 1850256-71-1 | Reference compound |
| HY-160859 | WRN inhibitor 8 | 3026502-95-1 | Reference compound |
| HY-16086 | Balaglitazone | 199113-98-9 | Reference compound |
| HY-160864 | Torbafylline | 105102-21-4 | Reference compound |
| HY-160865 | PRMT5-IN-35 | 1989620-03-2 | Reference compound |
| HY-160866 | (Rac)-D3S-001 | 2706637-43-4 | Reference compound |
| HY-160869 | Firefly luciferase-IN-2 | 796108-95-7 | Dye Reagents |
| HY-160870 | Firefly luciferase-IN-3 | 898155-17-4 | Dye Reagents |
| HY-160871 | Anticancer agent 208 | 894565-34-5 | Reference compound |
| HY-160873 | Firefly luciferase-IN-5 | 959557-37-0 | Dye Reagents |
| HY-160874 | GST-FH.4 | 1358386-87-4 | Reference compound |
| HY-160875 | GST-FH.1 | 920115-54-4 | Reference compound |
| HY-160876 | BC-1901S | 1358617-36-3 | Reference compound |
| HY-160877 | EBOV-IN-2 | Reference compound | |
| HY-160878 | EBOV-IN-3 | 2896193-40-9 | Reference compound |
| HY-160879 | EBOV-IN-4 | 2896193-43-2 | Reference compound |
| HY-160880 | EBOV-IN-5 | 68207-15-8 | Reference compound |
| HY-160881 | EBOV-IN-6 | Reference compound | |
| HY-160882 | EBOV-IN-7 | 68207-16-9 | Reference compound |
| HY-160883 | EBOV-IN-8 | 286854-12-4 | Reference compound |
| HY-160884 | DMT-2'-OMe-D-Ribitol phosphoramidite | 1470023-72-3 | Oligonucleotides |
| HY-160885 | NH2-Gly-PAB-Exatecan-D-glucuronic acid | 2763252-31-7 | Reference compound |
| HY-160885A | NH2-Gly-PAB-Exatecan-D-glucuronic acid (formic) | Reference compound | |
| HY-160887 | FPT | 2048491-06-9 | Reference compound |
| HY-160888 | ASP8302 | 1839583-42-4 | Reference compound |
| HY-160893 | PSMA-azide | 2374814-84-1 | ADC Related |
| HY-160896 | Autophagy-IN-5 | 1262888-20-9 | Reference compound |
| HY-160897 | Methoxy-PEG-C3-amide-C2-Mal | 883993-35-9 | Reference compound |
| HY-160899A | Thailanstatin A cyclohexane diamine (formic) | Reference compound | |
| HY-160900 | RN-1665 | 1803003-65-7 | Reference compound |
| HY-160901 | CP-289,503 | 1349637-14-4 | Reference compound |
| HY-160902 | 2G-HaloAUTAC | 2241668-58-4 | Reference compound |
| HY-160903 | Suzetrigine phenol | 2649467-91-2 | Reference compound |
| HY-160908 | Lipid 88 | 2982842-99-7 | Oligonucleotides |
| HY-160912 | ELOVL6-IN-5 | 1135000-36-0 | Reference compound |
| HY-160915 | WP836 | 266000-09-3 | Reference compound |
| HY-160917 | BAY-43-9695 | 233255-39-5 | Reference compound |
| HY-160920 | Sylsens B | 107595-44-8 | Dye Reagents |
| HY-160921 | Capeserod | 769901-96-4 | Reference compound |
| HY-160922 | BAY 249716 | 696628-24-7 | Reference compound |
| HY-160924 | MS147 | Reference compound | |
| HY-160926 | 16-Oxocafestol | 108664-98-8 | Natural Products |
| HY-160927 | Docosahexaenoyl Serinol | 1638355-62-0 | Reference compound |
| HY-160928 | Smurf1 modulator-1 | 1825371-51-4 | Reference compound |
| HY-160929 | Linafexor | 2765593-43-7 | Reference compound |
| HY-160930 | TOP1288 | 1630202-02-6 | Reference compound |
| HY-160931 | NMDA receptor modulator 8 | 1629853-49-1 | Reference compound |
| HY-160932 | RS-15385-198 | 121961-55-5 | Reference compound |
| HY-160937 | AZD-9574-acid | 2923687-90-3 | Reference compound |
| HY-160939 | ASK1-IN-6 | 2407451-82-3 | Reference compound |
| HY-16094 | Bethanidine (sulfate) | 114-85-2 | Reference compound |
| HY-160941 | CDK2-IN-29 | 247149-58-2 | Reference compound |
| HY-160943 | F594-1001 | 1215326-44-5 | Reference compound |
| HY-160943A | F594-1001 (hydrochloride) | Reference compound | |
| HY-160944 | hsa62 | 780822-35-7 | Reference compound |
| HY-160945 | NMT-IN-7 | 3032302-70-5 | ADC Related |
| HY-160956 | Nitto Phase HL UnyLinker 300 | Reference compound | |
| HY-160957 | Cap A (Acetonitrile/Acetic Anhydride, 80/20 v/v) | Oligonucleotides | |
| HY-160958 | Cap B (Acetonitrile/N-methylimidazole /pyridine, 50/20/30 v/v/v) | Reference compound | |
| HY-160959 | AN317 | 946074-35-7 | Reference compound |
| HY-160962 | SM1044 | 1331880-08-0 | Reference compound |
| HY-160966 | PROTAC BTK Degrader-10 | 2988804-46-0 | Reference compound |
| HY-160967 | MC-GGFG-PAB-Exatecan | 2928560-25-0 | ADC Related |
| HY-160971 | Ribonucleic Acid, Transfer from Brewing yeast | 9014-25-9 | Biochemical Assay Reagents |
| HY-160972 | MM0299 | 474255-10-2 | Reference compound |
| HY-160973 | ELF97 phosphate | 147394-94-3 | Biochemical Assay Reagents |
| HY-160978 | Timelotem | 96306-34-2 | Reference compound |
| HY-160979 | Bisfentidine | 96153-56-9 | Natural Products |
| HY-160980 | Sornidipine | 95105-77-4 | Reference compound |
| HY-160981 | Mal-PEG4-VCP-NB | 1345681-54-0 | ADC Related |
| HY-160982 | Mal-PEG3-VCP-NB | 1345681-77-7 | ADC Related |
| HY-160983 | PHYLPA-8 | 169736-88-3 | Reference compound |
| HY-160984 | Rotraxate | 92071-51-7 | Reference compound |
| HY-160985 | Lemidosul | 88041-40-1 | Reference compound |
| HY-160991 | Menabitan | 83784-21-8 | Reference compound |
| HY-160991A | Menabitan (dihydrochloride) | 58019-50-4 | Reference compound |
| HY-160992 | Vinepidine (sulfate) | 83200-11-7 | Reference compound |
| HY-160993 | Ciprostene | 81845-44-5 | Reference compound |
| HY-160994 | Pyrophendane | 7009-69-0 | Reference compound |
| HY-160995 | Crotoniazide | 7007-96-7 | Reference compound |
| HY-160996 | Glucosulfamide | 7007-76-3 | Reference compound |
| HY-160997 | Prosulpride | 68556-59-2 | Reference compound |
| HY-160998 | YM-344031 | 671204-98-1 | Reference compound |
| HY-16100 | BI 99179 | 1291779-76-4 | Reference compound |
| HY-161001 | AMOZ-CHPh-3-acid | 1393444-23-9 | Reference compound |
| HY-161002 | AMOZ-CHPh-4-O-C-acid | 1149378-54-0 | Reference compound |
| HY-161003 | AMOZ-CHPh-3-O-C-acid | 1416047-55-6 | Reference compound |
| HY-161004 | AMOZ-CH-acid | 1416047-56-7 | Reference compound |
| HY-161005 | TETS-Methyl benzoate | 2107375-54-0 | Reference compound |
| HY-161006 | TETS-C4-acid | Reference compound | |
| HY-161010 | DHFR-IN-13 | Reference compound | |
| HY-161011 | Spire2-FMN2 interaction-IN-1 | 1557337-03-7 | Reference compound |
| HY-161012 | RB-07-16 | Reference compound | |
| HY-161013 | Antiproliferative agent-44 | 3017217-08-9 | Reference compound |
| HY-161014 | DYRK2-IN-1 | Reference compound | |
| HY-161015 | JAK1-IN-13 | 2778330-90-6 | Reference compound |
| HY-161016 | TNF/IFN-γ-IN-1 | 876013-29-5 | Reference compound |
| HY-161017 | WDR91-IN-1 | 2759614-35-0 | Reference compound |
| HY-161018 | CF3–K11 | 3032121-66-4 | Reference compound |
| HY-161019 | JAK1/TYK2-IN-4 | 2734918-33-1 | Reference compound |
| HY-16102 | Bismuth subcitrate (potassium) | 880149-29-1 | Reference compound |
| HY-161020 | m-PEG12-OTs | 2103241-71-8 | Reference compound |
| HY-161021 | AC2 selective-IN-1 | Reference compound | |
| HY-161022 | FL118-C3-O-C-amide-C-NH2 | 2821769-41-7 | ADC Related |
| HY-161022A | FL118-C3-O-C-amide-C-NH2 (formate) | ADC Related | |
| HY-161022S | FL118-C3-O-C-amide-C-NH2-d5 | Isotope-Labeled Compounds | |
| HY-161022S1 | FL118-C3-O-C-amide-C-NH2-d5 (formate) | Isotope-Labeled Compounds | |
| HY-161024 | AC1Q3QWB | 46697-00-1 | Reference compound |
| HY-161025 | SYHA1813 | 1807466-30-3 | Reference compound |
| HY-161026 | JM-9 | Reference compound | |
| HY-161027 | DHP-B | Reference compound | |
| HY-161028 | Antibacterial agent 167 | 1940173-83-0 | Reference compound |
| HY-161029 | T14-A24 | Reference compound | |
| HY-16102R | Bismuth subcitrate (potassium) (Standard) | 880149-29-1 | Reference Standards |
| HY-16103 | Bitolterol (mesylate) | 30392-41-7 | Reference compound |
| HY-161030 | EGFR-IN-92 | Reference compound | |
| HY-161031 | EGFR-IN-93 | Reference compound | |
| HY-161039 | MDM2-p53-IN-18 | 1818291-95-0 | Reference compound |
| HY-16104 | BIX 02565 | 1311367-27-7 | Reference compound |
| HY-161040 | MDM2-p53-IN-19 | 1818292-01-1 | Reference compound |
| HY-161041 | MDM2-p53-IN-20 | 2095120-09-3 | Reference compound |
| HY-161042 | Neuroprotective agent 2 | 2996062-20-3 | Reference compound |
| HY-161043 | ECDD-S16 | Reference compound | |
| HY-161045 | T-1-DOCA | Reference compound | |
| HY-161046 | PLK1-IN-8 | Reference compound | |
| HY-161047 | Antiviral agent 45 | Reference compound | |
| HY-161048 | PDH E1-IN-1 | Reference compound | |
| HY-161049 | Antifungal agent 89 | Reference compound | |
| HY-161050 | YSR734 | 3032969-58-4 | Reference compound |
| HY-161051 | Anticancer agent 177 | Reference compound | |
| HY-161057 | HG-7-86-01 | 1258391-14-8 | Reference compound |
| HY-161058 | AChE-IN-49 | Reference compound | |
| HY-161059 | ZB-R-55 | 2416593-55-8 | Reference compound |
| HY-16106 | Talazoparib | 1207456-01-6 | Reference compound |
| HY-161060 | Zharp1-211 | 2258671-41-7 | Reference compound |
| HY-161061 | Arginase inhibitor 7 | 2377392-07-7 | Reference compound |
| HY-161062 | TAOA AM Ester trimethyl lock | Reference compound | |
| HY-161063 | DHFR-IN-14 | Reference compound | |
| HY-161064 | DHFR-IN-15 | Reference compound | |
| HY-161065 | HKI12134085 | 2102393-11-1 | Reference compound |
| HY-161066 | KRAS G13D-IN-1 | Reference compound | |
| HY-161067 | EGFR-IN-96 | Reference compound | |
| HY-161068 | hACE2/SP-IN-1 | Reference compound | |
| HY-161069 | Anti-infective agent 8 | Reference compound | |
| HY-16106A | (8R,9S)-Talazoparib | 1207456-00-5 | Reference compound |
| HY-16106S | Talazoparib-13C,d4 | Isotope-Labeled Compounds | |
| HY-16106S1 | Talazoparib-d4 | Isotope-Labeled Compounds | |
| HY-16107 | BMS-303141 | 943962-47-8 | Reference compound |
| HY-161070 | Antiviral agent 46 | 877660-90-7 | Reference compound |
| HY-161071 | Antioxidant/anticancer agent 1 | 1449470-38-5 | Reference compound |
| HY-161072 | CSC-6 | Reference compound | |
| HY-161074 | PNT6555 | 2715113-34-9 | Reference compound |
| HY-161075 | Microtubule inhibitor 8 | 2310293-81-1 | Reference compound |
| HY-161076 | KTt-45 | 2244987-60-6 | Reference compound |
| HY-161077 | QP5020 | 3027434-06-3 | Reference compound |
| HY-161078 | QP5038 | 3031429-88-3 | Reference compound |
| HY-161079 | TDI-8304 | 2307262-96-8 | Reference compound |
| HY-161080 | 4'-Ethynyl-2'-deoxycytidine | 232588-95-3 | Reference compound |
| HY-161082 | Topoisomerase I inhibitor 12 | Reference compound | |
| HY-161083 | PARP/EZH2-IN-2 | Reference compound | |
| HY-161084 | CSF1R-IN-18 | Reference compound | |
| HY-161085 | BI 1265162 | 3042822-44-3 | Reference compound |
| HY-161086 | Antibiofilm agent-4 | 3027083-73-1 | Reference compound |
| HY-161087 | β-catenin/BCL9 PPI-IN-1 | Reference compound | |
| HY-161088 | Anti-aging agent 1 | 1884611-28-2 | Reference compound |
| HY-161089 | Antiproliferative agent-45 | Reference compound | |
| HY-16108A | Squalene synthase-IN-3 (tripotassium) | 157126-15-3 | Reference compound |
| HY-16109 | BMS-188494 | 191866-32-7 | Reference compound |
| HY-161090 | AMPA receptor modulator-7 | Reference compound | |
| HY-161091 | AM-2-19 | 2761794-74-3 | Natural Products |
| HY-161092 | KIO-301 (chloride) | 1643463-59-5 | Reference compound |
| HY-161092A | KIO-301 (chloride) (hydrochloride) | Reference compound | |
| HY-161093 | PROTAC BRD4 Degrader-23 | Reference compound | |
| HY-161094 | Metallo-β-lactamase-IN-12 | 3028594-43-3 | Reference compound |
| HY-161095 | iRGD-CPT | Reference compound | |
| HY-161096 | Antitumor agent-127 | Reference compound | |
| HY-161097 | Antibacterial agent 171 | Reference compound | |
| HY-161098 | Apoptosis inducer 14 | 2750370-67-1 | Reference compound |
| HY-16110 | Tegafur-Uracil | 74578-38-4 | Reference compound |
| HY-161100 | BDM19 | 500273-31-4 | Reference compound |
| HY-161101 | MG degrader 1 | Reference compound | |
| HY-161102 | [Ru(phen)2(xant)] (hexafluorophosphate) | Reference compound | |
| HY-161103 | Angeloyl-CoA | 6247-64-9 | Enzyme |
| HY-161104 | Kv2.1-IN-1 | 2252448-93-2 | Reference compound |
| HY-161105 | FPIP | Reference compound | |
| HY-161106 | OX04528 | 3028055-45-7 | Reference compound |
| HY-161107 | OX04529 | Reference compound | |
| HY-161108 | PROTAC Chk1 degrader-1 | 2597167-34-3 | Reference compound |
| HY-161109 | Aβ42-IN-4 | 2387822-02-6 | Reference compound |
| HY-16111 | BMS-214662 | 195987-41-8 | Reference compound |
| HY-161110 | APP degrader-1 | Reference compound | |
| HY-161111 | KVS0001 | 3056394-59-0 | Reference compound |
| HY-161112 | LG157 | 2840558-89-4 | Reference compound |
| HY-161113 | Z8554052021 | Reference compound | |
| HY-161114 | MDOLL-0229 | 3036752-42-5 | Reference compound |
| HY-161115 | NR2E3 agonist 1 | 911211-69-3 | Reference compound |
| HY-161116 | AD-5584 | 2306525-79-9 | Reference compound |
| HY-161117 | AD-8007 | 1497439-74-3 | Reference compound |
| HY-161118 | MB327 | 61368-98-7 | Reference compound |
| HY-161119 | Drpitor1a | 73326-98-4 | Reference compound |
| HY-16111A | BMS-214662 (hydrochloride) | 195981-08-9 | Reference compound |
| HY-16111A1 | BMS-214662 (mesylate) | 474010-58-7 | Reference compound |
| HY-161120 | NLRP3-IN-27 | 2997864-57-8 | Reference compound |
| HY-161123 | WDR5-IN-8 | Reference compound | |
| HY-161124 | SrtA-IN-2 | Reference compound | |
| HY-161125 | (+)-JQ1-OH | Reference compound | |
| HY-161126 | EGFR-IN-98 | Reference compound | |
| HY-161127 | NT-B2R | Reference compound | |
| HY-161128 | Lenalidomide 4'-PEG1-amine (dihydrochloride) | 2624336-86-1 | Reference compound |
| HY-161129 | "Lenalidomide 4'-PEG2-amine (dihydrochloride)" | 2624336-88-3 | Reference compound |
| HY-161130 | "Lenalidomide 4'-PEG3-amine (dihydrochloride)" | 2624336-87-2 | Reference compound |
| HY-161131 | Lenalidomide 4'-alkyl-C3-azide | 2399455-71-9 | Reference compound |
| HY-161132 | Lenalidomide 4'-alkyl-C5-azide | 2399455-78-6 | Reference compound |
| HY-161133 | Lenalidomide 4'-PEG1-azide | 2399455-45-7 | Reference compound |
| HY-161134 | Lenalidomide 4'-PEG2-azide | 2399455-48-0 | Reference compound |
| HY-161135 | TBAJ-5307 | 2332831-92-0 | Reference compound |
| HY-161136 | EGFR/STAT3-IN-1 | Reference compound | |
| HY-161137 | LQFM215 | Reference compound | |
| HY-161138 | WK369 | Reference compound | |
| HY-161139 | JAK1-IN-14 | Reference compound | |
| HY-16114 | BNC105 | 945771-74-4 | Reference compound |
| HY-161140 | PI3Kα-IN-16 | 1448711-61-2 | Reference compound |
| HY-161141 | EGFR/c-Met-IN-2 | 2761180-01-0 | Reference compound |
| HY-161142 | Carbonic anhydrase/AChE-IN-1 | Reference compound | |
| HY-161143 | Carbonic anhydrase/AChE-IN-2 | Reference compound | |
| HY-161144 | AKT-IN-21 | Reference compound | |
| HY-161145 | EGFR/microtubule-IN-1 | 1970269-96-5 | Reference compound |
| HY-161146 | EGFR-IN-100 | Reference compound | |
| HY-161147 | COX-2-IN-37 | Reference compound | |
| HY-161148 | FtsZ-IN-9 | 1273524-44-9 | Reference compound |
| HY-161149 | CM-1758 | 2256079-39-5 | Reference compound |
| HY-16115 | BPH-652 | 157124-84-0 | Reference compound |
| HY-161150 | AChE/BChE-IN-17 | Reference compound | |
| HY-161151 | RecQ helicase-IN-1 | Reference compound | |
| HY-161152 | DNA relaxation-IN-1 | 2190506-29-5 | Reference compound |
| HY-161153 | Microtubule inhibitor 9 | Reference compound | |
| HY-161154 | HDAC3-IN-3 | 2170996-03-7 | Reference compound |
| HY-161155 | HDAC6-IN-31 | Reference compound | |
| HY-161156 | BChE-IN-26 | Reference compound | |
| HY-161157 | dTAG-13-NEG | 2451573-90-1 | Reference compound |
| HY-161157A | dTAG-13-NEG (TFA) | Reference compound | |
| HY-161158 | KCNK13-IN-1 | 361368-24-3 | Reference compound |
| HY-161159 | DMHBO+ | 2322286-81-5 | Dye Reagents |
| HY-161160 | Ac4ManNDAz | 1015698-39-1 | Reference compound |
| HY-161161 | aTAG 2139-NEG | 2758431-99-9 | Reference compound |
| HY-161162 | aTAG 2139 | 2387510-81-6 | Reference compound |
| HY-161163 | IND 1316 | 1888473-12-8 | Reference compound |
| HY-161164 | Tricyclic cytosine tC | 1174063-74-1 | Reference compound |
| HY-161166 | MM-02-57 | Reference compound | |
| HY-161167 | MM-02-08 | Reference compound | |
| HY-161168 | Cyclin K degrader 1 | Reference compound | |
| HY-161169 | TP0628103 | 2865102-08-3 | Reference compound |
| HY-161170 | Antimalarial agent 36 | 2982633-03-2 | Reference compound |
| HY-161171 | Antimalarial agent 37 | 2982633-16-7 | Reference compound |
| HY-161172 | Antibacterial agent 178 | Reference compound | |
| HY-161173 | PROTAC SOS1 degrader-5 | 2836273-61-9 | Reference compound |
| HY-161174 | Carbonic anhydrase inhibitor 17 | 3033849-05-4 | Reference compound |
| HY-161175 | IMP-1575 | 3026255-85-3 | Reference compound |
| HY-161176 | PROTAC KRAS G12D degrader 1 | 3033583-54-6 | Reference compound |
| HY-161177 | PROTAC KRAS G12D degrader 2 | Reference compound | |
| HY-161178 | LK-60 | Reference compound | |
| HY-161179 | TRK-IN-27 | Reference compound | |
| HY-16117A | Brostallicin | 203258-38-2 | Reference compound |
| HY-161180 | Antitumor agent-136 | 2484876-94-8 | Reference compound |
| HY-161181 | BTTES-acid | 2223032-74-2 | Reference compound |
| HY-161182 | uPSEM792 (hydrochloride) | 2341841-08-3 | Reference compound |
| HY-161183 | (S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc | Reference compound | |
| HY-161184 | Deoxy-thalidomide-piperidine-C-piperazine-C2-OH | Reference compound | |
| HY-161185 | Thalidomide-piperidine-O-azetidine-boc | 2991611-55-1 | Reference compound |
| HY-161186 | Thalidomide-piperidine-C-azetidine-C2-O-C-boc | Reference compound | |
| HY-161187 | Thalidomide-piperidine-1,6-diazaspiro[3.3]heptane-boc | Reference compound | |
| HY-161188 | Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH | Reference compound | |
| HY-161189 | Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc | Reference compound | |
| HY-161190 | Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH | Reference compound | |
| HY-161191 | Thalidomide-azetidine-piperazine-C2-O-C2-OH | Reference compound | |
| HY-161192 | Thalidomide-O-C4H4-N(Me)-piperidine-C-boc | Reference compound | |
| HY-161193 | Thalidomide-piperazine-(R)-C-pyrrolidine-C-boc | Reference compound | |
| HY-161194 | (S,R,S)-AHPC-acetyl-azetidine-PIP-boc | Reference compound | |
| HY-161195 | Deoxy-thalidomide-piperidine-C-piperazine-C-boc | Reference compound | |
| HY-161196 | Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C-boc | Reference compound | |
| HY-161197 | Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH | Reference compound | |
| HY-161198 | Thalidomide-azetidine-pyrrolidine-C-piperidine-C-boc | Reference compound | |
| HY-161199 | Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH | Reference compound | |
| HY-161200 | Thalidomide-piperazine-C-azetidine-C2-OH | Reference compound | |
| HY-161201 | Thalidomide-piperazine-pyrimidine-piperazine-C-boc | Reference compound | |
| HY-161202 | Thalidomide-piperidine-O-piperidine-C2-OH | Reference compound | |
| HY-161203 | Thalidomide-azetidine-piperazine-C2-O-C-boc | Reference compound | |
| HY-161204 | Thalidomide-O-C4H4-N(Me)-piperidine-boc | Reference compound | |
| HY-161205 | Thalidomide-PIP-(R)C-pyrrolidine-boc | 2839668-87-8 | Reference compound |
| HY-161206 | Thalidomide-Pip-C-Pip-O-C-boc | Reference compound | |
| HY-161207 | (S,R,S)-AHPC-acetyl-Pip-O-azetidine-boc | Reference compound | |
| HY-161208 | Deoxy-thalidomide-Pip-C-PIP-boc | 2963655-14-1 | Reference compound |
| HY-161209 | Thalidomide-2,6-diazaspiro[3.4]octane-C-Pip-boc | Reference compound | |
| HY-16121 | CAA-0225 | 244072-26-2 | Reference compound |
| HY-161210 | Thalidomide-azetidine-C-PIP-C-boc | 2589699-87-4 | Reference compound |
| HY-161211 | HSD17B13-IN-7 | 863564-16-3 | Reference compound |
| HY-161212 | HSD17B13-IN-8 | 2758802-02-5 | Reference compound |
| HY-161213 | HSD17B13-IN-11 | 2758802-03-6 | Reference compound |
| HY-161214 | HSD17B13-IN-12 | 2758802-04-7 | Reference compound |
| HY-161215 | HSD17B13-IN-14 | 2758802-05-8 | Reference compound |
| HY-161216 | HSD17B13-IN-15 | 2758802-07-0 | Reference compound |
| HY-161217 | HSD17B13-IN-16 | 2758802-09-2 | Reference compound |
| HY-161218 | HSD17B13-IN-17 | 2758802-10-5 | Reference compound |
| HY-161219 | HSD17B13-IN-18 | 2758802-14-9 | Reference compound |
| HY-16122 | CAL-130 (Racemate) | 474012-90-3 | Reference compound |
| HY-161220 | HSD17B13-IN-19 | 2758802-17-2 | Reference compound |
| HY-161221 | HSD17B13-IN-21 | 2758802-18-3 | Reference compound |
| HY-161222 | HSD17B13-IN-23 | 2758802-19-4 | Reference compound |
| HY-161223 | HSD17B13-IN-27 | 2758802-31-0 | Reference compound |
| HY-161224 | HSD17B13-IN-31 | 2758802-33-2 | Reference compound |
| HY-161225 | HSD17B13-IN-40 | 2770246-06-3 | Reference compound |
| HY-161226 | HSD17B13-IN-42 | 2770246-10-9 | Reference compound |
| HY-161227 | HSD17B13-IN-43 | 2770246-11-0 | Reference compound |
| HY-161228 | HSD17B13-IN-48 | 2770246-12-1 | Reference compound |
| HY-161229 | HSD17B13-IN-69 | 2770246-16-5 | Reference compound |
| HY-16122A | CAL-130 | 1431697-74-3 | Reference compound |
| HY-16122B | CAL-130 (Hydrochloride) | 1431697-78-7 | Reference compound |
| HY-16123 | Canfosfamide (hydrochloride) | 439943-59-6 | Reference compound |
| HY-161230 | HSD17B13-IN-75 | 2770246-20-1 | Reference compound |
| HY-161231 | HSD17B13-IN-78 | 2770246-21-2 | Reference compound |
| HY-161232 | HSD17B13-IN-79 | 2770246-31-4 | Reference compound |
| HY-161233 | BTX-6654 | Reference compound | |
| HY-161234 | KRAS ligand 3 | 2654741-53-2 | Reference compound |
| HY-161235 | BTX-7312 | Reference compound | |
| HY-161236 | KRAS ligand 4 | Reference compound | |
| HY-161237 | Antitrypanosomal agent 20 | Reference compound | |
| HY-161238 | SARS-CoV-2-IN-79 | Reference compound | |
| HY-161239 | (S)-IB-96212 | Reference compound | |
| HY-161239A | IB-96212 | Reference compound | |
| HY-16124 | Canfosfamide | 158382-37-7 | Reference compound |
| HY-161240 | MAO-B-IN-30 | 82973-15-7 | Reference compound |
| HY-161241 | Tyrosinase-IN-23 | Reference compound | |
| HY-161242 | CBI1 | Reference compound | |
| HY-161242A | CBI1 (formic) | Reference compound | |
| HY-161243 | AChE-IN-56 | Reference compound | |
| HY-161244 | FGA145 | Reference compound | |
| HY-161245 | FGA146 | Reference compound | |
| HY-161246 | uPSEM792 | 2323525-19-3 | Reference compound |
| HY-161247 | 5-HT2A antagonist 2 | 2641482-08-6 | Reference compound |
| HY-161248 | E7130 | Reference compound | |
| HY-161249 | Vanin-1-IN-4 | 2173134-02-4 | Reference compound |
| HY-16125 | Carboxyamidotriazole (Orotate) | 187739-60-2 | Reference compound |
| HY-161250 | Pomalidomide-NH-PEG6-amide-C2-CPI-1612 | Reference compound | |
| HY-161251 | SPOP-IN-2 | 3031640-86-2 | Reference compound |
| HY-161252 | PBD-monoamide | 2093165-00-3 | ADC Related |
| HY-161253 | OSU-ERb-12 | 2088837-20-9 | Reference compound |
| HY-161254 | ATPase-IN-3 | 1134203-12-5 | Reference compound |
| HY-161255 | 3,4-DAA | 2117759-07-4 | Reference compound |
| HY-161256 | Tubulin inhibitor 41 | 2770273-12-4 | Reference compound |
| HY-161257 | CDC20-IN-1 | Reference compound | |
| HY-161258 | Antibacterial agent 181 | Reference compound | |
| HY-161259 | JAK-IN-36 | Reference compound | |
| HY-16126 | Carboxyamidotriazole | 99519-84-3 | Reference compound |
| HY-161260 | P-gp inhibitor 20 | Reference compound | |
| HY-161261 | SARS-CoV-2-IN-81 | Reference compound | |
| HY-161262 | SB03178 | 2952588-12-2 | Reference compound |
| HY-161263 | Antibacterial agent 182 | Reference compound | |
| HY-161264 | Antiviral agent 49 | Reference compound | |
| HY-161265 | HIF-2α agonist 3 | Reference compound | |
| HY-161266 | COX-2/NLRP3-IN-1 | Reference compound | |
| HY-161267 | Mitochondrial respiration-IN-4 | Reference compound | |
| HY-161268 | NAE-IN-1 | Reference compound | |
| HY-161269 | EGFR-IN-101 | 2982583-44-6 | Reference compound |
| HY-16126R | Carboxyamidotriazole (Standard) | 99519-84-3 | Reference Standards |
| HY-161270 | HIV-1 protease-IN-13 | Reference compound | |
| HY-161271 | MLK-IN-2 | 2614255-51-3 | Reference compound |
| HY-161272 | Nav1.8-IN-6 | Reference compound | |
| HY-161273 | TRPV1 antagonist 6 | Reference compound | |
| HY-161274 | Bfl-1-IN-1 | Reference compound | |
| HY-161275 | BI-4732 | 2769715-68-4 | Reference compound |
| HY-161276 | BFC1108 | 692774-37-1 | Reference compound |
| HY-161277 | HSD17B13-IN-100 | 2770246-33-6 | Reference compound |
| HY-161278 | HSD17B13-IN-102 | 2770246-34-7 | Reference compound |
| HY-161279 | Antibiofilm agent-5 | Reference compound | |
| HY-161280 | PROTAC FLT-3 degrader 3 | Reference compound | |
| HY-161281 | α-Glucosidase-IN-49 | Reference compound | |
| HY-161282 | hCAII-IN-10 | Reference compound | |
| HY-161283 | JT21-25 | 2996864-57-2 | Reference compound |
| HY-161284 | MMP-9/10-IN-1 | Reference compound | |
| HY-161285 | MMP-9/10-IN-2 | Reference compound | |
| HY-161286 | hCAXII-IN-8 | Reference compound | |
| HY-161287 | HDAC6-IN-32 | Reference compound | |
| HY-161288 | UKTT15 | 2468199-58-6 | Reference compound |
| HY-161289 | Tyrosinase-IN-24 | Reference compound | |
| HY-16129 | CBP-501 | 565434-85-7 | Peptides |
| HY-161290 | PDE5-IN-12 | Reference compound | |
| HY-161291 | CDK2-IN-25 | Reference compound | |
| HY-161292 | DHFR-IN-16 | Reference compound | |
| HY-161293 | p38-α MAPK-IN-6 | 29368-40-9 | Reference compound |
| HY-161294 | COX-2-IN-41 | Reference compound | |
| HY-161295 | hCAIX/XII-IN-10 | Reference compound | |
| HY-161296 | TH6342 | Reference compound | |
| HY-161297 | NT-0249 | 2763617-39-4 | Reference compound |
| HY-161297A | NT-0249 (free base) | Reference compound | |
| HY-161298 | MAT2A-IN-15 | Reference compound | |
| HY-161299 | LAPTc-IN-1 | 930898-33-2 | Reference compound |
| HY-161300 | Antibacterial agent 191 | Reference compound | |
| HY-161301 | PI3K-IN-52 | Reference compound | |
| HY-161302 | Polθ/PARP-IN-1 | Reference compound | |
| HY-161303 | ZNF207-IN-1 | 2923208-52-8 | Reference compound |
| HY-161304 | HDAC6-IN-33 | 2444302-23-0 | Reference compound |
| HY-161305 | SE-7552 | 2243575-79-1 | Reference compound |
| HY-161306 | ITF5924 | 2760854-72-4 | Reference compound |
| HY-161307 | T-518 | 2276680-91-0 | Reference compound |
| HY-161308 | HPPD-IN-3 | 3024245-46-0 | Reference compound |
| HY-161309 | PfPKG-IN-2 | Reference compound | |
| HY-161310 | Metallo-β-lactamase-IN-15 | 1804934-57-3 | Reference compound |
| HY-161311 | AChE/BChE-IN-18 | Reference compound | |
| HY-161312 | Antifungal agent 93 | Reference compound | |
| HY-161313 | DYB-03 | 2982792-85-6 | Reference compound |
| HY-161315 | 15-LOX-IN-1 | Reference compound | |
| HY-161316 | NNMT-IN-5 | Reference compound | |
| HY-161317 | Gαq/11 protein-IN-1 | Reference compound | |
| HY-161318 | α-Glucosidase-IN-52 | Reference compound | |
| HY-161319 | EGFR-IN-104 | 2758904-45-7 | Reference compound |
| HY-161320 | EGFR-IN-105 | 831244-98-5 | Reference compound |
| HY-161321 | PTP1B-IN-24 | 2221707-61-3 | Reference compound |
| HY-161322 | hCAXII-IN-9 | Reference compound | |
| HY-161323 | FLT3-ITD/D835Y-IN-1 | Reference compound | |
| HY-161324 | Tubulin degrader 1 | Reference compound | |
| HY-161325 | Antileishmanial agent-26 | Reference compound | |
| HY-161326 | CXF-007 | 2727083-99-8 | Reference compound |
| HY-161327 | HBV-IN-44 | Reference compound | |
| HY-161328 | MAO-B-IN-31 | Reference compound | |
| HY-161329 | NLRP3-IN-32 | Reference compound | |
| HY-161330 | Anti-MRSA agent 10 | Reference compound | |
| HY-161331 | S16–1029 | 2653349-51-8 | Reference compound |
| HY-161332 | Antitumor agent-143 | Reference compound | |
| HY-161333 | ADS031 | Reference compound | |
| HY-161334 | CARM1-IN-4 | 2878481-07-1 | Reference compound |
| HY-161335 | HPK1-IN-43 | Reference compound | |
| HY-161336 | Alendronate prodrug-1 | Reference compound | |
| HY-161337 | PKL-IN-1 | Reference compound | |
| HY-161338 | Tubulin polymerization-IN-61 | 2758114-60-0 | Reference compound |
| HY-161339 | SIRT2-IN-13 | Reference compound | |
| HY-16134 | Celgosivir | 121104-96-9 | Reference compound |
| HY-161340 | Anti-melanoma agent 2 | 2361522-62-3 | Reference compound |
| HY-161341 | β-Glucuronidase responsive conjugate 1 | Reference compound | |
| HY-161342 | CTSL/CAPN1-IN-2 | 2410075-64-6 | Reference compound |
| HY-161343 | HDL-16 | 2373280-36-3 | Reference compound |
| HY-161344 | Z36-MP5 | 2839660-03-4 | Reference compound |
| HY-161345 | Meriolin 16 | Reference compound | |
| HY-161346 | EBET-1055 | Reference compound | |
| HY-161348 | AT-0174 | Reference compound | |
| HY-161349 | LTA4H-IN-4 | Reference compound | |
| HY-16134A | Celgosivir (hydrochloride) | 141117-12-6 | Reference compound |
| HY-16135 | CEP-11981 | 856691-93-5 | Reference compound |
| HY-161350 | ALK/HDAC-IN-1 | Reference compound | |
| HY-161351 | STAT3/AKT-IN-1 | Reference compound | |
| HY-161352 | NPI52 | 1429218-68-7 | Reference compound |
| HY-161353 | c-Met-IN-23 | Reference compound | |
| HY-161354 | JAK3 covalent inhibitor-2 | 2664050-97-7 | Reference compound |
| HY-161355 | α-Amylase/α-Glucosidase-IN-9 | Reference compound | |
| HY-161356 | BPR3P0128 | 1345406-09-8 | Reference compound |
| HY-161357 | KR-27370 | Reference compound | |
| HY-161358 | FAK-IN-20 | 3004967-41-0 | Reference compound |
| HY-161359 | BACE1-IN-14 | Reference compound | |
| HY-16135A | CEP-11981 (tosylate) | 901128-79-8 | Reference compound |
| HY-161360 | LXQ-217 | 2524718-79-2 | Reference compound |
| HY-161361 | MLKL-IN-7 | Reference compound | |
| HY-161362 | SR-3-65 | Reference compound | |
| HY-161363 | ERK2 allosteric-IN-1 | 872591-16-7 | Reference compound |
| HY-161364 | Antibacterial agent 200 | Reference compound | |
| HY-161365 | PLpro-IN-2 | Reference compound | |
| HY-161366 | OMS14 | Reference compound | |
| HY-161367 | VHL-SF2 | 3050690-24-6 | Reference compound |
| HY-161368 | BRD-SF2 | 3050690-26-8 | Reference compound |
| HY-161369 | CBPD-268 | 2832961-58-5 | Reference compound |
| HY-16137 | Cefaloglycin | 3577-01-3 | Reference compound |
| HY-161370 | VD4162 | 2574390-19-3 | Reference compound |
| HY-161371 | VD5123 | Reference compound | |
| HY-161372 | PARP1/c-Met-IN-1 | 2944101-99-7 | Reference compound |
| HY-161373 | PI3Kα-IN-22 | 2925030-26-6 | Reference compound |
| HY-161374 | Carbonic anhydrase inhibitor 20 | Reference compound | |
| HY-161375 | SDH-IN-13 | 2975187-87-0 | Reference compound |
| HY-161376 | M4K2281 | Reference compound | |
| HY-161377 | M4K2306 | 3034840-25-7 | Reference compound |
| HY-161378 | UCHL1-IN-1 | Reference compound | |
| HY-161379 | CLZX-205 | 3033694-01-5 | Reference compound |
| HY-16138 | Ivaltinostat | 936221-33-9 | Reference compound |
| HY-161380 | Antifungal agent 96 | Reference compound | |
| HY-161381 | PDE4-IN-15 | 3034837-89-0 | Reference compound |
| HY-161382 | NPFF2-R ligand 1 | Reference compound | |
| HY-161383 | CHK1-IN-9 | Reference compound | |
| HY-161384 | WJM-715 | Reference compound | |
| HY-161385 | Topoisomerase I inhibitor 16 | Reference compound | |
| HY-161386 | WRN inhibitor 7 | 444780-45-4 | Reference compound |
| HY-161387 | EBET-590 | 3031540-40-3 | Reference compound |
| HY-161388 | NSCLC-IN-1 | Reference compound | |
| HY-161389 | SP-alkyne | Reference compound | |
| HY-16138A | Ivaltinostat (formic) | Reference compound | |
| HY-161390 | SPC-alkyne | Reference compound | |
| HY-161391 | CW0134 | 1076235-18-1 | Reference compound |
| HY-161392 | CW2158 | Reference compound | |
| HY-161393 | RB-CO-PEG5-C2-CO-VH032 | Reference compound | |
| HY-161394 | SPRT | Reference compound | |
| HY-161395 | IDD-8E | Reference compound | |
| HY-161396 | Anti-inflammatory agent 76 | Reference compound | |
| HY-161397 | NA-1-157 | Reference compound | |
| HY-161398 | TGFβRII-IN-3 | 2351149-20-5 | Reference compound |
| HY-161400 | TGFβRII-IN-2 | Reference compound | |
| HY-161401 | PAR4 antagonist 2 | Reference compound | |
| HY-161402 | METTL16-IN-1 | Reference compound | |
| HY-161403 | CYP1B1-IN-8 | Reference compound | |
| HY-161404 | Antibacterial agent 202 | 3035899-61-4 | Reference compound |
| HY-161405 | NPFF1-R antagonist 1 | 3057753-40-6 | Reference compound |
| HY-161406 | DXPS-IN-1 | Reference compound | |
| HY-161407 | AURKA-IN-1 | Reference compound | |
| HY-161408 | GePhos1 | Reference compound | |
| HY-161408A | iGePhos1 | Reference compound | |
| HY-161409 | SC912 | Reference compound | |
| HY-16141 | Cilengitide | 188968-51-6 | Reference compound |
| HY-161410 | WH244 | 2941088-96-4 | Reference compound |
| HY-161411 | α-Glucosidase-IN-60 | Reference compound | |
| HY-161412 | STR-V-53 | 2798954-66-0 | Reference compound |
| HY-161413 | Antibacterial agent 204 | 1211465-32-5 | Reference compound |
| HY-161414 | trans-VUF25471 | Reference compound | |
| HY-161415 | BCL-xL/BCL-2 ligand 1 | 2941091-91-2 | Reference compound |
| HY-161417 | LIMK-IN-2 | 2747216-27-7 | Reference compound |
| HY-161418 | 1-NBX | Reference compound | |
| HY-161419 | EZH2-IN-18 | 2826234-37-9 | Reference compound |
| HY-161420 | TRPV1 antagonist 7 | Reference compound | |
| HY-161421 | α-Glucosidase-IN-61 | Reference compound | |
| HY-161425 | Antitumor agent-149 | 2368983-54-2 | Reference compound |
| HY-161427 | HSP90-IN-30 | Reference compound | |
| HY-161428 | ZINC000003015356 | 872861-28-4 | Reference compound |
| HY-161429 | Antidiabetic agent 5 | 2152667-21-3 | Reference compound |
| HY-16143 | Cilengitide (TFA) | 199807-35-7 | Reference compound |
| HY-161430 | RTx-161 | Reference compound | |
| HY-161431 | RTx-152 | 3035072-48-8 | Reference compound |
| HY-161432 | Antimicrobial agent-29 | 731793-27-4 | Reference compound |
| HY-161433 | VMAT2-IN-3 | Reference compound | |
| HY-161434 | PCSK9-IN-26 | 3033361-09-7 | Reference compound |
| HY-161435 | PCSK9-IN-27 | Reference compound | |
| HY-161436 | TPA-dT | Reference compound | |
| HY-161438 | Akt1-IN-3 | 3033576-50-7 | Reference compound |
| HY-161439 | Akt1-IN-4 | 3033577-05-5 | Reference compound |
| HY-161440 | SIK-IN-1 | 3033846-29-3 | Reference compound |
| HY-161441 | SIK-IN-2 | 3033846-20-4 | Reference compound |
| HY-161442 | SIK-IN-3 | Reference compound | |
| HY-161443 | TEAD-IN-9 | Reference compound | |
| HY-161444 | Piperazine-acetyl-PIP-AcOH | Reference compound | |
| HY-161445 | (S,R,S)-AHPC-Me-piperazine-acetyl-PIP-AcOH | Reference compound | |
| HY-161446 | USP1-IN-7 | 3033480-42-8 | Reference compound |
| HY-161447 | USP1-IN-8 | 3033480-77-9 | Isotope-Labeled Compounds |
| HY-161448 | Tau-aggregation-IN-3 | 3032869-59-0 | Reference compound |
| HY-161449 | JTT-654 | 916828-66-5 | Reference compound |
| HY-161450 | LHF418 | Reference compound | |
| HY-161451 | Lenalidomide nonanedioic acid | Reference compound | |
| HY-161452 | SOS1 Ligand intermediate-3 | Reference compound | |
| HY-161453 | BChE-IN-32 | Reference compound | |
| HY-161454 | Antiviral agent 54 | Reference compound | |
| HY-161455 | Xanthine oxidase-IN-13 | Reference compound | |
| HY-161456 | PHGDH-IN-5 | 17402-86-7 | Reference compound |
| HY-161457 | (Gly0.8Nap0.2)20 | Reference compound | |
| HY-161458 | GSK-3β inhibitor 16 | Reference compound | |
| HY-161459 | GLI1-IN-1 | 2923907-92-8 | Reference compound |
| HY-16146 | Combretastatin A-1 phosphate (tetrasodium) | 288847-34-7 | Reference compound |
| HY-161460 | Ferroptosis-IN-7 | Reference compound | |
| HY-161461 | E234G HYPE-IN-1 | 1341007-95-1 | Reference compound |
| HY-161462 | ERK2/p38α MAPK-IN-1 | 1016427-72-7 | Reference compound |
| HY-161463 | CDK2-IN-28 | 3025006-64-5 | Reference compound |
| HY-161464 | Chlopynostat | Reference compound | |
| HY-161465 | HDAC8-IN-7 | Reference compound | |
| HY-161466 | AChE-IN-62 | Reference compound | |
| HY-161467 | Aster-A Ligand-3 | 2375541-28-7 | Reference compound |
| HY-161468 | Thalidomide-N-C3-O-C4-O-C3-OH | Reference compound | |
| HY-161469 | α-Amylase/α-Glucosidase-IN-13 | Reference compound | |
| HY-16147 | Combretastatin A1 phosphate | 288847-35-8 | Reference compound |
| HY-161470 | WS-384 | 2247544-03-0 | Reference compound |
| HY-161471 | DCLK1-IN-5 | 3028774-14-0 | Reference compound |
| HY-161472 | Aldose reductase-IN-7 | Reference compound | |
| HY-161473 | Apoptosis inducer 16 | Reference compound | |
| HY-161474 | Antiproliferative agent-50 | 301675-59-2 | Reference compound |
| HY-161475 | Luciferase-IN-4 | 1020413-85-7 | Reference compound |
| HY-161476 | Ir-ImNO | Dye Reagents | |
| HY-161477 | Histamine/BSA | Biochemical Assay Reagents | |
| HY-161478 | Phosphoserine/BSA | Biochemical Assay Reagents | |
| HY-161479 | Melamine/OVA | Biochemical Assay Reagents | |
| HY-161480 | Melamine/BSA | Biochemical Assay Reagents | |
| HY-161481 | Melamine/bov igG | Biochemical Assay Reagents | |
| HY-161482 | Alginic acid/BSA | Biochemical Assay Reagents | |
| HY-161483 | CBP/p300 ligand 3 | 1936425-34-1 | Reference compound |
| HY-161484 | Penicillin G/OVA | Biochemical Assay Reagents | |
| HY-161485 | Gentamicin/BSA | Biochemical Assay Reagents | |
| HY-161486 | AOZ/OVA | Biochemical Assay Reagents | |
| HY-161487 | AOZ/BSA | Biochemical Assay Reagents | |
| HY-161488 | Eugenol/BSA | Biochemical Assay Reagents | |
| HY-161489 | Enrofloxacin/BSA | Biochemical Assay Reagents | |
| HY-161490 | AMOZ/BSA | Biochemical Assay Reagents | |
| HY-161491 | 1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid-linker/OVA | Biochemical Assay Reagents | |
| HY-161492 | Estradiol/OVA | Biochemical Assay Reagents | |
| HY-161493 | 1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid/BSA | Biochemical Assay Reagents | |
| HY-161494 | XYD190 | Reference compound | |
| HY-161495 | CBP/p300 ligand 4 | Reference compound | |
| HY-161496 | Boc-NHCH2-Ph-Py-NH2 | 3040121-14-7 | Reference compound |
| HY-161497 | Thalidomide-benzylamine-Py-NH2 | Reference compound | |
| HY-161498 | XYD198 | Reference compound | |
| HY-161499 | Boc-NHCH2-Ph-pyrimidine-NH2 | 3040121-15-8 | Reference compound |
| HY-161500 | Thalidomide-NHCH2-Ph-pyrimidine-NH2 | Reference compound | |
| HY-161501 | 3-Fluoro-evodiamine glucose | Reference compound | |
| HY-161502 | DHX-SP | Dye Reagents | |
| HY-161503 | PPO-IN-10 | 3034607-58-1 | Reference compound |
| HY-161504 | SDH-IN-14 | Reference compound | |
| HY-161505 | Transthyretin-IN-3 | 3008535-20-1 | Reference compound |
| HY-161506 | PDE1-IN-7 | 3027833-49-1 | Reference compound |
| HY-161507 | hCAI/II-IN-8 | 3036136-18-9 | Reference compound |
| HY-161508 | AChE/BChE-IN-19 | 3036136-22-5 | Reference compound |
| HY-161509 | PT-88 | 2803307-04-0 | Reference compound |
| HY-161511 | LPH-5 | 2641630-97-7 | Reference compound |
| HY-161512 | hAChE/hBACE-1-IN-4 | 229476-71-5 | Reference compound |
| HY-161513 | iNOS/COX-2-IN-1 | Reference compound | |
| HY-161514 | Xanthine oxidase-IN-15 | 2982794-86-3 | Reference compound |
| HY-161515 | BRD4/NAMPT-IN-1 | 3049218-28-9 | Reference compound |
| HY-161516 | HDAC6-IN-42 | Reference compound | |
| HY-161517 | PARP1-IN-20 | 2659357-95-4 | Reference compound |
| HY-161518 | PD-1/PD-L1-IN-44 | 3043669-06-0 | Reference compound |
| HY-161519 | PKM2 activator 7 | Reference compound | |
| HY-16152 | Crilvastatin | 120551-59-9 | Reference compound |
| HY-161520 | Glucocorticoid receptor/NF-κB modulator-1 | Reference compound | |
| HY-161521 | PLK1-IN-10 | 2991469-21-5 | Reference compound |
| HY-161522 | α-Glucosidase-IN-63 | 2375866-82-1 | Reference compound |
| HY-161523 | XOR/URAT1-IN-1 | 2810137-86-9 | Reference compound |
| HY-161524 | HDAC6-IN-43 | 3037978-19-8 | Reference compound |
| HY-161525 | 1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid linker/BSA | Biochemical Assay Reagents | |
| HY-161526 | T3/KLH | Biochemical Assay Reagents | |
| HY-161527 | 1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid-OVA | Biochemical Assay Reagents | |
| HY-161528 | T3/OVA | Biochemical Assay Reagents | |
| HY-161529 | Angiotensin I/BSA | Biochemical Assay Reagents | |
| HY-161530 | Angiotensin II/BSA | Biochemical Assay Reagents | |
| HY-161531 | Diethylstilbestrol/BSA | Biochemical Assay Reagents | |
| HY-161532 | Eugenol/OVA | Biochemical Assay Reagents | |
| HY-161533 | Digoxin/BSA | Biochemical Assay Reagents | |
| HY-161534 | Sulfadiazine/BSA | Biochemical Assay Reagents | |
| HY-161535 | Oxytetracycline/BSA | Biochemical Assay Reagents | |
| HY-161536 | PROTAC EGFR degrader 9 | 2992670-33-2 | Reference compound |
| HY-161537 | EGFR ligand-9 | 2992670-44-5 | Reference compound |
| HY-161538 | Lenalidomide-C6-Br | 2580970-60-9 | Reference compound |
| HY-161539 | KOR agonist 1 | Reference compound | |
| HY-161540 | Oxytetracycline/OVA | Biochemical Assay Reagents | |
| HY-161541 | Estradiol/BSA | Biochemical Assay Reagents | |
| HY-161542 | Isoniazid/BSA | Biochemical Assay Reagents | |
| HY-161543 | DHT/KLH | Biochemical Assay Reagents | |
| HY-161544 | Cholyglycine/BSA | Biochemical Assay Reagents | |
| HY-161545 | Sudan I/BSA | Biochemical Assay Reagents | |
| HY-161546 | Melamine/KLH | Biochemical Assay Reagents | |
| HY-161547 | Tetracycline/BSA | Biochemical Assay Reagents | |
| HY-161548 | Metronidazole/KLH | Biochemical Assay Reagents | |
| HY-161549 | Phosphotyrosine/BSA | Biochemical Assay Reagents | |
| HY-161551 | 25-OH Vitamin D3/KLH | Biochemical Assay Reagents | |
| HY-161552 | T3/BSA | Biochemical Assay Reagents | |
| HY-161553 | Biotin/KLH | Biochemical Assay Reagents | |
| HY-161554 | Clenbuterol/BSA | Biochemical Assay Reagents | |
| HY-161555 | Clenbuterol/KLH | Biochemical Assay Reagents | |
| HY-161556 | Alginic acid/KLH | Biochemical Assay Reagents | |
| HY-161557 | Ractopamine/BSA | Biochemical Assay Reagents | |
| HY-161558 | Ractopamine/KLH | Biochemical Assay Reagents | |
| HY-161559 | Sudan I/OVA | Biochemical Assay Reagents | |
| HY-161560 | Tacrolimus/BSA | Biochemical Assay Reagents | |
| HY-161561 | PROMETON/OVA | Biochemical Assay Reagents | |
| HY-161562 | PROMETON/BSA | Biochemical Assay Reagents | |
| HY-161563 | 4,4'-Sulfonyldiphenol/BSA | Biochemical Assay Reagents | |
| HY-161564 | T4/OVA | Biochemical Assay Reagents | |
| HY-161565 | Gastrin(1-17)/BSA | Biochemical Assay Reagents | |
| HY-161566 | DHT/BSA | Biochemical Assay Reagents | |
| HY-161567 | OX2R-IN-3 | 2791360-37-5 | Reference compound |
| HY-161568 | TEAD-IN-10 | 3032196-65-6 | Reference compound |
| HY-161569 | TEAD-IN-11 | 3032196-88-3 | Reference compound |
| HY-161570 | LRRK2-IN-12 | 3032733-05-1 | Reference compound |
| HY-161571 | LRRK2-IN-13 | 3032733-17-5 | Reference compound |
| HY-161572 | Nav1.8-IN-13 | 2785391-79-7 | Reference compound |
| HY-161573 | BAY-593 | 2413020-56-9 | Reference compound |
| HY-161573A | (7S)-BAY-593 | 2413068-25-2 | Reference compound |
| HY-161573B | BAY-593 (hydrochloride) | 2413020-57-0 | Reference compound |
| HY-161574 | LLC0424 | Reference compound | |
| HY-161575 | NSD2 ligand 1 | Reference compound | |
| HY-161576 | Thalidomide-Pip-N-boc | 2636798-54-2 | Reference compound |
| HY-161577 | BFC1103 | 701231-39-2 | Reference compound |
| HY-161578 | Dithio-CN03 | Reference compound | |
| HY-16158 | Cyclacillin | 3485-14-1 | Reference compound |
| HY-161580 | 3-Nitrotyrosine/BSA | Biochemical Assay Reagents | |
| HY-161581 | Metronidazole/OVA | Biochemical Assay Reagents | |
| HY-161583 | Marijuana/BSA | Biochemical Assay Reagents | |
| HY-161584 | Sudan I/KLH | Biochemical Assay Reagents | |
| HY-161585 | Diethylstilbestrol/KLH | Biochemical Assay Reagents | |
| HY-161586 | Chloramphenicol/BSA | Biochemical Assay Reagents | |
| HY-161587 | Chloramphenicol/OVA | Biochemical Assay Reagents | |
| HY-161588 | GABA/BSA | Biochemical Assay Reagents | |
| HY-161589 | GABA/KLH | Biochemical Assay Reagents | |
| HY-16158R | Cyclacillin (Standard) | 3485-14-1 | Reference Standards |
| HY-161590 | AHD/BSA | Biochemical Assay Reagents | |
| HY-161591 | SEM/BSA | Biochemical Assay Reagents | |
| HY-161594 | Furazolidone/BSA | Biochemical Assay Reagents | |
| HY-161595 | CDK5-IN-4 | 1212711-91-5 | Reference compound |
| HY-161596 | SmCB1-IN-1 | Reference compound | |
| HY-161597 | PROTAC DYRK2 degrader 1 | Reference compound | |
| HY-161598 | DYRK2 ligand 1 | Reference compound | |
| HY-16160 | Cysmethynil | 851636-83-4 | Reference compound |
| HY-161601 | Ferroptosis inducer-2 | 28657-88-7 | Reference compound |
| HY-161602 | EGFR/HER2-IN-13 | 3034701-46-4 | Reference compound |
| HY-161603 | EGFR/HER2-IN-14 | 3034701-54-4 | Reference compound |
| HY-161604 | HBV/HDV-IN-1 | 3034161-55-9 | Reference compound |
| HY-161605 | HBV/HDV-IN-2 | 3034161-76-4 | Reference compound |
| HY-161606 | PARP-1/2/7-IN-1 | 3034665-49-8 | Reference compound |
| HY-161607 | PARP7-IN-21 | 3034666-02-6 | Reference compound |
| HY-161608 | Myosin modulator 1 | 3034189-56-2 | Reference compound |
| HY-161609 | Myosin modulator 2 | 3034189-87-9 | Reference compound |
| HY-161610 | FGFR4-IN-21 | Reference compound | |
| HY-161611 | Plant 14-3-3-IN-1 | Reference compound | |
| HY-161612 | Mycosporine 2 glycine | 149092-45-5 | Reference compound |
| HY-161613 | 7-Bromoheptanoyl chloride | 50733-91-0 | Reference compound |
| HY-161614 | Tubulin inhibitor 44 | 3025180-36-0 | Reference compound |
| HY-161615 | PROTAC ATR degrader-2 | 3010273-12-5 | Reference compound |
| HY-161616 | ATR-IN-30 | 3010273-13-6 | Reference compound |
| HY-161617 | LASSBio-2052 | 2549160-15-6 | Reference compound |
| HY-161618 | MJ04 | 2099014-23-8 | Reference compound |
| HY-161619 | RMC-113 | 2258606-34-5 | Reference compound |
| HY-16162 | D-3263 | 947257-66-1 | Reference compound |
| HY-161620 | DW18134 | 2626988-87-0 | Reference compound |
| HY-161621 | JAK-IN-37 | Reference compound | |
| HY-161622 | K1586 | Reference compound | |
| HY-161623 | ERCC1/XPA interaction inhibitor 1 | Reference compound | |
| HY-161624 | Kv7.2 modulator 1 | 3034884-49-3 | Reference compound |
| HY-161625 | Kv7.2 modulator 2 | 2950243-05-5 | Reference compound |
| HY-161626 | PSMA binder-3 | 3049900-51-5 | Reference compound |
| HY-161627 | Anemoside A3-methyl 6-aminohexanoate | 2919975-48-5 | Reference compound |
| HY-161628 | Tapcin | Reference compound | |
| HY-161629 | TLR8 agonist 7 | 3034750-26-7 | Reference compound |
| HY-16162A | D-3263 (hydrochloride) | 1008763-54-9 | Reference compound |
| HY-161630 | TLR8 agonist 8 | 3034750-58-5 | Reference compound |
| HY-161631 | TLR8 agonist 9 | 3034750-61-0 | Reference compound |
| HY-161632 | PROTAC EGFR degrader 10 | 3034244-56-6 | Reference compound |
| HY-161633 | PROTAC EGFR degrader 11 | 3034244-71-5 | Reference compound |
| HY-161634 | PROTAC SOS1 degrader-8 | 3036155-11-7 | Reference compound |
| HY-161635 | SOS1 Ligand intermediate-4 | 3036155-94-6 | Reference compound |
| HY-161636 | PROTAC SOS1 degrader-9 | 3036155-21-9 | Reference compound |
| HY-161637 | E3 ligase Ligand 25 | 2633633-39-1 | Reference compound |
| HY-161638 | E3 Ligase Ligand-linker Conjugate 108 | 2911613-56-2 | Reference compound |
| HY-161639 | E3 ligase Ligand 26 | 2911613-35-7 | Reference compound |
| HY-161640 | E3 Ligase Ligand-linker Conjugate 109 | 2911613-55-1 | Reference compound |
| HY-161641 | Tubulin polymerization-IN-62 | Reference compound | |
| HY-161642 | DENV-2/ZIKV-IN-1 | Reference compound | |
| HY-161643 | S21-1011 | 2671859-87-1 | Reference compound |
| HY-161644 | STAT3-IN-27 | Reference compound | |
| HY-161645 | P-gp modulator-4 | Reference compound | |
| HY-161646 | P-selectin antagonist 1 | 2099111-75-6 | Reference compound |
| HY-161647 | Antitumor agent-156 | Reference compound | |
| HY-161648 | Anticancer agent 222 | Reference compound | |
| HY-161649 | hCYP1B1-IN-2 | 3043683-33-3 | Reference compound |
| HY-161650 | PROTAC BRD4 Degrader-26 | 3050769-37-1 | Reference compound |
| HY-161651 | BRD4 ligand 6 | 1101702-80-0 | Reference compound |
| HY-161651A | BRD4 ligand 6 (TFA) | 2763548-61-2 | Reference compound |
| HY-161652 | Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione | Reference compound | |
| HY-161653 | Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione | 3050769-33-7 | Reference compound |
| HY-161654 | PROTAC SOS1 degrader-10 | 3043923-74-3 | Reference compound |
| HY-161655 | SOS1 Ligand intermediate-5 | 3043923-70-9 | Reference compound |
| HY-161656 | PIP-C-3-Azaspiro[5.5]undecane-boc | 3027978-51-1 | Reference compound |
| HY-161657 | 2-Methoxyphenyl dihydrouracil-azaspiro[5.5]undecane-C-PIP | Reference compound | |
| HY-161658 | Aβ-IN-9 | Reference compound | |
| HY-161659 | Apoptosis inducer 19 | 3049296-75-2 | Reference compound |
| HY-16166 | Dalvastatin | 132100-55-1 | Reference compound |
| HY-161660 | DS44470011 | 1192586-35-8 | Reference compound |
| HY-161661 | Anticancer agent 223 | 1328150-75-9 | Reference compound |
| HY-161662 | ALK5-IN-80 | 3039952-63-8 | Reference compound |
| HY-161663 | Phosphodiesterase-IN-2 | 3047610-96-5 | Reference compound |
| HY-161664 | ZINC866533340 | Reference compound | |
| HY-161665 | BDZ-P7 | Reference compound | |
| HY-161666 | mCMY416 | Reference compound | |
| HY-161667 | GSK-3β/HDAC-IN-1 | Reference compound | |
| HY-161668 | Ru-Poma | Reference compound | |
| HY-161669 | NLRP3-IN-40 | Reference compound | |
| HY-161670 | NSD2-PWWP1 ligand 1 | Reference compound | |
| HY-161671 | GAT2711 | Reference compound | |
| HY-161672 | G-5758 | 2413455-99-7 | Reference compound |
| HY-161673 | CDC14A/B-IN-1 | 3048655-03-1 | Reference compound |
| HY-161674 | Monoamine Oxidase B inhibitor 4 | 424794-91-2 | Reference compound |
| HY-161675 | Lenalidomide-5-bromopentanamide | 2545963-24-2 | Reference compound |
| HY-161676 | DOTA-RBB-Ga | Reference compound | |
| HY-161677 | PD-L1/CD-73-IN-1 | 3048634-84-7 | Reference compound |
| HY-161679S | Pyruvate Carboxylase-IN-3 | Isotope-Labeled Compounds | |
| HY-16168 | Degarelix (acetate) | 934016-19-0 | Reference compound |
| HY-161680 | Pyruvate Carboxylase-IN-4 | 2369048-06-4 | Reference compound |
| HY-161681 | Formycin triphosphate | 16409-13-5 | Reference compound |
| HY-161682 | GPR84 antagonist 9 | 2654791-96-3 | Reference compound |
| HY-161683 | Tyk2-IN-19 | 2866415-98-5 | Reference compound |
| HY-161684 | JAK2-IN-10 | 3035735-18-0 | Isotope-Labeled Compounds |
| HY-161685 | Antibiofilm agent-8 | Reference compound | |
| HY-161686 | Carbonic anhydrase inhibitor 24 | Reference compound | |
| HY-161687 | Cisplatin/Dasatinib prodrug-1 | 3049801-09-1 | Reference compound |
| HY-161688 | HDAC-IN-73 | 2323571-16-8 | Reference compound |
| HY-161689 | Antibacterial agent 220 | Reference compound | |
| HY-16168A | Degarelix | 214766-78-6 | Reference compound |
| HY-16168AR | Degarelix (Standard) | 214766-78-6 | Reference Standards |
| HY-16168AS | Degarelix-d7 | Isotope-Labeled Compounds | |
| HY-16168B | Degarelix (acetate hydrate) | 934246-14-7 | Reference compound |
| HY-161690 | EF-4-177 | 2891574-93-7 | Reference compound |
| HY-161691 | EBOV-IN-9 | Reference compound | |
| HY-161692 | ERα degrader 8 | 2971837-95-1 | Reference compound |
| HY-161693 | Telomeric G4s ligand 1 | 3047091-81-3 | Reference compound |
| HY-161694 | DNMT1-IN-3 | 3025012-68-1 | Reference compound |
| HY-161695 | Angiogenesis inhibitor 6 | 2752466-36-5 | Reference compound |
| HY-161696 | AN5777 | 491586-42-6 | Reference compound |
| HY-161697 | hCAIX-IN-20 | 3047054-26-9 | Reference compound |
| HY-161699 | SDTWS01 | Reference compound | |
| HY-16170 | Desvenlafaxine (succinate) | 448904-47-0 | Reference compound |
| HY-161700 | BMS-737 | 1356053-63-8 | Reference compound |
| HY-161701 | (3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol | 1393651-00-7 | Reference compound |
| HY-161702 | RO6806051 | 1433901-75-7 | Reference compound |
| HY-161703 | 2-Hydroxy-3′-O-methyladenosine | 157309-10-9 | Reference compound |
| HY-161704 | AKT-IN-23 | 1226801-23-5 | Reference compound |
| HY-161705 | Anti-apoptotic agent 1 | 2563616-64-6 | Reference compound |
| HY-161706 | c-Fms-IN-15 | 3047930-25-3 | Reference compound |
| HY-161707 | MMP2-IN-4 | 92535-43-8 | Reference compound |
| HY-161708 | PROTAC FLT3/CDKs degrader-1 | Reference compound | |
| HY-161709 | FLT3/CDKs ligand-1 | 2452019-67-7 | Reference compound |
| HY-16171 | Diphenmanil (methylsulfate) | 62-97-5 | Reference compound |
| HY-161710 | XYD129 | Reference compound | |
| HY-161711 | CBP/p300 ligand 5 | Reference compound | |
| HY-161712 | Nampt-IN-12 | 2427862-70-0 | Reference compound |
| HY-161713 | PD-1/PD-L1-IN-45 | Reference compound | |
| HY-161714 | HH0043 | 2922069-42-7 | Reference compound |
| HY-161715 | LH708 | 1616757-93-7 | Reference compound |
| HY-161716 | LH1753 | 2650492-10-5 | Reference compound |
| HY-161717 | MRS5663 | 1377272-66-6 | Reference compound |
| HY-161718 | MRS8028 | 1784714-67-5 | Reference compound |
| HY-161719 | NF764 | Reference compound | |
| HY-16171R | Diphenmanil (methylsulfate) (Standard) | 62-97-5 | Reference Standards |
| HY-16172 | DMAPT | 791595-09-0 | Reference compound |
| HY-161721 | Cathepsin Inhibitor 4 | Reference compound | |
| HY-161722 | SARS-CoV-2 Mpro-IN-21 | 3041099-79-7 | Reference compound |
| HY-161723 | LH2-051 | 2358754-22-8 | Reference compound |
| HY-161724 | TFEB activator 2 | 3027414-04-3 | Reference compound |
| HY-161725 | TFEB activator 3 | 3027413-48-2 | Reference compound |
| HY-161726 | TLR7 agonist 23 | 2408268-38-0 | Reference compound |
| HY-161727 | P2Y14R antagonist 1 | 2728291-29-8 | Reference compound |
| HY-161728 | Antibacterial agent 223 | 833432-18-1 | Reference compound |
| HY-161729 | PLpro-IN-3 | 3047093-72-8 | Reference compound |
| HY-16172A | (S)-DMAPT | 870677-05-7 | Reference compound |
| HY-161730 | αvβ1 integrin-IN-3 | Reference compound | |
| HY-161731 | DS08701581 | Reference compound | |
| HY-161732 | GQN-B37-E | 2982663-28-3 | Reference compound |
| HY-161733 | GQN-B37-Me | Reference compound | |
| HY-161734 | Microtubule inhibitor 11 | Reference compound | |
| HY-161735 | CXCR4-IN-3 | Reference compound | |
| HY-161736 | ARN25499 | Reference compound | |
| HY-161737 | YT-8-8 | 892572-23-5 | Reference compound |
| HY-161738 | YOK-2204 | 2409959-99-3 | Reference compound |
| HY-161739 | YOK-1304 | 2409960-03-6 | Reference compound |
| HY-161740 | PHTPP-1304 | 2410081-60-4 | Reference compound |
| HY-161741 | VinclozolinM2-2204 | Reference compound | |
| HY-161742 | Fumagilin-105 | 2410081-58-0 | Reference compound |
| HY-161743 | PBA-1105 | 2410081-56-8 | Reference compound |
| HY-161743A | PBA-1105 (TFA) | Reference compound | |
| HY-161744 | PBA-1106 | 2410081-55-7 | Reference compound |
| HY-161745 | PBA-1105b | 2941386-60-1 | Reference compound |
| HY-161746 | Anle138b-F105 | 2941386-44-1 | Reference compound |
| HY-161747 | Tubulin inhibitor 46 | Reference compound | |
| HY-161748 | PD-1/PD-L1-IN-46 | Reference compound | |
| HY-161749 | PROTAC ALK degrader-1 | 3049802-45-8 | Reference compound |
| HY-161750 | PROTAC ALK degrader-2 | Reference compound | |
| HY-161751 | MJ34 | 2099015-13-9 | Reference compound |
| HY-161752 | Antibacterial agent 224 | Reference compound | |
| HY-161753 | CFTR potentiator 1 | Reference compound | |
| HY-161755 | Anticancer agent 232 | Reference compound | |
| HY-161756 | DNA Gyrase-IN-10 | Reference compound | |
| HY-161757 | Anti-inflammatory agent 86 | Reference compound | |
| HY-161758 | F0045(S) | 2716077-17-5 | Reference compound |
| HY-161759 | MS152 | Reference compound | |
| HY-161760 | Ferroptosis inducer-3 | Reference compound | |
| HY-161761 | Urease-IN-15 | Reference compound | |
| HY-161762 | RA-0002034 | 3038542-51-4 | Reference compound |
| HY-161762A | (E/Z)-RA-0002034 | 2305572-22-7 | Reference compound |
| HY-161763 | Tubulin polymerization-IN-65 | Reference compound | |
| HY-161764 | α-Glucosidase-IN-67 | Reference compound | |
| HY-161765 | iHSP110-33 | Reference compound | |
| HY-161766 | L687 | 2776151-36-9 | Reference compound |
| HY-161767 | JWJ-01-306 | Reference compound | |
| HY-161768 | VCC972839:01 | Reference compound | |
| HY-161769 | HL435 | Reference compound | |
| HY-161770 | HL389 | Reference compound | |
| HY-161771 | JNJ-7184 | 2347368-51-6 | Reference compound |
| HY-161772 | (S)-Gebr32a | 3055162-32-5 | Reference compound |
| HY-161773 | HL389-NHC2-PEG3-C2NH | Reference compound | |
| HY-161774 | ST80 | Reference compound | |
| HY-161775 | RET/TRKA-IN-1 | 3048634-52-9 | Reference compound |
| HY-161776 | P-gp/CDK2-IN-1 | Reference compound | |
| HY-161777 | SARS-CoV-2 Mpro-IN-23 | Reference compound | |
| HY-161778 | ZG-126 | 3049802-32-3 | Reference compound |
| HY-161779 | PLX-3618 | 2851986-76-8 | Reference compound |
| HY-161780 | Maleimide-PEG8-Val-Ala-PAB-SNS032 | ADC Related | |
| HY-161781 | HVH-2930 | 3034605-72-3 | Reference compound |
| HY-161782 | α-Amylase-IN-7 | 3049575-16-5 | Reference compound |
| HY-161783 | HDAC6-IN-45 | 3048532-05-1 | Reference compound |
| HY-161784 | GABAA receptor modulator-5 | 3021554-08-2 | Reference compound |
| HY-161785 | EGFR-IN-117 | 3035639-05-2 | Reference compound |
| HY-161786 | Bcl-2-IN-20 | Reference compound | |
| HY-161787 | G9a-IN-2 | 2648853-26-1 | Reference compound |
| HY-161788 | DNA Gyrase-IN-11 | 2497486-58-3 | Reference compound |
| HY-161789 | PROTAC SARS-CoV-2 Mpro degrader-3 | Reference compound | |
| HY-161790 | Mpro ligand 1 | Reference compound | |
| HY-161791 | Mpro ligand 2 | 2816967-14-1 | Reference compound |
| HY-161792 | N3-C5-O-C-Boc | 2836521-02-7 | Reference compound |
| HY-161793 | (S,R,S)-AHPC-NHCO-C-O-C5-N3 | 2816967-28-7 | Reference compound |
| HY-161794 | SP3N | Reference compound | |
| HY-161794A | SP3N (hydrochloride) | Reference compound | |
| HY-161795 | SP3CHO | Reference compound | |
| HY-161796 | UNC8732 | 2929304-05-0 | Reference compound |
| HY-161796A | UNC8732 (TFA) | 2929304-06-1 | Reference compound |
| HY-161797 | Antibacterial agent 227 | 301304-67-6 | Reference compound |
| HY-161798 | Orpinolide | Reference compound | |
| HY-161800 | Aminoacyl tRNA synthetase-IN-3 | Reference compound | |
| HY-161801 | MMV006833 | 701253-55-6 | Reference compound |
| HY-161802 | Antibacterial agent 228 | Reference compound | |
| HY-161803 | Anti-MRSA agent 12 | 2314380-76-0 | Reference compound |
| HY-161804 | GNF-2-deg | Reference compound | |
| HY-161805 | GNF-2-acid | 714962-05-7 | Reference compound |
| HY-161806 | ZXH-8-004 | Reference compound | |
| HY-161807 | DENV ligand 1 | 1628758-48-4 | Reference compound |
| HY-161808 | DENV ligand 2 | Reference compound | |
| HY-161810 | MRS8247 | 2991693-72-0 | Reference compound |
| HY-161811 | FEACYP | Reference compound | |
| HY-161812 | MOR agonist-4 | 3050669-97-8 | Reference compound |
| HY-161813 | Antibacterial agent 229 | 3049500-54-8 | Reference compound |
| HY-161814 | Apoptosis inducer 20 | Reference compound | |
| HY-161815 | Anti-inflammatory agent 89 | Reference compound | |
| HY-161816 | PI3K/AKT-IN-3 | 2488891-30-9 | Reference compound |
| HY-161817 | TGR5 agonist 5 | Reference compound | |
| HY-161818 | LLW-018 | 3049369-11-8 | Reference compound |
| HY-161819 | TRK-IN-29 | Reference compound | |
| HY-16182 | Ecamsule | 92761-26-7 | Reference compound |
| HY-161820 | IAV-IN-3 | 3049492-11-4 | Reference compound |
| HY-161821 | Antitumor agent-173 | Reference compound | |
| HY-161822 | Antibacterial agent 230 | 3049368-26-2 | Reference compound |
| HY-161823 | Anti-MRSA agent 13 | Reference compound | |
| HY-161824 | Antiproliferative agent-52 | 2913194-20-2 | Reference compound |
| HY-161825 | Tubulin polymerization-IN-66 | Reference compound | |
| HY-161826 | Antitumor agent-174 | Reference compound | |
| HY-161827 | Anti-MRSA agent 14 | 3050586-22-3 | Reference compound |
| HY-161828 | JWZ-5-13 | Reference compound | |
| HY-161829 | CDK7 ligand 1 | Reference compound | |
| HY-16182A | Ecamsule (disodium) | 90458-75-6 | Reference compound |
| HY-16182R | Ecamsule (Standard) | 92761-26-7 | Reference Standards |
| HY-16183 | Echothiopate iodide | 513-10-0 | Reference compound |
| HY-161830 | CDK7 ligand 2 | 2603381-71-9 | Reference compound |
| HY-161831 | Antitumor agent-175 | Reference compound | |
| HY-161832 | (S,R,S)-Me-AHPC-amide-C3-alkyne | 3016512-69-6 | Reference compound |
| HY-161833 | HSP90-IN-31 | 2117645-10-8 | Reference compound |
| HY-161834 | RG100204 | 2140901-88-6 | Reference compound |
| HY-161835 | SR140333B | 155418-06-7 | Reference compound |
| HY-161836 | α2AR agonist 1 | Reference compound | |
| HY-161837 | SARS-CoV-2 Mpro-IN-24 | Reference compound | |
| HY-161838 | ICT10336 | Reference compound | |
| HY-161839 | AKR1C2/3-IN-1 | Reference compound | |
| HY-16183A | Echothiopate (chloride) | 120087-68-5 | Reference compound |
| HY-161840 | Antitumor agent-176 | Reference compound | |
| HY-161841 | Antitumor agent-177 | Reference compound | |
| HY-161842 | AChE-IN-67 | Reference compound | |
| HY-161843 | Necroptosis-IN-4 | Reference compound | |
| HY-161844 | Virapinib | 1794091-10-3 | Reference compound |
| HY-161845 | Anticancer agent 240 | 3039831-27-8 | Reference compound |
| HY-161846 | Tyrosinase-IN-31 | 903206-81-5 | Reference compound |
| HY-161847 | HZ1 | 3030492-40-8 | Reference compound |
| HY-161848 | TCP-MP-CA | Reference compound | |
| HY-161849 | LSD1-IN-31 | Reference compound | |
| HY-161850 | ULK1-IN-3 | Reference compound | |
| HY-161851 | MDL3 | Reference compound | |
| HY-161852 | PI3K-IN-55 | Reference compound | |
| HY-161853 | TX-2552 | 2446767-14-0 | Reference compound |
| HY-161854 | LASSBio-1911 | Reference compound | |
| HY-161855 | VEGFR-2-IN-50 | Reference compound | |
| HY-161856 | Antifungal agent 106 | Reference compound | |
| HY-161857 | Akt/mTOR-IN-1 | Reference compound | |
| HY-161858 | EpskA21 | Reference compound | |
| HY-161859 | VEGFR-2/STAT-3-IN-1 | Reference compound | |
| HY-161860 | Antibacterial agent 233 | Reference compound | |
| HY-161861 | VEGFR-2/AKT-IN-1 | Reference compound | |
| HY-161862 | COX-2-IN-44 | Reference compound | |
| HY-161863 | Tubulin polymerization-IN-67 | Reference compound | |
| HY-161864 | STAT3-IN-29 | 2256751-16-1 | Reference compound |
| HY-161865 | Antitumor agent-180 | Reference compound | |
| HY-161866 | EGFR-IN-118 | Reference compound | |
| HY-161867 | Platelet aggregation-IN-1 | Reference compound | |
| HY-161868 | DLC-50 | 2928537-98-6 | Reference compound |
| HY-161869 | LSD1-IN-32 | Reference compound | |
| HY-16187 | EL-102 | 1233948-61-2 | Reference compound |
| HY-161870 | Antibiotic adjuvant 1 | 2351883-15-1 | Reference compound |
| HY-161871 | WEE1-IN-8 | 2493422-74-3 | Reference compound |
| HY-161872 | LC3in-C42 | Reference compound | |
| HY-161873 | PW507 | 2573850-59-4 | Reference compound |
| HY-161874 | RPS6-IN-1 | Reference compound | |
| HY-161875 | NAT1-IN-1 | Reference compound | |
| HY-161876 | GSTO1-IN-2 | 3020776-77-3 | Reference compound |
| HY-161877 | GS-7682 | 2694736-39-3 | Reference compound |
| HY-161878 | USP1-IN-10 | 2857051-98-8 | Reference compound |
| HY-161879 | WEE1-IN-9 | 2510782-14-4 | Reference compound |
| HY-161880 | WEE1-IN-10 | 2226938-19-6 | Reference compound |
| HY-161881 | SMARCA2-IN-9 | Reference compound | |
| HY-161882 | PROTAC SMARCA2 degrader-8 | 2669027-50-1 | Reference compound |
| HY-161883 | JP-2-249 | 3036530-41-0 | Reference compound |
| HY-161884 | SMARCA2/4-IN-1 | 76947-79-0 | Reference compound |
| HY-161885 | SMARCA2-IN-6 | 2270875-79-9 | Reference compound |
| HY-161886 | SMARCA2-IN-7 | 2270879-43-9 | Reference compound |
| HY-161887 | SMARCA2-IN-8 | 2270875-93-7 | Reference compound |
| HY-161888 | DCSM06 | 924855-67-4 | Reference compound |
| HY-161889 | DCSM06-05 | 880811-10-9 | Reference compound |
| HY-16189 | Elliptinium (acetate) | 58337-35-2 | Reference compound |
| HY-161890 | Antimycobacterial agent-8 | Reference compound | |
| HY-161891 | EGFR/Akt-IN-1 | Reference compound | |
| HY-161892 | FABP4-IN-4 | Reference compound | |
| HY-161893 | Anti-MRSA agent 15 | Reference compound | |
| HY-161894 | CFTR corrector 13 | Reference compound | |
| HY-161895 | CFTR corrector 14 | Reference compound | |
| HY-161896 | Transcription factor-IN-1 | Reference compound | |
| HY-161897 | CENP-E-IN-2 | Reference compound | |
| HY-161898 | CENP-E-IN-3 | Reference compound | |
| HY-161899 | MCHR1 antagonist 4 | 1574538-43-4 | Reference compound |
| HY-161900 | Apoptosis inducer 22 | Reference compound | |
| HY-161901 | BC-1293 | 1219395-86-4 | Reference compound |
| HY-161902 | MI-1904 | 3033379-90-4 | Reference compound |
| HY-161903 | Progranulin modulator-3 | 371116-39-1 | Reference compound |
| HY-161904 | CDYL-IN-1 | 2378625-66-0 | Reference compound |
| HY-161905 | ML471 | 2226227-77-4 | Reference compound |
| HY-161906 | SD-066-4 | 64640-77-3 | Reference compound |
| HY-161907 | h15-LOX-2 inhibitor 2 | Reference compound | |
| HY-161908 | h15-LOX-2 inhibitor 3 | 1164515-84-7 | Reference compound |
| HY-161909 | USP30-I-1 | 2511541-78-7 | Reference compound |
| HY-16191 | ELR510444 | 1233948-35-0 | Reference compound |
| HY-161910 | SH-E4A-66 | Reference compound | |
| HY-161911 | Necroptosis-IN-5 | Reference compound | |
| HY-161912 | 5TTU | Reference compound | |
| HY-161913 | AC-4-248 | Reference compound | |
| HY-161914 | P2X3 antagonist 39 | Reference compound | |
| HY-161915 | GLP-1R agonist 23 | 2855245-46-2 | Reference compound |
| HY-161916 | Polθ-IN-4 | 3043810-73-4 | Reference compound |
| HY-161917 | HPK1-IN-49 | 2845144-97-8 | Reference compound |
| HY-161918 | SARM1-IN-3 | 3046146-15-7 | Reference compound |
| HY-161919 | SARS-CoV-2 3CLpro-IN-25 | Reference compound | |
| HY-161920 | SIRT3-IN-1 | Reference compound | |
| HY-161921 | Antifungal agent 108 | Reference compound | |
| HY-161922 | Antibacterial agent 235 | Reference compound | |
| HY-161923 | EGFR-IN-120 | Reference compound | |
| HY-161924 | HIV-1 inhibitor-73 | Reference compound | |
| HY-161925 | sTGFBR3 antagonist 1 | Reference compound | |
| HY-161926 | YGT-31 | 2835447-74-8 | Reference compound |
| HY-161927 | EGFR-TK-IN-4 | 3053485-72-3 | Reference compound |
| HY-161928 | GPX4 activator 1 | 1030098-18-0 | Reference compound |
| HY-161929 | GPX4 activator 2 | 950365-31-8 | Reference compound |
| HY-161930 | PROTAC GPX4 degrader-3 | Reference compound | |
| HY-161931 | Demethyl-RSL3-boc | 2375354-07-5 | Reference compound |
| HY-161933 | 1-Adamantane-amide-C7-NH2 | 2860813-92-7 | Reference compound |
| HY-161934 | PARP1-IN-27 | Reference compound | |
| HY-161935 | 6-(12-Tridecene-1-yl)-2,4-Dihydroxy benzoic acid | Reference compound | |
| HY-161936 | Z21115 | 2958668-54-5 | Reference compound |
| HY-161937 | Antibacterial agent 236 | 2364479-10-5 | Reference compound |
| HY-161938 | BRD8518 | 1565828-01-4 | Reference compound |
| HY-161939 | 7030B-C5 | 370871-42-4 | Reference compound |
| HY-16194 | Emiglitate | 80879-63-6 | Reference compound |
| HY-161940 | PCSK9-IN-30 | Reference compound | |
| HY-161941 | MeIm | 2043947-71-1 | Reference compound |
| HY-161942 | PCSK9-IN-31 | 2247649-76-7 | Reference compound |
| HY-161943 | NEU3-IN-1 | Reference compound | |
| HY-161944 | α-Amylase-IN-8 | 1503788-07-5 | Reference compound |
| HY-161945 | IN-RNA-IN-2 | Reference compound | |
| HY-161946 | GBM CSCs-IN-1 | Reference compound | |
| HY-161947 | TOFA-Plasmalogen | Reference compound | |
| HY-161948 | Ferroptosis inducer-4 | Reference compound | |
| HY-161949 | AP-6 | 1369963-51-8 | Reference compound |
| HY-161950 | Tyrosinase-IN-33 | 137058-21-0 | Reference compound |
| HY-161951 | PPO-IN-15 | 3029518-71-3 | Reference compound |
| HY-161952 | JAB-3312 | 2245082-05-5 | Reference compound |
| HY-161953 | O-GlcNAcase-IN-2 | Reference compound | |
| HY-161954 | HDAC8-IN-12 | 3028095-13-5 | Reference compound |
| HY-161955 | TMV-IN-11 | 2991481-09-3 | Reference compound |
| HY-161956 | Antiviral agent 59 | Reference compound | |
| HY-161957 | Top1/2-IN-1 | Reference compound | |
| HY-161958 | dCE-2 | Reference compound | |
| HY-161959 | EP300/CBP ligand 1 | Reference compound | |
| HY-16196 | ENMD-1198 | 864668-87-1 | Reference compound |
| HY-161960 | EP300/CBP ligand 2 | Reference compound | |
| HY-161961 | Thalidomide-NH-C10-Boc | 2428400-25-1 | Reference compound |
| HY-161962 | D-Glucoside, octyl | 54549-23-4 | Biochemical Assay Reagents |
| HY-161963 | Arlacel A | 9049-98-3 | Biochemical Assay Reagents |
| HY-161964 | (2-Decyloxy)ethanol | 23238-40-6 | Biochemical Assay Reagents |
| HY-161965 | MK-3168 (12C) | 1242441-26-4 | Reference compound |
| HY-161966 | VEGFR-2-IN-52 | 3046428-94-5 | Reference compound |
| HY-161967 | JAK2/FLT3-IN-3 | 3038183-53-5 | Reference compound |
| HY-161968 | EGFR/PI3Kα-IN-1 | Reference compound | |
| HY-161969 | Tyrosinase-IN-34 | Reference compound | |
| HY-16197 | Epicochlioquinone A | 147384-57-4 | Reference compound |
| HY-161970 | XSJ05 | 1461652-87-8 | Reference compound |
| HY-161971 | Tyrosinase-IN-35 | 1613467-47-2 | Reference compound |
| HY-161972 | ZX782 | Reference compound | |
| HY-161973 | Hydroxyl-ML-210 | Reference compound | |
| HY-161974 | Adamantan-C-amide-PEG2-C-Br | Reference compound | |
| HY-161975 | ROS1-IN-2 | 2120337-16-6 | Reference compound |
| HY-161976 | ACC1-IN-2 | 3027705-67-2 | Reference compound |
| HY-161977 | Cbl-b-IN-26 | 3035443-17-2 | Reference compound |
| HY-161978 | CDK4/6-IN-22 | 3036014-62-4 | Reference compound |
| HY-161979 | HSD17B13-IN-103 | 3035000-89-3 | Reference compound |
| HY-161980 | Topoisomerases/ribosomes-IN-1 | Reference compound | |
| HY-161981 | Antitumor photosensitizer-8 | Reference compound | |
| HY-161982 | JNU-0921 | Reference compound | |
| HY-161983 | Neuraminidase-IN-22 | Reference compound | |
| HY-161984 | HDAC-IN-76 | Reference compound | |
| HY-161985 | PPARγ-IN-3 | Reference compound | |
| HY-161986 | HIV-1 inhibitor-74 | Reference compound | |
| HY-161987 | LpxH-IN-2 | 2923230-41-3 | Reference compound |
| HY-161988 | Antimicrobial agent-34 | Reference compound | |
| HY-161989 | DZ-837 | Reference compound | |
| HY-161990 | BCL6 ligand-2 | Reference compound | |
| HY-161991 | Caspase-3 activator 4 | 1817874-62-6 | Reference compound |
| HY-161992 | Nrf2 activator-11 | Reference compound | |
| HY-161993 | BI-9787 | 3043939-18-7 | Reference compound |
| HY-161994 | COX-2-IN-47 | 2043670-02-4 | Reference compound |
| HY-161995 | FGFR1/VEGFR2-IN-2 | Reference compound | |
| HY-161996 | IDO1-IN-25 | 2841467-86-3 | Reference compound |
| HY-161997 | hTopo-II/tubulin-IN-1 | Reference compound | |
| HY-161998 | Urease-IN-16 | 1203704-26-0 | Reference compound |
| HY-161999 | α-Glucosidase-IN-73 | Reference compound | |
| HY-16200 | Ethynylcytidine | 180300-43-0 | Reference compound |
| HY-162000 | hCAIX/XII-IN-13 | Reference compound | |
| HY-162001 | INX-315 | 2745060-92-6 | Reference compound |
| HY-162002 | WSD0628 | 2765448-96-0 | Reference compound |
| HY-162002A | (S)-WSD0628 | 2765449-10-1 | Reference compound |
| HY-162003 | DCPT1061 | 2289726-31-2 | Reference compound |
| HY-162003A | DCPT1061 (hydrochloride) | Reference compound | |
| HY-162004 | NF-κB-IN-14 | 3019972-01-8 | Reference compound |
| HY-162005 | AChE-IN-48 | Reference compound | |
| HY-162006 | Pim-1 kinase inhibitor 8 | 916038-47-6 | Reference compound |
| HY-162007 | PYRA-2 | Reference compound | |
| HY-162008 | S1g-10 | 3032432-71-3 | Reference compound |
| HY-162009 | CaMKK2-IN-1 | 3032691-65-6 | Reference compound |
| HY-162010 | MAT2A-IN-13 | 2851449-24-4 | Reference compound |
| HY-162011 | GPR183 antagonist-2 | 2924063-98-7 | Reference compound |
| HY-162012 | HC-258 | 3056128-12-9 | Reference compound |
| HY-162013 | NLRP3-IN-26 | 2927413-30-5 | Reference compound |
| HY-162014 | WDR5 degrader-1 | 3032434-45-7 | Reference compound |
| HY-162015 | LTA4H-IN-2 | 2851480-52-7 | Reference compound |
| HY-162016 | IP6K-IN-1 | Reference compound | |
| HY-162020 | SB1617 | Reference compound | |
| HY-162021 | Methotrexate triglutamate | 41600-14-0 | Reference compound |
| HY-162022 | BTA-188 | 314062-80-1 | Reference compound |
| HY-162023 | mTOR inhibitor-10 | 1144075-36-4 | Reference compound |
| HY-162024 | mTOR inhibitor-16 | 1144075-42-2 | Reference compound |
| HY-162025 | mTOR inhibitor-17 | 1144075-40-0 | Reference compound |
| HY-162026 | 11β-HSD1-IN-14 | 946394-50-9 | Reference compound |
| HY-162027 | PB118 | Reference compound | |
| HY-162028 | GaMF1.39 | 2568607-82-7 | Reference compound |
| HY-162029 | Tyrosinase-IN-20 | 1024364-57-5 | Reference compound |
| HY-162030 | MMT3-72 | 2996158-39-3 | Reference compound |
| HY-162031 | MMT3-72-M2 | 936091-74-6 | Reference compound |
| HY-162032 | FLT3-IN-25 | Reference compound | |
| HY-162033 | PAT1inh-A0030 | 1030097-65-4 | Reference compound |
| HY-162034 | FAK-IN-17 | Reference compound | |
| HY-162035 | MDM2-IN-23 | Reference compound | |
| HY-162036 | α-Amylase/α-Glucosidase-IN-7 | 1038094-94-8 | Reference compound |
| HY-162037 | CDDD11-8 | 2241659-94-7 | Reference compound |
| HY-162038 | RXP03 | 284667-65-8 | Reference compound |
| HY-162039 | MMP-11-IN-1 | Reference compound | |
| HY-162040 | P-gp inhibitor 17 | 2556388-58-8 | Reference compound |
| HY-162041 | AQIM-I | 2247881-73-6 | Reference compound |
| HY-162042 | AMPK activator 14 | 1356632-18-2 | Reference compound |
| HY-162043 | CKR-49-17 | Reference compound | |
| HY-162044 | COX-1/2-IN-6 | 327024-84-0 | Reference compound |
| HY-162045 | Ru-4T | Reference compound | |
| HY-162046 | Anticancer agent 178 | Reference compound | |
| HY-162050 | 8AQ−Cu−5Iu | Reference compound | |
| HY-162051 | CYP1B1-IN-6 | 2952712-68-2 | Reference compound |
| HY-162059 | Pim-1 kinase inhibitor 10 | 2918764-57-3 | Reference compound |
| HY-162060 | YPX-C-05 | 2894823-79-9 | Reference compound |
| HY-162061 | ChEs/MAOs-IN-1 | Reference compound | |
| HY-162062 | EGFR WT/T790M/L858R-IN-1 | Reference compound | |
| HY-162063 | hCAIX/XII-IN-9 | Reference compound | |
| HY-162064 | T-1-MBHEPA | Reference compound | |
| HY-162065 | N6F11 | 851398-76-0 | Reference compound |
| HY-162066 | DNDI-6174 | 2868298-43-3 | Reference compound |
| HY-162068 | Auristatin23 | 2375388-36-4 | Reference compound |
| HY-162069 | Antiviral agent 47 | 89419-23-8 | Reference compound |
| HY-16207 | FGH10019 | 1046045-61-7 | Reference compound |
| HY-162070 | CCK antagonist 1 | 742116-45-6 | Reference compound |
| HY-162071 | PKM2-IN-5 | 904457-46-1 | Reference compound |
| HY-162072 | PfThrRS-IN-1 | Reference compound | |
| HY-162073 | ZIKV-IN-8 | 3022924-04-2 | Reference compound |
| HY-162074 | Nipamovir | 2651908-78-8 | Reference compound |
| HY-162075 | RF16 | Reference compound | |
| HY-162076 | AEP-IN-3 | 2978521-26-3 | Reference compound |
| HY-162077 | HIV-IN-10 | 2413866-14-3 | Reference compound |
| HY-162078 | Antiproliferative agent-46 | Reference compound | |
| HY-162079 | Anticancer agent 183 | 3018960-58-9 | Reference compound |
| HY-16208 | Fluorapacin | 869811-23-4 | Reference compound |
| HY-162080 | METTL1-WDR4-IN-1 | 374705-10-9 | Reference compound |
| HY-162081 | BTK-IN-32 | 1015441-29-8 | Reference compound |
| HY-162082 | METTL1-WDR4-IN-2 | 2919742-07-5 | Reference compound |
| HY-162083 | CB2R/5-HT1AR agonist 1 | 2821085-76-9 | Reference compound |
| HY-162084 | BKN-1 | 1607831-82-2 | Reference compound |
| HY-162085 | Axl-IN-17 | 3048409-80-6 | Reference compound |
| HY-162086 | HDAC-IN-68 | Reference compound | |
| HY-162086A | HDAC-IN-68 (hydrochloride) | Reference compound | |
| HY-162087 | FabH-IN-2 | 3040281-87-3 | Reference compound |
| HY-162088 | DW71177 | 2241311-72-6 | Reference compound |
| HY-162089 | MY-1442 | 3050871-87-6 | Reference compound |
| HY-16209 | Forodesine (hydrochloride) | 284490-13-7 | Reference compound |
| HY-162090 | TRPC antagonist 1 | 3027139-12-1 | Reference compound |
| HY-162091 | Topoisomerase I inhibitor 13 | Reference compound | |
| HY-162092 | Multi-target Pt | 3041997-77-4 | Reference compound |
| HY-162093 | Aβ1–42 aggregation inhibitor 2 | 3036099-60-9 | Reference compound |
| HY-162094 | Antitubercular agent-44 | 3027135-80-1 | Reference compound |
| HY-162096 | Keap1-Nrf2-IN-17 | 3042821-85-9 | Reference compound |
| HY-162097 | RIPK1-IN-20 | 3026543-19-8 | Reference compound |
| HY-162098 | PROTAC tubulin-Degrader-1 | Reference compound | |
| HY-162099 | VEGFR-IN-4 | 3000483-29-1 | Reference compound |
| HY-16210 | Forodesine | 209799-67-7 | Reference compound |
| HY-162100 | MR-2088 | 2922531-69-7 | Reference compound |
| HY-162101 | Topoisomerase inhibitor 3 | 3026832-96-9 | Reference compound |
| HY-162102 | DDR1-IN-8 | 3038810-92-0 | Reference compound |
| HY-162103 | Axl-IN-18 | 3040329-68-5 | Reference compound |
| HY-162104 | BRCA2-RAD51-IN-1 | 2830213-53-9 | Reference compound |
| HY-162105 | Aromatase-IN-3 | Reference compound | |
| HY-162106 | PROTAC GPX4 degrader-2 | Reference compound | |
| HY-162107 | Dyrk1A-IN-6 | Reference compound | |
| HY-162108 | Antitumor agent-128 | 1942910-49-7 | Reference compound |
| HY-162109 | Thrombin inhibitor 11 | Reference compound | |
| HY-162110 | AM-9022 | 2446872-46-2 | Reference compound |
| HY-162110A | (S)-AM-9022 | 2446872-47-3 | Reference compound |
| HY-162111 | SARS-CoV-2-IN-73 | Reference compound | |
| HY-162113 | Antibacterial agent 174 | 2896196-09-9 | Reference compound |
| HY-162114 | PARP1-IN-18 | 2958609-64-6 | Reference compound |
| HY-162115 | TLR7 agonist 17 | 2410517-32-5 | Reference compound |
| HY-162116 | TLR7 agonist 18 | Reference compound | |
| HY-162117 | LBG30300 | Reference compound | |
| HY-162118 | RGH-122 | 2355304-05-9 | Reference compound |
| HY-162119 | PRL-IN-1 | 331431-75-5 | Reference compound |
| HY-16212 | FR901464 | 146478-72-0 | Natural Products |
| HY-162120 | FZQ-21 | Reference compound | |
| HY-162121 | Antitumor agent-129 | Reference compound | |
| HY-162122 | PPARα/γ agonist 3 | Reference compound | |
| HY-162123 | PPARα/δ agonist 2 | Reference compound | |
| HY-162124 | HDAC/NAMPT-IN-1 | 2898381-63-8 | Reference compound |
| HY-162125 | AT2 receptor ligand-1 | Reference compound | |
| HY-162126 | Tubulin polymerization-IN-58 | Reference compound | |
| HY-162127 | hAChE/hBACE-1-IN-3 | Reference compound | |
| HY-162128 | Antitumor agent-130 | Reference compound | |
| HY-162129 | Antitumor agent-131 | Reference compound | |
| HY-16213 | FURNIDIPINE | 138661-03-7 | Reference compound |
| HY-162130 | Antibacterial agent 176 | Reference compound | |
| HY-162131 | Antitumor agent-132 | Reference compound | |
| HY-162132 | WZB117-PPG | Reference compound | |
| HY-162133 | MSA-2-Pt | Reference compound | |
| HY-162134 | Trypanothione synthetase-IN-5 | Reference compound | |
| HY-162135 | MAT2A-IN-14 | Reference compound | |
| HY-162136 | GPR40 agonist 7 | 1821647-46-4 | Reference compound |
| HY-162137 | Hepatoprotective agent-1 | 1225971-07-2 | Reference compound |
| HY-162138 | BChE-IN-23 | 2020357-32-6 | Reference compound |
| HY-162139 | Urease-IN-11 | 517906-12-6 | Reference compound |
| HY-16214 | FX-11 | 213971-34-7 | Reference compound |
| HY-162140 | Tyrosinase-IN-21 | Reference compound | |
| HY-162141 | MD102 | 2755794-94-4 | Reference compound |
| HY-162142 | BB2-50F | 2226086-65-1 | Reference compound |
| HY-162143 | SKI-349 | 727686-80-8 | Reference compound |
| HY-162144 | BDM91288 | 2892824-53-0 | Reference compound |
| HY-162145 | AChE-IN-54 | Reference compound | |
| HY-162146 | NS3-IN-1 | Reference compound | |
| HY-162147 | Nur77 modulator 3 | 2097787-75-0 | Reference compound |
| HY-162148 | HNPMI | 1980848-48-3 | Reference compound |
| HY-162149 | Urease-IN-12 | Reference compound | |
| HY-16215 | Mipsagargin | 1245732-48-2 | Peptides |
| HY-162150 | Azalamellarin N | 1809535-57-6 | Reference compound |
| HY-162151 | SARS-CoV-2-IN-74 | Reference compound | |
| HY-162152 | biKEAP1 | Reference compound | |
| HY-162153 | CYY292 | 2644673-04-9 | Reference compound |
| HY-162154 | SARS-CoV-2-IN-75 | 2738323-08-3 | Reference compound |
| HY-162155 | Diarctigenin | Reference compound | |
| HY-162156 | TTK inhibitor 4 | 2964520-80-5 | Reference compound |
| HY-162158 | DA ZP1 | 1816254-69-9 | Dye Reagents |
| HY-162159 | Ac-Cys-NHMe | 10061-65-1 | Reference compound |
| HY-16216 | Gabapentin enacarbil | 478296-72-9 | Reference compound |
| HY-162160 | NR12S | 1221739-85-0 | Dye Reagents |
| HY-162161 | Flutax-2 | 301844-13-3 | Dye Reagents |
| HY-162162 | RXR agonist 1 | Reference compound | |
| HY-162163 | TLR7 agonist 19 | 2682008-42-8 | Reference compound |
| HY-162164 | Neuroprotective agent 3 | 130995-63-0 | Reference compound |
| HY-162165 | Neuroprotective agent 4 | 161095-11-0 | Reference compound |
| HY-162166 | COX-2/15-LOX/mPGES1-IN-1 | Reference compound | |
| HY-162167 | COX-1-IN-1 | 1369503-03-6 | Reference compound |
| HY-162168 | Anti-inflammatory agent 71 | Reference compound | |
| HY-162169 | α-Amylase/α-Glucosidase-IN-8 | Reference compound | |
| HY-16217 | Gadobutrol | 770691-21-9 | Reference compound |
| HY-162170 | Anti-inflammatory agent 72 | Reference compound | |
| HY-162171 | Antibacterial agent 179 | Reference compound | |
| HY-162172 | PARP7-IN-18 | 2819999-00-1 | Reference compound |
| HY-162173 | WYZ90 | Reference compound | |
| HY-162174 | MBL-IN-2 | Reference compound | |
| HY-162175 | TAMRA-isoADPr | Dye Reagents | |
| HY-162176 | 5-HT2A agonist 2 | Reference compound | |
| HY-162177 | SARS-CoV-2-IN-78 | 38716-45-9 | Reference compound |
| HY-16217A | Gadobutrol (hydrate) | 198637-52-4 | Reference compound |
| HY-162180 | E3 Ligase Ligand-linker Conjugate 2 | Reference compound | |
| HY-162181 | E3 Ligase Ligand-linker Conjugate 5 | 2839670-45-8 | Reference compound |
| HY-162182 | E3 Ligase Ligand-linker Conjugate 7 | 2758531-47-2 | Reference compound |
| HY-162183 | E3 Ligase Ligand-linker Conjugate 9 | Reference compound | |
| HY-162184 | E3 ligase Ligand-Linker Conjugate 11 | Reference compound | |
| HY-162185 | E3 Ligase Ligand-linker Conjugate 12 | Reference compound | |
| HY-162186 | E3 Ligase Ligand-linker Conjugate 13 | Reference compound | |
| HY-162187 | E3 Ligase Ligand-linker Conjugate 14 | Reference compound | |
| HY-162188 | E3 Ligase Ligand-linker Conjugate 15 | 2716124-25-1 | Reference compound |
| HY-162189 | E3 Ligase Ligand-linker Conjugate 16 | Reference compound | |
| HY-16219 | Gadoxetate (disodium) | 135326-22-6 | Reference compound |
| HY-162190 | E3 Ligase Ligand-linker Conjugate 17 | Reference compound | |
| HY-162191 | E3 Ligase Ligand-linker Conjugate 18 | Reference compound | |
| HY-162192 | E3 Ligase Ligand-linker Conjugate 20 | Reference compound | |
| HY-162193 | E3 Ligase Ligand-linker Conjugate 27 | Reference compound | |
| HY-162194 | E3 Ligase Ligand-linker Conjugate 28 | 2229717-76-2 | Reference compound |
| HY-162195 | E3 ligase Ligand-Linker Conjugate 34 | 2682113-65-9 | Reference compound |
| HY-162196 | E3 ligase Ligand-Linker Conjugate 39 | 2632308-04-2 | Reference compound |
| HY-162197 | E3 ligase Ligand-Linker Conjugate 41 | Reference compound | |
| HY-162198 | E3 ligase Ligand-Linker Conjugate 43 | Reference compound | |
| HY-162199 | E3 Ligase Ligand-linker Conjugate 45 | 2871775-00-5 | Reference compound |
| HY-162200 | E3 Ligase Ligand-linker Conjugate 47 | Reference compound | |
| HY-162201 | E3 Ligase Ligand-linker Conjugate 48 | 2520105-41-1 | Reference compound |
| HY-162202 | E3 Ligase Ligand-linker Conjugate 50 | 2918813-56-4 | Reference compound |
| HY-162203 | E3 Ligase Ligand-linker Conjugate 51 | 2589706-80-7 | Reference compound |
| HY-162204 | E3 Ligase Ligand-linker Conjugate 54 | 2229725-33-9 | Reference compound |
| HY-162205 | E3 Ligase Ligand-linker Conjugate 55 | Reference compound | |
| HY-162206 | E3 Ligase Ligand-linker Conjugate 58 | 2229725-27-1 | Reference compound |
| HY-162207 | HSD17B13-IN-54 | 2770247-49-7 | Reference compound |
| HY-162208 | HSD17B13-IN-55 | 2770247-58-8 | Reference compound |
| HY-162209 | HSD17B13-IN-63 | 2770247-51-1 | Reference compound |
| HY-162210 | HSD17B13-IN-65 | 2770247-59-9 | Reference compound |
| HY-162211 | HSD17B13-IN-84 | 2770247-73-7 | Reference compound |
| HY-162212 | HSD17B13-IN-85 | 2770247-76-0 | Reference compound |
| HY-162213 | HSD17B13-IN-86 | 2770247-78-2 | Reference compound |
| HY-162214 | HSD17B13-IN-90 | 2848620-81-3 | Reference compound |
| HY-162215 | HSD17B13-IN-88 | 2770247-93-1 | Reference compound |
| HY-162216 | HSD17B13-IN-89 | 2770247-94-2 | Reference compound |
| HY-162217 | HSD17B13-IN-91 | 2848620-83-5 | Reference compound |
| HY-162219 | HSD17B13-IN-93 | 2848620-87-9 | Reference compound |
| HY-162220 | HSD17B13-IN-94 | 2848620-90-4 | Reference compound |
| HY-162221 | HSD17B13-IN-95 | 2849338-41-4 | Reference compound |
| HY-162222 | HSD17B13-IN-96 | 2849338-43-6 | Reference compound |
| HY-162223 | HSD17B13-IN-97 | 2849338-44-7 | Reference compound |
| HY-162224 | HSD17B13-IN-98 | 2849338-45-8 | Reference compound |
| HY-162225 | HSD17B13-IN-99 | 2849338-46-9 | Reference compound |
| HY-162226 | Carbonic anhydrase inhibitor 19 | 3033374-40-9 | Reference compound |
| HY-162227 | Antitumor agent-138 | 2975168-22-8 | Reference compound |
| HY-162228 | VI-60 | Reference compound | |
| HY-162229 | GRL-190-21 | 2755957-14-1 | Reference compound |
| HY-162230 | PRMT5-IN-33 | Reference compound | |
| HY-162231 | HY-078020 | 2756222-90-7 | Reference compound |
| HY-162232 | mGluR2 agonist 1 | Reference compound | |
| HY-162232A | mGluR2 agonist 1 (hydrochloride) | Reference compound | |
| HY-162233 | SHP2-IN-25 | Reference compound | |
| HY-162234 | PKCTheta-IN-1 | 2948289-20-9 | Reference compound |
| HY-162235 | CVN766 | 1803557-42-7 | Reference compound |
| HY-162236 | SARS-CoV-2-IN-80 | 57341-12-5 | Reference compound |
| HY-162237 | RIPK1-IN-22 | Reference compound | |
| HY-162238 | OSM-S-106 | 2650846-59-4 | Reference compound |
| HY-162239 | Anticancer agent 187 | Reference compound | |
| HY-162240 | SJH1-51B | Reference compound | |
| HY-162241 | SJH1-62B | Reference compound | |
| HY-162242 | Cap-dependent endonuclease-IN-27 | Reference compound | |
| HY-162244 | COX-2-IN-40 | 444790-64-1 | Reference compound |
| HY-162245 | PROTAC SMARCA2 degrader-3 | 3024266-69-8 | Reference compound |
| HY-162246 | Nav1.8-IN-5 | 3023247-79-9 | Reference compound |
| HY-162247 | MDM2-IN-26 | 1818393-11-1 | Reference compound |
| HY-162248 | JAK1/2-IN-1 | 3023876-01-6 | Reference compound |
| HY-162249 | ASP6918 | Reference compound | |
| HY-162250 | MS8847 | 3050872-59-5 | Reference compound |
| HY-162252 | SIRT2-IN-12 | Reference compound | |
| HY-162253 | HIV-1 inhibitor-64 | 2919019-36-4 | Reference compound |
| HY-162254 | EGFR/ACK1-IN-1 | Reference compound | |
| HY-162255 | CDK2-IN-23 | 2488073-20-5 | Reference compound |
| HY-162256 | Antibacterial agent 184 | Reference compound | |
| HY-162257 | BTK-IN-34 | 3016419-52-3 | Reference compound |
| HY-162258 | AChE-IN-57 | Reference compound | |
| HY-162259 | QC-182 | 3032646-96-8 | Reference compound |
| HY-162260 | MNK-IN-4 | Reference compound | |
| HY-162261 | Antibacterial agent 186 | Reference compound | |
| HY-162262 | α-Glucosidase-IN-48 | Reference compound | |
| HY-162264 | Tubulin polymerization/V-ATPase-IN-1 | Reference compound | |
| HY-162265 | UCM-13369 | 2921944-77-4 | Reference compound |
| HY-162265A | UCM-13369 (dihydrochloride) | Reference compound | |
| HY-162266 | C3TD879 | 2850259-33-3 | Reference compound |
| HY-162267 | LPAR1 antagonist 1 | 3032275-33-2 | Reference compound |
| HY-162268 | MALT1-IN-13 | Reference compound | |
| HY-162269 | Nampt activator-5 | Reference compound | |
| HY-162270 | CDK2-IN-24 | Reference compound | |
| HY-162271 | Antibacterial agent 187 | Reference compound | |
| HY-162273 | Antibacterial agent 189 | Reference compound | |
| HY-162274 | Oxazepine | Reference compound | |
| HY-162275 | JMJD1C-IN-1 | 861224-48-8 | Reference compound |
| HY-162276 | Anticancer agent 188 | 1207377-56-7 | Reference compound |
| HY-162277 | BuChE-IN-10 | Reference compound | |
| HY-162278 | HSD17B13-IN-101 | Reference compound | |
| HY-162279 | Insecticidal agent 8 | Reference compound | |
| HY-16228 | Genz-644282 | 529488-28-6 | Reference compound |
| HY-162280 | PROTAC BTK Degrader-9 | Reference compound | |
| HY-162281 | PROTAC SOS1 degrader-6 | 3032282-51-9 | Reference compound |
| HY-162282 | PROTAC METTL3-14 degrader 1 | Reference compound | |
| HY-162283 | FGFR4-IN-18 | Reference compound | |
| HY-162284 | BAY-9835 | 3032487-31-0 | Reference compound |
| HY-162285 | Anticancer agent 189 | Reference compound | |
| HY-162286 | α-Glucosidase-IN-50 | Reference compound | |
| HY-162287 | α-Glucosidase-IN-51 | Reference compound | |
| HY-162288 | FAZ-3532 | 3036029-72-5 | Reference compound |
| HY-162289 | FAZ-3780 | 3036029-78-1 | Reference compound |
| HY-16229 | GGTI-2154 | 251577-10-3 | Reference compound |
| HY-162290 | Z2206320703 | Reference compound | |
| HY-162291 | Lck-IN-3 | Reference compound | |
| HY-162292 | Anticancer agent 190 | Reference compound | |
| HY-162293 | CDK8-IN-14 | 2924193-12-2 | Reference compound |
| HY-162294 | c-Myc inhibitor 13 | Reference compound | |
| HY-162295 | SARS-CoV-2-IN-83 | Reference compound | |
| HY-162296 | Antibacterial agent 188 | 88312-54-3 | Reference compound |
| HY-162297 | 4-(Sulfooxy)benzoic acid | 3233-38-3 | Reference compound |
| HY-162298 | γ-Linolenoyl monoethanolamide | 150314-37-7 | Reference compound |
| HY-162299 | EGFR kinase inhibitor 3 | 2922402-03-5 | Reference compound |
| HY-16229A | GGTI-2154 (hydrochloride) | 478908-50-8 | Reference compound |
| HY-16230 | GGTI-2417 | 501010-05-5 | Reference compound |
| HY-162300 | EGFR kinase inhibitor 4 | 2922402-05-7 | Reference compound |
| HY-162301 | P3FI-63 | 931596-95-1 | Reference compound |
| HY-162302 | NMY1009 | Reference compound | |
| HY-162303 | C175-0062 | 686736-69-6 | Reference compound |
| HY-162304 | MAGL-IN-14 | 2770967-04-7 | Reference compound |
| HY-162305 | MAGL-IN-15 | 2770967-08-1 | Reference compound |
| HY-162306 | GLP-1R agonist 18 | 2855243-02-4 | Reference compound |
| HY-162307 | Nrf2 degrader 1 | 3025286-00-1 | Reference compound |
| HY-162308 | NSD-IN-3 | 744260-15-9 | Reference compound |
| HY-162309 | CSF1R-IN-20 | 2935479-57-3 | Reference compound |
| HY-16231 | GGTI-2418 | 501010-06-6 | Reference compound |
| HY-162310 | Anticancer agent 193 | Reference compound | |
| HY-162311 | Anticancer agent 194 | 2767204-90-8 | Reference compound |
| HY-162312 | LLK203 | 2758090-62-7 | Reference compound |
| HY-162313 | NIP-22c | 2309384-85-6 | Reference compound |
| HY-162314 | TNIK-IN-8 | Reference compound | |
| HY-162315 | MAGL-IN-16 | Reference compound | |
| HY-162316 | NF-κB-IN-15 | Reference compound | |
| HY-162317 | AMPK-IN-5 | Reference compound | |
| HY-162318 | MYC degrader 1 | 2946670-96-6 | Reference compound |
| HY-162318A | MYC degrader 1 (TFA) | Reference compound | |
| HY-162319 | Tubulin/HDAC-IN-4 | Reference compound | |
| HY-16232 | Glufosfamide | 132682-98-5 | Reference compound |
| HY-162320 | PPARγ agonist 12 | Reference compound | |
| HY-162321 | ZINC57632462 | 1286482-29-8 | Reference compound |
| HY-162322 | VU0542270 | 1396814-79-1 | Reference compound |
| HY-162323 | EGFR-IN-106 | Reference compound | |
| HY-162324 | MX106-4C | Reference compound | |
| HY-162325 | WJ-39 | 3009908-95-3 | Reference compound |
| HY-162326 | VEGFR-2-IN-41 | Reference compound | |
| HY-162327 | PROTAC PAPD5 degrader 1 | Reference compound | |
| HY-162328 | Antibacterial agent 194 | 2157356-88-0 | Reference compound |
| HY-162329 | Antibacterial agent 195 | Reference compound | |
| HY-162330 | HDAC6-IN-36 | Reference compound | |
| HY-162331 | STING Degrader-1 | Reference compound | |
| HY-162332 | EGFR-PK/JNK-2-IN-1 | Reference compound | |
| HY-162333 | BAL-0028 | 2842012-69-3 | Reference compound |
| HY-162334 | HYOU1-IN-1 | 2832155-52-7 | Reference compound |
| HY-162336 | Casein kinase 1δ-IN-15 | 2765264-27-3 | Reference compound |
| HY-162337 | PPO-IN-8 | Reference compound | |
| HY-162338 | BChE-IN-29 | Reference compound | |
| HY-162339 | BChE-IN-30 | Reference compound | |
| HY-162340 | Z32439948 | 920845-86-9 | Reference compound |
| HY-162341 | Topoisomerase I inhibitor 15 | Reference compound | |
| HY-162342 | Topoisomerase I inhibitor 14 | Reference compound | |
| HY-162343 | PD-1/PD-L1-IN-41 | Reference compound | |
| HY-162344 | Ir-CA | 2870682-93-0 | Reference compound |
| HY-162345 | CK-963 | 2851991-63-2 | Reference compound |
| HY-162346 | KN-17 | Reference compound | |
| HY-162347 | Nav1.7-IN-13 | 2776235-57-3 | Reference compound |
| HY-162348 | Antitumor agent-145 | 2983120-65-4 | Reference compound |
| HY-162349 | PARP7/HDACs-IN-1 | Reference compound | |
| HY-162350 | TDI-11055 | Reference compound | |
| HY-162351 | EBP-IN-1 | Reference compound | |
| HY-162352 | SDU-071 | 3036109-10-8 | Reference compound |
| HY-162353 | AZ'9567 | Reference compound | |
| HY-162355 | SHP2-IN-27 | 2376012-00-7 | Reference compound |
| HY-162356 | PD-L1-IN-4 | 2597056-86-3 | Reference compound |
| HY-162357 | PD-L1-IN-5 | 2597056-85-2 | Reference compound |
| HY-162358 | DHFR-IN-17 | Reference compound | |
| HY-162359 | BIO-7488 | 2573211-25-1 | Reference compound |
| HY-162360 | EGFR-IN-109 | 3019971-97-9 | Reference compound |
| HY-162361 | HDAC1-IN-7 | 794552-20-8 | Reference compound |
| HY-162362 | MS8709 | 3060730-06-2 | Reference compound |
| HY-162363 | MD6a | Reference compound | |
| HY-162364 | p38-α MAPK-IN-7 | Reference compound | |
| HY-162365 | JD-02 | Reference compound | |
| HY-162366 | KRAS G12D inhibitor 20 | Reference compound | |
| HY-162367 | FLT3/CHK1-IN-2 | Reference compound | |
| HY-162368 | cPLA2α-IN-2 | Reference compound | |
| HY-162369 | PID-9 | Reference compound | |
| HY-162370 | CYP51-IN-16 | Reference compound | |
| HY-162371 | NRPSs-IN-1 | Reference compound | |
| HY-162372 | Hedgehog IN-6 | 2916444-33-0 | Reference compound |
| HY-162373 | α-Amylase/α-Glucosidase-IN-10 | Reference compound | |
| HY-162374 | ANO61 | 940476-20-0 | Reference compound |
| HY-162375 | AF299 | 832685-79-7 | Reference compound |
| HY-162376 | T3SS-IN-4 | 2316760-41-3 | Reference compound |
| HY-162378 | LT-630 | Reference compound | |
| HY-162379 | Anticancer agent 200 | Reference compound | |
| HY-162380 | Topoisomerase II inhibitor 18 | 2382959-65-9 | Reference compound |
| HY-162381 | Topoisomerase II inhibitor 19 | Reference compound | |
| HY-162382 | KTC1101 | 2764833-47-6 | Reference compound |
| HY-162384 | EPIC-0628 | Reference compound | |
| HY-162385 | COX-2-IN-42 | Reference compound | |
| HY-162386 | UM4118 | 324530-92-9 | Reference compound |
| HY-162387 | UK4b | 2171000-87-4 | Reference compound |
| HY-162388 | TIM-098a | Reference compound | |
| HY-162389 | Anticancer agent 202 | Reference compound | |
| HY-162390 | α-Amylase/α-Glucosidase-IN-11 | Reference compound | |
| HY-162392 | Anticancer agent 203 | Reference compound | |
| HY-162393 | XL44 | 2637949-91-6 | Reference compound |
| HY-162394 | Vasopressin V2 receptor antagonist 2 | Reference compound | |
| HY-162395 | α-Glucosidase-IN-58 | Reference compound | |
| HY-162396 | P-gp inhibitor 21 | Reference compound | |
| HY-162397 | Neopetromin | Natural Products | |
| HY-162398 | LQ23 | 2997615-62-8 | Reference compound |
| HY-162399 | PD-L1-IN-6 | Reference compound | |
| HY-162400 | TMV-IN-8 | 3023856-56-3 | Reference compound |
| HY-162401 | AZ7976 | 2813866-27-0 | Reference compound |
| HY-162402 | NLRP3-IN-33 | Reference compound | |
| HY-162403 | Antiviral agent 53 | Reference compound | |
| HY-162404 | Smad2/3-IN-2 | Reference compound | |
| HY-162405 | Smad2/3-IN-1 | Reference compound | |
| HY-162406 | UNC8969 | 3036049-17-6 | Reference compound |
| HY-162407 | I-As-1 | Reference compound | |
| HY-162408 | PAR4 antagonist 3 | 3057206-40-0 | Reference compound |
| HY-162409 | PAR4 antagonist 4 | 3057206-41-1 | Reference compound |
| HY-162410 | Fluplatin | Reference compound | |
| HY-162411 | E3 ligase Ligand 24 | 3038773-47-3 | Reference compound |
| HY-162412 | PROTAC AR/AR-V7 degrader-1 | 2841308-96-9 | Reference compound |
| HY-162413 | (R)-LW-Srci-8 | Reference compound | |
| HY-162414 | SARS-CoV-2-IN-84 | 214221-82-6 | Reference compound |
| HY-162415 | CSF1R-IN-22 | 2760585-35-9 | Reference compound |
| HY-162416 | CDK7-IN-27 | Reference compound | |
| HY-162417 | PPO-IN-12 | Reference compound | |
| HY-162418 | Antibacterial agent 203 | Reference compound | |
| HY-162420 | PPO-IN-9 | Reference compound | |
| HY-162421 | SL antagonist 1 | Reference compound | |
| HY-162422 | Mito-DK | Dye Reagents | |
| HY-162423 | CYB210010 | 2762568-47-6 | Reference compound |
| HY-162424 | ZBP1/RIP3/MLKL activator 1 | Reference compound | |
| HY-162425 | Anti-inflammatory agent 78 | Reference compound | |
| HY-162426 | UNC-CA2-103 | Reference compound | |
| HY-162427 | NMS-0963 | 2765304-82-1 | Reference compound |
| HY-162428 | PTPN2/1-IN-3 | Reference compound | |
| HY-162429 | Antibacterial agent 205 | Reference compound | |
| HY-162430 | Antibacterial agent 206 | Reference compound | |
| HY-162431 | MK-1084 | 2641216-67-1 | Reference compound |
| HY-162432 | MDM2-IN-27 | Reference compound | |
| HY-162433 | I-070 | Reference compound | |
| HY-162434 | I-128 | Reference compound | |
| HY-162435 | GLP-1R agonist 20 | Reference compound | |
| HY-162436 | GLP-1R agonist 21 | Reference compound | |
| HY-162437 | GLP-1R agonist 22 | Reference compound | |
| HY-162438 | PHD2-IN-2 | Reference compound | |
| HY-162439 | pan-KRAS-IN-6 | 3033565-36-2 | Reference compound |
| HY-162440 | pan-KRAS-IN-7 | Reference compound | |
| HY-162441 | pan-KRAS-IN-8 | Reference compound | |
| HY-162442 | pan-KRAS-IN-9 | Reference compound | |
| HY-162443 | pan-KRAS-IN-10 | Reference compound | |
| HY-162444 | KRAS G12D inhibitor 22 | Reference compound | |
| HY-162445 | KRASG12D-IN-3 | 3033638-63-7 | Reference compound |
| HY-162445S | KRASG12D-IN-3-d3 | 3033638-69-3 | Isotope-Labeled Compounds |
| HY-162446 | pan-KRAS-IN-13 | 3033637-76-9 | Reference compound |
| HY-162447 | P-gp inhibitor 22 | 1226674-74-3 | Reference compound |
| HY-162448 | SerBut | 63321-66-4 | Reference compound |
| HY-162449 | GIC-20 | 2942242-60-4 | Reference compound |
| HY-162450 | Antitumor agent-150 | Reference compound | |
| HY-162451 | Antibacterial agent 207 | Reference compound | |
| HY-162452 | Prolyl endopeptidase inhibitor 2 | 2362592-81-0 | Reference compound |
| HY-162453 | Anticancer agent 204 | Reference compound | |
| HY-162454 | DA-023 | 2585643-97-4 | Reference compound |
| HY-162455 | NA-014 | Reference compound | |
| HY-162456 | Anticancer agent 205 | Reference compound | |
| HY-162457 | Mn007 | 1843236-92-9 | Reference compound |
| HY-162458 | Antifungal agent 100 | 2975157-18-5 | Reference compound |
| HY-162459 | cGAS-IN-3 | Reference compound | |
| HY-16246 | Haloprogin | 777-11-7 | Reference compound |
| HY-162460 | ERK1/2 inhibitor 10 | Reference compound | |
| HY-162461 | HIV-1 inhibitor-66 | Reference compound | |
| HY-162462 | Antitumor agent-151 | Reference compound | |
| HY-162463 | Ir-UA | 3033235-42-3 | Reference compound |
| HY-162464 | MPD2 | Reference compound | |
| HY-162465 | BDW568 | 335401-44-0 | Reference compound |
| HY-162466 | ABA receptor agonist 1 | 2981430-43-5 | Reference compound |
| HY-162467 | Opabactin | 2407423-32-7 | Reference compound |
| HY-162469 | 6K465 | 2702965-27-1 | Reference compound |
| HY-16247 | Apoptone | 183387-50-0 | Reference compound |
| HY-162470 | DBPR728 | 2702965-64-6 | Reference compound |
| HY-162471 | GSK_WRN3 | 2923009-50-9 | Reference compound |
| HY-162472 | XRD-0394 | 2595308-10-2 | Reference compound |
| HY-162473 | MLEB-1934 | Reference compound | |
| HY-162474 | BZG2 | Reference compound | |
| HY-162475 | Fluorofolin | 2757070-32-7 | Reference compound |
| HY-162476 | SHP2-IN-28 | Reference compound | |
| HY-162477 | TS-24 | 1563260-97-8 | Reference compound |
| HY-162478 | GR-28 | Reference compound | |
| HY-162479 | PTP1B-IN-26 | Reference compound | |
| HY-162480 | PTP1B-IN-27 | Reference compound | |
| HY-162481 | Anticancer agent 210 | Reference compound | |
| HY-162482 | EGFR kinase inhibitor 5 | Reference compound | |
| HY-162483 | EGFR kinase inhibitor 6 | Reference compound | |
| HY-162484 | GZNL-P36 | Reference compound | |
| HY-162485 | DV-B-120 | Reference compound | |
| HY-162487 | HDAC-IN-72 | 763066-77-9 | Reference compound |
| HY-162488 | Laccase-IN-3 | Reference compound | |
| HY-162489 | Tyrosine kinase-IN-8 | Reference compound | |
| HY-162490 | TF-S14 | 2425563-60-4 | Reference compound |
| HY-162491 | JR-6 | Reference compound | |
| HY-162492 | Influenza A virus-IN-14 | Reference compound | |
| HY-162493 | MBL-IN-3 | 1452395-68-4 | Reference compound |
| HY-162494 | PAD4-IN-4 | Reference compound | |
| HY-162495 | IDOR-1117-2520 | 2737274-49-4 | Reference compound |
| HY-162496 | L-NBDNJ | Reference compound | |
| HY-162497 | Insecticidal agent 12 | Reference compound | |
| HY-162498 | Antileishmanial agent-29 | Reference compound | |
| HY-162499 | MY17 | Reference compound | |
| HY-162500 | Antifungal agent 99 | Reference compound | |
| HY-162501 | Yaddle1 | Reference compound | |
| HY-162502 | WZU-13 | 304882-43-7 | Reference compound |
| HY-162503 | ST166 (free acid) | 50580-23-9 | Reference compound |
| HY-162504 | 2'-RIBOTAC-U | Reference compound | |
| HY-162505 | SQA1 | 1255915-27-5 | Reference compound |
| HY-162506 | IGF-1R inhibitor-3 | 1227753-12-9 | Reference compound |
| HY-162507 | 2'-RIBOTAC-U recruiter-linker | Reference compound | |
| HY-162508 | KSK-104 | Reference compound | |
| HY-162509 | YS07 | Reference compound | |
| HY-162510 | SPDZi1 | Reference compound | |
| HY-162511 | IP2015 | 1320346-14-2 | Reference compound |
| HY-162512 | CB-0821 | 81430-62-8 | Reference compound |
| HY-162513 | DPP-4-IN-10 | 1123219-12-4 | Reference compound |
| HY-162514 | BBC0403 | 2644662-83-7 | Reference compound |
| HY-162515 | 8-OAc | 2550395-87-2 | Reference compound |
| HY-162516 | DBI-2 | 2939087-00-8 | Reference compound |
| HY-162517 | UMM-766 | 443643-17-2 | Reference compound |
| HY-162518 | Eg5-IN-3 | Reference compound | |
| HY-162519 | LZFPN-90 | Reference compound | |
| HY-16251A | Hetacillin | 3511-16-8 | Reference compound |
| HY-16252 | Hexafluorenium (dibromide) | 317-52-2 | Reference compound |
| HY-162520 | DJ-1-IN-1 | 797780-71-3 | Reference compound |
| HY-162521 | Antibacterial agent 215 | Reference compound | |
| HY-162522 | SL-IN-1 | Reference compound | |
| HY-162523 | hMAO-B-IN-8 | Reference compound | |
| HY-162524 | Tyrosinase-IN-28 | Reference compound | |
| HY-162525 | GS-9770 | 2306328-43-6 | Reference compound |
| HY-162526 | HIV capsid modulator 2 | Reference compound | |
| HY-162527 | Antibacterial agent 216 | Reference compound | |
| HY-162528 | CDK12-IN-7 | 3033863-94-1 | Reference compound |
| HY-162529 | CDK4/6-IN-19 | 3033950-86-3 | Reference compound |
| HY-162530 | CDK4/6-IN-20 | 3033950-84-1 | Reference compound |
| HY-162531 | KIF18A-IN-9 | 3034541-82-4 | Reference compound |
| HY-162532 | KIF18A-IN-10 | 3034542-28-1 | Reference compound |
| HY-162533 | GSPT1 degrader-4 | 3034764-32-1 | Reference compound |
| HY-162534 | GSPT1 degrader-5 | 3034764-38-7 | Reference compound |
| HY-162535 | GSPT1 degrader-6 | 3034764-41-2 | Reference compound |
| HY-162536 | Pan-RAS-IN-5 | Reference compound | |
| HY-162537 | LYP-8 | Reference compound | |
| HY-162538 | LC-MI-3 | Reference compound | |
| HY-162539 | T2-BDP589 | Dye Reagents | |
| HY-162540 | LLC355 | Reference compound | |
| HY-162541 | α-Glucosidase-IN-64 | Natural Products | |
| HY-162543 | 18:1 Liss Rhod PE | 384833-00-5 | Dye Reagents |
| HY-162544 | PROTAC HPK1 Degrader-2 | 2893885-31-7 | Reference compound |
| HY-162545 | HPK1-IN-47 | 2893885-42-0 | Reference compound |
| HY-162546 | 3-Hydroxypropanoic acid-pip-hydroquinone-dihydrouracil | Reference compound | |
| HY-162547 | Oxogestone phenpropionate | 16915-80-3 | Reference compound |
| HY-162548 | Homprenorphine | 16549-56-7 | Reference compound |
| HY-162549 | CPK20 | 2397708-22-2 | Reference compound |
| HY-16255 | Imirestat | 89391-50-4 | Reference compound |
| HY-162550 | Jobosic acid | 223611-93-6 | Reference compound |
| HY-162551 | PPO-IN-13 | Reference compound | |
| HY-162552 | KOR/DOR agonist 1 | Reference compound | |
| HY-162553 | GNE7599 | 2771069-76-0 | Reference compound |
| HY-162554 | CD73-IN-15 | Reference compound | |
| HY-162555 | BMS-986308 | 2254333-97-4 | Reference compound |
| HY-162557 | VEGFR-2-IN-45 | Reference compound | |
| HY-162558 | NCGC00351170 | 886536-76-1 | Reference compound |
| HY-162559 | SDH-IN-16 | Reference compound | |
| HY-16256 | Amrinone (lactate) | 75898-90-7 | Reference compound |
| HY-162560 | Antitumor agent-162 | Reference compound | |
| HY-162561 | GB1908 | Reference compound | |
| HY-162562 | E28362 | 930017-01-9 | Reference compound |
| HY-162563 | AK59 | Reference compound | |
| HY-162564 | Antibacterial agent 221 | 3034402-33-7 | Reference compound |
| HY-162565 | CDD-2807 | Reference compound | |
| HY-162566 | REM127 | 1417823-67-6 | Reference compound |
| HY-162567 | AP-4-139B | 2716909-84-9 | Reference compound |
| HY-162568 | 7-tert-Butylfascaplysin | Reference compound | |
| HY-162569 | Ru-TRZ2 | Reference compound | |
| HY-162570 | Volazocine | 15686-68-7 | Reference compound |
| HY-162572 | Bitipazone | 13456-08-1 | Reference compound |
| HY-162573 | Monoamine Oxidase B inhibitor 5 | 2969160-15-2 | Reference compound |
| HY-162574 | CYP11B2-IN-2 | 2241573-22-6 | Reference compound |
| HY-162575 | Anticancer agent 231 | 128519-30-2 | Reference compound |
| HY-162577 | FGFR-IN-14 | Reference compound | |
| HY-162578 | PPARα/γ agonist 4 | Reference compound | |
| HY-162579 | TLR7 agonist 22 | 3036114-68-5 | Reference compound |
| HY-162580 | SphK2-IN-3 | Reference compound | |
| HY-162581 | FCPR16 | 1917347-71-7 | Reference compound |
| HY-162582 | Z19153 | 2600702-14-3 | Reference compound |
| HY-162583 | PDE4-IN-17 | Reference compound | |
| HY-162584 | TRPC4/5-IN-2 | Reference compound | |
| HY-162585 | 5-HT1AR agonist 1 | Reference compound | |
| HY-162586 | PDHK-IN-7 | 1220965-73-0 | Reference compound |
| HY-162587 | Fagopyrine | 72393-03-4 | Reference compound |
| HY-162588 | MC-ND-18 | Reference compound | |
| HY-162589 | Lw13 | Reference compound | |
| HY-16259 | Indecainide (hydrochloride) | 73681-12-6 | Reference compound |
| HY-162590 | ECIN | 66160-25-6 | Reference compound |
| HY-162591 | MR33317 | Reference compound | |
| HY-162592 | EYA2-IN-1 | Reference compound | |
| HY-162593 | Tubulin inhibitor 45 | Reference compound | |
| HY-162594 | Antitumor agent-164 | 2757188-21-7 | Reference compound |
| HY-162595 | BDM88855 | 2892824-25-6 | Reference compound |
| HY-162595A | BDM88855 (hydrochloride) | 2892824-26-7 | Reference compound |
| HY-162596 | NRL-1049 | 1973494-16-4 | Reference compound |
| HY-162597 | Dyrk1A-IN-9 | Reference compound | |
| HY-162598 | CET-1 | Reference compound | |
| HY-162599 | Spirohypertone B | Natural Products | |
| HY-162600 | CDK8-IN-15 | 2988020-03-5 | Reference compound |
| HY-162601 | D-01 | Reference compound | |
| HY-162602 | EGFR-IN-115 | Reference compound | |
| HY-162603 | HDAC-IN-74 | 1449310-17-1 | Reference compound |
| HY-162604 | SARS-CoV-2-IN-90 | Reference compound | |
| HY-162605 | CYD0682 | Reference compound | |
| HY-162606 | MAO-A/B-IN-3 | 315210-31-2 | Reference compound |
| HY-162607 | STAT3-IN-28 | Reference compound | |
| HY-162608 | PROTAC JAK1 degrader 1 | 3052553-20-2 | Reference compound |
| HY-162609 | ST-2560 | Reference compound | |
| HY-16261 | Aldoxorubicin | 1361644-26-9 | ADC Related |
| HY-162610 | Thalidomide-alkyne-C4-NHBoc | 2093387-85-8 | Reference compound |
| HY-162611 | 8-Hydroxyoctanoic acid-thalidomide | 2399454-65-8 | Reference compound |
| HY-162613 | ASM-IN-2 | 2305789-66-4 | Reference compound |
| HY-162614 | Rogersonin E | Natural Products | |
| HY-162615 | Antibacterial agent 225 | Reference compound | |
| HY-162616 | SelSA | 1225038-92-5 | Reference compound |
| HY-162617 | PSB-KK1415 | 885896-26-4 | Reference compound |
| HY-162618 | PSB-KK1445 | 885896-54-8 | Reference compound |
| HY-162619 | CDK9-IN-33 | Reference compound | |
| HY-16261A | MC-DOXHZN | 151038-96-9 | ADC Related |
| HY-16261B | MC-DOXHZN (hydrochloride) | 480998-12-7 | ADC Related |
| HY-16261C | Aldoxorubicin (hydrochloride) | 1361563-03-2 | Reference compound |
| HY-162620 | α2A-AR agonist 1 | 2971825-58-6 | Reference compound |
| HY-162621 | BET-IN-25 | Reference compound | |
| HY-162622 | BET-IN-26 | Reference compound | |
| HY-162623 | EGFR/HER2-IN-15 | Reference compound | |
| HY-162624 | Quorum sensing-IN-5 | Reference compound | |
| HY-162625 | Tubulin inhibitor 47 | Reference compound | |
| HY-162626 | FGFR2 degrader 1 | Reference compound | |
| HY-162627 | LDHA-IN-6 | 3043790-18-4 | Reference compound |
| HY-162629 | LDHA-IN-7 | 3043790-15-1 | Reference compound |
| HY-162630 | HDAC6-IN-44 | Reference compound | |
| HY-162631 | IDH1 Inhibitor 9 | 3037967-71-5 | Reference compound |
| HY-162632 | Hit 14 | 440338-68-1 | Reference compound |
| HY-162633 | USP1-IN-9 | 2925548-22-5 | Reference compound |
| HY-162634 | α-Amylase/α-Glucosidase-IN-15 | Reference compound | |
| HY-162635 | α-Amylase/α-Glucosidase-IN-14 | Reference compound | |
| HY-162636 | 5HT6-ligand-2 | Reference compound | |
| HY-162637 | CTL26 | Reference compound | |
| HY-162638 | GSK-3β inhibitor 18 | Reference compound | |
| HY-162639 | α-Glucosidase-IN-68 | 1624628-01-8 | Reference compound |
| HY-162640 | ROR1-IN-1 | 3053223-31-4 | Reference compound |
| HY-162641 | AF-45 | Reference compound | |
| HY-162642 | Bfl-1-IN-3 | Reference compound | |
| HY-162643 | Antitumor agent-169 | Reference compound | |
| HY-162644 | Antitumor agent-170 | Reference compound | |
| HY-162645 | BPR5K230 | 3029897-97-7 | Reference compound |
| HY-162646 | FXIIa-IN-5 | 3047411-80-0 | Reference compound |
| HY-162647 | PI3Kδ-IN-22 | Reference compound | |
| HY-162648 | Succinate dehydrogenase-IN-1 | 2969128-94-5 | Reference compound |
| HY-162649 | TIC10g | 754998-88-4 | Reference compound |
| HY-16265 | JI-101 | 900573-88-8 | Reference compound |
| HY-162650 | SL44 | Reference compound | |
| HY-162651 | PROTAC BRD9 Degrader-8 | Reference compound | |
| HY-162652 | HSR-IN-1 | Reference compound | |
| HY-162653 | CDKL2-IN-1 | 2471972-15-1 | Reference compound |
| HY-162654 | FXIIIa-IN-1 | 55909-92-7 | Reference compound |
| HY-162655 | SLF80821178 | 2764877-61-2 | Reference compound |
| HY-162655A | SLF80821178 (hydrochloride) | 2764877-62-3 | Reference compound |
| HY-162656 | DHFR-IN-19 | 41927-06-4 | Reference compound |
| HY-162657 | AChE-IN-74 | Reference compound | |
| HY-162658 | Leuxinostat | Reference compound | |
| HY-162659 | β2AR ligand 1 | 3051498-44-0 | Reference compound |
| HY-16266 | JNJ-DGAT1-A | 1092067-85-0 | Reference compound |
| HY-162660 | BI-9508 | Reference compound | |
| HY-162661 | P2Y14R antagonist 2 | 2989271-65-8 | Reference compound |
| HY-162662 | VU6008677 | 2170550-99-7 | Reference compound |
| HY-162663 | VU0448088 | 1417616-42-2 | Reference compound |
| HY-162664 | STING antagonist 1 | 3036981-21-9 | Reference compound |
| HY-162665 | WIZ degrader 1 | 2839552-68-8 | Reference compound |
| HY-162666 | TMEM175 modulator 1 | 3038770-25-8 | Reference compound |
| HY-162667 | EX05 | 2892307-20-7 | Reference compound |
| HY-162668 | N-Biotinyl-N'-Boc-1,4-butanediamine | 1001575-89-8 | Biochemical Assay Reagents |
| HY-162669 | Mu opioid receptor antagonist 8 | 3040171-60-3 | Reference compound |
| HY-162670 | Anticancer agent 238 | Reference compound | |
| HY-162671 | BuChE-IN-12 | 1363947-94-7 | Reference compound |
| HY-162672 | Antibacterial agent 231 | Reference compound | |
| HY-162673 | α-Amylase/α-Glucosidase-IN-16 | Reference compound | |
| HY-162674 | MERS-CoV-IN-2 | Reference compound | |
| HY-162675 | COB-187 | 1862177-86-3 | Reference compound |
| HY-162676 | SJ45566 | Reference compound | |
| HY-162677 | MT-1207 | 1610794-70-1 | Reference compound |
| HY-162678 | HDAC-IN-75 | Reference compound | |
| HY-162679 | c-Met degrader-1 | Reference compound | |
| HY-16268 | Kartogenin | 4727-31-5 | Reference compound |
| HY-162680 | OSC-GCDI(P) | Reference compound | |
| HY-162681 | eeAChE-IN-3 | Reference compound | |
| HY-162682 | 5-HT6R antagonist 4 | Reference compound | |
| HY-162683 | (S)-PHA533533 | 437982-89-3 | Reference compound |
| HY-162684 | Antitubercular agent-46 | Reference compound | |
| HY-162686 | MYC-IN-3 | 3042878-82-7 | Reference compound |
| HY-162687 | Antibacterial agent 232 | 2694805-94-0 | Reference compound |
| HY-162688 | Anticancer agent 239 | Reference compound | |
| HY-162689 | GprA | Reference compound | |
| HY-16268A | Kartogenin (sodium) | 1401168-39-5 | Reference compound |
| HY-162690 | DNA polymerase-IN-5 | Reference compound | |
| HY-162691 | DEP-5 | Reference compound | |
| HY-162692 | DNA-PK-IN-14 | 2766001-96-9 | Reference compound |
| HY-162693 | AChE-IN-68 | Reference compound | |
| HY-162694 | Ferroptosis-IN-10 | Reference compound | |
| HY-162695 | Antitumor agent-168 | Reference compound | |
| HY-162696 | mCMQ069 | 3025257-02-4 | Reference compound |
| HY-162697 | α-Glucosidase-IN-69 | Reference compound | |
| HY-162698 | JMF4073 | 1927930-61-7 | Reference compound |
| HY-162699 | LY2023-001 | 327031-30-1 | Reference compound |
| HY-162700 | MK2-IN-6 | Reference compound | |
| HY-162701 | Antiviral agent 58 | 939655-35-3 | Reference compound |
| HY-162702 | AZ'3137 | 2960179-55-7 | Reference compound |
| HY-162703 | Lipid-lowering agent-2 | Reference compound | |
| HY-162704 | JMV7048 | 2871774-88-6 | Reference compound |
| HY-162706 | BSJ-5-63 | 2519823-37-9 | Reference compound |
| HY-162707 | RA-0002323-01 | Reference compound | |
| HY-162708 | KHKI-01128 | Reference compound | |
| HY-162709 | KHKI-01215 | Reference compound | |
| HY-16271 | Kevetrin (hydrochloride) | 66592-89-0 | Reference compound |
| HY-162710 | LTA4H-IN-5 | Reference compound | |
| HY-162711 | Methylbiocin | 23370-12-9 | Reference compound |
| HY-162712 | OX-201 | 2460722-03-4 | Reference compound |
| HY-162713 | MTX-531 | 2791417-66-6 | Reference compound |
| HY-162714 | C3N-Dbn-Trp2 | 2631659-57-7 | Reference compound |
| HY-162715 | EV-A71-IN-2 | Reference compound | |
| HY-162716 | GPX4-IN-10 | Reference compound | |
| HY-162717 | GPX4-IN-11 | 951570-56-2 | Reference compound |
| HY-162718 | GPX4-IN-12 | 931704-14-2 | Reference compound |
| HY-162719 | RH12 | Reference compound | |
| HY-16271S | Kevetrin (hydrochloride)-13C2,15N3 | 2300178-72-5 | Isotope-Labeled Compounds |
| HY-162720 | NNRT-IN-4 | Reference compound | |
| HY-162721 | Anticancer agent 242 | Reference compound | |
| HY-162722 | GSK-3 inhibitor 6 | 1772823-37-6 | Reference compound |
| HY-162723 | FOSL1 degrader 1 | Reference compound | |
| HY-162725 | TLR7 agonist 24 | Reference compound | |
| HY-162726 | GCS-11 | Reference compound | |
| HY-162727 | GCS-12 | Reference compound | |
| HY-162728 | RO-76 | Reference compound | |
| HY-162729 | LSD1-IN-34 | Reference compound | |
| HY-16273 | L-778123 | 183499-57-2 | Reference compound |
| HY-162730 | OPB-171775 | 2131210-15-4 | Reference compound |
| HY-162731 | MASTL-IN-3 | 2883041-26-5 | Reference compound |
| HY-162732 | MASTL-IN-4 | 2883041-36-7 | Reference compound |
| HY-162733 | SVC-02 | 2911548-33-7 | Reference compound |
| HY-162734 | BRD5075 | Reference compound | |
| HY-162735 | BRD5080 | Reference compound | |
| HY-162736 | 1-Piperazinehexanoic acid | 17096-76-3 | Reference compound |
| HY-162737 | 1-Piperazinehexanoic acid-thalidomide | 2819682-33-0 | Reference compound |
| HY-162738 | JMV6944 | 2871774-93-3 | Reference compound |
| HY-162739 | SMARCA2-IN-1 | 2568055-21-8 | Reference compound |
| HY-16273A | L-778123 (hydrochloride) | 253863-00-2 | Reference compound |
| HY-16273B | L-778123 (dihydrochloride) | 183499-56-1 | Reference compound |
| HY-16274 | Lapaquistat acetate | 189060-13-7 | Reference compound |
| HY-162740 | SMARCA2-IN-2 | 2568055-24-1 | Reference compound |
| HY-162741 | PROTAC SMARCA2/4-degrader-33 | 2568276-36-6 | Reference compound |
| HY-162742 | PROTAC SMARCA2 degrader-16 | 2568276-37-7 | Reference compound |
| HY-162743 | PROTAC SMARCA2/4-degrader-29 | 2568273-82-3 | Reference compound |
| HY-162744 | PROTAC SMARCA2/4-degrader-31 | 2568273-83-4 | Reference compound |
| HY-162745 | SMARCA2 degrader-20 | 2568273-85-6 | Reference compound |
| HY-162746 | PROTAC SMARCA2 degrader-9 | 2568276-39-9 | Reference compound |
| HY-162747 | PROTAC SMARCA2 degrader-17 | 2568276-43-5 | Reference compound |
| HY-162748 | PROTAC SMARCA2/4-degrader-30 | 2568276-44-6 | Reference compound |
| HY-162749 | G9D-4 | Reference compound | |
| HY-162750 | ZJCK-6-46 | Reference compound | |
| HY-162751 | Anticancer agent 249 | Reference compound | |
| HY-162752 | Anticancer agent 250 | Reference compound | |
| HY-162753 | ZW-1226 | 2351940-23-1 | Reference compound |
| HY-162754 | LMP7/LMP2-IN-1 | 3053755-09-9 | Reference compound |
| HY-162755 | SHP2-IN-30 | Reference compound | |
| HY-162756 | CK1-IN-4 | Reference compound | |
| HY-162757 | Anticonvulsant agent 5 | Reference compound | |
| HY-162758 | ALR2-IN-5 | Reference compound | |
| HY-162759 | Sigma-1 receptor antagonist 6 | 1335032-28-4 | Reference compound |
| HY-16276 | Osilodrostat | 928134-65-0 | Reference compound |
| HY-162760 | COMT-IN-1 | 2987884-27-3 | Reference compound |
| HY-162761 | COX-1/2-IN-9 | Reference compound | |
| HY-162762 | PAR-2 antagonist 1 | 313957-41-4 | Reference compound |
| HY-162763 | FLQY2 | 794512-88-2 | Reference compound |
| HY-162764 | Androgen receptor degrader-5 | 2902679-11-0 | Reference compound |
| HY-162765 | TRPV4-IN-5 | 3046390-54-6 | Reference compound |
| HY-162766 | Antitumor agent-184 | 3040164-45-9 | Reference compound |
| HY-162767 | KUNG65 | 2144469-30-5 | Reference compound |
| HY-162768 | Grp94 Inhibitor-2 | Reference compound | |
| HY-162769 | HDAC3-IN-5 | Reference compound | |
| HY-16276A | Osilodrostat (phosphate) | 1315449-72-9 | Reference compound |
| HY-162770 | Antiproliferative agent-55 | Reference compound | |
| HY-162771 | Mu opioid receptor agonist 1 | Reference compound | |
| HY-162772 | IDH1/2-IN-1 | Reference compound | |
| HY-162773 | MET-IN-1 | Reference compound | |
| HY-162774A | GRP75-IN-1 (dihydrochloride) | Reference compound | |
| HY-162775 | TST1N-224 | 50566-97-7 | Reference compound |
| HY-162776 | Succinate dehydrogenase-IN-3 | Reference compound | |
| HY-162777 | SARS-CoV-2-IN-93 | Reference compound | |
| HY-162778 | FM-1088 | 2410561-64-5 | Reference compound |
| HY-162779 | CDD-3290 | Reference compound | |
| HY-16278 | Pradigastat | 956136-95-1 | Reference compound |
| HY-162780 | Mcl-1 inhibitor 19 | Reference compound | |
| HY-162781 | HDAC1/6-IN-2 | Reference compound | |
| HY-162782A | V–C6–Bg-PhCl (TFA) | Reference compound | |
| HY-162783 | AZ-PRMT5i-1 | 2918814-96-5 | Reference compound |
| HY-162784 | CYP51-IN-19 | 3006888-90-7 | Reference compound |
| HY-162785 | XC219 | Reference compound | |
| HY-162786 | Nurr1 agonist 11 | 1090335-04-8 | Reference compound |
| HY-162787 | Adenosine receptor antagonist 5 | Reference compound | |
| HY-162788 | EGFR-IN-121 | 418799-16-3 | Reference compound |
| HY-162789 | Galectin-3-IN-5 | Reference compound | |
| HY-16278A | Pradigastat (sodium) | 956136-98-4 | Reference compound |
| HY-162790 | SARS-CoV-2-IN-95 | 2817810-96-9 | Reference compound |
| HY-162791 | (1s,4s)-C1-Piperidine-C1-cyclohexane-C1 | Reference compound | |
| HY-162792 | E3 Ligase Ligand-linker Conjugate 112 | Reference compound | |
| HY-162793 | RdRP-IN-8 | Reference compound | |
| HY-162794 | YCH3124 | Reference compound | |
| HY-162795 | HBV-IN-47 | Reference compound | |
| HY-162796 | TS-2 | Reference compound | |
| HY-162797 | PDE4-IN-18 | Reference compound | |
| HY-162798 | ROCK2-IN-9 | Reference compound | |
| HY-162799 | ChoKα inhibitor-6 | Reference compound | |
| HY-162801 | Neuraminidase-IN-21 | Reference compound | |
| HY-162802 | PI3K/AKT-IN-4 | Reference compound | |
| HY-162803 | c-Met-IN-24 | Reference compound | |
| HY-162804 | ATP synthase inhibitor 3 | Reference compound | |
| HY-162805 | iNOS/TopoI-IN-1 | Reference compound | |
| HY-162807 | TMV-IN-10 | 443749-05-1 | Reference compound |
| HY-162808 | GTSE1-IN-1 | 3002034-34-3 | Reference compound |
| HY-162809 | XMU-MP-9 | 2251130-41-1 | Reference compound |
| HY-16281 | Lecimibide | 130804-35-2 | Reference compound |
| HY-162810 | ICOS-IN-1 | 1006002-58-9 | Reference compound |
| HY-162811 | LAG-3 biner 1 | 1830484-40-6 | Reference compound |
| HY-162812 | H3R antagonist 4 | Reference compound | |
| HY-162813 | PROTAC SMARCA2/4-degrader-25 | Reference compound | |
| HY-162814 | SMARCA2/4-ligand-3 | Reference compound | |
| HY-162815 | PROTAC SMARCA2/4-degrader-26 | Reference compound | |
| HY-162816 | PROTAC HPK1 Degrader-3 | Reference compound | |
| HY-162817 | N′-Nitrosonornicotine N-glucuronide | 864071-82-9 | Biochemical Assay Reagents |
| HY-162818 | Antibacterial agent 237 | Reference compound | |
| HY-162819 | Apoptosis inducer 26 | Reference compound | |
| HY-162820 | Bcl-2-IN-21 | Reference compound | |
| HY-162821 | LI-3948 | 3024591-38-3 | Reference compound |
| HY-162822 | P-gp modulator-5 | Reference compound | |
| HY-162824 | Antitumor photosensitizer-6 | 2938922-20-2 | Reference compound |
| HY-162825 | Antitumor photosensitizer-7 | Reference compound | |
| HY-162826 | Apoptosis inducer 27 | Reference compound | |
| HY-162827 | RAR/RXR agonist-1 | Reference compound | |
| HY-162828 | STAT3/HDAC-IN-2 | Reference compound | |
| HY-162829 | hURAT1 inhibitor 1 | Reference compound | |
| HY-162830 | 5-LOX/MAOs-IN-1 | 33865-93-9 | Reference compound |
| HY-162831 | MPC-IN-1 | Reference compound | |
| HY-162832 | Amyloid-β-IN-1 | Reference compound | |
| HY-162833 | Antileishmanial agent-30 | Reference compound | |
| HY-162834 | PROTAC SMARCA2/4-degrader-27 | 2375564-54-6 | Reference compound |
| HY-162835 | PROTAC SMARCA2/4-degrader-28 | 2409844-88-6 | Reference compound |
| HY-162836 | Rifamycin B | 13929-35-6 | Reference compound |
| HY-162837 | AURKA against 1 | Reference compound | |
| HY-162838 | TCF199 | Reference compound | |
| HY-162839 | Cerastecin D | 3018085-89-4 | Reference compound |
| HY-162840 | Thalidomide-azetidin-3-one | 2770869-33-3 | Reference compound |
| HY-162841 | HPK1 ligand 1 | Reference compound | |
| HY-162842 | HPK1-IN-51 | Reference compound | |
| HY-162845 | TLR7/8 agonist 11 | Reference compound | |
| HY-162846 | NLRP3-IN-44 | 3040298-34-5 | Reference compound |
| HY-162847 | S24–14 | 2348566-35-6 | Reference compound |
| HY-162848 | IHMT-PI3K-315 | Reference compound | |
| HY-162849 | PKMYT1-IN-3 | Reference compound | |
| HY-162850 | DOR agonist 2 | 1212540-02-7 | Reference compound |
| HY-162851 | Adenosine receptor agonist 1 | Reference compound | |
| HY-162852 | OAF89 | Reference compound | |
| HY-162853 | Mtb-IN-8 | 2549199-96-2 | Reference compound |
| HY-162854 | Diacylglycerol acyltransferase inhibitor-2 | 2186700-48-9 | Reference compound |
| HY-162855 | E3 ligase Ligand 33 | 3023410-43-4 | Reference compound |
| HY-162856 | TRPV1-IN-2 | Reference compound | |
| HY-162857 | Heme Oxygenase-1-IN-3 | 1043712-39-5 | Reference compound |
| HY-162858 | BRD-810 | 2329719-65-3 | Reference compound |
| HY-162859 | AB25583 | 2565637-94-5 | Reference compound |
| HY-162860 | FO-4-15 | 1030759-58-0 | Reference compound |
| HY-162861 | 3-Methyl-chuangxinmycin | Reference compound | |
| HY-162862 | JAK-IN-38 | Reference compound | |
| HY-162863 | ERK-MYD88 interaction inhibitor 1 | 2215927-89-0 | Reference compound |
| HY-162864 | JX237 | 1021125-90-5 | Reference compound |
| HY-162865 | FGFR2-IN-3 | 389629-38-3 | Reference compound |
| HY-162866 | CXM102 | Reference compound | |
| HY-162867 | Photosensitizer-5 | Reference compound | |
| HY-162868 | c-Met/HDAC-IN-4 | Reference compound | |
| HY-162872 | NBI-35965 | 268546-19-6 | Reference compound |
| HY-162873 | MEK/RAF-IN-1 | Reference compound | |
| HY-162874 | diABZI-V/C-DBCO | 3035557-60-6 | Reference compound |
| HY-162875 | PROTAC BRD4 Degrader-27 | 2407163-44-2 | Reference compound |
| HY-162876 | PROTAC BRD4 ligand-3 | 1445994-28-4 | Reference compound |
| HY-162877 | AZD4144 | 2890191-41-8 | Reference compound |
| HY-162878 | CHF-6523 | 2500579-21-3 | Reference compound |
| HY-162879 | FAK inhibitor 7 | 2890814-94-3 | Reference compound |
| HY-162880 | RIPK1-IN-24 | 1358585-26-8 | Reference compound |
| HY-162881 | DS06652923 | Reference compound | |
| HY-162882 | CC15009 | 2482713-67-5 | Reference compound |
| HY-162883 | SHMT-IN-4 | 3014814-72-0 | Reference compound |
| HY-162884 | β-Glucuronidase-IN-4 | 2208619-76-3 | Reference compound |
| HY-162885 | YSY01A | 1194235-46-5 | Reference compound |
| HY-162886 | BSO-07 | Reference compound | |
| HY-162887 | VEGFR-2-IN-53 | Reference compound | |
| HY-162888 | WQ-C-401 | 2376694-72-1 | Reference compound |
| HY-162889 | Tyrosinase-IN-36 | Reference compound | |
| HY-16289 | Lodoxamide (tromethamine) | 63610-09-3 | Reference compound |
| HY-162890 | EGFR-IN-122 | 1807453-44-6 | Reference compound |
| HY-162891 | EGFR-IN-123 | 2543763-00-2 | Reference compound |
| HY-162892 | BRD4-IN-9 | 2468959-08-0 | Reference compound |
| HY-162893 | SX29 | Reference compound | |
| HY-162894 | Tyrosinase-IN-37 | 1899025-43-4 | Reference compound |
| HY-162895 | NL13 | Reference compound | |
| HY-162896 | And1 degrader 1 | 3029132-46-2 | Reference compound |
| HY-162897 | BAY-2413555 | 2206665-50-9 | Reference compound |
| HY-162898 | Anti-virulence factor-IN-1 | 2983120-29-0 | Reference compound |
| HY-162899 | DXR-IN-3 | 1465907-72-5 | Reference compound |
| HY-16290 | Lonaprisan | 211254-73-8 | Reference compound |
| HY-162900 | HSP90-IN-32 | 2169279-38-1 | Reference compound |
| HY-162901 | NLRP3-IN-48 | Reference compound | |
| HY-162902 | ALK5-IN-82 | 3001361-04-9 | Reference compound |
| HY-162903 | LN002 | 321372-40-1 | Reference compound |
| HY-162904 | BPU17 | 2198977-68-1 | Reference compound |
| HY-162905 | Antimalarial agent 43 | Reference compound | |
| HY-162906 | FLT3/HDAC-IN-2 | Reference compound | |
| HY-162907 | HDAC-IN-78 | Reference compound | |
| HY-162908 | TRPV1/CB2 agonist 1 | Reference compound | |
| HY-162909 | Tyrosinase-IN-38 | Reference compound | |
| HY-16291 | APTO-253 | 916151-99-0 | Reference compound |
| HY-162910 | HDAC-IN-79 | Reference compound | |
| HY-162911 | Enpp-1-IN-22 | 2954111-09-0 | Reference compound |
| HY-162912 | Enpp-1-IN-23 | 2954111-03-4 | Reference compound |
| HY-162913 | GSK-3β inhibitor 20 | 3044109-48-7 | Reference compound |
| HY-162914 | SARS-CoV-2-IN-96 | Reference compound | |
| HY-162915 | AChE-IN-75 | Reference compound | |
| HY-162916 | AChE-IN-76 | Reference compound | |
| HY-162917 | CD73-IN-16 | Reference compound | |
| HY-162918 | CD73-IN-17 | Reference compound | |
| HY-162919 | YK-2168 | 2571068-74-9 | Reference compound |
| HY-16291A | APTO-253 (hydrochloride) | 1691221-67-6 | Reference compound |
| HY-162920 | QGC583 | 2417001-25-1 | Reference compound |
| HY-162921 | KAT6-IN-2 | Reference compound | |
| HY-162922 | MAP4K4-IN-6 | Reference compound | |
| HY-162923 | Antibacterial agent 244 | Reference compound | |
| HY-162924 | SARS-CoV-IN-6 | 2244671-47-2 | Reference compound |
| HY-162925 | CGRP antagonist 6 | Reference compound | |
| HY-162926 | Antituberculosis agent-12 | Reference compound | |
| HY-162927 | p53-MDM2-IN-6 | 1054506-59-0 | Reference compound |
| HY-162928 | RIPK1-IN-26 | 2252271-96-6 | Reference compound |
| HY-162929 | TP-DEA2 | Reference compound | |
| HY-16293 | Lurbinectedin | 497871-47-3 | Reference compound |
| HY-162930 | PROTAC METTL3 degrader 1 | Reference compound | |
| HY-162932 | ATG12-IN-1 | 2950162-68-0 | Reference compound |
| HY-162933 | AChE-IN-77 | Reference compound | |
| HY-162934 | TFCP2L1-IN-1 | 364621-46-5 | Reference compound |
| HY-162935 | V-ATPase-IN-1 | 1243603-61-3 | Reference compound |
| HY-162936 | SILA-123 | 2911585-37-8 | Reference compound |
| HY-162937 | KIF18A-IN-13 | 3029503-57-6 | Reference compound |
| HY-162938 | Skp2 inhibitor 3 | Reference compound | |
| HY-162939 | TB22 | Reference compound | |
| HY-16293S | Lurbinectedin-d3 | Isotope-Labeled Compounds | |
| HY-16294 | LY2090314 | 603288-22-8 | Reference compound |
| HY-162940 | MerTK/Axl-IN-1 | 3036009-40-9 | Reference compound |
| HY-162941 | SGD-9501-TFA | ADC Related | |
| HY-162942 | SLC7A11-IN-3 | Reference compound | |
| HY-162943 | P60-L3-VHL | Reference compound | |
| HY-162944 | NA-Ir | 3031762-97-4 | Reference compound |
| HY-162946 | Alkyne-P60 | Peptides | |
| HY-162947 | 2-(2-(2-(6-Azidohexanamido)ethoxy)ethoxy)acetic acid | 3036674-82-2 | Reference compound |
| HY-162948 | (S,R,S)-AHPC-PEG2-C5-N3 | Reference compound | |
| HY-162949 | Piperidin-4-amine-C5-O-C1 | 1098625-76-3 | Reference compound |
| HY-162950 | Piperidin-4-amine-C5-O-C1-Thalidomide | 3038591-71-5 | Reference compound |
| HY-162951 | P2X7 receptor antagonist-5 | 3046388-16-0 | Reference compound |
| HY-162952 | cSRC/BCR-ABL1-IN-1 | Reference compound | |
| HY-162953 | Laccase-IN-4 | Reference compound | |
| HY-162954 | PDE11A4-IN-2 | Reference compound | |
| HY-162955 | LSD1/HDAC-IN-1 | 3056145-98-0 | Reference compound |
| HY-162956 | SARS-CoV-2-IN-97 | 364338-71-6 | Reference compound |
| HY-162957 | LasR-IN-5 | Reference compound | |
| HY-162958 | Photosensitizer-6 | 3052251-17-6 | Reference compound |
| HY-162959 | BWC0977 | 2254567-00-3 | Reference compound |
| HY-162960 | pan-KRAS degrader 1 | 2937327-83-6 | Reference compound |
| HY-162961 | Xanthine oxidase-IN-16 | Reference compound | |
| HY-162962 | IDO1/TDO-IN-7 | Reference compound | |
| HY-162963 | PPARδ agonist 11 | 2982696-04-6 | Reference compound |
| HY-162964 | EGFR-IN-126 | 2890621-88-0 | Reference compound |
| HY-162965 | Immunoproteasome activator 1 | 901728-48-1 | Reference compound |
| HY-162966 | MS7829 | Reference compound | |
| HY-162967 | MS8588 | Reference compound | |
| HY-162968 | MRTF-A-IN-1 | Reference compound | |
| HY-162969 | MRTF-A-IN-2 | Reference compound | |
| HY-16297 | Abemaciclib (methanesulfonate) | 1231930-82-7 | Reference compound |
| HY-162970 | XD23 | 2806007-82-7 | Reference compound |
| HY-162971 | KRAS inhibitor-33 | Reference compound | |
| HY-162972 | PROTAC PD-L1 degrader-2 | 2995357-09-8 | Reference compound |
| HY-162973 | PD-L1 ligand 1 | Reference compound | |
| HY-162974 | KRAS inhibitor-34 | 3054800-66-4 | Reference compound |
| HY-162975 | NVP-EVS459 (175Lu) | Reference compound | |
| HY-162976 | KRAS inhibitor-35 | 3030078-96-4 | Reference compound |
| HY-162977 | Orexin receptor activator-1 | 3038645-77-8 | Reference compound |
| HY-162978 | DGAT2-IN-3 | 3037141-61-7 | Reference compound |
| HY-162979 | GLP-1R agonist 25 | Reference compound | |
| HY-16297A | Abemaciclib | 1231929-97-7 | Reference compound |
| HY-16297AR | Abemaciclib (Standard) | 1231929-97-7 | Reference Standards |
| HY-16297AS | Abemaciclib-d8 | 2088650-53-5 | Isotope-Labeled Compounds |
| HY-16297R | Abemaciclib (methanesulfonate) (Standard) | 1231930-82-7 | Reference Standards |
| HY-162980 | NLRP3-IN-52 | Reference compound | |
| HY-162981 | PLpro-IN-7 | 3046158-99-7 | Reference compound |
| HY-162982 | KHK-IN-6 | 3043939-56-3 | Reference compound |
| HY-162983 | KRAS inhibitor-36 | 332373-49-6 | Reference compound |
| HY-162984 | SARS-CoV-2-IN-99 | 2394839-81-5 | Reference compound |
| HY-162985 | JHD205 | Reference compound | |
| HY-162986 | PKMYT1-IN-4 | 3047617-07-9 | Reference compound |
| HY-162987 | PKMYT1-IN-6 | Reference compound | |
| HY-162988 | Myt1-IN-5 | Reference compound | |
| HY-162989 | PRMT5-MTA-IN-2 | Reference compound | |
| HY-162991 | TCO-PAL-PARP | Dye Reagents | |
| HY-162992 | NLRP3-IN-53 | 3044779-14-5 | Reference compound |
| HY-162993 | HN2210 | Reference compound | |
| HY-162994 | KAT6A-IN-1 | 2991087-72-8 | Reference compound |
| HY-162995 | KAT6A-IN-2 | 2991087-74-0 | Reference compound |
| HY-162996 | Spns2-IN-2 | Reference compound | |
| HY-162997 | KAT6-IN-3 | Reference compound | |
| HY-162998 | AT2R antagonist 2 | Reference compound | |
| HY-162999 | TRIP13-IN-1 | Reference compound | |
| HY-163000 | EGFR-IN-129 | Reference compound | |
| HY-163001 | Microcolin H | 2408008-21-7 | Natural Products |
| HY-163002 | viFSP1 | 951945-67-8 | Reference compound |
| HY-163003 | Antitrypanosomal agent 19 | Reference compound | |
| HY-163004 | Type II TRK inhibitor 2 | Reference compound | |
| HY-163005 | α-Glucosidase-IN-43 | 3018963-27-1 | Reference compound |
| HY-163006 | EGFR/c-Met-IN-1 | 3020728-68-8 | Reference compound |
| HY-163007 | Malonylurea-cyclopentene-butanoic acid | Reference compound | |
| HY-163008 | Dicamba-5-aminopentanoic acid | 2339488-53-6 | Reference compound |
| HY-163009 | Dicamba-butyric acid | 2892008-11-4 | Reference compound |
| HY-163010 | Dicamba-propionic acid | 2892008-18-1 | Reference compound |
| HY-163011 | Dicamba-hex-5-ynoic acid | 2892008-20-5 | Reference compound |
| HY-163012 | Dicamba-6-amino-6-oxohexanoic acid | Reference compound | |
| HY-163013 | Dicamba-5-hydroxypentanoic acid | 2892008-29-4 | Reference compound |
| HY-163014 | Dicamba 1-azidopropane | 2892008-32-9 | Reference compound |
| HY-163015 | RNA polymerase-IN-1 | 2447106-74-1 | Reference compound |
| HY-163016 | RNA polymerase-IN-2 | 2447106-79-6 | Reference compound |
| HY-163017 | NP-5497-KA | Reference compound | |
| HY-163018 | Kv3.1 modulator 2 | Reference compound | |
| HY-163019 | EN884 | 2189497-60-5 | Reference compound |
| HY-163020 | Ametryn-acetic acid | 2222775-68-8 | Reference compound |
| HY-163021 | Simeton-acetic acid | 2222775-69-9 | Reference compound |
| HY-163022 | Simazine-acetic acid | 125454-26-4 | Reference compound |
| HY-163023 | Atrazine-acetic acid | 193889-80-4 | Reference compound |
| HY-163024 | Atrazine-3-mercaptopropanoic acid | 125454-31-1 | Reference compound |
| HY-163025 | Cyanazine-3-mercaptopropanoic acid | Reference compound | |
| HY-163026 | Cyromazine-3-mercaptopropanoic acid | 2365353-26-8 | Reference compound |
| HY-163027 | R079 | 2115659-62-4 | Reference compound |
| HY-163028 | ML-T7 | 459789-75-4 | Reference compound |
| HY-163029 | CTSL/B-IN-1 | Reference compound | |
| HY-163030 | LasB-IN-1 | Reference compound | |
| HY-163031 | MAO-B-IN-28 | 3028096-72-9 | Reference compound |
| HY-163032 | FABP4-IN-3 | Reference compound | |
| HY-163033 | Antitubercular agent-42 | Reference compound | |
| HY-163034 | Antitumor photosensitizer-5 | Reference compound | |
| HY-163035 | EM-163 | 1206480-93-4 | Reference compound |
| HY-163036 | Glucosamine–biotin adduct | 1825360-98-2 | Reference compound |
| HY-163037 | Pseudo-β-D-mannopyranose | 90694-07-8 | Reference compound |
| HY-163038 | Sulfamethoxazole-NO (hydrate) | Reference compound | |
| HY-163039 | DOTA-biotin | 188428-79-7 | Reference compound |
| HY-16304 | Mannose 1-phosphate | 27251-84-9 | Natural Products |
| HY-163040 | DOTA-Tyr-Lys-DOTA | 2757339-62-9 | Reference compound |
| HY-163041 | PD-1/PD-L1-IN-36 | 2714327-65-6 | Reference compound |
| HY-163042 | HSGN-218 | 2519410-44-5 | Reference compound |
| HY-163044 | C12-SPM | 2055647-81-7 | Biochemical Assay Reagents |
| HY-163045 | 4-Azidophenylarsonic acid | 861605-27-8 | Reference compound |
| HY-16304A | Mannose 1-phosphate (sodium) | Natural Products | |
| HY-16305 | Maribavir | 176161-24-3 | Reference compound |
| HY-163052 | Ciproquazone | 33453-23-5 | Reference compound |
| HY-163057 | 2,2',2''-Nitrilotris(NH-EG8-Lys-2,4-dinitroaniline) | 929540-19-2 | Reference compound |
| HY-16305R | Maribavir (Standard) | 176161-24-3 | Reference Standards |
| HY-16305S | Maribavir-d6 | Isotope-Labeled Compounds | |
| HY-16305S1 | Maribavir-d6 (TFA) | Isotope-Labeled Compounds | |
| HY-163062 | Tubulin/NRP1-IN-1 | 2983719-82-8 | Reference compound |
| HY-163063 | Antimalarial agent 34 | Reference compound | |
| HY-163064 | CC-3240 | 2922675-91-8 | Reference compound |
| HY-163065 | σ1 Receptor/μ Opioid receptor modulator 2 | 3009018-61-2 | Reference compound |
| HY-163066 | α-Glucosidase-IN-44 | Reference compound | |
| HY-163067 | SARS-CoV-2-IN-71 | Reference compound | |
| HY-163068 | FLT3-IN-24 | Reference compound | |
| HY-163069 | Antitubercular agent-43 | Reference compound | |
| HY-16307 | MB05032 | 261365-11-1 | Reference compound |
| HY-163070 | Antimalarial agent 35 | Reference compound | |
| HY-163071 | V023-9340 | 1048304-96-6 | Reference compound |
| HY-163072 | FXR antagonist 3 | 3024652-96-5 | Reference compound |
| HY-163073 | Anti-MRSA agent 9 | Reference compound | |
| HY-163074 | Ferroptosis-IN-6 | 1517780-59-4 | Reference compound |
| HY-163075 | SYB4 | 2101953-60-8 | Reference compound |
| HY-163076 | Anticancer agent 174 | 2987820-29-9 | Reference compound |
| HY-163077 | Anticancer agent 175 | Reference compound | |
| HY-163078 | C2-Gal-Dox | Reference compound | |
| HY-163079 | AlF-PD-FAPI | Reference compound | |
| HY-16308 | FBPase-IN-5 | 882755-95-5 | Reference compound |
| HY-163080S | Selenium-77 | 14681-72-2 | Isotope-Labeled Compounds |
| HY-163081 | PARP7-IN-17 | 3024030-10-9 | Reference compound |
| HY-163082 | GB1490 | 2172866-22-5 | Reference compound |
| HY-163083 | JN122 | Reference compound | |
| HY-163084 | HJ445A | 3032441-59-8 | Reference compound |
| HY-163085 | HIV capsid modulator 1 | 3031547-95-9 | Reference compound |
| HY-163087 | PT-91 | 3037561-48-8 | Reference compound |
| HY-163088 | CHIKV-IN-4 | 1269363-88-3 | Reference compound |
| HY-163089 | Anticancer agent 176 | Reference compound | |
| HY-16309 | MB-07803 | 882757-24-6 | Reference compound |
| HY-163090 | HR488B | Reference compound | |
| HY-163091 | EP4 receptor antagonist 5 | Reference compound | |
| HY-163093 | ATX inhibitor 24 | Reference compound | |
| HY-163094 | EGFR-IN-95 | 3027135-04-9 | Reference compound |
| HY-163095 | RH1115 | Reference compound | |
| HY-163096 | GPR88 agonist 3 | 2963597-44-4 | Reference compound |
| HY-163097 | ZCAN262 | Reference compound | |
| HY-163098 | JJ-OX-007 | Dye Reagents | |
| HY-163099 | P5(PEG24)-VC-PAB-Exatecan | 2928571-43-9 | Reference compound |
| HY-163101 | CP-96021 | 139401-43-7 | Reference compound |
| HY-163102 | IA-14069 | 2271216-04-5 | Reference compound |
| HY-163103 | (S)-Isomyosmine | 67209-94-3 | Reference compound |
| HY-163104 | Antibacterial agent 169 | 2879255-03-3 | Reference compound |
| HY-163105 | Tubulin/NEDDylation-IN-1 | Reference compound | |
| HY-163106 | W000113414_I13 | 853598-55-7 | Reference compound |
| HY-163107 | Antimycobacterial agent-7 | Reference compound | |
| HY-163108 | ATAD2-IN-1 | 3004556-06-0 | Reference compound |
| HY-163109 | Carbonic anhydrase inhibitor 16 | 4479-70-3 | Reference compound |
| HY-16311 | MB-7133 | 685111-92-6 | Reference compound |
| HY-163110 | NNRT-IN-2 | 2999794-78-2 | Reference compound |
| HY-163111 | Antibacterial agent 170 | 2764797-36-4 | Reference compound |
| HY-163112 | Anticancer agent 179 | Reference compound | |
| HY-163113 | Anticancer agent 180 | Natural Products | |
| HY-163114 | 2-Stearoxyphenethyl phosphocholin | 2170888-39-6 | Reference compound |
| HY-163115 | 2-Oleoxyphenethyl phosphocholin | 2170888-41-0 | Reference compound |
| HY-163116 | Anti-inflammatory agent 67 | Reference compound | |
| HY-163117 | Anti-inflammatory agent 68 | Reference compound | |
| HY-163118 | Topoisomerase II inhibitor 17 | Reference compound | |
| HY-163119 | Pim-1 kinase inhibitor 9 | Reference compound | |
| HY-16312 | MDL-29951 | 130798-51-5 | Reference compound |
| HY-163120 | Myosin-IN-1 | 849011-39-8 | Reference compound |
| HY-163121 | PST3.1a | 1096144-06-7 | Reference compound |
| HY-163122 | 5-Formylsalicylic acid | 616-76-2 | Reference compound |
| HY-163124 | HBV-IN-43 | 2305897-05-4 | Reference compound |
| HY-163125 | BHEPN | Reference compound | |
| HY-163126 | AChE-IN-52 | 2214210-63-4 | Reference compound |
| HY-163127 | AUTAC2-2G | Reference compound | |
| HY-163128 | SPL-IN-1 | 353770-24-8 | Reference compound |
| HY-163129 | BPU | Reference compound | |
| HY-163131 | Glucosylceramide synthase-IN-4 | 2776965-41-2 | Reference compound |
| HY-163132 | DDABT1 | 2777045-35-7 | Reference compound |
| HY-163133 | PIKfyve-IN-3 | Reference compound | |
| HY-163134 | DNA-PK-IN-12 | 2792146-91-7 | Reference compound |
| HY-163136 | Autophagy/REV-ERB-IN-1 | Reference compound | |
| HY-163136A | Autophagy/REV-ERB-IN-1 (hydrochloride) | Reference compound | |
| HY-163137 | Telomerase-IN-6 | Reference compound | |
| HY-163138 | DAT-IN-1 | Reference compound | |
| HY-163139 | Physagulide Y | Natural Products | |
| HY-163140 | IL-33 probe-1 | Reference compound | |
| HY-163141 | PCSK9-IN-24 | 2974496-96-1 | Reference compound |
| HY-163142 | Antibacterial agent 172 | 3023114-93-1 | Reference compound |
| HY-163143 | HDAC8-IN-6 | Reference compound | |
| HY-163144 | DAS-5-oCRBN | Reference compound | |
| HY-163145 | α-Synuclein inhibitor 11 | Reference compound | |
| HY-163146 | TME-HYM (PH Probe) | Dye Reagents | |
| HY-163147 | PAN endonuclease-IN-1 | 2378640-67-4 | Reference compound |
| HY-163148 | PHD-IN-3 | 2924181-77-9 | Reference compound |
| HY-163149 | AB-452 | 2226178-35-2 | Reference compound |
| HY-163150 | 5-HT6R antagonist 3 | Reference compound | |
| HY-163151 | JE-133 | 2579171-69-8 | Reference compound |
| HY-163152 | PROTAC BRM degrader-1 | 2378051-80-8 | Reference compound |
| HY-163153 | Anticancer agent 184 | Reference compound | |
| HY-163154 | JJC8-091 | 1627576-76-4 | Reference compound |
| HY-163155 | RDS03-94 | 2324108-96-3 | Reference compound |
| HY-163156 | JJC12-009 | Reference compound | |
| HY-163157 | Insecticidal agent 7 | 2951079-77-7 | Reference compound |
| HY-163158 | DHODH-IN-24 | 418775-30-1 | Reference compound |
| HY-163159 | NP3-562 | 2409825-32-5 | Reference compound |
| HY-16316 | Metipranolol hydrochloride | 36592-77-5 | Reference compound |
| HY-163160 | BET-IN-23 | 2953287-57-3 | Reference compound |
| HY-163161 | HIV-1 inhibitor-62 | Reference compound | |
| HY-163162 | Anhydro-Ouabain | 3029806-33-2 | Reference compound |
| HY-163163S | 18:1-21:2-18:1 TG-d5 | 2342574-90-5 | Isotope-Labeled Compounds |
| HY-163164S | 18:1-17:1-18:1 TG-d5 | 2342574-91-6 | Isotope-Labeled Compounds |
| HY-163165S | 16:0-19:2-16:0 TG-d5 | 2342574-87-0 | Isotope-Labeled Compounds |
| HY-163166S | 18:1-19:2-18:1 TG-d5 | 2342574-89-2 | Isotope-Labeled Compounds |
| HY-163167 | VH 032 amide-alkylC5-azide | 2821804-11-7 | Reference compound |
| HY-163168 | aTAG 4531 | 2412985-00-1 | Reference compound |
| HY-163169 | Phenyl-glutarimide 4'-oxyacetic acid | 2782024-58-0 | Reference compound |
| HY-163170 | FMF-04-159-R | 2741262-15-5 | Reference compound |
| HY-163171 | ARN11391 | 1214569-31-9 | Reference compound |
| HY-163172 | Miro1 Reducer | 2624336-91-8 | Reference compound |
| HY-163173 | TEAD-IN-8 | 1008768-41-9 | Reference compound |
| HY-163174 | II399 | 2928480-72-0 | Reference compound |
| HY-163175 | BChE-IN-24 | Reference compound | |
| HY-163176 | WB518 | Reference compound | |
| HY-163177 | HIV-1 inhibitor-63 | Reference compound | |
| HY-163179 | NLRP3-IN-28 | 2922814-80-8 | Reference compound |
| HY-163180 | AKT-IN-22 | 1313880-28-2 | Reference compound |
| HY-163181 | MSU-43085 | 2810846-51-4 | Reference compound |
| HY-163182 | CSNK2A-IN-2 | Reference compound | |
| HY-163183 | JAK3/BTK-IN-7 | 2844387-16-0 | Reference compound |
| HY-163184 | DCLK1-IN-3 | Reference compound | |
| HY-163185 | DCLK1-IN-4 | Reference compound | |
| HY-163186 | SARS-CoV-2 Mpro-IN-13 | Reference compound | |
| HY-163187 | COX-2/LOX-IN-1 | Reference compound | |
| HY-163188 | COX-2/LOX-IN-2 | Reference compound | |
| HY-163189 | c-ABL-IN-6 | Reference compound | |
| HY-163190 | NDM-1 inhibitor-4 | 604811-49-6 | Reference compound |
| HY-163191 | NDM-1 inhibitor-5 | 1613045-02-5 | Reference compound |
| HY-163192 | W6134 | 2983540-55-0 | Reference compound |
| HY-163193 | MJO445 | 1968-56-5 | Reference compound |
| HY-163194 | Cbl-b-IN-16 | Reference compound | |
| HY-163195 | Tubulin inhibitor 40 | Reference compound | |
| HY-163196 | PSMA-IN-4 | 1561171-59-2 | Reference compound |
| HY-163197 | JSF-2827 | Reference compound | |
| HY-163198 | ASCT2-IN-1 | 3032651-18-3 | Reference compound |
| HY-163199 | ASCT2-IN-2 | Reference compound | |
| HY-163200 | Cu(I) chelator 1 | Reference compound | |
| HY-163201 | TMV-IN-7 | Reference compound | |
| HY-163202 | MAGL-IN-13 | Reference compound | |
| HY-163203 | DDC18-8A | Reference compound | |
| HY-163204 | RhQ-DMB | Reference compound | |
| HY-163205 | VU6067416 | 3027515-24-5 | Reference compound |
| HY-163206 | SARS-CoV-2-IN-77 | Reference compound | |
| HY-163207 | sEH/HDAC6-IN-1 | 2847838-67-7 | Reference compound |
| HY-163208 | VH 032 amide-alkylC9-amine (hydrochloride) | 2758364-04-2 | Reference compound |
| HY-163209 | VH 032 amide-PEG6-amine (hydrochloride) | 2763910-08-1 | Reference compound |
| HY-16321 | Micafungin (sodium) | 208538-73-2 | Reference compound |
| HY-163210 | Pomalidomide 5'-fluoro-6'-piperazine-4-methylpiperidine (hydrochloride) | 2758431-94-4 | Reference compound |
| HY-163211 | SARS-CoV-2 Mpro-IN-14 | 2679814-93-6 | Reference compound |
| HY-163212 | PreQ1-alkyne | 2771096-76-3 | Reference compound |
| HY-163213 | Psoralen-triethylene glycol azide | 1352815-11-2 | Reference compound |
| HY-163214 | (S)-PROTAC PTK6 ligand-1-(2S,4R)-O-CH2-O-hygric acid | Reference compound | |
| HY-163215 | (S)-PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc | Reference compound | |
| HY-163216 | PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc | Reference compound | |
| HY-163217 | PROTAC PTK6 ligand-2,7-diazaspiro[3.5]nonane-Boc | Reference compound | |
| HY-163218 | PROTAC PTK6 ligand-1-(2S,4R)-O-CH2-O-hygric acid | Reference compound | |
| HY-163219 | VHL Ligand 8-PEG2-O-piperidine-Boc | Reference compound | |
| HY-16321R | Micafungin (sodium) (Standard) | 208538-73-2 | Reference Standards |
| HY-16322 | Minodronic acid | 180064-38-4 | Reference compound |
| HY-163220 | (S,R,S)-AHPC-CO-CH2-O-CH2-piperidine-Boc | Reference compound | |
| HY-163221 | (S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-N(Me)-Boc | Reference compound | |
| HY-163222 | 4-Methylanisole-dihydrouracil-imidazo[1,2-a]pyridine-piperidine-NH-Boc | Reference compound | |
| HY-163223 | (S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc | Reference compound | |
| HY-163224 | (S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc | Reference compound | |
| HY-163225 | (S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc | Reference compound | |
| HY-163226 | (1R,5S)-Thalidomide-3,8-diazabicyclo[3.2.1]octane-(1R,4r)-cyclohexane-NH-Boc | Reference compound | |
| HY-163227 | (1R,4R)-Thalidomide-2,5-diazabicyclo[2.2.1]heptane-(1R,4r)-cyclohexane-NH-Boc | Reference compound | |
| HY-163228 | PROTAC PTK6 ligand-O-C2-O-piperidine-Boc | Reference compound | |
| HY-163229 | (1r,4r)-Thalidomide-piperidine-N(Me)-CH-cyclohexane-NH-Boc | Reference compound | |
| HY-16322A | Minodronic acid (hydrate) | 155648-60-5 | Reference compound |
| HY-16322S | Minodronic acid-d4 | 1807367-80-1 | Isotope-Labeled Compounds |
| HY-163230 | (1R,5S)-Thalidomide-3,8-diazabicyclo[3.2.1]octane-Boc | Reference compound | |
| HY-163231 | (S,R,S)-AHPC-CO-CH2-azetidine-piperazine-CH2-COOH | Reference compound | |
| HY-163232 | Phthalimidinoglutarimide-piperidine-NH-Boc | 2229720-55-0 | Reference compound |
| HY-163233 | Phthalimidinoglutarimide-5-piperazine | Reference compound | |
| HY-163234 | Phthalimidinoglutarimide-piperidine-NH2 | 2591197-83-8 | Reference compound |
| HY-163235 | Phenyl phenylcarbamate-CH-5-methoxypicolinamide-CH-CH-Ph-CF3 | Reference compound | |
| HY-163236 | Thalidomide-piperidine-O-azetidine-acetic acid | Reference compound | |
| HY-163237 | Thalidomide-piperidine-O-azetidineethanol | Reference compound | |
| HY-163238 | Thalidomide-azetidine-CH-piperazineethanol | Reference compound | |
| HY-163239 | (R)-Thalidomide-piperazine-pyrrolidineethanol | Reference compound | |
| HY-163240 | HSD17B13-IN-24 | 2770246-37-0 | Reference compound |
| HY-163241 | HSD17B13-IN-25 | 2770246-39-2 | Reference compound |
| HY-163242 | HSD17B13-IN-28 | 2770246-42-7 | Reference compound |
| HY-163243 | HSD17B13-IN-29 | 2770246-48-3 | Reference compound |
| HY-163244 | HSD17B13-IN-30 | 2770246-58-5 | Reference compound |
| HY-163245 | HSD17B13-IN-32 | 2770246-61-0 | Reference compound |
| HY-163246 | HSD17B13-IN-34 | 2770246-68-7 | Reference compound |
| HY-163247 | HSD17B13-IN-35 | 2770246-69-8 | Reference compound |
| HY-163248 | HSD17B13-IN-37 | 2770246-71-2 | Reference compound |
| HY-163249 | HSD17B13-IN-49 | 2770246-74-5 | Reference compound |
| HY-16325 | Miriplatin (hydrate) | 250159-48-9 | Reference compound |
| HY-163250 | HSD17B13-IN-51 | 2770246-75-6 | Reference compound |
| HY-163251 | HSD17B13-IN-52 | 2770246-77-8 | Reference compound |
| HY-163252 | HSD17B13-IN-53 | 2770246-81-4 | Reference compound |
| HY-163253 | HSD17B13-IN-56 | 2770246-82-5 | Reference compound |
| HY-163253S | HSD17B13-IN-56-d3 | 2770247-60-2 | Isotope-Labeled Compounds |
| HY-163254 | HSD17B13-IN-57 | 2770246-86-9 | Reference compound |
| HY-163255 | HSD17B13-IN-58 | 2770246-89-2 | Reference compound |
| HY-163256 | HSD17B13-IN-59 | 2770247-11-3 | Reference compound |
| HY-163257 | HSD17B13-IN-60 | 2770247-20-4 | Reference compound |
| HY-163258 | HSD17B13-IN-61 | 2770247-26-0 | Reference compound |
| HY-163259 | HSD17B13-IN-62 | 2770247-32-8 | Reference compound |
| HY-163259S | HSD17B13-IN-62-d3 | 2770247-67-9 | Isotope-Labeled Compounds |
| HY-16325A | Miriplatin | 141977-79-9 | Reference compound |
| HY-163260 | HSD17B13-IN-64 | 2770247-34-0 | Reference compound |
| HY-163261 | HSD17B13-IN-66 | 2770247-37-3 | Reference compound |
| HY-163262 | HSD17B13-IN-71 | 2770247-40-8 | Reference compound |
| HY-163263 | HSD17B13-IN-80 | 2770247-42-0 | Reference compound |
| HY-163263S | HSD17B13-IN-80-d3 | 2770247-70-4 | Isotope-Labeled Compounds |
| HY-163263S1 | HSD17B13-IN-80-d2 | 2770247-90-8 | Isotope-Labeled Compounds |
| HY-163264 | HSD17B13-IN-81 | 2770247-45-3 | Reference compound |
| HY-163265 | HSD17B13-IN-82 | 2770247-47-5 | Reference compound |
| HY-163266 | HSD17B13-IN-83 | 2770247-41-9 | Reference compound |
| HY-163267 | ZNL0325 | Reference compound | |
| HY-163268 | Carbonic anhydrase inhibitor 18 | Reference compound | |
| HY-163269 | MPT | 2413282-48-9 | Reference compound |
| HY-163270 | PM534 | 2446376-25-4 | Reference compound |
| HY-163271 | XL-126 | 3033576-12-1 | Reference compound |
| HY-163272 | GPX4/CDK-IN-1 | Reference compound | |
| HY-163273 | FGFR4-IN-17 | 3011805-61-8 | Reference compound |
| HY-163274 | NOD1 antagonist-1 | Reference compound | |
| HY-163275 | MDM2-IN-24 | Reference compound | |
| HY-163276 | OX2R-IN-2 | Reference compound | |
| HY-163277 | PIPE-3297 | Reference compound | |
| HY-163278 | Lck-IN-2 | 2615173-24-3 | Reference compound |
| HY-163279 | Fluopipamine | 885902-66-9 | Reference compound |
| HY-163280 | JGB-1-155 | 3011930-28-9 | Reference compound |
| HY-163281 | FSY-OSO2F | 1839622-49-9 | Dye Reagents |
| HY-163282 | NB512 | Reference compound | |
| HY-163283 | 6′-Methyl paeonol | 6540-66-5 | Reference compound |
| HY-163284 | SDH-IN-12 | 3027210-28-9 | Reference compound |
| HY-163285 | PDE3B-IN-1 | 3032458-01-5 | Reference compound |
| HY-163286 | BODIQPy-TPA | 2738333-02-1 | Dye Reagents |
| HY-163287 | QPy-TPA | 2738332-94-8 | Dye Reagents |
| HY-163288 | EZH2/HSP90-IN-29 | Reference compound | |
| HY-163290 | HDAC-MB | Dye Reagents | |
| HY-163291 | AM4085 | Reference compound | |
| HY-163292 | Antibacterial agent 180 | Reference compound | |
| HY-163293 | Mcl-1 inhibitor 18 | Reference compound | |
| HY-163294 | PPARγ agonist 10 | 2445990-92-9 | Reference compound |
| HY-163295 | BTK degrader-1 | 2377645-56-0 | Reference compound |
| HY-163297 | Antifungal agent 90 | 3023095-87-3 | Reference compound |
| HY-163298 | Herbicidal agent 2 | 3024668-43-4 | Reference compound |
| HY-163299 | pan-KRAS-IN-5 | 3027172-23-9 | Reference compound |
| HY-163300 | NLRP3-IN-30 | Reference compound | |
| HY-163301 | Antitumor agent-139 | Reference compound | |
| HY-163303 | Tyk2-IN-15 | 3010873-44-3 | Reference compound |
| HY-163304 | Tyk2-IN-16 | 3010874-30-0 | Reference compound |
| HY-163305 | Tyk2-IN-17 | 3010874-31-1 | Reference compound |
| HY-163307 | PD-1/PD-L1-IN-39 | Reference compound | |
| HY-163308 | Bcl-2-IN-18 | Reference compound | |
| HY-163309 | Bcl-2-IN-19 | Reference compound | |
| HY-163310 | Transketolase-IN-5 | Reference compound | |
| HY-163311 | Transketolase-IN-6 | Reference compound | |
| HY-163312S | Tyk2-IN-18-d5 | 3018160-63-6 | Isotope-Labeled Compounds |
| HY-163313S | Tyk2-IN-19-d6 | 3018160-65-8 | Isotope-Labeled Compounds |
| HY-163314S | Tyk2-IN-18-d3 | 3018160-68-1 | Isotope-Labeled Compounds |
| HY-163315 | YPLP | 2414391-44-7 | Reference compound |
| HY-163316 | SIRT4-IN-1 | Reference compound | |
| HY-163317 | MMC(TMZ)-TOC | Peptides | |
| HY-163317A | MMC(TMZ)-TOC (TFA) | Reference compound | |
| HY-163318 | NS2B/NS3-IN-8 | 1021221-94-2 | Reference compound |
| HY-163319 | NCA029 | Reference compound | |
| HY-163320 | AChE/Aβ-IN-5 | 181114-32-9 | Reference compound |
| HY-163321 | DapE-IN-1 | Reference compound | |
| HY-163322 | MAO-A inhibitor 2 | Reference compound | |
| HY-163323 | AKR1C3-IN-12 | 891075-67-5 | Reference compound |
| HY-163324 | 2-Me PeER (chloride) | Dye Reagents | |
| HY-163324A | 2-Me PeER | Reference compound | |
| HY-163325 | Fli-1-IN-1 (fumarate) | Reference compound | |
| HY-163325A | Fli-1-IN-1 | 3027140-81-1 | Reference compound |
| HY-163326 | Tyrosinase-IN-25 | Reference compound | |
| HY-163327 | pFBC | Reference compound | |
| HY-163328 | DHODH-IN-25 | 2619531-95-0 | Reference compound |
| HY-163329 | BCH-HSP-C01 | Reference compound | |
| HY-163330 | 8-Azakinetin riboside | 2347524-00-7 | Reference compound |
| HY-163331 | Cresomycin | 2999743-51-8 | Reference compound |
| HY-163332 | MPO-IN-6 | Reference compound | |
| HY-163334 | GGDPS-IN-1 | Reference compound | |
| HY-163335 | MPO-IN-7 | Reference compound | |
| HY-163336 | 14,15-Leukotriene A4 methyl ester | 75290-58-3 | Reference compound |
| HY-163337 | Antifungal agent 92 | 3020687-94-6 | Reference compound |
| HY-163338 | Metallo-β-lactamase-IN-13 | 1802366-23-9 | Reference compound |
| HY-163339 | Metallo-β-lactamase-IN-14 | 1802367-43-6 | Reference compound |
| HY-163340 | GA32 | 1386811-71-7 | Reference compound |
| HY-163341 | PAR4 antagonist 1 | 2173201-65-3 | Reference compound |
| HY-163342 | Antibacterial agent 190 | Reference compound | |
| HY-163343 | Enpp-1-IN-20 | Reference compound | |
| HY-163345 | 5-HT7R antagonist 2 | 1448808-50-1 | Reference compound |
| HY-163346 | TPEG-P | Reference compound | |
| HY-163347 | FXIIa-IN-3 | Reference compound | |
| HY-163348 | FXIIa-IN-4 | Reference compound | |
| HY-163349 | TUG-2099 | Reference compound | |
| HY-163350 | TUG-2208 | Reference compound | |
| HY-163351 | PDI-IN-2 | Reference compound | |
| HY-163352 | Chitinase-IN-6 | Reference compound | |
| HY-163353 | Antibacterial agent 193 | Reference compound | |
| HY-163354 | EGFR-IN-103 | 2568506-66-9 | Reference compound |
| HY-163355 | COX-2/15-LOX-IN-5 | 443790-30-5 | Reference compound |
| HY-163356 | Tubulin polymerization-IN-60 | 2361303-91-3 | Reference compound |
| HY-163357 | CDK2/MDM2-IN-1 | Reference compound | |
| HY-163358 | SLC3037 | Reference compound | |
| HY-163359 | CYP17A1/HDAC6-IN-1 | 3047489-22-2 | Reference compound |
| HY-16336 | Motexafin gadolinium | 246252-06-2 | Reference compound |
| HY-163360 | PI3Kα-IN-19 | 885692-56-8 | Reference compound |
| HY-163361 | PI3Kα-IN-20 | 228999-57-3 | Reference compound |
| HY-163362 | HIV-1 inhibitor-65 | Reference compound | |
| HY-163363 | β-AR antagonist 2 | 2779507-62-7 | Reference compound |
| HY-163364 | DS-22-inf-021 | 945170-74-1 | Reference compound |
| HY-163365 | UTX-143 | Reference compound | |
| HY-163366 | TRK-IN-28 | 2991504-43-7 | Reference compound |
| HY-163367 | MATE-IN-1 | Reference compound | |
| HY-163368 | HDAC6-IN-34 | 1432508-73-0 | Reference compound |
| HY-163369 | HDAC6-IN-35 | 1394615-06-5 | Reference compound |
| HY-163370 | HIF-1α-IN-7 | 3026685-76-4 | Reference compound |
| HY-163371 | EGFR WT/T790M-IN-1 | Reference compound | |
| HY-163372 | PROTAC HPK1 Degrader-1 | 3034182-97-0 | Reference compound |
| HY-163373 | 13,14-Dihydro-15-keto prostaglandin D1 | 1392219-79-2 | Reference compound |
| HY-163374 | Cdc7-IN-20 | Reference compound | |
| HY-163375 | Methyl cis-12-octadecenoate | 2733-86-0 | Reference compound |
| HY-163376 | 17-Trifluoromethylphenyl trinor prostaglandin F2α ethyl amide | 1621369-73-0 | Reference compound |
| HY-163377 | AZ5385 | 848439-89-4 | Reference compound |
| HY-163378 | C5aR1 antagonist 1 | 2365325-67-1 | Reference compound |
| HY-163379 | C5aR1 antagonist 2 | 2365161-92-6 | Reference compound |
| HY-163380 | CA/MAO-B-IN-1 | Reference compound | |
| HY-163381 | Antiproliferative agent-48 | 1621594-62-4 | Reference compound |
| HY-163382 | Cbz-Gly-Pro-Ala-O-cinnamyl | Reference compound | |
| HY-163383 | L-Ent-oxPt(IV) | Reference compound | |
| HY-163384 | (S)-CE-123 | 2378384-49-5 | Reference compound |
| HY-163385 | ALKBH1-IN-1 | Reference compound | |
| HY-163386 | HFTC-HClO 1 | Reference compound | |
| HY-163387 | CHI3L1-IN-1 | 2982256-78-8 | Reference compound |
| HY-163388 | CHI3L1-IN-2 | 2982257-63-4 | Reference compound |
| HY-163389 | Mpro/Cathepsin L-IN-1 | Reference compound | |
| HY-16339 | N3PT | 13860-66-7 | Reference compound |
| HY-163390 | RIP1 kinase inhibitor 9 | Reference compound | |
| HY-163392 | Neuraminidase-IN-17 | 2935407-34-2 | Reference compound |
| HY-163393 | Neuraminidase-IN-18 | 2935407-32-0 | Reference compound |
| HY-163394 | CB2 receptor agonist 6 | Reference compound | |
| HY-163395 | 3-Tosylimidazolidine-2,4-dione | Reference compound | |
| HY-163396 | EGFR-IN-107 | Reference compound | |
| HY-163397 | Antibacterial agent 196 | Reference compound | |
| HY-163398 | TLR7-IN-1 | 3026308-79-9 | Reference compound |
| HY-163399 | Antibacterial agent 197 | 54387-80-3 | Reference compound |
| HY-163401 | Epoxykynin | 640263-95-2 | Reference compound |
| HY-163402 | "EGFR-IN-108 (chloride )" | Reference compound | |
| HY-163403 | VEGFR-2-IN-43 | Reference compound | |
| HY-163404 | Urease-IN-13 | Reference compound | |
| HY-163405 | Galectin-3-IN-3 | 2491661-50-6 | Reference compound |
| HY-163406 | PDE1-IN-6 | 2877017-16-6 | Reference compound |
| HY-163407 | Galectin-3-IN-4 | 2496515-38-7 | Reference compound |
| HY-163408 | ALP-IN-1 | Reference compound | |
| HY-163409 | CGK012 | 2044497-76-7 | Reference compound |
| HY-163410 | AU-24118 | Reference compound | |
| HY-163411 | Neutrophil elastase inhibitor 6 | Reference compound | |
| HY-163412 | IKKβ-IN-3 | Reference compound | |
| HY-163413 | BRD4-BD1-IN-3 | Reference compound | |
| HY-163414 | hCAIX/XII-IN-11 | Reference compound | |
| HY-163415 | MAO-IN-5 | 906728-07-2 | Reference compound |
| HY-163417 | HER2-IN-15 | Reference compound | |
| HY-163418 | HER2-IN-17 | Reference compound | |
| HY-163419 | HER2-IN-18 | Reference compound | |
| HY-163420 | HER2-IN-16 | Reference compound | |
| HY-163421 | hERG-IN-2 | 2414055-95-9 | Reference compound |
| HY-163422S | PHSHPALTPEQK-(Lys-13C6,15N2) | Isotope-Labeled Compounds | |
| HY-163423S | TELAEPTSTR-(Arg-13C6,15N4) | Isotope-Labeled Compounds | |
| HY-163424S | SSVFVADPK-(Lys-13C6,15N2) | Isotope-Labeled Compounds | |
| HY-163425S | AILNYVANK-(Lys-13C6,15N2) | Isotope-Labeled Compounds | |
| HY-163426S | AFFGHYLYEVAR-(Arg-13C6,15N4) | Isotope-Labeled Compounds | |
| HY-163427S | FNLEALVTHTLPFEK-(Lys-13C6,15N2) | Isotope-Labeled Compounds | |
| HY-163428 | Perzebertinib | 2414056-31-6 | Reference compound |
| HY-163429 | J-1149 | 2883580-95-6 | Reference compound |
| HY-16343 | NB-598 | 131060-14-5 | Reference compound |
| HY-163430 | HDAC-IN-71 | 2995354-52-2 | Reference compound |
| HY-163431 | URAT1 inhibitor 10 | 3012586-38-5 | Reference compound |
| HY-163432 | YGL-12 | Reference compound | |
| HY-163433 | α-Glucosidase-IN-57 | Reference compound | |
| HY-163434 | PRMT5/EGFR-IN-1 | Reference compound | |
| HY-163435 | Anticancer agent 201 | Reference compound | |
| HY-163436 | F44-A13 | 1338190-14-9 | Reference compound |
| HY-163437 | Antitubercular agent-45 | Reference compound | |
| HY-163438 | BKIDC-1553 | 1951431-34-7 | Reference compound |
| HY-163439 | α-Amylase/α-Glucosidase-IN-12 | Reference compound | |
| HY-16343A | NB-598 (hydrochloride) | 136719-25-0 | Reference compound |
| HY-16343C | NB-598 (Maleate) | 155294-62-5 | Reference compound |
| HY-16344 | Nedocromil sodium | 69049-74-7 | Reference compound |
| HY-163440 | PROTAC NAMPT Degrader-1 | Reference compound | |
| HY-163441 | BChE-IN-31 | Reference compound | |
| HY-163442A | PIM3-IN-1 (hydrochloride) | Reference compound | |
| HY-163443 | PPAR agonist 4 | Reference compound | |
| HY-163444 | Apoptosis inducer 15 | Reference compound | |
| HY-163445 | NAMPT activator-6 | 2237267-86-4 | Reference compound |
| HY-163448 | NPP1-IN-2 | Reference compound | |
| HY-163449 | NPP3-IN-1 | Reference compound | |
| HY-163450 | Nimbiol | 561-95-5 | Natural Products |
| HY-163451 | Apoptosis inducer 17 | Reference compound | |
| HY-163452 | Squalene synthase-IN-2 | Reference compound | |
| HY-163453 | HER2-IN-19 | Reference compound | |
| HY-163454 | NorA-IN-2 | Reference compound | |
| HY-163455 | pan-HCN-IN-1 | 1334308-63-2 | Reference compound |
| HY-163456 | Chx-HT | Reference compound | |
| HY-163457 | Antileishmanial agent-27 | Reference compound | |
| HY-163458 | Anti-inflammatory agent 77 | Reference compound | |
| HY-163459 | HWY-289 | 908001-51-4 | Reference compound |
| HY-16346 | Netupitant | 290297-26-6 | Reference compound |
| HY-163460 | MS8535 | Reference compound | |
| HY-163461 | 4F-DDC | Reference compound | |
| HY-163462 | Poacic acid | 160097-32-5 | Reference compound |
| HY-163463 | PTP1B-IN-25 | Reference compound | |
| HY-163464 | Plasma kallikrein-IN-5 | Reference compound | |
| HY-163465 | DTNP | 3010266-66-4 | Dye Reagents |
| HY-163466 | FXR agonist 7 | Reference compound | |
| HY-163467 | CHEMBL4224880 | 2095850-54-5 | Reference compound |
| HY-163468 | SRC-3-IN-1 | Reference compound | |
| HY-163469 | SRC-3-IN-2 | 3074959-44-4 | Reference compound |
| HY-16346R | Netupitant (Standard) | 290297-26-6 | Reference Standards |
| HY-16346S | Netupitant-d6 | 2070015-31-3 | Isotope-Labeled Compounds |
| HY-163470 | Luciferase activator-1 | 315703-95-8 | Reference compound |
| HY-163471 | PDGFRα/β/VEGFR-2-IN-1 | Reference compound | |
| HY-163472 | PR280 | Reference compound | |
| HY-163473 | IITR08367 | Reference compound | |
| HY-163474 | MAO-B-IN-32 | Reference compound | |
| HY-163475 | CXCL-CXCR1/2-IN-1 | 2415653-55-1 | Reference compound |
| HY-163476 | PIP5K1C-IN-1 | 3060954-15-3 | Reference compound |
| HY-163477 | PIP5K1C-IN-2 | 3060954-34-6 | Reference compound |
| HY-163478 | TNIK-IN-9 | Reference compound | |
| HY-163479 | MNK1/2-IN-7 | 2548283-27-6 | Reference compound |
| HY-163480 | PF-06835375 | 2796997-12-9 | Inhibitory Antibodies |
| HY-163481 | Antibiofilm agent-6 | Reference compound | |
| HY-163482 | ELQ-596 | 3023709-98-7 | Reference compound |
| HY-163483 | ELQ-598 | 3023709-99-8 | Reference compound |
| HY-163484 | ELQ-650 | 3023710-00-8 | Reference compound |
| HY-163485 | AR antagonist 8 | Reference compound | |
| HY-163486 | Antituberculosis agent-10 | 2095636-19-2 | Reference compound |
| HY-163487 | Puxitatug samrotecan drug-linker | 3025787-81-6 | Reference compound |
| HY-163488 | pan-KRAS-IN-14 | Reference compound | |
| HY-163489 | pan-KRAS-IN-15 | 3034052-52-0 | Reference compound |
| HY-16349 | Nimorazole | 6506-37-2 | Reference compound |
| HY-163490 | PKMYT1-IN-1 | 3033609-83-2 | Reference compound |
| HY-163491 | PKMYT1-IN-2 | 3033609-84-3 | Reference compound |
| HY-163492 | PARP7-IN-19 | Reference compound | |
| HY-163493 | NLRP3-IN-35 | Reference compound | |
| HY-163494 | NLRP3-IN-36 | Reference compound | |
| HY-163495 | HPK1-IN-44 | Reference compound | |
| HY-163496 | HPK1-IN-45 | Reference compound | |
| HY-163497 | NLRP3-IN-38 | 3033054-46-2 | Reference compound |
| HY-163498 | NLRP3-IN-37 | 3033054-51-9 | Reference compound |
| HY-163499 | NAMPT activator-7 | Reference compound | |
| HY-16349R | Nimorazole (Standard) | 6506-37-2 | Reference Standards |
| HY-16350 | BOLD-100 | 197723-00-5 | Reference compound |
| HY-163500 | NAMPT activator-8 | 3034104-30-5 | Reference compound |
| HY-163501 | PI3Kα-IN-23 | Reference compound | |
| HY-163502 | PROTAC STAT3 degrader-3 | Reference compound | |
| HY-163503 | HDAC6-IN-38 | 3030872-95-5 | Reference compound |
| HY-163504 | PAR4 antagonist 5 | 3024653-17-3 | Reference compound |
| HY-163505 | Anti-MRSA agent 11 | 3029704-83-1 | Reference compound |
| HY-163506 | Ebselen derivative 1 | 3030492-59-9 | Reference compound |
| HY-163507 | ALK5-IN-79 | 2725056-38-0 | Reference compound |
| HY-163508 | Antibacterial agent 210 | Reference compound | |
| HY-163509 | COX-2-IN-43 | 1023524-40-4 | Reference compound |
| HY-163510 | AR/AR-V7-IN-1 | 2964558-54-9 | Reference compound |
| HY-163511 | PI3K/Akt/mTOR-IN-4 | Reference compound | |
| HY-163512 | Anti-inflammatory agent 79 | Reference compound | |
| HY-163513 | AACA | 2515609-54-6 | Reference compound |
| HY-163514 | hAChE-IN-8 | Reference compound | |
| HY-163515 | Anticancer agent 207 | Reference compound | |
| HY-163516 | HBV-IN-45 | Reference compound | |
| HY-163517 | Antibacterial agent 211 | Reference compound | |
| HY-163518 | Antitumor agent-153 | Reference compound | |
| HY-163519 | α-Synuclein inhibitor 13 | Reference compound | |
| HY-163520 | IDO1-IN-24 | Reference compound | |
| HY-163521 | Neuraminidase-IN-19 | 3040120-40-6 | Reference compound |
| HY-163522 | Neuraminidase-IN-20 | Reference compound | |
| HY-163523 | PYRIB-SO 2 | Reference compound | |
| HY-163524 | NAE-IN-2 | Reference compound | |
| HY-163526 | STAT3-IN-26 | 3033746-27-6 | Reference compound |
| HY-163527 | FGFR-IN-13 | 2962941-25-7 | Reference compound |
| HY-163528 | Antibacterial agent 213 | Reference compound | |
| HY-163529 | HN0037 | 2233566-79-3 | Reference compound |
| HY-163529A | (S)-HN0037 | 2233566-78-2 | Reference compound |
| HY-163530 | GPR41 modulator 1 | 3050768-93-6 | Reference compound |
| HY-163531 | GPR41 modulator 2 | 3050769-11-1 | Reference compound |
| HY-163532 | FLS-359 | 2309398-79-4 | Reference compound |
| HY-163533 | CPD-002 | 2617376-08-4 | Reference compound |
| HY-163534 | PD-1/PD-L1-IN-43 | Reference compound | |
| HY-163535 | J208 | 2116468-11-0 | Reference compound |
| HY-163536 | TGF-β1/Smad3-IN-1 | Reference compound | |
| HY-163537 | AChE/BuChE-IN-5 | Reference compound | |
| HY-163538 | TYM-3-98 | Reference compound | |
| HY-163540 | NP-BTA | 544420-99-7 | Reference compound |
| HY-163541 | SMS121 | Reference compound | |
| HY-163542 | Pneumolysin-IN-1 | 330842-49-4 | Reference compound |
| HY-163543 | Progranulin modulator-2 | Reference compound | |
| HY-163544 | δ-Tocotrienol prodrug-1 | 128254-90-0 | Reference compound |
| HY-163545 | Tc-Me2P | Reference compound | |
| HY-163546 | HSV-1-IN-1 | Reference compound | |
| HY-163547 | PPAR agonist 5 | Reference compound | |
| HY-163548 | SPP-002 | Reference compound | |
| HY-163549 | APN-PEG5-VC-PAB-MMAE | Reference compound | |
| HY-16355 | NVP-QAV-572 | 957209-68-6 | Reference compound |
| HY-163550 | 5-MethylCytosine/BSA | Biochemical Assay Reagents | |
| HY-163551 | BNP peptide/KLH | Biochemical Assay Reagents | |
| HY-163552 | Prostaglandin F2a/BSA | Biochemical Assay Reagents | |
| HY-163553 | Metronidazole/BSA | Biochemical Assay Reagents | |
| HY-163555 | BZO/BSA | Biochemical Assay Reagents | |
| HY-163556 | COT/BSA | Biochemical Assay Reagents | |
| HY-163558 | Anticancer agent 212 | Reference compound | |
| HY-163559 | HPPD-IN-4 | 3028731-23-6 | Reference compound |
| HY-163560 | Insecticidal agent 10 | 3026314-21-3 | Reference compound |
| HY-163561 | CARM1-IN-6 | 1269199-96-3 | Reference compound |
| HY-163562 | JYQ-164 | Reference compound | |
| HY-163563 | JYQ-173 | Reference compound | |
| HY-163564 | JYQ-194 | Reference compound | |
| HY-163565 | BIIB129 | 2770960-52-4 | Reference compound |
| HY-163566 | Apoptosis inducer 18 | Reference compound | |
| HY-163567 | RSV-IN-10 | Reference compound | |
| HY-163568 | RSV-IN-11 | Reference compound | |
| HY-163569 | FGFR4-IN-20 | Reference compound | |
| HY-16357 | Octimibate | 89838-96-0 | Reference compound |
| HY-163570 | PPO-IN-11 | Reference compound | |
| HY-163571 | CYP51-IN-17 | Reference compound | |
| HY-163572 | PIP5K1α-IN-1 | 3063813-76-0 | Reference compound |
| HY-163573 | FANCM-BTR PPI-IN-1 | 3033990-61-0 | Reference compound |
| HY-163574 | TDP-43-IN-1 | 3033951-71-9 | Reference compound |
| HY-163575 | TDP-43-IN-2 | 3033951-93-5 | Reference compound |
| HY-163576 | GID4-IN-1 | 3034834-45-9 | Reference compound |
| HY-163577 | Akt1-IN-5 | 3034252-53-1 | Reference compound |
| HY-163578 | Akt1-IN-6 | 3034254-12-8 | Reference compound |
| HY-163579 | Akt1-IN-7 | 3034255-09-6 | Reference compound |
| HY-163580 | HBV/HDV-IN-3 | 2883679-03-4 | Reference compound |
| HY-163581A | HBV/HDV-IN-4 (hydrochloride) | 3034059-40-7 | Reference compound |
| HY-163582 | PROTAC SOS1 degrader-7 | 3036155-26-4 | Reference compound |
| HY-163583 | SOS1 Ligand intermediate-6 | 3036156-01-8 | Reference compound |
| HY-163585 | PRMT5-IN-36 | 3034033-75-2 | Reference compound |
| HY-163586 | PRMT5-IN-37 | 3034033-98-9 | Reference compound |
| HY-163587 | PRMT5-IN-39-d3 | 3034033-85-4 | Isotope-Labeled Compounds |
| HY-163588 | PRMT5-IN-39 | 3030464-01-5 | Reference compound |
| HY-163589 | PRMT5-IN-40 | 3034034-95-9 | Reference compound |
| HY-163590 | PRMT5-IN-41 | 3034034-32-4 | Reference compound |
| HY-163591 | PRMT5-IN-36-d3 | 3034034-10-8 | Isotope-Labeled Compounds |
| HY-163592 | PRMT5-IN-43 | 3034746-11-4 | Reference compound |
| HY-163593 | PRMT5-IN-44 | 3034746-35-2 | Reference compound |
| HY-163594 | Pan-RAS-IN-3 | 3034588-80-9 | Reference compound |
| HY-163595 | Pan-RAS-IN-4 | 3024060-23-6 | Reference compound |
| HY-163596 | PTPN2-IN-1 | 3033936-66-9 | Reference compound |
| HY-163597 | HIF-2α-IN-10 | 3034532-74-3 | Reference compound |
| HY-163598 | HIF-2α-IN-11 | 3034589-50-6 | Reference compound |
| HY-163599 | HIF-2α-IN-12 | 3034488-33-7 | Reference compound |
| HY-163600 | HIF-2α-IN-13 | 3034488-42-8 | Reference compound |
| HY-163601 | HIF-2α-IN-14 | 3033981-37-9 | Reference compound |
| HY-163602 | HIF-2α-IN-15 | 3033981-70-0 | Reference compound |
| HY-163603 | HIF-2α-IN-16 | 3033981-97-1 | Reference compound |
| HY-163604 | PDE4B/D-IN-1 | 3034683-55-8 | Reference compound |
| HY-163605 | PDE4B/D-IN-2 | 3034683-66-1 | Reference compound |
| HY-163606 | PDE4B/D-IN-3 | 3034683-69-4 | Reference compound |
| HY-163607 | SpiD3 | 3033533-25-1 | Reference compound |
| HY-163608 | Ac-macropa | Reference compound | |
| HY-163609 | PROTAC AKR1C3 degrader-1 | Reference compound | |
| HY-163610 | AKR1C3-IN-13 | Reference compound | |
| HY-163611 | XY039 | Reference compound | |
| HY-163612 | XY077 | Reference compound | |
| HY-163613 | NS163 | Reference compound | |
| HY-163614 | SARS-CoV-2-IN-87 | Reference compound | |
| HY-163615 | Antimicrobial agent-32 | Reference compound | |
| HY-163616 | Anticancer agent 221 | Reference compound | |
| HY-163617 | c-PB2(OH)2 | Reference compound | |
| HY-163618 | DHMQ | Dye Reagents | |
| HY-163619 | Anticancer agent 227 | Reference compound | |
| HY-16361A | Omigapil (maleate) | 200189-97-5 | Reference compound |
| HY-163620 | LHQ490 | Reference compound | |
| HY-163621 | Cap-dependent endonuclease-IN-28 | Reference compound | |
| HY-163622 | USP10-IN-3 | 3059565-11-3 | Reference compound |
| HY-163623 | Phenolphthalein bisphosphate (sodium) | 68807-90-9 | Biochemical Assay Reagents |
| HY-163624 | Bfl-1-IN-2 | Reference compound | |
| HY-163625 | Mtb-IN-7 | Reference compound | |
| HY-163626 | STK17A/B-IN-1 | 3002038-21-0 | Reference compound |
| HY-163626A | STK17A/B-IN-1 (hydrochloride) | Reference compound | |
| HY-163627 | SARS-CoV-2 Mpro-IN-19 | Reference compound | |
| HY-163628 | SARS-CoV-2 Mpro-IN-20 | Reference compound | |
| HY-163629 | Anticancer agent 224 | Reference compound | |
| HY-16363 | Omtriptolide | 195883-06-8 | Reference compound |
| HY-163630 | Antibacterial agent 217 | Reference compound | |
| HY-163631 | Antibacterial agent 218 | Reference compound | |
| HY-163632 | EGFR-IN-112 | 2758436-98-3 | Reference compound |
| HY-163633 | CYP51-IN-18 | Reference compound | |
| HY-163634 | YZK-C22 | 1111646-44-6 | Reference compound |
| HY-163635 | Antifungal agent 102 | Reference compound | |
| HY-163636 | Deltaflexin3 | Reference compound | |
| HY-163637 | Sodium Channel inhibitor 5 | Reference compound | |
| HY-163638 | BRD4 degrader-1 | Reference compound | |
| HY-163639 | BRD4 degrader-2 | 3036530-43-2 | Reference compound |
| HY-163640 | CDK4 degrader 1 | Reference compound | |
| HY-163641 | AR Degrader-1 | Reference compound | |
| HY-163642 | TNF-α agonistic 1 | 2379727-88-3 | Reference compound |
| HY-163643 | STING modulator-7 | 702662-64-4 | Reference compound |
| HY-163644 | VT-105 | 2417718-38-6 | Reference compound |
| HY-163645 | P2Y12 antagonist 1 | 6222-65-7 | Reference compound |
| HY-163646 | (Rac)-TZ3O | 2218754-19-7 | Reference compound |
| HY-163647 | Lenalidomide-COCH-PEG2-azido | 2380273-88-9 | Reference compound |
| HY-163648 | Suloxifen | 25827-12-7 | Reference compound |
| HY-163649 | A17 | 2568186-47-8 | Reference compound |
| HY-163650 | DTPD-Q | 252950-56-4 | Reference compound |
| HY-163651 | (R)-Vorbipiprant | 2502965-92-4 | Reference compound |
| HY-163652 | Glicetanile | 24455-58-1 | Reference compound |
| HY-163653 | Zemprocitinib | 2417414-44-7 | Reference compound |
| HY-163654 | Ferroptosis-IN-8 | Reference compound | |
| HY-163655 | Glutaminyl Cyclase Inhibitor 6 | Reference compound | |
| HY-163656 | MAT2A inhibitor 5 | 2957874-18-7 | Reference compound |
| HY-163657 | HER2-IN-20 | Reference compound | |
| HY-163658 | PARP-1-IN-23 | 2976497-48-8 | Reference compound |
| HY-163659 | Anti-Influenza agent 6 | 2917502-08-8 | Reference compound |
| HY-16366 | Briciclib | 865783-99-9 | Reference compound |
| HY-163660 | Carbonic anhydrase inhibitor 23 | Reference compound | |
| HY-163661 | p53-MDM2-IN-5 | 2750075-06-8 | Reference compound |
| HY-163662 | AE027 | 1011351-65-7 | Reference compound |
| HY-163663 | AZ14133346 | Reference compound | |
| HY-163664 | Tubulin polymerization-IN-63 | 3040385-73-4 | Reference compound |
| HY-163665 | AHR antagonist 8 | Reference compound | |
| HY-163666 | HIV-1 inhibitor-68 | Reference compound | |
| HY-163667 | Atoxifent | Reference compound | |
| HY-163668 | MK-2118 | 2218504-06-2 | Reference compound |
| HY-163669 | ITI-333 | 2117619-00-6 | Reference compound |
| HY-163670 | TLR7 agonist 21 | Reference compound | |
| HY-163671 | PW0729 | 2767348-36-5 | Reference compound |
| HY-163672 | Glucocorticoid receptor modulator 3 | 2688785-13-7 | Reference compound |
| HY-163673 | Glucocorticoid receptor modulator 4 | 2688785-30-8 | Reference compound |
| HY-163674 | Mincle agonist 1 | Reference compound | |
| HY-163675 | Maleimide-PEG8-Val-Ala-PAB | Reference compound | |
| HY-163676 | MI-217 | Reference compound | |
| HY-163677 | ARM165 | Reference compound | |
| HY-163678 | Pomalidomide-CO-C7-NH-CO-C3-COOH | Reference compound | |
| HY-163679 | PROTAC ERα Degrader-9 | Reference compound | |
| HY-163680 | ERα degrader 9 | Reference compound | |
| HY-163681 | Zamzetoclax | 2388470-64-0 | Reference compound |
| HY-163683 | EB-PSMA-617 | 2375590-67-1 | ADC Related |
| HY-163684 | Zoracopan | 2243483-63-6 | Reference compound |
| HY-163685 | Bisobrin | 22407-74-5 | Reference compound |
| HY-163687 | Tropirine | 19410-02-7 | Reference compound |
| HY-163688 | Quindecamine (acetate) | 19146-62-4 | Reference compound |
| HY-163689 | Vicadrostat | 1868065-21-7 | Reference compound |
| HY-163690 | HTRA1-IN-1 | 3052552-04-9 | Reference compound |
| HY-163691 | Antitumor agent-163 | Reference compound | |
| HY-163692 | Tubulin polymerization-IN-64 | Reference compound | |
| HY-163693 | Antifungal agent 104 | Reference compound | |
| HY-163694 | ADRA2A antagonist 1 | Reference compound | |
| HY-163695 | NLRP3-IN-41 | 1209698-02-1 | Reference compound |
| HY-163696A | HV1-IN-1 (hydrochloride) | 1609461-57-5 | Reference compound |
| HY-163697 | WEE1-IN-7 | 2924006-98-2 | Reference compound |
| HY-163698 | SIRT-IN-4 | Reference compound | |
| HY-163699 | MUS81-IN-1 | Reference compound | |
| HY-163700 | Fabl inhibitor 1 | Reference compound | |
| HY-163701 | hA2AAR antagonist 1 | 2842150-81-4 | Reference compound |
| HY-163702 | CHF-6550 | 3052116-62-5 | Reference compound |
| HY-163703 | D4R antagonist-2 | Reference compound | |
| HY-163704 | KRN7000 analog 1 | Reference compound | |
| HY-163705 | BR-cpd7 | Reference compound | |
| HY-163706 | SARS-CoV-2-IN-88 | Reference compound | |
| HY-163707 | UR778Br | 866127-80-2 | Reference compound |
| HY-163708 | Antibacterial agent | Reference compound | |
| HY-163709 | PROTAC FAK degrader 2 | Reference compound | |
| HY-16371 | Ortataxel | 186348-23-2 | Reference compound |
| HY-163710 | hCA/VEGFR-2-IN-5 | Reference compound | |
| HY-163711 | trans-[Ru(2TU)(PPh3)2(bipy)]PF6 | 2407376-95-6 | Reference compound |
| HY-163712 | 17-Epiestriol | 1228-72-4 | Reference compound |
| HY-163713 | SARS-CoV-2-IN-89 | 1016762-41-6 | Reference compound |
| HY-163714 | IRAP-IN-1 | Reference compound | |
| HY-163715 | Antitumor agent-165 | Reference compound | |
| HY-163716 | Antibacterial agent 222 | Reference compound | |
| HY-163717 | HPK1-IN-48 | Reference compound | |
| HY-163718 | Ferroptosis-IN-9 | Reference compound | |
| HY-163719 | PARP7-IN-22 | 2946705-91-3 | Reference compound |
| HY-16372 | CP 461 | 227619-96-7 | Reference compound |
| HY-163720 | KRAS G12C inhibitor 63 | Reference compound | |
| HY-163721 | CDK7-IN-29 | 3024545-83-0 | Reference compound |
| HY-163722 | EGFR/DHFR-IN-1 | Reference compound | |
| HY-163723 | EGFR-IN-116 | Reference compound | |
| HY-163724 | LW-216 | 2146090-18-6 | Reference compound |
| HY-163725 | DHFR-IN-18 | Reference compound | |
| HY-163726 | GLUT1/EGFR-IN-1 | 2393787-80-7 | Reference compound |
| HY-163727 | MMV1557817 | 2065197-82-0 | Reference compound |
| HY-163728 | DSP-6745 | 2235409-96-6 | Reference compound |
| HY-163729 | I-BET787 | 2201082-98-4 | Reference compound |
| HY-16373 | CP-609754 | 1190094-64-4 | Reference compound |
| HY-163731 | EGR-1-IN-1 | Reference compound | |
| HY-163732 | TEAD-IN-16 | Reference compound | |
| HY-163733 | AKU-005 | 1515855-85-2 | Reference compound |
| HY-163734 | Tyrosinase-IN-30 | Reference compound | |
| HY-163735 | BA6b9 | 609335-29-7 | Reference compound |
| HY-163736 | mPGES-1/5-LOX-IN-1 | Reference compound | |
| HY-163737 | ST-401 | 2419942-78-0 | Reference compound |
| HY-163738 | Furin-IN-2 | Reference compound | |
| HY-163739 | LETC | 951131-13-8 | Reference compound |
| HY-163740 | VEGFR-2-IN-46 | Reference compound | |
| HY-163741 | EZH2-IN-19 | 3026848-13-2 | Reference compound |
| HY-163742 | SARS-CoV-2 Mpro-IN-22 | 1236310-35-2 | Natural Products |
| HY-163743 | SIC-19 | 713112-69-7 | Reference compound |
| HY-163744 | NLRP3-IN-42 | Reference compound | |
| HY-163746 | BuChE-IN-11 | Reference compound | |
| HY-163747 | VEGFR-2-IN-47 | Reference compound | |
| HY-163748 | GSK-3β inhibitor 17 | 2521624-67-7 | Reference compound |
| HY-163749 | STING-IN-8 | Reference compound | |
| HY-16375 | Ozarelix | 295350-45-7 | Peptides |
| HY-163750 | KMU-11342 | Reference compound | |
| HY-163751 | STING-IN-9 | Reference compound | |
| HY-163752 | CS17919 | 2379346-41-3 | Reference compound |
| HY-163753 | Carbonic anhydrase inhibitor 25 | Reference compound | |
| HY-163754 | TMV-IN-9 | 412315-55-0 | Reference compound |
| HY-163755 | GPER activator 1 | 2629960-35-4 | Reference compound |
| HY-163756 | NLRP3-IN-43 | 2769903-01-5 | Reference compound |
| HY-163757 | PROTAC PD-L1 degrader-1 | Reference compound | |
| HY-163758 | COOH-C3-CONH-C7-COOH | Reference compound | |
| HY-163759 | HuR degrader 2 | 3040301-46-7 | Reference compound |
| HY-163760 | ZM-32 | 2667585-44-4 | Reference compound |
| HY-163761 | LT166 | Reference compound | |
| HY-163762 | Antibacterial agent 226 | Reference compound | |
| HY-163763 | T-10418 | 1608784-68-4 | Reference compound |
| HY-163764 | Bfl-1-IN-4 | Reference compound | |
| HY-163765 | Antimalarial agent 41 | Reference compound | |
| HY-163766 | Antiproliferative agent-51 | Reference compound | |
| HY-163767 | Antitumor agent-171 | 3003004-76-7 | Reference compound |
| HY-163768 | Antitumor agent-172 | 3027905-74-1 | Reference compound |
| HY-163769 | DUB-IN-8 | Reference compound | |
| HY-163770 | Anticancer agent 233 | Reference compound | |
| HY-163771 | Pyruvate Carboxylase-IN-5 | Reference compound | |
| HY-163772 | Fraxinellone analog 1 | Reference compound | |
| HY-163773 | RSV-IN-13 | Reference compound | |
| HY-163774 | WDR5-MYC-IN-1 | Reference compound | |
| HY-163775 | Anti-inflammatory agent 88 | Reference compound | |
| HY-163776 | Insecticidal agent 13 | 3007662-84-9 | Reference compound |
| HY-163777 | Talaroterphenyl A | Natural Products | |
| HY-163778 | ZM600 | Reference compound | |
| HY-163779 | β-Glucocerebrosidase modulator 1 | Reference compound | |
| HY-163780 | AChE-IN-66 | Reference compound | |
| HY-163781 | Antifungal agent 105 | 3038220-10-6 | Reference compound |
| HY-163782 | SMIP-031 | Reference compound | |
| HY-163783 | CSNK2-IN-1 | Reference compound | |
| HY-163784 | AKR1C3-IN-14 | 1057882-82-2 | Reference compound |
| HY-163785 | 1"-α-Azido-RDPr | Reference compound | |
| HY-163786 | PROTAC CDK4/6 degrader 1 | 3025082-14-5 | Reference compound |
| HY-163787 | YY173 | 330550-51-1 | Reference compound |
| HY-163788 | C5-CONH-C2-N-CH3 | 1251346-48-1 | Reference compound |
| HY-163789 | Desthiobiotin-PEG3-triazole-DBCO-sulfo-Maleimide | Biochemical Assay Reagents | |
| HY-16379 | Pacritinib | 937272-79-2 | Reference compound |
| HY-163790 | Desthiobiotin-PEG3-sulfo-Maleimide | Biochemical Assay Reagents | |
| HY-163791 | Fluorescein Biotin Azide | Biochemical Assay Reagents | |
| HY-163793 | Biotin-2-sulfopropanoic acid (TEA) | Biochemical Assay Reagents | |
| HY-163794 | DC371739 | 2135765-21-6 | Reference compound |
| HY-163795 | GPR183-IN-1 | 2924063-70-5 | Reference compound |
| HY-163796 | GPR183-IN-2 | 2924064-10-6 | Reference compound |
| HY-163797 | WRN inhibitor 10 | Reference compound | |
| HY-163798 | Menin-MLL inhibitor 33 | Reference compound | |
| HY-163799 | PRMT5-MTA-IN-1 | 3048425-88-0 | Reference compound |
| HY-16379A | Pacritinib (hydrochloride) | 1228923-43-0 | Reference compound |
| HY-16379B | Pacritinib (citrate) | 1228923-42-9 | Reference compound |
| HY-16379R | Pacritinib (Standard) | 937272-79-2 | Reference Standards |
| HY-163801 | Nurr1 agonist 9 | Reference compound | |
| HY-163802 | Nurr1 agonist 10 | Reference compound | |
| HY-163803 | CM-444 | Reference compound | |
| HY-163804 | Cyprocide-B | 49809-25-8 | Reference compound |
| HY-163806 | NT376 | 2820208-97-5 | Reference compound |
| HY-163807 | 22-SLF | Reference compound | |
| HY-163808 | Anticancer agent 237 | 17822-61-6 | Reference compound |
| HY-163809 | BRD9 Degrader-2 | 3033018-68-4 | Reference compound |
| HY-16381 | Pasireotide | 396091-73-9 | Peptides |
| HY-163810 | BRD9 Degrader-3 | 3033018-77-5 | Reference compound |
| HY-163811 | BRD9 Degrader-4 | 3024541-39-4 | Reference compound |
| HY-163812 | ER degrader 9 | 3023359-75-0 | Reference compound |
| HY-163813 | AR Degrader-2 | 3023359-76-1 | Reference compound |
| HY-163814 | CDK2 degrader 1 | 3036604-59-5 | Reference compound |
| HY-163815 | CDK2 degrader 2 | 3030271-16-7 | Reference compound |
| HY-163816 | Antiproliferative agent-53-d3 | 2923508-77-2 | Isotope-Labeled Compounds |
| HY-163817 | PARP1/2-IN-3 | 3032451-58-1 | Reference compound |
| HY-163818 | WIZ degrader 2 | 2839552-69-9 | Reference compound |
| HY-163819 | WIZ degrader 3 | 2839637-72-6 | Reference compound |
| HY-16381A | Pasireotide (acetate) | 396091-76-2 | Peptides |
| HY-16381B | Pasireotide (diaspartate) | 1421446-02-7 | Peptides |
| HY-16381C | (2R)-Pasireotide (diaspartate) | 820232-50-6 | Reference compound |
| HY-16382 | PCI-27483 | 871266-63-6 | Reference compound |
| HY-163820 | WIZ degrader 4 | 2879250-22-1 | Reference compound |
| HY-163821 | HO-CONH-C3-PEG3-NH2 | 2136574-39-3 | Reference compound |
| HY-163822 | WIZ degrader 5 | 2879250-73-2 | Reference compound |
| HY-163823 | WIZ degrader 6 | 3036553-87-1 | Reference compound |
| HY-163824 | WIZ degrader 7 | 3036553-83-7 | Reference compound |
| HY-163825 | RNB-61 | Reference compound | |
| HY-163826 | Benzothiazole-CH2(NH-CO-CH2Cl)-CONH-CH2-Ph | Reference compound | |
| HY-163827 | ABBV-992 | 2792171-84-5 | Reference compound |
| HY-163828 | PPA24 | 3035032-77-7 | Reference compound |
| HY-163829 | TLR2 agonist 1 | Reference compound | |
| HY-163830 | Pegasus | Reference compound | |
| HY-163831 | AZ12559322 | 947184-66-9 | Reference compound |
| HY-163832 | FPPS-IN-2 | Reference compound | |
| HY-163833 | MMV1634566 | Reference compound | |
| HY-163834 | HDAC6-IN-47 | Reference compound | |
| HY-163835 | UniPR1454 | Reference compound | |
| HY-163836 | HMBPP analog 1 | Reference compound | |
| HY-163837 | PD-1/PD-L1-IN-48 | Reference compound | |
| HY-163838 | Quorum sensing-IN-6 | Reference compound | |
| HY-163839 | DS-1093a | Reference compound | |
| HY-16384 | L-156602 | 125228-51-5 | Reference compound |
| HY-163840 | GFRα2/3-IN-1 | Reference compound | |
| HY-163841 | Antitumor agent-181 | Reference compound | |
| HY-163842 | Cathepsin K inhibitor 7 | Reference compound | |
| HY-163843 | Antibacterial agent 234 | Reference compound | |
| HY-163844 | PD-1/PD-L1-IN-49 | Reference compound | |
| HY-163845 | YX862 | Reference compound | |
| HY-163846 | HDAC8-IN-10 | Reference compound | |
| HY-163847 | Anti-osteoporosis agent-9 | Reference compound | |
| HY-163848 | Anti-inflammatory agent 90 | Reference compound | |
| HY-163849 | Mizoribine prodrug-1 | 2237237-22-6 | Reference compound |
| HY-163850 | Mizoribine prodrug-2 (trifluoroacetate) | 2237237-32-8 | Reference compound |
| HY-163851 | PROTAC Vif degrader-1 | Reference compound | |
| HY-163852 | HIV-1 inhibitor-72 | 2801703-79-5 | Reference compound |
| HY-163853 | Antidiabetic agent 6 | Reference compound | |
| HY-163854 | HSP70-IN-6 | 3048341-44-9 | Reference compound |
| HY-163855 | KGP-25 | Reference compound | |
| HY-163856 | CDK7-IN-30 | 3040999-70-7 | Reference compound |
| HY-163857 | SARS-CoV-2-IN-91 | Reference compound | |
| HY-163858 | Haspin-IN-4 | Reference compound | |
| HY-163859 | LSD1-IN-33 | Reference compound | |
| HY-163860 | EGFR-TK-IN-3 | Reference compound | |
| HY-163861 | Tl45b | Reference compound | |
| HY-163862 | PPARα agonist 3 | Reference compound | |
| HY-163863 | Fast Red RC salt, 97% | 85252-22-8 | Biochemical Assay Reagents |
| HY-163864 | PROTAC SMARCA2/4-degrader-11 | 2568276-71-9 | Reference compound |
| HY-163865 | PROTAC SMARCA2 degrader-13 | 2568276-72-0 | Reference compound |
| HY-163866 | PROTAC SMARCA2 degrader-14 | 2568276-73-1 | Reference compound |
| HY-163867 | PROTAC SMARCA2 degrader-15 | 2568276-78-6 | Reference compound |
| HY-163868 | PROTAC SMARCA2/4-degrader-15 | 2568276-81-1 | Reference compound |
| HY-163869 | PROTAC SMARCA2/4-degrader-16 | 2568273-64-1 | Reference compound |
| HY-16387 | PF 00337210 | 854514-88-8 | Reference compound |
| HY-163870 | PROTAC SMARCA2/4-degrader-17 | 2568276-88-8 | Reference compound |
| HY-163871 | PROTAC SMARCA2/4-degrader-18 | 2568276-91-3 | Reference compound |
| HY-163872 | PROTAC SMARCA2/4-degrader-10 | 2568277-33-6 | Reference compound |
| HY-163873 | PROTAC SMARCA2/4-degrader-20 | 2568277-38-1 | Reference compound |
| HY-163874 | PROTAC SMARCA2 degrader-12 | 2568277-42-7 | Reference compound |
| HY-163875 | PROTAC SMARCA2/4-degrader-22 | 2568277-48-3 | Reference compound |
| HY-163876 | PROTAC SMARCA2/4-degrader-23 | 2568277-50-7 | Reference compound |
| HY-163877 | PROTAC SMARCA2/4-degrader-19 | 2568277-57-4 | Reference compound |
| HY-163879 | hMAO-B-IN-9 | Reference compound | |
| HY-163880 | EGFR-IN-119 | Reference compound | |
| HY-163881 | VEGFR-IN-5 | Reference compound | |
| HY-163882 | CUHK242 | 2408055-05-8 | Reference compound |
| HY-163883 | BChE-IN-34 | 2215768-12-8 | Reference compound |
| HY-163884 | BDE33872639 | Reference compound | |
| HY-163885 | SSZ | 1262287-23-9 | Reference compound |
| HY-163886 | KHK-IN-5 | 3043939-40-5 | Reference compound |
| HY-163887 | PBZ1038 | 2043687-46-1 | Reference compound |
| HY-163888 | NO-IN-1 | Reference compound | |
| HY-163889 | Ferroptosis/apoptosis inducer-1 | Reference compound | |
| HY-163890 | Succinate dehydrogenase-IN-2 | 3023681-83-3 | Reference compound |
| HY-163891 | Antifungal agent 107 | 2684411-12-7 | Reference compound |
| HY-163892 | POLRMT-IN-1 | Reference compound | |
| HY-163893 | Apoptosis inducer 23 | Reference compound | |
| HY-163894 | HDAC6-IN-48 | Reference compound | |
| HY-163895 | δ opioid receptor antagonist 1 | Dye Reagents | |
| HY-163896 | β-Catenin modulator-7 | 2892294-93-6 | Reference compound |
| HY-163897 | PROTAC NCOA4 degrader-1 | Reference compound | |
| HY-163899 | (+)-Crinatusin A1 | Reference compound | |
| HY-163900 | Galectin-8N-IN-2 | 3055149-84-0 | Reference compound |
| HY-163901 | E6-272 | 945142-65-4 | Reference compound |
| HY-163902 | SP100030 analogue 1 | 154934-68-6 | Reference compound |
| HY-163903 | OH-C2-PEG3-NHCO-C3-COOH | Reference compound | |
| HY-163904 | (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH | Reference compound | |
| HY-163905 | EG-2184 | 2770297-66-8 | Reference compound |
| HY-163906 | Anti-MRSA agent 16 | Reference compound | |
| HY-163907 | α-Glucosidase-IN-71 | Reference compound | |
| HY-163908 | SARS-CoV-2-IN-94 | Reference compound | |
| HY-163909 | AChE-IN-72 | Reference compound | |
| HY-16391 | Glasdegib | 1095173-27-5 | Reference compound |
| HY-163910 | Herbicidal agent 5 | Reference compound | |
| HY-163911 | SDH-IN-19 | Reference compound | |
| HY-163912 | JZD-07 | 2917528-98-2 | Reference compound |
| HY-163913 | SARS-CoV-IN-5 | Reference compound | |
| HY-163914 | Telomerase-IN-7 | 444320-44-9 | Reference compound |
| HY-163915 | 8-(4-(Trifluoromethyl)anilino)quercetin | Reference compound | |
| HY-163916 | SalA-VS-07 | 2445895-33-8 | Reference compound |
| HY-163917 | SalA-VS-08 | 2439152-14-2 | Reference compound |
| HY-163918 | N,N-Dimethyl-idarubicin | 3033865-16-3 | Reference compound |
| HY-163919 | N,N-Dimethyl-idarubicin-trisaccharide | 3033865-28-7 | Reference compound |
| HY-16391A | Glasdegib (maleate) | 2030410-25-2 | Reference compound |
| HY-16391B | Glasdegib (hydrochloride) | 1095173-64-0 | Reference compound |
| HY-16391S1 | Glasdegib-d4 | Isotope-Labeled Compounds | |
| HY-163920 | PROTAC HDAC8 Degrader-1 | Reference compound | |
| HY-163921 | HDAC8-IN-11 | 3035977-24-0 | Reference compound |
| HY-163922 | CRBN ligand-1-piperidine-Me | Reference compound | |
| HY-163923 | Apoptosis inducer 24 | 2763063-09-6 | Reference compound |
| HY-163924 | Apoptosis inducer 25 | 2763063-15-4 | Reference compound |
| HY-163925 | Lu-AAZTA-NI-PSMA-093 | Reference compound | |
| HY-163926 | SMARCA2/4-IN-2 | 1339378-93-6 | Reference compound |
| HY-163927 | E3 ligase Ligand 29 | 2154341-52-1 | Reference compound |
| HY-163928 | Pomalidomide-cyclohexane | 2924858-40-0 | Reference compound |
| HY-163929 | 5-Aminothalidomide-cyclohexane | 2924858-26-2 | Reference compound |
| HY-163930 | (S,R,S)-AHPC-CO-cyclohexane-C2 | Reference compound | |
| HY-163931 | E3 Ligase Ligand-linker Conjugate 111 | Reference compound | |
| HY-163932 | (S,R,S)-AHPC-O-CF3 | 2641373-92-2 | Reference compound |
| HY-163933 | (S,R,S)-AHPC-CO-C-cyclohexane | 2010985-17-6 | Reference compound |
| HY-163934 | (S,R,S)-AHPC-phenylacetic acid | 2010985-19-8 | Reference compound |
| HY-163935 | (S,R,S)-AHPC-m-Tolylacetic acid | Reference compound | |
| HY-163936 | (S,R,S)-AHPC-p-toluic acid | Reference compound | |
| HY-163937 | "(S,R,S)-AHPC-O-CF3 -CO-cyclohexane" | Reference compound | |
| HY-163938 | PROTAC erf3a Degrader-1 | 3033871-19-8 | Reference compound |
| HY-163938A | PROTAC erf3a Degrader-2 | 3033871-15-4 | Reference compound |
| HY-163939 | RGT-018 | 2794934-49-7 | Reference compound |
| HY-16394 | PG-11047 (tetrahydrochloride) | 206991-64-2 | Reference compound |
| HY-163940 | LX1 | 2647877-84-5 | Reference compound |
| HY-163941 | GSK_WRN2 | Reference compound | |
| HY-163942 | GSK_WRN4 | 2923008-66-4 | Reference compound |
| HY-163943 | UNI418 | 1802068-51-4 | Reference compound |
| HY-163944 | LL-K12-18 | Reference compound | |
| HY-163945 | ZTA-261 | 3049368-51-3 | Reference compound |
| HY-163947 | UG-480 | Reference compound | |
| HY-163949 | SMARCA2/4-IN-3 | Reference compound | |
| HY-16395 | PG-11047 | 308145-19-9 | Reference compound |
| HY-163950 | (S,R,S)-AHPC-O-CF3-CO-cyclohexene-Bpin | Reference compound | |
| HY-163951 | (S,R,S)-AHPC-Ac | 2361116-63-2 | Reference compound |
| HY-163952 | (S,R,S)-AHPC-Ac-CO-cyclohexene-Bpin | Reference compound | |
| HY-163953 | (S,R,S)-AHPC-Ala | 2641319-58-4 | Reference compound |
| HY-163954 | (S,R,S)-AHPC-Ala-CO-cyclohexene-Bpin | Reference compound | |
| HY-163957 | Tambjamine LY2 | Reference compound | |
| HY-163958 | PD-L1-IN-7 | 3024733-03-4 | Reference compound |
| HY-163959 | PF-07853578 | 3036158-98-9 | Reference compound |
| HY-163960 | NH2-Ph-NH-cyclohexane-NH-Boc | 3033871-69-8 | Reference compound |
| HY-163961 | (S)-Thalidomide-NH-cyclohexane-NH-Ph-NH2 | Reference compound | |
| HY-163961A | Thalidomide-NH-cyclohexane-NH-Ph-NH2 | Reference compound | |
| HY-163962 | L18I | 2451070-32-7 | Reference compound |
| HY-163963 | IBT6A-CO-ethyne | 1970122-88-3 | Reference compound |
| HY-163964 | Lenalidomide-C3-PEG3-N3 | Reference compound | |
| HY-163965 | Antitumor agent-185 | Reference compound | |
| HY-163966 | Decarboxyl ofloxacin | 123155-82-8 | Biochemical Assay Reagents |
| HY-163966R | Decarboxyl ofloxacin (Standard) | 123155-82-8 | Reference Standards |
| HY-163967 | Clindamycin 2,4-diphosphate | 1309048-48-3 | Biochemical Assay Reagents |
| HY-163968 | Elmycin B | 128233-09-0 | Biochemical Assay Reagents |
| HY-163969 | (±)-myo-Inositol-1-phosphate | 573-35-3 | Biochemical Assay Reagents |
| HY-16397 | Phenformin | 114-86-3 | Reference compound |
| HY-163970 | Heparin disaccharide I-A (sodium) | 136098-00-5 | Biochemical Assay Reagents |
| HY-163971 | Granulocyte-macrophage colony-stimulating factor | 83869-56-1 | Biochemical Assay Reagents |
| HY-163972 | Cocamidopropyl betaine | 86438-79-1 | Biochemical Assay Reagents |
| HY-163973 | α-D-Glucopyranosyl β-D-arabino-2-hexulofuranosidonic acid | 150787-99-8 | Biochemical Assay Reagents |
| HY-163974 | MRS7292 | 2092913-97-6 | Reference compound |
| HY-163975 | α-Glucosidase-IN-72 | Reference compound | |
| HY-163976 | 3-Indoxyl phosphate (bis(2-amino-2-methyl-1,3-propanediol)) | 107475-12-7 | Biochemical Assay Reagents |
| HY-163977 | Silyl-ether based ROMP Monomer | 1621108-00-6 | Biochemical Assay Reagents |
| HY-163978 | YGZ-331 | 1350113-04-0 | Reference compound |
| HY-163979 | Antifungal agent 109 | Reference compound | |
| HY-16397A | Phenformin (hydrochloride) | 834-28-6 | Reference compound |
| HY-16397AR | Phenformin (hydrochloride) (Standard) | 834-28-6 | Reference Standards |
| HY-16397AS | Phenformin-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-16398 | Pipobroman | 54-91-1 | Reference compound |
| HY-163980 | AChE-IN-73 | Reference compound | |
| HY-163981 | ABCB1-IN-2 | Reference compound | |
| HY-163982 | FOXJ1 agonist 1 | Reference compound | |
| HY-163983 | Tubulin polymerization-IN-68 | 2924156-96-5 | Reference compound |
| HY-163984 | Antibacterial agent 240 | 2899202-97-0 | Reference compound |
| HY-163985 | PROTAC FGFR2 degrader 1 | Reference compound | |
| HY-163986 | Pomalidomide-C2-NHCO-C6 | Reference compound | |
| HY-163987 | SIRT3 activator 2 | 3061491-60-6 | Reference compound |
| HY-163988 | Amylose azure | 71501-06-9 | Biochemical Assay Reagents |
| HY-163989 | N-Ethylheptanamide | 54007-34-0 | Reference compound |
| HY-16399 | Pladienolide B | 445493-23-2 | Reference compound |
| HY-163990 | Poly(ethylene glycol) diacrylamide (MW 2000) | 160556-48-9 | Biochemical Assay Reagents |
| HY-163990A | Poly(ethylene glycol) diacrylamide (MW 3400) | 160556-48-9 | Biochemical Assay Reagents |
| HY-163990B | Poly(ethylene glycol) diacrylamide (MW 3700) | 160556-48-9 | Biochemical Assay Reagents |
| HY-163990C | Poly(ethylene glycol) diacrylamide (MW 4000) | 160556-48-9 | Biochemical Assay Reagents |
| HY-163990D | Poly(ethylene glycol) diacrylamide (MW 6000) | 160556-48-9 | Biochemical Assay Reagents |
| HY-163990E | Poly(ethylene glycol) diacrylamide (MW 10000) | 160556-48-9 | Biochemical Assay Reagents |
| HY-163991 | (Z-Asp-Glu-Val-Asp)2-Rh110 | 220846-75-3 | Biochemical Assay Reagents |
| HY-163992S | VTMTRDTSISTAYMELSR-(Ile-13C6,15N) | Isotope-Labeled Compounds | |
| HY-163993S | GMDRWGQGTLVTVSS-(Leu-13C6,15N) | Isotope-Labeled Compounds | |
| HY-163994 | Ibuterol (hydrochloride) | 57576-17-7 | Reference compound |
| HY-163995 | GPX4-IN-13 | 2644044-43-7 | Oligonucleotides |
| HY-163996 | DD202-114 | 2886728-09-0 | Reference compound |
| HY-163997 | Antimalarial agent 42 | Reference compound | |
| HY-163998 | TLR4-IN-1 | 2617578-93-3 | Reference compound |
| HY-163999 | TMV-IN-12 | 2861919-00-6 | Reference compound |
| HY-164000 | CFTR corrector 15 | 1170387-92-4 | Reference compound |
| HY-164002 | PF-303 | 1609465-78-2 | Reference compound |
| HY-164003 | Dapabutan | 6582-31-6 | Reference compound |
| HY-164004 | Stevaladil | 6535-03-1 | Reference compound |
| HY-164005 | CBP/EP300 bromodomain receptor-IN-1 | 1190262-14-6 | Reference compound |
| HY-164009 | Teniloxazine | 62473-79-4 | Reference compound |
| HY-16401 | Zalypsis | 308359-57-1 | Reference compound |
| HY-164010 | SUN-1334H (free base) | 607737-00-8 | Reference compound |
| HY-164011 | Alaproclate | 60719-82-6 | Reference compound |
| HY-164012 | Proxicromil | 60400-92-2 | Reference compound |
| HY-164013 | Brazergoline | 60019-20-7 | Reference compound |
| HY-164014 | 9-CCN | 596592-83-5 | Reference compound |
| HY-164018A | PMEG-DP (disodium) | Reference compound | |
| HY-164021 | Brovanexine (hydrochloride) | 54340-60-2 | Reference compound |
| HY-164022 | Acridorex | 47487-22-9 | Reference compound |
| HY-164025 | DB775 | 475976-08-0 | Reference compound |
| HY-164026 | ISR modulator-1 | 2842928-87-2 | Reference compound |
| HY-164027 | MyoMed 205 | 2614161-13-4 | Reference compound |
| HY-16403 | Polythiazide | 346-18-9 | Reference compound |
| HY-164031 | Cloperidone | 4052-13-5 | Oligonucleotides |
| HY-164032 | Dimethandrolone undecanoate | 366472-45-9 | Reference compound |
| HY-164033 | HOE 689 | 33156-28-4 | Reference compound |
| HY-164034 | Ganglefene | 299-61-6 | Reference compound |
| HY-164035 | DOPE-PEG-DBCO (MW 2000) | Biochemical Assay Reagents | |
| HY-164036 | Lolamicin | 2930690-12-1 | Reference compound |
| HY-164036R | Lolamicin (Standard) | 2930690-12-1 | Reference Standards |
| HY-164037 | Riselcaftor | 2799652-36-9 | Reference compound |
| HY-164039 | Talorasib | 2648584-48-7 | Reference compound |
| HY-164040 | Zavolosotine | 2604416-66-0 | Reference compound |
| HY-164041 | Staurosporine-Boc | 120685-17-8 | Reference compound |
| HY-164043 | (S,R,S)-AHPC(Me)-amido-C2-acid | 2365173-01-7 | Reference compound |
| HY-164049 | TG8-260 | 2490544-50-6 | Reference compound |
| HY-16405 | PR-104 | 851627-62-8 | Reference compound |
| HY-164050 | HDAC2-IN-2 | 332169-78-5 | Reference compound |
| HY-164051 | 1650-M15 | 850935-88-5 | Reference compound |
| HY-164052 | Antiparasitic agent-23 | 556055-08-4 | Reference compound |
| HY-164053 | MicroRNA modulator-1 | 756865-61-9 | Reference compound |
| HY-164054 | MicroRNA modulator-2 | 438599-31-6 | Reference compound |
| HY-164055 | HL1 | 202828-10-2 | Reference compound |
| HY-164056 | EGFR T790M/L858R-IN-8 | 333419-97-9 | Reference compound |
| HY-164058 | LZCap AG(3'Acm) RFP mRNA | Oligonucleotides | |
| HY-164059 | LZCap AG(3'Acm) mCherry mRNA | Oligonucleotides | |
| HY-16406 | PR-104 (sodium) | 851627-80-0 | Reference compound |
| HY-164060 | LZCap AG(3'Acm) RLuc mRNA | Oligonucleotides | |
| HY-164061 | LZCap AG(3'Acm) GLuc mRNA | Oligonucleotides | |
| HY-164062 | LZCap AG(3'Acm) Cas9 mRNA | Oligonucleotides | |
| HY-164064 | Anticancer agent 230 | 2485052-87-5 | Reference compound |
| HY-164065 | Sodium Hyaluronate Hydroxypropyltrimonium Chloride | 1714127-68-0 | Natural Products |
| HY-164066 | Sodium Acetylated Hyaluronate | 287390-12-9 | Natural Products |
| HY-164067 | Silylanization hyaluronate ester | 135507-00-5 | Natural Products |
| HY-164068 | Cross-linked sodium hyaluronate gel | Natural Products | |
| HY-164069 | Aldehyde Sodium Hyaluronate | Natural Products | |
| HY-164070 | Dextran Hydroxypropyltrimonium Chloride | 83855-79-2 | Reference compound |
| HY-164071 | Carboxymethyl Dextran (CM-Dextran) | 9044-05-7 | Natural Products |
| HY-164072 | DBCO-Dextran | Reference compound | |
| HY-164073 | Allylate Dextran | Reference compound | |
| HY-164076 | mPEG-Epoxide | Reference compound | |
| HY-164077 | mPEG-PLGA | 743423-15-6 | Natural Products |
| HY-164082 | Methyl clofenapate | 21340-68-1 | Reference compound |
| HY-164083 | GR65630 | 113140-33-3 | Reference compound |
| HY-164084 | DBCO-NHCO-C5-O-phenylethenesulfonyl fluoride | 2849417-34-9 | Reference compound |
| HY-164085 | Azide-C3-NHCO-C3-NHS ester | 920748-93-2 | Reference compound |
| HY-164088 | DBM-C5-VC-PAB-MMAE | 1644228-55-6 | ADC Related |
| HY-164090 | Adenosine 3'-phosphate 5'-phosphosulfate | 482-67-7 | Reference compound |
| HY-164091 | Mevalonate 5-phosphate | 73566-35-5 | Reference compound |
| HY-164092 | Eicosanoyl-CoA | 15895-27-9 | Reference compound |
| HY-164093 | Isovaleryl-CoA | 6244-91-3 | Reference compound |
| HY-164094 | Isobutyryl-CoA | 15621-60-0 | Natural Products |
| HY-164094A | Isobutyryl-CoA (trisodium) | Enzyme | |
| HY-164098 | JWZ-7-7-Neg1 | 3008612-30-1 | Reference compound |
| HY-164099 | LSD1/HDAC6-IN-2 | 2982787-50-6 | Reference compound |
| HY-164102 | TNF-α-IN-18 | 1272322-42-5 | Reference compound |
| HY-164105 | S-Lactylglutathione | 25138-66-3 | Reference compound |
| HY-164112 | 1,2-Dioleoyl-sn-glycero-3-(cytidine diphosphate) (ammonium) | 799812-77-4 | Biochemical Assay Reagents |
| HY-164117 | BNN6 | 106476-75-9 | Reference compound |
| HY-164122 | Antiviral agent 56 | 524055-95-6 | Reference compound |
| HY-164123 | Antibiofilm agent-9 | 2001602-07-7 | Reference compound |
| HY-164125 | 6-O-Bis[1-(2-nitrophenyl)-ethoxyphosphoryl]-D-trehalose | 1404341-61-2 | Reference compound |
| HY-164126 | 6-O-Bis-(4,5-dimethoxy-2-nitrobenzyloxyphosphoryl)-D-trehalose | 1404341-58-7 | Reference compound |
| HY-164128 | AHL modulator-1 | 942296-18-6 | Reference compound |
| HY-16413 | Protokylol (hydrochloride) | 136-69-6 | Reference compound |
| HY-164130 | AChE-IN-65 | 98704-22-4 | Reference compound |
| HY-164136 | 17β-HSD5 inhibitor 1 | 243638-37-1 | Reference compound |
| HY-164137 | 17β-HSD5 inhibitor 2 | 1106941-19-8 | Reference compound |
| HY-164138 | 17β-HSD5 inhibitor 3 | 948581-46-2 | Reference compound |
| HY-164139 | Antiviral agent 57 | 3027227-86-4 | Reference compound |
| HY-164140 | EM 1404 | 243836-37-5 | Reference compound |
| HY-164142 | ETB | 634589-47-2 | Reference compound |
| HY-164143 | T638 | 2770585-67-4 | Reference compound |
| HY-164144 | EPZ033294 | 1887195-17-6 | Reference compound |
| HY-164145 | CDD-1653 | 3034216-44-6 | Reference compound |
| HY-164146 | BCN-HS-PEG2(vcPABC-MMAE)2 | 2126083-82-5 | ADC Related |
| HY-164151 | ERK-IN-8 | 2226293-75-8 | Reference compound |
| HY-164152 | ADC Control Human IgG1-Deruxtecan (DAR 4) | ADC Related | |
| HY-164152A | ADC Control Human IgG1-Deruxtecan (DAR 8) | ADC Related | |
| HY-164153 | ADC Control Human IgG1-vcMMAE | ADC Related | |
| HY-164154 | ADC Control Human IgG1-vcMMAF | ADC Related | |
| HY-164159 | α-Glucosylrutin | 130603-71-3 | Reference compound |
| HY-164160 | 1,2-Dipalmitoyl-rac-glycero-3-phospho-L-serine | 3036-82-6 | Biochemical Assay Reagents |
| HY-164165 | Paclitaxel-2′-succinate NHS ester | 245110-80-9 | Reference compound |
| HY-164166 | Fmoc-Sar-Sar-Sar-OH | 2749824-37-9 | Peptides |
| HY-164170 | Photocaged DAP | 2321346-88-5 | Reference compound |
| HY-164179 | dGpdG | 15180-30-0 | Reference compound |
| HY-164181 | Fmoc-protected DMT-Dt PEG2 NH2 amidite | 2416858-32-5 | Reference compound |
| HY-164182S | Myristoleyl carnitine-d3 | 1803252-79-0 | Isotope-Labeled Compounds |
| HY-164183 | Trimethaphan (bromide) | 21035-85-8 | Reference compound |
| HY-164185 | P12FR2 sodium | Oligonucleotides | |
| HY-164186 | M9-5 sodium | Oligonucleotides | |
| HY-164187 | "m7(3'Ma-Cy7)Gppp(2'OMe)ApG ammonium " | Oligonucleotides | |
| HY-164188 | m7(3'Ma-Cy5)Gppp(2'OMe)ApG (triammonium) | Oligonucleotides | |
| HY-164189 | m7(3'Ma-Cy3)Gppp(2'OMe)ApG ammonium | Oligonucleotides | |
| HY-164190 | "m7(3'Ma-Biotin)Gppp(2'OMe)ApG ammonium " | Oligonucleotides | |
| HY-164191 | "m7(3'Ma-Peg5-FAM)Gppp(2'OMe)ApG ammonium " | Oligonucleotides | |
| HY-164192 | m7(3'AcmG)(5')ppp(5')(2'OMeA)pG ammonium | Oligonucleotides | |
| HY-164193 | m7(3'AcmG)(5')ppp(5')(2'OMeA)pU (ammonium) | Oligonucleotides | |
| HY-16420 | R112 | 575474-82-7 | Reference compound |
| HY-164201 | HIV-1 inhibitor-69 | 257891-65-9 | Reference compound |
| HY-164202 | ORM-5029 | Reference compound | |
| HY-164207 | VLPA-GlcNAc | 474644-34-3 | Reference compound |
| HY-164209 | DBCO-PEG3-C1-acid | 2249926-65-4 | Reference compound |
| HY-16421 | Ragaglitazar | 222834-30-2 | Reference compound |
| HY-164210 | DBCO-PEG2-C2-acid | 2305845-07-0 | Reference compound |
| HY-164211 | DBCO-PEG2-OH | 2181837-96-5 | Reference compound |
| HY-164212 | DBCO-PEG1-OH | 2754384-62-6 | Reference compound |
| HY-164220 | PPM1A-IN-1 | 2919466-30-9 | Reference compound |
| HY-164226 | Rosuvastatin impurity-1 | Reference compound | |
| HY-164227 | Vericiguat impurity-2 | Reference compound | |
| HY-164228 | Vericiguat impurity-3 | Reference compound | |
| HY-164229 | Mianserin impurity-1 | 73771-03-6 | Reference compound |
| HY-16423 | Rapacuronium bromide | 156137-99-4 | Reference compound |
| HY-164233 | YX968 | 2742732-92-7 | Reference compound |
| HY-164236 | C22 Glucosylceramide (d18:1/22:0) | 119242-44-3 | Natural Products |
| HY-164236S | C22 Glucosylceramide (d18:1/22:0)-d4 | 2738376-81-1 | Isotope-Labeled Compounds |
| HY-164238 | LysoPC(18:3) | 62512-91-8 | Natural Products |
| HY-164239 | NH2-PEG3-VC-PAB-MMAE | 2641442-97-7 | ADC Related |
| HY-164247 | UnyLinker 12 | 852684-08-3 | Oligonucleotides |
| HY-164248 | Ac-rG | 21967-06-6 | Oligonucleotides |
| HY-164249 | DMT-rG(Ac) | 231957-27-0 | Oligonucleotides |
| HY-16425 | RG2833 | 1215493-56-3 | Reference compound |
| HY-164252 | DMT-2'-F-U | 2923-90-2 | Oligonucleotides |
| HY-164253 | TBS-rG(Ac) | 1256468-15-1 | Oligonucleotides |
| HY-164259 | AJM 290 | 840474-95-5 | Reference compound |
| HY-164263 | N-Acetylphytosphingosine | 21830-28-4 | Reference compound |
| HY-164264 | Caged MK801 | 217176-91-5 | Reference compound |
| HY-164267 | Sphingomyelin (d18:1,C14:0) | 121999-55-1 | Reference compound |
| HY-164271 | 10-Boc-SN-38 | 362497-15-2 | ADC Related |
| HY-164272 | 2'-O-TBDMS-Paclitaxel | 114655-02-6 | ADC Related |
| HY-164273 | Azidoacetyl-Val-Cit-PAB-OH | 2285375-34-8 | ADC Related |
| HY-164275 | Alkyne-Val-Cit-PAB-OH | 2748039-76-9 | ADC Related |
| HY-164278 | diABZI-V/C-Mal | 3035557-55-9 | Reference compound |
| HY-164279 | YTR107 | 1207615-74-4 | Reference compound |
| HY-164283 | DOCP | 1360461-57-9 | Oligonucleotides |
| HY-164284 | LK-2 | 2649762-09-2 | Reference compound |
| HY-164285 | MYX1715 | 2445448-66-6 | Reference compound |
| HY-164288 | TDI-6570 | 2287331-29-5 | Reference compound |
| HY-164290 | Rhodady C10 | 1367579-04-1 | Reference compound |
| HY-164293 | Methyl (5α,7α)-7-hydroxy-3-oxocholan-24-oate | 14772-96-4 | Reference compound |
| HY-164294 | Aluminum phthalocyanine disulfonate | 68637-19-4 | Reference compound |
| HY-164295 | U-78517 | 122003-11-6 | Reference compound |
| HY-164296 | SMP-96745 | 2760408-63-5 | ADC Related |
| HY-164303 | Val-Cit-PAB-DEA-Duo-DM | 1698870-53-9 | ADC Related |
| HY-164304 | INF 195 | 1211379-56-4 | Reference compound |
| HY-164306 | PROTAC PARP1 degrader-2 | 2923686-62-6 | Reference compound |
| HY-164307 | Pebezertinib | 2769954-39-2 | Reference compound |
| HY-164308 | SA-15-P | 852846-00-5 | Reference compound |
| HY-164309 | DBCO-PEG3-Glu-Val-Cit-PABC-MMAE | 2861998-23-2 | ADC Related |
| HY-164310 | TCO-PEG3-Glu-Val-Cit-PABC-MMAF | 2862795-63-7 | ADC Related |
| HY-164311 | GPR17 modulator-1 | 3039853-91-0 | Reference compound |
| HY-164315 | KRAS G12C inhibitor 67 | 2649788-46-3 | Reference compound |
| HY-164316 | FT-FAPI-12_9 | 2883407-81-4 | Reference compound |
| HY-164316A | FT-FAPI-12_9 (TFA) | Reference compound | |
| HY-164320 | Anticancer agent 245 | 2130040-60-5 | Reference compound |
| HY-164322 | Cyproflanilide | 2375110-88-4 | Reference compound |
| HY-164326 | KAL-21404358 | 1065573-84-3 | Reference compound |
| HY-16433 | Risarestat | 79714-31-1 | Reference compound |
| HY-164336 | Amino-PEG16-alcohol | 2933173-97-6 | Reference compound |
| HY-16434 | DGAT1-IN-3 | 939375-07-2 | Reference compound |
| HY-164341 | TAU-IN-2 | 1417823-63-2 | Reference compound |
| HY-164342 | Netobimin | 88255-01-0 | Reference compound |
| HY-164343 | 17,17-Ethylendioxyandrost-5-en-3β-ol | 7745-40-6 | Reference compound |
| HY-164344 | PCSK9 allosteric binder-1 | 2215932-06-0 | Reference compound |
| HY-164349 | WZ-2-033 | 2416196-47-7 | Reference compound |
| HY-164350 | KRAS inhibitor-27 | 3033690-83-1 | Reference compound |
| HY-164357 | 14-Deoxypoststerone | 1360460-98-5 | Reference compound |
| HY-164358 | α-Gracinoic acid | 2180947-76-4 | Reference compound |
| HY-16436 | Rolapitant (hydrochloride hydrate) | 914462-92-3 | Reference compound |
| HY-164360 | αVβ8-IN-1 | 3048440-55-4 | Reference compound |
| HY-164361 | 2′-Hydroxy-2,3-dimethoxychalcone | 42220-80-4 | Reference compound |
| HY-164364A | DOTAGA.(SA.FAPi)2 (TFA) | Reference compound | |
| HY-164364B | DOTAGA.(SA.FAPi)2 analogue (TFA) | Reference compound | |
| HY-164365 | PROTAC K-Ras Degrader-2 | 3043670-74-9 | Reference compound |
| HY-164367 | Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT | 2396667-62-0 | ADC Related |
| HY-164368 | GLUT4 activator 2 | 2761446-81-3 | Reference compound |
| HY-164369 | Antibiofilm agent-10 | 22812-29-9 | Reference compound |
| HY-16437 | RP-64477 | 135239-65-5 | Reference compound |
| HY-164370 | Hesperidin dihydrochalcone | 35573-79-6 | Reference compound |
| HY-164371 | (+)-JJ-74-138 | 2135545-34-3 | Reference compound |
| HY-164372 | 17-Demethoxy-reblastatin | 299173-64-1 | Reference compound |
| HY-164373 | SC428 | 1898232-70-6 | Reference compound |
| HY-164374 | AK963/40708899 | 445007-59-0 | Reference compound |
| HY-164376 | CDK4/6-IN-21 | 2102887-41-0 | Reference compound |
| HY-164376A | CDK4/6-IN-21 (maleate) | 2765997-88-2 | Reference compound |
| HY-164379 | DOTA-PEG4-alkyne | 2080307-47-5 | Reference compound |
| HY-16438 | RRx-001 | 925206-65-1 | Reference compound |
| HY-164382 | ER-851 | 2685738-33-2 | Reference compound |
| HY-164384 | DFX117 | 2125500-60-7 | Reference compound |
| HY-164385 | NSC126405 | 17581-52-1 | Reference compound |
| HY-164386 | Defoslimod | 171092-39-0 | Reference compound |
| HY-164387 | Sutetinib | 1259519-20-4 | Reference compound |
| HY-164387A | Sutetinib (maleate) | 1701408-75-4 | Reference compound |
| HY-164388 | Z-VAD | 162852-62-2 | Reference compound |
| HY-164389 | SML-10-70-1 | 1536470-98-0 | Reference compound |
| HY-164390 | 6′SLN | 64364-50-7 | Reference compound |
| HY-164391 | Pomalidomide-C2-amide-C4-Br | 2545963-02-6 | Reference compound |
| HY-164392 | TAS-121 | 1451370-01-6 | Reference compound |
| HY-164393 | ON044580 | 1035199-04-2 | Reference compound |
| HY-164394 | EMD 1204831 | 1100598-15-9 | Oligonucleotides |
| HY-164395 | Sipuleucel-T | 917381-47-6 | Reference compound |
| HY-164397 | XMU-MP-5 | Reference compound | |
| HY-164399 | SST0116CL1 | 1799802-29-1 | Reference compound |
| HY-164400 | SIJ1777 | 839707-55-0 | Reference compound |
| HY-164401 | QBS10072S | 1802735-28-9 | Reference compound |
| HY-164402 | NSC-124854 | 1033942-30-1 | Reference compound |
| HY-164404 | NADI-351 | 2503017-11-4 | Reference compound |
| HY-16441 | Tegafur-gimeracil-oteracil (potassium) | 150863-82-4 | Reference compound |
| HY-164410 | MO-I-1100 | 1585217-40-8 | Reference compound |
| HY-164411 | KRC-00715 | 2079853-72-6 | Reference compound |
| HY-164412 | Phosphatidylcholine (C18:2,C20:4) | 85082-02-6 | Natural Products |
| HY-164413 | CLM3 | 1312024-59-1 | Reference compound |
| HY-164414 | CCT129254 | 885500-12-9 | Reference compound |
| HY-164416 | DBCO-Dextran sulfate (MW 40000) | Reference compound | |
| HY-164417 | Kv7.2/Kv7.3 activator-1 | 2376398-43-3 | Reference compound |
| HY-164419 | Atesidorsen | 872063-57-5 | Oligonucleotides |
| HY-164419A | Atesidorsen (sodium) | 1826859-79-3 | Oligonucleotides |
| HY-164421 | PhpC | Reference compound | |
| HY-164426 | HEI3090 | 2377167-56-9 | Reference compound |
| HY-164427 | SHP2-IN-31 | 2411321-35-0 | Reference compound |
| HY-164428 | AE 51310 | 433966-92-8 | Reference compound |
| HY-164429 | VIP236 | 2418533-90-9 | Reference compound |
| HY-16443 | S-4048 | 173534-37-7 | Reference compound |
| HY-164430 | Arpromidine | 106669-71-0 | Reference compound |
| HY-164431 | 4-(Azidomethyl)-L-phenylalanine | 1446772-80-0 | Reference compound |
| HY-164434 | Xanthosine-5'-monophosphate | 523-98-8 | Oligonucleotides |
| HY-16444 | Sagopilone | 305841-29-6 | Reference compound |
| HY-164445 | STAT3-IN-32 | 2591440-71-8 | Reference compound |
| HY-16445 | Sapacitabine | 151823-14-2 | Reference compound |
| HY-164451 | GSI-18 | 362653-62-1 | Reference compound |
| HY-164452 | A-1155905 | 2228052-37-5 | Reference compound |
| HY-164453 | A-1248767 | 2228052-38-6 | Reference compound |
| HY-164454 | AJI-100 | 844435-10-5 | Reference compound |
| HY-164455 | AJI-214 | 1395886-20-0 | Reference compound |
| HY-164456 | AMI-408 | 78866-14-5 | Reference compound |
| HY-164457 | ASN-001 | 1429329-63-4 | Reference compound |
| HY-164459 | AZ8010 | 1035270-44-0 | Reference compound |
| HY-16445A | CNDAC | 135598-68-4 | Reference compound |
| HY-16445B | CNDAC (hydrochloride) | 134665-72-8 | Reference compound |
| HY-16445BR | CNDAC (hydrochloride) (Standard) | 134665-72-8 | Reference Standards |
| HY-16446 | SAR125844 | 1116743-46-4 | Reference compound |
| HY-164460 | AZD1897 | 1204181-93-0 | Reference compound |
| HY-164461 | AZD6918 | 905585-60-6 | Reference compound |
| HY-164462 | BHA536 | 919992-85-1 | Reference compound |
| HY-164463 | BMI-135 | 1608099-90-6 | Reference compound |
| HY-164464 | BPI-15086 | 1644502-33-9 | Reference compound |
| HY-164465 | C086 | 1160107-44-7 | Reference compound |
| HY-164466 | CAD204520 | 2682205-20-3 | Reference compound |
| HY-164467 | CCT070535 | 485319-41-3 | Reference compound |
| HY-164468 | Ch282-5 | 65891-87-4 | Reference compound |
| HY-164469 | CHMFL-48 | 2479290-65-6 | Reference compound |
| HY-164473 | DETD-35 | 1836209-98-3 | Reference compound |
| HY-164474 | DS03090629 | Reference compound | |
| HY-164475 | PARP1-IN-29 | 1567375-93-2 | Reference compound |
| HY-164476 | ES-072 | 2089721-94-6 | Reference compound |
| HY-164477 | FL442 | 1431166-12-9 | Reference compound |
| HY-164478 | G-631 | 1507370-78-6 | Reference compound |
| HY-164479 | GA001 | 2097880-27-6 | Reference compound |
| HY-16448 | Saxagliptin (hydrochloride) | 709031-78-7 | Reference compound |
| HY-164480 | GTCpFE | 1588866-45-8 | Reference compound |
| HY-164482 | HG-6-63-01 | 2177298-99-4 | Reference compound |
| HY-164483 | HS-345 | 1462329-41-4 | Reference compound |
| HY-164484 | IHMT-RAF-128 | 2479289-15-9 | Reference compound |
| HY-164485 | INI-4001 | 2549050-07-7 | Reference compound |
| HY-164487 | JBJ-08-178-01 | 2401867-58-9 | Reference compound |
| HY-164488 | KT D606 | 1429063-06-8 | Reference compound |
| HY-164489 | KU004 | 1260401-93-1 | Reference compound |
| HY-16448R | Saxagliptin (hydrochloride) (Standard) | 709031-78-7 | Reference Standards |
| HY-164490 | LS-106 | Reference compound | |
| HY-164492 | LSN3074753 | 1455031-68-1 | Reference compound |
| HY-164493 | KRASG12C IN-13 | 2409131-50-4 | Reference compound |
| HY-164495 | Sob-AM2 | 2128258-47-7 | Reference compound |
| HY-164496 | KL-50 | 1161826-19-2 | Reference compound |
| HY-164497 | NSC 641396 | 605685-94-7 | Reference compound |
| HY-16450 | SB 204990 | 154566-12-8 | Reference compound |
| HY-164500 | MC3629 | 1375163-30-6 | Reference compound |
| HY-164501 | Mps-BAY1 | 1309593-24-5 | Reference compound |
| HY-164502 | NAP1051 | 864516-77-8 | Oligonucleotides |
| HY-164503 | Neptinib | 2085843-51-0 | Reference compound |
| HY-164505 | NRMA-9 | 2375659-16-6 | Reference compound |
| HY-164506 | NRMA-8 | 2375659-15-5 | Reference compound |
| HY-164507 | NRMA-7 | 2375659-14-4 | Reference compound |
| HY-164510 | N-Formyldemecolcine | 14686-61-4 | Reference compound |
| HY-164512 | NRMA-I | 1417653-47-4 | Reference compound |
| HY-164513 | NHTD | 2540915-70-4 | Reference compound |
| HY-164514 | NMS-P626 | 942471-37-6 | Reference compound |
| HY-164515 | ONC213 | 1977540-13-8 | Reference compound |
| HY-164516 | ONCOII | 1263564-94-8 | Reference compound |
| HY-164517 | ONO-7579 | 1622212-25-2 | Reference compound |
| HY-164518 | PF-3837 | 2772910-13-9 | Reference compound |
| HY-164519 | PF-7006 | 2771955-09-8 | Reference compound |
| HY-164520 | PMED-1 | 491828-75-2 | Reference compound |
| HY-164521 | PMMB-187 | 2162952-37-4 | Reference compound |
| HY-164523 | PV1162 | 1346559-65-6 | Reference compound |
| HY-164524 | SBI-0640726 | 1321827-45-5 | Reference compound |
| HY-164525 | SD-7300 | 748120-89-0 | Reference compound |
| HY-164526 | SH1573 | 2376068-96-9 | Reference compound |
| HY-164527 | Si306 | 1640012-88-9 | Reference compound |
| HY-164528 | SJ26 | 1801288-67-4 | Reference compound |
| HY-164529 | SJ-C1044 | 2121503-76-0 | Reference compound |
| HY-164530 | SKLB646 | 1970149-05-3 | Reference compound |
| HY-164532 | NS3736 | 265646-94-4 | Reference compound |
| HY-164535 | Maridebart cafraglutide | 2887445-76-1 | ADC Related |
| HY-164536 | SLCB050 | 1848971-16-3 | Reference compound |
| HY-164537 | SPI-001 | 1220996-46-2 | Reference compound |
| HY-164539 | TMU 35435 | 2231800-32-9 | Reference compound |
| HY-164542 | TQ05310 | 2071196-10-4 | Reference compound |
| HY-164544 | USP7-055 | 2413943-73-2 | Reference compound |
| HY-164546 | WB436B | 2248552-84-1 | Reference compound |
| HY-164547 | WHN-88 | 2490686-86-5 | Reference compound |
| HY-164548 | WK88-1 | 958888-32-9 | Reference compound |
| HY-164549 | XMD15-44 | 1240489-67-1 | Reference compound |
| HY-164550 | YF438 | 2247210-09-7 | Reference compound |
| HY-164551 | YLL545 | 1423126-69-5 | Reference compound |
| HY-164552 | ZNU-IMB-Z15 | 920915-26-0 | Reference compound |
| HY-164553 | ZSQ836 | 2634811-35-9 | Oligonucleotides |
| HY-164556 | 3′-Deoxy-5′-AMP | 17434-81-0 | Reference compound |
| HY-164556A | 3′-Deoxy-5′-AMP (sodium) | 71997-30-3 | Reference compound |
| HY-164557 | 3′-Deoxyadenosine 5′-triphosphate | 73-04-1 | Reference compound |
| HY-164557A | 3′-Deoxyadenosine 5′-triphosphate (trisodium) | 71997-32-5 | Reference compound |
| HY-164560 | MALT1-IN-14 | 3047242-55-4 | Reference compound |
| HY-164561 | TASIN-30 | 1678515-93-9 | Reference compound |
| HY-164566 | POSH-IN-2 | 348145-43-7 | Reference compound |
| HY-164567 | SID 125240931 | 701245-29-6 | Reference compound |
| HY-164568 | 7β,16α-Dihydroxybufalin | 773133-78-1 | Reference compound |
| HY-164569 | NH2 DOTA-GA | 1639843-65-4 | ADC Related |
| HY-164574 | BCN-DOTA | 2565792-45-0 | ADC Related |
| HY-164575 | NH2-NODAGA | 1630114-57-6 | ADC Related |
| HY-164576 | NCS-MP-NODA | 1374994-81-6 | ADC Related |
| HY-164577 | BCN-DOTA-GA | 2416980-98-6 | ADC Related |
| HY-164579 | NH2-GG-DSPE | 1364335-16-9 | Reference compound |
| HY-164580 | RO3244794 | 361457-01-4 | Reference compound |
| HY-164581 | DMTr-2'-O-C22-rG-3'-CE-Phosphoramidite | 2923115-75-5 | Oligonucleotides |
| HY-164582 | DMTr-2'-O-C22-rC-3'-CE-Phosphoramidite | 2923115-93-7 | Oligonucleotides |
| HY-164583 | DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite | 2923115-67-5 | Oligonucleotides |
| HY-164587 | E197 | 2378515-04-7 | Reference compound |
| HY-164588 | NH2-PEG4-NODA-GA | 2306108-46-1 | ADC Related |
| HY-164589 | NOPO | 1397275-76-1 | ADC Related |
| HY-16459 | Glycididazole (sodium) | 173357-17-0 | Reference compound |
| HY-164590 | BCN-NODAGA | 2256055-98-6 | ADC Related |
| HY-164591 | THP(Bz)3-NH2 | 827331-42-0 | ADC Related |
| HY-164592 | DTPA-tetra(tBu)ester | 180152-83-4 | ADC Related |
| HY-164593 | NH-CH2-CH2-DOTAM | 2685840-60-0 | ADC Related |
| HY-164594 | TA-DOTA-GA | ADC Related | |
| HY-164595 | IHMT-MST1-39 | 2414484-01-6 | Reference compound |
| HY-164596 | THP(Bz3)-Glu | ADC Related | |
| HY-164598 | Amino-tri-(azide-PEG4-ethoxymethyl)-methane | Reference compound | |
| HY-164599 | TA-DOTA | 2451069-30-8 | ADC Related |
| HY-164603 | 3p-C-NOTA | 2166455-20-3 | ADC Related |
| HY-164605 | (6S)-CP-470711 | 300552-09-4 | Reference compound |
| HY-164607 | YL-5092 | 3056857-07-6 | Reference compound |
| HY-16461 | Solenopsin | 137038-57-4 | Reference compound |
| HY-164619 | CDK9-IN-34 | 252725-86-3 | Reference compound |
| HY-16462 | CDK9-IN-2 | 1263369-28-3 | Reference compound |
| HY-164620 | Antifungal agent 112 | 68380-53-0 | Reference compound |
| HY-164621 | A3AR antagonist 5 | 333436-43-4 | Reference compound |
| HY-164623 | CUTAG CPG (pore size 1000 Å, 25-35 μmol/g) | Reference compound | |
| HY-164632 | KRAS inhibitor-32 | 3056974-05-8 | Reference compound |
| HY-164637 | Aniline-PEG3-C1-Boc | 2115897-27-1 | ADC Related |
| HY-164642 | Ribulose 1,5-bisphosphate | 24218-00-6 | Natural Products |
| HY-164643 | Antifungal agent 113 | 1373311-69-3 | Reference compound |
| HY-164645 | pan-KRAS-IN-16 | 2368246-78-8 | Reference compound |
| HY-164647 | Val-Ala-PABC-N(Mesylpropane)-Exatecan | 2842021-73-0 | ADC Related |
| HY-164648 | Flosatidil | 113593-34-3 | Reference compound |
| HY-164649 | Atibeprone | 153420-96-3 | Reference compound |
| HY-16465 | IRL-1620 | 142569-99-1 | Peptides |
| HY-164650 | Pirodomast | 108310-20-9 | Reference compound |
| HY-164652 | m-BBIG (dihydrochloride) | 181147-28-4 | Reference compound |
| HY-164653 | DOTAEt | 137076-50-7 | ADC Related |
| HY-164654 | DOTA-PEG10-azide | ADC Related | |
| HY-164656 | DOTA-tris(acid)-amido-PEG24-amido-PEG24-DSPE | ADC Related | |
| HY-164657 | Polyamidoamine (20% in methanol) | 153891-46-4 | ADC Related |
| HY-16465A | IRL-1620 (TFA) | Peptides | |
| HY-16466 | Spliceostatin A | 391611-36-2 | Reference compound |
| HY-164662 | mTOR inhibitor-24 | 1144075-38-6 | Reference compound |
| HY-164663 | Solpecainol | 155321-96-3 | Reference compound |
| HY-164664 | CDK2-IN-30 | 2640038-22-6 | Reference compound |
| HY-164666 | Cericlamine | 112922-55-1 | Reference compound |
| HY-164668 | ADC Control Human IgG1-SN-38 | ADC Related | |
| HY-164669 | ADC Control Human IgG1-DM4 | ADC Related | |
| HY-16467 | Squalamine lactate | 320725-47-1 | Natural Products |
| HY-164670 | D228 | 2676188-98-8 | Reference compound |
| HY-164675 | gp120-IN-3 | 869474-87-3 | Reference compound |
| HY-164676 | PLH2058 | 2525206-41-9 | Reference compound |
| HY-164677 | PLH1215 | 1332084-64-6 | Reference compound |
| HY-16468 | Squalamine | 148717-90-2 | Natural Products |
| HY-164681 | Sunepitron | 131831-03-3 | Reference compound |
| HY-164682 | AMD 3329 (octahydrobromide) | 170861-77-5 | Reference compound |
| HY-164683 | MRP1-IN-1 | 246238-55-1 | Reference compound |
| HY-164684 | Dichlorobenzamil | 1166-01-4 | Reference compound |
| HY-164685 | T-0156 (free base) | 324572-92-1 | Reference compound |
| HY-164689 | Cadmium pyrithione | 18897-36-4 | Reference compound |
| HY-16469 | SR 13668 | 637774-61-9 | Reference compound |
| HY-164690A | Nicotinamide-guanine dinucleotide (sodium) | 2600354-60-5 | Enzyme |
| HY-164694 | Emupertinib | 2472802-77-8 | Reference compound |
| HY-164702 | BL-B01D1 | Reference compound | |
| HY-164703 | Lumateperone metabolite 1 | 1469777-40-9 | Reference compound |
| HY-164704 | JA2 | 277333-45-6 | Reference compound |
| HY-164705 | Mal-Toxophore | 2592504-91-9 | ADC Related |
| HY-164706 | m-PEG6-Lys-Mal-Toxophore-quinoline | 2369100-39-8 | ADC Related |
| HY-164707 | MC7 | 2222981-66-8 | ADC Related |
| HY-164710 | Biotinylated leptomycin B | Reference compound | |
| HY-164712 | E-Cadherin activator-1 | 912787-60-1 | Reference compound |
| HY-164713 | PARP1-IN-31 | 684234-60-4 | Reference compound |
| HY-164714 | HSL-IN-5 | 308830-70-8 | Reference compound |
| HY-164718 | Sevabertinib | 2521285-05-0 | Reference compound |
| HY-16472 | Sulfacytine | 17784-12-2 | Reference compound |
| HY-164720 | DSPE-PEG-OH (MW 4000) | Reference compound | |
| HY-164721 | DSPE-PEG-OH (MW 6000) | Reference compound | |
| HY-164722 | DSPE-PEG-OH (MW 8000) | Reference compound | |
| HY-164723 | DSPE-PEG-OH (MW 10000) | Reference compound | |
| HY-164724 | Bis-PEG30-NHS ester | Reference compound | |
| HY-164725 | FAPI-mFS | 3023869-94-2 | Peptides |
| HY-164726 | Estrogen receptor modulator 11 | 96719-63-0 | Reference compound |
| HY-164728 | Pregabalin diacid | 5702-99-8 | Reference compound |
| HY-164729 | FZ-AD005 | ADC Related | |
| HY-16472R | Sulfacytine (Standard) | 17784-12-2 | Reference Standards |
| HY-16473 | Sulfoxone (disodium) | 144-75-2 | Reference compound |
| HY-164730 | Epratuzumab Tesirine | ADC Related | |
| HY-164731 | Mal-PEG12-DOTA | ADC Related | |
| HY-164732 | Fmoc-Lys(DOTA)-OH | 1611478-62-6 | ADC Related |
| HY-164734 | Raludotatug Deruxtecan | ADC Related | |
| HY-16474 | Relugolix | 737789-87-6 | Reference compound |
| HY-164740 | Plozasiran | 2379776-40-4 | Oligonucleotides |
| HY-164740A | Plozasiran (sodium) | 2379776-41-5 | Oligonucleotides |
| HY-164745 | L-β-Ethynylserine | 65207-64-9 | Reference compound |
| HY-164746 | 4′-Hydroxy Nitazene | 94758-81-3 | Reference compound |
| HY-164747 | Isotodesnitazene | 2732926-27-9 | Reference compound |
| HY-164749 | K-Ras-IN-4 | 3044773-77-2 | Reference compound |
| HY-16474R | Relugolix (Standard) | 737789-87-6 | Reference Standards |
| HY-16474S | Relugolix-d6 | Isotope-Labeled Compounds | |
| HY-16475 | TAK-441 | 1186231-83-3 | Reference compound |
| HY-164756 | PKCTheta-IN-2 | 1810742-60-9 | Reference compound |
| HY-164757 | PARP-1-IN-32 | 374069-33-7 | Reference compound |
| HY-164759 | Nampt-IN-13 | 2592504-89-5 | Reference compound |
| HY-164762 | Trastuzumab rezetecan | 2924909-11-3 | ADC Related |
| HY-164763 | SHR-A1201 | ADC Related | |
| HY-164764 | ADX61623 | 1067189-44-9 | Reference compound |
| HY-164765 | NLRP3-IN-56 | 3048421-42-4 | Reference compound |
| HY-164766 | ICG-DBCO-1-Maltotriose | Dye Reagents | |
| HY-164768 | LT25 | 2023788-40-9 | Reference compound |
| HY-16477 | Talaporfin (sodium) | 220201-34-3 | Reference compound |
| HY-164770 | Adenosyl-(3′→5′)-uridine | 3051-84-1 | Reference compound |
| HY-164771 | Uridylyl-(3′→5′)-adenosine | 3256-24-4 | Reference compound |
| HY-164774 | (4S)-GLP-1 receptor agonist 14 | 2758659-09-3 | Reference compound |
| HY-16477A | Talaporfin | 110230-98-3 | Reference compound |
| HY-16478 | Trifluridine/tipiracil hydrochloride mixture | 733030-01-8 | Reference compound |
| HY-164781 | KOTX1 | 1788963-83-6 | Reference compound |
| HY-164782 | PT3 | 2710273-81-5 | Reference compound |
| HY-164785 | TCO-PEG5-C2-Mal | 2748951-17-7 | Reference compound |
| HY-164787 | N-MeVal-Val-Dil-Dap-2-(pyridin-3-yl)ethanamine | 1448364-29-1 | ADC Related |
| HY-164788 | GGFG-PAB-MMAE | 3049886-19-0 | ADC Related |
| HY-164789 | Sacituzumab tirumotecan | 2768350-77-0 | ADC Related |
| HY-164792 | DBCO-PEG3-VC-Exatecan | 2754384-70-6 | ADC Related |
| HY-164793 | TGFBR1-IN-2 | 733806-89-8 | Reference compound |
| HY-164794 | Pyridyl disulfide-Dexamethasone | 1438897-17-6 | ADC Related |
| HY-164795 | SBI-810 | 1849603-79-7 | Reference compound |
| HY-164795A | SBI-810 (hydrochloride) | 2772746-58-2 | Reference compound |
| HY-164799 | FXR agonist 12 | 1831862-88-4 | Reference compound |
| HY-164802 | Pan-RAS-IN-7 | 2642135-72-4 | Reference compound |
| HY-164803 | CBD3063 | 1281060-70-5 | Reference compound |
| HY-164804 | N-Lactylvaline | 70190-98-6 | Reference compound |
| HY-164805 | N-Lactylleucine | 112757-17-2 | Reference compound |
| HY-164807 | SARD279 | 1489236-55-6 | Reference compound |
| HY-164813 | oxLig-1 | 352523-18-3 | Reference compound |
| HY-164814 | GPR27 agonist-1 | 651295-98-6 | Reference compound |
| HY-164815 | S 8849-1 (free base) | 104732-22-1 | Reference compound |
| HY-164816 | FITC-SAHA | 1160823-10-8 | Reference compound |
| HY-164817 | CB1/2 receptor-1 | 1260669-31-5 | Reference compound |
| HY-164819 | UNC10099984A | 1354030-25-3 | Reference compound |
| HY-16482 | Teglicar | 250694-07-6 | Reference compound |
| HY-164825 | Pyridoxine tri(2-hexyldecanoate) | 564478-51-9 | Reference compound |
| HY-164826 | Acetyl zingerone | 30881-23-3 | Reference compound |
| HY-164827 | CDK2 degrader 3 | 2862772-71-0 | Reference compound |
| HY-164829 | Mal-C5-Gly-Gly-Phe-MMAE | 3056230-14-6 | Reference compound |
| HY-164835 | VcMMAE-Deruxtecan | 2760408-75-9 | ADC Related |
| HY-164836 | Deruxtecan-Eribulin | ADC Related | |
| HY-164837 | VcMMAE-Eribulin | ADC Related | |
| HY-164838 | ABC47 | 1831135-57-9 | Reference compound |
| HY-164839 | Clofarabine-5'-diphosphate | 167620-89-5 | Reference compound |
| HY-164839A | Clofarabine-5'-diphosphate (trisodium) | Reference compound | |
| HY-164840 | Clofarabine-5'-triphosphate | 134646-41-6 | Reference compound |
| HY-164840A | Clofarabine-5'-triphosphate (trisodium) | Reference compound | |
| HY-16485 | Telavancin (hydrochloride) | 560130-42-9 | Reference compound |
| HY-164852 | WRN inhibitor 13 | 2923009-51-0 | Reference compound |
| HY-164853 | Kanglexin | 2228847-12-7 | Reference compound |
| HY-164854 | (R)-DOTAGA2 | 914639-15-9 | Reference compound |
| HY-164860 | Glucocorticoid receptor agonist-5 | 2913231-72-6 | Reference compound |
| HY-164861 | Camptothecin analog-2 | 3047369-35-4 | ADC Related |
| HY-164862 | N-(NHS ester-PEG2)-N-bis(PEG3-azide) | Reference compound | |
| HY-164863 | β-GalNAc-PEG4-Azide | 879004-92-9 | Reference compound |
| HY-164864 | DU-14 (PTP1B/TC-PTP PROTAC) | 3053413-58-1 | Reference compound |
| HY-164867 | Fmoc-L-Dap(NBSD)-OH | 3023933-33-4 | Reference compound |
| HY-164868 | SARS-CoV-2-IN-106 | 2863607-73-0 | Reference compound |
| HY-164869 | 1-Hex-GlcNAlk | 2863607-71-8 | Reference compound |
| HY-16487 | Temafloxacin | 108319-06-8 | Reference compound |
| HY-164870 | FFAR1/FFAR4 agonist-1 | 2839486-16-5 | Reference compound |
| HY-164875 | Apt-A-FAM-AS | Oligonucleotides | |
| HY-164879 | TBK1 siRNA-1 | Oligonucleotides | |
| HY-16487R | Temafloxacin (Standard) | 108319-06-8 | Reference Standards |
| HY-16488 | Temoporfin | 122341-38-2 | Reference compound |
| HY-164880 | TBK1 siRNA-2 | Oligonucleotides | |
| HY-164881 | TBK1 siRNA-3 | Oligonucleotides | |
| HY-164882 | MetsiRNA-1 | Oligonucleotides | |
| HY-164883 | MetsiRNA-2 | Oligonucleotides | |
| HY-164884 | MetsiRNA-3 | Oligonucleotides | |
| HY-164885 | Adenosine Kinase siRNA-1 | Oligonucleotides | |
| HY-164886 | Adenosine Kinase siRNA-2 | Oligonucleotides | |
| HY-164887 | Adenosine Kinase siRNA-3 | Oligonucleotides | |
| HY-164888 | FAK siRNA-1 | Oligonucleotides | |
| HY-164889 | FAK siRNA-2 | Oligonucleotides | |
| HY-16489 | Terodiline | 15793-40-5 | Reference compound |
| HY-164890 | FAKsiRNA-3 | Oligonucleotides | |
| HY-164891 | EM12-FS | 2839138-44-0 | Reference compound |
| HY-164893 | ABBV-154 | ADC Related | |
| HY-164894 | ABBV-3373 | ADC Related | |
| HY-164895 | PIN1 degrader-1 | Reference compound | |
| HY-164899 | 2A3 | 2765091-45-8 | Reference compound |
| HY-16489A | Terodiline (hydrochloride) | 7082-21-5 | Reference compound |
| HY-164900 | Se-NADA | 2571574-70-2 | Dye Reagents |
| HY-164903 | UDP-D-GalNAlk | 1608127-25-8 | Reference compound |
| HY-164903A | UDP-D-GalNAlk (disodium) | 2370947-52-5 | Reference compound |
| HY-164905 | DGK-IN-8 | 3039488-69-9 | Reference compound |
| HY-164906 | TMX-2138 | 2488892-07-3 | Reference compound |
| HY-164907 | GSK-3β inhibitor 22 | 1005199-84-7 | Reference compound |
| HY-164909 | PZ-3022 | 2170608-85-0 | Reference compound |
| HY-16491 | Tesetaxel | 333754-36-2 | Reference compound |
| HY-164910 | AHL-Pu-2 | 1838570-66-3 | Reference compound |
| HY-164911 | VU0546110 | 1421523-00-3 | Reference compound |
| HY-164913 | PSB-SB-1203 | 1399049-80-9 | Reference compound |
| HY-164915 | 5-InoAz | 1218932-97-8 | Reference compound |
| HY-164919 | Calotatug ginistinag | 2847102-44-5 | ADC Related |
| HY-164920 | WR 199507 (trihydrobromide) | 57514-28-0 | ADC Related |
| HY-164923 | SPA107 | 179939-69-6 | Reference compound |
| HY-164924 | ERD-12310A | Reference compound | |
| HY-164925 | ER ligand-4 | Reference compound | |
| HY-164926 | PARP1-IN-33 | 2640677-68-3 | Reference compound |
| HY-164927 | Tivoxavir marboxil | 2417851-93-3 | Reference compound |
| HY-164928 | PTAD-PEG8-alkyne | Reference compound | |
| HY-164929 | PTAD-PEG8-azide | Reference compound | |
| HY-164949 | Ribociclib acetate | 2762182-61-4 | Reference compound |
| HY-164951 | C1-BCEA-Acm | 2223042-67-7 | Reference compound |
| HY-164954 | ADC Control Human IgG1-McMMAF | ADC Related | |
| HY-164955 | TTK/PLK1-IN-1 | 1817791-70-0 | Reference compound |
| HY-164956 | TB-9 | 1415033-91-8 | Reference compound |
| HY-164957 | SGN-B6A | ADC Related | |
| HY-164958 | TB-11 | 1415033-93-0 | Peptides |
| HY-164959 | ZINC00230567 | 300816-12-0 | Reference compound |
| HY-16496 | Thiarabine | 26599-17-7 | Reference compound |
| HY-164964 | TRV045 | 2256030-24-5 | Reference compound |
| HY-164970 | TANGO1-L Human scramble negative control | Reference compound | |
| HY-164977 | JCS-1 | Reference compound | |
| HY-164978 | KIF18A-IN-14 | 3051552-75-8 | Reference compound |
| HY-164979 | KIF18A-IN-15 | 3051552-64-5 | Reference compound |
| HY-16498 | Tigapotide | 848084-83-3 | Peptides |
| HY-164980 | KIF18A-IN-16 | 3033981-01-7 | Reference compound |
| HY-164981 | p-SCN-Bn-DOTA(tBu)4 | 1703752-99-1 | Reference compound |
| HY-164982 | S-N6-Methyladenosylhomocysteine | 53228-06-1 | Reference compound |
| HY-164984 | m3227G(5)ppp(5')A | 123212-19-1 | Reference compound |
| HY-164984A | m3227G(5)ppp(5')A (triammonium) | Reference compound | |
| HY-164985 | m3227G(5)ppp(5')Am | 178422-14-5 | Reference compound |
| HY-164985A | m3227G(5)ppp(5')Am (triammonium) | Reference compound | |
| HY-164986 | m3227G(5)ppp(5')m6Am | Reference compound | |
| HY-164986A | m3227G(5)ppp(5')m6Am (triammonium) | Reference compound | |
| HY-164988 | TX2-120-1 | 1603845-45-9 | Reference compound |
| HY-164992 | Trastuzumab vedotin | ADC Related | |
| HY-164995 | L1BC8 | 2417370-68-2 | Reference compound |
| HY-164997 | 15-keto Prostaglandin F1α | 21562-58-3 | Reference compound |
| HY-164998 | 15-Hydroxy Lubiprostone | 475992-30-4 | Reference compound |
| HY-164999 | N,N'-Bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine | 30414-15-4 | Reference compound |
| HY-16500 | Tolrestat | 82964-04-3 | Reference compound |
| HY-165000 | 3,4-Difluoro isopropyl U-47700 | 2752265-46-4 | Reference compound |
| HY-165001 | 2,4-Difluoro U-48800 (hydrochloride) | 2740304-36-1 | Reference compound |
| HY-165005 | 14S(15R)-EET methyl ester | 110901-52-5 | Reference compound |
| HY-165006 | 1-Palmitoyl-2-elaidoyl-3-linoleoyl-rac-glycerol | 149494-16-6 | Reference compound |
| HY-165008 | 1,2,3-Tri-12(Z)-heneicosanoyl glycerol | 169054-26-6 | Reference compound |
| HY-16500R | Tolrestat (Standard) | 82964-04-3 | Reference Standards |
| HY-165012 | 1,3-Dioleoyl-2-heptadecanoyl glycerol | 195891-94-2 | Reference compound |
| HY-165014 | 2C-I-FLY (hydrochloride) | 2898740-47-9 | Reference compound |
| HY-165017 | Etheroleic acid | 169217-38-3 | Natural Products |
| HY-165019 | 3,4-Dichloro-N,N-dimethcathinone (hydrochloride) | 2748344-06-9 | Reference compound |
| HY-16502 | Crocetin (disodium) | 591230-99-8 | Natural Products |
| HY-165020 | Ethyl 8(Z),11(Z),14(Z)-octadecatrienoate | 2347415-30-7 | Natural Products |
| HY-165021 | 3,4-Difluoro propyl U-47700 | 2741276-45-7 | Reference compound |
| HY-165022 | (±)14(15)-EpEDE | 351533-80-7 | Natural Products |
| HY-165023 | 4-Bromo-α-pyrrolidinovalerophenone (hydrochloride) | 850352-17-9 | Reference compound |
| HY-165024 | (±)5(6)-Epete methyl ester | 127716-49-8 | Natural Products |
| HY-165026 | 1,2,3-tri-γ-Linolenoyl glycerol | 60756-74-3 | Reference compound |
| HY-165027 | DL-1′-Acetoxychavicol acetate | 53890-21-4 | Reference compound |
| HY-165028 | 7-Methoxy apigeninidin (chloride) | 161773-51-9 | Reference compound |
| HY-165029 | 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC | 17708-90-6 | Oligonucleotides |
| HY-16503 | Treosulfan | 299-75-2 | Reference compound |
| HY-165030 | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC | 154436-51-8 | Reference compound |
| HY-165031 | C16 (2'(S)-Hydroxy) ceramide (d18:1/16:0) | 890041-50-6 | Reference compound |
| HY-165032 | C24 (2'(S)-Hydroxy) ceramide (d18:1/24:0) | 112317-53-0 | Reference compound |
| HY-165033 | C24 (2'(R)-Hydroxy) ceramide (d18:1/24:0) | 64655-47-6 | Reference compound |
| HY-165034 | C18 ((±)-2'-Hydroxy) ceramide (d18:1/18:0) | 34249-41-7 | Natural Products |
| HY-165035 | Glucosylceramide (gaucher's spleen) | 85305-87-9 | Natural Products |
| HY-165036 | 1,2-Dieicosapentaenoyl-3-palmitoyl-rac-glycerol | 115433-29-9 | Reference compound |
| HY-165037 | 1,2-Dimyristoyl-3-eicosapentaenoyl-rac-glycerol | 116198-40-4 | Reference compound |
| HY-165038 | 1,2-Didecanoyl-3-stearoyl-rac-glycerol | 139665-46-6 | Reference compound |
| HY-165039 | 1,3-Dioleoyl-2-octanoyl glycerol | 139979-77-4 | Reference compound |
| HY-16504 | Treprostinil (sodium) | 289480-64-4 | Reference compound |
| HY-165040 | 1-Palmitoyl-2-stearoyl-rac-glycerol | 20296-26-8 | Reference compound |
| HY-165041 | 1,3-Dioleoyl-2-stearoyl glycerol | 2410-29-9 | Reference compound |
| HY-165042 | 1,2-Dipalmitoyl-3-decanoyl-rac-glycerol | 93378-78-0 | Reference compound |
| HY-165043 | 1,3-Diarachidonoyl glycerol | 95034-09-6 | Reference compound |
| HY-165044 | 1,3-Di-α-linolenoyl glycerol | 98242-77-4 | Reference compound |
| HY-165045 | 1,2-Dipentadecanoyl-rac-glycerol | 98896-79-8 | Reference compound |
| HY-165046 | 1,2,3-Trilinoelaidoyl glycerol | 5188-25-0 | Reference compound |
| HY-165047 | 1-Palmitoyl-2-linoleoyl-3-stearoyl-rac-glycerol | 2190-12-7 | Reference compound |
| HY-165048 | 1,3-Distearoyl-2-linoleoyl glycerol | 2190-13-8 | Reference compound |
| HY-165049 | 1-Stearoyl-2-oleoyl-3-linoleoyl-rac-glycerol | 2190-14-9 | Reference compound |
| HY-16504S | Treprostinil-13C2-d1 (Sodium) | Isotope-Labeled Compounds | |
| HY-16505 | Triclofos (sodium) | 7246-20-0 | Reference compound |
| HY-165050 | 1,3-Dilinoleoyl-2-stearoyl glycerol | 2190-18-3 | Reference compound |
| HY-165051 | 1,3-Dibutyryl-2-oleoyl glycerol | 175878-34-9 | Reference compound |
| HY-165052 | 1,3-Didocosahexaenoyl-2-palmitoyl glycerol | 197016-86-7 | Reference compound |
| HY-165053 | 1,3-Distearoyl-2-palmitoyl glycerol | 2190-24-1 | Reference compound |
| HY-165054 | 1-Palmitoyl-2-stearoyl-3-oleoyl-rac-glycerol | 2190-28-5 | Reference compound |
| HY-165055 | 1-Oleoyl-2-palmitoyl-3-linoleoyl-rac-glycerol | 2534-97-6 | Reference compound |
| HY-165056 | 1,2-Dipalmitoyl-3-linoleoyl-rac-glycerol | 2535-35-5 | Reference compound |
| HY-165057 | Himbadine | 24932-15-8 | Natural Products |
| HY-165058 | Himandridine | 15521-76-3 | Natural Products |
| HY-16506 | Trimethaphan camsylate | 68-91-7 | Reference compound |
| HY-165060 | (±)2-(14,15-Epoxyeicosatrienoyl) glycerol | 848667-56-1 | Oligonucleotides |
| HY-165061 | 5(Z),11(Z),14(Z)-Eicosatrienoic acid | 7019-85-4 | Reference compound |
| HY-165062 | C18 Sphingomyelin (d18:1/18:0) | 54336-69-5 | Natural Products |
| HY-165063 | Oleoyl 3-carbacyclic phosphatidic acid | 779333-58-3 | Reference compound |
| HY-165064 | C2 L-Erythro ceramide (d18:1/2:0) | 150338-90-2 | Natural Products |
| HY-165065 | ISP-I-28 | 221650-34-6 | Reference compound |
| HY-165066 | EOS (d18:1/30:0/18:2) | 97040-38-5 | Natural Products |
| HY-165067 | 14,15-EE-8(Z)-E | 519038-93-8 | Natural Products |
| HY-165068 | SOCLAC | 126586-82-1 | Reference compound |
| HY-165069 | N-Docosanoyl-D-erythro-sphingosylphosphorylcholine | 94359-12-3 | Natural Products |
| HY-165070 | SABRAC | 886212-98-2 | Reference compound |
| HY-165071 | (±)16(17)-EpDPA | 155073-46-4 | Natural Products |
| HY-165072 | C2 3'-Sulfo galactosylceramide (d18:1/2:0) | 252846-08-5 | Natural Products |
| HY-165073 | 15(R)-15-Methyl prostaglandin A2 | 96440-68-5 | Oligonucleotides |
| HY-165074 | 17-Phenyl trinor-13,14-dihydro prostaglandin A2 | 130209-80-2 | Reference compound |
| HY-165075 | C26 Sphingomyelin (d18:1/26:0) | 221097-57-0 | Reference compound |
| HY-165075S | C26 Sphingomyelin (d18:1/26:0)-d4 | Isotope-Labeled Compounds | |
| HY-165076 | 19(R)-Hydroxy prostaglandin A2 | 52087-58-8 | Reference compound |
| HY-165077 | NSC 245214 | 31554-45-7 | Reference compound |
| HY-165078 | (±)11(12)-EpETE | 504435-15-8 | Natural Products |
| HY-165079 | 3-Iodoamphetamine (hydrochloride) | 20110-56-9 | Reference compound |
| HY-16508 | Ulipristal acetate | 126784-99-4 | Reference compound |
| HY-165080 | 16,16-Dimethyl prostaglandin D2 | 64072-59-9 | Reference compound |
| HY-165081 | Docosaenoyl ethanolamide | 18190-74-4 | Natural Products |
| HY-165082 | Tricosanoyl ethanolamide | 171022-15-4 | Natural Products |
| HY-165083 | Prostaglandin E2 p-acetamidophenyl ester | 57790-52-0 | Reference compound |
| HY-165084 | Erucate (sodium) | 383908-63-2 | Natural Products |
| HY-165085 | Prostaglandin E2 p-benzamidophenyl ester | 57790-53-1 | Reference compound |
| HY-165086 | PON-PC | 135726-46-4 | Natural Products |
| HY-165087 | C6 Biotin ceramide (d18:1/6:0) | 192070-02-3 | Reference compound |
| HY-165088 | 15(S)-Acetate prostaglandin A2 methyl ester | 36323-03-2 | Reference compound |
| HY-165089 | 1,2-Dioleoyl-3-lauroyl-rac-glycerol | 4016-52-8 | Reference compound |
| HY-16508R | Ulipristal acetate (Standard) | 126784-99-4 | Reference Standards |
| HY-16508S | Ulipristal acetate-d6 | 1621894-64-1 | Isotope-Labeled Compounds |
| HY-16508S1 | Ulipristal acetate-d3 | 1621894-62-9 | Isotope-Labeled Compounds |
| HY-16509 | UNBS5162 | 956590-23-1 | Reference compound |
| HY-165090 | 1,3-Distearoyl-2-lauroyl glycerol | 56183-45-0 | Reference compound |
| HY-165091 | 1,2-Dioctanoyl-3-decanoyl-rac-glycerol | 69095-45-0 | Reference compound |
| HY-165092 | 1-Arachidoyl-2-palmitoyl-3-oleoyl-rac-glycerol | 81637-57-2 | Reference compound |
| HY-165093 | 1-Arachidoyl-2-oleoyl-3-palmitoyl-rac-glycerol | 81655-42-7 | Reference compound |
| HY-165094 | 1-Myristoyl-2-linoleoyl-3-palmitoyl-rac-glycerol | 105595-41-3 | Reference compound |
| HY-165095 | 1,2-Dipalmitoleoyl-3-palmitoyl-rac-glycerol | 74257-22-0 | Reference compound |
| HY-165097 | 1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC | 154436-48-3 | Reference compound |
| HY-165098 | 3-Aminoisobutyric acid (sodium salt) | 84796-61-2 | Reference compound |
| HY-165099 | C-8 Ceramide-1-phosphate | 158983-53-0 | Natural Products |
| HY-16510 | UNC926 | 1184136-10-4 | Reference compound |
| HY-165100 | 1,3-Dipalmitoleoyl glycerol | 106352-09-4 | Reference compound |
| HY-165101 | 10-Methyl lauric acid | 7416-57-1 | Natural Products |
| HY-165102 | 1,3-Dipalmitoyl-2-elaidoyl glycerol | 32221-51-5 | Reference compound |
| HY-165103 | Clazamycin A (hydrochloride) | 71743-75-4 | Reference compound |
| HY-165104 | β-L-Gulopyranosyl-caldarchaetidyl-glycerol | 416880-23-4 | Reference compound |
| HY-165105 | 1,3-Dioleoyl-2-decanoyl glycerol | 81246-69-7 | Reference compound |
| HY-165106 | 1,2-Dibutyryl-3-palmitoyl-rac-glycerol | 74055-98-4 | Reference compound |
| HY-165107 | 1,2-Dioctanoyl-3-stearoyl-rac-glycerol | 56149-05-4 | Reference compound |
| HY-165108 | 1,2-Dilinoleoyl-3-α-linolenoyl-rac-glycerol | 55771-89-6 | Reference compound |
| HY-165109 | 1,3-Dioleoyl-2-lauroyl glycerol | 383189-71-7 | Reference compound |
| HY-16510A | UNC926 (hydrochloride) | 1782573-49-2 | Reference compound |
| HY-16511 | Upamostat | 590368-25-5 | Reference compound |
| HY-165110 | 1-Stearoyl-2-palmitoyl-3-oleoyl-rac-glycerol | 35984-52-2 | Reference compound |
| HY-165111 | 1,2-Dioleoyl-3-myristoyl-rac-glycerol | 35804-98-9 | Reference compound |
| HY-165112 | 1,2-Dioleoyl-3-α-linolenoyl-rac-glycerol | 90318-80-2 | Reference compound |
| HY-165113 | 1,2-Distearoyl-3-arachidoyl-rac-glycerol | 77145-69-8 | Reference compound |
| HY-165114 | 6-Hydroxyramulosin | 29913-85-7 | Reference compound |
| HY-165115 | 1,2-Dipalmitoyl-3-pentadecanoyl-rac-glycerol | 68810-06-0 | Reference compound |
| HY-165116 | 1-1(Z)-Octadecenyl-2-docosahexaenoyl-sn-glycero-3-PE | 206059-98-5 | Natural Products |
| HY-165117 | Bactobolamine | 78013-07-7 | Reference compound |
| HY-165118 | Pentadecanoyl-L-carnitine (chloride) | 173686-57-2 | Reference compound |
| HY-165119 | 1-Stearoyl-2-eicosapentaenoyl-sn-glycero-3-PE | 96935-44-3 | Reference compound |
| HY-165120 | Heptadecanoyl-L-carnitine (chloride) | 173686-69-6 | Reference compound |
| HY-165121 | 1,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride) | 328250-28-8 | Reference compound |
| HY-165122 | 1,2-Dioleoyl-3(S)-trimethylammoniumpropane (chloride) | 428506-51-8 | Reference compound |
| HY-165123 | Mepartricin | 11121-32-7 | Reference compound |
| HY-165124 | 1,2,3,4,6,7,8-Heptachlorodibenz | 35822-46-9 | Reference compound |
| HY-165124S | 1,2,3,4,6,7,8-Heptachlorodibenz-13C12 | 109719-83-7 | Isotope-Labeled Compounds |
| HY-165125 | (S)-VU0637120 | 1175940-86-9 | Reference compound |
| HY-165126 | Schizophyllan | 9050-67-3 | Reference compound |
| HY-165127 | Octopinic acid | 20197-09-5 | Reference compound |
| HY-165128 | Alternapyrone | 676340-02-6 | Reference compound |
| HY-165129 | CP102 | 126055-13-8 | Reference compound |
| HY-16513 | VAL-083 | 23261-20-3 | Reference compound |
| HY-165130 | 7(S),10(S)-DiHOME | 252255-87-1 | Reference compound |
| HY-165131 | Δ7-Avenasterol | 7212-91-1 | Natural Products |
| HY-165132 | Floramultine | 1354-66-1 | Natural Products |
| HY-165133 | (–)-Kreysigine | 23117-57-9 | Natural Products |
| HY-165134 | Circumdatin A | 223130-52-7 | Natural Products |
| HY-165135 | Rac-Sphingosylphosphorylcholine | 82970-80-7 | Natural Products |
| HY-165136 | Sphingomyelins, milk | 475662-40-9 | Natural Products |
| HY-165137 | 4-Methylthiocanthin-6-one | 500299-14-9 | Natural Products |
| HY-165138 | Methyl piliformate | 898221-37-9 | Reference compound |
| HY-165139 | N,N'-Bis(2,3-dihydroxybenzoyl)-O-L-seryl-L-dehydroalanine | 73410-35-2 | Reference compound |
| HY-16514 | Vindesine | 53643-48-4 | Reference compound |
| HY-165140 | Dopastin | 37134-80-8 | Reference compound |
| HY-165141 | (+)-Anominine | 120991-21-1 | Reference compound |
| HY-165142 | Aureonitol | 71774-51-1 | Reference compound |
| HY-165143 | Bassianin | 54278-73-8 | Reference compound |
| HY-165145 | Carbazomycin C | 108073-62-7 | Natural Products |
| HY-165151 | Urobilin (hydrochloride) | 28925-89-5 | Reference compound |
| HY-165152 | KAS 08 | 203861-20-5 | Reference compound |
| HY-165153 | Ala-D-γ-Glu-Lys-D-Ala-D-Ala (TFA) | 62182-55-2 | Reference compound |
| HY-165154 | Cyclamidomycin | 35663-85-5 | Natural Products |
| HY-165155 | CysLT1 receptor antagonist-1 | 119515-00-3 | Reference compound |
| HY-165156 | DPPE-MPEG (2000) | 459429-07-3 | Oligonucleotides |
| HY-165157 | 1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC | 84460-45-7 | Reference compound |
| HY-165158 | C18 D-threo ceramide (d18:1/18:0) | 252039-53-5 | Reference compound |
| HY-16516 | Vitamin CK3 | 1085703-32-7 | Reference compound |
| HY-165160 | N-Glycolyl-ganglioside GM3 (ammonium) | 69345-49-9 | Reference compound |
| HY-165161 | POSH-IN-1 | 328960-84-5 | Reference compound |
| HY-165162 | 4-(Dimethylamino)-1-methylpyridinium (iodide) | 7538-79-6 | Oligonucleotides |
| HY-165163 | Globotetraosylceramide (porcine RBC) | 11034-93-8 | Reference compound |
| HY-165164 | Methotrexate-alpha-alanine | 116819-28-4 | Reference compound |
| HY-16516R | Vitamin CK3 (Standard) | 1085703-32-7 | Reference Standards |
| HY-16518 | Voreloxin (Hydrochloride) | 175519-16-1 | Reference compound |
| HY-16521 | VX-166 | 800408-39-3 | Reference compound |
| HY-165245 | SBI-183 | 625403-59-0 | Reference compound |
| HY-16526 | Pilaralisib | 934526-89-3 | Reference compound |
| HY-165272 | Antibiotic SF-2132 | 87003-23-4 | Natural Products |
| HY-165277 | ε-Biotinamidocaproyl-β-alanyl-β-alanyl-lisinopril | 130007-47-5 | Reference compound |
| HY-165291 | Olaflur (hydrofluoride) | 6818-37-7 | Reference compound |
| HY-165292 | (-)-α-Eudesmol | 473-16-5 | Natural Products |
| HY-16531 | YF-2 | 1311423-89-8 | Reference compound |
| HY-16531A | YF-2 (hydrochloride) | 1312005-62-1 | Reference compound |
| HY-16532 | Zoptarelin doxorubicin | 139570-93-7 | Peptides |
| HY-165362 | AO-1535 | 87178-48-1 | Reference compound |
| HY-165378 | (E)-Dothiepin (hydrochloride) | 25627-36-5 | Reference compound |
| HY-165393 | Elaidyl-sulfamide | 945009-57-4 | Reference compound |
| HY-165398 | Leucylleucine methyl ester | 13022-42-9 | Reference compound |
| HY-165420 | GC-IN-2 | 333441-43-3 | Reference compound |
| HY-165421 | Mps1-IN-10 | 2489220-49-5 | Reference compound |
| HY-165422 | ALKBH5-IN-3 | 1505579-77-0 | Reference compound |
| HY-165430 | Antiviral agent 67 | 25111-96-0 | Reference compound |
| HY-165438 | Sergliflozin-A | 360775-96-8 | Reference compound |
| HY-165447 | (S,S)-Lysinoalanine | 23250-50-2 | Reference compound |
| HY-165473 | Hexadecylphosphoserine | 133321-35-4 | Reference compound |
| HY-165473A | Hexadecylphosphoserine (TFA) | Reference compound | |
| HY-165483 | Nothramicin | 205752-47-2 | Natural Products |
| HY-165484 | AVP-13358 | 459805-03-9 | Reference compound |
| HY-165495 | Pafenolol | 75949-61-0 | Reference compound |
| HY-165496 | KAT-IN-2 | 164789-02-0 | Reference compound |
| HY-165497 | Felbinac (tris) | 935886-64-9 | Reference compound |
| HY-165512 | Nicanartine | 150443-71-3 | Reference compound |
| HY-165514A | Nafimidone (hydrochloride) | 70891-37-1 | Reference compound |
| HY-165517 | Methyl acetimidate | 14777-29-8 | Reference compound |
| HY-165524 | AM 92016 | 178894-81-0 | Reference compound |
| HY-165529 | Camostat | 59721-28-7 | Reference compound |
| HY-165537 | Siphonaxanthin | 28526-44-5 | Reference compound |
| HY-165544 | Decamethonium (chloride) | 3198-38-7 | Reference compound |
| HY-165550 | Sphingosine | 134053-67-1 | Natural Products |
| HY-16558 | Butein | 487-52-5 | Natural Products |
| HY-16558R | Butein (Standard) | 487-52-5 | Reference Standards |
| HY-16559 | Riviciclib hydrochloride | 920113-03-7 | Reference compound |
| HY-165595 | Glutamic acid-alanine-glycine mixture | 8058-79-5 | Reference compound |
| HY-16559A | Riviciclib | 920113-02-6 | Reference compound |
| HY-16560 | Camptothecin | 7689-03-4 | Natural Products |
| HY-165600A | Trimedoxime | 56-97-3 | Reference compound |
| HY-165603 | Si5-N14 | 3006860-57-4 | Reference compound |
| HY-165604 | C14-490 | 2639634-82-3 | Reference compound |
| HY-165605 | Homogeraniol | 459-88-1 | Reference compound |
| HY-16560B | (R)-Camptothecin | 110351-92-3 | Reference compound |
| HY-16560R | Camptothecin (Standard) | 7689-03-4 | Reference Standards |
| HY-16560S | Camptothecin-d5 | 1329616-37-6 | Isotope-Labeled Compounds |
| HY-16561 | Resveratrol | 501-36-0 | Natural Products |
| HY-165611 | (+)-Lupinine | 7635-60-1 | Reference compound |
| HY-16561A | cis-Resveratrol | 61434-67-1 | Natural Products |
| HY-16561G | Resveratrol (GMP) | 501-36-0 | GMP Small Molecules |
| HY-16561R | Resveratrol (Standard) | 501-36-0 | Reference Standards |
| HY-16561S | Resveratrol-d4 | 1089051-56-8 | Isotope-Labeled Compounds |
| HY-16561S1 | Resveratrol-13C6 | Isotope-Labeled Compounds | |
| HY-16561S2 | (E/Z)-Resveratrol-13C6 | 1185247-70-4 | Isotope-Labeled Compounds |
| HY-16562 | Irinotecan | 97682-44-5 | Reference compound |
| HY-165622 | Butaclamol | 36504-93-5 | Reference compound |
| HY-16562A | Irinotecan (hydrochloride) | 100286-90-6 | Natural Products |
| HY-16562AR | Irinotecan (hydrochloride) (Standard) | 100286-90-6 | Reference Standards |
| HY-16562AS | Irinotecan-d5 (hydrochloride) | 718612-73-8 | Isotope-Labeled Compounds |
| HY-16562R | Irinotecan (Standard) | 97682-44-5 | Reference Standards |
| HY-16562S | Irinotecan-d10 | 718613-28-6 | Isotope-Labeled Compounds |
| HY-16562S1 | Irinotecan-d10 (hydrochloride) | 718612-62-5 | Isotope-Labeled Compounds |
| HY-16563 | Narciclasine | 29477-83-6 | Natural Products |
| HY-165634 | (R)-Azelnidipine | 722455-08-5 | Reference compound |
| HY-165637S | (±)11(12)-DiHET-d11 | Isotope-Labeled Compounds | |
| HY-165639S | 4(Z),7(Z),10(Z)-Tridecatrienoic acid-d5 | 2714157-62-5 | Isotope-Labeled Compounds |
| HY-16563R | Narciclasine (Standard) | 29477-83-6 | Reference Standards |
| HY-16564 | Deferasirox (Fe3+ chelate) | 554435-83-5 | Reference compound |
| HY-165640S | (±)8(9)-DiHET-d11 | Isotope-Labeled Compounds | |
| HY-165641 | N-Octadecanoyl-sulfatide | 244215-65-4 | Natural Products |
| HY-165641S | N-Octadecanoyl-sulfatide-d3 | 2699608-06-3 | Isotope-Labeled Compounds |
| HY-165645 | Protectin D1-d5 | Isotope-Labeled Compounds | |
| HY-165648S | PtdIns-(1-palmitoyl-d9, 2-palmitoyl) (sodium salt) | 2993275-09-3 | Isotope-Labeled Compounds |
| HY-165649 | Methyl hentriacontanoate | 77630-51-4 | Natural Products |
| HY-16565 | 10-Deacetylbaccatin III | 32981-86-5 | Natural Products |
| HY-165650S | C16 Ganglioside GM1-d9 (d18:1/16:0-d9) (ammonium salt) | 2750534-76-8 | Isotope-Labeled Compounds |
| HY-165653S | (±)-Asenapine-13C,d3 (hydrochloride) | 1261392-55-5 | Isotope-Labeled Compounds |
| HY-165655 | 17(S)-HDHA-d5 Ethyl ester | Isotope-Labeled Compounds | |
| HY-165656 | 15(S)-HETE-d8 ethyl ester | Isotope-Labeled Compounds | |
| HY-165657S | EOP (t18:0/28:0/18:2)-d11 | Isotope-Labeled Compounds | |
| HY-165659S | Psilocybin-d10 | 2641522-10-1 | Isotope-Labeled Compounds |
| HY-16565R | 10-Deacetylbaccatin III (Standard) | 32981-86-5 | Reference Standards |
| HY-16566 | Kanamycin | 59-01-8 | Reference compound |
| HY-165660S | 2,3-Dinor-6-ketoProstaglandinF1α-d9(sodium salt) | Isotope-Labeled Compounds | |
| HY-165661S | Oleic acid-hydroxy Oleoyl Leucine-d7 | Isotope-Labeled Compounds | |
| HY-165662S | Pranoprofen-13C-d3 | Isotope-Labeled Compounds | |
| HY-165663S | 1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC | Isotope-Labeled Compounds | |
| HY-165664S | β-Glycerophosphate-d5 (sodium salt hydrate) | Isotope-Labeled Compounds | |
| HY-165665S | C16 Ganglioside GM3-d9 (ammonium salt) | Isotope-Labeled Compounds | |
| HY-165666S | Etodesnitazene-d5 (citrate) | Isotope-Labeled Compounds | |
| HY-165667S | Prednisolone-d7 | Isotope-Labeled Compounds | |
| HY-165668S | Pitavastatin lactone-d4 | Isotope-Labeled Compounds | |
| HY-16566A | Kanamycin (sulfate) | 25389-94-0 | Natural Products |
| HY-16566AR | Kanamycin (sulfate) (Standard) | 25389-94-0 | Reference Standards |
| HY-16566R | Kanamycin (Standard) | 59-01-8 | Reference Standards |
| HY-16567 | Asenapine (hydrochloride) | 1412458-61-7 | Reference compound |
| HY-165670S | 7-(β-Hydroxyethyl)theophylline-d6 | Isotope-Labeled Compounds | |
| HY-165673S | 9(S)-Hexahydrocannabinol-d9 | Isotope-Labeled Compounds | |
| HY-165674S | 11-dehydro-2,3-dinor Thromboxane B2-d9 | Isotope-Labeled Compounds | |
| HY-165675S | (Z)-10-Oxooctadec-12-enoic-17,17,18,18,18-d5 acid | Isotope-Labeled Compounds | |
| HY-165676AS | C16 Ganglioside GM2-d9 (d18:1/16:0-d9) (ammonium salt) | 2750534-90-6 | Isotope-Labeled Compounds |
| HY-165677 | C22 Galactosylceramide | 74645-25-3 | Reference compound |
| HY-165677S | C22 Galactosylceramide-d4 | 2750534-73-5 | Isotope-Labeled Compounds |
| HY-165678S | (±)-10-Hydroxy-12(Z)-Octadecenoic acid-d5 | Isotope-Labeled Compounds | |
| HY-165679S | 5(Z),8(Z),11(Z)-Heptadecatrienoic acid-d11 | Isotope-Labeled Compounds | |
| HY-16567S | Asenapine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-16568 | Irinotecan (hydrochloride trihydrate) | 136572-09-3 | Reference compound |
| HY-165680S | CEP-Lysine-d4 | 2702446-72-6 | Isotope-Labeled Compounds |
| HY-165682S | Altenuisol-d3 | Isotope-Labeled Compounds | |
| HY-165683S | Alternariol-3-beta-glucoside-d3 | Isotope-Labeled Compounds | |
| HY-165684 | Benalaxyl metabolite M1-d9 | Isotope-Labeled Compounds | |
| HY-165686 | Benalaxyl metabolite M2-13C3 | Isotope-Labeled Compounds | |
| HY-165687 | Nicosulfuron metabolite UCSN-d6 | Isotope-Labeled Compounds | |
| HY-165688S | Alternariol-9-monomethylether-3-glucoside-d3 | Isotope-Labeled Compounds | |
| HY-16568R | Irinotecan (hydrochloride trihydrate) (Standard) | 136572-09-3 | Reference Standards |
| HY-16569 | Colchicine | 64-86-8 | Natural Products |
| HY-165690 | N,N-Dimethylaminosulfonic acid-d3 | Isotope-Labeled Compounds | |
| HY-165691S | Chlorothalonil Metabolite R611553-13C2,15N2 (sodium salt) | Isotope-Labeled Compounds | |
| HY-165693S | Sodium 2-((2,6-bis(methyl-d3)phenyl-3,4,5-d3)amino)-2-oxoethane-1-sulfonate | Isotope-Labeled Compounds | |
| HY-165694S | 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-13C2,15N2 | Isotope-Labeled Compounds | |
| HY-165695S | 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-15N2 | Isotope-Labeled Compounds | |
| HY-165696S | 2,4-Dicarbamoyl-3,5,6-trichlorobenzenesulfonate (sodium)-13C2,15N2 | Isotope-Labeled Compounds | |
| HY-165696S1 | 2,4-Dicarbamoyl-3,5,6-trichlorobenzenesulfonate (sodium)-15N2 | Isotope-Labeled Compounds | |
| HY-165697S | N1-(2-(Ethoxy-d5)phenyl)-N2-(2-ethylphenyl)oxalamide-d5 | Isotope-Labeled Compounds | |
| HY-165698S | Flupyrsulfuron-methyl-d6 (sodium) | Isotope-Labeled Compounds | |
| HY-165699S | Methanone, 1,1′-[1,4-butanediylbis[oxy(2-hydroxy-4,1-phenylene)]]bis[phenyl-d10 | Isotope-Labeled Compounds | |
| HY-16569R | Colchicine (Standard) | 64-86-8 | Reference Standards |
| HY-16569S | Colchicine-d6 | 1217651-73-4 | Isotope-Labeled Compounds |
| HY-16569S1 | Colchicine-d3 | 1217625-62-1 | Isotope-Labeled Compounds |
| HY-165700S | Iodosulfuron methyl ester-d3 | Isotope-Labeled Compounds | |
| HY-165701S | Hydroxyterbuthylazinel-d3 | Isotope-Labeled Compounds | |
| HY-165702S | 2-Pyridinesulfonamide, N-[[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl]-3-(2,2,2-trifluoroethoxy)-d6 | Isotope-Labeled Compounds | |
| HY-165703S | Prothioconazole-S-methyl-d3 | Isotope-Labeled Compounds | |
| HY-165704S | 2-(3-Carbamoyl-1-((6-chloropyridin-3-yl)methyl)ureido)ethane-1-sulfonate (sodium)-d4 | Isotope-Labeled Compounds | |
| HY-165705S | Bisphenol A diglycidyl ether carboxy-diol-d14 | Isotope-Labeled Compounds | |
| HY-165706 | 11(S)-Hydroperoxy-7(Z),9(E),13(Z)-hexadecatrienoic acid | 145298-78-8 | Natural Products |
| HY-165707 | 3-(((Z)-Octadec-9-en-1-yl)oxy)propane-1,2-diyl dioleate | 10322-38-0 | Natural Products |
| HY-165708 | 7(E)-Nonadecenol | 2692623-28-0 | Natural Products |
| HY-165708A | (Z)-Nonadec-7-en-1-ol | 2692623-27-9 | Natural Products |
| HY-165709 | 13-Oxo-6(Z),9(Z)-octadecadienoic acid | 1802047-22-8 | Natural Products |
| HY-165710 | 10-Methylheptadecanoic acid | 26429-10-7 | Natural Products |
| HY-165711 | 1-Docosahexaenoyl-2-stearoyl-sn-glycero-3-phosphatidylcholine | 99264-99-0 | Natural Products |
| HY-165712 | Dimethyl (5E,8E,11E)-icosa-5,8,11-trienedioate | 2692622-79-8 | Natural Products |
| HY-165713 | Dimethyl docosanedioate | 22399-98-0 | Natural Products |
| HY-165714 | 13-Oxo-9(Z),11(E),15(Z)-octadecatrienoic acid | 148981-17-3 | Natural Products |
| HY-165715 | 3-(Hexadecyloxy)propane-1,2-diyl dioleate | 61616-00-0 | Natural Products |
| HY-165716 | 11(S)-Hydroxy-7(Z),9(E),13(Z)-hexadecatrienoic acid | 874393-55-2 | Natural Products |
| HY-165717 | 1-Palmitoleoyl-2-vaccenoyl-sn-glycero-3-phosphatidylethanolamine | 1832660-38-4 | Natural Products |
| HY-165718 | 1-Docosapentaenoyl-2-hydroxy-sn-glycero-3-phosphatidylcholine | 2201069-26-1 | Natural Products |
| HY-165719 | Arachidyl arachidate | 22432-80-0 | Natural Products |
| HY-165720 | 7(Z),10(Z),13(Z),16(Z)-Docosatetraenol | 1187449-54-2 | Natural Products |
| HY-165721 | 11(Z)-Eicosenoyl chloride | 103213-61-2 | Natural Products |
| HY-165722 | 1-Chloro-3-(oleoyloxy)propan-2-yl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate | 1400563-61-2 | Natural Products |
| HY-165723 | 13(E)-Brassidyl acetate | 2692623-47-3 | Natural Products |
| HY-165724 | 13(E)-Docosenol | 5634-26-4 | Natural Products |
| HY-165725 | Dimethyl hexacosanedioate | 86797-43-5 | Natural Products |
| HY-165726 | Arachidyl arachidonate | 2692623-69-9 | Natural Products |
| HY-165727 | 7(Z),10(Z),13(Z),16(Z)-Docosatetraenoyl chloride | 960593-69-5 | Natural Products |
| HY-165728 | (Z)-Octadec-9-en-1-yl methylglycinate | 10025-06-6 | Natural Products |
| HY-165729 | 1-Palmitoyl-2-linoleoylphosphatidylcholine | 6931-84-6 | Natural Products |
| HY-165730 | Octaprenol | 5905-42-0 | Natural Products |
| HY-165731 | 1-Palmitoyl-3-bromopropanediol | 30557-00-7 | Natural Products |
| HY-165732 | 1-Palmitoyl-2-oleoyl-3-bromopropanediol | 80749-30-0 | Natural Products |
| HY-165733 | Octaprenyl-MPDA | 112430-37-2 | Natural Products |
| HY-165734 | 10-Undecenyl acetate | 112-19-6 | Natural Products |
| HY-165735 | Octyl methane sulfonate | 16156-52-8 | Natural Products |
| HY-165736 | 10-Undecyl methane sulfonate | 52355-50-7 | Natural Products |
| HY-165737 | 1-Palmitoyl-2-stearoyl-3-chloropropanediol | 1185060-41-6 | Natural Products |
| HY-165738 | (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaen-4-ynoic acid | 660429-97-0 | Natural Products |
| HY-165739 | Oleyl arachidate | 22393-96-0 | Natural Products |
| HY-165740 | Ganglioside GD2 | 65988-71-8 | Natural Products |
| HY-165741 | 1-Palmitoyl-3-stearoyl-2-chloropropanediol | 1639207-44-5 | Natural Products |
| HY-165742 | 1-Stearoyl-3-bromopropanediol | 30557-01-8 | Natural Products |
| HY-165743 | 11(Z)-Eicosenyl acetate | 66731-37-1 | Natural Products |
| HY-165744 | 10,13-Epoxy-10,12-octadecadienoic acid | 4179-43-5 | Natural Products |
| HY-165745 | Arachidyl behenate | 42233-14-7 | Natural Products |
| HY-165746 | 1-Stearoyl-3-linoleoyl-2-chloropropanediol | 1639207-43-4 | Natural Products |
| HY-165747 | 13-Methylpentadecanoic acid | 20121-96-4 | Natural Products |
| HY-165748 | 7(Z),10(Z),13(Z),16(Z),19(Z)-Docosapentaenol | 164221-13-0 | Natural Products |
| HY-165749 | Decaprenol | 51743-70-5 | Natural Products |
| HY-165750 | 1-Stearoyl-2-chloropropanediol | 2345637-43-4 | Natural Products |
| HY-165751 | Oleyl arachidonate | 2692623-72-4 | Natural Products |
| HY-165752 | 10-Heneicosanol | 259231-08-8 | Natural Products |
| HY-165753 | 13-Hydroxy-9(Z),15(Z)-octadecadienoic acid | 1802047-06-8 | Natural Products |
| HY-165754 | 10(E)-Heptadecenol | 98329-34-1 | Natural Products |
| HY-165755 | Oleyl behenate | 66161-52-2 | Natural Products |
| HY-165756 | 11(Z)-Etheroleic acid | 190598-37-9 | Natural Products |
| HY-165757 | 1-Lauroyl-2-oleoyl-3-chloropropanediol | 2134106-80-0 | Natural Products |
| HY-165758 | 7(Z),10(Z),13(Z),16(Z),19(Z)-Docosapentaenoyl chloride | 960593-70-8 | Natural Products |
| HY-165759 | 1-Stearoyl-2-Linoleoyl-3-chloropropanediol | 1429655-88-8 | Natural Products |
| HY-165760 | 10-Hydroxy-11(E)-octadecenoic acid | 160057-59-0 | Natural Products |
| HY-165761 | D-Threo-sphingosine | 6036-85-7 | Natural Products |
| HY-165762 | 13-Hydroxy-9(E),11(E)-octadecadienoic acid | 32819-31-1 | Natural Products |
| HY-165763 | Oleyl laurate | 19149-85-0 | Natural Products |
| HY-165764 | Arachidyl linoleate | 914926-14-0 | Natural Products |
| HY-165765 | 8-Hydroxyoctadecanoic acid | 6807-91-6 | Natural Products |
| HY-165765A | 8(R)-Hydroxyoctadecanoic acid | 1212331-85-5 | Natural Products |
| HY-165766 | 1-Stearoyl-2-oleoyl-3-bromopropanediol | 30334-64-6 | Natural Products |
| HY-165767 | 10-Hydroxy-11(E),15(Z)-octadecadienoic acid | 1488409-91-1 | Natural Products |
| HY-165768 | (2S,3R)-2-Aminodocosane-1,3-diol | 1428630-19-6 | Natural Products |
| HY-165769 | Oleyl linoleate | 17673-59-5 | Natural Products |
| HY-16576A | SMI-4a | 438190-29-5 | Reference compound |
| HY-165771 | Arachidyl linolenate | 1447798-59-5 | Natural Products |
| HY-165772 | 10-Hydroxy-12(Z)-octadecenoic acid | 34932-12-2 | Natural Products |
| HY-165773 | 10-Hydroxy-8(E),12(Z)-octadecadienoic acid | 82846-48-8 | Natural Products |
| HY-165774 | 13-Hydroxy-6(Z),9(Z)-octadecadienoic acid | 317385-83-4 | Natural Products |
| HY-165775 | Phosphatidylinositol 3-phospha1,2-dipalmitoyl (ammonium) | 496808-37-8 | Natural Products |
| HY-165776 | 10-Methylhexadecanoic acid | 17001-26-2 | Natural Products |
| HY-165777 | 1-Stearoyl-2-oleoyl-3-chloropropanediol | 1429655-87-7 | Natural Products |
| HY-165778 | 10(E)-Heptadecenoyl chloride | 2692623-75-7 | Natural Products |
| HY-165779 | 13-Hydroperoxy-9(E),11(E)-octadecadienoic acid | 63121-48-2 | Natural Products |
| HY-16578 | GW9662 | 22978-25-2 | Reference compound |
| HY-165781 | DHA Ceramide | 218608-43-6 | Natural Products |
| HY-165783 | 10(Z)-Nonadecenol | 66855-80-9 | Natural Products |
| HY-165784 | 10(E)-Nonadecenol | 82672-56-8 | Natural Products |
| HY-165786 | 10(Z)-Nonadecenoyl chloride | 95548-27-9 | Natural Products |
| HY-165788 | 10(E)-Pentadecenol | 64437-44-1 | Natural Products |
| HY-165789 | 10(Z)-Pentadecenol | 64437-42-9 | Natural Products |
| HY-16578S | GW9662-d5 | 2117730-84-2 | Isotope-Labeled Compounds |
| HY-16579 | Etifoxine (hydrochloride) | 56776-32-0 | Reference compound |
| HY-165790 | Petroselinyl methane sulfonate | 67373-99-3 | Natural Products |
| HY-165791 | 1,3-Dioleylglycerylether | 34043-04-4 | Natural Products |
| HY-165792 | 10(Z)-Heptadecenol | 73010-83-0 | Natural Products |
| HY-165793 | 10-Oxo-11(E)-octadecenoic acid | 501121-00-2 | Natural Products |
| HY-165794 | 10(Z)-Pentadecenoyl chloride | 2692623-74-6 | Natural Products |
| HY-165795 | Oleyl linolenate | 17673-63-1 | Natural Products |
| HY-165796 | 1,3-Dilinolenoyl-2-chloropropanediol | 2692623-29-1 | Natural Products |
| HY-165797 | 10(Z)-Heptadecenoyl chloride | 126761-39-5 | Natural Products |
| HY-165798 | Arachidyl myristate | 22413-00-9 | Natural Products |
| HY-165799 | 1,3-Didecanoyl-2-chloropropanediol | 2241680-27-1 | Natural Products |
| HY-16579A | Etifoxine | 21715-46-8 | Reference compound |
| HY-16579AR | Etifoxine (Standard) | 21715-46-8 | Reference Standards |
| HY-16579AS2 | Etifoxine-d5 | 1346598-10-4 | Isotope-Labeled Compounds |
| HY-165800 | 10(Z)-Heptadecenyl acetate | 73010-82-9 | Natural Products |
| HY-165801 | Oleyl myristoleate | 2692623-65-5 | Natural Products |
| HY-165802 | Pentadecyl methane sulfonate | 62732-70-1 | Natural Products |
| HY-165803 | Behenyl arachidonate | 1613724-41-6 | Natural Products |
| HY-165804 | (8(Z),11Z)-Methyl 13-(3-pentyloxiran-2-yl)trideca-8,11-dienoate | 2692622-73-2 | Natural Products |
| HY-165805 | 10-Oxo-11(E),15(Z)-octadecadienoic acid | 1488409-84-2 | Natural Products |
| HY-165806 | Oleyl palmitate | 2906-55-0 | Natural Products |
| HY-165807 | Arachidyl oleate | 22393-88-0 | Natural Products |
| HY-165808 | 11-Methyltridecanoic acid | 29709-05-5 | Natural Products |
| HY-165809 | Petroselaidyl methane sulfonate | 2692623-49-5 | Natural Products |
| HY-16581 | DL-threo-2-methylisocitrate | 71183-66-9 | Reference compound |
| HY-165810 | 10-Oxo-12(Z)-octadecenoic acid | 103521-29-5 | Natural Products |
| HY-165811 | 8(Z),11(Z),14(Z)-Eicosatrienol | 14602-40-5 | Natural Products |
| HY-165812 | Behenyl laurate | 42231-82-3 | Natural Products |
| HY-165813 | 8(Z),11(Z),14(Z)-Eicosatrienoyl chloride | 126104-52-7 | Natural Products |
| HY-165814 | Octadecanoyl coenzyme A | 362-66-3 | Natural Products |
| HY-165815 | Pentadecaprenyl-MPDA | 108045-17-6 | Natural Products |
| HY-165816 | Eicosyl hexadecanoate | 22413-01-0 | Natural Products |
| HY-165817 | 10(Z)-Pentadecenyl acetate | 64437-43-0 | Natural Products |
| HY-165818 | Octadecanoyl-L-erythro-sphingosine | 252039-52-4 | Natural Products |
| HY-165819 | Behenyl lignocerate | 42233-59-0 | Natural Products |
| HY-16581A | DL-threo-2-methylisocitrate (sodium) | Reference compound | |
| HY-16582 | Sonidegib (diphosphate) | 1218778-77-8 | Reference compound |
| HY-165820 | Pentadecaprenol | 10589-52-3 | Natural Products |
| HY-165821 | 12(R)-Bromo-13(R)-hydroxy-9(Z)-octadecenoic acid | 2692622-65-2 | Natural Products |
| HY-165822 | Octadecaprenol | 26012-96-4 | Natural Products |
| HY-165823 | 10(Z),13(Z)-Nonadecadienol | 66855-81-0 | Natural Products |
| HY-165824 | 11,14-Eicosadienyl methane sulfonate | 72996-07-7 | Natural Products |
| HY-165825 | Behenyl linoleate | 914926-16-2 | Natural Products |
| HY-165826 | 8(Z),11(Z),14(Z)-Heptadecatrienal | 56797-44-5 | Natural Products |
| HY-165827 | Behenyl myristate | 42232-05-3 | Natural Products |
| HY-165828 | Ethyl (8Z,11Z,14Z)-octadeca-8,11,14,17-tetraenoate | 2580285-53-4 | Natural Products |
| HY-165829 | 12-Tridecenyl acetate | 84801-18-3 | Natural Products |
| HY-16582A | Sonidegib | 956697-53-3 | Reference compound |
| HY-16582AS | Sonidegib-d4 | Isotope-Labeled Compounds | |
| HY-165830 | Octadecaprenyl-MPDA | 93265-83-9 | Natural Products |
| HY-165831 | Para-nitrophenyllinoleate | 6562-50-1 | Natural Products |
| HY-165832 | Arachidyl palmitoleate | 22522-34-5 | Natural Products |
| HY-165833 | 12-Tridecenoyl chloride | 857078-98-9 | Natural Products |
| HY-165834 | 11,14,17-Eicosatrienyl methane sulfonate | 2692623-51-9 | Natural Products |
| HY-165835 | 10(Z),13(Z)-Nonadecadienoyl chloride | 960593-66-2 | Natural Products |
| HY-165836 | Para-nitrophenyl oleate | 17363-90-5 | Natural Products |
| HY-165837 | Arachidyl stearate | 22413-02-1 | Natural Products |
| HY-165838 | 12-Pentacosanol | 138966-98-0 | Natural Products |
| HY-165839 | 11-Dodecenoyl chloride | 84465-81-6 | Natural Products |
| HY-165840 | Behenyl myristoleate | 2692623-62-2 | Natural Products |
| HY-165841 | 11(E)-Octadecenol | 57716-88-8 | Natural Products |
| HY-165842 | 11(Z),14(Z),17(Z)-Eicosatrienol | 133585-85-0 | Natural Products |
| HY-165843 | 9-Hydroperoxy-10(E),12(E)-octadecadienoic acid | 63121-49-3 | Natural Products |
| HY-165844 | 9-Hydroxy-10-oxo-12(Z)-octadecenoic acid | 26369-27-7 | Natural Products |
| HY-165845 | 9-Hydroxy-10-oxo-12(Z),15(Z)-octadecadienoic acid | 51146-89-5 | Natural Products |
| HY-165846 | Palmityl myristoleate | 64660-84-0 | Natural Products |
| HY-165847 | Octadecyl methane sulfonate | 31081-59-1 | Natural Products |
| HY-165848 | 11-Eicosenyl methane sulfonate | 72434-97-0 | Natural Products |
| HY-165849 | Behenyl arachidate | 42232-87-1 | Natural Products |
| HY-16585 | VS-5584 | 1246560-33-7 | Reference compound |
| HY-165850 | Behenyl palmitate | 42232-33-7 | Natural Products |
| HY-165851 | 12-Oxo-9(Z)-octadecenoic acid | 5455-97-0 | Natural Products |
| HY-165852 | 11(Z),14(Z),17(Z)-Eicosatrienoyl chloride | 104926-33-2 | Natural Products |
| HY-165853 | Palmityl linoleate | 219138-04-2 | Natural Products |
| HY-165854 | 12-Oxo-9(Z)-dodecenoic acid | 60485-39-4 | Natural Products |
| HY-165855 | Octanoyl-galactosylceramide | 41613-16-5 | Natural Products |
| HY-165856 | 1,2-Di-O-hexadecyl-sn-glycero-3-phosphatidylethanolamine | 71030-38-1 | Natural Products |
| HY-165857 | 12-Hydroxy-9(Z),13(E)-octadecadienoic acid | 82854-54-4 | Natural Products |
| HY-165858 | Oleyl palmitoleate | 22393-98-2 | Natural Products |
| HY-165859 | 2-Aminoethyl ((R)-2,3-bis(hexadecyloxy)propyl) hydrogen phosphate | 61423-61-8 | Natural Products |
| HY-16586 | PFI-1 | 1403764-72-6 | Reference compound |
| HY-165860 | 11(Z),14(Z),17(Z)-Eicosatrienyl acetate | 864754-69-8 | Natural Products |
| HY-165861 | Palmityl linolenate | 1272984-91-4 | Natural Products |
| HY-165862 | C80-Dolichol | 37839-88-6 | Natural Products |
| HY-165863 | Palmitelaidyl methane sulfonate | 1192259-25-8 | Natural Products |
| HY-165864 | (E)-Octadec-9-ene-1,12-diol | 45245-68-9 | Natural Products |
| HY-165864A | (9E,12R)-9-Octadecene-1,12-diol | 35732-93-5 | Reference compound |
| HY-165865 | Palmityl behenate | 42233-11-4 | Natural Products |
| HY-165866 | 13(E)-Docosenoyl chloride | 59044-32-5 | Natural Products |
| HY-165867 | 1,2-Dieicosapentaenoyl-sn-glycero-3-phosphatidylcholine | 98819-78-4 | Natural Products |
| HY-165868 | Palmityl arachidonate | 171262-16-1 | Natural Products |
| HY-165869 | Cholesteryl 11(E)-vaccenate | 19485-83-7 | Natural Products |
| HY-165869A | Cholesteryl 11(Z)-vaccenate | 13110-26-4 | Natural Products |
| HY-16587 | Saridegib | 1037210-93-7 | Reference compound |
| HY-165870 | 1,2-Dihexanoyl-sn-glycero-3-phosphatidylcholine | 53892-41-4 | Natural Products |
| HY-165871 | 16-Methyloctadecanoic acid | 17001-28-4 | Natural Products |
| HY-165872 | 11(E)-Vaccenyl acetate | 69282-64-0 | Natural Products |
| HY-165873 | 8-(5-Hexylfuran-2-yl)octanoic acid | 4179-44-6 | Natural Products |
| HY-165874 | Palmityl arachidate | 22413-05-4 | Natural Products |
| HY-165875 | 13(R)-HODE Cholesteryl ester | 330800-94-7 | Natural Products |
| HY-165875A | 13(S)-HODE Cholesteryl ester | 141554-21-4 | Natural Products |
| HY-165876 | 1,2-Dilauroyl-sn-Glycero-3-Phosphatidylcholine | 18656-40-1 | Natural Products |
| HY-165877 | 1,2-Diheptadecanoin-sn-glycero-3-phosphatidylserine (sodium) | 799268-51-2 | Natural Products |
| HY-165878 | 1,6-Hexadecanediol | 28047-88-3 | Natural Products |
| HY-165879 | 13(Z),16(Z)-Docosadienol | 72996-09-9 | Natural Products |
| HY-16587A | Saridegib (hydrochloride) | 1169829-40-6 | Reference compound |
| HY-165880 | Palmitoyl sulfatide | 89771-78-8 | Natural Products |
| HY-165881 | Cholesteryl brassidate | 79728-52-2 | Natural Products |
| HY-165882 | 13(Z),16(Z)-Docosadienoyl chloride | 960593-67-3 | Natural Products |
| HY-165883 | 15(Z)-Tetracosenol | 50995-29-4 | Natural Products |
| HY-165884 | 13(S)-Hydroxy-6(Z),9(Z),11(E)-octadecatrienoic acid | 74784-20-6 | Natural Products |
| HY-165885 | 1,2-Dioleoyl-3-bromopropanediol | 1044566-90-6 | Natural Products |
| HY-165886 | Palmitoyl glucose | 477697-05-5 | Natural Products |
| HY-165887 | Methyl 16-methyloctadecanoate | 2490-16-6 | Natural Products |
| HY-165888 | 13(Z),16(Z)-Docosadienyl acetate | 2692623-46-2 | Natural Products |
| HY-165889 | 1,2-Dipentadecanoyl-sn-glycero-3-phosphatidylcholine | 67896-63-3 | Natural Products |
| HY-16589 | Oligomycin A | 579-13-5 | Natural Products |
| HY-165890 | 13(Z),16(Z),19(Z)-Docosatrienol | 133585-86-1 | Natural Products |
| HY-165891 | 13(S)-Hydroxy-9(Z),11(E)-octadecadiene-(2-biotinyl)hydrazide | 1176496-97-1 | Natural Products |
| HY-165892 | Dodecanoyl-galactosylceramide | 41613-14-3 | Natural Products |
| HY-165893 | Methyl 17-methyloctadecanoate | 55124-97-5 | Natural Products |
| HY-165894 | Myristoleyl behenate | 2692623-60-0 | Natural Products |
| HY-165895 | 1,2-Dipentadecanoyl-sn-glycero-3-phosphatidylethanolamine | 109032-52-2 | Natural Products |
| HY-165896 | Palmitoleyl myristoleate | 2692623-64-4 | Natural Products |
| HY-165897 | Methyl 18-methylnonadecanoate | 65301-91-9 | Natural Products |
| HY-165898 | Myristyl linolenate | 210757-15-6 | Natural Products |
| HY-165899 | C85-Dolichol | 57229-24-0 | Natural Products |
| HY-16589R | Oligomycin A (Standard) | 579-13-5 | Reference Standards |
| HY-16590 | X-376 | 1365267-27-1 | Reference compound |
| HY-165900 | Dodecaprenol | 10589-57-8 | Natural Products |
| HY-165901 | Methyl 19-methyleicosanoate | 95799-86-3 | Natural Products |
| HY-165902 | 3-Hydroxy-13(Z),16(Z),19(Z)-docosatrienoic acid | 2692622-68-5 | Natural Products |
| HY-165903 | Methyl 2-hydroxyoctanoate | 73634-76-1 | Natural Products |
| HY-165904 | 17,17-Dimethyllinoleic acid | 2692622-58-3 | Natural Products |
| HY-165905 | Myristyl linoleate | 914926-09-3 | Natural Products |
| HY-165906 | 3-Hydroxy-11(Z),14(Z),17(Z)-eicosatrienoic acid | 328408-17-9 | Natural Products |
| HY-165907 | Methyl 2-fluoropalmitate | 137676-82-5 | Natural Products |
| HY-165908 | 18-Hydroxy-9(Z)-octadecenoic acid | 24753-52-4 | Natural Products |
| HY-165909 | 3-Hydroxy-11(Z),14(Z)-eicosadienoic acid | 1214975-42-4 | Natural Products |
| HY-16590R | X-376 (Standard) | 1365267-27-1 | Reference Standards |
| HY-16591 | Birinapant | 1260251-31-7 | Reference compound |
| HY-165910 | 11(E)-Vaccenyl methane sulfonate | 2692623-50-8 | Natural Products |
| HY-165911 | C90-Dolichol | 26113-10-0 | Natural Products |
| HY-165912 | 11(R),12(S),13(S)-Trihydroxy-9(Z)-octadecenoic acid | 874393-58-5 | Natural Products |
| HY-165913 | Methyl 20-hydroxyeicosanoate | 37477-29-5 | Natural Products |
| HY-165914 | 1,2-Distearoyl-3-bromopropanediol | 96873-03-9 | Natural Products |
| HY-165916 | 12-Heptacosanol | 31849-16-8 | Natural Products |
| HY-165918 | Methyl 9(S),10(S)-epoxy-11(S)-hydroxy-12(Z)-octadecenoate | 102053-72-5 | Natural Products |
| HY-165919 | 11(Z),14(Z)-Eicosadienol | 72996-06-6 | Natural Products |
| HY-16592 | Brefeldin A | 20350-15-6 | Natural Products |
| HY-165920 | 11(Z),14(Z)-Eicosadienoyl chloride | 150989-05-2 | Natural Products |
| HY-165921 | 11(Z)-Vaccenyl methane sulfonate | 648880-73-3 | Natural Products |
| HY-165922 | Methyl 9(S),10(R)-epoxy-13(S)-hydroxy-11(E),15(Z)-octadecadienoate | 911634-08-7 | Natural Products |
| HY-165923 | 11(Z),14(Z)-Eicosadienyl acetate | 864754-67-6 | Natural Products |
| HY-165924 | 1,2-Diheptadecenoyl-sn-glycero-3-phosphatidylcholine | 135726-81-7 | Natural Products |
| HY-165925 | Methyl 9(S),10(R)-epoxy-13(S)-hydroxy-11(E)-octadecenoate | 71201-26-8 | Natural Products |
| HY-165926 | 1,2-Dipalmitoyl-3-bromopropanediol | 34607-52-8 | Natural Products |
| HY-165927 | Methyl 9,10-cis-methylene-12(Z)-octadecenoate | 439101-10-7 | Natural Products |
| HY-165928 | 12(S)-Bromo-13(S)-hydroxy-9(Z)-octadecenoic acid | 2692622-64-1 | Natural Products |
| HY-165929 | N‐(2‐(N‐Palmitoleoyl)aminoethyl)maleimide | 2692622-80-1 | Natural Products |
| HY-16592R | Brefeldin A (Standard) | 20350-15-6 | Reference Standards |
| HY-16593 | GS-9256 | 1001094-46-7 | Reference compound |
| HY-165930 | Methyl 22-hydroxydocosanoate | 38646-51-4 | Natural Products |
| HY-165931 | Methyl 27-hydroxyheptacosanoate | 369635-50-7 | Natural Products |
| HY-165932 | 13(Z)-Docosenoyl chloride | 7459-29-2 | Natural Products |
| HY-165933 | Methyl 9-methylundecanoate | 5569-52-8 | Natural Products |
| HY-165934 | 13(Z)-Erucyl acetate | 103213-57-6 | Natural Products |
| HY-165935 | N‐(2‐(N‐Palmitoyl)aminoethyl)maleimide | 1644179-60-1 | Natural Products |
| HY-165936 | 15-Hydroxy-9(Z),12(Z)-octadecadienoic acid | 52222-88-5 | Natural Products |
| HY-165937 | 13(Z),16(Z),19(Z)-Docosatrienoyl chloride | 960593-68-4 | Natural Products |
| HY-165938 | Myristoleyl oleate | 2692623-67-7 | Natural Products |
| HY-165939 | Myristoleyl palmitate | 2692623-56-4 | Natural Products |
| HY-16594 | Lactacystin | 133343-34-7 | Natural Products |
| HY-165940 | Linoleyl arachidate | 1211905-55-3 | Natural Products |
| HY-165941 | Methyl 10-methylheptadecanoate | 2490-25-7 | Natural Products |
| HY-165942 | Methyl 10-methylhexadecanoate | 2490-51-9 | Natural Products |
| HY-165943 | 2-Hydroperoxy-9(Z)-octadecenoic acid | 53705-95-6 | Natural Products |
| HY-165944 | 14(R),15(S)-Dihydroxy-5(Z),8(Z),10(E),12(E)-eicosatetraenoic acid | 82263-61-4 | Natural Products |
| HY-165945 | 14(Z)-Etherolenic acid | 220308-61-2 | Natural Products |
| HY-165946 | 2-Hydroxy-3,7,11,15-tetramethylhexadecanoic acid | 14721-68-7 | Natural Products |
| HY-165947 | 14(Z)-Tricosenol | 50995-26-1 | Natural Products |
| HY-165948 | 14(S),15(S)-Dihydroxy-5(Z),8(Z),10(E),12(E)-eicosatetraenoic acid | 82263-60-3 | Natural Products |
| HY-165949 | 2-Hydroxy-9(Z),12(Z),15(Z)-octadecatrienoic acid | 22324-71-6 | Natural Products |
| HY-165951 | 14(Z)-Tricosenoyl chloride | 2692623-76-8 | Natural Products |
| HY-165952 | 14(Z)-Tricosenyl acetate | 2692623-48-4 | Natural Products |
| HY-165953 | 3-Hydroxy-7(Z),10(Z),13(Z16(Z)-docosatetraenoic acid | 205519-76-2 | Natural Products |
| HY-165954 | 15-Oxo-9(Z),12(Z)-octadecadienoic acid | 1211949-02-8 | Natural Products |
| HY-165955 | Linoleyl oleate | 17673-58-4 | Natural Products |
| HY-165956 | 4(Z),7(Z),10(Z),13(Z),16(Z),19(Z)-Docosahexaenol | 102783-20-0 | Natural Products |
| HY-165957 | 15(R)-Hydroxy-11(Z),13(E)-eicosadienoic acid | 330800-92-5 | Natural Products |
| HY-165958 | 3-Hydroxy-7(Z),10(Z),13(Z16(Z),19(Z)-docosapentaenoic acid | 2244989-16-8 | Natural Products |
| HY-165959 | 2-Hydroxyhexadecanoyl-D-erythro-dihydrosphingosine | 190249-36-6 | Natural Products |
| HY-16596 | CNX-1351 | 1276105-89-5 | Reference compound |
| HY-165960 | 3-Hydroxy-8(Z),11(Z),14(Z)-eicosatrienoic acid | 328408-16-8 | Natural Products |
| HY-165961 | Linoleyl palmitate | 914926-22-0 | Natural Products |
| HY-165962 | 4(Z),7(Z),10(Z),13(Z),16(Z),19(Z)-Docosahexaenyl acetate | 163041-99-4 | Natural Products |
| HY-165963 | 3-Hydroxyhexadecanedioic acid | 103810-59-9 | Natural Products |
| HY-165964 | Linoleyl palmitoleate | 125368-93-6 | Natural Products |
| HY-165965 | 5-Hydroxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid,methyl ester | 70968-99-9 | Natural Products |
| HY-165966 | 3-Hydroxyeicosanoic acid | 67882-24-0 | Natural Products |
| HY-165967 | 21-Methyldocosanoic acid | 59708-74-6 | Natural Products |
| HY-165968 | 23-Methyltetracosanoic acid | 94245-49-5 | Natural Products |
| HY-165969 | Linoleyl myristoleate | 2692657-19-3 | Natural Products |
| HY-165970 | 24-Methylpentacosanoic acid | 6006-91-3 | Natural Products |
| HY-165971 | 25-Methylhexacosanoic acid | 128156-70-7 | Natural Products |
| HY-165972 | Linoleyl myristate | 914926-20-8 | Natural Products |
| HY-165973 | Linoleyl linolenate | 125369-03-1 | Natural Products |
| HY-165974 | 9(E)-Elaidyl acetate | 22147-38-2 | Natural Products |
| HY-165975 | (2S)-3-Keto sphinganine (d6:0) (hydrochloride) | 1314999-30-8 | Natural Products |
| HY-165976 | rel-(9R,10R)-9,10-Dihydroxyhexadecanoic acid | 2027-46-5 | Natural Products |
| HY-165977 | Phosphatidylinositol 4-phosphate, 1,2-dipalmitoyl (ammonium) | 127996-98-9 | Natural Products |
| HY-165978 | Linoleyl linoleate | 17673-62-0 | Natural Products |
| HY-165979 | Phosphatidylinositol bis-4,5-phosphate, 1,2-dioctanoyl (sodium) | 1234574-20-9 | Natural Products |
| HY-165980 | 9(E)-Hexadecenoyl chloride | 112713-36-7 | Natural Products |
| HY-165981 | Stearyl linoleate | 17673-53-9 | Natural Products |
| HY-165982 | Linoleyl laurate | 914926-18-4 | Natural Products |
| HY-165983 | Phosphatidylinositol 5-phosphate, 1,2-dipalmitoyl (sodium) | 209050-66-8 | Natural Products |
| HY-165984 | Phosphatidylinositol tris-3,4,5-phosphate, 1,2-dioctanoyl (sodium) | 2694047-16-8 | Natural Products |
| HY-165985 | (2S)-3-Keto sphinganine (d8:0) (hydrochloride) | 1314998-90-7 | Natural Products |
| HY-165986 | N-Tricosanoyl ceramide trihexoside | 536745-84-3 | Natural Products |
| HY-165987 | Linoleyl behenate | 914926-28-6 | Natural Products |
| HY-165988 | Linoleyl arachidonate | 2692623-73-5 | Natural Products |
| HY-165989 | Phytanic acid ethyl ester | 3862-29-1 | Natural Products |
| HY-165990 | Undecyl methanesulfonate | 159438-86-5 | Natural Products |
| HY-165992 | Methyl 10-methyloctadecanoate | 2490-19-9 | Natural Products |
| HY-165993 | Linolenyl Palmitoleate | 125368-94-7 | Natural Products |
| HY-165994 | Stearyl arachidonate | 2416860-67-6 | Natural Products |
| HY-165995 | Tricosanoyl chloride | 663618-08-4 | Natural Products |
| HY-165997 | 1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC | 126901-45-9 | Natural Products |
| HY-165998 | Stearyl palmitoleate | 22393-84-6 | Natural Products |
| HY-165999 | Tricosanyl acetate | 84845-60-3 | Natural Products |
| HY-166000 | Methyl (9R,10S)-9,10-dihydroxyoctadecanoate | 3639-30-3 | Natural Products |
| HY-166001 | Methyl 10(R),11(R)-epoxy-9(S)-hydroxy-12(Z)-octadece | 135276-32-3 | Natural Products |
| HY-166001A | Methyl 10(S),11(S)-epoxy-9(S)-hydroxy-12(Z)-octadecenoate | 135357-33-4 | Natural Products |
| HY-166002 | 6(E)-Octadecenol | 62972-94-5 | Natural Products |
| HY-166003 | 6(E)-Octadecenoyl chloride | 150989-03-0 | Natural Products |
| HY-166004 | Methyl 10-(2-hexylcyclopropyl)decanoate | 5965-63-9 | Natural Products |
| HY-166005 | Myristoleyl laurate | 2692623-52-0 | Natural Products |
| HY-166006 | Myristoleyl myristate | 2692623-54-2 | Natural Products |
| HY-166007 | Methyl 11-methyl-12(E)-octadecenoate | 211239-44-0 | Natural Products |
| HY-166008 | Methyl 10(S),11(S)-epoxy-9(S)-hydroxy-12(Z),15(Z)-octadecadienoate | 282091-43-4 | Natural Products |
| HY-166009 | Methyl (Z)-11-methyloctadec-6-enoate | 2692622-70-9 | Natural Products |
| HY-166010 | 15(S)-Hydroperoxy-11(Z),13(E)-eicosadienoic acid | 145375-41-3 | Natural Products |
| HY-166011 | 6(E)-Petroselaidyl acetate | 84801-20-7 | Natural Products |
| HY-166012 | 6(Z)-Octadecenol | 2774-87-0 | Natural Products |
| HY-166013 | Heneicosanyl acetate | 84845-59-0 | Natural Products |
| HY-166014 | 11,14-Eicosadienoate (sodium) | 87092-34-0 | Natural Products |
| HY-166015 | 11-Eicosenate (sodium) | 88400-43-5 | Natural Products |
| HY-166016 | 15(Z)-Nervonyl acetate | 1823102-39-1 | Natural Products |
| HY-166017 | Ethyl 10(E)-heptadecenoate | 150324-17-7 | Natural Products |
| HY-166018 | Tricosanyl lignocerate | 42233-16-9 | Natural Products |
| HY-166019 | Methyl 11-methyltridecanoate | 5487-62-7 | Natural Products |
| HY-166020 | Methyl (11R)-11-hydroxy-9,12-octadecadienoate | 1214984-21-0 | Natural Products |
| HY-166021 | Methyl 11(R),12(R)-epoxy-13(S)-hydroxy-9(Z)-octadecen | 200059-50-3 | Natural Products |
| HY-166022 | 6(Z)-Octadecenoyl chloride | 21330-53-0 | Natural Products |
| HY-166023 | Heneicosanyl lignocerate | 42233-15-8 | Natural Products |
| HY-166024 | 18(S)-Methyleicosanoic acid | 340257-50-3 | Natural Products |
| HY-166025 | 12,13-Dihydroxy-9,15-octadecadienoic acid | 85416-59-7 | Natural Products |
| HY-166026 | Tridecanoyl chloride | 17746-06-4 | Natural Products |
| HY-166027 | 6(Z)-Petroselinyl acetate | 108321-50-2 | Natural Products |
| HY-166028 | Ethyl 10(E)-pentadecenoate | 2692622-81-2 | Natural Products |
| HY-166029 | 3-Hydroxyoctadecanedioic acid | 103825-90-7 | Natural Products |
| HY-166030 | threo-12,13-Dihydroxyoctadecanoic acid | 73837-56-6 | Natural Products |
| HY-166031 | Heneicosaprenol | 101978-45-4 | Natural Products |
| HY-166032 | 11,14,17-Eicosatrienoate (sodium) | 103302-16-5 | Natural Products |
| HY-166033 | 3-Hydroxypentadecanoic acid | 32602-70-3 | Natural Products |
| HY-166034 | Tridecyl methane sulfonate | 62732-69-8 | Natural Products |
| HY-166035 | 6(Z),9(Z)-Octadecadien-1,18-dioic acid | 45267-68-3 | Natural Products |
| HY-166036 | 6,7-Dihydroxyoctadecanoic acid | 583-84-6 | Natural Products |
| HY-166037 | Myristoleyl myristoleate | 2692623-63-3 | Natural Products |
| HY-166038 | Myristoleyl stearate | 2692623-58-6 | Natural Products |
| HY-166039 | Myristyl arachidate | 22413-04-3 | Natural Products |
| HY-166040 | 6(Z),9(Z)-Tricosadiene | 125239-97-6 | Natural Products |
| HY-166041 | trans-12,13-Epoxy-9(Z)-octadecenoic acid | 28396-98-7 | Natural Products |
| HY-166042 | Heneicosyl methane sulfonate | 623171-54-0 | Natural Products |
| HY-166043 | Ethyl 10(Z)-heptadecenoate | 150324-16-6 | Natural Products |
| HY-166044 | threo-9,10-Dihydroxyoctadecanoic acid | 10067-09-1 | Natural Products |
| HY-166045 | 6(Z),9(Z),12(Z)-γ Linolenyl acetate | 185554-25-0 | Natural Products |
| HY-166046 | 3(R)-Hydroxyhexadecanoic acid | 20595-04-4 | Natural Products |
| HY-166047 | Heptadecanyl heptadecanoate | 36617-50-2 | Natural Products |
| HY-166048 | Methyl 11(R),12(S),13(S)-trihydroxy-12(Z)-octadecenoate | 102735-56-8 | Natural Products |
| HY-166049 | Methyl (9Z,12Z)-11-hydroxyoctadeca-9,12-dienoate | 158956-78-6 | Natural Products |
| HY-166050 | trans-12,13-Epoxy-octadecanoic acid | 32381-05-8 | Natural Products |
| HY-166051 | 4(Z)-Undecenal | 68820-32-6 | Natural Products |
| HY-166052 | 6(Z),9(Z),12(Z)-Octadecatrienoyl chloride | 54562-14-0 | Natural Products |
| HY-166053 | Tetradecaprenol | 119629-02-6 | Natural Products |
| HY-166054 | 11(E)-Vaccenate (sodium) | 104233-68-3 | Natural Products |
| HY-166055 | 11(Z)-Vaccenate (sodium) | 56338-65-9 | Natural Products |
| HY-166056 | Ethyl 10(Z)-nonadecenoate | 122342-31-8 | Natural Products |
| HY-166057 | trans-15,16-Epoxy-octadecanoic acid | 2692622-59-4 | Natural Products |
| HY-166058 | Heptadecanyl stearate | 18299-82-6 | Natural Products |
| HY-166059 | Myristyl arachidonate | 683274-21-7 | Natural Products |
| HY-166060 | Myristoleyl arachidate | 2692623-59-7 | Natural Products |
| HY-166061 | Myristoleyl arachidonate | 2692623-70-2 | Natural Products |
| HY-166062 | trans-5,6-Epoxy-9(Z),12(Z)-octadecadienoic acid | 2692622-60-7 | Natural Products |
| HY-166063 | Tetradecyl methane sulfonate | 6222-16-8 | Natural Products |
| HY-166064 | Methyl 11(S),12(S)-epoxy-13(S)-hydroxy-9(Z),15(Z)-octadecadienoate | 874393-57-4 | Natural Products |
| HY-166065 | Methyl 12-hydroxy-9(E)-octadecenoate | 23224-20-6 | Natural Products |
| HY-166066 | N-Tetracosanoyl-phytosphingosine | 34437-74-6 | Natural Products |
| HY-166067 | Methyl (Z)-12-oxooctadec-9-enoate | 3047-65-2 | Natural Products |
| HY-166068 | 5(Z),8(Z),11(Z),14(Z)-Arachidonyl acetate | 56663-39-9 | Natural Products |
| HY-166069 | Docosadienoate (sodium) | 2692623-43-9 | Natural Products |
| HY-166070 | Ethyl 10(Z)-pentadecenoate | 151259-45-9 | Natural Products |
| HY-166071 | Heptadecanoate (sodium) | 1002-82-0 | Natural Products |
| HY-166072 | trans-9,10-Epoxyhexadecanoic acid | 73392-13-9 | Natural Products |
| HY-166073 | Heptadecaprenol | 101978-44-3 | Natural Products |
| HY-166075 | Ethyl 10(Z),13(Z)-nonadecadienoate | 877124-17-9 | Natural Products |
| HY-166076 | Ethyl 9(E)-tetradecenoate | 68862-25-9 | Natural Products |
| HY-166077 | 5(Z),8(Z),11(Z),14(Z),17(Z)-Eicosapentaenol | 164221-12-9 | Natural Products |
| HY-166078 | Sodium undecanoate | 17265-30-4 | Natural Products |
| HY-166080 | 7B,27-Dihydroxycholesterol | 149055-91-4 | Natural Products |
| HY-166081 | Heneicosanoic acid (sodium) | 87092-35-1 | Natural Products |
| HY-166082 | Ethyl 9(E),12(E)-octadecadienoate | 6114-21-2 | Natural Products |
| HY-166083 | Heptadecyl methane sulfonate | 62732-71-2 | Natural Products |
| HY-166084 | Docosatetraenoate (sodium) | 2692623-45-1 | Natural Products |
| HY-166085 | 9(E)-Octadecenoyl chloride | 7459-35-0 | Natural Products |
| HY-166086 | Ethyl 11-dodecenoate | 76063-06-4 | Natural Products |
| HY-166087 | Docosatrienoic acid (sodium) | 2692623-44-0 | Natural Products |
| HY-166088 | Myristelaidate (sodium) | 2692623-41-7 | Natural Products |
| HY-166089 | N,N-dimethyl sphingosine (d17:1) | 474943-92-5 | Natural Products |
| HY-166090 | Nonadecanoyl chloride | 59410-47-8 | Natural Products |
| HY-166091 | Nonadecanyl acetate | 1577-43-1 | Natural Products |
| HY-166092 | Heptanoyl-L-carnitine | 40225-15-8 | Natural Products |
| HY-166093 | Methyl 12(R),13(S)-epoxy-9(S)-hydroxy-10(E),15(Z)-octadecadienoate | 911634-07-6 | Natural Products |
| HY-166094 | Methyl 12(S),13(S)-epoxy-11(S)-hydroxy-9(Z),15(Z)-octadecadienoate | 221633-52-9 | Natural Products |
| HY-166095 | Methyl 10-methyldodecanoate | 5129-65-7 | Natural Products |
| HY-166096 | Elaidic acid (sodium) | 18175-45-6 | Natural Products |
| HY-166097 | Ethyl 9(Z)-tetradecenoate | 24880-50-0 | Natural Products |
| HY-166098 | Ethyl 11(E)-eicosenoate | 2692622-85-6 | Natural Products |
| HY-166099 | Myristoleate (sodium) | 1011489-29-4 | Natural Products |
| HY-166100 | Sodium tridecanoate | 3015-50-7 | Natural Products |
| HY-166101 | Nervonate (sodium) | 18175-85-4 | Natural Products |
| HY-166103 | Pentadecanoate (sodium) | 4268-63-7 | Natural Products |
| HY-166104 | Nonadecanoate (sodium) | 4268-61-5 | Natural Products |
| HY-166106 | Propyl oleate | 111-59-1 | Natural Products |
| HY-166107 | Palmitelaidate (sodium) | 2692623-42-8 | Natural Products |
| HY-166108 | Palmitoleyl linolenate | 2692623-68-8 | Natural Products |
| HY-166109 | Nonaprenol | 15639-69-7 | Natural Products |
| HY-166110 | Tetracosanoyl-L-carnitine | 123359-35-3 | Natural Products |
| HY-166111 | Heptaprenol | 5905-41-9 | Natural Products |
| HY-166112 | Palmitoleyl arachidonate | 2692623-71-3 | Natural Products |
| HY-166113 | Undecaprenyl-mpda monophosphate | 72983-15-4 | Natural Products |
| HY-166114 | Heptaprenyl-MPDA | 108045-15-4 | Natural Products |
| HY-166116 | Nonyl methane sulfonate | 74087-34-6 | Natural Products |
| HY-166117 | N-Hexanoyl-biotin-disialoganglioside GD3 | 2692623-21-3 | Natural Products |
| HY-166118 | N-Hexanoyl-biotin-galactosylceramide | 2692623-23-5 | Natural Products |
| HY-166119 | Linoleoyl-CoA | 6709-57-5 | Natural Products |
| HY-166120 | Methyl 3-hydroxypentadecanoate | 112538-88-2 | Natural Products |
| HY-166121 | N-Hexanoyl-biotin-lactosylceramide | 2692623-24-6 | Natural Products |
| HY-166122 | Ethyl 11(E)-octadecenoate | 89296-48-0 | Natural Products |
| HY-166123 | Methyl 30-hydroxytriacontanoate | 79162-70-2 | Natural Products |
| HY-166124 | 9(Z),12(Z)-Octadecadienoyl-l-carnitine | 32426-29-2 | Natural Products |
| HY-166127 | N-Hexanoyl-biotin-monosialoganglioside GM1 | 2692623-20-2 | Natural Products |
| HY-166130 | Methyl 3(R,S)-hydroxy-10(Z),13(Z),16(Z)-docosatrienoate | 2692622-75-4 | Natural Products |
| HY-166131 | Ethyl 11(Z)-octadecenoate | 137202-20-1 | Natural Products |
| HY-166133 | 9(Z),12(Z),15(Z)-alpha Linolenyl acetate | 7796-85-2 | Natural Products |
| HY-166134 | Methyl 3(R,S)-hydroxy-11(Z),14(Z)-eicosadienoate | 1427187-08-3 | Natural Products |
| HY-166136 | Methyl 2-hydroxydodecanoate | 51067-85-7 | Natural Products |
| HY-166137 | Ethyl 11(Z)-eicosenoate | 137202-21-2 | Natural Products |
| HY-166139 | Methyl 3(R,S)-hydroxy-13(Z),16(Z),19(Z)-docosatrienoate | 2692622-78-7 | Natural Products |
| HY-166146 | Methyl 3(R,S)-hydroxy-7(Z),10(Z),13(Z),16(Z)-docosatetraenoate | 2692622-76-5 | Natural Products |
| HY-166148 | Myristelaidyl methane sulfonate | 1353865-70-9 | Natural Products |
| HY-166149 | Linolenyl palmitate | 2692623-57-5 | Natural Products |
| HY-16615 | SIRT-IN-1 | 1431411-60-7 | Reference compound |
| HY-166150 | Methyl 3(R,S)-hydroxy-7(Z),14(Z),13(Z),16(Z),19(Z)-docosapentaenoate | 2692622-77-6 | Natural Products |
| HY-166159 | Methyl 3(R,S)-hydroxy-8(Z),11(Z),14(Z)-eicosatrienoate | 126869-46-3 | Natural Products |
| HY-16616 | SIRT-IN-2 | 1431411-66-3 | Reference compound |
| HY-166163 | Linolenyl oleate | 17673-61-9 | Natural Products |
| HY-166164 | Myristyl palmitoleate | 22393-82-4 | Natural Products |
| HY-166165 | Methyl 7(R)-hydroxyhexadecanoate | 1212082-49-9 | Natural Products |
| HY-166166 | Ethyl 9(E)-hexadecenoate | 68862-27-1 | Natural Products |
| HY-166168 | Linolenyl myristoleate | 2692623-66-6 | Natural Products |
| HY-16617 | Auglurant | 1396337-04-4 | Reference compound |
| HY-166186 | 9(E)-Tetradecenoyl chloride | 150989-01-8 | Natural Products |
| HY-166187 | 9(E),12(E)-Octadecadienoyl chloride | 96724-05-9 | Natural Products |
| HY-166188 | Methyl 13(S)-hydroxy-14(S),15(S)-epoxy-5(Z),8(Z),11(Z)-eicosatrienoate | 96243-93-5 | Natural Products |
| HY-166189 | 9(S),10(S),11(R)-Trihydroxy-12(Z)-octadecenoic acid | 339186-36-6 | Natural Products |
| HY-16619 | AM-5262 | 1222088-90-5 | Reference compound |
| HY-166190 | Lauryl linoleate | 795300-43-5 | Natural Products |
| HY-166191 | Lauryl linolenate | 1286724-00-2 | Natural Products |
| HY-166192 | Lauryl myristate | 2040-64-4 | Natural Products |
| HY-166193 | Methyl 14-methylhexadecanoate | 2490-49-5 | Natural Products |
| HY-166194 | Methyl 14(S),15(S)-epoxy-11(R,S)-hydroxy-5(Z),8(Z),12(E)-eicosatrienoate | 911634-03-2 | Natural Products |
| HY-166195 | 9(S),10(S),13(S)-Trihydroxy-11(E),15(Z)-octadecadienoic acid | 53279-40-6 | Natural Products |
| HY-166196 | 9(S),12(S),13(S)-Trihydroxy-10(E),15(Z)-octadecadienoic acid | 51146-90-8 | Natural Products |
| HY-166197 | Methyl 15-methylheptadecanoate | 54833-55-5 | Natural Products |
| HY-166198 | 9(Z)-Octadecenedioic acid | 20701-68-2 | Natural Products |
| HY-166199 | Methyl 15(R)-hydroxy-9(Z),12(Z)-octadecadienoate | 177746-99-5 | Natural Products |
| HY-16620 | DF 461 | 937051-40-6 | Reference compound |
| HY-166200 | Methyl 15-oxo-9(Z),12(Z)-octadecadienoate | 2692622-74-3 | Natural Products |
| HY-166201 | Lauryl myristoleate | 180252-24-8 | Natural Products |
| HY-166202 | Lauryl palmitate | 42232-29-1 | Natural Products |
| HY-166203 | Lauryl arachidonate | 125187-25-9 | Natural Products |
| HY-166204 | N-(2-Hydroxyethyl)-7(Z),10(Z),13(Z),16(Z),19(Z)-docosapentaenamide | 351317-23-2 | Natural Products |
| HY-166205 | Linolenyl laurate | 2692623-53-1 | Natural Products |
| HY-166206 | (9Z,11E)-Octadecadien ethanolamide | 198123-92-1 | Natural Products |
| HY-166207 | 9(S),10(S),11(R)-Trihydroxy-12(Z),15(Z)-octadecadienoic acid | 339186-37-7 | Natural Products |
| HY-166208 | Lauryl behenate | 42233-07-8 | Natural Products |
| HY-166209 | Ethyl 8(Z)-eicosenoate | 150324-18-8 | Natural Products |
| HY-166210 | 9(Z)-Tetradecenoyl chloride | 95548-25-7 | Natural Products |
| HY-166211 | Linolenyl linolenate | 125369-04-2 | Natural Products |
| HY-166212 | Linolenyl linoleate | 125369-02-0 | Natural Products |
| HY-166213 | Ethyl 6(Z),9(Z),12(Z),15(Z),18(Z),21(Z)-tetracosahexaenoate | 2435680-90-1 | Natural Products |
| HY-166214 | Ethyl 7(E)-nonadecenoate | 2692622-84-5 | Natural Products |
| HY-166214A | Ethyl 7(Z)-nonadecenoate | 2692622-83-4 | Natural Products |
| HY-166215 | Ethyl 5(Z)-eicosenoate | 116430-55-8 | Natural Products |
| HY-166216 | Linolenyl myristate | 2692623-55-3 | Natural Products |
| HY-166217 | Heptyl methane sulfonate | 16156-51-7 | Natural Products |
| HY-166218 | 9(Z),12(Z)-Linoleyl acetate | 5999-95-1 | Natural Products |
| HY-166219 | 9(Z),12(Z),15(Z)-Octadecatrienoyl chloride | 59044-29-0 | Natural Products |
| HY-166220 | Isopentenyl monophosphate (disodium) | 881829-74-9 | Natural Products |
| HY-166221 | Linolenyl behenate | 2692623-61-1 | Natural Products |
| HY-166222 | Ethyl 11(Z),14(Z),17(Z)-eicosatrienoate | 99660-95-4 | Natural Products |
| HY-166223 | Lignoceryl behenate | 42233-17-0 | Natural Products |
| HY-166224 | cis-12,13-Epoxy-9(Z),15(Z)-octadecadienoic acid | 100019-37-2 | Natural Products |
| HY-166225 | Lignoceryl lignocerate | 1001-43-0 | Natural Products |
| HY-166226 | C2 Sphingomyelin (d18:1/2:0) | 74713-54-5 | Natural Products |
| HY-166227 | N-Nonadecanoyl-sulfatide | 2692623-78-0 | Natural Products |
| HY-166228 | cis-12,13-Epoxy-octadecanoic acid | 32381-04-7 | Natural Products |
| HY-166229 | Ethyl 12-tridecenoate | 120127-03-9 | Natural Products |
| HY-16622A | GSK 1842799 (TFA) | 1005407-76-0 | Reference compound |
| HY-16622B | GSK 1842799 (hydrochloride) | 1277165-15-7 | Reference compound |
| HY-166230 | Ethyl 6(Z)-octadecenoate | 34302-52-8 | Natural Products |
| HY-166231 | Ethyl 21-methyldocosanoate | 1194774-66-7 | Natural Products |
| HY-166232 | Ethyl 14(Z)-tricosenoate | 2692622-89-0 | Natural Products |
| HY-166233 | Ethyl 15(Z)-tetracosenoate | 137888-64-3 | Natural Products |
| HY-166234 | Linoelaidyl methane sulfonate | 1192259-28-1 | Natural Products |
| HY-166235 | cis-14,15-Epoxy-11(Z)-eicosenoic acid | 109281-37-0 | Natural Products |
| HY-166236 | Ethyl 12(Z)-heneicosenoate | 2692622-86-7 | Natural Products |
| HY-166237 | Ethyl 12(Z),15(Z)-heneicosadienoate | 2692622-87-8 | Natural Products |
| HY-166238 | rel-Linoleic acid-biotin | 2692623-19-9 | Natural Products |
| HY-166239 | cis-15,16-Epoxy-9(Z),12(Z)-octadecadienoic acid | 64044-08-2 | Natural Products |
| HY-166240 | N-Undecanoylglycine | 83871-09-4 | Natural Products |
| HY-166241 | cis-5,6-Epoxy-9(Z),12(Z)-octadecadienoic acid | 2692622-61-8 | Natural Products |
| HY-166242 | Nervonyl methane sulfonate | 51040-60-9 | Natural Products |
| HY-166243 | cis-6,7-Epoxy-octadecanoic acid | 13980-05-7 | Natural Products |
| HY-166244 | Ethyl 13(Z),16(Z)-docosadienoate | 1394295-82-9 | Natural Products |
| HY-166245 | cis-9,10-Epoxy-12(Z),15(Z)-octadecadienoic acid | 36747-82-7 | Natural Products |
| HY-166246 | N-Hexanoylsphingosylphosphorylcholine | 182493-45-4 | Natural Products |
| HY-166247 | cis-9,10-Epoxyhexadecanoic acid | 29243-99-0 | Natural Products |
| HY-166248 | Ethyl 13(Z),16(Z),19(Z)-docosatrienoate | 2692622-88-9 | Natural Products |
| HY-166249 | cis-9,10-Methylenehexadecanoic acid | 4675-60-9 | Natural Products |
| HY-166250 | N-Hexanoyl-glucosylceramide | 2692623-77-9 | Natural Products |
| HY-166251 | Ethyl 14-pentadecenoate | 1403621-03-3 | Natural Products |
| HY-166252 | Lyso-dihydrosphingomyelin | 21658-11-7 | Natural Products |
| HY-166253 | N-Hexanoyl-biotin-sulfatide | 2692623-25-7 | Natural Products |
| HY-166254 | CLA 10(E),12(Z) ethyl ester | 330214-87-4 | Natural Products |
| HY-166255 | Gamma linolenyl methane sulfonate | 60187-52-2 | Natural Products |
| HY-166256 | CLA 9c,11tr ethyl ester | 330214-86-3 | Natural Products |
| HY-166257 | Lyso-sulfatide (bovine) | 38621-58-8 | Natural Products |
| HY-166258 | Colneleic acid | 52761-34-9 | Natural Products |
| HY-166259 | C95-Dolichol | 42436-66-8 | Natural Products |
| HY-166260 | γ,γ-Dimethylallyl monophosphate-DA | 1397200-33-7 | Natural Products |
| HY-166261 | Colnelenic acid | 52591-16-9 | Natural Products |
| HY-166262 | C19-Ceramide | 67492-17-5 | Natural Products |
| HY-166263 | Eicosanoyl chloride | 40140-09-8 | Natural Products |
| HY-166264 | Methyl (±)-trans-9,10-epoxyoctadecanoate | 6084-76-0 | Natural Products |
| HY-166265 | cis-11,12-Epoxy-14(Z)-eicosenoic acid | 109217-14-3 | Natural Products |
| HY-166266 | Eicosaprenol | 87205-86-5 | Natural Products |
| HY-166267 | Hexaprenol | 77551-14-5 | Natural Products |
| HY-166268 | Cholesteryl undecanoate | 24385-24-8 | Natural Products |
| HY-166269 | Nonadecaprenal (C95) | 2692623-79-1 | Natural Products |
| HY-166270 | N-Acetylsphingosylphosphorylcholine | 148306-05-2 | Natural Products |
| HY-166271 | Cholesteryl tridecanoate | 25605-87-2 | Natural Products |
| HY-166272 | Nonadecaprenol | 62032-41-1 | Natural Products |
| HY-166273 | Eicosyl methane sulfonate | 3381-25-7 | Natural Products |
| HY-166274 | Cholesteryl tricosanoate | 1616116-26-7 | Natural Products |
| HY-166275 | Elaidyl methane sulfonate | 59101-13-2 | Natural Products |
| HY-166276 | Cholesteryl petroselinate | 19485-80-4 | Natural Products |
| HY-166277 | C30-Ceramide | 871540-97-5 | Natural Products |
| HY-166278 | Ethyl hexacosanoate | 29030-81-7 | Natural Products |
| HY-166279 | C55-Dihydroprenyl-mpda | 2694047-17-9 | Natural Products |
| HY-166280 | Erucyl methane sulfonate | 102542-59-6 | Natural Products |
| HY-166281 | N-Dodecanoyl-NBD-sulfatide | 128969-80-2 | Natural Products |
| HY-166282 | C6 NBD-L-threo-dihydrosphingosine | 114301-98-3 | Natural Products |
| HY-166285 | Cholesteryl petroselaidate | 19485-81-5 | Natural Products |
| HY-166286 | Cholesteryl pentadecanoate | 25605-88-3 | Natural Products |
| HY-166287 | Cholesteryl 11,14,17-eicosatrienoate | 77690-64-3 | Natural Products |
| HY-166288 | 2-Oxo-9(Z),12(Z),15(Z)-octadecatrienoic acid | 2692622-62-9 | Natural Products |
| HY-166289 | Cholesteryl myristoleate | 30950-26-6 | Natural Products |
| HY-166290 | Acetyl-D-carnitine (chloride) | 5061-35-8 | Natural Products |
| HY-166291 | Cholesteryl myristelaidate | 29193-93-9 | Natural Products |
| HY-166292 | All-trans-solanesyl-DPTA | 146340-00-3 | Natural Products |
| HY-166293 | 7DW8-5 | 1056025-00-3 | Natural Products |
| HY-166294 | Cholesteryl isovalerate | 41328-97-6 | Natural Products |
| HY-166295 | Alpha linolenyl methane sulfonate | 51040-61-0 | Natural Products |
| HY-166296 | Cholesteryl heneicosanoate | 238413-60-0 | Natural Products |
| HY-166297 | Butyryl coenzyme A (lithium) | 369651-89-8 | Natural Products |
| HY-166298 | Cholesteryl gamma linolenate | 99518-16-8 | Natural Products |
| HY-166299 | C110-dolichol | 73742-38-8 | Natural Products |
| HY-166300 | C105-Dolichol | 73742-37-7 | Natural Products |
| HY-166301 | Ethyl 4(Z),7(Z),10(Z),13(Z),16(Z)-nonadecapentaenoate | 2692622-82-3 | Natural Products |
| HY-166302 | Cholesteryl docosapentaenoate | 70110-49-5 | Natural Products |
| HY-166302A | Cholesteryl 4,7,10,13,16-docosapentaenoate | 74892-02-7 | Reference compound |
| HY-166303 | C115-Dolichol | 68688-74-4 | Natural Products |
| HY-166304 | Nonadecyl methane sulfonate | 62732-72-3 | Natural Products |
| HY-166305 | C12-Dihydro-ceramide | 197302-96-8 | Natural Products |
| HY-166306 | Dodecaprenyl-MPDA (ammonium) | 102850-25-9 | Natural Products |
| HY-166308 | Hexadecaprenol | 10589-53-4 | Natural Products |
| HY-166309 | Crotonyl-CoA (tetralithium) | 116912-55-1 | Natural Products |
| HY-166310 | C12-NBD-L-Threo-sphingosine | 474943-08-3 | Natural Products |
| HY-166311 | Hexadecyl methane sulfonate | 20779-14-0 | Natural Products |
| HY-166312 | Dodecyl methane sulfonate | 51323-71-8 | Natural Products |
| HY-166313 | Docosanoyl-L-carnitine (hydrochloride) | 2133456-10-5 | Natural Products |
| HY-166314 | Eicosanoyl-L-carnitine (chloride) | 149116-07-4 | Natural Products |
| HY-166315 | C15-Ceramide | 67492-15-3 | Natural Products |
| HY-166315S | C15-Ceramide-d7 | Isotope-Labeled Compounds | |
| HY-166316 | erythro-9,10-Dihydroxy-12(Z)-octadecenoic acid | 59959-49-8 | Natural Products |
| HY-166317 | Dorignic acid | 2692622-66-3 | Natural Products |
| HY-166318 | N-Dodecanoyl-sulfatide | 852100-88-0 | Natural Products |
| HY-166319 | Docosyl methane sulfonate | 123253-22-5 | Natural Products |
| HY-16632 | ELND 006 | 1333990-84-3 | Reference compound |
| HY-166320 | erythro-9,10-Dihydroxyoctadecanoic acid | 3639-32-5 | Natural Products |
| HY-166321 | erythro-12,13-Dihydroxy-9(Z)-octadecenoic acid | 59981-84-9 | Natural Products |
| HY-166322 | erythro-5,6-Dihydroxy-9(Z),12(Z)-octadecadienoic acid | 2692622-63-0 | Natural Products |
| HY-166323 | DOPE-N-nonadecanoyl | 1246297-94-8 | Natural Products |
| HY-166324 | Hexadecanedioyl-mono-coenzyme A | 111278-02-5 | Natural Products |
| HY-166325A | Ganglioside GD3-d3 (ammonium) | 2692624-24-9 | Isotope-Labeled Compounds |
| HY-166326 | Hexanoyl coenzyme A (lithium) | 369656-99-5 | Natural Products |
| HY-166327 | Hexacosanoyl-L-carnitine (hydrochloride) | 590386-14-4 | Natural Products |
| HY-166328 | Palmitoyl coenzyme A (potassium) | 369657-00-1 | Natural Products |
| HY-16633 | ELND 007 | 1444006-79-4 | Reference compound |
| HY-16634 | MI-888 (TFA) | 1303609-30-4 | Reference compound |
| HY-166341S | S 8849-1-d4 (free base) | 1330822-91-7 | Isotope-Labeled Compounds |
| HY-16635 | Setipiprant | 866460-33-5 | Reference compound |
| HY-16636 | ML337 | 1443118-44-2 | Reference compound |
| HY-166363S | Beraprost-d3 | Isotope-Labeled Compounds | |
| HY-16637 | Folic acid | 59-30-3 | Natural Products |
| HY-16637A | Folic acid (sodium) | 6484-89-5 | Natural Products |
| HY-16637B | Folcysteine | 8064-47-9 | Reference compound |
| HY-16637D | Folic acid (disodium) | 29704-76-5 | Reference compound |
| HY-16637R | Folic acid (Standard) | 59-30-3 | Reference Standards |
| HY-16637S | Folic acid-d2 | 69022-87-3 | Isotope-Labeled Compounds |
| HY-16637S1 | Folic acid-d4 | 171777-72-3 | Isotope-Labeled Compounds |
| HY-16637S2 | (Rac)-Folic acid-13C5,15N | Isotope-Labeled Compounds | |
| HY-16637S3 | Folic acid-13C5 | 1207282-75-4 | Isotope-Labeled Compounds |
| HY-16637S4 | Folic acid-13C5,15N | 2687960-47-8 | Isotope-Labeled Compounds |
| HY-16637S5 | Folic acid-13C6 | 161406-20-8 | Isotope-Labeled Compounds |
| HY-16638 | CB 3717 | 76849-19-9 | Reference compound |
| HY-166384 | Palmitoleyl myristate | 22393-89-1 | Natural Products |
| HY-166385 | 3-Hydroxy-10(Z),13(Z),16(Z)-docosatrienoic acid | 2692622-67-4 | Natural Products |
| HY-166386 | Palmitoleyl oleate | 22393-99-3 | Natural Products |
| HY-166388 | Palmitoleyl palmitate | 22393-90-4 | Natural Products |
| HY-166389 | Palmitoleyl palmitoleate | 22393-97-1 | Natural Products |
| HY-16639 | ML314 | 1448895-09-7 | Reference compound |
| HY-166390 | Palmitoleyl stearate | 22393-91-5 | Natural Products |
| HY-16640 | TCJL37 | 1258294-34-6 | Reference compound |
| HY-16642A | LY2828360 | 1231220-79-3 | Reference compound |
| HY-16643 | Linerixibat | 1345982-69-5 | Reference compound |
| HY-166441 | Heneicosanoyl chloride | 77582-61-7 | Natural Products |
| HY-166478S | O-Desmethyl carvedilol-d5 | 1794817-24-5 | Isotope-Labeled Compounds |
| HY-166519 | (2-Hydroxypropyl)-α-cyclodextrin (MW 1180) | 128446-33-3 | Biochemical Assay Reagents |
| HY-16652 | Apabetalone | 1044870-39-4 | Reference compound |
| HY-16654 | ML254 | 1428630-86-7 | Reference compound |
| HY-16656 | BMS-767778 | 915729-95-2 | Reference compound |
| HY-166560 | DSPE-Fluor 488 | Biochemical Assay Reagents | |
| HY-16657 | TAPI-1 | 163847-77-6 | Reference compound |
| HY-16657A | (S,S)-TAPI-1 | 171235-71-5 | Reference compound |
| HY-16658 | Z-VAD(OMe)-FMK | 187389-52-2 | Reference compound |
| HY-16658B | Z-VAD-FMK | 161401-82-7 | Reference compound |
| HY-16658C | Z-VA-DL-D-FMK | 220644-02-0 | Reference compound |
| HY-16659 | EHT 1864 | 754240-09-0 | Reference compound |
| HY-16660 | INH1 | 313553-47-8 | Reference compound |
| HY-166606 | DSPE-polysarcosine66 | Biochemical Assay Reagents | |
| HY-16661 | Skp2 Inhibitor C1 | 432001-69-9 | Reference compound |
| HY-16662 | Oncrasin-1 | 75629-57-1 | Reference compound |
| HY-16663 | ITX3 | 347323-96-0 | Reference compound |
| HY-16664 | SJ-172550 | 431979-47-4 | Reference compound |
| HY-166644 | DPPE-PEG-amine (MW 2000) | 1034152-14-1 | Biochemical Assay Reagents |
| HY-166648 | DSPE-PEG-Maleimide (MW 2000) | Biochemical Assay Reagents | |
| HY-16665 | iCRT 14 | 677331-12-3 | Reference compound |
| HY-166651 | DSPE-Hyd-PEG-Mal (MW 2000) | Biochemical Assay Reagents | |
| HY-166654 | DSPE-Amide-PEG-Rhodamine (MW 2000) | Biochemical Assay Reagents | |
| HY-16666 | 3CAI | 28755-03-5 | Reference compound |
| HY-16667 | HLM006474 | 353519-63-8 | Reference compound |
| HY-166670S | Ketoconazole carbonyl-13C | Isotope-Labeled Compounds | |
| HY-16668 | Tyrphostin A1 | 2826-26-8 | Reference compound |
| HY-166680 | DOPE-PEG-FITC (MW 5000) | Biochemical Assay Reagents | |
| HY-16669 | Mcl1-IN-1 | 713492-66-1 | Reference compound |
| HY-16670 | Dafadine-A | 1065506-69-5 | Reference compound |
| HY-16671 | CFTR(inh)-172 | 307510-92-5 | Reference compound |
| HY-16672 | AVX 13616 | 900814-48-4 | Reference compound |
| HY-16673 | PSN632408 | 857652-30-3 | Reference compound |
| HY-16674 | 10-Oxo Docetaxel | 167074-97-7 | Reference compound |
| HY-16675 | 7-Epi-10-oxo-docetaxel | 162784-72-7 | Reference compound |
| HY-16676 | 7-Epi-docetaxel | 153381-68-1 | Reference compound |
| HY-16677A | Mofegiline (hydrochloride) | 120635-25-8 | Reference compound |
| HY-16678 | Helioxanthin | 18920-47-3 | Natural Products |
| HY-16679 | Helioxanthin derivative 5-4-2 | 203935-39-1 | Reference compound |
| HY-16680 | Helioxanthin 8-1 | 840529-13-7 | Reference compound |
| HY-166807 | Palmitate-PEG-Mal (MW 1000) | Biochemical Assay Reagents | |
| HY-16681 | AGN 194310 | 229961-45-9 | Reference compound |
| HY-16682 | AGN 196996 | 958295-17-5 | Reference compound |
| HY-16683 | AGN 205728 | 859498-05-8 | Reference compound |
| HY-166833 | DOPE-PEG-Rhodamine B (MW 5000) | Biochemical Assay Reagents | |
| HY-16684 | AGN-195183 | 367273-07-2 | Reference compound |
| HY-166846 | DOPE-PEG-FITC (MW 2000) | Biochemical Assay Reagents | |
| HY-166848 | DOPE-PEG-Cy5.5 (MW 2000) | Biochemical Assay Reagents | |
| HY-166849 | DOPE-PEG-Cy5 (MW 5000) | Biochemical Assay Reagents | |
| HY-16685 | AGN 205327 | 2070018-29-8 | Reference compound |
| HY-166850 | DOPE-PEG-Cy5.5 (MW 5000) | Biochemical Assay Reagents | |
| HY-166852 | DOPE-PEG-Cy5 (MW 2000) | Biochemical Assay Reagents | |
| HY-166857 | DMPE-PEG-amine (TFA) (MW 2000) | Biochemical Assay Reagents | |
| HY-16686 | α-Tocopherol (phosphate) | 38976-17-9 | Reference compound |
| HY-166863 | L-erythro-Sphingosine(synthetic) | 6036-75-5 | Biochemical Assay Reagents |
| HY-166869S | N,N-Dimethyl-2-(methylthio)aniline-d3 | Isotope-Labeled Compounds | |
| HY-16686R | α-Tocopherol (phosphate) (Standard) | 38976-17-9 | Reference Standards |
| HY-16687 | Eltoprazine | 98224-03-4 | Reference compound |
| HY-166870 | 4-Nitrophenyl 4,6-O-(phenylmethylene)-α-D-galactopyranoside | 85906-27-0 | Biochemical Assay Reagents |
| HY-166871 | DSPE-PEG-endo-BCN (MW 5000) | Biochemical Assay Reagents | |
| HY-166872S | N-Benzyl paroxetine-d6 | 3047060-13-6 | Isotope-Labeled Compounds |
| HY-166873S | Fluvoxamine-d3 | 1185245-55-9 | Isotope-Labeled Compounds |
| HY-166874 | DSPE-PEG-endo-BCN (MW 2000) | Biochemical Assay Reagents | |
| HY-166875S | Apramycin acetate-d7 (acetate) | Isotope-Labeled Compounds | |
| HY-166876S | Nicergoline impurity 18-d4 | Isotope-Labeled Compounds | |
| HY-166878S | SAR107375E impurity 13-d8 | Isotope-Labeled Compounds | |
| HY-166879S | SAR107375E Impurity 14-d8 | Isotope-Labeled Compounds | |
| HY-16687A | Eltoprazine (hydrochloride) | 98206-09-8 | Reference compound |
| HY-16687B | Eltoprazine (dihydrochloride) | 143485-51-2 | Reference compound |
| HY-16688 | RU 24969 | 66611-26-5 | Reference compound |
| HY-166880S | Mildronate-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-166881S | Saxagliptin-13C,d2-2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-166882S | 5-Hydroxy saxagliptin-13C,d2-1 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-166883 | DOPE-PEG-Rhodamine B (MW 2000) | Biochemical Assay Reagents | |
| HY-166884 | 1,2:4,5-Bis-O-(1-methylethylidene)-β-D-psicopyranose | 18422-54-3 | Biochemical Assay Reagents |
| HY-166885S | Ceftazidime-d6 (sodium) | Isotope-Labeled Compounds | |
| HY-166886S | BEA 2180 alcohol-d3 | Isotope-Labeled Compounds | |
| HY-166887S | Tiotropium bromide impurity-d3 | Isotope-Labeled Compounds | |
| HY-166889S | 2,4,5-Trichloro-4'-methoxy-biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-16688A | RU 24969 (succinate) | 107008-28-6 | Reference compound |
| HY-16688B | RU 24969 (hemisuccinate) | 66611-27-6 | Reference compound |
| HY-16689 | VU 0240551 | 893990-34-6 | Reference compound |
| HY-166891S | Tiotropium EP Impurity G-d3(Iodide) | Isotope-Labeled Compounds | |
| HY-166893S | 1,2,3,6,7,8-Hexachloronaphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-166894S | 3,3′,4,4′,5,5′-Hexabromo diphenyl ether-13C12 | 1401355-58-5 | Isotope-Labeled Compounds |
| HY-166895S | 1,3,4,6,8-Pentachloro dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-166896S | 2,3,3',4',5,5'-Hexachloro-1,1'-biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-166897S | 1,2,3,4,8,9-Hexachlorodibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-166898S | trans Nonachlor-13C10 | 1262969-06-1 | Isotope-Labeled Compounds |
| HY-166899S | 1,3-Dibromo-2,7,8-trichlorodibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-16690 | BTS | 1576-37-0 | Reference compound |
| HY-166900S | 3,3′,4,5′-Tetrabromodiphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-166901S | 2,3′,4,5,5′-Pentachloro-4′-methoxy biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-166903S | 2,3,4,5-Tetrachlorodiphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-166904S | 2,2′,4,4′,6-Pentabromo diphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-166906S | cis-Nonachlor-13C10 | 2484171-06-2 | Isotope-Labeled Compounds |
| HY-166908S | 2,2',3,3',4,4',5,6,6'-Nonabromo diphenyl ether-13C12 | 1367487-33-9 | Isotope-Labeled Compounds |
| HY-166909S | 1,4,5-Trichloronaphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-16691 | AK-7 | 420831-40-9 | Reference compound |
| HY-166912S | 1,2,3,5,6,7-Hexachloro-naphthalene-13C10 | 219526-47-3 | Isotope-Labeled Compounds |
| HY-166914S | 2,2',3,3',4,5,5'-Heptachloro-4'-methoxybiphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-166915S | 1,4,6-Trichloro naphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-166917S | 1,3,6,8-Tetrachloro-dibenzofuran-13C12 | 1236286-05-7 | Isotope-Labeled Compounds |
| HY-166918S | 2,3,6,7-Tetrachloro biphenylene-13C12 | Isotope-Labeled Compounds | |
| HY-166919S | cis-Chlordane-13C8 | 475275-01-5 | Isotope-Labeled Compounds |
| HY-16692 | ISO-1 | 478336-92-4 | Reference compound |
| HY-166920S | 2,2′,3,4,5-Pentachlorodiphenyl ether-13C12 | 1621005-50-2 | Isotope-Labeled Compounds |
| HY-166922S | 2,3,4,5-Tetrachloro-4′-methoxy biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-166923S | 2-Chloro dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-166924S | 1,2,3,4,6-Pentachloro-dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-166925S | 2′,3,3′,4′,5,5′-Hexachloro-4-biphenylol-13C12 | Isotope-Labeled Compounds | |
| HY-166926S | 2,2′,3,4,5,5′-Hexachloro diphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-166927S | 2,2′,4,4′,5-Pentabromo diphenyl ether-13C12 | 488710-21-0 | Isotope-Labeled Compounds |
| HY-166928S | 1,3,6,8-Tetrachloro-9H-carbazole-13C12 | Isotope-Labeled Compounds | |
| HY-166929S | 2,2′,3,4′,5,5′,6-Heptachloro-4-methoxy biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-16693 | LDN-27219 | 312946-37-5 | Reference compound |
| HY-166931S | 2,2',4,4'-Tetrabromo-6-methoxy-diphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-166933S | 1,2,3,6,7-Pentachloro-naphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-166934S | Endosulfan-13C9 (sulfate) | Isotope-Labeled Compounds | |
| HY-166935S | 2,3-Dibromo-7,8-dichloro-dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-166936S | 1,2,3,4,5,6,8-Heptachloronaphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-166939S | 3,4,5,6-Tetrabromo[1,1′-biphenyl]-2,2′-diol-13C12 | Isotope-Labeled Compounds | |
| HY-16694 | BAMB-4 | 891025-25-5 | Reference compound |
| HY-166940S | 2′,3′,4′,5′-Tetrachloro-4-biphenylol-13C12 | Isotope-Labeled Compounds | |
| HY-166942S | 1,2,3,8,9-Pentachloro-dibenzo-p-dioxin-13C12 | Isotope-Labeled Compounds | |
| HY-166945S | 2,3,3′,4,5,5′-Hexachloro-4′-methoxy biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-166948S | 1,2,3,8,9-Pentachloro dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-166949S | 1,2,8,9-Tetrachloro-dibenzo-p-dioxin-13C12 | Isotope-Labeled Compounds | |
| HY-16695 | MIM1 | 509102-00-5 | Reference compound |
| HY-166950S | 2,2′,3,4,4′,6-Hexabromo diphenyl ether-13C12 | 488710-25-4 | Isotope-Labeled Compounds |
| HY-166951S | 1,2,4,7,8-Pentachloro dibenzo-p-dioxin-13C12 | Isotope-Labeled Compounds | |
| HY-166952S | 2′,3,4′,5,5′-Pentachloro-4-biphenylol-13C12 | Isotope-Labeled Compounds | |
| HY-166953S | 1,2,3,4,6,8-Hexachloro-dibenzo-p-dioxin-13C12 | Isotope-Labeled Compounds | |
| HY-166954 | Sialyllacto-N-neohexaose II | 118023-83-9 | Biochemical Assay Reagents |
| HY-166956S | Chlordene-13C10 | Isotope-Labeled Compounds | |
| HY-166957S | 1,2,3,7,8-Pentachloro naphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-166958S | 1,2,3,4,6,7,9-Heptachloro dibenzo-p-dioxin-13C12 | Isotope-Labeled Compounds | |
| HY-166959S | 2,3,8-Trichloro dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-16696 | SN 2 | 823218-99-1 | Reference compound |
| HY-166960S | 2,2′,4,4′-Tetrabromo-6-hydroxydiphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-166961S | 2′,4′,5′-Trichloro-4-biphenylol-13C12 | Isotope-Labeled Compounds | |
| HY-166962S | 2,3-Dichloro dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-166963S | 3,4,4′-Trichloro diphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-166965 | Neu5Gc(α2,6)N-Acetylgalactosamine | 72506-87-7 | Biochemical Assay Reagents |
| HY-166966 | 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl trichloroacetimidate | 121238-27-5 | Biochemical Assay Reagents |
| HY-166967 | 1,3,4,6-Tetra-O-acetyl-2-deoxy-2-trifluoracetamido-D-glucose | 7139-63-1 | Biochemical Assay Reagents |
| HY-166968 | DSPE-PEG-COOH (MW 5000) | Biochemical Assay Reagents | |
| HY-166969 | Bergamot oil | 8007-75-8 | Biochemical Assay Reagents |
| HY-16697 | CID 16020046 | 834903-43-4 | Reference compound |
| HY-166970 | 3α,4β,3α-Galactotetraose | 56038-38-1 | Biochemical Assay Reagents |
| HY-166971 | 4-Nitrophenyl-α-D-maltoheptaoside | 74173-31-2 | Biochemical Assay Reagents |
| HY-166972 | Polysarcosine 50 | Biochemical Assay Reagents | |
| HY-166973 | Polysarcosine 20 | Biochemical Assay Reagents | |
| HY-166974 | Polysarcosine 150 | Biochemical Assay Reagents | |
| HY-166975 | Polysarcosine 100 | Biochemical Assay Reagents | |
| HY-166976 | Trifucosyllacto-N-hexaose | 116883-09-1 | Biochemical Assay Reagents |
| HY-166977 | Methyl ricinelaidate | 7706-01-6 | Biochemical Assay Reagents |
| HY-166978 | D-Lyxosylamine | 39840-37-4 | Biochemical Assay Reagents |
| HY-166979 | Stearic acid-mPEG (MW 2000) | Biochemical Assay Reagents | |
| HY-16698 | kb-NB77-78 | 1350622-33-1 | Reference compound |
| HY-166980 | m-PEG-DPPE (MW 2000) | Biochemical Assay Reagents | |
| HY-166981 | DSPE-PEG-TCO (MW 2000) | Biochemical Assay Reagents | |
| HY-166982 | DSPE-PEG-PA (MW 2000) | Biochemical Assay Reagents | |
| HY-166983 | m-PEG-DMG (MW 5000) | Biochemical Assay Reagents | |
| HY-166984 | Phytic acid (calcium) | 23183-60-0 | Biochemical Assay Reagents |
| HY-166985 | 1,2-O-Isopropylidene-3-O-methyl-α-D-xylopentodialdofuranose-(1,4) | 43138-66-5 | Biochemical Assay Reagents |
| HY-166986 | 2-O-[2-(Acetylamino)-2-deoxy-β-D-glucopyranosyl]-D-mannose | 34621-73-3 | Biochemical Assay Reagents |
| HY-166987 | 1-(8Z-Tetradecenoyl)-rac-glycerol | 488862-82-4 | Biochemical Assay Reagents |
| HY-166988 | 1-Tridecanoyl-2-hydroxy-sn-glycero-3-phosphocholine | 20559-17-5 | Biochemical Assay Reagents |
| HY-166989 | 1-undecanoyl-2-hydroxy-sn-glycero-3-phosphocholine | 27869-41-6 | Biochemical Assay Reagents |
| HY-16699 | Nexturastat A | 1403783-31-2 | Reference compound |
| HY-166990 | Methoxypolyethylene glycol maleimide (MW 5000) | 99126-64-4 | Biochemical Assay Reagents |
| HY-166990A | Methoxypolyethylene glycol maleimide (MW 10000) | 99126-64-4 | Biochemical Assay Reagents |
| HY-166990B | Methoxypolyethylene glycol maleimide (MW 2000) | 99126-64-4 | Biochemical Assay Reagents |
| HY-166990C | Methoxypolyethylene glycol maleimide (MW 750) | 99126-64-4 | Biochemical Assay Reagents |
| HY-166991 | 2,3-Dihydroxypropyl (8Z)-8-heptadecenoate | 749266-30-6 | Biochemical Assay Reagents |
| HY-166992 | 1,2-Dioleoyl-sn-glycero-3-PA (ammonium) | Biochemical Assay Reagents | |
| HY-166993 | Cy5-PEG-methyltetrazine (MW 5000) | Biochemical Assay Reagents | |
| HY-166994 | Heptyl 7-bromoheptanoate | 3034992-68-9 | Biochemical Assay Reagents |
| HY-166995 | Bis-Vinylsulfone-PEG (MW 5000) | Biochemical Assay Reagents | |
| HY-166996 | Bis(N-2-ethoxyethyl 2-hexyldecanoate)amine | 2985009-59-2 | Biochemical Assay Reagents |
| HY-166997 | AL-A12 | 3037065-56-5 | Biochemical Assay Reagents |
| HY-166998 | m-PEG-Vinylsulfone (MW 5000) | Biochemical Assay Reagents | |
| HY-166999 | m-PEG-Vinylsulfone (MW 20000) | Biochemical Assay Reagents | |
| HY-16700 | PNU-159682 | 202350-68-3 | ADC Related |
| HY-167000 | m-PEG-Vinylsulfone (MW 10000) | Biochemical Assay Reagents | |
| HY-167002 | RM 137-15 | Biochemical Assay Reagents | |
| HY-167003 | L16 | Biochemical Assay Reagents | |
| HY-167004 | IAJD93 | 3076338-50-3 | Biochemical Assay Reagents |
| HY-167004A | IAJD249 | 3076338-32-1 | Biochemical Assay Reagents |
| HY-167005 | PLGA10000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167006 | PLGA10000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167008 | PLGA1000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167009 | PLGA1000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-16700G | PNU-159682 (GMP) | 202350-68-3 | GMP Small Molecules |
| HY-16701 | BV6 | 1001600-56-1 | Reference compound |
| HY-167010 | PLGA1000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167011 | Al-28 | Biochemical Assay Reagents | |
| HY-167012 | 306Oi9-cis2 | 3027930-39-5 | Biochemical Assay Reagents |
| HY-167013 | PLGA1000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167014 | PLGA2000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167015 | 1O14 | Biochemical Assay Reagents | |
| HY-167016 | Cholesterol-undecanoate-glucose conjugate | Biochemical Assay Reagents | |
| HY-167018 | PLGA2000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167019 | PLGA2000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-16702 | Pifithrin-β | 60477-34-1 | Reference compound |
| HY-167020 | PLGA3000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167021 | Cholesterol-doxorubicin | Biochemical Assay Reagents | |
| HY-167022 | DSPE-PEG-azide (MW 600) | Biochemical Assay Reagents | |
| HY-167023 | PLGA3000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167024 | Cholesterol valerate | Biochemical Assay Reagents | |
| HY-167025 | Cholesterol laurate | Biochemical Assay Reagents | |
| HY-167026 | PLGA3000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167027 | PLGA3000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167028 | DSPE-PEG-alkyne (MW 2000) | Biochemical Assay Reagents | |
| HY-167029 | PLGA4000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-16702A | Pifithrin-β (hydrobromide) | 511296-88-1 | Reference compound |
| HY-167030 | PLGA4000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167031 | DOPE-PEG-DBCO (MW 5000) | Biochemical Assay Reagents | |
| HY-167032 | PLGA4000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167033 | PLGA4000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167034 | PLGA5000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167035 | PLGA5000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167036 | DMG-PEG-Mal (MW 2000) | Biochemical Assay Reagents | |
| HY-167037 | PLGA5000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167038 | PLGA5000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167039 | PLLA5000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-16704 | ESI-09 | 263707-16-0 | Reference compound |
| HY-167040 | PLLA10000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167041 | PLLA5000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167042 | PLLA10000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167043 | PLLA10000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167044 | PLLA5000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167045 | PLLA10000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167046 | PLLA1000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167047 | PLLA5000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167048 | PLLA1000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167049 | PLLA4000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-16705 | BRD4770 | 1374601-40-7 | Reference compound |
| HY-167050 | PLLA1000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167051 | PLLA1000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167052 | PLLA2000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167053 | PLLA4000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167054 | PLLA2000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167055 | PLLA4000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-167056 | PLLA4000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167057 | PLLA3000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167058 | PLLA3000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167059 | PLLA3000-PEG2000-VS | Biochemical Assay Reagents | |
| HY-16706 | Remodelin | 949912-58-7 | Reference compound |
| HY-167060 | PLLA3000-PEG1000-VS | Biochemical Assay Reagents | |
| HY-167061 | PLLA2000-PEG5000-VS | Biochemical Assay Reagents | |
| HY-167062 | PLLA2000-PEG3000-VS | Biochemical Assay Reagents | |
| HY-167063 | Azide-pSar20 | Biochemical Assay Reagents | |
| HY-167064 | DSPE-pSar50 | Biochemical Assay Reagents | |
| HY-167065 | DSPE-pSar20 | Biochemical Assay Reagents | |
| HY-167066 | DSPE-pSar150 | Biochemical Assay Reagents | |
| HY-167067 | DSPE-pSar100 | Biochemical Assay Reagents | |
| HY-167068 | Azide-pSar150 | Biochemical Assay Reagents | |
| HY-167069 | Azide-pSar100 | Biochemical Assay Reagents | |
| HY-16706A | Remodelin (hydrobromide) | 1622921-15-6 | Reference compound |
| HY-16707 | CH 5450 | 252557-97-4 | Peptides |
| HY-167071 | PLLA-azide (MW 5000) | Biochemical Assay Reagents | |
| HY-167079A | OPC-18750 (hydrochloride) | 145364-90-5 | Reference compound |
| HY-16708 | ZLN024 | 723249-01-2 | Reference compound |
| HY-16708A | ZLN024 (hydrochloride) | 1883548-91-1 | Reference compound |
| HY-16709 | USP7-IN-1 | 1381291-36-6 | Reference compound |
| HY-167091 | (Rac)-Beraprost | 88430-50-6 | Reference compound |
| HY-16710 | GPDA | 65096-46-0 | Dye Reagents |
| HY-16711 | SB225002 | 182498-32-4 | Reference compound |
| HY-167114 | (Rac)-Aurora A/PKC-IN-1 | 2143100-98-3 | Reference compound |
| HY-167115 | PLLA-azide (MW 20000) | Biochemical Assay Reagents | |
| HY-167117 | PLLA-azide (MW 10000) | Biochemical Assay Reagents | |
| HY-167118 | PLLA5000-PEG6000-PLLA5000 | Biochemical Assay Reagents | |
| HY-167119 | PLLA5000-PEG8000-PLLA5000 | Biochemical Assay Reagents | |
| HY-16712 | LDN-214117 | 1627503-67-6 | Reference compound |
| HY-167120 | PLLA6000-PEG1000-PLLA6000 | Biochemical Assay Reagents | |
| HY-167124 | PLLA6000-PEG2000-PLLA6000 | Biochemical Assay Reagents | |
| HY-167126 | PLLA6000-PEG3000-PLLA6000 | Biochemical Assay Reagents | |
| HY-167128 | PLLA8000-PEG8000-PLLA8000 | Biochemical Assay Reagents | |
| HY-16713 | (S)-(-)-5-Fluorowillardiine | 140187-23-1 | Reference compound |
| HY-167130 | PLLA8000-PEG6000-PLLA8000 | Biochemical Assay Reagents | |
| HY-167132 | PLLA6000-PEG4000-PLLA6000 | Biochemical Assay Reagents | |
| HY-167134 | PLLA8000-PEG4000-PLLA8000 | Biochemical Assay Reagents | |
| HY-167136 | PLLA8000-PEG3000-PLLA8000 | Biochemical Assay Reagents | |
| HY-167137 | PLLA6000-PEG6000-PLLA6000 | Biochemical Assay Reagents | |
| HY-167138 | PLLA8000-PEG2000-PLLA8000 | Biochemical Assay Reagents | |
| HY-167139 | PLLA8000-PEG1000-PLLA8000 | Biochemical Assay Reagents | |
| HY-16713A | (S)-(-)-5-Fluorowillardiine (hydrochloride) | 1321546-70-6 | Reference compound |
| HY-16714 | 4-Azido-L-phenylalanine | 33173-53-4 | Reference compound |
| HY-167140 | PLLA6000-PEG8000-PLLA6000 | Biochemical Assay Reagents | |
| HY-167143 | 3-(Bromomethyl)phenyl isothiocyanate | 155863-31-3 | Biochemical Assay Reagents |
| HY-16714A | 4-Azido-L-phenylalanine (hydrochloride) | 34670-43-4 | Reference compound |
| HY-16715 | Acumapimod | 836683-15-9 | Reference compound |
| HY-16716 | Basmisanil | 1159600-41-5 | Reference compound |
| HY-167168 | (S)-Azelnidipine | 722455-09-6 | Reference compound |
| HY-16718 | Dagrocorat | 1044535-52-5 | Reference compound |
| HY-167181 | 1,1′-Bis(phenylphosphino)ferrocene | 480444-12-0 | Biochemical Assay Reagents |
| HY-16718A | Dagrocorat (hydrochloride) | 1044535-61-6 | Reference compound |
| HY-16719 | Dapaconazole | 1269726-67-1 | Reference compound |
| HY-167203 | AJG049 (free base) | 195991-49-2 | Reference compound |
| HY-167208 | SR-302 | 2771319-74-3 | Reference compound |
| HY-16721 | Cyclopropavir | 632325-71-4 | Reference compound |
| HY-16722 | Fosdagrocorat | 1044535-58-1 | Reference compound |
| HY-167221 | 1,4-Bis(4,6-dibromo-2-carboxyphenyl) butanedioate | 71337-52-5 | Biochemical Assay Reagents |
| HY-167228 | 2,3,4-Tri-O-benzyl-L-rhamnopyranose | 210426-02-1 | Biochemical Assay Reagents |
| HY-16723 | Funapide | 1259933-16-8 | Reference compound |
| HY-167230 | Methyl 6-deoxy-2,3,4-tris-O-(phenylmethyl)-L-galactopyranoside | 67576-77-6 | Biochemical Assay Reagents |
| HY-167231 | Neocarraoctaose 41,43,45,47-tetrasulfate (tetrasodium) | 133647-94-6 | Biochemical Assay Reagents |
| HY-16723A | (R)-Funapide | 1259933-15-7 | Reference compound |
| HY-16724 | Indoximod | 110117-83-4 | Reference compound |
| HY-167241 | D-myo-Inositol,1,5,6-tris(dihydrogen phosphate),ammonium salt | 135027-58-6 | Biochemical Assay Reagents |
| HY-167242 | ZTB23(R) | 306324-21-0 | Reference compound |
| HY-167244 | AI 3-23445 | 5823-25-6 | Reference compound |
| HY-167253 | p-Nitrophenyl 4,6-benzylidene-β-D-glucopyranoside | 83167-73-1 | Biochemical Assay Reagents |
| HY-167256 | Gentamicin C1 | 25876-10-2 | Natural Products |
| HY-167259 | Chromoionophore XVII | 156122-91-7 | Biochemical Assay Reagents |
| HY-16726 | Polmacoxib | 301692-76-2 | Reference compound |
| HY-167261 | Polygalacturonic acid (potassium) | 108321-62-6 | Biochemical Assay Reagents |
| HY-16726R | Polmacoxib (Standard) | 301692-76-2 | Reference Standards |
| HY-16727 | Presatovir | 1353625-73-6 | Reference compound |
| HY-167270 | Rhoduline acid | 87-03-6 | Reference compound |
| HY-16728 | Rapastinel | 117928-94-6 | Reference compound |
| HY-167287 | myo-Inositol,tetraphosphate,pentaammonium salt | 103497-71-8 | Biochemical Assay Reagents |
| HY-16728A | Rapastinel (acetate) | 491872-39-0 | Reference compound |
| HY-16728B | Rapastinel (Trifluoroacetate) | 1435786-04-1 | Reference compound |
| HY-16729 | Relenopride | 1221416-43-8 | Reference compound |
| HY-167290 | N-(Azido-PEG3)-N-bis(PEG3-NHS ester) | 2055042-58-3 | Reference compound |
| HY-167291 | D-Arabinose 5-phosphate (sodium) | 89927-09-3 | Biochemical Assay Reagents |
| HY-167294 | PLLA5000-PEG5000-Thiol | Biochemical Assay Reagents | |
| HY-167295 | PLLA5000-PEG3000-Thiol | Biochemical Assay Reagents | |
| HY-167296 | PLLA5000-PEG2000-Thiol | Biochemical Assay Reagents | |
| HY-167297 | PLLA5000-PEG1000-Thiol | Biochemical Assay Reagents | |
| HY-167298 | PLLA4000-PEG5000-Thiol | Biochemical Assay Reagents | |
| HY-167299 | PLLA4000-PEG3000-Thiol | Biochemical Assay Reagents | |
| HY-16729A | Relenopride (hydrochloride) | 1221416-42-7 | Reference compound |
| HY-16730 | Sarolaner | 1398609-39-6 | Reference compound |
| HY-167300 | PLLA4000-PEG2000-Thiol | Biochemical Assay Reagents | |
| HY-167301 | PLLA4000-PEG1000-Thiol | Biochemical Assay Reagents | |
| HY-167302 | PLLA3000-PEG5000-Thiol | Biochemical Assay Reagents | |
| HY-167303 | PLLA3000-PEG3000-Thiol | Biochemical Assay Reagents | |
| HY-167304 | PLLA3000-PEG2000-Thiol | Biochemical Assay Reagents | |
| HY-167305 | PLLA3000-PEG1000-Thiol | Biochemical Assay Reagents | |
| HY-167306 | PLLA2000-PEG5000-Thiol | Biochemical Assay Reagents | |
| HY-167307 | PLLA2000-PEG3000-Thiol | Biochemical Assay Reagents | |
| HY-167308 | PLLA2000-PEG2000-Thiol | Biochemical Assay Reagents | |
| HY-167309 | PLLA2000-PEG1000-Thiol | Biochemical Assay Reagents | |
| HY-16731 | Sembragiline | 676479-06-4 | Reference compound |
| HY-167310 | PLLA1000-PEG5000-Thiol | Biochemical Assay Reagents | |
| HY-167311 | PLLA1000-PEG3000-Thiol | Biochemical Assay Reagents | |
| HY-167312 | PLLA1000-PEG2000-Thiol | Biochemical Assay Reagents | |
| HY-167313 | PLLA1000-PEG1000-Thiol | Biochemical Assay Reagents | |
| HY-167314 | PLLA10000-PEG5000-Thiol | Biochemical Assay Reagents | |
| HY-167315 | PLLA10000-PEG3000-Thiol | Biochemical Assay Reagents | |
| HY-167316 | PLLA10000-PEG2000-Thiol | Biochemical Assay Reagents | |
| HY-167317 | PLLA10000-PEG1000-Thiol | Biochemical Assay Reagents | |
| HY-167318 | PLLA5000-PEG5000-SPDP | Biochemical Assay Reagents | |
| HY-167319 | PLLA5000-PEG3000-SPDP | Biochemical Assay Reagents | |
| HY-16732 | Tradipitant | 622370-35-8 | Reference compound |
| HY-167320 | PLLA5000-PEG2000-SPDP | Biochemical Assay Reagents | |
| HY-167321 | PLLA5000-PEG1000-SPDP | Biochemical Assay Reagents | |
| HY-167322 | PLLA4000-PEG5000-SPDP | Biochemical Assay Reagents | |
| HY-167323 | PLLA4000-PEG3000-SPDP | Biochemical Assay Reagents | |
| HY-167324 | PLLA4000-PEG2000-SPDP | Biochemical Assay Reagents | |
| HY-167325 | PLLA4000-PEG1000-SPDP | Biochemical Assay Reagents | |
| HY-167326 | PLLA3000-PEG5000-SPDP | Biochemical Assay Reagents | |
| HY-167327 | PLLA3000-PEG3000-SPDP | Biochemical Assay Reagents | |
| HY-167328 | PLLA3000-PEG2000-SPDP | Biochemical Assay Reagents | |
| HY-167329 | PLLA3000-PEG1000-SPDP | Biochemical Assay Reagents | |
| HY-16733 | Verinurad | 1352792-74-5 | Reference compound |
| HY-167330 | PLLA2000-PEG5000-SPDP | Biochemical Assay Reagents | |
| HY-167331 | PLLA2000-PEG3000-SPDP | Biochemical Assay Reagents | |
| HY-167332 | PLLA2000-PEG2000-SPDP | Biochemical Assay Reagents | |
| HY-167333 | PLLA2000-PEG1000-SPDP | Biochemical Assay Reagents | |
| HY-167334 | PLLA1000-PEG5000-SPDP | Biochemical Assay Reagents | |
| HY-167335 | PLLA1000-PEG3000-SPDP | Biochemical Assay Reagents | |
| HY-167336 | PLLA1000-PEG2000-SPDP | Biochemical Assay Reagents | |
| HY-167337 | PLLA1000-PEG1000-SPDP | Biochemical Assay Reagents | |
| HY-167338 | PLLA10000-PEG5000-SPDP | Biochemical Assay Reagents | |
| HY-167339 | PLLA10000-PEG3000-SPDP | Biochemical Assay Reagents | |
| HY-16734 | Amiselimod | 942399-20-4 | Reference compound |
| HY-167340 | PLLA10000-PEG2000-SPDP | Biochemical Assay Reagents | |
| HY-167341 | PLLA10000-PEG1000-SPDP | Biochemical Assay Reagents | |
| HY-167342 | PLLA5000-PEG4000-PLLA5000 | Biochemical Assay Reagents | |
| HY-167343 | PLLA5000-PEG3000-PLLA5000 | Biochemical Assay Reagents | |
| HY-167344 | PLLA5000-PEG2000-PLLA5000 | Biochemical Assay Reagents | |
| HY-167345 | PLLA5000-PEG1000-PLLA5000 | Biochemical Assay Reagents | |
| HY-167346 | PLLA4000-PEG8000-PLLA4000 | Biochemical Assay Reagents | |
| HY-167347 | PLLA4000-PEG6000-PLLA4000 | Biochemical Assay Reagents | |
| HY-167348 | PLLA4000-PEG4000-PLLA4000 | Biochemical Assay Reagents | |
| HY-167349 | PLLA4000-PEG3000-PLLA4000 | Biochemical Assay Reagents | |
| HY-16734A | Amiselimod (hydrochloride) | 942398-84-7 | Reference compound |
| HY-16735 | Avoralstat | 918407-35-9 | Reference compound |
| HY-167350 | PLLA4000-PEG2000-PLLA4000 | Biochemical Assay Reagents | |
| HY-167351 | PLLA4000-PEG1000-PLLA4000 | Biochemical Assay Reagents | |
| HY-167352 | PLLA3000-PEG8000-PLLA3000 | Biochemical Assay Reagents | |
| HY-167353 | PLLA3000-PEG6000-PLLA3000 | Biochemical Assay Reagents | |
| HY-167354 | PLLA3000-PEG4000-PLLA3000 | Biochemical Assay Reagents | |
| HY-167355 | PLLA3000-PEG3000-PLLA3000 | Biochemical Assay Reagents | |
| HY-167356 | PLLA3000-PEG2000-PLLA3000 | Biochemical Assay Reagents | |
| HY-167357 | PLLA3000-PEG1000-PLLA3000 | Biochemical Assay Reagents | |
| HY-167358 | PLLA2000-PEG8000-PLLA2000 | Biochemical Assay Reagents | |
| HY-167359 | PLLA2000-PEG6000-PLLA2000 | Biochemical Assay Reagents | |
| HY-16736 | Centanafadine | 924012-43-1 | Reference compound |
| HY-167360 | PLLA2000-PEG4000-PLLA2000 | Biochemical Assay Reagents | |
| HY-167361 | PLLA2000-PEG3000-PLLA2000 | Biochemical Assay Reagents | |
| HY-167362 | PLLA2000-PEG2000-PLLA2000 | Biochemical Assay Reagents | |
| HY-167363 | PLLA2000-PEG1000-PLLA2000 | Biochemical Assay Reagents | |
| HY-167364 | PLLA1000-PEG8000-PLLA1000 | Biochemical Assay Reagents | |
| HY-167365 | PLLA1000-PEG6000-PLLA1000 | Biochemical Assay Reagents | |
| HY-167366 | PLLA1000-PEG4000-PLLA1000 | Biochemical Assay Reagents | |
| HY-167367 | PLLA1000-PEG3000-PLLA1000 | Biochemical Assay Reagents | |
| HY-167368 | PLLA1000-PEG2000-PLLA1000 | Biochemical Assay Reagents | |
| HY-167369 | PLLA1000-PEG1000-PLLA1000 | Biochemical Assay Reagents | |
| HY-16736A | Centanafadine (hydrochloride) | 923981-14-0 | Reference compound |
| HY-16737 | Elafibranor | 923978-27-2 | Reference compound |
| HY-167370 | PLLA5000-PEG5000-BIO | Biochemical Assay Reagents | |
| HY-167371 | PLLA5000-PEG2000-BIO | Biochemical Assay Reagents | |
| HY-167372 | PLLA5000-PEG1000-BIO | Biochemical Assay Reagents | |
| HY-167373 | PLLA4000-PEG5000-BIO | Biochemical Assay Reagents | |
| HY-167374 | PLLA4000-PEG2000-BIO | Biochemical Assay Reagents | |
| HY-167375 | PLLA4000-PEG1000-BIO | Biochemical Assay Reagents | |
| HY-167376 | PLLA3000-PEG5000-BIO | Biochemical Assay Reagents | |
| HY-167377 | PLLA3000-PEG2000-BIO | Biochemical Assay Reagents | |
| HY-167378 | PLLA3000-PEG1000-BIO | Biochemical Assay Reagents | |
| HY-167379 | PLLA2000-PEG5000-BIO | Biochemical Assay Reagents | |
| HY-16737A | (E/Z)-Elafibranor | 824932-88-9 | Reference compound |
| HY-16738 | Eleclazine | 1443211-72-0 | Reference compound |
| HY-167380 | PLLA2000-PEG2000-BIO | Biochemical Assay Reagents | |
| HY-167381 | PLLA2000-PEG1000-BIO | Biochemical Assay Reagents | |
| HY-167382 | PLLA1000-PEG5000-BIO | Biochemical Assay Reagents | |
| HY-167383 | PLLA1000-PEG2000-BIO | Biochemical Assay Reagents | |
| HY-167384 | PLLA1000-PEG1000-BIO | Biochemical Assay Reagents | |
| HY-167385 | PLLA10000-PEG5000-BIO | Biochemical Assay Reagents | |
| HY-167386 | PLLA10000-PEG2000-BIO | Biochemical Assay Reagents | |
| HY-167387 | PLLA10000-PEG1000-BIO | Biochemical Assay Reagents | |
| HY-167388 | PLLA5000-PEG5000-ALK | Biochemical Assay Reagents | |
| HY-167389 | PLLA5000-PEG3000-ALK | Biochemical Assay Reagents | |
| HY-16738A | Eleclazine (hydrochloride) | 1448754-43-5 | Reference compound |
| HY-16739 | Emeramide | 351994-94-0 | Reference compound |
| HY-167390 | PLLA5000-PEG2000-ALK | Biochemical Assay Reagents | |
| HY-167391 | PLLA5000-PEG1000-ALK | Biochemical Assay Reagents | |
| HY-167392 | PLLA4000-PEG5000-ALK | Biochemical Assay Reagents | |
| HY-167393 | PLLA4000-PEG3000-ALK | Biochemical Assay Reagents | |
| HY-167394 | PLLA4000-PEG2000-ALK | Biochemical Assay Reagents | |
| HY-167395 | PLLA4000-PEG1000-ALK | Biochemical Assay Reagents | |
| HY-167396 | PLLA3000-PEG5000-ALK | Biochemical Assay Reagents | |
| HY-167397 | PLLA3000-PEG3000-ALK | Biochemical Assay Reagents | |
| HY-167398 | PLLA3000-PEG2000-ALK | Biochemical Assay Reagents | |
| HY-167399 | PLLA3000-PEG1000-ALK | Biochemical Assay Reagents | |
| HY-16740 | Eprociclovir | 145512-85-2 | Reference compound |
| HY-167400 | PLLA2000-PEG5000-ALK | Biochemical Assay Reagents | |
| HY-167401 | PLLA2000-PEG3000-ALK | Biochemical Assay Reagents | |
| HY-167402 | PLLA2000-PEG2000-ALK | Biochemical Assay Reagents | |
| HY-167403 | PLLA2000-PEG1000-ALK | Biochemical Assay Reagents | |
| HY-167404 | PLLA1000-PEG5000-ALK | Biochemical Assay Reagents | |
| HY-167405 | PLLA1000-PEG3000-ALK | Biochemical Assay Reagents | |
| HY-167406 | PLLA1000-PEG2000-ALK | Biochemical Assay Reagents | |
| HY-167407 | PLLA1000-PEG1000-ALK | Biochemical Assay Reagents | |
| HY-167408 | PLLA10000-PEG5000-ALK | Biochemical Assay Reagents | |
| HY-167409 | PLLA10000-PEG3000-ALK | Biochemical Assay Reagents | |
| HY-16740A | Eprociclovir (potassium) | 219657-37-1 | Reference compound |
| HY-16740B | Eprociclovir (sodium) | 219657-36-0 | Reference compound |
| HY-167410 | PLLA10000-PEG2000-ALK | Biochemical Assay Reagents | |
| HY-167411 | PLLA5000-PEG5000-FOL | Biochemical Assay Reagents | |
| HY-167412 | PLLA5000-PEG2000-FOL | Biochemical Assay Reagents | |
| HY-167413 | PLLA20000-PEG5000-FOL | Biochemical Assay Reagents | |
| HY-167414 | PLLA20000-PEG2000-FOL | Biochemical Assay Reagents | |
| HY-167415 | PLLA10000-PEG5000-FOL | Biochemical Assay Reagents | |
| HY-167416 | PLLA10000-PEG2000-FOL | Biochemical Assay Reagents | |
| HY-167417 | PLLA5000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-167418 | PLLA5000-PEG3000-NH2 | Biochemical Assay Reagents | |
| HY-167419 | PLLA5000-PEG2000-NH2 | Biochemical Assay Reagents | |
| HY-16742 | Gepotidacin | 1075236-89-3 | Reference compound |
| HY-167420 | PLLA5000-PEG1000-NH2 | Biochemical Assay Reagents | |
| HY-167421 | PLLA4000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-167422 | PLLA4000-PEG3000-NH2 | Biochemical Assay Reagents | |
| HY-167423 | PLLA4000-PEG2000-NH2 | Biochemical Assay Reagents | |
| HY-167424 | PLLA4000-PEG1000-NH2 | Biochemical Assay Reagents | |
| HY-167425 | PLLA3000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-167426 | PLLA3000-PEG3000-NH2 | Biochemical Assay Reagents | |
| HY-167427 | PLLA3000-PEG2000-NH2 | Biochemical Assay Reagents | |
| HY-167428 | PLLA3000-PEG1000-NH2 | Biochemical Assay Reagents | |
| HY-167429 | PLLA30000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-16742A | Gepotidacin (S enantiomer) | 2319789-82-5 | Reference compound |
| HY-16742B | Gepotidacin (mesylate hydrate) | 1624306-20-2 | Reference compound |
| HY-16742BR | Gepotidacin (mesylate hydrate) (Standard) | 1624306-20-2 | Reference Standards |
| HY-16742C | Gepotidacin (hydrochloride) | 1075235-46-9 | Reference compound |
| HY-16742R | Gepotidacin (Standard) | 1075236-89-3 | Reference Standards |
| HY-16743 | Ibiglustat | 1401090-53-6 | Reference compound |
| HY-167430 | PLLA2000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-167431 | PLLA2000-PEG3000-NH2 | Biochemical Assay Reagents | |
| HY-167432 | PLLA2000-PEG2000-NH2 | Biochemical Assay Reagents | |
| HY-167433 | PLLA2000-PEG1000-NH2 | Biochemical Assay Reagents | |
| HY-167434 | PLLA20000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-167435 | PLLA1000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-167436 | PLLA1000-PEG3000-NH2 | Biochemical Assay Reagents | |
| HY-167437 | PLLA1000-PEG2000-NH2 | Biochemical Assay Reagents | |
| HY-167438 | PLLA1000-PEG1000-NH2 | Biochemical Assay Reagents | |
| HY-167439 | PLLA10000-PEG5000-NH2 | Biochemical Assay Reagents | |
| HY-16743A | Ibiglustat (L-Malic acid) | 1629063-78-0 | Reference compound |
| HY-16743B | Ibiglustat (succinate) | 1629063-80-4 | Reference compound |
| HY-16743C | Ibiglustat (hydrochloride) | 1629063-79-1 | Reference compound |
| HY-167440 | PLLA10000-PEG3000-NH2 | Biochemical Assay Reagents | |
| HY-167441 | PLLA10000-PEG2000-NH2 | Biochemical Assay Reagents | |
| HY-167442 | PLLA10000-PEG1000-NH2 | Biochemical Assay Reagents | |
| HY-167443 | PLLA5000-PEG5000-N3 | Biochemical Assay Reagents | |
| HY-167444 | PLLA5000-PEG3000-N3 | Biochemical Assay Reagents | |
| HY-167445 | PLLA5000-PEG2000-N3 | Biochemical Assay Reagents | |
| HY-167446 | PLLA5000-PEG1000-N3 | Biochemical Assay Reagents | |
| HY-167447 | PLLA4000-PEG5000-N3 | Biochemical Assay Reagents | |
| HY-167448 | PLLA4000-PEG3000-N3 | Biochemical Assay Reagents | |
| HY-167449 | PLLA4000-PEG2000-N3 | Biochemical Assay Reagents | |
| HY-16745 | Lascufloxacin | 848416-07-9 | Reference compound |
| HY-167450 | PLLA4000-PEG1000-N3 | Biochemical Assay Reagents | |
| HY-167451 | PLLA3000-PEG5000-N3 | Biochemical Assay Reagents | |
| HY-167452 | PLLA3000-PEG3000-N3 | Biochemical Assay Reagents | |
| HY-167453 | PLLA3000-PEG2000-N3 | Biochemical Assay Reagents | |
| HY-167454 | PLLA3000-PEG1000-N3 | Biochemical Assay Reagents | |
| HY-167455 | PLLA2000-PEG5000-N3 | Biochemical Assay Reagents | |
| HY-167456 | PLLA2000-PEG3000-N3 | Biochemical Assay Reagents | |
| HY-167457 | PLLA2000-PEG2000-N3 | Biochemical Assay Reagents | |
| HY-167458 | PLLA2000-PEG1000-N3 | Biochemical Assay Reagents | |
| HY-167459 | PLLA1000-PEG5000-N3 | Biochemical Assay Reagents | |
| HY-16745A | Lascufloxacin (hydrochloride) | 1433857-09-0 | Reference compound |
| HY-167460 | PLLA1000-PEG3000-N3 | Biochemical Assay Reagents | |
| HY-167461 | PLLA1000-PEG2000-N3 | Biochemical Assay Reagents | |
| HY-167462 | PLLA1000-PEG1000-N3 | Biochemical Assay Reagents | |
| HY-167463 | PLLA10000-PEG5000-N3 | Biochemical Assay Reagents | |
| HY-167464 | PLLA10000-PEG3000-N3 | Biochemical Assay Reagents | |
| HY-167465 | PLLA10000-PEG2000-N3 | Biochemical Assay Reagents | |
| HY-167466 | PLLA10000-PEG1000-N3 | Biochemical Assay Reagents | |
| HY-167469 | PLLA5000-PEG5000-RhB | Biochemical Assay Reagents | |
| HY-16746S | Lavamilast-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-16747 | Maralixibat (chloride) | 228113-66-4 | Reference compound |
| HY-167470 | PLLA5000-PEG3000-RhB | Biochemical Assay Reagents | |
| HY-167471 | PLLA5000-PEG2000-RhB | Biochemical Assay Reagents | |
| HY-167472 | PLLA5000-PEG1000-RhB | Biochemical Assay Reagents | |
| HY-167473 | PLLA4000-PEG5000-RhB | Biochemical Assay Reagents | |
| HY-167474 | PLLA4000-PEG3000-RhB | Biochemical Assay Reagents | |
| HY-167475 | PLLA4000-PEG2000-RhB | Biochemical Assay Reagents | |
| HY-167476 | PLLA4000-PEG1000-RhB | Biochemical Assay Reagents | |
| HY-167477 | PLLA3000-PEG5000-RhB | Biochemical Assay Reagents | |
| HY-167478 | PLLA3000-PEG3000-RhB | Biochemical Assay Reagents | |
| HY-167479 | PLLA3000-PEG2000-RhB | Biochemical Assay Reagents | |
| HY-16748 | Nelonicline | 1026134-63-3 | Reference compound |
| HY-167480 | PLLA3000-PEG1000-RhB | Biochemical Assay Reagents | |
| HY-167481 | PLLA2000-PEG5000-RhB | Biochemical Assay Reagents | |
| HY-167482 | PLLA2000-PEG3000-RhB | Biochemical Assay Reagents | |
| HY-167483 | PLLA2000-PEG2000-RhB | Biochemical Assay Reagents | |
| HY-167484 | PLLA2000-PEG1000-RhB | Biochemical Assay Reagents | |
| HY-167485 | PLLA1000-PEG5000-RhB | Biochemical Assay Reagents | |
| HY-167486 | PLLA1000-PEG3000-RhB | Biochemical Assay Reagents | |
| HY-167487 | PLLA1000-PEG2000-RhB | Biochemical Assay Reagents | |
| HY-167488 | PLLA1000-PEG1000-RhB | Biochemical Assay Reagents | |
| HY-167489 | PLLA10000-PEG5000-RhB | Biochemical Assay Reagents | |
| HY-16748A | Nelonicline (citrate) | 1026136-84-4 | Reference compound |
| HY-16749 | Pexidartinib | 1029044-16-3 | Reference compound |
| HY-167490 | PLLA10000-PEG3000-RhB | Biochemical Assay Reagents | |
| HY-167491 | PLLA10000-PEG2000-RhB | Biochemical Assay Reagents | |
| HY-167492 | PLLA10000-PEG1000-RhB | Biochemical Assay Reagents | |
| HY-16749A | Pexidartinib (hydrochloride) | 2040295-03-0 | Reference compound |
| HY-16750 | Radalbuvir | 1314795-11-3 | Reference compound |
| HY-16751 | Ralinepag | 1187856-49-0 | Reference compound |
| HY-16752 | Relebactam | 1174018-99-5 | Reference compound |
| HY-16752A | Relebactam (sodium) | 1502858-91-4 | Reference compound |
| HY-16752R | Relebactam (Standard) | 1174018-99-5 | Reference Standards |
| HY-16752S1 | Relebactam-d9 | Isotope-Labeled Compounds | |
| HY-16753 | Ridinilazole | 308362-25-6 | Reference compound |
| HY-167537 | D-Ribulose o-nitrophenylhydrazone | 6155-41-5 | Biochemical Assay Reagents |
| HY-167538 | sn-Glycero-3-phosphocholine 1:1 cadmium chloride adduct | 64681-08-9 | Biochemical Assay Reagents |
| HY-16754 | Seletalisib | 1362850-20-1 | Reference compound |
| HY-167541 | Dansyl-L-aspartic acid (dicyclohexylammonium) | 53332-29-9 | Biochemical Assay Reagents |
| HY-167542 | meso-1,2-Bis(4-methoxyphenyl)ethylenediamine | 117106-36-2 | Biochemical Assay Reagents |
| HY-167543 | Ceftibuten (hydrate) | 118081-37-1 | Biochemical Assay Reagents |
| HY-167544 | Sucrose acetoisobutyrate (90% solution) | 126-13-6 | Biochemical Assay Reagents |
| HY-167545 | 1-Palmitoyl-2-oleoylphosphatidylethanolamine | 10015-88-0 | Biochemical Assay Reagents |
| HY-167546 | Prednisone 21-aldehyde | 70522-55-3 | Biochemical Assay Reagents |
| HY-167547 | 1,2-Dipalmitoyl-sn-glycero-3-phospho(ethylene glycol) (sodium) | 148439-06-9 | Biochemical Assay Reagents |
| HY-167548 | L-α-Phosphatidylinositol-4,5-bisphosphate ammonium | 383907-42-4 | Biochemical Assay Reagents |
| HY-167549 | N-C16-Deoxysphinganine | 378755-69-2 | Biochemical Assay Reagents |
| HY-16755 | Solcitinib | 1206163-45-2 | Reference compound |
| HY-167550 | cis-9,12-Eicosadienoic acid | 70240-72-1 | Biochemical Assay Reagents |
| HY-167552 | Bis-N,N-glycinemethylenefluorescein | 25639-40-1 | Biochemical Assay Reagents |
| HY-167553 | 18:1 Phosphatidylethanol (sodium) | 322647-53-0 | Biochemical Assay Reagents |
| HY-167554 | 2-Eicosenoic acid | 109264-21-3 | Biochemical Assay Reagents |
| HY-167555 | 6-Dehydro prednisolone | 2427-64-7 | Biochemical Assay Reagents |
| HY-167556 | C.I.Direct Blue 199 | 12222-04-7 | Biochemical Assay Reagents |
| HY-167557 | 9(Z),12(Z),15(Z)-Heneicosatrienoic acid | 18211-44-4 | Biochemical Assay Reagents |
| HY-167558 | 18:1 Lactosyl PE | 474943-47-0 | Biochemical Assay Reagents |
| HY-167559 | N-Isobutyryl-D-cysteine | 124529-07-3 | Biochemical Assay Reagents |
| HY-16756 | Toreforant | 952494-46-1 | Reference compound |
| HY-167560 | 2(E),8(Z),11(Z),14(Z)-Eicosatetraenoic acid | 165190-25-0 | Biochemical Assay Reagents |
| HY-167561 | Linear B trisaccharide | 101627-01-4 | Biochemical Assay Reagents |
| HY-167562 | Mead acid methyl ester | 14602-39-2 | Biochemical Assay Reagents |
| HY-167563 | 3-(Decyloxy)propanoic acid | 7420-16-8 | Biochemical Assay Reagents |
| HY-167564 | N-12:0-1-Deoxysphinganine | 1246298-40-7 | Biochemical Assay Reagents |
| HY-167565 | Guazatine acetate salt | 115044-19-4 | Biochemical Assay Reagents |
| HY-167566 | Poly-L-proline | 25191-13-3 | Biochemical Assay Reagents |
| HY-167567 | 16:0 DNP PE | 474943-09-4 | Biochemical Assay Reagents |
| HY-167568 | 14:0 PE-DTPA (Gd) | 827020-81-5 | Biochemical Assay Reagents |
| HY-167569 | (Rac)-1-Palmitoyl-glycero-3-phosphocholine | 17364-18-0 | Biochemical Assay Reagents |
| HY-16757 | Trofinetide | 853400-76-7 | Peptides |
| HY-167570 | 6β-Hydroxy prednisolone | 16355-29-6 | Biochemical Assay Reagents |
| HY-167571 | 12:0 Diether PC | 72593-72-7 | Biochemical Assay Reagents |
| HY-167572 | 18:0 (9,10dibromo) PC | 217075-01-9 | Biochemical Assay Reagents |
| HY-167573 | 16:0-10 Doxyl PC | 188004-25-3 | Biochemical Assay Reagents |
| HY-167574 | 16:0-18:0(11-12BR) PC | 324054-54-8 | Biochemical Assay Reagents |
| HY-167575 | Sphingosyl PE (d18:1) | 90850-31-0 | Biochemical Assay Reagents |
| HY-167576 | C18:1 Lyso PAF | 87907-66-2 | Biochemical Assay Reagents |
| HY-167577 | 3,17β-O-Bis(methoxymethyl)estradiol | 113680-55-0 | Biochemical Assay Reagents |
| HY-167578 | Hepta-o-acetyl-lactose-1-o-trichloroacetimidate | 106256-89-7 | Biochemical Assay Reagents |
| HY-167579 | 4-trans,7-cis,10-cis,13-cis,16-cis,19-cis-Docosahexaenoic acid | 955920-48-6 | Biochemical Assay Reagents |
| HY-16758 | Verosudil | 1414854-42-4 | Reference compound |
| HY-167580 | 18:1 Hemi BMP (S,R) | 474943-36-7 | Biochemical Assay Reagents |
| HY-167581 | Borage oil, from Borago officinalis seeds | 84012-16-8 | Biochemical Assay Reagents |
| HY-167582S | Oxidized 18:2 cholesterol-d7 | 2936622-60-3 | Isotope-Labeled Compounds |
| HY-167583S | 17:0-20:3 PI-d5 | 2936622-59-0 | Isotope-Labeled Compounds |
| HY-167584S | 3α,12α-Dihydroxy-5β-cholestanoic acid-d5 | 2936622-36-3 | Isotope-Labeled Compounds |
| HY-167585S | 16:0-18:2 PC-d5 | 2936622-37-4 | Isotope-Labeled Compounds |
| HY-167586S | 18:0-22:6 PC-d9 | Isotope-Labeled Compounds | |
| HY-167587S | 1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero(d5)-3-phosphocholine | 2936622-61-4 | Isotope-Labeled Compounds |
| HY-167588S | 1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero(d5)-3-phosphoethanolamine | 2936622-54-5 | Isotope-Labeled Compounds |
| HY-167589S | Linoleoy L-carnitine-d9 | 2847775-86-2 | Isotope-Labeled Compounds |
| HY-16758A | Verosudil (hydrochloride) | 1414854-44-6 | Reference compound |
| HY-16759 | Verubecestat | 1286770-55-5 | Reference compound |
| HY-167590S | 1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero(d5)-3-phospho-(1’-rac-glycerol)(sodium) | 2936622-53-4 | Isotope-Labeled Compounds |
| HY-167592S | 17:0-20:3 PS-d5 | 2936622-56-7 | Isotope-Labeled Compounds |
| HY-167593S | C18:0-d7 GM1 Ceramide | Isotope-Labeled Compounds | |
| HY-167594S | C18:0-d7 GM2 Ceramide | Isotope-Labeled Compounds | |
| HY-167595S | C18:0-d7 GD3 Ceramide (d18:1/18:0-d7) | Isotope-Labeled Compounds | |
| HY-167596S | C18:0-d7 GD2 Ceramide (d18:1/18:0-d7) | Isotope-Labeled Compounds | |
| HY-167597S | C18:0-d7 GD1b Ceramide (d18:1/18:0-d7) | Isotope-Labeled Compounds | |
| HY-167598S | C18:0-d7 GB4 Ceramide (d18:1/18:0-d7) | Isotope-Labeled Compounds | |
| HY-167599S | C18:0-d7 Fuc-GM1 Ceramide (d18:1/18:0-d7) | Isotope-Labeled Compounds | |
| HY-16759A | Verubecestat (TFA) | 2095432-65-6 | Reference compound |
| HY-16759B | Verubecestat (tosylate) | 1875153-95-9 | Reference compound |
| HY-16760 | 9-cis-Retinol acetate | 29584-22-3 | Reference compound |
| HY-167600AS | 18:0 PA-d70 | Isotope-Labeled Compounds | |
| HY-16760S | 9-cis-Retinol acetate-d5 | 1217219-62-9 | Isotope-Labeled Compounds |
| HY-16762 | Artefenomel | 1029939-86-3 | Reference compound |
| HY-167627 | Colupulone | 21621-94-3 | Natural Products |
| HY-167628 | Metamizole (hemimagnesium) | 6150-97-6 | Reference compound |
| HY-167629 | Gibberellenic acid | 546-09-8 | Reference compound |
| HY-16763 | Asapiprant | 932372-01-5 | Reference compound |
| HY-167630 | Ketoprofen (sodium) | 57495-14-4 | Reference compound |
| HY-167631 | Desfluoro nebivolol | 99200-13-2 | Reference compound |
| HY-167632 | meso-Zeaxanthin | 31272-50-1 | Reference compound |
| HY-167633 | Oxomemazine (hydrochloride) | 4784-40-1 | Reference compound |
| HY-167635 | Decarbamoylmitomycin C | 26909-37-5 | Reference compound |
| HY-167636 | 7-Hydroxy ropinirole (bromide) | 81654-57-1 | Reference compound |
| HY-167637 | 4-Hydroxyclonidine | 57101-48-1 | Reference compound |
| HY-167638 | Fenretinide glucuronide | 79982-82-4 | Reference compound |
| HY-167639 | (S)-Ramosetron | 132036-90-9 | Reference compound |
| HY-16764 | Avarofloxacin | 878592-87-1 | Reference compound |
| HY-167640 | 8-Hydroxychlorpromazine | 3926-67-8 | Reference compound |
| HY-167641 | Malvone A | 915764-62-4 | Natural Products |
| HY-167642 | (Z)-Rilpivirine | 500287-94-5 | Reference compound |
| HY-167643 | Hydroxy tipelukast | 1027597-04-1 | Reference compound |
| HY-167644 | Cefoxazole | 36920-48-6 | Reference compound |
| HY-167645 | Pramoxine | 140-65-8 | Reference compound |
| HY-167646 | Ammuxetine | 1202707-24-1 | Reference compound |
| HY-167647 | Menoctone | 14561-42-3 | Reference compound |
| HY-167648 | PD 158771 | 189152-50-9 | Reference compound |
| HY-167649 | Poskine | 585-14-8 | Reference compound |
| HY-16764A | Acorafloxacin (hydrochloride) | 1001162-01-1 | Reference compound |
| HY-16765 | Axelopran | 949904-48-7 | Reference compound |
| HY-167650 | Fletazepam | 34482-99-0 | Reference compound |
| HY-167651 | TAN-1057C | 128126-46-5 | Reference compound |
| HY-167653 | FR-145715 | 149917-31-7 | Reference compound |
| HY-167654 | Treloxinate | 30910-27-1 | Reference compound |
| HY-167655 | KF-19418 | 147508-06-3 | Oligonucleotides |
| HY-167656 | Oxocularine | 3395-23-1 | Reference compound |
| HY-167657 | Tizolemide | 56488-58-5 | Reference compound |
| HY-167658 | Tuclazepam | 51037-88-8 | Reference compound |
| HY-167659 | Isomylamine (hydrochloride) | 24357-98-0 | Reference compound |
| HY-16765A | Axelopran (sulfate) | 949904-50-1 | Reference compound |
| HY-16766 | Decoglurant | 911115-16-7 | Reference compound |
| HY-167660 | Glypinamide | 1228-19-9 | Reference compound |
| HY-167661 | 2,3-Dimethoxy-4-(methylthio)benzeneethanamine | 78335-87-2 | Reference compound |
| HY-167662 | Sopromidine | 79313-75-0 | Reference compound |
| HY-167663 | Ebalzotan | 149494-37-1 | Reference compound |
| HY-167664 | KY-455 | 178469-71-1 | Reference compound |
| HY-167665 | Fluprazine | 76716-60-4 | Reference compound |
| HY-167668 | Tipindole | 7489-66-9 | Reference compound |
| HY-167669 | Tioxacin | 34976-39-1 | Reference compound |
| HY-16767 | Doravirine | 1338225-97-0 | Reference compound |
| HY-167671 | BE-10988 | 135261-89-1 | Natural Products |
| HY-167672 | Propizepine | 10321-12-7 | Reference compound |
| HY-167673 | RNF5-IN-1 | 1807639-36-6 | Reference compound |
| HY-167674 | Bmapn | 109453-73-8 | Reference compound |
| HY-167675 | R-137696 | 695185-73-0 | Reference compound |
| HY-167676 | Cofpropamine | 80539-94-2 | Reference compound |
| HY-167677 | ASP-2205 | 1334440-09-3 | Reference compound |
| HY-167679 | Scio-323 | 309913-51-7 | Reference compound |
| HY-16767S1 | Doravirine-13C,d3 | Isotope-Labeled Compounds | |
| HY-16768 | Fevipiprant | 872365-14-5 | Reference compound |
| HY-167680 | Denagliptin | 483369-58-0 | Reference compound |
| HY-167681 | Carprazidil | 68020-77-9 | Reference compound |
| HY-167685 | (E/Z)-Aureusidin | 480-70-6 | Reference compound |
| HY-167686 | Variabilin | 3187-52-8 | Reference compound |
| HY-167687 | (RS)-Minesapride | 1184662-02-9 | Reference compound |
| HY-167688 | GSK-1562590 | 1003877-55-1 | Reference compound |
| HY-167689 | Parethoxycaine (hydrochloride) | 136-46-9 | Reference compound |
| HY-167690 | MK-6186 | 1034474-19-5 | Reference compound |
| HY-167692 | JI069 | 850019-35-1 | Reference compound |
| HY-167694 | Antiproliferative agent-62 | 856435-40-0 | Reference compound |
| HY-167695 | Propiosyringone | 5650-43-1 | Reference compound |
| HY-167696 | 11β-HSD1-IN-16 | 314051-55-3 | Reference compound |
| HY-167697 | Antifungal agent 120 | 387371-82-6 | Reference compound |
| HY-167698 | Dibenamine | 51-50-3 | Reference compound |
| HY-167699 | Cyclodrine | 52109-93-0 | Reference compound |
| HY-16770 | Sarecycline | 1035654-66-0 | Reference compound |
| HY-167701 | OBHSA | 1404508-27-5 | Reference compound |
| HY-167702 | (Rac)-Acetoxyvalerenic acid | 81397-67-3 | Reference compound |
| HY-167704 | NF023 | 99777-90-9 | Reference compound |
| HY-167705 | (R)-7,7'-Dihydrotaiwanin C | 216955-79-2 | Natural Products |
| HY-167706 | Diethyl-Lodoxamide | 53882-13-6 | Reference compound |
| HY-167707 | Q-VD(OMe)-OPh | 402592-44-3 | Reference compound |
| HY-167708 | Valomaciclovir | 195157-34-7 | Reference compound |
| HY-167709 | Azacosterol | 313-05-3 | Reference compound |
| HY-16771 | Valbenazine | 1025504-45-3 | Reference compound |
| HY-167710 | CRCD2 | 941185-83-7 | Reference compound |
| HY-167712 | (2R,3S)-Azelaprag | 2049979-31-7 | Reference compound |
| HY-167714 | Cefazaflur | 58665-96-6 | Reference compound |
| HY-167715 | Traxanox | 58712-69-9 | Reference compound |
| HY-167716 | Zidovudine diphosphate | 106060-89-3 | Reference compound |
| HY-167717 | (Rac)-Eflucimibe | 191791-65-8 | Reference compound |
| HY-167719 | Dersalazine | 188913-58-8 | Reference compound |
| HY-16771A | Valbenazine (tosylate) | 1639208-54-0 | Reference compound |
| HY-16771B | Valbenazine (dihydrochloride) | 1639208-51-7 | Reference compound |
| HY-16772 | EPI-743 | 1213269-98-7 | Reference compound |
| HY-167724 | Laurylmethicone | 139614-44-1 | Reference compound |
| HY-167728 | Taxusin | 19605-80-2 | Oligonucleotides |
| HY-16773 | Vedroprevir | 1098189-15-1 | Reference compound |
| HY-167731 | Monorden diacetate | 100262-15-5 | Reference compound |
| HY-167734 | Pemedolac | 114716-16-4 | Reference compound |
| HY-167735 | Salvizol | 3785-44-2 | Reference compound |
| HY-167736 | (2R)-Naroparcil | 252647-51-1 | Reference compound |
| HY-167737 | (-)-Vorozole | 132042-69-4 | Reference compound |
| HY-167739 | (S,S)-Dehydroemetine | 2649-50-5 | Reference compound |
| HY-16774 | Vericiguat | 1350653-20-1 | Reference compound |
| HY-167740 | Glycerophosphoinositol (lysine) | 425642-33-7 | Reference compound |
| HY-167741 | Chlorisondamine | 69-27-2 | Reference compound |
| HY-167743 | Platelet aggregation-IN-2 | 41552-94-7 | Reference compound |
| HY-167745 | DDR1-IN-9 | 1934246-20-4 | Reference compound |
| HY-167746 | Nevirapine quinone methide | 1061160-22-2 | Reference compound |
| HY-16774R | Vericiguat (Standard) | 1350653-20-1 | Reference Standards |
| HY-16774S | Vericiguat-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-16774S2 | Vericiguat-d6 | Isotope-Labeled Compounds | |
| HY-16775 | Vilaprisan | 1262108-14-4 | Reference compound |
| HY-167759 | Pomalidomide-PEG2-acetic acid | 2143097-05-4 | Reference compound |
| HY-16776 | Censavudine | 634907-30-5 | Reference compound |
| HY-167768 | SOS1 activator 2 | 2245237-54-9 | Reference compound |
| HY-16776A | (2S,5S)-Censavudine | Reference compound | |
| HY-16777 | Entasobulin | 501921-61-5 | Reference compound |
| HY-16779 | Fosravuconazole | 351227-64-0 | Reference compound |
| HY-16779B | Fosravuconazole (L-lysine ethanolate) | 914361-45-8 | Reference compound |
| HY-16780 | Gemilukast | 1232861-58-3 | Reference compound |
| HY-167801 | 2,3,4,6-Tetra-O-pivaloyl-β-D-glucopyranosyl isothiocyanate | 958300-06-6 | Biochemical Assay Reagents |
| HY-167802 | 1-Palmitoyl-propanediol-3-phosphocholine | 68124-68-5 | Biochemical Assay Reagents |
| HY-167803 | N-(2'-(R)-Hydroxynervonoyl)-D-erythro-sphingosine | 1246298-50-9 | Biochemical Assay Reagents |
| HY-167804 | Beclomethasone 21-propionate | 69224-79-9 | Biochemical Assay Reagents |
| HY-167805 | D-Glucose 6-phosphate (potassium) | 103192-55-8 | Biochemical Assay Reagents |
| HY-167806 | N-C16-desoxymethylsphingosine | 1246298-57-6 | Biochemical Assay Reagents |
| HY-167807 | 1-Palmitoyl-2-(6,7-dibromo)stearoyl-sn-glycero-3-phosphocholine | 324054-50-4 | Biochemical Assay Reagents |
| HY-167808 | cis-9,12-Hexadecadienoic acid | 5070-03-1 | Biochemical Assay Reagents |
| HY-167809 | 1-Palmitoyl-2-cholesterylcarbonoyl-sn-glycero-3-phosphocholine | 1085528-78-4 | Biochemical Assay Reagents |
| HY-16781 | Grapiprant | 415903-37-6 | Reference compound |
| HY-167810 | 1,3-Dipentadecanoin(C15:0) | 59891-25-7 | Biochemical Assay Reagents |
| HY-167811 | 1,2-Dipalmitoyl-sn-glycero-3-[phospho-rac-(3-lysyl(1-glycerol))] (hydrochloride) | 1246303-06-9 | Biochemical Assay Reagents |
| HY-167812 | Trimethylsilyl-L-(+)-rhamnose | 108392-01-4 | Biochemical Assay Reagents |
| HY-167813 | 1-O-Palmityl-2-O-methyl-rac-glycero-3-phosphocholine | 85405-05-6 | Biochemical Assay Reagents |
| HY-167814 | Trimethylsilyl-D-(+)-mannitol | 14317-07-8 | Biochemical Assay Reagents |
| HY-167815 | myo-Inositol hexasulfate (hexapotassium) | 28434-25-5 | Biochemical Assay Reagents |
| HY-167816 | 1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine | 253685-28-8 | Biochemical Assay Reagents |
| HY-167817 | 1,2-Dioleoyl-sn-glycero-3-phosphopropanol (sodium) | 384835-46-5 | Biochemical Assay Reagents |
| HY-167818 | Bazedoxifene bis-β-D-glucuronide | 328933-67-1 | Biochemical Assay Reagents |
| HY-167819 | D-Erythro-sphingosyl phosphoinositol | 799812-72-9 | Biochemical Assay Reagents |
| HY-16782 | Pexmetinib | 945614-12-0 | Reference compound |
| HY-167820 | 3-Ketosphingosine | 19767-16-9 | Biochemical Assay Reagents |
| HY-167821 | (5R)-Platyphyllone | 257301-36-3 | Natural Products |
| HY-167822 | Caramboxin | 1531600-36-8 | Reference compound |
| HY-167824 | SSR180711 | 298198-52-4 | Reference compound |
| HY-167825 | Barakol | 24506-68-1 | Natural Products |
| HY-167826 | Spiropidion | 1229023-00-0 | Reference compound |
| HY-167827 | Hsp90-IN-34 | 439588-33-7 | Reference compound |
| HY-167828 | ARN25062 | 3036492-85-7 | Reference compound |
| HY-167830 | SDM-8 | 2242777-37-1 | Reference compound |
| HY-167831 | Vermistatin | 72669-21-7 | Natural Products |
| HY-167832 | PT109 | 2059104-90-2 | Reference compound |
| HY-167834 | Farinomalein A | 1175521-35-3 | Reference compound |
| HY-167835A | Tembetarine (chloride) | 2824-94-4 | Natural Products |
| HY-167836 | BNN-20 | 847-75-6 | Reference compound |
| HY-167837 | Hypolaetin | 27696-41-9 | Natural Products |
| HY-167838 | Coelogin | 82358-31-4 | Reference compound |
| HY-167839 | (R)-JAK2/STAT3-IN-1 | 2485758-49-2 | Reference compound |
| HY-16784 | Samatasvir | 1312547-19-5 | Reference compound |
| HY-167840 | IMMH-010 (maleate) | 2541982-47-0 | Reference compound |
| HY-167841 | Anti-MRSA agent 19 | 667410-81-3 | Reference compound |
| HY-167842 | 22-Thiocyanatosalvinorin A | 1174223-49-4 | Reference compound |
| HY-167843 | Alborixin | 57760-36-8 | Natural Products |
| HY-167845 | LD03-DEX | 2102449-40-9 | Reference compound |
| HY-167846 | YLIU-4-105-1 | 2417685-83-5 | Reference compound |
| HY-167847 | IRI-514 | 147489-65-4 | Reference compound |
| HY-167848 | DMP-728 (free base) | 153345-74-5 | Reference compound |
| HY-167849 | Sofpironium (tosylate) | 2409055-48-5 | Reference compound |
| HY-16785 | Veledimex | 1093130-72-3 | Reference compound |
| HY-167850 | Noberastine (maleate) | 111922-05-5 | Reference compound |
| HY-167851 | CCX662 | 1226686-54-9 | Reference compound |
| HY-167852 | GX-585 | 2098540-08-8 | Reference compound |
| HY-167853 | KR-31080 | 174800-22-7 | Reference compound |
| HY-167854 | KW-2450 (free base) | 904899-25-8 | Reference compound |
| HY-167855 | MRS4833 | 2801627-78-9 | Reference compound |
| HY-167856 | RTI-122 | 3034664-39-3 | Reference compound |
| HY-167857 | (Rac)-Glutipyran | 350993-69-0 | Reference compound |
| HY-167858 | LK-732 | 673485-33-1 | Reference compound |
| HY-167859 | Hispidulin 7-glucuronide | 31105-76-7 | Natural Products |
| HY-16785A | Veledimex (racemate) | 755013-59-3 | Reference compound |
| HY-16785B | Veledimex (S enantiomer) | 1093131-03-3 | Reference compound |
| HY-16786 | AI-10-49 | 1256094-72-0 | Reference compound |
| HY-167860 | BE-12406B | 132417-97-1 | Natural Products |
| HY-167861 | Acefurtiamine | 10072-48-7 | Reference compound |
| HY-167862 | UCM-05194 | 2411412-36-5 | Reference compound |
| HY-167863 | Piritrexim (isethionate) | 79483-69-5 | Reference compound |
| HY-167864 | M4K2308 | 3034840-18-8 | Reference compound |
| HY-167865 | O-1269 | 336615-64-6 | Reference compound |
| HY-167866 | Ersentilide | 125279-79-0 | Reference compound |
| HY-167867 | Utibaprilat | 109683-79-6 | Reference compound |
| HY-167868 | DWP-05195 | 904309-12-2 | Reference compound |
| HY-167869 | A-849529 | 819058-88-3 | Reference compound |
| HY-16787 | ICA-121431 | 313254-51-2 | Reference compound |
| HY-167870 | Piceatannol 4'-O-glucoside | 116181-54-5 | Natural Products |
| HY-167871 | BRD4 Inhibitor-36 | 2247236-61-7 | Reference compound |
| HY-167872 | Bifeprofen | 108210-73-7 | Oligonucleotides |
| HY-167873 | Habenariol | 216752-89-5 | Reference compound |
| HY-167874 | ASP-8731 | 2488255-42-9 | Reference compound |
| HY-167875 | Neflumozide | 86636-93-3 | Reference compound |
| HY-167876 | PQR514 | 1927857-55-3 | Reference compound |
| HY-167877 | PS-166276 | 348089-57-6 | Reference compound |
| HY-167878 | Pentomone | 67102-87-8 | Reference compound |
| HY-167879 | (Rac)-NPD6433 | 895908-81-3 | Reference compound |
| HY-167879A | NPD6433 | Reference compound | |
| HY-167880 | BMY-25551 | 105139-98-8 | Reference compound |
| HY-167881 | MLS-0053105 | 370572-36-4 | Reference compound |
| HY-167884 | PF-1367550 | 319461-60-4 | Natural Products |
| HY-167885 | SN-35210 (free base) | 1450615-41-4 | Natural Products |
| HY-167886 | GA 0113 | 200639-61-8 | Reference compound |
| HY-167887 | 7PPD-Q | 2894124-00-4 | Reference compound |
| HY-167888 | NPD4928 | 956965-61-0 | Reference compound |
| HY-167890 | Flufenoxadiazam | 1839120-27-2 | Reference compound |
| HY-167891 | GPD-1116 | 690690-72-3 | Reference compound |
| HY-167892 | DRF-8417 | 439903-56-7 | Reference compound |
| HY-167893 | AGH-107 | 2172907-10-5 | Reference compound |
| HY-167894 | DA-8031 | 1148027-74-0 | Reference compound |
| HY-167895 | Terfluranol | 64396-09-4 | Reference compound |
| HY-167896 | Hepzidine | 1096-72-6 | Reference compound |
| HY-167897 | UR-AK49 | 902154-32-9 | Reference compound |
| HY-167898 | MeS-IMPY | 955376-42-8 | Reference compound |
| HY-167899 | PXT-012253 | 1835647-08-9 | Reference compound |
| HY-167900 | CMV-423 | 186829-19-6 | Reference compound |
| HY-167901 | Dinoxyline | 757176-96-8 | Reference compound |
| HY-167902 | YM-31636 (free base) | 159081-22-8 | Reference compound |
| HY-167903 | Tesimide | 35423-09-7 | Reference compound |
| HY-167904 | Iosefamate (meglumine) | 80234-74-8 | Reference compound |
| HY-167905 | ATL444 | 867054-13-5 | Reference compound |
| HY-167906 | Lunamarine | 483-52-3 | Reference compound |
| HY-167911 | Cidofovir (sodium) | 127749-27-3 | Reference compound |
| HY-167915 | Fosopamine (hydrochloride) | 135962-35-5 | Reference compound |
| HY-167919 | 1-(1-Adamantyl)-3-butyl-2-thiourea | 25444-87-5 | Reference compound |
| HY-167920 | Glutathione sulfonate | 1637-70-3 | Reference compound |
| HY-167922 | (R,R,S)-GAT107 | 1426240-47-2 | Reference compound |
| HY-167924 | Ono 3307 (free base) | 76472-28-1 | Reference compound |
| HY-167925 | Rec 15/2615 | 173059-47-7 | Reference compound |
| HY-167926 | 3-Bromo-4,5-dihydroxybenzoic acid methyl ester | 65841-10-3 | Natural Products |
| HY-167927 | Mefuparib | 1392502-82-7 | Reference compound |
| HY-167931 | Cinnamohydrazide | 3538-69-0 | Reference compound |
| HY-167932 | Mifepristone methochloride | 109345-60-0 | Reference compound |
| HY-167933 | (Rac)-Sabcomeline (hydrochloride) | 133642-67-8 | Reference compound |
| HY-167934 | Isomer-CM 352 | 1542205-84-4 | Reference compound |
| HY-167935 | LCC-12 (formic) | 3029253-76-4 | Reference compound |
| HY-167936 | cis-AY 9944 | 1245-84-7 | Reference compound |
| HY-167937 | Propyl-GSK2793660 | 1613458-71-1 | Reference compound |
| HY-167938 | (E/Z)-PG-11047 | 949933-50-0 | Reference compound |
| HY-167939 | (R)-Bambuterol | 788821-30-7 | Reference compound |
| HY-167945 | AMD-3329 | 170861-87-7 | Reference compound |
| HY-167946 | CP-866087 | 519052-04-1 | Reference compound |
| HY-167947 | (Rac)-Sabcomeline | 149156-36-5 | Reference compound |
| HY-167948 | Dacomitinib metabolite M1/2 | 1262034-38-7 | Reference compound |
| HY-167950 | PPARα/γ agonist 5 | 849150-59-0 | Reference compound |
| HY-167952 | mTOR inhibitor-25 | 1144075-34-2 | Reference compound |
| HY-167989 | Orenasitecan | 2418533-89-6 | Reference compound |
| HY-167993 | (R)-GNA-T phosphoramidite | 851050-23-2 | Reference compound |
| HY-168001 | TcNTPDase1-IN-1 | 1332833-27-8 | Reference compound |
| HY-168002 | MPO-IN-8 | 62578-87-4 | Reference compound |
| HY-168003 | ADAMTS7-IN-1 | Reference compound | |
| HY-168004 | FolB-IN-1 | Reference compound | |
| HY-168005 | NSC799462 | Reference compound | |
| HY-168006 | NSC819701 | Reference compound | |
| HY-168007 | NSC804515 | Reference compound | |
| HY-168008 | P-gp inhibitor 25 | 3031431-31-6 | Reference compound |
| HY-168009 | NLRP3-IN-45 | Reference compound | |
| HY-168011 | GPX4-IN-14 | Reference compound | |
| HY-168012 | Pan-RAS-IN-6 | Reference compound | |
| HY-168013 | KRASG12C IN-14 | Reference compound | |
| HY-168014 | 5-Methylthio DMT | 5102-11-4 | Reference compound |
| HY-168015 | 5-Oxo leukotriene B4 | 195061-92-8 | Reference compound |
| HY-168016 | PROTAC YAP degrader-1 | 3058483-58-9 | Reference compound |
| HY-168017 | NSC682769 | 205048-79-9 | Reference compound |
| HY-168018 | Demethyl-NSC682769 | Reference compound | |
| HY-168019 | (S,R,S)-AHPC-PEG2-C2-boc | 2923734-95-4 | Reference compound |
| HY-168020 | SJ-106C | Reference compound | |
| HY-168021 | MAO-A/SERT-IN-1 | 3001361-38-9 | Reference compound |
| HY-168022 | CAM2602 | 3056388-47-4 | Reference compound |
| HY-168023 | NOD1-IN-1 | 687627-78-7 | Reference compound |
| HY-168024 | NOD1/2-IN-1 | Reference compound | |
| HY-168025 | VU6007496 | 2127101-85-1 | Reference compound |
| HY-168026 | CEP1347-VHL-02 | Reference compound | |
| HY-168027 | CEP-1347-acid | 874098-83-6 | Reference compound |
| HY-168028 | mGluR2 modulator 5 | 1639898-35-3 | Reference compound |
| HY-168030 | hCAIX-IN-23 | Reference compound | |
| HY-168031 | AChE/BChE-IN-21 | 2756368-79-1 | Reference compound |
| HY-168032 | MAGL-IN-18 | 3036792-74-9 | Reference compound |
| HY-168033 | AhR agonist 8 | 3036895-67-4 | Reference compound |
| HY-168034 | diABZI-4 | 2138299-65-5 | Reference compound |
| HY-168035 | W4275 | 3051650-00-8 | Reference compound |
| HY-168036 | PIN1 inhibitor 3 | 3039570-04-9 | Reference compound |
| HY-168037 | PROTAC PIN1 degrader-1 | 3038591-59-9 | Reference compound |
| HY-168038 | PIN1 ligand-1 | 3038591-92-0 | Reference compound |
| HY-168039 | Boc-NH-Piperidine-C5-OH | 1229442-84-5 | Reference compound |
| HY-168040 | Thalidomide-O-C5-piperidine-NH-Boc | Reference compound | |
| HY-168041 | LRRK2-IN-15 | Reference compound | |
| HY-168042 | Antibacterial agent 243 | Reference compound | |
| HY-168043 | STAT3-IN-35 | 2849535-96-0 | Reference compound |
| HY-168044 | ALKBH1-IN-3 | Reference compound | |
| HY-168045 | HBV-IN-48 | 2743466-04-6 | Reference compound |
| HY-168046 | ALG-055009 | 2542029-03-6 | Reference compound |
| HY-168047 | EBOV-IN-10 | 3040400-51-6 | Reference compound |
| HY-168048 | ZINC09518833 | 893983-51-2 | Reference compound |
| HY-168049 | ZLY06 | 2834727-04-5 | Reference compound |
| HY-168050 | nsP2 Protease-IN-1 | Reference compound | |
| HY-168051 | TLX agonist 2 | Reference compound | |
| HY-168052 | hAChE-IN-9 | Reference compound | |
| HY-168053 | HMGB1-IN-3 | 5195-71-1 | Reference compound |
| HY-168054 | PROTAC K-Ras Degrader-3 | 3043670-68-1 | Reference compound |
| HY-168055 | (S)-Deoxy-thalidomide | 107657-57-8 | Reference compound |
| HY-168056 | KRAS ligand 5 | 3043896-37-0 | Reference compound |
| HY-168057 | PROTAC CDK2 Degrader-1 | 3024971-78-3 | Reference compound |
| HY-168058 | WXC-25 | Reference compound | |
| HY-168059 | JAK3-IN-15 | Reference compound | |
| HY-168060 | (8R)-8-Hydroxyepoxyboetirane A | Reference compound | |
| HY-168061 | HldA/E-IN-1 | 2593325-52-9 | Reference compound |
| HY-168062 | ZYZ-17 | Reference compound | |
| HY-168063 | Antibiofilm agent-11 | Reference compound | |
| HY-168064 | EGFR-IN-124 | Reference compound | |
| HY-168065 | Keap1-Nrf2-IN-22 | 2955083-85-7 | Reference compound |
| HY-168066 | Antifungal agent 117 | Reference compound | |
| HY-168067 | CDK-IN-14 | Reference compound | |
| HY-168068 | Res-Glu3 | Reference compound | |
| HY-168069 | DHFR-IN-20 | Reference compound | |
| HY-168070 | COX-2-IN-48 | Reference compound | |
| HY-168071 | Pim-1 kinase inhibitor 11 | Reference compound | |
| HY-168072 | GP130-IN-1 | 2955243-69-1 | Reference compound |
| HY-168073 | EGFR/VEGFR2-IN-1 | Reference compound | |
| HY-168074 | 4″-C18 EGCG | Reference compound | |
| HY-168075 | Boc-PIP-Me-CH2-2,7-diazaspiro[3.5]nonane | Reference compound | |
| HY-168076 | (S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-CH2-Me-PIP-Boc | 3043672-77-8 | Reference compound |
| HY-168077 | Antibiofilm agent-12 | 480452-24-2 | Reference compound |
| HY-168078 | PD-1/PD-L1-IN-50 | Reference compound | |
| HY-168079 | GSK-3β inhibitor 21 | Reference compound | |
| HY-168080 | PD-1/PD-L1-IN-51 | Reference compound | |
| HY-168081 | PD-1/PD-L1-IN-52 | 2856391-46-1 | Reference compound |
| HY-168082 | Dot1L-IN-8 | Reference compound | |
| HY-168083 | Dot1L-IN-9 | Reference compound | |
| HY-168084 | IL-17-IN-1 | Reference compound | |
| HY-168085 | CV-4-26 | Reference compound | |
| HY-168086 | LSD1-IN-35 | 2992690-04-5 | Reference compound |
| HY-168087 | GSK3335103 | 1893340-21-0 | Reference compound |
| HY-168088 | DNMT1/HDAC-IN-1 | Reference compound | |
| HY-168089 | NLRP3-IN-49 | Reference compound | |
| HY-168090 | Anti-osteoporosis agent-11 | 2869099-50-1 | Reference compound |
| HY-168091 | YM-I-26 | 2585015-90-1 | Reference compound |
| HY-168092 | VS-15 | 951948-78-0 | Reference compound |
| HY-168093 | Cetzole | 3043764-86-6 | Reference compound |
| HY-168094 | PARP1-IN-30 | 908803-38-3 | Reference compound |
| HY-168095 | CXCR4 antagonist 10 | Reference compound | |
| HY-168096 | iNOs-IN-5 | Reference compound | |
| HY-168097 | Ferroptosis inducer-6 | 2933939-15-0 | Reference compound |
| HY-168098 | P2Y6R antagonist 1 | Reference compound | |
| HY-168099 | ERα degrader 10 | Reference compound | |
| HY-168100 | LpxC-IN-14 | Reference compound | |
| HY-168101 | ERα degrader 11 | 3052336-87-2 | Reference compound |
| HY-168102 | Antiproliferative agent-59 | Reference compound | |
| HY-168103 | FBPase-IN-3 | Reference compound | |
| HY-168104 | VEGFR-2-IN-55 | Reference compound | |
| HY-168105 | RET-IN-27 | Reference compound | |
| HY-168106 | ZMF-24 | Reference compound | |
| HY-168107 | SARS-CoV-2-IN-98 | Reference compound | |
| HY-168108 | Antifungal agent 115 | Reference compound | |
| HY-168109 | Antibacterial agent 246 | Reference compound | |
| HY-168110 | HPK1-IN-52 | 2994298-66-5 | Reference compound |
| HY-168111 | BNZ-111 | 3022361-60-7 | Reference compound |
| HY-168112 | EGFR-IN-127 | Reference compound | |
| HY-168113 | Antiproliferative agent-60 | Reference compound | |
| HY-168114 | Multi-kinase inhibitor 3 | 2648279-76-7 | Reference compound |
| HY-168115 | Multi-kinase inhibitor 4 | 2648279-77-8 | Reference compound |
| HY-168116 | RIPK1-IN-27 | Reference compound | |
| HY-168117 | HP-101 | Reference compound | |
| HY-168118 | Ferroptosis-IN-14 | Reference compound | |
| HY-168119 | HPK1-IN-53 | Reference compound | |
| HY-168120 | Carvacrol-C4-3-hydroxybenzoic acid | Reference compound | |
| HY-168121 | USP7-IN-15 | Reference compound | |
| HY-168122 | Apoptosis inducer 29 | Reference compound | |
| HY-168123 | Antitubercular agent-47 | 2956713-87-2 | Reference compound |
| HY-168124 | Carbonic anhydrase inhibitor 26 | Reference compound | |
| HY-168125 | JNK-IN-18 | Reference compound | |
| HY-168126 | VEGFR-2-IN-56 | Reference compound | |
| HY-168127 | VEGFR-2-IN-57 | Reference compound | |
| HY-168128 | Tubulin polymerization-IN-69 | Reference compound | |
| HY-168129 | GSK3β/mTOR modulator 1 | Reference compound | |
| HY-168130 | TNF-α/IL-1β-IN-1 | Reference compound | |
| HY-168131 | PROTAC EZH2 Degrader-3 | Reference compound | |
| HY-168132 | Thalidomide-NH-C-C6H10-C-acid | Reference compound | |
| HY-168133 | SIRT2-IN-16 | Reference compound | |
| HY-168134 | CDK-IN-15 | 3036232-03-5 | Reference compound |
| HY-168135 | PROTAC c-Met degrader-1 | 3056647-52-7 | Reference compound |
| HY-168136 | NOD2 agonist 1 | Reference compound | |
| HY-168137 | NOD2 agonist 2 | Reference compound | |
| HY-168138 | MAO-B-IN-34 | 86710-21-6 | Reference compound |
| HY-168139 | MRS4865 | 2801624-14-4 | Reference compound |
| HY-168140 | TGR5 agonist 6 | 2925211-47-6 | Reference compound |
| HY-168141 | Androgen receptor antagonist 11 | 2719816-32-5 | Reference compound |
| HY-168142 | YD1130 | Reference compound | |
| HY-168143 | YD1342 | Reference compound | |
| HY-168144 | DJ-53 | Reference compound | |
| HY-168145 | MAGL-IN-19 | 2411570-42-6 | Reference compound |
| HY-168146 | NADH-IN-2 | 67273-56-7 | Reference compound |
| HY-168147 | Enpp-1-IN-24 | Reference compound | |
| HY-168148S | CZL-046 | 3032444-02-0 | Isotope-Labeled Compounds |
| HY-168149 | Mip-IN-2 | Reference compound | |
| HY-168150 | Topoisomerase I/II inhibitor 5 | Reference compound | |
| HY-168151 | EGFR-IN-128 | Reference compound | |
| HY-168152 | SARS-CoV-2 3CLpro-IN-26 | Reference compound | |
| HY-168153 | HDAC-IN-80 | Reference compound | |
| HY-168154 | COMT-IN-2 | Reference compound | |
| HY-168155 | Mps1-IN-9 | Reference compound | |
| HY-168156 | PCSK9-IN-32 | Reference compound | |
| HY-168157 | TLR7 agonist 26 | 1641544-09-3 | Reference compound |
| HY-168158 | NOD2 agonist 3 | 2289702-58-3 | Reference compound |
| HY-168159 | TLR7 agonist 27 | Reference compound | |
| HY-168161 | Keap1-Nrf2-IN-23 | 2771115-65-0 | Reference compound |
| HY-168162 | ZLC491 | 3053716-46-1 | Reference compound |
| HY-168163 | CDK12/13 ligand 1 | 2244986-40-9 | Reference compound |
| HY-168164 | 4-Methoxycinnamyl alcohol | 53484-50-7 | Reference compound |
| HY-168165 | Adefovir diphosphate | 129556-87-2 | Reference compound |
| HY-168166 | CHET3 | 2489231-47-0 | Reference compound |
| HY-168167 | BuChE-IN-14 | 38455-99-1 | Reference compound |
| HY-168168 | (5aS,6R,6aR)-MK-8666 | 1544739-76-5 | Reference compound |
| HY-168169 | hMAO-B-IN-10 | Reference compound | |
| HY-168170 | EGFR/VEGFR2-IN-2 | Reference compound | |
| HY-168171 | ERK1/2 inhibitor 11 | Reference compound | |
| HY-168172 | LDH-IN-3 | Reference compound | |
| HY-168173 | EGFR-IN-130 | Reference compound | |
| HY-168175 | PROTAC HDAC8 Degrader-2 | Reference compound | |
| HY-168176 | HDAC8 ligand 1 | Reference compound | |
| HY-168177 | ROS-IN-3 | Reference compound | |
| HY-168178 | Hsp110-STAT3 interaction-IN-2 | Reference compound | |
| HY-168179 | RORγt inverse agonist 32 | 2301159-96-4 | Reference compound |
| HY-168180 | WEE1-IN-11 | 2975172-98-4 | Reference compound |
| HY-168181 | ERAP1-IN-2 | Reference compound | |
| HY-168182 | Menin-MLL inhibitor 34 | Reference compound | |
| HY-168183 | MG28 | 2659360-91-3 | Reference compound |
| HY-168184 | WJM280 | Reference compound | |
| HY-168185 | α-glucosidase/PTP1B-IN-1 | Reference compound | |
| HY-168186 | P-gp inhibitor 26 | 3055666-79-7 | Reference compound |
| HY-168187 | Src Inhibitor 3 | Reference compound | |
| HY-168188 | CYP51-IN-21 | 3053864-59-5 | Reference compound |
| HY-168189 | HIV-1 inhibitor-76 | Reference compound | |
| HY-168190 | PROTAC TBL1X degrader-1 | Reference compound | |
| HY-168191 | TBL1X ligand 1 | 1083160-12-6 | Reference compound |
| HY-168192 | Thalidomide-NH-C4-amide-C3-Br | Reference compound | |
| HY-168193 | 5-Amino-N-(3-bromopropyl)pentanamide | 2848129-72-4 | Reference compound |
| HY-168195 | DYR530 | 2410298-39-2 | Reference compound |
| HY-168197 | Thalidomide-F-piperidine-piperazine-Cbz | Reference compound | |
| HY-168200 | 1-(5-Iodo-2-pyridinyl)-4-piperidinecarboxylic acid | 2037137-82-7 | Reference compound |
| HY-168201 | MJP6412 | Reference compound | |
| HY-168202 | CCS1477a | Reference compound | |
| HY-168203 | Thalidomide-piperidine-O-Ph-NH2 | Reference compound | |
| HY-168204 | 3-Acetyl-28-N-(3-guanidinobutoxy)-oleanolic acid | Reference compound | |
| HY-168205 | HSP90-IN-33 | Reference compound | |
| HY-168206 | Autophagy-IN-6 | Reference compound | |
| HY-168207 | TH023 | Reference compound | |
| HY-168208 | Antimalarial agent 45 | Reference compound | |
| HY-168209 | LBM22 | Reference compound | |
| HY-168210 | Antifungal agent 122 | 3054212-80-2 | Reference compound |
| HY-168211 | LQ-38 | Reference compound | |
| HY-168212 | PDE4-IN-22 | Reference compound | |
| HY-168213 | FLT3-IN-27 | Reference compound | |
| HY-168214 | Kv7.2/Kv7.3 agonist 1 | 2315450-35-0 | Reference compound |
| HY-168215 | YDR1 | 2951015-31-7 | Reference compound |
| HY-168217 | Thalidomide-piperazine-piperidine-2-F-Ph-CHO | Reference compound | |
| HY-168218 | Boc-Piperazine-piperidine-2-F-Ph-CHO | 2951015-64-6 | Reference compound |
| HY-168219 | JMS-175-2 | 3042887-70-4 | Reference compound |
| HY-168220 | FX-171-C | 3042887-97-5 | Reference compound |
| HY-168221 | YD54 | 2951015-30-6 | Reference compound |
| HY-168222 | Thalidomide-PEG1-OTs | 2850354-04-8 | Reference compound |
| HY-168223 | Boc-Piperazine-2-F-Ph-CHO | 501126-37-0 | Reference compound |
| HY-168224 | Thalidomide-PEG1-piperazine-2-F-Ph-CHO | Reference compound | |
| HY-168225 | PROTAC SMARCA2/4-degrader-35 | 2933253-85-9 | Reference compound |
| HY-168226 | E3 ligase Ligand 34 | 2931870-73-2 | Reference compound |
| HY-168227 | trans-Boronic acid pinacol-pyrazole-C-cyclobutane-O-piperidine-Boc | 2933254-71-6 | Reference compound |
| HY-168228 | E3 Ligase Ligand-linker Conjugate 123 | Reference compound | |
| HY-168229 | PROTAC SMARCA2 degrader-27 | 2410314-57-5 | Reference compound |
| HY-168230 | SMARCA2 ligand-9 | 1997320-33-8 | Reference compound |
| HY-168231 | trans-Boc-Piperidine-C-PIP-O-cyclobutane-OH | Reference compound | |
| HY-168232 | E3 ligase Ligand 35 | Reference compound | |
| HY-168233 | E3 Ligase Ligand-linker Conjugate 124 | Reference compound | |
| HY-168234 | PROTAC SMARCA2 degrader-31 | 2380274-45-1 | Reference compound |
| HY-168235 | (S,R,S)-AHPC-Me-amide-C9-acid | 2376139-66-9 | Reference compound |
| HY-168236 | PROTAC SMARCA2 degrader-28 | 2641510-88-3 | Reference compound |
| HY-168237 | SMARCA2 ligand-10 | 3024271-84-6 | Reference compound |
| HY-168238 | (4-(3-Bromobenzyl)piperazin-1-yl)(piperidin-4-yl)methanone | Reference compound | |
| HY-168239 | Thalidomide-piperidine-CO-piperazine-C-3-Br-Ph | Reference compound | |
| HY-168240 | NMDAR antagonist 2 | Reference compound | |
| HY-168241 | Flucopride | 1639925-34-0 | Reference compound |
| HY-168242 | PROTAC BRM/BRG1 degrader-1 | 2724268-88-4 | Reference compound |
| HY-168243 | E3 ligase Ligand 36 | 3031995-12-4 | Reference compound |
| HY-168244 | TsO-C2-Piperidine-O-azetidine-CO-Ph-C2-OH | Reference compound | |
| HY-168245 | E3 Ligase Ligand-linker Conjugate 126 | Reference compound | |
| HY-168246 | PROTAC SMARCA2 degrader-29 | 2865193-25-3 | Reference compound |
| HY-168247 | PROTAC BRM/BRG1 degrader-2 | 2933124-32-2 | Reference compound |
| HY-168248 | BRM/BRG1 ligand 2 | 2933125-88-1 | Reference compound |
| HY-168249 | trans-4-(2-Chloropyrimidin-5-yl)cyclohexanecarboxylic acid | Reference compound | |
| HY-168250 | trans-(S,R,S)-AHPC-Me-Amide-cyclohexane-pyrimidine-Cl | Reference compound | |
| HY-168251 | PROTAC BRM/BRG1 degrader-3 | 2933125-05-2 | Reference compound |
| HY-168252 | BRM/BRG1 ligand 3 | 2933126-51-1 | Reference compound |
| HY-168253 | E3 ligase Ligand 37 | Reference compound | |
| HY-168254 | E3 Ligase Ligand-linker Conjugate 127 | 2410316-12-8 | Reference compound |
| HY-168255 | PROTAC BRM/BRG1 degrader-4 | Reference compound | |
| HY-168256 | E3 Ligase Ligand-linker Conjugate 128 | 2933127-18-3 | Reference compound |
| HY-168257 | PROTAC SMARCA2 degrader-30 | 2408393-67-7 | Reference compound |
| HY-168258 | Antibiofilm agent-13 | Reference compound | |
| HY-168259 | PLpro-IN-8 | Reference compound | |
| HY-168260 | CQ-Mito | Reference compound | |
| HY-168261 | CQ-ER | Reference compound | |
| HY-168262 | Antitrypanosomal agent 22 | Reference compound | |
| HY-168263 | PRMT5-IN-45 | Reference compound | |
| HY-168264 | MC1 | Reference compound | |
| HY-168265 | Dyrk1A-IN-11 | 3058626-26-6 | Reference compound |
| HY-168266 | MS1172 | 3058588-43-2 | Reference compound |
| HY-168267 | XH161-180 | 3058588-52-3 | Reference compound |
| HY-168268 | c-Met-IN-26 | 1635406-97-1 | Reference compound |
| HY-168269 | Tyk2-IN-20 | 3058568-08-1 | Reference compound |
| HY-168270 | PROTAC ER Degrader-11 | 2846112-04-5 | Reference compound |
| HY-168271 | ER ligand-2 | Reference compound | |
| HY-168272 | (3S)Lenalidomide-piperazine-C-piperidine | 2520107-24-6 | Reference compound |
| HY-168273 | Glutaminyl cyclases-IN-2 | Reference compound | |
| HY-168274 | PROTAC TRIB2 degrader-1 | Reference compound | |
| HY-168275 | TRIB2 ligand-1 | 2652012-89-8 | Reference compound |
| HY-168276 | Boc-Nonanol | 3036972-61-6 | Reference compound |
| HY-168277 | 5-Aminothalidomide-C9-Boc | 3053782-32-1 | Reference compound |
| HY-168278 | Ga-CY03 | Reference compound | |
| HY-168279 | VEGF-IN-1 | Reference compound | |
| HY-168280 | AS1411-C4-VH032 | Reference compound | |
| HY-168281 | P6P-10,10 | Reference compound | |
| HY-168282 | DD205-291 | 3047066-15-6 | Reference compound |
| HY-168283 | HPK1 ligand 2 | Reference compound | |
| HY-168284 | E3 Ligase Ligand-linker Conjugate 129 | Reference compound | |
| HY-168285 | LE01 | 2718125-83-6 | ADC Related |
| HY-168286 | FGFR-IN-16 | 2170748-42-0 | Reference compound |
| HY-168287 | HDAC3/8 ligand-1 | Reference compound | |
| HY-168288 | MEK ligand-2 | 212631-56-6 | Reference compound |
| HY-168289 | 12-((4-Bromobutyl)amino)dodecanoic acid | Reference compound | |
| HY-168290 | (S,R,S)-AHPC-Me-12-((4-Bromobutyl)amino)dodecanamide | Reference compound | |
| HY-168291 | Thalidomide-NH-CH2-CONH-C6-Br | Reference compound | |
| HY-168292 | BTK ligand 9 | 1709786-35-5 | Reference compound |
| HY-168293 | p62-ZZ ligand 1 | 2409960-13-8 | Reference compound |
| HY-168294 | D-Galacturonate | 552-12-5 | Reference compound |
| HY-168295 | p62-ZZ Ligand-Linker Conjugate 1 | 2410081-73-9 | Reference compound |
| HY-168296 | AR ligand-29 | 88378-55-6 | Reference compound |
| HY-168297 | Piperidine-C2-Pip-C-COOH | Reference compound | |
| HY-168298 | Lenalidomide-6-F-piperidine-C2-Pip-C-COOH | Reference compound | |
| HY-168299 | AR ligand-30 | 2505498-73-5 | Reference compound |
| HY-168300 | Antiangiogenic agent 7 | 2527888-07-7 | Reference compound |
| HY-168301 | CL-13 | Reference compound | |
| HY-168302 | BTK ligand 10 | Reference compound | |
| HY-168303 | (S)-4-(1-(Pyrrolidin-3-ylmethyl)piperidin-4-yl)aniline | Reference compound | |
| HY-168304 | (R)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 | Reference compound | |
| HY-168305 | EGFR ligand-11 | 2550394-08-4 | Reference compound |
| HY-168306 | 8-Iodooctan-1-amine | Reference compound | |
| HY-168307 | Me-Thalidomide-O-C8-NH2 | 2550393-20-7 | Reference compound |
| HY-168308 | (S)-Deoxy-thalidomide-Br | Reference compound | |
| HY-168309 | 7-(Piperidin-4-ylmethyl)-2,7-diazaspiro[3.5]nonane | 2894098-26-9 | Reference compound |
| HY-168310 | (S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-C-Pip | Reference compound | |
| HY-168311 | PROTAC IRAK4 ligand-5 | 2654056-24-1 | Reference compound |
| HY-168312 | Thalidomide-NH-C2-2-azaspiro[3.3]heptane | 2573305-00-5 | Reference compound |
| HY-168313 | 2-(2-Azaspiro[3.3]heptan-6-yl)ethanamine | Reference compound | |
| HY-168314 | BTK ligand 11 | Reference compound | |
| HY-168315 | (5-(Bromomethyl)pyrazin-2-yl)methanol | Reference compound | |
| HY-168316 | E3 Ligase Ligand-linker Conjugate 146 | Reference compound | |
| HY-168317 | LNK2-S | 2983134-61-6 | ADC Related |
| HY-168318 | Bestatin-amide-PEG3-CH2-acid | Reference compound | |
| HY-168319 | PI3Kγ ligand 1 | 2769753-45-7 | Reference compound |
| HY-168320 | N-Stearoyltyrosine | 57993-25-6 | Reference compound |
| HY-168321 | 6-Hydroxy-2′-methoxyflavone | 61546-59-6 | Reference compound |
| HY-168322 | 2-Hydroxy nile red (trifluoromethanesulfonate) | 888327-74-0 | Oligonucleotides |
| HY-168323 | UP163 | 591242-60-3 | Reference compound |
| HY-168324 | UP158 | 489402-33-7 | Reference compound |
| HY-168325 | UP12 | 443353-87-5 | Reference compound |
| HY-168326 | Antiproliferative agent-64 | 1139263-21-0 | Reference compound |
| HY-168327 | LH10 | Reference compound | |
| HY-168328 | FKK6 | 2238839-34-2 | Reference compound |
| HY-168329 | TGR5 agonist 7 | Reference compound | |
| HY-168331 | FXR agonist 10 | Reference compound | |
| HY-168332 | FXR agonist 11 | 2768502-17-4 | Reference compound |
| HY-168333 | 5-HT6 inverse agonist 1 | 2727088-38-0 | Reference compound |
| HY-168334 | 5-HT2C agonist-4 | 2730085-33-1 | Reference compound |
| HY-168335 | hDHODH-IN-16 | Reference compound | |
| HY-168336 | E0924G | 2909474-29-7 | Reference compound |
| HY-168337 | SET-171 | 3052985-32-4 | Reference compound |
| HY-168338 | CB2 receptor agonist 8 | Reference compound | |
| HY-168339 | Tyk2-IN-22 | 933667-23-3 | Reference compound |
| HY-168340 | COX-2/15-LOX-IN-6 | Reference compound | |
| HY-168341 | sGC activator 2 | Reference compound | |
| HY-168342 | Anti-Trypanosoma cruzi agent-6 | Reference compound | |
| HY-168343 | Ga-DOTA-Olmutinib | Reference compound | |
| HY-168344 | CACPD2011a-0001278239 | 1030781-08-8 | Reference compound |
| HY-168345 | Ap4dT | 1146545-74-5 | Reference compound |
| HY-168346 | TS-002455 | 2702331-04-0 | Reference compound |
| HY-168347 | TH152 | 1622917-95-6 | Reference compound |
| HY-168348 | (R)-4-(1-(Pyrrolidin-3-ylmethyl)piperidin-4-yl)aniline | Reference compound | |
| HY-168349 | (S)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 | Reference compound | |
| HY-168350 | Chlorphine | 6440-26-2 | Reference compound |
| HY-168351 | Fluorphine | 6440-42-2 | Reference compound |
| HY-168352 | Orphine | 59708-49-5 | Reference compound |
| HY-168354 | Desmethylflutiazepam | 41191-07-5 | Reference compound |
| HY-168355 | Δ8-THC methyl ether | 1451-20-3 | Reference compound |
| HY-168357 | Cannabiphorol | 55824-14-1 | Reference compound |
| HY-168358 | 4'-Fluoro diazepam | 52357-79-6 | Reference compound |
| HY-168360 | Bufotenidine (iodide) | 5787-02-0 | Reference compound |
| HY-168361 | 8β-Hydroxy-exo-THC | 52522-55-1 | Reference compound |
| HY-168362 | Tetrahydrocannabivarin acetate | 885123-57-9 | Reference compound |
| HY-168363 | Ciclotizolam | 58765-21-2 | Reference compound |
| HY-168364 | 1(R),2(S)-epoxy Cannabidiol | 2345666-26-2 | Reference compound |
| HY-168365 | (±)-Pellotine (hydrochloride) | 26126-01-2 | Reference compound |
| HY-168366 | R-6890 | 3222-88-6 | Reference compound |
| HY-168367 | 2-Hydroxyethylflurazepam | 20971-53-3 | Reference compound |
| HY-168368 | exo-Tetrahydrocannabivarin | 137008-69-6 | Reference compound |
| HY-168369 | Anti-inflammatory agent 94 | 501927-29-3 | Reference compound |
| HY-168370 | YHS-12 | 2959463-68-2 | Reference compound |
| HY-168371 | 1-Palmitoyl-2-13(S)-HODE-sn-glycero-3-PC | 161923-56-4 | Reference compound |
| HY-168372 | 1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC | 92345-33-0 | Natural Products |
| HY-168373 | 1-Stearoyl-2-Eicosapentaenoyl-sn-glycero-3-PC | 99264-98-9 | Reference compound |
| HY-168374 | DSPE-PEG(2000)-Mannose | 1829524-73-3 | Biochemical Assay Reagents |
| HY-168374A | DSPE-PEG1000-Mannose | 1829524-73-3 | Biochemical Assay Reagents |
| HY-168375 | BODIPY-Palmitate | 1246809-50-6 | Reference compound |
| HY-168376 | 9(10)-Nitrooleate | 1092676-99-7 | Reference compound |
| HY-168377 | Fluo-4 (potassium) | 1199351-32-0 | Reference compound |
| HY-168378 | D-Val-Leu-Lys-pNA | 63589-93-5 | Reference compound |
| HY-168379 | DLAC | 70803-56-4 | Reference compound |
| HY-168380 | Lipid C3 | 2639634-93-6 | Reference compound |
| HY-168381 | Lipid A6 | 3037332-21-8 | Reference compound |
| HY-168382 | 5R(6S)-EET | 98103-46-9 | Reference compound |
| HY-168382A | 5S(6R)-EET | 98103-47-0 | Reference compound |
| HY-168383 | (E/Z)-Resomelagon (acetate) | 959850-74-9 | Reference compound |
| HY-168384 | M04 | 875158-73-9 | Reference compound |
| HY-168385 | 1,3-Dimyristoyl-2-oleoylglycerol | 66908-04-1 | Reference compound |
| HY-168386 | 1,2-Dipalmitoyl-3-Myristoyl-rac-glycerol | 60138-14-9 | Reference compound |
| HY-168387 | ITK ligand 1 | Reference compound | |
| HY-168388 | Piperidine-C2-piperazine-Boc | 2222119-35-7 | Reference compound |
| HY-168389 | Thalidomide-piperidine-C2-piperazine-Boc | Reference compound | |
| HY-168390 | 1,2-Stearin-3-linolein | 2442-53-7 | Reference compound |
| HY-168391 | 1-Lauroyl-2-oleoyl-3-palmitoyl-rac-glycerol | 51604-51-4 | Reference compound |
| HY-168392 | Propylene glycol monopalmitate | 29013-28-3 | Reference compound |
| HY-168393 | 1,3-Dipalmitoyl-2-stearoyl glycerol | 2177-97-1 | Reference compound |
| HY-168394 | 1,2-Dipalmitoyl-3-stearoyl-rac-glycerol | 2177-98-2 | Reference compound |
| HY-168396 | Glioroseinol | 2673270-41-0 | Reference compound |
| HY-168397 | tetranor-Prostaglandin E1 | 23923-84-4 | Reference compound |
| HY-168398 | 9(S),12(S),13(S)-TriHODE | 95341-44-9 | Reference compound |
| HY-168399 | PEG(2000)-C-DMG | 1443687-74-8 | Reference compound |
| HY-168400 | 3',4'-Tetramethylene-α-pyrrolidinobutiophenone (hydrochloride) | 2749504-65-0 | Reference compound |
| HY-168401 | 3',4'-Trimethylene-α-ethylaminovalerophenone (hydrochloride) | 2748590-67-0 | Reference compound |
| HY-168402 | 3',4'-Trimethylene-α-pyrrolidinobutiophenone (hydrochloride) | 2749618-47-9 | Reference compound |
| HY-168403 | 3',4'-Trimethylene-α-pyrrolidinohexanophenone (hydrochloride) | 2748304-64-3 | Reference compound |
| HY-168404 | Tropacocaine (hydrochloride) | 637-23-0 | Reference compound |
| HY-168405 | 2C-iP | 1498978-47-4 | Reference compound |
| HY-168406 | 4-Methoxy DiPT (hydrochloride) | 2749504-56-9 | Reference compound |
| HY-168407 | 7-Methoxy DiPT (hydrochloride) | 2749302-95-0 | Reference compound |
| HY-168408 | 5-AEDB (hydrochloride) | 796869-33-5 | Reference compound |
| HY-168411 | 3',4'-Trimethylene-α-pyrrolidinovalerophenone (hydrochloride) | 2748590-83-0 | Reference compound |
| HY-168412 | 25C-NB3OMe (hydrochloride) | 1566571-57-0 | Reference compound |
| HY-168413 | 3',4'-Methylenedioxy-N,N-diethylcathinone (hydrochloride) | 2749303-12-4 | Reference compound |
| HY-168415 | 3,4-DMA-NBOMe (hydrochloride) | 2748343-73-7 | Reference compound |
| HY-168416 | 4-EA-NBOMe (hydrochloride) | 2749282-75-3 | Reference compound |
| HY-168417 | 4-MMA-NBOMe (hydrochloride) | 2703178-01-0 | Reference compound |
| HY-168418 | ADB-BINACA | 2748155-93-1 | Reference compound |
| HY-168421 | 3',4'-Dimethyl-α-ethylaminovalerophenone (hydrochloride) | 2748485-09-6 | Reference compound |
| HY-168422 | 3',4'-Dimethyl-α-pyrrolidinovalerophenone (hydrochloride) | 2748485-15-4 | Reference compound |
| HY-168423 | 3,4-Methylenedioxy-N-propylcathinone (hydrochloride) | 2749504-71-8 | Reference compound |
| HY-168425 | β-Methoxy 2C-B (hydrochloride) | 98537-39-4 | Reference compound |
| HY-168426 | N-Methyl Homarylamine (hydrochloride) | 136366-39-7 | Reference compound |
| HY-168427 | Avitinib (maleate dihydrate) | 1822357-78-7 | Reference compound |
| HY-168428 | CHI-KAT8i5 | Reference compound | |
| HY-168429 | 3HKT-IN-1 | 889947-05-1 | Reference compound |
| HY-168430 | SARS-CoV-2 3CLpro-IN-30 | Reference compound | |
| HY-168431 | GK420 | 1621517-60-9 | Reference compound |
| HY-168432 | KK181N1 | Reference compound | |
| HY-168433 | LSD1/EGFR-IN-1 | 336171-65-4 | Reference compound |
| HY-168434 | Urease-IN-19 | Reference compound | |
| HY-168435 | VEGFR-2-IN-63 | Reference compound | |
| HY-168436 | Tyrosinase-IN-40 | Reference compound | |
| HY-168437 | LIN28-IN-2 | Reference compound | |
| HY-168438 | ERBB agonist-1 | 930856-19-2 | Reference compound |
| HY-168439 | HLB-0532259 | 2566733-45-5 | Reference compound |
| HY-168440 | Aurora-A ligand 1 | 2541626-73-5 | Reference compound |
| HY-168441 | NCGC00537446 | Reference compound | |
| HY-168442 | KRAS inhibitor-40 | 3059496-56-6 | Reference compound |
| HY-168443 | HTR2A antagonist 1 | Reference compound | |
| HY-168444 | CDK4/6-IN-23 | Reference compound | |
| HY-168445 | MAT2A-IN-21 | 3062073-94-0 | Reference compound |
| HY-168446 | PKR-IN-1 | 3057531-75-3 | Reference compound |
| HY-168447 | D-PheTrAP | 2241298-26-8 | Reference compound |
| HY-168448 | dBAZ2 | Reference compound | |
| HY-168449 | BAZ2A/B ligand 1 | Reference compound | |
| HY-168450 | trans-Cyclohexane-p-bis(C-OTs) | 134424-54-7 | Reference compound |
| HY-168451 | trans-VH 101-Thiol-C-cyclohexane-p-C-OTs | Reference compound | |
| HY-168452 | RNase L ligand 1 | Reference compound | |
| HY-168453 | dBAZ2B | Reference compound | |
| HY-168454 | trans-VH032-Cyclopropane-F-C-cyclohexane-p-C-OTs | Reference compound | |
| HY-168455 | RNAse L RIBOTAC | Reference compound | |
| HY-168456 | RNA recruiter 1 | Reference compound | |
| HY-168457 | RNase L ligand 2 | 3025538-34-2 | Reference compound |
| HY-168458 | RNA recruiter-linker 1 | Reference compound | |
| HY-168459 | MAGL-IN-21 | Reference compound | |
| HY-168460 | RNA recruiter 2 | Oligonucleotides | |
| HY-168461 | AK-968-11563024 | 3056223-03-8 | Reference compound |
| HY-168462 | α-Glucosidase-IN-82 | Reference compound | |
| HY-168463 | Y16524 | Reference compound | |
| HY-168464 | Y16526 | Reference compound | |
| HY-168465 | α-Glucosidase-IN-83 | Reference compound | |
| HY-168466 | Anti-neuroinflammation agent 2 | 3040102-76-6 | Reference compound |
| HY-168467 | Anti-obesity agent 1 | Reference compound | |
| HY-168468 | SKLB102 | 242473-63-8 | Reference compound |
| HY-168469 | EGFR-IN-148 | Reference compound | |
| HY-168470 | Antifungal agent 125 | 3062972-37-3 | Reference compound |
| HY-168471 | AAL-149 | 177258-60-5 | Reference compound |
| HY-168472 | 13-TP prodrug | Reference compound | |
| HY-168473 | 13-TP | Reference compound | |
| HY-168474 | P2X4 antagonist-4 | Reference compound | |
| HY-168475 | DD0-2363 | Reference compound | |
| HY-168476 | BRN3OMe | 188349-22-6 | Reference compound |
| HY-168477 | HDAC1-IN-8 | 3066143-73-2 | Reference compound |
| HY-168478 | Antibacterial agent 263 | Reference compound | |
| HY-168479 | VB1080 | Reference compound | |
| HY-168480 | SOS2 ligand 1 | 690696-36-7 | Reference compound |
| HY-168481 | GLP-1R agonist 27 | Reference compound | |
| HY-168482 | NF-κB/MAPK-IN-2 | Reference compound | |
| HY-168483 | FTO-IN-13 | 687600-25-5 | Reference compound |
| HY-168484 | T-10430 | Reference compound | |
| HY-168485 | PPARα/δ agonist 3 | 3050611-33-8 | Reference compound |
| HY-168486 | Biotin protein ligase-IN-1 | Reference compound | |
| HY-168487 | PROTAC WDR5 degrader 1 | 2737222-94-3 | Reference compound |
| HY-168488 | WDR5 ligand 2 | 2737222-78-3 | Reference compound |
| HY-168489 | OBI-992 drug-linker | 3039487-10-7 | Reference compound |
| HY-168490 | Poly(ethylene glycol)methyl ether thiol (MW 800) | Biochemical Assay Reagents | |
| HY-168490A | Poly(ethylene glycol)methyl ether thiol (MW 2000) | Biochemical Assay Reagents | |
| HY-168490B | Poly(ethylene glycol)methyl ether thiol (MW 6000) | Biochemical Assay Reagents | |
| HY-168491 | Enpp-1-IN-25 | 3067908-20-4 | Reference compound |
| HY-168492 | TrxR/EGFR-IN-1 | 3038386-42-1 | Reference compound |
| HY-168493 | FLT3/VEGFR2-IN-1 | Reference compound | |
| HY-168494 | GluN2A Allosteric modulator 1 | Reference compound | |
| HY-168495 | α-Amylase-IN-12 | 1799667-33-6 | Reference compound |
| HY-168496 | Herbicidal agent 8 | Reference compound | |
| HY-168497 | C-MS023 | Reference compound | |
| HY-168498 | GJG057 | 2761767-18-2 | Reference compound |
| HY-168500 | Metallo-β-lactamase-IN-16 | 2058069-25-1 | Reference compound |
| HY-168501 | Neuroprotective agent 6 | Reference compound | |
| HY-168502 | HDAC-IN-81 | 2787560-44-3 | Reference compound |
| HY-168503 | NLRP3-IN-54 | Reference compound | |
| HY-168504 | LSD1-IN-36 | Reference compound | |
| HY-168505 | MSC-5046 | Reference compound | |
| HY-168506 | MSC-1254 | Reference compound | |
| HY-168507 | SG31 | Reference compound | |
| HY-168508 | PB200 | Reference compound | |
| HY-168509 | IMPDH-IN-1 | Reference compound | |
| HY-168510 | ATV03 | Reference compound | |
| HY-168511 | DNA Gyrase-IN-13 | 2247443-72-5 | Reference compound |
| HY-168512 | BRAFV600E-IN-1 | Reference compound | |
| HY-168513 | ALK-IN-29 | Reference compound | |
| HY-168514 | SOS1/EGFR-IN-2 | Reference compound | |
| HY-168515 | CDK9-IN-35 | Reference compound | |
| HY-168516 | FXR/CES2 modulator 1 | 3004676-87-0 | Reference compound |
| HY-168517 | PIM-1/CK2-IN-2 | Reference compound | |
| HY-168518 | PROTAC CDK9 degrader-9 | Reference compound | |
| HY-168519 | STAT3-IN-36 | 3055766-74-7 | Reference compound |
| HY-168520 | NLRP3-IN-57 | Reference compound | |
| HY-168521 | αvβ6-IN-1 | Reference compound | |
| HY-168522 | αvβ6-IN-2 | Reference compound | |
| HY-168523 | S1647 | 259528-99-9 | Reference compound |
| HY-168524 | SOAT-IN-1 | 898440-60-3 | Reference compound |
| HY-168525 | IC-1k | Reference compound | |
| HY-168526 | Keap1-Nrf2-IN-24 | Reference compound | |
| HY-168527 | Acaricide agent 1 | Reference compound | |
| HY-168528 | WS-917 | Reference compound | |
| HY-168529 | NU074381b | Reference compound | |
| HY-168530 | PDL1 degrader-1 | Reference compound | |
| HY-168531 | EMU-116 | 2241724-59-2 | Reference compound |
| HY-168532 | ST2-IN-1 | Reference compound | |
| HY-168533 | ZG-2305 | 2962103-54-2 | Reference compound |
| HY-168534 | WX-02-23 | 2929223-35-6 | Reference compound |
| HY-168535 | SJ6145 | 1010913-79-7 | Reference compound |
| HY-168536 | SJ46411 | Reference compound | |
| HY-168537 | LB-102 | 2227154-23-4 | Reference compound |
| HY-168538 | Antitrypanosomal agent 21 | Reference compound | |
| HY-168539 | TM11 | Reference compound | |
| HY-168540 | PROTAC MPS1 degrader 1 | Reference compound | |
| HY-168541 | Pomalidomide-N-Glutarylglycine | Reference compound | |
| HY-168542 | TTK ligand 2 | Reference compound | |
| HY-168543 | PROTAC MPS1 degrader 2 | Reference compound | |
| HY-168544 | Succinic acid-Pomalidomide | 2417174-32-2 | Reference compound |
| HY-168545 | TTK ligand 3 | Reference compound | |
| HY-168546 | CFT-1297 | Reference compound | |
| HY-168547S | AR89-d6 | 3021566-15-1 | Isotope-Labeled Compounds |
| HY-168548 | pAF-Oxime-PEG4-OH | Reference compound | |
| HY-168550 | STI-8811 drug-linker | 2833733-13-2 | Reference compound |
| HY-168551 | PROTAC ALK degrader-3 | Reference compound | |
| HY-168552 | 3-Hydroxyazetidine-Cyclohexanol | 1553176-51-4 | Reference compound |
| HY-168553 | 3-Hydroxyazetidine-Cyclohexanol-5-Aminothalidomide | Reference compound | |
| HY-168554 | STING-IN-10 | Reference compound | |
| HY-168555 | YJ1206 | 3053716-98-3 | Reference compound |
| HY-168556 | YJ9069 | Reference compound | |
| HY-168557 | SARS-CoV-2-IN-101 | Reference compound | |
| HY-168558 | PDE4B/D-IN-4 | Reference compound | |
| HY-168559 | EGFR-IN-131 | Reference compound | |
| HY-168560 | MMP Inhibitor 4 | Reference compound | |
| HY-168561 | NLRP3-IN-58 | 2956014-05-2 | Reference compound |
| HY-168562 | σ1 Receptor ligand 1 | Reference compound | |
| HY-168563 | BuChE-IN-15 | Reference compound | |
| HY-168564 | SARS-CoV-2 3CLpro-IN-27 | Reference compound | |
| HY-168565 | Tubulin polymerization-IN-70 | Reference compound | |
| HY-168566 | EV206 | 2247047-81-8 | Reference compound |
| HY-168567 | RIPK2-IN-6 | 2242432-02-4 | Reference compound |
| HY-168568 | SARS-CoV-2 Mpro-IN-28 | 2443360-60-7 | Reference compound |
| HY-168569 | DDD489 | 3003871-42-6 | Reference compound |
| HY-168570 | Insecticidal agent 16 | 3046365-94-7 | Reference compound |
| HY-168571 | BTF | Reference compound | |
| HY-168572 | MZ82 | 2944457-11-6 | Reference compound |
| HY-168573 | AZ99 | Reference compound | |
| HY-168574 | SZU-B6 | 3059333-98-8 | Reference compound |
| HY-168577 | KRAS G12D inhibitor 25 | 2768099-61-0 | Reference compound |
| HY-168579 | c-Kit-IN-6 | Reference compound | |
| HY-168580 | c-Kit-IN-7 | 2941026-35-1 | Reference compound |
| HY-168581 | c-Kit-IN-8 | 2941024-89-9 | Reference compound |
| HY-168582 | IL-17-IN-2 | 3058278-46-6 | Reference compound |
| HY-168583 | WRN inhibitor 11 | 3058317-61-3 | Reference compound |
| HY-168584 | SARS-CoV-2-IN-102 | 3055041-73-8 | Reference compound |
| HY-168585 | GLP-1R agonist 26 | 3058090-73-3 | Reference compound |
| HY-168586 | PROTAC IRAK4 degrader-12 | 2919995-09-6 | Reference compound |
| HY-168587 | Antitumor agent-189 | Reference compound | |
| HY-168589 | Apoptosis inducer 30 | Reference compound | |
| HY-168590 | MAO-B-IN-36 | Reference compound | |
| HY-168591 | CTSC-IN-1 | Reference compound | |
| HY-168592 | WRN inhibitor 12 | 3044040-29-8 | Reference compound |
| HY-168593 | PROTAC KDM3 degrader-1 | Reference compound | |
| HY-168594 | α-Glucosidase/NLRP3-IN-1 | Reference compound | |
| HY-168595 | CSNK2-IN-2 | Reference compound | |
| HY-168596 | RhoA-ROCK-IN-1 | Reference compound | |
| HY-168597 | FGFR1/VEGFR2-IN-3 | Reference compound | |
| HY-168598 | α-Amylase-IN-9 | 301359-47-7 | Reference compound |
| HY-168599 | SARS-CoV-2 Mpro-IN-31 | 870153-73-4 | Reference compound |
| HY-168600 | SARS-CoV-2 Mpro-IN-32 | 2961016-95-3 | Reference compound |
| HY-168601 | WWP1/2-IN-1 | Reference compound | |
| HY-168602 | NSC-217913 | 79100-27-9 | Reference compound |
| HY-168603 | AChE/CA I-IN-1 | Reference compound | |
| HY-168604 | CA Ⅱ-IN-1 | Reference compound | |
| HY-168605 | DH-18 | Reference compound | |
| HY-168606A | "p53-MDM2-IN-7 (hydrochloride )" | Reference compound | |
| HY-168607 | ALK5-IN-83 | Reference compound | |
| HY-168608 | TRPM7-IN-1 | 1909225-07-5 | Reference compound |
| HY-168609 | CRI9 | Reference compound | |
| HY-168610 | YTH-IN-1 | 2189366-92-3 | Reference compound |
| HY-168611 | PROTAC IRAK4 ligand-4 | 2434841-55-9 | Reference compound |
| HY-168612 | E3 Ligase Ligand-linker Conjugate 125 | 2918284-14-5 | Reference compound |
| HY-168614 | MGD-4 | 2991817-99-1 | Reference compound |
| HY-168615 | MGD-28 | 2991818-13-2 | Reference compound |
| HY-168616 | CL-A3-7 | 2763661-39-6 | Reference compound |
| HY-168619 | DNA crosslinker 6 | 272791-87-4 | Reference compound |
| HY-168620 | CDK6-IN-1 | 2743517-28-2 | Reference compound |
| HY-168621 | DPP-4-IN-13 | Reference compound | |
| HY-168622 | AChE-IN-79 | Reference compound | |
| HY-168623 | EGFR-IN-134 | Reference compound | |
| HY-168624 | VAV1 degrader-2 | 3050683-29-6 | Reference compound |
| HY-168625 | VAV1 degrader-3 | 3050683-38-7 | Reference compound |
| HY-168626A | Antibacterial agent 252 (hydrochloride) | 2841472-37-3 | Reference compound |
| HY-168627 | EGFR-IN-135 | Reference compound | |
| HY-168628 | BET-IN-27 | 3054869-29-0 | Reference compound |
| HY-168629 | FXR agonist 9 | 2982502-32-7 | Reference compound |
| HY-168630 | FtsZ-IN-11 | 3042897-74-2 | Reference compound |
| HY-168631 | Antibacterial agent 254 | 2418779-48-1 | Reference compound |
| HY-168632 | Topoisomerase I/II inhibitor 6 | Reference compound | |
| HY-168633 | PSMA/GRPR ligand 1 | Reference compound | |
| HY-168634 | SJ46421 | Reference compound | |
| HY-168635 | SJ46420 | Reference compound | |
| HY-168636 | p53 Activator 13 | Reference compound | |
| HY-168637 | SIAIS562055 | Reference compound | |
| HY-168638 | PROTAC SOS1 ligand 1 | 3027977-34-7 | Reference compound |
| HY-168639 | AMPK activator 15 | Reference compound | |
| HY-168640 | RIP3 activator 1 | 1456899-52-7 | Reference compound |
| HY-168641 | PROTAC HIF-1α degrader-1 | Reference compound | |
| HY-168643 | Me-(S,R,S)-AHPC-PEG2-OTs | 3033933-58-0 | Reference compound |
| HY-168644 | Erα-IN-1 | Reference compound | |
| HY-168646 | SJ46411-Br | Reference compound | |
| HY-168647 | KAC-50.1 | Reference compound | |
| HY-168648 | DNA Gyrase/DHFR-IN-1 | Reference compound | |
| HY-168649 | JH-LPH-107 | 3053068-92-8 | Reference compound |
| HY-168650 | ROCK/HDAC-IN-1 | Reference compound | |
| HY-168651 | FBPase-IN-4 | Reference compound | |
| HY-168652 | 4-PivO-NMT chloride | 3019920-38-5 | Reference compound |
| HY-168653 | FGFR-IN-15 | Reference compound | |
| HY-168654 | WEE1 degrader 1 | Reference compound | |
| HY-168655 | EGFR/VEGFR2-IN-3 | 710972-61-5 | Reference compound |
| HY-168656 | Ac-Atovaquone | 129700-44-3 | Reference compound |
| HY-168657 | PARP1/2-IN-4 | 2093102-22-6 | Reference compound |
| HY-168658 | CDK12/13 ligand 2 | Reference compound | |
| HY-168659 | E3 Ligase Ligand-linker Conjugate 130 | Reference compound | |
| HY-168660 | CPD-10 | 3055471-57-0 | Reference compound |
| HY-168662 | Palbociclib-CH2COOH | 2139329-57-8 | Reference compound |
| HY-168663 | E3 Ligase Ligand-linker Conjugate 131 | 3055814-59-7 | Reference compound |
| HY-168664 | CPD-39 | 3055472-38-0 | Reference compound |
| HY-168667 | E3 ligase Ligand 40 | Reference compound | |
| HY-168668 | E3 Ligase Ligand-linker Conjugate 132 | 3055816-67-3 | Reference compound |
| HY-168669 | PROTAC K-Ras Degrader-5 | 3052745-16-8 | Reference compound |
| HY-168671 | pan-KRAS ligand 1 | 2886012-31-1 | Reference compound |
| HY-168672 | E3 Ligase Ligand-linker Conjugate 133 | 3052750-99-6 | Reference compound |
| HY-168673 | CDK1-IN-6 | Reference compound | |
| HY-168674 | Antibacterial agent 255 | 945980-50-7 | Reference compound |
| HY-168676 | STING ligand-2 | 1307526-16-4 | Reference compound |
| HY-168677 | E3 Ligase Ligand-linker Conjugate 134 | Reference compound | |
| HY-168678 | PROTAC K-Ras Degrader-6 | 3052745-46-4 | Reference compound |
| HY-168680 | E3 Ligase Ligand-linker Conjugate 135 | 3052748-49-6 | Reference compound |
| HY-168681 | Sirtuin-IN-2 | Reference compound | |
| HY-168682 | Adamantane-Butyl alcohol | 31685-38-8 | Reference compound |
| HY-168683 | CDK8 ligand 1 | 2924557-38-8 | Reference compound |
| HY-168684 | E3 Ligase Ligand-linker Conjugate 136 | 2761394-06-1 | Reference compound |
| HY-168685 | c-Myc ligand 1 | 1942834-87-8 | Reference compound |
| HY-168686 | 6-Hydroxy-1-(4-(2-hydroxyethyl)piperazin-1-yl)hexan-1-one | 2859434-39-0 | Reference compound |
| HY-168687 | E3 Ligase Ligand-linker Conjugate 137 | Reference compound | |
| HY-168690 | 6-Aminocaproic acid-(S,R,S)-AHPC-Me | 2380273-49-2 | Reference compound |
| HY-168691 | PTPN2 ligand 1 | 3032975-34-8 | Reference compound |
| HY-168692 | 3-(2-(4-Methylpiperazin-1-yl)ethyl)azetidin-3-ol | 1782009-18-0 | Reference compound |
| HY-168693 | Target Protein Ligand-Linker Conjugates 2 | Reference compound | |
| HY-168694 | E3 Ligase Ligand-linker Conjugate 147 | Reference compound | |
| HY-168695 | BRD9 ligand-7 | Reference compound | |
| HY-168696 | E3 Ligase Ligand-linker Conjugate 148 | Reference compound | |
| HY-168697 | AR ligand-37 | Reference compound | |
| HY-168698 | (4-(1H-1,2,3-Triazol-4-yl)phenyl)methanol | 2149801-20-5 | Oligonucleotides |
| HY-168699 | E3 ligase Ligand 45 | Oligonucleotides | |
| HY-168700 | G12D ligand 1 | Oligonucleotides | |
| HY-168701 | E3 Ligase Ligand-linker Conjugate 149 | Oligonucleotides | |
| HY-168702 | FLT3 ligand-2 | 950769-51-4 | Reference compound |
| HY-168704 | YAP/TAZ-TEAD-IN-2 | Reference compound | |
| HY-168705 | Anti-MRSA agent 20 | Reference compound | |
| HY-168706 | LXQ-87 | 2524718-73-6 | Reference compound |
| HY-168707 | CK2-IN-14 | Reference compound | |
| HY-168708 | AH2-14c | Reference compound | |
| HY-168709 | Nrf2 activator 18 | Reference compound | |
| HY-168710 | TLR4/NF-κB-IN-1 | 3050836-94-4 | Reference compound |
| HY-168711 | P-gp inhibitor 27 | Reference compound | |
| HY-168712 | FXIa-IN-15 | 3053222-76-4 | Reference compound |
| HY-168713 | LZ-007 | 2920000-23-1 | Reference compound |
| HY-168714 | Microtubule inhibitor 12 | Reference compound | |
| HY-168715 | SHP2-IN-33 | 2894017-46-8 | Reference compound |
| HY-168716 | SOS1-IN-17 | Reference compound | |
| HY-168717 | Antitumor agent-190 | Reference compound | |
| HY-168718 | FAK-IN-22 | 2703920-02-7 | Reference compound |
| HY-168719 | PPARγ agonist 16 | 2218046-01-4 | Reference compound |
| HY-168720 | Apoptosis inducer 32 | Reference compound | |
| HY-168721 | Tubulin inhibitor 48 | 63589-51-5 | Reference compound |
| HY-168722 | PROTAC PARP1 degrader-3 | Reference compound | |
| HY-168723 | Piperidine-C-Pip-C2-Pip-C2-OH | Reference compound | |
| HY-168724 | Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH | Reference compound | |
| HY-168725 | PROTAC KSP-IN-1 | Reference compound | |
| HY-168726 | Octane-1,8-diamine-Glycolic acid | 167613-63-0 | Reference compound |
| HY-168727 | KSP ligand 1 | 1802248-16-3 | Reference compound |
| HY-168728 | MAO-B-IN-37 | 894280-02-5 | Reference compound |
| HY-168729 | Antibacterial agent 256 | 3052804-28-8 | Reference compound |
| HY-168730 | Anticancer agent 259 | Reference compound | |
| HY-168731 | AChE/BChE-IN-25 | Reference compound | |
| HY-168732 | MCG-02 | Reference compound | |
| HY-168733 | LDHA-IN-9 | 862719-04-8 | Reference compound |
| HY-168734 | CB2 receptor agonist 9 | 2374894-21-8 | Reference compound |
| HY-168735 | SLC26A4-IN-1 | 5010-56-0 | Reference compound |
| HY-168736 | CRC-IN-1 | 3023350-74-2 | Reference compound |
| HY-168737 | NEK7-IN-2 | Reference compound | |
| HY-168738 | Limnetrelvir | 2923500-04-1 | Reference compound |
| HY-168739 | Topoisomerase I inhibitor 17 | 2413582-45-1 | Reference compound |
| HY-168740 | URAT1 inhibitor 11 | 2416416-13-0 | Reference compound |
| HY-168741 | FLT3-ITD-IN-2 | Reference compound | |
| HY-168742 | V1a/V2 antagonist 1 | Reference compound | |
| HY-168747 | 4-Bromo-2,5-DMMA | 155638-80-5 | Reference compound |
| HY-168750 | MDMB-FUBICA | 1971007-91-6 | Reference compound |
| HY-168756 | Byssochlamic acid | 743-51-1 | Reference compound |
| HY-168757 | PSMA precursor-1 | 1423622-48-3 | Reference compound |
| HY-168758 | Delta3,5-cholestadien-7-one | 567-72-6 | Reference compound |
| HY-168759 | 11α-Hydroxytestosterone | 3066-12-4 | Reference compound |
| HY-168760 | (5α)-3,6-Dioxocholan-24-oic acid | 6929-22-2 | Reference compound |
| HY-168761 | N-Cholyl-L-alanine | 18416-54-1 | Reference compound |
| HY-168762 | C32 Ceramide | 34227-73-1 | Natural Products |
| HY-168763 | C23 Phytoceramide | 844866-89-3 | Reference compound |
| HY-168764 | C16 Galactosylceramide | 34324-89-5 | Natural Products |
| HY-168765 | LY433771 | 220862-64-6 | Reference compound |
| HY-168766 | O-Acetylsalicylhydroxamic acid | 199854-00-7 | Reference compound |
| HY-168767 | CA IX-IN-3 | 333413-02-8 | Reference compound |
| HY-168768 | FerroLOXIN-1 | 2773428-48-9 | Reference compound |
| HY-168770 | Cl-Necrostatin-1 | 862377-51-3 | Reference compound |
| HY-168771 | gamma-DGG (TFA) | 71822-19-0 | Reference compound |
| HY-168772 | Glycyl-L-Proline (TFA) | 76397-13-2 | Reference compound |
| HY-168773 | (R)-AS-1 | 2506367-95-7 | Reference compound |
| HY-168774 | 17(S)-HDoTE | 105835-39-0 | Reference compound |
| HY-168775 | Lipid 29d | 2921586-67-4 | Reference compound |
| HY-168776 | (S)-C12-200 | 1226552-44-8 | Oligonucleotides |
| HY-168777 | Lipid 7-1 | 2795392-95-7 | Reference compound |
| HY-168778 | (±)-Δ7-Mesembrenone | 80287-15-6 | Reference compound |
| HY-168779 | ε-Rhodomycinone | 21288-60-8 | Reference compound |
| HY-168780 | 1-Palmitoyl-2-arachidoyl-3-oleoyl-rac-glycerol | 669762-61-2 | Reference compound |
| HY-168781 | Arachidoyl glycine | 617703-96-5 | Reference compound |
| HY-168782 | Resolvin D2 n-3 DPA | 2093111-29-4 | Reference compound |
| HY-168783 | 7(Z),10(Z),13(Z)-Hexadecatrienoic acid methyl ester | 77388-16-0 | Reference compound |
| HY-168784 | LTD4 antagonist 2 | 107813-86-5 | Reference compound |
| HY-168785 | 1,3-Dilinoelaidoyl glycerol | 372490-73-8 | Reference compound |
| HY-168786 | 4,6,4'-Trihydroxy-3'-methoxyaurone | 873787-99-6 | Reference compound |
| HY-168787 | 1,3-Dieicosapentaenoyl glycerol | 140670-41-3 | Reference compound |
| HY-168788 | 8(S)-Hydroxy-9(R)-hexahydrocannabinol | 74509-39-0 | Reference compound |
| HY-168789 | 8(R)-Hydroxy-9(R)-hexahydrocannabinol | 42793-11-3 | Reference compound |
| HY-168790 | 8(S)-Hydroxy-9(S)-hexahydrocannabinol | 36403-93-7 | Reference compound |
| HY-168791 | 8(R)-Hydroxy-9(S)-Hexahydrocannabinol | 36403-92-6 | Reference compound |
| HY-168792 | (±)-9-Nor-9α-hydroxy Hexahydrocannabinol | 56469-26-2 | Reference compound |
| HY-168793 | (±)-9-Nor-9β-hydroxy Hexahydrocannabinol | 56469-25-1 | Reference compound |
| HY-168794 | 11-Hydroxy-9(R)-hexahydrocannabinol | 64663-39-4 | Reference compound |
| HY-168795 | 11-Hydroxy-9(S)-hexahydrocannabinol | 74523-47-0 | Reference compound |
| HY-168796 | 1-Palmitoyl-2-13(S)-HpODE-sn-glycero-3-PC | 444997-11-9 | Reference compound |
| HY-168797 | 1,2-Dihexanoyl-sn-glycero-3-PS (sodium) | 321862-85-5 | Reference compound |
| HY-168798 | Cardiolipin (sodium) | 2260669-33-6 | Reference compound |
| HY-168799 | 3-Methoxy prostaglandin F1α | 54432-43-8 | Reference compound |
| HY-168800 | 19(R)-Hydroxy prostaglandin F1α | 81371-59-7 | Reference compound |
| HY-168801 | 13,14-Dihydro-15-keto-tetranor prostaglandin F1β | 23015-45-4 | Reference compound |
| HY-168802 | 9-Keto tafluprost | 261179-75-3 | Reference compound |
| HY-168803 | BDW-OH | 573976-22-4 | Reference compound |
| HY-168804 | SOTS-1 (technical grade) | 223507-96-8 | Reference compound |
| HY-168806 | 3-Chloro PCP (hydrochloride) | 1934-43-6 | Reference compound |
| HY-168807 | 2-Methyl-α-ethylaminobutiophenone (hydrochloride) | 18267-89-5 | Reference compound |
| HY-168808 | 4-Methyl-N-propylcathinone (hydrochloride) | 2802790-62-9 | Reference compound |
| HY-168809 | Norbaeocystin | 21420-59-7 | Reference compound |
| HY-168811 | α-Pyrrolidino-2-phenylacetophenone (hydrochloride) | 27590-61-0 | Reference compound |
| HY-168812 | 3,4-Methylenedioxy-α-pyrrolidinoisohexanophenone (hydrochloride) | 24622-58-0 | Reference compound |
| HY-168813 | Δ9-THCH | 36482-24-3 | Reference compound |
| HY-168814 | 3α-Benzoyloxytropane (hydrochloride) | 55623-27-3 | Reference compound |
| HY-168815 | Methylketobemidone | 64058-44-2 | Reference compound |
| HY-168816 | Dipyanone (hydrochloride) | 102762-20-9 | Reference compound |
| HY-168817 | Δ9-Tetrahydrocannabiorcol | 22972-65-2 | Reference compound |
| HY-168818 | N-(1-Phenethyl-4-piperidyl)-N-phenethylpropanamide (hydrochloride) | 28456-30-6 | Reference compound |
| HY-168819 | Δ8-iso-THC | 23050-47-7 | Reference compound |
| HY-168820 | 2-Naphthyl U-47700 | 67579-80-0 | Reference compound |
| HY-168821 | PiPT | 1354632-00-0 | Reference compound |
| HY-168824 | Cypenamine (hydrochloride) | 5588-23-8 | Reference compound |
| HY-168825 | 2-Methyl-α-pyrrolidinovalerophenone (hydrochloride) | 850352-13-5 | Reference compound |
| HY-168826 | N-(1-Benzyl-4-piperidyl)-N-benzylpropanamide (hydrochloride) | 117994-42-0 | Reference compound |
| HY-168827 | (±)-Threo-4-methylmethylphenidate (hydrochloride) | 680996-70-7 | Reference compound |
| HY-168828 | Δ9-THC-Ethyl | 134840-81-6 | Reference compound |
| HY-168829 | 4-Methylphenmetrazine (hydrochloride) | 1998216-41-3 | Reference compound |
| HY-168831 | N-Propyl hexylone (hydrochloride) | 27912-42-1 | Reference compound |
| HY-168832 | N-Benzyl-3,4-DMA (hydrochloride) | 2980-07-6 | Reference compound |
| HY-168834 | Flubrotizolam | 57801-95-3 | Reference compound |
| HY-168835 | N,N-Diethyl hexylone (hydrochloride) | 17763-17-6 | Reference compound |
| HY-168836 | 4-Dimethylamino-N-benzylcathinone (hydrochloride) | 2740524-43-8 | Reference compound |
| HY-168840 | Insecticidal agent 17 | Reference compound | |
| HY-168841 | p38α-MK2-IN-1 | 3031770-03-0 | Reference compound |
| HY-168842 | PRMT5-IN-47 | 3065081-87-7 | Reference compound |
| HY-168843 | PSP205 | 837408-39-6 | Reference compound |
| HY-168844 | Antibacterial agent 259 | 2090706-08-2 | Reference compound |
| HY-168845 | CDK2/9-IN-1 | 2222285-23-4 | Reference compound |
| HY-168846 | CDK8/19-IN-3 | Reference compound | |
| HY-168847 | INCB159020 | 2923669-20-7 | Reference compound |
| HY-168848 | KT32 | 3028278-67-0 | Reference compound |
| HY-168849 | Topoisomerase inhibitor 5 | 2758889-92-6 | Reference compound |
| HY-168850 | MTDH-SND1 blocker 2 | 3052204-80-2 | Reference compound |
| HY-168851 | PARP1-IN-35 | Reference compound | |
| HY-168852 | Antimicrobial agent-37 | Reference compound | |
| HY-168853 | Antibacterial agent 261 | 3036109-97-1 | Reference compound |
| HY-168854 | TBC-1 | 2522115-48-4 | Reference compound |
| HY-168855 | hCAII/IX-IN-1 | Reference compound | |
| HY-168856 | hCAII/XII-IN-1 | Reference compound | |
| HY-168857 | GSK-3β inhibitor 24 | 3069913-37-4 | Reference compound |
| HY-168858 | TRK-IN-30 | Reference compound | |
| HY-168859 | JNK3 inhibitor-9 | Reference compound | |
| HY-168860 | Antituberculosis agent-13 | Reference compound | |
| HY-168861 | NDM-1 inhibitor-8 | Reference compound | |
| HY-168862 | Insecticidal agent 18 | Reference compound | |
| HY-168863 | FF2049 | Reference compound | |
| HY-168864 | POI ligand 1 | Reference compound | |
| HY-168865 | E3 ligase Ligand 53 | Reference compound | |
| HY-168866 | E3 Ligase Ligand-linker Conjugate 160 | Reference compound | |
| HY-168867 | RD-23 | 3053537-06-4 | Reference compound |
| HY-168868 | RET ligand-2 | 3053537-08-6 | Reference compound |
| HY-168869 | Tamoxifen-PEG-Clozapine | Reference compound | |
| HY-168870 | OH-PEG3-C2-Succinamic acid-2-(Methylamino)ethanol | Reference compound | |
| HY-168871 | E3 Ligase Ligand-linker Conjugate 161 | Reference compound | |
| HY-168872 | API32 | 162320-41-4 | Reference compound |
| HY-168873 | Anti-MRSA agent 23 | 2607085-75-4 | Reference compound |
| HY-168874 | TrxR1-IN-2 | Reference compound | |
| HY-168875 | TrxR1 prodrug-1 | Reference compound | |
| HY-168876 | AZ14240475 | Reference compound | |
| HY-168877 | FMP | Reference compound | |
| HY-168878 | EP652 | 3050819-22-9 | Reference compound |
| HY-168879 | GPX4-IN-16 | Reference compound | |
| HY-168880 | ROMK-IN-2 | 2254335-06-1 | Reference compound |
| HY-168881 | Antibacterial agent 262 | 3034291-67-0 | Reference compound |
| HY-168882 | PKM2 modulator 1 | Reference compound | |
| HY-168883 | PKM2 modulator 2 | 1356760-50-3 | Reference compound |
| HY-168884 | AV457 | 2713387-11-0 | Reference compound |
| HY-168885 | ZSH-512 | 2923210-02-8 | Reference compound |
| HY-168886 | Anticancer agent 263 | Reference compound | |
| HY-168887 | ZSA-51 | Reference compound | |
| HY-168888 | COX-2-IN-52 | Reference compound | |
| HY-168889 | HRSV/hCoV-229E-IN-1 | Reference compound | |
| HY-168890 | TRF2-IN-1 | Reference compound | |
| HY-168891 | LC3B recruiter 1 | 1281081-32-0 | Reference compound |
| HY-168892 | LC3B recruiter 2 | 380636-64-6 | Reference compound |
| HY-168893 | K882 | Reference compound | |
| HY-168894 | CT-1 | Reference compound | |
| HY-168895 | c-Fos-IN-1 | Reference compound | |
| HY-168896 | CDK9 autophagic degrader 1 | 3066836-42-5 | Reference compound |
| HY-168897 | LC3B ligand 1 | 902959-52-8 | Reference compound |
| HY-168898 | 1,3-Propanediol-SNS-032 | Reference compound | |
| HY-168899 | FAK-IN-24 | 3062175-62-3 | Reference compound |
| HY-168900 | Antibiofilm agent-16 | Reference compound | |
| HY-168901 | Hck-IN-2 | Reference compound | |
| HY-168902 | Proteasome-IN-7 | Reference compound | |
| HY-168903 | STAT3-IN-41 | Reference compound | |
| HY-168904 | BI-1942 | 1236524-95-0 | Reference compound |
| HY-168905 | SGC-CAMKK2-1 | 2561494-76-4 | Reference compound |
| HY-168906 | BI-113823 | 1119282-90-4 | Reference compound |
| HY-168907 | OICR11029 | 2374711-65-4 | Reference compound |
| HY-168908 | LIJTF500025 | 2838087-03-7 | Reference compound |
| HY-168909 | MRK-952 | Reference compound | |
| HY-168910 | PROTAC c-Met degrader-3 | Reference compound | |
| HY-168911 | E3 Ligase Ligand-linker Conjugate 168 | Reference compound | |
| HY-168912 | 3,9-Diazaspiro[5.5]undecane-3-carboxylic acid | Reference compound | |
| HY-168913 | CTT2274 | Reference compound | |
| HY-168914 | AI-181 | Reference compound | |
| HY-168915 | ML-B01 | Reference compound | |
| HY-168916 | Jun13296 | 3063566-68-4 | Reference compound |
| HY-168917 | 9-AMN | Reference compound | |
| HY-168918 | Insecticidal agent 19 | Reference compound | |
| HY-168919 | KRASG12C IN-16 | Reference compound | |
| HY-168920 | NSD-IN-4 | Reference compound | |
| HY-168921 | ABCB1-IN-3 | Reference compound | |
| HY-168922 | Keap1-Nrf2-IN-25 | Reference compound | |
| HY-168923 | HR-568 | Reference compound | |
| HY-168924 | Wnt/β-catenin activator 1 | Reference compound | |
| HY-168925 | EXQ-2d | Reference compound | |
| HY-168926 | NQO2-IN-1 | 2920687-14-3 | Reference compound |
| HY-168927 | Apoptosis inducer 36 | 2831492-41-0 | Reference compound |
| HY-168928 | Antibiofilm agent prodrug 1 | Reference compound | |
| HY-168929 | SHP1 activator 1 | Reference compound | |
| HY-168930 | ATX inhibitor 25 | 2951100-44-8 | Reference compound |
| HY-168931 | CCOE-5 | Reference compound | |
| HY-168932 | Antiangiogenic agent 8 | Reference compound | |
| HY-168933 | KWR095 | 3057980-16-9 | Reference compound |
| HY-168934 | KWR137 | Reference compound | |
| HY-168935 | Anti-inflammatory agent 95 | Reference compound | |
| HY-168936 | DP-15 | 3033837-71-4 | Reference compound |
| HY-168937 | HS-PEG-NH2 (Mn 2000) | Biochemical Assay Reagents | |
| HY-168937A | HS-PEG-NH2 (Mn 5000) | Biochemical Assay Reagents | |
| HY-168937B | HS-PEG-NH2 (Mn 3500) | Biochemical Assay Reagents | |
| HY-168937C | HS-PEG-NH2 (Mn 7500) | Biochemical Assay Reagents | |
| HY-168938 | Poly(ethylene glycol) methyl ether maleimide (Mn 2000) | Biochemical Assay Reagents | |
| HY-168939 | Poly(ethylene glycol) 2-mercaptoethyl ether acetic acid (Mn 1000) | 165729-81-7 | Biochemical Assay Reagents |
| HY-168939A | Poly(ethylene glycol) 2-mercaptoethyl ether acetic acid (Mn 2000) | 165729-81-7 | Biochemical Assay Reagents |
| HY-168939B | Poly(ethylene glycol) 2-mercaptoethyl ether acetic acid (Mn 3400) | 165729-81-7 | Biochemical Assay Reagents |
| HY-168939C | Poly(ethylene glycol) 2-mercaptoethyl ether acetic acid (Mn 5000) | 165729-81-7 | Biochemical Assay Reagents |
| HY-168940 | NH2-PEG-COOH (Mn 1100) | 139729-28-5 | Biochemical Assay Reagents |
| HY-168940A | NH2-PEG-COOH (Mn 3500) | 139729-28-5 | Biochemical Assay Reagents |
| HY-168940B | NH2-PEG-COOH (Mn 2000) | 139729-28-5 | Biochemical Assay Reagents |
| HY-168940C | NH2-PEG-COOH (Mn 10100) | 139729-28-5 | Biochemical Assay Reagents |
| HY-168941 | HS-PEG-COOH (MW 7500) | Biochemical Assay Reagents | |
| HY-168941A | HS-PEG-COOH (MW 3500) | Biochemical Assay Reagents | |
| HY-168943 | PLGA nanoparticles, 100nm | Biochemical Assay Reagents | |
| HY-168943A | PLGA nanoparticles, 200nm | Biochemical Assay Reagents | |
| HY-168943B | PLGA nanoparticles, 500nm | Biochemical Assay Reagents | |
| HY-168943C | PLGA nanoparticles, 1μm | Biochemical Assay Reagents | |
| HY-168944 | ABCB1-IN-4 | 1500779-21-4 | Reference compound |
| HY-168946 | InhA-IN-9 | Reference compound | |
| HY-168947 | Green Fluorescent PLGA nanoparticles, 100nm | Biochemical Assay Reagents | |
| HY-168947A | Green Fluorescent PLGA nanoparticles, 200nm | Biochemical Assay Reagents | |
| HY-168947B | Green Fluorescent PLGA nanoparticles, 500nm | Biochemical Assay Reagents | |
| HY-168948 | Quorum sensing-IN-9 | 3063543-24-5 | Reference compound |
| HY-168950 | ANXA3 degrader 1 | Reference compound | |
| HY-168951 | (R)-SL18 | 3023189-40-1 | Reference compound |
| HY-168952 | GHN105 | Reference compound | |
| HY-168953 | Lysosomal P-gp targeted agent 1 | 3043797-88-9 | Reference compound |
| HY-168954 | CSF1R-IN-26 | Reference compound | |
| HY-168955 | Antibacterial agent 269 | Reference compound | |
| HY-168956 | Pks13-IN-2 | Reference compound | |
| HY-168957 | RuDiOBn | 13459-13-7 | Reference compound |
| HY-168958 | Ferroptosis-IN-18 | 2247525-20-6 | Reference compound |
| HY-168959 | Antiparasitic agent-25 | Reference compound | |
| HY-168960 | ROS inducer 8 | Reference compound | |
| HY-168961 | α-Amylase/α-Glucosidase-IN-18 | Reference compound | |
| HY-168962 | HDAC-IN-88 | Reference compound | |
| HY-168963 | PROTAC BTK Degrader-13 | Reference compound | |
| HY-168964 | Ethanolamine-Thalidomide-4-OH | 1957235-61-8 | Reference compound |
| HY-168965 | BTK ligand 15 | 2668225-98-5 | Reference compound |
| HY-168966 | PDE2 inhibitor 6 | 2097493-39-3 | Reference compound |
| HY-168967 | BAY-277 | Reference compound | |
| HY-168968S | ZJY-54 | Isotope-Labeled Compounds | |
| HY-168969 | AA-BR-157 | Reference compound | |
| HY-168970 | MT2A ligand 1 | Reference compound | |
| HY-168971 | Paeoniflorin-6′-O-benzene sulfonate | 1390658-79-3 | Reference compound |
| HY-168972 | Famlasertib | 2375591-69-6 | Reference compound |
| HY-168973 | Fexlamose | 1285607-08-0 | Reference compound |
| HY-168974 | Fosizensertib | 2905377-00-4 | Reference compound |
| HY-168975 | Fosrugocrixan | 2408145-38-8 | Reference compound |
| HY-168976 | Gadosircoclamide | 1801159-68-1 | Reference compound |
| HY-168977 | Inidascamine | 903884-71-9 | Reference compound |
| HY-168978 | Irodanoprost | 2055490-48-5 | Reference compound |
| HY-168979 | Itareparib | 1606995-47-4 | Reference compound |
| HY-168980 | Lanisidenib | 2135537-20-9 | Reference compound |
| HY-168981 | Larubrilstat | 2765226-31-9 | Reference compound |
| HY-168982 | Lomonitinib | 2923221-56-9 | Reference compound |
| HY-168983 | Lonitoclax | 2952589-57-8 | Reference compound |
| HY-168984 | Milpecitinib | 1415819-54-3 | Reference compound |
| HY-168985 | Mirivadelgat | 1804941-96-5 | Reference compound |
| HY-168986 | Moxetomidate | 1567838-90-7 | Reference compound |
| HY-168987 | Netanasvir | 2007900-70-9 | Reference compound |
| HY-168988 | Olisutrigine (bromide) | 1393836-45-7 | Reference compound |
| HY-168989 | Olorigliflozin | 2035989-50-3 | Reference compound |
| HY-168990 | Ontunisertib | 2647949-48-0 | Reference compound |
| HY-168991 | Laporolimus | 1504576-27-5 | Reference compound |
| HY-168992 | UNC6535 | Reference compound | |
| HY-168993 | BRCA2-IN-2 | Reference compound | |
| HY-168994 | DfrA1-IN-1 | 2488069-21-0 | Reference compound |
| HY-168995 | BAR-072 | 2068867-65-0 | Reference compound |
| HY-168996 | LA-CB1 | 3032908-44-1 | Reference compound |
| HY-168997 | CB1R agonist 1 | Reference compound | |
| HY-168998 | Yck2-IN-1 | 401816-26-0 | Reference compound |
| HY-168999 | TSWV-IN-2 | Reference compound | |
| HY-16900 | Rolipram | 61413-54-5 | Reference compound |
| HY-169000 | CFTR corrector 16 | 1210305-23-9 | Reference compound |
| HY-169001 | 5-HT2A/5-HT2C inverse agonist 1 | 2718990-76-0 | Reference compound |
| HY-169002 | PP5-IN-2 | Reference compound | |
| HY-169003 | STT3A/B-IN-1 | 3067184-99-7 | Reference compound |
| HY-169004 | CBT-295 | Reference compound | |
| HY-169005 | Cbl-b-IN-27 | Reference compound | |
| HY-169006 | Evo312 | 2820245-53-0 | Reference compound |
| HY-169007 | STAT3-IN-34 | Reference compound | |
| HY-169008 | PROTAC ACC degrader-1 | Reference compound | |
| HY-169009 | (Rac)-Spirotetramat-enol | 382608-09-5 | Reference compound |
| HY-16900A | (R)-(-)-Rolipram | 85416-75-7 | Reference compound |
| HY-16900R | Rolipram (Standard) | 61413-54-5 | Reference Standards |
| HY-16901 | Firsocostat | 1434635-54-7 | Reference compound |
| HY-169010 | Pomalidomide-CO-C5-Br | 2227423-38-1 | Reference compound |
| HY-169011 | Phytoene desaturase-IN-3 | Reference compound | |
| HY-169012 | PSB-21110 | Reference compound | |
| HY-169013 | DDO-3733 | 2923531-63-7 | Reference compound |
| HY-169014 | HDAC-IN-77 | Reference compound | |
| HY-169017 | MTT5 | Reference compound | |
| HY-169019 | XJTU-L453 | 3008290-92-1 | Reference compound |
| HY-16901A | Firsocostat (S enantiomer) | 2128714-16-7 | Reference compound |
| HY-16902 | RO9021 | 1446790-62-0 | Reference compound |
| HY-169020 | SL agonist 1 | 2375196-54-4 | Reference compound |
| HY-169021 | JNK-1-IN-3 | 3056388-71-4 | Reference compound |
| HY-169022 | 4-FPBUA | 2089636-93-9 | Reference compound |
| HY-169023 | Antiangiogenic agent 6 | Reference compound | |
| HY-169024 | GSK-3β inhibitor 19 | Reference compound | |
| HY-169025 | ADH-353 | 2711712-81-9 | Reference compound |
| HY-169026 | DCN1-IN-2 | 2543578-57-8 | Reference compound |
| HY-169028 | 8-Iso prostaglandin E2 isopropyl ester | 330589-21-4 | Reference compound |
| HY-169029 | 1,2,3-Trinervonoyl glycerol | 81913-24-8 | Reference compound |
| HY-16903 | PKC-IN-1 | 1046787-18-1 | Reference compound |
| HY-169030 | Diarachidonin | 82231-61-6 | Reference compound |
| HY-169031 | 1,2-Dioctanoyl-3-linoleoyl-rac-glycerol | 88286-44-6 | Reference compound |
| HY-169032 | Dipalmitolein | 60586-59-6 | Reference compound |
| HY-169033 | Di-γ-linolenin | 372516-95-5 | Reference compound |
| HY-169034 | Dimyristolein | 372516-89-7 | Reference compound |
| HY-169035 | 1,2,3-Tri-13(Z),16(Z)-docosadienoyl-glycerol | 958760-53-7 | Reference compound |
| HY-169036 | 1,2-Di-13(Z)-docosenoyl-3-oleoyl-rac-glycerol | 60003-02-3 | Reference compound |
| HY-169037 | Δ8-Tetrahydrocannabinoquinone | 19542-59-7 | Reference compound |
| HY-169038 | 11(Z),14(Z)-Eicosadienoic acid ethanolamide | 162758-92-1 | Reference compound |
| HY-169039 | Δ9-THCQ | 860480-30-4 | Reference compound |
| HY-16904 | RI-2 | 1417162-36-7 | Reference compound |
| HY-169040 | 28-Aminobetulin | 25613-16-5 | Reference compound |
| HY-169041 | Δ4(8)-iso-THC | 23050-59-1 | Reference compound |
| HY-169042 | Mono-11(Z)-eicosenoin | 62207-88-9 | Reference compound |
| HY-169043 | (±)7(S),8(R)-EDT | 355016-21-6 | Reference compound |
| HY-169044 | (±)10,11-EDT | 355016-20-5 | Reference compound |
| HY-169045 | (±)13,14-EDT | 355016-19-2 | Reference compound |
| HY-169046 | (±)13,14-DiHDoTrE | 944908-94-5 | Reference compound |
| HY-169047 | PAMAM dendrimer G1.5 carboxylate (sodium) | 251970-28-2 | Reference compound |
| HY-169048 | CDK2/4-IN-2 | 3034898-59-1 | Reference compound |
| HY-169049 | Smurf1 ligand 1 | Reference compound | |
| HY-16905 | T338C Src-IN-1 | 1351926-90-3 | Reference compound |
| HY-169050 | Thalidomide-piperidine | 2924858-38-6 | Reference compound |
| HY-169051 | SIRT-IN-5 | Reference compound | |
| HY-169052 | Cyy-272 | 2644673-01-6 | Reference compound |
| HY-169053 | SU1261 | 3061890-98-7 | Reference compound |
| HY-169054 | NCATS-SM4420 | 1352286-61-3 | Reference compound |
| HY-169055 | SARS-CoV-2 Mpro-IN-25 | 2205006-23-9 | Reference compound |
| HY-169056 | SLC7A11-IN-2 | 14668-59-8 | Reference compound |
| HY-169057 | BI1543673 | Reference compound | |
| HY-169058 | GSTP1-1 inhibitor 2 | Reference compound | |
| HY-169059 | Ferroptosis-IN-12 | Reference compound | |
| HY-16906 | T338C Src-IN-2 | 1351927-00-8 | Reference compound |
| HY-169060 | LDHA-IN-8 | Reference compound | |
| HY-169061 | WQQ-345 | Reference compound | |
| HY-169062 | RJF02215 | 883028-78-2 | Reference compound |
| HY-169063 | ZINC05925939 | Reference compound | |
| HY-169064 | HIV-1 inhibitor-75 | Reference compound | |
| HY-169065 | Antibacterial agent 241 | 558638-15-6 | Reference compound |
| HY-169066 | INSR agonist 1 | Reference compound | |
| HY-169067 | 10-Methoxy-canthin-6-one | 86293-40-5 | Reference compound |
| HY-169068 | Antifeedant agent 1 | Reference compound | |
| HY-169069 | Antifungal agent 110 | Reference compound | |
| HY-16907 | GSK-364735 | 863434-13-3 | Reference compound |
| HY-169070 | Anti-osteoporosis agent-10 | Reference compound | |
| HY-169071S | ATX-1905 | 3035983-65-1 | Isotope-Labeled Compounds |
| HY-169072 | PROTAC MLKL Degrader-2 | Reference compound | |
| HY-169073 | TC13172-NH-COOH | Reference compound | |
| HY-169074 | Thalidomide-N-methylpiperazine | 2924858-30-8 | Reference compound |
| HY-169075 | CDK/HDAC-IN-4 | Reference compound | |
| HY-169076 | FLT3/HDAC-IN-1 | Reference compound | |
| HY-169077 | IKZF3 degrader 1 | Reference compound | |
| HY-169078 | ML234 | Reference compound | |
| HY-169079 | RNAP-NusG-IN-1 | Reference compound | |
| HY-16907A | GSK-364735 (potassium) | 912672-93-6 | Reference compound |
| HY-16907B | GSK-364735 (sodium) | 863437-78-9 | Reference compound |
| HY-16908 | Lefamulin | 1061337-51-6 | Reference compound |
| HY-169080 | ABCA1 inducer 1 | 2839627-76-6 | Reference compound |
| HY-169081 | QS-57 | Reference compound | |
| HY-169082 | JQ-1 (carboxylic acid)-NH-C2-NH-COOH | Reference compound | |
| HY-169083 | Bcl-2-IN-22 | Reference compound | |
| HY-169084 | ST-IN-1 | Reference compound | |
| HY-169085 | LRAT-IN-1 | 2820064-05-7 | Reference compound |
| HY-169086 | KL-465 | Reference compound | |
| HY-169087 | MJBIA9836 | Reference compound | |
| HY-169088 | VL285 Phenol-PEG2-Cl | Reference compound | |
| HY-169089 | RP-182-PEG3-K(palmitic acid) | Reference compound | |
| HY-16908A | Lefamulin (acetate) | 1350636-82-6 | Reference compound |
| HY-16908AR | Lefamulin (acetate) (Standard) | 1350636-82-6 | Reference Standards |
| HY-16909 | Leptomycin B | 87081-35-4 | Reference compound |
| HY-169090 | TS-002902 | Reference compound | |
| HY-169091 | TS-002266 | Reference compound | |
| HY-169092 | PF-07957472 | 3041047-51-9 | Reference compound |
| HY-169093 | MS41 | 2768610-97-3 | Reference compound |
| HY-169094 | PFI-6-COOH | 2768514-05-0 | Reference compound |
| HY-169095 | (S,R,S)-AHPC-Me-CO-C9-NH2 | 2458219-94-6 | Reference compound |
| HY-169096 | DPP-21 | 2924883-83-8 | Reference compound |
| HY-169098 | HSP90/LSD1-IN-1 | Reference compound | |
| HY-169099 | Antiproliferative agent-56 | Reference compound | |
| HY-16910 | WIKI4 | 838818-26-1 | Reference compound |
| HY-169100 | Antiproliferative agent-57 | Reference compound | |
| HY-169101 | KSRP-IN-1 | Reference compound | |
| HY-169102 | CHIKV nsP2 protease-IN-1 | Reference compound | |
| HY-169103 | Neuroprotective agent 5 | Reference compound | |
| HY-169104 | InhA-IN-8 | Reference compound | |
| HY-169105 | DNA Gyrase-IN-12 | Reference compound | |
| HY-169106 | Topoisomerase inhibitor 4 | 3021532-95-3 | Reference compound |
| HY-169107 | RIPK1-IN-25 | Reference compound | |
| HY-169108 | DprE1-IN-11 | Reference compound | |
| HY-169109 | DAPK1-IN-1 | 1429522-04-2 | Reference compound |
| HY-16910G | WIKI4 (GMP) | 838818-26-1 | GMP Small Molecules |
| HY-16911 | AFN-1252 | 620175-39-5 | Reference compound |
| HY-169110 | DPP-4-IN-12 | Reference compound | |
| HY-169111 | SHP2-IN-32 | 3043685-80-6 | Reference compound |
| HY-169112 | HCV-IN-46 | Reference compound | |
| HY-169113 | EPZ032597 | 1887193-58-9 | Reference compound |
| HY-169114 | Goxalapladib | 412950-27-7 | Reference compound |
| HY-169115 | PD-0299685 | 313651-33-1 | Reference compound |
| HY-169115A | (Rac)-PD0299685 | 313651-02-4 | Reference compound |
| HY-169116 | D5R agonist 1 | Reference compound | |
| HY-169117 | α-Glucosidase-IN-74 | Reference compound | |
| HY-169118 | EGR-1-IN-2 | 152367-54-9 | Reference compound |
| HY-169119 | Antifungal agent 114 | Reference compound | |
| HY-16911R | AFN-1252 (Standard) | 620175-39-5 | Reference Standards |
| HY-16912 | Petadeferitrin | 911714-45-9 | Reference compound |
| HY-169120 | FKB04 | Reference compound | |
| HY-169122 | LLC1 | Reference compound | |
| HY-169124 | Apoptosis inducer 28 | Reference compound | |
| HY-169125 | HBV-IN-49 | 380458-45-7 | Reference compound |
| HY-169126 | β-catenin modulator IIa-661 | 1015859-04-7 | Reference compound |
| HY-169127 | Seganserin | 87729-89-3 | Reference compound |
| HY-169128 | Clopipazan | 60085-78-1 | Reference compound |
| HY-169129 | LY-295501 | 150869-74-2 | Reference compound |
| HY-16913 | Desferriferrithiocin | 76045-30-2 | Reference compound |
| HY-169130 | Lyso BD-1 | Reference compound | |
| HY-169131 | ALKBH1-IN-3 prodrug | 3056005-98-9 | Reference compound |
| HY-169132 | Anti-MRSA agent 17 | Reference compound | |
| HY-169133 | GDCNF-11 | 2991588-80-6 | Reference compound |
| HY-169134 | PROTAC 20S proteasome subunit β5 degrader 1 | Reference compound | |
| HY-169135 | PROTAC 20S proteasome subunit β5 degrader 2 | Reference compound | |
| HY-169136 | U 101958 | 170856-57-2 | Reference compound |
| HY-169137 | Falintolol | 90581-63-8 | Reference compound |
| HY-169138 | ZD 2138 | 140841-32-3 | Reference compound |
| HY-169139 | Spiroglumide | 137795-35-8 | Reference compound |
| HY-16914 | MC1568 | 852475-26-4 | Reference compound |
| HY-169140 | Zalospirone | 114298-18-9 | Reference compound |
| HY-169141 | BIIB021-NH-C2-piperidine-CO-Me | Reference compound | |
| HY-169142 | N-(7-Aminoheptyl)-2-bromoacetamide | 2863663-69-6 | Reference compound |
| HY-169144 | Bortezomib analog | Reference compound | |
| HY-169146 | Ferroptosis inducer-5 | 3043764-74-2 | Reference compound |
| HY-169147 | MY-11B | 2929223-25-4 | Reference compound |
| HY-169148 | YT117R | Reference compound | |
| HY-16915 | RPR-260243 | 668463-35-2 | Reference compound |
| HY-169150 | JQ-1 carboxylic acid-PEG3-C2-NH2 | 2098790-24-8 | Reference compound |
| HY-169151 | PROTAC BRD4-DCAF1 degrader-1 | 3036944-87-0 | Reference compound |
| HY-169152 | DCAF1 ligand 1 | 3036941-01-9 | Reference compound |
| HY-169153 | Cot inhibitor-3 | 1984784-12-4 | Reference compound |
| HY-169154 | ChlaDUB1-IN-1 | Reference compound | |
| HY-169155 | OsMo | Reference compound | |
| HY-169156 | HDAC6-IN-49 | Reference compound | |
| HY-169157 | HDAC6-IN-50 | 3060094-56-3 | Reference compound |
| HY-169158 | Bortezomib analog 1 | Reference compound | |
| HY-169159 | SIRT6 activator 2 | 2867630-96-2 | Reference compound |
| HY-16916 | NS1643 | 448895-37-2 | Reference compound |
| HY-169160 | Anti-MRSA agent 18 | Reference compound | |
| HY-169161 | Antibacterial agent 245 | 2757692-28-5 | Reference compound |
| HY-169162 | hBChE-IN-3 | Reference compound | |
| HY-169163 | BChE-IN-36 | Reference compound | |
| HY-169164 | Antiproliferative agent-58 | Reference compound | |
| HY-169165 | 14α-Demethylase-IN-1 | 3026164-55-3 | Reference compound |
| HY-169166 | HIV-1 protease-IN-14 | Reference compound | |
| HY-169167 | COX-2-IN-49 | Reference compound | |
| HY-169168 | Herbicidal agent 6 | Reference compound | |
| HY-169169 | Insecticidal agent 14 | Reference compound | |
| HY-169170 | PARP1/BRD4-IN-3 | Reference compound | |
| HY-169171 | Cathepsin L-IN-5 | Reference compound | |
| HY-169172 | Bfl-1-IN-5 | Reference compound | |
| HY-169173 | AL284 | 2270876-07-6 | Reference compound |
| HY-169174 | Antifungal agent 116 | Reference compound | |
| HY-169175 | CN-CC-861 | Reference compound | |
| HY-169176 | LpxC-IN-15 | Reference compound | |
| HY-169177 | JNK-1-IN-4 | 3047795-60-5 | Reference compound |
| HY-169178 | VU6016235 | 2344787-70-6 | Reference compound |
| HY-169179 | AK-1690 | 2984505-88-4 | Reference compound |
| HY-16918 | Heptamidine | 94345-47-8 | Reference compound |
| HY-169180 | AK-068-OH | 2982851-61-4 | Reference compound |
| HY-169181 | Lenalidomide-7-bromohept-1-yne | 2619511-78-1 | Reference compound |
| HY-169182 | AK-068 | 2982851-09-0 | Reference compound |
| HY-169183 | Myokinasib-II | Reference compound | |
| HY-169184 | GDC-9918 | 2570375-06-1 | Reference compound |
| HY-169185 | Sigma-2 Radioligand 2 | 2860554-31-8 | Reference compound |
| HY-169186 | TMV-IN-13 | Reference compound | |
| HY-169187 | Antibacterial agent 247 | Reference compound | |
| HY-169188 | NLRP3-IN-50 | Reference compound | |
| HY-169189 | CD73-IN-18 | 3037968-61-6 | Reference compound |
| HY-16918A | Heptamidine (dimethanesulfonate) | 161374-55-6 | Reference compound |
| HY-169190 | PD-1/PD-L1-IN-53 | 3024006-29-6 | Reference compound |
| HY-169191 | Quorum sensing-IN-8 | Reference compound | |
| HY-169192 | BAR-2227 | 2409154-23-8 | Reference compound |
| HY-169193 | Azocarnil | Reference compound | |
| HY-169194 | Antimalarial agent 44 | Reference compound | |
| HY-169195 | CAIX/CAXII-IN-3 | Reference compound | |
| HY-169196 | D-687 | 2276762-06-0 | Reference compound |
| HY-169197 | D-688 | 2276762-07-1 | Reference compound |
| HY-169198 | GSD-16-24 | Reference compound | |
| HY-169199 | BAY-405 | 2442532-66-1 | Reference compound |
| HY-169200 | SARS-CoV-2 Mpro-IN-26 | Reference compound | |
| HY-169201 | Nrf2 activator-12 | 3020661-05-3 | Reference compound |
| HY-169202 | Antifungal agent 118 | 3055029-65-4 | Reference compound |
| HY-169203 | Antifungal agent 119 | Reference compound | |
| HY-169204 | Mito-fisetin mF3 | Reference compound | |
| HY-169205 | AChE/BChE-IN-22 | Reference compound | |
| HY-169206 | PF-3166 | Reference compound | |
| HY-169207 | NNRT-IN-5 | 3032803-00-9 | Reference compound |
| HY-169208 | MerTK-IN-1 | 3036376-10-7 | Reference compound |
| HY-169209 | CA-M11 | Reference compound | |
| HY-169210 | ECDD-S18 | Reference compound | |
| HY-169211 | DHFR-IN-21 | Reference compound | |
| HY-169212 | I194496 | 445238-07-3 | Reference compound |
| HY-169213 | LN-439A | 2991822-04-7 | Reference compound |
| HY-169214 | AV22-149 | Reference compound | |
| HY-169215 | Anti-inflammatory agent 93 | Reference compound | |
| HY-169216 | Multi-target kinase inhibitor 3 | Reference compound | |
| HY-169217 | CYP3A4-IN-4 | Reference compound | |
| HY-169218 | WK692 | 2694055-38-2 | Reference compound |
| HY-169219 | DK06 | Reference compound | |
| HY-169220S | RORγ/DHODH-IN-1 | 3000567-76-7 | Isotope-Labeled Compounds |
| HY-169221 | Perindopril arginine | 612548-45-5 | Reference compound |
| HY-169222S | RORγ/DHODH-IN-2 | 3000567-45-0 | Isotope-Labeled Compounds |
| HY-169223 | Roxatidine (hydrochloride) | 97900-88-4 | Reference compound |
| HY-169224 | SARS-CoV-2-IN-100 | 374543-46-1 | Reference compound |
| HY-169225 | PDIC-NN | 932740-48-2 | Reference compound |
| HY-169226 | HDAC6-IN-51 | 2994634-78-3 | Reference compound |
| HY-169227 | NLRP3-IN-55 | Reference compound | |
| HY-169228 | WS-11 | 2759280-09-4 | Reference compound |
| HY-169229 | GM-60186 | Reference compound | |
| HY-16923 | Crobenetine | 221019-25-6 | Reference compound |
| HY-169230 | BCR-ABL-IN-9 | Reference compound | |
| HY-169231 | BCR-ABL-IN-10 | Reference compound | |
| HY-169232 | PCC16 (chloride) | Peptides | |
| HY-169233 | MED6-189 | 2650073-66-6 | Reference compound |
| HY-169234 | BChE-IN-35 | Reference compound | |
| HY-169235 | DHHC3 degrader 1 | Reference compound | |
| HY-169236 | COOH-C-PEG2-NHCO-C2-COOH | 947504-71-4 | Reference compound |
| HY-169237 | Pomalidomide-C2-CONH-PEG2-C-COOH | Reference compound | |
| HY-169238 | 17β-HSD7-IN-1 | Reference compound | |
| HY-169239 | MAGL-IN-20 | 2607107-76-4 | Reference compound |
| HY-16923A | Crobenetine (hydrochloride) | 221018-88-8 | Reference compound |
| HY-169240 | MX69-102 | Reference compound | |
| HY-169241 | B3 | Reference compound | |
| HY-169242 | JAK1-IN-16 | Reference compound | |
| HY-169244 | CDK-TCIP1 | 3008612-35-6 | Reference compound |
| HY-169245 | CDK-TCIP2 | Reference compound | |
| HY-169246 | CDK2-IN-32 | Reference compound | |
| HY-169247 | Pam2CS-DMAPA | Reference compound | |
| HY-169248 | DNA-PK-IN-15 | 2663852-17-1 | Reference compound |
| HY-169249 | Aekatperone | Reference compound | |
| HY-16925 | MI-503 | 1857417-13-0 | Reference compound |
| HY-169250 | TMPRSS13-IN-1 | Peptides | |
| HY-169251 | α-Glucosidase-IN-75 | Reference compound | |
| HY-169252 | Antifungal agent 121 | 343362-45-8 | Reference compound |
| HY-169253 | ROS inducer 5 | Reference compound | |
| HY-169254 | sPLA2 inhibitor 2 | Reference compound | |
| HY-169255 | sPLA2 inhibitor 3 | Reference compound | |
| HY-169256 | ZINC4497834 | 767310-01-0 | Reference compound |
| HY-169257 | SCR-7952 | 2798856-04-7 | Reference compound |
| HY-169258 | PDE4-IN-21 | Reference compound | |
| HY-169259 | HDAC9-IN-1 | Reference compound | |
| HY-16926 | CK-666 | 442633-00-3 | Reference compound |
| HY-169260 | SARS-CoV-2 Mpro-IN-27 | Reference compound | |
| HY-169261 | 7-Methoxy-9-methylfuro[2,3-b]-quinoline-4,5,8(9H)-trione | 859304-28-2 | Reference compound |
| HY-169262 | PLD-IN-1 | Reference compound | |
| HY-169263 | AC10142A | 2963581-29-3 | Reference compound |
| HY-169264 | SJYHJ-026 | Reference compound | |
| HY-169265 | BRD-K20733377 | 452350-43-5 | Reference compound |
| HY-169266 | BRD-K56819078 | 693231-07-1 | Reference compound |
| HY-169267 | BRD-K44839765 | 303066-86-6 | Reference compound |
| HY-169268 | Aβ-IN-10 | Reference compound | |
| HY-169269 | PROTAC SMARCA2 degrader-18 | 2408393-47-3 | Reference compound |
| HY-16927 | CK-869 | 388592-44-7 | Reference compound |
| HY-169270 | PROTAC SMARCA2 degrader-19 | 2567913-00-0 | Reference compound |
| HY-169271 | PROTAC SMARCA2 degrader-20 | 2660324-41-2 | Reference compound |
| HY-169272 | PROTAC SMARCA2 degrader-21 | 2891464-61-0 | Reference compound |
| HY-169273 | PROTAC SMARCA2 degrader-22 | 2760246-90-8 | Reference compound |
| HY-169274 | PROTAC SMARCA2 degrader-23 | 2892523-67-8 | Reference compound |
| HY-169275 | PROTAC SMARCA2 degrader-24 | 2755761-70-5 | Reference compound |
| HY-169276 | PROTAC SMARCA2 degrader-25 | 2770571-17-8 | Reference compound |
| HY-169277 | PXR Ligand 1 | Reference compound | |
| HY-169278 | PROTAC SMARCA2 degrader-26 | 2760247-27-4 | Reference compound |
| HY-169279 | PROTAC SMARCA2/4-degrader-34 | Reference compound | |
| HY-16928 | Cytochalasin B | 14930-96-2 | Natural Products |
| HY-169280 | PXR Ligand 2 | 3059971-00-2 | Reference compound |
| HY-169281 | Antiviral agent 61 | Reference compound | |
| HY-169282 | RGS2–Galpha-q interaction-IN-1 | Reference compound | |
| HY-169283 | α-Glycosidase-IN-2 | Reference compound | |
| HY-169284 | Polθ-IN-5 | 3058636-12-4 | Reference compound |
| HY-169285 | Polθ-IN-6 | 3058496-94-6 | Reference compound |
| HY-169286 | [Au(L4)(CyJohnPhos)]SbF6 | Reference compound | |
| HY-169287 | TriPEX-ClO4 | Reference compound | |
| HY-169288 | α-Synuclein modulator 1 | 3058709-40-0 | Reference compound |
| HY-169289 | PIQ-2 | 3035141-23-9 | Reference compound |
| HY-16928R | Cytochalasin B (Standard) | 14930-96-2 | Reference Standards |
| HY-16929 | Latrunculin A | 76343-93-6 | Natural Products |
| HY-169290 | JAK/HDAC-IN-4 | Reference compound | |
| HY-169291 | Antiviral agent 62 | Reference compound | |
| HY-169292 | Antitumor agent-188 | Reference compound | |
| HY-169293 | Antiproliferative agent-63 | 3048082-38-5 | Reference compound |
| HY-169294 | SLC6A8 corrector 1 | Reference compound | |
| HY-169295 | RAP 1 | 2220208-75-1 | Reference compound |
| HY-169296 | IMPDH2-IN-4 | Reference compound | |
| HY-169298 | Ferroptosis-IN-15 | 1260669-24-6 | Reference compound |
| HY-169299 | TOPOI/PARP-1-IN-2 | Reference compound | |
| HY-169300 | KR-40795 | Reference compound | |
| HY-169301 | Gpr35 modulator 1 | 2994189-01-2 | Reference compound |
| HY-169302 | GPR35 activator-1 | 2855918-34-0 | Reference compound |
| HY-169303 | Gpr35 modulator 2 | 3049339-96-7 | Reference compound |
| HY-169304 | Gpr35 modulator 3 | 3055887-18-5 | Reference compound |
| HY-169306 | IL-17A inhibitor 4 | Reference compound | |
| HY-169307 | BTK-IN-38 | 2758410-51-2 | Reference compound |
| HY-169308 | EGFR-IN-132 | 2809982-20-3 | Reference compound |
| HY-169309 | EGFR-IN-133 | 2809982-26-9 | Reference compound |
| HY-16931 | SMIFH2 | 340316-62-3 | Reference compound |
| HY-169310 | ATM Inhibitor-11 | 2878473-51-7 | Reference compound |
| HY-169311 | KRAS inhibitor-37 | 3058573-95-5 | Reference compound |
| HY-169312 | KRAS inhibitor-38 | 3059496-10-2 | Reference compound |
| HY-169313 | HRSV/HMPV-IN-1 | 2994287-06-6 | Reference compound |
| HY-169314 | JNK-IN-19 | 3059122-56-1 | Reference compound |
| HY-169315 | Nrf2 activator 17 | 3059044-55-9 | Reference compound |
| HY-169316 | YAP/TAZ inhibitor-4 | Reference compound | |
| HY-169317 | DGKζ-IN-6 | 3058005-75-4 | Reference compound |
| HY-169318 | DGKζ-IN-7 | 3058006-33-7 | Reference compound |
| HY-169319 | FAK-IN-21 | 2919213-32-2 | Reference compound |
| HY-169320 | SJPYT-328 | 2998548-72-2 | Reference compound |
| HY-169321 | 20:2 (11,14) Cholesterol ester | 70110-48-4 | Reference compound |
| HY-169322 | APL-1081 | 2921735-80-8 | ADC Related |
| HY-169323 | APL-1091 | 2921735-87-5 | Reference compound |
| HY-169324 | APL-1092 | 2921735-91-1 | ADC Related |
| HY-169325 | (S)-ACE-OH | Reference compound | |
| HY-169326S | JAK2-IN-11 | 3057053-17-2 | Isotope-Labeled Compounds |
| HY-169327 | MD-265 | 2415160-21-1 | Reference compound |
| HY-169328 | Tyrosinase-IN-39 | Reference compound | |
| HY-169329 | BIO-2007817 | Reference compound | |
| HY-16933 | L-Alanosine | 5854-93-3 | Reference compound |
| HY-169330 | 3β,5α,6β-Trihydroxycholanic acid | 16030-92-5 | Reference compound |
| HY-169331 | H2S scavenger 1 (triflate) | Reference compound | |
| HY-169332 | Piezo1 agonist 1-d2 | 3058199-62-2 | Isotope-Labeled Compounds |
| HY-169333 | 1,4-Dihydropyridine | Reference compound | |
| HY-169334 | BDK-IN-1 | Reference compound | |
| HY-169335 | HIV-1 inhibitor-77 | Reference compound | |
| HY-169336 | CQ-16 | 3024354-59-1 | Reference compound |
| HY-169338 | Antibacterial agent 253 | Reference compound | |
| HY-169339 | Villalstonine | 2723-56-0 | Natural Products |
| HY-16934 | ML352 | 1649450-12-3 | Reference compound |
| HY-169340 | SAR-150640 | 433212-21-6 | Reference compound |
| HY-169342 | ETD001 | 2227484-71-9 | Reference compound |
| HY-169343 | FIZ1 degrader 1 | 1957235-62-9 | Reference compound |
| HY-169344 | CDK7-IN-31 | 2943043-62-5 | Reference compound |
| HY-169345 | VU6043653 | 3032791-06-0 | Reference compound |
| HY-169346 | Pred17 | Reference compound | |
| HY-169347 | dCK1α-2 | Reference compound | |
| HY-169348 | β-catenin-IN-8 | 259130-14-8 | Reference compound |
| HY-169349 | Androgen receptor antagonist 12 | 6605-17-0 | Reference compound |
| HY-16935 | Mavatrep | 956274-94-5 | Reference compound |
| HY-169350 | EA-B2L | 1354444-72-6 | Reference compound |
| HY-169352 | Mal-Exo-EVC | Reference compound | |
| HY-169353 | Mal-Exo-EEVC | Reference compound | |
| HY-169354 | Lariciresinol 4-O-β-D-glucopyranoside | 143663-00-7 | Natural Products |
| HY-169355 | TrimTAC1 | Reference compound | |
| HY-169356 | Acepromazine-OTs | 102951-20-2 | Reference compound |
| HY-169357 | Acepromazine-1-Piperazinepropanamine | Reference compound | |
| HY-169358 | L134 | Reference compound | |
| HY-169359 | L321 | Reference compound | |
| HY-16935S | Mavatrep-d6 | Isotope-Labeled Compounds | |
| HY-16936 | JH-II-127 | 1700693-08-8 | Reference compound |
| HY-169360 | SD-436 | 2497585-50-7 | Reference compound |
| HY-169361 | STAT3 ligand 5 | Reference compound | |
| HY-169362 | Lenalidomide-Pip-butyn | 2497589-76-9 | Reference compound |
| HY-169363 | PDL1 degrader-2 | Reference compound | |
| HY-169364 | 2-Methylbiphenyl-oxadiazole-NH-Ph-NH-PEG3-C2-NH-Boc | Reference compound | |
| HY-169365 | 2-Methylbiphenyl-oxadiazole-NH-Ph-CHO | 2766689-18-1 | Reference compound |
| HY-169366 | Bis[bis(3,5-dimethylphenyl)phosphino]methane | 167109-95-7 | Reference compound |
| HY-169367 | ERD-1233 | Reference compound | |
| HY-169368 | Thalidomide-O-Triazole-C4-amino | 2412988-59-9 | Reference compound |
| HY-169369 | TRAP-1 | Reference compound | |
| HY-16937 | ISA-2011B | 1395347-24-6 | Reference compound |
| HY-169370 | STAT3 HiBiT degrader 1 | 2767166-30-1 | Reference compound |
| HY-169371 | SOS1 Ligand intermediate-7 | 2836274-66-7 | Reference compound |
| HY-169372 | (S,R,S)-AHPC-CO-C4-bromine | 2162120-79-6 | Reference compound |
| HY-169373 | Lenalidomide-Glycolic acid | 2229976-15-0 | Reference compound |
| HY-169374 | Naproxen Gilteritinib | 1373410-40-2 | Reference compound |
| HY-169375 | RSL3-4-Me | 3049087-33-1 | Reference compound |
| HY-169376 | Boc-piperazine-C13-OTs | 2700269-84-5 | Reference compound |
| HY-169377 | Lenalidomide-C13-piperazine-Boc | 3043895-40-2 | Reference compound |
| HY-169378 | CSI86 | Reference compound | |
| HY-169379 | CSI118 (TFA) | 3063898-01-8 | Reference compound |
| HY-16938 | 5'-Methylthioadenosine | 2457-80-9 | Natural Products |
| HY-169380 | PARL-IN-2 | Reference compound | |
| HY-169381 | hMcl-1-IN-1 | Reference compound | |
| HY-169382 | Melatonin-Tamoxifen Conjugate | Reference compound | |
| HY-169383 | FA4-Cu | Reference compound | |
| HY-169384 | Antimycobacterial agent-10 | Reference compound | |
| HY-169385 | ATC-324 | 2925060-81-5 | Reference compound |
| HY-169386 | YT 6-2 analog-1 | 2409960-12-7 | Reference compound |
| HY-169387 | YT 6-2-PEG3-C2-NH2 | Reference compound | |
| HY-169388 | YT 6-2 | 2409959-90-4 | Reference compound |
| HY-169389 | OICR41114 | Reference compound | |
| HY-16938R | 5'-Methylthioadenosine (Standard) | 2457-80-9 | Reference Standards |
| HY-16938S | 5'-Methylthioadenosine-13C6 | 2421187-73-5 | Isotope-Labeled Compounds |
| HY-16938S1 | 5'-Methylthioadenosine-d3 | 174838-38-1 | Isotope-Labeled Compounds |
| HY-169390 | OICR-8268-acrylic acid | Reference compound | |
| HY-169391 | OICR-8268-acrylic acid-amino-PEG9-amine | Reference compound | |
| HY-169392 | D5B | Reference compound | |
| HY-169393 | N-Butyl lithocholic acid | 135013-42-2 | Reference compound |
| HY-169394 | 5-HT1AR agonist 2 | Reference compound | |
| HY-169395 | (S,R,S)-AHPC-CO-PEG-C2-iodine | 3057447-11-4 | Reference compound |
| HY-169396 | TAE648 | 2769753-10-6 | Reference compound |
| HY-169397 | Thalidomide-NH-CH2-CONH-C2-PEG-bromine | Reference compound | |
| HY-16940 | 24(S)-Hydroxycholesterol | 474-73-7 | Natural Products |
| HY-169400 | HDACs/EZH2-IN-1 | Reference compound | |
| HY-169401 | L321-NH-C3-PEG3-C1-NH2 | Reference compound | |
| HY-169402 | PDE1-IN-9 | 2982945-41-3 | ADC Related |
| HY-169403 | NW16 | Reference compound | |
| HY-169404 | PPARγ agonist 15 | Reference compound | |
| HY-169405 | AAK1/HDACs-IN-1 | Reference compound | |
| HY-169406 | α-Glucosidase-IN-76 | Reference compound | |
| HY-169407 | AKT-IN-24 | Reference compound | |
| HY-169408 | EGFR-IN-137 | Reference compound | |
| HY-169409 | VEGFR-2-IN-59 | Reference compound | |
| HY-16940A | 24(R)-Hydroxycholesterol | 27460-26-0 | Reference compound |
| HY-16941 | Damulin A | 1202868-74-3 | Natural Products |
| HY-169410 | SARS-CoV-2 3CLpro-IN-29 | Reference compound | |
| HY-169411 | α-Glucosidase-IN-77 | Reference compound | |
| HY-169412 | MAPK-IN-3 | 2848599-79-9 | Reference compound |
| HY-169413 | AKT-IN-25 | 1619929-59-7 | Reference compound |
| HY-169414 | WRN inhibitor 15 | Reference compound | |
| HY-169415 | DBL-6-13 | Reference compound | |
| HY-169416 | Anti-MRSA agent 21 | 3060716-02-8 | Reference compound |
| HY-169418 | Tubulin polymerization-IN-71 | Reference compound | |
| HY-169419 | SARS-CoV-2-IN-108 | Reference compound | |
| HY-16942 | Damulin B | 1202868-75-4 | Natural Products |
| HY-169420 | IL-6-IN-1 | Reference compound | |
| HY-169421 | Nav1.7-IN-18 | Reference compound | |
| HY-169422 | GSK4418959 | 3064599-36-3 | Reference compound |
| HY-169423 | WRN inhibitor 17 | 3064599-40-9 | Reference compound |
| HY-169424 | WRN inhibitor 18 | 3064599-42-1 | Reference compound |
| HY-169425 | TMV-IN-14 | 3051649-38-5 | Reference compound |
| HY-169426 | Anti-amyloid agent-2 | Reference compound | |
| HY-169427 | FRF-06-057 | Reference compound | |
| HY-169428 | EGFR-IN-138 | Reference compound | |
| HY-169429 | CHIKV-IN-5 | 2568903-91-1 | Reference compound |
| HY-16943 | Moiramide B | 155233-31-1 | Reference compound |
| HY-169430 | AGU654 | 3038861-74-1 | Reference compound |
| HY-169431 | VEGFR-2/AKT-IN-2 | Reference compound | |
| HY-169432 | TET-13 | Reference compound | |
| HY-169433 | Naph-Se-TMZ | Reference compound | |
| HY-169434 | LTB | Reference compound | |
| HY-169435 | TK-OH | 861587-94-2 | Reference compound |
| HY-169436 | Lon-TK | Reference compound | |
| HY-169437 | Nitro-Naphthalimide-C2-acylamide | 2097636-43-4 | Reference compound |
| HY-169438 | NNISC-2 | 2097636-47-8 | Reference compound |
| HY-169439 | Temozolomide-amino (hydrochloride) | 449187-98-8 | Reference compound |
| HY-169440 | 6-Fluoro-N,N-diethyltryptamine | 2836-69-3 | Reference compound |
| HY-169442 | Methylmethaqualone | 1915-80-6 | Reference compound |
| HY-169443 | Nitromethaqualone | 340-52-3 | Reference compound |
| HY-169445 | (±)-Meclonazepam | 67027-56-9 | Reference compound |
| HY-169446 | ALEPH (hydrochloride) | 61638-08-2 | Reference compound |
| HY-169447 | 2,3,4-Trimethoxyamphetamine (hydrochloride) | 6010-77-1 | Reference compound |
| HY-169448 | Ethylpropyltryptamine | 850032-68-7 | Reference compound |
| HY-169449 | 16-Carboxymitragynine | 1224429-90-6 | Reference compound |
| HY-169450 | (-)-9-Hydroxycorynantheidine | 425623-55-8 | Reference compound |
| HY-169451 | Cannabidiolic acid methyl ester | 55658-71-4 | Reference compound |
| HY-169452 | Cannabidiol-C4 | Reference compound | |
| HY-169453 | Cannabigerobutol | 2468125-69-9 | Reference compound |
| HY-169457 | Aeruginascin | 114264-95-8 | Reference compound |
| HY-169459 | Δ8-THCH | 20622-30-4 | Reference compound |
| HY-16946 | CP-610431 | 591778-83-5 | Reference compound |
| HY-169460 | 6-Methoxy DMT | 2426-88-2 | Reference compound |
| HY-169461 | Δ8-THCO | 22972-64-1 | Reference compound |
| HY-169462 | CBDE | 2552798-14-6 | Reference compound |
| HY-169463 | 11-Hydroxy cannabinol | 30432-08-7 | Reference compound |
| HY-169464 | Cannabinol-7-oic acid | 53989-32-5 | Reference compound |
| HY-169465 | 3-Methyl phencyclidine (hydrochloride) | 91164-59-9 | Reference compound |
| HY-169466 | 5-Methoxy-N,N-dimethyltryptamine Nb-oxide | 4006-02-4 | Reference compound |
| HY-169467 | 5-Chloro-α-methyltryptamine | 712-07-2 | Reference compound |
| HY-169468 | Δ8-THC-C8 | 431041-39-3 | Reference compound |
| HY-169469 | N-Phenethylnoroxymorphone | 4778-94-3 | Reference compound |
| HY-169470 | Pridinol (hydrochloride) | 968-58-1 | Reference compound |
| HY-169471 | 4ʹ-Chloro deschloroalprazolam | 92262-72-1 | Reference compound |
| HY-169472 | 11-Deoxy prostaglandin F1β | 37785-99-2 | Reference compound |
| HY-169473 | 1,2,3-Tri-13(E)-docosenoyl glycerol | 37635-44-2 | Reference compound |
| HY-169474 | Starburst 1st generation (13.93% in water) | 142986-44-5 | Reference compound |
| HY-169475 | 1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin | 19408-74-3 | Reference compound |
| HY-169476 | Pyrrolidine linoleamide | 3140-51-0 | Reference compound |
| HY-169477 | PAMAM dendrimer G0.5 carboxylate (sodium) | 339334-01-9 | Reference compound |
| HY-169478 | Lipid N2-3L | 2924606-55-1 | Oligonucleotides |
| HY-169479 | Betulinic glycine amide | 174740-40-0 | Reference compound |
| HY-169480 | Lipid C2 | 3003022-09-8 | Reference compound |
| HY-169481 | AP-1 | 3027918-96-0 | Reference compound |
| HY-169482 | ALK protein ligand-1 | 2764870-80-4 | Reference compound |
| HY-169483 | PDIC-NC | 2633013-75-7 | Reference compound |
| HY-169484 | SIL lipid | 1566559-79-2 | Reference compound |
| HY-169485 | Aspinolide B | 188605-15-4 | Reference compound |
| HY-169486 | D-threo-Biopterin | 13019-52-8 | Reference compound |
| HY-169487 | SMARCA2 ligand-12 | 2755762-94-6 | Reference compound |
| HY-169488 | SMARCA2 ligand-12-3-methylazetidine | Reference compound | |
| HY-169489 | 2F-Pyrimidine-piperidine-spiro[3.3]heptane-acid | Reference compound | |
| HY-169490 | Target Protein Ligand-Linker Conjugates 4 | Reference compound | |
| HY-169491 | Pantothenate-AMC | 1224691-12-6 | Reference compound |
| HY-169492 | Triglyceride OLO,sn | 2190-19-4 | Reference compound |
| HY-169493 | OPPD-Q | 2952779-34-7 | Reference compound |
| HY-169494 | Karrikinolide 3-ethyl ester | 1030604-40-0 | Reference compound |
| HY-169495 | ent-Corey PG-lactone diol | 53110-06-8 | Reference compound |
| HY-169496 | TBS-Corey lactone aldehyde | "64091-14-1" | Reference compound |
| HY-169497 | MTDB | 1063592-32-4 | Reference compound |
| HY-169498 | 2-Dodecylfuran | 75308-12-2 | Reference compound |
| HY-169499 | (R)-2-(3-(2-Ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxylic Acid | 1809064-89-8 | Reference compound |
| HY-16950 | 4-Hydroxytamoxifen | 68047-06-3 | Reference compound |
| HY-169500 | Mitomycin Z | 74148-47-3 | Reference compound |
| HY-169501 | WIN 62577 | 138091-43-7 | Reference compound |
| HY-169502 | Lobatoside C | 124275-97-4 | Reference compound |
| HY-169504 | MI-4F | 346460-45-5 | Reference compound |
| HY-169505 | Aurora kinase inhibitor-13 | 792965-51-6 | Reference compound |
| HY-169506 | Angolamycin | 1402-83-1 | Reference compound |
| HY-169507 | Anthelvencin A | 58616-25-4 | Reference compound |
| HY-169508 | BMD4503-1 | 301357-76-6 | Reference compound |
| HY-169509 | Topoisomerase I/II inhibitor 8 | 355400-87-2 | Reference compound |
| HY-16950A | (E/Z)-4-Hydroxytamoxifen | 68392-35-8 | Reference compound |
| HY-16950AR | (E/Z)-4-Hydroxytamoxifen (Standard) | 68392-35-8 | Reference Standards |
| HY-16950B | (E)-4-Hydroxytamoxifen | 174592-47-3 | Reference compound |
| HY-16950BS | (E)-4-Hydroxytamoxifen-d5 | Isotope-Labeled Compounds | |
| HY-16951 | VU-1545 | 890764-63-3 | Reference compound |
| HY-169510 | Aurachin C | 108354-14-9 | Natural Products |
| HY-169511 | Anthrotainin | 148084-40-6 | Reference compound |
| HY-169512 | MMB-4 | 2058-89-1 | Reference compound |
| HY-169513 | MK2-IN-7 | 77607-70-6 | Reference compound |
| HY-169514 | TrkA-IN-8 | 128889-33-8 | Reference compound |
| HY-169516 | VEGFR-2-IN-65 | 371213-22-8 | Reference compound |
| HY-169517 | Protein kinase inhibitor 10 | 871317-00-9 | Reference compound |
| HY-169518 | TERT activator-2 | 332939-29-4 | Reference compound |
| HY-16952 | Bepridil | 64706-54-3 | Reference compound |
| HY-169520 | VEGFR/PDGFR-IN-1 | 342785-98-2 | Reference compound |
| HY-169521 | DNA Gyrase-IN-16 | 756843-31-9 | Reference compound |
| HY-16952A | Bepridil (hydrochloride hydrate) | 74764-40-2 | Reference compound |
| HY-16953 | JNJ 303 | 878489-28-2 | Reference compound |
| HY-169534 | AKT-IN-26 | 547704-53-0 | Reference compound |
| HY-169536 | CFTR activator 2 | 871700-29-7 | Reference compound |
| HY-16954 | ARV-825 | 1818885-28-7 | Reference compound |
| HY-169541 | CDK8-IN-18 | 642002-74-2 | Reference compound |
| HY-169545 | Glucokinase activator 8 | 349549-38-8 | Reference compound |
| HY-169546 | TrkA-IN-7 | 296888-45-4 | Reference compound |
| HY-169547 | ETNK-IN-1 | 301330-94-9 | Reference compound |
| HY-16955 | Plazomicin | 1154757-24-0 | Reference compound |
| HY-169551 | ATPase-IN-5 | 401590-85-0 | Reference compound |
| HY-169555 | ASK1-IN-7 | 1427537-92-5 | Reference compound |
| HY-169556 | CK1δ-IN-7 | 882220-11-3 | Reference compound |
| HY-169557 | CDKI-IN-1 | 1185726-51-5 | Reference compound |
| HY-16955A | Plazomicin (sulfate) | 1380078-95-4 | Reference compound |
| HY-16956 | Onatasertib | 1228013-30-6 | Reference compound |
| HY-169565 | ETNK-IN-2 | 301330-81-4 | Reference compound |
| HY-169566 | EGFR-IN-146 | 166039-38-9 | Reference compound |
| HY-169567 | PKM2-IN-9 | 498568-75-5 | Reference compound |
| HY-169568 | EGFR-IN-147 | 91769-08-3 | Reference compound |
| HY-169569 | β-Catenin modulator-8 | 902586-39-4 | Reference compound |
| HY-16957 | LJ001 | 851305-26-5 | Reference compound |
| HY-169570 | EGFR-IN-149 | 401638-52-6 | Reference compound |
| HY-169571 | Antimicrobial agent-38 | 430444-03-4 | Reference compound |
| HY-169572 | IGF-1R inhibitor-5 | 331652-38-1 | Reference compound |
| HY-169573 | Casein kinase 1δ-IN-16 | 851467-69-1 | Reference compound |
| HY-169574 | Casein kinase 1δ-IN-17 | 450394-66-8 | Reference compound |
| HY-169575 | PARP1-IN-36 | 1606996-12-6 | Reference compound |
| HY-169576 | LRRK2-IN-16 | 852375-30-5 | Reference compound |
| HY-169577 | Casein kinase 1δ-IN-18 | 522626-08-0 | Reference compound |
| HY-169578 | PKC-IN-5 | 904458-98-6 | Reference compound |
| HY-169579 | PLK1-IN-11 | 73663-97-5 | Oligonucleotides |
| HY-16958 | PD 404182 | 72596-74-8 | Reference compound |
| HY-169581 | DIM-C-pPhtBu | 94944-80-6 | Reference compound |
| HY-169587 | Protein kinase G inhibitor-3 | 331964-66-0 | Reference compound |
| HY-16958R | PD 404182 (Standard) | 72596-74-8 | Reference Standards |
| HY-16959 | CEP dipeptide 1 | 816432-15-2 | Peptides |
| HY-169592 | Autophagy-IN-7 | 324031-29-0 | Reference compound |
| HY-169596 | Arphamenine A | 96551-81-4 | Reference compound |
| HY-169600 | IGF-1R inhibitor-4 | 443097-57-2 | Reference compound |
| HY-169602 | GSK-3β inhibitor 26 | 70169-39-0 | Reference compound |
| HY-169603 | AZ513 | 1335231-15-6 | Reference compound |
| HY-169605 | LIMK1 inhibitor 1 | 332904-10-6 | Reference compound |
| HY-169606 | GSK-3β inhibitor 25 | 75620-25-6 | Reference compound |
| HY-169608 | BCR-ABL-IN-11 | 2362-25-6 | Reference compound |
| HY-169609 | JNK-IN-22 | 771503-50-5 | Reference compound |
| HY-16961 | Sitravatinib | 1123837-84-2 | Reference compound |
| HY-169611 | Serotonin (maleate) | 18525-25-2 | Reference compound |
| HY-169614 | 2002-G12 | 313666-93-2 | Reference compound |
| HY-16961A | Sitravatinib (malate) | 2244864-88-6 | Reference compound |
| HY-16962 | CC-115 | 1228013-15-7 | Reference compound |
| HY-169622 | RAD51-IN-9 | 103056-35-5 | Reference compound |
| HY-169623 | FGFR1 inhibitor-14 | 442534-83-0 | Reference compound |
| HY-169624 | GPV574 | 635703-12-7 | Reference compound |
| HY-169626 | VEGFR-IN-6 | 683235-34-9 | Reference compound |
| HY-169627 | VEGFR-IN-7 | 683235-33-8 | Reference compound |
| HY-169628 | Topoisomerase I/II inhibitor 7 | 489413-54-9 | Reference compound |
| HY-169629 | CK2 inhibitor 4 | 474263-21-3 | Reference compound |
| HY-16962A | CC-115 (hydrochloride) | 1300118-55-1 | Reference compound |
| HY-16963 | GW627368 | 439288-66-1 | Reference compound |
| HY-169630 | DBMB | 314027-66-2 | Reference compound |
| HY-169632 | GSK3β-IN-1 | 757198-76-8 | Reference compound |
| HY-169633 | CDK8-IN-17 | 451458-32-5 | Reference compound |
| HY-169634 | JD118 | 315704-83-7 | Reference compound |
| HY-169635 | Mycobacterium Tuberculosis-IN-6 | 260428-61-3 | Reference compound |
| HY-16965 | TH287 | 1609960-30-6 | Reference compound |
| HY-169651 | GABA-IN-4 | 61-38-1 | Reference compound |
| HY-169652 | NPC26 | 864860-32-2 | Reference compound |
| HY-169657 | UMPK ligand 1 | 1621866-83-8 | Reference compound |
| HY-169659 | 8-Methyl-4-oxo-N,N-dipropyl-4H-thieno[3,2-c]chromene-2-carboxamide | 902516-53-4 | Reference compound |
| HY-16965A | TH287 (hydrochloride) | 1638211-05-8 | Reference compound |
| HY-16966 | SBI-0206965 | 1884220-36-3 | Reference compound |
| HY-169668 | WAY-606344 | 380423-28-9 | Reference compound |
| HY-169669 | FGFR1 inhibitor-17 | 308298-51-3 | Reference compound |
| HY-16967 | MM41 | 1429028-96-5 | Reference compound |
| HY-169670 | Protein kinase inhibitor 13 | 721964-45-0 | Reference compound |
| HY-169671 | 21H7 | 217317-45-8 | Reference compound |
| HY-169674 | JNK-IN-20 | 346663-56-7 | Reference compound |
| HY-169675 | Lacripep | 2243095-21-6 | Reference compound |
| HY-169677 | Casein kinase 1δ-IN-30 | 849012-74-4 | Reference compound |
| HY-169678 | GRK6-IN-5 | 33495-39-5 | Reference compound |
| HY-16968 | SW033291 | 459147-39-8 | Reference compound |
| HY-169683 | CDK2-IN-39 | 730945-59-2 | Reference compound |
| HY-169684 | Vaccarin C | 177602-12-9 | Reference compound |
| HY-169685 | p38 MAPK-IN-6 | 421578-44-1 | Reference compound |
| HY-169688 | NA-17 | 1708948-28-0 | Reference compound |
| HY-169689 | Casein kinase 1δ-IN-19 | 782452-74-8 | Reference compound |
| HY-16969 | Dihexa | 1401708-83-5 | Reference compound |
| HY-169690 | Casein kinase 1δ-IN-20 | 757224-44-5 | Reference compound |
| HY-169692 | Casein kinase 1δ-IN-21 | 782457-22-1 | Reference compound |
| HY-169697 | Thiocillin | 4414-51-1 | Reference compound |
| HY-169699 | 2-Chloromethcathinone (hydrochloride) | 90869-66-2 | Reference compound |
| HY-169701 | Casein kinase 1δ-IN-22 | 756849-12-4 | Reference compound |
| HY-169702 | Casein kinase 1δ-IN-23 | 729579-66-2 | Reference compound |
| HY-169703 | SPA0355 | 1251839-15-2 | Reference compound |
| HY-169704 | Ogerin analogue 1 | 1125453-08-8 | Reference compound |
| HY-169705 | Casein kinase 1δ-IN-24 | 326034-30-4 | Reference compound |
| HY-169706 | Casein kinase 1δ-IN-25 | 753468-25-6 | Reference compound |
| HY-169707 | GCGR antagonist 3 | 1421349-19-0 | Reference compound |
| HY-169708 | PRMT5-IN-49 | 428853-17-2 | Reference compound |
| HY-169709 | Casein kinase 1δ-IN-26 | 756857-71-3 | Reference compound |
| HY-169710 | FGFR1 inhibitor-16 | 606958-57-0 | Reference compound |
| HY-169713 | CK1δ-IN-5 | 956753-89-2 | Reference compound |
| HY-169719 | CK1δ-IN-6 | 565167-37-5 | Reference compound |
| HY-16972 | SR9243 | 1613028-81-1 | Reference compound |
| HY-169723 | CP 524515 | 262352-13-6 | Reference compound |
| HY-169724 | RBx-0597 | 929105-33-9 | Reference compound |
| HY-169728 | SID 24785302 | 378197-09-2 | Reference compound |
| HY-16973 | Fluralaner | 864731-61-3 | Reference compound |
| HY-169730 | Wnt pathway inhibitor 5 | 1385817-77-5 | Reference compound |
| HY-169731 | RO27-3225 (trifluoroacetate) | 1373926-49-8 | Reference compound |
| HY-169732 | Gadoquatrane | 2048221-65-2 | Reference compound |
| HY-169735 | Aurora A inhibitor 4 | 371224-09-8 | Reference compound |
| HY-169736 | JNK-IN-21 | 756849-36-2 | Reference compound |
| HY-169737 | Inulobiose | 470-58-6 | Reference compound |
| HY-169739 | DG 381B | 564-16-9 | Reference compound |
| HY-16973R | Fluralaner (Standard) | 864731-61-3 | Reference Standards |
| HY-16973S | Fluralaner-13C2,15N,d3 | Isotope-Labeled Compounds | |
| HY-16973S3 | Fluralaner-d5 | Isotope-Labeled Compounds | |
| HY-16973S4 | Fluralaner-d3 | Isotope-Labeled Compounds | |
| HY-16973S5 | Fluralaner-d2 | Isotope-Labeled Compounds | |
| HY-16974 | Afoxolaner | 1093861-60-9 | Reference compound |
| HY-169740 | L-Luciferin | 34500-31-7 | Reference compound |
| HY-169741 | DDR1-IN-10 | 3038810-93-1 | Reference compound |
| HY-169742 | Epibatidine | 140111-52-0 | Reference compound |
| HY-169743 | Pegamine | 31431-93-3 | Natural Products |
| HY-169745 | 9,12,13-Trihydroxy-10-octadecenoic acid | 29907-56-0 | Reference compound |
| HY-169746 | Antiviral agent 63 | 1613591-70-0 | Reference compound |
| HY-16974R | Afoxolaner (Standard) | 1093861-60-9 | Reference Standards |
| HY-16975 | SH-4-54 | 1456632-40-8 | Reference compound |
| HY-169750 | Hydroxytyrosol 1-O-glucoside | 76873-99-9 | Reference compound |
| HY-169751 | Dihydro-N-caffeoyltyramine | 501939-19-1 | Reference compound |
| HY-169752 | APJ receptor agonist 11 | 2135515-67-0 | Reference compound |
| HY-169753 | AHR-IN-1 | 2247951-12-6 | Reference compound |
| HY-169754 | BP Fluor 350 NHS ester | 200554-19-4 | Dye Reagents |
| HY-169755 | Tyrphostin 63 | 5553-97-9 | Reference compound |
| HY-169756 | L17E-OH | 2305578-13-4 | Reference compound |
| HY-169758 | CEE321 | 2098545-89-0 | Reference compound |
| HY-169759 | Veronicafolin | 19587-65-6 | Natural Products |
| HY-16976 | GDC-0339 | 1428569-85-0 | Reference compound |
| HY-169761 | WIZ-IN-1 | 2879251-63-3 | Reference compound |
| HY-169763 | D-F07 | 2361297-58-5 | Reference compound |
| HY-169764 | Pseudane V | 109072-26-6 | Reference compound |
| HY-169768 | (E/Z)-Etherolenic acid | 2247927-22-4 | Reference compound |
| HY-169777 | WAY-214156 | 1007853-40-8 | Oligonucleotides |
| HY-169779 | PTX80 | 2376297-69-5 | Reference compound |
| HY-16978 | TG6-10-1 | 1415716-58-3 | Reference compound |
| HY-169780 | (S)-AMG-628 | 862269-92-9 | Reference compound |
| HY-169782 | CJZ3 | 766508-73-0 | Reference compound |
| HY-169783 | Gigantetrocin | 134955-48-9 | Natural Products |
| HY-169784 | PPI-1040 | 1436673-69-6 | Reference compound |
| HY-169785 | 7-Methyl DMT | 65882-39-5 | Reference compound |
| HY-169786 | 5-HT2A receptor agonist-5 | 2957888-63-8 | Reference compound |
| HY-169788 | Graveolinine | 4179-37-7 | Natural Products |
| HY-169789 | PKN3-IN-1 | 2361545-75-5 | Reference compound |
| HY-169790 | Phomarin | 6866-87-1 | Natural Products |
| HY-169791 | ECPLA | 2349367-50-4 | Reference compound |
| HY-169792 | HPG1860 | 2226133-29-3 | Reference compound |
| HY-169793 | Thalicpureine | 218900-91-5 | Natural Products |
| HY-169794 | N-Palmitoyl-phenylalanine | 37571-96-3 | Oligonucleotides |
| HY-169795 | C8 D-threo Ceramide (d18:1/8:0) | 175892-43-0 | Reference compound |
| HY-169796 | Panepophenanthrin | 409064-57-9 | Reference compound |
| HY-169797 | STAT3-IN-38 | 3033049-16-7 | Reference compound |
| HY-169798 | 1,9-Dimethylmethylene blue | 23481-50-7 | Reference compound |
| HY-169799 | Cholylglycylamidofluorescein | 168912-70-7 | Dye Reagents |
| HY-16980 | Eravacycline | 1207283-85-9 | Reference compound |
| HY-169801 | Rofleponide 21-palmitate | 144653-57-6 | Reference compound |
| HY-169803 | L-657926 | 113243-00-8 | Reference compound |
| HY-169804 | ENPP3 Inhibitor 1 | 2803505-90-8 | Reference compound |
| HY-169805 | Pulcherosine | 126723-16-8 | Reference compound |
| HY-169806 | Methalthiazide | 5611-64-3 | Reference compound |
| HY-169807 | O-2172 | 521062-92-0 | Reference compound |
| HY-169808 | BOMA | 540496-84-2 | Reference compound |
| HY-169809 | SIRT1-IN-5 | 863589-21-3 | Reference compound |
| HY-16980A | Eravacycline (dihydrochloride) | 1334714-66-7 | Reference compound |
| HY-16980S | Eravacycline-d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-16981 | SB-332235 | 276702-15-9 | Reference compound |
| HY-169810 | PKZ18 | 849658-87-3 | Oligonucleotides |
| HY-169811 | CPW-86-363 | 84080-55-7 | Reference compound |
| HY-169812 | Dihydrobiochanin A | 83920-62-1 | Natural Products |
| HY-169813 | Yakuchinone B | 81840-57-5 | Natural Products |
| HY-169814 | LU-25-077 | 221549-70-8 | Reference compound |
| HY-169815 | HCV NS5B polymerase-IN-2 | 438476-59-6 | Reference compound |
| HY-169816 | MMV03 | 375394-80-2 | Oligonucleotides |
| HY-169817 | PAR-2-IN-2 | 313986-65-1 | Reference compound |
| HY-169818 | Keto lovastatin | 96497-73-3 | Reference compound |
| HY-169819 | Calcium influx inducer compound 634 | 882291-37-4 | Reference compound |
| HY-16982 | Cercosporamide | 131436-22-1 | Natural Products |
| HY-169820 | CE-178253 (benzenesulfonate) | 956246-95-0 | Reference compound |
| HY-169821 | SGLT1/2-IN-8 | 2206679-16-3 | Reference compound |
| HY-169822 | 5′-Guanidinonaltrindole | 219655-56-8 | Reference compound |
| HY-169823 | BAS-118 | 218936-13-1 | Reference compound |
| HY-169824 | TRPML modulator 1 | 2171065-77-1 | Reference compound |
| HY-169825 | (S)-PF-04995274 | 2170558-28-6 | Reference compound |
| HY-169826 | N-Lithocholyl-L-Leucine | 2095154-73-5 | Reference compound |
| HY-169827 | EMD-132338 | 167364-01-4 | Reference compound |
| HY-169828 | Ketopynalin | 300843-20-3 | Oligonucleotides |
| HY-169829 | CL-424032 | 312634-62-1 | Reference compound |
| HY-16983 | GNE-3500 | 1537859-24-7 | Reference compound |
| HY-169830 | 2-(Cyclohexylmethyl)-plumbagin | 3033734-59-4 | Reference compound |
| HY-169831 | HUP-55 | 3006795-68-9 | Reference compound |
| HY-169832 | Sulfanegen | 80003-64-1 | Reference compound |
| HY-169833 | BL 6341A | 78441-84-6 | Reference compound |
| HY-169834 | NAAA-IN-6 | 1831115-37-7 | Reference compound |
| HY-169835 | 1-Benzyl-APDC | 171336-76-8 | Reference compound |
| HY-169836 | Des-ethyl-carafiban | 170565-45-4 | Reference compound |
| HY-169837 | PD-147693 | 163239-24-5 | Reference compound |
| HY-169838 | WYneC | 74763-44-3 | Reference compound |
| HY-16984 | GNE-4997 | 1705602-02-3 | Reference compound |
| HY-169841 | IHCH-7086 | 2957888-70-7 | Reference compound |
| HY-169842 | NSC 645827 | 128113-19-9 | Reference compound |
| HY-169843 | Cotylenin A | 12708-37-1 | Natural Products |
| HY-169844 | D-19050 | 149690-78-8 | Reference compound |
| HY-169847 | ZK-806450 | 247188-27-8 | Reference compound |
| HY-169848 | (S)-Batylalcohol | 6129-13-1 | Reference compound |
| HY-169849 | EphA2 antagonist 1 | 1428095-28-6 | Reference compound |
| HY-16985 | Darolutamide | 1297538-32-9 | Reference compound |
| HY-169850 | 7,8-Dihydroxy-4H-chromen-4-one | 59887-99-9 | Reference compound |
| HY-169851 | JANEX-1-M | 406484-24-0 | Reference compound |
| HY-169852 | Doxapram intermediate-1 | 3192-92-5 | Reference compound |
| HY-169853 | M351-0056 | 1189495-81-5 | Reference compound |
| HY-169854 | N-γ-L-Glutamyl-4-aminobutyric acid | 3183-72-0 | Reference compound |
| HY-169855 | Apaziquone hydroquinone | 1177895-58-7 | Reference compound |
| HY-169856 | Pradimicin L | 142062-87-1 | Reference compound |
| HY-169857 | AS2690168 (freebase) | 1393999-78-4 | Reference compound |
| HY-169857A | AS2690168 (hydrochloride) | 1393899-47-2 | Reference compound |
| HY-169858 | Prostaglandin E2 Inhibitor 3 | 3054217-03-4 | Reference compound |
| HY-169859 | EP4 receptor antagonist 7 | 3035217-40-1 | Oligonucleotides |
| HY-16985R | Darolutamide (Standard) | 1297538-32-9 | Reference Standards |
| HY-16985S | Darolutamide-d4 | 2484757-20-0 | Isotope-Labeled Compounds |
| HY-16986 | EPZ011989 | 1598383-40-4 | Reference compound |
| HY-169860 | BCRP-IN-2 | 2953730-35-1 | Reference compound |
| HY-169861 | PROTAC SMARCA2/4 degrader-37 | 2688882-69-9 | Reference compound |
| HY-169862 | Germinone A | 2375197-79-6 | Reference compound |
| HY-169863 | DC360 | 2324152-25-0 | Reference compound |
| HY-169864 | KRO-105714 | 1137536-21-0 | Reference compound |
| HY-169865 | Bac-429 | 2227449-70-7 | Reference compound |
| HY-169866 | WyneO | 1648555-11-6 | Reference compound |
| HY-169867 | BNTX | 129468-28-6 | Reference compound |
| HY-169868 | NOTA-FAPI-52 | 2374782-69-9 | Reference compound |
| HY-169869 | pan-Raf/RTK inhibitor 1 | 1980821-53-1 | Reference compound |
| HY-16986A | EPZ011989 (trifluoroacetate) | 1598383-41-5 | Reference compound |
| HY-16986B | EPZ011989 (hydrochloride) | 2095432-26-9 | Reference compound |
| HY-16987 | IDO-IN-3 | 2070018-30-1 | Reference compound |
| HY-169870 | Dexmecamylamine | 107538-05-6 | Reference compound |
| HY-169871 | Argiotoxin 636 | 105029-41-2 | Natural Products |
| HY-169878 | CNJ-294 | 1029713-99-2 | Oligonucleotides |
| HY-16988 | SR9011 | 1379686-29-9 | Reference compound |
| HY-169882 | Tubulin inhibitor 49 | 1023875-75-3 | Reference compound |
| HY-169883 | PKM2-IN-7 | 1011641-78-3 | Reference compound |
| HY-169884 | MCI-INI-3 | 1011366-31-6 | Reference compound |
| HY-169887S | Benztropine-13C-d3 (mesylate) | Isotope-Labeled Compounds | |
| HY-16988A | SR9011 (hydrochloride) | 2070014-94-5 | Reference compound |
| HY-16989 | SR9009 | 1379686-30-2 | Reference compound |
| HY-169892S | 4-Hydroxy Nonenal Glutathione-d3 | Isotope-Labeled Compounds | |
| HY-169894S | (S)-ADB-BINACA-d5 | Isotope-Labeled Compounds | |
| HY-169896S | Aeruginascin-d3 | Isotope-Labeled Compounds | |
| HY-169898S | SR 144528-d3 | Isotope-Labeled Compounds | |
| HY-16990 | Ac-YVAD-cmk | 178603-78-6 | Reference compound |
| HY-169903 | SMIP34 | 1189710-20-0 | Reference compound |
| HY-169904 | AKV-9 | 1307262-15-2 | Reference compound |
| HY-169905 | GR–14-3-3 stabilizer-1 | 271798-59-5 | Reference compound |
| HY-169906 | Anticancer agent 257 | 2891997-46-7 | Reference compound |
| HY-169907 | Anticancer agent 258 | 2891984-12-4 | Reference compound |
| HY-169908 | STAT3-IN-37 | 3055844-98-6 | Reference compound |
| HY-16991 | Terutroban | 165538-40-9 | Reference compound |
| HY-169910 | CDK2 degrader 4 | 2924122-01-8 | Reference compound |
| HY-169912 | CDK2 degrader 5 | 2923574-11-0 | Reference compound |
| HY-169913 | ERAP1 modulator-1 | 2766036-51-3 | Reference compound |
| HY-169914 | Igmesine (hydrochloride) | 130152-35-1 | Reference compound |
| HY-169915 | ERAP1 modulator-2 | 2643320-62-9 | Reference compound |
| HY-169916 | GuaB-IN-1 | Reference compound | |
| HY-169917 | THP-1/MV-4-11 against-1 | 2978623-53-7 | Reference compound |
| HY-169918 | SHP2-IN-34 | 2924065-12-1 | Reference compound |
| HY-169919 | HDM-IN-1 | 3020690-76-7 | Reference compound |
| HY-169920 | HIV-1 inhibitor-79 | Reference compound | |
| HY-169921 | c-Myc inhibitor 15 | Reference compound | |
| HY-169922 | HDAC-IN-82 | Reference compound | |
| HY-169923 | HDAC-IN-83 | Reference compound | |
| HY-169924 | IAV replication-IN-1 | 2327297-30-1 | Reference compound |
| HY-169925 | BM-962 | 1391107-57-5 | Reference compound |
| HY-169926 | AK-4 | Reference compound | |
| HY-169927 | Ferroptosis-IN-16 | Reference compound | |
| HY-169928 | WRN inhibitor 14 | Reference compound | |
| HY-169929 | KCC2 potentiators-1 | 3058906-46-7 | Reference compound |
| HY-16992A | W-54011 | 405098-33-1 | Reference compound |
| HY-16993 | OICR-9429 | 1801787-56-3 | Reference compound |
| HY-169930 | ATR kinase-IN-2 | 1613196-91-0 | Reference compound |
| HY-169931 | ATR kinase-IN-3 | 1613196-92-1 | Reference compound |
| HY-169932 | APOL1-IN-2 | 2956781-84-1 | Reference compound |
| HY-169933 | NEK7-IN-1 | 2738569-12-3 | Reference compound |
| HY-169934 | SIRT1-IN-4 | 445405-18-5 | Reference compound |
| HY-169936 | ERAP1-IN-3 | Reference compound | |
| HY-169937 | (R)-SR-C-107 | Reference compound | |
| HY-169938 | LSD1/HDAC-IN-2 | 2966782-82-9 | Reference compound |
| HY-169939 | 1ACTA | 2196076-49-8 | Reference compound |
| HY-16994 | OICR-0547 | 1801873-49-3 | Reference compound |
| HY-169940 | Fibrostat | Reference compound | |
| HY-169941 | ERα/ERβ antagonist-1 | 2482778-93-6 | Reference compound |
| HY-169942 | 3-(1-Carboxyvinyloxy)benzoic acid | 16929-37-6 | Reference compound |
| HY-169946 | WEE1/PKMYT1-IN-1 | 3047737-15-2 | Reference compound |
| HY-169947 | DDO-6079 | 2648334-53-4 | Reference compound |
| HY-169948 | BML-265 | 183321-62-2 | Reference compound |
| HY-169949 | TAK-756 | Reference compound | |
| HY-16995 | Pirinixic acid | 50892-23-4 | Reference compound |
| HY-169950 | NMDA agonist 1 | 2576586-47-3 | Reference compound |
| HY-169951 | Lu AF90103 | 2577196-14-4 | Reference compound |
| HY-169952 | RORγt inverse agonist 33 | Reference compound | |
| HY-169953 | BT-Amide | Reference compound | |
| HY-169954 | CRBN ligand-10 | Reference compound | |
| HY-169955 | WIZ degrader 8 | 2879251-26-8 | Reference compound |
| HY-169957 | ROS-ERS inducer 2 | Reference compound | |
| HY-169958 | EZH2-IN-22 | 2766231-05-2 | Reference compound |
| HY-169959 | OTs-PEG3-NHCO-Thalidomide | 2716123-18-9 | Reference compound |
| HY-16996 | BD-1047 | 138356-20-4 | Reference compound |
| HY-169960 | 2DII | Reference compound | |
| HY-169961 | BChE-IN-38 | 3054159-55-3 | Reference compound |
| HY-169962 | hCA I-IN-4 | 3054159-56-4 | Reference compound |
| HY-169963 | PDE1-IN-8 | Reference compound | |
| HY-169964 | TSPO/Carbonic Anhydrase Modulator 1 | Reference compound | |
| HY-169965 | Succinate dehydrogenase-IN-4 | Reference compound | |
| HY-169966 | Boc-CH2-O-(CH2)4-OTs | 1973409-82-3 | Reference compound |
| HY-169967 | AR ligand-31 | Reference compound | |
| HY-169968 | E3 ligase Ligand 41 | 2375196-68-0 | Reference compound |
| HY-169969 | E3 Ligase Ligand-linker Conjugate 139 | 2375197-04-7 | Reference compound |
| HY-16996A | BD-1047 (dihydrobromide) | 138356-21-5 | Reference compound |
| HY-16997 | Itacitinib | 1334298-90-6 | Reference compound |
| HY-169970 | Me-(S,R,S)-AHPC-CO-CH2-Br | Reference compound | |
| HY-169972 | Succinate dehydrogenase-IN-5 | Reference compound | |
| HY-169973 | PhoPS | Reference compound | |
| HY-169974 | SARS-CoV-2-IN-107 | Reference compound | |
| HY-169975 | tert-Butyl 4-(4-(piperazin-1-ylmethyl)piperidin-1-yl)benzoate | 2566692-49-5 | Reference compound |
| HY-169976 | E3 Ligase Ligand-linker Conjugate 140 | 2753651-22-6 | Reference compound |
| HY-169977 | CKP-25 | Reference compound | |
| HY-169978 | ER ligand-3 | Reference compound | |
| HY-169979 | E3 Ligase Ligand-linker Conjugate 141 | 2229724-20-1 | Reference compound |
| HY-16997A | Itacitinib adipate | 1334302-63-4 | Reference compound |
| HY-16998 | SR2211 | 1359164-11-6 | Reference compound |
| HY-169980 | Mivebresib-alkyne | 2409674-37-7 | Reference compound |
| HY-169981 | PDE4-IN-24 | Reference compound | |
| HY-169982 | EGFR-IN-136 | Reference compound | |
| HY-169983 | PI3Kδ-IN-23 | 3051828-81-7 | Reference compound |
| HY-169984S | Tyk2-IN-22-d3 | 1771691-32-7 | Isotope-Labeled Compounds |
| HY-169985 | CK2-IN-13 | Reference compound | |
| HY-169986S | TyK2-IN-21-d3 | 2583719-08-6 | Reference compound |
| HY-169987 | bc1 Complex-IN-1 | 2883052-97-7 | Reference compound |
| HY-169988 | BRD9 ligand-5 | 2633634-64-5 | Reference compound |
| HY-169989 | CRBN ligand-11 | 2962967-27-5 | Reference compound |
| HY-16999 | RO8994 | 1309684-94-3 | Reference compound |
| HY-169990 | E3 Ligase Ligand-linker Conjugate 142 | 2704621-78-1 | Reference compound |
| HY-169991 | 1-(3,3-Difluoro-4-piperidinyl)piperazine | 2168258-10-2 | Reference compound |
| HY-169992 | 1-Bromo-4-(ethynyloxy)butane | Reference compound | |
| HY-169993 | ALG-000184 | 2495324-72-4 | Reference compound |
| HY-169994 | BC13 | 3036645-03-8 | Reference compound |
| HY-169995 | E3 Ligase Ligand-linker Conjugate 143 | Reference compound | |
| HY-169996 | NP3-253 | 2557349-50-3 | Reference compound |
| HY-169997 | LU9 | Reference compound | |
| HY-169998 | XJ5 | Reference compound | |
| HY-169999 | AAP4 | Reference compound | |
| HY-17000 | Tolvaptan | 150683-30-0 | Reference compound |
| HY-170001S | Palmitoyl-L-carnitine-d9 (chloride) | Isotope-Labeled Compounds | |
| HY-170004S | 18-hydroxy Oleoyl Leucine-d7 | Isotope-Labeled Compounds | |
| HY-170006S | 9(R)-Hexahydrocannabinol-d9 | Isotope-Labeled Compounds | |
| HY-170007S | 5(Z),8(Z)-Tetradecadienoic Acid-d11 | Isotope-Labeled Compounds | |
| HY-17000A | (R)-(+)-Tolvaptan | 331947-66-1 | Reference compound |
| HY-17000R | Tolvaptan (Standard) | 150683-30-0 | Reference Standards |
| HY-17000S | Tolvaptan-d7 | 1246818-18-7 | Isotope-Labeled Compounds |
| HY-17001 | Flupirtine (Maleate) | 75507-68-5 | Reference compound |
| HY-170010S | (E)-5-OAHSA-d17 | 2714169-20-5 | Isotope-Labeled Compounds |
| HY-170013S | N-Pyrrolidino Metonitazene-d3 (citrate) | Isotope-Labeled Compounds | |
| HY-170014S | 2-Hydroxyethylflurazepam-d4 (CRM) | Isotope-Labeled Compounds | |
| HY-170019 | RET-IN-28 | 2479961-45-8 | Reference compound |
| HY-17001A | Flupirtine | 56995-20-1 | Reference compound |
| HY-17001AR | Flupirtine (Standard) | 56995-20-1 | Reference Standards |
| HY-17001R | Flupirtine (Maleate) (Standard) | 75507-68-5 | Reference Standards |
| HY-17002 | Suplatast (Tosilate) | 94055-76-2 | Reference compound |
| HY-170023 | Samidorphan isoquinoline dioxolane | 361525-83-9 | Reference compound |
| HY-170027 | LW1564 | 2668337-39-9 | Reference compound |
| HY-170028 | NL3 | 2395867-03-3 | Reference compound |
| HY-17003 | Saquinavir (mesylate) | 149845-06-7 | Reference compound |
| HY-170032 | Oxotremorine | 70-22-4 | Reference compound |
| HY-170033 | 3-Carboxamidonaltrexone | 421552-35-4 | Reference compound |
| HY-170035 | GlcCer (d18:1/18:0) | 95119-86-1 | Natural Products |
| HY-170039 | (±)-8'-Hydroxy cannabichromene | 132032-41-8 | Reference compound |
| HY-17003R | Saquinavir (mesylate) (Standard) | 149845-06-7 | Reference Standards |
| HY-17004 | Olmesartan | 144689-24-7 | Reference compound |
| HY-170040 | (±)-6',7'-Epoxy cannabichromene | 134840-95-2 | Reference compound |
| HY-170041 | (±)-6',7'-Dihydroxy cannabichromene | 134840-96-3 | Reference compound |
| HY-170042 | 5'-Hydroxy-9(S)-hexahydrocannabinol | 127349-00-2 | Reference compound |
| HY-170042A | 5'-Hydroxy-9(R)-hexahydrocannabinol | 127367-74-2 | Reference compound |
| HY-170043 | 10(S)-Hydroxy-9(R)-hexahydrocannabinol | 73648-83-6 | Reference compound |
| HY-170043A | 10(R)-Hydroxy-9(S)-hexahydrocannabinol | 60948-21-2 | Reference compound |
| HY-170044 | iso-Hexahydrocannabinol | 23050-50-2 | Reference compound |
| HY-170045 | (±)-9α-Hydroxy hexahydrocannabinol | 16964-49-1 | Reference compound |
| HY-170046 | Fluetizolam | 40054-88-4 | Reference compound |
| HY-170047 | 11-Nor-9(R)-carboxy-hexahydrocannabinol | 64663-38-3 | Reference compound |
| HY-170047A | 11-Nor-9(S)-carboxy-hexahydrocannabinol | 64663-37-2 | Reference compound |
| HY-170048 | MDMB-FUB7AICA | 2751267-51-1 | Reference compound |
| HY-170049 | 5-Chloro DMT (hydrochloride) | 1016-45-1 | Reference compound |
| HY-17004R | Olmesartan (Standard) | 144689-24-7 | Reference Standards |
| HY-17004S | Olmesartan-d4 | 1420880-41-6 | Isotope-Labeled Compounds |
| HY-17004S1 | Olmesartan-d6 | 1185144-74-4 | Isotope-Labeled Compounds |
| HY-17005 | Olmesartan medoxomil | 144689-63-4 | Reference compound |
| HY-170050 | 4-Methyl-α-pyrrolidinoisohexanophenone (hydrochloride) | 850352-10-2 | Reference compound |
| HY-170051 | 4-Methyl-α-isopropylaminovalerophenone (hydrochloride) | 18296-68-9 | Reference compound |
| HY-170052 | α-Isopropylaminohexanophenone (hydrochloride) | 18296-61-2 | Reference compound |
| HY-170053 | 4-Hydroxy MPT | 763035-03-6 | Reference compound |
| HY-170054 | Para-fluoro 4-ANBP | 131587-27-4 | Reference compound |
| HY-170055 | Meta-fluoro 4-ANBP | 131587-28-5 | Reference compound |
| HY-170056 | 2α-Methyl-5α-androstan-17-one-3α-glucuronide | 361432-78-2 | Reference compound |
| HY-170057 | Pseudoephedrine tert-butyl carbamate | 152614-95-4 | Reference compound |
| HY-170058 | CRBN ligand-12 | 2820501-20-8 | Reference compound |
| HY-17005R | Olmesartan medoxomil (Standard) | 144689-63-4 | Reference Standards |
| HY-17005S | Olmesartan medoxomil-d6 | 1127298-67-2 | Isotope-Labeled Compounds |
| HY-17006 | Caspofungin (diacetate) | 179463-17-3 | Reference compound |
| HY-17006A | Caspofungin | 162808-62-0 | Reference compound |
| HY-17006AS | Caspofungin-d4 | 1131958-73-0 | Isotope-Labeled Compounds |
| HY-17006R | Caspofungin (diacetate) (Standard) | 179463-17-3 | Reference Standards |
| HY-17006S | Caspofungin-d4 (diacetate) | Isotope-Labeled Compounds | |
| HY-17007 | Saquinavir | 127779-20-8 | Reference compound |
| HY-170074 | CRBN ligand-14 | 3050687-74-3 | Reference compound |
| HY-170075 | CRBN ligand-16 | 3050687-81-2 | Reference compound |
| HY-170076 | CRBN ligand-17 | 3050687-80-1 | Reference compound |
| HY-17007R | Saquinavir (Standard) | 127779-20-8 | Reference Standards |
| HY-17007S | Saquinavir-d9 | 1356355-11-7 | Isotope-Labeled Compounds |
| HY-17007S2 | Saquinavir-13C6 | Isotope-Labeled Compounds | |
| HY-17008 | Toltrazuril (sulfone) | 69004-04-2 | Reference compound |
| HY-17008R | Toltrazuril (sulfone) (Standard) | 69004-04-2 | Reference Standards |
| HY-17009 | Iguratimod | 123663-49-0 | Reference compound |
| HY-170095 | CRBN ligand-63 | 3049446-57-0 | Reference compound |
| HY-17009R | Iguratimod (Standard) | 123663-49-0 | Reference Standards |
| HY-17010 | Retapamulin | 224452-66-8 | Reference compound |
| HY-170108 | CRBN ligand-47 | 3059455-81-8 | Reference compound |
| HY-17010R | Retapamulin (Standard) | 224452-66-8 | Reference Standards |
| HY-17011 | Croconazole | 77175-51-0 | Reference compound |
| HY-17012 | Dapitant | 153438-49-4 | Reference compound |
| HY-170126 | CRBN ligand-74 | 3065251-87-5 | Reference compound |
| HY-170127 | CRBN ligand-76 | 3065251-82-0 | Reference compound |
| HY-17013 | Dofequidar | 129716-58-1 | Reference compound |
| HY-170131 | CRBN ligand-84 | 3065251-76-2 | Reference compound |
| HY-17013A | Dofequidar (fumarate) | 153653-30-6 | Reference compound |
| HY-17013D | Dofequidar (sesquifumarate) | 158681-49-3 | Reference compound |
| HY-17015 | Peramivir (trihydrate) | 1041434-82-5 | Reference compound |
| HY-17015A | Peramivir | 330600-85-6 | Reference compound |
| HY-17015R | Peramivir (trihydrate) (Standard) | 1041434-82-5 | Reference Standards |
| HY-17016 | Oseltamivir (phosphate) | 204255-11-8 | Reference compound |
| HY-17016R | Oseltamivir (phosphate) (Standard) | 204255-11-8 | Reference Standards |
| HY-17016S | Oseltamivir-d5 (phosphate) | Isotope-Labeled Compounds | |
| HY-17016S1 | Oseltamivir-d3 (phosphate) | Isotope-Labeled Compounds | |
| HY-17016S3 | Oseltamivir-13C,d3 (phosphate) | 2734920-81-9 | Isotope-Labeled Compounds |
| HY-17018 | Napitane | 148152-63-0 | Reference compound |
| HY-17018A | Napitane (mesylate) | 149189-73-1 | Reference compound |
| HY-17020 | Miglustat | 72599-27-0 | Reference compound |
| HY-17020A | Miglustat (hydrochloride) | 210110-90-0 | Reference compound |
| HY-17020S | Miglustat-d9 | 1883545-56-9 | Isotope-Labeled Compounds |
| HY-17021 | Esomeprazole | 119141-88-7 | Reference compound |
| HY-170213 | CRBN ligand-183 | 3065251-92-2 | Reference compound |
| HY-170218 | NLRP3-IN-76 | Reference compound | |
| HY-170219 | RMM23 | Reference compound | |
| HY-17021A | Esomeprazole (magnesium salt) | 1198768-91-0 | Reference compound |
| HY-17021B | Esomeprazole (potassium salt) | 161796-84-5 | Reference compound |
| HY-17021C | Esomeprazole (hemistrontium) | 914613-86-8 | Reference compound |
| HY-17021R | Esomeprazole (Standard) | 119141-88-7 | Reference Standards |
| HY-17021S | Esomeprazole-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-17021S1 | Esomeprazole-d3 | Isotope-Labeled Compounds | |
| HY-17021S2 | Esomeprazole-d3 (potassium) | Isotope-Labeled Compounds | |
| HY-17022 | Esomeprazole magnesium (trihydrate) | 217087-09-7 | Reference compound |
| HY-170224 | dNTP Mixture,10 mM Solution,PCR Grade | Biochemical Assay Reagents | |
| HY-170226 | BET-IN-28 | Reference compound | |
| HY-170227 | Autotaxin-IN-7 | Reference compound | |
| HY-170228 | c-Kit-IN-9 | Reference compound | |
| HY-17022R | Esomeprazole magnesium (trihydrate) (Standard) | 217087-09-7 | Reference Standards |
| HY-17023 | Esomeprazole (sodium) | 161796-78-7 | Reference compound |
| HY-170232 | RIPK1-IN-29 | Reference compound | |
| HY-170233 | NLRP3-IN-75 | Reference compound | |
| HY-170236 | nNOS-IN-5 | 2945955-27-9 | Reference compound |
| HY-170237 | SIK2/3-IN-1 | 3038863-24-7 | Reference compound |
| HY-17023R | Esomeprazole (sodium) (Standard) | 161796-78-7 | Reference Standards |
| HY-17023S | Esomeprazole-d6 (sodium) | 922731-04-2 | Isotope-Labeled Compounds |
| HY-17024 | Cyclopamine | 4449-51-8 | Natural Products |
| HY-17024R | Cyclopamine (Standard) | 4449-51-8 | Reference Standards |
| HY-17025 | Rifabutin | 72559-06-9 | Reference compound |
| HY-17025R | Rifabutin (Standard) | 72559-06-9 | Reference Standards |
| HY-17025S | Rifabutin-d7 | 2747918-39-2 | Isotope-Labeled Compounds |
| HY-17025S1 | Rifabutin-d6 | Isotope-Labeled Compounds | |
| HY-17026 | Gemcitabine | 95058-81-4 | Reference compound |
| HY-17026A | Gemcitabine triphosphate | 110988-86-8 | Reference compound |
| HY-17026E | Gemcitabine triphosphate (trisodium) | Reference compound | |
| HY-17026R | Gemcitabine (Standard) | 95058-81-4 | Reference Standards |
| HY-17028 | Besifloxacin (Hydrochloride) | 405165-61-9 | Reference compound |
| HY-17028A | (Rac)-Besifloxacin (hydrochloride) | 1398566-43-2 | Reference compound |
| HY-17028R | Besifloxacin (Hydrochloride) (Standard) | 405165-61-9 | Reference Standards |
| HY-17029 | Epothilone B | 152044-54-7 | Reference compound |
| HY-17029R | Epothilone B (Standard) | 152044-54-7 | Reference Standards |
| HY-17030 | Acamprosate (calcium) | 77337-73-6 | Reference compound |
| HY-170301 | Keap1-IN-1 | Reference compound | |
| HY-170302 | CMP233 | 307001-06-5 | Reference compound |
| HY-170303 | AR ligand-32 | 2505498-74-6 | Reference compound |
| HY-170304 | E3 ligase Ligand 44 | 2505504-49-2 | Reference compound |
| HY-170305 | E3 Ligase Ligand-linker Conjugate 145 | Reference compound | |
| HY-170306 | LZ9 | 844441-29-8 | Reference compound |
| HY-170307 | Thalidomide-NH-amido-C4-Br | 3027457-50-4 | Reference compound |
| HY-170308 | IspE kinase-IN-1 | Reference compound | |
| HY-170309 | NZ-804 | 2858658-44-1 | Reference compound |
| HY-17030R | Acamprosate (calcium) (Standard) | 77337-73-6 | Reference Standards |
| HY-17030S | Acamprosate-d3 (calcium) | 1225580-94-8 | Isotope-Labeled Compounds |
| HY-17031 | SBE-β-CD | 182410-00-0 | Biochemical Assay Reagents |
| HY-170310 | AP-238 | 140924-11-4 | Reference compound |
| HY-170311 | YAP/TEAD-IN-1 | Reference compound | |
| HY-170312 | Antimicrobial-IN-1 | Reference compound | |
| HY-170313 | GLUT-1-IN-4 | 735-16-0 | Reference compound |
| HY-170314 | EA-89 | Reference compound | |
| HY-170315 | Ethyne-C2-Pip-CO-Pip-Boc | 2633726-46-0 | Reference compound |
| HY-170316 | Ibetazol | Reference compound | |
| HY-170317 | EA-89-Succinic acid | Reference compound | |
| HY-170318 | Adhibin | Reference compound | |
| HY-170319 | Lenalidomide-ethyne-C2-Pip-CO-Pip | Reference compound | |
| HY-17032 | Indeloxazine | 60929-23-9 | Reference compound |
| HY-170321 | Apoptosis inducer 31 | Reference compound | |
| HY-170322 | human TDO2-IN-1 | Reference compound | |
| HY-170323 | 4-TM.P | 2089575-84-6 | Reference compound |
| HY-170324 | BTK-IN-40 | 1791400-83-3 | Reference compound |
| HY-170325 | 17alpha-Hydroxywithanolide D | Reference compound | |
| HY-170326 | HSP90-IN-35 | 1207597-54-3 | Reference compound |
| HY-170327 | ZCL279 | 664975-73-9 | Reference compound |
| HY-170328 | Hsp90-IN-36 | Reference compound | |
| HY-170329 | PROTAC AR Degrader-8 | 3044108-04-2 | Reference compound |
| HY-17032A | Indeloxazine (hydrochloride) | 65043-22-3 | Reference compound |
| HY-17033 | Rocuronium | 143558-00-3 | Reference compound |
| HY-170330 | AR ligand-33 | Reference compound | |
| HY-170331 | IFNα-IN-1 | 2700322-66-1 | Reference compound |
| HY-170332 | PROTAC ER Degrader-15 | Reference compound | |
| HY-170333 | Lipid A-11 | 2996998-09-3 | Reference compound |
| HY-170334 | ER ligand-7 | Reference compound | |
| HY-170335 | PROTAC c-Met degrader-2 | 2254608-80-3 | Reference compound |
| HY-170336 | PROTAC ERα Degrader-10 | 2421260-43-5 | Reference compound |
| HY-170337 | N-Me-Thalidomide-NH-C6-NH2 | 2375536-48-2 | Reference compound |
| HY-170339 | ER ligand-5 | 2421262-07-7 | Reference compound |
| HY-17034 | Medetomidine | 86347-14-0 | Reference compound |
| HY-170340 | PROTAC ER Degrader-14 | 2504911-73-1 | Reference compound |
| HY-170341 | ER ligand-6 | 2504914-79-6 | Reference compound |
| HY-170342 | KOR agonist 3 | Reference compound | |
| HY-170343 | PROTAC SMARCA2 degrader-32 | 3033586-50-1 | Reference compound |
| HY-170347 | PROTAC SMARCA2/4 degrader-36 | 3033588-00-7 | Reference compound |
| HY-170348 | (S)-(S,R,S,R)-AHPC-Me-N3 | 2958620-43-2 | Reference compound |
| HY-170349 | SMARCA2 ligand-11 | 3033592-44-5 | Reference compound |
| HY-17034A | Dexmedetomidine (hydrochloride) | 145108-58-3 | Reference compound |
| HY-17034AR | Dexmedetomidine (hydrochloride) (Standard) | 145108-58-3 | Reference Standards |
| HY-17034AS | Dexmedetomidine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17034B | Medetomidine (hydrochloride) | 86347-15-1 | Reference compound |
| HY-17034BS | Medetomidine-d3 (hydrochloride) | 1246820-20-1 | Isotope-Labeled Compounds |
| HY-17034BS1 | Medetomidine-13C,d3 (hydrochloride) | 1216630-06-6 | Isotope-Labeled Compounds |
| HY-17035 | Doramectin | 117704-25-3 | Natural Products |
| HY-170350 | Pomalidomide-PEG2-OMs | 2140807-37-8 | Reference compound |
| HY-170351 | NH2-PEG2-OMs | Reference compound | |
| HY-170352 | E3 Ligase Ligand-linker Conjugate 150 | Reference compound | |
| HY-170353 | E3 ligase Ligand 46 | 3033591-48-6 | Reference compound |
| HY-170354 | SMARCA2/4-ligand-4 | 3033592-40-1 | Reference compound |
| HY-170356 | E3 Ligase Ligand-linker Conjugate 151 | Reference compound | |
| HY-170357 | SARS-CoV-2 3CLpro-IN-28 | 2603242-35-7 | Reference compound |
| HY-170358 | Antileishmanial agent-31 | 861382-34-5 | Reference compound |
| HY-170359 | Antifungal agent 124 | Reference compound | |
| HY-17035R | Doramectin (Standard) | 117704-25-3 | Reference Standards |
| HY-17036 | Naphthoquine (phosphate) | 173531-58-3 | Reference compound |
| HY-170360 | UCB9386 | Reference compound | |
| HY-170361 | MTHFD2-IN-5 | 3068001-31-7 | Reference compound |
| HY-170362 | cGAS-IN-4 | 2987886-49-5 | Reference compound |
| HY-170363 | Proteasome-IN-6 | Reference compound | |
| HY-170364 | NLRP3-IN-60 | Reference compound | |
| HY-170365 | HPK1-IN-55 | 3048537-58-9 | Reference compound |
| HY-170366 | VEGFR-2-IN-58 | Reference compound | |
| HY-170367 | Antimicrobial agent-35 | Reference compound | |
| HY-170369 | SHO1122147 | Reference compound | |
| HY-17037 | Pirenzepine (dihydrochloride) | 29868-97-1 | Reference compound |
| HY-170370 | RORγt inverse agonist 34 | 2247604-77-7 | Reference compound |
| HY-170371 | E3 ligase Ligand 47 | Reference compound | |
| HY-170373 | RET ligand-1 | 3028787-16-5 | Reference compound |
| HY-170376 | 2-(2-Aminoethoxy)ethyl 2-(adamantan-1-yl)acetate | 1489237-17-3 | Reference compound |
| HY-170377 | ER degrader 10 | 3035311-43-1 | Reference compound |
| HY-170378 | Laccase-IN-5 | Reference compound | |
| HY-170379 | HDAC-IN-84 | Reference compound | |
| HY-17037A | Pirenzepine | 28797-61-7 | Reference compound |
| HY-17037R | Pirenzepine (dihydrochloride) (Standard) | 29868-97-1 | Reference Standards |
| HY-17037S | Pirenzepine-d8 | 1189944-02-2 | Isotope-Labeled Compounds |
| HY-17037S1 | Pirenzepine-d8 (dihydrochloride) | 2982740-97-4 | Isotope-Labeled Compounds |
| HY-17038 | Agomelatine | 138112-76-2 | Reference compound |
| HY-170380 | XY221 | Reference compound | |
| HY-170381 | α-syn aggregation inhibitor-1 | Reference compound | |
| HY-170382 | ER covalent antagonist-1 | 2757498-74-9 | Reference compound |
| HY-170383 | CCW16-C4-NHBoc | Reference compound | |
| HY-170384 | Br-C4-NHBoc | 1690587-08-6 | Reference compound |
| HY-170386 | TXY541 | 1499168-63-6 | Reference compound |
| HY-170387 | MRS8209 | Reference compound | |
| HY-170389 | BChE-IN-39 | Reference compound | |
| HY-17038A | Agomelatine (hydrochloride) | 1176316-99-6 | Reference compound |
| HY-17038B | Agomelatine (L(+)-Tartaric acid) | 824393-18-2 | Reference compound |
| HY-17038R | Agomelatine (Standard) | 138112-76-2 | Reference Standards |
| HY-17038S | Agomelatine-d6 | 1079389-42-6 | Isotope-Labeled Compounds |
| HY-17038S1 | Agomelatine-d4 | 1079389-44-8 | Isotope-Labeled Compounds |
| HY-17038S2 | Agomelatine-d3 | 1079389-38-0 | Isotope-Labeled Compounds |
| HY-17039 | Alcaftadine | 147084-10-4 | Reference compound |
| HY-170390 | AB3067 | Reference compound | |
| HY-170392 | Vasorelaxant agent-1 | Reference compound | |
| HY-170393 | iBFAR2 | 353484-02-3 | Reference compound |
| HY-170394 | Apoptosis inducer 33 | Reference compound | |
| HY-170395 | GHP-88309 | 1269267-87-9 | Reference compound |
| HY-170396 | ABCG2-IN-4 | 2559759-63-4 | Reference compound |
| HY-170397 | ADORA2A/PDE4D-IN-1 | 1321513-73-8 | Reference compound |
| HY-170398 | ZG297 | 2999673-52-6 | Reference compound |
| HY-170399 | SARS-CoV-2 PLpro-IN-1 | 3053753-61-7 | Reference compound |
| HY-17039R | Alcaftadine (Standard) | 147084-10-4 | Reference Standards |
| HY-17040 | Darunavir | 206361-99-1 | Reference compound |
| HY-170400 | LNK4-S | 2845165-06-0 | Reference compound |
| HY-170401 | Antibacterial agent 260 | Reference compound | |
| HY-170402 | SIRT6-IN-4 | Reference compound | |
| HY-170403 | LSD1-IN-38 | Reference compound | |
| HY-170404 | KF-52 | Reference compound | |
| HY-170405 | YB-3–17 | 2940242-88-4 | Reference compound |
| HY-170406 | BCL-XL-IN-3 | 1949840-87-2 | Reference compound |
| HY-170409 | BNN27 | 1195795-81-3 | Reference compound |
| HY-17041 | Darunavir (Ethanolate) | 635728-49-3 | Reference compound |
| HY-170410 | EMD-95885 | 178165-43-0 | Reference compound |
| HY-170411 | WNT7A-IN-1 | 29133-39-9 | Reference compound |
| HY-170412 | Cox B-IN-1 | Reference compound | |
| HY-170413 | PROTAC BTK Degrader-12 | 2736508-65-7 | Reference compound |
| HY-170415 | EGR-1-IN-3 | 1700655-93-1 | Reference compound |
| HY-170416 | ROS inducer 6 | Reference compound | |
| HY-170417 | hAChE/hBuChE/GSK-3β-IN-1 | Reference compound | |
| HY-170418 | ALK/ROS1-IN-5 | Reference compound | |
| HY-170419 | APJ receptor agonist 10 | 3037373-19-3 | Reference compound |
| HY-17041R | Darunavir (Ethanolate) (Standard) | 635728-49-3 | Reference Standards |
| HY-17042 | Cetirizine | 83881-51-0 | Natural Products |
| HY-170420 | JNK-1-IN-5 | 3047794-08-8 | Reference compound |
| HY-170421 | MAT2A-IN-16 | 3025016-60-5 | Reference compound |
| HY-170422 | 18:1 Lysyl PG | 1246303-07-0 | Biochemical Assay Reagents |
| HY-170423 | 18:1 (Δ9-Trans) PG | 322647-40-5 | Biochemical Assay Reagents |
| HY-170424 | D-myo-Inositol-1,3,4,5-tetrakisphosphate (potassium) | 135269-51-1 | Biochemical Assay Reagents |
| HY-170425 | CDK7-IN-32 | 2055741-42-7 | Reference compound |
| HY-170426 | DGKζ-IN-9 | 3062706-10-6 | Reference compound |
| HY-170427 | DGKζ-IN-10 | 3062708-86-2 | Reference compound |
| HY-170428 | IPS-06061 | 3064065-83-1 | Reference compound |
| HY-170429 | BJP-07-017-3 | 2468783-22-2 | Reference compound |
| HY-17042A | Cetirizine (dihydrochloride) | 83881-52-1 | Reference compound |
| HY-17042AR | Cetirizine (dihydrochloride) (Standard) | 83881-52-1 | Reference Standards |
| HY-17042AS | Cetirizine-d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-17042AS1 | Cetirizine-d8 (dihydrochloride) | 2070015-04-0 | Isotope-Labeled Compounds |
| HY-17042B | (S)-Cetirizine (dihydrochloride) | 163837-48-7 | Reference compound |
| HY-17042R | Cetirizine (Standard) | 83881-51-0 | Reference Standards |
| HY-17042S | Cetirizine-d4 | 1219803-84-5 | Isotope-Labeled Compounds |
| HY-17042S1 | Cetirizine-d8 | 774596-22-4 | Isotope-Labeled Compounds |
| HY-17043 | Loratadine | 79794-75-5 | Reference compound |
| HY-170430 | HGC652 | 3055558-98-7 | Reference compound |
| HY-170431 | SAL-0010042 | 521298-46-4 | Reference compound |
| HY-170432 | PARP1-IN-34 | Reference compound | |
| HY-170433 | DefNEtTrp | Reference compound | |
| HY-170434 | Bfl-1-IN-6 | Reference compound | |
| HY-170435 | PDE5-IN-13 | Reference compound | |
| HY-170436 | NFh-NMe-2 | Reference compound | |
| HY-170437 | MOR modulator-1 | 2976336-81-7 | Reference compound |
| HY-170438 | EGFR-IN-139 | 1574321-31-5 | Reference compound |
| HY-170439 | JAK3-IN-16 | 1962125-80-9 | Reference compound |
| HY-17043R | Loratadine (Standard) | 79794-75-5 | Reference Standards |
| HY-17043S | Loratadine-d4 | 381727-27-1 | Isotope-Labeled Compounds |
| HY-17043S1 | Loratadine-d5 | 1398065-63-8 | Isotope-Labeled Compounds |
| HY-17043S2 | Loratadine-d4-1 | 2748435-73-4 | Isotope-Labeled Compounds |
| HY-17043S3 | Loratadine-13C6 | Isotope-Labeled Compounds | |
| HY-17044 | Duvelisib | 1201438-56-3 | Reference compound |
| HY-170440 | ATV2301 | 3049172-60-0 | Reference compound |
| HY-170441 | CDK2-IN-36 | 3054692-45-1 | Reference compound |
| HY-170442 | CDK2-IN-37 | 3054692-62-2 | Reference compound |
| HY-170443 | PF-07265028 | 2736458-30-1 | Reference compound |
| HY-170444 | ADS1017 | Reference compound | |
| HY-170445 | Neuraminidase-IN-23 | Reference compound | |
| HY-170446 | MyD88-IN-2 | 3067479-71-1 | Reference compound |
| HY-170447 | NOD1 antagonist-2 | Reference compound | |
| HY-170448 | PROTAC AR Degrader-9 | Reference compound | |
| HY-170449 | E3 ligase Ligand 48 | Reference compound | |
| HY-17044A | Duvelisib (R enantiomer) | 1261590-48-0 | Reference compound |
| HY-170450 | AR ligand-38 | Reference compound | |
| HY-170451 | KT-253 | 2713618-08-5 | Reference compound |
| HY-170452 | MDM2 ligand 4 | Reference compound | |
| HY-170453 | iHAC | Reference compound | |
| HY-170454 | 5-Keto-D-gluconic acid (potassium) | 91446-96-7 | Biochemical Assay Reagents |
| HY-170455 | 18:1 PE (DOPE) pSar25 | 2936622-32-9 | Biochemical Assay Reagents |
| HY-170456 | DPCB | 1394812-57-7 | Biochemical Assay Reagents |
| HY-170457 | OChemsPC | 155401-41-5 | Biochemical Assay Reagents |
| HY-170458 | 18:0-18:2 PG (sodium) | 474943-26-5 | Biochemical Assay Reagents |
| HY-170459 | 18:1-12:0 Biotin PE | 799812-67-2 | Biochemical Assay Reagents |
| HY-170460 | α-D-Galactopyranosylphenyl isothiocyanate | 120967-92-2 | Biochemical Assay Reagents |
| HY-170461 | 18:1 Dimethyl PE | 96687-22-8 | Biochemical Assay Reagents |
| HY-170462 | CSPD substrate | 142849-53-4 | Biochemical Assay Reagents |
| HY-170463 | 16:0 Phosphatidylpropanol | 92609-91-1 | Biochemical Assay Reagents |
| HY-170464 | PChemsPC | 155401-40-4 | Biochemical Assay Reagents |
| HY-170465 | 1,2-Distearoyl-3-butyryl-glycerol | 139665-43-3 | Reference compound |
| HY-170466 | 16:0-12 Doxyl PC | 217499-54-2 | Biochemical Assay Reagents |
| HY-170467 | 1-Stearoyl-2-lauroyl-rac-glycerol | 199274-84-5 | Reference compound |
| HY-170469 | 1,2-Dioleoyl-3-caprin | 88286-47-9 | Reference compound |
| HY-170470 | 1,2-Diarachidoyl-rac-glycerol | 89648-24-8 | Reference compound |
| HY-170471 | 1-Arachidoyl-rac-glycerol | 50906-68-8 | Reference compound |
| HY-170472 | Bpin-Bedaquiline | 2375174-10-8 | Reference compound |
| HY-170473 | Wheat germ oil | 68917-73-7 | Biochemical Assay Reagents |
| HY-170474 | 2-Methyl-N,N-dimethyltryptamine | 1080-95-1 | Reference compound |
| HY-170475 | 5-MeO-MET | 16977-53-0 | Reference compound |
| HY-170476 | Δ8-THCB | 51768-59-3 | Reference compound |
| HY-170477 | Δ8-THCP | 51768-60-6 | Reference compound |
| HY-170480 | Silk fibroin (MW 100000) | Biochemical Assay Reagents | |
| HY-170481 | Silk fibroin, suitable for cell culture | Biochemical Assay Reagents | |
| HY-170482 | Bouin's solution | Biochemical Assay Reagents | |
| HY-170483 | Antitumor agent-191 | Reference compound | |
| HY-170484 | KAI-11101 | Reference compound | |
| HY-170485 | Thrombin inhibitor 13 | Reference compound | |
| HY-170486 | MLK3-IN-1 | Reference compound | |
| HY-170487 | MAO-B-IN-38 | Reference compound | |
| HY-170488 | CM-728 | 2925046-28-0 | Reference compound |
| HY-170489 | Antifungal agent 123 | Reference compound | |
| HY-170490 | TTQ-SA | Reference compound | |
| HY-170491 | GSK-3β inhibitor 23 | Reference compound | |
| HY-170492 | sEH inhibitor-19 | Reference compound | |
| HY-170493 | Antiviral agent 66 | Reference compound | |
| HY-170494 | AS-254s | Reference compound | |
| HY-170495 | HDAC6 degrader-5 | Reference compound | |
| HY-170496 | Fluc-IN-1 | 2940242-10-2 | Reference compound |
| HY-170497 | EGFR-IN-140 | Reference compound | |
| HY-170498 | GABA-A Receptor Ligand-1 | Reference compound | |
| HY-170499 | VU6024578 | Reference compound | |
| HY-170500 | MAT2A-IN-17 | 2447684-81-1 | Reference compound |
| HY-170501 | MAT2A-IN-18 | 2923986-27-8 | Reference compound |
| HY-170502 | MAT2A-IN-19 | 2850245-72-4 | Reference compound |
| HY-170503 | MAT2A-IN-20 | 3018834-98-2 | Reference compound |
| HY-170504 | ZHAWOC25153 | Reference compound | |
| HY-170505 | Icafolin-methyl | 2254752-21-9 | Reference compound |
| HY-170506 | KB-208 | 1282128-68-0 | Reference compound |
| HY-170507 | CDK-IN-16 | Reference compound | |
| HY-170508 | Aromatase-IN-4 | 3060588-16-8 | Reference compound |
| HY-170509 | Ferroptosis-IN-17 | Reference compound | |
| HY-170510 | GB2095 | 2574415-75-9 | Reference compound |
| HY-170511 | GLP-1 receptor agonist 15 | 2757506-39-9 | Reference compound |
| HY-170512 | Mal-GGFG-PAB-MMAE | 3055607-18-3 | ADC Related |
| HY-170513 | 3'-Ethoxy-5,6-dihydrospinosyn J 17-pseudoaglycone | 2055494-09-0 | Reference compound |
| HY-170514 | 1,2,3,7,8,9-Hexachlorodibenzofuran | 72918-21-9 | Reference compound |
| HY-170515 | RNF5 agonist 1 | 69909-92-8 | Reference compound |
| HY-170516 | GLP-1 receptor agonist 16 | 2902596-52-3 | Reference compound |
| HY-170517 | PKMYT1-IN-8 | Reference compound | |
| HY-170518 | IKZF-IN-1 | Reference compound | |
| HY-170519 | K13787 | 2248016-83-1 | Reference compound |
| HY-170520 | Antibiofilm agent-14 | 2601306-22-1 | Reference compound |
| HY-170522 | ISM012-042 | Reference compound | |
| HY-170523 | RU-0415529 | 1358734-35-6 | Reference compound |
| HY-170524 | TDI-015051 | 3052313-73-9 | Reference compound |
| HY-170525 | CD73-IN-19 | 333329-22-9 | Reference compound |
| HY-170526 | ERK2 IN-5 | 353250-09-6 | Reference compound |
| HY-170527 | Anticancer agent 260 | 345994-70-9 | Reference compound |
| HY-170528 | DBCO-PEG3-NHS | 2249926-63-2 | Reference compound |
| HY-170529 | NLRP3-IN-61 | 3060585-94-3 | Reference compound |
| HY-170530 | NLRP3-IN-62 | 3059965-71-5 | Reference compound |
| HY-170531 | SR 142948-C3-NHMe | 1613265-52-3 | Reference compound |
| HY-170532 | NLRP3-IN-63 | 3064696-02-9 | Reference compound |
| HY-170533 | NLRP3-IN-64 | 3047549-19-6 | Reference compound |
| HY-170534 | Ac-EEVC-OH | 2921734-44-1 | Reference compound |
| HY-170535 | NLRP3-IN-65 | 3052859-81-8 | Reference compound |
| HY-170536 | NLRP3-IN-66 | 3052155-88-8 | Reference compound |
| HY-170537 | NLRP3-IN-67 | 3055022-81-3 | Reference compound |
| HY-170538 | LOX-IN-4 | 2125956-92-3 | Reference compound |
| HY-170540 | NOX4-IN-1 | Reference compound | |
| HY-170541 | FUT8-IN-1 | Reference compound | |
| HY-170542 | ZINC20906412 | Reference compound | |
| HY-170543 | Dual Galectin-3/EGFR-IN-1 | Reference compound | |
| HY-170544 | RIPK1-IN-28 | 2968509-28-4 | Reference compound |
| HY-170545 | SARS-CoV-2 Mpro-IN-35 | Reference compound | |
| HY-170546 | MU1920 | Reference compound | |
| HY-170547 | DNA polymerase-IN-6 | 2701561-91-1 | Reference compound |
| HY-170548 | α-Amylase-IN-10 | 3061941-94-1 | Reference compound |
| HY-170549 | VEGFR-2-IN-60 | Reference compound | |
| HY-170550 | KRAS G12C inhibitor 69 | Reference compound | |
| HY-170551 | CA IX/VEGFR-2-IN-3 | Reference compound | |
| HY-170552 | KC12 | Reference compound | |
| HY-170553 | ZPD-2 | Reference compound | |
| HY-170554 | ABBV-706 | Reference compound | |
| HY-170557 | Topoisomerase IIα-IN-10 | Reference compound | |
| HY-170558 | FW-1 | Reference compound | |
| HY-170559 | EGFR-IN-141 | 3054263-27-0 | Reference compound |
| HY-170560 | AChE/hCA I-IN-1 | 155140-19-5 | Reference compound |
| HY-170561 | AChE/BuChE-IN-6 | Reference compound | |
| HY-170562 | STEP-IN-1 | Reference compound | |
| HY-170563 | Tubulin polymerization-IN-72 | Reference compound | |
| HY-170564 | PTPN22-IN-2 | Reference compound | |
| HY-170565 | CHD-1 | 3041166-70-2 | Reference compound |
| HY-170567 | DNA gyrase/Topo IV-IN-1 | Reference compound | |
| HY-170568 | Tubulin polymerization-IN-73 | Reference compound | |
| HY-170569 | Cetagliptin | 2243737-33-7 | Reference compound |
| HY-170570 | PFM046 | 3053859-57-4 | Reference compound |
| HY-170571 | BE2647 | Reference compound | |
| HY-170572 | PB01 | 368434-78-0 | Reference compound |
| HY-170573 | LOXL2-IN-1 | 2125665-47-4 | Reference compound |
| HY-170573A | LOXL2-IN-1 (tosylate) | Reference compound | |
| HY-170574 | CQ627 | Reference compound | |
| HY-170575 | Pks13-IN-1 | Reference compound | |
| HY-170576 | FLT3-IN-28 | Reference compound | |
| HY-170577 | PKM2-IN-8 | Reference compound | |
| HY-170578 | SIRT2-IN-17 | Reference compound | |
| HY-170579 | Antioxidant agent-20 | Reference compound | |
| HY-170580 | Topo I/II-IN-1 | Reference compound | |
| HY-170581 | PPARγ/δ modulator 2 | Reference compound | |
| HY-170582 | PTP1B-IN-29 | Reference compound | |
| HY-170583 | hAChE-IN-10 | 3058182-98-9 | Reference compound |
| HY-170585 | COX-2-IN-51 | 3064260-49-4 | Reference compound |
| HY-170586 | JAK05 | Reference compound | |
| HY-170587 | Glucocorticoid receptor drug-linke 1 | 3048601-02-8 | ADC Related |
| HY-170588 | α-Glucosidase-IN-78 | Reference compound | |
| HY-170589 | GPR17 antagonist 1 | 1574405-61-0 | Reference compound |
| HY-170590 | VEGFR-2-IN-61 | Reference compound | |
| HY-170591 | p53 Activator 14 | 2922588-44-9 | Reference compound |
| HY-170592 | dALK-3 | Reference compound | |
| HY-170593 | ChREBPα/14-3-3 regulator-1 | 3067202-14-3 | Reference compound |
| HY-170594 | Antitumor agent-192 | Reference compound | |
| HY-170595 | PROTAC LZK-IN-1 | 2763268-64-8 | Reference compound |
| HY-170598 | HP211206 | Reference compound | |
| HY-170599 | H117 | Reference compound | |
| HY-170600 | Boc-Ala(Me)-H117 | Reference compound | |
| HY-170601 | PROTAC JNK1-targeted-1 | Reference compound | |
| HY-170603 | PRMT5-targeted fluorescent ligand-1 | Reference compound | |
| HY-170604 | MMP-2 Inhibitor-4 | Reference compound | |
| HY-170605 | BA-AZT1 | Reference compound | |
| HY-170606 | α-Glucosidase-IN-79 | Reference compound | |
| HY-170607 | HPCR | 176897-13-5 | Reference compound |
| HY-170608 | Urease-IN-18 | Reference compound | |
| HY-170609 | Antimicrobial agent-36 | Reference compound | |
| HY-170610 | mPGES-1/sEH-IN-1 | Reference compound | |
| HY-170611 | IL-17-IN-3 | Reference compound | |
| HY-170615 | Autophagy inducer 6 | Reference compound | |
| HY-170616 | JH-FK-08 | Reference compound | |
| HY-170617 | hSTING agonist-1 | Reference compound | |
| HY-170618 | 1-Myristoyl-3-butyryl-rac-glycerol | 100732-08-9 | Reference compound |
| HY-170619 | 1,3-Dieicosenoyl glycerol | 128230-18-2 | Reference compound |
| HY-170620 | PROTAC PARP1 degrader-4 | Reference compound | |
| HY-170621 | STAT1/3-IN-1 | 2958649-56-2 | Reference compound |
| HY-170622 | 1,2-Distearoyl-3-decanoyl-rac-glycerol | 127931-28-6 | Reference compound |
| HY-170623 | 1-Palmitoyl-2-stearoyl-3-butyryl-rac-glycerol | 152914-63-1 | Reference compound |
| HY-170624 | 4,5-MDAI (hydrochloride) | 124399-90-2 | Reference compound |
| HY-170625 | 1-Lauroyl-2-palmitoyl-rac-glycerol | 199274-83-4 | Reference compound |
| HY-170626 | 1-Palmitoyl-3-butyryl-rac-glycerol | 20358-82-1 | Reference compound |
| HY-170627 | (±)-threo-4-Fluoromethylphenidate (hydrochloride) | 2703832-68-0 | Reference compound |
| HY-170628 | 1-Myristoyl-3-oleoyl-rac-glycerol | 215055-21-3 | Reference compound |
| HY-170629 | 3,4-Dimethylmethcathinone metabolite (hydrochloride) | 4865-62-7 | Reference compound |
| HY-170630 | 1,3-Di-9(E)-palmitoleoyl glycerol | 372490-69-2 | Reference compound |
| HY-170631 | 1,2-Dielaidoyl-3-palmitoyl-rac-glycerol | 68069-77-2 | Reference compound |
| HY-170632 | Tripetroselinin | 3296-43-3 | Reference compound |
| HY-170633 | 1,2-Dielaidoyl-3-stearoyl-rac-glycerol | 93452-41-6 | Reference compound |
| HY-170634 | 1-Stearoyl-2-linoleoyl-3-oleoyl-rac-glycerol | 7162-26-7 | Reference compound |
| HY-170635 | 1-Palmitoyl-3-arachidoyl-rac-glycerol | 90669-23-1 | Reference compound |
| HY-170636 | 1,2,3-Tri-10(Z)-undecenoyl glycerol | 93824-29-4 | Reference compound |
| HY-170637 | 1,3-Dinervonoyl glycerol | 960594-30-3 | Reference compound |
| HY-170638 | 1,3-Dieicosatrienoin | 960594-33-6 | Reference compound |
| HY-170639 | 1,2-Diheptadecanoyl-rac-glycerol | 98896-81-2 | Reference compound |
| HY-170640 | FLT3-IN-29 | Reference compound | |
| HY-170641 | 1-Palmitoyl-3-lauroyl-rac-glycerol | 51604-53-6 | Reference compound |
| HY-170642 | Trimyristolein | 99483-10-0 | Reference compound |
| HY-170643 | G4/hTERT-IN-4 | Reference compound | |
| HY-170645 | Neuroprotectin D1 methyl ester | 934005-36-4 | Reference compound |
| HY-170646 | Influenza A virus-IN-15 | Reference compound | |
| HY-170647 | SEPT9-IN-1 | Reference compound | |
| HY-170648 | TS-IN-5 | Reference compound | |
| HY-170649 | RdRP-IN-9 | 1101848-34-3 | Reference compound |
| HY-170650 | SMase-IN-1 | 33017-85-5 | Reference compound |
| HY-170651 | CDK4/6/HDAC-IN-1 | Reference compound | |
| HY-170652 | ZQMT-10 | 1791309-86-8 | Reference compound |
| HY-170653 | Anticancer agent 262 | Reference compound | |
| HY-170654 | Opioid receptor antagonist 1 | 1559075-15-8 | Reference compound |
| HY-170655 | PDI-IN-4 | Reference compound | |
| HY-170656 | PI3K/mTOR Inhibitor-17 | Reference compound | |
| HY-170657 | DPP-4-IN-14 | Reference compound | |
| HY-170658 | AChE-IN-80 | Reference compound | |
| HY-170659 | NF-κB-IN-18 | Reference compound | |
| HY-170661 | EGFR-IN-142 | Reference compound | |
| HY-170662 | VEGFR-2-IN-62 | Reference compound | |
| HY-170663 | β-1,4-GALT1-IN-1 | Reference compound | |
| HY-170664 | Hexocannabitriol | 380495-68-1 | Reference compound |
| HY-170665 | EGFR T790M/L858R-IN-9 | Reference compound | |
| HY-170666 | Afubiata | 2985275-14-5 | Reference compound |
| HY-170667 | Autophagy activator-1 | 99174-40-0 | Reference compound |
| HY-170668 | DDO-02267 | 2919768-58-2 | Reference compound |
| HY-170669 | PROTAC XPO1 degrader-1 | Reference compound | |
| HY-170670 | DQ661 | 2027551-01-3 | Reference compound |
| HY-170671 | E3 ligase Ligand 49 | 1911013-66-5 | Reference compound |
| HY-170672 | XPO1-ligand-1 | Reference compound | |
| HY-170673 | E3 Ligase Ligand-linker Conjugate 156 | Reference compound | |
| HY-170674 | ND-L11B (free base) | Reference compound | |
| HY-170674A | ND-L11B (TFA) | Reference compound | |
| HY-170675 | Ferroptosis-IN-13 | Reference compound | |
| HY-170676 | 1,3-Dilinoleoyl-2-docosahexaenoyl glycerol | 157363-75-2 | Reference compound |
| HY-170677 | 1,3-Ditridecanoyl glycerol | 59891-27-9 | Reference compound |
| HY-170678 | 1-Myristoyl-3-docosanoyl-rac-glycerol | 115877-95-7 | Reference compound |
| HY-170679 | 1,3-Dioctanoyl glycerol | 1429-66-9 | Reference compound |
| HY-170680 | 1,2-Dilinoleoyl-3-stearoyl-rac-glycerol | 2190-17-2 | Reference compound |
| HY-170681 | 1,3-Didocosanoyl-2-oleoyl glycerol | 77145-68-7 | Reference compound |
| HY-170682 | 25B-NB3OMe (hydrochloride) | 1566571-55-8 | Reference compound |
| HY-170683 | 25H-NB4OMe (hydrochloride) | 1566571-54-7 | Reference compound |
| HY-170684 | DHX9-IN-19 | 2973400-78-9 | Reference compound |
| HY-170685 | 3,4-Methylenedioxy-N-isopropylcathinone (hydrochloride) | 2749298-40-4 | Reference compound |
| HY-170686 | BRD4 Inhibitor-38 | Reference compound | |
| HY-170687 | AT2R-IN-1 | 2896132-06-0 | Reference compound |
| HY-170688 | Antibacterial agent 119 | Reference compound | |
| HY-170689 | CG-3-246 | Reference compound | |
| HY-170690 | FGFR4-IN-22 | 2922812-74-4 | Reference compound |
| HY-170691 | hAChE/hBuChE-IN-1 | Reference compound | |
| HY-170692 | Hypoglycemic agent 3 | Reference compound | |
| HY-170693 | exo-Tetrahydrocannabivarin methyl ether | 132213-92-4 | Reference compound |
| HY-170695 | exo-THCP | 2897582-92-0 | Reference compound |
| HY-170696 | Δ8-THCPA-A | 2897582-89-5 | Reference compound |
| HY-170697 | 4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-Hydroxyethyl)-docosapentaenamide | 211817-55-9 | Reference compound |
| HY-170698 | 13,14-Dihydro-15-keto-tetranor prostaglandin E2 | 20675-85-8 | Reference compound |
| HY-170699 | Δ8-THCBA-A | 2022178-63-6 | Reference compound |
| HY-170700 | CHM-FUBIATA | 922092-52-2 | Reference compound |
| HY-170701 | 5-Nitro-2-(bromoacetamido)benzophenone | 2011-70-3 | Reference compound |
| HY-170702 | 10α-Hydroxy-Δ8-THC | 24902-23-6 | Reference compound |
| HY-170703 | Carmagerol | 140396-81-2 | Reference compound |
| HY-170704 | DSPE-PEG2000-TCO | 1480940-53-1 | Reference compound |
| HY-170705 | Δ9-THCP acetate | 2829292-82-0 | Reference compound |
| HY-170706 | DSPE-PEG2000-COOH | 1445832-74-5 | Reference compound |
| HY-170708 | N-Allylnoriso-LSD | 176108-44-4 | Reference compound |
| HY-170709 | 6',7'-Epoxy cannabigerol | 140381-46-0 | Reference compound |
| HY-170710 | Δ8-THC-ethyl | 51768-58-2 | Reference compound |
| HY-170711 | Adamdec1 Rat Pre-designed siRNA Set A-2 (2-OMe) | Reference compound | |
| HY-170712 | Adamdec1 Rat Pre-designed siRNA Set A-3 (2-OMe) | Reference compound | |
| HY-170713 | siRNA negative control (2-OMe) | Reference compound | |
| HY-170714 | siRNA positive control (Rat GAPDH) (2-OMe) | Reference compound | |
| HY-170715 | FAM negative control (2-OMe) | Reference compound | |
| HY-170716 | Adamdec1 Rat Pre-designed siRNA Set A-1 (2-OMe) | Reference compound | |
| HY-170717 | 3-Methylnordiazepam | 4699-82-5 | Reference compound |
| HY-170719 | 4-Chloro modafinil | 90280-12-9 | Reference compound |
| HY-170720 | CH-FUBIATA | 922038-77-5 | Reference compound |
| HY-170721 | Nitemazepam | 40762-03-6 | Reference compound |
| HY-170722 | Cannabigerolic acid monomethyl ether | 29624-08-6 | Reference compound |
| HY-170723 | JAK-IN-39 | 2250013-34-2 | Reference compound |
| HY-170725 | (-)-11-Hydroxy-Δ8-tetrahydrocannabivarin | 1421594-84-4 | Reference compound |
| HY-170726 | (±)-CBCP | 55824-16-3 | Reference compound |
| HY-170727 | Cannabinol acetate | 51895-51-3 | Reference compound |
| HY-170730 | Tosyl-methamphetamine | 74810-23-4 | Reference compound |
| HY-170731 | 3-Methoxymethamphetamine (hydrochloride) | 79896-22-3 | Reference compound |
| HY-170732 | 2,3,6-Trimethoxyamphetamine (hydrochloride) | 5556-75-2 | Reference compound |
| HY-170733 | Cannabidiol monomethyl ether | 1972-05-0 | Reference compound |
| HY-170734 | Cannabidiol-C8 | 2552798-28-2 | Reference compound |
| HY-170735 | 4-Chloroethamphetamine (hydrochloride) | 54779-54-3 | Reference compound |
| HY-170736 | Methamphetamine ethyl carbamate | 120504-67-8 | Reference compound |
| HY-170737 | N-Isopropyl butylone | 17762-92-4 | Reference compound |
| HY-170738 | CAY10799 (potassium) | 34200-97-0 | Reference compound |
| HY-170739 | Δ9-THCBA-A | 60007-98-9 | Reference compound |
| HY-170740 | Cannabigerophorol | 55824-15-2 | Reference compound |
| HY-170741 | N-Ethyl-3,4-DMA (hydrochloride) | 70932-27-3 | Reference compound |
| HY-170742 | N,N-Dimethyl-3,4-DMA (hydrochloride) | 70932-19-3 | Reference compound |
| HY-170743 | β-Hydroxy 2C-B (hydrochloride) | 807631-10-3 | Reference compound |
| HY-170744 | (±)-Cannabichromebutolic acid | 2691096-32-7 | Reference compound |
| HY-170746 | Cannabigerobutolic acid | 2468125-68-8 | Reference compound |
| HY-170747 | 9-tert-Butyldoxycycline | 233585-94-9 | Reference compound |
| HY-170749 | DFO-BCN | 2910882-32-3 | ADC Related |
| HY-170757 | Spermidine-alkyne | 1627941-31-4 | Reference compound |
| HY-170757A | Spermidine-alkyne (trihydrochloride) | Reference compound | |
| HY-170760 | Antibacterial agent 258 | 3054254-13-3 | Reference compound |
| HY-170761 | KEAP1-NRF2 PPI-IN-1 | Reference compound | |
| HY-170762 | Mcl-1 inhibitor 21 | 2155856-87-2 | Reference compound |
| HY-170762A | (+)-Mcl-1 inhibitor 21 | 2157421-23-1 | Reference compound |
| HY-170762B | (-)-Mcl-1 inhibitor 21 | 2157421-24-2 | Reference compound |
| HY-170763 | Mcl-1 inhibitor 22 | 2326420-06-6 | Reference compound |
| HY-170763A | (+)-Mcl-1 inhibitor 22 | 2332611-98-8 | Reference compound |
| HY-170763B | (-)-Mcl-1 inhibitor 22 | 2332611-95-5 | Reference compound |
| HY-170764 | M3686 | 2738550-24-6 | Reference compound |
| HY-170765 | ATX-IN-1 | Reference compound | |
| HY-170766 | PIN1 inhibitor 4 | Reference compound | |
| HY-170767 | SARS-CoV-2-IN-109 | Reference compound | |
| HY-170768 | Alkaline tryptase-IN-1 | Reference compound | |
| HY-170769 | FLT3 Ligand-Linker Conjugate 1 | 2769753-49-1 | Reference compound |
| HY-170770 | TLR7/8 agonist 12 | Reference compound | |
| HY-170771 | α5-GABAA receptor modulator 1 | Reference compound | |
| HY-170772 | Dual Cathepsin L/JAK-IN-1 | 2450279-41-9 | Reference compound |
| HY-170773 | Mtb-IN-9 | 924871-27-2 | Reference compound |
| HY-170774 | Hypoxia inducer-1 | Reference compound | |
| HY-170775 | AChE-IN-83 | 2828439-12-7 | Reference compound |
| HY-170776 | AXL/Angiokinase-IN-1 | Reference compound | |
| HY-170777 | SLU-10906 | 3065121-94-7 | Reference compound |
| HY-170778 | Tubulin polymerization-IN-77 | 3023350-32-2 | Reference compound |
| HY-170779 | DOTA-NI-FAPI-04 | Reference compound | |
| HY-170780 | DSM1465 | Reference compound | |
| HY-170781 | MDI-114215 | Reference compound | |
| HY-170782 | CZP-IN-1 | Reference compound | |
| HY-170783 | DXR-IN-4 | Reference compound | |
| HY-170784 | TKL-IN-1 | Reference compound | |
| HY-170785 | pan-KRAS-IN-17 | 3026014-12-7 | Reference compound |
| HY-170786 | IRX5010 | 856683-59-5 | Reference compound |
| HY-170787 | TZEP7 | 2566714-41-6 | Reference compound |
| HY-170788 | PDE7A-IN-1 | Reference compound | |
| HY-170789 | H1R ligand-1 | 19642-70-7 | Reference compound |
| HY-170790 | HZS60 | 3027529-88-7 | Reference compound |
| HY-170791 | CIB-L43 | 1082942-70-8 | Reference compound |
| HY-170792 | PRMT5-IN-48 | 2640287-77-8 | Reference compound |
| HY-170793 | PD-L1/VISTA-IN-1 | 2978623-09-3 | Reference compound |
| HY-170794 | ALT-007 | 2035010-37-6 | Reference compound |
| HY-170795 | AtHPPD-IN-1 | Reference compound | |
| HY-170796 | α-Amylase-IN-11 | Reference compound | |
| HY-170797 | α-Glucosidase-IN-80 | Reference compound | |
| HY-170798 | Monoamine Oxidase B inhibitor 6 | 101091-29-6 | Reference compound |
| HY-170799 | HNC-1664 | 2127358-36-3 | Reference compound |
| HY-170800 | DPP-4-IN-15 | 3035300-36-5 | Reference compound |
| HY-170801 | Anticonvulsant agent 7 | Reference compound | |
| HY-170802 | Anti-MRSA agent 22 | Reference compound | |
| HY-170803 | KPC-IN-1 | Reference compound | |
| HY-170804 | P2X4 antagonist-3 | Reference compound | |
| HY-170805 | UNC0737 | 1327276-39-0 | Reference compound |
| HY-170806 | ERα degrader 12 | Reference compound | |
| HY-170807 | Katanin-IN-1 | Reference compound | |
| HY-170808 | PROTAC BRD4 Degrader-28 | Reference compound | |
| HY-170809 | RET-IN-29 | Reference compound | |
| HY-170810 | E.coli Gyrase B-IN-1 | Reference compound | |
| HY-170811 | DCDQ | 27631-29-4 | Reference compound |
| HY-170812 | BET/Aurora kinase-IN-1 | 2674064-32-3 | Reference compound |
| HY-170813 | P162-0948 | 1358201-44-1 | Reference compound |
| HY-170814 | G-quadruplex ligand 3 | Reference compound | |
| HY-170815 | CDK4/9-IN-1 | 2577288-83-4 | Reference compound |
| HY-170816 | CYP51/Hsp90-IN-1 | Reference compound | |
| HY-170817 | SMI-1074 | 3033592-13-8 | Reference compound |
| HY-170818 | Grp94 Inhibitor-3 | Reference compound | |
| HY-170819 | VK13 | Reference compound | |
| HY-170820 | XYD049 | 3006788-11-7 | Reference compound |
| HY-170823 | PRC1-IN-1 | 2396639-29-3 | Reference compound |
| HY-170824 | SMD-3236 | 3033586-31-8 | Reference compound |
| HY-170825 | (trans-4-Ethynylcyclohexyl)methyl methanesulfonate | 1639795-23-5 | Reference compound |
| HY-170826 | SMARCA2 ligand-14 | Reference compound | |
| HY-170827 | E3 Ligase Ligand-linker Conjugate 159 | Reference compound | |
| HY-170828 | SMD-1087 | 3033586-04-5 | Reference compound |
| HY-170830 | Mtb against-1 | Reference compound | |
| HY-170831 | DS79932728 | 2757191-62-9 | Reference compound |
| HY-170832 | Menin–KMT2A-IN-1 | Reference compound | |
| HY-170833 | Anticonvulsant agent 8 | Reference compound | |
| HY-170834 | Antiproliferative agent-66 | Reference compound | |
| HY-170835 | NDM-1 inhibitor-7 | 26151-73-5 | Reference compound |
| HY-170836 | NLRP3-IN-69 | 3027608-60-9 | Reference compound |
| HY-170837 | STAT5-IN-3 | Reference compound | |
| HY-170838 | PDHK1-IN-1 | Reference compound | |
| HY-170839 | TRPV1-IN-3 | 87657-67-8 | Reference compound |
| HY-170840 | Antimalarial agent 47 | Reference compound | |
| HY-170841 | HDAC3/BRD4-IN-1 | Reference compound | |
| HY-170842 | TDK-HCPT | Reference compound | |
| HY-170843 | Antitumor agent-198 | Reference compound | |
| HY-170844 | MU147 | 2379405-61-3 | Reference compound |
| HY-170845 | MU1409 | 2379671-78-8 | Reference compound |
| HY-170846 | FGFRs-IN-1 | Reference compound | |
| HY-170847 | Anti-MRSA agent 24 | 2379890-92-1 | Reference compound |
| HY-170848 | Antimalarial agent 48 | 2035422-63-8 | Reference compound |
| HY-170849 | Nur77 modulator 4 | Reference compound | |
| HY-170850 | MKLP2-IN-1 | 2929345-46-8 | Reference compound |
| HY-170851 | GL392 | Reference compound | |
| HY-170852 | QZ2135 | Reference compound | |
| HY-170853 | RET ligand-3 | Reference compound | |
| HY-170854 | RET Ligand-Linker Conjugate-1 | Reference compound | |
| HY-170855A | YW-N-7 (TFA) | Reference compound | |
| HY-170856 | RET ligand-4 | Reference compound | |
| HY-170858 | E3 Ligase Ligand-linker Conjugate 162 | Reference compound | |
| HY-170859 | AH078 | Reference compound | |
| HY-170860 | CK1δ/CK1ε liagnd-1 | Reference compound | |
| HY-170862 | E3 Ligase Ligand-linker Conjugate 163 | Reference compound | |
| HY-170863 | ZSH-2208 | 2131803-75-1 | Reference compound |
| HY-170864 | BKS3031A | 1449771-90-7 | Reference compound |
| HY-170865 | OncoFAP-GlyPro-MMAF | Reference compound | |
| HY-170866 | α-Glucosidase-IN-81 | Reference compound | |
| HY-170867 | Nrf2/HO-1 activator 3 | Reference compound | |
| HY-170868 | CL2A-FL118 | 3025194-00-4 | Reference compound |
| HY-170869 | PROTAC FGFR1 degrader-1 | Reference compound | |
| HY-170872 | PT-129 | Reference compound | |
| HY-170873 | G3BP1/2-Targeting ligand-1 | Reference compound | |
| HY-170874 | PPARγ modulator-2 | 2897652-01-4 | Reference compound |
| HY-170877 | SHP2-IN-35 | Reference compound | |
| HY-170879 | JD123 | 696629-98-8 | Reference compound |
| HY-170883 | Type-I/-II Photosensitizer-1 | Reference compound | |
| HY-170884 | ICD inducer-1 | Reference compound | |
| HY-170885 | Group II intron-IN-1 | 836644-25-8 | Reference compound |
| HY-170886 | SARS-CoV-2 Mpro-IN-36 | Reference compound | |
| HY-170887 | MAO-B-IN-39 | Reference compound | |
| HY-170893 | CAIX/CAXII-IN-4 | Reference compound | |
| HY-170894 | SARS-CoV-2 Mpro-IN-37 | Reference compound | |
| HY-170895 | Hsp90-IN-38 | 3065556-04-6 | Reference compound |
| HY-170897 | CDK2-IN-40 | 3065079-44-6 | Reference compound |
| HY-170898 | Antidepressant agent 8 | 3066104-04-6 | Reference compound |
| HY-170899 | TLR7 agonist 28 | 1801518-98-8 | Reference compound |
| HY-170900 | SJ44236 | Reference compound | |
| HY-170901 | E3 Ligase Ligand-linker Conjugate 165 | 2789679-85-0 | Reference compound |
| HY-170902 | GABAA receptor modulator-4 | Reference compound | |
| HY-170903 | GABAA receptor modulator-3 | Reference compound | |
| HY-170904 | NLRP3-IN-72 | 3043952-13-9 | Reference compound |
| HY-170905S | MAT2A-IN-22 | 2925330-18-1 | Isotope-Labeled Compounds |
| HY-170906S | MAT2A-IN-23 | 2925324-58-7 | Isotope-Labeled Compounds |
| HY-170907 | HDAC-IN-85 | Reference compound | |
| HY-170908 | Pellotine | 19622-05-0 | Reference compound |
| HY-170909 | PIKfyve-IN-4 | Reference compound | |
| HY-170910 | Hsp90-IN-39 | 3065556-75-1 | Reference compound |
| HY-170911 | KIT/PDGFRA-IN-1 | Reference compound | |
| HY-170912 | Topo I/II-IN-2 | Reference compound | |
| HY-170914 | JPHM-2-167 | 1258877-17-6 | Reference compound |
| HY-170915 | DDO-3055 | 1842340-93-5 | Reference compound |
| HY-170916 | Angiogenesis inhibitor 7 | 922029-50-3 | Reference compound |
| HY-170917 | PHD2-IN-4 | 2924181-60-0 | Reference compound |
| HY-170918 | BKCa activator-1 | Reference compound | |
| HY-170919 | FGFR2/3-IN-2 | 3025799-28-1 | Reference compound |
| HY-170920 | Herbicide safener-4 | 3056059-99-2 | Reference compound |
| HY-170921 | USP1-IN-11 | Reference compound | |
| HY-170922 | SARS-CoV-2-IN-110 | Reference compound | |
| HY-170924 | Tubulin polymerization-IN-76 | Reference compound | |
| HY-170925 | AChE-IN-81 | Reference compound | |
| HY-170926 | CQ1373 | Reference compound | |
| HY-170927 | JAK-IN-40 | Reference compound | |
| HY-170928 | DA-0157 | 2756978-82-0 | Reference compound |
| HY-170929 | EMT inhibitor-3 | 2930726-89-7 | Reference compound |
| HY-170930 | Anticonvulsant agent 9 | Reference compound | |
| HY-170931 | AMPK activator 16 | 2252336-04-0 | Reference compound |
| HY-170932 | EGFR/COX-2-IN-1 | Reference compound | |
| HY-170933 | SGK1-IN-6 | 3046378-98-4 | Reference compound |
| HY-170934 | BW710 | Reference compound | |
| HY-170935 | SRSF1-IN-1 | Reference compound | |
| HY-170936 | MY-1576 | Reference compound | |
| HY-170937 | Urease-IN-20 | 2998940-98-8 | Reference compound |
| HY-170938 | AChE-IN-82 | Reference compound | |
| HY-170940 | Dyrk1A-IN-12 | 2243701-11-1 | Reference compound |
| HY-170942 | CDK9/PARP-IN-1 | 3032818-67-7 | Reference compound |
| HY-170943 | Antidiabetic agent 7 | Reference compound | |
| HY-170944 | BAG3/HSP70-IN-1 | Reference compound | |
| HY-170945 | Antidepressant agent 9 | 143899-90-5 | Reference compound |
| HY-170946 | WR-S-462 | Reference compound | |
| HY-170947 | Antitumor agent-195 | Reference compound | |
| HY-170949 | STING-IN-11 | 2925028-15-3 | Reference compound |
| HY-170950 | P2Y14 antagonist 1 | Reference compound | |
| HY-170951 | AR antagonist 10 | 3068489-78-8 | Reference compound |
| HY-170952 | LYG-409 | 3053857-55-6 | Reference compound |
| HY-170953 | QXG-6442 | Reference compound | |
| HY-170954 | C-Met/Axl-IN-1 | Reference compound | |
| HY-170955 | HA-CD44 interaction inhibitor 3 | Reference compound | |
| HY-170956 | BTN3A1 ligand-1 | Reference compound | |
| HY-170957 | 5-LOX/NO-IN-1 | Reference compound | |
| HY-170958 | Scr-IN-1 | Reference compound | |
| HY-170959 | NYY-6a | Reference compound | |
| HY-170960 | TACC3 inhibitor 2 | 2642351-96-8 | Reference compound |
| HY-170961 | SDUY816 | Reference compound | |
| HY-170962 | SDUY817 | Reference compound | |
| HY-170963 | LASSBio-1985 | Reference compound | |
| HY-170964 | HPH-15 | 1009838-93-0 | Reference compound |
| HY-170965 | Anticancer agent 264 | Reference compound | |
| HY-170966 | HDAC1-IN-9 | Reference compound | |
| HY-170967 | IPH10 | Reference compound | |
| HY-170968 | EGFR-IN-150 | 3037323-16-0 | Reference compound |
| HY-170969 | HIV-1 inhibitor-81 | Reference compound | |
| HY-170970 | Mtb-IN-10 | Reference compound | |
| HY-170971 | Src Inhibitor 4 | Reference compound | |
| HY-170972 | PARP/NAMPT-IN-1 | 2755825-45-5 | Reference compound |
| HY-170973 | KOR agonist 4 | Reference compound | |
| HY-170974 | SDH-IN-20 | Reference compound | |
| HY-170975 | UG-650 | Reference compound | |
| HY-170976 | BuChE-IN-16 | Reference compound | |
| HY-170977 | JAK1/STAT3-IN-1 | Reference compound | |
| HY-170978 | PROTAC CDK9 degrader-11 | 3039540-19-4 | Reference compound |
| HY-170979 | CDK9 ligand 3 | 3039540-24-1 | Reference compound |
| HY-170980 | E3 Ligase Ligand-linker Conjugate 166 | 2930001-60-6 | Reference compound |
| HY-170983 | MC-25B | Reference compound | |
| HY-170986 | E3 ligase Ligand 57 | Reference compound | |
| HY-170987 | FKBP12 Ligand-Linker Conjugate 1 | 2765059-01-4 | Reference compound |
| HY-170988 | FKBP12 ligand-1 | 178446-02-1 | Reference compound |
| HY-170989 | BRD4 degrader-5 | Reference compound | |
| HY-170991 | C12-rrw-NH2 | Reference compound | |
| HY-170992 | Autophagy agonist-1 | Reference compound | |
| HY-170993 | Antimicrobial agent-39 | Reference compound | |
| HY-170994 | I2-IRs ligand-1 | Reference compound | |
| HY-170995 | PROTAC ROR1 degrader-1 | Reference compound | |
| HY-170996 | ROR1 ligand-1 | Reference compound | |
| HY-170997 | CypA ligand-1 | Reference compound | |
| HY-170998 | ATG16L1 stabilizer-1 | Reference compound | |
| HY-170999 | Antitumor agent-196 | 2705841-17-2 | Reference compound |
| HY-171000 | Propiverine N-oxide | 111071-96-6 | Reference compound |
| HY-171001 | ZM522 | 1454575-38-2 | Reference compound |
| HY-171002 | PAD2-IN-2 | Reference compound | |
| HY-171002A | PAD2-IN-2 (TFA) | Reference compound | |
| HY-171003 | SOBRAC | 362678-28-2 | Reference compound |
| HY-171004 | KRN7000 analog 8 | 2300074-31-9 | Reference compound |
| HY-171005 | VPC162134 | 1245813-92-6 | Reference compound |
| HY-171006 | IRF1-IN-1 | 701225-07-2 | Reference compound |
| HY-171007 | IRF1-IN-2 | 708245-32-3 | Reference compound |
| HY-171008 | Linoleoyl ethanolamide phosphate | 419566-71-5 | Reference compound |
| HY-171009 | FAK-IN-23 | 2491708-73-5 | Reference compound |
| HY-171013 | THR-β agonist 8 | 2832859-77-3 | Reference compound |
| HY-171015 | 10-(Phosphonooxy)-1-decanole | 235097-47-9 | Reference compound |
| HY-171016 | D-Biopterin | 13039-62-8 | Reference compound |
| HY-171019 | Lipid 119-23 | 2953044-98-7 | Reference compound |
| HY-171020 | 8-Nitro-2'3'cGMP | Reference compound | |
| HY-171021 | 8-Nitro-2'3'cAMP | Reference compound | |
| HY-171024 | Cannabinol ethyl | 99623-70-8 | Reference compound |
| HY-171025 | Cannabiorcol | 19825-73-1 | Reference compound |
| HY-171026 | Despropionyl remifentanil | 938184-95-3 | Reference compound |
| HY-171027 | PTP1B/TC-PTP IN-1 | 3053414-48-2 | Reference compound |
| HY-171028 | 3-Hydroxy desalkylflurazepam | 17617-60-6 | Reference compound |
| HY-171029 | C902 | 1395472-39-5 | Reference compound |
| HY-171030 | Pro-GA | 2222067-12-9 | Reference compound |
| HY-171031 | TFGF-18 | 2222662-20-4 | Reference compound |
| HY-171032 | (R)-YNT-3708 | 2923137-94-2 | Reference compound |
| HY-171033 | ASM-IN-3 | 2342576-75-2 | Reference compound |
| HY-171034 | PQA-18 | 1604678-82-1 | Reference compound |
| HY-171035 | PRL-295 | 2377770-85-7 | Reference compound |
| HY-171036 | GAPDH-IN-1 | 252212-58-1 | Reference compound |
| HY-171037 | Prostaglandin Bx | 39306-29-1 | Reference compound |
| HY-171038 | STAT3-IN-39 | 3037596-35-0 | Reference compound |
| HY-171039 | Tribromobisphenol A | 6386-73-8 | Reference compound |
| HY-171040 | Δ4-Iso-THC | 23050-57-9 | Reference compound |
| HY-171041 | PreQ1-biotin | 2971850-25-4 | Reference compound |
| HY-171043 | 3-Hydroxy desalkylgidazepam | 37891-18-2 | Reference compound |
| HY-171044 | Anticancer agent 261 | 860456-56-0 | Reference compound |
| HY-171045 | Abz-FRF(4NO2) | 249618-84-6 | Peptides |
| HY-171047 | Autophagy inducer 7 | 944159-20-0 | Reference compound |
| HY-171048 | GTx-027 | 928122-40-1 | Reference compound |
| HY-171049 | Androgen receptor modulator 3 | 1018971-95-3 | Reference compound |
| HY-171051 | Pasodacigib | 2648721-77-9 | Reference compound |
| HY-171060 | Mc-Pro-PAB-MMAE | 2766450-03-5 | ADC Related |
| HY-171069 | FFA2 agonist-1 | 1312799-06-6 | Reference compound |
| HY-171113 | CP-LC-1074 | Reference compound | |
| HY-171114 | DMT7 | Reference compound | |
| HY-171115 | Pyrone-211 | 90632-45-4 | Reference compound |
| HY-171119 | NSD2-PWWP1-IN-1 | 2797183-30-1 | Reference compound |
| HY-171120 | NSD2-PWWP1-IN-2 | 2797183-32-3 | Reference compound |
| HY-171121 | NSD2-PWWP1-IN-3 | 2797183-35-6 | Reference compound |
| HY-171124 | Tilatamig samrotecan | ADC Related | |
| HY-171125 | Maytansine derivative M24 | 2226467-81-6 | ADC Related |
| HY-171126 | DM21-L-G | 2243689-87-2 | ADC Related |
| HY-171127 | IMGC-936 | ADC Related | |
| HY-171128 | PTX-M | 2130882-23-2 | Reference compound |
| HY-171130 | Cy3 MicroRNA Antagomir Negative Control | Reference compound | |
| HY-171131 | BTK-IN-41 | 2251799-53-6 | Reference compound |
| HY-171132 | PRMT3-IN-5 | 2204250-25-7 | Reference compound |
| HY-171133 | Dopaminechrome | 39984-17-3 | Reference compound |
| HY-171135 | Cetuximab MMAE | ADC Related | |
| HY-171138 | Mal-VC-PAB-DMEA-PNU-159682 | 1178887-17-6 | ADC Related |
| HY-171139 | PROTAC HDAC6 degrader 2 | Reference compound | |
| HY-171140 | PROTAC HDAC6 degrader 3 | Reference compound | |
| HY-171141 | HDAC6 ligand-2 | Reference compound | |
| HY-171146 | HSN748 | 2409925-53-5 | Reference compound |
| HY-171148 | F1-RIBOTAC | 3019907-96-8 | Oligonucleotides |
| HY-171152 | NSC 357754 | 2938216-28-3 | Reference compound |
| HY-171159 | MC-Val-Cit-PAB-Sunitinib | Reference compound | |
| HY-171160 | WYFA-15 | Reference compound | |
| HY-171164 | Nirmatrelvir analog-1 | 2883654-29-1 | Reference compound |
| HY-171165 | JC168 | 1784751-83-2 | Reference compound |
| HY-171170 | 18:0-LPS | 119786-67-3 | Natural Products |
| HY-171174 | CDK8-IN-16 | 1860885-61-5 | Reference compound |
| HY-171175 | UniPR500 | 2085767-98-0 | Reference compound |
| HY-171176 | 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-(5-Cl)-Exatecan | 2813269-48-4 | ADC Related |
| HY-171177 | P5SA-2 | 864717-20-4 | Reference compound |
| HY-171178 | DK2403 | 2902651-64-1 | Reference compound |
| HY-171179 | BD-Oligo | 1357578-02-9 | Reference compound |
| HY-171180 | AF615 | 122510-61-6 | Reference compound |
| HY-171181 | ZINC20451377 | 2306303-35-3 | Reference compound |
| HY-171182 | D3017 | 130403-18-8 | Reference compound |
| HY-171183 | AB8939 | 1974336-09-8 | Reference compound |
| HY-171184 | EAPB0503 | 1140627-77-5 | Reference compound |
| HY-171185 | CP-611,781 | 368454-88-0 | Reference compound |
| HY-171186 | EAPB0202 | 681284-82-2 | Reference compound |
| HY-171187 | Chlorzolamide | 5541-92-4 | Reference compound |
| HY-171189 | C-467929 | 351891-58-2 | Reference compound |
| HY-171190 | ELQ-316 | 1354745-69-9 | Reference compound |
| HY-171191 | REGN5093-M114 | ADC Related | |
| HY-171194 | VU0530244 | 1396886-30-8 | Reference compound |
| HY-171195 | VU0631019 | 1235656-95-7 | Reference compound |
| HY-171199 | In vivo Igkc Mouse Pre-designed siRNA-1 | Oligonucleotides | |
| HY-171200 | In vivo Igkc Mouse Pre-designed siRNA-2 | Oligonucleotides | |
| HY-171201 | In vivo Igkc Mouse Pre-designed siRNA-3 | Oligonucleotides | |
| HY-171202 | In vivo Jun Mouse Pre-designed siRNA-1 | Oligonucleotides | |
| HY-171203 | In vivo Jun Mouse Pre-designed siRNA-2 | Oligonucleotides | |
| HY-171204 | In vivo Jun Mouse Pre-designed siRNA-3 | Oligonucleotides | |
| HY-171205 | In vivo Jund Mouse Pre-designed siRNA-1 | Oligonucleotides | |
| HY-171206 | In vivo Jund Mouse Pre-designed siRNA-2 | Oligonucleotides | |
| HY-171207 | In vivo Jund Mouse Pre-designed siRNA-3 | Oligonucleotides | |
| HY-171208 | In vivo Stat1 Mouse Pre-designed siRNA-1 | Oligonucleotides | |
| HY-171209 | In vivo Stat1 Mouse Pre-designed siRNA-2 | Oligonucleotides | |
| HY-171210 | In vivo Stat1 Mouse Pre-designed siRNA-3 | Oligonucleotides | |
| HY-171217 | TG-100435 | 867330-68-5 | Reference compound |
| HY-171218 | CGP062464 | 121405-24-1 | Reference compound |
| HY-171224 | CRBN ligand-45 | 3065496-78-5 | Reference compound |
| HY-171229 | 1-Acetyl-DHAP | 2267338-53-2 | Reference compound |
| HY-171230 | MTH1 activator-1 | 2803422-60-6 | Reference compound |
| HY-171232 | Jimscaline | 890309-57-6 | Reference compound |
| HY-171233 | MRSA antibiotic 2 | 667410-02-8 | Reference compound |
| HY-171234 | R-4066 | 66194-36-3 | Reference compound |
| HY-171235 | 5-HT2A antagonist 3 | 1134815-69-2 | Reference compound |
| HY-171236 | FEKAP | 2324155-84-0 | Reference compound |
| HY-171237 | mPGES1-IN-9 | 556033-92-2 | Reference compound |
| HY-171238 | Dihydroechinofuran | 142130-52-7 | Reference compound |
| HY-171241 | Imolamine | 318-23-0 | ADC Related |
| HY-171242 | LNK01004 | 2445500-24-1 | Reference compound |
| HY-171244 | Sodium Channel inhibitor 6 | 2877755-11-6 | Reference compound |
| HY-171247 | CDD-1281 | 3034215-91-0 | Reference compound |
| HY-171248 | CDD-1115 | 3034215-86-3 | Reference compound |
| HY-171249 | CDD-1431 | 3034216-31-1 | Reference compound |
| HY-171251 | RGS10 modulator-1 | 1113116-62-3 | Reference compound |
| HY-171252 | EGFR-IN-145 | 852407-49-9 | Reference compound |
| HY-171253 | Clotizolam | 54123-06-7 | Reference compound |
| HY-171254 | p38-α MAPK-IN-9 | 868272-50-8 | Reference compound |
| HY-171255 | KRAS G12D inhibitor 26 | 2972625-49-1 | Reference compound |
| HY-171264 | Mfsd2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-171265 | MRG003 | ADC Related | |
| HY-171269 | Anetumab-MMAE | ADC Related | |
| HY-171270 | Clivatuzumab-MMAE | ADC Related | |
| HY-171272 | PRDX1-IN-3 | 2566976-46-1 | Reference compound |
| HY-171274 | DOCK5-IN-1 | 149775-26-8 | Reference compound |
| HY-171275 | p38 MAP Kinase-IN-1 | 815595-27-8 | Reference compound |
| HY-171276 | Anti-neuroinflammation agent 3 | 928316-71-6 | Reference compound |
| HY-171277 | Casein kinase 1δ-IN-27 | 1095706-65-2 | Reference compound |
| HY-171278 | Casein kinase 1δ-IN-28 | 1095750-94-9 | Reference compound |
| HY-171279 | Casein kinase 1δ-IN-29 | 1177418-39-1 | Reference compound |
| HY-171281 | Human microRNA 200c | Reference compound | |
| HY-171289 | Neu5Acα2-6GalNAcα1-4GlcNac | 1015759-32-6 | Reference compound |
| HY-171290 | Casein kinase 1δ-IN-31 | 2567490-30-4 | Reference compound |
| HY-171291 | Protein kinase inhibitor 14 | 928319-09-9 | Reference compound |
| HY-171292 | CK1δ-IN-9 | 3057263-82-5 | Reference compound |
| HY-171293 | Protein kinase inhibitor 15 | 928317-20-8 | Reference compound |
| HY-171294 | Protein kinase inhibitor 16 | 928316-79-4 | Reference compound |
| HY-171295 | p38 Kinase inhibitor 7 | 815595-14-3 | Reference compound |
| HY-171296 | p38 Kinase inhibitor 8 | 815595-25-6 | Reference compound |
| HY-171297 | p38-α MAPK-IN-10 | 200801-77-0 | Reference compound |
| HY-171298 | CK1δ-IN-10 | 2765374-31-8 | Reference compound |
| HY-171300 | p38α inhibitor 8 | 1572047-63-2 | Reference compound |
| HY-171301 | p38α MAPK/CK1δ inhibitor-1 | 1572047-84-7 | Reference compound |
| HY-171306 | MK16 | Oligonucleotides | |
| HY-171317 | SMARt751 | 1616370-52-5 | Reference compound |
| HY-171328 | RG-15 | 1076189-55-3 | Reference compound |
| HY-171331 | AB-3PRGD2 | 2416165-76-7 | Reference compound |
| HY-171334 | (Rac)-P1D-34 | 2957895-04-2 | Reference compound |
| HY-171334A | P1D-34 | Reference compound | |
| HY-171347 | gamma-secretase modulator 6 | 1255700-88-9 | Reference compound |
| HY-171362 | PSI-7410 | 1015073-44-5 | Reference compound |
| HY-171362A | PSI-7410 (sodium) | Reference compound | |
| HY-171366 | lirucitinib | 2458115-78-9 | Reference compound |
| HY-171368 | L-Histidine buffer,Sterile | Biochemical Assay Reagents | |
| HY-171417 | 6-Alkyne-F-araNAD | 1119281-04-7 | Reference compound |
| HY-171442 | PIN1 ligand-2 | 2957895-02-0 | Reference compound |
| HY-171442A | (R)-PIN1 ligand-2 | Reference compound | |
| HY-171443 | Lyso-Monosialoganglioside GM3 | 94458-63-6 | Reference compound |
| HY-171446 | TAK-075 | 667931-33-1 | Reference compound |
| HY-171447 | LPT99 | 1263477-83-3 | Reference compound |
| HY-171448 | SU-740 | 134336-72-4 | Reference compound |
| HY-171449 | SCH 211803 | 331765-50-5 | Reference compound |
| HY-171450 | VMD-928 | 1802770-18-8 | Reference compound |
| HY-171451 | RMGPa-IN-1 | 958237-73-5 | Reference compound |
| HY-171454 | DA-1241 | 1914136-10-9 | Reference compound |
| HY-171456 | PD-224378 | 466678-44-4 | Reference compound |
| HY-171457 | WR-27653 | 6042-36-0 | Reference compound |
| HY-171458 | U-104067 | 172035-69-7 | Reference compound |
| HY-171459 | LEQ803 | 1211441-59-6 | Reference compound |
| HY-171460 | Win 45164 | 83880-39-1 | Reference compound |
| HY-171461 | CGS 24592 | 147923-04-4 | Reference compound |
| HY-171462 | SMW139 | 2133010-38-3 | Reference compound |
| HY-171463 | AC-271337 | 1246494-36-9 | Reference compound |
| HY-171464 | Lp(a)-IN-5 | 2924841-79-0 | Reference compound |
| HY-171465 | Lp(a)-IN-6 | 2566425-77-0 | Reference compound |
| HY-171467 | MRS7799 | 224040-19-1 | Reference compound |
| HY-171469 | SKP-451 | 181137-41-7 | Reference compound |
| HY-171470 | RS-57067 | 179382-91-3 | Reference compound |
| HY-171471 | SKF 10810 | 22196-65-2 | Reference compound |
| HY-171472 | A-86929 | 171961-95-8 | Reference compound |
| HY-171476 | CP-865569 | 478833-25-9 | Reference compound |
| HY-171477 | Metahexestrol | 71953-72-5 | Reference compound |
| HY-171478 | SQ 11,447 | 33406-68-7 | Reference compound |
| HY-171481 | Thio-acridone | 6540-78-9 | Reference compound |
| HY-171489 | Mal-VC-PAB-EDA-N-Ac-Calicheamicin | 2028299-61-6 | ADC Related |
| HY-171493 | mCherry mRNA(N1-Me-Pseudo UTP) | Oligonucleotides | |
| HY-171498 | gDIS3-13 | Reference compound | |
| HY-171499 | Cenersen | 872847-66-0 | Reference compound |
| HY-171507 | Mal-Val-Ala-amide-(3)PEA-PNU-159682 | 2682939-56-4 | ADC Related |
| HY-171508 | Mal-PNU-159682 | 1204819-90-8 | Reference compound |
| HY-171509 | Mal-N(Me)-C6-N(Me)-PNU-159682 | 2682939-57-5 | ADC Related |
| HY-171540 | AnCDA-IN-1 | 1185081-36-0 | Reference compound |
| HY-171541 | CDA-IN-1 | 354562-11-1 | Reference compound |
| HY-171542 | CDA-IN-2 | 2559404-67-8 | Reference compound |
| HY-171543 | PARP1-IN-37 | 952474-39-4 | Reference compound |
| HY-171544 | AGS-16C3F | ADC Related | |
| HY-171558 | PI3K-IN-56 | 2633645-58-4 | Reference compound |
| HY-171559 | TCO-PEG5-NHS ester | 2714310-77-5 | Reference compound |
| HY-171561 | DOTAM-Maleimide (triTFA) | Biochemical Assay Reagents | |
| HY-171561G | DOTAM-Maleimide (triTFA) (GMP) | GMP Small Molecules | |
| HY-171562 | Cholesterol-SA-PEG-Azide (MW 2000) | Biochemical Assay Reagents | |
| HY-171580 | Mc-PEG4-Val-Ala-PAB-Exatecan | ADC Related | |
| HY-171647 | RNAP-σ interaction inhibitor-1 | 2408055-45-6 | Reference compound |
| HY-171648 | RNAP-σ interaction inhibitor-2 | 3077454-53-3 | Reference compound |
| HY-172000 | (S)-3-Keto sphinganine (d18:0) (hydrochloride) | 25515-53-1 | Reference compound |
| HY-172001 | α-GalCer analog 8 | 922727-14-8 | Reference compound |
| HY-172002 | 3'-O-Methylguanosine-5'-O-triphosphate (sodium) | 98923-57-0 | Reference compound |
| HY-172003 | Isoorotidine | 489-36-1 | Reference compound |
| HY-172004 | N-Desmethyl asenapine | 128915-56-0 | Reference compound |
| HY-172005 | 10,11-Dihydroxycarbamazepine | 35079-97-1 | Reference compound |
| HY-172006 | Probetaenone I | 115473-44-4 | Reference compound |
| HY-172007 | Acremine F | 863480-61-9 | Reference compound |
| HY-172008 | (±)-Biotin sulfoxide | 23015-53-4 | Reference compound |
| HY-172009 | 8-Amino-7-oxononanoic acid (hydrochloride) | 21286-96-4 | Reference compound |
| HY-172010 | 4-Hydroxyphenylpropionylglycine | 3850-43-9 | Reference compound |
| HY-172011 | Strychnospermine | 509-45-5 | Reference compound |
| HY-172012 | Porantherine | 33529-61-2 | Reference compound |
| HY-172013 | N-Methylcanadium (iodide) | 100176-93-0 | Reference compound |
| HY-172014 | CP-LC-0743 | 3040858-73-6 | Reference compound |
| HY-172015 | CP-LC-1143 | 3040859-45-5 | Reference compound |
| HY-172016 | CP-LC-0867 | 3040858-96-3 | Reference compound |
| HY-172017 | CP-LC-1254 | 3040859-52-4 | Reference compound |
| HY-172018 | CP-LC-0729 | 3040858-60-1 | Reference compound |
| HY-172019 | Glyceryl dilaurate | 27638-00-2 | Reference compound |
| HY-172020 | 1,3-Diheptadecanoyl glycerol | 71431-35-1 | Reference compound |
| HY-172021 | Didocosanoin | 99880-64-5 | Reference compound |
| HY-172022 | Dipalmitelaidin | 372516-90-0 | Reference compound |
| HY-172023 | apo-Enterobactin | 30414-16-5 | Reference compound |
| HY-172024 | Betulin ditosylate | 77265-02-2 | Reference compound |
| HY-172025 | 28-Acetyl-2,3-indolobetulin | 56855-69-7 | Reference compound |
| HY-172026 | N-Nitroso clonidine | 148950-49-6 | Reference compound |
| HY-172027 | Remdesivir methylpropyl ester analog | 3047145-80-9 | Reference compound |
| HY-172028 | 6-(2-Aminopropyl)indole | 21005-63-0 | Reference compound |
| HY-172029 | 3,4-Methylenedioxy pyrovalerone metabolite 2 (hydrochloride) | 2748289-38-3 | Reference compound |
| HY-172030 | 2C-T (hydrochloride) | 61638-10-6 | Reference compound |
| HY-172031 | 3,4-MDPA (hydrochloride) | 74341-77-8 | Reference compound |
| HY-172032 | 4'-Fluoro-α-pyrrolidinopropiophenone (hydrochloride) | 28117-76-2 | Reference compound |
| HY-172035 | 5-Fluoro PB-22 5-hydroxyquinoline isomer | 2365471-33-4 | Reference compound |
| HY-172036 | 5-Fluoro PB-22 6-hydroxyquinoline isomer | 2365471-03-8 | Reference compound |
| HY-172037 | 5-Fluoro PB-22 7-hydroxyquinoline isomer | 1630756-70-5 | Reference compound |
| HY-172040 | PB-22 5-Hydroxyquinoline isomer | 1885091-23-5 | Reference compound |
| HY-172041 | PB-22 6-Hydroxyquinoline isomer | 2365471-56-1 | Reference compound |
| HY-172042 | PB-22 7-Hydroxyquinoline isomer | 1629062-76-5 | Reference compound |
| HY-172043 | 5-Fluoro PB-22 N-(2-fluoropentyl) isomer | 2365471-10-7 | Reference compound |
| HY-172044 | 5-Fluoro PB-22 N-(3-fluoropentyl) isomer | 2365471-07-2 | Reference compound |
| HY-172045 | 5-Fluoro PB-22 N-(4-fluoropentyl) isomer | 2365471-15-2 | Reference compound |
| HY-172047 | 5-Fluoro PB-22 5-hydroxyisoquinoline isomer | 2365471-16-3 | Reference compound |
| HY-172048 | 5-Fluoro PB-22 6-hydroxyisoquinoline isomer | 2365471-44-7 | Reference compound |
| HY-172049 | 5-Fluoro PB-22 7-hydroxyisoquinoline isomer | 2365471-81-2 | Reference compound |
| HY-172050 | PB-22 5-Hydroxyisoquinoline isomer | 2365471-14-1 | Reference compound |
| HY-172051 | PB-22 6-Hydroxyisoquinoline isomer | 1797131-58-8 | Reference compound |
| HY-172052 | PB-22 7-Hydroxyisoquinoline isomer | 2365471-61-8 | Reference compound |
| HY-172053 | PB-22 8-Hydroxyisoquinoline isomer | 1798021-82-5 | Reference compound |
| HY-172054 | PB-22 N-(4-Hydroxypentyl)-3-carboxyindole metabolite | 2704733-57-1 | Reference compound |
| HY-172055 | PB-22 N-(5-Hydroxypentyl)-3-carboxyindole metabolite | 1459236-34-0 | Reference compound |
| HY-172056 | PB-22 N-Pentanoic acid-3-carboxyindole metabolite | 1630022-95-5 | Reference compound |
| HY-172057 | 4-Fluoromethcathinone metabolite (hydrochloride) | 7799-72-6 | Reference compound |
| HY-172058 | 5-Fluoro THJ | 2180934-72-7 | Reference compound |
| HY-172059 | 3C-P (hydrochloride) | 2749897-26-3 | Reference compound |
| HY-172060 | 2,5-DMMA | 54687-43-3 | Reference compound |
| HY-172061 | 3,4-EDMC (hydrochloride) | 30253-44-2 | Reference compound |
| HY-172062 | 4-Fluoro PV8 (hydrochloride) | 2748485-01-8 | Reference compound |
| HY-172063 | 3-CAF | 2219324-25-9 | Reference compound |
| HY-172064 | 4-Methyl PV8 (hydrochloride) | 2748590-98-7 | Reference compound |
| HY-172065 | 3,4-Dimethoxy-α-pyrrolidinohexanophenone (hydrochloride) | 2748409-11-0 | Reference compound |
| HY-172066 | 3,4-Dimethoxymethcathinone (hydrochloride) | 22930-82-1 | Reference compound |
| HY-172067 | ER ligand-9 | 3026011-20-8 | Reference compound |
| HY-172068 | 25B-NB4OMe (hydrochloride) | 1566571-56-9 | Reference compound |
| HY-172069 | ADB-BICA | 2219319-40-9 | Reference compound |
| HY-172070 | Metaescaline (hydrochloride) | 90132-32-4 | Reference compound |
| HY-172071 | Methamnetamine (hydrochloride) | 2748623-12-1 | Reference compound |
| HY-172073 | MDMB-FUBICA metabolite 3 | 2693397-46-3 | Reference compound |
| HY-172074 | N-Propylnorketamine (hydrochloride) | 2749326-65-4 | Reference compound |
| HY-172076 | N,N-Diethylpentylone (hydrochloride) | 17763-15-4 | Reference compound |
| HY-172077 | 4-MA-NBOMe (hydrochloride) | 2749298-47-1 | Reference compound |
| HY-172078 | N-Methyl benzedrone (hydrochloride) | 2749433-00-7 | Reference compound |
| HY-172079 | 3-Chloroethcathinone (hydrochloride) | 2748225-41-2 | Reference compound |
| HY-172080 | (-)-7-Nor-7-carboxy cannabidiol | 63958-77-0 | Reference compound |
| HY-172082 | MEP-FUBICA | 2749985-70-2 | Reference compound |
| HY-172085 | SH514 | Reference compound | |
| HY-172086 | TrxR-IN-7 | Reference compound | |
| HY-172087 | VDR agonist 3 | Reference compound | |
| HY-172088 | Tubulin/MMP-IN-3 | Reference compound | |
| HY-172089 | TG101209 analog 1 | Reference compound | |
| HY-172090 | MASP-2-IN-1 | Reference compound | |
| HY-172091 | CZY43 | Reference compound | |
| HY-172092 | BG11 | 3065877-52-0 | Reference compound |
| HY-172093 | HIV-1 inhibitor-80 | Reference compound | |
| HY-172094 | AMPK-IN-6 | Reference compound | |
| HY-172095 | BRD4 Inhibitor-39 | Reference compound | |
| HY-172096 | cSRC/BCR-ABL-IN-1 | Reference compound | |
| HY-172097 | HL22 | Reference compound | |
| HY-172098 | CpNMT-IN-1 | Reference compound | |
| HY-172099 | EP4 receptor agonist 3 | 634193-29-6 | Reference compound |
| HY-172100 | p38-α MAPK-IN-8 | Reference compound | |
| HY-172101 | AChE/MAO-B-IN-7 | Reference compound | |
| HY-172102 | NLRP3-IN-68 | Reference compound | |
| HY-172103 | hCAI/II-IN-10 | Reference compound | |
| HY-172104 | EGFR-IN-143 | Reference compound | |
| HY-172105 | Anti-NASH agent 2 | 3028778-28-8 | Reference compound |
| HY-172106 | TRPC5-IN-5 | 738603-63-9 | Reference compound |
| HY-172107 | HPK1-IN-56 | 2901054-39-3 | Reference compound |
| HY-172108 | TGFβRI-IN-7 | Reference compound | |
| HY-172109 | DNA Gyrase-IN-15 | Reference compound | |
| HY-172110 | Apoptosis inducer 35 | Reference compound | |
| HY-172111 | EGFR-IN-144 | Reference compound | |
| HY-172112 | VEGFR-2-IN-64 | Reference compound | |
| HY-172113 | H122 | Reference compound | |
| HY-172114 | Thalidomide-4-piperidineacetaldehyde | 2222115-36-6 | Reference compound |
| HY-172115 | BGC4 | Reference compound | |
| HY-172116 | Mitochondria modulator-2 | Reference compound | |
| HY-172117 | Boc-methylglycine-C2-bromine | 1198592-36-7 | Reference compound |
| HY-172118 | CDKL5/GSK3-IN-1 | 844442-32-6 | Reference compound |
| HY-172120 | GPR119 agonist 3 | 2097502-14-0 | Reference compound |
| HY-172121 | NMDA agonist 2 | Reference compound | |
| HY-172122 | FXR/HSD17B13 modulator 1 | 3067566-36-0 | Reference compound |
| HY-172123 | PRV-IN-1 | Reference compound | |
| HY-172124 | PROTAC BRD4 Degrader-29 | Reference compound | |
| HY-172125 | AMPRO-222 | Reference compound | |
| HY-172126 | JQ-1 (carboxylic acid)-NH-C2-NH-AMPRO-222 | Reference compound | |
| HY-172127 | NUAK1-IN-1 | Reference compound | |
| HY-172128 | NUAK1-IN-2 | Reference compound | |
| HY-172129 | HDAC6-IN-52 | 2636786-68-8 | Reference compound |
| HY-172130 | PI3Kδ/BET-IN-1 | 3054869-10-9 | Reference compound |
| HY-172131 | Emoquine-1 | Reference compound | |
| HY-172132 | MurA-IN-5 | Reference compound | |
| HY-172133 | HDAC3-IN-6 | Reference compound | |
| HY-172134 | NLRP3-IN-70 | 1997362-01-2 | Reference compound |
| HY-172135 | PDE4-IN-26 | Reference compound | |
| HY-172136 | LSQ-28 | Reference compound | |
| HY-172137 | FAPI-FUSCC-07 | Reference compound | |
| HY-172138 | α-Glucosidase-IN-84 | Reference compound | |
| HY-172139 | PI3Kα-IN-25 | Reference compound | |
| HY-172140 | Ebio3 | Reference compound | |
| HY-172141 | Ebio2 | Reference compound | |
| HY-172142 | PDK1-IN-4 | Reference compound | |
| HY-172143 | ATUX-8385 | 2088956-86-7 | Reference compound |
| HY-172144 | JB300 | 3038446-90-8 | Reference compound |
| HY-172145 | Thalidomide-O-CH2-CO-NH-C2-PEG2-NH-Boc | 1957235-73-2 | Reference compound |
| HY-172146 | CDK4/6-IN-24 | 2662813-96-7 | Reference compound |
| HY-172147 | SSTR4 agonist 5 | 2761347-44-6 | Reference compound |
| HY-172148 | Itaconic acid prodrug-1 | 2641132-66-1 | Reference compound |
| HY-172149 | Naltrindole 5′-isothiocyanate | 126876-64-0 | Reference compound |
| HY-172150 | XH02 | Reference compound | |
| HY-172151 | PPO-IN-17 | Reference compound | |
| HY-172152 | MP-010 | 3024617-59-9 | Reference compound |
| HY-172153 | CDK2-IN-41 | Reference compound | |
| HY-172154 | SSB-2548 | 350994-70-6 | Reference compound |
| HY-172155 | MEK1-IN-1 | Reference compound | |
| HY-172156 | EGFR-TK-IN-5 | Reference compound | |
| HY-172157 | HDAC11-IN-2 | 2919766-97-3 | Reference compound |
| HY-172158 | ALKBH5-IN-5 | 140481-05-6 | Reference compound |
| HY-172159 | FF2039 | Reference compound | |
| HY-172160 | HER2-IN-21 | 906437-59-0 | Reference compound |
| HY-172161 | CCR6 antagonist 2 | Reference compound | |
| HY-172162 | LC-04-045 | Reference compound | |
| HY-172163 | FITC-dextran sulfate (MW 4kDa) | Biochemical Assay Reagents | |
| HY-172163A | FITC-dextran sulfate (MW 10kDa) | Biochemical Assay Reagents | |
| HY-172163B | FITC-dextran sulfate (MW 40kDa) | Biochemical Assay Reagents | |
| HY-172163C | FITC-dextran sulfate (MW 500kDa) | Biochemical Assay Reagents | |
| HY-172164 | FITC-lysine-dextran (MW 4kDa) | Biochemical Assay Reagents | |
| HY-172164A | FITC-lysine-dextran (MW 10kDa) | Biochemical Assay Reagents | |
| HY-172164B | FITC-lysine-dextran (MW 70kDa) | Biochemical Assay Reagents | |
| HY-172164C | FITC-lysine-dextran (MW 500kDa) | Biochemical Assay Reagents | |
| HY-172165 | Lysine-dextran (MW 4kDa) | Biochemical Assay Reagents | |
| HY-172165A | Lysine-dextran (MW 10kDa) | Biochemical Assay Reagents | |
| HY-172165B | Lysine-dextran (MW 20kDa) | Biochemical Assay Reagents | |
| HY-172165C | Lysine-dextran (MW 40kDa) | Biochemical Assay Reagents | |
| HY-172165D | Lysine-dextran (MW 70kDa) | Biochemical Assay Reagents | |
| HY-172165E | Lysine-dextran (MW 150kDa) | Biochemical Assay Reagents | |
| HY-172165H | Lysine-dextran (MW 500kDa) | Biochemical Assay Reagents | |
| HY-172166 | TRITC-lysine-dextran (MW 4kDa) | Biochemical Assay Reagents | |
| HY-172166A | TRITC-lysine-dextran (MW 10kDa) | Biochemical Assay Reagents | |
| HY-172166B | TRITC-lysine-dextran (MW 70kDa) | Biochemical Assay Reagents | |
| HY-172166C | TRITC-lysine-dextran (MW 500kDa) | Biochemical Assay Reagents | |
| HY-172167 | PD-L1/HDAC-IN-1 | 2923313-69-1 | Reference compound |
| HY-172168 | Orange Fluorescent PLGA nanoparticles, 100nm | Biochemical Assay Reagents | |
| HY-172168A | Orange Fluorescent PLGA nanoparticles, 200nm | Biochemical Assay Reagents | |
| HY-172168B | Orange Fluorescent PLGA nanoparticles, 500nm | Biochemical Assay Reagents | |
| HY-172169 | PPARγ-IN-5 | 3038323-12-2 | Reference compound |
| HY-172170 | LSD1-IN-39 | 3024554-34-2 | Reference compound |
| HY-172171 | GSK3β-IN-2 | 3068378-38-8 | Reference compound |
| HY-172172 | TS-IN-6 | Reference compound | |
| HY-172173 | CYP17A1-IN-1 | Reference compound | |
| HY-172174 | Red Fluorescent PLGA nanoparticles, 100nm | Biochemical Assay Reagents | |
| HY-172174A | Red Fluorescent PLGA nanoparticles, 200nm | Biochemical Assay Reagents | |
| HY-172174B | Red Fluorescent PLGA nanoparticles, 500nm | Biochemical Assay Reagents | |
| HY-172175 | HYS-072 | Reference compound | |
| HY-172176 | RA-PR058 | Reference compound | |
| HY-172177 | ROCK/HDAC-IN-2 | Reference compound | |
| HY-172178 | hCAIX/XII-IN-14 | Reference compound | |
| HY-172179 | EGFR/VEGFR2-IN-5 | Reference compound | |
| HY-172180 | DNMT-IN-4 | Reference compound | |
| HY-172181 | NSC380324 | Reference compound | |
| HY-172182 | ONO-2920632 | 2230296-66-7 | Reference compound |
| HY-172183 | Potato dextrose agar | Biochemical Assay Reagents | |
| HY-172184 | Sabouraud dextrose agar | Biochemical Assay Reagents | |
| HY-172185 | E3 Ligase Ligand-linker Conjugate 172 | Reference compound | |
| HY-172186 | Acryl:Bis 19:1, powder | Biochemical Assay Reagents | |
| HY-172187 | Acryl:Bis 29:1, powder | Biochemical Assay Reagents | |
| HY-172188 | Acryl:Bis 37.5:1, powder | Biochemical Assay Reagents | |
| HY-172189 | Sabouraud dextrose broth | Biochemical Assay Reagents | |
| HY-172190 | MS Medium | Biochemical Assay Reagents | |
| HY-172191 | Czapek dox agar | Biochemical Assay Reagents | |
| HY-172192 | Yeast peptone dextrose | Biochemical Assay Reagents | |
| HY-172193 | UBD1031 | Reference compound | |
| HY-172194 | CDK7-IN-33 | 2796279-20-2 | Reference compound |
| HY-172195 | FS-694 | 1417404-27-3 | Reference compound |
| HY-172196 | LH168 | Reference compound | |
| HY-172197 | MRK-990 | Reference compound | |
| HY-172198 | GSK3-IN-10 | 844441-56-1 | Reference compound |
| HY-172199 | THX6 | Reference compound | |
| HY-172200 | PD-L1/HDAC6-IN-1 | 2834094-36-7 | Reference compound |
| HY-172201 | NF-κB-IN-19 | Reference compound | |
| HY-172202 | Clodronate liposomes | Biochemical Assay Reagents | |
| HY-172203 | BI-1915 | 752237-67-5 | Reference compound |
| HY-172204 | SIRT-IN-7 | 1620634-65-2 | Reference compound |
| HY-172205 | CHL2310 | Reference compound | |
| HY-172206 | TSO-13 | Reference compound | |
| HY-172207 | POPTc80-IN-1 | Reference compound | |
| HY-172208 | PROTAC cGAS degrader-1 | Reference compound | |
| HY-172209 | PPIA-IN-1 | Reference compound | |
| HY-172210 | DDO-8958 | 3017180-18-3 | Reference compound |
| HY-172211 | α-Amylase/α-Glucosidase-IN-17 | Reference compound | |
| HY-172212 | SDH-IN-23 | Reference compound | |
| HY-172213 | (3S,6R)-NML | 1585965-04-3 | Reference compound |
| HY-172214 | AB-343 | Reference compound | |
| HY-172215 | PPO-IN-18 | Reference compound | |
| HY-172216 | EV-A71-IN-3 | Reference compound | |
| HY-172217 | DNMT1-IN-5 | 2982511-19-1 | Reference compound |
| HY-172218 | Lenalidomide-hex-5-ynoic acid | 2379870-47-8 | Reference compound |
| HY-172219 | CUR-IPA | Reference compound | |
| HY-172220 | ChlaDUB1-IN-2 | Reference compound | |
| HY-172221 | SOS1-IN-18 | Reference compound | |
| HY-172222 | Antifungal agent 127 | 3070364-24-5 | Reference compound |
| HY-172224 | PARP1/CDK12-IN-1 | Reference compound | |
| HY-172225 | [Ru(phen)2(HMPIP)](PF6)2 | Reference compound | |
| HY-172226 | P2Y14R antagonist 3 | Reference compound | |
| HY-172236 | Soclenicant | 1020634-41-6 | Reference compound |
| HY-172237 | Sosimerasib | 2839563-01-6 | Reference compound |
| HY-172239 | Tarvicopan | 2378381-06-5 | Reference compound |
| HY-172240 | Tosposertib | 1418305-55-1 | Reference compound |
| HY-172241 | Tapencarium | 1436920-57-8 | Reference compound |
| HY-172242 | Verducatib | 1887236-33-0 | Reference compound |
| HY-172243 | Xeruborbactam isoboxil | 2708983-65-5 | Reference compound |
| HY-172244 | Zaladenant | 2246426-52-6 | Reference compound |
| HY-172245 | Zeltociclib | 2789697-52-3 | Reference compound |
| HY-172246 | Zilvetrigine | 3002072-52-5 | Reference compound |
| HY-172250 | 8-Hydroxyerythromycin A | 51433-35-3 | Reference compound |
| HY-172251 | FGFR-IN-17 | Reference compound | |
| HY-172252 | CSN5-IN-2 | Reference compound | |
| HY-172253 | (5R)-Dimethylbenzene-camptothecin | Reference compound | |
| HY-172254 | PPO-IN-19 | 3058267-27-6 | Reference compound |
| HY-172255 | PI4KIII beta inhibitor 4 | 3029505-94-7 | Reference compound |
| HY-172256 | PI4KIII beta inhibitor 5 | 3029506-23-5 | Reference compound |
| HY-172257 | HIF-PHD-IN-4 | Reference compound | |
| HY-172258 | 5-HT2B antagonist-2 | Reference compound | |
| HY-172259 | Toyaburgine | Reference compound | |
| HY-172260 | PPO-IN-20 | Reference compound | |
| HY-172261 | YY-23 | 1365029-75-9 | Reference compound |
| HY-172262 | WEHI-3773 | Natural Products | |
| HY-172263 | KU13 | 3066104-44-4 | Reference compound |
| HY-172264 | XT17 | Reference compound | |
| HY-172265 | FKBP12 PROTAC FM4 | Reference compound | |
| HY-172266 | FKBP12 Ligand-Linker Conjugate 2 | Reference compound | |
| HY-172267 | 1,2-Dioleoyl-sn-glycero-3-succinate | 127640-49-7 | Reference compound |
| HY-172268 | R6G phosphoramidite, 6-isomer | 1355330-47-0 | Dye Reagents |
| HY-172269 | BP Fluor 488 | 2500973-94-2 | Dye Reagents |
| HY-172271 | DSPE-PEG1000-LyP-1 | Biochemical Assay Reagents | |
| HY-172271A | DSPE-PEG2000-LyP-1 | Biochemical Assay Reagents | |
| HY-172271B | DSPE-PEG3000-LyP-1 | Biochemical Assay Reagents | |
| HY-172272 | DSPE-PEG1000-A7R | Biochemical Assay Reagents | |
| HY-172272A | DSPE-PEG2000-A7R | Biochemical Assay Reagents | |
| HY-172272B | DSPE-PEG5000-A7R | Biochemical Assay Reagents | |
| HY-172273 | DSPE-PEG1000-M2pep | Biochemical Assay Reagents | |
| HY-172273A | DSPE-PEG2000-M2pep | Biochemical Assay Reagents | |
| HY-172273B | DSPE-PEG5000-M2pep | Biochemical Assay Reagents | |
| HY-172274 | DSPE-PEG1000-APRPG | Biochemical Assay Reagents | |
| HY-172274A | DSPE-PEG2000-APRPG | Biochemical Assay Reagents | |
| HY-172274B | DSPE-PEG5000-APRPG | Biochemical Assay Reagents | |
| HY-172275 | DSPE-PEG1000-pPB | Biochemical Assay Reagents | |
| HY-172275A | DSPE-PEG2000-pPB | Biochemical Assay Reagents | |
| HY-172275B | DSPE-PEG5000-pPB | Biochemical Assay Reagents | |
| HY-172276 | DSPE-PEG1000-R8 | Biochemical Assay Reagents | |
| HY-172276A | DSPE-PEG2000-R8 | Biochemical Assay Reagents | |
| HY-172276B | DSPE-PEG5000-R8 | Biochemical Assay Reagents | |
| HY-172277 | DSPE-PEG1000-R9 | Biochemical Assay Reagents | |
| HY-172277A | DSPE-PEG2000-R9 | Biochemical Assay Reagents | |
| HY-172277B | DSPE-PEG5000-R9 | Biochemical Assay Reagents | |
| HY-172278 | DSPE-PEG1000-CGKRK | Biochemical Assay Reagents | |
| HY-172278A | DSPE-PEG2000-CGKRK | Biochemical Assay Reagents | |
| HY-172278B | DSPE-PEG5000-CGKRK | Biochemical Assay Reagents | |
| HY-172279 | DSPE-PEG1000-TAT | Biochemical Assay Reagents | |
| HY-172279A | DSPE-PEG2000-TAT | Biochemical Assay Reagents | |
| HY-172279B | DSPE-PEG3000-TAT | Biochemical Assay Reagents | |
| HY-172280 | DSPE-PEG1000-octreotide | Biochemical Assay Reagents | |
| HY-172280A | DSPE-PEG2000-octreotide | Biochemical Assay Reagents | |
| HY-172280B | DSPE-PEG5000-octreotide | Biochemical Assay Reagents | |
| HY-172281 | DSPE-PEG1000-CCK8 | Biochemical Assay Reagents | |
| HY-172281A | DSPE-PEG2000-CCK8 | Biochemical Assay Reagents | |
| HY-172281B | DSPE-PEG5000-CCK8 | Biochemical Assay Reagents | |
| HY-172284 | 6-TAMRA cadaverine | 709025-58-1 | Dye Reagents |
| HY-172285 | Cy3 hydrazide | 871514-32-8 | Dye Reagents |
| HY-172286 | Cy7 NHS ester | 1432019-64-1 | Dye Reagents |
| HY-172287 | DBCO-PEG2-Val-Cit-PAB-MMAE | 2845934-59-8 | ADC Related |
| HY-172288 | N-TETAMINE-pSar45 | 2847775-93-1 | Reference compound |
| HY-172289 | 3,3'-(Propylimino)bis[N-(2-aminoethyl)propanamide] | 2933216-18-1 | Reference compound |
| HY-172290 | Benzyl N1-[PEG1-NHS]-N6-(t-Boc)-L-lysinate | 2639400-46-5 | ADC Related |
| HY-172291 | Mal-amide-PEG8-Val-Cit-PAB-PNP | 1964490-09-2 | ADC Related |
| HY-172292 | Cbz-GGFG-Bn | 1599440-17-1 | Reference compound |
| HY-172293 | Elaidolinoleyl alcohol | 20063-91-6 | Reference compound |
| HY-172294 | Mes-PEG2-CH2-t-butyl ester | 189104-56-1 | Reference compound |
| HY-172295 | Tetrafluoro-thalidomide | 179033-21-7 | Reference compound |
| HY-172296 | Biotinamide-C3-PEG3-C-alkyne | 1252785-15-1 | Reference compound |
| HY-172297 | Pyrazole N-Desmethyl sildenafil | 139755-95-6 | Reference compound |
| HY-172299 | Delmadinone acetate | 13698-49-2 | Reference compound |
| HY-172301 | 3-(Octadecyloxy)-2,2-bis[(octadecyloxy)methyl]-1-propanol | 158846-96-9 | Reference compound |
| HY-172302 | Phthalimide-PEG2-Boc | 1596368-98-7 | Reference compound |
| HY-172303 | Methyl 5-(4-methylpiperazin-1-yl)pentanoate | 1831933-81-3 | Reference compound |
| HY-172304 | Phthalimide-PEG1-amine | 1415328-85-6 | Reference compound |
| HY-172305 | Phenylmethyl N-(8-bromooctyl)carbamate | 209179-21-5 | Reference compound |
| HY-172306 | 1,19-Bis(1-hexylheptyl) 10-oxononadecanedioate | 2097939-26-7 | Reference compound |
| HY-172307 | m7(3'OMeG)(5')pp-1-imidazol | 2089461-53-8 | Reference compound |
| HY-172308 | t-Boc-aminooxy-PEG4-phthalimide | 2496687-01-3 | Reference compound |
| HY-172309 | UBQ-3 NHS ester | 2516243-92-6 | Dye Reagents |
| HY-172310 | 1-(Pentan-5-ol)-2-hydroxyl-3,4-bis(TBDMS-hexane) | 2256087-31-5 | Reference compound |
| HY-172316 | BAY 3389934 | 2915316-40-2 | Reference compound |
| HY-172317 | AZD2389 | 2791472-12-1 | Reference compound |
| HY-172318 | IAMA-6 | 2497525-96-7 | Reference compound |
| HY-172320 | BMS-986238 | 2919596-13-5 | Peptides |
| HY-172348 | BRD-9327 | Reference compound | |
| HY-172349 | JNJ-2901 | 2059985-55-4 | Reference compound |
| HY-172350 | WEHI-P8 | Reference compound | |
| HY-172351 | PEG-bis-amine (MW 400) | 24991-53-5 | Biochemical Assay Reagents |
| HY-172351A | PEG-bis-amine (MW 6000) | 24991-53-5 | Biochemical Assay Reagents |
| HY-172351B | PEG-bis-amine (MW 10000) | 24991-53-5 | Biochemical Assay Reagents |
| HY-172352 | PEG tosylate (MW 900) | 58320-73-3 | Biochemical Assay Reagents |
| HY-172352A | PEG tosylate (MW 2000) | 58320-73-3 | Biochemical Assay Reagents |
| HY-172353 | Poly(ethylene glycol) dibenzoate (MW 410) | 9004-86-8 | Biochemical Assay Reagents |
| HY-172354 | Acrylate-PEG-NHS (MW 2000) | Biochemical Assay Reagents | |
| HY-172354A | Acrylate-PEG-NHS (MW 3500) | Biochemical Assay Reagents | |
| HY-172354B | Acrylate-PEG-NHS (MW 5000) | Biochemical Assay Reagents | |
| HY-172355 | Azide-PEG-NHS (MW 3500) | Biochemical Assay Reagents | |
| HY-172355A | Azide-PEG-NHS (MW 5000) | Biochemical Assay Reagents | |
| HY-172356 | Biotin-PEG-NH2 (MW 3700) | Biochemical Assay Reagents | |
| HY-172356A | Biotin-PEG-NH2 (MW 5300) | Biochemical Assay Reagents | |
| HY-172357 | Poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) | 80181-31-3 | Biochemical Assay Reagents |
| HY-172358 | Water soluble silk fibroin | Biochemical Assay Reagents | |
| HY-172359 | PROTAC HDAC6 degrader 4 | Reference compound | |
| HY-172360 | HDAC6 ligand-3 | Reference compound | |
| HY-172361 | Thalidomide-F-NH-C6-adize | Reference compound | |
| HY-172362 | SDH-IN-22 | Reference compound | |
| HY-172363 | Succinate dehydrogenase-IN-6 | Reference compound | |
| HY-172364 | PLK1-IN-12 | Reference compound | |
| HY-172365 | P7–2302 | Reference compound | |
| HY-172366 | BQ0413 | 3055338-52-5 | Reference compound |
| HY-172367 | Tc-BQ0413 | Reference compound | |
| HY-172368 | PROTAC CARM1/IKZF3 degrader-1 | Reference compound | |
| HY-172369 | CARM1/IKZF3 ligand 1 | Reference compound | |
| HY-172370 | Thalidomide-NH-C4-Boc | 2226139-38-2 | Reference compound |
| HY-172371 | Hypoxystat | 2414508-40-8 | Reference compound |
| HY-172372 | IRAK4-IN-30 | 2967595-45-3 | Reference compound |
| HY-172373 | NRTT-IN-1 | 2623861-05-0 | Reference compound |
| HY-172374 | KV1.3-IN-2 | 2640023-16-9 | Reference compound |
| HY-172375 | E3 Ligase Ligand-linker Conjugate 170 | 2379572-21-9 | Reference compound |
| HY-172376 | PCL Nanoparticles, 100nm | Biochemical Assay Reagents | |
| HY-172376A | PCL Nanoparticles, 500nm | Biochemical Assay Reagents | |
| HY-172377 | Poly(L-lactide) (MW 5000) | Biochemical Assay Reagents | |
| HY-172377A | Poly(L-lactide) (MW 10000) | Biochemical Assay Reagents | |
| HY-172377B | Poly(L-lactide) (MW 20000) | Biochemical Assay Reagents | |
| HY-172377C | Poly(L-lactide) (MW 40000) | Biochemical Assay Reagents | |
| HY-172378 | Poly(styrene)-block-poly(acrylic acid) (PS:PAA 30000:2000) | Biochemical Assay Reagents | |
| HY-172378A | Poly(styrene)-block-poly(acrylic acid) (PS:PAA 3,000:5,000,DDMAT terminated) | Biochemical Assay Reagents | |
| HY-172379 | Alginate aldehyde, 20% aldehyde content | Biochemical Assay Reagents | |
| HY-172379A | Alginate aldehyde, 35% aldehyde content | Biochemical Assay Reagents | |
| HY-172380 | PCL-PEG-PCL diacrylate (MW 200) | Biochemical Assay Reagents | |
| HY-172380A | PCL-PEG-PCL diacrylate (MW 800) | Biochemical Assay Reagents | |
| HY-172381 | Poly(guluronate), low endotoxin | Biochemical Assay Reagents | |
| HY-172382 | Poly(D,L-lactide-co-glycolide), 50:50 | Biochemical Assay Reagents | |
| HY-172382A | Poly(D,L-lactide-co-glycolide), 75:25 | Biochemical Assay Reagents | |
| HY-172382B | Poly(D,L-lactide-co-glycolide), 65:35 | Biochemical Assay Reagents | |
| HY-172383 | Polysuccinimide | 31586-29-5 | Biochemical Assay Reagents |
| HY-172384 | Glycerol ethoxylate | 31694-55-0 | Biochemical Assay Reagents |
| HY-172385 | 16:0 DGS | 108032-13-9 | Biochemical Assay Reagents |
| HY-172387 | CM Cross-linked dextran C 25 | Biochemical Assay Reagents | |
| HY-172387A | CM Cross-linked dextran C 50 | Biochemical Assay Reagents | |
| HY-172388 | QAE Cross-linked dextran A 50 | Biochemical Assay Reagents | |
| HY-172388A | QAE Cross-linked dextran A 25 | Biochemical Assay Reagents | |
| HY-172389 | Methyl 2,3,4,6-tetrakis-O-(phenylmethyl)-D-glucopyranoside | 84799-77-9 | Biochemical Assay Reagents |
| HY-172390 | Florfenicol-propanoate-piperidin | 2975141-09-2 | Reference compound |
| HY-172392 | HSND80 | Reference compound | |
| HY-172393 | TCF4/β-catenin-IN-1 | Reference compound | |
| HY-172394 | ZSNI-21 | Reference compound | |
| HY-172395 | TopoII/tubulin-IN-1 | Reference compound | |
| HY-172396 | PD-L1/VISTA-IN-2 | Reference compound | |
| HY-172397 | Mycobacterium Tuberculosis-IN-7 | Reference compound | |
| HY-172398 | FAM phosphoramidite, 5-isomer | 147566-42-5 | Dye Reagents |
| HY-172399 | FTO-IN-14 | Reference compound | |
| HY-172400 | FXIa-IN-16 | 3046390-69-3 | Reference compound |
| HY-172401 | CDC20-IN-2 | Reference compound | |
| HY-172406 | MAPK-IN-4 | Reference compound | |
| HY-172407 | KOR agonist 5 | Reference compound | |
| HY-172408 | NNRT-IN-6 | Reference compound | |
| HY-172409 | CB1R antagonist 2 | Reference compound | |
| HY-172410 | GLP-1R agonist 28 | Reference compound | |
| HY-172411 | GLP-1R agonist 29 | Reference compound | |
| HY-172412 | Alixorexton | 2648347-56-0 | Reference compound |
| HY-172413 | Amezalpat | 1616372-41-8 | Reference compound |
| HY-172414 | Andamertinib | 2254145-43-0 | Reference compound |
| HY-172415 | Atebimetinib | 2669009-92-9 | Reference compound |
| HY-172416 | Balomenib | 2939850-17-4 | Reference compound |
| HY-172417 | Becondogrel | 1416696-44-0 | Reference compound |
| HY-172418 | Betovumeline | 1314018-44-4 | Reference compound |
| HY-172419 | Blixeprodil | 2881017-49-6 | Reference compound |
| HY-172420 | Bretisilocin | 2698331-35-8 | Reference compound |
| HY-172421 | Cendifensine | 1034048-49-1 | Reference compound |
| HY-172422 | Danifexor | 2648738-68-3 | Reference compound |
| HY-172423 | Darlifarnib | 2939824-30-1 | Reference compound |
| HY-172424 | Delocamten | 2417411-02-8 | Reference compound |
| HY-172425 | Deulumateperone | 2102683-75-8 | Reference compound |
| HY-172426 | Dirozalkib | 1893419-37-8 | Reference compound |
| HY-172427 | Elsovaptan | 2296801-25-5 | Reference compound |
| HY-172428 | Encofosbuvir | 2232134-77-7 | Reference compound |
| HY-172429 | Enozertinib | 2489185-38-6 | Reference compound |
| HY-172430S | Epaldeudomide | 1918159-31-5 | Isotope-Labeled Compounds |
| HY-172431 | Opakalim | 2376397-93-0 | Reference compound |
| HY-172432 | Plodicitinib | 2360992-48-7 | Reference compound |
| HY-172433 | Refisolone | 202718-04-5 | Reference compound |
| HY-172434 | Rezosicone | 1414777-24-4 | Reference compound |
| HY-172435 | Rezuforimod | 1431754-15-2 | Reference compound |
| HY-172436 | Rocavorexant | 2115665-09-1 | Reference compound |
| HY-172437 | Secutrelvir | 2996148-73-1 | Reference compound |
| HY-172438 | Setomagpran | 2991434-57-0 | Reference compound |
| HY-172439S | Simedeutirom | 2403721-24-2 | Isotope-Labeled Compounds |
| HY-172442 | Hyaluronidase | 9001-54-1 | Enzyme |
| HY-172443 | Keratin sulfate | 169799-44-4 | Biochemical Assay Reagents |
| HY-172444 | Protein hydrolyzates, silk | 96690-41-4 | Biochemical Assay Reagents |
| HY-172445 | Deoxyribonucleic acid sodium salt from salmon testes | 438545-06-3 | Biochemical Assay Reagents |
| HY-172446 | SMARCA2/4-ligand-5 | 2271348-89-9 | Reference compound |
| HY-172447 | 1,5-Dideoxy-1,5-imino-D-mannitol | 146747-37-7 | Reference compound |
| HY-172448 | YY2201 | Reference compound | |
| HY-172449 | GLI1-IN-3 | Reference compound | |
| HY-172450 | AIM4 | 1841140-38-2 | Reference compound |
| HY-172451 | MC4762 | Reference compound | |
| HY-172452 | RSV L-protein-6 | Reference compound | |
| HY-172453 | XW-032 | Reference compound | |
| HY-172454 | SHP2-IN-36 | Reference compound | |
| HY-172455 | TREK inhibitor-3 | 3023854-95-4 | Reference compound |
| HY-172456 | JSF-4898 | Reference compound | |
| HY-172457 | NUCC-0200808 | Reference compound | |
| HY-172458 | Z-3578 | 473687-20-6 | Reference compound |
| HY-172460 | AChE/BChE/MAO-B-IN-5 | 1432738-00-5 | Reference compound |
| HY-172461 | MAO-IN-6 | Reference compound | |
| HY-172462 | Mtb-IN-11 | Reference compound | |
| HY-172463 | DSPE-PEG1000-cRGD | Biochemical Assay Reagents | |
| HY-172464 | DSPE-PEG2000-cRGD | Biochemical Assay Reagents | |
| HY-172465 | DSPE-PEG5000-cRGD | Biochemical Assay Reagents | |
| HY-172466 | DSPE-PEG1000-CTT2 | Biochemical Assay Reagents | |
| HY-172467 | DSPE-PEG2000-CTT2 | Biochemical Assay Reagents | |
| HY-172468 | DSPE-PEG5000-CTT2 | Biochemical Assay Reagents | |
| HY-172469 | DSPE-PEG1000-GE11 | Biochemical Assay Reagents | |
| HY-172470 | DSPE-PEG2000-GE11 | Biochemical Assay Reagents | |
| HY-172471 | DSPE-PEG5000-GE11 | Biochemical Assay Reagents | |
| HY-172472 | DSPE-PEG1000-NGR | Biochemical Assay Reagents | |
| HY-172473 | DSPE-PEG2000-NGR | Biochemical Assay Reagents | |
| HY-172474 | DSPE-PEG5000-NGR | Biochemical Assay Reagents | |
| HY-172475 | DSPE-PEG1000-YIGSR | Biochemical Assay Reagents | |
| HY-172476 | DSPE-PEG2000-YIGSR | Biochemical Assay Reagents | |
| HY-172477 | DSPE-PEG5000-YIGSR | Biochemical Assay Reagents | |
| HY-172478 | DSPE-PEG1000-F3 | Biochemical Assay Reagents | |
| HY-172479 | DSPE-PEG2000-F3 | Biochemical Assay Reagents | |
| HY-172480 | DSPE-PEG5000-F3 | Biochemical Assay Reagents | |
| HY-172481 | DSPE-PEG1000-TAASGVRSMH | Biochemical Assay Reagents | |
| HY-172482 | DSPE-PEG2000-TAASGVRSMH | Biochemical Assay Reagents | |
| HY-172483 | DSPE-PEG3000-TAASGVRSMH | Biochemical Assay Reagents | |
| HY-172484 | DSPE-PEG1000-LTLRWVGLMS | Biochemical Assay Reagents | |
| HY-172485 | DSPE-PEG2000-LTLRWVGLMS | Biochemical Assay Reagents | |
| HY-172486 | DSPE-PEG5000-LTLRWVGLMS | Biochemical Assay Reagents | |
| HY-172487 | DSPE-PEG1000-K237 | Biochemical Assay Reagents | |
| HY-172488 | DSPE-PEG2000-K237 | Biochemical Assay Reagents | |
| HY-172489 | DSPE-PEG5000-K237 | Biochemical Assay Reagents | |
| HY-172490 | DSPE-PEG1000-ESBP | Biochemical Assay Reagents | |
| HY-172491 | DSPE-PEG2000-ESBP | Biochemical Assay Reagents | |
| HY-172492 | DSPE-PEG5000-ESBP | Biochemical Assay Reagents | |
| HY-172493 | DSPE-PEG1000-iRGD | Biochemical Assay Reagents | |
| HY-172494 | DSPE-PEG2000-iRGD | Biochemical Assay Reagents | |
| HY-172495 | DSPE-PEG3000-iRGD | Biochemical Assay Reagents | |
| HY-172496 | DSPE-PEG1000-CREKA | Biochemical Assay Reagents | |
| HY-172497 | DSPE-PEG2000-CREKA | Biochemical Assay Reagents | |
| HY-172498 | DSPE-PEG5000-CREKA | Biochemical Assay Reagents | |
| HY-172499 | DSPE-PEG1000-SP94 | Biochemical Assay Reagents | |
| HY-172500 | DSPE-PEG2000-SP94 | Biochemical Assay Reagents | |
| HY-172501 | DSPE-PEG5000-SP94 | Biochemical Assay Reagents | |
| HY-172502 | DSPE-PEG1000-KAA | Biochemical Assay Reagents | |
| HY-172503 | DSPE-PEG2000-KAA | Biochemical Assay Reagents | |
| HY-172504 | DSPE-PEG5000-KAA | Biochemical Assay Reagents | |
| HY-172505 | Mal-PEG12-t-butyl ester | 1443214-98-9 | Reference compound |
| HY-172506 | 3-Azidopropanoyl chloride | 14468-87-2 | Reference compound |
| HY-172507 | 3'-O-Methylguanosine-5'-diphosphate | 78771-34-3 | Reference compound |
| HY-172508 | Perylene dU phosphoramidite | 908117-78-2 | Dye Reagents |
| HY-172509 | N-Tetradecyl-pSar25 | 120468-71-5 | Reference compound |
| HY-172510 | N-Hexadecyl-pSar25 | 120468-76-0 | Oligonucleotides |
| HY-172511 | m-PEG9-4-Nitrophenyl carbonate | 1186428-41-0 | Reference compound |
| HY-172512 | 3'-O-Methylguanosine-5'-monophosphate | 400806-41-9 | Reference compound |
| HY-172513 | Methyltetrazine-PEG11-DBCO | 2183440-28-8 | Reference compound |
| HY-172514 | (1R,2S,3R)-Aprepitant | 1185502-97-9 | Reference compound |
| HY-172515 | ent-Oseltamivir | 1035895-88-5 | Reference compound |
| HY-172516 | 1-Palmitoyl-2-(propargylacetyl)-sn-glycero-3-phosphocholine | 1353897-91-2 | Reference compound |
| HY-172517 | 1-(Dipropylamino)-11-((tert-Butyldimethylsilyl)oxy)-5-(6-((tert-butyldimethylsilyl)oxy)hexyl)undecan-5-ol | 2256087-33-7 | Reference compound |
| HY-172518 | 1-Piperidinepentanoic acid | 4766-55-6 | Reference compound |
| HY-172523 | CDA-IN-3 | 932889-57-1 | Reference compound |
| HY-172542 | TTBK1/2-IN-1 | 2342571-09-7 | Reference compound |
| HY-172543 | TTBK1/2-IN-2 | 2857982-35-3 | Reference compound |
| HY-172544 | TTBK1/2-IN-3 | 2857982-34-2 | Reference compound |
| HY-172545 | AMG28 | 1202764-07-5 | Reference compound |
| HY-172562 | BTR2004 | Reference compound | |
| HY-172564 | BTR2000-Gly-Gly-Gly | Reference compound | |
| HY-172594 | HPK1-IN-57 | Reference compound | |
| HY-172601 | HDAC3-IN-7 | Reference compound | |
| HY-172603 | HIV-1 inhibitor-82 | 43099-56-5 | Reference compound |
| HY-172604 | Neuroprotective agent 10 | Reference compound | |
| HY-172606 | NagZ-IN-1 | Reference compound | |
| HY-172609 | SL-176 | 1809556-48-6 | Reference compound |
| HY-172615 | AMPTX-1 | 3033019-04-1 | Reference compound |
| HY-172619 | BS-153 | 1935692-54-8 | Reference compound |
| HY-172622 | α-Amylase/α-Glucosidase-IN-19 | 223505-23-5 | Reference compound |
| HY-172623 | EGFR/HER2-IN-17 | Reference compound | |
| HY-172676 | GW461484A | 401815-65-4 | Reference compound |
| HY-172677 | IIP0943 | 3040106-93-9 | Reference compound |
| HY-172678 | PUC-10 | 2095549-31-6 | Reference compound |
| HY-172679 | PUC-55 | Reference compound | |
| HY-172680 | DSPE-PEG1000-VIP | Biochemical Assay Reagents | |
| HY-172681 | DSPE-PEG2000-VIP | Biochemical Assay Reagents | |
| HY-172682 | DSPE-PEG5000-VIP | Biochemical Assay Reagents | |
| HY-172683 | DSPE-PEG1000-GRGDS | Biochemical Assay Reagents | |
| HY-172684 | DSPE-PEG2000-GRGDS | Biochemical Assay Reagents | |
| HY-172685 | DSPE-PEG5000-GRGDS | Biochemical Assay Reagents | |
| HY-172686 | DSPE-PEG1000-CSTSMLKAC | Biochemical Assay Reagents | |
| HY-172687 | DSPE-PEG2000-CSTSMLKAC | Biochemical Assay Reagents | |
| HY-172688 | DSPE-PEG5000-CSTSMLKAC | Biochemical Assay Reagents | |
| HY-172689 | DSPE-PEG1000-THRPPMWSPVWP | Biochemical Assay Reagents | |
| HY-172690 | DSPE-PEG2000-THRPPMWSPVWP | Biochemical Assay Reagents | |
| HY-172691 | DSPE-PEG5000-THRPPMWSPVWP | Biochemical Assay Reagents | |
| HY-172692 | DSPE-PEG1000-TH | Biochemical Assay Reagents | |
| HY-172693 | DSPE-PEG2000-TH | Biochemical Assay Reagents | |
| HY-172694 | DSPE-PEG5000-TH | Biochemical Assay Reagents | |
| HY-172695 | DSPE-PEG1000-WYRGRL | Biochemical Assay Reagents | |
| HY-172696 | DSPE-PEG2000-WYRGRL | Biochemical Assay Reagents | |
| HY-172697 | DSPE-PEG5000-WYRGRL | Biochemical Assay Reagents | |
| HY-172698 | DSPE-PEG1000-ANG | Biochemical Assay Reagents | |
| HY-172699 | DSPE-PEG2000-ANG | Biochemical Assay Reagents | |
| HY-172700 | DSPE-PEG5000-ANG | Biochemical Assay Reagents | |
| HY-172701 | DSPE-PEG1000-NYZL1 | Biochemical Assay Reagents | |
| HY-172702 | DSPE-PEG2000-NYZL1 | Biochemical Assay Reagents | |
| HY-172703 | DSPE-PEG5000-NYZL1 | Biochemical Assay Reagents | |
| HY-172704 | DSPE-PEG1000-RVG29 | Biochemical Assay Reagents | |
| HY-172705 | DSPE-PEG2000-RVG29 | Biochemical Assay Reagents | |
| HY-172706 | DSPE-PEG5000-RVG29 | Biochemical Assay Reagents | |
| HY-172707 | DSPE-PEG1000-PP1 | Biochemical Assay Reagents | |
| HY-172708 | DSPE-PEG2000-PP1 | Biochemical Assay Reagents | |
| HY-172709 | DSPE-PEG5000-PP1 | Biochemical Assay Reagents | |
| HY-172710 | DSPE-PEG1000-R6H4 | Biochemical Assay Reagents | |
| HY-172711 | DSPE-PEG2000-R6H4 | Biochemical Assay Reagents | |
| HY-172712 | DSPE-PEG3000-R6H4 | Biochemical Assay Reagents | |
| HY-172713 | DSPE-PEG1000-MPG | Biochemical Assay Reagents | |
| HY-172714 | DSPE-PEG2000-MPG | Biochemical Assay Reagents | |
| HY-172715 | DSPE-PEG5000-MPG | Biochemical Assay Reagents | |
| HY-172716 | (Z)-14-Tricosenoic acid | 105305-00-8 | Natural Products |
| HY-172717 | TAMRA-PEG4-t-butyl ester | 2353409-64-8 | Dye Reagents |
| HY-172718 | (Z)-11-Eicosen-1-ol | 62442-62-0 | Reference compound |
| HY-172719 | Fmoc-PEG9-alcohol | 868594-51-8 | Reference compound |
| HY-172720 | Azide-PEG5-Ms | 940951-97-3 | Reference compound |
| HY-172721 | Cy3B maleimide | 926905-86-4 | Dye Reagents |
| HY-172722 | DSPE-PEG1000-T7 | Biochemical Assay Reagents | |
| HY-172723 | DSPE-PEG2000-T7 | Biochemical Assay Reagents | |
| HY-172724 | DSPE-PEG5000-T7 | Biochemical Assay Reagents | |
| HY-172725 | DSPE-PEG1000-EB1 | Biochemical Assay Reagents | |
| HY-172726 | DSPE-PEG2000-EB1 | Biochemical Assay Reagents | |
| HY-172727 | DSPE-PEG5000-EB1 | Biochemical Assay Reagents | |
| HY-172728 | Difluorocarboxyfluorescein NHS Ester, 6-isomer | 2702251-82-7 | Dye Reagents |
| HY-172729 | Phenylmethyl N-(10-bromodecyl)carbamate | 1555589-26-8 | Reference compound |
| HY-172730 | 2,2,3,3,4,4,5,5,5-Nonafluoro-N-(2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)ethyl)pentanamide | 2119569-22-9 | Reference compound |
| HY-172731 | 8-Oxo-dATP | 3056945-23-1 | Natural Products |
| HY-172732 | PRMT5-IN-50 | 3002409-47-1 | Reference compound |
| HY-172733 | PRMT5-MTA-IN-3 | 3028674-29-2 | Reference compound |
| HY-172733S | PRMT5-MTA-IN-3-d3 | 3052146-54-7 | Isotope-Labeled Compounds |
| HY-172734 | FG-2101 | 2919723-66-1 | Reference compound |
| HY-172736 | BMS-986458 | 3005272-36-3 | Reference compound |
| HY-172737 | RP-1664 | 2980682-00-4 | Reference compound |
| HY-172738 | E3 Ligase Ligand-linker Conjugate 175 | Reference compound | |
| HY-172739 | E3 Ligase Ligand-linker Conjugate 176 | 3005273-99-1 | Reference compound |
| HY-172740 | BCL6 ligand-3 | Reference compound | |
| HY-172757 | α-Glucosidase-IN-88 | Reference compound | |
| HY-172758 | α-Glucosidase-IN-89 | Reference compound | |
| HY-172759 | PKMYT1-IN-9 | 3055031-36-9 | Reference compound |
| HY-172760 | CIM-834 | Reference compound | |
| HY-172761 | AX-53802 | 1008482-71-0 | Reference compound |
| HY-172762 | S234984 | Reference compound | |
| HY-172769 | CM112 | Reference compound | |
| HY-172770 | KMG-1068 | Reference compound | |
| HY-172772 | Anti-PEDV agent 1 | Reference compound | |
| HY-172773 | PAA-38 | Reference compound | |
| HY-172774 | TRPV1 antagonist 10 | 896584-55-7 | Reference compound |
| HY-172775 | Spirovirimat | Reference compound | |
| HY-172777 | SDH-IN-25 | 3052432-15-9 | Reference compound |
| HY-172778 | HNW005 | Reference compound | |
| HY-172779 | AURKA-IN-2 | Reference compound | |
| HY-172782 | BuChE-IN-20 | Reference compound | |
| HY-172783 | Aromatase-IN-5 | Reference compound | |
| HY-172784 | Anticancer agent 273 | Reference compound | |
| HY-172785 | PI3K-IN-57 | Reference compound | |
| HY-172789 | mTOR inhibitor-27 | 457086-01-0 | Reference compound |
| HY-172800 | (S,R,S)-AHPC-Me-8-Sulfamoyloctanoic acid | Reference compound | |
| HY-172803 | Ferroptosis inducer-7 | Reference compound | |
| HY-172804 | SDH-IN-26 | Reference compound | |
| HY-172805 | Glycogen phosphorylase-IN-2 | Reference compound | |
| HY-172806 | PARP14 inhibitor 1 | 3035493-13-8 | Reference compound |
| HY-172808 | BNS808 | 2836313-12-1 | Reference compound |
| HY-172809 | LSD1-IN-42 | Reference compound | |
| HY-172820 | Trastuzumab envedotin | ADC Related | |
| HY-172822 | TLT8 | Reference compound | |
| HY-172825 | KL4-219A | Reference compound | |
| HY-172828 | BRD4 ligand 7 | Reference compound | |
| HY-172835 | Rapavir | Reference compound | |
| HY-172836S | GLP-1 receptor agonist 17-d3 | 3074098-20-4 | Isotope-Labeled Compounds |
| HY-173000 | STAT3-IN-40 | 3053241-01-0 | Reference compound |
| HY-173001 | AuL1 | Reference compound | |
| HY-173002 | MS9024 | Reference compound | |
| HY-173003 | EP-3945 | 3057176-00-5 | Reference compound |
| HY-173005 | JZ19 | Reference compound | |
| HY-173006 | AZ3246 | 2893978-54-4 | Reference compound |
| HY-173007 | ALK/PI3K/AKT-IN-1 | 3050831-84-7 | Reference compound |
| HY-173008 | YTHDF2-IN-1 | Reference compound | |
| HY-173009 | PROTAC CG167 | Reference compound | |
| HY-173010 | Me-(S,R,S)-AHPC-CO-C5-N3 | 2590689-22-6 | Reference compound |
| HY-173011 | RJS308 | Reference compound | |
| HY-173012 | CypA ligand-2 | Reference compound | |
| HY-173013 | TWH106 | Reference compound | |
| HY-173014 | Gemfibrozil glucoside | 2396744-05-9 | Reference compound |
| HY-173015 | PPO-IN-16 | Reference compound | |
| HY-173016 | HINT1-IN-1 | Reference compound | |
| HY-173018 | ML283 | 1403245-31-7 | Reference compound |
| HY-173020 | W23-1006 | 3035498-92-8 | Reference compound |
| HY-173021 | Succinate dehydrogenase-IN-7 | Reference compound | |
| HY-173022 | BDM_92499 | Reference compound | |
| HY-173023 | IDOi-Pt(IV) prodrug-1 | Reference compound | |
| HY-173024 | TRPC4/5-IN-3 | 3053390-98-7 | Reference compound |
| HY-173025 | Nurr1 agonist 12 | Reference compound | |
| HY-173026 | Herbicidal agent 7 | Reference compound | |
| HY-173027 | SPB07935 | 634190-75-3 | Reference compound |
| HY-173028 | RH01201 | 300664-41-9 | Reference compound |
| HY-173029 | UAMC-4821 | Reference compound | |
| HY-173030 | Opioid receptor agonist 1 | Reference compound | |
| HY-173031 | KTX-005 | 162182-77-6 | Reference compound |
| HY-173032 | VU6033685 | Reference compound | |
| HY-173033 | MI-883 | 2530027-71-3 | Reference compound |
| HY-173034 | PTP1B-IN-30 | Reference compound | |
| HY-173035 | α-Glucosidase-IN-85 | Reference compound | |
| HY-173038 | EGFR-IN-151 | Reference compound | |
| HY-173039 | α-Tubulin polymerization-IN-1 | Reference compound | |
| HY-173040 | Anticancer agent 266 | Reference compound | |
| HY-173041 | Arginase inhibitor 9 | Reference compound | |
| HY-173042 | CDK12/13-IN-2 | Reference compound | |
| HY-173043 | 5-HT6R antagonist 6 | Reference compound | |
| HY-173044 | 5-HT1AR/5-HT6R ligand-1 | Reference compound | |
| HY-173045 | 5-HT5AR/5-HT6R ligand-1 | Reference compound | |
| HY-173046 | NLRP3-IN-71 | 3026419-44-0 | Reference compound |
| HY-173047 | KRASG12C IN-15 | 2768868-14-8 | Reference compound |
| HY-173048 | CLPP-2068 | Reference compound | |
| HY-173049 | 2N4R Tau/α-Syn against-1 | Reference compound | |
| HY-173050 | NEU-1017 | 1800426-38-3 | Reference compound |
| HY-173051 | Antiparasitic agent-24 | Reference compound | |
| HY-173052 | SLW131 | 681511-84-2 | Reference compound |
| HY-173053 | HDAC-IN-87 | 3039482-69-1 | Reference compound |
| HY-173054 | FtsZ-IN-12 | Reference compound | |
| HY-173055 | Ferroleuton | Reference compound | |
| HY-173056 | Ruthenoleuton | Reference compound | |
| HY-173057 | BMX-IN-3 | 2657662-64-9 | Reference compound |
| HY-173058 | NtPPO-IN-1 | Reference compound | |
| HY-173059 | CDK12/13-IN-3 | 3029608-57-6 | Reference compound |
| HY-173060 | ERK1/2 inhibitor 13 | Reference compound | |
| HY-173062 | BRD4 Inhibitor-40 | 2994635-04-8 | Reference compound |
| HY-173063 | TLR8 antagonist-1 | 1111460-83-3 | Reference compound |
| HY-173064 | DS-103 | Reference compound | |
| HY-173065 | CDK9-IN-36 | Reference compound | |
| HY-173066 | NU227326 | 3048196-52-4 | Reference compound |
| HY-173067 | IDO1 ligand-1 | 3048196-74-0 | Reference compound |
| HY-173068 | 2-(4-(Piperazin-1-yl)piperidin-1-yl)acetic acid | Reference compound | |
| HY-173069 | E3 Ligase Ligand-linker Conjugate 169 | Reference compound | |
| HY-173070 | TLR7 agonist 29 | Reference compound | |
| HY-173071 | DprE1-IN-13 | Reference compound | |
| HY-173072 | SJPYT-310 | 2883814-84-2 | Reference compound |
| HY-173073 | Insecticidal agent 20 | Reference compound | |
| HY-173074 | Microtubulin-IN-1 | 3025180-14-4 | Reference compound |
| HY-173075 | Anticancer agent 267 | Reference compound | |
| HY-173076 | HDAC11-IN-1 | Peptides | |
| HY-173077 | PD-L1/LpxC-IN-1 | Reference compound | |
| HY-173079 | TLR7 agonist 30 | Reference compound | |
| HY-173080 | Antibacterial agent 267 | Reference compound | |
| HY-173081 | 4"-(2-(p-Chlorophenyl)acetoxyl)spiramycin | Reference compound | |
| HY-173082 | 10-SLF | 2765058-89-5 | Reference compound |
| HY-173083 | MDA7 | 1103840-28-3 | Reference compound |
| HY-173084 | BRD6257 | Reference compound | |
| HY-173085S | TPPSSGEPPK-(Lys-13C6,15N2) (TFA) | Isotope-Labeled Compounds | |
| HY-173086S | TPSLPTPPTR-(Arg-13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-173087S | TPPSSGEPPKSGDR-(Arg-13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-173088S | IPAK(pT)PPAPK-(Lys-13C6,15N2) (TFA) | Isotope-Labeled Compounds | |
| HY-173089S | TPSLP(pT)PP(pT)REPK-(Lys-13C6,15N2) (TFA) | Isotope-Labeled Compounds | |
| HY-173090S | VAVVR(pT)PPK(pS)PSSAK-(Lys-13C6,15N2) (TFA) | Isotope-Labeled Compounds | |
| HY-173091S | pyroE-QEAVEGGC(Cam)SHLGQSYADR-(Arg-13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-173092 | PRMT5 ligand 1 | 1616393-25-9 | Reference compound |
| HY-173093 | Me-(S,R,S)-AHPC-CO-CH2-PEG4-O-CH2-COOH | 2250056-13-2 | Reference compound |
| HY-173097 | (S,R,S)-AHPC-Boc derivative 1 | 2086298-33-9 | Reference compound |
| HY-173098S | YLPNPA(Leu-13C6,15N)QR (TFA) | Isotope-Labeled Compounds | |
| HY-173099S | GNSP(Ile-13C6,15N)SQR (TFA) | Isotope-Labeled Compounds | |
| HY-173100S | GIFP(Leu-13C6,15N)AER (TFA) | Isotope-Labeled Compounds | |
| HY-173101S | GHFP(Leu-13C6,15N)AER (TFA) | Isotope-Labeled Compounds | |
| HY-173102S | LQEEIDAVL(Pro-13C5,15N)NK (TFA) | Isotope-Labeled Compounds | |
| HY-173103S | FYDPL(Ala-13C3,15N)GK (TFA) | Isotope-Labeled Compounds | |
| HY-173104S | SLPAS(Leu-13C6,15N)QR (TFA) | Isotope-Labeled Compounds | |
| HY-173105S | TPEEAHALSA(Pro-13C5,15N)TSR (TFA) | Isotope-Labeled Compounds | |
| HY-173106S | YTASD(Leu-13C6,15N)FR (TFA) | Isotope-Labeled Compounds | |
| HY-173107S | Haemoglobin HbA0 (a2b2), U-15N | Isotope-Labeled Compounds | |
| HY-173108S | Haemoglobin HbA2 (a2d2), U-15N | Isotope-Labeled Compounds | |
| HY-173114 | Anti-inflammatory agent 96 | Reference compound | |
| HY-173115 | 15-LOX-IN-2 | Reference compound | |
| HY-173116 | DOTA-XYIMSR-01 | 2051527-54-7 | Reference compound |
| HY-173117 | RA306 | Reference compound | |
| HY-173119 | SKLB-D18 | Reference compound | |
| HY-173120 | HBV-IN-51 | Reference compound | |
| HY-173121 | KR019 | Reference compound | |
| HY-173122 | Akt1-IN-8 | 2247688-87-3 | Reference compound |
| HY-173123 | LSD1-IN-40 | Reference compound | |
| HY-173124 | CDK2/FLT4/PDGFRA-IN-1 | Reference compound | |
| HY-173125 | FDU73 | Reference compound | |
| HY-173126 | BTK ligand-14 | Reference compound | |
| HY-173127 | E3 Ligase Ligand-linker Conjugate 171 | Reference compound | |
| HY-173128 | TZOA | 2106826-77-9 | Reference compound |
| HY-173129 | Anti-inflammatory agent 97 | Reference compound | |
| HY-173130 | α-Glucosidase-IN-86 | Reference compound | |
| HY-173131 | 5-HT4R agonist-2 | Reference compound | |
| HY-173132 | AKR1Cs-IN-1 | Reference compound | |
| HY-173133 | Antitumor agent-199 | 3063469-69-9 | Reference compound |
| HY-173134 | SARS-CoV-2 RdRp-IN-1 | Reference compound | |
| HY-173135 | PROTAC KDM4 degrader-1 | Reference compound | |
| HY-173136 | KDM4 ligand-1 | Reference compound | |
| HY-173137 | KDM4 Ligand-Linker Conjugate 1 | Reference compound | |
| HY-173138 | FCOB02 | 3064236-41-2 | Reference compound |
| HY-173139 | TEAD-IN-19 | Reference compound | |
| HY-173140 | Anticancer agent 268 | Reference compound | |
| HY-173141 | mTOR inhibitor-26 | Reference compound | |
| HY-173142 | Neuroprotective agent 7 | Reference compound | |
| HY-173143 | BTK-IN-42 | Reference compound | |
| HY-173144 | AChE-IN-85 | Reference compound | |
| HY-173145 | CD13-IN-1 | Reference compound | |
| HY-173146 | EGFR-IN-153 | Reference compound | |
| HY-173147 | CDK2-IN-42 | Reference compound | |
| HY-173148 | TKB272 | 2892688-18-3 | Reference compound |
| HY-173149 | CDD-2789 | 3052084-77-9 | Reference compound |
| HY-173150 | YAP-IN-1 | Reference compound | |
| HY-173151 | BRCA2-IN-1 | Reference compound | |
| HY-173152 | AChE/BChE-IN-26 | Reference compound | |
| HY-173153 | BRAFV600E/JNK-IN-1 | Reference compound | |
| HY-173154 | NK7-902 | Reference compound | |
| HY-173155 | AKT1-IN-9 | Reference compound | |
| HY-173156 | UNC10013 | Reference compound | |
| HY-173158 | AUR1545 | 3031593-79-7 | Reference compound |
| HY-173159 | BMS-185354 | 110952-22-2 | Reference compound |
| HY-173161 | Mc-d-Val-d-Cit-PAB-PNP | 1350456-68-6 | ADC Related |
| HY-173163 | (E)-2,6-Di-tert-butyl-4-(4-(diethylamino)styryl)pyrylium (trifluoromethanesulfonate) | 2811663-45-1 | Reference compound |
| HY-173164 | EGFR/BRAFV600E-IN-4 | Reference compound | |
| HY-173165 | OA-Br-1 | Reference compound | |
| HY-173166 | PPARγ agonist 17 | 3054652-58-0 | Reference compound |
| HY-173171 | Lyso-PE-PEG5000 (sodium) | Biochemical Assay Reagents | |
| HY-173175 | 5'-O-DMT-2'-O-TBDMS-2-Thiouridine 3'-CE phosphoramidite | 163496-21-7 | Reference compound |
| HY-173176 | 4-(2-Azidoethyl)phenol | 74447-34-0 | Reference compound |
| HY-173177 | PSF-IN-2 | 185418-37-5 | Reference compound |
| HY-173178 | LNS8801 | 925419-55-2 | Reference compound |
| HY-173180 | 5-LOX-IN-8 | Reference compound | |
| HY-173181 | Anticonvulsant agent 10 | Reference compound | |
| HY-173182 | Antitumor agent-200 | 3046118-64-0 | Reference compound |
| HY-173183 | α-Glucosidase-IN-87 | Reference compound | |
| HY-173184 | HDAC6-IN-53 | Reference compound | |
| HY-173185 | RIP1-IN-1 | Reference compound | |
| HY-173186 | TLK1-IN-1 | Reference compound | |
| HY-173187 | Keap1-Nrf2-IN-27 | Reference compound | |
| HY-173188 | EGFR-IN-154 | Reference compound | |
| HY-173190 | Antibacterial agent 271 | Reference compound | |
| HY-173192 | Antibacterial agent 272 | Reference compound | |
| HY-173194 | Carbonic anhydrase inhibitor 29 | Reference compound | |
| HY-173197 | PBP4-IN-1 | Reference compound | |
| HY-173198 | Kaiso-IN-1 | Reference compound | |
| HY-173199 | PRRSV-IN-1 | 801220-43-9 | Reference compound |
| HY-173203 | CDK2-IN-43 | Reference compound | |
| HY-173204 | Influenza virus-IN-9 | Reference compound | |
| HY-173205 | Antimycobacterial agent-11 | Reference compound | |
| HY-173206 | Antifungal agent 128 | Reference compound | |
| HY-173207 | Antiplatelet agent 3 | 1623073-71-1 | Reference compound |
| HY-173209 | NLRP3-IN-73 | Reference compound | |
| HY-173210 | TNF-α-IN-22 | 2251689-60-6 | Reference compound |
| HY-173211 | anti-TNBC agent-8 | Reference compound | |
| HY-173212 | PLK1-IN-13 | 3038489-48-1 | Reference compound |
| HY-173213 | Antileishmanial agent-33 | Reference compound | |
| HY-173214 | FLT3-ITD-IN-3 | 3018150-80-3 | Reference compound |
| HY-173215 | 3-Dimethylaminopropyl deacetylforskolin | Reference compound | |
| HY-173216 | Pseudorabies virus-IN-1 | Reference compound | |
| HY-173217 | PPARα agonist 5 | Reference compound | |
| HY-173218 | anti-NSCLC agent-1 | Reference compound | |
| HY-173219 | SrtA-IN-1 | Reference compound | |
| HY-173220 | DHFR-IN-23 | Reference compound | |
| HY-173221 | MJ210 | Reference compound | |
| HY-173222 | P-gp inhibitor 28 | Reference compound | |
| HY-173223 | Tyrosinase-IN-41 | Reference compound | |
| HY-173224 | CDK2/PIM1-IN-1 | Reference compound | |
| HY-173225 | MRSA/VRE-IN-1 | Reference compound | |
| HY-173226 | BACE1-IN-15 | Reference compound | |
| HY-173227 | TrkC-IN-1 | 1877313-32-0 | Reference compound |
| HY-173228 | Anticancer agent 269 | Reference compound | |
| HY-173230 | ABCA1 inducer 2 | 2451589-46-9 | Reference compound |
| HY-173231 | hURAT1 inhibitor 2 | 1402818-99-8 | Reference compound |
| HY-173232 | VEGFR-2-IN-66 | Reference compound | |
| HY-173233 | PLK1-IN-14 | Reference compound | |
| HY-173234 | GI-Y2 | 1008710-58-4 | Reference compound |
| HY-173235 | Galectin-3-IN-6 | 2604662-64-6 | Reference compound |
| HY-173236 | STAT4-IN-1 | Reference compound | |
| HY-173237 | CDK4/6/BRD4-IN-1 | Reference compound | |
| HY-173238 | Antibacterial agent 273 | Reference compound | |
| HY-173239 | Antibacterial agent 274 | Reference compound | |
| HY-173240 | IPMCL-28b | Reference compound | |
| HY-173241 | Poly-L-lysine-Ahx-FITC (MW 15000-30000) | Biochemical Assay Reagents | |
| HY-173241A | Poly-L-lysine-Ahx-FITC (MW 30000-70000) | Biochemical Assay Reagents | |
| HY-173242 | Cholesteryl 2-methylbutyrate | 41328-98-7 | Reference compound |
| HY-173243 | Val-Ala-PAB-SN38 | 3025787-76-9 | ADC Related |
| HY-173244 | cis-12-Heneicosenoic acid | 3515-84-2 | Reference compound |
| HY-173245 | CL15H6 | 2256087-40-6 | Reference compound |
| HY-173246 | GalNAc-NAG25 phosphoramidite | 2130036-52-9 | Biochemical Assay Reagents |
| HY-173247 | GalNAc-NAG37 phosphoramidite | 2199491-27-3 | Biochemical Assay Reagents |
| HY-173248 | GalNAc-NAG15 phosphoramidite | 2920438-06-6 | Biochemical Assay Reagents |
| HY-173249 | Poly-L-lysine,succinylated (MW >50000) | Biochemical Assay Reagents | |
| HY-173250 | YN14-H | Reference compound | |
| HY-173251S | ENX-101 | Isotope-Labeled Compounds | |
| HY-173253 | E3 Ligase Ligand-linker Conjugate 173 | 2907682-88-4 | Reference compound |
| HY-173254 | MurA-IN-6 | 333740-13-9 | Reference compound |
| HY-173255 | DAO-dBET1 | Reference compound | |
| HY-173256 | Hyp-dBET1 | Reference compound | |
| HY-173257 | Cath-L-dBET1 | Reference compound | |
| HY-173258 | 5-Carboxy-2′-deoxycytidine | 1210427-59-0 | Oligonucleotides |
| HY-173259 | PARP7-IN-23 | 3071875-24-3 | Reference compound |
| HY-173261 | Tri-GalNAc(OAc)3-Cbz | 1159408-63-5 | Reference compound |
| HY-173262 | PARP7-IN-24 | 3072866-54-4 | Reference compound |
| HY-173263 | AChE-IN-86 | Reference compound | |
| HY-173264 | SDH-IN-24 | Reference compound | |
| HY-173265 | CypB-IN-1 | Reference compound | |
| HY-173266 | TO-1187 | Reference compound | |
| HY-173267 | hCES2A-IN-2 | Reference compound | |
| HY-173268 | UNC9426 | 3051784-94-9 | Reference compound |
| HY-173269 | 5-HT2A receptor agonist-7 | 3066340-41-5 | Reference compound |
| HY-173270 | Antibacterial synergist 3 | Reference compound | |
| HY-173271 | GHSR-1a agonist-1 | 3060887-25-1 | Reference compound |
| HY-173272 | BT-114143 | 2796343-04-7 | Reference compound |
| HY-173273 | YJZ5118 | 3031861-18-1 | Reference compound |
| HY-173274 | CB039 | 3056259-55-0 | Reference compound |
| HY-173275 | PDGFRα kinase inhibitor 3 | Reference compound | |
| HY-173276 | SARM1-IN-4 | 3069378-18-0 | Reference compound |
| HY-173277 | FtsZ-IN-13 | 914357-88-3 | Reference compound |
| HY-173278 | AIC263282 | Reference compound | |
| HY-173279 | CYP19A1-IN-1 | 889959-22-2 | Reference compound |
| HY-173280 | Brefeldin A 4-O-nicotinate | 3035018-34-6 | Reference compound |
| HY-173281 | MAT2A-IN-24 | 3031093-57-6 | Reference compound |
| HY-173282 | Aβ aggregation-IN-2 | Reference compound | |
| HY-173283 | Antifungal agent 129 | Reference compound | |
| HY-173284 | DDR1-IN-11 | 639089-54-6 | Reference compound |
| HY-173285 | SARS-CoV-2 Mpro-IN-38 | Reference compound | |
| HY-173286 | LNP Lipid-182 | 2089253-10-9 | Oligonucleotides |
| HY-173287 | LNP Lipid-48 | 2089251-73-8 | Oligonucleotides |
| HY-173288 | MAO-B-IN-40 | 2486914-15-0 | Reference compound |
| HY-173289 | LNP Lipid-26 | 2089251-49-8 | Oligonucleotides |
| HY-173290 | PDE4D inhibitor 1 | Reference compound | |
| HY-173291 | Tau ligand-1 | 3063166-64-0 | Reference compound |
| HY-173292 | ALC-0315 analogue-4 | 2036273-14-8 | Reference compound |
| HY-173293 | ASK1-IN-8 | 2570985-89-4 | Reference compound |
| HY-173294 | NLRP3-IN-74 | Reference compound | |
| HY-173295 | LNP Lipid II-10 | 2036272-60-1 | Oligonucleotides |
| HY-173296 | MAGL-IN-222 | 877804-65-4 | Reference compound |
| HY-173297 | LNP Lipid-12 | 2036272-53-2 | Oligonucleotides |
| HY-173298 | PDHK1-IN-2 | 2870691-38-4 | Reference compound |
| HY-173299 | 10,12-cis, cis-Octadecadienoic acid | 7307-45-1 | Reference compound |
| HY-173300 | Sulfo-PBA | 1193111-38-4 | Reference compound |
| HY-173301 | PDHK1-IN-3 | Reference compound | |
| HY-173302 | sEH inhibitor-20 | Reference compound | |
| HY-173303 | PEG3-Bis-nitrophenyl carbonate | 669013-00-7 | Reference compound |
| HY-173305 | Mpro/PLPro-IN-2 | Reference compound | |
| HY-173307 | Nrf2 activator 19 | Reference compound | |
| HY-173308 | QSY-21 | 1200894-41-2 | Dye Reagents |
| HY-173309 | P53/TLR2 modulator-1 | Reference compound | |
| HY-173310 | CDK2-IN-44 | 3051587-93-7 | Reference compound |
| HY-173311 | Cbl-b-IN-28 | Reference compound | |
| HY-173312 | Antimalarial agent 49 | Reference compound | |
| HY-173313 | Ferroptosis-IN-19 | 3025114-13-7 | Reference compound |
| HY-173314 | EGFR-IN-155 | Reference compound | |
| HY-173315 | pan-BET/BD2-IN-1 | Reference compound | |
| HY-173316 | STING-IN-12 | Reference compound | |
| HY-173317 | STING-IN-13 | Reference compound | |
| HY-173318 | Anti-MRSA agent 25 | Reference compound | |
| HY-173319 | FAP-IN-5 | Reference compound | |
| HY-173320 | HEMTAC WEE1 degrader-1 | 3002417-64-0 | Reference compound |
| HY-173321 | PAD4-IN-5 | 3071873-52-1 | Reference compound |
| HY-173322 | Lp(a)-IN-8 | 3070206-18-4 | Reference compound |
| HY-173323 | Lp(a)-IN-7 | 3070232-49-1 | Reference compound |
| HY-173324 | LPA2 antagonist 5 | 3070072-52-2 | Reference compound |
| HY-173325 | LPA2 antagonist 6 | 3072671-88-3 | Reference compound |
| HY-173326 | STING-IN-14 | 3070953-78-2 | Reference compound |
| HY-173327 | BRD4 degrader-6 | 3055207-38-7 | Reference compound |
| HY-173329 | KRAS inhibitor-41 | 3056974-50-3 | Reference compound |
| HY-173330 | HDAC-IN-89 | Reference compound | |
| HY-173331 | Antitumor agent-201 | Reference compound | |
| HY-173332 | 15-LOX-1 inhibitor 2 | Reference compound | |
| HY-173333 | PROTAC SMARCA2/4 degrader-38 | Reference compound | |
| HY-173334 | hMAO-B-IN-11 | Reference compound | |
| HY-173335 | PLA2-IN-1 | Reference compound | |
| HY-173336 | MAO-B-IN-42 | 2568016-10-2 | Reference compound |
| HY-173337 | HSP90α-IN-1 | 184897-90-3 | Reference compound |
| HY-173338 | MSRV-IN-1 | 1438403-50-9 | Reference compound |
| HY-173339 | VIP36 | Reference compound | |
| HY-173340 | LRH-1 agonist-1 | Reference compound | |
| HY-173341 | SOF-436 | 2224491-20-5 | Reference compound |
| HY-173342 | Neocryptolepine-Cl | 1150313-15-7 | Reference compound |
| HY-173344 | DB-10 | Reference compound | |
| HY-173345 | BRCA2-RAD51-IN-2 | Reference compound | |
| HY-173347 | BLINK11 | Reference compound | |
| HY-173348 | BLINK15 | Reference compound | |
| HY-173349 | TDI-012804 | Reference compound | |
| HY-173350 | Ran-IN-1 | 2301869-11-2 | Reference compound |
| HY-173351 | G-6599 | 2901806-51-5 | Reference compound |
| HY-173352 | USP7 activator 1 | 868940-26-5 | Reference compound |
| HY-173355 | RCB18350 | 3052630-27-7 | Reference compound |
| HY-173356 | Antiparasitic agent-26 | Reference compound | |
| HY-173357 | TYD-68 | Reference compound | |
| HY-173358 | E3 Ligase Ligand-linker Conjugate 174 | 2703765-01-7 | Reference compound |
| HY-173360 | PDE10A-IN-5 | Reference compound | |
| HY-173361 | Anticancer agent 270 | Reference compound | |
| HY-173362 | SARS-CoV-2 Mpro-IN-39 | Reference compound | |
| HY-173363 | CHEMBL4444839 | 2316841-82-2 | Reference compound |
| HY-173364 | EB-TCIP | Reference compound | |
| HY-173365 | VEGFR-2-IN-67 | Reference compound | |
| HY-173366 | dGEM3 | Reference compound | |
| HY-173367 | Anticancer agent 271 | Reference compound | |
| HY-173368 | Antiproliferative agent-67 | Reference compound | |
| HY-173369 | PROTAC MAGL degrader-1 | Reference compound | |
| HY-173371 | BRI-50460 | Reference compound | |
| HY-173372 | PROTAC AR Degrader-10 | Reference compound | |
| HY-173373 | AR ligand-39 | 2156591-18-1 | Reference compound |
| HY-173374 | DOTAGA-FAP-2286-ALB | Reference compound | |
| HY-173375 | Mycobacterium Tuberculosis-IN-8 | Reference compound | |
| HY-173376 | C12 DG PEG (MW 2000) | Biochemical Assay Reagents | |
| HY-173378 | E3 ligase Ligand 59 | 2913165-27-0 | Reference compound |
| HY-173379 | C10 DG PEG 2000 | Biochemical Assay Reagents | |
| HY-173380 | C8 DG PEG 2000 | Biochemical Assay Reagents | |
| HY-173381 | Cholesteryl-PEG2000-Biotin | Biochemical Assay Reagents | |
| HY-173381A | Cholesteryl-PEG1000-Biotin | Biochemical Assay Reagents | |
| HY-173383 | DOPE-DOTA sodium | Biochemical Assay Reagents | |
| HY-173384 | DSPE-DOTA sodium | Biochemical Assay Reagents | |
| HY-173385 | Cholesteryl-PEG1000-Azide | Biochemical Assay Reagents | |
| HY-173387 | 4F-Docetaxel | 912272-09-4 | Natural Products |
| HY-173388 | Nitric oxide production-IN-2 | 1019984-44-1 | Reference compound |
| HY-173390 | BCN-E-BCN | 2059099-03-3 | Reference compound |
| HY-173463 | Sirtuin modulator 8 | 925437-38-3 | Reference compound |
| HY-17350 | Anitrazafen | 63119-27-7 | Reference compound |
| HY-17351 | Tezosentan | 180384-57-0 | Reference compound |
| HY-17352 | Clazosentan | 180384-56-9 | Reference compound |
| HY-17352A | Clazosentan (disodium) | 503271-02-1 | Reference compound |
| HY-17353 | BIBR 1532 | 321674-73-1 | Reference compound |
| HY-17354 | (R)-Baclofen | 69308-37-8 | Reference compound |
| HY-17354A | (R)-Baclofen (hydrochloride) | 63701-55-3 | Reference compound |
| HY-17355 | Pramipexole (dihydrochloride) | 104632-25-9 | Reference compound |
| HY-173552 | TCIP3 | 3067681-36-8 | Reference compound |
| HY-17355A | Dexpramipexole (dihydrochloride) | 104632-27-1 | Reference compound |
| HY-17355AR | Dexpramipexole (dihydrochloride) (Standard) | 104632-27-1 | Reference Standards |
| HY-17355B | Dexpramipexole | 104632-28-2 | Reference compound |
| HY-17355BS | Dexpramipexole-d3 (dihydrochloride) | 1432230-09-5 | Isotope-Labeled Compounds |
| HY-17355S | Pramipexole-d7 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-17355S1 | Pramipexole-d5 (dihydrochloride) | 1217601-58-5 | Isotope-Labeled Compounds |
| HY-17355S2 | Pramipexole-d7-1 (dihydrochloride) | 2702798-58-9 | Isotope-Labeled Compounds |
| HY-17356 | Fenofibrate | 49562-28-9 | Reference compound |
| HY-17356G | Fenofibrate (GMP) | 49562-28-9 | GMP Small Molecules |
| HY-17356R | Fenofibrate (Standard) | 49562-28-9 | Reference Standards |
| HY-17356S | Fenofibrate-d6 | 1092484-56-4 | Isotope-Labeled Compounds |
| HY-17356S1 | Fenofibrate-d4 | 1092484-57-5 | Isotope-Labeled Compounds |
| HY-17356S2 | Fenofibrate-13C6 | 1261395-55-4 | Isotope-Labeled Compounds |
| HY-17357 | Nepafenac | 78281-72-8 | Reference compound |
| HY-17357R | Nepafenac (Standard) | 78281-72-8 | Reference Standards |
| HY-17357S | Nepafenac-d5 | 1246814-53-8 | Isotope-Labeled Compounds |
| HY-17358 | Loteprednol Etabonate | 82034-46-6 | Reference compound |
| HY-17358R | Loteprednol Etabonate (Standard) | 82034-46-6 | Reference Standards |
| HY-17358S | Loteprednol Etabonate-d5 | 2026643-11-6 | Isotope-Labeled Compounds |
| HY-17358S1 | Loteprednol Etabonate-d3 | Isotope-Labeled Compounds | |
| HY-17359 | Deferasirox | 201530-41-8 | Reference compound |
| HY-17359R | Deferasirox (Standard) | 201530-41-8 | Reference Standards |
| HY-17359S | Deferasirox-d4 | 1133425-75-8 | Isotope-Labeled Compounds |
| HY-17359S1 | Deferasirox-13C6 | 1261392-79-3 | Isotope-Labeled Compounds |
| HY-17360 | Tiotropium (Bromide) | 136310-93-5 | Reference compound |
| HY-17360R | Tiotropium (Bromide) (Standard) | 136310-93-5 | Reference Standards |
| HY-17360S | Tiotropium-d3 (bromide) | 1127226-56-5 | Isotope-Labeled Compounds |
| HY-17360S1 | Tiotropium-d6 (bromide) | 1126775-44-7 | Isotope-Labeled Compounds |
| HY-17361 | Etofenamate | 30544-47-9 | Reference compound |
| HY-17361R | Etofenamate (Standard) | 30544-47-9 | Reference Standards |
| HY-17361S | Etofenamate-d4 | 1329837-73-1 | Isotope-Labeled Compounds |
| HY-17362 | Vancomycin (hydrochloride) | 1404-93-9 | Natural Products |
| HY-173625 | P5(PEG12)-VC-PAB-Exatecan | 2928571-52-0 | ADC Related |
| HY-173626 | EN1441 | 2196448-47-0 | Reference compound |
| HY-173629 | RMC-5127 | Reference compound | |
| HY-17362R | Vancomycin (hydrochloride) (Standard) | 1404-93-9 | Reference Standards |
| HY-17363 | Dimethyl fumarate | 624-49-7 | Natural Products |
| HY-173630 | BMS-986449 | Reference compound | |
| HY-173631 | (S)-dHTC1 | 3081383-46-9 | Reference compound |
| HY-173632 | AMG410 | 3040175-17-2 | Reference compound |
| HY-173633 | BrAc-Val-Ala | ADC Related | |
| HY-173634 | Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB-Exatecan | 3059991-66-8 | ADC Related |
| HY-173635 | Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB | ADC Related | |
| HY-173637 | AZD0022 | 2958627-18-2 | Reference compound |
| HY-173639 | AZD0516 | Reference compound | |
| HY-17363R | Dimethyl fumarate (Standard) | 624-49-7 | Reference Standards |
| HY-17363S | Dimethyl fumarate-d6 | 66487-95-4 | Isotope-Labeled Compounds |
| HY-17363S1 | Dimethyl fumarate-d2 | 23057-98-9 | Isotope-Labeled Compounds |
| HY-17364 | Temozolomide | 85622-93-1 | Reference compound |
| HY-173640 | ID11916 | 2785317-21-5 | Reference compound |
| HY-173641 | MNN-02-155 | 3067681-22-2 | Reference compound |
| HY-173642 | NCGC00238624 | 2768230-55-1 | Reference compound |
| HY-17364R | Temozolomide (Standard) | 85622-93-1 | Reference Standards |
| HY-17364S | Temozolomide-d3 | 208107-14-6 | Isotope-Labeled Compounds |
| HY-17365 | Octreotide (acetate) | 79517-01-4 | Peptides |
| HY-17366 | Clozapine N-oxide | 34233-69-7 | Reference compound |
| HY-17366A | Clozapine N-oxide (dihydrochloride) | 2250025-93-3 | Reference compound |
| HY-17366AR | Clozapine N-oxide (dihydrochloride) (Standard) | 2250025-93-3 | Reference Standards |
| HY-17366R | Clozapine N-oxide (Standard) | 34233-69-7 | Reference Standards |
| HY-17367 | Atazanavir | 198904-31-3 | Reference compound |
| HY-17367A | Atazanavir (sulfate) | 229975-97-7 | Reference compound |
| HY-17367AR | Atazanavir (sulfate) (Standard) | 229975-97-7 | Reference Standards |
| HY-17367R | Atazanavir (Standard) | 198904-31-3 | Reference Standards |
| HY-17367S | Atazanavir-d15 | 1092540-56-1 | Isotope-Labeled Compounds |
| HY-17367S1 | Atazanavir-d18 | 1092540-52-7 | Isotope-Labeled Compounds |
| HY-17367S2 | Atazanavir-d9 | 1092540-51-6 | Isotope-Labeled Compounds |
| HY-17367S3 | Atazanavir-d5 | 1132747-14-8 | Isotope-Labeled Compounds |
| HY-17367S4 | Atazanavir-d6 | 1092540-50-5 | Isotope-Labeled Compounds |
| HY-17367S5 | Atazanavir-d24 | 1092540-58-3 | Isotope-Labeled Compounds |
| HY-17368 | Rivastigmine | 123441-03-2 | Reference compound |
| HY-17368R | Rivastigmine (Standard) | 123441-03-2 | Reference Standards |
| HY-17368S1 | (Rac)-Rivastigmine-d6 | 194930-04-6 | Isotope-Labeled Compounds |
| HY-17368S2 | Rivastigmine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17369 | Tirofiban (hydrochloride monohydrate) | 150915-40-5 | Reference compound |
| HY-17369A | Tirofiban (hydrochloride) | 142373-60-2 | Reference compound |
| HY-17369B | Tirofiban | 144494-65-5 | Reference compound |
| HY-17369BR | Tirofiban (Standard) | 144494-65-5 | Reference Standards |
| HY-17369BS | Tirofiban-d9 | 1332075-40-7 | Isotope-Labeled Compounds |
| HY-17369R | Tirofiban (hydrochloride monohydrate) (Standard) | 150915-40-5 | Reference Standards |
| HY-17371 | Oxaliplatin | 61825-94-3 | Reference compound |
| HY-17371A | (rel)-Oxaliplatin | 63121-00-6 | Reference compound |
| HY-17371R | Oxaliplatin (Standard) | 61825-94-3 | Reference Standards |
| HY-17371S | Oxaliplatin-d10 | 1132819-16-9 | Isotope-Labeled Compounds |
| HY-17372 | Rofecoxib | 162011-90-7 | Reference compound |
| HY-17372R | Rofecoxib (Standard) | 162011-90-7 | Reference Standards |
| HY-17372S | Rofecoxib-d5 | 544684-93-7 | Isotope-Labeled Compounds |
| HY-17373 | Posaconazole | 171228-49-2 | Reference compound |
| HY-17373A | Posaconazole (hydrate) | 1198769-38-8 | Reference compound |
| HY-17373R | Posaconazole (Standard) | 171228-49-2 | Reference Standards |
| HY-17373S | Posaconazole-d5 | 1217785-83-5 | Isotope-Labeled Compounds |
| HY-17373S1 | Posaconazole-d4 | 1133712-26-1 | Isotope-Labeled Compounds |
| HY-17373S2 | Posaconazole-d3 | Isotope-Labeled Compounds | |
| HY-17373S3 | Posaconazole-d7 | Isotope-Labeled Compounds | |
| HY-17374 | Benfotiamine | 22457-89-2 | Reference compound |
| HY-17374R | Benfotiamine (Standard) | 22457-89-2 | Reference Standards |
| HY-17375 | Allylestrenol | 432-60-0 | Reference compound |
| HY-17375R | Allylestrenol (Standard) | 432-60-0 | Reference Standards |
| HY-17376 | Ezetimibe | 163222-33-1 | Reference compound |
| HY-17376R | Ezetimibe (Standard) | 163222-33-1 | Reference Standards |
| HY-17376S | Ezetimibe-d4 | 1093659-90-5 | Isotope-Labeled Compounds |
| HY-17376S1 | Ezetimibe-d4-1 | 1093659-89-2 | Isotope-Labeled Compounds |
| HY-17377 | Vicriviroc (maleate) | 599179-03-0 | Reference compound |
| HY-17378 | Dabigatran (ethyl ester) | 429658-95-7 | Reference compound |
| HY-17379 | Atorvastatin (hemicalcium salt) | 134523-03-8 | Reference compound |
| HY-17379R | Atorvastatin (hemicalcium salt) (Standard) | 134523-03-8 | Reference Standards |
| HY-17380 | (S)-Timolol (maleate) | 26921-17-5 | Reference compound |
| HY-17380R | (S)-Timolol (maleate) (Standard) | 26921-17-5 | Reference Standards |
| HY-17380S | (S)-Timolol-d9 (maleate) | Isotope-Labeled Compounds | |
| HY-17381 | Idarubicin (hydrochloride) | 57852-57-0 | Reference compound |
| HY-17381A | Idarubicin | 58957-92-9 | Reference compound |
| HY-17381R | Idarubicin (hydrochloride) (Standard) | 57852-57-0 | Reference Standards |
| HY-17382 | Metoclopramide | 364-62-5 | Reference compound |
| HY-17382A | Metoclopramide (hydrochloride hydrate) | 54143-57-6 | Reference compound |
| HY-17382AR | Metoclopramide (hydrochloride hydrate) (Standard) | 54143-57-6 | Reference Standards |
| HY-17382B | Metoclopramide (hydrochloride) | 7232-21-5 | Reference compound |
| HY-17382C | Metoclopramide (dihydrochloride) | 2576-84-3 | Reference compound |
| HY-17382R | Metoclopramide (Standard) | 364-62-5 | Reference Standards |
| HY-17382S | Metoclopramide-d3 | 1216522-89-2 | Isotope-Labeled Compounds |
| HY-17383 | Levomefolate (calcium) | 151533-22-1 | Reference compound |
| HY-17383A | Levomefolate (disodium) | 1423663-76-6 | Reference compound |
| HY-17383R | Levomefolate (calcium) (Standard) | 151533-22-1 | Reference Standards |
| HY-17383S | Levomefolate-13C5 (calcium) | Isotope-Labeled Compounds | |
| HY-17384 | Valspodar | 121584-18-7 | Reference compound |
| HY-17385 | Atomoxetine (hydrochloride) | 82248-59-7 | Reference compound |
| HY-17385R | Atomoxetine (hydrochloride) (Standard) | 82248-59-7 | Reference Standards |
| HY-17385S | Atomoxetine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17386 | Rosiglitazone | 122320-73-4 | Reference compound |
| HY-17386A | Rosiglitazone (hydrochloride) | 302543-62-0 | Reference compound |
| HY-17386B | Rosiglitazone (potassium) | 316371-84-3 | Reference compound |
| HY-17386R | Rosiglitazone (Standard) | 122320-73-4 | Reference Standards |
| HY-17386S | Rosiglitazone-d3 | 1132641-22-5 | Isotope-Labeled Compounds |
| HY-17386S1 | Rosiglitazone-d4 | 1132641-21-4 | Isotope-Labeled Compounds |
| HY-17386S2 | Rosiglitazone-d4-1 | 1132641-20-3 | Isotope-Labeled Compounds |
| HY-17387 | (-)-Huperzine A | 102518-79-6 | Natural Products |
| HY-17387S1 | (-)-Huperzine A-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17388 | (±)-Huperzine A | 120786-18-7 | Natural Products |
| HY-17389 | Genipin | 6902-77-8 | Natural Products |
| HY-17389A | 7-Deoxy-10-hydroxyloganetin | 76267-48-6 | Natural Products |
| HY-17389R | Genipin (Standard) | 6902-77-8 | Reference Standards |
| HY-17390 | Loxapine | 1977-10-2 | Reference compound |
| HY-17390A | Loxapine (succinate) | 27833-64-3 | Reference compound |
| HY-17390AR | Loxapine (succinate) (Standard) | 27833-64-3 | Reference Standards |
| HY-17390B | Loxapine (hydrochloride) | 54810-23-0 | Reference compound |
| HY-17390BS | Loxapine-d8 (hydrochloride) | 1246820-19-8 | Isotope-Labeled Compounds |
| HY-17390BS2 | Loxapine-d8 | 1189455-63-7 | Isotope-Labeled Compounds |
| HY-17390R | Loxapine (Standard) | 1977-10-2 | Reference Standards |
| HY-17391 | Pamabrom | 606-04-2 | Reference compound |
| HY-17392 | Zalcitabine | 7481-89-2 | Reference compound |
| HY-17392R | Zalcitabine (Standard) | 7481-89-2 | Reference Standards |
| HY-17393 | Carboplatin | 41575-94-4 | Reference compound |
| HY-17393S | Carboplatin-d4 | Isotope-Labeled Compounds | |
| HY-17394 | Cisplatin | 15663-27-1 | Reference compound |
| HY-17395 | Terbinafine hydrochloride | 78628-80-5 | Reference compound |
| HY-17395A | Terbinafine | 91161-71-6 | Reference compound |
| HY-17395AR | Terbinafine (Standard) | 91161-71-6 | Reference Standards |
| HY-17395AS | Terbinafine-d7 | 1185240-27-0 | Isotope-Labeled Compounds |
| HY-17395AS1 | Terbinafine-d3 | 1133210-36-2 | Isotope-Labeled Compounds |
| HY-17395B | Terbinafine (lactate) | 335276-86-3 | Reference compound |
| HY-17395R | Terbinafine hydrochloride (Standard) | 78628-80-5 | Reference Standards |
| HY-17395S | Terbinafine-d3 (hydrochloride) | 1310012-15-7 | Isotope-Labeled Compounds |
| HY-17395S1 | Terbinafine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17396 | Butenafine (Hydrochloride) | 101827-46-7 | Reference compound |
| HY-17396R | Butenafine (Hydrochloride) (Standard) | 101827-46-7 | Reference Standards |
| HY-17396S | Butenafine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17397 | Strontium Ranelate | 135459-87-9 | Reference compound |
| HY-17397R | Strontium Ranelate (Standard) | 135459-87-9 | Reference Standards |
| HY-17398 | Mitiglinide (calcium) | 145525-41-3 | Reference compound |
| HY-17399 | Racecadotril | 81110-73-8 | Reference compound |
| HY-17399R | Racecadotril (Standard) | 81110-73-8 | Reference Standards |
| HY-17399S | Racecadotril-d5 | 1246815-11-1 | Isotope-Labeled Compounds |
| HY-17400 | Tegafur | 17902-23-7 | Reference compound |
| HY-17400R | Tegafur (Standard) | 17902-23-7 | Reference Standards |
| HY-17401 | Ranolazine (dihydrochloride) | 95635-56-6 | Reference compound |
| HY-17401S | Ranolazine-d8 (dihydrochloride) | 1219802-60-4 | Isotope-Labeled Compounds |
| HY-17402 | Nisoldipine | 63675-72-9 | Reference compound |
| HY-17402R | Nisoldipine (Standard) | 63675-72-9 | Reference Standards |
| HY-17402S | Nisoldipine-d6 | 1285910-03-3 | Isotope-Labeled Compounds |
| HY-17402S1 | Nisoldipine-d4 | 1219795-47-7 | Isotope-Labeled Compounds |
| HY-17402S2 | Nisoldipine-d7 | 1189718-34-0 | Isotope-Labeled Compounds |
| HY-17402S3 | Nisoldipine-d3 | Isotope-Labeled Compounds | |
| HY-17403 | Manidipine (dihydrochloride) | 89226-75-5 | Reference compound |
| HY-17404 | Cilnidipine | 132203-70-4 | Reference compound |
| HY-17404R | Cilnidipine (Standard) | 132203-70-4 | Reference Standards |
| HY-17404S | Cilnidipine-d7 | Isotope-Labeled Compounds | |
| HY-17404S1 | Cilnidipine-d4 | Isotope-Labeled Compounds | |
| HY-17405 | Alarelin (Acetate) | 79561-22-1 | Peptides |
| HY-17405R | Alarelin (Acetate) (Standard) | 79561-22-1 | Reference Standards |
| HY-17406 | Tolcapone | 134308-13-7 | Reference compound |
| HY-17406R | Tolcapone (Standard) | 134308-13-7 | Reference Standards |
| HY-17406S | Tolcapone-d7 | Isotope-Labeled Compounds | |
| HY-17406S1 | Tolcapone-d4 | 1246816-93-2 | Isotope-Labeled Compounds |
| HY-17407 | Ziprasidone (hydrochloride monohydrate) | 138982-67-9 | Reference compound |
| HY-17407R | Ziprasidone (hydrochloride monohydrate) (Standard) | 138982-67-9 | Reference Standards |
| HY-17408 | Mevastatin | 73573-88-3 | Natural Products |
| HY-17408R | Mevastatin (Standard) | 73573-88-3 | Reference Standards |
| HY-17409 | Nystatin | 1400-61-9 | Natural Products |
| HY-17410 | Iloperidone | 133454-47-4 | Reference compound |
| HY-17410A | Iloperidone (hydrochloride) | 1299470-39-5 | Reference compound |
| HY-17410S | Iloperidone-d3 | 1071167-49-1 | Isotope-Labeled Compounds |
| HY-17410S1 | Iloperidone-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17410S2 | Iloperidone-13C,d3 | Isotope-Labeled Compounds | |
| HY-17411 | Limonin | 1180-71-8 | Natural Products |
| HY-17411R | Limonin (Standard) | 1180-71-8 | Reference Standards |
| HY-17412 | Minocycline (hydrochloride) | 13614-98-7 | Reference compound |
| HY-17412A | Minocycline | 10118-90-8 | Reference compound |
| HY-17412AS | Minocycline-d6 | 1036070-10-6 | Isotope-Labeled Compounds |
| HY-17412B | 4-Epiminocycline | 43168-51-0 | Reference compound |
| HY-17412R | Minocycline (hydrochloride) (Standard) | 13614-98-7 | Reference Standards |
| HY-17412S | Minocycline-d6 (hydrochloride) | 1035979-33-9 | Isotope-Labeled Compounds |
| HY-17412S1 | Minocycline-d6 (sulfate) | Isotope-Labeled Compounds | |
| HY-17413 | Zidovudine | 30516-87-1 | Reference compound |
| HY-17413R | Zidovudine (Standard) | 30516-87-1 | Reference Standards |
| HY-17413S | Zidovudine-d3 | Isotope-Labeled Compounds | |
| HY-17413S1 | Zidovudine-13C,d3 | Isotope-Labeled Compounds | |
| HY-17413S2 | Zidovudine-d4 | Isotope-Labeled Compounds | |
| HY-17416 | Guanfacine (hydrochloride) | 29110-48-3 | Reference compound |
| HY-17416A | Guanfacine | 29110-47-2 | Reference compound |
| HY-17416AS | Guanfacine-13C,15N3 | 1189924-28-4 | Isotope-Labeled Compounds |
| HY-17416AS1 | Guanfacine-15N3,13C2 | Isotope-Labeled Compounds | |
| HY-17416R | Guanfacine (hydrochloride) (Standard) | 29110-48-3 | Reference Standards |
| HY-17416S | Guanfacine-d2 (hydrochloride) | 1398065-88-7 | Isotope-Labeled Compounds |
| HY-17416S2 | Guanfacine-13C,d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17417 | Naloxone (hydrochloride) | 357-08-4 | Reference compound |
| HY-17417A | Naloxone | 465-65-6 | Reference compound |
| HY-17417AR | Naloxone (Standard) | 465-65-6 | Reference Standards |
| HY-17417AS | Naloxone-d5 | 1261079-38-2 | Isotope-Labeled Compounds |
| HY-17417R | Naloxone (hydrochloride) (Standard) | 357-08-4 | Reference Standards |
| HY-17419 | Ifosfamide | 3778-73-2 | Reference compound |
| HY-17419A | (R)-Ifosfamide | 66849-34-1 | Reference compound |
| HY-17419R | Ifosfamide (Standard) | 3778-73-2 | Reference Standards |
| HY-17419S1 | Ifosfamide-d4 | 1189701-13-0 | Isotope-Labeled Compounds |
| HY-17419S2 | Ifosfamide-d4-1 | 2012598-80-8 | Isotope-Labeled Compounds |
| HY-17420 | Cyclophosphamide | 50-18-0 | Reference compound |
| HY-17420A | Cyclophosphamide (hydrate) | 6055-19-2 | Reference compound |
| HY-17420AR | Cyclophosphamide (hydrate) (Standard) | 6055-19-2 | Reference Standards |
| HY-17420AS | Cyclophosphamide-d8 (hydrate) | Isotope-Labeled Compounds | |
| HY-17420S | Cyclophosphamide-d4 | 173547-45-0 | Isotope-Labeled Compounds |
| HY-17420S1 | Cyclophosphamide-d8 | 1178903-96-2 | Isotope-Labeled Compounds |
| HY-17421 | Tenatoprazole | 113712-98-4 | Reference compound |
| HY-17421A | Tenatoprazole (sodium) | 335299-59-7 | Reference compound |
| HY-17422 | Acyclovir | 59277-89-3 | Reference compound |
| HY-17422A | Acyclovir (sodium) | 69657-51-8 | Reference compound |
| HY-17422B | Acyclovir monophosphate | 66341-16-0 | Reference compound |
| HY-17422C | Acyclovir alaninate | 84499-64-9 | Reference compound |
| HY-17422D | Acyclovir (hydrochloride) | 1628039-62-2 | Reference compound |
| HY-17422R | Acyclovir (Standard) | 59277-89-3 | Reference Standards |
| HY-17422S1 | Acyclovir-d4 | 1185179-33-2 | Isotope-Labeled Compounds |
| HY-17423 | Abacavir | 136470-78-5 | Reference compound |
| HY-17423A | Abacavir (sulfate) | 188062-50-2 | Reference compound |
| HY-17423AR | Abacavir (sulfate) (Standard) | 188062-50-2 | Reference Standards |
| HY-17423B | Abacavir (monosulfate) | 216699-07-9 | Reference compound |
| HY-17423D | ent-Abacavir | 136470-79-6 | Reference compound |
| HY-17423E | Abacavir (hydrochloride) | 136777-48-5 | Reference compound |
| HY-17423R | Abacavir (Standard) | 136470-78-5 | Reference Standards |
| HY-17423S | Abacavir-d4 | 1260619-56-4 | Isotope-Labeled Compounds |
| HY-17423S1 | rel-Abacavir-d4 | 1217731-56-0 | Isotope-Labeled Compounds |
| HY-17424 | Penciclovir | 39809-25-1 | Reference compound |
| HY-17424R | Penciclovir (Standard) | 39809-25-1 | Reference Standards |
| HY-17424S | Penciclovir-d4 | 1020719-72-5 | Isotope-Labeled Compounds |
| HY-17425 | Valacyclovir | 124832-26-4 | Reference compound |
| HY-17425A | Valacyclovir (hydrochloride) | 124832-27-5 | Reference compound |
| HY-17425AR | Valacyclovir (hydrochloride) (Standard) | 124832-27-5 | Reference Standards |
| HY-17425AS | Valacyclovir-d8 (hydrochloride) | 1279033-32-7 | Isotope-Labeled Compounds |
| HY-17425AS1 | Valacyclovir-d4 (hydrochloride) | 1331910-75-8 | Isotope-Labeled Compounds |
| HY-17425B | Valacyclovir (hydrochloride hydrate) | 1218948-84-5 | Reference compound |
| HY-17426 | Famciclovir | 104227-87-4 | Reference compound |
| HY-17426R | Famciclovir (Standard) | 104227-87-4 | Reference Standards |
| HY-17426S | Famciclovir-d4 | 1020719-42-9 | Isotope-Labeled Compounds |
| HY-17426S1 | Famciclovir-d6 | 2587293-47-6 | Isotope-Labeled Compounds |
| HY-17427 | Emtricitabine | 143491-57-0 | Reference compound |
| HY-17427R | Emtricitabine (Standard) | 143491-57-0 | Reference Standards |
| HY-17427S | Emtricitabine-15N,d2 | 2714436-53-8 | Isotope-Labeled Compounds |
| HY-17427S2 | Emtricitabine-13C,15N2 | 1217820-69-3 | Isotope-Labeled Compounds |
| HY-17427S4 | Emtricitabine-d2 | Isotope-Labeled Compounds | |
| HY-17428 | Tripelennamine (hydrochloride) | 154-69-8 | Reference compound |
| HY-17428A | Tripelennamine | 91-81-6 | Reference compound |
| HY-17428B | Tripelennamine (citrate) | 6138-56-3 | Reference compound |
| HY-17428R | Tripelennamine (hydrochloride) (Standard) | 154-69-8 | Reference Standards |
| HY-17429 | Flecainide (acetate) | 54143-56-5 | Reference compound |
| HY-17429R | Flecainide (acetate) (Standard) | 54143-56-5 | Reference Standards |
| HY-17429S | Flecainide-d4 (acetate) | 1276197-21-7 | Isotope-Labeled Compounds |
| HY-17430 | Amprenavir | 161814-49-9 | Reference compound |
| HY-17430R | Amprenavir (Standard) | 161814-49-9 | Reference Standards |
| HY-17430S | Amprenavir-d4 | 1217661-20-5 | Isotope-Labeled Compounds |
| HY-17430S1 | Amprenavir-d4-1 | 2738376-78-6 | Isotope-Labeled Compounds |
| HY-17430S2 | Amprenavir-13C6 | Isotope-Labeled Compounds | |
| HY-17431 | Fosamprenavir (Calcium Salt) | 226700-81-8 | Reference compound |
| HY-17431R | Fosamprenavir (Calcium Salt) (Standard) | 226700-81-8 | Reference Standards |
| HY-17435 | 4'-Demethylepipodophyllotoxin | 6559-91-7 | Natural Products |
| HY-17435R | 4'-Demethylepipodophyllotoxin (Standard) | 6559-91-7 | Reference Standards |
| HY-17436 | Clevidipine | 167221-71-8 | Reference compound |
| HY-17436R | Clevidipine (Standard) | 167221-71-8 | Reference Standards |
| HY-17436S1 | Clevidipine-d7 | Isotope-Labeled Compounds | |
| HY-17436S3 | (R)-Clevidipine-13C,d3 | Isotope-Labeled Compounds | |
| HY-17436S4 | Clevidipine-15N,d10 | Isotope-Labeled Compounds | |
| HY-17437 | Mefloquine | 53230-10-7 | Reference compound |
| HY-17437A | Mefloquine (hydrochloride) | 51773-92-3 | Reference compound |
| HY-17437AR | Mefloquine (hydrochloride) (Standard) | 51773-92-3 | Reference Standards |
| HY-17438 | Cidofovir | 113852-37-2 | Reference compound |
| HY-17438A | Cidofovir (dihydrate) | 149394-66-1 | Reference compound |
| HY-17438R | Cidofovir (Standard) | 113852-37-2 | Reference Standards |
| HY-17439 | Salinomycin (sodium salt) | 55721-31-8 | Reference compound |
| HY-17439R | Salinomycin (sodium salt) (Standard) | 55721-31-8 | Reference Standards |
| HY-17440 | Rocuronium (Bromide) | 119302-91-9 | Reference compound |
| HY-17440R | Rocuronium (Bromide) (Standard) | 119302-91-9 | Reference Standards |
| HY-17442 | Azathramycin | 76801-85-9 | Reference compound |
| HY-17442R | Azathramycin (Standard) | 76801-85-9 | Reference Standards |
| HY-17443 | Sivelestat | 127373-66-4 | Reference compound |
| HY-17443A | Sivelestat (sodium) | 150374-95-1 | Reference compound |
| HY-17443B | Sivelestat (sodium tetrahydrate) | 201677-61-4 | Reference compound |
| HY-17443BR | Sivelestat (sodium tetrahydrate) (Standard) | 201677-61-4 | Reference Standards |
| HY-17444 | Tesaglitazar | 251565-85-2 | Reference compound |
| HY-17445 | Muraglitazar | 331741-94-7 | Reference compound |
| HY-17446 | Icatibant | 130308-48-4 | Peptides |
| HY-17446R | Icatibant (Standard) | 130308-48-4 | Reference Standards |
| HY-17447 | Tranylcypromine | 155-09-9 | Reference compound |
| HY-17447A | Tranylcypromine (hydrochloride) | 1986-47-6 | Reference compound |
| HY-17447AG | Tranylcypromine (hydrochloride) (GMP) | 1986-47-6 | GMP Small Molecules |
| HY-17447AS | (1S,2R)-Tranylcypromine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17447B | (1S,2R)-Tranylcypromine (hydrochloride) | 4548-34-9 | Reference compound |
| HY-17447SA | Tranylcypromine-d5 (hydrochloride) | 107077-98-5 | Isotope-Labeled Compounds |
| HY-17448 | Varespladib methyl | 172733-08-3 | Reference compound |
| HY-17449 | Fosbretabulin (disodium) | 168555-66-6 | Natural Products |
| HY-17450 | Aplaviroc | 461443-59-4 | Reference compound |
| HY-17450A | Aplaviroc (hydrochloride) | 461023-63-2 | Reference compound |
| HY-17451 | Glibornuride | 26944-48-9 | Reference compound |
| HY-17451R | Glibornuride (Standard) | 26944-48-9 | Reference Standards |
| HY-17452 | Cefditoren (sodium) | 104146-53-4 | Reference compound |
| HY-17452A | Cefditoren Pivoxil | 117467-28-4 | Reference compound |
| HY-17452AR | Cefditoren Pivoxil (Standard) | 117467-28-4 | Reference Standards |
| HY-17452AS | Cefditoren Pivoxil-d3 | Isotope-Labeled Compounds | |
| HY-17452B | Cefditoren Pivoxil (hydrochloride) | 1448435-17-3 | Reference compound |
| HY-17453 | Salmeterol (xinafoate) | 94749-08-3 | Reference compound |
| HY-17453R | Salmeterol (xinafoate) (Standard) | 94749-08-3 | Reference Standards |
| HY-17453S | Salmeterol-d3 (xinafoate) | Isotope-Labeled Compounds | |
| HY-17453S1 | Salmeterol-13C6 (xinafoate) | Isotope-Labeled Compounds | |
| HY-17455 | Pramiracetam | 68497-62-1 | Reference compound |
| HY-17455R | Pramiracetam (Standard) | 68497-62-1 | Reference Standards |
| HY-17456 | Omberacetam | 157115-85-0 | Reference compound |
| HY-17456R | Omberacetam (Standard) | 157115-85-0 | Reference Standards |
| HY-17457 | Levalbuterol (tartrate) | 661464-94-4 | Reference compound |
| HY-17458 | Azilsartan (medoxomil monopotassium) | 863031-24-7 | Reference compound |
| HY-17459 | Clopidogrel (hydrogen sulfate) | 120202-66-6 | Reference compound |
| HY-17459R | Clopidogrel (hydrogen sulfate) (Standard) | 120202-66-6 | Reference Standards |
| HY-17459S | Clopidogrel-d3 (hydrogen sulfate) | 1217643-68-9 | Isotope-Labeled Compounds |
| HY-17460 | Garenoxacin | 194804-75-6 | Reference compound |
| HY-17460A | Garenoxacin (Mesylate hydrate) | 223652-90-2 | Reference compound |
| HY-17460AR | Garenoxacin (Mesylate hydrate) (Standard) | 223652-90-2 | Reference Standards |
| HY-17460B | Garenoxacin (mesylate) | 223652-82-2 | Reference compound |
| HY-17460R | Garenoxacin (Standard) | 194804-75-6 | Reference Standards |
| HY-17461 | Cortisone | 53-06-5 | Natural Products |
| HY-17461A | Cortisone acetate | 50-04-4 | Natural Products |
| HY-17461AR | Cortisone acetate (Standard) | 50-04-4 | Reference Standards |
| HY-17461R | Cortisone (Standard) | 53-06-5 | Reference Standards |
| HY-17461S | Cortisone-13C3 | 2350278-95-2 | Isotope-Labeled Compounds |
| HY-17461S1 | Cortisone-d8 | 1257650-98-8 | Isotope-Labeled Compounds |
| HY-17461S3 | Cortisone-d2 | 2687960-86-5 | Isotope-Labeled Compounds |
| HY-17462 | Adrenosterone | 382-45-6 | Natural Products |
| HY-17463 | Prednisolone | 50-24-8 | Natural Products |
| HY-17463R | Prednisolone (Standard) | 50-24-8 | Reference Standards |
| HY-17463S | Prednisolone-d8 | Isotope-Labeled Compounds | |
| HY-17464 | Cilostazol | 73963-72-1 | Reference compound |
| HY-17464R | Cilostazol (Standard) | 73963-72-1 | Reference Standards |
| HY-17464S | Cilostazol-d11 | 1073608-02-2 | Isotope-Labeled Compounds |
| HY-17464S1 | Cilostazol-d4 | 1215541-47-1 | Isotope-Labeled Compounds |
| HY-17464S2 | Cilostazol-d2 | 1073608-03-3 | Isotope-Labeled Compounds |
| HY-17464S3 | Cilostazol-d6 | 1246641-05-3 | Isotope-Labeled Compounds |
| HY-17465 | Glycopyrrolate | 596-51-0 | Reference compound |
| HY-17465R | Glycopyrrolate (Standard) | 596-51-0 | Reference Standards |
| HY-17465S | Glycopyrrolate-d5 (bromide) | Isotope-Labeled Compounds | |
| HY-17466 | Sancycline | 808-26-4 | Reference compound |
| HY-17466A | Sancycline (hydrochloride) | 6625-20-3 | Reference compound |
| HY-17466R | Sancycline (Standard) | 808-26-4 | Reference Standards |
| HY-17468 | Bumetanide | 28395-03-1 | Reference compound |
| HY-17468A | Bumetanide (sodium) | 28434-74-4 | Reference compound |
| HY-17468R | Bumetanide (Standard) | 28395-03-1 | Reference Standards |
| HY-17468S | Bumetanide-d5 | 1216739-35-3 | Isotope-Labeled Compounds |
| HY-17468S1 | Bumetanide-d5 Butyl Ester | 1216685-32-3 | Isotope-Labeled Compounds |
| HY-17469 | Gimeracil | 103766-25-2 | Reference compound |
| HY-17469S | Gimeracil-13C3,15N | 1261394-32-4 | Isotope-Labeled Compounds |
| HY-17470 | Mizoribine | 50924-49-7 | Natural Products |
| HY-17470R | Mizoribine (Standard) | 50924-49-7 | Reference Standards |
| HY-17471A | Metformin (hydrochloride) | 1115-70-4 | Reference compound |
| HY-17471AR | Metformin (hydrochloride) (Standard) | 1115-70-4 | Reference Standards |
| HY-17473 | Embelin | 550-24-3 | Natural Products |
| HY-17473R | Embelin (Standard) | 550-24-3 | Reference Standards |
| HY-17474 | Parecoxib | 198470-84-7 | Reference compound |
| HY-17474A | Parecoxib (Sodium) | 198470-85-8 | Reference compound |
| HY-17474AR | Parecoxib (Sodium) (Standard) | 198470-85-8 | Reference Standards |
| HY-17474AS | Parecoxib-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-17474R | Parecoxib (Standard) | 198470-84-7 | Reference Standards |
| HY-17474S | Parecoxib-d3 | Isotope-Labeled Compounds | |
| HY-17474S1 | Parecoxib-d5 | Isotope-Labeled Compounds | |
| HY-17475 | Nifenazone | 2139-47-1 | Reference compound |
| HY-17476 | Carbasalate calcium | 5749-67-7 | Reference compound |
| HY-17476R | Carbasalate calcium (Standard) | 5749-67-7 | Reference Standards |
| HY-17477 | Guacetisal | 55482-89-8 | Reference compound |
| HY-17477R | Guacetisal (Standard) | 55482-89-8 | Reference Standards |
| HY-17478A | Magnesium salicylate | 18917-89-0 | Reference compound |
| HY-17479 | Amfenac | 51579-82-9 | Reference compound |
| HY-17479A | Amfenac (Sodium Hydrate) | 61618-27-7 | Reference compound |
| HY-17479AR | Amfenac (Sodium Hydrate) (Standard) | 61618-27-7 | Reference Standards |
| HY-17479B | Amfenac (sodium) | 61941-56-8 | Reference compound |
| HY-17479BS | Amfenac-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-17479S | Amfenac-d5 | 2749329-56-2 | Isotope-Labeled Compounds |
| HY-17480 | Bendazac | 20187-55-7 | Reference compound |
| HY-17481 | Bumadizone | 3583-64-0 | Reference compound |
| HY-17481A | Bumadizone (calcium) | 34461-73-9 | Reference compound |
| HY-17482 | Difenpiramide | 51484-40-3 | Reference compound |
| HY-17483 | Oxametacin | 27035-30-9 | Reference compound |
| HY-17484 | Ampiroxicam | 99464-64-9 | Reference compound |
| HY-17484R | Ampiroxicam (Standard) | 99464-64-9 | Reference Standards |
| HY-17485 | Alminoprofen | 39718-89-3 | Reference compound |
| HY-17485R | Alminoprofen (Standard) | 39718-89-3 | Reference Standards |
| HY-17486 | Ibuproxam | 53648-05-8 | Reference compound |
| HY-17487 | Miroprofen | 55843-86-2 | Reference compound |
| HY-17488 | Morniflumate | 65847-85-0 | Reference compound |
| HY-17490 | Oxaceprol | 33996-33-7 | Natural Products |
| HY-17490R | Oxaceprol (Standard) | 33996-33-7 | Reference Standards |
| HY-17490S | Oxaceprol-d3 | Isotope-Labeled Compounds | |
| HY-17491 | Proquazone | 22760-18-5 | Reference compound |
| HY-17492 | Zafirlukast | 107753-78-6 | Reference compound |
| HY-17492R | Zafirlukast (Standard) | 107753-78-6 | Reference Standards |
| HY-17492S | Zafirlukast-d7 | 1217174-18-9 | Isotope-Labeled Compounds |
| HY-17492S1 | Zafirlukast-13C,d3 | Isotope-Labeled Compounds | |
| HY-17492S2 | Zafirlukast-13C,d6 | Isotope-Labeled Compounds | |
| HY-17492S3 | Zafirlukast-d6 | 1109278-84-3 | Isotope-Labeled Compounds |
| HY-17493 | MI-773 | 1303607-07-9 | Reference compound |
| HY-17494 | Timolol | 26839-75-8 | Reference compound |
| HY-17494A | Timolol (hemihydrate) | 91524-16-2 | Reference compound |
| HY-17494B | Timolol (hemimaleate) | 33305-95-2 | Reference compound |
| HY-17494R | Timolol (Standard) | 26839-75-8 | Reference Standards |
| HY-17494S | (Rac)-Timolol-d5 (maleate) | 1217260-21-3 | Isotope-Labeled Compounds |
| HY-17494S1 | Timolol-d9 (maleate) | Isotope-Labeled Compounds | |
| HY-17495 | Carteolol | 51781-06-7 | Reference compound |
| HY-17495A | Carteolol hydrochloride | 51781-21-6 | Reference compound |
| HY-17495AR | Carteolol hydrochloride (Standard) | 51781-21-6 | Reference Standards |
| HY-17495AS | Carteolol-d9 (hydrochloride) | 1346602-13-8 | Isotope-Labeled Compounds |
| HY-17496S | (R)-Timolol-d9 (maleate) | Isotope-Labeled Compounds | |
| HY-17497 | Acebutolol | 37517-30-9 | Reference compound |
| HY-17497A | Acebutolol (hydrochloride) | 34381-68-5 | Reference compound |
| HY-17497AR | Acebutolol (hydrochloride) (Standard) | 34381-68-5 | Reference Standards |
| HY-17497S | Acebutolol-d7 | 2701782-36-5 | Isotope-Labeled Compounds |
| HY-17497S1 | Acebutolol-d5 | 1189500-68-2 | Isotope-Labeled Compounds |
| HY-17498 | Atenolol | 29122-68-7 | Reference compound |
| HY-17498A | (S)-Atenolol | 93379-54-5 | Natural Products |
| HY-17498B | Atenolol (hydrochloride) | 51706-40-2 | Reference compound |
| HY-17498R | Atenolol (Standard) | 29122-68-7 | Reference Standards |
| HY-17498S | Atenolol-d7 | 1202864-50-3 | Isotope-Labeled Compounds |
| HY-17498S1 | Atenolol-d6 | 81346-72-7 | Isotope-Labeled Compounds |
| HY-17498S3 | Atenolol-13C6 | Isotope-Labeled Compounds | |
| HY-17499 | EGFR-IN-12 | 879127-07-8 | Reference compound |
| HY-17500 | Ataciguat | 254877-67-3 | Reference compound |
| HY-17501 | Bambuterol | 81732-65-2 | Reference compound |
| HY-17501A | Bambuterol hydrochloride | 81732-46-9 | Reference compound |
| HY-17501AR | Bambuterol hydrochloride (Standard) | 81732-46-9 | Reference Standards |
| HY-17501S | Bambuterol-d9 (hydrochloride) | 1794810-59-5 | Isotope-Labeled Compounds |
| HY-17502 | Simvastatin | 79902-63-9 | Reference compound |
| HY-17502R | Simvastatin (Standard) | 79902-63-9 | Reference Standards |
| HY-17502S | Simvastatin-d11 | 1002347-74-1 | Isotope-Labeled Compounds |
| HY-17502S1 | Simvastatin-d3 | 1002347-61-6 | Isotope-Labeled Compounds |
| HY-17503 | Metoprolol | 51384-51-1 | Reference compound |
| HY-17503A | Metoprolol (succinate) | 98418-47-4 | Reference compound |
| HY-17503AR | Metoprolol (succinate) (Standard) | 98418-47-4 | Reference Standards |
| HY-17503AS | Metoprolol-d7 (hydrochloride) | 1219798-61-4 | Isotope-Labeled Compounds |
| HY-17503AS1 | Metoprolol-d6 (succinate) | Isotope-Labeled Compounds | |
| HY-17503B | Metoprolol (tartrate) | 56392-17-7 | Reference compound |
| HY-17503BR | Metoprolol (tartrate) (Standard) | 56392-17-7 | Reference Standards |
| HY-17503BS | Metoprolol-d6 (tartrate) | Isotope-Labeled Compounds | |
| HY-17503C | Metoprolol (fumarate) | 80274-67-5 | Reference compound |
| HY-17503D | Metoprolol (Hydrochloride) | 56392-18-8 | Reference compound |
| HY-17503R | Metoprolol (Standard) | 51384-51-1 | Reference Standards |
| HY-17503S | Metoprolol-d7 | 959787-96-3 | Isotope-Labeled Compounds |
| HY-17503S1 | (R)-Metoprolol-d7 | 1292907-84-6 | Isotope-Labeled Compounds |
| HY-17503S2 | (S)-Metoprolol-d7 | 1292906-91-2 | Isotope-Labeled Compounds |
| HY-17503S3 | Metoprolol-d5 | 959786-79-9 | Isotope-Labeled Compounds |
| HY-17504 | Rosuvastatin (Calcium) | 147098-20-2 | Reference compound |
| HY-17504A | Rosuvastatin | 287714-41-4 | Reference compound |
| HY-17504AS | Rosuvastatin-d3 | 1133429-16-9 | Isotope-Labeled Compounds |
| HY-17504AS1 | Rosuvastatin-d6 | 2070009-40-2 | Isotope-Labeled Compounds |
| HY-17504B | Rosuvastatin (Sodium) | 147098-18-8 | Reference compound |
| HY-17504BS | Rosuvastatin-d3 (sodium) | 1279031-70-7 | Isotope-Labeled Compounds |
| HY-17504BS1 | Rosuvastatin-d6 (sodium) | 2070009-41-3 | Isotope-Labeled Compounds |
| HY-17504BS2 | Rosuvastatin-13C,d3 (sodium) | Isotope-Labeled Compounds | |
| HY-17504C | (3R,5R)-Rosuvastatin | 1094100-06-7 | Reference compound |
| HY-17504D | (3S,5R)-Rosuvastatin | 1242184-42-4 | Reference compound |
| HY-17504R | Rosuvastatin (Calcium) (Standard) | 147098-20-2 | Reference Standards |
| HY-17504S | Rosuvastatin-d6 (calcium) | Isotope-Labeled Compounds | |
| HY-17505 | Candesartan Cilexetil | 145040-37-5 | Reference compound |
| HY-17505R | Candesartan Cilexetil (Standard) | 145040-37-5 | Reference Standards |
| HY-17506 | Azithromycin | 83905-01-5 | Reference compound |
| HY-17506A | Azithromycin (hydrate) | 117772-70-0 | Reference compound |
| HY-17506AR | Azithromycin (hydrate) (Standard) | 117772-70-0 | Reference Standards |
| HY-17506R | Azithromycin (Standard) | 83905-01-5 | Reference Standards |
| HY-17506S | Azithromycin-d3 | 163921-65-1 | Isotope-Labeled Compounds |
| HY-17506S1 | Azithromycin-13C,d3 | Isotope-Labeled Compounds | |
| HY-17507 | Pantoprazole | 102625-70-7 | Reference compound |
| HY-17507A | Pantoprazole (sodium) | 138786-67-1 | Reference compound |
| HY-17507AR | Pantoprazole (sodium) (Standard) | 138786-67-1 | Reference Standards |
| HY-17507B | Pantoprazole (sodium hydrate) | 164579-32-2 | Reference compound |
| HY-17507BR | Pantoprazole (sodium hydrate) (Standard) | 164579-32-2 | Reference Standards |
| HY-17507CS | (R)-(+)-Pantoprazole-d6 | Isotope-Labeled Compounds | |
| HY-17507E | S-Pantoprazole (sodium trihydrate) | 1416988-58-3 | Reference compound |
| HY-17507R | Pantoprazole (Standard) | 102625-70-7 | Reference Standards |
| HY-17507S | Pantoprazole-d6 | 922727-65-9 | Isotope-Labeled Compounds |
| HY-17507S1 | Pantoprazole-d3 | 922727-37-5 | Isotope-Labeled Compounds |
| HY-17507S2 | Pantoprazole-d8 | 934294-34-5 | Isotope-Labeled Compounds |
| HY-17507S4 | Pantoprazole-d4 | 934294-71-0 | Isotope-Labeled Compounds |
| HY-17508 | Clarithromycin | 81103-11-9 | Reference compound |
| HY-17508R | Clarithromycin (Standard) | 81103-11-9 | Reference Standards |
| HY-17508S | Clarithromycin-13C,d3 | Isotope-Labeled Compounds | |
| HY-17508S1 | Clarithromycin-d3 | 959119-22-3 | Isotope-Labeled Compounds |
| HY-17509 | Deracoxib | 169590-41-4 | Reference compound |
| HY-17509R | Deracoxib (Standard) | 169590-41-4 | Reference Standards |
| HY-17509S | Deracoxib-d3 | 2012598-48-8 | Isotope-Labeled Compounds |
| HY-17510 | Gossypol (acetic acid) | 12542-36-8 | Natural Products |
| HY-17510R | Gossypol (acetic acid) (Standard) | 12542-36-8 | Reference Standards |
| HY-17511 | Potassium oxonate | 2207-75-2 | Reference compound |
| HY-17512 | Losartan | 114798-26-4 | Reference compound |
| HY-17512A | Losartan (potassium) | 124750-99-8 | Reference compound |
| HY-17512AR | Losartan (potassium) (Standard) | 124750-99-8 | Reference Standards |
| HY-17512AS | Losartan-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17512R | Losartan (Standard) | 114798-26-4 | Reference Standards |
| HY-17512S | Losartan-d4 | 1030937-27-9 | Isotope-Labeled Compounds |
| HY-17512S1 | Losartan-d3 Carboxylic Acid | 1189729-40-5 | Isotope-Labeled Compounds |
| HY-17512S3 | Losartan-d2 | 1030936-22-1 | Isotope-Labeled Compounds |
| HY-17512S4 | Losartan-d9 | 1030937-18-8 | Isotope-Labeled Compounds |
| HY-17513 | Amicarbazone | 129909-90-6 | Reference compound |
| HY-17513R | Amicarbazone (Standard) | 129909-90-6 | Reference Standards |
| HY-17514 | Itraconazole | 84625-61-6 | Reference compound |
| HY-17514R | Itraconazole (Standard) | 84625-61-6 | Reference Standards |
| HY-17514S | Itraconazole-d5 | 1217510-38-7 | Isotope-Labeled Compounds |
| HY-17514S1 | Itraconazole-d3 | 1217512-35-0 | Isotope-Labeled Compounds |
| HY-17514S2 | Itraconazole-d9 | 1309272-50-1 | Isotope-Labeled Compounds |
| HY-17515 | Ipfencarbazone | 212201-70-2 | Reference compound |
| HY-17515R | Ipfencarbazone (Standard) | 212201-70-2 | Reference Standards |
| HY-17516 | Tolfenpyrad | 129558-76-5 | Reference compound |
| HY-17516R | Tolfenpyrad (Standard) | 129558-76-5 | Reference Standards |
| HY-17517 | Tiadinil | 223580-51-6 | Reference compound |
| HY-17518 | Valifenalate | 283159-90-0 | Reference compound |
| HY-17518A | (S,S)-Valifenalate | 283159-94-4 | Reference compound |
| HY-17518R | Valifenalate (Standard) | 283159-90-0 | Reference Standards |
| HY-17519 | Novaluron | 116714-46-6 | Reference compound |
| HY-17519R | Novaluron (Standard) | 116714-46-6 | Reference Standards |
| HY-17520 | Penthiopyrad | 183675-82-3 | Reference compound |
| HY-17520R | Penthiopyrad (Standard) | 183675-82-3 | Reference Standards |
| HY-17521 | Flumorph | 211867-47-9 | Reference compound |
| HY-17521R | Flumorph (Standard) | 211867-47-9 | Reference Standards |
| HY-17522 | Meptyldinocap | 131-72-6 | Reference compound |
| HY-17522R | Meptyldinocap (Standard) | 131-72-6 | Reference Standards |
| HY-17523 | Athidathion | 19691-80-6 | Reference compound |
| HY-17524 | Benoxafos | 16759-59-4 | Reference compound |
| HY-17525 | Bethoxazin | 163269-30-5 | Reference compound |
| HY-17527 | Cloxyfonac | 6386-63-6 | Reference compound |
| HY-17527R | Cloxyfonac (Standard) | 6386-63-6 | Reference Standards |
| HY-17528 | Cyhalofop | 122008-78-0 | Reference compound |
| HY-17528R | Cyhalofop (Standard) | 122008-78-0 | Reference Standards |
| HY-17530 | Aldicarb (sulfone) | 1646-88-4 | Reference compound |
| HY-17530R | Aldicarb (sulfone) (Standard) | 1646-88-4 | Reference Standards |
| HY-17530S | Aldicarb sulfone-13C2,d3 | 1261170-76-6 | Isotope-Labeled Compounds |
| HY-17531 | Pyraclonil | 158353-15-2 | Reference compound |
| HY-17531R | Pyraclonil (Standard) | 158353-15-2 | Reference Standards |
| HY-17532 | Haloxon | 321-55-1 | Reference compound |
| HY-17533 | Chromafenozide | 143807-66-3 | Reference compound |
| HY-17534 | Furilazole | 121776-33-8 | Reference compound |
| HY-17534R | Furilazole (Standard) | 121776-33-8 | Reference Standards |
| HY-17535 | Methasulfocarb | 66952-49-6 | Reference compound |
| HY-17536 | Selinexor | 1393477-72-9 | Reference compound |
| HY-17536A | (E)-Selinexor | 1421923-86-5 | Reference compound |
| HY-17536R | Selinexor (Standard) | 1393477-72-9 | Reference Standards |
| HY-17537 | APY29 | 1216665-49-4 | Reference compound |
| HY-17538 | ZLN005 | 49671-76-3 | Reference compound |
| HY-17538AS | ZLN005-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-17538S | ZLN005-d4 | 2410443-42-2 | Isotope-Labeled Compounds |
| HY-17539 | KPT-276 | 1421919-75-6 | Reference compound |
| HY-17540 | HBX 19818 | 1426944-49-1 | Reference compound |
| HY-17541 | Cysteine Protease inhibitor | 921625-62-9 | Reference compound |
| HY-17541A | Cysteine Protease inhibitor (hydrochloride) | 2197053-49-7 | Reference compound |
| HY-17542 | PLpro inhibitor | 1093070-14-4 | Reference compound |
| HY-17543 | ML-323 | 1572414-83-5 | Reference compound |
| HY-17545 | LGK974 | 1243244-14-5 | Reference compound |
| HY-17547 | NMS-E973 | 1253584-84-7 | Reference compound |
| HY-17548 | VMY-1-103 | 1209002-43-6 | Reference compound |
| HY-17549 | Adrafinil | 63547-13-7 | Reference compound |
| HY-17550 | Sunifiram | 314728-85-3 | Reference compound |
| HY-17550R | Sunifiram (Standard) | 314728-85-3 | Reference Standards |
| HY-17551 | NMDA | 6384-92-5 | Natural Products |
| HY-17552 | sn-Glycero-3-phosphocholine | 28319-77-9 | Natural Products |
| HY-17552R | sn-Glycero-3-phosphocholine (Standard) | 28319-77-9 | Reference Standards |
| HY-17552S | sn-Glycero-3-phosphocholine-d9 | 2260669-07-4 | Isotope-Labeled Compounds |
| HY-17553 | Coluracetam | 135463-81-9 | Reference compound |
| HY-17553R | Coluracetam (Standard) | 135463-81-9 | Reference Standards |
| HY-17554 | (R)-Oxiracetam | 68252-28-8 | Reference compound |
| HY-17555 | Meclofenoxate (hydrochloride) | 3685-84-5 | Reference compound |
| HY-17555A | Meclofenoxate | 51-68-3 | Reference compound |
| HY-17555R | Meclofenoxate (hydrochloride) (Standard) | 3685-84-5 | Reference Standards |
| HY-17556 | Folinic acid | 58-05-9 | Natural Products |
| HY-17556A | Folinic acid (disodium) | 163254-40-8 | Reference compound |
| HY-17556B | Folinic acid (calcium hydrate) | 1097832-14-8 | Reference compound |
| HY-17556R | Folinic acid (Standard) | 58-05-9 | Reference Standards |
| HY-17556S1 | Folinic acid-d4 (calcium hydrate) | Isotope-Labeled Compounds | |
| HY-17557 | Calcium N5-methyltetrahydrofolate | 26560-38-3 | Reference compound |
| HY-17557R | Calcium N5-methyltetrahydrofolate (Standard) | 26560-38-3 | Reference Standards |
| HY-17558 | Apramycin | 37321-09-8 | Reference compound |
| HY-17558R | Apramycin (Standard) | 37321-09-8 | Reference Standards |
| HY-17560 | Demeclocycline (hydrochloride) | 64-73-3 | Natural Products |
| HY-17560R | Demeclocycline (hydrochloride) (Standard) | 64-73-3 | Reference Standards |
| HY-17561 | G-418 (disulfate) | 108321-42-2 | Natural Products |
| HY-17561R | G-418 (disulfate) (Standard) | 108321-42-2 | Reference Standards |
| HY-17562 | 2-Amino-5-bromo-4-methylpyridine | 98198-48-2 | Biochemical Assay Reagents |
| HY-17563 | 2'-Deoxyguanosine | 961-07-9 | Natural Products |
| HY-17563R | 2'-Deoxyguanosine (Standard) | 961-07-9 | Reference Standards |
| HY-17563S1 | 2'-Deoxyguanosine-13C10,15N5 | 872624-05-0 | Isotope-Labeled Compounds |
| HY-17563S2 | 2'-Deoxyguanosine-13C10 | 1245539-86-9 | Isotope-Labeled Compounds |
| HY-17563S3 | 2'-Deoxyguanosine-d13 | Isotope-Labeled Compounds | |
| HY-17563S4 | 2'-Deoxyguanosine-15N5 | 686353-29-7 | Isotope-Labeled Compounds |
| HY-17564 | 2'-Deoxycytidine (hydrochloride) | 3992-42-5 | Oligonucleotides |
| HY-17564R | 2'-Deoxycytidine (hydrochloride) (Standard) | 3992-42-5 | Reference Standards |
| HY-17565 | Bleomycin (sulfate) | 9041-93-4 | Natural Products |
| HY-17565A | Bleomycin (hydrochloride) | 67763-87-5 | Reference compound |
| HY-17566 | Capreomycin (sulfate) | 1405-37-4 | Natural Products |
| HY-17567 | Heparin | 9005-49-6 | Natural Products |
| HY-17567A | Heparin (sodium salt) | 9041-08-1 | Reference compound |
| HY-17567B | Heparin (Lithium salt) | 9045-22-1 | Reference compound |
| HY-17567C | Heparin (sodium salt) (MW 15kDa) | 9041-08-1 | Reference compound |
| HY-17568 | Nonivamide | 2444-46-4 | Natural Products |
| HY-17568R | Nonivamide (Standard) | 2444-46-4 | Reference Standards |
| HY-17569 | Difluprednate | 23674-86-4 | Reference compound |
| HY-17569R | Difluprednate (Standard) | 23674-86-4 | Reference Standards |
| HY-17570 | Desoximetasone | 382-67-2 | Reference compound |
| HY-17570R | Desoximetasone (Standard) | 382-67-2 | Reference Standards |
| HY-17571 | Oxytocin | 50-56-6 | Peptides |
| HY-17571A | Oxytocin (acetate) | 6233-83-6 | Peptides |
| HY-17571F | Biotin-Oxytocin | Peptides | |
| HY-17572 | Atosiban | 90779-69-4 | Peptides |
| HY-17572A | Atosiban (acetate) | 914453-95-5 | Peptides |
| HY-17572AR | Atosiban (acetate) (Standard) | 914453-95-5 | Reference Standards |
| HY-17572R | Atosiban (Standard) | 90779-69-4 | Reference Standards |
| HY-17573 | Carbetocin | 37025-55-1 | Peptides |
| HY-17573A | Carbetocin (acetate) | 1631754-28-3 | Peptides |
| HY-17573R | Carbetocin (Standard) | 37025-55-1 | Reference Standards |
| HY-17574 | Thio-TEPA | 52-24-4 | Reference compound |
| HY-17574R | Thio-TEPA (Standard) | 52-24-4 | Reference Standards |
| HY-17576 | Satraplatin | 129580-63-8 | Reference compound |
| HY-17577 | Berberine (chloride hydrate) | 68030-18-2 | Natural Products |
| HY-17577R | Berberine (chloride hydrate) (Standard) | 68030-18-2 | Reference Standards |
| HY-17578 | Pneumocandin B0 | 135575-42-7 | Natural Products |
| HY-17579 | Micafungin | 235114-32-6 | Reference compound |
| HY-17580 | Fidaxomicin | 873857-62-6 | Natural Products |
| HY-17580R | Fidaxomicin (Standard) | 873857-62-6 | Reference Standards |
| HY-17580S | Fidaxomicin-d7 | 2143934-06-7 | Isotope-Labeled Compounds |
| HY-17581 | Buparvaquone | 88426-33-9 | Reference compound |
| HY-17581R | Buparvaquone (Standard) | 88426-33-9 | Reference Standards |
| HY-17582 | Decloxizine | 3733-63-9 | Reference compound |
| HY-17582R | Decloxizine (Standard) | 3733-63-9 | Reference Standards |
| HY-17583 | Griseofulvin | 126-07-8 | Natural Products |
| HY-17583R | Griseofulvin (Standard) | 126-07-8 | Reference Standards |
| HY-17583S | Griseofulvin-d3 | 1279033-22-5 | Isotope-Labeled Compounds |
| HY-17583S1 | Griseofulvin-13C,d3 | 1329612-29-4 | Isotope-Labeled Compounds |
| HY-17584 | Linaclotide | 851199-59-2 | Reference compound |
| HY-17584A | Linaclotide (acetate) | 851199-60-5 | Reference compound |
| HY-17584R | Linaclotide (Standard) | 851199-59-2 | Reference Standards |
| HY-17585 | Mepenzolate (bromide) | 76-90-4 | Reference compound |
| HY-17586 | Dalbavancin (hydrochloride) | 2227366-51-8 | Reference compound |
| HY-17586A | Dalbavancin | 171500-79-1 | Reference compound |
| HY-17586AS | Dalbavancin-d6 | 1126461-54-8 | Isotope-Labeled Compounds |
| HY-17587 | 4-Methylbenzylidene camphor | 36861-47-9 | Reference compound |
| HY-17587R | 4-Methylbenzylidene camphor (Standard) | 36861-47-9 | Reference Standards |
| HY-17587S | 4-Methylbenzylidene camphor-d4 | 1219806-41-3 | Isotope-Labeled Compounds |
| HY-17589 | Chloroquine (phosphate) | 50-63-5 | Reference compound |
| HY-17589A | Chloroquine | 54-05-7 | Reference compound |
| HY-17589AR | Chloroquine (Standard) | 54-05-7 | Reference Standards |
| HY-17589AS | Chloroquine-d5 | 1854126-41-2 | Isotope-Labeled Compounds |
| HY-17589B | Chloroquine (dihydrochloride) | 3545-67-3 | Reference compound |
| HY-17589BR | Chloroquine (dihydrochloride) (Standard) | 3545-67-3 | Reference Standards |
| HY-17589R | Chloroquine (phosphate) (Standard) | 50-63-5 | Reference Standards |
| HY-17589S | Chloroquine-d5 (diphosphate) | 1854126-42-3 | Isotope-Labeled Compounds |
| HY-17589S1 | Chloroquine-d4 (phosphate) | Isotope-Labeled Compounds | |
| HY-17590 | Radafaxine (hydrochloride) | 106083-71-0 | Reference compound |
| HY-17591 | Penicillin G (potassium) | 113-98-4 | Natural Products |
| HY-17591R | Penicillin G (potassium) (Standard) | 113-98-4 | Reference Standards |
| HY-17591S | Penicillin G-d5 (potassium) | Isotope-Labeled Compounds | |
| HY-17592 | Bithionol | 97-18-7 | Reference compound |
| HY-17592A | Bithionol (sulfoxide) | 844-26-8 | Reference compound |
| HY-17592R | Bithionol (Standard) | 97-18-7 | Reference Standards |
| HY-17593 | Solithromycin | 760981-83-7 | Reference compound |
| HY-17593R | Solithromycin (Standard) | 760981-83-7 | Reference Standards |
| HY-17594 | Oxyclozanide | 2277-92-1 | Reference compound |
| HY-17594R | Oxyclozanide (Standard) | 2277-92-1 | Reference Standards |
| HY-17595 | Mebendazole | 31431-39-7 | Reference compound |
| HY-17595R | Mebendazole (Standard) | 31431-39-7 | Reference Standards |
| HY-17595S | Mebendazole-d3 | 1173021-87-8 | Isotope-Labeled Compounds |
| HY-17595S1 | Mebendazole-d8 | 1286787-80-1 | Isotope-Labeled Compounds |
| HY-17596 | Closantel | 57808-65-8 | Reference compound |
| HY-17596A | Closantel (sodium) | 61438-64-0 | Reference compound |
| HY-17596AR | Closantel (sodium) (Standard) | 61438-64-0 | Reference Standards |
| HY-17596R | Closantel (Standard) | 57808-65-8 | Reference Standards |
| HY-17596S | Closantel-13C6 | 1325559-20-3 | Isotope-Labeled Compounds |
| HY-17597 | Febantel | 58306-30-2 | Reference compound |
| HY-17597R | Febantel (Standard) | 58306-30-2 | Reference Standards |
| HY-17598 | Rafoxanide | 22662-39-1 | Reference compound |
| HY-17598R | Rafoxanide (Standard) | 22662-39-1 | Reference Standards |
| HY-17598S | Rafoxanide-13C6 | 1353867-98-7 | Isotope-Labeled Compounds |
| HY-17599 | Piperazine (citrate) | 144-29-6 | Reference compound |
| HY-17600 | Acalabrutinib | 1420477-60-6 | Reference compound |
| HY-176000 | Sulphostin | Reference compound | |
| HY-176001 | DPP8/9-IN-1 | Reference compound | |
| HY-176007 | Fluprostenol methyl amide | Reference compound | |
| HY-176008 | Lauric acid leelamide | 2095306-47-9 | Reference compound |
| HY-176009 | 15-keto Cloprostenol isopropyl ester | Reference compound | |
| HY-17600R | Acalabrutinib (Standard) | 1420477-60-6 | Reference Standards |
| HY-17600S | Acalabrutinib-d4 | 2699608-18-7 | Isotope-Labeled Compounds |
| HY-17601 | Alofanib | 1612888-66-0 | Reference compound |
| HY-176010 | Dehydroepiandrosterone sulfate 17-(O-carboxymethyl)oxime (sodium) | Reference compound | |
| HY-176014 | 17-Phenyl trinor prostaglandin F2α glycinamide | Reference compound | |
| HY-176017 | 2,3-Dinor fluprostenol | Reference compound | |
| HY-176019 | Methylcarbamyl PAF C-8 | Reference compound | |
| HY-17602 | Amcasertib | 1129403-56-0 | Reference compound |
| HY-176020 | Cumyl-chsinaca | Reference compound | |
| HY-176024 | 2'-Deoxy-3'-O-isovaleryladenosine-5'-O-triphosphate (triethylammonium) | Reference compound | |
| HY-17603 | Belizatinib | 1357920-84-3 | Reference compound |
| HY-176036 | MS1262 | 3070323-06-4 | Reference compound |
| HY-176039 | TUG-2181 | 2653994-24-0 | Reference compound |
| HY-176040 | IXA62 | 956783-34-9 | Reference compound |
| HY-176041 | Troponin modulator 1 | 1448792-38-8 | Reference compound |
| HY-176043 | PCSK9 autophagic degrader 2 | 2974497-11-3 | Reference compound |
| HY-176044 | PCSK9 ligand 2 | 3039841-82-9 | Reference compound |
| HY-176045 | LC3B ligand 2 | Reference compound | |
| HY-176046 | E3 Ligase Ligand-linker Conjugate 183 | 3081572-35-9 | Reference compound |
| HY-17605 | Bictegravir | 1611493-60-7 | Reference compound |
| HY-176057 | S118 | 2677041-36-8 | Reference compound |
| HY-176058 | HDAC6-IN-57 | Reference compound | |
| HY-176059 | HBV-IN-52 | Reference compound | |
| HY-17605A | Bictegravir (sodium) | 1807988-02-8 | Reference compound |
| HY-17605AR | Bictegravir (sodium) (Standard) | 1807988-02-8 | Reference Standards |
| HY-17605R | Bictegravir (Standard) | 1611493-60-7 | Reference Standards |
| HY-17605S | Bictegravir-15N,d2 | Isotope-Labeled Compounds | |
| HY-17605S1 | Bictegravir-d5 | Isotope-Labeled Compounds | |
| HY-17605S2 | Bictegravir-d4 | Isotope-Labeled Compounds | |
| HY-17605S4 | Bictegravir-d7 | 2171092-56-9 | Isotope-Labeled Compounds |
| HY-17606 | Cenerimod | 1262414-04-9 | Reference compound |
| HY-176060 | Platelet aggregation-IN-3 | 1029802-21-8 | Reference compound |
| HY-176062 | PPARγ modulator-3 | Reference compound | |
| HY-176067 | LO-4-25 | Reference compound | |
| HY-176068 | 3-Cl-Pyridine-amide-acrylaldehyde-piperazine | Reference compound | |
| HY-176070 | HRG038 | Reference compound | |
| HY-17608 | Daprodustat | 960539-70-2 | Reference compound |
| HY-17608R | Daprodustat (Standard) | 960539-70-2 | Reference Standards |
| HY-17609 | Difelikefalin | 1024828-77-0 | Peptides |
| HY-17609C | Difelikefalin (acetate) | 2803411-76-7 | Peptides |
| HY-17609S | Difelikefalin-d5 | Isotope-Labeled Compounds | |
| HY-17610 | Enerisant | 1152747-82-4 | Reference compound |
| HY-17610A | Enerisant (hydrochloride) | 1152749-07-9 | Reference compound |
| HY-17611 | Etripamil | 1593673-23-4 | Reference compound |
| HY-17611A1 | Etripamil (hydrochloride) | 2560549-35-9 | Reference compound |
| HY-17612 | Evenamide | 1092977-61-1 | Reference compound |
| HY-17612A | Evenamide (hydrochloride) | 1092977-06-4 | Reference compound |
| HY-17613 | Evocalcet | 870964-67-3 | Reference compound |
| HY-17613R | Evocalcet (Standard) | 870964-67-3 | Reference Standards |
| HY-17613S | Evocalcet-d4 | Isotope-Labeled Compounds | |
| HY-17614 | Ezutromid | 945531-77-1 | Reference compound |
| HY-17615 | Fosnetupitant | 1703748-89-3 | Reference compound |
| HY-17616 | Ingenol disoxate | 1383547-60-1 | Reference compound |
| HY-17617 | Nastorazepide | 209219-38-5 | Reference compound |
| HY-17618 | Pemafibrate | 848259-27-8 | Reference compound |
| HY-17618A | Rac-Pemafibrate | 848258-31-1 | Reference compound |
| HY-17618R | Pemafibrate (Standard) | 848259-27-8 | Reference Standards |
| HY-17618S | Pemafibrate-d4 | 2924193-31-5 | Isotope-Labeled Compounds |
| HY-17620 | Sacubitrilat | 149709-44-4 | Reference compound |
| HY-17620R | Sacubitrilat (Standard) | 149709-44-4 | Reference Standards |
| HY-17620S | Sacubitrilat-d4 | Isotope-Labeled Compounds | |
| HY-17621 | Sparsentan | 254740-64-2 | Reference compound |
| HY-17621S | Sparsentan-d5 | 1801597-09-0 | Isotope-Labeled Compounds |
| HY-17622 | Tavilermide | 263251-78-1 | Reference compound |
| HY-17623 | Tegoprazan | 942195-55-3 | Reference compound |
| HY-17623C | (R)-Tegoprazan | 942195-56-4 | Reference compound |
| HY-17623D | Tegoprazan (Benzoate) | Reference compound | |
| HY-17623R | Tegoprazan (Standard) | 942195-55-3 | Reference Standards |
| HY-17623S | Tegoprazan-d6 | Isotope-Labeled Compounds | |
| HY-17624 | Framycetin | 119-04-0 | Reference compound |
| HY-17624A | Framycetin (sulfate) | 4146-30-9 | Reference compound |
| HY-17624AR | Framycetin (sulfate) (Standard) | 4146-30-9 | Reference Standards |
| HY-17625 | Acebilustat | 943764-99-6 | Reference compound |
| HY-17626B | Alalevonadifloxacin (hydrochloride) | 396132-82-4 | Reference compound |
| HY-17626C | (R)-Alalevonadifloxacin (mesylate) | 2892364-59-7 | Reference compound |
| HY-17627 | Avacopan | 1346623-17-3 | Reference compound |
| HY-17627R | Avacopan (Standard) | 1346623-17-3 | Reference Standards |
| HY-17628 | Cefiderocol | 1225208-94-5 | Reference compound |
| HY-17628S1 | Cefiderocol-d6 | Isotope-Labeled Compounds | |
| HY-17629 | Dapansutrile | 54863-37-5 | Reference compound |
| HY-17630 | Edasalonexent | 1204317-86-1 | Reference compound |
| HY-17631A | Edonerpic (maleate) | 519187-97-4 | Reference compound |
| HY-17632 | Tarloxotinib (bromide) | 1636180-98-7 | Reference compound |
| HY-17633 | Fonadelpar | 515138-06-4 | Reference compound |
| HY-17634 | Glecaprevir | 1365970-03-1 | Reference compound |
| HY-17635 | Leniolisib | 1354690-24-6 | Reference compound |
| HY-17635A | Leniolisib (phosphate) | 1354691-97-6 | Reference compound |
| HY-17635S | Leniolisib-d5 | Isotope-Labeled Compounds | |
| HY-17637 | Lumateperone | 313368-91-1 | Reference compound |
| HY-17637S2 | Lumateperone-d4 | 2102683-55-4 | Isotope-Labeled Compounds |
| HY-17638 | Mizagliflozin | 666843-10-3 | Reference compound |
| HY-17638A | Mizagliflozin (sebacate) | 1169392-27-1 | Reference compound |
| HY-17639 | Navamepent | 1251537-11-7 | Reference compound |
| HY-17640 | Nicodicosapent | 1269181-69-2 | Reference compound |
| HY-17641 | Olumacostat glasaretil | 1261491-89-7 | Reference compound |
| HY-17642 | Omidenepag | 1187451-41-7 | Reference compound |
| HY-17643 | Oteseconazole | 1340593-59-0 | Reference compound |
| HY-17643R | Oteseconazole (Standard) | 1340593-59-0 | Reference Standards |
| HY-17644 | Redaporfin | 1224104-08-8 | Reference compound |
| HY-17645 | Tenalisib | 1639417-53-0 | Reference compound |
| HY-17646 | Verdiperstat | 890655-80-8 | Reference compound |
| HY-17647 | Zoliflodacin | 1620458-09-4 | Reference compound |
| HY-17647R | Zoliflodacin (Standard) | 1620458-09-4 | Reference Standards |
| HY-18002 | Oleanolic acid derivative 1 | 1724-18-1 | Reference compound |
| HY-18003 | Oleanolic acid derivative 2 | 211516-63-1 | Reference compound |
| HY-18005 | 4-Aza-Oleanolic acid methyl ester | 557766-15-1 | Reference compound |
| HY-18006 | NKP608 | 177707-12-9 | Reference compound |
| HY-18007 | ALW-II-41-27 | 1186206-79-0 | Reference compound |
| HY-18008 | PS-1145 | 431898-65-6 | Reference compound |
| HY-18009 | (Z)-LFM-A13 | 244240-24-2 | Reference compound |
| HY-18010 | PCI 29732 | 330786-25-9 | Reference compound |
| HY-18012 | Spebrutinib | 1202757-89-8 | Reference compound |
| HY-18012A | Spebrutinib (besylate) | 1360053-81-1 | Reference compound |
| HY-18013 | JNJ-40355003 | 1394894-41-7 | Reference compound |
| HY-18016 | CGI 560 | 845269-74-1 | Reference compound |
| HY-18018 | RN486 | 1242156-23-5 | Reference compound |
| HY-18030 | CEP-28122 | 1022958-60-6 | Reference compound |
| HY-18030A | CEP-28122 (mesylate salt) | 2070009-30-0 | Reference compound |
| HY-18030B | CEP-28122 (mesylate hydrochloride) | 1354545-57-5 | Reference compound |
| HY-18037 | AMG-7980 | 947192-73-6 | Reference compound |
| HY-18039 | WAY-361789 | 1040718-40-8 | Reference compound |
| HY-18052 | AM-8553 | 1352064-70-0 | Reference compound |
| HY-18053 | AZD 4017 | 1024033-43-9 | Reference compound |
| HY-18054 | BVT 2733 | 376640-41-4 | Reference compound |
| HY-18054A | BVT-2733 (hydrochloride) | 376641-65-5 | Reference compound |
| HY-18055 | BVT-14225 | 376638-65-2 | Reference compound |
| HY-18056 | PF-915275 | 857290-04-1 | Reference compound |
| HY-18057 | BVT-3498 | 376641-49-5 | Reference compound |
| HY-18060 | Bradanicline | 639489-84-2 | Reference compound |
| HY-18060A | Bradanicline (hydrochloride) | 1111941-90-2 | Reference compound |
| HY-18061 | Ochromycinone | 111540-00-2 | Natural Products |
| HY-18061R | Ochromycinone (Standard) | 111540-00-2 | Reference Standards |
| HY-18062 | Pyrimethamine | 58-14-0 | Reference compound |
| HY-18062R | Pyrimethamine (Standard) | 58-14-0 | Reference Standards |
| HY-18062S | Pyrimethamine-d3 | 1189936-99-9 | Isotope-Labeled Compounds |
| HY-18063 | ML252 | 1392494-64-2 | Reference compound |
| HY-18063A | ML252 (hydrochloride) | 2309887-61-2 | Reference compound |
| HY-18071 | BI-9627 | 1204329-34-9 | Reference compound |
| HY-18071A | BI-9627 (hydrochloride) | 1422252-46-7 | Reference compound |
| HY-18072 | GSK2606414 | 1337531-36-8 | Reference compound |
| HY-18075 | LPA2 antagonist 1 | 1017606-66-4 | Reference compound |
| HY-18076 | LPA1 receptor antagonist 1 | 1396006-71-5 | Reference compound |
| HY-18078 | PQ-10 | 927691-21-2 | Reference compound |
| HY-18079 | BILB 1941 | 494856-61-0 | Reference compound |
| HY-18080 | SA 47 | 792236-07-8 | Reference compound |
| HY-18081 | PF 750 | 959151-50-9 | Reference compound |
| HY-18082 | AGI-5198 | 1355326-35-0 | Reference compound |
| HY-18085 | Quercetin | 117-39-5 | Natural Products |
| HY-18085A | Quercetin (hydrate) | 849061-97-8 | Natural Products |
| HY-18085AS | Quercetin-d3 (hydrate) | Isotope-Labeled Compounds | |
| HY-18085G | Quercetin (GMP) | 117-39-5 | GMP Small Molecules |
| HY-18085R | Quercetin (Standard) | 117-39-5 | Reference Standards |
| HY-18085S | Quercetin-d5 | 263711-78-0 | Isotope-Labeled Compounds |
| HY-18085S1 | Quercetin-d3 | 263711-79-1 | Isotope-Labeled Compounds |
| HY-18085S2 | Quercetin-13C3 | Isotope-Labeled Compounds | |
| HY-18086 | TCS PIM-1 1 | 491871-58-0 | Reference compound |
| HY-18095 | CX-6258 | 1202916-90-2 | Reference compound |
| HY-18095A | CX-6258 (hydrochloride hydrate) | 1353858-99-7 | Reference compound |
| HY-18095B | CX-6258 (hydrochloride) | 1353859-00-3 | Reference compound |
| HY-18099 | S1RA | 878141-96-9 | Reference compound |
| HY-18099A | S1RA (hydrochloride) | 1265917-14-3 | Reference compound |
| HY-18100 | PRE-084 | 138847-85-5 | Reference compound |
| HY-18100A | PRE-084 (hydrochloride) | 75136-54-8 | Reference compound |
| HY-18100AR | PRE-084 (hydrochloride) (Standard) | 75136-54-8 | Reference Standards |
| HY-18101A | BD1063 (dhydrochloride) | 206996-13-6 | Reference compound |
| HY-18102 | GLPG0492 | 1215085-92-9 | Reference compound |
| HY-18102A | GLPG0492 (R enantiomer) | 1215085-93-0 | Reference compound |
| HY-18102BS | GLPG0492-13C,d3 (racemate) | Isotope-Labeled Compounds | |
| HY-18106 | BM 957 | 1391107-54-2 | Reference compound |
| HY-18112 | AZ-4217 | 1383846-83-0 | Reference compound |
| HY-18137 | PF-04995274 | 1331782-27-4 | Reference compound |
| HY-18138 | PF-03382792 | 1400811-63-3 | Reference compound |
| HY-18157 | SCH 900229 | 1100361-36-1 | Reference compound |
| HY-18161 | CCT241736 | 1402709-93-6 | Reference compound |
| HY-18162 | JNJ-42153605 | 1254977-87-1 | Reference compound |
| HY-18163 | GNE-7915 | 1351761-44-8 | Reference compound |
| HY-18163A | GNE-7915 (tosylate) | 2070015-00-6 | Reference compound |
| HY-18164 | TASP0277308 | 945725-50-8 | Reference compound |
| HY-18166 | NIBR0213 | 1233332-14-3 | Reference compound |
| HY-18169 | MUT056399 | 1269055-85-7 | Reference compound |
| HY-18172 | KCC2 blocker 1 | 1228439-36-8 | Reference compound |
| HY-18172A | (+)-KCC2 blocker 1 | 1228439-71-1 | Reference compound |
| HY-18172B | (-)-KCC2 blocker 1 | 1228439-73-3 | Reference compound |
| HY-18173 | AZD8329 | 1048668-70-7 | Reference compound |
| HY-18174 | Prexasertib | 1234015-52-1 | Reference compound |
| HY-18174A | Prexasertib (dihydrochloride) | 1234015-54-3 | Reference compound |
| HY-18174B | Prexasertib (Mesylate Hydrate) | 1234015-57-6 | Reference compound |
| HY-18174C | Prexasertib (mesylate) | 1234015-55-4 | Reference compound |
| HY-18174E | Prexasertib (dimesylate) | 1234015-58-7 | Reference compound |
| HY-18174H | Prexasertib (lactate) | 2781996-46-9 | Reference compound |
| HY-18175 | CCT244747 | 1404095-34-6 | Reference compound |
| HY-18179 | AZD2932 | 883986-34-3 | Reference compound |
| HY-18185 | JNJ 17029259 | 314267-57-7 | Reference compound |
| HY-18187 | Ki 23057 | 516523-31-2 | Reference compound |
| HY-18200 | Atopaxar | 751475-53-3 | Reference compound |
| HY-18200A | Atopaxar (hydrochloride) | 474544-83-7 | Reference compound |
| HY-18200B | Atopaxar (hydrobromide) | 474550-69-1 | Reference compound |
| HY-18204 | Valsartan | 137862-53-4 | Reference compound |
| HY-18204A | Sacubitril/Valsartan | 936623-90-4 | Reference compound |
| HY-18204R | Valsartan (Standard) | 137862-53-4 | Reference Standards |
| HY-18204S | Valsartan-d9 | 1089736-73-1 | Isotope-Labeled Compounds |
| HY-18204S1 | Valsartan-d3 | 1331908-02-1 | Isotope-Labeled Compounds |
| HY-18204S2 | Valsartan-d8 | 1089736-72-0 | Isotope-Labeled Compounds |
| HY-18204S3 | (Rac)-Valsartan-d9 | Isotope-Labeled Compounds | |
| HY-18205 | RXPA 380 | 564479-79-4 | Reference compound |
| HY-18206 | Lisinopril | 76547-98-3 | Natural Products |
| HY-18206A | Lisinopril (dihydrate) | 83915-83-7 | Reference compound |
| HY-18206AR | Lisinopril (dihydrate) (Standard) | 83915-83-7 | Reference Standards |
| HY-18206S | Lisinopril-d5 | 1356905-39-9 | Isotope-Labeled Compounds |
| HY-18206S1 | (S)-Lisinopril-d5 (sodium) | 1356847-28-3 | Isotope-Labeled Compounds |
| HY-18206S2 | Lisinopril-13C5,15N | Isotope-Labeled Compounds | |
| HY-18207 | Fasidotril | 135038-57-2 | Reference compound |
| HY-18208 | Omapatrilat | 167305-00-2 | Reference compound |
| HY-18211 | CGS 35601 | 849066-09-7 | Reference compound |
| HY-18213 | EGFR-IN-9 | 1226549-39-8 | Reference compound |
| HY-18219 | Walrycin B | 878419-78-4 | Reference compound |
| HY-18219R | Walrycin B (Standard) | 878419-78-4 | Reference Standards |
| HY-18227 | B-Raf IN 1 | 950736-05-7 | Reference compound |
| HY-18228 | CP-352664 | 1097883-05-0 | Reference compound |
| HY-18233 | Manogepix | 936339-60-5 | Reference compound |
| HY-18234 | Leupeptin | 55123-66-5 | Peptides |
| HY-18234A | Leupeptin (hemisulfate) | 103476-89-7 | Natural Products |
| HY-18234AR | Leupeptin (hemisulfate) (Standard) | 103476-89-7 | Reference Standards |
| HY-18234B | Leupeptin Ac-LL | 24365-47-7 | Reference compound |
| HY-18234C | Leupeptin Ac-LL (hydrochloride) | 24125-16-4 | Biochemical Assay Reagents |
| HY-18236 | MDL-28170 | 88191-84-8 | Reference compound |
| HY-18237 | KX1-004 | 518058-84-9 | Reference compound |
| HY-18252 | Avanafil | 330784-47-9 | Reference compound |
| HY-18252A | Avanafil (dibenzenesulfonate) | 330784-48-0 | Reference compound |
| HY-18252B | (R)-Avanafil | 1638497-26-3 | Reference compound |
| HY-18252R | Avanafil (Standard) | 330784-47-9 | Reference Standards |
| HY-18252S | Avanafil-13C,d3 | 2738376-89-9 | Isotope-Labeled Compounds |
| HY-18252S1 | Avanafil-13C5,15N,d2 | Isotope-Labeled Compounds | |
| HY-18252S2 | Avanafil-d4 | 2012598-68-2 | Isotope-Labeled Compounds |
| HY-18252S3 | Avanafil-13C5 | Isotope-Labeled Compounds | |
| HY-18253 | Udenafil | 268203-93-6 | Reference compound |
| HY-18253R | Udenafil (Standard) | 268203-93-6 | Reference Standards |
| HY-18253S | Udenafil-d7 | 1175992-76-3 | Isotope-Labeled Compounds |
| HY-18256 | Ombrabulin (hydrochloride) | 253426-24-3 | Reference compound |
| HY-18257 | Rolitetracycline | 751-97-3 | Reference compound |
| HY-18257R | Rolitetracycline (Standard) | 751-97-3 | Reference Standards |
| HY-18258 | Berberine (chloride) | 633-65-8 | Natural Products |
| HY-18258R | Berberine (chloride) (Standard) | 633-65-8 | Reference Standards |
| HY-18258S | Berberine-d6 (chloride) | Isotope-Labeled Compounds | |
| HY-18259 | 103D5R | 773852-25-8 | Reference compound |
| HY-18260 | Bisphenol A | 80-05-7 | Natural Products |
| HY-18260R | Bisphenol A (Standard) | 80-05-7 | Reference Standards |
| HY-18260S | Bisphenol A-d16 | 96210-87-6 | Isotope-Labeled Compounds |
| HY-18260S1 | Bisphenol A-d6 | 86588-58-1 | Isotope-Labeled Compounds |
| HY-18260S2 | Bisphenol A-13C12 | 263261-65-0 | Isotope-Labeled Compounds |
| HY-18260S3 | Bisphenol A-d8 | 92739-58-7 | Isotope-Labeled Compounds |
| HY-18260S4 | Bisphenol A-d4 | 102438-62-0 | Isotope-Labeled Compounds |
| HY-18260S5 | Bisphenol A-d4-1 | 347841-41-2 | Isotope-Labeled Compounds |
| HY-18260S6 | Bisphenol A-d14 | 120155-79-5 | Isotope-Labeled Compounds |
| HY-18263 | Elubrixin (hydrochloride) | 688763-65-7 | Reference compound |
| HY-18263A | Elubrixin | 688763-64-6 | Reference compound |
| HY-18263C | Elubrixin (tosylate) | 960495-43-6 | Reference compound |
| HY-18271 | CaMKII-IN-1 | 1208123-85-6 | Reference compound |
| HY-18277 | MK-7145 | 1255204-84-2 | Reference compound |
| HY-18282 | AZ876 | 898800-26-5 | Reference compound |
| HY-18284 | AS1938909 | 1243155-40-9 | Reference compound |
| HY-18285 | Longdaysin | 1353867-91-0 | Reference compound |
| HY-18286 | NCGC00229600 | 1338824-20-6 | Reference compound |
| HY-18287 | MRT-83 | 1263131-92-5 | Reference compound |
| HY-18287A | MRT-83 (hydrochloride) | 1359944-60-7 | Reference compound |
| HY-18292 | ARN2966 | 102212-26-0 | Reference compound |
| HY-18293 | NSC 33994 | 82058-16-0 | Reference compound |
| HY-18295 | Erteberel | 533884-09-2 | Reference compound |
| HY-18295A | rel-Erteberel | 533883-77-1 | Reference compound |
| HY-18296 | AKT-IN-1 | 1357158-81-6 | Reference compound |
| HY-18297 | ASK1-IN-5 | 1124381-69-6 | Reference compound |
| HY-18298 | PD 173955 analog 1 | 185039-99-0 | Reference compound |
| HY-18299 | Purvalanol B | 212844-54-7 | Reference compound |
| HY-18299A | Purvalanol A | 212844-53-6 | Reference compound |
| HY-18299B | (S)-Purvalanol B | 2310135-61-4 | Reference compound |
| HY-18300 | Filgotinib | 1206161-97-8 | Reference compound |
| HY-18300A | Filgotinib (maleate) | 1802998-75-9 | Reference compound |
| HY-18300R | Filgotinib (Standard) | 1206161-97-8 | Reference Standards |
| HY-18300S | Filgotinib-d4 | 2041095-50-3 | Isotope-Labeled Compounds |
| HY-18301 | JAK-IN-35 | 936091-15-5 | Reference compound |
| HY-18302 | c-Kit-IN-5-1 | 1003311-62-3 | Reference compound |
| HY-18303 | AMG-47a | 882663-88-9 | Reference compound |
| HY-18304 | BMS-3 | 1338247-30-5 | Reference compound |
| HY-18305 | BMS-5 | 1338247-35-0 | Reference compound |
| HY-18306 | SB 242235 | 193746-75-7 | Reference compound |
| HY-18307 | SYN1143 | 913376-84-8 | Reference compound |
| HY-18309 | MET kinase-IN-4 | 888719-03-7 | Reference compound |
| HY-18310 | NIBR-17 | 944396-88-7 | Reference compound |
| HY-18312 | PF-4618433 | 1166393-85-6 | Reference compound |
| HY-18313 | S6K1-IN-1 | 1265789-88-5 | Reference compound |
| HY-18314 | GW 441756 | 504433-23-2 | Reference compound |
| HY-18315 | Bayer-18 | 1251752-12-1 | Reference compound |
| HY-18316 | RO495 | 1258296-60-4 | Reference compound |
| HY-18317 | JNJ-38158471 | 951151-97-6 | Reference compound |
| HY-18318 | Takeda-6D | 1125632-93-0 | Reference compound |
| HY-18324 | CRS3123 | 1013915-71-3 | Reference compound |
| HY-18325 | AN-3485 | 1213827-99-6 | Reference compound |
| HY-18325A | AN-3485 (hydrochloride) | 1213786-72-1 | Reference compound |
| HY-18327 | HLI98C | 317326-90-2 | Reference compound |
| HY-18329 | TDP-665759 | 787632-66-0 | Reference compound |
| HY-18330 | MI 63 | 908027-21-4 | Reference compound |
| HY-18331 | MI-219 | 908027-55-4 | Reference compound |
| HY-18332 | Amitifadine | 410074-73-6 | Reference compound |
| HY-18332A | Amitifadine (hydrochloride) | 410074-74-7 | Reference compound |
| HY-18332C | DOV-216,303 (Free Base) | 66504-40-3 | Reference compound |
| HY-18333 | EG00229 | 1018927-63-3 | Reference compound |
| HY-18336 | GlyH-101 | 328541-79-3 | Reference compound |
| HY-18337 | IOWH-032 | 1191252-49-9 | Reference compound |
| HY-18340 | (R)-CR8 | 294646-77-8 | Reference compound |
| HY-18340A | (R)-CR8 (trihydrochloride) | 1786438-30-9 | Reference compound |
| HY-18341 | L-Thyroxine | 51-48-9 | Natural Products |
| HY-18341A | L-Thyroxine (sodium salt pentahydrate) | 6106-07-6 | Reference compound |
| HY-18341B | L-Thyroxine (sodium) | 55-03-8 | Reference compound |
| HY-18341BR | L-Thyroxine (sodium) (Standard) | 55-03-8 | Reference Standards |
| HY-18341F | Biotin-(L-Thyroxine) | 149734-00-9 | Dye Reagents |
| HY-18341F1 | Biotin-hexanamide-(L-Thyroxine) | 2278192-78-0 | Dye Reagents |
| HY-18341R | L-Thyroxine (Standard) | 51-48-9 | Reference Standards |
| HY-18341S1 | Thyroxine hydrochloride-13C6 | 1421769-38-1 | Isotope-Labeled Compounds |
| HY-18341S2 | L-Thyroxine-13C6 | 720710-30-5 | Isotope-Labeled Compounds |
| HY-18341S3 | L-Thyroxine-13C6,15N | 1431868-11-9 | Isotope-Labeled Compounds |
| HY-18341S4 | L-Thyroxine-13C6-1 | 1217780-14-7 | Isotope-Labeled Compounds |
| HY-18342 | Diflunisal | 22494-42-4 | Reference compound |
| HY-18342R | Diflunisal (Standard) | 22494-42-4 | Reference Standards |
| HY-18342S | Diflunisal-d3 | 1286107-99-0 | Isotope-Labeled Compounds |
| HY-18342S1 | Diflunisal-13C6 | Isotope-Labeled Compounds | |
| HY-18343 | CP-31398 | 259199-65-0 | Reference compound |
| HY-18343A | CP-31398 (dihydrochloride) | 1217195-61-3 | Reference compound |
| HY-18344 | Satavaptan | 185913-78-4 | Reference compound |
| HY-18345 | SR 49059 | 150375-75-0 | Reference compound |
| HY-18346 | Mozavaptan | 137975-06-5 | Reference compound |
| HY-18346S | Mozavaptan-d6 | 2750534-83-7 | Isotope-Labeled Compounds |
| HY-18347 | Conivaptan | 210101-16-9 | Reference compound |
| HY-18347A | Conivaptan (hydrochloride) | 168626-94-6 | Reference compound |
| HY-18347AR | Conivaptan (hydrochloride) (Standard) | 168626-94-6 | Reference Standards |
| HY-18350 | Indimitecan | 915360-05-3 | Reference compound |
| HY-18350A | Indimitecan (hydrochloride) | 915303-04-7 | Reference compound |
| HY-18351 | Indotecan | 915303-09-2 | Reference compound |
| HY-18351A | Indotecan (hydrochloride) | 1228035-68-4 | Reference compound |
| HY-18353 | mTOR inhibitor-3 | 1207358-59-5 | Reference compound |
| HY-18354 | GSK1104252A | 1001397-20-1 | Reference compound |
| HY-18360 | TMP269 | 1314890-29-3 | Reference compound |
| HY-18361 | TMP195 | 1314891-22-9 | Reference compound |
| HY-18362 | HDAC-IN-5 | 1314890-51-1 | Reference compound |
| HY-18366 | RU-SKI 43 | 1043797-53-0 | Reference compound |
| HY-18366A | RU-SKI 43 (hydrochloride) | 1782573-67-4 | Reference compound |
| HY-18370 | HIF-2α-IN-3 | 313964-19-1 | Reference compound |
| HY-18371 | TC-S 7009 | 1422955-31-4 | Reference compound |
| HY-18372 | UNC1021 | 1322591-19-4 | Reference compound |
| HY-18373 | UNC1079 | 1418741-86-2 | Reference compound |
| HY-18377 | Bioymifi | 1420071-30-2 | Reference compound |
| HY-18398 | N6-Threonylcarbamoyladenosine | 24719-82-2 | Reference compound |
| HY-18399 | YM-1 | 409086-68-6 | Reference compound |
| HY-18406 | HSP70-IN-4 | 1427450-47-2 | Reference compound |
| HY-18407 | N-Methylisatoic anhydride | 10328-92-4 | Reference compound |
| HY-18408 | 5S rRNA modificator | 1415238-77-5 | Reference compound |
| HY-18500 | (βS)-β-Hydroxy-L-histidine (hydrochloride) | 220195-81-3 | Reference compound |
| HY-18507 | AD57 | 1093380-42-7 | Reference compound |
| HY-18507A | AD57 (hydrochloride) | 2320261-72-9 | Reference compound |
| HY-18509 | IRE1α kinase-IN-2 | 1414938-21-8 | Reference compound |
| HY-18510 | IRE1α kinase-IN-7 | 1414938-22-9 | Reference compound |
| HY-18522 | AA26-9 | 1312782-34-5 | Reference compound |
| HY-18540 | KT109 | 1402612-55-8 | Reference compound |
| HY-18541 | KT172 | 1402612-56-9 | Reference compound |
| HY-18544 | AA38-3 | 65815-76-1 | Reference compound |
| HY-18551 | DAGLβ-IN-1 | 1402612-61-6 | Reference compound |
| HY-18555 | TMPA | 1258275-73-8 | Reference compound |
| HY-18563 | 4-Phenoxybenzylamine | 107622-80-0 | Reference compound |
| HY-18564 | HCV-IN-3 | 1401839-25-5 | Reference compound |
| HY-18569 | 3-Indoleacetic acid | 87-51-4 | Biochemical Assay Reagents |
| HY-18569A | 3-Indoleacetic acid (sodium) | 6505-45-9 | Natural Products |
| HY-18569AR | 3-Indoleacetic acid (sodium) (Standard) | 6505-45-9 | Reference Standards |
| HY-18569R | 3-Indoleacetic acid (standard) | 87-51-4 | Reference Standards |
| HY-18569S | 3-Indoleacetic acid-d5 | 76937-78-5 | Isotope-Labeled Compounds |
| HY-18569S1 | 3-Indoleacetic acid-d4 | 76937-77-4 | Isotope-Labeled Compounds |
| HY-18569S2 | 3-Indoleacetic acid-2,2-d2 | 24420-86-8 | Isotope-Labeled Compounds |
| HY-18569S3 | 3-Indoleacetic acid-d7 | 1173020-21-7 | Isotope-Labeled Compounds |
| HY-18569S4 | 3-Indoleacetic acid-13C6 | 100849-36-3 | Isotope-Labeled Compounds |
| HY-18570 | 1-Naphthaleneacetic acid | 86-87-3 | Biochemical Assay Reagents |
| HY-18570A | 1-Naphthaleneacetic acid (potassium salt) | 15165-79-4 | Reference compound |
| HY-18570AR | 1-Naphthaleneacetic acid (potassium salt) (Standard) | 15165-79-4 | Reference Standards |
| HY-18570R | 1-Naphthaleneacetic acid (Standard) | 86-87-3 | Reference Standards |
| HY-18572 | 2,4-D | 94-75-7 | Natural Products |
| HY-18572A | 2,4-D (sodium salt) | 2702-72-9 | Reference compound |
| HY-18572AR | 2,4-D (sodium salt) (Standard) | 2702-72-9 | Reference Standards |
| HY-18572R | 2,4-D (Standard) | 94-75-7 | Reference Standards |
| HY-18572S | 2,4-D-13C6 | 150907-52-1 | Isotope-Labeled Compounds |
| HY-18572S1 | 2,4-D-d3 | 202480-67-9 | Isotope-Labeled Compounds |
| HY-18572S2 | 2,4-D-d5 | 352438-69-8 | Isotope-Labeled Compounds |
| HY-18573 | Naxillin | 301176-96-5 | Reference compound |
| HY-18593 | Mal-β-CD | 104723-60-6 | Biochemical Assay Reagents |
| HY-18594 | NSC-41589 | 6310-41-4 | Reference compound |
| HY-18595 | BI 224436 | 1155419-89-8 | Reference compound |
| HY-18596 | SB-215505 | 162100-15-4 | Reference compound |
| HY-18597 | LB-100 | 1632032-53-1 | Reference compound |
| HY-18598 | Chitinase-IN-1 | 1579991-61-9 | Reference compound |
| HY-18599 | Chitinase-IN-2 | 1579991-63-1 | Reference compound |
| HY-18599A | Chitinase-IN-2 (hydrochloride) | 2070014-83-2 | Reference compound |
| HY-18600 | Azimilide | 149908-53-2 | Reference compound |
| HY-18600A | Azimilide (dihydrochloride) | 149888-94-8 | Reference compound |
| HY-18600AS | Azimilide-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-18600B | (E)-Azimilide | 1294552-65-0 | Reference compound |
| HY-18601 | (±)-BI-D | 1416258-16-6 | Reference compound |
| HY-18602 | FIIN-2 | 1633044-56-0 | Reference compound |
| HY-18603 | FIIN-3 | 1637735-84-2 | Reference compound |
| HY-18604 | K-Ras G12C-IN-1 | 1629265-17-3 | Reference compound |
| HY-18605 | K-Ras G12C-IN-2 | 1629267-75-9 | Reference compound |
| HY-18606 | K-Ras G12C-IN-3 | 1629268-19-4 | Reference compound |
| HY-18607 | SGK1-IN-1 | 1279829-87-6 | Reference compound |
| HY-18609 | PD158780 | 171179-06-9 | Reference compound |
| HY-18610 | Diclofensine (hydrochloride) | 34041-84-4 | Reference compound |
| HY-18610A | Diclofensine | 67165-56-4 | Reference compound |
| HY-18610R | Diclofensine (hydrochloride) (Standard) | 34041-84-4 | Reference Standards |
| HY-18611 | RS102895 (hydrochloride) | 1173022-16-6 | Reference compound |
| HY-18611A | RS102895 | 300815-41-2 | Reference compound |
| HY-18613 | CAY10603 | 1045792-66-2 | Reference compound |
| HY-18614 | LY900009 | 209984-68-9 | Reference compound |
| HY-18617 | rel-SB-612111 (hydrochloride) | 371980-94-8 | Reference compound |
| HY-18618 | SB-612111 | 371980-98-2 | Reference compound |
| HY-18618A | SB-612111 (hydrochloride) | Reference compound | |
| HY-18619 | YL-109 | 36341-25-0 | Reference compound |
| HY-18620 | DZ2002 | 33231-14-0 | Reference compound |
| HY-18621 | OTS514 | 1338540-63-8 | Reference compound |
| HY-18621A | OTS514 (hydrochloride) | 2319647-76-0 | Reference compound |
| HY-18621B | (S)-OTS514 | 1338541-25-5 | Reference compound |
| HY-18622 | PP58 | 212391-58-7 | Reference compound |
| HY-18623 | VI 16832 | 1430218-51-1 | Reference compound |
| HY-18625 | VEGFR-2-IN-5 | 1430089-64-7 | Reference compound |
| HY-18625A | VEGFR-2-IN-5 (hydrochloride) | 2700435-52-3 | Reference compound |
| HY-18626 | NK 314 | 208237-49-4 | Reference compound |
| HY-18627 | PFI-2 | 1627676-59-8 | Reference compound |
| HY-18627A | PFI-2 (hydrochloride) | 1627607-87-7 | Reference compound |
| HY-18628 | UMI-77 | 518303-20-3 | Reference compound |
| HY-18628S | UMI-77-d4 | Isotope-Labeled Compounds | |
| HY-18629 | SU9516 | 377090-84-1 | Reference compound |
| HY-18629A | (E/Z)-SU9516 | 666837-93-0 | Reference compound |
| HY-18630 | Ro 48-8071 | 161582-11-2 | Reference compound |
| HY-18630A | Ro 48-8071 (fumarate) | 189197-69-1 | Reference compound |
| HY-18632 | GSK2879552 | 1401966-69-5 | Reference compound |
| HY-18632A | GSK2879552 (dihydrochloride) | 1902123-72-1 | Reference compound |
| HY-18633 | MDK83190 | 79183-19-0 | Reference compound |
| HY-18634 | NSC319726 | 71555-25-4 | Reference compound |
| HY-18636 | LEQ506 | 1204975-42-7 | Reference compound |
| HY-18637 | LDN-57444 | 668467-91-2 | Reference compound |
| HY-18638 | TCID | 30675-13-9 | Reference compound |
| HY-18639 | Nodinitib-1 | 799264-47-4 | Reference compound |
| HY-18641 | Ki16198 | 355025-13-7 | Reference compound |
| HY-18642 | CYP3cide | 1390637-82-7 | Reference compound |
| HY-18642A | (R)-CYP3cide | Reference compound | |
| HY-18643 | TZ9 | 1002789-86-7 | Reference compound |
| HY-18644 | CWHM-12 | 1564286-55-0 | Reference compound |
| HY-18646 | 23,25-Dihydroxy-24-oxovitamin D3 | 84164-55-6 | Reference compound |
| HY-18649 | Galidesivir (hydrochloride) | 222631-44-9 | Reference compound |
| HY-18649A | Galidesivir | 249503-25-1 | Reference compound |
| HY-18649B | Galidesivir (dihydrochloride) | 1373208-51-5 | Reference compound |
| HY-18650 | KU 59403 | 845932-30-1 | Reference compound |
| HY-18651 | (E/Z)-Rigosertib (sodium) | 1225497-78-8 | Biochemical Assay Reagents |
| HY-18652 | Avutometinib | 946128-88-7 | Reference compound |
| HY-18652A | Avutometinib (potassium) | 946128-90-1 | Reference compound |
| HY-18654 | ADX88178 | 1235318-89-4 | Reference compound |
| HY-18657 | TEPP-46 | 1221186-53-3 | Reference compound |
| HY-18658 | Siremadlin | 1448867-41-1 | Reference compound |
| HY-18658A | Siremadlin (R Enantiomer) | 1448867-42-2 | Reference compound |
| HY-18660 | Ciraparantag | 1438492-26-2 | Reference compound |
| HY-18660A | Ciraparantag (TFA) | 1438492-27-3 | Reference compound |
| HY-18660B | Ciraparantag (acetate) | 1644388-83-9 | Reference compound |
| HY-18660S | Ciraparantag-d8 (tetra(hydrochloride) diacetate) | Isotope-Labeled Compounds | |
| HY-18662 | RQ-00203078 | 1254205-52-1 | Reference compound |
| HY-18663 | CP-465022 | 199655-36-2 | Reference compound |
| HY-18663A | CP-465022 (maleate) | 199656-46-7 | Reference compound |
| HY-18663B | CP-465022 (hydrochloride) | 1785666-59-2 | Reference compound |
| HY-18664 | PFI-4 | 900305-37-5 | Reference compound |
| HY-18665 | GSK-5959 | 901245-65-6 | Reference compound |
| HY-18666 | D77 | 497836-10-9 | Reference compound |
| HY-18667 | LTV-1 | 347379-29-7 | Reference compound |
| HY-18668 | Integrin antagonist 27 | 593274-97-6 | Reference compound |
| HY-18669 | ML346 | 100872-83-1 | Reference compound |
| HY-18670 | HQ-415 | 430462-93-4 | Reference compound |
| HY-18671 | BoNT-IN-1 | 694443-03-3 | Reference compound |
| HY-18672 | SMER18 | 944153-47-3 | Reference compound |
| HY-18673 | PROTO-1 | 312951-85-2 | Reference compound |
| HY-18674 | K-Ras-IN-1 | 84783-01-7 | Reference compound |
| HY-18675 | IQ-R | 1345445-57-9 | Dye Reagents |
| HY-18676 | OSU-T315 | 2070015-22-2 | Reference compound |
| HY-18676B | ILK-IN-2 | 1333146-24-9 | Reference compound |
| HY-18678 | Bremelanotide | 189691-06-3 | Peptides |
| HY-18678A | Bremelanotide (Acetate) | 1607799-13-2 | Peptides |
| HY-18679 | TC-N 22A | 1314140-00-5 | Reference compound |
| HY-18680 | PU-WS13 | 1454619-14-7 | Reference compound |
| HY-18681 | Voxelotor | 1446321-46-5 | Reference compound |
| HY-18681S | Voxelotor-d6 | 2170187-39-8 | Isotope-Labeled Compounds |
| HY-18682 | Centrinone | 1798871-30-3 | Reference compound |
| HY-18683 | Centrinone-B | 1798871-31-4 | Reference compound |
| HY-18684 | SIBA | 35899-54-8 | Reference compound |
| HY-18685 | CPDA | 1415834-63-7 | Reference compound |
| HY-18686 | AS1949490 | 1203680-76-5 | Reference compound |
| HY-18687 | APNEA | 89705-21-5 | Reference compound |
| HY-18688 | 5,6-Bis(4-methoxyphenyl)-2,3-diphenylthieno[3,2-b]furan | 81385-77-5 | Reference compound |
| HY-18689 | SYM2206 | 173952-44-8 | Reference compound |
| HY-18690 | Enasidenib | 1446502-11-9 | Reference compound |
| HY-18690A | Enasidenib (mesylate) | 1650550-25-6 | Reference compound |
| HY-18690S | Enasidenib-d6 | 2095569-76-7 | Isotope-Labeled Compounds |
| HY-18694 | CGS 27023A | 169799-04-6 | Reference compound |
| HY-18696 | AMG-337 | 1173699-31-4 | Reference compound |
| HY-18697 | JD-5037 | 1392116-14-1 | Reference compound |
| HY-18698 | L-701324 | 142326-59-8 | Reference compound |
| HY-18699 | CIQ | 486427-17-2 | Reference compound |
| HY-18700 | BRD73954 | 1440209-96-0 | Reference compound |
| HY-18702 | Targocil | 1200443-21-5 | Reference compound |
| HY-18704 | Cyslabdan | 956507-17-8 | Natural Products |
| HY-18705 | Azoramide | 932986-18-0 | Reference compound |
| HY-18706 | trans-Tranilast | 70806-55-2 | Reference compound |
| HY-18707 | K-Ras(G12C) inhibitor 12 | 1469337-95-8 | Reference compound |
| HY-18708 | Erdafitinib | 1346242-81-6 | Reference compound |
| HY-18708R | Erdafitinib (Standard) | 1346242-81-6 | Reference Standards |
| HY-18709 | Tyk2-IN-3 | 1779493-12-7 | Reference compound |
| HY-18710 | BMS-066 | 914946-88-6 | Reference compound |
| HY-18711 | SCR-1481B1 (free base) | 1174161-69-3 | Reference compound |
| HY-18711A | SCR-1481B1 | 1174161-86-4 | Reference compound |
| HY-18712 | BG45 | 926259-99-6 | Reference compound |
| HY-18713 | CRT0066854 | 1438881-19-6 | Reference compound |
| HY-18713A | CRT0066854 (hydrochloride) | 2250019-91-9 | Reference compound |
| HY-18714 | BRD7116 | 329059-55-4 | Reference compound |
| HY-18715 | Ornidazole (Levo-) | 166734-83-4 | Reference compound |
| HY-18716 | Dextrorotation nimorazole phosphate ester | 1124347-33-6 | Reference compound |
| HY-18717 | Mutant IDH1-IN-2 | 1429176-69-1 | Reference compound |
| HY-18719 | Endoxifen (Z-isomer) | 112093-28-4 | Reference compound |
| HY-18719A | Endoxifen (Z-isomer hydrochloride) | 1032008-74-4 | Reference compound |
| HY-18719B | Endoxifen (hydrochloride) | 1197194-41-4 | Reference compound |
| HY-18719BR | Endoxifen (hydrochloride) (Standard) | 1197194-41-4 | Reference Standards |
| HY-18719C | Endoxifen (E-isomer hydrochloride) | 1197194-61-8 | Reference compound |
| HY-18719D | Endoxifen (E-isomer) | 114828-90-9 | Reference compound |
| HY-18719E | Endoxifen | 110025-28-0 | Reference compound |
| HY-18719ER | Endoxifen (Standard) | 110025-28-0 | Reference Standards |
| HY-18719ES | Endoxifen-d5 | 1185244-45-4 | Isotope-Labeled Compounds |
| HY-18721 | Salicylhydroxamic acid | 89-73-6 | Biochemical Assay Reagents |
| HY-18723 | Yoda 1 | 448947-81-7 | Reference compound |
| HY-18725 | P2X7-IN-2 | 1058709-63-9 | Reference compound |
| HY-18725A | P2X7-IN-2 (TFA) | Reference compound | |
| HY-18728 | STF-31 | 724741-75-7 | Reference compound |
| HY-18729A | L-NAME (hydrochloride) | 51298-62-5 | Reference compound |
| HY-18729AR | L-NAME (hydrochloride) (Standard) | 51298-62-5 | Reference Standards |
| HY-18730 | 1400W | 180001-34-7 | Reference compound |
| HY-18731 | 1400W (Dihydrochloride) | 214358-33-5 | Reference compound |
| HY-18732 | L-NMMA | 17035-90-4 | Reference compound |
| HY-18732A | L-NMMA (acetate) | 53308-83-1 | Reference compound |
| HY-18732B | L-NMMA (citrate) | 209913-88-2 | Reference compound |
| HY-18732C | L-NMMA (hydrochloride) | 156706-47-7 | Reference compound |
| HY-18733 | Lipoic acid | 1200-22-2 | Natural Products |
| HY-18733R | Lipoic acid (Standard) | 1200-22-2 | Reference Standards |
| HY-18733S | Lipoic acid-d4 | 1448263-85-1 | Isotope-Labeled Compounds |
| HY-18734 | Carboxy-PTIO | 145757-47-7 | Reference compound |
| HY-18734A | Carboxy-PTIO (potassium) | 148819-94-7 | Reference compound |
| HY-18738 | Pyrrolidinedithiocarbamate (ammonium) | 5108-96-3 | Reference compound |
| HY-18739 | Phorbol 12-myristate 13-acetate | 16561-29-8 | Natural Products |
| HY-18740A | Trequinsin (hydrochloride) | 78416-81-6 | Reference compound |
| HY-18741 | VR23 | 1624602-30-7 | Reference compound |
| HY-18743 | Coelenterazine | 55779-48-1 | Dye Reagents |
| HY-18744 | FLT3-IN-2 | 923562-23-6 | Reference compound |
| HY-18745 | BzATP (triethylammonium) | 112898-15-4 | Reference compound |
| HY-18748 | BQR-695 | 1513879-21-4 | Reference compound |
| HY-18749 | SC79 | 305834-79-1 | Reference compound |
| HY-18750 | Zorifertinib | 1626387-80-1 | Reference compound |
| HY-18750A | Zorifertinib (hydrochloride) | 1626387-81-2 | Reference compound |
| HY-18754 | FR 167653 free base | 158876-65-4 | Reference compound |
| HY-18754A | FR 167653 | 158876-66-5 | Reference compound |
| HY-18756 | NSC-87877 | 56990-57-9 | Reference compound |
| HY-18756A | NSC-87877 (disodium) | 56932-43-5 | Reference compound |
| HY-18758 | IN-1130 | 868612-83-3 | Reference compound |
| HY-18759 | BMS-751324 | 948842-66-8 | Reference compound |
| HY-18760 | LY2812223 | 1311385-20-2 | Reference compound |
| HY-18761 | Cobalt phthalocyanine | 3317-67-7 | Reference compound |
| HY-18762 | 6-Thio-2'-Deoxyguanosine | 789-61-7 | Reference compound |
| HY-18763 | Indobufen | 63610-08-2 | Reference compound |
| HY-18763A | Indobufen (sodium) | 94135-04-3 | Reference compound |
| HY-18763R | Indobufen (Standard) | 63610-08-2 | Reference Standards |
| HY-18763S | Indobufen-d5 | Isotope-Labeled Compounds | |
| HY-18764 | BpV(pic) (potassium hydrate) | 148556-27-8 | Reference compound |
| HY-18766 | EW-7195 | 1352609-28-9 | Reference compound |
| HY-18767 | Ivosidenib | 1448347-49-6 | Reference compound |
| HY-18767A | (R,S)-Ivosidenib | 2070009-31-1 | Reference compound |
| HY-18767S2 | Ivosidenib-13C5 | Isotope-Labeled Compounds | |
| HY-18767S3 | Ivosidenib-d5 | 2329582-02-5 | Isotope-Labeled Compounds |
| HY-18768 | NCT-501 | 1802088-50-1 | Reference compound |
| HY-18768A | NCT-501 (hydrochloride) | 2080306-22-3 | Reference compound |
| HY-18769 | BMS-978587 | 1629125-65-0 | Reference compound |
| HY-18770 | IDO-IN-5 | 1402837-79-9 | Reference compound |
| HY-18770A | IDO-IN-6 | 1402837-76-6 | Reference compound |
| HY-18770B | Navoximod | 1402837-78-8 | Reference compound |
| HY-18770C | IDO-IN-8 | 1402837-77-7 | Reference compound |
| HY-18771 | O4I1 | 175135-47-4 | Reference compound |
| HY-18772 | O4I2 | 165682-93-9 | Reference compound |
| HY-18773 | Oct3/4-inducer-1 | 1016535-83-3 | Reference compound |
| HY-18775 | N6-(4-Hydroxybenzyl)adenosine | 110505-75-4 | Reference compound |
| HY-18776 | A2AR-agonist-1 | 41552-95-8 | Reference compound |
| HY-18777 | KC7F2 | 927822-86-4 | Reference compound |
| HY-18778 | Obicetrapib | 866399-87-3 | Reference compound |
| HY-18779 | PF-4840154 | 1332708-14-1 | Reference compound |
| HY-18780 | RR6 | 1351758-37-6 | Reference compound |
| HY-18785 | Indirubin Derivative E804 | 854171-35-0 | Reference compound |
| HY-18787 | c-Fms-IN-2 | 791587-67-2 | Reference compound |
| HY-18791 | c-Fms-IN-1 | 885703-64-0 | Reference compound |
| HY-18817 | AFG210 | 228400-22-4 | Reference compound |
| HY-18819 | BCR-ABL-IN-2 | 897369-18-5 | Reference compound |
| HY-18832 | AWL-II-38.3 | 1135205-94-5 | Reference compound |
| HY-18833 | ALW-II-49-7 | 1135219-23-6 | Reference compound |
| HY-18840 | BBT594 | 882405-89-2 | Reference compound |
| HY-18849 | ERK2-IN-3 | 1415050-57-5 | Reference compound |
| HY-18850 | MAPK13-IN-1 | 229002-10-2 | Reference compound |
| HY-18862 | PF-03715455 | 1056164-52-3 | Reference compound |
| HY-18874 | p38-α MAPK-IN-1 | 443913-15-3 | Reference compound |
| HY-18899 | Nec-3a | 1504558-72-8 | Reference compound |
| HY-18900 | Nec-4 | 1041644-43-2 | Reference compound |
| HY-18901 | RIPK1-IN-4 | 1481641-08-0 | Reference compound |
| HY-18926 | VEGFR2-IN-7 | 174258-31-2 | Reference compound |
| HY-18928 | FAK inhibitor 5 | 1426683-30-8 | Reference compound |
| HY-18930 | NU6300 | 2070015-09-5 | Reference compound |
| HY-18931 | (Rac)-NSC305787 | 785718-37-8 | Reference compound |
| HY-18931A | (Rac)-NSC305787 (hydrochloride) | 53868-26-1 | Reference compound |
| HY-18932 | DEL-22379 | 181223-80-3 | Reference compound |
| HY-18933 | BI-69A11 | 1233322-09-2 | Reference compound |
| HY-18935 | CBL0137 | 1197996-80-7 | Reference compound |
| HY-18935A | CBL0137 (hydrochloride) | 1197397-89-9 | Reference compound |
| HY-18936 | Alda-1 | 349438-38-6 | Reference compound |
| HY-18937 | WEHI-345 | 1354825-58-3 | Reference compound |
| HY-18938 | Selonsertib | 1448428-04-3 | Reference compound |
| HY-18938A | Selonsertib (hydrochloride) | 1448428-05-4 | Reference compound |
| HY-18939 | N6-Cyclohexyladenosine | 36396-99-3 | Reference compound |
| HY-18940 | Cilobradine | 147541-45-5 | Reference compound |
| HY-18940A | Cilobradine (hydrochloride) | 186097-54-1 | Reference compound |
| HY-18941 | Eglumegad | 176199-48-7 | Reference compound |
| HY-18941B | (rel)-Eglumegad | 176027-90-0 | Reference compound |
| HY-18941C | Eglumegad (hydrochloride) | Reference compound | |
| HY-18942 | VER-00158411 | 1174664-88-0 | Reference compound |
| HY-18944 | FIT-039 | 1113044-49-7 | Reference compound |
| HY-18947 | SKLB-23bb | 1815580-06-3 | Reference compound |
| HY-18948 | GSK321 | 1816331-63-1 | Reference compound |
| HY-18949 | JI6 | 856436-16-3 | Reference compound |
| HY-18950 | GSK2795039 | 1415925-18-6 | Reference compound |
| HY-18951 | ONO-4059 analog | 1351635-67-0 | Reference compound |
| HY-18952A | (Z)-SU5614 | 1055412-47-9 | Reference compound |
| HY-18953 | mTOR inhibitor-23 | 1685280-21-0 | Reference compound |
| HY-18954 | NMS-P118 | 1262417-51-5 | Reference compound |
| HY-18955 | BI-847325 | 1207293-36-4 | Reference compound |
| HY-18956 | (E/Z)-Icerguastat | 13098-73-2 | Reference compound |
| HY-18956A | (E/Z)-Icerguastat (hydrochloride) | 32597-86-7 | Reference compound |
| HY-18956B | (E/Z)-Icerguastat (acetate) | 469866-31-7 | Reference compound |
| HY-18957 | Lifirafenib | 1446090-79-4 | Reference compound |
| HY-18957A | rel-Lifirafenib | 1446090-77-2 | Reference compound |
| HY-18957B | Lifirafenib (maleate) | 1854985-74-2 | Reference compound |
| HY-18957C | Lifirafenib (hydrochloride) | 2025320-97-0 | Reference compound |
| HY-18958 | CCT245737 | 1489389-18-5 | Reference compound |
| HY-18958A | (S)-CCT245737 | 1489389-23-2 | Reference compound |
| HY-18959 | CWP232228 | 1144044-02-9 | Reference compound |
| HY-18960 | CHZ868 | 1895895-38-1 | Reference compound |
| HY-18961 | PD 407824 | 622864-54-4 | Reference compound |
| HY-18962 | AMI-1 | 20324-87-2 | Reference compound |
| HY-18962A | AMI-1 (free acid) | 134-47-4 | Reference compound |
| HY-18963 | Lavendustin A | 125697-92-9 | Natural Products |
| HY-18963R | Lavendustin A (Standard) | 125697-92-9 | Reference Standards |
| HY-18964 | MG-101 | 110044-82-1 | Reference compound |
| HY-18965 | TAS-301 | 193620-69-8 | Reference compound |
| HY-18966 | PF-04418948 | 1078166-57-0 | Reference compound |
| HY-18967 | Caficrestat | 1355612-71-3 | Reference compound |
| HY-18968 | LDHA-IN-4 | 1370290-34-8 | Reference compound |
| HY-18969 | LDC3140 | 1453833-30-1 | Reference compound |
| HY-18970 | TG6-129 | 1164464-14-5 | Reference compound |
| HY-18971 | TG4-155 | 1164462-05-8 | Reference compound |
| HY-18972 | Plixorafenib | 1393466-87-9 | Reference compound |
| HY-18973 | Dp44mT | 152095-12-0 | Reference compound |
| HY-18974 | MCT1-IN-2 | 227321-12-2 | Reference compound |
| HY-18975 | I-BRD9 | 1714146-59-4 | Reference compound |
| HY-18976 | UF010 | 537672-41-6 | Reference compound |
| HY-18977 | KML29 | 1380424-42-9 | Reference compound |
| HY-18978 | GR79236 | 124555-18-6 | Reference compound |
| HY-18979 | Lactimidomycin | 134869-15-1 | Natural Products |
| HY-18980 | Rottlerin | 82-08-6 | Natural Products |
| HY-18981 | Decursin | 5928-25-6 | Natural Products |
| HY-18981R | Decursin (Standard) | 5928-25-6 | Reference Standards |
| HY-18982 | Anisomycin | 22862-76-6 | Natural Products |
| HY-18982R | Anisomycin (Standard) | 22862-76-6 | Reference Standards |
| HY-18983 | Calyculin A | 101932-71-2 | Reference compound |
| HY-18985 | Phorbol 12,13-dibutyrate | 37558-16-0 | Reference compound |
| HY-18986 | SAR405838 | 1303607-60-4 | Reference compound |
| HY-18986S | SAR405838-d10 | Isotope-Labeled Compounds | |
| HY-18987 | Duocarmycin MA | 1613286-57-9 | ADC Related |
| HY-18988 | ETC-159 | 1638250-96-0 | Reference compound |
| HY-18990 | GSK180736A | 817194-38-0 | Reference compound |
| HY-18991 | CCG215022 | 1813527-81-9 | Reference compound |
| HY-18992 | AS2444697 | 1287665-60-4 | Reference compound |
| HY-18992R | AS2444697 (Standard) | 1287665-60-4 | Reference Standards |
| HY-18996 | Adjudin | 252025-52-8 | Reference compound |
| HY-18997 | PLX7904 | 1393465-84-3 | Reference compound |
| HY-18998 | LMK-235 | 1418033-25-6 | Reference compound |
| HY-18999 | 4-epi-Chlortetracycline (hydrochloride) | 101342-45-4 | Reference compound |
| HY-18999R | 4-epi-Chlortetracycline (hydrochloride) (Standard) | 101342-45-4 | Reference Standards |
| HY-19003 | Isomazole | 86315-52-8 | Reference compound |
| HY-19003A | Isomazole (hydrochloride) | 87359-33-9 | Reference compound |
| HY-19004 | 711389-S (hydrochloride) | 94899-83-9 | Reference compound |
| HY-19005 | GYKI-32887 | 78463-86-2 | Reference compound |
| HY-19006 | ZK-91296 | 83910-34-3 | Reference compound |
| HY-19007 | Mifentidine | 83184-43-4 | Reference compound |
| HY-19009 | Carboxyethylgermanium sesquioxide | 12758-40-6 | Reference compound |
| HY-19010 | BMY-25368 | 86134-80-7 | Reference compound |
| HY-19010A | BMY-25368 (hydrochloride) | 86134-36-3 | Reference compound |
| HY-19012 | N-1518 | 93750-14-2 | Reference compound |
| HY-19015 | Probimane | 108093-90-9 | Reference compound |
| HY-19017 | Fenclozine | 75626-98-1 | Reference compound |
| HY-19017B | Fenclozine (dimaleate) | 76823-82-0 | Reference compound |
| HY-19022 | BW A256C | 98410-36-7 | Reference compound |
| HY-19023 | L-651896 | 99134-29-9 | Reference compound |
| HY-19024 | Merbarone | 97534-21-9 | Reference compound |
| HY-19025 | CV-159 | 86384-98-7 | Reference compound |
| HY-19026 | Siguazodan | 115344-47-3 | Reference compound |
| HY-19030 | TA-1801 | 88352-44-7 | Reference compound |
| HY-19036 | SDZ NVI 085 | 104195-17-7 | Reference compound |
| HY-19037 | SM-2470 | 99899-45-3 | Reference compound |
| HY-19040 | Ro 16-8714 | 90505-66-1 | Reference compound |
| HY-19041 | CGP-35949 (sodium) | 111130-13-3 | Reference compound |
| HY-19042 | YM-16638 | 104073-72-5 | Reference compound |
| HY-19043 | RS-93522 | 104060-12-0 | Reference compound |
| HY-19044 | SKF 95601 | 103949-62-8 | Reference compound |
| HY-19047 | CD-349 | 88594-08-5 | Reference compound |
| HY-19048 | CP-66948 | 101189-47-3 | Reference compound |
| HY-19050 | BRL-42715 | 102209-75-6 | Reference compound |
| HY-19052 | Trombodipine | 113658-85-8 | Reference compound |
| HY-19053 | NP-252 | 132031-81-3 | Reference compound |
| HY-19054 | CGP-20376 | 81059-04-3 | Reference compound |
| HY-19057 | Vatinoxan | 114914-42-0 | Reference compound |
| HY-19057A | Vatinoxan (hydrochloride) | 130466-38-5 | Reference compound |
| HY-19058 | NC-1300-B | 104340-41-2 | Reference compound |
| HY-19061 | CGP 28014 | 111757-17-6 | Reference compound |
| HY-19062 | SM-6586 | 103898-38-0 | Reference compound |
| HY-19063 | SCH-34826 | 105262-04-2 | Reference compound |
| HY-19065 | Ru-32514 | 90807-98-0 | Reference compound |
| HY-19071 | BK-218 | 110008-56-5 | Reference compound |
| HY-19072 | BRL-36378 | 84768-09-2 | Reference compound |
| HY-19081 | KB-5246 | 119474-55-4 | Reference compound |
| HY-19082 | Y-23684 | 118288-67-8 | Reference compound |
| HY-19083 | SIM-6080 | 118790-68-4 | Reference compound |
| HY-19084 | Ro-24-0238 | 120555-31-9 | Reference compound |
| HY-19085 | KW-6055 | 63233-46-5 | Reference compound |
| HY-19093 | WF11605 | 127475-47-2 | Reference compound |
| HY-19094 | DuP-532 | 124750-95-4 | Reference compound |
| HY-19095 | TNP-351 | 125991-51-7 | Reference compound |
| HY-19097 | Ro-24-4736 | 125030-71-9 | Reference compound |
| HY-19100 | ADX-10061 | 128022-68-4 | Reference compound |
| HY-19101 | ONO-3307 | 76472-29-2 | Reference compound |
| HY-19102 | NSP-805 | 125068-54-4 | Reference compound |
| HY-19109 | RG-7152 | 107813-63-8 | Reference compound |
| HY-19110 | RG-12915 | 136174-04-4 | Reference compound |
| HY-19111 | R-82150 | 126320-77-2 | Reference compound |
| HY-19115 | YM-430 | 153192-22-4 | Reference compound |
| HY-19118 | KP1019 | 124875-20-3 | Reference compound |
| HY-19120 | KB-5492 (anhydrous) | 129200-10-8 | Reference compound |
| HY-19121 | TCV-309 | 131311-25-6 | Reference compound |
| HY-19121A | TCV-309 (chloride) | 121494-09-5 | Reference compound |
| HY-19123 | Z-321 | 130849-58-0 | Reference compound |
| HY-19126 | CL-184005 | 140466-18-8 | Reference compound |
| HY-19134 | EMD 56551 | 133109-86-1 | Reference compound |
| HY-19135 | A-77003 | 134878-17-4 | Reference compound |
| HY-19136 | WAY-100289 | 136013-69-9 | Reference compound |
| HY-19137 | Pibrozelesin | 154889-68-6 | Reference compound |
| HY-19141 | L-691121 | 136075-60-0 | Reference compound |
| HY-19143 | L-697639 | 135525-77-8 | Reference compound |
| HY-19144 | ONO-3805 | 119347-91-0 | Reference compound |
| HY-19145 | PD-134672 | 135704-06-2 | Reference compound |
| HY-19146 | CL-275838 | 115931-65-2 | Reference compound |
| HY-19147 | BMY-43748 | 132195-65-4 | Reference compound |
| HY-19148A | 7U85 (hydrochloride) | 120097-92-9 | Reference compound |
| HY-19149 | Ro24-7429 | 139339-45-0 | Reference compound |
| HY-19151 | Fuzapladib | 141283-87-6 | Reference compound |
| HY-19151A | Fuzapladib (sodium) | 141284-73-3 | Reference compound |
| HY-19151B | Fuzapladib (potassium) | 141284-74-4 | Reference compound |
| HY-19151C | Fuzapladib (calcium) | 141284-77-7 | Reference compound |
| HY-19153 | Nepaprazole | 156601-79-5 | Reference compound |
| HY-19154 | Montirelin | 90243-66-6 | Reference compound |
| HY-19155A | ICI-D 8731 | 135015-84-8 | Reference compound |
| HY-19156 | ZD-6888 | 138620-04-9 | Reference compound |
| HY-19156A | ZD-6888 (hydrochloride) | 138620-17-4 | Reference compound |
| HY-19157 | Metesind (glucuronate) | 157182-23-5 | Reference compound |
| HY-19158 | Org 13011 | 142494-12-0 | Reference compound |
| HY-19160 | BMS-180680 | 142654-34-0 | Reference compound |
| HY-19163 | SC-52012 | 145643-15-8 | Reference compound |
| HY-19164 | BOF-4272 | 142181-44-0 | Reference compound |
| HY-19167 | Ecraprost | 136892-64-3 | Reference compound |
| HY-19168 | Perzinfotel | 144912-63-0 | Reference compound |
| HY-19171 | Aranose | 167396-23-8 | Reference compound |
| HY-19176 | S-15261 | 159978-02-6 | Reference compound |
| HY-19183 | E-5324 | 141799-76-0 | Reference compound |
| HY-19188 | GL-331 | 127882-73-9 | Reference compound |
| HY-19189 | Terbogrel | 149979-74-8 | Reference compound |
| HY-19191 | L-159282 | 157263-00-8 | Reference compound |
| HY-19193 | CP-105696 | 158081-99-3 | Reference compound |
| HY-19194 | A-80987 | 144141-97-9 | Reference compound |
| HY-19199 | E-3620 | 151213-86-4 | Reference compound |
| HY-19202 | rac-Olodanrigan | 152362-51-1 | Reference compound |
| HY-19204 | Zinc phthalocyanine | 14320-04-8 | Dye Reagents |
| HY-19205A | CMI-392 | 205654-37-1 | Reference compound |
| HY-19206 | R-84760 | 157824-23-2 | Reference compound |
| HY-19210 | SB-209670 | 157659-79-5 | Reference compound |
| HY-19212 | S-2474 | 158089-95-3 | Reference compound |
| HY-19213 | L-693612 | 138301-71-0 | Reference compound |
| HY-19213A | L-693612 (hydrochloride) | 138301-72-1 | Reference compound |
| HY-19214 | Elisartan | 149968-26-3 | Reference compound |
| HY-19216 | KR-30450 | 172489-10-0 | Reference compound |
| HY-19217 | Thioflosulide | 158205-05-1 | Reference compound |
| HY-19218 | RPR-106541 | 159001-35-1 | Reference compound |
| HY-19219 | BMS-189664 | 162166-80-5 | Reference compound |
| HY-19219A | BMS-189664 (hydrochloride) | 185252-36-2 | Reference compound |
| HY-19223 | Pumaprazole | 158364-59-1 | Reference compound |
| HY-19225 | Ensaculin | 209969-60-8 | Reference compound |
| HY-19225A | Ensaculin (free base) | 155773-59-4 | Reference compound |
| HY-19229 | TAK-029 | 176655-58-6 | Reference compound |
| HY-19231 | DPI-3290 | 182417-73-8 | Reference compound |
| HY-19232 | R-87366 | 144779-91-9 | Reference compound |
| HY-19236 | PNU-103017 | 166335-18-8 | Reference compound |
| HY-19239 | FP-21399 | 170020-61-8 | Reference compound |
| HY-19243 | GV-196771A | 166974-23-8 | Reference compound |
| HY-19249 | Z-335 (sodium) | 146731-14-8 | Reference compound |
| HY-19250 | U-101017 | 170568-47-5 | Reference compound |
| HY-19254 | ZD-0892 | 171964-73-1 | Reference compound |
| HY-19255 | FK-788 | 227951-89-5 | Reference compound |
| HY-19259 | GP3269 | 186393-42-0 | Reference compound |
| HY-19261 | T-0632 | 169042-78-8 | Reference compound |
| HY-19262 | TAK-218 | 156756-10-4 | Reference compound |
| HY-19263 | BMS-193884 | 176960-47-7 | Reference compound |
| HY-19264 | 264W94 | 178961-24-5 | Reference compound |
| HY-19267 | Ro-48-6791 | 172407-17-9 | Reference compound |
| HY-19269 | FK706 | 144055-55-0 | Reference compound |
| HY-19271 | NS-2710 | 184220-36-8 | Reference compound |
| HY-19273 | Rimeporide | 187870-78-6 | Reference compound |
| HY-19273A | Rimeporide hydrochloride | 187870-95-7 | Reference compound |
| HY-19274 | ZD-1611 | 186497-38-1 | Reference compound |
| HY-19279A | JTH-601 (free base) | 171277-06-8 | Reference compound |
| HY-19282A | (5R)-BW-4030W92 | 189013-61-4 | Reference compound |
| HY-19283 | DU125530 | 161611-99-0 | Reference compound |
| HY-19284 | FR-146687 | 146939-64-2 | Reference compound |
| HY-19285 | Sulfaclozine | 102-65-8 | Reference compound |
| HY-19285A | Sulfaclozine (sodium) | 23307-72-4 | Reference compound |
| HY-19285AR | Sulfaclozine (sodium) (Standard) | 23307-72-4 | Reference Standards |
| HY-19285R | Sulfaclozine (Standard) | 102-65-8 | Reference Standards |
| HY-19286 | Eflucimibe | 202340-45-2 | Reference compound |
| HY-19288 | Valomaciclovir stearate | 195156-77-5 | Reference compound |
| HY-19292 | AS-601811 | 194979-95-8 | Reference compound |
| HY-19296 | BDCRB | 142356-43-2 | Reference compound |
| HY-19298 | S-8921 | 151165-96-7 | Reference compound |
| HY-19300A | PNU-142731A | 214212-38-1 | Reference compound |
| HY-19301 | J 104871 | 191088-19-4 | Reference compound |
| HY-19303 | CRA-2059 | 256649-36-2 | Reference compound |
| HY-19303A | CRA-2059 (hydrochloride) | Reference compound | |
| HY-19303B | CRA-2059 (TFA) | Reference compound | |
| HY-19304 | Amelubant | 346735-24-8 | Reference compound |
| HY-19306 | SB-267268 | 205678-26-8 | Reference compound |
| HY-19307 | SB-273005 | 205678-31-5 | Reference compound |
| HY-19308 | RWJ-51204 | 205701-85-5 | Reference compound |
| HY-19310 | AMP-579 | 213453-89-5 | Reference compound |
| HY-19312 | 3-Methyladenine | 5142-23-4 | Natural Products |
| HY-19312AS | 3-Methyladenine-d3 (hydroiodide) | Isotope-Labeled Compounds | |
| HY-19312R | 3-Methyladenine (Standard) | 5142-23-4 | Reference Standards |
| HY-19312S | 3-Methyladenine-d3 | 110953-39-4 | Isotope-Labeled Compounds |
| HY-19313 | LLY-507 | 1793053-37-8 | Reference compound |
| HY-19314 | Azvudine | 1011529-10-4 | Reference compound |
| HY-19314A | Azvudine (hydrochloride) | 1333126-31-0 | Reference compound |
| HY-19316 | NU2058 | 161058-83-9 | Reference compound |
| HY-19317 | ITE | 448906-42-1 | Reference compound |
| HY-19318 | Fmoc-Val-Cit-PAB | 159858-22-7 | ADC Related |
| HY-19318A | Fmoc-Val-D-Cit-PAB | 1350456-67-5 | ADC Related |
| HY-19318B | Fmoc-D-Val-Cit-PAB | 1350456-65-3 | ADC Related |
| HY-19318C | Fmoc-D-Val-D-Cit-PAB | 1350456-69-7 | ADC Related |
| HY-19318G | Fmoc-Val-Cit-PAB (GMP) | 159858-22-7 | GMP Small Molecules |
| HY-19319 | MI-136 | 1628316-74-4 | Reference compound |
| HY-19320 | Orexin 2 Receptor Agonist | 1796565-52-0 | Reference compound |
| HY-19321 | PF-06282999 | 1435467-37-0 | Reference compound |
| HY-19322 | PIM447 | 1210608-43-7 | Reference compound |
| HY-19322B | PIM-447 (dihydrochloride) | 1820565-69-2 | Reference compound |
| HY-19322C | (1S,3R,5R)-PIM447 (dihydrochloride) | Reference compound | |
| HY-19323 | Ceralasertib | 1352226-88-0 | Reference compound |
| HY-19323A | (S)-Ceralasertib | 1352226-87-9 | Reference compound |
| HY-19324 | EPZ031686 | 2095161-11-6 | Reference compound |
| HY-19325 | SKI2852 | 1346554-47-9 | Reference compound |
| HY-19326 | SU1498 | 168835-82-3 | Reference compound |
| HY-19327 | ACY-738 | 1375465-91-0 | Reference compound |
| HY-19328 | ACY-775 | 1375466-18-4 | Reference compound |
| HY-19329 | HA130 | 1229652-21-4 | Reference compound |
| HY-19330 | DASA-58 | 1203494-49-8 | Reference compound |
| HY-19331 | WZB117 | 1223397-11-2 | Reference compound |
| HY-19332 | Kifunensine | 109944-15-2 | Natural Products |
| HY-19332R | Kifunensine (Standard) | 109944-15-2 | Reference Standards |
| HY-19333 | OG-L002 | 1357302-64-7 | Reference compound |
| HY-19333A | OG-L002 (hydrochloride) | 1357299-45-6 | Reference compound |
| HY-19334 | L755507 | 159182-43-1 | Reference compound |
| HY-19336 | BAZ2-ICR | 1665195-94-7 | Reference compound |
| HY-19337 | Ketodarolutamide | 1297537-33-7 | Reference compound |
| HY-19339 | Tenovin-3 | 1011301-27-1 | Reference compound |
| HY-19340 | TMS | 24144-92-1 | Reference compound |
| HY-19341 | Compound 401 | 168425-64-7 | Reference compound |
| HY-19343 | XL-281 | 870603-16-0 | Reference compound |
| HY-19344 | Lifitegrast | 1025967-78-5 | Reference compound |
| HY-19344A | Lifitegrast (sodium) | 1119276-80-0 | Reference compound |
| HY-19344R | Lifitegrast (Standard) | 1025967-78-5 | Reference Standards |
| HY-19344S | Lifitegrast-d4 | Isotope-Labeled Compounds | |
| HY-19344S1 | Lifitegrast-d6 | 2249814-79-5 | Isotope-Labeled Compounds |
| HY-19344S2 | Lifitegrast-d4-1 | Isotope-Labeled Compounds | |
| HY-19345 | Vacquinol-1 | 5428-80-8 | Reference compound |
| HY-19345A | Vacquinol-1 (dihydrochloride) | 2309312-85-2 | Reference compound |
| HY-19346 | AR-13324 analog (mesylate) | 2095432-73-6 | Reference compound |
| HY-19347 | WDR5-0103 | 890190-22-4 | Reference compound |
| HY-19348 | Pimelic Diphenylamide 106 | 937039-45-7 | Reference compound |
| HY-19350 | BML-210 | 537034-17-6 | Reference compound |
| HY-19351 | MN-64 | 92831-11-3 | Reference compound |
| HY-19352 | T56-LIMKi | 924473-59-6 | Reference compound |
| HY-19353 | SR7826 | 1219728-20-7 | Reference compound |
| HY-19354 | Aglafoline | 143901-35-3 | Reference compound |
| HY-19355 | Rocagloic acid | 190385-15-0 | Natural Products |
| HY-19356 | Rocaglamide | 84573-16-0 | Natural Products |
| HY-19356A | Didesmethylrocaglamide | 177262-30-5 | Reference compound |
| HY-19357 | E3330 | 136164-66-4 | Reference compound |
| HY-19358 | 2-Methyl-5-HT | 78263-90-8 | Reference compound |
| HY-19358A | 2-Methyl-5-HT (hydrochloride) | 845861-49-6 | Reference compound |
| HY-19358B | 2-Methyl-5-HT (maleate) | 78263-91-9 | Reference compound |
| HY-19359 | Vilagletistat | 1542132-88-6 | Reference compound |
| HY-19360 | Sulprostone | 60325-46-4 | Reference compound |
| HY-19361 | L-826266 | 244101-03-9 | Reference compound |
| HY-19362 | AZD3264 | 1609281-86-8 | Reference compound |
| HY-19363 | GW4869 | 6823-69-4 | Reference compound |
| HY-19364 | Ferroquine | 185055-67-8 | Reference compound |
| HY-19365 | AB-MECA | 152918-26-8 | Reference compound |
| HY-19366 | Nav1.7-IN-2 | 1332295-35-8 | Reference compound |
| HY-19367 | MD-39-AM | 72564-74-0 | Reference compound |
| HY-19369 | L-685458 | 292632-98-5 | Reference compound |
| HY-19370 | FPS-ZM1 | 945714-67-0 | Reference compound |
| HY-19371 | Lorediplon | 917393-39-6 | Reference compound |
| HY-19373 | RWJ-445167 | 226566-43-4 | Reference compound |
| HY-19374 | BAY-27-9955 | 202855-56-9 | Reference compound |
| HY-19375 | SB-235699 | 180869-32-3 | Reference compound |
| HY-19376 | NAMI-A | 201653-76-1 | Reference compound |
| HY-19378 | MIV-150 | 231957-54-3 | Reference compound |
| HY-19381 | WAY-151932 | 220460-92-4 | Reference compound |
| HY-19383 | Ertiprotafib | 251303-04-5 | Reference compound |
| HY-19384 | Enflicoxib | 251442-94-1 | Reference compound |
| HY-19387 | Didox | 69839-83-4 | Reference compound |
| HY-19391 | UK-240455 | 178908-09-3 | Reference compound |
| HY-19393 | SCH 351591 | 444659-43-2 | Reference compound |
| HY-19394 | CLX-0921 | 249886-47-3 | Reference compound |
| HY-19394A | (E)-CLX-0921 | 606932-81-4 | Reference compound |
| HY-19396 | Ingliforib | 186392-65-4 | Reference compound |
| HY-19399 | Iroxanadine | 276690-58-5 | Reference compound |
| HY-19399A | (±)-Iroxanadine | 203805-20-3 | Reference compound |
| HY-19399B | Iroxanadine (sulfate) | 276690-61-0 | Reference compound |
| HY-19399C | Iroxanadine (hydrobromide) | 276690-62-1 | Reference compound |
| HY-19399D | Iroxanadine (hydrochloride) | 276690-59-6 | Reference compound |
| HY-19400 | DPC-681 | 284661-68-3 | Reference compound |
| HY-19401 | L-796568 | 211031-81-1 | Reference compound |
| HY-19401A | L-796568 (free base) | 211031-01-5 | Reference compound |
| HY-19404 | Embeconazole | 329744-44-7 | Reference compound |
| HY-19406 | AE-3763 | 291778-77-3 | Reference compound |
| HY-19407 | Nor-LY-510929 | 471854-50-9 | Reference compound |
| HY-19408 | Pyr10 | 1315323-00-2 | Reference compound |
| HY-19409 | AJG049 | 195991-50-5 | Reference compound |
| HY-19411 | SSR180711 (hydrochloride) | 446031-79-4 | Reference compound |
| HY-19412 | DMS-612 | 56967-08-9 | Reference compound |
| HY-19414 | MLN-4760 | 305335-31-3 | Reference compound |
| HY-19414A | (R)-MLN-4760 | 305335-29-9 | Reference compound |
| HY-19415 | SB-435495 | 304694-39-1 | Reference compound |
| HY-19415A | SB-435495 (hydrochloride) | 304694-41-5 | Reference compound |
| HY-19415B | SB-435495 (ditartrate) | 304694-43-7 | Reference compound |
| HY-19416 | AEOL-10150 (pentachloride) | 286475-30-7 | Reference compound |
| HY-19417 | Wf-516 (hydrochloride) | 310392-93-9 | Reference compound |
| HY-19417A | Wf-516 | 310392-94-0 | Reference compound |
| HY-19418 | KRP-101 | 311770-26-0 | Reference compound |
| HY-19420 | UK 357903 | 247580-98-9 | Reference compound |
| HY-19421 | Orazamide | 2574-78-9 | Reference compound |
| HY-19422 | PNU-248686A | 341498-89-3 | Reference compound |
| HY-19424 | Hemin | 16009-13-5 | Natural Products |
| HY-19425 | NS-220 | 377731-45-8 | Reference compound |
| HY-19427 | AZD9056 | 345304-65-6 | Reference compound |
| HY-19427A | AZD9056 (hydrochloride) | 345303-91-5 | Reference compound |
| HY-19429A | SLV-317 | 393183-40-9 | Reference compound |
| HY-19430 | Pimelic Diphenylamide 106 (analog) | 2070015-24-4 | Reference compound |
| HY-19431 | Ro 46-8443 | 175556-12-4 | Reference compound |
| HY-19432 | UBP-282 | 544697-47-4 | Reference compound |
| HY-19433A | (S)-ATPO | 252930-37-3 | Reference compound |
| HY-19434 | trans-ACPD | 67684-64-4 | Reference compound |
| HY-19434A | cis-ACPD | 477331-06-9 | Reference compound |
| HY-19435 | GYKI-47261 | 220445-20-5 | Reference compound |
| HY-19435A | GYKI-47261 (dihydrochloride) | 1217049-32-5 | Reference compound |
| HY-19436 | Solabegron | 252920-94-8 | Reference compound |
| HY-19436A | Solabegron (hydrochloride) | 451470-34-1 | Reference compound |
| HY-19436S | Solabegron-d8 | 1250988-09-0 | Isotope-Labeled Compounds |
| HY-19437 | Bimolane | 74550-97-3 | Reference compound |
| HY-19438 | Divaplon | 90808-12-1 | Reference compound |
| HY-19440 | Esonarimod | 101973-77-7 | Reference compound |
| HY-19442 | Idrabiotaparinux | 774531-07-6 | Reference compound |
| HY-19443 | UCB-35440 | 299460-62-1 | Reference compound |
| HY-19445 | Gastrazole | 862583-15-1 | Reference compound |
| HY-19447 | Besifovir | 441785-25-7 | Reference compound |
| HY-19447A | Besifovir Dipivoxil (maleate) | 1039623-01-2 | Reference compound |
| HY-19456 | SSR-241586 | 1239279-30-1 | Reference compound |
| HY-19459 | Ocaphane | 2185-98-0 | Reference compound |
| HY-19459A | Ocaphane (free acid) | 3734-80-3 | Reference compound |
| HY-19463A | F15845 | 470454-73-0 | Reference compound |
| HY-19464 | Org 43553 | 501444-88-8 | Reference compound |
| HY-19465 | Dasolampanel | 503294-13-1 | Reference compound |
| HY-19467 | SCH 486757 | 524019-25-8 | Reference compound |
| HY-19468 | ERB-196 | 550997-55-2 | Reference compound |
| HY-19469 | Roluperidone | 359625-79-9 | Reference compound |
| HY-19470 | Topilutamide | 260980-89-0 | Reference compound |
| HY-19470R | Topilutamide (Standard) | 260980-89-0 | Reference Standards |
| HY-19471 | (rac)-ZK-304709 | 1010440-84-2 | Reference compound |
| HY-19472 | RWJ-58643 | 287183-00-0 | Reference compound |
| HY-19472A | RWJ-58643 (hydrochloride) | 287182-52-9 | Reference compound |
| HY-19474 | Maytansinol | 57103-68-1 | Natural Products |
| HY-19474R | Maytansinol (Standard) | 57103-68-1 | Reference Standards |
| HY-19475 | Taprizosin | 210538-44-6 | Reference compound |
| HY-19476 | AG-7404 | 343565-99-1 | Reference compound |
| HY-19477 | SB-616234-A | 908601-49-0 | Reference compound |
| HY-19480 | Ulodesine | 548486-59-5 | Reference compound |
| HY-19483 | ABT-670 | 630119-43-6 | Reference compound |
| HY-19485 | XL-784 | 1224964-36-6 | Reference compound |
| HY-19486 | UR-1505 | 651331-92-9 | Reference compound |
| HY-19487 | Ribocil | 1381289-58-2 | Reference compound |
| HY-19487A | Ribocil B | 1825355-55-2 | Reference compound |
| HY-19488 | Ribocil-C (Racemate) | 2309762-18-1 | Reference compound |
| HY-19488A | Ribocil-C | 1825355-56-3 | Reference compound |
| HY-19488B | Ribocil-C (R enantiomer) | 2177266-81-6 | Reference compound |
| HY-19489 | (±)-Levomepromazine | 851-68-3 | Reference compound |
| HY-19489S | (±)-Levomepromazine-d6 | 1189805-51-3 | Isotope-Labeled Compounds |
| HY-19489S1 | (Rac)-Levomepromazine-d3 (hydrochloride) | 1216745-60-6 | Isotope-Labeled Compounds |
| HY-19489S3 | (±)-Levomepromazine-d3 | 1185071-29-7 | Isotope-Labeled Compounds |
| HY-19490 | VQW-765 | 669770-29-0 | Reference compound |
| HY-19490A | (S)-VQW-765 | Reference compound | |
| HY-19495 | OT-730 | 870809-51-1 | Reference compound |
| HY-19496 | 4-Butyl-alpha-agarofuran | 272126-07-5 | Natural Products |
| HY-19497 | Canosimibe | 768394-99-6 | Reference compound |
| HY-19498 | WAY-204688 | 796854-35-8 | Reference compound |
| HY-19499 | AMG-009 | 1027847-67-1 | Reference compound |
| HY-19500 | SC-75416 | 215122-74-0 | Reference compound |
| HY-19502 | Artemisone | 255730-18-8 | Reference compound |
| HY-19504 | AVE3085 | 450348-85-3 | Reference compound |
| HY-19505 | TPA-023B | 425377-76-0 | Reference compound |
| HY-19509 | IQP-0528 | 301297-45-0 | Reference compound |
| HY-19510 | RORγt inhibitor 4 | 1426803-07-7 | Reference compound |
| HY-19511 | GSK2018682 | 1034688-30-6 | Reference compound |
| HY-19511A | GSK2018682 (hydrochloride) | 1034687-52-9 | Reference compound |
| HY-19512 | ACH-806 | 870142-71-5 | Reference compound |
| HY-19513 | MB-07344 | 852947-39-8 | Reference compound |
| HY-19513A | MB-07344 (sodium) | Reference compound | |
| HY-19514 | Fosfluridine tidoxil | 174638-15-4 | Reference compound |
| HY-19517 | R1663 | 865451-66-7 | Reference compound |
| HY-19518 | Latanoprostene bunod | 860005-21-6 | Reference compound |
| HY-19518R | Latanoprostene bunod (Standard) | 860005-21-6 | Reference Standards |
| HY-19519 | Ladarixin | 849776-05-2 | Reference compound |
| HY-19519A | Ladarixin (sodium) | 865625-56-5 | Reference compound |
| HY-19521 | SRX251 | 512784-94-0 | Reference compound |
| HY-19522 | Seladelpar | 851528-79-5 | Reference compound |
| HY-19522A | Seladelpar sodium salt | 3026272-26-1 | Reference compound |
| HY-19522B | Seladelpar (lysine) | 928821-41-4 | Reference compound |
| HY-19522C | Seladelpar (Lysine dihydrate) | 928821-40-3 | Reference compound |
| HY-19527 | IST5-002 | 13484-66-7 | Reference compound |
| HY-19528 | SAH | 979-92-0 | Natural Products |
| HY-19528R | SAH (Standard) | 979-92-0 | Reference Standards |
| HY-19528S | SAH-d4 | Isotope-Labeled Compounds | |
| HY-19528S1 | SAH-13C5 | Isotope-Labeled Compounds | |
| HY-19528S2 | SAH-13C10 | 2687960-02-5 | Isotope-Labeled Compounds |
| HY-19529 | Ro 46-2005 | 150725-87-4 | Reference compound |
| HY-19530 | PF-2771 | 2070009-55-9 | Reference compound |
| HY-19532 | ZM241385 | 139180-30-6 | Reference compound |
| HY-19532S | ZM241385-d7 | Isotope-Labeled Compounds | |
| HY-19533 | SCH 58261 | 160098-96-4 | Reference compound |
| HY-19535 | Nemiralisib (hydrochloride) | 1254036-77-5 | Reference compound |
| HY-19535A | Nemiralisib | 1254036-71-9 | Reference compound |
| HY-19535B | Nemiralisib (succinate) | 1364799-98-3 | Reference compound |
| HY-19536 | LLL12 | 1260247-42-4 | Reference compound |
| HY-19537 | NI-57 | 1883548-89-7 | Reference compound |
| HY-19538 | FRAX1036 | 1432908-05-8 | Reference compound |
| HY-19539 | NSC-658497 | 909197-38-2 | Reference compound |
| HY-19540 | GSK864 | 1816331-66-4 | Reference compound |
| HY-19541 | I-CBP112 | 1640282-31-0 | Reference compound |
| HY-19541A | I-CBP112 (hydrochloride) | 2147701-33-3 | Reference compound |
| HY-19542 | C6 Ceramide | 124753-97-5 | Reference compound |
| HY-19542A | N-Hexanoyl-L-erythro-sphingosine | 189894-78-8 | Natural Products |
| HY-19542S | Ceramide C6-d7 | 2692624-22-7 | Isotope-Labeled Compounds |
| HY-19542S1 | C6 Ceramide-d11 | Isotope-Labeled Compounds | |
| HY-19543 | Brusatol | 14907-98-3 | Natural Products |
| HY-19544 | JAK3-IN-1 | 1805787-93-2 | Reference compound |
| HY-19545 | SCH-23390 | 87075-17-0 | Reference compound |
| HY-19545A | SCH-23390 (hydrochloride) | 125941-87-9 | Reference compound |
| HY-19546 | BAY-598 | 1906919-67-2 | Reference compound |
| HY-19546A | (R)-BAY-598 | 1906920-28-2 | Reference compound |
| HY-19548 | BEC | 63107-40-4 | Reference compound |
| HY-19548A | BEC (hydrochloride) | 222638-67-7 | Reference compound |
| HY-19549 | RX-37 | 1627715-60-9 | Reference compound |
| HY-19550 | PF-06442609 | 1402002-76-9 | Reference compound |
| HY-19551 | Apogossypolone | 886578-07-0 | Reference compound |
| HY-19553 | LP99 | 1808951-93-0 | Reference compound |
| HY-19554 | MM-401 | 1442106-10-6 | Reference compound |
| HY-19554A | MM-401 (TFA) | 1442106-11-7 | Reference compound |
| HY-19555 | Seco Rapamycin | 147438-27-5 | Reference compound |
| HY-19555A | Seco Rapamycin (sodium salt) | 148554-65-8 | Reference compound |
| HY-19555AR | Seco Rapamycin (sodium salt) (Standard) | 148554-65-8 | Reference Standards |
| HY-19556 | (+)-SJ733 | 1424799-20-1 | Reference compound |
| HY-19558 | IDX184 | 1036915-08-8 | Reference compound |
| HY-19559 | JNJ-46778212 | 1363281-27-9 | Reference compound |
| HY-19560 | SBI-0640756 | 1821280-29-8 | Reference compound |
| HY-19562 | PF-06260933 | 1811510-56-1 | Reference compound |
| HY-19562A | PF-06260933 (hydrochloride) | 1883548-86-4 | Reference compound |
| HY-19563 | A-893 | 1868232-32-9 | Reference compound |
| HY-19564 | JX06 | 729-46-4 | Reference compound |
| HY-19566 | NQDI-1 | 175026-96-7 | Reference compound |
| HY-19567 | PK 11195 | 85532-75-8 | Reference compound |
| HY-19568 | Peficitinib | 944118-01-8 | Reference compound |
| HY-19568A | Peficitinib (hydrobromide) | 1353219-05-2 | Reference compound |
| HY-19568B | Peficitinib (hydrochloride) | 1353219-06-3 | Reference compound |
| HY-19568R | Peficitinib (Standard) | 944118-01-8 | Reference Standards |
| HY-19569 | Upadacitinib | 1310726-60-3 | Reference compound |
| HY-19569A | Upadacitinib (tartrate tetrahydrate) | 1607431-21-9 | Reference compound |
| HY-19569R | Upadacitinib (Standard) | 1310726-60-3 | Reference Standards |
| HY-19569S1 | Upadacitinib-d5 | Isotope-Labeled Compounds | |
| HY-19570A | NSC 15830 (hydrochloride) | 2508026-62-6 | Reference compound |
| HY-19572 | ACT-678689 | 1783256-96-1 | Reference compound |
| HY-19574 | FPR Agonist 43 | 903895-98-7 | Reference compound |
| HY-19577 | Ambamustine | 85754-59-2 | Reference compound |
| HY-19578A | Isamoltan (hydrochloride) | 99740-06-4 | Reference compound |
| HY-19578B | Isamoltane (hemifumarate) | 874882-92-5 | Reference compound |
| HY-19580 | Ramixotidine | 84071-15-8 | Reference compound |
| HY-19581 | Baquiloprim | 102280-35-3 | Reference compound |
| HY-19581R | Baquiloprim (Standard) | 102280-35-3 | Reference Standards |
| HY-19581S | Baquiloprim-d6 | 1228182-50-0 | Isotope-Labeled Compounds |
| HY-19583 | Cicaprost | 94079-80-8 | Reference compound |
| HY-19584 | Variotin | 19504-77-9 | Natural Products |
| HY-19585 | Enloplatin | 111523-41-2 | Reference compound |
| HY-19586 | Albifylline | 107767-55-5 | Reference compound |
| HY-19587 | Ditercalinium (chloride) | 74517-42-3 | Reference compound |
| HY-19589 | JTS-653 | 942614-99-5 | Reference compound |
| HY-19590 | Etarotene | 87719-32-2 | Reference compound |
| HY-19593 | Nikkomycin Z | 59456-70-1 | Reference compound |
| HY-19594 | Teclozan | 5560-78-1 | Reference compound |
| HY-19594R | Teclozan (Standard) | 5560-78-1 | Reference Standards |
| HY-19596 | Fenprinast | 75184-94-0 | Reference compound |
| HY-19599 | Vorozole | 129731-10-8 | Reference compound |
| HY-19599A | (Rac)-Vorozole | 118949-22-7 | Reference compound |
| HY-19601 | Carzelesin | 119813-10-4 | Reference compound |
| HY-19602 | Cedefingol | 35301-24-7 | Reference compound |
| HY-19606 | Cytogenin | 132971-59-6 | Reference compound |
| HY-19608 | GSK1016790A | 942206-85-1 | Reference compound |
| HY-19609 | Calicheamicin | 108212-75-5 | ADC Related |
| HY-19610 | α-Amanitin | 23109-05-9 | ADC Related |
| HY-19612A | DDP-38003 (dihydrochloride) | 1831167-98-6 | Reference compound |
| HY-19612B | DDP-38003 (trihydrochloride) | Reference compound | |
| HY-19614 | BMS-795311 | 939390-99-5 | Reference compound |
| HY-19615 | MS023 | 1831110-54-3 | Reference compound |
| HY-19615A | MS023 (trihydrochloride) | 2108631-19-0 | Reference compound |
| HY-19615B | MS023 (dihydrochloride) | 1992047-64-9 | Reference compound |
| HY-19617 | EGFR-IN-1 | 1625677-63-5 | Reference compound |
| HY-19617A | EGFR-IN-1 (hydrochloride) | 2227455-78-7 | Reference compound |
| HY-19617B | EGFR-IN-1 (TFA) | 2753348-63-7 | Reference compound |
| HY-19618 | BRD3308 | 1550053-02-5 | Reference compound |
| HY-19619 | m-3M3FBS | 200933-14-8 | Reference compound |
| HY-19620 | Branaplam | 1562338-42-4 | Reference compound |
| HY-19620A | Branaplam (hydrochloride) | 1562338-39-9 | Reference compound |
| HY-19621 | THS-044 | 62054-67-5 | Reference compound |
| HY-19622 | PF-9184 | 1221971-47-6 | Reference compound |
| HY-19623 | VU0092273 | 393110-43-5 | Reference compound |
| HY-19624 | NVP-ACC789 | 300842-64-2 | Reference compound |
| HY-19625 | MCB-613 | 1162656-22-5 | Reference compound |
| HY-19625A | (E/Z)-MCB-613 | 296792-62-6 | Reference compound |
| HY-19626 | NSC23925 | 858474-14-3 | Reference compound |
| HY-19627 | Naldemedine | 916072-89-4 | Reference compound |
| HY-19627A | Naldemedine (tosylate) | 1345728-04-2 | Reference compound |
| HY-19628 | OD36 | 1638644-62-8 | Reference compound |
| HY-19628A | OD36 (hydrochloride) | 2387510-88-3 | Reference compound |
| HY-19630 | ML289 | 1382481-79-9 | Reference compound |
| HY-19631 | Ilginatinib (maleate) | 1354799-87-3 | Reference compound |
| HY-19631A | Ilginatinib | 1239358-86-1 | Reference compound |
| HY-19631B | Ilginatinib hydrochloride | 1239358-85-0 | Reference compound |
| HY-19632 | Fezolinetant | 1629229-37-3 | Reference compound |
| HY-19633 | CS-003 (Free base) | 191672-52-3 | Reference compound |
| HY-19633A | CS-003 | 216776-73-7 | Reference compound |
| HY-19634 | YK-3-237 | 1215281-19-8 | Reference compound |
| HY-19635 | G-5555 | 1648863-90-4 | Reference compound |
| HY-19635A | G-5555 (hydrochloride) | 2319590-15-1 | Reference compound |
| HY-19636 | JNJ-42165279 | 1346528-50-4 | Reference compound |
| HY-19636A | JNJ-42165279 (dihydrochloride) | 1346528-51-5 | Reference compound |
| HY-19637 | SW044248 | 522650-83-5 | Reference compound |
| HY-19638 | Cangrelor | 163706-06-7 | Reference compound |
| HY-19638A | Cangrelor (tetrasodium) | 163706-36-3 | Reference compound |
| HY-19639 | E-982 | 858102-78-0 | Reference compound |
| HY-19640 | AG-85 | 152503-91-8 | Reference compound |
| HY-19641 | AH13205 | 148436-63-9 | Biochemical Assay Reagents |
| HY-19642 | Glesatinib | 936694-12-1 | Reference compound |
| HY-19642A | Glesatinib (hydrochloride) | 1123838-51-6 | Reference compound |
| HY-19643 | JTK-109 | 480462-62-2 | Reference compound |
| HY-19644 | GSK2256294A | 1142090-23-0 | Reference compound |
| HY-19646 | Zoliprofen | 56355-17-0 | Reference compound |
| HY-19647 | Ritipenem acoxil | 87238-52-6 | Reference compound |
| HY-19648 | Ebiratide | 105611-68-5 | Peptides |
| HY-19648B | Ebiratide (TFA) | Peptides | |
| HY-19649 | Candoxatril | 123122-55-4 | Reference compound |
| HY-19650 | Pumosetrag Hydrochloride | 194093-42-0 | Reference compound |
| HY-19651 | Zanapezil (free base) | 142852-50-4 | Reference compound |
| HY-19651A | Zanapezil | 142852-51-5 | Reference compound |
| HY-19651B | Zanapezil (fumarate) | 263248-42-6 | Reference compound |
| HY-19652A | (S)-Oxybutynin (hydrochloride) | 230949-16-3 | Reference compound |
| HY-19652S1 | (S)-Oxybutynin-d10 | 1189190-86-0 | Isotope-Labeled Compounds |
| HY-19654 | GSK598809 | 863680-45-9 | Reference compound |
| HY-19654B | (-)-GSK598809 | 863680-46-0 | Reference compound |
| HY-19654C | (-)-GSK598809 (hydrochloride) | 863766-31-8 | Reference compound |
| HY-19655 | Cethromycin | 205110-48-1 | Reference compound |
| HY-19655S | Cethromycin-d6 | Isotope-Labeled Compounds | |
| HY-19656 | HMR1426 | 262376-75-0 | Reference compound |
| HY-19657 | Oxypurinol | 2465-59-0 | Natural Products |
| HY-19657R | Oxypurinol (Standard) | 2465-59-0 | Reference Standards |
| HY-19657S | Oxypurinol-13C,15N2 | Isotope-Labeled Compounds | |
| HY-19658 | Serazapine | 115313-22-9 | Reference compound |
| HY-19660 | Inogatran | 155415-08-0 | Reference compound |
| HY-19661 | Tecadenoson | 204512-90-3 | Reference compound |
| HY-19662 | Cronidipine | 113759-50-5 | Reference compound |
| HY-19663 | Lemildipine | 94739-29-4 | Reference compound |
| HY-19664 | Pranidipine | 99522-79-9 | Reference compound |
| HY-19665 | Lanepitant | 170566-84-4 | Reference compound |
| HY-19666 | DPI 201-106 | 97730-95-5 | Reference compound |
| HY-19667 | BMS-561392 | 611227-74-8 | Reference compound |
| HY-19667A | BMS-561392 (formate) | 2922280-85-9 | Reference compound |
| HY-19668A | SGS518 (oxalate) | 445441-27-0 | Reference compound |
| HY-19670 | Befetupitant | 290296-68-3 | Reference compound |
| HY-19671 | Apomine | 126411-13-0 | Reference compound |
| HY-19672 | Lirimilast | 329306-27-6 | Reference compound |
| HY-19673 | KUL-7211 | 220129-58-8 | Reference compound |
| HY-19673A | KUL-7211 (racemate) | 911196-40-2 | Reference compound |
| HY-19674 | SSR182289 | 363151-21-7 | Reference compound |
| HY-19675 | Naproxen etemesil | 385800-16-8 | Reference compound |
| HY-19676 | Pralnacasan | 192755-52-5 | Reference compound |
| HY-19677 | Cipemastat | 190648-49-8 | Reference compound |
| HY-19678C | Trospectomycin (dihydrochloride) | 85951-37-7 | Biochemical Assay Reagents |
| HY-19679 | Quinacainol | 86073-85-0 | Reference compound |
| HY-19679A | Quinacainol (dihydrochloride) | 83255-74-7 | Reference compound |
| HY-19680 | Prinomide (tromethamine) | 109636-76-2 | Reference compound |
| HY-19682 | Enciprazine | 68576-86-3 | Reference compound |
| HY-19684 | Pancopride | 121650-80-4 | Reference compound |
| HY-19686 | Ipsapirone | 95847-70-4 | Reference compound |
| HY-19686A | Ipsapirone (hydrochloride) | 92589-98-5 | Reference compound |
| HY-19687 | Zopolrestat | 110703-94-1 | Reference compound |
| HY-19688A | Sitamaquine (hydrochloride) | 5330-29-0 | Reference compound |
| HY-19688B | Sitamaquine (tosylate) | 1019640-33-5 | Reference compound |
| HY-19690 | Ritobegron (hydrochloride) | 476333-91-2 | Reference compound |
| HY-19692 | Itasetron | 123258-84-4 | Reference compound |
| HY-19693 | Cariporide | 159138-80-4 | Reference compound |
| HY-19694 | BRD7552 | 1137359-47-7 | Reference compound |
| HY-19695 | (-)-p-Bromotetramisole (oxalate) | 62284-79-1 | Biochemical Assay Reagents |
| HY-19696 | Tauroursodeoxycholate | 14605-22-2 | Natural Products |
| HY-19696A | Tauroursodeoxycholate (sodium) | 35807-85-3 | Reference compound |
| HY-19696AS | Tauroursodeoxycholate-d4 (sodium) | 2410279-95-5 | Isotope-Labeled Compounds |
| HY-19696B | Tauroursodeoxycholate (dihydrate) | 117609-50-4 | Reference compound |
| HY-19696R | Tauroursodeoxycholate (Standard) | 14605-22-2 | Reference Standards |
| HY-19696S | Tauroursodeoxycholate-d5 | 1207294-25-4 | Isotope-Labeled Compounds |
| HY-19696S1 | Tauroursodeoxycholate-d4 | 2410279-94-4 | Isotope-Labeled Compounds |
| HY-19696S2 | Tauroursodeoxycholate-d4-1 | 2573035-17-1 | Isotope-Labeled Compounds |
| HY-19697 | Aminocaproyl-Val-Cit-PABC-MMAE | 1374407-35-8 | Reference compound |
| HY-19698 | 4-Chlorophenoxyacetic acid (4-CPA) | 122-88-3 | Biochemical Assay Reagents |
| HY-19698A | 4-Chlorophenoxyacetic acid (sodium) | 13730-98-8 | Biochemical Assay Reagents |
| HY-19698AR | 4-Chlorophenoxyacetic acid (sodium) (Standard) | 13730-98-8 | Reference Standards |
| HY-19698R | 4-Chlorophenoxyacetic acid (4-CPA) (Standard) | 122-88-3 | Reference Standards |
| HY-19700 | trans-Zeatin | 1637-39-4 | Natural Products |
| HY-19700R | trans-Zeatin (Standard) | 1637-39-4 | Reference Standards |
| HY-19700S | trans-Zeatin-d5 | 72963-19-0 | Isotope-Labeled Compounds |
| HY-19702 | PKR activator 3 | 1628428-01-2 | Reference compound |
| HY-19705 | Adriforant | 943057-12-3 | Reference compound |
| HY-19705B | Adriforant (hydrochloride) | 2096455-90-0 | Reference compound |
| HY-19706 | ARS-853 | 1629268-00-3 | Reference compound |
| HY-19707 | 4μ8C | 14003-96-4 | Reference compound |
| HY-19708 | KIRA6 | 1589527-65-0 | Reference compound |
| HY-19710 | MKC3946 | 1093119-54-0 | Reference compound |
| HY-19711 | STING agonist-1 | 702662-50-8 | Reference compound |
| HY-19712 | LJH685 | 1627710-50-2 | Reference compound |
| HY-19713 | LJI308 | 1627709-94-7 | Reference compound |
| HY-19714 | XY1 | 1624117-53-8 | Reference compound |
| HY-19715 | SGC707 | 1687736-54-4 | Reference compound |
| HY-19717 | DCVC | 13419-46-0 | Reference compound |
| HY-19717S | DCVC-13C3,15N | Isotope-Labeled Compounds | |
| HY-19718 | OTS964 | 1338542-14-5 | Reference compound |
| HY-19719 | Miransertib | 1313881-70-7 | Reference compound |
| HY-19719A | Miransertib (hydrochloride) | 1313883-00-9 | Reference compound |
| HY-19720 | Emixustat | 1141777-14-1 | Reference compound |
| HY-19720A | Emixustat (hydrochloride) | 1141934-97-5 | Reference compound |
| HY-19721 | ABT-639 | 1235560-28-7 | Reference compound |
| HY-19725 | A-1155463 | 1235034-55-5 | Reference compound |
| HY-19726 | NSC59984 | 803647-40-7 | Reference compound |
| HY-19727 | FOY 251 (free base) | 71079-08-8 | Reference compound |
| HY-19727A | FOY 251 | 71079-09-9 | Reference compound |
| HY-19729 | Naquotinib | 1448232-80-1 | Reference compound |
| HY-19730 | Olmutinib | 1353550-13-6 | Reference compound |
| HY-19730A | Olmutinib (hydrochloride) | 1842366-97-5 | Reference compound |
| HY-19731 | SID 3712249 | 522606-67-3 | Reference compound |
| HY-19732 | BIBS 39 | 133085-33-3 | Reference compound |
| HY-19733 | Lumateperone (tosylate) | 1187020-80-9 | Reference compound |
| HY-19733S | Lumateperone-13C,d3 (tosylate) | Isotope-Labeled Compounds | |
| HY-19734 | NK-252 | 1414963-82-8 | Reference compound |
| HY-19735 | KJ Pyr 9 | 581073-80-5 | Reference compound |
| HY-19736 | TY-52156 | 934369-14-9 | Reference compound |
| HY-19737A | DG172 (dihydrochloride) | 1361504-77-9 | Reference compound |
| HY-19738 | NQTrp | 185351-19-3 | Reference compound |
| HY-19739 | JW74 | 863405-60-1 | Reference compound |
| HY-19740 | BIA 10-2474 | 1233855-46-3 | Reference compound |
| HY-19741 | A-1331852 | 1430844-80-6 | Reference compound |
| HY-19742A | Lecozotan (hydrochloride) | 433282-68-9 | Reference compound |
| HY-19743 | Triazavirin | 928659-17-0 | Reference compound |
| HY-19744 | T6167923 | 2437475-16-4 | Reference compound |
| HY-19745 | BMS-202 | 1675203-84-5 | Reference compound |
| HY-19745A | N-deacetylated BMS-202 | 2310135-18-1 | Reference compound |
| HY-19745B | BMS-202 (hydrochloride) | 2089334-95-0 | Reference compound |
| HY-19747 | HPOB | 1429651-50-2 | Reference compound |
| HY-19748 | LED209 | 245342-14-7 | Reference compound |
| HY-19749 | PD 151746 | 181765-30-0 | Reference compound |
| HY-19750 | TBA-7371 | 1494675-86-3 | Reference compound |
| HY-19752A | VU0357017 (hydrochloride) | 1135242-13-5 | Reference compound |
| HY-19753 | KS176 | 1253452-78-6 | Reference compound |
| HY-19754 | CRA-026440 | 847460-34-8 | Reference compound |
| HY-19754A | CRA-026440 (hydrochloride) | 847459-98-7 | Reference compound |
| HY-19755 | S-5751 | 209268-36-0 | Reference compound |
| HY-19756 | OTX008 | 286936-40-1 | Reference compound |
| HY-19757 | Lp-PLA2-IN-1 | 1420367-28-7 | Reference compound |
| HY-19758A | Sirtuin modulator 1 | 2070015-26-6 | Reference compound |
| HY-19759 | SRT 2183 | 1001908-89-9 | Reference compound |
| HY-19760 | I-BET282 | 1422554-34-4 | Reference compound |
| HY-19760B | I-BET282E | 2885162-99-0 | Reference compound |
| HY-19761 | RIP2 kinase inhibitor 2 | 1581270-11-2 | Reference compound |
| HY-19762 | GSK1940029 | 1150701-66-8 | Reference compound |
| HY-19763 | Ifupinostat | 1235449-52-1 | Reference compound |
| HY-19764 | GSK2983559 active metabolite | 1423186-80-4 | Reference compound |
| HY-19765 | GSK2798745 | 1419609-94-1 | Reference compound |
| HY-19767 | GSK 3008348 | 1629249-33-7 | Reference compound |
| HY-19767A | GSK 3008348 (hydrochloride) | 1629249-40-6 | Reference compound |
| HY-19768 | Danirixin | 954126-98-8 | Reference compound |
| HY-19770 | GSK2981278 | 1474110-21-8 | Reference compound |
| HY-19771 | amyloid P-IN-1 | 1819986-22-5 | Reference compound |
| HY-19772 | GSK3117391 | 1018673-42-1 | Reference compound |
| HY-19773 | β-Lactamase-IN-1 | 1075237-97-6 | Reference compound |
| HY-19774 | GNE-0946 | 1677667-24-1 | Reference compound |
| HY-19775 | GNE-6468 | 1677668-27-7 | Reference compound |
| HY-19776 | 3α-Aminocholestane | 2206-20-4 | Reference compound |
| HY-19778 | (R)-BPO-27 | 1415390-47-4 | Reference compound |
| HY-19778A | BPO-27 (racemate) | 1314873-02-3 | Reference compound |
| HY-19779 | JTT 551 | 776309-04-7 | Reference compound |
| HY-19791 | N-Acetyl-Calicheamicin | 108212-76-6 | Reference compound |
| HY-19792 | Mertansine | 139504-50-0 | ADC Related |
| HY-19793 | RS-1 | 312756-74-4 | Reference compound |
| HY-19794 | MP-A08 | 219832-49-2 | Reference compound |
| HY-19795 | ML240 | 1346527-98-7 | Reference compound |
| HY-19796 | Icomidocholic acid | 246529-22-6 | Reference compound |
| HY-19796R | Icomidocholic acid (Standard) | 246529-22-6 | Reference Standards |
| HY-19797 | ML241 | 1346528-06-0 | Reference compound |
| HY-19797A | ML241 (hydrochloride) | 2070015-13-1 | Reference compound |
| HY-19798 | PI4KIIIbeta-IN-9 | 1429624-84-9 | Reference compound |
| HY-19800 | ML-098 | 878978-76-8 | Reference compound |
| HY-19801 | CVT-10216 | 1005334-57-5 | Reference compound |
| HY-19803 | Naquotinib (mesylate) | 1448237-05-5 | Reference compound |
| HY-19804 | Photo-lysine | 1863117-91-2 | Biochemical Assay Reagents |
| HY-19804A | Photo-lysine (hydrochloride) | Biochemical Assay Reagents | |
| HY-19805 | STO-609 | 52029-86-4 | Reference compound |
| HY-19805A | STO-609 (acetate) | 1173022-21-3 | Reference compound |
| HY-19806 | Ceftolozane | 689293-68-3 | Reference compound |
| HY-19806A | Ceftolozane (sulfate) | 936111-69-2 | Reference compound |
| HY-19807 | Indirubin-3'-monoxime | 160807-49-8 | Reference compound |
| HY-19808 | C-DIM12 | 178946-89-9 | Reference compound |
| HY-19809 | MI-463 | 1628317-18-9 | Reference compound |
| HY-19810 | MI-538 | 1857417-10-7 | Reference compound |
| HY-19811 | Fmoc-Val-Cit-PAB-MMAE | 1350456-56-2 | ADC Related |
| HY-19812 | Acetylene-linker-Val-Cit-PABC-MMAE | 1411977-95-1 | ADC Related |
| HY-19813A | mDPR-Val-Cit-PAB-MMAE (TFA) | 2185872-76-6 | Reference compound |
| HY-19814 | Toripristone | 91935-26-1 | Reference compound |
| HY-19815 | Olafertinib | 1660963-42-7 | Reference compound |
| HY-19816 | Avitinib | 1557267-42-1 | Reference compound |
| HY-19816A | Avitinib (maleate) | 1557268-88-8 | Reference compound |
| HY-19817 | PRT4165 | 31083-55-3 | Reference compound |
| HY-19818 | NAN-190 | 102392-05-2 | Reference compound |
| HY-19818A | NAN-190 (hydrobromide) | 115338-32-4 | Reference compound |
| HY-19819 | NSC117079 | 500363-63-3 | Reference compound |
| HY-19820 | NSC45586 | 739301-85-0 | Reference compound |
| HY-19820A | NSC45586 (sodium) | 6300-44-3 | Reference compound |
| HY-19821 | Fmoc-Ile-OH | 71989-23-6 | Peptides |
| HY-19821S | Fmoc-Ile-OH-15N | 204633-89-6 | Isotope-Labeled Compounds |
| HY-19821S1 | Fmoc-Ile-OH-13C6,15N | 1217442-29-9 | Isotope-Labeled Compounds |
| HY-19822 | Elacestrant | 722533-56-4 | Reference compound |
| HY-19822A | Elacestrant (dihydrochloride) | 1349723-93-8 | Reference compound |
| HY-19822B | Elacestrant (S enantiomer dihydrochloride) | 2309762-30-7 | Reference compound |
| HY-19822D | Elacestrant (S enantiomer) | 2309762-29-4 | Reference compound |
| HY-19822S | Elacestrant-d4 | Isotope-Labeled Compounds | |
| HY-19822S1 | Elacestrant-d4-1 | Isotope-Labeled Compounds | |
| HY-19822S2 | Elacestrant-d10 | Isotope-Labeled Compounds | |
| HY-19822S3 | Elacestrant-d6 | Isotope-Labeled Compounds | |
| HY-19824 | 3PO | 18550-98-6 | Reference compound |
| HY-19825 | Rebeccamycin | 93908-02-2 | Natural Products |
| HY-19826 | Isofistularin-3 | ADC Related | |
| HY-19827 | Aeroplysinin 1 | 28656-91-9 | Natural Products |
| HY-19828 | Herboxidiene | 142861-00-5 | Natural Products |
| HY-19829 | Sandramycin | 100940-65-6 | Natural Products |
| HY-19830 | AN3199 | 1187187-10-5 | Reference compound |
| HY-19831 | 4EGI-1 | 315706-13-9 | Reference compound |
| HY-19831A | (Z)-4EGI-1 | 901787-88-0 | Reference compound |
| HY-19832 | SC66 | 871361-88-5 | Reference compound |
| HY-19833 | CFG920 | 1260006-20-9 | Reference compound |
| HY-19834 | Fenebrutinib | 1434048-34-6 | Reference compound |
| HY-19835 | LY2922470 | 1423018-12-5 | Reference compound |
| HY-19836 | Zimlovisertib | 1817626-54-2 | Reference compound |
| HY-19837 | BMS-986120 | 1478712-37-6 | Reference compound |
| HY-19838 | JNJ-63533054 | 1802326-66-4 | Reference compound |
| HY-19840 | Voxilaprevir | 1535212-07-7 | Reference compound |
| HY-19842 | GS-9667 | 618380-90-8 | Reference compound |
| HY-19843 | MK-0941 | 1137916-97-2 | Reference compound |
| HY-19843A | MK-0941 (free base) | 752240-01-0 | Reference compound |
| HY-19845 | Ordopidine | 871351-60-9 | Reference compound |
| HY-19845A | Ordopidine (hydrochloride) | 871351-61-0 | Reference compound |
| HY-19846 | VRX-03011 | 869493-26-5 | Reference compound |
| HY-19848 | Cevoglitazar | 839673-52-8 | Reference compound |
| HY-19849 | BGC-20-1531 (free base) | 736183-35-0 | Reference compound |
| HY-19850 | Exeporfinium (chloride) | 718638-68-7 | Reference compound |
| HY-19851 | Rovafovir etalafenamide | 912809-27-9 | Reference compound |
| HY-19855 | AZD-5069 | 878385-84-3 | Reference compound |
| HY-19856 | Valnivudine (hydrochloride) | 956483-03-7 | Reference compound |
| HY-19857 | Sulcardine (sulfate) | 343935-61-5 | Reference compound |
| HY-19858 | LY-466195 | 317844-33-0 | Reference compound |
| HY-19859 | AMG-222 (tosylate) | 1163719-08-1 | Reference compound |
| HY-19861 | SMP-028 | 914389-14-3 | Reference compound |
| HY-19863 | F-15599 | 635323-95-4 | Reference compound |
| HY-19863A | F-15599 (tosylate) | 955112-72-8 | Reference compound |
| HY-19864 | Aganepag | 910562-18-4 | Reference compound |
| HY-19866 | Darexaban glucuronide | 432029-12-4 | Reference compound |
| HY-19867A | Burixafor (hydrobromide) | 1191450-19-7 | Reference compound |
| HY-19870 | Setmelanotide | 920014-72-8 | Peptides |
| HY-19870A | Setmelanotide (TFA) | Peptides | |
| HY-19870C | Setmelanotide (monoacetate) | 2759937-80-7 | Reference compound |
| HY-19871 | AZD-3199 | 925243-19-2 | Reference compound |
| HY-19872 | AZD-6280 | 942436-93-3 | Reference compound |
| HY-19873 | SL-052 | 925438-34-2 | Reference compound |
| HY-19874 | RFI-641 | 197366-24-8 | Reference compound |
| HY-19875 | Seridopidine | 883631-51-4 | Reference compound |
| HY-19876 | PL37 | 935481-06-4 | Reference compound |
| HY-19877 | GSK932121 | 958457-44-8 | Reference compound |
| HY-19880 | RWJ-676070 | 813426-25-4 | Reference compound |
| HY-19881 | ABT-288 | 948845-91-8 | Reference compound |
| HY-19882 | BAL-30072 | 941285-15-0 | Reference compound |
| HY-19883 | Lusutrombopag | 1110766-97-6 | Reference compound |
| HY-19883R | Lusutrombopag (Standard) | 1110766-97-6 | Reference Standards |
| HY-19883S | Lusutrombopag-d13 | Isotope-Labeled Compounds | |
| HY-19884 | Relamorelin | 661472-41-9 | Peptides |
| HY-19884A | Relamorelin (acetate) | 1809080-14-5 | Peptides |
| HY-19884B | Relamorelin (TFA) | 2863659-22-5 | Peptides |
| HY-19886 | F 16915 | 92510-91-3 | Reference compound |
| HY-19887 | Tilapertin | 1000690-85-6 | Reference compound |
| HY-19888 | GSK-1482160 | 1001389-72-5 | Reference compound |
| HY-19889 | JNJ-18038683 | 851376-05-1 | Reference compound |
| HY-19889A | JNJ-18038683 (free base) | 851373-91-6 | Reference compound |
| HY-19890 | Aminaftone | 14748-94-8 | Reference compound |
| HY-19891A | Pixatimod (free acid) | 1144617-49-1 | Reference compound |
| HY-19892 | Brilacidin | 1224095-98-0 | Reference compound |
| HY-19892A | Brilacidin (tetrahydrochloride) | 1224095-99-1 | Reference compound |
| HY-19893 | Antroquinonol | 1010081-09-0 | Reference compound |
| HY-19895 | DS-8587 | 1356918-39-2 | Reference compound |
| HY-19896 | COTI-2 | 1039455-84-9 | Reference compound |
| HY-19897 | 4SC-203 | 895533-09-2 | Reference compound |
| HY-19899 | APD-916 | 1021169-11-8 | Reference compound |
| HY-19900 | ITX5061 | 1252679-52-9 | Reference compound |
| HY-19902 | GSK1521498 | 1426543-84-1 | Reference compound |
| HY-19903 | ASP-9521 | 1126084-37-4 | Reference compound |
| HY-19904 | Adomeglivant | 1488363-78-5 | Reference compound |
| HY-19904A | (+/-)-Adomeglivant | 872260-47-4 | Reference compound |
| HY-19904B | (+)-Adomeglivant | 872260-19-0 | Reference compound |
| HY-19905 | GW-597901 | 452339-68-3 | Reference compound |
| HY-19907 | Liafensine | 1198790-53-2 | Reference compound |
| HY-19908 | BAY-85-8501 | 1161921-82-9 | Reference compound |
| HY-19908B | (R)-BAY-85-8501 | 2446175-39-7 | Reference compound |
| HY-19909 | NRC-2694 | 936446-61-6 | Reference compound |
| HY-19909A | NRC-2694-A | 1172626-99-1 | Reference compound |
| HY-19910 | Acoziborole | 1266084-51-8 | Reference compound |
| HY-19911 | Pefcalcitol | 381212-03-9 | Reference compound |
| HY-19912 | Fruquintinib | 1194506-26-7 | Reference compound |
| HY-19912R | Fruquintinib (Standard) | 1194506-26-7 | Reference Standards |
| HY-19914 | MK-1064 | 1207253-08-4 | Reference compound |
| HY-19915 | Contezolid | 1112968-42-9 | Reference compound |
| HY-19915A | Contezolid acefosamil | 1807497-11-5 | Reference compound |
| HY-19915B | Contezolid acefosamil (sodium) | 1807365-35-0 | Reference compound |
| HY-19916 | Lisavanbulin | 1263384-43-5 | Reference compound |
| HY-19916A | Lisavanbulin (dihydrochloride) | 1387574-54-0 | Reference compound |
| HY-19917 | JNJ-39220675 | 959740-39-7 | Reference compound |
| HY-19918A | Anatabine (dicitrate) | Reference compound | |
| HY-19919 | BMS-779788 | 918348-67-1 | Reference compound |
| HY-19920 | AVX001 | 300553-18-8 | Reference compound |
| HY-19921 | JTK-853 | 954389-09-4 | Reference compound |
| HY-19923 | Aganepag isopropyl | 910562-20-8 | Reference compound |
| HY-19924 | GSK-1440115 | 1003878-16-7 | Reference compound |
| HY-19925 | AIC-292 | 1187917-12-9 | Reference compound |
| HY-19926 | GDC-0425 | 1200129-48-1 | Reference compound |
| HY-19927A | DA-6886 (monohydrochloride) | 1645260-76-9 | Reference compound |
| HY-19928 | Vactosertib | 1352608-82-2 | Reference compound |
| HY-19928A | Vactosertib (Hydrochloride) | 1352610-25-3 | Reference compound |
| HY-19929 | Tanimilast | 1239278-59-1 | Reference compound |
| HY-19929A | (R)-Tanimilast | Reference compound | |
| HY-19930 | Vaborbactam | 1360457-46-0 | Reference compound |
| HY-19931 | COH29 | 1190932-38-7 | Reference compound |
| HY-19933 | Vibegron | 1190389-15-1 | Reference compound |
| HY-19934 | Pifusertib | 1402602-94-1 | Reference compound |
| HY-19934A | Pifusertib (hydrochloride) | 2930090-28-9 | Reference compound |
| HY-19936 | ACHN-975 | 1410809-36-7 | Reference compound |
| HY-19936A | ACHN-975 (TFA) | 1410809-37-8 | Reference compound |
| HY-19937 | Saroglitazar | 495399-09-2 | Reference compound |
| HY-19937A | Saroglitazar (magnesium) | 1639792-20-3 | Reference compound |
| HY-19937S1 | Saroglitazar-d4 | Isotope-Labeled Compounds | |
| HY-19939S | VX-984 | 1476074-39-1 | Isotope-Labeled Compounds |
| HY-19939S2 | (R)-VX-984 | 2448475-19-0 | Isotope-Labeled Compounds |
| HY-19940 | Olitigaltin | 1450824-22-2 | Reference compound |
| HY-19942A | TD-5471 hydrochloride | 530084-35-6 | Reference compound |
| HY-19943 | TLC388 | 1432468-79-5 | Reference compound |
| HY-19944 | Dimethylenastron | 863774-58-7 | Reference compound |
| HY-19945 | DAA-1106 | 220551-92-8 | Reference compound |
| HY-19946 | Eptapirone | 179756-58-2 | Reference compound |
| HY-19946A | Eptapirone (fumarate) | 179756-85-5 | Reference compound |
| HY-19947 | PF-06291874 | 1393124-08-7 | Reference compound |
| HY-19948 | Leucomethylene blue (mesylate) | 1236208-20-0 | Dye Reagents |
| HY-19949 | HIF-2α-IN-1 | 1799948-06-3 | Reference compound |
| HY-19950 | 5-HT2A receptor agonist-6 | 1028307-48-3 | Reference compound |
| HY-19952 | Pleconaril | 153168-05-9 | Reference compound |
| HY-19952R | Pleconaril (Standard) | 153168-05-9 | Reference Standards |
| HY-19952S | Pleconaril-d4 | 2749329-20-0 | Isotope-Labeled Compounds |
| HY-19956 | GI254023X | 260264-93-5 | Reference compound |
| HY-19957 | Zoligratinib | 1265229-25-1 | Reference compound |
| HY-19958 | XEN907 | 912656-34-9 | Reference compound |
| HY-19959 | Mirin | 1198097-97-0 | Reference compound |
| HY-19960 | BCTC | 393514-24-4 | Reference compound |
| HY-19961 | KIN1408 | 1903800-11-2 | Reference compound |
| HY-19962 | Paxalisib | 1382979-44-3 | Reference compound |
| HY-19964 | Potassium clavulanate cellulose | Reference compound | |
| HY-19965 | UK-2A | 167173-85-5 | Natural Products |
| HY-19966 | K858 (Racemic) | 72926-24-0 | Reference compound |
| HY-19969 | YM-90709 | 163769-88-8 | Reference compound |
| HY-19970 | KM11060 | 774549-97-2 | Reference compound |
| HY-19971 | ML239 | 1378872-36-6 | Reference compound |
| HY-19972 | ML243 | 1426576-80-8 | Reference compound |
| HY-19973 | ML354 | 89159-60-4 | Reference compound |
| HY-19974 | TAK-220 | 333994-00-6 | Reference compound |
| HY-19975 | RN-1734 | 946387-07-1 | Reference compound |
| HY-19976 | RN-1747 | 1024448-59-6 | Reference compound |
| HY-19977 | YU238259 | 1943733-16-1 | Reference compound |
| HY-19978 | RO-3 | 1026582-88-6 | Reference compound |
| HY-19979 | RCM-1 | 339163-65-4 | Reference compound |
| HY-19980 | Eprenetapopt | 5291-32-7 | Reference compound |
| HY-19980A | PRIMA-1 | 5608-24-2 | Reference compound |
| HY-19981 | Derazantinib | 1234356-69-4 | Reference compound |
| HY-19981A | Derazantinib (Racemate) | 2309668-44-6 | Reference compound |
| HY-19981B | Derazantinib (dihydrochloride) | 1821329-75-2 | Reference compound |
| HY-19982 | AKT-IN-6 | 1430056-54-4 | Reference compound |
| HY-19983 | ASP5878 | 1453208-66-6 | Reference compound |
| HY-19984 | CCT-251921 | 1607837-31-9 | Reference compound |
| HY-19985 | PF-06459988 | 1428774-45-1 | Reference compound |
| HY-19985A | (3S,4S)-PF-06459988 | 1858291-14-1 | Reference compound |
| HY-19986 | AAL993 | 269390-77-4 | Reference compound |
| HY-19987 | BML-284 | 853220-52-7 | Reference compound |
| HY-19987A | BML-284 (hydrochloride) | 2095432-75-8 | Reference compound |
| HY-19988 | THZ1-R | 1621523-07-6 | Reference compound |
| HY-19989 | MK-571 | 115104-28-4 | Reference compound |
| HY-19989A | MK-571 (sodium) | 115103-85-0 | Reference compound |
| HY-19990 | ALK kinase inhibitor-1 | 1462949-64-9 | Reference compound |
| HY-19991 | BMS-1 | 1675201-83-8 | Reference compound |
| HY-19991A | (Rac)-BMS-1 | 1675201-97-4 | Reference compound |
| HY-19992 | 3-Bromopyruvic acid | 1113-59-3 | Reference compound |
| HY-19994 | ML264 | 1550008-55-3 | Reference compound |
| HY-19995 | GSK137647A | 349085-82-1 | Reference compound |
| HY-19996 | AH-7614 | 6326-06-3 | Reference compound |
| HY-19997 | Mannose triflate | 92051-23-5 | Biochemical Assay Reagents |
| HY-19998 | Taprenepag isopropyl | 1005549-94-9 | Reference compound |
| HY-19999 | PF-CBP1 | 1962928-21-7 | Reference compound |
| HY-19999A | PF-CBP1 hydrochloride | 2070014-93-4 | Reference compound |
| HY-20003 | (-)-Corey lactone benzoate | 39746-00-4 | Reference compound |
| HY-200129 | PCNA-IN-1 | 1417653-45-2 | Reference compound |
| HY-20019 | L-165041 | 79558-09-1 | Reference compound |
| HY-20022 | 3,4-Dibromothiophene | 3141-26-2 | Biochemical Assay Reagents |
| HY-20026 | 2-Bromo-3-pyridinol | 6602-32-0 | Biochemical Assay Reagents |
| HY-20042 | 2-Amino-3-hydroxynitrobenzene | 603-85-0 | Biochemical Assay Reagents |
| HY-200444 | Lipid catechol | 2930813-52-6 | Oligonucleotides |
| HY-200615 | Methyl 4,4-difluoro-1-cyclohexene-1-carboxylate | 1785316-56-4 | Reference compound |
| HY-200656 | 3-(4-Chloropyridin-2-yl)oxetan-3-amine (hydrochloride) | 2879235-73-9 | Reference compound |
| HY-20070 | BMS-566394 | 503166-51-6 | Reference compound |
| HY-20074 | (+)-Pinanediol | 18680-27-8 | Biochemical Assay Reagents |
| HY-20128 | Piperazin-2-one | 5625-67-2 | Biochemical Assay Reagents |
| HY-201283A | ((R)-3-Hydroxybutanoyl)-L-phenylalanine (lithium) | 3017120-68-9 | Peptides |
| HY-20128S | Piperazin-2-one-d6 | 1219803-71-0 | Isotope-Labeled Compounds |
| HY-20140 | 5'-O-DMT-dT | 40615-39-2 | Oligonucleotides |
| HY-20142 | 3’-O-(t-Butyldiphenylsilyl) thymidine | 83467-48-5 | Reference compound |
| HY-20153 | Ethyl 2-(2-(2-(4-chlorophenoxy)phenyl)-N-methylacetamido)acetate | 1035404-17-1 | Peptides |
| HY-201580 | ER ligand-8 | 2229713-97-5 | Reference compound |
| HY-20159S | Nicotinonitrile-d4 | 1020719-32-7 | Isotope-Labeled Compounds |
| HY-20165 | N-Carbobenzoxy-L-glutamic acid | 1155-62-0 | Peptides |
| HY-20167 | H-Glu(OtBu)-OtBu | 16874-06-9 | Peptides |
| HY-20167A | H-Glu(OtBu)-OtBu (hydrochloride) | 32677-01-3 | Peptides |
| HY-20180 | Pictilisib (dimethanesulfonate) | 957054-33-0 | Reference compound |
| HY-202399 | TCO-PEG2-NHS ester | 2250217-33-3 | Reference compound |
| HY-20240 | tert-Butyl (6-aminospiro[3.3]heptan-2-yl)carbamate | 1239589-52-6 | Reference compound |
| HY-20302 | (2S,3AS,7aS)-Octahydroindole-2-carboxylic acid | 80875-98-5 | Biochemical Assay Reagents |
| HY-20302R | (2S,3AS,7aS)-Octahydroindole-2-carboxylic acid (Standard) | 80875-98-5 | Reference Standards |
| HY-20304 | 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | 210907-84-9 | Biochemical Assay Reagents |
| HY-20336 | Mc-Val-Cit-PABC-PNP | 159857-81-5 | ADC Related |
| HY-20336G | Mc-Val-Cit-PABC-PNP (GMP) | 159857-81-5 | GMP Small Molecules |
| HY-20349 | Monobehenin | 30233-64-8 | Reference compound |
| HY-20362 | 4-Azaindole | 272-49-1 | Biochemical Assay Reagents |
| HY-20386S | 2-Chloro-N,N-dimethylacetamide-d3 | 1219802-19-3 | Isotope-Labeled Compounds |
| HY-20390S | Lapatinib impurity 18-d4 | Isotope-Labeled Compounds | |
| HY-20403 | PF-562271 (hydrochloride) | 939791-41-0 | Reference compound |
| HY-20436 | 4’-Bromoacetophenone | 99-90-1 | Biochemical Assay Reagents |
| HY-20457 | TL8-506 | 1268163-15-0 | Reference compound |
| HY-20459 | 4-Methoxypyridin-2-amine | 10201-73-7 | Biochemical Assay Reagents |
| HY-20460 | 2-Carboethoxyimidazole | 33543-78-1 | Biochemical Assay Reagents |
| HY-20512 | N,N'-Dibenzylethylenediamine | 140-28-3 | Biochemical Assay Reagents |
| HY-20512S | N,N'-Dibenzylethylenediamine-d4 | 1219795-20-6 | Isotope-Labeled Compounds |
| HY-20551 | (+)-Dibenzoyl-D-tartaric acid | 17026-42-5 | Biochemical Assay Reagents |
| HY-20556 | DBU | 6674-22-2 | Reference compound |
| HY-20558 | D-(+)-Malic acid | 636-61-3 | Natural Products |
| HY-20558R | D-(+)-Malic acid (Standard) | 636-61-3 | Reference Standards |
| HY-20559 | 4-Chloro-3-nitrobenzoic acid | 96-99-1 | Biochemical Assay Reagents |
| HY-20560 | (Ac)Phe-Lys(Alloc)-PABC-PNP | 2070009-39-9 | ADC Related |
| HY-20561 | N-Methyl-L-valine | 2480-23-1 | Peptides |
| HY-20561A | N-Methyl-D-valine | 88930-14-7 | Peptides |
| HY-20582 | L-Prolinamide | 7531-52-4 | Peptides |
| HY-20582S | L-Prolinamide-d3 | 1276197-55-7 | Isotope-Labeled Compounds |
| HY-20584 | 10-Deacetyl-7-xylosyl paclitaxel | 90332-63-1 | Natural Products |
| HY-20585 | 2-Acetylthiophene | 88-15-3 | Biochemical Assay Reagents |
| HY-20587 | CRAC intermediate 1 | 1249343-86-9 | Reference compound |
| HY-20588 | CRAC intermediate 2 | 123066-64-8 | Reference compound |
| HY-20685 | Palmitoylethanolamide | 544-31-0 | Natural Products |
| HY-20685R | Palmitoylethanolamide (Standard) | 544-31-0 | Reference Standards |
| HY-20685S | Palmitoylethanolamide-d4 | 1159908-45-8 | Isotope-Labeled Compounds |
| HY-20685S2 | Palmitoylethanolamide-d5 | 2117730-91-1 | Isotope-Labeled Compounds |
| HY-20696 | Tetrahydro-β-carboline | 16502-01-5 | Reference compound |
| HY-20696R | Tetrahydro-β-carboline (Standard) | 16502-01-5 | Reference Standards |
| HY-20737 | 2-Bromobenzimidazole | 54624-57-6 | Biochemical Assay Reagents |
| HY-20755 | 2,2,2-Trifluoro-N-(2-hydroxyethyl)acetamide | 6974-29-4 | Biochemical Assay Reagents |
| HY-20778S | Trimethylsulfonium-d9 (iodide) | 106776-17-4 | Isotope-Labeled Compounds |
| HY-20794 | 8-Hydroxyjulolidine | 41175-50-2 | Reference compound |
| HY-20797 | Boc-Piperazine-OH | 77279-24-4 | Reference compound |
| HY-20797S | 1-BOC-4-(2-Hydroxyethyl)piperazine-d4 | 1219802-10-4 | Isotope-Labeled Compounds |
| HY-20803 | 2,3-Dihydroxyquinoxaline | 15804-19-0 | Reference compound |
| HY-20808 | Antioxidant agent-15 | 596-38-3 | Reference compound |
| HY-20834 | α-Cyclobutylglycine | 28024-69-3 | Peptides |
| HY-20838 | 2-(Tetrahydropyran-4-yl)glycine | 53284-84-7 | Peptides |
| HY-20838A | (R)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)acetic acid | 475649-32-2 | Peptides |
| HY-20838B | (S)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)ethanoic acid | 811842-25-8 | Peptides |
| HY-20841 | Boc-(2S)-Gly-4-pyranoyl | 711017-85-5 | Peptides |
| HY-20861 | (R)-2-amino-3-cyclobutylpropanoic acid | 174266-00-3 | Peptides |
| HY-20874 | Deschlorodemethyldiazepam | 2898-08-0 | Reference compound |
| HY-20878 | Tyrphostin AG 879 | 148741-30-4 | Reference compound |
| HY-20897A | 5-Bromo-L-tryptophan | 25197-99-3 | Peptides |
| HY-20899 | 6-Bromo-L-tryptophan | 52448-17-6 | Reference compound |
| HY-21045 | 5-Fluoro-L-tryptophan | 16626-02-1 | Reference compound |
| HY-21065 | Tienilic acid | 40180-04-9 | Reference compound |
| HY-21065R | Tienilic acid (Standard) | 40180-04-9 | Reference Standards |
| HY-21075 | 3-Furanoic acid | 488-93-7 | Natural Products |
| HY-21088 | 3-Amino-2-piperidinone | 1892-22-4 | Natural Products |
| HY-21089 | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine (hydrochloride) | 28783-41-7 | Biochemical Assay Reagents |
| HY-21098 | PD-168077 | 190383-31-4 | Reference compound |
| HY-21098A | PD-168077 maleate | 630117-19-0 | Reference compound |
| HY-21170B | Trifluoromethanesulfonate (lithium) | 33454-82-9 | Biochemical Assay Reagents |
| HY-21170E | Zinc trifluoromethanesulfonate | 54010-75-2 | Reference compound |
| HY-21179 | Trimethylsilyl trifluoromethylsulfonate | 27607-77-8 | Reference compound |
| HY-21190 | Perfluorobutylsulfonyl fluoride | 375-72-4 | Reference compound |
| HY-21191 | Perfluorobutanesulfonic acid | 375-73-5 | Reference compound |
| HY-21193 | Perfluorovaleric acid | 2706-90-3 | Reference compound |
| HY-21193R | Perfluorovaleric acid (Standard) | 2706-90-3 | Reference Standards |
| HY-21194 | Perfluorohexanoic acid | 307-24-4 | Reference compound |
| HY-21195 | Perfluorohexylsulfonyl fluoride | 423-50-7 | Reference compound |
| HY-21196A | Potassium perfluorohexanesulfonate | 3871-99-6 | Reference compound |
| HY-21197 | Perfluoroenanthic acid | 375-85-9 | Reference compound |
| HY-21200 | Perfluoroheptanesulfonic acid | 375-92-8 | Reference compound |
| HY-21210 | 6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)- | 32602-11-2 | Reference compound |
| HY-21226 | Levoglucosenone | 37112-31-5 | Biochemical Assay Reagents |
| HY-21242 | MMT-Hexylaminolinker Phosphoramidite | 114616-27-2 | Reference compound |
| HY-21268 | Methyl linolenate | 301-00-8 | Natural Products |
| HY-21268S | Methyl linolenate-13C18 | Isotope-Labeled Compounds | |
| HY-21286 | N2-Isobutyryl-2'-O-methylguanosine | 63264-29-9 | Reference compound |
| HY-21289 | SU5205 | 3476-86-6 | Reference compound |
| HY-21290 | SU-4942 | 76086-99-2 | Reference compound |
| HY-21291 | SU-4313 | 186611-55-2 | Reference compound |
| HY-21292 | SU5214 | 186611-04-1 | Reference compound |
| HY-21293 | SU5201 | 114727-43-4 | Reference compound |
| HY-21297 | 3,5-Dihydroxy-2-naphthoic acid | 89-35-0 | Reference compound |
| HY-21323 | Isophthalic acid | 121-91-5 | Biochemical Assay Reagents |
| HY-21323R | Isophthalic acid (Standard) | 121-91-5 | Reference Standards |
| HY-21323S | Isophthalic-2,4,5,6 Acid-d4 | 148472-48-4 | Isotope-Labeled Compounds |
| HY-21336 | 3-Azetidinemethanol (hydrochloride) | 928038-44-2 | Reference compound |
| HY-21496 | 4-(Bromomethyl)benzoic acid | 6232-88-8 | Reference compound |
| HY-21509 | 8-Hydroxycoumarin | 2442-31-1 | Reference compound |
| HY-21545 | 5'-O-DMT-Bz-rA | 81246-82-4 | Oligonucleotides |
| HY-21577 | Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine | 175724-30-8 | ADC Related |
| HY-21586 | 7-Methyl-guanosine-5'-triphosphate (disodium) | 104809-18-9 | Reference compound |
| HY-21586B | 7-Methyl-guanosine-5'-triphosphate (sodium) | Biochemical Assay Reagents | |
| HY-21598S | 2,4-Dichloro-6-phenyl-1,3,5-triazine-d5 | 1480589-62-5 | Isotope-Labeled Compounds |
| HY-21601 | 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine | 81265-93-2 | Oligonucleotides |
| HY-21623 | Dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct | 95464-05-4 | Biochemical Assay Reagents |
| HY-21626 | 4-Tolylboronic acid | 5720-05-8 | Biochemical Assay Reagents |
| HY-21629 | N-Boc-4-piperidinemethanol | 123855-51-6 | Biochemical Assay Reagents |
| HY-21648 | 2'-OMe-Ac-C Phosphoramidite | 199593-09-4 | Oligonucleotides |
| HY-21703 | 3'-TBDMS-Bz-rA Phosphoramidite | 129451-75-8 | Oligonucleotides |
| HY-21713 | DMT-2'O-Methyl-rC(tac) phosphoramidite | 179486-26-1 | Reference compound |
| HY-21745 | MurA-IN-4 | 318280-69-2 | Reference compound |
| HY-21754 | Hygric acid | 475-11-6 | Natural Products |
| HY-21796 | 1-Methyl-3-phenylpropylamine | 22374-89-6 | Reference compound |
| HY-21930 | Pomalidomide-PEG4-C-COOH | 2097938-44-6 | Reference compound |
| HY-21953S | 3-Dehydroxy Chlorthalidone-d4 | 2673270-30-7 | Isotope-Labeled Compounds |
| HY-21972 | BCI-121 | 432529-82-3 | Reference compound |
| HY-21978 | 6-Chloro-2-iodopurine-9-riboside | 313477-85-9 | Reference compound |
| HY-21983 | O-Acetyl-N-[(1,1-dimethylethoxy)carbonyl]-L-threonine | 45214-52-6 | Peptides |
| HY-21994 | Org-12962 (hydrochloride) | 210821-63-9 | Reference compound |
| HY-21995 | BGC20-761 | 17375-63-2 | Reference compound |
| HY-21997 | DMT-2'fluoro-da(bz) amidite | 136834-22-5 | Biochemical Assay Reagents |
| HY-21999 | tert-Butyl 6-aminocaproate | 5514-98-7 | Reference compound |
| HY-22002 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-5-methyl-L-norleucine | 180414-94-2 | Peptides |
| HY-22009A | Strontium chloride,anhydrous grade,99.99% metals basis | 10476-85-4 | Biochemical Assay Reagents |
| HY-22009C | Strontium chloride,monohydrate grade,99.99% metals basis | 10476-85-4 | Biochemical Assay Reagents |
| HY-22024 | 5-Hydroxyflavone | 491-78-1 | Natural Products |
| HY-22044 | ICA | 3374-88-7 | Reference compound |
| HY-22055B | AN-12-H5 intermediate-1 | 254882-14-9 | Reference compound |
| HY-22062 | Fmoc-Chg-OH | 161321-36-4 | Peptides |
| HY-22166 | Glycolic acid oxidase inhibitor 1 | 77529-42-1 | Reference compound |
| HY-22167 | Methyl 2-hydroxy-4-methylvalerate | 40348-72-9 | Natural Products |
| HY-22167R | Methyl 2-hydroxy-4-methylvalerate (Standard) | 40348-72-9 | Reference Standards |
| HY-22183 | Anticonvulsant agent 3 | 59565-51-4 | Reference compound |
| HY-22252 | 4-Aminosalicylic acid (hemicalcium) | 133-15-3 | Reference compound |
| HY-22274 | DMPG (sodium) | 200880-40-6 | Biochemical Assay Reagents |
| HY-22274S | DMPG-d54 (sodium) | 326495-45-8 | Isotope-Labeled Compounds |
| HY-22295 | Fmoc-GABA-OH | 116821-47-7 | Biochemical Assay Reagents |
| HY-22296 | Fmoc-Thr-OBu-t | 120791-76-6 | Peptides |
| HY-22297 | Fmoc-Ser-OtBu | 110797-35-8 | Peptides |
| HY-22306 | β-D-Glucose pentaacetate | 604-69-3 | Natural Products |
| HY-22306S | β-D-Glucose pentaacetate-13C6 | 213020-65-6 | Isotope-Labeled Compounds |
| HY-22335 | Amino-PEG4-C2-amine | 68960-97-4 | Reference compound |
| HY-22340 | Azido-PEG4-alcohol | 86770-67-4 | Reference compound |
| HY-22365 | 1-Ethyl-3-methyl-1H-pyrazole-5-carboxylic acid | 50920-65-5 | Biochemical Assay Reagents |
| HY-22385 | Salsolidine | 5784-74-7 | Natural Products |
| HY-22385A | Salsolidine (hydrochloride) | 63283-42-1 | Natural Products |
| HY-22385B | (S)-Salsolidine | 493-48-1 | Natural Products |
| HY-22391 | tert-Butyl (7-aminoheptyl)carbamate | 99733-18-3 | Reference compound |
| HY-22393 | Diethylene Glycol Monobenzyl Ether | 2050-25-1 | Reference compound |
| HY-22437 | (±)-Darifenacin | 133033-93-9 | Reference compound |
| HY-22437S | (±)-Darifenacin-d4 | 1189701-43-6 | Isotope-Labeled Compounds |
| HY-22437S1 | (±)-Darifenacin-d4 (hydrobromide) | 2747914-16-3 | Isotope-Labeled Compounds |
| HY-22445 | MY05 | 667909-97-9 | Reference compound |
| HY-23020 | Boc3Arg | 108787-91-3 | Reference compound |
| HY-23033 | Tempone-H | 3637-11-4 | Reference compound |
| HY-23034 | Guaiacolsulfonate | 7134-11-4 | Reference compound |
| HY-23053 | H-D-SER(TBU)-OH | 18783-53-4 | Peptides |
| HY-23059 | 4-Dodecylbenzenesulfonic acid | 121-65-3 | Biochemical Assay Reagents |
| HY-23093 | L-Aspartyl-L-phenylalanine | 13433-09-5 | Reference compound |
| HY-23093R | L-Aspartyl-L-phenylalanine (Standard) | 13433-09-5 | Reference Standards |
| HY-23095 | Thalidomide-5-OH | 64567-60-8 | Reference compound |
| HY-23105 | Amino-PEG6-amine | 76927-70-3 | Reference compound |
| HY-23119 | Sodium thiocyanate, GR, 99% | 540-72-7 | Natural Products |
| HY-23120 | 1-Hydroxyguanidine (sulfate) | 6345-29-5 | Reference compound |
| HY-23122 | Boc-His-OMe | 2488-14-4 | Peptides |
| HY-23127 | Decyltriphenylphosphonium (bromide) | 32339-43-8 | Reference compound |
| HY-23148 | 1-Methylisatin | 2058-74-4 | Reference compound |
| HY-23149S | N,N,N-Trimethyl-1,3-propanediamine-d6 | 1219803-54-9 | Isotope-Labeled Compounds |
| HY-23155 | 2-Phenylethyl isothiocyanate | 2257-09-2 | Reference compound |
| HY-23155S | 2-Phenylethyl isothiocyanate-d5 | 912627-98-6 | Isotope-Labeled Compounds |
| HY-23166 | Bis-PEG1-acid | 5961-83-1 | Reference compound |
| HY-23167 | Acid-PEG4-C2-Boc | 1835759-85-7 | Reference compound |
| HY-23171 | 1,2-Di-O-acetyl-5-O-benzoyl-3-deoxy-3-fluoro-D-ribofuranose | 159099-24-8 | Reference compound |
| HY-23174 | Methyl acetyl-L-cysteinate | 7652-46-2 | Peptides |
| HY-23185 | N-((Benzyloxy)carbonyl)-O-(tert-butyl)-L-threonine | 16966-09-9 | Peptides |
| HY-23188 | Loratadine-d5-1 | 1020719-57-6 | Isotope-Labeled Compounds |
| HY-23190 | 17-Trifluoromethylphenyl-13,14-dihydro trinor prostaglandin F1α | 1027401-98-4 | Reference compound |
| HY-23193 | BMS-199945 | 1026926-30-6 | Reference compound |
| HY-23195 | Potassium 2-hydroxy-2-methylsuccinate | 1030365-02-6 | Natural Products |
| HY-23196S | Minoxidil-d10 | 1020718-66-4 | Isotope-Labeled Compounds |
| HY-23199 | H2-003 | 1060438-30-3 | Reference compound |
| HY-23206 | DAN-1 EE (hydrochloride) | 1049720-51-5 | Reference compound |
| HY-23212 | 2-Amino-1,3-bis(carboxylethoxy)propane | 1020112-73-5 | Reference compound |
| HY-23212A | 2-Amino-1,3-bis(carboxylethoxy)propane (hydrochloride) | 2421153-68-4 | Reference compound |
| HY-23331S | 4-Methylimidazolidine-2-thione-d3 | 2140327-66-6 | Isotope-Labeled Compounds |
| HY-23337S | 1-Methyl-3-((tetrahydrofuran-3-yl)methyl)urea-d3 | Isotope-Labeled Compounds | |
| HY-23338 | TNKS-2-IN-1 | 4765-59-7 | Reference compound |
| HY-23399 | Dibromoacetic acid | 631-64-1 | Reference compound |
| HY-23399R | Dibromoacetic acid (Standard) | 631-64-1 | Reference Standards |
| HY-23408 | Tos-PEG3 | 77544-68-4 | Reference compound |
| HY-23417 | PEG5-Tos | 155130-15-7 | Reference compound |
| HY-23424 | Teoc-MeLeu-OH | 2411590-92-4 | Peptides |
| HY-23430 | TES | 7365-44-8 | Biochemical Assay Reagents |
| HY-23430A | TES (sodium) | 70331-82-7 | Biochemical Assay Reagents |
| HY-23430S | TES-d15 | 1219794-63-4 | Isotope-Labeled Compounds |
| HY-23460 | p-Ethynylphenylalanine | 278605-15-5 | Reference compound |
| HY-23460A | p-Ethynylphenylalanine (hydrochloride) | 188640-63-3 | Reference compound |
| HY-23497 | Poly(4-vinylphenol) | 24979-70-2 | Natural Products |
| HY-23498 | Benzo[k]fluoranthene | 207-08-9 | Reference compound |
| HY-23498R | Benzo[k]fluoranthene (Standard) | 207-08-9 | Reference Standards |
| HY-23498S | Benzo[k]fluoranthene-d12 | 93952-01-3 | Isotope-Labeled Compounds |
| HY-23499 | Indeno[1,2,3-cd]pyrene | 193-39-5 | Reference compound |
| HY-23499R | Indeno[1,2,3-cd]pyrene (Standard) | 193-39-5 | Reference Standards |
| HY-23499S | Indeno[1,2,3-cd]pyrene-d12 | 203578-33-0 | Isotope-Labeled Compounds |
| HY-23506 | 1-Aminohydantoin | 6301-02-6 | Reference compound |
| HY-23506S | 1-Aminohydantoin-13C3 | 957509-31-8 | Isotope-Labeled Compounds |
| HY-23524 | HSL-IN-3 | 346656-34-6 | Reference compound |
| HY-23539C | Sodium thiosulfate pentahydrate (GR,≥99.5%) | 10102-17-7 | Biochemical Assay Reagents |
| HY-23629 | 16-Aminohexadecanoic acid | 17437-22-8 | Reference compound |
| HY-23641 | NH-bis(C1-Boc) | 85916-13-8 | ADC Related |
| HY-23642 | Mal-amido-(CH2COOH)2 | 207613-14-7 | ADC Related |
| HY-23656 | Methyl 4-oxobutanoate | 13865-19-5 | Reference compound |
| HY-23789 | 2′-O-(2-Methoxyethyl)guanosine | 473278-54-5 | Biochemical Assay Reagents |
| HY-23790 | N6-Benzoyl-2'-O-(2-methoxyethyl)adenosine | 333335-93-6 | Reference compound |
| HY-23805S | 3,6-Dichloro-9H-carbazole-13C12 | Isotope-Labeled Compounds | |
| HY-23848 | 8-Nonynoic acid | 30964-01-3 | Reference compound |
| HY-23861 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N5,N5-dimethyl-L-glutamine | 1146118-59-3 | Peptides |
| HY-23909 | 7,7-Dimethyl-(5Z,8Z)-eicosadienoic acid | 89560-01-0 | Reference compound |
| HY-23926 | PYBG | 680622-71-3 | Dye Reagents |
| HY-23999 | BI-0115 | 4929-23-1 | Reference compound |
| HY-24063 | Malonyl-L-Carnitine (chloride) | 2417978-94-8 | Natural Products |
| HY-24126 | Bis(2-cyanoethyl) diisopropylphosphoramidite | 102690-88-0 | Reference compound |
| HY-24144 | Tesirine intermediate-2 | 1430738-34-3 | Reference compound |
| HY-24238 | DLCI-1 | 2244569-14-8 | Reference compound |
| HY-24312 | AD-mix-α | 153130-59-7 | Biochemical Assay Reagents |
| HY-24350 | Trimethylsulfoxonium-d9 Iodide | 23726-00-3 | Isotope-Labeled Compounds |
| HY-24385S | N-Nitrosodipropylamine-d14 | 93951-96-3 | Isotope-Labeled Compounds |
| HY-24385S1 | N-Nitrosodipropylamine-d7 | Isotope-Labeled Compounds | |
| HY-24400 | Methyl 2,3-O-isopropylidene-5-O-tosyl-D-ribonucleoside | 4137-56-8 | Biochemical Assay Reagents |
| HY-24463 | 3,4-Di-O-acetyl-L-fucal | 54621-94-2 | Reference compound |
| HY-24470B | 1-(9H-Fluoren-9-yl)ethanol | 3023-49-2 | Reference compound |
| HY-24574 | (E)-5-Octadecene | 7206-21-5 | Reference compound |
| HY-24592 | (S,E)-Cyclooct-2-enol | 93301-76-9 | Reference compound |
| HY-27787 | α-Eleostearic acid | 506-23-0 | Reference compound |
| HY-27861S | 3,4-Dihydro-7-methoxy-6-isoquinolinol-d3 | Isotope-Labeled Compounds | |
| HY-27949 | N-Acetyllactosamine Heptaacetate | 73208-61-4 | Biochemical Assay Reagents |
| HY-27979 | Ethyl acrylate-methyl methacrylate copolymer | 9010-88-2 | Reference compound |
| HY-28009 | 2-((7Z,10Z)-Hexadeca-7,10-dien-1-yl)oxirane | 1883429-78-4 | Reference compound |
| HY-28099 | VEC6 | 3431-16-1 | Reference compound |
| HY-28229A | 2(E)-Nonenedioic acid | 757219-33-3 | Natural Products |
| HY-28259 | 2-Bromo-3',4'-(methylenedioxy)propiophenone | 52190-28-0 | Reference compound |
| HY-28325 | AMC-04 | 792928-94-0 | Reference compound |
| HY-29035 | Dopamine acrylamide | 201610-44-8 | Reference compound |
| HY-29090 | ML228 analog | 1357026-36-8 | Reference compound |
| HY-29244 | ATIC-IN-2 | 67095-44-7 | Reference compound |
| HY-29268 | β-Carboline-1-carboxylic acid | 26052-96-0 | Reference compound |
| HY-29282A | 5-Oxo-5-(prop-2-yn-1-ylamino)pent-2-enoic acid | Reference compound | |
| HY-29347 | Ocrylate | 6701-17-3 | Reference compound |
| HY-29350 | Polyglycerol-polyricinoleate | 29894-35-7 | Biochemical Assay Reagents |
| HY-29504 | Hexaethylene glycol monotridecyl ether | 930-09-6 | Biochemical Assay Reagents |
| HY-29866 | Tubulin polymerization-IN-75 | 5325-66-6 | Reference compound |
| HY-30004 | 1-Aminocyclopropane-1-carboxylic acid | 22059-21-8 | Natural Products |
| HY-30004R | 1-Aminocyclopropane-1-carboxylic acid (Standard) | 22059-21-8 | Reference Standards |
| HY-30004S | 1-Aminocyclopropane-1-carboxylic acid-d4 | 84392-07-4 | Isotope-Labeled Compounds |
| HY-30006 | 1-Aminocyclobutanecarboxylic acid | 22264-50-2 | Reference compound |
| HY-30008 | Cycloleucine | 52-52-8 | Reference compound |
| HY-30011 | 5-Chloro-7-azaindole | 866546-07-8 | Biochemical Assay Reagents |
| HY-30012 | 5-Bromo-7-azaindole | 183208-35-7 | Biochemical Assay Reagents |
| HY-30013 | 4-Chloro-7-azaindole | 55052-28-3 | Biochemical Assay Reagents |
| HY-30014 | 4-Bromo-7-azaindole | 348640-06-2 | Biochemical Assay Reagents |
| HY-30017 | 3-Bromo-7-azaindole | 74420-15-8 | Biochemical Assay Reagents |
| HY-30059 | 6-Bromo-2-tetralone | 4133-35-1 | Biochemical Assay Reagents |
| HY-30072 | 7-Bromo-1-tetralone | 32281-97-3 | Biochemical Assay Reagents |
| HY-30090 | N-Boc-L-phenylalanine methyl ester | 51987-73-6 | Peptides |
| HY-30099 | O,O,S-Trimethyl ester phosphorothioic acid | 152-20-5 | Biochemical Assay Reagents |
| HY-30105 | N-Boc-piperazine | 57260-71-6 | Reference compound |
| HY-30120 | tert-Butyl N-[(1S,2S)-2-aminocyclohexyl]carbamate | 180683-64-1 | Biochemical Assay Reagents |
| HY-30133 | 5-Bromo-2-thiophenecarboxylic acid | 7311-63-9 | Biochemical Assay Reagents |
| HY-30139 | 4-Amino-2-chloropyrimidine | 7461-50-9 | Biochemical Assay Reagents |
| HY-30151 | Methoxsalen | 298-81-7 | Natural Products |
| HY-30151R | Methoxsalen (Standard) | 298-81-7 | Reference Standards |
| HY-30151S | Methoxsalen-d3 | 80386-99-8 | Isotope-Labeled Compounds |
| HY-30152 | Xanthotoxol | 2009-24-7 | Natural Products |
| HY-30152R | Xanthotoxol (Standard) | 2009-24-7 | Reference Standards |
| HY-30156 | 2,3-Dihydro-7-azaindole | 10592-27-5 | Biochemical Assay Reagents |
| HY-30167 | D-Valinol | 4276-09-9 | Peptides |
| HY-30167A | L-Valinol | 2026-48-4 | Peptides |
| HY-30170 | N-Methylphenethylamine | 589-08-2 | Natural Products |
| HY-30215 | (S)-Leucic acid | 13748-90-8 | Natural Products |
| HY-30215R | (S)-Leucic acid (Standard) | 13748-90-8 | Reference Standards |
| HY-30216 | (R)-Leucic acid | 20312-37-2 | Natural Products |
| HY-30216A | Leucic acid | 498-36-2 | Peptides |
| HY-30216AR | Leucic acid (Standard) | 498-36-2 | Reference Standards |
| HY-30216R | (R)-Leucic acid (Standard) | 20312-37-2 | Reference Standards |
| HY-30217 | (S)-2-Hydroxy-3-methylbutanoic acid | 17407-55-5 | Reference compound |
| HY-30219 | D-(+)-Phenyllactic acid | 7326-19-4 | Natural Products |
| HY-30219R | D-?(+)?-?Phenyllactic acid (Standard) | 7326-19-4 | Reference Standards |
| HY-30220 | (S)-2-Hydroxy-3-phenylpropanoic acid | 20312-36-1 | Natural Products |
| HY-30230 | L-Aspartic acid 4-benzyl ester | 2177-63-1 | Peptides |
| HY-30231 | Z-Asp(OBzl)-OH | 3479-47-8 | Peptides |
| HY-30232 | L-Glutamate-γ-benzyl ester | 1676-73-9 | Peptides |
| HY-30234 | Clemizole | 442-52-4 | Reference compound |
| HY-30234A | Clemizole (hydrochloride) | 1163-36-6 | Reference compound |
| HY-30234S | Clemizole-d4 | Isotope-Labeled Compounds | |
| HY-30235 | Benzydamine | 642-72-8 | Reference compound |
| HY-30235A | Benzydamine (hydrochloride) | 132-69-4 | Reference compound |
| HY-30235AR | Benzydamine (hydrochloride) (Standard) | 132-69-4 | Reference Standards |
| HY-30235S | Benzydamine-d6 (hydrochloride) | 1246817-20-8 | Isotope-Labeled Compounds |
| HY-30236 | 5-Bromoindole | 10075-50-0 | Reference compound |
| HY-30237 | (R)-Roscovitine | 186692-46-6 | Reference compound |
| HY-30237S | (R)-Roscovitine-d7 | Isotope-Labeled Compounds | |
| HY-30263 | 4-Heptyloxyphenol | 13037-86-0 | Reference compound |
| HY-30267 | 4-Hydroxyphenyl acetate | 3233-32-7 | Reference compound |
| HY-30269 | 4-Hydroxyphenyl benzoate | 2444-19-1 | Reference compound |
| HY-30270 | Mequinol | 150-76-5 | Natural Products |
| HY-30270R | Mequinol (Standard) | 150-76-5 | Reference Standards |
| HY-30270S | Mequinol-d4 | 126840-02-6 | Isotope-Labeled Compounds |
| HY-30271 | 4-Butoxyphenol | 122-94-1 | Biochemical Assay Reagents |
| HY-30272 | Monobenzone | 103-16-2 | Reference compound |
| HY-30272R | Monobenzone (Standard) | 103-16-2 | Reference Standards |
| HY-30318 | Clofop | 26129-32-8 | Reference compound |
| HY-30756 | tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate | 236406-55-6 | Reference compound |
| HY-31962 | Bourgeonal | 18127-01-0 | Reference compound |
| HY-32004 | Coumalic acid | 500-05-0 | Natural Products |
| HY-32007 | N1,N1-Dimethylpropane-1,2-diamine | 108-15-6 | Reference compound |
| HY-32015 | Cot inhibitor-1 | 915365-57-0 | Reference compound |
| HY-32018 | Cot inhibitor-2 | 915363-56-3 | Reference compound |
| HY-32067 | Aceclidine | 827-61-2 | Reference compound |
| HY-32067A | Aceclidine (hydrochloride) | 6109-70-2 | Reference compound |
| HY-32067AS | Aceclidine-d3 (hydrochloride) | 2713384-81-5 | Isotope-Labeled Compounds |
| HY-32083 | 9-Bromo-1-nonanol | 55362-80-6 | Reference compound |
| HY-32088 | Ethyl 10-bromodecanoate | 55099-31-5 | Reference compound |
| HY-32100 | 5-Hydroxyquinoline | 578-67-6 | Biochemical Assay Reagents |
| HY-32126 | 1-Fluoronaphthalene | 321-38-0 | Reference compound |
| HY-32126R | 1-Fluoronaphthalene (Standard) | 321-38-0 | Reference Standards |
| HY-32135 | N-Phenethylbenzamide | 3278-14-6 | Natural Products |
| HY-32136 | 1-Phenyl-3,4-dihydroisoquinoline | 52250-50-7 | Reference compound |
| HY-32144 | 1-(3-Nitrophenyl)ethanone | 121-89-1 | Natural Products |
| HY-32149 | 1-Bromo-3-iodobenzene | 591-18-4 | Biochemical Assay Reagents |
| HY-32181 | Fluorenone | 486-25-9 | Biochemical Assay Reagents |
| HY-32181S | Fluorenone-d8 | 137219-34-2 | Isotope-Labeled Compounds |
| HY-32208S | tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate-d4 | 1808106-94-6 | Isotope-Labeled Compounds |
| HY-32219 | T863 | 701232-20-4 | Reference compound |
| HY-32237 | 4-Chlorophenyl-2-pyridinylmethanol | 27652-89-7 | Reference compound |
| HY-32247 | DCAF | 40114-84-9 | Reference compound |
| HY-32264 | X-Neu5Ac (sodium) | 160369-85-7 | Reference compound |
| HY-32290 | Methyl DL-pyroglutamate | 54571-66-3 | Biochemical Assay Reagents |
| HY-32291 | Methyl L-pyroglutamate | 4931-66-2 | Reference compound |
| HY-32329 | Setiptiline | 57262-94-9 | Reference compound |
| HY-32329A | Setiptiline (maleate) | 85650-57-3 | Reference compound |
| HY-32329S | Setiptiline-d3 | 1795024-97-3 | Isotope-Labeled Compounds |
| HY-32337 | Tacalcitol | 57333-96-7 | Reference compound |
| HY-32337R | Tacalcitol (Standard) | 57333-96-7 | Reference Standards |
| HY-32338 | Tacalcitol (monohydrate) | 93129-94-3 | Reference compound |
| HY-32339 | Maxacalcitol | 103909-75-7 | Reference compound |
| HY-32340 | Lexacalcitol | 131875-08-6 | Reference compound |
| HY-32341 | Seocalcitol | 134404-52-7 | Reference compound |
| HY-32342 | Falecalcitriol | 83805-11-2 | Reference compound |
| HY-32343 | Secalciferol | 55721-11-4 | Natural Products |
| HY-32343S | Secalciferol-d6 | 1440957-55-0 | Isotope-Labeled Compounds |
| HY-32344 | Inecalcitol | 163217-09-2 | Reference compound |
| HY-32345 | Elocalcitol | 199798-84-0 | Reference compound |
| HY-32346 | Atocalcitol | 302904-82-1 | Reference compound |
| HY-32348 | Doxercalciferol | 54573-75-0 | Reference compound |
| HY-32348R | Doxercalciferol (Standard) | 54573-75-0 | Reference Standards |
| HY-32348S1 | Doxercalciferol-d6 | Isotope-Labeled Compounds | |
| HY-32349 | Ercalcidiol | 21343-40-8 | Natural Products |
| HY-32349R | Ercalcidiol (Standard) | 21343-40-8 | Reference Standards |
| HY-32349S | Ercalcidiol-d3 | 1217467-39-4 | Isotope-Labeled Compounds |
| HY-32350 | Ercalcitriol | 60133-18-8 | Natural Products |
| HY-32350R | Ercalcitriol (Standard) | 60133-18-8 | Reference Standards |
| HY-32350S | Ercalcitriol-13C,d3 | Isotope-Labeled Compounds | |
| HY-32350S1 | Ercalcitriol-d3 | 1261254-46-9 | Isotope-Labeled Compounds |
| HY-32351 | Calcifediol | 19356-17-3 | Natural Products |
| HY-32351A | Calcifediol (monohydrate) | 63283-36-3 | Reference compound |
| HY-32351AR | Calcifediol (monohydrate) (Standard) | 63283-36-3 | Reference Standards |
| HY-32351AS | Calcifediol-d6 (monohydrate) | 2483831-70-3 | Isotope-Labeled Compounds |
| HY-32351AS1 | Calcifediol-13C5 (monohydrate) | Isotope-Labeled Compounds | |
| HY-32351B | 3-epi-Calcifediol | 73809-05-9 | Natural Products |
| HY-32351BR | 3-epi-Calcifediol (Standard) | 73809-05-9 | Reference Standards |
| HY-32351R | Calcifediol (Standard) | 19356-17-3 | Reference Standards |
| HY-32351S | Calcifediol-d3 | 140710-94-7 | Isotope-Labeled Compounds |
| HY-32364 | 3-arylisoquinolinamine derivative | 1029008-71-6 | Reference compound |
| HY-32685 | N-Cbz-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester | 286961-15-7 | Biochemical Assay Reagents |
| HY-32687A | L-Serine methyl ester (hydrochloride) | 5680-80-8 | Peptides |
| HY-32688 | Boc-Ser-OMe | 2766-43-0 | Peptides |
| HY-32709 | Telcagepant | 781649-09-0 | Reference compound |
| HY-32709S | Telcagepant-d8 | 1132641-75-8 | Isotope-Labeled Compounds |
| HY-32718 | Pelitinib | 257933-82-7 | Reference compound |
| HY-32721 | Neratinib | 698387-09-6 | Reference compound |
| HY-32721B | Neratinib (maleate) | 915942-22-2 | Reference compound |
| HY-32721R | Neratinib (Standard) | 698387-09-6 | Reference Standards |
| HY-32721S | Neratinib-d6 | 1259519-18-0 | Isotope-Labeled Compounds |
| HY-32735 | Triptolide | 38748-32-2 | Natural Products |
| HY-32735R | Triptolide (Standard) | 38748-32-2 | Reference Standards |
| HY-32735S | Triptolide-d3 | Isotope-Labeled Compounds | |
| HY-32736 | Triptonide | 38647-11-9 | Natural Products |
| HY-32736R | Triptonide (Standard) | 38647-11-9 | Reference Standards |
| HY-32739 | 5-Methylpyrazine-2-carboxylic acid | 5521-55-1 | Biochemical Assay Reagents |
| HY-32742 | 4-Bromo-2-fluoropyridine | 128071-98-7 | Biochemical Assay Reagents |
| HY-32746 | 5-Bromo-2-fluoropyridine | 766-11-0 | Biochemical Assay Reagents |
| HY-32748 | 2-Bromo-5-fluoropyridine | 41404-58-4 | Biochemical Assay Reagents |
| HY-32751 | 3-Bromo-2-chlorolpyridine | 52200-48-3 | Biochemical Assay Reagents |
| HY-32752 | 4-Bromo-2-chloropyridine | 73583-37-6 | Biochemical Assay Reagents |
| HY-32753 | 2-Chloro-3-iodopyridine | 78607-36-0 | Biochemical Assay Reagents |
| HY-32754 | 2-Chloro-4-iodopyridine | 153034-86-7 | Biochemical Assay Reagents |
| HY-32755 | 3-Bromo-2-methoxypyridine | 13472-59-8 | Biochemical Assay Reagents |
| HY-32756 | 5-Bromo-2-methoxypyridine | 13472-85-0 | Biochemical Assay Reagents |
| HY-32778 | Methyl 5-bromopyridine-2-carboxylate | 29682-15-3 | Biochemical Assay Reagents |
| HY-32786 | 6-Bromonicotinaldehyde | 149806-06-4 | Biochemical Assay Reagents |
| HY-32788 | 6-Methoxypyridine-3-carbaldehyde | 65873-72-5 | Biochemical Assay Reagents |
| HY-32791 | 2-Chloronicotinaldehyde | 36404-88-3 | Biochemical Assay Reagents |
| HY-32796 | 2-Chloro-3-methyl-5-nitropyridine | 22280-56-4 | Biochemical Assay Reagents |
| HY-32800 | 6-Chloro-2-methyl-3-nitropyridine | 22280-60-0 | Biochemical Assay Reagents |
| HY-32806 | 2-Chloro-4-methyl-3-nitropyridine | 23056-39-5 | Biochemical Assay Reagents |
| HY-32813 | 2-Amino-3-iodopyridine | 104830-06-0 | Biochemical Assay Reagents |
| HY-32828 | 3-Amino-5-bromo-2-chloropyridine | 588729-99-1 | Biochemical Assay Reagents |
| HY-32833 | 2-Chloro-3-pyridinol | 6636-78-8 | Biochemical Assay Reagents |
| HY-32836 | 2-Bromo-6-(hydroxymethyl)pyridine | 33674-96-3 | Biochemical Assay Reagents |
| HY-32837 | 5-Bromo-2-(hydroxymethyl)pyridine | 88139-91-7 | Biochemical Assay Reagents |
| HY-32854 | 4-Bromo-3-(trifluoromethyl)aniline | 393-36-2 | Reference compound |
| HY-32865 | tert-Butyl 2,2,2-trichloroacetimidate | 98946-18-0 | Reference compound |
| HY-32874S | 1,9-Dibromononane-d18 | 150017-89-3 | Isotope-Labeled Compounds |
| HY-32883 | 2,4-Difluorophenylboronic acid | 144025-03-6 | Biochemical Assay Reagents |
| HY-32884 | 2,5-Difluorophenylboronic acid | 193353-34-3 | Biochemical Assay Reagents |
| HY-32885 | 2,6-Difluorophenylboronic acid | 162101-25-9 | Biochemical Assay Reagents |
| HY-32886 | 3,4-Difluorophenylboronic acid | 168267-41-2 | Biochemical Assay Reagents |
| HY-32887 | 3,5-Difluorophenylboronic acid | 156545-07-2 | Biochemical Assay Reagents |
| HY-32892 | 3,4,5-Trifluorophenylboronic acid | 143418-49-9 | Biochemical Assay Reagents |
| HY-32894 | 2,3-Dichlorophenylboronic acid | 151169-74-3 | Biochemical Assay Reagents |
| HY-32895 | 2,4-Dichlorophenylboronic acid | 68716-47-2 | Biochemical Assay Reagents |
| HY-32897 | 3,4-Dichlorophenylboronic acid | 151169-75-4 | Biochemical Assay Reagents |
| HY-32898 | 3,5-Dichlorophenylboronic acid | 67492-50-6 | Biochemical Assay Reagents |
| HY-32901 | 4-Chloro-3-fluorophenylboronic acid | 137504-86-0 | Biochemical Assay Reagents |
| HY-32902 | 3-(Trifluoromethyl)phenylboronic acid | 1423-26-3 | Biochemical Assay Reagents |
| HY-32908 | 4-(Trifluoromethoxy)phenylboronic acid | 139301-27-2 | Biochemical Assay Reagents |
| HY-32909 | 2,5-Dimethylphenylboronic acid | 85199-06-0 | Biochemical Assay Reagents |
| HY-32914 | 4-Fluoro-2-methylphenylboronic acid | 139911-29-8 | Biochemical Assay Reagents |
| HY-32915 | 2-Chloro-4-methylphenylboronic acid | 145349-62-8 | Biochemical Assay Reagents |
| HY-32917 | 2,4-Dimethoxyphenylboronic acid | 133730-34-4 | Biochemical Assay Reagents |
| HY-32919 | 3,4-Dimethoxyphenylboronic acid | 122775-35-3 | Biochemical Assay Reagents |
| HY-32920 | 3,5-Dimethoxyphenylboronic acid | 192182-54-0 | Biochemical Assay Reagents |
| HY-32922 | (3-Fluoro-4-methoxyphenyl)boronic acid | 149507-26-6 | Biochemical Assay Reagents |
| HY-32923 | 2-Fluoro-3-methoxyphenylboronic acid | 352303-67-4 | Biochemical Assay Reagents |
| HY-32924 | 5-Fluoro-2-methoxyphenylboronic acid | 179897-94-0 | Biochemical Assay Reagents |
| HY-32927 | 3-Cyanophenylboronic acid | 150255-96-2 | Biochemical Assay Reagents |
| HY-32928 | 4-Cyanobenzeneboronic acid | 126747-14-6 | Biochemical Assay Reagents |
| HY-32933 | 4-Acetylphenylboronic acid | 149104-90-5 | Reference compound |
| HY-32950 | 2-Fluoropyridine-3-boronic acid | 174669-73-9 | Biochemical Assay Reagents |
| HY-32951 | 2-Fluoropyridine-4-boronic acid | 401815-98-3 | Biochemical Assay Reagents |
| HY-32952 | 2-Fluoropyridine-5-boronic acid | 351019-18-6 | Biochemical Assay Reagents |
| HY-32953 | 2-Chloropyridine-3-boronic acid | 381248-04-0 | Biochemical Assay Reagents |
| HY-32954 | 2-Chloropyridine-4-boronic acid | 458532-96-2 | Biochemical Assay Reagents |
| HY-32955 | 2-Chloropyridine-5-boronic acid | 444120-91-6 | Biochemical Assay Reagents |
| HY-32956 | 2-Methoxypyridine-3-boronic acid | 163105-90-6 | Biochemical Assay Reagents |
| HY-32957 | 2-Methoxypyridine-5-boronic acid | 163105-89-3 | Biochemical Assay Reagents |
| HY-32959 | N-Boc-2-pyrroleboronic acid | 135884-31-0 | Biochemical Assay Reagents |
| HY-33009 | AS057278 | 402-61-9 | Reference compound |
| HY-33013S | Clevidipine impurity 24-13C,d3 | Isotope-Labeled Compounds | |
| HY-33037 | Phenazine-1-carboxylic acid | 2538-68-3 | Natural Products |
| HY-33037R | Phenazine-1-carboxylic acid (Standard) | 2538-68-3 | Reference Standards |
| HY-33040 | 2,2',4'-Trichloroacetophenone | 4252-78-2 | Reference compound |
| HY-33046 | N-Boc-dolaproine | 120205-50-7 | Reference compound |
| HY-33046A | N-Boc-dolaproine (dicyclohexylamine) | 1369427-40-6 | Reference compound |
| HY-33048 | Monomethyl auristatin E intermediate-1 | 120205-48-3 | Reference compound |
| HY-33169 | 1,2,3,4-Tetrahydro-β-carboline-1-carboxylic acid | 6649-91-8 | Reference compound |
| HY-33212 | D-N-Acetylgalactosamine | 1811-31-0 | Natural Products |
| HY-33212R | D-N-Acetylgalactosamine (Standard) | 1811-31-0 | Reference Standards |
| HY-33212S | D-N-Acetylgalactosamine-13C | 478518-53-5 | Isotope-Labeled Compounds |
| HY-33228 | 5-Methyl-DL-tryptophan | 951-55-3 | Peptides |
| HY-33241 | N-Boc-hexahydro-1H-azepine-4-one | 188975-88-4 | Biochemical Assay Reagents |
| HY-33259 | (R)-2-amino-2-cyclopentylacetic acid | 2521-86-0 | Peptides |
| HY-33287 | 2-Bromothiazole-5-carboxylic acid | 54045-76-0 | Biochemical Assay Reagents |
| HY-33291 | N-Benzyloxycarbonyl-2-phosphonoglycine trimethyl ester | 88568-95-0 | Biochemical Assay Reagents |
| HY-33292 | (1R,2R)-N-Boc-1,2-cyclohexanediamine | 146504-07-6 | Biochemical Assay Reagents |
| HY-33298 | LM10 | 1316695-35-8 | Reference compound |
| HY-33299 | Serpin B9-IN-1 | 154235-77-5 | Biochemical Assay Reagents |
| HY-33319 | methyl D-cysteinate | 88806-98-8 | Peptides |
| HY-33338 | Salacetamide | 487-48-9 | Reference compound |
| HY-33350 | Clofilium tosylate | 92953-10-1 | Reference compound |
| HY-33351 | Eugenin | 480-34-2 | Natural Products |
| HY-33353 | GSK-4716 | 101574-65-6 | Reference compound |
| HY-33354 | Nitrochin | 56-57-5 | Reference compound |
| HY-33366 | Boc-NH-PEG3-CH2COOH | 462100-06-7 | Reference compound |
| HY-33451 | 4-Dibenzofurancarboxylic acid | 2786-05-2 | Reference compound |
| HY-33466 | (S)-Methyl 2-amino-2-cyclopentylacetate hydrochloride | 14328-62-2 | Peptides |
| HY-33540S | 1-(Chlorocarbonyl)piperidine-d10 | 1219803-31-2 | Isotope-Labeled Compounds |
| HY-33549 | α-Methyl-p-tyrosine | 658-48-0 | Reference compound |
| HY-33549S | DL-Metirosine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-33615 | Methyl azetidine-3-carboxylate (hydrochloride) | 100202-39-9 | ADC Related |
| HY-33672S | 9-Phenylcarbazole-d13 | 2847910-31-8 | Isotope-Labeled Compounds |
| HY-33798 | 3-Bromocarbazole | 1592-95-6 | Biochemical Assay Reagents |
| HY-33838 | eIF4A3-IN-8 | 18474-59-4 | Reference compound |
| HY-33849 | 5-Amino-1H-indazole | 19335-11-6 | Biochemical Assay Reagents |
| HY-33868 | 3-Amino-4-chloropyridine | 20511-15-3 | Biochemical Assay Reagents |
| HY-33878 | 2-PPA | 21203-86-1 | Reference compound |
| HY-33893 | Indole-3-methanamine | 22259-53-6 | Natural Products |
| HY-33900 | Dihydrofuran-3(2H)-one | 22929-52-8 | Reference compound |
| HY-33914 | 4-Hydroxymethylpyrazole | 25222-43-9 | Natural Products |
| HY-33914R | 4-Hydroxymethylpyrazole (Standard) | 25222-43-9 | Reference Standards |
| HY-33921 | 4-(1-Piperazinyl)-1H-Indole (hydrochloride) | 255714-24-0 | Reference compound |
| HY-33939 | Imidazo[1,2-a]pyrazine | 274-79-3 | Biochemical Assay Reagents |
| HY-33948 | 1-Amino-2-methylpropan-2-ol | 2854-16-2 | Biochemical Assay Reagents |
| HY-33948S | 1-Amino-2-methylpropan-2-ol-d6 | 1953176-77-6 | Isotope-Labeled Compounds |
| HY-34018 | 1-Bromo-4-tert-butylbenzene | 3972-65-4 | Biochemical Assay Reagents |
| HY-34027 | Ethyl 5-methyl-1H-pyrazole-3-carboxylate | 4027-57-0 | Biochemical Assay Reagents |
| HY-34053 | 2-Amino-5-fluorobenzoic acid | 446-08-2 | Biochemical Assay Reagents |
| HY-34054 | 2,4-Dichloro-5-nitropyridine | 4487-56-3 | Biochemical Assay Reagents |
| HY-34068 | Pyrazinamine | 5049-61-6 | Biochemical Assay Reagents |
| HY-34097 | 5-Bromo-2,3-dihydro-1H-isoindol-1-one | 552330-86-6 | Biochemical Assay Reagents |
| HY-34123S | N-(2-Bromoethyl)phthalimide-d4 | 1009307-39-4 | Isotope-Labeled Compounds |
| HY-34154 | 4-(Dimethylamino)phenol | 619-60-3 | Reference compound |
| HY-34190 | 2-Pyrimidineacetic acid | 66621-73-6 | Reference compound |
| HY-34204 | 2'-Hydroxy-4'-methylacetophenone | 6921-64-8 | Natural Products |
| HY-34222 | 7-Deazaguanine | 7355-55-7 | Reference compound |
| HY-34346 | tert-Butyl (2-hydrazinyl-2-oxoethyl)carbamate | 6926-09-6 | Peptides |
| HY-34350 | 2-(Aminomethyl)phenol | 932-30-9 | Natural Products |
| HY-34386 | 6(5H)-Phenanthridinone | 1015-89-0 | Reference compound |
| HY-34392 | 4'-(Methylsulfonyl)acetophenone | 10297-73-1 | Biochemical Assay Reagents |
| HY-34408 | 6-Methoxy-1-tetralone | 1078-19-9 | Biochemical Assay Reagents |
| HY-34409 | 3-Methyl-2-butenal | 107-86-8 | Natural Products |
| HY-34410 | (R)-2-Aminopent-4-enoic acid hydrochloride | 108412-04-0 | Peptides |
| HY-34417 | Dipivaloylmethane | 1118-71-4 | Biochemical Assay Reagents |
| HY-34419 | Dioctylamine | 1120-48-5 | Reference compound |
| HY-34428S | 4-Fluorobenzonitrile-13C6 | Isotope-Labeled Compounds | |
| HY-34428S1 | 4-Fluorobenzonitrile-d4 | 1080497-29-5 | Isotope-Labeled Compounds |
| HY-34431 | Purine | 120-73-0 | Natural Products |
| HY-34431R | Purine (Standard) | 120-73-0 | Reference Standards |
| HY-34439 | 2,5-Dimethylpyrazine | 123-32-0 | Natural Products |
| HY-34439R | 2,5-Dimethylpyrazine (Standard) | 123-32-0 | Reference Standards |
| HY-34439S1 | 2,5-Dimethylpyrazine-d3 | 1335401-78-9 | Isotope-Labeled Compounds |
| HY-34444S | 1,1-Dioxothiolan-d8 | 51219-88-6 | Isotope-Labeled Compounds |
| HY-34449 | Methylboronic acid | 13061-96-6 | Biochemical Assay Reagents |
| HY-34449S | Methylboronic acid-d3 | 1332481-37-4 | Isotope-Labeled Compounds |
| HY-34451 | Tri-tert-butylphosphine (tetrafluoroborate) | 131274-22-1 | Biochemical Assay Reagents |
| HY-34463 | Phenoxazine | 135-67-1 | Biochemical Assay Reagents |
| HY-34464 | 2,7-Dibromocarbazole | 136630-39-2 | Biochemical Assay Reagents |
| HY-34465 | 5-Methyl-2-thiophenecarboxaldehyde | 13679-70-4 | Natural Products |
| HY-34465R | 5-Methyl-2-thiophenecarboxaldehyde (Standard) | 13679-70-4 | Reference Standards |
| HY-34469 | 2-Cyanophenylboronic acid | 138642-62-3 | Biochemical Assay Reagents |
| HY-34470 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-D-phenylalanine | 138775-05-0 | Peptides |
| HY-34477 | 2-Iodoacetamide | 144-48-9 | Reference compound |
| HY-34477S1 | 2-Iodoacetamide-d4 | 1219802-64-8 | Isotope-Labeled Compounds |
| HY-34480 | 2-Methylpropane-2-sulfinamide | 146374-27-8 | Biochemical Assay Reagents |
| HY-34487 | 1,3-Dimethoxybenzene | 151-10-0 | Reference compound |
| HY-34487R | 1,3-Dimethoxybenzene (Standard) | 151-10-0 | Reference Standards |
| HY-34487S | 1,3-Dimethoxybenzene-d10 | 340257-57-0 | Isotope-Labeled Compounds |
| HY-34487S1 | 1,3-Dimethoxybenzene-d4 | 362049-44-3 | Isotope-Labeled Compounds |
| HY-34487S2 | 1,3-Dimethoxybenzene-d6 | 16469-85-5 | Isotope-Labeled Compounds |
| HY-34487S3 | 1,3-Dimethoxybenzene-d3 | 78955-99-4 | Isotope-Labeled Compounds |
| HY-34490 | 4-Bromoisoquinoline | 1532-97-4 | Biochemical Assay Reagents |
| HY-34494 | 2,8-Quinolinediol | 15450-76-7 | Biochemical Assay Reagents |
| HY-34497 | Ethyl 3-trifluoromethylpyrazole-4-carboxylate | 155377-19-8 | Biochemical Assay Reagents |
| HY-34498S | 4-Chloro-2-methylphenol-d4 | 1219804-06-4 | Isotope-Labeled Compounds |
| HY-34502 | 6-Cyanoindole | 15861-36-6 | Biochemical Assay Reagents |
| HY-34505 | 1-Methyl-5-pyrazolecarboxylic acid | 16034-46-1 | Biochemical Assay Reagents |
| HY-34511 | 1,4-Benzodioxane-6-boronic acid | 164014-95-3 | Biochemical Assay Reagents |
| HY-34515 | 3,4,7,8-Tetramethyl-1,10-phenanthroline | 1660-93-1 | Biochemical Assay Reagents |
| HY-34516 | D-Ornithine (hydrochloride) | 16682-12-5 | Natural Products |
| HY-34519 | (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid tert-butyl ester | 16874-12-7 | Peptides |
| HY-34540 | (αS)-α-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-pyridinepropanoic acid | 185379-40-2 | Peptides |
| HY-34544 | 2-Hexylthiophene | 18794-77-9 | Natural Products |
| HY-34544R | 2-Hexylthiophene (Standard) | 18794-77-9 | Reference Standards |
| HY-34580 | Methyl 3,5-dihydroxybenzoate | 2150-44-9 | Biochemical Assay Reagents |
| HY-34588 | D-4-Hydroxyphenylglycine | 22818-40-2 | Reference compound |
| HY-34588R | D-4-Hydroxyphenylglycine (Standard) | 22818-40-2 | Reference Standards |
| HY-34590 | 3-Amino-2,6-piperidinedione | 2353-44-8 | Reference compound |
| HY-34595 | Pyrazoloadenine | 2380-63-4 | Reference compound |
| HY-34596 | 4-Hydroxyindole | 2380-94-1 | Reference compound |
| HY-34596R | 4-Hydroxyindole (Standard) | 2380-94-1 | Reference Standards |
| HY-34597 | (S)-2-Amino-3-(4-bromophenyl)propanoic acid | 24250-84-8 | Peptides |
| HY-34603 | 1-Methyl-1H-pyrazole-3-carboxylic acid | 25016-20-0 | Biochemical Assay Reagents |
| HY-34604 | 3-Ethynylpyridine | 2510-23-8 | Biochemical Assay Reagents |
| HY-34607 | 1,4-Dithiapentalene | 251-41-2 | Biochemical Assay Reagents |
| HY-34611 | Boc-L-2,4-Diaminobutyric acid | 25691-37-6 | Peptides |
| HY-34614 | Tricyclohexylphosphine | 2622-14-2 | Reference compound |
| HY-34619 | [Hydroxy(tosyloxy)iodo]benzene | 27126-76-7 | Biochemical Assay Reagents |
| HY-34621S | 1-Bromo-3-ethylbenzene-d5 | 1185314-09-3 | Isotope-Labeled Compounds |
| HY-34628 | Tri-O-acetyl-D-glucal | 2873-29-2 | Biochemical Assay Reagents |
| HY-34628S | Tri-O-acetyl-D-glucal-13C | 478529-35-0 | Isotope-Labeled Compounds |
| HY-34628S1 | Tri-O-acetyl-D-glucall-13C-1 | 478529-36-1 | Isotope-Labeled Compounds |
| HY-34628S2 | Tri-O-acetyl-D-glucal-13C-2 | 478529-37-2 | Isotope-Labeled Compounds |
| HY-34631 | Oxazole | 288-42-6 | Biochemical Assay Reagents |
| HY-34643 | 6-Heptynoic acid | 30964-00-2 | Reference compound |
| HY-34656 | 5-Fluoro-2-pyridinecarbonitrile | 327056-62-2 | Biochemical Assay Reagents |
| HY-34663 | (αR)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]benzeneacetic acid | 33125-05-2 | Peptides |
| HY-34666 | trans-D-4-Hydroxyproline | 3398-22-9 | Biochemical Assay Reagents |
| HY-34673 | 1-Fluoro-2-iodobenzene | 348-52-7 | Biochemical Assay Reagents |
| HY-34692 | 3,4-Dihydro-2H-pyran-2-methanol | 3749-36-8 | Biochemical Assay Reagents |
| HY-34696 | Ethyl indole-2-carboxylate | 3770-50-1 | Biochemical Assay Reagents |
| HY-34713 | N-Methylphenethylamine (hydrochloride) | 4104-43-2 | Reference compound |
| HY-34717 | Tetrabutylammonium (tetrafluoroborate) | 429-42-5 | Biochemical Assay Reagents |
| HY-34738 | Boc-β-Ala-ol | 58885-58-8 | Peptides |
| HY-34740 | Ethylmalonic acid | 601-75-2 | Natural Products |
| HY-34740R | Ethylmalonic acid (Standard) | 601-75-2 | Reference Standards |
| HY-34740S | Ethylmalonic acid-d3 | 70907-93-6 | Isotope-Labeled Compounds |
| HY-34740S1 | Ethylmalonic acid-d5 | 66311-22-6 | Isotope-Labeled Compounds |
| HY-34751 | 2-Thiophenemethanol | 636-72-6 | Biochemical Assay Reagents |
| HY-34758 | N-Nitroso-N-methylurea | 684-93-5 | Reference compound |
| HY-34767 | (R)-2-Methylpiperazine | 75336-86-6 | Biochemical Assay Reagents |
| HY-34781 | 4'-Trifluoromethyl-2-biphenyl carboxylic acid | 84392-17-6 | Reference compound |
| HY-34849 | (R)-(-)-1-(9-Anthryl)-2,2,2-trifluoroethanol | 53531-34-3 | Reference compound |
| HY-34887 | Acridone-4-carboxylic acid | 24782-64-7 | Reference compound |
| HY-35028 | Boc-Glu-Ofm | 133906-29-3 | Peptides |
| HY-35094S | (7E,9E)-β-Ionylideneacetaldehyde-d5 | 1185244-72-7 | Isotope-Labeled Compounds |
| HY-35261 | Mal-PEG2-NH2 | 660843-22-1 | Reference compound |
| HY-35261A | Mal-PEG2-NH2 (TFA) | 660843-23-2 | Reference compound |
| HY-35513 | 3-Aminobenzene-1,2-diol | 20734-66-1 | Reference compound |
| HY-40002 | 4-Boc-Aminopiperidine | 73874-95-0 | Biochemical Assay Reagents |
| HY-400056 | SC209 intermediate-2 | 1977557-83-7 | ADC Related |
| HY-40007 | 1-Boc-4-(aminomethyl)piperidine | 144222-22-0 | Biochemical Assay Reagents |
| HY-40013 | Boc-Inp-OH | 84358-13-4 | Biochemical Assay Reagents |
| HY-40014 | 1-Boc-Nipecotic acid | 84358-12-3 | Biochemical Assay Reagents |
| HY-400145 | mPEG45-Epoxide | 40349-67-5 | Reference compound |
| HY-400147 | mPEG45-diol | 122202-39-5 | Reference compound |
| HY-400191 | Fmoc-Gly-(d-Gly)-allyl propionate | ADC Related | |
| HY-400191A | Fmoc-Gly-Gly-allyl propionate | 2766214-15-5 | ADC Related |
| HY-40019S | 1-Boc-4-piperidone-d4 | 1014695-53-4 | Isotope-Labeled Compounds |
| HY-40020 | 1-Boc-3-piperidone | 98977-36-7 | Biochemical Assay Reagents |
| HY-40021 | 1-Boc-2-Piperidone | 85908-96-9 | Biochemical Assay Reagents |
| HY-40022 | (R)-1-Boc-3-Hydroxypiperidine | 143900-43-0 | Biochemical Assay Reagents |
| HY-40023 | (S)-1-Boc-3-hydroxypiperidine | 143900-44-1 | Biochemical Assay Reagents |
| HY-40028 | (S)-3-Boc-aminopiperidine | 216854-23-8 | Biochemical Assay Reagents |
| HY-40029 | (S)-1-Boc-3-aminopiperidine | 625471-18-3 | Biochemical Assay Reagents |
| HY-400312 | Cbz-D-Leu-Val-Boc | 135219-72-6 | Reference compound |
| HY-400316 | Exatecan intermediate 8 | ADC Related | |
| HY-400342 | SMD-3040 intermediate-1 | 3033110-45-8 | Reference compound |
| HY-400345 | tBu-C18 diacid-D-Glu-OtBu | 2454675-51-3 | Reference compound |
| HY-400356 | Glucocorticoid receptor agonist-1 phosphate Gly-Glu (TFA) | 2734877-83-7 | ADC Related |
| HY-400361 | BocNH-PEG2-CH2COONHS | 911102-04-0 | Reference compound |
| HY-40040 | (S)-1-Boc-3-methylpiperazine | 147081-29-6 | Biochemical Assay Reagents |
| HY-40041 | (R)-1-Boc-3-methyl-piperazine | 163765-44-4 | Biochemical Assay Reagents |
| HY-400528 | CLK1-IN-4 | 332939-32-9 | Reference compound |
| HY-400540 | Padoprazanum | 2756367-23-2 | Reference compound |
| HY-400541 | NBD dodecanoic acid N-succinimidyl ester | 689263-76-1 | Dye Reagents |
| HY-400648 | Folic acid methyl ester | 1348988-65-7 | Reference compound |
| HY-400676 | NH2-PEG4-GGFG-CH2-O-CH2-Cbz | 2914227-55-5 | ADC Related |
| HY-400677 | NH2-PEG4-GGFG-NH-CH2-O-CH2COOH | 2914227-54-4 | ADC Related |
| HY-400684 | Tubulysin A intermediate-1 | ADC Related | |
| HY-400685 | SMD-3040 intermediate-2 | 2632308-00-8 | ADC Related |
| HY-400687 | TAM558 intermediate-1 | Reference compound | |
| HY-400688 | TAM558 intermediate-2 | 2135877-76-6 | Reference compound |
| HY-400689 | TAM558 intermediate-3 | Reference compound | |
| HY-400690 | TAM558 intermediate-4 | Reference compound | |
| HY-400705 | Duocarmycin SA intermediate-1 | 919535-07-2 | Reference compound |
| HY-400706 | Duocarmycin SA intermediate-2 | 2209030-98-6 | Reference compound |
| HY-400708 | (R)-Benzyl 2-cyclopropyl-2-hydroxyacetate | 2414393-47-6 | ADC Related |
| HY-400766 | BWA-522 intermediate-2 | Reference compound | |
| HY-400770 | MC-GGFG-AM-(10Me-11F-Camptothecin) intermediate-1 | 1241391-14-9 | ADC Related |
| HY-400785 | Dapagliflozin impurity A | 2452300-94-4 | Reference compound |
| HY-400878 | Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal | 2345732-83-2 | ADC Related |
| HY-400882 | Tosylate-DPA-714 | 958233-17-5 | Reference compound |
| HY-400897 | 7α,25-Dihydroxycholesterol intermediate-1 | 1326612-12-7 | Reference compound |
| HY-400902 | YAP/TAZ inhibitor-3 | 2506273-81-8 | Reference compound |
| HY-40091 | 1-Boc-3-Aminopyrrolidine | 186550-13-0 | Biochemical Assay Reagents |
| HY-40097 | (R)-1-Boc-3-aminopyrrolidine | 147081-49-0 | Biochemical Assay Reagents |
| HY-40098 | (S)-1-Boc-3-aminopyrrolidine | 147081-44-5 | Biochemical Assay Reagents |
| HY-40102 | (S)-1-Boc-2-(aminomethyl)pyrrolidine | 119020-01-8 | Biochemical Assay Reagents |
| HY-401056 | BWA-522 intermediate-3 | 3032602-27-7 | Reference compound |
| HY-40114 | Boc-L-proline | 15761-39-4 | Biochemical Assay Reagents |
| HY-40115 | N-Boc-D-proline | 37784-17-1 | Biochemical Assay Reagents |
| HY-40118 | Boc-Pro-OMe | 59936-29-7 | Peptides |
| HY-401257 | Methyl (1S,3R)-2-(2-iodoacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate | Reference compound | |
| HY-401269 | tert-Butyl (2-(4-(2-(5-(3,5-dimethylisoxazol-4-yl)-1-(2-morpholinoethyl)-1H-benzo[d]imidazol-2-yl)ethyl)phenoxy)ethyl)carbamate | 2306467-21-8 | Reference compound |
| HY-40135 | L-Hydroxyproline | 51-35-4 | Natural Products |
| HY-40135R | L-Hydroxyproline (Standard) | 51-35-4 | Reference Standards |
| HY-40135S | L-Hydroxyproline-d3 | 1356016-86-8 | Isotope-Labeled Compounds |
| HY-40136 | cis-4-Hydroxy-L-proline | 618-27-9 | Natural Products |
| HY-40136R | cis-4-Hydroxy-L-proline (Standard) | 618-27-9 | Reference Standards |
| HY-40136S | cis-4-Hydroxy-L-proline-d3 | Isotope-Labeled Compounds | |
| HY-401383 | Poly(acrylic acid) (MW 10000~60000) | 9003-01-4 | Natural Products |
| HY-40141 | 1-Boc-azetidine-3-carboxylic acid | 142253-55-2 | ADC Related |
| HY-40142 | 1-N-Boc-3-hydroxyazetidine | 141699-55-0 | ADC Related |
| HY-401424 | Cremophor EL-36 | 61791-12-6 | Biochemical Assay Reagents |
| HY-40144 | Azetidin-3-ol (hydrochloride) | 18621-18-6 | ADC Related |
| HY-40145 | 1-Boc-3-iodoazetidine | 254454-54-1 | Biochemical Assay Reagents |
| HY-40146 | tert-Butyl 3-oxoazetidine-1-carboxylate | 398489-26-4 | Biochemical Assay Reagents |
| HY-401475 | Protein kinase inhibitor 9 | 262433-52-3 | Reference compound |
| HY-401485 | Pyk2-IN-2 | 1271418-15-5 | Reference compound |
| HY-401505 | TD1092 intermediate-1 | 1584239-82-6 | Reference compound |
| HY-40151 | Methyl 1-Boc-azetidine-3-carboxylate | 610791-05-4 | ADC Related |
| HY-40152 | 1-Boc-azetidine-3-yl-methanol | 142253-56-3 | ADC Related |
| HY-40156 | 5-Fluoroindole | 399-52-0 | Biochemical Assay Reagents |
| HY-40156A | Mycobacterium Tuberculosis-IN-5 | Reference compound | |
| HY-40158 | 4-Nitroindole | 4769-97-5 | Biochemical Assay Reagents |
| HY-40161 | Indole-3-carboxylic acid | 771-50-6 | Natural Products |
| HY-401613 | E3 ligase Ligand 43 | 2821795-71-3 | Reference compound |
| HY-40161R | Indole-3-carboxylic acid (Standard) | 771-50-6 | Reference Standards |
| HY-40161S | Indole-3-carboxylic acid-d4 | 1258955-93-9 | Isotope-Labeled Compounds |
| HY-40171 | NH2-C2-NH-Boc | 57260-73-8 | Reference compound |
| HY-40171S | NH2-C2-NH-Boc-d4 | 509148-73-6 | Isotope-Labeled Compounds |
| HY-40172 | tert-Butyl (3-aminopropyl)carbamate | 75178-96-0 | Biochemical Assay Reagents |
| HY-40174A | N-Boc-N-methylethylenediamine | 121492-06-6 | Biochemical Assay Reagents |
| HY-401757 | Anticaries agent-1 | 198649-97-7 | Reference compound |
| HY-40178 | NH2-C4-NH-Boc | 68076-36-8 | Reference compound |
| HY-40181 | 1-Boc-homopiperazine | 112275-50-0 | Biochemical Assay Reagents |
| HY-40190 | 5-Bromo-2,3-dihydro-1H-inden-1-one | 34598-49-7 | Biochemical Assay Reagents |
| HY-401913 | endo CNTinh-03 | 345288-49-5 | Reference compound |
| HY-401925 | Phos-tag Acrylamide AAL-107 | 871839-54-2 | Reference compound |
| HY-402035 | 7-(6-(Bis(4-methoxybenzyl)amino)-3-chloro-4-methylpyridin-2-yl)-2-chloro-5,8-difluoro-6-(trifluoromethyl)quinazolin-4(3H)-one | Reference compound | |
| HY-402090 | SJG-136 intermediate-2 | 2246368-23-8 | Reference compound |
| HY-402091 | SJG-136 intermediate-1 | 232931-64-5 | ADC Related |
| HY-402237 | Nampt-IN-15 | 2222981-61-3 | Reference compound |
| HY-40226 | 4-Amino-1-Boc-piperidine-4-carboxylic acid | 183673-71-4 | Biochemical Assay Reagents |
| HY-402277 | 2-[[[4-(Acetylamino)phenyl]sulfonyl][(4-fluorophenyl)methyl]amino]-N-(9-ethyl-9H-carbazol-3-yl)acetamide | 785821-19-4 | Reference compound |
| HY-40228 | (R)-(+)-tert-Butylsulfinamide | 196929-78-9 | Biochemical Assay Reagents |
| HY-40229 | (S)-(-)-tert-Butylsulfinamide | 343338-28-3 | Biochemical Assay Reagents |
| HY-402309 | IGF-1R modulator 1 | 2375424-89-6 | Reference compound |
| HY-402321 | 2-Octyl-4(1H)-quinolone | 80554-60-5 | Natural Products |
| HY-402361 | TERT activator-1 | 666699-46-3 | Reference compound |
| HY-402383 | O-(((2R,3S,5R)-5-(5-Bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl) O,S-dihydrogen phosphorothioate | Reference compound | |
| HY-402410 | TETi76 | 1451750-73-4 | Reference compound |
| HY-40249 | 1-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester | 286961-14-6 | Biochemical Assay Reagents |
| HY-402545 | (-)-Brompheniramine | 32656-44-3 | Reference compound |
| HY-402634 | 2-(4-(6-Oxo-6,7,8,9-tetrahydro-2,7,9a-triazabenzo[cd]azulen-1-yl)phenoxy)ethyl 4-methylbenzenesulfonate | 2107319-08-2 | Reference compound |
| HY-40269 | L-Pyroglutamic acid ethyl ester | 7149-65-7 | Biochemical Assay Reagents |
| HY-402723 | hCAVII/IX-IN-1 | 1300714-76-4 | Reference compound |
| HY-402739 | 5-([1,4'-Bipiperidin]-1'-yl)-2-(2,4-dimethylphenylsulfonamido)benzoic acid dihydrochloride | Reference compound | |
| HY-402815 | (E)-4-(Naphthalen-2-yl)but-3-en-2-one | 51557-10-9 | Reference compound |
| HY-40284A | 3-Piperidinopropiophenone (hydrochloride) | 886-06-6 | Reference compound |
| HY-402853 | 3-(Tritylthio)propylamine | 426828-04-8 | Reference compound |
| HY-40293 | N,N-Bis(trifluoromethylsulfonyl)aniline | 37595-74-7 | Biochemical Assay Reagents |
| HY-402939A | N-sec-butyl Pentylone (hydrochloride) | 17763-05-2 | Reference compound |
| HY-40294 | Indazole | 271-44-3 | Reference compound |
| HY-40309 | Dibenzo-18-crown-6 | 14187-32-7 | Biochemical Assay Reagents |
| HY-40350 | 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | 90213-66-4 | Biochemical Assay Reagents |
| HY-40351 | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 | Biochemical Assay Reagents |
| HY-40354 | Tofacitinib | 477600-75-2 | Reference compound |
| HY-403544 | CbzNH-(C5-O)2-C4-Boc | 2324147-95-5 | Reference compound |
| HY-40354A | Tofacitinib (citrate) | 540737-29-9 | Reference compound |
| HY-40354AR | Tofacitinib (citrate) (Standard) | 540737-29-9 | Reference Standards |
| HY-40354AS | Tofacitinib-d3 (citrate) | 2701680-77-3 | Isotope-Labeled Compounds |
| HY-40354B | (3S,4R)-Tofacitinib | 1092578-48-7 | Reference compound |
| HY-40354C | (3S,4S)-Tofacitinib | 1092578-47-6 | Reference compound |
| HY-40354D | (3R,4S)-Tofacitinib | 1092578-46-5 | Reference compound |
| HY-40354R | Tofacitinib (Standard) | 477600-75-2 | Reference Standards |
| HY-40354S | Tofacitinib-13C3 | Isotope-Labeled Compounds | |
| HY-40354S1 | Tofacitinib-13C3,15N | Isotope-Labeled Compounds | |
| HY-40354S2 | Tofacitinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-40354S3 | Tofacitinib-13C | Isotope-Labeled Compounds | |
| HY-40354S5 | Tofacitinib-d3 | Isotope-Labeled Compounds | |
| HY-40421 | (R)-3-Fluoropyrrolidine (hydrochloride) | 136725-55-8 | Biochemical Assay Reagents |
| HY-41000 | 2-Amino-4-bromopyridine | 84249-14-9 | Biochemical Assay Reagents |
| HY-41004 | 3-Isoquinolinecarboxylic acid | 6624-49-3 | Reference compound |
| HY-41043 | Taltobulin intermediate-2 | 91133-59-4 | Reference compound |
| HY-41045 | (Rac)-Taltobulin intermediate-1 | 676487-35-7 | Reference compound |
| HY-41047 | Taltobulin intermediate-1 | 228266-38-4 | Reference compound |
| HY-41048 | (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate | 58561-04-9 | Peptides |
| HY-41049 | NSC 135130 | 24164-06-5 | Reference compound |
| HY-41051 | (2S)-2-[[(tert-Butoxy)carbonyl](methyl)amino]-3-methylbutanoic acid | 45170-31-8 | Peptides |
| HY-41054 | Taltobulin intermediate-3 | 610786-69-1 | Reference compound |
| HY-41055 | Taltobulin intermediate-4 | 187345-37-5 | Reference compound |
| HY-41060 | tert-Butoxycarbonyl-D-valine | 22838-58-0 | Peptides |
| HY-41061 | D-Boc Valine methyl ester | 106391-85-9 | Reference compound |
| HY-41062 | N-Boc-MeVal | 1268729-59-4 | Reference compound |
| HY-41063 | N-Boc-N-methyl-D-Valinol | 2165479-27-4 | Reference compound |
| HY-41064 | N-Boc-N-methyl-D-Valaldehyde | 2165540-24-7 | Reference compound |
| HY-41066 | Taltobulin intermediate-5 | 2459946-53-1 | Reference compound |
| HY-41067 | Taltobulin intermediate-6 | Reference compound | |
| HY-41069 | Taltobulin intermediate-7 | Reference compound | |
| HY-41070 | Taltobulin intermediate-8 | 676487-38-0 | Reference compound |
| HY-41071 | (6R)-Taltobulin intermediate-9 | Reference compound | |
| HY-41074 | N,O-Dimethylhydroxylamine (hydrochloride) | 6638-79-5 | Biochemical Assay Reagents |
| HY-41076 | Ca2+ channel agonist 1 | 1402821-24-2 | Reference compound |
| HY-41094 | cis-Isolimonenol | 22972-51-6 | Natural Products |
| HY-41121 | Boc-L-Ala-OH | 15761-38-3 | Peptides |
| HY-41121S | Boc-Ala-OH-1-13C | 201740-78-5 | Isotope-Labeled Compounds |
| HY-41121S1 | Boc-L-Ala-OH-3-13C | 201740-79-6 | Isotope-Labeled Compounds |
| HY-41121S2 | Boc-L-Ala-OH-2-13C | 201612-65-9 | Isotope-Labeled Compounds |
| HY-41121S3 | Boc-L-Ala-OH-d3 | 161602-47-7 | Isotope-Labeled Compounds |
| HY-41121S4 | Boc-L-Ala-OH-15N | 139952-87-7 | Isotope-Labeled Compounds |
| HY-41121S5 | Boc-L-Ala-OH-d4 | 714964-61-1 | Isotope-Labeled Compounds |
| HY-41121S6 | Boc-L-Ala-OH-d | 88181-11-7 | Isotope-Labeled Compounds |
| HY-41189 | Fmoc-Val-Cit-PAB-PNP | 863971-53-3 | ADC Related |
| HY-41202 | 2,3-O-(1-Methylethylidene)-D-ribose | 13199-25-2 | Biochemical Assay Reagents |
| HY-41240 | (R)-3-Aminoazepan-2-one | 28957-33-7 | Reference compound |
| HY-41257 | Boc-L-Tyrosine methyl ester | 4326-36-7 | Peptides |
| HY-41257A | N-tert-Butoxycarbonyl-D-tyrosine methyl ester | 76757-90-9 | Peptides |
| HY-41267 | Cyclohexylglycine | 5664-29-9 | Peptides |
| HY-41268 | 3-Methoxyphenylethylamine | 2039-67-0 | Dye Reagents |
| HY-41304 | Benzenepropanol | 122-97-4 | Biochemical Assay Reagents |
| HY-41309 | D-Norvaline | 2013-12-9 | Peptides |
| HY-41314 | Ethyl 3-methyl-2-butenoate | 638-10-8 | Natural Products |
| HY-41318 | N-Z-L-proline methyl ester | 5211-23-4 | Peptides |
| HY-41324 | 7-keto-Deoxycholic acid | 911-40-0 | Natural Products |
| HY-41324R | 7-keto-Deoxycholic acid (Standard) | 911-40-0 | Reference Standards |
| HY-41325 | 7,12-Diketolithocholic acid | 517-33-9 | Reference compound |
| HY-41340 | 2-Aminopyrimidine | 109-12-6 | Biochemical Assay Reagents |
| HY-41340R | 2-Aminopyrimidine (Standard) | 109-12-6 | Reference Standards |
| HY-41341S | 1,4-Bis(bromomethyl)benzene-d8 | 74903-77-8 | Isotope-Labeled Compounds |
| HY-41343 | Triacetyl-ganciclovir | 86357-14-4 | Biochemical Assay Reagents |
| HY-41344 | Ganciclovir mono-O-acetate | 88110-89-8 | Reference compound |
| HY-41344R | Ganciclovir mono-O-acetate (Standard) | 88110-89-8 | Reference Standards |
| HY-41357 | 2,3-O-(1-Methylethylidene)-L-lyxonic acid γ-lactone | 152006-17-2 | Biochemical Assay Reagents |
| HY-41390 | (+)-Benzylphenethylamine | 38235-77-7 | Biochemical Assay Reagents |
| HY-41404 | Piperonylic acid | 94-53-1 | Natural Products |
| HY-41407 | 2,3-Dimethoxybenzaldehyde | 86-51-1 | Reference compound |
| HY-41413 | Phenyl 2-bromoacetate | 620-72-4 | Biochemical Assay Reagents |
| HY-41414 | (S)-(+)-2-Phenylglycinol | 20989-17-7 | Biochemical Assay Reagents |
| HY-41417 | Octanoic acid | 124-07-2 | Natural Products |
| HY-41417R | Octanoic acid (Standard) | 124-07-2 | Reference Standards |
| HY-41417S | Octanoic acid-d15 | 69974-55-6 | Isotope-Labeled Compounds |
| HY-41417S1 | Octanoic acid-d3 | 156779-05-4 | Isotope-Labeled Compounds |
| HY-41417S2 | Octanoic acid-d2 | 64118-36-1 | Isotope-Labeled Compounds |
| HY-41417S3 | Octanoic acid-13C | 59669-16-8 | Isotope-Labeled Compounds |
| HY-41417S4 | Octanoic acid-13C4 | 159118-65-7 | Isotope-Labeled Compounds |
| HY-41417S6 | Octanoic acid-d5 | Isotope-Labeled Compounds | |
| HY-41456 | Ethyl 2-cyano-2-(hydroxyimino)acetate | 3849-21-6 | Biochemical Assay Reagents |
| HY-41461 | 5-Amino-3H-imidazole-4-Carboxamide | 360-97-4 | Natural Products |
| HY-41461A | 5-Amino-3H-imidazole-4-carboxamide (hydrochloride) | 72-40-2 | Biochemical Assay Reagents |
| HY-41461AR | 5-Amino-3H-imidazole-4-carboxamide (hydrochloride) (Standard) | 72-40-2 | Reference Standards |
| HY-41461R | 5-Amino-3H-imidazole-4-Carboxamide (Standard) | 360-97-4 | Reference Standards |
| HY-41463S | 4-(Butylamino)benzoic acid-d7 | 1219803-44-7 | Isotope-Labeled Compounds |
| HY-41464 | Ethyl 4-nitrobenzoate | 99-77-4 | Biochemical Assay Reagents |
| HY-41464R | Ethyl 4-nitrobenzoate (Standard) | 99-77-4 | Reference Standards |
| HY-41465 | 4-Chlorobenzoic acid | 74-11-3 | Biochemical Assay Reagents |
| HY-41494 | o-Toluic acid | 118-90-1 | Natural Products |
| HY-41494R | o-Toluic acid (Standard) | 118-90-1 | Reference Standards |
| HY-41494S | O-Toluic acid-d7 | 207742-73-2 | Isotope-Labeled Compounds |
| HY-41494S1 | o-Toluic acid-13C | 70838-82-3 | Isotope-Labeled Compounds |
| HY-41496 | 2-Amino-6-methylbenzoic acid | 4389-50-8 | Biochemical Assay Reagents |
| HY-41509S1 | N-Boc-N,N′-dimethylethylenediamine-d6 | 2540948-49-8 | Isotope-Labeled Compounds |
| HY-41532S | Cyclopropane-carbonyl Chloride-d5 | 1219794-96-3 | Isotope-Labeled Compounds |
| HY-41541 | Tetraethylene glycol monotosylate | 77544-60-6 | ADC Related |
| HY-41547 | Thalidomide 4-fluoride | 835616-60-9 | Reference compound |
| HY-41549 | Pomalidomide-PEG4-Ph-NH2 | 1818885-63-0 | Reference compound |
| HY-41551 | 4-Chloro-2-methoxyphenylboronic acid | 762287-57-0 | Biochemical Assay Reagents |
| HY-41570 | 3-Formylsalicylic acid | 610-04-8 | Reference compound |
| HY-41587 | D-Glucose pentaacetate | 83-87-4 | Biochemical Assay Reagents |
| HY-41588 | 2,3,4,6-Tetra-O-acetyl-D-glucopyranose, 96% | 10343-06-3 | Biochemical Assay Reagents |
| HY-41589 | α-D-Glucopyranose, 2,3,4,6-tetraacetate | 74808-10-9 | Biochemical Assay Reagents |
| HY-41616 | Methoxymethyl propionate | 70767-92-9 | Reference compound |
| HY-41631 | Boc-Pyr-Oet | 144978-12-1 | Peptides |
| HY-41648 | IDH1 Inhibitor 8 | 1448346-63-1 | Reference compound |
| HY-41650 | Boc-Ala-NMe(OMe) | 87694-49-3 | Peptides |
| HY-41656 | D-Praziquanamine | 55375-92-3 | Reference compound |
| HY-41676S | 4-Chlorobenzonitrile-d4 | 1219794-82-7 | Isotope-Labeled Compounds |
| HY-41677 | 4-Cyanophenylhydrazine (hydrochloride) | 2863-98-1 | Biochemical Assay Reagents |
| HY-41680S | 4-Aminobenzonitrile-d4 | 1331866-32-0 | Isotope-Labeled Compounds |
| HY-41681 | 6-Chloro-1-hexanol | 2009-83-8 | Biochemical Assay Reagents |
| HY-41681S | 6-Chloro-1-hexanol-d6 | 1219794-83-8 | Isotope-Labeled Compounds |
| HY-41685 | Benzyltrimethylammonium (dichloroiodide) | 114971-52-7 | Biochemical Assay Reagents |
| HY-41700 | D-Alanine | 338-69-2 | Natural Products |
| HY-41700R | D-Alanine (Standard) | 338-69-2 | Reference Standards |
| HY-41700S | D-Alanine-d3 | 177614-69-6 | Isotope-Labeled Compounds |
| HY-41700S1 | D-Alanine-d4 | 1202063-27-1 | Isotope-Labeled Compounds |
| HY-41700S2 | D-Alanine-d1 | 56595-54-1 | Isotope-Labeled Compounds |
| HY-41700S3 | D-Alanine-d7 | 2483831-62-3 | Isotope-Labeled Compounds |
| HY-41755 | 2-Fluorophenol | 367-12-4 | Biochemical Assay Reagents |
| HY-41793 | 3'-O-(t-Butyldimethylsilyl)-2'-deoxy-2'-fluorouridine | 1445379-59-8 | Reference compound |
| HY-41826 | 4-Bromobiphenyl | 92-66-0 | Biochemical Assay Reagents |
| HY-41826R | 4-Bromobiphenyl (Standard) | 92-66-0 | Reference Standards |
| HY-41826S1 | 4-Bromo-1,1'-biphenyl-d9 | 142475-00-1 | Isotope-Labeled Compounds |
| HY-41832 | 4,6-Dichloro-2-(methylthio)pyrimidine | 6299-25-8 | Biochemical Assay Reagents |
| HY-41840 | D-Glucurono-6,3-lactone acetonide | 20513-98-8 | Biochemical Assay Reagents |
| HY-41877 | Succinimide | 123-56-8 | Biochemical Assay Reagents |
| HY-41877S | Succinimide-15N | 32807-36-6 | Isotope-Labeled Compounds |
| HY-41880S | Glutaric anhydride-d6 | 1219794-53-2 | Isotope-Labeled Compounds |
| HY-41882 | (S)-4-Benzyl-2-oxazolidone | 90719-32-7 | Biochemical Assay Reagents |
| HY-41912 | Boc-Nle-OH | 6404-28-0 | Peptides |
| HY-41912A | D-(-)-Norleucine | 327-56-0 | Peptides |
| HY-41912AS | D-2-Aminohexanoic acid-d9 | 2185812-01-3 | Isotope-Labeled Compounds |
| HY-41912B | Boc-D-norleucine | 55674-63-0 | Peptides |
| HY-41915 | O-Benzylhydroxylamine (hydrochloride) | 2687-43-6 | Biochemical Assay Reagents |
| HY-41916S | Sodium methanesulfinate-d3 | 2129597-38-0 | Isotope-Labeled Compounds |
| HY-41919 | Mal-L-PA-NH-Boc | 1491152-23-8 | ADC Related |
| HY-41921 | Propargyl-PEG3-alcohol | 208827-90-1 | Reference compound |
| HY-41922 | Propargyl-PEG2-CH2COOH | 944561-46-0 | Reference compound |
| HY-41939 | 1-(2-Hydroxyethyl)piperazine | 103-76-4 | Biochemical Assay Reagents |
| HY-41940 | Dasatinib intermediate-1 | 302964-08-5 | Reference compound |
| HY-41945 | 2,6-Dichloro-4-iodopyridine | 98027-84-0 | Biochemical Assay Reagents |
| HY-41957 | trans-1,2-Cyclohexanediamine | 1121-22-8 | Biochemical Assay Reagents |
| HY-41982 | D-Glucuronic acid lactone | 32449-92-6 | Natural Products |
| HY-41982R | D-Glucuronic acid lactone (Standard) | 32449-92-6 | Reference Standards |
| HY-41984 | Diacetone-D-glucose | 582-52-5 | Biochemical Assay Reagents |
| HY-42034 | Hydroquinine | 522-66-7 | Natural Products |
| HY-42034R | Hydroquinine (Standard) | 522-66-7 | Reference Standards |
| HY-42045 | Pyrimidine-5-boronic acid pinacol ester | 321724-19-0 | Biochemical Assay Reagents |
| HY-42065 | Boc-Asp-OH | 13726-67-5 | Peptides |
| HY-42066 | L-Aspartic acid 1-benzyl ester | 7362-93-8 | Peptides |
| HY-42067 | (tert-Butoxycarbonyl)-D-aspartic acid | 62396-48-9 | Peptides |
| HY-42068 | (-)-Aspartic acid | 1783-96-6 | Natural Products |
| HY-42068R | (-)-Aspartic acid (Standard) | 1783-96-6 | Reference Standards |
| HY-42069 | 1-Benzyl D-Aspartate | 79337-40-9 | Peptides |
| HY-42084 | 4-(2-Methoxyethyl)phenol | 56718-71-9 | Biochemical Assay Reagents |
| HY-42084R | 4-(2-Methoxyethyl)phenol (Standard) | 56718-71-9 | Reference Standards |
| HY-42110 | Deschloroclozapine | 1977-07-7 | Reference compound |
| HY-42110A | Deschloroclozapine (dihydrochloride) | Reference compound | |
| HY-42118S | 4-(4-Fluorobenzylamino)-1-methylpiperidine-d2 | Isotope-Labeled Compounds | |
| HY-42121 | 4-Bromo-2-fluoro-1-iodobenzene | 105931-73-5 | Biochemical Assay Reagents |
| HY-42145 | 3-Maleimidopropionic acid | 7423-55-4 | Reference compound |
| HY-42146 | BMPS | 55750-62-4 | ADC Related |
| HY-42149 | NH2-PEG2-C2-Boc | 756525-95-8 | ADC Related |
| HY-42151 | Mal-amido-PEG2-C2-acid | 756525-98-1 | Reference compound |
| HY-42213 | N1,N4-Bis-Boc-spermidine | 85503-20-4 | Reference compound |
| HY-42222 | N1,N5-Bis-boc-spermidine | 68076-39-1 | Reference compound |
| HY-42223 | (1R,3S)-3-Amino-cyclopentanol | 1110772-05-8 | Reference compound |
| HY-42225 | Methyl 7α-hydroxy-3-ketocholanoate | 14773-00-3 | Reference compound |
| HY-42346 | ZH8651 | 73918-56-6 | Reference compound |
| HY-42354 | D-α-Aminocyclohexylacetic acid | 14328-52-0 | Peptides |
| HY-42356 | Methyl (2R)-2-amino-2-cyclohexylethanoate hydrochloride | 14328-64-4 | Peptides |
| HY-42359 | N-(4-Carboxycyclohexylmethyl)maleimide | 64987-82-2 | Reference compound |
| HY-42360 | SMCC | 64987-85-5 | ADC Related |
| HY-42364 | Boc-Glu(OMe)-OMe | 59279-60-6 | Peptides |
| HY-42397S | 1-Bromo-2-fluorobenzene-d4 | 50592-35-3 | Isotope-Labeled Compounds |
| HY-42424 | (S,R,S)-AHPC-Me (hydrochloride) | 1948273-03-7 | Reference compound |
| HY-42424A | (S,R,S)-AHPC-Me (dihydrochloride) | 2504950-56-3 | Reference compound |
| HY-42427 | NH2-PEG2-CH2-Boc | 1948273-09-3 | Reference compound |
| HY-42448 | tert-Butyl (2S,4R)-4-hydroxy-2-hydroxymethylpyrrolidine-1-carboxylate | 61478-26-0 | Peptides |
| HY-42484 | ER-076349 | 253128-15-3 | Reference compound |
| HY-42487 | Exatecan Intermediate 1 | 110351-94-5 | Reference compound |
| HY-42487A | (rac)-Exatecan Intermediate 1 | 102978-40-5 | Reference compound |
| HY-42487B | (R)-Exatecan Intermediate 1 | 110351-91-2 | Reference compound |
| HY-42487S | Exatecan Intermediate 1-d5 | 1346617-23-9 | Isotope-Labeled Compounds |
| HY-42488 | Hydroxy-PEG3-(CH2)2-Boc | 186020-66-6 | ADC Related |
| HY-42489 | N3-PEG3-CH2CH2-Boc | 252881-73-5 | ADC Related |
| HY-42490 | N3-PEG3-CH2CH2COOH | 1056024-94-2 | ADC Related |
| HY-42569 | Methyl 3-hydroxypropanoate | 6149-41-3 | Reference compound |
| HY-42617 | Hydroxy-PEG4-CH2-Boc | 169751-72-8 | Reference compound |
| HY-42618 | Azido-PEG4-CH2-Boc | 864681-04-9 | ADC Related |
| HY-42619 | Amino-PEG4-C1-Boc | 864680-64-8 | Reference compound |
| HY-42620 | Tos-PEG4-CH2-Boc | 169751-73-9 | Reference compound |
| HY-42637 | N3-PEG3-CH2COOH | 172531-37-2 | Reference compound |
| HY-42640 | Boc-NH-PEG4-CH2COOH | 876345-13-0 | ADC Related |
| HY-42649 | NSC 14699 | 2513-33-9 | Natural Products |
| HY-42680 | D-Tagatose | 87-81-0 | Natural Products |
| HY-42680R | D-Tagatose (Standard) | 87-81-0 | Reference Standards |
| HY-42680S | D-Tagatose-13C | 478506-42-2 | Isotope-Labeled Compounds |
| HY-42680S1 | D-Tagatose-13C-1 | 478506-44-4 | Isotope-Labeled Compounds |
| HY-42682 | D(+)-Galactosamine (hydrochloride) | 1772-03-8 | Reference compound |
| HY-42682R | D(+)-Galactosamine (hydrochloride) (Standard) | 1772-03-8 | Reference Standards |
| HY-42682S1 | D(+)-Galactosamine-13C (hydrochloride) | 478518-54-6 | Isotope-Labeled Compounds |
| HY-42688 | Tributylammonium (hemipyrophosphate) | 5975-18-8 | Reference compound |
| HY-42709 | Z-Val-Ala-OH | 24787-89-1 | Peptides |
| HY-42745 | m-PEG2-Tos | 50586-80-6 | ADC Related |
| HY-42757B | Benzyl ethyl-L-valinate hydrochloride | 1259396-60-5 | Peptides |
| HY-42771 | Thalidomide-4-O-CH2-COO(t-Bu) | 1950635-36-5 | Reference compound |
| HY-42772 | 2-(4-Azidobutyl)isoindoline-1,3-dione | 66917-06-4 | Reference compound |
| HY-42773 | tert-Butyl (8-aminooctyl)carbamate | 88829-82-7 | Reference compound |
| HY-42774 | Ms-PEG4-MS | 55400-73-2 | Reference compound |
| HY-42776 | NH2-PEG3-C2-NH-Boc | 101187-40-0 | Reference compound |
| HY-42780 | Thalidomide-O-amido-C8-NHBoc | 1950635-34-3 | Reference compound |
| HY-42792 | 5-Deoxy-L-arabinose | 13039-56-0 | Biochemical Assay Reagents |
| HY-42822A | Methyl-β-D-xylopyranoside | 612-05-5 | Biochemical Assay Reagents |
| HY-42849 | Sultopride | 53583-79-2 | Reference compound |
| HY-42849A | Sultopride hydrochloride | 23694-17-9 | Reference compound |
| HY-42904 | Potassium tert-butyl malonate | 75486-33-8 | Reference compound |
| HY-42912 | N-Boc-dolaproine-OH ((+)-phenylethylamine) | Reference compound | |
| HY-42912A | N-Boc-dolaproine-OH (dicyclohexylamine) | Reference compound | |
| HY-42935A | Heptanoate (sodium) | 10051-45-3 | Biochemical Assay Reagents |
| HY-42937 | Crocetin (meglumine) | Natural Products | |
| HY-42938 | (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | 1194550-59-8 | Peptides |
| HY-42972 | DBCO-acid | 1353016-70-2 | ADC Related |
| HY-42972G | DBCO-acid (GMP) | 1353016-70-2 | GMP Small Molecules |
| HY-42973 | DBCO-NHS ester | 1353016-71-3 | ADC Related |
| HY-42974 | DBCO-PEG3-acid | 2754384-59-1 | Reference compound |
| HY-42984 | BHQ-2 NHS | 916753-62-3 | Reference compound |
| HY-42990 | Hydrogenated soya phosphatidylcholine | 97281-48-6 | Reference compound |
| HY-42994 | tert-Butyl (R)-N-benzyl-N-(2-chloropropyl)glycinate | 888494-24-4 | Peptides |
| HY-43001 | (−)-G-Lactone | 43119-28-4 | Reference compound |
| HY-43048 | 2-(2-((6-Chlorohexyl)oxy)ethoxy)acetic acid | 2231744-57-1 | Reference compound |
| HY-43055 | Cl-PEG2-acid | 170304-76-4 | Reference compound |
| HY-43057 | iBu-rG | 64350-24-9 | Reference compound |
| HY-43058 | 5'-O-DMT-ibu-rG | 81246-83-5 | Reference compound |
| HY-43059 | 5'-O-DMT-2'-O-iBu-N-Bz-Guanosine | 81279-39-2 | Oligonucleotides |
| HY-43060 | 5'-DMT-3'-TBDMS-ibu-rG | 81256-89-5 | Oligonucleotides |
| HY-43066 | DMT-2'-O-TBDMS-G(dmf)-CE-phosphoramidite | 149559-87-5 | Reference compound |
| HY-43146 | Monomethyl auristatin E intermediate-3 | Reference compound | |
| HY-43147 | Monomethyl auristatin E intermediate-4 | 1823777-46-3 | Reference compound |
| HY-43149 | Monomethyl auristatin E intermediate-5 | 1822810-13-8 | Reference compound |
| HY-43279 | Fmoc-Gly-NH-CH2-O-CH2COOH | 1599440-08-0 | Reference compound |
| HY-43304 | N-Boc-dolaproine-methyl | 164456-57-9 | Reference compound |
| HY-43421 | Solifenacin N-oxide | 180272-28-0 | Reference compound |
| HY-43426 | (R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose | 6612-91-5 | Reference compound |
| HY-43426A | 5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose | 6022-96-4 | Reference compound |
| HY-43452S | Fesoterodine-d7 (hydrochloride) | 2747918-96-1 | Isotope-Labeled Compounds |
| HY-43459 | (4-(Thiazol-2-ylcarbamoyl)piperidine-1-carbonyl)-L-leucine | 1814897-92-1 | Peptides |
| HY-43466 | Methyl desoxycholate | 3245-38-3 | Natural Products |
| HY-43470 | 3α,12β-Dihydroxycholanoic acid | 570-62-7 | Natural Products |
| HY-43470R | 3α,12β-Dihydroxycholanoic acid (Standard) | 570-62-7 | Reference Standards |
| HY-43515 | ESI1 | Reference compound | |
| HY-43520 | BODIPY-FL | 165599-63-3 | Dye Reagents |
| HY-43521 | Ibrutinib-MPEA | 1710768-30-1 | Reference compound |
| HY-43533 | Tarlox-TKI | 2135696-72-7 | Reference compound |
| HY-43538 | 5-Bromopentanoyl chloride | 4509-90-4 | Reference compound |
| HY-43564 | Exatecan Intermediate 5 | 143655-70-3 | Reference compound |
| HY-43565 | Exatecan intermediate 9 | 2290562-59-1 | Reference compound |
| HY-43565B | Exatecan intermediate 10 | Reference compound | |
| HY-43565C | (1S,9R)-Ac-Exatecan | Reference compound | |
| HY-43575 | Oseltamivir-acetate | 1191921-01-3 | Reference compound |
| HY-43581 | endo-BCN-O-PNB | 1263166-91-1 | Reference compound |
| HY-43586 | BR351 precursor | 960113-89-7 | Reference compound |
| HY-43614 | Propynol Ethoxylate | 3973-18-0 | Reference compound |
| HY-43670 | Chlorthalidone impurity | 5270-74-6 | Reference compound |
| HY-43670A | Chlorthalidone impurity (ammonium) | Reference compound | |
| HY-43670R | Chlorthalidone impurity (Standard) | 5270-74-6 | Reference Standards |
| HY-43702A | 1-(3-Aminopropyl)-1H-pyrrole-2,5-dione (hydrochloride) | 1257852-74-6 | Reference compound |
| HY-43711 | Nor-benzetimide | 19315-71-0 | Reference compound |
| HY-43721 | N-Boc-4-pentyne-1-amine | 151978-50-6 | Reference compound |
| HY-43722 | Lenalidomide-Br | 2093387-36-9 | Reference compound |
| HY-43723 | PROTAC BET-binding moiety 2 | 916493-82-8 | Reference compound |
| HY-43727 | 6-Bromo-2-(bromomethyl)-3-fluoropyridine | 1187836-89-0 | Reference compound |
| HY-43747 | α-Acetobromoglucose, contains 1% CaCO3 as stabilizer | 572-09-8 | Biochemical Assay Reagents |
| HY-43781 | Fmoc-Lys(Boc)-PAB-OH | 870487-06-2 | Reference compound |
| HY-43869 | Vipivotide tetraxetan Ligand-Linker Conjugate | 1703768-74-4 | ADC Related |
| HY-43913 | (R)-eIF4A3-IN-2 | 2095484-82-3 | Reference compound |
| HY-43948 | Hexyl methanesulfonate | 16156-50-6 | Natural Products |
| HY-43948R | Hexyl methanesulfonate (Standard) | 16156-50-6 | Reference Standards |
| HY-43961 | E3 ligase Ligand 8 | 1225383-33-4 | Reference compound |
| HY-43973 | N-(tert-Butoxycarbonyl)-S-butylhomocysteine | 1396969-20-2 | Peptides |
| HY-44012 | SMARCA-BD ligand 1 for PROTAC | 1997319-92-2 | Reference compound |
| HY-44012A | SMARCA-BD ligand 1 for PROTAC (dihydrochloride) | 2369053-68-7 | Reference compound |
| HY-44012B | SMARCA-BD ligand 1 for PROTAC (hydrochloride) | 2380272-56-8 | Reference compound |
| HY-44057 | 2,2-Dibutylpropane-1,3-diol | 24765-57-9 | Reference compound |
| HY-44062 | G9a-IN-1 | 1350752-07-6 | Reference compound |
| HY-44063 | Thalidomide-NH-PEG3-NH-Boc | 2204246-03-5 | Reference compound |
| HY-44070 | N-(tert-Butoxycarbonyl)-O-(tert-butyl)-L-threonyl-L-proline | 1432793-68-4 | Peptides |
| HY-44076 | LAP | 85073-19-4 | Biochemical Assay Reagents |
| HY-44087 | Ethyl (E)-3-(1-pyrrolidinyl)crotonate | 54716-02-8 | Biochemical Assay Reagents |
| HY-44103 | Desmethyl-QCA276 | 2126819-55-2 | Reference compound |
| HY-44132 | Dehydro Palonosetron | 135729-56-5 | Reference compound |
| HY-44132A | Dehydro Palonosetron (hydrochloride) | 135729-55-4 | Reference compound |
| HY-44132AR | Dehydro Palonosetron (hydrochloride) (Standard) | 135729-55-4 | Reference Standards |
| HY-44134 | Dimethyl 2-oxoglutarate | 13192-04-6 | Biochemical Assay Reagents |
| HY-44134R | Dimethyl 2-oxoglutarate (Standard) | 13192-04-6 | Reference Standards |
| HY-44135 | 7-Hydroxy-3-(4-hydroxybenzylidene)chroman-4-one | 110064-50-1 | Natural Products |
| HY-44137 | Humic acid (sodium),50-60% (as humic acid) | 68131-04-4 | Natural Products |
| HY-44141 | tert-Butyl 3-(2-iodoethoxy)propanoate | 2296723-16-3 | Reference compound |
| HY-44146 | Defactinib analogue-1 | 2296719-34-9 | Reference compound |
| HY-44148 | FAK ligand-Linker Conjugate 1 | 2307461-45-4 | Reference compound |
| HY-44149 | m-C-tri(CH2-PEG1-NHS ester) | 173414-89-6 | ADC Related |
| HY-44153 | KV2 channel inhibitor-1 | 689297-68-5 | Reference compound |
| HY-44154 | PSB-CB5 | 1627710-30-8 | Reference compound |
| HY-44157 | ALS-I | 308818-13-5 | Reference compound |
| HY-44170 | Pantothenate kinase-IN-2 | 902614-04-4 | Reference compound |
| HY-44177 | Val-Cit-PAB-MMAF (sodium) | ADC Related | |
| HY-44178 | Diethyl butylmalonate | 133-08-4 | Reference compound |
| HY-44178S | Diethyl butylmalonate-D9 | 1189865-34-6 | Isotope-Labeled Compounds |
| HY-44220 | 5-O-Benzoyl-1,2-di-O-isopropylidene-3-keto-alpha-D-xylofuranoside | 6698-46-0 | Reference compound |
| HY-44221 | MAC glucuronide linker-1 | 2222981-71-5 | ADC Related |
| HY-44222 | MAC glucuronide linker-2 | 229977-57-5 | ADC Related |
| HY-44234 | Fmoc-Gly-Gly-Phe-OtBu | 236426-37-2 | ADC Related |
| HY-44234A | Fmoc-Gly-Gly-D-Phe-OtBu | ADC Related | |
| HY-44235 | MC-Gly-Gly-Phe | 1599440-15-9 | ADC Related |
| HY-44235A | MC-Gly-Gly-D-Phe | ADC Related | |
| HY-44246 | MC-Gly-Gly-Phe-Gly | 2413428-36-9 | ADC Related |
| HY-44249 | Thalidomide-CH2NH2 (hydrochloride) | 444287-40-5 | Reference compound |
| HY-44307 | 84-B10 | 698346-43-9 | Reference compound |
| HY-44327 | 3,4-O-Isopropylidene-D-mannitol | 3969-84-4 | Biochemical Assay Reagents |
| HY-44342 | 1,5-Dihydroxy-1,2,3,4-tetrahydronaphthalene | 40771-26-4 | Biochemical Assay Reagents |
| HY-44358 | Remdesivir nucleoside monophosphate | 1911578-74-9 | Reference compound |
| HY-44369 | Exatecan Intermediate 6 | 143655-58-7 | Reference compound |
| HY-44370 | Boc-Gly-Gly-Gly-Gly-Gly | 330807-97-1 | Reference compound |
| HY-44408 | 2-(4-Bromophenoxy)ethanol | 34743-88-9 | Reference compound |
| HY-44432 | Navitoclax-piperazine | 2143096-93-7 | Reference compound |
| HY-44484 | MAC-5576 | 219929-01-8 | Reference compound |
| HY-44630 | VH 032 amide-alkylC6-acid | 2172819-75-7 | Reference compound |
| HY-44680 | L-Cystine N-carboxyanhydride | 51507-96-1 | Reference compound |
| HY-44688 | S.pombe lumazine synthase-IN-1 | 331726-35-3 | Reference compound |
| HY-44745S | 4-Ethyl-1,4,7,8-tetrahydro-3H,10H-spiro[pyrano[3,4-f]indolizine-6,2'-[1,3]dioxolane]-3,10-dione-d5 | 1346605-23-9 | Isotope-Labeled Compounds |
| HY-44809 | Izilendustat | 1303512-02-8 | Reference compound |
| HY-44809A | Izilendustat (hydrochloride) | 1303513-80-5 | Reference compound |
| HY-44824 | SMARCA2 ligand-13 | 2660235-29-8 | Reference compound |
| HY-44980 | Fmoc-Gly-NH-CH2-acetyloxy | 1599440-06-8 | Reference compound |
| HY-44980G | Fmoc-Gly-NH-CH2-acetyloxy (GMP) | 1599440-06-8 | GMP Small Molecules |
| HY-45018 | Tos-PEG3-CH2COOtBu | 1530778-24-5 | Reference compound |
| HY-45072 | Croscarmellose sodium | 74811-65-7 | Reference compound |
| HY-45131 | Cholesterol absorption inhibitor 1 | 190595-65-4 | Reference compound |
| HY-45157 | Exatecan Intermediate 7 | 182182-32-7 | Reference compound |
| HY-45171 | Exatecan intermediate 12 | 110351-93-4 | Reference compound |
| HY-45264 | 2,6-Dichlorobenzen-3,4,5-d3-amine | 77435-48-4 | Isotope-Labeled Compounds |
| HY-45281 | N6-Benzoyl-5'-O-DMT-3'-O-methyladenosine 3'CE-phosphoramidite | 179479-02-8 | Reference compound |
| HY-45290 | trans-1,2-Cyclohexanediaminetetraacetic acid | 13291-61-7 | Biochemical Assay Reagents |
| HY-45409 | DMT-2′Fluoro-dU Phosphoramidite | 146954-75-8 | Oligonucleotides |
| HY-45464 | 2,3,4,6-Tetra-O-benzyl-D-glucitol | 14233-48-8 | Biochemical Assay Reagents |
| HY-45491 | Dmt-2'-f-dc(ac) amidite | 159414-99-0 | Oligonucleotides |
| HY-45492 | DMT-2'Fluoro-DG(IB) Amidite | 144089-97-4 | Oligonucleotides |
| HY-45493 | L-Mannose,6-deoxy,diethyl dithioacetal | 6748-70-5 | Biochemical Assay Reagents |
| HY-45509 | TLB 150 Benzoate | 1208070-53-4 | Reference compound |
| HY-45545 | Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH | 2264011-98-3 | Reference compound |
| HY-45609 | L-Cysteine S-sulfate (sodium hydrate) | 150465-29-5 | Reference compound |
| HY-45661 | Inixaciclib | 2370913-42-9 | Reference compound |
| HY-45669 | Fmoc-Gly-Gly-Phe-Gly-CH2-O-CH2-Cbz | 2264011-97-2 | Reference compound |
| HY-45672 | Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH | 1599440-20-6 | Reference compound |
| HY-45672G | Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (GMP) | 1599440-20-6 | GMP Small Molecules |
| HY-45808 | Thalidomide-azetidine-CHO | 2416132-70-0 | Reference compound |
| HY-45826 | MRX343 | 1112968-16-7 | Reference compound |
| HY-45842S | 4,6-Dichloro-N-methylpyridazine-3-carboxamide-d3 | 1609393-89-6 | Isotope-Labeled Compounds |
| HY-45854 | GWP-042 | 1645486-93-6 | Reference compound |
| HY-45894 | tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu | 1118767-16-0 | Reference compound |
| HY-46004 | Taltobulin intermediate-10 | 1822592-72-2 | Reference compound |
| HY-46005 | Taltobulin intermediate-11 | 1822561-77-2 | Reference compound |
| HY-46006 | Taltobulin intermediate-12 | Reference compound | |
| HY-46036 | Fluralaner analogue-2 | 864731-37-3 | Reference compound |
| HY-46081 | Exatecan Intermediate 3 | Reference compound | |
| HY-46142 | 16,17-Dihydroapovincamine | 57130-30-0 | Natural Products |
| HY-46225 | DEX-maleimide | 2754462-35-4 | Reference compound |
| HY-46262 | JAK-IN-15 | 1973485-05-0 | Reference compound |
| HY-46317 | DMT-5Me-dC(Bz)-CE Phosphoramidite | 105931-57-5 | Reference compound |
| HY-46340 | AZD9496 deacrylic acid phenol | 2173404-70-9 | Reference compound |
| HY-46346 | Fmoc-Gly-NH-CH2-O-CH2-Cbz | 1599440-07-9 | Reference compound |
| HY-46369 | 1-p-Chlorobenzyl-1,2,3-triazole-5′-O-DMT-dU Phosphoramidite | Reference compound | |
| HY-46398 | Fmoc-Val-Phe-Boc | 258879-48-0 | Reference compound |
| HY-46531 | Thalidomide-5-NH2-CH2-COOH | 2412056-27-8 | Reference compound |
| HY-46568 | CDK7/12-IN-1 | 2654075-94-0 | Reference compound |
| HY-46572 | Benzyl 2-cyclopropyl-2-hydroxyacetate | 182747-31-5 | Reference compound |
| HY-46575 | (R)-2-(But-3-en-1-yl)oxirane | 137688-20-1 | Reference compound |
| HY-46749 | Muvalaplin (tetrahydrochloride) | 2565656-71-3 | Reference compound |
| HY-46759 | Genevant CL1 | 1450888-71-7 | Reference compound |
| HY-46759A | Genevant CL1 (monohydrochloride) | Biochemical Assay Reagents | |
| HY-46760 | CCD Lipid01 | 1799316-64-5 | Reference compound |
| HY-46846 | Styrene-divinylbenzene sulfonated copolymer | 69011-20-7 | Reference compound |
| HY-46859 | Fmoc-Asp(OtBu)-CH2COOH | 1803002-89-2 | Reference compound |
| HY-46866 | Isoegomaketone | 34348-59-9 | Reference compound |
| HY-47018 | BCN-HS-PEG2-VA-PABC-SG3199 | 2126805-05-6 | Reference compound |
| HY-47026 | Protein kinase inhibitor 6 | 348-45-8 | Reference compound |
| HY-47030 | Ferric citrate (hydrate) | 2338-05-8 | Biochemical Assay Reagents |
| HY-47070 | VH 101, acid | 2408341-97-7 | Reference compound |
| HY-47176 | QTZ | 2883232-39-9 | Dye Reagents |
| HY-47228 | KB-5492 (free base) | 113594-64-2 | Reference compound |
| HY-47272 | N6-Benzoyl-9-β-D-arabinofuranosyladenine | 79896-97-2 | Reference compound |
| HY-47272A | N6-Benzoyl-9-β-D-arabinofuranosyladenine (hydrate) | Reference compound | |
| HY-47308 | 1,2-Bis(3-(trifluoromethyl)phenyl)diselane | 53973-75-4 | Reference compound |
| HY-47351 | N-Acetyl-2',3'-acetyl-guanosine | 65360-02-3 | Reference compound |
| HY-47373 | Folate-PEG3-C2-acid | Reference compound | |
| HY-47573 | CCG273441 | 2750414-35-6 | Reference compound |
| HY-47595 | WAY-621089 | 303790-92-3 | Reference compound |
| HY-47596 | WAY-612453 | 300809-10-3 | Reference compound |
| HY-47597 | Protein kinase G inhibitor-2 | 612829-80-8 | Reference compound |
| HY-47598 | Analgesic agent-3 | 796115-75-8 | Reference compound |
| HY-47599 | WAY-639418 | 643042-43-7 | Reference compound |
| HY-47600 | WAY-323756 | 854135-42-5 | Reference compound |
| HY-47601 | WAY-637940 | 795282-95-0 | Reference compound |
| HY-47634 | WAY-658675 | 545382-94-3 | Reference compound |
| HY-47663 | 5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid | 2212021-83-3 | Reference compound |
| HY-47687 | WAY-221060 | 1351406-38-6 | Reference compound |
| HY-47709 | STING ligand-3 | 2762552-73-6 | Reference compound |
| HY-47733 | CDK1/2/4-IN-2 | 677701-62-1 | Reference compound |
| HY-47762S | 3-Methoxyacetaminophen-d3 | 1246816-53-4 | Isotope-Labeled Compounds |
| HY-47812 | Cbz-D-Glu(Bn)-Gly-Gly-Gly-Gly | Reference compound | |
| HY-47820 | Tesirine intermediate-1 | 1430738-05-8 | Reference compound |
| HY-47821 | WAY-655978 | 692869-98-0 | Reference compound |
| HY-47822 | WAY-354574 | 851873-40-0 | Reference compound |
| HY-47823 | GPCR agonist-2 | 291528-35-3 | Reference compound |
| HY-47824 | WAY-313165 | 332399-50-5 | Reference compound |
| HY-47825 | WAY-660222 | 867294-23-3 | Reference compound |
| HY-47826 | WAY-604603 | 41335-62-0 | Reference compound |
| HY-47851 | VH 101, thiol | 2358775-81-0 | Reference compound |
| HY-47858 | Exatecan-2-(aminomethoxy)acetamide-Gly-Fmoc | 1599440-09-1 | Reference compound |
| HY-47873 | WAY-119918 | 428831-87-2 | Reference compound |
| HY-47874 | WAY-639729 | 113214-30-5 | Reference compound |
| HY-47875 | N-(2-Hydroxyphenyl)picolinamide | 88530-99-8 | Reference compound |
| HY-47876 | WAY-659590 | 867283-39-4 | Reference compound |
| HY-47877 | WAY-300570 | 308295-11-6 | Reference compound |
| HY-47878 | WAY-300569 | 315235-68-8 | Reference compound |
| HY-47879 | WAY-304671 | 330837-95-1 | Reference compound |
| HY-47888 | PLN-1474 | 2408065-32-5 | Reference compound |
| HY-47968 | SC209 intermediate-1 | 1977557-93-9 | Reference compound |
| HY-47979 | FAP-IN-2 | 2471983-20-5 | Reference compound |
| HY-47979A | FAP-IN-2 (TFA) | Reference compound | |
| HY-48187 | KRAS inhibitor-39 | Reference compound | |
| HY-48238 | WAY-329600 | 956959-79-8 | Reference compound |
| HY-48239 | WAY-358981 | 307322-32-3 | Reference compound |
| HY-48240 | WAY-608094 | 312590-55-9 | Reference compound |
| HY-48241 | WAY-616296 | 503065-67-6 | Reference compound |
| HY-48242 | WAY-328127 | 912784-67-9 | Reference compound |
| HY-48243 | WAY-381644 | 379713-58-3 | Reference compound |
| HY-48244 | WAY-313201 | 571904-77-3 | Reference compound |
| HY-48289 | PKA/AKAP-IN-2 | 304888-67-3 | Reference compound |
| HY-482934 | 2’-Deoxy-2’-fluoroinosine | 80049-87-2 | Reference compound |
| HY-48321 | N-Cbz-glycyl-glycyl-D-phenylalanine | 1802522-76-4 | Reference compound |
| HY-48394A | Bis-S-C2-N(N-Me)-C2-OH (dihydrochloride) | Reference compound | |
| HY-48517 | L2H2-6OTD intermediate-1 | 912656-47-4 | Reference compound |
| HY-48564 | TAM558 intermediate-5 | 1415659-15-2 | Reference compound |
| HY-48625 | L2H2-6OTD intermediate-2 | 890403-75-5 | Reference compound |
| HY-48626 | L2H2-6OTD intermediate-3 | Reference compound | |
| HY-48668 | AcLys-PABC-VC-Aur0101 intermediate-1 | 1609108-48-6 | Reference compound |
| HY-48682 | AKT ligand-2 | 2376139-61-4 | Reference compound |
| HY-48692 | Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) | 2360920-01-8 | Reference compound |
| HY-48814 | 3-Epideoxycholic acid | 570-63-8 | Reference compound |
| HY-48817 | Nor-SCH-12679 (maleate) | 20049-44-9 | Reference compound |
| HY-48868 | WAY-215718 | 128175-06-4 | Reference compound |
| HY-48869 | PI3K-IN-46 | 304645-61-2 | Reference compound |
| HY-48870 | WAY-324728 | 544670-38-4 | Reference compound |
| HY-48871 | WAY-325811 | 869632-12-2 | Reference compound |
| HY-48873 | 5'-O-DMT-5-Ethynyl-2'-deoxyuridine 3'-CE phosphoramidite | 188411-06-5 | Oligonucleotides |
| HY-48876 | p-NH2-Bn-DOTA | 181065-46-3 | Biochemical Assay Reagents |
| HY-48878 | Exatecan analog 36 | Reference compound | |
| HY-48882 | Lead salicylate | 15748-73-9 | Reference compound |
| HY-48896 | Glucose pentasulfate (potassium) | 359435-44-2 | Biochemical Assay Reagents |
| HY-48917 | C10 Bisphosphonate | 15049-93-1 | Reference compound |
| HY-48932 | IRAK4 ligand-12 | 2573304-97-7 | Reference compound |
| HY-48934 | PD-1/PD-L1-IN-29 intermediate-1 | 220095-93-2 | ADC Related |
| HY-48955 | WAY-649123 | 801244-46-2 | Reference compound |
| HY-48957 | WAY-629450 | 851901-67-2 | Reference compound |
| HY-48958 | Protein kinase G inhibitor-1 | 354544-70-0 | Reference compound |
| HY-48959 | α7β1 integrin modulator-1 | 849121-82-0 | Reference compound |
| HY-48973 | 2'-Fluoro-2'-deoxy-ara-U-3'-phosphoramidite | 1190089-70-3 | Oligonucleotides |
| HY-48999A | FSK (hydrochloride) | 3033987-42-4 | Reference compound |
| HY-49000 | DMT-locMeC(bz) phosphoramidite | 206055-82-5 | Oligonucleotides |
| HY-49053 | N-Boc-dolaproine-amide-Me-Phe | 3026596-72-2 | Reference compound |
| HY-49064 | WAY-313356 | 325694-03-9 | Reference compound |
| HY-49065 | WAY-658494 | 1351358-93-4 | Reference compound |
| HY-49066 | Sodium Channel inhibitor 4 | 587843-16-1 | Reference compound |
| HY-49069 | Anti-osteoporosis agent-7 | 445254-59-1 | Reference compound |
| HY-49070 | WAY-604440 | 501113-03-7 | Reference compound |
| HY-49071 | Tuberculosis inhibitor 12 | 793729-44-9 | Reference compound |
| HY-49072 | WAY-620473 | 743451-55-0 | Reference compound |
| HY-49073 | p38 MAP Kinase Inhibitor Ⅵ | 421578-46-3 | Reference compound |
| HY-49074 | WAY-604439 | 521281-98-1 | Reference compound |
| HY-49075 | WAY-622252 | 1897-80-9 | Reference compound |
| HY-49076 | RORγ inverse agonist 1 | 529500-72-9 | Reference compound |
| HY-49116 | CP26 | 500285-30-3 | Reference compound |
| HY-49198 | 2'-Deoxy-2'-fluoro-N4-benzoyl-5-methylcytidine | 182495-81-4 | Oligonucleotides |
| HY-49199 | 2',3',5'-Tri-O-(t-butyldimethylsilyl)-4'-C-hydroxymethyl uridine | 232588-97-5 | Oligonucleotides |
| HY-49200 | DMT-2'-F-dC(Bz)-CE-Phosphoramidite | 182495-83-6 | Oligonucleotides |
| HY-49203 | 2’-O-Acetyl-3,5-bis-O-(2,4-dichlorobenzyl)adenosine | 2095417-66-4 | Oligonucleotides |
| HY-49205 | 3,5-Bis-O-(2,4-dichlorobenzyl)adenosine | 2095417-71-1 | Oligonucleotides |
| HY-49206 | CbzNH-PEG8-amide-bis(pentayl-5OBz) | Reference compound | |
| HY-49210 | DMT-locG(ib) Phosphoramidite | 206055-77-8 | Oligonucleotides |
| HY-49214 | 5-Formylindole-CE phosphoramidite | 460355-05-9 | Oligonucleotides |
| HY-49223 | diMal-O-CH2COOH | 1620837-47-9 | Reference compound |
| HY-49319 | USP7-IN-14 | Reference compound | |
| HY-49372A | Thalidomide 5-pyrrolidine-CHO | 2416132-74-4 | Reference compound |
| HY-49373 | AChE-IN-64 | 148305-62-8 | Reference compound |
| HY-49382 | Fluocinolone acetonide 3-benzylaniline | 2166375-81-9 | ADC Related |
| HY-49393 | BRD9 ligand-6 | 2460248-49-9 | Reference compound |
| HY-49395A | (S)-4-(4-((4-(4-((2,6-Dioxopiperidin-3-yl)carbamoyl)-3-fluorophenyl)piperazin-1-yl)methyl)piperidin-1-yl)benzoic acid hydrochloride | Reference compound | |
| HY-49412 | Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CO-CH3 | 2866301-96-2 | Reference compound |
| HY-49413 | Monomethyl auristatin E intermediate-2 | ADC Related | |
| HY-49421 | BTK ligand 12 | 1791402-91-9 | Reference compound |
| HY-49432 | KTX-582 intermediate-2 | 2434850-07-2 | ADC Related |
| HY-49435 | KTX-582 intermediate-3 | 2573304-30-8 | ADC Related |
| HY-49436 | KTX-582 intermediate-1 | 845508-29-4 | ADC Related |
| HY-49444 | EN450 | 793719-01-4 | Reference compound |
| HY-49450 | WAY-385995 | 6484-31-7 | Reference compound |
| HY-49453 | Fmoc-Gly-Gly-(D-Phe)-Gly-CH2-O-CH2-Cbz | Reference compound | |
| HY-49457 | Copper(II) ionophore I | 125769-67-7 | Reference compound |
| HY-49458 | WAY-232897 | 149045-58-9 | Reference compound |
| HY-49459 | Casein kinase 1δ-IN-14 | 793722-88-0 | Reference compound |
| HY-49460 | WAY-639299 | 796059-20-6 | Reference compound |
| HY-49463 | Fmoc-Gly-Gly-Phe-Gly-CH2-O-CH2-Gly-CH2-O-CH2-Cbz | Reference compound | |
| HY-49484 | EGGGG-PEG8-amide-bis(deoxyglucitol) | 2842855-38-1 | Reference compound |
| HY-49514 | SOS1 Ligand intermediate-1 | 2380273-21-0 | Reference compound |
| HY-49515 | SOS1 Ligand intermediate-2 | 2380273-24-3 | Reference compound |
| HY-49537 | ER ligand-10 | 1075742-56-1 | Reference compound |
| HY-49556 | (S)-Benzyl 2-cyclopropyl-2-hydroxyacetate | 2414393-48-7 | Reference compound |
| HY-49597 | Pin1 modulator 1 | 301688-74-4 | Reference compound |
| HY-49601 | WAY-329738 | 957511-97-6 | Reference compound |
| HY-49861 | Exatecan intermediate 11 | ADC Related | |
| HY-49929 | MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH | 2778374-70-0 | ADC Related |
| HY-50001 | Nucleozin | 341001-38-5 | Reference compound |
| HY-50055 | EtDO-P4 | 245329-78-6 | Reference compound |
| HY-50071 | 6-Amino-5-nitropyridin-2-one | 211555-30-5 | Reference compound |
| HY-50081 | CCR2-RA-[R] | 512177-83-2 | Reference compound |
| HY-50084 | CCR2-RA | 512177-31-0 | Reference compound |
| HY-50094 | Pictilisib | 957054-30-7 | Reference compound |
| HY-50097 | 3-Bromo-2-methylaniline | 55289-36-6 | Biochemical Assay Reagents |
| HY-50098 | Mardepodect | 898562-94-2 | Reference compound |
| HY-50098A | Mardepodect (hydrochloride) | 2070014-78-5 | Reference compound |
| HY-50101 | Mavorixafor | 558447-26-0 | Reference compound |
| HY-50101A | Mavorixafor (trihydrochloride) | 2309699-17-8 | Reference compound |
| HY-50101C | Mavorixafor (hydrochloride) | 880549-30-4 | Reference compound |
| HY-50108 | GW 4064 | 278779-30-9 | Reference compound |
| HY-50108A | (E)-GW 4064 | 1089660-72-9 | Reference compound |
| HY-50158 | Glucagon receptor antagonist-2 | 202917-18-8 | Reference compound |
| HY-50159 | Glucagon receptor antagonist-3 | 202917-17-7 | Reference compound |
| HY-50162 | GPR120 modulator 1 | 1050506-75-6 | Reference compound |
| HY-50172 | GPR120 modulator 2 | 1050506-87-0 | Reference compound |
| HY-50175 | Laropiprant | 571170-77-9 | Reference compound |
| HY-50175A | Laropiprant (sodium) | 572874-50-1 | Reference compound |
| HY-50202 | Etomoxir | 124083-20-1 | Reference compound |
| HY-50202A | Etomoxir (sodium salt) | 828934-41-4 | Reference compound |
| HY-50284 | N-Boc-indole-2-boronic acid | 213318-44-6 | Biochemical Assay Reagents |
| HY-50289 | Sorbinil | 68367-52-2 | Reference compound |
| HY-50290 | Meluadrine | 134865-33-1 | Reference compound |
| HY-50290A | Meluadrine tartrate | 134865-37-5 | Reference compound |
| HY-50291 | HOKU-81 | 58020-43-2 | Reference compound |
| HY-50295 | CI-1040 | 212631-79-3 | Reference compound |
| HY-50297 | 1-Acetyl-2-deoxy-3,5-di-O-benzoylribofuranose | 51255-12-0 | Biochemical Assay Reagents |
| HY-50301 | Ethyl 2-aminothiazole-5-carboxylate | 32955-21-8 | Biochemical Assay Reagents |
| HY-50514 | AT9283 | 896466-04-9 | Reference compound |
| HY-50542 | 7-Azaindole | 271-63-6 | Biochemical Assay Reagents |
| HY-50662 | A-769662 | 844499-71-4 | Reference compound |
| HY-50663 | MK 0893 | 870823-12-4 | Reference compound |
| HY-50665 | LY518674 | 425671-29-0 | Reference compound |
| HY-50667 | Apixaban | 503612-47-3 | Reference compound |
| HY-50667R | Apixaban (Standard) | 503612-47-3 | Reference Standards |
| HY-50667S | Apixaban-13C,d3 | 1261393-15-0 | Isotope-Labeled Compounds |
| HY-50667S1 | Apixaban-d3 | 1131996-12-7 | Isotope-Labeled Compounds |
| HY-50669 | MK-0812 | 624733-88-6 | Reference compound |
| HY-50669A | MK-0812 (Succinate) | 851916-42-2 | Reference compound |
| HY-50670 | DGAT-1 inhibitor 2 | 942999-61-3 | Reference compound |
| HY-50671 | Zosuquidar (trihydrochloride) | 167465-36-3 | Reference compound |
| HY-50671R | Zosuquidar (trihydrochloride) (Standard) | 167465-36-3 | Reference Standards |
| HY-50672 | MK-0731 | 845256-65-7 | Reference compound |
| HY-50673 | Dactolisib | 915019-65-7 | Reference compound |
| HY-50673A | Dactolisib (hydrochloride) | 2319647-83-9 | Reference compound |
| HY-50674 | INCB3344 | 1262238-11-8 | Reference compound |
| HY-50674A | INCB3344 (R-isomer) | Reference compound | |
| HY-50675 | GRA Ex-25 | 307983-31-9 | Reference compound |
| HY-50680 | HCVP-IN-1 | 877225-09-7 | Reference compound |
| HY-50682 | Azeliragon | 603148-36-3 | Reference compound |
| HY-50682A | Azeliragon (dihydrochloride) | 1284150-65-7 | Reference compound |
| HY-50683 | JNJ-38877605 | 943540-75-8 | Reference compound |
| HY-50683S | JNJ-38877605-d1 | 1936472-36-4 | Isotope-Labeled Compounds |
| HY-50685 | A 410099.1 | 762274-58-8 | Reference compound |
| HY-50686 | Tivantinib | 905854-02-6 | Reference compound |
| HY-50687 | (3S,4S)-Tivantinib | 905854-03-7 | Reference compound |
| HY-50688 | SB-265610 | 211096-49-0 | Reference compound |
| HY-50691 | GW-1100 | 306974-70-9 | Reference compound |
| HY-50692 | CAY10734 | 635701-59-6 | Reference compound |
| HY-50694 | Senicapoc | 289656-45-7 | Reference compound |
| HY-50695 | GSK 625433 | 885264-71-1 | Reference compound |
| HY-50696 | Nutlin-3 | 548472-68-0 | Reference compound |
| HY-50697 | A-740003 | 861393-28-4 | Reference compound |
| HY-50698 | BI 2536 | 755038-02-9 | Reference compound |
| HY-50703 | MK-2461 | 917879-39-1 | Reference compound |
| HY-50706 | Selumetinib | 606143-52-6 | Reference compound |
| HY-50706A | Selumetinib (sulfate) | 943332-08-9 | Reference compound |
| HY-50707 | (Rac)-TTA-P2 | 918430-49-6 | Reference compound |
| HY-50709 | A939572 | 1032229-33-6 | Reference compound |
| HY-50710 | KU-0063794 | 938440-64-3 | Reference compound |
| HY-50713 | Calcium-Sensing receptor antagonist I | 478963-79-0 | Reference compound |
| HY-50714 | Quiflapon (sodium) | 147030-01-1 | Reference compound |
| HY-50719S1 | 2-Acetyl-1-pyrroline-13C5 | Isotope-Labeled Compounds | |
| HY-50722 | NNC 55-0396 | 357400-13-6 | Reference compound |
| HY-50722A | (Rac)-NNC 55-0396 | 2517420-92-5 | Reference compound |
| HY-50723 | 3-Methylxanthine | 1076-22-8 | Natural Products |
| HY-50723R | 3-Methylxanthine (Standard) | 1076-22-8 | Reference Standards |
| HY-50723S | 3-Methylxanthine-13C4,15N3 | 1173018-93-3 | Isotope-Labeled Compounds |
| HY-50723S1 | 3-Methylxanthine-d3 | Isotope-Labeled Compounds | |
| HY-50730 | Asparagusic acid | 2224-02-4 | Natural Products |
| HY-50733 | CX-5011 (free base) | 1009821-06-0 | Reference compound |
| HY-50733A | CX-5011 | 1333382-30-1 | Reference compound |
| HY-50735 | Fiacitabine | 69123-90-6 | Reference compound |
| HY-50736 | DUB-IN-1 | 924296-18-4 | Reference compound |
| HY-50737 | DUB-IN-3 | 924296-17-3 | Reference compound |
| HY-50737A | DUB-IN-2 | 924296-19-5 | Reference compound |
| HY-50751 | Linifanib | 796967-16-3 | Reference compound |
| HY-50751G | Linifanib (GMP) | 796967-16-3 | GMP Small Molecules |
| HY-50751S | Linifanib-d4 | Isotope-Labeled Compounds | |
| HY-50752 | LY-411575 | 209984-57-6 | Reference compound |
| HY-50752A | LY-411575 (isomer 1) | 209984-58-7 | Reference compound |
| HY-50752B | LY-411575 (isomer 2) | 2070009-70-8 | Reference compound |
| HY-50752C | LY-411575 (isomer 3) | 2070009-28-6 | Reference compound |
| HY-50754 | gamma-secretase modulator 2 | 1093978-89-2 | Reference compound |
| HY-50759 | Ispinesib | 336113-53-2 | Reference compound |
| HY-50759S | Ispinesib-d5 | Isotope-Labeled Compounds | |
| HY-50760 | L-692585 | 145455-35-2 | Reference compound |
| HY-50761 | Libenzapril | 109214-55-3 | Reference compound |
| HY-50767 | Palbociclib | 571190-30-2 | Reference compound |
| HY-50767A | Palbociclib (monohydrochloride) | 827022-32-2 | Reference compound |
| HY-50767B | Palbociclib (dihydrochloride) | 1831842-69-3 | Reference compound |
| HY-50767C | Palbociclib (hydrochloride) | 571189-11-2 | Reference compound |
| HY-50767D | Palbociclib (orotate) | 2757498-64-7 | Reference compound |
| HY-50767R | Palbociclib (Standard) | 571190-30-2 | Reference Standards |
| HY-50767S | Palbociclib-d8 | 1628752-83-9 | Isotope-Labeled Compounds |
| HY-50767S1 | Palbociclib-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-50768 | VTP-27999 | 942142-51-0 | Reference compound |
| HY-50769 | VTP-27999 (TFA) | 1013937-63-7 | Reference compound |
| HY-50807 | 4-Nitrophenylboronic acid | 24067-17-2 | Biochemical Assay Reagents |
| HY-50822 | 4-Bromo-2-methoxyaniline | 59557-91-4 | Biochemical Assay Reagents |
| HY-50844 | Ibutamoren (Mesylate) | 159752-10-0 | Reference compound |
| HY-50845 | Avagacestat | 1146699-66-2 | Reference compound |
| HY-50846 | SCH772984 | 942183-80-4 | Reference compound |
| HY-50847 | ZSTK474 | 475110-96-4 | Reference compound |
| HY-50848 | BW A868C | 118675-50-6 | Reference compound |
| HY-50855 | Silmitasertib | 1009820-21-6 | Reference compound |
| HY-50855B | Silmitasertib (sodium salt) | 1309357-15-0 | Reference compound |
| HY-50856 | Ruxolitinib | 941678-49-5 | Reference compound |
| HY-50856A | Ruxolitinib (S enantiomer) | 941685-37-6 | Reference compound |
| HY-50856R | Ruxolitinib (Standard) | 941678-49-5 | Reference Standards |
| HY-50856S | Deuruxolitinib | 1513883-39-0 | Isotope-Labeled Compounds |
| HY-50856S2 | Ruxolitinib-d9 | 1513883-55-0 | Isotope-Labeled Compounds |
| HY-50858 | Ruxolitinib (phosphate) | 1092939-17-7 | Reference compound |
| HY-50859 | Ruxolitinib (sulfate) | 1092939-16-6 | Reference compound |
| HY-50861 | AZD3988 | 892489-52-0 | Reference compound |
| HY-50862 | Akt1/Akt2-IN-1 | 893422-47-4 | Reference compound |
| HY-50864 | GDC-0879 | 905281-76-7 | Reference compound |
| HY-50865 | PDE-9 inhibitor | 1082743-70-1 | Reference compound |
| HY-50866 | NVP-AEW541 | 475489-16-8 | Reference compound |
| HY-50866B | NVP-AEW541 (dihydrochloride) | 2320261-63-8 | Reference compound |
| HY-50867 | Lestaurtinib | 111358-88-4 | Reference compound |
| HY-50868 | Bafetinib | 859212-16-1 | Reference compound |
| HY-50874 | BCX 1470 | 217099-43-9 | Reference compound |
| HY-50875 | BCX 1470 (methanesulfonate) | 217099-44-0 | Reference compound |
| HY-50876 | Daporinad | 658084-64-1 | Reference compound |
| HY-50877 | GSK461364 | 929095-18-1 | Reference compound |
| HY-50878 | Crizotinib | 877399-52-5 | Reference compound |
| HY-50878A | Crizotinib (hydrochloride) | 1415560-69-8 | Reference compound |
| HY-50878AS | Crizotinib-d9 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-50878B | Crizotinib (acetate) | 877399-53-6 | Reference compound |
| HY-50878R | Crizotinib (Standard) | 877399-52-5 | Reference Standards |
| HY-50878S | Crizotinib-d5 | 1395950-84-1 | Isotope-Labeled Compounds |
| HY-50878S1 | Crizotinib-d8 | 1523579-82-9 | Isotope-Labeled Compounds |
| HY-50878S2 | Crizotinib-d9 | 1523580-59-7 | Isotope-Labeled Compounds |
| HY-50879 | Elacridar | 143664-11-3 | Reference compound |
| HY-50880 | Elacridar (hydrochloride) | 143851-98-3 | Reference compound |
| HY-50882 | ELN318463 | 851600-86-7 | Reference compound |
| HY-50882A | ELN318463 (racemate) | 851599-82-1 | Reference compound |
| HY-50883 | BMS 299897 | 290315-45-6 | Reference compound |
| HY-50884 | BMS 433796 | 935525-13-6 | Reference compound |
| HY-50887 | L-873724 | 603139-12-4 | Reference compound |
| HY-50889 | gamma-secretase modulator 3 | 1431697-84-5 | Reference compound |
| HY-50892 | (Rac)-Roscovitine | 186692-44-4 | Reference compound |
| HY-50895 | Gefitinib | 184475-35-2 | Reference compound |
| HY-50895A | Gefitinib (hydrochloride) | 184475-55-6 | Reference compound |
| HY-50895B | Gefitinib (dihydrochloride) | 184475-56-7 | Reference compound |
| HY-50895G | Gefitinib (GMP) | 184475-35-2 | GMP Small Molecules |
| HY-50895R | Gefitinib (Standard) | 184475-35-2 | Reference Standards |
| HY-50895S | Gefitinib-d8 | 857091-32-8 | Isotope-Labeled Compounds |
| HY-50895S1 | Gefitinib-d6 | 1228664-49-0 | Isotope-Labeled Compounds |
| HY-50895S2 | Gefitinib-d3 | 1173976-40-3 | Isotope-Labeled Compounds |
| HY-50896 | Erlotinib | 183321-74-6 | Reference compound |
| HY-50896R | Erlotinib (Standard) | 183321-74-6 | Reference Standards |
| HY-50896S | Erlotinib-d6 | 1034651-23-4 | Isotope-Labeled Compounds |
| HY-50896S1 | Erlotinib-13C6 | 1211107-68-4 | Isotope-Labeled Compounds |
| HY-50896S2 | Erlotinib-d4 | 1130852-41-3 | Isotope-Labeled Compounds |
| HY-50896S3 | Erlotinib-d8 | 1266656-97-6 | Isotope-Labeled Compounds |
| HY-50898 | Lapatinib | 231277-92-2 | Reference compound |
| HY-50898A | Lapatinib (ditosylate) | 388082-77-7 | Reference compound |
| HY-50898B | Lapatinib (ditosylate monohydrate) | 388082-78-8 | Reference compound |
| HY-50898C | Lapatinib (tosylate) | 1187538-35-7 | Reference compound |
| HY-50898CS | Lapatinib-d4 (tosylate) | 2749856-05-9 | Isotope-Labeled Compounds |
| HY-50898R | Lapatinib (Standard) | 231277-92-2 | Reference Standards |
| HY-50898S | Lapatinib-d4 | 1184263-99-7 | Isotope-Labeled Compounds |
| HY-50898S1 | Lapatinib-d7 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-50898S2 | Lapatinib-d5 | 2748212-14-6 | Isotope-Labeled Compounds |
| HY-50898S3 | Lapatinib-d4-1 | 1184264-15-0 | Isotope-Labeled Compounds |
| HY-50898S4 | Lapatinib-d7 | 1009307-23-6 | Isotope-Labeled Compounds |
| HY-50900 | gamma-Secretase Modulators | 937812-80-1 | Reference compound |
| HY-50901 | ONO-AE3-208 | 402473-54-5 | Reference compound |
| HY-50901A | ONO-AE3-208 (sodium salt) | 2309931-05-1 | Reference compound |
| HY-50903 | Rivaroxaban | 366789-02-8 | Reference compound |
| HY-50903R | Rivaroxaban (Standard) | 366789-02-8 | Reference Standards |
| HY-50903S | Rivaroxaban-d4 | 1132681-38-9 | Isotope-Labeled Compounds |
| HY-50904 | Nintedanib | 656247-17-5 | Reference compound |
| HY-50904R | Nintedanib (Standard) | 656247-17-5 | Reference Standards |
| HY-50904S | Nintedanib-d3 | 1624587-84-3 | Isotope-Labeled Compounds |
| HY-50904S1 | Nintedanib-13C,d3 | Isotope-Labeled Compounds | |
| HY-50904S2 | Nintedanib-d8 | 1624587-87-6 | Isotope-Labeled Compounds |
| HY-50905 | Dovitinib | 405169-16-6 | Reference compound |
| HY-50905S | Dovitinib-d8 | 1246819-84-0 | Isotope-Labeled Compounds |
| HY-50906 | LY404039 | 635318-11-5 | Reference compound |
| HY-50907 | ABT-737 | 852808-04-9 | Reference compound |
| HY-50907S | ABT-737-d8 | 1217686-68-4 | Isotope-Labeled Compounds |
| HY-50908 | Ridaforolimus | 572924-54-0 | Reference compound |
| HY-50909 | Perifosine | 157716-52-4 | Reference compound |
| HY-50910 | Temsirolimus | 162635-04-3 | Reference compound |
| HY-50911 | Turofexorate isopropyl | 629664-81-9 | Reference compound |
| HY-50912 | Plerixafor (octahydrochloride) | 155148-31-5 | Reference compound |
| HY-50914 | AZD5597 | 924641-59-8 | Reference compound |
| HY-50919 | Paricalcitol | 131918-61-1 | Reference compound |
| HY-50919R | Paricalcitol (Standard) | 131918-61-1 | Reference Standards |
| HY-50934 | Tacedinaline | 112522-64-2 | Reference compound |
| HY-50935 | Troglitazone | 97322-87-7 | Reference compound |
| HY-50935R | Troglitazone (Standard) | 97322-87-7 | Reference Standards |
| HY-50935S | Troglitazone-d4 | 2749370-85-0 | Isotope-Labeled Compounds |
| HY-50936S | Trabectedin-d3 | Isotope-Labeled Compounds | |
| HY-50937 | ST 2825 | 894787-30-5 | Reference compound |
| HY-50938 | D149 Dye | 786643-20-7 | Dye Reagents |
| HY-50940 | AT7519 | 844442-38-2 | Reference compound |
| HY-50940A | AT7519 (TFA) | 1431697-85-6 | Reference compound |
| HY-50943 | AT7519 (Hydrochloride) | 902135-91-5 | Reference compound |
| HY-50946 | Imatinib (Mesylate) | 220127-57-1 | Reference compound |
| HY-50946R | Imatinib (Mesylate) (Standard) | 220127-57-1 | Reference Standards |
| HY-50948 | Bay 65-1942 (hydrochloride) | 600734-06-3 | Reference compound |
| HY-50949 | Bay 65-1942 (free base) | 600734-02-9 | Reference compound |
| HY-50949A | Bay 65-1942 (R form) | 758683-21-5 | Reference compound |
| HY-51424 | PLX-4720 | 918505-84-7 | Reference compound |
| HY-51424S | PLX-4720-d7 | 1304096-50-1 | Isotope-Labeled Compounds |
| HY-52101 | CMK | 821794-90-5 | Reference compound |
| HY-52101A | FMK | 821794-92-7 | Reference compound |
| HY-52101C | FMK-MEA | 1414811-15-6 | Reference compound |
| HY-52102 | 2-(Chloromethyl)pyrimidine hydrochloride | 936643-80-0 | Reference compound |
| HY-52112 | BCDA | 3252-36-6 | Dye Reagents |
| HY-52121 | Windaus ketone | 55812-80-1 | Reference compound |
| HY-52155S | NSC 89275-d12 | 93951-66-7 | Isotope-Labeled Compounds |
| HY-59001 | Sappanchalcone | 94344-54-4 | Natural Products |
| HY-59021 | 2-(4-Biphenylyl)-5-phenyl-1,3,4-oxadiazole | 852-38-0 | Dye Reagents |
| HY-59047 | Tolimidone | 41964-07-2 | Reference compound |
| HY-59059 | 5-(2-Aminopropyl)indole | 3784-30-3 | Reference compound |
| HY-59090 | 1-Azakenpaullone | 676596-65-9 | Reference compound |
| HY-59097 | (E/Z)-Tapinarof | 115781-08-3 | Reference compound |
| HY-59105 | SC-560 | 188817-13-2 | Reference compound |
| HY-59121 | (S)-isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate | 1334513-02-8 | Peptides |
| HY-59121A | Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate | 1337529-56-2 | Peptides |
| HY-59125 | (R,R)-(+)-Hydrobenzoin | 52340-78-0 | Natural Products |
| HY-59132 | 2-Amino-1-phenylethanol | 7568-93-6 | Natural Products |
| HY-59135 | (S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoic acid | 162537-11-3 | Peptides |
| HY-59135R | (S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoic acid (Standard) | 162537-11-3 | Reference Standards |
| HY-59137 | 1-Methylimidazole | 616-47-7 | Reference compound |
| HY-59137S | 1-Methylimidazole-d6 | 285978-27-0 | Isotope-Labeled Compounds |
| HY-59137S1 | 1-Methyl-imidazole-d3 | 16650-76-3 | Isotope-Labeled Compounds |
| HY-59137S2 | 1-Methylimidazole-d3-1 | 4166-68-1 | Isotope-Labeled Compounds |
| HY-59140 | (S)-2-Amino-3,3-dimethylbutanoic acid | 20859-02-3 | Peptides |
| HY-59140S1 | (S)-2-Amino-3,3-dimethylbutanoic acid-18O, d2 | Isotope-Labeled Compounds | |
| HY-59140S2 | (S)-2-Amino-3,3-dimethylbutanoic acid-d6 | Isotope-Labeled Compounds | |
| HY-59156 | Triazabicyclodecene | 5807-14-7 | Biochemical Assay Reagents |
| HY-59162 | 2,6-Dibromopyridine | 626-05-1 | Biochemical Assay Reagents |
| HY-59165 | 5-Bromopyridin-2-ol | 13466-38-1 | Biochemical Assay Reagents |
| HY-59174 | 5-Bromothiophene-2-carbaldehyde | 4701-17-1 | Biochemical Assay Reagents |
| HY-59197 | 2-Chloro-5-cyanopyridine | 33252-28-7 | Biochemical Assay Reagents |
| HY-59201A | A-582941 (dihydrochloride) | 848591-90-2 | Reference compound |
| HY-59204 | 3-Chloro-4-fluorophenylboronic acid | 144432-85-9 | Biochemical Assay Reagents |
| HY-59208 | 4-Quinolinol | 611-36-9 | Reference compound |
| HY-59219 | Cyclopropylboronic acid | 411235-57-9 | Biochemical Assay Reagents |
| HY-59226 | 5-Pyrimidylboronic acid | 109299-78-7 | Biochemical Assay Reagents |
| HY-59227 | 6-Bromooxindole | 99365-40-9 | Biochemical Assay Reagents |
| HY-59228 | 5-Bromo-2-nitropyridine | 39856-50-3 | Biochemical Assay Reagents |
| HY-59233 | 6-Bromoindole | 52415-29-9 | Biochemical Assay Reagents |
| HY-59234 | 3,6-Dibromopyridazine | 17973-86-3 | Biochemical Assay Reagents |
| HY-59237 | 2-Amino-3-nitropyridine | 4214-75-9 | Biochemical Assay Reagents |
| HY-59243 | 4,7-Dichloroquinoline | 86-98-6 | Biochemical Assay Reagents |
| HY-59243R | 4,7-Dichloroquinoline (Standard) | 86-98-6 | Reference Standards |
| HY-59243S | 4,7-Dichloroquinoline-15N | 366495-92-3 | Isotope-Labeled Compounds |
| HY-59260 | N-Boc-L-tert-Leucine | 62965-35-9 | Peptides |
| HY-59261 | 2-Amino-5-bromopyrazine | 59489-71-3 | Biochemical Assay Reagents |
| HY-59266 | 4-(Ethoxycarbonyl)-1-cyclohexanone | 17159-79-4 | Biochemical Assay Reagents |
| HY-59270 | Tricyclohexylphosphonium (tetrafluoroborate) | 58656-04-5 | Biochemical Assay Reagents |
| HY-59272 | 2,4-Thiazolidinedione | 2295-31-0 | Biochemical Assay Reagents |
| HY-59273 | 5-Nitroindole | 6146-52-7 | Biochemical Assay Reagents |
| HY-59289 | 2-Fluoro-6-methoxybenzeneboronic acid | 78495-63-3 | Biochemical Assay Reagents |
| HY-59291 | Levacetylleucine | 1188-21-2 | Natural Products |
| HY-59299 | 3-Bromothiophene | 872-31-1 | Biochemical Assay Reagents |
| HY-59301 | 4-Methoxyindole | 4837-90-5 | Biochemical Assay Reagents |
| HY-59302 | Indole-5-carboxylic acid, 98% | 1670-81-1 | Biochemical Assay Reagents |
| HY-59303 | 1H-Imidazole-5-carboxaldehyde | 3034-50-2 | Biochemical Assay Reagents |
| HY-59304 | 2,4-Dibromothiazole | 4175-77-3 | Biochemical Assay Reagents |
| HY-59307 | Pyrrole-3-carboxaldehyde | 7126-39-8 | Biochemical Assay Reagents |
| HY-59318 | 2-Amino-6-bromobenzothiazole | 15864-32-1 | Biochemical Assay Reagents |
| HY-59320 | 4-Thiazolecarboxylic acid | 3973-08-8 | Biochemical Assay Reagents |
| HY-59335 | 2-Amino-6-chloropyrazine | 33332-28-4 | Biochemical Assay Reagents |
| HY-59343 | 2-Amino-5-bromothiazole hydrobromide | 61296-22-8 | Biochemical Assay Reagents |
| HY-59354 | Maleic hydrazide | 123-33-1 | Reference compound |
| HY-59354R | Maleic hydrazide (Standard) | 123-33-1 | Reference Standards |
| HY-59354S | Maleic hydrazide-d2 | 2398483-97-9 | Isotope-Labeled Compounds |
| HY-59354S1 | 1,2-Dihydropyridazine-3,6-dione-3,4,5,6-13C4 | 2140327-62-2 | Isotope-Labeled Compounds |
| HY-59377 | 2-Amino-3-methoxybenzoic acid | 3177-80-8 | Biochemical Assay Reagents |
| HY-59384 | MOMBA | 6880-04-2 | Reference compound |
| HY-60040 | (R)-2-amino-3-cyclohexylpropanoic acid | 58717-02-5 | Peptides |
| HY-60174 | 2-BZP | 84477-71-4 | Reference compound |
| HY-60194 | 6-Bromo-2-pyridinecarboxaldehyde | 34160-40-2 | Biochemical Assay Reagents |
| HY-60206 | 5-Acetyl-2-bromopyridine | 139042-59-4 | Biochemical Assay Reagents |
| HY-60218 | 1-Boc-3-(hydroxymethyl)pyrrolidine | 114214-69-6 | Biochemical Assay Reagents |
| HY-60256 | (R)-Pyrrolidine-3-carboxylic acid | 72580-54-2 | Peptides |
| HY-60263 | (3R)-3-Pyrrolidinemethanol | 110013-18-8 | Reference compound |
| HY-60264 | (S)-Butoxycarbonylamino-cyclopropyl-acetic acid | 155976-13-9 | Peptides |
| HY-60265 | Boc-D-Cyclopropylglycine | 609768-49-2 | Peptides |
| HY-60280 | Di-tert-butyl iminodicarboxylate | 51779-32-9 | Biochemical Assay Reagents |
| HY-60298 | 6-Bromo-1H-indazole | 79762-54-2 | Biochemical Assay Reagents |
| HY-60325 | 4-Chloro-pyridin-2-ylamine | 19798-80-2 | Biochemical Assay Reagents |
| HY-60346 | 2-Pyrimidinecarboxylic acid | 31519-62-7 | Reference compound |
| HY-60347A | 2-Aminomethylpyrimidine (hydrochloride) | 372118-67-7 | Reference compound |
| HY-60351 | 5-Aminopyrimidine | 591-55-9 | Biochemical Assay Reagents |
| HY-60351S | 5-Aminopyrimidine-d3 | 2222933-95-9 | Isotope-Labeled Compounds |
| HY-65000 | H-Lys(Boc)-OMe hydrochloride | 2389-48-2 | Peptides |
| HY-65003 | 2-Chloroisonicotinic acid | 6313-54-8 | Biochemical Assay Reagents |
| HY-65008 | N-Demethylricinine | 21642-98-8 | Natural Products |
| HY-65036 | 4-Bromo-2-hydroxypyridine | 36953-37-4 | Biochemical Assay Reagents |
| HY-65039 | Boc-Hyp-OMe | 74844-91-0 | ADC Related |
| HY-65039A | rel-Boc-Hyp-OMe | 1145663-09-7 | Reference compound |
| HY-65119 | 3-Chloroindole | 16863-96-0 | Natural Products |
| HY-65119R | 3-Chloroindole (Standard) | 16863-96-0 | Reference Standards |
| HY-65254 | 5-Amino-2-fluoropyridine | 1827-27-6 | Biochemical Assay Reagents |
| HY-65255 | 2-Amino-5-methylpyrazine | 5521-58-4 | Biochemical Assay Reagents |
| HY-65257 | 3-Aminoisonicotinic acid | 7579-20-6 | Biochemical Assay Reagents |
| HY-66004 | 4-Acetamidophenyl acetate | 2623-33-8 | Reference compound |
| HY-66004R | 4-Acetamidophenyl acetate (Standard) | 2623-33-8 | Reference Standards |
| HY-66005 | Acetaminophen | 103-90-2 | Reference compound |
| HY-66005R | Acetaminophen (Standard) | 103-90-2 | Reference Standards |
| HY-66005S | Acetaminophen-d4 | 64315-36-2 | Isotope-Labeled Compounds |
| HY-66005S1 | Acetaminophen-d3 | 60902-28-5 | Isotope-Labeled Compounds |
| HY-66005S2 | Acetaminophen-d7 | 1219798-53-4 | Isotope-Labeled Compounds |
| HY-66005S3 | Acetaminophen-13C6 | 2132405-57-1 | Isotope-Labeled Compounds |
| HY-66005S4 | Acetaminophen-13C2,15N | 360769-21-7 | Isotope-Labeled Compounds |
| HY-66005S5 | Acetaminophen-d5 | Isotope-Labeled Compounds | |
| HY-66006AS | 4-Acetaminophen sulfate-d3 (potassium) | 1188263-45-7 | Isotope-Labeled Compounds |
| HY-66006S | 4-Acetaminophen sulfate-d3 | 1020718-78-8 | Isotope-Labeled Compounds |
| HY-66006S1 | 4-Acetaminophen sulfate-d4 | 1261397-46-9 | Isotope-Labeled Compounds |
| HY-66007 | Ac-β-Ala-OH | 3025-95-4 | Natural Products |
| HY-66008 | N-Acetyl mesalazine | 51-59-2 | Reference compound |
| HY-66008R | N-Acetyl mesalazine (Standard) | 51-59-2 | Reference Standards |
| HY-66008S | N-Acetyl mesalazine-d3 | 93968-79-7 | Isotope-Labeled Compounds |
| HY-66008S1 | N-Acetyl mesalazine-d3-1 | 1309935-89-4 | Isotope-Labeled Compounds |
| HY-66008S2 | N-Acetyl mesalazine-13C6 | 1261392-91-9 | Isotope-Labeled Compounds |
| HY-66009 | Epalrestat | 82159-09-9 | Reference compound |
| HY-66009R | Epalrestat (Standard) | 82159-09-9 | Reference Standards |
| HY-66010 | Cinepazide (Maleate) | 26328-04-1 | Reference compound |
| HY-66010A | Cinepazide | 23887-46-9 | Reference compound |
| HY-66011 | Moxifloxacin (Hydrochloride) | 186826-86-8 | Reference compound |
| HY-66011A | Moxifloxacin | 151096-09-2 | Reference compound |
| HY-66011AR | Moxifloxacin (Standard) | 151096-09-2 | Reference Standards |
| HY-66011AS | Moxifloxacin-d4 | 2596386-23-9 | Isotope-Labeled Compounds |
| HY-66011AS2 | Moxifloxacin-d3 (hydrochloride) | 2734919-98-1 | Isotope-Labeled Compounds |
| HY-66011AS3 | Moxifloxacin-d3-1 (hydrochloride) | 1246816-75-0 | Isotope-Labeled Compounds |
| HY-66011AS4 | Moxifloxacin-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-66011AS5 | Moxifloxacin-d5 | 1092356-43-8 | Isotope-Labeled Compounds |
| HY-66011AS6 | Moxifloxacin-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-66011B | (Rac)-Moxifloxacin | 354812-41-2 | Reference compound |
| HY-66011BR | (Rac)-Moxifloxacin (Standard) | 354812-41-2 | Reference Standards |
| HY-66011BS | (Rac)-Moxifloxacin-d4 | 2512220-27-6 | Isotope-Labeled Compounds |
| HY-66011R | Moxifloxacin (Hydrochloride) (Standard) | 186826-86-8 | Reference Standards |
| HY-66011S | rac cis-Moxifloxacin-d4 (hydrochloride) | 1217802-65-7 | Isotope-Labeled Compounds |
| HY-66012 | Proparacaine (Hydrochloride) | 5875-06-9 | Reference compound |
| HY-66012R | Proparacaine (Hydrochloride) (Standard) | 5875-06-9 | Reference Standards |
| HY-66015 | Palmitoyl hexapeptide-12 | 171263-26-6 | Peptides |
| HY-66018 | N2-(1-oxohexadecyl)-L-lysyl-L-valyl-L-Lysine 2,2,2-trifluoroacetate (1:2) | 623172-56-5 | Reference compound |
| HY-66019 | FITC | 3326-32-7 | Dye Reagents |
| HY-66020 | 6-FITC | 3326-31-6 | Dye Reagents |
| HY-66021 | 6-FAM | 3301-79-9 | Dye Reagents |
| HY-66022 | 5-FAM | 76823-03-5 | Dye Reagents |
| HY-66024 | Fmoc-Lys(Boc,Me)-OH | 951695-85-5 | Peptides |
| HY-66025 | Fmoc-Lys(Me)2-OH (hydrochloride) | 252049-10-8 | Peptides |
| HY-66026 | Fmoc-Lys(Me)3-OH Chloride | 201004-29-7 | Peptides |
| HY-66029 | 6-(Trifluoromethyl)nicotinic acid | 231291-22-8 | Biochemical Assay Reagents |
| HY-66030 | 5-Bromo-2-trifluoromethylpyridine | 436799-32-5 | Biochemical Assay Reagents |
| HY-66035 | 4-(Trifluoromethyl)nicotinic acid | 158063-66-2 | Reference compound |
| HY-66047 | 2,4-Dihydroxypyrimidine-5-carboxylic Acid | 23945-44-0 | Natural Products |
| HY-66048 | 5-Amino-2-picoline | 3430-14-6 | Biochemical Assay Reagents |
| HY-66051 | 2-Bromo-3-pyridinamine | 39856-58-1 | Biochemical Assay Reagents |
| HY-66052 | 3-Amino-5-bromopyridine | 13535-01-8 | Biochemical Assay Reagents |
| HY-66053 | 5-Bromo-3-pyridinol | 74115-13-2 | Biochemical Assay Reagents |
| HY-66054 | 3-Methylpyrazole | 1453-58-3 | Reference compound |
| HY-69014 | 2-O-Methylcytosine | 3289-47-2 | Natural Products |
| HY-69015 | Thiazole-5-carboxyaldehyde | 1003-32-3 | Biochemical Assay Reagents |
| HY-69019 | 7-Nitroindazole | 2942-42-9 | Reference compound |
| HY-69019A | 7-Nitroindazole (sodium) | 161467-34-1 | Reference compound |
| HY-69047 | 6-Chloro-7-deazaguanine | 84955-31-7 | Reference compound |
| HY-69052 | 1-Methyl-1H-pyrazole-4-carboxaldehyde | 25016-11-9 | Biochemical Assay Reagents |
| HY-69055 | 7-Bromoisoquinoline | 58794-09-5 | Biochemical Assay Reagents |
| HY-69077 | 5-Bromo-1H-pyrazolo[3,4-b]pyridine | 875781-17-2 | Biochemical Assay Reagents |
| HY-69085 | 4-Bromo-1H-indazole | 186407-74-9 | Biochemical Assay Reagents |
| HY-69089 | 8-Bromoisoquinoline | 63927-22-0 | Biochemical Assay Reagents |
| HY-69092 | 6-Bromoisoquinoline | 34784-05-9 | Biochemical Assay Reagents |
| HY-69094 | 6-Bromoquinoxaline | 50998-17-9 | Biochemical Assay Reagents |
| HY-69111 | Ethyl oxazole-4-carboxylate | 23012-14-8 | Biochemical Assay Reagents |
| HY-69166 | 1H-Indazol-5-ol | 15579-15-4 | Biochemical Assay Reagents |
| HY-69172 | RS-25344 | 152814-89-6 | Reference compound |
| HY-69174 | 1-Amino-2,5-anhydro-1-deoxy-D-mannitol | 228862-97-3 | Biochemical Assay Reagents |
| HY-69175 | 2,5-Anhydro-D-mannose | 495-75-0 | Biochemical Assay Reagents |
| HY-69188S | 3,4-Dihydro-2H-benzo[b][1,4]thiazine-d2 | Isotope-Labeled Compounds | |
| HY-69220 | 7-Octynoic acid | 10297-09-3 | Reference compound |
| HY-69249 | 1-(5-Bromo-2-fluorophenyl)ethanone | 198477-89-3 | Biochemical Assay Reagents |
| HY-69260 | tert-Butyl 4-formylpiperidine-1-carboxylate | 137076-22-3 | Reference compound |
| HY-69262 | 2-(Hexadecyloxy)-1,3-propanediol | 1931-78-8 | Natural Products |
| HY-69317 | RS14203 | 159925-31-2 | Reference compound |
| HY-69341 | 3-Hydroxy-4-nitrobenzoic acid | 619-14-7 | Biochemical Assay Reagents |
| HY-69348 | (S)-(-)-3-Boc-2,2-dimethyloxazolidine-4-carboxaldehyde | 102308-32-7 | Biochemical Assay Reagents |
| HY-69359 | Nipecotic acid | 498-95-3 | Reference compound |
| HY-69360 | 2,5-Dibromothiazole | 4175-78-4 | Biochemical Assay Reagents |
| HY-70002 | Enzalutamide | 915087-33-1 | Reference compound |
| HY-70002A | N-desmethyl Enzalutamide | 1242137-16-1 | Reference compound |
| HY-70002AS | N-desmethyl Enzalutamide-d6 | Isotope-Labeled Compounds | |
| HY-70002B | Enzalutamide carboxylic acid | 1242137-15-0 | Reference compound |
| HY-70002BR | Enzalutamide carboxylic acid (Standard) | 1242137-15-0 | Reference Standards |
| HY-70002BS | Enzalutamide carboxylic acid-d6 | Isotope-Labeled Compounds | |
| HY-70002R | Enzalutamide (Standard) | 915087-33-1 | Reference Standards |
| HY-70002S | Deutenzalutamide | 1443331-82-5 | Isotope-Labeled Compounds |
| HY-70002S1 | Enzalutamide-d6 | 1443331-94-9 | Isotope-Labeled Compounds |
| HY-70003 | Carboxypeptidase G2 (CPG2) Inhibitor | 192203-60-4 | Reference compound |
| HY-70005 | CPA inhibitor | 223532-02-3 | Reference compound |
| HY-70006 | Galeterone | 851983-85-2 | Reference compound |
| HY-70013 | Abiraterone | 154229-19-3 | Reference compound |
| HY-70013R | Abiraterone (Standard) | 154229-19-3 | Reference Standards |
| HY-70013S | Abiraterone-d4 | 2122245-62-7 | Isotope-Labeled Compounds |
| HY-70020 | Cevimeline | 107233-08-9 | Reference compound |
| HY-70020B | Cevimeline (hydrochloride) | 107220-28-0 | Reference compound |
| HY-70026 | Tri(2-methylphenyl)phosphine | 6163-58-2 | Biochemical Assay Reagents |
| HY-70027 | p53 and MDM2 proteins-interaction-inhibitor (chiral) | 939981-37-0 | Reference compound |
| HY-70027A | p53 and MDM2 proteins-interaction-inhibitor (dihydrochloride) | 2070009-27-5 | Reference compound |
| HY-70028 | p53 and MDM2 proteins-interaction-inhibitor (racemic) | 939983-14-9 | Reference compound |
| HY-70035 | Otamixaban | 193153-04-7 | Reference compound |
| HY-70037 | Cinacalcet | 226256-56-0 | Reference compound |
| HY-70037A | Cinacalcet (hydrochloride) | 364782-34-3 | Reference compound |
| HY-70037AR | Cinacalcet (hydrochloride) (Standard) | 364782-34-3 | Reference Standards |
| HY-70037AS | Cinacalcet-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-70037S | Cinacalcet-d3 | Isotope-Labeled Compounds | |
| HY-70044 | GSK-1070916 | 942918-07-2 | Reference compound |
| HY-70050 | Alosetron (Hydrochloride(1:X)) | 132414-02-9 | Reference compound |
| HY-70050A | Alosetron | 122852-42-0 | Reference compound |
| HY-70050AS | Alosetron-d3 | 1190043-13-0 | Isotope-Labeled Compounds |
| HY-70050B | Alosetron ((Z)-2-butenedioate) | 122852-43-1 | Reference compound |
| HY-70050C | Alosetron (Hydrochloride) | 122852-69-1 | Reference compound |
| HY-70050CR | Alosetron (Hydrochloride) (Standard) | 122852-69-1 | Reference Standards |
| HY-70050CS | Alosetron-d3 (hydrochloride) | 1189919-71-8 | Isotope-Labeled Compounds |
| HY-70053 | Fesoterodine | 286930-02-7 | Reference compound |
| HY-70053A | Fesoterodine (L-mandelate) | 1206695-46-6 | Reference compound |
| HY-70057 | Safinamide | 133865-89-1 | Reference compound |
| HY-70057A | Safinamide (mesylate) | 202825-46-5 | Reference compound |
| HY-70057R | Safinamide (Standard) | 133865-89-1 | Reference Standards |
| HY-70057S1 | Safinamide-d4-1 | 2748522-33-8 | Isotope-Labeled Compounds |
| HY-70057S4 | Safinamide-d5 | Isotope-Labeled Compounds | |
| HY-70059 | LY341495 | 201943-63-7 | Reference compound |
| HY-70059A | (Rac)-LY341495 | Reference compound | |
| HY-70061 | TCS7010 | 1158838-45-9 | Reference compound |
| HY-70062 | Pevonedistat | 905579-51-3 | Reference compound |
| HY-70063 | Buparlisib | 944396-07-0 | Reference compound |
| HY-70068 | SB-408124 | 288150-92-5 | Reference compound |
| HY-70069 | GSK256066 (Trifluoroacetate) | 1415560-64-3 | Reference compound |
| HY-70072 | D609 | 83373-60-8 | Reference compound |
| HY-70073 | Zaurategrast | 455264-31-0 | Reference compound |
| HY-70074 | CCG-63802 | 620112-78-9 | Reference compound |
| HY-70075 | CCG-63808 | 620113-73-7 | Reference compound |
| HY-70081 | Sumanirole | 179386-43-7 | Reference compound |
| HY-70081A | Sumanirole (maleate) | 179386-44-8 | Reference compound |
| HY-70083 | SPK-601 | 1096687-52-3 | Reference compound |
| HY-75004 | 3-(1-Naphthoyl)indole | 109555-87-5 | Reference compound |
| HY-75005 | 1-Boc-4-carboxymethyl piperazine | 156478-71-6 | Reference compound |
| HY-75026 | N-Boc-4-hydroxypiperidine | 109384-19-2 | Biochemical Assay Reagents |
| HY-75035 | Calcipotriol Impurity C | 113082-99-8 | Reference compound |
| HY-75035R | Calcipotriol Impurity C (Standard) | 113082-99-8 | Reference Standards |
| HY-75041 | Calcitriol Impurities A | 73837-24-8 | Reference compound |
| HY-75054 | Abiraterone acetate | 154229-18-2 | Reference compound |
| HY-75054R | Abiraterone acetate (Standard) | 154229-18-2 | Reference Standards |
| HY-75054S | Abiraterone acetate-d4 | Isotope-Labeled Compounds | |
| HY-75054S1 | Abiraterone acetate-d3 | 2122245-10-5 | Isotope-Labeled Compounds |
| HY-75062 | Ethyl 2-oxocyclohexanecarboxylate | 1655-07-8 | Biochemical Assay Reagents |
| HY-75070 | (+)-1-(1-Naphthyl)ethylamine | 3886-70-2 | Biochemical Assay Reagents |
| HY-75072S | (Rac)-Bepotastine-d6 | Isotope-Labeled Compounds | |
| HY-75087 | (R)-pyrrolidine-2-carboxylic acid | 344-25-2 | Natural Products |
| HY-75087R | (R)-pyrrolidine-2-carboxylic acid (Standard) | 344-25-2 | Reference Standards |
| HY-75087S | (R)-Pyrrolidine-2-carboxylic acid-d3 | 1994265-09-6 | Isotope-Labeled Compounds |
| HY-75088 | 1-Bromo-3,5-bis(trifluoromethyl)benzene | 328-70-1 | Biochemical Assay Reagents |
| HY-75095 | (S)-(-)-1-Phenylethanamine | 2627-86-3 | Natural Products |
| HY-75100S | 3-(Bromomethyl)benzonitrile-d6 | 1219802-21-7 | Isotope-Labeled Compounds |
| HY-75102 | 4-Boronobenzoic acid | 14047-29-1 | Biochemical Assay Reagents |
| HY-75124 | (Rac)-AZD 6482 | 663620-70-0 | Reference compound |
| HY-75129 | Pyridin-3-ylboronic acid | 1692-25-7 | Biochemical Assay Reagents |
| HY-75149 | 5-Bromo-2-chloro-3-nitropyridine | 67443-38-3 | Biochemical Assay Reagents |
| HY-75153 | Formimidamide (acetate) | 3473-63-0 | Biochemical Assay Reagents |
| HY-75161 | (-)-Menthol | 2216-51-5 | Natural Products |
| HY-75161R | (-)-Menthol (Standard) | 2216-51-5 | Reference Standards |
| HY-75200 | N-(Benzyloxycarbonyloxy)succinimide | 13139-17-8 | Biochemical Assay Reagents |
| HY-75212 | 5-Bromo-1,3-benzodioxole | 2635-13-4 | Biochemical Assay Reagents |
| HY-75213 | 1,4-Dioxaspiro[4.5]decan-8-one | 4746-97-8 | Biochemical Assay Reagents |
| HY-75247 | Coumaran | 496-16-2 | Natural Products |
| HY-75251 | 2,3-Dihydrobenzofuran-5-carboxaldehyde | 55745-70-5 | Biochemical Assay Reagents |
| HY-75256S | (Rac)-Remelteon-d3 | 1185146-24-0 | Isotope-Labeled Compounds |
| HY-75263 | 2-Amino-3-benzyloxypyridine | 24016-03-3 | Biochemical Assay Reagents |
| HY-75279 | N-Acetyl-β-neuraminic acid methyl ester | 22900-11-4 | Natural Products |
| HY-75308 | Azetidine-2-carboxylic acid | 2517-04-6 | Natural Products |
| HY-75326 | (S)-2-Aminopropanamide (hydrochloride) | 33208-99-0 | Biochemical Assay Reagents |
| HY-75331 | Glycine tert-butyl ester hydrochloride | 27532-96-3 | Peptides |
| HY-75332 | Z-D-Phg-OH | 17609-52-8 | Peptides |
| HY-75342 | Methyl vanillate | 3943-74-6 | Natural Products |
| HY-75342R | Methyl vanillate (Standard) | 3943-74-6 | Reference Standards |
| HY-75342S | Methyl vanillate-d3 | 1394230-40-0 | Isotope-Labeled Compounds |
| HY-75355 | 1,3-Cyclopentanedione | 3859-41-4 | Biochemical Assay Reagents |
| HY-75379 | 3-(4-Nitro-phenyl)-L-alanine ethyl ester hydrochloride | 58816-66-3 | Peptides |
| HY-75385 | Zaurategrast ethyl ester | 455264-30-9 | Reference compound |
| HY-75385A | Zaurategrast ethyl ester sulfate | 1214261-78-5 | Reference compound |
| HY-75401 | Methyl 2-(2-(5-chloro-2-phenoxyphenyl)-N-methylacetamido)acetate | 1180843-76-8 | Peptides |
| HY-75420 | 5-Bromo-3-methylpyridin-2-amine | 3430-21-5 | Biochemical Assay Reagents |
| HY-75423 | 5-Bromo-3-methylpyridin-2-ol | 89488-30-2 | Biochemical Assay Reagents |
| HY-75424A | 2-(Trifluoromethyl)cinnamic acid | 2062-25-1 | Reference compound |
| HY-75476 | 4-Aminophenylacetic acid | 1197-55-3 | Biochemical Assay Reagents |
| HY-75502 | Rotigotine | 99755-59-6 | Reference compound |
| HY-75502R | Rotigotine (Standard) | 99755-59-6 | Reference Standards |
| HY-75513 | 2-Amino-4-(trifluoromethyl)pyridine | 106447-97-6 | Biochemical Assay Reagents |
| HY-75564 | Cyclo(Ala-Gly) | 4526-77-6 | Natural Products |
| HY-75564R | Cyclo(Ala-Gly) (Standard) | 4526-77-6 | Reference Standards |
| HY-75577 | 4-Amino-3-methoxybenzoic acid | 2486-69-3 | Biochemical Assay Reagents |
| HY-75578 | dTAG Targeting Ligand 1 | 755039-56-6 | Reference compound |
| HY-75597 | 4-Aminophenylboronic acid pinacol ester | 214360-73-3 | Biochemical Assay Reagents |
| HY-75625 | 2-Hydroxy-4-methoxybenzoic acid | 2237-36-7 | Natural Products |
| HY-75637 | 3-Amino-5-methylpyrazole | 31230-17-8 | Biochemical Assay Reagents |
| HY-75680 | FaX-IN-1 | 503614-91-3 | Reference compound |
| HY-75706 | N-Descyclopropanecarbaldehyde Olaparib | 763111-47-3 | Reference compound |
| HY-75777 | 4-Morpholinoaniline | 2524-67-6 | Biochemical Assay Reagents |
| HY-75800 | Lomibuvir | 1026785-55-6 | Reference compound |
| HY-75813 | 2-Aminonicotinaldehyde | 7521-41-7 | Biochemical Assay Reagents |
| HY-75814 | 4-Isopropoxybenzoic acid | 13205-46-4 | Reference compound |
| HY-75828 | Dibenzylideneacetone | 538-58-9 | Reference compound |
| HY-75839 | Dronedarone (Hydrochloride) | 141625-93-6 | Reference compound |
| HY-75839R | Dronedarone (Hydrochloride) (Standard) | 141625-93-6 | Reference Standards |
| HY-75853 | 3,5-Dibromo-D-tyrosine | 50299-42-8 | Peptides |
| HY-75867 | M2 ion channel blocker | 1190215-03-2 | Reference compound |
| HY-75884 | 2-(Triphenylphosphoranylidene)acetaldehyde | 2136-75-6 | Biochemical Assay Reagents |
| HY-75887 | 5-Nitrosalicylaldehyde | 97-51-8 | Reference compound |
| HY-75920 | Inhoffen Lythgoe diol | 64190-52-9 | Biochemical Assay Reagents |
| HY-75947 | (S)-tert-butyl 1-hydroxy-3-phenylpropan-2-ylcarbamate | 66605-57-0 | Peptides |
| HY-75949 | L-Norvaline ethyl ester HCl | 40918-51-2 | Peptides |
| HY-75954 | 2-Hydroxyhexanoic acid | 6064-63-7 | Natural Products |
| HY-75954R | 2-Hydroxyhexanoic acid (Standard) | 6064-63-7 | Reference Standards |
| HY-75957 | DMP 777 | 157341-41-8 | Reference compound |
| HY-75958 | Vitamin D4 | 511-28-4 | Reference compound |
| HY-75958S1 | Vitamin D4-d5 | Isotope-Labeled Compounds | |
| HY-75968S | 2,6-Difluorobenzoic acid-d3 | 1219804-21-3 | Isotope-Labeled Compounds |
| HY-75970 | Boc-Propargylamine | 92136-39-5 | Biochemical Assay Reagents |
| HY-75992 | trans-Doxercalciferol | 74007-20-8 | Reference compound |
| HY-76006 | 3-Hydroxybenzaldehyde | 100-83-4 | Natural Products |
| HY-76006R | 3-Hydroxybenzaldehyde (Standard) | 100-83-4 | Reference Standards |
| HY-76025S | 1,4-Dibromobenzene-d4 | 4165-56-4 | Isotope-Labeled Compounds |
| HY-76030 | Nortropinone (hydrochloride) | 25602-68-0 | Biochemical Assay Reagents |
| HY-76043 | H-Hyp-OMe (hydrochloride) | 40216-83-9 | ADC Related |
| HY-76047 | Methyl 6-methylnicotinate | 5470-70-2 | Biochemical Assay Reagents |
| HY-76082 | L-Pyroglutamic acid | 98-79-3 | Natural Products |
| HY-76082A | L-Pyroglutamic acid (sodium) | 28874-51-3 | Biochemical Assay Reagents |
| HY-76082R | L-Pyroglutamic acid (Standard) | 98-79-3 | Reference Standards |
| HY-76082S | L-Pyroglutamic acid-d5 | 1086136-22-2 | Isotope-Labeled Compounds |
| HY-76082S1 | L-Pyroglutamic acid-13C5 | 55443-56-6 | Isotope-Labeled Compounds |
| HY-76104 | (2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride | 77449-94-6 | ADC Related |
| HY-76105 | D-Proline, 4-hydroxy-, methyl ester (hydrochloride) | 114676-59-4 | ADC Related |
| HY-76120 | 3-Trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (hydrochloride) | 762240-92-6 | Biochemical Assay Reagents |
| HY-76134 | Methyl prolinate hydrochloride | 2133-40-6 | Biochemical Assay Reagents |
| HY-76144 | 4-Aminobenzothioamide | 4714-67-4 | Reference compound |
| HY-76189 | 1-Methyl-1H-pyrazol-3-amine | 1904-31-0 | Biochemical Assay Reagents |
| HY-76194A | 3,4-Dihydronaphthalen-1-one | 529-34-0 | Biochemical Assay Reagents |
| HY-76194AR | 3,4-Dihydronaphthalen-1-one (Standard) | 529-34-0 | Reference Standards |
| HY-76199 | trans-4-Hydroxycyclohexanecarboxylic acid | 3685-26-5 | Natural Products |
| HY-76199R | trans-4-Hydroxycyclohexanecarboxylic acid (Standard) | 3685-26-5 | Reference Standards |
| HY-76200 | Voriconazole | 137234-62-9 | Reference compound |
| HY-76200B | Voriconazole (camphorsulfonate) | 137234-71-0 | Reference compound |
| HY-76200R | Voriconazole (Standard) | 137234-62-9 | Reference Standards |
| HY-76200S | Voriconazole-d3 | 1217661-14-7 | Isotope-Labeled Compounds |
| HY-76201 | Dexrazoxane (hydrochloride) | 149003-01-0 | Reference compound |
| HY-76204 | Glycine ethyl ester monohydrochloride | 623-33-6 | Peptides |
| HY-76204S | Glycine ethyl ester-13C (hydrochloride) | 58420-91-0 | Isotope-Labeled Compounds |
| HY-76204S1 | Glycine ethyl ester-13C2 (hydrochloride) | 1246819-31-7 | Isotope-Labeled Compounds |
| HY-76205 | 2-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 4530-18-1 | Peptides |
| HY-76206S | (E)-1,4-Dibromobut-2-ene-d6 | 118886-18-3 | Isotope-Labeled Compounds |
| HY-76210 | 5-Hydroxypyrazine-2-Carboxylic Acid | 34604-60-9 | Reference compound |
| HY-76210R | 5-Hydroxypyrazine-2-Carboxylic Acid (Standard) | 34604-60-9 | Reference Standards |
| HY-76212 | ATB107 | 455325-51-6 | Reference compound |
| HY-76214 | Dibenzyl hydrazodicarboxylate | 5394-50-3 | Reference compound |
| HY-76222 | Isatoic anhydride | 118-48-9 | Reference compound |
| HY-76224 | 3-Furaldehyde | 498-60-2 | Natural Products |
| HY-76225 | Ammonium glycyrrhizinate | 53956-04-0 | Natural Products |
| HY-76225R | Ammonium glycyrrhizinate (Standard) | 53956-04-0 | Reference Standards |
| HY-76228 | 1H-pyrazole | 288-13-1 | Natural Products |
| HY-76251 | Etodolac | 41340-25-4 | Reference compound |
| HY-76251R | Etodolac (Standard) | 41340-25-4 | Reference Standards |
| HY-76251S1 | (rac)-Etodolac-d3 | 1276197-46-6 | Isotope-Labeled Compounds |
| HY-76251S3 | Etodolac-d4 | Isotope-Labeled Compounds | |
| HY-76253 | Benzylamine hydrochloride | 3287-99-8 | Biochemical Assay Reagents |
| HY-76253S | Phenylmethanamine-d7 (Hydrochloride) | 352431-27-7 | Isotope-Labeled Compounds |
| HY-76255 | 4-Nitrophenyl (tert-butoxycarbonyl)-L-phenylalaninate | 7535-56-0 | Peptides |
| HY-76260 | Faropenem sodium | 122547-49-3 | Reference compound |
| HY-76260R | Faropenem sodium (Standard) | 122547-49-3 | Reference Standards |
| HY-76274 | (1S,2R)-2-Amino-1,2-diphenylethanol | 23364-44-5 | Biochemical Assay Reagents |
| HY-76293 | I2906 | 331963-29-2 | Reference compound |
| HY-76299 | Galanthamine | 357-70-0 | Natural Products |
| HY-76299R | Galanthamine (Standard) | 357-70-0 | Reference Standards |
| HY-76299S | Galanthamine-d6 | 1128109-00-1 | Isotope-Labeled Compounds |
| HY-76299S1 | Galanthamine-O-methyl-d3 | 1279031-09-2 | Isotope-Labeled Compounds |
| HY-76299S2 | Galanthamine-d3 (hydrochloride) | 2012598-44-4 | Isotope-Labeled Compounds |
| HY-76316 | Bergaptol | 486-60-2 | Natural Products |
| HY-76316R | Bergaptol (Standard) | 486-60-2 | Reference Standards |
| HY-76317 | Z-DL-Pro-OH | 5618-96-2 | Peptides |
| HY-76326S | (S)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole-d3 | 1217698-26-4 | Isotope-Labeled Compounds |
| HY-76353 | 2-Pyrazinecarboxylic acid | 98-97-5 | Biochemical Assay Reagents |
| HY-76353R | 2-Pyrazinecarboxylic acid (Standard) | 98-97-5 | Reference Standards |
| HY-76353S | Pyrazinecarboxylic acid-d3 | 1794791-32-4 | Isotope-Labeled Compounds |
| HY-76366 | (S)-N-Boc-3-hydroxypyrrolidine | 101469-92-5 | Biochemical Assay Reagents |
| HY-76383 | LR-90 | 245075-84-7 | Reference compound |
| HY-76409 | Otamixaban (hydrochloride) | 409081-12-5 | Reference compound |
| HY-76440 | 3-Oxetanone | 6704-31-0 | Biochemical Assay Reagents |
| HY-76446 | Ethyl (triphenylphosphoranylidene) acetate | 1099-45-2 | Biochemical Assay Reagents |
| HY-76448 | Ethyl 2-(benzylamino)acetate hydrochloride | 6344-42-9 | Peptides |
| HY-76459 | Diethyl (cyanomethyl)phosphonate | 2537-48-6 | Biochemical Assay Reagents |
| HY-76474 | BAY 61-3606 | 732983-37-8 | Reference compound |
| HY-76474A | BAY 61-3606 (hydrochloride) | 1615197-10-8 | Reference compound |
| HY-76475 | (S)-(-)-Butane-1,2,4-triol | 42890-76-6 | Natural Products |
| HY-76475R | (S)-(-)-Butane-1,2,4-triol (Standard) | 42890-76-6 | Reference Standards |
| HY-76476 | (S)-Tetrahydrofuran-3-ol | 86087-23-2 | Biochemical Assay Reagents |
| HY-76486 | Ethyl nitroacetate | 626-35-7 | Biochemical Assay Reagents |
| HY-76487 | Tetrahydro-4H-pyran-4-one | 29943-42-8 | Biochemical Assay Reagents |
| HY-76504 | 2,6-Dimethoxybenzoic acid | 1466-76-8 | Natural Products |
| HY-76511 | Verlukast | 120443-16-5 | Reference compound |
| HY-76511S | Verlukast-d6 | 153698-86-3 | Isotope-Labeled Compounds |
| HY-76520 | Sitaxsentan | 184036-34-8 | Reference compound |
| HY-76520S | Sitaxsentan-13C6 | Isotope-Labeled Compounds | |
| HY-76542 | Vitamin D2 | 50-14-6 | Natural Products |
| HY-76542A | 5,6-trans-Vitamin D2 | 51744-66-2 | Reference compound |
| HY-76542AR | 5,6-trans-Vitamin D2 (Standard) | 51744-66-2 | Reference Standards |
| HY-76542B | (R)-Vitamin D2 | 116559-84-3 | Reference compound |
| HY-76542BR | (R)-Vitamin D2 (Standard) | 116559-84-3 | Reference Standards |
| HY-76542S | Vitamin D2-d6 | 1311259-89-8 | Isotope-Labeled Compounds |
| HY-76547 | p-Toluic acid | 99-94-5 | Natural Products |
| HY-76547S | p-Toluic acid-d4 | 1219798-71-6 | Isotope-Labeled Compounds |
| HY-76547S1 | p-Toluic acid-d7 | 1219798-76-1 | Isotope-Labeled Compounds |
| HY-76547S2 | p-Toluic acid-d3 | 19215-16-8 | Isotope-Labeled Compounds |
| HY-76548 | tert-Butyl p-Toluate | 13756-42-8 | Reference compound |
| HY-76558 | Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate | 5909-24-0 | Biochemical Assay Reagents |
| HY-76562 | Methyl 6-bromopicolinate | 26218-75-7 | Biochemical Assay Reagents |
| HY-76569 | Desfesoterodine | 207679-81-0 | Reference compound |
| HY-76569B | 5-Hydroxymethyl tolterodine (formate) | 380636-49-7 | Reference compound |
| HY-76569R | Desfesoterodine (Standard) | 207679-81-0 | Reference Standards |
| HY-76569S1 | (R)-Hydroxytolterodine-d14 | 1191280-58-6 | Isotope-Labeled Compounds |
| HY-76570 | (Rac)-5-Hydroxymethyl Tolterodine | 200801-70-3 | Reference compound |
| HY-76570A | (Rac)-5-Hydroxymethyl Tolterodine (hydrochloride) | 250214-40-5 | Reference compound |
| HY-76570S | (Rac)-5-Hydroxymethyl Tolterodine-d14 | 1185071-13-9 | Isotope-Labeled Compounds |
| HY-76570S1 | 5-Hydroxymethyl Tolterodine-d14 (formate) | Isotope-Labeled Compounds | |
| HY-76570S2 | (Rac)-5-hydroxymethyl Tolterodine-d5 | 2012598-78-4 | Isotope-Labeled Compounds |
| HY-76573 | ML-10 | 1216897-16-3 | Reference compound |
| HY-76574 | 3-(Trifluoromethyl)benzaldehyde | 454-89-7 | Reference compound |
| HY-76584 | 4-Phenoxyphenylboronic acid | 51067-38-0 | Biochemical Assay Reagents |
| HY-76585 | Paricalcitol-d6 | 2070009-67-3 | Isotope-Labeled Compounds |
| HY-76595S | 1-Bromo-4-phenoxybenzene-d5 | 93951-83-8 | Isotope-Labeled Compounds |
| HY-76595S1 | 4-Bromo diphenyl ether-13C12 | 488710-15-2 | Isotope-Labeled Compounds |
| HY-76612 | SB-408124 (Hydrochloride) | 1431697-90-3 | Reference compound |
| HY-76632 | 4-Hydroxyisophthalic acid | 636-46-4 | Reference compound |
| HY-76633 | Dimethyl 4-hydroxyisophthalate | 5985-24-0 | Reference compound |
| HY-76633R | Dimethyl 4-hydroxyisophthalate (Standard) | 5985-24-0 | Reference Standards |
| HY-76648 | NBD-556 | 333353-44-9 | Reference compound |
| HY-76649 | NBD-557 | 333352-59-3 | Reference compound |
| HY-76652 | VTP-27999 (Hydrochloride) | 1264191-73-2 | Reference compound |
| HY-76657 | Alvimopan (monohydrate) | 1383577-62-5 | Reference compound |
| HY-76657A | Alvimopan (dihydrate) | 170098-38-1 | Reference compound |
| HY-76657AR | Alvimopan (dihydrate) (Standard) | 170098-38-1 | Reference Standards |
| HY-76665 | Anticancer agent 209 | 545445-44-1 | Reference compound |
| HY-76667 | 3-(Boc-amino)propyl bromide | 83948-53-2 | Reference compound |
| HY-76688 | (Rac)-Tivantinib | 1239986-50-5 | Reference compound |
| HY-76691 | D-Ribonolactone | 5336-08-3 | Natural Products |
| HY-76693 | 2,3-O-Isopropylidene-D-ribonolactone | 30725-00-9 | Biochemical Assay Reagents |
| HY-76701 | 4-Nitrothalidomide | 19171-18-7 | Reference compound |
| HY-76705 | Methyl N-methylanthranilate | 85-91-6 | Natural Products |
| HY-76705R | Methyl N-methylanthranilate (Standard) | 85-91-6 | Reference Standards |
| HY-76711 | Naltrexone | 16590-41-3 | Reference compound |
| HY-76711R | Naltrexone (Standard) | 16590-41-3 | Reference Standards |
| HY-76711S | Naltrexone-d4 | 2070009-29-7 | Isotope-Labeled Compounds |
| HY-76735 | Methyl 2-aminonicotinate | 14667-47-1 | Biochemical Assay Reagents |
| HY-76737S | 1-Chloro-4-phenoxybenzene-d5 | 93951-85-0 | Isotope-Labeled Compounds |
| HY-76772 | Cevimeline (hydrochloride hemihydrate) | 153504-70-2 | Reference compound |
| HY-76772A | (+)-Cevimeline (hydrochloride hemihydrate) | Reference compound | |
| HY-76772B | (-)-Cevimeline (hydrochloride hemihydrate) | Reference compound | |
| HY-76779 | 4-(Chloromethyl)-7-hydroxycoumarin | 25392-41-0 | Reference compound |
| HY-76801 | 24, 25-Dihydroxy VD2 | 58050-55-8 | Reference compound |
| HY-76802 | Calcitriol Derivatives | 2070009-24-2 | Reference compound |
| HY-76814 | Calcitriol-d6 | 78782-99-7 | Isotope-Labeled Compounds |
| HY-76835 | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 | Biochemical Assay Reagents |
| HY-76847 | Chenodeoxycholic Acid | 474-25-9 | Natural Products |
| HY-76847A | Chenodeoxycholic acid (sodium) | 2646-38-0 | Reference compound |
| HY-76847R | Chenodeoxycholic Acid (Standard) | 474-25-9 | Reference Standards |
| HY-76847S | Chenodeoxycholic Acid-d4 | 99102-69-9 | Isotope-Labeled Compounds |
| HY-76847S1 | Chenodeoxycholic Acid-d9 | Isotope-Labeled Compounds | |
| HY-76847S2 | Chenodeoxycholic acid-13C | 52918-92-0 | Isotope-Labeled Compounds |
| HY-76847S3 | Chenodeoxycholic acid-d5 | 52840-12-7 | Isotope-Labeled Compounds |
| HY-76847S4 | Chenodeoxycholic acid-d2 | 57770-00-0 | Isotope-Labeled Compounds |
| HY-76897 | 5-Bromo-2-chloropyrimidine | 32779-36-5 | Biochemical Assay Reagents |
| HY-76915 | 24, 25-Dihydroxy VD3 | 40013-87-4 | Natural Products |
| HY-76929S | tert-Butyl 4-aminobenzoate-13C6 | 1793059-78-5 | Isotope-Labeled Compounds |
| HY-76937 | Impurity of Doxercalciferol | 127516-23-8 | Reference compound |
| HY-76938 | Actarit | 18699-02-0 | Reference compound |
| HY-76938AS1 | Actarit-d6 (sodium) | Isotope-Labeled Compounds | |
| HY-76948 | 5-R-Rivaroxaban | 865479-71-6 | Reference compound |
| HY-76948R | 5-R-Rivaroxaban (Standard) | 865479-71-6 | Reference Standards |
| HY-76962 | (S)-2-Methylpyrrolidine-2-carboxylic acid | 42856-71-3 | Peptides |
| HY-76971 | Dechloro Rivaroxaban | 1415566-28-7 | Reference compound |
| HY-76981 | 5-Hydroxy-1-tetralone | 28315-93-7 | Natural Products |
| HY-76996S1 | (S)-5-Hydroxymethyl Tolterodine-d14 (formate) | Isotope-Labeled Compounds | |
| HY-77009 | JNK-IN-13 | 345986-38-1 | Reference compound |
| HY-77021 | (S)-ethyl 2-amino-4-fluoro-4-methylpentanoate | 156047-39-1 | Peptides |
| HY-77026 | (S)-Ethyl 2-amino-4-fluoro-4-methylpentanoate sulfate | 848949-85-9 | Peptides |
| HY-77036 | Furagin | 1672-88-4 | Reference compound |
| HY-77036R | Furagin (Standard) | 1672-88-4 | Reference Standards |
| HY-77048 | IRAK-4 protein kinase inhibitor 2 | 301675-24-1 | Reference compound |
| HY-77049 | 1-Trityl-1H-imidazole-4-carbaldehyde | 33016-47-6 | Biochemical Assay Reagents |
| HY-77057 | 5-Cyanoindole | 15861-24-2 | Biochemical Assay Reagents |
| HY-77101 | AP24592 | 694499-26-8 | Reference compound |
| HY-77111 | cis-INCB3344 | 1285539-85-6 | Reference compound |
| HY-77113 | B-Raf IN 11 | 918504-27-5 | Reference compound |
| HY-77132 | Z-Ala-OSu | 3401-36-3 | Peptides |
| HY-77151 | Ethyl 2-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoate | 1258638-92-4 | Peptides |
| HY-77160 | Ethyl 3-(4-fluorophenyl)-3-oxopropanoate | 1999-00-4 | Biochemical Assay Reagents |
| HY-77173 | Demethoxyencecalin | 19013-07-1 | Natural Products |
| HY-77175 | Methyl 2-(triphenylphosphoranylidene)acetate | 2605-67-6 | Biochemical Assay Reagents |
| HY-77195 | Poloxime | 17302-61-3 | Reference compound |
| HY-77251 | TAK1/MAP4K2 inhibitor 1 | 1315330-11-0 | Reference compound |
| HY-77274 | Calcitriol Impurities D | 103656-40-2 | Reference compound |
| HY-77278 | 25-Hydroxytachysterol3 | 39932-44-0 | Reference compound |
| HY-77293 | (E)-[6]-Dehydroparadol | 878006-06-5 | Reference compound |
| HY-77324S | 4-(Trifluoromethyl)aniline-d4 | 1219795-48-8 | Isotope-Labeled Compounds |
| HY-77336 | 6-Chloro-7-iodo-7-deazapurine | 123148-78-7 | Natural Products |
| HY-77433 | o-Iodobenzoic acid | 88-67-5 | Biochemical Assay Reagents |
| HY-77434 | 9-Dihydro-13-acetylbaccatin III | 142203-65-4 | Natural Products |
| HY-77475 | 1-Cbz-3-Hydroxyazetidine | 128117-22-6 | ADC Related |
| HY-77490 | (R)-(-)-1,3-Butanediol | 6290-03-5 | Reference compound |
| HY-77490A | 1,3-Butanediol | 107-88-0 | Reference compound |
| HY-77490AR | 1,3-Butanediol (Standard) | 107-88-0 | Reference Standards |
| HY-77491 | FAAH/MAGL-IN-5 | 1010096-65-7 | Reference compound |
| HY-77493 | (rel)-Tivantinib | 905853-99-8 | Reference compound |
| HY-77519 | N-(4-Cyanophenyl)glycine | 42288-26-6 | Peptides |
| HY-77519R | N-(4-Cyanophenyl)glycine (Standard) | 42288-26-6 | Reference Standards |
| HY-77521 | Dabigatran (ethyl ester hydrochloride) | 211914-50-0 | Reference compound |
| HY-77537 | 7-Deazaxanthine | 39929-79-8 | Reference compound |
| HY-77543 | 7-Deazahypoxanthine | 3680-71-5 | Biochemical Assay Reagents |
| HY-77554 | Cephalomannine | 71610-00-9 | Natural Products |
| HY-77554R | Cephalomannine (Standard) | 71610-00-9 | Reference Standards |
| HY-77572 | 7-Epi 10-desacetyl paclitaxel | 78454-17-8 | Natural Products |
| HY-77572R | 7-Epi 10-desacetyl paclitaxel (Standard) | 78454-17-8 | Reference Standards |
| HY-77574 | 7-xylosyltaxol | 90332-66-4 | Natural Products |
| HY-77584 | (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid | 552335-47-4 | Peptides |
| HY-77591 | Cysteamine (hydrochloride) | 156-57-0 | Natural Products |
| HY-77591R | Cysteamine (hydrochloride) (Standard) | 156-57-0 | Reference Standards |
| HY-77591S | Cysteamine-d4 (hydrochloride) | 1219805-04-5 | Isotope-Labeled Compounds |
| HY-77593 | (2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid | 147266-92-0 | ADC Related |
| HY-77630 | (R)-2-(((Benzyloxy)carbonyl)amino)-3,3-dimethylbutanoic acid | 70874-05-4 | Peptides |
| HY-77635 | Z-D-Chg-OH | 69901-85-5 | Peptides |
| HY-77641 | Cinnamoylglycine | 16534-24-0 | Natural Products |
| HY-77641R | Cinnamoylglycine (Standard) | 16534-24-0 | Reference Standards |
| HY-77641S | Cinnamoylglycine-d2 | 1219806-46-8 | Isotope-Labeled Compounds |
| HY-77642 | 4-(Methylsulfonyl)phenylboronic acid | 149104-88-1 | Biochemical Assay Reagents |
| HY-77644 | 5'-Deoxy-5'-iodouridine | 14259-58-6 | Reference compound |
| HY-77645 | 4',5'-Didehydro-5'-deoxyuridine | 14365-63-0 | Reference compound |
| HY-77650 | 4'-C-Azidouridine | 139442-01-6 | Reference compound |
| HY-77651 | Nucleoside-Analog-1 | 876707-99-2 | Reference compound |
| HY-77652 | Nucleoside-Analog-2 | 876708-01-9 | Reference compound |
| HY-77734 | AR-C133913XX | 1251765-07-7 | Reference compound |
| HY-77738 | 4-Trifluoromethylphenylboronic acid | 128796-39-4 | Biochemical Assay Reagents |
| HY-77757 | Z-D-Asp-OH | 78663-07-7 | Peptides |
| HY-77785 | 2-Amino-5-chlorobenzophenone | 719-59-5 | Biochemical Assay Reagents |
| HY-77785R | 2-Amino-5-chlorobenzophenone (Standard) | 719-59-5 | Reference Standards |
| HY-77785S | 2-Amino-5-Chlorobenzophenone-d5 | 65854-72-0 | Isotope-Labeled Compounds |
| HY-77801 | (R)-2-Amino-4-mercaptobutanoic acid | 6027-14-1 | Peptides |
| HY-77802 | (2R,2'R)-4,4'-Disulfanediylbis(2-aminobutanoic acid) | 6027-15-2 | Peptides |
| HY-77813 | Benzyl isothiocyanate | 622-78-6 | Natural Products |
| HY-77813R | Benzyl isothiocyanate (Standard) | 622-78-6 | Reference Standards |
| HY-77813S | Benzyl isothiocyanate-d7 | 1246818-63-2 | Isotope-Labeled Compounds |
| HY-77817 | Pyrrole-2-carboxaldehyde | 1003-29-8 | Natural Products |
| HY-77817R | Pyrrole-2-carboxaldehyde (Standard) | 1003-29-8 | Reference Standards |
| HY-77822 | 5-Amino-2-chlorobenzotrifluoride | 320-51-4 | Biochemical Assay Reagents |
| HY-77822R | 5-Amino-2-chlorobenzotrifluoride (Standard) | 320-51-4 | Reference Standards |
| HY-77839 | Cortodoxone | 152-58-9 | Natural Products |
| HY-77839R | Cortodoxone (Standard) | 152-58-9 | Reference Standards |
| HY-77839S | Cortodoxone-d5 | 1258063-56-7 | Isotope-Labeled Compounds |
| HY-77839S1 | Cortodoxone-d2 | 1271728-08-5 | Isotope-Labeled Compounds |
| HY-77873 | 4,5-Dimethoxybenzene-1,2-diamine | 27841-33-4 | Reference compound |
| HY-77894 | Ethyl (tert-Butoxycarbonyl)glycinate | 14719-37-0 | Peptides |
| HY-77910 | 4-(4-Bromophenyl)-4-hydroxypiperidine | 57988-58-6 | Reference compound |
| HY-77956 | Thyminose | 533-67-5 | Natural Products |
| HY-77956R | Thyminose (Standard) | 533-67-5 | Reference Standards |
| HY-77956S | Thyminose-13C | 478511-57-8 | Isotope-Labeled Compounds |
| HY-77956S1 | Thyminose-13C-1 | 478511-60-3 | Isotope-Labeled Compounds |
| HY-77956S2 | Thyminose-13C-2 | 159838-86-5 | Isotope-Labeled Compounds |
| HY-77956S3 | Thyminose-d2 | 478511-68-1 | Isotope-Labeled Compounds |
| HY-77956S4 | Thyminose-d3 | Isotope-Labeled Compounds | |
| HY-77957 | 1-O-Methyl-2-deoxy-D-ribose | 60134-26-1 | Biochemical Assay Reagents |
| HY-77959 | 6-Maleimidocapronic acid | 55750-53-3 | Reference compound |
| HY-77961 | 6-Maleimidocaproic acid hydrazide (TFA) | 151038-94-7 | Biochemical Assay Reagents |
| HY-77962 | 2-Thiobarbituric acid | 504-17-6 | Dye Reagents |
| HY-77995 | 2-Methoxybenzaldehyde | 135-02-4 | Natural Products |
| HY-77995R | 2-Methoxybenzaldehyde (Standard) | 135-02-4 | Reference Standards |
| HY-77995S | 2-Methoxybenzaldehyde-d3 | 56248-49-8 | Isotope-Labeled Compounds |
| HY-78000 | Methyl 4-formylbenzoate | 1571-08-0 | Biochemical Assay Reagents |
| HY-78004S | 1,2-Diphenylethane-d14 | 94371-89-8 | Isotope-Labeled Compounds |
| HY-78004S1 | 1,2-Diphenylethane-d4 | 20389-19-9 | Isotope-Labeled Compounds |
| HY-78008 | N-[(1,1-Dimethylethoxy)carbonyl]-L-leucyl-L-leucine | 73401-65-7 | Peptides |
| HY-78035 | Citraconic anhydride | 616-02-4 | Biochemical Assay Reagents |
| HY-78036 | Mesaconic acid | 498-24-8 | Natural Products |
| HY-78036R | Mesaconic acid (Standard) | 498-24-8 | Reference Standards |
| HY-78086 | m-Tolualdehyde | 620-23-5 | Natural Products |
| HY-78086R | m-Tolualdehyde (Standard) | 620-23-5 | Reference Standards |
| HY-78096 | O-Deshydroxyethyl bosentan | 174227-14-6 | Reference compound |
| HY-78105 | [(tert-butoxycarbonyl)amino](3-chlorophenyl)acetic acid | 669713-92-2 | Peptides |
| HY-78131 | Ibuprofen | 15687-27-1 | Reference compound |
| HY-78131A | (S)-(+)-Ibuprofen | 51146-56-6 | Reference compound |
| HY-78131AR | (S)-(+)-Ibuprofen (Standard) | 51146-56-6 | Reference Standards |
| HY-78131AS | (S)-(+)-Ibuprofen-d3 | 1329643-44-8 | Isotope-Labeled Compounds |
| HY-78131B | (R)-(-)-Ibuprofen | 51146-57-7 | Reference compound |
| HY-78131BS | (R)-(-)-Ibuprofen-d3 | 121702-86-1 | Isotope-Labeled Compounds |
| HY-78131C | Ibuprofen (sodium) | 31121-93-4 | Reference compound |
| HY-78131CS | Ibuprofen-d3 (sodium) | 1219805-09-0 | Isotope-Labeled Compounds |
| HY-78131R | Ibuprofen (Standard) | 15687-27-1 | Reference Standards |
| HY-78131S | Ibuprofen-d3 | 121662-14-4 | Isotope-Labeled Compounds |
| HY-78131S1 | Ibuprofen-13C,d3 | 1261394-40-4 | Isotope-Labeled Compounds |
| HY-78131S2 | Ibuprofen-d4 | Isotope-Labeled Compounds | |
| HY-78131S3 | Ibuprofen-13C6 | 1216459-54-9 | Isotope-Labeled Compounds |
| HY-78139 | L-Xylose | 609-06-3 | Natural Products |
| HY-78139R | L-Xylose (Standard) | 609-06-3 | Reference Standards |
| HY-78139S | L-Xylose-1-13C | 178101-87-6 | Isotope-Labeled Compounds |
| HY-78139S1 | L-Xylose-2-13C | 478506-63-7 | Isotope-Labeled Compounds |
| HY-78139S2 | L-Xylose-5-13C | 478506-64-8 | Isotope-Labeled Compounds |
| HY-78144 | 4-Methylsalicylic acid | 50-85-1 | Reference compound |
| HY-78168 | Azilsartan methyl ester | 147403-52-9 | Reference compound |
| HY-78192 | N-[N-[(1,1-Dimethylethoxy)carbonyl]-2-methylalanyl]-D-tryptophan | 159634-94-3 | Reference compound |
| HY-78197 | 3,5-Dimethylisoxazole-4-boronic acid pinacol ester | 832114-00-8 | Biochemical Assay Reagents |
| HY-78211 | Ethyl 3-oxopentanoate | 4949-44-4 | Biochemical Assay Reagents |
| HY-78216 | 2-Thiooxamic acid ethyl ester | 16982-21-1 | Biochemical Assay Reagents |
| HY-78237 | Nelociguat | 625115-52-8 | Reference compound |
| HY-78243 | 4-Bromopyrazole | 2075-45-8 | Biochemical Assay Reagents |
| HY-78248 | 4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine | 941685-27-4 | Biochemical Assay Reagents |
| HY-78263 | MNS | 1485-00-3 | Reference compound |
| HY-78315 | 2',3',4'-Trimethoxyacetophenone | 13909-73-4 | Natural Products |
| HY-78327AS | (S)-(+)-Modafinic acid-d5 | Isotope-Labeled Compounds | |
| HY-78337 | Methyl pyrimidine-2-carboxylate | 34253-03-7 | Biochemical Assay Reagents |
| HY-78349 | A 77-01 | 607737-87-1 | Reference compound |
| HY-78428 | CDK-IN-6 | 779353-02-5 | Reference compound |
| HY-78446 | KSD 2405 | 620-24-6 | Natural Products |
| HY-78451S | 2-Benzimidazolethiol-d4 | 931581-17-8 | Isotope-Labeled Compounds |
| HY-78494 | 1-Naphthaleneboronic acid | 13922-41-3 | Biochemical Assay Reagents |
| HY-78509 | Dibenzosuberone | 1210-35-1 | Reference compound |
| HY-78542 | Deshydroxyethoxy ticagrelor | 220347-05-7 | Reference compound |
| HY-78542S | Deshydroxyethoxy Ticagrelor-d7 | 2734919-83-4 | Isotope-Labeled Compounds |
| HY-78571 | 3-Methylbenzoic acid | 99-04-7 | Biochemical Assay Reagents |
| HY-78571S | 3-Methylbenzoic acid-d7 | 733046-94-1 | Isotope-Labeled Compounds |
| HY-78573 | 5-Methylsalicylic acid | 89-56-5 | Biochemical Assay Reagents |
| HY-78574 | N-Benzoylcytidine | 13089-48-0 | Reference compound |
| HY-78644 | 4-Nitroimidazole | 3034-38-6 | Biochemical Assay Reagents |
| HY-78644R | 4-Nitroimidazole (Standard) | 3034-38-6 | Reference Standards |
| HY-78667 | 6,7-Dihydro-4-benzo[b]thiophenone | 13414-95-4 | Biochemical Assay Reagents |
| HY-78695 | JQ-1 (carboxylic acid) | 202592-23-2 | Reference compound |
| HY-78699 | 2-Hydrazinobenzothiazole | 615-21-4 | Reference compound |
| HY-78700 | 4-Bromobenzoic acid | 586-76-5 | Biochemical Assay Reagents |
| HY-78726 | Fosamprenavir | 226700-79-4 | Reference compound |
| HY-78726A | Fosamprenavir (sodium) | 226700-80-7 | Reference compound |
| HY-78726S | Fosamprenavir-d4 | 1133702-41-6 | Isotope-Labeled Compounds |
| HY-78726S2 | Fosamprenavir-13C6 | Isotope-Labeled Compounds | |
| HY-78727 | Ibrutinib deacryloylpiperidine | 330786-24-8 | Reference compound |
| HY-78733 | N-Fmoc-L-valine N-succinimidyl ester | 130878-68-1 | Peptides |
| HY-78736 | Val-Cit-PAB-OSBT | 2210262-26-1 | Reference compound |
| HY-78736G | Val-Cit-PAB-OSBT (GMP) | 2210262-26-1 | GMP Small Molecules |
| HY-78738 | MC-Val-Cit-PAB | 159857-80-4 | ADC Related |
| HY-78738G | MC-Val-Cit-PAB (GMP) | 159857-80-4 | GMP Small Molecules |
| HY-78746A | (3S,4R,5S)-rel-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxylic acid | 1219086-89-1 | Peptides |
| HY-78824 | Glycine, N-[(1,1-dimethylethoxy)carbonyl]thio-L-phenylalanyl-, methyl ester | 128421-85-2 | Peptides |
| HY-78828A | (S)-Dolaphenine (hydrochloride) | 135383-60-7 | Reference compound |
| HY-78841 | (2S,4S)-Sacubitril | 149709-63-7 | Reference compound |
| HY-78841S | (2S,4S)-Sacubitril-d4 | Isotope-Labeled Compounds | |
| HY-78843 | Boc-Bip(4,4')-OH | 147923-08-8 | Peptides |
| HY-78846 | 2R,4R-Sacubitril | 766480-48-2 | Reference compound |
| HY-78847 | 2R,4S-Sacubitril | 761373-05-1 | Reference compound |
| HY-78847R | 2R,4S-Sacubitril (Standard) | 761373-05-1 | Reference Standards |
| HY-78854 | 4-Phenoxybenzoic acid | 2215-77-2 | Biochemical Assay Reagents |
| HY-78869 | Mutated EGFR-IN-1 | 1421372-66-8 | Reference compound |
| HY-78871S | 1-(Methyl-d3)piperazine | 1093380-08-5 | Isotope-Labeled Compounds |
| HY-78871S1 | N-Methylpiperazine-d11 | 1319723-22-2 | Isotope-Labeled Compounds |
| HY-78871S2 | N-Methylpiperazine-d4 | 343864-02-8 | Isotope-Labeled Compounds |
| HY-78871S3 | N-Methylpiperazine-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-78871S6 | N-Methylpiperazine-d3 (hydrochloride) | 2043778-87-4 | Isotope-Labeled Compounds |
| HY-78884 | Anticancer agent 9 | 592542-61-5 | Reference compound |
| HY-78897 | CBZ-L-Isoleucine | 3160-59-6 | Peptides |
| HY-78899 | Monomethyl auristatin E intermediate-6 | 135383-54-9 | Reference compound |
| HY-78899A | (4R,5S)-Monomethyl auristatin E intermediate-6 | Reference compound | |
| HY-78901 | Monomethyl auristatin E intermediate-7 | 135383-55-0 | Reference compound |
| HY-78901A | Monomethyl auristatin E intermediate-8 | Reference compound | |
| HY-78903 | Monomethyl auristatin E intermediate-9 | 120205-58-5 | Reference compound |
| HY-78903A | Monomethyl auristatin E intermediate-10 | Reference compound | |
| HY-78906 | N-Benzyl-L-isoleucine | 1859-49-0 | Peptides |
| HY-78907 | (2S,3S)-2-(Benzyl(methyl)amino)-3-methylpentanoic acid | 4125-97-7 | Peptides |
| HY-78908 | Monomethyl auristatin E intermediate-11 | 870640-62-3 | Reference compound |
| HY-78910 | Monomethyl auristatin E intermediate-12 | 870640-61-2 | Reference compound |
| HY-78911 | Monomethyl auristatin E intermediate-13 | 870640-64-5 | Reference compound |
| HY-78912 | D-Alloisoleucine | 1509-35-9 | Peptides |
| HY-78913 | Monomethyl auristatin E intermediate-14 | 1932791-56-4 | Reference compound |
| HY-78921 | Fmoc-3VVD-OH | 863971-44-2 | ADC Related |
| HY-78921AG | Fmoc-3VVD-OH (GMP) | 863971-44-2 | GMP Small Molecules |
| HY-78924 | N-Boc-D-prolinol | 83435-58-9 | Biochemical Assay Reagents |
| HY-78926 | 1-Boc-2-(S)-pyrrolidinemethanol | 69610-40-8 | Biochemical Assay Reagents |
| HY-78927 | N-Boc-L-Prolinal | 69610-41-9 | Peptides |
| HY-78931 | Boc-Dap-NE | 160800-65-7 | ADC Related |
| HY-78931A | (R,S,S,R,S)-Boc-Dap-NE | 2994330-72-0 | Reference compound |
| HY-78931B | (S,S,S,S,R)-Boc-Dap-NE | 3026594-75-9 | Reference compound |
| HY-78931C | (S,S,R,S,R)-Boc-Dap-NE | 3026595-14-9 | Reference compound |
| HY-78931E | (R,S,R,S,R)-Boc-Dap-NE | Reference compound | |
| HY-78931F | (R,S,S,S,R)-Boc-Dap-NE | Reference compound | |
| HY-78931G | Boc-Dap-NE (GMP) | 160800-65-7 | GMP Small Molecules |
| HY-78932 | Dap-NE | 160800-82-8 | Reference compound |
| HY-78932A | Dap-NE (hydrochloride) | 2019182-02-4 | Reference compound |
| HY-78932C | (2S,3R)-Dap-NE (hydrochloride) | Reference compound | |
| HY-78932D | (2R,3R)-Dap-NE (hydrochloride) | Reference compound | |
| HY-78932G | Dap-NE (hydrochloride) (GMP) | 2019182-02-4 | GMP Small Molecules |
| HY-78933 | Fmoc-MMAE | 474645-26-6 | ADC Related |
| HY-78961 | 6-Maleimidohexanoic acid N-hydroxysuccinimide ester | 55750-63-5 | ADC Related |
| HY-78975 | 2-(Hydroxymethyl)-pyrimidine | 42839-09-8 | Reference compound |
| HY-78985 | Benzene-1,3,5-tricarboxylic acid | 554-95-0 | Biochemical Assay Reagents |
| HY-78985S | Benzene-1,3,5-tricarboxylic acid-d3 | 62790-27-6 | Isotope-Labeled Compounds |
| HY-79034 | 3,3-Dimethylcyclohexanone | 2979-19-3 | Biochemical Assay Reagents |
| HY-79046 | Boc-L-2-aminobutanoic acid | 34306-42-8 | Peptides |
| HY-79077 | Osimertinib (dimesylate) | 2070014-82-1 | Reference compound |
| HY-79080 | (3R,5S)-5-([1,1′-Biphenyl]-4-ylmethyl)-3-methyl-2-pyrrolidinone | 1038924-70-7 | Reference compound |
| HY-79096 | Boc-L-phenylalanine | 13734-34-4 | Biochemical Assay Reagents |
| HY-79096S | BOC-L-Phenylalanine-13C | 84771-22-2 | Isotope-Labeled Compounds |
| HY-79096S1 | BOC-L-phenylalanine-d5 | 121695-40-7 | Isotope-Labeled Compounds |
| HY-79096S2 | BOC-L-phenylalanine-d8 | 106881-07-6 | Isotope-Labeled Compounds |
| HY-79106 | L-Biphenylalanine | 155760-02-4 | Peptides |
| HY-79123 | (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | 122350-59-8 | Peptides |
| HY-79125 | Fmoc-Hyp(Bom)-OH | 187223-15-0 | ADC Related |
| HY-79128 | Fmoc-L-Lys (Boc)-OH | 71989-26-9 | Peptides |
| HY-79128S | Fmoc-L-Lys (Boc)-OH-15N2 | 1217447-72-7 | Isotope-Labeled Compounds |
| HY-79128S1 | Fmoc-L-Lys (Boc)-OH-13C6,15N2 | 850080-89-6 | Isotope-Labeled Compounds |
| HY-79128S2 | Fmoc-L-Lys (Boc)-OH-13C | 1242058-72-5 | Isotope-Labeled Compounds |
| HY-79129 | Fmoc-D-Trp(Boc)-OH | 163619-04-3 | ADC Related |
| HY-79130 | Fmoc-(S)-phenylglycine | 102410-65-1 | Peptides |
| HY-79131 | Fmoc-Phe-OH | 35661-40-6 | Peptides |
| HY-79131S | Fmoc-Phe-OH-13C6 | 446276-60-4 | Isotope-Labeled Compounds |
| HY-79131S1 | Fmoc-Phe-OH-13C9,15N | 1217455-27-0 | Isotope-Labeled Compounds |
| HY-79131S2 | Fmoc-Phe-OH-d5 | 225918-67-2 | Isotope-Labeled Compounds |
| HY-79131S3 | Fmoc-Phe-OH-15N | 125700-32-5 | Isotope-Labeled Compounds |
| HY-79131S4 | Fmoc-Phe-OH-d8 | 1353853-39-0 | Isotope-Labeled Compounds |
| HY-79131S5 | Fmoc-Phe-OH-13C | 916262-84-5 | Isotope-Labeled Compounds |
| HY-79132 | N-Fmoc-O-benzyl-L-tyrosine | 71989-40-7 | Peptides |
| HY-79135 | Pasireotide (ditrifluoroacetate) | Peptides | |
| HY-79136 | Pasireotide (L-aspartate salt) | 396091-77-3 | Peptides |
| HY-79139 | Pteroic acid | 119-24-4 | Reference compound |
| HY-79139R | Pteroic acid (Standard) | 119-24-4 | Reference Standards |
| HY-79165 | (2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3,4-difluorophenyl)propionic acid | 198474-90-7 | Peptides |
| HY-79171 | 3,4-Difluorophenylalanine | 32133-36-1 | Peptides |
| HY-79196 | Monomethyl auristatin E intermediate-15 | 173653-47-9 | Reference compound |
| HY-79198 | Monomethyl auristatin E intermediate-16 | 2380991-16-0 | Reference compound |
| HY-79205 | Monomethyl auristatin E intermediate-17 | 2382378-57-4 | Reference compound |
| HY-79253 | MMAF intermediate 1 | 161485-82-1 | Reference compound |
| HY-79254 | MMAF intermediate 2 | 864238-20-0 | Reference compound |
| HY-79255 | Fmoc-MMAF-OMe | 863971-38-4 | Reference compound |
| HY-79256 | MMAF-OMe | 863971-12-4 | ADC Related |
| HY-79258 | Dov-Val-Dil-OH | 133120-89-5 | Reference compound |
| HY-79271 | S-tert-Leucine N-methylamide | 89226-12-0 | Peptides |
| HY-79288 | (2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3-fluorophenyl)propionic acid | 114873-01-7 | Peptides |
| HY-79294 | H-D-Phe(3-F)-OH | 110117-84-5 | Peptides |
| HY-79295 | N-BOC-3-Fluoro-D-phenylalanine | 114873-11-9 | Peptides |
| HY-79315 | 6-Dehydronandrolone acetate | 2590-41-2 | Reference compound |
| HY-79333 | L-Alanine, N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-, 1-methylethyl ester | 1256490-31-9 | Peptides |
| HY-79334 | (S)-(+)-1,2-Propanediol | 4254-15-3 | Natural Products |
| HY-79334R | (S)-(+)-1,2-Propanediol (Standard) | 4254-15-3 | Reference Standards |
| HY-79369 | Succinic anhydride | 108-30-5 | ADC Related |
| HY-79369R | Succinic anhydride (Standard) | 108-30-5 | Reference Standards |
| HY-79369S | Succinic anhydride-d4 | 14341-86-7 | Isotope-Labeled Compounds |
| HY-79369S1 | Succinic anhydride-13C2 | 67519-25-9 | Isotope-Labeled Compounds |
| HY-79404 | N-(Tert-Butoxycarbonyl)-L-neopentylglycine | 79777-82-5 | Peptides |
| HY-79404A | Boc-beta-t-butyl-d-alanine | 112695-98-4 | Peptides |
| HY-79415 | 4-Methyl-L-leucine | 57224-50-7 | Peptides |
| HY-79417 | (S)-N-Methyl-N-methoxy-2-(tert-butoxycarbonylamino)-4-methylpentanamide | 87694-50-6 | Peptides |
| HY-79444 | Bis(pinacolato)diborane | 73183-34-3 | Biochemical Assay Reagents |
| HY-79457 | S-Methylisothiourea (sulfate) | 867-44-7 | Reference compound |
| HY-79490 | Ac-Exatecan | 2922852-48-8 | Reference compound |
| HY-79490S | Ac-Exatecan-d5 | Isotope-Labeled Compounds | |
| HY-79491 | (S)-2-Aminobutyramide (hydrochloride) | 7682-20-4 | Biochemical Assay Reagents |
| HY-79491R | (S)-2-Aminobutyramide (hydrochloride) (Standard) | 7682-20-4 | Reference Standards |
| HY-79491S | (S)-2-Aminobutyramide-d3 (hydrochloride) | 1217605-54-3 | Isotope-Labeled Compounds |
| HY-79494 | Glyoxalic acid (50% in water) | 298-12-4 | Natural Products |
| HY-79504 | Ferrocene | 102-54-5 | Reference compound |
| HY-79504S | Ferrocene-d10 | 12082-87-0 | Isotope-Labeled Compounds |
| HY-79511 | FAAH-IN-2 | 184475-71-6 | Reference compound |
| HY-79513 | (R)-Methyl 2-(tert-butoxycarbonylamino)-3-hydroxypropanoate | 95715-85-8 | Peptides |
| HY-79531 | IDO-IN-1 | 914638-30-5 | Reference compound |
| HY-79541 | 2-Bromo-1,4-difluorobenzene | 399-94-0 | Biochemical Assay Reagents |
| HY-79541S | 2-Bromo-1,4-difluorobenzene-d3 | 1219795-54-6 | Isotope-Labeled Compounds |
| HY-79548 | (+)-1,2-Diphenylethylenediamine | 35132-20-8 | Biochemical Assay Reagents |
| HY-79576 | Estrone 3-methyl ether | 1624-62-0 | Reference compound |
| HY-79576S | Estrone 3-methyl ether-d3 | 1093230-99-9 | Isotope-Labeled Compounds |
| HY-79576S2 | Estrone 3-methyl ether-13C6 | Isotope-Labeled Compounds | |
| HY-79583 | Glutaminase-IN-3 | 1439399-45-7 | Reference compound |
| HY-79584 | Propargyl-Tos | 23418-85-1 | ADC Related |
| HY-79587S | Benzil-d10 | 77092-81-0 | Isotope-Labeled Compounds |
| HY-79593 | MRE-269 | 475085-57-5 | Natural Products |
| HY-79593S1 | MRE-269-d6 | 1265295-56-4 | Isotope-Labeled Compounds |
| HY-79593S2 | MRE-269-d7 | 1265295-20-2 | Isotope-Labeled Compounds |
| HY-79593S3 | MRE-269-d7 (sodium) | 2249828-87-1 | Isotope-Labeled Compounds |
| HY-79594 | Methyl 4-aminobutanoate (hydrochloride) | 13031-60-2 | Biochemical Assay Reagents |
| HY-79602 | p-Toluenesulfonamide | 70-55-3 | Biochemical Assay Reagents |
| HY-79602R | p-Toluenesulfonamide (Standard) | 70-55-3 | Reference Standards |
| HY-79602S | 4-Tolyl-d4-sulfonamide | 1219795-34-2 | Isotope-Labeled Compounds |
| HY-79631 | (Tetrahydro-2H-pyran-4-yl)methanol | 14774-37-9 | Biochemical Assay Reagents |
| HY-79635 | Methyl indole-3-carboxylate | 942-24-5 | Natural Products |
| HY-79635R | Methyl indole-3-carboxylate (Standard) | 942-24-5 | Reference Standards |
| HY-79638 | 4-(2-Bromoacetyl)benzonitrile | 20099-89-2 | Reference compound |
| HY-79647 | Fmoc-OSu | 82911-69-1 | Biochemical Assay Reagents |
| HY-79648 | Fmoc-Aib-OH | 94744-50-0 | Peptides |
| HY-79648S | Fmoc-Methylalanine-d3 | 1216885-36-7 | Isotope-Labeled Compounds |
| HY-79676 | Methyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate | 93267-04-0 | Peptides |
| HY-79680 | (S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid | 623950-02-7 | Peptides |
| HY-79691 | (S)-3-(Boc-amino)pyrrolidine | 122536-76-9 | Biochemical Assay Reagents |
| HY-79708A | O-Methyl-D-valine (hydrochloride) | 7146-15-8 | Peptides |
| HY-79709 | N-(Methoxycarbonyl)-D-valine methyl ester | 153575-98-5 | Peptides |
| HY-79722 | 4-trans-Hydroxycyclohexylamine | 27489-62-9 | Natural Products |
| HY-79775 | 2-Oxo-2-phenylethyl ((benzyloxy)carbonyl)-L-alaninate | 6530-41-2 | Peptides |
| HY-79779S | 1-Bromo-4-(bromomethyl)benzene-d6 | 229948-68-9 | Isotope-Labeled Compounds |
| HY-79779S1 | 1-Bromo-4-(bromomethyl)benzene-d4 | 2708280-84-4 | Isotope-Labeled Compounds |
| HY-79805 | Amino-3,5-dibromopyrazine | 24241-18-7 | Biochemical Assay Reagents |
| HY-79861 | benzyl (tert-Butoxycarbonyl)-L-leucyl-L-phenylalaninate | 70637-26-2 | Peptides |
| HY-79862 | Benzyl L-leucyl-L-phenylalaninate (TFA) | 70637-28-4 | Peptides |
| HY-79863 | (6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate | 868540-15-2 | Peptides |
| HY-79877 | Boc-Ser(Tos)-OMe | 56926-94-4 | Peptides |
| HY-79880 | N,N'-Carbonyldiimidazole | 530-62-1 | Reference compound |
| HY-79908A | L-Phenylalanine benzyl ester (hydrochloride) | 2462-32-0 | Peptides |
| HY-79909 | L-Phenylalanine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-leucyl]-, phenylmethyl ester | 140834-91-9 | Peptides |
| HY-79919 | D-Phenylalanine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-leucyl]-, phenylmethyl ester | 159549-97-0 | Peptides |
| HY-79930 | D-Phenylalanine, N-[N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl]-, phenylmethyl ester | 159549-96-9 | Peptides |
| HY-80002 | BMX-IN-1 | 1431525-23-3 | Reference compound |
| HY-80003 | QL47 | 1469988-75-7 | Reference compound |
| HY-80012 | SJB3-019A | 2070015-29-9 | Reference compound |
| HY-80013 | THZ1 | 1604810-83-4 | Reference compound |
| HY-80013A | THZ1 (Hydrochloride) | Reference compound | |
| HY-80013B | (E/Z)-THZ1 (dihydrochloride) | 2095433-94-4 | Reference compound |
| HY-90001 | Ritonavir | 155213-67-5 | Reference compound |
| HY-90001R | Ritonavir (Standard) | 155213-67-5 | Reference Standards |
| HY-90001S | Ritonavir-d6 | 1616968-73-0 | Isotope-Labeled Compounds |
| HY-90001S1 | Ritonavir-13C,d3 | Isotope-Labeled Compounds | |
| HY-90001S2 | Ritonavir-d8 | Isotope-Labeled Compounds | |
| HY-90001S3 | rel-Ritonavir-d6 | 1217720-20-1 | Isotope-Labeled Compounds |
| HY-90003 | Tianeptine | 72797-41-2 | Reference compound |
| HY-90003A | Tianeptine (sodium salt) | 30123-17-2 | Reference compound |
| HY-90003AR | Tianeptine (sodium salt) (Standard) | 30123-17-2 | Reference Standards |
| HY-90003S | Tianeptine-d12 | 1189870-26-5 | Isotope-Labeled Compounds |
| HY-90004 | Methyl 3-hydroxybenzoate | 19438-10-9 | Biochemical Assay Reagents |
| HY-90005 | Etravirine | 269055-15-4 | Reference compound |
| HY-90005R | Etravirine (Standard) | 269055-15-4 | Reference Standards |
| HY-90005S | Etravirine-d4 | 1142095-93-9 | Isotope-Labeled Compounds |
| HY-90006 | 5-Fluorouracil | 51-21-8 | Reference compound |
| HY-90006R | 5-Fluorouracil (Standard) | 51-21-8 | Reference Standards |
| HY-90006S | 5-Fluorouracil-d1 | 90344-84-6 | Isotope-Labeled Compounds |
| HY-90006S1 | 5-Fluorouracil-13C,15N2 | 1189423-58-2 | Isotope-Labeled Compounds |
| HY-90006S2 | 5-Fluorouracil-15N2 | 68941-95-7 | Isotope-Labeled Compounds |
| HY-90006S3 | 5-Fluorouracil-13C4,15N2 | 202407-03-2 | Isotope-Labeled Compounds |
| HY-90009 | Nortadalafil | 171596-36-4 | Reference compound |
| HY-90009A | Tadalafil | 171596-29-5 | Reference compound |
| HY-90009AR | Tadalafil (Standard) | 171596-29-5 | Reference Standards |
| HY-90009AS | Tadalafil-13C2,d3 | Isotope-Labeled Compounds | |
| HY-90009B | 12-epi-Tadalafil | 171596-27-3 | Reference compound |
| HY-90009BS | cis-Tadalafil-d3 | 1329799-70-3 | Isotope-Labeled Compounds |
| HY-90009BS2 | cis-ent-Tadalafil-d3 | Isotope-Labeled Compounds | |
| HY-90009C | ent-Tadalafil | 629652-72-8 | Reference compound |
| HY-90009D | (6S,12aR)-Tadalafil | 171596-28-4 | Reference compound |
| HY-90009R | Nortadalafil (Standard) | 171596-36-4 | Reference Standards |
| HY-90009S | Tadalafil-d3 | 960226-55-5 | Isotope-Labeled Compounds |
| HY-90010 | Tolterodine (tartrate) | 124937-52-6 | Reference compound |
| HY-90010R | Tolterodine (tartrate) (Standard) | 124937-52-6 | Reference Standards |
| HY-90010S | Tolterodine tartrate-d14 | 1191280-48-4 | Isotope-Labeled Compounds |
| HY-91018 | Trimethyl[3-(trimethoxysilyl)propyl]ammonium (chloride) (50% in methanol) | 35141-36-7 | Biochemical Assay Reagents |
| HY-91054 | Triethoxyoctylsilane | 2943-75-1 | Reference compound |
| HY-A0002 | Solifenacin (Succinate) | 242478-38-2 | Reference compound |
| HY-A0002R | Solifenacin (Succinate) (Standard) | 242478-38-2 | Reference Standards |
| HY-A0002S | Solifenacin-d5 (succinate) | Isotope-Labeled Compounds | |
| HY-A0003 | Lenalidomide | 191732-72-6 | Reference compound |
| HY-A0003A | Lenalidomide (hydrochloride) | 1243329-97-6 | Reference compound |
| HY-A0003B | Lenalidomide (hemihydrate) | 847871-99-2 | Reference compound |
| HY-A0003R | Lenalidomide (Standard) | 191732-72-6 | Reference Standards |
| HY-A0003S | Lenalidomide-d5 | 1227162-34-6 | Isotope-Labeled Compounds |
| HY-A0003S2 | Lenalidomide-13C5,15N | Isotope-Labeled Compounds | |
| HY-A0003S3 | Lenalidomide-d4 | 1130061-52-7 | Isotope-Labeled Compounds |
| HY-A0004 | Decitabine | 2353-33-5 | Reference compound |
| HY-A0004R | Decitabine (Standard) | 2353-33-5 | Reference Standards |
| HY-A0004S | Decitabine-13C5 | Isotope-Labeled Compounds | |
| HY-A0005 | Clofarabine | 123318-82-1 | Reference compound |
| HY-A0005R | Clofarabine (Standard) | 123318-82-1 | Reference Standards |
| HY-A0006 | Pentostatin | 53910-25-1 | Reference compound |
| HY-A0006R | Pentostatin (Standard) | 53910-25-1 | Reference Standards |
| HY-A0007 | Rotigotine (Hydrochloride) | 125572-93-2 | Reference compound |
| HY-A0007R | Rotigotine (Hydrochloride) (Standard) | 125572-93-2 | Reference Standards |
| HY-A0007S | Rotigotine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0008 | Talipexole (dihydrochloride) | 36085-73-1 | Reference compound |
| HY-A0009 | Galanthamine (hydrobromide) | 1953-04-4 | Natural Products |
| HY-A0009R | Galanthamine (hydrobromide) (Standard) | 1953-04-4 | Reference Standards |
| HY-A0009S | Galanthamine-d3 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-A0010 | Eletriptan (hydrobromide) | 177834-92-3 | Reference compound |
| HY-A0010R | Eletriptan (hydrobromide) (Standard) | 177834-92-3 | Reference Standards |
| HY-A0012 | Darifenacin (hydrobromide) | 133099-07-7 | Reference compound |
| HY-A0012R | Darifenacin (hydrobromide) (Standard) | 133099-07-7 | Reference Standards |
| HY-A0013 | Bosentan | 147536-97-8 | Reference compound |
| HY-A0013A | Bosentan (hydrate) | 157212-55-0 | Reference compound |
| HY-A0013AR | Bosentan (hydrate) (Standard) | 157212-55-0 | Reference Standards |
| HY-A0014 | Ramelteon | 196597-26-9 | Reference compound |
| HY-A0014R | Ramelteon (Standard) | 196597-26-9 | Reference Standards |
| HY-A0014S | Ramelteon-d5 | 1134159-63-9 | Isotope-Labeled Compounds |
| HY-A0014S1 | Ramelteon-d3 | 1432057-38-9 | Isotope-Labeled Compounds |
| HY-A0015 | Bepotastine (besilate) | 190786-44-8 | Reference compound |
| HY-A0015A | (Rac)-Bepotastine (besilate) | 1415692-17-9 | Reference compound |
| HY-A0015R | Bepotastine (besilate) (Standard) | 190786-44-8 | Reference Standards |
| HY-A0015S | Bepotastine-d6 (besylate) | Isotope-Labeled Compounds | |
| HY-A0016 | Dronedarone | 141626-36-0 | Reference compound |
| HY-A0016R | Dronedarone (Standard) | 141626-36-0 | Reference Standards |
| HY-A0016S | Dronedarone-d6 (hydrochloride) | 1329809-23-5 | Isotope-Labeled Compounds |
| HY-A0016S3 | Dronedarone-d6 | 1132693-87-8 | Isotope-Labeled Compounds |
| HY-A0018 | Palonosetron | 135729-61-2 | Reference compound |
| HY-A0019 | Paliperidone | 144598-75-4 | Natural Products |
| HY-A0019A | Paliperidone palmitate | 199739-10-1 | Reference compound |
| HY-A0019BS | (R)-9-Hydroxy Risperidone-d4 | Isotope-Labeled Compounds | |
| HY-A0019R | Paliperidone (Standard) | 144598-75-4 | Reference Standards |
| HY-A0019S | Paliperidone-d4 | 1020719-55-4 | Isotope-Labeled Compounds |
| HY-A0020 | Eldecalcitol | 104121-92-8 | Reference compound |
| HY-A0020R | Eldecalcitol (Standard) | 104121-92-8 | Reference Standards |
| HY-A0020S | Eldecalcitol-d6 | Isotope-Labeled Compounds | |
| HY-A0021 | Palonosetron (hydrochloride) | 135729-62-3 | Reference compound |
| HY-A0021AS | (S,R)-Palonosetron-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0021C | (R,R)-Palonosetron Hydrochloride | 135729-75-8 | Reference compound |
| HY-A0021R | Palonosetron (hydrochloride) (Standard) | 135729-62-3 | Reference Standards |
| HY-A0021S | Palonosetron-d3 (hydrochloride) | 1246816-81-8 | Isotope-Labeled Compounds |
| HY-A0022 | Azaphen | 24853-80-3 | Natural Products |
| HY-A0022A | Azaphen (dihydrochloride monohydrate) | 63302-99-8 | Reference compound |
| HY-A0023 | Alogliptin (Benzoate) | 850649-62-6 | Reference compound |
| HY-A0023A | Alogliptin | 850649-61-5 | Reference compound |
| HY-A0023AR | Alogliptin (Standard) | 850649-61-5 | Reference Standards |
| HY-A0023AS | Alogliptin-13C,d3 | 1246817-18-4 | Isotope-Labeled Compounds |
| HY-A0023AS1 | Alogliptin-d3 | 1133421-35-8 | Isotope-Labeled Compounds |
| HY-A0023AS2 | Alogliptin-13C,d3 (benzoate) | Isotope-Labeled Compounds | |
| HY-A0023R | Alogliptin (Benzoate) (Standard) | 850649-62-6 | Reference Standards |
| HY-A0024 | Tolterodine | 124937-51-5 | Reference compound |
| HY-A0024AS | (Rac)-Tolterodine-d14 (tartrate) | 1191280-48-4 | Isotope-Labeled Compounds |
| HY-A0024AS1 | (Rac)-Tolterodine-d5 | 2747918-62-1 | Isotope-Labeled Compounds |
| HY-A0024S | Tolterodine-d14 (hydrochloride) | 1217645-16-3 | Isotope-Labeled Compounds |
| HY-A0025 | (R)-2-Acetoxy-2-phenylacetic acid | 51019-43-3 | Biochemical Assay Reagents |
| HY-A0027 | Fenspiride (hydrochloride) | 5053-08-7 | Reference compound |
| HY-A0027A | Fenspiride | 5053-06-5 | Reference compound |
| HY-A0027AS | Fenspiride-d5 | 1246911-67-0 | Isotope-Labeled Compounds |
| HY-A0030 | Fesoterodine (fumarate) | 286930-03-8 | Reference compound |
| HY-A0030R | Fesoterodine (fumarate) (Standard) | 286930-03-8 | Reference Standards |
| HY-A0030S | Fesoterodine-d7 (fumarate) | 2747918-94-9 | Isotope-Labeled Compounds |
| HY-A0031 | Bazedoxifene | 198481-32-2 | Reference compound |
| HY-A0031A | Bazedoxifene (hydrochloride) | 198480-56-7 | Reference compound |
| HY-A0031R | Bazedoxifene (Standard) | 198481-32-2 | Reference Standards |
| HY-A0031S | Bazedoxifene-d4 | 1133695-49-4 | Isotope-Labeled Compounds |
| HY-A0031S2 | Bazedoxifene-d4 (acetate) | 1795027-71-2 | Isotope-Labeled Compounds |
| HY-A0032 | Valganciclovir | 175865-60-8 | Reference compound |
| HY-A0032A | Valganciclovir (hydrochloride) | 175865-59-5 | Reference compound |
| HY-A0032AR | Valganciclovir (hydrochloride) (Standard) | 175865-59-5 | Reference Standards |
| HY-A0032AS | Valganciclovir-d8 (hydrochloride) | 1132088-63-1 | Isotope-Labeled Compounds |
| HY-A0032S | Valganciclovir-d5 (TFA) | 1402924-31-5 | Isotope-Labeled Compounds |
| HY-A0033 | Darifenacin | 133099-04-4 | Reference compound |
| HY-A0033S1 | Darifenacin-d4 | 1095598-84-7 | Isotope-Labeled Compounds |
| HY-A0034 | Solifenacin | 242478-37-1 | Reference compound |
| HY-A0034R | Solifenacin (Standard) | 242478-37-1 | Reference Standards |
| HY-A0035 | Faropenem | 106560-14-9 | Reference compound |
| HY-A0036 | Bazedoxifene (acetate) | 198481-33-3 | Reference compound |
| HY-A0036B | Bazedoxifene (acetate)-B | 198481-33-3 | Reference compound |
| HY-A0036D | Bazedoxifene (acetate)-D | 198481-33-3 | Reference compound |
| HY-A0036R | Bazedoxifene (acetate) (Standard) | 198481-33-3 | Reference Standards |
| HY-A0037 | Lasofoxifene | 180916-16-9 | Reference compound |
| HY-A0038 | Lasofoxifene (tartrate) | 190791-29-8 | Reference compound |
| HY-A0039 | Eletriptan | 143322-58-1 | Reference compound |
| HY-A0039S | Eletriptan-d3 | 1287040-94-1 | Isotope-Labeled Compounds |
| HY-A0039S1 | Eletriptan-d5 | 1126745-65-0 | Isotope-Labeled Compounds |
| HY-A0039S2 | Eletriptan-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0040 | Talipexole | 101626-70-4 | Reference compound |
| HY-A0042 | Rufinamide | 106308-44-5 | Reference compound |
| HY-A0042R | Rufinamide (Standard) | 106308-44-5 | Reference Standards |
| HY-A0042S | Rufinamide-d2 | 1129491-38-8 | Isotope-Labeled Compounds |
| HY-A0042S1 | Rufinamide-15N,d2 | 1795037-48-7 | Isotope-Labeled Compounds |
| HY-A0042S2 | Rufinamide-15N,d2-1 | 2012598-91-1 | Isotope-Labeled Compounds |
| HY-A0043 | Cilazapril | 88768-40-5 | Reference compound |
| HY-A0043A | Cilazapril (monohydrate) | 92077-78-6 | Reference compound |
| HY-A0043AR | Cilazapril (monohydrate) (Standard) | 92077-78-6 | Reference Standards |
| HY-A0043B | Cilazapril (hydrochloride) | 88824-78-6 | Reference compound |
| HY-A0043R | Cilazapril (Standard) | 88768-40-5 | Reference Standards |
| HY-A0052S | (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 | Isotope-Labeled Compounds | |
| HY-A0057 | Gabapentin | 60142-96-3 | Reference compound |
| HY-A0057A | Gabapentin (hydrochloride) | 60142-95-2 | Reference compound |
| HY-A0057AS | Gabapentin-d6 (hydrochloride) | 1432061-73-8 | Isotope-Labeled Compounds |
| HY-A0057AS2 | Gabapentin-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0057R | Gabapentin (Standard) | 60142-96-3 | Reference Standards |
| HY-A0057S | Gabapentin-d4 | 1185039-20-6 | Isotope-Labeled Compounds |
| HY-A0058 | Retinyl glucoside | 136778-12-6 | Reference compound |
| HY-A0059 | Nifuratel | 4936-47-4 | Reference compound |
| HY-A0059R | Nifuratel (Standard) | 4936-47-4 | Reference Standards |
| HY-A0060 | Malotilate | 59937-28-9 | Reference compound |
| HY-A0061 | Trifluridine | 70-00-8 | Reference compound |
| HY-A0061R | Trifluridine (Standard) | 70-00-8 | Reference Standards |
| HY-A0061S | Trifluridine-13C,15N2 | 2086328-10-9 | Isotope-Labeled Compounds |
| HY-A0062 | Telithromycin | 191114-48-4 | Reference compound |
| HY-A0062R | Telithromycin (Standard) | 191114-48-4 | Reference Standards |
| HY-A0063 | Tipiracil (hydrochloride) | 183204-72-0 | Reference compound |
| HY-A0063A | Tipiracil | 183204-74-2 | Reference compound |
| HY-A0063R | Tipiracil (hydrochloride) (Standard) | 183204-72-0 | Reference Standards |
| HY-A0064 | Verapamil (hydrochloride) | 152-11-4 | Reference compound |
| HY-A0064R | Verapamil (hydrochloride) (Standard) | 152-11-4 | Reference Standards |
| HY-A0064S | Verapamil-d3 (hydrochloride) | 2714485-49-9 | Isotope-Labeled Compounds |
| HY-A0064S1 | Verapamil-d6 (hydrochloride) | 1185032-80-7 | Isotope-Labeled Compounds |
| HY-A0065 | Palbociclib (isethionate) | 827022-33-3 | Reference compound |
| HY-A0066 | Tolazoline | 59-98-3 | Reference compound |
| HY-A0066A | Tolazoline (hydrochloride) | 59-97-2 | Natural Products |
| HY-A0066AR | Tolazoline (hydrochloride) (Standard) | 59-97-2 | Reference Standards |
| HY-A0067 | Oxybenzone | 131-57-7 | Reference compound |
| HY-A0067R | Oxybenzone (Standard) | 131-57-7 | Reference Standards |
| HY-A0067S | Oxybenzone-d5 | 1219798-54-5 | Isotope-Labeled Compounds |
| HY-A0068 | Aurothioglucose | 12192-57-3 | Reference compound |
| HY-A0069 | Doxylamine (succinate) | 562-10-7 | Reference compound |
| HY-A0069A | Doxylamine | 469-21-6 | Reference compound |
| HY-A0069AS | Doxylamine-d5 | 1173020-59-1 | Isotope-Labeled Compounds |
| HY-A0069R | Doxylamine (succinate) (Standard) | 562-10-7 | Reference Standards |
| HY-A0069S | Doxylamine-d5 (succinate) | 1216840-94-6 | Isotope-Labeled Compounds |
| HY-A0070 | Liothyronine (sodium) | 55-06-1 | Reference compound |
| HY-A0070A | Liothyronine | 6893-02-3 | Natural Products |
| HY-A0070AG | Liothyronine (GMP) | 6893-02-3 | GMP Small Molecules |
| HY-A0070AR | Liothyronine (Standard) | 6893-02-3 | Reference Standards |
| HY-A0070AS1 | Liothyronine-13C9,15N | 1213569-04-0 | Isotope-Labeled Compounds |
| HY-A0070AS2 | Liothyronine-13C6-1 | 1213431-76-5 | Isotope-Labeled Compounds |
| HY-A0070AS3 | Liothyronine-d3 | Isotope-Labeled Compounds | |
| HY-A0070B | Liothyronine (sodium hydrate) | 345957-19-9 | Reference compound |
| HY-A0070C | Liothyronine (hydrochloride) | 6138-47-2 | Reference compound |
| HY-A0070R | Liothyronine (sodium) (Standard) | 55-06-1 | Reference Standards |
| HY-A0071 | Tildipirosin | 328898-40-4 | Reference compound |
| HY-A0071R | Tildipirosin (Standard) | 328898-40-4 | Reference Standards |
| HY-A0072S | Zilpaterol-d7 | 1217818-36-4 | Isotope-Labeled Compounds |
| HY-A0074 | DTPA-tetra (t-Bu ester) | 174267-71-1 | Biochemical Assay Reagents |
| HY-A0075 | Decloxizine (dihydrochloride) | 13073-96-6 | Reference compound |
| HY-A0076 | Tebipenem | 161715-21-5 | Reference compound |
| HY-A0076R | Tebipenem (Standard) | 161715-21-5 | Reference Standards |
| HY-A0077 | Perphenazine | 58-39-9 | Reference compound |
| HY-A0077A | Perphenazine (dihydrochloride) | 2015-28-3 | Reference compound |
| HY-A0077AS | Perphenazine-d8 (dihydrochloride) | 2070015-23-3 | Isotope-Labeled Compounds |
| HY-A0077R | Perphenazine (Standard) | 58-39-9 | Reference Standards |
| HY-A0077S1 | Perphenazine-d4 | 155593-75-2 | Isotope-Labeled Compounds |
| HY-A0077S2 | Perphenazine-d6 (fumarate) | 1261432-36-3 | Isotope-Labeled Compounds |
| HY-A0078 | Mebeverine (hydrochloride) | 2753-45-9 | Reference compound |
| HY-A0078R | Mebeverine (hydrochloride) (Standard) | 2753-45-9 | Reference Standards |
| HY-A0078S | Mebeverine-d6 (hydrochloride) | 1329647-20-2 | Isotope-Labeled Compounds |
| HY-A0079 | Tetracaine | 94-24-6 | Reference compound |
| HY-A0079R | Tetracaine (Standard) | 94-24-6 | Reference Standards |
| HY-A0080 | Aminohippurate (sodium) | 94-16-6 | Reference compound |
| HY-A0081 | Fluphenazine (dihydrochloride) | 146-56-5 | Reference compound |
| HY-A0081R | Fluphenazine (dihydrochloride) (Standard) | 146-56-5 | Reference Standards |
| HY-A0081S | Fluphenazine-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-A0082 | Diphenidol (hydrochloride) | 3254-89-5 | Reference compound |
| HY-A0082R | Diphenidol (hydrochloride) (Standard) | 3254-89-5 | Reference Standards |
| HY-A0082S | Diphenidol-d10 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0083 | Methacholine (chloride) | 62-51-1 | Reference compound |
| HY-A0083B | Methacholine (bromide) | 333-31-3 | Reference compound |
| HY-A0083C | Methacholine (iodide) | 625-19-4 | Reference compound |
| HY-A0083R | Methacholine (chloride) (Standard) | 62-51-1 | Reference Standards |
| HY-A0084 | Procainamide (hydrochloride) | 614-39-1 | Reference compound |
| HY-A0084A | Procainamide | 51-06-9 | Reference compound |
| HY-A0084AR | Procainamide (Standard) | 51-06-9 | Reference Standards |
| HY-A0084R | Procainamide (hydrochloride) (Standard) | 614-39-1 | Reference Standards |
| HY-A0084S | Procainamide-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0084S1 | Procainamide-13C2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0086 | Netilmicin (sulfate) | 56391-57-2 | Reference compound |
| HY-A0086R | Netilmicin (sulfate) (Standard) | 56391-57-2 | Reference Standards |
| HY-A0087 | Octocrylene | 6197-30-4 | Reference compound |
| HY-A0087R | Octocrylene (Standard) | 6197-30-4 | Reference Standards |
| HY-A0088 | Cefotaxime (sodium) | 64485-93-4 | Reference compound |
| HY-A0088A | Cefotaxime | 63527-52-6 | Reference compound |
| HY-A0088AR | Cefotaxime (Standard) | 63527-52-6 | Reference Standards |
| HY-A0088R | Cefotaxime (sodium) (Standard) | 64485-93-4 | Reference Standards |
| HY-A0088S | Cefotaxime-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-A0089 | Colistin (sulfate) | 1264-72-8 | Natural Products |
| HY-A0089R | Colistin (sulfate) (Standard) | 1264-72-8 | Reference Standards |
| HY-A0090 | Nitrofurantoin | 67-20-9 | Reference compound |
| HY-A0090A | Nitrofurantoin (sodium) | 54-87-5 | Reference compound |
| HY-A0090R | Nitrofurantoin (Standard) | 67-20-9 | Reference Standards |
| HY-A0090S | Nitrofurantoin-13C3 | 1217226-46-4 | Isotope-Labeled Compounds |
| HY-A0091 | Pargyline (hydrochloride) | 306-07-0 | Reference compound |
| HY-A0091A | Pargyline | 555-57-7 | Reference compound |
| HY-A0091AR | Pargyline (Standard) | 555-57-7 | Reference Standards |
| HY-A0091R | Pargyline (hydrochloride) (Standard) | 306-07-0 | Reference Standards |
| HY-A0092 | Trimethadione | 127-48-0 | Reference compound |
| HY-A0092R | Trimethadione (Standard) | 127-48-0 | Reference Standards |
| HY-A0093 | Mexiletine (hydrochloride) | 5370-01-4 | Reference compound |
| HY-A0093R | Mexiletine (hydrochloride) (Standard) | 5370-01-4 | Reference Standards |
| HY-A0093S | Mexiletine-d6 (hydrochloride) | 1329835-60-0 | Isotope-Labeled Compounds |
| HY-A0093S1 | Mexiletine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0095 | Flibanserin | 167933-07-5 | Reference compound |
| HY-A0095A | Flibanserin (hydrochloride) (propan-2-ol) (hydrate) | Reference compound | |
| HY-A0095AS | Flibanserin-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0095B | Flibanserin (hydrochloride) | 147359-76-0 | Reference compound |
| HY-A0095R | Flibanserin (Standard) | 167933-07-5 | Reference Standards |
| HY-A0095S | Flibanserin-d4 | 2122830-90-2 | Isotope-Labeled Compounds |
| HY-A0095S1 | Flibanserin-d4-1 | 2122830-91-3 | Isotope-Labeled Compounds |
| HY-A0096 | Iloprost | 78919-13-8 | Reference compound |
| HY-A0096A | (Z)-Iloprost | 82889-99-4 | Reference compound |
| HY-A0096R | Iloprost (Standard) | 78919-13-8 | Reference Standards |
| HY-A0096S | Iloprost-d4 | 1035094-10-0 | Isotope-Labeled Compounds |
| HY-A0097 | Teicoplanin | 61036-62-2 | Natural Products |
| HY-A0097A | Teicoplanin (sodium) | 184539-13-7 | Natural Products |
| HY-A0098 | Tunicamycin | 11089-65-9 | Natural Products |
| HY-A0100 | Thiamine monochloride | 59-43-8 | Natural Products |
| HY-A0100R | Thiamine monochloride (Standard) | 59-43-8 | Reference Standards |
| HY-A0102 | AMCA | 701-54-2 | Reference compound |
| HY-A0103 | Xanthan gum | 11138-66-2 | Biochemical Assay Reagents |
| HY-A0104 | HPMC (Viscosity:11250-21000mPa.s) | 9004-65-3 | Reference compound |
| HY-A0104A | HPMC (Type I,Viscosity:30mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104B | HPMC (Type I,Viscosity:100mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104C | HPMC (Type I,Viscosity:400mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104D | HPMC (Type I,Viscosity:4000mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104E | HPMC (Type II,Viscosity:100mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104F | HPMC (Type II,Viscosity:400mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104G | HPMC (Type II,Viscosity:4000mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104I | HPMC (Type II,Viscosity:100000mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0104J | HPMC (Type II,Viscosity:5mPa.s) | 9004-65-3 | Reference compound |
| HY-A0104K | HPMC (Type II,Viscosity:3mPa.s) | 9004-65-3 | Biochemical Assay Reagents |
| HY-A0106 | Levamisole | 14769-73-4 | Reference compound |
| HY-A0106R | Levamisole (Standard) | 14769-73-4 | Reference Standards |
| HY-A0107 | Tetracycline | 60-54-8 | Natural Products |
| HY-A0107R | Tetracycline (Standard) | 60-54-8 | Reference Standards |
| HY-A0107S | Tetracycline-d6 | 2373374-42-4 | Isotope-Labeled Compounds |
| HY-A0107S2 | Tetracycline-d6-1 | Isotope-Labeled Compounds | |
| HY-A0108A | Trimethyl phosphate | 512-56-1 | Biochemical Assay Reagents |
| HY-A0108S | Trimethyl phosphate-d9 | 32176-12-8 | Isotope-Labeled Compounds |
| HY-A0110A | Cefotiam hexetil (hydrochloride) | 95789-30-3 | Reference compound |
| HY-A0110AR | Cefotiam hexetil (hydrochloride) (Standard) | 95789-30-3 | Reference Standards |
| HY-A0111 | Cefetamet | 65052-63-3 | Reference compound |
| HY-A0111A | Cefetamet (sodium) | 65243-25-6 | Reference compound |
| HY-A0111B | Cefetamet (hydrochloride) | 724438-16-8 | Reference compound |
| HY-A0111R | Cefetamet (Standard) | 65052-63-3 | Reference Standards |
| HY-A0113 | Cilazaprilat | 90139-06-3 | Reference compound |
| HY-A0113S | Cilazaprilat-d5 | Isotope-Labeled Compounds | |
| HY-A0114 | Moexiprilat | 103775-14-0 | Reference compound |
| HY-A0114S | Moexiprilat-d5 | 1356840-08-8 | Isotope-Labeled Compounds |
| HY-A0115 | Ramiprilat | 87269-97-4 | Reference compound |
| HY-A0115R | Ramiprilat (Standard) | 87269-97-4 | Reference Standards |
| HY-A0115S1 | Ramiprilat-d5 | 2021255-43-4 | Isotope-Labeled Compounds |
| HY-A0115S2 | Ramiprilat-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0116 | Trandolaprilate | 87679-71-8 | Reference compound |
| HY-A0116A | Trandolaprilate (hydrate) | 951393-55-8 | Reference compound |
| HY-A0116R | Trandolaprilate (Standard) | 87679-71-8 | Reference Standards |
| HY-A0116S | Trandolaprilate-d5 | 1356841-27-4 | Isotope-Labeled Compounds |
| HY-A0116S1 | Trandolaprilate-d6 | Isotope-Labeled Compounds | |
| HY-A0117 | Temocaprilat | 110221-53-9 | Reference compound |
| HY-A0118 | Naloxegol | 854601-70-0 | Reference compound |
| HY-A0118A | Naloxegol (oxalate) | 1354744-91-4 | Reference compound |
| HY-A0118AS | Naloxegol-d5 (oxalate) | Isotope-Labeled Compounds | |
| HY-A0118S | Naloxegol-13C,d3 | Isotope-Labeled Compounds | |
| HY-A0118S1 | Naloxegol-13C,d2 | Isotope-Labeled Compounds | |
| HY-A0119 | Nitroprusside (disodium dihydrate) | 13755-38-9 | Reference compound |
| HY-A0122 | Plicamycin | 18378-89-7 | Reference compound |
| HY-A0124 | Sapropterin | 62989-33-7 | Natural Products |
| HY-A0124A | Sapropterin (dihydrochloride) | 69056-38-8 | Reference compound |
| HY-A0124AR | Sapropterin (dihydrochloride) (Standard) | 69056-38-8 | Reference Standards |
| HY-A0125 | Alizapride | 59338-93-1 | Reference compound |
| HY-A0125A | Alizapride (hydrochloride) | 59338-87-3 | Reference compound |
| HY-A0125AS | Alizapride-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0126A | Epoprostenol (sodium) | 61849-14-7 | Reference compound |
| HY-A0126AR | Epoprostenol (sodium) (Standard) | 61849-14-7 | Reference Standards |
| HY-A0127 | Etofibrate | 31637-97-5 | Reference compound |
| HY-A0128 | Buclizine | 82-95-1 | Reference compound |
| HY-A0128A | Buclizine (dihydrochloride) | 129-74-8 | Reference compound |
| HY-A0128AR | Buclizine (dihydrochloride) (Standard) | 129-74-8 | Reference Standards |
| HY-A0129 | Histamine (phosphate) | 51-74-1 | Natural Products |
| HY-A0129R | Histamine (phosphate) (Standard) | 51-74-1 | Reference Standards |
| HY-A0130 | Sulfalene | 152-47-6 | Reference compound |
| HY-A0130R | Sulfalene (Standard) | 152-47-6 | Reference Standards |
| HY-A0130S | Sulfalene-13C6 | Isotope-Labeled Compounds | |
| HY-A0132 | N-Acetyl-D-glucosamine | 7512-17-6 | Natural Products |
| HY-A0132R | N-Acetyl-D-glucosamine (Standard) | 7512-17-6 | Reference Standards |
| HY-A0132S1 | N-Acetyl-D-glucosamine-13C | 253679-94-6 | Isotope-Labeled Compounds |
| HY-A0132S10 | N-Acetyl-D-glucosamine-13C2,15N | 478529-44-1 | Isotope-Labeled Compounds |
| HY-A0132S11 | N-Acetyl-D-glucosamine-13C,15N-1 | Isotope-Labeled Compounds | |
| HY-A0132S12 | N-Acetyl-D-glucosamine-13C6 | 1194446-34-8 | Isotope-Labeled Compounds |
| HY-A0132S13 | N-Acetyl-D-glucosamine-13C8,15N | Isotope-Labeled Compounds | |
| HY-A0132S14 | N-Acetyl-D-glucosamine-d3 | 77369-11-0 | Isotope-Labeled Compounds |
| HY-A0132S2 | N-Acetyl-D-glucosamine-13C-1 | 478518-87-5 | Isotope-Labeled Compounds |
| HY-A0132S3 | N-Acetyl-D-glucosamine-2-13C | 478518-89-7 | Isotope-Labeled Compounds |
| HY-A0132S4 | N-Acetyl-D-glucosamine-18O | Isotope-Labeled Compounds | |
| HY-A0132S5 | N-Acetyl-D-glucosamine-13C-3 | 478529-39-4 | Isotope-Labeled Compounds |
| HY-A0132S7 | N-Acetyl-D-glucosamine-15N | 478518-85-3 | Isotope-Labeled Compounds |
| HY-A0132S8 | N-Acetyl-D-glucosamine-13C,15N | 478529-40-7 | Isotope-Labeled Compounds |
| HY-A0132S9 | N-Acetyl-D-glucosamine-13C3,15N | 478529-43-0 | Isotope-Labeled Compounds |
| HY-A0133 | Chlorphenesin | 104-29-0 | Reference compound |
| HY-A0133R | Chlorphenesin (Standard) | 104-29-0 | Reference Standards |
| HY-A0134 | Isoflurane | 26675-46-7 | Reference compound |
| HY-A0135 | Enflurane | 13838-16-9 | Reference compound |
| HY-A0139 | Thiothixene | 5591-45-7 | Reference compound |
| HY-A0140 | Drotaverine | 14009-24-6 | Reference compound |
| HY-A0142 | Dapiprazole | 72822-12-9 | Reference compound |
| HY-A0142A | Dapiprazole (hydrochloride) | 72822-13-0 | Reference compound |
| HY-A0143 | Dihomo-γ-linolenic acid | 1783-84-2 | Natural Products |
| HY-A0143A | Dihomo-γ-linolenic acid (sodium) | 65881-87-0 | Natural Products |
| HY-A0143S | Dihomo-γ-linolenic acid-d6 | 81540-86-5 | Isotope-Labeled Compounds |
| HY-A0144 | Etilefrine | 709-55-7 | Reference compound |
| HY-A0144A | Etilefrine (hydrochloride) | 943-17-9 | Biochemical Assay Reagents |
| HY-A0144AR | Etilefrine (hydrochloride) (Standard) | 943-17-9 | Reference Standards |
| HY-A0145 | Phenprocoumon | 435-97-2 | Reference compound |
| HY-A0145R | Phenprocoumon (Standard) | 435-97-2 | Reference Standards |
| HY-A0147 | Grepafloxacin | 119914-60-2 | Reference compound |
| HY-A0147A | Grepafloxacin (hydrochloride) | 161967-81-3 | Reference compound |
| HY-A0148 | Halofantrine | 69756-53-2 | Reference compound |
| HY-A0148A | Halofantrine (hydrochloride) | 36167-63-2 | Reference compound |
| HY-A0148AR | Halofantrine (hydrochloride) (Standard) | 36167-63-2 | Reference Standards |
| HY-A0148B | (-)-Halofantrine | 66051-76-1 | Reference compound |
| HY-A0149 | Phenindamine | 82-88-2 | Reference compound |
| HY-A0150 | Alclometasone | 67452-97-5 | Reference compound |
| HY-A0151 | Thioproperazine | 316-81-4 | Reference compound |
| HY-A0152 | D-Thyroxine | 51-49-0 | Natural Products |
| HY-A0152A | D-Thyroxine (sodium) | 137-53-1 | Reference compound |
| HY-A0152R | D-Thyroxine (Standard) | 51-49-0 | Reference Standards |
| HY-A0153 | Cephapirin | 21593-23-7 | Reference compound |
| HY-A0153A | Cephapirin (sodium) | 24356-60-3 | Reference compound |
| HY-A0153AR | Cephapirin (sodium) (Standard) | 24356-60-3 | Reference Standards |
| HY-A0153R | Cephapirin (Standard) | 21593-23-7 | Reference Standards |
| HY-A0154 | Deslanoside | 17598-65-1 | Natural Products |
| HY-A0154R | Deslanoside (Standard) | 17598-65-1 | Reference Standards |
| HY-A0155 | Viomycin | 32988-50-4 | Natural Products |
| HY-A0157 | Dimethothiazine | 7456-24-8 | Reference compound |
| HY-A0157A | Dimethothiazine (mesylate) | 13115-40-7 | Reference compound |
| HY-A0157B | Dimethothiazine (hydrochloride) | 34396-64-0 | Reference compound |
| HY-A0158 | Diflorasone | 2557-49-5 | Reference compound |
| HY-A0158R | Diflorasone (Standard) | 2557-49-5 | Reference Standards |
| HY-A0160 | Indalpine | 63758-79-2 | Reference compound |
| HY-A0161 | Chlophedianol | 791-35-5 | Reference compound |
| HY-A0161A | Chlophedianol (hydrochloride) | 511-13-7 | Reference compound |
| HY-A0161S | Chlophedianol-13C6 | Isotope-Labeled Compounds | |
| HY-A0162 | Quinupristin | 120138-50-3 | Peptides |
| HY-A0162A | Quinupristin (mesylate) | Peptides | |
| HY-A0162R | Quinupristin (Standard) | 120138-50-3 | Reference Standards |
| HY-A0163 | Zuclopenthixol | 53772-83-1 | Reference compound |
| HY-A0163A | Clopenthixol | 982-24-1 | Reference compound |
| HY-A0163B | Zuclopenthixol (dihydrochloride) | 58045-23-1 | Reference compound |
| HY-A0163BR | Zuclopenthixol (dihydrochloride) (Standard) | 58045-23-1 | Reference Standards |
| HY-A0163C | trans-Clopenthixol (dihydrochloride) | 58045-22-0 | Reference compound |
| HY-A0163CR | trans-Clopenthixol (dihydrochloride) (Standard) | 58045-22-0 | Reference Standards |
| HY-A0163D | trans-Clopenthixol | 53772-84-2 | Reference compound |
| HY-A0163S | Zuclopenthixol-d4 (succinate salt) | 1246833-97-5 | Isotope-Labeled Compounds |
| HY-A0164 | Cinolazepam | 75696-02-5 | Reference compound |
| HY-A0165 | Tofisopam | 22345-47-7 | Reference compound |
| HY-A0165R | Tofisopam (Standard) | 22345-47-7 | Reference Standards |
| HY-A0166 | Cilastatin | 82009-34-5 | Reference compound |
| HY-A0166A | Cilastatin (sodium) | 81129-83-1 | Reference compound |
| HY-A0166AR | Cilastatin (sodium) (Standard) | 81129-83-1 | Reference Standards |
| HY-A0166R | Cilastatin (Standard) | 82009-34-5 | Reference Standards |
| HY-A0166S | Cilastatin-15N,d3 | 2738376-83-3 | Isotope-Labeled Compounds |
| HY-A0167 | Gadopentetate (dimeglumine) | 86050-77-3 | Reference compound |
| HY-A0168 | Regadenoson | 313348-27-5 | Reference compound |
| HY-A0168A | Regadenoson (hydrate) | 875148-45-1 | Reference compound |
| HY-A0168R | Regadenoson (Standard) | 313348-27-5 | Reference Standards |
| HY-A0168S | Regadenoson-d3 | Isotope-Labeled Compounds | |
| HY-A0169 | Methyl aminolevulinate | 33320-16-0 | Reference compound |
| HY-A0169A | Methyl aminolevulinate (hydrochloride) | 79416-27-6 | Reference compound |
| HY-A0170 | Trovafloxacin | 147059-72-1 | Reference compound |
| HY-A0170R | Trovafloxacin (Standard) | 147059-72-1 | Reference Standards |
| HY-A0171 | Benzoctamine | 17243-39-9 | Reference compound |
| HY-A0171A | Benzoctamine (hydrochloride) | 10085-81-1 | Reference compound |
| HY-A0172 | Captodiame | 486-17-9 | Reference compound |
| HY-A0173 | Progabide | 62666-20-0 | Reference compound |
| HY-A0175 | Butriptyline | 35941-65-2 | Reference compound |
| HY-A0176 | Glisoxepide | 25046-79-1 | Reference compound |
| HY-A0178 | Isothipendyl | 482-15-5 | Reference compound |
| HY-A0178A | Isothipendyl (hydrochloride) | 1225-60-1 | Reference compound |
| HY-A0178AR | Isothipendyl (hydrochloride) (Standard) | 1225-60-1 | Reference Standards |
| HY-A0178S | Isothipendyl-d6 | 1330265-10-5 | Isotope-Labeled Compounds |
| HY-A0179 | Paramethasone | 53-33-8 | Reference compound |
| HY-A0181 | Adenosine monophosphate | 61-19-8 | Natural Products |
| HY-A0181A | Adenosine 5'-monophosphate (monohydrate) | 18422-05-4 | Natural Products |
| HY-A0181AR | Adenosine 5'-monophosphate (monohydrate) (Standard) | 18422-05-4 | Reference Standards |
| HY-A0181BS | Adenosine monophosphate-13C10,15N5 (disodium) | Isotope-Labeled Compounds | |
| HY-A0181R | Adenosine monophosphate (Standard) | 61-19-8 | Reference Standards |
| HY-A0181S | Adenosine monophosphate-13C10,15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-A0181S1 | Adenosine monophosphate-15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-A0181S2 | Adenosine monophosphate-d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-A0181S3 | Adenosine monophosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-A0181S4 | Adenosine monophosphate-13C10,15N5,d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-A0181S5 | Adenosine monophosphate-15N5,d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-A0182 | Felypressin | 56-59-7 | Peptides |
| HY-A0182A | Felypressin (acetate) | 914453-97-7 | Peptides |
| HY-A0182R | Felypressin (Standard) | 56-59-7 | Reference Standards |
| HY-A0183 | Phosphatidylserine | 1446756-47-3 | Reference compound |
| HY-A0184 | Remikiren | 126222-34-2 | Reference compound |
| HY-A0185 | Calcium Gluceptate | 29039-00-7 | Reference compound |
| HY-A0190 | Ceruletide | 17650-98-5 | Peptides |
| HY-A0190R | Ceruletide (Standard) | 17650-98-5 | Reference Standards |
| HY-A0191 | Dexbrompheniramine | 132-21-8 | Reference compound |
| HY-A0191A | Dexbrompheniramine (maleate) | 2391-03-9 | Reference compound |
| HY-A0195 | Carboprost (tromethamine) | 58551-69-2 | Reference compound |
| HY-A0195R | Carboprost (tromethamine) (Standard) | 58551-69-2 | Reference Standards |
| HY-A0196 | Gadoversetamide | 131069-91-5 | Reference compound |
| HY-A0198 | Adinazolam | 37115-32-5 | Reference compound |
| HY-A0198A | Adinazolam (mesylate) | 57938-82-6 | Reference compound |
| HY-A0198S | Adinazolam-d5 | Isotope-Labeled Compounds | |
| HY-A0199 | Sodium tetradecyl sulfate | 139-88-8 | Reference compound |
| HY-A0203 | Pentosan Polysulfate | 37300-21-3 | Reference compound |
| HY-A0203A | Pentosan Polysulfate (Sodium) (W/W 43%) | 140207-93-8 | Reference compound |
| HY-A0208 | Rosoxacin | 40034-42-2 | Reference compound |
| HY-A0210 | Cerulenin | 17397-89-6 | Natural Products |
| HY-A0211 | Carphenazine | 2622-30-2 | Reference compound |
| HY-A0213 | Tiludronate | 89987-06-4 | Reference compound |
| HY-A0213A | Tiludronate (disodium) | 149845-07-8 | Reference compound |
| HY-A0213AS | Tiludronate-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-A0213B | Tiludronate (disodium hemihydrate) | 155453-10-4 | Reference compound |
| HY-A0214 | Colistin methanesulfonate (sodium salt) | 8068-28-8 | Reference compound |
| HY-A0215 | Doxacurium (chloride) | 106819-53-8 | Reference compound |
| HY-A0220 | Rescinnamine | 24815-24-5 | Natural Products |
| HY-A0221 | Ridogrel | 110140-89-1 | Reference compound |
| HY-A0223 | Iophendylate | 99-79-6 | Reference compound |
| HY-A0225B | Pirbuterol (dihydrochloride) | 38029-10-6 | Reference compound |
| HY-A0229 | Saprisartan | 146623-69-0 | Reference compound |
| HY-A0229A | Saprisartan (potassium) | 146613-90-3 | Reference compound |
| HY-A0230 | Spirapril | 83647-97-6 | Reference compound |
| HY-A0230A | Spirapril (hydrochloride) | 94841-17-5 | Reference compound |
| HY-A0231 | Glymidine (sodium) | 3459-20-9 | Reference compound |
| HY-A0232 | Heptabarbital | 509-86-4 | Reference compound |
| HY-A0234 | Stepronin | 72324-18-6 | Reference compound |
| HY-A0234R | Stepronin (Standard) | 72324-18-6 | Reference Standards |
| HY-A0235 | Antrafenine | 55300-29-3 | Reference compound |
| HY-A0236 | Aprindine | 37640-71-4 | Reference compound |
| HY-A0236A | Aprindine (hydrochloride) | 33237-74-0 | Reference compound |
| HY-A0241 | Dalfopristin | 112362-50-2 | Reference compound |
| HY-A0241R | Dalfopristin (Standard) | 112362-50-2 | Reference Standards |
| HY-A0243 | Aceprometazine | 13461-01-3 | Reference compound |
| HY-A0245 | Dihydrotachysterol | 67-96-9 | Reference compound |
| HY-A0245R | Dihydrotachysterol (Standard) | 67-96-9 | Reference Standards |
| HY-A0246 | Flucloxacillin | 5250-39-5 | Reference compound |
| HY-A0246A | Flucloxacillin sodium | 1847-24-1 | Reference compound |
| HY-A0246AR | Flucloxacillin sodium (Standard) | 1847-24-1 | Reference Standards |
| HY-A0248 | Polymyxin B (Sulfate) | 1405-20-5 | Natural Products |
| HY-A0248A | Polymyxin B1 | 4135-11-9 | Natural Products |
| HY-A0248B | Polymyxin B2 | 34503-87-2 | Reference compound |
| HY-A0248BR | Polymyxin B2 (Standard) | 34503-87-2 | Reference Standards |
| HY-A0248C | Polymyxin B2 (Sulfate) | 108965-69-1 | Reference compound |
| HY-A0249 | Bevantolol | 59170-23-9 | Reference compound |
| HY-A0250 | Tasosartan | 145733-36-4 | Reference compound |
| HY-A0250R | Tasosartan (Standard) | 145733-36-4 | Reference Standards |
| HY-A0251 | Cefpodoxime | 80210-62-4 | Reference compound |
| HY-A0251AS | Cefpodoxime proxetil EP impurity A-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-A0251R | Cefpodoxime (Standard) | 80210-62-4 | Reference Standards |
| HY-A0251S | Cefpodoxime-d3 | 2477791-28-7 | Isotope-Labeled Compounds |
| HY-A0252 | Bupranolol | 14556-46-8 | Reference compound |
| HY-A0252A | Bupranolol (hydrochloride) | 15148-80-8 | Reference compound |
| HY-A0252R | Bupranolol (Standard) | 14556-46-8 | Reference Standards |
| HY-A0253 | Cefacetrile | 10206-21-0 | Reference compound |
| HY-A0253R | Cefacetrile (Standard) | 10206-21-0 | Reference Standards |
| HY-A0253S | Cefacetrile-13C3 | Isotope-Labeled Compounds | |
| HY-A0255 | Clocortolone | 4828-27-7 | Reference compound |
| HY-A0256 | Clavulanic acid | 58001-44-8 | Reference compound |
| HY-A0256A | Clavulanate (potassium) | 61177-45-5 | Reference compound |
| HY-A0256B | Clavulanate (lithium) | 61177-44-4 | Reference compound |
| HY-A0256BR | Clavulanate (lithium) (Standard) | 61177-44-4 | Reference Standards |
| HY-A0256R | Clavulanic acid (Standard) | 58001-44-8 | Reference Standards |
| HY-A0257 | Prenylamine | 390-64-7 | Reference compound |
| HY-A0257A | Prenylamine (lactate) | 69-43-2 | Reference compound |
| HY-A0257AR | Prenylamine (lactate) (Standard) | 69-43-2 | Reference Standards |
| HY-A0258A | Metubine | 7601-55-0 | Reference compound |
| HY-A0259 | Floctafenine | 23779-99-9 | Reference compound |
| HY-A0261 | Pentagastrin | 5534-95-2 | Peptides |
| HY-A0261A | Pentagastrin (meglumine) | 57448-84-7 | Peptides |
| HY-A0266 | Gadobenic acid | 113662-23-0 | Reference compound |
| HY-A0267 | Bitolterol | 30392-40-6 | Reference compound |
| HY-A0269 | Mecillinam | 32887-01-7 | Reference compound |
| HY-A0269R | Mecillinam (Standard) | 32887-01-7 | Reference Standards |
| HY-A0269S | Mecillinam-d12 | Isotope-Labeled Compounds | |
| HY-A0270 | Diphenidol | 972-02-1 | Reference compound |
| HY-A0270S | Diphenadol-d10 | Isotope-Labeled Compounds | |
| HY-A0271 | Aluminum Glycinate | 13682-92-3 | Reference compound |
| HY-A0272 | Sodium laureth sulfate (70% in water) | 9004-82-4 | Reference compound |
| HY-A0273 | Propyphenazone | 479-92-5 | Reference compound |
| HY-A0273R | Propyphenazone (Standard) | 479-92-5 | Reference Standards |
| HY-A0273S | Propyphenazone-d3 | 162935-29-7 | Isotope-Labeled Compounds |
| HY-A0274 | Ramosetron | 132036-88-5 | Reference compound |
| HY-A0274S | Ramosetron-d3 (hydrochloride) | 1330266-04-0 | Isotope-Labeled Compounds |
| HY-A0275 | Amezinium (methylsulfate) | 30578-37-1 | Reference compound |
| HY-A0276 | Gentamicin (sulfate) | 1405-41-0 | Natural Products |
| HY-A0276A | Gentamicin | 1403-66-3 | Reference compound |
| HY-A0276R | Gentamicin (sulfate) (Standard) | 1405-41-0 | Reference Standards |
| HY-A0277 | Cyproconazole | 94361-06-5 | Reference compound |
| HY-A0277R | Cyproconazole (Standard) | 94361-06-5 | Reference Standards |
| HY-A0278 | Hexaconazole | 79983-71-4 | Reference compound |
| HY-A0278R | Hexaconazole (Standard) | 79983-71-4 | Reference Standards |
| HY-A0279 | Pristinamycin | 270076-60-3 | Natural Products |
| HY-A0279A | Pristinamycin IA | 3131-03-1 | Natural Products |
| HY-A0279AR | Pristinamycin IA (Standard) | 3131-03-1 | Reference Standards |
| HY-A0280 | Roslin 2 (bromide) | 29574-21-8 | Reference compound |
| HY-A0281 | 4-Phenylbutyric acid | 1821-12-1 | Reference compound |
| HY-A0281S | 4-Phenylbutyric acid-d11 | 358730-86-6 | Isotope-Labeled Compounds |
| HY-A0281S2 | 4-Phenylbutyric acid-d5 | 64138-52-9 | Isotope-Labeled Compounds |
| HY-A0281S3 | 4-Phenylbutyric acid-d2 | 461391-24-2 | Isotope-Labeled Compounds |
| HY-A0282 | L-Ornithine L-aspartate | 3230-94-2 | Reference compound |
| HY-A0285 | Norethisterone enanthate | 3836-23-5 | Reference compound |
| HY-A0285R | Norethisterone enanthate (Standard) | 3836-23-5 | Reference Standards |
| HY-A0287 | Clomiphene | 911-45-5 | Reference compound |
| HY-A0287A | Clomifene (hydrochloride) | 57049-00-0 | Reference compound |
| HY-A0287S | Clomifene-d5 (hydrochloride) | 1346606-66-3 | Isotope-Labeled Compounds |
| HY-A0288 | Loteprednol | 129260-79-3 | Reference compound |
| HY-A0293 | Pyrvinium pamoate | 3546-41-6 | Reference compound |
| HY-A0293R | Pyrvinium pamoate (Standard) | 3546-41-6 | Reference Standards |
| HY-A0294 | Ertapenem | 153832-46-3 | Reference compound |
| HY-A0294A | Ertapenem (disodium) | 153832-38-3 | Reference compound |
| HY-A0294AR | Ertapenem (disodium) (Standard) | 153832-38-3 | Reference Standards |
| HY-A0294AS | Ertapenem-d4 (disodium) | 1356934-56-9 | Isotope-Labeled Compounds |
| HY-A0294S | Ertapenem-d4 | 1356992-95-4 | Isotope-Labeled Compounds |
| HY-A0295 | (R)-Propranolol (hydrochloride) | 13071-11-9 | Reference compound |
| HY-A0296 | Chlormethiazole hydrochloride | 6001-74-7 | Reference compound |
| HY-A0298 | EZH2-IN-2 | 2238821-31-1 | Reference compound |
| HY-A0299 | H-Gly-Pro-Hyp-OH | 2239-67-0 | Peptides |
| HY-A0299A | H-Gly-Pro-Hyp-OH (acetate) | 103192-50-3 | Reference compound |
| HY-A0300 | Cyclopeptide-5 | 197172-76-2 | Reference compound |
| HY-B0002 | Ondansetron (hydrochloride) | 99614-01-4 | Reference compound |
| HY-B0002A | Ondansetron (hydrochloride dihydrate) | 103639-04-9 | Reference compound |
| HY-B0002AR | Ondansetron (hydrochloride dihydrate) (Standard) | 103639-04-9 | Reference Standards |
| HY-B0002B | Ondansetron | 99614-02-5 | Reference compound |
| HY-B0002BR | Ondansetron (Standard) | 99614-02-5 | Reference Standards |
| HY-B0002BS | Ondansetron-d5 | 1219798-86-3 | Isotope-Labeled Compounds |
| HY-B0002BS1 | Ondansetron-d3 | 1132757-82-4 | Isotope-Labeled Compounds |
| HY-B0002BS2 | Ondansetron-13C,d3 | 2699607-85-5 | Isotope-Labeled Compounds |
| HY-B0002S | Ondansetron-d3 (hydrochloride) | 1346605-02-4 | Isotope-Labeled Compounds |
| HY-B0002S1 | Ondansetron-d6 (hydrochloride) | 1225442-22-7 | Isotope-Labeled Compounds |
| HY-B0003 | Gemcitabine (hydrochloride) | 122111-03-9 | Reference compound |
| HY-B0003A | 1'-epi Gemcitabine (hydrochloride) | 122111-05-1 | Reference compound |
| HY-B0003AS | (2S)-Gemcitabine-13C,15N2 (hydrochloride) | 1262897-74-4 | Isotope-Labeled Compounds |
| HY-B0003R | Gemcitabine (hydrochloride) (Standard) | 122111-03-9 | Reference Standards |
| HY-B0003S | Gemcitabine-13C,15N2 (hydrochloride) | 2757566-59-7 | Isotope-Labeled Compounds |
| HY-B0004 | Doxofylline | 69975-86-6 | Reference compound |
| HY-B0004R | Doxofylline (Standard) | 69975-86-6 | Reference Standards |
| HY-B0004S | Doxofylline-d6 | 1219805-99-8 | Isotope-Labeled Compounds |
| HY-B0004S1 | Doxofylline-d4 | 1346599-13-0 | Isotope-Labeled Compounds |
| HY-B0005 | Toremifene (citrate) | 89778-27-8 | Reference compound |
| HY-B0005A | Toremifene | 89778-26-7 | Reference compound |
| HY-B0005AS | Toremifene-d6 | Isotope-Labeled Compounds | |
| HY-B0005R | Toremifene (citrate) (Standard) | 89778-27-8 | Reference Standards |
| HY-B0005S | Toremifene-d6 (citrate) | 1246833-71-5 | Isotope-Labeled Compounds |
| HY-B0005S1 | Toremifene-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0006 | Carvedilol | 72956-09-3 | Reference compound |
| HY-B0006A | Carvedilol (phosphate hemihydrate) | 610309-89-2 | Reference compound |
| HY-B0006B | (S)-Carvedilol | 95094-00-1 | Reference compound |
| HY-B0006BS | (S)-Carvedilol-d4 | 2747915-23-5 | Isotope-Labeled Compounds |
| HY-B0006C | (R)-Carvedilol | 95093-99-5 | Reference compound |
| HY-B0006CS | (R)-Carvedilol-d4 | 2747915-92-8 | Isotope-Labeled Compounds |
| HY-B0006R | Carvedilol (Standard) | 72956-09-3 | Reference Standards |
| HY-B0006S | Carvedilol-d3 | 1020719-25-8 | Isotope-Labeled Compounds |
| HY-B0006S1 | Carvedilol-d4 | 1133705-56-2 | Isotope-Labeled Compounds |
| HY-B0006S2 | Carvedilol-d5 | 929106-58-1 | Isotope-Labeled Compounds |
| HY-B0007 | Baclofen | 1134-47-0 | Reference compound |
| HY-B0007B | (S)-Baclofen | 66514-99-6 | Reference compound |
| HY-B0007C | Baclofen (hydrochloride) | 28311-31-1 | Reference compound |
| HY-B0007R | Baclofen (Standard) | 1134-47-0 | Reference Standards |
| HY-B0007S | Baclofen-d4 | 1189938-30-4 | Isotope-Labeled Compounds |
| HY-B0007S2 | Baclofen-d5 (hydrochloride) | 2012598-58-0 | Isotope-Labeled Compounds |
| HY-B0008 | Sulindac | 38194-50-2 | Reference compound |
| HY-B0008A | Sulindac (sodium) | 63804-15-9 | Reference compound |
| HY-B0008R | Sulindac (Standard) | 38194-50-2 | Reference Standards |
| HY-B0008S | Sulindac-d3 | Isotope-Labeled Compounds | |
| HY-B0009 | Flumazenil | 78755-81-4 | Reference compound |
| HY-B0009R | Flumazenil (Standard) | 78755-81-4 | Reference Standards |
| HY-B0010 | Formoterol (fumarate) | 43229-80-7 | Reference compound |
| HY-B0010A | Arformoterol | 67346-49-0 | Reference compound |
| HY-B0010AS | Formoterol-d3 | 1198353-13-7 | Isotope-Labeled Compounds |
| HY-B0010B | Formoterol-1 | 73573-87-2 | Reference compound |
| HY-B0010C | (S,S)-Formoterol | 67346-48-9 | Reference compound |
| HY-B0010D | Arformoterol (tartrate) | 200815-49-2 | Reference compound |
| HY-B0010DR | Arformoterol (tartrate) (Standard) | 200815-49-2 | Reference Standards |
| HY-B0010E | Arformoterol (maleate) | 1254575-18-2 | Reference compound |
| HY-B0010S | Formoterol-d6 | 1020719-45-2 | Isotope-Labeled Compounds |
| HY-B0011 | Docetaxel | 114977-28-5 | Reference compound |
| HY-B0011A | Docetaxel (Trihydrate) | 148408-66-6 | Reference compound |
| HY-B0011AR | Docetaxel (Trihydrate) (Standard) | 148408-66-6 | Reference Standards |
| HY-B0011AS | Docetaxel-d5 (trihydrate) | Isotope-Labeled Compounds | |
| HY-B0011R | Docetaxel (Standard) | 114977-28-5 | Reference Standards |
| HY-B0011S | Docetaxel-d9 | 940867-25-4 | Isotope-Labeled Compounds |
| HY-B0012 | Pamidronic acid | 40391-99-9 | Reference compound |
| HY-B0012A | Pamidronate (disodium) | 57248-88-1 | Reference compound |
| HY-B0012AR | Pamidronate (disodium) (Standard) | 57248-88-1 | Reference Standards |
| HY-B0012B | Pamidronic acid (sodium) | 89131-02-2 | Reference compound |
| HY-B0013 | Lavofloxacin (lactate) | 294662-18-3 | Reference compound |
| HY-B0015 | Paclitaxel | 33069-62-4 | Natural Products |
| HY-B0015R | Paclitaxel (Standard) | 33069-62-4 | Reference Standards |
| HY-B0015S | Paclitaxel-d5 | 1129540-33-5 | Isotope-Labeled Compounds |
| HY-B0015S1 | Paclitaxel-d5 (benzoyloxy) | 1261254-56-1 | Isotope-Labeled Compounds |
| HY-B0016 | Capecitabine | 154361-50-9 | Reference compound |
| HY-B0016R | Capecitabine (Standard) | 154361-50-9 | Reference Standards |
| HY-B0016S | Capecitabine-d11 | 1132662-08-8 | Isotope-Labeled Compounds |
| HY-B0017 | Telbivudine | 3424-98-4 | Reference compound |
| HY-B0017R | Telbivudine (Standard) | 3424-98-4 | Reference Standards |
| HY-B0017S | Telbivudine-d4 | 1134182-00-5 | Isotope-Labeled Compounds |
| HY-B0018 | Docetaxal | 125354-16-7 | Reference compound |
| HY-B0019 | Azasetron | 123040-69-7 | Reference compound |
| HY-B0019C | (R)-Azasetron (besylate) | 2025360-91-0 | Reference compound |
| HY-B0019S | Azasetron-d3 (hydrochloride) | 1216505-58-6 | Isotope-Labeled Compounds |
| HY-B0020 | Tropisetron (Hydrochloride) | 105826-92-4 | Reference compound |
| HY-B0020R | Tropisetron (Hydrochloride) (Standard) | 105826-92-4 | Reference Standards |
| HY-B0021 | Doxifluridine | 3094-09-5 | Reference compound |
| HY-B0021R | Doxifluridine (Standard) | 3094-09-5 | Reference Standards |
| HY-B0021S | Doxifluridine-d2 | 84258-25-3 | Isotope-Labeled Compounds |
| HY-B0021S1 | Doxifluridine-d3 | Isotope-Labeled Compounds | |
| HY-B0022 | Flutamide | 13311-84-7 | Reference compound |
| HY-B0022R | Flutamide (Standard) | 13311-84-7 | Reference Standards |
| HY-B0022S | Flutamide-d7 | 223134-72-3 | Isotope-Labeled Compounds |
| HY-B0023 | Azelnidipine | 123524-52-7 | Reference compound |
| HY-B0023R | Azelnidipine (Standard) | 123524-52-7 | Reference Standards |
| HY-B0023S | Azelnidipine-d7 | Isotope-Labeled Compounds | |
| HY-B0024 | Prulifloxacin | 123447-62-1 | Reference compound |
| HY-B0024R | Prulifloxacin (Standard) | 123447-62-1 | Reference Standards |
| HY-B0025 | Voglibose | 83480-29-9 | Natural Products |
| HY-B0025R | Voglibose (Standard) | 83480-29-9 | Reference Standards |
| HY-B0026 | Ceftiofur (hydrochloride) | 103980-44-5 | Reference compound |
| HY-B0026R | Ceftiofur (hydrochloride) (Standard) | 103980-44-5 | Reference Standards |
| HY-B0027 | Valnemulin (hydrochloride) | 133868-46-9 | Reference compound |
| HY-B0027R | Valnemulin (hydrochloride) (Standard) | 133868-46-9 | Reference Standards |
| HY-B0028 | Fludarabine (phosphate) | 75607-67-9 | Reference compound |
| HY-B0028R | Fludarabine (phosphate) (Standard) | 75607-67-9 | Reference Standards |
| HY-B0030 | D-Cycloserine | 68-41-7 | Natural Products |
| HY-B0030R | D-Cycloserine (Standard) | 68-41-7 | Reference Standards |
| HY-B0031 | Quetiapine (hemifumarate) | 111974-72-2 | Reference compound |
| HY-B0031R | Quetiapine (hemifumarate) (Standard) | 111974-72-2 | Reference Standards |
| HY-B0031S | Quetiapine-d4 (fumarate) | 1287376-15-1 | Isotope-Labeled Compounds |
| HY-B0031S1 | Quetiapine-d4 (hemifumarate) | 1217310-65-0 | Isotope-Labeled Compounds |
| HY-B0031S2 | Quetiapine-d8 (fumarate) | 1185247-12-4 | Isotope-Labeled Compounds |
| HY-B0031S3 | Quetiapine-d8 (hemifumarate) | Isotope-Labeled Compounds | |
| HY-B0031S4 | Quetiapine (hemifumarate)-d8 | 1435938-24-1 | Isotope-Labeled Compounds |
| HY-B0031S5 | Quetiapine-d4-1 (fumarate) | 2820085-77-4 | Isotope-Labeled Compounds |
| HY-B0032 | Lurasidone (Hydrochloride) | 367514-88-3 | Reference compound |
| HY-B0032A | Lurasidone | 367514-87-2 | Reference compound |
| HY-B0032AR | Lurasidone (Standard) | 367514-87-2 | Reference Standards |
| HY-B0032AS | Lurasidone-d8 | 1132654-54-6 | Isotope-Labeled Compounds |
| HY-B0032R | Lurasidone (Hydrochloride) (Standard) | 367514-88-3 | Reference Standards |
| HY-B0032S | Lurasidone-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0033 | Vigabatrin (hydrochloride) | 1391054-02-6 | Reference compound |
| HY-B0033S | Vigabatrin-13C,d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0034 | Donepezil (Hydrochloride) | 120011-70-3 | Reference compound |
| HY-B0034R | Donepezil (Hydrochloride) (Standard) | 120011-70-3 | Reference Standards |
| HY-B0034S | Donepezil-d5 (hydrochloride) | 1883548-90-0 | Isotope-Labeled Compounds |
| HY-B0034S1 | Donepezil-d4 (hydrochloride) | 1219798-88-5 | Isotope-Labeled Compounds |
| HY-B0035 | Sulfamethazine | 57-68-1 | Reference compound |
| HY-B0035A | Sulfamethazine (sodium) | 1981-58-4 | Reference compound |
| HY-B0035AR | Sulfamethazine (sodium) (Standard) | 1981-58-4 | Reference Standards |
| HY-B0035B | Sulfamethazine 100 µg/mL in acetonitrile | 57-68-1 | Biochemical Assay Reagents |
| HY-B0035R | Sulfamethazine (Standard) | 57-68-1 | Reference Standards |
| HY-B0035S | Sulfamethazine-d4 | 1020719-82-7 | Isotope-Labeled Compounds |
| HY-B0035S2 | Sulfamethazine-13C6 | 77643-91-5 | Isotope-Labeled Compounds |
| HY-B0050 | Delmopinol | 79874-76-3 | Reference compound |
| HY-B0051 | Carbazeran | 70724-25-3 | Reference compound |
| HY-B0055 | Azulene | 275-51-4 | Natural Products |
| HY-B0055R | Azulene (Standard) | 275-51-4 | Reference Standards |
| HY-B0061 | Tandospirone (citrate) | 112457-95-1 | Reference compound |
| HY-B0062 | Dovitinib (lactate hydrate) | 915769-50-5 | Reference compound |
| HY-B0063 | Gimatecan | 292618-32-7 | Reference compound |
| HY-B0067 | Amrubicin | 110267-81-7 | Reference compound |
| HY-B0067A | Amrubicin (hydrochloride) | 110311-30-3 | Reference compound |
| HY-B0067B | (R)-Amrubicin | 92395-36-3 | Reference compound |
| HY-B0068 | Azasetron (hydrochloride) | 123040-16-4 | Reference compound |
| HY-B0069 | Fludarabine | 21679-14-1 | Reference compound |
| HY-B0069R | Fludarabine (Standard) | 21679-14-1 | Reference Standards |
| HY-B0071 | Granisetron | 109889-09-0 | Reference compound |
| HY-B0071A | Granisetron (Hydrochloride) | 107007-99-8 | Reference compound |
| HY-B0071AR | Granisetron (Hydrochloride) (Standard) | 107007-99-8 | Reference Standards |
| HY-B0071AS | Granisetron-d6 (Hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0071R | Granisetron (Standard) | 109889-09-0 | Reference Standards |
| HY-B0071S1 | Granisetron-d4 | 1224925-90-9 | Isotope-Labeled Compounds |
| HY-B0071S2 | Granisetron-d6 | 1224925-80-7 | Isotope-Labeled Compounds |
| HY-B0072 | Tropisetron | 89565-68-4 | Reference compound |
| HY-B0072S | Tropisetron-d5 | 1220284-86-5 | Isotope-Labeled Compounds |
| HY-B0075 | Melatonin | 73-31-4 | Natural Products |
| HY-B0075R | Melatonin (standard) | 73-31-4 | Reference Standards |
| HY-B0075S | Melatonin-d4 | 66521-38-8 | Isotope-Labeled Compounds |
| HY-B0075S1 | Melatonin-d3 | 90735-69-6 | Isotope-Labeled Compounds |
| HY-B0075S2 | Melatonin-d7 | 615251-68-8 | Isotope-Labeled Compounds |
| HY-B0076 | Bisoprolol (hemifumarate) | 104344-23-2 | Reference compound |
| HY-B0076S | Bisoprolol-d7 (hemifumarate) | Isotope-Labeled Compounds | |
| HY-B0077 | Bendamustine (hydrochloride) | 3543-75-7 | Reference compound |
| HY-B0077R | Bendamustine (hydrochloride) (Standard) | 3543-75-7 | Reference Standards |
| HY-B0077S1 | Bendamustine-d8 (hydrochloride) | 1185068-23-8 | Isotope-Labeled Compounds |
| HY-B0078 | Dacarbazine | 4342-03-4 | Reference compound |
| HY-B0078A | Dacarbazine (citrate) | 64038-56-8 | Reference compound |
| HY-B0078B | Dacarbazine (hydrochloride) | 17925-90-5 | Reference compound |
| HY-B0078R | Dacarbazine (Standard) | 4342-03-4 | Reference Standards |
| HY-B0078S | Dacarbazine-d6 | 1185241-28-4 | Isotope-Labeled Compounds |
| HY-B0079 | Sugammadex (sodium) | 343306-79-6 | Reference compound |
| HY-B0079A | Sugammadex | 343306-71-8 | Reference compound |
| HY-B0080 | Folinic acid (calcium salt pentahydrate) | 6035-45-6 | Reference compound |
| HY-B0083 | Leflunomide | 75706-12-6 | Reference compound |
| HY-B0083R | Leflunomide (Standard) | 75706-12-6 | Reference Standards |
| HY-B0083S | Leflunomide-d4 | 1189987-23-2 | Isotope-Labeled Compounds |
| HY-B0083S1 | Leflunomide-13C6 | Isotope-Labeled Compounds | |
| HY-B0084 | Dienogest | 65928-58-7 | Reference compound |
| HY-B0084R | Dienogest (Standard) | 65928-58-7 | Reference Standards |
| HY-B0084S | Dienogest-d4 | Isotope-Labeled Compounds | |
| HY-B0084S1 | Dienogest-d5 | Isotope-Labeled Compounds | |
| HY-B0084S2 | Dienogest-d6 | Isotope-Labeled Compounds | |
| HY-B0084S3 | Dienogest-13C2,15N | Isotope-Labeled Compounds | |
| HY-B0084S4 | Dienogest-13C,15N,d4 | Isotope-Labeled Compounds | |
| HY-B0089 | Acarbose | 56180-94-0 | Natural Products |
| HY-B0089A | Acarbose (sulfate) | 1221158-13-9 | Natural Products |
| HY-B0089R | Acarbose (Standard) | 56180-94-0 | Reference Standards |
| HY-B0089S | Acarbose-d4 | 1260619-60-0 | Isotope-Labeled Compounds |
| HY-B0091 | Adapalene | 106685-40-9 | Reference compound |
| HY-B0091A | Adapalene (sodium salt) | 911110-93-5 | Reference compound |
| HY-B0091R | Adapalene (Standard) | 106685-40-9 | Reference Standards |
| HY-B0091S | Adapalene-d3 | 1276433-89-6 | Isotope-Labeled Compounds |
| HY-B0093 | Benazepril | 86541-75-5 | Reference compound |
| HY-B0093A | Benazepril (hydrochloride) | 86541-74-4 | Reference compound |
| HY-B0093AR | Benazepril (hydrochloride) (Standard) | 86541-74-4 | Reference Standards |
| HY-B0093AS | Benazepril-d5 (hydrochloride) | 1279026-26-4 | Isotope-Labeled Compounds |
| HY-B0093R | Benazepril (Standard) | 86541-75-5 | Reference Standards |
| HY-B0094 | Artemisinin | 63968-64-9 | Natural Products |
| HY-B0094R | Artemisinin (Standard) | 63968-64-9 | Reference Standards |
| HY-B0094S | Artemisinin-d3 | 176652-07-6 | Isotope-Labeled Compounds |
| HY-B0094S3 | Artemisinin-13C,d4 | Isotope-Labeled Compounds | |
| HY-B0097 | Floxuridine | 50-91-9 | Reference compound |
| HY-B0097R | Floxuridine (Standard) | 50-91-9 | Reference Standards |
| HY-B0098 | Doxazosin | 74191-85-8 | Reference compound |
| HY-B0098A | Doxazosin (mesylate) | 77883-43-3 | Reference compound |
| HY-B0098AR | Doxazosin (mesylate) (Standard) | 77883-43-3 | Reference Standards |
| HY-B0098BS | Doxazosin-d8 (hydrochloride) | 1219803-95-8 | Isotope-Labeled Compounds |
| HY-B0098S | Doxazosin-d8 | 1126848-44-9 | Isotope-Labeled Compounds |
| HY-B0099 | Edaravone | 89-25-8 | Reference compound |
| HY-B0099R | Edaravone (Standard) | 89-25-8 | Reference Standards |
| HY-B0099S | Edaravone-d5 | 1228765-67-0 | Isotope-Labeled Compounds |
| HY-B0101 | Fluconazole | 86386-73-4 | Reference compound |
| HY-B0101A | Fluconazole (hydrate) | 155347-36-7 | Reference compound |
| HY-B0101B | Fluconazole (mesylate) | 159532-41-9 | Reference compound |
| HY-B0101R | Fluconazole (Standard) | 86386-73-4 | Reference Standards |
| HY-B0101S | Fluconazole-d4 | 1124197-58-5 | Isotope-Labeled Compounds |
| HY-B0101S1 | Fluconazole-13C2,15N | 1309935-84-9 | Isotope-Labeled Compounds |
| HY-B0102 | Fluoxetine | 54910-89-3 | Reference compound |
| HY-B0102A | Fluoxetine (hydrochloride) | 56296-78-7 | Reference compound |
| HY-B0102AR | Fluoxetine (hydrochloride) (Standard) | 56296-78-7 | Reference Standards |
| HY-B0102AS | Fluoxetine-d5 (hydrochloride) | 1173020-43-3 | Isotope-Labeled Compounds |
| HY-B0102B | (S)-Fluoxetine (hydrochloride) | 114247-06-2 | Reference compound |
| HY-B0102C | (R)-Fluoxetine (hydrochloride) | 114247-09-5 | Reference compound |
| HY-B0102D | Fluoxetine (oxalate) | 114414-02-7 | Reference compound |
| HY-B0102S | Fluoxetine-d6 | 2319722-07-9 | Isotope-Labeled Compounds |
| HY-B0103 | Fluvoxamine | 54739-18-3 | Reference compound |
| HY-B0103A | Fluvoxamine (maleate) | 61718-82-9 | Reference compound |
| HY-B0103AR | Fluvoxamine (maleate) (Standard) | 61718-82-9 | Reference Standards |
| HY-B0103AS | (E)-Fluvoxamine-d4 (maleate) | 1432075-74-5 | Isotope-Labeled Compounds |
| HY-B0103AS1 | Fluvoxamine-d4 (maleate) | Isotope-Labeled Compounds | |
| HY-B0103AS2 | Fluvoxamine-13C, d3 (maleate) | Isotope-Labeled Compounds | |
| HY-B0103R | Fluvoxamine (Standard) | 54739-18-3 | Reference Standards |
| HY-B0104 | Glimepiride | 93479-97-1 | Reference compound |
| HY-B0104R | Glimepiride (Standard) | 93479-97-1 | Reference Standards |
| HY-B0104S | Glimepiride-d5 | 1028809-90-6 | Isotope-Labeled Compounds |
| HY-B0104S1 | Glimepiride-d4-1 | 1131981-29-7 | Isotope-Labeled Compounds |
| HY-B0104S2 | Glimepiride-d8 | 2012598-49-9 | Isotope-Labeled Compounds |
| HY-B0104S3 | Glimepiride-d4-2 | 1131981-32-2 | Isotope-Labeled Compounds |
| HY-B0105 | Ketoconazole | 65277-42-1 | Reference compound |
| HY-B0105A | (+)-Ketoconazole | 142128-59-4 | Reference compound |
| HY-B0105B | (-)-Ketoconazole | 142128-57-2 | Reference compound |
| HY-B0105BS | (-)-Ketoconazole-d3 | 1217766-70-5 | Isotope-Labeled Compounds |
| HY-B0105R | Ketoconazole (Standard) | 65277-42-1 | Reference Standards |
| HY-B0105S | Ketoconazole-d8 | 1217706-96-1 | Isotope-Labeled Compounds |
| HY-B0105S1 | Ketoconazole-d4 | 1398065-75-2 | Isotope-Labeled Compounds |
| HY-B0106 | Levetiracetam | 102767-28-2 | Reference compound |
| HY-B0106A | Etiracetam | 33996-58-6 | Reference compound |
| HY-B0106AR | Etiracetam (Standard) | 33996-58-6 | Reference Standards |
| HY-B0106AS | Etiracetam-d3 | 2714408-84-9 | Isotope-Labeled Compounds |
| HY-B0106R | Levetiracetam (Standard) | 102767-28-2 | Reference Standards |
| HY-B0106S | Levetiracetam-d6 | 1133229-29-4 | Isotope-Labeled Compounds |
| HY-B0106S1 | Levetiracetam-d3 | 1217851-16-5 | Isotope-Labeled Compounds |
| HY-B0107 | Acitretin | 55079-83-9 | Reference compound |
| HY-B0107A | Acitretin (sodium) | 925701-88-8 | Reference compound |
| HY-B0107R | Acitretin (Standard) | 55079-83-9 | Reference Standards |
| HY-B0108 | Daptomycin | 103060-53-3 | Natural Products |
| HY-B0109 | Dorzolamide | 120279-96-1 | Reference compound |
| HY-B0109A | Dorzolamide (hydrochloride) | 130693-82-2 | Reference compound |
| HY-B0109AR | Dorzolamide (hydrochloride) (Standard) | 130693-82-2 | Reference Standards |
| HY-B0109AS | Dorzolamide-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0109AS1 | Dorzolamide-d5(hydrochloride) | 2749856-75-3 | Isotope-Labeled Compounds |
| HY-B0109S | Dorzolamide-d5 | 1227097-70-2 | Isotope-Labeled Compounds |
| HY-B0110 | Gestodene | 60282-87-3 | Reference compound |
| HY-B0110R | Gestodene (Standard) | 60282-87-3 | Reference Standards |
| HY-B0110S | Gestodene-d6 | 1542211-40-4 | Isotope-Labeled Compounds |
| HY-B0111 | Drospirenone | 67392-87-4 | Reference compound |
| HY-B0111R | Drospirenone (Standard) | 67392-87-4 | Reference Standards |
| HY-B0111RS | Drospirenone-13C3 | Isotope-Labeled Compounds | |
| HY-B0111S | Drospirenone-d4 | 2376035-94-6 | Isotope-Labeled Compounds |
| HY-B0111S1 | Drospirenone-d4-1 | Isotope-Labeled Compounds | |
| HY-B0112 | Minoxidil | 38304-91-5 | Reference compound |
| HY-B0112R | Minoxidil (Standard) | 38304-91-5 | Reference Standards |
| HY-B0113 | Omeprazole | 73590-58-6 | Reference compound |
| HY-B0113A | Omeprazole (sodium) | 95510-70-6 | Reference compound |
| HY-B0113AR | Omeprazole (sodium) (Standard) | 95510-70-6 | Reference Standards |
| HY-B0113R | Omeprazole (Standard) | 73590-58-6 | Reference Standards |
| HY-B0113S | Omeprazole-d3 | 922731-01-9 | Isotope-Labeled Compounds |
| HY-B0113S1 | Omeprazole-d3-1 | 934293-92-2 | Isotope-Labeled Compounds |
| HY-B0113S2 | Omeprazole metabolite Omeprazole sulfone (methoxy-d3) | 1189891-71-1 | Isotope-Labeled Compounds |
| HY-B0113S3 | Omeprazole-13C,d3 | 1261395-28-1 | Isotope-Labeled Compounds |
| HY-B0113S4 | Omeprazole-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-B0113S5 | Omeprazole-d6 | 922731-02-0 | Isotope-Labeled Compounds |
| HY-B0114 | Oxcarbazepine | 28721-07-5 | Reference compound |
| HY-B0114R | Oxcarbazepine (Standard) | 28721-07-5 | Reference Standards |
| HY-B0114S | Oxcarbazepine-d4 | 1020719-71-4 | Isotope-Labeled Compounds |
| HY-B0114S1 | Oxcarbazepine-d4-1 | 1134188-71-8 | Isotope-Labeled Compounds |
| HY-B0114S2 | Oxcarbazepine-d8-1 | 1261396-65-9 | Isotope-Labeled Compounds |
| HY-B0114S3 | Oxcarbazepine-d10 | 2749432-28-6 | Isotope-Labeled Compounds |
| HY-B0115 | Pizotifen | 15574-96-6 | Reference compound |
| HY-B0115A | Pizotifen (malate) | 5189-11-7 | Reference compound |
| HY-B0115R | Pizotifen (Standard) | 15574-96-6 | Reference Standards |
| HY-B0115S | Pizotyline-d3 | Isotope-Labeled Compounds | |
| HY-B0116 | Stavudine | 3056-17-5 | Reference compound |
| HY-B0116A | Stavudine (sodium) | 134624-73-0 | Reference compound |
| HY-B0116R | Stavudine (Standard) | 3056-17-5 | Reference Standards |
| HY-B0116S | Stavudine-d4 | 1219803-67-4 | Isotope-Labeled Compounds |
| HY-B0117 | Tigecycline | 220620-09-7 | Reference compound |
| HY-B0117A | Tigecycline (hydrochloride) | 197654-04-9 | Reference compound |
| HY-B0117B | Tigecycline (mesylate) | 1135871-27-0 | Reference compound |
| HY-B0117C | Tigecycline (tetramesylate) | Reference compound | |
| HY-B0117D | Tigecycline (hydrate) | 1229002-07-6 | Reference compound |
| HY-B0117R | Tigecycline (Standard) | 220620-09-7 | Reference Standards |
| HY-B0117S | Tigecycline-d9 | 2699607-86-6 | Isotope-Labeled Compounds |
| HY-B0118A | Vecuronium (bromide) | 50700-72-6 | Reference compound |
| HY-B0118AR | Vecuronium (bromide) (Standard) | 50700-72-6 | Reference Standards |
| HY-B0119 | Risedronic acid (sodium) | 115436-72-1 | Reference compound |
| HY-B0121 | Sumatriptan succinate | 103628-48-4 | Reference compound |
| HY-B0121A | Sumatriptan hydrochloride | 103628-62-2 | Reference compound |
| HY-B0121B | Sumatriptan | 103628-46-2 | Reference compound |
| HY-B0121BS | Sumatriptan-d6 (succinate) | 1215621-31-0 | Isotope-Labeled Compounds |
| HY-B0121BS2 | Sumatriptan-d5 | Isotope-Labeled Compounds | |
| HY-B0121BS3 | Sumatriptan-d6 (formate) | Isotope-Labeled Compounds | |
| HY-B0121R | Sumatriptan (succinate) (Standard) | 103628-48-4 | Reference Standards |
| HY-B0122 | Topiramate | 97240-79-4 | Reference compound |
| HY-B0122A | Topiramate (lithium) | 488127-53-3 | Reference compound |
| HY-B0122R | Topiramate (Standard) | 97240-79-4 | Reference Standards |
| HY-B0122S | Topiramate-13C6 | Isotope-Labeled Compounds | |
| HY-B0122S1 | Topiramate-13C | Isotope-Labeled Compounds | |
| HY-B0122SS1 | Topiramate-13C6-1 | Isotope-Labeled Compounds | |
| HY-B0124 | Zonisamide | 68291-97-4 | Reference compound |
| HY-B0124A | Zonisamide (sodium) | 68291-98-5 | Reference compound |
| HY-B0124R | Zonisamide (Standard) | 68291-97-4 | Reference Standards |
| HY-B0124S | Zonisamide-d4 | 1020720-04-0 | Isotope-Labeled Compounds |
| HY-B0124S1 | Zonisamide-13C2,15N | 1188265-58-8 | Isotope-Labeled Compounds |
| HY-B0124S2 | Zonisamide-13C6 | Isotope-Labeled Compounds | |
| HY-B0125 | Ofloxacin | 82419-36-1 | Reference compound |
| HY-B0125AS | Ofloxacin-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0125R | Ofloxacin (Standard) | 82419-36-1 | Reference Standards |
| HY-B0125S | Ofloxacin-d3 | 1173147-91-5 | Isotope-Labeled Compounds |
| HY-B0125S1 | Ofloxacin-d8 | 1219170-21-4 | Isotope-Labeled Compounds |
| HY-B0126 | Marbofloxacin | 115550-35-1 | Reference compound |
| HY-B0126A | Marbofloxacin (hydrochloride) | 115551-26-3 | Reference compound |
| HY-B0126AS | Marbofloxacin-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0126R | Marbofloxacin (Standard) | 115550-35-1 | Reference Standards |
| HY-B0126S | Marbofloxacin-d8 | 1185053-37-5 | Isotope-Labeled Compounds |
| HY-B0128 | Diphylline | 479-18-5 | Reference compound |
| HY-B0128R | Diphylline (Standard) | 479-18-5 | Reference Standards |
| HY-B0129 | Aztreonam | 78110-38-0 | Reference compound |
| HY-B0129R | Aztreonam (Standard) | 78110-38-0 | Reference Standards |
| HY-B0129S | Aztreonam-d6 | 1127452-94-1 | Isotope-Labeled Compounds |
| HY-B0130 | Perindopril | 82834-16-0 | Reference compound |
| HY-B0130A | Perindopril (erbumine) | 107133-36-8 | Reference compound |
| HY-B0130AR | Perindopril (erbumine) (Standard) | 107133-36-8 | Reference Standards |
| HY-B0130AS | Perindopril-d3 (erbumine) | Isotope-Labeled Compounds | |
| HY-B0130S | Perindopril-d4 (erbumine) | 1356929-59-3 | Isotope-Labeled Compounds |
| HY-B0130S1 | Perindopril-d5 | Isotope-Labeled Compounds | |
| HY-B0131 | Prostaglandin E1 | 745-65-3 | Natural Products |
| HY-B0131A | Alprostadil (sodium) | 27930-45-6 | Reference compound |
| HY-B0131R | Prostaglandin E1 (Standard) | 745-65-3 | Reference Standards |
| HY-B0131S | Prostaglandin E1-d4 | 211105-33-8 | Isotope-Labeled Compounds |
| HY-B0131S2 | Prostaglandin E1-d9 | 2342573-59-3 | Isotope-Labeled Compounds |
| HY-B0132 | Norfloxacin | 70458-96-7 | Reference compound |
| HY-B0132A | Norfloxacin (hydrochloride) | 68077-27-0 | Reference compound |
| HY-B0132B | Norfloxacin (nicotinate) | 118803-81-9 | Reference compound |
| HY-B0132R | Norfloxacin (Standard) | 70458-96-7 | Reference Standards |
| HY-B0132S | Norfloxacin-d5 | 1015856-57-1 | Isotope-Labeled Compounds |
| HY-B0132S1 | Norfloxacin-d8 | 1216601-32-9 | Isotope-Labeled Compounds |
| HY-B0133 | Natamycin | 7681-93-8 | Natural Products |
| HY-B0133R | Natamycin (Standard) | 7681-93-8 | Reference Standards |
| HY-B0134 | Bestatin | 58970-76-6 | Natural Products |
| HY-B0134A | Bestatin (hydrochloride) | 65391-42-6 | Natural Products |
| HY-B0134AR | Bestatin (hydrochloride) (Standard) | 65391-42-6 | Reference Standards |
| HY-B0134AS | Bestatin-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0134B | Bestatin (trifluoroacetate) | 223763-80-2 | Natural Products |
| HY-B0134R | Bestatin (Standard) | 58970-76-6 | Reference Standards |
| HY-B0134S1 | Bestatin-d10 | Isotope-Labeled Compounds | |
| HY-B0135 | Furosemide | 54-31-9 | Reference compound |
| HY-B0135A | Furosemide (sodium) | 41733-55-5 | Reference compound |
| HY-B0135R | Furosemide (Standard) | 54-31-9 | Reference Standards |
| HY-B0135S | Furosemide-d5 | 1189482-35-6 | Isotope-Labeled Compounds |
| HY-B0136 | Cefdinir | 91832-40-5 | Reference compound |
| HY-B0136R | Cefdinir (Standard) | 91832-40-5 | Reference Standards |
| HY-B0136S | Cefdinir-13C,15N2 | Isotope-Labeled Compounds | |
| HY-B0137 | Prilocaine | 721-50-6 | Reference compound |
| HY-B0137A | Prilocaine (hydrochloride) | 1786-81-8 | Reference compound |
| HY-B0137AR | Prilocaine (hydrochloride) (Standard) | 1786-81-8 | Reference Standards |
| HY-B0137AS | Prilocaine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0137B | Prilocaine (acetate) | Reference compound | |
| HY-B0137R | Prilocaine (Standard) | 721-50-6 | Reference Standards |
| HY-B0138 | Ketorolac (tromethamine salt) | 74103-07-4 | Reference compound |
| HY-B0138R | Ketorolac (tromethamine salt) (Standard) | 74103-07-4 | Reference Standards |
| HY-B0139 | Flucytosine | 2022-85-7 | Reference compound |
| HY-B0139AS | Flucytosine-15N3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0139R | Flucytosine (Standard) | 2022-85-7 | Reference Standards |
| HY-B0139S | Flucytosine-13C,15N2 | 1216616-31-7 | Isotope-Labeled Compounds |
| HY-B0140 | Aminophylline | 317-34-0 | Reference compound |
| HY-B0140R | Aminophylline (Standard) | 317-34-0 | Reference Standards |
| HY-B0141 | Estradiol | 50-28-2 | Natural Products |
| HY-B0141A | Alpha-Estradiol | 57-91-0 | Natural Products |
| HY-B0141AR | Alpha-Estradiol (Standard) | 57-91-0 | Reference Standards |
| HY-B0141AS | Alpha-Estradiol-d3 | Isotope-Labeled Compounds | |
| HY-B0141AS1 | Alpha-Estradiol-d2 | 81586-94-9 | Isotope-Labeled Compounds |
| HY-B0141C | Estradiol (hemihydrate) | 35380-71-3 | Natural Products |
| HY-B0141R | Estradiol (Standard) | 50-28-2 | Reference Standards |
| HY-B0141S | Estradiol-d3 | 79037-37-9 | Isotope-Labeled Compounds |
| HY-B0141S1 | Estradiol-d4 | 66789-03-5 | Isotope-Labeled Compounds |
| HY-B0141S2 | Estradiol-d5 | 221093-45-4 | Isotope-Labeled Compounds |
| HY-B0141S3 | Estradiol-d2 | 53866-33-4 | Isotope-Labeled Compounds |
| HY-B0141S4 | Estradiol-13C6 | Isotope-Labeled Compounds | |
| HY-B0141S5 | Estradiol-13C2 | 82938-05-4 | Isotope-Labeled Compounds |
| HY-B0141S6 | Estradiol-d2-1 | 3188-46-3 | Isotope-Labeled Compounds |
| HY-B0141S7 | rel-Estradiol-13C6 | Isotope-Labeled Compounds | |
| HY-B0143 | Niacin | 59-67-6 | Natural Products |
| HY-B0143A | Niacin (hydrochloride) | 636-79-3 | Reference compound |
| HY-B0143R | Niacin (standard) | 59-67-6 | Reference Standards |
| HY-B0143S2 | Niacin-d4 | 66148-15-0 | Isotope-Labeled Compounds |
| HY-B0143S3 | Niacin-13C6 | 1189954-79-7 | Isotope-Labeled Compounds |
| HY-B0143S4 | Niacin-15N,13C3 | 2483829-87-2 | Isotope-Labeled Compounds |
| HY-B0144 | Pitavastatin (Calcium) | 147526-32-7 | Reference compound |
| HY-B0144A | Pitavastatin | 147511-69-1 | Reference compound |
| HY-B0144AS | Pitavastatin-d4 | 2070009-71-9 | Isotope-Labeled Compounds |
| HY-B0144AS1 | Pitavastatin-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-B0144B | Pitavastatin (sodium) | 574705-92-3 | Reference compound |
| HY-B0144BS | Pitavastatin-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-B0144R | Pitavastatin (Calcium) (Standard) | 147526-32-7 | Reference Standards |
| HY-B0144S | Pitavastatin-d4 (hemicalcium) | Isotope-Labeled Compounds | |
| HY-B0146 | Verteporfin | 129497-78-5 | Reference compound |
| HY-B0146R | Verteporfin (Standard) | 129497-78-5 | Reference Standards |
| HY-B0147 | Pefloxacin | 70458-92-3 | Reference compound |
| HY-B0147A | Pefloxacin (mesylate) | 70458-95-6 | Reference compound |
| HY-B0147AR | Pefloxacin (mesylate) (Standard) | 70458-95-6 | Reference Standards |
| HY-B0147B | Pefloxacin (mesylate dihydrate) | 149676-40-4 | Reference compound |
| HY-B0147BR | Pefloxacin (mesylate dihydrate) (Standard) | 149676-40-4 | Reference Standards |
| HY-B0147R | Pefloxacin (Standard) | 70458-92-3 | Reference Standards |
| HY-B0147S | Pefloxacin-d5 | 1228182-51-1 | Isotope-Labeled Compounds |
| HY-B0147S1 | Pefloxacin-d3 | 2733455-58-6 | Isotope-Labeled Compounds |
| HY-B0148 | Risedronic acid | 105462-24-6 | Reference compound |
| HY-B0148R | Risedronic acid (Standard) | 105462-24-6 | Reference Standards |
| HY-B0148S | Risedronic acid-d4 | 1035438-80-2 | Isotope-Labeled Compounds |
| HY-B0149 | Tranexamic acid | 1197-18-8 | Reference compound |
| HY-B0149R | Tranexamic acid (Standard) | 1197-18-8 | Reference Standards |
| HY-B0149S | Tranexamic acid-d2 | Isotope-Labeled Compounds | |
| HY-B0149S1 | Tranexamic acid-d2-1 | 2714435-89-7 | Isotope-Labeled Compounds |
| HY-B0149S2 | Tranexamic acid-13C6 | Isotope-Labeled Compounds | |
| HY-B0149S3 | Tranexamic acid-13C2,15N | 1292837-95-6 | Isotope-Labeled Compounds |
| HY-B0150 | Nicotinamide | 98-92-0 | Natural Products |
| HY-B0150A | Nicotinamide (Hydrochloride) | 25334-23-0 | Reference compound |
| HY-B0150R | Nicotinamide (Standard) | 98-92-0 | Reference Standards |
| HY-B0150S | Nicotinamide-d4 | 347841-88-7 | Isotope-Labeled Compounds |
| HY-B0150S1 | Nicotinamide-15N,13C3 | 2117346-85-5 | Isotope-Labeled Compounds |
| HY-B0150S2 | Nicotinamide-13C6 | 2749910-55-0 | Isotope-Labeled Compounds |
| HY-B0150S3 | Nicotinamide-d3 | 2162970-00-3 | Isotope-Labeled Compounds |
| HY-B0151 | Pregnenolone | 145-13-1 | Natural Products |
| HY-B0151R | Pregnenolone (Standard) | 145-13-1 | Reference Standards |
| HY-B0151S | Pregnenolone-d4 | Isotope-Labeled Compounds | |
| HY-B0151S1 | Pregnenolone-13C2,d2 | 2483824-26-4 | Isotope-Labeled Compounds |
| HY-B0151S2 | Pregnenolone-d4-1 | 61574-54-7 | Isotope-Labeled Compounds |
| HY-B0152 | Adenine | 73-24-5 | Natural Products |
| HY-B0152A | Adenine (hydrochloride) | 2922-28-3 | Natural Products |
| HY-B0152AR | Adenine (hydrochloride) (Standard) | 2922-28-3 | Reference Standards |
| HY-B0152B | Adenine (hemisulfate) | 321-30-2 | Natural Products |
| HY-B0152R | Adenine (Standard) | 73-24-5 | Reference Standards |
| HY-B0152S | Adenine-d1 | 109923-52-6 | Isotope-Labeled Compounds |
| HY-B0152S1 | Adenine-13C | 86967-48-8 | Isotope-Labeled Compounds |
| HY-B0152S2 | Adenine-13C5,15N5 | Isotope-Labeled Compounds | |
| HY-B0152S3 | Adenine-13C5 | Isotope-Labeled Compounds | |
| HY-B0152S4 | Adenine-15N5 | Isotope-Labeled Compounds | |
| HY-B0152S7 | Adenine-15N5 (hydrochloride hydrate) | Isotope-Labeled Compounds | |
| HY-B0153A | Ticlopidine (hydrochloride) | 53885-35-1 | Reference compound |
| HY-B0153AR | Ticlopidine (hydrochloride) (Standard) | 53885-35-1 | Reference Standards |
| HY-B0153AS | Ticlopidine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0154 | Fluticasone (propionate) | 80474-14-2 | Reference compound |
| HY-B0154R | Fluticasone (propionate) (Standard) | 80474-14-2 | Reference Standards |
| HY-B0154S | Fluticasone propionate-d3 | Isotope-Labeled Compounds | |
| HY-B0154S1 | Fluticasone propionate-d5 | 1093258-28-6 | Isotope-Labeled Compounds |
| HY-B0155 | Vicriviroc | 306296-47-9 | Reference compound |
| HY-B0155B | Vicriviroc (malate) | 541503-81-5 | Reference compound |
| HY-B0157 | Ketotifen | 34580-13-7 | Reference compound |
| HY-B0157A | Ketotifen (fumarate) | 34580-14-8 | Reference compound |
| HY-B0157AR | Ketotifen (fumarate) (Standard) | 34580-14-8 | Reference Standards |
| HY-B0157AS | Ketotifen-d3 (fumarate) | 1795138-23-6 | Isotope-Labeled Compounds |
| HY-B0157R | Ketotifen (Standard) | 34580-13-7 | Reference Standards |
| HY-B0157S | Ketotifen-13C,d3 | 2748522-40-7 | Isotope-Labeled Compounds |
| HY-B0157S1 | Ketotifen-d3 | 126939-17-1 | Isotope-Labeled Compounds |
| HY-B0158 | Cytidine | 65-46-3 | Natural Products |
| HY-B0158R | Cytidine (Standard) | 65-46-3 | Reference Standards |
| HY-B0158S | Cytidine-d2 | 40632-25-5 | Isotope-Labeled Compounds |
| HY-B0158S1 | Cytidine-13C | 201996-57-8 | Isotope-Labeled Compounds |
| HY-B0158S2 | Cytidine-13C-1 | 478511-19-2 | Isotope-Labeled Compounds |
| HY-B0158S3 | Cytidine-d2-1 | 478511-21-6 | Isotope-Labeled Compounds |
| HY-B0158S4 | Cytidine-d1 | 177978-30-2 | Isotope-Labeled Compounds |
| HY-B0158S5 | Cytidine-13C9,15N3 | 202406-79-9 | Isotope-Labeled Compounds |
| HY-B0158S6 | Cytidine-15N3 | Isotope-Labeled Compounds | |
| HY-B0158S7 | Cytidine-13C9 | Isotope-Labeled Compounds | |
| HY-B0158S8 | Cytidine-d13 | Isotope-Labeled Compounds | |
| HY-B0159 | Balofloxacin | 127294-70-6 | Reference compound |
| HY-B0159A | Balofloxacin (dihydrate) | 151060-21-8 | Reference compound |
| HY-B0159R | Balofloxacin (Standard) | 127294-70-6 | Reference Standards |
| HY-B0160 | Lafutidine | 118288-08-7 | Reference compound |
| HY-B0160R | Lafutidine (Standard) | 118288-08-7 | Reference Standards |
| HY-B0160S | Lafutidine-d10 | 1795136-26-3 | Isotope-Labeled Compounds |
| HY-B0161 | Duloxetine | 116539-59-4 | Reference compound |
| HY-B0161A | Duloxetine (hydrochloride) | 136434-34-9 | Reference compound |
| HY-B0161AR | Duloxetine (hydrochloride) (Standard) | 136434-34-9 | Reference Standards |
| HY-B0161AS | Duloxetine-d3 (hydrochloride) | 1435727-97-1 | Isotope-Labeled Compounds |
| HY-B0161AS1 | Duloxetine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0161BS | (±)-Duloxetine-d7 (maleate) | Isotope-Labeled Compounds | |
| HY-B0161BS1 | (±)-Duloxetine-d7 | Isotope-Labeled Compounds | |
| HY-B0161C | (R)-Duloxetine | 116539-60-7 | Reference compound |
| HY-B0161CR | (R)-Duloxetine (Standard) | 116539-60-7 | Reference Standards |
| HY-B0161D | (R)-Duloxetine (hydrochloride) | 910138-96-4 | Reference compound |
| HY-B0161E | (±)-Duloxetine (hydrochloride) | 947316-47-4 | Reference compound |
| HY-B0161ES | (±)-Duloxetine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0161S | Duloxetine-d7 | 919514-01-5 | Isotope-Labeled Compounds |
| HY-B0161S3 | Duloxetine-d5 (oxalate) | 1276197-53-5 | Isotope-Labeled Compounds |
| HY-B0162 | Ivabradine | 155974-00-8 | Reference compound |
| HY-B0162A | Ivabradine (hydrochloride) | 148849-67-6 | Reference compound |
| HY-B0162AR | Ivabradine (hydrochloride) (Standard) | 148849-67-6 | Reference Standards |
| HY-B0162AS | Ivabradine-d6 (hydrochloride) | 2070009-63-9 | Isotope-Labeled Compounds |
| HY-B0162AS1 | Ivabradine-d3 (hydrochloride) | 1217809-61-4 | Isotope-Labeled Compounds |
| HY-B0162S | Ivabradine-d6 | Isotope-Labeled Compounds | |
| HY-B0163 | Detomidine | 76631-46-4 | Reference compound |
| HY-B0163A | Detomidine (hydrochloride) | 90038-01-0 | Reference compound |
| HY-B0163AR | Detomidine (hydrochloride) (Standard) | 90038-01-0 | Reference Standards |
| HY-B0164 | Mizolastine | 108612-45-9 | Reference compound |
| HY-B0164A | Mizolastine (dihydrochloride) | 1056596-82-7 | Reference compound |
| HY-B0164R | Mizolastine (Standard) | 108612-45-9 | Reference Standards |
| HY-B0164S | Mizolastine-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0165 | Pravastatin | 81093-37-0 | Reference compound |
| HY-B0165A | Pravastatin (sodium) | 81131-70-6 | Natural Products |
| HY-B0165AR | Pravastatin (sodium) (Standard) | 81131-70-6 | Reference Standards |
| HY-B0165AS | Pravastatin-13C,d3 (sodium) | Isotope-Labeled Compounds | |
| HY-B0165CS | Pravastatin-d3 (sodium salt) | 1329836-90-9 | Isotope-Labeled Compounds |
| HY-B0165S | Pravastatin-d9 (sodium) | Isotope-Labeled Compounds | |
| HY-B0166 | L-Ascorbic acid | 50-81-7 | Natural Products |
| HY-B0166A | L-Ascorbic acid (sodium salt) | 134-03-2 | Natural Products |
| HY-B0166AR | L-Ascorbic acid (sodium salt) (Standard) | 134-03-2 | Reference Standards |
| HY-B0166C | L-Ascorbic acid (calcium dihydrate) | 5743-28-2 | Biochemical Assay Reagents |
| HY-B0166CR | L-Ascorbic acid (calcium dihydrate) (Standard) | 5743-28-2 | Reference Standards |
| HY-B0166D | Niacinamide ascorbate | 1987-71-9 | Natural Products |
| HY-B0166G | L-Ascorbic acid (GMP) | 50-81-7 | GMP Small Molecules |
| HY-B0166GL | L-Ascorbic acid (GMP Like) | 50-81-7 | GMP Small Molecules |
| HY-B0166R | L-Ascorbic acid (Standard) | 50-81-7 | Reference Standards |
| HY-B0166S | L-Ascorbic acid-13C6 | 1354064-87-1 | Isotope-Labeled Compounds |
| HY-B0166S1 | L-Ascorbic acid-13C | 178101-88-7 | Isotope-Labeled Compounds |
| HY-B0166S2 | L-Ascorbic acid-13C-1 | 178101-89-8 | Isotope-Labeled Compounds |
| HY-B0166S3 | L-Ascorbic acid-13C-2 | 1313730-17-4 | Isotope-Labeled Compounds |
| HY-B0166S4 | L-Ascorbic acid-13C-3 | Isotope-Labeled Compounds | |
| HY-B0166S5 | L-Ascorbic acid-13C-4 | 149153-08-2 | Isotope-Labeled Compounds |
| HY-B0166S6 | L-Ascorbic acid-d2 | 82977-10-4 | Isotope-Labeled Compounds |
| HY-B0166S8 | L-Ascorbic acid-13C6-1 | 1331939-77-5 | Isotope-Labeled Compounds |
| HY-B0167 | Salicylic acid | 69-72-7 | Natural Products |
| HY-B0167A | Sodium Salicylate | 54-21-7 | Natural Products |
| HY-B0167AR | Sodium Salicylate (Standard) | 54-21-7 | Reference Standards |
| HY-B0167R | Salicylic acid (Standard) | 69-72-7 | Reference Standards |
| HY-B0167S | Salicylic acid-d6 | 285979-87-5 | Isotope-Labeled Compounds |
| HY-B0167S1 | Salicylic acid-13C6 | 1189678-81-6 | Isotope-Labeled Compounds |
| HY-B0168 | Milnacipran | 92623-85-3 | Reference compound |
| HY-B0168A | Milnacipran (hydrochloride) | 101152-94-7 | Reference compound |
| HY-B0168AR | Milnacipran (hydrochloride) (Standard) | 101152-94-7 | Reference Standards |
| HY-B0168AS | Milnacipran-d5 (hydrochloride) | 2750534-79-1 | Isotope-Labeled Compounds |
| HY-B0168B | Milnacipran ((1S-cis) hydrochloride) | 175131-60-9 | Reference compound |
| HY-B0168BS | Milnacipran-d5 ((1S-cis) hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0168S | Milnacipran-d10 (hydrochloride) | 1217774-40-7 | Isotope-Labeled Compounds |
| HY-B0170 | Azatadine | 3964-81-6 | Reference compound |
| HY-B0170A | Azatadine (dimaleate) | 3978-86-7 | Reference compound |
| HY-B0171 | Antipyrine | 60-80-0 | Reference compound |
| HY-B0171R | Antipyrine (Standard) | 60-80-0 | Reference Standards |
| HY-B0171S | Antipyrine-d3 | 65566-62-3 | Isotope-Labeled Compounds |
| HY-B0172 | Lithocholic acid | 434-13-9 | Natural Products |
| HY-B0172A | Isoallolithocholic acid | 2276-93-9 | Reference compound |
| HY-B0172AR | Isoallolithocholic acid (Standard) | 2276-93-9 | Reference Standards |
| HY-B0172AS | Isoallolithocholic acid-d2 | 2410277-69-7 | Isotope-Labeled Compounds |
| HY-B0172AS1 | Isoallolithocholic acid-d4 | 2410277-60-8 | Isotope-Labeled Compounds |
| HY-B0172B | Isolithocholic acid | 1534-35-6 | Natural Products |
| HY-B0172BR | Isolithocholic acid (Standard) | 1534-35-6 | Reference Standards |
| HY-B0172R | Lithocholic acid (Standard) | 434-13-9 | Reference Standards |
| HY-B0172S | Lithocholic acid-d4 | 83701-16-0 | Isotope-Labeled Compounds |
| HY-B0172S1 | Lithocholic acid-d5 | 52840-06-9 | Isotope-Labeled Compounds |
| HY-B0174 | Olsalazine (Disodium) | 6054-98-4 | Reference compound |
| HY-B0174A | Olsalazine | 15722-48-2 | Reference compound |
| HY-B0174AR | Olsalazine (Standard) | 15722-48-2 | Reference Standards |
| HY-B0174AS | Olsalazine-13C6 | Isotope-Labeled Compounds | |
| HY-B0174AS1 | Olsalazine-d3 | Isotope-Labeled Compounds | |
| HY-B0174AS2 | Olsalazine-d3,15N | Isotope-Labeled Compounds | |
| HY-B0174R | Olsalazine (Disodium) (Standard) | 6054-98-4 | Reference Standards |
| HY-B0175 | Toltrazuril | 69004-03-1 | Reference compound |
| HY-B0175R | Toltrazuril (Standard) | 69004-03-1 | Reference Standards |
| HY-B0175S | Toltrazuril-d3 | 1353867-75-0 | Isotope-Labeled Compounds |
| HY-B0176A | Sertraline (hydrochloride) | 79559-97-0 | Reference compound |
| HY-B0176AR | Sertraline (hydrochloride) (Standard) | 79559-97-0 | Reference Standards |
| HY-B0176AS | rel-Sertraline-d3 (hydrochloride) | 1330180-66-9 | Isotope-Labeled Compounds |
| HY-B0176AS1 | (±)-cis-Sertraline-d3 (hydrochloride) | 1217741-83-7 | Isotope-Labeled Compounds |
| HY-B0177 | Tinidazole | 19387-91-8 | Reference compound |
| HY-B0177R | Tinidazole (Standard) | 19387-91-8 | Reference Standards |
| HY-B0177S | Tinidazole-d5 | 1216767-04-2 | Isotope-Labeled Compounds |
| HY-B0178A | Guanidine (hydrochloride) | 50-01-1 | Natural Products |
| HY-B0178AR | Guanidine (hydrochloride) (Standard) | 50-01-1 | Reference Standards |
| HY-B0178AS | Guanidine-13C,15N3 (hydrochloride) | 285977-73-3 | Isotope-Labeled Compounds |
| HY-B0178AS1 | Guanidine-d5 (hydrochloride) | 108694-93-5 | Isotope-Labeled Compounds |
| HY-B0180 | Imiquimod | 99011-02-6 | Reference compound |
| HY-B0180A | Imiquimod (hydrochloride) | 99011-78-6 | Reference compound |
| HY-B0180B | Imiquimod (maleate) | 896106-16-4 | Reference compound |
| HY-B0180C | Imiquimod (dihydrochloride) | 2995277-02-4 | Reference compound |
| HY-B0180R | Imiquimod (Standard) | 99011-02-6 | Reference Standards |
| HY-B0180S | Imiquimod-d6 | Isotope-Labeled Compounds | |
| HY-B0180S1 | Imiquimod-d9 | 2712126-48-0 | Isotope-Labeled Compounds |
| HY-B0180S2 | Imiquimod-d7 | Isotope-Labeled Compounds | |
| HY-B0181 | Altretamine | 645-05-6 | Reference compound |
| HY-B0181A | Altretamine (hydrochloride) | 2975-00-0 | Reference compound |
| HY-B0181R | Altretamine (Standard) | 645-05-6 | Reference Standards |
| HY-B0182 | Carmofur | 61422-45-5 | Reference compound |
| HY-B0182R | Carmofur (Standard) | 61422-45-5 | Reference Standards |
| HY-B0183 | Ellagic acid | 476-66-4 | Natural Products |
| HY-B0183A | Ellagic acid (hydrate) | 314041-08-2 | Natural Products |
| HY-B0183B | Ellagic acid (dihydrate) | 133039-73-3 | Biochemical Assay Reagents |
| HY-B0183R | Ellagic acid (Standard) | 476-66-4 | Reference Standards |
| HY-B0183S | Ellagic acid-13C12 | Isotope-Labeled Compounds | |
| HY-B0184 | Felbamate | 25451-15-4 | Reference compound |
| HY-B0184A | Felbamate (hydrate) | 1177501-39-1 | Reference compound |
| HY-B0184R | Felbamate (Standard) | 25451-15-4 | Reference Standards |
| HY-B0184S | Felbamate-d4 | 106817-52-1 | Isotope-Labeled Compounds |
| HY-B0184S1 | Felbamate-d5 | 1191888-51-3 | Isotope-Labeled Compounds |
| HY-B0185 | Lidocaine | 137-58-6 | Reference compound |
| HY-B0185A | Lidocaine (hydrochloride) | 73-78-9 | Reference compound |
| HY-B0185AS | Lidocaine-d10 (hydrochloride) | 1189959-13-4 | Isotope-Labeled Compounds |
| HY-B0185AS1 | Lidocaine-d6 (hydrochloride) | 2517378-96-8 | Isotope-Labeled Compounds |
| HY-B0185B | Lidocaine (hydrochloride hydrate) | 6108-05-0 | Reference compound |
| HY-B0185BR | Lidocaine (hydrochloride hydrate) (Standard) | 6108-05-0 | Reference Standards |
| HY-B0185G | Lidocaine (GMP) | 137-58-6 | GMP Small Molecules |
| HY-B0185R | Lidocaine (Standard) | 137-58-6 | Reference Standards |
| HY-B0185S | Lidocaine-d10 N-Oxide | 851528-10-4 | Isotope-Labeled Compounds |
| HY-B0185S1 | Lidocaine-d10 | 851528-09-1 | Isotope-Labeled Compounds |
| HY-B0185S2 | Lidocaine-d6 | 1215823-29-2 | Isotope-Labeled Compounds |
| HY-B0186 | Cefoselis | 122841-10-5 | Reference compound |
| HY-B0186A | Cefoselis (hydrochloride) | 911212-25-4 | Reference compound |
| HY-B0186B | Cefoselis (sulfate) | 122841-12-7 | Reference compound |
| HY-B0186BR | Cefoselis (sulfate) (Standard) | 122841-12-7 | Reference Standards |
| HY-B0187 | Doripenem | 148016-81-3 | Reference compound |
| HY-B0187A | Doripenem (monohydrate) | 364622-82-2 | Reference compound |
| HY-B0187AR | Doripenem (monohydrate) (Standard) | 364622-82-2 | Reference Standards |
| HY-B0188 | Mianserin | 24219-97-4 | Reference compound |
| HY-B0188A | Mianserin (hydrochloride) | 21535-47-7 | Natural Products |
| HY-B0188AR | Mianserin (hydrochloride) (Standard) | 21535-47-7 | Reference Standards |
| HY-B0188AS | Mianserin-d3 (hydrochloride) | 1219804-97-3 | Isotope-Labeled Compounds |
| HY-B0188S | Mianserin-d3 | 81957-76-8 | Isotope-Labeled Compounds |
| HY-B0189 | Mosapride | 112885-41-3 | Reference compound |
| HY-B0189A | Mosapride (citrate) | 112885-42-4 | Reference compound |
| HY-B0189B | Mosapride (citrate dihydrate) | 636582-62-2 | Reference compound |
| HY-B0189S1 | Mosapride-d5 | 1246820-66-5 | Isotope-Labeled Compounds |
| HY-B0190 | Nafamostat | 81525-10-2 | Reference compound |
| HY-B0190A | Nafamostat (mesylate) | 82956-11-4 | Reference compound |
| HY-B0190B | Nafamostat (hydrochloride) | 80251-32-7 | Reference compound |
| HY-B0190S1 | Nafamostat formate salt-13C6 | Isotope-Labeled Compounds | |
| HY-B0191 | Bimatoprost | 155206-00-1 | Reference compound |
| HY-B0191A | 5,6-trans-Bimatoprost | 1163135-95-2 | Reference compound |
| HY-B0191B | Bimatoprost methyl ester | 38315-47-8 | Reference compound |
| HY-B0191C | N-Desethyl Bimatoprost | 155205-89-3 | Reference compound |
| HY-B0191R | Bimatoprost (Standard) | 155206-00-1 | Reference Standards |
| HY-B0191S | Bimatoprost-d5 | Isotope-Labeled Compounds | |
| HY-B0191S1 | Bimatoprost-d4 | Isotope-Labeled Compounds | |
| HY-B0192 | Alfuzosin | 81403-80-7 | Reference compound |
| HY-B0192A | Alfuzosin (hydrochloride) | 81403-68-1 | Reference compound |
| HY-B0192AR | Alfuzosin (hydrochloride) (Standard) | 81403-68-1 | Reference Standards |
| HY-B0192AS | Alfuzosin-d3 (hydrochloride) | 1216383-97-9 | Isotope-Labeled Compounds |
| HY-B0192AS1 | Alfuzosin-d7 (hydrochloride) | 1276197-14-8 | Isotope-Labeled Compounds |
| HY-B0192S | Alfuzosin-d7 | 1133386-93-2 | Isotope-Labeled Compounds |
| HY-B0192S1 | Alfuzosin-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0192S2 | Alfuzosin-d3 | 1006724-55-5 | Isotope-Labeled Compounds |
| HY-B0192S3 | Alfuzosin-d6 | 1006717-31-2 | Isotope-Labeled Compounds |
| HY-B0192S3A | Alfuzosin (hydrochloride)-d6 | 1006717-24-3 | Isotope-Labeled Compounds |
| HY-B0193 | Prazosin | 19216-56-9 | Reference compound |
| HY-B0193A | Prazosin (hydrochloride) | 19237-84-4 | Reference compound |
| HY-B0193AR | Prazosin (hydrochloride) (Standard) | 19237-84-4 | Reference Standards |
| HY-B0193AS | Prazosin-d8 (hydrochloride) | 1189508-34-6 | Isotope-Labeled Compounds |
| HY-B0193R | Prazosin (Standard) | 19216-56-9 | Reference Standards |
| HY-B0193S | Prazosin-d8 | 1006717-55-0 | Isotope-Labeled Compounds |
| HY-B0194 | Tizanidine | 51322-75-9 | Reference compound |
| HY-B0194A | Tizanidine (hydrochloride) | 64461-82-1 | Reference compound |
| HY-B0194AR | Tizanidine (hydrochloride) (Standard) | 64461-82-1 | Reference Standards |
| HY-B0194AS | Tizanidine-d4 (hydrochloride) | 1188263-51-5 | Isotope-Labeled Compounds |
| HY-B0194R | Tizanidine (Standard) | 51322-75-9 | Reference Standards |
| HY-B0194S | Tizanidine-d4 | 1188331-19-2 | Isotope-Labeled Compounds |
| HY-B0195 | Tranilast | 53902-12-8 | Reference compound |
| HY-B0195A | Tranilast (sodium) | 104931-56-8 | Reference compound |
| HY-B0195R | Tranilast (Standard) | 53902-12-8 | Reference Standards |
| HY-B0196 | Venlafaxine | 93413-69-5 | Reference compound |
| HY-B0196A | Venlafaxine (hydrochloride) | 99300-78-4 | Reference compound |
| HY-B0196AR | Venlafaxine (hydrochloride) (Standard) | 99300-78-4 | Reference Standards |
| HY-B0196AS | Venlafaxine-d10 (hydrochloride) | 1216539-56-8 | Isotope-Labeled Compounds |
| HY-B0196AS1 | Venlafaxine-d6 (hydrochloride) | 1062606-12-5 | Isotope-Labeled Compounds |
| HY-B0196B | (S)-Venlafaxine | 93413-44-6 | Reference compound |
| HY-B0196S | Venlafaxine-d6 | 1020720-02-8 | Isotope-Labeled Compounds |
| HY-B0196S1 | Venlafaxine-d6-1 | 940297-06-3 | Isotope-Labeled Compounds |
| HY-B0196S2 | Venlafaxine-d4 | Isotope-Labeled Compounds | |
| HY-B0196S3 | Venlafaxine-d10 | 940297-16-5 | Isotope-Labeled Compounds |
| HY-B0197 | Naratriptan | 121679-13-8 | Reference compound |
| HY-B0197A | Naratriptan (hydrochloride) | 143388-64-1 | Reference compound |
| HY-B0197AR | Naratriptan (hydrochloride) (Standard) | 143388-64-1 | Reference Standards |
| HY-B0197AS | Naratriptan-d3 (hydrochloride) | 1190021-64-7 | Isotope-Labeled Compounds |
| HY-B0197S | Naratriptan-d3 | 1190043-69-6 | Isotope-Labeled Compounds |
| HY-B0198 | Cefaclor | 53994-73-3 | Reference compound |
| HY-B0198A | Cefaclor (monohydrate) | 70356-03-5 | Reference compound |
| HY-B0198AR | Cefaclor (monohydrate) (Standard) | 70356-03-5 | Reference Standards |
| HY-B0198R | Cefaclor (Standard) | 53994-73-3 | Reference Standards |
| HY-B0198S | Cefaclor-d5 | 1426173-90-1 | Isotope-Labeled Compounds |
| HY-B0199 | Mycophenolate Mofetil | 128794-94-5 | Reference compound |
| HY-B0199A | Mycophenolate mofetil (hydrochloride) | 116680-01-4 | Reference compound |
| HY-B0199AS | Mycophenolate Mofetil-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0199R | Mycophenolate Mofetil (Standard) | 128794-94-5 | Reference Standards |
| HY-B0199S | Mycophenolate Mofetil-d4 | 1132748-21-0 | Isotope-Labeled Compounds |
| HY-B0200 | Cephalexin | 15686-71-2 | Reference compound |
| HY-B0200A | Cephalexin (hydrochloride) | 59695-59-9 | Reference compound |
| HY-B0200AR | Cephalexin (hydrochloride) (Standard) | 59695-59-9 | Reference Standards |
| HY-B0200B | Cephalexin (monohydrate) | 23325-78-2 | Reference compound |
| HY-B0200BR | Cephalexin (monohydrate) (Standard) | 23325-78-2 | Reference Standards |
| HY-B0200BS | Cephalexin-d5 (monohydrate) | Isotope-Labeled Compounds | |
| HY-B0200C | Cephalexin (hydrochloride monohydrate) | 105879-42-3 | Reference compound |
| HY-B0200D | Cephalexin (lysine) | 53950-14-4 | Reference compound |
| HY-B0200R | Cephalexin (Standard) | 15686-71-2 | Reference Standards |
| HY-B0200S | Cephalexin-d5 | 2101505-56-8 | Isotope-Labeled Compounds |
| HY-B0202 | Irbesartan | 138402-11-6 | Reference compound |
| HY-B0202A | Irbesartan (hydrochloride) | 329055-23-4 | Reference compound |
| HY-B0202AS | Irbesartan-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0202R | Irbesartan (Standard) | 138402-11-6 | Reference Standards |
| HY-B0202S | Irbesartan-d4 | 1216883-23-6 | Isotope-Labeled Compounds |
| HY-B0202S1 | Irbesartan-d6 | Isotope-Labeled Compounds | |
| HY-B0202S2 | Irbesartan-d6-1 | 2375621-21-7 | Isotope-Labeled Compounds |
| HY-B0202S3 | Irbesartan-d7 | Isotope-Labeled Compounds | |
| HY-B0202S4 | Irbesartan-13C,d4 | Isotope-Labeled Compounds | |
| HY-B0203 | Nebivolol | 118457-14-0 | Reference compound |
| HY-B0203A | Nebivolol (hydrochloride) | 152520-56-4 | Reference compound |
| HY-B0203AR | Nebivolol (hydrochloride) (Standard) | 152520-56-4 | Reference Standards |
| HY-B0203B | (Rac)-Nebivolol | 99200-09-6 | Reference compound |
| HY-B0203BS1 | (rac)-Nebivolol-d4 | 1219407-55-2 | Isotope-Labeled Compounds |
| HY-B0203BS2 | (Rac)-Nebivolol-d2,15N | Isotope-Labeled Compounds | |
| HY-B0204 | Pimobendan | 74150-27-9 | Reference compound |
| HY-B0204A | Pimobendan (hydrochloride) | 77469-98-8 | Reference compound |
| HY-B0204B | (-)-Pimobendan | 118428-37-8 | Reference compound |
| HY-B0204R | Pimobendan (Standard) | 74150-27-9 | Reference Standards |
| HY-B0204S1 | Pimobendan-d3 | Isotope-Labeled Compounds | |
| HY-B0204S2 | Pimobendan-d4 | Isotope-Labeled Compounds | |
| HY-B0205 | Candesartan | 139481-59-7 | Reference compound |
| HY-B0205R | Candesartan (Standard) | 139481-59-7 | Reference Standards |
| HY-B0205S | Candesartan-d4 | 1346604-70-3 | Isotope-Labeled Compounds |
| HY-B0205S1 | Candesartan-d5 | 1189650-58-5 | Isotope-Labeled Compounds |
| HY-B0206 | Rizatriptan (benzoate) | 145202-66-0 | Reference compound |
| HY-B0206R | Rizatriptan (benzoate) (Standard) | 145202-66-0 | Reference Standards |
| HY-B0206S | Rizatriptan-d6 (benzoate) | 1216984-85-8 | Isotope-Labeled Compounds |
| HY-B0207A | Pyridostigmine (bromide) | 101-26-8 | Reference compound |
| HY-B0207AR | Pyridostigmine (bromide) (Standard) | 101-26-8 | Reference Standards |
| HY-B0207AS | Pyridostigmine-d6 (bromide) | 2375858-08-3 | Isotope-Labeled Compounds |
| HY-B0207AS1 | Pyridostigmine-d3 (bromide) | Isotope-Labeled Compounds | |
| HY-B0208 | Methimazole | 60-56-0 | Reference compound |
| HY-B0208R | Methimazole (Standard) | 60-56-0 | Reference Standards |
| HY-B0208S | Methimazole-d3 | 1160932-07-9 | Isotope-Labeled Compounds |
| HY-B0209 | Metolazone | 17560-51-9 | Reference compound |
| HY-B0209R | Metolazone (Standard) | 17560-51-9 | Reference Standards |
| HY-B0209S | Metolazone-d7 | 2714484-71-4 | Isotope-Labeled Compounds |
| HY-B0210 | Cefoperazone | 62893-19-0 | Reference compound |
| HY-B0210A | Cefoperazone (sodium salt) | 62893-20-3 | Reference compound |
| HY-B0210AR | Cefoperazone (sodium salt) (Standard) | 62893-20-3 | Reference Standards |
| HY-B0210C | Cefoperazone (dihydrate) | 113826-44-1 | Reference compound |
| HY-B0210R | Cefoperazone (Standard) | 62893-19-0 | Reference Standards |
| HY-B0210S | Cefoperazone-d5 | 2410425-70-4 | Isotope-Labeled Compounds |
| HY-B0211 | Riluzole | 1744-22-5 | Reference compound |
| HY-B0211A | Riluzole hydrochloride | 850608-87-6 | Reference compound |
| HY-B0211R | Riluzole (Standard) | 1744-22-5 | Reference Standards |
| HY-B0211S | Riluzole-13C,15N2 | 1215552-03-6 | Isotope-Labeled Compounds |
| HY-B0211S1 | Riluzole-13C6 | Isotope-Labeled Compounds | |
| HY-B0212 | Sulfapyridine | 144-83-2 | Reference compound |
| HY-B0212R | Sulfapyridine (Standard) | 144-83-2 | Reference Standards |
| HY-B0212S | Sulfapyridine-d4 | 1189863-86-2 | Isotope-Labeled Compounds |
| HY-B0213 | Sulfameter | 651-06-9 | Reference compound |
| HY-B0213R | Sulfameter (Standard) | 651-06-9 | Reference Standards |
| HY-B0213S | Sulfameter-d4 | 1189483-96-2 | Isotope-Labeled Compounds |
| HY-B0213S1 | Sulfameter-13C6 | Isotope-Labeled Compounds | |
| HY-B0214 | Prednisone | 53-03-2 | Reference compound |
| HY-B0214R | Prednisone (Standard) | 53-03-2 | Reference Standards |
| HY-B0214S | Prednisone-d8 | Isotope-Labeled Compounds | |
| HY-B0214S1 | Prednisone-d7 | Isotope-Labeled Compounds | |
| HY-B0214S2 | Prednisone-d4 | Isotope-Labeled Compounds | |
| HY-B0214S3 | Prednisone-13C2,d2 | Isotope-Labeled Compounds | |
| HY-B0215 | Acetylcysteine | 616-91-1 | Natural Products |
| HY-B0215A | Acetylcysteine (extracted from plants) | 616-91-1 | Reference compound |
| HY-B0215R | Acetylcysteine (Standard) | 616-91-1 | Reference Standards |
| HY-B0215S | Acetylcysteine-d3 | 131685-11-5 | Isotope-Labeled Compounds |
| HY-B0215S1 | Acetylcysteine-15N | Isotope-Labeled Compounds | |
| HY-B0216 | Ethinylestradiol | 57-63-6 | Natural Products |
| HY-B0216R | Ethinylestradiol (Standard) | 57-63-6 | Reference Standards |
| HY-B0216S | Ethynyl Estradiol-d4 | 350820-06-3 | Isotope-Labeled Compounds |
| HY-B0216S2 | Ethynyl Estradiol-13C2 | 2483735-63-1 | Isotope-Labeled Compounds |
| HY-B0217 | Nitazoxanide | 55981-09-4 | Reference compound |
| HY-B0217R | Nitazoxanide (Standard) | 55981-09-4 | Reference Standards |
| HY-B0217S | Nitazoxanide-d4 | 1246819-17-9 | Isotope-Labeled Compounds |
| HY-B0218 | Orlistat | 96829-58-2 | Reference compound |
| HY-B0218R | Orlistat (Standard) | 96829-58-2 | Reference Standards |
| HY-B0218S | Orlistat-d3 | 1356930-46-5 | Isotope-Labeled Compounds |
| HY-B0219 | Allopurinol | 315-30-0 | Reference compound |
| HY-B0219A | Allopurinol (sodium) | 17795-21-0 | Reference compound |
| HY-B0219R | Allopurinol (Standard) | 315-30-0 | Reference Standards |
| HY-B0219S | Allopurinol-d2 | 916979-34-5 | Isotope-Labeled Compounds |
| HY-B0220 | Erythromycin | 114-07-8 | Natural Products |
| HY-B0220A | Erythromycin lactobionate | 3847-29-8 | Reference compound |
| HY-B0220B | Erythromycin (gluceptate) | 23067-13-2 | Reference compound |
| HY-B0220C | Erythromycin (aspartate) | 30010-41-4 | Reference compound |
| HY-B0220D | Erythromycin (thiocyanate) | 7704-67-8 | Natural Products |
| HY-B0220DR | Erythromycin (thiocyanate) (Standard) | 7704-67-8 | Reference Standards |
| HY-B0220E | Erythromycin A (dihydrate) | 59319-72-1 | Reference compound |
| HY-B0220F | Erythromycin (glutamate) | 16667-03-1 | Reference compound |
| HY-B0220H | Erythromycin (hydrochloride) | 14271-02-4 | Reference compound |
| HY-B0220R | Erythromycin (Standard) | 114-07-8 | Reference Standards |
| HY-B0220S | Erythromycin-d6 | 959119-25-6 | Isotope-Labeled Compounds |
| HY-B0220S1 | Erythromycin-13C,d3 | 2378755-50-9 | Isotope-Labeled Compounds |
| HY-B0220S2 | Erythromycin-d3 | 959119-26-7 | Isotope-Labeled Compounds |
| HY-B0220S3 | Erythromycin-13C2 | 202114-52-1 | Isotope-Labeled Compounds |
| HY-B0221 | Amphotericin B | 1397-89-3 | Natural Products |
| HY-B0221A | Amphotericin B (trihydrate) | 1202017-46-6 | Natural Products |
| HY-B0221R | Amphotericin B (Standard) | 1397-89-3 | Reference Standards |
| HY-B0221S | Amphotericin B-13C6 | Isotope-Labeled Compounds | |
| HY-B0222 | 1-Docosanol | 661-19-8 | Natural Products |
| HY-B0222R | 1-Docosanol (Standard) | 661-19-8 | Reference Standards |
| HY-B0222S | 1-Docosanol-d45 | Isotope-Labeled Compounds | |
| HY-B0223 | Albendazole | 54965-21-8 | Reference compound |
| HY-B0223R | Albendazole (Standard) | 54965-21-8 | Reference Standards |
| HY-B0223S | Albendazole-d3 | 1353867-92-1 | Isotope-Labeled Compounds |
| HY-B0223S2 | Albendazole-d7 | 1287076-43-0 | Isotope-Labeled Compounds |
| HY-B0224 | Chlorothiazide | 58-94-6 | Reference compound |
| HY-B0224A | Chlorothiazide (sodium) | 7085-44-1 | Reference compound |
| HY-B0224R | Chlorothiazide (Standard) | 58-94-6 | Reference Standards |
| HY-B0224S | Chlorothiazide-13C,15N2 | 1189440-79-6 | Isotope-Labeled Compounds |
| HY-B0225 | Methyldopa | 555-30-6 | Natural Products |
| HY-B0225A | Methyldopa (hydrochloride) | 884-39-9 | Reference compound |
| HY-B0225AS | Methyldopa-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0225B | Methyldopa (hydrate) | 41372-08-1 | Reference compound |
| HY-B0225BR | Methyldopa (hydrate) (Standard) | 41372-08-1 | Reference Standards |
| HY-B0226 | Nitrofurazone | 59-87-0 | Reference compound |
| HY-B0226A | (E)-Nitrofurazone | 112574-44-4 | Reference compound |
| HY-B0226R | Nitrofurazone (Standard) | 59-87-0 | Reference Standards |
| HY-B0226S | Nitrofurazone-13C,15N2 | 1217220-85-3 | Isotope-Labeled Compounds |
| HY-B0227 | Ketoprofen | 22071-15-4 | Reference compound |
| HY-B0227A | Ketoprofen (lysinate) | 57469-78-0 | Reference compound |
| HY-B0227AR | Ketoprofen (lysinate) (Standard) | 57469-78-0 | Reference Standards |
| HY-B0227R | Ketoprofen (Standard) | 22071-15-4 | Reference Standards |
| HY-B0227S | Ketoprofen-d3 | 159490-55-8 | Isotope-Labeled Compounds |
| HY-B0227S1 | Ketoprofen-d4 | 1219805-29-4 | Isotope-Labeled Compounds |
| HY-B0227S2 | Ketoprofen-13C,d3 | 1189508-77-7 | Isotope-Labeled Compounds |
| HY-B0227S3 | Ketoprofen-13C6 | 1261392-46-4 | Isotope-Labeled Compounds |
| HY-B0228 | Adenosine | 58-61-7 | Natural Products |
| HY-B0228R | Adenosine (Standard) | 58-61-7 | Reference Standards |
| HY-B0228S | Adenosine-d1 | 109923-50-4 | Isotope-Labeled Compounds |
| HY-B0228S1 | Adenosine-13C5 | 159496-13-6 | Isotope-Labeled Compounds |
| HY-B0228S10 | (R)-3-Hydroxybutanoic acid-13C2 (sodium) | 202114-54-3 | Isotope-Labeled Compounds |
| HY-B0228S11 | Adenosine-15N5 | 168566-57-2 | Isotope-Labeled Compounds |
| HY-B0228S12 | Adenosine-d13 | Isotope-Labeled Compounds | |
| HY-B0228S13 | Adenosine-13C10 | 1887761-94-5 | Isotope-Labeled Compounds |
| HY-B0228S14 | Adenosine-d9 | Isotope-Labeled Compounds | |
| HY-B0228S2 | Adenosine-2′-13C | 714950-52-4 | Isotope-Labeled Compounds |
| HY-B0228S3 | Adenosine-3′-13C | 714950-53-5 | Isotope-Labeled Compounds |
| HY-B0228S4 | Adenosine-1′-13C | 201996-55-6 | Isotope-Labeled Compounds |
| HY-B0228S5 | Adenosine-13C | 54447-57-3 | Isotope-Labeled Compounds |
| HY-B0228S6 | Adenosine-d2 | 82741-17-1 | Isotope-Labeled Compounds |
| HY-B0228S7 | Adenosine-d1-1 | 119540-53-3 | Isotope-Labeled Compounds |
| HY-B0228S8 | Adenosine-d1-2 | Isotope-Labeled Compounds | |
| HY-B0229 | Zolmitriptan | 139264-17-8 | Reference compound |
| HY-B0229S | Zolmitriptan-d6 | 1217644-84-2 | Isotope-Labeled Compounds |
| HY-B0230 | Phenylbutazone | 50-33-9 | Reference compound |
| HY-B0230A | Thiazolinobutazone | 54749-86-9 | Reference compound |
| HY-B0230B | Pyrazinobutazone | 4985-25-5 | Reference compound |
| HY-B0230R | Phenylbutazone (Standard) | 50-33-9 | Reference Standards |
| HY-B0230S | Phenylbutazone(diphenyl-d10) | 1219794-69-0 | Isotope-Labeled Compounds |
| HY-B0230S1 | Phenylbutazone-d9 | 1189479-75-1 | Isotope-Labeled Compounds |
| HY-B0230S2 | Phenylbutazone-13C12 | 1325559-13-4 | Isotope-Labeled Compounds |
| HY-B0231 | Enalaprilat (dihydrate) | 84680-54-6 | Reference compound |
| HY-B0231A | Enalaprilat | 76420-72-9 | Reference compound |
| HY-B0231AS | Enalaprilat-d5 | 349554-00-3 | Isotope-Labeled Compounds |
| HY-B0231BS | Enalaprilat-d5 (sodium) | 1356922-29-6 | Isotope-Labeled Compounds |
| HY-B0231R | Enalaprilat (dihydrate) (Standard) | 84680-54-6 | Reference Standards |
| HY-B0232 | Dofetilide | 115256-11-6 | Reference compound |
| HY-B0232R | Dofetilide (Standard) | 115256-11-6 | Reference Standards |
| HY-B0232S | Dofetilide-d4 | 1189700-56-8 | Isotope-Labeled Compounds |
| HY-B0233 | Isradipine | 75695-93-1 | Reference compound |
| HY-B0233R | Isradipine (Standard) | 75695-93-1 | Reference Standards |
| HY-B0233S | Isradipine-d3 | 1189959-59-8 | Isotope-Labeled Compounds |
| HY-B0233S1 | Isradipine-d6 | 1261398-97-3 | Isotope-Labeled Compounds |
| HY-B0233S2 | Isradipine-d7 | Isotope-Labeled Compounds | |
| HY-B0234 | Estrone | 53-16-7 | Natural Products |
| HY-B0234R | Estrone (Standard) | 53-16-7 | Reference Standards |
| HY-B0234S | Estrone-13C3 | 1241684-29-6 | Isotope-Labeled Compounds |
| HY-B0234S1 | Estrone-d2 | 350820-16-5 | Isotope-Labeled Compounds |
| HY-B0234S2 | Estrone-d4 | 53866-34-5 | Isotope-Labeled Compounds |
| HY-B0234S3 | Estrone-13C2 | 82938-06-5 | Isotope-Labeled Compounds |
| HY-B0234S4 | Estrone-d2-1 | 56588-58-0 | Isotope-Labeled Compounds |
| HY-B0235 | Trichlormethiazide | 133-67-5 | Reference compound |
| HY-B0235A | Trichlormethiazide (sodium) | 91996-54-2 | Reference compound |
| HY-B0235R | Trichlormethiazide (Standard) | 133-67-5 | Reference Standards |
| HY-B0236 | 6-Aminocaproic acid | 60-32-2 | Natural Products |
| HY-B0236A | 6-Aminocaproic acid (hydrochloride) | 4321-58-8 | Reference compound |
| HY-B0236R | 6-Aminocaproic acid (Standard) | 60-32-2 | Reference Standards |
| HY-B0236S | 6-Aminocaproic acid-d6 | 1228656-08-3 | Isotope-Labeled Compounds |
| HY-B0236S1 | 6-Aminocaproic acid-d10 | 461432-51-9 | Isotope-Labeled Compounds |
| HY-B0237 | Aminoglutethimide | 125-84-8 | Reference compound |
| HY-B0238 | Amorolfine (hydrochloride) | 78613-38-4 | Reference compound |
| HY-B0238R | Amorolfine (hydrochloride) (Standard) | 78613-38-4 | Reference Standards |
| HY-B0239 | Chloramphenicol | 56-75-7 | Natural Products |
| HY-B0239R | Chloramphenicol (Standard) | 56-75-7 | Reference Standards |
| HY-B0239S | Chloramphenicol-d5 | 202480-68-0 | Isotope-Labeled Compounds |
| HY-B0239S1 | DL-threo-Chloramphenicol-d5 | 1420043-66-8 | Isotope-Labeled Compounds |
| HY-B0239S2 | Threo-Chloramphenicol-d6 | Isotope-Labeled Compounds | |
| HY-B0239S3 | Chloramphenicol-d4 | Isotope-Labeled Compounds | |
| HY-B0240 | Disulfiram | 97-77-8 | Reference compound |
| HY-B0240R | Disulfiram (Standard) | 97-77-8 | Reference Standards |
| HY-B0241 | Ipratropium (bromide) | 22254-24-6 | Reference compound |
| HY-B0241R | Ipratropium (bromide) (Standard) | 22254-24-6 | Reference Standards |
| HY-B0241S | Ipratropium-d3 (bromide) | Isotope-Labeled Compounds | |
| HY-B0241S1 | Ipratropium-d7 (bromide) | Isotope-Labeled Compounds | |
| HY-B0242 | Sulfanilamide | 63-74-1 | Reference compound |
| HY-B0242R | Sulfanilamide (Standard) | 63-74-1 | Reference Standards |
| HY-B0242S1 | Sulfanilamide-d4 | 77435-46-2 | Isotope-Labeled Compounds |
| HY-B0243 | Meprednisone | 1247-42-3 | Reference compound |
| HY-B0243R | Meprednisone (Standard) | 1247-42-3 | Reference Standards |
| HY-B0244 | Praziquantel | 55268-74-1 | Reference compound |
| HY-B0244R | Praziquantel (Standard) | 55268-74-1 | Reference Standards |
| HY-B0244S | Praziquantel-d11 | 1246343-36-1 | Isotope-Labeled Compounds |
| HY-B0245 | Busulfan | 55-98-1 | Reference compound |
| HY-B0245S | Busulfan-d8 | 116653-28-2 | Isotope-Labeled Compounds |
| HY-B0246 | Carbamazepine | 298-46-4 | Reference compound |
| HY-B0246R | Carbamazepine (Standard) | 298-46-4 | Reference Standards |
| HY-B0246S | Carbamazepine-d10 | 132183-78-9 | Isotope-Labeled Compounds |
| HY-B0246S1 | Carbamazepine-d2 | 1189902-21-3 | Isotope-Labeled Compounds |
| HY-B0246S2 | Carbamazepine-d8 | 1538624-35-9 | Isotope-Labeled Compounds |
| HY-B0246S3 | Carbamazepine-(Ph)d8 | Isotope-Labeled Compounds | |
| HY-B0246S4 | Carbamazepine-d4 | Isotope-Labeled Compounds | |
| HY-B0247 | Torsemide | 56211-40-6 | Reference compound |
| HY-B0247R | Torsemide (Standard) | 56211-40-6 | Reference Standards |
| HY-B0247S | Torsemide-d7 | 1189375-06-1 | Isotope-Labeled Compounds |
| HY-B0248 | Desonide | 638-94-8 | Reference compound |
| HY-B0248R | Desonide (Standard) | 638-94-8 | Reference Standards |
| HY-B0249 | Didanosine | 69655-05-6 | Oligonucleotides |
| HY-B0249R | Didanosine (Standard) | 69655-05-6 | Reference Standards |
| HY-B0249S | Didanosine-d2 | Isotope-Labeled Compounds | |
| HY-B0250 | Lamivudine | 134678-17-4 | Reference compound |
| HY-B0250A | Lamivudine (salicylate) | 173522-96-8 | Reference compound |
| HY-B0250R | Lamivudine (Standard) | 134678-17-4 | Reference Standards |
| HY-B0250S | Lamivudine-15N,d2 | Isotope-Labeled Compounds | |
| HY-B0250S1 | Lamivudine-13C,15N2,d2 | Isotope-Labeled Compounds | |
| HY-B0250S2 | Lamivudine-13C,15N3 | 1261394-64-2 | Isotope-Labeled Compounds |
| HY-B0251 | Eplerenone | 107724-20-9 | Reference compound |
| HY-B0251R | Eplerenone (Standard) | 107724-20-9 | Reference Standards |
| HY-B0251S | Eplerenone-d3 | Isotope-Labeled Compounds | |
| HY-B0251S1 | Eplerenone-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0252 | Hydrochlorothiazide | 58-93-5 | Reference compound |
| HY-B0252R | Hydrochlorothiazide (Standard) | 58-93-5 | Reference Standards |
| HY-B0252S | Hydrochlorothiazid-d2 | 1219798-89-6 | Isotope-Labeled Compounds |
| HY-B0252S1 | Hydrochlorothiazid-13C,d2 | 1190006-03-1 | Isotope-Labeled Compounds |
| HY-B0252S2 | Hydrochlorothiazide-13C6 | 1261396-79-5 | Isotope-Labeled Compounds |
| HY-B0252S3 | Hydrochlorothiazide-15N2,13C,d2 | 2140316-81-8 | Isotope-Labeled Compounds |
| HY-B0253 | Piroxicam | 36322-90-4 | Reference compound |
| HY-B0253A | Piroxicam (olamine) | 85056-47-9 | Reference compound |
| HY-B0253R | Piroxicam (Standard) | 36322-90-4 | Reference Standards |
| HY-B0253S | Piroxicam-d3 | 942047-64-5 | Isotope-Labeled Compounds |
| HY-B0253S1 | Piroxicam-d4 | Isotope-Labeled Compounds | |
| HY-B0254 | Glipizide | 29094-61-9 | Reference compound |
| HY-B0254R | Glipizide (Standard) | 29094-61-9 | Reference Standards |
| HY-B0254S | Glipizide-d11 | 1189426-07-0 | Isotope-Labeled Compounds |
| HY-B0255 | Adefovir dipivoxil | 142340-99-6 | Reference compound |
| HY-B0255R | Adefovir dipivoxil (Standard) | 142340-99-6 | Reference Standards |
| HY-B0256 | Azathioprine | 446-86-6 | Reference compound |
| HY-B0256A | Azathioprine (sodium) | 55774-33-9 | Reference compound |
| HY-B0256R | Azathioprine (Standard) | 446-86-6 | Reference Standards |
| HY-B0256S | Azathioprine-d3 | 2702733-53-5 | Isotope-Labeled Compounds |
| HY-B0256S1 | Azathioprine-13C4 | 1346600-71-2 | Isotope-Labeled Compounds |
| HY-B0257 | Levonorgestrel | 797-63-7 | Reference compound |
| HY-B0257A | Dydrogesterone | 152-62-5 | Reference compound |
| HY-B0257AR | Dydrogesterone (Standard) | 152-62-5 | Reference Standards |
| HY-B0257AS | Dydrogesterone-d6 | Isotope-Labeled Compounds | |
| HY-B0257R | Levonorgestrel (Standard) | 797-63-7 | Reference Standards |
| HY-B0257S | Levonorgestrel-d8 | Isotope-Labeled Compounds | |
| HY-B0257S1 | Norgestrel-d6 | 2376035-98-0 | Isotope-Labeled Compounds |
| HY-B0258 | Gemfibrozil | 25812-30-0 | Reference compound |
| HY-B0258R | Gemfibrozil (Standard) | 25812-30-0 | Reference Standards |
| HY-B0258S | Gemfibrozil-d6 | 1184986-45-5 | Isotope-Labeled Compounds |
| HY-B0258S1 | Gemfibrozil-d6-1 | 1160569-36-7 | Isotope-Labeled Compounds |
| HY-B0259 | Indapamide | 26807-65-8 | Reference compound |
| HY-B0259A | Indapamide (hemihydrate) | 180004-24-4 | Reference compound |
| HY-B0259R | Indapamide (Standard) | 26807-65-8 | Reference Standards |
| HY-B0259S | (rac)-Indapamide-d3 | 1217052-38-4 | Isotope-Labeled Compounds |
| HY-B0259S1 | Indapamide-13C,d3 | 2934053-07-1 | Isotope-Labeled Compounds |
| HY-B0259S3 | Indapamide-d6 | Isotope-Labeled Compounds | |
| HY-B0260 | Methylprednisolone | 83-43-2 | Reference compound |
| HY-B0260R | Methylprednisolone (Standard) | 83-43-2 | Reference Standards |
| HY-B0260S | Methylprednisolone-d3 | Isotope-Labeled Compounds | |
| HY-B0260S2 | Methylprednisolone-d4 | Isotope-Labeled Compounds | |
| HY-B0260S3 | Methylprednisolone-d7 | Isotope-Labeled Compounds | |
| HY-B0260S4 | Methylprednisolone-d2 | Isotope-Labeled Compounds | |
| HY-B0261 | Meloxicam | 71125-38-7 | Reference compound |
| HY-B0261A | Meloxicam (sodium) | 71125-39-8 | Reference compound |
| HY-B0261R | Meloxicam (Standard) | 71125-38-7 | Reference Standards |
| HY-B0261S | Meloxicam-d3 | 942047-63-4 | Isotope-Labeled Compounds |
| HY-B0261S1 | Meloxicam-d3-1 | 1227358-55-5 | Isotope-Labeled Compounds |
| HY-B0261S2 | Meloxicam-13C,d3 | 1309936-00-2 | Isotope-Labeled Compounds |
| HY-B0262 | Methocarbamol | 532-03-6 | Reference compound |
| HY-B0262R | Methocarbamol (Standard) | 532-03-6 | Reference Standards |
| HY-B0262S | Methocarbamol-d5 | 1189699-70-4 | Isotope-Labeled Compounds |
| HY-B0262S1 | Methocarbamol-d3 | 1346600-86-9 | Isotope-Labeled Compounds |
| HY-B0262S2 | Methocarbamol-13C,d3 | 2747917-88-8 | Isotope-Labeled Compounds |
| HY-B0263 | Thiabendazole | 148-79-8 | Reference compound |
| HY-B0263R | Thiabendazole (Standard) | 148-79-8 | Reference Standards |
| HY-B0263S | Thiabendazole-d4 | 1190007-20-5 | Isotope-Labeled Compounds |
| HY-B0263S1 | Thiabendazole-13C6 | 2140327-29-1 | Isotope-Labeled Compounds |
| HY-B0264 | Guaifenesin | 93-14-1 | Natural Products |
| HY-B0264R | Guaifenesin (Standard) | 93-14-1 | Reference Standards |
| HY-B0264S | Guaifenesin-d3 | 1189924-85-3 | Isotope-Labeled Compounds |
| HY-B0264S1 | Guaifenesin-d5 | 1329563-41-8 | Isotope-Labeled Compounds |
| HY-B0265 | Nimodipine | 66085-59-4 | Reference compound |
| HY-B0265R | Nimodipine (Standard) | 66085-59-4 | Reference Standards |
| HY-B0265S | Nimodipine-d7 | 1246815-36-0 | Isotope-Labeled Compounds |
| HY-B0266 | Gadodiamide (hydrate) | 122795-43-1 | Reference compound |
| HY-B0267 | Oxybutynin | 5633-20-5 | Reference compound |
| HY-B0267A | Oxybutynin (chloride) | 1508-65-2 | Reference compound |
| HY-B0267AR | Oxybutynin (chloride) (Standard) | 1508-65-2 | Reference Standards |
| HY-B0267AS | Oxybutynin-d11 (chloride) | 1185151-95-4 | Isotope-Labeled Compounds |
| HY-B0267B | (R)-Oxybutynin (hydrochloride) | 1207344-05-5 | Reference compound |
| HY-B0267BS | Oxybutynin-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0267C | (R)-Oxybutynin | 119618-21-2 | Reference compound |
| HY-B0267CS | (R)-Oxybutynin-d10 | 1189190-67-7 | Isotope-Labeled Compounds |
| HY-B0267R | Oxybutynin (Standard) | 5633-20-5 | Reference Standards |
| HY-B0268 | Enoxacin | 74011-58-8 | Reference compound |
| HY-B0268A | Enoxacin (hydrate) | 84294-96-2 | Reference compound |
| HY-B0268AR | Enoxacin (hydrate) (Standard) | 84294-96-2 | Reference Standards |
| HY-B0268R | Enoxacin (Standard) | 74011-58-8 | Reference Standards |
| HY-B0268S1 | Enoxacin-d8 (hydrochloride) | 2930288-95-0 | Isotope-Labeled Compounds |
| HY-B0268S2 | Enoxacin-d8 (hydrate) | Isotope-Labeled Compounds | |
| HY-B0269 | Rifapentine | 61379-65-5 | Reference compound |
| HY-B0269R | Rifapentine (Standard) | 61379-65-5 | Reference Standards |
| HY-B0269S | Rifapentine-d9 | Isotope-Labeled Compounds | |
| HY-B0270 | Suprofen | 40828-46-4 | Reference compound |
| HY-B0270R | Suprofen (Standard) | 40828-46-4 | Reference Standards |
| HY-B0271 | Pyrazinamide | 98-96-4 | Reference compound |
| HY-B0271R | Pyrazinamide (Standard) | 98-96-4 | Reference Standards |
| HY-B0271S | Pyrazinamide-d3 | 1432059-16-9 | Isotope-Labeled Compounds |
| HY-B0271S1 | Pyrazinamide-13C,15N | Isotope-Labeled Compounds | |
| HY-B0272 | Rifampicin | 13292-46-1 | Reference compound |
| HY-B0272R | Rifampicin (Standard) | 13292-46-1 | Reference Standards |
| HY-B0272S | Rifampicin-d3 | 1262052-36-7 | Isotope-Labeled Compounds |
| HY-B0272S1 | Rifampicin-d8 | Isotope-Labeled Compounds | |
| HY-B0272S2 | Rifampicin-d4 | Isotope-Labeled Compounds | |
| HY-B0272S3 | Rifampicin-d11 | Isotope-Labeled Compounds | |
| HY-B0273 | Sulfadiazine | 68-35-9 | Reference compound |
| HY-B0273A | Sulfadiazine (sodium) | 547-32-0 | Reference compound |
| HY-B0273AR | Sulfadiazine (sodium) (Standard) | 547-32-0 | Reference Standards |
| HY-B0273B | Sulfadiazine 100 µg/mL in methanol | 68-35-9 | Biochemical Assay Reagents |
| HY-B0273R | Sulfadiazine (Standard) | 68-35-9 | Reference Standards |
| HY-B0273S | Sulfadiazine-d4 | 1020719-78-1 | Isotope-Labeled Compounds |
| HY-B0273S1 | Sulfadiazine-13C6 | 1189426-16-1 | Isotope-Labeled Compounds |
| HY-B0274 | Chlorprothixene | 113-59-7 | Reference compound |
| HY-B0274A | Chlorprothixene (hydrochloride) | 6469-93-8 | Reference compound |
| HY-B0274AR | Chlorprothixene (hydrochloride) (Standard) | 6469-93-8 | Reference Standards |
| HY-B0274AS | Chlorprothixene-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0274CS | (E/Z)-Chlorprothixene-d6 (hydrochloride) | 1246832-91-6 | Isotope-Labeled Compounds |
| HY-B0274R | Chlorprothixene (Standard) | 113-59-7 | Reference Standards |
| HY-B0275 | Oxytetracycline | 79-57-2 | Natural Products |
| HY-B0275A | Oxytetracycline (hydrochloride) | 2058-46-0 | Natural Products |
| HY-B0275AR | Oxytetracycline (hydrochloride) (Standard) | 2058-46-0 | Reference Standards |
| HY-B0275B | Oxytetracycline (dihydrate) | 6153-64-6 | Natural Products |
| HY-B0275BR | Oxytetracycline (dihydrate) (Standard) | 6153-64-6 | Reference Standards |
| HY-B0275C | Oxytetracycline (calcium) | 7179-50-2 | Reference compound |
| HY-B0275R | Oxytetracycline (Standard) | 79-57-2 | Reference Standards |
| HY-B0275S | Oxytetracycline-d6 | Isotope-Labeled Compounds | |
| HY-B0275S1 | Oxytetracycline-d3 | Isotope-Labeled Compounds | |
| HY-B0276 | Ethionamide | 536-33-4 | Natural Products |
| HY-B0276A | Ethionamide (hydrochloride) | 3684-73-9 | Reference compound |
| HY-B0276R | Ethionamide (Standard) | 536-33-4 | Reference Standards |
| HY-B0276S | Ethionamide-d3 | Isotope-Labeled Compounds | |
| HY-B0277 | Vidarabine | 5536-17-4 | Natural Products |
| HY-B0277A | Vidarabine phosphate | 29984-33-6 | Reference compound |
| HY-B0277AR | Vidarabine phosphate (Standard) | 29984-33-6 | Reference Standards |
| HY-B0277R | Vidarabine (Standard) | 5536-17-4 | Reference Standards |
| HY-B0278 | Bacitracin (Zinc) | 1405-89-6 | Reference compound |
| HY-B0278R | Bacitracin (Zinc) (Standard) | 1405-89-6 | Reference Standards |
| HY-B0279 | Ramipril | 87333-19-5 | Reference compound |
| HY-B0279R | Ramipril (Standard) | 87333-19-5 | Reference Standards |
| HY-B0279S | Ramipril-d5 | 1132661-86-9 | Isotope-Labeled Compounds |
| HY-B0279S1 | Ramipril-d3 | 2673269-81-1 | Isotope-Labeled Compounds |
| HY-B0279S2 | Ramipril-d4 | 1132661-83-6 | Isotope-Labeled Compounds |
| HY-B0280 | Ranolazine | 95635-55-5 | Reference compound |
| HY-B0280R | Ranolazine (Standard) | 95635-55-5 | Reference Standards |
| HY-B0280S | Ranolazine-d5 | 1092804-87-9 | Isotope-Labeled Compounds |
| HY-B0280S1 | Ranolazine-d8 | 1092804-88-0 | Isotope-Labeled Compounds |
| HY-B0280S2 | Ranolazine-d3 | 1054624-77-9 | Isotope-Labeled Compounds |
| HY-B0281A | Ranitidine (hydrochloride) | 66357-59-3 | Reference compound |
| HY-B0281AR | Ranitidine (hydrochloride) (Standard) | 66357-59-3 | Reference Standards |
| HY-B0281AS | Ranitidine-d6 (hydrochloride) | 1185238-09-8 | Isotope-Labeled Compounds |
| HY-B0282 | Acetylcholine (chloride) | 60-31-1 | Natural Products |
| HY-B0282A | Acetylcholine (bromide) | 66-23-9 | Biochemical Assay Reagents |
| HY-B0282AS | Acetylcholine-d9 (bromide) | 93449-32-2 | Isotope-Labeled Compounds |
| HY-B0282AS1 | Acetylcholine-d4 (bromide) | 93449-31-1 | Isotope-Labeled Compounds |
| HY-B0282AS2 | Acetylcholine-d13 (bromide) | Isotope-Labeled Compounds | |
| HY-B0282AS3 | Acetylcholine-d16 (bromide) | 347841-43-4 | Isotope-Labeled Compounds |
| HY-B0282R | Acetylcholine (chloride) (Standard) | 60-31-1 | Reference Standards |
| HY-B0282S | Acetylcholine-d4 (chloride) | 344298-94-8 | Isotope-Labeled Compounds |
| HY-B0282S1 | Acetylcholine-d9 (chloride) | 344298-95-9 | Isotope-Labeled Compounds |
| HY-B0283 | Acipimox | 51037-30-0 | Reference compound |
| HY-B0283A | Acipimox (sodium) | 76958-97-9 | Reference compound |
| HY-B0283R | Acipimox (Standard) | 51037-30-0 | Reference Standards |
| HY-B0283S | Acipimox-d4 | 1246816-28-3 | Isotope-Labeled Compounds |
| HY-B0283S1 | Acipimox-13C2,15N2 | 2012598-41-1 | Isotope-Labeled Compounds |
| HY-B0284 | Nifedipine | 21829-25-4 | Reference compound |
| HY-B0284A | Nifedipine (hydrochloride) | 60299-11-8 | Reference compound |
| HY-B0284R | Nifedipine (Standard) | 21829-25-4 | Reference Standards |
| HY-B0284S | Nifedipine-d6 | 1188266-14-9 | Isotope-Labeled Compounds |
| HY-B0284S1 | Nifedipine-d4 | 1219798-99-8 | Isotope-Labeled Compounds |
| HY-B0284S2 | Nifedipine-13C8 | 1173023-46-5 | Isotope-Labeled Compounds |
| HY-B0285 | Amiloride | 2609-46-3 | Reference compound |
| HY-B0285A | Amiloride (hydrochloride) | 2016-88-8 | Reference compound |
| HY-B0285AR | Amiloride (hydrochloride) (Standard) | 2016-88-8 | Reference Standards |
| HY-B0285AS | Amiloride-15N3 (hydrochloride) | 1216796-18-7 | Isotope-Labeled Compounds |
| HY-B0285B | Amiloride hydrochloride dihydrate | 17440-83-4 | Reference compound |
| HY-B0285BR | Amiloride hydrochloride dihydrate (Standard) | 17440-83-4 | Reference Standards |
| HY-B0285S | Amiloride-15N3 | 1217169-93-1 | Isotope-Labeled Compounds |
| HY-B0286 | Chlorpheniramine | 132-22-9 | Reference compound |
| HY-B0286A | Chlorpheniramine (maleate) | 113-92-8 | Reference compound |
| HY-B0286AR | Chlorpheniramine (maleate) (Standard) | 113-92-8 | Reference Standards |
| HY-B0286AS | Chlorpheniramine-d4 (maleate) | 2747915-71-3 | Isotope-Labeled Compounds |
| HY-B0286R | Chlorpheniramine (Standard) | 132-22-9 | Reference Standards |
| HY-B0286S | Chlorpheniramine-d6 (maleate) | 1219806-45-7 | Isotope-Labeled Compounds |
| HY-B0286S1 | Chlorpheniramine-d4 | 1216414-56-0 | Isotope-Labeled Compounds |
| HY-B0286S2 | Chlorpheniramine-d6 | 1185054-60-7 | Isotope-Labeled Compounds |
| HY-B0287 | Clofibrate | 637-07-0 | Reference compound |
| HY-B0287R | Clofibrate (Standard) | 637-07-0 | Reference Standards |
| HY-B0287S | Clofibrate-d4 | 1189654-03-2 | Isotope-Labeled Compounds |
| HY-B0288A | Fenoprofen (Calcium) | 34597-40-5 | Reference compound |
| HY-B0288B | Fenoprofen (Calcium hydrate) | 71720-56-4 | Reference compound |
| HY-B0288BR | Fenoprofen (Calcium hydrate) (Standard) | 71720-56-4 | Reference Standards |
| HY-B0289 | Erdosteine | 84611-23-4 | Reference compound |
| HY-B0289R | Erdosteine (Standard) | 84611-23-4 | Reference Standards |
| HY-B0289S | Erdosteine-13C4 | Isotope-Labeled Compounds | |
| HY-B0289S2 | Erdosteine-d4 | Isotope-Labeled Compounds | |
| HY-B0290 | Pranlukast | 103177-37-3 | Reference compound |
| HY-B0290A | Pranlukast (hemihydrate) | 150821-03-7 | Reference compound |
| HY-B0290R | Pranlukast (Standard) | 103177-37-3 | Reference Standards |
| HY-B0290S1 | Pranlukast-d4 | 2713172-43-9 | Isotope-Labeled Compounds |
| HY-B0291 | Oxfendazole | 53716-50-0 | Reference compound |
| HY-B0291R | Oxfendazole (Standard) | 53716-50-0 | Reference Standards |
| HY-B0292 | Atracurium | 64228-79-1 | Reference compound |
| HY-B0292A | Atracurium (besylate) | 64228-81-5 | Reference compound |
| HY-B0292AR | Atracurium (besylate) (Standard) | 64228-81-5 | Reference Standards |
| HY-B0293 | Butoconazole (nitrate) | 64872-77-1 | Reference compound |
| HY-B0293A | Butoconazole | 64872-76-0 | Reference compound |
| HY-B0293R | Butoconazole (nitrate) (Standard) | 64872-77-1 | Reference Standards |
| HY-B0294 | Flubendazole | 31430-15-6 | Reference compound |
| HY-B0294R | Flubendazole (Standard) | 31430-15-6 | Reference Standards |
| HY-B0294S | Flubendazole-d3 | 1173021-08-3 | Isotope-Labeled Compounds |
| HY-B0295 | Chloroxine | 773-76-2 | Reference compound |
| HY-B0295R | Chloroxine (Standard) | 773-76-2 | Reference Standards |
| HY-B0298 | Clemastine | 15686-51-8 | Reference compound |
| HY-B0298A | Clemastine (fumarate) | 14976-57-9 | Reference compound |
| HY-B0298AR | Clemastine (fumarate) (Standard) | 14976-57-9 | Reference Standards |
| HY-B0298AS | Clemastine-d5 (fumarate) | Isotope-Labeled Compounds | |
| HY-B0299 | Oxibendazole | 20559-55-1 | Reference compound |
| HY-B0299R | Oxibendazole (Standard) | 20559-55-1 | Reference Standards |
| HY-B0300 | Penicillamine | 52-67-5 | Natural Products |
| HY-B0300R | Penicillamine (Standard) | 52-67-5 | Reference Standards |
| HY-B0300S | Penicillamine-d3 | 2925655-01-0 | Isotope-Labeled Compounds |
| HY-B0301 | Bifonazole | 60628-96-8 | Reference compound |
| HY-B0301R | Bifonazole (Standard) | 60628-96-8 | Reference Standards |
| HY-B0302 | Etidronic acid,60% in water | 2809-21-4 | Reference compound |
| HY-B0302A | Etidronic acid (disodium) | 7414-83-7 | Reference compound |
| HY-B0302AR | Etidronic acid (disodium) (Standard) | 7414-83-7 | Reference Standards |
| HY-B0302AS | Etidronic acid-d3 (disodium) | 358730-93-5 | Isotope-Labeled Compounds |
| HY-B0303 | Diphenhydramine | 58-73-1 | Reference compound |
| HY-B0303A | Diphenhydramine (hydrochloride) | 147-24-0 | Reference compound |
| HY-B0303AR | Diphenhydramine (hydrochloride) (Standard) | 147-24-0 | Reference Standards |
| HY-B0303AS | Diphenhydramine-d6 (hydrochloride) | 1189986-72-8 | Isotope-Labeled Compounds |
| HY-B0303AS1 | Diphenhydramine-d5 (hydrochloride) | 1219795-16-0 | Isotope-Labeled Compounds |
| HY-B0303R | Diphenhydramine (Standard) | 58-73-1 | Reference Standards |
| HY-B0304 | Dapoxetine | 119356-77-3 | Reference compound |
| HY-B0304A | Dapoxetine (hydrochloride) | 129938-20-1 | Reference compound |
| HY-B0304AR | Dapoxetine (hydrochloride) (Standard) | 129938-20-1 | Reference Standards |
| HY-B0304AS | Dapoxetine-d7 (hydrochloride) | 2699607-47-9 | Isotope-Labeled Compounds |
| HY-B0304AS1 | Dapoxetine-d6 (hydrochloride) | 1246814-76-5 | Isotope-Labeled Compounds |
| HY-B0304AS2 | (rac)-Dapoxetine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0304R | Dapoxetine (Standard) | 119356-77-3 | Reference Standards |
| HY-B0304S | Dapoxetine-d6 | 1132642-58-0 | Isotope-Labeled Compounds |
| HY-B0305 | Roxatidine acetate | 78628-28-1 | Reference compound |
| HY-B0305A | Roxatidine (Acetate Hydrochloride) | 93793-83-0 | Reference compound |
| HY-B0306 | Prothionamide | 14222-60-7 | Reference compound |
| HY-B0306R | Prothionamide (Standard) | 14222-60-7 | Reference Standards |
| HY-B0306S | Prothionamide-d5 | 1330261-26-1 | Isotope-Labeled Compounds |
| HY-B0307 | Idoxuridine | 54-42-2 | Reference compound |
| HY-B0307A | Idoxuridine (hydrate) | 17140-71-5 | Reference compound |
| HY-B0307R | Idoxuridine (Standard) | 54-42-2 | Reference Standards |
| HY-B0308 | Sparfloxacin | 110871-86-8 | Reference compound |
| HY-B0308R | Sparfloxacin (Standard) | 110871-86-8 | Reference Standards |
| HY-B0308S | Sparfloxacin-d5 | Isotope-Labeled Compounds | |
| HY-B0309 | Felodipine | 72509-76-3 | Reference compound |
| HY-B0309R | Felodipine (Standard) | 72509-76-3 | Reference Standards |
| HY-B0309S1 | Felodipine-d5 | 1242281-38-4 | Isotope-Labeled Compounds |
| HY-B0309S2 | Felodipine-d3 | 1219795-30-8 | Isotope-Labeled Compounds |
| HY-B0310 | Nizatidine | 76963-41-2 | Reference compound |
| HY-B0310R | Nizatidine (Standard) | 76963-41-2 | Reference Standards |
| HY-B0310S | Nizatidine-d3 | 1246833-99-7 | Isotope-Labeled Compounds |
| HY-B0311 | Carbidopa | 28860-95-9 | Reference compound |
| HY-B0311A | Carbidopa (monohydrate) | 38821-49-7 | Reference compound |
| HY-B0311AR | Carbidopa (monohydrate) (Standard) | 38821-49-7 | Reference Standards |
| HY-B0311AS | Carbidopa-d3 (monohydrate) | 1276197-58-0 | Isotope-Labeled Compounds |
| HY-B0311CS | (Rac)-Carbidopa-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0311CS1 | (Rac)-Carbidopa-d5 | 1185134-76-2 | Isotope-Labeled Compounds |
| HY-B0311D | Carbidopa (hydrochloride) | 65132-60-7 | Reference compound |
| HY-B0311S1 | Carbidopa-d3-1 | Isotope-Labeled Compounds | |
| HY-B0312 | Dipyridamole | 58-32-2 | Reference compound |
| HY-B0312R | Dipyridamole (Standard) | 58-32-2 | Reference Standards |
| HY-B0312S | Dipyridamole-d20 | 1189983-52-5 | Isotope-Labeled Compounds |
| HY-B0312S1 | Dipyridamole-d16 | Isotope-Labeled Compounds | |
| HY-B0313 | Hydroxyurea | 127-07-1 | Reference compound |
| HY-B0313R | Hydroxyurea (Standard) | 127-07-1 | Reference Standards |
| HY-B0314 | Talc | 14807-96-6 | Reference compound |
| HY-B0315 | Vitamin B12 | 68-19-9 | Natural Products |
| HY-B0315A | Biotin-Vitamin B12 | Dye Reagents | |
| HY-B0315B | Vitamin B12 (hydrate) | 194937-59-2 | Natural Products |
| HY-B0315R | Vitamin B12 (Standard) | 68-19-9 | Reference Standards |
| HY-B0315S | Vitamin B12-13C7 | Isotope-Labeled Compounds | |
| HY-B0316 | Avobenzone | 70356-09-1 | Reference compound |
| HY-B0316R | Avobenzone (Standard) | 70356-09-1 | Reference Standards |
| HY-B0316S | Avobenzone-13C,d3 | 2933758-47-3 | Isotope-Labeled Compounds |
| HY-B0316S1 | Avobenzone-d3 | 2518100-58-6 | Isotope-Labeled Compounds |
| HY-B0317 | Amlodipine | 88150-42-9 | Reference compound |
| HY-B0317A | Amlodipine (maleate) | 88150-47-4 | Reference compound |
| HY-B0317AR | Amlodipine (maleate) (Standard) | 88150-47-4 | Reference Standards |
| HY-B0317AS | Amlodipine-d4 (maleate) | 2714486-25-4 | Isotope-Labeled Compounds |
| HY-B0317AS1 | Amlodipine-d9 (maleate) | Isotope-Labeled Compounds | |
| HY-B0317B | Amlodipine (besylate) | 111470-99-6 | Reference compound |
| HY-B0317BR | Amlodipine (besylate) (Standard) | 111470-99-6 | Reference Standards |
| HY-B0317BS | Amlodipine-d4 (besylate) | Isotope-Labeled Compounds | |
| HY-B0317C | Amlodipine (mesylate) | 246852-12-0 | Reference compound |
| HY-B0317D | (R)-Amlodipine | 103129-81-3 | Reference compound |
| HY-B0317DR | (R)-Amlodipine (Standard) | 103129-81-3 | Reference Standards |
| HY-B0317DS | (R)-Amlodipine-d4 | 1346616-97-4 | Isotope-Labeled Compounds |
| HY-B0317F | Amlodipine (hydrochloride) | 246852-07-3 | Reference compound |
| HY-B0317R | Amlodipine (Standard) | 88150-42-9 | Reference Standards |
| HY-B0317S | Amlodipine-1,1,2,2-d4 (maleate) | 1185246-15-4 | Isotope-Labeled Compounds |
| HY-B0317S1 | Amlodipine-d4 | 1185246-14-3 | Isotope-Labeled Compounds |
| HY-B0318 | Metronidazole | 443-48-1 | Natural Products |
| HY-B0318A | Metronidazole (hydrochloride) | 69198-10-3 | Reference compound |
| HY-B0318AS | Metronidazole-d4 (hydrochloride) | 1261397-74-3 | Isotope-Labeled Compounds |
| HY-B0318R | Metronidazole (Standard) | 443-48-1 | Reference Standards |
| HY-B0318S | Metronidazole-13C2,15N2 | 1173020-03-5 | Isotope-Labeled Compounds |
| HY-B0318S1 | Metronidazole-d4 | 1261392-47-5 | Isotope-Labeled Compounds |
| HY-B0318S2 | Metronidazole-d3 | 83413-09-6 | Isotope-Labeled Compounds |
| HY-B0319 | Tioconazole | 65899-73-2 | Reference compound |
| HY-B0319R | Tioconazole (Standard) | 65899-73-2 | Reference Standards |
| HY-B0320A | Cromolyn (sodium) | 15826-37-6 | Reference compound |
| HY-B0320AR | Cromolyn (sodium) (Standard) | 15826-37-6 | Reference Standards |
| HY-B0321 | Tropicamide | 1508-75-4 | Isotope-Labeled Compounds |
| HY-B0321R | Tropicamide (Standard) | 1508-75-4 | Reference Standards |
| HY-B0321S | Tropicamide-d3 | 2673270-13-6 | Isotope-Labeled Compounds |
| HY-B0322 | Sulfamethoxazole | 723-46-6 | Reference compound |
| HY-B0322A | Sulfamethoxazole (sodium) | 4563-84-2 | Reference compound |
| HY-B0322AR | Sulfamethoxazole (sodium) (Standard) | 4563-84-2 | Reference Standards |
| HY-B0322B | Sulfamethoxazole 1000 µg/mL in methanol | 723-46-6 | Biochemical Assay Reagents |
| HY-B0322R | Sulfamethoxazole (Standard) | 723-46-6 | Reference Standards |
| HY-B0322S | Sulfamethoxazole-d4 | 1020719-86-1 | Isotope-Labeled Compounds |
| HY-B0322S1 | Sulfamethoxazole-13C6 | 1196157-90-0 | Isotope-Labeled Compounds |
| HY-B0323 | Sulfisoxazole | 127-69-5 | Reference compound |
| HY-B0323A | Sulfisoxazole (diethanolamine) | 4299-60-9 | Reference compound |
| HY-B0323C | Sulfisoxazole 100 µg/mL in methanol | 127-69-5 | Biochemical Assay Reagents |
| HY-B0323R | Sulfisoxazole (Standard) | 127-69-5 | Reference Standards |
| HY-B0324A | Crystal Violet | 548-62-9 | Dye Reagents |
| HY-B0324AS | Crystal Violet-d6 | 1266676-01-0 | Isotope-Labeled Compounds |
| HY-B0325 | Phenindione | 83-12-5 | Reference compound |
| HY-B0325R | Phenindione (Standard) | 83-12-5 | Reference Standards |
| HY-B0325S | Phenindione-d5 | 70711-53-4 | Isotope-Labeled Compounds |
| HY-B0326 | Alibendol | 26750-81-2 | Reference compound |
| HY-B0327 | Irsogladine | 57381-26-7 | Reference compound |
| HY-B0327A | Irsogladine (maleate) | 84504-69-8 | Reference compound |
| HY-B0328 | Triamcinolone | 124-94-7 | Natural Products |
| HY-B0328R | Triamcinolone (Standard) | 124-94-7 | Reference Standards |
| HY-B0329 | Isoniazid | 54-85-3 | Reference compound |
| HY-B0329R | Isoniazid (Standard) | 54-85-3 | Reference Standards |
| HY-B0329S | Isoniazid-d4 | 774596-24-6 | Isotope-Labeled Compounds |
| HY-B0330 | Levofloxacin | 100986-85-4 | Reference compound |
| HY-B0330A | Levofloxacin (hydrate) | 138199-71-0 | Reference compound |
| HY-B0330AR | Levofloxacin (hydrate) (Standard) | 138199-71-0 | Reference Standards |
| HY-B0330B | Levofloxacin (hydrochloride) | 177325-13-2 | Reference compound |
| HY-B0330BR | Levofloxacin (hydrochloride) (Standard) | 177325-13-2 | Reference Standards |
| HY-B0330BS | Levofloxacin-d8 (hydrochloride) | 2699607-50-4 | Isotope-Labeled Compounds |
| HY-B0330BS1 | Levofloxacin-d3 (hydrochloride) | 1173021-78-7 | Isotope-Labeled Compounds |
| HY-B0330C | Levofloxacin (sodium) | 872606-49-0 | Reference compound |
| HY-B0330D | (R)-Ofloxacin | 100986-86-5 | Reference compound |
| HY-B0330DR | (R)-Ofloxacin (Standard) | 100986-86-5 | Reference Standards |
| HY-B0330DS | (R)-Ofloxacin-d3 | 1346617-10-4 | Isotope-Labeled Compounds |
| HY-B0330R | Levofloxacin (Standard) | 100986-85-4 | Reference Standards |
| HY-B0330S | Levofloxacin-d8 | 1217716-71-6 | Isotope-Labeled Compounds |
| HY-B0330S1 | (S)-Ofloxacin-d3 | 2208780-63-4 | Isotope-Labeled Compounds |
| HY-B0330S2 | Levofloxacin-13C,d3 | 1261398-33-7 | Isotope-Labeled Compounds |
| HY-B0331 | Enalapril | 75847-73-3 | Reference compound |
| HY-B0331A | Enalapril (maleate) | 76095-16-4 | Reference compound |
| HY-B0331AR | Enalapril (maleate) (Standard) | 76095-16-4 | Reference Standards |
| HY-B0331AS | Enalapril-d5 (maleate) | 349554-02-5 | Isotope-Labeled Compounds |
| HY-B0331B | Enalapril (sodium) | 149404-21-7 | Reference compound |
| HY-B0331S1 | Enalapril-d3 | 1356847-94-3 | Isotope-Labeled Compounds |
| HY-B0332 | Menadione | 58-27-5 | Natural Products |
| HY-B0332R | Menadione (Standard) | 58-27-5 | Reference Standards |
| HY-B0332S | Menadione-d3 | 5172-16-7 | Isotope-Labeled Compounds |
| HY-B0333 | Sulfamethizole | 144-82-1 | Reference compound |
| HY-B0333R | Sulfamethizole (Standard) | 144-82-1 | Reference Standards |
| HY-B0333S | Sulfamethizole-d4 | Isotope-Labeled Compounds | |
| HY-B0333S2 | Sulfamethizole-d4-1 | 2470130-12-0 | Isotope-Labeled Compounds |
| HY-B0334 | Sulbactam | 68373-14-8 | Reference compound |
| HY-B0334A | Sulbactam (sodium) | 69388-84-7 | Reference compound |
| HY-B0334AR | Sulbactam (sodium) (Standard) | 69388-84-7 | Reference Standards |
| HY-B0334AS | Sulbactam-d5 (sodium) | 1322625-44-4 | Isotope-Labeled Compounds |
| HY-B0334AS1 | Sulbactam-d2 (sodium) | 948027-82-5 | Isotope-Labeled Compounds |
| HY-B0334R | Sulbactam (Standard) | 68373-14-8 | Reference Standards |
| HY-B0334S | Sulbactam-d3 | Isotope-Labeled Compounds | |
| HY-B0335 | Tolfenamic Acid | 13710-19-5 | Reference compound |
| HY-B0335R | Tolfenamic Acid (Standard) | 13710-19-5 | Reference Standards |
| HY-B0335S | Tolfenamic acid-d4 | 1246820-82-5 | Isotope-Labeled Compounds |
| HY-B0335S1 | Tolfenamic acid-13C6 | 1420043-61-3 | Isotope-Labeled Compounds |
| HY-B0336 | Pranoprofen | 52549-17-4 | Reference compound |
| HY-B0336R | Pranoprofen (Standard) | 52549-17-4 | Reference Standards |
| HY-B0337 | Sulfadimethoxine | 122-11-2 | Reference compound |
| HY-B0337A | Sulfadimethoxine (sodium) | 1037-50-9 | Reference compound |
| HY-B0337AR | Sulfadimethoxine (sodium) (Standard) | 1037-50-9 | Reference Standards |
| HY-B0337B | Sulfadimethoxine 1000 µg/mL in methanol | 122-11-2 | Biochemical Assay Reagents |
| HY-B0337R | Sulfadimethoxine (Standard) | 122-11-2 | Reference Standards |
| HY-B0337S | Sulfadimethoxine-d4 | 1020719-80-5 | Isotope-Labeled Compounds |
| HY-B0337S1 | Sulfadimethoxine-d6 | 73068-02-7 | Isotope-Labeled Compounds |
| HY-B0337S2 | Sulfadimethoxine-13C6 | 1334378-48-1 | Isotope-Labeled Compounds |
| HY-B0338 | Rimantadine | 13392-28-4 | Reference compound |
| HY-B0338A | Rimantadine (hydrochloride) | 1501-84-4 | Reference compound |
| HY-B0338AR | Rimantadine (hydrochloride) (Standard) | 1501-84-4 | Reference Standards |
| HY-B0338S | Rimantadine-d4 (hydrochloride) | 350818-67-6 | Isotope-Labeled Compounds |
| HY-B0339 | Primidone | 125-33-7 | Reference compound |
| HY-B0339R | Primidone (Standard) | 125-33-7 | Reference Standards |
| HY-B0339S | Primidone-d5 | 73738-06-4 | Isotope-Labeled Compounds |
| HY-B0340 | Nefiracetam | 77191-36-7 | Reference compound |
| HY-B0340R | Nefiracetam (Standard) | 77191-36-7 | Reference Standards |
| HY-B0341 | Nicorandil | 65141-46-0 | Reference compound |
| HY-B0341R | Nicorandil (Standard) | 65141-46-0 | Reference Standards |
| HY-B0341S | Nicorandil-d4 | 1132681-23-2 | Isotope-Labeled Compounds |
| HY-B0342 | Meglumine | 6284-40-8 | Reference compound |
| HY-B0342A | Meglumine (Excipient) | 6284-40-8 | Reference compound |
| HY-B0342R | Meglumine (Standard) | 6284-40-8 | Reference Standards |
| HY-B0343 | Sarafloxacin | 98105-99-8 | Reference compound |
| HY-B0343A | Sarafloxacin (hydrochloride) | 91296-87-6 | Reference compound |
| HY-B0343AR | Sarafloxacin (hydrochloride) (Standard) | 91296-87-6 | Reference Standards |
| HY-B0343AS | Sarafloxacin-d8 (hydrochloride) | 2733145-07-6 | Isotope-Labeled Compounds |
| HY-B0343BS | Sarafloxacin-d8 (hydrochloride trihydrate) | Isotope-Labeled Compounds | |
| HY-B0343C | Sarafloxacin (hydrochloride) 100 μg/mL in methanol | 91296-87-6 | Biochemical Assay Reagents |
| HY-B0343R | Sarafloxacin (Standard) | 98105-99-8 | Reference Standards |
| HY-B0343S | Sarafloxacin-d8 | 1352879-52-7 | Isotope-Labeled Compounds |
| HY-B0344 | Methscopolamine (bromide) | 155-41-9 | Reference compound |
| HY-B0345A | ATP (disodium salt) | 987-65-5 | Natural Products |
| HY-B0345AR | ATP (disodium) (Standard) | 987-65-5 | Reference Standards |
| HY-B0345AS | ATP-18O4 (disodium salt) | 2483830-61-9 | Isotope-Labeled Compounds |
| HY-B0346 | Propylthiouracil | 51-52-5 | Reference compound |
| HY-B0346R | Propylthiouracil (Standard) | 51-52-5 | Reference Standards |
| HY-B0346S | Propylthiouracil-d5 | 1189423-94-6 | Isotope-Labeled Compounds |
| HY-B0347 | Lacidipine | 103890-78-4 | Reference compound |
| HY-B0347R | Lacidipine (Standard) | 103890-78-4 | Reference Standards |
| HY-B0347S1 | Lacidipine-13C8 | 1261432-01-2 | Isotope-Labeled Compounds |
| HY-B0347S3 | Lacidipine-13C4 | Isotope-Labeled Compounds | |
| HY-B0348 | Liranaftate | 88678-31-3 | Reference compound |
| HY-B0348R | Liranaftate (Standard) | 88678-31-3 | Reference Standards |
| HY-B0349 | Meclizine (dihydrochloride) | 1104-22-9 | Reference compound |
| HY-B0349A | Meclizine | 569-65-3 | Reference compound |
| HY-B0349B | Meclizine (dihydrochloride monohydrate) | 31884-77-2 | Reference compound |
| HY-B0349R | Meclizine (dihydrochloride) (Standard) | 1104-22-9 | Reference Standards |
| HY-B0349S | Meclizine-d8 | 1246816-06-7 | Isotope-Labeled Compounds |
| HY-B0351 | Taurine | 107-35-7 | Natural Products |
| HY-B0351R | Taurine (Standard) | 107-35-7 | Reference Standards |
| HY-B0351S | Taurine-d4 | 342611-14-7 | Isotope-Labeled Compounds |
| HY-B0351S1 | Taurine-13C2 | 70155-54-3 | Isotope-Labeled Compounds |
| HY-B0351S2 | Taurine-13C2,15N | 2483830-42-6 | Isotope-Labeled Compounds |
| HY-B0352 | Mirtazapine | 85650-52-8 | Reference compound |
| HY-B0352A | (S)-Mirtazapine | 61337-87-9 | Reference compound |
| HY-B0352AS | (S)-Mirtazapine-d3 | Isotope-Labeled Compounds | |
| HY-B0352B | (R)-Mirtazapine | 61364-37-2 | Reference compound |
| HY-B0352BS | (R)-Mirtazapine-d3 | Isotope-Labeled Compounds | |
| HY-B0352R | Mirtazapine (Standard) | 85650-52-8 | Reference Standards |
| HY-B0352S | Mirtazapine-d3 | 1216678-68-0 | Isotope-Labeled Compounds |
| HY-B0352S2 | Mirtazapine-d4 | 1215898-55-7 | Isotope-Labeled Compounds |
| HY-B0352S3 | Mirtazapine-d4 (hydrochloride) | 1215587-73-7 | Isotope-Labeled Compounds |
| HY-B0353 | Chlormezanone | 80-77-3 | Reference compound |
| HY-B0353R | Chlormezanone (Standard) | 80-77-3 | Reference Standards |
| HY-B0354A | Urapidil (hydrochloride) | 64887-14-5 | Reference compound |
| HY-B0354AR | Urapidil (hydrochloride) (Standard) | 64887-14-5 | Reference Standards |
| HY-B0355 | Ginkgolide A | 15291-75-5 | Natural Products |
| HY-B0355R | Ginkgolide A (Standard) | 15291-75-5 | Reference Standards |
| HY-B0356 | Ciprofloxacin | 85721-33-1 | Reference compound |
| HY-B0356A | Ciprofloxacin (monohydrochloride) | 93107-08-5 | Reference compound |
| HY-B0356AR | Ciprofloxacin (monohydrochloride) (Standard) | 93107-08-5 | Reference Standards |
| HY-B0356AS | Ciprofloxacin-d8 (hydrochloride hydrate) | Isotope-Labeled Compounds | |
| HY-B0356AS1 | Ciprofloxacin-13C3,15N (monohydrochloride) | 2483830-12-0 | Isotope-Labeled Compounds |
| HY-B0356B | Ciprofloxacin (hydrochloride monohydrate) | 86393-32-0 | Reference compound |
| HY-B0356BR | Ciprofloxacin (hydrochloride monohydrate) (Standard) | 86393-32-0 | Reference Standards |
| HY-B0356BS | Ciprofloxacin-d8 (hydrochloride monohydrate) | Isotope-Labeled Compounds | |
| HY-B0356R | Ciprofloxacin (Standard) | 85721-33-1 | Reference Standards |
| HY-B0356S | Ciprofloxacin-d8 (hydrochloride) | 1216659-54-9 | Isotope-Labeled Compounds |
| HY-B0356S1 | Ciprofloxacin-d8 | 1130050-35-9 | Isotope-Labeled Compounds |
| HY-B0356S2 | Ciprofloxacin-d4 | Isotope-Labeled Compounds | |
| HY-B0357 | Diclazuril | 101831-37-2 | Reference compound |
| HY-B0357A | Diclazuril (potassium) | 112209-98-0 | Reference compound |
| HY-B0357B | Diclazuril (sodium) | 112209-99-1 | Reference compound |
| HY-B0357R | Diclazuril (Standard) | 101831-37-2 | Reference Standards |
| HY-B0357S | Diclazuril-d4 | 1632495-80-7 | Isotope-Labeled Compounds |
| HY-B0358 | Flunarizine | 52468-60-7 | Reference compound |
| HY-B0358A | Flunarizine (dihydrochloride) | 30484-77-6 | Reference compound |
| HY-B0358AR | Flunarizine (dihydrochloride) (Standard) | 30484-77-6 | Reference Standards |
| HY-B0358AS | Flunarizine-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B0358R | Flunarizine (Standard) | 52468-60-7 | Reference Standards |
| HY-B0359 | Fenticonazole (Nitrate) | 73151-29-8 | Reference compound |
| HY-B0359R | Fenticonazole (Nitrate) (Standard) | 73151-29-8 | Reference Standards |
| HY-B0360 | Rebamipide | 90098-04-7 | Reference compound |
| HY-B0360S | Rebamipide-d4 | 1219409-06-9 | Isotope-Labeled Compounds |
| HY-B0361 | Aspartame | 22839-47-0 | Peptides |
| HY-B0361R | Aspartame (Standard) | 22839-47-0 | Reference Standards |
| HY-B0361S | Aspartame-d3 | 1356841-28-5 | Isotope-Labeled Compounds |
| HY-B0361S1 | Aspartame-d5 | 1356849-17-6 | Isotope-Labeled Compounds |
| HY-B0362A | Phentolamine (mesylate) | 65-28-1 | Reference compound |
| HY-B0362AR | Phentolamine (mesylate) (Standard) | 65-28-1 | Reference Standards |
| HY-B0363 | Nimesulide | 51803-78-2 | Reference compound |
| HY-B0363R | Nimesulide (Standard) | 51803-78-2 | Reference Standards |
| HY-B0363S | Nimesulide-d5 | 1330180-22-7 | Isotope-Labeled Compounds |
| HY-B0363S1 | Nimesulide-13C6 | Isotope-Labeled Compounds | |
| HY-B0364A | Dyclonine (hydrochloride) | 536-43-6 | Reference compound |
| HY-B0364AR | Dyclonine (hydrochloride) (Standard) | 536-43-6 | Reference Standards |
| HY-B0364AS | Dyclonine-d9 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0365AS | Memantine-d6 (hydrochloride) | 1189713-18-5 | Isotope-Labeled Compounds |
| HY-B0366A | Cyproheptadine (hydrochloride) | 969-33-5 | Reference compound |
| HY-B0366AR | Cyproheptadine (hydrochloride) (Standard) | 969-33-5 | Reference Standards |
| HY-B0367 | Lornoxicam | 70374-39-9 | Natural Products |
| HY-B0367R | Lornoxicam (Standard) | 70374-39-9 | Reference Standards |
| HY-B0367S | Lornoxicam-d4 | 1216527-48-8 | Isotope-Labeled Compounds |
| HY-B0368 | Captopril | 62571-86-2 | Reference compound |
| HY-B0368A | Captopril (hydrochloride) | 198342-23-3 | Reference compound |
| HY-B0368C | epi-D-Captopril | 112243-88-6 | Reference compound |
| HY-B0368R | Captopril (Standard) | 62571-86-2 | Reference Standards |
| HY-B0368S | Captopril-d3 | 1356383-38-4 | Isotope-Labeled Compounds |
| HY-B0368S1 | Captopril-13C5,15N | Isotope-Labeled Compounds | |
| HY-B0369A | Orphenadrine (citrate) | 4682-36-4 | Reference compound |
| HY-B0369AR | Orphenadrine (citrate) (Standard) | 4682-36-4 | Reference Standards |
| HY-B0369AS | Orphenadrine-d3 (citrate) | Isotope-Labeled Compounds | |
| HY-B0370 | Tolnaftate | 2398-96-1 | Reference compound |
| HY-B0370R | Tolnaftate (Standard) | 2398-96-1 | Reference Standards |
| HY-B0370S | Tolnaftate-d7 | 1329835-64-4 | Isotope-Labeled Compounds |
| HY-B0371 | Terazosin | 63590-64-7 | Reference compound |
| HY-B0371A | Terazosin (hydrochloride dihydrate) | 70024-40-7 | Reference compound |
| HY-B0371AR | Terazosin (hydrochloride dihydrate) (Standard) | 70024-40-7 | Reference Standards |
| HY-B0371B | (R)-Terazosin | 109351-34-0 | Reference compound |
| HY-B0371D | (S)-Terazosin | 109351-33-9 | Reference compound |
| HY-B0371F | Terazosin (hydrochloride) | 63074-08-8 | Reference compound |
| HY-B0371FR | Terazosin (hydrochloride) (Standard) | 63074-08-8 | Reference Standards |
| HY-B0371S | Terazosin-d8 | 1006718-20-2 | Isotope-Labeled Compounds |
| HY-B0372 | Bromhexine | 3572-43-8 | Reference compound |
| HY-B0372A | Bromhexine (hydrochloride) | 611-75-6 | Reference compound |
| HY-B0372AR | Bromhexine (hydrochloride) (Standard) | 611-75-6 | Reference Standards |
| HY-B0372AS | Bromhexine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0373 | Tiopronin | 1953-02-2 | Natural Products |
| HY-B0373S | Tiopronin-13C,d3 | 1189695-13-3 | Isotope-Labeled Compounds |
| HY-B0373S1 | Tiopronin-d3 | 1189700-74-0 | Isotope-Labeled Compounds |
| HY-B0374 | Moxonidine | 75438-57-2 | Reference compound |
| HY-B0374A | Moxonidine (hydrochloride) | 75536-04-8 | Reference compound |
| HY-B0374AS | Moxonidine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0374R | Moxonidine (Standard) | 75438-57-2 | Reference Standards |
| HY-B0374S | Moxonidine-d4 | 1794811-52-1 | Isotope-Labeled Compounds |
| HY-B0374S1 | Moxonidine-d7 | Isotope-Labeled Compounds | |
| HY-B0374S2 | Moxonidine-d3 | Isotope-Labeled Compounds | |
| HY-B0375 | Argatroban | 74863-84-6 | Reference compound |
| HY-B0375A | Argatroban (monohydrate) | 141396-28-3 | Reference compound |
| HY-B0375AR | Argatroban (monohydrate) (Standard) | 141396-28-3 | Reference Standards |
| HY-B0375R | Argatroban (Standard) | 74863-84-6 | Reference Standards |
| HY-B0375S | Argatroban-d3 | 1356847-56-7 | Isotope-Labeled Compounds |
| HY-B0375S1 | Argatroban-13C6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0376 | Mecarbinate | 15574-49-9 | Reference compound |
| HY-B0377 | Famotidine | 76824-35-6 | Reference compound |
| HY-B0377G | Famotidine (GMP) | 76824-35-6 | GMP Small Molecules |
| HY-B0377R | Famotidine (Standard) | 76824-35-6 | Reference Standards |
| HY-B0377S | Famotidine-13C,d3 | 2744683-81-4 | Isotope-Labeled Compounds |
| HY-B0377S1 | Famotidine-13C | Isotope-Labeled Compounds | |
| HY-B0378A | Moexipril (hydrochloride) | 82586-52-5 | Reference compound |
| HY-B0378AR | Moexipril (hydrochloride) (Standard) | 82586-52-5 | Reference Standards |
| HY-B0378AS | Moexipril-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0379A | Adiphenine (hydrochloride) | 50-42-0 | Reference compound |
| HY-B0379AR | Adiphenine (hydrochloride) (Standard) | 50-42-0 | Reference Standards |
| HY-B0380 | Trimebutine | 39133-31-8 | Reference compound |
| HY-B0380A | Trimebutine (maleate) | 34140-59-5 | Reference compound |
| HY-B0380AR | Trimebutine (maleate) (Standard) | 34140-59-5 | Reference Standards |
| HY-B0380B | Trimebutine (3-TCBS) | 1456509-46-8 | Reference compound |
| HY-B0380R | Trimebutine (Standard) | 39133-31-8 | Reference Standards |
| HY-B0380S1 | Trimebutine-d5 (fumarate) | 2747915-18-8 | Isotope-Labeled Compounds |
| HY-B0380S2 | Trimebutine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0381 | Betaxolol | 63659-18-7 | Reference compound |
| HY-B0381A | Betaxolol (hydrochloride) | 63659-19-8 | Reference compound |
| HY-B0381AR | Betaxolol (hydrochloride) (Standard) | 63659-19-8 | Reference Standards |
| HY-B0381AS | Betaxolol-d7 (hydrochloride) | 1219802-92-2 | Isotope-Labeled Compounds |
| HY-B0381B | Levobetaxolol (hydrochloride) | 116209-55-3 | Reference compound |
| HY-B0381R | Betaxolol (Standard) | 63659-18-7 | Reference Standards |
| HY-B0381S | Betaxolol-d5 | 1189957-99-0 | Isotope-Labeled Compounds |
| HY-B0382 | Fosinopril (sodium) | 88889-14-9 | Reference compound |
| HY-B0382R | Fosinopril (sodium) (Standard) | 88889-14-9 | Reference Standards |
| HY-B0383 | Almotriptan (malate) | 181183-52-8 | Reference compound |
| HY-B0383A | Almotriptan | 154323-57-6 | Reference compound |
| HY-B0383AS2 | Almotriptan-d3 (benzoate) | Isotope-Labeled Compounds | |
| HY-B0383R | Almotriptan (malate) (Standard) | 181183-52-8 | Reference Standards |
| HY-B0384 | Temocapril (hydrochloride) | 110221-44-8 | Reference compound |
| HY-B0385 | Gabexate (mesylate) | 56974-61-9 | Reference compound |
| HY-B0385R | Gabexate (mesylate) (Standard) | 56974-61-9 | Reference Standards |
| HY-B0386 | Flunixin (meglumine) | 42461-84-7 | Reference compound |
| HY-B0386R | Flunixin (meglumine) (Standard) | 42461-84-7 | Reference Standards |
| HY-B0387 | Ibutilide (fumarate) | 122647-32-9 | Reference compound |
| HY-B0387A | Ibutilide | 122647-31-8 | Reference compound |
| HY-B0387R | Ibutilide (fumarate) (Standard) | 122647-32-9 | Reference Standards |
| HY-B0387S | Ibutilide-d5 (fumarate) | Isotope-Labeled Compounds | |
| HY-B0388 | Probucol | 23288-49-5 | Reference compound |
| HY-B0388R | Probucol (Standard) | 23288-49-5 | Reference Standards |
| HY-B0388S | Probucol-13C3 | 1173019-29-8 | Isotope-Labeled Compounds |
| HY-B0388S1 | Probucol-d6 | Isotope-Labeled Compounds | |
| HY-B0389 | D-Glucose | 50-99-7 | Natural Products |
| HY-B0389A | D-Glucose-13C6 | 110187-42-3 | Isotope-Labeled Compounds |
| HY-B0389F | Biotin-D-Glucose | Dye Reagents | |
| HY-B0389R | D-Glucose (Standard) | 50-99-7 | Reference Standards |
| HY-B0389S | D-Glucose-13C6,d7 | 201417-01-8 | Isotope-Labeled Compounds |
| HY-B0389S1 | D-Glucose-d1 | 56570-89-9 | Isotope-Labeled Compounds |
| HY-B0389S10 | D-Glucose-13C | 101615-88-7 | Isotope-Labeled Compounds |
| HY-B0389S11 | D-Glucose-13C-1 | 84270-10-0 | Isotope-Labeled Compounds |
| HY-B0389S12 | D-Glucose-13C-2 | 120388-24-1 | Isotope-Labeled Compounds |
| HY-B0389S13 | D-Glucose-13C-3 | 105931-74-6 | Isotope-Labeled Compounds |
| HY-B0389S14 | D-Glucose-13C2 | 201741-04-0 | Isotope-Labeled Compounds |
| HY-B0389S15 | D-Glucose-13C2-4 | 138079-87-5 | Isotope-Labeled Compounds |
| HY-B0389S16 | D-Glucose-13C-4 | 40762-22-9 | Isotope-Labeled Compounds |
| HY-B0389S17 | D-Glucose-13C-5 | 106032-62-6 | Isotope-Labeled Compounds |
| HY-B0389S18 | D-Glucose-13C3-1 | 478529-32-7 | Isotope-Labeled Compounds |
| HY-B0389S19 | D-Glucose-13C,d | 201136-45-0 | Isotope-Labeled Compounds |
| HY-B0389S2 | D-Glucose-d12-1 | 89798-27-6 | Isotope-Labeled Compounds |
| HY-B0389S20 | D-Glucose-13C,d-1 | 201417-06-3 | Isotope-Labeled Compounds |
| HY-B0389S21 | D-Glucose-13C,d2 | 478529-33-8 | Isotope-Labeled Compounds |
| HY-B0389S22 | D-Glucose-13C2,d2 | 157171-80-7 | Isotope-Labeled Compounds |
| HY-B0389S23 | D-Glucose-d2-1 | 478529-48-5 | Isotope-Labeled Compounds |
| HY-B0389S24 | D-Glucose-d4 | 478529-49-6 | Isotope-Labeled Compounds |
| HY-B0389S25 | D-Glucose-13C,d1 | 83379-46-8 | Isotope-Labeled Compounds |
| HY-B0389S26 | D-Glucose-d2-2 | 1009828-82-3 | Isotope-Labeled Compounds |
| HY-B0389S29 | D-Glucose-18O | 3343-70-2 | Isotope-Labeled Compounds |
| HY-B0389S3 | D-Glucose-d1-1 | 136864-16-9 | Isotope-Labeled Compounds |
| HY-B0389S30 | D-Glucose-18O-1 | Isotope-Labeled Compounds | |
| HY-B0389S31 | D-Glucose-18O-2 | Isotope-Labeled Compounds | |
| HY-B0389S32 | D-Glucose-18O-3 | Isotope-Labeled Compounds | |
| HY-B0389S4 | D-Glucose-d1-2 | 51517-59-0 | Isotope-Labeled Compounds |
| HY-B0389S5 | D-Glucose-d2 | 18991-62-3 | Isotope-Labeled Compounds |
| HY-B0389S6 | D-Glucose-d7 | 66034-51-3 | Isotope-Labeled Compounds |
| HY-B0389S7 | D-Glucose-d1-3 | 106032-60-4 | Isotope-Labeled Compounds |
| HY-B0389S8 | D-Glucose-d1-4 | 106032-61-5 | Isotope-Labeled Compounds |
| HY-B0389S9 | D-Glucose-13C3-2 | 478529-47-4 | Isotope-Labeled Compounds |
| HY-B0390 | Mestranol | 72-33-3 | Reference compound |
| HY-B0390R | Mestranol (Standard) | 72-33-3 | Reference Standards |
| HY-B0390S | Mestranol-d2 | Isotope-Labeled Compounds | |
| HY-B0390S1 | Mestranol-d4 | Isotope-Labeled Compounds | |
| HY-B0391 | Naftopidil | 57149-07-2 | Reference compound |
| HY-B0391A | Naftopidil (dihydrochloride) | 57149-08-3 | Reference compound |
| HY-B0391B | Naftopidil (hydrochloride) | 1164469-60-6 | Reference compound |
| HY-B0391R | Naftopidil (Standard) | 57149-07-2 | Reference Standards |
| HY-B0391S1 | Naftopidil-d5 | 2747918-58-5 | Isotope-Labeled Compounds |
| HY-B0391S2 | Naftopidil-d7 | Isotope-Labeled Compounds | |
| HY-B0392 | (S)-(+)-Rolipram | 85416-73-5 | Reference compound |
| HY-B0393 | Fudosteine | 13189-98-5 | Reference compound |
| HY-B0394 | Atropine (sulfate monohydrate) | 5908-99-6 | Natural Products |
| HY-B0394R | Atropine (sulfate monohydrate) (Standard) | 5908-99-6 | Reference Standards |
| HY-B0394S | Atropine-d5 | Isotope-Labeled Compounds | |
| HY-B0395 | Sitafloxacin | 127254-12-0 | Reference compound |
| HY-B0395A | Sitafloxacin (hydrochloride) | 346607-37-2 | Reference compound |
| HY-B0395B | Sitafloxacin (monohydrate) | 163253-37-0 | Reference compound |
| HY-B0395C | Sitafloxacin (hydrate) | 163253-35-8 | Reference compound |
| HY-B0395CR | Sitafloxacin (hydrate) (Standard) | 163253-35-8 | Reference Standards |
| HY-B0395D | (1R,2S,7R)-Sitafloxacin | 127254-10-8 | Reference compound |
| HY-B0395DS | (1R,2S,7R)-Sitafloxacin-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0395S | Sitafloxacin-d4 | Isotope-Labeled Compounds | |
| HY-B0396 | Tebipenem pivoxil | 161715-24-8 | Reference compound |
| HY-B0396A | Tebipenem pivoxil (hydrochloride) | 211558-19-9 | Reference compound |
| HY-B0396R | Tebipenem pivoxil (Standard) | 161715-24-8 | Reference Standards |
| HY-B0397 | Dichlorphenamide | 120-97-8 | Reference compound |
| HY-B0397A | Dichlorphenamide (disodium) | 76382-13-3 | Reference compound |
| HY-B0397R | Dichlorphenamide (Standard) | 120-97-8 | Reference Standards |
| HY-B0398 | Nalidixic acid | 389-08-2 | Natural Products |
| HY-B0398A | Nalidixic acid (sodium salt) | 3374-05-8 | Reference compound |
| HY-B0398AR | Nalidixic acid (sodium salt) (Standard) | 3374-05-8 | Reference Standards |
| HY-B0398R | Nalidixic acid (Standard) | 389-08-2 | Reference Standards |
| HY-B0398S | Nalidixic Acid-d5 | 1189467-36-4 | Isotope-Labeled Compounds |
| HY-B0399 | L-Carnitine | 541-15-1 | Natural Products |
| HY-B0399A | DL-Carnitine | 406-76-8 | Natural Products |
| HY-B0399G | L-Carnitine (GMP) | 541-15-1 | GMP Small Molecules |
| HY-B0399R | L-Carnitine (Standard) | 541-15-1 | Reference Standards |
| HY-B0399S | L-Carnitine-d9 | 126827-79-0 | Isotope-Labeled Compounds |
| HY-B0400 | D-Sorbitol | 50-70-4 | Natural Products |
| HY-B0400A | L-Sorbitol | 6706-59-8 | Biochemical Assay Reagents |
| HY-B0400AS | L-Sorbitol-13C | Isotope-Labeled Compounds | |
| HY-B0400AS1 | L-Sorbitol-13C-1 | Isotope-Labeled Compounds | |
| HY-B0400B | D-Sorbitol, for cell culture | 50-70-4 | Biochemical Assay Reagents |
| HY-B0400BR | D-Sorbitol, for cell culture (Standard) | 50-70-4 | Reference Standards |
| HY-B0400C | D-Sorbitol, M150 (Excipient) | 50-70-4 | Reference compound |
| HY-B0400D | D-Sorbitol, M200 (Excipient) | 50-70-4 | Reference compound |
| HY-B0400E | D-Sorbitol, M400 (Excipient) | 50-70-4 | Reference compound |
| HY-B0400R | D-Sorbitol (Standard) | 50-70-4 | Reference Standards |
| HY-B0400S | D-Sorbitol-d8 | 287962-59-8 | Isotope-Labeled Compounds |
| HY-B0400S1 | D-Sorbitol-13C | 287100-73-6 | Isotope-Labeled Compounds |
| HY-B0400S10 | D-Sorbitol-d4 | 2714472-87-2 | Isotope-Labeled Compounds |
| HY-B0400S15 | D-Sorbitol-18O-1 | Isotope-Labeled Compounds | |
| HY-B0400S16 | D-Sorbitol-13C6 | 121067-66-1 | Isotope-Labeled Compounds |
| HY-B0400S2 | D-Sorbitol-13C-1 | Isotope-Labeled Compounds | |
| HY-B0400S3 | D-Sorbitol-13C-2 | Isotope-Labeled Compounds | |
| HY-B0400S4 | D-Sorbitol-d2 | 1931877-15-4 | Isotope-Labeled Compounds |
| HY-B0400S7 | D-Sorbitol-d1-2 | 1931877-16-5 | Isotope-Labeled Compounds |
| HY-B0400S8 | D-Sorbitol-d2-1 | 2714432-33-2 | Isotope-Labeled Compounds |
| HY-B0400S9 | D-Sorbitol-d2-2 | 1931877-14-3 | Isotope-Labeled Compounds |
| HY-B0401 | Tolbutamide | 64-77-7 | Reference compound |
| HY-B0401A | Tolbutamide (sodium) | 473-41-6 | Reference compound |
| HY-B0401R | Tolbutamide (Standard) | 64-77-7 | Reference Standards |
| HY-B0401S | Tolbutamide-d9 | 1219794-57-6 | Isotope-Labeled Compounds |
| HY-B0401S1 | Tolbutamide-13C | Isotope-Labeled Compounds | |
| HY-B0402 | Amantadine | 768-94-5 | Reference compound |
| HY-B0402A | Amantadine (hydrochloride) | 665-66-7 | Reference compound |
| HY-B0402AR | Amantadine (hydrochloride) (Standard) | 665-66-7 | Reference Standards |
| HY-B0402B | Amantadine (sulfate) | 31377-23-8 | Reference compound |
| HY-B0402R | Amantadine (Standard) | 768-94-5 | Reference Standards |
| HY-B0402S | Amantadine-d15 | 33830-10-3 | Isotope-Labeled Compounds |
| HY-B0402S1 | Amantadine-d6 | 1219805-53-4 | Isotope-Labeled Compounds |
| HY-B0404A | Benserazide (hydrochloride) | 14919-77-8 | Reference compound |
| HY-B0404AR | Benserazide (hydrochloride) (Standard) | 14919-77-8 | Reference Standards |
| HY-B0404AS | Benserazide-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0405 | Bupivacaine | 38396-39-3 | Reference compound |
| HY-B0405A | Bupivacaine (hydrochloride) | 18010-40-7 | Reference compound |
| HY-B0405AR | Bupivacaine (hydrochloride) (Standard) | 18010-40-7 | Reference Standards |
| HY-B0405S | Bupivacaine-d9 | 474668-57-0 | Isotope-Labeled Compounds |
| HY-B0406 | Bethanechol | 674-38-4 | Reference compound |
| HY-B0406A | Bethanechol (chloride) | 590-63-6 | Reference compound |
| HY-B0406AS | Bethanechol-d6 (chloride) | Isotope-Labeled Compounds | |
| HY-B0407A | Chlorpromazine (hydrochloride) | 69-09-0 | Reference compound |
| HY-B0407AR | Chlorpromazine (hydrochloride) (Standard) | 69-09-0 | Reference Standards |
| HY-B0407AS | Chlorpromazine-d6 (hydrochloride) | 1228182-46-4 | Isotope-Labeled Compounds |
| HY-B0408A | Clindamycin (hydrochloride) | 21462-39-5 | Reference compound |
| HY-B0408AR | Clindamycin (hydrochloride) (Standard) | 21462-39-5 | Reference Standards |
| HY-B0409A | Clonidine (hydrochloride) | 4205-91-8 | Reference compound |
| HY-B0409AR | Clonidine (hydrochloride) (Standard) | 4205-91-8 | Reference Standards |
| HY-B0409S | Clonidine-d4 | 62497-68-1 | Isotope-Labeled Compounds |
| HY-B0410 | Pramipexole | 104632-26-0 | Reference compound |
| HY-B0410A | Pramipexole (dihydrochloride hydrate) | 191217-81-9 | Reference compound |
| HY-B0410AR | Pramipexole (dihydrochloride hydrate) (Standard) | 191217-81-9 | Reference Standards |
| HY-B0410R | Pramipexole (Standard) | 104632-26-0 | Reference Standards |
| HY-B0410S1 | Pramipexole-d5 | 1217975-28-4 | Isotope-Labeled Compounds |
| HY-B0411 | Domperidone | 57808-66-9 | Reference compound |
| HY-B0411A | Domperidone (monomaleate) | 83898-65-1 | Reference compound |
| HY-B0411AR | Domperidone (monomaleate) (Standard) | 83898-65-1 | Reference Standards |
| HY-B0411R | Domperidone (Standard) | 57808-66-9 | Reference Standards |
| HY-B0411S | Domperidone-d6 | 1329614-18-7 | Isotope-Labeled Compounds |
| HY-B0411S2 | Domperidone-13C6 | Isotope-Labeled Compounds | |
| HY-B0412 | Estriol | 50-27-1 | Natural Products |
| HY-B0412R | Estriol (Standard) | 50-27-1 | Reference Standards |
| HY-B0412S | Estriol-d2 | 53866-32-3 | Isotope-Labeled Compounds |
| HY-B0412S1 | Estriol-d1 | 55727-98-5 | Isotope-Labeled Compounds |
| HY-B0412S2 | Estriol-d3 | 79037-36-8 | Isotope-Labeled Compounds |
| HY-B0412S3 | Estriol-13C3 | 1255639-56-5 | Isotope-Labeled Compounds |
| HY-B0412S4 | Estriol-d3-1 | 2687960-79-6 | Isotope-Labeled Compounds |
| HY-B0413 | Fenbendazole | 43210-67-9 | Reference compound |
| HY-B0413R | Fenbendazole (Standard) | 43210-67-9 | Reference Standards |
| HY-B0413S | Fenbendazole-d3 | 1228182-47-5 | Isotope-Labeled Compounds |
| HY-B0414 | Fleroxacin | 79660-72-3 | Reference compound |
| HY-B0414AS | Fleroxacin-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0414R | Fleroxacin (Standard) | 79660-72-3 | Reference Standards |
| HY-B0415 | Fluocinolone (Acetonide) | 67-73-2 | Reference compound |
| HY-B0415R | Fluocinolone (Acetonide) (Standard) | 67-73-2 | Reference Standards |
| HY-B0416 | Gallamine Triethiodide | 65-29-2 | Reference compound |
| HY-B0416R | Gallamine Triethiodide (Standard) | 65-29-2 | Reference Standards |
| HY-B0417A | Lincomycin (hydrochloride) | 859-18-7 | Natural Products |
| HY-B0417AR | Lincomycin (hydrochloride) (Standard) | 859-18-7 | Reference Standards |
| HY-B0418A | Loperamide (hydrochloride) | 34552-83-5 | Reference compound |
| HY-B0418AR | Loperamide (hydrochloride) (Standard) | 34552-83-5 | Reference Standards |
| HY-B0418AS | Loperamide-d6 (hydrochloride) | 1189469-46-2 | Isotope-Labeled Compounds |
| HY-B0419 | Manidipine | 89226-50-6 | Reference compound |
| HY-B0419S | Manidipine-d4 | 1189656-59-4 | Isotope-Labeled Compounds |
| HY-B0420A | Moroxydine (hydrochloride) | 3160-91-6 | Reference compound |
| HY-B0420AR | Moroxydine (hydrochloride) (Standard) | 3160-91-6 | Reference Standards |
| HY-B0421 | Mycophenolic acid | 24280-93-1 | Natural Products |
| HY-B0421A | Mycophenolic acid (sodium) | 37415-62-6 | Reference compound |
| HY-B0421AR | Mycophenolic acid (sodium) (Standard) | 37415-62-6 | Reference Standards |
| HY-B0421R | Mycophenolic acid (Standard) | 24280-93-1 | Reference Standards |
| HY-B0421S | Mycophenolic acid-d3 | 1185242-90-3 | Isotope-Labeled Compounds |
| HY-B0421S2 | Mycophenolic acid-13C17 | 1202866-92-9 | Isotope-Labeled Compounds |
| HY-B0422 | Nateglinide | 105816-04-4 | Reference compound |
| HY-B0422R | Nateglinide (Standard) | 105816-04-4 | Reference Standards |
| HY-B0422S | Nateglinide-d5 | 1227666-13-8 | Isotope-Labeled Compounds |
| HY-B0423 | Neostigmine (Bromide) | 114-80-7 | Reference compound |
| HY-B0423R | Neostigmine (Bromide) (Standard) | 114-80-7 | Reference Standards |
| HY-B0424 | Nitrendipine | 39562-70-4 | Reference compound |
| HY-B0424R | Nitrendipine (Standard) | 39562-70-4 | Reference Standards |
| HY-B0424S | Nitrendipine-d5 | 2469554-26-3 | Isotope-Labeled Compounds |
| HY-B0425 | Novobiocin | 303-81-1 | Natural Products |
| HY-B0425A | Novobiocin (sodium) | 1476-53-5 | Natural Products |
| HY-B0426A | Olopatadine (hydrochloride) | 140462-76-6 | Reference compound |
| HY-B0426AR | Olopatadine (hydrochloride) (Standard) | 140462-76-6 | Reference Standards |
| HY-B0426AS | Olopatadine-d3 (hydrochloride) | 1331635-21-2 | Isotope-Labeled Compounds |
| HY-B0426AS1 | (Z)-Olopatadine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0426AS2 | Olopatadine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0428 | Ozagrel | 82571-53-7 | Reference compound |
| HY-B0428A | Ozagrel (sodium) | 189224-26-8 | Reference compound |
| HY-B0428B | Ozagrel (hydrochloride) | 78712-43-3 | Reference compound |
| HY-B0428BR | Ozagrel (hydrochloride) (Standard) | 78712-43-3 | Reference Standards |
| HY-B0428D | (E/Z)-Ozagrel (sodium) | 130952-46-4 | Reference compound |
| HY-B0429 | Pancuronium (dibromide) | 15500-66-0 | Reference compound |
| HY-B0429R | Pancuronium (dibromide) (Standard) | 15500-66-0 | Reference Standards |
| HY-B0430 | D-Pantothenic acid | 79-83-4 | Natural Products |
| HY-B0430A | D-Pantothenic acid (sodium) | 867-81-2 | Reference compound |
| HY-B0430AR | D-Pantothenic acid (sodium) (Standard) | 867-81-2 | Reference Standards |
| HY-B0430B | (±)-Pantothenic acid | 599-54-2 | Reference compound |
| HY-B0430S | Pantothenic acid-13C3,15N (hemicalcium) | 356786-94-2 | Isotope-Labeled Compounds |
| HY-B0431 | Phenoxybenzamine | 59-96-1 | Reference compound |
| HY-B0431A | Phenoxybenzamine (hydrochloride) | 63-92-3 | Reference compound |
| HY-B0431AR | Phenoxybenzamine (hydrochloride) (Standard) | 63-92-3 | Reference Standards |
| HY-B0431AS | Phenoxybenzamine-d5 (hydrochloride) | 1329838-45-0 | Isotope-Labeled Compounds |
| HY-B0431AS1 | Phenoxybenzamine (benzyl-2,3,4,5,6-d5) (hydrochloride) | 1398065-71-8 | Isotope-Labeled Compounds |
| HY-B0431S | Phenoxybenzamine-d5 | 1309283-11-1 | Isotope-Labeled Compounds |
| HY-B0432 | Propafenone | 54063-53-5 | Reference compound |
| HY-B0432A | Propafenone (hydrochloride) | 34183-22-7 | Reference compound |
| HY-B0432AR | Propafenone (hydrochloride) (Standard) | 34183-22-7 | Reference Standards |
| HY-B0432AS | Propafenone-d7 (hydrochloride) | 1219799-06-0 | Isotope-Labeled Compounds |
| HY-B0432AS2 | Propafenone-d5 (hydrochloride) | 1346605-05-7 | Isotope-Labeled Compounds |
| HY-B0432AS3 | Propafenone-d5 (hydrochloride)(Ethyl) | 1398066-02-8 | Isotope-Labeled Compounds |
| HY-B0432AS4 | Propafenone-(phenyl-d5) (hydrochloride) | 93909-48-9 | Isotope-Labeled Compounds |
| HY-B0432B | (S)-Propafenone | 107381-32-8 | Reference compound |
| HY-B0432R | Propafenone (Standard) | 54063-53-5 | Reference Standards |
| HY-B0433A | Quinine (hydrochloride dihydrate) | 6119-47-7 | Natural Products |
| HY-B0433AR | Quinine (hydrochloride dihydrate) (Standard) | 6119-47-7 | Reference Standards |
| HY-B0433B | Quinine (hemisulfate) | 804-63-7 | Natural Products |
| HY-B0434 | Ribavirin | 36791-04-5 | Reference compound |
| HY-B0434G | Ribavirin (GMP) | 36791-04-5 | GMP Small Molecules |
| HY-B0434R | Ribavirin (Standard) | 36791-04-5 | Reference Standards |
| HY-B0434S | Ribavirin-13C5 | 1646818-35-0 | Isotope-Labeled Compounds |
| HY-B0434S1 | Ribavirin-15N, d2 | Isotope-Labeled Compounds | |
| HY-B0435 | Roxithromycin | 80214-83-1 | Reference compound |
| HY-B0435R | Roxithromycin (Standard) | 80214-83-1 | Reference Standards |
| HY-B0435S | Roxithromycin-d7 | Isotope-Labeled Compounds | |
| HY-B0436 | Salbutamol (hemisulfate) | 51022-70-9 | Reference compound |
| HY-B0436R | Salbutamol (hemisulfate) (Standard) | 51022-70-9 | Reference Standards |
| HY-B0437 | Sotalol (hydrochloride) | 959-24-0 | Reference compound |
| HY-B0437AS | Sotalol-d6 (hydrochloride) | 1246820-85-8 | Isotope-Labeled Compounds |
| HY-B0437R | Sotalol (hydrochloride) (Standard) | 959-24-0 | Reference Standards |
| HY-B0437S | Sotalol-d6 | 1246912-17-3 | Isotope-Labeled Compounds |
| HY-B0438 | Spectinomycin (dihydrochloride) | 21736-83-4 | Natural Products |
| HY-B0438R | Spectinomycin (dihydrochloride) (Standard) | 21736-83-4 | Reference Standards |
| HY-B0439 | Sulfadoxine | 2447-57-6 | Reference compound |
| HY-B0439R | Sulfadoxine (Standard) | 2447-57-6 | Reference Standards |
| HY-B0439S | Sulfadoxine-d4 | 1330266-05-1 | Isotope-Labeled Compounds |
| HY-B0439S1 | Sulfadoxine D3 | 1262770-70-6 | Isotope-Labeled Compounds |
| HY-B0440 | Tenoxicam | 59804-37-4 | Reference compound |
| HY-B0440R | Tenoxicam (Standard) | 59804-37-4 | Reference Standards |
| HY-B0440S | Tenoxicam-d3 | Isotope-Labeled Compounds | |
| HY-B0441 | Tobramycin | 32986-56-4 | Natural Products |
| HY-B0441A | Tobramycin (sulfate) | 49842-07-1 | Natural Products |
| HY-B0441AR | Tobramycin (sulfate) (Standard) | 49842-07-1 | Reference Standards |
| HY-B0441R | Tobramycin (Standard) | 32986-56-4 | Reference Standards |
| HY-B0442 | Vardenafil | 224785-90-4 | Reference compound |
| HY-B0442A | Vardenafil (hydrochloride) | 224785-91-5 | Reference compound |
| HY-B0442AS | Vardenafil-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0442B | Vardenafil (hydrochloride trihydrate) | 330808-88-3 | Reference compound |
| HY-B0442BR | Vardenafil (hydrochloride trihydrate) (Standard) | 330808-88-3 | Reference Standards |
| HY-B0442C | Vardenafil (dihydrochloride) | 224789-15-5 | Reference compound |
| HY-B0442CR | Vardenafil (dihydrochloride) (Standard) | 224789-15-5 | Reference Standards |
| HY-B0442R | Vardenafil (Standard) | 224785-90-4 | Reference Standards |
| HY-B0442S | Vardenafil-d5 | 1189685-70-8 | Isotope-Labeled Compounds |
| HY-B0442S1 | Vardenafil-d4 | 2012598-83-1 | Isotope-Labeled Compounds |
| HY-B0444 | Maprotiline (hydrochloride) | 10347-81-6 | Reference compound |
| HY-B0444A | Maprotiline | 10262-69-8 | Reference compound |
| HY-B0444R | Maprotiline (hydrochloride) (Standard) | 10347-81-6 | Reference Standards |
| HY-B0444S | Maprotiline-d5 (hydrochloride) | 1794942-12-3 | Isotope-Labeled Compounds |
| HY-B0444S1 | Maprotiline-d3 (hydrochloride) | 1329496-63-0 | Isotope-Labeled Compounds |
| HY-B0445 | NAD+ | 53-84-9 | Natural Products |
| HY-B0445A | NAD (sodium) | 20111-18-6 | Biochemical Assay Reagents |
| HY-B0445B | α-NAD | 7298-93-3 | Reference compound |
| HY-B0445S | NAD+-13C5 (ammonium) | Isotope-Labeled Compounds | |
| HY-B0445S1 | NAD+-13C5 | 1859096-06-2 | Isotope-Labeled Compounds |
| HY-B0446 | Naphazoline (hydrochloride) | 550-99-2 | Reference compound |
| HY-B0446R | Naphazoline (hydrochloride) (Standard) | 550-99-2 | Reference Standards |
| HY-B0448 | Phenytoin | 57-41-0 | Reference compound |
| HY-B0448A | Phenytoin (sodium) | 630-93-3 | Reference compound |
| HY-B0448AR | Phenytoin (sodium) (Standard) | 630-93-3 | Reference Standards |
| HY-B0448R | Phenytoin (Standard) | 57-41-0 | Reference Standards |
| HY-B0448S | Phenytoin-d10 | 65854-97-9 | Isotope-Labeled Compounds |
| HY-B0448S1 | Phenytoin-15n2,13c | 78213-26-0 | Isotope-Labeled Compounds |
| HY-B0448S2 | Phenytoin-d5 | Isotope-Labeled Compounds | |
| HY-B0449 | Methacycline (hydrochloride) | 3963-95-9 | Reference compound |
| HY-B0449R | Methacycline (hydrochloride) (Standard) | 3963-95-9 | Reference Standards |
| HY-B0450 | Ciclopirox | 29342-05-0 | Reference compound |
| HY-B0450A | Ciclopirox (olamine) | 41621-49-2 | Reference compound |
| HY-B0450AG | Ciclopirox (olamine) (GMP) | 41621-49-2 | GMP Small Molecules |
| HY-B0450AR | Ciclopirox (olamine) (Standard) | 41621-49-2 | Reference Standards |
| HY-B0450R | Ciclopirox (Standard) | 29342-05-0 | Reference Standards |
| HY-B0450S | Ciclopirox-d11 | Isotope-Labeled Compounds | |
| HY-B0450S1 | Ciclopirox-d11 (sodium) | Isotope-Labeled Compounds | |
| HY-B0451 | Dopamine | 51-61-6 | Natural Products |
| HY-B0451A | Dopamine (hydrochloride) | 62-31-7 | Natural Products |
| HY-B0451AR | Dopamine (hydrochloride) (Standard) | 62-31-7 | Reference Standards |
| HY-B0451AS1 | Dopamine-13C6 (hydrochloride) | 335080-94-9 | Isotope-Labeled Compounds |
| HY-B0451AS2 | Dopamine-d2 (hydrochloride) | 27160-01-6 | Isotope-Labeled Compounds |
| HY-B0451AS3 | Dopamine-d2-1 (hydrochloride) | 83008-33-7 | Isotope-Labeled Compounds |
| HY-B0451AS4 | Dopamine-d3 (hydrochloride) | 53587-30-7 | Isotope-Labeled Compounds |
| HY-B0451AS5 | Dopamine-13C (hydrochloride) | 335081-04-4 | Isotope-Labeled Compounds |
| HY-B0451AS6 | Dopamine-13C,15N (hydrochloride) | 369656-74-6 | Isotope-Labeled Compounds |
| HY-B0451AS7 | Dopamine-d5 (hydrochloride) | 2193106-55-5 | Isotope-Labeled Compounds |
| HY-B0452 | Ritodrine (hydrochloride) | 23239-51-2 | Reference compound |
| HY-B0452A | Ritodrine | 26652-09-5 | Reference compound |
| HY-B0452R | Ritodrine (hydrochloride) (Standard) | 23239-51-2 | Reference Standards |
| HY-B0452S1 | Ritodrine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0453 | Econazole (nitrate) | 24169-02-6 | Reference compound |
| HY-B0453R | Econazole (nitrate) (Standard) | 24169-02-6 | Reference Standards |
| HY-B0454 | Miconazole | 22916-47-8 | Reference compound |
| HY-B0454A | Miconazole (nitrate) | 22832-87-7 | Reference compound |
| HY-B0454AS | Miconazole-d5 (nitrate) (2,4-Dichlorobenzyloxy-d5) | 1398065-80-9 | Isotope-Labeled Compounds |
| HY-B0454R | Miconazole (Standard) | 22916-47-8 | Reference Standards |
| HY-B0454S | Miconazole-d5 | 1216653-50-7 | Isotope-Labeled Compounds |
| HY-B0454S1 | Miconazole-d5 (nitrate) | 1216653-51-8 | Isotope-Labeled Compounds |
| HY-B0454S2 | Miconazole-d2 | 2140316-33-0 | Isotope-Labeled Compounds |
| HY-B0455 | Lomefloxacin (hydrochloride) | 98079-52-8 | Reference compound |
| HY-B0455A | Lomefloxacin | 98079-51-7 | Reference compound |
| HY-B0455AR | Lomefloxacin (Standard) | 98079-51-7 | Reference Standards |
| HY-B0455B | Lomefloxacin (aspartate) | 211690-33-4 | Reference compound |
| HY-B0455R | Lomefloxacin (hydrochloride) (Standard) | 98079-52-8 | Reference Standards |
| HY-B0455S | Lomefloxacin-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0456 | Riboflavin | 83-88-5 | Natural Products |
| HY-B0456R | Riboflavin (Standard) | 83-88-5 | Reference Standards |
| HY-B0456S | Riboflavin-13C4,15N2 | 1217461-14-7 | Isotope-Labeled Compounds |
| HY-B0456S1 | Riboflavin-5-Phosphate-13C4,15N2-1 | Isotope-Labeled Compounds | |
| HY-B0456S2 | Riboflavin-13C5 | Isotope-Labeled Compounds | |
| HY-B0456S3 | Riboflavin-d3 | Isotope-Labeled Compounds | |
| HY-B0456S5 | Riboflavin-d8 | Isotope-Labeled Compounds | |
| HY-B0457 | Clomipramine (hydrochloride) | 17321-77-6 | Reference compound |
| HY-B0457A | Clomipramine | 303-49-1 | Reference compound |
| HY-B0457AR | Clomipramine (Standard) | 303-49-1 | Reference Standards |
| HY-B0457AS | Clomipramine-d3 | 136765-29-2 | Isotope-Labeled Compounds |
| HY-B0457R | Clomipramine (hydrochloride) (Standard) | 17321-77-6 | Reference Standards |
| HY-B0457S | Clomipramine-d3 (hydrochloride) | 1398065-86-5 | Isotope-Labeled Compounds |
| HY-B0457S1 | Clomipramine-d6 (hydrochloride) | 1189882-28-7 | Isotope-Labeled Compounds |
| HY-B0457S2 | Clomipramine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0458 | Cefprozil (monohydrate) | 121123-17-9 | Reference compound |
| HY-B0458A | Cefprozil | 92665-29-7 | Reference compound |
| HY-B0458AS | Cefprozil-d4 | 1426173-48-9 | Isotope-Labeled Compounds |
| HY-B0458R | Cefprozil (monohydrate) (Standard) | 121123-17-9 | Reference Standards |
| HY-B0459 | Scopine | 498-45-3 | Natural Products |
| HY-B0459A | Scopine (hydrochloride) | 85700-55-6 | Reference compound |
| HY-B0460 | Tiotropium (bromide monohydrate) | 411207-31-3 | Reference compound |
| HY-B0461 | Trospium (chloride) | 10405-02-4 | Reference compound |
| HY-B0461R | Trospium (chloride) (Standard) | 10405-02-4 | Reference Standards |
| HY-B0461S | Trospium-d8 (chloride) | Isotope-Labeled Compounds | |
| HY-B0462 | Azelastine (hydrochloride) | 79307-93-0 | Reference compound |
| HY-B0462A | Azelastine | 58581-89-8 | Reference compound |
| HY-B0462AS | Azelastine-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0462B | (S)-Azelastine (hydrochloride) | 153408-27-6 | Reference compound |
| HY-B0462C | (R)-Azelastine (hydrochloride) | 153408-28-7 | Reference compound |
| HY-B0462D | (S)-Azelastine | 143228-85-7 | Reference compound |
| HY-B0462R | Azelastine (hydrochloride) (Standard) | 79307-93-0 | Reference Standards |
| HY-B0462S | Azelastine-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0462S1 | Azelastine-d4 (hydrochloride) | 2747915-85-9 | Isotope-Labeled Compounds |
| HY-B0463 | Clomiphene (citrate) | 50-41-9 | Reference compound |
| HY-B0463R | Clomiphene (citrate) (Standard) | 50-41-9 | Reference Standards |
| HY-B0464 | Hydralazine (hydrochloride) | 304-20-1 | Reference compound |
| HY-B0464A | Hydralazine | 86-54-4 | Reference compound |
| HY-B0464R | Hydralazine (hydrochloride) (Standard) | 304-20-1 | Reference Standards |
| HY-B0464S | Hydralazine-d4 (hydrochloride) | 2749234-32-8 | Isotope-Labeled Compounds |
| HY-B0464S1 | Hydralazine-d5 (hydrochloride) | 2012598-61-5 | Isotope-Labeled Compounds |
| HY-B0465 | Oxacillin (sodium monohydrate) | 7240-38-2 | Reference compound |
| HY-B0465R | Oxacillin (sodium monohydrate) (Standard) | 7240-38-2 | Reference Standards |
| HY-B0466 | Cloxacillin (sodium monohydrate) | 7081-44-9 | Reference compound |
| HY-B0466A | Cloxacillin | 61-72-3 | Reference compound |
| HY-B0466B | Cloxacillin (sodium) | 642-78-4 | Reference compound |
| HY-B0466BR | Cloxacillin (sodium) (Standard) | 642-78-4 | Reference Standards |
| HY-B0466R | Cloxacillin (sodium monohydrate) (Standard) | 7081-44-9 | Reference Standards |
| HY-B0467 | Amoxicillin (sodium) | 34642-77-8 | Reference compound |
| HY-B0467A | Amoxicillin | 26787-78-0 | Reference compound |
| HY-B0467AR | Amoxicillin (Standard) | 26787-78-0 | Reference Standards |
| HY-B0467AS | Amoxicillin-13C6 | Isotope-Labeled Compounds | |
| HY-B0467B | Amoxicillin (trihydrate) | 61336-70-7 | Reference compound |
| HY-B0467BR | Amoxicillin (trihydrate) (Standard) | 61336-70-7 | Reference Standards |
| HY-B0467C | Amoxicillin (arginine) | 59261-05-1 | Reference compound |
| HY-B0467R | Amoxicillin (sodium) (Standard) | 34642-77-8 | Reference Standards |
| HY-B0467S | Amoxicillin-d4 | 2673270-36-3 | Isotope-Labeled Compounds |
| HY-B0468 | Isoprenaline (hydrochloride) | 51-30-9 | Reference compound |
| HY-B0468R | Isoprenaline (hydrochloride) (Standard) | 51-30-9 | Reference Standards |
| HY-B0468S | Isoprenaline-d7 (hydrochloride) | 2517584-04-0 | Isotope-Labeled Compounds |
| HY-B0469 | Medroxyprogesterone acetate | 71-58-9 | Natural Products |
| HY-B0469R | Medroxyprogesterone acetate (Standard) | 71-58-9 | Reference Standards |
| HY-B0469S | Medroxyprogesterone acetate-d3 | Isotope-Labeled Compounds | |
| HY-B0470 | Neomycin (sulfate) | 1405-10-3 | Natural Products |
| HY-B0470R | Neomycin (sulfate) (Standard) | 1405-10-3 | Reference Standards |
| HY-B0471 | Phenylephrine (hydrochloride) | 61-76-7 | Reference compound |
| HY-B0471R | Phenylephrine (hydrochloride) (Standard) | 61-76-7 | Reference Standards |
| HY-B0471S | Phenylephrine-d3 (hydrochloride) | 1217858-50-8 | Isotope-Labeled Compounds |
| HY-B0471S1 | Phenylephrine-2,4,6-d3 (hydrochloride) | 1276197-50-2 | Isotope-Labeled Compounds |
| HY-B0471S2 | (S)-Phenylephrine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0471S3 | Phenylephrine-d6 (hydrochloride) | 1089675-56-8 | Isotope-Labeled Compounds |
| HY-B0472 | Streptomycin (sulfate) | 3810-74-0 | Natural Products |
| HY-B0472R | Streptomycin (sulfate) (Standard) | 3810-74-0 | Reference Standards |
| HY-B0473 | Tetracaine (hydrochloride) | 136-47-0 | Reference compound |
| HY-B0473R | Tetracaine (hydrochloride) (Standard) | 136-47-0 | Reference Standards |
| HY-B0473S | Tetracaine-d6 (hydrochloride) | 80404-52-0 | Isotope-Labeled Compounds |
| HY-B0474 | Tetracycline (hydrochloride) | 64-75-5 | Natural Products |
| HY-B0474R | Tetracycline (hydrochloride) (Standard) | 64-75-5 | Reference Standards |
| HY-B0475 | Xylometazoline (hydrochloride) | 1218-35-5 | Reference compound |
| HY-B0475A | Xylometazoline | 526-36-3 | Reference compound |
| HY-B0475R | Xylometazoline (hydrochloride) (Standard) | 1218-35-5 | Reference Standards |
| HY-B0475S | Xylometazoline-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0476 | Phenacetin | 62-44-2 | Reference compound |
| HY-B0476R | Phenacetin (Standard) | 62-44-2 | Reference Standards |
| HY-B0476S | Phenacetin-d5 | 69323-74-6 | Isotope-Labeled Compounds |
| HY-B0476S1 | Phenacetin-13C | 72156-72-0 | Isotope-Labeled Compounds |
| HY-B0477 | Quinapril (hydrochloride) | 82586-55-8 | Reference compound |
| HY-B0477A | Quinapril | 85441-61-8 | Reference compound |
| HY-B0477AS | Quinapril-d5 | 1279029-79-6 | Isotope-Labeled Compounds |
| HY-B0477AS2 | Quinapril-d4 | Isotope-Labeled Compounds | |
| HY-B0477R | Quinapril (hydrochloride) (Standard) | 82586-55-8 | Reference Standards |
| HY-B0478 | Trazodone (hydrochloride) | 25332-39-2 | Reference compound |
| HY-B0478A | Trazodone | 19794-93-5 | Reference compound |
| HY-B0478AR | Trazodone (Standard) | 19794-93-5 | Reference Standards |
| HY-B0478AS | Trazodone-d6 (hydrochloride) | 1181578-71-1 | Isotope-Labeled Compounds |
| HY-B0478R | Trazodone (hydrochloride) (Standard) | 25332-39-2 | Reference Standards |
| HY-B0479 | Thiamphenicol | 15318-45-3 | Reference compound |
| HY-B0479R | Thiamphenicol (Standard) | 15318-45-3 | Reference Standards |
| HY-B0479S | Thiamphenicol-d3 | 2211914-19-9 | Isotope-Labeled Compounds |
| HY-B0479S1 | Thiamphenicol-d3-1 | 1217723-41-5 | Isotope-Labeled Compounds |
| HY-B0480 | Brompheniramine (maleate) | 980-71-2 | Reference compound |
| HY-B0480A | Brompheniramine | 86-22-6 | Reference compound |
| HY-B0480AR | Brompheniramine (Standard) | 86-22-6 | Reference Standards |
| HY-B0480R | Brompheniramine (maleate) (Standard) | 980-71-2 | Reference Standards |
| HY-B0481 | Miglitol | 72432-03-2 | Reference compound |
| HY-B0481S1 | Miglitol-d4 | 2714473-10-4 | Isotope-Labeled Compounds |
| HY-B0482 | Acemetacin | 53164-05-9 | Reference compound |
| HY-B0482R | Acemetacin (Standard) | 53164-05-9 | Reference Standards |
| HY-B0482S1 | Acemetacin-13C6 | Isotope-Labeled Compounds | |
| HY-B0483 | Tioxolone | 4991-65-5 | Reference compound |
| HY-B0483R | Tioxolone (Standard) | 4991-65-5 | Reference Standards |
| HY-B0484 | Buflomedil (hydrochloride) | 35543-24-9 | Reference compound |
| HY-B0484A | Buflomedil | 55837-25-7 | Reference compound |
| HY-B0484R | Buflomedil (hydrochloride) (Standard) | 35543-24-9 | Reference Standards |
| HY-B0485 | Fluocinonide | 356-12-7 | Reference compound |
| HY-B0485R | Fluocinonide (Standard) | 356-12-7 | Reference Standards |
| HY-B0485S | Fluocinonide-d6 | Isotope-Labeled Compounds | |
| HY-B0486 | Lonidamine | 50264-69-2 | Reference compound |
| HY-B0486R | Lonidamine (Standard) | 50264-69-2 | Reference Standards |
| HY-B0487 | Ethisterone | 434-03-7 | Reference compound |
| HY-B0487R | Ethisterone (Standard) | 434-03-7 | Reference Standards |
| HY-B0488 | Clorsulon | 60200-06-8 | Reference compound |
| HY-B0488R | Clorsulon (Standard) | 60200-06-8 | Reference Standards |
| HY-B0489 | Arecoline (hydrobromide) | 300-08-3 | Natural Products |
| HY-B0489A | Arecoline (hydrochloride) | 61-94-9 | Natural Products |
| HY-B0489R | Arecoline (hydrobromide) (Standard) | 300-08-3 | Reference Standards |
| HY-B0490 | Hygromycin B | 31282-04-9 | Natural Products |
| HY-B0490R | Hygromycin B (Standard) | 31282-04-9 | Reference Standards |
| HY-B0491A | Carbazochrome (sodium sulfonate) | 51460-26-5 | Reference compound |
| HY-B0491AR | Carbazochrome (sodium sulfonate) (Standard) | 51460-26-5 | Reference Standards |
| HY-B0492 | Paroxetine (hydrochloride) | 78246-49-8 | Reference compound |
| HY-B0492A | Paroxetine (hydrochloride hemihydrate) | 110429-35-1 | Reference compound |
| HY-B0492AR | Paroxetine (hydrochloride hemihydrate) (Standard) | 110429-35-1 | Reference Standards |
| HY-B0492R | Paroxetine (hydrochloride) (Standard) | 78246-49-8 | Reference Standards |
| HY-B0492S | rel-Paroxetine-d4-1 (hydrochloride) | 1217753-24-6 | Isotope-Labeled Compounds |
| HY-B0492S1 | Paroxetine-d4 (hydrochloride) | 2714485-95-5 | Isotope-Labeled Compounds |
| HY-B0493 | Niflumic acid | 4394-00-7 | Reference compound |
| HY-B0493R | Niflumic acid (Standard) | 4394-00-7 | Reference Standards |
| HY-B0493S | Niflumic Acid-d5 | 1794811-58-7 | Isotope-Labeled Compounds |
| HY-B0493S1 | Niflumic acid-13C6 | 1325559-33-8 | Isotope-Labeled Compounds |
| HY-B0494 | Bufexamac | 2438-72-4 | Reference compound |
| HY-B0494R | Bufexamac (Standard) | 2438-72-4 | Reference Standards |
| HY-B0495 | Lamotrigine | 84057-84-1 | Reference compound |
| HY-B0495A | Lamotrigine (hydrate) | 375347-20-9 | Reference compound |
| HY-B0495R | Lamotrigine (Standard) | 84057-84-1 | Reference Standards |
| HY-B0495S | Lamotrigine-13C3,d3 | 1246815-13-3 | Isotope-Labeled Compounds |
| HY-B0495S1 | Lamotrigine-13C,d3 | 2517756-06-6 | Isotope-Labeled Compounds |
| HY-B0495S3 | Lamotrigine-13C2,15N | 2483830-10-8 | Isotope-Labeled Compounds |
| HY-B0495S4 | Lamotrigine-13C3 | 1188265-38-4 | Isotope-Labeled Compounds |
| HY-B0495S5 | Lamotrigine-d3 | 1132746-94-1 | Isotope-Labeled Compounds |
| HY-B0495S6 | Lamotrigine-13C2,15N2,d3 | Isotope-Labeled Compounds | |
| HY-B0495S7 | Lamotrigine-13C | 2140316-15-8 | Isotope-Labeled Compounds |
| HY-B0495S8 | Lamotrigine-13C7,15N | Isotope-Labeled Compounds | |
| HY-B0496 | PMSF | 329-98-6 | Reference compound |
| HY-B0497 | Niclosamide | 50-65-7 | Reference compound |
| HY-B0497A | Niclosamide (sodium) | 40321-86-6 | Reference compound |
| HY-B0497B | Niclosamide (monohydrate) | 73360-56-2 | Reference compound |
| HY-B0497BS | Niclosamide-13C6 (monohydrate) | 1325559-12-3 | Isotope-Labeled Compounds |
| HY-B0497C | Niclosamide (olamine) | 1420-04-8 | Reference compound |
| HY-B0497CR | Niclosamide (olamine) (Standard) | 1420-04-8 | Reference Standards |
| HY-B0497G | Niclosamide (GMP) | 50-65-7 | GMP Small Molecules |
| HY-B0497R | Niclosamide (Standard) | 50-65-7 | Reference Standards |
| HY-B0497S1 | Niclosamide-13C6 | 1325808-64-7 | Isotope-Labeled Compounds |
| HY-B0497S2 | Niclosamide-d3 | 2665663-60-3 | Isotope-Labeled Compounds |
| HY-B0498 | Bindarit | 130641-38-2 | Natural Products |
| HY-B0499A | Otilonium (bromide) | 26095-59-0 | Reference compound |
| HY-B0499AR | Otilonium (bromide) (Standard) | 26095-59-0 | Reference Standards |
| HY-B0499AS1 | Otilonium-d4 (bromide) | Isotope-Labeled Compounds | |
| HY-B0500 | Alverine (citrate) | 5560-59-8 | Reference compound |
| HY-B0500A | Alverine | 150-59-4 | Reference compound |
| HY-B0500AS | Alverine-d5 (citrate) | 1215327-00-6 | Isotope-Labeled Compounds |
| HY-B0500B | Alverine (hydrochloride) | 5982-87-6 | Reference compound |
| HY-B0500R | Alverine (citrate) (Standard) | 5560-59-8 | Reference Standards |
| HY-B0501 | Danofloxacin (mesylate) | 119478-55-6 | Reference compound |
| HY-B0501R | Danofloxacin (mesylate) (Standard) | 119478-55-6 | Reference Standards |
| HY-B0501S | Danofloxacin-d3 (mesylate) | 1217860-94-0 | Isotope-Labeled Compounds |
| HY-B0502 | Enrofloxacin | 93106-60-6 | Reference compound |
| HY-B0502A | Enrofloxacin (monohydrochloride) | 93106-59-3 | Reference compound |
| HY-B0502AR | Enrofloxacin (monohydrochloride) (Standard) | 93106-59-3 | Reference Standards |
| HY-B0502AS | Enrofloxacin-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0502AS1 | Enrofloxacin-d5 (hydriodide) | 1219795-24-0 | Isotope-Labeled Compounds |
| HY-B0502R | Enrofloxacin (Standard) | 93106-60-6 | Reference Standards |
| HY-B0502S | Enrofloxacin-d5 | 1173021-92-5 | Isotope-Labeled Compounds |
| HY-B0503 | 2-Thiouracil | 141-90-2 | Reference compound |
| HY-B0503S | 2-Thiouracil-13C,15N2 | Isotope-Labeled Compounds | |
| HY-B0504 | Creatinine | 60-27-5 | Natural Products |
| HY-B0504R | Creatinine (Standard) | 60-27-5 | Reference Standards |
| HY-B0504S | Creatinine-d3 | 143827-20-7 | Isotope-Labeled Compounds |
| HY-B0504S1 | Creatinine-13C | 1173022-95-1 | Isotope-Labeled Compounds |
| HY-B0504S2 | Creatinine-d5 | Isotope-Labeled Compounds | |
| HY-B0505 | Moguisteine | 119637-67-1 | Reference compound |
| HY-B0506 | Nadifloxacin | 124858-35-1 | Reference compound |
| HY-B0506R | Nadifloxacin (Standard) | 124858-35-1 | Reference Standards |
| HY-B0506S1 | Nadifloxacin-d5 | Isotope-Labeled Compounds | |
| HY-B0507 | Sulfathiazole | 72-14-0 | Reference compound |
| HY-B0507A | Sulfathiazole (sodium) | 144-74-1 | Reference compound |
| HY-B0507AR | Sulfathiazole (sodium) (Standard) | 144-74-1 | Reference Standards |
| HY-B0507B | Sulfathiazole (100 µg/mL in acetonitrile) | 72-14-0 | Biochemical Assay Reagents |
| HY-B0507R | Sulfathiazole (Standard) | 72-14-0 | Reference Standards |
| HY-B0507S | Sulfathiazole-d4 | 1020719-89-4 | Isotope-Labeled Compounds |
| HY-B0508 | Ornidazole | 16773-42-5 | Natural Products |
| HY-B0508R | Ornidazole (Standard) | 16773-42-5 | Reference Standards |
| HY-B0508S | Ornidazole-d5 | 2747915-64-4 | Isotope-Labeled Compounds |
| HY-B0508S1 | Ornidazole-13C2,15N2 | Isotope-Labeled Compounds | |
| HY-B0509 | Amikacin (hydrate) | 1257517-67-1 | Reference compound |
| HY-B0509A | Amikacin | 37517-28-5 | Reference compound |
| HY-B0509AR | Amikacin (Standard) | 37517-28-5 | Reference Standards |
| HY-B0509B | Amikacin (disulfate) | 39831-55-5 | Reference compound |
| HY-B0509BR | Amikacin (disulfate) (Standard) | 39831-55-5 | Reference Standards |
| HY-B0510 | Trimethoprim | 738-70-5 | Reference compound |
| HY-B0510A | Trimethoprim (sulfate) | 56585-33-2 | Reference compound |
| HY-B0510B | Trimethoprim (hydrochloride) | 60834-30-2 | Reference compound |
| HY-B0510C | Trimethoprim (lactate) | 23256-42-0 | Reference compound |
| HY-B0510CR | Trimethoprim (lactate) (Standard) | 23256-42-0 | Reference Standards |
| HY-B0510R | Trimethoprim (Standard) | 738-70-5 | Reference Standards |
| HY-B0510S | Trimethoprim-d9 | 1189460-62-5 | Isotope-Labeled Compounds |
| HY-B0510S2 | Trimethoprim-d3 | 1189923-38-3 | Isotope-Labeled Compounds |
| HY-B0510S3 | Trimethoprim-13C3 | 1189970-95-3 | Isotope-Labeled Compounds |
| HY-B0511 | Biotin | 58-85-5 | Natural Products |
| HY-B0511A | Biotin (sodium) | 56085-82-6 | Reference compound |
| HY-B0511R | Biotin (Standard) | 58-85-5 | Reference Standards |
| HY-B0511S | Biotin-d2-1 | 1217481-41-8 | Isotope-Labeled Compounds |
| HY-B0511S1 | rel-Biotin-d4 | 1217850-77-5 | Isotope-Labeled Compounds |
| HY-B0511S2 | Biotin-d2 | Isotope-Labeled Compounds | |
| HY-B0511S3 | Biotin-13C5 | Isotope-Labeled Compounds | |
| HY-B0512 | Sulfamerazine | 127-79-7 | Reference compound |
| HY-B0512A | Sulfamerazine (sodium salt) | 127-58-2 | Reference compound |
| HY-B0512R | Sulfamerazine (Standard) | 127-79-7 | Reference Standards |
| HY-B0512S | Sulfamerazine-d4 | 1020719-84-9 | Isotope-Labeled Compounds |
| HY-B0512S1 | Sulfamerazine-13C6 | 1196157-80-8 | Isotope-Labeled Compounds |
| HY-B0513 | Methylthiouracil | 56-04-2 | Reference compound |
| HY-B0513R | Methylthiouracil (Standard) | 56-04-2 | Reference Standards |
| HY-B0515 | Ibandronate (Sodium Monohydrate) | 138926-19-9 | Reference compound |
| HY-B0515A | Ibandronic acid | 114084-78-5 | Reference compound |
| HY-B0515AS | Ibandronic Acid-d3 (sodium salt) | 1329834-28-7 | Isotope-Labeled Compounds |
| HY-B0515AS1 | Ibandronic acid-d3 | 1130899-41-0 | Isotope-Labeled Compounds |
| HY-B0515B | Ibandronate (Sodium) | 138844-81-2 | Reference compound |
| HY-B0515R | Ibandronate (Sodium Monohydrate) (Standard) | 138926-19-9 | Reference Standards |
| HY-B0516 | Articaine (hydrochloride) | 23964-57-0 | Reference compound |
| HY-B0516A | Articaine | 23964-58-1 | Reference compound |
| HY-B0516AR | Articaine (Standard) | 23964-58-1 | Reference Standards |
| HY-B0516R | Articaine (hydrochloride) (Standard) | 23964-57-0 | Reference Standards |
| HY-B0517 | Mepivacaine | 96-88-8 | Reference compound |
| HY-B0517A | Mepivacaine (hydrochloride) | 1722-62-9 | Reference compound |
| HY-B0517AR | Mepivacaine (hydrochloride) (Standard) | 1722-62-9 | Reference Standards |
| HY-B0517R | Mepivacaine (Standard) | 96-88-8 | Reference Standards |
| HY-B0517S | Mepivacaine-d3 | 1346597-90-7 | Isotope-Labeled Compounds |
| HY-B0518A | Naftifine (hydrochloride) | 65473-14-5 | Reference compound |
| HY-B0518AR | Naftifine (hydrochloride) (Standard) | 65473-14-5 | Reference Standards |
| HY-B0518AS | Naftifine-d3 (hydrochloride) | 1246833-81-7 | Isotope-Labeled Compounds |
| HY-B0519 | Tylosin (tartrate) | 74610-55-2 | Natural Products |
| HY-B0519A | Tylosin | 1401-69-0 | Natural Products |
| HY-B0519AR | Tylosin (Standard) | 1401-69-0 | Reference Standards |
| HY-B0519AS | Tylosin-d3 | Isotope-Labeled Compounds | |
| HY-B0519B | Tylosin (phosphate) | 1405-53-4 | Natural Products |
| HY-B0519BR | Tylosin (phosphate) (Standard) | 1405-53-4 | Reference Standards |
| HY-B0519C | Tylosin (lactate) | 11034-63-2 | Reference compound |
| HY-B0519R | Tylosin (tartrate) (Standard) | 74610-55-2 | Reference Standards |
| HY-B0520 | Benztropine | 86-13-5 | Reference compound |
| HY-B0520A | Benztropine (mesylate) | 132-17-2 | Reference compound |
| HY-B0520AR | Benztropine (mesylate) (Standard) | 132-17-2 | Reference Standards |
| HY-B0520AS | Benztropine-13C,d3 (mesylate) | Isotope-Labeled Compounds | |
| HY-B0520AS1 | Benztropine-d3 (mesylate) | 202529-16-6 | Isotope-Labeled Compounds |
| HY-B0521 | Altrenogest | 850-52-2 | Reference compound |
| HY-B0521R | Altrenogest (Standard) | 850-52-2 | Reference Standards |
| HY-B0521S | Altrenogest-d5 | Isotope-Labeled Compounds | |
| HY-B0522 | Ampicillin | 69-53-4 | Reference compound |
| HY-B0522A | Ampicillin (sodium) | 69-52-3 | Reference compound |
| HY-B0522AR | Ampicillin (sodium) (Standard) | 69-52-3 | Reference Standards |
| HY-B0522B | Ampicillin (trihydrate) | 7177-48-2 | Reference compound |
| HY-B0522BR | Ampicillin (trihydrate) (Standard) | 7177-48-2 | Reference Standards |
| HY-B0522C | L-(+)-Ampicillin | 19379-33-0 | Reference compound |
| HY-B0522R | Ampicillin (Standard) | 69-53-4 | Reference Standards |
| HY-B0522S | Ampicillin-d5 | 1426173-65-0 | Isotope-Labeled Compounds |
| HY-B0523 | Anagrelide | 68475-42-3 | Reference compound |
| HY-B0523A | Anagrelide (hydrochloride) | 58579-51-4 | Reference compound |
| HY-B0523AR | Anagrelide (hydrochloride) (Standard) | 58579-51-4 | Reference Standards |
| HY-B0523B | Anagrelide (hydrochloride monohydrate) | 823178-43-4 | Reference compound |
| HY-B0523S | Anagrelide-13C2,15N,d2 | Isotope-Labeled Compounds | |
| HY-B0524 | Betahistine | 5638-76-6 | Reference compound |
| HY-B0524A | Betahistine (dihydrochloride) | 5579-84-0 | Reference compound |
| HY-B0524AR | Betahistine (dihydrochloride) (Standard) | 5579-84-0 | Reference Standards |
| HY-B0524AS | Betahistine-d3 (dihydrochloride) | 244094-72-2 | Isotope-Labeled Compounds |
| HY-B0524AS1 | Betahistine-13C,d3 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B0525 | Carbenicillin | 4697-36-3 | Reference compound |
| HY-B0525A | Carbenicillin (disodium) | 4800-94-6 | Reference compound |
| HY-B0525AR | Carbenicillin (disodium) (Standard) | 4800-94-6 | Reference Standards |
| HY-B0526 | Flumequine | 42835-25-6 | Reference compound |
| HY-B0526R | Flumequine (Standard) | 42835-25-6 | Reference Standards |
| HY-B0526S | Flumequine-13C3 | 1185049-09-5 | Isotope-Labeled Compounds |
| HY-B0527 | Amitriptyline | 50-48-6 | Reference compound |
| HY-B0527A | Amitriptyline (hydrochloride) | 549-18-8 | Reference compound |
| HY-B0527AR | Amitriptyline (hydrochloride) (Standard) | 549-18-8 | Reference Standards |
| HY-B0527AS | Amitriptyline-d6 (hydrochloride) | 203645-63-0 | Isotope-Labeled Compounds |
| HY-B0528 | Octopamine | 104-14-3 | Natural Products |
| HY-B0528A | Octopamine (hydrochloride) | 770-05-8 | Natural Products |
| HY-B0528AR | Octopamine (hydrochloride) (Standard) | 770-05-8 | Reference Standards |
| HY-B0528AS | Octopamine-d4 (hydrochloride) | 1219803-62-9 | Isotope-Labeled Compounds |
| HY-B0528S | Octopamine-d3 | 111988-19-3 | Isotope-Labeled Compounds |
| HY-B0529 | Azlocillin | 37091-66-0 | Reference compound |
| HY-B0529A | Azlocillin (sodium salt) | 37091-65-9 | Reference compound |
| HY-B0529AR | Azlocillin (sodium salt) (Standard) | 37091-65-9 | Reference Standards |
| HY-B0529R | Azlocillin (Standard) | 37091-66-0 | Reference Standards |
| HY-B0530 | Azacyclonol | 115-46-8 | Reference compound |
| HY-B0530A | Azacyclonol (hydrochloride) | 1798-50-1 | Reference compound |
| HY-B0530R | Azacyclonol (Standard) | 115-46-8 | Reference Standards |
| HY-B0531 | Triflusal | 322-79-2 | Reference compound |
| HY-B0531R | Triflusal (Standard) | 322-79-2 | Reference Standards |
| HY-B0531S | Triflusal-d3 | 2748541-63-9 | Isotope-Labeled Compounds |
| HY-B0532 | Trifluoperazine | 117-89-5 | Reference compound |
| HY-B0532A | Trifluoperazine (dihydrochloride) | 440-17-5 | Reference compound |
| HY-B0532AR | Trifluoperazine (dihydrochloride) (Standard) | 440-17-5 | Reference Standards |
| HY-B0532AS | Trifluoperazine-d3 (dihydrochloride) | 1432064-02-2 | Isotope-Labeled Compounds |
| HY-B0532B | Trifluoperazine (dimaleate) | 605-75-4 | Reference compound |
| HY-B0532S | Trifluoperazine-d8 | Isotope-Labeled Compounds | |
| HY-B0534 | Moclobemide | 71320-77-9 | Reference compound |
| HY-B0534R | Moclobemide (Standard) | 71320-77-9 | Reference Standards |
| HY-B0534S | Moclobemide-d8 | 2309010-25-9 | Isotope-Labeled Compounds |
| HY-B0534S1 | Moclobemide-d4 | Isotope-Labeled Compounds | |
| HY-B0535 | Ethambutol | 74-55-5 | Reference compound |
| HY-B0535A | Ethambutol (dihydrochloride) | 1070-11-7 | Natural Products |
| HY-B0535AR | Ethambutol (dihydrochloride) (Standard) | 1070-11-7 | Reference Standards |
| HY-B0535AS | Ethambutol-d4 dihydrochloride | Isotope-Labeled Compounds | |
| HY-B0535R | Ethambutol (Standard) | 74-55-5 | Reference Standards |
| HY-B0535S | Ethambutol-d4 | 1129526-19-7 | Isotope-Labeled Compounds |
| HY-B0535S1 | Ethambutol-d10 | 1129526-24-4 | Isotope-Labeled Compounds |
| HY-B0535S2 | Ethambutol-d8 | 1129526-23-3 | Isotope-Labeled Compounds |
| HY-B0536 | Clinafloxacin | 105956-97-6 | Reference compound |
| HY-B0536A | Clinafloxacin (hydrochloride) | 105956-99-8 | Reference compound |
| HY-B0536R | Clinafloxacin (Standard) | 105956-97-6 | Reference Standards |
| HY-B0537 | Pentamidine | 100-33-4 | Reference compound |
| HY-B0537A | Pentamidine (dihydrochloride) | 50357-45-4 | Reference compound |
| HY-B0537AS | Pentamidine-d4 (dihydrochloride) | 1276197-32-0 | Isotope-Labeled Compounds |
| HY-B0537B | Pentamidine (isethionate) | 140-64-7 | Reference compound |
| HY-B0537BR | Pentamidine (isethionate) (Standard) | 140-64-7 | Reference Standards |
| HY-B0537C | Pentamidine (dimesylate) | 6823-79-6 | Reference compound |
| HY-B0537R | Pentamidine (Standard) | 100-33-4 | Reference Standards |
| HY-B0538A | Pemirolast (potassium) | 100299-08-9 | Reference compound |
| HY-B0539 | Desloratadine | 100643-71-8 | Natural Products |
| HY-B0539R | Desloratadine (Standard) | 100643-71-8 | Reference Standards |
| HY-B0539S | Desloratadine-d4 | 381727-29-3 | Isotope-Labeled Compounds |
| HY-B0539S1 | Desloratadine-d9 | 1795024-82-6 | Isotope-Labeled Compounds |
| HY-B0539S2 | Desloratadine-3,3,5,5-d4 | 2713301-38-1 | Isotope-Labeled Compounds |
| HY-B0539S3 | Desloratadine-d5 | 1020719-34-9 | Isotope-Labeled Compounds |
| HY-B0539S4 | Desloratadine-d4 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-B0540 | Disodium monofluorophosphate | 10163-15-2 | Biochemical Assay Reagents |
| HY-B0541 | Cyclamic acid | 100-88-9 | Reference compound |
| HY-B0541S | Cyclamic Acid-d11 | 1215770-73-2 | Isotope-Labeled Compounds |
| HY-B0543 | Allylthiourea | 109-57-9 | Reference compound |
| HY-B0543R | Allylthiourea (Standard) | 109-57-9 | Reference Standards |
| HY-B0544 | Sodium Picosulfate | 10040-45-6 | Reference compound |
| HY-B0544R | Sodium Picosulfate (Standard) | 10040-45-6 | Reference Standards |
| HY-B0545 | Probenecid | 57-66-9 | Reference compound |
| HY-B0545R | Probenecid (Standard) | 57-66-9 | Reference Standards |
| HY-B0545S | Probenecid-d14 | 1189657-87-1 | Isotope-Labeled Compounds |
| HY-B0545S1 | Probenecid-d7 | 2012598-90-0 | Isotope-Labeled Compounds |
| HY-B0546 | Procaine | 59-46-1 | Reference compound |
| HY-B0546A | Procaine (hydrochloride) | 51-05-8 | Reference compound |
| HY-B0546AR | Procaine (hydrochloride) (Standard) | 51-05-8 | Reference Standards |
| HY-B0546AS | Procaine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0547 | Homatropine | 87-00-3 | Reference compound |
| HY-B0547A | Homatropine (Bromide) | 51-56-9 | Reference compound |
| HY-B0547AR | Homatropine (Bromide) (Standard) | 51-56-9 | Reference Standards |
| HY-B0548 | Hydroxyzine | 68-88-2 | Reference compound |
| HY-B0548A | Hydroxyzine (dihydrochloride) | 2192-20-3 | Reference compound |
| HY-B0548AR | Hydroxyzine (dihydrochloride) (Standard) | 2192-20-3 | Reference Standards |
| HY-B0548AS | Hydroxyzine-d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B0548AS1 | Hydroxyzine-d4' (dihydrochloride) | 1219805-91-0 | Isotope-Labeled Compounds |
| HY-B0548AS2 | Hydroxyzine-d8 (dihydrochloride) | 1808202-93-8 | Isotope-Labeled Compounds |
| HY-B0548R | Hydroxyzine (Standard) | 68-88-2 | Reference Standards |
| HY-B0548S1 | Hydroxyzine D8 | 1189480-47-4 | Isotope-Labeled Compounds |
| HY-B0549 | Flavoxate | 15301-69-6 | Reference compound |
| HY-B0549A | Flavoxate (hydrochloride) | 3717-88-2 | Reference compound |
| HY-B0549AR | Flavoxate (hydrochloride) (Standard) | 3717-88-2 | Reference Standards |
| HY-B0549AS | Flavoxate-d4 (hydrochloride) | 1189678-43-0 | Isotope-Labeled Compounds |
| HY-B0549S | Flavoxate-d5 | 2748541-85-5 | Isotope-Labeled Compounds |
| HY-B0550 | Bismuth Subsalicylate | 14882-18-9 | Reference compound |
| HY-B0550R | Bismuth Subsalicylate (Standard) | 14882-18-9 | Reference Standards |
| HY-B0551 | Doxapram | 309-29-5 | Reference compound |
| HY-B0551A | Doxapram (hydrochloride hydrate) | 7081-53-0 | Reference compound |
| HY-B0551AR | Doxapram (hydrochloride hydrate) (Standard) | 7081-53-0 | Reference Standards |
| HY-B0551S | Doxapram-d8 | Isotope-Labeled Compounds | |
| HY-B0552 | Dibucaine | 85-79-0 | Reference compound |
| HY-B0552A | Dibucaine (hydrochloride) | 61-12-1 | Reference compound |
| HY-B0552AR | Dibucaine (hydrochloride) (Standard) | 61-12-1 | Reference Standards |
| HY-B0552R | Dibucaine (Standard) | 85-79-0 | Reference Standards |
| HY-B0552S | Dibucaine-d9 | 98006-44-1 | Isotope-Labeled Compounds |
| HY-B0553 | Methazolamide | 554-57-4 | Reference compound |
| HY-B0553R | Methazolamide (Standard) | 554-57-4 | Reference Standards |
| HY-B0553S | Methazolamide-d6 | 1795142-30-1 | Isotope-Labeled Compounds |
| HY-B0554 | Norethindrone | 68-22-4 | Reference compound |
| HY-B0554R | Norethindrone (Standard) | 68-22-4 | Reference Standards |
| HY-B0554S | Norethindrone-d6 | 2376036-05-2 | Isotope-Labeled Compounds |
| HY-B0554S1 | Norethindrone-13C2 | 201741-02-8 | Isotope-Labeled Compounds |
| HY-B0554S2 | Norethindrone-d8 | Isotope-Labeled Compounds | |
| HY-B0555 | Nafcillin | 147-52-4 | Reference compound |
| HY-B0555A | Nafcillin (sodium monohydrate) | 7177-50-6 | Reference compound |
| HY-B0555AR | Nafcillin (sodium monohydrate) (Standard) | 7177-50-6 | Reference Standards |
| HY-B0555B | Nafcillin (sodium) | 985-16-0 | Reference compound |
| HY-B0555BR | Nafcillin (sodium) (Standard) | 985-16-0 | Reference Standards |
| HY-B0555BS | Nafcillin-d5 (sodium) | 1356354-25-0 | Isotope-Labeled Compounds |
| HY-B0556 | Tetrahydrozoline | 84-22-0 | Reference compound |
| HY-B0556A | Tetrahydrozoline (hydrochloride) | 522-48-5 | Reference compound |
| HY-B0556AR | Tetrahydrozoline (hydrochloride) (Standard) | 522-48-5 | Reference Standards |
| HY-B0556AS | Tetrahydrozoline-d4 (hydrochloride) | 1246814-66-3 | Isotope-Labeled Compounds |
| HY-B0556B | Tetrahydrozoline (nitrate) | 118201-38-0 | Reference compound |
| HY-B0556R | Tetrahydrozoline (Standard) | 84-22-0 | Reference Standards |
| HY-B0557 | Bisacodyl | 603-50-9 | Reference compound |
| HY-B0557R | Bisacodyl (Standard) | 603-50-9 | Reference Standards |
| HY-B0558 | Carbimazole | 22232-54-8 | Reference compound |
| HY-B0558R | Carbimazole (Standard) | 22232-54-8 | Reference Standards |
| HY-B0558S | Carbimazole-d5 | Isotope-Labeled Compounds | |
| HY-B0559 | Nabumetone | 42924-53-8 | Reference compound |
| HY-B0559R | Nabumetone (Standard) | 42924-53-8 | Reference Standards |
| HY-B0559S | Nabumetone-d3 | 1216770-08-9 | Isotope-Labeled Compounds |
| HY-B0560A | Ammonium aluminum sulfate dodecahydrate | 7784-26-1 | Biochemical Assay Reagents |
| HY-B0560B | Barium sulfate | 7727-43-7 | Biochemical Assay Reagents |
| HY-B0561 | Spironolactone | 52-01-7 | Reference compound |
| HY-B0561R | Spironolactone (Standard) | 52-01-7 | Reference Standards |
| HY-B0561S | Spironolactone-d7 | Isotope-Labeled Compounds | |
| HY-B0561S1 | Spironolactone-d3 | Isotope-Labeled Compounds | |
| HY-B0561S2 | Spironolactone-d3-1 | Isotope-Labeled Compounds | |
| HY-B0562 | Methyclothiazide | 135-07-9 | Reference compound |
| HY-B0562R | Methyclothiazide (Standard) | 135-07-9 | Reference Standards |
| HY-B0563 | Ropivacaine | 84057-95-4 | Reference compound |
| HY-B0563A | Ropivacaine (hydrochloride monohydrate) | 132112-35-7 | Reference compound |
| HY-B0563AR | Ropivacaine (hydrochloride monohydrate) (Standard) | 132112-35-7 | Reference Standards |
| HY-B0563B | Ropivacaine (hydrochloride) | 98717-15-8 | Reference compound |
| HY-B0563BS | Ropivacaine-d7 (hydrochloride) | 1217667-10-1 | Isotope-Labeled Compounds |
| HY-B0563C | Ropivacaine (mesylate) | 854056-07-8 | Reference compound |
| HY-B0563R | Ropivacaine (Standard) | 84057-95-4 | Reference Standards |
| HY-B0563S | (Rac)-Ropivacaine-d7 | 1392208-04-6 | Isotope-Labeled Compounds |
| HY-B0563S1 | Ropivacaine-d7 | 684647-62-9 | Isotope-Labeled Compounds |
| HY-B0564 | Sodium nitroprusside | 14402-89-2 | Reference compound |
| HY-B0565 | Ronidazole | 7681-76-7 | Reference compound |
| HY-B0565R | Ronidazole (Standard) | 7681-76-7 | Reference Standards |
| HY-B0565S | Ronidazole-d3 | 1015855-87-4 | Isotope-Labeled Compounds |
| HY-B0566 | Guanabenz (Acetate) | 23256-50-0 | Reference compound |
| HY-B0566R | Guanabenz (Acetate) (Standard) | 23256-50-0 | Reference Standards |
| HY-B0567 | Dequalinium (Chloride) | 522-51-0 | Reference compound |
| HY-B0567R | Dequalinium (Chloride) (Standard) | 522-51-0 | Reference Standards |
| HY-B0568 | Deferiprone | 30652-11-0 | Reference compound |
| HY-B0568R | Deferiprone (Standard) | 30652-11-0 | Reference Standards |
| HY-B0568S | Deferiprone-d3 | 1346601-82-8 | Isotope-Labeled Compounds |
| HY-B0569 | Hexamethonium (Bromide) | 55-97-0 | Reference compound |
| HY-B0570 | Decamethonium (Bromide) | 541-22-0 | Reference compound |
| HY-B0570A | Decamethonium (Bromide)(Reagent for Ion-Pair Chromatography,99%) | 541-22-0 | Biochemical Assay Reagents |
| HY-B0572 | Zinc Pyrithione | 13463-41-7 | Reference compound |
| HY-B0572R | Zinc Pyrithione (Standard) | 13463-41-7 | Reference Standards |
| HY-B0573 | Propranolol (hydrochloride) | 318-98-9 | Natural Products |
| HY-B0573A | (S)-(-)-Propranolol (hydrochloride) | 4199-10-4 | Reference compound |
| HY-B0573B | Propranolol | 525-66-6 | Natural Products |
| HY-B0573BS | Propranolol-d7 | 98897-23-5 | Isotope-Labeled Compounds |
| HY-B0573CS | (R)-Propranolol-d7 | 1346617-25-1 | Isotope-Labeled Compounds |
| HY-B0573R | Propranolol (hydrochloride) (Standard) | 318-98-9 | Reference Standards |
| HY-B0573S | Propranolol-d7 (hydrochloride) | 1613439-56-7 | Isotope-Labeled Compounds |
| HY-B0573S1 | Propranolol-d7 (ring-d7) | 344298-99-3 | Isotope-Labeled Compounds |
| HY-B0574 | Mefenamic acid | 61-68-7 | Reference compound |
| HY-B0574R | Mefenamic acid (Standard) | 61-68-7 | Reference Standards |
| HY-B0574S | Mefenamic acid-d4 | 1216745-79-7 | Isotope-Labeled Compounds |
| HY-B0574S1 | Mefenamic Acid-d3 | 1189707-81-0 | Isotope-Labeled Compounds |
| HY-B0574S2 | Mefenamic acid-13C6 | 1325559-19-0 | Isotope-Labeled Compounds |
| HY-B0575 | Triamterene | 396-01-0 | Reference compound |
| HY-B0575R | Triamterene (Standard) | 396-01-0 | Reference Standards |
| HY-B0575S | Triamterene-d5 | 1189922-23-3 | Isotope-Labeled Compounds |
| HY-B0576 | Sulfacetamide (sodium) | 127-56-0 | Reference compound |
| HY-B0576R | Sulfacetamide (sodium) (Standard) | 127-56-0 | Reference Standards |
| HY-B0577 | Latanoprost | 130209-82-4 | Reference compound |
| HY-B0577R | Latanoprost (Standard) | 130209-82-4 | Reference Standards |
| HY-B0577S | Latanoprost-d4 | Isotope-Labeled Compounds | |
| HY-B0578 | Loxoprofen | 68767-14-6 | Reference compound |
| HY-B0578A | Loxoprofen (sodium) | 80382-23-6 | Reference compound |
| HY-B0578AR | Loxoprofen (sodium) (Standard) | 80382-23-6 | Reference Standards |
| HY-B0578B | Loxoprofen (sodium) (dihydrate) | 226721-96-6 | Reference compound |
| HY-B0578R | Loxoprofen (Standard) | 68767-14-6 | Reference Standards |
| HY-B0578S | Loxoprofen-d4 | Isotope-Labeled Compounds | |
| HY-B0579 | Cyclosporin A | 59865-13-3 | Natural Products |
| HY-B0579R | Cyclosporin A (Standard) | 59865-13-3 | Reference Standards |
| HY-B0579S | Cyclosporin A-d4 | Isotope-Labeled Compounds | |
| HY-B0579S1 | Cyclosporin A-d3 | 222295-76-3 | Isotope-Labeled Compounds |
| HY-B0579S2 | Cyclosporin A acetate-d4 | Isotope-Labeled Compounds | |
| HY-B0579S3 | Cyclosporin A-13C2,d4 | Isotope-Labeled Compounds | |
| HY-B0579S5 | Cyclosporin A-d12 | Isotope-Labeled Compounds | |
| HY-B0580 | Ketorolac | 74103-06-3 | Reference compound |
| HY-B0580A | (S)-Ketorolac | 66635-92-5 | Reference compound |
| HY-B0580B | (R)-Ketorolac | 66635-93-6 | Reference compound |
| HY-B0580C | Ketorolac (hemicalcium) | 167105-81-9 | Reference compound |
| HY-B0580D | Ketorolac (hydrochloride) | 218934-99-7 | Reference compound |
| HY-B0580R | Ketorolac (Standard) | 74103-06-3 | Reference Standards |
| HY-B0580S | Ketorolac-d5 | 1215767-66-0 | Isotope-Labeled Compounds |
| HY-B0580S1 | Ketorolac-d4 | 1216451-53-4 | Isotope-Labeled Compounds |
| HY-B0580S2 | Ketorolac-13C6 | Isotope-Labeled Compounds | |
| HY-B0581 | Dexrazoxane | 24584-09-6 | Reference compound |
| HY-B0581R | Dexrazoxane (Standard) | 24584-09-6 | Reference Standards |
| HY-B0584 | Travoprost | 157283-68-6 | Reference compound |
| HY-B0584A | 5,6-trans-Travoprost | 1563176-59-9 | Reference compound |
| HY-B0584R | Travoprost (Standard) | 157283-68-6 | Reference Standards |
| HY-B0584S2 | Travoprost-d7 | Isotope-Labeled Compounds | |
| HY-B0585 | Piracetam | 7491-74-9 | Reference compound |
| HY-B0585R | Piracetam (Standard) | 7491-74-9 | Reference Standards |
| HY-B0585S | Piracetam-d8 | 1329799-64-5 | Isotope-Labeled Compounds |
| HY-B0585S1 | Piracetam-d6 | Isotope-Labeled Compounds | |
| HY-B0586 | Methylcobalamin | 13422-55-4 | Natural Products |
| HY-B0586R | Methylcobalamin (Standard) | 13422-55-4 | Reference Standards |
| HY-B0588 | Brinzolamide | 138890-62-7 | Reference compound |
| HY-B0588A | Brinzolamide (hydrochloride) | 150937-43-2 | Reference compound |
| HY-B0588AS | Brinzolamide-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0588R | Brinzolamide (Standard) | 138890-62-7 | Reference Standards |
| HY-B0588S | Brinzolamide-d5 | 1217651-02-9 | Isotope-Labeled Compounds |
| HY-B0589 | Atorvastatin | 134523-00-5 | Reference compound |
| HY-B0589C | (3S,5S)-Atorvastatin | 501121-34-2 | Reference compound |
| HY-B0589E | Atorvastatin (hemicalcium trihydrate) | 344920-08-7 | Reference compound |
| HY-B0589H | Atorvastatin (strontium) | 1072903-92-4 | Reference compound |
| HY-B0589R | Atorvastatin (Standard) | 134523-00-5 | Reference Standards |
| HY-B0589S | Atorvastatin-d5 (hemicalcium) | 222412-82-0 | Isotope-Labeled Compounds |
| HY-B0589S1 | Atorvastatin-d5 (sodium) | 222412-87-5 | Isotope-Labeled Compounds |
| HY-B0590 | Tetrabenazine | 58-46-8 | Reference compound |
| HY-B0590A | Tetrabenazine (Racemate) | 718635-93-9 | Reference compound |
| HY-B0590B | (+)-Tetrabenazine | 1026016-83-0 | Reference compound |
| HY-B0590D | (-)-Tetrabenazine | 1026016-84-1 | Reference compound |
| HY-B0590E | Tetrabenazine (mesylate) | 804-53-5 | Reference compound |
| HY-B0590R | Tetrabenazine (Standard) | 58-46-8 | Reference Standards |
| HY-B0590S | Tetrabenazine-d6 | 1392826-25-3 | Isotope-Labeled Compounds |
| HY-B0590S1 | (+)-Tetrabenazine D6 | 1977511-05-9 | Isotope-Labeled Compounds |
| HY-B0590S3 | Tetrabenazine-d7 | 2701977-99-1 | Isotope-Labeled Compounds |
| HY-B0591 | Memantine | 19982-08-2 | Reference compound |
| HY-B0591S | Memantine-d3 (hydrochloride) | 1329802-06-3 | Isotope-Labeled Compounds |
| HY-B0592 | Trandolapril | 87679-37-6 | Reference compound |
| HY-B0592A | Trandolapril (hydrochloride) | 87725-72-2 | Reference compound |
| HY-B0592R | Trandolapril (Standard) | 87679-37-6 | Reference Standards |
| HY-B0592S | Trandolapril-d5 | 1356847-98-7 | Isotope-Labeled Compounds |
| HY-B0592S2 | rac-Trandolapril-d5 | Isotope-Labeled Compounds | |
| HY-B0593 | Ceftazidime | 72558-82-8 | Reference compound |
| HY-B0593A | Ceftazidime (pentahydrate) | 78439-06-2 | Reference compound |
| HY-B0593AR | Ceftazidime (pentahydrate) (Standard) | 78439-06-2 | Reference Standards |
| HY-B0593R | Ceftazidime (Standard) | 72558-82-8 | Reference Standards |
| HY-B0593S | Ceftazidime-d5 | Isotope-Labeled Compounds | |
| HY-B0594 | Iohexol | 66108-95-0 | Reference compound |
| HY-B0594R | Iohexol (Standard) | 66108-95-0 | Reference Standards |
| HY-B0594S | Iohexol-d5 | 928623-33-0 | Isotope-Labeled Compounds |
| HY-B0595 | Ramosetron (Hydrochloride) | 132907-72-3 | Reference compound |
| HY-B0595R | Ramosetron (Hydrochloride) (Standard) | 132907-72-3 | Reference Standards |
| HY-B0596 | Taltirelin | 103300-74-9 | Reference compound |
| HY-B0596A | Taltirelin (acetate) | 1549593-23-8 | Reference compound |
| HY-B0596S | Taltirelin-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0597 | Fondaparinux (sodium) | 114870-03-0 | Reference compound |
| HY-B0597R | Fondaparinux (sodium) (Standard) | 114870-03-0 | Reference Standards |
| HY-B0600 | Tafluprost | 209860-87-7 | Reference compound |
| HY-B0600R | Tafluprost (Standard) | 209860-87-7 | Reference Standards |
| HY-B0601 | Tafluprost acid | 209860-88-8 | Reference compound |
| HY-B0601R | Tafluprost acid (Standard) | 209860-88-8 | Reference Standards |
| HY-B0602 | Desvenlafaxine | 93413-62-8 | Reference compound |
| HY-B0602A | Desvenlafaxine (succinate hydrate) | 386750-22-7 | Reference compound |
| HY-B0602AS | Desvenlafaxine-d6 (succinate hydrate) | Isotope-Labeled Compounds | |
| HY-B0602B | Desvenlafaxine (fumarate) | 93414-04-1 | Reference compound |
| HY-B0602C | Desvenlafaxine (hydrochloride) | 300827-87-6 | Reference compound |
| HY-B0602D | (S)-(+)-O-Desmethyl Venlafaxine | 142761-12-4 | Reference compound |
| HY-B0602R | Desvenlafaxine (Standard) | 93413-62-8 | Reference Standards |
| HY-B0602S | (R)-(-)-O-Desmethyl Venlafaxine-d6 | 1062609-96-4 | Isotope-Labeled Compounds |
| HY-B0602S1 | (S)-(+)-O-Desmethyl Venlafaxine-d6 | 1062609-99-7 | Isotope-Labeled Compounds |
| HY-B0602S2 | Desvenlafaxine-d6 | 1062605-69-9 | Isotope-Labeled Compounds |
| HY-B0602S3 | Desvenlafaxine-d10 | 1062607-49-1 | Isotope-Labeled Compounds |
| HY-B0603 | Fluticasone | 90566-53-3 | Reference compound |
| HY-B0603R | Fluticasone (Standard) | 90566-53-3 | Reference Standards |
| HY-B0606 | Diquafosol (tetrasodium) | 211427-08-6 | Reference compound |
| HY-B0606A | Diquafosol | 59985-21-6 | Reference compound |
| HY-B0607 | Nitisinone | 104206-65-7 | Reference compound |
| HY-B0607R | Nitisinone (Standard) | 104206-65-7 | Reference Standards |
| HY-B0607S | Nitisinone-d3 | Isotope-Labeled Compounds | |
| HY-B0608 | Chlorhexidine (digluconate) (20% in water) | 18472-51-0 | Reference compound |
| HY-B0609 | Fosfomycin (tromethamine) | 78964-85-9 | Reference compound |
| HY-B0612 | Lercanidipine | 100427-26-7 | Reference compound |
| HY-B0612A | Lercanidipine (hydrochloride) | 132866-11-6 | Reference compound |
| HY-B0612AR | Lercanidipine (hydrochloride) (Standard) | 132866-11-6 | Reference Standards |
| HY-B0612AS | Lercanidipine-13C,d3 (hydrochloride) | 1261397-71-0 | Isotope-Labeled Compounds |
| HY-B0612AS1 | Lercanidipine-13C,d3-1 (hydrochloride) | 2747918-20-1 | Isotope-Labeled Compounds |
| HY-B0612B | (S)-Lercanidipine | 185197-71-1 | Reference compound |
| HY-B0612C | (R)-Lercanidipine | 185197-70-0 | Reference compound |
| HY-B0612D | (R)-Lercanidipine (hydrochloride) | 187731-34-6 | Reference compound |
| HY-B0612DS | (R)-Lercanidipine-d3 (hydrochloride) | 1217724-52-1 | Isotope-Labeled Compounds |
| HY-B0612DS1 | Lercanidipine-d3 (hydrochloride) | 1189954-18-4 | Isotope-Labeled Compounds |
| HY-B0612E | (S)-Lercanidipine (hydrochloride) | 184866-29-3 | Reference compound |
| HY-B0612ES | (S)-Lercanidipine-d3 (hydrochloride) | 1217740-02-7 | Isotope-Labeled Compounds |
| HY-B0614 | Mafenide | 138-39-6 | Reference compound |
| HY-B0614A | Mafenide (Acetate) | 13009-99-9 | Reference compound |
| HY-B0614AR | Mafenide (Acetate) (Standard) | 13009-99-9 | Reference Standards |
| HY-B0614B | Mafenide (hydrochloride) | 138-37-4 | Reference compound |
| HY-B0614BR | Mafenide (hydrochloride) (Standard) | 138-37-4 | Reference Standards |
| HY-B0615A | Moricizine (Hydrochloride) | 29560-58-5 | Reference compound |
| HY-B0615AS | Moricizine-d8(Hydrochloride) | 2300178-76-9 | Isotope-Labeled Compounds |
| HY-B0616 | Cefepime (Dihydrochloride Monohydrate) | 123171-59-5 | Reference compound |
| HY-B0616R | Cefepime (Dihydrochloride Monohydrate) (Standard) | 123171-59-5 | Reference Standards |
| HY-B0617 | S-Adenosyl-L-methionine | 29908-03-0 | Natural Products |
| HY-B0617A | S-Adenosyl-L-methionine (tosylate) | 52248-03-0 | Natural Products |
| HY-B0617AR | S-Adenosyl-L-methionine (tosylate) (Standard) | 52248-03-0 | Reference Standards |
| HY-B0617B | S-Adenosyl-L-methionine (1,4-butanedisulfonate) | 200393-05-1 | Reference compound |
| HY-B0617S | S-Adenosyl-L-methionine-d3 | 68684-40-2 | Isotope-Labeled Compounds |
| HY-B0617S2 | S-Adenosyl-L-methionine-13C (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B0619 | Zaltoprofen | 74711-43-6 | Reference compound |
| HY-B0619S1 | Zaltoprofen-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0621 | Triclabendazole | 68786-66-3 | Reference compound |
| HY-B0621R | Triclabendazole (Standard) | 68786-66-3 | Reference Standards |
| HY-B0621S | Triclabendazole-d3 | 1353867-93-2 | Isotope-Labeled Compounds |
| HY-B0621S1 | Triclabendazole-13C,d3 | 2938916-53-9 | Isotope-Labeled Compounds |
| HY-B0623 | Ropinirole | 91374-21-9 | Reference compound |
| HY-B0623A | Ropinirole (hydrochloride) | 91374-20-8 | Reference compound |
| HY-B0623AR | Ropinirole (hydrochloride) (Standard) | 91374-20-8 | Reference Standards |
| HY-B0623AS1 | Ropinirole-d7 (hydrochloride) | 1261396-31-9 | Isotope-Labeled Compounds |
| HY-B0623AS2 | Ropinirole-d3 (hydrochloride) | 1329611-00-8 | Isotope-Labeled Compounds |
| HY-B0623AS3 | Ropinirole-d14 (hydrochloride) | 1276197-10-4 | Isotope-Labeled Compounds |
| HY-B0623S | Ropinirole-d14 | 1132746-05-4 | Isotope-Labeled Compounds |
| HY-B0623S1 | Ropinirole-d3 | 1132746-02-1 | Isotope-Labeled Compounds |
| HY-B0625 | Ciclesonide | 126544-47-6 | Reference compound |
| HY-B0625R | Ciclesonide (Standard) | 126544-47-6 | Reference Standards |
| HY-B0625S | Ciclesonide-d7 | 1225382-70-6 | Isotope-Labeled Compounds |
| HY-B0627 | Metformin | 657-24-9 | Reference compound |
| HY-B0627A | Metformin (glycinate) | 121369-64-0 | Reference compound |
| HY-B0628 | Vinflunine | 162652-95-1 | Natural Products |
| HY-B0629 | Mometasone | 105102-22-5 | Reference compound |
| HY-B0629R | Mometasone (Standard) | 105102-22-5 | Reference Standards |
| HY-B0629S | Mometasone-d5 | Isotope-Labeled Compounds | |
| HY-B0631 | Alendronic acid | 66376-36-1 | Reference compound |
| HY-B0631S | Alendronic acid-d6 | 1035437-39-8 | Isotope-Labeled Compounds |
| HY-B0632 | Diltiazem | 42399-41-7 | Reference compound |
| HY-B0632A | Diltiazem (malate) | 144604-00-2 | Reference compound |
| HY-B0632B | (2R,3R)-Diltiazem (hydrochloride) | 42399-54-2 | Reference compound |
| HY-B0632R | Diltiazem (Standard) | 42399-41-7 | Reference Standards |
| HY-B0632S | Diltiazem-d6 | 1242184-41-3 | Isotope-Labeled Compounds |
| HY-B0632S2 | Diltiazem-d4 | 112259-41-3 | Isotope-Labeled Compounds |
| HY-B0633 | Hyaluronic acid (sodium) | 9067-32-7 | Natural Products |
| HY-B0633A | Hyaluronic acid | 9004-61-9 | Natural Products |
| HY-B0633C | Hyaluronic acid (Mw:1000-2000Da) | 9004-61-9 | Natural Products |
| HY-B0633D | Hyaluronic acid (sodium) (MW 200-1560) | 9067-32-7 | Reference compound |
| HY-B0633E | Hyaluronic acid, low endotoxin | 9004-61-9 | Biochemical Assay Reagents |
| HY-B0634 | Aceclofenac | 89796-99-6 | Reference compound |
| HY-B0634R | Aceclofenac (Standard) | 89796-99-6 | Reference Standards |
| HY-B0634S | Aceclofenac-d4 | Isotope-Labeled Compounds | |
| HY-B0636 | Triamcinolone acetonide | 76-25-5 | Reference compound |
| HY-B0636R | Triamcinolone acetonide (Standard) | 76-25-5 | Reference Standards |
| HY-B0636S | Triamcinolone acetonide-d7 | Isotope-Labeled Compounds | |
| HY-B0636S2 | Triamcinolone acetonide-d7-1 | Isotope-Labeled Compounds | |
| HY-B0636S3 | Triamcinolone acetonide-d6 | 352431-33-5 | Isotope-Labeled Compounds |
| HY-B0637 | Bezafibrate | 41859-67-0 | Reference compound |
| HY-B0637R | Bezafibrate (Standard) | 41859-67-0 | Reference Standards |
| HY-B0637S | Bezafibrate-d6 | 1219802-74-0 | Isotope-Labeled Compounds |
| HY-B0637S1 | Bezafibrate-d4 | 1189452-53-6 | Isotope-Labeled Compounds |
| HY-B0637S2 | Bezafibrate-13C6 | Isotope-Labeled Compounds | |
| HY-B0639 | Amifostine | 20537-88-6 | Reference compound |
| HY-B0639A | Amifostine (trihydrate) | 112901-68-5 | Reference compound |
| HY-B0639C | Amifostine (sodium) | 59178-37-9 | Reference compound |
| HY-B0640 | Epinastine | 80012-43-7 | Reference compound |
| HY-B0640A | Epinastine (hydrochloride) | 108929-04-0 | Reference compound |
| HY-B0640AR | Epinastine (hydrochloride) (Standard) | 108929-04-0 | Reference Standards |
| HY-B0640S | Epinastine-13C,d3 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-B0641 | Felbinac | 5728-52-9 | Reference compound |
| HY-B0641R | Felbinac (Standard) | 5728-52-9 | Reference Standards |
| HY-B0642 | Isosorbide mononitrate | 16051-77-7 | Reference compound |
| HY-B0642R | Isosorbide mononitrate (Standard) | 16051-77-7 | Reference Standards |
| HY-B0643 | Dirithromycin | 62013-04-1 | Reference compound |
| HY-B0643R | Dirithromycin (Standard) | 62013-04-1 | Reference Standards |
| HY-B0644 | Sucralfate | 54182-58-0 | Reference compound |
| HY-B0644R | Sucralfate (Standard) | 54182-58-0 | Reference Standards |
| HY-B0645 | Prednisolone (disodium phosphate) | 125-02-0 | Reference compound |
| HY-B0645R | Prednisolone (disodium phosphate) (Standard) | 125-02-0 | Reference Standards |
| HY-B0647 | Butylphthalide | 6066-49-5 | Natural Products |
| HY-B0647A | (3S)-Butylphthalide | 3413-15-8 | Reference compound |
| HY-B0647R | Butylphthalide (Standard) | 6066-49-5 | Reference Standards |
| HY-B0647S1 | Butylphthalide-d3 | Isotope-Labeled Compounds | |
| HY-B0648 | Medroxyprogesterone | 520-85-4 | Reference compound |
| HY-B0648R | Medroxyprogesterone (Standard) | 520-85-4 | Reference Standards |
| HY-B0648S | Medroxyprogesterone-d3 | 162462-69-3 | Isotope-Labeled Compounds |
| HY-B0648S1 | Medroxyprogesterone-d7 | Isotope-Labeled Compounds | |
| HY-B0649 | Propofol | 2078-54-8 | Reference compound |
| HY-B0649R | Propofol (Standard) | 2078-54-8 | Reference Standards |
| HY-B0649S | Propofol-d17 | 1261393-54-7 | Isotope-Labeled Compounds |
| HY-B0649S1 | Propofol-d18 | 1189467-93-3 | Isotope-Labeled Compounds |
| HY-B0652 | Etonogestrel | 54048-10-1 | Reference compound |
| HY-B0652R | Etonogestrel (Standard) | 54048-10-1 | Reference Standards |
| HY-B0652S1 | Etonogestrel-d6 | Isotope-Labeled Compounds | |
| HY-B0653 | Levobupivacaine | 27262-47-1 | Reference compound |
| HY-B0653A | Levobupivacaine (hydrochloride) | 27262-48-2 | Reference compound |
| HY-B0653AS | Levobupivacaine-d9 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0655 | Zofenopril (calcium) | 81938-43-4 | Reference compound |
| HY-B0656 | Rabeprazole | 117976-89-3 | Reference compound |
| HY-B0656A | Rabeprazole (sodium) | 117976-90-6 | Reference compound |
| HY-B0656AR | Rabeprazole (sodium) (Standard) | 117976-90-6 | Reference Standards |
| HY-B0656AS | Rabeprazole-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-B0656AS1 | Rabeprazole-d3 (sodium) | 1216494-11-9 | Isotope-Labeled Compounds |
| HY-B0656AS2 | Rabeprazole-d4 (potassium) | Isotope-Labeled Compounds | |
| HY-B0656AS3 | Rabeprazole-13C,d3 (sodium) | Isotope-Labeled Compounds | |
| HY-B0656R | Rabeprazole (Standard) | 117976-89-3 | Reference Standards |
| HY-B0656S | Rabeprazole-d4 | 934295-48-4 | Isotope-Labeled Compounds |
| HY-B0656S1 | Rabeprazole-13C,d3 | 1261392-48-6 | Isotope-Labeled Compounds |
| HY-B0657 | Clodronic acid | 10596-23-3 | Reference compound |
| HY-B0657A | Clodronic acid (disodium salt) | 22560-50-5 | Reference compound |
| HY-B0658A | Zinc (acetate dihydrate), ACS, 98% | 5970-45-6 | Biochemical Assay Reagents |
| HY-B0659 | Brimonidine | 59803-98-4 | Reference compound |
| HY-B0659A | Brimonidine (tartrate) | 70359-46-5 | Reference compound |
| HY-B0659AR | Brimonidine (tartrate) (Standard) | 70359-46-5 | Reference Standards |
| HY-B0659AS | Brimonidine-d4 (D-tartrate) | 1316758-27-6 | Isotope-Labeled Compounds |
| HY-B0659R | Brimonidine (Standard) | 59803-98-4 | Reference Standards |
| HY-B0659S | Brimonidine-d4 | 1184971-51-4 | Isotope-Labeled Compounds |
| HY-B0660 | Eicosapentaenoic Acid | 10417-94-4 | Natural Products |
| HY-B0660A | Eicosapentaenoic acid (metformin) | 1384526-74-2 | Reference compound |
| HY-B0660R | Eicosapentaenoic Acid (Standard) | 10417-94-4 | Reference Standards |
| HY-B0660S | Eicosapentaenoic Acid-d5 | 1197205-73-4 | Isotope-Labeled Compounds |
| HY-B0660S1 | Eicosapentaenoic acid 1,2,3,4,5-13C5 | Isotope-Labeled Compounds | |
| HY-B0661 | Tamsulosin | 106133-20-4 | Reference compound |
| HY-B0661A | Tamsulosin (hydrochloride) | 106463-17-6 | Reference compound |
| HY-B0661AR | Tamsulosin (hydrochloride) (Standard) | 106463-17-6 | Reference Standards |
| HY-B0661AS | Tamsulosin-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0661AS1 | Tamsulosin-d4 (hydrochloride) | 2518100-55-3 | Isotope-Labeled Compounds |
| HY-B0661C | Tamsolusin (hydrochloride) | 80223-99-0 | Reference compound |
| HY-B0661CS | (Rac)-Tamsulosin-d3 (hydrochloride) | 1189923-88-3 | Isotope-Labeled Compounds |
| HY-B0661R | Tamsulosin (Standard) | 106133-20-4 | Reference Standards |
| HY-B0661S | Tamsulosin-d4 | 1231943-97-7 | Isotope-Labeled Compounds |
| HY-B0662 | Imidafenacin | 170105-16-5 | Reference compound |
| HY-B0662A | Imidafenacin (hydrochloride) | 893421-54-0 | Reference compound |
| HY-B0662R | Imidafenacin (Standard) | 170105-16-5 | Reference Standards |
| HY-B0664 | Ciprofibrate | 52214-84-3 | Reference compound |
| HY-B0664S | Ciprofibrate-d6 | 2070015-05-1 | Isotope-Labeled Compounds |
| HY-B0665 | Fibrin | 9001-31-4 | Natural Products |
| HY-B0667 | Balsalazide | 80573-04-2 | Reference compound |
| HY-B0667A | Balsalazide (sodium hydrate) | 150399-21-6 | Reference compound |
| HY-B0667S1 | Balsalazide-d4 | 2714315-25-8 | Isotope-Labeled Compounds |
| HY-B0670A | Dihydroergotamine (mesylate) | 6190-39-2 | Reference compound |
| HY-B0670AR | Dihydroergotamine (mesylate) (Standard) | 6190-39-2 | Reference Standards |
| HY-B0670S | Dihydroergotamine-d3 | 1356841-80-9 | Isotope-Labeled Compounds |
| HY-B0671 | Vancomycin | 1404-90-6 | Natural Products |
| HY-B0671R | Vancomycin (Standard) | 1404-90-6 | Reference Standards |
| HY-B0671S3 | Vancomycin-d10 (TFA) | Isotope-Labeled Compounds | |
| HY-B0672 | Estradiol valerate | 979-32-8 | Reference compound |
| HY-B0672R | Estradiol valerate (Standard) | 979-32-8 | Reference Standards |
| HY-B0672S | Estradiol valerianate-d9 | 1316648-98-2 | Isotope-Labeled Compounds |
| HY-B0672S1 | Estradiol valerianate-d4 | 2673269-82-2 | Isotope-Labeled Compounds |
| HY-B0673 | Pirfenidone | 53179-13-8 | Reference compound |
| HY-B0673R | Pirfenidone (Standard) | 53179-13-8 | Reference Standards |
| HY-B0673S | Pirfenidone-d5 | 1020719-62-3 | Isotope-Labeled Compounds |
| HY-B0673S1 | Deupirfenidone | 1093951-85-9 | Isotope-Labeled Compounds |
| HY-B0674 | Ebastine | 90729-43-4 | Reference compound |
| HY-B0674R | Ebastine (Standard) | 90729-43-4 | Reference Standards |
| HY-B0674S | Ebastine-d5 | 1216953-13-7 | Isotope-Labeled Compounds |
| HY-B0674S1 | Ebastine-d6 | Isotope-Labeled Compounds | |
| HY-B0678 | Metaxalone | 1665-48-1 | Reference compound |
| HY-B0678R | Metaxalone (Standard) | 1665-48-1 | Reference Standards |
| HY-B0678S | Metaxalone-d3 | 1192812-66-0 | Isotope-Labeled Compounds |
| HY-B0678S1 | Metaxalone-d6 | 1189944-95-3 | Isotope-Labeled Compounds |
| HY-B0679 | Lubiprostone | 136790-76-6 | Reference compound |
| HY-B0679R | Lubiprostone (Standard) | 136790-76-6 | Reference Standards |
| HY-B0679S | Lubiprostone-d7 | 1217675-13-2 | Isotope-Labeled Compounds |
| HY-B0680 | Lubiprostone (hemiketal) | 333963-40-9 | Reference compound |
| HY-B0680S | Lubiprostone (hemiketal)-d7 | Isotope-Labeled Compounds | |
| HY-B0681 | Acamprosate | 77337-76-9 | Reference compound |
| HY-B0682 | Mitiglinide | 145375-43-5 | Reference compound |
| HY-B0682A | Mitiglinide (calcium hydrate) | 207844-01-7 | Reference compound |
| HY-B0682AR | Mitiglinide (calcium hydrate) (Standard) | 207844-01-7 | Reference Standards |
| HY-B0682S | Mitiglinide-d8 (calcium hydrate) | Isotope-Labeled Compounds | |
| HY-B0682S1 | (2R)-Mitiglinide-d5 (calcium) | Isotope-Labeled Compounds | |
| HY-B0682S2 | Mitiglinide-d5 (calcium) | Isotope-Labeled Compounds | |
| HY-B0683 | Limaprost | 74397-12-9 | Reference compound |
| HY-B0683S | Limaprost-d3 | 1263190-37-9 | Isotope-Labeled Compounds |
| HY-B0684 | Iopamidol | 60166-93-0 | Reference compound |
| HY-B0684R | Iopamidol (Standard) | 60166-93-0 | Reference Standards |
| HY-B0684S | Iopamidol-d8 | 1795778-90-3 | Isotope-Labeled Compounds |
| HY-B0686 | Eptifibatide | 188627-80-7 | Peptides |
| HY-B0686A | Eptifibatide (monoacetate) | 1248559-53-6 | Peptides |
| HY-B0686B | Eptifibatide (acetate) | 881997-86-0 | Peptides |
| HY-B0686BR | Eptifibatide (acetate) (Standard) | 881997-86-0 | Reference Standards |
| HY-B0688 | Dapsone | 80-08-0 | Reference compound |
| HY-B0688R | Dapsone (Standard) | 80-08-0 | Reference Standards |
| HY-B0688S | Dapsone-d8 | 557794-38-4 | Isotope-Labeled Compounds |
| HY-B0688S1 | Dapsone-d4 | 1346602-12-7 | Isotope-Labeled Compounds |
| HY-B0688S2 | Dapsone-13C12 | 1632119-29-9 | Isotope-Labeled Compounds |
| HY-B0688S3 | Dapsone-15N2 | 287476-19-1 | Isotope-Labeled Compounds |
| HY-B0689 | Indinavir | 150378-17-9 | Reference compound |
| HY-B0689A | Indinavir (sulfate) | 157810-81-6 | Reference compound |
| HY-B0689B | Indinavir (sulfate ethanolate) | 2563866-80-6 | Reference compound |
| HY-B0689C | (threo)-Indinavir | 360558-79-8 | Reference compound |
| HY-B0689S | Indinavir-d6 | 185897-02-3 | Isotope-Labeled Compounds |
| HY-B0689S1 | Indinavir-13C4,15N | Isotope-Labeled Compounds | |
| HY-B0690 | Fosinopril | 98048-97-6 | Reference compound |
| HY-B0690S | Fosinopril-d5 | Isotope-Labeled Compounds | |
| HY-B0691 | Ecabet | 33159-27-2 | Reference compound |
| HY-B0691A | Ecabet (sodium) | 86408-72-2 | Reference compound |
| HY-B0692 | Cefepime | 88040-23-7 | Reference compound |
| HY-B0692A | Cefepime (chloride) | 107648-79-3 | Reference compound |
| HY-B0692R | Cefepime (Standard) | 88040-23-7 | Reference Standards |
| HY-B0693 | Ranitidine | 66357-35-5 | Reference compound |
| HY-B0693A | Ranitidine (bismuth citrate) | 128345-62-0 | Reference compound |
| HY-B0696 | Tiagabine | 115103-54-3 | Reference compound |
| HY-B0696A | Tiagabine (hydrochloride) | 145821-59-6 | Reference compound |
| HY-B0696AR | Tiagabine (hydrochloride) (Standard) | 145821-59-6 | Reference Standards |
| HY-B0696AS | Tiagabine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0696B | Tiagabine hydrochloride hydrate | 145821-57-4 | Reference compound |
| HY-B0696S | Tiagabine-d6 | 1217672-34-8 | Isotope-Labeled Compounds |
| HY-B0696S1 | Tiagabine-d4 | Isotope-Labeled Compounds | |
| HY-B0698 | Ceftibuten | 97519-39-6 | Reference compound |
| HY-B0698A | Ceftibuten (dihydrate) | 118081-34-8 | Reference compound |
| HY-B0698B | Ceftibuten (monohydrate) | 1346153-47-6 | Reference compound |
| HY-B0699 | Cefpirome | 84957-29-9 | Reference compound |
| HY-B0700 | Rosiglitazone (sodium) | 316371-83-2 | Reference compound |
| HY-B0702 | Nicergoline | 27848-84-6 | Reference compound |
| HY-B0702R | Nicergoline (Standard) | 27848-84-6 | Reference Standards |
| HY-B0702S | Nicergoline-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0703 | Eslicarbazepine acetate | 236395-14-5 | Reference compound |
| HY-B0703R | Eslicarbazepine acetate (Standard) | 236395-14-5 | Reference Standards |
| HY-B0703S | Eslicarbazepine acetate-d4 | Isotope-Labeled Compounds | |
| HY-B0704 | Azelaic acid | 123-99-9 | Natural Products |
| HY-B0704R | Azelaic acid (Standard) | 123-99-9 | Reference Standards |
| HY-B0704S | Azelaic acid-d14 | 119176-67-9 | Isotope-Labeled Compounds |
| HY-B0705 | Desflurane | 57041-67-5 | Reference compound |
| HY-B0706 | Flomoxef | 99665-00-6 | Reference compound |
| HY-B0706A | Flomoxef (sodium) | 92823-03-5 | Reference compound |
| HY-B0706AR | Flomoxef (sodium) (Standard) | 92823-03-5 | Reference Standards |
| HY-B0708 | β-Estradiol 17-acetate | 1743-60-8 | Natural Products |
| HY-B0710 | Betaine | 107-43-7 | Natural Products |
| HY-B0710S | Betaine-13C3 | 309762-22-9 | Isotope-Labeled Compounds |
| HY-B0711 | Carglumic Acid | 1188-38-1 | Reference compound |
| HY-B0711R | Carglumic Acid (Standard) | 1188-38-1 | Reference Standards |
| HY-B0712 | Ceftriaxone | 73384-59-5 | Reference compound |
| HY-B0712A | Ceftriaxone (sodium hydrate) | 104376-79-6 | Reference compound |
| HY-B0712AR | Ceftriaxone (sodium hydrate) (Standard) | 104376-79-6 | Reference Standards |
| HY-B0712B | Ceftriaxone (sodium salt) | 74578-69-1 | Reference compound |
| HY-B0712R | Ceftriaxone (Standard) | 73384-59-5 | Reference Standards |
| HY-B0712S | Ceftriaxone-d3 (disodium) | 1132650-38-4 | Isotope-Labeled Compounds |
| HY-B0712S1 | Ceftriaxone-13C2,d3 (triethylammonium salt) | Isotope-Labeled Compounds | |
| HY-B0713 | Amlexanox | 68302-57-8 | Reference compound |
| HY-B0713R | Amlexanox (Standard) | 68302-57-8 | Reference Standards |
| HY-B0714 | Dexketoprofen (trometamol) | 156604-79-4 | Reference compound |
| HY-B0714R | Dexketoprofen (trometamol) (Standard) | 156604-79-4 | Reference Standards |
| HY-B0714S | Dexketoprofen-d3 (trometamol) | 2747914-78-7 | Isotope-Labeled Compounds |
| HY-B0715 | Pentoxifylline | 6493-05-6 | Reference compound |
| HY-B0715R | Pentoxifylline (Standard) | 6493-05-6 | Reference Standards |
| HY-B0715S | Pentoxifylline-d6 | 1185878-98-1 | Isotope-Labeled Compounds |
| HY-B0715S2 | Pentoxifylline-d5 | 1185995-18-9 | Isotope-Labeled Compounds |
| HY-B0715S3 | Pentoxifylline-d3 | 1185878-97-0 | Isotope-Labeled Compounds |
| HY-B0716 | Urapidil | 34661-75-1 | Reference compound |
| HY-B0716R | Urapidil (Standard) | 34661-75-1 | Reference Standards |
| HY-B0716S1 | Urapidil-d3 | 1398066-08-4 | Isotope-Labeled Compounds |
| HY-B0716S2 | Urapidil-d4 | 1795122-12-1 | Isotope-Labeled Compounds |
| HY-B0717 | Tocofersolan | 9002-96-4 | Reference compound |
| HY-B0718 | Methoxyflurane | 76-38-0 | Reference compound |
| HY-B0719 | Ingenol Mebutate | 75567-37-2 | Natural Products |
| HY-B0719R | Ingenol Mebutate (Standard) | 75567-37-2 | Reference Standards |
| HY-B0722 | Histamine (dihydrochloride) | 56-92-8 | Natural Products |
| HY-B0722R | Histamine (dihydrochloride) (Standard) | 56-92-8 | Reference Standards |
| HY-B0723 | Ospemifene | 128607-22-7 | Reference compound |
| HY-B0723S | Ospemifene-d4 | Isotope-Labeled Compounds | |
| HY-B0723S2 | Ospemifene-d5 | Isotope-Labeled Compounds | |
| HY-B0724A | Pazufloxacin (mesylate) | 163680-77-1 | Reference compound |
| HY-B0724AR | Pazufloxacin (mesylate) (Standard) | 163680-77-1 | Reference Standards |
| HY-B0724B | Pazufloxacin | 127045-41-4 | Reference compound |
| HY-B0724BS | Pazufloxacin-d4 | 1346602-96-7 | Isotope-Labeled Compounds |
| HY-B0725 | Doxepin (Hydrochloride) | 1229-29-4 | Reference compound |
| HY-B0725A | Doxepin | 1668-19-5 | Reference compound |
| HY-B0725R | Doxepin (Hydrochloride) (Standard) | 1229-29-4 | Reference Standards |
| HY-B0725S | Doxepin-d3 (hydrochloride) | 347840-07-7 | Isotope-Labeled Compounds |
| HY-B0726 | Pilocarpine (Hydrochloride) | 54-71-7 | Natural Products |
| HY-B0726A | Pilocarpine | 92-13-7 | Reference compound |
| HY-B0726R | Pilocarpine (Hydrochloride) (Standard) | 54-71-7 | Reference Standards |
| HY-B0726S | Pilocarpine-d3 (hydrochloride) | 1217838-88-4 | Isotope-Labeled Compounds |
| HY-B0726S1 | Pilocarpine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0727 | Betamethasone valerate | 2152-44-5 | Reference compound |
| HY-B0727R | Betamethasone valerate (Standard) | 2152-44-5 | Reference Standards |
| HY-B0729 | Polaprezinc | 107667-60-7 | Reference compound |
| HY-B0730 | Pamidronate (disodium pentahydrate) | 109552-15-0 | Reference compound |
| HY-B0730R | Pamidronate (disodium pentahydrate) (Standard) | 109552-15-0 | Reference Standards |
| HY-B0731 | Perospirone (hydrochloride) | 129273-38-7 | Reference compound |
| HY-B0731A | Perospirone | 150915-41-6 | Reference compound |
| HY-B0731AS | Perospirone-d8 | Isotope-Labeled Compounds | |
| HY-B0731R | Perospirone (hydrochloride) (Standard) | 129273-38-7 | Reference Standards |
| HY-B0732 | Itopride (hydrochloride) | 122892-31-3 | Reference compound |
| HY-B0732A | Itopride | 122898-67-3 | Reference compound |
| HY-B0732AS | Itopride-d6 | 1346746-82-4 | Isotope-Labeled Compounds |
| HY-B0732R | Itopride (hydrochloride) (Standard) | 122892-31-3 | Reference Standards |
| HY-B0732S | Itopride-d6 (hydrochloride) | 1346601-02-2 | Isotope-Labeled Compounds |
| HY-B0733 | Fotemustine | 92118-27-9 | Reference compound |
| HY-B0734 | Cefotiam | 61622-34-2 | Reference compound |
| HY-B0734A | Cefotiam (hydrochloride) | 66309-69-1 | Reference compound |
| HY-B0734B | Cefotiam (dihydrochloride hydrate) | Reference compound | |
| HY-B0735 | Fenoldopam | 67227-56-9 | Reference compound |
| HY-B0735A | Fenoldopam (mesylate) | 67227-57-0 | Reference compound |
| HY-B0735AR | Fenoldopam (mesylate) (Standard) | 67227-57-0 | Reference Standards |
| HY-B0736 | Sertaconazole | 99592-32-2 | Reference compound |
| HY-B0736A | Sertaconazole (nitrate) | 99592-39-9 | Reference compound |
| HY-B0736AR | Sertaconazole (nitrate) (Standard) | 99592-39-9 | Reference Standards |
| HY-B0738 | Dithranol | 1143-38-0 | Reference compound |
| HY-B0738R | Dithranol (Standard) | 1143-38-0 | Reference Standards |
| HY-B0739 | Citicoline | 987-78-0 | Natural Products |
| HY-B0739A | Citicoline (sodium) | 33818-15-4 | Natural Products |
| HY-B0739AR | Citicoline (sodium) (Standard) | 33818-15-4 | Reference Standards |
| HY-B0739AS | Citicoline-d9 (sodium) | Isotope-Labeled Compounds | |
| HY-B0739R | Citicoline (Standard) | 987-78-0 | Reference Standards |
| HY-B0740 | Cyclobenzaprine (hydrochloride) | 6202-23-9 | Reference compound |
| HY-B0740R | Cyclobenzaprine (hydrochloride) (Standard) | 6202-23-9 | Reference Standards |
| HY-B0740S | Cyclobenzaprine-d3 (hydrochloride) | 1184983-42-3 | Isotope-Labeled Compounds |
| HY-B0740S1 | Cyclobenzaprine-13C,d3 (hydrochloride) | 1261394-10-8 | Isotope-Labeled Compounds |
| HY-B0740S2 | Cyclobenzaprine-d6 (hydrochloride) | 2748492-38-6 | Isotope-Labeled Compounds |
| HY-B0740S3 | Cyclobenzaprine-d3-1 (hydrochloride) | 2712897-38-4 | Isotope-Labeled Compounds |
| HY-B0742 | Hydroxyprogesterone caproate | 630-56-8 | Reference compound |
| HY-B0742R | Hydroxyprogesterone caproate (Standard) | 630-56-8 | Reference Standards |
| HY-B0743A | Pipecuronium (bromide) | 52212-02-9 | Reference compound |
| HY-B0744 | Eflornithine | 70052-12-9 | Reference compound |
| HY-B0744A | Eflornithine (hydrochloride) | 68278-23-9 | Reference compound |
| HY-B0744B | Eflornithine (hydrochloride hydrate) | 96020-91-6 | Reference compound |
| HY-B0744BR | Eflornithine (hydrochloride hydrate) (Standard) | 96020-91-6 | Reference Standards |
| HY-B0744C | L-Eflornithine | 66640-93-5 | Reference compound |
| HY-B0744D | L-Eflornithine (monohydrochloride) | 69955-42-6 | Reference compound |
| HY-B0745 | Ramatroban | 116649-85-5 | Reference compound |
| HY-B0745S | Ramatroban-d4 | Isotope-Labeled Compounds | |
| HY-B0746 | Flurbiprofen (sodium) | 56767-76-1 | Reference compound |
| HY-B0746R | Flurbiprofen (sodium) (Standard) | 56767-76-1 | Reference Standards |
| HY-B0747 | Eicosapentaenoic acid ethyl ester | 86227-47-6 | Reference compound |
| HY-B0747R | Eicosapentaenoic acid ethyl ester (Standard) | 86227-47-6 | Reference Standards |
| HY-B0747S | Eicosapentaenoic acid ethyl ester-d5 | 1392217-44-5 | Isotope-Labeled Compounds |
| HY-B0750 | Dolasetron | 115956-12-2 | Reference compound |
| HY-B0750A | Dolasetron (Mesylate) | 115956-13-3 | Reference compound |
| HY-B0750B | Dolasetron (Mesylate hydrate) | 878143-33-0 | Reference compound |
| HY-B0750BR | Dolasetron (Mesylate hydrate) (Standard) | 878143-33-0 | Reference Standards |
| HY-B0750S | Dolasetron-d4 | Isotope-Labeled Compounds | |
| HY-B0750S1 | Dolasetron-d5 | Isotope-Labeled Compounds | |
| HY-B0751 | Fumagillin | 23110-15-8 | Natural Products |
| HY-B0751R | Fumagillin (Standard) | 23110-15-8 | Reference Standards |
| HY-B0753 | Gliclazide | 21187-98-4 | Reference compound |
| HY-B0753R | Gliclazide (Standard) | 21187-98-4 | Reference Standards |
| HY-B0753S | Gliclazide-d4 | 1185039-30-8 | Isotope-Labeled Compounds |
| HY-B0754 | Hematoporphyrin | 14459-29-1 | Natural Products |
| HY-B0754A | Hematoporphyrin (dihydrochloride) | 17696-69-4 | Reference compound |
| HY-B0755 | Etimicin (sulfate) | 362045-44-1 | Reference compound |
| HY-B0756 | Cefazolin (sodium pentahydrate) | 115850-11-8 | Reference compound |
| HY-B0757 | Vitamin E nicotinate | 43119-47-7 | Reference compound |
| HY-B0757A | (±)-α-Tocopherol nicotinate | 51898-34-1 | Biochemical Assay Reagents |
| HY-B0757AR | (±)-α-Tocopherol nicotinate (Standard) | 51898-34-1 | Reference Standards |
| HY-B0758 | Troxipide | 30751-05-4 | Reference compound |
| HY-B0758R | Troxipide (Standard) | 30751-05-4 | Reference Standards |
| HY-B0760 | Fenofibric acid | 42017-89-0 | Reference compound |
| HY-B0760R | Fenofibric acid (Standard) | 42017-89-0 | Reference Standards |
| HY-B0760S | Fenofibric acid-d6 | 1092484-69-9 | Isotope-Labeled Compounds |
| HY-B0760S1 | Fenofibric acid-13C8 | Isotope-Labeled Compounds | |
| HY-B0760S2 | Fenofibric acid-d4 | Isotope-Labeled Compounds | |
| HY-B0761 | (R,R)-Glycopyrrolate | 475468-09-8 | Reference compound |
| HY-B0762 | Acetyl-L-carnitine (hydrochloride) | 5080-50-2 | Natural Products |
| HY-B0762S | Acetyl-L-carnitine-d3 (hydrochloride) | 1334532-17-0 | Isotope-Labeled Compounds |
| HY-B0762S1 | Acetyl-L-carnitine-d3-1 (hydrochloride) | 362049-62-5 | Isotope-Labeled Compounds |
| HY-B0763 | Ibudilast | 50847-11-5 | Reference compound |
| HY-B0763R | Ibudilast (Standard) | 50847-11-5 | Reference Standards |
| HY-B0763S1 | Ibudilast-d7 | 2713301-45-0 | Isotope-Labeled Compounds |
| HY-B0763S2 | Ibudilast-d7-1 | 1204192-90-4 | Isotope-Labeled Compounds |
| HY-B0764 | Bucladesine (sodium) | 16980-89-5 | Reference compound |
| HY-B0764A | Bucladesine (calcium) | 938448-87-4 | Reference compound |
| HY-B0764B | Bucladesine | 362-74-3 | Reference compound |
| HY-B0764G | Bucladesine (GMP) | 362-74-3 | GMP Small Molecules |
| HY-B0764R | Bucladesine (sodium) (Standard) | 16980-89-5 | Reference Standards |
| HY-B0765 | Dehydroepiandrosterone sulfate (sodium) | 1099-87-2 | Natural Products |
| HY-B0765R | Dehydroepiandrosterone sulfate (sodium) (Standard) | 1099-87-2 | Reference Standards |
| HY-B0766 | Bicyclol | 118159-48-1 | Reference compound |
| HY-B0767 | Spinosyn A | 131929-60-7 | Natural Products |
| HY-B0767R | Spinosyn A (Standard) | 131929-60-7 | Reference Standards |
| HY-B0768 | Lomerizine | 101477-55-8 | Reference compound |
| HY-B0768A | Lomerizine dihydrochloride | 101477-54-7 | Reference compound |
| HY-B0768AR | Lomerizine dihydrochloride (Standard) | 101477-54-7 | Reference Standards |
| HY-B0768S | Lomerizine-d4 | Isotope-Labeled Compounds | |
| HY-B0769 | Phenylephrine | 59-42-7 | Reference compound |
| HY-B0769R | Phenylephrine (Standard) | 59-42-7 | Reference Standards |
| HY-B0770 | Artemotil | 75887-54-6 | Natural Products |
| HY-B0771 | Cefozopran | 113359-04-9 | Reference compound |
| HY-B0771A | Cefozopran (hydrochloride) | 113981-44-5 | Reference compound |
| HY-B0771AR | Cefozopran (hydrochloride) (Standard) | 113981-44-5 | Reference Standards |
| HY-B0772 | Nifekalant | 130636-43-0 | Reference compound |
| HY-B0772A | Nifekalant (hydrochloride) | 130656-51-8 | Reference compound |
| HY-B0772AR | Nifekalant (hydrochloride) (Standard) | 130656-51-8 | Reference Standards |
| HY-B0772S | Nifekalant-d4 | Isotope-Labeled Compounds | |
| HY-B0773 | Paroxetine (mesylate) | 217797-14-3 | Reference compound |
| HY-B0774 | Seratrodast | 112665-43-7 | Reference compound |
| HY-B0774R | Seratrodast (Standard) | 112665-43-7 | Reference Standards |
| HY-B0775 | Betamethasone-17-butyrate-21-propionate | 5534-02-1 | Reference compound |
| HY-B0777 | Moxidectin | 113507-06-5 | Reference compound |
| HY-B0777R | Moxidectin (Standard) | 113507-06-5 | Reference Standards |
| HY-B0777S | Moxidectin-d3 | Isotope-Labeled Compounds | |
| HY-B0778 | Milbemycin oxime | 129496-10-2 | Natural Products |
| HY-B0778R | Milbemycin oxime (Standard) | 129496-10-2 | Reference Standards |
| HY-B0779 | Teprenone | 6809-52-5 | Reference compound |
| HY-B0779A | (5E,9E,13E)-Teprenone | 3796-63-2 | Reference compound |
| HY-B0779R | Teprenone (Standard) | 6809-52-5 | Reference Standards |
| HY-B0780 | Fimasartan | 247257-48-3 | Reference compound |
| HY-B0780S | Fimasartan-d6 | Isotope-Labeled Compounds | |
| HY-B0781 | Promethazine (hydrochloride) | 58-33-3 | Reference compound |
| HY-B0781R | Promethazine (hydrochloride) (Standard) | 58-33-3 | Reference Standards |
| HY-B0781S | Promethazine-d4 (hydrochloride) | 1173018-74-0 | Isotope-Labeled Compounds |
| HY-B0781S1 | Promethazine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0782 | Acetazolamide | 59-66-5 | Reference compound |
| HY-B0782A | Acetazolamide (sodium) | 1424-27-7 | Reference compound |
| HY-B0782R | Acetazolamide (Standard) | 59-66-5 | Reference Standards |
| HY-B0782S | Acetazolamide-d3 | 1189904-01-5 | Isotope-Labeled Compounds |
| HY-B0782S1 | Acetazolamide-13C2,d3 | Isotope-Labeled Compounds | |
| HY-B0782S2 | Acetazolamide-15N,d3 | 1261393-93-4 | Isotope-Labeled Compounds |
| HY-B0787 | Gadodiamide | 131410-48-5 | Reference compound |
| HY-B0787R | Gadodiamide (Standard) | 131410-48-5 | Reference Standards |
| HY-B0788 | LY2409881 | 946518-61-2 | Reference compound |
| HY-B0788A | LY2409881 (trihydrochloride) | 946518-60-1 | Reference compound |
| HY-B0789 | SU6656 | 330161-87-0 | Reference compound |
| HY-B0790 | TAI-1 | 1334921-03-7 | Reference compound |
| HY-B0791 | Altiratinib | 1345847-93-9 | Reference compound |
| HY-B0792 | CZC-54252 | 1191911-27-9 | Reference compound |
| HY-B0792A | CZC-54252 (hydrochloride) | 1784253-05-9 | Reference compound |
| HY-B0793 | AZ-5104 | 1421373-98-9 | Reference compound |
| HY-B0793S1 | AZ-5104-d2 | 2719691-01-5 | Isotope-Labeled Compounds |
| HY-B0794 | AZ7550 | 1421373-99-0 | Reference compound |
| HY-B0794A | AZ7550 (hydrochloride) | 2309762-40-9 | Reference compound |
| HY-B0794B | AZ7550 Mesylate | 2319837-99-3 | Reference compound |
| HY-B0794BR | AZ7550 Mesylate (Standard) | 2319837-99-3 | Reference Standards |
| HY-B0794S | AZ7550-d5 | 2719690-99-8 | Isotope-Labeled Compounds |
| HY-B0795 | MHY1485 | 326914-06-1 | Reference compound |
| HY-B0796 | Bismuth potassium citrate | 57644-54-9 | Reference compound |
| HY-B0797 | Etretinate | 54350-48-0 | Reference compound |
| HY-B0797R | Etretinate (Standard) | 54350-48-0 | Reference Standards |
| HY-B0797S | Etretinate-d3 | 1185237-13-1 | Isotope-Labeled Compounds |
| HY-B0798 | Cefpiramide (sodium) | 74849-93-7 | Reference compound |
| HY-B0799 | Dihydroergotoxine (mesylate) | 8067-24-1 | Reference compound |
| HY-B0800 | Guanethidine (sulfate) | 645-43-2 | Reference compound |
| HY-B0800R | Guanethidine (sulfate) (Standard) | 645-43-2 | Reference Standards |
| HY-B0801 | Fexofenadine | 83799-24-0 | Reference compound |
| HY-B0801A | Fexofenadine (hydrochloride) | 153439-40-8 | Reference compound |
| HY-B0801AR | Fexofenadine (hydrochloride) (Standard) | 153439-40-8 | Reference Standards |
| HY-B0801AS | Fexofenadine-d10 (hydrochloride) | 1215821-44-5 | Isotope-Labeled Compounds |
| HY-B0801S | Fexofenadine-d6 | 548783-71-7 | Isotope-Labeled Compounds |
| HY-B0801S1 | Fexofenadine-d6 Methyl Ester | 1286458-00-1 | Isotope-Labeled Compounds |
| HY-B0801S2 | Fexofenadine-d3 | Isotope-Labeled Compounds | |
| HY-B0801S3 | Fexofenadine-d10 | 1215900-18-7 | Isotope-Labeled Compounds |
| HY-B0801S4 | Fexofenadine-d3-1 | Isotope-Labeled Compounds | |
| HY-B0802 | Terbutaline (sulfate) | 23031-32-5 | Reference compound |
| HY-B0802A | Terbutaline | 23031-25-6 | Reference compound |
| HY-B0802AR | Terbutaline (Standard) | 23031-25-6 | Reference Standards |
| HY-B0802AS | Terbutaline-d9 | 1189658-09-0 | Isotope-Labeled Compounds |
| HY-B0802AS1 | Terbutaline-d3 | Isotope-Labeled Compounds | |
| HY-B0802R | Terbutaline (sulfate) (Standard) | 23031-32-5 | Reference Standards |
| HY-B0803 | Lumefantrine | 82186-77-4 | Reference compound |
| HY-B0803R | Lumefantrine (Standard) | 82186-77-4 | Reference Standards |
| HY-B0803S | Lumefantrine-d18 | 1185240-53-2 | Isotope-Labeled Compounds |
| HY-B0803S1 | Lumefantrine-d9 | 2477594-24-2 | Isotope-Labeled Compounds |
| HY-B0804 | Nadolol | 42200-33-9 | Reference compound |
| HY-B0804R | Nadolol (Standard) | 42200-33-9 | Reference Standards |
| HY-B0804S | Nadolol-d9 | 94513-92-5 | Isotope-Labeled Compounds |
| HY-B0806 | Proguanil | 500-92-5 | Reference compound |
| HY-B0806A | Proguanil (hydrochloride) | 637-32-1 | Reference compound |
| HY-B0806AR | Proguanil (hydrochloride) (Standard) | 637-32-1 | Reference Standards |
| HY-B0806AS | Proguanil-d4 (hydrochloride) | 1189671-34-8 | Isotope-Labeled Compounds |
| HY-B0806AS1 | Proguanil-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0806R | Proguanil (Standard) | 500-92-5 | Reference Standards |
| HY-B0806S | Proguanil-d6 | Isotope-Labeled Compounds | |
| HY-B0806S1 | Proguanil-d4 | 1189805-15-9 | Isotope-Labeled Compounds |
| HY-B0807A | Prochlorperazine (dimaleate) | 84-02-6 | Reference compound |
| HY-B0808 | Oxaprozin | 21256-18-8 | Reference compound |
| HY-B0808A | Oxaprozin (potassium) | 174064-08-5 | Reference compound |
| HY-B0808R | Oxaprozin (Standard) | 21256-18-8 | Reference Standards |
| HY-B0808S | Oxaprozin-d4 | Isotope-Labeled Compounds | |
| HY-B0808S1 | Oxaprozin-d5 | 2933758-40-6 | Isotope-Labeled Compounds |
| HY-B0809 | Theophylline | 58-55-9 | Natural Products |
| HY-B0809A | Theophylline (monohydrate) | 5967-84-0 | Reference compound |
| HY-B0809B | Theophylline (sodium acetate) | 8002-89-9 | Reference compound |
| HY-B0809R | Theophylline (Standard) | 58-55-9 | Reference Standards |
| HY-B0809S | Theophylline-d6 | 117490-39-8 | Isotope-Labeled Compounds |
| HY-B0809S1 | Theophylline-d3 | 65566-68-9 | Isotope-Labeled Compounds |
| HY-B0810 | Pivmecillinam | 32886-97-8 | Reference compound |
| HY-B0810A | Pivmecillinam (hydrochloride) | 32887-03-9 | Reference compound |
| HY-B0810AR | Pivmecillinam (hydrochloride) (Standard) | 32887-03-9 | Reference Standards |
| HY-B0811 | Salicylamide | 65-45-2 | Natural Products |
| HY-B0811R | Salicylamide (Standard) | 65-45-2 | Reference Standards |
| HY-B0812 | 5-Sulfosalicylic acid (dihydrate) | 5965-83-3 | Biochemical Assay Reagents |
| HY-B0813 | Treprostinil (diethanolamine) | 830354-48-8 | Reference compound |
| HY-B0813R | Treprostinil (diethanolamine) (Standard) | 830354-48-8 | Reference Standards |
| HY-B0814 | Levocetirizine | 130018-77-8 | Reference compound |
| HY-B0814S | Levocetirizine-d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B0814S1 | Levocetirizine-d4 | 1133210-23-7 | Isotope-Labeled Compounds |
| HY-B0815 | Chlorpyrifos | 2921-88-2 | Reference compound |
| HY-B0815R | Chlorpyrifos (Standard) | 2921-88-2 | Reference Standards |
| HY-B0815S | Chlorpyrifos-d10 | 285138-81-0 | Isotope-Labeled Compounds |
| HY-B0816 | Etofenprox | 80844-07-1 | Reference compound |
| HY-B0816R | Etofenprox (Standard) | 80844-07-1 | Reference Standards |
| HY-B0817 | Pyridaben | 96489-71-3 | Reference compound |
| HY-B0817R | Pyridaben (Standard) | 96489-71-3 | Reference Standards |
| HY-B0817S | Pyridaben-d13 | 2468638-05-1 | Isotope-Labeled Compounds |
| HY-B0819 | Phoxim | 14816-18-3 | Reference compound |
| HY-B0819R | Phoxim (Standard) | 14816-18-3 | Reference Standards |
| HY-B0820 | Nitenpyram | 150824-47-8 | Reference compound |
| HY-B0820R | Nitenpyram (Standard) | 150824-47-8 | Reference Standards |
| HY-B0821 | Pymetrozine | 123312-89-0 | Reference compound |
| HY-B0821R | Pymetrozine (Standard) | 123312-89-0 | Reference Standards |
| HY-B0822 | Fipronil | 120068-37-3 | Reference compound |
| HY-B0822R | Fipronil (Standard) | 120068-37-3 | Reference Standards |
| HY-B0822S1 | Fipronil-13C6 | Isotope-Labeled Compounds | |
| HY-B0823 | Acetamiprid | 135410-20-7 | Reference compound |
| HY-B0823A | (E/Z)-Acetamiprid | 160430-64-8 | Reference compound |
| HY-B0823R | Acetamiprid (Standard) | 135410-20-7 | Reference Standards |
| HY-B0823S | Acetamiprid-d3 | 1353869-35-8 | Isotope-Labeled Compounds |
| HY-B0824 | Bifenthrin | 82657-04-3 | Reference compound |
| HY-B0824A | (1R)-cis-Bifenthrin | 439680-76-9 | Reference compound |
| HY-B0824R | Bifenthrin (Standard) | 82657-04-3 | Reference Standards |
| HY-B0825 | (E)-Fenpyroximate | 134098-61-6 | Reference compound |
| HY-B0825R | (E)-Fenpyroximate (Standard) | 134098-61-6 | Reference Standards |
| HY-B0826 | Spirodiclofen | 148477-71-8 | Reference compound |
| HY-B0826R | Spirodiclofen (Standard) | 148477-71-8 | Reference Standards |
| HY-B0827 | Dinotefuran | 165252-70-0 | Reference compound |
| HY-B0827A | (R)-Dinotefuran | 406466-53-3 | Reference compound |
| HY-B0827B | (S)-Dinotefuran | 322639-07-6 | Reference compound |
| HY-B0827R | Dinotefuran (Standard) | 165252-70-0 | Reference Standards |
| HY-B0827S | Dinotefuran-d3 | 2934813-27-9 | Isotope-Labeled Compounds |
| HY-B0828 | Triazophos | 24017-47-8 | Reference compound |
| HY-B0828R | Triazophos (Standard) | 24017-47-8 | Reference Standards |
| HY-B0828S | Triazophos-d5 | 1773496-62-0 | Isotope-Labeled Compounds |
| HY-B0830 | Isoprocarb | 2631-40-5 | Reference compound |
| HY-B0830R | Isoprocarb (Standard) | 2631-40-5 | Reference Standards |
| HY-B0830S | Isoprocarb-d3 | 2662756-69-4 | Isotope-Labeled Compounds |
| HY-B0831 | Buprofezin | 69327-76-0 | Reference compound |
| HY-B0831R | Buprofezin (Standard) | 69327-76-0 | Reference Standards |
| HY-B0831S | Buprofezin-d6 | 2140803-94-5 | Isotope-Labeled Compounds |
| HY-B0832 | Profenofos | 41198-08-7 | Reference compound |
| HY-B0832R | Profenofos (Standard) | 41198-08-7 | Reference Standards |
| HY-B0833 | Thiamethoxam | 153719-23-4 | Reference compound |
| HY-B0833R | Thiamethoxam (Standard) | 153719-23-4 | Reference Standards |
| HY-B0833S | Thiamethoxam-d4 | 1331642-98-8 | Isotope-Labeled Compounds |
| HY-B0833S1 | Thiamethoxam-d3 | 1294048-82-0 | Isotope-Labeled Compounds |
| HY-B0834 | (±)-Indoxacarb | 144171-61-9 | Reference compound |
| HY-B0834R | (±)-Indoxacarb (Standard) | 144171-61-9 | Reference Standards |
| HY-B0835 | Fenobucarb | 3766-81-2 | Reference compound |
| HY-B0835R | Fenobucarb (Standard) | 3766-81-2 | Reference Standards |
| HY-B0835S | Fenobucarb-d3 | 2662756-72-9 | Isotope-Labeled Compounds |
| HY-B0836 | λ-Cyhalothrin | 91465-08-6 | Reference compound |
| HY-B0836R | λ-Cyhalothrin (Standard) | 91465-08-6 | Reference Standards |
| HY-B0837 | Emamectin (Benzoate) | 155569-91-8 | Reference compound |
| HY-B0838 | Imidacloprid | 138261-41-3 | Reference compound |
| HY-B0838R | Imidacloprid (Standard) | 138261-41-3 | Reference Standards |
| HY-B0838S | Imidacloprid-d4 | 1015855-75-0 | Isotope-Labeled Compounds |
| HY-B0840 | Chlorfenapyr | 122453-73-0 | Reference compound |
| HY-B0840R | Chlorfenapyr (Standard) | 122453-73-0 | Reference Standards |
| HY-B0841 | Acephate | 30560-19-1 | Reference compound |
| HY-B0841R | Acephate (Standard) | 30560-19-1 | Reference Standards |
| HY-B0841S | Acephate-d3 | 2140327-70-2 | Isotope-Labeled Compounds |
| HY-B0842 | Thiophanate-Methyl | 23564-05-8 | Reference compound |
| HY-B0842R | Thiophanate-Methyl (Standard) | 23564-05-8 | Reference Standards |
| HY-B0842S | Thiophanate-methyl-d6 | 1398065-77-4 | Isotope-Labeled Compounds |
| HY-B0843 | Metalaxyl | 57837-19-1 | Reference compound |
| HY-B0843A | Metalaxyl-M | 70630-17-0 | Reference compound |
| HY-B0843AR | Metalaxyl-M (Standard) | 70630-17-0 | Reference Standards |
| HY-B0843AS | Metalaxyl-M-d6 | 1398112-32-7 | Isotope-Labeled Compounds |
| HY-B0843R | Metalaxyl (Standard) | 57837-19-1 | Reference Standards |
| HY-B0843S | Metalaxyl-13C6 | 1356199-69-3 | Isotope-Labeled Compounds |
| HY-B0843S1 | Metalaxyl-d6 | Isotope-Labeled Compounds | |
| HY-B0845 | Prochloraz | 67747-09-5 | Reference compound |
| HY-B0845R | Prochloraz (Standard) | 67747-09-5 | Reference Standards |
| HY-B0846 | Dimethomorph | 110488-70-5 | Reference compound |
| HY-B0846R | Dimethomorph (Standard) | 110488-70-5 | Reference Standards |
| HY-B0846S | Dimethomorph-d8 | 1346606-71-0 | Isotope-Labeled Compounds |
| HY-B0847 | Propiconazole | 60207-90-1 | Reference compound |
| HY-B0847R | Propiconazole (Standard) | 60207-90-1 | Reference Standards |
| HY-B0847S | Propiconazole-d7 | 1246818-14-3 | Isotope-Labeled Compounds |
| HY-B0847S1 | Propiconazole-d3 (nitrate) | 2699607-26-4 | Isotope-Labeled Compounds |
| HY-B0848 | Tricyclazole | 41814-78-2 | Reference compound |
| HY-B0848R | Tricyclazole (Standard) | 41814-78-2 | Reference Standards |
| HY-B0849 | Azoxystrobin | 131860-33-8 | Reference compound |
| HY-B0849A | (Z)-Azoxystrobin | 143130-94-3 | Reference compound |
| HY-B0849R | Azoxystrobin (Standard) | 131860-33-8 | Reference Standards |
| HY-B0849S | Azoxystrobin-d4 | 1346606-39-0 | Isotope-Labeled Compounds |
| HY-B0849S1 | Azoxystrobin-d3 | Isotope-Labeled Compounds | |
| HY-B0850 | Difenoconazole | 119446-68-3 | Reference compound |
| HY-B0850R | Difenoconazole (Standard) | 119446-68-3 | Reference Standards |
| HY-B0850S | Difenoconazole-d6 (hydrochloride) | 2748435-81-4 | Isotope-Labeled Compounds |
| HY-B0851 | Triadimenol | 55219-65-3 | Reference compound |
| HY-B0851R | Triadimenol (Standard) | 55219-65-3 | Reference Standards |
| HY-B0851S | Triadimenol-d4 | 2121989-56-6 | Isotope-Labeled Compounds |
| HY-B0852 | Tebuconazole | 107534-96-3 | Reference compound |
| HY-B0852R | Tebuconazole (Standard) | 107534-96-3 | Reference Standards |
| HY-B0852S | Tebuconazole-d9 | 1246818-83-6 | Isotope-Labeled Compounds |
| HY-B0853 | Paclobutrazol | 76738-62-0 | Reference compound |
| HY-B0853R | Paclobutrazol (Standard) | 76738-62-0 | Reference Standards |
| HY-B0853S | (Rac)-Paclobutrazol-15N3 | 2642083-16-5 | Isotope-Labeled Compounds |
| HY-B0854 | Mancozeb | 8018-01-7 | Reference compound |
| HY-B0854R | Mancozeb (Standard) | 8018-01-7 | Reference Standards |
| HY-B0856 | Validamycin A | 37248-47-8 | Natural Products |
| HY-B0856R | Validamycin A (Standard) | 37248-47-8 | Reference Standards |
| HY-B0859 | MCPA | 94-74-6 | Reference compound |
| HY-B0859R | MCPA (Standard) | 94-74-6 | Reference Standards |
| HY-B0859S | MCPA-13C8 | Isotope-Labeled Compounds | |
| HY-B0859S1 | MCPA-d3 | 352431-14-2 | Isotope-Labeled Compounds |
| HY-B0860 | Diuron | 330-54-1 | Reference compound |
| HY-B0860R | Diuron (Standard) | 330-54-1 | Reference Standards |
| HY-B0860S | Diuron-d6 | 1007536-67-5 | Isotope-Labeled Compounds |
| HY-B0861 | Cyhalofop-butyl | 122008-85-9 | Reference compound |
| HY-B0861R | Cyhalofop-butyl (Standard) | 122008-85-9 | Reference Standards |
| HY-B0862 | Pendimethalin | 40487-42-1 | Reference compound |
| HY-B0862R | Pendimethalin (Standard) | 40487-42-1 | Reference Standards |
| HY-B0862S | Pendimethalin-d5 | 1219803-39-0 | Isotope-Labeled Compounds |
| HY-B0863 | Glyphosate | 1071-83-6 | Reference compound |
| HY-B0863B | Glyphosate (isopropylammonium) | 38641-94-0 | Reference compound |
| HY-B0863R | Glyphosate (Standard) | 1071-83-6 | Reference Standards |
| HY-B0863S | Glyphosate-d2 | 2733532-11-9 | Isotope-Labeled Compounds |
| HY-B0863S2 | Glyphosate-d2-1 | Isotope-Labeled Compounds | |
| HY-B0863S3 | Glyphosate-13C2,15N | 1185107-63-4 | Isotope-Labeled Compounds |
| HY-B0865 | Pyrazosulfuron-ethyl | 93697-74-6 | Reference compound |
| HY-B0865R | Pyrazosulfuron-ethyl (Standard) | 93697-74-6 | Reference Standards |
| HY-B0866 | Ametryn | 834-12-8 | Reference compound |
| HY-B0866R | Ametryn (Standard) | 834-12-8 | Reference Standards |
| HY-B0866S | Ametryn-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0867 | 2,4-D Butyl ester | 94-80-4 | Reference compound |
| HY-B0867R | 2,4-D Butyl ester (Standard) | 94-80-4 | Reference Standards |
| HY-B0868 | 2,4-D isooctyl ester | 25168-26-7 | Reference compound |
| HY-B0869A | Bispyribac (sodium) | 125401-92-5 | Reference compound |
| HY-B0869AR | Bispyribac (sodium) (Standard) | 125401-92-5 | Reference Standards |
| HY-B0870 | Bensulfuron-methyl | 83055-99-6 | Reference compound |
| HY-B0870R | Bensulfuron-methyl (Standard) | 83055-99-6 | Reference Standards |
| HY-B0870S | Bensulfuron-methyl-d6 | 1309928-44-6 | Isotope-Labeled Compounds |
| HY-B0871 | Quinclorac | 84087-01-4 | Reference compound |
| HY-B0871R | Quinclorac (Standard) | 84087-01-4 | Reference Standards |
| HY-B0872 | Thidiazuron | 51707-55-2 | Biochemical Assay Reagents |
| HY-B0872R | Thidiazuron (Standard) | 51707-55-2 | Reference Standards |
| HY-B0873 | Uniconazole | 83657-22-1 | Reference compound |
| HY-B0873R | Uniconazole (Standard) | 83657-22-1 | Reference Standards |
| HY-B0874 | Alpha-Cypermethrin | 67375-30-8 | Reference compound |
| HY-B0874R | Alpha-Cypermethrin (Standard) | 67375-30-8 | Reference Standards |
| HY-B0875 | Cefmenoxime (hydrochloride) | 75738-58-8 | Reference compound |
| HY-B0875A | Cefmenoxime | 65085-01-0 | Reference compound |
| HY-B0875B | Cefmenoxime (sodium) | 65085-02-1 | Reference compound |
| HY-B0875R | Cefmenoxime (hydrochloride) (Standard) | 75738-58-8 | Reference Standards |
| HY-B0876 | Fomepizole | 7554-65-6 | Reference compound |
| HY-B0876A | Fomepizole (hydrochloride) | 56010-88-9 | Reference compound |
| HY-B0876R | Fomepizole (Standard) | 7554-65-6 | Reference Standards |
| HY-B0877 | Halcinonide | 3093-35-4 | Reference compound |
| HY-B0877R | Halcinonide (Standard) | 3093-35-4 | Reference Standards |
| HY-B0878 | Halobetasol propionate | 66852-54-8 | Reference compound |
| HY-B0878R | Halobetasol propionate (Standard) | 66852-54-8 | Reference Standards |
| HY-B0878S | Halobetasol propionate-d5 | Isotope-Labeled Compounds | |
| HY-B0879 | Suramin | 145-63-1 | Reference compound |
| HY-B0879A | Suramin (sodium salt) | 129-46-4 | Reference compound |
| HY-B0879AR | Suramin (sodium salt) (Standard) | 129-46-4 | Reference Standards |
| HY-B0880 | 4-Aminobenzohydrazide | 5351-17-7 | Reference compound |
| HY-B0881 | Acetohexamide | 968-81-0 | Reference compound |
| HY-B0881R | Acetohexamide (Standard) | 968-81-0 | Reference Standards |
| HY-B0882 | Edrophonium (chloride) | 116-38-1 | Reference compound |
| HY-B0882R | Edrophonium (chloride) (Standard) | 116-38-1 | Reference Standards |
| HY-B0882S | Edrophonium-d5 (chloride) | Isotope-Labeled Compounds | |
| HY-B0883 | Proflavine (hemisulfate) | 1811-28-5 | Dye Reagents |
| HY-B0884 | Minaprine | 25905-77-5 | Reference compound |
| HY-B0884A | Minaprine (dihydrochloride) | 25953-17-7 | Reference compound |
| HY-B0885 | Econazole | 27220-47-9 | Reference compound |
| HY-B0885R | Econazole (Standard) | 27220-47-9 | Reference Standards |
| HY-B0886 | Iproniazid (phosphate) | 305-33-9 | Reference compound |
| HY-B0886A | Iproniazid | 54-92-2 | Reference compound |
| HY-B0886R | Iproniazid (phosphate) (Standard) | 305-33-9 | Reference Standards |
| HY-B0887 | Permethrin | 52645-53-1 | Reference compound |
| HY-B0887A | (+)-trans-Permethrin | 51877-74-8 | Reference compound |
| HY-B0887B | (-)-trans-Permethrin | 54774-47-9 | Reference compound |
| HY-B0887BR | (-)-trans-Permethrin (Standard) | 54774-47-9 | Reference Standards |
| HY-B0887C | 1R-cis-Permethrin | 54774-45-7 | Reference compound |
| HY-B0887D | (-)-cis-Permethrin | 54774-46-8 | Reference compound |
| HY-B0887R | Permethrin (Standard) | 52645-53-1 | Reference Standards |
| HY-B0887S | Permethrin-d5 | 1794760-19-2 | Isotope-Labeled Compounds |
| HY-B0887S1 | Permethrin-d9 | Isotope-Labeled Compounds | |
| HY-B0888 | Sulfacetamide (sodium monohydrate) | 6209-17-2 | Reference compound |
| HY-B0888R | Sulfacetamide (sodium monohydrate) (Standard) | 6209-17-2 | Reference Standards |
| HY-B0889 | Ethacridine (lactate monohydrate) | 6402-23-9 | Reference compound |
| HY-B0889R | Ethacridine (lactate monohydrate) (Standard) | 6402-23-9 | Reference Standards |
| HY-B0890 | Zomepirac (sodium salt) | 64092-48-4 | Reference compound |
| HY-B0890A | Zomepirac | 33369-31-2 | Reference compound |
| HY-B0891 | 17α-Hydroxyprogesterone | 68-96-2 | Natural Products |
| HY-B0891R | 17α-Hydroxyprogesterone (Standard) | 68-96-2 | Reference Standards |
| HY-B0891S | 17α-Hydroxyprogesterone-d8 | 850023-80-2 | Isotope-Labeled Compounds |
| HY-B0891S1 | 17α-Hydroxyprogesterone-13C3 | 1356154-92-1 | Isotope-Labeled Compounds |
| HY-B0892 | Benzyl alcohol | 100-51-6 | Natural Products |
| HY-B0892R | Benzyl alcohol (Standard) | 100-51-6 | Reference Standards |
| HY-B0892S | Benzyl alcohol-α-13C-α,α-d2 | 285977-71-1 | Isotope-Labeled Compounds |
| HY-B0892S1 | Benzyl alcohol-d7 | 71258-23-6 | Isotope-Labeled Compounds |
| HY-B0892S2 | Benzyl alcohol-d5 | 68661-10-9 | Isotope-Labeled Compounds |
| HY-B0892S3 | Benzyl alcohol-13C6 | 201740-95-6 | Isotope-Labeled Compounds |
| HY-B0892S4 | Benzyl alcohol-d1 | 14915-25-4 | Isotope-Labeled Compounds |
| HY-B0892S5 | Benzyl alcohol-13C | 54522-91-7 | Isotope-Labeled Compounds |
| HY-B0893 | 3-Pyridinemethanol | 100-55-0 | Reference compound |
| HY-B0894 | Resorcinol monoacetate | 102-29-4 | Reference compound |
| HY-B0895 | Hydroxyzine (pamoate) | 10246-75-0 | Reference compound |
| HY-B0895R | Hydroxyzine (pamoate) (Standard) | 10246-75-0 | Reference Standards |
| HY-B0896 | Triacetin | 102-76-1 | Reference compound |
| HY-B0896R | Triacetin (Standard) | 102-76-1 | Reference Standards |
| HY-B0896S1 | Triacetin-d5 | 159510-46-0 | Isotope-Labeled Compounds |
| HY-B0896S2 | Triacetin-d9 | 2733570-86-8 | Isotope-Labeled Compounds |
| HY-B0897 | Bisoctrizole | 103597-45-1 | Reference compound |
| HY-B0897R | Bisoctrizole (Standard) | 103597-45-1 | Reference Standards |
| HY-B0898 | Ceftiofur (sodium) | 104010-37-9 | Reference compound |
| HY-B0898R | Ceftiofur (sodium) (Standard) | 104010-37-9 | Reference Standards |
| HY-B0898S | Ceftiofur-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-B0900 | Anethole | 104-46-1 | Natural Products |
| HY-B0901 | Bromperidol | 10457-90-6 | Reference compound |
| HY-B0901A | Bromperidol (hydrochloride) | 59453-24-6 | Reference compound |
| HY-B0901R | Bromperidol (Standard) | 10457-90-6 | Reference Standards |
| HY-B0901S1 | Bromperidol-d4-1 | Isotope-Labeled Compounds | |
| HY-B0902A | Rufloxacin hydrochloride | 106017-08-7 | Reference compound |
| HY-B0902AR | Rufloxacin hydrochloride (Standard) | 106017-08-7 | Reference Standards |
| HY-B0903 | Hexylene glycol | 107-41-5 | Reference compound |
| HY-B0903R | Hexylene glycol (Standard) | 107-41-5 | Reference Standards |
| HY-B0903S | Hexylene glycol-d12 | 284474-72-2 | Isotope-Labeled Compounds |
| HY-B0905 | Tilmicosin | 108050-54-0 | Reference compound |
| HY-B0905A | Tilmicosin (phosphate) | 137330-13-3 | Reference compound |
| HY-B0905AR | Tilmicosin (phosphate) (Standard) | 137330-13-3 | Reference Standards |
| HY-B0905R | Tilmicosin (Standard) | 108050-54-0 | Reference Standards |
| HY-B0905S | Tilmicosin-d3 | 2714486-61-8 | Isotope-Labeled Compounds |
| HY-B0906 | Bucetin | 1083-57-4 | Reference compound |
| HY-B0908 | Meticrane | 1084-65-7 | Reference compound |
| HY-B0908R | Meticrane (Standard) | 1084-65-7 | Reference Standards |
| HY-B0910 | Pyrithioxin | 1098-97-1 | Natural Products |
| HY-B0910A | Pyrithioxin (dihydrochloride) | 10049-83-9 | Reference compound |
| HY-B0910AR | Pyrithioxin (dihydrochloride) (Standard) | 10049-83-9 | Reference Standards |
| HY-B0911 | Chlorophyllin sodium copper salt | 11006-34-1 | Reference compound |
| HY-B0911R | Chlorophyllin sodium copper salt (Standard) | 11006-34-1 | Reference Standards |
| HY-B0914 | 10-Undecenoic acid,98% (stabilized with TBC) | 112-38-9 | Natural Products |
| HY-B0914A | 10-Undecenoic acid (zinc salt) | 557-08-4 | Natural Products |
| HY-B0914AR | 10-Undecenoic acid (zinc salt) (Standard) | 557-08-4 | Reference Standards |
| HY-B0914B | 10-Undecenoic acid (copper) | 35322-29-3 | Reference compound |
| HY-B0914R | 10-Undecenoic acid (Standard) | 112-38-9 | Reference Standards |
| HY-B0915 | Orbifloxacin | 113617-63-3 | Reference compound |
| HY-B0915R | Orbifloxacin (Standard) | 113617-63-3 | Reference Standards |
| HY-B0915S | Orbifloxacin-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0916 | Propoxur | 114-26-1 | Reference compound |
| HY-B0916R | Propoxur (Standard) | 114-26-1 | Reference Standards |
| HY-B0916S | Propoxur-d3 | 1219798-56-7 | Isotope-Labeled Compounds |
| HY-B0917 | Bromindione | 1146-98-1 | Reference compound |
| HY-B0918 | Chlorindione | 1146-99-2 | Reference compound |
| HY-B0918R | Chlorindione (Standard) | 1146-99-2 | Reference Standards |
| HY-B0919 | Azaserine | 115-02-6 | Reference compound |
| HY-B0919R | Azaserine (Standard) | 115-02-6 | Reference Standards |
| HY-B0920 | Tolazamide | 1156-19-0 | Reference compound |
| HY-B0920R | Tolazamide (Standard) | 1156-19-0 | Reference Standards |
| HY-B0921 | Succinylsulfathiazole | 116-43-8 | Reference compound |
| HY-B0921R | Succinylsulfathiazole (Standard) | 116-43-8 | Reference Standards |
| HY-B0922 | Dicloralurea | 116-52-9 | Reference compound |
| HY-B0923 | Danthron | 117-10-2 | Natural Products |
| HY-B0923R | Danthron (Standard) | 117-10-2 | Reference Standards |
| HY-B0924 | Anisindione | 117-37-3 | Reference compound |
| HY-B0925 | Oxacillin (sodium salt) | 1173-88-2 | Reference compound |
| HY-B0925A | Oxacillin | 66-79-5 | Reference compound |
| HY-B0925AS | Oxacillin-d5 | Isotope-Labeled Compounds | |
| HY-B0925R | Oxacillin (sodium salt) (Standard) | 1173-88-2 | Reference Standards |
| HY-B0925S | Oxacillin-13C6 (sodium) | Isotope-Labeled Compounds | |
| HY-B0926 | Diatrizoic acid | 117-96-4 | Reference compound |
| HY-B0926A | Sodium diatrizoate | 737-31-5 | Reference compound |
| HY-B0926AR | Sodium diatrizoate (Standard) | 737-31-5 | Reference Standards |
| HY-B0926B | Diatrizoate meglumine | 131-49-7 | Biochemical Assay Reagents |
| HY-B0926R | Diatrizoic acid (Standard) | 117-96-4 | Reference Standards |
| HY-B0927 | Hydrastine | 118-08-1 | Natural Products |
| HY-B0927R | Hydrastine (Standard) | 118-08-1 | Reference Standards |
| HY-B0928 | Homosalate | 118-56-9 | Reference compound |
| HY-B0928R | Homosalate (Standard) | 118-56-9 | Reference Standards |
| HY-B0928S | Homosalate-d4 | Isotope-Labeled Compounds | |
| HY-B0929 | Octisalate | 118-60-5 | Reference compound |
| HY-B0929R | Octisalate (Standard) | 118-60-5 | Reference Standards |
| HY-B0930 | Efloxate | 119-41-5 | Reference compound |
| HY-B0930R | Efloxate (Standard) | 119-41-5 | Reference Standards |
| HY-B0931 | Citiolone | 1195-16-0 | Reference compound |
| HY-B0931R | Citiolone (Standard) | 1195-16-0 | Reference Standards |
| HY-B0932 | Levocarnitine propionate (hydrochloride) | 119793-66-7 | Reference compound |
| HY-B0932R | Levocarnitine propionate (hydrochloride) (Standard) | 119793-66-7 | Reference Standards |
| HY-B0932S | Levocarnitine propionate-d3 (hydrochloride) | 1334532-19-2 | Isotope-Labeled Compounds |
| HY-B0932S1 | Levocarnitine propionate-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0932S2 | Levocarnitine propionate-d9 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0933 | Gadoteridol | 120066-54-8 | Reference compound |
| HY-B0933A | Gadoteridol (pentahydrate) | Reference compound | |
| HY-B0933R | Gadoteridol (Standard) | 120066-54-8 | Reference Standards |
| HY-B0934 | Ethylparaben | 120-47-8 | Reference compound |
| HY-B0934R | Ethylparaben (Standard) | 120-47-8 | Reference Standards |
| HY-B0934S | Ethylparaben-d4 | 1219795-53-5 | Isotope-Labeled Compounds |
| HY-B0935 | Benzyl benzoate | 120-51-4 | Natural Products |
| HY-B0935R | Benzyl benzoate (Standard) | 120-51-4 | Reference Standards |
| HY-B0935S | Benzyl benzoate-d5 | 347840-01-1 | Isotope-Labeled Compounds |
| HY-B0935S1 | Benzyl benzoate-d12 | 352431-26-6 | Isotope-Labeled Compounds |
| HY-B0937 | Amprolium | 121-25-5 | Reference compound |
| HY-B0937A | Amprolium (hydrochloride) | 137-88-2 | Reference compound |
| HY-B0937AR | Amprolium (hydrochloride) (Standard) | 137-88-2 | Reference Standards |
| HY-B0937S | Amprolium-d7 (bromide hydrobromide) | Isotope-Labeled Compounds | |
| HY-B0938 | Mephentermine (hemisulfate) | 1212-72-2 | Reference compound |
| HY-B0939 | Etebenecid | 1213-06-5 | Reference compound |
| HY-B0940 | Ethylvanillin | 121-32-4 | Reference compound |
| HY-B0940R | Ethylvanillin (Standard) | 121-32-4 | Reference Standards |
| HY-B0940S | Ethylvanillin-d5 | 1335401-74-5 | Isotope-Labeled Compounds |
| HY-B0941 | 6-Benzylaminopurine | 1214-39-7 | Natural Products |
| HY-B0941R | 6-Benzylaminopurine (Standard) | 1214-39-7 | Reference Standards |
| HY-B0941S | 6-Benzylaminopurine-d5 | 2322358-20-1 | Isotope-Labeled Compounds |
| HY-B0942 | Benzethonium (chloride) | 121-54-0 | Reference compound |
| HY-B0942R | Benzethonium (chloride) (Standard) | 121-54-0 | Reference Standards |
| HY-B0942S | Benzethonium-d7 (chloride) | Isotope-Labeled Compounds | |
| HY-B0942S1 | Benzethonium-d6 (chloride) | Isotope-Labeled Compounds | |
| HY-B0944 | Pidotimod | 121808-62-6 | Reference compound |
| HY-B0944R | Pidotimod (Standard) | 121808-62-6 | Reference Standards |
| HY-B0945 | Nitromide | 121-81-3 | Reference compound |
| HY-B0946 | Sulfamonomethoxine | 1220-83-3 | Reference compound |
| HY-B0946R | Sulfamonomethoxine (Standard) | 1220-83-3 | Reference Standards |
| HY-B0946S | Sulfamonomethoxine-d4 | 1286538-12-2 | Isotope-Labeled Compounds |
| HY-B0946S1 | Sulfamonomethoxine-d3 | Isotope-Labeled Compounds | |
| HY-B0946S2 | Sulfamonomethoxine-13C6 | 1416768-32-5 | Isotope-Labeled Compounds |
| HY-B0946S3 | Sulfamonomethoxine-d3-1 | 2704162-84-3 | Isotope-Labeled Compounds |
| HY-B0947 | Sulfanitran | 122-16-7 | Reference compound |
| HY-B0947R | Sulfanitran (Standard) | 122-16-7 | Reference Standards |
| HY-B0947S1 | Sulfanitran-13C6 | 1353867-79-4 | Isotope-Labeled Compounds |
| HY-B0949 | Protriptyline (hydrochloride) | 1225-55-4 | Reference compound |
| HY-B0949A | Protriptyline | 438-60-8 | Reference compound |
| HY-B0949AS | Protriptyline-d3 | 136765-50-9 | Isotope-Labeled Compounds |
| HY-B0949R | Protriptyline (hydrochloride) (Standard) | 1225-55-4 | Reference Standards |
| HY-B0949S | Protriptyline (N-methyl-d3) (hydrochloride) | 1435934-21-6 | Isotope-Labeled Compounds |
| HY-B0950 | Mefexamide | 1227-61-8 | Reference compound |
| HY-B0950A | Mefexamide (hydrochloride) | 3413-64-7 | Reference compound |
| HY-B0952 | 2-Aminoheptane | 123-82-0 | Reference compound |
| HY-B0953A | Pipenzolate (bromide) | 125-51-9 | Reference compound |
| HY-B0954 | Oxyphencyclimine (hydrochloride) | 125-52-0 | Reference compound |
| HY-B0954A | Oxyphencyclimine | 125-53-1 | Reference compound |
| HY-B0955 | Oxethazaine | 126-27-2 | Reference compound |
| HY-B0955R | Oxethazaine (Standard) | 126-27-2 | Reference Standards |
| HY-B0956 | Paromomycin (sulfate) | 1263-89-4 | Natural Products |
| HY-B0956A | Paromomycin | 7542-37-2 | Natural Products |
| HY-B0956R | Paromomycin (sulfate) (Standard) | 1263-89-4 | Reference Standards |
| HY-B0957 | Erythromycin Ethylsuccinate | 1264-62-6 | Natural Products |
| HY-B0957R | Erythromycin Ethylsuccinate (Standard) | 1264-62-6 | Reference Standards |
| HY-B0957S | Erythromycin ethylsuccinate-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0958 | Mupirocin | 12650-69-0 | Natural Products |
| HY-B0958A | Mupirocin (calcium) | 104486-81-9 | Reference compound |
| HY-B0958R | Mupirocin (Standard) | 12650-69-0 | Reference Standards |
| HY-B0959 | Chloramine-T | 127-65-1 | Reference compound |
| HY-B0960 | Sulfabenzamide | 127-71-9 | Reference compound |
| HY-B0960R | Sulfabenzamide (Standard) | 127-71-9 | Reference Standards |
| HY-B0960S | Sulfabenzamide-d4 | 2732981-22-3 | Isotope-Labeled Compounds |
| HY-B0961 | Merbromin | 129-16-8 | Dye Reagents |
| HY-B0962 | Piperidolate (hydrochloride) | 129-77-1 | Reference compound |
| HY-B0962A | Piperidolate | 82-98-4 | Reference compound |
| HY-B0962AR | Piperidolate (Standard) | 82-98-4 | Reference Standards |
| HY-B0963 | Cloxiquine | 130-16-5 | Reference compound |
| HY-B0963R | Cloxiquine (Standard) | 130-16-5 | Reference Standards |
| HY-B0964 | Riboflavin phosphate (sodium) | 130-40-5 | Natural Products |
| HY-B0964A | Riboflavin phosphate | 146-17-8 | Natural Products |
| HY-B0964R | Riboflavin phosphate (sodium) (Standard) | 130-40-5 | Reference Standards |
| HY-B0965 | Thioridazine (hydrochloride) | 130-61-0 | Reference compound |
| HY-B0965A | Thioridazine | 50-52-2 | Reference compound |
| HY-B0965AR | Thioridazine (Standard) | 50-52-2 | Reference Standards |
| HY-B0965AS | Thioridazine-d3 (hydrochloride) | 1189928-36-6 | Isotope-Labeled Compounds |
| HY-B0965R | Thioridazine (hydrochloride) (Standard) | 130-61-0 | Reference Standards |
| HY-B0966 | Dioxybenzone | 131-53-3 | Reference compound |
| HY-B0966R | Dioxybenzone (Standard) | 131-53-3 | Reference Standards |
| HY-B0966S | Dioxybenzone-d3 | Isotope-Labeled Compounds | |
| HY-B0967 | Phthalylsulfacetamide | 131-69-1 | Reference compound |
| HY-B0968 | Trimetazidine (dihydrochloride) | 13171-25-0 | Reference compound |
| HY-B0968A | Trimetazidine | 5011-34-7 | Reference compound |
| HY-B0968AR | Trimetazidine (Standard) | 5011-34-7 | Reference Standards |
| HY-B0968R | Trimetazidine (dihydrochloride) (Standard) | 13171-25-0 | Reference Standards |
| HY-B0968S | Trimetazidine-d8 (dihydrochloride) | 1219795-37-5 | Isotope-Labeled Compounds |
| HY-B0968S1 | Trimetazidine-d9 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B0970 | Diphenylpyraline (hydrochloride) | 132-18-3 | Reference compound |
| HY-B0971 | Pheniramine (maleate) | 132-20-7 | Reference compound |
| HY-B0971A | Pheniramine | 86-21-5 | Reference compound |
| HY-B0971AR | Pheniramine (Standard) | 86-21-5 | Reference Standards |
| HY-B0971R | Pheniramine (maleate) (Standard) | 132-20-7 | Reference Standards |
| HY-B0971S | Pheniramine-d6 (maleate) | Isotope-Labeled Compounds | |
| HY-B0972 | Cinchophen | 132-60-5 | Reference compound |
| HY-B0972R | Cinchophen (Standard) | 132-60-5 | Reference Standards |
| HY-B0973 | Dibenzothiophene | 132-65-0 | Reference compound |
| HY-B0973R | Dibenzothiophene (Standard) | 132-65-0 | Reference Standards |
| HY-B0973S | Dibenzothiophene-d8 | 33262-29-2 | Isotope-Labeled Compounds |
| HY-B0974 | Methicillin (sodium salt) | 132-92-3 | Reference compound |
| HY-B0974R | Methicillin (sodium salt) (Standard) | 132-92-3 | Reference Standards |
| HY-B0975 | Penicillin V (Potassium) | 132-98-9 | Natural Products |
| HY-B0975A | Penicillin V | 87-08-1 | Reference compound |
| HY-B0975AR | Penicillin V (Standard) | 87-08-1 | Reference Standards |
| HY-B0975AS | Penicillin V-d5 | 1356837-87-0 | Isotope-Labeled Compounds |
| HY-B0975R | Penicillin V (Potassium) (Standard) | 132-98-9 | Reference Standards |
| HY-B0975S | Penicillin V-13C6 (potassium) | Isotope-Labeled Compounds | |
| HY-B0975S1 | Penicillin V-d5 (potassium) | 2699607-22-0 | Isotope-Labeled Compounds |
| HY-B0976 | Fenoterol | 13392-18-2 | Reference compound |
| HY-B0976A | Fenoterol (hydrobromide) | 1944-12-3 | Reference compound |
| HY-B0976AR | Fenoterol (hydrobromide) (Standard) | 1944-12-3 | Reference Standards |
| HY-B0976AS | Fenoterol-d6 (hydrobromide) | 1286129-04-1 | Isotope-Labeled Compounds |
| HY-B0977 | Dicloxacillin (Sodium hydrate) | 13412-64-1 | Reference compound |
| HY-B0977R | Dicloxacillin (Sodium hydrate) (Standard) | 13412-64-1 | Reference Standards |
| HY-B0978 | Diethyltoluamide | 134-62-3 | Reference compound |
| HY-B0978R | Diethyltoluamide (Standard) | 134-62-3 | Reference Standards |
| HY-B0978S | Diethyltoluamide-d10 | 1215576-01-4 | Isotope-Labeled Compounds |
| HY-B0978S1 | Diethyltoluamide-d7 | 1219799-37-7 | Isotope-Labeled Compounds |
| HY-B0979 | Lobeline (hydrochloride) | 134-63-4 | Natural Products |
| HY-B0979R | Lobeline (hydrochloride) (Standard) | 134-63-4 | Reference Standards |
| HY-B0982 | Pindolol | 13523-86-9 | Reference compound |
| HY-B0982R | Pindolol (Standard) | 13523-86-9 | Reference Standards |
| HY-B0982S | Pindolol-d7 | 1185031-19-9 | Isotope-Labeled Compounds |
| HY-B0983 | Hydrocortisone 17-butyrate | 13609-67-1 | Reference compound |
| HY-B0983R | Hydrocortisone 17-butyrate (Standard) | 13609-67-1 | Reference Standards |
| HY-B0984 | Fendiline (hydrochloride) | 13636-18-5 | Reference compound |
| HY-B0984A | Fendiline | 13042-18-7 | Reference compound |
| HY-B0985 | Phenazopyridine (hydrochloride) | 136-40-3 | Reference compound |
| HY-B0985A | Phenazopyridine | 94-78-0 | Reference compound |
| HY-B0985R | Phenazopyridine (hydrochloride) (Standard) | 136-40-3 | Reference Standards |
| HY-B0986 | Hexylresorcinol | 136-77-6 | Reference compound |
| HY-B0986R | Hexylresorcinol (Standard) | 136-77-6 | Reference Standards |
| HY-B0987 | Ascorbyl palmitate | 137-66-6 | Reference compound |
| HY-B0987R | Ascorbyl palmitate (Standard) | 137-66-6 | Reference Standards |
| HY-B0988 | Deferoxamine (mesylate) | 138-14-7 | Reference compound |
| HY-B0988R | Deferoxamine (mesylate) (Standard) | 138-14-7 | Reference Standards |
| HY-B0989 | Carzenide | 138-41-0 | Reference compound |
| HY-B0990 | Thiostrepton | 1393-48-2 | Peptides |
| HY-B0991 | Amoxapine | 14028-44-5 | Reference compound |
| HY-B0991R | Amoxapine (Standard) | 14028-44-5 | Reference Standards |
| HY-B0991S | Amoxapine-d8 | 1189671-27-9 | Isotope-Labeled Compounds |
| HY-B0992 | Nithiamide | 140-40-9 | Reference compound |
| HY-B0992R | Nithiamide (Standard) | 140-40-9 | Reference Standards |
| HY-B0993 | Mangafodipir (trisodium) | 140678-14-4 | Reference compound |
| HY-B0993A | Mangafodipir | 155319-91-8 | Reference compound |
| HY-B0994 | Cyanoacetohydrazide | 140-87-4 | Reference compound |
| HY-B0996 | Hexetidine | 141-94-6 | Reference compound |
| HY-B0996R | Hexetidine (Standard) | 141-94-6 | Reference Standards |
| HY-B0997 | Hydroquinidine | 1435-55-8 | Natural Products |
| HY-B0997R | Hydroquinidine (Standard) | 1435-55-8 | Reference Standards |
| HY-B0998 | Dehydrocholate (sodium) | 145-41-5 | Natural Products |
| HY-B0999 | Chlorindanol | 145-94-8 | Reference compound |
| HY-B1000 | Selenomethionine | 1464-42-2 | Natural Products |
| HY-B1000A | L-SelenoMethionine | 3211-76-5 | Natural Products |
| HY-B1000AR | L-SelenoMethionine (Standard) | 3211-76-5 | Reference Standards |
| HY-B1000R | Selenomethionine (Standard) | 1464-42-2 | Reference Standards |
| HY-B1001 | Todralazine | 14679-73-3 | Reference compound |
| HY-B1001A | Todralazine (hydrochloride) | 3778-76-5 | Reference compound |
| HY-B1002 | Oxolinic acid | 14698-29-4 | Reference compound |
| HY-B1002R | Oxolinic acid (Standard) | 14698-29-4 | Reference Standards |
| HY-B1002S | Oxolinic acid-d5 | 1189890-98-9 | Isotope-Labeled Compounds |
| HY-B1003A | Phenethicillin (potassium) | 132-93-4 | Reference compound |
| HY-B1004 | Dinitolmide | 148-01-6 | Reference compound |
| HY-B1004R | Dinitolmide (Standard) | 148-01-6 | Reference Standards |
| HY-B1005 | 8-Hydroxyquinoline | 148-24-3 | Reference compound |
| HY-B1005R | 8-Hydroxyquinoline (Standard) | 148-24-3 | Reference Standards |
| HY-B1006 | Pilocarpine (nitrate) | 148-72-1 | Natural Products |
| HY-B1006R | Pilocarpine (nitrate) (Standard) | 148-72-1 | Reference Standards |
| HY-B1007 | Butacaine | 149-16-6 | Reference compound |
| HY-B1008 | 4-Aminobenzoic acid | 150-13-0 | Natural Products |
| HY-B1008R | 4-Aminobenzoic acid (Standard) | 150-13-0 | Reference Standards |
| HY-B1008S | 4-Aminobenzoic acid-d4 | 350820-01-8 | Isotope-Labeled Compounds |
| HY-B1009 | Ethylenediaminetetraacetic acid (trisodium salt) | 150-38-9 | Reference compound |
| HY-B1011 | Edoxudine | 15176-29-1 | Reference compound |
| HY-B1012 | Quinestrol | 152-43-2 | Reference compound |
| HY-B1012R | Quinestrol (Standard) | 152-43-2 | Reference Standards |
| HY-B1013 | Flurandrenolide | 1524-88-5 | Reference compound |
| HY-B1013R | Flurandrenolide (Standard) | 1524-88-5 | Reference Standards |
| HY-B1014 | Acenocoumarol | 152-72-7 | Reference compound |
| HY-B1014S | Acenocoumarol-d5 | 1185071-64-0 | Isotope-Labeled Compounds |
| HY-B1014S1 | Acenocoumarol-d4 | 2937878-24-3 | Isotope-Labeled Compounds |
| HY-B1015 | Etosalamide | 15302-15-5 | Reference compound |
| HY-B1016 | Trapidil | 15421-84-8 | Reference compound |
| HY-B1016R | Trapidil (Standard) | 15421-84-8 | Reference Standards |
| HY-B1017 | Molindone (hydrochloride) | 15622-65-8 | Reference compound |
| HY-B1017R | Molindone (hydrochloride) (Standard) | 15622-65-8 | Reference Standards |
| HY-B1018A | Phenelzine (sulfate) | 156-51-4 | Reference compound |
| HY-B1018AS | Phenelzine-d5 (sulfate) | 1219798-40-9 | Isotope-Labeled Compounds |
| HY-B1019 | Sulpiride | 15676-16-1 | Reference compound |
| HY-B1019R | Sulpiride (Standard) | 15676-16-1 | Reference Standards |
| HY-B1021 | Vincamine | 1617-90-9 | Natural Products |
| HY-B1021R | Vincamine (Standard) | 1617-90-9 | Reference Standards |
| HY-B1022 | Dimesna | 16208-51-8 | Reference compound |
| HY-B1022A | Dimesna (free acid) | 45127-11-5 | Reference compound |
| HY-B1023 | Mexenone | 1641-17-4 | Reference compound |
| HY-B1023R | Mexenone (Standard) | 1641-17-4 | Reference Standards |
| HY-B1024 | DL-Panthenol | 16485-10-2 | Biochemical Assay Reagents |
| HY-B1025 | Digoxigenin | 1672-46-4 | Dye Reagents |
| HY-B1025R | Digoxigenin (Standard) | 1672-46-4 | Dye Reagents |
| HY-B1026 | Adelmidrol | 1675-66-7 | Reference compound |
| HY-B1027 | 4-Nonylphenol polyethoxylate | 26027-38-3 | Reference compound |
| HY-B1028 | Pantethine | 16816-67-4 | Natural Products |
| HY-B1028R | Pantethine (Standard) | 16816-67-4 | Reference Standards |
| HY-B1028S | Pantethine-15N2 | Isotope-Labeled Compounds | |
| HY-B1029 | Danazol | 17230-88-5 | Reference compound |
| HY-B1029R | Danazol (Standard) | 17230-88-5 | Reference Standards |
| HY-B1030 | Lanatoside C | 17575-22-3 | Natural Products |
| HY-B1030R | Lanatoside C (Standard) | 17575-22-3 | Reference Standards |
| HY-B1032 | Dropropizine | 17692-31-8 | Reference compound |
| HY-B1032R | Dropropizine (Standard) | 17692-31-8 | Reference Standards |
| HY-B1033 | Metergoline | 17692-51-2 | Reference compound |
| HY-B1034 | Vanitiolide | 17692-71-6 | Reference compound |
| HY-B1035 | Levobunolol (hydrochloride) | 27912-14-7 | Reference compound |
| HY-B1035A | Levobunolol | 47141-42-4 | Reference compound |
| HY-B1035C | ent-Levobunolol (hydrochloride) | 27867-05-6 | Reference compound |
| HY-B1036 | Decoquinate | 18507-89-6 | Reference compound |
| HY-B1036R | Decoquinate (Standard) | 18507-89-6 | Reference Standards |
| HY-B1037 | Salbutamol | 18559-94-9 | Reference compound |
| HY-B1037B | Salbutamol (adipate) | 149234-08-2 | Reference compound |
| HY-B1037R | Salbutamol (Standard) | 18559-94-9 | Reference Standards |
| HY-B1037S | Salbutamol-d3 | 1219798-60-3 | Isotope-Labeled Compounds |
| HY-B1037S2 | Salbutamol-d9 | 1173021-73-2 | Isotope-Labeled Compounds |
| HY-B1037S3 | Salbutamol-d9 (acetate) | 1781417-68-2 | Isotope-Labeled Compounds |
| HY-B1038 | L-Cysteine methyl ester (hydrochloride) | 18598-63-5 | Reference compound |
| HY-B1039 | Ambroxol | 18683-91-5 | Reference compound |
| HY-B1039A | Ambroxol (hydrochloride) | 23828-92-4 | Reference compound |
| HY-B1039AR | Ambroxol (hydrochloride) (Standard) | 23828-92-4 | Reference Standards |
| HY-B1039AS | Ambroxol-d5 (hydrochloride) | 2741380-71-0 | Isotope-Labeled Compounds |
| HY-B1039C | Ambroxol (acefylline) | 96989-76-3 | Reference compound |
| HY-B1039R | Ambroxol (Standard) | 18683-91-5 | Reference Standards |
| HY-B1040 | Ftaxilide | 19368-18-4 | Reference compound |
| HY-B1041 | Aminoguanidine (hydrochloride) | 1937-19-5 | Reference compound |
| HY-B1041A | Aminoguanidine | 79-17-4 | Reference compound |
| HY-B1042 | Oxolamine (citrate) | 1949-20-8 | Reference compound |
| HY-B1043 | Piromidic acid | 19562-30-2 | Natural Products |
| HY-B1043R | Piromidic acid (Standard) | 19562-30-2 | Reference Standards |
| HY-B1044 | Idramantone | 20098-14-0 | Reference compound |
| HY-B1045 | Chlorazanil (hydrochloride) | 2019-25-2 | Reference compound |
| HY-B1045A | Chlorazanil | 500-42-5 | Reference compound |
| HY-B1046 | Clofazimine | 2030-63-9 | Dye Reagents |
| HY-B1046R | Clofazimine (Standard) | 2030-63-9 | Reference Standards |
| HY-B1046S | Clofazimine-d7 | Isotope-Labeled Compounds | |
| HY-B1047 | Carsalam | 2037-95-8 | Reference compound |
| HY-B1048 | Pasiniazid | 2066-89-9 | Reference compound |
| HY-B1050 | Gemifloxacin (mesylate) | 210353-53-0 | Reference compound |
| HY-B1050R | Gemifloxacin (mesylate) (Standard) | 210353-53-0 | Reference Standards |
| HY-B1051 | Flumethasone | 2135-17-3 | Reference compound |
| HY-B1051R | Flumethasone (Standard) | 2135-17-3 | Reference Standards |
| HY-B1052 | Lofexidine (hydrochloride) | 21498-08-8 | Reference compound |
| HY-B1052A | Lofexidine | 31036-80-3 | Reference compound |
| HY-B1052S | Lofexidine-d4 (hydrochloride) | 1206845-57-9 | Isotope-Labeled Compounds |
| HY-B1052S1 | Lofexidine-d4 | 78302-26-8 | Isotope-Labeled Compounds |
| HY-B1053 | Iotalamic acid | 2276-90-6 | Reference compound |
| HY-B1053B | Iothalamate (sodium) | 1225-20-3 | Reference compound |
| HY-B1053R | Iotalamic acid (Standard) | 2276-90-6 | Reference Standards |
| HY-B1053S | Iotalamic acid-d3 | 928623-31-8 | Isotope-Labeled Compounds |
| HY-B1054 | Famprofazone | 22881-35-2 | Reference compound |
| HY-B1055 | Pentoxyverine (citrate) | 23142-01-0 | Reference compound |
| HY-B1055R | Pentoxyverine (citrate) (Standard) | 23142-01-0 | Reference Standards |
| HY-B1056 | Procodazole | 23249-97-0 | Reference compound |
| HY-B1056R | Procodazole (Standard) | 23249-97-0 | Reference Standards |
| HY-B1057 | Nefopam (hydrochloride) | 23327-57-3 | Reference compound |
| HY-B1057R | Nefopam (hydrochloride) (Standard) | 23327-57-3 | Reference Standards |
| HY-B1057S | Nefopam-d3 (hydrochloride) | 1346603-30-2 | Isotope-Labeled Compounds |
| HY-B1057S1 | Nefopam-d4 (hydrochloride) | 2747915-60-0 | Isotope-Labeled Compounds |
| HY-B1057S2 | Nefopam-d3 | 1346747-15-6 | Isotope-Labeled Compounds |
| HY-B1058 | Benfluorex (hydrochloride) | 23642-66-2 | Reference compound |
| HY-B1058A | Benfluorex | 23602-78-0 | Reference compound |
| HY-B1058R | Benfluorex (hydrochloride) (Standard) | 23642-66-2 | Reference Standards |
| HY-B1059 | Levosulpiride | 23672-07-3 | Reference compound |
| HY-B1059R | Levosulpiride (Standard) | 23672-07-3 | Reference Standards |
| HY-B1059S | Levosulpiride-d3 | 124020-27-5 | Isotope-Labeled Compounds |
| HY-B1060 | Methylprednisolone succinate (sodium) | 2375-03-3 | Reference compound |
| HY-B1061 | Nicotinic acid N-oxide | 2398-81-4 | Reference compound |
| HY-B1062 | Dexchlorpheniramine (maleate) | 2438-32-6 | Reference compound |
| HY-B1062R | Dexchlorpheniramine (maleate) (Standard) | 2438-32-6 | Reference Standards |
| HY-B1063 | Terpin (hydrate) | 2451-01-6 | Reference compound |
| HY-B1063R | Terpin (hydrate) (Standard) | 2451-01-6 | Reference Standards |
| HY-B1064 | Clindamycin phosphate | 24729-96-2 | Reference compound |
| HY-B1064A | Clindamycin phosphate (hydrochloride) | 64023-51-4 | Reference compound |
| HY-B1064R | Clindamycin phosphate (Standard) | 24729-96-2 | Reference Standards |
| HY-B1065 | Aceglutamide | 2490-97-3 | Natural Products |
| HY-B1065R | Aceglutamide (Standard) | 2490-97-3 | Reference Standards |
| HY-B1066 | Butylhydroxyanisole | 25013-16-5 | Reference compound |
| HY-B1066R | Butylhydroxyanisole (Standard) | 25013-16-5 | Reference Standards |
| HY-B1067 | Antazoline (hydrochloride) | 2508-72-7 | Reference compound |
| HY-B1067A | Antazoline | 91-75-8 | Reference compound |
| HY-B1067AR | Antazoline (Standard) | 91-75-8 | Reference Standards |
| HY-B1067B | Antazoline (phosphate) | 154-68-7 | Reference compound |
| HY-B1067BR | Antazoline (phosphate) (Standard) | 154-68-7 | Reference Standards |
| HY-B1067R | Antazoline (hydrochloride) (Standard) | 2508-72-7 | Reference Standards |
| HY-B1068 | Tyloxapol | 25301-02-4 | Reference compound |
| HY-B1068R | Tyloxapol (Standard) | 25301-02-4 | Reference Standards |
| HY-B1069 | Molsidomine | 25717-80-0 | Reference compound |
| HY-B1069R | Molsidomine (Standard) | 25717-80-0 | Reference Standards |
| HY-B1070 | DL-Xylose | 25990-60-7 | Natural Products |
| HY-B1071 | Lasalocid | 25999-31-9 | Natural Products |
| HY-B1071A | Lasalocid (sodium) | 25999-20-6 | Natural Products |
| HY-B1071AR | Lasalocid (sodium) (Standard) | 25999-20-6 | Reference Standards |
| HY-B1071R | Lasalocid (Standard) | 25999-31-9 | Reference Standards |
| HY-B1072 | Phenothrin | 26002-80-2 | Reference compound |
| HY-B1072A | D-Phenothrin | 26046-85-5 | Reference compound |
| HY-B1072R | Phenothrin (Standard) | 26002-80-2 | Reference Standards |
| HY-B1073 | Morantel (tartrate) | 26155-31-7 | Reference compound |
| HY-B1073R | Morantel (tartrate) (Standard) | 26155-31-7 | Reference Standards |
| HY-B1074 | Ethamsylate | 2624-44-4 | Reference compound |
| HY-B1074R | Ethamsylate (Standard) | 2624-44-4 | Reference Standards |
| HY-B1075 | Fosfomycin (calcium) | 26016-98-8 | Reference compound |
| HY-B1075A | Fosfomycin | 23155-02-4 | Reference compound |
| HY-B1075AS | (Rac)-Fosfomycin (benzylamine)-13C3 | 1216461-18-5 | Isotope-Labeled Compounds |
| HY-B1075R | Fosfomycin (calcium) (Standard) | 26016-98-8 | Reference Standards |
| HY-B1076 | Medrysone | 2668-66-8 | Reference compound |
| HY-B1076R | Medrysone (Standard) | 2668-66-8 | Reference Standards |
| HY-B1077 | Penfluridol | 26864-56-2 | Reference compound |
| HY-B1077R | Penfluridol (Standard) | 26864-56-2 | Reference Standards |
| HY-B1078 | Cefazolin (sodium) | 27164-46-1 | Reference compound |
| HY-B1078R | Cefazolin (sodium) (Standard) | 27164-46-1 | Reference Standards |
| HY-B1079 | Suxibuzone | 27470-51-5 | Reference compound |
| HY-B1079R | Suxibuzone (Standard) | 27470-51-5 | Reference Standards |
| HY-B1080 | Tilorone (dihydrochloride) | 27591-69-1 | Reference compound |
| HY-B1080A | Tilorone | 27591-97-5 | Reference compound |
| HY-B1080R | Tilorone (dihydrochloride) (Standard) | 27591-69-1 | Reference Standards |
| HY-B1081 | Oxidopamine (hydrochloride) | 28094-15-7 | Reference compound |
| HY-B1081A | Oxidopamine (hydrobromide) | 636-00-0 | Reference compound |
| HY-B1083 | Modaline (sulfate) | 2856-75-9 | Reference compound |
| HY-B1084 | Cinoctramide | 28598-08-5 | Reference compound |
| HY-B1085 | Cinoxacin | 28657-80-9 | Reference compound |
| HY-B1085R | Cinoxacin (Standard) | 28657-80-9 | Reference Standards |
| HY-B1085S | Cinoxacin-d5 | 2732985-25-8 | Isotope-Labeled Compounds |
| HY-B1086 | Afalanine | 2901-75-9 | Reference compound |
| HY-B1087 | Prednisolone (hemisuccinate) | 2920-86-7 | Reference compound |
| HY-B1087R | Prednisolone (hemisuccinate) (Standard) | 2920-86-7 | Reference Standards |
| HY-B1088 | Clopidol | 2971-90-6 | Reference compound |
| HY-B1088R | Clopidol (Standard) | 2971-90-6 | Reference Standards |
| HY-B1089 | Ethynodiol diacetate | 297-76-7 | Reference compound |
| HY-B1089R | Ethynodiol diacetate (Standard) | 297-76-7 | Reference Standards |
| HY-B1090 | Cinnarizine | 298-57-7 | Reference compound |
| HY-B1090R | Cinnarizine (Standard) | 298-57-7 | Reference Standards |
| HY-B1090S | Cinnarizine-d8 | 1185242-27-6 | Isotope-Labeled Compounds |
| HY-B1092 | Gluconate (Calcium) | 299-28-5 | Reference compound |
| HY-B1092A | Gluconate (sodium) | 527-07-1 | Natural Products |
| HY-B1092AR | Gluconate (sodium) (Standard) | 527-07-1 | Reference Standards |
| HY-B1092AS | Gluconate-1-13C (sodium) | 2687959-99-3 | Isotope-Labeled Compounds |
| HY-B1092R | Gluconate (Calcium) (Standard) | 299-28-5 | Reference Standards |
| HY-B1093 | Fenchlorphos | 299-84-3 | Reference compound |
| HY-B1093R | Fenchlorphos (Standard) | 299-84-3 | Reference Standards |
| HY-B1094 | Aklomide | 3011-89-0 | Reference compound |
| HY-B1095 | Chlormadinone acetate | 302-22-7 | Reference compound |
| HY-B1095R | Chlormadinone acetate (Standard) | 302-22-7 | Reference Standards |
| HY-B1095S1 | Chlormadinone acetate-d6-1 | Isotope-Labeled Compounds | |
| HY-B1095S2 | Chlormadinone acetate-d3 | Isotope-Labeled Compounds | |
| HY-B1096 | Etamivan | 304-84-7 | Reference compound |
| HY-B1096R | Etamivan (Standard) | 304-84-7 | Reference Standards |
| HY-B1098 | Hydroxyamphetamine | 103-86-6 | Reference compound |
| HY-B1098A | Hydroxyamphetamine (hydrobromide) | 306-21-8 | Reference compound |
| HY-B1098B | Hydroxyamphetamine (hydrochloride) | 876-26-6 | Reference compound |
| HY-B1099 | Hycanthone | 3105-97-3 | Reference compound |
| HY-B1100 | Estradiol cypionate | 313-06-4 | Reference compound |
| HY-B1100R | Estradiol cypionate (Standard) | 313-06-4 | Reference Standards |
| HY-B1101 | Pimethixene | 314-03-4 | Reference compound |
| HY-B1101A | Pimethixene maleate | 13187-06-9 | Reference compound |
| HY-B1101AR | Pimethixene maleate (Standard) | 13187-06-9 | Reference Standards |
| HY-B1102 | Evans Blue | 314-13-6 | Biochemical Assay Reagents |
| HY-B1103 | Hydroxyhexamide | 3168-01-2 | Reference compound |
| HY-B1103R | Hydroxyhexamide (Standard) | 3168-01-2 | Reference Standards |
| HY-B1104 | Indoprofen | 31842-01-0 | Reference compound |
| HY-B1104R | Indoprofen (Standard) | 31842-01-0 | Reference Standards |
| HY-B1105A | Ethylnorepinephrine (hydrochloride) | 3198-07-0 | Reference compound |
| HY-B1106 | Tetrahydroxyquinone | 319-89-1 | Reference compound |
| HY-B1106A | Tetrahydroxyquinone (monohydrate) | 1215458-51-7 | Reference compound |
| HY-B1107 | Naftidrofuryl (oxalate) | 3200-06-4 | Reference compound |
| HY-B1107R | Naftidrofuryl (oxalate) (Standard) | 3200-06-4 | Reference Standards |
| HY-B1108 | Labetalol (hydrochloride) | 32780-64-6 | Reference compound |
| HY-B1108R | Labetalol (hydrochloride) (Standard) | 32780-64-6 | Reference Standards |
| HY-B1108S | Labetalol (hydrochloride)-d5 | 2713514-78-2 | Isotope-Labeled Compounds |
| HY-B1109 | N-Acetylprocainamide | 32795-44-1 | Reference compound |
| HY-B1109R | N-Acetylprocainamide (Standard) | 32795-44-1 | Reference Standards |
| HY-B1110 | Nomifensine | 24526-64-5 | Reference compound |
| HY-B1110A | Nomifensine (maleate) | 32795-47-4 | Reference compound |
| HY-B1110S | Nomifensine-d3 (maleate) | 1795140-41-8 | Isotope-Labeled Compounds |
| HY-B1111 | Amitraz | 33089-61-1 | Reference compound |
| HY-B1111R | Amitraz (Standard) | 33089-61-1 | Reference Standards |
| HY-B1111S | Amitraz-d6 | 2734300-36-6 | Isotope-Labeled Compounds |
| HY-B1111S1 | Amitraz-d3 | Isotope-Labeled Compounds | |
| HY-B1112 | Fluorothyl | 333-36-8 | Reference compound |
| HY-B1113 | Diazinon | 333-41-5 | Reference compound |
| HY-B1113R | Diazinon (Standard) | 333-41-5 | Reference Standards |
| HY-B1114 | Gliquidone | 33342-05-1 | Reference compound |
| HY-B1114R | Gliquidone (Standard) | 33342-05-1 | Reference Standards |
| HY-B1114S | Gliquidone-d6 | Isotope-Labeled Compounds | |
| HY-B1115 | Buspirone (hydrochloride) | 33386-08-2 | Reference compound |
| HY-B1115A | Buspirone | 36505-84-7 | Reference compound |
| HY-B1115AR | Buspirone (Standard) | 36505-84-7 | Reference Standards |
| HY-B1115AS | Buspirone-d8 | 204395-49-3 | Isotope-Labeled Compounds |
| HY-B1115R | Buspirone (hydrochloride) (Standard) | 33386-08-2 | Reference Standards |
| HY-B1115S | Buspirone-d8 (hydrochloride) | 1216761-39-5 | Isotope-Labeled Compounds |
| HY-B1115S1 | Buspirone-d8 (di(hydrochloride)) | Isotope-Labeled Compounds | |
| HY-B1116 | Metaraminol (tartrate) | 33402-03-8 | Reference compound |
| HY-B1116A | Metaraminol | 54-49-9 | Reference compound |
| HY-B1116R | Metaraminol (tartrate) (Standard) | 33402-03-8 | Reference Standards |
| HY-B1117 | Cefoxitin (sodium) | 33564-30-6 | Reference compound |
| HY-B1117R | Cefoxitin (sodium) (Standard) | 33564-30-6 | Reference Standards |
| HY-B1118 | Secnidazole | 3366-95-8 | Reference compound |
| HY-B1118A | Secnidazole (hemihydrate) | 227622-73-3 | Reference compound |
| HY-B1118R | Secnidazole (Standard) | 3366-95-8 | Reference Standards |
| HY-B1118S | Secnidazole-d6 | 1346603-27-7 | Isotope-Labeled Compounds |
| HY-B1118S1 | Secnidazole-13C2, 15N2 | Isotope-Labeled Compounds | |
| HY-B1118S2 | Secnidazole-d4 | Isotope-Labeled Compounds | |
| HY-B1119 | Triclosan | 3380-34-5 | Reference compound |
| HY-B1119R | Triclosan (Standard) | 3380-34-5 | Reference Standards |
| HY-B1119S | Triclosan-d3 | 1020719-98-5 | Isotope-Labeled Compounds |
| HY-B1120 | Temephos | 3383-96-8 | Reference compound |
| HY-B1120R | Temephos (Standard) | 3383-96-8 | Reference Standards |
| HY-B1120S | Temephos-d12 | 1219795-39-7 | Isotope-Labeled Compounds |
| HY-B1121 | Flunisolide | 3385-03-3 | Reference compound |
| HY-B1121A | Flunisolide (hemihydrate) | 77326-96-6 | Reference compound |
| HY-B1121AR | Flunisolide (hemihydrate) (Standard) | 77326-96-6 | Reference Standards |
| HY-B1121S | Flunisolide-d6 | Isotope-Labeled Compounds | |
| HY-B1122 | L-Cycloserine | 339-72-0 | Natural Products |
| HY-B1122R | L-Cycloserine (Standard) | 339-72-0 | Reference Standards |
| HY-B1123 | Auranofin | 34031-32-8 | Reference compound |
| HY-B1124 | Fipexide | 34161-24-5 | Reference compound |
| HY-B1124A | Fipexide (hydrochloride) | 34161-23-4 | Reference compound |
| HY-B1124R | Fipexide (Standard) | 34161-24-5 | Reference Standards |
| HY-B1125 | Glucosamine | 3416-24-8 | Natural Products |
| HY-B1125R | Glucosamine (Standard) | 3416-24-8 | Reference Standards |
| HY-B1125S | Glucosamine-13C6 | Isotope-Labeled Compounds | |
| HY-B1126 | Orphenadrine (hydrochloride) | 341-69-5 | Reference compound |
| HY-B1126R | Orphenadrine (hydrochloride) (Standard) | 341-69-5 | Reference Standards |
| HY-B1126S | Orphenadrine-d3 (hydrochloride) | 1309283-23-5 | Isotope-Labeled Compounds |
| HY-B1127 | Betamipron | 3440-28-6 | Reference compound |
| HY-B1127R | Betamipron (Standard) | 3440-28-6 | Reference Standards |
| HY-B1128 | Cefamandole | 34444-01-4 | Reference compound |
| HY-B1128A | Cefamandole (sodium) | 30034-03-8 | Reference compound |
| HY-B1128AR | Cefamandole (sodium) (Standard) | 30034-03-8 | Reference Standards |
| HY-B1128B | Cefamandole (lithium) | 58648-57-0 | Reference compound |
| HY-B1130 | Isoxicam | 34552-84-6 | Reference compound |
| HY-B1130R | Isoxicam (Standard) | 34552-84-6 | Reference Standards |
| HY-B1131 | Taurocholic acid (sodium salt hydrate) | 345909-26-4 | Natural Products |
| HY-B1131R | Taurocholic acid (sodium salt hydrate) (Standard) | 345909-26-4 | Reference Standards |
| HY-B1132 | Clidinium (bromide) | 3485-62-9 | Reference compound |
| HY-B1132R | Clidinium (bromide) (Standard) | 3485-62-9 | Reference Standards |
| HY-B1132S | Clidinium-d5 (bromide) | Isotope-Labeled Compounds | |
| HY-B1133 | Sulbentine | 350-12-9 | Reference compound |
| HY-B1134 | Imazalil | 35554-44-0 | Natural Products |
| HY-B1134A | Imazalil (sulfate) | 58594-72-2 | Reference compound |
| HY-B1134AS | Imazalil-d5 (sulfate) | 1398065-92-3 | Isotope-Labeled Compounds |
| HY-B1134R | Imazalil (Standard) | 35554-44-0 | Reference Standards |
| HY-B1135 | Benzbromarone | 3562-84-3 | Reference compound |
| HY-B1135R | Benzbromarone (Standard) | 3562-84-3 | Reference Standards |
| HY-B1135S | Benzbromarone-d5 | Isotope-Labeled Compounds | |
| HY-B1136 | Menbutone | 3562-99-0 | Reference compound |
| HY-B1137 | Ramifenazone | 3615-24-5 | Reference compound |
| HY-B1137R | Ramifenazone (Standard) | 3615-24-5 | Reference Standards |
| HY-B1137S | Ramifenazone-d7 | 1330180-51-2 | Isotope-Labeled Compounds |
| HY-B1138 | Fenbufen | 36330-85-5 | Reference compound |
| HY-B1138R | Fenbufen (Standard) | 36330-85-5 | Reference Standards |
| HY-B1138S | Fenbufen-d9 | 1189940-96-2 | Isotope-Labeled Compounds |
| HY-B1139 | Tolperisone (hydrochloride) | 3644-61-9 | Reference compound |
| HY-B1139A | Tolperisone | 728-88-1 | Reference compound |
| HY-B1139AS | Tolperisone-d10 | 1185196-91-1 | Isotope-Labeled Compounds |
| HY-B1139R | Tolperisone (hydrochloride) (Standard) | 3644-61-9 | Reference Standards |
| HY-B1139S | Tolperisone-d10 (hydrochloride) | 1185160-65-9 | Isotope-Labeled Compounds |
| HY-B1140 | Diazoxide | 364-98-7 | Reference compound |
| HY-B1140R | Diazoxide (Standard) | 364-98-7 | Reference Standards |
| HY-B1140S | Diazoxide-d3 | 1432063-51-8 | Isotope-Labeled Compounds |
| HY-B1141 | Eprodisate (disodium) | 36589-58-9 | Reference compound |
| HY-B1142 | Lipoamide | 940-69-2 | Natural Products |
| HY-B1143 | Broxaldine | 3684-46-6 | Reference compound |
| HY-B1144A | Chlormidazole (hydrochloride) | 74298-63-8 | Reference compound |
| HY-B1145 | Chlorhexidine (dihydrochloride) | 3697-42-5 | Reference compound |
| HY-B1145R | Chlorhexidine (dihydrochloride) (Standard) | 3697-42-5 | Reference Standards |
| HY-B1145S | Chlorhexidine-d8 (dihydrochloride) | 2012598-75-1 | Isotope-Labeled Compounds |
| HY-B1146 | Denatonium (benzoate) | 3734-33-6 | Reference compound |
| HY-B1146R | Denatonium (benzoate) (Standard) | 3734-33-6 | Reference Standards |
| HY-B1147 | Diloxanide furoate | 3736-81-0 | Reference compound |
| HY-B1147R | Diloxanide furoate (Standard) | 3736-81-0 | Reference Standards |
| HY-B1148 | Furaltadone (hydrochloride) | 3759-92-0 | Reference compound |
| HY-B1148A | Furaltadone | 139-91-3 | Reference compound |
| HY-B1148AR | Furaltadone (Standard) | 139-91-3 | Reference Standards |
| HY-B1148AS | Furaltadone-d5 | 1015855-64-7 | Isotope-Labeled Compounds |
| HY-B1148B | Furaltadone (L-tartrate) | 14343-71-6 | Reference compound |
| HY-B1148R | Furaltadone (hydrochloride) (Standard) | 3759-92-0 | Reference Standards |
| HY-B1149 | Bacampicillin | 50972-17-3 | Reference compound |
| HY-B1149A | Bacampicillin (hydrochloride) | 37661-08-8 | Reference compound |
| HY-B1149AR | Bacampicillin (hydrochloride) (Standard) | 37661-08-8 | Reference Standards |
| HY-B1150 | Clofoctol | 37693-01-9 | Natural Products |
| HY-B1150R | Clofoctol (Standard) | 37693-01-9 | Reference Standards |
| HY-B1151 | Climbazole | 38083-17-9 | Reference compound |
| HY-B1151R | Climbazole (Standard) | 38083-17-9 | Reference Standards |
| HY-B1151S | Climbazole-d4 | 1185117-79-6 | Isotope-Labeled Compounds |
| HY-B1152 | Piperacetazine | 3819-00-9 | Reference compound |
| HY-B1153 | Glafenine | 3820-67-5 | Reference compound |
| HY-B1153A | Glafenine (hydrochloride) | 65513-72-6 | Reference compound |
| HY-B1154 | Penbutolol (sulfate) | 38363-32-5 | Reference compound |
| HY-B1154R | Penbutolol (sulfate) (Standard) | 38363-32-5 | Reference Standards |
| HY-B1155 | Hydrocortisone phosphate | 3863-59-0 | Reference compound |
| HY-B1156 | Cephradine | 38821-53-3 | Reference compound |
| HY-B1156A | Cephradine (sodium) | 57584-26-6 | Reference compound |
| HY-B1156R | Cephradine (Standard) | 38821-53-3 | Reference Standards |
| HY-B1157 | Trioxsalen | 3902-71-4 | Reference compound |
| HY-B1157R | Trioxsalen (Standard) | 3902-71-4 | Reference Standards |
| HY-B1158 | Imidazolidinyl urea | 39236-46-9 | Reference compound |
| HY-B1158R | Imidazolidinyl urea (Standard) | 39236-46-9 | Reference Standards |
| HY-B1159 | Nitroxoline | 4008-48-4 | Reference compound |
| HY-B1159R | Nitroxoline (Standard) | 4008-48-4 | Reference Standards |
| HY-B1159S | Nitroxoline-d4 | Isotope-Labeled Compounds | |
| HY-B1159S1 | Nitroxoline-d5 | Isotope-Labeled Compounds | |
| HY-B1160 | Bitoscanate | 4044-65-9 | Reference compound |
| HY-B1161 | Methoprene | 40596-69-8 | Reference compound |
| HY-B1161A | S-Methoprene | 65733-16-6 | Reference compound |
| HY-B1161AR | S-Methoprene (Standard) | 65733-16-6 | Reference Standards |
| HY-B1161R | Methoprene (Standard) | 40596-69-8 | Reference Standards |
| HY-B1161S | Methoprene-d7 | 2673270-24-9 | Isotope-Labeled Compounds |
| HY-B1162 | Sulisobenzone | 4065-45-6 | Reference compound |
| HY-B1162R | Sulisobenzone (Standard) | 4065-45-6 | Reference Standards |
| HY-B1164 | Bromopride | 4093-35-0 | Reference compound |
| HY-B1164A | Bromopride (hydrochloride) | 52423-56-0 | Reference compound |
| HY-B1165 | Cyproheptadine (hydrochloride sesquihydrate) | 41354-29-4 | Reference compound |
| HY-B1165R | Cyproheptadine (hydrochloride sesquihydrate) (Standard) | 41354-29-4 | Reference Standards |
| HY-B1166 | Cefamandole nafate | 42540-40-9 | Reference compound |
| HY-B1167 | Ajmaline | 4360-12-7 | Natural Products |
| HY-B1167A | Ajmaline (hydrochloride) | 4410-48-4 | Natural Products |
| HY-B1167R | Ajmaline (Standard) | 4360-12-7 | Reference Standards |
| HY-B1169 | Timonacic | 444-27-9 | Reference compound |
| HY-B1170 | Cyclandelate | 456-59-7 | Reference compound |
| HY-B1170R | Cyclandelate (Standard) | 456-59-7 | Reference Standards |
| HY-B1172 | Lactulose | 4618-18-2 | Reference compound |
| HY-B1172R | Lactulose (Standard) | 4618-18-2 | Reference Standards |
| HY-B1173 | (+)-Camphor | 464-49-3 | Natural Products |
| HY-B1173R | (+)-Camphor (Standard) | 464-49-3 | Reference Standards |
| HY-B1174 | Bekanamycin | 4696-76-8 | Natural Products |
| HY-B1174R | Bekanamycin (Standard) | 4696-76-8 | Reference Standards |
| HY-B1175 | (2S,5R,6R)-Ticarcillin (disodium) | 4697-14-7 | Reference compound |
| HY-B1175R | (2S,5R,6R)-Ticarcillin (disodium) (Standard) | 4697-14-7 | Reference Standards |
| HY-B1176 | Equilin | 474-86-2 | Reference compound |
| HY-B1176R | Equilin (Standard) | 474-86-2 | Reference Standards |
| HY-B1176S | Equilin-d4 | 285979-79-5 | Isotope-Labeled Compounds |
| HY-B1176S1 | Equilin-d2 | Isotope-Labeled Compounds | |
| HY-B1177 | Crotamiton | 483-63-6 | Reference compound |
| HY-B1177R | Crotamiton (Standard) | 483-63-6 | Reference Standards |
| HY-B1178 | Cotinine | 486-56-6 | Natural Products |
| HY-B1178A | R-(+)-Cotinine | 32162-64-4 | Reference compound |
| HY-B1178R | Cotinine (Standard) | 486-56-6 | Reference Standards |
| HY-B1178S | (Rac)-Cotinine-d3 | 110952-70-0 | Isotope-Labeled Compounds |
| HY-B1178S1 | (Rac)-Cotinine-d4 | 350818-68-7 | Isotope-Labeled Compounds |
| HY-B1178S2 | (Rac)-Cotinine-d7 | Isotope-Labeled Compounds | |
| HY-B1179 | Dipyrocetyl | 486-79-3 | Reference compound |
| HY-B1179R | Dipyrocetyl (Standard) | 486-79-3 | Reference Standards |
| HY-B1180 | Vinburnine | 4880-88-0 | Natural Products |
| HY-B1180R | Vinburnine (Standard) | 4880-88-0 | Reference Standards |
| HY-B1181 | Hydrastinine (hydrochloride) | 4884-68-8 | Natural Products |
| HY-B1181A | Hydrastinine | 6592-85-4 | Natural Products |
| HY-B1182 | Chromocarb | 4940-39-0 | Reference compound |
| HY-B1183 | Hydrocortisone acetate | 50-03-3 | Natural Products |
| HY-B1183R | Hydrocortisone acetate (Standard) | 50-03-3 | Reference Standards |
| HY-B1184 | Mephenytoin | 50-12-4 | Reference compound |
| HY-B1184A | (S)-Mephenytoin | 70989-04-7 | Reference compound |
| HY-B1184AR | (S)-Mephenytoin (Standard) | 70989-04-7 | Reference Standards |
| HY-B1184R | Mephenytoin (Standard) | 50-12-4 | Reference Standards |
| HY-B1184S1 | Mephenytoin-d5 | 1185032-66-9 | Isotope-Labeled Compounds |
| HY-B1184S2 | Mephenytoin-d8 | Isotope-Labeled Compounds | |
| HY-B1184S3 | Mephenytoin-13C,d3 | 1261398-53-1 | Isotope-Labeled Compounds |
| HY-B1185 | Beclamide | 501-68-8 | Reference compound |
| HY-B1186 | Dixanthogen | 502-55-6 | Reference compound |
| HY-B1186R | Dixanthogen (Standard) | 502-55-6 | Reference Standards |
| HY-B1188 | Propantheline (bromide) | 50-34-0 | Reference compound |
| HY-B1188A | Propantheline | 298-50-0 | Reference compound |
| HY-B1188R | Propantheline (bromide) (Standard) | 50-34-0 | Reference Standards |
| HY-B1188S | Propantheline-d3 (bromide) | 64717-35-7 | Isotope-Labeled Compounds |
| HY-B1189 | Meglutol | 503-49-1 | Natural Products |
| HY-B1189S | Meglutol-d3 | 59060-36-5 | Isotope-Labeled Compounds |
| HY-B1190 | Cefadroxil | 50370-12-2 | Reference compound |
| HY-B1190A | Cefadroxil (hydrate) | 66592-87-8 | Reference compound |
| HY-B1190AR | Cefadroxil (hydrate) (Standard) | 66592-87-8 | Reference Standards |
| HY-B1190BS | L-Cefadroxil-d4 (trifluoroacetate) | Isotope-Labeled Compounds | |
| HY-B1190R | Cefadroxil (Standard) | 50370-12-2 | Reference Standards |
| HY-B1190S | Cefadroxil-d4 (hydrate) | 1426174-38-0 | Isotope-Labeled Compounds |
| HY-B1190S1 | Cefadroxil-d4 (trifluoroacetate) | Isotope-Labeled Compounds | |
| HY-B1190S2 | Cefadroxil-13C6 | Isotope-Labeled Compounds | |
| HY-B1191 | Nanofin | 504-03-0 | Reference compound |
| HY-B1192 | Estradiol benzoate | 50-50-0 | Reference compound |
| HY-B1192R | Estradiol benzoate (Standard) | 50-50-0 | Reference Standards |
| HY-B1192S | Estradiol benzoate-d3 | 1192354-74-7 | Isotope-Labeled Compounds |
| HY-B1193 | Terfenadine | 50679-08-8 | Reference compound |
| HY-B1193R | Terfenadine (Standard) | 50679-08-8 | Reference Standards |
| HY-B1194 | Tetramisole (hydrochloride) | 5086-74-8 | Reference compound |
| HY-B1194A | Tetramisole | 5036-02-2 | Reference compound |
| HY-B1194R | Tetramisole (hydrochloride) (Standard) | 5086-74-8 | Reference Standards |
| HY-B1196 | Tiapride (hydrochloride) | 51012-33-0 | Reference compound |
| HY-B1196A | Tiapride | 51012-32-9 | Reference compound |
| HY-B1196R | Tiapride (hydrochloride) (Standard) | 51012-33-0 | Reference Standards |
| HY-B1197 | Amcinonide | 51022-69-6 | Reference compound |
| HY-B1197R | Amcinonide (Standard) | 51022-69-6 | Reference Standards |
| HY-B1198 | Piperonyl butoxide | 51-03-6 | Reference compound |
| HY-B1198R | Piperonyl butoxide (Standard) | 51-03-6 | Reference Standards |
| HY-B1198S | Piperonyl butoxide-d9 | 1329834-53-8 | Isotope-Labeled Compounds |
| HY-B1199 | Nialamide | 51-12-7 | Reference compound |
| HY-B1199A | Nialamide (hydrochloride) | 1161-03-1 | Reference compound |
| HY-B1200 | Pralidoxime (chloride) | 51-15-0 | Reference compound |
| HY-B1200R | Pralidoxime (chloride) (Standard) | 51-15-0 | Reference Standards |
| HY-B1201 | Tiratricol | 51-24-1 | Reference compound |
| HY-B1201R | Tiratricol (Standard) | 51-24-1 | Reference Standards |
| HY-B1202 | Alrestatin | 51411-04-2 | Reference compound |
| HY-B1202A | Alrestatin (sodium) | 51876-97-2 | Reference compound |
| HY-B1203 | Fludrocortisone | 127-31-1 | Reference compound |
| HY-B1203A | Fludrocortisone acetate | 514-36-3 | Reference compound |
| HY-B1203AR | Fludrocortisone acetate (Standard) | 514-36-3 | Reference Standards |
| HY-B1203AS | Fludrocortisone acetate-d5 | Isotope-Labeled Compounds | |
| HY-B1203R | Fludrocortisone (Standard) | 127-31-1 | Reference Standards |
| HY-B1203S | Fludrocortisone-d5 | Isotope-Labeled Compounds | |
| HY-B1203S1 | Fludrocortisone-d2 | Isotope-Labeled Compounds | |
| HY-B1204 | Histamine | 51-45-6 | Natural Products |
| HY-B1204R | Histamine (Standard) | 51-45-6 | Reference Standards |
| HY-B1204S | Histamine-α,α,β,β-d4 (dihydrochloride) | 344299-48-5 | Isotope-Labeled Compounds |
| HY-B1204S1 | Histamine-d4 | 751471-48-4 | Isotope-Labeled Compounds |
| HY-B1204S2 | Histamine-13C5, 15N3 | Isotope-Labeled Compounds | |
| HY-B1204S3 | Histamine-13C5 | 2897532-68-0 | Isotope-Labeled Compounds |
| HY-B1204S4 | Histamine-15N3 | Isotope-Labeled Compounds | |
| HY-B1205 | Atropine | 51-55-8 | Natural Products |
| HY-B1205A | Atropine (sulfate) | 55-48-1 | Natural Products |
| HY-B1205AR | Atropine (sulfate) (Standard) | 55-48-1 | Reference Standards |
| HY-B1205B | Atropine (hydrobromide) | 6415-90-3 | Reference compound |
| HY-B1205R | Atropine (Standard) | 51-55-8 | Reference Standards |
| HY-B1205S | (Rac)-Atropine-d3 | 1276197-36-4 | Isotope-Labeled Compounds |
| HY-B1206 | Neostigmine (methyl sulfate) | 51-60-5 | Reference compound |
| HY-B1206R | Neostigmine (methyl sulfate) (Standard) | 51-60-5 | Reference Standards |
| HY-B1207 | Urethane | 51-79-6 | Natural Products |
| HY-B1207R | Urethane (Standard) | 51-79-6 | Reference Standards |
| HY-B1207S | Urethane-d5 | 73962-07-9 | Isotope-Labeled Compounds |
| HY-B1209 | Etofylline | 519-37-9 | Reference compound |
| HY-B1209R | Etofylline (Standard) | 519-37-9 | Reference Standards |
| HY-B1210 | Pipemidic acid | 51940-44-4 | Reference compound |
| HY-B1210R | Pipemidic acid (Standard) | 51940-44-4 | Reference Standards |
| HY-B1211 | Dehydroacetic acid | 520-45-6 | Reference compound |
| HY-B1211R | Dehydroacetic acid (Standard) | 520-45-6 | Reference Standards |
| HY-B1212 | Broxyquinoline | 521-74-4 | Reference compound |
| HY-B1213 | Trimipramine (maleate) | 521-78-8 | Reference compound |
| HY-B1213A | Trimipramine | 739-71-9 | Reference compound |
| HY-B1213AR | Trimipramine (Standard) | 739-71-9 | Reference Standards |
| HY-B1213AS | Trimipramine-d3 (N-methyl-d3) (maleate) | Isotope-Labeled Compounds | |
| HY-B1213R | Trimipramine (maleate) (Standard) | 521-78-8 | Reference Standards |
| HY-B1213S | Trimipramine-d3 (maleate) | 1185245-93-5 | Isotope-Labeled Compounds |
| HY-B1214 | Prednisolone acetate | 52-21-1 | Reference compound |
| HY-B1214R | Prednisolone acetate (Standard) | 52-21-1 | Reference Standards |
| HY-B1214S | Prednisolone acetate-d8 | Isotope-Labeled Compounds | |
| HY-B1215 | Dimenhydrinate | 523-87-5 | Reference compound |
| HY-B1215R | Dimenhydrinate (Standard) | 523-87-5 | Reference Standards |
| HY-B1216 | Oxeladin (citrate) | 52432-72-1 | Reference compound |
| HY-B1216R | Oxeladin (citrate) (Standard) | 52432-72-1 | Reference Standards |
| HY-B1217 | Bronopol | 52-51-7 | Reference compound |
| HY-B1217R | Bronopol (Standard) | 52-51-7 | Reference Standards |
| HY-B1217S | Bronopol-d4 | Isotope-Labeled Compounds | |
| HY-B1218 | Sulfaphenazole | 526-08-9 | Reference compound |
| HY-B1218R | Sulfaphenazole (Standard) | 526-08-9 | Reference Standards |
| HY-B1221 | Flufenamic acid | 530-78-9 | Reference compound |
| HY-B1221R | Flufenamic acid (Standard) | 530-78-9 | Reference Standards |
| HY-B1221S | Flufenamic acid-d4 | 1185071-99-1 | Isotope-Labeled Compounds |
| HY-B1221S1 | Flufenamic acid-13C6 | 1325559-30-5 | Isotope-Labeled Compounds |
| HY-B1222 | Sisomicin (sulfate) | 53179-09-2 | Natural Products |
| HY-B1222A | Sisomicin | 32385-11-8 | Reference compound |
| HY-B1222AR | Sisomicin (Standard) | 32385-11-8 | Reference Standards |
| HY-B1222R | Sisomicin (sulfate) (Standard) | 53179-09-2 | Reference Standards |
| HY-B1223 | Anethole trithione | 532-11-6 | Natural Products |
| HY-B1224 | Exalamide | 53370-90-4 | Reference compound |
| HY-B1225 | Promazine (hydrochloride) | 53-60-1 | Reference compound |
| HY-B1225A | Promazine | 58-40-2 | Reference compound |
| HY-B1225R | Promazine (hydrochloride) (Standard) | 53-60-1 | Reference Standards |
| HY-B1225S | Promazine-d6 (hydrochloride) | 1246819-33-9 | Isotope-Labeled Compounds |
| HY-B1226 | Diperodon (hydrochloride) | 537-12-2 | Reference compound |
| HY-B1227 | Carprofen | 53716-49-7 | Reference compound |
| HY-B1227R | Carprofen (Standard) | 53716-49-7 | Reference Standards |
| HY-B1227S | Carprofen-d3 | 1173019-42-5 | Isotope-Labeled Compounds |
| HY-B1227S1 | Carprofen-13C,d3 | 2012598-34-2 | Isotope-Labeled Compounds |
| HY-B1228 | Ribostamycin (sulfate) | 53797-35-6 | Natural Products |
| HY-B1229 | Isovaleramide | 541-46-8 | Natural Products |
| HY-B1230 | Camylofine | 54-30-8 | Reference compound |
| HY-B1230A | Camylofin (dihydrochloride) | 5892-41-1 | Reference compound |
| HY-B1231 | Heptaminol (hydrochloride) | 543-15-7 | Reference compound |
| HY-B1231R | Heptaminol (hydrochloride) (Standard) | 543-15-7 | Reference Standards |
| HY-B1232 | Metyrapone | 54-36-4 | Reference compound |
| HY-B1232A | Metyrapone (Tartrate) | 908-35-0 | Reference compound |
| HY-B1232R | Metyrapone (Standard) | 54-36-4 | Reference Standards |
| HY-B1233 | Octodrine | 543-82-8 | Natural Products |
| HY-B1233A | Octodrine (hydrochloride) | 5984-59-8 | Reference compound |
| HY-B1234 | Octinoxate | 5466-77-3 | Natural Products |
| HY-B1234A | (E)-Octinoxate | 83834-59-7 | Reference compound |
| HY-B1234AS | (E)-Octinoxate-13C,d3 | 2734919-82-3 | Isotope-Labeled Compounds |
| HY-B1234R | Octinoxate (Standard) | 5466-77-3 | Reference Standards |
| HY-B1234S | Octinoxate-13C,d3 | Isotope-Labeled Compounds | |
| HY-B1235 | Acetohydroxamic acid | 546-88-3 | Reference compound |
| HY-B1235R | Acetohydroxamic acid (Standard) | 546-88-3 | Reference Standards |
| HY-B1236 | Sulfacarbamide | 547-44-4 | Reference compound |
| HY-B1237 | Suloctidil | 54767-75-8 | Reference compound |
| HY-B1237A | Suloctidil (hydrochloride) | 54767-71-4 | Reference compound |
| HY-B1238 | Pronethalol | 54-80-8 | Reference compound |
| HY-B1238A | Pronethalol (hydrochloride) | 51-02-5 | Reference compound |
| HY-B1239 | Drofenine (hydrochloride) | 548-66-3 | Reference compound |
| HY-B1239A | Drofenine | 1679-76-1 | Reference compound |
| HY-B1240 | Droperidol | 548-73-2 | Reference compound |
| HY-B1240R | Droperidol (Standard) | 548-73-2 | Reference Standards |
| HY-B1241 | Dihydrostreptomycin (sulfate) | 5490-27-7 | Reference compound |
| HY-B1241A | Dihydrostreptomycin | 128-46-1 | Reference compound |
| HY-B1241R | Dihydrostreptomycin (sulfate) (Standard) | 5490-27-7 | Reference Standards |
| HY-B1243 | Propoxycaine (hydrochloride) | 550-83-4 | Reference compound |
| HY-B1244 | Dimetridazole | 551-92-8 | Reference compound |
| HY-B1244R | Dimetridazole (Standard) | 551-92-8 | Reference Standards |
| HY-B1244S | Dimetridazole-d3 | 64678-69-9 | Isotope-Labeled Compounds |
| HY-B1245 | Salsalate | 552-94-3 | Reference compound |
| HY-B1245R | Salsalate (Standard) | 552-94-3 | Reference Standards |
| HY-B1246 | Thonzonium (bromide) | 553-08-2 | Reference compound |
| HY-B1246R | Thonzonium (bromide) (Standard) | 553-08-2 | Reference Standards |
| HY-B1247 | Protoporphyrin IX | 553-12-8 | Natural Products |
| HY-B1247A | Protoporphyrin IX (disodium) | 50865-01-5 | Reference compound |
| HY-B1247R | Protoporphyrin IX (Standard) | 553-12-8 | Reference Standards |
| HY-B1248 | Chlorhexidine | 55-56-1 | Reference compound |
| HY-B1248A | Chlorhexidine (acetate hydrate) | 206986-79-0 | Reference compound |
| HY-B1248R | Chlorhexidine (Standard) | 55-56-1 | Reference Standards |
| HY-B1250 | Acedoben | 556-08-1 | Biochemical Assay Reagents |
| HY-B1250A | Acedoben (sodium) | 29305-16-6 | Biochemical Assay Reagents |
| HY-B1250R | Acedoben (Standard) | 556-08-1 | Reference Standards |
| HY-B1250S | Acedoben-d3 | 57742-39-9 | Isotope-Labeled Compounds |
| HY-B1251 | Guanethidine | 55-65-2 | Reference compound |
| HY-B1252 | Cefalonium | 5575-21-3 | Reference compound |
| HY-B1252A | Cefalonium (hydrate) | 1486466-27-6 | Reference compound |
| HY-B1252AS | Cefalonium-d4 (hydrate) | Isotope-Labeled Compounds | |
| HY-B1252B | Cefalonium (dihydrate) | 1385046-35-4 | Reference compound |
| HY-B1252BR | Cefalonium (dihydrate) (Standard) | 1385046-35-4 | Reference Standards |
| HY-B1252R | Cefalonium (Standard) | 5575-21-3 | Reference Standards |
| HY-B1253 | Chlormethine (hydrochloride) | 55-86-7 | Reference compound |
| HY-B1253R | Chlormethine (hydrochloride) (Standard) | 55-86-7 | Reference Standards |
| HY-B1254 | Altizide | 5588-16-9 | Reference compound |
| HY-B1256 | Cefuroxime (sodium) | 56238-63-2 | Reference compound |
| HY-B1256A | Cefuroxime | 55268-75-2 | Reference compound |
| HY-B1256AR | Cefuroxime (Standard) | 55268-75-2 | Reference Standards |
| HY-B1256R | Cefuroxime (sodium) (Standard) | 56238-63-2 | Reference Standards |
| HY-B1256S | Cefuroxime-d3 | 1803240-98-3 | Isotope-Labeled Compounds |
| HY-B1257 | Cefmetazole (sodium) | 56796-39-5 | Reference compound |
| HY-B1257R | Cefmetazole (sodium) (Standard) | 56796-39-5 | Reference Standards |
| HY-B1258 | 4-(Aminomethyl)benzoic acid | 56-91-7 | Reference compound |
| HY-B1258R | 4-(Aminomethyl)benzoic acid (Standard) | 56-91-7 | Reference Standards |
| HY-B1258S | Intermediate of tranexamic Acid-13C2,15N | Isotope-Labeled Compounds | |
| HY-B1259 | 6-Acetamidohexanoic acid | 57-08-9 | Natural Products |
| HY-B1260 | Cetrimonium (bromide) | 57-09-0 | Reference compound |
| HY-B1260S | Cetrimonium (bromide)-d42 | 907216-28-8 | Isotope-Labeled Compounds |
| HY-B1260S1 | Cetrimonium-d33 (bromide) | 347841-42-3 | Isotope-Labeled Compounds |
| HY-B1260S2 | Cetrimonium-d3 (bromide) | 1092921-73-7 | Isotope-Labeled Compounds |
| HY-B1260S3 | Cetrimonium-d9(bromide) | 95217-14-4 | Isotope-Labeled Compounds |
| HY-B1262 | Acetophenazine (dimaleate) | 5714-00-1 | Reference compound |
| HY-B1263 | Chlorobutanol | 57-15-8 | Reference compound |
| HY-B1263R | Chlorobutanol (Standard) | 57-15-8 | Reference Standards |
| HY-B1264 | Celiprolol (hydrochloride) | 57470-78-7 | Reference compound |
| HY-B1264R | Celiprolol (hydrochloride) (Standard) | 57470-78-7 | Reference Standards |
| HY-B1265 | Hydrocortisone 17-valerate | 57524-89-7 | Reference compound |
| HY-B1265R | Hydrocortisone 17-valerate (Standard) | 57524-89-7 | Reference Standards |
| HY-B1266 | Physostigmine (salicylate) | 57-64-7 | Reference compound |
| HY-B1266R | Physostigmine (salicylate) (Standard) | 57-64-7 | Reference Standards |
| HY-B1267 | Sulfaguanidine | 57-67-0 | Reference compound |
| HY-B1267R | Sulfaguanidine (Standard) | 57-67-0 | Reference Standards |
| HY-B1267S | Sulfaguanidine-d4 | Isotope-Labeled Compounds | |
| HY-B1267S1 | Sulfaguanidine-13C6 | Isotope-Labeled Compounds | |
| HY-B1268 | Docusate (Sodium) | 577-11-7 | Reference compound |
| HY-B1268R | Docusate (Sodium) (Standard) | 577-11-7 | Reference Standards |
| HY-B1270 | Isoxsuprine hydrochloride | 579-56-6 | Reference compound |
| HY-B1270A | Isoxsuprine | 395-28-8 | Reference compound |
| HY-B1270R | Isoxsuprine hydrochloride (Standard) | 579-56-6 | Reference Standards |
| HY-B1270S | Isoxsuprine-d6 (hydrochloride) | 2706004-35-3 | Isotope-Labeled Compounds |
| HY-B1271 | Sulfinpyrazone | 57-96-5 | Reference compound |
| HY-B1271R | Sulfinpyrazone (Standard) | 57-96-5 | Reference Standards |
| HY-B1272 | Desipramine (hydrochloride) | 58-28-6 | Reference compound |
| HY-B1272A | Desipramine | 50-47-5 | Reference compound |
| HY-B1272AS | Desipramine-d4 | 61361-34-0 | Isotope-Labeled Compounds |
| HY-B1272AS1 | Desipramine-d3 | 65100-49-4 | Isotope-Labeled Compounds |
| HY-B1272R | Desipramine (hydrochloride) (Standard) | 58-28-6 | Reference Standards |
| HY-B1273 | Fenipentol | 583-03-9 | Dye Reagents |
| HY-B1274 | Cinromide | 58473-74-8 | Reference compound |
| HY-B1275 | Cephalothin (sodium) | 58-71-9 | Reference compound |
| HY-B1275A | Cephalothin | 153-61-7 | Reference compound |
| HY-B1275AR | Cephalothin (Standard) | 153-61-7 | Reference Standards |
| HY-B1275R | Cephalothin (sodium) (Standard) | 58-71-9 | Reference Standards |
| HY-B1276 | Metaproterenol (hemisulfate) | 5874-97-5 | Reference compound |
| HY-B1276A | Metaproterenol | 586-06-1 | Reference compound |
| HY-B1276R | Metaproterenol (hemisulfate) (Standard) | 5874-97-5 | Reference Standards |
| HY-B1276S | Metaproterenol-d7 (hemisulfate) | Isotope-Labeled Compounds | |
| HY-B1277 | Trihexyphenidyl (hydrochloride) | 52-49-3 | Reference compound |
| HY-B1277A | Trihexyphenidyl | 144-11-6 | Reference compound |
| HY-B1277AS | Trihexyphenidyl-d5 | Isotope-Labeled Compounds | |
| HY-B1277R | Trihexyphenidyl (hydrochloride) (Standard) | 52-49-3 | Reference Standards |
| HY-B1277S | Trihexyphenidyl-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1278 | D-α-Tocopherol acetate | 58-95-7 | Natural Products |
| HY-B1278A | DL-α-Tocopherol acetate | 52225-20-4 | Reference compound |
| HY-B1278AR | DL-α-Tocopherol acetate (Standard) | 52225-20-4 | Reference Standards |
| HY-B1278AS | DL-α-Tocopherol acetate-13C4,d6 | Isotope-Labeled Compounds | |
| HY-B1278B | (±)-α-Tocopherol acetate | 7695-91-2 | Biochemical Assay Reagents |
| HY-B1278BR | (±)-α-Tocopherol acetate (Standard) | 7695-91-2 | Reference Standards |
| HY-B1278S1 | α-Tocopherol-d6 (acetate) | 143731-16-2 | Isotope-Labeled Compounds |
| HY-B1279 | Metamizole (sodium hydrate) | 5907-38-0 | Reference compound |
| HY-B1279A | Metamizole (sodium) | 68-89-3 | Reference compound |
| HY-B1279AS | Metamizole-d3 (sodium) | 2512223-60-6 | Isotope-Labeled Compounds |
| HY-B1279R | Metamizole (sodium hydrate) (Standard) | 5907-38-0 | Reference Standards |
| HY-B1280 | Nikethamide | 59-26-7 | Reference compound |
| HY-B1280R | Nikethamide (Standard) | 59-26-7 | Reference Standards |
| HY-B1281 | Mepyramine maleate | 59-33-6 | Reference compound |
| HY-B1281R | Mepyramine maleate (Standard) | 59-33-6 | Reference Standards |
| HY-B1282 | Sulfaquinoxaline | 59-40-5 | Reference compound |
| HY-B1282A | Sulfaquinoxaline (sodium salt) | 967-80-6 | Reference compound |
| HY-B1282AR | Sulfaquinoxaline (sodium salt) (Standard) | 967-80-6 | Reference Standards |
| HY-B1282R | Sulfaquinoxaline (Standard) | 59-40-5 | Reference Standards |
| HY-B1282S | Sulfaquinoxaline-d4 | 1329652-02-9 | Isotope-Labeled Compounds |
| HY-B1283 | Mephenesin | 59-47-2 | Reference compound |
| HY-B1283R | Mephenesin (Standard) | 59-47-2 | Reference Standards |
| HY-B1283S | Mephenesin-d3 | Isotope-Labeled Compounds | |
| HY-B1285 | Dimercaprol | 59-52-9 | Reference compound |
| HY-B1285R | Dimercaprol (Standard) | 59-52-9 | Reference Standards |
| HY-B1286 | Piperacillin (sodium) | 59703-84-3 | Reference compound |
| HY-B1286R | Piperacillin (sodium) (Standard) | 59703-84-3 | Reference Standards |
| HY-B1287 | Citalopram (hydrobromide) | 59729-32-7 | Reference compound |
| HY-B1287R | Citalopram (hydrobromide) (Standard) | 59729-32-7 | Reference Standards |
| HY-B1287S | Citalopram-d3 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-B1288 | Oxybuprocaine (hydrochloride) | 5987-82-6 | Reference compound |
| HY-B1288A | Oxybuprocaine | 99-43-4 | Reference compound |
| HY-B1288R | Oxybuprocaine (hydrochloride) (Standard) | 5987-82-6 | Reference Standards |
| HY-B1289 | Cetylpyridinium (chloride monohydrate) | 6004-24-6 | Reference compound |
| HY-B1289R | Cetylpyridinium (chloride monohydrate) (Standard) | 6004-24-6 | Reference Standards |
| HY-B1290 | 2-Phenylethanol | 60-12-8 | Natural Products |
| HY-B1290R | 2-Phenylethanol (Standard) | 60-12-8 | Reference Standards |
| HY-B1290S | 2-Phenylethanol-d4 | 107473-33-6 | Isotope-Labeled Compounds |
| HY-B1290S1 | 2-Phenylethanol-d9 | 42950-74-3 | Isotope-Labeled Compounds |
| HY-B1290S2 | 2-Phenylethanol-d5 | 35845-63-7 | Isotope-Labeled Compounds |
| HY-B1290S3 | 2-Phenylethanol-13C2 | 68661-17-6 | Isotope-Labeled Compounds |
| HY-B1292 | Iodipamide | 606-17-7 | Reference compound |
| HY-B1292R | Iodipamide (Standard) | 606-17-7 | Reference Standards |
| HY-B1294 | Amrinone | 60719-84-8 | Reference compound |
| HY-B1294R | Amrinone (Standard) | 60719-84-8 | Reference Standards |
| HY-B1295 | Lithium citrate (tetrahydrate) | 6080-58-6 | Biochemical Assay Reagents |
| HY-B1296 | Promethazine | 60-87-7 | Reference compound |
| HY-B1296S | Promethazine-d6 (hydrochloride) | 1189947-02-1 | Isotope-Labeled Compounds |
| HY-B1296S1 | Promethazine-d4 | 1173147-64-2 | Isotope-Labeled Compounds |
| HY-B1297 | Ceforanide | 60925-61-3 | Reference compound |
| HY-B1297R | Ceforanide (Standard) | 60925-61-3 | Reference Standards |
| HY-B1298 | Methoxamine (hydrochloride) | 61-16-5 | Reference compound |
| HY-B1298A | Methoxamine | 390-28-3 | Reference compound |
| HY-B1299 | Cephalosporin C | 61-24-5 | Reference compound |
| HY-B1299A | Cephalosporin C zinc salt | 59143-60-1 | Reference compound |
| HY-B1300 | Cefonicid (sodium) | 61270-78-8 | Reference compound |
| HY-B1300A | Cefonicid | 61270-58-4 | Reference compound |
| HY-B1300B | Cefonicid (monosodium) | 71420-79-6 | Reference compound |
| HY-B1300R | Cefonicid (sodium) (Standard) | 61270-78-8 | Reference Standards |
| HY-B1301 | Triprolidine (hydrochloride monohydrate) | 6138-79-0 | Reference compound |
| HY-B1301R | Triprolidine (hydrochloride monohydrate) (Standard) | 6138-79-0 | Reference Standards |
| HY-B1302 | Quinidine hydrochloride monohydrate | 6151-40-2 | Natural Products |
| HY-B1303 | Mebhydrolin (napadisylate) | 6153-33-9 | Reference compound |
| HY-B1303A | Mebhydrolin | 524-81-2 | Reference compound |
| HY-B1303R | Mebhydrolin (napadisylate) (Standard) | 6153-33-9 | Reference Standards |
| HY-B1304 | (-)-Sparteine (sulfate pentahydrate) | 6160-12-9 | Natural Products |
| HY-B1304A | (+)-Sparteine (sulfate pentahydrate) | Natural Products | |
| HY-B1305 | Chloropyramine hydrochloride | 6170-42-9 | Reference compound |
| HY-B1305R | Chloropyramine hydrochloride (Standard) | 6170-42-9 | Reference Standards |
| HY-B1306 | 4-Aminohippuric acid | 61-78-9 | Natural Products |
| HY-B1306R | 4-Aminohippuric acid (Standard) | 61-78-9 | Reference Standards |
| HY-B1306S | 4-Aminohippuric acid-d4 | 1219805-41-0 | Isotope-Labeled Compounds |
| HY-B1307 | Zoxazolamine | 61-80-3 | Reference compound |
| HY-B1308 | Adrenalone (hydrochloride) | 62-13-5 | Reference compound |
| HY-B1308A | Adrenalone | 99-45-6 | Reference compound |
| HY-B1308R | Adrenalone (hydrochloride) (Standard) | 62-13-5 | Reference Standards |
| HY-B1309 | Metacetamol | 621-42-1 | Natural Products |
| HY-B1311 | Proadifen (hydrochloride) | 62-68-0 | Reference compound |
| HY-B1311R | Proadifen (hydrochloride) (Standard) | 62-68-0 | Reference Standards |
| HY-B1313 | Lobendazole | 6306-71-4 | Reference compound |
| HY-B1315 | Carbaryl | 63-25-2 | Reference compound |
| HY-B1315R | Carbaryl (Standard) | 63-25-2 | Reference Standards |
| HY-B1315S | Carbaryl-d3 | 1433961-56-8 | Isotope-Labeled Compounds |
| HY-B1315S1 | Carbaryl-d7 | 362049-56-7 | Isotope-Labeled Compounds |
| HY-B1316 | Trimetozine | 635-41-6 | Reference compound |
| HY-B1317 | Thonzylamine | 91-85-0 | Reference compound |
| HY-B1317A | Thonzylamine (hydrochloride) | 63-56-9 | Reference compound |
| HY-B1317R | Thonzylamine (Standard) | 91-85-0 | Reference Standards |
| HY-B1318 | Foscarnet (sodium) | 63585-09-1 | Reference compound |
| HY-B1319 | Pramocaine (hydrochloride) | 637-58-1 | Reference compound |
| HY-B1319R | Pramocaine (hydrochloride) (Standard) | 637-58-1 | Reference Standards |
| HY-B1319S1 | Pramocaine-d9 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1320 | Meclofenamic acid (sodium) | 6385-02-0 | Reference compound |
| HY-B1320R | Meclofenamic acid (sodium) (Standard) | 6385-02-0 | Reference Standards |
| HY-B1322 | Amodiaquine (dihydrochloride dihydrate) | 6398-98-7 | Reference compound |
| HY-B1322A | Amodiaquine | 86-42-0 | Reference compound |
| HY-B1322AS | Amodiaquine-d10 | 1189449-70-4 | Isotope-Labeled Compounds |
| HY-B1322AS1 | Amodiaquine-d10 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1322B | Amodiaquine (dihydrochloride) | 69-44-3 | Reference compound |
| HY-B1322R | Amodiaquine (dihydrochloride dihydrate) (Standard) | 6398-98-7 | Reference Standards |
| HY-B1323 | Dipivefrin (hydrochloride) | 64019-93-8 | Reference compound |
| HY-B1323R | Dipivefrin (hydrochloride) (Standard) | 64019-93-8 | Reference Standards |
| HY-B1323S | Dipivefrin-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1324 | Oxiconazole nitrate | 64211-46-7 | Reference compound |
| HY-B1324A | Oxiconazole | 64211-45-6 | Reference compound |
| HY-B1324R | Oxiconazole nitrate (Standard) | 64211-46-7 | Reference Standards |
| HY-B1325 | Cefuroxime axetil | 64544-07-6 | Reference compound |
| HY-B1325R | Cefuroxime axetil (Standard) | 64544-07-6 | Reference Standards |
| HY-B1326 | Bemegride | 64-65-3 | Reference compound |
| HY-B1327 | Chlortetracycline (hydrochloride) | 64-72-2 | Natural Products |
| HY-B1327A | Chlortetracycline | 57-62-5 | Reference compound |
| HY-B1327R | Chlortetracycline (hydrochloride) (Standard) | 64-72-2 | Reference Standards |
| HY-B1327S | Chlortetracycline-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1328 | Pyridoxine | 65-23-6 | Natural Products |
| HY-B1328R | Pyridoxine (Standard) | 65-23-6 | Reference Standards |
| HY-B1328S | Pyridoxine-d5 | 688302-31-0 | Isotope-Labeled Compounds |
| HY-B1328S1 | Pyridoxine-d3 | 1190043-14-1 | Isotope-Labeled Compounds |
| HY-B1328S2 | Pyridoxine-d2 | 5027-84-9 | Isotope-Labeled Compounds |
| HY-B1328S3 | Pyridoxine-13C4 | Isotope-Labeled Compounds | |
| HY-B1329 | Apramycin (sulfate) | 65710-07-8 | Natural Products |
| HY-B1329R | Apramycin (sulfate) (Standard) | 65710-07-8 | Reference Standards |
| HY-B1330 | Proglumide | 6620-60-6 | Reference compound |
| HY-B1331 | Cyromazine | 66215-27-8 | Natural Products |
| HY-B1331R | Cyromazine (Standard) | 66215-27-8 | Reference Standards |
| HY-B1331S | Cyromazine-d4 | 1219804-19-9 | Isotope-Labeled Compounds |
| HY-B1331S1 | Cyromazine-13C3 | 1808990-94-4 | Isotope-Labeled Compounds |
| HY-B1332 | Ipratropium (bromide hydrate) | 66985-17-9 | Reference compound |
| HY-B1332R | Ipratropium (bromide hydrate) (Standard) | 66985-17-9 | Reference Standards |
| HY-B1334 | Perhexiline | 6621-47-2 | Reference compound |
| HY-B1334A | Perhexiline (maleate) | 6724-53-4 | Reference compound |
| HY-B1334AS | Perhexiline-d11 (maleate) | Isotope-Labeled Compounds | |
| HY-B1335 | Pentetic acid | 67-43-6 | Dye Reagents |
| HY-B1335R | Pentetic acid (Standard) | 67-43-6 | Dye Reagents |
| HY-B1336 | Furazolidone | 67-45-8 | Reference compound |
| HY-B1336R | Furazolidone (Standard) | 67-45-8 | Reference Standards |
| HY-B1336S | Furazolidone-d4 | 1217222-76-8 | Isotope-Labeled Compounds |
| HY-B1337 | Choline (chloride) | 67-48-1 | Reference compound |
| HY-B1337B | Glycerophosphoinositol (choline) | 425642-32-6 | Reference compound |
| HY-B1337C | Choline (chloride), >98% | 67-48-1 | Reference compound |
| HY-B1337R | Choline (chloride) (Standard) | 67-48-1 | Reference Standards |
| HY-B1337S | Choline-d4 (chloride) | 285979-70-6 | Isotope-Labeled Compounds |
| HY-B1337S1 | Choline-d9 (chloride) | 61037-86-3 | Isotope-Labeled Compounds |
| HY-B1337S2 | Choline-d6 (chloride) | Isotope-Labeled Compounds | |
| HY-B1337S3 | Choline-d13 (chloride) | 352438-97-2 | Isotope-Labeled Compounds |
| HY-B1337S4 | Choline Chloride-13C3 | Isotope-Labeled Compounds | |
| HY-B1337S5 | Choline-13C2 (chloride) | 202190-49-6 | Isotope-Labeled Compounds |
| HY-B1339 | Dicyclomine (hydrochloride) | 67-92-5 | Reference compound |
| HY-B1339A | Dicyclomine | 77-19-0 | Reference compound |
| HY-B1339AS | Dicyclomine-d4 | Isotope-Labeled Compounds | |
| HY-B1339R | Dicyclomine (hydrochloride) (Standard) | 67-92-5 | Reference Standards |
| HY-B1340 | Carbadox | 6804-07-5 | Reference compound |
| HY-B1340R | Carbadox (Standard) | 6804-07-5 | Reference Standards |
| HY-B1340S | Carbadox-d3 | 1185240-06-5 | Isotope-Labeled Compounds |
| HY-B1341 | Norethynodrel | 68-23-5 | Reference compound |
| HY-B1342 | Vitamin A | 68-26-8 | Natural Products |
| HY-B1342A | 13-cis-Vitamin A | 2052-63-3 | Reference compound |
| HY-B1342R | Vitamin A (Standard) | 68-26-8 | Reference Standards |
| HY-B1342S | Vitamin A-d8 | 212848-81-2 | Isotope-Labeled Compounds |
| HY-B1342S1 | Vitamin A-d6 | 2483831-77-0 | Isotope-Labeled Compounds |
| HY-B1342S2 | Vitamin A-d4 | 118063-12-0 | Isotope-Labeled Compounds |
| HY-B1342S3 | Vitamin A-13C3 | Isotope-Labeled Compounds | |
| HY-B1342S4 | Vitamin A-d5 | 1185244-58-9 | Isotope-Labeled Compounds |
| HY-B1342S5 | Vitamin A-d3 | 118139-35-8 | Isotope-Labeled Compounds |
| HY-B1343 | Pridinol (mesylate) | 6856-31-1 | Reference compound |
| HY-B1343A | Pridinol | 511-45-5 | Reference compound |
| HY-B1343AS | Pridinol-d5 | Isotope-Labeled Compounds | |
| HY-B1343R | Pridinol (mesylate) (Standard) | 6856-31-1 | Reference Standards |
| HY-B1344 | Oxantel (pamoate) | 68813-55-8 | Reference compound |
| HY-B1344R | Oxantel (pamoate) (Standard) | 68813-55-8 | Reference Standards |
| HY-B1345 | Piroctone olamine | 68890-66-4 | Reference compound |
| HY-B1345R | Piroctone olamine (Standard) | 68890-66-4 | Reference Standards |
| HY-B1346 | DL-Glutamine | 6899-04-3 | Natural Products |
| HY-B1346R | DL-Glutamine (Standard) | 6899-04-3 | Reference Standards |
| HY-B1347 | Clorprenaline hydrochloride | 6933-90-0 | Reference compound |
| HY-B1347R | Clorprenaline hydrochloride (Standard) | 6933-90-0 | Reference Standards |
| HY-B1348 | Dimethadione | 695-53-4 | Reference compound |
| HY-B1348R | Dimethadione (Standard) | 695-53-4 | Reference Standards |
| HY-B1349 | Mepiroxol | 6968-72-5 | Reference compound |
| HY-B1350 | Fusidic acid | 6990-06-3 | Natural Products |
| HY-B1350A | Fusidic acid (sodium salt) | 751-94-0 | Natural Products |
| HY-B1350AR | Fusidic acid (sodium salt) (Standard) | 751-94-0 | Reference Standards |
| HY-B1350R | Fusidic acid (Standard) | 6990-06-3 | Reference Standards |
| HY-B1350S | Fusidic acid-d6 | Isotope-Labeled Compounds | |
| HY-B1351 | Bilberry Extract | 84082-34-8 | Natural Products |
| HY-B1352 | L-Ornithine | 70-26-8 | Natural Products |
| HY-B1353 | Paroxypropione | 70-70-2 | Reference compound |
| HY-B1354 | Cefpiramide | 70797-11-4 | Reference compound |
| HY-B1355 | Oxyphenbutazone (monohydrate) | 7081-38-1 | Reference compound |
| HY-B1355A | Oxyphenbutazone | 129-20-4 | Reference compound |
| HY-B1355AS | Oxyphenbutazone-d9 | 1189693-23-9 | Isotope-Labeled Compounds |
| HY-B1355AS1 | Oxyphenbutazone-13C6 | Isotope-Labeled Compounds | |
| HY-B1355R | Oxyphenbutazone (monohydrate) (Standard) | 7081-38-1 | Reference Standards |
| HY-B1357 | Digitoxin | 71-63-6 | Natural Products |
| HY-B1357R | Digitoxin (Standard) | 71-63-6 | Reference Standards |
| HY-B1358 | Lincomycin (hydrochloride monohydrate) | 7179-49-9 | Natural Products |
| HY-B1358R | Lincomycin (hydrochloride monohydrate) (Standard) | 7179-49-9 | Reference Standards |
| HY-B1359 | Methylene blue (trihydrate) | 7220-79-3 | Reference compound |
| HY-B1359A | Methylene blue indicator | 7220-79-3 | Biochemical Assay Reagents |
| HY-B1360 | Chlorquinaldol | 72-80-0 | Reference compound |
| HY-B1360R | Chlorquinaldol (Standard) | 72-80-0 | Reference Standards |
| HY-B1361 | Estropipate | 7280-37-7 | Natural Products |
| HY-B1361R | Estropipate (Standard) | 7280-37-7 | Reference Standards |
| HY-B1362 | Iopromide | 73334-07-3 | Reference compound |
| HY-B1362R | Iopromide (Standard) | 73334-07-3 | Reference Standards |
| HY-B1362S | Iopromide-d3 | Isotope-Labeled Compounds | |
| HY-B1363 | Bendroflumethiazide | 73-48-3 | Reference compound |
| HY-B1363R | Bendroflumethiazide (Standard) | 73-48-3 | Reference Standards |
| HY-B1363S | Bendroflumethiazide-d5 | 1330183-13-5 | Isotope-Labeled Compounds |
| HY-B1363S1 | Bendroflumethiazide-d7 | Isotope-Labeled Compounds | |
| HY-B1364 | Quinethazone | 73-49-4 | Reference compound |
| HY-B1365 | Prednicarbate | 73771-04-7 | Reference compound |
| HY-B1365R | Prednicarbate (Standard) | 73771-04-7 | Reference Standards |
| HY-B1366 | Meclocycline (Sulfosalicylate Salt) | 73816-42-9 | Reference compound |
| HY-B1366A | Meclocycline | 2013-58-3 | Reference compound |
| HY-B1366R | Meclocycline (Sulfosalicylate Salt) (Standard) | 73816-42-9 | Reference Standards |
| HY-B1367 | Carbenoxolone (disodium) | 7421-40-1 | Reference compound |
| HY-B1368 | Fenclonine | 7424-00-2 | Reference compound |
| HY-B1369 | Imipenem (monohydrate) | 74431-23-5 | Natural Products |
| HY-B1369A | Imipenem | 64221-86-9 | Reference compound |
| HY-B1369AS | Imipenem-d4 | 1261396-26-2 | Isotope-Labeled Compounds |
| HY-B1369R | Imipenem (monohydrate) (Standard) | 74431-23-5 | Reference Standards |
| HY-B1370 | Hydroxychloroquine (sulfate) | 747-36-4 | Reference compound |
| HY-B1370A | (S)-Hydroxychloroquine | 137433-24-0 | Reference compound |
| HY-B1370B | (R)-Hydroxychloroquine | 137433-23-9 | Reference compound |
| HY-B1370E | (R)-Hydroxychloroquine (phosphate) | 2488706-20-1 | Reference compound |
| HY-B1370R | Hydroxychloroquine (sulfate) (Standard) | 747-36-4 | Reference Standards |
| HY-B1370S | Hydroxychloroquine-d4 (sulfate) | 1854126-45-6 | Isotope-Labeled Compounds |
| HY-B1371 | Spiperone | 749-02-0 | Reference compound |
| HY-B1371A | Spiperone (hydrochloride) | 2022-29-9 | Reference compound |
| HY-B1372 | Tribromoethyl alcohol | 75-80-9 | Reference compound |
| HY-B1374 | Florfenicol | 73231-34-2 | Reference compound |
| HY-B1374R | Florfenicol (Standard) | 73231-34-2 | Reference Standards |
| HY-B1374S | ent-Florfenicol-d3 | 1217619-10-7 | Isotope-Labeled Compounds |
| HY-B1374S1 | Florfenicol-d3 | 2213400-85-0 | Isotope-Labeled Compounds |
| HY-B1374S2 | Florfenicol-13C6 | Isotope-Labeled Compounds | |
| HY-B1375 | Pyrithyldione | 77-04-3 | Reference compound |
| HY-B1376 | Methsuximide | 77-41-8 | Reference compound |
| HY-B1376R | Methsuximide (Standard) | 77-41-8 | Reference Standards |
| HY-B1377 | Acedapsone | 77-46-3 | Reference compound |
| HY-B1378 | Ethosuximide | 77-67-8 | Reference compound |
| HY-B1378R | Ethosuximide (Standard) | 77-67-8 | Reference Standards |
| HY-B1378S | Ethosuximide-d3 | 1189703-33-0 | Isotope-Labeled Compounds |
| HY-B1378S1 | Ethosuximide-d5 | 1989660-59-4 | Isotope-Labeled Compounds |
| HY-B1381 | Cefixime | 79350-37-1 | Reference compound |
| HY-B1381A | Cefixime (trihydrate) | 125110-14-7 | Reference compound |
| HY-B1381AR | Cefixime (trihydrate) (Standard) | 125110-14-7 | Reference Standards |
| HY-B1381R | Cefixime (Standard) | 79350-37-1 | Reference Standards |
| HY-B1382 | Pempidine | 79-55-0 | Reference compound |
| HY-B1382A | Pempidine (hydrochloride) | 6152-95-0 | Reference compound |
| HY-B1383 | Dichlorisone acetate | 79-61-8 | Natural Products |
| HY-B1384 | Retinyl palmitate | 79-81-2 | Natural Products |
| HY-B1386 | Halazone | 80-13-7 | Reference compound |
| HY-B1387 | Sulfamethoxypyridazine | 80-35-3 | Reference compound |
| HY-B1387R | Sulfamethoxypyridazine (Standard) | 80-35-3 | Reference Standards |
| HY-B1387S1 | Sulfamethoxypyridazine-d3 | 1172846-03-5 | Isotope-Labeled Compounds |
| HY-B1388 | Homatropine (methylbromide) | 80-49-9 | Reference compound |
| HY-B1388R | Homatropine (methylbromide) (Standard) | 80-49-9 | Reference Standards |
| HY-B1389 | Lactitol (monohydrate) | 81025-04-9 | Reference compound |
| HY-B1389R | Lactitol (monohydrate) (Standard) | 81025-04-9 | Reference Standards |
| HY-B1390A | Saccharin (sodium) | 128-44-9 | Reference compound |
| HY-B1390AR | Saccharin (sodium) (Standard) | 128-44-9 | Reference Standards |
| HY-B1390B | Saccharin (sodium hydrate) | 82385-42-0 | Reference compound |
| HY-B1390BR | Saccharin (sodium hydrate) (Standard) | 82385-42-0 | Reference Standards |
| HY-B1391 | D-Panthenol | 81-13-0 | Natural Products |
| HY-B1391R | D-Panthenol (Standard) | 81-13-0 | Reference Standards |
| HY-B1391S | D-Panthenol-d6 | 2747917-52-6 | Isotope-Labeled Compounds |
| HY-B1392 | Esmolol (hydrochloride) | 81161-17-3 | Reference compound |
| HY-B1392A | Esmolol | 81147-92-4 | Reference compound |
| HY-B1392R | Esmolol (hydrochloride) (Standard) | 81161-17-3 | Reference Standards |
| HY-B1392S | Esmolol-d7 (hydrochloride) | 1346598-13-7 | Isotope-Labeled Compounds |
| HY-B1393 | Dehydrocholic acid | 81-23-2 | Reference compound |
| HY-B1393R | Dehydrocholic acid (Standard) | 81-23-2 | Reference Standards |
| HY-B1394 | Khellin | 82-02-0 | Natural Products |
| HY-B1394R | Khellin (Standard) | 82-02-0 | Reference Standards |
| HY-B1395 | Mecamylamine (hydrochloride) | 826-39-1 | Reference compound |
| HY-B1395A | Mecamylamine | 60-40-2 | Reference compound |
| HY-B1395R | Mecamylamine (hydrochloride) (Standard) | 826-39-1 | Reference Standards |
| HY-B1395S1 | Mecamylamine (hydrochloride)-13C4,15N | Isotope-Labeled Compounds | |
| HY-B1396 | Nefazodone (hydrochloride) | 82752-99-6 | Reference compound |
| HY-B1396R | Nefazodone (hydrochloride) (Standard) | 82752-99-6 | Reference Standards |
| HY-B1396S | Nefazodone-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1396S1 | Nefazodone-d6 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B1396S3 | Nefazodone-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1397 | Cyclizine | 82-92-8 | Reference compound |
| HY-B1397A | Cyclizine (dihydrochloride) | 5897-18-7 | Reference compound |
| HY-B1397B | Cyclizine (lactate) | 5897-19-8 | Reference compound |
| HY-B1397C | Cyclizine (hydrochloride) | 303-25-3 | Reference compound |
| HY-B1397S | Cyclizine-d3 | 1170155-67-5 | Isotope-Labeled Compounds |
| HY-B1398 | Ampyrone | 83-07-8 | Reference compound |
| HY-B1398R | Ampyrone (Standard) | 83-07-8 | Reference Standards |
| HY-B1398S | Ampyrone-d3 | 1329792-51-9 | Isotope-Labeled Compounds |
| HY-B1399 | 3-Methylsalicylic acid | 83-40-9 | Reference compound |
| HY-B1400 | Diiodohydroxyquinoline | 83-73-8 | Reference compound |
| HY-B1400R | Diiodohydroxyquinoline (Standard) | 83-73-8 | Reference Standards |
| HY-B1401 | Euquinine | 83-75-0 | Reference compound |
| HY-B1402 | Hydrocortisone hemisuccinate | 2203-97-6 | Reference compound |
| HY-B1402A | Hydrocortisone hemisuccinate (hydrate) | 83784-20-7 | Reference compound |
| HY-B1402B | Hydrocortisone hemisuccinate (sodium) | 125-04-2 | Reference compound |
| HY-B1402R | Hydrocortisone hemisuccinate (Standard) | 2203-97-6 | Reference Standards |
| HY-B1403 | Dienestrol | 84-17-3 | Reference compound |
| HY-B1403R | Dienestrol (Standard) | 84-17-3 | Reference Standards |
| HY-B1403S | Dienestrol-d2 | 1346606-45-8 | Isotope-Labeled Compounds |
| HY-B1403S1 | E,E-Dienestrol-d6-1 | Isotope-Labeled Compounds | |
| HY-B1404 | Nylidrin (hydrochloride) | 849-55-8 | Reference compound |
| HY-B1404R | Nylidrin (hydrochloride) (Standard) | 849-55-8 | Reference Standards |
| HY-B1405 | Dehydroisoandrosterone 3-acetate | 853-23-6 | Reference compound |
| HY-B1405R | Dehydroisoandrosterone 3-acetate (Standard) | 853-23-6 | Reference Standards |
| HY-B1406 | Acetrizoic acid | 85-36-9 | Reference compound |
| HY-B1407 | Phthalylsulfathiazole | 85-73-4 | Reference compound |
| HY-B1407R | Phthalylsulfathiazole (Standard) | 85-73-4 | Reference Standards |
| HY-B1408 | Salicylanilide | 87-17-2 | Reference compound |
| HY-B1409 | Isosorbide dinitrate | 87-33-2 | Reference compound |
| HY-B1409R | Isosorbide dinitrate (Standard) | 87-33-2 | Reference Standards |
| HY-B1409S | Isosorbide dinitrate-13C6 | Isotope-Labeled Compounds | |
| HY-B1410 | Ioversol | 87771-40-2 | Reference compound |
| HY-B1410R | Ioversol (Standard) | 87771-40-2 | Reference Standards |
| HY-B1411 | i-Inositol | 87-89-8 | Natural Products |
| HY-B1411R | i-Inositol (Standard) | 87-89-8 | Reference Standards |
| HY-B1411S | i-Inositol-d6 | 68922-44-1 | Isotope-Labeled Compounds |
| HY-B1411S1 | i-Inositol-d1 | Isotope-Labeled Compounds | |
| HY-B1413 | Eprobemide | 87940-60-1 | Reference compound |
| HY-B1414 | Chloroxylenol | 88-04-0 | Reference compound |
| HY-B1414R | Chloroxylenol (Standard) | 88-04-0 | Reference Standards |
| HY-B1414S | Chloroxylenol-d6 | 1407521-66-7 | Isotope-Labeled Compounds |
| HY-B1415 | Clofibric acid | 882-09-7 | Reference compound |
| HY-B1415R | Clofibric acid (Standard) | 882-09-7 | Reference Standards |
| HY-B1415S | Clofibric acid-d4 | 1184991-14-7 | Isotope-Labeled Compounds |
| HY-B1416A | Efaroxan (hydrochloride) | 89197-00-2 | Reference compound |
| HY-B1417 | Nortriptyline (hydrochloride) | 894-71-3 | Reference compound |
| HY-B1417R | Nortriptyline (hydrochloride) (Standard) | 894-71-3 | Reference Standards |
| HY-B1417S | Nortriptyline-d3 (hydrochloride) | 203784-52-5 | Isotope-Labeled Compounds |
| HY-B1418 | Tazobactam | 89786-04-9 | Natural Products |
| HY-B1418R | Tazobactam (Standard) | 89786-04-9 | Reference Standards |
| HY-B1418S2 | Tazobactam-15N,d2 | Isotope-Labeled Compounds | |
| HY-B1419 | Salicyl alcohol | 90-01-7 | Natural Products |
| HY-B1419R | Salicyl alcohol (Standard) | 90-01-7 | Reference Standards |
| HY-B1422 | 9-Aminoacridine | 90-45-9 | Dye Reagents |
| HY-B1422R | 9-Aminoacridine (Standard) | 90-45-9 | Reference Standards |
| HY-B1422S | 9-Aminoacridine-13C6 | Isotope-Labeled Compounds | |
| HY-B1423 | Lobeline | 90-69-7 | Natural Products |
| HY-B1424 | Benzthiazide | 91-33-8 | Reference compound |
| HY-B1425 | Ethoxyquin | 91-53-2 | Reference compound |
| HY-B1425R | Ethoxyquin (Standard) | 91-53-2 | Reference Standards |
| HY-B1426 | Iodixanol | 92339-11-2 | Reference compound |
| HY-B1427 | Gamibetal | 924-49-2 | Reference compound |
| HY-B1428 | 2-Ethoxybenzamide | 938-73-8 | Reference compound |
| HY-B1428R | 2-Ethoxybenzamide (Standard) | 938-73-8 | Reference Standards |
| HY-B1429 | Chlorpropamide | 94-20-2 | Reference compound |
| HY-B1429R | Chlorpropamide (Standard) | 94-20-2 | Reference Standards |
| HY-B1430 | Butamben | 94-25-7 | Reference compound |
| HY-B1430R | Butamben (Standard) | 94-25-7 | Reference Standards |
| HY-B1430S | Butamben-d9 | Isotope-Labeled Compounds | |
| HY-B1431 | Butylparaben | 94-26-8 | Reference compound |
| HY-B1431A | Butylparaben (sodium) | 36457-20-2 | Reference compound |
| HY-B1431R | Butylparaben (Standard) | 94-26-8 | Reference Standards |
| HY-B1431S | Butylparaben-d4 | 1219798-67-0 | Isotope-Labeled Compounds |
| HY-B1431S1 | Butylparaben-13C6 | 1416711-53-9 | Isotope-Labeled Compounds |
| HY-B1431S2 | Butylparaben-d9 | 1216904-65-2 | Isotope-Labeled Compounds |
| HY-B1433 | Perindoprilat | 95153-31-4 | Reference compound |
| HY-B1433S | Perindoprilat-d3 (disodium) | Isotope-Labeled Compounds | |
| HY-B1434 | 7-Aminocephalosporanic acid | 957-68-6 | Reference compound |
| HY-B1434R | 7-Aminocephalosporanic acid (Standard) | 957-68-6 | Reference Standards |
| HY-B1435 | Moxisylyte (hydrochloride) | 964-52-3 | Reference compound |
| HY-B1435A | Moxisylyte | 54-32-0 | Reference compound |
| HY-B1436 | Nifuroxazide | 965-52-6 | Reference compound |
| HY-B1436R | Nifuroxazide (Standard) | 965-52-6 | Reference Standards |
| HY-B1436S | Nifuroxazide-d4 | 1188487-83-3 | Isotope-Labeled Compounds |
| HY-B1436S1 | Nifuroxazide-13C6 | Isotope-Labeled Compounds | |
| HY-B1437 | Acetarsol | 97-44-9 | Reference compound |
| HY-B1438 | Canrenone | 976-71-6 | Natural Products |
| HY-B1438R | Canrenone (Standard) | 976-71-6 | Reference Standards |
| HY-B1438S | Canrenone-d6 | Isotope-Labeled Compounds | |
| HY-B1438S1 | Canrenone-d4 | Isotope-Labeled Compounds | |
| HY-B1438S2 | Canrenone-d7 | Isotope-Labeled Compounds | |
| HY-B1439B | Lorglumide sodium salt | 1021868-76-7 | Reference compound |
| HY-B1440 | Ethaverine (hydrochloride) | 985-13-7 | Reference compound |
| HY-B1440R | Ethaverine (hydrochloride) (Standard) | 985-13-7 | Reference Standards |
| HY-B1442 | Acetylleucine | 99-15-0 | Reference compound |
| HY-B1444 | Isoconazole (nitrate) | 24168-96-5 | Reference compound |
| HY-B1444R | Isoconazole (nitrate) (Standard) | 24168-96-5 | Reference Standards |
| HY-B1445 | Minoxidil sulfate | 83701-22-8 | Reference compound |
| HY-B1446 | Esomeprazole magnesium | 161973-10-0 | Reference compound |
| HY-B1448 | Benidipine (hydrochloride) | 91599-74-5 | Reference compound |
| HY-B1448A | Benidipine | 105979-17-7 | Reference compound |
| HY-B1448AS | (Rac)-Benidipine-d7 | Isotope-Labeled Compounds | |
| HY-B1449 | Uridine | 58-96-8 | Natural Products |
| HY-B1449R | Uridine (Standard) | 58-96-8 | Reference Standards |
| HY-B1449S | Uridine-15N2 | 92487-68-8 | Isotope-Labeled Compounds |
| HY-B1449S1 | Uridine-13C | 201996-62-5 | Isotope-Labeled Compounds |
| HY-B1449S10 | Uridine-13C5 | 159496-16-9 | Isotope-Labeled Compounds |
| HY-B1449S12 | Uridine-d12 | Isotope-Labeled Compounds | |
| HY-B1449S2 | Uridine-13C-1 | 478511-11-4 | Isotope-Labeled Compounds |
| HY-B1449S3 | Uridine-13C-2 | 478511-14-7 | Isotope-Labeled Compounds |
| HY-B1449S4 | Uridine-13C-3 | 478511-16-9 | Isotope-Labeled Compounds |
| HY-B1449S5 | Uridine-d2 | 82740-98-5 | Isotope-Labeled Compounds |
| HY-B1449S6 | Uridine-d | 89434-96-8 | Isotope-Labeled Compounds |
| HY-B1449S7 | Uridine 13C-4 | 35803-42-0 | Isotope-Labeled Compounds |
| HY-B1449S8 | Uridine-d2-1 | 40632-21-1 | Isotope-Labeled Compounds |
| HY-B1449S9 | Uridine-13C,15N2 | 369656-75-7 | Isotope-Labeled Compounds |
| HY-B1451 | Imidapril (hydrochloride) | 89396-94-1 | Reference compound |
| HY-B1451A | Imidapril | 89371-37-9 | Reference compound |
| HY-B1451S | Imidapril-d3 (hydrochloride) | 1356017-30-5 | Isotope-Labeled Compounds |
| HY-B1452 | Licofelone | 156897-06-2 | Reference compound |
| HY-B1452S1 | Licofelone-d6 | 1178549-81-9 | Isotope-Labeled Compounds |
| HY-B1453 | (±)-Carnitine (chloride) | 461-05-2 | Natural Products |
| HY-B1453R | (±)-Carnitine (chloride) (Standard) | 461-05-2 | Reference Standards |
| HY-B1453S | L-Carnitine-d3 (hydrochloride) | 350818-62-1 | Isotope-Labeled Compounds |
| HY-B1453S1 | (±)-Carnitine-d9 (chloride) | 1219386-75-0 | Isotope-Labeled Compounds |
| HY-B1454 | Clindamycin palmitate (hydrochloride) | 25507-04-4 | Reference compound |
| HY-B1454R | Clindamycin palmitate (hydrochloride) (Standard) | 25507-04-4 | Reference Standards |
| HY-B1455 | Clindamycin | 18323-44-9 | Reference compound |
| HY-B1455R | Clindamycin (Standard) | 18323-44-9 | Reference Standards |
| HY-B1455S | Clindamycin-d3 (hydrochloride) | 1356933-72-6 | Isotope-Labeled Compounds |
| HY-B1455S1 | Clindamycin-13C,d3 | 2140264-63-5 | Isotope-Labeled Compounds |
| HY-B1456A | Fenoprofen | 29679-58-1 | Reference compound |
| HY-B1456AR | Fenoprofen (Standard) | 29679-58-1 | Reference Standards |
| HY-B1456AS | Fenoprofen-13C6 (sodium hydrate) | Isotope-Labeled Compounds | |
| HY-B1459 | Dicloxacillin (sodium) | 343-55-5 | Reference compound |
| HY-B1459A | Dicloxacillin | 3116-76-5 | Reference compound |
| HY-B1459AR | Dicloxacillin (Standard) | 3116-76-5 | Reference Standards |
| HY-B1459AS | Dicloxacillin-13C4 | Isotope-Labeled Compounds | |
| HY-B1460 | Sulconazole (mononitrate) | 61318-91-0 | Reference compound |
| HY-B1460B | Sulconazole | 61318-90-9 | Reference compound |
| HY-B1460R | Sulconazole (mononitrate) (Standard) | 61318-91-0 | Reference Standards |
| HY-B1461 | Deoxyarbutin | 53936-56-4 | Natural Products |
| HY-B1462 | Chlorzoxazone | 95-25-0 | Reference compound |
| HY-B1462R | Chlorzoxazone (Standard) | 95-25-0 | Reference Standards |
| HY-B1462S | Chlorzoxazone-d3 | 1185173-60-7 | Isotope-Labeled Compounds |
| HY-B1462S1 | Chlorzoxazone-13C | 616865-28-2 | Isotope-Labeled Compounds |
| HY-B1462S2 | Chlorzoxazone-13C,15N,d2 | Isotope-Labeled Compounds | |
| HY-B1463 | Penicillin G sodium salt | 69-57-8 | Natural Products |
| HY-B1463R | Penicillin G sodium salt (Standard) | 69-57-8 | Reference Standards |
| HY-B1464 | Cetylpyridinium (chloride) | 123-03-5 | Reference compound |
| HY-B1464R | Cetylpyridinium (chloride) (Standard) | 123-03-5 | Reference Standards |
| HY-B1465 | 1-Hexadecanol | 36653-82-4 | Natural Products |
| HY-B1465R | 1-Hexadecanol (Standard) | 36653-82-4 | Reference Standards |
| HY-B1465S | 1-Hexadecanol-d31 | 203633-15-2 | Isotope-Labeled Compounds |
| HY-B1465S1 | 1-Hexadecanol-d33 | 284474-73-3 | Isotope-Labeled Compounds |
| HY-B1465S2 | 1-Hexadecanol-d5 | 1219799-18-4 | Isotope-Labeled Compounds |
| HY-B1465S3 | 1-Hexadecanol-d3 | 75736-52-6 | Isotope-Labeled Compounds |
| HY-B1465S4 | 1-Hexadecanol-d4 | 1398065-49-0 | Isotope-Labeled Compounds |
| HY-B1466 | Mezlocillin (sodium) | 42057-22-7 | Reference compound |
| HY-B1466A | Mezlocillin | 51481-65-3 | Reference compound |
| HY-B1466R | Mezlocillin (sodium) (Standard) | 42057-22-7 | Reference Standards |
| HY-B1467 | Domiphen (bromide) | 538-71-6 | Reference compound |
| HY-B1467R | Domiphen (bromide) (Standard) | 538-71-6 | Reference Standards |
| HY-B1468 | 8-Azaguanine | 134-58-7 | Natural Products |
| HY-B1469 | Isosorbide | 652-67-5 | Reference compound |
| HY-B1469R | Isosorbide (Standard) | 652-67-5 | Reference Standards |
| HY-B1470 | Azaperone | 1649-18-9 | Reference compound |
| HY-B1470R | Azaperone (Standard) | 1649-18-9 | Reference Standards |
| HY-B1470S | Azaperone-d4 | 1173021-72-1 | Isotope-Labeled Compounds |
| HY-B1471 | Fluorometholone acetate | 3801-06-7 | Reference compound |
| HY-B1471R | Fluorometholone acetate (Standard) | 3801-06-7 | Reference Standards |
| HY-B1472 | Deoxycorticosterone acetate | 56-47-3 | Natural Products |
| HY-B1472R | Deoxycorticosterone acetate (Standard) | 56-47-3 | Reference Standards |
| HY-B1473 | Serotonin (hydrochloride) | 153-98-0 | Natural Products |
| HY-B1473A | Serotonin | 50-67-9 | Natural Products |
| HY-B1473AS | Serotonin-d4 | 58264-95-2 | Isotope-Labeled Compounds |
| HY-B1473S | Serotonin-d4 (hydrochloride) | 2469263-61-2 | Isotope-Labeled Compounds |
| HY-B1473S1 | Serotonin-13C2,15N (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1474 | Alexidine | 22573-93-9 | Reference compound |
| HY-B1474S1 | Alexidine-d10 | 1246818-47-2 | Isotope-Labeled Compounds |
| HY-B1475 | Anisotropine (bromide) | 80-50-2 | Reference compound |
| HY-B1476 | NSC 42196 | 17140-60-2 | Natural Products |
| HY-B1476R | NSC 42196 (Standard) | 17140-60-2 | Reference Standards |
| HY-B1477 | Clopamide | 636-54-4 | Reference compound |
| HY-B1477R | Clopamide (Standard) | 636-54-4 | Reference Standards |
| HY-B1478 | Dimaprit (dihydrochloride) | 23256-33-9 | Reference compound |
| HY-B1480 | Ethoxzolamide | 452-35-7 | Reference compound |
| HY-B1480S | Ethoxzolamide-d5 | 3054664-97-7 | Isotope-Labeled Compounds |
| HY-B1481 | Isoetharine (mesylate) | 7279-75-6 | Reference compound |
| HY-B1481A | Isoetharine | 530-08-5 | Reference compound |
| HY-B1481B | Isoetharine (hydrochloride) | 50-96-4 | Reference compound |
| HY-B1482 | Mesoridazine (benzenesulfonate) | 32672-69-8 | Reference compound |
| HY-B1482A | Mesoridazine | 5588-33-0 | Reference compound |
| HY-B1483 | Methapyrilene (hydrochloride) | 135-23-9 | Reference compound |
| HY-B1484 | Moxalactam (sodium salt) | 64953-12-4 | Reference compound |
| HY-B1484A | Moxalactam | 64952-97-2 | Reference compound |
| HY-B1484R | Moxalactam (sodium salt) (Standard) | 64953-12-4 | Reference Standards |
| HY-B1485 | Nalmefene (hydrochloride) | 58895-64-0 | Reference compound |
| HY-B1486 | Oxprenolol (hydrochloride) | 6452-73-9 | Reference compound |
| HY-B1486A | Oxprenolol | 6452-71-7 | Reference compound |
| HY-B1486AS | Oxprenolol-d7 | 1189805-10-4 | Isotope-Labeled Compounds |
| HY-B1486R | Oxprenolol (hydrochloride) (Standard) | 6452-73-9 | Reference Standards |
| HY-B1486S | Oxprenolol-d7 (hydrochloride) | 1189649-47-5 | Isotope-Labeled Compounds |
| HY-B1487 | Procyclidine (hydrochloride) | 1508-76-5 | Reference compound |
| HY-B1487A | Procyclidine | 77-37-2 | Reference compound |
| HY-B1487R | Procyclidine (hydrochloride) (Standard) | 1508-76-5 | Reference Standards |
| HY-B1487S1 | Procyclidine-d5 | Isotope-Labeled Compounds | |
| HY-B1488 | Tacrine (hydrochloride) | 1684-40-8 | Reference compound |
| HY-B1488R | Tacrine (hydrochloride) (Standard) | 1684-40-8 | Reference Standards |
| HY-B1489 | Tolmetin (sodium dihydrate) | 64490-92-2 | Reference compound |
| HY-B1489R | Tolmetin (sodium dihydrate) (Standard) | 64490-92-2 | Reference Standards |
| HY-B1490 | Imipramine (hydrochloride) | 113-52-0 | Reference compound |
| HY-B1490A | Imipramine | 50-49-7 | Reference compound |
| HY-B1490AS | Imipramine-d6 | 65100-45-0 | Isotope-Labeled Compounds |
| HY-B1490AS1 | Imipramine-d4 | 96705-18-9 | Isotope-Labeled Compounds |
| HY-B1490AS3 | Imipramine-d4-1 | 773801-61-9 | Isotope-Labeled Compounds |
| HY-B1490R | Imipramine (hydrochloride) (Standard) | 113-52-0 | Reference Standards |
| HY-B1490S | Imipramine-d4 (hydrochloride) | 61361-33-9 | Isotope-Labeled Compounds |
| HY-B1490S1 | Imipramine-d3 (hydrochloride) | 112898-42-7 | Isotope-Labeled Compounds |
| HY-B1493 | Bentiromide | 37106-97-1 | Peptides |
| HY-B1493R | Bentiromide (Standard) | 37106-97-1 | Reference Standards |
| HY-B1494 | Picrotoxinin | 17617-45-7 | Natural Products |
| HY-B1494R | Picrotoxinin (Standard) | 17617-45-7 | Reference Standards |
| HY-B1495 | Quipazine (maleate) | 5786-68-5 | Reference compound |
| HY-B1496 | Tranylcypromine (hemisulfate) | 13492-01-8 | Reference compound |
| HY-B1496R | Tranylcypromine (hemisulfate) (Standard) | 13492-01-8 | Reference Standards |
| HY-B1497 | Silver sulfadiazine | 22199-08-2 | Reference compound |
| HY-B1497R | Silver sulfadiazine (Standard) | 22199-08-2 | Reference Standards |
| HY-B1500 | 2,2,2-Trichloroethanol | 115-20-8 | Natural Products |
| HY-B1500R | 2,2,2-Trichloroethanol (Standard) | 115-20-8 | Reference Standards |
| HY-B1505 | Acefylline | 652-37-9 | Natural Products |
| HY-B1505A | Acefylline (piperazine) | 18833-13-1 | Reference compound |
| HY-B1505R | Acefylline (Standard) | 652-37-9 | Reference Standards |
| HY-B1506 | Acepromazine | 61-00-7 | Reference compound |
| HY-B1506A | Acepromazine (maleate) | 3598-37-6 | Reference compound |
| HY-B1506AR | Acepromazine (maleate) (Standard) | 3598-37-6 | Reference Standards |
| HY-B1506AS | Acepromazine-d6 (maleate) | 1331655-50-5 | Isotope-Labeled Compounds |
| HY-B1508 | Vitamin K4 | 573-20-6 | Reference compound |
| HY-B1508R | Vitamin K4 (Standard) | 573-20-6 | Reference Standards |
| HY-B1510 | Acrivastine | 87848-99-5 | Reference compound |
| HY-B1510R | Acrivastine (Standard) | 87848-99-5 | Reference Standards |
| HY-B1510S | Acrivastine-d7 | 172165-56-9 | Isotope-Labeled Compounds |
| HY-B1511 | Cyclic AMP | 60-92-4 | Natural Products |
| HY-B1511A | Cyclic AMP (sodium) | 37839-81-9 | Biochemical Assay Reagents |
| HY-B1511R | Cyclic AMP (Standard) | 60-92-4 | Reference Standards |
| HY-B1511S | Cyclic AMP-13C5 | 2170095-23-3 | Isotope-Labeled Compounds |
| HY-B1513 | α-Cyclodextrin | 10016-20-3 | Natural Products |
| HY-B1514 | Allantoic acid | 99-16-1 | Natural Products |
| HY-B1514R | Allantoic acid (Standard) | 99-16-1 | Reference Standards |
| HY-B1516 | Alovudine | 25526-93-6 | Reference compound |
| HY-B1517 | Alprenolol | 13655-52-2 | Reference compound |
| HY-B1517A | Alprenolol (hydrochloride) | 13707-88-5 | Reference compound |
| HY-B1517AR | Alprenolol (hydrochloride) (Standard) | 13707-88-5 | Reference Standards |
| HY-B1517B | Alprenolol (benzoate) | 67824-72-0 | Reference compound |
| HY-B1521 | Aluminum Hydroxide | 21645-51-2 | Reference compound |
| HY-B1521R | Aluminum Hydroxide (Standard) | 21645-51-2 | Reference Standards |
| HY-B1526 | Thiacetazone | 104-06-3 | Reference compound |
| HY-B1526R | Thiacetazone (Standard) | 104-06-3 | Reference Standards |
| HY-B1529 | Ammonium citrate dibasic, 99% | 3012-65-5 | Biochemical Assay Reagents |
| HY-B1529A | Citric acid (triammonium) | 3458-72-8 | Biochemical Assay Reagents |
| HY-B1530 | Ammonium lactate (60% in water) | 515-98-0 | Reference compound |
| HY-B1532 | Anabasine | 494-52-0 | Natural Products |
| HY-B1532R | Anabasine (Standard) | 494-52-0 | Reference Standards |
| HY-B1533A | Anazolene (trisodium) | 3861-73-2 | Dye Reagents |
| HY-B1537 | Azaribine | 2169-64-4 | Reference compound |
| HY-B1538A | Bamethan (hemisulfate) | 5716-20-1 | Reference compound |
| HY-B1538AR | Bamethan (hemisulfate) (Standard) | 5716-20-1 | Reference Standards |
| HY-B1538S | Bamethan-d9 (acetate) | Isotope-Labeled Compounds | |
| HY-B1539A | Fuchsine base (monohydrochloride) | 632-99-5 | Dye Reagents |
| HY-B1540 | Beclometasone | 4419-39-0 | Reference compound |
| HY-B1540R | Beclometasone (Standard) | 4419-39-0 | Reference Standards |
| HY-B1540S | Beclomethasone-d5 | 1263143-48-1 | Isotope-Labeled Compounds |
| HY-B1541 | Bemesetron | 40796-97-2 | Reference compound |
| HY-B1542 | Benactyzine | 302-40-9 | Reference compound |
| HY-B1542A | Benactyzine hydrochloride | 57-37-4 | Reference compound |
| HY-B1542AR | Benactyzine hydrochloride (Standard) | 57-37-4 | Reference Standards |
| HY-B1543 | Benmoxin | 7654-03-7 | Reference compound |
| HY-B1546 | Benzamil | 2898-76-2 | Reference compound |
| HY-B1546A | Benzamil (hydrochloride) | 161804-20-2 | Reference compound |
| HY-B1547A | Benzetimide (hydrochloride) | 5633-14-7 | Reference compound |
| HY-B1548 | Benznidazole | 22994-85-0 | Reference compound |
| HY-B1548R | Benznidazole (Standard) | 22994-85-0 | Reference Standards |
| HY-B1549 | Lauryl benzalkonium (chloride) | 139-07-1 | Reference compound |
| HY-B1549R | Lauryl benzalkonium (chloride) (Standard) | 139-07-1 | Reference Standards |
| HY-B1549S | Lauryl benzalkonium-d7 (chloride) | 1998128-83-8 | Isotope-Labeled Compounds |
| HY-B1550 | Benzoin | 119-53-9 | Natural Products |
| HY-B1550R | Benzoin (Standard) | 119-53-9 | Reference Standards |
| HY-B1550S | Benzoin-d10 | 56830-64-9 | Isotope-Labeled Compounds |
| HY-B1551 | Benzonatate | 104-31-4 | Reference compound |
| HY-B1551R | Benzonatate (Standard) | 104-31-4 | Reference Standards |
| HY-B1552B | Benzoquinonium (dibromide) | Reference compound | |
| HY-B1555 | Benzyl nicotinate | 94-44-0 | Reference compound |
| HY-B1555R | Benzyl nicotinate (Standard) | 94-44-0 | Reference Standards |
| HY-B1556 | Benzyl salicylate | 118-58-1 | Natural Products |
| HY-B1556R | Benzyl salicylate (Standard) | 118-58-1 | Reference Standards |
| HY-B1556S | Benzyl salicylate-d4 | 1219802-40-0 | Isotope-Labeled Compounds |
| HY-B1557 | Betazole | 105-20-4 | Reference compound |
| HY-B1557A | Betazole (dihydrochloride) | 138-92-1 | Reference compound |
| HY-B1557R | Betazole (Standard) | 105-20-4 | Reference Standards |
| HY-B1558 | Bifemelane | 90293-01-9 | Reference compound |
| HY-B1558A | Bifemelane (hydrochloride) | 62232-46-6 | Reference compound |
| HY-B1559 | Allethrin | 584-79-2 | Reference compound |
| HY-B1559R | Allethrin (Standard) | 584-79-2 | Reference Standards |
| HY-B1560 | Bismuth subgallate | 99-26-3 | Reference compound |
| HY-B1562 | Bopindolol | 62658-63-3 | Reference compound |
| HY-B1562B | Bopindolol (malonate) | 82857-38-3 | Reference compound |
| HY-B1562C | Bopindolol (fumarate) | 79125-22-7 | Reference compound |
| HY-B1565S | UV Absorber 326-d3 | Isotope-Labeled Compounds | |
| HY-B1567 | Bromocyclen | 1715-40-8 | Reference compound |
| HY-B1567R | Bromocyclen (Standard) | 1715-40-8 | Reference Standards |
| HY-B1568 | Bromodiphenhydramine | 118-23-0 | Reference compound |
| HY-B1568A | Bromodiphenhydramine (hydrochloride) | 1808-12-4 | Reference compound |
| HY-B1568AR | Bromodiphenhydramine (hydrochloride) (Standard) | 1808-12-4 | Reference Standards |
| HY-B1570 | Bromofos | 2104-96-3 | Reference compound |
| HY-B1571 | Bromophenol blue | 115-39-9 | Dye Reagents |
| HY-B1573A | (±)-Butaclamol (hydrochloride) | 36504-94-6 | Reference compound |
| HY-B1575 | Butopyronoxyl | 532-34-3 | Reference compound |
| HY-B1580 | Calcium propionate | 4075-81-4 | Biochemical Assay Reagents |
| HY-B1580A | Calcium propionate, meets analytical specification of E282 | 4075-81-4 | Biochemical Assay Reagents |
| HY-B1580AR | Calcium propionate, meets analytical specification of E282 (Standard) | 4075-81-4 | Reference Standards |
| HY-B1580B | Calcium propionate, United States Pharmacopeia (USP) Reference Standard | 4075-81-4 | Biochemical Assay Reagents |
| HY-B1581 | L-Canavanine | 543-38-4 | Peptides |
| HY-B1581A | L-Canavanine (sulfate) | 2219-31-0 | Natural Products |
| HY-B1582A | Canrenoate (potassium) | 2181-04-6 | Reference compound |
| HY-B1583 | (Z)-Capsaicin | 25775-90-0 | Reference compound |
| HY-B1583R | (Z)-Capsaicin (Standard) | 25775-90-0 | Reference Standards |
| HY-B1584 | Captan | 133-06-2 | Reference compound |
| HY-B1584R | Captan (Standard) | 133-06-2 | Reference Standards |
| HY-B1584S | Captan-d6 | 1330190-00-5 | Isotope-Labeled Compounds |
| HY-B1585 | Caramiphen | 77-22-5 | Reference compound |
| HY-B1585A | Caramiphen (hydrochloride) | 125-85-9 | Reference compound |
| HY-B1587 | Carbazochrome | 69-81-8 | Reference compound |
| HY-B1587R | Carbazochrome (Standard) | 69-81-8 | Reference Standards |
| HY-B1588 | Carbenoxolone | 5697-56-3 | Natural Products |
| HY-B1588S | Carbenoxolone-d4 | Isotope-Labeled Compounds | |
| HY-B1589 | (±)-Carbinoxamine | 486-16-8 | Reference compound |
| HY-B1589A | Carbinoxamine maleate salt | 3505-38-2 | Reference compound |
| HY-B1589AR | Carbinoxamine maleate salt (Standard) | 3505-38-2 | Reference Standards |
| HY-B1589AS | Carbinoxamine-d6 (maleate) | Isotope-Labeled Compounds | |
| HY-B1589S | (±)-Carbinoxamine-d6 | 1216872-59-1 | Isotope-Labeled Compounds |
| HY-B1592 | Carbomycin | 4564-87-8 | Reference compound |
| HY-B1594 | Carbromal | 77-65-6 | Reference compound |
| HY-B1594R | Carbromal (Standard) | 77-65-6 | Reference Standards |
| HY-B1595 | Cefmetazole | 56796-20-4 | Reference compound |
| HY-B1596 | Ceftizoxime | 68401-81-0 | Reference compound |
| HY-B1596A | Ceftizoxime sodium | 68401-82-1 | Reference compound |
| HY-B1596R | Ceftizoxime (Standard) | 68401-81-0 | Reference Standards |
| HY-B1597 | Cetalkonium (chloride) | 122-18-9 | Reference compound |
| HY-B1597R | Cetalkonium (chloride) (Standard) | 122-18-9 | Reference Standards |
| HY-B1599 | Chloramphenicol palmitate | 530-43-8 | Reference compound |
| HY-B1599R | Chloramphenicol palmitate (Standard) | 530-43-8 | Reference Standards |
| HY-B1603S | Chlorophenothane-d8 | 93952-18-2 | Isotope-Labeled Compounds |
| HY-B1604 | Chloroprocaine (hydrochloride) | 3858-89-7 | Reference compound |
| HY-B1604A | Chloroprocaine | 133-16-4 | Reference compound |
| HY-B1604R | Chloroprocaine (hydrochloride) (Standard) | 3858-89-7 | Reference Standards |
| HY-B1606 | Chlorothymol | 89-68-9 | Reference compound |
| HY-B1607 | Chlorphenoxamine | 77-38-3 | Reference compound |
| HY-B1607R | Chlorphenoxamine (Standard) | 77-38-3 | Reference Standards |
| HY-B1608 | Chromium chloride | 10025-73-7 | Biochemical Assay Reagents |
| HY-B1610 | Sodium citrate (dihydrate) | 6132-04-3 | Natural Products |
| HY-B1610E | Sodium citrate dihydrate, meets USP testing specifications | 6132-04-3 | Biochemical Assay Reagents |
| HY-B1610ER | Sodium citrate dihydrate, meets USP testing specifications (Standard) | 6132-04-3 | Reference Standards |
| HY-B1610H | Sodium citrate dihydrate, United States Pharmacopeia (USP) Reference Standard | 6132-04-3 | Biochemical Assay Reagents |
| HY-B1610I | Sodium citrate dihydrate, for molecular biology | 6132-04-3 | Biochemical Assay Reagents |
| HY-B1610J | Sodium Citrate Buffer, 0.5M, pH 5.0 | Biochemical Assay Reagents | |
| HY-B1610K | Sodium Citrate Buffer, 0.5M, pH 5.5 | Biochemical Assay Reagents | |
| HY-B1610L | Sodium Citrate Buffer, 0.5M, pH 6.0 | Biochemical Assay Reagents | |
| HY-B1610M | Sodium Citrate Buffer, 0.5M, pH 6.5 | Biochemical Assay Reagents | |
| HY-B1610N | Sodium Citrate Buffer, 0.1M, pH 4.0 | Biochemical Assay Reagents | |
| HY-B1610R | Sodium citrate (dihydrate) (Standard) | 6132-04-3 | Reference Standards |
| HY-B1613 | Clebopride | 55905-53-8 | Reference compound |
| HY-B1613A | Clebopride (malate) | 57645-91-7 | Reference compound |
| HY-B1613AR | Clebopride (malate) (Standard) | 57645-91-7 | Reference Standards |
| HY-B1614 | Clenbuterol (hydrochloride) | 21898-19-1 | Natural Products |
| HY-B1614R | Clenbuterol (hydrochloride) (Standard) | 21898-19-1 | Reference Standards |
| HY-B1615 | Clenbuterol | 37148-27-9 | Reference compound |
| HY-B1615R | Clenbuterol (Standard) | 37148-27-9 | Reference Standards |
| HY-B1615S | Clenbuterol-d9 | 129138-58-5 | Isotope-Labeled Compounds |
| HY-B1616 | Clobetasone butyrate | 25122-57-0 | Reference compound |
| HY-B1616R | Clobetasone butyrate (Standard) | 25122-57-0 | Reference Standards |
| HY-B1617 | Zuclomiphene | 15690-55-8 | Reference compound |
| HY-B1617A | Zuclomiphene (citrate) | 7619-53-6 | Reference compound |
| HY-B1617AS | Zuclomiphene-d4 (citrate) | 2714316-71-7 | Isotope-Labeled Compounds |
| HY-B1617AS1 | Zuclomiphene-d5 (citrate) | 1795132-80-7 | Isotope-Labeled Compounds |
| HY-B1617AS2 | Zuclomiphene d10 Citrate salt | Isotope-Labeled Compounds | |
| HY-B1618 | Corticosterone | 50-22-6 | Natural Products |
| HY-B1618R | Corticosterone (Standard) | 50-22-6 | Reference Standards |
| HY-B1618S | Corticosterone-d8 | 1271728-07-4 | Isotope-Labeled Compounds |
| HY-B1618S1 | Corticosterone-d4 | 2243253-91-8 | Isotope-Labeled Compounds |
| HY-B1619 | Cromolyn | 16110-51-3 | Reference compound |
| HY-B1619S | Cromoglicic acid-d5 | 2140317-08-2 | Isotope-Labeled Compounds |
| HY-B1620 | Polyvinylpyrrolidone K30 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620B | Polyvinylpyrrolidone K15 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620C | Polyvinylpyrrolidone K17 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620D | Polyvinylpyrrolidone K25 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620E | Polyvinylpyrrolidone K60 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620H | Polyvinylpyrrolidone K90 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620I | Polyvinylpyrrolidone K120 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620J | Polyvinylpyrrolidone, average Mw～10000 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620K | Polyvinylpyrrolidone, average Mw~29000 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620L | Polyvinylpyrrolidone, average Mw~40000 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620M | Polyvinylpyrrolidone, average Mw～55000 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620N | Polyvinylpyrrolidone, average Mw～360000 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1620O | Polyvinylpyrrolidone, average Mw~1300000 | 9003-39-8 | Biochemical Assay Reagents |
| HY-B1621 | Cyclopentolate | 512-15-2 | Reference compound |
| HY-B1621A | Cyclopentolate (hydrochloride) | 5870-29-1 | Reference compound |
| HY-B1621AR | Cyclopentolate (hydrochloride) (Standard) | 5870-29-1 | Reference Standards |
| HY-B1622 | Cyproheptadine | 129-03-3 | Reference compound |
| HY-B1622R | Cyproheptadine (Standard) | 129-03-3 | Reference Standards |
| HY-B1622S | Cyproheptadine-d3 | 2712455-05-3 | Isotope-Labeled Compounds |
| HY-B1623 | Cyproterone | 2098-66-0 | Reference compound |
| HY-B1623R | Cyproterone (Standard) | 2098-66-0 | Reference Standards |
| HY-B1623S | Cyproterone-d4 | Isotope-Labeled Compounds | |
| HY-B1624 | Debrisoquin | 1131-64-2 | Natural Products |
| HY-B1624A | Debrisoquin (hemisulfate) | 581-88-4 | Reference compound |
| HY-B1625 | Deferoxamine | 70-51-9 | Reference compound |
| HY-B1625R | Deferoxamine (Standard) | 70-51-9 | Reference Standards |
| HY-B1626A | Demecarium Bromide | 56-94-0 | Reference compound |
| HY-B1626AR | Demecarium Bromide (Standard) | 56-94-0 | Reference Standards |
| HY-B1629 | Dichlorodiphenylmethane | 2051-90-3 | Reference compound |
| HY-B1630 | Stilbestrol dipropionate | 130-80-3 | Reference compound |
| HY-B1635 | Disofenin | 65717-97-7 | Biochemical Assay Reagents |
| HY-B1636 | Dithiazanine (iodide) | 514-73-8 | Dye Reagents |
| HY-B1637 | Ditiocarb sodium | 148-18-5 | Reference compound |
| HY-B1637A | Sodium diethyldithiocarbamate,98% | 148-18-5 | Reference compound |
| HY-B1637S | Ditiocarb-d10 (sodium) | 1261395-23-6 | Isotope-Labeled Compounds |
| HY-B1638S | Dodecylamine-25d | 1219802-72-8 | Isotope-Labeled Compounds |
| HY-B1639 | Enoximone | 77671-31-9 | Reference compound |
| HY-B1640 | Ethacrynic acid | 58-54-8 | Reference compound |
| HY-B1640A | Ethacrynic acid (sodium) | 6500-81-8 | Reference compound |
| HY-B1640R | Ethacrynic acid (Standard) | 58-54-8 | Reference Standards |
| HY-B1640S | Ethacrynic acid-13C2,d5 | Isotope-Labeled Compounds | |
| HY-B1642 | Ethotoin | 86-35-1 | Reference compound |
| HY-B1642R | Ethotoin (Standard) | 86-35-1 | Reference Standards |
| HY-B1642S | Ethotoin-d5 | 2714409-09-1 | Isotope-Labeled Compounds |
| HY-B1643 | Ethyl Vanillate | 617-05-0 | Reference compound |
| HY-B1643R | Ethyl Vanillate (Standard) | 617-05-0 | Reference Standards |
| HY-B1645 | Ammonium iron(III) citrate | 1185-57-5 | Natural Products |
| HY-B1648 | Ferric pyrophosphate | 10058-44-3 | Biochemical Assay Reagents |
| HY-B1651 | Iron(II) fumarate | 141-01-5 | Reference compound |
| HY-B1651R | Iron(II) fumarate (Standard) | 141-01-5 | Reference Standards |
| HY-B1654 | Flavin adenine dinucleotide | 146-14-5 | Natural Products |
| HY-B1654A | Flavin adenine dinucleotide (disodium salt) | 84366-81-4 | Natural Products |
| HY-B1654AR | Flavin adenine dinucleotide (disodium salt) (Standard) | 84366-81-4 | Reference Standards |
| HY-B1654R | Flavin adenine dinucleotide (Standard) | 146-14-5 | Reference Standards |
| HY-B1654S | Flavin adenine dinucleotide-13C5 (ammonium) | Isotope-Labeled Compounds | |
| HY-B1655 | Fluspirilene | 1841-19-6 | Reference compound |
| HY-B1656 | Fomocaine | 17692-39-6 | Reference compound |
| HY-B1657 | Fosphenytoin | 93390-81-9 | Reference compound |
| HY-B1657A | Fosphenytoin (disodium) | 92134-98-0 | Reference compound |
| HY-B1657AR | Fosphenytoin (disodium) (Standard) | 92134-98-0 | Reference Standards |
| HY-B1657AS | Fosphenytoin-d10 (disodium) | Isotope-Labeled Compounds | |
| HY-B1658 | Frovatriptan | 158747-02-5 | Reference compound |
| HY-B1658A | Frovatriptan (succinate hydrate) | 158930-17-7 | Reference compound |
| HY-B1658AR | Frovatriptan (succinate hydrate) (Standard) | 158930-17-7 | Reference Standards |
| HY-B1658B | Frovatriptan (succinate) | 158930-09-7 | Reference compound |
| HY-B1658BS | Frovatriptan-d3 (succinate) | Isotope-Labeled Compounds | |
| HY-B1658CS | ent-Frovatriptan-d3 (succinate) | Isotope-Labeled Compounds | |
| HY-B1658S | Frovatriptan-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1659 | Glycerol | 56-81-5 | Biochemical Assay Reagents |
| HY-B1659AS | D-Glycerol-3-13C | 154278-20-3 | Isotope-Labeled Compounds |
| HY-B1659R | Glycerol (Standard) | 56-81-5 | Reference Standards |
| HY-B1659S | Glycerol-13C3,d8 | 1215679-18-7 | Isotope-Labeled Compounds |
| HY-B1659S1 | Glycerol-13C | 98292-00-3 | Isotope-Labeled Compounds |
| HY-B1659S2 | Glycerol-13C-1 | 82425-96-5 | Isotope-Labeled Compounds |
| HY-B1659S3 | Glycerol-d1 | Isotope-Labeled Compounds | |
| HY-B1659S4 | Glycerol-13C2 | 102088-01-7 | Isotope-Labeled Compounds |
| HY-B1659S5 | Glycerol-13C3 | 63346-81-6 | Isotope-Labeled Compounds |
| HY-B1659S6 | Glycerol-d5 | 62502-71-0 | Isotope-Labeled Compounds |
| HY-B1659S8 | Glycerol-d3 | 7325-16-8 | Isotope-Labeled Compounds |
| HY-B1660 | Guanadrel (sulfate) | 22195-34-2 | Reference compound |
| HY-B1661 | Hexamethonium (chloride) | 60-25-3 | Biochemical Assay Reagents |
| HY-B1662 | Hexestrol | 84-16-2 | Reference compound |
| HY-B1662R | Hexestrol (Standard) | 84-16-2 | Reference Standards |
| HY-B1662S | (Rac)-Hexestrol-d4 | 1189950-25-1 | Isotope-Labeled Compounds |
| HY-B1662S1 | (Rac)-Hexestrol-d6 | 1215476-12-2 | Isotope-Labeled Compounds |
| HY-B1662S2 | (Rac)-Hexestrol-d6 (hexane-2,2,3,4,5,5-d6) | 1219798-48-7 | Isotope-Labeled Compounds |
| HY-B1664 | Iopanoic acid | 96-83-3 | Reference compound |
| HY-B1664R | Iopanoic acid (Standard) | 96-83-3 | Reference Standards |
| HY-B1665 | Isobutamben | 94-14-4 | Reference compound |
| HY-B1665R | Isobutamben (Standard) | 94-14-4 | Reference Standards |
| HY-B1667 | Isopropamide (iodide) | 71-81-8 | Reference compound |
| HY-B1667R | Isopropamide (iodide) (Standard) | 71-81-8 | Reference Standards |
| HY-B1670 | (-)-Isoproterenol | 51-31-0 | Reference compound |
| HY-B1670A | (-)-Isoproterenol (hydrochloride) | 5984-95-2 | Reference compound |
| HY-B1671 | (+)-Kavain | 500-64-1 | Natural Products |
| HY-B1671R | (+)-Kavain (Standard) | 500-64-1 | Reference Standards |
| HY-B1673 | D-Lactose (monohydrate) | 64044-51-5 | Natural Products |
| HY-B1673R | D-Lactose (monohydrate) (Standard) | 64044-51-5 | Reference Standards |
| HY-B1674 | (±)-Leucine | 328-39-2 | Natural Products |
| HY-B1674R | (±)-Leucine (Standard) | 328-39-2 | Reference Standards |
| HY-B1674S | (±)-Leucine-d10 | 29909-01-1 | Isotope-Labeled Compounds |
| HY-B1674S4 | (±)-Leucine-d7 | 259225-40-6 | Isotope-Labeled Compounds |
| HY-B1675 | Levalbuterol | 34391-04-3 | Reference compound |
| HY-B1675A | Levalbuterol (hydrochloride) | 50293-90-8 | Reference compound |
| HY-B1675AR | Levalbuterol (hydrochloride) (Standard) | 50293-90-8 | Reference Standards |
| HY-B1677 | Lidofenin | 59160-29-1 | Reference compound |
| HY-B1680 | Lithium citrate | 919-16-4 | Reference compound |
| HY-B1682 | Loracarbef | 76470-66-1 | Reference compound |
| HY-B1682A | Loracarbef (hydrate) | 121961-22-6 | Reference compound |
| HY-B1682AR | Loracarbef (hydrate) (Standard) | 121961-22-6 | Reference Standards |
| HY-B1684 | Mebrofenin | 78266-06-5 | Biochemical Assay Reagents |
| HY-B1684R | Mebrofenin (Standard) | 78266-06-5 | Reference Standards |
| HY-B1689AS | Methantheline-d3 (bromide) | Isotope-Labeled Compounds | |
| HY-B1690 | Methdilazine | 1982-37-2 | Reference compound |
| HY-B1690A | Methdilazine (hydrochloride) | 1229-35-2 | Reference compound |
| HY-B1690AR | Methdilazine (hydrochloride) (Standard) | 1229-35-2 | Reference Standards |
| HY-B1691 | Methenamine (hippurate) | 5714-73-8 | Reference compound |
| HY-B1691R | Methenamine (hippurate) (Standard) | 5714-73-8 | Reference Standards |
| HY-B1692 | L-Methionine-DL-sulfoximine | 15985-39-4 | Reference compound |
| HY-B1693 | Levomepromazine | 60-99-1 | Reference compound |
| HY-B1693R | Levomepromazine (Standard) | 60-99-1 | Reference Standards |
| HY-B1694 | Methoxyphenamine | 93-30-1 | Reference compound |
| HY-B1694A | Methoxyphenamine (hydrochloride) | 5588-10-3 | Reference compound |
| HY-B1695 | Methyl nicotinate | 93-60-7 | Natural Products |
| HY-B1695R | Methyl nicotinate (Standard) | 93-60-7 | Reference Standards |
| HY-B1695S | Methyl nicotinate-d4 | 345909-99-1 | Isotope-Labeled Compounds |
| HY-B1696 | Methyldopate | 6014-30-8 | Reference compound |
| HY-B1696A | Methyldopate (hydrochloride) | 2508-79-4 | Reference compound |
| HY-B1699 | Metrizoic acid | 1949-45-7 | Biochemical Assay Reagents |
| HY-B1700A | Mivacurium (dichloride) | 106861-44-3 | Reference compound |
| HY-B1700AR | Mivacurium (dichloride) (Standard) | 106861-44-3 | Reference Standards |
| HY-B1700B | (S,S)-Mivacurium (dichloride) | Reference compound | |
| HY-B1701 | Vitamin B1 monophosphate (chloride) | 532-40-1 | Natural Products |
| HY-B1701R | Vitamin B1 monophosphate (chloride) (Standard) | 532-40-1 | Reference Standards |
| HY-B1702 | Nifuroxime | 6236-05-1 | Reference compound |
| HY-B1703 | Nifursol | 16915-70-1 | Reference compound |
| HY-B1703R | Nifursol (Standard) | 16915-70-1 | Reference Standards |
| HY-B1703S | Nifursol-13C6 | Isotope-Labeled Compounds | |
| HY-B1704 | Nisoxetine | 53179-07-0 | Reference compound |
| HY-B1704A | Nisoxetine (hydrochloride) | 57754-86-6 | Reference compound |
| HY-B1708 | Nordefrin | 74812-63-8 | Reference compound |
| HY-B1710 | Norethindrone acetate | 51-98-9 | Reference compound |
| HY-B1710R | Norethindrone acetate (Standard) | 51-98-9 | Reference Standards |
| HY-B1710S | Norethindrone acetate-d8 | Isotope-Labeled Compounds | |
| HY-B1711 | Norfenefrine | 536-21-0 | Reference compound |
| HY-B1711A | Norfenefrine (hydrochloride) | 4779-94-6 | Reference compound |
| HY-B1711AR | Norfenefrine (hydrochloride) (Standard) | 4779-94-6 | Reference Standards |
| HY-B1712 | 2-Hydroxy-4-(octyloxy)benzophenone | 1843-05-6 | Biochemical Assay Reagents |
| HY-B1713A | DL-Ornithine (hydrochloride) | 1069-31-4 | Biochemical Assay Reagents |
| HY-B1714 | NSC 601980 (analog) | 91757-46-9 | Reference compound |
| HY-B1714A | NSC 601980 | 2070018-27-6 | Reference compound |
| HY-B1715 | Oxiracetam | 62613-82-5 | Reference compound |
| HY-B1715R | Oxiracetam (Standard) | 62613-82-5 | Reference Standards |
| HY-B1716 | L-5-Hydroxytryptophan | 4350-09-8 | Natural Products |
| HY-B1716R | L-5-Hydroxytryptophan (Standard) | 4350-09-8 | Reference Standards |
| HY-B1716S | L-5-Hydroxytryptophan-d3 | 1276197-29-5 | Isotope-Labeled Compounds |
| HY-B1716S1 | L-5-Hydroxytryptophan-d3-1 | Isotope-Labeled Compounds | |
| HY-B1716S2 | L-5-Hydroxytryptophan-d4 | 1246818-91-6 | Isotope-Labeled Compounds |
| HY-B1717 | Oxolamine | 959-14-8 | Reference compound |
| HY-B1717A | Oxolamine (hydrochloride) | 1219-20-1 | Reference compound |
| HY-B1718 | Choline theophyllinate | 4499-40-5 | Reference compound |
| HY-B1718R | Choline theophyllinate (Standard) | 4499-40-5 | Reference Standards |
| HY-B1719A | Oxyphenonium (bromide) | 50-10-2 | Reference compound |
| HY-B1719AR | Oxyphenonium (bromide) (Standard) | 50-10-2 | Reference Standards |
| HY-B1721 | Parametadione | 115-67-3 | Reference compound |
| HY-B1724 | Perflubron | 423-55-2 | Reference compound |
| HY-B1724R | Perflubron (Standard) | 423-55-2 | Reference Standards |
| HY-B1726 | Phenacaine | 101-93-9 | Reference compound |
| HY-B1727 | Phenanthrene | 85-01-8 | Reference compound |
| HY-B1727R | Phenanthrene (Standard) | 85-01-8 | Reference Standards |
| HY-B1727S | Phenanthrene-d10 | 1517-22-2 | Isotope-Labeled Compounds |
| HY-B1729 | Phenoxyethanol | 122-99-6 | Reference compound |
| HY-B1729R | Phenoxyethanol (Standard) | 122-99-6 | Reference Standards |
| HY-B1729S | Phenoxyethanol-d2 | 21273-38-1 | Isotope-Labeled Compounds |
| HY-B1729S1 | Phenoxyethanol-d4 | 1219804-65-5 | Isotope-Labeled Compounds |
| HY-B1730 | Phensuximide | 86-34-0 | Reference compound |
| HY-B1730R | Phensuximide (Standard) | 86-34-0 | Reference Standards |
| HY-B1731 | Phenyl salicylate | 118-55-8 | Reference compound |
| HY-B1731R | Phenyl salicylate (Standard) | 118-55-8 | Reference Standards |
| HY-B1732 | DL-3-Phenylalanine | 150-30-1 | Peptides |
| HY-B1732R | DL-3-Phenylalanine (Standard) | 150-30-1 | Reference Standards |
| HY-B1732S | DL-3-Phenylalanine-15N | 81387-53-3 | Isotope-Labeled Compounds |
| HY-B1732S1 | DL-3-Phenylalanine-13C | 286425-42-1 | Isotope-Labeled Compounds |
| HY-B1732S2 | DL-3-Phenylalanine-d8 | 29909-00-0 | Isotope-Labeled Compounds |
| HY-B1732S3 | DL-3-Phenylalanine-13C-1 | 64193-01-7 | Isotope-Labeled Compounds |
| HY-B1732S4 | DL-3-Phenylalanine-d7 | 74228-83-4 | Isotope-Labeled Compounds |
| HY-B1732S5 | DL-3-Phenylalanine-d1 | 14246-24-3 | Isotope-Labeled Compounds |
| HY-B1733 | Phenyltoloxamine | 92-12-6 | Reference compound |
| HY-B1734 | 16-Dehydropregnenolone acetate | 979-02-2 | Reference compound |
| HY-B1735 | Picotamide | 32828-81-2 | Reference compound |
| HY-B1737 | Pirenperone | 75444-65-4 | Reference compound |
| HY-B1738 | Pralidoxime | 6735-59-7 | Reference compound |
| HY-B1738A | Pralidoxime (iodide) | 94-63-3 | Reference compound |
| HY-B1738B | Pralidoxime (methanesulfonate) | 154-97-2 | Reference compound |
| HY-B1739 | Pregnenolone monosulfate | 1247-64-9 | Natural Products |
| HY-B1740 | Pregnenolone acetate | 1778-02-5 | Reference compound |
| HY-B1741 | Proflavine | 92-62-6 | Reference compound |
| HY-B1741A | Proflavine (dihydrochloride) | 531-73-7 | Dye Reagents |
| HY-B1742 | Proxyphylline | 603-00-9 | Natural Products |
| HY-B1742R | Proxyphylline (Standard) | 603-00-9 | Reference Standards |
| HY-B1743 | Puromycin | 53-79-2 | Natural Products |
| HY-B1743A | Puromycin (dihydrochloride) | 58-58-2 | Natural Products |
| HY-B1743AR | Puromycin (dihydrochloride) (Standard) | 58-58-2 | Reference Standards |
| HY-B1743AS | Puromycin-d3 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-B1743R | Puromycin (Standard) | 53-79-2 | Reference Standards |
| HY-B1743S | Puromycin-d3 | Isotope-Labeled Compounds | |
| HY-B1744 | Pyridoxal phosphate | 54-47-7 | Natural Products |
| HY-B1744R | Pyridoxal phosphate (Standard) | 54-47-7 | Reference Standards |
| HY-B1744S | Pyridoxal phosphate-d5 | 1246818-16-5 | Isotope-Labeled Compounds |
| HY-B1745 | Pyridoxylamine | 85-87-0 | Natural Products |
| HY-B1745A | Pyridoxylamine (dihydrochloride) | 524-36-7 | Natural Products |
| HY-B1745AR | Pyridoxylamine (dihydrochloride) (Standard) | 524-36-7 | Reference Standards |
| HY-B1745R | Pyridoxylamine (Standard) | 85-87-0 | Reference Standards |
| HY-B1746 | Pyridoxamine 5′-phosphate | 529-96-4 | Reference compound |
| HY-B1746R | Pyridoxamine 5′-phosphate (Standard) | 529-96-4 | Reference Standards |
| HY-B1747 | Pyrithione | 1121-30-8 | Reference compound |
| HY-B1747A | Pyrithione (sodium) | 15922-78-8 | Reference compound |
| HY-B1751 | Quinidine (15% dihydroquinidine) | 56-54-2 | Natural Products |
| HY-B1751A | Quinidine (sulfate) | 50-54-4 | Reference compound |
| HY-B1751B | Quinine (sulfate) | 549-56-4 | Reference compound |
| HY-B1751C | Quinine (hydrobromide) | 549-49-5 | Reference compound |
| HY-B1751D | Quinidine (sulfate dihydrate) | 6591-63-5 | Natural Products |
| HY-B1751E | Quinidine polygalacturonate | 27555-34-6 | Reference compound |
| HY-B1751F | Quinidine (gluconic acid) | 7054-25-3 | Reference compound |
| HY-B1751R | Quinidine (15% dihydroquinidine) (Standard) | 56-54-2 | Reference Standards |
| HY-B1751S | Quinidine-d3 | 1267657-68-0 | Isotope-Labeled Compounds |
| HY-B1752 | Quinpirole | 80373-22-4 | Reference compound |
| HY-B1752A | Quinpirole (hydrochloride) | 85798-08-9 | Reference compound |
| HY-B1754 | Rimexolone | 49697-38-3 | Reference compound |
| HY-B1755 | Risocaine | 94-12-2 | Reference compound |
| HY-B1756 | Rotenone | 83-79-4 | Natural Products |
| HY-B1756R | Rotenone (Standard) | 83-79-4 | Reference Standards |
| HY-B1761 | Santonin | 481-06-1 | Natural Products |
| HY-B1761R | Santonin (Standard) | 481-06-1 | Reference Standards |
| HY-B1768 | Succimer | 304-55-2 | Reference compound |
| HY-B1770 | Sodium Iodide,99% | 7681-82-5 | Biochemical Assay Reagents |
| HY-B1773A | Sodium propionate | 137-40-6 | Biochemical Assay Reagents |
| HY-B1773AR | Sodium propionate (Standard) | 137-40-6 | Reference Standards |
| HY-B1773AS | Propanoic-13C (sodium) | 62601-06-3 | Isotope-Labeled Compounds |
| HY-B1773AS3 | Propanoic-13C3 (sodium) | 152571-51-2 | Isotope-Labeled Compounds |
| HY-B1773AS4 | Propanoic-d5 (sodium) | 202529-18-8 | Isotope-Labeled Compounds |
| HY-B1773AS5 | Sodium Propionate-d3 | 1210410-35-7 | Isotope-Labeled Compounds |
| HY-B1776 | Spermidine | 124-20-9 | Natural Products |
| HY-B1776A | Spermidine (hydrochloride) | 334-50-9 | Natural Products |
| HY-B1776AR | Spermidine (hydrochloride) (Standard) | 334-50-9 | Reference Standards |
| HY-B1776AS | Spermidine-d8 (hydrochloride) | 1173019-26-5 | Isotope-Labeled Compounds |
| HY-B1776AS1 | Spermidine-13C4 (hydrochloride) | 1313734-84-7 | Isotope-Labeled Compounds |
| HY-B1776R | Spermidine (Standard) | 124-20-9 | Reference Standards |
| HY-B1776S | Spermidine-d6 | 2514812-10-1 | Isotope-Labeled Compounds |
| HY-B1777 | Spermine | 71-44-3 | Natural Products |
| HY-B1777A | Spermine (tetrahydrochloride) | 306-67-2 | Natural Products |
| HY-B1777AR | Spermine (tetrahydrochloride) (Standard) | 306-67-2 | Reference Standards |
| HY-B1777AS | Spermine-d8 (tetrahydrochloride) | 1173022-85-9 | Isotope-Labeled Compounds |
| HY-B1777R | Spermine (Standard) | 71-44-3 | Reference Standards |
| HY-B1779 | Sucrose | 57-50-1 | Natural Products |
| HY-B1779R | Sucrose (Standard) | 57-50-1 | Reference Standards |
| HY-B1779S3 | Sucrose-d14 | Isotope-Labeled Compounds | |
| HY-B1779S5 | Sucrose-13C6 | Isotope-Labeled Compounds | |
| HY-B1781 | Sulfachloropyridazine | 80-32-0 | Reference compound |
| HY-B1781A | Sulfachloropyridazine (sodium) | 23282-55-5 | Reference compound |
| HY-B1781R | Sulfachloropyridazine (Standard) | 80-32-0 | Reference Standards |
| HY-B1781S | Sulfachloropyridazine-13C6 | 2731998-51-7 | Isotope-Labeled Compounds |
| HY-B1782 | Sulfamoxole | 729-99-7 | Reference compound |
| HY-B1782R | Sulfamoxole (Standard) | 729-99-7 | Reference Standards |
| HY-B1784 | Sulfisomidin | 515-64-0 | Reference compound |
| HY-B1784R | Sulfisomidin (Standard) | 515-64-0 | Reference Standards |
| HY-B1785 | 5-Sulfosalicylic acid | 97-05-2 | Reference compound |
| HY-B1786 | Sulindac sulfide | 49627-27-2 | Reference compound |
| HY-B1786A | (E/Z)-Sulindac sulfide | 32004-67-4 | Reference compound |
| HY-B1786R | Sulindac sulfide (Standard) | 49627-27-2 | Reference Standards |
| HY-B1786S | Sulindac sulfide-d3 | 250608-66-3 | Isotope-Labeled Compounds |
| HY-B1787 | Sulindac sulfone | 59973-80-7 | Reference compound |
| HY-B1787S | Sulindac sulfone-d3 | 250608-67-4 | Isotope-Labeled Compounds |
| HY-B1788 | Taurocholic acid | 81-24-3 | Natural Products |
| HY-B1788R | Taurocholic acid (Standard) | 81-24-3 | Reference Standards |
| HY-B1788S | Taurocholic acid-d4 (sodium) | 2410279-93-3 | Isotope-Labeled Compounds |
| HY-B1788S1 | Taurocholic acid-d4 | 252030-90-3 | Isotope-Labeled Compounds |
| HY-B1788S2 | Taurocholic acid-d5 | 2044276-13-1 | Isotope-Labeled Compounds |
| HY-B1789 | Telenzepine | 80880-90-6 | Reference compound |
| HY-B1789A | Telenzepine (dihydrochloride) | 147416-96-4 | Reference compound |
| HY-B1790 | Terconazole | 67915-31-5 | Reference compound |
| HY-B1790R | Terconazole (Standard) | 67915-31-5 | Reference Standards |
| HY-B1790S | Terconazole-d4 | 1398065-50-3 | Isotope-Labeled Compounds |
| HY-B1793 | Tetraethylammonium (chloride) | 56-34-8 | Reference compound |
| HY-B1794 | Thiethylperazine | 1420-55-9 | Reference compound |
| HY-B1794A | Thiethylperazine (dimaleate) | 1179-69-7 | Reference compound |
| HY-B1796 | Thymol iodide | 552-22-7 | Reference compound |
| HY-B1797 | Thyropropic acid | 51-26-3 | Reference compound |
| HY-B1798 | Tocainide | 41708-72-9 | Reference compound |
| HY-B1798A | Tocainide (hydrochloride) | 71395-14-7 | Reference compound |
| HY-B1799 | Tolmetin | 26171-23-3 | Reference compound |
| HY-B1799A | Tolmetin (sodium) | 35711-34-3 | Reference compound |
| HY-B1799R | Tolmetin (Standard) | 26171-23-3 | Reference Standards |
| HY-B1800 | Tolonidine | 4201-22-3 | Reference compound |
| HY-B1800R | Tolonidine (Standard) | 4201-22-3 | Reference Standards |
| HY-B1802 | Tosufloxacin | 100490-36-6 | Reference compound |
| HY-B1802A | Tosufloxacin (tosylate hydrate) | 1400591-39-0 | Natural Products |
| HY-B1802AR | Tosufloxacin (tosylate hydrate) (Standard) | 1400591-39-0 | Reference Standards |
| HY-B1802B | Tosufloxacin (hydrochloride) | 104051-69-6 | Reference compound |
| HY-B1802C | Tosufloxacin (tosylate) | 115964-29-9 | Reference compound |
| HY-B1802CR | Tosufloxacin (tosylate) (Standard) | 115964-29-9 | Reference Standards |
| HY-B1803A | Tracazolate (hydrochloride) | 1135210-68-2 | Reference compound |
| HY-B1804 | Tricaprilin | 538-23-8 | Natural Products |
| HY-B1804S | Tricaprilin-13C3 | 65402-55-3 | Isotope-Labeled Compounds |
| HY-B1804S1 | Tricaprilin-d50 | Isotope-Labeled Compounds | |
| HY-B1804S2 | Tricaprilin-d15 | 352431-24-4 | Isotope-Labeled Compounds |
| HY-B1805 | Triclocarban | 101-20-2 | Reference compound |
| HY-B1805R | Triclocarban (Standard) | 101-20-2 | Reference Standards |
| HY-B1805S | Triclocarban-d4 | 1219799-29-7 | Isotope-Labeled Compounds |
| HY-B1805S1 | Triclocarban-13C13 | Isotope-Labeled Compounds | |
| HY-B1806A | Tridihexethyl (chloride) | 4310-35-4 | Reference compound |
| HY-B1808 | Triprolidine | 486-12-4 | Reference compound |
| HY-B1808A | Triprolidine (hydrochloride) | 550-70-9 | Reference compound |
| HY-B1808S | (E/Z)-Triprolidine-d8 (hydrochloride) | 1795134-06-3 | Isotope-Labeled Compounds |
| HY-B1810 | Tulobuterol | 41570-61-0 | Reference compound |
| HY-B1810R | Tulobuterol (Standard) | 41570-61-0 | Reference Standards |
| HY-B1810S | Tulobuterol-d9 (hydrochloride) | 1325559-14-5 | Isotope-Labeled Compounds |
| HY-B1811 | Vasopressin | 11000-17-2 | Peptides |
| HY-B1811AS1 | Vasopressin-d5 (TFA) | Isotope-Labeled Compounds | |
| HY-B1811S1 | Vasopressin-d5 | Isotope-Labeled Compounds | |
| HY-B1812 | Veratrole | 91-16-7 | Natural Products |
| HY-B1812R | Veratrole (Standard) | 91-16-7 | Reference Standards |
| HY-B1812S | Veratrole-d4 | 126840-15-1 | Isotope-Labeled Compounds |
| HY-B1812S1 | Veratrole-d2 | 203645-56-1 | Isotope-Labeled Compounds |
| HY-B1812S2 | Veratrole-d10 | 362049-43-2 | Isotope-Labeled Compounds |
| HY-B1812S3 | Veratrole-d6 | 24658-24-0 | Isotope-Labeled Compounds |
| HY-B1812S4 | Veratrole-d2-1 | 3047059-94-6 | Isotope-Labeled Compounds |
| HY-B1813A | (±)-Vesamicol (hydrochloride) | 120447-62-3 | Reference compound |
| HY-B1814 | Vitamin K5 | 83-70-5 | Reference compound |
| HY-B1815 | Xanthinol Nicotinate | 437-74-1 | Reference compound |
| HY-B1815R | Xanthinol Nicotinate (Standard) | 437-74-1 | Reference Standards |
| HY-B1816 | Zaprinast | 37762-06-4 | Reference compound |
| HY-B1817 | Zinc acetate | 557-34-6 | Reference compound |
| HY-B1817A | Zinc acetate, 99.99% trace metals basis | 557-34-6 | Biochemical Assay Reagents |
| HY-B1818 | Zinc carbonate | 3486-35-9 | Reference compound |
| HY-B1820 | Zinc sulphate | 7733-02-0 | Reference compound |
| HY-B1821 | Zinc sulfide | 1314-98-3 | Reference compound |
| HY-B1824 | Cefpirome sulfate | 98753-19-6 | Reference compound |
| HY-B1824R | Cefpirome sulfate (Standard) | 98753-19-6 | Reference Standards |
| HY-B1825 | Cefoxitin | 35607-66-0 | Reference compound |
| HY-B1825R | Cefoxitin (Standard) | 35607-66-0 | Reference Standards |
| HY-B1826 | Adefovir | 106941-25-7 | Reference compound |
| HY-B1826S2 | Adefovir-d4 | 1190021-70-5 | Isotope-Labeled Compounds |
| HY-B1827 | D-Galacturonic acid (hydrate) | 91510-62-2 | Natural Products |
| HY-B1827A | D-Galacturonic acid | 685-73-4 | Natural Products |
| HY-B1827R | D-Galacturonic acid (hydrate) (Standard) | 91510-62-2 | Reference Standards |
| HY-B1828 | Spectinomycin | 1695-77-8 | Reference compound |
| HY-B1828A | Spectinomycin (dihydrochloride pentahydrate) | 22189-32-8 | Reference compound |
| HY-B1828AR | Spectinomycin (dihydrochloride pentahydrate) (Standard) | 22189-32-8 | Reference Standards |
| HY-B1829 | Dexamethasone phosphate | 312-93-6 | Reference compound |
| HY-B1829A | Dexamethasone phosphate (disodium) | 2392-39-4 | Reference compound |
| HY-B1829AR | Dexamethasone phosphate (disodium) (Standard) | 2392-39-4 | Reference Standards |
| HY-B1829R | Dexamethasone phosphate (Standard) | 312-93-6 | Reference Standards |
| HY-B1829S | Dexamethasone phosphate-d4 | Isotope-Labeled Compounds | |
| HY-B1830 | Estradiol enanthate | 4956-37-0 | Reference compound |
| HY-B1830R | Estradiol enanthate (Standard) | 4956-37-0 | Reference Standards |
| HY-B1831 | Oritavancin | 171099-57-3 | Reference compound |
| HY-B1831A | Oritavancin (diphosphate) | 192564-14-0 | Reference compound |
| HY-B1831AR | Oritavancin (diphosphate) (Standard) | 192564-14-0 | Reference Standards |
| HY-B1832 | Prednisone acetate | 125-10-0 | Reference compound |
| HY-B1832R | Prednisone acetate (Standard) | 125-10-0 | Reference Standards |
| HY-B1832S | Prednisone acetate-d3 | Isotope-Labeled Compounds | |
| HY-B1833 | Afloqualone | 56287-74-2 | Reference compound |
| HY-B1833R | Afloqualone (Standard) | 56287-74-2 | Reference Standards |
| HY-B1833S | Afloqualone-d7 | Isotope-Labeled Compounds | |
| HY-B1834 | Megestrol | 3562-63-8 | Reference compound |
| HY-B1834R | Megestrol (Standard) | 3562-63-8 | Reference Standards |
| HY-B1834S1 | Megestrol-d5 | Isotope-Labeled Compounds | |
| HY-B1836 | Meldonium | 76144-81-5 | Reference compound |
| HY-B1836A | Meldonium (dihydrate) | 86426-17-7 | Reference compound |
| HY-B1836AR | Meldonium (dihydrate) (Standard) | 86426-17-7 | Reference Standards |
| HY-B1836S | Meldonium-d3 | Isotope-Labeled Compounds | |
| HY-B1837 | Cyfluthrin | 68359-37-5 | Reference compound |
| HY-B1837A | β-Cyfluthrin | 1820573-27-0 | Reference compound |
| HY-B1837AR | β-Cyfluthrin (Standard) | 1820573-27-0 | Reference Standards |
| HY-B1837R | Cyfluthrin (Standard) | 68359-37-5 | Reference Standards |
| HY-B1837S | Cyfluthrin-d6 | 2483831-11-2 | Isotope-Labeled Compounds |
| HY-B1838 | Asulam | 3337-71-1 | Reference compound |
| HY-B1839 | Fluazinam | 79622-59-6 | Reference compound |
| HY-B1839R | Fluazinam (Standard) | 79622-59-6 | Reference Standards |
| HY-B1841 | Forchlorfenuron | 68157-60-8 | Natural Products |
| HY-B1841R | Forchlorfenuron (Standard) | 68157-60-8 | Reference Standards |
| HY-B1841S | Forchlorfenuron-d5 | 1398065-87-6 | Isotope-Labeled Compounds |
| HY-B1842 | Fluroxypyr | 69377-81-7 | Reference compound |
| HY-B1842R | Fluroxypyr (Standard) | 69377-81-7 | Reference Standards |
| HY-B1842S | Fluroxypyr-13C2 | Isotope-Labeled Compounds | |
| HY-B1843 | Fuberidazole | 3878-19-1 | Reference compound |
| HY-B1843R | Fuberidazole (Standard) | 3878-19-1 | Reference Standards |
| HY-B1844 | Flucythrinate | 70124-77-5 | Reference compound |
| HY-B1845 | Florasulam | 145701-23-1 | Reference compound |
| HY-B1845R | Florasulam (Standard) | 145701-23-1 | Reference Standards |
| HY-B1845S | Florasulam-13C,d3 | Isotope-Labeled Compounds | |
| HY-B1847 | Terbuthylazine | 5915-41-3 | Reference compound |
| HY-B1847R | Terbuthylazine (Standard) | 5915-41-3 | Reference Standards |
| HY-B1847S1 | Terbuthylazine-d5 | 222986-60-9 | Isotope-Labeled Compounds |
| HY-B1848 | Hexaflumuron | 86479-06-3 | Reference compound |
| HY-B1848R | Hexaflumuron (Standard) | 86479-06-3 | Reference Standards |
| HY-B1849 | Hexazinone | 51235-04-2 | Reference compound |
| HY-B1849R | Hexazinone (Standard) | 51235-04-2 | Reference Standards |
| HY-B1849S | Hexazinone-d6 | 1219804-22-4 | Isotope-Labeled Compounds |
| HY-B1850 | Halosulfuron-methyl | 100784-20-1 | Reference compound |
| HY-B1850R | Halosulfuron-methyl (Standard) | 100784-20-1 | Reference Standards |
| HY-B1850S | Halosulfuron-methyl-d6 | Isotope-Labeled Compounds | |
| HY-B1851 | Hexythiazox | 78587-05-0 | Reference compound |
| HY-B1851R | Hexythiazox (Standard) | 78587-05-0 | Reference Standards |
| HY-B1851S | Hexythiazox-d11 | 2714418-33-2 | Isotope-Labeled Compounds |
| HY-B1852 | Sulfometuron-methyl | 74222-97-2 | Reference compound |
| HY-B1852R | Sulfometuron-methyl (Standard) | 74222-97-2 | Reference Standards |
| HY-B1853 | Simetryn | 1014-70-6 | Reference compound |
| HY-B1853R | Simetryn (Standard) | 1014-70-6 | Reference Standards |
| HY-B1855 | cis-Heptachlor epoxide | 1024-57-3 | Biochemical Assay Reagents |
| HY-B1855R | cis-Heptachlor epoxide (Standard) | 1024-57-3 | Reference Standards |
| HY-B1856 | Haloxyfop | 69806-34-4 | Reference compound |
| HY-B1856R | Haloxyfop (Standard) | 69806-34-4 | Reference Standards |
| HY-B1856S | Haloxyfop-d4 | 127893-34-9 | Isotope-Labeled Compounds |
| HY-B1858 | Isoprothiolane | 50512-35-1 | Reference compound |
| HY-B1858R | Isoprothiolane (Standard) | 50512-35-1 | Reference Standards |
| HY-B1858S | Isoprothiolane-d4 | 1715020-82-8 | Isotope-Labeled Compounds |
| HY-B1859 | Isoproturon | 34123-59-6 | Reference compound |
| HY-B1859R | Isoproturon (Standard) | 34123-59-6 | Reference Standards |
| HY-B1859S1 | Isoproturon-d3 | 352438-80-3 | Isotope-Labeled Compounds |
| HY-B1860 | Imazapic | 104098-48-8 | Reference compound |
| HY-B1860R | Imazapic (Standard) | 104098-48-8 | Reference Standards |
| HY-B1863 | Iprobenfos | 26087-47-8 | Reference compound |
| HY-B1863R | Iprobenfos (Standard) | 26087-47-8 | Reference Standards |
| HY-B1864 | Kasugamycin | 6980-18-3 | Reference compound |
| HY-B1864A | Kasugamycin (hydrochloride) | 19408-46-9 | Natural Products |
| HY-B1864AR | Kasugamycin (hydrochloride) (Standard) | 19408-46-9 | Reference Standards |
| HY-B1864B | Kasugamycin (hydrochloride hydrate) | 200132-83-8 | Reference compound |
| HY-B1864BR | Kasugamycin (hydrochloride hydrate) (Standard) | 200132-83-8 | Reference Standards |
| HY-B1864C | Kasugamycin (sulfate) | 78822-08-9 | Reference compound |
| HY-B1866 | Linuron | 330-55-2 | Reference compound |
| HY-B1866R | Linuron (Standard) | 330-55-2 | Reference Standards |
| HY-B1866S | Linuron-d6 | 1219804-76-8 | Isotope-Labeled Compounds |
| HY-B1869 | Metsulfuron-methyl | 74223-64-6 | Reference compound |
| HY-B1869R | Metsulfuron-methyl (Standard) | 74223-64-6 | Reference Standards |
| HY-B1870 | Metaldehyde | 108-62-3 | Reference compound |
| HY-B1870R | Metaldehyde (Standard) | 108-62-3 | Reference Standards |
| HY-B1870S | Metaldehyde-d16 | 1219805-73-8 | Isotope-Labeled Compounds |
| HY-B1871 | Metolachlor | 51218-45-2 | Reference compound |
| HY-B1871R | Metolachlor (Standard) | 51218-45-2 | Reference Standards |
| HY-B1871S | Metolachlor-d6 | 1219803-97-0 | Isotope-Labeled Compounds |
| HY-B1873 | Methoxychlor | 72-43-5 | Reference compound |
| HY-B1873S | Methoxychlor-d6 | 106031-79-2 | Isotope-Labeled Compounds |
| HY-B1874 | Metoxuron | 19937-59-8 | Reference compound |
| HY-B1874S | Metoxuron-d6 | 2030182-41-1 | Isotope-Labeled Compounds |
| HY-B1875 | Monuron | 150-68-5 | Reference compound |
| HY-B1875S | Monuron-d6 | 217488-65-8 | Isotope-Labeled Compounds |
| HY-B1876 | Nicosulfuron | 111991-09-4 | Reference compound |
| HY-B1876R | Nicosulfuron (Standard) | 111991-09-4 | Reference Standards |
| HY-B1876S | Nicosulfuron-d6 | 1189419-41-7 | Isotope-Labeled Compounds |
| HY-B1877 | Nitrofen | 1836-75-5 | Reference compound |
| HY-B1877R | Nitrofen (Standard) | 1836-75-5 | Reference Standards |
| HY-B1878 | Faltan | 133-07-3 | Reference compound |
| HY-B1878R | Faltan (Standard) | 133-07-3 | Reference Standards |
| HY-B1878S | Faltan-d4 | 1327204-12-5 | Isotope-Labeled Compounds |
| HY-B1880 | Oxadiazon | 19666-30-9 | Reference compound |
| HY-B1880R | Oxadiazon (Standard) | 19666-30-9 | Reference Standards |
| HY-B1881 | Pirimiphos-methyl | 29232-93-7 | Reference compound |
| HY-B1881R | Pirimiphos-methyl (Standard) | 29232-93-7 | Reference Standards |
| HY-B1881S | Pirimiphos-methyl-d6 | 1793055-06-7 | Isotope-Labeled Compounds |
| HY-B1882 | Propazine | 139-40-2 | Reference compound |
| HY-B1882R | Propazine (Standard) | 139-40-2 | Reference Standards |
| HY-B1882S | Propazine-d14 | 1219802-87-5 | Isotope-Labeled Compounds |
| HY-B1883 | Propyzamide | 23950-58-5 | Reference compound |
| HY-B1883R | Propyzamide (Standard) | 23950-58-5 | Reference Standards |
| HY-B1883S | 3,5-Dichloro-N-(2-methylbut-3-yn-2-yl)benzamide-d3 | 1219805-79-4 | Isotope-Labeled Compounds |
| HY-B1884 | Procymidone | 32809-16-8 | Reference compound |
| HY-B1884R | Procymidone (Standard) | 32809-16-8 | Reference Standards |
| HY-B1885 | Fenitrothion | 122-14-5 | Reference compound |
| HY-B1885R | Fenitrothion (Standard) | 122-14-5 | Reference Standards |
| HY-B1885S | Fenitrothion-d6 | 203645-59-4 | Isotope-Labeled Compounds |
| HY-B1886 | Chlorocholine (chloride) | 999-81-5 | Reference compound |
| HY-B1886R | Chlorocholine (chloride) (Standard) | 999-81-5 | Reference Standards |
| HY-B1886S | Chlorocholine-d4 (chloride) | Isotope-Labeled Compounds | |
| HY-B1886S1 | Chlorocholine-d9 (chloride) | 1219257-11-0 | Isotope-Labeled Compounds |
| HY-B1888 | Bromfenac | 91714-94-2 | Reference compound |
| HY-B1888A | Bromfenac (sodium) | 91714-93-1 | Reference compound |
| HY-B1888AS | Bromfenac-d4 (sodium) | 2749400-35-7 | Isotope-Labeled Compounds |
| HY-B1888B | Bromfenac (sodium hydrate) | 120638-55-3 | Reference compound |
| HY-B1890 | (±)-Catechin | 7295-85-4 | Natural Products |
| HY-B1890R | (±)-Catechin (Standard) | 7295-85-4 | Reference Standards |
| HY-B1892 | Cefazolin | 25953-19-9 | Reference compound |
| HY-B1892R | Cefazolin (Standard) | 25953-19-9 | Reference Standards |
| HY-B1892S1 | Cefazolin-13C2,15N | 2101505-58-0 | Isotope-Labeled Compounds |
| HY-B1893 | Fluorometholone | 426-13-1 | Reference compound |
| HY-B1893R | Fluorometholone (Standard) | 426-13-1 | Reference Standards |
| HY-B1894 | Cefetamet pivoxyl | 65243-33-6 | Reference compound |
| HY-B1894A | Cefetamet pivoxil (hydrochloride) | 111696-23-2 | Reference compound |
| HY-B1894AR | Cefetamet pivoxil (hydrochloride) (Standard) | 111696-23-2 | Reference Standards |
| HY-B1894R | Cefetamet pivoxyl (Standard) | 65243-33-6 | Reference Standards |
| HY-B1895 | Levodropropizine | 99291-25-5 | Reference compound |
| HY-B1895R | Levodropropizine (Standard) | 99291-25-5 | Reference Standards |
| HY-B1895S | Levodropropizine-d8 | Isotope-Labeled Compounds | |
| HY-B1895S1 | Levodropropizine-d5 | Isotope-Labeled Compounds | |
| HY-B1896 | Piperaquine | 4085-31-8 | Reference compound |
| HY-B1896A | Piperaquine (phosphate) | 85547-56-4 | Reference compound |
| HY-B1896B | Piperaquine (tetraphosphate tetrahydrate) | 915967-82-7 | Reference compound |
| HY-B1896S | Piperaquine-d6 | 1261394-71-1 | Isotope-Labeled Compounds |
| HY-B1897A | Menadione bisulfite (sodium) | 130-37-0 | Reference compound |
| HY-B1897AR | Menadione bisulfite (sodium) (Standard) | 130-37-0 | Reference Standards |
| HY-B1898 | Metadoxine | 74536-44-0 | Reference compound |
| HY-B1899 | Taurodeoxycholic acid | 516-50-7 | Natural Products |
| HY-B1899A | Taurodeoxycholic acid (sodium hydrate) | 110026-03-4 | Reference compound |
| HY-B1899AR | Taurodeoxycholic acid (sodium hydrate) (Standard) | 110026-03-4 | Reference Standards |
| HY-B1899BS | Taurodeoxycholic acid-d4 (sodium salt) | 2410279-82-0 | Isotope-Labeled Compounds |
| HY-B1899R | Taurodeoxycholic acid (Standard) | 516-50-7 | Reference Standards |
| HY-B1899S | Taurodeoxycholic acid-d5 | Isotope-Labeled Compounds | |
| HY-B1899S1 | Taurodeoxycholic acid-d4 | 1332881-65-8 | Isotope-Labeled Compounds |
| HY-B1900 | Methylprednisolone succinate | 2921-57-5 | Reference compound |
| HY-B1900R | Methylprednisolone succinate (Standard) | 2921-57-5 | Reference Standards |
| HY-B1901 | Eperisone (hydrochloride) | 56839-43-1 | Reference compound |
| HY-B1901S | Eperisone-d10 (hydrochloride) | 1246819-46-4 | Isotope-Labeled Compounds |
| HY-B1902 | Diaveridine | 5355-16-8 | Reference compound |
| HY-B1902R | Diaveridine (Standard) | 5355-16-8 | Reference Standards |
| HY-B1902S | Diaveridine-d6 | Isotope-Labeled Compounds | |
| HY-B1904 | Fluphenazine decanoate | 5002-47-1 | Reference compound |
| HY-B1904A | Fluphenazine decanoate (dihydrochloride) | 2376-65-0 | Reference compound |
| HY-B1904R | Fluphenazine decanoate (Standard) | 5002-47-1 | Reference Standards |
| HY-B1906 | Streptomycin | 57-92-1 | Reference compound |
| HY-B1906R | Streptomycin (Standard) | 57-92-1 | Reference Standards |
| HY-B1907 | Rifamycin (sodium) | 14897-39-3 | Natural Products |
| HY-B1907A | Rifamycin | 6998-60-3 | Reference compound |
| HY-B1907R | Rifamycin (sodium) (Standard) | 14897-39-3 | Reference Standards |
| HY-B1908 | Midecamycin | 35457-80-8 | Natural Products |
| HY-B1908R | Midecamycin (Standard) | 35457-80-8 | Reference Standards |
| HY-B1909 | Quizalofop-ethyl | 76578-14-8 | Biochemical Assay Reagents |
| HY-B1909R | Quizalofop-ethyl (Standard) | 76578-14-8 | Reference Standards |
| HY-B1909S | Quizalofop-ethyl-d3 | 1398065-84-3 | Isotope-Labeled Compounds |
| HY-B1912 | Amidosulfuron | 120923-37-7 | Reference compound |
| HY-B1912R | Amidosulfuron (Standard) | 120923-37-7 | Reference Standards |
| HY-B1912S | Amidosulfuron-d6 | Isotope-Labeled Compounds | |
| HY-B1912S1 | Amidosulfuron-13C2,d6 | Isotope-Labeled Compounds | |
| HY-B1914 | Tebufenpyrad | 119168-77-3 | Reference compound |
| HY-B1914R | Tebufenpyrad (Standard) | 119168-77-3 | Reference Standards |
| HY-B1915 | Micronomicin | 52093-21-7 | Reference compound |
| HY-B1916 | Acetylspiramycin | 24916-51-6 | Reference compound |
| HY-B1916R | Acetylspiramycin (Standard) | 24916-51-6 | Reference Standards |
| HY-B1918 | (+)-Bornyl acetate | 20347-65-3 | Natural Products |
| HY-B1920 | Josamycin | 16846-24-5 | Natural Products |
| HY-B1920A | Josamycin (hydrochloride) | 11033-19-5 | Reference compound |
| HY-B1920R | Josamycin (Standard) | 16846-24-5 | Reference Standards |
| HY-B1921 | Miocamycin | 55881-07-7 | Reference compound |
| HY-B1923 | Piperacillin | 61477-96-1 | Reference compound |
| HY-B1923A | Piperacillin (hydrate) | 66258-76-2 | Reference compound |
| HY-B1923R | Piperacillin (Standard) | 61477-96-1 | Reference Standards |
| HY-B1923S | Piperacillin-d5 | Isotope-Labeled Compounds | |
| HY-B1924 | Norvancomycin (hydrochloride) | 213997-73-0 | Reference compound |
| HY-B1931S | Di-n-nonyl phthalate-3,4,5,6-d4 | 1202865-43-7 | Isotope-Labeled Compounds |
| HY-B1934 | Methyl stearate | 112-61-8 | Natural Products |
| HY-B1934R | Methyl stearate (Standard) | 112-61-8 | Reference Standards |
| HY-B1934S1 | Methyl stearate-d35 | 29823-25-4 | Isotope-Labeled Compounds |
| HY-B1937 | Sodium dodecylbenzenesulfonate | 25155-30-0 | Biochemical Assay Reagents |
| HY-B1937R | Sodium dodecylbenzenesulfonate (Standard) | 25155-30-0 | Reference Standards |
| HY-B1941 | 4-tert-Octylphenol | 140-66-9 | Natural Products |
| HY-B1941R | 4-tert-Octylphenol (Standard) | 140-66-9 | Reference Standards |
| HY-B1941S | 4-tert-Octylphenol-3,5-d2 | 1173021-20-9 | Isotope-Labeled Compounds |
| HY-B1941S1 | 4-tert-Octylphenol-13C6 | 1173020-24-0 | Isotope-Labeled Compounds |
| HY-B1944S | Dipropyl phthalate-d4 | 358731-29-0 | Isotope-Labeled Compounds |
| HY-B1945 | DEHP | 117-81-7 | Natural Products |
| HY-B1945R | DEHP (Standard) | 117-81-7 | Reference Standards |
| HY-B1945S | DEHP-d4 | 93951-87-2 | Isotope-Labeled Compounds |
| HY-B1945S1 | DEHP-d38 | 352431-42-6 | Isotope-Labeled Compounds |
| HY-B1946 | Dimethoate | 60-51-5 | Reference compound |
| HY-B1946R | Dimethoate (Standard) | 60-51-5 | Reference Standards |
| HY-B1946S | Dimethoate-d6 | 1219794-81-6 | Isotope-Labeled Compounds |
| HY-B1948 | Diniconazole | 83657-24-3 | Reference compound |
| HY-B1948AS | Diclopentezol-d9 | Isotope-Labeled Compounds | |
| HY-B1948R | Diniconazole (Standard) | 83657-24-3 | Reference Standards |
| HY-B1950 | Quizalofop-p-ethyl | 100646-51-3 | Reference compound |
| HY-B1950R | Quizalofop-p-ethyl (Standard) | 100646-51-3 | Reference Standards |
| HY-B1951 | Trietazine | 1912-26-1 | Reference compound |
| HY-B1951R | Trietazine (Standard) | 1912-26-1 | Reference Standards |
| HY-B1952 | Diethylene glycol | 111-46-6 | Biochemical Assay Reagents |
| HY-B1952R | Diethylene glycol (Standard) | 111-46-6 | Reference Standards |
| HY-B1952S | Diethylene glycol-d8 | 102867-56-1 | Isotope-Labeled Compounds |
| HY-B1953 | Thiacloprid | 111988-49-9 | Reference compound |
| HY-B1953R | Thiacloprid (Standard) | 111988-49-9 | Reference Standards |
| HY-B1953S | Thiacloprid-d4 | 1793071-39-2 | Isotope-Labeled Compounds |
| HY-B1955 | 4',4-Dibromobiphenyl | 92-86-4 | Reference compound |
| HY-B1955S | 4',4-Dibromobiphenyl-d8 | 80523-79-1 | Isotope-Labeled Compounds |
| HY-B1960 | Canthaxanthin | 514-78-3 | Natural Products |
| HY-B1960R | Canthaxanthin (Standard) | 514-78-3 | Reference Standards |
| HY-B1965 | Direct blue 6 | 2602-46-2 | Reference compound |
| HY-B1966S | Diphenyl phthalate-3,4,5,6-d4 | 1398065-61-6 | Isotope-Labeled Compounds |
| HY-B1970 | o,p'-DDT | 789-02-6 | Reference compound |
| HY-B1970S | o,p'-DDT-d8 | 221899-88-3 | Isotope-Labeled Compounds |
| HY-B1971 | Deltamethrin | 52918-63-5 | Reference compound |
| HY-B1971R | Deltamethrin (Standard) | 52918-63-5 | Reference Standards |
| HY-B1971S | Deltamethrin-d5 | 2140301-99-9 | Isotope-Labeled Compounds |
| HY-B1971S1 | Deltamethrin-d6 | 2483831-10-1 | Isotope-Labeled Compounds |
| HY-B1972 | Napropamide | 15299-99-7 | Reference compound |
| HY-B1972R | Napropamide (Standard) | 15299-99-7 | Reference Standards |
| HY-B1973 | Diflubenzuron | 35367-38-5 | Reference compound |
| HY-B1973R | Diflubenzuron (Standard) | 35367-38-5 | Reference Standards |
| HY-B1973S | Diflubenzuron-d4 | 1219795-45-5 | Isotope-Labeled Compounds |
| HY-B1975 | Dithianon | 3347-22-6 | Reference compound |
| HY-B1975R | Dithianon (Standard) | 3347-22-6 | Reference Standards |
| HY-B1977 | Dipropetryn | 4147-51-7 | Reference compound |
| HY-B1978 | Iprodione | 36734-19-7 | Reference compound |
| HY-B1978R | Iprodione (Standard) | 36734-19-7 | Reference Standards |
| HY-B1978S | Iprodione-d5 | 1215631-57-4 | Isotope-Labeled Compounds |
| HY-B1979 | Isochlorthion | 2463-84-5 | Reference compound |
| HY-B1984 | p,p'-DDD | 72-54-8 | Reference compound |
| HY-B1984R | p,p'-DDD (Standard) | 72-54-8 | Reference Standards |
| HY-B1984S | p,p'-DDD-d8 | 93952-20-6 | Isotope-Labeled Compounds |
| HY-B1986 | p,p'-DDE | 72-55-9 | Reference compound |
| HY-B1986R | p,p'-DDE (Standard) | 72-55-9 | Reference Standards |
| HY-B1986S | p,p'-DDE-d8 | 93952-19-3 | Isotope-Labeled Compounds |
| HY-B1987 | 2,6-Dichlorobenzonitrile | 1194-65-6 | Reference compound |
| HY-B1991 | Terbutryn | 886-50-0 | Reference compound |
| HY-B1991R | Terbutryn (Standard) | 886-50-0 | Reference Standards |
| HY-B1991S | Terbutryn-d5 | 1219804-47-3 | Isotope-Labeled Compounds |
| HY-B2004 | Thifluzamide | 130000-40-7 | Reference compound |
| HY-B2004R | Thifluzamide (Standard) | 130000-40-7 | Reference Standards |
| HY-B2005 | Terbumeton | 33693-04-8 | Reference compound |
| HY-B2006 | Fenvalerate | 51630-58-1 | Reference compound |
| HY-B2006R | Fenvalerate (Standard) | 51630-58-1 | Reference Standards |
| HY-B2006S | Fenvalerate-d5 | 1246815-00-8 | Isotope-Labeled Compounds |
| HY-B2006S1 | Fenvalerate-d6 | 82523-66-8 | Isotope-Labeled Compounds |
| HY-B2007 | Fluazifop-P-butyl | 79241-46-6 | Reference compound |
| HY-B2007R | Fluazifop-P-butyl (Standard) | 79241-46-6 | Reference Standards |
| HY-B2008 | Famoxadone | 131807-57-3 | Reference compound |
| HY-B2008R | Famoxadone (Standard) | 131807-57-3 | Reference Standards |
| HY-B2009 | Flufenoxuron | 101463-69-8 | Reference compound |
| HY-B2009R | Flufenoxuron (Standard) | 101463-69-8 | Reference Standards |
| HY-B2010 | Fomesafen | 72178-02-0 | Reference compound |
| HY-B2010R | Fomesafen (Standard) | 72178-02-0 | Reference Standards |
| HY-B2010S | Fomesafen-d3 | Isotope-Labeled Compounds | |
| HY-B2011 | Flutolanil | 66332-96-5 | Reference compound |
| HY-B2011R | Flutolanil (Standard) | 66332-96-5 | Reference Standards |
| HY-B2012 | Flusilazole | 85509-19-9 | Reference compound |
| HY-B2012R | Flusilazole (Standard) | 85509-19-9 | Reference Standards |
| HY-B2013 | Fenoxaprop-P-ethyl | 71283-80-2 | Reference compound |
| HY-B2013R | Fenoxaprop-P-ethyl (Standard) | 71283-80-2 | Reference Standards |
| HY-B2015 | Carbosulfan | 55285-14-8 | Reference compound |
| HY-B2015R | Carbosulfan (Standard) | 55285-14-8 | Reference Standards |
| HY-B2015S | Carbosulfan-d18 | 1189903-75-0 | Isotope-Labeled Compounds |
| HY-B2016 | Anilofos | 64249-01-0 | Reference compound |
| HY-B2016R | Anilofos (Standard) | 64249-01-0 | Reference Standards |
| HY-B2020 | Fenuron | 101-42-8 | Biochemical Assay Reagents |
| HY-B2020R | Fenuron (Standard) | 101-42-8 | Reference Standards |
| HY-B2020S | Fenuron-d5 | 1219802-06-8 | Isotope-Labeled Compounds |
| HY-B2021 | τ-Fluvalinate | 102851-06-9 | Reference compound |
| HY-B2023 | Chlorotoluron | 15545-48-9 | Reference compound |
| HY-B2023R | Chlorotoluron (Standard) | 15545-48-9 | Reference Standards |
| HY-B2023S | Chlorotoluron-d6 | 1219803-48-1 | Isotope-Labeled Compounds |
| HY-B2024 | Cloquintocet-mexyl | 99607-70-2 | Reference compound |
| HY-B2024R | Cloquintocet-mexyl (Standard) | 99607-70-2 | Reference Standards |
| HY-B2025S | Chlorpyrifos methyl-d6 | 2083629-84-7 | Isotope-Labeled Compounds |
| HY-B2026 | Propamocarb | 24579-73-5 | Reference compound |
| HY-B2026R | Propamocarb (Standard) | 24579-73-5 | Reference Standards |
| HY-B2026S | Propamocarb-d7 | 1398065-89-8 | Isotope-Labeled Compounds |
| HY-B2028 | Propargite | 2312-35-8 | Reference compound |
| HY-B2028R | Propargite (Standard) | 2312-35-8 | Reference Standards |
| HY-B2029 | Phosalone | 2310-17-0 | Reference compound |
| HY-B2029R | Phosalone (Standard) | 2310-17-0 | Reference Standards |
| HY-B2030 | Propanil | 709-98-8 | Reference compound |
| HY-B2030R | Propanil (Standard) | 709-98-8 | Reference Standards |
| HY-B2030S | Propanil-d5 | 1398065-82-1 | Isotope-Labeled Compounds |
| HY-B2031 | Pyriproxyfen | 95737-68-1 | Reference compound |
| HY-B2031R | Pyriproxyfen (Standard) | 95737-68-1 | Reference Standards |
| HY-B2031S | Pyriproxyfen-d6 | 2673269-99-1 | Isotope-Labeled Compounds |
| HY-B2031S1 | Pyriproxyfen-d4 | 2446366-95-4 | Isotope-Labeled Compounds |
| HY-B2032 | Phenmedipham | 13684-63-4 | Reference compound |
| HY-B2032R | Phenmedipham (Standard) | 13684-63-4 | Reference Standards |
| HY-B2032S | Phenmedipham-d3 | 1773497-41-8 | Isotope-Labeled Compounds |
| HY-B2033 | Pyrimethanil | 53112-28-0 | Reference compound |
| HY-B2033R | Pyrimethanil (Standard) | 53112-28-0 | Reference Standards |
| HY-B2033S | Pyrimethanil-13C,15N2 | Isotope-Labeled Compounds | |
| HY-B2033S1 | Pyrimethanil-d5 | 2118244-83-8 | Isotope-Labeled Compounds |
| HY-B2034 | Picloram | 1918-02-1 | Reference compound |
| HY-B2034R | Picloram (Standard) | 1918-02-1 | Reference Standards |
| HY-B2035 | Pretilachlor | 51218-49-6 | Reference compound |
| HY-B2035R | Pretilachlor (Standard) | 51218-49-6 | Reference Standards |
| HY-B2039 | Bentazone | 25057-89-0 | Reference compound |
| HY-B2039R | Bentazone (Standard) | 25057-89-0 | Reference Standards |
| HY-B2039S | Bentazone-13C10,15N | Isotope-Labeled Compounds | |
| HY-B2039S1 | Bentazone-d7 | 131842-77-8 | Isotope-Labeled Compounds |
| HY-B2041 | Benfuracarb | 82560-54-1 | Reference compound |
| HY-B2041R | Benfuracarb (Standard) | 82560-54-1 | Reference Standards |
| HY-B2042 | Butachlor | 23184-66-9 | Reference compound |
| HY-B2042R | Butachlor (Standard) | 23184-66-9 | Reference Standards |
| HY-B2044 | Bromopropylate | 18181-80-1 | Reference compound |
| HY-B2044R | Bromopropylate (Standard) | 18181-80-1 | Reference Standards |
| HY-B2045 | Benfluralin | 1861-40-1 | Reference compound |
| HY-B2045R | Benfluralin (Standard) | 1861-40-1 | Reference Standards |
| HY-B2046 | Simazine | 122-34-9 | Reference compound |
| HY-B2046R | Simazine (Standard) | 122-34-9 | Reference Standards |
| HY-B2046S | Simazine-d10 | 220621-39-6 | Isotope-Labeled Compounds |
| HY-B2048 | Pencycuron | 66063-05-6 | Reference compound |
| HY-B2048R | Pencycuron (Standard) | 66063-05-6 | Reference Standards |
| HY-B2048S | Pencycuron-d5 | 83286-58-2 | Isotope-Labeled Compounds |
| HY-B2049 | Triflumuron | 64628-44-0 | Reference compound |
| HY-B2049R | Triflumuron (Standard) | 64628-44-0 | Reference Standards |
| HY-B2050 | Trifluralin | 1582-09-8 | Reference compound |
| HY-B2050R | Trifluralin (Standard) | 1582-09-8 | Reference Standards |
| HY-B2050S | Trifluralin-d14 | 347841-79-6 | Isotope-Labeled Compounds |
| HY-B2051 | Triclopyr | 55335-06-3 | Reference compound |
| HY-B2051R | Triclopyr (Standard) | 55335-06-3 | Reference Standards |
| HY-B2053 | Tolclofos-methyl | 57018-04-9 | Reference compound |
| HY-B2053R | Tolclofos-methyl (Standard) | 57018-04-9 | Reference Standards |
| HY-B2054 | Tebufenozide | 112410-23-8 | Reference compound |
| HY-B2054R | Tebufenozide (Standard) | 112410-23-8 | Reference Standards |
| HY-B2054S | Tebufenozide-d9 | 2469006-89-9 | Isotope-Labeled Compounds |
| HY-B2055 | Teflubenzuron | 83121-18-0 | Reference compound |
| HY-B2055R | Teflubenzuron (Standard) | 83121-18-0 | Reference Standards |
| HY-B2056 | Triforine | 26644-46-2 | Reference compound |
| HY-B2056R | Triforine (Standard) | 26644-46-2 | Reference Standards |
| HY-B2058 | Triticonazole | 131983-72-7 | Reference compound |
| HY-B2058R | Triticonazole (Standard) | 131983-72-7 | Reference Standards |
| HY-B2060 | Tiamulin | 55297-95-5 | Reference compound |
| HY-B2060A | Tiamulin (fumarate) | 55297-96-6 | Reference compound |
| HY-B2060AR | Tiamulin (fumarate) (Standard) | 55297-96-6 | Reference Standards |
| HY-B2060R | Tiamulin (Standard) | 55297-95-5 | Reference Standards |
| HY-B2060S1 | Tiamulin-d10-1 (hydrochloride) | 2750534-93-9 | Isotope-Labeled Compounds |
| HY-B2062 | Chlorthal-dimethyl | 1861-32-1 | Reference compound |
| HY-B2062R | Chlorthal-dimethyl (Standard) | 1861-32-1 | Reference Standards |
| HY-B2062S | Chlorthal-dimethyl-d6 | 350818-66-5 | Isotope-Labeled Compounds |
| HY-B2063 | Chlorobenzuron | 57160-47-1 | Reference compound |
| HY-B2063R | Chlorobenzuron (Standard) | 57160-47-1 | Reference Standards |
| HY-B2064 | Carboxin | 5234-68-4 | Natural Products |
| HY-B2064R | Carboxin (Standard) | 5234-68-4 | Reference Standards |
| HY-B2065 | Scopolamine (hydrochloride) | 55-16-3 | Natural Products |
| HY-B2066 | Clofentezine | 74115-24-5 | Reference compound |
| HY-B2066R | Clofentezine (Standard) | 74115-24-5 | Reference Standards |
| HY-B2067 | Cymoxanil | 57966-95-7 | Reference compound |
| HY-B2067R | Cymoxanil (Standard) | 57966-95-7 | Reference Standards |
| HY-B2067S | Cymoxanil-d3 | 2140803-92-3 | Isotope-Labeled Compounds |
| HY-B2068 | Iron sucrose | 8047-67-4 | Reference compound |
| HY-B2070 | Methylbenactyzium Bromide | 3166-62-9 | Reference compound |
| HY-B2072 | Cephaloridine | 50-59-9 | Reference compound |
| HY-B2072A | Cephaloridine (hydrate) | 102039-86-1 | Reference compound |
| HY-B2072AR | Cephaloridine (hydrate) (Standard) | 102039-86-1 | Reference Standards |
| HY-B2073 | Clocapramine | 47739-98-0 | Reference compound |
| HY-B2073A | Clocapramine (dihydrochloride hydrate) | 60789-62-0 | Reference compound |
| HY-B2075 | Dimetacrine | 4757-55-5 | Reference compound |
| HY-B2077 | Enviomycin | 33103-22-9 | Peptides |
| HY-B2078 | Eprazinone | 10402-90-1 | Reference compound |
| HY-B2078A | Eprazinone (dihydrochloride) | 10402-53-6 | Reference compound |
| HY-B2080 | Etidocaine | 36637-18-0 | Reference compound |
| HY-B2080A | Etidocaine (hydrochloride) | 36637-19-1 | Reference compound |
| HY-B2081 | Etozolin | 73-09-6 | Reference compound |
| HY-B2081A | Etozolin (hydrochloride) | 53-90-7 | Reference compound |
| HY-B2082 | Fursultiamine | 804-30-8 | Reference compound |
| HY-B2082R | Fursultiamine (Standard) | 804-30-8 | Reference Standards |
| HY-B2085 | Arsthinenol | 119-96-0 | Reference compound |
| HY-B2087 | Glycerol phenylbutyrate | 611168-24-2 | Reference compound |
| HY-B2087R | Glycerol phenylbutyrate (Standard) | 611168-24-2 | Reference Standards |
| HY-B2089 | Cinitapride | 66564-14-5 | Reference compound |
| HY-B2089R | Cinitapride (Standard) | 66564-14-5 | Reference Standards |
| HY-B2089S | Cinitapride-d5 | 2714421-62-0 | Isotope-Labeled Compounds |
| HY-B2090 | Pipazethate | 2167-85-3 | Reference compound |
| HY-B2091 | Azidocillin | 17243-38-8 | Reference compound |
| HY-B2091A | Azidocillin (sodium) | 35334-12-4 | Reference compound |
| HY-B2094 | Arbekacin | 51025-85-5 | Reference compound |
| HY-B2096 | Oleic acid (ethanolamine) | 2272-11-9 | Reference compound |
| HY-B2097 | Incadronate (disodium) | 138330-18-4 | Reference compound |
| HY-B2098 | Lucanthone | 479-50-5 | Reference compound |
| HY-B2098A | Lucanthone (hydrochloride) | 548-57-2 | Reference compound |
| HY-B2099 | Buformin | 692-13-7 | Reference compound |
| HY-B2099A | Buformin (hydrochloride) | 1190-53-0 | Reference compound |
| HY-B2099S | Buformin-d9 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B2102 | Oxyphenisatine | 125-13-3 | Reference compound |
| HY-B2102R | Oxyphenisatine (Standard) | 125-13-3 | Reference Standards |
| HY-B2106 | Polidocanol,Hydroxyl Value 40-60 mgKOH/g | 9002-92-0 | Reference compound |
| HY-B2106C | PEG 23 lauryl ether | 2765321-63-7 | Reference compound |
| HY-B2106D | Polyoxyethylene (10) lauryl ether | 9002-92-0 | Biochemical Assay Reagents |
| HY-B2106DR | Polyoxyethylene (10) lauryl ether (Standard) | 9002-92-0 | Reference Standards |
| HY-B2111 | (R)-(+)-Atenolol | 56715-13-0 | Reference compound |
| HY-B2112 | Valethamate (bromide) | 90-22-2 | Reference compound |
| HY-B2113 | Bromisoval | 496-67-3 | Reference compound |
| HY-B2113R | Bromisoval (Standard) | 496-67-3 | Reference Standards |
| HY-B2114 | Escin | 6805-41-0 | Natural Products |
| HY-B2115 | Sulfogaiacol | 1321-14-8 | Reference compound |
| HY-B2116 | Osalmid | 526-18-1 | Reference compound |
| HY-B2117 | Valpromide | 2430-27-5 | Reference compound |
| HY-B2117R | Valpromide (Standard) | 2430-27-5 | Reference Standards |
| HY-B2118 | Pancreatin | 8049-47-6 | Reference compound |
| HY-B2119 | Sodium tauroglycocholate | 41945-48-6 | Reference compound |
| HY-B2120 | 2-Amino-5-nitrobenzophenone | 1775-95-7 | Reference compound |
| HY-B2121 | 6-Methoxy-2-naphthoic acid | 2471-70-7 | Reference compound |
| HY-B2121R | 6-Methoxy-2-naphthoic acid (Standard) | 2471-70-7 | Reference Standards |
| HY-B2122 | Maltitol | 585-88-6 | Natural Products |
| HY-B2122R | Maltitol (Standard) | 585-88-6 | Reference Standards |
| HY-B2123 | Lactose | 63-42-3 | Natural Products |
| HY-B2123R | Lactose (Standard) | 63-42-3 | Reference Standards |
| HY-B2124 | 10,11-Dihydrocarbamazepine | 3564-73-6 | Reference compound |
| HY-B2124R | 10,11-Dihydrocarbamazepine (Standard) | 3564-73-6 | Reference Standards |
| HY-B2127 | Azobenzene | 103-33-3 | Reference compound |
| HY-B2127R | Azobenzene (Standard) | 103-33-3 | Reference Standards |
| HY-B2127S | Azobenzene-d10 | 30504-49-5 | Isotope-Labeled Compounds |
| HY-B2130 | Uric acid | 69-93-2 | Natural Products |
| HY-B2130A | Uric acid (sodium) | 1198-77-2 | Reference compound |
| HY-B2130R | Uric acid (Standard) | 69-93-2 | Reference Standards |
| HY-B2130S | Uric acid-13C,15N3 | 2421217-23-2 | Isotope-Labeled Compounds |
| HY-B2130S1 | Uric acid-15N2 | 62948-75-8 | Isotope-Labeled Compounds |
| HY-B2130S2 | Uric acid-13C5 | Isotope-Labeled Compounds | |
| HY-B2131 | Iminodibenzyl | 494-19-9 | Biochemical Assay Reagents |
| HY-B2132 | Tryptamine | 61-54-1 | Natural Products |
| HY-B2132S | Tryptamine-d2 (hydrochloride) | 362049-48-7 | Isotope-Labeled Compounds |
| HY-B2132S1 | Tryptamine-d4 (hydrochloride) | 340257-60-5 | Isotope-Labeled Compounds |
| HY-B2133 | Cloperastine (hydrochloride) | 14984-68-0 | Reference compound |
| HY-B2133R | Cloperastine (hydrochloride) (Standard) | 14984-68-0 | Reference Standards |
| HY-B2134 | Casanthranol | 8024-48-4 | Natural Products |
| HY-B2136 | Tannic acid | 1401-55-4 | Natural Products |
| HY-B2136R | Tannic acid (Standard) | 1401-55-4 | Reference Standards |
| HY-B2137 | S-(+)-Ketoprofen | 22161-81-5 | Reference compound |
| HY-B2137R | S-(+)-Ketoprofen (Standard) | 22161-81-5 | Reference Standards |
| HY-B2137S | S-(+)-Ketoprofen-d3 | 2747914-77-6 | Isotope-Labeled Compounds |
| HY-B2138 | Ethopabate | 59-06-3 | Reference compound |
| HY-B2138R | Ethopabate (Standard) | 59-06-3 | Reference Standards |
| HY-B2140 | Multifungin | 3679-64-9 | Reference compound |
| HY-B2141 | Bendazol | 621-72-7 | Reference compound |
| HY-B2142 | Chlorbicyclen | 2550-75-6 | Reference compound |
| HY-B2143 | Montmorillonite | 1318-93-0 | Reference compound |
| HY-B2144A | Chitosan (MW 150000) | 9012-76-4 | Reference compound |
| HY-B2144B | Chitosan (MW 30000) | 9012-76-4 | Reference compound |
| HY-B2144C | Chitosan (≥95% deacetylated,viscosity 100-200 mPa.s) | 9012-76-4 | Biochemical Assay Reagents |
| HY-B2144E | Chitosan (≥90% deacetylated, Low viscosity,<200mPa.s) | 9012-76-4 | Biochemical Assay Reagents |
| HY-B2144F | Chitosan (≥80% deacetylated, Medium viscosity,200-400mPa.s) | 9012-76-4 | Biochemical Assay Reagents |
| HY-B2144G | Chitosan (≥80% deacetylated, High viscosity,>400mPa.s) | 9012-76-4 | Biochemical Assay Reagents |
| HY-B2144H | Chitosan hydrochloride (80%-90% deacetylated) | 70694-72-3 | Biochemical Assay Reagents |
| HY-B2144I | Chitosan (≥90% deacetylated,viscosity 10 mPa.s) | 9012-76-4 | Biochemical Assay Reagents |
| HY-B2144J | Chitosan (≥90% deacetylated,viscosity 650-700 mPa.s) | 9012-76-4 | Biochemical Assay Reagents |
| HY-B2144K | Chitosan (≥85% deacetylated, viscosity>90 mPa.s, MW 15000) | 9012-76-4 | Biochemical Assay Reagents |
| HY-B2145 | Ilaprazole (sodium) | 172152-50-0 | Reference compound |
| HY-B2145A | Ilaprazole (sodium hydrate) | 2322264-11-7 | Reference compound |
| HY-B2147 | 2-Aminobenzenesulfonamide | 3306-62-5 | Reference compound |
| HY-B2148 | Myclobutanil | 88671-89-0 | Reference compound |
| HY-B2148R | Myclobutanil (Standard) | 88671-89-0 | Reference Standards |
| HY-B2149 | Quadrol | 102-60-3 | Reference compound |
| HY-B2150 | 4-Hydroxyantipyrine | 1672-63-5 | Reference compound |
| HY-B2150R | 4-Hydroxyantipyrine (Standard) | 1672-63-5 | Reference Standards |
| HY-B2150S | 4-Hydroxyantipyrine-d3 | 65566-65-6 | Isotope-Labeled Compounds |
| HY-B2151 | Digitoxigenin | 143-62-4 | Natural Products |
| HY-B2152 | Hemicholinium 3 | 312-45-8 | Reference compound |
| HY-B2153 | Tetraethylenepentamine (pentahydrochloride) | 4961-41-5 | Biochemical Assay Reagents |
| HY-B2154 | Loxiglumide | 107097-80-3 | Reference compound |
| HY-B2155 | Acotiamide (monohydrochloride trihydrate) | 773092-05-0 | Reference compound |
| HY-B2155R | Acotiamide (monohydrochloride trihydrate) (Standard) | 773092-05-0 | Reference Standards |
| HY-B2156 | Menaquinone-4 | 863-61-6 | Natural Products |
| HY-B2156R | Menaquinone-4 (Standard) | 863-61-6 | Reference Standards |
| HY-B2156S | Menaquinone-4-d7 | 1233937-25-1 | Isotope-Labeled Compounds |
| HY-B2156S1 | Menaquinone-4-13C6 | Isotope-Labeled Compounds | |
| HY-B2157 | Robenidine hydrochloride | 25875-50-7 | Reference compound |
| HY-B2157R | Robenidine hydrochloride (Standard) | 25875-50-7 | Reference Standards |
| HY-B2157S | Robenidine-d8 (hydrochloride) | 1173097-77-2 | Isotope-Labeled Compounds |
| HY-B2158 | Chlorotrianisene | 569-57-3 | Reference compound |
| HY-B2158R | Chlorotrianisene (Standard) | 569-57-3 | Reference Standards |
| HY-B2158S | Chlorotrianisene-d9 | 1276197-26-2 | Isotope-Labeled Compounds |
| HY-B2162 | Chondroitin sulfate | 9007-28-7 | Natural Products |
| HY-B2162A | Chondroitin sulfate sodium (from shark cartilage) | 9082-07-9 | Biochemical Assay Reagents |
| HY-B2162B | Chondroitin sulfate (from bovine) | 9007-28-7 | Biochemical Assay Reagents |
| HY-B2162C | Chondroitin sulfate (from pig) | 9007-28-7 | Biochemical Assay Reagents |
| HY-B2162D | Chondroitin sulfate (from chicken) | 9007-28-7 | Biochemical Assay Reagents |
| HY-B2162E | Chondroitin sulfate (from shark cartilage) | 9007-28-7 | Biochemical Assay Reagents |
| HY-B2163 | Astaxanthin | 472-61-7 | Natural Products |
| HY-B2165 | Bendazac L-Lysine | 81919-14-4 | Reference compound |
| HY-B2167 | Docosahexaenoic acid | 6217-54-5 | Natural Products |
| HY-B2167R | Docosahexaenoic acid (Standard) | 6217-54-5 | Reference Standards |
| HY-B2167S | Docosahexaenoic acid-d5 | 1197205-71-2 | Isotope-Labeled Compounds |
| HY-B2167S2 | Docosahexaenoic acid-13C4 | Isotope-Labeled Compounds | |
| HY-B2168 | Mequitazine | 29216-28-2 | Reference compound |
| HY-B2168R | Mequitazine (Standard) | 29216-28-2 | Reference Standards |
| HY-B2168S | Mequitazine-d8 (hydrobromide) | Isotope-Labeled Compounds | |
| HY-B2169 | Melperone | 3575-80-2 | Reference compound |
| HY-B2169R | Melperone (Standard) | 3575-80-2 | Reference Standards |
| HY-B2169S2 | Melperone-d4 (hydrochloride) | 1219798-80-7 | Isotope-Labeled Compounds |
| HY-B2170 | Octenidine | 71251-02-0 | Reference compound |
| HY-B2170A | Octenidine (dihydrochloride) | 70775-75-6 | Reference compound |
| HY-B2170B | Octenidine (saccharin) | 86767-75-1 | Reference compound |
| HY-B2171 | Carubicin | 50935-04-1 | Natural Products |
| HY-B2171A | Carubicin (hydrochloride) | 52794-97-5 | Natural Products |
| HY-B2171AR | Carubicin (hydrochloride) (Standard) | 52794-97-5 | Reference Standards |
| HY-B2172 | Vitamin K | 12001-79-5 | Natural Products |
| HY-B2173 | Thiamine disulfide (dinitrate) | 109125-52-2 | Biochemical Assay Reagents |
| HY-B2174 | Ethacridine (lactate) | 1837-57-6 | Reference compound |
| HY-B2175 | Aspirin Aluminum | 23413-80-1 | Reference compound |
| HY-B2176 | ATP | 56-65-5 | Natural Products |
| HY-B2176A | ATP (disodium trihydrate) | 51963-61-2 | Natural Products |
| HY-B2176B | ATP (dimagnesium) | 74804-12-9 | Biochemical Assay Reagents |
| HY-B2176C | ATP (dipotassium) | 42373-41-1 | Oligonucleotides |
| HY-B2176D | ATP (ditromethamine) | 102047-34-7 | Oligonucleotides |
| HY-B2176E | ATP (magnesium) | 1476-84-2 | Reference compound |
| HY-B2176R | ATP (Standard) | 56-65-5 | Reference Standards |
| HY-B2176S | ATP-13C10,15N5 | 752972-20-6 | Isotope-Labeled Compounds |
| HY-B2176S2 | ATP-13C (dilithium) | Isotope-Labeled Compounds | |
| HY-B2176S3 | ATP-15N5,d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-B2176S4 | ATP-d14 (dilithium) | Isotope-Labeled Compounds | |
| HY-B2176S5 | ATP-15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-B2176S6 | ATP-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-B2177 | Apronal | 528-92-7 | Reference compound |
| HY-B2177R | Apronal (Standard) | 528-92-7 | Reference Standards |
| HY-B2178 | Emedastine (difumarate) | 87233-62-3 | Reference compound |
| HY-B2178R | Emedastine (difumarate) (Standard) | 87233-62-3 | Reference Standards |
| HY-B2179 | Cloperastine fendizoate | 85187-37-7 | Reference compound |
| HY-B2181 | Bismuth subnitrate | 1304-85-4 | Reference compound |
| HY-B2182 | Bismuth subcarbonate | 5892-10-4 | Reference compound |
| HY-B2182R | Bismuth subcarbonate (Standard) | 5892-10-4 | Reference Standards |
| HY-B2184 | Sofalcone | 64506-49-6 | Reference compound |
| HY-B2184R | Sofalcone (Standard) | 64506-49-6 | Reference Standards |
| HY-B2184S | Sofalcone-d4 | Isotope-Labeled Compounds | |
| HY-B2186 | Piperazine adipate | 142-88-1 | Reference compound |
| HY-B2186R | Piperazine adipate (Standard) | 142-88-1 | Reference Standards |
| HY-B2187 | Diacetazotol | 83-63-6 | Reference compound |
| HY-B2188 | S-Methyl-L-cysteine | 1187-84-4 | Natural Products |
| HY-B2191 | Sodium gualenate | 6223-35-4 | Reference compound |
| HY-B2191R | Sodium gualenate (Standard) | 6223-35-4 | Reference Standards |
| HY-B2192 | Amylase | 9000-92-4 | Natural Products |
| HY-B2192A | Diastase, Aspergillus oryzae | 9000-92-4 | Enzyme |
| HY-B2193 | α-Amylase | 9000-90-2 | Natural Products |
| HY-B2193A | α-Amylase, Human Saliva | 9000-90-2 | Enzyme |
| HY-B2193B | α-Amylase, Human Pancreas | 9000-90-2 | Enzyme |
| HY-B2193C | α-Amylase, Porcine Pancreatic | 9000-90-2 | Enzyme |
| HY-B2194 | γ-Oryzanol | 11042-64-1 | Natural Products |
| HY-B2195 | Aldioxa | 5579-81-7 | Reference compound |
| HY-B2196 | Gastric mucin | 84082-64-4 | Biochemical Assay Reagents |
| HY-B2200 | Calcium citrate tetrahydrate, 99% | 5785-44-4 | Biochemical Assay Reagents |
| HY-B2201 | Citric acid (trisodium) | 68-04-2 | Biochemical Assay Reagents |
| HY-B2203 | Monocalcium glycerophosphate | 27214-00-2 | Biochemical Assay Reagents |
| HY-B2203A | Calcium glycerophosphate | 1336-00-1 | Biochemical Assay Reagents |
| HY-B2205 | Magnesium silicate | 1343-88-0 | Reference compound |
| HY-B2206 | Gefarnate | 51-77-4 | Reference compound |
| HY-B2208 | Glycol salicylate | 87-28-5 | Reference compound |
| HY-B2208R | Glycol salicylate (Standard) | 87-28-5 | Reference Standards |
| HY-B2209 | Hydroxocobalamin | 13422-51-0 | Reference compound |
| HY-B2209A | Hydroxocobalamin (monohydrochloride) | 59461-30-2 | Reference compound |
| HY-B2209AR | Hydroxocobalamin (monohydrochloride) (Standard) | 59461-30-2 | Reference Standards |
| HY-B2209B | Hydroxocobalamin (acetate) | 22465-48-1 | Reference compound |
| HY-B2209BR | Hydroxocobalamin (acetate) (Standard) | 22465-48-1 | Reference Standards |
| HY-B2209R | Hydroxocobalamin (Standard) | 13422-51-0 | Reference Standards |
| HY-B2210 | Diisopropylammonium (dichloroacetate) | 660-27-5 | Biochemical Assay Reagents |
| HY-B2212 | Dibenzoyl Thiamine | 299-88-7 | Reference compound |
| HY-B2215 | Dimemorfan (phosphate) | 36304-84-4 | Reference compound |
| HY-B2217 | Calcium hydroxide | 1305-62-0 | Reference compound |
| HY-B2217D | Calcium hydroxide, ACS, 95% | 1305-62-0 | Biochemical Assay Reagents |
| HY-B2218D | Magnesium hydroxide, 99%(KT) | 1309-42-8 | Biochemical Assay Reagents |
| HY-B2219 | Stearic acid | 57-11-4 | Natural Products |
| HY-B2219A | Calcium stearate | 1592-23-0 | Reference compound |
| HY-B2219R | Stearic acid (Standard) | 57-11-4 | Reference Standards |
| HY-B2219S | Stearic acid-1-13C | 85541-42-0 | Isotope-Labeled Compounds |
| HY-B2219S1 | Stearic acid-d2 | 19905-58-9 | Isotope-Labeled Compounds |
| HY-B2219S2 | Stearic acid-13C18 | 287100-83-8 | Isotope-Labeled Compounds |
| HY-B2219S3 | Stearic acid-d3 | 62163-39-7 | Isotope-Labeled Compounds |
| HY-B2219S4 | Stearic Acid-d35 | 17660-51-4 | Isotope-Labeled Compounds |
| HY-B2219S5 | Stearic acid-9,10-d2 | 57396-97-1 | Isotope-Labeled Compounds |
| HY-B2219S6 | Stearic acid-d5 | 211443-83-3 | Isotope-Labeled Compounds |
| HY-B2219S7 | Stearic acid-d4 | 130048-57-6 | Isotope-Labeled Compounds |
| HY-B2219S8 | Stearic acid-d1 | 62163-41-1 | Isotope-Labeled Compounds |
| HY-B2219S9 | Stearic acid-d7 | 951209-59-9 | Isotope-Labeled Compounds |
| HY-B2220 | Cellulase | 9012-54-8 | Natural Products |
| HY-B2220A | Cellulase R-10 from Trichoderma Vride | 9012-54-8 | Enzyme |
| HY-B2220B | Thermostable cellulase (recombinant) | 9012-54-8 | Enzyme |
| HY-B2221 | Cellulose | 9004-34-6 | Biochemical Assay Reagents |
| HY-B2221B | Hydroxyethyl cellulose | 9004-62-0 | Reference compound |
| HY-B2221B1 | Hydroxyethyl cellulose, Viscosity(2%):150mPa.s | 9004-62-0 | Biochemical Assay Reagents |
| HY-B2221B2 | Hydroxyethyl cellulose, Viscosity(2%):40000mPa.s | 9004-62-0 | Biochemical Assay Reagents |
| HY-B2221B3 | Hydroxyethyl cellulose, Viscosity(2%):6000mPa.s | 9004-62-0 | Biochemical Assay Reagents |
| HY-B2221C | CM Cellulose CM-32 | 9000-11-7 | Biochemical Assay Reagents |
| HY-B2221S | U-13C Cellulose high DP from potato | Isotope-Labeled Compounds | |
| HY-B2221S1 | U-13C Cellulose from chicory | Isotope-Labeled Compounds | |
| HY-B2221S2 | U-13C Cellulose high DP from wheat | Isotope-Labeled Compounds | |
| HY-B2221S3 | U-13C Cellulose high DP from maize | Isotope-Labeled Compounds | |
| HY-B2221S4 | U-13C Cellulose high DP from maize (high purity) | Isotope-Labeled Compounds | |
| HY-B2221S5 | U-13C Cellulose from broccoli | Isotope-Labeled Compounds | |
| HY-B2223 | Thiamine nitrate | 532-43-4 | Reference compound |
| HY-B2223R | Thiamine nitrate (Standard) | 532-43-4 | Reference Standards |
| HY-B2224 | Thiamine disulfide | 67-16-3 | Reference compound |
| HY-B2224R | Thiamine disulfide (Standard) | 67-16-3 | Reference Standards |
| HY-B2225A | Starch (from potato) | 9005-25-8 | Biochemical Assay Reagents |
| HY-B2225AS | Starch-13C12 (from potato) | Isotope-Labeled Compounds | |
| HY-B2225B | Starch (from corn) | 9005-25-8 | Biochemical Assay Reagents |
| HY-B2225C | Starch (pregelatinized) | 9005-25-8 | Reference compound |
| HY-B2226 | Sodium copper chlorophyllin B | 28302-36-5 | Reference compound |
| HY-B2226R | Sodium copper chlorophyllin B (Standard) | 28302-36-5 | Reference Standards |
| HY-B2227 | Lactate | 50-21-5 | Natural Products |
| HY-B2227A | Lactate (calcium) | 814-80-2 | Reference compound |
| HY-B2227B | Lactate (sodium) (60% in water) | 72-17-3 | Reference compound |
| HY-B2227BS | Lactate-d4 (sodium) (60% in water) | 344299-52-1 | Isotope-Labeled Compounds |
| HY-B2227BS1 | Lactate-d3 (sodium) (60% in water) | 1219802-24-0 | Isotope-Labeled Compounds |
| HY-B2227BS3 | Lactate-13C-1 (sodium) (20% in water) | 201595-70-2 | Isotope-Labeled Compounds |
| HY-B2227C | Lactate (potassium),60% in water | 996-31-6 | Reference compound |
| HY-B2227D | Calcium 2-hydroxypropanoate (pentahydrate) | 5743-47-5 | Biochemical Assay Reagents |
| HY-B2227F | Lactate-Biotin | Dye Reagents | |
| HY-B2227R | Lactate (Standard) | 50-21-5 | Reference Standards |
| HY-B2228 | Proteinase, Aspergillus oryzae | 9001-92-7 | Enzyme |
| HY-B2229 | Sulbutiamine | 3286-46-2 | Reference compound |
| HY-B2229R | Sulbutiamine (Standard) | 3286-46-2 | Reference Standards |
| HY-B2229S | Sulbutiamine-d14 | 2749973-05-3 | Isotope-Labeled Compounds |
| HY-B2230 | Hinokitiol | 499-44-5 | Natural Products |
| HY-B2232 | Benzalkonium (chloride) (51% in water) | 8001-54-5 | Reference compound |
| HY-B2233 | Phosphorylcholine (chloride) | 107-73-3 | Reference compound |
| HY-B2233A | Calcium phosphorylcholine chloride, 98% | 4826-71-5 | Biochemical Assay Reagents |
| HY-B2233AS | Calcium phosphorylcholine-d9 (chloride) | 344299-43-0 | Isotope-Labeled Compounds |
| HY-B2233B | Phosphorylcholine | 3616-04-4 | Natural Products |
| HY-B2234 | Povidone iodine | 25655-41-8 | Reference compound |
| HY-B2235 | Lecithin | 8002-43-5 | Natural Products |
| HY-B2235A | L-α-Lecithin (egg yolk), 75% | 8002-43-5 | Biochemical Assay Reagents |
| HY-B2235B | L-α-Lecithin (egg yolk, Type XVI-E), 99% | 8002-43-5 | Biochemical Assay Reagents |
| HY-B2235C | L-α-Lecithin (soybean) | 8002-43-5 | Biochemical Assay Reagents |
| HY-B2236 | DL-Lysine | 70-54-2 | Natural Products |
| HY-B2236A | DL-Lysine (monohydrate) | 885701-25-7 | Reference compound |
| HY-B2236S | DL-Lysine-d4 (dihydrochloride) | 284664-88-6 | Isotope-Labeled Compounds |
| HY-B2236S1 | DL-Lysine-13C6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B2236S2 | DL-Lysine-13C6,15N2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B2236S3 | DL-Lysine-15N2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B2237 | Lysozyme from chicken egg white | 12650-88-3 | Natural Products |
| HY-B2237A | Lysozyme chloride | 9066-59-5 | Enzyme |
| HY-B2239 | Riboflavin Tetrabutyrate | 752-56-7 | Reference compound |
| HY-B2239R | Riboflavin Tetrabutyrate (Standard) | 752-56-7 | Reference Standards |
| HY-B2241A | Potassiumalum, for cell culture | 7784-24-9 | Biochemical Assay Reagents |
| HY-B2242 | Calcium phosphate | 7757-93-9 | Reference compound |
| HY-B2242A | Calcium phosphate (Excipient) | 7757-93-9 | Reference compound |
| HY-B2242B | Calcium hydrogen phosphate, 98% | 7757-93-9 | Biochemical Assay Reagents |
| HY-B2243 | Anhydrous sodium dihydrogen phosphate | 7558-80-7 | Reference compound |
| HY-B2243A | Anhydrous sodium dihydrogen phosphate, for HPLC | 7558-80-7 | Biochemical Assay Reagents |
| HY-B2243B | Anhydrous sodium dihydrogen phosphate, for molecular biology | 7558-80-7 | Biochemical Assay Reagents |
| HY-B2243BR | Anhydrous sodium dihydrogen phosphate, for molecular biology (Standard) | 7558-80-7 | Reference Standards |
| HY-B2243D | Anhydrous sodium dihydrogen phosphate, for cell culture | 7558-80-7 | Biochemical Assay Reagents |
| HY-B2243H | Anhydrous sodium dihydrogen phosphate, meets USP testing specifications | 7558-80-7 | Biochemical Assay Reagents |
| HY-B2244 | Tacrine (hydrochloride) (hydrate) | 206658-92-6 | Reference compound |
| HY-B2244R | Tacrine (hydrochloride) (hydrate) (Standard) | 206658-92-6 | Reference Standards |
| HY-B2245 | Estradiol dipropionate | 113-38-2 | Reference compound |
| HY-B2246 | L-Carnitine (hydrochloride) | 6645-46-1 | Natural Products |
| HY-B2246R | L-Carnitine (hydrochloride) (Standard) | 6645-46-1 | Reference Standards |
| HY-B2246S | L-Carnitine-d9 (chloride) | 2687961-04-0 | Isotope-Labeled Compounds |
| HY-B2247 | PLGA (50:50) | 34346-01-5 | Oligonucleotides |
| HY-B2247A | PLGA (75:25) | 34346-01-5 | Reference compound |
| HY-CE00001 | (2R,3S)-3-Fluoro-2-methylhexadecanoyl-CoA | Enzyme | |
| HY-CE00002 | (15Z)-3-Oxotetracosenoyl-CoA | Enzyme | |
| HY-CE00003 | (15Z)-Tetracosenoyl-CoA | 88362-35-0 | Enzyme |
| HY-CE00004 | (1-Hydroxycyclohexan-1-yl)acetyl-CoA | Enzyme | |
| HY-CE00004A | (1-Hydroxycyclohexyl)acetyl-CoA | 880544-92-3 | Enzyme |
| HY-CE00005 | (15Z,18Z,21Z,24Z)-3-Oxotriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00006 | (1-Methylpentyl)succinyl-CoA | Enzyme | |
| HY-CE00008 | (2-Trans,6-cis)-dodeca-2,6-dienoyl-CoA | Enzyme | |
| HY-CE00009B | (10E,12Z)-Hexadecadienoyl-CoA | Enzyme | |
| HY-CE00010A | (20Z,23Z,26Z,29Z,32Z)-Octatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00011 | (11Z,14Z,17Z,20Z)-3-Oxohexacosatetraenoyl-CoA | Enzyme | |
| HY-CE00012 | (11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA | Enzyme | |
| HY-CE00013A | (21Z,24Z,27Z,30Z)-3-Oxohexatriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00014 | (11Z,14Z,17Z,20Z,23Z)-3-Oxohexacosapentaenoyl-CoA | Enzyme | |
| HY-CE00015 | (11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA | Enzyme | |
| HY-CE00016 | (21Z,24Z,27Z,30Z)-Hexatriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00018 | (12Z,15Z,18Z,21Z)-3-Oxotetracosatetraenoyl-CoA | Enzyme | |
| HY-CE00019 | (10Z,13Z)-Nonadecadienoyl-CoA | Enzyme | |
| HY-CE00020 | (21Z,24Z,27Z,30Z,33Z)-3-Oxohexatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00021 | (10Z,13Z,16Z)-3-Oxodocosatrienoyl-CoA | Enzyme | |
| HY-CE00022 | (15Z,18Z,21Z,24Z,27Z)-Triacontapentaenoyl-CoA | Enzyme | |
| HY-CE00023 | (12Z,15Z,18Z,21Z)-Tetracosatetraenoyl-CoA | Enzyme | |
| HY-CE00024 | (21Z,24Z,27Z,30Z,33Z)-Hexatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00025A | (10Z,13Z,16Z)-Docosatrienoyl-CoA | Enzyme | |
| HY-CE00027 | (12Z,15Z,18Z,21Z,24Z)-Triacontapentaenoyl-CoA | Enzyme | |
| HY-CE00028 | (15Z,18Z,21Z,24Z)-Triacontatetraenoyl-CoA | Enzyme | |
| HY-CE00029 | (23Z,26Z,29Z,32Z)-3-Oxooctatriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00030 | (12Z,15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00031 | (10Z,13Z,16Z,19Z)-3-Oxodocosatetraenoyl-CoA | Enzyme | |
| HY-CE00032 | (23Z,26Z,29Z,32Z)-Octatriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00033 | (12Z,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA | Enzyme | |
| HY-CE00034 | (15Z,18Z,21Z,24Z,27Z)-3-Oxotriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00035 | (23Z,26Z,29Z,32Z,35Z)-3-Oxooctatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00036A | (10Z,13Z,16Z,19Z)-Docosatetraenoyl-CoA | Enzyme | |
| HY-CE00037 | (13Z)-3-Oxodocosenoyl-CoA | Enzyme | |
| HY-CE00038 | (23Z,26Z,29Z,32Z,35Z)-Octatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00039A | (10Z,13Z,16Z,19Z,22Z)-Octacosapentaenoyl-CoA | Enzyme | |
| HY-CE00040 | (24E)-3Alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-en-26-oyl-CoA | Enzyme | |
| HY-CE00041A | (10Z,13Z,16Z,19Z,22Z,25Z)-3-Oxooctacosahexaenoyl-CoA | Enzyme | |
| HY-CE00042 | (16Z,19Z,22Z,25Z,28Z)-Tetratriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00043 | (16Z,19Z,22Z,25Z,28Z,31Z)-3-Oxotetratriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00044 | (13Z)-3-Oxoicosenoyl-CoA | Enzyme | |
| HY-CE00045A | (10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA | Enzyme | |
| HY-CE00046 | (24E)-3Alpha,7alpha-dihydroxy-5beta-cholest-24-en-26-oyl-CoA | Enzyme | |
| HY-CE00047 | (16Z,19Z,22Z,25Z,28Z,31Z)-Tetratriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00049 | (17Z)-Hexacosenoyl-CoA | Enzyme | |
| HY-CE00051A | (11E)-Octadecenoyl-CoA | 13673-89-7 | Enzyme |
| HY-CE00052 | (17Z,20Z,23Z,26Z)-3-Oxodotriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00053 | (24R,25R)-3Alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oyl-CoA | Enzyme | |
| HY-CE00054 | (13Z)-Icosenoyl-CoA | Enzyme | |
| HY-CE00055 | (17Z,20Z,23Z,26Z)-Dotriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00056 | (24R,25R)-3Alpha,7alpha,24-trihydroxy-5beta-cholestan-26-oyl-CoA | Enzyme | |
| HY-CE00057 | (13Z,16Z)-Docosadi-13,16-enoyl-CoA | Enzyme | |
| HY-CE00058A | (11E,13Z)-Octadecadienoyl-CoA | Enzyme | |
| HY-CE00059 | (17Z,20Z,23Z,26Z,29Z)-3-Oxodotriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00060 | (13Z,16Z,19Z)-3-Oxodocosatrienoyl-CoA | Enzyme | |
| HY-CE00062 | (17Z,20Z,23Z,26Z,29Z)-Dotriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00064A | (11Z)-18-Hydroxyoctadecenoyl-CoA | Enzyme | |
| HY-CE00065 | (25S)-3-Oxocholest-4-en-26-oyl-CoA | Enzyme | |
| HY-CE00066A | (11Z)-3-Oxohexadecenoyl-CoA | Enzyme | |
| HY-CE00067 | (13Z,16Z,19Z,22Z)-3-Oxooctacosatetraenoyl-CoA | Enzyme | |
| HY-CE00068A | (11Z)-3-Oxoicosa-11-enoyl-CoA | Enzyme | |
| HY-CE00069 | (13Z,16Z,19Z,22Z)-Octacosatetraenoyl-CoA | Enzyme | |
| HY-CE00070 | (11Z)-3-Oxooctadecenoyl-CoA | Enzyme | |
| HY-CE00071 | (13Z,16Z,19Z,22Z,25Z)-3-Oxooctacosapentaenoyl-CoA | Enzyme | |
| HY-CE00072 | (11Z)-Eicosenoyl-CoA | Enzyme | |
| HY-CE00073 | (11Z)-Hexadec-11-enoyl-CoA | 154826-81-0 | Enzyme |
| HY-CE00074 | (25S)-3Alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA | Enzyme | |
| HY-CE00075 | (13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA | Enzyme | |
| HY-CE00076 | (18Z,21Z,24Z,27Z,30Z)-Hexatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00077 | (25S)-3Beta-hydroxy-5-cholesten-26-oyl-CoA | Enzyme | |
| HY-CE00078 | (18Z,21Z,24Z,27Z,30Z,33Z)-3-Oxohexatriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00079 | (18Z,21Z,24Z,27Z,30Z,33Z)-Hexatriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00080A | (11Z)-Tetradecenoyl-CoA | Enzyme | |
| HY-CE00081 | (19Z,22Z,25Z,28Z)-3-Oxotetratriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00082 | (2E)-2-Methylbutenoyl-CoA | Enzyme | |
| HY-CE00084 | (14Z)-Tetradecenoyl-CoA | Enzyme | |
| HY-CE00085 | (19Z,22Z,25Z,28Z)-Tetratriacontatetraenoyl-CoA | Enzyme | |
| HY-CE00086 | (14E)-Hexadecenoyl-CoA | Enzyme | |
| HY-CE00086B | (14Z)-Hexadecenoyl-CoA | Enzyme | |
| HY-CE00087 | (19Z,22Z,25Z,28Z,31Z)-3-Oxotetratriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00089 | (19Z,22Z,25Z,28Z,31Z)-Tetratriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00091 | (1R)-(Methylenecyclopropyl)acetyl-CoA | Enzyme | |
| HY-CE00091A | (1S)-(Methylenecyclopropyl)acetyl-CoA | Enzyme | |
| HY-CE00093 | (14Z,17Z,20Z,23Z,26Z)-Dotriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00094A | (11Z,14Z)-3-Oxoicosa-11,14-dienoyl-CoA | Enzyme | |
| HY-CE00096 | (2E)-3-(2,4-Dihydroxyphenyl)prop-2-enoyl-CoA | Enzyme | |
| HY-CE00097 | (14Z,17Z,20Z,23Z,26Z,29Z)-3-Oxodotriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00098 | (2E)-5-Methylhexa-2,4-dienoyl-CoA | Enzyme | |
| HY-CE00100 | (2E)-Octadecenoyl-CoA | Enzyme | |
| HY-CE00101 | (14Z,17Z,20Z,23Z,26Z,29Z)-Dotriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00102 | (2E)-Butenoyl-CoA | Enzyme | |
| HY-CE00103 | (11Z,14Z)-Icosadienoyl-CoA | Enzyme | |
| HY-CE00104 | (2,3,3-Trimethyl-5-oxocyclopent-3-enyl)acetyl-CoA | Enzyme | |
| HY-CE00108 | (2-Sulfanyl-3-phenylpropanoyl)-phe-tyr-CoA | Enzyme | |
| HY-CE00109 | (2E)-Hexacosenoyl-CoA | Enzyme | |
| HY-CE00112A | (11Z,14Z,17Z)-3-Oxoicosatrienoyl-CoA | Enzyme | |
| HY-CE00114 | (2E)-Hexadecenedioyl-CoA | Enzyme | |
| HY-CE00115 | (2E)-Pentenoyl-CoA | Enzyme | |
| HY-CE00116 | (11Z,14Z,17Z)-Icosatrienoyl-CoA | Enzyme | |
| HY-CE00118A | (2E)-Tetradecenedioyl-CoA | 138149-23-2 | Enzyme |
| HY-CE00119 | (2R)-2-Methyltetradecanoyl-CoA | 157478-87-0 | Enzyme |
| HY-CE00120 | (3E)-tetradecenoyl-CoA | 429685-08-5 | Enzyme |
| HY-CE00121A | (2E,21Z,24Z,27Z,30Z,33Z)-Hexatriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00125 | (3E,5Z)-Tetradecadienoyl-CoA | 1038748-71-8 | Enzyme |
| HY-CE00126 | (2R)-Ethylmalonyl-CoA | Enzyme | |
| HY-CE00127 | (3E,5Z,8Z,11Z,14Z)-Icosapentaenoyl-CoA | Enzyme | |
| HY-CE00128A | (2E,23Z,26Z,29Z,32Z,35Z)-Octatriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00131 | (3E,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA | Enzyme | |
| HY-CE00132 | (3R)-3,5-Dihydroxy-3-methylpentanoyl-CoA | Enzyme | |
| HY-CE00133 | (3R)-3-Carboxy-3-hydroxypropanoyl-CoA | 37527-23-4 | Enzyme |
| HY-CE00134 | (2R)-Sulfonatepropionyl-CoA | 2353483-68-6 | Enzyme |
| HY-CE00135 | (2R)-Sulfonatepropionyl-amino(dethia)-CoA | 2396507-34-7 | Enzyme |
| HY-CE00136 | (3R)-3-Isopropenyl-6-oxoheptanoyl-CoA | 1245946-20-6 | Enzyme |
| HY-CE00140 | (2S)-2,6-Dimethylheptanoyl-CoA | 204120-64-9 | Enzyme |
| HY-CE00143A | (2E,5E)-Tetradecadienoyl-CoA | 429673-51-8 | Enzyme |
| HY-CE00143C | (2E,5Z)-Tetradecadienoyl-CoA | Enzyme | |
| HY-CE00144 | (3R)-3-Hydroxyoctanoyl-CoA | 117249-49-7 | Enzyme |
| HY-CE00146 | (2E,5Z)-Dodecadieonyl-CoA | 164415-14-9 | Enzyme |
| HY-CE00149 | (2S)-2-Methylpentadecanoyl-CoA | 205369-74-0 | Enzyme |
| HY-CE00150 | (2S)-2-Methyltetradecanoyl-CoA | 157401-02-0 | Enzyme |
| HY-CE00151 | (2S)-Methylsuccinyl-CoA | 849618-59-3 | Enzyme |
| HY-CE00152 | (3R)-Citramalyl-CoA | 940911-58-0 | Enzyme |
| HY-CE00156 | (2S)-Pristanoyl-CoA | 883551-76-6 | Enzyme |
| HY-CE00158 | (2S)-Sulfonatepropionyl-CoA | 2396507-26-7 | Enzyme |
| HY-CE00160 | (2S)-Sulfonatepropionyl-amino(dethia)-CoA | 2396507-34-7 | Enzyme |
| HY-CE00162 | (2S,3R)-3-Fluoro-2-methylhexadecanoyl-CoA | Enzyme | |
| HY-CE00168A | (3R)-Hydroxyhexadecanedioyl-CoA | 138168-91-9 | Enzyme |
| HY-CE00170 | (2Z)-4-Carboxy-2-sulfanylbut-2-enoyl-CoA | Enzyme | |
| HY-CE00171 | (2Z)-5-Carboxy-2-sulfanylpent-2-enoyl-CoA | Enzyme | |
| HY-CE00172 | (3,4-Dihydroxyphenyl)propionyl-CoA | 920318-19-0 | Enzyme |
| HY-CE00175 | (3R,10Z,13Z,16Z,19Z,22Z,25Z)-3-Hydroxyoctacosahexaenoyl-CoA | Enzyme | |
| HY-CE00176 | (3-Hydroxybenzoyl)-CoA | 1809614-79-6 | Enzyme |
| HY-CE00178 | (3E)-Nonenoyl-CoA | 1883602-81-0 | Enzyme |
| HY-CE00179 | (3R,11Z)-3-Hydroxyicosenoyl-CoA | Enzyme | |
| HY-CE00180 | (3E)-Octenoyl-CoA | 6375-77-5 | Enzyme |
| HY-CE00181 | (3R,11Z)-3-hydroxyoctadecenoyl-CoA | Enzyme | |
| HY-CE00182 | (2S)-2-Hydroxy-2-(propan-2-yl)butanedioyl-CoA | Enzyme | |
| HY-CE00183 | (2S)-2-Hydroxyhexadecanoyl-CoA | Enzyme | |
| HY-CE00184 | (2S)-2-Hydroxyoctadecanoyl-CoA | 38861-93-7 | Enzyme |
| HY-CE00185 | (2S)-Methylmalonyl-CoA | 73173-91-8 | Enzyme |
| HY-CE00186 | (2S,6R,10R)-Trimethyl-hendecanoyl-CoA | Enzyme | |
| HY-CE00188A | (2E,14Z,17Z,20Z,23Z,26Z,29Z)-Dotriacontaheptaenoyl-CoA | Enzyme | |
| HY-CE00189A | (2E,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA | Enzyme | |
| HY-CE00190A | (2E,13Z,16Z,19Z,22Z)-Octacosapentaenoyl-CoA | Enzyme | |
| HY-CE00191A | (2E,13Z)-Icosadienoyl-CoA | Enzyme | |
| HY-CE00192A | (2E,13Z)-Docosadienoyl-CoA | Enzyme | |
| HY-CE00193A | (2E,12Z,15Z,18Z,21Z,24Z,27Z)-Triacontaheptaenoyl-CoA | Enzyme | |
| HY-CE00195A | (2E,11Z,14Z,17Z,20Z,23Z)-Hexacosahexaenoyl-CoA | Enzyme | |
| HY-CE00196A | (2E,11Z,14Z,17Z,20Z)-Hexacosapentaenoyl-CoA | Enzyme | |
| HY-CE00197A | (2E,11Z,14Z,17Z)-Icosatetraenoyl-CoA | 105831-42-3 | Enzyme |
| HY-CE00198A | (2E,11Z,14Z)-Icosatrienoyl-CoA | Enzyme | |
| HY-CE00199A | (2E,11Z)-Octadecadienoyl-CoA | Enzyme | |
| HY-CE00200A | (2E,10Z,13Z,16Z,19Z,22Z,25Z)-Octacosaheptaenoyl-CoA | Enzyme | |
| HY-CE00201A | (2E,23Z,26Z,29Z,32Z)-Octatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00203A | (2E,11Z)-Icosadienoyl-CoA | Enzyme | |
| HY-CE00205A | (2E,4E,8Z,11Z,14Z)-Icosapentaenoyl-CoA | 328408-15-7 | Enzyme |
| HY-CE00206 | (3R,11Z,14Z)-3-Hydroxyicosadienoyl-CoA | Enzyme | |
| HY-CE00207 | (3R,11Z,14Z,17Z)-3-Hydroxyicosatrienoyl-CoA | Enzyme | |
| HY-CE00208 | (3R,11Z,14Z,17Z,20Z)-3-Hydroxyhexacosatetraenoyl-CoA | Enzyme | |
| HY-CE00209 | (3R,11Z,14Z,17Z,20Z,23Z)-3-Hydroxyhexacosapentaenoyl-CoA | Enzyme | |
| HY-CE00211 | (3R,12Z,15Z,18Z,21Z,24Z,27Z)-3-Hydroxytriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00212A | (2E,15Z)-Tetracosadienoyl-CoA | Enzyme | |
| HY-CE00213 | (2S,5S)-5-Carboxymethylproline-CoA | 828922-94-7 | Enzyme |
| HY-CE00214 | (3R,13Z)-3-Hydroxydocosenoyl-CoA | Enzyme | |
| HY-CE00215 | (3R,13Z)-3-Hydroxyicosenoyl-CoA | Enzyme | |
| HY-CE00217 | (3R,13Z,16Z,19Z,22Z)-3-Hydroxyoctacosatetraenoyl-CoA | Enzyme | |
| HY-CE00218 | (2S,3R)-3-Hydroxy-2-methylpentanedioyl-CoA | Enzyme | |
| HY-CE00219A | (2E,15Z,18Z,21Z,24Z)-Triacontapentaenoyl-CoA | Enzyme | |
| HY-CE00220A | (2E,5Z)-Octadienoyl-CoA | 207726-45-2 | Enzyme |
| HY-CE00221A | (2E,15Z,18Z,21Z,24Z,27Z)-Triacontahexaenoyl-CoA | Enzyme | |
| HY-CE00223A | (2E,16Z,19Z,22Z,25Z,28Z,31Z)-Tetratriacontaheptaenoyl-CoA | Enzyme | |
| HY-CE00225 | (2E,8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosaheptaenoyl-CoA | Enzyme | |
| HY-CE00226 | (2R)-2,6-Dimethylheptanoyl-CoA | 204120-64-9 | Enzyme |
| HY-CE00227 | (2E,9E)-Octadecadienoyl-CoA | Enzyme | |
| HY-CE00228A | (2E,17Z,20Z,23Z,26Z)-Dotriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00230 | (2E,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA | Enzyme | |
| HY-CE00231 | (2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexa-2,6,9,12,15,18-enoyl-CoA | Enzyme | |
| HY-CE00232A | (2E,17Z,20Z,23Z,26Z,29Z)-Dotriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00234A | (2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA | Enzyme | |
| HY-CE00235 | (2E,8Z,11Z,14Z)-Icosatetraenoyl-CoA | Enzyme | |
| HY-CE00236 | (2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahepta-2,6,9,12,15,18,21-enoyl-CoA | Enzyme | |
| HY-CE00237 | (2E,9Z,12Z)-Octadecatrienoyl-CoA | Enzyme | |
| HY-CE00238A | (2E,18Z,21Z,24Z,27Z,30Z,33Z)-Hexatriacontaheptaenoyl-CoA | Enzyme | |
| HY-CE00239A | (2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA | Enzyme | |
| HY-CE00240 | (2E,9Z)-Hexadecadienoyl-CoA | Enzyme | |
| HY-CE00241 | (2E,7Z)-Tetradecadienoyl-CoA | Enzyme | |
| HY-CE00242A | (2E,7Z)-Hexadecadienoyl-CoA | Enzyme | |
| HY-CE00243A | (2E,19Z,22Z,25Z,28Z)-Tetratriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00244 | (2E,9Z)-Octadecadienoyl-CoA | 61083-44-1 | Enzyme |
| HY-CE00245 | (2E,7Z,10Z)-Hexadecatrienoyl-CoA | Enzyme | |
| HY-CE00246A | (2E,19Z,22Z,25Z,28Z,31Z)-Tetratriacontahexaenoyl-CoA | Enzyme | |
| HY-CE00249A | (2E,21Z,24Z,27Z,30Z)-Hexatriacontapentaenoyl-CoA | Enzyme | |
| HY-CE00479 | (6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA | 676656-93-2 | Enzyme |
| HY-CP001 | D-Trehalose, Carrier Protein | 99-20-7 | Biochemical Assay Reagents |
| HY-CP002 | Bovine Serum Albumin, Carrier Protein | 9048-46-8 | Biochemical Assay Reagents |
| HY-D0001 | Alcian Blue 8GX | 33864-99-2 | Dye Reagents |
| HY-D0002 | 7-Amino-4-methylcoumarin (hydrogensulfate) | 207673-94-7 | Dye Reagents |
| HY-D0003 | Methyl Blue | 28983-56-4 | Dye Reagents |
| HY-D0004 | Azure B | 531-55-5 | Dye Reagents |
| HY-D0004R | Azure B (Standard) | 531-55-5 | Reference Standards |
| HY-D0006 | Bathophenanthroline | 1662-01-7 | Dye Reagents |
| HY-D0006A | Bathophenanthroline disulfonic acid (sodium) | 98645-86-4 | Dye Reagents |
| HY-D0007 | Blue Tetrazolium | 1871-22-3 | Biochemical Assay Reagents |
| HY-D0008 | Brilliant green | 633-03-4 | Biochemical Assay Reagents |
| HY-D0008R | Brilliant green (Standard) | 633-03-4 | Reference Standards |
| HY-D0009 | Bromocresol green (sodium) | 62625-32-5 | Dye Reagents |
| HY-D0010 | Bromopyrogallol red | 16574-43-9 | Dye Reagents |
| HY-D0011 | Brom0phenol blue (sodium) | 62625-28-9 | Biochemical Assay Reagents |
| HY-D0011A | Bromophenol red (sultone form) | 2800-80-8 | Dye Reagents |
| HY-D0012 | Bromothymol Blue | 76-59-5 | Dye Reagents |
| HY-D0012A | Bromothymol Blue (sodium) | 34722-90-2 | Biochemical Assay Reagents |
| HY-D0013 | Chlorophenol red | 4430-20-0 | Dye Reagents |
| HY-D0014 | Brilliant blue G-250 | 6104-58-1 | Biochemical Assay Reagents |
| HY-D0015 | Cresol red, 97% | 1733-12-6 | Dye Reagents |
| HY-D0015A | Cresol Red (sodium) | 62625-29-0 | Dye Reagents |
| HY-D0016 | 5-Cyano-2,3-di-(p-tolyl)tetrazolium chloride | 90217-02-0 | Dye Reagents |
| HY-D0017 | Dansyl chloride | 605-65-2 | Dye Reagents |
| HY-D0017S | Dansyl chloride-d6 | 1276379-68-0 | Isotope-Labeled Compounds |
| HY-D0018 | DCIP (sodium) | 620-45-1 | Dye Reagents |
| HY-D0018A | DCIP (hydrate sodium) | 283164-79-4 | Biochemical Assay Reagents |
| HY-D0018R | DCIP (sodium) (Standard) | 620-45-1 | Reference Standards |
| HY-D0020 | 2,2'-Bipyridine | 366-18-7 | Dye Reagents |
| HY-D0020R | 2,2'-Bipyridine (Standard) | 366-18-7 | Reference Standards |
| HY-D0021 | Ethidium (bromide) | 1239-45-8 | Dye Reagents |
| HY-D0022 | 5-Aminofluorescein | 3326-34-9 | Dye Reagents |
| HY-D0022A | 6-Aminofluorescein | 51649-83-3 | Dye Reagents |
| HY-D0023 | Pyranine | 6358-69-6 | Dye Reagents |
| HY-D0023A | Pyranine (hydrate) | Dye Reagents | |
| HY-D0024 | Sudan I | 842-07-9 | Dye Reagents |
| HY-D0024R | Sudan I (Standard) | 842-07-9 | Reference Standards |
| HY-D0025 | 7-Amino-4-methylcoumarin-3-acetic acid | 106562-32-7 | Dye Reagents |
| HY-D0026 | AMCA,SE | 113721-87-2 | Dye Reagents |
| HY-D0027 | 7-Amino-4-methylcoumarin | 26093-31-2 | Dye Reagents |
| HY-D0027R | 7-Amino-4-methylcoumarin (Standard) | 26093-31-2 | Dye Reagents |
| HY-D0028 | 6-(4-Acetamido-1,8-naphthalamido)hexanoic acid | 172227-59-7 | Dye Reagents |
| HY-D0029 | 5(6)-Aminofluorescein | 27599-63-9 | Dye Reagents |
| HY-D0030 | 2-Anthracenylsulfonyl chloride | 17407-98-6 | Dye Reagents |
| HY-D0031 | 8-Aminopyrene-1,3,6-trisulfonic acid (trisodium) | 196504-57-1 | Dye Reagents |
| HY-D0032 | DAF-2DA | 205391-02-2 | Dye Reagents |
| HY-D0033 | Roxyl-9 | 202582-08-9 | Reference compound |
| HY-D0034 | 9,10-Anthracenediyl-bis(methylene)dimalonic acid | 307554-62-7 | Dye Reagents |
| HY-D0035 | MPAC-Br | 177093-58-2 | Dye Reagents |
| HY-D0036 | Br-Mmc | 35231-44-8 | Dye Reagents |
| HY-D0037 | 5-Bromomethyl-fluorescein | 148942-72-7 | Dye Reagents |
| HY-D0038 | BTBCT | 525560-81-0 | Dye Reagents |
| HY-D0039 | 3-Cyanoumbelliferone | 19088-73-4 | Dye Reagents |
| HY-D0040 | Calcein | 1461-15-0 | Dye Reagents |
| HY-D0041 | Calcein-AM | 148504-34-1 | Dye Reagents |
| HY-D0042 | NBD-Cl | 10199-89-0 | Dye Reagents |
| HY-D0043 | 5(6)-ROX | 198978-94-8 | Dye Reagents |
| HY-D0044 | 5(6)-Carboxy-X-rhodamin N-succinimidyl ester | 114616-32-9 | Dye Reagents |
| HY-D0045 | 5-Carboxy-X-rhodamin N-succinimidyl ester | 209734-74-7 | Dye Reagents |
| HY-D0046 | Coumarin-6-sulfonyl chloride | 10543-42-7 | Biochemical Assay Reagents |
| HY-D0047 | 5-CFDA | 79955-27-4 | Dye Reagents |
| HY-D0048 | 5-TAMRA-SE | 150810-68-7 | Dye Reagents |
| HY-D0049 | 6-TAMRA-SE | 150810-69-8 | Dye Reagents |
| HY-D0050 | 5(6)-Carboxy-2',7'-dichlorofluorescein diacetate N-succinimidyl ester | 147265-60-9 | Dye Reagents |
| HY-D0051 | 5(6)-Carboxy-eosin | 132201-84-4 | Dye Reagents |
| HY-D0052 | 5(6)-Carboxyeosin-diacetate | 161338-87-0 | Dye Reagents |
| HY-D0053 | 6-ROX | 194785-18-7 | Dye Reagents |
| HY-D0053A | 6-ROX (hydrochloride) | 1689512-96-6 | Dye Reagents |
| HY-D0054 | 9-(2-Carboxy-2-cyanovinyl)julolidine | 142978-18-5 | Dye Reagents |
| HY-D0055 | 3-Cyano-7-ethoxycoumarin | 117620-77-6 | Dye Reagents |
| HY-D0056 | 5-Carboxyfluorescein diacetate N-succinimidyl ester | 150206-05-6 | Dye Reagents |
| HY-D0058 | 3,3'-Dipropylthiacarbocyanine (iodide) | 53336-12-2 | Dye Reagents |
| HY-D0059 | 4-(4,5-Diphenyl-1H-imidazol-2-yl)benzoyl chloride | 162756-62-9 | Dye Reagents |
| HY-D0060 | 4-Di-2-ASP | 105802-46-8 | Dye Reagents |
| HY-D0061 | 4-(7-Diethylaminocoumarin-3-yl)benzoyl cyanide | 203256-20-6 | Dye Reagents |
| HY-D0062 | (-)-8,8-Dichlorocampherylsulfonyl-oxaziridine | 139628-16-3 | Dye Reagents |
| HY-D0063 | 6,7-Diethoxy-4-methylcoumarin | 314744-06-4 | Dye Reagents |
| HY-D0064 | 6,7-Dihydroxy-4-coumarinylacetic acid | 88404-14-2 | Dye Reagents |
| HY-D0065 | 6,7-Dimethoxy-4-coumarinylacetic acid | 88404-26-6 | Dye Reagents |
| HY-D0066 | 7-Diethylaminocoumarin-3-carbohydrazide | 100343-98-4 | Dye Reagents |
| HY-D0067 | 7ACC1 | 50995-74-9 | Dye Reagents |
| HY-D0068 | DEAC, SE | 139346-57-9 | Dye Reagents |
| HY-D0069 | CPM | 76877-33-3 | Dye Reagents |
| HY-D0070 | DAF-2T | 208850-35-5 | Dye Reagents |
| HY-D0071 | N-4-(5,6-Dimethoxy-N-phthalimidinyl)phenylmaleimide | 143503-03-1 | Dye Reagents |
| HY-D0072 | 1-(Dichloro-1,3,5-triazinyl)-pyrene | 3224-36-0 | Dye Reagents |
| HY-D0073 | 2,3-Diaminonaphthalene | 771-97-1 | Dye Reagents |
| HY-D0074 | Prodan | 70504-01-7 | Dye Reagents |
| HY-D0075 | DHPDS (disodium salt) | 61255-63-8 | Dye Reagents |
| HY-D0076 | 4,5-Diaminofluorescein | 205391-01-1 | Dye Reagents |
| HY-D0077 | 2',7'-Difluorofluorescein | 195136-58-4 | Reference compound |
| HY-D0078 | DCIA | 76877-34-4 | Dye Reagents |
| HY-D0079 | Dihydroethidium | 104821-25-2 | Dye Reagents |
| HY-D0080 | Laurdan | 74515-25-6 | Dye Reagents |
| HY-D0081 | 4,5-Diamino-N,N,N',N'-tetraethyl-rhodamin | 261351-43-3 | Dye Reagents |
| HY-D0081A | 5,6-Diamino-N,N,N',N'-tetraethyl-rhodamin | 261351-45-5 | Dye Reagents |
| HY-D0082 | 7-Diethylamino-4-methylcoumarin | 91-44-1 | Dye Reagents |
| HY-D0082R | 7-Diethylamino-4-methylcoumarin (Standard) | 91-44-1 | Dye Reagents |
| HY-D0083 | DiI | 41085-99-8 | Dye Reagents |
| HY-D0084 | 3,3'-Dihexyloxacarbocyanine iodide | 53213-82-4 | Dye Reagents |
| HY-D0085 | DiSC3(5) | 53213-94-8 | Dye Reagents |
| HY-D0086 | DIDS (sodium salt) | 67483-13-0 | Dye Reagents |
| HY-D0087 | MDCC | 156571-46-9 | Dye Reagents |
| HY-D0088 | 7-Diethylamino-3-N-(4-maleimidopropyl)carbamoylcoumarin | 160291-54-3 | Dye Reagents |
| HY-D0089 | O'-(carboxymethyl)fluoresceinamide | 442151-50-0 | Dye Reagents |
| HY-D0090 | MQAE | 162558-52-3 | Dye Reagents |
| HY-D0091 | 7-Ethoxy-4-trifluoromethylcoumarin | 115453-82-2 | Dye Reagents |
| HY-D0092 | 7-Ethoxy-4-methylcoumarin | 87-05-8 | Reference compound |
| HY-D0092R | 7-Ethoxy-4-methylcoumarin (Standard) | 87-05-8 | Reference Standards |
| HY-D0093 | Ethidium homodimer | 61926-22-5 | Dye Reagents |
| HY-D0094 | 2-Ethoxy-2-(2-naphthyl)ethanenitril | 33224-80-5 | Dye Reagents |
| HY-D0095 | B261 | 127070-69-3 | Dye Reagents |
| HY-D0096 | 3-(2-Furoyl)quinoline-2-carboxaldehyde | 126769-01-5 | Dye Reagents |
| HY-D0097 | 7-Fluorobenzofurazan-4-sulfonic acid (ammonium) | 84806-27-9 | Dye Reagents |
| HY-D0098 | Fluorescein-5-maleimide | 75350-46-8 | Dye Reagents |
| HY-D0099 | Fluorescein-5-thiosemicarbazide | 76863-28-0 | Dye Reagents |
| HY-D0100 | Fluorescein-diacetate-5-isothiocyanat | 118378-76-0 | Dye Reagents |
| HY-D0101 | Fluorescein-diphosphat (diammonium) | 197777-66-5 | Dye Reagents |
| HY-D0101A | Fluorescein-diphosphat (ammonium) | 197777-68-7 | Dye Reagents |
| HY-D0102 | 4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole | 91366-65-3 | Dye Reagents |
| HY-D0103 | Fluorescein diacetate 5-maleimide | 150322-01-3 | Dye Reagents |
| HY-D0104 | Fluorescein-O-acetate | 233759-98-3 | Dye Reagents |
| HY-D0105 | Fluorescein diacetate 6-isothiocyanate | 890090-49-0 | Dye Reagents |
| HY-D0107 | Fluorescein dicaproate | 7364-90-1 | Dye Reagents |
| HY-D0108 | Fluorescein dilaurate | 7308-90-9 | Dye Reagents |
| HY-D0110A | Fura-2 (pentapotassium) | 113694-64-7 | Dye Reagents |
| HY-D0110B | Fura-2 (pentasodium) | Dye Reagents | |
| HY-D0111 | 4-Fluoro-2,1,3-benzoxadiazole | 29270-55-1 | Dye Reagents |
| HY-D0112 | 7-Hydroxycoumarin-4-acetic acid | 6950-82-9 | Dye Reagents |
| HY-D0113 | 7-Hydroxy-4-methyl-2(1H)-quinolone | 20513-71-7 | Dye Reagents |
| HY-D0114 | 3-Carboxy-7-Hydroxycoumarin | 779-27-1 | Dye Reagents |
| HY-D0115 | 7-Hydroxycoumarin-3-carboxylic acid N-succinimidyl ester | 134471-24-2 | Dye Reagents |
| HY-D0116 | 8-Hydroxypyrene-1,3,6-trisulfonic acid | 27928-00-3 | Dye Reagents |
| HY-D0117 | BHHCT | 200862-70-0 | Dye Reagents |
| HY-D0118 | A-205 | 127044-59-1 | Dye Reagents |
| HY-D0119 | IPB | 161617-45-4 | Dye Reagents |
| HY-D0120 | CytoRed | 251292-24-7 | Dye Reagents |
| HY-D0121 | INDO 1 | 96314-96-4 | Dye Reagents |
| HY-D0121A | INDO 1 (pentapotassium) | 132319-56-3 | Dye Reagents |
| HY-D0122 | 6-Iodoacetamidofluorescein | 73264-12-7 | Dye Reagents |
| HY-D0124 | Phthalimidylbenzenesulfonyl chloride | 126565-42-2 | Dye Reagents |
| HY-D0125 | 4-(1-Methylhydrazino)-7-nitrobenzofurazan | 214147-22-5 | Dye Reagents |
| HY-D0126 | 4-(2-Methyl-4-thiazolyl)phenol | 30686-73-8 | Biochemical Assay Reagents |
| HY-D0127 | Merocyanin 540 | 62796-23-0 | Dye Reagents |
| HY-D0128 | 4-Methylherniarin | 2555-28-4 | Reference compound |
| HY-D0129 | 8-Methoxypyrene-1,3,6-trisulfonate (trisodium) | 82962-86-5 | Dye Reagents |
| HY-D0130 | Xanthamide 8 | 442151-56-6 | Dye Reagents |
| HY-D0131 | 2-Methoxy-2-(naphthalen-2-yl)acetonitrile | 118736-08-6 | Dye Reagents |
| HY-D0132 | N-(4-Methylumbelliferyl)-maleinimid | 211565-47-8 | Dye Reagents |
| HY-D0133 | NBD-X acid | 88235-25-0 | Dye Reagents |
| HY-D0134 | NIR-797-isothiocyanate | 152111-91-6 | Dye Reagents |
| HY-D0135 | 12-(7-Nitrobenzofurazan-4-ylamino)dodecanoic acid | 96801-39-7 | Dye Reagents |
| HY-D0136 | 4-Nitro-7-piperazinobenzofurazan | 139332-66-4 | Dye Reagents |
| HY-D0137 | 2-(Benzyloxy)-2-(naphthalen-2-yl)acetonitrile | 500372-25-8 | Dye Reagents |
| HY-D0138 | 2-(Naphthalen-2-yl)-2-(pentyloxy)acetonitrile | 500372-26-9 | Dye Reagents |
| HY-D0139 | Octadecyl Rhodamine B (perchlorate) | 142179-00-8 | Dye Reagents |
| HY-D0140 | Chromoionophore I | 125829-24-5 | Dye Reagents |
| HY-D0141 | 12-(1-Pyrenyl)dodecanoic acid | 69168-45-2 | Dye Reagents |
| HY-D0142 | Pyrene-1,3,6,8-tetrasulfonic acid (tetrasodium) | 59572-10-0 | Dye Reagents |
| HY-D0143 | Quinine | 130-95-0 | Natural Products |
| HY-D0143A | Quinine (dihydrochloride) | 60-93-5 | Natural Products |
| HY-D0143AR | Quinine (dihydrochloride) (Standard) | 60-93-5 | Reference Standards |
| HY-D0143B | Quinine (hemisulfate hydrate) | 207671-44-1 | Natural Products |
| HY-D0143R | Quinine (Standard) | 130-95-0 | Reference Standards |
| HY-D0144 | Resorufin methyl ether | 5725-89-3 | Dye Reagents |
| HY-D0145 | 7-Ethoxyresorufin | 5725-91-7 | Dye Reagents |
| HY-D0145S | 7-Ethoxyresorufin-d5 | 2749329-28-8 | Isotope-Labeled Compounds |
| HY-D0146 | Resorufin benzyl ether | 87687-02-3 | Dye Reagents |
| HY-D0147 | Resorufin pentyl ether | 87687-03-4 | Dye Reagents |
| HY-D0148 | Ru(bpy)2(phen-ITC)(PF6)2 | 288399-07-5 | Dye Reagents |
| HY-D0149 | 4-(Trifluoromethyl)umbelliferone | 575-03-1 | Dye Reagents |
| HY-D0150 | Thiazole Orange | 107091-89-4 | Dye Reagents |
| HY-D0150A | (Z)-Thiazole Orange (iodide) | 2394903-71-8 | Dye Reagents |
| HY-D0151 | Tetramethylrhodamine-5-maleimide | 174568-67-3 | Dye Reagents |
| HY-D0152 | Tetramethylrhodamine-6-maleimide | 174568-68-4 | Dye Reagents |
| HY-D0153 | Tetramethylrhodamine-5-isothiocyanate | 80724-19-2 | Dye Reagents |
| HY-D0154 | 6-TRITC | 80724-20-5 | Dye Reagents |
| HY-D0155 | Zinpyr-1 | 288574-78-7 | Dye Reagents |
| HY-D0156 | ZnAF-1 | 321859-09-0 | Dye Reagents |
| HY-D0157 | ZnAF-2 | 321859-11-4 | Biochemical Assay Reagents |
| HY-D0158 | ZnAF-2 DA | 357339-96-9 | Biochemical Assay Reagents |
| HY-D0159 | ZnAF-1F | 443302-08-7 | Dye Reagents |
| HY-D0159A | ZnAF-1F (tetraTFA) | Dye Reagents | |
| HY-D0160 | ZnAF-2F | 443302-09-8 | Biochemical Assay Reagents |
| HY-D0161 | ZnAF-2F DA | 443302-10-1 | Dye Reagents |
| HY-D0162 | Malachite green (hemioxalate) | 2437-29-8 | Dye Reagents |
| HY-D0162R | Malachite green (hemioxalate) (Standard) | 2437-29-8 | Reference Standards |
| HY-D0163 | Methyl Green | 14855-76-6 | Dye Reagents |
| HY-D0164 | Naphthol AS-BI | 1237-75-8 | Dye Reagents |
| HY-D0165 | Naphthoresorcinol | 132-86-5 | Dye Reagents |
| HY-D0166 | Neutral Red | 553-24-2 | Dye Reagents |
| HY-D0166A | Neutral Red (IND) | 553-24-2 | Dye Reagents |
| HY-D0167 | NHS-5(6)Carboxyrhodamine | 150408-83-6 | Dye Reagents |
| HY-D0168 | Orcinol | 504-15-4 | Dye Reagents |
| HY-D0169 | Phenol Red | 143-74-8 | Dye Reagents |
| HY-D0169A | Phenol Red (sodium salt) | 34487-61-1 | Dye Reagents |
| HY-D0170 | Ferene (disodium) | 79551-14-7 | Biochemical Assay Reagents |
| HY-D0172 | Tetrabutylammonium (bromide) | 1643-19-2 | Biochemical Assay Reagents |
| HY-D0175 | 3-Aminopropyltriethoxysilane | 919-30-2 | Biochemical Assay Reagents |
| HY-D0176 | Dextrosil KA,65% in water | 3327-22-8 | Biochemical Assay Reagents |
| HY-D0176R | Dextrosil KA (Standard) | 3327-22-8 | Reference Standards |
| HY-D0177 | (Benzotriazol-1-yloxy)tripyrrolidinophosphonium (hexafluorophosphate) | 128625-52-5 | Biochemical Assay Reagents |
| HY-D0178 | 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide (hydrochloride) | 25952-53-8 | Biochemical Assay Reagents |
| HY-D0179 | Cyclam | 295-37-4 | Dye Reagents |
| HY-D0180 | 18-Crown-6-ether | 17455-13-9 | Biochemical Assay Reagents |
| HY-D0181 | 1-Acetylimidazole | 2466-76-4 | Reference compound |
| HY-D0183 | ATP-polyamine-biotin | 1800401-93-7 | Biochemical Assay Reagents |
| HY-D0184 | 2'-Deoxycytidine | 951-77-9 | Natural Products |
| HY-D0184R | 2'-Deoxycytidine (Standard) | 951-77-9 | Reference Standards |
| HY-D0184S2 | 2'-Deoxycytidine-15N3 | Isotope-Labeled Compounds | |
| HY-D0184S3 | 2'-Deoxycytidine-13C9,15N3 | 1987883-22-6 | Isotope-Labeled Compounds |
| HY-D0184S4 | 2'-Deoxycytidine-d13 | Isotope-Labeled Compounds | |
| HY-D0184S5 | 2'-Deoxycytidine-13C9 | Isotope-Labeled Compounds | |
| HY-D0184S6 | 2'-Deoxycytidine-13C,15N3 | Isotope-Labeled Compounds | |
| HY-D0185 | 2'-Deoxyguanosine monohydrate | 312693-72-4 | Natural Products |
| HY-D0185S | 2'-Deoxyguanosine-d2 (monohydrate) | 478511-28-3 | Isotope-Labeled Compounds |
| HY-D0185S1 | 2'-Deoxyguanosine-d (monohydrate) | Isotope-Labeled Compounds | |
| HY-D0185S4 | 2'-Deoxyguanosine-13C10,15N5 (monohydrate) | 2483830-26-6 | Isotope-Labeled Compounds |
| HY-D0186 | 2'-Deoxyuridine | 951-78-0 | Natural Products |
| HY-D0186R | 2'-Deoxyuridine (Standard) | 951-78-0 | Reference Standards |
| HY-D0186S | 2'-Deoxyuridine-1′-13C | 478510-85-9 | Isotope-Labeled Compounds |
| HY-D0186S1 | 2'-Deoxyuridine-2′-13C | 478510-87-1 | Isotope-Labeled Compounds |
| HY-D0186S2 | 2'-Deoxyuridine-3′-13C | 478510-89-3 | Isotope-Labeled Compounds |
| HY-D0186S3 | 2'-Deoxyuridine-5′-13C | 478510-91-7 | Isotope-Labeled Compounds |
| HY-D0186S4 | 2'-Deoxyuridine-d2 | 478511-30-7 | Isotope-Labeled Compounds |
| HY-D0186S5 | 2'-Deoxyuridine-d | Isotope-Labeled Compounds | |
| HY-D0186S7 | 2'-Deoxyuridine-13C,15N2 | 369656-76-8 | Isotope-Labeled Compounds |
| HY-D0186S8 | 2'-Deoxyuridine-d2-1 | 40632-23-3 | Isotope-Labeled Compounds |
| HY-D0187 | L-Glutathione reduced | 70-18-8 | Biochemical Assay Reagents |
| HY-D0187B | L-Glutathione reduced (monosodium) | 20167-21-9 | Dye Reagents |
| HY-D0187R | L-Glutathione reduced (Standard) | 70-18-8 | Reference Standards |
| HY-D0187S | L-Glutathione reduced-13C2,15N | 815610-65-2 | Isotope-Labeled Compounds |
| HY-D0187S4 | L-Glutathione reduced-13C | Isotope-Labeled Compounds | |
| HY-D0187S5 | L-Glutathione reduced-d2 | Isotope-Labeled Compounds | |
| HY-D0187S6 | L-Glutathione reduced-15N | Isotope-Labeled Compounds | |
| HY-D0190 | 2-Thenoyltrifluoroacetone | 326-91-0 | Reference compound |
| HY-D0193 | Ponceau 4R | 2611-82-7 | Dye Reagents |
| HY-D0193A | Ponceau 4R (85%) | 2611-82-7 | Dye Reagents |
| HY-D0194 | 5(6)-Carboxy-2',7'-dichlorofluorescein | 111843-78-8 | Dye Reagents |
| HY-D0195 | Acesulfame (potassium) | 55589-62-3 | Reference compound |
| HY-D0195R | Acesulfame (potassium) (Standard) | 55589-62-3 | Reference Standards |
| HY-D0195S | Acesulfame-d4 (potassium) | 1623054-53-4 | Isotope-Labeled Compounds |
| HY-D0198 | Acid yellow 61 | 12217-38-8 | Dye Reagents |
| HY-D0199 | Adenosine 5'-diphosphate (disodium) | 16178-48-6 | Biochemical Assay Reagents |
| HY-D0199S | Adenosine 5′-diphosphate-15N5 (disodium) | Isotope-Labeled Compounds | |
| HY-D0200S | Adipic acid dihydrazide-d8 | 1202865-37-9 | Isotope-Labeled Compounds |
| HY-D0202 | Arsenazo III | 1668-00-4 | Dye Reagents |
| HY-D0203 | Basic green 4 | 569-64-2 | Dye Reagents |
| HY-D0203R | Basic green 4 (Standard) | 569-64-2 | Dye Reagents |
| HY-D0205 | (RS)-Carbocisteine | 25390-17-4 | Reference compound |
| HY-D0205A | Carbocisteine | 638-23-3 | Reference compound |
| HY-D0205AR | Carbocisteine (Standard) | 638-23-3 | Reference Standards |
| HY-D0205AS1 | Carbocisteine-13C3-1 | 1391068-19-1 | Isotope-Labeled Compounds |
| HY-D0205AS2 | Carbocisteine-d3 | Isotope-Labeled Compounds | |
| HY-D0206 | Chromotropic acid (disodium) | 129-96-4 | Dye Reagents |
| HY-D0208 | Fluorescein (sodium) | 518-47-8 | Dye Reagents |
| HY-D0210 | N-Ethyl-o-toluidine | 94-68-8 | Dye Reagents |
| HY-D0211 | Phenolphthalein | 77-09-8 | Dye Reagents |
| HY-D0211R | Phenolphthalein (Standard) | 77-09-8 | Dye Reagents |
| HY-D0212 | Solvent blue 97 | 32724-62-2 | Dye Reagents |
| HY-D0213 | Sudan Black B | 4197-25-5 | Dye Reagents |
| HY-D0214 | Rose Bengal (sodium) | 632-69-9 | Dye Reagents |
| HY-D0214A | Rose bengal lactone | 4159-77-7 | Dye Reagents |
| HY-D0214R | Rose Bengal (sodium) (Standard) | 632-69-9 | Reference Standards |
| HY-D0215 | Safranin | 477-73-6 | Dye Reagents |
| HY-D0216 | Salicylaldoxime | 94-67-7 | Natural Products |
| HY-D0217 | Sulfobromophthalein (disodium salt) | 71-67-0 | Dye Reagents |
| HY-D0218 | Thioflavin T | 2390-54-7 | Dye Reagents |
| HY-D0219 | Thymol blue | 76-61-9 | Dye Reagents |
| HY-D0219A | Thymol Blue (sodium) | 62625-21-2 | Dye Reagents |
| HY-D0220 | Toluidine Blue | 92-31-9 | Dye Reagents |
| HY-D0220A | Toluidine Blue (purity 36%) | Dye Reagents | |
| HY-D0221 | 2,4,6-Tri-2-pyridinyl-1,3,5-triazine | 3682-35-7 | Dye Reagents |
| HY-D0222 | N,N-Dimethyl-1-naphthylamine | 86-56-6 | Dye Reagents |
| HY-D0223 | 1-(2-Pyridylazo)-2-naphthol | 85-85-8 | Biochemical Assay Reagents |
| HY-D0226 | Quinizarin | 81-64-1 | Dye Reagents |
| HY-D0226R | Quinizarin (Standard) | 81-64-1 | Reference Standards |
| HY-D0227 | THAM | 77-86-1 | Reference compound |
| HY-D0227A | THAM (hydrochloride) | 1185-53-1 | Reference compound |
| HY-D0227AR | THAM (hydrochloride) (Standard) | 1185-53-1 | Reference Standards |
| HY-D0227B | THAM (acetate) | 6850-28-8 | Reference compound |
| HY-D0227ES | THAM-d11 (for molecular biology) | 202656-13-1 | Isotope-Labeled Compounds |
| HY-D0227F | THAM hydrochloride (≥99%, reagent grade) | 1185-53-1 | Biochemical Assay Reagents |
| HY-D0227J | THAM hydrochloride (≥99%, for cell culture) | 1185-53-1 | Biochemical Assay Reagents |
| HY-D0227R | THAM (Standard) | 77-86-1 | Reference Standards |
| HY-D0228 | 4-(4-Nitrophenylazo)resorcinol | 74-39-5 | Dye Reagents |
| HY-D0230 | Tetrabromo-o-sulfobenzoic anhydride | 68460-01-5 | Dye Reagents |
| HY-D0232 | Brilliant Blue R250 | 6104-59-2 | Dye Reagents |
| HY-D0233 | Leucocrystal violet | 603-48-5 | Dye Reagents |
| HY-D0233R | Leucocrystal violet (Standard) | 603-48-5 | Dye Reagents |
| HY-D0233S | Leucocrystal violet-d6 | 1173023-92-1 | Isotope-Labeled Compounds |
| HY-D0234 | o-Cresolphthalein | 596-27-0 | Biochemical Assay Reagents |
| HY-D0235 | Alizarin yellow GG | 584-42-9 | Dye Reagents |
| HY-D0236 | Congo Red | 573-58-0 | Dye Reagents |
| HY-D0236R | Congo Red (Standard) | 573-58-0 | Dye Reagents |
| HY-D0237 | Betahistine (mesylate) | 54856-23-4 | Reference compound |
| HY-D0237R | Betahistine (mesylate) (Standard) | 54856-23-4 | Reference Standards |
| HY-D0239 | 4-Nitro-m-phenylenediamine | 5131-58-8 | Dye Reagents |
| HY-D0240 | Flavanthrone | 475-71-8 | Dye Reagents |
| HY-D0241 | 4-Aminodiphenylamine (sulfate) | 4477-28-5 | Dye Reagents |
| HY-D0242 | Vat Red 15 | 4216-02-8 | Dye Reagents |
| HY-D0245 | Direct Red 23 | 3441-14-3 | Dye Reagents |
| HY-D0247 | Chrysophenine | 2870-32-8 | Dye Reagents |
| HY-D0248 | Acid Blue 45 | 2861-02-1 | Dye Reagents |
| HY-D0249 | Sunset Yellow FCF | 2783-94-0 | Dye Reagents |
| HY-D0249R | Sunset Yellow FCF (Standard) | 2783-94-0 | Dye Reagents |
| HY-D0250 | o-Cresolphthalein complexone | 2411-89-4 | Dye Reagents |
| HY-D0251 | Fluorescein | 2321-07-5 | Dye Reagents |
| HY-D0251R | Fluorescein (Standard) | 2321-07-5 | Dye Reagents |
| HY-D0252 | m-Cresol purple | 2303-01-7 | Biochemical Assay Reagents |
| HY-D0253 | Victoria Blue R | 2185-86-6 | Dye Reagents |
| HY-D0254 | Gallein | 2103-64-2 | Dye Reagents |
| HY-D0256 | Direct Black 38 | 1937-37-7 | Dye Reagents |
| HY-D0256A | Direct Black 38 (free acid) | 22244-14-0 | Dye Reagents |
| HY-D0257 | Tartrazine | 1934-21-0 | Dye Reagents |
| HY-D0257R | Tartrazine (Standard) | 1934-21-0 | Dye Reagents |
| HY-D0258 | Alizarin Yellow R (sodium) | 1718-34-9 | Dye Reagents |
| HY-D0259 | Erythrosine B | 16423-68-0 | Dye Reagents |
| HY-D0259R | Erythrosine B (Standard) | 16423-68-0 | Dye Reagents |
| HY-D0261 | Tiron | 149-45-1 | Reference compound |
| HY-D0264 | 1,8-Dinitroanthraquinone | 129-39-5 | Dye Reagents |
| HY-D0265 | Thymolphthalein | 125-20-2 | Biochemical Assay Reagents |
| HY-D0267 | Quinaldine red | 117-92-0 | Biochemical Assay Reagents |
| HY-D0269 | 1-Amino-4-hydroxyanthraquinone | 116-85-8 | Dye Reagents |
| HY-D0272 | 2,3,4-Trihydroxybenzophenone | 1143-72-2 | Dye Reagents |
| HY-D0272S | 2,3,4-Trihydroxybenzophenone-d5 | 2708278-23-1 | Isotope-Labeled Compounds |
| HY-D0273 | 4'-Aminoazobenzene-4-sulphonic acid | 104-23-4 | Dye Reagents |
| HY-D0276 | m-Cresol purple (sodium) | 62625-31-4 | Biochemical Assay Reagents |
| HY-D0277 | Eriochrome black T | 1787-61-7 | Dye Reagents |
| HY-D0278 | Pigment red 170 | 2786-76-7 | Dye Reagents |
| HY-D0279 | Pigment orange 13 | 3520-72-7 | Dye Reagents |
| HY-D0280 | Pigment red 57-1 | 5281-04-9 | Dye Reagents |
| HY-D0281 | Pigment Yellow 14 | 5468-75-7 | Dye Reagents |
| HY-D0283 | Pigment Yellow 83 | 5567-15-7 | Dye Reagents |
| HY-D0284 | Pigment Yellow 139 | 36888-99-0 | Dye Reagents |
| HY-D0285 | 3,4,9,10-Perylenetetracarboxylic-diimide | 81-33-4 | Dye Reagents |
| HY-D0286 | Fluorol Yellow 088 | 81-37-8 | Dye Reagents |
| HY-D0287 | Solvent red 52 | 81-39-0 | Dye Reagents |
| HY-D0288 | Disperse red 86 | 81-68-5 | Dye Reagents |
| HY-D0289 | Disperse violet 8 | 82-33-7 | Dye Reagents |
| HY-D0290 | Quinoline yellow 2SF | 83-08-9 | Dye Reagents |
| HY-D0291 | 4-(9H-Carbazol-3-ylamino)phenol | 86-72-6 | Dye Reagents |
| HY-D0292 | 1,4-Bis(mesitylamino)anthraquinone | 116-75-6 | Dye Reagents |
| HY-D0293 | Acid Blue 1 | 116-95-0 | Dye Reagents |
| HY-D0294 | 4-(2,4-Dinitroanilino)phenol | 119-15-3 | Dye Reagents |
| HY-D0296 | Isoviolanthrone | 128-64-3 | Dye Reagents |
| HY-D0297 | Solvent blue 12 | 128-83-6 | Dye Reagents |
| HY-D0298 | 4,4'-Diamino-1,1'-iminodianthraquinone | 128-87-0 | Dye Reagents |
| HY-D0299 | 1,8-Diamino-4,5-dihydroxyanthraquinone | 128-94-9 | Dye Reagents |
| HY-D0300 | Leucomalachite green | 129-73-7 | Dye Reagents |
| HY-D0300R | Leucomalachite green (Standard) | 129-73-7 | Dye Reagents |
| HY-D0300S | Leucomalachite green-d5 | 947601-82-3 | Isotope-Labeled Compounds |
| HY-D0300S1 | Leucomalachite green-d6 | 1173021-13-0 | Isotope-Labeled Compounds |
| HY-D0301 | Vat-brown-3 | 131-92-0 | Dye Reagents |
| HY-D0303 | Chrysoidine G (free base) | 495-54-5 | Dye Reagents |
| HY-D0303A | Chrysoidine G | 532-82-1 | Dye Reagents |
| HY-D0303AR | Chrysoidine G (Standard) | 532-82-1 | Dye Reagents |
| HY-D0304 | Rhodamine B base | 509-34-2 | Biochemical Assay Reagents |
| HY-D0305 | Tropaeolin O | 547-57-9 | Dye Reagents |
| HY-D0306 | Tris(4-aminophenyl)methane | 548-61-8 | Dye Reagents |
| HY-D0307 | Amaranth (free acid) | 642-59-1 | Dye Reagents |
| HY-D0307A | Amaranth | 915-67-3 | Dye Reagents |
| HY-D0307AR | Amaranth (Standard) | 915-67-3 | Dye Reagents |
| HY-D0309 | Rhodamine 6G | 989-38-8 | Dye Reagents |
| HY-D0309A | Rhodamine 6G (indicator) | 989-38-8 | Biochemical Assay Reagents |
| HY-D0309R | Rhodamine 6G (Standard) | 989-38-8 | Dye Reagents |
| HY-D0310 | Fluorescent Brightener 135 | 1041-00-5 | Dye Reagents |
| HY-D0310R | Fluorescent Brightener 135 (Standard) | 1041-00-5 | Reference Standards |
| HY-D0311 | Bismarck Brown Y | 1052-38-6 | Dye Reagents |
| HY-D0312 | Chrome Dark Blue | 1058-92-0 | Dye Reagents |
| HY-D0313 | Ethyl 8'-apo-caroten-8'-oate | 1109-11-1 | Dye Reagents |
| HY-D0314 | Solvent Red 1 (C.I.) | 1229-55-6 | Dye Reagents |
| HY-D0314R | Solvent Red 1 (C.I.) (Standard) | 1229-55-6 | Dye Reagents |
| HY-D0314S | 1-(2-Methoxyphenyl)azo-2-naphthol-d3 | 1398109-09-5 | Isotope-Labeled Compounds |
| HY-D0315 | Disperse red 74 | 1533-74-0 | Dye Reagents |
| HY-D0316 | Disperse red 167:1 | 1533-78-4 | Dye Reagents |
| HY-D0317 | Chrome Pure Blue BX | 1796-92-5 | Dye Reagents |
| HY-D0318 | Mordant Black PV | 2052-25-7 | Dye Reagents |
| HY-D0319 | C.I. Basic Blue 8 | 2185-87-7 | Dye Reagents |
| HY-D0321 | Disperse Blue 183 | 2309-94-6 | Dye Reagents |
| HY-D0322 | Vat Red 10 | 2379-79-5 | Dye Reagents |
| HY-D0323 | Vat Black 27 | 2379-81-9 | Dye Reagents |
| HY-D0324 | Pigment Yellow 101 | 2387-03-3 | Dye Reagents |
| HY-D0325 | Direct Black BH (sodium) | 2429-73-4 | Dye Reagents |
| HY-D0326 | Vat Brown 1 | 2475-33-4 | Dye Reagents |
| HY-D0327 | Solvent Yellow 56 | 2481-94-9 | Dye Reagents |
| HY-D0329 | Direct Blue 78 | 2503-73-3 | Dye Reagents |
| HY-D0330 | Mordant black 17 | 2538-85-4 | Biochemical Assay Reagents |
| HY-D0331 | Reactive Blue 19 | 2580-78-1 | Dye Reagents |
| HY-D0332 | Disperse Orange 1 | 2581-69-3 | Dye Reagents |
| HY-D0333 | Direct Red 80 | 2610-10-8 | Dye Reagents |
| HY-D0334 | Direct Red 81 | 2610-11-9 | Dye Reagents |
| HY-D0337 | Pigment Red 4 | 2814-77-9 | Dye Reagents |
| HY-D0338 | Direct Yellow 26 | 2829-42-7 | Dye Reagents |
| HY-D0339 | Disperse Yellow 3 | 2832-40-8 | Dye Reagents |
| HY-D0340 | Fluorescent Brightener 185 | 2866-43-5 | Dye Reagents |
| HY-D0341 | Disperse Red 11 | 2872-48-2 | Dye Reagents |
| HY-D0342 | Disperse Red 1 | 2872-52-8 | Dye Reagents |
| HY-D0344 | Giuba Black D | 2945-96-2 | Dye Reagents |
| HY-D0345 | Pigment Red 178 | 3049-71-6 | Dye Reagents |
| HY-D0346 | Disperse Blue 85 | 3177-13-7 | Dye Reagents |
| HY-D0347 | Disperse Red 17 | 3179-89-3 | Dye Reagents |
| HY-D0347R | Disperse Red 17 (Standard) | 3179-89-3 | Dye Reagents |
| HY-D0348 | Celliton Fast Blue Green B | 3179-90-6 | Reference compound |
| HY-D0349 | Disperse Red 13 | 3180-81-2 | Dye Reagents |
| HY-D0350 | Direct Yellow 50 | 3214-47-9 | Dye Reagents |
| HY-D0351 | Fluorescent Brightener 134 | 3426-43-5 | Dye Reagents |
| HY-D0352 | Permanent Orange | 3468-63-1 | Dye Reagents |
| HY-D0352R | Permanent Orange (Standard) | 3468-63-1 | Reference Standards |
| HY-D0354 | Mordant Orange 6 | 3564-27-0 | Dye Reagents |
| HY-D0355 | Flazo Orange | 3566-94-7 | Dye Reagents |
| HY-D0356 | Eriochrome Black A | 3618-58-4 | Dye Reagents |
| HY-D0360 | Mordant Blue 9 | 3624-68-8 | Dye Reagents |
| HY-D0361 | Direct red 26 | 3687-80-7 | Dye Reagents |
| HY-D0362 | Indanthren Olive GB | 3772-98-3 | Dye Reagents |
| HY-D0363 | Pigment Red 166 | 3905-19-9 | Dye Reagents |
| HY-D0364 | Disperse Orange 44 | 4058-30-4 | Dye Reagents |
| HY-D0365 | Pigment Yellow 147 | 4118-16-5 | Dye Reagents |
| HY-D0366 | Acid Violet 17 | 4129-84-4 | Dye Reagents |
| HY-D0367 | Fluorescent Brightener 28 (25% in water) | 4193-55-9 | Dye Reagents |
| HY-D0368 | Pigment Yellow 108 | 4216-01-7 | Dye Reagents |
| HY-D0370 | Solvent Yellow 16 | 4314-14-1 | Dye Reagents |
| HY-D0371 | Acid blue 62 | 4368-56-3 | Dye Reagents |
| HY-D0372 | Vat Black 25 | 4395-53-3 | Dye Reagents |
| HY-D0373 | Indanthren Brown LMG | 4465-47-8 | Dye Reagents |
| HY-D0374 | Reactive Blue 4 (sodium) | 4499-01-8 | Dye Reagents |
| HY-D0375 | Pigment Yellow 17 | 4531-49-1 | Dye Reagents |
| HY-D0376 | Solvent Yellow 93 | 4702-90-3 | Dye Reagents |
| HY-D0377 | Solvaperm Green G | 4851-50-7 | Dye Reagents |
| HY-D0378 | Acid Green 9 | 4857-81-2 | Dye Reagents |
| HY-D0380 | Pigment Yellow 109 | 5045-40-9 | Dye Reagents |
| HY-D0381 | Disperse Yellow 42 | 5124-25-4 | Dye Reagents |
| HY-D0382 | Disperse Orange 30 | 5261-31-4 | Dye Reagents |
| HY-D0383 | Pigment Red 146 | 5280-68-2 | Dye Reagents |
| HY-D0384 | Pigment Red 144 | 5280-78-4 | Dye Reagents |
| HY-D0385 | Pigment Yellow 95 | 5280-80-8 | Dye Reagents |
| HY-D0386 | Bismarck Brown R | 5421-66-9 | Dye Reagents |
| HY-D0387 | Pigment Yellow 93 | 5580-57-4 | Dye Reagents |
| HY-D0388 | Acid Brown 5 | 5850-05-5 | Dye Reagents |
| HY-D0389 | Acid Brown 14 | 5850-16-8 | Dye Reagents |
| HY-D0390 | Acid green 20 | 5850-39-5 | Dye Reagents |
| HY-D0391 | C.I Acid orange 8 | 5850-86-2 | Dye Reagents |
| HY-D0392 | C. I. Pigment yellow 16 | 5979-28-2 | Dye Reagents |
| HY-D0393 | Disperse red 54 | 6021-61-0 | Dye Reagents |
| HY-D0394 | C.I. Pigment red 2 | 6041-94-7 | Dye Reagents |
| HY-D0395 | C.I. Mordant Orange 29 | 6054-86-0 | Dye Reagents |
| HY-D0396 | C.I. Direct red 16 | 6227-02-7 | Dye Reagents |
| HY-D0397 | C.I. Direct Violet 9 | 6227-14-1 | Dye Reagents |
| HY-D0398 | Acid red 42 | 6245-60-9 | Dye Reagents |
| HY-D0399 | C.I. Acid blue 40 | 6247-34-3 | Dye Reagents |
| HY-D0400 | C.I. Disperse yellow 23 | 6250-23-3 | Dye Reagents |
| HY-D0401 | Direct brown 44 | 6252-62-6 | Dye Reagents |
| HY-D0402 | Acid black 26 | 6262-07-3 | Dye Reagents |
| HY-D0403 | Chlorantine yellow | 6272-71-5 | Dye Reagents |
| HY-D0404 | Direct red 254 | 6300-50-1 | Dye Reagents |
| HY-D0405 | C.I. Pigment yellow 74 | 6358-31-2 | Dye Reagents |
| HY-D0406 | C.I. Basic yellow 37 | 6358-36-7 | Dye Reagents |
| HY-D0407 | C.I. Acid black 94 | 6358-80-1 | Dye Reagents |
| HY-D0408 | C.I. Pigment red 38 | 6358-87-8 | Dye Reagents |
| HY-D0409 | C.I. Mordant yellow 8 | 6359-83-7 | Dye Reagents |
| HY-D0410 | C.I. Acid yellow 200 | 6359-95-1 | Dye Reagents |
| HY-D0411 | Xylene Fast Yellow 2G | 6359-98-4 | Dye Reagents |
| HY-D0412 | C.I. Acid yellow 48 | 6359-99-5 | Dye Reagents |
| HY-D0413 | C.I. Acid red 37 | 6360-07-2 | Dye Reagents |
| HY-D0414 | C.I. Acid blue 158 | 6370-08-7 | Dye Reagents |
| HY-D0415 | C.I. Vat blue 22 | 6373-20-2 | Dye Reagents |
| HY-D0416 | Disperse yellow 9 | 6373-73-5 | Dye Reagents |
| HY-D0416R | Disperse yellow 9 (Standard) | 6373-73-5 | Dye Reagents |
| HY-D0417 | C.I. Acid orange 3 | 6373-74-6 | Dye Reagents |
| HY-D0418 | C.I. Acid yellow 42 | 6375-55-9 | Dye Reagents |
| HY-D0419 | C.I. Direct green 26 | 6388-26-7 | Dye Reagents |
| HY-D0420 | C.I. Acid red 151 | 6406-56-0 | Dye Reagents |
| HY-D0421 | C.I. Solvent yellow 18 | 6407-78-9 | Dye Reagents |
| HY-D0422 | C.I. Acid red 183 | 6408-31-7 | Dye Reagents |
| HY-D0423 | C.I. Acid green 27 | 6408-57-7 | Dye Reagents |
| HY-D0424 | C.I. Acid blue 25 | 6408-78-2 | Dye Reagents |
| HY-D0425 | C.I. Direct red 84 | 6409-83-2 | Dye Reagents |
| HY-D0426 | C.I. Pigment red 8 | 6410-30-6 | Dye Reagents |
| HY-D0427 | C.I. Pigment red 12 | 6410-32-8 | Dye Reagents |
| HY-D0428 | C.I. Pigment red 9 | 6410-38-4 | Dye Reagents |
| HY-D0429 | C.I. Pigment red 5 | 6410-41-9 | Dye Reagents |
| HY-D0430 | Acid Red 249 | 6416-66-6 | Dye Reagents |
| HY-D0431 | C.I. Pigment blue 56 | 6417-46-5 | Dye Reagents |
| HY-D0432 | Direct yellow 34 | 6420-33-3 | Dye Reagents |
| HY-D0433 | C.I. Vat Blue 16 | 6424-76-6 | Dye Reagents |
| HY-D0434 | C.I. Acid blue 40 (sodium salt) | 6424-85-7 | Dye Reagents |
| HY-D0435 | C.I. Acid brown 120 | 6428-26-8 | Dye Reagents |
| HY-D0436 | C.I. Direct black 32 | 6428-38-2 | Dye Reagents |
| HY-D0437 | C.I. Direct blue 75 | 6428-60-0 | Dye Reagents |
| HY-D0438 | C.I. Acid red 114 | 6459-94-5 | Dye Reagents |
| HY-D0439 | C.I. Mordant yellow 12 | 6470-98-0 | Dye Reagents |
| HY-D0440 | C.I. Direct green 28 | 6471-09-6 | Dye Reagents |
| HY-D0441 | C.I. Pigment red 23 | 6471-49-4 | Dye Reagents |
| HY-D0442 | C.I. Pigment red 14 | 6471-50-7 | Dye Reagents |
| HY-D0443 | C.I. Direct black 22 | 6473-13-8 | Dye Reagents |
| HY-D0444 | C.I. Acid brown 121 | 6487-04-3 | Dye Reagents |
| HY-D0445 | C.I. Pigment orange 16 | 6505-28-8 | Dye Reagents |
| HY-D0446 | C.I. Acid orange 33 | 6507-77-3 | Dye Reagents |
| HY-D0447 | C.I. Acid red 374 | 6507-78-4 | Dye Reagents |
| HY-D0448 | C.I. Acid red 154 | 6507-79-5 | Dye Reagents |
| HY-D0450 | C.I. Pigment red 112 | 6535-46-2 | Dye Reagents |
| HY-D0451 | C.I. Direct orange 102 | 6598-63-6 | Dye Reagents |
| HY-D0452 | C.I. Acid brown 75 | 6637-87-2 | Dye Reagents |
| HY-D0453 | Disperse orange A | 6657-32-5 | Dye Reagents |
| HY-D0454 | C.I. Disperse red 54 | 6657-37-0 | Dye Reagents |
| HY-D0456 | C.I. Direct violet 66 | 6798-03-4 | Dye Reagents |
| HY-D0457 | C.I. Solvent red 179 | 6829-22-7 | Dye Reagents |
| HY-D0458 | C.I. Acid red 106 | 6844-74-2 | Dye Reagents |
| HY-D0459 | C.I. Pigment brown 25 | 6992-11-6 | Dye Reagents |
| HY-D0460 | C.I. Pigment red 48 | 7023-61-2 | Dye Reagents |
| HY-D0461 | beta-Naphthol violet | 7143-21-7 | Dye Reagents |
| HY-D0462 | Direct Yellow 44 | 7248-45-5 | Dye Reagents |
| HY-D0463 | Disperse yellow 54 | 7576-65-0 | Dye Reagents |
| HY-D0464 | Pigment red 48:1 | 7585-41-3 | Dye Reagents |
| HY-D0465 | C.I. Direct black 80 | 8003-69-8 | Dye Reagents |
| HY-D0466 | Acid orange 51 | 8003-88-1 | Dye Reagents |
| HY-D0468 | Basic Brown 1 | 10114-58-6 | Dye Reagents |
| HY-D0470 | Acid orange 74 | 10127-27-2 | Dye Reagents |
| HY-D0472 | C.I. Acid red 97 | 10169-02-5 | Dye Reagents |
| HY-D0473 | C.I. Direct yellow 27 | 10190-68-8 | Dye Reagents |
| HY-D0474 | Acid green 12 | 10241-21-1 | Dye Reagents |
| HY-D0475 | C.I.Solvent yellow 176 | 10319-14-9 | Dye Reagents |
| HY-D0476 | C.I. Acid yellow 99 | 10343-58-5 | Dye Reagents |
| HY-D0477 | C.I. Acid red 57 | 12217-34-4 | Dye Reagents |
| HY-D0478 | C.I. Basic red 14 | 12217-48-0 | Dye Reagents |
| HY-D0479 | Disperse Blue 60 | 12217-80-0 | Dye Reagents |
| HY-D0480 | C.I. Acid black 60 | 12218-95-0 | Dye Reagents |
| HY-D0481 | C.I. Acid orange 67 | 12220-06-3 | Dye Reagents |
| HY-D0482 | C.I. Direct blue 80 | 12222-00-3 | Dye Reagents |
| HY-D0483 | Direct yellow 106 | 12222-60-5 | Dye Reagents |
| HY-D0484 | C.I. Disperse yellow 70 | 12223-91-5 | Dye Reagents |
| HY-D0485 | Fluorescent brightener 24 | 12224-02-1 | Dye Reagents |
| HY-D0486 | C.I. Pigment violet 32 | 12225-08-0 | Dye Reagents |
| HY-D0487 | C.I. Pigment yellow 97 | 12225-18-2 | Dye Reagents |
| HY-D0488 | C.I. Pigment orange 36 | 12236-62-3 | Dye Reagents |
| HY-D0489 | C.I. Pigment orange 38 | 12236-64-5 | Dye Reagents |
| HY-D0490 | C.I. Acid yellow 49 | 12239-15-5 | Dye Reagents |
| HY-D0491 | C.I. Disperse blue 79 | 12239-34-8 | Dye Reagents |
| HY-D0492 | C.I. Basic blue 41 | 12270-13-2 | Dye Reagents |
| HY-D0493 | C.I. Pigment yellow 62 | 12286-66-7 | Dye Reagents |
| HY-D0494 | C.I. Acid yellow 151 | 12715-61-6 | Dye Reagents |
| HY-D0495 | C.I. Acid brown 83 | 13011-68-2 | Dye Reagents |
| HY-D0496 | C.I. Mordant green 17 | 13301-33-2 | Dye Reagents |
| HY-D0497 | C.I. Disperse orange 37 | 13301-61-6 | Dye Reagents |
| HY-D0497R | C.I. Disperse orange 37 (Standard) | 13301-61-6 | Dye Reagents |
| HY-D0498 | 2-N-Ethyl-p-(6-methoxybenzothiazol-2-yl)azoanilinoethanol | 13486-43-6 | Dye Reagents |
| HY-D0499 | Pigment yellow 73 | 13515-40-7 | Dye Reagents |
| HY-D0501 | Cationic red GTL | 14254-17-2 | Dye Reagents |
| HY-D0502 | C.I.Pigment red 88 | 14295-43-3 | Dye Reagents |
| HY-D0505 | Eosin Y | 15086-94-9 | Dye Reagents |
| HY-D0505A | Eosin Y (disodium) | 17372-87-1 | Dye Reagents |
| HY-D0508 | C.I. Acid red 138 | 15792-43-5 | Dye Reagents |
| HY-D0509 | C.I. Acid yellow 172 | 15792-51-5 | Dye Reagents |
| HY-D0510 | C.I. Pigment orange 34 | 15793-73-4 | Dye Reagents |
| HY-D0511 | Pigment yellow 111 | 15993-42-7 | Dye Reagents |
| HY-D0512 | Fluorescent brightener 251 | 16324-27-9 | Dye Reagents |
| HY-D0513 | Disperse red 65 | 16586-43-9 | Dye Reagents |
| HY-D0514 | Reactive blue 5 | 16823-51-1 | Dye Reagents |
| HY-D0515 | Disperse red 73 | 16889-10-4 | Dye Reagents |
| HY-D0516 | Solvent Blue 35 | 17354-14-2 | Dye Reagents |
| HY-D0517 | Disperse brown 4 | 17464-91-4 | Dye Reagents |
| HY-D0518 | Direct red 227 | 17791-81-0 | Dye Reagents |
| HY-D0519 | C.I. Pigment red 52:1 | 17852-99-2 | Dye Reagents |
| HY-D0520 | Fluorescent brightener 85 | 17958-73-5 | Dye Reagents |
| HY-D0521 | Disperse orange 29 | 19800-42-1 | Dye Reagents |
| HY-D0522 | Reactive orange 16 | 20262-58-2 | Dye Reagents |
| HY-D0523 | C.I. Food Blue 5:2 | 20262-76-4 | Dye Reagents |
| HY-D0524 | Disperse black 9 | 20721-50-0 | Dye Reagents |
| HY-D0528 | Disperse brown 1 | 23355-64-8 | Dye Reagents |
| HY-D0531 | C.I. Pigment red 123 | 24108-89-2 | Dye Reagents |
| HY-D0532 | N-[5-2-[Azo]phenyl]acetamide | 24112-48-9 | Dye Reagents |
| HY-D0533 | Disperse blue 165:1 | 24170-60-3 | Dye Reagents |
| HY-D0534 | 2-4-(2-Cyanoethyl)(2-phenylethyl)aminophenylazo-5-nitrobenzonitrile | 24610-00-2 | Dye Reagents |
| HY-D0536 | C.I. Acid black 132 | 27425-58-7 | Dye Reagents |
| HY-D0539 | Direct red 239 | 28706-25-4 | Dye Reagents |
| HY-D0540 | Direct orange 118 | 28706-33-4 | Dye Reagents |
| HY-D0542 | Disperse orange 25 | 31482-56-1 | Dye Reagents |
| HY-D0543 | Pigment yellow 151 | 31837-42-0 | Dye Reagents |
| HY-D0545 | Disperse red 91 | 34231-26-0 | Dye Reagents |
| HY-D0546 | Solvent yellow 124 | 34432-92-3 | Dye Reagents |
| HY-D0549 | Pigment red 266 | 36968-27-1 | Dye Reagents |
| HY-D0551 | C.I. Basic red 24 | 37216-10-7 | Dye Reagents |
| HY-D0552 | Disperse orange 62 | 37672-70-1 | Dye Reagents |
| HY-D0553 | Cationic golden yellow 2K | 38936-35-5 | Dye Reagents |
| HY-D0554 | Sumitone fast red b | 40618-31-3 | Dye Reagents |
| HY-D0555 | C.I. Disperse orange 73 | 40690-89-9 | Dye Reagents |
| HY-D0558 | Disperse blue 165 | 41642-51-7 | Dye Reagents |
| HY-D0559 | C.I. Disperse blue 284 | 42783-06-2 | Dye Reagents |
| HY-D0560 | C.I. Pigment red 247 | 43035-18-3 | Dye Reagents |
| HY-D0563 | Direct yellow 86 | 50925-42-3 | Dye Reagents |
| HY-D0565 | Disperse blue 291G | 51868-46-3 | Dye Reagents |
| HY-D0566 | Pigment red 185 | 51920-12-8 | Dye Reagents |
| HY-D0568 | Pigment red 242 | 52238-92-3 | Dye Reagents |
| HY-D0571 | Pigment yellow 75 | 52320-66-8 | Dye Reagents |
| HY-D0572 | Acid red 260 | 52333-30-9 | Dye Reagents |
| HY-D0575 | Disperse violet 93 | 52697-38-8 | Dye Reagents |
| HY-D0576 | Pigment orange 62 | 52846-56-7 | Dye Reagents |
| HY-D0578 | Basic yellow 28 | 54060-92-3 | Dye Reagents |
| HY-D0579 | Basic red 18:1 | 54229-13-9 | Dye Reagents |
| HY-D0583 | Disperse blue 291 | 56548-64-2 | Dye Reagents |
| HY-D0584 | Reactive orange 86 | 57359-00-9 | Dye Reagents |
| HY-D0585 | Procion red MX 8B | 57583-69-4 | Dye Reagents |
| HY-D0588 | Acid red 266 | 57741-47-6 | Dye Reagents |
| HY-D0589 | Disperse green 9 | 58979-46-7 | Dye Reagents |
| HY-D0590 | C.I. Pigment red 187 | 59487-23-9 | Dye Reagents |
| HY-D0592 | Dispersol yellow brown XF | 59709-38-5 | Dye Reagents |
| HY-D0594 | Disperse Red 278 | 61355-92-8 | Dye Reagents |
| HY-D0596 | Pigment Red 188 | 61847-48-1 | Dye Reagents |
| HY-D0597 | C.I. Mordant red 94 | 61931-83-7 | Dye Reagents |
| HY-D0603 | Pigment Yellow 183 | 65212-77-3 | Dye Reagents |
| HY-D0605 | Solvent Black 46 | 65294-17-9 | Dye Reagents |
| HY-D0610 | Disperse Violet 33 | 66882-16-4 | Dye Reagents |
| HY-D0611 | Disperse Yellow 86 | 67338-59-4 | Dye Reagents |
| HY-D0613 | Acid Red 337 | 67786-14-5 | Dye Reagents |
| HY-D0616 | Pigment Yellow 182 | 67906-31-4 | Dye Reagents |
| HY-D0622 | Reactive Green 19 | 68110-31-6 | Dye Reagents |
| HY-D0624 | Procion Yellow H-E 4R | 68133-40-4 | Dye Reagents |
| HY-D0625 | Disperse Red 177 | 68133-69-7 | Dye Reagents |
| HY-D0626 | Pigment Yellow 154 | 68134-22-5 | Dye Reagents |
| HY-D0632 | Pigment Red 147 | 68227-78-1 | Dye Reagents |
| HY-D0634 | Reactive Black 39 | 68259-02-9 | Dye Reagents |
| HY-D0636 | Pigment Yellow 155 | 68516-73-4 | Dye Reagents |
| HY-D0637 | Disperse Blue 106 | 68516-81-4 | Dye Reagents |
| HY-D0639 | Reactive Brown 23 | 68892-31-9 | Dye Reagents |
| HY-D0640 | Acid Orange 116 | 68959-00-2 | Dye Reagents |
| HY-D0643 | C.I. Disperse orange 33 | 69472-19-1 | Dye Reagents |
| HY-D0644 | Disperse blue 102 | 69766-79-6 | Dye Reagents |
| HY-D0648 | Direct red 9 | 70209-93-7 | Dye Reagents |
| HY-D0650 | Acid violet 54 | 70210-05-8 | Dye Reagents |
| HY-D0651 | Acid red 119 | 70210-06-9 | Dye Reagents |
| HY-D0652 | Disperse orange 80 | 70210-10-5 | Dye Reagents |
| HY-D0653 | Reactive orange 35 | 70210-13-8 | Dye Reagents |
| HY-D0655 | Reactive red 24 | 70210-20-7 | Dye Reagents |
| HY-D0658 | Direct blue 85 | 70210-31-0 | Dye Reagents |
| HY-D0659 | Acid brown 58 | 70210-34-3 | Dye Reagents |
| HY-D0660 | Acid red 131 | 70210-37-6 | Dye Reagents |
| HY-D0661 | Reactive red 45 | 70210-46-7 | Dye Reagents |
| HY-D0665 | Lanasol yellow 4G | 70247-70-0 | Dye Reagents |
| HY-D0667 | Disperse yellow 211 | 70528-90-4 | Dye Reagents |
| HY-D0668 | Reactive orange 13 | 70616-89-6 | Dye Reagents |
| HY-D0669 | Reactive orange 4 | 70616-90-9 | Dye Reagents |
| HY-D0673 | Disperse red 311 | 70729-65-6 | Dye Reagents |
| HY-D0676 | Acid yellow 199 | 70865-20-2 | Dye Reagents |
| HY-D0678 | C.I. Reactive yellow 86 | 70865-29-1 | Dye Reagents |
| HY-D0683 | Direct yellow 28 | 71033-21-1 | Dye Reagents |
| HY-D0686 | C.I. Pigment red 221 | 71566-54-6 | Dye Reagents |
| HY-D0687 | Disperse red 324 | 71617-28-2 | Dye Reagents |
| HY-D0689 | Pigment yellow 168 | 71832-85-4 | Dye Reagents |
| HY-D0690 | Pigment orange 64 | 72102-84-2 | Dye Reagents |
| HY-D0691 | Reactive yellow 25 | 72139-14-1 | Dye Reagents |
| HY-D0692 | Reactive red 124 | 72152-49-9 | Dye Reagents |
| HY-D0697 | Pigment red 95 | 72639-39-5 | Dye Reagents |
| HY-D0700 | Reactive red 24:1 | 72829-25-5 | Dye Reagents |
| HY-D0702 | Solvent red 195 | 72968-71-9 | Dye Reagents |
| HY-D0705 | Acid Yellow 9 monosodium salt | 74543-21-8 | Dye Reagents |
| HY-D0711 | Indocyanine green | 3599-32-4 | Dye Reagents |
| HY-D0711R | Indocyanine green (Standard) | 3599-32-4 | Dye Reagents |
| HY-D0711S2 | Indocyanine green-d7 | 2861905-57-7 | Isotope-Labeled Compounds |
| HY-D0712 | α-CN-TO | 1416045-49-2 | Dye Reagents |
| HY-D0713 | 7ACC2 | 1472624-85-3 | Reference compound |
| HY-D0714 | Tetrazolium Red | 298-96-4 | Biochemical Assay Reagents |
| HY-D0715 | Fluorescamine | 38183-12-9 | Dye Reagents |
| HY-D0715R | Fluorescamine (Standard) | 38183-12-9 | Dye Reagents |
| HY-D0716 | Fluo-3AM | 121714-22-5 | Dye Reagents |
| HY-D0717 | DAF-FM DA | 254109-22-3 | Dye Reagents |
| HY-D0718 | Nile Red | 7385-67-3 | Dye Reagents |
| HY-D0719 | Fluorescein Diacetate | 596-09-8 | Dye Reagents |
| HY-D0719R | Fluorescein Diacetate (Standard) | 596-09-8 | Reference Standards |
| HY-D0720 | Lucigenin | 2315-97-1 | Dye Reagents |
| HY-D0721 | 6-CFDA | 3348-03-6 | Dye Reagents |
| HY-D0722 | 5(6)-CFDA | 124387-19-5 | Dye Reagents |
| HY-D0723 | 5(6)-TAMRA SE | 246256-50-8 | Dye Reagents |
| HY-D0724 | Basic violet 16 (phosphate) | 75535-16-9 | Dye Reagents |
| HY-D0725 | C.I. Pigment yellow 180 | 77804-81-0 | Dye Reagents |
| HY-D0727 | Pigment yellow 174 | 78952-72-4 | Dye Reagents |
| HY-D0728 | Fluorescent Brightener ER-III | 79026-03-2 | Dye Reagents |
| HY-D0731 | Pigment yellow 128 | 79953-85-8 | Dye Reagents |
| HY-D0734 | Pigment yellow 194 | 82199-12-0 | Dye Reagents |
| HY-D0739 | Disperse yellow 241 | 83249-52-9 | Dye Reagents |
| HY-D0741 | Pigment black 32 | 83524-75-8 | Dye Reagents |
| HY-D0745 | Acid red 405 | 83833-37-8 | Dye Reagents |
| HY-D0754 | Remazol marine blue | 84229-70-9 | Dye Reagents |
| HY-D0757 | Disperse blue 366 | 84870-65-5 | Dye Reagents |
| HY-D0774 | Direct Black 168 | 85631-88-5 | Dye Reagents |
| HY-D0783 | 5-Maleimido-eosin | 150322-02-4 | Dye Reagents |
| HY-D0784 | 5-ROX | 216699-35-3 | Dye Reagents |
| HY-D0785 | NBD-F | 29270-56-2 | Dye Reagents |
| HY-D0786 | 3-Morpholinobenzanthrone | 299927-47-2 | Dye Reagents |
| HY-D0787 | NBD-undecanoic acid | 351002-77-2 | Dye Reagents |
| HY-D0788 | Dimidium bromide | 518-67-2 | Biochemical Assay Reagents |
| HY-D0788R | Dimidium bromide (Standard) | 518-67-2 | Reference Standards |
| HY-D0789 | ANTS | 5398-34-5 | Dye Reagents |
| HY-D0790 | 10-Octadecylacridine orange (bromide) | 75168-16-0 | Dye Reagents |
| HY-D0791 | TRITC | 95197-95-8 | Dye Reagents |
| HY-D0793 | Oenthacid-4-(trifluormethyl)-umbelliferone | 351002-79-4 | Dye Reagents |
| HY-D0796 | Propyl red | 2641-01-2 | Dye Reagents |
| HY-D0797 | Azomethine-H (monosodium) | 5941-07-1 | Dye Reagents |
| HY-D0798 | Catechol violet | 115-41-3 | Biochemical Assay Reagents |
| HY-D0799 | Sulfo-NHS-LC-Biotin (sodium) | 191671-46-2 | Dye Reagents |
| HY-D0799A | Sulfo-NHS-LC-Biotin | 190598-57-3 | Dye Reagents |
| HY-D0800 | Mordant Blue 29 | 1667-99-8 | Biochemical Assay Reagents |
| HY-D0801 | Calmagite | 3147-14-6 | Dye Reagents |
| HY-D0802 | Biotin NHS | 35013-72-0 | Dye Reagents |
| HY-D0803 | Thymoquinone | 490-91-5 | Natural Products |
| HY-D0803R | Thymoquinone (Standard) | 490-91-5 | Reference Standards |
| HY-D0805 | Eosin 5-isothiocyanate | 60520-47-0 | Dye Reagents |
| HY-D0807 | 5-IAF | 63368-54-7 | Dye Reagents |
| HY-D0808 | Meldola blue | 7057-57-0 | Dye Reagents |
| HY-D0812 | Xylenol blue | 125-31-5 | Dye Reagents |
| HY-D0813 | Zincon (sodium) | 62625-22-3 | Dye Reagents |
| HY-D0814 | DAPI (dihydrochloride) | 28718-90-3 | Dye Reagents |
| HY-D0814A | DAPI (dihydrochloride) (solution) | 28718-90-3 | Dye Reagents |
| HY-D0815 | Propidium (Iodide) | 25535-16-4 | Dye Reagents |
| HY-D0816 | Rhodamine 123 | 62669-70-9 | Dye Reagents |
| HY-D0817 | Rhodamine 110 | 13558-31-1 | Dye Reagents |
| HY-D0818 | CY3-YNE | 1010386-62-5 | Dye Reagents |
| HY-D0819 | CY5-SE | 146368-14-1 | Dye Reagents |
| HY-D0819A | CY5-SE (triethylamine salt) | 1497420-70-8 | Dye Reagents |
| HY-D0820 | CY5-YNE | 1345823-20-2 | Dye Reagents |
| HY-D0821 | CY5 | 146368-11-8 | Dye Reagents |
| HY-D0822 | CY3 | 146368-13-0 | Dye Reagents |
| HY-D0823 | CY3-SE | 146368-16-3 | Dye Reagents |
| HY-D0824 | CY7-SE | 477908-53-5 | Dye Reagents |
| HY-D0824A | CY7-SE (triethylamine) | Dye Reagents | |
| HY-D0825 | CY7 | 943298-08-6 | Dye Reagents |
| HY-D0826 | Cy2-SE (iodine) | 186205-33-4 | Dye Reagents |
| HY-D0827 | Cy2 | 260430-02-2 | Dye Reagents |
| HY-D0828 | 3,6-Dichlorotrimellitic acid | 137071-78-4 | Dye Reagents |
| HY-D0829 | 3,6-Dichlorotrimellitic anhydride | 81742-10-1 | Dye Reagents |
| HY-D0830 | Calcein (tetraethyl ester) | 1170856-93-5 | Dye Reagents |
| HY-D0831 | WST-8 | 193149-74-5 | Dye Reagents |
| HY-D0832 | CY5-N3 | 1621101-43-6 | Dye Reagents |
| HY-D0833 | Tricalcium phosphate | 7758-87-4 | Biochemical Assay Reagents |
| HY-D0835 | Hydroxylapatite (25-45 μm) | 1306-06-5 | Natural Products |
| HY-D0835A | Hydroxylapatite (<50 nm) | 1306-06-5 | Dye Reagents |
| HY-D0836 | EDTA (dipotassium dihydrate) | 25102-12-9 | Biochemical Assay Reagents |
| HY-D0837 | Imidazole | 288-32-4 | Biochemical Assay Reagents |
| HY-D0837R | Imidazole (Standard) | 288-32-4 | Reference Standards |
| HY-D0837S | Imidazole-d4 | 6923-01-9 | Isotope-Labeled Compounds |
| HY-D0838 | Dodecyltrimethylammonium (bromide) | 1119-94-4 | Isotope-Labeled Compounds |
| HY-D0838S | Dodecyltrimethylammonium-d25 (bromide) | 2309360-05-0 | Isotope-Labeled Compounds |
| HY-D0838S1 | Dodecyltrimethylammonium-d34(bromide) | 2259752-12-8 | Isotope-Labeled Compounds |
| HY-D0839 | Tetradecyltrimethylammonium (bromide) | 1119-97-7 | Reference compound |
| HY-D0839S1 | Tetradecyltrimethylammonium-d29 (bromide) | 95523-73-2 | Isotope-Labeled Compounds |
| HY-D0839S2 | Tetradecyltrimethylammonium-d38 (bromide) | 95523-72-1 | Isotope-Labeled Compounds |
| HY-D0841 | Guanidine thiocyanate | 593-84-0 | Biochemical Assay Reagents |
| HY-D0842 | Bovine Serum Albumin | 9048-46-8 | Biochemical Assay Reagents |
| HY-D0842A | Bovine Serum Albumin (Low Endotoxin,Fatty acid free) | 9048-46-8 | Biochemical Assay Reagents |
| HY-D0843 | N-Ethylmaleimide | 128-53-0 | Reference compound |
| HY-D0843R | N-Ethylmaleimide (Standard) | 128-53-0 | Reference Standards |
| HY-D0843S | N-Ethylmaleimide-d5 | 360768-37-2 | Isotope-Labeled Compounds |
| HY-D0844 | Glutathione oxidized | 27025-41-8 | Peptides |
| HY-D0844R | Glutathione oxidized (Standard) | 27025-41-8 | Reference Standards |
| HY-D0844S | Glutathione oxidized-13C4,15N2 | 1416898-83-3 | Isotope-Labeled Compounds |
| HY-D0845 | Nitrosoglutathione | 57564-91-7 | Dye Reagents |
| HY-D0845R | Nitrosoglutathione (Standard) | 57564-91-7 | Reference Standards |
| HY-D0846 | Diethyl pyrocarbonate | 1609-47-8 | Biochemical Assay Reagents |
| HY-D0848 | N,N'-Methylenebisacrylamide | 110-26-9 | Biochemical Assay Reagents |
| HY-D0849 | Sodium iodoacetate | 305-53-3 | Biochemical Assay Reagents |
| HY-D0850 | Tartaric acid (disodium dihydrate) | 6106-24-7 | Biochemical Assay Reagents |
| HY-D0850R | Tartaric acid (disodium dihydrate) (Standard) | 6106-24-7 | Reference Standards |
| HY-D0851 | Sodium molybdate | 7631-95-0 | Biochemical Assay Reagents |
| HY-D0852 | Sodium orthovanadate | 13721-39-6 | Biochemical Assay Reagents |
| HY-D0852A | Sodium metavanadate, 99% | 13718-26-8 | Biochemical Assay Reagents |
| HY-D0853 | DiAzKs | 1253643-88-7 | Dye Reagents |
| HY-D0853A | DiAzKs (hydrochloride) | 2421187-79-1 | Dye Reagents |
| HY-D0854 | Acid Red (sodium) | 3244-88-0 | Biochemical Assay Reagents |
| HY-D0855 | ADA | 26239-55-4 | Biochemical Assay Reagents |
| HY-D0855A | ADA (disodium) | 41689-31-0 | Biochemical Assay Reagents |
| HY-D0856 | Bis-Tris | 6976-37-0 | Biochemical Assay Reagents |
| HY-D0856R | Bis-Tris (Standard) | 6976-37-0 | Reference Standards |
| HY-D0856S | Bis-Tris-d19 | 352534-93-1 | Isotope-Labeled Compounds |
| HY-D0857 | HEPES | 7365-45-9 | Biochemical Assay Reagents |
| HY-D0857S | HEPES-d18 | 203805-87-2 | Isotope-Labeled Compounds |
| HY-D0858 | MES | 4432-31-9 | Biochemical Assay Reagents |
| HY-D0858A | MES (monohydrate) | 145224-94-8 | Biochemical Assay Reagents |
| HY-D0858AR | MES (monohydrate) (Standard) | 145224-94-8 | Reference Standards |
| HY-D0858B | MES (sodium salt) | 71119-23-8 | Biochemical Assay Reagents |
| HY-D0858C | MES (hydrate) | 1266615-59-1 | Biochemical Assay Reagents |
| HY-D0858D | MES (hemisodium) | 117961-21-4 | Reference compound |
| HY-D0858E | MES (potassium) | 39946-25-3 | Biochemical Assay Reagents |
| HY-D0858S | MES-d13 | 352534-94-2 | Isotope-Labeled Compounds |
| HY-D0859 | MOPS | 1132-61-2 | Reference compound |
| HY-D0859A | MOPS (sodium salt) | 71119-22-7 | Biochemical Assay Reagents |
| HY-D0859S | MOPS-d15 | 1219799-30-0 | Isotope-Labeled Compounds |
| HY-D0860 | Tricine | 5704-04-1 | Biochemical Assay Reagents |
| HY-D0860S | Tricine-d8 | 352534-96-4 | Isotope-Labeled Compounds |
| HY-D0861 | EGTA | 67-42-5 | Biochemical Assay Reagents |
| HY-D0861A | EGTA (tetrasodium) | 13368-13-3 | Biochemical Assay Reagents |
| HY-D0862 | DIDNTB | 145551-16-2 | Biochemical Assay Reagents |
| HY-D0864 | 3-(N-Tosyl-L-alaninyloxy)-5-phenylpyrrole | 99740-00-8 | Biochemical Assay Reagents |
| HY-D0866 | ACES | 7365-82-4 | Reference compound |
| HY-D0867 | BES | 10191-18-1 | Biochemical Assay Reagents |
| HY-D0867A | BES (sodium) | 66992-27-6 | Biochemical Assay Reagents |
| HY-D0868 | Bicine | 150-25-4 | Reference compound |
| HY-D0869 | CAPS | 1135-40-6 | Biochemical Assay Reagents |
| HY-D0869S | 3-(Cyclohexylamino)-1-propanesulfonic Acid-d17 | 1219804-15-5 | Isotope-Labeled Compounds |
| HY-D0870 | CAPSO | 73463-39-5 | Biochemical Assay Reagents |
| HY-D0870A | CAPSO (sodium) | 102601-34-3 | Biochemical Assay Reagents |
| HY-D0871 | CHES | 103-47-9 | Dye Reagents |
| HY-D0872 | DIPSO | 68399-80-4 | Biochemical Assay Reagents |
| HY-D0873 | HEPPS | 16052-06-5 | Biochemical Assay Reagents |
| HY-D0874 | HEPPSO | 68399-78-0 | Biochemical Assay Reagents |
| HY-D0875 | PIPES | 5625-37-6 | Biochemical Assay Reagents |
| HY-D0875S | PIPES-d18 | 352534-95-3 | Isotope-Labeled Compounds |
| HY-D0876 | POPSO,99% with 2H2O | 68189-43-5 | Biochemical Assay Reagents |
| HY-D0877 | TAPS | 29915-38-6 | Biochemical Assay Reagents |
| HY-D0878 | TAPSO | 68399-81-5 | Biochemical Assay Reagents |
| HY-D0881 | TODB (free base) | 127544-88-1 | Biochemical Assay Reagents |
| HY-D0882 | Adenosine 5'-diphosphate (dicyclohexylammonium) | 102029-87-8 | Biochemical Assay Reagents |
| HY-D0883 | Kryptofix 221 | 31364-42-8 | Biochemical Assay Reagents |
| HY-D0884 | L-Lactic acid (lithium) | 27848-80-2 | Biochemical Assay Reagents |
| HY-D0885 | Phosphocreatine | 67-07-2 | Natural Products |
| HY-D0885A | Sodium creatine phosphate dibasic tetrahydrate | 71519-72-7 | Natural Products |
| HY-D0885B | Phosphocreatine (disodium) | 922-32-7 | Natural Products |
| HY-D0885C | Phosphocreatine (dipotassium) | 18838-38-5 | Natural Products |
| HY-D0885D | Phosphocreatine (disodium hydrate) | 19333-65-4 | Natural Products |
| HY-D0886 | β-Glycerophosphate (disodium salt pentahydrate) | 13408-09-8 | Reference compound |
| HY-D0887 | Disodium 5'-inosinate | 4691-65-0 | Natural Products |
| HY-D0888 | 3,5-Dichlorophenyldiazonium tetrafluoroborate | 350-67-4 | Biochemical Assay Reagents |
| HY-D0889 | Glycylglycine | 556-50-3 | Natural Products |
| HY-D0889R | Glycylglycine (Standard) | 556-50-3 | Reference Standards |
| HY-D0890 | ABEI | 66612-29-1 | Biochemical Assay Reagents |
| HY-D0891 | NSP-AS | 211106-69-3 | Dye Reagents |
| HY-D0892 | NSP-DMAE-NHS | 194357-64-7 | Enzyme |
| HY-D0893 | NSP-SA-NHS | 199293-83-9 | Dye Reagents |
| HY-D0895 | 3,4,5,6-Tetrabromophenolsulfonephthalein | 77172-72-6 | Dye Reagents |
| HY-D0896 | ANS | 82-76-8 | Biochemical Assay Reagents |
| HY-D0896A | ANS (ammonium) | 28836-03-5 | Reference compound |
| HY-D0897 | 3-(1-naphthalenylamino)-1-Propanesulfonic acid sodium salt | 104484-71-1 | Biochemical Assay Reagents |
| HY-D0898 | 2,4-Dichlorobenzenediazonium (tetrafluoroborate) | 21872-70-8 | Biochemical Assay Reagents |
| HY-D0899 | Taloxin | 75062-54-3 | Biochemical Assay Reagents |
| HY-D0900 | 1,2,3,4-Tetrahydrobenzo[h]quinolin-3-ol | 5423-67-6 | Biochemical Assay Reagents |
| HY-D0902 | Triethanolamine borate | 283-56-7 | Biochemical Assay Reagents |
| HY-D0903 | 1,8-Diazafluoren-9-one | 54078-29-4 | Dye Reagents |
| HY-D0904 | Acetylthiocholine (iodide) | 1866-15-5 | Biochemical Assay Reagents |
| HY-D0905 | S-n-Butyrylthiocholine (iodide) | 1866-16-6 | Biochemical Assay Reagents |
| HY-D0906 | AHMT | 1750-12-5 | Biochemical Assay Reagents |
| HY-D0906R | AHMT (Standard) | 1750-12-5 | Reference Standards |
| HY-D0907 | Beth hydrochloride hydrate | 38894-11-0 | Biochemical Assay Reagents |
| HY-D0908 | Ninhydrin | 485-47-2 | Dye Reagents |
| HY-D0909 | 5-Bromo-4-chloro-3-indolyl octanoate | 129541-42-0 | Biochemical Assay Reagents |
| HY-D0910 | 5-Bromo-6-chloro-1H-indol-3-yl acetate | 102185-48-8 | Biochemical Assay Reagents |
| HY-D0911 | 5-Bromo-6-chloro-3-indolyl phosphate p-toluidine | 6769-80-8 | Biochemical Assay Reagents |
| HY-D0912 | 3,3',5,5'-Tetraethylbenzidine | 2095-04-7 | Dye Reagents |
| HY-D0913 | 1-Methyl-7-nitroisatoic anhydride | 73043-80-8 | Dye Reagents |
| HY-D0914 | Fast Green FCF | 2353-45-9 | Dye Reagents |
| HY-D0914A | Fast green FCF (free acid) | 25738-40-3 | Dye Reagents |
| HY-D0915 | Brilliant Blue FCF | 3844-45-9 | Dye Reagents |
| HY-D0916 | Thiazole orange dimer YOYO 1 | 143413-85-8 | Dye Reagents |
| HY-D0917 | TO-PRO 1 | 157199-59-2 | Dye Reagents |
| HY-D0918 | YO-PRO-1 | 152068-09-2 | Dye Reagents |
| HY-D0919 | YO-PRO-3 | 157199-62-7 | Dye Reagents |
| HY-D0920 | TOTO-3 | 166196-17-4 | Dye Reagents |
| HY-D0921 | Heptamethine cyanine dye-1 | 162411-29-2 | Dye Reagents |
| HY-D0922 | Cy3.5 | 1284240-77-2 | Dye Reagents |
| HY-D0922A | Cy3.5 (acetate) | Dye Reagents | |
| HY-D0924 | Cy5.5 | 210892-23-2 | Dye Reagents |
| HY-D0924A | Cy5.5 (acetate) | Dye Reagents | |
| HY-D0924B | Cy5.5 (TEA) | Dye Reagents | |
| HY-D0925 | Cy5.5-SE | 442912-55-2 | Dye Reagents |
| HY-D0925B | Cy5.5-SE (TEA) | Dye Reagents | |
| HY-D0926 | Cy7.5 | 847180-48-7 | Dye Reagents |
| HY-D0928 | Sudan II | 3118-97-6 | Biochemical Assay Reagents |
| HY-D0928R | Sudan II (Standard) | 3118-97-6 | Reference Standards |
| HY-D0929 | Orange I | 523-44-4 | Dye Reagents |
| HY-D0930 | OrangeIV | 554-73-4 | Biochemical Assay Reagents |
| HY-D0931 | Sudan III | 85-86-9 | Dye Reagents |
| HY-D0931R | Sudan III (Standard) | 85-86-9 | Dye Reagents |
| HY-D0931S | Sudan III-d6 | 1014689-17-8 | Isotope-Labeled Compounds |
| HY-D0932 | Sudan IV | 85-83-6 | Dye Reagents |
| HY-D0932R | Sudan IV (Standard) | 85-83-6 | Dye Reagents |
| HY-D0932S | Sudan IV-d6 | 1014689-18-9 | Isotope-Labeled Compounds |
| HY-D0933 | Auramine O | 2465-27-2 | Dye Reagents |
| HY-D0934 | (5)6-Carboxytetramethylrhodamine | 117557-83-2 | Dye Reagents |
| HY-D0935 | 4-Methylumbelliferyl-β-D-glucuronide | 6160-80-1 | Biochemical Assay Reagents |
| HY-D0935A | 4-Methylumbelliferyl-β-D-glucuronide hydrate | 881005-91-0 | Dye Reagents |
| HY-D0936 | SPQ | 83907-40-8 | Dye Reagents |
| HY-D0937 | Methoxy-PMS | 65162-13-2 | Biochemical Assay Reagents |
| HY-D0938 | CFDA-SE | 150347-59-4 | Dye Reagents |
| HY-D0939 | Direct Blue 1 | 2610-05-1 | Dye Reagents |
| HY-D0940 | H2DCFDA | 4091-99-0 | Dye Reagents |
| HY-D0941 | 5-Carboxytetramethylrhodamine | 150322-05-7 | Dye Reagents |
| HY-D0942 | Acridine Orange (zinc chloride salt) | 10127-02-3 | Dye Reagents |
| HY-D0943 | Nuclear Fast Red | 6409-77-4 | Dye Reagents |
| HY-D0944 | Giemsa stain | 51811-82-6 | Dye Reagents |
| HY-D0945 | Xylene Cyanol FF | 2650-17-1 | Dye Reagents |
| HY-D0946 | Azure II | 37247-10-2 | Biochemical Assay Reagents |
| HY-D0947 | Azure A (chloride) | 531-53-3 | Dye Reagents |
| HY-D0948 | Celestine Blue | 1562-90-9 | Dye Reagents |
| HY-D0949 | Pyronine B | Dye Reagents | |
| HY-D0950A | Methyl Green (zinc chloride) | 7114-03-6 | Dye Reagents |
| HY-D0951 | Methyl violet dye | 84434-47-9 | Dye Reagents |
| HY-D0952 | Acridine Orange base | 494-38-2 | Dye Reagents |
| HY-D0953 | Direct Blue 86 | 1330-38-7 | Dye Reagents |
| HY-D0954 | Jenner's Stain | 62851-42-7 | Dye Reagents |
| HY-D0955 | Thionin (acetate) | 78338-22-4 | Dye Reagents |
| HY-D0956 | Acridine yellow G | 135-49-9 | Dye Reagents |
| HY-D0957 | Ethyl Violet | 2390-59-2 | Dye Reagents |
| HY-D0958 | Methylene blue (hydrate) | 122965-43-9 | Reference compound |
| HY-D0958R | Methylene blue (hydrate) (Standard) | 122965-43-9 | Reference Standards |
| HY-D0960 | C.I. Solvent Blue 43 | 61813-75-0 | Dye Reagents |
| HY-D0961 | Gallocyanine (chloride) | 1562-85-2 | Reference compound |
| HY-D0962 | Azure B eosinate | 62298-42-4 | Dye Reagents |
| HY-D0963 | 16,17-Bis(decyloxy)violanthrone | 71550-33-9 | Dye Reagents |
| HY-D0965 | Procion Blue HB | 12236-82-7 | Dye Reagents |
| HY-D0967 | Cy5-bifunctional dye | 146368-15-2 | Dye Reagents |
| HY-D0968 | Cy 3 (Non-Sulfonated) | 146397-20-8 | Dye Reagents |
| HY-D0968A | Cy 3 (Non-Sulfonated) (potassium) | 1311966-47-8 | Dye Reagents |
| HY-D0968B | Cy 3 (Non-Sulfonated) (triethylamine) | Dye Reagents | |
| HY-D0969 | DiO | 34215-57-1 | Dye Reagents |
| HY-D0970 | Diphenyl Blue | 72-57-1 | Dye Reagents |
| HY-D0971 | Pyronin Y | 92-32-0 | Dye Reagents |
| HY-D0972 | Thioflavine S | 1326-12-1 | Dye Reagents |
| HY-D0973 | EGTA-AM | 99590-86-0 | Biochemical Assay Reagents |
| HY-D0974 | Sulforhodamine B (sodium salt) | 3520-42-1 | Dye Reagents |
| HY-D0975 | Sulfo-SMCC (sodium) | 92921-24-9 | Biochemical Assay Reagents |
| HY-D0976 | NF279 | 202983-32-2 | Reference compound |
| HY-D0978 | γ-(6-Aminohexyl)-ATP-biotin | 1705572-09-3 | Dye Reagents |
| HY-D0979 | γ-[(6-Aminohexyl)-imido]-ATP-biotin | 2579331-99-8 | Dye Reagents |
| HY-D0980 | Biotin-DADOO | 138529-46-1 | Biochemical Assay Reagents |
| HY-D0980A | Biotin-DADOO (TFA) | 194920-57-5 | Dye Reagents |
| HY-D0981 | 7-Amino-4-(trifluoromethyl)coumarin | 53518-15-3 | Dye Reagents |
| HY-D0982 | Zinquin | 151606-29-0 | Dye Reagents |
| HY-D0983 | Trypan red | 574-64-1 | Dye Reagents |
| HY-D0984 | TMRM | 115532-49-5 | Dye Reagents |
| HY-D0984A | TMRM Perchlorate | 115532-50-8 | Dye Reagents |
| HY-D0985A | TMRE | 115532-52-0 | Dye Reagents |
| HY-D0986 | TMA-DPH | 115534-33-3 | Dye Reagents |
| HY-D0987 | Stains-All | 7423-31-6 | Dye Reagents |
| HY-D0988 | R-PE (R-Phycoerythrin) | 11016-17-4 | Dye Reagents |
| HY-D0989 | Rhod-2 AM | 145037-81-6 | Dye Reagents |
| HY-D0991 | Pro-AMC | 221208-87-3 | Dye Reagents |
| HY-D0993 | Acridine Orange 10-Nonyl Bromide | 75168-11-5 | Dye Reagents |
| HY-D0994 | 4-Methylumbelliferyl phosphate | 3368-04-5 | Dye Reagents |
| HY-D0994A | 4-Methylumbelliferyl phosphate (disodium) | 22919-26-2 | Dye Reagents |
| HY-D0995 | 7-Methyl-6-thioguanosine | 55727-10-1 | Dye Reagents |
| HY-D0996 | LDS-751 | 181885-68-7 | Dye Reagents |
| HY-D1005 | Poloxamer 407 (F127) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A | Poloxamer 188 | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A1 | Poloxamer 101 (L31) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A10 | Poloxamer 184 (L64) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A11 | Poloxamer 185 (P65) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A12 | Poloxamer 212 (L72) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A13 | Poloxamer 215 (P75) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A14 | Poloxamer 217 (F77) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A15 | Poloxamer 234 (P84) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A16 | Poloxamer 235 (P85) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A17 | Poloxamer 238 (F88) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A19 | Poloxamer 333 (P103) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A2 | Poloxamer 105 (L35) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A20 | Poloxamer 334 (P104) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A21 | Poloxamer 335 (P105) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A22 | Poloxamer 338 (F108) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A23 | Poloxamer 401 (L121) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A24 | Poloxamer 402 (L122) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A25 | Poloxamer 403 (P123) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A4 | Poloxamer 122 (L42) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A5 | Poloxamer 123 (L43) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A6 | Poloxamer 124 (L44) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A7 | Poloxamer 125 (L45) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A8 | Poloxamer 181 (L61) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005A9 | Poloxamer 183 (L63) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005B | Poloxamer 237 (F87) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005F | Poloxamer 182 (L62) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1005H | Poloxamer 188 (F68) | 9003-11-6 | Biochemical Assay Reagents |
| HY-D1020 | 7-Aminoactinomycin D | 7240-37-1 | Dye Reagents |
| HY-D1021 | AA-dUTP sodium salt | 936327-10-5 | Biochemical Assay Reagents |
| HY-D1022 | Biotin-16-dUTP | 86303-26-6 | Dye Reagents |
| HY-D1022A | Biotin-16-dUTP (trisodium) | Dye Reagents | |
| HY-D1023 | 5-BrdUTP sodium salt | 102212-99-7 | Biochemical Assay Reagents |
| HY-D1024 | Coelenterazine h | 50909-86-9 | Dye Reagents |
| HY-D1024A | Coelenterazine h (hydrochloride) | Dye Reagents | |
| HY-D1025 | C-Phycocyanin | 11016-15-2 | Dye Reagents |
| HY-D1026 | CUG | 64664-99-9 | Dye Reagents |
| HY-D1027 | Dansylcadaverine | 10121-91-2 | Dye Reagents |
| HY-D1028 | DiD perchlorate | 127274-91-3 | Dye Reagents |
| HY-D1029 | Biotin-11-dUTP | 86303-25-5 | Dye Reagents |
| HY-D1029A | Biotin-11-dUTP (trisodium) | Dye Reagents | |
| HY-D1030 | Fluorescein Biotin | 134759-22-1 | Dye Reagents |
| HY-D1032 | DiZHSeC | 2230724-46-4 | Dye Reagents |
| HY-D1033 | Biotin-tagged KR-33493 | 1872262-53-7 | Dye Reagents |
| HY-D1035 | Direct blue 218 | 28407-37-6 | Dye Reagents |
| HY-D1036 | Basic red 18 (acetate) | 85187-95-7 | Dye Reagents |
| HY-D1036A | Basic red 18 | 25198-22-5 | Dye Reagents |
| HY-D1037 | Disperse red 50 | 40880-51-1 | Dye Reagents |
| HY-D1038 | Disperse orange 31 | 68391-42-4 | Dye Reagents |
| HY-D1039 | Disperse blue ANT | 88938-51-6 | Dye Reagents |
| HY-D1040 | Cy5.5-COOH | 1449612-07-0 | Dye Reagents |
| HY-D1040A | CY5.5-COOH (chloride) | 2410537-32-3 | Dye Reagents |
| HY-D1041 | ICG-OSu | 1622335-40-3 | Dye Reagents |
| HY-D1042 | 1,4-Dichloro 5-carboxytetramethylrhodamine | 198546-47-3 | Dye Reagents |
| HY-D1043 | 1,4-Dichloro 6-carboxytetramethylrhodamine | 407581-83-3 | Dye Reagents |
| HY-D1044 | Rhodamine 101 (chloride) | 64339-18-0 | Dye Reagents |
| HY-D1045 | Dabcyl acid | 6268-49-1 | Dye Reagents |
| HY-D1045A | Dabcyl acid (sodium) | 845-46-5 | Dye Reagents |
| HY-D1046 | Dabcyl acid, SE | 146998-31-4 | Dye Reagents |
| HY-D1047 | Cy2 DiC18 | 68006-80-4 | Dye Reagents |
| HY-D1048 | DiR | 100068-60-8 | Dye Reagents |
| HY-D1049 | DNP-X acid | 10466-72-5 | Dye Reagents |
| HY-D1050 | DNP-X, SE | 82321-04-8 | Dye Reagents |
| HY-D1051 | Cy3-N3 | Dye Reagents | |
| HY-D1052 | Cy7-YNE | Dye Reagents | |
| HY-D1053 | CY7-N3 | Dye Reagents | |
| HY-D1054 | Cy2 (iodine) | 186205-37-8 | Dye Reagents |
| HY-D1055 | MitoSOX Red | 1003197-00-9 | Dye Reagents |
| HY-D1056 | Lipopolysaccharides, from E. coli O55:B5 | Biochemical Assay Reagents | |
| HY-D1056A1 | Lipopolysaccharides, from E. coli O111:B4 | Biochemical Assay Reagents | |
| HY-D1056A2 | Lipopolysaccharides, from E. coli O127:B8 | Biochemical Assay Reagents | |
| HY-D1056A3 | Lipopolysaccharides, from E. coli O26:B6 | Biochemical Assay Reagents | |
| HY-D1056A4 | Lipopolysaccharides, from E. coli O128:B12 | Biochemical Assay Reagents | |
| HY-D1056A5 | Lipopolysaccharides, from E. coli K-235 | Biochemical Assay Reagents | |
| HY-D1056B1 | Lipopolysaccharides, from Proteus vulgaris | Biochemical Assay Reagents | |
| HY-D1056B2 | Lipopolysaccharides, from Proteus mirabilis | Biochemical Assay Reagents | |
| HY-D1056B3 | Lipopolysaccharides, from Klebsiella pneumoniae | Biochemical Assay Reagents | |
| HY-D1056B4 | Lipopolysaccharides, from Salmonella typhosa | Biochemical Assay Reagents | |
| HY-D1056C1 | Lipopolysaccharides, from S. enterica serotype enteritidis | Biochemical Assay Reagents | |
| HY-D1056C2 | Lipopolysaccharides, from S. enterica serotype minnesota | Biochemical Assay Reagents | |
| HY-D1056C3 | Lipopolysaccharides, from S. enterica serotype typhimurium | Biochemical Assay Reagents | |
| HY-D1056C4 | Lipopolysaccharides, from S. enterica serotype abortus equi | Biochemical Assay Reagents | |
| HY-D1056D | Lipopolysaccharides, from P. gingivalis | Biochemical Assay Reagents | |
| HY-D1056E | Lipopolysaccharides, from P. aeruginosa 10 | Biochemical Assay Reagents | |
| HY-D1056F | Biotin-Lipopolysaccharide, from E.coli O111:B4 | Biochemical Assay Reagents | |
| HY-D1056H | Lipopolysaccharides, from S. marcescens | Biochemical Assay Reagents | |
| HY-D1056I | Lipopolysaccharides, from Akkermansia muciniphila | Biochemical Assay Reagents | |
| HY-D1061 | 2,4,5,6-Tetraaminopyrimidine | 1004-74-6 | Dye Reagents |
| HY-D1062 | Pigment yellow 3 | 6486-23-3 | Dye Reagents |
| HY-D1063 | IR-780 | 207399-07-3 | Dye Reagents |
| HY-D1064 | Pigment red 57 | 5858-81-1 | Dye Reagents |
| HY-D1065 | NIR-H2O2 | 1392488-04-8 | Dye Reagents |
| HY-D1066 | NIR-Thiol (dinitrobenzenesulfonate) | Dye Reagents | |
| HY-D1067 | NIR dye-1 | 1392488-07-1 | Dye Reagents |
| HY-D1068 | Cy5-DBCO | 1564286-24-3 | Dye Reagents |
| HY-D1069 | DBCO-Cy3 | 1782950-79-1 | Dye Reagents |
| HY-D1070 | DBCO-PEG4-TAMRA | 1895849-41-8 | Dye Reagents |
| HY-D1071 | DBCO-PEG12-TCO | 2055022-06-3 | Dye Reagents |
| HY-D1072 | DiOC5(3) | 53213-81-3 | Dye Reagents |
| HY-D1073 | DiOC7(3) | 53213-83-5 | Dye Reagents |
| HY-D1074 | DiOC3(3) | 53213-79-9 | Dye Reagents |
| HY-D1075 | 1,1',3,3,3',3'-Hexamethylindodicarbocyanine (iodide) | 36536-22-8 | Dye Reagents |
| HY-D1076 | DiIC16(3) | 84109-11-5 | Dye Reagents |
| HY-D1078 | 5(6)-Carboxy-2',7'-dichlorofluorescein diacetate | 127770-45-0 | Dye Reagents |
| HY-D1079 | 5-[(2-aminoethyl)amino]-1-Naphthalenesulfonic acid sodium salt | 100900-07-0 | Reference compound |
| HY-D1080 | EDANS | 50402-56-7 | Dye Reagents |
| HY-D1080R | EDANS (Standard) | 50402-56-7 | Dye Reagents |
| HY-D1081 | 6-DTAF (hydrochloride) | 118357-32-7 | Dye Reagents |
| HY-D1082 | 5-DTAF | 51306-35-5 | Dye Reagents |
| HY-D1083 | 7-Methoxycoumarin-3-carboxylic acid, SE | 150321-92-9 | Dye Reagents |
| HY-D1084 | 7-Hydroxy-4-methylcoumarin-3-acetic acid | 5852-10-8 | Reference compound |
| HY-D1085 | AMCA-X SE | 216309-02-3 | Dye Reagents |
| HY-D1086 | 6-Carboxy-X-rhodamine, succinimidyl ester | 216699-36-4 | Dye Reagents |
| HY-D1089 | 6-JOE, SE | 113394-23-3 | Dye Reagents |
| HY-D1090 | JOE | 82855-40-1 | Reference compound |
| HY-D1091 | DiSBAC2(3) | 47623-98-3 | Dye Reagents |
| HY-D1092 | DiBAC4(5) | 63560-89-4 | Dye Reagents |
| HY-D1093 | Carboxy SNARF-1, acetoxymethyl ester (5/6-mixture) | 126208-13-7 | Dye Reagents |
| HY-D1094 | Carboxy-SNARF 1 (5/6-mixture) | 126208-12-6 | Dye Reagents |
| HY-D1095 | Cy7 DiAcid | 1268616-88-1 | Dye Reagents |
| HY-D1096 | Sulfo-Cy5 diacid (potassium) | 252255-40-6 | Dye Reagents |
| HY-D1097 | Cyanine 3.18 | 146397-17-3 | Dye Reagents |
| HY-D1097A | Cyanine 3.18 (TEA) | Dye Reagents | |
| HY-D1098 | SYBR Green II | 195199-08-7 | Dye Reagents |
| HY-D1098A | SYBR Green II (Ionic form) | 178919-00-1 | Dye Reagents |
| HY-D1100 | DNA intercalator 1 | 864281-61-8 | Dye Reagents |
| HY-D1101 | DNA intercalator 2 | 864281-69-6 | Dye Reagents |
| HY-D1102 | DNA intercalator 3 | 864281-70-9 | Dye Reagents |
| HY-D1103 | SiR dye 1 | 1808181-14-7 | Dye Reagents |
| HY-D1104 | SiR dye 2 | 2166078-18-6 | Dye Reagents |
| HY-D1105 | SiR dye 3 | 2227225-07-0 | Dye Reagents |
| HY-D1106 | Py-BODIPY-NHS ester | 201998-61-0 | Dye Reagents |
| HY-D1107 | NCT-TFP | 2379390-73-3 | Reference compound |
| HY-D1108 | 6 TMR Tre | Dye Reagents | |
| HY-D1109 | 5(6)-SFX ,SE | 114616-31-8 | Dye Reagents |
| HY-D1110 | TFAX 594,SE | 295348-87-7 | Dye Reagents |
| HY-D1111 | TFAX 568, SE | 878549-44-1 | Dye Reagents |
| HY-D1112 | TFAX 546,SE (triethylammonium) | Dye Reagents | |
| HY-D1113 | TFAX 488,TFP | 878546-79-3 | Dye Reagents |
| HY-D1114 | TFAX 488,SE (dilithium) | 222164-96-7 | Dye Reagents |
| HY-D1116 | MitoMark Red I | 167095-09-2 | Dye Reagents |
| HY-D1117 | NADA-green | 2253733-11-6 | Dye Reagents |
| HY-D1118 | BODIPY 576/589 | 150173-78-7 | Dye Reagents |
| HY-D1119 | AF647-NHS ester | 407627-60-5 | Dye Reagents |
| HY-D1119A | AF647-NHS ester (tripotassium) | 1453856-34-2 | Dye Reagents |
| HY-D1119B | AF647-NHS ester (trisodium) | Dye Reagents | |
| HY-D1119C | AF647-NHS ester (triTEA) | 407627-61-6 | Dye Reagents |
| HY-D1120 | Indoine blue | 4569-88-4 | Dye Reagents |
| HY-D1121 | Acid black 24 | 3071-73-6 | Dye Reagents |
| HY-D1122 | Janus green B | 2869-83-2 | Dye Reagents |
| HY-D1123 | Indigosol brown IBR | 23725-15-7 | Dye Reagents |
| HY-D1124 | Mordant brown 1 | 3564-15-6 | Dye Reagents |
| HY-D1128 | Disperse red 151 | 70210-08-1 | Dye Reagents |
| HY-D1129 | Basic yellow 40 | 29556-33-0 | Dye Reagents |
| HY-D1131 | Janus green | 4618-88-6 | Dye Reagents |
| HY-D1132 | Basic red 12 | 6320-14-5 | Dye Reagents |
| HY-D1133 | ASPT | 159721-38-7 | Biochemical Assay Reagents |
| HY-D1135 | Pigment yellow 81 | 22094-93-5 | Dye Reagents |
| HY-D1137 | C.I. Pigment yellow 110 | 5590-18-1 | Dye Reagents |
| HY-D1138 | Reactive red 120 | 61951-82-4 | Dye Reagents |
| HY-D1139 | Pigment red 177 | 4051-63-2 | Dye Reagents |
| HY-D1141 | Astrazone pink FG | 3648-36-0 | Dye Reagents |
| HY-D1142 | Acid orange 156 | 68555-86-2 | Dye Reagents |
| HY-D1143 | Acid Red 4 | 5858-39-9 | Dye Reagents |
| HY-D1144 | Acid blue 260 | 67827-60-5 | Dye Reagents |
| HY-D1148 | HKGreen-4I | 1448821-82-6 | Dye Reagents |
| HY-D1150 | Mito-PN | 2674101-37-0 | Dye Reagents |
| HY-D1151 | HKOH-1 | 2031170-96-2 | Dye Reagents |
| HY-D1154 | β-Ala-Lys(AMCA) | 180342-52-3 | Dye Reagents |
| HY-D1155 | Pigment red 176 | 12225-06-8 | Dye Reagents |
| HY-D1156 | HKSOX-1m (5/6-mixture) | 1786411-19-5 | Dye Reagents |
| HY-D1156A | HKSOX-1m (5/6-mixture) (hydrobromide) | Dye Reagents | |
| HY-D1157 | HKPerox-2 | 2245230-79-7 | Dye Reagents |
| HY-D1158 | HKOCl-4m | 2031170-88-2 | Dye Reagents |
| HY-D1159 | HKOH-1r | 2138472-08-7 | Dye Reagents |
| HY-D1160 | Erythrosin Yellowish | 33239-19-9 | Dye Reagents |
| HY-D1161 | True Blue | 71431-30-6 | Dye Reagents |
| HY-D1162 | Solvent orange 62 | 52256-37-8 | Dye Reagents |
| HY-D1163 | Chromium(III) acetate | 1066-30-4 | Reference compound |
| HY-D1164 | Pigment red 63:1 | 6417-83-0 | Dye Reagents |
| HY-D1165 | Direct red 31 | 5001-72-9 | Dye Reagents |
| HY-D1168 | Oil Red O | 1320-06-5 | Dye Reagents |
| HY-D1169 | BDP R6G carboxylic acid | 174881-57-3 | Dye Reagents |
| HY-D1170 | Acid alizarin red B | 1836-22-2 | Dye Reagents |
| HY-D1171 | Fluorescent brightener 220 | 16470-24-9 | Dye Reagents |
| HY-D1173 | Acid blue 113 | 3351-05-1 | Dye Reagents |
| HY-D1174 | Rhodamine 700 | 63561-42-2 | Dye Reagents |
| HY-D1175 | Alizarin cyanin green F | 4403-90-1 | Dye Reagents |
| HY-D1176 | Calcium Green 1AM | 186501-28-0 | Dye Reagents |
| HY-D1177 | Solvent orange 60 | 6925-69-5 | Dye Reagents |
| HY-D1179 | Solvent violet 38 | 68239-76-9 | Dye Reagents |
| HY-D1180 | DTTCI | 3071-70-3 | Dye Reagents |
| HY-D1181 | New Fuchsin | 3248-91-7 | Biochemical Assay Reagents |
| HY-D1183 | Direct blue 67 | 3354-97-0 | Dye Reagents |
| HY-D1186 | 2-Aza-ε-adenosine | 50663-82-6 | Dye Reagents |
| HY-D1187 | 2-Aza-ε-cAMP | 50663-90-6 | Dye Reagents |
| HY-D1187A | 2-Aza-ε-cAMP (sodium) | 1380911-15-8 | Dye Reagents |
| HY-D1188 | PARP7-probe-1 | 2379390-76-6 | Reference compound |
| HY-D1189 | YADA | 1471982-33-8 | Dye Reagents |
| HY-D1190 | DC271 | 198696-03-6 | Reference compound |
| HY-D1191 | SYBR green I (chloride) | 2225748-05-8 | Dye Reagents |
| HY-D1192 | 3-Nitrotetrazolium blue (chloride) | 38184-50-8 | Dye Reagents |
| HY-D1193 | Tetranitroblue tetrazolium (chloride) | 1184-43-6 | Biochemical Assay Reagents |
| HY-D1195 | Vat Blue 2 | 29245-44-1 | Dye Reagents |
| HY-D1196 | Direct Blue 71 | 4399-55-7 | Dye Reagents |
| HY-D1198 | Eosin B | 548-24-3 | Dye Reagents |
| HY-D1199 | Blue FPG-A (trisodium) | 78617-94-4 | Reference compound |
| HY-D1200 | Malachite Green Carbinol base | 510-13-4 | Reference compound |
| HY-D1200A | Malachite Green Carbinol base (hydrochloride) | 123333-61-9 | Biochemical Assay Reagents |
| HY-D1201 | Pigment Red 245 | 68016-05-7 | Dye Reagents |
| HY-D1202 | Disperse Violet 63 | 64294-88-8 | Dye Reagents |
| HY-D1203 | Acid Brown 4 | 5858-51-5 | Dye Reagents |
| HY-D1204 | Pigment Yellow 65 | 6528-34-3 | Dye Reagents |
| HY-D1205 | 4-Carboxy-pennsylvania green | 879288-14-9 | Dye Reagents |
| HY-D1206 | Hide powder Azure | 37340-54-8 | Dye Reagents |
| HY-D1207 | Direct Orange 26 | 3626-36-6 | Dye Reagents |
| HY-D1208 | CDP-Star | 160081-62-9 | Dye Reagents |
| HY-D1209 | Acid Red 35 | 6441-93-6 | Dye Reagents |
| HY-D1210 | Solvent Orange 14 | 6368-70-3 | Dye Reagents |
| HY-D1211 | 10-Dodecylacridine Orange Bromide | 41387-42-2 | Dye Reagents |
| HY-D1212 | BCIP (dipotassium) | 390748-26-2 | Dye Reagents |
| HY-D1213 | 4-Nitrocatechol sulfate (dipotassium salt) | 14528-64-4 | Reference compound |
| HY-D1214 | Basic Red 46 | 12221-69-1 | Dye Reagents |
| HY-D1215 | Pigment Red 31 | 6448-96-0 | Dye Reagents |
| HY-D1216 | Solvent Yellow 98 | 12671-74-8 | Dye Reagents |
| HY-D1217 | Pigment Yellow 12 | 6358-85-6 | Dye Reagents |
| HY-D1218 | Fast Red TR (napadisylate) | 51503-28-7 | Dye Reagents |
| HY-D1219 | Disperse blue 359 | 62570-50-7 | Dye Reagents |
| HY-D1220 | Pigment blue 60 | 81-77-6 | Dye Reagents |
| HY-D1221 | 6-Fluorescein phosphoramidite | 204697-37-0 | Dye Reagents |
| HY-D1222 | Vat violet 13 | 4424-87-7 | Dye Reagents |
| HY-D1223 | AF488 NHS ester (diTEA) | Dye Reagents | |
| HY-D1224 | Chlorophenol red-β-D-galactopyranoside | 99792-79-7 | Dye Reagents |
| HY-D1224A | Chlorophenol red β-D-galactopyranoside (sodium) | 99792-50-4 | Biochemical Assay Reagents |
| HY-D1225 | Reactive red 180 | 98114-32-0 | Dye Reagents |
| HY-D1226 | Direct violet 51 | 5489-77-0 | Dye Reagents |
| HY-D1227 | Acid violet 1 | 6441-91-4 | Dye Reagents |
| HY-D1228 | Pigment Red 22 | 6448-95-9 | Dye Reagents |
| HY-D1229 | Pigment Red 48:4 | 5280-66-0 | Dye Reagents |
| HY-D1230 | Mordant red 15 | 6359-29-1 | Dye Reagents |
| HY-D1232 | BDP TMR NHS ester | 485397-12-4 | Dye Reagents |
| HY-D1233 | Pigment red 202 | 3089-17-6 | Dye Reagents |
| HY-D1235 | Fluorescent brightener 210 | 28950-61-0 | Dye Reagents |
| HY-D1237 | BODIPY 505/515 | 21658-70-8 | Dye Reagents |
| HY-D1238 | Direct red 79 | 1937-34-4 | Dye Reagents |
| HY-D1239 | BODIPY R6G NHS ester | 335193-70-9 | Dye Reagents |
| HY-D1240 | Rhodamine 101 (inner salt) | 116450-56-7 | Dye Reagents |
| HY-D1241 | Janus red | 2636-31-9 | Dye Reagents |
| HY-D1242 | CI Vat green 1 | 128-58-5 | Dye Reagents |
| HY-D1243 | Reactive yellow 3 | 6539-67-9 | Dye Reagents |
| HY-D1244 | CO probe 1 | 1043865-37-7 | Dye Reagents |
| HY-D1245 | Oxazole blue | 157199-56-9 | Dye Reagents |
| HY-D1246 | Ethidium monoazide (bromide) | 58880-05-0 | Dye Reagents |
| HY-D1247 | Hydroxynaphthol Blue | 63451-35-4 | Biochemical Assay Reagents |
| HY-D1248 | CBQCA | 131124-59-9 | Dye Reagents |
| HY-D1249 | Calcein (mixture of isomers) | 154071-48-4 | Dye Reagents |
| HY-D1250 | Mito-TRFS | 1859102-62-7 | Dye Reagents |
| HY-D1251 | TRFS-red | Dye Reagents | |
| HY-D1252 | Fast-TRFS | 2966536-18-3 | Dye Reagents |
| HY-D1253 | TP-TRFS | 2937819-61-7 | Reference compound |
| HY-D1254 | Trx-red | 2368978-96-3 | Dye Reagents |
| HY-D1255 | Sel-green | 1574299-37-8 | Dye Reagents |
| HY-D1256 | Msr-blue | 2966537-39-1 | Dye Reagents |
| HY-D1257 | Msr-Ratio | 2290635-22-0 | Dye Reagents |
| HY-D1258 | AC-green | 2937705-58-1 | Dye Reagents |
| HY-D1259 | NEP | 2414276-32-5 | Dye Reagents |
| HY-D1260 | FM-red | Dye Reagents | |
| HY-D1261 | Naph-EA-mal | 210292-65-2 | Dye Reagents |
| HY-D1262 | BODIPY-TS | 1808174-52-8 | Dye Reagents |
| HY-D1264 | PMQA | 1263820-18-3 | Dye Reagents |
| HY-D1265 | EtS-DMAB | 2929446-76-2 | Dye Reagents |
| HY-D1266 | RB-OPD | 1034863-51-8 | Dye Reagents |
| HY-D1267 | PAO-Nap | 1613402-20-2 | Reference compound |
| HY-D1268 | Seph-PAO | 851461-65-9 | Dye Reagents |
| HY-D1269 | Rhodamine-N3 (chloride) | 2363751-90-8 | Dye Reagents |
| HY-D1270 | Direct Violet 1 | 2586-60-9 | Dye Reagents |
| HY-D1272 | Sulfo-Cy3 amine | 2183440-43-7 | Dye Reagents |
| HY-D1273 | Vat Blue 6 | 130-20-1 | Reference compound |
| HY-D1274 | Sulfo-cyanine3 azide | 1658416-54-6 | Dye Reagents |
| HY-D1274A | Sulfo-cyanine3 azide (sodium) | 2055138-89-9 | Dye Reagents |
| HY-D1274B | Sulfo-cyanine3 azide (TEA) | Dye Reagents | |
| HY-D1274C | Sulfo-cyanine3 azide (potassium) | Dye Reagents | |
| HY-D1275 | CAY10731 | 2119597-33-8 | Dye Reagents |
| HY-D1277 | Pigment red 21 | 6410-26-0 | Dye Reagents |
| HY-D1278 | 4-(5)-(((4-ChloroMethyl)Benzoyl)AMino)TetraMethylrhodaMine | 323192-14-9 | Dye Reagents |
| HY-D1280 | NanoLuc substrate 1 | 2412089-75-7 | Dye Reagents |
| HY-D1281 | NanoLuc substrate 2 | 2412089-80-4 | Dye Reagents |
| HY-D1283 | Mordant red 19 | 1934-24-3 | Dye Reagents |
| HY-D1284 | BOP-JF646 | Dye Reagents | |
| HY-D1286 | Serum CG probe 1 | Dye Reagents | |
| HY-D1287 | Serum CG probe 2 | Dye Reagents | |
| HY-D1288 | (Rac)-tris-NTA | 1146592-99-5 | Reference compound |
| HY-D1288A | tris-NTA | 862778-60-7 | Reference compound |
| HY-D1289 | GA-PEG5-bromide | Dye Reagents | |
| HY-D1290 | Antheraxanthin | 640-03-9 | Dye Reagents |
| HY-D1291 | Photoacoustic contrast agent-1 | 2255329-06-5 | Dye Reagents |
| HY-D1291A | Photoacoustic contrast agent-1 (perchlorate) | 2255329-07-6 | Reference compound |
| HY-D1292 | Photoacoustic contrast agent-2 | 2255329-08-7 | Dye Reagents |
| HY-D1292A | Photoacoustic contrast agent-2 (perchlorate) | 2255329-09-8 | Dye Reagents |
| HY-D1292C | Photoacoustic contrast agent-2 (acetate) | Dye Reagents | |
| HY-D1293 | Photosensitizer-1 | 1886-13-1 | Reference compound |
| HY-D1293A | Photosensitizer-1 (hydrochloride) | 2771189-66-1 | Dye Reagents |
| HY-D1294 | SY-21 NHS ester | 788146-37-2 | Reference compound |
| HY-D1295 | Pyrene azide 3 | 2252168-06-0 | Reference compound |
| HY-D1296 | Green DND-26 | 220524-71-0 | Dye Reagents |
| HY-D1297 | ER-Tracker Green | 730931-46-1 | Dye Reagents |
| HY-D1298 | Dye 40 | 220524-78-7 | Dye Reagents |
| HY-D1299 | meso-CF3-BODIPY 2 | 1642327-22-7 | Dye Reagents |
| HY-D1300 | LysoTracker Red | 231946-72-8 | Dye Reagents |
| HY-D1301 | BODIPY 581/591 C11 | 217075-36-0 | Dye Reagents |
| HY-D1302 | Near-IR fluorescent probe-1 | 1836131-69-1 | Dye Reagents |
| HY-D1303 | Marina blue | 215868-23-8 | Dye Reagents |
| HY-D1304 | Alexa fluor 488 azide (ditriethylamine) | 1006592-64-8 | Dye Reagents |
| HY-D1305 | ATTO 488 carboxylic acid | 1443553-08-9 | Dye Reagents |
| HY-D1306 | TAMRA azide, 6-isomer | 1192590-89-8 | Dye Reagents |
| HY-D1307 | Sulfo-cyanine7 alkyne | 2183440-55-1 | Dye Reagents |
| HY-D1307A | Sulfo-cyanine7 alkyne (potassium) | 2183440-56-2 | Dye Reagents |
| HY-D1308 | Sulfo-Cyanine5.5 azide (tripotassium) | 2382994-65-0 | Dye Reagents |
| HY-D1309 | Sulfo-cyanine3 NHS ester (sodium) | 1424150-38-8 | Dye Reagents |
| HY-D1310 | Sulfo-cyanine3.5 NHS ester (tripotassium) | 176978-76-0 | Dye Reagents |
| HY-D1311 | R110 azide, 6-isomer | 1622395-29-2 | Dye Reagents |
| HY-D1312 | Pyrene azide 2 | 1807512-45-3 | Reference compound |
| HY-D1313 | PEP azide | 1807521-02-3 | Dye Reagents |
| HY-D1314 | FAM azide, 6-isomer | 1386385-76-7 | Dye Reagents |
| HY-D1315 | Cyanine7 NHS ester (tetrafluoroborate) | 2408482-09-5 | Dye Reagents |
| HY-D1316 | Cyanine7 azide (chloride) | 1557149-65-1 | Dye Reagents |
| HY-D1317 | Cyanine7.5 carboxylic acid (chloride) | 1803099-44-6 | Dye Reagents |
| HY-D1317A | Cyanine7.5 carboxylic | 1686147-68-1 | Dye Reagents |
| HY-D1318 | Cyanine7.5 azide (chloride) | 1628790-36-2 | Dye Reagents |
| HY-D1319A | Cyanine5 carboxylic acid (bromide) | 666829-25-0 | Dye Reagents |
| HY-D1320 | Cyanine5 azide (chloride) | 1267539-32-1 | Dye Reagents |
| HY-D1321 | Cy 5 amine (hydrochloride) | 1807529-70-9 | Dye Reagents |
| HY-D1321A | Cy 5 amine (TFA) | Dye Reagents | |
| HY-D1322 | Cyanine5.5 NHS ester (tetrafluoroborate) | 2375105-86-3 | Dye Reagents |
| HY-D1323 | Cyanine5.5 maleimide (chloride) | 2409591-45-1 | Dye Reagents |
| HY-D1324 | Cyanine5.5 hydrazide (dichloride) | Dye Reagents | |
| HY-D1325 | Cyanine5.5 alkyne (chloride) | 1628790-37-3 | Dye Reagents |
| HY-D1326 | Cyanine3 carboxylic acid | 1361402-15-4 | Dye Reagents |
| HY-D1327 | Cyanine3 azide (chloride) | 1167421-28-4 | Dye Reagents |
| HY-D1328 | BDP TMR maleimide | 2183473-34-7 | Dye Reagents |
| HY-D1329 | BDP TMR azide | 2183473-25-6 | Dye Reagents |
| HY-D1330 | BDP R6G azide | 2183473-23-4 | Dye Reagents |
| HY-D1331 | BDP FL tetrazine | 2042193-77-9 | Dye Reagents |
| HY-D1332 | BODIPY FL hydrazide (hydrochloride) | 2183473-45-0 | Dye Reagents |
| HY-D1333 | BDP 630/650 alkyne | 2006345-38-4 | Dye Reagents |
| HY-D1335 | TAMRA amine, 5-isomer | 2158336-47-9 | Dye Reagents |
| HY-D1336 | FAM amine, 6-isomer | 2183440-42-6 | Dye Reagents |
| HY-D1337 | Cyanine7 carboxylic acid (chloride) | 1628790-40-8 | Dye Reagents |
| HY-D1338 | Cyanine3.5 carboxylic acid (chloride) | 1802928-88-6 | Dye Reagents |
| HY-D1339 | Cyanine7 hydrazide (dichloride) | 2183440-63-1 | Dye Reagents |
| HY-D1340 | Sulfo-Cyanine7 maleimide (potassium) | 2183440-60-8 | Dye Reagents |
| HY-D1341 | Coumberone | 878019-47-7 | Dye Reagents |
| HY-D1342 | Coumberol | 878019-53-5 | Dye Reagents |
| HY-D1343 | DMNPE-caged D-luciferin | 223920-67-0 | Dye Reagents |
| HY-D1344 | BDP 630/650 azide | 2183473-22-3 | Dye Reagents |
| HY-D1345 | SiR-COOH | 1418275-26-9 | Dye Reagents |
| HY-D1346 | 610CP | 1877282-17-1 | Dye Reagents |
| HY-D1347 | BDP 650/665 alkyne | 2006345-40-8 | Dye Reagents |
| HY-D1348 | BDP R6G alkyne | 2006345-31-7 | Dye Reagents |
| HY-D1349 | Bodipy TR alkyne | 2006345-35-1 | Dye Reagents |
| HY-D1350 | 5-ROX-alkyne | 2264016-88-6 | Dye Reagents |
| HY-D1352 | Sulfo-Cyanine7 NHS ester (potassium) | 1603861-95-5 | Dye Reagents |
| HY-D1352A | Sulfo-Cyanine7 NHS ester (TEA) | Dye Reagents | |
| HY-D1353 | LipidGreen 2 | 1382764-52-4 | Dye Reagents |
| HY-D1354 | Azide MegaStokes dye 673 | 1246853-81-5 | Dye Reagents |
| HY-D1355 | Azide cyanine dye 728 | 1188332-22-0 | Dye Reagents |
| HY-D1356 | Azide MegaStokes dye 735 | 1246853-82-6 | Dye Reagents |
| HY-D1357 | Alkyne MegaStokes dye 735 | 1246853-79-1 | Dye Reagents |
| HY-D1358 | Alkyne MegaStokes dye 608 | 1188292-56-9 | Dye Reagents |
| HY-D1359 | Mito Red | 1021902-10-2 | Dye Reagents |
| HY-D1360 | Pyrogallol red | 32638-88-3 | Biochemical Assay Reagents |
| HY-D1361 | Alkyne cyanine dye 718 | 1188292-54-7 | Dye Reagents |
| HY-D1362 | BDP 630/650 maleimide | 2183473-31-4 | Dye Reagents |
| HY-D1363 | BDP R6G maleimide | 2183473-32-5 | Dye Reagents |
| HY-D1364 | Pyrene maleimide | 1869968-64-8 | Reference compound |
| HY-D1365 | Sulfo-Cy3(Me)COOH | 1121756-11-3 | Dye Reagents |
| HY-D1365A | Sulfo-Cy3(Me)COOH (TEA) | Dye Reagents | |
| HY-D1366 | Sulfo-Cyanine5.5 carboxylic acid | 2183440-68-6 | Dye Reagents |
| HY-D1366A | Sulfo-Cyanine5.5 carboxylic acid (potassium) | 2183440-69-7 | Dye Reagents |
| HY-D1367 | Sulfo-Cyanine7 carboxylic acid | 2104632-29-1 | Dye Reagents |
| HY-D1368 | BDP FL amine (hydrochloride) | 2183473-03-0 | Dye Reagents |
| HY-D1369 | BDP R6G amine (hydrochloride) | 2183473-06-3 | Dye Reagents |
| HY-D1370 | BDP TMR amine | 2183473-08-5 | Dye Reagents |
| HY-D1371 | BDP TR amine (hydrochloride) | 2183473-18-7 | Dye Reagents |
| HY-D1372 | Cyanine3 amine (hydrochloride) | 2247688-56-6 | Dye Reagents |
| HY-D1372A | Cyanine3 amine (TFA) | Dye Reagents | |
| HY-D1373 | HBC | 156840-13-0 | Dye Reagents |
| HY-D1374 | Sulfo-Cy5 carboxylic acid (potassium) | 1144107-82-3 | Dye Reagents |
| HY-D1375 | Sulfo-Cy5 amine | 2183440-44-8 | Dye Reagents |
| HY-D1375A | Sulfo-Cy5 amine (hydrochloride) | Dye Reagents | |
| HY-D1376 | Sulfo-Cyanine5.5 amine (potassium) | 2183440-46-0 | Dye Reagents |
| HY-D1376A | Sulfo-Cyanine5.5 amine | 2183440-45-9 | Dye Reagents |
| HY-D1377 | Citrulline-specific probe-rhodamine (hydrate) | 2309313-01-5 | Dye Reagents |
| HY-D1378 | C-Laurdan | 959839-06-6 | Dye Reagents |
| HY-D1379 | Azophloxine | 3734-67-6 | Dye Reagents |
| HY-D1380 | SiR-NHS | 1426090-09-6 | Dye Reagents |
| HY-D1381 | CH1055-PEG | 1988753-67-8 | Dye Reagents |
| HY-D1382 | BrIR2 | 2089258-78-4 | Dye Reagents |
| HY-D1383 | LZ-1105 | 2369809-51-6 | Dye Reagents |
| HY-D1385 | JF526–Pepstatin A (TFA) | 2410614-07-0 | Dye Reagents |
| HY-D1386 | JF526-Taxol (TFA) | 2410613-93-1 | Dye Reagents |
| HY-D1387 | Naloxone fluorescein (acetate) | 2080300-52-1 | Dye Reagents |
| HY-D1388 | Cyanine3 NHS ester tetrafluoroborate | 2632339-91-2 | Dye Reagents |
| HY-D1389 | Sulfo-CY-5.5 NHS ester (tripotassium) | 2419286-92-1 | Dye Reagents |
| HY-D1390 | Sulfo-Cy5-Mal (potassium) | 2242791-82-6 | Dye Reagents |
| HY-D1390A | Sulfo-Cy5-Mal | 2130955-10-9 | Dye Reagents |
| HY-D1391 | PbS/CdS QDs | Dye Reagents | |
| HY-D1392 | Ag2Te QDs | Dye Reagents | |
| HY-D1393 | Pb:Ag2Se QDs | Dye Reagents | |
| HY-D1394 | AgAuSe QDs | Dye Reagents | |
| HY-D1395 | RH-EDA | Reference compound | |
| HY-D1396 | Br-DAPI | 2387906-44-5 | Dye Reagents |
| HY-D1397 | Kbz probe 1 | 2606820-58-8 | Dye Reagents |
| HY-D1398 | LtIA-F | Reference compound | |
| HY-D1399 | Kdn probe-1 | 2857099-16-0 | Dye Reagents |
| HY-D1400 | HBTP-H2S (chloride) | Dye Reagents | |
| HY-D1401 | OG 488, acid | 195136-52-8 | Dye Reagents |
| HY-D1402 | 5MP-Fluorescein | 2100282-58-2 | Dye Reagents |
| HY-D1403 | L-Biotin-NH-5MP | 2100288-18-2 | Dye Reagents |
| HY-D1404 | 5MP-Propargyl | 2100286-15-3 | Dye Reagents |
| HY-D1405 | Br-5MP-Fluorescein | 2468100-39-0 | Dye Reagents |
| HY-D1406 | L-Biotin-NH-5MP-Br | 2468100-38-9 | Dye Reagents |
| HY-D1407 | Br-5MP-Propargyl | 2468100-37-8 | Dye Reagents |
| HY-D1408 | DMTr-4'-Me-U-CED-TBDMS phosphoramidite | 1260508-74-4 | Dye Reagents |
| HY-D1409 | DMTr-4'-F-U-CED-TBDMS phosphoramidite | Dye Reagents | |
| HY-D1410 | DMTr-4'-F-5-Me-U-CED phosphoramidite | 2758388-05-3 | Dye Reagents |
| HY-D1411 | DMTr-4'-CF3-5-Me-U-CED phosphoramidite | Oligonucleotides | |
| HY-D1414 | Cyanine 3 Bisfunctional MTSEA Dye (potassium) | Dye Reagents | |
| HY-D1415 | Cyanine 5 Bisfunctional MTSEA Dye (potassium) | Dye Reagents | |
| HY-D1416 | HMBR | 1287651-36-8 | Dye Reagents |
| HY-D1417 | P-BP-SFAC | 2247391-82-6 | Dye Reagents |
| HY-D1418 | CP-BP-SFAC | Dye Reagents | |
| HY-D1419 | mCP-BP-SFAC | Dye Reagents | |
| HY-D1420 | TCP-BP-SFAC | Dye Reagents | |
| HY-D1421 | PKH 67 | 257277-27-3 | Dye Reagents |
| HY-D1422 | ER Thermo Yellow | 1445108-32-6 | Dye Reagents |
| HY-D1423 | Dibromobimane | 68654-25-1 | Dye Reagents |
| HY-D1424 | Coelenterazine hcp | 123437-32-1 | Dye Reagents |
| HY-D1425 | DCVJ | 58293-56-4 | Dye Reagents |
| HY-D1426 | Di-12-ANEPPQ | 217176-86-8 | Dye Reagents |
| HY-D1427 | Di-2-ANEPEQ | 160605-94-7 | Dye Reagents |
| HY-D1428 | Di-4-ANEPPDHQ | 797785-10-5 | Dye Reagents |
| HY-D1429 | ER-Tracker Blue-White DPX | 287715-95-1 | Dye Reagents |
| HY-D1431 | ER-Tracker Red | Dye Reagents | |
| HY-D1432 | FITC-C6-DEVD-FMK | Dye Reagents | |
| HY-D1433 | FITC-C6-LEHD-FMK | Dye Reagents | |
| HY-D1434 | FM1-43 | 149838-22-2 | Dye Reagents |
| HY-D1435 | Oxonol VI | 64724-75-0 | Dye Reagents |
| HY-D1436 | PBFI | 124549-11-7 | Dye Reagents |
| HY-D1438 | RH 414 | 161433-30-3 | Dye Reagents |
| HY-D1439 | RH 795 | 172807-13-5 | Dye Reagents |
| HY-D1440 | Rhodamine B, tetramethyl-, isothiocyanate | 6749-36-6 | Dye Reagents |
| HY-D1441 | Zinquin AM ester | 181530-16-5 | Dye Reagents |
| HY-D1442 | SBFI (tetraammonium) | 172651-12-6 | Dye Reagents |
| HY-D1443 | BSB | 291766-06-8 | Dye Reagents |
| HY-D1444 | Propidium monoazide | 91416-20-5 | Dye Reagents |
| HY-D1445 | LysoSensor PDMPO | Dye Reagents | |
| HY-D1446 | 3′,6′-Bis(allyloxy)-Fluoran | 855751-82-5 | Dye Reagents |
| HY-D1447 | Fluo-3FF (pentapotassium) | 348079-14-1 | Dye Reagents |
| HY-D1449 | IR-1061 | 155614-01-0 | Dye Reagents |
| HY-D1450 | IR-1048 | 155613-98-2 | Dye Reagents |
| HY-D1451 | PKH 26 | 154214-55-8 | Dye Reagents |
| HY-D1452 | BDP-4 | 2566625-99-6 | Dye Reagents |
| HY-D1453 | Immune initiator-1 | 3036258-19-9 | Reference compound |
| HY-D1454 | Nitro Blue Diformazan | 16325-01-2 | Dye Reagents |
| HY-D1456 | TEPC466 | 2621957-88-6 | Dye Reagents |
| HY-D1457 | DND-189 | 152584-38-8 | Dye Reagents |
| HY-D145729F | FAM-Danvatirsen | Dye Reagents | |
| HY-D1458 | Peroxyfluor 1 | 817170-66-4 | Dye Reagents |
| HY-D1459 | BODIPY 665/676 | 164106-16-5 | Dye Reagents |
| HY-D1460 | Fluorescein Di-β-D-Glucuronide | 134869-04-8 | Dye Reagents |
| HY-D1461 | Fluorescein Di-β-D-Glucopyranoside | 129787-66-2 | Dye Reagents |
| HY-D1462 | CellTracker Blue CMAC | 147963-22-2 | Dye Reagents |
| HY-D1463 | Nile Blue Methacrylamide | 699018-10-5 | Dye Reagents |
| HY-D1464 | CH1055 | 1622250-38-7 | Dye Reagents |
| HY-D1464A | CH1055 (triethylamine) | Dye Reagents | |
| HY-D1465 | Alexa 532 | 222159-92-4 | Dye Reagents |
| HY-D1468 | Phototherapeutic agent-1 | 2555045-67-3 | Reference compound |
| HY-D1469 | 5-Carboxyrhodamine 6G succinimidyl ester | 209112-21-0 | Dye Reagents |
| HY-D1470 | BADAN | 210832-86-3 | Dye Reagents |
| HY-D1471 | 10-(3-Sulfopropyl)acridinium Betaine | 83907-41-9 | Dye Reagents |
| HY-D1472 | Azure A eosinate | 62298-43-5 | Dye Reagents |
| HY-D1473 | 2-(2-Benzoxazolyl)phenyl benzoate | 477934-10-4 | Dye Reagents |
| HY-D1474 | WNT7A-IN-1 (sodium) | 33628-03-4 | Reference compound |
| HY-D1475 | SIR-6-COOH | 1426090-03-0 | Dye Reagents |
| HY-D1477 | 5(6)-Carboxyfluorescein diisobutyrate | 287111-44-8 | Dye Reagents |
| HY-D1478 | Fluorescent polyamine probe-1 | 2678634-03-0 | Dye Reagents |
| HY-D1479 | Crocein Scarlet 7B | 6226-76-2 | Dye Reagents |
| HY-D1480 | Crystal Ponceau 6R | 2766-77-0 | Dye Reagents |
| HY-D1481 | 6,7-Diaminoquinoxaline-2,3-dione (dihydrochloride) | 17498-26-9 | Dye Reagents |
| HY-D1482 | Sulfo-Cy5-tetrazine | 1801695-57-7 | Dye Reagents |
| HY-D1482A | Sulfo Cy5-tetrazine (sodium) | Dye Reagents | |
| HY-D1483 | 3,3-Dibutylthiacarbocyanine (iodide) | 53213-85-7 | Dye Reagents |
| HY-D1484 | Ethyl red (iodide) | 634-21-9 | Dye Reagents |
| HY-D148410F | Cy5-Zorevunensen negative control | Dye Reagents | |
| HY-D1485 | 3,3'-Diethylthiacyanine (iodide) | 2197-01-5 | Dye Reagents |
| HY-D1486 | 4,4-Difluoro-8-(4'-iodophenyl)-1,7-bis-(1'-napthyl)-4-bora-3alpha,4alpha-diaza-s-indacene | 216255-54-8 | Dye Reagents |
| HY-D1487 | Patman | 87393-54-2 | Dye Reagents |
| HY-D1488 | Ethyl benzo[6,7]-4-oxo-4H-quinolizine-3-carboxlate | 101192-30-7 | Dye Reagents |
| HY-D1489 | Ethyl eosin | 6359-05-3 | Dye Reagents |
| HY-D1490 | Fast red TR salt hemi(zinc chloride) | 89453-69-0 | Dye Reagents |
| HY-D1491 | Fast Red Violet LB | 32348-81-5 | Dye Reagents |
| HY-D1491A | Fast Red Violet LB (Zinc chloride) | Dye Reagents | |
| HY-D1492 | Fast Sulphon Black F | 3682-47-1 | Dye Reagents |
| HY-D1493 | FIM-1 | 220518-50-3 | Dye Reagents |
| HY-D1495 | Fluorescent red NIR 880 | 177194-52-4 | Dye Reagents |
| HY-D1496 | Fluorescent Red Mega 485 NHS-ester | 890317-36-9 | Dye Reagents |
| HY-D1497 | Fluorescent Red Mega 480 | 540528-00-5 | Dye Reagents |
| HY-D1498 | Mag-Fluo-4 AM | 1097709-31-3 | Dye Reagents |
| HY-D1499 | Fluorescent red 610 | 482379-37-3 | Dye Reagents |
| HY-D1500 | Fluorescent NIR 885 | 177194-56-8 | Dye Reagents |
| HY-D1501 | Fura PE-3 (potassium) | 172890-83-4 | Dye Reagents |
| HY-D1502 | FURA-PE3/AM | 172890-84-5 | Dye Reagents |
| HY-D1503 | Glut-Phe-AMC | 58632-47-6 | Dye Reagents |
| HY-D1504 | IR-797 (chloride) | 110992-55-7 | Dye Reagents |
| HY-D1505 | 4-(N,N-Dimethylamino)azobenzene-4'-isothiocyanate | 7612-98-8 | Dye Reagents |
| HY-D1506 | Fl-DIBO | 1407523-31-2 | Dye Reagents |
| HY-D1507 | 1-[3-(Succinimidyloxycarbonyl)benzyl]-4-[2-(3,4-dihydro-2H-1-benzopyran-6-yl)-5-oxazolyl]pyridinium (bromide) | 155863-03-9 | Dye Reagents |
| HY-D1508 | 2-(Pyren-1-ylaminocarbonyl)ethyl methanethiosulfonate | 384342-64-7 | Dye Reagents |
| HY-D1509 | Phenazine ethosulfate | 10510-77-7 | Dye Reagents |
| HY-D1510 | 4-Nitrophenyl 2-O-(β-L-Fucopyranosyl)-β-D-Galactopyranoside | 77640-21-2 | Reference compound |
| HY-D1511 | Oxonol Blue | 51858-17-4 | Dye Reagents |
| HY-D1512 | Oxonol 595 | 88969-31-7 | Dye Reagents |
| HY-D1513 | O-Methyl-O-(N-butylfluorescein)phosphate | 887406-94-2 | Dye Reagents |
| HY-D1514 | NIR-641 N-succinimidyl ester | 190714-26-2 | Dye Reagents |
| HY-D1515 | FM1-84 | 303727-66-4 | Dye Reagents |
| HY-D1516 | NerveGreen C3 | 1331918-65-0 | Dye Reagents |
| HY-D1517 | FM 2-10 | 336185-20-7 | Dye Reagents |
| HY-D1518 | NerveGreen C1 | 2563610-25-1 | Dye Reagents |
| HY-D1519 | Naphthalene-1,2-dicarbaldehyde | 74057-36-6 | Dye Reagents |
| HY-D1520 | Naphthol AS-GR phosphate (disodium) | 100929-51-9 | Dye Reagents |
| HY-D1521 | N-(NBD-Aminolauroyl)safingol | 474943-07-2 | Dye Reagents |
| HY-D1522 | N,N'-Bis[2-(acetamido)ethyl]-N,N'-dimethyl rhodamine | 1022835-74-0 | Dye Reagents |
| HY-D1523 | Z-Arg-Arg-4MβNA (triacetate) | 100900-19-4 | Dye Reagents |
| HY-D1524 | N-(Aminoethyl)-8-naphthylamine-1-sulfonic acid | 50402-57-8 | Dye Reagents |
| HY-D1524A | N-(Aminoethyl)-8-naphthylamine-1-sulfonic acid (sodium) | 185503-88-2 | Dye Reagents |
| HY-D1525 | N-(7-Nitrobenzofurazan-4-yl)phallacidin | 73413-78-2 | Dye Reagents |
| HY-D1526 | N-(4-Anilino-1-naphthyl)maleimide | 50539-45-2 | Dye Reagents |
| HY-D1527 | N-(3-Fluoranthenyl)maleimide | 60354-76-9 | Dye Reagents |
| HY-D1528 | MTSEA-Fluorescein | 1356019-48-1 | Dye Reagents |
| HY-D1529 | 4-Methylumbelliferyl phosphate (2-amino-2-methyl-1,3-propanediol) | 107475-10-5 | Dye Reagents |
| HY-D1530 | 4-Methylumbelliferyl-N-acetyl-α-D-glucosaminide | 80265-04-9 | Dye Reagents |
| HY-D1531 | 4-Methyl-2-phenylchromenylium (tetrafluoroborate) | 155614-08-7 | Dye Reagents |
| HY-D1532 | DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS | 263718-22-5 | Dye Reagents |
| HY-D1533 | RhoNox-1 | 1447815-38-4 | Dye Reagents |
| HY-D1534 | H-L-Ile-Amc (TFA) | 191723-68-9 | Reference compound |
| HY-D1535 | IR 813 (perchlorate) | 201024-57-9 | Dye Reagents |
| HY-D1536 | Glycine cresol red | 77031-64-2 | Dye Reagents |
| HY-D1537 | Dibenzocyclooctyne-Cy5.5 | 2643308-61-4 | Dye Reagents |
| HY-D1539 | Cyanine 5.5 azide | 1557136-25-0 | Dye Reagents |
| HY-D1540 | Cyanine5.5 amine | 2097714-45-7 | Dye Reagents |
| HY-D1541 | Sulfo-Cyanine5.5 alkyne | Dye Reagents | |
| HY-D1542 | Mucicarmine | 51395-97-2 | Dye Reagents |
| HY-D1543 | Pyronin B | 2150-48-3 | Dye Reagents |
| HY-D1544 | Uniblue A (sodium) | 14541-90-3 | Dye Reagents |
| HY-D1545 | Violamine R | 6252-76-2 | Dye Reagents |
| HY-D1546 | Biotin-C2-maleimide | 139554-72-6 | Dye Reagents |
| HY-D1547 | 1-(3',6'-Bis(ethylamino)-2',7'-dimethyl-3-oxospiro[isoindoline-1,9'-xanthen]-2-yl)-3-phenylurea | 957493-98-0 | Dye Reagents |
| HY-D1548 | 1-(Azidomethyl)pyrene | 1006061-57-9 | Dye Reagents |
| HY-D1549 | o-Pah | 1181844-41-6 | Dye Reagents |
| HY-D1550 | 10-(4-(Bis(2-acetoxyethyl)amino)phenyl)-BODIPY 505/515 | 886212-87-9 | Dye Reagents |
| HY-D1551 | 10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 886212-86-8 | Dye Reagents |
| HY-D1553 | BODIPY-C12 | 1029138-21-3 | Dye Reagents |
| HY-D1554 | Cyanine5 tetrazine | Dye Reagents | |
| HY-D1555 | Cyanine7 DBCO | 2692677-77-1 | Dye Reagents |
| HY-D1556 | 18:1 PE CF | 384832-91-1 | Biochemical Assay Reagents |
| HY-D1557 | Cyanine5.5 tetrazine | Dye Reagents | |
| HY-D1558 | 1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs | 1825368-13-5 | Dye Reagents |
| HY-D1560 | FG 488 DHPE | 438476-80-3 | Dye Reagents |
| HY-D1561 | FG 488 BAPTA-2 AM | 2484828-10-4 | Dye Reagents |
| HY-D1562 | CytoTrace Red CMTPX | Dye Reagents | |
| HY-D1563 | CypHer 5 | 312961-83-4 | Dye Reagents |
| HY-D1564 | Cy7.5 hydrazide | Dye Reagents | |
| HY-D1565 | Cy7.5 maleimide | 2270866-73-2 | Dye Reagents |
| HY-D1566 | Sulfo-Cy7.5 maleimide | Dye Reagents | |
| HY-D1567 | Cy7.5 NHS ester | 2708152-94-5 | Dye Reagents |
| HY-D1568 | Sulfo-Cy7.5 NHS ester | 2736437-44-6 | Dye Reagents |
| HY-D1568A | Sulfo-Cy7.5 NHS ester (tripotassium) | Dye Reagents | |
| HY-D1569 | CellTracker Orange CMRA Dye | 3031711-06-2 | Dye Reagents |
| HY-D1570 | BODIPY FL C12 | 158757-79-0 | Dye Reagents |
| HY-D1571 | CellTracker Blue CMF2HC Dye | 215868-45-4 | Dye Reagents |
| HY-D1572 | Carbostyril 165 | 26078-23-9 | Dye Reagents |
| HY-D1573 | C6 NBD Phytoceramide | 114301-99-4 | Dye Reagents |
| HY-D1574 | C6 NBD Sphingomyelin | 94885-04-8 | Dye Reagents |
| HY-D1575 | C6 NBD Galactosylceramide | 170212-26-7 | Dye Reagents |
| HY-D1576 | C6 NBD L-threo-dihydroceramide | Dye Reagents | |
| HY-D1577 | C6 NBD Lactosylceramide | 474943-04-9 | Dye Reagents |
| HY-D1578 | C12FDGlcU | 423762-14-5 | Dye Reagents |
| HY-D1579 | C12 NBD Globotriaosylceramide | 2692623-26-8 | Dye Reagents |
| HY-D1580 | C12 NBD Lactosylceramide | 474943-06-1 | Dye Reagents |
| HY-D1581 | BODIPY 505/515-8-C3-COOH | 878674-84-1 | Dye Reagents |
| HY-D1582 | C12 NBD Phytoceramide | Dye Reagents | |
| HY-D1583 | Cyanine5 DBCO | 2360411-64-7 | Dye Reagents |
| HY-D1584 | C12 NBD Sphingomyelin | 254117-01-6 | Dye Reagents |
| HY-D1585 | BODIPY TR methyl ester | 150152-63-9 | Dye Reagents |
| HY-D1586 | Cyanine5 Boc-hydrazide (chloride) | Dye Reagents | |
| HY-D1587 | 8-Phenyl-2,6-diethyl-BODIPY 505/515 | 189264-25-3 | Dye Reagents |
| HY-D1588 | BODIPY-X-Alkyne | 1173281-82-7 | Dye Reagents |
| HY-D1589 | 8-Methyl-2,6-diphenylethynyl-BODIPY 505/515 | 1870842-52-6 | Dye Reagents |
| HY-D1590 | BODIPY Green 8-P2M | 929679-22-1 | Dye Reagents |
| HY-D1591 | BODIPY R6G methyl ester | 150173-71-0 | Dye Reagents |
| HY-D1592 | BODIPY TMR C5-maleimide | 937803-31-1 | Dye Reagents |
| HY-D1593 | BODIPY TMR-X alkyne | 2923990-43-4 | Dye Reagents |
| HY-D1594 | BODIPY TR Cadaverine | 217190-24-4 | Dye Reagents |
| HY-D1595 | BODIPY FL Cholesterol | Dye Reagents | |
| HY-D1596 | Cyanine 3.5 (chloride) | 2231670-86-1 | Dye Reagents |
| HY-D1596A | Cyanine 3.5 (bromide) | Dye Reagents | |
| HY-D1597 | Cyanine3.5 azide (chloride) | Dye Reagents | |
| HY-D1598 | Sulfo-CY3 tetrazine (potassium) | Dye Reagents | |
| HY-D1599 | Rhodamine 6G hydrazide | 932013-08-6 | Dye Reagents |
| HY-D1600 | Sulfo-Cyanine5.5 maleimide (potassium) | 2183440-58-4 | Dye Reagents |
| HY-D1601 | N-Aminofluorescein | 98907-26-7 | Dye Reagents |
| HY-D1602 | BODIPY FL-DHPE | 217075-07-5 | Dye Reagents |
| HY-D1603 | BODIPY FL-EDA | 209541-26-4 | Dye Reagents |
| HY-D1604 | BODIPY FL Ethylamine | 1229571-00-9 | Dye Reagents |
| HY-D1605 | BODIPY FL L-Cystine | 1180490-57-6 | Dye Reagents |
| HY-D1606 | BODIPY FL prazosin | 175799-93-6 | Dye Reagents |
| HY-D1607 | BODIPY FL SSE | 217190-17-5 | Dye Reagents |
| HY-D1608 | BODIPY FL Thapsigargin | 216571-99-2 | Dye Reagents |
| HY-D1609 | BODIPY FL Verapamil (hydrochloride) | 216571-88-9 | Dye Reagents |
| HY-D1610 | BODIPY FL C5 | 217075-24-6 | Dye Reagents |
| HY-D1611 | BODIPY FL-C5 NHS Ester | 133867-52-4 | Dye Reagents |
| HY-D1612 | BODIPY FL C5-Ceramide | 133867-53-5 | Dye Reagents |
| HY-D1613 | BODIPY FL C5-HPC | 161106-88-3 | Dye Reagents |
| HY-D1614 | BODIPY 493/503 methyl bromide | 216434-81-0 | Dye Reagents |
| HY-D1615 | BODIPY 530/550 NHS ester | 216961-93-2 | Dye Reagents |
| HY-D1616 | 5-Bromo-5'-methyl BAPTA tetramethyl ester | Dye Reagents | |
| HY-D1617 | BODIPY 500/510 C1, C12 | 144672-74-2 | Dye Reagents |
| HY-D1618 | Cyanine3 maleimide (tetrafluoroborate) | 2755154-93-7 | Dye Reagents |
| HY-D1619 | Cyanine3 hydrazide (dichloride) | 2695564-68-0 | Dye Reagents |
| HY-D1620 | H2TPTBP | 80528-89-8 | Dye Reagents |
| HY-D1621 | 3-NBD-C12 Cholesterol | 186833-02-3 | Dye Reagents |
| HY-D1622 | Cyanine3 DBCO (hexafluorophosphate) | 2692677-79-3 | Dye Reagents |
| HY-D1623 | Cyanine3 carboxylic acid (chloride) | 1032678-01-5 | Dye Reagents |
| HY-D1624 | 3,3'-Diheptylthiacarbocyanine (iodide) | 53213-88-0 | Dye Reagents |
| HY-D1625 | Cy5 DBCO (chloride) | 2182601-72-3 | Dye Reagents |
| HY-D1626 | DiSC18(3) | 53533-50-9 | Dye Reagents |
| HY-D1627 | CellTracker CM-DiI | 180854-97-1 | Dye Reagents |
| HY-D1628 | Calcium Green BAPTA-2 AM | 163634-11-5 | Dye Reagents |
| HY-D1629 | Calcium Orange AM | 172646-19-4 | Dye Reagents |
| HY-D1630 | 4-Di-10-ASP | 95378-73-7 | Dye Reagents |
| HY-D1631 | Calcium Green-5N AM | 216699-33-1 | Dye Reagents |
| HY-D1632 | 4-MU-α-GlcNS (sodium) | 460085-45-4 | Dye Reagents |
| HY-D1633 | 4-Methylumbelliferyl-β-D-galactopyranoside 6-sulfate | 126938-14-5 | Dye Reagents |
| HY-D1633A | 4-Methylumbelliferyl-β-D-galactopyranoside 6-sulfate (sodium) | 206443-06-3 | Dye Reagents |
| HY-D1634 | Bz-FVR-AMC | 88899-22-3 | Dye Reagents |
| HY-D1634A | Bz-FVR-AMC (TFA) | Dye Reagents | |
| HY-D1635 | Sulfo-NHS-LC-LC-Biotin | 194041-66-2 | Dye Reagents |
| HY-D1636 | 5-Nitro BAPTA | 124251-83-8 | Dye Reagents |
| HY-D1637 | 5-Nitro BAPTA tetramethyl ester | 172646-43-4 | Dye Reagents |
| HY-D1639 | 5,5'-Dibromo BAPTA (tetrapotassium) | 73630-11-2 | Dye Reagents |
| HY-D1639A | 5,5'-Dibromo-BAPTA | 111248-72-7 | Biochemical Assay Reagents |
| HY-D1640 | 5',5-Difluoro BAPTA (tetrapotassium) | 152290-47-6 | Reference compound |
| HY-D1641 | 5,5'-Dimethyl BAPTA (tetrapotassium) | 73630-09-8 | Dye Reagents |
| HY-D1643 | 5,5'-Dinitro BAPTA AM | 172646-47-8 | Reference compound |
| HY-D1645 | DANSYL-X, SE | 217176-82-4 | Dye Reagents |
| HY-D1646 | BDP TR methyltetrazine | 2183473-54-1 | Dye Reagents |
| HY-D1647 | 7-Hydroxycoumarinyl-γ-linolenate | 161180-12-7 | Dye Reagents |
| HY-D1648 | 8-(2,4,6-Trimethylphenyl)-BODIPY | 870753-29-0 | Dye Reagents |
| HY-D1649 | BDP R6G amine | 2183473-05-2 | Dye Reagents |
| HY-D1650 | BDP 630/650 carboxylic acid | 2183512-02-7 | Dye Reagents |
| HY-D1651 | BDP 630/650 amine | 2183473-00-7 | Dye Reagents |
| HY-D1652 | Ac-LEHD-AMC | 292633-16-0 | Dye Reagents |
| HY-D1653 | BDP 581/591 NHS ester | 654651-21-5 | Dye Reagents |
| HY-D1654 | BDP 581/591 maleimide | 2183473-29-0 | Dye Reagents |
| HY-D1655 | BDP 581/591 DBCO | Dye Reagents | |
| HY-D1656 | BDP 581/591 carboxylic acid | 480999-04-0 | Dye Reagents |
| HY-D1657 | BDP 581/591 azide | 2183473-20-1 | Dye Reagents |
| HY-D1658 | BDP 581/591 amine (hydrochloride) | 2183472-97-9 | Dye Reagents |
| HY-D1659 | BDP 581/591 alkyne | 2006345-34-0 | Dye Reagents |
| HY-D1660 | Acridine homodimer | 57576-49-5 | Reference compound |
| HY-D1661 | BDP 564/570 NHS ester | 150173-90-3 | Dye Reagents |
| HY-D1662 | BDP 558/568 NHS ester | 150173-73-2 | Dye Reagents |
| HY-D1663 | APTAB | 86727-71-1 | Dye Reagents |
| HY-D1664 | BDP 558/568 alkyne | Dye Reagents | |
| HY-D1665 | BDP 558/568 amine | Dye Reagents | |
| HY-D1666 | BDP 558/568 azide | 3050768-42-5 | Dye Reagents |
| HY-D1667 | BDP 558/568 hydrazide | Dye Reagents | |
| HY-D1668 | Biotin-11-dCTP | Dye Reagents | |
| HY-D1669 | Biotin-11-UTP | Dye Reagents | |
| HY-D1670 | Z-Gly-Pro-AMC | 68542-93-8 | Dye Reagents |
| HY-D1671 | TRITC-DHPE | Dye Reagents | |
| HY-D1672 | TMR Biocytin | 749247-49-2 | Dye Reagents |
| HY-D1673 | Tetrabromorhodamine 123 (bromide) | 623903-26-4 | Dye Reagents |
| HY-D1674 | Sulforhodamine G | 5873-16-5 | Dye Reagents |
| HY-D1675 | 6-HoeHESIR | Dye Reagents | |
| HY-D1676 | Thymolphthalein monophosphate (disodium hydrate) | 123359-43-3 | Dye Reagents |
| HY-D1677 | 5(6)-Carboxynaphthofluorescein | 128724-35-6 | Dye Reagents |
| HY-D1678 | 5(6)-Carboxynaphthofluorescein diacetate | 164256-07-9 | Dye Reagents |
| HY-D1679 | Phalloidin-f-HM-SiR | Dye Reagents | |
| HY-D1680 | LysoSR-549 | Dye Reagents | |
| HY-D1681 | Rhod-590 AM Ester | Dye Reagents | |
| HY-D1682 | NFQ1 | 1262391-07-0 | Dye Reagents |
| HY-D1683 | NBD-PE | 178119-00-1 | Dye Reagents |
| HY-D1683A | NBD-X PE | Dye Reagents | |
| HY-D1684 | DCDAPH | 125113-96-4 | Dye Reagents |
| HY-D1685 | BZiPAR | 254451-46-2 | Dye Reagents |
| HY-D1686 | Biotin-16-UTP | 186033-13-6 | Dye Reagents |
| HY-D1686B | Biotin-16-UTP (tetrasodium) | Dye Reagents | |
| HY-D1687 | Flubi-2 | Dye Reagents | |
| HY-D1688 | Flubida-2 | Dye Reagents | |
| HY-D1689 | Rf470DL | 2758364-03-1 | Dye Reagents |
| HY-D1690 | sBADA (TFA) | Dye Reagents | |
| HY-D1690A | sBADA | 2376838-11-6 | Dye Reagents |
| HY-D1691 | BODIPY-581/591 NHS ester | 150152-70-8 | Dye Reagents |
| HY-D1692 | BODIPY 650/665 NHS ester | 1818267-45-6 | Dye Reagents |
| HY-D1693 | FBBBE | 1522117-83-4 | Dye Reagents |
| HY-D1694 | LysoTracker Yellow HCK 123 | 1064123-31-4 | Dye Reagents |
| HY-D1695 | LYCBX | 223914-41-8 | Dye Reagents |
| HY-D1696 | MitoTracker Orange CMTMRos | 199116-50-2 | Dye Reagents |
| HY-D1697 | OGDA | 2758364-01-9 | Dye Reagents |
| HY-D1699 | PFB-FDG | 209540-64-7 | Dye Reagents |
| HY-D1700 | Mag-indo-1/AM | 130926-94-2 | Dye Reagents |
| HY-D1701 | Mag-Fura-2 AM | 130100-20-8 | Dye Reagents |
| HY-D1702 | Mag-Fura-2 (tetrapotassium) | 132319-57-4 | Dye Reagents |
| HY-D1703 | Oxazine 170 (perchlorate) | 62669-60-7 | Dye Reagents |
| HY-D1704 | Bodipy TMR-X muscimol | 849464-08-0 | Dye Reagents |
| HY-D1705 | Ac-ANW-AMC | 2357123-49-8 | Dye Reagents |
| HY-D1706 | AMCA-6-dUTP | 758665-99-5 | Dye Reagents |
| HY-D1707 | FDGlcU | 209540-67-0 | Dye Reagents |
| HY-D1708 | RuBP-4S | Dye Reagents | |
| HY-D1709 | Z-AA-R110-PEG | Reference compound | |
| HY-D1710 | Anti-α-Tubulin Antibody, AF555 conjugate | Reference compound | |
| HY-D1711 | MHI-148 | 172971-76-5 | Dye Reagents |
| HY-D1713 | CM-H2DCFDA | 850013-49-9 | Dye Reagents |
| HY-D1716 | S0456 | 1252007-83-2 | Dye Reagents |
| HY-D1718 | BDP FL-PEG5-acid | 2093197-98-7 | Dye Reagents |
| HY-D1719 | Cypate | 95837-47-1 | Dye Reagents |
| HY-D1719A | Cypate (hydrochloride) | Dye Reagents | |
| HY-D1720 | Cy5-dATP | Dye Reagents | |
| HY-D1721 | Fluorescein-12-dATP | Dye Reagents | |
| HY-D1722 | Tetramethylrhodamine-dUTP | Dye Reagents | |
| HY-D1723 | EthD-III | Dye Reagents | |
| HY-D1724 | IR-806 | Dye Reagents | |
| HY-D1725 | Cy3-dCTP | Dye Reagents | |
| HY-D1726 | 8RK59 | 2705841-53-6 | Dye Reagents |
| HY-D1727 | CellTracker Red CMTPX | Dye Reagents | |
| HY-D1730 | AF488 NHS ester | 1374019-99-4 | Dye Reagents |
| HY-D1730A | AF488 NHS ester (TEA) | Dye Reagents | |
| HY-D1732 | FITC-hyodeoxycholic acid | 2374144-21-3 | Dye Reagents |
| HY-D1734 | FITC-GW3965 | 2374144-23-5 | Dye Reagents |
| HY-D1735 | BODIPY TR Ceramide | 571186-05-5 | Dye Reagents |
| HY-D1736 | BODIPY FL-C16 | 158757-82-5 | Dye Reagents |
| HY-D1738 | DAPI (dilactate) | 28718-91-4 | Dye Reagents |
| HY-D1739 | DDAO phosphate (diammonium) | 500883-59-0 | Dye Reagents |
| HY-D1740 | Dihydrotetramethylrosamine | 105284-17-1 | Dye Reagents |
| HY-D1741 | DiOC16(3) | 161433-32-5 | Dye Reagents |
| HY-D1742 | DRAQ5 | 254098-36-7 | Dye Reagents |
| HY-D1743 | DPH propionic acid | 84294-98-4 | Dye Reagents |
| HY-D1744 | ICG Maleimide | 2143933-81-5 | Dye Reagents |
| HY-D1745 | Liptracker-Green | 1369583-75-4 | Dye Reagents |
| HY-D1746 | EDTA-AM | 162303-59-5 | Dye Reagents |
| HY-D1747 | Rhodamine 3B (perchlorate) | 23857-69-4 | Dye Reagents |
| HY-D1748 | Rhodamine B hexyl ester (perchlorate) | 877933-92-1 | Dye Reagents |
| HY-D1749 | C6 NBD L-threo-ceramide | 114301-96-1 | Dye Reagents |
| HY-D1750 | Rhodamine B thiolactone | 111883-10-4 | Dye Reagents |
| HY-D1751 | RIM-1 | 150206-04-5 | Dye Reagents |
| HY-D1752 | JC-9 | 522592-13-8 | Dye Reagents |
| HY-D1753 | Lucifer yellow cadaverine | 149733-79-9 | Dye Reagents |
| HY-D1754 | Lucifer yellow CH (ammonium) | 188904-20-3 | Dye Reagents |
| HY-D1755 | Fluo-3FF AM | 348079-13-0 | Dye Reagents |
| HY-D1756 | ROX NHS ester, 6-isomer | 117491-83-5 | Dye Reagents |
| HY-D1757 | Lucifer yellow ethylenediamine | 161578-11-6 | Dye Reagents |
| HY-D1758 | Fura-5F AM | Dye Reagents | |
| HY-D1759 | Fura-4F AM | Dye Reagents | |
| HY-D1760 | Sodium-binding benzofuran isophthalate | 124549-08-2 | Dye Reagents |
| HY-D1761 | Fura-4F (pentapotassium) | 299172-08-0 | Dye Reagents |
| HY-D1762 | Styryl 6 | 76433-27-7 | Dye Reagents |
| HY-D1764 | TDBC-4 | 85012-34-6 | Dye Reagents |
| HY-D1765 | FM 1-43FX | 1415018-97-1 | Dye Reagents |
| HY-D1767 | Tempocholine | 50669-92-6 | Dye Reagents |
| HY-D1768 | Fluo-4FF AM | Dye Reagents | |
| HY-D1769 | N-hydroxy Rhodamine B amide | 1115867-62-3 | Dye Reagents |
| HY-D1770 | NBD Dihexadecylamine | 117056-66-3 | Dye Reagents |
| HY-D1771 | Thionin (perchlorate) | 25137-58-0 | Dye Reagents |
| HY-D1772 | Nile Blue A perchlorate | 53340-16-2 | Dye Reagents |
| HY-D1773 | YOYO-3 | 156312-20-8 | Dye Reagents |
| HY-D1774 | 5-ROX-SE | 344402-35-3 | Dye Reagents |
| HY-D1775 | LysoTracker Blue DND-22 | 215247-93-1 | Dye Reagents |
| HY-D1776 | FFP-18-AM | 348079-15-2 | Dye Reagents |
| HY-D1777 | Pyrromethene 605 | 137829-80-2 | Dye Reagents |
| HY-D1779 | Fura-5F (pentapotassium) | 299172-15-9 | Dye Reagents |
| HY-D1781 | NTPAN-MI | 2411398-95-1 | Dye Reagents |
| HY-D1782 | Selenomethylene blue | 85670-01-5 | Dye Reagents |
| HY-D1783 | MitoTracker Deep Red FM | 873315-86-7 | Dye Reagents |
| HY-D1790 | Vari Fluor 640 SE | Dye Reagents | |
| HY-D1791 | Vari Fluor 750 SE | Dye Reagents | |
| HY-D1792 | Vari Fluor 555 SE | Dye Reagents | |
| HY-D1794 | Vari Fluor 405 SE | Dye Reagents | |
| HY-D1795 | Vari Fluor 532 SE | Dye Reagents | |
| HY-D1796 | Vari Fluor 594 SE | Dye Reagents | |
| HY-D1797 | Vari Fluor 660 SE | Dye Reagents | |
| HY-D1798 | Vari Fluor 350 SE | Dye Reagents | |
| HY-D1799 | Vari Fluor 568 SE | Dye Reagents | |
| HY-D1800 | Vari Fluor 680 SE | Dye Reagents | |
| HY-D1801 | Vari Fluor 488 SE | Dye Reagents | |
| HY-D1802 | Vari Fluor 425 SE | Dye Reagents | |
| HY-D1803 | Vari Fluor 565 SE | Dye Reagents | |
| HY-D1804 | Vari Fluor 680-Streptavidin | Dye Reagents | |
| HY-D1805 | Vari Fluor 647-Streptavidin | Dye Reagents | |
| HY-D1806 | Vari Fluor 594-Streptavidin | Dye Reagents | |
| HY-D1807 | Vari Fluor 555-Streptavidin | Dye Reagents | |
| HY-D1808 | Vari Fluor 488-Streptavidin | Dye Reagents | |
| HY-D1809 | Vari Fluor 405-Streptavidin | Dye Reagents | |
| HY-D1810 | Sulfo-Cy3-E-dUTP | Dye Reagents | |
| HY-D1811 | Vari Fluor 555-dUTP | Dye Reagents | |
| HY-D1812 | Vari Fluor 488-dUTP | Dye Reagents | |
| HY-D1813 | Vari Fluor 594-dUTP | Dye Reagents | |
| HY-D1814 | Vari Fluor 640-dUTP | Dye Reagents | |
| HY-D1815 | Allophycocyanin | Dye Reagents | |
| HY-D1816 | Vari Fluor 555-Phalloidin | Dye Reagents | |
| HY-D1817 | Vari Fluor 488-Phalloidin | Dye Reagents | |
| HY-D1818 | Vari Fluor 680-Phalloidin | Dye Reagents | |
| HY-D1819 | Vari Fluor 633-Phalloidin | Dye Reagents | |
| HY-D1820 | Vari Fluor 594-Phalloidin | Dye Reagents | |
| HY-D1821 | Vari Fluor 750 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1822 | Vari Fluor 555 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1823 | Vari Fluor 647A Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1824 | Vari Fluor 488 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1825 | Vari Fluor 532 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1826 | Vari Fluor 594 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1827 | Vari Fluor 660 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1828 | Vari Fluor 640 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1829 | Vari Fluor 568 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1830 | Vari Fluor 680 Carboxylic acid（free acid） | Dye Reagents | |
| HY-D1831 | Vari Fluor 620 TSA（200×） | Dye Reagents | |
| HY-D1832 | Vari Fluor 532 TSA (200×) | Dye Reagents | |
| HY-D1833 | Vari Fluor 680 TSA (200×) | Dye Reagents | |
| HY-D1834 | Vari Fluor 640 TSA（200×） | Dye Reagents | |
| HY-D1835 | Vari Fluor 594 TSA（200×） | Dye Reagents | |
| HY-D1836 | Vari Fluor 555 TSA (200x) | Dye Reagents | |
| HY-D1837 | Vari Fluor 488 TSA（200×） | Dye Reagents | |
| HY-D1838 | Vari Fluor 350 TSA（200×） | Dye Reagents | |
| HY-D1839 | Biotin TSA（200×） | Dye Reagents | |
| HY-D1840 | Tyramide Amplification Buffer | Dye Reagents | |
| HY-D1845 | Cy3B | 228272-69-3 | Dye Reagents |
| HY-D1846 | Sulfo-Cy7.5 dimethyl | Dye Reagents | |
| HY-D1847 | Cy7.5 tetrazine (tetrafluoroborate) | Dye Reagents | |
| HY-D1848 | Sulfo-Cy3-NHS (disodium) | Dye Reagents | |
| HY-D1849 | Cy3B NHS ester | 228272-52-4 | Dye Reagents |
| HY-D1850 | Sulfo-Cy7.5 azide | Dye Reagents | |
| HY-D1851 | Trisulfo-Cy3 amine (disodium) | Dye Reagents | |
| HY-D1852 | Cy3B amine (chloride) | Dye Reagents | |
| HY-D1853 | Sulfo-Cy5 carboxylic acid | 1121756-16-8 | Dye Reagents |
| HY-D1853A | Sulfo-Cy5 carboxylic acid (TEA) | Dye Reagents | |
| HY-D1859 | Sulfo-Cy7.5 alkyne | Dye Reagents | |
| HY-D1860 | Cy3 alkyne (chloride) | Dye Reagents | |
| HY-D1861 | Sulfo-Cy3 hydrazide | 2144762-62-7 | Dye Reagents |
| HY-D1862 | Cy7.5 alkyne (chloride) | Dye Reagents | |
| HY-D1863 | sulfo-Cy7.5 amine | Dye Reagents | |
| HY-D1864 | Sulfo-Cy7.5 dicarboxylic acid | Dye Reagents | |
| HY-D1865 | Cy3 dimethyl (iodide) | 25470-94-4 | Dye Reagents |
| HY-D1866 | Sulfo-Cy7.5 carboxylic acid | 2760599-02-6 | Dye Reagents |
| HY-D1867 | Sulfo-Cy3-PEG2-TCO (disodium) | Dye Reagents | |
| HY-D1868 | Cy3 azide plus | 2669097-28-1 | Dye Reagents |
| HY-D1869 | 800CW maleimide | Dye Reagents | |
| HY-D1870 | Sulfo-Cy3-PEG3-biotin (potassium) | Dye Reagents | |
| HY-D1871 | Cy3 maleimide (chloride) | 1838643-41-6 | Dye Reagents |
| HY-D1872 | 800CW NHS ester | 956579-01-4 | Dye Reagents |
| HY-D1873 | 800CW acid | 1088919-86-1 | Dye Reagents |
| HY-D1876 | ZY-2 | Dye Reagents | |
| HY-D1877 | ZY-1 | Dye Reagents | |
| HY-D1878 | SPiDER-βGal-1 | 1824699-57-1 | Dye Reagents |
| HY-D1879 | SPiDER-βGal-2 | 1824699-55-9 | Dye Reagents |
| HY-D1880 | Sulfo-Cy5 hydrazide | 2055138-61-7 | Dye Reagents |
| HY-D1881 | Sulfo-Cy7 carboxylic acid | 1251915-04-4 | Dye Reagents |
| HY-D1881A | Sulfo-Cy7 carboxylic acid (TEA) | Dye Reagents | |
| HY-D1882 | Cy5.5 hydrazide | Dye Reagents | |
| HY-D1883 | Cy7.5-COOH | 1144107-81-2 | Dye Reagents |
| HY-D1883A | Cy7.5-COOH (TEA) | Dye Reagents | |
| HY-D1885 | Vari Fluor 647 Carboxylic acid (free acid) | Dye Reagents | |
| HY-D1886 | Vari Fluor 647 SE | Dye Reagents | |
| HY-D1890 | N-(2-Aminooxyethyl)-7-DCCAm | 1384475-20-0 | Dye Reagents |
| HY-D1891 | 6-HEX, SE | 902171-56-6 | Dye Reagents |
| HY-D1892 | 6-Hexachloro-fluorescein phosphoramidite | 1360547-55-2 | Dye Reagents |
| HY-D1893 | HEX azide, 6-isomer | 1450752-91-6 | Dye Reagents |
| HY-D1894 | 5-Br-PAPS | 81608-06-2 | Dye Reagents |
| HY-D1895 | 3,5-DiBr-PAESA | 100743-65-5 | Dye Reagents |
| HY-D1895A | 3,5-DiBr-PAESA (sodium) | 164581-25-3 | Dye Reagents |
| HY-D1896 | Chloride Ionophore IV | 187404-67-7 | Dye Reagents |
| HY-D1897 | 6-TET phosphoramidite | 877049-90-6 | Dye Reagents |
| HY-D1898 | 6-TET Azide | 1450752-90-5 | Dye Reagents |
| HY-D1899 | VIC phosphoramidite, 6-isomer | 1414265-81-8 | Dye Reagents |
| HY-D1900 | VIC azide, 6-isomer | Dye Reagents | |
| HY-D1901 | FAM-dT phosphoramidite | 637330-26-8 | Dye Reagents |
| HY-D1903 | Fura Red AM | 218280-33-2 | Dye Reagents |
| HY-D1904 | D-Luciferin 6'-methyl ether | 3022-11-5 | Dye Reagents |
| HY-D1905 | ICG acid | Dye Reagents | |
| HY-D1906 | BDP R6G NHS ester | 1443457-59-7 | Dye Reagents |
| HY-D1911 | ATTO 665 Biotin | Dye Reagents | |
| HY-D1913 | FerroOrange | Dye Reagents | |
| HY-D1915 | ATTO 390 | 914203-49-9 | Dye Reagents |
| HY-D1916 | ATTO 594 | 1253909-75-9 | Dye Reagents |
| HY-D1917 | ATTO 390 NHS ester | 914203-48-8 | Dye Reagents |
| HY-D1918 | ATTO 390 maleimide | 914203-50-2 | Dye Reagents |
| HY-D1919 | ATTO 390 amine | Dye Reagents | |
| HY-D1920 | ATTO 390 azide | 1609584-74-8 | Dye Reagents |
| HY-D1921 | ATTO 390 iodoacetamide | Dye Reagents | |
| HY-D1922 | ATTO 390 streptavidin | Dye Reagents | |
| HY-D1923 | ATTO 390 biotin | 2390361-82-5 | Dye Reagents |
| HY-D1924 | ATTO 390 alkyne | Dye Reagents | |
| HY-D1925 | ATTO 425 maleimide | 892156-52-4 | Dye Reagents |
| HY-D1926 | ATTO 425 streptavidin | Dye Reagents | |
| HY-D1927 | ATTO 425 biotin | Dye Reagents | |
| HY-D1928 | ATTO 425 amine | Dye Reagents | |
| HY-D1929 | ATTO 594 NHS ester | Dye Reagents | |
| HY-D1930 | ATTO 425 azide | 1609584-73-7 | Dye Reagents |
| HY-D1931 | ATTO 590 | 639065-13-7 | Dye Reagents |
| HY-D1932 | ATTO 590 NHS ester | 670269-33-7 | Dye Reagents |
| HY-D1933 | ATTO 590 maleimide | Dye Reagents | |
| HY-D1934 | ATTO 465 | 1173022-07-5 | Dye Reagents |
| HY-D1935 | ATTO 465 NHS ester | 1173020-88-6 | Dye Reagents |
| HY-D1936 | ATTO 465 maleimid | 1173022-13-3 | Dye Reagents |
| HY-D1937 | ATTO 465 streptavidin | Dye Reagents | |
| HY-D1938 | ATTO 465 biotin | Dye Reagents | |
| HY-D1939 | ATTO 465 amine | Dye Reagents | |
| HY-D1940 | ATTO 465 azide | Dye Reagents | |
| HY-D1941 | ATTO 590 streptavidin | Dye Reagents | |
| HY-D1942 | ATTO 590 biotin | 2243123-45-5 | Dye Reagents |
| HY-D1943 | ATTO 590 amine | Dye Reagents | |
| HY-D1944 | ATTO 590 azide | Dye Reagents | |
| HY-D1945 | ATTO 590 iodacetamid | Dye Reagents | |
| HY-D1946 | ATTO 590 alkyne | Dye Reagents | |
| HY-D1947 | ATTO 700 Streptavidin | Dye Reagents | |
| HY-D1948 | ATTO 594 maleimid | Dye Reagents | |
| HY-D1949 | ATTO 594 streptavidin | Dye Reagents | |
| HY-D1950 | ATTO 633 | 2982225-57-8 | Dye Reagents |
| HY-D1951 | ATTO 594 biotin | Dye Reagents | |
| HY-D1952 | ATTO 594 amine | Dye Reagents | |
| HY-D1953 | ATTO 594 azide | Dye Reagents | |
| HY-D1955 | ATTO 594 iodacetamid | Dye Reagents | |
| HY-D1956 | ATTO 594 alkin | Dye Reagents | |
| HY-D1957 | ATTO 633 NHS ester | 2982226-58-2 | Dye Reagents |
| HY-D1958 | ATTO 565 | 722538-90-1 | Dye Reagents |
| HY-D1959 | ATTO 565 NHS ester | 1443553-12-5 | Dye Reagents |
| HY-D1960 | ATTO 633 maleimid | Dye Reagents | |
| HY-D1961 | ATTO 565 maleimide | Dye Reagents | |
| HY-D1962 | ATTO 633 streptavidin | Dye Reagents | |
| HY-D1963 | ATTO 565 streptavidin | Dye Reagents | |
| HY-D1964 | ATTO 633 biotin | Dye Reagents | |
| HY-D1965 | ATTO 700 Biotin | Dye Reagents | |
| HY-D1967 | ATTO 633 azide | Dye Reagents | |
| HY-D1968 | ATTO 700 Azide | Dye Reagents | |
| HY-D1969 | ATTO 700 Alkin | Dye Reagents | |
| HY-D1970 | ATTO 700 Cadaverin | Dye Reagents | |
| HY-D1971 | ATTO 725 | Dye Reagents | |
| HY-D1972 | ATTO 610 carboxy | Dye Reagents | |
| HY-D1974 | ATTO 610 NHS-ester | Dye Reagents | |
| HY-D1975 | ATTO 725 Carboxy | Dye Reagents | |
| HY-D1976 | ATTO 610 maleimid | Dye Reagents | |
| HY-D1977 | ATTO 610 streptavidin | Dye Reagents | |
| HY-D1978 | ATTO 610 biotin | Dye Reagents | |
| HY-D1979 | ATTO 725 NHS-Ester | Dye Reagents | |
| HY-D1980 | ATTO 620 carboxy | Dye Reagents | |
| HY-D1981 | ATTO 633 iodacetamid | Dye Reagents | |
| HY-D1982 | ATTO 725 Maleimid | Dye Reagents | |
| HY-D1983 | ATTO 620 NHS-ester | Dye Reagents | |
| HY-D1984 | ATTO 633 alkin | Dye Reagents | |
| HY-D1985 | ATTO 725 Streptavidin | Dye Reagents | |
| HY-D1986 | ATTO 620 maleimid | Dye Reagents | |
| HY-D1987 | ATTO 620 streptavidin | Dye Reagents | |
| HY-D1988 | ATTO 620 biotin | Dye Reagents | |
| HY-D1989 | ATTO 725 Biotin | Dye Reagents | |
| HY-D1990 | ATTO 620 azide | Dye Reagents | |
| HY-D1991 | ATTO 647 | 906664-68-4 | Dye Reagents |
| HY-D1993 | ATTO 647 NHS ester | Dye Reagents | |
| HY-D1994 | ATTO 647 maleimid | Dye Reagents | |
| HY-D1995 | ATTO 647 streptavidin | Dye Reagents | |
| HY-D1996 | ATTO 647 biotin | Dye Reagents | |
| HY-D1997 | ATTO 665 | 1210944-09-4 | Dye Reagents |
| HY-D1999 | ATTO 665 NHS ester | Dye Reagents | |
| HY-D2000 | ATTO 488 | 923585-42-6 | Dye Reagents |
| HY-D2001 | ATTO 488 NHS ester | 863772-22-9 | Dye Reagents |
| HY-D2001A | ATTO 488 NHS ester (TEA) | Dye Reagents | |
| HY-D2002 | ATTO 488 maleimide | 1219127-42-0 | Dye Reagents |
| HY-D2003 | ATTO 565 biotin | Dye Reagents | |
| HY-D2004 | ATTO 488 streptavidin | 1430816-27-5 | Dye Reagents |
| HY-D2005 | ATTO 565 amine | Dye Reagents | |
| HY-D2006 | ATTO 565 azide | Dye Reagents | |
| HY-D2007 | ATTO 488 biotin | Dye Reagents | |
| HY-D2008 | ATTO 488 amine | Dye Reagents | |
| HY-D2009 | ATTO 565 iodacetamid | Dye Reagents | |
| HY-D2010 | ATTO 488 azide | 1976022-32-8 | Dye Reagents |
| HY-D2011 | ATTO 565 hydrazid | Dye Reagents | |
| HY-D2012 | ATTO 488 iodacetamid | 2305285-47-4 | Dye Reagents |
| HY-D2013 | ATTO 488 hydrazid | Dye Reagents | |
| HY-D2014 | ATTO 565 alkyne | Dye Reagents | |
| HY-D2015 | ATTO 488 alkyne | Dye Reagents | |
| HY-D2016 | ATTO 565 cadaverine | Dye Reagents | |
| HY-D2017 | ATTO 550 | 1251752-59-6 | Dye Reagents |
| HY-D2018 | ATTO 550 carboxy | Dye Reagents | |
| HY-D2019 | ATTO 550 NHS ester | 1005770-00-2 | Dye Reagents |
| HY-D2020 | ATTO 665 maleimid | Dye Reagents | |
| HY-D2021 | ATTO 550 maleimide | 870534-97-7 | Dye Reagents |
| HY-D2022 | ATTO 514 | 1639809-02-1 | Dye Reagents |
| HY-D2023 | ATTO 665 streptavidin | Dye Reagents | |
| HY-D2024 | ATTO 550 streptavidin | Dye Reagents | |
| HY-D2025 | ATTO 550 biotin | Dye Reagents | |
| HY-D2026 | ATTO 514 NHS ester | Dye Reagents | |
| HY-D2027 | ATTO 550 amine | Dye Reagents | |
| HY-D2028 | ATTO 514 maleimid | Dye Reagents | |
| HY-D2029 | ATTO 550 azide | Dye Reagents | |
| HY-D2030 | ATTO 514 streptavidin | Dye Reagents | |
| HY-D2031 | ATTO 514 biotin | Dye Reagents | |
| HY-D2032 | ATTO 514 amine | Dye Reagents | |
| HY-D2033 | ATTO 514 azide | Dye Reagents | |
| HY-D2034 | ATTO 514 hydrazid | Dye Reagents | |
| HY-D2035 | ATTO 514 alkyne | Dye Reagents | |
| HY-D2036 | ATTO 550 iodacetamid | Dye Reagents | |
| HY-D2037 | ATTO 550 hydrazid | Dye Reagents | |
| HY-D2038 | ATTO 550 alkyne | Dye Reagents | |
| HY-D2039 | ATTO 550 cadaverin | Dye Reagents | |
| HY-D2040 | 5-ROX tetrazine | Dye Reagents | |
| HY-D2041 | 3-HTC | 1356543-39-9 | Dye Reagents |
| HY-D2042 | ATTO 610 | Dye Reagents | |
| HY-D2043 | ATTO 620 | Dye Reagents | |
| HY-D2044 | ATTO 532 | 911287-46-2 | Dye Reagents |
| HY-D2045 | ATTO 532 carboxy | Dye Reagents | |
| HY-D2046 | ATTO 532 NHS ester | 924660-19-5 | Dye Reagents |
| HY-D2047 | ATTO 532 maleimide | 1632109-97-7 | Dye Reagents |
| HY-D2048 | ATTO 532 streptavidin | Dye Reagents | |
| HY-D2049 | ATTO 532 biotin | Dye Reagents | |
| HY-D2050 | ATTO 532 amine | Dye Reagents | |
| HY-D2051 | ATTO 532 azide | Dye Reagents | |
| HY-D2052 | ATTO 532 iodacetamid | Dye Reagents | |
| HY-D2053 | ATTO 532 hydrazid | Dye Reagents | |
| HY-D2054 | ATTO 532 alkin | Dye Reagents | |
| HY-D2055 | ATTO 532 cadaverin | Dye Reagents | |
| HY-D2056 | ATTO 700 | Dye Reagents | |
| HY-D2057 | ATTO 700 carboxy | Dye Reagents | |
| HY-D2058 | ATTO 700 NHS ester | Dye Reagents | |
| HY-D2059 | ATTO 700 maleimide | Dye Reagents | |
| HY-D2060 | ATTO 740 | 1188422-44-7 | Dye Reagents |
| HY-D2061 | ATTO 740 carboxy | Dye Reagents | |
| HY-D2062 | ATTO 740 NHS ester | 1448146-89-1 | Dye Reagents |
| HY-D2063 | ATTO 740 maleimide | Dye Reagents | |
| HY-D2064 | ATTO 680 streptavidin | Dye Reagents | |
| HY-D2065 | ATTO 680 biotin | Dye Reagents | |
| HY-D2066 | ATTO 680 amine | Dye Reagents | |
| HY-D2067 | ATTO 680 azide | Dye Reagents | |
| HY-D2068 | ATTO 680 iodacetamid | Dye Reagents | |
| HY-D2069 | ATTO 680 alkin | Dye Reagents | |
| HY-D2070 | ATTO 680 cadaverin | Dye Reagents | |
| HY-D2071 | ATTO 680 | 422310-48-3 | Dye Reagents |
| HY-D2072 | ATTO 680 carboxy | Dye Reagents | |
| HY-D2073 | ATTO 680 NHS ester | 1537182-26-5 | Dye Reagents |
| HY-D2074 | ATTO 680 maleimide | 2413537-75-2 | Dye Reagents |
| HY-D2075 | ATTO 740 streptavidin | Dye Reagents | |
| HY-D2076 | ATTO 740 biotin | Dye Reagents | |
| HY-D2077 | ATTO 725 azide | Dye Reagents | |
| HY-D2078 | ATTO 665 amine | Dye Reagents | |
| HY-D2079 | ATTO 665 azide | Dye Reagents | |
| HY-D2080 | ATTO 665 iodacetamid | Dye Reagents | |
| HY-D2081 | ATTO 665 alkin | Dye Reagents | |
| HY-D2083 | BODIPY 540 (purity 99%) | 1446240-77-2 | Dye Reagents |
| HY-D2090 | PE-VF620 Maleimide | Dye Reagents | |
| HY-D2091 | PE-VF647 Maleimide | Dye Reagents | |
| HY-D2092 | PE-VF680 Maleimide | Dye Reagents | |
| HY-D2093 | PE-VF750 Maleimide | Dye Reagents | |
| HY-D2094 | PerCP Maleimide | Dye Reagents | |
| HY-D2095 | Medical fluorophore 33 | Dye Reagents | |
| HY-D2096 | Alexa fluor 647 NHS ester | 1620475-28-6 | Dye Reagents |
| HY-D2096A | Alexa fluor 647 NHS ester (TEA) | Dye Reagents | |
| HY-D2098 | TAMRA-PEG2-NH2 | 1425379-69-6 | Dye Reagents |
| HY-D2099 | Coumarin-PEG2-SCO | 2488239-94-5 | Dye Reagents |
| HY-D2100 | Cy5-DSPE | 2260669-68-7 | Dye Reagents |
| HY-D2100A | Cy5-DSPE (chloride ammonium) | 2260669-69-8 | Dye Reagents |
| HY-D2100B | Cy5-DSPE (chloride) | Dye Reagents | |
| HY-D2101 | TAMRA-PEG3-NH2 | Dye Reagents | |
| HY-D2102 | TAMRA-PEG7-NH2 | Dye Reagents | |
| HY-D2103 | TAMRA-PEG3-Maleimide | Dye Reagents | |
| HY-D2104 | TAMRA-PEG7-Maleimide | Dye Reagents | |
| HY-D2105 | TAMRA-PEG3-NHS | Dye Reagents | |
| HY-D2106 | TAMRA-PEG4-NHS | Dye Reagents | |
| HY-D2107 | TAMRA-PEG8-NHS | Dye Reagents | |
| HY-D2108 | TAMRA-PEG3-COOH | Dye Reagents | |
| HY-D2109 | TAMRA-PEG4-COOH | Dye Reagents | |
| HY-D2110 | TAMRA-PEG8-COOH | Dye Reagents | |
| HY-D2111 | TAMRA-PEG2-N3 | Dye Reagents | |
| HY-D2112 | TAMRA-PEG7-N3 | Dye Reagents | |
| HY-D2113 | TAMRA-PEG3-Alkyne | Dye Reagents | |
| HY-D2114 | TAMRA-PEG8-Alkyne | Dye Reagents | |
| HY-D2115 | NBDT | 2376850-99-4 | Dye Reagents |
| HY-D2116 | TAMRA-PEG8-Me-Tet | Dye Reagents | |
| HY-D2117 | TAMRA-PEG4-Me-Tet | Dye Reagents | |
| HY-D2118 | TAMRA-PEG3-Me-Tet | Dye Reagents | |
| HY-D2119 | CQ-Lyso | 2089438-23-1 | Dye Reagents |
| HY-D2120 | Cy3-PEG3-endo-BCN | Dye Reagents | |
| HY-D2120A | Cy3-PEG3-exo-BCN | Dye Reagents | |
| HY-D2121 | Cy3-PEG7-endo-BCN | Dye Reagents | |
| HY-D2121A | Cy3-PEG7-exo-BCN | Dye Reagents | |
| HY-D2122 | Cy3-PEG2-SCO | Dye Reagents | |
| HY-D2123 | Cy3-PEG3-SCO | Dye Reagents | |
| HY-D2124 | Cy3-PEG7-SCO | Dye Reagents | |
| HY-D2132 | Sulfo-Cy5.5-ALN | Dye Reagents | |
| HY-D2133 | Cy5-ALN | 1629601-00-8 | Dye Reagents |
| HY-D2134 | Cy5-PEG3-Tetrazin | Dye Reagents | |
| HY-D2136 | Cy3-PEG2-Azide | Dye Reagents | |
| HY-D2137 | Cy3-PEG3-Azide | Dye Reagents | |
| HY-D2138 | Cy3-PEG7-Azide | Dye Reagents | |
| HY-D2139 | Cy3-PEG3-Alkyne | Dye Reagents | |
| HY-D2140 | Cy3-PEG4-Alkyne | Dye Reagents | |
| HY-D2141 | Cy3-PEG8-Alkyne | Dye Reagents | |
| HY-D2142 | Cy5-PEG2-TCO | Dye Reagents | |
| HY-D2143 | Cy5-PEG3-TCO | Dye Reagents | |
| HY-D2144 | Cy5-PEG7-TCO | Dye Reagents | |
| HY-D2145 | Cy5-PEG2-TCO4 | Dye Reagents | |
| HY-D2146 | Cy5-PEG3-TCO4 | Dye Reagents | |
| HY-D2147 | Cy5-PEG7-TCO4 | Dye Reagents | |
| HY-D2148 | AF 430 tetrazine | Dye Reagents | |
| HY-D2149 | Cy5-PEG7-exo-BCN | Dye Reagents | |
| HY-D2150 | AF 430 maleimide | Dye Reagents | |
| HY-D2151 | AF 430 hydrazide | Dye Reagents | |
| HY-D2152 | Cy5-PEG3-SCO | Dye Reagents | |
| HY-D2153 | Cy5-PEG2-SCO | Dye Reagents | |
| HY-D2154 | AF 430 carboxylic acid | Dye Reagents | |
| HY-D2155 | Texas red-X 4-succinimidyl ester | 178623-11-5 | Dye Reagents |
| HY-D2156 | AF 430 azide | Dye Reagents | |
| HY-D2157 | Coumarin 343 X NHS ester | 946123-12-2 | Dye Reagents |
| HY-D2158 | Cy5-PEG7-SCO | Dye Reagents | |
| HY-D2159 | Cy5-PEG8-Tetrazin | Dye Reagents | |
| HY-D2160 | AF 647 carboxylic acid | Dye Reagents | |
| HY-D2161 | AF 594 azide | Dye Reagents | |
| HY-D2161A | AF 594 azide (triethylamine) | Dye Reagents | |
| HY-D2162 | AF 594 carboxylic acid | Dye Reagents | |
| HY-D2163 | AF 430 amine | Dye Reagents | |
| HY-D2164 | AF 430 alkyne | Dye Reagents | |
| HY-D2165 | AF 594 streptavidin | Dye Reagents | |
| HY-D2166 | AF 594 NHS ester | Dye Reagents | |
| HY-D2167 | AF 568 alkyne | Dye Reagents | |
| HY-D2168 | AF 568 azide | Dye Reagents | |
| HY-D2169 | AF 568 carboxylic acid | Dye Reagents | |
| HY-D2170 | AF488 streptavidin | Dye Reagents | |
| HY-D2171 | AF488 DBCO | Dye Reagents | |
| HY-D2171A | AF488 DBCO (ditriethylamine) | Dye Reagents | |
| HY-D2172 | AF488 carboxylic acid | Dye Reagents | |
| HY-D2173 | AF488 azide | Dye Reagents | |
| HY-D2174 | AF488 amine | Dye Reagents | |
| HY-D2175 | AF 555 NHS ester | Dye Reagents | |
| HY-D2176 | AF 555 carboxylic acid | Dye Reagents | |
| HY-D2177 | AF 555 azide | Dye Reagents | |
| HY-D2178 | AF 568 NHS ester | Dye Reagents | |
| HY-D2179 | AF 568 DBCO | Dye Reagents | |
| HY-D2180 | Preactivated APC-Cy5.5 Maleimide | Dye Reagents | |
| HY-D2181 | Preactivated PE-Cy5.5 Maleimide | Dye Reagents | |
| HY-D2182 | Preactivated PE-Cy5 Maleimide | Dye Reagents | |
| HY-D2183 | 6-Carboxy-JF5252 | 1811539-31-7 | Dye Reagents |
| HY-D2186 | BTD probe-1 | 2095485-22-4 | Dye Reagents |
| HY-D2187 | 6-TAMRA maleimide | 1508249-06-6 | Dye Reagents |
| HY-D2188 | IMP-2373 | Dye Reagents | |
| HY-D2189 | IRDye 700DX | 916821-46-0 | Dye Reagents |
| HY-D2190 | Ag2S Oil phase (1200 nm) | Dye Reagents | |
| HY-D2191 | Ag2S-COOH (1200 nm) | Dye Reagents | |
| HY-D2192 | Ag2S-PEG-NH2 (1200 nm) | Dye Reagents | |
| HY-D2193 | AgAuSe Oil phase (1000 nm) | Dye Reagents | |
| HY-D2194 | AgAuSe-COOH (1000 nm) | Dye Reagents | |
| HY-D2195 | AgAuSe-PEG-NH2 (1000 nm) | Dye Reagents | |
| HY-D2196 | AgAuSe Oil phase (1120 nm) | Dye Reagents | |
| HY-D2197 | AgAuSe-COOH (1120 nm) | Dye Reagents | |
| HY-D2198 | AgAuSe-PEG-NH2 (1120 nm) | Dye Reagents | |
| HY-D2200 | Cy5.5(Me)-C3-DBCO | Dye Reagents | |
| HY-D2201 | Fluorescent ACKR3 antagonist 1 | Dye Reagents | |
| HY-D2203 | BODIPY BDP4 | Dye Reagents | |
| HY-D2204 | SHP1-IN-1 | 2956720-62-8 | Dye Reagents |
| HY-D2205 | Cy7 tyramide | Dye Reagents | |
| HY-D2206 | SiR650-CH2F | Dye Reagents | |
| HY-D2207 | SiR700-CH2F | Dye Reagents | |
| HY-D2208 | SYTM Green | Dye Reagents | |
| HY-D2209 | SiR-PEG4-Me-tetrazine | Dye Reagents | |
| HY-D2210 | SiR-PEG3-azide | Dye Reagents | |
| HY-D2211 | SiR-PEG4-NHS ester | Dye Reagents | |
| HY-D2212 | SiR-PEG4-Maleimide | Dye Reagents | |
| HY-D2213 | SiR-PEG4-COOH | Dye Reagents | |
| HY-D2214 | SiR-PEG4-BCN | Dye Reagents | |
| HY-D2215 | Mito-CCY | 2102192-83-4 | Dye Reagents |
| HY-D2216 | SiR-azide | 3031722-00-3 | Dye Reagents |
| HY-D2217 | Cy7 tetrazine | Dye Reagents | |
| HY-D2218 | SiR-alkyne | Dye Reagents | |
| HY-D2219 | Sulfo-Cy7 tetrazine | Dye Reagents | |
| HY-D2220 | SiR-Hoechst | Dye Reagents | |
| HY-D2221 | Sulfo-Cy3 dUTP | Dye Reagents | |
| HY-D2222 | 5-HMSiR-Hochest | 2996108-30-4 | Dye Reagents |
| HY-D2223 | Sulfo-Cy5 dUTP | Dye Reagents | |
| HY-D2224 | Sulfo-Cy5.5 dUTP | Dye Reagents | |
| HY-D2225 | IR-34 | 1895075-93-0 | Dye Reagents |
| HY-D2226 | Sulfo-Cy5-PEG3-Biotin | Dye Reagents | |
| HY-D2227 | IR-58 | 2374274-85-6 | Dye Reagents |
| HY-D2228 | IR-7 | 1895075-45-2 | Dye Reagents |
| HY-D2229 | Sulfo-Cy3.5 amine | Dye Reagents | |
| HY-D2230 | Cy3.5 alkyne | Dye Reagents | |
| HY-D2231 | Cy3.5 maleimide | Dye Reagents | |
| HY-D2232 | SiR-PEG4-azide | Dye Reagents | |
| HY-D2233 | SiR-PEG4-alkyne | Dye Reagents | |
| HY-D2234 | SiR-PEG3-TCO | 3017315-33-9 | Dye Reagents |
| HY-D2235 | SiR-Me-tetrazine | Dye Reagents | |
| HY-D2236 | SiR-tetrazine | 2643948-31-4 | Dye Reagents |
| HY-D2237 | SiR-Maleimide | 2296718-56-2 | Dye Reagents |
| HY-D2238 | Disulfo-ICG-NHS (disodium) | Dye Reagents | |
| HY-D2239 | Sulfo-Cy3.5 maleimide | Dye Reagents | |
| HY-D2240 | Sulfo-Cy3.5-DBCO | Dye Reagents | |
| HY-D2241 | Sulfo-Cy7-DBCO | Dye Reagents | |
| HY-D2242 | Sulfo-Cy7.5 DBCO | Dye Reagents | |
| HY-D2243 | Cy3.5 tetrazine | Dye Reagents | |
| HY-D2244 | Cy3 phosphoramidite | 182873-76-3 | Dye Reagents |
| HY-D2245 | Cy5.5 phosphoramidite | Dye Reagents | |
| HY-D2246 | ICG-SH | 2387670-76-8 | Dye Reagents |
| HY-D2247 | ICG-CBT | Dye Reagents | |
| HY-D2248 | ICG-TCO | Dye Reagents | |
| HY-D2249 | DiSulfo-ICG maleimide | Dye Reagents | |
| HY-D2250 | Disulfo-ICG carboxylic acid | 2757507-18-7 | Dye Reagents |
| HY-D2251 | DiSulfo-ICG hydrazide | Dye Reagents | |
| HY-D2252 | Disulfo-ICG amine | Dye Reagents | |
| HY-D2253 | Direct Blue 108 | 1324-58-9 | Dye Reagents |
| HY-D2254 | CTB probe-1 | 2077078-94-3 | Dye Reagents |
| HY-D2255 | BDP FL ceramide | 2730893-01-1 | Dye Reagents |
| HY-D2256 | BDP TMR ceramide | Dye Reagents | |
| HY-D2258 | Bio-17-ATP | 687627-29-8 | Dye Reagents |
| HY-D2259 | PFI-7 | 2910938-58-6 | Dye Reagents |
| HY-D2260 | hMSCs-Neu (perchlorate) | 2320522-38-9 | Dye Reagents |
| HY-D2261 | BODIPY-cholesterol conjugate-1 | 1638745-25-1 | Dye Reagents |
| HY-D2262 | BODIPY-cholesterol conjugate-2 | 1638745-26-2 | Dye Reagents |
| HY-D2263 | BODIPY-cholesterol conjugate-3 | 1638745-27-3 | Dye Reagents |
| HY-D2264 | Caffeine orange | 1632296-13-9 | Dye Reagents |
| HY-D2266 | FluoBar1 | Dye Reagents | |
| HY-D2267 | JF646-Hoechst | 2462011-60-3 | Dye Reagents |
| HY-D2268 | QM-FN-SO3 | 2316820-94-5 | Dye Reagents |
| HY-D2268A | QM-FN-SO3 (ammonium) | Dye Reagents | |
| HY-D2270 | Halo tag TMR | 2764890-88-0 | Dye Reagents |
| HY-D2274 | EZH2-AF647 | Dye Reagents | |
| HY-D2275 | Polyglyceryl-10 Laurate mixture-Foam | Biochemical Assay Reagents | |
| HY-D2276 | Polyglyceryl-10 Laurate mixture-LB | Biochemical Assay Reagents | |
| HY-D2277 | Fluorescein-CM2 | 1394821-44-3 | Dye Reagents |
| HY-D2278 | GDP-Fucose-Cy5 | Dye Reagents | |
| HY-D2279 | NFL-NH2 | Dye Reagents | |
| HY-D2280 | Estrogen receptor β/HDAC probe 1 | 3057270-84-2 | Dye Reagents |
| HY-D2281 | FAP Ligand 2 | Dye Reagents | |
| HY-D2283 | Photo-DL-lysine | Dye Reagents | |
| HY-D2283S | Photo-DL-lysine-d2 | Isotope-Labeled Compounds | |
| HY-D2283S1 | Photo-lysine-d2 | Isotope-Labeled Compounds | |
| HY-D2283S2 | Photo-lysine-d2-1 | Isotope-Labeled Compounds | |
| HY-D2284 | SGPL1 fluorogenic substrate | 1166838-84-1 | Dye Reagents |
| HY-D2285 | MOR-CES2 | 2956672-93-6 | Dye Reagents |
| HY-D2286 | HBT-Fl-BnB | Dye Reagents | |
| HY-D2287 | CalFluor 555 azide | 1798305-99-3 | Dye Reagents |
| HY-D2287A | CalFluor 555 azide (chloride) | Dye Reagents | |
| HY-D2288 | CalFluor 580 azide | 1798306-00-9 | Dye Reagents |
| HY-D2289 | CalFluor 647 azide | 1798306-01-0 | Dye Reagents |
| HY-D2290 | Demethoxy-BODIPY TMR NHS ester | Dye Reagents | |
| HY-D2291 | BODIPY TMR NHS ester | 2671036-80-7 | Dye Reagents |
| HY-D2292 | BODIPY TMR acid | Dye Reagents | |
| HY-D2294 | FD dye 7 | Dye Reagents | |
| HY-D2295 | Mito-FerroGreen | Dye Reagents | |
| HY-D2297 | AIE-GA | 2653341-16-1 | Dye Reagents |
| HY-D2299 | AIE-ER | 2653341-17-2 | Dye Reagents |
| HY-D2300 | mgc(3Me)FDA | 2763442-01-7 | Dye Reagents |
| HY-D2301 | mgc(3Me)FL | Dye Reagents | |
| HY-D2302 | mgc(3Me)DEAC | 2763442-02-8 | Dye Reagents |
| HY-D2303 | mgc(3Me)TMR (5/6 mix) | Dye Reagents | |
| HY-D2304 | mgc(3Me)JF549 | Dye Reagents | |
| HY-D2306 | DBCO-PEG-SH | Dye Reagents | |
| HY-D2309 | IRDye700Dx (Maleimide) | Dye Reagents | |
| HY-D2310 | CXCR2 Probe 1 | Dye Reagents | |
| HY-D2311 | CDK19 Probe 1 | Dye Reagents | |
| HY-D2312 | Mito-Rh-S | Dye Reagents | |
| HY-D2314 | Cyanine 7-amine (chloride hydrochloride) | 1650559-73-1 | Dye Reagents |
| HY-D2315 | Probe-Cys | Dye Reagents | |
| HY-D2316 | Flipper-TR probe | Dye Reagents | |
| HY-D2317 | HaloFlipper 30 | Dye Reagents | |
| HY-D2318 | Flipper-TR 5 | 2081888-04-0 | Dye Reagents |
| HY-D2320 | ER Flipper-TR 28 | 2334078-37-2 | Dye Reagents |
| HY-D2321 | Lyso Flipper-TR 29 | 2324152-35-2 | Dye Reagents |
| HY-D2322 | SupraFlipper 31 | Dye Reagents | |
| HY-D2323 | ER PhotoFlipper 32 | Dye Reagents | |
| HY-D2324 | EE-Flipper 33 | 2804069-30-3 | Dye Reagents |
| HY-D2325 | Arg-Flipper 34 | 2804069-31-4 | Dye Reagents |
| HY-D2327 | DPP-8/9 probe-1 | 3020859-80-4 | Dye Reagents |
| HY-D2328 | Alexa Fluor 680 NHS ester | 407628-15-3 | Dye Reagents |
| HY-D2329 | Fluorescein-PEG4-NHS ester | Dye Reagents | |
| HY-D2331 | ZL-12A probe | Dye Reagents | |
| HY-D2332 | SiR-Halo | 1418275-31-6 | Dye Reagents |
| HY-D2333 | RhFNMB | Dye Reagents | |
| HY-D2334 | AlF-NOTA-c-d-VAP | Dye Reagents | |
| HY-D2335 | SERTlight | Dye Reagents | |
| HY-D2336 | PROTAC Aster-A degrader-1 | Dye Reagents | |
| HY-D2337 | Quinophthalone | 5662-03-3 | Dye Reagents |
| HY-D2338 | PMBD | Dye Reagents | |
| HY-D2341 | 6FC-GABA-Taxol | 3055969-34-8 | Dye Reagents |
| HY-D2342 | SARS-CoV-2 3CLpro probe-1 | Dye Reagents | |
| HY-D2343 | PB0822 | Dye Reagents | |
| HY-D2344 | 3-BTD | 325721-44-6 | Dye Reagents |
| HY-D2345 | GZ22-4 | Dye Reagents | |
| HY-D2346 | HBmito Crimson | Dye Reagents | |
| HY-D2348 | ACE | 3058751-62-2 | Dye Reagents |
| HY-D2348A | ACE (TFA) | Dye Reagents | |
| HY-D2353 | Biotin-PEG3-benzophenone | 756525-96-9 | Dye Reagents |
| HY-D2355 | tris-NTA Biotin | 1070867-85-4 | Dye Reagents |
| HY-D2357 | Lactat-CY5 | Dye Reagents | |
| HY-D2358 | Glucosamine-CY5.5 | Dye Reagents | |
| HY-D2359 | Glucosamine-FITC | Dye Reagents | |
| HY-D2360 | O-Carboranylphenoxyacetanilide | 1220716-15-3 | Dye Reagents |
| HY-D2361 | Adenosine 2'-PEG-Biotin | 362028-97-5 | Dye Reagents |
| HY-D2363 | DOTA.SA.FAPi (TFA) | Peptides | |
| HY-D2365 | QSY 21 NHS | 304014-13-9 | Dye Reagents |
| HY-D2367 | Rhodamine B NHS ester | 144700-55-0 | Dye Reagents |
| HY-D2371 | 3-BTMD | 2115701-43-2 | Dye Reagents |
| HY-D2373 | CY5.5-PEG2000-Mal | Dye Reagents | |
| HY-D2374 | CY5.5-PEG5000-Mal | Dye Reagents | |
| HY-D2376 | BH-Vis | Dye Reagents | |
| HY-D2377 | F8 | Dye Reagents | |
| HY-D2378 | Abenacianine | 2231255-31-3 | Reference compound |
| HY-D2379 | HMRG | 1629965-68-9 | Dye Reagents |
| HY-D2379A | closed-HMRG | 7449-51-6 | Dye Reagents |
| HY-D2380 | H2S probe 1 | Dye Reagents | |
| HY-D2381 | AF 488 maleimide | Dye Reagents | |
| HY-D2387 | Sulfo CY3.5 hydrazide | Dye Reagents | |
| HY-D2388 | Sulfo CY5.5 hydrazide | Dye Reagents | |
| HY-D2388A | Sulfo Cy5.5-hydrazide (sodium) | Dye Reagents | |
| HY-D2395 | B-Phycoerythrin | Dye Reagents | |
| HY-D2396 | Sulfo SMCC R-phycoerythrin | Dye Reagents | |
| HY-D2397 | Cross-Linked Allophycocyanin | Dye Reagents | |
| HY-D2401F | Cy5-Polystyrene microsphere (100nm) | Dye Reagents | |
| HY-D2413 | BODIPY FL VH032 | 2770675-66-4 | Dye Reagents |
| HY-D2414 | SCOTfluor-89 | 2490298-72-9 | Dye Reagents |
| HY-D2415 | BODIPY-FL staurosporine | 2411845-57-1 | Dye Reagents |
| HY-D2416S | JFX650 | 2396479-84-6 | Isotope-Labeled Compounds |
| HY-D2417 | SiRA 2 | 2365417-91-8 | Dye Reagents |
| HY-D2418 | PS-SCOTfluor-12 | 2351933-31-6 | Dye Reagents |
| HY-D2420 | Biotin-PEG5-Mal | Dye Reagents | |
| HY-D2421 | DEAE-dex-Cy5 | Dye Reagents | |
| HY-D2422A | Cy5.5-Paclitaxel | Dye Reagents | |
| HY-D2422B | Cy5-Paclitaxel | Dye Reagents | |
| HY-D2424 | Disperse Red 343 | 68385-96-6 | Dye Reagents |
| HY-D2425 | Disperse Red 153 | 78564-87-1 | Dye Reagents |
| HY-D2426 | Cy3-Transferrin | Dye Reagents | |
| HY-D2427 | Cy3-PEG-Amine | Dye Reagents | |
| HY-D2428 | OVA-PEG-Cy3 | Dye Reagents | |
| HY-D2429 | Dextran-PEG-Cy3 | Dye Reagents | |
| HY-D2430 | Chitosan-PEG-Cy3 | Dye Reagents | |
| HY-D2431 | Galactose-PEG-Cy3 | Dye Reagents | |
| HY-D2432 | Mannose-PEG-Cy3 | Dye Reagents | |
| HY-D2433 | Glucose-PEG2000-Cy3 | Dye Reagents | |
| HY-D2434 | HRP-PEG-Cy3 | Dye Reagents | |
| HY-D2435 | MTX-PEG-Cy3 | Dye Reagents | |
| HY-D2436 | PTX-PEG-Cy3 | Dye Reagents | |
| HY-D2437 | DOX-PEG-Cy3 | Dye Reagents | |
| HY-D2438 | CDDP-PEG-Cy3 | Dye Reagents | |
| HY-D2439 | RGD-PEG-Cy3 | Dye Reagents | |
| HY-D2440 | cRGD-PEG-Cy3 | Dye Reagents | |
| HY-D2441 | TAT-PEG-Cy3 | Dye Reagents | |
| HY-D2442 | Cy3-PEG-NH2 | Dye Reagents | |
| HY-D2443 | AF594 DBCO | Dye Reagents | |
| HY-D2444 | AF555 NHS | 407627-68-3 | Dye Reagents |
| HY-D2445 | AF405 acid | 852953-60-7 | Dye Reagents |
| HY-D2446 | BDP 650/665 azide | Dye Reagents | |
| HY-D2447 | BDP 650/665 DBCO | Dye Reagents | |
| HY-D2448 | Cy3-PEG-Thiol | Dye Reagents | |
| HY-D2449 | DQ-BSA-RED | Dye Reagents | |
| HY-D2452 | Cy3-Ccisplatin | Dye Reagents | |
| HY-D2459 | Alexa Fluor 430 NHS ester | Dye Reagents | |
| HY-D2460 | Dextran-CY5.5 | Dye Reagents | |
| HY-D2465 | CY5-Dextran (MW60-80k) | Dye Reagents | |
| HY-D2466 | Dextran-CY3 | Dye Reagents | |
| HY-D2468 | HRP-Streptavidin | Dye Reagents | |
| HY-D2474 | PSP | 3030735-86-2 | Dye Reagents |
| HY-D2475 | 2-Amino-5-methoxybenzamidoxime | 1359828-78-6 | Dye Reagents |
| HY-D2476 | H2S Fluorescent probe 1 | 433254-36-5 | Dye Reagents |
| HY-D2477 | Sulfo-QSY21-NHS | 1974271-78-7 | Dye Reagents |
| HY-D2479 | DMANI | 2978635-30-0 | Dye Reagents |
| HY-D2480 | BODIPY 480/508-cholesteryl linoleate | 2260795-60-4 | Dye Reagents |
| HY-D2481 | Asante potassium green-2 (TMA) | 1369302-21-5 | Dye Reagents |
| HY-D2482 | Asante potassium green-1 AM | 1369302-18-0 | Dye Reagents |
| HY-D2483 | Asante potassium green-1 (TMA) | 1369302-17-9 | Dye Reagents |
| HY-D2485 | Sulfo Cy3 bis COOH | Dye Reagents | |
| HY-D2486 | Sulfo Cy3 bis NHS ester | Dye Reagents | |
| HY-D2487 | Sulfo Cy5 bis COOH | Dye Reagents | |
| HY-D2488 | Sulfo Cy5.5-maleimide | Dye Reagents | |
| HY-D2489 | Cy5-tetrazine | Dye Reagents | |
| HY-D2490 | Sulfo Cy5.5-N3 | Dye Reagents | |
| HY-D2492 | Sulfo Cy7 bis-COOH | Dye Reagents | |
| HY-D2493 | Cyanine7 carboxylic acid | 1144107-78-7 | Dye Reagents |
| HY-D2494 | Sulfo Cy7 bis-NHS ester | Dye Reagents | |
| HY-D2495 | Cy7 SE (nosulfo) | Dye Reagents | |
| HY-D2497 | Sulfo Cy7 bis-SH | Dye Reagents | |
| HY-D2498 | Cy7 maleimide | Dye Reagents | |
| HY-D2499 | Sulfo Cy7 DBCO (potassium) | Dye Reagents | |
| HY-D2500 | CY7 DBCO (chloride) | Dye Reagents | |
| HY-D2501 | Sulfo Cy7 N3 | Dye Reagents | |
| HY-D2502 | Cy7 hydrazide | Dye Reagents | |
| HY-D2504 | Sulfo ICG-tetrazine | Dye Reagents | |
| HY-D2505 | Cy3-PEG-NH2 (MW 1000) | Dye Reagents | |
| HY-D2506 | Cy3-PEG-NH2 (MW 3400) | Dye Reagents | |
| HY-D2507 | Cy3-PEG-NH2 (MW 5000) | Dye Reagents | |
| HY-D2508 | Cy3-PEG-NH2 (MW 10000) | Dye Reagents | |
| HY-D2509 | Cy3-PEG-SH (MW 1000) | Dye Reagents | |
| HY-D2510 | Cy3-PEG-SH (MW 2000) | Dye Reagents | |
| HY-D2511 | Cy3-PEG-SH (MW 3400) | Dye Reagents | |
| HY-D2512 | Cy3-PEG-SH (MW 5000) | Dye Reagents | |
| HY-D2513 | Cy3-PEG-SH (MW 10000) | Dye Reagents | |
| HY-D2514 | Cy3-PEG-DSPE (MW 1000) | Dye Reagents | |
| HY-D2516 | Cy3-PEG-DSPE (MW 3400) | Dye Reagents | |
| HY-D2517 | Cy3-PEG-DSPE (MW 5000) | Dye Reagents | |
| HY-D2518 | Cy3-PEG-DSPE (MW 10000) | Dye Reagents | |
| HY-D2519 | Cy3-PEG-biotin (MW 2000) | Dye Reagents | |
| HY-D2520 | Cy3-PEG-biotin (MW 5000) | Dye Reagents | |
| HY-D2521 | Cy3-PEG-DBCO (MW 2000) | Dye Reagents | |
| HY-D2522 | Cy3-PEG-DBCO (MW 5000) | Dye Reagents | |
| HY-D2523 | Cy3-PEG-FA (MW 2000) | Dye Reagents | |
| HY-D2524 | Cy3-PEG-FA (MW 5000) | Dye Reagents | |
| HY-D2525 | Cy3-PEG-DMPE | Dye Reagents | |
| HY-D2526 | Cy3 IRGD-PEG-DSPE | Dye Reagents | |
| HY-D2527 | Biotin-PEG4-amide-PEG2-C6-Cl | 1070801-79-4 | Dye Reagents |
| HY-D2529 | Cy5-PEG-SH (MW 2000) | Dye Reagents | |
| HY-D2530 | Cy5-PEG-SH (MW 3400) | Dye Reagents | |
| HY-D2531 | Cy5-PEG-SH (MW 5000) | Dye Reagents | |
| HY-D2532 | Cy5-PEG-SH (MW 10000) | Dye Reagents | |
| HY-D2533 | Cy5-PEG-N3 (MW 2000) | Dye Reagents | |
| HY-D2534 | Cy5-PEG-N3 (MW 3400) | Dye Reagents | |
| HY-D2535 | Cy5-PEG-N3 (MW 5000) | Dye Reagents | |
| HY-D2536 | Cy5-PEG-N3 (MW 10000) | Dye Reagents | |
| HY-D2537 | Cy3-PEG-N3 (MW 2000) | Dye Reagents | |
| HY-D2538 | Cy3-PEG-N3 (MW 3400) | Dye Reagents | |
| HY-D2539 | Cy3-PEG-N3 (MW 5000) | Dye Reagents | |
| HY-D2540 | Cy3-PEG-N3 (MW 10000) | Dye Reagents | |
| HY-D2541 | Cy5-PEG-DSPE (MW 1000) | Dye Reagents | |
| HY-D2542 | Cy5-PEG-DSPE (MW 2000) | Dye Reagents | |
| HY-D2543 | Cy5-PEG-DSPE (MW 3400) | Dye Reagents | |
| HY-D2544 | Cy5-PEG-DSPE (MW 5000) | Dye Reagents | |
| HY-D2545 | Cy5-PEG-DSPE (MW 10000) | Dye Reagents | |
| HY-D2546 | Cy5-PEG-biotin (MW 2000) | Dye Reagents | |
| HY-D2547 | Cy5-PEG-biotin (MW 5000) | Dye Reagents | |
| HY-D2548 | Cy5-PEG-DBCO (MW 2000) | Dye Reagents | |
| HY-D2549 | Cy5-PEG-DBCO (MW 5000) | Dye Reagents | |
| HY-D2550 | Cy5-PEG-FA (MW 2000) | Dye Reagents | |
| HY-D2551 | Cy5-PEG-FA (MW 5000) | Dye Reagents | |
| HY-D2552 | Cy5.5-PEG-NH2 (MW 1000) | Dye Reagents | |
| HY-D2553 | Cy5.5-PEG-NH2 (MW 3400) | Dye Reagents | |
| HY-D2554 | Cy5.5-PEG-NH2 (MW 5000) | Dye Reagents | |
| HY-D2555 | Cy5.5-PEG-NH2 (MW 10000) | Dye Reagents | |
| HY-D2556 | Cy5.5-PEG-SH (MW 1000) | Dye Reagents | |
| HY-D2557 | Cy5.5-PEG-SH (MW 3400) | Dye Reagents | |
| HY-D2558 | Cy5.5-PEG-SH (MW 5000) | Dye Reagents | |
| HY-D2559 | Cy5.5-PEG-SH (MW 10000) | Dye Reagents | |
| HY-D2560 | Cy5.5-PEG-N3 (MW 2000) | Dye Reagents | |
| HY-D2561 | Cy5.5-PEG-N3 (MW 3400) | Dye Reagents | |
| HY-D2562 | Cy5.5-PEG-N3 (MW 5000) | Dye Reagents | |
| HY-D2563 | Cy5.5-PEG-N3 (MW 10000) | Dye Reagents | |
| HY-D2564 | Cy5.5-PEG-DSPE (MW 1000) | Dye Reagents | |
| HY-D2565 | Cy5.5-PEG-DSPE (MW 2000) | Dye Reagents | |
| HY-D2566 | Cy5.5-PEG-DSPE (MW 3400) | Dye Reagents | |
| HY-D2567 | Cy5.5-PEG-DSPE (MW 5000) | Dye Reagents | |
| HY-D2568 | Cy5.5-PEG-DSPE (MW 10000) | Dye Reagents | |
| HY-D2569 | Cy5.5-PEG-Biotin (MW 2000) | Dye Reagents | |
| HY-D2570 | Cy5.5-PEG-Biotin (MW 5000) | Dye Reagents | |
| HY-D2571 | Cy5.5-PEG-DBCO (MW 2000) | Dye Reagents | |
| HY-D2572 | Cy5.5-PEG-DBCO (MW 5000) | Dye Reagents | |
| HY-D2573 | Cy5.5-PEG-FA (MW 2000) | Dye Reagents | |
| HY-D2574 | Cy5.5-PEG-FA (MW 5000) | Dye Reagents | |
| HY-D2575 | WYneN | 3052492-38-0 | Dye Reagents |
| HY-D2579 | Sulfo DBCO-UBQ-2 | Dye Reagents | |
| HY-D2582 | DMAO | Dye Reagents | |
| HY-D2620 | CAR-2 | 3030055-40-1 | Reference compound |
| HY-D2639 | TPE-PY | 3032077-04-3 | Dye Reagents |
| HY-D2730 | N14G-Fe | Dye Reagents | |
| HY-D2731 | Cy5-NO2-6 | Dye Reagents | |
| HY-D2732 | NFC nitro probe 1 | 1604838-69-8 | Dye Reagents |
| HY-D2733 | N14G | Dye Reagents | |
| HY-D2734 | Heparin-Cy3 | Dye Reagents | |
| HY-D2735 | QSY-9-succinimidyl ester | 304014-17-3 | Dye Reagents |
| HY-D2736 | BP Light 800 NHS ester | 2131095-32-2 | Dye Reagents |
| HY-D2737 | DMT-BH2 amidite | 374591-98-7 | Dye Reagents |
| HY-D2738 | BP Fluor 532 NHS ester | 2791287-15-3 | Dye Reagents |
| HY-D2739 | SIMA phosphoramidite, 6-isomer | 1411797-05-1 | Dye Reagents |
| HY-D2740 | ROX azide, 6-isomer | 1422178-12-8 | Dye Reagents |
| HY-D2741 | MB 488 NHS ester | 2766408-55-1 | Dye Reagents |
| HY-D2742 | DMT-BH1 amidite | 374591-94-3 | Dye Reagents |
| HY-D2743 | ROX alkyne, 6-isomer | 2097422-22-3 | Dye Reagents |
| HY-D2744 | BP Fluor 488 TCO | 2766559-05-9 | Dye Reagents |
| HY-D2745 | BP Fluor 594 NHS ester | 1638544-48-5 | Dye Reagents |
| HY-D2746 | Cy5.5 bis-NHS ester | 2183440-77-7 | Dye Reagents |
| HY-D2747 | BP Fluor 405 acid | 1638784-10-7 | Dye Reagents |
| HY-D2748 | 5-JOE azide | 1422178-11-7 | Dye Reagents |
| HY-D2749 | Sulfo-Bis-(N,N'-carboxylic acid)-Cy5 | 2353410-10-1 | Dye Reagents |
| HY-D2750 | Sulfo-Cy5 picolyl azide | 2669097-38-3 | Dye Reagents |
| HY-D2751 | BP Fluor 488 cadaverine | 1178534-61-6 | Dye Reagents |
| HY-D2752 | Cy5.5 dimethyl | 138248-58-5 | Dye Reagents |
| HY-D2753 | BDP 650/665 X NHS ester | 1616842-78-4 | Dye Reagents |
| HY-D2754 | BP Light 550 carboxylic acid | 1638197-36-0 | Dye Reagents |
| HY-D2755 | BP Light 650 carboxylic acid | 1638197-45-1 | Dye Reagents |
| HY-D2756 | OG 488 alkyne | 1801181-54-3 | Dye Reagents |
| HY-D2757 | 5(6)-Carboxyrhodamine 110 NHS ester | 135926-06-6 | Dye Reagents |
| HY-D2758 | TAMRA DBCO, 5-isomer | 1911598-65-6 | Dye Reagents |
| HY-D2759 | Cyanine3B azide | 1914113-85-1 | Dye Reagents |
| HY-D2760 | BP Fluor 488 acid | 1027930-57-9 | Dye Reagents |
| HY-D2761 | DY-680-NHS ester | 1264737-80-5 | Dye Reagents |
| HY-D2763 | BP Fluor 532 maleimide | 890928-51-5 | Dye Reagents |
| HY-D2764 | Difluorocarboxyfluorescein cadaverine, 5-isomer | 886210-16-8 | Dye Reagents |
| HY-D2765 | BP Fluor 405 cadaverine | 757156-70-0 | Dye Reagents |
| HY-D2766 | DyLight 550 NHS ester | 1340586-78-8 | Dye Reagents |
| HY-D2767 | MB 660R NHS Ester | 1201771-13-2 | Dye Reagents |
| HY-D2768 | BP Fluor 430 NHS ester | 467233-93-8 | Dye Reagents |
| HY-D2769 | Oregon green 488 azide | 2648246-11-9 | Dye Reagents |
| HY-D2770 | Cyanine3.5 dimethyl | 42849-61-6 | Dye Reagents |
| HY-D2771 | BP Fluor 405 NHS ester | 2131079-93-9 | Dye Reagents |
| HY-D2772 | 5-TAMRA Cadaverine | 383912-87-6 | Dye Reagents |
| HY-D2773 | 5-Carboxyrhodamine 110 NHS ester | 219729-26-7 | Dye Reagents |
| HY-D2774 | TechnoDye 498/505 | 105237-27-2 | Dye Reagents |
| HY-D2775 | Cobalt(II) ions probe 1 | 3047612-66-5 | Dye Reagents |
| HY-D2776 | Primary antibody and secondary antibody eluent, specially for mIHC experiments | Dye Reagents | |
| HY-D2794 | FITC-PEG-NH2 (MW 400) | Dye Reagents | |
| HY-D2794A | FITC-PEG-NH2 (MW 1000) | Dye Reagents | |
| HY-D2794B | FITC-PEG-NH2 (MW 5000) | Dye Reagents | |
| HY-D2794C | FITC-PEG-NH2 (MW 10000) | Dye Reagents | |
| HY-D2795 | FITC-PEG-COOH (MW 400) | Dye Reagents | |
| HY-D2795A | FITC-PEG-COOH (MW 1000) | Dye Reagents | |
| HY-D2795B | FITC-PEG-COOH (MW 5000) | Dye Reagents | |
| HY-D2795C | FITC-PEG-COOH (MW 10000) | Dye Reagents | |
| HY-D2796 | FITC-PEG-OH (MW 400) | Dye Reagents | |
| HY-D2796A | FITC-PEG-OH (MW 1000) | Dye Reagents | |
| HY-D2796B | FITC-PEG-OH (MW 5000) | Dye Reagents | |
| HY-D2796C | FITC-PEG-OH (MW 10000) | Dye Reagents | |
| HY-D2797 | Chitosan-Cy7 (MW 2000) | Dye Reagents | |
| HY-D2798 | FITC-PEG-SH (MW 400) | Dye Reagents | |
| HY-D2798A | FITC-PEG-SH (MW 1000) | Dye Reagents | |
| HY-D2798B | FITC-PEG-SH (MW 5000) | Dye Reagents | |
| HY-D2798C | FITC-PEG-SH (MW 10000) | Dye Reagents | |
| HY-D2799 | Chitosan-Cy7 (MW 7000) | Dye Reagents | |
| HY-D2800 | FITC-PEG-MAL (MW 400) | Dye Reagents | |
| HY-D2800A | FITC-PEG-MAL (MW 1000) | Dye Reagents | |
| HY-D2800B | FITC-PEG-MAL (MW 3400) | Dye Reagents | |
| HY-D2800C | FITC-PEG-MAL (MW 5000) | Dye Reagents | |
| HY-D2800D | FITC-PEG-MAL (MW 10000) | Dye Reagents | |
| HY-D2801 | FITC-PEG-NHS (MW 400) | Dye Reagents | |
| HY-D2801A | FITC-PEG-NHS (MW 1000) | Dye Reagents | |
| HY-D2801B | FITC-PEG-NHS (MW 3400) | Dye Reagents | |
| HY-D2801C | FITC-PEG-NHS (MW 5000) | Dye Reagents | |
| HY-D2802 | FITC-PEG-N3 (MW 400) | Dye Reagents | |
| HY-D2802A | FITC-PEG-N3 (MW 1000) | Dye Reagents | |
| HY-D2802B | FITC-PEG-N3 (MW 3400) | Dye Reagents | |
| HY-D2802C | FITC-PEG-N3 (MW 5000) | Dye Reagents | |
| HY-D2802D | FITC-PEG-N3 (MW 10000) | Dye Reagents | |
| HY-D2804 | Chitosan-Cy7 (MW 10000) | Dye Reagents | |
| HY-D2814 | Chitosan-Cy7 (MW 100000) | Dye Reagents | |
| HY-D2816 | Chitosan-Cy7.5 (MW 2000) | Dye Reagents | |
| HY-D2817 | FITC-PLL | Dye Reagents | |
| HY-D2820 | Chitosan-Cy7.5 (MW 75000) | Dye Reagents | |
| HY-D2824 | Chitosan-Cy7.5 (MW 10000) | Dye Reagents | |
| HY-D2825 | Chitosan-Cy7.5 (MW 100000) | Dye Reagents | |
| HY-D2826 | FITC-Chitosan (MW 100000) | Dye Reagents | |
| HY-D2826A | FITC-Chitosan (MW 40000) | Dye Reagents | |
| HY-D2826B | FITC-Chitosan (MW 20000) | Dye Reagents | |
| HY-D2826C | FITC-Chitosan (MW 10000) | Dye Reagents | |
| HY-D2826D | FITC-Chitosan (MW 5000) | Dye Reagents | |
| HY-D2826E | FITC-Chitosan (MW 2000) | Dye Reagents | |
| HY-D2835 | m-PEG1000-PEI-Cy5 | Dye Reagents | |
| HY-D2836 | FITC-HA (MW 1000000) | Dye Reagents | |
| HY-D2836A | FITC-HA (MW 500000) | Dye Reagents | |
| HY-D2836B | FITC-HA (MW 200000) | Dye Reagents | |
| HY-D2836C | FITC-HA (MW 100000) | Dye Reagents | |
| HY-D2836D | FITC-HA (MW 50000) | Dye Reagents | |
| HY-D2836E | FITC-HA (MW 10000) | Dye Reagents | |
| HY-D2836H | FITC-HA (MW 7000) | Dye Reagents | |
| HY-D2836I | FITC-HA (MW 5000) | Dye Reagents | |
| HY-D2836J | FITC-HA (MW 3000) | Dye Reagents | |
| HY-D2837 | m-PEG2000-PEI-Cy5 | Dye Reagents | |
| HY-D2838 | m-PEG5000-PEI-Cy5 | Dye Reagents | |
| HY-D2839 | m-PEG10000-PEI-Cy5 | Dye Reagents | |
| HY-D2840 | FITC-mPEG (MW 350) | Dye Reagents | |
| HY-D2840A | FITC-mPEG (MW 550) | Dye Reagents | |
| HY-D2840B | FITC-mPEG (MW 750) | Dye Reagents | |
| HY-D2840C | FITC-mPEG (MW 1000) | Dye Reagents | |
| HY-D2840D | FITC-mPEG (MW 2000) | Dye Reagents | |
| HY-D2840E | FITC-mPEG (MW 5000) | Dye Reagents | |
| HY-D2840H | FITC-mPEG (MW 10000) | Dye Reagents | |
| HY-D2840I | FITC-mPEG (MW 20000) | Dye Reagents | |
| HY-D2841 | FITC-Heparin | Dye Reagents | |
| HY-D2842 | FITC-PEG-biotin (MW 400) | Dye Reagents | |
| HY-D2842A | FITC-PEG-biotin (MW 1000) | Dye Reagents | |
| HY-D2842B | FITC-PEG-biotin (MW 2000) | Dye Reagents | |
| HY-D2842C | FITC-PEG-biotin (MW 3400) | Dye Reagents | |
| HY-D2842D | FITC-PEG-biotin (MW 5000) | Dye Reagents | |
| HY-D2842E | FITC-PEG-biotin (MW 10000) | Dye Reagents | |
| HY-D2844 | FITC-PEG-FA (MW 400) | Dye Reagents | |
| HY-D2844A | FITC-PEG-FA (MW 1000) | Dye Reagents | |
| HY-D2844B | FITC-PEG-FA (MW 2000) | Dye Reagents | |
| HY-D2844C | FITC-PEG-FA (MW 3400) | Dye Reagents | |
| HY-D2844D | FITC-PEG-FA (MW 5000) | Dye Reagents | |
| HY-D2844E | FITC-PEG-FA (MW 10000) | Dye Reagents | |
| HY-D2845 | 4-arm-PEG-FITC (MW 2000) | Dye Reagents | |
| HY-D2845A | 4-arm-PEG-FITC (MW 5000) | Dye Reagents | |
| HY-D2845B | 4-arm-PEG-FITC (MW 10000) | Dye Reagents | |
| HY-DN1132F | FITC-trehalose | Biochemical Assay Reagents | |
| HY-DN7075F | FITC-inulin | Biochemical Assay Reagents | |
| HY-DNP159AF | House dust mite extract, from D.pteronyssinus (biotinylated) | Biochemical Assay Reagents | |
| HY-DNP159F | House dust mite extract, from D.farinae (biotinylated) | Biochemical Assay Reagents | |
| HY-E0001 | Cooling Rack | Kits | |
| HY-E0080A | Dichloromethane-d2 100 µg/mL in methanol | 1665-00-5 | Isotope-Labeled Compounds |
| HY-E0087 | 96-well Storage Plate Lid | Screening Libraries | |
| HY-E0156 | 8-Channel Handheld Screw Cap Decapper | Screening Libraries | |
| HY-E0194 | Round Cap Drivers for 8-Channel Handheld Screw Cap Decapper | Screening Libraries | |
| HY-E0209 | 384-well Storage Plate | Screening Libraries | |
| HY-E0224 | 0.5 mL Tube | Reference compound | |
| HY-E0225 | 0.5 mL SBS Rack | Screening Libraries | |
| HY-E70001 | Recombinant Human Luteinizing Hormone | Enzyme | |
| HY-E70002 | Deamino-NADPH | 42934-87-2 | Enzyme |
| HY-E70003 | Glutamate dehydrogenase | 9001-46-1 | Enzyme |
| HY-E70004 | Microbial neutral proteinase | 9068-59-1 | Enzyme |
| HY-E70005A | Collagenase, Type I | 9001-12-1 | Enzyme |
| HY-E70005B | Collagenase, Type II | 9001-12-1 | Enzyme |
| HY-E70005C | Collagenase, Type III | 9001-12-1 | Enzyme |
| HY-E70005D | Collagenase IV, Clostridium histolytica | 9001-12-1 | Enzyme |
| HY-E70005E | Collagenase, Type V | 9001-12-1 | Enzyme |
| HY-E70005H | Collagenase, Type VIII | 9001-12-1 | Enzyme |
| HY-E70005I | Collagenase, Type VI | 9001-12-1 | Enzyme |
| HY-E70005J | Collagenase, Type VII | 9001-12-1 | Enzyme |
| HY-E70005K | Collagenase (Type A, animal free) | 9001-12-1 | Enzyme |
| HY-E70005L | Collagenase (Type B, animal free) | 9001-12-1 | Enzyme |
| HY-E70005M | Collagenase (Type C, animal free) | 9001-12-1 | Enzyme |
| HY-E70005N | Collagenase (Type D, animal free) | 9001-12-1 | Enzyme |
| HY-E70005O | Collagenase (Type A, filtered, animal free) | 9001-12-1 | Enzyme |
| HY-E70005P | Collagenase (Type B, filtered, animal free) | 9001-12-1 | Enzyme |
| HY-E70005Q | Collagenase (Type C, filtered, animal free) | 9001-12-1 | Enzyme |
| HY-E70007 | Catechol O-methyltransferase, porcine liver | 9012-25-3 | Enzyme |
| HY-E70008 | Lumbokinase | 556743-18-1 | Enzyme |
| HY-E70009 | Acyl-CoA oxidase | 61116-22-1 | Enzyme |
| HY-E70010 | Aldose 1-epimerase | 9031-76-9 | Enzyme |
| HY-E70011 | Levanase | 9041-11-6 | Enzyme |
| HY-E70012 | Penicillinase | 9001-74-5 | Enzyme |
| HY-E70013 | Lichenase, Microorganism | 37288-51-0 | Enzyme |
| HY-E70014 | FAD-dependent glucose dehydrogenase | 37250-84-3 | Enzyme |
| HY-E70015 | Phosphoenolpyruvate carboxylase, Microorganism | 9067-77-0 | Enzyme |
| HY-E70016 | Terminal deoxyribonucleotidyltransferase | 9027-67-2 | Enzyme |
| HY-E70017 | Peptidase, microorganism | 9031-96-3 | Enzyme |
| HY-E70018 | Picornain 3C | 97162-88-4 | Enzyme |
| HY-E70019 | alpha-2-3,6-sialidase (BiNanH2) | Enzyme | |
| HY-E70020 | UDP-Glc dehydrogenase (UGDH) | Enzyme | |
| HY-E70021 | UDP-Glc 4-epimerase (GalE) | Enzyme | |
| HY-E70022 | D-Mannose isomerase (PsMaSeAF) | 9031-25-8 | Enzyme |
| HY-E70023 | Sphingolipid ceramide N-deacylase (SCDase) | 170347-55-4 | Enzyme |
| HY-E70024 | CMP-sialic acid synthetase (NmCSS) | 9067-82-7 | Enzyme |
| HY-E70025 | N-Acetylglucosamine-1-P uridyltransferase, Homo sapien | Enzyme | |
| HY-E70026 | L-fucokinase/GDP-fucose pyrophos-phorylase (FKP) | 37278-00-5 | Enzyme |
| HY-E70028 | UDP-sugar pyrophosphorylase (BlUSP) | 223918-15-8 | Enzyme |
| HY-E70029 | α-1,6-Fucosidase, lactobacillus casei | Enzyme | |
| HY-E70030 | GlcNAc 1-P uridyltransferase (CjGlmU) | Enzyme | |
| HY-E70031 | GDP-mannose pyrophosphorylase (ManC) | 37278-24-3 | Enzyme |
| HY-E70032 | N-Acetylhexosamine kinase (NahK) | 1609980-80-4 | Enzyme |
| HY-E70033 | D-galactosyl-β1-3-N-acetyl-D-hexosamine phosphorylase (BiGalHexNAcP) | Enzyme | |
| HY-E70034 | Galactokinase (BiGalK) | 9030-53-9 | Enzyme |
| HY-E70035 | Glucuronokinase (AtGlcAK) | 9026-62-4 | Enzyme |
| HY-E70036 | Galcuronokinase (AtGalAK) | Enzyme | |
| HY-E70037 | GlcNAc kinase (EcNagK) | Enzyme | |
| HY-E70038 | Endoglycoceramidase II (EGCase II) | 2763216-34-6 | Enzyme |
| HY-E70039 | alpha-2-3,6,8-Sialidosidase (SpNanA) | Enzyme | |
| HY-E70040 | Endoglycoceramidase I (EGCase I) | 2768502-40-3 | Enzyme |
| HY-E70042 | Nucleoside hydrolase (IAGNH) | 9025-44-9 | Enzyme |
| HY-E70043 | Ganglioside sialidase (AuSialidase S) | 2170331-76-5 | Enzyme |
| HY-E70044 | beta-1, 3-N-Acetylhexaminyltransferase (LgtA) | 37277-64-8 | Enzyme |
| HY-E70046 | β-1,4-Galactosyltransferase, neisseria meningitides | 9054-94-8 | Enzyme |
| HY-E70047 | alpha-1,4-Galactosyltransferase (LgtC) | 52725-57-2 | Enzyme |
| HY-E70048 | beta-1,3-N-Acetylgalactosaminyltransferase (LgtD) | 62213-46-1 | Enzyme |
| HY-E70049 | beta-1,4-N-Acetylgalactosaminyltransferase (CgtA) | 67338-98-1 | Enzyme |
| HY-E70050 | beta-1,3-Galactosyltransferase (CgtB) | 37217-28-0 | Enzyme |
| HY-E70051 | alpha-1,3-N-Acetylgalactosaminyltransferase (Pm1138) | 9067-69-0 | Enzyme |
| HY-E70052 | alpha-1,3-Galactosyltransferase (a1,3GalT) | 128449-51-4 | Enzyme |
| HY-E70053 | alpha-1,3-Galactosyltransferase (GTB) | 37257-33-3 | Enzyme |
| HY-E70054 | beta-1,3-Galactosyltransferase (WbgO) | 9073-46-5 | Enzyme |
| HY-E70055 | α-2,6-Sialyltransferase, pasteurella multocida (P-1059) | 9075-81-4 | Enzyme |
| HY-E70056 | α2,3-Sialyltransferase, Pasteurella multocida (P-1059) | 71124-51-1 | Enzyme |
| HY-E70057 | alpha-2,8-Sialyltransferase (CstII) | 67339-00-8 | Enzyme |
| HY-E70058 | α-1-3,4 Fucosyltransferase, helicobacter pylori | 37277-69-3 | Enzyme |
| HY-E70059 | alpha-1,2-Fucosyltransferase (α1,2FucT) | 56093-23-3 | Enzyme |
| HY-E70060 | beta-1,4-Galactosyltransferase (LgtE) | 9054-94-8 | Enzyme |
| HY-E70061 | alpha-1,3-N-Acetylgalactosaminyltransferase (BgtA) | 9067-69-0 | Enzyme |
| HY-E70062 | α-2,3-Sialyltransferase, pasteurella multocida | 71124-51-1 | Enzyme |
| HY-E70063 | alpha-2,3-Sialyltransferase (Phα2,3SiaT) | 71124-51-1 | Enzyme |
| HY-E70064 | alpha-1,3-Fucosyltransferase (α1,3FucT) | 37277-69-3 | Enzyme |
| HY-E70065 | alpha-2,3-Sialyltransferase (PmST2) | 71124-51-1 | Enzyme |
| HY-E70066 | UDP-sugar pyrophosphorylase (AtUSP) | 223918-15-8 | Enzyme |
| HY-E70067 | GlcNAc 1-P uridyltransferase (PmGlmU) | Enzyme | |
| HY-E70068 | Endo-β-N-acetylglucosaminidase (Endo S) | 37278-88-9 | Enzyme |
| HY-E70069 | Endo S2, Streptococcus pyogenes | 37278-88-9 | Enzyme |
| HY-E70070 | Endo-β-N-acetylglucosaminidase (Endo A) | 37278-88-9 | Enzyme |
| HY-E70073 | Ganglioside sialidase (AuSialidase M2) | 2170331-76-5 | Enzyme |
| HY-E70074 | Monoamine oxidase, plasma | 9001-66-5 | Enzyme |
| HY-E70075 | α-Glycerophosphate Dehydrogenase-Triosephosphate | Enzyme | |
| HY-E70076 | Subtilisin, bacillus licheniformis | 9014-01-1 | Enzyme |
| HY-E70077 | Penicillinase (from calf stomach) | 9001-74-5 | Enzyme |
| HY-E70078 | Cystathionine β-synthase | 9023-99-8 | Enzyme |
| HY-E70079 | Cystathionine β-lyase, Recombinant Microorganisms | 9055-05-4 | Enzyme |
| HY-E70080 | Vaccinia virus capping enzyme | Enzyme | |
| HY-E70081 | mRNA Cap 2'-O-methyltransferase | Enzyme | |
| HY-E70082 | Fructosyl amino acid oxidase | 109603-58-9 | Enzyme |
| HY-E70084 | Tth DNA polymerase | 2409055-60-1 | Enzyme |
| HY-E70085 | Moloney murine leukemia virus RT | Enzyme | |
| HY-E70086 | Taq DNA polymerase | 2304873-37-6 | Enzyme |
| HY-E70086A | Taq DNA Polymerase, Glycerol-free | 2304873-37-6 | Enzyme |
| HY-E70087 | Enhanced Taq DNA polymerase | Enzyme | |
| HY-E70090 | T7 RNA polymerase | 9014-24-8 | Enzyme |
| HY-E70091 | T4 RNA ligase | Enzyme | |
| HY-E70094 | T4 UvsX Recombinase | Enzyme | |
| HY-E70095 | T4 UvsY Protein | Enzyme | |
| HY-E70097 | Sialidase (α2-3-6-8-9) | Enzyme | |
| HY-E70098 | RNase H2 | Enzyme | |
| HY-E70103 | α-L-Arabinofuranosidase | 9067-74-7 | Enzyme |
| HY-E70104 | α-Rhamnosidase | 37288-35-0 | Enzyme |
| HY-E70105 | α-Xylosidase | 53362-86-0 | Enzyme |
| HY-E70107 | Cellobiohydrolase I | 37329-65-0 | Enzyme |
| HY-E70108 | Cytidylate kinase | 37278-21-0 | Enzyme |
| HY-E70110 | Endo-1,4-β-mannanase | 37288-54-3 | Enzyme |
| HY-E70113 | β-Fructosidase | 37288-56-5 | Enzyme |
| HY-E70115 | Feruloyl esterase | 134712-49-5 | Enzyme |
| HY-E70116 | Isoamylase | 9067-73-6 | Enzyme |
| HY-E70119 | Pectate Lyase | 9015-75-2 | Enzyme |
| HY-E70120 | Phosphomannose isomerase | 9023-88-5 | Enzyme |
| HY-E70121 | Succinyl-CoA synthetase | 9080-33-5 | Enzyme |
| HY-E70122 | Uridylate kinase | 9036-23-1 | Enzyme |
| HY-E70124A | Esterase, Bacillus subtilis | 9013-79-0 | Enzyme |
| HY-E70124B | Esterase, Bacillus stearothermophilus | 9013-79-0 | Enzyme |
| HY-E70124C | Esterase, Rabbit liver | 9013-79-0 | Enzyme |
| HY-E70125 | Arogenate dehydratase | 76600-70-9 | Enzyme |
| HY-E70127 | Serratiopeptidase | 37312-62-2 | Enzyme |
| HY-E70128 | Leucyl aminopeptidase | 9001-61-0 | Enzyme |
| HY-E70130 | Snailase, Snail gastrointestinal | 158736-45-9 | Enzyme |
| HY-E70131 | Endo H, Streptomyces picatus | 37278-88-9 | Enzyme |
| HY-E70132 | Endo-β-N-acetylglucosaminidase D | 37278-88-9 | Enzyme |
| HY-E70133 | Endo-β-N-acetylglucosaminidase F2 | 37278-88-9 | Enzyme |
| HY-E70134 | Endo-β-N-acetylglucosaminidase F3 | 37278-88-9 | Enzyme |
| HY-E70135 | Endo-β-N-acetylglucosaminidase F1 | 37278-88-9 | Enzyme |
| HY-E70136 | Endo-β-Galactosidase | 52720-51-1 | Enzyme |
| HY-E70137 | AMG 118 (Immobilized cephalosporin C acylase) | Enzyme | |
| HY-E70138 | β-1,4-Galactosyltransferase 7 | Enzyme | |
| HY-E70139 | UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2 | Enzyme | |
| HY-E70140 | α-1,4-N-Acetylglucosaminyltransferase 4 | Enzyme | |
| HY-E70141 | β-1,3-N-Acetylglucosaminyltransferase 4 | Enzyme | |
| HY-E70142 | Glucosaminyl (N-acetyl) Transferase 1 | Enzyme | |
| HY-E70143 | Glucosaminyl (N-acetyl) Transferase 2 | Enzyme | |
| HY-E70144 | N-Acetylglucosaminyltransferase 1 | Enzyme | |
| HY-E70145 | N-Acetylglucosaminyltransferase III | Enzyme | |
| HY-E70146 | ST3 β-Gal α-2,3-Sialyltransferase 2 | Enzyme | |
| HY-E70147 | ST3 β-Gal α-2,3-Sialyltransferase 6 | Enzyme | |
| HY-E70148 | ST6 Gal Sialyltransferase 1 | Enzyme | |
| HY-E70149 | ST6 Gal Sialyltransferase 2 | Enzyme | |
| HY-E70150 | ST6 Sialyltransferase 1 | Enzyme | |
| HY-E70151 | ST6 Sialyltransferase 2 | Enzyme | |
| HY-E70152 | ST6 Sialyltransferase 4 | Enzyme | |
| HY-E70153 | Fucosyltransferase 2 | Enzyme | |
| HY-E70154 | Fucosyltransferase 3 | Enzyme | |
| HY-E70155 | Fucosyltransferase 5 | Enzyme | |
| HY-E70156 | Fucosyltransferase 7 | Enzyme | |
| HY-E70157 | Fucosyltransferase 8 | Enzyme | |
| HY-E70158 | Fucosyltransferase 9 | Enzyme | |
| HY-E70159 | Fucosyltransferase 11 | Enzyme | |
| HY-E70160 | Protein O-Fucosyltransferase 1 | Enzyme | |
| HY-E70161 | Carbohydrate Sulfotransferase 1 | Enzyme | |
| HY-E70162 | Carbohydrate Sulfotransferase 2 | Enzyme | |
| HY-E70163 | Carbohydrate Sulfotransferase 3 | Enzyme | |
| HY-E70164 | Carbohydrate Sulfotransferase 4 | Enzyme | |
| HY-E70165 | Carbohydrate Sulfotransferase 5 | Enzyme | |
| HY-E70166 | Carbohydrate Sulfotransferase 6 | Enzyme | |
| HY-E70167 | Carbohydrate Sulfotransferase 7 | Enzyme | |
| HY-E70168 | Carbohydrate Sulfotransferase 10 | Enzyme | |
| HY-E70169 | Galactose-3-O-sulfotransferase 2 | Enzyme | |
| HY-E70170 | Heparan Sulfate 2-O-Sulfotransferase 1 | Enzyme | |
| HY-E70171 | Heparan Sulfate 3-O-Sulfotransferase 1 | Enzyme | |
| HY-E70172 | Heparan Sulfate 3-O-Sulfotransferase 4 | Enzyme | |
| HY-E70173 | Heparan Sulfate 6-O-Sulfotransferase 1 | Enzyme | |
| HY-E70174 | Heparan Sulfate 6-O-Sulfotransferase 3 | Enzyme | |
| HY-E70175 | Heparan Sulfate Glucosamine 3-O-Sulfotransferase 3 | Enzyme | |
| HY-E70176 | N-Deacetylase/N-Sulfotransferase 1 | Enzyme | |
| HY-E70177 | N-Deacetylase/N-Sulfotransferase 2 | Enzyme | |
| HY-E70178 | Protein O-Glucosyltransferase 1 | Enzyme | |
| HY-E70179 | β-1,4-Glucuronyltransferase 1 | Enzyme | |
| HY-E70180 | α-Galactosidase A | Enzyme | |
| HY-E70181 | Galactosylceramidase | Enzyme | |
| HY-E70183 | Lysosomal α-Glucosidase | Enzyme | |
| HY-E70184 | α-N-Acetylglucosaminidase | Enzyme | |
| HY-E70185 | Lysosomal α-mannosidase | Enzyme | |
| HY-E70186 | Arylsulfatase B | 55354-43-3 | Enzyme |
| HY-E70187 | Arylsulfatase G | Enzyme | |
| HY-E70188 | N-Acetylgalactosamine-6-Sulfatase | Enzyme | |
| HY-E70189 | Tyrosylprotein Sulfotransferase 1 | Enzyme | |
| HY-E70190 | Tyrosylprotein Sulfotransferase 2 | Enzyme | |
| HY-E70191 | β-1,4-Galactosyltransferase 2 | Enzyme | |
| HY-E70192 | Acetyltrypsin, Bovine pancreas | Enzyme | |
| HY-E70193 | Keratinase | 37341-53-0 | Enzyme |
| HY-E70194 | Endoproteinase Glu-C | 137010-42-5 | Enzyme |
| HY-E70196 | Endoproteinase Asp-N | 55576-49-3 | Enzyme |
| HY-E70197 | Calpain-1 (pig) | 689772-75-6 | Enzyme |
| HY-E70197A | Calpain-1, Human Erythrocyte | Enzyme | |
| HY-E70198 | Pepsin (MS Grade) | 9001-75-6 | Enzyme |
| HY-E70199 | Aminopeptidase N (rat) | 9054-63-1 | Enzyme |
| HY-E70200 | Recombinant Kex2 protease | 99676-46-7 | Enzyme |
| HY-E70201 | Carboxypeptidase B (MS grade) | 9025-24-5 | Enzyme |
| HY-E70202 | Recombinant enterokinase | 9014-74-8 | Enzyme |
| HY-E70203 | Recombinant aprotinin | 9087-70-1 | Enzyme |
| HY-E70204 | AluI Methyltransferase | 92228-38-1 | Enzyme |
| HY-E70206 | CpG Methyltransferase | 1809633-78-0 | Enzyme |
| HY-E70207 | dam Methyltransferase | 69553-52-2 | Enzyme |
| HY-E70209 | EcoRI Methyltransferase | 81458-00-6 | Enzyme |
| HY-E70210 | GpC Methyltransferase | Enzyme | |
| HY-E70211 | HaeIII Methyltransferase | 92228-40-5 | Enzyme |
| HY-E70212 | Hhal Methyltransferase | 91448-96-3 | Enzyme |
| HY-E70215 | TaqI Methyltransferase | Enzyme | |
| HY-E70216 | Bsu DNA polymerase, Large fragment | Enzyme | |
| HY-E70217 | Uracil DNA Glycosylase (UDG/UNG), heat-sensitive | 59088-21-0 | Enzyme |
| HY-E70218 | Cas9 Nuclease | 1425049-49-5 | Enzyme |
| HY-E70219 | SpCas9 D10A Nickase | Enzyme | |
| HY-E70220 | AsCas12a Nuclease | Enzyme | |
| HY-E70221 | α-Acetolactate decarboxylase, from Bacillus subtilis | 9025-02-9 | Enzyme |
| HY-E70222 | Phytase, from Aspergillus niger | 37288-11-2 | Enzyme |
| HY-E70225 | Hemocoagulase, deinagkistrodonacutus | 9001-13-2 | Enzyme |
| HY-E70226 | Cathepsin S, human | 71965-46-3 | Enzyme |
| HY-E70227 | Cathepsin G, human neutrophils | 56645-49-9 | Enzyme |
| HY-E70228 | Cathepsin H, human liver | 60748-73-4 | Enzyme |
| HY-E70229 | Cyclooxygenase 1, sheep | 329967-85-3 | Enzyme |
| HY-E70230 | Staphylokinase, staphylococcus aureus | 9040-61-3 | Enzyme |
| HY-E70231 | Defibrase, deinagkistrodonacutus | 9039-61-6 | Enzyme |
| HY-E70232 | Asparagine-tRNA ligase | 37211-76-0 | Enzyme |
| HY-E70233 | Histidyl-tRNA synthetase, human | 9068-78-4 | Enzyme |
| HY-E70234 | Sortase A, S. aureus | 9033-39-0 | Enzyme |
| HY-E70236 | CoA-S-S-CoA | 31664-36-5 | Enzyme |
| HY-E70237 | (E)-Cinnamoyl-coA | 76109-04-1 | Enzyme |
| HY-E70238 | 2-Azido-NAD | 126609-61-8 | Enzyme |
| HY-E70239 | 2-Methylbutyryl-CoA | 6712-02-3 | Enzyme |
| HY-E70239A | (S)-2-Methylbutyryl-CoA (tetrasodium) | Enzyme | |
| HY-E70240 | 3-Hydroxyoctadecanoyl-CoA | 42578-91-6 | Enzyme |
| HY-E70241 | 3-Hydroxypropionyl-CoA | 157786-88-4 | Enzyme |
| HY-E70242 | 3-Ketohexanoyl-CoA | 19774-86-8 | Enzyme |
| HY-E70243 | Tigloyl-CoA | 6247-62-7 | Enzyme |
| HY-E70246 | Nonanoyl-CoA | 17331-98-5 | Enzyme |
| HY-E70247 | (S)-3-Hydroxyhexanoyl-CoA | 79171-47-4 | Enzyme |
| HY-E70248 | S-(3-Hydroxydodecanoate)-CoA | 72059-49-5 | Enzyme |
| HY-E70249 | 3-Hydroxydecanoyl-CoA | 79171-49-6 | Enzyme |
| HY-E70250 | Neocryptolepine | 114414-78-7 | Enzyme |
| HY-E70251 | 22:6 Coenzyme A | 800377-20-2 | Enzyme |
| HY-E70252 | 1-Pyrenebutanoyl-CoA | 81923-89-9 | Enzyme |
| HY-E70253 | Tridecanoyl-CoA (triammonium) | 1246304-38-0 | Enzyme |
| HY-E70254 | Tricosanoyl-CoA (triammonium) | 799812-97-8 | Enzyme |
| HY-E70255 | 26:0 Coenzyme A | 799813-02-8 | Enzyme |
| HY-E70256 | 12:0 Coenzyme A | 799812-84-3 | Enzyme |
| HY-E70257 | 24:0 Coenzyme A | 799812-99-0 | Enzyme |
| HY-E70258 | 24:1 Coenzyme A (triammonium) | 800376-90-3 | Enzyme |
| HY-E70259 | 18:2 (n6) Coenzyme A (triammonium) | 1246304-39-1 | Enzyme |
| HY-E70260 | 16-NBD-16:0 Coenzyme A (triammonium) | 1367862-09-6 | Enzyme |
| HY-E70261 | 16-Azidohexadecanoyl-CoA (triammonium) | 2260670-37-7 | Enzyme |
| HY-E70262 | Acetoyl-CoA (triammonium) | 799812-78-5 | Enzyme |
| HY-E70263 | 04:1 Coenzyme A (trisodium) | 2260670-60-6 | Enzyme |
| HY-E70264 | 16:0 Coenzyme A (triammonium) | 799812-86-5 | Enzyme |
| HY-E70265 | 18:0 Coenzyme A (triammonium) | 799812-87-6 | Enzyme |
| HY-E70266 | Arachidoyl-CoA (triammonium) | 799812-91-2 | Enzyme |
| HY-E70267 | 22:0 Coenzyme A (triammonium) | 799812-95-6 | Enzyme |
| HY-E70268 | Pentacosanoyl-CoA | 852100-90-4 | Enzyme |
| HY-E70269 | (11Z-Octadecenoyl)-CoA (triammonium) | 852060-66-3 | Enzyme |
| HY-E70270 | (6Z-Octadecenoyl)-CoA | 70954-87-9 | Enzyme |
| HY-E70271 | γ-Linolenoyl-CoA | 27843-61-4 | Enzyme |
| HY-E70272 | 2-Hydroxystearoyl-CoA | 38861-93-7 | Enzyme |
| HY-E70273 | Tetradecyl-CoA (triammonium) | 852043-48-2 | Enzyme |
| HY-E70274 | 17:1(n7) Coenzyme A (triammonium) | 1246304-40-4 | Enzyme |
| HY-E70275 | Nonadecanoyl-CoA | 25045-61-8 | Enzyme |
| HY-E70276 | Heneicosanoyl-CoA | 103404-53-1 | Enzyme |
| HY-E70277 | Hexadecyl-CoA | 71425-89-3 | Enzyme |
| HY-E70278 | (9Z-Octadecenyl)-CoA (triammonium) | 2260670-62-8 | Enzyme |
| HY-E70279 | Phytanoyl-CoA | 146622-45-9 | Enzyme |
| HY-E70280 | Recombinant endoglycoceramidase I | Enzyme | |
| HY-E70281 | Recombinant endoglycoceramidase II | Enzyme | |
| HY-E70282 | Recombinant endoglycoceramidase I assisted by activator II | Enzyme | |
| HY-E70283 | Recombinant endoglycoceramidase II assisted by activator II | Enzyme | |
| HY-E70284 | Keratanase II,bacillus circulans,expressed in E.coli | Enzyme | |
| HY-E70285 | beta-1,4-Galactosyltransferase 1 (Y285L) | Enzyme | |
| HY-E70286 | N-Acetylglucosaminyltransferase V | 83588-90-3 | Enzyme |
| HY-E70287 | ST6 Sialyltransferase 5 | Enzyme | |
| HY-E70288 | ST6 Sialyltransferase 6 | Enzyme | |
| HY-E70289 | Bovin beta-1,4-galactosyltransferase 1 (Y289L) | Enzyme | |
| HY-E70290 | N-Acetylgalactosaminyltransferase 1 | Enzyme | |
| HY-E70291 | N-Acetylgalactosaminyltransferase 4 | Enzyme | |
| HY-E70292 | N-Acetylgalactosaminyltransferase 11 | Enzyme | |
| HY-E70293 | N-Acetylgalactosaminyltransferase 12 | Enzyme | |
| HY-E70294 | N-Acetylgalactosaminyltransferase 13 | Enzyme | |
| HY-E70295 | N-Acetylgalactosaminyltransferase 14 | Enzyme | |
| HY-E70296 | Glucosaminyl (N-acetyl) transferase 4 | Enzyme | |
| HY-E70297 | N-Acetylglucosaminyltransferase IVa | Enzyme | |
| HY-E70298 | ST3 β-Gal α-2,3-Sialyltransferase 1 | Enzyme | |
| HY-E70299 | ST3 β-Gal α-2,3-Sialyltransferase 5 | Enzyme | |
| HY-E70300 | ST8 alpha-2,8-Sialyltransferase 8B | Enzyme | |
| HY-E70301 | ST8 alpha-2,8-Sialyltransferase 4 | Enzyme | |
| HY-E70302 | ST8 alpha-2,8-Sialyltransferase 6 | Enzyme | |
| HY-E70303 | Fucosyltransferase 6 | 2178088-82-7 | Enzyme |
| HY-E70304 | Mannosyl-oligosaccharide 1,2-α-mannosidase IA | 1505450-17-8 | Enzyme |
| HY-E70305 | GlcNAc-1-Phosphotransferase | 84012-69-1 | Enzyme |
| HY-E70306 | Zymolyase, Arthrobacter luteus | Enzyme | |
| HY-E70308 | Glucose isomerase (immobilized) | 9055-00-9 | Enzyme |
| HY-E70310 | BD-10X | Enzyme | |
| HY-E70311 | TLL-10X | Enzyme | |
| HY-E70312 | CalB-10Xup | Enzyme | |
| HY-E70313 | CalB-10X | Enzyme | |
| HY-E70314 | Nuclease SM | Enzyme | |
| HY-E70315 | Chimax-G | Enzyme | |
| HY-E70316 | Chimax-O | Enzyme | |
| HY-E70318 | AMK-GX | Enzyme | |
| HY-E70319 | AMK-EX | Enzyme | |
| HY-E70320 | AMK618 | Enzyme | |
| HY-E70321 | AMK518 | Enzyme | |
| HY-E70322 | AMK328 | Enzyme | |
| HY-E70323 | AMK318 | Enzyme | |
| HY-E70324 | AMK218 | Enzyme | |
| HY-E70325 | Maltogenic amylase | 160611-47-2 | Enzyme |
| HY-E70326 | Acid Protease, Aspergillus niger | Enzyme | |
| HY-E70327 | Aspartate Aminotransferase, Human | Enzyme | |
| HY-E70328 | Alkalophilic Proteinase, Streptomyces sp | Enzyme | |
| HY-E70329 | P-Hydroxybenzoate hydroxylase, native microorganism | 9059-23-8 | Enzyme |
| HY-E70330 | Neutral Proteinase, Bacillus sp. | 70851-98-8 | Enzyme |
| HY-E70331 | Acid Stable Protease | Enzyme | |
| HY-E70332 | Lipase, Aspergillus niger | Enzyme | |
| HY-E70333 | Rapidase Revelation Aroma (AR2000), Aspergillus niger | Enzyme | |
| HY-E70334 | Carboxypeptidase Y, Baker's yeast (S. cerevisiae) | Enzyme | |
| HY-E70335 | Colipase, Porcine | Enzyme | |
| HY-E70336 | Peroxidase, Lignin | 93792-13-3 | Enzyme |
| HY-E70337 | Heparanase 1, Human | Enzyme | |
| HY-E70338 | Ketoamine oxidase | Enzyme | |
| HY-E70339 | Phenylethanolamine N-methyl transferase, bovine | Enzyme | |
| HY-E70340 | Lipoamide dehydrogenase, porcine | Enzyme | |
| HY-E70341 | Histamine N-methyl transferase, rat | 9029-80-5 | Enzyme |
| HY-E70343 | Human leukocyte esterase (unsonicated) | Enzyme | |
| HY-E70344 | Cystathionine γ-lyase | 9012-96-8 | Enzyme |
| HY-E70345 | Homocysteine methyltransferase | 9012-40-2 | Enzyme |
| HY-E70346 | S-Adenosylmethionine synthetase | 9012-52-6 | Enzyme |
| HY-E70347 | Tn5 Transposase | 308064-67-7 | Enzyme |
| HY-E70348 | L-Methionine γ-lyase, pseudomonas putida | Enzyme | |
| HY-E70349 | Betaine homocysteine S-methyltransferase | 9029-78-1 | Enzyme |
| HY-E70350 | Ribonuclease T2, Aspergillus oryzae | Enzyme | |
| HY-E70351 | Trypsin-Chymotrypsin 1:1 | Enzyme | |
| HY-E70352 | Trypsin-Chymotrypsin 1:250 | Enzyme | |
| HY-E70353 | Trypsin-Chymotrypsin 6:1 | Enzyme | |
| HY-E70354 | Protease for flavors | 37259-58-8 | Enzyme |
| HY-E70356 | Neutrophil Elastase (NEG),Human | Enzyme | |
| HY-E70357 | Alkaline Phosphatase (ALP), Human Placental | Enzyme | |
| HY-E70358 | Acid Phosphatase, Prostatic (ACP/PAP) | Enzyme | |
| HY-E70359 | Alkaline Phosphatase (ALP), Porcine Kidney | Enzyme | |
| HY-E70360 | Acid Phosphatase (ACP), Sweet Potato | Enzyme | |
| HY-E70361 | Whole Leukocyte Esterase, Human | Enzyme | |
| HY-E70362 | Butyrylcholinesterase (BCHE), Horse Serum | Enzyme | |
| HY-E70364 | IgdE protease | 1892548-76-3 | Enzyme |
| HY-E70368 | Collagenase G (Recombinant) | Enzyme | |
| HY-E70369 | Collagenase H (Recombinant) | Enzyme | |
| HY-E70370 | hrv 3c Protease | Enzyme | |
| HY-E70371 | Cre recombinase | 1943614-02-5 | Enzyme |
| HY-E70372 | SUMO Protease | 1607459-82-4 | Enzyme |
| HY-E70373 | λ Protein phosphatase | 401941-75-1 | Enzyme |
| HY-E70375 | Fructosyl-peptide oxidase (FPOX-CE) | 153302-42-2 | Enzyme |
| HY-E70376 | Pfu DNA Polymerase | 2304873-45-6 | Enzyme |
| HY-E70377 | Cu/Zn Superoxide dismutase | Enzyme | |
| HY-E70378 | Mn Superoxide dismutase | 1569269-06-2 | Enzyme |
| HY-E70379 | Tte UvrD Helicase | Enzyme | |
| HY-E70380 | Endopeptidase, arctic marine microbial | Enzyme | |
| HY-E70381 | dsDNase | Enzyme | |
| HY-E70382 | Shrimp Alkaline Phosphatase | Enzyme | |
| HY-E70385 | Oxalate Oxidase | 9031-79-2 | Enzyme |
| HY-E70387 | Ligninase | 42613-30-9 | Enzyme |
| HY-E70389 | Human Kallikrein | Enzyme | |
| HY-E70390 | C1s Enzyme | Enzyme | |
| HY-E70391 | C1r Enzyme | Enzyme | |
| HY-E70392 | Recombinant Trypsin | Enzyme | |
| HY-E70393 | Human Factor VIIa | Enzyme | |
| HY-E70393A | Human Factor IXa Beta | Enzyme | |
| HY-E70393B | Human Factor Xa | Enzyme | |
| HY-E70393C | Human Factor XIa | Enzyme | |
| HY-E70393D | Human Factor Alpha XIIa | Enzyme | |
| HY-E70393E | Human Factor XIIa Beta | Enzyme | |
| HY-E70393H | Human Factor XIIIa | Enzyme | |
| HY-E70393I | Bovine Factor IXa Beta | Enzyme | |
| HY-E70393J | Bovine Factor XIa | Enzyme | |
| HY-E70395 | Prolyl endopeptidase | 72162-84-6 | Enzyme |
| HY-E70396 | Pectolyase Y-23, A. japonicus | 9033-35-6 | Enzyme |
| HY-E70397 | Dipeptidyl peptidase IV | 54249-88-6 | Enzyme |
| HY-E70398 | Sorbitol dehydrogenase | 9028-21-1 | Enzyme |
| HY-E70399 | Formimino-L-glutamic acid Transferase, porcine liver | 9032-83-1 | Enzyme |
| HY-E70400 | Thermostable T7 RNA Polymerase | Enzyme | |
| HY-E70401 | Golden Taq DNA Polymerase | Enzyme | |
| HY-E70402 | Double-block Hotstart Taq DNA Polymerase | Enzyme | |
| HY-E70403 | Warm-Start M-MLV Reverse Transcriptase | Enzyme | |
| HY-E70404 | FastTaq DNA Polymerase(5'→3' exo-) | Enzyme | |
| HY-E70405 | Guanylyltransferase | 593278-77-4 | Enzyme |
| HY-E70406 | Cholesterol Dehydrogenase, Nocardia sp. | 67775-34-2 | Enzyme |
| HY-E70407 | Sorbitol-6-phosphate 2-dehydrogenase, escherichia coli | 37250-69-4 | Enzyme |
| HY-E70408 | 12α-Hydroxysteroid dehydrogenase, bacillus sphaericus | 61642-40-8 | Enzyme |
| HY-E70409 | Diacetinase, bacillus subtilis | Enzyme | |
| HY-E70410 | NAD Synthetase | 9032-69-3 | Enzyme |
| HY-E70412 | Galactose 1-dehydrogenase, E.coli | Enzyme | |
| HY-E70412A | Galactose 1-dehydrogenase, pseudomonas fluorescens | Enzyme | |
| HY-E70413 | Amino acid arylamidase, hog kidney | 9012-21-9 | Enzyme |
| HY-E70414 | DNase B, Escherichia coli | Enzyme | |
| HY-E70417 | Glycerol-3-phosphate dehydrogenase, Saccharomyces cerevisiae | 9001-49-4 | Enzyme |
| HY-E70418 | Epoxide hydrolase | 9048-63-9 | Enzyme |
| HY-E70419 | PQQ-Dependent glucose dehydrogenase, microorganism | 81669-60-5 | Enzyme |
| HY-E70420 | SpeB cysteine protease | 9025-51-8 | Enzyme |
| HY-E70421 | Butelase 1 ligase | Enzyme | |
| HY-E70422 | Cyclomaltodextrinase | 37288-41-8 | Enzyme |
| HY-E70423 | UDP-glucuronic acid decarboxylase | 9024-68-4 | Enzyme |
| HY-E70424 | Glucose-1-phosphate thymidyltransferase | 9026-03-3 | Enzyme |
| HY-E70425 | Sucrose synthase | 9030-05-1 | Enzyme |
| HY-E70426 | Polyphosphate kinase (RsPPK) | 9026-44-2 | Enzyme |
| HY-E70427 | Dipeptidyl peptidase IX (human) | 1609146-77-1 | Enzyme |
| HY-E70428 | D-Xylose dehydrogenase | 62931-20-8 | Enzyme |
| HY-E70429 | Ketohexokinases | 9030-50-6 | Enzyme |
| HY-E70430 | N-Acylhexosamine oxidase | 121479-58-1 | Enzyme |
| HY-E70431 | D-Xylonolactone lactonase | 317374-28-0 | Enzyme |
| HY-E70432 | Dipeptidyl peptidase VII (human) | Enzyme | |
| HY-E70433 | SaCas9 | Enzyme | |
| HY-E70434 | Dipeptidyl peptidase III (human) | 1609146-78-2 | Enzyme |
| HY-E70435 | Prolylendopeptidase, myxococcus xanthus | Enzyme | |
| HY-E70436 | Human keratinocyte transglutaminase | 80146-85-6 | Enzyme |
| HY-E70437 | Guinea pig liver transglutaminase | 80146-85-6 | Enzyme |
| HY-E70438 | Endoproteinase Pro-C | 137903-41-4 | Enzyme |
| HY-E70439 | Human epidermal transglutaminase | 80146-85-6 | Enzyme |
| HY-E70440 | L-Arabinose isomerase | 9023-80-7 | Enzyme |
| HY-E70441 | Guanosine kinase | 55467-46-4 | Enzyme |
| HY-E70442 | Methionine aminopeptidase | 61229-81-0 | Enzyme |
| HY-E70443 | Chondroitinase ABC I | 9024-13-9 | Enzyme |
| HY-E70444 | Chondroitinase ABC II | 9024-13-9 | Enzyme |
| HY-E70445 | Chondroitinase AC II | 9047-57-8 | Enzyme |
| HY-E70446 | Exolytic heparinase | 9025-39-2 | Enzyme |
| HY-E70447 | UDP-4-Keto-6-deoxy-D-glucose 3,5-epimerase/4-reductase (ApmUGER) | 68189-53-7 | Enzyme |
| HY-E70448 | Thimet oligopeptidase | 110639-28-6 | Enzyme |
| HY-E70449 | Salt active endonuclease | Enzyme | |
| HY-E70451 | Phosphopentomutase | 9026-77-1 | Enzyme |
| HY-E70452 | Recombinant microbial transglutaminase | 80146-85-6 | Enzyme |
| HY-E70453 | Human prostate transglutaminase | 80146-85-6 | Enzyme |
| HY-E70454 | Human neuronal transglutaminase | 80146-85-6 | Enzyme |
| HY-E70457 | Human CYP1A2,High-Reductase | Enzyme | |
| HY-E70458 | Human CYP3A4,High-Reductase | Enzyme | |
| HY-E70459 | Human CYP3A4,High-Reductase+b5 | Enzyme | |
| HY-E70460 | Human CYP2C9,Low-Reductase | Enzyme | |
| HY-E70461 | Human CYP2D6,High-Reductase | Enzyme | |
| HY-E70462 | Human CYP2C19,High-Reductase | Enzyme | |
| HY-E70463 | Human CYP2E1,High-Reductase | Enzyme | |
| HY-E70464 | Human CYP3A4,Low-Reductase | Enzyme | |
| HY-E70465 | Human CYP2A6,High-Reductase | Enzyme | |
| HY-E70466 | Human CYP1A2,Low-Reductase | Enzyme | |
| HY-E70467 | Human CYP2D6,Low-Reductase | Enzyme | |
| HY-E70468 | Human CYP1A1,High-Reductase | Enzyme | |
| HY-E70469 | Human CYP3A5,Low-Reductase | Enzyme | |
| HY-E70470 | Human CYP2B6,Low-Reductase | Enzyme | |
| HY-E70471 | Human CYP2C8,High-Reductase | Enzyme | |
| HY-E70472 | Human CYP1A1,Low-Reductase | Enzyme | |
| HY-E70473 | Human CYP2C9,High-Reductase | Enzyme | |
| HY-E70474 | Human CYP2B6,High-Reductase | Enzyme | |
| HY-E70475 | Human CYP2C18,Low-Reductase | Enzyme | |
| HY-E70476 | Human CYP1B1,Low-Reductase | Enzyme | |
| HY-E70477 | Human CYP4A11,Low-Reductase | Enzyme | |
| HY-E70478 | Human CYP4A11,High-Reductase | Enzyme | |
| HY-E70479 | Human CYP2C19,Low-Reductase | Enzyme | |
| HY-E70480 | Human CYP2A13,Low-Reductase | Enzyme | |
| HY-E70481 | Human CYP2A13,High-Reductase | Enzyme | |
| HY-E70482 | Human CYP2J2,Low-Reductase | Enzyme | |
| HY-E70483 | Human CYP3A4,Low-Reductase +b5 | Enzyme | |
| HY-E70484 | Human CYP2E1,High-Reductase+b5 | Enzyme | |
| HY-E70485 | Human CYP2C9,High-Reductase+b5 | Enzyme | |
| HY-E70486 | Human CYP2C9,Low-Reductase +b5 | Enzyme | |
| HY-E70487 | Human CYP4F2,Low-Reductase+b5 | Enzyme | |
| HY-E70488 | Human CYP2B6,High-Reductase+b5 | Enzyme | |
| HY-E70489 | Human CYP4A11,High-Reductase+b5 | Enzyme | |
| HY-E70490 | Human CYP3A5,Low-Reductase +b5 | Enzyme | |
| HY-E70491 | Human CYP3A5,High-Reductase | Enzyme | |
| HY-E70492 | Human CYP2C8,Low-Reductase | Enzyme | |
| HY-E70493 | Human CYP3A5,High-Reductase +b5 | Enzyme | |
| HY-E70494 | Human CYP2C8,High-Reductase+b5 | Enzyme | |
| HY-E70495 | Human CYP2C8,Low-Reductase+b5 | Enzyme | |
| HY-E70496 | Human CYP3A7,Low-Reductase | Enzyme | |
| HY-E70497 | Human CYP3A7,Low-Reductase+b5 | Enzyme | |
| HY-E70498 | Human CYP4F3,Low-Reductase | Enzyme | |
| HY-E70499 | Human CYP4F3,High-Reductase | Enzyme | |
| HY-E70500 | Human CYP4F3,Low-Reductase+b5 | Enzyme | |
| HY-E70501 | Human CYP4F3,High-Reductase+b5 | Enzyme | |
| HY-E70502 | Human CYP3A7,High-Reductase | Enzyme | |
| HY-E70503 | Human CYP3A7,High-Reductase+b5 | Enzyme | |
| HY-E70504 | Human CYP2B6,Low-Reductase+b5 | Enzyme | |
| HY-E70505 | Human CYP2C19,Low-Reductase+b5 | Enzyme | |
| HY-E70506 | Human CYP2C19,High-Reductase+b5 | Enzyme | |
| HY-E70507 | Human CYP2A6,High-Reductase+b5 | Enzyme | |
| HY-E70508 | Human CYP17A1,Low-Reductase | Enzyme | |
| HY-E70509 | Human CYP17A1,High-Reductase | Enzyme | |
| HY-E70510 | Human CYP46A1,Low-Reductase | Enzyme | |
| HY-E70511 | Human CYP46A1,High-Reductase | Enzyme | |
| HY-E70512 | Human CYP17A1,High-Reductase+b5 | Enzyme | |
| HY-E70513 | Human CYP26A1,Low-Reductase | Enzyme | |
| HY-E70514 | Human CYP26B1,Low-Reductase | Enzyme | |
| HY-E70515 | Human CYP51,High-Reductase | Enzyme | |
| HY-E70516 | Inosine-5'-monophosphate dehydrogenase, Microorganism | 9028-93-7 | Enzyme |
| HY-E70517 | Histamine dehydrogenase, Microorganism | 89190-47-6 | Enzyme |
| HY-E70518 | Oxalate decarboxylase, Microorganism | 9024-97-9 | Enzyme |
| HY-E70519 | Tyramine oxidase, Microorganism | 37255-42-8 | Enzyme |
| HY-E70520 | Salicylate hydroxylase, Microorganism | 9059-28-3 | Enzyme |
| HY-E70522 | Dihydrofolate reductase | 9002-03-3 | Enzyme |
| HY-E70523 | Pentanoyl Coenzyme A | 4752-33-4 | Enzyme |
| HY-E70524 | Alpha 2 Antiplasmin, Human Plasma | 138757-15-0 | Enzyme |
| HY-E70525 | Alpha 2 Macroglobulin, Human Plasma | 403067-13-0 | Enzyme |
| HY-E70525A | Alpha 2 Macroglobulin, Human Plasma, Fast Form | 403067-13-0 | Enzyme |
| HY-E70527 | Proteinase 3 (PR3), Human Neutrophil | 1221997-79-0 | Enzyme |
| HY-E70528 | PreScission protease | 2178107-79-2 | Enzyme |
| HY-E70529 | Ribonucleoside vanadyl complexes | Enzyme | |
| HY-E70530 | Collagenase/Neutral protease 1 (animal free) | Enzyme | |
| HY-E70531 | Collagenase/Neutral protease 2 (animal free) | Enzyme | |
| HY-E70532 | Ribonuclease T2 (animal free) | 37278-25-4 | Enzyme |
| HY-E70533 | C1r Proenzyme | Enzyme | |
| HY-E70534 | C1s Proenzyme | Enzyme | |
| HY-E70535 | Des-Gla-Human Activated Protein C | Enzyme | |
| HY-E70536 | Des-Gla-Human Factor VIIa | Enzyme | |
| HY-E70537 | Des-Gla-Human Factor X | Enzyme | |
| HY-E70538 | Des-Gla-Human Factor XaB | Enzyme | |
| HY-E70539 | Des-Gla-Human Protein C | Enzyme | |
| HY-E70540 | Des-Gla-Human Prothrombin | Enzyme | |
| HY-E70541 | Human Factor IX | 9001-28-9 | Enzyme |
| HY-E70541A | Bovine Factor IX | 9001-28-9 | Enzyme |
| HY-E70541B | Canine Factor IX | 9001-28-9 | Enzyme |
| HY-E70542 | Bovine Factor V/Va | Enzyme | |
| HY-E70543 | Human Factor VII | 9001-25-6 | Enzyme |
| HY-E70544 | Human Factor X | 9001-29-0 | Enzyme |
| HY-E70544A | Bovine Factor X | 9001-29-0 | Enzyme |
| HY-E70544B | Canine Factor X | 9001-29-0 | Enzyme |
| HY-E70544C | Rabbit Factor X | 9001-29-0 | Enzyme |
| HY-E70545 | Human Factor XI | 9013-55-2 | Enzyme |
| HY-E70546 | Human Factor XII | Enzyme | |
| HY-E70547 | Human Factor XIII | 9013-56-3 | Enzyme |
| HY-E70547A | Murine Factor XIII | 9013-56-3 | Enzyme |
| HY-E70548 | Human Glu-Plasminogen | Enzyme | |
| HY-E70549 | Human Lys-Plasminogen | Enzyme | |
| HY-E70550 | Human Prekallikrein | 9055-02-1 | Enzyme |
| HY-E70552 | Human Protein S | Enzyme | |
| HY-E70553 | Human Protein Z | Enzyme | |
| HY-E70554 | Human Prothrombin | 9001-26-7 | Enzyme |
| HY-E70554A | Bovine Prothrombin | 9001-26-7 | Enzyme |
| HY-E70555 | PNGase A | Enzyme | |
| HY-E70558 | 5α-reductase, Rat(Sprague-Dawley) Liver | Enzyme | |
| HY-E70558A | 5α-reductase, Rat(Sprague-Dawley) Testis | Enzyme | |
| HY-E70559 | Prostaglandin D synthase | 65802-85-9 | Enzyme |
| HY-ER007 | Potassium sodium tartrate | 304-59-6 | Biochemical Assay Reagents |
| HY-ER010 | 1H-Imidazole (hydrochloride) | 1467-16-9 | Biochemical Assay Reagents |
| HY-ER013B | Sodium carbonate anhydrous, 99.999% trace metals basis | 497-19-8 | Biochemical Assay Reagents |
| HY-ER013C | Sodium carbonate anhydrous, 99.8% | 497-19-8 | Biochemical Assay Reagents |
| HY-ER013E | Sodium carbonate anhydrous, United States Pharmacopeia (USP) Reference Standard | 497-19-8 | Biochemical Assay Reagents |
| HY-ER013I | Sodium carbonate anhydrous, meets analytical specification of Ph. Eur., BP, NF, FCC, E500 | 497-19-8 | Biochemical Assay Reagents |
| HY-ER017 | N-Iodosuccinimide | 516-12-1 | Biochemical Assay Reagents |
| HY-ER019 | Benzyltributylammonium (chloride) | 23616-79-7 | Biochemical Assay Reagents |
| HY-F0001 | NADH (disodium salt) | 606-68-8 | Natural Products |
| HY-F0001A | NADH (disodium hydrate) | 1949720-50-6 | Reference compound |
| HY-F0001R | NADH (disodium salt) (Standard) | 606-68-8 | Reference Standards |
| HY-F0002 | NADP (sodium salt) | 1184-16-3 | Oligonucleotides |
| HY-F0002A | NADP (disodium salt) | 24292-60-2 | Natural Products |
| HY-F0002R | NADP (sodium salt) (Standard) | 1184-16-3 | Reference Standards |
| HY-F0003 | NADPH (tetrasodium salt) | 2646-71-1 | Oligonucleotides |
| HY-F0003A | NADPH (tetracyclohexanamine) | 100929-71-3 | Oligonucleotides |
| HY-F0003R | NADPH (tetrasodium salt) (Standard) | 2646-71-1 | Reference Standards |
| HY-F0004 | β-Nicotinamide mononucleotide | 1094-61-7 | Natural Products |
| HY-F0004R | β-Nicotinamide mononucleotide (Standard) | 1094-61-7 | Reference Standards |
| HY-F0004S | β-Nicotinamide mononucleotide-d4 | Isotope-Labeled Compounds | |
| HY-G0001 | Lurasidone metabolite 14283 | 186204-31-9 | Reference compound |
| HY-G0001A | Lurasidone Metabolite 14283 hydrochloride | 186204-32-0 | Reference compound |
| HY-G0001S | Lurasidone Metabolite 14283-d8 | 2070009-43-5 | Isotope-Labeled Compounds |
| HY-G0002 | Lurasidone metabolite 14326 | 186204-33-1 | Reference compound |
| HY-G0002A | Lurasidone metabolite 14326 (hydrochloride) | Reference compound | |
| HY-G0002S | Lurasidone Metabolite 14326-d8 | Isotope-Labeled Compounds | |
| HY-G0003 | Iloperidone metabolite Hydroxy Iloperidone | 133454-55-4 | Reference compound |
| HY-G0003R | Iloperidone metabolite Hydroxy Iloperidone (Standard) | 133454-55-4 | Reference Standards |
| HY-G0003S1 | Iloperidone metabolite Hydroxy Iloperidone-d3 | 1504554-02-2 | Isotope-Labeled Compounds |
| HY-G0004 | Acetaminophen metabolite 3-hydroxy-acetaminophen | 37519-14-5 | Reference compound |
| HY-G0004R | Acetaminophen metabolite 3-hydroxy-acetaminophen (Standard) | 37519-14-5 | Reference Standards |
| HY-G0005 | Duloxetine metabolite Para-Naphthol Duloxetine | 949095-98-1 | Reference compound |
| HY-G0006 | Omeprazole sulfide | 73590-85-9 | Reference compound |
| HY-G0006R | Omeprazole sulfide (Standard) | 73590-85-9 | Reference Standards |
| HY-G0007 | Omeprazole sulfone | 88546-55-8 | Reference compound |
| HY-G0007R | Omeprazole sulfone (Standard) | 88546-55-8 | Reference Standards |
| HY-G0007S | Omeprazole sulfone-d3 | 2749628-17-7 | Isotope-Labeled Compounds |
| HY-G0007S1 | Omeprazole sulfone-13C,d3 | 1261393-28-5 | Isotope-Labeled Compounds |
| HY-G0008 | O-Desmethyl Mebeverine alcohol | 155172-67-1 | Reference compound |
| HY-G0008A | O-Desmethyl Mebeverine alcohol (hydrochloride) | 856620-39-8 | Reference compound |
| HY-G0008AR | O-Desmethyl Mebeverine alcohol (hydrochloride) (Standard) | 856620-39-8 | Reference Standards |
| HY-G0009 | Ritonavir metabolite | 176655-55-3 | Reference compound |
| HY-G0010 | Netupitant metabolite N-desmethyl Netupitant | 290296-72-9 | Reference compound |
| HY-G0010S | N-desmethyl Netupitant-d6 | 2070015-21-1 | Isotope-Labeled Compounds |
| HY-G0011 | Netupitant metabolite Netupitant N-oxide | 910808-11-6 | Reference compound |
| HY-G0011S | Netupitant N-oxide-d6 | Isotope-Labeled Compounds | |
| HY-G0012 | Netupitant metabolite Monohydroxy Netupitant | 910808-12-7 | Reference compound |
| HY-G0012S | Monohydroxy Netupitant-d6 | Isotope-Labeled Compounds | |
| HY-G0014 | Quetiapine sulfoxide | 329216-63-9 | Reference compound |
| HY-G0014A | Quetiapine sulfoxide (dihydrochloride) | 329218-11-3 | Reference compound |
| HY-G0014AR | Quetiapine sulfoxide (dihydrochloride) (Standard) | 329218-11-3 | Reference Standards |
| HY-G0014B | Quetiapine sulfoxide hydrochloride | 2448341-72-6 | Reference compound |
| HY-G0014S | Quetiapine Sulfoxide-d8 | 1330238-38-4 | Isotope-Labeled Compounds |
| HY-G0016 | N-Acetyl dapsone | 565-20-8 | Reference compound |
| HY-G0016S | N-Acetyl dapsone-d4 | 2070015-08-4 | Isotope-Labeled Compounds |
| HY-G0016S1 | N-Acetyl dapsone-d4-1 | 2070015-28-8 | Isotope-Labeled Compounds |
| HY-G0016S2 | N-Acetyl dapsone-d8 | 1215635-13-4 | Isotope-Labeled Compounds |
| HY-G0017 | N-Desmethyl imatinib | 404844-02-6 | Reference compound |
| HY-G0017A | N-Desmethyl imatinib (mesylate) | 404844-03-7 | Reference compound |
| HY-G0017R | N-Desmethyl imatinib (Standard) | 404844-02-6 | Reference Standards |
| HY-G0017S | N-Desmethyl imatinib-d8 | 1185103-28-9 | Isotope-Labeled Compounds |
| HY-G0017S1 | N-Desmethyl imatinib-d4 | Isotope-Labeled Compounds | |
| HY-G0018 | Norgestimate metabolite Norelgestromin | 53016-31-2 | Reference compound |
| HY-G0018R | Norgestimate metabolite Norelgestromin (Standard) | 53016-31-2 | Reference Standards |
| HY-G0018S | Norgestimate metabolite norelgestromin-d6 | 1263184-13-9 | Isotope-Labeled Compounds |
| HY-G0020S1 | Nicotine N-β-D-glucuronide-d3 | 329002-74-6 | Isotope-Labeled Compounds |
| HY-G0021 | N-Desmethylclozapine | 6104-71-8 | Reference compound |
| HY-G0021R | N-Desmethylclozapine (Standard) | 6104-71-8 | Reference Standards |
| HY-G0021S | N-Desmethylclozapine-d8 | 1189888-77-4 | Isotope-Labeled Compounds |
| HY-G0021S1 | N-Desmethylclozapine-d8 (hydrochloride) | 2705402-91-9 | Isotope-Labeled Compounds |
| HY-G0022 | Doxorubicinol (hydrochloride) | 63950-05-0 | Natural Products |
| HY-G0023 | Niraparib metabolite M1 | 1476777-06-6 | Reference compound |
| HY-G0023R | Niraparib metabolite M1 (Standard) | 1476777-06-6 | Reference Standards |
| HY-G0024A | Vildagliptin carboxylic acid metabolite (TFA) | 565453-41-0 | Reference compound |
| HY-G0025 | Tetrabenazine Metabolite | 924854-60-4 | Reference compound |
| HY-I0008 | 3-(Trifluoromethyl)cinnamic acid | 779-89-5 | Reference compound |
| HY-I0020 | Galanthaminone | 510-77-0 | Reference compound |
| HY-I0021 | Bepotastine | 125602-71-3 | Reference compound |
| HY-I0021A | Bepotastine (tosylate) | 1160415-45-1 | Reference compound |
| HY-I0034 | (S)-Quinuclidin-3-amine (dihydrochloride) | 119904-90-4 | Biochemical Assay Reagents |
| HY-I0034R | (S)-Quinuclidin-3-amine (dihydrochloride) (Standard) | 119904-90-4 | Reference Standards |
| HY-I0035 | (S)-N-Glycidylphthalimide | 161596-47-0 | Natural Products |
| HY-I0096 | Indole-2-carboxylic acid | 1477-50-5 | Natural Products |
| HY-I0096S | Indole-2-carboxylic acid-13C | 1216839-31-4 | Isotope-Labeled Compounds |
| HY-I0100 | Methyl 2-deoxy-3,5-di-O-toluoyl-D-ribofuranoside | 4330-34-1 | Reference compound |
| HY-I0102 | (2S)-Methyl 2-(2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate | 402958-95-6 | Peptides |
| HY-I0109 | (S)-2-(((benzyloxy)carbonyl)amino)-2-cyclohexylacetic acid | 69901-75-3 | Peptides |
| HY-I0115 | (S)-2-((S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoic acid | 402958-96-7 | Peptides |
| HY-I0124 | 2-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoic acid | 1289942-66-0 | Peptides |
| HY-I0125 | Methyl 2-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoate | 1332524-01-2 | Peptides |
| HY-I0144 | Thiazolidine | 504-78-9 | Reference compound |
| HY-I0169 | (R)-Amino-N-benzyl-3-methoxypropionamide | 196601-69-1 | Reference compound |
| HY-I0172 | L-tert-Leucine Methyl Ester Hydrochloride | 63038-27-7 | Peptides |
| HY-I0177 | Vilazodone carboxylic acid | 163521-19-5 | Reference compound |
| HY-I0179 | ITMN 4077 | 790305-05-4 | Reference compound |
| HY-I0180A | Ticagrelor EP Impurity E (hydrochloride) | 1402222-66-5 | Reference compound |
| HY-I0201 | 4-Fluorobenzeneboronic acid | 1765-93-1 | Biochemical Assay Reagents |
| HY-I0202S | 1-Bromo-4-fluorobenzene-d4 | 50592-31-9 | Isotope-Labeled Compounds |
| HY-I0210 | 4-Iodoaniline, 98% | 540-37-4 | Biochemical Assay Reagents |
| HY-I0210S | 4-Iodoaniline-13C6 | 233600-80-1 | Isotope-Labeled Compounds |
| HY-I0230 | Solifenacin (hydrochloride) | 180468-39-7 | Reference compound |
| HY-I0230S | Solifenacin-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-I0259 | 8-Amino-2-naphthol | 118-46-7 | Biochemical Assay Reagents |
| HY-I0293S | Alogliptin impurity 7-d3 | 2714473-43-3 | Isotope-Labeled Compounds |
| HY-I0301 | D-(+)-Glucono-1,5-lactone | 90-80-2 | Natural Products |
| HY-I0301R | D-(+)-Glucono-1,5-lactone (Standard) | 90-80-2 | Reference Standards |
| HY-I0301S | D-(+)-Glucono-1,5-lactone-1-13C | Isotope-Labeled Compounds | |
| HY-I0304 | 2-Chloro-4-hydroxypyridine | 17368-12-6 | Biochemical Assay Reagents |
| HY-I0308 | 1-Methyl-1H-pyrazole-4-boronic acid pinacol ester | 761446-44-0 | Biochemical Assay Reagents |
| HY-I0312 | 4-Iodopyrazole | 3469-69-0 | Biochemical Assay Reagents |
| HY-I0314 | 1H-Pyrazole-4-boronic acid pinacol ester | 269410-08-4 | Biochemical Assay Reagents |
| HY-I0352 | Epiandrosterone | 481-29-8 | Natural Products |
| HY-I0357S | Hexyl chlorocarbonate-d13 | 2708278-38-8 | Isotope-Labeled Compounds |
| HY-I0377 | Boc-D-tert-leucine | 124655-17-0 | Peptides |
| HY-I0383 | Canagliflozin (hemihydrate) | 928672-86-0 | Reference compound |
| HY-I0392AS | (S)-Cinacalcet-d3 (hydrochloride) | 2673269-84-4 | Isotope-Labeled Compounds |
| HY-I0392S | (S)-Cinacalcet-d3 | Isotope-Labeled Compounds | |
| HY-I0393 | 3-(2-Thienyl)-L-alanine | 22951-96-8 | Peptides |
| HY-I0400 | N-Acetylneuraminic acid | 131-48-6 | Natural Products |
| HY-I0400R | N-Acetylneuraminic acid (Standard) | 131-48-6 | Reference Standards |
| HY-I0400S | N-Acetylneuraminic acid-13C | 64162-77-2 | Isotope-Labeled Compounds |
| HY-I0400S1 | N-Acetylneuraminic acid-13C-1 | 1032998-24-5 | Isotope-Labeled Compounds |
| HY-I0400S2 | N-Acetylneuraminic acid-13C-2 | 220803-19-0 | Isotope-Labeled Compounds |
| HY-I0400S3 | N-Acetylneuraminic acid-13C-3 | Isotope-Labeled Compounds | |
| HY-I0406 | Sofosbuvir impurity F | 1337482-17-3 | Reference compound |
| HY-I0408 | Sofosbuvir impurity G | 1337482-15-1 | Reference compound |
| HY-I0422 | L-Porretine | 74163-81-8 | Biochemical Assay Reagents |
| HY-I0423 | 3-(2-Thienyl)-D-alanine | 62561-76-6 | Peptides |
| HY-I0447 | 4-Aminosalicylic acid | 65-49-6 | Reference compound |
| HY-I0447A | Sodium 4-aminosalicylate (dihydrate) | 6018-19-5 | Reference compound |
| HY-I0447AR | Sodium 4-aminosalicylate (dihydrate) (Standard) | 6018-19-5 | Reference Standards |
| HY-I0447R | 4-Aminosalicylic acid (Standard) | 65-49-6 | Reference Standards |
| HY-I0450 | Anticancer agent 265 | 184177-83-1 | Reference compound |
| HY-I0454 | Rivaroxaban EP Impurity I | 1151893-81-0 | Reference compound |
| HY-I0459S | Apixaban acid-13C,d3 | 2748468-47-3 | Isotope-Labeled Compounds |
| HY-I0466 | Glutarimide | 1121-89-7 | Reference compound |
| HY-I0501 | 2'-Aminoacetophenone | 551-93-9 | Natural Products |
| HY-I0501R | 2'-Aminoacetophenone (Standard) | 551-93-9 | Reference Standards |
| HY-I0508 | Phthalic acid | 88-99-3 | Natural Products |
| HY-I0508R | Phthalic acid (Standard) | 88-99-3 | Reference Standards |
| HY-I0508S | Phthalic acid-d4 | 87976-26-9 | Isotope-Labeled Compounds |
| HY-I0510 | Carfilzomib intermediate-1 | 868540-16-3 | Reference compound |
| HY-I0512 | Sofosbuvir impurity I | 2164516-85-0 | Reference compound |
| HY-I0513 | Sofosbuvir impurity N | 1394157-34-6 | Reference compound |
| HY-I0515 | Sofosbuvir impurity K | 1496552-51-2 | Reference compound |
| HY-I0516 | PSI 352707 | 1233335-78-8 | Reference compound |
| HY-I0517 | H-Ala-OEt.HCl | 1115-59-9 | Peptides |
| HY-I0519 | L-Alanine methyl ester hydrochloride | 2491-20-5 | Peptides |
| HY-I0561 | 2-Fluoro-5-bromobenzaldehyde | 93777-26-5 | Biochemical Assay Reagents |
| HY-I0591 | N-Formyl-L-leucine | 6113-61-7 | Peptides |
| HY-I0596 | D-Ribonic acid,2-C-methyl,γ-lactone,2,3,5-tribenzoate | 7392-74-7 | Biochemical Assay Reagents |
| HY-I0603 | (R)-Ramelteon | 196597-27-0 | Reference compound |
| HY-I0606B | (R)-(+)-2,2-Dimethyl-1,3-dioxolane-4-carboxaldehyde | 15186-48-8 | Reference compound |
| HY-I0626 | Cytosine | 71-30-7 | Natural Products |
| HY-I0626R | Cytosine (Standard) | 71-30-7 | Reference Standards |
| HY-I0626S | Cytosine-13C2,15N3 | 285978-06-5 | Isotope-Labeled Compounds |
| HY-I0626S1 | Cytosine-13C,15N2 | 181517-10-2 | Isotope-Labeled Compounds |
| HY-I0626S2 | Cytosine-d2 | 106391-24-6 | Isotope-Labeled Compounds |
| HY-I0627 | N4-Benzoylcytosine | 26661-13-2 | Biochemical Assay Reagents |
| HY-I0630 | (R)-2-formamido-4-methylpentanoic acid | 44978-39-4 | Peptides |
| HY-I0635 | (Rac)-Apremilast | 253168-86-4 | Reference compound |
| HY-I0636 | (R)-Apremilast | 608141-44-2 | Reference compound |
| HY-I0637 | Isovanillin | 621-59-0 | Natural Products |
| HY-I0637R | Isovanillin (Standard) | 621-59-0 | Reference Standards |
| HY-I0637S | Isovanillin-d3 | 74495-73-1 | Isotope-Labeled Compounds |
| HY-I0660 | Picolinic acid | 98-98-6 | Natural Products |
| HY-I0660R | Picolinic acid (Standard) | 98-98-6 | Reference Standards |
| HY-I0678 | Regorafénib N-oxyde (M2) | 835621-11-9 | Reference compound |
| HY-I0678R | Regorafénib N-oxyde (M2) (Standard) | 835621-11-9 | Reference Standards |
| HY-I0678S | Regorafénib N-oxyde-d3 (M2) | 1333489-03-4 | Isotope-Labeled Compounds |
| HY-I0678S1 | Regorafénib N-oxyde (M2)-13C,d3 | 2140317-01-5 | Isotope-Labeled Compounds |
| HY-I0703 | Diacetone-D-mannitol, 97% | 1707-77-3 | Biochemical Assay Reagents |
| HY-I0705S | Ethyl 2-bromopropionate-d3 | 1398066-14-2 | Isotope-Labeled Compounds |
| HY-I0708 | 1-Methyl-3-pyrrolidinol | 13220-33-2 | Biochemical Assay Reagents |
| HY-I0717 | 1-Acetylnaphthalene | 941-98-0 | Biochemical Assay Reagents |
| HY-I0717S | 1-Acetylnaphthalene-d3 | 95046-87-0 | Isotope-Labeled Compounds |
| HY-I0718 | (R)-1,1'-Binaphthyl-2,2'-diyl hydrogenphosphate | 39648-67-4 | Biochemical Assay Reagents |
| HY-I0719 | Sofosbuvir impurity B | Reference compound | |
| HY-I0723 | Sofosbuvir impurity D | Reference compound | |
| HY-I0726 | Enantiomer of Sofosbuvir | Reference compound | |
| HY-I0727 | Sofosbuvir impurity E | Reference compound | |
| HY-I0735 | Sofosbuvir impurity M | 2095551-10-1 | Reference compound |
| HY-I0736 | Isonicotinic acid | 55-22-1 | Natural Products |
| HY-I0736R | Isonicotinic acid (Standard) | 55-22-1 | Reference Standards |
| HY-I0736S | Isonicotinic acid-d4 | 53907-55-4 | Isotope-Labeled Compounds |
| HY-I0746 | 3-Aminobenzoic acid | 99-05-8 | Reference compound |
| HY-I0746R | 3-Aminobenzoic acid (Standard) | 99-05-8 | Reference Standards |
| HY-I0746S | 3-Aminobenzoic acid-d4 | 78399-79-8 | Isotope-Labeled Compounds |
| HY-I0749A | (S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate | 868539-99-5 | Peptides |
| HY-I0773 | Boc-L-homophenylalanine | 100564-78-1 | Biochemical Assay Reagents |
| HY-I0775 | (S)-methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate | 1140908-89-9 | Peptides |
| HY-I0781 | Boc-Hyp-OH | 13726-69-7 | ADC Related |
| HY-I0786 | (2S,4R)-Teneligliptin | 1404559-15-4 | Reference compound |
| HY-I0834 | (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran | 915095-94-2 | Natural Products |
| HY-I0865 | Pentafluorophenol | 771-61-9 | Biochemical Assay Reagents |
| HY-I0882 | 2-Isopropoxy-5-methylaniline | 69676-24-0 | Reference compound |
| HY-I0903 | SCH 51048 | 161532-65-6 | Reference compound |
| HY-I0917 | (tert-Butoxycarbonyl)-D-leucine | 16937-99-8 | Peptides |
| HY-I0924 | Methyl D-phenylalaninate | 21685-51-8 | Peptides |
| HY-I0924A | D-Phe-OMe monohydrochloride | 13033-84-6 | Peptides |
| HY-I0931 | Boc-L-Leu-OH | 13139-15-6 | Peptides |
| HY-I0938 | Sofosbuvir impurity H | Reference compound | |
| HY-I0959 | 5-Chlorouracil | 1820-81-1 | Biochemical Assay Reagents |
| HY-I0959R | 5-Chlorouracil (Standard) | 1820-81-1 | Reference Standards |
| HY-I0960 | Uracil | 66-22-8 | Natural Products |
| HY-I0960R | Uracil (Standard) | 66-22-8 | Reference Standards |
| HY-I0960S | Uracil-13C2,15N2 | 181517-11-3 | Isotope-Labeled Compounds |
| HY-I0960S1 | Uracil-13C4 | Isotope-Labeled Compounds | |
| HY-I0960S2 | Uracil-13C | 35803-45-3 | Isotope-Labeled Compounds |
| HY-I0960S3 | Uracil-13C4,15N2 | 202407-06-5 | Isotope-Labeled Compounds |
| HY-I0960S4 | Uracil-d2 | 24897-52-7 | Isotope-Labeled Compounds |
| HY-I0960S5 | Uracil-15N2 | 5522-55-4 | Isotope-Labeled Compounds |
| HY-I0960S6 | Uracil-d2-1 | 20666-60-8 | Isotope-Labeled Compounds |
| HY-I0960S7 | Uracil-d1 | 24897-50-5 | Isotope-Labeled Compounds |
| HY-I0960S8 | Uracil-d1-1 | 24897-51-6 | Isotope-Labeled Compounds |
| HY-I0960S9 | Uracil-d4 | 24897-55-0 | Isotope-Labeled Compounds |
| HY-I0975 | Sofosbuvir impurity J | 1334513-10-8 | Reference compound |
| HY-I0983S | 1,1,3,3-Tetramethylurea-d12 | 51219-89-7 | Isotope-Labeled Compounds |
| HY-I0996 | 1,1-Dimethylethyl 4-(4-amino-3-pyridinyl)-1-piperazinecarboxylate | 1023594-50-4 | Reference compound |
| HY-I0998 | 1,1-Dimethylethyl 4-(5-amino-3-pyridinyl)-1-piperazinecarboxylate | 1245914-05-9 | Reference compound |
| HY-I1029 | L-Homophenylalanine | 943-73-7 | Biochemical Assay Reagents |
| HY-I1044 | Benzyloxycarbonyl-D-alloisoleucine | 55723-45-0 | Peptides |
| HY-I1060 | L-Alloisoleucine | 1509-34-8 | Natural Products |
| HY-I1060S | L-Alloisoleucine-d10 | 202529-06-4 | Isotope-Labeled Compounds |
| HY-I1061 | L-Alloisoleucine, N-[(phenylmethoxy)carbonyl]- | 55723-48-3 | Peptides |
| HY-I1070 | D-Isoleucine | 319-78-8 | Reference compound |
| HY-I1107 | MOC-Val-OH | 74761-42-5 | Peptides |
| HY-I1111 | Fmoc-L-Val-OH | 68858-20-8 | Peptides |
| HY-I1111S | Fmoc-L-Val-OH-d8 | 1007834-06-1 | Isotope-Labeled Compounds |
| HY-I1111S1 | Fmoc-L-Val-OH-1-13C | 286460-74-0 | Isotope-Labeled Compounds |
| HY-I1111S2 | Fmoc-L-Val-OH-13C5,15N | 1217442-94-8 | Isotope-Labeled Compounds |
| HY-I1111S3 | Fmoc-L-Val-OH-13C5 | Isotope-Labeled Compounds | |
| HY-I1111S4 | Fmoc-L-Val-OH-15N | 125700-35-8 | Isotope-Labeled Compounds |
| HY-I1112 | Fmoc-N-Me-Val-OH | 84000-11-3 | Reference compound |
| HY-I1120 | SGLT2-IN-1 | 864070-37-1 | Reference compound |
| HY-I1124 | L-Valine-d8 | 35045-72-8 | Isotope-Labeled Compounds |
| HY-I1124R | L-Valine-d8 (Standard) | 35045-72-8 | Reference Standards |
| HY-I1162 | Diethyl acetamidomalonate | 1068-90-2 | Biochemical Assay Reagents |
| HY-I1196 | Sofosbuvir impurity L | Reference compound | |
| HY-I1208 | D-Valsartan | 137862-87-4 | Reference compound |
| HY-K0001 | Exosome Protein Lysis Buffer | Kits | |
| HY-K0010 | Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) | Kits | |
| HY-K0011 | Protease Inhibitor Cocktail, mini-Tablet (EDTA-Free) | Kits | |
| HY-K0012 | Protease Inhibitor Cocktail, Bacteria (EDTA-Free, 100× in DMSO) | Kits | |
| HY-K0013 | Protease and Phosphatase Inhibitor Cocktail (EDTA-Free, 10× in ddH2O) | Kits | |
| HY-K0014 | Penicillin-Streptomycin-Neomycin (PSN) (100×), Sterile | Kits | |
| HY-K0016 | Kinase Assay Buffer | Kits | |
| HY-K0017 | Kinase Inhibitor Cocktail | Kits | |
| HY-K0021 | Phosphatase Inhibitor Cocktail I (100X in DMSO) | Kits | |
| HY-K0022 | Phosphatase Inhibitor Cocktail II (100X in ddH2O) | Kits | |
| HY-K0023 | Phosphatase Inhibitor Cocktail III (100X in DMSO) | Kits | |
| HY-K0030 | Deacetylase Inhibitor Cocktail (100× in 70% DMSO) | Kits | |
| HY-K0200 | Magnetic Stand | Kits | |
| HY-K0201 | Anti-HA Magnetic Beads | Kits | |
| HY-K0201A | Anti-HA Magnetic Beads (1 μm) | Kits | |
| HY-K0202 | Protein A/G Magnetic Beads | Kits | |
| HY-K0202K | IP/Co-IP Kit (Protein A/G Magnetic Beads) | Kits | |
| HY-K0203 | Protein A Magnetic Beads | Kits | |
| HY-K0204 | Protein G Magnetic Beads | Kits | |
| HY-K0205 | Protein L Magnetic Beads | Kits | |
| HY-K0206 | Anti-c-Myc Magnetic Beads | Kits | |
| HY-K0206A | Anti-c-Myc Magnetic Beads (1 μm) | Kits | |
| HY-K0207 | Anti-Flag Magnetic Beads | Kits | |
| HY-K0208 | Streptavidin Magnetic Beads | Kits | |
| HY-K0209 | Anti-His Magnetic Beads | Kits | |
| HY-K0210 | Ni-NTA His-Tag Purification Agarose | Kits | |
| HY-K0211 | Glutathione Agarose | Kits | |
| HY-K0213 | Protein A Agarose | Kits | |
| HY-K0214 | Protein G Agarose | Kits | |
| HY-K0215 | Protein L Agarose | Kits | |
| HY-K0217 | Anti-Flag Affinity Gel | Kits | |
| HY-K0218A | Streptavidin Agarose 6FF | Kits | |
| HY-K0219 | High-Affinity Iodoacetyl Agarose | Kits | |
| HY-K0220 | Ni-NTA 6FF Prepacked Column | Kits | |
| HY-K0221 | Affinity Chromatography Column | Kits | |
| HY-K0222 | Anti-GST Magnetic Beads | Kits | |
| HY-K0223 | Hydroxyl Magnetic Beads(200nm,10mg/ml) | Kits | |
| HY-K0224 | Amino magnetic beads (200 nm,10mg/mL) | Kits | |
| HY-K0225 | Carboxyl Magnetic Beads(200nm,10mg/ml) | Kits | |
| HY-K0226 | CHO Magnetic Beads (200nm, 10mg/mL) | Kits | |
| HY-K0227 | NHS Magnetic Beads (200nm, 10mg/mL) | Kits | |
| HY-K0228 | Oligo (dT)30 Magnetic Beads | Kits | |
| HY-K0229 | Anti-GFP Affinity Gel | Kits | |
| HY-K0230 | Protein A/G Agarose | Kits | |
| HY-K0231 | Anti-c-Myc Affinity Gel | Kits | |
| HY-K0232 | Anti-HA Affinity Gel | Kits | |
| HY-K0233 | Anti-RFP Affinity Gel | Kits | |
| HY-K0234 | Glutathione Magnetic Agarose Beads | Kits | |
| HY-K0235 | Anti-YFP Affinity Gel | Kits | |
| HY-K0236 | Anti-Flag Magnetic Agarose Beads | Kits | |
| HY-K0237 | Anti-HA Magnetic Agarose Beads | Kits | |
| HY-K0238 | Ni-IDA Agarose | Kits | |
| HY-K0239 | Strep-Tag II Agarose | Kits | |
| HY-K0240 | Ni-IDA Magnetic Agarose Beads | Kits | |
| HY-K0241 | Ni-NTA Magnetic Agarose Beads | Kits | |
| HY-K0242 | Protein A Plus Magnetic Agarose Beads | Kits | |
| HY-K0243 | Protein G Plus Magnetic Agarose Beads | Kits | |
| HY-K0246 | Anti-GFP Magnetic Agarose Beads | Kits | |
| HY-K0247 | ConA Magnetic Beads | Kits | |
| HY-K0301 | Cell Counting Kit-8 | Kits | |
| HY-K0302 | Cell-ATP Viability Detection Kit | Kits | |
| HY-K0304 | Human CD3+ T Cells Negative Selection Kit | Kits | |
| HY-K0305 | Human CD34+ Cells Negative Selection Kit | Kits | |
| HY-K0306 | Mouse CD3+ T Cells Negative Selection Kit | Kits | |
| HY-K0307 | Mouse CD4+ T Cells Negative Selection Kit | Kits | |
| HY-K0308 | Mouse CD4+ Cell Positive Selection Kit | Kits | |
| HY-K0309 | Mouse CD8+ T Cells Negative Selection Kit | Kits | |
| HY-K0310 | Mouse CD8+ Cell Positive Selection Kit | Kits | |
| HY-K0311 | GSH/GSSG Assay Kit | Kits | |
| HY-K0313 | NAD+/NADH Assay Kit (WST-8) | Kits | |
| HY-K0314 | ATP Assay Kit | Kits | |
| HY-K0315 | Hematoxylin-Eosin Staining Kit | Kits | |
| HY-K0316 | Serum Replacement | Kits | |
| HY-K0318 | Nitric Oxide Detection Kit | Kits | |
| HY-K0319 | Lipid Peroxidation (MDA) Assay Kit | Kits | |
| HY-K0320 | ROS Assay Kit | Kits | |
| HY-K0321 | Fumarase Activity Assay Kit (WST-8) | Kits | |
| HY-K0322 | Cell Ferrous Iron (Fe2+) Assay Kit (Fluorometric) | Kits | |
| HY-K0350 | Mouse Neutrophil Negative Selection Kit | Kits | |
| HY-K0351 | Human CD8+ T Cells Negative Selection Kit | Kits | |
| HY-K0352 | Human CD4+ T Cells Negative Selection Kit | Kits | |
| HY-K0353 | Human CD3/CD28 T Cell Activation Magnetic Beads | Kits | |
| HY-K0501 | SYBR Green qPCR Master Mix | Kits | |
| HY-K0501A | SYBR Green qPCR Master Mix (Universal) | Kits | |
| HY-K0510A | RT Master Mix for qPCR II | Kits | |
| HY-K0511 | RT Master Mix for qPCR (gDNA digester plus) | Kits | |
| HY-K0511A | RT Master Mix for qPCR II (gDNA digester plus) | Kits | |
| HY-K0512 | microRNA RT Master Mix for qPCR III (poly A) | Kits | |
| HY-K0513 | RT Master Mix for qPCR III-1 | Kits | |
| HY-K0521 | SYBR Green qPCR Master Mix (High ROX) | Kits | |
| HY-K0522 | SYBR Green qPCR Master Mix (Low ROX) | Kits | |
| HY-K0523 | SYBR Green qPCR Master Mix (No ROX) | Kits | |
| HY-K0524 | 2-Color Tracking SYBR qPCR Master Mix (Universal) | Kits | |
| HY-K0531 | 2× PCR Master Mix (with Dye) | Kits | |
| HY-K0532 | 2× Fast PCR Master Mix (with Dye) | Kits | |
| HY-K0533 | 2× High-Fidelity PCR Master Mix | Kits | |
| HY-K0533A | 2× High-Fidelity PCR Master Mix (with Dye) | Kits | |
| HY-K0551 | Mycoplasma Detection Kit (Luminescence) | Kits | |
| HY-K0552 | Mycoplasma Detection Kit (PCR) | Kits | |
| HY-K0553 | Mycoplasma Detection Kit (qPCR) | Kits | |
| HY-K0601 | JC-1 Mitochondrial Membrane Potential Assay Kit | Kits | |
| HY-K0702 | Antibody Labeling Kit-VF 488 | Kits | |
| HY-K0801 | 50 bp DNA Marker | Kits | |
| HY-K0802 | 100 bp DNA Marker | Kits | |
| HY-K0803 | 100 bp plus DNA Marker | Kits | |
| HY-K0804 | 500 bp DNA Marker | Kits | |
| HY-K0805 | 1 kb DNA Marker | Kits | |
| HY-K0806 | 2 kb DNA Marker | Kits | |
| HY-K0807 | 5 kb DNA Marker | Kits | |
| HY-K0808 | 15 kb DNA Marker | Kits | |
| HY-K0901 | AMCA Phalloidin | Kits | |
| HY-K0902 | Fluorescein Phalloidin | Kits | |
| HY-K0903 | Rhodamine Phalloidin | Kits | |
| HY-K1000 | WB/IP Lysis Buffer | Kits | |
| HY-K1001 | RIPA Lysis Buffer (Strong) | Kits | |
| HY-K1002 | NP-40 Lysis Buffer | Kits | |
| HY-K1003 | Mammalian Active Protein Extraction Reagent | Kits | |
| HY-K1004 | SYBR Green I Nucleic Acid Gel Stain | Kits | |
| HY-K1005 | Ultra High Sensitivity ECL Kit | Kits | |
| HY-K1006 | Penicillin-Streptomycin (100×), sterile | Kits | |
| HY-K1007 | Red Nucleic Acid Gel Stain (10,000 ×) | Kits | |
| HY-K1008 | Gentamicin-Amphotericin B (500×), Sterile | Kits | |
| HY-K1010 | Penicillin-Streptomycin-Glutam (100×), Sterile | Kits | |
| HY-K1011 | 3 Color Prestained Protein Marker (10-190 kDa) | Kits | |
| HY-K1012 | Serum/Protein-Free Cell Freezing Medium | Kits | |
| HY-K1013 | Renilla-Firefly Luciferase Dual Assay Kit | Kits | |
| HY-K1014 | PolyFast Transfection Reagent | Kits | |
| HY-K1015 | TAE Powder (1 L of 1×) | Kits | |
| HY-K1016 | TBE Powder (1 L of 1×) | Kits | |
| HY-K1018 | Tris-MES-SDS Powder (1 L of 1×) | Kits | |
| HY-K1019 | Tris-MOPS-SDS Powder (1 L of 1×) | Kits | |
| HY-K1020 | Tris-Glycine-SDS Powder (1 L of 1×) | Kits | |
| HY-K1021 | Tris-Glycine Powder (1 L of 1×) | Kits | |
| HY-K1022 | PBS-T Powder (1 L of 1×) | Kits | |
| HY-K1023 | PBS Powder (1 L of 1×) | Kits | |
| HY-K1024 | PBS Powder (2 L of 1×) | Kits | |
| HY-K1025 | TBS-T Powder (1 L of 1×) | Kits | |
| HY-K1026 | TBS Powder (1 L of 1×) | Kits | |
| HY-K1027 | Rapid Blocking Buffer (TBS-T) Powder (100 mL of 1×) | Kits | |
| HY-K1028 | Transfer Buffer (Semi Dry) Powder (1 L of 1×) | Kits | |
| HY-K1029 | Agarose With TAE Powder (1%) | Kits | |
| HY-K1030 | SDS dust-free Powder | Kits | |
| HY-K1031 | Agarose | Kits | |
| HY-K1032 | 6× DNA Loading Buffer with SDS | Kits | |
| HY-K1033 | RNase Inhibitor | Kits | |
| HY-K1034 | Tris-HEPES-SDS Powder (500 mL of 1×) | Kits | |
| HY-K1041 | Seamless DNA Assembly Plus Kit | Kits | |
| HY-K1041A | Seamless DNA Assembly Ultra Kit | Kits | |
| HY-K1042 | AntiFade Mounting Medium | Kits | |
| HY-K1043 | CEPT Cocktail | Kits | |
| HY-K1044 | Polymyxin B, Sterile (1,000×) | Kits | |
| HY-K1046 | L-Glutamine (100×), Sterile | Kits | |
| HY-K1047 | AntiFade Mounting Medium (with DAPI) | Kits | |
| HY-K1048 | AntiFade Reagent (with DAPI) | Kits | |
| HY-K1049 | T4 DNA Ligase (Fast) | Kits | |
| HY-K1050 | Gentamicin, Sterile | Kits | |
| HY-K1051 | Hygromycin B, Sterile | Kits | |
| HY-K1052 | Amphotericin B, Sterile | Kits | |
| HY-K1053 | Bleomycin D1 Selection Antibiotic, Sterile | Kits | |
| HY-K1054 | Blasticidin S, Sterile | Kits | |
| HY-K1055 | Kanamycin sulfate (100x), Sterile | Kits | |
| HY-K1056 | G418 Selective Antibiotic, Sterile | Kits | |
| HY-K1057 | Puromycin, Sterile | Kits | |
| HY-K1058 | Antibiotic-Antifungal (100 ×), Sterile | Kits | |
| HY-K1059 | BM-Cyclin | Kits | |
| HY-K1060 | Mitochondria Isolation Kit for Cultured Cells | Kits | |
| HY-K1061 | Mitochondria Isolation Kit for Tissue | Kits | |
| HY-K1062 | Exosome Isolation and Purification Kit (from cell culture media) | Kits | |
| HY-K1063 | Exosome Isolation and Purification Kit (from plasma and serum) | Kits | |
| HY-K1063A | Exosome Isolation and Purification Plus Kit (From Plasma and Serum) | Kits | |
| HY-K1064 | Exosome Protein Detection Kit (CD63 & TSG101) | Kits | |
| HY-K1065 | Exosome Isolation and Purification Kit (from body fluids) | Kits | |
| HY-K1067 | Exosome Isolation and Purification Kit (From Tissue) | Kits | |
| HY-K1068 | Exosome Protein Detection Kit (CD81) | Kits | |
| HY-K1069 | Lentivirus Solution Buffer | Kits | |
| HY-K1070 | Apoptosis and Necrosis Assay Kit | Kits | |
| HY-K1071 | Cell Cycle and Apoptosis Analysis Kit (PI staining) | Kits | |
| HY-K1072 | Cell Apoptosis Analysis Kit (Hoechst staining) | Kits | |
| HY-K1073 | Annexin V-FITC/PI Apoptosis Detection Kit | Kits | |
| HY-K1074 | Annexin V-EGFP/PI Apoptosis Detection Kit | Kits | |
| HY-K1075 | Annexin V-PE Apoptosis Detection Kit | Kits | |
| HY-K1076 | Annexin V-mCherry Apoptosis Detection Kit | Kits | |
| HY-K1077 | Annexin V-mCherry/SYTOX Green Apoptosis Detection Kit | Kits | |
| HY-K1078 | One Step TUNEL Apoptosis Detection Kit (FITC) | Kits | |
| HY-K1079 | One Step TUNEL Apoptosis Detection Kit (Cyanine 3) | Kits | |
| HY-K1080 | Annexin V-iFluor 488/PI Apoptosis Detection Kit | Kits | |
| HY-K1084 | VF 647 Click-iT EdU Universal Cell Proliferation Detection Kit | Kits | |
| HY-K1085 | VF 594 Click-iT EdU Universal Cell Proliferation Detection Kit | Kits | |
| HY-K1086 | VF 555 Click-iT EdU Universal Cell Proliferation Detection Kit | Kits | |
| HY-K1087 | VF 488 Click-iT EdU Universal Cell Proliferation Detection Kit | Kits | |
| HY-K1088 | VF 488 Caspase 3 Assay Kit for Live Cells | Kits | |
| HY-K1089 | Cell Senescence β-Galactosidase Staining Kit | Kits | |
| HY-K1090 | Cytotoxicity LDH Assay Kit | Kits | |
| HY-K1091 | TUNEL Apoptosis Detection Kit (Biotin) | Kits | |
| HY-K1091A | Biotin Apoptosis Detection Kit (TUNEL) | Kits | |
| HY-K1092 | YO-PRO-1/PI Apoptosis and Necrosis Detection Kit | Kits | |
| HY-K1093 | VF 647A-Annexin V-PI Apoptosis Detection Kit | Kits | |
| HY-K1094 | Viability/Cytotoxicity Assay Kit for Live & Dead Cells (Calcein/PI) | Kits | |
| HY-K1095 | Live & Dead Bacterial Viability and Counting Kit | Kits | |
| HY-K1096 | Annexin V-FITC/7-AAD Apoptosis Detection Kit | Kits | |
| HY-K1097 | Gram Stain Kit | Kits | |
| HY-K1098 | Exosome Isolation and Purification Kit (From Milk) | Kits | |
| HY-K1100 | SDS-PAGE Sample Loading Buffer (4×) | Kits | |
| HY-K1101 | 3-Color Prestained Protein Marker (2.7-40 kDa) | Kits | |
| HY-K1103 | Coomassie Blue Fast Staining Solution (No Heating, 10×) | Kits | |
| HY-K1105A | One Step Colored Rapid Gel Preparation Kit (12.5%) | Kits | |
| HY-K1107 | DAB Peroxidase Substrate Kit (Blue-Purple Color) | Kits | |
| HY-K1108 | SDS-PAGE Protein Loading Buffer (non-Reducing, 5×) | Kits | |
| HY-K1109 | Ponceau Staining Solution (Ready-to-use, 1×) | Kits | |
| HY-K1501 | NADP+/NADPH Assay Kit (WST-8) | Kits | |
| HY-K2001 | Bradford Protein Assay Kit | Kits | |
| HY-K2005 | High Sensitivity ECL Kit | Kits | |
| HY-K2006 | Sensitive ECL Kit | Kits | |
| HY-K2012 | Serum/Protein-Free Cell Freezing Medium (Low DMSO) | Kits | |
| HY-K2014 | PEI Transfection Reagent | Kits | |
| HY-K2015 | Lentivirus Transfection Reagent | Kits | |
| HY-K2016 | Protein Transfection Reagent | Kits | |
| HY-K2017 | siRNA/miRNA Transfection Reagent | Kits | |
| HY-K2018 | OptiLNP RNA Transfection Reagent | Kits | |
| HY-K2019 | OptiLNP RNA Transfection Reagent (Stem Cells) | Kits | |
| HY-K2020 | OptiLNP RNA Transfection Reagent (Primary Immune Cells) | Kits | |
| HY-K2021 | OptiLNP RNA Transfection Reagent (Immune Cells) | Kits | |
| HY-K2022 | In vivo OptiLNP RNA Transfection Reagent (Systemic Effect) | Kits | |
| HY-K2023 | In vivo OptiLNP RNA Transfection Reagent (Local Effect) | Kits | |
| HY-K2024 | In vivo OptiLNP RNA Transfection Reagent (Liver-targeted) | Kits | |
| HY-K2025 | In vivo OptiLNP RNA Transfection Reagent (Lung-targeted) | Kits | |
| HY-K2026 | OptiLNP Short-Chain RNA Transfection Reagent | Kits | |
| HY-K2027 | OptiLNP Gene Editing Kit | Kits | |
| HY-K2028 | OptiLNP Gene Editing Kit (Immune Cells) | Kits | |
| HY-K2101 | HOLO Human Interleukin-2 (IL-2) Detection Kit | Kits | |
| HY-K2102 | HOLO Human Interleukin-5 (IL-5) Detection Kit | Kits | |
| HY-K2103 | HOLO Human Interleukin-6 (IL-6) Detection Kit | Kits | |
| HY-K2104 | HOLO Human Interleukin-8 (IL-8) Detection Kit | Kits | |
| HY-K2105 | HOLO Human Interleukin-10 (IL-10) Detection Kit | Kits | |
| HY-K2106 | HOLO Human Interleukin-12p70 (IL-12p70) Detection Kit | Kits | |
| HY-K2107 | HOLO Human Interleukin-17A (IL-17A) Detection Kit | Kits | |
| HY-K2108 | HOLO Human Interleukin-17F (IL-17F) Detection Kit | Kits | |
| HY-K2109 | HOLO Human Interleukin-22 (IL-22) Detection Kit | Kits | |
| HY-K2110 | HOLO Human Interferon-γ (IFN-γ) Detection Kit | Kits | |
| HY-K2111 | HOLO Mouse Interferon-γ (IFN-γ) Detection Kit | Kits | |
| HY-K2112 | HOLO Human Tumor Necrosis Factor-α (TNF-α) Detection Kit | Kits | |
| HY-K2113 | HOLO Human Tumor Necrosis Factor-β (TNF-β) Detection Kit | Kits | |
| HY-K2114 | HOLO Mouse Tumor Necrosis Factor-α (TNF-α) Detection Kit | Kits | |
| HY-K2115 | HOLO Human Interleukin-2 Receptor (IL-2R) Detection Kit | Kits | |
| HY-K2116 | HOLO Human Interleukin-1β (IL-1β) Detection Kit | Kits | |
| HY-K2117 | HOLO Mouse Interleukin-6 (IL-6) Detection Kit | Kits | |
| HY-K2118 | HOLO Mouse Interleukin-2 (IL-2) Detection Kit | Kits | |
| HY-K2610 | Caspase 1 Activity Assay Kit | Kits | |
| HY-K2611 | Caspase 3 Activity Assay Kit | Kits | |
| HY-K3001 | DMEM (High Glucose, L-Glutamine, Pyruvate, Phenol Red, no HEPES) | Kits | |
| HY-K3002 | DMEM/F-12 (1:1), L-Glutamine, Phenol Red, HEPES | Kits | |
| HY-K3003 | DMEM (Low Glucose, L-Glutamine, Pyruvate, Phenol Red, no HEPES) | Kits | |
| HY-K3004 | RPMI 1640 (L-Glutamine, Phenol Red, no HEPES) | Kits | |
| HY-K3005 | PBS Buffer (1×) | Kits | |
| HY-K3006 | PBS Buffer (10×) | Kits | |
| HY-K3007 | 0.25% Trypsin-EDTA (1x), phenol red | Kits | |
| HY-K3008 | DPBS Buffer (1×) | Kits | |
| HY-K3009 | 0.25% Trypsin-EDTA (1×), no phenol red | Kits | |
| HY-K3010 | Red Blood Cell Lysis Buffer | Kits | |
| HY-K3011 | MEM Non-Essential Amino Acids Solution (100X) | Kits | |
| HY-K3012 | N-2 Supplement (100×), Sterile | Kits | |
| HY-K3012A | N-2 Serum-free Supplement (100×) | Kits | |
| HY-K3013 | Bi-27 Supplement (50×), Sterile | Kits | |
| HY-K3013A | Bi-27 Serum-free Supplement (50×) | Kits | |
| HY-K3014 | Bi-27 Supplement (50×), Vitamin A-Free, Sterile | Kits | |
| HY-K3014A | Bi-27 Serum-free Supplement (50×), Vitamin A-Free | Kits | |
| HY-K3015 | Density Gradient Medium (Iodixanol) | Kits | |
| HY-K3016 | HAT Supplement (50×) | Kits | |
| HY-K3017 | HT Supplement (50×) | Kits | |
| HY-K3018 | ITS Supplement (100×) | Kits | |
| HY-K3019 | Lipid Concentrate (Chemically Defined) | Kits | |
| HY-K3020 | Nabac Removal Reagent | Kits | |
| HY-K3101 | Human Neuroblastoma Cell Culture Medium | Kits | |
| HY-K3102 | Human Acute Myeloid Leukemia Cell Culture Medium | Kits | |
| HY-K6001 | Basement Membrane Matrix (Phenol Red) | Kits | |
| HY-K6002 | Basement Membrane Matrix | Kits | |
| HY-K6003 | Basement Membrane Matrix GFR (Phenol Red) | Kits | |
| HY-K6004 | Basement Membrane Matrix GFR | Kits | |
| HY-K6005 | Basement Membrane Matrix HC (Phenol Red) | Kits | |
| HY-K6006 | Basement Membrane Matrix IPSC-qualified | Kits | |
| HY-K6007 | Basement Membrane Matrix for Organoid Culture | Kits | |
| HY-K6008 | Basement Membrane Matrix HC | Kits | |
| HY-K6009 | Basement Membrane Matrix GFR&HC | Kits | |
| HY-K6010 | Tissue Storage Solution | Kits | |
| HY-K6011 | Tumor Tissue Dissociation Solution | Kits | |
| HY-K6012 | Tissue Dissociation Solution | Kits | |
| HY-K6013 | Organoid Dissociation Solution | Kits | |
| HY-K6014 | Organoid Cryopreservation Medium (Serum Free) | Kits | |
| HY-K6015 | Organoid Recovery Solution | Kits | |
| HY-K6016 | Organoid Vitality Assay Kit | Kits | |
| HY-K6017 | 3D Cell-ATP Viability Detection Kit | Kits | |
| HY-K6101 | Human Breast Cancer Organoid Kit | Kits | |
| HY-K6102 | Human Lung Adenocarcinoma Organoid Kit | Kits | |
| HY-K6103 | Human Small Cell Lung Cancer Organoid Kit | Kits | |
| HY-K6104 | Human Colorectal Cancer Organoid Kit | Kits | |
| HY-K6105 | Human Gastric Cancer Organoid Kit | Kits | |
| HY-K6106 | Human Cholangiocarcinoma Organoid Kit | Kits | |
| HY-K6107 | Human Cervical Cancer Organoid Kit | Kits | |
| HY-K6108 | Human Esophageal Cancer Organoid Kit | Kits | |
| HY-K6109 | Human Endometrial Cancer Organoid Kit | Kits | |
| HY-K6110 | Human Pancreatic Cancer Organoid Kit | Kits | |
| HY-K6111 | Human Head and Neck Squamous Cell Carcinoma Organoid Kit | Kits | |
| HY-K6112 | Human Colonic Organoid Kit | Kits | |
| HY-K6113 | Human Intestinal Organoid Kit | Kits | |
| HY-K6114 | Human Gastric Epithelial Organoid Kit | Kits | |
| HY-K6115 | Human Pancreatic Organoid Kit | Kits | |
| HY-K6116 | Human Kidney Tubular Organoid Kit | Kits | |
| HY-K6117 | Human Liver Ductal organoid (expansion) Kit | Kits | |
| HY-K6118 | Mouse Liver Ductal Organoid (expansion) Kit | Kits | |
| HY-K6119 | Mouse Intestinal Organoid Kit | Kits | |
| HY-K6120 | Mouse Colonic Organoid Kit | Kits | |
| HY-K6124 | Human Hepatocellular Carcinoma Organoid Kit | Kits | |
| HY-KD1001 | Vari Fluor 3-colour Multiple Fluorescent Staining Kit (For mouse samples) | Dye Reagents | |
| HY-KD1002 | Vari Fluor 3-colour Multiple Fluorescent Staining Kit (For all samples) | Dye Reagents | |
| HY-KD1003 | Vari Fluor 4-colour Multiple Fluorescent Staining Kit (For mouse samples) | Dye Reagents | |
| HY-KD1004 | Vari Fluor 4-colour Multiple Fluorescent Staining Kit (For all samples) | Dye Reagents | |
| HY-KD1005 | Vari Fluor 5-colour Multiple Fluorescent Staining Kit (For mouse samples) | Dye Reagents | |
| HY-KD1006 | Vari Fluor 5-colour Multiple Fluorescent Staining Kit (For all samples) | Dye Reagents | |
| HY-KD1007 | Vari Fluor 6-colour Multiple Fluorescent Staining Kit (For mouse samples) | Dye Reagents | |
| HY-KD1008 | Vari Fluor 6-colour Multiple Fluorescent Staining Kit (For all samples) | Dye Reagents | |
| HY-KD1009 | Vari Fluor 7-colour Multiple Fluorescent Staining Kit (For mouse samples) | Dye Reagents | |
| HY-KD1010 | Vari Fluor 7-colour Multiple Fluorescent Staining Kit (For all samples) | Dye Reagents | |
| HY-KD1025 | Halo Green Kit | Dye Reagents | |
| HY-KD1026 | Lyso Deep Red Kit | Dye Reagents | |
| HY-KD1027 | Lyso Green Kit | Dye Reagents | |
| HY-KD1028 | Lyso Red Kit | Dye Reagents | |
| HY-KD1029 | Mito Red Kit | Dye Reagents | |
| HY-KD1030 | Tubulin Deep Red Kit | Dye Reagents | |
| HY-KE7001 | ApaL I | Enzyme | |
| HY-KE7002 | Avr II | Enzyme | |
| HY-KE7003 | Asc I | Enzyme | |
| HY-KE7004 | BamH I | Enzyme | |
| HY-KE7005 | Bcl I | Enzyme | |
| HY-KE7006 | Bgl II | Enzyme | |
| HY-KE7007 | Bsa I | Enzyme | |
| HY-KE7008 | BstB I | Enzyme | |
| HY-KE7009 | BstE II | Enzyme | |
| HY-KE7010 | Cla I | Enzyme | |
| HY-KE7011 | Dpn I | Enzyme | |
| HY-KE7012 | Dpn II | Enzyme | |
| HY-KE7013 | Eag I | Enzyme | |
| HY-KE7014 | EcoR I | Enzyme | |
| HY-KE7015 | EcoR V | Enzyme | |
| HY-KE7016 | Esp3 I | Enzyme | |
| HY-KE7017 | Fsp I | Enzyme | |
| HY-KE7018 | Hind III | Enzyme | |
| HY-KE7019 | Hinf I | Enzyme | |
| HY-KE7020 | Hpa I | Enzyme | |
| HY-KE7022 | Kpn I | Enzyme | |
| HY-KE7023 | Mlu I | Enzyme | |
| HY-KE7024 | Mnl I | Enzyme | |
| HY-KE7025 | Nco I | Enzyme | |
| HY-KE7026 | Nde I | Enzyme | |
| HY-KE7027 | Nhe I | Enzyme | |
| HY-KE7028 | Not I | Enzyme | |
| HY-KE7029 | Nsi I | Enzyme | |
| HY-KE7030 | Pac I | Enzyme | |
| HY-KE7031 | Pst I | Enzyme | |
| HY-KE7032 | Pvu Ⅱ | Enzyme | |
| HY-KE7033 | Sac I | Enzyme | |
| HY-KE7034 | Sac II | Enzyme | |
| HY-KE7035 | Sal I | Enzyme | |
| HY-KE7036 | Sbf I | Enzyme | |
| HY-KE7037 | Sfi I | Enzyme | |
| HY-KE7038 | Sma I | Enzyme | |
| HY-KE7039 | Spe I | Enzyme | |
| HY-KE7040 | Sph I | Enzyme | |
| HY-KE7041 | Ssp I | Enzyme | |
| HY-KE7042 | Stu I | Enzyme | |
| HY-KE7043 | Taq I | Enzyme | |
| HY-KE7044 | Xba I | Enzyme | |
| HY-KE7045 | Xho I | Enzyme | |
| HY-KE7046 | Nru I | Enzyme | |
| HY-KE7047 | Age I | Enzyme | |
| HY-KE7048 | BspQ I | Enzyme | |
| HY-KE7049 | Sge I | Enzyme | |
| HY-KE7050 | BsmB I | Enzyme | |
| HY-KE7051 | Bsa I, ADCF | Enzyme | |
| HY-KE7052 | BsmB I, ADCF | Enzyme | |
| HY-KE7053 | EcoR I, ADCF | Enzyme | |
| HY-KE7054 | Xba I, ADCF | Enzyme | |
| HY-KE7055 | RNase R | Enzyme | |
| HY-KE7056 | RNase III | Enzyme | |
| HY-KE7057 | O-Glycosidase | Enzyme | |
| HY-KE7058 | Ribonuclease H | Enzyme | |
| HY-KE7066 | FnCas12a | Enzyme | |
| HY-KE7067 | Lambda DNA | Enzyme | |
| HY-KE8001 | Phi29 DNA Polymerase | Enzyme | |
| HY-KE8002 | Bst DNA Polymerase, Full Length | Enzyme | |
| HY-KE8003 | Bst DNA Polymerase, Large Fragment | Enzyme | |
| HY-KE8004 | Reverse Transcriptase | Enzyme | |
| HY-KE8005 | T7 Endonuclease I | Enzyme | |
| HY-KE8006 | Terminal Deoxynucleotidyl Transferase (TdT) | Enzyme | |
| HY-KE8007 | DNA Polymerase I (E.coli) | Enzyme | |
| HY-KE8008 | T4 DNA Polymerase | Enzyme | |
| HY-KE8009 | Taq DNA Ligase | Enzyme | |
| HY-KE8010 | Exonuclease I | Enzyme | |
| HY-KE8011 | Phi29 DNA Polymerase (mutant) | Enzyme | |
| HY-KT001 | E3 Ligase Ligand-Linker Conjugate Kit | Reference compound | |
| HY-N0001 | (-)-Epicatechin | 490-46-0 | Natural Products |
| HY-N0001A | (+)-Epicatechin | 35323-91-2 | Natural Products |
| HY-N0001R | (-)-Epicatechin (Standard) | 490-46-0 | Reference Standards |
| HY-N0001S | (±)-Epicatechin-13C3 | 1217780-28-3 | Isotope-Labeled Compounds |
| HY-N0001S2 | (-)-Epicatechin-13C3 | Isotope-Labeled Compounds | |
| HY-N0002 | (-)-Epicatechin gallate | 1257-08-5 | Natural Products |
| HY-N0002R | (-)-Epicatechin gallate (Standard) | 1257-08-5 | Reference Standards |
| HY-N0003 | Honokiol | 35354-74-6 | Natural Products |
| HY-N0003R | Honokiol (Standard) | 35354-74-6 | Reference Standards |
| HY-N0004 | Oridonin | 28957-04-2 | Natural Products |
| HY-N0004R | Oridonin (Standard) | 28957-04-2 | Reference Standards |
| HY-N0005 | Curcumin | 458-37-7 | Natural Products |
| HY-N0005R | Curcumin (Standard) | 458-37-7 | Reference Standards |
| HY-N0005S | Curcumin-d6 | 1246833-26-0 | Isotope-Labeled Compounds |
| HY-N0005S1 | Curcumin-d3 | Isotope-Labeled Compounds | |
| HY-N0006 | Demethoxycurcumin | 22608-11-3 | Natural Products |
| HY-N0006A | (E/Z)-Demethoxycurcumin | 24939-17-1 | Natural Products |
| HY-N0006R | Demethoxycurcumin (Standard) | 22608-11-3 | Reference Standards |
| HY-N0006S | Demethoxycurcumin-d7 | 2470243-19-5 | Isotope-Labeled Compounds |
| HY-N0006S1 | Demethoxycurcumin-d4 | Isotope-Labeled Compounds | |
| HY-N0007 | (E,E)-Bisdemethoxycurcumin | 33171-05-0 | Natural Products |
| HY-N0007A | Bisdemethoxycucurmin | 24939-16-0 | Natural Products |
| HY-N0007AR | Bisdemethoxycucurmin (Standard) | 24939-16-0 | Reference Standards |
| HY-N0007R | (E,E)-Bisdemethoxycurcumin (Standard) | 33171-05-0 | Reference Standards |
| HY-N0007S | Bisdemethoxycurcumin-d8 | 2470233-08-8 | Isotope-Labeled Compounds |
| HY-N0008 | Orcinol glucoside | 21082-33-7 | Natural Products |
| HY-N0008R | Orcinol glucoside (Standard) | 21082-33-7 | Reference Standards |
| HY-N0009 | Geniposide | 24512-63-8 | Natural Products |
| HY-N0009R | Geniposide (Standard) | 24512-63-8 | Reference Standards |
| HY-N0010 | Geniposidic acid | 27741-01-1 | Natural Products |
| HY-N0010R | Geniposidic acid (Standard) | 27741-01-1 | Reference Standards |
| HY-N0011 | Baohuoside I | 113558-15-9 | Natural Products |
| HY-N0011R | Baohuoside I (Standard) | 113558-15-9 | Reference Standards |
| HY-N0012 | Glycitin | 40246-10-4 | Natural Products |
| HY-N0012R | Glycitin (Standard) | 40246-10-4 | Reference Standards |
| HY-N0013 | Vitexin | 3681-93-4 | Natural Products |
| HY-N0013R | Vitexin (Standard) | 3681-93-4 | Reference Standards |
| HY-N0014 | Icariin | 489-32-7 | Natural Products |
| HY-N0014R | Icariin (Standard) | 489-32-7 | Reference Standards |
| HY-N0015 | Astragalin | 480-10-4 | Natural Products |
| HY-N0015R | Astragalin (Standard) | 480-10-4 | Reference Standards |
| HY-N0016 | Glycitein | 40957-83-3 | Natural Products |
| HY-N0016R | Glycitein (Standard) | 40957-83-3 | Reference Standards |
| HY-N0017 | Bergenin | 477-90-7 | Natural Products |
| HY-N0017R | Bergenin (Standard) | 477-90-7 | Reference Standards |
| HY-N0018 | Daidzin | 552-66-9 | Natural Products |
| HY-N0018R | Daidzin (Standard) | 552-66-9 | Reference Standards |
| HY-N0019 | Daidzein | 486-66-8 | Natural Products |
| HY-N0019R | Daidzein (Standard) | 486-66-8 | Reference Standards |
| HY-N0019S | Daidzein-d4 | 1219803-57-2 | Isotope-Labeled Compounds |
| HY-N0019S1 | Daidzein-d6 | 291759-05-2 | Isotope-Labeled Compounds |
| HY-N0020 | Echinacoside | 82854-37-3 | Natural Products |
| HY-N0020R | Echinacoside (Standard) | 82854-37-3 | Reference Standards |
| HY-N0021 | Verbascoside | 61276-17-3 | Natural Products |
| HY-N0021R | Verbascoside (Standard) | 61276-17-3 | Reference Standards |
| HY-N0022 | Isoacteoside | 61303-13-7 | Natural Products |
| HY-N0022R | Isoacteoside (Standard) | 61303-13-7 | Reference Standards |
| HY-N0023 | Cistanoside A | 93236-42-1 | Natural Products |
| HY-N0025 | Jionoside D | 120406-34-0 | Natural Products |
| HY-N0026 | 2'-Acetylacteoside | 94492-24-7 | Natural Products |
| HY-N0026R | 2'-Acetylacteoside (Standard) | 94492-24-7 | Reference Standards |
| HY-N0028 | Forsythiaside A | 79916-77-1 | Natural Products |
| HY-N0028R | Forsythiaside A (Standard) | 79916-77-1 | Reference Standards |
| HY-N0029 | Forsythoside B | 81525-13-5 | Natural Products |
| HY-N0029R | Forsythoside B (Standard) | 81525-13-5 | Reference Standards |
| HY-N0031 | Plantamajoside | 104777-68-6 | Natural Products |
| HY-N0031R | Plantamajoside (Standard) | 104777-68-6 | Reference Standards |
| HY-N0033 | Poliumoside | 94079-81-9 | Natural Products |
| HY-N0033R | Poliumoside (Standard) | 94079-81-9 | Reference Standards |
| HY-N0034 | Arctiin | 20362-31-6 | Natural Products |
| HY-N0034R | Arctiin (Standard) | 20362-31-6 | Reference Standards |
| HY-N0035 | Arctigenin | 7770-78-7 | Natural Products |
| HY-N0035R | Arctigenin (Standard) | 7770-78-7 | Reference Standards |
| HY-N0036 | Costunolide | 553-21-9 | Natural Products |
| HY-N0036R | Costunolide (Standard) | 553-21-9 | Reference Standards |
| HY-N0037 | Albiflorin | 39011-90-0 | Natural Products |
| HY-N0037R | Albiflorin (Standard) | 39011-90-0 | Reference Standards |
| HY-N0038 | Alantolactone | 546-43-0 | Natural Products |
| HY-N0038R | Alantolactone (Standard) | 546-43-0 | Reference Standards |
| HY-N0039 | Ginsenoside Rb1 | 41753-43-9 | Natural Products |
| HY-N0039R | Ginsenoside Rb1 (Standard) | 41753-43-9 | Reference Standards |
| HY-N0040 | Ginsenoside Rb2 | 11021-13-9 | Natural Products |
| HY-N0040R | Ginsenoside Rb2 (Standard) | 11021-13-9 | Reference Standards |
| HY-N0041 | Ginsenoside Rb3 | 68406-26-8 | Natural Products |
| HY-N0041R | Ginsenoside Rb3 (Standard) | 68406-26-8 | Reference Standards |
| HY-N0042 | Ginsenoside Rc | 11021-14-0 | Natural Products |
| HY-N0042R | Ginsenoside Rc (Standard) | 11021-14-0 | Reference Standards |
| HY-N0043 | Ginsenoside Rd | 52705-93-8 | Natural Products |
| HY-N0043R | Ginsenoside Rd (Standard) | 52705-93-8 | Reference Standards |
| HY-N0044 | Ginsenoside Re | 52286-59-6 | Natural Products |
| HY-N0044R | Ginsenoside Re (Standard) | 52286-59-6 | Reference Standards |
| HY-N0045 | Ginsenoside Rg1 | 22427-39-0 | Natural Products |
| HY-N0045R | Ginsenoside Rg1 (Standard) | 22427-39-0 | Reference Standards |
| HY-N0046 | Notoginsenoside Fe | 88105-29-7 | Natural Products |
| HY-N0047 | Polyphyllin I | 50773-41-6 | Natural Products |
| HY-N0047R | Polyphyllin I (Standard) | 50773-41-6 | Reference Standards |
| HY-N0048 | Polyphyllin II | 76296-72-5 | Natural Products |
| HY-N0049 | Nuciferine | 475-83-2 | Natural Products |
| HY-N0049R | Nuciferine (Standard) | 475-83-2 | Reference Standards |
| HY-N0050 | Allomatrine | 641-39-4 | Natural Products |
| HY-N0052 | Sanguinarine | 2447-54-3 | Natural Products |
| HY-N0052A | Sanguinarine (chloride) | 5578-73-4 | Natural Products |
| HY-N0052AR | Sanguinarine (chloride) (Standard) | 5578-73-4 | Reference Standards |
| HY-N0052C | Sanguinarine (gluconate) | 132210-34-5 | Natural Products |
| HY-N0053 | Psoralen | 66-97-7 | Natural Products |
| HY-N0053R | Psoralen (Standard) | 66-97-7 | Reference Standards |
| HY-N0054 | Osthole | 484-12-8 | Natural Products |
| HY-N0054R | Osthole (Standard) | 484-12-8 | Reference Standards |
| HY-N0054S | Osthole-d3 | Isotope-Labeled Compounds | |
| HY-N0055 | Chlorogenic acid | 327-97-9 | Natural Products |
| HY-N0055R | Chlorogenic acid (Standard) | 327-97-9 | Reference Standards |
| HY-N0055S | Chlorogenic acid-13C3 | Isotope-Labeled Compounds | |
| HY-N0056 | Isochlorogenic acid A | 2450-53-5 | Natural Products |
| HY-N0056R | Isochlorogenic acid A (Standard) | 2450-53-5 | Reference Standards |
| HY-N0057 | 3,4-Dicaffeoylquinic acid | 14534-61-3 | Natural Products |
| HY-N0057R | 3,4-Dicaffeoylquinic acid (Standard) | 14534-61-3 | Reference Standards |
| HY-N0058 | 4,5-Dicaffeoylquinic acid | 57378-72-0 | Natural Products |
| HY-N0058R | 4,5-Dicaffeoylquinic acid (Standard) | 57378-72-0 | Reference Standards |
| HY-N0059 | D-arabinose | 10323-20-3 | Natural Products |
| HY-N0059A | L-(+)-Lyxose | 1949-78-6 | Biochemical Assay Reagents |
| HY-N0059AS | L-(+)-Lyxose-13C | Isotope-Labeled Compounds | |
| HY-N0059AS1 | L-(+)-Lyxose-13C-1 | Isotope-Labeled Compounds | |
| HY-N0059R | D-arabinose (Standard) | 10323-20-3 | Reference Standards |
| HY-N0059S | D-Arabinose-13C | Isotope-Labeled Compounds | |
| HY-N0059S1 | D-Arabinose-13C-1 | 139657-60-6 | Isotope-Labeled Compounds |
| HY-N0059S2 | D-arabinose-13C-2 | Isotope-Labeled Compounds | |
| HY-N0059S3 | D-Arabinose-13C-3 | 101615-87-6 | Isotope-Labeled Compounds |
| HY-N0059S4 | D-Arabinose-d2 | 2419933-20-1 | Isotope-Labeled Compounds |
| HY-N0059S5 | D-Arabinose-d5 | Isotope-Labeled Compounds | |
| HY-N0059S6 | D-Arabinose-d6 | Isotope-Labeled Compounds | |
| HY-N0060 | Ferulic acid | 1135-24-6 | Natural Products |
| HY-N0060A | Ferulic acid (sodium) | 24276-84-4 | Natural Products |
| HY-N0060AR | Ferulic acid (sodium) (Standard) | 24276-84-4 | Reference Standards |
| HY-N0060B | (E)-Ferulic acid | 537-98-4 | Natural Products |
| HY-N0060BR | (E)-Ferulic acid (Standard) | 537-98-4 | Reference Standards |
| HY-N0060BS | (E)-Ferulic acid-d3 | 860605-59-0 | Isotope-Labeled Compounds |
| HY-N0060R | Ferulic acid (Standard) | 1135-24-6 | Reference Standards |
| HY-N0060S1 | Ferulic acid-13C3 | 1261170-81-3 | Isotope-Labeled Compounds |
| HY-N0061 | Ethyl ferulate | 4046-02-0 | Natural Products |
| HY-N0062 | Angoroside C | 115909-22-3 | Natural Products |
| HY-N0062R | Angoroside C (Standard) | 115909-22-3 | Reference Standards |
| HY-N0063 | Punicalagin | 65995-63-3 | Natural Products |
| HY-N0063R | Punicalagin (Standard) | 65995-63-3 | Reference Standards |
| HY-N0064 | Macelignan | 107534-93-0 | Natural Products |
| HY-N0064R | Macelignan (Standard) | 107534-93-0 | Reference Standards |
| HY-N0065 | Eudesmol | 51317-08-9 | Natural Products |
| HY-N0067 | γ-Aminobutyric acid | 56-12-2 | Natural Products |
| HY-N0067R | γ-Aminobutyric acid (Standard) | 56-12-2 | Reference Standards |
| HY-N0067S | γ-Aminobutyric acid-d6 | 70607-85-1 | Isotope-Labeled Compounds |
| HY-N0067S1 | γ-Aminobutyric acid-d2 | 67910-98-9 | Isotope-Labeled Compounds |
| HY-N0067S2 | γ-Aminobutyric acid-4,4-d2 | 107022-06-0 | Isotope-Labeled Compounds |
| HY-N0067S3 | γ-Aminobutyric acid-13C4 | Isotope-Labeled Compounds | |
| HY-N0068 | Solasodine | 126-17-0 | Natural Products |
| HY-N0068R | Solasodine (Standard) | 126-17-0 | Reference Standards |
| HY-N0069 | Solamargine | 20311-51-7 | Natural Products |
| HY-N0069R | Solamargine (Standard) | 20311-51-7 | Reference Standards |
| HY-N0070 | Solasonine | 19121-58-5 | Natural Products |
| HY-N0070R | Solasonine (Standard) | 19121-58-5 | Reference Standards |
| HY-N0071 | Crotonoside | 1818-71-9 | Natural Products |
| HY-N0072 | Brazilin | 474-07-7 | Natural Products |
| HY-N0072R | Brazilin (Standard) | 474-07-7 | Reference Standards |
| HY-N0073 | Sarsasapogenin | 126-19-2 | Natural Products |
| HY-N0073A | Spirostan-3-ol | 82597-74-8 | Natural Products |
| HY-N0073R | Sarsasapogenin (Standard) | 126-19-2 | Reference Standards |
| HY-N0074 | Byakangelicol | 26091-79-2 | Natural Products |
| HY-N0075 | (Rac)-Byakangelicin | 19573-01-4 | Natural Products |
| HY-N0075R | (Rac)-Byakangelicin (Standard) | 19573-01-4 | Reference Standards |
| HY-N0076 | Bilobalide | 33570-04-6 | Natural Products |
| HY-N0076R | Bilobalide (Standard) | 33570-04-6 | Reference Standards |
| HY-N0077 | Ginkgolic Acid | 22910-60-7 | Natural Products |
| HY-N0077R | Ginkgolic Acid (Standard) | 22910-60-7 | Reference Standards |
| HY-N0078 | Ginkgolic Acid (C13:0) | 20261-38-5 | Natural Products |
| HY-N0078R | Ginkgolic Acid (C13:0) (Standard) | 20261-38-5 | Reference Standards |
| HY-N0079 | Praeruptorin C | 72463-77-5 | Natural Products |
| HY-N0080 | Ulopterol | 28095-18-3 | Natural Products |
| HY-N0081 | (±)-Praeruptorin A | 73069-25-7 | Natural Products |
| HY-N0081A | (-)-Praeruptorin A | 14017-71-1 | Natural Products |
| HY-N0081R | (±)-Praeruptorin A (Standard) | 73069-25-7 | Reference Standards |
| HY-N0082 | Praeruptorin B | 73069-28-0 | Natural Products |
| HY-N0082R | Praeruptorin B (Standard) | 73069-28-0 | Reference Standards |
| HY-N0083 | Betulin | 473-98-3 | Natural Products |
| HY-N0083R | Betulin (Standard) | 473-98-3 | Reference Standards |
| HY-N0083S | Betulin-d3 | Isotope-Labeled Compounds | |
| HY-N0084 | Betulinaldehyde | 13159-28-9 | Natural Products |
| HY-N0085 | Dimethylfraxetin | 6035-49-0 | Natural Products |
| HY-N0086 | N6-Methyladenosine | 1867-73-8 | Natural Products |
| HY-N0086R | N6-Methyladenosine (Standard) | 1867-73-8 | Reference Standards |
| HY-N0086S | N6-Methyladenosine-d3 | 139896-43-8 | Isotope-Labeled Compounds |
| HY-N0086S1 | N6-Methyladenosine-13C | 2232870-66-3 | Isotope-Labeled Compounds |
| HY-N0086S2 | N6-Methyladenosine-13C4 | Isotope-Labeled Compounds | |
| HY-N0086S3 | N6-Methyladenosine-13C3 | Isotope-Labeled Compounds | |
| HY-N0087 | Gambogic Acid | 2752-65-0 | Natural Products |
| HY-N0087R | Gambogic Acid (Standard) | 2752-65-0 | Reference Standards |
| HY-N0088 | Apocynin | 498-02-2 | Natural Products |
| HY-N0088R | Apocynin (Standard) | 498-02-2 | Reference Standards |
| HY-N0088S | Apocynin-d3 | 80404-23-5 | Isotope-Labeled Compounds |
| HY-N0089 | Schisandrin B | 61281-37-6 | Natural Products |
| HY-N0089R | Schisandrin B (Standard) | 61281-37-6 | Reference Standards |
| HY-N0090S | Guanosine-1'-13C Monohydrate | 478511-32-9 | Isotope-Labeled Compounds |
| HY-N0090S1 | Guanosine-d2 (hydrate) | 478511-34-1 | Isotope-Labeled Compounds |
| HY-N0090S2 | Guanosine-d1 (hydrate) | Isotope-Labeled Compounds | |
| HY-N0090S3 | Guanosine-13C10,15N5 (hydrate) | 2483830-53-9 | Isotope-Labeled Compounds |
| HY-N0091 | Hypoxanthine | 68-94-0 | Natural Products |
| HY-N0091R | Hypoxanthine (Standard) | 68-94-0 | Reference Standards |
| HY-N0091S | Hypoxanthine-13C5,15N4 | 1987883-25-9 | Isotope-Labeled Compounds |
| HY-N0091S1 | Hypoxanthine-13C,15N2 | 244769-71-9 | Isotope-Labeled Compounds |
| HY-N0091S2 | Hypoxanthine-13C5 | 2086337-18-8 | Isotope-Labeled Compounds |
| HY-N0091S3 | Hypoxanthine-13C2,15N | 1330265-04-7 | Isotope-Labeled Compounds |
| HY-N0091S4 | Hypoxanthine-13C2,15N-1 | 1246820-04-1 | Isotope-Labeled Compounds |
| HY-N0091S5 | Hypoxanthine-d4 | 2483831-32-7 | Isotope-Labeled Compounds |
| HY-N0091S6 | Hypoxanthine-d2 | 697807-02-6 | Isotope-Labeled Compounds |
| HY-N0091S7 | Hypoxanthine-15N4 | 77910-30-6 | Isotope-Labeled Compounds |
| HY-N0092 | Inosine | 58-63-9 | Natural Products |
| HY-N0092R | Inosine (Standard) | 58-63-9 | Reference Standards |
| HY-N0092S | Inosine-2,8-d2 | 697807-01-5 | Isotope-Labeled Compounds |
| HY-N0092S1 | Inosine-13C | Isotope-Labeled Compounds | |
| HY-N0092S2 | Inosine-13C5 | Isotope-Labeled Compounds | |
| HY-N0092S3 | Inosine-13C10,15N4 | Isotope-Labeled Compounds | |
| HY-N0092S4 | Inosine-13C3 | Isotope-Labeled Compounds | |
| HY-N0093 | Ancitabine (hydrochloride) | 10212-25-6 | Reference compound |
| HY-N0093A | Ancitabine | 31698-14-3 | Reference compound |
| HY-N0093R | Ancitabine (hydrochloride) (Standard) | 10212-25-6 | Reference Standards |
| HY-N0094 | Ipriflavone | 35212-22-7 | Reference compound |
| HY-N0094R | Ipriflavone (Standard) | 35212-22-7 | Reference Standards |
| HY-N0095 | (S)-10-Hydroxycamptothecin | 19685-09-7 | Natural Products |
| HY-N0095R | (S)-10-Hydroxycamptothecin (Standard) | 19685-09-7 | Reference Standards |
| HY-N0096 | Rotundine | 483-14-7 | Natural Products |
| HY-N0097 | Guanosine | 118-00-3 | Natural Products |
| HY-N0097A | 9-β-D-Arabinofuranosylguanine | 38819-10-2 | Reference compound |
| HY-N0097R | Guanosine (Standard) | 118-00-3 | Reference Standards |
| HY-N0097S1 | Guanosine-8-d-1 | Isotope-Labeled Compounds | |
| HY-N0097S3 | Guanosine-15N5 | Isotope-Labeled Compounds | |
| HY-N0097S4 | Guanosine-13C10 | Isotope-Labeled Compounds | |
| HY-N0097S5 | Guanosine-d13 | Isotope-Labeled Compounds | |
| HY-N0097S6 | Guanosine-13C10,15N5 | 202406-81-3 | Isotope-Labeled Compounds |
| HY-N0098 | Vanillin | 121-33-5 | Natural Products |
| HY-N0098R | Vanillin (Standard) | 121-33-5 | Reference Standards |
| HY-N0098S | Vanillin-13C,d3 | 1794789-90-4 | Isotope-Labeled Compounds |
| HY-N0098S1 | 4-Hydroxy-3-methoxy benzaldehyde-d3 | 74495-74-2 | Isotope-Labeled Compounds |
| HY-N0098S2 | Vanillin-13C6 | 201595-58-6 | Isotope-Labeled Compounds |
| HY-N0098S3 | Vanillin-13C | 86884-84-6 | Isotope-Labeled Compounds |
| HY-N0100 | Naringenin | 480-41-1 | Natural Products |
| HY-N0100S | Naringenin-d4 | 1192260-78-8 | Isotope-Labeled Compounds |
| HY-N0101 | Neohesperidin | 13241-33-3 | Natural Products |
| HY-N0101R | Neohesperidin (Standard) | 13241-33-3 | Reference Standards |
| HY-N0102 | Isoliquiritigenin | 961-29-5 | Natural Products |
| HY-N0102R | Isoliquiritigenin (Standard) | 961-29-5 | Reference Standards |
| HY-N0103 | Sophocarpine | 6483-15-4 | Natural Products |
| HY-N0103A | Sophocarpine (monohydrate) | 145572-44-7 | Natural Products |
| HY-N0103R | Sophocarpine (Standard) | 6483-15-4 | Reference Standards |
| HY-N0104 | Curcumol | 4871-97-0 | Natural Products |
| HY-N0104R | Curcumol (Standard) | 4871-97-0 | Reference Standards |
| HY-N0105 | Rhein | 478-43-3 | Natural Products |
| HY-N0105R | Rhein (Standard) | 478-43-3 | Reference Standards |
| HY-N0105S2 | Rhein-13C4 | 1189928-10-6 | Isotope-Labeled Compounds |
| HY-N0106 | (Rac)-Salvianic acid A (sodium) | 67920-52-9 | Natural Products |
| HY-N0106R | (Rac)-Salvianic acid A (sodium) (Standard) | 67920-52-9 | Reference Standards |
| HY-N0107 | Cyclovirobuxine D | 860-79-7 | Natural Products |
| HY-N0107R | Cyclovirobuxine D (Standard) | 860-79-7 | Reference Standards |
| HY-N0108 | Physcion | 521-61-9 | Natural Products |
| HY-N0108R | Physcion (Standard) | 521-61-9 | Reference Standards |
| HY-N0108S | Physcion-d3 | 1215751-27-1 | Isotope-Labeled Compounds |
| HY-N0109 | Salidroside | 10338-51-9 | Natural Products |
| HY-N0109R | Salidroside (Standard) | 10338-51-9 | Reference Standards |
| HY-N0110 | Palmatine (chloride) | 10605-02-4 | Natural Products |
| HY-N0110A | Palmatine | 3486-67-7 | Natural Products |
| HY-N0110B | Palmatine (hydroxide) | 131-04-4 | Natural Products |
| HY-N0110R | Palmatine (chloride) (Standard) | 10605-02-4 | Reference Standards |
| HY-N0111 | Coenzyme Q10 | 303-98-0 | Natural Products |
| HY-N0111R | Coenzyme Q10 (Standard) | 303-98-0 | Reference Standards |
| HY-N0111S | Coenzyme Q10-d6 | 110971-02-3 | Isotope-Labeled Compounds |
| HY-N0111S2 | Coenzyme Q10-d9 | 2687960-97-8 | Isotope-Labeled Compounds |
| HY-N0112 | Dihydromyricetin | 27200-12-0 | Natural Products |
| HY-N0112R | Dihydromyricetin (Standard) | 27200-12-0 | Reference Standards |
| HY-N0112S | Dihydromyricetin-d4 | Isotope-Labeled Compounds | |
| HY-N0113 | Hordenine | 539-15-1 | Natural Products |
| HY-N0113A | Hordenine (sulfate) | 62493-39-4 | Natural Products |
| HY-N0113B | Hordenine (hydrochloride) | 6027-23-2 | Natural Products |
| HY-N0113BR | Hordenine (hydrochloride) (Standard) | 6027-23-2 | Reference Standards |
| HY-N0113BS | Hordenine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0113R | Hordenine (Standard) | 539-15-1 | Reference Standards |
| HY-N0113S | Hordenine-d6 | 1346598-66-0 | Isotope-Labeled Compounds |
| HY-N0114 | Evodiamine | 518-17-2 | Natural Products |
| HY-N0114A | (±)-Evodiamine | 518-18-3 | Natural Products |
| HY-N0114R | Evodiamine (Standard) | 518-17-2 | Reference Standards |
| HY-N0115 | Gastrodin | 62499-27-8 | Natural Products |
| HY-N0115R | Gastrodin (Standard) | 62499-27-8 | Reference Standards |
| HY-N0116 | Hematoxylin | 517-28-2 | Dye Reagents |
| HY-N0117 | Indirubin | 479-41-4 | Natural Products |
| HY-N0117A | (Z)-Indirubin | 906748-38-7 | Reference compound |
| HY-N0117AS | (Z)-Indirubin-d4 | Isotope-Labeled Compounds | |
| HY-N0117AS1 | (Z)-Indirubin-d8 | Isotope-Labeled Compounds | |
| HY-N0117R | Indirubin (Standard) | 479-41-4 | Reference Standards |
| HY-N0119 | Naringin Dihydrochalcone | 18916-17-1 | Natural Products |
| HY-N0119R | Naringin Dihydrochalcone (Standard) | 18916-17-1 | Reference Standards |
| HY-N0120 | (E/Z)-Polydatin | 65914-17-2 | Natural Products |
| HY-N0120A | Polydatin | 27208-80-6 | Natural Products |
| HY-N0120AR | Polydatin (Standard) | 27208-80-6 | Reference Standards |
| HY-N0121 | Sesamin | 607-80-7 | Natural Products |
| HY-N0121A | (-)-Sesamin | 13079-95-3 | Natural Products |
| HY-N0121R | Sesamin (Standard) | 607-80-7 | Reference Standards |
| HY-N0121S | Sesamin-d8 | 3047060-14-7 | Isotope-Labeled Compounds |
| HY-N0122 | 5-Hydroxytryptophan | 56-69-9 | Natural Products |
| HY-N0123 | Aloin-A | 1415-73-2 | Natural Products |
| HY-N0123R | Aloin-A (Standard) | 1415-73-2 | Reference Standards |
| HY-N0124 | Dioscin | 19057-60-4 | Natural Products |
| HY-N0124R | Dioscin (Standard) | 19057-60-4 | Reference Standards |
| HY-N0125 | Diosmetin | 520-34-3 | Natural Products |
| HY-N0125R | Diosmetin (Standard) | 520-34-3 | Reference Standards |
| HY-N0125S | Diosmetin-d3 | 1189728-54-8 | Isotope-Labeled Compounds |
| HY-N0126 | Xanthone | 90-47-1 | Natural Products |
| HY-N0126R | Xanthone (Standard) | 90-47-1 | Reference Standards |
| HY-N0127 | Yohimbine (Hydrochloride) | 65-19-0 | Natural Products |
| HY-N0127R | Yohimbine (Hydrochloride) (Standard) | 65-19-0 | Reference Standards |
| HY-N0128 | Sclareol | 515-03-7 | Natural Products |
| HY-N0128R | Sclareol (Standard) | 515-03-7 | Reference Standards |
| HY-N0129 | Sclareolide | 564-20-5 | Natural Products |
| HY-N0129R | Sclareolide (Standard) | 564-20-5 | Reference Standards |
| HY-N0130 | Shikimic acid | 138-59-0 | Natural Products |
| HY-N0130R | Shikimic acid (Standard) | 138-59-0 | Reference Standards |
| HY-N0131 | Stigmasterol | 83-48-7 | Natural Products |
| HY-N0131R | Stigmasterol (Standard) | 83-48-7 | Reference Standards |
| HY-N0131S1 | Stigmasterol-d5-1 | 2260669-29-0 | Isotope-Labeled Compounds |
| HY-N0132 | Synephrine | 94-07-5 | Natural Products |
| HY-N0132A | Synephrine (hydrochloride) | 5985-28-4 | Natural Products |
| HY-N0132AR | Synephrine (hydrochloride) (Standard) | 5985-28-4 | Reference Standards |
| HY-N0132B | Synephrine (hemitartrate) | 16589-24-5 | Natural Products |
| HY-N0132R | Synephrine (Standard) | 94-07-5 | Reference Standards |
| HY-N0133 | Tangeretin | 481-53-8 | Natural Products |
| HY-N0133R | Tangeretin (Standard) | 481-53-8 | Reference Standards |
| HY-N0134 | Tanshinone I | 568-73-0 | Natural Products |
| HY-N0134R | Tanshinone I (Standard) | 568-73-0 | Reference Standards |
| HY-N0135 | Tanshinone IIA | 568-72-9 | Natural Products |
| HY-N0135R | Tanshinone IIA (Standard) | 568-72-9 | Reference Standards |
| HY-N0136 | Taxifolin | 480-18-2 | Natural Products |
| HY-N0136A | (±)-Taxifolin | 24198-97-8 | Natural Products |
| HY-N0136B | (-)-Taxifolin | 111003-33-9 | Natural Products |
| HY-N0136R | Taxifolin (Standard) | 480-18-2 | Reference Standards |
| HY-N0136S | Taxifolin-d3 | Isotope-Labeled Compounds | |
| HY-N0136S1 | (±)-Taxifolin-13C3 | Isotope-Labeled Compounds | |
| HY-N0137 | Tetrahydropapaverine (hydrochloride) | 6429-04-5 | Reference compound |
| HY-N0137A | (R)-Tetrahydropapaverine (hydrochloride) | 54417-53-7 | Reference compound |
| HY-N0138 | Theobromine | 83-67-0 | Natural Products |
| HY-N0138R | Theobromine (Standard) | 83-67-0 | Reference Standards |
| HY-N0138S | Theobromine-d6 | 117490-40-1 | Isotope-Labeled Compounds |
| HY-N0138S1 | Theobromine-d3 | 65566-69-0 | Isotope-Labeled Compounds |
| HY-N0139 | Troxerutin | 7085-55-4 | Natural Products |
| HY-N0139R | Troxerutin (Standard) | 7085-55-4 | Reference Standards |
| HY-N0140 | Ursolic acid | 77-52-1 | Natural Products |
| HY-N0140R | Ursolic acid (Standard) | 77-52-1 | Reference Standards |
| HY-N0141 | Parthenolide | 20554-84-1 | Natural Products |
| HY-N0141R | Parthenolide (Standard) | 20554-84-1 | Reference Standards |
| HY-N0142 | Phloretin | 60-82-2 | Natural Products |
| HY-N0142R | Phloretin (Standard) | 60-82-2 | Reference Standards |
| HY-N0143 | Phlorizin | 60-81-1 | Natural Products |
| HY-N0143A | Phlorizin (dihydrate) | 7061-54-3 | Biochemical Assay Reagents |
| HY-N0143R | Phlorizin (Standard) | 60-81-1 | Reference Standards |
| HY-N0144 | Piperine | 94-62-2 | Natural Products |
| HY-N0144B | Isochavicine | 30511-77-4 | Natural Products |
| HY-N0144R | Piperine (Standard) | 94-62-2 | Reference Standards |
| HY-N0145 | Puerarin | 3681-99-0 | Natural Products |
| HY-N0145R | Puerarin (Standard) | 3681-99-0 | Reference Standards |
| HY-N0146 | Quercetin (dihydrate) | 6151-25-3 | Natural Products |
| HY-N0146R | Quercetin (dihydrate) (Standard) | 6151-25-3 | Reference Standards |
| HY-N0147 | Rutaecarpine | 84-26-4 | Natural Products |
| HY-N0147R | Rutaecarpine (Standard) | 84-26-4 | Reference Standards |
| HY-N0148 | Rutin | 153-18-4 | Natural Products |
| HY-N0148A | Rutin (hydrate) | 207671-50-9 | Natural Products |
| HY-N0148R | Rutin (Standard) | 153-18-4 | Reference Standards |
| HY-N0149 | Salicin | 138-52-3 | Natural Products |
| HY-N0149R | Salicin (Standard) | 138-52-3 | Reference Standards |
| HY-N0150 | Monensin (sodium) | 22373-78-0 | Natural Products |
| HY-N0150R | Monensin (sodium) (Standard) | 22373-78-0 | Reference Standards |
| HY-N0151 | Morin (monohydrate) | 6202-27-3 | Natural Products |
| HY-N0152 | Myricitrin | 17912-87-7 | Natural Products |
| HY-N0152R | Myricitrin (Standard) | 17912-87-7 | Reference Standards |
| HY-N0153 | Naringin | 10236-47-2 | Natural Products |
| HY-N0153A | Naringin (hydrate) | 132203-74-8 | Natural Products |
| HY-N0153R | Naringin (Standard) | 10236-47-2 | Reference Standards |
| HY-N0154 | Neohesperidin dihydrochalcone | 20702-77-6 | Natural Products |
| HY-N0154R | Neohesperidin dihydrochalcone (Standard) | 20702-77-6 | Reference Standards |
| HY-N0155 | Nobiletin | 478-01-3 | Natural Products |
| HY-N0155R | Nobiletin (Standard) | 478-01-3 | Reference Standards |
| HY-N0156 | Oleanolic acid | 508-02-1 | Natural Products |
| HY-N0156R | Oleanolic acid (Standard) | 508-02-1 | Reference Standards |
| HY-N0156S | Oleanolic acid-d3 | 946530-77-4 | Isotope-Labeled Compounds |
| HY-N0157 | Orotic acid | 65-86-1 | Natural Products |
| HY-N0157A | Orotic acid (zinc) | 68399-76-8 | Natural Products |
| HY-N0157C | Orotic acid (potassium) | 24598-73-0 | Biochemical Assay Reagents |
| HY-N0157R | Orotic acid (Standard) | 65-86-1 | Reference Standards |
| HY-N0157S1 | Orotic acid-13C,15N2 (monohydrate) | 1346602-15-0 | Isotope-Labeled Compounds |
| HY-N0158 | Oxymatrine | 16837-52-8 | Natural Products |
| HY-N0158R | Oxymatrine (Standard) | 16837-52-8 | Reference Standards |
| HY-N0159 | Paeonol | 552-41-0 | Natural Products |
| HY-N0159R | Paeonol (Standard) | 552-41-0 | Reference Standards |
| HY-N0159S | Paeonol-d3 | 55712-78-2 | Isotope-Labeled Compounds |
| HY-N0160 | Kinetin | 525-79-1 | Natural Products |
| HY-N0160R | Kinetin (Standard) | 525-79-1 | Reference Standards |
| HY-N0162 | Luteolin | 491-70-3 | Natural Products |
| HY-N0162R | Luteolin (Standard) | 491-70-3 | Reference Standards |
| HY-N0163 | Magnolol | 528-43-8 | Natural Products |
| HY-N0163R | Magnolol (Standard) | 528-43-8 | Reference Standards |
| HY-N0164 | Matrine | 519-02-8 | Natural Products |
| HY-N0164R | Matrine (Standard) | 519-02-8 | Reference Standards |
| HY-N0165 | Methyl-Hesperidin | 11013-97-1 | Natural Products |
| HY-N0165R | Methyl-Hesperidin (Standard) | 11013-97-1 | Reference Standards |
| HY-N0166 | Gramine | 87-52-5 | Natural Products |
| HY-N0166R | Gramine (Standard) | 87-52-5 | Reference Standards |
| HY-N0167 | Gynostemma Extract | 80321-63-7 | Natural Products |
| HY-N0168 | Hesperetin | 520-33-2 | Natural Products |
| HY-N0168A | (Rac)-Hesperetin | 69097-99-0 | Natural Products |
| HY-N0168AR | (Rac)-Hesperetin (Standard) | 69097-99-0 | Reference Standards |
| HY-N0168AS | (Rac)-Hesperetin-d3 | 1346605-26-2 | Isotope-Labeled Compounds |
| HY-N0168AS1 | (Rac)-Hesperetin-13C,d3 | 2750534-85-9 | Isotope-Labeled Compounds |
| HY-N0168S | Hesperetin-d3 | Isotope-Labeled Compounds | |
| HY-N0169 | Hyodeoxycholic acid | 83-49-8 | Natural Products |
| HY-N0169A | Hyodeoxycholic acid (sodium) | 10421-49-5 | Biochemical Assay Reagents |
| HY-N0169B | Murideoxycholic acid | 668-49-5 | Natural Products |
| HY-N0169R | Hyodeoxycholic acid (Standard) | 83-49-8 | Reference Standards |
| HY-N0169S | Hyodeoxycholic acid-d5 | Isotope-Labeled Compounds | |
| HY-N0170 | Indole-3-carbinol | 700-06-1 | Natural Products |
| HY-N0171 | Beta-Sitosterol (purity>80%) | 83-46-5 | Natural Products |
| HY-N0171A | Beta-Sitosterol (purity>98%) | 83-46-5 | Natural Products |
| HY-N0171AR | Beta-Sitosterol (purity>98%) (Standard) | 83-46-5 | Reference Standards |
| HY-N0171B | Beta-Sitosterol (purity>75%) | 83-46-5 | Natural Products |
| HY-N0171R | Beta-Sitosterol (Standard) | 83-46-5 | Reference Standards |
| HY-N0172 | Caffeic acid | 331-39-5 | Natural Products |
| HY-N0172R | Caffeic acid (Standard) | 331-39-5 | Reference Standards |
| HY-N0172S | Caffeic acid-13C3 | 1185245-82-2 | Isotope-Labeled Compounds |
| HY-N0173 | Cinchonidine | 485-71-2 | Natural Products |
| HY-N0173R | Cinchonidine (Standard) | 485-71-2 | Reference Standards |
| HY-N0174 | Cryptotanshinone | 35825-57-1 | Natural Products |
| HY-N0174R | Cryptotanshinone (Standard) | 35825-57-1 | Reference Standards |
| HY-N0175 | Cytisinicline | 485-35-8 | Natural Products |
| HY-N0175R | Cytisinicline (Standard) | 485-35-8 | Reference Standards |
| HY-N0176 | Dihydroartemisinin | 71939-50-9 | Natural Products |
| HY-N0176A | α-Dihydroartemisinin | 81496-81-3 | Natural Products |
| HY-N0176R | Dihydroartemisinin (Standard) | 71939-50-9 | Reference Standards |
| HY-N0176S | Dihydroartemisinin-d3 | 176774-98-4 | Isotope-Labeled Compounds |
| HY-N0176S3 | Dihydroartemisinin-d5 | Isotope-Labeled Compounds | |
| HY-N0177 | Diosgenin | 512-04-9 | Natural Products |
| HY-N0177R | Diosgenin (Standard) | 512-04-9 | Reference Standards |
| HY-N0178 | Diosmin | 520-27-4 | Natural Products |
| HY-N0178R | Diosmin (Standard) | 520-27-4 | Reference Standards |
| HY-N0179 | Ecdysone | 3604-87-3 | Natural Products |
| HY-N0180 | 18β-Glycyrrhetinic acid | 471-53-4 | Natural Products |
| HY-N0180R | 18β-Glycyrrhetinic acid (Standard) | 471-53-4 | Reference Standards |
| HY-N0180S | 18β-Glycyrrhetinic acid-d3 | Isotope-Labeled Compounds | |
| HY-N0181 | Ergosterol | 57-87-4 | Natural Products |
| HY-N0181A | Lumisterol | 474-69-1 | Natural Products |
| HY-N0181R | Ergosterol (Standard) | 57-87-4 | Reference Standards |
| HY-N0182 | Fisetin | 528-48-3 | Natural Products |
| HY-N0182A | Fisetin (quarterhydrate) | Natural Products | |
| HY-N0182R | Fisetin (Standard) | 528-48-3 | Reference Standards |
| HY-N0182S3 | Fisetin-d5 | 2909407-29-8 | Isotope-Labeled Compounds |
| HY-N0183 | Formononetin | 485-72-3 | Natural Products |
| HY-N0183R | Formononetin (Standard) | 485-72-3 | Reference Standards |
| HY-N0183S4 | Formononetin-d3-1 | Isotope-Labeled Compounds | |
| HY-N0184 | Glycyrrhizic acid | 1405-86-3 | Natural Products |
| HY-N0184A | Dipotassium glycyrrhizinate | 68797-35-3 | Natural Products |
| HY-N0184AR | Dipotassium glycyrrhizinate (Standard) | 68797-35-3 | Reference Standards |
| HY-N0184R | Glycyrrhizic acid (Standard) | 1405-86-3 | Reference Standards |
| HY-N0186 | Indole-3-butyric acid | 133-32-4 | Biochemical Assay Reagents |
| HY-N0186A | Indole-3-butyric acid (potassium) | 60096-23-3 | Reference compound |
| HY-N0186R | Indole-3-butyric acid (Standard) | 133-32-4 | Reference Standards |
| HY-N0187 | 4-Methylumbelliferone | 90-33-5 | Natural Products |
| HY-N0187R | 4-Methylumbelliferone (Standard) | 90-33-5 | Reference Standards |
| HY-N0188 | Esculin | 531-75-9 | Natural Products |
| HY-N0188R | Esculin (Standard) | 531-75-9 | Reference Standards |
| HY-N0189 | Aloe emodin | 481-72-1 | Natural Products |
| HY-N0189R | Aloe emodin (Standard) | 481-72-1 | Reference Standards |
| HY-N0190 | Amygdalin | 29883-15-6 | Natural Products |
| HY-N0190R | Amygdalin (Standard) | 29883-15-6 | Reference Standards |
| HY-N0191 | Andrographolide | 5508-58-7 | Natural Products |
| HY-N0191A | 14-epi-Andrographolide | 142037-79-4 | Natural Products |
| HY-N0191R | Andrographolide (Standard) | 5508-58-7 | Reference Standards |
| HY-N0192 | Arbutin | 497-76-7 | Natural Products |
| HY-N0192R | Arbutin (Standard) | 497-76-7 | Reference Standards |
| HY-N0192S | Arbutin-d4 | Isotope-Labeled Compounds | |
| HY-N0193 | Artesunate | 88495-63-0 | Natural Products |
| HY-N0193R | Artesunate (Standard) | 88495-63-0 | Reference Standards |
| HY-N0193S | Artesunate-d3 | 1316303-44-2 | Isotope-Labeled Compounds |
| HY-N0193S1 | Artesunate-d4 | 1316753-15-7 | Isotope-Labeled Compounds |
| HY-N0194 | Asiatic acid | 464-92-6 | Natural Products |
| HY-N0194R | Asiatic acid (Standard) | 464-92-6 | Reference Standards |
| HY-N0195 | Azomycin | 527-73-1 | Natural Products |
| HY-N0195R | Azomycin (Standard) | 527-73-1 | Reference Standards |
| HY-N0196 | Baicalein | 491-67-8 | Natural Products |
| HY-N0196A | Baicalein (hydrate) | 352000-07-8 | Natural Products |
| HY-N0196R | Baicalein (Standard) | 491-67-8 | Reference Standards |
| HY-N0197 | Baicalin | 21967-41-9 | Natural Products |
| HY-N0197R | Baicalin (Standard) | 21967-41-9 | Reference Standards |
| HY-N0198 | Nordihydroguaiaretic acid | 500-38-9 | Natural Products |
| HY-N0198R | Nordihydroguaiaretic acid (Standard) | 500-38-9 | Reference Standards |
| HY-N0199 | Albaspidin AA | 3570-40-9 | Natural Products |
| HY-N0201 | Atractylenolide I | 73069-13-3 | Natural Products |
| HY-N0201R | Atractylenolide I (Standard) | 73069-13-3 | Reference Standards |
| HY-N0202 | Atractylenolide II | 73069-14-4 | Natural Products |
| HY-N0202R | Atractylenolide II (Standard) | 73069-14-4 | Reference Standards |
| HY-N0203 | Atractylenolide III | 73030-71-4 | Natural Products |
| HY-N0203R | Atractylenolide III (Standard) | 73030-71-4 | Reference Standards |
| HY-N0204 | Pulchinenoside A | 129724-84-1 | Natural Products |
| HY-N0205 | Pulchinenoside C | 129741-57-7 | Natural Products |
| HY-N0205R | Pulchinenoside C (Standard) | 129741-57-7 | Reference Standards |
| HY-N0206 | Ardisiacrispin A | 23643-61-0 | Natural Products |
| HY-N0207 | Patchouli alcohol | 5986-55-0 | Natural Products |
| HY-N0207R | Patchouli alcohol (Standard) | 5986-55-0 | Reference Standards |
| HY-N0208 | Kaempferol-3-O-glucorhamnoside | 40437-72-7 | Natural Products |
| HY-N0210 | D-Galactose | 59-23-4 | Natural Products |
| HY-N0210R | D-Galactose (Standard) | 59-23-4 | Reference Standards |
| HY-N0210S | D-Galactose-13C | 70849-30-8 | Isotope-Labeled Compounds |
| HY-N0210S1 | D-Galactose-13C-2 | 478518-56-8 | Isotope-Labeled Compounds |
| HY-N0210S11 | D-Galactose-d2-1 | 1176791-08-4 | Isotope-Labeled Compounds |
| HY-N0210S12 | D-Galactose-13C,d1 | 370565-96-1 | Isotope-Labeled Compounds |
| HY-N0210S16 | D-Galactose-13C6 | 74134-89-7 | Isotope-Labeled Compounds |
| HY-N0210S2 | D-Galactose-13C-3 | 478518-58-0 | Isotope-Labeled Compounds |
| HY-N0210S3 | D-Galactose-13C-4 | 478518-60-4 | Isotope-Labeled Compounds |
| HY-N0210S4 | D-Galactose-13C-5 | 478518-62-6 | Isotope-Labeled Compounds |
| HY-N0210S5 | D-Galactose-d1 | 64267-73-8 | Isotope-Labeled Compounds |
| HY-N0210S6 | D-Galactose-d1-1 | 64429-86-3 | Isotope-Labeled Compounds |
| HY-N0210S7 | D-Galactose-d1-2 | 478518-70-6 | Isotope-Labeled Compounds |
| HY-N0210S8 | D-Galactose-d1-3 | 478518-71-7 | Isotope-Labeled Compounds |
| HY-N0210S9 | D-Galactose-d2 | 35669-34-2 | Isotope-Labeled Compounds |
| HY-N0211 | Cyasterone | 17086-76-9 | Natural Products |
| HY-N0211R | Cyasterone (Standard) | 17086-76-9 | Reference Standards |
| HY-N0212 | Peimine | 23496-41-5 | Natural Products |
| HY-N0212R | Peimine (Standard) | 23496-41-5 | Reference Standards |
| HY-N0213 | Peiminine | 18059-10-4 | Natural Products |
| HY-N0213R | Peiminine (Standard) | 18059-10-4 | Reference Standards |
| HY-N0214 | Peimisine | 19773-24-1 | Natural Products |
| HY-N0214A | Peimisine (hydrochloride) | 900498-44-4 | Natural Products |
| HY-N0214R | Peimisine (Standard) | 19773-24-1 | Reference Standards |
| HY-N0215 | L-Phenylalanine | 63-91-2 | Natural Products |
| HY-N0215R | L-Phenylalanine (Standard) | 63-91-2 | Reference Standards |
| HY-N0215S | L-Phenylalanine-d7 | 69113-60-6 | Isotope-Labeled Compounds |
| HY-N0215S1 | L-Phenylalanine-d8 | 17942-32-4 | Isotope-Labeled Compounds |
| HY-N0215S10 | L-Phenylalanine-13C9 | 439685-11-7 | Isotope-Labeled Compounds |
| HY-N0215S11 | L-Phenylalanine-13C9,15N | 878339-23-2 | Isotope-Labeled Compounds |
| HY-N0215S12 | L-Phenylalanine-d5 | 56253-90-8 | Isotope-Labeled Compounds |
| HY-N0215S13 | L-Phenylalanine-d1 | 54793-54-3 | Isotope-Labeled Compounds |
| HY-N0215S14 | L-Phenylalanine-15N,d8 | Isotope-Labeled Compounds | |
| HY-N0215S2 | L-Phenylalanine-13C | 81201-86-7 | Isotope-Labeled Compounds |
| HY-N0215S3 | L-Phenylalanine-d2 | 221346-31-2 | Isotope-Labeled Compounds |
| HY-N0215S4 | DL-Phenylalanine-d5 | 284664-89-7 | Isotope-Labeled Compounds |
| HY-N0215S5 | L-Phenylalanine-15N | 29700-34-3 | Isotope-Labeled Compounds |
| HY-N0215S6 | DL-Phenylalanine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0215S7 | L-Phenylalanine-3-13C | 136056-02-5 | Isotope-Labeled Compounds |
| HY-N0215S8 | L-Phenylalanine-13C6 | 180268-82-0 | Isotope-Labeled Compounds |
| HY-N0215S9 | L-Phenylalanine-13C9,15N,d8 | 1994331-22-4 | Isotope-Labeled Compounds |
| HY-N0216 | Benzoic acid | 65-85-0 | Natural Products |
| HY-N0216A | Benzoic acid (lithium) | 553-54-8 | Reference compound |
| HY-N0216BS | Benzoic-3,5 Acid-d2 | 37960-84-2 | Isotope-Labeled Compounds |
| HY-N0216R | Benzoic acid (Standard) | 65-85-0 | Reference Standards |
| HY-N0216S | Benzoic acid-d5 | 1079-02-3 | Isotope-Labeled Compounds |
| HY-N0216S1 | Benzoic acid-13C6 | 125945-98-4 | Isotope-Labeled Compounds |
| HY-N0216S2 | Benzoic acid-13C | 3880-99-7 | Isotope-Labeled Compounds |
| HY-N0217 | Benzoylaconine | 466-24-0 | Natural Products |
| HY-N0218 | Benzoylmesaconine | 63238-67-5 | Natural Products |
| HY-N0219 | Bicuculline | 485-49-4 | Natural Products |
| HY-N0219R | Bicuculline (Standard) | 485-49-4 | Reference Standards |
| HY-N0220 | Dauricine | 524-17-4 | Natural Products |
| HY-N0220R | Dauricine (Standard) | 524-17-4 | Reference Standards |
| HY-N0221 | Daurisoline | 70553-76-3 | Natural Products |
| HY-N0221S | Daurisoline-d2 | Isotope-Labeled Compounds | |
| HY-N0221S1 | Daurisoline-d5 | Isotope-Labeled Compounds | |
| HY-N0221S2 | Daurisoline-d11 | Isotope-Labeled Compounds | |
| HY-N0222 | Avicularin | 572-30-5 | Natural Products |
| HY-N0222R | Avicularin (Standard) | 572-30-5 | Reference Standards |
| HY-N0223 | Epibetulinic acid | 38736-77-5 | Natural Products |
| HY-N0224 | Epigoitrin | 1072-93-1 | Natural Products |
| HY-N0224A | Goitrin | 500-12-9 | Natural Products |
| HY-N0225 | (-)-Epigallocatechin | 970-74-1 | Natural Products |
| HY-N0225R | (-)-Epigallocatechin (Standard) | 970-74-1 | Reference Standards |
| HY-N0226 | Epiberberine | 6873-09-2 | Natural Products |
| HY-N0226A | Epiberberine (chloride) | 889665-86-5 | Natural Products |
| HY-N0227 | 7-epi-Taxol | 105454-04-4 | Natural Products |
| HY-N0227R | 7-epi-Taxol (Standard) | 105454-04-4 | Reference Standards |
| HY-N0228 | Scoparone | 120-08-1 | Natural Products |
| HY-N0228R | Scoparone (Standard) | 120-08-1 | Reference Standards |
| HY-N0229 | L-Alanine | 56-41-7 | Natural Products |
| HY-N0229R | L-Alanine (Standard) | 56-41-7 | Reference Standards |
| HY-N0229S | L-Alanine-2-13C,15N | 285977-86-8 | Isotope-Labeled Compounds |
| HY-N0229S1 | L-Alanine-1-13C | 21764-56-7 | Isotope-Labeled Compounds |
| HY-N0229S10 | L-Alanine-13C3,15N | 202407-38-3 | Isotope-Labeled Compounds |
| HY-N0229S11 | L-Alanine-1-13C,15N | 141794-74-3 | Isotope-Labeled Compounds |
| HY-N0229S12 | L-Alanine-d3 | 63546-27-0 | Isotope-Labeled Compounds |
| HY-N0229S13 | L-Alanine-d7 | 74280-71-0 | Isotope-Labeled Compounds |
| HY-N0229S14 | L-Alanine-15N,d4 | Isotope-Labeled Compounds | |
| HY-N0229S15 | L-Alanine-13C2,15N | 312623-85-1 | Isotope-Labeled Compounds |
| HY-N0229S16 | L-Alanine-d3-1 | 19470-97-4 | Isotope-Labeled Compounds |
| HY-N0229S19 | L-Alanine-1,2-13C2 | 920314-10-9 | Isotope-Labeled Compounds |
| HY-N0229S2 | L-Alanine-15N | 25713-23-9 | Isotope-Labeled Compounds |
| HY-N0229S3 | L-Alanine-d4 | 18806-29-6 | Isotope-Labeled Compounds |
| HY-N0229S4 | L-Alanine-13C,d1 | 160033-81-8 | Isotope-Labeled Compounds |
| HY-N0229S5 | L-Alanine-13C3,15N,d4 | 1500092-09-0 | Isotope-Labeled Compounds |
| HY-N0229S6 | L-Alanine-3-13C | 65163-25-9 | Isotope-Labeled Compounds |
| HY-N0229S7 | L-Alanine-2-13C | 62656-85-3 | Isotope-Labeled Compounds |
| HY-N0229S8 | L-Alanine-13C3 | 100108-77-8 | Isotope-Labeled Compounds |
| HY-N0229S9 | L-Alanine-13C2 | 65163-26-0 | Isotope-Labeled Compounds |
| HY-N0230 | β-Alanine | 107-95-9 | Natural Products |
| HY-N0230R | β-Alanine (Standard) | 107-95-9 | Reference Standards |
| HY-N0230S | β-Alanine-13C3,15N | 285978-07-6 | Isotope-Labeled Compounds |
| HY-N0230S1 | β-Alanine-15N | 204451-53-6 | Isotope-Labeled Compounds |
| HY-N0230S2 | β-Alanine-d4 | 116173-67-2 | Isotope-Labeled Compounds |
| HY-N0230S5 | β-Alanine-13C | 65138-34-3 | Isotope-Labeled Compounds |
| HY-N0231 | Bavachalcone | 28448-85-3 | Natural Products |
| HY-N0231R | Bavachalcone (Standard) | 28448-85-3 | Reference Standards |
| HY-N0232 | Psoralidin | 18642-23-4 | Natural Products |
| HY-N0232R | Psoralidin (Standard) | 18642-23-4 | Reference Standards |
| HY-N0233 | Bavachin | 19879-32-4 | Natural Products |
| HY-N0233R | Bavachin (Standard) | 19879-32-4 | Reference Standards |
| HY-N0234 | Bavachinin | 19879-30-2 | Natural Products |
| HY-N0234R | Bavachinin (Standard) | 19879-30-2 | Reference Standards |
| HY-N0235 | Bakuchiol | 10309-37-2 | Natural Products |
| HY-N0235R | Bakuchiol (Standard) | 10309-37-2 | Reference Standards |
| HY-N0236 | Corylin | 53947-92-5 | Natural Products |
| HY-N0236R | Corylin (Standard) | 53947-92-5 | Reference Standards |
| HY-N0237 | Atractyloside A | 126054-77-1 | Natural Products |
| HY-N0238 | Atractylodin | 55290-63-6 | Natural Products |
| HY-N0238R | Atractylodin (Standard) | 55290-63-6 | Reference Standards |
| HY-N0239 | Bulleyaconitine A | 107668-79-1 | Natural Products |
| HY-N0239R | Bulleyaconitine A (Standard) | 107668-79-1 | Reference Standards |
| HY-N0240 | Herbacetin | 527-95-7 | Natural Products |
| HY-N0240R | Herbacetin (Standard) | 527-95-7 | Reference Standards |
| HY-N0241 | Rhodionin | 85571-15-9 | Natural Products |
| HY-N0242 | Fraxinellone | 28808-62-0 | Natural Products |
| HY-N0242R | Fraxinellone (Standard) | 28808-62-0 | Reference Standards |
| HY-N0243 | Theaflavin | 4670-05-7 | Natural Products |
| HY-N0243R | Theaflavin (Standard) | 4670-05-7 | Reference Standards |
| HY-N0244 | Theaflavin-3'-gallate | 28543-07-9 | Natural Products |
| HY-N0244R | Theaflavin-3'-gallate (Standard) | 28543-07-9 | Reference Standards |
| HY-N0245 | Theaflavin-3-gallate | 30462-34-1 | Natural Products |
| HY-N0245R | Theaflavin-3-gallate (Standard) | 30462-34-1 | Reference Standards |
| HY-N0246 | Saikosaponin A | 20736-09-8 | Natural Products |
| HY-N0246R | Saikosaponin A (Standard) | 20736-09-8 | Reference Standards |
| HY-N0247 | Saikosaponin B1 | 58558-08-0 | Natural Products |
| HY-N0247R | Saikosaponin B1 (Standard) | 58558-08-0 | Reference Standards |
| HY-N0248 | Saikosaponin B2 | 58316-41-9 | Natural Products |
| HY-N0248R | Saikosaponin B2 (Standard) | 58316-41-9 | Reference Standards |
| HY-N0249 | Saikosaponin C | 20736-08-7 | Natural Products |
| HY-N0249R | Saikosaponin C (Standard) | 20736-08-7 | Reference Standards |
| HY-N0250 | Saikosaponin D | 20874-52-6 | Natural Products |
| HY-N0250R | Saikosaponin D (Standard) | 20874-52-6 | Reference Standards |
| HY-N0252 | Catharanthine | 2468-21-5 | Natural Products |
| HY-N0252A | Catharanthine (Tartrate) | 4168-17-6 | Natural Products |
| HY-N0252B | Catharanthine (Sulfate) | 153230-94-5 | Natural Products |
| HY-N0252R | Catharanthine (Standard) | 2468-21-5 | Reference Standards |
| HY-N0253 | Hederacoside C | 14216-03-6 | Natural Products |
| HY-N0253R | Hederacoside C (Standard) | 14216-03-6 | Reference Standards |
| HY-N0254 | Hederacoside D | 760961-03-3 | Natural Products |
| HY-N0254R | Hederacoside D (Standard) | 760961-03-3 | Reference Standards |
| HY-N0255 | alpha-Hederin | 27013-91-8 | Natural Products |
| HY-N0255R | alpha-Hederin (Standard) | 27013-91-8 | Reference Standards |
| HY-N0256 | Hederagenin | 465-99-6 | Natural Products |
| HY-N0256R | Hederagenin (Standard) | 465-99-6 | Reference Standards |
| HY-N0257 | Epimedin A | 110623-72-8 | Natural Products |
| HY-N0257R | Epimedin A (Standard) | 110623-72-8 | Reference Standards |
| HY-N0258 | Epimedin A1 | 140147-77-9 | Natural Products |
| HY-N0258R | Epimedin A1 (Standard) | 140147-77-9 | Reference Standards |
| HY-N0259 | Epimedin B | 110623-73-9 | Natural Products |
| HY-N0259R | Epimedin B (Standard) | 110623-73-9 | Reference Standards |
| HY-N0260 | Epmedin C | 110642-44-9 | Natural Products |
| HY-N0260R | Epmedin C (Standard) | 110642-44-9 | Reference Standards |
| HY-N0261 | Aurantio-obtusin | 67979-25-3 | Natural Products |
| HY-N0261R | Aurantio-obtusin (Standard) | 67979-25-3 | Reference Standards |
| HY-N0262 | Cordycepin | 73-03-0 | Natural Products |
| HY-N0262R | Cordycepin (Standard) | 73-03-0 | Reference Standards |
| HY-N0263 | Toosendanin | 58812-37-6 | Natural Products |
| HY-N0263R | Toosendanin (Standard) | 58812-37-6 | Reference Standards |
| HY-N0264 | Ligustrazine | 1124-11-4 | Natural Products |
| HY-N0264R | Ligustrazine (Standard) | 1124-11-4 | Reference Standards |
| HY-N0264S1 | Ligustrazine-d12 | 65127-74-4 | Isotope-Labeled Compounds |
| HY-N0265 | Asperosaponin VI | 39524-08-8 | Natural Products |
| HY-N0265R | Asperosaponin VI (Standard) | 39524-08-8 | Reference Standards |
| HY-N0266 | Dipsacoside B | 33289-85-9 | Natural Products |
| HY-N0266R | Dipsacoside B (Standard) | 33289-85-9 | Reference Standards |
| HY-N0267 | Hypaconitine | 6900-87-4 | Natural Products |
| HY-N0267R | Hypaconitine (Standard) | 6900-87-4 | Reference Standards |
| HY-N0268 | Irisflorentin | 41743-73-1 | Natural Products |
| HY-N0268R | Irisflorentin (Standard) | 41743-73-1 | Reference Standards |
| HY-N0269 | Echinatin | 34221-41-5 | Natural Products |
| HY-N0269R | Echinatin (Standard) | 34221-41-5 | Reference Standards |
| HY-N0270 | Ononin | 486-62-4 | Natural Products |
| HY-N0270R | Ononin (Standard) | 486-62-4 | Reference Standards |
| HY-N0271 | Echinocystic acid | 510-30-5 | Natural Products |
| HY-N0271R | Echinocystic acid (Standard) | 510-30-5 | Reference Standards |
| HY-N0272 | Eleutheroside E | 39432-56-9 | Natural Products |
| HY-N0272R | Eleutheroside E (Standard) | 39432-56-9 | Reference Standards |
| HY-N0273 | Brassinolide | 72962-43-7 | Natural Products |
| HY-N0274 | Caffeic acid phenethyl ester | 104594-70-9 | Natural Products |
| HY-N0275 | (±)-10-Hydroxycamptothecin | 64439-81-2 | Natural Products |
| HY-N0276 | Flaconitine | 77181-26-1 | Natural Products |
| HY-N0277 | Aconine | 509-20-6 | Natural Products |
| HY-N0278 | Anemonin | 508-44-1 | Natural Products |
| HY-N0278A | (Rac)-Anemonin | 90921-11-2 | Natural Products |
| HY-N0279 | Cardamonin | 18956-16-6 | Natural Products |
| HY-N0280 | Corosolic acid | 4547-24-4 | Natural Products |
| HY-N0280R | Corosolic acid (Standard) | 4547-24-4 | Reference Standards |
| HY-N0281 | Daphnetin | 486-35-1 | Natural Products |
| HY-N0281R | Daphnetin (Standard) | 486-35-1 | Reference Standards |
| HY-N0282 | Demecolcine | 477-30-5 | Natural Products |
| HY-N0282R | Colcemid (Standard) | 477-30-5 | Reference Standards |
| HY-N0283 | Diacerein | 13739-02-1 | Natural Products |
| HY-N0283R | Diacerein (Standard) | 13739-02-1 | Reference Standards |
| HY-N0283S | Diacerein-d6 | 1325559-27-0 | Isotope-Labeled Compounds |
| HY-N0284 | Esculetin | 305-01-1 | Natural Products |
| HY-N0284R | Esculetin (Standard) | 305-01-1 | Reference Standards |
| HY-N0285 | Imperatorin | 482-44-0 | Natural Products |
| HY-N0285R | Imperatorin (Standard) | 482-44-0 | Reference Standards |
| HY-N0285S | Imperatorin-d6 | Isotope-Labeled Compounds | |
| HY-N0286 | Isoimperatorin | 482-45-1 | Natural Products |
| HY-N0286R | Isoimperatorin (Standard) | 482-45-1 | Reference Standards |
| HY-N0286S | Isoimperatorin-d6 | Isotope-Labeled Compounds | |
| HY-N0287 | Lycopene | 502-65-8 | Natural Products |
| HY-N0288 | Lycorine | 476-28-8 | Natural Products |
| HY-N0288A | Lycorine (hydrochloride monohydrate) | 6150-58-9 | Biochemical Assay Reagents |
| HY-N0289 | Lycorine (hydrochloride) | 2188-68-3 | Natural Products |
| HY-N0289R | Lycorine (hydrochloride) (Standard) | 2188-68-3 | Reference Standards |
| HY-N0290 | Mangiferin | 4773-96-0 | Natural Products |
| HY-N0290R | Mangiferin (Standard) | 4773-96-0 | Reference Standards |
| HY-N0292 | Oleuropein | 32619-42-4 | Natural Products |
| HY-N0292R | Oleuropein (Standard) | 32619-42-4 | Reference Standards |
| HY-N0293 | Paeoniflorin | 23180-57-6 | Natural Products |
| HY-N0293R | Paeoniflorin (Standard) | 23180-57-6 | Reference Standards |
| HY-N0294 | Protocatechuic acid | 99-50-3 | Natural Products |
| HY-N0294R | Protocatechuic acid (Standard) | 99-50-3 | Reference Standards |
| HY-N0294S1 | Protocatechuic acid-13C7 | Isotope-Labeled Compounds | |
| HY-N0295 | Protocatechualdehyde | 139-85-5 | Natural Products |
| HY-N0295R | Protocatechualdehyde (Standard) | 139-85-5 | Reference Standards |
| HY-N0297 | Sinensetin | 2306-27-6 | Natural Products |
| HY-N0297R | Sinensetin (Standard) | 2306-27-6 | Reference Standards |
| HY-N0298 | Stachydrine | 471-87-4 | Natural Products |
| HY-N0299 | Stachyose (hydrate) | 54261-98-2 | Natural Products |
| HY-N0300 | Tetrahydropalmatine | 2934-97-6 | Natural Products |
| HY-N0300A | Tetrahydropalmatine (hydrochloride) | 6024-85-7 | Natural Products |
| HY-N0300R | Tetrahydropalmatine (Standard) | 2934-97-6 | Reference Standards |
| HY-N0301 | Thiocolchicoside | 602-41-5 | Reference compound |
| HY-N0301R | Thiocolchicoside (Standard) | 602-41-5 | Reference Standards |
| HY-N0302 | Gypsoside | 15588-68-8 | Natural Products |
| HY-N0303 | Idebenone | 58186-27-9 | Reference compound |
| HY-N0303R | Idebenone (Standard) | 58186-27-9 | Reference Standards |
| HY-N0304 | L-DOPA | 59-92-7 | Natural Products |
| HY-N0304A | L-DOPA (sodium) | 63302-01-2 | Reference compound |
| HY-N0304R | L-DOPA (Standard) | 59-92-7 | Reference Standards |
| HY-N0304S | L-DOPA-d6 | 713140-75-1 | Isotope-Labeled Compounds |
| HY-N0304S1 | L-DOPA-13C6 | 201417-12-1 | Isotope-Labeled Compounds |
| HY-N0304S2 | L-DOPA-13C | 586971-29-1 | Isotope-Labeled Compounds |
| HY-N0305 | 5-Aminolevulinic acid (hydrochloride) | 5451-09-2 | Natural Products |
| HY-N0305R | 5-Aminolevulinic acid (hydrochloride) (Standard) | 5451-09-2 | Reference Standards |
| HY-N0305S | 5-Aminolevulinic acid-15N (hydrochloride) | 116571-80-3 | Isotope-Labeled Compounds |
| HY-N0305S1 | 5-Aminolevulinic acid-d2 (hydrochloride) | 187237-35-0 | Isotope-Labeled Compounds |
| HY-N0305S2 | 5-Aminolevulinic acid-13C (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0305S3 | 5-Aminolevulinic acid-13C-1 (hydrochloride) | 129720-94-1 | Isotope-Labeled Compounds |
| HY-N0306 | Hederasaponin B | 36284-77-2 | Natural Products |
| HY-N0306R | Hederasaponin B (Standard) | 36284-77-2 | Reference Standards |
| HY-N0307 | Ciwujianoside B | 114902-16-8 | Natural Products |
| HY-N0307R | Ciwujianoside B (Standard) | 114902-16-8 | Reference Standards |
| HY-N0308 | Octyl acetate | 112-14-1 | Natural Products |
| HY-N0308R | Octyl acetate (Standard) | 112-14-1 | Reference Standards |
| HY-N0309 | Soyasaponin Ba | 114590-20-4 | Natural Products |
| HY-N0309R | Soyasaponin Ba (Standard) | 114590-20-4 | Reference Standards |
| HY-N0310 | Soyasaponin Bb | 51330-27-9 | Natural Products |
| HY-N0310R | Soyasaponin Bb (Standard) | 51330-27-9 | Reference Standards |
| HY-N0311 | Emodin-8-glucoside | 23313-21-5 | Natural Products |
| HY-N0311R | Emodin-8-glucoside (Standard) | 23313-21-5 | Reference Standards |
| HY-N0312 | Rhein-8-glucoside (calcium) | 113443-70-2 | Natural Products |
| HY-N0313 | Euphol | 514-47-6 | Natural Products |
| HY-N0314 | Pectolinarin | 28978-02-1 | Natural Products |
| HY-N0314R | Pectolinarin (Standard) | 28978-02-1 | Reference Standards |
| HY-N0315 | Allicin | 539-86-6 | Natural Products |
| HY-N0316 | Mollugin | 55481-88-4 | Natural Products |
| HY-N0316R | Mollugin (Standard) | 55481-88-4 | Reference Standards |
| HY-N0318 | Salvianolic acid A | 96574-01-5 | Natural Products |
| HY-N0318R | Salvianolic acid A (Standard) | 96574-01-5 | Reference Standards |
| HY-N0319 | Salvianolic acid C | 115841-09-3 | Natural Products |
| HY-N0319R | Salvianolic acid C (Standard) | 115841-09-3 | Reference Standards |
| HY-N0320 | Salvianolic acid D | 142998-47-8 | Natural Products |
| HY-N0320R | Salvianolic acid D (Standard) | 142998-47-8 | Reference Standards |
| HY-N0321 | Caftaric acid | 67879-58-7 | Natural Products |
| HY-N0321R | Caftaric acid (Standard) | 67879-58-7 | Reference Standards |
| HY-N0322 | Cholesterol | 57-88-5 | Natural Products |
| HY-N0322A | Cholesterol (Water Soluble) | Natural Products | |
| HY-N0322B | Cholesterol (Excipient) | 57-88-5 | Natural Products |
| HY-N0322BR | Cholesterol (Excipient) (Standard) | 57-88-5 | Reference Standards |
| HY-N0322R | Cholesterol (Standard) | 57-88-5 | Reference Standards |
| HY-N0322S | Cholesterol-d7 | 83199-47-7 | Isotope-Labeled Compounds |
| HY-N0322S1 | Cholesterol-d6 | 60816-17-3 | Isotope-Labeled Compounds |
| HY-N0322S2 | Cholesterol-d6-1 | 92543-08-3 | Isotope-Labeled Compounds |
| HY-N0322S3 | Cholesterol-13C5 | 150044-24-9 | Isotope-Labeled Compounds |
| HY-N0322S4 | Cholesterol-13C3 | Isotope-Labeled Compounds | |
| HY-N0322S5 | Cholesterol-13C2 | 78887-48-6 | Isotope-Labeled Compounds |
| HY-N0322S6 | Cholesterol-d4 | 956029-28-0 | Isotope-Labeled Compounds |
| HY-N0322S7 | Cholesterol-d1 | 51467-57-3 | Isotope-Labeled Compounds |
| HY-N0322S8 | Cholesterol-18O | 59613-51-3 | Isotope-Labeled Compounds |
| HY-N0323 | Bilirubin | 635-65-4 | Natural Products |
| HY-N0324 | Cholic acid | 81-25-4 | Natural Products |
| HY-N0324A | Cholic acid (sodium) | 361-09-1 | Natural Products |
| HY-N0324AR | Cholic acid (sodium) (Standard) | 361-09-1 | Reference Standards |
| HY-N0324B | Cholic acid (sodium hydrate) | 206986-87-0 | Natural Products |
| HY-N0324F | Cholic acid-Biotin | Dye Reagents | |
| HY-N0324R | Cholic acid (Standard) | 81-25-4 | Reference Standards |
| HY-N0324S | Cholic acid-d4 | 116380-66-6 | Isotope-Labeled Compounds |
| HY-N0324S1 | Cholic acid-d5 | 53007-09-3 | Isotope-Labeled Compounds |
| HY-N0324S2 | Cholic acid-13C | 52886-36-9 | Isotope-Labeled Compounds |
| HY-N0325 | DL-Methionine | 59-51-8 | Natural Products |
| HY-N0325R | DL-Methionine (Standard) | 59-51-8 | Reference Standards |
| HY-N0325S | DL-Methionine-13C | 68799-90-6 | Isotope-Labeled Compounds |
| HY-N0325S1 | DL-Methionine-d1 | 67866-74-4 | Isotope-Labeled Compounds |
| HY-N0325S3 | DL-Methionine-d3 | 284665-20-9 | Isotope-Labeled Compounds |
| HY-N0325S4 | DL-Methionine-d4 | 93709-61-6 | Isotope-Labeled Compounds |
| HY-N0326 | L-Methionine | 63-68-3 | Natural Products |
| HY-N0326R | L-Methionine (Standard) | 63-68-3 | Reference Standards |
| HY-N0326S | L-Methionine-15N | 82572-25-6 | Isotope-Labeled Compounds |
| HY-N0326S1 | L-Methionine-13C,d5 | 2483824-33-3 | Isotope-Labeled Compounds |
| HY-N0326S10 | L-Methionine-d4 | 67866-75-5 | Isotope-Labeled Compounds |
| HY-N0326S2 | L-Methionine-13C,d3 | 73488-65-0 | Isotope-Labeled Compounds |
| HY-N0326S3 | L-Methionine-13C | 49705-26-2 | Isotope-Labeled Compounds |
| HY-N0326S4 | L-Methionine-1-13C | 81202-04-2 | Isotope-Labeled Compounds |
| HY-N0326S5 | L-Methionine-13C5 | 202326-57-6 | Isotope-Labeled Compounds |
| HY-N0326S6 | L-Methionine-13C5,15N | 202468-47-1 | Isotope-Labeled Compounds |
| HY-N0326S7 | L-Methionine-d3 | 13010-53-2 | Isotope-Labeled Compounds |
| HY-N0326S8 | L-Methionine-d8 | 2483831-58-7 | Isotope-Labeled Compounds |
| HY-N0326S9 | L-Methionine-15N,d8 | Isotope-Labeled Compounds | |
| HY-N0327 | Lobetyolin | 129277-38-9 | Natural Products |
| HY-N0328 | alpha-Mangostin | 6147-11-1 | Natural Products |
| HY-N0328R | alpha-Mangostin (Standard) | 6147-11-1 | Reference Standards |
| HY-N0329 | Deltaline | 6836-11-9 | Natural Products |
| HY-N0330 | Momordin Ic | 96990-18-0 | Natural Products |
| HY-N0330R | Momordin Ic (Standard) | 96990-18-0 | Reference Standards |
| HY-N0331 | Ziyuglycoside I | 35286-58-9 | Natural Products |
| HY-N0331R | Ziyuglycoside I (Standard) | 35286-58-9 | Reference Standards |
| HY-N0332 | Ziyuglycoside II | 35286-59-0 | Natural Products |
| HY-N0332R | Ziyuglycoside II (Standard) | 35286-59-0 | Reference Standards |
| HY-N0333 | Yunaconitine | 70578-24-4 | Natural Products |
| HY-N0334 | (+)-Magnoflorine | 2141-09-5 | Natural Products |
| HY-N0334A | (+)-Magnoflorine (iodide) | 4277-43-4 | Natural Products |
| HY-N0335 | Indigo | 482-89-3 | Dye Reagents |
| HY-N0335R | Indigo (Standard) | 482-89-3 | Dye Reagents |
| HY-N0336 | 3-Butylidenephthalide | 551-08-6 | Natural Products |
| HY-N0336A | (Z)-3-Butylidenephthalide | 72917-31-8 | Natural Products |
| HY-N0337 | Eugenol,98% (stabilized with TBC) | 97-53-0 | Natural Products |
| HY-N0337R | Eugenol (Standard) | 97-53-0 | Reference Standards |
| HY-N0337S | Eugenol-d3 | 1335401-17-6 | Isotope-Labeled Compounds |
| HY-N0338 | (-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside | 136997-64-3 | Natural Products |
| HY-N0338R | (-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside (Standard) | 136997-64-3 | Reference Standards |
| HY-N0339 | Syringic acid | 530-57-4 | Natural Products |
| HY-N0339R | Syringic acid (Standard) | 530-57-4 | Reference Standards |
| HY-N0339S | Syringic acid-d6 | 84759-06-8 | Isotope-Labeled Compounds |
| HY-N0340 | Scopolamine butylbromide | 149-64-4 | Natural Products |
| HY-N0340R | Scopolamine butylbromide (Standard) | 149-64-4 | Reference Standards |
| HY-N0341 | Scopolin | 531-44-2 | Natural Products |
| HY-N0341R | Scopolin (Standard) | 531-44-2 | Reference Standards |
| HY-N0342 | Scopoletin | 92-61-5 | Natural Products |
| HY-N0342R | Scopoletin (Standard) | 92-61-5 | Reference Standards |
| HY-N0343 | Helicid | 80154-34-3 | Natural Products |
| HY-N0343A | 4-Formylpyrnyl-β-D-glucopyranoside | 26993-16-8 | Natural Products |
| HY-N0343R | Helicid (Standard) | 80154-34-3 | Reference Standards |
| HY-N0344 | Farrerol | 24211-30-1 | Natural Products |
| HY-N0344R | Farrerol (Standard) | 24211-30-1 | Reference Standards |
| HY-N0346A | (E)-Ethyl p-methoxycinnamate | 24393-56-4 | Natural Products |
| HY-N0346AR | (E)-Ethyl p-methoxycinnamate (Standard) | 24393-56-4 | Reference Standards |
| HY-N0347 | 17α-Hydroxyprogesterone acetate | 302-23-8 | Reference compound |
| HY-N0347R | 17α-Hydroxyprogesterone acetate (Standard) | 302-23-8 | Reference Standards |
| HY-N0348 | Dexamethasone 9,11-epoxide | 24916-90-3 | Reference compound |
| HY-N0349 | Methyl paraben | 99-76-3 | Natural Products |
| HY-N0349R | Methyl paraben (Standard) | 99-76-3 | Reference Standards |
| HY-N0349S | Methyl paraben-d4 | 362049-51-2 | Isotope-Labeled Compounds |
| HY-N0349S1 | Methyl paraben-13C6 | 1581694-95-2 | Isotope-Labeled Compounds |
| HY-N0351 | p-Coumaric acid | 501-98-4 | Natural Products |
| HY-N0351A | cis-p-Coumaric acid | 4501-31-9 | Natural Products |
| HY-N0351R | p-Coumaric acid (Standard) | 501-98-4 | Reference Standards |
| HY-N0351S | p-Coumaric acid-13C3 | 1261170-80-2 | Isotope-Labeled Compounds |
| HY-N0351S1 | p-Coumaric acid-d6 | 2708298-33-1 | Isotope-Labeled Compounds |
| HY-N0352 | Tuberostemonine | 6879-01-2 | Natural Products |
| HY-N0352R | Tuberostemonine (Standard) | 6879-01-2 | Reference Standards |
| HY-N0353 | Curdione | 13657-68-6 | Natural Products |
| HY-N0353R | Curdione (Standard) | 13657-68-6 | Reference Standards |
| HY-N0354 | Anthraquinone | 84-65-1 | Natural Products |
| HY-N0354R | Anthraquinone (Standard) | 84-65-1 | Reference Standards |
| HY-N0354S | Anthraquinone-d8 | 10439-39-1 | Isotope-Labeled Compounds |
| HY-N0355 | (+)-Catechin hydrate | 225937-10-0 | Natural Products |
| HY-N0356 | (-)-Catechin gallate | 130405-40-2 | Natural Products |
| HY-N0356R | (-)-Catechin gallate (Standard) | 130405-40-2 | Reference Standards |
| HY-N0356S | (+/-)-Catechin Gallate-13C3 | Isotope-Labeled Compounds | |
| HY-N0357 | 3,29-Dibenzoyl rarounitriol | 873001-54-8 | Natural Products |
| HY-N0358 | 1,4-Dicaffeoylquinic acid | 1182-34-9 | Natural Products |
| HY-N0358R | 1,4-Dicaffeoylquinic acid (Standard) | 1182-34-9 | Reference Standards |
| HY-N0359 | Cynarin | 30964-13-7 | Natural Products |
| HY-N0359A | (E)-Cynarin | 212891-05-9 | Natural Products |
| HY-N0359R | Cynarin (Standard) | 30964-13-7 | Reference Standards |
| HY-N0360 | Dihydrotanshinone I | 87205-99-0 | Natural Products |
| HY-N0360R | Dihydrotanshinone I (Standard) | 87205-99-0 | Reference Standards |
| HY-N0361 | Dihydrocapsaicin | 19408-84-5 | Natural Products |
| HY-N0361R | Dihydrocapsaicin (Standard) | 19408-84-5 | Reference Standards |
| HY-N0361S | Dihydrocapsaicin-d3 | 1330261-21-6 | Isotope-Labeled Compounds |
| HY-N0362 | Columbianadin | 5058-13-9 | Natural Products |
| HY-N0362R | Columbianadin (Standard) | 5058-13-9 | Reference Standards |
| HY-N0363 | (+)-Columbianetin | 3804-70-4 | Natural Products |
| HY-N0363A | (+)-Columbianetin acetate | 23180-65-6 | Natural Products |
| HY-N0363AR | (+)-Columbianetin acetate (Standard) | 23180-65-6 | Reference Standards |
| HY-N0363R | (+)-Columbianetin (Standard) | 3804-70-4 | Reference Standards |
| HY-N0364 | Falcarindiol | 55297-87-5 | Natural Products |
| HY-N0365 | Sennoside A | 81-27-6 | Natural Products |
| HY-N0365R | Sennoside A (Standard) | 81-27-6 | Reference Standards |
| HY-N0366 | Sennoside B | 128-57-4 | Natural Products |
| HY-N0366R | Sennoside B (Standard) | 128-57-4 | Reference Standards |
| HY-N0367 | Trans-Anethole | 4180-23-8 | Natural Products |
| HY-N0367R | Trans-Anethole (Standard) | 4180-23-8 | Reference Standards |
| HY-N0367S | Trans-Anethole-d3 | 444904-67-0 | Isotope-Labeled Compounds |
| HY-N0368 | Linalool,98% (stabilized with MEHQ) | 78-70-6 | Natural Products |
| HY-N0368R | Linalool (Standard) | 78-70-6 | Reference Standards |
| HY-N0368S | Linalool-d3 | 1216673-02-7 | Isotope-Labeled Compounds |
| HY-N0368S1 | Linalool-13C3 | Isotope-Labeled Compounds | |
| HY-N0368S2 | Linalool-d6 | Isotope-Labeled Compounds | |
| HY-N0370 | Bergapten | 484-20-8 | Natural Products |
| HY-N0370R | Bergapten (Standard) | 484-20-8 | Reference Standards |
| HY-N0370S | Bergapten-d3 | 2749409-59-2 | Isotope-Labeled Compounds |
| HY-N0371 | Pachymic acid | 29070-92-6 | Natural Products |
| HY-N0371R | Pachymic acid (Standard) | 29070-92-6 | Reference Standards |
| HY-N0372 | Licochalcone A | 58749-22-7 | Natural Products |
| HY-N0372R | Licochalcone A (Standard) | 58749-22-7 | Reference Standards |
| HY-N0373 | Licochalcone B | 58749-23-8 | Natural Products |
| HY-N0373R | Licochalcone B (Standard) | 58749-23-8 | Reference Standards |
| HY-N0374 | Licochalcone C | 144506-14-9 | Natural Products |
| HY-N0375 | 18α-Glycyrrhetinic acid | 1449-05-4 | Natural Products |
| HY-N0375R | 18α-Glycyrrhetinic acid (Standard) | 1449-05-4 | Reference Standards |
| HY-N0376 | Liquiritin | 551-15-5 | Natural Products |
| HY-N0376R | Liquiritin (Standard) | 551-15-5 | Reference Standards |
| HY-N0377 | Liquiritigenin | 578-86-9 | Natural Products |
| HY-N0377A | (±)-Liquiritigenin | 69097-97-8 | Natural Products |
| HY-N0377R | Liquiritigenin (Standard) | 578-86-9 | Reference Standards |
| HY-N0378 | D-Mannitol | 69-65-8 | Natural Products |
| HY-N0378A | D-Mannitol, M200 (Excipient) | 69-65-8 | Natural Products |
| HY-N0378B | D-Mannitol, M100 (Excipient) | 69-65-8 | Natural Products |
| HY-N0378R | D-Mannitol (Standard) | 69-65-8 | Reference Standards |
| HY-N0378S | D-Mannitol-d8 | Isotope-Labeled Compounds | |
| HY-N0378S1 | D-Mannitol-13C | 132202-29-0 | Isotope-Labeled Compounds |
| HY-N0378S2 | D-Mannitol-13C6 | 287112-34-9 | Isotope-Labeled Compounds |
| HY-N0378S3 | D-Mannitol-2-13C | 287100-69-0 | Isotope-Labeled Compounds |
| HY-N0378S4 | D-Mannitol-d2 | 2649096-16-0 | Isotope-Labeled Compounds |
| HY-N0378S5 | D-Mannitol-d1 | 75607-68-0 | Isotope-Labeled Compounds |
| HY-N0378S6 | D-Mannitol-13C,d2 | 1217463-58-5 | Isotope-Labeled Compounds |
| HY-N0379 | D-Mannose | 3458-28-4 | Natural Products |
| HY-N0379R | D-Mannose (Standard) | 3458-28-4 | Reference Standards |
| HY-N0379S10 | D-Mannose-13C-5 | 115973-81-4 | Isotope-Labeled Compounds |
| HY-N0379S11 | D-Mannose-d | Isotope-Labeled Compounds | |
| HY-N0379S12 | D-Mannose-d-1 | Isotope-Labeled Compounds | |
| HY-N0379S13 | D-Mannose-d-2 | Isotope-Labeled Compounds | |
| HY-N0379S14 | D-Mannose-13C,d | Isotope-Labeled Compounds | |
| HY-N0379S15 | D-mannose-d7 | Isotope-Labeled Compounds | |
| HY-N0379S17 | D-Mannose-d-3 | 288846-86-6 | Isotope-Labeled Compounds |
| HY-N0379S18 | D-Mannose-13C6,d7 | Isotope-Labeled Compounds | |
| HY-N0379S19 | D-Mannose-d-4 | Isotope-Labeled Compounds | |
| HY-N0379S2 | D-Mannose-18O | Isotope-Labeled Compounds | |
| HY-N0379S20 | D-Mannose-13C,d-2 | Isotope-Labeled Compounds | |
| HY-N0379S22 | D-Mannose-13C6 | 287100-74-7 | Isotope-Labeled Compounds |
| HY-N0379S5 | D-Mannose-13C | 70849-31-9 | Isotope-Labeled Compounds |
| HY-N0379S6 | D-Mannose-13C-1 | 70849-16-0 | Isotope-Labeled Compounds |
| HY-N0379S7 | D-Mannose-13C-2 | 101615-89-8 | Isotope-Labeled Compounds |
| HY-N0379S8 | D-Mannose-13C-3 | 1485504-72-0 | Isotope-Labeled Compounds |
| HY-N0379S9 | D-Mannose-13C-4 | Isotope-Labeled Compounds | |
| HY-N0380 | Nardosinone | 23720-80-1 | Natural Products |
| HY-N0380R | Nardosinone (Standard) | 23720-80-1 | Reference Standards |
| HY-N0381 | Maackiain | 19908-48-6 | Natural Products |
| HY-N0382 | Galangin | 548-83-4 | Natural Products |
| HY-N0382R | Galangin (Standard) | 548-83-4 | Reference Standards |
| HY-N0382S | Galangin-13C3 | Isotope-Labeled Compounds | |
| HY-N0384 | Homovanillic acid | 306-08-1 | Natural Products |
| HY-N0384R | Homovanillic acid (Standard) | 306-08-1 | Reference Standards |
| HY-N0384S | Homovanillic acid-d3 | 74495-71-9 | Isotope-Labeled Compounds |
| HY-N0384S1 | Homovanillic acid-d2 | 53587-33-0 | Isotope-Labeled Compounds |
| HY-N0384S2 | Homovanillic acid-d5 | 53587-32-9 | Isotope-Labeled Compounds |
| HY-N0384S3 | Homovanillic acid-13C6,18O | 202468-52-8 | Isotope-Labeled Compounds |
| HY-N0384S4 | Homovanillic acid-d3-1 | 68408-02-6 | Isotope-Labeled Compounds |
| HY-N0384S5 | Homovanillic acid-13C,d3 | Isotope-Labeled Compounds | |
| HY-N0385 | Gomisin J | 66280-25-9 | Natural Products |
| HY-N0386 | Griffonilide | 61371-55-9 | Natural Products |
| HY-N0386R | Griffonilide (Standard) | 61371-55-9 | Reference Standards |
| HY-N0387 | Rhynchophylline | 76-66-4 | Natural Products |
| HY-N0387R | Rhynchophylline (Standard) | 76-66-4 | Reference Standards |
| HY-N0388 | Gelsemine | 509-15-9 | Natural Products |
| HY-N0388R | Gelsemine (Standard) | 509-15-9 | Reference Standards |
| HY-N0389 | Columbin | 546-97-4 | Natural Products |
| HY-N0389R | Columbin (Standard) | 546-97-4 | Reference Standards |
| HY-N0390 | L-Glutamine | 56-85-9 | Natural Products |
| HY-N0390R | L-Glutamine (Standard) | 56-85-9 | Reference Standards |
| HY-N0390S | L-Glutamine-15N | 80143-57-3 | Isotope-Labeled Compounds |
| HY-N0390S1 | L-Glutamine-13C5 | 184161-19-1 | Isotope-Labeled Compounds |
| HY-N0390S10 | L-Glutamine-1,2-13C2 | Isotope-Labeled Compounds | |
| HY-N0390S11 | L-Glutamine-2-13C | 180991-02-0 | Isotope-Labeled Compounds |
| HY-N0390S15 | L-Glutamine-d4 | Isotope-Labeled Compounds | |
| HY-N0390S2 | L-Glutamine-d5 | 14341-78-7 | Isotope-Labeled Compounds |
| HY-N0390S3 | L-Glutamine-13C5,15N2,d5 | 2123439-02-9 | Isotope-Labeled Compounds |
| HY-N0390S4 | L-Glutamine-5-13C | 159680-32-7 | Isotope-Labeled Compounds |
| HY-N0390S5 | L-Glutamine-1-13C | 159663-16-8 | Isotope-Labeled Compounds |
| HY-N0390S6 | L-Glutamine-13C5,15N2 | 285978-14-5 | Isotope-Labeled Compounds |
| HY-N0390S7 | L-Glutamine-15N2,d5 | Isotope-Labeled Compounds | |
| HY-N0390S8 | L-Glutamine-15N2 | 204451-48-9 | Isotope-Labeled Compounds |
| HY-N0390S9 | L-Glutamine-15N-1 | 59681-32-2 | Isotope-Labeled Compounds |
| HY-N0391 | L-Citrulline | 372-75-8 | Natural Products |
| HY-N0391A | L-Citrulline (DL-malate) | 70796-17-7 | Reference compound |
| HY-N0391R | L-Citrulline (Standard) | 372-75-8 | Reference Standards |
| HY-N0391S2 | L-Citrulline-d6 | 1331908-61-2 | Isotope-Labeled Compounds |
| HY-N0391S3 | L-Citrulline-13C | 94740-46-2 | Isotope-Labeled Compounds |
| HY-N0391S4 | L-Citrulline-d4 | 1217474-00-4 | Isotope-Labeled Compounds |
| HY-N0391S5 | L-Citrulline-d7 | 2483831-24-7 | Isotope-Labeled Compounds |
| HY-N0392 | Polygalasaponin F | 882664-74-6 | Natural Products |
| HY-N0392R | Polygalasaponin F (Standard) | 882664-74-6 | Reference Standards |
| HY-N0393 | Glabridin | 59870-68-7 | Natural Products |
| HY-N0393R | Glabridin (Standard) | 59870-68-7 | Reference Standards |
| HY-N0394 | L-Cystine | 56-89-3 | Natural Products |
| HY-N0394R | L-Cystine (Standard) | 56-89-3 | Reference Standards |
| HY-N0394S1 | L-Cystine-d4 | 1192736-38-1 | Isotope-Labeled Compounds |
| HY-N0394S2 | (S)-L-Cystine-15N2 | Isotope-Labeled Compounds | |
| HY-N0394S3 | L-Cystine-34S2 | 113512-08-6 | Isotope-Labeled Compounds |
| HY-N0394S4 | L-Cystine-3,3'-13C2 | 2483736-13-4 | Isotope-Labeled Compounds |
| HY-N0395 | Fructose | 7660-25-5 | Natural Products |
| HY-N0395R | Fructose (Standard) | 7660-25-5 | Reference Standards |
| HY-N0396 | Harpagoside | 19210-12-9 | Natural Products |
| HY-N0396R | Harpagoside (Standard) | 19210-12-9 | Reference Standards |
| HY-N0397 | Harpagide | 6926-08-5 | Natural Products |
| HY-N0397R | Harpagide (Standard) | 6926-08-5 | Reference Standards |
| HY-N0398 | Sec-O-Glucosylhamaudol | 80681-44-3 | Natural Products |
| HY-N0398R | Sec-O-Glucosylhamaudol (Standard) | 80681-44-3 | Reference Standards |
| HY-N0399 | Wogonoside | 51059-44-0 | Natural Products |
| HY-N0399R | Wogonoside (Standard) | 51059-44-0 | Reference Standards |
| HY-N0400 | Wogonin | 632-85-9 | Natural Products |
| HY-N0400R | Wogonin (Standard) | 632-85-9 | Reference Standards |
| HY-N0401 | Ligustilide | 4431-01-0 | Natural Products |
| HY-N0401A | (Z)-Ligustilide | 81944-09-4 | Natural Products |
| HY-N0401AS | (Z)-Ligustilide-d7 | Isotope-Labeled Compounds | |
| HY-N0401B | (E)-Ligustilide | 81944-08-3 | Natural Products |
| HY-N0402 | Artemether | 71963-77-4 | Natural Products |
| HY-N0402R | Artemether (Standard) | 71963-77-4 | Reference Standards |
| HY-N0402S | Artemether-d3 | 93787-85-0 | Isotope-Labeled Compounds |
| HY-N0403 | 2,3,4',5-Tetrahydroxystilbene 2-O-β-D-glucoside | 55327-45-2 | Natural Products |
| HY-N0404 | Sinigrin | 3952-98-5 | Natural Products |
| HY-N0404R | Sinigrin (Standard) | 3952-98-5 | Reference Standards |
| HY-N0405 | Orientin | 28608-75-5 | Natural Products |
| HY-N0405R | Orientin (Standard) | 28608-75-5 | Reference Standards |
| HY-N0406 | 2"-O-beta-L-galactopyranosylorientin | 861691-37-4 | Natural Products |
| HY-N0406R | 2"-O-beta-L-galactopyranosylorientin (Standard) | 861691-37-4 | Reference Standards |
| HY-N0407 | Picroside I | 27409-30-9 | Natural Products |
| HY-N0407R | Picroside I (Standard) | 27409-30-9 | Reference Standards |
| HY-N0408 | Picroside II | 39012-20-9 | Natural Products |
| HY-N0408R | Picroside II (Standard) | 39012-20-9 | Reference Standards |
| HY-N0409 | Picroside III | 64461-95-6 | Natural Products |
| HY-N0409R | Picroside III (Standard) | 64461-95-6 | Reference Standards |
| HY-N0410 | Daucosterol | 474-58-8 | Natural Products |
| HY-N0410R | Daucosterol (Standard) | 474-58-8 | Reference Standards |
| HY-N0411 | β-Carotene | 7235-40-7 | Natural Products |
| HY-N0411R | β-Carotene (Standard) | 7235-40-7 | Reference Standards |
| HY-N0411S1 | β-Carotene-d8 | 53163-44-3 | Isotope-Labeled Compounds |
| HY-N0411S4 | β-Carotene-13C10 | 301150-50-5 | Isotope-Labeled Compounds |
| HY-N0412 | Sesamoside | 117479-87-5 | Natural Products |
| HY-N0412R | Sesamoside (Standard) | 117479-87-5 | Reference Standards |
| HY-N0413 | Hupehenine | 98243-57-3 | Natural Products |
| HY-N0413R | Hupehenine (Standard) | 98243-57-3 | Reference Standards |
| HY-N0414 | Trigonelline | 535-83-1 | Natural Products |
| HY-N0414R | Trigonelline (Standard) | 535-83-1 | Reference Standards |
| HY-N0415 | Trigonelline (chloride) | 6138-41-6 | Natural Products |
| HY-N0415R | Trigonelline (chloride) (Standard) | 6138-41-6 | Reference Standards |
| HY-N0415S | Trigonelline-d3 (chloride) | Isotope-Labeled Compounds | |
| HY-N0416 | Cucurbitacin B | 6199-67-3 | Natural Products |
| HY-N0416R | Cucurbitacin B (Standard) | 6199-67-3 | Reference Standards |
| HY-N0417 | Cucurbitacin E | 18444-66-1 | Natural Products |
| HY-N0417R | Cucurbitacin E (Standard) | 18444-66-1 | Reference Standards |
| HY-N0418 | Quercitrin | 522-12-3 | Natural Products |
| HY-N0418R | Quercitrin (Standard) | 522-12-3 | Reference Standards |
| HY-N0419 | Quercimeritrin | 491-50-9 | Natural Products |
| HY-N0419R | Quercimeritrin (Standard) | 491-50-9 | Reference Standards |
| HY-N0420 | Succinic acid | 110-15-6 | Natural Products |
| HY-N0420A | Succinic acid (tromethamine) | 84540-64-7 | Reference compound |
| HY-N0420R | Succinic acid (Standard) | 110-15-6 | Reference Standards |
| HY-N0420S | Succinic acid-d6 | 21668-90-6 | Isotope-Labeled Compounds |
| HY-N0420S1 | Succinic-2,2,3,3-d4 acid | 14493-42-6 | Isotope-Labeled Compounds |
| HY-N0420S2 | Succinic acid-13C4 | 201595-67-7 | Isotope-Labeled Compounds |
| HY-N0420S3 | Butanedioic acid-13C2 | 79864-95-2 | Isotope-Labeled Compounds |
| HY-N0420S4 | Succinic acid-13C2 | 61128-08-3 | Isotope-Labeled Compounds |
| HY-N0421 | Cinobufagin | 470-37-1 | Natural Products |
| HY-N0421R | Cinobufagin (Standard) | 470-37-1 | Reference Standards |
| HY-N0423 | Sophoricoside | 152-95-4 | Natural Products |
| HY-N0423R | Sophoricoside (Standard) | 152-95-4 | Reference Standards |
| HY-N0424 | Cyclogalegenin | 84605-18-5 | Natural Products |
| HY-N0424R | Cyclogalegenin (Standard) | 84605-18-5 | Reference Standards |
| HY-N0426 | Alismoxide | 87701-68-6 | Natural Products |
| HY-N0427 | Phellodendrine | 6873-13-8 | Natural Products |
| HY-N0428 | Obacunone | 751-03-1 | Natural Products |
| HY-N0428R | Obacunone (Standard) | 751-03-1 | Reference Standards |
| HY-N0429 | Diosbulbin B | 20086-06-0 | Natural Products |
| HY-N0430 | Coptisine | 3486-66-6 | Natural Products |
| HY-N0430A | Coptisine (Sulfate) | 1198398-71-8 | Natural Products |
| HY-N0431 | Astragaloside IV | 84687-43-4 | Natural Products |
| HY-N0431R | Astragaloside IV (Standard) | 84687-43-4 | Reference Standards |
| HY-N0432 | Astragaloside I | 84680-75-1 | Natural Products |
| HY-N0432R | Astragaloside I (Standard) | 84680-75-1 | Reference Standards |
| HY-N0433 | Astragaloside II | 84676-89-1 | Natural Products |
| HY-N0433R | Astragaloside II (Standard) | 84676-89-1 | Reference Standards |
| HY-N0434 | Astragaloside III | 84687-42-3 | Natural Products |
| HY-N0434R | Astragaloside III (Standard) | 84687-42-3 | Reference Standards |
| HY-N0435 | Isorhamnetin 3-gentiobioside | 17429-69-5 | Natural Products |
| HY-N0436 | Engeletin | 572-31-6 | Natural Products |
| HY-N0436R | Engeletin (Standard) | 572-31-6 | Reference Standards |
| HY-N0437 | Progesterone | 57-83-0 | Natural Products |
| HY-N0437R | Progesterone (Standard) | 57-83-0 | Reference Standards |
| HY-N0437S | Progesterone-d9 | 15775-74-3 | Isotope-Labeled Compounds |
| HY-N0437S1 | Progesterone-13C5 | 2687960-32-1 | Isotope-Labeled Compounds |
| HY-N0437S2 | Progesterone-13C3 | 327048-87-3 | Isotope-Labeled Compounds |
| HY-N0437S3 | Progesterone-13C2 | 82938-07-6 | Isotope-Labeled Compounds |
| HY-N0438 | Pimpinellin | 131-12-4 | Natural Products |
| HY-N0439 | Asiaticoside | 16830-15-2 | Natural Products |
| HY-N0439R | Asiaticoside (Standard) | 16830-15-2 | Reference Standards |
| HY-N0440 | Germacrone | 6902-91-6 | Natural Products |
| HY-N0440R | Germacrone (Standard) | 6902-91-6 | Reference Standards |
| HY-N0441 | Neferine | 2292-16-2 | Natural Products |
| HY-N0442 | 5-O-Methylvisammioside | 84272-85-5 | Natural Products |
| HY-N0442R | 5-O-Methylvisammioside (Standard) | 84272-85-5 | Reference Standards |
| HY-N0443 | N-Methylcytisine | 486-86-2 | Natural Products |
| HY-N0443R | N-Methylcytisine (Standard) | 486-86-2 | Reference Standards |
| HY-N0444 | Rubiadin | 117-02-2 | Natural Products |
| HY-N0444R | Rubiadin (Standard) | 117-02-2 | Reference Standards |
| HY-N0445 | 2-Hydroxy-4-methoxybenzaldehyde | 673-22-3 | Natural Products |
| HY-N0446 | 10-Methoxycamptothecin | 19685-10-0 | Natural Products |
| HY-N0446R | 10-Methoxycamptothecin (Standard) | 19685-10-0 | Reference Standards |
| HY-N0447 | 8-Gingerol | 23513-08-8 | Natural Products |
| HY-N0447R | 8-Gingerol (Standard) | 23513-08-8 | Reference Standards |
| HY-N0448 | 10-Gingerol | 23513-15-7 | Natural Products |
| HY-N0448R | 10-Gingerol (Standard) | 23513-15-7 | Reference Standards |
| HY-N0449 | Nordihydrocapsaicin | 28789-35-7 | Natural Products |
| HY-N0449R | Nordihydrocapsaicin (Standard) | 28789-35-7 | Reference Standards |
| HY-N0450 | Sinapine (thiocyanate) | 7431-77-8 | Natural Products |
| HY-N0450R | Sinapine (thiocyanate) (Standard) | 7431-77-8 | Reference Standards |
| HY-N0451 | Acacetin | 480-44-4 | Natural Products |
| HY-N0451R | Acacetin (Standard) | 480-44-4 | Reference Standards |
| HY-N0452 | Hyperoside | 482-36-0 | Natural Products |
| HY-N0452R | Hyperoside (Standard) | 482-36-0 | Reference Standards |
| HY-N0453 | Hypericin | 548-04-9 | Natural Products |
| HY-N0453R | Hypericin (Standard) | 548-04-9 | Reference Standards |
| HY-N0453S | Hypericin-d10 | Isotope-Labeled Compounds | |
| HY-N0453S1 | Hypericin-d2 | Isotope-Labeled Compounds | |
| HY-N0454 | DL-Arginine | 7200-25-1 | Natural Products |
| HY-N0455 | L-Arginine | 74-79-3 | Natural Products |
| HY-N0455A | L-Arginine (hydrochloride) | 1119-34-2 | Natural Products |
| HY-N0455AR | L-Arginine (hydrochloride) (Standard) | 1119-34-2 | Reference Standards |
| HY-N0455AS | L-Arginine-15N2 (hydrochloride) | 204633-92-1 | Isotope-Labeled Compounds |
| HY-N0455AS1 | L-Arginine-15N4 (hydrochloride) | 204633-95-4 | Isotope-Labeled Compounds |
| HY-N0455AS11 | L-Arginine-13C6,d14 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0455AS2 | L-Arginine-d7 (hydrochloride) | 204244-77-9 | Isotope-Labeled Compounds |
| HY-N0455AS3 | L-Arginine-1-13C (hydrochloride) | 2483735-41-5 | Isotope-Labeled Compounds |
| HY-N0455AS4 | L-Arginine-13C6,15N4,d7 (hydrochloride) | 2483829-29-2 | Isotope-Labeled Compounds |
| HY-N0455AS5 | L-Arginine-1,2-13C2 (hydrochloride) | 201740-75-2 | Isotope-Labeled Compounds |
| HY-N0455AS6 | L-Arginine-13C6 (hydrochloride) | 201740-91-2 | Isotope-Labeled Compounds |
| HY-N0455AS7 | L-Arginine-13C (hydrochloride) | 94740-43-9 | Isotope-Labeled Compounds |
| HY-N0455AS8 | L-Arginine-13C6,15N4 (hydrochloride) | 202468-25-5 | Isotope-Labeled Compounds |
| HY-N0455AS9 | L-Arginine-15N4,d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0455B | L-Arginine (L-glutamate) | 4320-30-3 | Natural Products |
| HY-N0455BR | L-Arginine (L-glutamate) (Standard) | 4320-30-3 | Reference Standards |
| HY-N0455D | L-Arginine (butanoate) | 80407-72-3 | Natural Products |
| HY-N0455R | L-Arginine (Standard) | 74-79-3 | Reference Standards |
| HY-N0457 | Chicoric acid | 6537-80-0 | Natural Products |
| HY-N0457A | L-Chicoric Acid | 70831-56-0 | Natural Products |
| HY-N0457AR | L-Chicoric Acid (Standard) | 70831-56-0 | Reference Standards |
| HY-N0457R | Chicoric acid (Standard) | 6537-80-0 | Reference Standards |
| HY-N0458 | Pedunculoside | 42719-32-4 | Natural Products |
| HY-N0458R | Pedunculoside (Standard) | 42719-32-4 | Reference Standards |
| HY-N0459 | 3,5-O-Dicaffeoylquinic acid | 89919-62-0 | Natural Products |
| HY-N0459R | 3,5-O-Dicaffeoylquinic acid (Standard) | 89919-62-0 | Reference Standards |
| HY-N0460 | 1-Caffeoylquinic acid | 1241-87-8 | Natural Products |
| HY-N0460R | 1-Caffeoylquinic acid (Standard) | 1241-87-8 | Reference Standards |
| HY-N0462 | Corilagin | 23094-69-1 | Natural Products |
| HY-N0462R | Corilagin (Standard) | 23094-69-1 | Reference Standards |
| HY-N0463 | Blinin | 125675-09-4 | Natural Products |
| HY-N0464 | D-(-)-Quinic acid | 77-95-2 | Natural Products |
| HY-N0464R | D-(-)-Quinic acid (Standard) | 77-95-2 | Reference Standards |
| HY-N0464S | Quinic acid-13C3 | Isotope-Labeled Compounds | |
| HY-N0465 | Olaquindox | 23696-28-8 | Reference compound |
| HY-N0465R | Olaquindox (Standard) | 23696-28-8 | Reference Standards |
| HY-N0465S | Olaquindox-d4 | 1189487-82-8 | Isotope-Labeled Compounds |
| HY-N0466 | Rebaudioside A | 58543-16-1 | Natural Products |
| HY-N0466R | Rebaudioside A (Standard) | 58543-16-1 | Reference Standards |
| HY-N0467 | Rebaudioside C | 63550-99-2 | Natural Products |
| HY-N0467R | Rebaudioside C (Standard) | 63550-99-2 | Reference Standards |
| HY-N0468 | Rebaudioside D | 63279-13-0 | Natural Products |
| HY-N0468R | Rebaudioside D (Standard) | 63279-13-0 | Reference Standards |
| HY-N0469 | L-Lysine | 56-87-1 | Natural Products |
| HY-N0469A | L-Lysine (sulfite) | 53411-64-6 | Natural Products |
| HY-N0469R | L-Lysine (Standard) | 56-87-1 | Reference Standards |
| HY-N0469S | L-Lysine-d3 (hydrochloride) | 2330878-43-6 | Isotope-Labeled Compounds |
| HY-N0469S1 | L-Lysine-13C6 (dihydrochloride) | 201740-81-0 | Isotope-Labeled Compounds |
| HY-N0469S2 | L-Lysine-15N-1 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-N0470 | L-Lysine (hydrochloride) | 657-27-2 | Natural Products |
| HY-N0470R | L-Lysine (hydrochloride) (Standard) | 657-27-2 | Reference Standards |
| HY-N0470S | L-Lysine-15N2 (hydrochloride) | 1217460-44-0 | Isotope-Labeled Compounds |
| HY-N0470S1 | L-Lysine-13C6,15N2,d9 (dihydrochloride) | 1994268-57-3 | Isotope-Labeled Compounds |
| HY-N0470S2 | L-Lysine-13C (dihydrochloride) | 202190-50-9 | Isotope-Labeled Compounds |
| HY-N0470S3 | L-Lysine-13C6,15N2 (hydrochloride) | 1200447-00-2 | Isotope-Labeled Compounds |
| HY-N0470S4 | L-Lysine-d8 (hydrochloride) | 344298-93-7 | Isotope-Labeled Compounds |
| HY-N0470S5 | L-Lysine-d9 (hydrochloride) | 2708343-64-8 | Isotope-Labeled Compounds |
| HY-N0470S6 | L-Lysine-d4 (hydrochloride) | 284664-96-6 | Isotope-Labeled Compounds |
| HY-N0470S8 | L-Lysine-13C6 (hydrochloride) | 1228077-86-8 | Isotope-Labeled Compounds |
| HY-N0471 | L-Hyoscyamine | 101-31-5 | Natural Products |
| HY-N0471A | L-Hyoscyamine (sulfate) | 620-61-1 | Natural Products |
| HY-N0471AR | L-Hyoscyamine (sulfate) (Standard) | 620-61-1 | Reference Standards |
| HY-N0471B | L-Hyoscyamine (hydrobromide) | 306-03-6 | Natural Products |
| HY-N0471C | L-Hyoscyamine (sulfate hydrate) | 6835-16-1 | Reference compound |
| HY-N0471R | L-Hyoscyamine (Standard) | 101-31-5 | Reference Standards |
| HY-N0471S | L-Hyoscyamine-d3 | Isotope-Labeled Compounds | |
| HY-N0472 | Geraniin | 60976-49-0 | Natural Products |
| HY-N0472R | Geraniin (Standard) | 60976-49-0 | Reference Standards |
| HY-N0473 | L-Tyrosine | 60-18-4 | Natural Products |
| HY-N0473A | L-Tyrosine (disodium salt) | 69847-45-6 | Natural Products |
| HY-N0473R | L-Tyrosine (Standard) | 60-18-4 | Reference Standards |
| HY-N0473S | L-Tyrosine-d4 | 62595-14-6 | Isotope-Labeled Compounds |
| HY-N0473S1 | L-Tyrosine-15N | 35424-81-8 | Isotope-Labeled Compounds |
| HY-N0473S10 | L-Tyrosine-d2-1 | 30811-19-9 | Isotope-Labeled Compounds |
| HY-N0473S11 | L-Tyrosine-15N,d7 | Isotope-Labeled Compounds | |
| HY-N0473S12 | L-Tyrosine-17O | 104931-15-9 | Isotope-Labeled Compounds |
| HY-N0473S13 | L-Tyrosine-d2-2 | 57746-15-3 | Isotope-Labeled Compounds |
| HY-N0473S14 | L-Tyrosine-d5 | 1226919-57-8 | Isotope-Labeled Compounds |
| HY-N0473S15 | L-Tyrosine-d3 | 71939-39-4 | Isotope-Labeled Compounds |
| HY-N0473S16 | L-Tyrosine-13C,15N | 2483830-06-2 | Isotope-Labeled Compounds |
| HY-N0473S2 | L-Tyrosine-13C6 | 201595-63-3 | Isotope-Labeled Compounds |
| HY-N0473S3 | L-Tyrosine-13C9 | 55443-60-2 | Isotope-Labeled Compounds |
| HY-N0473S4 | L-Tyrosine-13C | 110622-46-3 | Isotope-Labeled Compounds |
| HY-N0473S5 | L-Tyrosine-4-13C | 81201-90-3 | Isotope-Labeled Compounds |
| HY-N0473S6 | L-Tyrosine-3,5-13C2 | 70479-98-0 | Isotope-Labeled Compounds |
| HY-N0473S7 | L-Tyrosine-1-13C | 81201-89-0 | Isotope-Labeled Compounds |
| HY-N0473S8 | L-Tyrosine-d2 | 72963-27-0 | Isotope-Labeled Compounds |
| HY-N0473S9 | L-Tyrosine-d7 | 130551-49-4 | Isotope-Labeled Compounds |
| HY-N0474 | Tyrosol | 501-94-0 | Natural Products |
| HY-N0474R | Tyrosol (Standard) | 501-94-0 | Reference Standards |
| HY-N0475 | Triptophenolide | 74285-86-2 | Natural Products |
| HY-N0475R | Triptophenolide (Standard) | 74285-86-2 | Reference Standards |
| HY-N0476 | Wilforlide A | 84104-71-2 | Natural Products |
| HY-N0476R | Wilforlide A (Standard) | 84104-71-2 | Reference Standards |
| HY-N0478 | Neoline | 466-26-2 | Natural Products |
| HY-N0479 | Licarin B | 51020-87-2 | Natural Products |
| HY-N0480 | Reserpine | 50-55-5 | Natural Products |
| HY-N0480A | Reserpine (hydrochloride) | 16994-56-2 | Natural Products |
| HY-N0480R | Reserpine (Standard) | 50-55-5 | Reference Standards |
| HY-N0480S | Reserpine-d9 | 84759-11-5 | Isotope-Labeled Compounds |
| HY-N0481 | Roburic acid | 6812-81-3 | Natural Products |
| HY-N0481R | Roburic acid (Standard) | 6812-81-3 | Reference Standards |
| HY-N0482 | Phillyrin | 487-41-2 | Natural Products |
| HY-N0482R | Phillyrin (Standard) | 487-41-2 | Reference Standards |
| HY-N0483 | Phillygenin | 487-39-8 | Natural Products |
| HY-N0484 | Liensinine | 2586-96-1 | Natural Products |
| HY-N0485 | Liensinine (Diperchlorate) | 5088-90-4 | Natural Products |
| HY-N0486 | L-Leucine | 61-90-5 | Natural Products |
| HY-N0486R | L-Leucine (Standard) | 61-90-5 | Reference Standards |
| HY-N0486S | L-Leucine-d10 | 106972-44-5 | Isotope-Labeled Compounds |
| HY-N0486S1 | L-Leucine-13C | 74292-94-7 | Isotope-Labeled Compounds |
| HY-N0486S10 | L-Leucine-18O2 | 73579-45-0 | Isotope-Labeled Compounds |
| HY-N0486S11 | L-Leucine-d1 | 89836-93-1 | Isotope-Labeled Compounds |
| HY-N0486S12 | L-Leucine-d2 | 362049-59-0 | Isotope-Labeled Compounds |
| HY-N0486S13 | L-Leucine-15N,d10 | Isotope-Labeled Compounds | |
| HY-N0486S2 | L-Leucine-13C6 | 201740-84-3 | Isotope-Labeled Compounds |
| HY-N0486S3 | L-Leucine-15N | 59935-31-8 | Isotope-Labeled Compounds |
| HY-N0486S4 | L-Leucine-d7 | 92751-17-2 | Isotope-Labeled Compounds |
| HY-N0486S5 | L-Leucine-2-13C | 201612-66-0 | Isotope-Labeled Compounds |
| HY-N0486S6 | L-Leucine-2-13C,15N | 285977-88-0 | Isotope-Labeled Compounds |
| HY-N0486S7 | L-Leucine-1-13C,15N | 80134-83-4 | Isotope-Labeled Compounds |
| HY-N0486S8 | L-Leucine-13C6,15N | 202406-52-8 | Isotope-Labeled Compounds |
| HY-N0486S9 | L-Leucine-d3 | 87828-86-2 | Isotope-Labeled Compounds |
| HY-N0487 | Glucosamine (sulfate) | 29031-19-4 | Natural Products |
| HY-N0488 | Vincristine (sulfate) | 2068-78-2 | Natural Products |
| HY-N0488A | Vincristine | 57-22-7 | Natural Products |
| HY-N0488R | Vincristine (sulfate) (Standard) | 2068-78-2 | Reference Standards |
| HY-N0488S | Vincristine-d3 (sulfate) | 1246817-10-6 | Isotope-Labeled Compounds |
| HY-N0488S1 | Vincristine-d3-ester (sulfate) | 1217854-24-4 | Isotope-Labeled Compounds |
| HY-N0488S2 | Vincristine-d6 (sulfate) | Isotope-Labeled Compounds | |
| HY-N0491 | (-)-Sparteine (sulfate) | 299-39-8 | Reference compound |
| HY-N0492 | α-Lipoic Acid | 1077-28-7 | Natural Products |
| HY-N0492A | α-Lipoic Acid (sodium) | 2319-84-8 | Natural Products |
| HY-N0492AR | α-Lipoic Acid (sodium) (Standard) | 2319-84-8 | Reference Standards |
| HY-N0492R | α-Lipoic Acid (Standard) | 1077-28-7 | Reference Standards |
| HY-N0492S | α-Lipoic Acid-d5 | 1189471-66-6 | Isotope-Labeled Compounds |
| HY-N0493 | Pectolinarigenin | 520-12-7 | Natural Products |
| HY-N0493R | Pectolinarigenin (Standard) | 520-12-7 | Reference Standards |
| HY-N0494 | Gentiopicroside | 20831-76-9 | Natural Products |
| HY-N0494R | Gentiopicroside (Standard) | 20831-76-9 | Reference Standards |
| HY-N0495 | Aloenin | 38412-46-3 | Natural Products |
| HY-N0495R | Aloenin (Standard) | 38412-46-3 | Reference Standards |
| HY-N0496 | Ruscogenin | 472-11-7 | Natural Products |
| HY-N0496R | Ruscogenin (Standard) | 472-11-7 | Reference Standards |
| HY-N0498 | Nitidine (chloride) | 13063-04-2 | Natural Products |
| HY-N0498R | Nitidine (chloride) (Standard) | 13063-04-2 | Reference Standards |
| HY-N0499 | Cyanidin (Chloride) | 528-58-5 | Natural Products |
| HY-N0499A | Cyanidin | 13306-05-3 | Natural Products |
| HY-N0499R | Cyanidin (Chloride) (Standard) | 528-58-5 | Reference Standards |
| HY-N0500 | Mogroside III | 130567-83-8 | Natural Products |
| HY-N0501 | 11-oxo-mogroside V | 126105-11-1 | Natural Products |
| HY-N0501R | 11-oxo-mogroside V (Standard) | 126105-11-1 | Reference Standards |
| HY-N0502 | Mogroside V | 88901-36-4 | Natural Products |
| HY-N0502R | Mogroside V (Standard) | 88901-36-4 | Reference Standards |
| HY-N0504 | Lovastatin | 75330-75-5 | Natural Products |
| HY-N0504R | Lovastatin (Standard) | 75330-75-5 | Reference Standards |
| HY-N0504S1 | Lovastatin-d9 | Isotope-Labeled Compounds | |
| HY-N0504S2 | Lovastatin-d3 | 1002345-93-8 | Isotope-Labeled Compounds |
| HY-N0505 | Rosiridin | 100462-37-1 | Natural Products |
| HY-N0505R | Rosiridin (Standard) | 100462-37-1 | Reference Standards |
| HY-N0506 | Rosarin | 84954-93-8 | Natural Products |
| HY-N0506R | Rosarin (Standard) | 84954-93-8 | Reference Standards |
| HY-N0507 | Rosavin | 84954-92-7 | Natural Products |
| HY-N0507R | Rosavin (Standard) | 84954-92-7 | Reference Standards |
| HY-N0508 | Rosin | 85026-55-7 | Natural Products |
| HY-N0508R | Rosin (Standard) | 85026-55-7 | Reference Standards |
| HY-N0509 | Astilbin | 29838-67-3 | Natural Products |
| HY-N0509R | Astilbin (Standard) | 29838-67-3 | Reference Standards |
| HY-N0510 | Aristolochic acid A | 313-67-7 | Natural Products |
| HY-N0510A | Aristolochic acid A (sodium) | 10190-99-5 | Natural Products |
| HY-N0510R | Aristolochic acid A (Standard) | 313-67-7 | Reference Standards |
| HY-N0511 | Aristolochic acid B | 475-80-9 | Natural Products |
| HY-N0511R | Aristolochic acid B (Standard) | 475-80-9 | Reference Standards |
| HY-N0512 | Loganin | 18524-94-2 | Natural Products |
| HY-N0512R | Loganin (Standard) | 18524-94-2 | Reference Standards |
| HY-N0513 | Loganic acid | 22255-40-9 | Natural Products |
| HY-N0513R | Loganic acid (Standard) | 22255-40-9 | Reference Standards |
| HY-N0515 | Ophiopogonin D | 945619-74-9 | Natural Products |
| HY-N0515R | Ophiopogonin D (Standard) | 945619-74-9 | Reference Standards |
| HY-N0516 | Casticin | 479-91-4 | Natural Products |
| HY-N0516R | Casticin (Standard) | 479-91-4 | Reference Standards |
| HY-N0517 | Erianin | 95041-90-0 | Natural Products |
| HY-N0517R | Erianin (Standard) | 95041-90-0 | Reference Standards |
| HY-N0518 | Toddalolactone | 483-90-9 | Natural Products |
| HY-N0518R | Toddalolactone (Standard) | 483-90-9 | Reference Standards |
| HY-N0519 | Calycosin | 20575-57-9 | Natural Products |
| HY-N0519R | Calycosin (Standard) | 20575-57-9 | Reference Standards |
| HY-N0520 | Calycosin-7-O-β-D-glucoside | 20633-67-4 | Natural Products |
| HY-N0520R | Calycosin-7-O-β-D-glucoside (Standard) | 20633-67-4 | Reference Standards |
| HY-N0521 | (-)-Gallocatechin | 3371-27-5 | Natural Products |
| HY-N0521A | (+)-Gallocatechin | 970-73-0 | Natural Products |
| HY-N0521AS | (+)-Gallocatechin-13C3 | Isotope-Labeled Compounds | |
| HY-N0521R | (-)-Gallocatechin (Standard) | 3371-27-5 | Reference Standards |
| HY-N0522 | (-)-Gallocatechin gallate | 4233-96-9 | Natural Products |
| HY-N0522R | (-)-Gallocatechin gallate (Standard) | 4233-96-9 | Reference Standards |
| HY-N0523 | Gallic acid | 149-91-7 | Natural Products |
| HY-N0523A | Gallic acid (hydrate) | 5995-86-8 | Natural Products |
| HY-N0523AR | Gallic acid (hydrate) (Standard) | 5995-86-8 | Reference Standards |
| HY-N0523R | Gallic acid (Standard) | 149-91-7 | Reference Standards |
| HY-N0523S | Gallic acid-d2 | 294660-92-7 | Isotope-Labeled Compounds |
| HY-N0524 | Propyl gallate | 121-79-9 | Natural Products |
| HY-N0524R | Propyl gallate (Standard) | 121-79-9 | Reference Standards |
| HY-N0525 | Ethyl gallate | 831-61-8 | Natural Products |
| HY-N0525R | Ethyl gallate (Standard) | 831-61-8 | Reference Standards |
| HY-N0526 | 2"-O-Galloylhyperin | 53209-27-1 | Natural Products |
| HY-N0526R | 2"-O-Galloylhyperin (Standard) | 53209-27-1 | Reference Standards |
| HY-N0527 | Pentagalloylglucose | 14937-32-7 | Natural Products |
| HY-N0527R | Pentagalloylglucose (Standard) | 14937-32-7 | Reference Standards |
| HY-N0528 | Linarin | 480-36-4 | Natural Products |
| HY-N0528R | Linarin (Standard) | 480-36-4 | Reference Standards |
| HY-N0529 | Rosmarinic acid | 20283-92-5 | Natural Products |
| HY-N0529R | Rosmarinic acid (Standard) | 20283-92-5 | Reference Standards |
| HY-N0530 | Dryocrassin ABBA | 12777-70-7 | Natural Products |
| HY-N0531 | Filixic acid ABA | 38226-84-5 | Natural Products |
| HY-N0532 | Morroniside | 25406-64-8 | Natural Products |
| HY-N0532R | Morroniside (Standard) | 25406-64-8 | Reference Standards |
| HY-N0533 | Glucosyl-vitexin | 76135-82-5 | Natural Products |
| HY-N0534 | Vitexin-2"-O-rhamnoside | 64820-99-1 | Natural Products |
| HY-N0534R | Vitexin-2"-O-rhamnoside (Standard) | 64820-99-1 | Reference Standards |
| HY-N0535 | (+)-Magnoflorine (chloride) | 6681-18-1 | Natural Products |
| HY-N0535R | (+)-Magnoflorine (chloride) (Standard) | 6681-18-1 | Reference Standards |
| HY-N0537 | Xylose | 58-86-6 | Natural Products |
| HY-N0537R | Xylose (Standard) | 58-86-6 | Reference Standards |
| HY-N0537S | Xylose-18O | Isotope-Labeled Compounds | |
| HY-N0537S12 | Xylose-d1-3 | 288846-89-9 | Isotope-Labeled Compounds |
| HY-N0537S13 | Xylose-d1-4 | 288846-91-3 | Isotope-Labeled Compounds |
| HY-N0537S2 | Xylose-1-13C | 70849-21-7 | Isotope-Labeled Compounds |
| HY-N0537S3 | Xylose-2-13C | 131771-69-2 | Isotope-Labeled Compounds |
| HY-N0537S4 | Xylose-5-13C | 139657-63-9 | Isotope-Labeled Compounds |
| HY-N0537S5 | Xylose-3-13C | Isotope-Labeled Compounds | |
| HY-N0537S6 | Xylose-4-13C | Isotope-Labeled Compounds | |
| HY-N0537S9 | Xylose-d6 | 2687960-63-8 | Isotope-Labeled Compounds |
| HY-N0538 | Xylitol | 87-99-0 | Natural Products |
| HY-N0538R | Xylitol (Standard) | 87-99-0 | Reference Standards |
| HY-N0538S | Xylitol-1-13C | Isotope-Labeled Compounds | |
| HY-N0538S1 | Xylitol-2-13C | Isotope-Labeled Compounds | |
| HY-N0538S2 | Xylitol-5-13C | Isotope-Labeled Compounds | |
| HY-N0538S4 | Xylitol-d7 | Isotope-Labeled Compounds | |
| HY-N0539 | Calceolarioside B | 105471-98-5 | Natural Products |
| HY-N0539R | Calceolarioside B (Standard) | 105471-98-5 | Reference Standards |
| HY-N0540 | Cynaroside | 5373-11-5 | Reference compound |
| HY-N0540R | Cynaroside (Standard) | 5373-11-5 | Reference Standards |
| HY-N0541 | Pseudoginsenoside F11 | 69884-00-0 | Natural Products |
| HY-N0541R | Pseudoginsenoside F11 (Standard) | 69884-00-0 | Reference Standards |
| HY-N0542 | Pseudoginsenoside RT5 | 98474-78-3 | Natural Products |
| HY-N0542R | Pseudoginsenoside RT5 (Standard) | 98474-78-3 | Reference Standards |
| HY-N0543 | Allantoin | 97-59-6 | Natural Products |
| HY-N0543R | Allantoin (Standard) | 97-59-6 | Reference Standards |
| HY-N0543S | Allantoin-13C2,15N4 | 1219402-51-3 | Isotope-Labeled Compounds |
| HY-N0545 | Taurocholic acid (sodium) | 145-42-6 | Natural Products |
| HY-N0545R | Taurocholic acid (sodium) (Standard) | 145-42-6 | Reference Standards |
| HY-N0545S | Taurocholic acid-13C2,15N (sodium) | 2483830-59-5 | Isotope-Labeled Compounds |
| HY-N0546 | Ligustroflavone | 260413-62-5 | Natural Products |
| HY-N0546R | Ligustroflavone (Standard) | 260413-62-5 | Reference Standards |
| HY-N0547 | Nomilin | 1063-77-0 | Natural Products |
| HY-N0547R | Nomilin (Standard) | 1063-77-0 | Reference Standards |
| HY-N0548 | α-Angelica lactone | 591-12-8 | Natural Products |
| HY-N0549R | (-)-α-Pinene (Standard) | 7785-26-4 | Reference Standards |
| HY-N0550R | (-)-β-Pinene (Standard) | 18172-67-3 | Reference Standards |
| HY-N0551 | Wedelolactone | 524-12-9 | Natural Products |
| HY-N0551R | Wedelolactone (Standard) | 524-12-9 | Reference Standards |
| HY-N0553 | Gypenoside XVII | 80321-69-3 | Natural Products |
| HY-N0553R | Gypenoside XVII (Standard) | 80321-69-3 | Reference Standards |
| HY-N0554 | Escin IA | 123748-68-5 | Natural Products |
| HY-N0554R | Escin IA (Standard) | 123748-68-5 | Reference Standards |
| HY-N0555 | Escin IB | 26339-90-2 | Natural Products |
| HY-N0555R | Escin IB (Standard) | 26339-90-2 | Reference Standards |
| HY-N0556 | Isoescin IA | 219944-39-5 | Natural Products |
| HY-N0556R | Isoescin IA (Standard) | 219944-39-5 | Reference Standards |
| HY-N0557 | Isoescin IB | 219944-46-4 | Natural Products |
| HY-N0557R | Isoescin IB (Standard) | 219944-46-4 | Reference Standards |
| HY-N0558 | Alnustone | 33457-62-4 | Natural Products |
| HY-N0558R | Alnustone (Standard) | 33457-62-4 | Reference Standards |
| HY-N0559 | Kirenol | 52659-56-0 | Natural Products |
| HY-N0559R | Kirenol (Standard) | 52659-56-0 | Reference Standards |
| HY-N0560 | Oroxylin A | 480-11-5 | Natural Products |
| HY-N0560R | Oroxylin A (Standard) | 480-11-5 | Reference Standards |
| HY-N0561 | Lathyrol | 34420-19-4 | Natural Products |
| HY-N0561R | Lathyrol (Standard) | 34420-19-4 | Reference Standards |
| HY-N0562 | 5,15-Diacetyl-3-benzoyllathyrol | 218916-52-0 | Natural Products |
| HY-N0563 | Alizarin | 72-48-0 | Dye Reagents |
| HY-N0563R | Alizarin (Standard) | 72-48-0 | Dye Reagents |
| HY-N0564 | Notopterol | 88206-46-6 | Natural Products |
| HY-N0564R | Notopterol (Standard) | 88206-46-6 | Reference Standards |
| HY-N0565 | Doxycycline | 564-25-0 | Reference compound |
| HY-N0565A | Doxycycline (hydrochloride) | 10592-13-9 | Reference compound |
| HY-N0565AR | Doxycycline (hydrochloride) (Standard) | 10592-13-9 | Reference Standards |
| HY-N0565AS | Doxycycline-d3 hydrochloride | 2747918-45-0 | Isotope-Labeled Compounds |
| HY-N0565B | Doxycycline hyclate | 24390-14-5 | Reference compound |
| HY-N0565BR | Doxycycline hyclate (Standard) | 24390-14-5 | Reference Standards |
| HY-N0565C | Doxycycline (calcium) | 94088-85-4 | Reference compound |
| HY-N0565R | Doxycycline (Standard) | 564-25-0 | Reference Standards |
| HY-N0565S1 | Doxycycline-d3 (hyclate) (major) | Isotope-Labeled Compounds | |
| HY-N0565S3 | Doxycycline-13C,d3 | 1902958-13-7 | Isotope-Labeled Compounds |
| HY-N0566 | 23-Hydroxybetulinic acid | 85999-40-2 | Natural Products |
| HY-N0566R | 23-Hydroxybetulinic acid (Standard) | 85999-40-2 | Reference Standards |
| HY-N0567 | Hydroxysafflor yellow A | 78281-02-4 | Natural Products |
| HY-N0567R | Hydroxysafflor yellow A (Standard) | 78281-02-4 | Reference Standards |
| HY-N0568 | Madecassoside | 34540-22-2 | Natural Products |
| HY-N0568R | Madecassoside (Standard) | 34540-22-2 | Reference Standards |
| HY-N0569 | Madecassic acid | 18449-41-7 | Natural Products |
| HY-N0569R | Madecassic acid (Standard) | 18449-41-7 | Reference Standards |
| HY-N0570 | Hydroxytyrosol | 10597-60-1 | Natural Products |
| HY-N0570R | Hydroxytyrosol (Standard) | 10597-60-1 | Reference Standards |
| HY-N0570S | Hydroxytyrosol-d4 | 1330260-89-3 | Isotope-Labeled Compounds |
| HY-N0570S1 | Hydroxytyrosol-d5 | Isotope-Labeled Compounds | |
| HY-N0571 | Purpurin | 81-54-9 | Natural Products |
| HY-N0571R | Purpurin (Standard) | 81-54-9 | Reference Standards |
| HY-N0572 | 9-Hydroxycamptothecin | 67656-30-8 | Natural Products |
| HY-N0573 | Umbelliferone | 93-35-6 | Natural Products |
| HY-N0573R | Umbelliferone (Standard) | 93-35-6 | Reference Standards |
| HY-N0573S | Umbelliferone-d5 | 1215373-23-1 | Isotope-Labeled Compounds |
| HY-N0575 | Pinocembrin | 480-39-7 | Natural Products |
| HY-N0575R | Pinocembrin (Standard) | 480-39-7 | Reference Standards |
| HY-N0576 | Solanesol | 13190-97-1 | Natural Products |
| HY-N0576R | Solanesol (Standard) | 13190-97-1 | Reference Standards |
| HY-N0577 | Apiin | 26544-34-3 | Natural Products |
| HY-N0577R | Apiin (Standard) | 26544-34-3 | Reference Standards |
| HY-N0578 | Apigenin 7-glucoside | 578-74-5 | Natural Products |
| HY-N0578R | Apigenin 7-glucoside (Standard) | 578-74-5 | Reference Standards |
| HY-N0579 | Fraxin | 524-30-1 | Natural Products |
| HY-N0579R | Fraxin (Standard) | 524-30-1 | Reference Standards |
| HY-N0580 | Fraxetin | 574-84-5 | Natural Products |
| HY-N0580R | Fraxetin (Standard) | 574-84-5 | Reference Standards |
| HY-N0581 | Qingyangshengenin A | 106644-33-1 | Natural Products |
| HY-N0582 | Otophylloside B | 106758-54-7 | Natural Products |
| HY-N0583 | Hydrocortisone | 50-23-7 | Natural Products |
| HY-N0583R | Hydrocortisone (Standard) | 50-23-7 | Reference Standards |
| HY-N0583S1 | Hydrocortisone-d7 | Isotope-Labeled Compounds | |
| HY-N0583S2 | Hydrocortisone-d4 | 73565-87-4 | Isotope-Labeled Compounds |
| HY-N0583S3 | Hydrocortisone-d3 | 115699-92-8 | Isotope-Labeled Compounds |
| HY-N0583S5 | Hydrocortisone-d2 | 1257650-73-9 | Isotope-Labeled Compounds |
| HY-N0584 | Anisodamine | 55869-99-3 | Natural Products |
| HY-N0584A | Anisodamine (hydrobromide) | 55449-49-5 | Natural Products |
| HY-N0584AR | Anisodamine (hydrobromide) (Standard) | 55449-49-5 | Reference Standards |
| HY-N0584B | Anisodamine (hydrochloride) | 131674-05-0 | Natural Products |
| HY-N0585 | (Rac)-Norcantharidin | 5442-12-6 | Natural Products |
| HY-N0586 | Norisoboldine | 23599-69-1 | Natural Products |
| HY-N0586A | Norisoboldine (hydrochloride) | 5083-84-1 | Natural Products |
| HY-N0586R | Norisoboldine (Standard) | 23599-69-1 | Reference Standards |
| HY-N0587 | Demethylzeylasteral | 107316-88-1 | Natural Products |
| HY-N0587R | Demethylzeylasteral (Standard) | 107316-88-1 | Reference Standards |
| HY-N0588 | Deapioplatycodin D | 78763-58-3 | Natural Products |
| HY-N0589 | Dehydrodiisoeugenol | 2680-81-1 | Natural Products |
| HY-N0589R | Dehydrodiisoeugenol (Standard) | 2680-81-1 | Reference Standards |
| HY-N0590 | Corynoxeine | 630-94-4 | Natural Products |
| HY-N0590R | Corynoxeine (Standard) | 630-94-4 | Reference Standards |
| HY-N0591 | Dehydrocostus Lactone | 477-43-0 | Natural Products |
| HY-N0591R | Dehydrocostus Lactone (Standard) | 477-43-0 | Reference Standards |
| HY-N0592 | Demethyleneberberine | 25459-91-0 | Natural Products |
| HY-N0592A | Demethyleneberberine (chloride) | 16705-03-6 | Natural Products |
| HY-N0593 | Deoxycholic acid | 83-44-3 | Natural Products |
| HY-N0593A | Deoxycholic acid sodium salt | 302-95-4 | Natural Products |
| HY-N0593B | Deoxycholic acid (sodium hydrate) | 145224-92-6 | Natural Products |
| HY-N0593R | Deoxycholic acid (Standard) | 83-44-3 | Reference Standards |
| HY-N0593S | Deoxycholic acid-d4 | 112076-61-6 | Isotope-Labeled Compounds |
| HY-N0593S1 | Deoxycholic acid-d5 | 52840-14-9 | Isotope-Labeled Compounds |
| HY-N0593S2 | Deoxycholic acid-d6 | Isotope-Labeled Compounds | |
| HY-N0593S3 | Deoxycholic acid-13C | 52886-37-0 | Isotope-Labeled Compounds |
| HY-N0594 | Deacetylasperulosidic Acid | 14259-55-3 | Natural Products |
| HY-N0594R | Deacetylasperulosidic Acid (Standard) | 14259-55-3 | Reference Standards |
| HY-N0595 | Genistin | 529-59-9 | Natural Products |
| HY-N0595R | Genistin (Standard) | 529-59-9 | Reference Standards |
| HY-N0596 | Panaxadiol | 19666-76-3 | Natural Products |
| HY-N0596R | Panaxadiol (Standard) | 19666-76-3 | Reference Standards |
| HY-N0597 | Panaxatriol | 32791-84-7 | Natural Products |
| HY-N0597R | Panaxatriol (Standard) | 32791-84-7 | Reference Standards |
| HY-N0598 | Ginsenoside F1 | 53963-43-2 | Natural Products |
| HY-N0598R | Ginsenoside F1 (Standard) | 53963-43-2 | Reference Standards |
| HY-N0600 | Ginsenoside F3 | 62025-50-7 | Natural Products |
| HY-N0601 | Ginsenoside Rf | 52286-58-5 | Natural Products |
| HY-N0601R | Ginsenoside Rf (Standard) | 52286-58-5 | Reference Standards |
| HY-N0602 | Ginsenoside Rg2 | 52286-74-5 | Natural Products |
| HY-N0602R | Ginsenoside Rg2 (Standard) | 52286-74-5 | Reference Standards |
| HY-N0603 | 20(S)-Ginsenoside Rg3 | 14197-60-5 | Natural Products |
| HY-N0603R | 20(S)-Ginsenoside Rg3 (Standard) | 14197-60-5 | Reference Standards |
| HY-N0604 | Ginsenoside Rh1 | 63223-86-9 | Natural Products |
| HY-N0604R | Ginsenoside Rh1 (Standard) | 63223-86-9 | Reference Standards |
| HY-N0605 | Ginsenoside Rh2 | 78214-33-2 | Natural Products |
| HY-N0605R | Ginsenoside Rh2 (Standard) | 78214-33-2 | Reference Standards |
| HY-N0606 | Ginsenoside Rh3 | 105558-26-7 | Natural Products |
| HY-N0606R | Ginsenoside Rh3 (Standard) | 105558-26-7 | Reference Standards |
| HY-N0607 | Ginsenoside Ro | 34367-04-9 | Natural Products |
| HY-N0607R | Ginsenoside Ro (Standard) | 34367-04-9 | Reference Standards |
| HY-N0608 | Myrislignan | 171485-39-5 | Natural Products |
| HY-N0608A | (Rac)-Myrislignan | 41535-95-9 | Natural Products |
| HY-N0610 | Trans-Cinnamic acid | 140-10-3 | Natural Products |
| HY-N0610A | Cinnamic acid | 621-82-9 | Natural Products |
| HY-N0610AR | Cinnamic acid (Standard) | 621-82-9 | Reference Standards |
| HY-N0610AS | Cinnamic acid-d6 | 91453-04-2 | Isotope-Labeled Compounds |
| HY-N0610AS2 | Cinnamic acid-13C3 | 2734410-01-4 | Isotope-Labeled Compounds |
| HY-N0610R | trans-Cinnamic acid (Standard) | 140-10-3 | Reference Standards |
| HY-N0610S | trans-Cinnamic acid-d5 | 352431-48-2 | Isotope-Labeled Compounds |
| HY-N0610S1 | trans-Cinnamic acid-d7 | 343338-31-8 | Isotope-Labeled Compounds |
| HY-N0611 | alpha-Boswellic acid | 471-66-9 | Natural Products |
| HY-N0611R | alpha-Boswellic acid (Standard) | 471-66-9 | Reference Standards |
| HY-N0612 | Siamenoside I | 126105-12-2 | Natural Products |
| HY-N0612R | Siamenoside I (Standard) | 126105-12-2 | Reference Standards |
| HY-N0613 | Sauchinone | 177931-17-8 | Natural Products |
| HY-N0613R | Sauchinone (Standard) | 177931-17-8 | Reference Standards |
| HY-N0614 | Sucralose | 56038-13-2 | Reference compound |
| HY-N0614A | Sucralose (Excipient) | 56038-13-2 | Natural Products |
| HY-N0614R | Sucralose (Standard) | 56038-13-2 | Reference Standards |
| HY-N0614S | Sucralose-d6 | 1459161-55-7 | Isotope-Labeled Compounds |
| HY-N0615 | Notoginsenoside R1 | 80418-24-2 | Natural Products |
| HY-N0615R | Notoginsenoside R1 (Standard) | 80418-24-2 | Reference Standards |
| HY-N0616 | Trifolirhizin | 6807-83-6 | Natural Products |
| HY-N0616R | Trifolirhizin (Standard) | 6807-83-6 | Reference Standards |
| HY-N0617 | Sanggenon C | 80651-76-9 | Natural Products |
| HY-N0618 | Sanggenon D | 81422-93-7 | Natural Products |
| HY-N0619 | Mulberroside A | 102841-42-9 | Natural Products |
| HY-N0619A | cis-Mulberroside A | 166734-06-1 | Natural Products |
| HY-N0619R | Mulberroside A (Standard) | 102841-42-9 | Reference Standards |
| HY-N0620 | Mulberroside C | 102841-43-0 | Natural Products |
| HY-N0621 | Morin | 480-16-0 | Natural Products |
| HY-N0621R | Morin (Standard) | 480-16-0 | Reference Standards |
| HY-N0622 | Morusin | 62596-29-6 | Natural Products |
| HY-N0622R | Morusin (Standard) | 62596-29-6 | Reference Standards |
| HY-N0623 | L-Tryptophan | 73-22-3 | Natural Products |
| HY-N0623R | L-Tryptophan (standard) | 73-22-3 | Reference Standards |
| HY-N0623S | L-Tryptophan-d5 | 62595-11-3 | Isotope-Labeled Compounds |
| HY-N0623S1 | L-Tryptophan-13C | 115709-68-7 | Isotope-Labeled Compounds |
| HY-N0623S10 | L-Phenylalanine,Indole-15N | 84344-22-9 | Isotope-Labeled Compounds |
| HY-N0623S2 | L-Tryptophan-13C11 | 202114-65-6 | Isotope-Labeled Compounds |
| HY-N0623S3 | L-Tryptophan-1-13C | 81201-92-5 | Isotope-Labeled Compounds |
| HY-N0623S4 | L-Tryptophan-13C11,15N2 | 202406-50-6 | Isotope-Labeled Compounds |
| HY-N0623S5 | L-Tryptophan-d8 | 1233395-93-1 | Isotope-Labeled Compounds |
| HY-N0623S6 | L-Tryptophan-15N2,d8 | Isotope-Labeled Compounds | |
| HY-N0623S7 | L-Tryptophan-15N | Isotope-Labeled Compounds | |
| HY-N0623S8 | L-Tryptophan-15N2 | 204634-20-8 | Isotope-Labeled Compounds |
| HY-N0623S9 | L-Tryptophan-d3 | 133519-78-5 | Isotope-Labeled Compounds |
| HY-N0624 | Complanatoside A | 146501-37-3 | Natural Products |
| HY-N0625A | Alpinetin | 36052-37-6 | Natural Products |
| HY-N0625AR | Alpinetin (Standard) | 36052-37-6 | Reference Standards |
| HY-N0626 | Sorbic acid | 110-44-1 | Natural Products |
| HY-N0626A | Potassium sorbate | 24634-61-5 | Natural Products |
| HY-N0626AR | Potassium sorbate (Standard) | 24634-61-5 | Reference Standards |
| HY-N0626R | Sorbic acid (Standard) | 110-44-1 | Reference Standards |
| HY-N0627 | Kaempferol-7-O-β-D-glucopyranoside | 16290-07-6 | Natural Products |
| HY-N0628 | Kaempferitrin | 482-38-2 | Natural Products |
| HY-N0628R | Kaempferitrin (Standard) | 482-38-2 | Reference Standards |
| HY-N0629 | Maslinic acid | 4373-41-5 | Natural Products |
| HY-N0629R | Maslinic acid (Standard) | 4373-41-5 | Reference Standards |
| HY-N0630 | Shanzhiside methyl ester | 64421-28-9 | Natural Products |
| HY-N0630R | Shanzhiside methyl ester (Standard) | 64421-28-9 | Reference Standards |
| HY-N0631 | Cornuside | 131189-57-6 | Natural Products |
| HY-N0631R | Cornuside (Standard) | 131189-57-6 | Reference Standards |
| HY-N0632 | Esculentoside A | 65497-07-6 | Natural Products |
| HY-N0632R | Esculentoside A (Standard) | 65497-07-6 | Reference Standards |
| HY-N0633 | Muscone | 541-91-3 | Natural Products |
| HY-N0633R | Muscone (Standard) | 541-91-3 | Reference Standards |
| HY-N0634 | Cimifugin | 37921-38-3 | Natural Products |
| HY-N0634R | Cimifugin (Standard) | 37921-38-3 | Reference Standards |
| HY-N0635 | Prim-O-glucosylcimifugin | 80681-45-4 | Natural Products |
| HY-N0635R | Prim-O-glucosylcimifugin (Standard) | 80681-45-4 | Reference Standards |
| HY-N0636 | Eriocitrin | 13463-28-0 | Natural Products |
| HY-N0636R | Eriocitrin (Standard) | 13463-28-0 | Reference Standards |
| HY-N0637 | Eriodictyol | 552-58-9 | Natural Products |
| HY-N0637A | (±)-Eriodictyol | 4049-38-1 | Natural Products |
| HY-N0637AR | (±)-Eriodictyol (Standard) | 4049-38-1 | Reference Standards |
| HY-N0637R | Eriodictyol (Standard) | 552-58-9 | Reference Standards |
| HY-N0638 | Dendrobine | 2115-91-5 | Natural Products |
| HY-N0638R | Dendrobine (Standard) | 2115-91-5 | Reference Standards |
| HY-N0639 | Punicalin | 65995-64-4 | Natural Products |
| HY-N0639R | Punicalin (Standard) | 65995-64-4 | Reference Standards |
| HY-N0640 | Kuromanin (chloride) | 7084-24-4 | Natural Products |
| HY-N0640R | Kuromanin (chloride) (Standard) | 7084-24-4 | Reference Standards |
| HY-N0642 | α-L-Rhamnose monohydrate | 6155-35-7 | Natural Products |
| HY-N0643 | Carnosol | 5957-80-2 | Natural Products |
| HY-N0643R | Carnosol (Standard) | 5957-80-2 | Reference Standards |
| HY-N0644 | Carnosic acid | 3650-09-7 | Natural Products |
| HY-N0644R | Carnosic acid (Standard) | 3650-09-7 | Reference Standards |
| HY-N0645 | Dicoumarol | 66-76-2 | Natural Products |
| HY-N0646 | Silydianin | 29782-68-1 | Natural Products |
| HY-N0646R | Silydianin (Standard) | 29782-68-1 | Reference Standards |
| HY-N0647 | Silychristin | 33889-69-9 | Natural Products |
| HY-N0647R | Silychristin (Standard) | 33889-69-9 | Reference Standards |
| HY-N0648 | Monotropein | 5945-50-6 | Natural Products |
| HY-N0648R | Monotropein (Standard) | 5945-50-6 | Reference Standards |
| HY-N0649 | Narcissin | 604-80-8 | Natural Products |
| HY-N0649R | Narcissin (Standard) | 604-80-8 | Reference Standards |
| HY-N0650 | L-Serine | 56-45-1 | Natural Products |
| HY-N0650R | L-Serine (Standard) | 56-45-1 | Reference Standards |
| HY-N0650S | L-Serine-13C3 | 201595-68-8 | Isotope-Labeled Compounds |
| HY-N0650S1 | L-Serine-13C | 89232-77-9 | Isotope-Labeled Compounds |
| HY-N0650S10 | L-Serine-15N | 59935-32-9 | Isotope-Labeled Compounds |
| HY-N0650S11 | L-Serine-d7 | 935275-35-7 | Isotope-Labeled Compounds |
| HY-N0650S12 | L-Serine-d3,15n | Isotope-Labeled Compounds | |
| HY-N0650S2 | L-Serine-1-13C | 81201-84-5 | Isotope-Labeled Compounds |
| HY-N0650S3 | L-Serine-13C3,15N,d3 | 1994299-33-0 | Isotope-Labeled Compounds |
| HY-N0650S4 | L-Serine-2-13C | 89232-76-8 | Isotope-Labeled Compounds |
| HY-N0650S5 | L-Serine-13C3,15N | 202407-34-9 | Isotope-Labeled Compounds |
| HY-N0650S6 | L-Serine1-13C,15N | 2483830-04-0 | Isotope-Labeled Compounds |
| HY-N0650S7 | L-Serine-d2 | 95034-57-4 | Isotope-Labeled Compounds |
| HY-N0650S8 | L-Serine-d3 | 105591-10-4 | Isotope-Labeled Compounds |
| HY-N0650S9 | L-Serine-15N,d3 | Isotope-Labeled Compounds | |
| HY-N0651 | Spinosin | 72063-39-9 | Natural Products |
| HY-N0651R | Spinosin (Standard) | 72063-39-9 | Reference Standards |
| HY-N0652 | 2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside | 82373-94-2 | Natural Products |
| HY-N0652R | 2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside (Standard) | 82373-94-2 | Reference Standards |
| HY-N0654 | Corypalmine | 27313-86-6 | Natural Products |
| HY-N0655 | D-Pinitol | 10284-63-6 | Natural Products |
| HY-N0655R | D-Pinitol (Standard) | 10284-63-6 | Reference Standards |
| HY-N0656 | Usnic acid | 125-46-2 | Natural Products |
| HY-N0656A | (+)-Usnic acid | 7562-61-0 | Natural Products |
| HY-N0656AR | (+)-Usnic acid (Standard) | 7562-61-0 | Reference Standards |
| HY-N0657 | Pinoresinol Diglucoside | 63902-38-5 | Natural Products |
| HY-N0657R | Pinoresinol Diglucoside (Standard) | 63902-38-5 | Reference Standards |
| HY-N0658 | L-Threonine | 72-19-5 | Natural Products |
| HY-N0658A | DL-Threonine | 80-68-2 | Natural Products |
| HY-N0658AR | DL-Threonine (Standard) | 80-68-2 | Reference Standards |
| HY-N0658R | L-Threonine (Standard) | 72-19-5 | Reference Standards |
| HY-N0658S | L-Threonine-15N | 80681-09-0 | Isotope-Labeled Compounds |
| HY-N0658S1 | L-Threonine-d5 | 1217456-38-6 | Isotope-Labeled Compounds |
| HY-N0658S2 | L-Threonine-13C4,15N,d5 | 2378755-51-0 | Isotope-Labeled Compounds |
| HY-N0658S3 | L-Threonine-13C4,15N | 202468-39-1 | Isotope-Labeled Compounds |
| HY-N0658S4 | L-Threonine-15N,d5 | Isotope-Labeled Compounds | |
| HY-N0658S5 | L-Threonine-d2 | 1202936-45-5 | Isotope-Labeled Compounds |
| HY-N0658S6 | L-Threonine-13C4 | 55443-53-3 | Isotope-Labeled Compounds |
| HY-N0659 | Jujuboside A | 55466-04-1 | Natural Products |
| HY-N0659R | Jujuboside A (Standard) | 55466-04-1 | Reference Standards |
| HY-N0660 | Jujuboside B | 55466-05-2 | Natural Products |
| HY-N0660R | Jujuboside B (Standard) | 55466-05-2 | Reference Standards |
| HY-N0661 | Alliin | 556-27-4 | Natural Products |
| HY-N0661R | Alliin (Standard) | 556-27-4 | Reference Standards |
| HY-N0662 | Amentoflavone | 1617-53-4 | Natural Products |
| HY-N0662R | Amentoflavone (Standard) | 1617-53-4 | Reference Standards |
| HY-N0663 | Talatisamine | 20501-56-8 | Natural Products |
| HY-N0664 | Aucubin | 479-98-1 | Natural Products |
| HY-N0664R | Aucubin (Standard) | 479-98-1 | Reference Standards |
| HY-N0665 | Specnuezhenide | 39011-92-2 | Natural Products |
| HY-N0665R | Specnuezhenide (Standard) | 39011-92-2 | Reference Standards |
| HY-N0666 | L-Aspartic acid | 56-84-8 | Natural Products |
| HY-N0666A | L-Aspartic acid (potassium) | 1115-63-5 | Natural Products |
| HY-N0666AR | L-Aspartic acid (potassium) (Standard) | 1115-63-5 | Reference Standards |
| HY-N0666B | Aspartic acid (calcium) | 10389-09-0 | Natural Products |
| HY-N0666BR | Aspartic acid (calcium) (Standard) | 10389-09-0 | Reference Standards |
| HY-N0666C | L-Aspartic aicd (sodium) | 3792-50-5 | Natural Products |
| HY-N0666D | L-Aspartic aicd (disodium) | 5598-53-8 | Natural Products |
| HY-N0666E | L-Aspartic acid (monocesium) | 845744-47-0 | Natural Products |
| HY-N0666R | L-Aspartic acid (Standard) | 56-84-8 | Reference Standards |
| HY-N0666S | L-Aspartic acid-13C | 81201-97-0 | Isotope-Labeled Compounds |
| HY-N0666S1 | L-Aspartic acid-13C4,15N | 202468-27-7 | Isotope-Labeled Compounds |
| HY-N0666S10 | L-Aspartic acid-C13-1 | 68261-19-8 | Isotope-Labeled Compounds |
| HY-N0666S2 | DL-Aspartic acid-d3 | 14341-75-4 | Isotope-Labeled Compounds |
| HY-N0666S3 | L-Aspartic acid-15N | 3715-16-0 | Isotope-Labeled Compounds |
| HY-N0666S4 | L-Aspartic acid-13C4 | 55443-54-4 | Isotope-Labeled Compounds |
| HY-N0666S5 | L-Aspartic acid-13C4,15N,d3 | 1217475-13-2 | Isotope-Labeled Compounds |
| HY-N0666S6 | L-Aspartic acid-1,4-13C2 | 101247-29-4 | Isotope-Labeled Compounds |
| HY-N0666S7 | L-Aspartic acid-1,4-13C2,15N | 2483830-03-9 | Isotope-Labeled Compounds |
| HY-N0666S8 | L-Aspartic acid-d3 | 3842-25-9 | Isotope-Labeled Compounds |
| HY-N0666S9 | L-Aspartic acid-15N,d3 | 1308264-52-9 | Isotope-Labeled Compounds |
| HY-N0667 | L-Asparagine | 70-47-3 | Natural Products |
| HY-N0667R | L-Asparagine (Standard) | 70-47-3 | Reference Standards |
| HY-N0667S | L-Asparagine-13C4,15N2,d8 | 1217464-18-0 | Isotope-Labeled Compounds |
| HY-N0667S1 | L-Asparagine-15N2,d8 | 1217473-37-4 | Isotope-Labeled Compounds |
| HY-N0667S2 | L-Asparagine-15N2 (monohydrate) | 287484-32-6 | Isotope-Labeled Compounds |
| HY-N0667S3 | L-Asparagine-13C4 (monohydrate) | 286460-82-0 | Isotope-Labeled Compounds |
| HY-N0667S4 | L-Asparagine-4-13C (monohydrate) | 286437-12-5 | Isotope-Labeled Compounds |
| HY-N0667S5 | L-Asparagine-d3 (hydrate) | 2483831-59-8 | Isotope-Labeled Compounds |
| HY-N0667S7 | L-Asparagine-13C4,15N2 | 781596-75-6 | Isotope-Labeled Compounds |
| HY-N0668 | Rubusoside | 64849-39-4 | Natural Products |
| HY-N0668R | Rubusoside (Standard) | 64849-39-4 | Reference Standards |
| HY-N0669 | Stevioside | 57817-89-7 | Natural Products |
| HY-N0669R | Stevioside (Standard) | 57817-89-7 | Reference Standards |
| HY-N0670 | Tenacissoside H | 191729-45-0 | Natural Products |
| HY-N0671 | Rhapontin | 155-58-8 | Natural Products |
| HY-N0671R | Rhapontin (Standard) | 155-58-8 | Reference Standards |
| HY-N0672 | Pseudolaric Acid C | 82601-41-0 | Natural Products |
| HY-N0672R | Pseudolaric Acid C (Standard) | 82601-41-0 | Reference Standards |
| HY-N0673 | Pseudolaric Acid A | 82508-32-5 | Natural Products |
| HY-N0673R | Pseudolaric Acid A (Standard) | 82508-32-5 | Reference Standards |
| HY-N0674 | Dehydrocorydaline | 30045-16-0 | Natural Products |
| HY-N0674A | Dehydrocorydaline (chloride) | 10605-03-5 | Natural Products |
| HY-N0674B | Dehydrocorydaline (hydroxyl) | Natural Products | |
| HY-N0675 | Anhydrovinblastine | 38390-45-3 | Natural Products |
| HY-N0675A | Anhydrovinblastine (sulfate) | Natural Products | |
| HY-N0676 | Dehydroandrographolide | 134418-28-3 | Natural Products |
| HY-N0676R | Dehydroandrographolide (Standard) | 134418-28-3 | Reference Standards |
| HY-N0677 | Dehydroandrographolide succinate | 786593-06-4 | Natural Products |
| HY-N0677A | Kalii Dehydrographolidi Succinas | 76958-99-1 | Natural Products |
| HY-N0677AR | Kalii Dehydrographolidi Succinas (Standard) | 76958-99-1 | Reference Standards |
| HY-N0678 | Icaritin | 118525-40-9 | Natural Products |
| HY-N0678R | Icaritin (Standard) | 118525-40-9 | Reference Standards |
| HY-N0679 | Retinyl acetate | 127-47-9 | Natural Products |
| HY-N0679R | Retinyl acetate (Standard) | 127-47-9 | Reference Standards |
| HY-N0679S | Retinyl acetate-d3 | 118139-36-9 | Isotope-Labeled Compounds |
| HY-N0679S4 | Retinyl acetate-d4 | 118139-40-5 | Isotope-Labeled Compounds |
| HY-N0680 | Thiamine (hydrochloride) | 67-03-8 | Natural Products |
| HY-N0680R | Thiamine (hydrochloride) (Standard) | 67-03-8 | Reference Standards |
| HY-N0680S | Thiamine monochloride-13C (hydrochloride) | 1257525-77-1 | Isotope-Labeled Compounds |
| HY-N0680S1 | Thiamine-d3 (hydrochloride) | 2241872-28-4 | Isotope-Labeled Compounds |
| HY-N0680S2 | Thiamine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0680S3 | Thiamine-13C3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0681 | D-Pantothenic acid (hemicalcium salt) | 137-08-6 | Natural Products |
| HY-N0681R | D-Pantothenic acid (hemicalcium salt) (Standard) | 137-08-6 | Reference Standards |
| HY-N0682 | Pyridoxine (hydrochloride) | 58-56-0 | Natural Products |
| HY-N0682R | Pyridoxine (hydrochloride) (Standard) | 58-56-0 | Reference Standards |
| HY-N0682S | Pyridoxine-d3 (hydrochloride) | 1189921-12-7 | Isotope-Labeled Compounds |
| HY-N0682S1 | Pyridoxine-d2 (hydrochloride) | 5027-82-7 | Isotope-Labeled Compounds |
| HY-N0682S2 | Pyridoxine-d5 (hydrochloride) | 82896-38-6 | Isotope-Labeled Compounds |
| HY-N0682S3 | Pyridoxine-13C4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0683 | α-Vitamin E | 59-02-9 | Natural Products |
| HY-N0683A | rel-α-Vitamin E | 2074-53-5 | Natural Products |
| HY-N0683R | α-Vitamin E (Standard) | 59-02-9 | Reference Standards |
| HY-N0683S | 2-ambo-Vitamin E-13C6 | 2140857-08-3 | Isotope-Labeled Compounds |
| HY-N0683S1 | 2-ambo-Vitamin E-13C3 | 2140857-06-1 | Isotope-Labeled Compounds |
| HY-N0683S6 | α-Vitamin E-d11 | 2874378-75-1 | Isotope-Labeled Compounds |
| HY-N0684 | Vitamin K1 | 84-80-0 | Natural Products |
| HY-N0684A | cis-Vitamin K1 | 16033-41-3 | Reference compound |
| HY-N0684AS | cis-Vitamin K1-d7 | Isotope-Labeled Compounds | |
| HY-N0684R | Vitamin K1 (Standard) | 84-80-0 | Reference Standards |
| HY-N0684S | Vitamin K1-d7 | 1373049-34-3 | Isotope-Labeled Compounds |
| HY-N0684S1 | Vitamin K1-d4 | 5172-18-9 | Isotope-Labeled Compounds |
| HY-N0684S3 | Vitamin K1-13C6 | Isotope-Labeled Compounds | |
| HY-N0684S4 | Vitamin K1-d3 | 5172-17-8 | Isotope-Labeled Compounds |
| HY-N0685 | Pseudohypericin | 55954-61-5 | Natural Products |
| HY-N0685R | Pseudohypericin (Standard) | 55954-61-5 | Reference Standards |
| HY-N0686 | Pseudoprotodioscin | 102115-79-7 | Natural Products |
| HY-N0686R | Pseudoprotodioscin (Standard) | 102115-79-7 | Reference Standards |
| HY-N0687 | Vindoline | 2182-14-1 | Natural Products |
| HY-N0688 | Linderane | 13476-25-0 | Natural Products |
| HY-N0688R | Linderane (Standard) | 13476-25-0 | Reference Standards |
| HY-N0690 | Schisandrin C | 61301-33-5 | Natural Products |
| HY-N0690R | Schisandrin C (Standard) | 61301-33-5 | Reference Standards |
| HY-N0691 | Schisandrin | 7432-28-2 | Natural Products |
| HY-N0691R | Schisandrin (Standard) | 7432-28-2 | Reference Standards |
| HY-N0692 | Schisandrol B | 58546-54-6 | Natural Products |
| HY-N0692R | Schisandrol B (Standard) | 58546-54-6 | Reference Standards |
| HY-N0693 | Schisandrin A | 61281-38-7 | Natural Products |
| HY-N0693R | Schisandrin A (Standard) | 61281-38-7 | Reference Standards |
| HY-N0694 | Schisantherin A | 58546-56-8 | Natural Products |
| HY-N0694R | Schisantherin A (Standard) | 58546-56-8 | Reference Standards |
| HY-N0695 | Schisantherin B | 58546-55-7 | Natural Products |
| HY-N0695R | Schisantherin B (Standard) | 58546-55-7 | Reference Standards |
| HY-N0696 | Sipeimine | 61825-98-7 | Natural Products |
| HY-N0696R | Sipeimine (Standard) | 61825-98-7 | Reference Standards |
| HY-N0697 | Crocin | 42553-65-1 | Natural Products |
| HY-N0697R | Crocin (Standard) | 42553-65-1 | Reference Standards |
| HY-N0698 | Crocin II | 55750-84-0 | Natural Products |
| HY-N0698R | Crocin II (Standard) | 55750-84-0 | Reference Standards |
| HY-N0699 | Daphnoretin | 2034-69-7 | Natural Products |
| HY-N0699R | Daphnoretin (Standard) | 2034-69-7 | Reference Standards |
| HY-N0700 | alpha-Asarone | 2883-98-9 | Natural Products |
| HY-N0700R | alpha-Asarone (Standard) | 2883-98-9 | Reference Standards |
| HY-N0701 | (-)-Asarinin | 133-04-0 | Natural Products |
| HY-N0701A | Asarinin | 133-05-1 | Natural Products |
| HY-N0701C | DL-Asarinin | 7076-24-6 | Natural Products |
| HY-N0701R | (-)-Asarinin (Standard) | 133-04-0 | Reference Standards |
| HY-N0702 | Tenuifolin | 20183-47-5 | Natural Products |
| HY-N0702R | Tenuifolin (Standard) | 20183-47-5 | Reference Standards |
| HY-N0703 | Schaftoside | 51938-32-0 | Natural Products |
| HY-N0703R | Schaftoside (Standard) | 51938-32-0 | Reference Standards |
| HY-N0704 | Agrimol B | 55576-66-4 | Natural Products |
| HY-N0705 | Curculigoside | 85643-19-2 | Natural Products |
| HY-N0705R | Curculigoside (Standard) | 85643-19-2 | Reference Standards |
| HY-N0706 | Gracillin | 19083-00-2 | Natural Products |
| HY-N0706R | Gracillin (Standard) | 19083-00-2 | Reference Standards |
| HY-N0707 | (S)-Indoximod | 21339-55-9 | Natural Products |
| HY-N0707S | (S)-Indoximod-d3 | 1801851-87-5 | Isotope-Labeled Compounds |
| HY-N0708 | Vanillic acid | 121-34-6 | Natural Products |
| HY-N0708R | Vanillic acid (Standard) | 121-34-6 | Reference Standards |
| HY-N0709 | Coumarin | 91-64-5 | Natural Products |
| HY-N0709R | Coumarin (Standard) | 91-64-5 | Reference Standards |
| HY-N0709S | Coumarin-d4 | 185056-83-1 | Isotope-Labeled Compounds |
| HY-N0709S1 | Coumarin-d6 | 116295-83-1 | Isotope-Labeled Compounds |
| HY-N0710 | alpha-Cyperone | 473-08-5 | Natural Products |
| HY-N0710R | alpha-Cyperone (Standard) | 473-08-5 | Reference Standards |
| HY-N0711 | Carvacrol | 499-75-2 | Natural Products |
| HY-N0711R | Carvacrol (Standard) | 499-75-2 | Reference Standards |
| HY-N0712 | Typhaneoside | 104472-68-6 | Natural Products |
| HY-N0712R | Typhaneoside (Standard) | 104472-68-6 | Reference Standards |
| HY-N0713 | Diosmetin-7-O-β-D-glucopyranoside | 20126-59-4 | Natural Products |
| HY-N0714 | Berbamine | 478-61-5 | Natural Products |
| HY-N0714A | Berbamine (dihydrochloride) | 6078-17-7 | Natural Products |
| HY-N0716 | Berberine | 2086-83-1 | Natural Products |
| HY-N0716A | Berberine (hemisulfate) | 316-41-6 | Natural Products |
| HY-N0716AR | Berberine (hemisulfate) (Standard) | 316-41-6 | Reference Standards |
| HY-N0716B | Berberine (sulfate) | 633-66-9 | Natural Products |
| HY-N0716BR | Berberine (sulfate) (Standard) | 633-66-9 | Reference Standards |
| HY-N0717 | L-Valine | 72-18-4 | Natural Products |
| HY-N0717A | D-Valine | 640-68-6 | Reference compound |
| HY-N0717AS | D-Valine-d8 | 1116448-82-8 | Isotope-Labeled Compounds |
| HY-N0717R | L-Valine (Standard) | 72-18-4 | Reference Standards |
| HY-N0717S | L-Valine-15N | 59935-29-4 | Isotope-Labeled Compounds |
| HY-N0717S1 | L-Valine-13C5,15N | 202407-30-5 | Isotope-Labeled Compounds |
| HY-N0717S2 | L-Valine-13C5,15N,d8 | 1994261-62-9 | Isotope-Labeled Compounds |
| HY-N0717S3 | L-Valine-13C5,15N,d2 | 201417-09-6 | Isotope-Labeled Compounds |
| HY-N0717S4 | L-Valine-1-13C | 81201-85-6 | Isotope-Labeled Compounds |
| HY-N0717S5 | L-Valine-2-13C | 73834-52-3 | Isotope-Labeled Compounds |
| HY-N0717S6 | L-Valine-13C5 | 55443-52-2 | Isotope-Labeled Compounds |
| HY-N0717S7 | L-Valine-1-13C,15N | 87019-54-3 | Isotope-Labeled Compounds |
| HY-N0717S8 | L-Valine-d1 | 77257-03-5 | Isotope-Labeled Compounds |
| HY-N0717S9 | L-Valine-15N,d8 | Isotope-Labeled Compounds | |
| HY-N0718 | Valepotriate | 18296-44-1 | Natural Products |
| HY-N0718R | Valepotriate (Standard) | 18296-44-1 | Reference Standards |
| HY-N0719 | Fargesin | 31008-19-2 | Natural Products |
| HY-N0719R | Fargesin (Standard) | 31008-19-2 | Reference Standards |
| HY-N0720 | Neobavaisoflavone | 41060-15-5 | Natural Products |
| HY-N0720R | Neobavaisoflavone (Standard) | 41060-15-5 | Reference Standards |
| HY-N0721 | Neoandrographolide | 27215-14-1 | Natural Products |
| HY-N0721R | Neoandrographolide (Standard) | 27215-14-1 | Reference Standards |
| HY-N0722 | Neochlorogenic acid | 906-33-2 | Natural Products |
| HY-N0722R | Neochlorogenic acid (Standard) | 906-33-2 | Reference Standards |
| HY-N0723 | Neomangiferin | 64809-67-2 | Natural Products |
| HY-N0723R | Neomangiferin (Standard) | 64809-67-2 | Reference Standards |
| HY-N0724 | Mesaconitine | 2752-64-9 | Natural Products |
| HY-N0724R | Mesaconitine (Standard) | 2752-64-9 | Reference Standards |
| HY-N0725 | Cucurbitacin S | 60137-06-6 | Natural Products |
| HY-N0726 | Dracorhodin perchlorate | 125536-25-6 | Natural Products |
| HY-N0726R | Dracorhodin perchlorate (Standard) | 125536-25-6 | Reference Standards |
| HY-N0728 | α-Linolenic acid | 463-40-1 | Natural Products |
| HY-N0728A | α-Linolenic acid (sodium) | 822-18-4 | Reference compound |
| HY-N0728R | α-Linolenic acid (Standard) | 463-40-1 | Reference Standards |
| HY-N0728S | α-Linolenic acid-d5 | 145191-04-4 | Isotope-Labeled Compounds |
| HY-N0728S2 | α-Linolenic acid-d14 | 1622944-40-4 | Isotope-Labeled Compounds |
| HY-N0728S3 | α-Linolenic acid-13C18 | 287111-28-8 | Isotope-Labeled Compounds |
| HY-N0729 | Linoleic acid | 60-33-3 | Natural Products |
| HY-N0729G | Linoleic acid (GMP) | 60-33-3 | GMP Small Molecules |
| HY-N0729S | Linoleic acid-d4 | 79050-23-0 | Isotope-Labeled Compounds |
| HY-N0729S1 | Linoleic acid-d11 | 2055171-21-4 | Isotope-Labeled Compounds |
| HY-N0729S2 | Linoleic acid-13C18 | 287111-25-5 | Isotope-Labeled Compounds |
| HY-N0729S3 | Linoleic acid-13C1 | 98353-71-0 | Isotope-Labeled Compounds |
| HY-N0729S4 | Linoleic acid-d5 | 1169764-58-2 | Isotope-Labeled Compounds |
| HY-N0729S5 | Linoleic acid-d2 | 31447-29-7 | Isotope-Labeled Compounds |
| HY-N0730 | Diosgenin glucoside | 14144-06-0 | Natural Products |
| HY-N0730R | Diosgenin glucoside (Standard) | 14144-06-0 | Reference Standards |
| HY-N0731 | Genkwanin | 437-64-9 | Natural Products |
| HY-N0731R | Genkwanin (Standard) | 437-64-9 | Reference Standards |
| HY-N0732 | Jolkinolide B | 37905-08-1 | Natural Products |
| HY-N0732R | Jolkinolide B (Standard) | 37905-08-1 | Reference Standards |
| HY-N0733 | Glucosamine (hydrochloride) | 66-84-2 | Natural Products |
| HY-N0733R | Glucosamine (hydrochloride) (Standard) | 66-84-2 | Reference Standards |
| HY-N0733S | Glucosamine-13C (hydrochloride) | 84247-63-2 | Isotope-Labeled Compounds |
| HY-N0733S1 | Glucosamine-2-13C (hydrochloride) | 1220349-37-0 | Isotope-Labeled Compounds |
| HY-N0733S2 | Glucosamine-13C,15N (hydrochloride) | 143553-09-7 | Isotope-Labeled Compounds |
| HY-N0733S3 | Glucosamine-6-13C (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0733S4 | Glucosamine-15N (hydrochloride) | 42927-60-6 | Isotope-Labeled Compounds |
| HY-N0733S5 | Glucosamine-13C6,15N (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0735 | Phellodendrine (chloride) | 104112-82-5 | Natural Products |
| HY-N0735R | Phellodendrine (chloride) (Standard) | 104112-82-5 | Reference Standards |
| HY-N0736 | Coptisine (chloride) | 6020-18-4 | Natural Products |
| HY-N0736R | Coptisine (chloride) (Standard) | 6020-18-4 | Reference Standards |
| HY-N0737 | Harmine (hydrochloride) | 343-27-1 | Natural Products |
| HY-N0737A | Harmine | 442-51-3 | Natural Products |
| HY-N0737AR | Harmine (Standard) | 442-51-3 | Reference Standards |
| HY-N0738 | Stachydrine hydrochloride | 4136-37-2 | Natural Products |
| HY-N0738R | Stachydrine hydrochloride (Standard) | 4136-37-2 | Reference Standards |
| HY-N0739 | Betaine (chloride) | 590-46-5 | Natural Products |
| HY-N0739R | Betaine (chloride) (Standard) | 590-46-5 | Reference Standards |
| HY-N0739S | Betaine-d3 (chloride) | 1219349-47-9 | Isotope-Labeled Compounds |
| HY-N0739S1 | Betaine-d9 (chloride) | 285979-85-3 | Isotope-Labeled Compounds |
| HY-N0740 | Jatrorrhizine (chloride) | 6681-15-8 | Natural Products |
| HY-N0740R | Jatrorrhizine (chloride) (Standard) | 6681-15-8 | Reference Standards |
| HY-N0741 | Leonurine | 24697-74-3 | Natural Products |
| HY-N0741A | Leonurine (hydrochloride) | 24735-18-0 | Natural Products |
| HY-N0741AR | Leonurine (hydrochloride) (Standard) | 24735-18-0 | Reference Standards |
| HY-N0742 | Absinthin | 1362-42-1 | Natural Products |
| HY-N0742R | Absinthin (Standard) | 1362-42-1 | Reference Standards |
| HY-N0743 | Senkyunolide A | 63038-10-8 | Natural Products |
| HY-N0744 | Senkyunolide H | 94596-27-7 | Natural Products |
| HY-N0745 | Senkyunolide I | 94596-28-8 | Natural Products |
| HY-N0746 | Oxysophocarpine | 26904-64-3 | Natural Products |
| HY-N0746R | Oxysophocarpine (Standard) | 26904-64-3 | Reference Standards |
| HY-N0747 | Oxypeucedanin | 737-52-0 | Natural Products |
| HY-N0747R | Oxypeucedanin (Standard) | 737-52-0 | Reference Standards |
| HY-N0748 | Oxypaeoniflorin | 39011-91-1 | Natural Products |
| HY-N0748R | Oxypaeoniflorin (Standard) | 39011-91-1 | Reference Standards |
| HY-N0749 | Jatrorrhizine | 3621-38-3 | Natural Products |
| HY-N0749A | Jatrorrhizine (hydroxide) | 483-43-2 | Natural Products |
| HY-N0750 | Monocrotaline | 315-22-0 | Natural Products |
| HY-N0751 | Scutellarin | 27740-01-8 | Natural Products |
| HY-N0751R | Scutellarin (Standard) | 27740-01-8 | Reference Standards |
| HY-N0752 | Scutellarein | 529-53-3 | Natural Products |
| HY-N0752R | Scutellarein (Standard) | 529-53-3 | Reference Standards |
| HY-N0753 | Eupalinolide B | 877822-41-8 | Natural Products |
| HY-N0754 | Eupalinolide A | 877822-40-7 | Natural Products |
| HY-N0755 | Rhoifolin | 17306-46-6 | Natural Products |
| HY-N0755R | Rhoifolin (Standard) | 17306-46-6 | Reference Standards |
| HY-N0756 | Bornyl acetate | 76-49-3 | Natural Products |
| HY-N0756A | (-)-Bornyl acetate | 5655-61-8 | Natural Products |
| HY-N0756AR | (-)-Bornyl acetate (Standard) | 5655-61-8 | Reference Standards |
| HY-N0756R | Bornyl acetate (Standard) | 76-49-3 | Reference Standards |
| HY-N0757 | 8-O-Acetylharpagide | 6926-14-3 | Natural Products |
| HY-N0757R | 8-?O-?Acetylharpagide (Standard) | 6926-14-3 | Reference Standards |
| HY-N0758 | Barlerin | 57420-46-9 | Natural Products |
| HY-N0758R | Barlerin (Standard) | 57420-46-9 | Reference Standards |
| HY-N0759 | Acetylcorynoline | 18797-80-3 | Natural Products |
| HY-N0761 | Isoferulic acid | 537-73-5 | Natural Products |
| HY-N0761A | trans-Isoferulic acid | 25522-33-2 | Natural Products |
| HY-N0761AR | trans-Isoferulic acid (Standard) | 25522-33-2 | Reference Standards |
| HY-N0761AS | trans-Isoferulic acid-d3 | 1028203-97-5 | Isotope-Labeled Compounds |
| HY-N0761R | Isoferulic acid (Standard) | 537-73-5 | Reference Standards |
| HY-N0762 | Isobavachin | 31524-62-6 | Natural Products |
| HY-N0763 | Angelicin | 523-50-2 | Natural Products |
| HY-N0763R | Angelicin (Standard) | 523-50-2 | Reference Standards |
| HY-N0764 | Isobergapten | 482-48-4 | Natural Products |
| HY-N0764R | Isobergapten (Standard) | 482-48-4 | Reference Standards |
| HY-N0765 | Isoliquiritin | 5041-81-6 | Natural Products |
| HY-N0765R | Isoliquiritin (Standard) | 5041-81-6 | Reference Standards |
| HY-N0766 | Isorhynchophylline | 6859-01-4 | Natural Products |
| HY-N0766R | Isorhynchophylline (Standard) | 6859-01-4 | Reference Standards |
| HY-N0767 | Isoorientin | 4261-42-1 | Natural Products |
| HY-N0767R | Isoorientin (Standard) | 4261-42-1 | Reference Standards |
| HY-N0768 | Quercetin 3-O-β-D-glucofuranoside | 21637-25-2 | Natural Products |
| HY-N0768R | Quercetin 3-O-β-D-glucofuranoside (Standard) | 21637-25-2 | Reference Standards |
| HY-N0769 | Isopimpinellin | 482-27-9 | Natural Products |
| HY-N0769R | Isopimpinellin (Standard) | 482-27-9 | Reference Standards |
| HY-N0770 | Isoliensinine | 6817-41-0 | Natural Products |
| HY-N0771 | L-Isoleucine | 73-32-5 | Natural Products |
| HY-N0771R | L-Isoleucine (Standard) | 73-32-5 | Reference Standards |
| HY-N0771S | L-Isoleucine-13C6 | 201740-82-1 | Isotope-Labeled Compounds |
| HY-N0771S1 | DL-Isoleucine-d10 | 29909-02-2 | Isotope-Labeled Compounds |
| HY-N0771S2 | L-Isoleucine-15N | 59935-30-7 | Isotope-Labeled Compounds |
| HY-N0771S3 | L-Isoleucine-d10 | 35045-71-7 | Isotope-Labeled Compounds |
| HY-N0771S4 | L-Isoleucine-1-13C | 81202-01-9 | Isotope-Labeled Compounds |
| HY-N0771S5 | L-Isoleucine-13C6,15N,d10 | 2483829-34-9 | Isotope-Labeled Compounds |
| HY-N0771S6 | L-Cysteine-13C3,15N,d3 | 1994304-88-9 | Isotope-Labeled Compounds |
| HY-N0771S7 | L-Isoleucine-15N,d10 | Isotope-Labeled Compounds | |
| HY-N0771S8 | L-Isoleucine-d1 | 127290-60-2 | Isotope-Labeled Compounds |
| HY-N0771S9 | L-Isoleucine-13C6,15N | 202468-35-7 | Isotope-Labeled Compounds |
| HY-N0772 | Isomangiferin | 24699-16-9 | Natural Products |
| HY-N0772R | Isomangiferin (Standard) | 24699-16-9 | Reference Standards |
| HY-N0773 | Isovitexin | 38953-85-4 | Natural Products |
| HY-N0773R | Isovitexin (Standard) | 38953-85-4 | Reference Standards |
| HY-N0774 | Isofraxidin | 486-21-5 | Natural Products |
| HY-N0774R | Isofraxidin (Standard) | 486-21-5 | Reference Standards |
| HY-N0775 | Isocorynoxeine | 51014-29-0 | Natural Products |
| HY-N0775R | Isocorynoxeine (Standard) | 51014-29-0 | Reference Standards |
| HY-N0776 | Isorhamnetin | 480-19-3 | Natural Products |
| HY-N0776R | Isorhamnetin (Standard) | 480-19-3 | Reference Standards |
| HY-N0777 | Isorhamnetin-3-O-glucoside | 5041-82-7 | Natural Products |
| HY-N0778 | Isorhamnetin-3-O-neohespeidoside | 55033-90-4 | Natural Products |
| HY-N0778R | Isorhamnetin-3-O-neohespeidoside (Standard) | 55033-90-4 | Reference Standards |
| HY-N0779 | Isosilybin | 72581-71-6 | Natural Products |
| HY-N0779A | Silybin | 802918-57-6 | Natural Products |
| HY-N0779AR | Silybin (Standard) | 802918-57-6 | Reference Standards |
| HY-N0779R | Isosilybin (Standard) | 72581-71-6 | Reference Standards |
| HY-N0780 | Isoalantolactone | 470-17-7 | Natural Products |
| HY-N0780R | Isoalantolactone (Standard) | 470-17-7 | Reference Standards |
| HY-N0781 | Linderalactone | 728-61-0 | Natural Products |
| HY-N0781R | Linderalactone (Standard) | 728-61-0 | Reference Standards |
| HY-N0783 | Eupatilin | 22368-21-4 | Natural Products |
| HY-N0783R | Eupatilin (Standard) | 22368-21-4 | Reference Standards |
| HY-N0784 | Ginkgolide B | 15291-77-7 | Natural Products |
| HY-N0784R | Ginkgolide B (Standard) | 15291-77-7 | Reference Standards |
| HY-N0785 | Ginkgolide C | 15291-76-6 | Natural Products |
| HY-N0785R | Ginkgolide C (Standard) | 15291-76-6 | Reference Standards |
| HY-N0786 | Ginkgolide J | 107438-79-9 | Natural Products |
| HY-N0786R | Ginkgolide J (Standard) | 107438-79-9 | Reference Standards |
| HY-N0787 | Cryptochlorogenic acid | 905-99-7 | Natural Products |
| HY-N0787R | Cryptochlorogenic acid (Standard) | 905-99-7 | Reference Standards |
| HY-N0788 | Indaconitine | 4491-19-4 | Natural Products |
| HY-N0789 | Delsoline | 509-18-2 | Natural Products |
| HY-N0790 | Lupeol | 545-47-1 | Natural Products |
| HY-N0790R | Lupeol (Standard) | 545-47-1 | Reference Standards |
| HY-N0791 | Tectoridin | 611-40-5 | Natural Products |
| HY-N0791R | Tectoridin (Standard) | 611-40-5 | Reference Standards |
| HY-N0792 | Tectorigenin | 548-77-6 | Natural Products |
| HY-N0792R | Tectorigenin (Standard) | 548-77-6 | Reference Standards |
| HY-N0793 | Protopine | 130-86-9 | Natural Products |
| HY-N0793A | Protopine (hydrochloride) | 6164-47-2 | Natural Products |
| HY-N0793R | Protopine (Standard) | 130-86-9 | Reference Standards |
| HY-N0794 | Proanthocyanidins | 20347-71-1 | Natural Products |
| HY-N0795 | Procyanidin B1 | 20315-25-7 | Natural Products |
| HY-N0795R | Procyanidin B1 (Standard) | 20315-25-7 | Reference Standards |
| HY-N0796 | Procyanidin B2 | 29106-49-8 | Natural Products |
| HY-N0796R | Procyanidin B2 (Standard) | 29106-49-8 | Reference Standards |
| HY-N0797 | (20S)-Protopanaxadiol | 30636-90-9 | Natural Products |
| HY-N0797R | (20S)-Protopanaxadiol (Standard) | 30636-90-9 | Reference Standards |
| HY-N0798 | 20(R)-Protopanaxatriol | 1453-93-6 | Natural Products |
| HY-N0798R | 20(R)-Protopanaxatriol (Standard) | 1453-93-6 | Reference Standards |
| HY-N0799 | Protodioscin | 55056-80-9 | Natural Products |
| HY-N0799R | Protodioscin (Standard) | 55056-80-9 | Reference Standards |
| HY-N0800 | Protosappanin B | 102036-29-3 | Natural Products |
| HY-N0800R | Protosappanin B (Standard) | 102036-29-3 | Reference Standards |
| HY-N0801 | Polygalacic acid | 22338-71-2 | Natural Products |
| HY-N0802 | Tenuigenin | 2469-34-3 | Natural Products |
| HY-N0802R | Tenuigenin (Standard) | 2469-34-3 | Reference Standards |
| HY-N0803 | Myrcene,75% (stabilized with BHT) | 123-35-3 | Natural Products |
| HY-N0803R | Myrcene (Standard) | 123-35-3 | Reference Standards |
| HY-N0803S | Myrcene-d6 | 75351-99-4 | Isotope-Labeled Compounds |
| HY-N0803S1 | Myrcene-13C3 | Isotope-Labeled Compounds | |
| HY-N0804 | Narirutin | 14259-46-2 | Natural Products |
| HY-N0804A | Isonaringin | 108815-81-2 | Natural Products |
| HY-N0804AR | Isonaringin (Standard) | 108815-81-2 | Reference Standards |
| HY-N0804R | Narirutin (Standard) | 14259-46-2 | Reference Standards |
| HY-N0805 | Alisol B 23-acetate | 26575-95-1 | Natural Products |
| HY-N0805A | Alisol B | 18649-93-9 | Natural Products |
| HY-N0805AR | Alisol B (Standard) | 18649-93-9 | Reference Standards |
| HY-N0805R | Alisol B 23-acetate (Standard) | 26575-95-1 | Reference Standards |
| HY-N0806 | Sweroside | 14215-86-2 | Natural Products |
| HY-N0806R | Sweroside (Standard) | 14215-86-2 | Reference Standards |
| HY-N0807 | Swertiamarin | 17388-39-5 | Natural Products |
| HY-N0807R | Swertiamarin (Standard) | 17388-39-5 | Reference Standards |
| HY-N0808 | Camphor | 76-22-2 | Natural Products |
| HY-N0808R | Camphor (Standard) | 76-22-2 | Reference Standards |
| HY-N0809 | Sesamolin | 526-07-8 | Natural Products |
| HY-N0809R | Sesamolin (Standard) | 526-07-8 | Reference Standards |
| HY-N0810 | Timosaponin AIII | 41059-79-4 | Natural Products |
| HY-N0810R | Timosaponin AIII (Standard) | 41059-79-4 | Reference Standards |
| HY-N0811 | Anemarsaponin B | 139051-27-7 | Natural Products |
| HY-N0812 | Timosaponin BII | 136656-07-0 | Natural Products |
| HY-N0812R | Timosaponin BII (Standard) | 136656-07-0 | Reference Standards |
| HY-N0813 | Anemarsaponin E | 136565-73-6 | Natural Products |
| HY-N0814 | Phytic acid (50% in water) | 83-86-3 | Natural Products |
| HY-N0814A | Phytic acid (dodecasodium hydrate) | 123408-98-0 | Natural Products |
| HY-N0814B | Phytic acid (hexasodium) | 34367-89-0 | Natural Products |
| HY-N0814R | Phytic acid (Standard) | 83-86-3 | Reference Standards |
| HY-N0815 | Resibufogenin | 465-39-4 | Natural Products |
| HY-N0815R | Resibufogenin (Standard) | 465-39-4 | Reference Standards |
| HY-N0816 | Polyphyllin VI | 55916-51-3 | Natural Products |
| HY-N0816R | Polyphyllin VI (Standard) | 55916-51-3 | Reference Standards |
| HY-N0817 | Polyphyllin G | 76296-75-8 | Natural Products |
| HY-N0818 | Chikusetsusaponin Iva | 51415-02-2 | Natural Products |
| HY-N0818R | Chikusetsusaponin Iva (Standard) | 51415-02-2 | Reference Standards |
| HY-N0819 | Raddeanin A | 89412-79-3 | Natural Products |
| HY-N0820 | Catalpol | 2415-24-9 | Natural Products |
| HY-N0820R | Catalpol (Standard) | 2415-24-9 | Reference Standards |
| HY-N0821 | Lithospermoside | 63492-69-3 | Natural Products |
| HY-N0821R | Lithospermoside (Standard) | 63492-69-3 | Reference Standards |
| HY-N0822 | Shikonin | 517-89-5 | Natural Products |
| HY-N0822R | Shikonin (Standard) | 517-89-5 | Reference Standards |
| HY-N0823 | Lithospermic acid | 28831-65-4 | Natural Products |
| HY-N0823R | Lithospermic acid (Standard) | 28831-65-4 | Reference Standards |
| HY-N0824 | Syringin | 118-34-3 | Natural Products |
| HY-N0824R | Syringin (Standard) | 118-34-3 | Reference Standards |
| HY-N0825 | Nodakenin | 495-31-8 | Natural Products |
| HY-N0825R | Nodakenin (Standard) | 495-31-8 | Reference Standards |
| HY-N0826 | Corynoline | 18797-79-0 | Natural Products |
| HY-N0826R | Corynoline (Standard) | 18797-79-0 | Reference Standards |
| HY-N0827 | Perillene | 539-52-6 | Natural Products |
| HY-N0828 | Pterostilbene | 537-42-8 | Natural Products |
| HY-N0828R | Pterostilbene (Standard) | 537-42-8 | Reference Standards |
| HY-N0829 | Shionone | 10376-48-4 | Natural Products |
| HY-N0829R | Shionone (Standard) | 10376-48-4 | Reference Standards |
| HY-N0830 | Palmitic acid | 57-10-3 | Natural Products |
| HY-N0830A | Palmitic acid (calcium) | 542-42-7 | Natural Products |
| HY-N0830B | Palmitic acid (sodium) | 408-35-5 | Biochemical Assay Reagents |
| HY-N0830BS | Palmitic acid-13C (sodium) | 201612-54-6 | Isotope-Labeled Compounds |
| HY-N0830BS1 | Palmitic acid-13C16 (sodium) | 2483736-17-8 | Isotope-Labeled Compounds |
| HY-N0830BS2 | Palmitic acid-d3 (sodium) | 347841-37-6 | Isotope-Labeled Compounds |
| HY-N0830BS3 | Palmitic acid-d31 (sodium) | 467235-83-2 | Isotope-Labeled Compounds |
| HY-N0830R | Palmitic acid (Standard) | 57-10-3 | Reference Standards |
| HY-N0830S | Palmitic acid-1,2,3,4-13C4 | 287100-89-4 | Isotope-Labeled Compounds |
| HY-N0830S1 | Palmitic acid-15,15,16,16,16-d5 | 285979-77-3 | Isotope-Labeled Compounds |
| HY-N0830S10 | Palmitic acid-13C2 | 86683-25-2 | Isotope-Labeled Compounds |
| HY-N0830S11 | Palmitic acid-d2-1 | 62690-28-2 | Isotope-Labeled Compounds |
| HY-N0830S12 | Palmitic acid-d4-1 | 75736-47-9 | Isotope-Labeled Compounds |
| HY-N0830S13 | Palmitic acid-d4-2 | 75736-57-1 | Isotope-Labeled Compounds |
| HY-N0830S14 | Palmitic acid-d17 | 81462-28-4 | Isotope-Labeled Compounds |
| HY-N0830S15 | Palmitic acid-d2-2 | 272442-14-5 | Isotope-Labeled Compounds |
| HY-N0830S16 | Palmitic acid-d2-3 | 83293-32-7 | Isotope-Labeled Compounds |
| HY-N0830S17 | Palmitic acid-d2-4 | 30719-28-9 | Isotope-Labeled Compounds |
| HY-N0830S18 | Palmitic acid-d1 | 358730-99-1 | Isotope-Labeled Compounds |
| HY-N0830S19 | Palmitic acid-d2-5 | 1219805-64-7 | Isotope-Labeled Compounds |
| HY-N0830S2 | Palmitic acid-d31 | 39756-30-4 | Isotope-Labeled Compounds |
| HY-N0830S20 | Palmitic acid-d9 | 1173022-49-5 | Isotope-Labeled Compounds |
| HY-N0830S21 | Palmitic acid-d5 | 1219802-61-5 | Isotope-Labeled Compounds |
| HY-N0830S3 | Palmitic acid-1-13C | 57677-53-9 | Isotope-Labeled Compounds |
| HY-N0830S4 | Palmitic acid-d2 | 62689-96-7 | Isotope-Labeled Compounds |
| HY-N0830S5 | Palmitic acid-d3 | 75736-53-7 | Isotope-Labeled Compounds |
| HY-N0830S6 | Palmitic acid-13C16 | 56599-85-0 | Isotope-Labeled Compounds |
| HY-N0830S7 | Palmitic acid-d4 | 75736-49-1 | Isotope-Labeled Compounds |
| HY-N0830S8 | Palmitic acid-9,10-d2 | 78387-70-9 | Isotope-Labeled Compounds |
| HY-N0830S9 | Palmitic acid-13C | 287100-87-2 | Isotope-Labeled Compounds |
| HY-N0831 | Jaceosidin | 18085-97-7 | Natural Products |
| HY-N0831R | Jaceosidin (Standard) | 18085-97-7 | Reference Standards |
| HY-N0832 | L-Histidine | 71-00-1 | Natural Products |
| HY-N0832R | L-Histidine (Standard) | 71-00-1 | Reference Standards |
| HY-N0832S | L-Histidine-15N3 | 1217456-12-6 | Isotope-Labeled Compounds |
| HY-N0832S1 | L-Histidine-13C6,15N3 | 741656-40-6 | Isotope-Labeled Compounds |
| HY-N0832S1A | L-Histidine-13C6,15N3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N0833 | L-Hisidine (monohydrocholoride) | 645-35-2 | Natural Products |
| HY-N0834 | Pulsatilla saponin D | 68027-15-6 | Natural Products |
| HY-N0835 | (20S)-Protopanaxatriol | 34080-08-5 | Natural Products |
| HY-N0835R | (20S)-Protopanaxatriol (Standard) | 34080-08-5 | Reference Standards |
| HY-N0836 | Jervine | 469-59-0 | Natural Products |
| HY-N0836R | Jervine (Standard) | 469-59-0 | Reference Standards |
| HY-N0837 | Veratramine | 60-70-8 | Natural Products |
| HY-N0837R | Veratramine (Standard) | 60-70-8 | Reference Standards |
| HY-N0838 | Cephalotaxine | 24316-19-6 | Natural Products |
| HY-N0839 | Quillaic acid | 631-01-6 | Natural Products |
| HY-N0839R | Quillaic acid (Standard) | 631-01-6 | Reference Standards |
| HY-N0840 | Bruceantin | 41451-75-6 | Natural Products |
| HY-N0841 | Bruceine A | 25514-31-2 | Natural Products |
| HY-N0842 | Bevirimat | 174022-42-5 | Natural Products |
| HY-N0842R | Bevirimat (Standard) | 174022-42-5 | Reference Standards |
| HY-N0843 | Kauniolide | 81066-45-7 | Natural Products |
| HY-N0845 | Epoxymicheliolide | 1343403-10-0 | Natural Products |
| HY-N0847 | Micheliolide | 68370-47-8 | Natural Products |
| HY-N0848 | Epibrassinolide | 78821-43-9 | Natural Products |
| HY-N0848R | Epibrassinolide (Standard) | 78821-43-9 | Reference Standards |
| HY-N0849 | Dictamine | 484-29-7 | Natural Products |
| HY-N0849R | Dictamine (Standard) | 484-29-7 | Reference Standards |
| HY-N0850 | Benzoylhypaconine | 63238-66-4 | Natural Products |
| HY-N0851 | Foresaconitine | 73870-35-6 | Natural Products |
| HY-N0852 | Benzoylpaeoniflorin | 38642-49-8 | Natural Products |
| HY-N0853 | Alisol A | 19885-10-0 | Natural Products |
| HY-N0853A | Alisol A 24-acetate | 18674-16-3 | Natural Products |
| HY-N0853AR | Alisol A 24-acetate (Standard) | 18674-16-3 | Reference Standards |
| HY-N0853R | Alisol A (Standard) | 19885-10-0 | Reference Standards |
| HY-N0854 | Alisol F | 155521-45-2 | Natural Products |
| HY-N0855 | Alisol G | 155521-46-3 | Natural Products |
| HY-N0856 | Alisol C 23-acetate | 26575-93-9 | Natural Products |
| HY-N0856R | Alisol C 23-acetate (Standard) | 26575-93-9 | Reference Standards |
| HY-N0857 | Deoxyandrographolide | 79233-15-1 | Natural Products |
| HY-N0858 | Gomisin G | 62956-48-3 | Natural Products |
| HY-N0858R | Gomisin G (Standard) | 62956-48-3 | Reference Standards |
| HY-N0859 | Schisanhenol | 69363-14-0 | Natural Products |
| HY-N0859A | Schisanhenol B | 102681-52-7 | Natural Products |
| HY-N0859B | Schisanchinin D | 1614245-13-4 | Natural Products |
| HY-N0859R | Schisanhenol (Standard) | 69363-14-0 | Reference Standards |
| HY-N0860 | Schisantherin E | 64917-83-5 | Natural Products |
| HY-N0861 | Ikarisoside F | 113558-14-8 | Natural Products |
| HY-N0862 | Harringtonine | 26833-85-2 | Natural Products |
| HY-N0863 | Methyl protodioscin | 54522-52-0 | Natural Products |
| HY-N0864 | Macranthoidin B | 136849-88-2 | Natural Products |
| HY-N0864R | Macranthoidin B (Standard) | 136849-88-2 | Reference Standards |
| HY-N0865 | Ingenol | 30220-46-3 | Natural Products |
| HY-N0866 | 20-Deoxyingenol | 54706-99-9 | Natural Products |
| HY-N0867 | 13-Oxyingenol-13-dodecanoate | 54706-70-6 | Natural Products |
| HY-N0868 | 20-O-Acetylingenol-3-angelate | 82425-35-2 | Natural Products |
| HY-N0869 | Ingenol-5,20-acetonide | 77573-43-4 | Natural Products |
| HY-N0870 | Ingenol-5,20-acetonide-3-O-angelate | 87980-68-5 | Natural Products |
| HY-N0871 | Ingenol-3,4,5,20-diacetonide | 77573-44-5 | Natural Products |
| HY-N0872 | Isosteviol | 27975-19-5 | Natural Products |
| HY-N0872R | Isosteviol (Standard) | 27975-19-5 | Reference Standards |
| HY-N0873 | Sagittatoside A | 118525-35-2 | Natural Products |
| HY-N0873A | Iso-Sagittatoside A | 503456-08-4 | Natural Products |
| HY-N0874 | Sagittatoside B | 118525-36-3 | Natural Products |
| HY-N0875 | IKarisoside A | 55395-07-8 | Natural Products |
| HY-N0876 | Arenobufagin | 464-74-4 | Natural Products |
| HY-N0877 | Bufalin | 465-21-4 | Natural Products |
| HY-N0877R | Bufalin (Standard) | 465-21-4 | Reference Standards |
| HY-N0878 | Bufotalin | 471-95-4 | Natural Products |
| HY-N0879 | Pseudobufarenogin | 17008-69-4 | Natural Products |
| HY-N0880 | Cinobufotalin | 1108-68-5 | Natural Products |
| HY-N0881 | Desacetylcinobufagin | 4026-95-3 | Natural Products |
| HY-N0882 | Desacetylcinobufotalin | 4099-30-3 | Natural Products |
| HY-N0883 | Gamabufotalin | 465-11-2 | Natural Products |
| HY-N0885 | Telocinobufagin | 472-26-4 | Natural Products |
| HY-N0886 | Aloin B | 28371-16-6 | Natural Products |
| HY-N0886R | Aloin B (Standard) | 28371-16-6 | Reference Standards |
| HY-N0887 | Isoastragaloside I | 84676-88-0 | Natural Products |
| HY-N0888 | Isoastragaloside II | 86764-11-6 | Natural Products |
| HY-N0889 | Ginkgetin | 481-46-9 | Natural Products |
| HY-N0889R | Ginkgetin (Standard) | 481-46-9 | Reference Standards |
| HY-N0890 | Tubeimoside I | 102040-03-9 | Natural Products |
| HY-N0890R | Tubeimoside I (Standard) | 102040-03-9 | Reference Standards |
| HY-N0891 | Tubeimoside II | 115810-12-3 | Natural Products |
| HY-N0891R | Tubeimoside II (Standard) | 115810-12-3 | Reference Standards |
| HY-N0892 | AKBA | 67416-61-9 | Natural Products |
| HY-N0892R | AKBA (Standard) | 67416-61-9 | Reference Standards |
| HY-N0893 | Tetrahydrocurcumin | 36062-04-1 | Natural Products |
| HY-N0893R | Tetrahydrocurcumin (Standard) | 36062-04-1 | Reference Standards |
| HY-N0893S | Tetrahydrocurcumin-d6 | 1794898-13-7 | Isotope-Labeled Compounds |
| HY-N0894 | Octahydrocurcumin | 36062-07-4 | Natural Products |
| HY-N0894A | (3R,5R)-Octahydrocurcumin | 408324-14-1 | Natural Products |
| HY-N0894B | (3S,5S)-Octahydrocurcumin | 112494-41-4 | Natural Products |
| HY-N0895 | Britannilactone | 33620-72-3 | Natural Products |
| HY-N0896 | Inulicin | 33627-41-7 | Natural Products |
| HY-N0897 | Corylifol A | 775351-88-7 | Natural Products |
| HY-N0897R | Corylifol A (Standard) | 775351-88-7 | Reference Standards |
| HY-N0898 | Catechin | 154-23-4 | Natural Products |
| HY-N0898A | (-)-Catechin | 18829-70-4 | Natural Products |
| HY-N0898AR | (-)-Catechin (Standard) | 18829-70-4 | Reference Standards |
| HY-N0898R | Catechin (Standard) | 154-23-4 | Reference Standards |
| HY-N0898S | Catechin-13C3 | Isotope-Labeled Compounds | |
| HY-N0899 | Wilforine | 11088-09-8 | Natural Products |
| HY-N0899R | Wilforine (Standard) | 11088-09-8 | Reference Standards |
| HY-N0900 | Cimiracemoside D | 290821-39-5 | Natural Products |
| HY-N0901 | Corynoxine | 6877-32-3 | Natural Products |
| HY-N0901A | Corynoxine B | 17391-18-3 | Natural Products |
| HY-N0901AR | Corynoxine B (Standard) | 17391-18-3 | Reference Standards |
| HY-N0901B | Corynoxine (hydrochloride) | Natural Products | |
| HY-N0902 | Dihydrosanguinarine | 3606-45-9 | Natural Products |
| HY-N0903 | Dihydrochelerythrine | 6880-91-7 | Natural Products |
| HY-N0904 | Ginsenoside C-K | 39262-14-1 | Natural Products |
| HY-N0904R | Ginsenoside C-K (Standard) | 39262-14-1 | Reference Standards |
| HY-N0905 | Ginsenoside Rh4 | 174721-08-5 | Natural Products |
| HY-N0906 | Ginsenoside Rk3 | 364779-15-7 | Natural Products |
| HY-N0907 | Ginsenoside Rg6 | 147419-93-0 | Natural Products |
| HY-N0908 | Ginsenoside Rg5 | 186763-78-0 | Natural Products |
| HY-N0908R | Ginsenoside Rg5 (Standard) | 186763-78-0 | Reference Standards |
| HY-N0909 | Notoginsenoside R2 | 80418-25-3 | Natural Products |
| HY-N0909R | Notoginsenoside R2 (Standard) | 80418-25-3 | Reference Standards |
| HY-N0910 | Notoginsenoside Ft1 | 155683-00-4 | Natural Products |
| HY-N0911 | Rehmannioside A | 81720-05-0 | Natural Products |
| HY-N0912 | Rehmannioside D | 81720-08-3 | Natural Products |
| HY-N0912R | Rehmannioside D (Standard) | 81720-08-3 | Reference Standards |
| HY-N0913 | Manninotriose | 13382-86-0 | Natural Products |
| HY-N0913A | Isomaltotriose | 3371-50-4 | Reference compound |
| HY-N0913AR | Isomaltotriose (Standard) | 3371-50-4 | Reference Standards |
| HY-N0913R | Manninotriose (Standard) | 13382-86-0 | Reference Standards |
| HY-N0914 | Ajugol | 52949-83-4 | Natural Products |
| HY-N0914R | Ajugol (Standard) | 52949-83-4 | Reference Standards |
| HY-N0915 | Melittoside | 19467-03-9 | Natural Products |
| HY-N0915R | Melittoside (Standard) | 19467-03-9 | Reference Standards |
| HY-N0916 | Monomelittoside | 20633-72-1 | Natural Products |
| HY-N0917 | 6''-O-Malonylgenistin | 51011-05-3 | Dye Reagents |
| HY-N0918 | Desmethoxyyangonin | 15345-89-8 | Natural Products |
| HY-N0918R | Desmethoxyyangonin (Standard) | 15345-89-8 | Reference Standards |
| HY-N0919 | Yangonin | 500-62-9 | Natural Products |
| HY-N0919R | Yangonin (Standard) | 500-62-9 | Reference Standards |
| HY-N0920 | Dihydrokavain | 587-63-3 | Natural Products |
| HY-N0920R | Dihydrokavain (Standard) | 587-63-3 | Reference Standards |
| HY-N0921 | Dihydromethysticin | 19902-91-1 | Natural Products |
| HY-N0921R | Dihydromethysticin (Standard) | 19902-91-1 | Reference Standards |
| HY-N0922 | Methysticin | 20697-20-5 | Natural Products |
| HY-N0923 | Corydaline | 518-69-4 | Natural Products |
| HY-N0923R | Corydaline (Standard) | 518-69-4 | Reference Standards |
| HY-N0924 | (±)-Stylopine | 4312-32-7 | Natural Products |
| HY-N0924A | (±)-Stylopine (hydrochloride) | 96087-21-7 | Natural Products |
| HY-N0924B | (-)-Stylopine | 84-39-9 | Natural Products |
| HY-N0925 | Tetrahydroberberine | 522-97-4 | Natural Products |
| HY-N0925R | Tetrahydroberberine (Standard) | 522-97-4 | Reference Standards |
| HY-N0926 | Columbamine | 3621-36-1 | Natural Products |
| HY-N0926A | Columbamine (chloride) | 1916-10-5 | Natural Products |
| HY-N0927 | (-)-Isocorypalmine | 483-34-1 | Natural Products |
| HY-N0928 | Mimosine | 500-44-7 | Natural Products |
| HY-N0929 | Hexahydrocurcumin | 36062-05-2 | Natural Products |
| HY-N0929R | Hexahydrocurcumin (Standard) | 36062-05-2 | Reference Standards |
| HY-N0930B | Galegine (hydrochloride) | 2368870-39-5 | Natural Products |
| HY-N0931 | Santacruzamate A | 1477949-42-0 | Natural Products |
| HY-N0931R | Santacruzamate A (Standard) | 1477949-42-0 | Reference Standards |
| HY-N0932 | Catechin (hydrate) | 88191-48-4 | Natural Products |
| HY-N0935 | Ligustrazine (hydrochloride) | 76494-51-4 | Natural Products |
| HY-N0936 | Coixol | 532-91-2 | Natural Products |
| HY-N0938 | Safflower yellow | 1401-20-3 | Dye Reagents |
| HY-N0940 | Batatasin I | 51415-00-0 | Natural Products |
| HY-N0941 | beta-Mangostin | 20931-37-7 | Natural Products |
| HY-N0941R | beta-Mangostin (Standard) | 20931-37-7 | Reference Standards |
| HY-N0942 | (-)-Corlumine | 79082-64-7 | Natural Products |
| HY-N0943 | (-)-Epiafzelechin | 24808-04-6 | Natural Products |
| HY-N0944 | (-)-Heraclenol | 139079-42-8 | Natural Products |
| HY-N0945 | (-)-N-Methylsedridine | 41447-15-8 | Natural Products |
| HY-N0946 | (-)-Pinoresinol 4-O-glucoside | 41607-20-9 | Natural Products |
| HY-N0947 | (-)-Anomalin | 4970-26-7 | Natural Products |
| HY-N0947R | (-)-Anomalin (Standard) | 4970-26-7 | Reference Standards |
| HY-N0948A | (+)-Rhododendrol | 59092-94-3 | Natural Products |
| HY-N0949 | (-)-Variabilin | 370102-93-5 | Natural Products |
| HY-N0950 | (-)-Conocarpan | 56319-02-9 | Natural Products |
| HY-N0951 | (+)-Isolariciresinol 9'-O-glucoside | 63358-12-3 | Natural Products |
| HY-N0952 | (+)-Lyoniresinol 3α-O-β-D-glucopyranoside | 87585-32-8 | Natural Products |
| HY-N0953 | (+)-N-Methylallosedridine | 41447-16-9 | Natural Products |
| HY-N0954 | (+)-Pinoresinol diacetate | 32971-25-8 | Natural Products |
| HY-N0955 | (+)-Puerol B 2''-O-glucoside | 868409-19-2 | Natural Products |
| HY-N0956 | (+)-S-Myricanol glucoside | 449729-89-9 | Natural Products |
| HY-N0957 | (±)-Pinoresinol | 4263-88-1 | Natural Products |
| HY-N0958 | (16R)-Dihydrositsirikine | 6519-26-2 | Natural Products |
| HY-N0959 | (16R)-E-Isositsirikine | 6519-27-3 | Natural Products |
| HY-N0960 | (2,4-Dihydroxyphenyl)acetonitrile | 57576-34-8 | Natural Products |
| HY-N0961 | (2S,3S)-(-)-Glucodistylin | 129212-92-6 | Natural Products |
| HY-N0962 | (3R)-Hydrangenol 8-O-glucoside pentaacetate | 113270-98-7 | Natural Products |
| HY-N0962A | (3S)-Hydrangenol 8-O-glucoside pentaacetate | 113270-99-8 | Natural Products |
| HY-N0963 | (3S,7S)-5,6-Dehydro-4''-de-O-methylcentrolobine | 227289-51-2 | Natural Products |
| HY-N0964 | (E)-1-(4-Hydroxyphenyl)dec-1-en-3-one | 958631-84-0 | Natural Products |
| HY-N0965 | (E)-Aldosecologanin | 471271-55-3 | Natural Products |
| HY-N0966 | (R,E)-Deca-2-ene-4,6-diyne-1,8-diol | 931116-24-4 | Natural Products |
| HY-N0967 | (S,E)-Deca-2,9-diene-4,6-diyne-1,8-diol | 931114-98-6 | Natural Products |
| HY-N0968 | 1-Methyl-2-[(Z)-6-undecenyl]-4(1H)-quinolone | 120693-49-4 | Natural Products |
| HY-N0969 | (Z)-Akuammidine | 113973-31-2 | Natural Products |
| HY-N0970 | (4Z)-Lachnophyllum lactone | 81122-95-4 | Natural Products |
| HY-N0972 | Methyl isoeugenol glycol | 20133-19-1 | Natural Products |
| HY-N0973 | 1-(4-Methoxycinnamoyl)pyrrole | 736140-70-8 | Natural Products |
| HY-N0974 | 1,10:4,5-Diepoxy-7(11)-germacren-8-one | 32179-18-3 | Natural Products |
| HY-N0975 | 1,11b-Dihydro-11b-hydroxymaackiain | 210537-05-6 | Natural Products |
| HY-N0976 | 1,11b-Dihydro-11b-hydroxymedicarpin | 210537-04-5 | Natural Products |
| HY-N0977 | 1,18-Octadecanediol | 3155-43-9 | Natural Products |
| HY-N0978 | 1,2,3,19-Tetrahydroxy-12-ursen-28-oic acid | 113558-03-5 | Natural Products |
| HY-N0979 | 1,2--4,5-Di-O-isopropylidene-β-D-fructopyranose | 25018-67-1 | Natural Products |
| HY-N0980 | 1,4-Dihydro-1,2-dimethyl-4-oxo-3-quinolinecarboxylic acid | 73281-83-1 | Natural Products |
| HY-N0981 | 1,2-O-Isopropylidene-beta-D-fructopyranose | 66900-93-4 | Natural Products |
| HY-N0982 | 1,3,5-Cadinatriene-3,8-diol | 941227-27-6 | Natural Products |
| HY-N0983 | 1,3,7-Trihydroxy-2-prenylxanthone | 20245-39-0 | Natural Products |
| HY-N0984 | 1,3-Diacetylvilasinin | 78012-28-9 | Natural Products |
| HY-N0985 | 1,4,5,6-Tetrahydroxy-7,8-diprenylxanthone | 776325-66-7 | Natural Products |
| HY-N0986 | 1,4,5,6-Tetrahydroxy-7-(3-methylbut-2-enyl)xanthone | 1001424-68-5 | Natural Products |
| HY-N0987 | 1,4,6-Trihydroxy-5-methoxy-7-prenylxanthone | 160623-47-2 | Natural Products |
| HY-N0988 | 1β,4β,7α-Trihydroxyeudesmane | 145400-02-8 | Natural Products |
| HY-N0990 | 1,5,15-Trimethylmorindol | 942609-65-6 | Natural Products |
| HY-N0991 | 1,5,8-Trihydroxy-3-methoxy-2-prenylxanthone | 110187-11-6 | Natural Products |
| HY-N0992 | 1,6,7-Trihydroxyxanthone | 25577-04-2 | Natural Products |
| HY-N0993 | 1,6,8-Trideoxyshanzhigenin | 99173-00-9 | Natural Products |
| HY-N0994 | 1,6-Dioxaspiro[4.5]decane-2-methanol | 83015-88-7 | Natural Products |
| HY-N0995 | 1,7-Bis(4-hydroxyphenyl)hept-1-en-3-one | 1083200-79-6 | Natural Products |
| HY-N0996 | 1,7-Bis(4-hydroxyphenyl)hept-6-en-3-ol | 1083195-05-4 | Natural Products |
| HY-N0997 | (6E)-1,7-Bis(4-hydroxyphenyl)-6-hepten-3-one | 1251830-57-5 | Natural Products |
| HY-N0998 | 1,7-Bis(4-hydroxyphenyl)-hepta-4E,6E-dien-3-one | 332371-82-1 | Natural Products |
| HY-N0999 | 1,7-Diepi-8,15-cedranediol | 40768-81-8 | Natural Products |
| HY-N1000 | 1,7-Dihydroxy-3-methoxy-2-prenylxanthone | 77741-58-3 | Natural Products |
| HY-N10000 | Hirudonucleodisulfide B | 1072789-38-8 | Natural Products |
| HY-N10002 | Caffeoyltryptophan | 109163-69-1 | Natural Products |
| HY-N10004S | 1-Deoxy-1-L-proline-D-fructose-13C6 | 1083053-47-7 | Isotope-Labeled Compounds |
| HY-N10007 | Dodoviscin J | 1372527-42-8 | Natural Products |
| HY-N10009 | Cudraflavone B | 19275-49-1 | Natural Products |
| HY-N1001 | 1,9-Caryolanediol 9-acetate | 155488-34-9 | Natural Products |
| HY-N10013 | β-Damascone | 23726-91-2 | Natural Products |
| HY-N10013R | β-Damascone (Standard) | 23726-91-2 | Reference Standards |
| HY-N10014 | Bulnesol | 22451-73-6 | Natural Products |
| HY-N10015 | 7-Methoxy-4-methyl-coumarin-8-ol | 22084-94-2 | Natural Products |
| HY-N10016 | Chlorogenic acid butyl ester | 132741-56-1 | Natural Products |
| HY-N10017 | Lucidone F | 1446750-73-7 | Natural Products |
| HY-N10018 | Cimiside E | 154822-57-8 | Natural Products |
| HY-N10020 | Patulitrin | 19833-25-1 | Natural Products |
| HY-N10021 | Benzo[e]pyrene | 192-97-2 | Natural Products |
| HY-N10023 | Physalin O | 120849-18-5 | Natural Products |
| HY-N10024 | Ganolactone | 173268-82-1 | Natural Products |
| HY-N10029 | Edgeworoside C | 126221-40-7 | Natural Products |
| HY-N10030 | 11-O-Syringylbergenin | 126485-47-0 | Natural Products |
| HY-N10034 | Cyclocarioside F | 1403937-43-8 | Natural Products |
| HY-N10037 | Marginatoxin | 1422536-56-8 | Natural Products |
| HY-N1004 | 10-Hydroxy-16-epiaffinine | 82513-70-0 | Natural Products |
| HY-N10040 | Poststerone | 10162-99-9 | Natural Products |
| HY-N10042 | Herbacetin 3,8-O-diglucoside | 99224-12-1 | Natural Products |
| HY-N10043 | 5,2',6'-Trihydroxy-6,7,8-trimethoxyflavone | 98187-98-5 | Natural Products |
| HY-N10044 | 3-Feruloyl-4-caffeoylquinic acid | 96990-65-7 | Natural Products |
| HY-N10046 | ent-17-Hydroxykauran-3-one | 960589-81-5 | Natural Products |
| HY-N10047 | 7,8-Didehydrocimigenol | 150972-72-8 | Natural Products |
| HY-N10048 | Agroastragaloside I | 156769-94-7 | Natural Products |
| HY-N10049 | Elatoside E | 156980-30-2 | Natural Products |
| HY-N1005 | 10-Hydroxydihydroperaksine | 451478-47-0 | Natural Products |
| HY-N10050 | Coreoside B | 1580464-83-0 | Natural Products |
| HY-N10054 | Trichosanatine | 169626-16-8 | Natural Products |
| HY-N10057 | 5-epi-Jinkoheremol | 2567930-96-3 | Natural Products |
| HY-N10059 | Quebecol | 1360605-46-4 | Natural Products |
| HY-N1006 | 10-Hydroxyscandine | 119188-47-5 | Natural Products |
| HY-N10060 | Millmerranone A | Natural Products | |
| HY-N10061 | (9S)-Macrocidin B | Natural Products | |
| HY-N10062 | Amakusamine | 2923661-84-9 | Natural Products |
| HY-N10063 | Penispidin A | Natural Products | |
| HY-N10064 | Ficusonolide | 1800503-81-4 | Natural Products |
| HY-N10066 | Anti-inflammatory agent 5 | Natural Products | |
| HY-N10067 | Micromonosporamide A | Natural Products | |
| HY-N10069 | Bonducellin | 83162-84-9 | Natural Products |
| HY-N1007 | 10-O-Acetylisocalamendiol | 1432064-69-1 | Natural Products |
| HY-N10070 | Lucidumol A | 217476-73-8 | Natural Products |
| HY-N10071 | Poricoic acid G | 415724-84-4 | Natural Products |
| HY-N10073 | Eupahualin C | 108525-39-9 | Natural Products |
| HY-N10074 | Polygalacin D2 | 66663-92-1 | Natural Products |
| HY-N10076 | Ganomycin I | 1191255-15-8 | Natural Products |
| HY-N10077 | Eriosemation | 162616-72-0 | Natural Products |
| HY-N10078 | Gardenin D | 29202-00-4 | Natural Products |
| HY-N10079 | Suchilactone | 50816-74-5 | Natural Products |
| HY-N1008 | 10-O-Caffeoyl deacetyldaphylloside | 83348-22-5 | Natural Products |
| HY-N10080 | Paspalinine | 63722-91-8 | Natural Products |
| HY-N10081 | Leucinostatin D | 108426-90-0 | Natural Products |
| HY-N10082 | Trigoxyphin A | 1236874-00-2 | Natural Products |
| HY-N10083 | Selaginellin | 941269-84-7 | Natural Products |
| HY-N10084 | Cordifolioside A | 155179-20-7 | Natural Products |
| HY-N10085 | Parvisoflavanone | 49776-79-6 | Natural Products |
| HY-N10086 | Cypellocarpin C | 294856-66-9 | Natural Products |
| HY-N10087 | Angustifoline | 550-43-6 | Natural Products |
| HY-N10087A | Angustifoline (hydrochloride) | 133398-34-2 | Natural Products |
| HY-N10088 | Yukovanol | 76265-12-8 | Natural Products |
| HY-N10089 | Psiguadial D | 1402066-95-8 | Natural Products |
| HY-N1009 | 10-O-Methylprotosappanin B | 111830-77-4 | Natural Products |
| HY-N10090 | Musellarin B | 1392476-32-2 | Natural Products |
| HY-N10091 | 2,3-Dihydro-3α-methoxynimbolide | 1607828-35-2 | Natural Products |
| HY-N10092 | Saucerneol | 88497-86-3 | Natural Products |
| HY-N10093 | Chamaejasmine | 69618-96-8 | Natural Products |
| HY-N10094 | Maculosidine | 522-19-0 | Natural Products |
| HY-N10095 | Sikokianin A | 106293-99-6 | Natural Products |
| HY-N10096 | Epoxyazadiradione | 18385-59-6 | Natural Products |
| HY-N10097 | Chamigrenol | 19822-80-1 | Natural Products |
| HY-N10098 | Citrusin B | 105279-10-5 | Natural Products |
| HY-N10099 | Forestine | 91794-14-8 | Natural Products |
| HY-N1010 | 10-Hydroxyneoline | 132362-42-6 | Natural Products |
| HY-N10100 | Epiglobulol | 88728-58-9 | Natural Products |
| HY-N10101 | Eriobofuran | 97218-06-9 | Natural Products |
| HY-N10102 | Boscialin | 129277-03-8 | Natural Products |
| HY-N10103 | Neoschaftoside | 61328-41-4 | Natural Products |
| HY-N10105 | 7-Methoxyneochamaejasmine A | 402828-38-0 | Natural Products |
| HY-N10106 | Dihydromyristicin | 52811-28-6 | Natural Products |
| HY-N10108 | Protosappanin A dimethyl acetal | 868405-37-2 | Natural Products |
| HY-N10109 | Gallinamide A | 1208232-55-6 | Natural Products |
| HY-N10109A | Gallinamide A (TFA) | 1352920-57-0 | Natural Products |
| HY-N1011 | 10-O-Vanilloylaucubin | 193969-08-3 | Natural Products |
| HY-N10110 | (±)-Phrymarolin II | 23720-86-7 | Natural Products |
| HY-N10113 | Verrucarin J | 4643-58-7 | Natural Products |
| HY-N10114 | Hyperectumine | Natural Products | |
| HY-N10115 | Huanglongmycin N | 2881024-09-3 | Natural Products |
| HY-N10116A | Calamenene | 483-77-2 | Natural Products |
| HY-N10117 | 2,3-Bis(3-indolylmethyl)indole | 138250-72-3 | Natural Products |
| HY-N10118 | NK007 | 2488661-53-4 | Natural Products |
| HY-N10119 | Ganoderterpene A | 2682180-85-2 | Natural Products |
| HY-N1012 | (-)-11,13-Dehydroeriolin | 87441-73-4 | Natural Products |
| HY-N10120 | Methylsyringin | 139742-20-4 | Natural Products |
| HY-N10123 | Indolokine A5 | 951207-88-8 | Natural Products |
| HY-N10126 | (3ξ,4ξ,5ξ,6ξ,7ξ,11ξ)-3,6-Dihydroxy-8-oxo-9-eremophilene-12-oic acid | Natural Products | |
| HY-N10127 | Lepidiline C | 2750933-59-4 | Natural Products |
| HY-N10128 | (8′α,9′β-Dihydroxy)-3-farnesylindole | Natural Products | |
| HY-N1013 | 11,12-De(methylenedioxy)danuphylline | 888482-17-5 | Natural Products |
| HY-N10130 | Isouvaretin | Natural Products | |
| HY-N10131 | Biatractylolide | 182426-37-5 | Natural Products |
| HY-N10132 | Microgrewiapine A | 1420777-30-5 | Natural Products |
| HY-N10133 | Licoflavanone | 119240-82-3 | Natural Products |
| HY-N1014 | 11α,12β-Di-O-acetyltenacigenin B | 857897-01-9 | Natural Products |
| HY-N10140 | Galloyl-bis-HHDP glucose | Natural Products | |
| HY-N10144 | Shinpterocarpin | 157414-04-5 | Natural Products |
| HY-N10145 | Cannabisin G | 163136-20-7 | Natural Products |
| HY-N10149 | Nauclefine | 57103-51-2 | Natural Products |
| HY-N1015 | 11,13-Dihydroivalin | 150150-61-1 | Natural Products |
| HY-N10151 | Notoginsenoside R3 | 87741-76-2 | Natural Products |
| HY-N10155A | BE-18591 | 147138-01-0 | Natural Products |
| HY-N10156 | 1,3,5-Trihydroxy-4-prenylxanthone | 53377-61-0 | Natural Products |
| HY-N10157 | 1,3,7-Trihydroxy-2-methoxyxanthone | 211948-69-5 | Natural Products |
| HY-N10158 | 1,7-Bis(4-hydroxyphenyl)-3-hydroxy-1,3-heptadien-5-one | 207792-17-4 | Natural Products |
| HY-N10159 | 1-Benzyl-I3C | 60941-76-6 | Natural Products |
| HY-N1016 | 3β-Hydroxy-11,12-epoxy–friedoolean-14-enyl palmitate | 495389-95-2 | Natural Products |
| HY-N10162 | 14-Benzoyl-8-O-methylaconine | 93772-68-0 | Natural Products |
| HY-N10163 | 1β,10β-Epoxydesacetoxymatricarin | 124020-39-9 | Natural Products |
| HY-N10164 | 5,6-Desmethylenedioxy-5-methoxyaglalactone | 922169-96-8 | Natural Products |
| HY-N10166 | Antioxidant agent-12 | 212201-12-2 | Natural Products |
| HY-N10167 | 7-(6'R-Hydroxy-3',7'-dimethylocta-2',7'-dienyloxy)coumarin | 118584-19-3 | Natural Products |
| HY-N10169 | Edgeworin | 120028-43-5 | Natural Products |
| HY-N1017 | 11β-Hydroxycedrelone | 283174-18-5 | Natural Products |
| HY-N10171 | GB-2a | 18412-96-9 | Natural Products |
| HY-N10172 | Irilone | 41653-81-0 | Natural Products |
| HY-N10173 | (+)-Epiloliolide | 38274-00-9 | Natural Products |
| HY-N10174 | Tomaymycin | 35050-55-6 | Natural Products |
| HY-N10175 | Berkeleyacetal C | 959772-67-9 | Natural Products |
| HY-N10176 | D-Isofloridoside | 23202-76-8 | Natural Products |
| HY-N10177 | Peniterphenyl A | 2864816-15-7 | Natural Products |
| HY-N10178 | Phainanoid A | 1643933-50-9 | Natural Products |
| HY-N10179 | Talaroenamine F | Natural Products | |
| HY-N1018 | 11-Hydroxygelsenicine | 1195760-68-9 | Natural Products |
| HY-N10180 | Bufospirostenin A | 2097252-84-9 | Natural Products |
| HY-N10181 | 11-Keto fusidic acid | 16711-91-4 | Natural Products |
| HY-N10182 | Spinacetin | 3153-83-1 | Natural Products |
| HY-N10183 | Crocin-4 | 55750-86-2 | Natural Products |
| HY-N10184 | Paecilaminol | 540770-33-0 | Natural Products |
| HY-N10185 | Cyclo(D-Ala-L-Pro) | 36238-64-9 | Natural Products |
| HY-N10186 | Dibefurin | 175448-33-6 | Natural Products |
| HY-N10188 | Nidurufin | 28458-23-3 | Natural Products |
| HY-N1019 | 11-Hydroxyhumantenine | 122590-04-9 | Natural Products |
| HY-N10190 | Asperaculane B | 2378379-27-0 | Natural Products |
| HY-N10191 | Hydroaurantiogliocladin | 776-33-0 | Natural Products |
| HY-N10192 | Aculene D | 2043948-38-3 | Natural Products |
| HY-N10193 | Aculene A | 2378379-28-1 | Natural Products |
| HY-N10194 | P-orlandin | 1407546-21-7 | Natural Products |
| HY-N10196 | Cerebroside D | 113773-89-0 | Natural Products |
| HY-N10197 | Pulixin | 2826264-81-5 | Natural Products |
| HY-N10198 | Acremonidin A | 701914-77-4 | Natural Products |
| HY-N1020 | 11-Hydroxyrankinidine | 122590-03-8 | Natural Products |
| HY-N10200 | 2,7-Dimethoxy-6-(1-acetoxyethyl)juglone | 68594-15-0 | Natural Products |
| HY-N10201 | Cytoglobosin C | 1221163-94-5 | Natural Products |
| HY-N10203 | Rostratin A | 752236-16-1 | Natural Products |
| HY-N10204 | Rostratin B | 752236-17-2 | Natural Products |
| HY-N10205 | Rostratin C | 752236-18-3 | Natural Products |
| HY-N10206 | 11-epi-Chaetomugilin I | 1319729-88-8 | Natural Products |
| HY-N10207 | Penicitide A | 1338332-27-6 | Natural Products |
| HY-N10208 | Aspericin C | 1216840-17-3 | Natural Products |
| HY-N10209 | Paecilomide | 1538575-22-2 | Natural Products |
| HY-N10210 | Saccharothrixin F | Natural Products | |
| HY-N10211 | Saccharothrixin K | 1808951-87-2 | Natural Products |
| HY-N10212 | Dendryphiellin D | 121678-87-3 | Natural Products |
| HY-N10213 | Septeremophilane E | Natural Products | |
| HY-N10214 | (-)-10,11-Dihydroxyfarnesol | 37133-76-9 | Natural Products |
| HY-N10215 | Canadensolide | 20421-31-2 | Natural Products |
| HY-N10216 | Cynodontin | 476-43-7 | Natural Products |
| HY-N10217 | Paneolilludinic acid | 847586-20-3 | Natural Products |
| HY-N10218 | Sterpurol D | Natural Products | |
| HY-N10219 | Dihydroaltenuene B | 887751-89-5 | Natural Products |
| HY-N1022 | 11-Hydroxytephrosin | 72458-85-6 | Natural Products |
| HY-N10220 | Paraherquamide E | 125600-53-5 | Natural Products |
| HY-N10221 | Petromurin C | 194608-29-2 | Natural Products |
| HY-N10222 | Roquefortine E | 871982-52-4 | Natural Products |
| HY-N10224 | Terpendole C | 156967-65-6 | Natural Products |
| HY-N10225 | Thielavin A | 71950-66-8 | Natural Products |
| HY-N10226 | Thielavin B | 71950-67-9 | Natural Products |
| HY-N10227 | Geodin | 427-63-4 | Natural Products |
| HY-N10228 | Gliorosein | 4373-40-4 | Natural Products |
| HY-N10229 | Harzianum A | 156250-74-7 | Natural Products |
| HY-N1023 | 11-O-Galloylbergenin | 82958-44-9 | Natural Products |
| HY-N10230 | MC 304 | 124709-28-0 | Natural Products |
| HY-N10231 | Agistatin D | 144096-47-9 | Natural Products |
| HY-N10232 | Agistatin E | 144096-48-0 | Natural Products |
| HY-N10233 | 6-Ethyl-2,7-dimethoxyjuglone | 15254-86-1 | Natural Products |
| HY-N10234 | Phenylpyropene A | 189564-20-3 | Natural Products |
| HY-N10235 | Tajixanthone | 35660-48-1 | Natural Products |
| HY-N10236 | Carbolactone | 155443-55-3 | Natural Products |
| HY-N10237 | Mycestericin C | 37817-99-5 | Natural Products |
| HY-N10238 | Mycestericin G | 172519-49-2 | Natural Products |
| HY-N10239 | Aquastatin A | 153821-50-2 | Natural Products |
| HY-N1024 | 11R,12-Dihydroxyspirovetiv-1(10)-en-2-one | 62574-30-5 | Natural Products |
| HY-N10240 | 9-Demethyl FR-901235 | 1029520-85-1 | Natural Products |
| HY-N10241 | Hortein | 346610-88-6 | Natural Products |
| HY-N10242 | Agonodepside B | 445298-41-9 | Natural Products |
| HY-N1024A | 11S,12-Dihydroxyspirovetiv-1(10)-en-2-one | 62623-86-3 | Natural Products |
| HY-N1025 | 12-Acetoxyabietic acid | 83905-81-1 | Natural Products |
| HY-N10255 | Trypacidin | 1900-29-4 | Natural Products |
| HY-N10256 | Varioxepine A | 1623451-72-8 | Natural Products |
| HY-N10257 | Burnettramic acid A aglycone | 2396676-46-1 | Natural Products |
| HY-N10258 | (+)-Sorokinianin | 162616-73-1 | Natural Products |
| HY-N10259 | Norfunalenone | 581786-63-2 | Natural Products |
| HY-N1026 | (-)-12α-Hydroxyevodol | 120722-04-5 | Natural Products |
| HY-N10260 | Curvulinic acid | 19053-94-2 | Natural Products |
| HY-N10261 | Methyl 3,4,5-trimethoxy-2-(2-(nicotinamido)benzamido)benzoate | 81469-77-4 | Natural Products |
| HY-N10262 | Piliformic acid | 98985-76-3 | Natural Products |
| HY-N10263 | Palmarumycin C3 | 159934-11-9 | Natural Products |
| HY-N10264 | Avrainvillamide | 269741-97-1 | Natural Products |
| HY-N10265 | Stephacidin B | 360765-75-9 | Natural Products |
| HY-N10267 | Carviolin | 478-35-3 | Natural Products |
| HY-N10268 | 3-Hydroxyterphenyllin | 66163-76-6 | Natural Products |
| HY-N10269 | Phomalactone | 28921-94-0 | Natural Products |
| HY-N1027 | 12α-Hydroxygrandiflorenic acid | 63768-17-2 | Natural Products |
| HY-N10270 | Verrucofortine | 113706-21-1 | Natural Products |
| HY-N10271 | SCH 38519 | 114970-20-6 | Natural Products |
| HY-N10272 | Avenaciolide | 26057-70-5 | Natural Products |
| HY-N10273 | Deoxyfusapyrone | 156856-32-5 | Natural Products |
| HY-N10274 | Herpotrichone B | 2411834-18-7 | Natural Products |
| HY-N10275 | Herpotrichone A | 2411834-17-6 | Natural Products |
| HY-N10276 | Morelloflavone | 16851-21-1 | Natural Products |
| HY-N10277 | Inubritannolide A | 2867549-30-0 | Natural Products |
| HY-N10278 | Pycnophorin | 103630-05-3 | Natural Products |
| HY-N10279 | Gymconopin C | 844493-85-2 | Natural Products |
| HY-N1028 | 12-Demethyl neocaesalpin F | 1228964-10-0 | Natural Products |
| HY-N10280 | Asperglaucin A | 2701570-79-6 | Natural Products |
| HY-N10281 | Asperglaucin B | 2701570-80-9 | Natural Products |
| HY-N10282 | Isodihydroauroglaucin | 74886-31-0 | Natural Products |
| HY-N10283 | Neoechinulin C | 55179-54-9 | Natural Products |
| HY-N10284 | Tetrahydroauroglaucin | 40434-07-9 | Natural Products |
| HY-N10285 | Phaeosphaone D | 2640137-78-4 | Natural Products |
| HY-N10286 | Chetoseminudin B | 658711-87-6 | Natural Products |
| HY-N10288 | Eucalyptacid A | 2940889-52-9 | Natural Products |
| HY-N10289 | Cytosporone C | 321661-63-6 | Natural Products |
| HY-N1029 | Norathyriol | 3542-72-1 | Natural Products |
| HY-N10290 | Cytochalasin K | 79648-72-9 | Natural Products |
| HY-N10291 | 10-Phenyl-[12]-cytochalasins Z16 | 1335214-29-3 | Natural Products |
| HY-N10292 | Chaetosemin J | 2230052-47-6 | Natural Products |
| HY-N10293 | Monaschromone | 1338576-70-7 | Natural Products |
| HY-N10294 | Epicoccone B | 1067224-41-2 | Natural Products |
| HY-N10295 | Flavipin | 483-53-4 | Natural Products |
| HY-N10296 | Curvulamine A | 1357824-67-9 | Natural Products |
| HY-N10297 | Curindolizine | 1899935-44-4 | Natural Products |
| HY-N10298 | Massarilactone H | 1393110-39-8 | Natural Products |
| HY-N10299 | Guignardone J | 1825374-57-9 | Natural Products |
| HY-N1030 | 12-Deoxo-12α-acetoxyelliptone | 150226-21-4 | Natural Products |
| HY-N10300 | Guignardone K | 1825374-58-0 | Natural Products |
| HY-N10301 | Guignardone L | 1821386-10-0 | Natural Products |
| HY-N10302 | Bipolamine G | 1357824-71-5 | Natural Products |
| HY-N10303 | Withangulatin A | 120824-03-5 | Natural Products |
| HY-N10304 | Isodispar B | 98192-64-4 | Natural Products |
| HY-N10305 | Clionamine B | 1042138-28-2 | Natural Products |
| HY-N10306 | Sycosterol A | Natural Products | |
| HY-N10307 | Anserinone B | 190895-96-6 | Natural Products |
| HY-N10308 | TF-DG-cThea | Natural Products | |
| HY-N10309 | TF-3ʹ-G-cThea | 2868305-75-1 | Natural Products |
| HY-N1031 | Vitexolide E | 958885-86-4 | Natural Products |
| HY-N10310 | TF-3-G-cThea | Natural Products | |
| HY-N10311 | Neosartoricin B | 1421708-43-1 | Natural Products |
| HY-N10312 | Yadanzigan | 76588-87-9 | Natural Products |
| HY-N10313 | Dehydrobruceine B | 53730-90-8 | Natural Products |
| HY-N10319 | Artepillin C | 72944-19-5 | Natural Products |
| HY-N10319R | Artepillin C (Standard) | 72944-19-5 | Reference Standards |
| HY-N1032 | (+)-12α-Hydroxyisodrimenin | 218780-16-6 | Natural Products |
| HY-N10320 | (-)-(E)-α-Atlantone | 108645-54-1 | Natural Products |
| HY-N10321 | Kanshone C | 117634-64-7 | Natural Products |
| HY-N10322 | 2-Hydroxyemodin | 641-90-7 | Reference compound |
| HY-N10323 | Corysamine (chloride) | 11028-77-6 | Natural Products |
| HY-N10325 | Sarbronine M | 1367624-30-3 | Natural Products |
| HY-N10327 | Calystegine A3 | 131580-36-4 | Natural Products |
| HY-N1033 | 12-Hydroxyjasmonic acid | 140631-27-2 | Natural Products |
| HY-N10330 | 7-Hydroxyneolamellarin A | 959662-26-1 | Natural Products |
| HY-N10332 | Leptosphaerodione | 138039-33-5 | Natural Products |
| HY-N10335 | Harringtonolide | 64761-48-4 | Natural Products |
| HY-N10336 | Notoginsenoside R4 | 87741-77-3 | Natural Products |
| HY-N10337 | Norjuziphine | 74119-87-2 | Natural Products |
| HY-N10338 | Mildiomycin | 67527-71-3 | Natural Products |
| HY-N1034 | 12-Oxocalanolide A | 161753-49-7 | Natural Products |
| HY-N10340 | Clausine E | 182261-83-2 | Natural Products |
| HY-N10343 | epi-Progoitrin | 19237-18-4 | Natural Products |
| HY-N10344 | Glucoarabin | 67920-64-3 | Natural Products |
| HY-N10345 | Glucobrassicanapin (potassium) | 245550-58-7 | Natural Products |
| HY-N10346 | Gluconapin (potassium) | 245550-57-6 | Natural Products |
| HY-N10346A | Gluconapin | 19041-09-9 | Natural Products |
| HY-N10347 | 11-(Methylsulfinyl)undecyl-glucosinolate | 186037-18-3 | Natural Products |
| HY-N10348 | Progoitrin | 585-95-5 | Natural Products |
| HY-N10349 | Gluconasturtiin | 499-30-9 | Natural Products |
| HY-N1035 | Urs-12-ene-3β,16β,22α-triol | 1242085-06-8 | Natural Products |
| HY-N10350 | 2,3-Dihydro-3-methoxywithaferin A | 21902-96-5 | Natural Products |
| HY-N10351 | 27-O-(tert-Butyldimethylsilyl)withaferin A | 1392820-18-6 | Natural Products |
| HY-N10352 | 4-epi-Withaferin A | 1214886-27-7 | Natural Products |
| HY-N10353 | 4-Methyl withaferin A | 1777780-94-5 | Natural Products |
| HY-N10354 | 27-Methyl withaferin A | 1777780-93-4 | Natural Products |
| HY-N10355 | 27-TBDMS-4-Dehydrowithaferin A | 1214886-31-3 | Natural Products |
| HY-N10356 | 4,27-Dimethyl withaferin A | 1777780-95-6 | Natural Products |
| HY-N10357 | 3-Ethylthio withaferin A | Natural Products | |
| HY-N10358 | 3-(2-Hydroxyethyl) thio withaferin A | Natural Products | |
| HY-N10359 | Isoandrographolide | 4176-96-9 | Natural Products |
| HY-N1036 | δ-Amyrin | 508-04-3 | Natural Products |
| HY-N10360 | Ellipyrone A | Natural Products | |
| HY-N10361 | Drupanin | 53755-58-1 | Natural Products |
| HY-N10362 | Ellipyrone B | Natural Products | |
| HY-N10363 | Pixinol | 162062-88-6 | Natural Products |
| HY-N10364 | 6β,7β-Epoxyasteriscunolide A | 1927017-53-5 | Natural Products |
| HY-N10365 | 6-(1-Hydroxyethyl)-5,6-dihydrochelerythrine | 2715007-88-6 | Natural Products |
| HY-N10366 | Dihydrochelirubine | 28342-26-9 | Natural Products |
| HY-N10367 | Corydamine | 49870-84-0 | Natural Products |
| HY-N10368 | Shinjulactone M | 103630-27-9 | Natural Products |
| HY-N10369 | 1,2,3,7-Tetrahydroxy-8-methoxy-6-methyl-9,10-anthraquinone | 130018-57-4 | Natural Products |
| HY-N1037 | δ-Amyrenone | 20248-08-2 | Reference compound |
| HY-N10370 | Morusignin L | 149733-95-9 | Natural Products |
| HY-N10371 | Physcion-8-O-β-gentiobioside | 84268-38-2 | Natural Products |
| HY-N10372 | 1,3-Dioleoyl-2-palmitoylglycerol | 1716-07-0 | Natural Products |
| HY-N10373 | Caffeoyl alcohol | 3598-26-3 | Natural Products |
| HY-N10374 | Perseitol | 527-06-0 | Natural Products |
| HY-N10375 | Kuwanon T | 100187-66-4 | Natural Products |
| HY-N10376 | Lagunamine | 126721-42-4 | Natural Products |
| HY-N10377 | Anhuienoside B | 1233510-75-2 | Natural Products |
| HY-N10378 | Rubrofusarin 6-O-β-D-glucopyranoside | 132922-80-6 | Natural Products |
| HY-N10379 | 19-epi-Scholaricine | 132923-06-9 | Natural Products |
| HY-N1038 | 13-Epijhanol | 133005-15-9 | Natural Products |
| HY-N10380 | Inonotusol F | 1534433-74-3 | Natural Products |
| HY-N10381 | Zedoalactone B | 170384-81-3 | Natural Products |
| HY-N10382 | 20,26-Dihydroxyecdysone | 19458-46-9 | Natural Products |
| HY-N10383 | (1E)-3-Methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one | 383368-26-1 | Natural Products |
| HY-N10384 | AChE-IN-17 | 460345-17-9 | Natural Products |
| HY-N10385 | Uvariol | 56362-97-1 | Natural Products |
| HY-N10386 | Dichotomine B | 755036-41-0 | Natural Products |
| HY-N10387 | Glucodichotomine B | 845673-16-7 | Natural Products |
| HY-N10388 | Copteroside G | 86438-31-5 | Natural Products |
| HY-N10389 | Odoratisol B | 891182-94-8 | Natural Products |
| HY-N1039 | 13-Epimanool | 1438-62-6 | Natural Products |
| HY-N10390 | 3β-Hydroxylanosta-8,24-dien-21-al | 96574-03-7 | Natural Products |
| HY-N10391 | (-)-Cleistenolide | 1003600-48-3 | Natural Products |
| HY-N10392 | (S)-Erypoegin K | 2055053-90-0 | Natural Products |
| HY-N10393 | Vibsanin A | 72506-14-0 | Natural Products |
| HY-N10394 | Metachromins X | 2408641-10-9 | Natural Products |
| HY-N10395 | (E)-Isoconiferin | 113349-27-2 | Natural Products |
| HY-N10396 | Verrucosin | 83198-63-4 | Natural Products |
| HY-N10397 | Maceneolignan H | 1314042-85-7 | Natural Products |
| HY-N10398 | Garcinielliptone HD | 1008376-90-6 | Natural Products |
| HY-N10399 | Cararosinol A | 651733-57-2 | Natural Products |
| HY-N1039A | Manool | 596-85-0 | Natural Products |
| HY-N1040 | 13-Hydroxy-8,11,13-podocarpatriene-18-oic acid | 61597-83-9 | Natural Products |
| HY-N10400 | Campneoside II | 95587-86-3 | Natural Products |
| HY-N10402 | Norbatzelladine L | 1187954-93-3 | Natural Products |
| HY-N10403 | 4-Hydroxyestradiol | 5976-61-4 | Reference compound |
| HY-N10403R | 4-Hydroxyestradiol (Standard) | 5976-61-4 | Reference Standards |
| HY-N10404 | Junceellolide C | 121769-82-2 | Natural Products |
| HY-N10405 | (R)-5-Hydroxy-1,7-diphenyl-3-heptanone | 100761-20-4 | Natural Products |
| HY-N10406 | Triptonoterpene | 99694-87-8 | Natural Products |
| HY-N10407 | Quercetin 3-O-rutinoside-7-O-glucoside | 30311-61-6 | Natural Products |
| HY-N10408 | Tripchlorolide | 132368-08-2 | Natural Products |
| HY-N10409 | Lucenin-2 | 29428-58-8 | Natural Products |
| HY-N1041 | 13-Methyl-8,11,13-podocarpatriene-3,12-diol | 769140-74-1 | Natural Products |
| HY-N10410 | Apigenin 6,8-di-C-α-L-arabinopyranoside | 73140-47-3 | Natural Products |
| HY-N10411 | Morin 3-O-β-D-glucopyranoside | 1169766-14-6 | Natural Products |
| HY-N10412 | Grosshemin | 22489-66-3 | Natural Products |
| HY-N10413 | Diphlorethohydroxycarmalol | 138529-04-1 | Natural Products |
| HY-N10414 | Primulic acid I | 65312-86-9 | Natural Products |
| HY-N10414R | Primulic acid I (Standard) | 65312-86-9 | Reference Standards |
| HY-N10416 | Neuroinflammatory-IN-1 | 83988-97-0 | Natural Products |
| HY-N10417 | Apoptosis inducer 5 | Natural Products | |
| HY-N10418 | Isorhapontin | 32727-29-0 | Natural Products |
| HY-N10419 | Cannabisin B | 144506-17-2 | Natural Products |
| HY-N1042 | 13-O-Acetylcorianin | 108887-44-1 | Natural Products |
| HY-N10420 | Hinokinin | 26543-89-5 | Natural Products |
| HY-N10420R | Hinokinin (Standard) | 26543-89-5 | Reference Standards |
| HY-N10421 | Dihydrocubebin | 24563-03-9 | Natural Products |
| HY-N10422 | Aloenin B | 106533-41-9 | Natural Products |
| HY-N10423 | Cubebin | 18423-69-3 | Natural Products |
| HY-N10424 | Brazilein | 600-76-0 | Natural Products |
| HY-N10425 | 2-Hydroxyalbrassitriol | 1176586-98-3 | Natural Products |
| HY-N10426 | (+)-Cembrene A | 72691-72-6 | Natural Products |
| HY-N10427 | 5,6-Epoxyergosterol | 23637-31-2 | Natural Products |
| HY-N10429 | Geissoschizoline | 18397-07-4 | Natural Products |
| HY-N1043 | 13-O-Deacetyltaxumairol Z | 220935-39-7 | Natural Products |
| HY-N10430 | Patentiflorin A | 857050-63-6 | Natural Products |
| HY-N10431 | Stigmane B | Natural Products | |
| HY-N10432 | Xanthine oxidase-IN-8 | 2571069-66-2 | Natural Products |
| HY-N10433 | Xanthine oxidase-IN-9 | 2571069-61-7 | Natural Products |
| HY-N10434 | Anti-inflammatory agent 28 | Natural Products | |
| HY-N10435 | Anti-inflammatory agent 29 | Natural Products | |
| HY-N10436 | Anti-inflammatory agent 30 | 2573174-21-5 | Natural Products |
| HY-N10437 | 6-Acetylnimbandiol | 1281766-66-2 | Natural Products |
| HY-N10438 | Ganodermaones B | Natural Products | |
| HY-N10439 | 3β-Acetoxy-hop-22(29)-ene | 76582-61-1 | Natural Products |
| HY-N10440 | 3-Oxo-hop-22(29)-ene | 25615-11-6 | Natural Products |
| HY-N10441 | 3β-Hydroxy-hop-22(29)-ene | 58801-23-3 | Natural Products |
| HY-N10442 | Herqueilenone A | 3000513-67-4 | Natural Products |
| HY-N10443 | Mammea A/BA | 5224-54-4 | Natural Products |
| HY-N10444 | Alterbrassicene B | 2575789-01-2 | Natural Products |
| HY-N10445 | Maydispenoid A | Natural Products | |
| HY-N10446 | Maydispenoid B | 3024647-69-3 | Natural Products |
| HY-N10447 | Kurzipene D | 2522596-01-4 | Natural Products |
| HY-N10448 | Sinulatumolin E | 2570255-85-3 | Natural Products |
| HY-N10449 | Resistomycin | 20004-62-0 | Natural Products |
| HY-N1045 | 13-Keto-8(14)-Podocarpen-18-oic acid | 63976-69-2 | Natural Products |
| HY-N10450 | Kumujian A | 72755-19-2 | Natural Products |
| HY-N10451 | Chlorogenin | 562-34-5 | Natural Products |
| HY-N10452 | Methyl maslinate | 22425-82-7 | Natural Products |
| HY-N10453 | Sinulatumolin D | Natural Products | |
| HY-N10454 | Sinulatumolin C | 2570255-84-2 | Natural Products |
| HY-N10455 | 24-Epicastasterone | 72050-71-6 | Natural Products |
| HY-N10456 | 1-Methyl-2-(8E)-8-tridecenyl-4(1H)-quinolinone | 98393-27-2 | Natural Products |
| HY-N10457 | Norstictic acid | 571-67-5 | Natural Products |
| HY-N10458 | Asperbisabolane L | Natural Products | |
| HY-N1046 | 7,15-Dihydroxypodocarp-8(14)-en-13-one | 262355-96-4 | Natural Products |
| HY-N10469 | Bleomycin B4 | 9060-11-1 | Natural Products |
| HY-N1047 | Baccatin | 66107-60-6 | Natural Products |
| HY-N10470 | Bleomycin A5 | 11116-32-8 | Natural Products |
| HY-N10471 | F3226-1387 | 618877-25-1 | Natural Products |
| HY-N10472 | STAT3-IN-14 | 123297-90-5 | Natural Products |
| HY-N10473 | Pulcherriminic acid | 957-86-8 | Natural Products |
| HY-N10474 | Obtusalin | 125164-64-9 | Natural Products |
| HY-N10475 | 4,12-Dimethoxy-6-(7,8-dihydroxy-7,8-dihydrostyryl)-2-pyrone | 149947-22-8 | Natural Products |
| HY-N10477 | gamma-Glutamylarginine | 31106-03-3 | Natural Products |
| HY-N10478A | Sitosterol sulfate (trimethylamine) | Reference compound | |
| HY-N10479 | Chorismic acid | 617-12-9 | Natural Products |
| HY-N1048 | 14-Benzoylneoline | 99633-05-3 | Natural Products |
| HY-N10480 | 4-O-Galloylalbiflorin | 1201580-97-3 | Natural Products |
| HY-N10482 | Tinophyllol | 96552-83-9 | Natural Products |
| HY-N10483 | Telekin | 6752-90-5 | Natural Products |
| HY-N10486 | BChE-IN-10 | 2185837-61-8 | Natural Products |
| HY-N10487 | Bleformin A | 1980064-35-4 | Natural Products |
| HY-N10488 | BChE-IN-11 | 133740-30-4 | Natural Products |
| HY-N10489 | BChE-IN-12 | 136966-86-4 | Natural Products |
| HY-N1049 | Zeorin | 22570-53-2 | Natural Products |
| HY-N10490 | Blestrin D | 145701-19-5 | Natural Products |
| HY-N10491 | Spongionellol A | Natural Products | |
| HY-N10492 | Spongionellol A analog 1 | Natural Products | |
| HY-N10493 | 7β,25-Dihydroxycholesterol | 64907-21-7 | Natural Products |
| HY-N10495 | Seconeolitsine | 2650074-56-7 | Natural Products |
| HY-N10496 | Sericoside | 55306-04-2 | Natural Products |
| HY-N10497 | Dihydro-β-erythroidine | 23255-54-1 | Natural Products |
| HY-N10499 | Caprazol | 740805-18-9 | Natural Products |
| HY-N1050 | Zederone | 7727-79-9 | Natural Products |
| HY-N10502 | Colletofragarone A2 | 181377-06-0 | Natural Products |
| HY-N10503 | Norartocarpetin | 520-30-9 | Natural Products |
| HY-N10507 | Methyl 14-methylpentadecanoate | 5129-60-2 | Natural Products |
| HY-N10508 | Calcitroic acid | 71204-89-2 | Natural Products |
| HY-N10509 | Blood-group A trisaccharide | 49777-13-1 | Natural Products |
| HY-N1051 | Zarzissine | 160568-14-9 | Natural Products |
| HY-N10510 | Blood group A antigen tetraose type 5 | 59957-92-5 | Natural Products |
| HY-N10511 | GM1a Ganglioside oligosaccharide | 67063-78-9 | Natural Products |
| HY-N10512 | Gangliotetraose | 75645-24-8 | Natural Products |
| HY-N10514 | Lacto-N-triose II | 75645-27-1 | Natural Products |
| HY-N10516 | Bacteriopheophytin | 17453-58-6 | Natural Products |
| HY-N10518 | Celloheptaose | 52646-27-2 | Natural Products |
| HY-N10519 | Cellooctaose | 120434-20-0 | Natural Products |
| HY-N10520 | Pectic acid | 9046-40-6 | Natural Products |
| HY-N10521 | 6'-Sialyllactose | 35890-39-2 | Natural Products |
| HY-N10523 | Myricoside | 76076-04-5 | Natural Products |
| HY-N10525 | 3α,4β-Galactotriose | 56038-36-9 | Natural Products |
| HY-N10526 | Isoglobotriaose | 41744-59-6 | Natural Products |
| HY-N10527 | Isoglobotetraose | 75645-26-0 | Natural Products |
| HY-N10528 | 3-Fucosyllactose | 41312-47-4 | Natural Products |
| HY-N10529 | Lacto-N-fucopentaose V | 60254-64-0 | Natural Products |
| HY-N1053 | Zanthobungeanine | 64190-94-9 | Natural Products |
| HY-N10530 | Lactodifucotetraose | 20768-11-0 | Natural Products |
| HY-N10531 | Lewis a trisaccharide | 56570-03-7 | Natural Products |
| HY-N10532 | Lacto-N-difucohexaose II | 62258-12-2 | Natural Products |
| HY-N10533 | N-Benzylpentadecanamide | 1572037-13-8 | Natural Products |
| HY-N10534 | Lewis X trisaccharide | 71208-06-5 | Natural Products |
| HY-N10535 | Lewis y tetrasaccharide | 82993-43-9 | Natural Products |
| HY-N10538 | Shishijimicin B | 503860-51-3 | Natural Products |
| HY-N10539 | Shishijimicin C | 503860-52-4 | Natural Products |
| HY-N1054 | Zamanic acid | 260393-05-3 | Natural Products |
| HY-N10541 | Aplyronine B | 151923-85-2 | Natural Products |
| HY-N10542 | Aplyronine C | 151923-86-3 | Natural Products |
| HY-N10543 | 5-O-(E)-p-Coumaroylquinic acid | 5746-55-4 | Natural Products |
| HY-N10543A | 3-p-Coumaroylquinic acid | 1899-30-5 | Natural Products |
| HY-N10544 | δ-Cadinene | 483-76-1 | Natural Products |
| HY-N10546 | Ganglioside GM1 | 37758-47-7 | Natural Products |
| HY-N10546A | Ganglioside GM1 (bovine) (ammonium) | 1007119-81-4 | Natural Products |
| HY-N10547 | 6-O-Methylcatalpol | 1617-84-1 | Natural Products |
| HY-N10549 | Gigantol | 83088-28-2 | Natural Products |
| HY-N1055 | Yunnandaphninine G | 1042143-83-8 | Natural Products |
| HY-N1056 | Yunnancoronarin A | 162762-93-8 | Natural Products |
| HY-N10560 | Wychimicin C | Natural Products | |
| HY-N10561 | Wychimicin A | Natural Products | |
| HY-N10563 | Coleon-U-quinone | 65714-83-2 | Natural Products |
| HY-N10564 | 8α,9α-Epoxycoleon-U-quinone | 93800-59-0 | Natural Products |
| HY-N1057 | Plantarenaloside | 72396-01-1 | Natural Products |
| HY-N10572 | Antibacterial synergist 2 | 2831355-88-3 | Natural Products |
| HY-N10573 | UDP-rhamnose | 1955-26-6 | Natural Products |
| HY-N10574 | Queuine | 72496-59-4 | Natural Products |
| HY-N10574A | Queuine (dihydrochloride) | 86496-18-6 | Natural Products |
| HY-N10577 | Chlorfortunone A | Natural Products | |
| HY-N10579 | Chrexanthomycin C | 3030587-55-1 | Natural Products |
| HY-N1058 | Yuehgesin C | 125072-68-6 | Natural Products |
| HY-N10581 | Flutimide | 162666-34-4 | Natural Products |
| HY-N10583 | Motuporin | 141672-08-4 | Natural Products |
| HY-N10585 | Malacidin B | 2254483-96-8 | Natural Products |
| HY-N10587 | Catechin 7-O-β-D-glucopyranoside | 65597-47-9 | Natural Products |
| HY-N10588 | Nardoguaianone K | 443128-65-2 | Natural Products |
| HY-N10588A | Nardoguaianone J | 443128-64-1 | Natural Products |
| HY-N10589 | (+)-trans-3'-Acetyl-4'-isobutyrylkhellactone | 1562996-11-5 | Natural Products |
| HY-N1059 | Yucalexin P-17 | 119642-82-9 | Natural Products |
| HY-N10590 | Arborescosidic acid | 325798-51-4 | Natural Products |
| HY-N10591 | Bruceantarin | 41451-76-7 | Natural Products |
| HY-N10592 | Herbacetin-3-sophoroside-8--glucoside | 77298-68-1 | Natural Products |
| HY-N10593 | Ladanetin-6-O-β-D-glucopyranoside | 89647-63-2 | Natural Products |
| HY-N10594 | Cirsiliol 4′-glucoside | 41087-98-3 | Natural Products |
| HY-N10595 | Ladanetin-6-O-β-(6′′-O-acetyl)glucoside | 1256959-27-9 | Natural Products |
| HY-N10596 | Scutellarin-7-diglucosidic acid | 150641-65-9 | Natural Products |
| HY-N10597 | 5'''-O-Feruloyl complanatoside B | 142473-98-1 | Natural Products |
| HY-N1060 | Yatein | 40456-50-6 | Natural Products |
| HY-N10600 | 3β-Acetoxyurs-12-en-11-one | 2348-66-5 | Natural Products |
| HY-N10601 | 11-Oxo-α-amyrin | 2118-90-3 | Natural Products |
| HY-N10602 | Caryatin | 1486-66-4 | Natural Products |
| HY-N10603 | Praeroside | 155969-61-2 | Natural Products |
| HY-N10604 | Dihydromaniwamycin E | 3033567-35-7 | Natural Products |
| HY-N10605 | Maniwamycin E | Natural Products | |
| HY-N10606 | Uvagrandol | Natural Products | |
| HY-N10607 | 2'-Hydroxy-3,4,4',6'-tetramethoxychalcone | 114021-62-4 | Natural Products |
| HY-N10608 | (-)-Isoledene | 95910-36-4 | Natural Products |
| HY-N10609 | 3′-O-Angeloylhamaudol | 84272-84-4 | Natural Products |
| HY-N10610 | Ethyl rosmarinate | 174591-47-0 | Natural Products |
| HY-N10611 | Elsinochrome A | 24568-67-0 | Dye Reagents |
| HY-N10612 | Petasin | 26577-85-5 | Natural Products |
| HY-N10616 | Pseudobaptigenin | 90-29-9 | Natural Products |
| HY-N10617 | Hygromycin A | 6379-56-2 | Natural Products |
| HY-N10618 | Epilactose | 50468-56-9 | Natural Products |
| HY-N1062 | Xerophilusin G | 304642-94-2 | Natural Products |
| HY-N10620 | Melitidin | 1162664-58-5 | Natural Products |
| HY-N10621 | 3,5-Dimethoxy-2,7-phenanthrenediol | 108352-70-1 | Natural Products |
| HY-N10623 | 5-epi-Arvestonate A | 2767066-84-0 | Natural Products |
| HY-N10624 | Koshidacin B | 2925302-01-6 | Natural Products |
| HY-N10626 | Neu5Gcα(2-6) N-Glycan | 125139-41-5 | Natural Products |
| HY-N10627 | NA2 Glycan | 71496-53-2 | Natural Products |
| HY-N10628 | Neu5Acα(2-6) N-Glycan | 1125602-44-9 | Natural Products |
| HY-N10629 | A2G0 Glycan | 84808-02-6 | Natural Products |
| HY-N1063 | Xanthoxylin | 90-24-4 | Natural Products |
| HY-N10630 | G-NGA2 N-Glycan | 103584-68-5 | Natural Products |
| HY-N10631 | Paucimannose | 70858-45-6 | Natural Products |
| HY-N10632 | Sialyllacto-N-tetraose b | 64003-54-9 | Natural Products |
| HY-N10633 | LSTc | 64003-55-0 | Natural Products |
| HY-N10634 | D-Glucosyl-β-1,1′-N-palmitoylsphingosine | 74365-77-8 | Natural Products |
| HY-N10634S | D-Glucosyl-β-N-palmitoylsphingosine-d3 | 71924-12-4 | Isotope-Labeled Compounds |
| HY-N10636 | D-lactosyl-β-1,1′ N-stearoyl-D-erythro-sphingosine | 125712-73-4 | Natural Products |
| HY-N10637 | N-Acetyldopamine dimer-1 | 315188-82-0 | Natural Products |
| HY-N10638 | N-Acetyldopamine dimer-2 | 916888-49-8 | Natural Products |
| HY-N10639 | (1α,2α,6β,8α,9α)-1,2,6,8,12-Pentakis(acetyloxy)-9-(benzoyloxy)dihydro-β-agarofuran | 128443-60-7 | Natural Products |
| HY-N1064 | Xanthoplanine | 6872-88-4 | Natural Products |
| HY-N10640 | Alismanol M | 2408810-59-1 | Natural Products |
| HY-N10641 | Epinodosinol | 27548-88-5 | Natural Products |
| HY-N10642 | Pedaliin 6''-acetate | 160789-41-3 | Natural Products |
| HY-N10643 | Lushanrubescensin H | 476640-22-9 | Natural Products |
| HY-N10644 | Complanatin | 142449-94-3 | Natural Products |
| HY-N10645 | Rhamnocitrin 3-O-β-D-apiofuranosyl(1→2)-β-D-glucopyranoside | 148031-68-9 | Natural Products |
| HY-N10646 | N-Acetyldopamine dimer-3 | 315188-81-9 | Natural Products |
| HY-N10647 | Isoscutellarein 8-O-β-D-glucuronide | 56317-09-0 | Natural Products |
| HY-N10648 | PTP1B-IN-20 | 3001295-81-1 | Natural Products |
| HY-N10649 | PTP1B-IN-21 | 3001295-85-5 | Natural Products |
| HY-N1065 | Xanthoxyletin | 84-99-1 | Natural Products |
| HY-N10653 | Altemicidin | 125399-82-8 | Natural Products |
| HY-N1066 | Xanthohumol D | 274675-25-1 | Natural Products |
| HY-N10661 | Ipomoeassin F | 915392-44-8 | Natural Products |
| HY-N10662 | Angelicone | 37719-98-5 | Natural Products |
| HY-N10663 | Kadsurenone | 95851-37-9 | Natural Products |
| HY-N10663A | (±)-7-epi-Kadsurenone | 245648-20-8 | Natural Products |
| HY-N10664 | Piperlactam S | 188546-49-8 | Natural Products |
| HY-N10667 | Zhebeiresinol | 151636-98-5 | Natural Products |
| HY-N10668 | 2-(3-Hydroxy-2-oxoindolin-3-yl)-acetic acid | 57061-17-3 | Natural Products |
| HY-N10669 | Apigenin 4′-O-β-D-glucopyranoside | 20486-34-4 | Natural Products |
| HY-N1067 | Xanthohumol | 6754-58-1 | Natural Products |
| HY-N10670 | Bursehernin | 40456-51-7 | Natural Products |
| HY-N10671 | Kuguacin N | 1141453-73-7 | Natural Products |
| HY-N10672 | Kuguacin R | 191097-54-8 | Natural Products |
| HY-N10673 | 10α-Hydroxyepigambogic acid | 1164201-85-7 | Natural Products |
| HY-N10676 | 8,8a-Dihydro-8-hydroxygambogic acid | 1097882-30-8 | Natural Products |
| HY-N10677 | S-30-Hydroxygambogic acid | 881027-36-7 | Natural Products |
| HY-N10678 | R-30-Hydroxygambogic acid | 881027-35-6 | Natural Products |
| HY-N1067A | (E/Z)-Xanthohumol | 569-83-5 | Natural Products |
| HY-N1067R | Xanthohumol (Standard) | 6754-58-1 | Reference Standards |
| HY-N1068 | Xanthinin | 153483-31-9 | Natural Products |
| HY-N10681 | Evonimine | 41758-69-4 | Natural Products |
| HY-N10682 | Hypoglaunine A | 228259-16-3 | Natural Products |
| HY-N10683 | 1b-Benzoyl-8a-cinnamoyl-4a,5a-dihydroxydihydroagarofuran | 268541-27-1 | Natural Products |
| HY-N10685 | 3,7,25-Trihydroxycucurbita-5,23-dien-19-al | 85372-65-2 | Natural Products |
| HY-N10686 | Tanshinone IIA anhydride | 61077-78-9 | Natural Products |
| HY-N10687 | Saprorthoquinone | 102607-41-0 | Natural Products |
| HY-N10689 | Microstegiol | 143246-41-7 | Natural Products |
| HY-N1069 | Wittifuran X | 1309478-07-6 | Natural Products |
| HY-N10691 | Protoapigenin | 879325-07-2 | Natural Products |
| HY-N10692 | 2-(trans-1,4-Dihydroxy-cyclohexyl)-5,7-dihydroxy-chromone | 1270013-29-0 | Natural Products |
| HY-N10693 | Protoapigenin 4′-O-β-D-glucoside | 163559-04-4 | Natural Products |
| HY-N10694 | Rehmannioside B | 81720-06-1 | Natural Products |
| HY-N10695 | Celangulatin C | 1000784-44-0 | Natural Products |
| HY-N10696 | Angulatin E | 403613-20-7 | Natural Products |
| HY-N10697 | Angulatin G | 1000784-46-2 | Natural Products |
| HY-N10698 | (2E,4E)-8-Hydroxy-2,7-dimethyl-decadien-(2,4)-disaeure-(1,10)-dioic acid | 2808401-10-5 | Natural Products |
| HY-N10699 | 6-Methoxykaempferol | 32520-55-1 | Natural Products |
| HY-N1070 | Wilsonine | 39024-12-9 | Natural Products |
| HY-N10700 | 25-O-Acetylcimigenol xyloside | 27994-12-3 | Natural Products |
| HY-N10701 | AChE/BChE-IN-11 | 80443-12-5 | Natural Products |
| HY-N10702 | PCSK9-IN-9 | Natural Products | |
| HY-N10703 | 1-Oxomiltirone | 142546-16-5 | Natural Products |
| HY-N10704 | 25-O-acetyl-7,8-didehydro-cimigenol-3-O-b-Dxylopyaranoside | 228251-30-7 | Natural Products |
| HY-N10706A | 3-Keto sphinganine (d18:0) (hydrochloride) | 35299-94-6 | Natural Products |
| HY-N1071 | Wilforol C | 168254-95-3 | Natural Products |
| HY-N1072 | Wilforgine | 37239-47-7 | Natural Products |
| HY-N1072R | Wilforgine (Standard) | 37239-47-7 | Reference Standards |
| HY-N1073 | Wighteone | 51225-30-0 | Natural Products |
| HY-N1074 | Warangalone | 4449-55-2 | Natural Products |
| HY-N10741 | Ellagic acid 4-O-β-D-xylopyranoside | 139163-18-1 | Natural Products |
| HY-N10742 | Maritimetin | 576-02-3 | Natural Products |
| HY-N10743 | Pipercide | 54794-74-0 | Natural Products |
| HY-N10744 | Arabidopyl alcohol | 1400234-92-5 | Natural Products |
| HY-N10745 | Angulatin B | 142546-07-4 | Natural Products |
| HY-N10746 | Polyporoid C | 1042362-47-9 | Natural Products |
| HY-N10747 | Polyporoid B | 1042362-45-7 | Natural Products |
| HY-N10748 | 2',3'-Dihydro-2'-hydroxyprotoapigenone | 1365655-88-4 | Natural Products |
| HY-N10749 | Aristolan-1(10)-en-9-ol | 114339-94-5 | Natural Products |
| HY-N1075 | Walsuronoid B | 942582-15-2 | Natural Products |
| HY-N10750 | 1α, 2α-Diacetoxy-8β-isobutanoyloxy-9α-benzoyloxy-15-β-(β-furancarbonyloxy)-4β, 6β-dihydroxy-β-dihydroagarofuran | 2170562-63-5 | Natural Products |
| HY-N10751 | (2E,4E)-Decadienoic acid | 30361-33-2 | Natural Products |
| HY-N10752 | 6,7-Dihydroxy-2-(2-phenylethyl)-5,6,7,8-tetrahydrochromone | 626236-07-5 | Natural Products |
| HY-N10754 | Aschantin | 13060-15-6 | Natural Products |
| HY-N10755 | (+)-ε-Viniferin | 129170-22-5 | Natural Products |
| HY-N10755A | (±)-ε-Viniferin | 253435-07-3 | Natural Products |
| HY-N10756 | Hyp9 | 3118-34-1 | Natural Products |
| HY-N10757 | Petunidin-3-O-(6-O-p-coumaryl)-5-O-diglucoside | 51939-66-3 | Natural Products |
| HY-N1076 | Wallichinine | 125292-97-9 | Natural Products |
| HY-N10760 | 2a,3a,23-Trihydroxyurs-12,20(30)-dien-28-oic acid | 143839-01-4 | Natural Products |
| HY-N10762 | 15,16-Dihydrotanshindiol C | 891854-96-9 | Natural Products |
| HY-N10763 | N-Methylcorydaldine | 6514-05-2 | Natural Products |
| HY-N10764 | Acetylexidonin | 116368-90-2 | Natural Products |
| HY-N10765 | Salvinolone | 120278-22-0 | Natural Products |
| HY-N10766 | Ampelopsin F | 151487-08-0 | Natural Products |
| HY-N10768 | 1-Dehydro-[10]-gingerdione | 136826-50-1 | Natural Products |
| HY-N10769 | Atanine | 7282-19-1 | Natural Products |
| HY-N1077 | Vomifoliol | 23526-45-6 | Natural Products |
| HY-N10770 | 5'-Geranyl-5,7,2',4'-tetrahydroxyflavone | 1221762-70-4 | Natural Products |
| HY-N10771 | (R)-2-Isopropyl-8,8,8a-trimethyl-6,7,8,8a-tetrahydrophenanthrene-3,4-diol | 2244560-40-3 | Natural Products |
| HY-N10772 | Albanin A | 73343-42-7 | Natural Products |
| HY-N10773 | 1-Oxomicrostegiol | 1631054-68-6 | Natural Products |
| HY-N10774 | Viroxocin | 1631054-69-7 | Natural Products |
| HY-N10776 | Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside | 56317-05-6 | Natural Products |
| HY-N10777 | 1-Ketoaethiopinone | 105062-36-0 | Natural Products |
| HY-N10778 | (19R,23E)-5b,19-Epoxy19-ethoxycucurbita-6,23-diene-3b,25-diol | 1301267-02-6 | Natural Products |
| HY-N10779 | Gnetifolin M | 439900-84-2 | Natural Products |
| HY-N1078 | Voleneol | 70389-88-7 | Natural Products |
| HY-N10780 | 5-Hydroxyseselin | 31525-75-4 | Natural Products |
| HY-N10781 | Isograndifoliol | 1445475-53-5 | Natural Products |
| HY-N10782 | Balanophonin | 80286-36-8 | Natural Products |
| HY-N10783 | (-)-Toddanol | 77715-99-2 | Natural Products |
| HY-N10784 | Kaempferol-3-O-[2″,6″-di-O-E-p-coumaroyl]-β-D-glucopyranoside | 121651-61-4 | Natural Products |
| HY-N10785 | Toddanone | 77636-08-9 | Natural Products |
| HY-N10786 | 1,3,6-Trihydroxy-5-methoxyxanthone | 41357-84-0 | Natural Products |
| HY-N10787 | Methylkushenol C | 128879-52-7 | Natural Products |
| HY-N10788 | Pomonic acid | 13849-90-6 | Natural Products |
| HY-N10789 | (2S)-4'-Hydroxy-7-methoxyflavan | 27348-54-5 | Natural Products |
| HY-N1079 | Vitexilactone | 61263-49-8 | Natural Products |
| HY-N10790 | RA-V | 64725-24-2 | Natural Products |
| HY-N10791 | Neobritannilactone B | 886990-00-7 | Natural Products |
| HY-N10792 | Methyl diacetoxy-6-gingerdiol | 863780-90-9 | Natural Products |
| HY-N10793 | RA-XI | 143277-27-4 | Natural Products |
| HY-N10794 | 18β-Hydroxy-3-epi-α-yohimbine | 81703-06-2 | Natural Products |
| HY-N10796 | Miltipolone | 131086-61-8 | Natural Products |
| HY-N10797 | (-)-Haplomyrfolin | 85404-48-4 | Natural Products |
| HY-N10798 | Kusunokinin | 58311-20-9 | Natural Products |
| HY-N10799 | Oroxylin A 7-O-β-D-glucuronide methyl ester | 82475-02-3 | Natural Products |
| HY-N1080 | Vitexdoin A | 1186021-77-1 | Natural Products |
| HY-N10800 | 1,2,6,7,8,9-Hexahydro-1,6,6-trimethyl-3,11-dioxanaphth[2,1-e]azulene-10,12-dione | 126979-78-0 | Natural Products |
| HY-N10801 | Salvianan A | 2162956-63-8 | Natural Products |
| HY-N10802 | 6-O-Isobutyrylbritannilactone | 1259933-02-2 | Natural Products |
| HY-N10803 | (+)-6-(3-Chloro-2-hydroxy-3-methylbutyl)-5,7-dimethoxycoumarin | 15575-50-5 | Natural Products |
| HY-N10804 | (23E)-5b,19-epoxycucurbita-6,23,25(26)-triene-3b-ol | 1301267-01-5 | Natural Products |
| HY-N10805 | Schisanlignone C | 144606-83-7 | Natural Products |
| HY-N10806 | Schisanlignone D | 144606-84-8 | Natural Products |
| HY-N10809 | 13-Hydroxygermacrone | 103994-29-2 | Natural Products |
| HY-N10811 | O-Methylcedrelopsin | 72916-61-1 | Natural Products |
| HY-N10812 | 8-(3-Ethoxy-2-hydroxy-3-methylbutyl)-5,7-dimethoxy-2H-chromen-2-one | 70849-88-6 | Natural Products |
| HY-N10813 | Ajugacumbin B | 124961-66-6 | Natural Products |
| HY-N10814 | (Z)-2-Angeloyloxymethyl-2-butenoic | 69188-40-5 | Natural Products |
| HY-N10815 | Anthriscinol | 69618-94-6 | Natural Products |
| HY-N10817 | (2S)-5-Methoxyflavan-7-ol | 35290-20-1 | Natural Products |
| HY-N10818 | Fipsomin | 2143936-83-6 | Natural Products |
| HY-N10819 | Arteminin | 466639-11-2 | Natural Products |
| HY-N1081A | Viteralone | 87440-75-3 | Natural Products |
| HY-N1082 | Visnagin | 82-57-5 | Natural Products |
| HY-N10820 | Psoracorylifol C | 879290-99-0 | Natural Products |
| HY-N10821A | Blestriarene A | 126721-53-7 | Natural Products |
| HY-N10822 | Ajugamarin F4 | 122587-84-2 | Natural Products |
| HY-N10824 | 2,3,5,6-Tetramethoxyaporphine | 5630-11-5 | Natural Products |
| HY-N10825 | Glucopyranoside,(3beta,25R)-17-hydroxyspirost-5-en-3-yl | 84914-58-9 | Natural Products |
| HY-N10829 | 4-Demethyldeoxypodophyllotoxin | 3590-93-0 | Natural Products |
| HY-N1083 | Viscidulin III | 92519-91-0 | Natural Products |
| HY-N10830 | (±)-Nirtetralin | 78185-63-4 | Natural Products |
| HY-N10831 | Ajuganipponin A | 936323-13-6 | Natural Products |
| HY-N10833 | 2-Hydroxy-1,3,4-trimethoxyanthraquinone | 94099-63-5 | Natural Products |
| HY-N10834 | (6E,12E)-Tetradecadiene-8,10-diyne-1,3-diol | 120166-71-4 | Natural Products |
| HY-N10835 | Gnetumontanin B | 809237-87-4 | Natural Products |
| HY-N10836 | Montixanthone | 876305-36-1 | Natural Products |
| HY-N10837 | rel-3R-Methoxy-4S-furanogermacra-1E,10(15)-dien-6-one | 1393342-06-7 | Natural Products |
| HY-N10838 | Ajudecunoid A | 124961-67-7 | Natural Products |
| HY-N10839 | Yuexiandajisu E | 866556-16-3 | Natural Products |
| HY-N1084 | Viscidulin III tetraacetate | 96684-81-0 | Natural Products |
| HY-N10840 | Furanogermacra-1(10)Z,4Z-dien-6-one | 88010-63-3 | Natural Products |
| HY-N10841 | Ajugalide D | 853247-65-1 | Natural Products |
| HY-N10842 | 6-Formyllimetin | 88140-31-2 | Natural Products |
| HY-N10843 | 4-O-Methylepisappanol | 112529-37-0 | Natural Products |
| HY-N10844 | Triptohairic acid | 220209-71-2 | Natural Products |
| HY-N10845 | Quercetin-3-O-b-D-galactopyranosyl-(1→6)-b-D-glucopyranoside | 878806-08-7 | Natural Products |
| HY-N10846 | Neotriptonoterpene | 117456-86-7 | Natural Products |
| HY-N10847 | 1-O-Acetyl-6beta-O-Isobutyrylbritannilactone | 1087072-50-1 | Natural Products |
| HY-N10849 | Zeylasterone | 78012-25-6 | Natural Products |
| HY-N1085 | Viscidulin I | 92519-95-4 | Natural Products |
| HY-N10850 | Blepharotriol | 849590-42-7 | Natural Products |
| HY-N10851 | 23-Nor-6-oxopristimerol | 118172-79-5 | Natural Products |
| HY-N10852 | Shikokianin | 24267-69-4 | Natural Products |
| HY-N10853 | 3′,5-Dihydroxy-4′,6,7-trimethoxyflavanone | 90850-99-0 | Natural Products |
| HY-N10854 | Lanosta-7,9(11),23,25(27)-tetraen-26-oic acid, 23,27-epoxy-3-oxo- | 130825-80-8 | Natural Products |
| HY-N10855 | 6α-Hydroxypolyporenic acid C | 24513-63-1 | Natural Products |
| HY-N10856 | 2H-1-Benzopyran-2-one, 6-[(1R,2S)-2,3-dihydroxy-1-methoxy-3-methylbutyl]-7-methoxy- | 425370-70-3 | Natural Products |
| HY-N10857 | 12-Hydroxymyricanone | 191999-68-5 | Natural Products |
| HY-N10858 | Chisocheton compound F | 157376-71-1 | Natural Products |
| HY-N1086 | Vinorine | 34020-07-0 | Natural Products |
| HY-N10860 | 5-O-beta-D-Glucopyranosylmyricanol | 90052-02-1 | Natural Products |
| HY-N10862 | (3R)-6,4'-Dihydroxy-8-methoxyhomoisoflavan | 770729-35-6 | Natural Products |
| HY-N10863 | Aurantiamide benzoate | 150881-02-0 | Natural Products |
| HY-N10864 | Imbricataflavone A | 133336-96-6 | Natural Products |
| HY-N10865 | Chloranthalactone E | 73215-92-6 | Natural Products |
| HY-N10866 | Phorbol 12-tiglate | 92214-56-7 | Natural Products |
| HY-N10867 | β-Acids colupulone | 468-27-9 | Natural Products |
| HY-N10868 | 8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide | 956707-04-3 | Natural Products |
| HY-N10869 | Pseudolaric acid C2-O-β-D-glucoside | 1206462-80-7 | Natural Products |
| HY-N1087 | Viniferol D | 625096-18-6 | Natural Products |
| HY-N10870 | Tupichinol C | 118204-66-3 | Natural Products |
| HY-N10871 | Neocryptomerin | 20931-36-6 | Natural Products |
| HY-N10872 | (Rac)-Phorbol-12-(2-methylbutyrate) | 92214-59-0 | Natural Products |
| HY-N10873 | Pseudolarifuroic acid | 130825-79-5 | Natural Products |
| HY-N10875 | Euphebracteolatin B | 768402-09-1 | Natural Products |
| HY-N10876 | 8-epi-Chlorajapolide F | 863301-69-3 | Natural Products |
| HY-N10877 | Chlorajapolide F | 1461760-59-7 | Natural Products |
| HY-N10879 | 5,7-Dimethoxyflavanone | 1036-72-2 | Natural Products |
| HY-N1088 | Vindorosine | 5231-60-7 | Natural Products |
| HY-N10880 | 2-((1R,2R)-2-Formyl-1,3,3-trimethylcyclohexyl)-4-hydroxy-5-isopropylbenzaldehyde | 1072444-55-3 | Natural Products |
| HY-N10881 | Dihydrocurcumenone | 142717-57-5 | Natural Products |
| HY-N10882 | 2-Hydroxy4,7-dimethoxy-9,10-dihydrophenanthrene | 1000408-77-4 | Natural Products |
| HY-N10883 | Agrostophyllidin | 178439-50-4 | Natural Products |
| HY-N10884 | Withasomniferolide A | 2365386-74-7 | Natural Products |
| HY-N10885 | α,β-Dihydro-4,6-dihydroxy-2-methoxy-3-methylchalcone | 1196133-44-4 | Natural Products |
| HY-N10886 | Eupatolitin | 29536-44-5 | Natural Products |
| HY-N10887 | Withasomniferolide B | 2365386-75-8 | Natural Products |
| HY-N10888 | (22R)-27-Hydroxy-1-oxowitha-2,5,24-trienolide | 81874-44-4 | Natural Products |
| HY-N10889 | Sominone | 98569-64-3 | Natural Products |
| HY-N1089 | Vincosamide | 23141-27-7 | Natural Products |
| HY-N10890 | Alpinoid D | 1041740-13-9 | Natural Products |
| HY-N10892 | Officinaruminane B | 1246282-67-6 | Natural Products |
| HY-N10893 | (-)-β-Peltatin-5-O-beta-D-glucopyranoside | 11024-59-2 | Natural Products |
| HY-N10894 | Murrayacarpin B | 120693-44-9 | Natural Products |
| HY-N10895 | 12-Hydroxyisobakuchiol | 178765-55-4 | Natural Products |
| HY-N10896 | 5,4'-Dihydroxy-7-methoxy-6-methylflavane | 770729-34-5 | Natural Products |
| HY-N10897 | Bruceantinol A | 948038-36-6 | Natural Products |
| HY-N10898 | (-)-Dihydroguaiaretic acid | 124649-78-1 | Natural Products |
| HY-N10899 | Bruceine J | 948038-38-8 | Natural Products |
| HY-N1090 | Villosin | 160598-92-5 | Natural Products |
| HY-N10900 | Bruceine C | 25514-30-1 | Natural Products |
| HY-N10901 | Droseron | 478-40-0 | Natural Products |
| HY-N10902 | Methyl pheophorbide a | 5594-30-9 | Natural Products |
| HY-N10904 | Broussonol E | 363134-28-5 | Natural Products |
| HY-N10905 | Rabdoserrin A | 96685-01-7 | Natural Products |
| HY-N10906 | (4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one | 491572-18-0 | Natural Products |
| HY-N10907 | 4(1H)-Quinolinone, 1-methyl-2-(5Z)-5-undecen-1-yl- | 182056-11-7 | Natural Products |
| HY-N10908 | Tanshinoic acid A | 2569515-88-2 | Natural Products |
| HY-N1091 | Vibsanin C | 74690-89-4 | Natural Products |
| HY-N10911 | 8-Hydroxy-9-isobutyryloxy-10-(2-methylbutanoyl)thymol | 84744-56-9 | Natural Products |
| HY-N10912 | Shizukanolide | 70578-36-8 | Natural Products |
| HY-N10913 | Chloranthalactone B | 66395-03-7 | Natural Products |
| HY-N10914 | 2-(2'-Hydroxy-4'-methylphenyl)propionic acid | 111044-84-9 | Natural Products |
| HY-N10915 | 2-Desoxypleniradin-4-0-a-L-rhamnopyranoside | 132185-76-3 | Natural Products |
| HY-N10917 | Xanthohumol I | 688360-06-7 | Natural Products |
| HY-N10919 | Tenulin | 19202-92-7 | Natural Products |
| HY-N1092 | Viburnitol | 488-76-6 | Natural Products |
| HY-N10920 | Genkwanol C | 151283-11-3 | Natural Products |
| HY-N10922 | (3S,4aS,10aS)-3-(Acetyloxy)-2,3,4,4a,10,10a-hexahydro-6-hydroxy-1,1,4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone | 878800-84-1 | Natural Products |
| HY-N10923 | trans-4-Hydroxy-2-nonenoic acid | 95087-42-6 | Natural Products |
| HY-N10924 | Strychnistenolide | 332372-09-5 | Natural Products |
| HY-N10925 | 9-Hydroxythymol | 61955-76-8 | Natural Products |
| HY-N10926 | (+)-Glaucarubinone | 1259-86-5 | Natural Products |
| HY-N10927 | 2,11,12-Trihydroxy-7,20-epoxy-8,11,13-abietatriene | 1608462-12-9 | Natural Products |
| HY-N10928 | Lettowienolide | 1189105-39-2 | Natural Products |
| HY-N1093 | (-)-Vestitol | 35878-41-2 | Natural Products |
| HY-N10930 | 7-Oxo-ganoderic acid Z | 929248-72-6 | Natural Products |
| HY-N10931 | 4,5-Dihydroxy-2-((5-methyl-3,8-dimethylene-2-oxododecahydroazuleno[6,5-b]furan-5-yl)oxy)tetrahydro-2H-pyran-3-yl acetate | 97941-42-9 | Natural Products |
| HY-N10934 | Ganoderic acid GS-1 | 1206781-64-7 | Natural Products |
| HY-N10935 | 2-Desoxyflorilenalin-L-α-arabinopyranoside | 97941-40-7 | Natural Products |
| HY-N10936 | Denudaquinol | 1189105-40-5 | Natural Products |
| HY-N10937 | 2-Desoxypleniradin-L-α-arabinopyranoside, 2-acetate | 97996-02-6 | Natural Products |
| HY-N10938 | Pseudoneolinderane | 20082-45-5 | Natural Products |
| HY-N10939 | Gluco-obtusin | 960135-79-9 | Natural Products |
| HY-N10941 | Tuberculatin | 90706-10-8 | Natural Products |
| HY-N10943 | (+)-Zuonin A | 79120-58-4 | Natural Products |
| HY-N10944 | Chrysoobtusin 2-β-D-glucoside | 96820-54-1 | Natural Products |
| HY-N10947 | Lanosta-7,9(11),24-trien-3β,15α-dihydrcxy-26-oic acid | 112430-68-9 | Natural Products |
| HY-N10948 | Justin C | 202655-28-5 | Natural Products |
| HY-N1095 | Verbenacine | 717901-03-6 | Natural Products |
| HY-N10950 | Vanicoside E | 208707-91-9 | Natural Products |
| HY-N10952 | Epicornuin F | 1812887-72-1 | Natural Products |
| HY-N10955 | Dichotomine H | 1384373-52-7 | Natural Products |
| HY-N10958 | Wikstrol A | 159736-35-3 | Natural Products |
| HY-N10959 | 4,15-Isoatriplicolide methylacrylate | 133559-38-3 | Natural Products |
| HY-N1096 | Veratraldehyde | 120-14-9 | Natural Products |
| HY-N10960 | Stellarine C | 66154-37-8 | Natural Products |
| HY-N10961 | Daphnodorin B | 95733-02-1 | Natural Products |
| HY-N10964 | 3,3',5,6,7,8-Hexamethoxy-4',5'-methylenedioxyflavone | 82668-99-3 | Natural Products |
| HY-N10965 | Gambogic acid B | 887923-50-4 | Natural Products |
| HY-N10966 | 2,3,4,6,7-Pentamethoxy-9,10-dihydrophenanthrene | 35323-53-6 | Natural Products |
| HY-N10967 | Isoatriplicolide tiglate | 133559-39-4 | Natural Products |
| HY-N10969 | (+)-5,7,4'-Trimethoxyafzelechin | 918428-88-3 | Natural Products |
| HY-N1096R | Veratraldehyde (Standard) | 120-14-9 | Reference Standards |
| HY-N1096S | 3,4-Dimethoxy-benzaldehyde-d6 | 1162658-05-0 | Isotope-Labeled Compounds |
| HY-N1096S1 | Veratraldehyde-d3 | 143318-06-3 | Isotope-Labeled Compounds |
| HY-N1097 | Venoterpine | 17948-42-4 | Natural Products |
| HY-N10971 | Noraucuparin | 1188276-88-1 | Natural Products |
| HY-N10973 | Abiesadine F | 1210347-46-8 | Natural Products |
| HY-N10974 | Abiesadine Q | 369364-79-4 | Natural Products |
| HY-N10975 | Leucanthogenin | 99615-00-6 | Natural Products |
| HY-N10977 | Piscerygenin | 67978-85-2 | Natural Products |
| HY-N10978 | (-)-8-Methoxyobliquin | 105249-48-7 | Natural Products |
| HY-N10979 | Caulophyllumine A | 1009318-60-8 | Natural Products |
| HY-N1098 | Velutin | 25739-41-7 | Natural Products |
| HY-N10980 | Ethyl everninate | 6110-36-7 | Natural Products |
| HY-N10981 | Barbatic acid | 17636-16-7 | Natural Products |
| HY-N10983 | 13β-Hydroxylupanine | 6870-60-6 | Natural Products |
| HY-N10984 | Jacquilenin | 7726-34-3 | Natural Products |
| HY-N10985 | Xanthone V1a | 103450-96-0 | Natural Products |
| HY-N10986 | (±)-Hydnocarpin | 298704-61-7 | Natural Products |
| HY-N10987 | Spiranthesol | 125263-69-6 | Natural Products |
| HY-N10988 | Eupatolin | 29725-50-6 | Natural Products |
| HY-N10989 | (20S)-Protopanaxadiol-3-one | 51116-90-6 | Natural Products |
| HY-N1098R | Velutin (Standard) | 25739-41-7 | Reference Standards |
| HY-N1099 | Vellosimine | 6874-98-2 | Natural Products |
| HY-N10990 | Ingol 7,8,12-triacetate 3-(4-methoxyphenyl)acetate | 944799-47-7 | Natural Products |
| HY-N10991 | Crocetin dialdehyde | 502-70-5 | Natural Products |
| HY-N10992 | Pomolic acid 3-acetate | 15914-62-2 | Natural Products |
| HY-N10993 | 4-O-Methyldebenzoylpaeoniflorin | 39712-18-0 | Natural Products |
| HY-N10994 | Peucenin 7-O-methyl ether | 13544-40-6 | Natural Products |
| HY-N10995 | 8-Methoxymarmesin | 13895-93-7 | Natural Products |
| HY-N10996 | (3β)-3-Hydroxyoleanan-12-one | 5916-18-7 | Natural Products |
| HY-N10998 | Chamaejasmenin A | 89618-14-4 | Natural Products |
| HY-N10999 | Z-GMCA | 31564-49-5 | Natural Products |
| HY-N1100 | Vasicinone | 486-64-6 | Natural Products |
| HY-N11000 | Heteropeucenin 7-methyl ether | 26213-95-6 | Natural Products |
| HY-N11001 | Erinacine U | 2234301-72-3 | Natural Products |
| HY-N11003 | Vanicoside A | 155179-22-9 | Natural Products |
| HY-N11004 | Erinacine C | 156101-09-6 | Natural Products |
| HY-N11008 | Physagulide J | 1496524-09-4 | Natural Products |
| HY-N11009 | 11-Oxomogroside II A1 | 942612-74-0 | Natural Products |
| HY-N1100R | Vasicinone (Standard) | 486-64-6 | Reference Standards |
| HY-N1101 | Vasicinolone | 84847-50-7 | Natural Products |
| HY-N11010 | Eclalbasaponin IV | 158511-61-6 | Natural Products |
| HY-N11011 | Withaphysalin A | 57423-72-0 | Natural Products |
| HY-N11015 | Withaphysalin R | 949172-12-7 | Natural Products |
| HY-N11016 | 1-Methoxymethyl-β-carboline | 55854-60-9 | Natural Products |
| HY-N11019 | Erinacine P | 291532-17-7 | Natural Products |
| HY-N1102 | Vasicinol | 5081-51-6 | Natural Products |
| HY-N11020 | Cabenoside D | 88901-40-0 | Natural Products |
| HY-N11021 | Feruloyl tyramine | 65646-26-6 | Natural Products |
| HY-N11023 | Mahanimbidine | 25488-37-3 | Natural Products |
| HY-N11025 | Kansenone | 543691-16-3 | Natural Products |
| HY-N11026 | 22-Beta-Acetoxyglycyrrhizin | 938042-17-2 | Natural Products |
| HY-N11027 | 5-O-Benzoyl-20-deoxyingenol | 54706-97-7 | Natural Products |
| HY-N11028 | Isophysalin G | 152221-21-1 | Natural Products |
| HY-N11029 | Dauriporphine | 88142-60-3 | Natural Products |
| HY-N1103 | Vasicine | 6159-55-3 | Natural Products |
| HY-N11030 | Futoamide | 23477-80-7 | Natural Products |
| HY-N11031 | Z-Antiepilepsirine | 111479-04-0 | Natural Products |
| HY-N11032 | Menisporphine | 83287-02-9 | Natural Products |
| HY-N11033 | Spiranthol A | 126192-35-6 | Natural Products |
| HY-N11034 | 24-Hydroxy-licorice-saponin A3 | 1262326-47-5 | Natural Products |
| HY-N11037 | Monnierisides A | 1401807-73-5 | Natural Products |
| HY-N11038 | Drynachromoside A | 1507388-29-5 | Natural Products |
| HY-N1103A | Vasicine (hydrochloride) | 7174-27-8 | Natural Products |
| HY-N1103AR | Vasicine (hydrochloride) (Standard) | 7174-27-8 | Reference Standards |
| HY-N11044 | (-)-Hydroxydihydrobovolide | 124097-54-7 | Natural Products |
| HY-N11046 | Epimedonin B | 1616061-69-8 | Natural Products |
| HY-N11047 | 7-O-methylepimedonin G | 2220243-40-1 | Natural Products |
| HY-N11048 | Amycolatopsin A | 2209112-96-7 | Natural Products |
| HY-N11049 | Xerophilusin A | 272459-37-7 | Natural Products |
| HY-N1105 | Vallesamine N-oxide | 126594-73-8 | Natural Products |
| HY-N11050 | Xerophilusin B | 167894-15-7 | Natural Products |
| HY-N11052 | Vernodalol | 65388-17-2 | Natural Products |
| HY-N11054 | Psoracorylifol B | 879290-98-9 | Natural Products |
| HY-N11055 | 7-O-Methyl-6-Prenylnaringenin | 261776-61-8 | Natural Products |
| HY-N11056 | Justicidin C | 17803-12-2 | Natural Products |
| HY-N11058 | Damnacanthol | 477-83-8 | Natural Products |
| HY-N11059 | Dehydroabietal | 13601-88-2 | Natural Products |
| HY-N1106 | Uzarigenin digitaloside | 61217-80-9 | Natural Products |
| HY-N11060 | (Rac)-Dehydrovomifoliol | 15764-81-5 | Natural Products |
| HY-N11061 | Withaphysalin D | 91599-21-2 | Natural Products |
| HY-N11063 | Obtusifolin-2-O-glucoside | 120163-18-0 | Natural Products |
| HY-N11064 | Rebaudioside S | 1931085-11-8 | Natural Products |
| HY-N11066 | Anhuienside F | 349655-29-4 | Natural Products |
| HY-N11067 | Taccalonolide E | 134954-57-7 | Natural Products |
| HY-N11068 | Huzhangoside C | 96315-52-5 | Natural Products |
| HY-N11069 | Nemerosin | 17187-79-0 | Natural Products |
| HY-N1107 | Uzarigenin | 466-09-1 | Natural Products |
| HY-N11070 | 23-Epi-26-deoxycimicifugoside | 1374149-12-8 | Natural Products |
| HY-N11071 | Monascorubramine | 3627-51-8 | Natural Products |
| HY-N11072 | Tremulacin | 29836-40-6 | Natural Products |
| HY-N11073 | Clematiganoside A | 1000293-05-9 | Natural Products |
| HY-N11076 | 12E,14-Trien-19-oic acid | 153042-80-9 | Natural Products |
| HY-N11077 | 4,5-Di-O-caffeoylquinic acid | 89886-30-6 | Natural Products |
| HY-N11078 | Shizukaol G | 165171-11-9 | Natural Products |
| HY-N11079 | Toonaciliatin M | 93930-04-2 | Natural Products |
| HY-N1108 | Uvedalin | 24694-79-9 | Natural Products |
| HY-N11080 | Cucurbitacin R | 55903-92-9 | Natural Products |
| HY-N11081 | Hexanorcucurbitacin D | 29065-05-2 | Natural Products |
| HY-N11082 | Isocucurbitacin D | 68422-20-8 | Natural Products |
| HY-N11083 | Dihydroisocucurbitacin B | 68354-21-2 | Natural Products |
| HY-N11084 | Salviaplebeiaside | 1236273-88-3 | Natural Products |
| HY-N11085 | Isophysalin A | 1363398-67-7 | Natural Products |
| HY-N11086 | Tris(dihydrocaffeoyl)spermidine | 859341-34-7 | Natural Products |
| HY-N11089 | 23,24-Dihydroisocucurbitacin D | 3877-89-2 | Natural Products |
| HY-N1109 | Uvaol | 545-46-0 | Natural Products |
| HY-N11090 | (+) N-Methylcorydine | 7224-60-4 | Natural Products |
| HY-N11091 | Dide-O-methylgrandisin | 50393-98-1 | Natural Products |
| HY-N11094 | Isopimarol acetate | 1686-65-3 | Natural Products |
| HY-N11096 | Sinococuline | 109351-36-2 | Natural Products |
| HY-N11097 | FK-3000 | 1054312-81-0 | Natural Products |
| HY-N11099 | (±)-Coclaurine | 2033-08-1 | Natural Products |
| HY-N1110 | Uncinatone | 1770782-39-2 | Natural Products |
| HY-N11100 | Geranin A | 226715-59-9 | Natural Products |
| HY-N11101 | Procyanidin A5' | 111466-30-9 | Natural Products |
| HY-N11102 | Thymidine-5'-diphosphate-L-rhamnose | 2147-59-3 | Natural Products |
| HY-N11102A | Thymidine-5'-diphosphate-L-rhamnose (disodium) | 214753-67-0 | Natural Products |
| HY-N11104 | Glaucoside A | 81474-91-1 | Natural Products |
| HY-N11106 | Gardenin C | 29550-05-8 | Natural Products |
| HY-N11107 | (±)-Paniculidine A | 106499-96-1 | Natural Products |
| HY-N11108 | Gochnatiolide A | 87606-12-0 | Natural Products |
| HY-N1111 | Uncaric acid | 123135-05-7 | Natural Products |
| HY-N11110 | Inuviscolide | 63109-30-8 | Natural Products |
| HY-N11111 | Glycyrrhizin-6'-methylester | 1185255-36-0 | Natural Products |
| HY-N11115 | Macedonoside A | 256441-31-3 | Natural Products |
| HY-N1112 | Uncargenin C | 152243-70-4 | Natural Products |
| HY-N11121 | 10-Hydroxy-2,6,10-trimethyl-2,6,11-dodeca-4-one | 54877-97-3 | Natural Products |
| HY-N11122 | 7-[α-L-Arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy]cuminol | 2414314-11-5 | Natural Products |
| HY-N11127 | Umuhengerin | 29215-55-2 | Natural Products |
| HY-N11128 | Solidagonic acid | 19941-91-4 | Natural Products |
| HY-N11129 | 3',4,4',6-Tetrahydroxyaurone 4-O-β-D-glucoside | 80830-19-9 | Natural Products |
| HY-N11131 | 9-O-Methylstecepharine | 267007-51-2 | Natural Products |
| HY-N11132 | 14-Episinomenine | 60761-53-7 | Natural Products |
| HY-N11136 | Schizolaenone C | 928760-56-9 | Natural Products |
| HY-N11137 | 3′-Omethyl-5′-hydroxydiplacone | 1005517-26-9 | Natural Products |
| HY-N11139 | Solidagolactone II | 24399-43-7 | Natural Products |
| HY-N1114 | Tupichilignan A | 69586-96-5 | Natural Products |
| HY-N11140 | Glu-Lys | 5891-53-2 | Peptides |
| HY-N11142 | Gb3(18:1/18:0) | 69283-33-6 | Natural Products |
| HY-N11142S | Gb3-d7 (18:1/18:0) | Isotope-Labeled Compounds | |
| HY-N1115 | Tubotaiwine | 6711-69-9 | Natural Products |
| HY-N1116 | Tsugafolin | 66568-97-6 | Natural Products |
| HY-N11161 | Solidagolactone III | 41943-76-4 | Natural Products |
| HY-N11163 | (Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate | 92357-16-9 | Natural Products |
| HY-N11164 | Mbamiloside A | 1356388-55-0 | Natural Products |
| HY-N11165 | 5,7,8,3′,4′,5′-Hexamethoxyflavone | 80324-51-2 | Natural Products |
| HY-N11166 | 3,5,7,8,3′,4′-Hexamethoxyflavone | 7741-47-1 | Natural Products |
| HY-N11169 | Apigravin | 72963-64-5 | Natural Products |
| HY-N1117 | Tristin | 139101-67-0 | Natural Products |
| HY-N11172 | Schibitubin I | 1609628-72-9 | Natural Products |
| HY-N11173 | cis-Melilotoside | 2446-60-8 | Natural Products |
| HY-N11173A | trans-Melilotoside | 618-67-7 | Natural Products |
| HY-N11177 | N-Nervonoyl-D-erythro-sphingosylphosphorylcholine | 94359-13-4 | Biochemical Assay Reagents |
| HY-N1118 | Triptotriterpenic acid A | 84108-17-8 | Natural Products |
| HY-N1119 | Triptoquinonide | 163513-81-3 | Natural Products |
| HY-N1120 | Triptoquinone B | 142937-50-6 | Natural Products |
| HY-N11200 | 3-Hydroxyisovalerylcarnitine | 99159-87-2 | Natural Products |
| HY-N11200R | 3-Hydroxyisovalerylcarnitine (Standard) | 99159-87-2 | Reference Standards |
| HY-N1121 | Triptonodiol | 117456-87-8 | Natural Products |
| HY-N1122 | Triptohypol F | 268541-26-0 | Natural Products |
| HY-N11222 | Nonanoylcarnitine | 151109-67-0 | Natural Products |
| HY-N11224 | Pregnanetriol | 1098-45-9 | Natural Products |
| HY-N1123 | Triptocallic acid D | 201534-09-0 | Natural Products |
| HY-N1124 | Triptocallic acid A | 190906-61-7 | Natural Products |
| HY-N11247 | Agrocin 84 | 59111-78-3 | Natural Products |
| HY-N1125 | Triptobenzene H | 146900-55-2 | Natural Products |
| HY-N11251 | Cirrhopetalanthrin | 120090-81-5 | Natural Products |
| HY-N11257 | 6,7-Diketolithocholic acid | 1643669-23-1 | Natural Products |
| HY-N1126 | Trilobatin 2''-acetate | 647853-82-5 | Natural Products |
| HY-N11262 | Sudachitin | 4281-28-1 | Natural Products |
| HY-N1127 | Tricin | 520-32-1 | Natural Products |
| HY-N11274 | T-MAS | 7448-02-4 | Natural Products |
| HY-N1127R | Tricin (Standard) | 520-32-1 | Reference Standards |
| HY-N1127S | Tricin-d6 | Isotope-Labeled Compounds | |
| HY-N1128 | Trichorabdal A | 85329-59-5 | Natural Products |
| HY-N11285 | 1,2,6-Tri-O-galloyl-β-D-glucose | 79886-49-0 | Natural Products |
| HY-N11286 | Tridocosahexaenoylglycerol | 124596-98-1 | Natural Products |
| HY-N11286R | Tridocosahexaenoylglycerol (Standard) | 124596-98-1 | Reference Standards |
| HY-N11287 | UDP-xylose | 3616-06-6 | Natural Products |
| HY-N11287A | UDP-xylose (disodium) | 108320-89-4 | Natural Products |
| HY-N11288 | Methyl salvionolate A | 1015171-69-3 | Natural Products |
| HY-N1129 | Trichokaurin | 23811-50-9 | Natural Products |
| HY-N11299 | 5-Cholestene-26-oic acid-3β-ol | 56845-87-5 | Natural Products |
| HY-N1131 | Triacetonamine | 826-36-8 | Natural Products |
| HY-N1131A | Triacetonamine (hydrochloride) | 33973-59-0 | Natural Products |
| HY-N1131B | Triacetonamine (monohydrate) | 10581-38-1 | Natural Products |
| HY-N1131S | Triacetonamine-d17 | 52168-48-6 | Isotope-Labeled Compounds |
| HY-N1132 | D-(+)-Trehalose | 99-20-7 | Natural Products |
| HY-N1132A | D-(+)-Trehalose dihydrate | 6138-23-4 | Natural Products |
| HY-N1132AR | D-(+)-Trehalose dihydrate (Standard) | 6138-23-4 | Reference Standards |
| HY-N1132R | D-(+)-Trehalose (Standard) | 99-20-7 | Reference Standards |
| HY-N1132S | D-(+)-Trehalose-d14 | 2028292-31-9 | Isotope-Labeled Compounds |
| HY-N1132S1 | D-(+)-Trehalose-d2 | 1334376-67-8 | Isotope-Labeled Compounds |
| HY-N1133 | trans-Methylisoeugenol | 6379-72-2 | Natural Products |
| HY-N1134 | (-)-Hinokiresinol | 17676-24-3 | Natural Products |
| HY-N1135 | Toxicarol isoflavone | 3044-60-8 | Natural Products |
| HY-N1136 | (+)-Totarol | 511-15-9 | Natural Products |
| HY-N1137 | Totaradiol | 3772-56-3 | Natural Products |
| HY-N1138 | Torososide A | 165689-32-7 | Natural Products |
| HY-N1139 | Torilolone | 13018-09-2 | Natural Products |
| HY-N11407 | Bagougeramine B | 104840-34-8 | Natural Products |
| HY-N11408 | Bagougeramine A | 104840-35-9 | Natural Products |
| HY-N11409A | Shikimate-3-phosphate (lithium) | Natural Products | |
| HY-N1141 | Torachrysone-8-O-b-D-glucoside | 64032-49-1 | Natural Products |
| HY-N11411 | 3-Hydroxypentan-2-one | 3142-66-3 | Natural Products |
| HY-N11412 | Leucopelargonidin | 520-17-2 | Natural Products |
| HY-N11415 | Aurachin SS | 2118401-92-4 | Natural Products |
| HY-N11416 | Glycodehydrocholic acid | 3415-45-0 | Natural Products |
| HY-N1142 | Torachrysone | 22649-04-3 | Natural Products |
| HY-N11420 | Coronatine | 62251-96-1 | Natural Products |
| HY-N11421 | 23-O-Demycinosyltylosin | 79592-92-0 | Natural Products |
| HY-N11422 | Mycaminosyltylonolide | 61257-02-1 | Natural Products |
| HY-N11422R | Mycaminosyltylonolide (Standard) | 61257-02-1 | Reference Standards |
| HY-N11423 | Santin | 27782-63-4 | Natural Products |
| HY-N11424 | Bilirubin diglucuronide | 17459-92-6 | Natural Products |
| HY-N11425 | Benzydamine N-Oxide | 36504-71-9 | Natural Products |
| HY-N11429 | Glycochenodeoxycholic acid 3-glucuronide | 79254-98-1 | Natural Products |
| HY-N1143 | Tomentin | 28449-62-9 | Natural Products |
| HY-N11430 | F1839-I | 159096-49-8 | Natural Products |
| HY-N11431 | ent-Toddalolactone | 1570054-19-1 | Natural Products |
| HY-N11432 | Apigenin-6-C-β-D-xylopyranosyl-8-C-α-L-arabinopyranoside | 85700-46-5 | Natural Products |
| HY-N11433 | Celosin L | 1950581-97-1 | Natural Products |
| HY-N11434 | Anisocoumarin H | 123237-86-5 | Natural Products |
| HY-N11435 | 6'-O-trans-Feruloylnodakenin | 131623-14-8 | Natural Products |
| HY-N11436 | Aconicarchamine B | 1275535-67-5 | Natural Products |
| HY-N11437 | 5-O-Primeverosylapigenin | 2382681-38-9 | Natural Products |
| HY-N11438 | 3'-Hydroxymirificin | 168035-02-7 | Natural Products |
| HY-N11439 | Albanol B | 87084-99-9 | Natural Products |
| HY-N1144 | Tombozine | 604-99-9 | Natural Products |
| HY-N11441 | cis-Ferulic acid 4-O-β-D-glucopyranoside | 94942-20-8 | Natural Products |
| HY-N11442 | Antitumor agent-89 | 938160-21-5 | Natural Products |
| HY-N11443 | Acetyllycoposerramine M | 1402242-53-8 | Natural Products |
| HY-N11444 | Arnocoumarin | 11037-15-3 | Natural Products |
| HY-N11445 | Aristolochic acid Va | 108779-46-0 | Natural Products |
| HY-N11446 | Amabiloside | 40555-38-2 | Natural Products |
| HY-N11447 | Arabelline | 133084-20-5 | Natural Products |
| HY-N11448 | Bupleuroside XIII | 197705-31-0 | Natural Products |
| HY-N11449 | Nardoaristolone B | 1422517-82-5 | Natural Products |
| HY-N1145 | Tokinolide B | 112966-16-2 | Natural Products |
| HY-N11450 | Complanatin I | 138505-45-0 | Natural Products |
| HY-N11451 | Lacto-N-fucopentaose III | 25541-09-7 | Natural Products |
| HY-N11452 | Cernuoside B | 260046-56-8 | Natural Products |
| HY-N11453 | Carmichasine B | 2245700-60-9 | Natural Products |
| HY-N11454 | Lacto-N-neodifucohexaose II | 2583908-45-4 | Natural Products |
| HY-N11455 | Lacto-N-difucohexaose I | 16789-38-1 | Natural Products |
| HY-N11457 | Swertiaside | 96087-14-8 | Natural Products |
| HY-N11458 | Raddeanoside R16 | 824401-05-0 | Natural Products |
| HY-N1146 | Toddalosin | 137182-37-7 | Natural Products |
| HY-N11460 | Chikusaikoside Ⅱ | 166338-14-3 | Natural Products |
| HY-N11461 | LNnDFH I | 62469-99-2 | Reference compound |
| HY-N11462 | Sikokianin E | 2253791-96-5 | Natural Products |
| HY-N11463 | Kuwanon K | 88524-66-7 | Natural Products |
| HY-N11464 | Kuwanon O | 89200-01-1 | Natural Products |
| HY-N11465 | (25R)-Spirost-4-ene-3,6,12-trione | 214681-62-6 | Natural Products |
| HY-N11466 | trans-Caffeoyl-6-O-D-gluconic acid | 1147861-80-0 | Natural Products |
| HY-N11468 | Homocapsaicin II | 71240-51-2 | Natural Products |
| HY-N11469 | Cyclobisdemethoxycurcumin | 1042441-12-2 | Natural Products |
| HY-N1147 | Tirotundin | 56377-67-4 | Natural Products |
| HY-N11470 | 1,1′-Disinomenine | 596-58-7 | Natural Products |
| HY-N11471 | Steppogenin-7,4'-di-O-β-D-glucoside | 1193750-99-0 | Natural Products |
| HY-N11472 | Rhamnocitrin 3-glucoside | 41545-37-3 | Natural Products |
| HY-N11473 | Umbelliferone 7-O-Rutinoside | 135064-04-9 | Natural Products |
| HY-N11475 | Selaginellin I | 1340493-24-4 | Natural Products |
| HY-N11476 | 5,7-Dihydroxycoumarin 7-O-β-D-glucopyranoside | 944726-22-1 | Natural Products |
| HY-N11477 | (2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid | 132282-70-3 | Natural Products |
| HY-N11478 | Villocarine A | 1319743-81-1 | Natural Products |
| HY-N11479 | Vallesiachotamine | 5523-37-5 | Natural Products |
| HY-N1148 | Tinospinoside C | 1383977-51-2 | Natural Products |
| HY-N11480 | (2E)-Leocarpinolide F | 2382907-32-4 | Natural Products |
| HY-N11481 | 3-epi-Padmatin | 140694-62-8 | Natural Products |
| HY-N11482 | Hydroxysaikosaponin C | 173559-74-5 | Natural Products |
| HY-N11483 | 2-Hydroxypinocembrin | 40489-17-6 | Natural Products |
| HY-N11484 | 5,6,7-Trihydroxyflavone-7-O-β-D-glucuronopyranoside | 164022-74-6 | Natural Products |
| HY-N11485 | (25R)-12α-Hydroxyspirost-4-en-3-one | 50888-50-1 | Natural Products |
| HY-N11486 | 16β-Hydroperoxyalisol B 23-acetate | 2221029-54-3 | Natural Products |
| HY-N11487 | Regaloside E | 123134-21-4 | Natural Products |
| HY-N11488 | 5,7,8-Trihydroxy-6-methoxy flavone-7-O-glucuronideb | 164022-76-8 | Natural Products |
| HY-N11489 | Regaloside K | 138772-00-6 | Natural Products |
| HY-N1149 | Tilifodiolide | 126724-95-6 | Natural Products |
| HY-N11490 | (25S)-12β-Hydroxyspirost-4-en-3-one | 122677-90-1 | Natural Products |
| HY-N11491 | 8-Demethoxycephatonine | 1457991-80-8 | Natural Products |
| HY-N11492 | 7(R)-7,8-Dihydrosinomenine | 65494-41-9 | Natural Products |
| HY-N11493 | Hypolaetin 7-glucoside | 32455-43-9 | Natural Products |
| HY-N11494 | Dauricumine | 345641-00-1 | Natural Products |
| HY-N11495 | Hypoletin-7-O-β-D-xylopyranoside | 126771-28-6 | Natural Products |
| HY-N11496 | 17(13→14)-Abeo-ent-3S*,13S*,16-trihydroxystrob-8(15)-ene | 2569209-22-7 | Natural Products |
| HY-N11497 | 3-O-Feruloyl-6′-O-(4-O-β-D-glucopyranosylferuloyl)sucrose | 117591-89-6 | Natural Products |
| HY-N11498 | β-Obscurine | 467-79-8 | Natural Products |
| HY-N11499 | Myricetin 3-O-α-L-arabinopyranoside | 132679-85-7 | Natural Products |
| HY-N1150 | Thymidine | 50-89-5 | Natural Products |
| HY-N11500 | 4,5-Dioxodehydroasimilobine | 82644-81-3 | Natural Products |
| HY-N11501 | 7-epi-Isogarcinol | 1141378-40-6 | Natural Products |
| HY-N11502 | (E)-(-)-Aspongopusamide B | 1632326-65-8 | Natural Products |
| HY-N11503 | Disialyllacto-N-tetraose | 61278-38-4 | Natural Products |
| HY-N11504 | Difucosyllacto-N-neohexaose | 64396-27-6 | Natural Products |
| HY-N11505 | Isopicropodophyllone | 55515-07-6 | Natural Products |
| HY-N11506 | lsocryptomerin | 20931-58-2 | Natural Products |
| HY-N11507 | Tibesaikosaponin V | 2319668-87-4 | Natural Products |
| HY-N11508 | Dihydrobaicalin | 56226-98-3 | Natural Products |
| HY-N11509 | Ekersenin | 53091-74-0 | Natural Products |
| HY-N1150R | Thymidine (Standard) | 50-89-5 | Reference Standards |
| HY-N1150S | Thymidine-d3 | 74848-84-3 | Isotope-Labeled Compounds |
| HY-N1150S1 | Thymidine-d4 | 347841-67-2 | Isotope-Labeled Compounds |
| HY-N1150S10 | Thymidine-d14 | 1134181-96-6 | Isotope-Labeled Compounds |
| HY-N1150S11 | Thymidine-13C10 | Isotope-Labeled Compounds | |
| HY-N1150S2 | Thymidine-13C | 478511-06-7 | Isotope-Labeled Compounds |
| HY-N1150S3 | Thymidine-13C-1 | 240407-53-8 | Isotope-Labeled Compounds |
| HY-N1150S4 | Thymidine-13C-2 | Isotope-Labeled Compounds | |
| HY-N1150S5 | Thymidine-2′-13C | 185553-96-2 | Isotope-Labeled Compounds |
| HY-N1150S6 | Thymidine-d2 | 132376-92-2 | Isotope-Labeled Compounds |
| HY-N1150S8 | Thymidine-13C10,15N2 | 1821188-00-4 | Isotope-Labeled Compounds |
| HY-N1150S9 | Thymidine-15N2 | Isotope-Labeled Compounds | |
| HY-N1151 | Thunberginol C | 147517-06-4 | Natural Products |
| HY-N11510 | Isocoreopsin | 30382-18-4 | Natural Products |
| HY-N11511 | 3α-Acetoxyurs-5:12-dien-24-oic acid | 1649436-95-2 | Natural Products |
| HY-N11512 | α-Glucosidase-IN-24 | 60354-05-4 | Natural Products |
| HY-N11513 | 16-Epipyromesaconitine | 132054-38-7 | Natural Products |
| HY-N11514 | Anti-osteoporosis agent-2 | 849693-09-0 | Natural Products |
| HY-N11515 | Saikosaponin S | 219690-93-4 | Natural Products |
| HY-N11516 | Erythro-guaiacylglycerol-β-ferulic acid ether | 1372162-61-2 | Natural Products |
| HY-N11519 | Polyporusterone C | 141360-90-9 | Natural Products |
| HY-N1152 | threo-Guaiacylglycerol beta-coniferyl ether | 869799-76-8 | Natural Products |
| HY-N11520 | Zedoarofuran | 213833-34-2 | Natural Products |
| HY-N11521 | 7-Methoxy obtusifolin | 1820806-09-4 | Natural Products |
| HY-N11522A | 5-Methyluridine-5'-triphosphate (trisodium) | Oligonucleotides | |
| HY-N11522S | 5-Methyluridine 5′-triphosphate-d15 (dilithium) | Isotope-Labeled Compounds | |
| HY-N11526 | 3-Hydroxy-2-(palmitoyloxy)propyl stearat | 14015-55-5 | Natural Products |
| HY-N11528 | Eugenitol | 491-48-5 | Natural Products |
| HY-N11529 | 9-Methoxyaristolactam I | 133462-30-3 | Natural Products |
| HY-N1153 | Threo-guaiacylglycerol | 27391-16-8 | Natural Products |
| HY-N11530 | Kouitchenside G | 1444411-75-9 | Natural Products |
| HY-N11531 | Kuwanon W | 95518-95-9 | Natural Products |
| HY-N11532 | Corynantheine | 18904-54-6 | Natural Products |
| HY-N11533 | 6-Formyl-isoophiopogonanone B | 88700-30-5 | Natural Products |
| HY-N11534 | Quercetin-3-O-sophoroside-7-O-glucoside | 42903-93-5 | Natural Products |
| HY-N11535 | Enacyloxin IIa | 126518-41-0 | Natural Products |
| HY-N11536 | erythro-Austrobailignan-6 | 114127-24-1 | Natural Products |
| HY-N11537 | 2-Methoxy-6-pentadecyl-1,4-benzoquinone | 144078-11-5 | Natural Products |
| HY-N11538 | Quercetin-3-O-(2′′-O-galloyl)-β-D-glucopyranoside | 69624-79-9 | Natural Products |
| HY-N11539 | 7-O-Primverosylpseudobaptigenin | 224957-15-7 | Natural Products |
| HY-N1154 | threo-Syringylglycerol | 121748-11-6 | Natural Products |
| HY-N11540 | Cnidioside B | 141896-54-0 | Natural Products |
| HY-N11541 | Norrubrofusarin | 3566-98-1 | Natural Products |
| HY-N11542 | Trachelogenin 4′-O-β-gentiobioside | 106647-13-6 | Natural Products |
| HY-N11543 | AH13 | 121795-56-0 | Natural Products |
| HY-N11544 | Inflexuside B | 1395048-86-8 | Natural Products |
| HY-N11545 | 1-O-Gentiobiosyl-3,7-dimethoxy-8-hydroxyxanthone | 487040-33-5 | Natural Products |
| HY-N11546 | Sapindoside B | 30994-75-3 | Natural Products |
| HY-N11547 | Leocarpinolide F | 145042-08-6 | Natural Products |
| HY-N11548 | Inflexuside A | 1395048-85-7 | Natural Products |
| HY-N11549 | Nodakenetin-Glucose-malonic acid | 1415796-06-3 | Natural Products |
| HY-N1155 | Theviridoside | 23407-76-3 | Natural Products |
| HY-N11550 | Salviandulin E | 158994-32-2 | Natural Products |
| HY-N11551 | Salvifaricin | 87321-87-7 | Natural Products |
| HY-N11552 | Sorbifolin | 23130-22-5 | Natural Products |
| HY-N11554 | (-)-Codonopsine | 26989-20-8 | Natural Products |
| HY-N11557 | Gossypetin 3-sophoroside-8-glucoside | 77306-93-5 | Natural Products |
| HY-N11559 | Methylzedoarondiol | 108944-66-7 | Natural Products |
| HY-N1156 | Thevetin B | 27127-79-3 | Natural Products |
| HY-N11561 | Aristolactam A III | 53948-08-6 | Natural Products |
| HY-N11562 | Aristololactam II | 55610-00-9 | Natural Products |
| HY-N11563 | Potentillanoside A | 1309589-79-4 | Natural Products |
| HY-N11564 | Aristololactam IIIa | 97399-89-8 | Natural Products |
| HY-N11566 | (+)-Oxypeucedanin methanolate | 52939-12-5 | Natural Products |
| HY-N1156A | α-Thevetin B | 144300-21-0 | Natural Products |
| HY-N1157 | Thevetiaflavone | 29376-68-9 | Natural Products |
| HY-N11570 | Phaeocaulisin E | 1443040-31-0 | Natural Products |
| HY-N11572 | Anticancer agent 96 | 1380680-89-6 | Natural Products |
| HY-N11573 | Kaempferol 3,7-bis(α-L-rhamnose-D-glucose) | 1392495-12-3 | Natural Products |
| HY-N11575 | Peucedanoside A | 946122-87-8 | Natural Products |
| HY-N11576 | Secalonic acid D | 35287-69-5 | Natural Products |
| HY-N1158 | Thevebioside | 114586-47-9 | Natural Products |
| HY-N11582 | Prodenialure A | 16725-53-4 | Natural Products |
| HY-N11583 | Jasmololone | 22054-39-3 | Natural Products |
| HY-N1159 | Teuclatriol | 152110-17-3 | Natural Products |
| HY-N11591 | Ganoderic acid T | 103992-91-2 | Natural Products |
| HY-N11598 | α-GLU | 59920-31-9 | Enzyme |
| HY-N1160 | Tetrahydroxysqualene | 1043629-23-7 | Natural Products |
| HY-N11600 | β-Apopicropodophyllin | 477-52-1 | Natural Products |
| HY-N11605S | C16(plasm)-18:1(d9) PC | 2770684-41-6 | Isotope-Labeled Compounds |
| HY-N11609S | Desethyloxybutynin-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N1161 | Tetrahydrolachnophyllum lactone | 56407-87-5 | Natural Products |
| HY-N11615 | Cyclo(Pro-Val) | 5654-87-5 | Natural Products |
| HY-N11615R | Cyclo(Pro-Val) (Standard) | 5654-87-5 | Reference Standards |
| HY-N11617 | Diosgenin palmitate | 4952-66-3 | Natural Products |
| HY-N11619 | Batatasin V | 65817-45-0 | Natural Products |
| HY-N1162 | Tetrahydroamentoflavone | 48236-96-0 | Natural Products |
| HY-N11620 | Sadopeptins A | Natural Products | |
| HY-N11621 | Sadopeptins B | Natural Products | |
| HY-N11624 | Axinelline A | 1593741-99-1 | Natural Products |
| HY-N1163 | Tetrahydroalstonine | 6474-90-4 | Natural Products |
| HY-N11630 | Pinellic acid | 97134-11-7 | Natural Products |
| HY-N11631 | 1-O-trans-Cinnamoyl-β-D-glucopyranose | 40004-96-4 | Natural Products |
| HY-N11635S | δ-4-tibolone-d5 | Isotope-Labeled Compounds | |
| HY-N11636 | Ganoderic acid S | 103963-38-8 | Natural Products |
| HY-N11637 | Ganoderenic acid K | 942950-94-9 | Natural Products |
| HY-N11637A | (Z)-Ganoderenic acid K | 1910062-54-2 | Natural Products |
| HY-N11638 | Ganoderic acid R | 103963-39-9 | Natural Products |
| HY-N11639 | Ganoderic acid Df | 1352033-73-8 | Natural Products |
| HY-N1164 | Tetrachyrin | 73483-88-2 | Natural Products |
| HY-N11640 | Methyl Ganoderic acid B | 81907-65-5 | Natural Products |
| HY-N11641 | Methyl ganoderate A acetonide | 1346453-53-9 | Natural Products |
| HY-N11642 | Ganodermacetal | 1443298-77-8 | Natural Products |
| HY-N11643 | Ganoderic acid Mk | 110024-14-1 | Natural Products |
| HY-N11644 | Lanosta-7,9(11),24-trien-3α-hydroxy-26-oic acid | 111372-80-6 | Natural Products |
| HY-N11645 | Ganoderic acid Mf | 108026-94-4 | Natural Products |
| HY-N11646 | Ganorbiformin B | 1421611-59-7 | Natural Products |
| HY-N11648 | Ganoderic acid T1 | Natural Products | |
| HY-N11649 | Methyl lucidenate Q | 648430-32-4 | Natural Products |
| HY-N1165 | Tereticornate A | 149751-81-5 | Natural Products |
| HY-N11650 | (22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid | 1846584-06-2 | Natural Products |
| HY-N11651 | Peganumine A | 1620517-85-2 | Natural Products |
| HY-N11652 | 6α-Hydroxylycopodine | 21061-92-7 | Natural Products |
| HY-N11653 | Bipolal | 155112-68-8 | Natural Products |
| HY-N11654 | Bilobol | 22910-86-7 | Natural Products |
| HY-N11655 | Antioxidant agent-10 | 1181635-91-5 | Natural Products |
| HY-N11656 | Poricoic acid H | 415724-85-5 | Natural Products |
| HY-N11657 | Sanggenon A | 76464-71-6 | Natural Products |
| HY-N11659 | 7α-O-Ethylmorroniside | 1116650-29-3 | Natural Products |
| HY-N1166 | Tephrosin | 76-80-2 | Natural Products |
| HY-N11660 | weak Hepatoprotective agent-1 | 1807808-90-7 | Natural Products |
| HY-N11661 | 2, 4-Dihydroxy-allylbenzene-2-O-β-D-glucopyranoside | 1416564-61-8 | Natural Products |
| HY-N11662 | Euphoheliosnoid A | 863401-14-3 | Natural Products |
| HY-N11663 | Dugesin C | 1403505-97-4 | Natural Products |
| HY-N11664 | Salvileucantholide | 158994-33-3 | Natural Products |
| HY-N11665 | Donasine | 1017237-81-8 | Natural Products |
| HY-N11667 | 18-O-Demethylpederin | 2120362-33-4 | Natural Products |
| HY-N11669 | Demycarosyl-3D-β-D-digitoxosylmithramycin SK | 1262896-48-9 | Natural Products |
| HY-N1166A | (Rac)-Tephrosin | 561-35-3 | Natural Products |
| HY-N1167 | Tenacissoside F | 260787-90-4 | Natural Products |
| HY-N11670 | 11(α)-Hydroxynepasaikosaponin k | 1152168-63-2 | Natural Products |
| HY-N11671 | 9α-Hydroxymatrine | 88509-92-6 | Natural Products |
| HY-N11675 | 5-Hydroxy-TSU-68 | 1035154-46-1 | Natural Products |
| HY-N11676 | 6-Hydroxy-TSU-68 | 1035154-49-4 | Natural Products |
| HY-N11677 | 7-Hydroxy-TSU-68 | 1035154-52-9 | Natural Products |
| HY-N11678 | Deoxynivalenol-3-β-D-glucoside | 131180-21-7 | Natural Products |
| HY-N11679 | Microcystin-LW | 157622-02-1 | Natural Products |
| HY-N1168 | Tenacigenin B | 80508-42-5 | Natural Products |
| HY-N11680 | Microcystin-LF | 154037-70-4 | Natural Products |
| HY-N11680R | Microcystin-LF (Standard) | 154037-70-4 | Reference Standards |
| HY-N11681 | Microcystin-WR | 138234-58-9 | Natural Products |
| HY-N11682 | Microcystin-LY | 123304-10-9 | Natural Products |
| HY-N11683 | 7-Desmethylmicrocystin-LR | 134842-07-2 | Natural Products |
| HY-N11684 | Cocoa butter | 8002-31-1 | Natural Products |
| HY-N1169 | Tectoroside | 124960-89-0 | Natural Products |
| HY-N11690 | Oleandrigenin | 465-15-6 | Natural Products |
| HY-N11691 | Thapsigargicin | 67526-94-7 | Natural Products |
| HY-N11692 | 9-Hydroxyoctadecanoic acid | 3384-24-5 | Natural Products |
| HY-N11694 | 9-O-Acetyl-fargesol | 449172-61-6 | Natural Products |
| HY-N11696 | 1-Oxotanshinone IIA | 909705-66-4 | Natural Products |
| HY-N11697 | α-Cryptoxanthin | 24480-38-4 | Natural Products |
| HY-N11698 | Bakuchicin | 4412-93-5 | Natural Products |
| HY-N11699 | Bequinostatin A | 151013-37-5 | Natural Products |
| HY-N1170 | Taxiphyllin | 21401-21-8 | Natural Products |
| HY-N11702 | Kaempferol-3-O-robinoside-7-O-glucoside | 114924-89-9 | Natural Products |
| HY-N11706 | β-Cedrene | 546-28-1 | Natural Products |
| HY-N11707 | Piscidic acid | 469-65-8 | Natural Products |
| HY-N11708 | (-)-Lariciresinol | 83327-19-9 | Natural Products |
| HY-N11709 | Theasaponin E1 | 220114-28-3 | Natural Products |
| HY-N1171 | Taxinine B | 18457-44-8 | Natural Products |
| HY-N11711 | Pumiloside | 126722-26-7 | Natural Products |
| HY-N11712 | 8-Dehydroxyshanzhiside | 1008532-71-5 | Natural Products |
| HY-N1172 | Taxifolin 3-O-bata-xylopyranoside | 40672-47-7 | Natural Products |
| HY-N11722 | Panduratin A | 89837-52-5 | Natural Products |
| HY-N11728 | 2,7"-Phloroglucinol-6,6'-bieckol | 1621988-60-0 | Natural Products |
| HY-N11729 | Pyrogallol-phloroglucinol-6,6-bieckol | 1415504-32-3 | Natural Products |
| HY-N1173 | Taxayuntin | 153229-31-3 | Natural Products |
| HY-N1174 | Taxagifine | 81489-69-2 | Natural Products |
| HY-N1175 | Taxacin | 117229-54-6 | Natural Products |
| HY-N11756 | Linearmycin A | 163596-98-3 | Natural Products |
| HY-N11758 | 5′-Des-O-methylharringtonine | 182325-73-1 | Natural Products |
| HY-N1176 | Tatarinoid A | 1229005-35-9 | Natural Products |
| HY-N11760 | 3-Butyl-5-hydroxyphthalate | 195142-72-4 | Natural Products |
| HY-N11761 | 4,5-Dihydropiperlonguminine | 23512-53-0 | Natural Products |
| HY-N11766 | Calythropsin | 152340-67-5 | Natural Products |
| HY-N11767 | Prenyletin | 15870-91-4 | Natural Products |
| HY-N11768 | 4-Methoxylonchocarpin | 51589-67-4 | Natural Products |
| HY-N11769 | Xanthohumol C | 189299-05-6 | Natural Products |
| HY-N1177 | Taraxerone | 514-07-8 | Natural Products |
| HY-N11770 | Rhamnetin 3-O-β-D-glucopyranoside | 27875-34-9 | Natural Products |
| HY-N11771 | Glyurallin B | 199331-53-8 | Natural Products |
| HY-N11772 | Mutanocyclin | 875455-92-8 | Natural Products |
| HY-N11772R | Mutanocyclin (Standard) | 875455-92-8 | Reference Standards |
| HY-N11774 | Euphornin | 80454-47-3 | Natural Products |
| HY-N11775 | Eudebeiolide B | 1934299-51-0 | Natural Products |
| HY-N11777 | (−)-N-Hydroxyapiosporamide | 1205676-02-3 | Natural Products |
| HY-N11778 | Bequinostatin C | 152175-74-1 | Natural Products |
| HY-N1178 | Taraxasterol | 1059-14-9 | Natural Products |
| HY-N11780 | Clavirolide L | Natural Products | |
| HY-N11781 | Forrestiacids J | 2920898-66-2 | Natural Products |
| HY-N11782 | Forrestiacids K | 2920898-65-1 | Natural Products |
| HY-N11787 | Cimicifuga racemosa extract | 84776-26-1 | Natural Products |
| HY-N11788 | Anti-inflammatory agent 43 | 2364631-99-0 | Natural Products |
| HY-N11789 | 3-Hydroxyirisquinone | 100205-29-6 | Natural Products |
| HY-N1178R | Taraxasterol (Standard) | 1059-14-9 | Reference Standards |
| HY-N1179 | Tanshinone IIB | 17397-93-2 | Natural Products |
| HY-N11790 | Resveratrol-4′-O-(6′′-O-galloyl)-glucopyranoside | 64898-03-9 | Natural Products |
| HY-N11791 | Qianhucoumarin B | 152615-14-0 | Natural Products |
| HY-N11792 | Pedunculosumoside F | 1283600-08-7 | Natural Products |
| HY-N11793 | 3-O-Methylquercetin 4',7-di-β-D-glucopyranoside | 47858-32-2 | Natural Products |
| HY-N11794 | 7-Ketologanin | 152-91-0 | Natural Products |
| HY-N11795 | Kingiside | 25406-67-1 | Natural Products |
| HY-N11796 | Anti-inflammatory agent 44 | 1005416-14-7 | Natural Products |
| HY-N11797 | 6,7-Dehydrodugesin A | 1542141-27-4 | Natural Products |
| HY-N11798 | Ophioglonol | 850894-19-8 | Natural Products |
| HY-N11799 | Neochilenin | 22255-19-2 | Natural Products |
| HY-N1180 | Tanshinlactone | 105351-70-0 | Natural Products |
| HY-N11800 | Transilin | 26931-68-0 | Natural Products |
| HY-N11801 | 6,7-Dihydrosalviandulin E | 1983982-37-1 | Natural Products |
| HY-N11802 | Salvileucalin A | 1053241-84-1 | Natural Products |
| HY-N11803 | Arundanine | 618852-71-4 | Natural Products |
| HY-N11807 | 3-epi-Tilifodiolide | 1983982-42-8 | Natural Products |
| HY-N11808 | Quercetin 3-galactosyl(1→2)rhamnoside | 189135-70-4 | Natural Products |
| HY-N11809 | Quercetin-3-O-(6''-O-Ecaffeoyl)-β-D-galactopyranoside | 316354-12-8 | Natural Products |
| HY-N1181 | Tamarixetin | 603-61-2 | Natural Products |
| HY-N11810 | Polyfuroside | 108886-03-9 | Natural Products |
| HY-N11812 | Erucifoline N-oxide | 123864-94-8 | Natural Products |
| HY-N1181R | Tamarixetin (Standard) | 603-61-2 | Reference Standards |
| HY-N1182 | Taiwanhomoflavone B | 509077-91-2 | Natural Products |
| HY-N11823 | Quercetin 3,7-diglucoside | 6892-74-6 | Natural Products |
| HY-N1183 | Taiwanhomoflavone A | 265120-00-1 | Natural Products |
| HY-N11834 | 14-Benzoylmesaconine-8-palmitate | 158584-86-2 | Natural Products |
| HY-N11835 | Asparenyldiol | 166762-98-7 | Natural Products |
| HY-N11840 | Mortatarin F | Natural Products | |
| HY-N11841 | Mortatarin G | 2477746-26-0 | Natural Products |
| HY-N11844 | Quercetin 3-(6″-caffeoylsophoroside) | 1032595-77-9 | Natural Products |
| HY-N11845 | Sigmoidin B | 87746-47-2 | Natural Products |
| HY-N11848 | D-Glucosamine 6-phosphate | 3616-42-0 | Natural Products |
| HY-N11848R | D-Glucosamine 6-phosphate (Standard) | 3616-42-0 | Reference Standards |
| HY-N11849 | Moracin N | 135248-05-4 | Natural Products |
| HY-N1185 | Tagitinin A | 59979-61-2 | Reference compound |
| HY-N11857 | Gentamicin C2 | 25876-11-3 | Natural Products |
| HY-N1186 | Tachioside | 109194-60-7 | Natural Products |
| HY-N11867A | 5(S)-5-Carboxystrictosidine | 34371-47-6 | Natural Products |
| HY-N1187 | Syzalterin | 94451-48-6 | Natural Products |
| HY-N11872 | Suffruticosol A | Natural Products | |
| HY-N11874 | Staphyloferrin A | 127902-98-1 | Natural Products |
| HY-N11875S | 6-Sulfatoxymelatonin-d4 (ammonium hydrate) | Isotope-Labeled Compounds | |
| HY-N11878 | Terpenomycin | Natural Products | |
| HY-N11879 | 6-C-Methylquercetin-3,4'-dimethyl ether | Natural Products | |
| HY-N1188 | Syringin pentaacetate | 92233-55-1 | Natural Products |
| HY-N11880 | 2-O-Sinapoyl makisterone A | Natural Products | |
| HY-N11882 | Plastoquinone | 4299-57-4 | Natural Products |
| HY-N11885 | Ferroptosis-IN-1 | Natural Products | |
| HY-N11886 | 5-NH2-Baicalein | 2478604-99-6 | Natural Products |
| HY-N11887 | Linocinnamarin | 554-87-0 | Natural Products |
| HY-N1189 | DL-Syringaresinol diacetate | 1990-77-8 | Natural Products |
| HY-N11891 | 4-(β-D-glucopyranosyloxy)benzoic acid | 15397-25-8 | Natural Products |
| HY-N11892 | 7-O-Methylaloesinol | 105317-69-9 | Natural Products |
| HY-N11893 | 8-C-Glucosyl-(R)-aloesol | 135097-55-1 | Natural Products |
| HY-N11894 | 1,3,6-Trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6'-O-acetyl)-beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranoside | 139742-39-5 | Natural Products |
| HY-N11895 | Isorabaichromone | 194669-79-9 | Natural Products |
| HY-N11896 | 10-Hydroxyaloin B | 134863-92-6 | Natural Products |
| HY-N11896A | 10-Hydroxyaloin A | 134863-91-5 | Natural Products |
| HY-N1190 | DL-Syringaresinol | 1177-14-6 | Natural Products |
| HY-N11900 | Dihydrodehydrodiconiferyl alcohol 9-Oglucoside | 106758-58-1 | Natural Products |
| HY-N11901 | Quercetin-3-O-[(6-caffeoyl)-β-glucopyranosyl (1→3) α-rhamnopyranoside]-7-O-α-rhamnopyranoside | 1459767-44-2 | Natural Products |
| HY-N11902 | 1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one | 149732-52-5 | Natural Products |
| HY-N11903 | (±)-Acuminatin | 72881-08-4 | Natural Products |
| HY-N11904 | Notoptol | 88206-49-9 | Natural Products |
| HY-N11905 | Kadsurenin A | 145701-12-8 | Natural Products |
| HY-N11906 | Diayangambin | 21453-68-9 | Natural Products |
| HY-N11909 | 8-O-4,8-O-4-Dehydrotriferulic acid | 848649-28-5 | Natural Products |
| HY-N1191 | Sventenic acid | 126778-79-8 | Natural Products |
| HY-N11910 | Kaempferol-3-O-[(6-caffeoyl)-β-glucopyranosyl (1→3) α-rhamnopyranoside]-7-O-α-rhamnopyranoside | 1459767-45-3 | Natural Products |
| HY-N11911 | Verazine | 14320-81-1 | Natural Products |
| HY-N11912 | Soladulcoside A | 137031-53-9 | Natural Products |
| HY-N11913 | Siderin | 53377-54-1 | Natural Products |
| HY-N11914 | Isolaureline | 475-84-3 | Natural Products |
| HY-N11916 | Kadsuphilin A | 887770-02-7 | Natural Products |
| HY-N11917 | Schisantherin S | 2230512-49-7 | Natural Products |
| HY-N11918 | Jervinone | 469-60-3 | Natural Products |
| HY-N11919 | Anticancer agent 149 | 1810733-76-6 | Natural Products |
| HY-N11920 | Kadsurenin B | 145701-13-9 | Natural Products |
| HY-N11921 | Kadsurin A analogue-1 | 155551-59-0 | Natural Products |
| HY-N11922 | Ipalbidine | 26294-41-7 | Natural Products |
| HY-N11923 | Lysimachigenoside C | 952304-73-3 | Natural Products |
| HY-N11924 | Foenumoside B | 877661-00-2 | Natural Products |
| HY-N11925 | (+)-Osbeckic acid | 112923-64-5 | Natural Products |
| HY-N11926 | Ipalbine | 23544-46-9 | Natural Products |
| HY-N11927 | Manwuweizic acid | 116963-87-2 | Natural Products |
| HY-N11928 | Changnanic acid | 136040-44-3 | Natural Products |
| HY-N11929 | (S)-(+)-Imperanene | 163634-08-0 | Natural Products |
| HY-N1193 | Sulfuretin | 120-05-8 | Natural Products |
| HY-N11930 | 5-Hydroxy-2-[2-(2-hydroxyphenyl)ethyl]chromone | 357637-15-1 | Natural Products |
| HY-N11931 | Grandivine A | 200574-22-7 | Natural Products |
| HY-N11932 | Piperulin A | 164268-04-6 | Natural Products |
| HY-N11933 | Benzylbenzofuran derivative-1 | 61240-30-0 | Natural Products |
| HY-N11934 | Piperkadsin A | 895543-36-9 | Natural Products |
| HY-N11935 | Isoguaiacin | 78341-26-1 | Natural Products |
| HY-N11936 | Rubriflorin B | 835875-96-2 | Natural Products |
| HY-N11939 | Kadsuralignan A | 913237-64-6 | Natural Products |
| HY-N1194 | Sulfocostunolide B | 1059671-65-6 | Natural Products |
| HY-N11940 | Acetyl-binankadsurin A | 77174-33-5 | Natural Products |
| HY-N11943 | Kadsulignan H | 144049-91-2 | Natural Products |
| HY-N11944 | Schiarisanrin E | 697228-90-3 | Natural Products |
| HY-N11945 | Schiarisanrin A | 130252-41-4 | Natural Products |
| HY-N11947 | Schisanlignone B | 135459-86-8 | Natural Products |
| HY-N11948 | Simmondsin | 51771-52-9 | Natural Products |
| HY-N11949 | Interiorin | 119139-55-8 | Natural Products |
| HY-N1194A | Sulfocostunolide A | 1016983-51-9 | Natural Products |
| HY-N1195 | Sugiol | 511-05-7 | Natural Products |
| HY-N11950 | N-Vanillyloctanamide | 58493-47-3 | Natural Products |
| HY-N11951 | Interiorin D | 133360-40-4 | Natural Products |
| HY-N11952 | Dihydropyrenophorin | 1073287-13-4 | Natural Products |
| HY-N11954 | Schiarisanrin C | 130252-44-7 | Natural Products |
| HY-N11955 | Cyclo(Ile-Leu) | 91741-17-2 | Natural Products |
| HY-N11957 | Angeloylbinankadsurin A | 77165-80-1 | Natural Products |
| HY-N11958 | 5-Hydroxy-3,6,7,4'-tetramethoxyflavone | 14787-34-9 | Natural Products |
| HY-N1196 | Suberosin | 581-31-7 | Natural Products |
| HY-N11961 | 2-Hydroxy-3-methoxybenzoic acid glucose ester | 172377-87-6 | Natural Products |
| HY-N11965 | 4'-Methoxyisoagarotetrol | 104901-10-2 | Natural Products |
| HY-N11966 | 2'-Hydroxylagarotetrol | 135308-83-7 | Natural Products |
| HY-N11967 | 2'-Hydroxylisoagarotetrol | 104926-77-4 | Natural Products |
| HY-N11968 | 6,7,8-Trihydroxy-2-(2-Phenethyl) chromone | 2803559-82-0 | Natural Products |
| HY-N11969 | Aquilarone B | 1404479-45-3 | Natural Products |
| HY-N1197 | Subelliptenone G | 162473-22-5 | Natural Products |
| HY-N11970 | Isocrenatoside | 221895-09-6 | Natural Products |
| HY-N11971 | Yunnankadsurin B | 51670-42-9 | Natural Products |
| HY-N11972 | β-Maaliene | 489-29-2 | Natural Products |
| HY-N11973 | 5,7-Dimethoxy-2,3-phenanthrenediol | 42050-16-8 | Natural Products |
| HY-N11974 | Isobatatasin I | 39499-84-8 | Natural Products |
| HY-N11975 | Glycyrrhizin-6′,6′′-dimethylester | 114006-81-4 | Natural Products |
| HY-N11976 | Glycyrrhizin-6′′-methylester | 1186016-30-7 | Natural Products |
| HY-N11977 | Stenophyllol B | 208834-81-5 | Natural Products |
| HY-N11978 | 6-Hydroxykynurenic acid | 3778-29-8 | Natural Products |
| HY-N11979 | Dihydronitidine | 13063-06-4 | Natural Products |
| HY-N1198 | Strictosamide | 23141-25-5 | Natural Products |
| HY-N11982 | Emeguisin A | 117032-54-9 | Natural Products |
| HY-N11983 | (25R)-Ruscogenin-3-yl α-L-rhamnopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→4)]-β-D-glucopyranoside | 1220707-31-2 | Natural Products |
| HY-N11985 | Ophiopogonone C | 477336-77-9 | Natural Products |
| HY-N11986 | Regaloside I | 126239-78-9 | Natural Products |
| HY-N11988 | Nortrachelogenin 5'-C-β-glucopyranoside | 858127-39-6 | Natural Products |
| HY-N11989 | Nanangenine B | 1609469-72-8 | Natural Products |
| HY-N1199 | Stilbostemin B | 162411-67-8 | Natural Products |
| HY-N11990 | Nortrachelogenin 4'-O-β-gentiobioside | 1961246-09-2 | Natural Products |
| HY-N11991 | 5-Methoxytracheloside | 1321810-65-4 | Natural Products |
| HY-N11992 | Aloenin-2'-p-coumaroyl ester | 106533-35-1 | Natural Products |
| HY-N11993 | Aloveroside A | 1246930-65-3 | Natural Products |
| HY-N11994 | Aloeresin G | 287486-23-1 | Natural Products |
| HY-N11995 | allo-Aloeresin D | 1059665-59-6 | Natural Products |
| HY-N11996 | Aloenin aglycone | 59163-53-0 | Natural Products |
| HY-N11997 | Feralolide | 149418-38-2 | Natural Products |
| HY-N11998 | Confusarin | 108909-02-0 | Natural Products |
| HY-N11999 | 5,4'-Dihydroxy-3,4,3'-trimethoxybibenzyl | 838826-34-9 | Natural Products |
| HY-N1200 | Stigmasterol glucoside | 19716-26-8 | Natural Products |
| HY-N12000 | Aquilarone C | 1404479-46-4 | Natural Products |
| HY-N12001 | 6-Epiagarotetrol | 2580359-99-3 | Natural Products |
| HY-N12002 | Diosgenin-3-O-rhamnosyl(1→2)[glucosyl(1→6)]glucoside | 1072072-37-7 | Natural Products |
| HY-N12003 | 19-Hydroxybaccatin V | 151636-93-0 | Natural Products |
| HY-N12004 | 19-Hydroxy-10-deacetylbaccatin III | 154083-99-5 | Natural Products |
| HY-N12005 | 6-Hydroxykaempferol 7-O-β-glucopyranoside | 70056-55-2 | Natural Products |
| HY-N12006 | 6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone | 1622982-59-5 | Natural Products |
| HY-N12007 | OAT1/3-IN-1 | 38393-73-6 | Natural Products |
| HY-N12008 | OAT1/3-IN-2 | 2195434-05-8 | Natural Products |
| HY-N12009 | 1-Desmethylobtusin | 90985-57-2 | Natural Products |
| HY-N1201 | Apigenin | 520-36-5 | Natural Products |
| HY-N12010 | 12-epi-Teucvidin | 125137-19-1 | Natural Products |
| HY-N12011 | 11-Oxoisomogroside V | 2149606-15-3 | Natural Products |
| HY-N12012 | 11-Oxomogroside II A2 | 2170761-37-0 | Natural Products |
| HY-N12013 | 11-Oxomogroside IV A | 952481-54-8 | Natural Products |
| HY-N12014 | Triptotriterpenic acid C | 123914-32-9 | Natural Products |
| HY-N12015 | Ginsenoside Ra6 | 1346522-89-1 | Natural Products |
| HY-N12016 | Fulvotomentoside B | 1021184-77-9 | Natural Products |
| HY-N12017 | 3-O-α-L-Rhamnopyranosyl-(1→2)-α-L-arabinopyranosyl hederagenin28-O-β-D-xylopyranosyl-(1→6)-β-D-glucopyranosyl ester | 128717-92-0 | Natural Products |
| HY-N12018 | Isomaltopaeoniflorin | 262350-54-9 | Natural Products |
| HY-N12019 | Parishin K | 1971915-61-3 | Natural Products |
| HY-N1201R | Apigenin (Standard) | 520-36-5 | Reference Standards |
| HY-N1201S | Apigenin-d5 | 263711-74-6 | Isotope-Labeled Compounds |
| HY-N1202 | Sitostanetriol | 20835-91-0 | Natural Products |
| HY-N12020 | Volucrin | 130217-31-1 | Natural Products |
| HY-N12021 | 7(8)-Dehydroschisandrol A | 75684-45-6 | Natural Products |
| HY-N12022 | 7(18)-Dehydroschisandro A | 135095-47-5 | Natural Products |
| HY-N12023 | Deacetylnomilin | 3264-90-2 | Natural Products |
| HY-N12024 | Linderanine C | 139681-96-2 | Natural Products |
| HY-N12025 | Eriodictyol 7-O-glucuronide | 125535-06-0 | Natural Products |
| HY-N12027 | AChE/BChE-IN-14 | Natural Products | |
| HY-N12028 | Acacetin 7-O-glucuronide | 38226-83-4 | Natural Products |
| HY-N12029 | Acacetin 7-O-β-sophoroside | 661470-05-9 | Natural Products |
| HY-N1203 | (5α)-Stigmastane-3,6-dione | 22149-69-5 | Natural Products |
| HY-N12030 | Acacetin 7-O-β-D-glucuronopyranosyl-(1→2)[α-L-rhamnopyranosyl-(1→6)]-β-D-glucopyranoside | 1220269-61-3 | Natural Products |
| HY-N12031 | Acacetin 7-O-(6′′-O-α-L-rhamnopyranosyl-β-sophoroside) | 661470-06-0 | Natural Products |
| HY-N12032 | Acacetin 7-O-β-D-xylopyranosyl-(1→2)[α-L-rhamnopyranosyl-(1→6)]-β-D-glucopyranoside | 64191-68-0 | Natural Products |
| HY-N12033 | 4'-Demethylpodophyllotoxone | 93780-84-8 | Natural Products |
| HY-N12034 | Picropodophyllin-β-D-glucoside | 1400-92-6 | Natural Products |
| HY-N12035 | Picropodophyllin-4-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranoside | 619296-83-2 | Natural Products |
| HY-N12036 | Dihydroobionin B | Natural Products | |
| HY-N12037 | (+)-7'-Methoxylariciresinol | 1426550-86-8 | Natural Products |
| HY-N12037A | 7′-Methoxylariciresinol | 848845-01-2 | Natural Products |
| HY-N12038 | Coumarinic acid | 495-79-4 | Natural Products |
| HY-N12039 | Juniper camphor | 473-04-1 | Natural Products |
| HY-N1204 | Soyacerebroside II | 115074-93-6 | Natural Products |
| HY-N12040 | γ-Isofagarine | 569-02-8 | Natural Products |
| HY-N12041 | Axl-IN-16 | Natural Products | |
| HY-N12042 | Taxamairin B | 110300-77-1 | Natural Products |
| HY-N12043 | Bidenoside C | 700877-55-0 | Natural Products |
| HY-N12044 | Asparanin A | 84633-33-0 | Natural Products |
| HY-N12046 | Schineolignin B | 1352185-26-2 | Natural Products |
| HY-N12047 | Schineolignin C | 1352185-28-4 | Natural Products |
| HY-N12048 | Schisandrathera D | 2694046-04-1 | Natural Products |
| HY-N12049 | (+)-Diasyringaresinol | 551-29-1 | Natural Products |
| HY-N1205 | Spathulenol | 6750-60-3 | Natural Products |
| HY-N12050 | Hosenkoside D | 156823-94-8 | Natural Products |
| HY-N12051 | Hosenkoside E | 156764-84-0 | Natural Products |
| HY-N12052 | Hosenkoside L | 161016-50-8 | Natural Products |
| HY-N12053 | Hosenkoside N | 156765-13-8 | Natural Products |
| HY-N12054 | Hosenkoside O | 161016-52-0 | Natural Products |
| HY-N12056 | Cyclo(L-leucyl-L-valyl) | 15136-24-0 | Natural Products |
| HY-N12058 | (Z)-9-Nonadecene | 51865-02-2 | Natural Products |
| HY-N12059 | 6,8-Di-C-β-D-xylopyranoside | 142759-72-6 | Natural Products |
| HY-N1206 | Specioside | 72514-90-0 | Natural Products |
| HY-N12060 | Ginkgo biloba extract | 90045-36-6 | Natural Products |
| HY-N12061 | Lucenin 3 | 12656-83-6 | Natural Products |
| HY-N12062 | Lucenin 1 | 35927-39-0 | Natural Products |
| HY-N12063 | Tetrahydropalmatrubine | 7762-76-7 | Natural Products |
| HY-N12065 | Parisyunnanoside H | 1369500-64-0 | Natural Products |
| HY-N12066 | Progenin III palmitate | 1459260-68-4 | Natural Products |
| HY-N12067 | Columbianetin β-D-glucopyranoside | 55836-35-6 | Natural Products |
| HY-N12068 | (S)-7-O-Methylpeucedanol 3′-O-β-D-glucopyranoside | 214627-06-2 | Natural Products |
| HY-N12069 | Praeroside IV | 117233-34-8 | Natural Products |
| HY-N12070 | 11-O-β-D-glucopyranosyl thamnosmonin | 952495-28-2 | Natural Products |
| HY-N12071 | Lucidin-ω-Me ether | 79560-36-4 | Natural Products |
| HY-N12072 | 3'-Methoxy-3,5,4'-trihydroxyflavone-7-neohesperidoside | 28283-76-3 | Natural Products |
| HY-N12073 | Monofucosyllacto-N-hexaose I | 341511-38-4 | Natural Products |
| HY-N12074 | Monofucosyllacto-N-hexaose III | 96656-34-7 | Natural Products |
| HY-N12075 | Dehydrodiscretamine (chloride) | 78134-82-4 | Natural Products |
| HY-N12077 | Eurycomanol 2-O-β-D-glucopyranoside | 126260-97-7 | Natural Products |
| HY-N12078 | 4-Chloro-3-methoxy-5-methylphenyl 6-O-(6-deoxy-β-L-mannopyranosyl)-β-D-glucopyranoside | 2839363-15-2 | Natural Products |
| HY-N12079 | (2,4-Dichloro-3,5-dimethoxyphenyl) methyl 6-O-β-D-glucopyranosyl-β-D-glucopyranoside | 2739844-79-0 | Natural Products |
| HY-N1208 | Spiradine F | 21040-64-2 | Natural Products |
| HY-N12080 | Pyroside | 10338-88-2 | Natural Products |
| HY-N12081 | Oxyresveratrol 4-O-β-D-glucopyranoside | 863329-68-4 | Natural Products |
| HY-N12082 | HIV-IN-8 | 130286-75-8 | Natural Products |
| HY-N12084 | Isolugrandoside | 221660-27-1 | Natural Products |
| HY-N12085 | Lugrandoside | 117457-37-1 | Natural Products |
| HY-N1209 | Spiramilactone B | 180961-65-3 | Natural Products |
| HY-N12090 | Limocitrin-3-rutinoside | 79384-27-3 | Natural Products |
| HY-N12091 | Preleoheterin | 151178-05-1 | Natural Products |
| HY-N12092 | PSX020 | 2600799-45-7 | Natural Products |
| HY-N12093 | Cevadine | 62-59-9 | Natural Products |
| HY-N12094 | Tanegoside | 131653-21-9 | Natural Products |
| HY-N12095 | Chavicol β-D-glucoside | 64703-98-6 | Natural Products |
| HY-N12096 | Galbinic acid | 56691-88-4 | Natural Products |
| HY-N12097 | Qianhucoumarin D | 20516-19-2 | Natural Products |
| HY-N12098 | d-Laserpitin | 134002-17-8 | Natural Products |
| HY-N1210 | Spiramine A | 114531-28-1 | Natural Products |
| HY-N12100 | Gonyautoxin I | 60748-39-2 | Natural Products |
| HY-N12101 | Anti-inflammatory agent 57 | 440094-34-8 | Natural Products |
| HY-N12102 | Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside | 1252572-36-3 | Natural Products |
| HY-N12105 | Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside | 1015175-06-0 | Natural Products |
| HY-N12107 | N-[(Z)-Hexadec-9-enoyl]homoserine lactone | 479050-94-7 | Natural Products |
| HY-N12108 | Forphenicine | 57784-96-0 | Natural Products |
| HY-N12109 | Albizziin | 585-23-9 | Natural Products |
| HY-N1211 | Splendoside | 81969-41-7 | Natural Products |
| HY-N12110 | SMU-CX1 | 10371-86-5 | Natural Products |
| HY-N12111 | S-(-)-N-trans-Feruloyl normetanephrine | 2705170-78-9 | Natural Products |
| HY-N12112 | Montbretin A | 115712-92-0 | Natural Products |
| HY-N12113 | 9-(Z)-Pentacosene | 51865-00-0 | Natural Products |
| HY-N12114 | 6′-Hydroxyjusticidin C | 904328-26-3 | Natural Products |
| HY-N12115 | Neoartanin | 104196-69-2 | Natural Products |
| HY-N12116 | Maceneolignan A | 1967042-42-7 | Natural Products |
| HY-N12117 | Arundamine | 475977-53-8 | Natural Products |
| HY-N12118 | Piperanine | 23512-46-1 | Natural Products |
| HY-N12119 | ent-Prostaglandin F2α | 54483-31-7 | Natural Products |
| HY-N12120 | Retrofractamide A | 94079-67-1 | Natural Products |
| HY-N12121 | Piperundecalidine | 88660-11-1 | Natural Products |
| HY-N12122 | Dehydropipernonaline | 107584-38-3 | Natural Products |
| HY-N12123 | Peimisine 3-O-β-D-glucopyranoside | 1407161-78-7 | Natural Products |
| HY-N12124 | Monascuspiloin | 1011244-19-1 | Natural Products |
| HY-N12125 | Entadamide A | 100477-88-1 | Natural Products |
| HY-N12126 | Sydowinin B | 58450-00-3 | Natural Products |
| HY-N12127 | Gymnoside I | 899430-01-4 | Natural Products |
| HY-N12128 | Ophiopogonin R | 1418183-25-1 | Natural Products |
| HY-N12129 | 6,6′-Dihydroxythiobinupharidine | 30343-70-5 | Natural Products |
| HY-N1213 | Sprengerinin C | 88861-91-0 | Natural Products |
| HY-N12130 | Celangulatin D | 1000784-45-1 | Natural Products |
| HY-N12131 | Ejaponine A | 1253119-28-6 | Natural Products |
| HY-N12133 | 4,7-Didehydroneophysalin B | 134461-76-0 | Natural Products |
| HY-N12134 | Methyl piperate | 6190-46-1 | Natural Products |
| HY-N12135 | 15α-Hydroxy-20-oxo-6,7-seco-ent-kaur-16-en-1,7α(6,11α)-diolide | 1355450-84-8 | Natural Products |
| HY-N12136 | 1α-Hydroxy-3-deoxypseudoanisatin | 258854-65-8 | Natural Products |
| HY-N12137 | Glycoside St-J | 203513-88-6 | Natural Products |
| HY-N12138 | Flaccidoside III | 140400-67-5 | Natural Products |
| HY-N12139 | Nitric oxide production-IN-1 | 1013405-26-9 | Natural Products |
| HY-N1214 | Squalene | 111-02-4 | Natural Products |
| HY-N12140 | 2'-epi-2'-O-Acetylthevetin B | 82145-55-9 | Natural Products |
| HY-N12141 | Flaccidoside II | 140694-19-5 | Natural Products |
| HY-N12142 | Anticancer agent 156 | Natural Products | |
| HY-N12143 | Acetylthevetin A | 1356494-03-5 | Natural Products |
| HY-N12144 | Arachidin 2 | 61517-87-1 | Natural Products |
| HY-N12145 | Streptimidone | 738-72-7 | Natural Products |
| HY-N12146 | Spinosyn D 17-pseudoaglycone | 131929-55-0 | Natural Products |
| HY-N12147 | Cannogenol 3-O-β-gentiobiosyl-(1→4)-α-L-thevetoside | 1841524-78-4 | Natural Products |
| HY-N12148 | Macrostemonoside I | 162413-63-0 | Natural Products |
| HY-N12149 | Axinysone B | 1114491-60-9 | Natural Products |
| HY-N1214A | (E/Z)-Squalene | 7683-64-9 | Natural Products |
| HY-N1214R | Squalene (Standard) | 111-02-4 | Reference Standards |
| HY-N1214S | Squalene-d6 | 1875101-86-2 | Isotope-Labeled Compounds |
| HY-N1215 | Squalene-2,3-glycol | 14031-37-9 | Natural Products |
| HY-N12150 | Isozedoarondiol | 108887-68-9 | Natural Products |
| HY-N12151 | Chaparrinone | 22611-34-3 | Natural Products |
| HY-N12152 | Molluscicidal agent-1 | 111567-21-6 | Natural Products |
| HY-N12153 | Theasaponin E2 | 220114-30-7 | Peptides |
| HY-N12154 | Ajugose | 512-72-1 | Natural Products |
| HY-N12155 | (2,4,6-Trichloro-3-hydroxy-5-methoxyphenyl)methyl β-D-glucopyranoside | 2839363-14-1 | Natural Products |
| HY-N12156 | Ajugasterone C 2-acetate | 154510-93-7 | Natural Products |
| HY-N12157 | Noratherosperminine | 74606-53-4 | Natural Products |
| HY-N12158 | Pipermethystine | 71627-22-0 | Natural Products |
| HY-N12159 | Uvaol diacetate | 157000-65-2 | Natural Products |
| HY-N1216 | Ssioriside | 126882-53-9 | Natural Products |
| HY-N12160 | Erythrodiol diacetate | 1896-77-1 | Natural Products |
| HY-N12161 | 3-Acetyl-11-keto-ursolic acid | 35959-01-4 | Natural Products |
| HY-N12162 | Obtusilin | 105870-59-5 | Natural Products |
| HY-N12163 | Stigmast-5-ene-3,7-dione | 206554-44-1 | Natural Products |
| HY-N12164 | Linearmycin B | 182291-65-2 | Natural Products |
| HY-N12165 | 1,3,5,6-Tetrahydroxy-8-methylxanthone | 213547-11-6 | Natural Products |
| HY-N12166 | 2,3,4,6,8-Pentahydroxy-1-methylxanthone | 548740-87-0 | Natural Products |
| HY-N12167 | 3-epi-Bufalin | 465-20-3 | Natural Products |
| HY-N12168 | Markogenin | 562-35-6 | Natural Products |
| HY-N12169 | Janthitrem A | 73561-89-4 | Natural Products |
| HY-N1217 | Stauntosaponin A | 1417887-91-2 | Natural Products |
| HY-N12170 | Kissoone C | 903559-03-5 | Natural Products |
| HY-N12171 | Isoreserpiline | 572-67-8 | Natural Products |
| HY-N12172 | Kissoone A | 903559-01-3 | Natural Products |
| HY-N12174 | Orthosphenic acid | 86632-20-4 | Natural Products |
| HY-N12176 | Euphenol | 564-60-3 | Natural Products |
| HY-N12177 | Cryptosporioptide A | 1647101-05-0 | Natural Products |
| HY-N12178 | 16-Deethylindanomycin | 106803-22-9 | Natural Products |
| HY-N12179 | Brevianamide M | 1174538-69-2 | Natural Products |
| HY-N1218 | Stellasterol | 2465-11-4 | Natural Products |
| HY-N12180 | Hodgkinsine B | 586955-76-2 | Natural Products |
| HY-N12180A | Hodgkinsine | 18210-71-4 | Natural Products |
| HY-N12181 | Brevianamide R | 1259316-09-0 | Natural Products |
| HY-N12183 | Brevianamide Q | 1259316-08-9 | Natural Products |
| HY-N12184 | Peniciside | 1367350-29-5 | Natural Products |
| HY-N12185 | Corycavine | 521-87-9 | Natural Products |
| HY-N12186 | Sibiricine | 24181-66-6 | Natural Products |
| HY-N12187 | 5,22-Dioxokopsane | 3703-90-0 | Natural Products |
| HY-N12188 | Stigmasta-3,5-dien-7-one | 2034-72-2 | Natural Products |
| HY-N12189 | 3β-(Acetyloxy)stigmast-5-en-7-one | 18376-53-9 | Natural Products |
| HY-N1219 | Stephanine | 517-63-5 | Natural Products |
| HY-N12190 | Centellasaponin A | 261767-77-5 | Natural Products |
| HY-N12191 | Cangorinine E-1 | 155944-24-4 | Natural Products |
| HY-N12192 | Ebenifoline E-II | 133740-16-6 | Natural Products |
| HY-N12193 | Cytochalasin N | 108050-28-8 | Natural Products |
| HY-N12194 | Cytochalasin O | 108050-26-6 | Natural Products |
| HY-N12195 | Cytochalasin R | 121964-47-4 | Natural Products |
| HY-N12196 | Terretonin | 71911-90-5 | Natural Products |
| HY-N12197 | Terretonin A | 865092-86-0 | Natural Products |
| HY-N12198 | Mollicellin H | 68455-09-4 | Natural Products |
| HY-N12199 | All-cis-3,6,9,12,15-octadecapentaenoic acid | 51592-59-7 | Natural Products |
| HY-N1220 | Stephavanine | 33116-33-5 | Natural Products |
| HY-N12200 | Mollicellin I | 1016605-29-0 | Natural Products |
| HY-N12201 | Funiculosin | 11055-06-4 | Natural Products |
| HY-N12202 | 6′-O-β-D-Glucopyranosylphlorigidoside C | 927691-83-6 | Natural Products |
| HY-N12203 | 5-Deoxypulchelloside I | 115075-53-1 | Natural Products |
| HY-N12204 | Triptonoterpenol | 110187-23-0 | Natural Products |
| HY-N12205 | Salicyloyltremuloidin | 10059-19-5 | Natural Products |
| HY-N12206 | Semicochliodinol | 194224-72-1 | Natural Products |
| HY-N12207 | Neohelmanthicin C | 918784-99-3 | Natural Products |
| HY-N12208 | Neohelmanthicin B | 918785-00-9 | Natural Products |
| HY-N12209 | Neohelmanthicin A | 920758-09-4 | Natural Products |
| HY-N1221 | Stigmast-4-en-3,6-dione | 23670-94-2 | Natural Products |
| HY-N12210 | Notrilobolide | 2363714-40-1 | Natural Products |
| HY-N12211 | Primulagenin A | 465-95-2 | Natural Products |
| HY-N12212 | Triptonoterpene Me ether | 173293-35-1 | Natural Products |
| HY-N12215 | 10-Hydroxyoleuropein | 84638-44-8 | Natural Products |
| HY-N12216 | Cyanidin 3-sophoroside-5-glucoside | 16727-02-9 | Natural Products |
| HY-N12218 | Roccellic acid | 29838-46-8 | Natural Products |
| HY-N12219 | Pyridindolol | 55812-46-9 | Natural Products |
| HY-N1222 | Stigmast-4-ene-3β,6β-diol | 113626-76-9 | Natural Products |
| HY-N12220 | Cinnamtannin D2 | 97233-47-1 | Natural Products |
| HY-N12221 | Cinnamtannin B2 | 88038-12-4 | Natural Products |
| HY-N12223 | Piericidin B | 16891-54-6 | Natural Products |
| HY-N12224 | 1-Heptadecanoyl-rac-glycerol | 5638-14-2 | Natural Products |
| HY-N12225 | Isoasiaticoside | 948827-09-6 | Natural Products |
| HY-N12228 | Phenelfamycin E | 114451-31-9 | Natural Products |
| HY-N1223 | Stigmasta-4,22,25-trien-3-one, (22E)- | 848669-09-0 | Natural Products |
| HY-N12231 | Carbazomycin B | 75139-38-7 | Natural Products |
| HY-N12232 | Carbazomycin D | 108073-63-8 | Natural Products |
| HY-N12233 | Condurango glycoside A | 11051-90-4 | Natural Products |
| HY-N12234 | Condurango glycoside C | 11051-92-6 | Natural Products |
| HY-N12235 | Sarglaroids F | Natural Products | |
| HY-N12236 | Condurango glycoside E3 | 115784-10-6 | Natural Products |
| HY-N12237 | Condurango glycoside A0 | 115810-21-4 | Natural Products |
| HY-N12238 | Condurango glycoside E0 | 115784-08-2 | Natural Products |
| HY-N12239 | Condurango glycoside E | 115784-07-1 | Natural Products |
| HY-N1224 | (22E,24R)-Stigmasta-4,22-dien-3-one | 55722-32-2 | Natural Products |
| HY-N12240 | Oleanolic aldehyde | 17020-22-3 | Natural Products |
| HY-N12241 | Sterebin F | 114489-87-1 | Natural Products |
| HY-N12242 | (-)-11,12-Methylenedioxykopsinaline | 88607-48-1 | Natural Products |
| HY-N12243 | Kopsininic acid | 7222-19-7 | Natural Products |
| HY-N12244 | Echitaminic acid | 7163-44-2 | Natural Products |
| HY-N12245 | Narciclasine-4-O-β-D-glucopyranoside | 141544-37-8 | Natural Products |
| HY-N12249 | 7-Deoxy-trans-dihydronarciclasine | 145987-74-2 | Natural Products |
| HY-N1225 | Stigmasta-4,25-dien-3-one | 848669-08-9 | Natural Products |
| HY-N12250 | 7-Deoxynarciclasine | 19622-83-4 | Natural Products |
| HY-N12251 | Gymnoside IX | 898827-00-4 | Natural Products |
| HY-N12252 | N-Acetylcytisine | 6018-52-6 | Natural Products |
| HY-N12253 | (19R)-13-Deoxy-19-hydroxyenmein | 16763-48-7 | Natural Products |
| HY-N12254 | Natsudaidain | 35154-55-3 | Natural Products |
| HY-N12255 | COTC | 57449-30-6 | Natural Products |
| HY-N12256 | cis-Emodin bianthrone | 61281-19-4 | Natural Products |
| HY-N12257 | Antimycin A2 | 27220-57-1 | Natural Products |
| HY-N12258 | Aranciamycin A | 960622-70-2 | Natural Products |
| HY-N12259 | 4(Z),7(Z)-Decadienoic acid | 169392-17-0 | Natural Products |
| HY-N1226 | Stigmasta-5,8-dien-3β-ol | 570-72-9 | Natural Products |
| HY-N12260 | Benanomicin A | 116249-65-1 | Natural Products |
| HY-N12261 | Benastatin B | 138968-86-2 | Natural Products |
| HY-N12262 | (+)-Epieudesmin | 60102-89-8 | Natural Products |
| HY-N12263 | 3,5,6,7,8,4'-Hexamethoxyflavone | 34170-18-8 | Natural Products |
| HY-N12264 | Burnettramic acid A | 2334483-46-2 | Natural Products |
| HY-N12265 | Versicolactone B | 108885-62-7 | Natural Products |
| HY-N12266 | 12-Hydroxyalbrassitriol | 2193060-23-8 | Natural Products |
| HY-N12267 | N,N′-Diferuloylputrescine | 42369-86-8 | Natural Products |
| HY-N12267A | Terrestribisamide | 91000-13-4 | Natural Products |
| HY-N12268 | Oxytroflavoside G | 1391144-89-0 | Natural Products |
| HY-N12269 | Madolin U | 327185-00-2 | Natural Products |
| HY-N1227 | 6α-Hydroxysitostanol | 112244-29-8 | Natural Products |
| HY-N12270 | Petanin (chloride) | 69915-09-9 | Natural Products |
| HY-N12271 | Antioxidant agent-14 | 1203589-26-7 | Natural Products |
| HY-N12272 | Soyasaponin Af | 117230-32-7 | Natural Products |
| HY-N12273 | Soyasaponin Ae | 117230-34-9 | Natural Products |
| HY-N12274 | Quercetin 5,3′-dimethyl ether | 40554-94-7 | Natural Products |
| HY-N12276 | (±)-Emodin bianthrone | 61281-20-7 | Natural Products |
| HY-N12277 | Celosin K | 1950579-53-9 | Natural Products |
| HY-N12278 | Micromarin F | 7336-40-5 | Natural Products |
| HY-N12279 | Yuanamide | 102421-42-1 | Natural Products |
| HY-N1228 | Soyacerebroside I | 114297-20-0 | Natural Products |
| HY-N12282 | Isovitexin 2′′-O-rhamnoside | 72036-50-1 | Natural Products |
| HY-N12283 | NF-κB-IN-13 | 117596-92-6 | Natural Products |
| HY-N12284 | 6-Methoxy-2-[2-(3′-methoxyphenyl)ethyl]chromone | 84294-88-2 | Natural Products |
| HY-N12285 | 6-Methoxy-2-(2-phenylethyl)chromone | 84294-89-3 | Natural Products |
| HY-N12286 | Denthyrsinin | 118169-17-8 | Natural Products |
| HY-N12287 | Curcapicycloside | 229971-57-7 | Natural Products |
| HY-N12288 | Wangzaozin A | 84294-86-0 | Natural Products |
| HY-N12289 | Kanzonol D | 155233-20-8 | Natural Products |
| HY-N12290 | 17-Hydroxygracillin | 90308-85-3 | Natural Products |
| HY-N12291 | 7,4'-Dihydroxyhomoisoflavane | 148462-00-4 | Natural Products |
| HY-N12292 | Acanthopanaxoside A | 915792-02-8 | Natural Products |
| HY-N12293 | Yemuoside YM12 | 125239-12-5 | Natural Products |
| HY-N12294 | Ciwujianoside D2 | 114892-57-8 | Natural Products |
| HY-N12295 | Ciwujianoside D1 | 114912-35-5 | Natural Products |
| HY-N12296 | Ciwujianoside C4 | 114906-75-1 | Natural Products |
| HY-N12297 | Ciwujianoside C2 | 114892-56-7 | Natural Products |
| HY-N12298 | Ciwujianoside C1 | 114906-73-9 | Natural Products |
| HY-N12299 | Parthenosin | 166196-16-3 | Natural Products |
| HY-N1230 | Sophoraisoflavone A | 117204-81-6 | Natural Products |
| HY-N12301 | Angustanoic acid G | 211814-30-1 | Natural Products |
| HY-N12302 | N1-Dihydrocaffeoyl, N10-caffeoyl spermidine | 1698873-84-5 | Natural Products |
| HY-N12304 | Xanthalin | 21800-48-6 | Natural Products |
| HY-N12305 | 4,5-O-Dicaffeoyl quinic acid methyl ester | 188742-80-5 | Natural Products |
| HY-N12306 | 5,7,3',4'-Tetrahydroxy-6-methoxyflavanone-7-glucoside | 1627598-00-8 | Natural Products |
| HY-N12307 | Gentiiridosides A | Natural Products | |
| HY-N12308 | Monbarbatain A | 138711-55-4 | Natural Products |
| HY-N12309 | 2′-O-Methylphloretin | 111316-17-7 | Natural Products |
| HY-N1231 | Sophoraflavanone G | 97938-30-2 | Natural Products |
| HY-N12316 | Goshuyuamide I | 126223-62-9 | Natural Products |
| HY-N12317 | Multiflorin B | 52657-01-9 | Natural Products |
| HY-N1231R | Sophoraflavanone G (Standard) | 97938-30-2 | Reference Standards |
| HY-N1232 | Songoroside A | 61617-29-6 | Natural Products |
| HY-N12320 | Majoranaquinone | 1596355-59-7 | Natural Products |
| HY-N12321 | 2',3'-Dihydroxy-4',6'-dimethoxychalcone | 54299-64-8 | Natural Products |
| HY-N12322 | Dihydrotetrodecamycin | 166403-10-7 | Natural Products |
| HY-N12323 | 6′-Galactosyllactose | 32581-31-0 | Natural Products |
| HY-N12326 | Multiflorin A | 1350028-90-8 | Natural Products |
| HY-N12327 | Ombuin-3-O-glucoside | 158642-42-3 | Natural Products |
| HY-N12329 | Fumonisin B4 | 136379-60-7 | Natural Products |
| HY-N1233 | Songoramine | 23179-78-4 | Natural Products |
| HY-N12333 | 4,4-Di(4-hydroxy-3-methoxyphenly)-2,3-dimethylbutanol | 913643-31-9 | Natural Products |
| HY-N12335 | Desacetylxanthanol | 72843-22-2 | Natural Products |
| HY-N12336 | Gnetuhainin I | 308105-06-8 | Natural Products |
| HY-N12338 | (+)-Licarin | 42016-15-9 | Natural Products |
| HY-N12339 | Wulfenioidin F | Natural Products | |
| HY-N1234 | Smyrindioloside | 87592-77-6 | Natural Products |
| HY-N12340 | Wulfenioidin H | Natural Products | |
| HY-N12341 | 17α-Deacetyltanghinin | 111614-46-1 | Natural Products |
| HY-N12342 | 17β-Tanghinigenin | 114612-75-8 | Natural Products |
| HY-N12343 | Tetrahydrorhombifoline | 3382-84-1 | Natural Products |
| HY-N12344 | n-Butyl α-D-fructofuranoside | 80971-59-1 | Natural Products |
| HY-N12345 | 5-Dexyexcoecafolin B | 1643370-00-6 | Natural Products |
| HY-N12347 | α-Glucosidase-IN-37 | 917078-12-7 | Natural Products |
| HY-N12348 | Emoghrelin | 928262-58-2 | Natural Products |
| HY-N12349 | Glucozaluzanin C | 57576-33-7 | Natural Products |
| HY-N1235 | Skullcapflavone I | 41060-16-6 | Natural Products |
| HY-N12350 | Ellagic acid 3-O-α-L-rhamnopyranoside | 1422265-57-3 | Natural Products |
| HY-N12351 | Ellagic acid 4-O-α-L-arabinopyranoside | 624739-20-4 | Natural Products |
| HY-N12352 | Eschweilenol C | 211371-02-7 | Natural Products |
| HY-N12353 | Stevisalioside A | 142934-44-9 | Natural Products |
| HY-N12354 | Stevisaliosides D | Natural Products | |
| HY-N12355 | Disporoside C | 244779-39-3 | Natural Products |
| HY-N12358 | Isogermafurenolide | 20267-89-4 | Natural Products |
| HY-N12359 | Mulberrofuran B | 79295-49-1 | Natural Products |
| HY-N1236 | Sitsirikine | 1245-00-7 | Natural Products |
| HY-N12360 | 2,3-Dehydrosilybin A | 25166-14-7 | Natural Products |
| HY-N12360A | 2,3-Dehydrosilybin B | 142796-24-5 | Natural Products |
| HY-N12360R | 2,3-Dehydrosilybin A (Standard) | 25166-14-7 | Reference Standards |
| HY-N12361 | Osmanthuside B | 94492-23-6 | Natural Products |
| HY-N12362 | Antiviral agent 41 | 68622-73-1 | Natural Products |
| HY-N12363 | (-)-Afzelechin | 19879-28-8 | Natural Products |
| HY-N12364 | Bufoserotonin C | 1002722-87-3 | Natural Products |
| HY-N12365 | Ginsenoside Rs2 | 87733-66-2 | Natural Products |
| HY-N12366 | Ginsenoside Rs1 | 87733-67-3 | Natural Products |
| HY-N12367 | Oroxylin 7-O-glucoside | 36948-77-3 | Natural Products |
| HY-N1237 | Sitosteryl palmitate | 2308-85-2 | Natural Products |
| HY-N12370 | Tenaxin I | 86926-52-5 | Natural Products |
| HY-N12371 | 5,8-Dihydroxy-6,7-dimethoxyflavone | 73202-52-5 | Natural Products |
| HY-N12372 | (±)-Dihydrocorynantheine | 4684-43-9 | Natural Products |
| HY-N12373 | Cynatratoside D | 97399-99-0 | Natural Products |
| HY-N12374 | Kadsulignan C | 137637-49-1 | Natural Products |
| HY-N12375 | Kadsuphilin J | 1017242-94-2 | Natural Products |
| HY-N12376 | Renchangianin B | 770733-54-5 | Natural Products |
| HY-N12377 | Isovaleroyl oxokadsuranol | 130252-45-8 | Natural Products |
| HY-N12378 | β-Patchoulene | 514-51-2 | Natural Products |
| HY-N12379 | Interiotherin D | 460090-66-8 | Natural Products |
| HY-N1238 | β-Sitostenone | 1058-61-3 | Natural Products |
| HY-N12380 | Stauntoside M | 1537167-62-6 | Natural Products |
| HY-N12381 | Spinasaponin E | 2867584-02-7 | Natural Products |
| HY-N12382 | 2-Phenethyl β-primeveroside | 129932-48-5 | Natural Products |
| HY-N12383 | Officinalisnin-II | 57944-19-1 | Natural Products |
| HY-N12383A | (25R)-Officinalisnin-II | 84800-14-6 | Natural Products |
| HY-N12384 | (25S)-Antcin B | 1312711-71-9 | Natural Products |
| HY-N12386 | SIRT1 activator 1 | Natural Products | |
| HY-N12388 | AChE-IN-46 | Natural Products | |
| HY-N12389 | Quellenin | 2243042-31-9 | Natural Products |
| HY-N1239 | Sitoindoside I | 18749-71-8 | Natural Products |
| HY-N12390 | Alternaphenol B2 | Natural Products | |
| HY-N12394 | Norwogonin-8-O-glucuronide | 118525-47-6 | Natural Products |
| HY-N12395 | Parishin G | 952283-93-1 | Natural Products |
| HY-N12396 | Cyclosporin U | 108027-45-8 | Natural Products |
| HY-N12398 | Psychotridine | 52617-25-1 | Natural Products |
| HY-N12399 | Aplithianines A | 3027425-38-0 | Natural Products |
| HY-N1240 | Sissotrin | 5928-26-7 | Natural Products |
| HY-N12400 | 10-Methyldodec-2-en-4-olide | 874359-15-6 | Natural Products |
| HY-N12401 | 10,13-Epoxy-11-methyl-octadecadienoic acid | 57818-39-0 | Natural Products |
| HY-N12405 | Encecalinol | 88728-56-7 | Natural Products |
| HY-N12408 | Globotriaosylsphingosine | 126550-86-5 | Natural Products |
| HY-N12409 | Neocucurbitacin A | 352359-53-6 | Natural Products |
| HY-N1241 | Sinensin | 28189-90-4 | Natural Products |
| HY-N12410 | 3,5-Diprenyl-4-hydroxyacetophenone | 41607-43-6 | Natural Products |
| HY-N12411 | (S)-O-Methylencecalinol | Natural Products | |
| HY-N12413 | Apicularen B | 220757-06-2 | Natural Products |
| HY-N12414 | Apicularen A | 220757-04-0 | Natural Products |
| HY-N12416 | ΔDi6S | 51449-08-2 | Natural Products |
| HY-N12418 | (20S)-18,19-Dehydrocamptothecin | 119403-33-7 | Natural Products |
| HY-N1242 | Sinapaldehyde glucoside | 154461-65-1 | Natural Products |
| HY-N12421 | Paulomycin A | 81988-77-4 | Natural Products |
| HY-N12422 | A2AAR antagonist 2 | Natural Products | |
| HY-N12423 | Bis-(-)-8-demethylmaritidine | Natural Products | |
| HY-N12424 | Elephanoside D | 1005340-21-5 | Natural Products |
| HY-N12425 | Heteroclitin A | 140369-75-1 | Natural Products |
| HY-N12426 | Heilaohuguosu F | 2763686-96-8 | Natural Products |
| HY-N12427 | Litchinol B | Natural Products | |
| HY-N12428 | 17-Hydroxyjolkinolide A | 65388-16-1 | Natural Products |
| HY-N12429 | Marstenacisside F1 | 2902666-68-4 | Natural Products |
| HY-N1243 | Tubulysin B | 205304-87-6 | Natural Products |
| HY-N12430 | Marsdenoside A | 858360-56-2 | Natural Products |
| HY-N12431 | Machilin A | 110269-50-6 | Natural Products |
| HY-N12432 | Glomeratide A | 1072028-74-0 | Natural Products |
| HY-N12433 | Tenuiphenone B | 870298-00-3 | Natural Products |
| HY-N12434 | Euphorblin R | 2230806-06-9 | Natural Products |
| HY-N12435 | Ingol 7,8,12-triacetate 3-phenylacetate | 944799-46-6 | Natural Products |
| HY-N12436 | 11α-O-Tigloyl-12β-O-acetyltenacigenin B | 154022-51-2 | Natural Products |
| HY-N12437 | Marsdenoside B | 858360-57-3 | Natural Products |
| HY-N12438 | 3-epi-Digitoxigenin | 545-52-8 | Natural Products |
| HY-N12439 | 2,2′-Dihydroxy-4,6-dimethoxy-3-methylacetophenone | 184706-61-4 | Natural Products |
| HY-N1244 | Sarmentosin | 71933-54-5 | Natural Products |
| HY-N12440 | Sarmenoside II | 947409-90-7 | Natural Products |
| HY-N12441 | Limocitrin 3,7-diglucoside | 111133-91-6 | Natural Products |
| HY-N12442 | Sarmenoside III | 947409-91-8 | Natural Products |
| HY-N12443 | Antioxidant agent-18 | 143016-73-3 | Natural Products |
| HY-N12444 | Tricetin 7-O-glucoside | 77298-67-0 | Natural Products |
| HY-N12445 | Quercetin-3'-O-glucoside | 19254-30-9 | Natural Products |
| HY-N12446 | 2'-O-Coumaroyl-(S)-aloesinol | 1059182-23-8 | Natural Products |
| HY-N12447 | C-2′-Decoumaroylaloeresin G | 1059182-21-6 | Natural Products |
| HY-N12449 | Aloinoside B | 11006-91-0 | Natural Products |
| HY-N1245 | Sarpagine | 482-68-8 | Natural Products |
| HY-N12450 | Aloinoside A | 56645-88-6 | Natural Products |
| HY-N12451 | Aloeresin J | 1431370-18-1 | Natural Products |
| HY-N12452 | Myrrhterpenoid O | 2604667-43-6 | Natural Products |
| HY-N12453 | Agarsenone | 1447457-27-3 | Natural Products |
| HY-N12454 | Isofuranodienone | 24268-42-6 | Natural Products |
| HY-N12455 | Comosone II | 1142922-55-1 | Natural Products |
| HY-N12456 | 4-Aminophenyl 6-deoxy-α-L-mannopyranoside | 183878-99-1 | Natural Products |
| HY-N12457 | Marsglobiferin | 147395-99-1 | Natural Products |
| HY-N12458 | Sitakisogenin | 53187-93-2 | Natural Products |
| HY-N12459 | Gymnemanol | 174324-52-8 | Natural Products |
| HY-N1246 | Savinin | 493-95-8 | Natural Products |
| HY-N12460 | Antimicrobial agent-27 | 1581276-60-9 | Natural Products |
| HY-N12466 | 3′-O-Demethyl-4′-N-demethyl-4′-N-acetyl-4′-epi-staurosporine | 2226941-29-1 | Natural Products |
| HY-N12467 | 24-Methylcholesterol | 23929-42-2 | Natural Products |
| HY-N12469 | Gypsogenin 3-O-glucuronide | 105762-16-1 | Natural Products |
| HY-N1247 | Scabertopin | 185213-52-9 | Natural Products |
| HY-N12471 | Gossypetin 3′-O-glucoside | 777080-67-8 | Natural Products |
| HY-N12472 | Floramanoside C | 1403981-95-2 | Natural Products |
| HY-N12473 | 25-Deacetylcucurbitacin A | 1135141-77-3 | Natural Products |
| HY-N12474 | 2-epi-Cucurbitacin B | 59015-72-4 | Natural Products |
| HY-N12478 | Ainsliadimer A | 1039431-94-1 | Natural Products |
| HY-N1248 | Scandine | 24314-59-8 | Natural Products |
| HY-N12481 | Cephalandole B | 915315-44-5 | Natural Products |
| HY-N12482 | Callicarboric acid A | Natural Products | |
| HY-N12483 | Catenulopyrizomicin A | Natural Products | |
| HY-N12485 | MAO-A inhibitor 1 | 119229-96-8 | Natural Products |
| HY-N12486 | Isofalcarintriol | Natural Products | |
| HY-N12486A | (3S,8R,9R)-Isofalcarintriol | 2962060-53-1 | Natural Products |
| HY-N1249 | Schleicheol 1 | 256445-66-6 | Natural Products |
| HY-N12490 | Dimethyl isorosmanol | 116064-19-8 | Natural Products |
| HY-N12492 | 11,12-Di-O-methylcarnosol | 25460-12-2 | Natural Products |
| HY-N12493 | Eucomoside B | 951672-66-5 | Natural Products |
| HY-N12494 | Diplacol | 76556-05-3 | Natural Products |
| HY-N12496 | Di-O-methylhonokiol | 68592-18-7 | Natural Products |
| HY-N12498 | Aureonuclemycin | 123970-01-4 | Natural Products |
| HY-N12499 | Eupalitin | 29536-41-2 | Natural Products |
| HY-N1250 | Schleicheol 2 | 256445-68-8 | Natural Products |
| HY-N12500 | 1'-O-Methyl neochebulinate | 1236310-34-1 | Natural Products |
| HY-N12501 | α-Ergostenol | 632-32-6 | Natural Products |
| HY-N12503 | Patuletin | 519-96-0 | Natural Products |
| HY-N12505 | Ponasteroside A | 20117-33-3 | Natural Products |
| HY-N12506 | Cimicifugic acid F | 220618-91-7 | Natural Products |
| HY-N12507 | Eupenicisirenin C | 2968309-12-6 | Natural Products |
| HY-N12508 | Meliponamycin A | 2954772-55-3 | Natural Products |
| HY-N12509 | (E)-Cinnamyl acetate | 21040-45-9 | Natural Products |
| HY-N1251 | Scholaricine | 99694-90-3 | Natural Products |
| HY-N12510 | Cyanidin 3-(6′′-malonylglucoside) | 94977-38-5 | Natural Products |
| HY-N12511 | Aristoquinoline | 2720562-34-3 | Natural Products |
| HY-N12512 | 6-O-p-Coumaroyl scandoside methyl ester | 83946-90-1 | Natural Products |
| HY-N12513 | Cyclo(L-Phe-trans-4-OH-L-Pro) | 118477-06-8 | Natural Products |
| HY-N12513R | Cyclo(L-Phe-trans-4-OH-L-Pro) (Standard) | 118477-06-8 | Reference Standards |
| HY-N12514 | Cyclomulberrin | 19275-51-5 | Natural Products |
| HY-N12515 | Pinuseldarone | Natural Products | |
| HY-N12516 | Ginsenoside Mc | 175484-06-7 | Natural Products |
| HY-N12517 | Citrusin C | 18604-50-7 | Natural Products |
| HY-N12519 | 1,2-Didehydrocryptotanshinone | 891854-92-5 | Natural Products |
| HY-N1252 | Scillascillin | 52706-07-7 | Natural Products |
| HY-N12520 | Helveticoside | 630-64-8 | Natural Products |
| HY-N12521 | (3β,24S)-3-Hydroxystigmast-5-en-7-one | 145163-97-9 | Natural Products |
| HY-N12524 | Cyclo(prolyltyrosyl) | 5654-84-2 | Natural Products |
| HY-N12525 | Bartsioside | 62133-72-6 | Natural Products |
| HY-N12526 | Isolappaol A | 131400-96-9 | Natural Products |
| HY-N12527 | Hyperelamine A | Natural Products | |
| HY-N12528 | 10,11-EDT | 2763501-00-2 | Natural Products |
| HY-N12529 | 13,14-EDT | 504435-14-7 | Natural Products |
| HY-N1253 | Scoparinol | 130838-00-5 | Natural Products |
| HY-N12530 | 16,17-EDT | 351533-79-4 | Natural Products |
| HY-N12532 | 8-Methoxykaempferol | 571-74-4 | Natural Products |
| HY-N12533 | Quinquenoside R1 | 85013-02-1 | Natural Products |
| HY-N12534 | Monaspin B | 2897653-87-9 | Natural Products |
| HY-N12535 | Tagitinin C | 59979-56-5 | Natural Products |
| HY-N12537 | PD-1/PD-L1-IN-38 | Natural Products | |
| HY-N12537A | (2R,3S)-PD-1/PD-L1-IN-38 | Natural Products | |
| HY-N12538 | trans-Cinnamic anhydride | 21947-71-7 | Natural Products |
| HY-N1254 | Scopoletin acetate | 56795-51-8 | Natural Products |
| HY-N12540 | Monogalactosyldiacylglycerol | 1932659-76-1 | Natural Products |
| HY-N12541 | Morunigrol C | 1174134-94-1 | Natural Products |
| HY-N12542 | 16-Anhydrodeacetylnerigoside | 69549-58-2 | Natural Products |
| HY-N12543 | Peonidin 3-rutinoside | 27539-32-8 | Natural Products |
| HY-N12544 | Magnoloside M | 1802727-92-9 | Natural Products |
| HY-N12545 | Magnoloside F | 1945997-27-2 | Natural Products |
| HY-N12546 | 22-Dihydrochondrillasterol | 18525-35-4 | Natural Products |
| HY-N12547 | 19-O-D-Carboxyglucopyranosyl-12-O-D-glucopyranosyl-11,16-dihydroxyabieta-8,11,13-triene | 1011714-20-7 | Natural Products |
| HY-N12548 | Thamnosmonin | 60094-90-8 | Natural Products |
| HY-N12549 | 4,2′,4′,6′-Tetramethoxychalcone | 94103-36-3 | Natural Products |
| HY-N1255 | Scoulerine | 6451-73-6 | Natural Products |
| HY-N12551 | 2-O-β-D-Glucopyranosylcucurbitacin F 25-acetate | 117869-71-3 | Natural Products |
| HY-N12552 | Cucurbitacin IIa 2-O-β-D-glucoside | 77704-34-8 | Natural Products |
| HY-N12555 | 6,6′-Didemethyl-7-methyl dragonbloodin A2 | Natural Products | |
| HY-N12556 | Hydroxyisogermafurenolide | 20267-91-8 | Natural Products |
| HY-N1256 | Sculponeatic acid | 1169806-02-3 | Natural Products |
| HY-N12560 | Fusaramin | 2374906-71-3 | Natural Products |
| HY-N12561 | Pestanoid A | Natural Products | |
| HY-N12563 | γ-Sitosterol | 83-47-6 | Natural Products |
| HY-N12566 | Erinacin B | 156101-10-9 | Natural Products |
| HY-N12567 | Gymnoside VII | 899430-07-0 | Natural Products |
| HY-N12569 | Orchidble | 87530-26-5 | Natural Products |
| HY-N1257 | Sculponeatin B | 85287-60-1 | Natural Products |
| HY-N12570 | Isoarundinin I | 151538-57-7 | Natural Products |
| HY-N12571 | 3-Hydroxylicochalcone A | 1381930-98-8 | Natural Products |
| HY-N12572 | Neoeuonymine | 33510-25-7 | Natural Products |
| HY-N125722 | Venturicidin A | 33538-71-5 | Natural Products |
| HY-N12573 | Dendronobilin B | 1002717-96-5 | Natural Products |
| HY-N12574 | Petunidin-3-(p-coumaroyl-rutinoside)-5-glucoside | 30678-24-1 | Natural Products |
| HY-N12575 | Physcion-8-O-(6'-O-malonyl)-glucoside | 1345826-33-6 | Natural Products |
| HY-N12576 | Koumidine | 1358-75-4 | Natural Products |
| HY-N12577 | Calendoflavobioside 5-O-glucoside | 1309795-36-5 | Natural Products |
| HY-N12578 | Polygalasaponin XXVIII | 176182-01-7 | Natural Products |
| HY-N12579 | Desacylsenegasaponin B | 163589-51-3 | Natural Products |
| HY-N1258 | Sculponeatin N | 1169805-98-4 | Natural Products |
| HY-N12580 | Mussaenosidic acid | 82451-22-7 | Natural Products |
| HY-N12581 | Kuwanon U | 123702-95-4 | Natural Products |
| HY-N12582 | 5-Methoxysuberenone | 85011-58-1 | Natural Products |
| HY-N12584 | Pulchinenoside E4 | 1415553-83-1 | Natural Products |
| HY-N12585 | Picfeltarraegenin I | 82145-63-9 | Natural Products |
| HY-N12586 | Pheophytin a | 603-17-8 | Natural Products |
| HY-N12587 | Platycoside F | 314756-03-1 | Natural Products |
| HY-N12588 | Quercetin 3-O-β-D-glucuronide-6′′-methyl ester | 79543-28-5 | Natural Products |
| HY-N12589 | 8-epi-Helenalin | 97643-91-9 | Natural Products |
| HY-N12590 | 6′′-O-Acetylsaikosaponin b2 | 104121-82-6 | Natural Products |
| HY-N12591 | Iso-isariin B | 2326436-93-3 | Natural Products |
| HY-N12592 | Procurcumadiol | 129673-90-1 | Natural Products |
| HY-N12595 | 22,23-Dihydroergosterol | 516-79-0 | Natural Products |
| HY-N12596 | Uralenol-3-methyl ether | 150853-98-8 | Natural Products |
| HY-N12598 | Delphinidin-3-rhamnoside (chloride) | 29907-19-5 | Natural Products |
| HY-N12599 | Stevioside E | 1309929-72-3 | Natural Products |
| HY-N1260 | Scutebarbatine A | 176520-13-1 | Natural Products |
| HY-N12600 | Thiolopyrrolone A | Natural Products | |
| HY-N12601 | Diselaginellin B | 1835299-12-1 | Natural Products |
| HY-N12603 | Typhatifolin B | Natural Products | |
| HY-N12604 | Penicisteck acid F | Natural Products | |
| HY-N12605 | hTRPA1-IN-1 | Natural Products | |
| HY-N12606 | Neodidymelliosides A | Natural Products | |
| HY-N12609 | 3β-Isodihydrocadambine | 62014-69-1 | Natural Products |
| HY-N1261 | Scutebarbatine B | 905929-95-5 | Natural Products |
| HY-N12612 | CNP0296775 | Natural Products | |
| HY-N12613 | Sydowimide A | Natural Products | |
| HY-N12614 | Diorcinol | 20282-75-1 | Natural Products |
| HY-N12615 | Anti-inflammatory agent 75 | Natural Products | |
| HY-N12617 | Bipolaricin R | Natural Products | |
| HY-N12618 | Crocapeptin C | Natural Products | |
| HY-N12619 | 12R,13S-Dihydroxyfumitremorgin C | 111427-99-7 | Natural Products |
| HY-N1262 | Scutebarbatine W | 1312716-25-8 | Natural Products |
| HY-N12621 | Antifungal agent 91 | Natural Products | |
| HY-N12622 | AChE-IN-58 | Natural Products | |
| HY-N12625 | (R)-(+)-O-Demethylbuchenavianine | 1364123-68-1 | Natural Products |
| HY-N12625A | (S)-(-)-O-Demethylbuchenavianine | 91147-18-1 | Natural Products |
| HY-N1263 | Scutebarbatine X | 1312716-26-9 | Natural Products |
| HY-N12634 | Pregnant mare serum gonadotropin | 9002-70-4 | Natural Products |
| HY-N12635 | Levinoid C | Natural Products | |
| HY-N12636 | Kagimminol A | Natural Products | |
| HY-N12637 | Kagimminol B | Natural Products | |
| HY-N12638 | Endolide F | Natural Products | |
| HY-N12643 | Gingerdione | 61871-71-4 | Natural Products |
| HY-N12647 | cis-Hinkiresinol | 230292-85-0 | Natural Products |
| HY-N12648 | Anemarsaponin E1 | 1276608-19-5 | Natural Products |
| HY-N12649 | Timosaponin E2 | 222018-47-5 | Natural Products |
| HY-N1265 | Scutebata A | 1207181-57-4 | Natural Products |
| HY-N12650 | Kaempferol 3-O-alpha-L-(2, 3-di-Z-p-coumaroyl) rhamnoside | 1197343-21-7 | Natural Products |
| HY-N12651 | Bipolaroxin | 100665-30-3 | Natural Products |
| HY-N12652 | Homobotcinolide | 177182-59-1 | Natural Products |
| HY-N12653 | Exserohilone | 99572-22-2 | Natural Products |
| HY-N12654 | Irumamycin | 81604-73-1 | Natural Products |
| HY-N12655 | Pladienolide A | 445493-22-1 | Natural Products |
| HY-N12656 | Versipelostatin | 477201-98-2 | Natural Products |
| HY-N12657 | Retinestatin | Natural Products | |
| HY-N12659 | Thaumatin B | 428847-42-1 | Natural Products |
| HY-N12660 | Quorum sensing-IN-4 | Natural Products | |
| HY-N12664 | α-Glucosidase-IN-54 | 174284-54-9 | Natural Products |
| HY-N12669 | Curcumin monoglucoside | 387818-26-0 | Natural Products |
| HY-N1267 | Scutebata C | 1207181-59-6 | Natural Products |
| HY-N12670 | Egg oil | 8001-17-0 | Natural Products |
| HY-N12675 | Phoslactomycin F | 122856-30-8 | Natural Products |
| HY-N12676 | Phoslactomycin E | 159991-62-5 | Natural Products |
| HY-N12677 | Isocannflavin B | 199167-23-2 | Natural Products |
| HY-N12679 | Phoslactomycin D | 122856-28-4 | Natural Products |
| HY-N1268 | Scutebata E | 1207181-61-0 | Natural Products |
| HY-N12680 | Phoslactomycin B | 122856-26-2 | Natural Products |
| HY-N12681 | Phoslactomycin A | 159991-67-0 | Natural Products |
| HY-N12682 | Phoslactomycin C | 159991-59-0 | Natural Products |
| HY-N12683 | Phaseollinisoflavan | 40323-57-7 | Natural Products |
| HY-N12688 | 2,3-Dihydrocalodenin B | Natural Products | |
| HY-N12689 | α-Glucosidase-IN-56 | 26788-86-3 | Natural Products |
| HY-N1269 | Scutebata F | 1207181-62-1 | Natural Products |
| HY-N12690 | Withaphysalin E | 118985-24-3 | Natural Products |
| HY-N12691 | Antiviral agent 51 | 2165969-58-2 | Natural Products |
| HY-N12693 | Isobiflorin | 152041-16-2 | Natural Products |
| HY-N12694 | 3-O-Methylellagic acid-4′-O-α-L-rhamnopyranoside | 51768-39-9 | Natural Products |
| HY-N12695 | Altertoxin III | 105579-74-6 | Natural Products |
| HY-N12697A | Polycarpine (hydrochloride) | 175669-29-1 | Natural Products |
| HY-N12698 | (9Z)-Antheraxanthin | 68831-78-7 | Natural Products |
| HY-N1270 | Scutebata G | 1207181-63-2 | Natural Products |
| HY-N12700 | Puberulic acid Ⅰ | 99-23-0 | Natural Products |
| HY-N12702 | Volvalerenal E | 1247014-33-0 | Natural Products |
| HY-N12703 | N-Acetyldopamine dimmers A | 1519015-73-6 | Natural Products |
| HY-N12704 | N-Acetyldopamine dimers B | 482579-01-1 | Natural Products |
| HY-N12705A | Thermohexamine (hydrochloride) | Natural Products | |
| HY-N12706 | Heilaohuguosu G | 2763689-78-5 | Natural Products |
| HY-N12707 | Kadsurenin C | 145722-88-9 | Natural Products |
| HY-N12708 | 23-O-β-D-Glucopyranosyl-20-isoveratramine | 148440-62-4 | Natural Products |
| HY-N1271 | Scutellaric acid | 102919-76-6 | Natural Products |
| HY-N12710 | Crenatoside | 61276-16-2 | Natural Products |
| HY-N12711 | Calycosin 7-O-xylosylglucoside | 224957-12-4 | Natural Products |
| HY-N12712 | Heteroclitin I | 1011762-96-1 | Natural Products |
| HY-N12714 | Interiorin C | 133360-39-1 | Natural Products |
| HY-N12715 | Valerena-4,7(11)-diene | 351222-66-7 | Natural Products |
| HY-N12716 | Longipedunin A | 886441-72-1 | Natural Products |
| HY-N12717 | Casuarinin | 79786-01-9 | Natural Products |
| HY-N12718 | Campneoside I | 95519-12-3 | Natural Products |
| HY-N12719 | Isocampneoside I | 1119034-95-5 | Natural Products |
| HY-N1272 | Secaubryenol | 925932-08-7 | Natural Products |
| HY-N12720 | Cynanoside J | 1800029-53-1 | Natural Products |
| HY-N12722 | Ophiocordylongiiside A | Natural Products | |
| HY-N12723 | Talaroderxine D | Natural Products | |
| HY-N12724 | Stauntoside R | 2172321-58-1 | Natural Products |
| HY-N12725 | Heteroclitin E | 140369-77-3 | Natural Products |
| HY-N12726 | Halociline | 2977255-36-8 | Natural Products |
| HY-N12728 | Heteroclitin G | 144027-74-7 | Natural Products |
| HY-N12729 | Schiarisanrin B | 130252-43-6 | Natural Products |
| HY-N12730 | Euphoscopin B | 81557-52-0 | Natural Products |
| HY-N12731 | Epieuphoscopin B | 126372-45-0 | Natural Products |
| HY-N12732 | cis-Tonghaosu | 4575-53-5 | Natural Products |
| HY-N12733 | Chrysindin A | 1374852-85-3 | Natural Products |
| HY-N12734 | Pebrellin | 13509-93-8 | Natural Products |
| HY-N12735 | Hymenoxin | 56003-01-1 | Natural Products |
| HY-N12736 | Dehydrodanshenol A | 1444618-61-4 | Natural Products |
| HY-N12737 | 15-epi-Danshenol A | 216987-13-2 | Natural Products |
| HY-N12738 | 2′,4′,6′-Trimethoxy-3′-methylacetophenone | 39701-13-8 | Natural Products |
| HY-N12739 | Sibiriquinone A | 723300-08-1 | Natural Products |
| HY-N1274 | (rac)-Secodihydro-hydramicromelin B | 1212148-58-7 | Natural Products |
| HY-N12740 | Napyradiomycin B4 | Natural Products | |
| HY-N12742 | Tamarixetin 3-O-β-d-apiofuranosyl-(1 → 2)-β-d-galactopyranoside | Natural Products | |
| HY-N12743 | Farobin A | 1245447-08-8 | Natural Products |
| HY-N12744 | 2-O-trans-p-Coumaroylalphitolic acid | 67911-63-1 | Natural Products |
| HY-N12745 | 3-Epigitoxigenin | 465-10-1 | Natural Products |
| HY-N12746 | Lasiokaurinin | 52554-74-2 | Natural Products |
| HY-N12747 | Dichlorogelignate | 164030-91-5 | Natural Products |
| HY-N12748 | 17βH-Gitoxigenin | 4433-59-4 | Natural Products |
| HY-N12749 | 16-Anhydro Digitalin | 7044-34-0 | Natural Products |
| HY-N1275 | 1,4-O-Diferuloylsecoisolariciresinol | 56973-66-1 | Natural Products |
| HY-N1276 | Secoisolariciresinol Monoglucoside | 63320-67-2 | Natural Products |
| HY-N12760 | Lobophorin CR-2 | 1800562-59-7 | Natural Products |
| HY-N12761 | Penpaxilloids A | Natural Products | |
| HY-N12762 | DGTS | 1607456-57-4 | Biochemical Assay Reagents |
| HY-N12763 | Sodium new houttuyfonate | 112714-99-5 | Natural Products |
| HY-N12767 | Salixteroside D | Natural Products | |
| HY-N1277 | Dimethyl secologanoside | 74713-15-8 | Natural Products |
| HY-N12776 | Illudalic acid | 18508-77-5 | Natural Products |
| HY-N12777 | Coixenolide | 29066-43-1 | Natural Products |
| HY-N1278 | Selinidin | 19427-82-8 | Natural Products |
| HY-N12782 | Strospeside | 595-21-1 | Natural Products |
| HY-N12783 | Digitoxigenin-3-O-β-D-quinovoside | 40950-57-0 | Natural Products |
| HY-N12784 | (6S,9R)-2-Hydroxy-4-(2,6,6-trimethyl-4-oxo-cyclohex-2-enyl)-butyric acid | 2089289-59-6 | Natural Products |
| HY-N12785 | 1-Methoxy-2,3-methylenedioxyxanthone | 63625-05-8 | Natural Products |
| HY-N12786 | 1,3-Dihydroxy-2-methoxyxanthone | 87339-74-0 | Natural Products |
| HY-N12787 | T-Muurolol | 19912-62-0 | Natural Products |
| HY-N12788 | T-Cadinol | 5937-11-1 | Natural Products |
| HY-N12789 | (-)-Schiarisanrin D | 188943-88-6 | Natural Products |
| HY-N1279 | Semialactone | 366450-46-6 | Natural Products |
| HY-N12790 | Arisanschinin D | 1314021-69-6 | Natural Products |
| HY-N12791 | Heteroclitin F | 144049-67-2 | Natural Products |
| HY-N12792 | 5,8-Dihydroxy-3',4',6,7-tetramethoxyflavone | 683278-67-3 | Natural Products |
| HY-N12793 | 5,6-Dihydroxy-8-methoxyflavone-7-O-glucuronide | 1169879-99-5 | Natural Products |
| HY-N12794 | 1,2,3-Trimethoxyxanthone | 27460-10-2 | Natural Products |
| HY-N12799 | Digitalin | 752-61-4 | Natural Products |
| HY-N1280 | Semilicoisoflavone B | 129280-33-7 | Natural Products |
| HY-N12800 | Paeonicluside | 448231-30-9 | Natural Products |
| HY-N12801 | 3-Hydroxy-1,2-dimethoxyxanthone | 20362-27-0 | Natural Products |
| HY-N12802 | Tenacissimoside J | 1514895-60-3 | Natural Products |
| HY-N12803 | 2,5-Dihydroxy-7-methoxyflavanone | 35486-66-9 | Natural Products |
| HY-N12804 | δ-Cadinol | 19435-97-3 | Natural Products |
| HY-N12806 | Ananonin A | 1314021-67-4 | Natural Products |
| HY-N12807 | Tenuifoliose D | 139682-04-5 | Natural Products |
| HY-N12808 | (E)-4-Methyl-5-styrylbenzene-1,3-diol | 2407559-34-4 | Natural Products |
| HY-N12809 | Binankadsurin A | 77165-79-8 | Natural Products |
| HY-N1281 | Sendanolactone | 64929-59-5 | Natural Products |
| HY-N12810 | Sanggenon O | 101664-32-8 | Natural Products |
| HY-N12811 | Tenuifoliose B | 139682-02-3 | Natural Products |
| HY-N12812 | Tenuifoliose J | 147742-15-2 | Natural Products |
| HY-N12813 | Tenuifoliose K | 147742-16-3 | Natural Products |
| HY-N12814 | Tenuifoliose C | 139682-03-4 | Natural Products |
| HY-N12815 | Benzoyl oxokadsuranol | 130252-47-0 | Natural Products |
| HY-N12816 | Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside | 1021362-93-5 | Natural Products |
| HY-N12817 | Anti-inflammatory agent 80 | 2128277-55-2 | Natural Products |
| HY-N12819 | 5,7,8-Trihydroxy-6,3',4'-trimethoxyflavone | 205518-06-5 | Natural Products |
| HY-N1282 | Seneciphylline | 480-81-9 | Natural Products |
| HY-N12820 | 3-O-6-Deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-tenacigenin C | 863767-80-0 | Natural Products |
| HY-N12821 | visamminol-3'-O-glucoside | 2254096-98-3 | Natural Products |
| HY-N12823 | Caprazene | 740805-17-8 | Natural Products |
| HY-N1282R | Seneciphylline (Standard) | 480-81-9 | Reference Standards |
| HY-N1283 | Seneciphyllinine | 90341-45-0 | Natural Products |
| HY-N12831 | 6-Methoxykaempferol 3-glucoside | 63422-27-5 | Natural Products |
| HY-N12832 | Dihydrokaempferide | 137225-59-3 | Natural Products |
| HY-N12833 | Dihydrokaempferol-3-O-β-D-glucoside | 31049-08-8 | Natural Products |
| HY-N12834 | Ecdysoside B | 1887196-18-0 | Natural Products |
| HY-N12836 | Peniditerpenoid A | Natural Products | |
| HY-N12837 | 8-Epiloganin | 79172-04-6 | Natural Products |
| HY-N12838 | Glycerol-2-(3-methoxy-4-hydroxybenzoicacid)ether | 80677-81-2 | Natural Products |
| HY-N12839 | 1-(4-Hydroxyphenyl)-2,3-dihydroxypropan-1-one | 1824624-21-6 | Natural Products |
| HY-N1284 | Seneganolide | 301530-12-1 | Natural Products |
| HY-N12840 | Logmalicid B | 1638895-74-5 | Natural Products |
| HY-N12841 | Limocitrin 7-O-β-D-glucopyranoside | 119628-58-9 | Natural Products |
| HY-N12842 | 2-Deoxokanshone L | 1884590-18-4 | Natural Products |
| HY-N12843 | 2-Deoxokanshone M | 53859-07-7 | Natural Products |
| HY-N12844 | Pseudolaroside B | 906482-63-1 | Natural Products |
| HY-N12845 | Pseudolaroside A | 885111-85-3 | Natural Products |
| HY-N12846 | Neokadsuranic acid A | 123929-80-6 | Natural Products |
| HY-N12848 | 24-Hydroxycyasterone | 627511-34-6 | Natural Products |
| HY-N1285 | Senkyunolide C | 91652-78-7 | Natural Products |
| HY-N12851 | 4-OHE | 2492-43-5 | Natural Products |
| HY-N12853 | 6-Methoxynaringenin-7-O-β-D-glucoside | 1351949-09-1 | Natural Products |
| HY-N12854 | Azaleatin-3-rutinoside | 63764-79-4 | Natural Products |
| HY-N12855 | Mutabiloside | 1073235-22-9 | Natural Products |
| HY-N12856 | Cyclo-olivil-9-O-β-glucopyranoside | 1105067-02-4 | Natural Products |
| HY-N12858 | Makisterone B | 20512-31-6 | Natural Products |
| HY-N12859 | Herbacetin 3-O-glucopyranoside-8-O-glucuronopyranoside | 135010-45-6 | Natural Products |
| HY-N1286 | Senkyunolide G | 94530-85-5 | Natural Products |
| HY-N12860 | Gossypetin 3-O-β-D-glucopyranoside | 38965-52-5 | Natural Products |
| HY-N12861 | Sengosterone | 22799-11-7 | Natural Products |
| HY-N12862 | Floramanoside A | 1487423-38-0 | Natural Products |
| HY-N12863 | Myricetin-3-O-robinoside | 145544-43-0 | Natural Products |
| HY-N12864 | Isocyasterone | 54082-42-7 | Natural Products |
| HY-N12865 | Protocatechuic acid 3-O-β-D-glucopyranoside | 20300-54-3 | Natural Products |
| HY-N12866 | Monensin C | 31980-87-7 | Natural Products |
| HY-N12867 | Amarasterone A | 20853-88-7 | Natural Products |
| HY-N12868 | 25-Epi-28-epi-cyasterone | 851727-39-4 | Natural Products |
| HY-N1287 | Sepinol | 72061-63-3 | Natural Products |
| HY-N12870 | (7S,8R)-4,9,9'-Trihydroxy-3,3',5-trimethoxy-8,4'-oxyneolignan 4-O-β-D-glucopyranoside | 2247433-05-0 | Natural Products |
| HY-N12871 | Floramanoside D | 1487423-55-1 | Natural Products |
| HY-N12872 | (2R)-O-[4'-(3"-Hydroxypropyl)-2',6'-dimethoxyphenyl]-3-O-β-Dglucopyranosyl-sn-glycerol | 2264030-46-6 | Natural Products |
| HY-N12873 | (E,E,E,)-10,12,14-Hexadecatrienal | 123363-47-3 | Natural Products |
| HY-N12874 | (E,E,Z)-10,12,14-Hexadecatrienal | 123200-21-5 | Natural Products |
| HY-N12875 | Ailancoumarin E | Natural Products | |
| HY-N12876 | (18α)-Oleanolic acid | 6880-10-0 | Natural Products |
| HY-N12877 | Ophiobolin H | 90108-64-8 | Natural Products |
| HY-N12878 | Calleryanin | 20300-53-2 | Natural Products |
| HY-N12879 | (R)-10,14-Dimethylpentadecyl isobutyrate | 164260-03-1 | Natural Products |
| HY-N1288 | Sequirin C | 18194-29-1 | Natural Products |
| HY-N12880 | (10E,12Z)-10,12-Hexadecadien-1-ol | 1002-94-4 | Natural Products |
| HY-N12881 | (Z,E)-10,12-Hexadecadienal | 69977-23-7 | Natural Products |
| HY-N12882 | (Z)-10-Hexadecen-1-ol | 64437-48-5 | Natural Products |
| HY-N12883 | (E,E)-11,13-Hexadecadien-1-ol | 98010-23-2 | Natural Products |
| HY-N12884 | (11Z,13E)-Hexadecadien-1-ol | 111872-80-1 | Natural Products |
| HY-N12885 | (11Z,13E)-Hexadecadienal | 73264-89-8 | Natural Products |
| HY-N12886 | (11Z)-Hexadecen-7-yn-1-yl acetate | 53042-80-1 | Natural Products |
| HY-N12887 | Mycothiazole | 114582-75-1 | Natural Products |
| HY-N12888 | 4E,6Z,10Z-Hexadecatrien-1-ol | 101373-00-6 | Natural Products |
| HY-N12889 | (E,Z)-4,6-Hexadecadien-1-ol | 158734-36-2 | Natural Products |
| HY-N1289 | Sequosempervirin B | 864719-17-5 | Natural Products |
| HY-N12891 | (5E,7Z)-5,7-Dodecadienal | 75539-65-0 | Natural Products |
| HY-N12892 | 5,7-Dodecadien-1-ol | 71510-51-5 | Natural Products |
| HY-N12893 | Sclerodione | 104855-19-8 | Natural Products |
| HY-N12894 | (Z,E)-7,11-Hexadecadienyl acetate | 53042-79-8 | Natural Products |
| HY-N12895 | (Z,Z)-7,11-Hexadecadienyl acetate | 52207-99-5 | Natural Products |
| HY-N12896 | (7Z)-7-Hexadecen-1-ol | 24880-48-6 | Natural Products |
| HY-N12897 | JBIR-94 | 1354794-10-7 | Natural Products |
| HY-N12898 | (Z)-Tetradec-7-en-1-ol | 40642-43-1 | Natural Products |
| HY-N12899 | 9-trans-Hexadecenol | 64437-47-4 | Natural Products |
| HY-N1290 | Sequosempervirin D | 864719-19-7 | Natural Products |
| HY-N12900 | TDD | 55062-34-5 | Natural Products |
| HY-N12901 | Fiscalin C | 149008-36-6 | Natural Products |
| HY-N12902 | (E)-9-Hexadecenyl acetate | 56218-69-0 | Natural Products |
| HY-N12903 | Carnemycin B | 1391935-53-7 | Natural Products |
| HY-N12904 | Communesin B | 148439-46-7 | Natural Products |
| HY-N12905 | Celastramycin A (isomer) | 491600-94-3 | Natural Products |
| HY-N12906 | Pyrrocidine A | 428439-24-1 | Natural Products |
| HY-N12907 | 4′-Oxomacrophorin A | 349147-29-1 | Natural Products |
| HY-N12908 | Roridin H | 29953-50-2 | Natural Products |
| HY-N12909 | (Z,E)-9,12-Tetradecadienal | 87092-33-9 | Natural Products |
| HY-N12910 | (Z)-9-Hexadecenyl acetate | 34010-20-3 | Natural Products |
| HY-N12911 | Tanzawaic acid E | 289500-83-0 | Natural Products |
| HY-N12912 | cis-9-Hexadecen-1-yl formate | 56218-81-6 | Natural Products |
| HY-N12913 | Antibiotic WB | 247919-66-0 | Natural Products |
| HY-N12914 | Tanzawaic acid B | 169181-33-3 | Natural Products |
| HY-N12915 | SHP2-IN-29 | 2130080-86-1 | Natural Products |
| HY-N12916 | Dihydrogeodin | 2151-16-8 | Natural Products |
| HY-N12918 | Lewis X tetrasaccharide | 23425-36-7 | Natural Products |
| HY-N12919 | (E)-3-Dodecenol | 68900-87-8 | Natural Products |
| HY-N1292 | Serpentinic acid | 605-14-1 | Natural Products |
| HY-N12920 | (Z)-3-Dodecenyl acetate | 38363-24-5 | Natural Products |
| HY-N12921 | (E)-8-Dodecenol | 42513-42-8 | Natural Products |
| HY-N12922 | (E,E)-8,10-dodecadienyl acetate | 53880-51-6 | Natural Products |
| HY-N12923 | IB-96212 aglycone | 220766-98-3 | Natural Products |
| HY-N12924 | Ethyl 3-octenoate | 1117-65-3 | Natural Products |
| HY-N12926 | Cistantubuloside C1 | 620632-36-2 | Natural Products |
| HY-N1293 | Serpentinine | 36519-42-3 | Natural Products |
| HY-N12931 | Maackia amurensis Lectin (MAA/MAL II) | Dye Reagents | |
| HY-N12931F | Maackia amurensis Lectin (MAA/MAL II)-Biotinylated | Dye Reagents | |
| HY-N12932 | (E)-10-Dodecenyl acetate | 35153-09-4 | Natural Products |
| HY-N12933 | 11-Octadecenal | 56554-95-1 | Natural Products |
| HY-N12934 | Z13,YN11-16:OH | 75089-05-3 | Natural Products |
| HY-N12935 | (Z)-13-Hexadecen-11-ynyl acetate | 78617-58-0 | Natural Products |
| HY-N12936 | (Z)-5-Tetradecenyl acetate | 35153-13-0 | Natural Products |
| HY-N12937 | (Z)-7-Decenyl acetate | 13857-03-9 | Natural Products |
| HY-N12938 | (Z)-7-Hexadecenyl acetate | 23192-42-9 | Natural Products |
| HY-N12939 | (11Z,13Z)-Hexadecadien-1-ol | 71720-83-7 | Natural Products |
| HY-N1294 | Serratenediol | 2239-24-9 | Natural Products |
| HY-N12941 | Macarangin | 129385-65-5 | Natural Products |
| HY-N12951 | Diosmetin 6,8-di-C-glucoside | 98813-28-6 | Natural Products |
| HY-N12952 | Falcarinolone | 18089-23-1 | Natural Products |
| HY-N12953 | Glucoalyssin | 499-37-6 | Natural Products |
| HY-N12953R | Glucoalyssin (Standard) | 499-37-6 | Reference Standards |
| HY-N12954 | (R)-Mucronulatol | 57128-11-7 | Natural Products |
| HY-N12955 | 8(R),9(S)-EET | 129172-62-9 | Natural Products |
| HY-N12958 | Uvarialeptone C | Natural Products | |
| HY-N12959 | 5,4'-Dihydroxy-6,8-dimethoxy-7-O-rhamnosyl flavone | 927406-46-0 | Natural Products |
| HY-N12960 | Artobiloxanthone | Natural Products | |
| HY-N12961 | Vulgaxanthin I | 904-62-1 | Natural Products |
| HY-N12962 | 11S(12R)-EET | 123931-40-8 | Natural Products |
| HY-N12962A | 11R(12S)-EET | 123931-38-4 | Natural Products |
| HY-N12963 | Quercetin-3,7-di-O-a-rhamnopyranoside | 28638-13-3 | Natural Products |
| HY-N12964 | 4-Hydroxycanthin-6-one | 106941-27-9 | Natural Products |
| HY-N12966 | (±)9,10-DiHODE | 1400693-71-1 | Natural Products |
| HY-N12968 | R-(-)-Columbianetin | 52842-47-4 | Natural Products |
| HY-N1297 | Sesartemin | 77394-27-5 | Natural Products |
| HY-N12970 | 14S(15R)-EET | 105304-92-5 | Natural Products |
| HY-N12973 | Peonidin 3-arabinoside | 27214-74-0 | Natural Products |
| HY-N12974 | Glucoconringiin | 28463-28-7 | Natural Products |
| HY-N12977 | Dipropenyl sulfide | 33922-80-4 | Natural Products |
| HY-N12978 | Benzyl β-gentiobioside | 56775-64-5 | Natural Products |
| HY-N12979 | γ-Gurjunene | 22567-17-5 | Natural Products |
| HY-N1298 | Sessilifoline A | 929637-35-4 | Natural Products |
| HY-N12980 | 4-O-p-Coumaroylquinic acid | 53539-37-0 | Natural Products |
| HY-N12982 | α-Calacorene | 21391-99-1 | Natural Products |
| HY-N12986 | Glucobrassicanapin | 19041-10-2 | Natural Products |
| HY-N12987 | Caffeoylcalleryanin | 20300-49-6 | Natural Products |
| HY-N12988 | Dihydrobonducellin | 103680-87-1 | Natural Products |
| HY-N12989 | 3′-O-Demethylarctigenin | 147022-95-5 | Natural Products |
| HY-N1299 | Shizukanolide C | 78749-47-0 | Natural Products |
| HY-N12991 | Picraquassioside B | 169312-05-4 | Natural Products |
| HY-N12992 | (3R)-3′,8-Dihydroxyvestitol | 122587-87-5 | Natural Products |
| HY-N12995 | α-Bulnesene | 3691-11-0 | Natural Products |
| HY-N12996 | Sitosterone | 67392-96-5 | Natural Products |
| HY-N12997 | Torachrysone 8-O-β-D-glucoside | 245724-09-8 | Natural Products |
| HY-N12998 | Torachrysone tetraglucoside | 245724-10-1 | Natural Products |
| HY-N1300 | Shizukanolide F | 120061-96-3 | Natural Products |
| HY-N13008 | 4-Hydroxy-sterigmatocystin | Natural Products | |
| HY-N1301 | Shizukaol C | 142279-41-2 | Reference compound |
| HY-N13014 | Indole-3-acetyl β-D-glucopyranose | 19817-95-9 | Natural Products |
| HY-N13014S2 | Indole-3-acetyl β-D-glucopyranose-d4 | Isotope-Labeled Compounds | |
| HY-N13015 | Quercetin 5-O-β-D-glucopyranoside | 34199-21-8 | Natural Products |
| HY-N13017 | Bhimanone | 701915-56-2 | Natural Products |
| HY-N13018 | M145724 | 90806-04-5 | Natural Products |
| HY-N13019 | Elmycin D | 169107-03-3 | Natural Products |
| HY-N1302 | Shizukaol D | 142279-42-3 | Natural Products |
| HY-N13020 | Scleropentaside D | 1360110-49-1 | Natural Products |
| HY-N13021 | 2-(2-Hydroxy-5-methoxyphenoxy)-acrylic acid | 79458-62-1 | Natural Products |
| HY-N13022 | Humic acid | 1415-93-6 | Natural Products |
| HY-N13024 | Radulone A | 221374-79-4 | Natural Products |
| HY-N13025 | 8-Acetylverrucarin L | 77101-88-3 | Natural Products |
| HY-N1303 | Shoreic acid | 21671-00-1 | Natural Products |
| HY-N13031 | Bellericagenin A | 141630-18-4 | Natural Products |
| HY-N13033 | p-Coumaryl alcohol 4-O-glucoside | 120442-73-1 | Natural Products |
| HY-N13036 | Isoorientin-7-O-[6-sinapoyl]-glucoside | 1016970-96-9 | Natural Products |
| HY-N13037 | Isovitexin 7-O-rutinoside | 212271-10-8 | Natural Products |
| HY-N13038 | Isovitexin-7-O-[6-feruloyl]-glucoside-4'-O-glucoside | 1016970-92-5 | Natural Products |
| HY-N13039 | Isoorientin-7-O-rutinoside | 35450-87-4 | Natural Products |
| HY-N1304 | Shyobunone | 21698-44-2 | Natural Products |
| HY-N13040 | Isoscoparin-7-O-glucoside | 50307-26-1 | Natural Products |
| HY-N13041 | Acacetin 7-O-(6-O-malonylglucoside) | 155049-92-6 | Natural Products |
| HY-N13047 | Ningnanmycin | 156410-09-2 | Natural Products |
| HY-N1305 | Sideritoflavone | 70360-12-2 | Natural Products |
| HY-N13057 | cis-Moschamine | 193224-24-7 | Natural Products |
| HY-N1306 | Sideroxylin | 3122-87-0 | Natural Products |
| HY-N13061 | Nervon | 17283-91-9 | Natural Products |
| HY-N13062 | Morusimic acid A | 455949-42-5 | Natural Products |
| HY-N13063 | Anticancer agent 235 | 2411108-21-7 | Natural Products |
| HY-N1307 | Sideroxylonal A | 145382-68-9 | Natural Products |
| HY-N13070 | 3β-Acetoxy-5α-lanosta-8,24-dien-21-oic acid | 117895-68-8 | Natural Products |
| HY-N13071 | 3α-Acetyl-20(29)-lupene-24-oic acid | 412942-35-9 | Natural Products |
| HY-N13073 | 6-Gingediol | 39886-85-6 | Natural Products |
| HY-N13075 | Mycoplanecin A | 72993-51-2 | Natural Products |
| HY-N13076 | Neo-sagittasine A | 1804014-67-2 | Natural Products |
| HY-N13077 | 3-Oxo-resibufogenin | 62859-80-7 | Natural Products |
| HY-N13078 | 3-epi-Resibufogenin | Natural Products | |
| HY-N13079 | 3-Epicinobufagin | 36121-84-3 | Natural Products |
| HY-N1308 | Simiarenol | 1615-94-7 | Natural Products |
| HY-N13080 | 3-Oxo-bufalin | 4029-65-6 | Natural Products |
| HY-N13081 | 3-Oxo-cinobufagin | 6869-66-5 | Natural Products |
| HY-N13082 | Deacetylescin Ia | 254896-53-2 | Natural Products |
| HY-N13083 | PCSK9-IN-28 | Natural Products | |
| HY-N13084 | 4''-O-Acetylsaikosaponin A | 102934-40-7 | Natural Products |
| HY-N13086 | Peniviridiol A | Natural Products | |
| HY-N13088 | Hyperidione D | Natural Products | |
| HY-N13089 | Pyrethrolone | 487-67-2 | Natural Products |
| HY-N1309 | Simiarenol acetate | 4965-99-5 | Natural Products |
| HY-N13090 | Hydrocotoin | 34425-64-4 | Natural Products |
| HY-N13093 | (7R,8R)-Threo-7,9,9′-trihydroxy-3,3′-dimethoxy-8-O-4′-neolignan -4-O-β-D-glucopyranoside | 1009838-88-3 | Natural Products |
| HY-N13094 | (7S,8S)-Threo-7,9,9′-trihydroxy-3,3′-dimethoxy-8-O-4′-neolignan-4-O-β-D-glucopyranoside | 1009838-87-2 | Natural Products |
| HY-N13095 | (+)-Plakevulin A | 518035-27-3 | Natural Products |
| HY-N13096 | Acacetin-7-O-(3-O-malonyl)-β-D-glucopyranoside | 1588563-85-2 | Natural Products |
| HY-N13097 | Cinerolone | 17190-74-8 | Natural Products |
| HY-N13098 | Elatoside F | 144118-18-3 | Natural Products |
| HY-N1310 | Simiarenone | 2318-78-7 | Natural Products |
| HY-N13100 | Colocynthin | 1398-78-3 | Natural Products |
| HY-N13100R | Colocynthin (Standard) | 1398-78-3 | Reference Standards |
| HY-N13103 | Sagittasine A | 957678-53-4 | Natural Products |
| HY-N13104 | Dracaenoside F | 109460-83-5 | Natural Products |
| HY-N13105 | Camelliagenin A 16-tiglate | 87387-63-1 | Natural Products |
| HY-N13106 | Camelliagenin A 22-angelate | 60419-37-6 | Natural Products |
| HY-N13107 | Saikochromone A | 132624-99-8 | Natural Products |
| HY-N13108 | 8-Formylophiopogonone B | 1316224-74-4 | Natural Products |
| HY-N13109 | Caprarioside | 1151862-69-9 | Natural Products |
| HY-N1311 | Simonsinol | 155709-40-3 | Natural Products |
| HY-N13110 | 23-Aldehyde-16-O-angeloybarringtogenol C | 1841090-13-8 | Natural Products |
| HY-N13111 | Neoliensinine | Natural Products | |
| HY-N13114 | 8-Gingerdione | 77334-06-6 | Natural Products |
| HY-N13115 | 21-Angeloyl-protoaescigenin | 35931-54-5 | Natural Products |
| HY-N13115A | Protoescigenin 21-tiglate | 7047-43-0 | Natural Products |
| HY-N13116 | 3-O-(2",3"-Dimethylbutanoyl)-13-O-decanoylingenol | 76663-56-4 | Natural Products |
| HY-N13117 | Pinocembrin 7-O-[4′′,6′′-(S)-HHDP]-β-D-glucoside | 205370-58-7 | Natural Products |
| HY-N13118 | Sinopodophylline B | 1369959-47-6 | Natural Products |
| HY-N1312 | Sinapaldehyde | 4206-58-0 | Natural Products |
| HY-N13120 | Tenacissoside A | 107352-30-7 | Natural Products |
| HY-N13121 | Daphnegiravone D | 2581826-37-9 | Natural Products |
| HY-N13122 | Tenacissoside B | 107424-13-5 | Natural Products |
| HY-N13123 | Tenacissoside C | 107347-58-0 | Natural Products |
| HY-N13125 | Tenacissoside E | 107347-56-8 | Natural Products |
| HY-N13126 | Marsdenoside K | 872993-77-6 | Natural Products |
| HY-N13127 | Segetalin C | 164991-90-6 | Natural Products |
| HY-N13128 | Icaritin-3-O-rhamnoside | 108195-76-2 | Natural Products |
| HY-N13129 | Koreanoside G | 2348441-29-0 | Natural Products |
| HY-N1313 | Sarcandrone B | 1190225-48-9 | Natural Products |
| HY-N13132 | Hellicoside | 132278-04-7 | Natural Products |
| HY-N13133 | Tuberostemonine D | 1627827-84-2 | Natural Products |
| HY-N13134 | Kadsutherin F | 2692637-03-7 | Natural Products |
| HY-N13135 | Kadsutherin G | 2692637-23-1 | Natural Products |
| HY-N13136 | Timosaponin D | 220095-97-6 | Natural Products |
| HY-N13137 | Timosaponin N | 1010804-67-7 | Natural Products |
| HY-N13138 | Angulasaponin B | 1628031-59-3 | Natural Products |
| HY-N13139 | Dexylosyltubeimoside Ⅲ | Natural Products | |
| HY-N1314 | Sarcandrone A | 1190225-47-8 | Natural Products |
| HY-N13142 | Luteolin 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside | 211561-67-0 | Natural Products |
| HY-N13143 | Calenduloside H | 26020-29-1 | Natural Products |
| HY-N13144 | Entagenic acid | 5951-41-7 | Natural Products |
| HY-N13145 | Azukisaponin II | 82793-03-1 | Natural Products |
| HY-N13146 | Azukisaponin VI | 82801-39-6 | Natural Products |
| HY-N13147 | Tetromycin C5 | 205433-86-9 | Natural Products |
| HY-N13149 | Tetromycin C1 | 205433-82-5 | Natural Products |
| HY-N1315 | Sarcandrolide D | 1207185-03-2 | Natural Products |
| HY-N13150 | N-Demethylvancomycin | 91700-98-0 | Natural Products |
| HY-N13150A | N-Demethylvancomycin (hydrochloride) | 198774-23-1 | Natural Products |
| HY-N13151 | 3-GlcA-28-AraRhaxyl-medicagenate | 128192-15-4 | Natural Products |
| HY-N13152 | Dihydrotrichotetronine | 199729-13-0 | Natural Products |
| HY-N13153 | Antioxidant agent-19 | 146564-36-5 | Natural Products |
| HY-N13154 | Malolactomycin C | 189759-03-3 | Natural Products |
| HY-N13156 | Amycolatopsin B | 2209112-97-8 | Natural Products |
| HY-N13157 | 11α-O-Benzoyl-12β-O-acetyltenacigenin B | 154022-52-3 | Natural Products |
| HY-N13158 | 11α-O-Actety-12β-O-tigloyl Tenacissoside A | 1070901-03-9 | Natural Products |
| HY-N13159 | Goodyeroside A | 211107-44-7 | Natural Products |
| HY-N1316 | Saprirearine | 453518-30-4 | Natural Products |
| HY-N13160 | Sanggenon F | 85889-03-8 | Natural Products |
| HY-N13161 | 28-Hydroxy-12-oleanen-3-one | 18100-50-0 | Natural Products |
| HY-N13162 | Hemsleyadin D | 586960-44-3 | Natural Products |
| HY-N13163 | 2-Epitripdiolide | 74409-90-8 | Natural Products |
| HY-N13164 | Polygalacin D3 | 849758-44-7 | Natural Products |
| HY-N13165A | Verticilla-4(20),7,11-triene | 386223-19-4 | Natural Products |
| HY-N13166 | Lycibarbarphenylpropanoid B | 1988786-72-6 | Natural Products |
| HY-N13167 | 3-Keto-tirucall-8,24-dien-21-oic acid | Natural Products | |
| HY-N13169 | Quercetin 3-O-(6-O-malonyl-β-D-galactoside) | 84392-08-5 | Natural Products |
| HY-N1317 | Salirepin | 26652-12-0 | Natural Products |
| HY-N13170 | Glycoside H2 | 73529-43-8 | Natural Products |
| HY-N13173 | α-Glucosidase-IN-70 | 136832-00-3 | Natural Products |
| HY-N13174 | Peanut procyanidin A | 1802175-67-2 | Natural Products |
| HY-N13175 | Panaxcerol B | 171520-42-6 | Natural Products |
| HY-N13176 | Stellettin B | 184885-91-4 | Natural Products |
| HY-N13177 | 25(S)Ruscogenin 3-O-α-L-rhamnopyranoside | 1869126-66-8 | Natural Products |
| HY-N13178 | Multiflorin | 157744-28-0 | Natural Products |
| HY-N13179 | Wilforic acid A | 193684-74-1 | Natural Products |
| HY-N1318 | Salvigenin | 19103-54-9 | Natural Products |
| HY-N13180 | 8,3′-Dihydroxy-7,4′-dimethoxyisoflavone | 210413-43-7 | Natural Products |
| HY-N13181 | 2-(3',4'-Dihydroxyphenyl)-1,3-benzodioxole-5-aldehyde | 213903-67-4 | Natural Products |
| HY-N13182 | Taxoquinone | 21764-41-0 | Natural Products |
| HY-N13183 | Hesperetin dihydrochalcone-4′-O-β-D-glucoside | 21940-36-3 | Natural Products |
| HY-N13184 | Giraldoid B | 2300952-67-2 | Natural Products |
| HY-N13185 | POPi | 769160-81-8 | Natural Products |
| HY-N13186 | δ-(E)-Deoxy-amplexichromanol | 1639050-37-5 | Natural Products |
| HY-N13187 | 7,3'-Dihydroxy flavonone-4'-O-β-D-glucopyranoside | 1442113-42-9 | Natural Products |
| HY-N13188 | 2'-Rhamnoechinacoside | 1422390-59-7 | Natural Products |
| HY-N13189 | cis-N-(4-Hydroxystyryl)benzamide | 115722-47-9 | Natural Products |
| HY-N1318S | Salvigenin-d9 | Isotope-Labeled Compounds | |
| HY-N1319 | Salvisyrianone | 250691-57-7 | Natural Products |
| HY-N13190 | (2R)-Eriodictyol-7-O-β-D-glucopyranoside | 1021946-00-8 | Natural Products |
| HY-N13191 | Ingenol 3-monobenzoate | 83036-64-0 | Natural Products |
| HY-N13192 | 3-Acetoxyflavone | 7578-68-9 | Natural Products |
| HY-N13193 | Pterosin A-2-O-glucoside | 504432-96-6 | Natural Products |
| HY-N13194 | (2R)-Pteroside B | 29774-74-1 | Natural Products |
| HY-N13195 | (15α)-15,26-Dihydroxylanosta-7,9(11),24-trien-3-one | 420781-85-7 | Natural Products |
| HY-N13196 | Arcopilin A | Natural Products | |
| HY-N13197 | 5,6-Dihydro-6-methyl-2H-pyran-2-one | 108-54-3 | Natural Products |
| HY-N13198 | 4-(4-Hydroxyphenyl)-2-butanone 4'-O-β-D-(2-O-galloyl-6-O-cinnamoyl)glucopyranoside | 356517-93-6 | Natural Products |
| HY-N13199 | 3-O-Dihydro-p-coumaroyltohogenol | Natural Products | |
| HY-N1320 | Sambutoxin | 160047-56-3 | Natural Products |
| HY-N13200 | Cranberry Extract | Natural Products | |
| HY-N13202 | Black Currant Extract | Natural Products | |
| HY-N13203 | Black Rice Extract | Natural Products | |
| HY-N13204 | Black Bean Hull Extract | Natural Products | |
| HY-N13205 | Mulberry Extract | Natural Products | |
| HY-N13206 | Elderberry Extract | Natural Products | |
| HY-N13207 | Acai Berry Extract | Natural Products | |
| HY-N13208 | Stevia Powder | Natural Products | |
| HY-N13209 | Epimedium Extract | Natural Products | |
| HY-N1321 | Samidin | 477-33-8 | Natural Products |
| HY-N13210 | Raspberry Extract | Natural Products | |
| HY-N13211 | Tribulus Terrestris Extract | Natural Products | |
| HY-N13212 | Wolfberry Extract | Natural Products | |
| HY-N13213 | Fenugreek Seed Extract | Natural Products | |
| HY-N13214 | Maca Extract (10:1) | Natural Products | |
| HY-N13215 | Tongkat Ali Extract | Natural Products | |
| HY-N13216 | Red Clover Extract | Natural Products | |
| HY-N13217 | Black Cohosh Extract | Natural Products | |
| HY-N13218 | Pueraria Extract | Natural Products | |
| HY-N13219 | Angelica Extract | Natural Products | |
| HY-N1322 | Sanggenol A | 174423-30-4 | Natural Products |
| HY-N13220 | Soybean Extract | Natural Products | |
| HY-N13221 | Apple Cider Vinegar Powder | Natural Products | |
| HY-N13222 | Lotus Leaf Extract | Natural Products | |
| HY-N13223 | White Kidney Bean Extract (10:1) | Natural Products | |
| HY-N13223A | White Kidney Bean Extract (30:1) | Natural Products | |
| HY-N13224 | Siberian Ginseng Extract | Natural Products | |
| HY-N13225 | Hops Flower Extract | Natural Products | |
| HY-N13226 | Lemon Balm Extract | Natural Products | |
| HY-N13227 | Valerian Extract | Natural Products | |
| HY-N13228 | St John's Wort Extract | Natural Products | |
| HY-N13229 | Green Tea Extract | Natural Products | |
| HY-N1323 | Sanggenol P | 1351931-30-0 | Natural Products |
| HY-N13230 | Rose Hips Extract | Natural Products | |
| HY-N13232 | Grape Skin Extract | Natural Products | |
| HY-N13233 | Pine Bark Extract | Natural Products | |
| HY-N13234 | Pomegranate Extract | Natural Products | |
| HY-N13235 | Garlic Extract | Natural Products | |
| HY-N13236 | Echinacea Purpurea Extract | Natural Products | |
| HY-N13238 | White Willow Bark Extract | Natural Products | |
| HY-N13239 | Dandelion Extract | Natural Products | |
| HY-N1324 | Sanggenon N | 92280-12-1 | Natural Products |
| HY-N13240 | Ginseng Extract | Natural Products | |
| HY-N13241 | Rhodiola Rosea Extract | Natural Products | |
| HY-N13242 | Cinnamon Bark Extract | Natural Products | |
| HY-N13243 | Reishi Mushroom Extract | Natural Products | |
| HY-N13245 | Milk Thistle Extract | Natural Products | |
| HY-N13246 | Cyanotis Arachnoidea Extract | Natural Products | |
| HY-N13247 | Ajuga Turkestanica Extract | Natural Products | |
| HY-N13248 | Mulberry Leaf Extract | Natural Products | |
| HY-N13249 | Horsetail Extract | Natural Products | |
| HY-N1325 | Sanshodiol | 54854-91-0 | Natural Products |
| HY-N13250 | Hawthorn Extract | Natural Products | |
| HY-N13251 | Verbena Extract | Natural Products | |
| HY-N13252 | Phellodendron Amurense Extract | Natural Products | |
| HY-N13253 | Celery Seed Extract | Natural Products | |
| HY-N13254 | Moringa Extract | Natural Products | |
| HY-N13255 | Withacnistin | 21902-99-8 | Natural Products |
| HY-N13258 | β-Citryl-L-glutamic acid | 73590-26-8 | Natural Products |
| HY-N13259 | Fluopsin C | 31323-25-8 | Natural Products |
| HY-N1326 | Santamarine | 4290-13-5 | Natural Products |
| HY-N13262 | Dactyllactone A | 2226393-57-1 | Natural Products |
| HY-N13267 | (-)-cis-Myrtanol | 51152-12-6 | Natural Products |
| HY-N1327 | Quinamine | 464-85-7 | Natural Products |
| HY-N13270 | Aquilegiolide | 94481-79-5 | Natural Products |
| HY-N13273 | Menisdaurilide | 67765-59-7 | Natural Products |
| HY-N13278 | 2-Acetyl-2-decarboxamidotetracycline | 6542-44-5 | Natural Products |
| HY-N13284 | 13-Hydroxy-9-octadecenoic acid | 324575-43-1 | Natural Products |
| HY-N13286 | Glycozolidal | 51971-09-6 | Natural Products |
| HY-N13288 | Cordysinin C/D | 148683-93-6 | Natural Products |
| HY-N13289 | 12β-Hydroxyresibufogenin | 2042-58-2 | Natural Products |
| HY-N1329 | Rutaretin | 13895-92-6 | Natural Products |
| HY-N13290 | 10-Chloroestra-1,4-diene-3,17-dione | 91413-55-7 | Natural Products |
| HY-N13291 | 6-O-Methylreticulol | 24350-93-4 | Natural Products |
| HY-N13292 | Actinorhodin | 1397-77-9 | Natural Products |
| HY-N13293 | Isopaynantheine | 22032-51-5 | Natural Products |
| HY-N13294 | Cernuumolide J | 2019163-02-9 | Natural Products |
| HY-N13295 | Indole-3-lactate-O-β-D-glucopyranoside | 143884-93-9 | Natural Products |
| HY-N13299 | Glucoberteroin | 29611-01-6 | Natural Products |
| HY-N1330 | Rubranol | 211126-61-3 | Natural Products |
| HY-N13301 | Aloe vera | 85507-69-3 | Natural Products |
| HY-N13302 | Cedrene | 11028-42-5 | Natural Products |
| HY-N13303 | Quercetin 7-O-(6''-O-malonyl)-beta-D-glucoside | 98767-37-4 | Natural Products |
| HY-N13304 | Epischisandrone | 98619-26-2 | Natural Products |
| HY-N13305 | Aristolactam AIa | 97399-90-1 | Natural Products |
| HY-N13306 | Quercetin 3-Caffeylrobinobioside | 957110-26-8 | Natural Products |
| HY-N13307 | 15-Deoxypulic acid | 95523-05-0 | Natural Products |
| HY-N13308 | 8-Hydroxy-ar-turmerone | 949081-09-8 | Natural Products |
| HY-N13309 | Torosachrysone 8-O-beta-gentiobioside | 94356-13-5 | Natural Products |
| HY-N1331 | Rubiprasin B | 125263-66-3 | Natural Products |
| HY-N13310 | 5-Hydroxy-7,8-dimethoxy (2R)-flavanone-5-O-beta-D-glucopyranoside | 942626-74-6 | Natural Products |
| HY-N13311 | 20-Dehydroeupatoriopicrin semiacetal | 94234-24-9 | Natural Products |
| HY-N13312 | Polygalin C | 934768-05-5 | Natural Products |
| HY-N13313 | Isolappaol C | 929905-15-7 | Natural Products |
| HY-N13314 | Magnaldehyde B | 92829-72-6 | Natural Products |
| HY-N13315 | Otophylloside J | 1015447-50-3 | Natural Products |
| HY-N13316 | Deltatsine | 92631-66-8 | Natural Products |
| HY-N13317 | Otophylloside H | 1015447-48-9 | Natural Products |
| HY-N13318 | Otophylloside L | 1015447-52-5 | Natural Products |
| HY-N13319 | 2'-Hydroxy-3',4',6'-trimethoxychalcone | 91856-16-5 | Natural Products |
| HY-N1332 | Rubiprasin A | 125263-65-2 | Natural Products |
| HY-N13320 | Rosmarinyl glucoside | 910028-78-3 | Natural Products |
| HY-N13321 | Vicinin 2 | 90456-53-4 | Natural Products |
| HY-N13322 | 7-Xylosyltaxol B | 90352-19-5 | Natural Products |
| HY-N13323 | Ylangenyl acetate | 90039-63-7 | Natural Products |
| HY-N13324 | Polygalasaponin E | 882664-72-4 | Natural Products |
| HY-N13325 | 2-Methoxyfuranoguaia-9-ene-8-one | 88010-62-2 | Natural Products |
| HY-N13326 | 3,4,5'-Trimethoxy-3',4'-methylenedioxy-7,9':7',9-diepoxylignan | 873867-94-8 | Natural Products |
| HY-N13327 | 3-Methoxyoxohernandaline | 872729-34-5 | Natural Products |
| HY-N13328 | 3',5'-Dimethoxybiphenyl-3-ol | 868666-20-0 | Natural Products |
| HY-N13329 | Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside | 868557-54-4 | Natural Products |
| HY-N1333 | Rubioncolin C | 132242-52-5 | Natural Products |
| HY-N13333 | Sphenanlignan | 866347-36-6 | Natural Products |
| HY-N13334 | 5,19-Epoxy-19S,25-dimethoxycucurbita-6,23-dien-3-ol | 85372-70-9 | Natural Products |
| HY-N13335 | 6-Methyl-7-O-methylaromadendrin | 852385-13-8 | Natural Products |
| HY-N13337 | threo-Guaiacylglycerol-beta-O-4'-dehydrodisinapyl ether | 844637-85-0 | Natural Products |
| HY-N1334 | Rubifolic acid | 80489-65-2 | Natural Products |
| HY-N13340 | Glaucoside C | 81474-89-7 | Natural Products |
| HY-N13341 | N-Methylcorydalmine(chloride) | 81010-29-9 | Natural Products |
| HY-N13342 | Aegineoside | 752209-48-6 | Natural Products |
| HY-N13343 | 1-Methoxycarbonyl-beta-carboline-N-oxide | 74690-74-7 | Natural Products |
| HY-N13344 | Orientalide | 72704-05-3 | Natural Products |
| HY-N13346 | Camaldulenic acid | 71850-15-2 | Natural Products |
| HY-N13347 | Cyclo(Pro-Trp) | 67889-75-2 | Natural Products |
| HY-N13348 | Emodin-8-O-beta-gentiobioside | 66466-22-6 | Natural Products |
| HY-N13349 | 5α-Hydroxychloranthalactone A | 66395-04-8 | Natural Products |
| HY-N1335 | Rubiarbonol B | 130288-60-7 | Natural Products |
| HY-N13350 | 1,5,6-Trihydroxy-3,7-dimethoxyxanthone | 65008-02-8 | Natural Products |
| HY-N13351 | Isomargaritene | 64271-11-0 | Natural Products |
| HY-N13353 | Margaritene | 64271-10-9 | Natural Products |
| HY-N13354 | Thalirugidine | 64215-95-8 | Natural Products |
| HY-N13357 | Rhamnetin 3-galactoside | 62858-07-5 | Natural Products |
| HY-N13358 | Pterodonoic acid | 62458-42-8 | Natural Products |
| HY-N13359 | Lappaol B | 62359-60-8 | Natural Products |
| HY-N1336 | Rubianthraquinone | 644967-44-2 | Natural Products |
| HY-N13360 | cis-epsilon-Viniferin | 62250-12-8 | Natural Products |
| HY-N13361 | Elodeoidileon A | Natural Products | |
| HY-N13362 | Annphenone | 61775-18-6 | Natural Products |
| HY-N13363 | 2-Keto-3-deoxy-6-phosphogluconate | 27244-54-8 | Natural Products |
| HY-N13364 | 3-Hydroxy-1,5-diphenyl-1-pentanone | 60669-64-9 | Natural Products |
| HY-N13365 | 1,10β-Epoxy-6β-isobutanoyloxy-9-oxofuranoeremophilane | 59742-11-9 | Natural Products |
| HY-N13366 | 3-Methylcrotonyl CoA | 6712-03-4 | Natural Products |
| HY-N13367 | 16-Oxoprometaphanine | 58738-31-1 | Natural Products |
| HY-N13368 | yfj | 58493-71-3 | Natural Products |
| HY-N13369 | Tessaric acid | 58142-10-2 | Natural Products |
| HY-N1337 | Rubelloside B | 167875-39-0 | Natural Products |
| HY-N13370 | 16-Deoxysaikogenin F | 57475-62-4 | Natural Products |
| HY-N13371 | Cyclo(Leu-Val) | 5625-50-3 | Natural Products |
| HY-N13372 | Cyclo(Tyr-Gly) | 5625-49-0 | Natural Products |
| HY-N13373 | Mirificin-4'-O-glucoside | 168035-01-6 | Natural Products |
| HY-N13374 | Stigmasta-4,22-diene-3beta,6beta-diol | 167958-89-6 | Natural Products |
| HY-N13375 | 3,4-O-dimethylcedrusin | 166021-14-3 | Natural Products |
| HY-N13376 | Lyciumamide B | 1647111-41-8 | Natural Products |
| HY-N13377 | Leachianol G | 164204-62-0 | Natural Products |
| HY-N13378 | Leachianol F | 164123-50-6 | Natural Products |
| HY-N13379 | Prionanthoside | 161842-81-5 | Natural Products |
| HY-N1338 | Royleanone | 6812-87-9 | Natural Products |
| HY-N13380 | 6′‐O‐Galloylsalidroside | 83013-86-9 | Natural Products |
| HY-N13381 | 7-O-Prenylscopoletin | 13544-37-1 | Natural Products |
| HY-N13382 | 15-Methoxy-16-oxo-15,16H-strictic acid | 1356388-38-9 | Natural Products |
| HY-N13383 | Quercetin 3,5,3'-trimethyl ether | 13459-09-1 | Natural Products |
| HY-N13384 | Schisphenin E | 1311376-52-9 | Natural Products |
| HY-N13385 | Stevioside D | 1310055-59-4 | Natural Products |
| HY-N13386 | Tigloylgomisin O | 130855-74-2 | Natural Products |
| HY-N13387 | Fargesol | 128855-64-1 | Natural Products |
| HY-N13389 | 2'-O-Methylbroussonin A | 127757-13-5 | Natural Products |
| HY-N1339 | Rosthornin B | 125181-21-7 | Natural Products |
| HY-N13390 | 24(31)-Dehydrocarboxyacetylquercinic acid | 127970-62-1 | Natural Products |
| HY-N13391 | Methylgomisin O | 1276654-07-9 | Natural Products |
| HY-N13392 | Benzoylmesaconine (hydrochloride) | 126266-38-4 | Natural Products |
| HY-N13393 | Licoarylcoumarin | 125709-31-1 | Natural Products |
| HY-N13394 | 6-Demethoxy-9'-deoxycleomiscosin A | 121587-18-6 | Natural Products |
| HY-N13395 | 30-Oxopseudotaraxasterol | 160481-71-0 | Natural Products |
| HY-N13396 | 3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol | 1221686-60-7 | Natural Products |
| HY-N13397 | 3-Oxosapriparaquinone | 119139-56-9 | Natural Products |
| HY-N13398 | 1-O-galloyl-6-O-cinnamoylglucose | 115746-69-5 | Natural Products |
| HY-N13399 | Neoarctin B | 155969-67-8 | Natural Products |
| HY-N1340 | Rosthornin A | 125164-55-8 | Natural Products |
| HY-N13400 | Monohydroxyisoaflavinine | 116865-09-9 | Natural Products |
| HY-N13401 | Methyl 7,15-dihydroxydehydroabietate | 155205-65-5 | Natural Products |
| HY-N13402 | Formononetin-8-C-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside | 1147858-78-3 | Natural Products |
| HY-N13403 | Galanganone C | 1922129-46-1 | Natural Products |
| HY-N13404 | Apigenin 7-O-methylglucuronide | 53538-13-9 | Natural Products |
| HY-N13405 | Ampelopsin G | 151487-09-1 | Natural Products |
| HY-N13406 | Adiantulupanone | 51511-05-8 | Natural Products |
| HY-N13407 | Isoeuphorbetin tetramethyl ether | 50677-55-9 | Natural Products |
| HY-N13409 | Gnetofuran B | 526214-79-9 | Natural Products |
| HY-N1341 | Roseoside | 54835-70-0 | Natural Products |
| HY-N13410 | 12-Hydroxyabietic acid | 3484-61-5 | Natural Products |
| HY-N13411 | Ganoderic acid L | 102607-24-9 | Natural Products |
| HY-N13412 | Neoorthosiphol A | 243448-72-8 | Natural Products |
| HY-N13413 | 6-O-(E)-Caffeoylglucopyranose | 209797-79-5 | Natural Products |
| HY-N13414 | (3R,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol | 232261-31-3 | Natural Products |
| HY-N13415 | Cassiaglycoside II | 2241081-56-9 | Natural Products |
| HY-N13416 | 6-Hydroxy-7-methoxydihydroligustilide | 210036-09-2 | Natural Products |
| HY-N13417 | threo-7-O-Methylguaiacylglycerol β-coniferyl ether | 150333-85-0 | Natural Products |
| HY-N13419 | 3β-Isodihydrocadambine 4-oxide | 1092371-18-0 | Natural Products |
| HY-N1342 | Rocaglaol | 147059-46-9 | Natural Products |
| HY-N13420 | 3beta-Acetoxy-11alpha,12alpha-epoxyoleanan-28,13beta-olide | 35738-25-1 | Natural Products |
| HY-N13421 | Ethyl 4-(rhamnosyloxy)benzylcarbamate | 208346-80-9 | Natural Products |
| HY-N13422 | Isonemerosin | 181524-79-8 | Natural Products |
| HY-N13423 | Cynanoside F | 1800029-50-8 | Natural Products |
| HY-N13424 | Quasipanaxatriol | 171903-78-9 | Natural Products |
| HY-N13426 | Orthosiphol A | 142741-25-1 | Natural Products |
| HY-N13427 | 21,23-Dihydro-23-hydroxy-21-oxozapoterin | 426266-88-8 | Natural Products |
| HY-N13428 | Platycogenin A | 1459719-53-9 | Natural Products |
| HY-N13429 | Ylangenol | 41610-69-9 | Natural Products |
| HY-N1343 | Robustine | 2255-50-7 | Natural Products |
| HY-N13430 | 9-Hydroxy-O-senecioyl-8,9-dihydrooroselol | 31456-63-0 | Natural Products |
| HY-N13431 | 16-Oxocleroda-3,13E-dien-15-oic acid | 117620-72-1 | Natural Products |
| HY-N13432 | Cyclo(Ala-Phe) | 14474-78-3 | Natural Products |
| HY-N13433 | Hydramicromelin B | 369391-55-9 | Natural Products |
| HY-N13435 | Tetrahymanone | 17822-06-9 | Natural Products |
| HY-N13436 | 14-Dehydrobrowniine | 4829-56-5 | Natural Products |
| HY-N13437 | Henricine | 107783-46-0 | Natural Products |
| HY-N13438 | 6beta-(Hexa-2,4-dienoyloxy)-9alpha,12-dihydroxydrimenol | 1136245-81-2 | Natural Products |
| HY-N13439 | Toddalolactone 3'-O-methyl ether | 143614-35-1 | Natural Products |
| HY-N1344 | Robtin | 4382-34-7 | Natural Products |
| HY-N13440 | Securoside A | 107172-40-7 | Natural Products |
| HY-N13441 | N1,N5,N10-(E)-tri-p-Coumaroylspermidine | 364368-18-3 | Natural Products |
| HY-N13442 | (R)-O-Isobutyroyllomatin | 440094-38-2 | Natural Products |
| HY-N13443 | Daucoidin A | 103629-87-4 | Natural Products |
| HY-N13444 | 10β-Hydroxycadina-4,11(13)-dien-12,8β-olide | 35001-23-1 | Natural Products |
| HY-N13445 | Polygalasaponin XLIX | 1033593-12-2 | Natural Products |
| HY-N13446 | Makisterone A 20,22-monoacetonide | 245323-24-4 | Natural Products |
| HY-N13447 | Cyclo(L-Leu-trans-4-hydroxy-L-Pro) | 115006-86-5 | Natural Products |
| HY-N13448 | β-Anhydrouzarigenin | 3080-20-4 | Natural Products |
| HY-N13449 | Isoedultin | 43043-08-9 | Natural Products |
| HY-N1345 | Robtein | 2679-65-4 | Natural Products |
| HY-N13450 | Cyclo(Phe-Hpro) | 1016899-94-7 | Natural Products |
| HY-N13451 | Cannabisin H | 403647-08-5 | Natural Products |
| HY-N13452 | Robinetinidin chloride | 3020-09-5 | Natural Products |
| HY-N13453 | Cyclo(Hpro-Leu) | 1016899-93-6 | Natural Products |
| HY-N13454 | Betmidin | 35589-22-1 | Natural Products |
| HY-N13455 | Safflospermidine A | 1111082-13-3 | Natural Products |
| HY-N13456 | Safflospermidine B | 1111082-11-1 | Natural Products |
| HY-N13457 | 3α-Acetoxy-20-oxo-29-norlupane-23,28-dioic acid | 262272-76-4 | Natural Products |
| HY-N13458 | 1,2-Epoxy-10(14)-furanogermacren-6-one | 383368-24-9 | Natural Products |
| HY-N13459 | Cyclo(Phe-Leu) | 3354-31-2 | Natural Products |
| HY-N1346 | Robinin | 301-19-9 | Natural Products |
| HY-N13460 | Peucenidin | 33044-93-8 | Natural Products |
| HY-N13461 | Tigogenin acetate | 2530-07-6 | Natural Products |
| HY-N13462 | Cyanidin-3-O-lathyroside chloride | 31073-32-2 | Natural Products |
| HY-N13463 | 4,9,9'-Trihydroxy-3,3'-dimethoxy-8,4'-oxyneolignan | 53505-68-3 | Natural Products |
| HY-N13464 | Decursitin D | 245446-61-1 | Natural Products |
| HY-N13465 | Cyclo(Tyr-Phe) | 5147-17-1 | Natural Products |
| HY-N13466 | (-)-Cadin-4,10(15)-dien-11-oic acid | 1124353-23-6 | Natural Products |
| HY-N13467 | Koenigicine | 24123-92-0 | Natural Products |
| HY-N13468 | Sibiricose A4 | 241125-73-5 | Natural Products |
| HY-N13469 | Bombiprenone | 21978-49-4 | Natural Products |
| HY-N1346R | Robinin (Standard) | 301-19-9 | Reference Standards |
| HY-N1347 | Robinetin | 490-31-3 | Natural Products |
| HY-N13471 | Suspenoidside B | 2161432-08-0 | Natural Products |
| HY-N13472 | Tataramide B | 187655-56-7 | Natural Products |
| HY-N13473 | Polygalasaponin XXXV | 184479-28-5 | Natural Products |
| HY-N13474 | Bruceantinol B | 1822332-33-1 | Natural Products |
| HY-N13476 | Voafinidine | 180059-77-2 | Natural Products |
| HY-N13477 | Andrographidine A | 113963-37-4 | Natural Products |
| HY-N13478 | N-trans-caffeoyloctopamine | 1378868-10-0 | Natural Products |
| HY-N13479 | Somnifericin | 173693-57-7 | Natural Products |
| HY-N1347R | Robinetin (Standard) | 490-31-3 | Reference Standards |
| HY-N1348 | Rivulobirin E | 237407-59-9 | Natural Products |
| HY-N13480 | Macrophylloside D | 179457-69-3 | Natural Products |
| HY-N13481 | Rotundanonic acid | 173357-19-2 | Natural Products |
| HY-N13482 | 14-Dehydrodelcosine | 1361-18-8 | Natural Products |
| HY-N13483 | Phyllanthusiin C | 142674-52-0 | Natural Products |
| HY-N13484 | 1,2-Methylenedioxy-3,10,11-trimethoxynoraporphine | 14050-90-9 | Natural Products |
| HY-N13485 | Hedyotol C | 97465-79-7 | Natural Products |
| HY-N13486 | Karaviloside X | 934739-34-1 | Natural Products |
| HY-N13487 | Karaviloside VIII | 934739-32-9 | Natural Products |
| HY-N13488 | 5,7-Dihydroxy-4H-chromen-4-one 3-O-β-D-xylopyranoside | 916204-15-4 | Natural Products |
| HY-N13489 | Karavilagenin B | 912329-02-3 | Natural Products |
| HY-N1349 | Rivulobirin B | 194145-29-4 | Natural Products |
| HY-N13490 | Grandiuvarin A | 882692-93-5 | Natural Products |
| HY-N13491 | 3β-Hydroxy-7β,25-dimethoxycucurbita-5,23-dien-19-al | 85372-69-6 | Natural Products |
| HY-N13492 | (19R,23E)-5β,19-Epoxy-19-methoxycucurbita-6,23,25-trien-3β-ol | 857028-20-7 | Natural Products |
| HY-N13493 | 5-Hydroxy-1,7-diphenyl-4-hepten-3-one | 856007-75-5 | Natural Products |
| HY-N13494 | 2''-O-Rhamnosylswertisin | 83889-78-5 | Natural Products |
| HY-N13495 | 7-(4-Hydroxy-3-methoxyphenyl)-5-methoxy-1-phenylheptan-3-one | 83161-95-9 | Natural Products |
| HY-N13496 | N-decyl-4-methoxyaniline | 733-40-4 | Natural Products |
| HY-N13497 | 3β,7β,19-Trihydroxy-25-methoxycucurbita-5,23-diene 7-O-glucoside | 81910-37-4 | Natural Products |
| HY-N13498 | Tsaokoarylone | 811471-20-2 | Natural Products |
| HY-N13499 | 5,6,7,4'-Tetramethoxyflavanone | 72943-90-9 | Natural Products |
| HY-N1350 | Riligustilide | 89354-45-0 | Natural Products |
| HY-N13500 | (2R,3R)-Glucodistylin | 27297-45-6 | Natural Products |
| HY-N13501 | 8-(1,1-Dimethylallyl)genistein | 651750-08-2 | Natural Products |
| HY-N13502 | Neochlorogenin 6-O-β-D-quinovopyranoside | 711025-86-4 | Natural Products |
| HY-N13503 | Methylepi-dihydrophaseate | 57761-30-5 | Natural Products |
| HY-N13504 | 3-Deoxy-11,13-dihydroisosecotanapartholide | 572924-43-7 | Natural Products |
| HY-N13505 | Flemichin D | 57096-07-8 | Natural Products |
| HY-N13506 | Yashabushidiol A | 52393-53-0 | Natural Products |
| HY-N13507 | Desacetylripariochromene B | 69790-24-5 | Natural Products |
| HY-N13508 | (4Z,6E)-5-Hydroxy-1,7-diphenylhepta-4,6-dien-3-one | 478313-96-1 | Natural Products |
| HY-N13509 | 2′-Hydroxy-3′,4′,6′-trimethoxydihydrochalcone | 1222818-87-2 | Natural Products |
| HY-N1351 | Richenoic acid | 134476-74-7 | Natural Products |
| HY-N13510 | (19R,23S)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol | 2281872-79-3 | Natural Products |
| HY-N13511 | 5,7,8-Trimethoxyflavanone | 69616-73-5 | Natural Products |
| HY-N13512 | Taiwanin E | 22743-05-1 | Natural Products |
| HY-N13513 | Illiciumlignan D | 2237239-36-8 | Natural Products |
| HY-N13514 | Taikuguasin D | 2185847-09-8 | Natural Products |
| HY-N13515 | Glochidiolide | 213528-23-5 | Natural Products |
| HY-N13516 | Alpinin B | 2125947-85-3 | Natural Products |
| HY-N13517 | Cernuine | 6880-84-8 | Natural Products |
| HY-N13518 | Nudaurine | 402469-62-9 | Natural Products |
| HY-N13519 | O-Deacetylfalconericine | 121880-22-6 | Natural Products |
| HY-N1352 | Rhuscholide A | 944804-58-4 | Natural Products |
| HY-N13520 | Trigochinin C | 1210299-33-4 | Natural Products |
| HY-N13521 | Trigonothyrin C | 1203471-31-1 | Natural Products |
| HY-N13522 | 7S-O-Methylmorroniside | 119943-45-2 | Natural Products |
| HY-N13523 | Inundoside E | 80244-83-3 | Natural Products |
| HY-N13524 | Solagenin 6-O-β-D-quinovopyranoside | 184686-03-1 | Natural Products |
| HY-N13525 | Neochlorogenin6-O-β-D-xylopyranosyl-(1→3)-β-D-quinovopyranoside | 184686-02-0 | Natural Products |
| HY-N13526 | Neochlorogenin6-O-α-L-rhamnopyranosyl-(1→3)-β-D-quinovopyranoside | 184686-01-9 | Natural Products |
| HY-N13528 | Phyllanthurinolactone | 168180-12-9 | Natural Products |
| HY-N13529 | Karavilagenin F | 1639024-15-9 | Natural Products |
| HY-N1353 | Rhamnocitrin | 569-92-6 | Natural Products |
| HY-N13530 | (19S,23S)-5B,19-Epoxy-19,23-Dimethoxycucurbita-6,24-Dien-3B-Ol | 1616120-83-2 | Natural Products |
| HY-N13531 | Linarin 4'''-acetate | 79541-06-3 | Natural Products |
| HY-N13532 | Greveichromenol | 35930-29-1 | Natural Products |
| HY-N13533 | Aromadendrin 7-O-methyl ether | 37971-69-0 | Natural Products |
| HY-N13534 | Torvoside D | 20735-79-9 | Natural Products |
| HY-N13535 | meso-Hannokinol | 79055-11-1 | Natural Products |
| HY-N13536 | 5-Methoxyjusticidin A | 205505-62-0 | Natural Products |
| HY-N13537 | 11β,13-Dihydrotaraxinic acid β-D-glucopyranosyl ester | 75911-16-9 | Natural Products |
| HY-N13538 | 5-Hydroxy-1,7-diphenylhept-6-en-3-one | 155239-30-8 | Natural Products |
| HY-N13539 | Chaetoglobosin Fex | 149457-95-4 | Natural Products |
| HY-N1353R | Rhamnocitrin (Standard) | 569-92-6 | Reference Standards |
| HY-N1354 | Reynoutrin | 549-32-6 | Natural Products |
| HY-N13540 | (R)-5-Hydroxy-7-(4-hydroxyphenyl)-1-phenylheptan-3-one | 1961196-24-6 | Natural Products |
| HY-N13541 | (19S,23R)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol | 1474062-47-9 | Natural Products |
| HY-N13542 | Apigenin 7-O-(2'',6''-di-O-E-p-coumaroyl)glucoside | 1448779-19-8 | Natural Products |
| HY-N13543 | 5-Hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one | 142831-06-9 | Natural Products |
| HY-N13544 | Lespedezaflavanone H | 138822-59-0 | Natural Products |
| HY-N13545 | 25-O-MethylkaravilageninD | 1363422-85-8 | Natural Products |
| HY-N13546 | Sachaconitine | 1361-02-0 | Natural Products |
| HY-N13547 | 3β,7β-Dihydroxy-25-methoxycucurbita-5,23-dien-19-al | 132587-67-8 | Natural Products |
| HY-N13548 | 25-EpitorvosideD | 1306729-49-6 | Natural Products |
| HY-N13549 | Ananolignan L | 1280213-70-8 | Natural Products |
| HY-N1355 | Reynosin | 28254-53-7 | Natural Products |
| HY-N13550 | Philippin A | 1848254-99-8 | Natural Products |
| HY-N13551 | Allantoin, (-)- | 7303-80-2 | Natural Products |
| HY-N13552 | Chrysin7-O-neohesperidoside | 35775-46-3 | Natural Products |
| HY-N13553 | Artanomaloide | 112823-41-3 | Natural Products |
| HY-N13554 | 14-O-Acetylsachaconitine | 102719-98-2 | Natural Products |
| HY-N13555 | (19R)-5β,19-Epoxy-19-methoxycucurbita-6,23-diene-3β,25-diol | 332950-28-4 | Natural Products |
| HY-N13556 | DorsmaninI | 329703-46-0 | Natural Products |
| HY-N13557 | 7-(4-Hydroxyphenyl)-5-methoxy-1-phenylheptan-3-one | 100667-53-6 | Natural Products |
| HY-N13558 | 7,4'-D-O-Methylvitexin2''-O-rhamnoside | 1236226-98-4 | Natural Products |
| HY-N13559 | Pieceid-2''-o-gallate | 105304-51-6 | Natural Products |
| HY-N1356 | Reticuline | 485-19-8 | Natural Products |
| HY-N13560 | Yashabushidiol B | 103729-38-0 | Natural Products |
| HY-N13561 | Phoenicein | 175556-07-7 | Natural Products |
| HY-N13562 | Norushinsunine | 3175-84-6 | Natural Products |
| HY-N13563 | Dihydromikanolide | 23758-04-5 | Natural Products |
| HY-N13564 | Tinosporoside A | 2244777-15-7 | Natural Products |
| HY-N13565 | Tinosporol B | 2244777-13-5 | Natural Products |
| HY-N13566 | Tinosporol A | 2244777-12-4 | Natural Products |
| HY-N13567 | Alloptaeroxylin | 4670-29-5 | Natural Products |
| HY-N13568 | Flavanthrinin | 130827-45-1 | Natural Products |
| HY-N13569 | Stachartone A | 2209109-64-6 | Natural Products |
| HY-N1356A | (R)-Reticuline | 3968-19-2 | Natural Products |
| HY-N1357 | Rauvotetraphylline E | 1422506-53-3 | Natural Products |
| HY-N13570 | Severibuxine | 219998-24-0 | Natural Products |
| HY-N13575 | Gancaonin J | 129280-37-1 | Natural Products |
| HY-N13576 | Karaviloside XI | 934739-35-2 | Natural Products |
| HY-N13577 | Coryximine | 127460-61-1 | Natural Products |
| HY-N13578 | Soyasapogenol A 21-O-α-L-rhamnopyranoside | 2067321-88-2 | Natural Products |
| HY-N13579 | Momordicin IV | 894412-35-2 | Natural Products |
| HY-N1358 | Rauvotetraphylline C | 1422506-51-1 | Natural Products |
| HY-N13580 | Teuvincenone B | 127419-64-1 | Natural Products |
| HY-N13581 | 6a,7-Dehydroboldine | 91599-23-4 | Natural Products |
| HY-N13582 | Muricarpone B | 886226-15-9 | Natural Products |
| HY-N13583 | 10-Epiteuclatriol | 151563-36-9 | Natural Products |
| HY-N13584 | 3''-Demethylhexahydrocurcumin | 881008-71-5 | Natural Products |
| HY-N13585 | Imbricatin | 84504-71-2 | Natural Products |
| HY-N13586 | Pukateine | 81-67-4 | Natural Products |
| HY-N13587 | Onjixanthone I | 136083-92-6 | Natural Products |
| HY-N13588 | 14-O-Acetylneoline | 1354-86-5 | Natural Products |
| HY-N13589 | Isooxoflaccidin | 135010-50-3 | Natural Products |
| HY-N1359 | Rauvotetraphylline B | 1422506-50-0 | Natural Products |
| HY-N13590 | O-Methylmurrayamine A | 134779-20-7 | Natural Products |
| HY-N13591 | Rossicaside B | 80458-55-5 | Natural Products |
| HY-N13592 | Demethylagrimonolide 6-O-glucoside | 1257408-55-1 | Natural Products |
| HY-N13593 | Tannagine | 123750-34-5 | Natural Products |
| HY-N13594 | (6R,9R)-3-Oxo-α-ionol glucoside | 77699-19-5 | Natural Products |
| HY-N13595 | 5-Hydroxy-3,6,7,8,3'-pentamethoxy-4',5'-methylenedioxyflavone | 82669-01-0 | Natural Products |
| HY-N13596 | Kaempferol 3,5-dimethyl ether | 1486-65-3 | Natural Products |
| HY-N13597 | 5,5'-Dihydroxy-3,8,3',4'-tetramethoxy-6,7-methylenedioxyflavone | 82668-96-0 | Natural Products |
| HY-N13599 | Pleionesin C | 1222077-25-9 | Natural Products |
| HY-N1360 | Rauvotetraphylline A | 1422506-49-7 | Natural Products |
| HY-N13600 | 3,5,8,3'-Tetramethoxy-6,7,4',5'-bis(methylenedioxy)flavone | 82668-93-7 | Natural Products |
| HY-N13601 | Glycocitrine I | 82354-36-7 | Natural Products |
| HY-N13602 | Yukocitrine | 145940-32-5 | Natural Products |
| HY-N13603 | Diosbulbin E | 67567-14-0 | Natural Products |
| HY-N13605 | Orthosiphol B | 144078-08-0 | Natural Products |
| HY-N13606 | N-Methoxy-3-hydroxymethylcarbazole | 142768-49-8 | Natural Products |
| HY-N13607 | cis-Vitisin B | 142507-86-6 | Natural Products |
| HY-N1361 | Rauvoyunine B | 1414883-82-1 | Natural Products |
| HY-N13610 | 3-O-Methylellagic acid 4-O-rhamnoside | 639089-97-7 | Natural Products |
| HY-N13615 | Citrusinine I | 86680-32-2 | Natural Products |
| HY-N13616 | Sonderianol | 85563-65-1 | Natural Products |
| HY-N13617 | Hainanolidol | 73213-63-5 | Natural Products |
| HY-N13618 | Isostephodeline | 56648-85-2 | Natural Products |
| HY-N13619 | Stephodeline | 56596-12-4 | Natural Products |
| HY-N1362 | Salvianolic acid B | 121521-90-2 | Natural Products |
| HY-N13620 | Boschnaloside | 72963-55-4 | Natural Products |
| HY-N13621 | Pityrogrammin | 55601-60-0 | Natural Products |
| HY-N13622 | 6-Methoxykaempferol 3-O-galactoside | 72945-43-8 | Natural Products |
| HY-N13623 | 3,7,8-Tri-O-methylellagic acid 2-O-rutinoside | 56470-18-9 | Natural Products |
| HY-N13624 | Helichrysoside | 56343-26-1 | Natural Products |
| HY-N13625 | Atalaphylline | 28233-35-4 | Natural Products |
| HY-N13626 | Aesculioside C | 254896-65-6 | Natural Products |
| HY-N13627 | Vesticarpan | 69853-46-9 | Natural Products |
| HY-N13628 | Taccaoside E | 1858199-00-4 | Natural Products |
| HY-N13629 | Withaphysalin C | 57485-60-6 | Natural Products |
| HY-N1362R | Salvianolic acid B (Standard) | 121521-90-2 | Reference Standards |
| HY-N1363 | Royal Jelly acid | 14113-05-4 | Natural Products |
| HY-N13630 | Schisandrolic acid | 55511-17-6 | Natural Products |
| HY-N13631 | 5-O-Methyllatifolin | 18525-14-9 | Natural Products |
| HY-N13632 | 5,6,4'-Trihydroxy-3,7-dimethoxyflavone | 56226-95-0 | Natural Products |
| HY-N13633 | Oregonin | 55303-93-0 | Natural Products |
| HY-N13634 | 3'-Hydroxy-3,5,6,7,8,4',5'-heptamethoxyflavone | 5244-28-0 | Natural Products |
| HY-N13635 | Actinodaphnine | 517-69-1 | Natural Products |
| HY-N13636 | Amurine | 4984-99-0 | Natural Products |
| HY-N13637 | Browniine | 5140-42-1 | Natural Products |
| HY-N13638 | 6-[(3,3-dimethyloxiran-2-yl)methyl]-5,7-dimethoxychromen-2-one | 77636-05-6 | Natural Products |
| HY-N13639 | β-D-Glucopyranosyl taraxinic ester | 75911-14-7 | Natural Products |
| HY-N1363R | Royal Jelly acid (Standard) | 14113-05-4 | Reference Standards |
| HY-N13640 | 7,4'-Dihydroxy-6,8-diprenylflavanone | 50939-03-2 | Natural Products |
| HY-N13641 | 8,8''-Biskoenigine | 477890-82-7 | Natural Products |
| HY-N13642 | Gneafricanin F | 477561-12-9 | Natural Products |
| HY-N13643 | Murrastinine C | 20105-20-8 | Natural Products |
| HY-N13644 | Nandinaside A | 1813517-23-5 | Natural Products |
| HY-N13645 | Inophyllum E | 17312-31-1 | Natural Products |
| HY-N13646 | Callosin | 166197-43-9 | Natural Products |
| HY-N13647 | Murrayamine C | 73385-58-7 | Natural Products |
| HY-N13648 | 11-Methylforsythide | 159598-00-2 | Natural Products |
| HY-N13649 | Isocalophyllic acid | 157810-76-9 | Natural Products |
| HY-N1365 | Isoscopoletin | 776-86-3 | Natural Products |
| HY-N13650 | Caloxanthone B | 155233-17-3 | Natural Products |
| HY-N13651 | Rhodomyrtosone I | 1402725-98-7 | Natural Products |
| HY-N13652 | Oxoflaccidin | 121817-24-1 | Natural Products |
| HY-N13653 | 4'-O-Methylatalantoflavone | 1205687-49-5 | Natural Products |
| HY-N13654 | 1,3-Dihydroxy-2,4-diprenylacridone | 1205687-48-4 | Natural Products |
| HY-N13655 | Periplocoside F | 119902-17-9 | Natural Products |
| HY-N13656 | N-Methoxy-3-formylcarbazole | 117592-01-5 | Natural Products |
| HY-N13657 | Flaccidin | 115531-76-5 | Natural Products |
| HY-N13658 | 2',6'-Dimethoxypaulownin | 115196-22-0 | Natural Products |
| HY-N13659 | Anhydroscandenolide | 114742-71-1 | Natural Products |
| HY-N1365R | Isoscopoletin (Standard) | 776-86-3 | Reference Standards |
| HY-N1366 | Herniarin | 531-59-9 | Natural Products |
| HY-N13660 | Icariside B5 | 114226-08-3 | Natural Products |
| HY-N13661 | Shanciol H | 1114905-55-3 | Natural Products |
| HY-N13662 | 7-Hydroxy-1-methoxy-3-methylcarbazole | 107672-54-8 | Natural Products |
| HY-N13663 | Atalafoline | 107259-49-4 | Natural Products |
| HY-N13664 | Hortiamide | 106055-13-4 | Natural Products |
| HY-N13665 | Junosine | 103956-34-9 | Natural Products |
| HY-N13666 | 2,3-Dihydro-6-methylginkgetin | 1013649-09-6 | Natural Products |
| HY-N13667 | Digicitrin | 5065-10-1 | Natural Products |
| HY-N13668 | Rhodomyrtone | 468757-69-9 | Natural Products |
| HY-N13669 | Mikanin | 4324-53-2 | Natural Products |
| HY-N1366A | Herniarin (standard) | 531-59-9 | Natural Products |
| HY-N1366S | Herniarin-d3 | 1600535-74-7 | Isotope-Labeled Compounds |
| HY-N13670 | Forsythide dimethyl ester | 42830-22-8 | Natural Products |
| HY-N13671 | Adoxoside | 42830-26-2 | Natural Products |
| HY-N13672 | Macedonic acid | 39022-00-9 | Natural Products |
| HY-N13673 | 2-Hydroxy-1,8-dimethoxyxanthone | 38974-76-4 | Natural Products |
| HY-N13674 | 1,5-Dihydroxy-6,7-dimethoxyxanthone | 38710-31-5 | Natural Products |
| HY-N13675 | Buxifoliadine C | 263007-67-6 | Natural Products |
| HY-N13676 | Buxifoliadine B | 263007-66-5 | Natural Products |
| HY-N13677 | Buxifoliadine A | 263007-65-4 | Natural Products |
| HY-N13678 | Nuchensin | 25782-24-5 | Natural Products |
| HY-N13679 | Aesculioside D | 254896-66-7 | Natural Products |
| HY-N13680 | Fortunolide A | 252574-51-9 | Natural Products |
| HY-N13681 | (-)-Cedrusin | 404335-99-5 | Natural Products |
| HY-N13682 | Koenigine | 28513-33-9 | Natural Products |
| HY-N13683 | N-Methylatalaphylline | 28233-34-3 | Natural Products |
| HY-N13684 | 4-(4-Hydroxy-3-methoxyphenyl)butane-1,2-diol | 39115-22-5 | Natural Products |
| HY-N13685 | Buxifoliadine H | 263007-72-3 | Natural Products |
| HY-N13686 | Chiricanine A | 350593-30-5 | Natural Products |
| HY-N13687 | 24,24-Dimethyl-5α-lanosta-9(11),25-dien-3β-ol | 33762-29-7 | Natural Products |
| HY-N13688 | Calophyllic acid | 36626-19-4 | Natural Products |
| HY-N13689 | Goyaglycoside d | 333332-50-6 | Natural Products |
| HY-N13690 | 5-Methoxyseselin | 31525-76-5 | Natural Products |
| HY-N13691 | Pipoxide chlorohydrin | 29228-15-7 | Natural Products |
| HY-N13692 | Cinchonain Ia | 85081-24-9 | Natural Products |
| HY-N13696 | 1,7-Dimethoxyxanthone | 5042-06-8 | Natural Products |
| HY-N13697 | Trigochinin B | 1210299-32-3 | Natural Products |
| HY-N13698 | Cyclo(Leu-Leu) | 1436-27-7 | Natural Products |
| HY-N1369R | Menthol (Standard) | 1490-04-6 | Reference Standards |
| HY-N1369S | Menthol-d4 | 1217765-02-0 | Isotope-Labeled Compounds |
| HY-N1369S1 | Menthol-d2 | 1335435-38-5 | Isotope-Labeled Compounds |
| HY-N1370 | Tanshinone IIA sulfonate (sodium) | 69659-80-9 | Natural Products |
| HY-N13700 | Quadranoside III | 267001-54-7 | Natural Products |
| HY-N13701 | 3β,7β,15α-Trihydroxy-4-(hydroxymethyl)-11,23-dioxo-lanost-8-en-26-oic acid | 1961358-03-1 | Natural Products |
| HY-N13702 | Secoaristolenedioic acid | 2756011-83-1 | Natural Products |
| HY-N13703 | (2S)-(+)-2-Hydroxynaringenin-4'-O-β-D-glucopyranoside | 1616614-47-1 | Natural Products |
| HY-N13704 | (19S,23E)-5β,19-Epoxy-19-methoxycucurbita-6,23,25-trien-3β-ol | 874287-87-3 | Natural Products |
| HY-N13705 | 3β,7β-Dihydroxy-11,15,23-trioxo-lanost-8,16-dien-26-oic acid | 952285-97-1 | Natural Products |
| HY-N13706 | 3β,15α-Dihydroxy-7,11,23-trioxo-lanost-8-dien-26-oic acid | 117354-72-0 | Natural Products |
| HY-N13707 | 3′-Hydroxytectorigenin-7-O-β-D-xylosyl-(1→6)-β-D-glucopyranoside | 2408020-53-9 | Natural Products |
| HY-N13708 | 4'-Methoxy-5,6-dihydroxyisoflavone-7-O-β-D-glucopyranoside | 959960-45-3 | Natural Products |
| HY-N13709 | 12β-Acetoxy-7β-hydroxy-3,11,15,23-tetraoxo-5a-lanosta-8,20-dien-26-oic acid | 1245946-62-6 | Natural Products |
| HY-N1370R | Tanshinone IIA sulfonate (sodium) (Standard) | 69659-80-9 | Reference Standards |
| HY-N1371 | Clinodiside A | 916347-31-4 | Natural Products |
| HY-N13710 | 20-Hydroxylucidenic acid E2 | 852567-75-0 | Natural Products |
| HY-N13711 | Filiformine | 208252-25-9 | Natural Products |
| HY-N13712 | Lucidenic lactone | 250643-34-6 | Natural Products |
| HY-N13713 | Benzoyl (S)-(-)-malic acid | 22138-51-8 | Natural Products |
| HY-N13714 | O-Methylcassythine | 3984-10-9 | Natural Products |
| HY-N13715 | Thalicminine | 16408-77-8 | Natural Products |
| HY-N13716 | Lucidenic acid O | 250643-33-5 | Natural Products |
| HY-N13717 | Ganoderic acid GS-3 | 1206781-66-9 | Natural Products |
| HY-N13718 | Irisolidone 7-O-β-D-glucopyranoside | 6009-88-7 | Natural Products |
| HY-N13719 | Tectorigenin 7-O-β-D-glucosyl-(1→6)-β-D-glucoside | 67604-94-8 | Natural Products |
| HY-N1372A | Fangchinoline | 436-77-1 | Natural Products |
| HY-N1372AR | Fangchinoline (Standard) | 436-77-1 | Reference Standards |
| HY-N1373 | Sophoridine | 6882-68-4 | Natural Products |
| HY-N13739 | Taraxinic acid | 75911-33-0 | Natural Products |
| HY-N1373A | d-Sophoridine | 83148-91-8 | Natural Products |
| HY-N1373R | Sophoridine (Standard) | 6882-68-4 | Reference Standards |
| HY-N1374 | Magnolin | 31008-18-1 | Natural Products |
| HY-N13742 | Dihydrohonokiol B | 219565-74-9 | Natural Products |
| HY-N1374R | Magnolin (Standard) | 31008-18-1 | Reference Standards |
| HY-N1375 | Qingyangshengenin | 84745-94-8 | Natural Products |
| HY-N13759 | Mumeose K | 2132384-01-9 | Natural Products |
| HY-N1376 | (20R)-Ginsenoside Rg3 | 38243-03-7 | Natural Products |
| HY-N1377 | Nevadensin | 10176-66-6 | Natural Products |
| HY-N13772 | 3'-O-Methyltaxifolin | 55812-91-4 | Natural Products |
| HY-N1377R | Nevadensin (Standard) | 10176-66-6 | Reference Standards |
| HY-N1378 | (E)-Cardamonin | 19309-14-9 | Natural Products |
| HY-N1378R | (E)-Cardamonin (Standard) | 19309-14-9 | Reference Standards |
| HY-N13798 | ADHPE | 138870-97-0 | Natural Products |
| HY-N1380 | Guaiacol | 90-05-1 | Natural Products |
| HY-N1380R | Guaiacol (Standard) | 90-05-1 | Reference Standards |
| HY-N1380S | Guaiacol-d7 | 1065473-05-3 | Isotope-Labeled Compounds |
| HY-N1380S1 | Guaiacol-d3 | 74495-69-5 | Isotope-Labeled Compounds |
| HY-N1380S2 | Guaiacol-13C6 | 202326-52-1 | Isotope-Labeled Compounds |
| HY-N1380S3 | Guaiacol-d4 | 7329-52-4 | Isotope-Labeled Compounds |
| HY-N1380S4 | Guaiacol-d4-1 | 20189-11-1 | Isotope-Labeled Compounds |
| HY-N1381 | Periplocin | 13137-64-9 | Natural Products |
| HY-N1381R | Periplocin (Standard) | 13137-64-9 | Reference Standards |
| HY-N1382 | Asperuloside | 14259-45-1 | Natural Products |
| HY-N1382R | Asperuloside (Standard) | 14259-45-1 | Reference Standards |
| HY-N1384 | Ambroxide | 6790-58-5 | Natural Products |
| HY-N1384R | Ambroxide (Standard) | 6790-58-5 | Reference Standards |
| HY-N1386 | 2-Methoxycinnamic acid | 6099-03-2 | Natural Products |
| HY-N13866 | Cucumarioside A2-2 | 95499-80-2 | Natural Products |
| HY-N13868 | Saquayamycin C1 | 99260-69-2 | Natural Products |
| HY-N13869 | Asperlin | 30387-51-0 | Natural Products |
| HY-N1387 | 4-Methoxycinnamic acid | 830-09-1 | Natural Products |
| HY-N13870 | Saquayamycin A1 | 99260-66-9 | Natural Products |
| HY-N13871 | Anguibactin | 104245-09-2 | Natural Products |
| HY-N13873 | Saricandin | 178494-90-1 | Natural Products |
| HY-N13874 | Andrastin B | 174232-43-0 | Natural Products |
| HY-N13875 | Antiblastin | 544-51-4 | Natural Products |
| HY-N13876 | Andrastin D | 184432-08-4 | Natural Products |
| HY-N13877 | Arugomycin | 88465-80-9 | Natural Products |
| HY-N13878 | Anguinomycin B | 111278-00-3 | Natural Products |
| HY-N13879 | Amphistin | 199783-52-3 | Natural Products |
| HY-N1387R | 4-Methoxycinnamic acid (Standard) | 830-09-1 | Reference Standards |
| HY-N1388 | Tussilagone | 104012-37-5 | Natural Products |
| HY-N13880 | Adustin | 69579-74-4 | Natural Products |
| HY-N13881 | Amythiamicin C | 156620-47-2 | Natural Products |
| HY-N13882 | Aldgamycin F | 55141-41-8 | Natural Products |
| HY-N13883 | Aerocavin | 113702-00-4 | Natural Products |
| HY-N13884 | Amythiamicin D | 156620-46-1 | Natural Products |
| HY-N13885 | Amythiamicin A | 152741-89-4 | Natural Products |
| HY-N13886 | Anicequol | 440368-05-8 | Natural Products |
| HY-N13887 | Aerocyanidin | 113701-99-8 | Natural Products |
| HY-N13888 | Schizostatin | 163564-55-4 | Natural Products |
| HY-N13889 | Altiloxin A | 92675-11-1 | Natural Products |
| HY-N1388R | Tussilagone (Standard) | 104012-37-5 | Reference Standards |
| HY-N1389 | Carmine | 1390-65-4 | Dye Reagents |
| HY-N13890 | Arginomycin | 106133-33-9 | Natural Products |
| HY-N13891 | Arisostatin A | 271574-41-5 | Natural Products |
| HY-N13892 | Alisamycin | 136398-54-4 | Natural Products |
| HY-N13893 | Altiloxin B | 92675-14-4 | Natural Products |
| HY-N13894 | Auramycin A | 78173-92-9 | Natural Products |
| HY-N13895 | Auramycin B | 78173-91-8 | Natural Products |
| HY-N13896 | Aureoquinone | 321658-21-3 | Natural Products |
| HY-N13897 | Avidinorubicin | 135447-13-1 | Natural Products |
| HY-N13898 | Alldimycin A | 122397-46-0 | Natural Products |
| HY-N1390 | Syringaldehyde | 134-96-3 | Natural Products |
| HY-N13900 | Arisostatin B | 271574-42-6 | Natural Products |
| HY-N13901 | Arisugacin A | 167114-89-8 | Natural Products |
| HY-N13902 | Arisugacin B | 182068-83-3 | Natural Products |
| HY-N13904 | Argyrin A | 174423-37-1 | Natural Products |
| HY-N13905 | Alliacol A | 79232-29-4 | Natural Products |
| HY-N13906 | Alliacol B | 79232-33-0 | Natural Products |
| HY-N1390R | Syringaldehyde (Standard) | 134-96-3 | Reference Standards |
| HY-N1391 | 10-Deacetyltaxol | 78432-77-6 | Natural Products |
| HY-N13912 | Anticapsin | 28978-07-6 | Natural Products |
| HY-N13915 | Scorodonin | 74660-77-8 | Natural Products |
| HY-N13916 | Alternaric acid | 10088-62-7 | Natural Products |
| HY-N13917 | Argyrin B | 174423-36-0 | Natural Products |
| HY-N13918 | Scyphostatin | 169062-93-5 | Natural Products |
| HY-N13919 | Avilamycin B | 73240-30-9 | Natural Products |
| HY-N1391R | 10-Deacetyltaxol (Standard) | 78432-77-6 | Reference Standards |
| HY-N13920 | Avilamycin C | 69787-80-0 | Natural Products |
| HY-N13921 | Aphidicolin-3,18-orthoacetate | 92681-39-5 | Natural Products |
| HY-N13922 | Scytalol A | 208183-19-1 | Natural Products |
| HY-N13923 | Arisugacin C | 261950-90-7 | Natural Products |
| HY-N13924 | Arisugacin D | 261950-94-1 | Natural Products |
| HY-N13925 | Arisugacin E | 261951-22-8 | Natural Products |
| HY-N13926 | Arisugacin F | 261951-44-4 | Natural Products |
| HY-N13927 | Arisugacin G | 261951-57-9 | Natural Products |
| HY-N13928 | Arisugacin H | 261951-59-1 | Natural Products |
| HY-N13929 | Scytalidin | 39012-16-3 | Natural Products |
| HY-N1393 | 2-Methoxybenzoic acid | 579-75-9 | Natural Products |
| HY-N13930 | Azicemicin A | 154163-93-6 | Natural Products |
| HY-N13931 | Azicemicin B | 162857-75-2 | Natural Products |
| HY-N13932 | Arabenoic acid | 136468-08-1 | Natural Products |
| HY-N13934 | Scytalol B | 208183-20-4 | Natural Products |
| HY-N13936 | Argyrin C | 444300-77-0 | Natural Products |
| HY-N13937 | Scytalol C | 208183-22-6 | Natural Products |
| HY-N13938 | Azinomycin A | 106486-77-5 | Natural Products |
| HY-N1393R | 2-Methoxybenzoic acid (Standard) | 579-75-9 | Reference Standards |
| HY-N1393S | 2-Methoxybenzoic acid-13C6 | Isotope-Labeled Compounds | |
| HY-N1393S1 | 2-Methoxybenzoic acid-d3 | 96739-36-5 | Isotope-Labeled Compounds |
| HY-N1394 | p-Anisic acid | 100-09-4 | Natural Products |
| HY-N13940 | Argyrin D | 444300-78-1 | Natural Products |
| HY-N13941 | Baciphelacin | 57765-71-6 | Natural Products |
| HY-N13942 | Argyrin E | 444300-73-6 | Natural Products |
| HY-N13943 | Scytalol D | 208183-24-8 | Natural Products |
| HY-N13944 | Argyrin F | 444300-74-7 | Natural Products |
| HY-N13945 | Argyrin G | 444300-75-8 | Natural Products |
| HY-N13946 | Pyralomicin 1a | 139636-03-6 | Natural Products |
| HY-N13947 | Pyralomicin 1b | 139636-04-7 | Natural Products |
| HY-N13948 | Argyrin H | 444300-76-9 | Natural Products |
| HY-N13949 | Seitomycin | 630391-05-8 | Natural Products |
| HY-N1394R | p-Anisic acid (Standard) | 100-09-4 | Reference Standards |
| HY-N1394S | p-Anisic acid-13C6 | 1173022-97-3 | Isotope-Labeled Compounds |
| HY-N1394S1 | p-Anisic acid-d4 | 152404-46-1 | Isotope-Labeled Compounds |
| HY-N1395 | Acetagastrodin | 64291-41-4 | Natural Products |
| HY-N13950 | Bacithrocin A | 160433-47-6 | Natural Products |
| HY-N13951 | Aranochlor A | 208466-05-1 | Natural Products |
| HY-N13952 | Arylomycin A1 | 459844-19-0 | Natural Products |
| HY-N13953 | Pyralomicin 1c | 139635-99-7 | Natural Products |
| HY-N13954 | Pyralomicin 1d | 139635-98-6 | Natural Products |
| HY-N13955 | Bacithrocin B | 160433-51-2 | Natural Products |
| HY-N13956 | Arylomycin A3 | 459844-21-4 | Natural Products |
| HY-N13957 | Bacithrocin C | 160433-50-1 | Natural Products |
| HY-N13958 | Arylomycin A4 | 459844-22-5 | Natural Products |
| HY-N13959 | Seldomycin factor 1 | 56276-04-1 | Natural Products |
| HY-N13960 | Bacithrocin D | 96440-64-1 | Natural Products |
| HY-N13961 | Seldomycin factor 2 | 54333-78-7 | Natural Products |
| HY-N13962 | Bagremycin A | 377775-45-6 | Natural Products |
| HY-N13963 | Bagremycin B | 93316-63-3 | Natural Products |
| HY-N13964 | Seldomycin factor 3 | 56276-05-2 | Natural Products |
| HY-N13966 | Pyralomicin 2a | 139636-00-3 | Natural Products |
| HY-N13967 | Pyralomicin 2b | 139635-97-5 | Natural Products |
| HY-N13968 | Pyralomicin 2c | 139636-01-4 | Natural Products |
| HY-N13969 | Arylomycin A5 | 459844-23-6 | Natural Products |
| HY-N13971 | Bamicetin | 43043-14-7 | Natural Products |
| HY-N13972 | Arylomycin B1 | 459844-24-7 | Natural Products |
| HY-N13973 | Baumycin A1 | 64314-28-9 | Natural Products |
| HY-N13974 | Baumycin B1 | 64253-72-1 | Natural Products |
| HY-N13975 | Belactosin A | 189871-53-2 | Natural Products |
| HY-N13976 | Belactosin C | 189871-55-4 | Natural Products |
| HY-N13977 | Carpetimycin A | 76025-73-5 | Natural Products |
| HY-N13978 | Carpetimycin B | 76094-36-5 | Natural Products |
| HY-N13979 | Carpetimycin C | 87695-64-5 | Natural Products |
| HY-N13980 | Carpetimycin D | 87139-37-5 | Natural Products |
| HY-N13981 | Arylomycin B2 | 459844-25-8 | Natural Products |
| HY-N13982 | Arylomycin B3 | 459844-26-9 | Natural Products |
| HY-N13983 | Arylomycin B4 | 459844-27-0 | Natural Products |
| HY-N13984 | Arylomycin B5 | 459844-28-1 | Natural Products |
| HY-N13985 | Arylomycin B6 | 459844-29-2 | Natural Products |
| HY-N13986 | Seldomycin factor 5 | 56276-26-7 | Natural Products |
| HY-N13987 | Arylomycin B7 | 459844-30-5 | Natural Products |
| HY-N1399 | Androsin | 531-28-2 | Natural Products |
| HY-N13990 | Senfolomycin A | 11017-36-0 | Natural Products |
| HY-N13991 | Senfolomycin B | 11031-56-4 | Natural Products |
| HY-N13992 | Barbamide | 174630-03-6 | Natural Products |
| HY-N13993 | Aranorosinol A | 145147-04-2 | Natural Products |
| HY-N13994 | Clavamycin A | 103059-93-4 | Natural Products |
| HY-N13995 | Serratamolide | 5285-25-6 | Natural Products |
| HY-N13996 | Clavamycin B | 103080-36-0 | Natural Products |
| HY-N13997 | Clavamycin C | 103059-94-5 | Natural Products |
| HY-N13998 | Cephalonic acid | 18456-04-7 | Natural Products |
| HY-N13999 | Clavamycin D | 103059-95-6 | Natural Products |
| HY-N1399R | Androsin (Standard) | 531-28-2 | Reference Standards |
| HY-N1400 | (20R)-Ginsenoside Rh1 | 80952-71-2 | Natural Products |
| HY-N14003 | Clavamycin E | 103059-96-7 | Natural Products |
| HY-N14004 | Clavamycin F | 103059-97-8 | Natural Products |
| HY-N14005 | Cephamycin A | 34279-78-2 | Natural Products |
| HY-N14007 | Cephamycin B | 34279-77-1 | Natural Products |
| HY-N14008 | Carriomycin | 65978-43-0 | Natural Products |
| HY-N14009 | Carzinophillin A | 106486-76-4 | Natural Products |
| HY-N1400R | (20R)-Ginsenoside Rh1 (Standard) | 80952-71-2 | Reference Standards |
| HY-N1401 | 20(R)-Ginsenoside Rh2 | 112246-15-8 | Natural Products |
| HY-N14010 | Cationomycin | 80394-65-6 | Natural Products |
| HY-N14011 | Cedarmycin A | 363624-69-5 | Natural Products |
| HY-N14012 | Cedarmycin B | 363624-70-8 | Natural Products |
| HY-N14013 | Chondramide A | 172430-60-3 | Natural Products |
| HY-N14014 | Arizonin B1 | 108890-89-7 | Natural Products |
| HY-N14015 | Cerexin A | 55467-31-7 | Natural Products |
| HY-N14016 | Chaetiacandin | 96989-32-1 | Natural Products |
| HY-N14017 | Chelocardin | 29144-42-1 | Natural Products |
| HY-N14018 | Glidobactin A | 108351-50-4 | Natural Products |
| HY-N14019 | Glidobactin B | 108351-51-5 | Natural Products |
| HY-N1401R | 20(R)-Ginsenoside Rh2 (Standard) | 112246-15-8 | Reference Standards |
| HY-N1402 | Oxysophoridine | 54809-74-4 | Natural Products |
| HY-N14020 | Glidobactin C | 108351-52-6 | Natural Products |
| HY-N14021 | Petasites japonicus extract | 91845-41-9 | Natural Products |
| HY-N14022 | Glidobactin F | 119259-72-2 | Natural Products |
| HY-N14023 | Glidobactin G | 119259-71-1 | Natural Products |
| HY-N14025 | Chicamycin B | 89675-39-8 | Natural Products |
| HY-N14027 | Chondramide B | 172430-61-4 | Natural Products |
| HY-N14028 | Coriolin A | 33404-85-2 | Natural Products |
| HY-N14029 | Coriolin B | 33400-89-4 | Natural Products |
| HY-N1403 | Tigogenin | 77-60-1 | Natural Products |
| HY-N14030 | Coriolin C | 33400-90-7 | Natural Products |
| HY-N14031 | Chimeramycin A | 87084-47-7 | Natural Products |
| HY-N14032 | Chimeramycin B | 87092-83-9 | Natural Products |
| HY-N14035 | Garcinia cambogia extract | 90045-23-1 | Natural Products |
| HY-N14037 | Chondramide C | 172430-62-5 | Natural Products |
| HY-N14038 | Crocacin A | 157698-34-5 | Natural Products |
| HY-N14039 | Pinus pinaster bark extract | 90082-75-0 | Natural Products |
| HY-N1403R | Tigogenin (Standard) | 77-60-1 | Reference Standards |
| HY-N1404 | Sodium aescinate | 20977-05-3 | Natural Products |
| HY-N14040 | Crocacin B | 237425-37-5 | Natural Products |
| HY-N14041 | Arizonin A2 | 108890-88-6 | Natural Products |
| HY-N14042 | Arizonin B2 | 108905-76-6 | Natural Products |
| HY-N14043 | Crocacin C | 237425-38-6 | Natural Products |
| HY-N14044 | Crocacin D | 237425-39-7 | Natural Products |
| HY-N14045 | Celesticetin | 2520-21-0 | Natural Products |
| HY-N14046 | Celesticetin B | 42715-01-5 | Natural Products |
| HY-N14048 | Cepacin A | 91682-95-0 | Natural Products |
| HY-N14049 | Cepacin B | 91682-94-9 | Natural Products |
| HY-N1405 | Cucurbitacin I | 2222-07-3 | Natural Products |
| HY-N14050 | Cinatrin A | 136266-33-6 | Natural Products |
| HY-N14051 | Arizonin C1 | 1526958-62-2 | Natural Products |
| HY-N14052 | Arizonin C3 | 108925-06-0 | Natural Products |
| HY-N14053 | Arohynapene A | 154445-08-6 | Natural Products |
| HY-N14054 | Chondramide D | 172430-63-6 | Natural Products |
| HY-N14056 | Chrolactomycin | 227606-82-8 | Natural Products |
| HY-N14057 | Cycloheptamycin | 30270-78-1 | Natural Products |
| HY-N14058 | Halymecin A | 165561-10-4 | Natural Products |
| HY-N14059 | Halymecin B | 167173-81-1 | Natural Products |
| HY-N1405R | Cucurbitacin I (Standard) | 2222-07-3 | Reference Standards |
| HY-N1406 | 6-Methylcoumarin | 92-48-8 | Reference compound |
| HY-N14060 | Halymecin C | 167173-82-2 | Natural Products |
| HY-N14061 | Halymecin D | 167173-83-3 | Natural Products |
| HY-N14062 | Halymecin E | 167173-84-4 | Natural Products |
| HY-N14063 | Cycloleucomelone | 112209-48-0 | Natural Products |
| HY-N14066 | Ascochitine | 3615-05-2 | Natural Products |
| HY-N14067 | Cytosaminomycin A | 157878-02-9 | Natural Products |
| HY-N14068 | Cytosaminomycin B | 157878-03-0 | Natural Products |
| HY-N14069 | Cytosaminomycin C | 157878-04-1 | Natural Products |
| HY-N1406R | 6-Methylcoumarin (Standard) | 92-48-8 | Reference Standards |
| HY-N1407 | Polygalaxanthone III | 162857-78-5 | Natural Products |
| HY-N1407R | Polygalaxanthone III (Standard) | 162857-78-5 | Reference Standards |
| HY-N1408 | trans-Trimethoxyresveratrol | 22255-22-7 | Natural Products |
| HY-N14085 | Chrymutasin A | 155213-40-4 | Natural Products |
| HY-N14086 | Chrymutasin B | 155213-41-5 | Natural Products |
| HY-N14087 | Chrymutasin C | 155232-80-7 | Natural Products |
| HY-N14088 | Chrysospermin A | 160824-57-7 | Natural Products |
| HY-N14089 | Chrysospermin B | 160791-54-8 | Natural Products |
| HY-N14090 | Chrysospermin C | 160791-55-9 | Natural Products |
| HY-N14091 | Chrysospermin D | 160791-56-0 | Natural Products |
| HY-N14092 | Chuangxinmycin | 63339-68-4 | Natural Products |
| HY-N14095 | Curromycin A | 97412-76-5 | Natural Products |
| HY-N1410 | Triacetylresveratrol | 42206-94-0 | Natural Products |
| HY-N14101 | Cinatrin B | 136266-34-7 | Natural Products |
| HY-N14102 | Chlorflavonin | 23363-64-6 | Natural Products |
| HY-N14103 | Cinatrin C1 | 136266-35-8 | Natural Products |
| HY-N14104 | Cinatrin C2 | 136266-36-9 | Natural Products |
| HY-N14105 | Cinatrin C3 | 136266-37-0 | Natural Products |
| HY-N14106 | Cinerubin R | 147657-35-0 | Natural Products |
| HY-N14107 | Cinnabarin | 146-90-7 | Natural Products |
| HY-N14108 | Chlorocardicin | 95927-71-2 | Natural Products |
| HY-N14109 | Chloronectrin | 38965-84-3 | Natural Products |
| HY-N1411 | Platycodin D | 58479-68-8 | Natural Products |
| HY-N14110 | Curromycin B | 97412-77-6 | Natural Products |
| HY-N14111 | Cuevaene A | 1246172-08-6 | Natural Products |
| HY-N14112 | Cuevaene B | 274684-11-6 | Natural Products |
| HY-N14113 | Cytosaminomycin D | 157878-05-2 | Natural Products |
| HY-N14114 | Curvularol | 339293-67-3 | Natural Products |
| HY-N14115 | γ-Chloronorvaline | 76265-38-8 | Natural Products |
| HY-N14116 | Garlic oil | 8000-78-0 | Natural Products |
| HY-N14117 | Curvulic acid | 652-55-1 | Natural Products |
| HY-N14118 | Chloropolysporin B | 105650-11-1 | Natural Products |
| HY-N14119 | Chloropolysporin C | 105650-12-2 | Natural Products |
| HY-N1411R | Platycodin D (Standard) | 58479-68-8 | Reference Standards |
| HY-N1412 | 1,3-Dicaffeoylquinic acid | 19870-46-3 | Natural Products |
| HY-N14120 | Opoponax oil | 8021-36-1 | Natural Products |
| HY-N14121 | Cladosporide A | 310897-84-8 | Natural Products |
| HY-N14122 | Cladosporide B | 376368-81-9 | Natural Products |
| HY-N14123 | Cladosporide C | 376368-82-0 | Natural Products |
| HY-N14124 | Cladosporide D | 376368-83-1 | Natural Products |
| HY-N14125 | Chloroquinocin | 585533-78-4 | Natural Products |
| HY-N14126 | Chlovalicin | 179799-38-3 | Natural Products |
| HY-N14127 | Cirramycin A1 | 25339-90-6 | Natural Products |
| HY-N14128 | Cirramycin B1 | 57425-25-9 | Natural Products |
| HY-N14129 | Citreamicin β | 128999-30-4 | Natural Products |
| HY-N1412A | Dicaffeoylquininic acid | 251320-66-8 | Natural Products |
| HY-N1412R | 1,3-Dicaffeoylquinic acid (Standard) | 19870-46-3 | Reference Standards |
| HY-N1413 | Noricaritin | 5240-95-9 | Natural Products |
| HY-N14130 | Cyclothialidine B | 194276-76-1 | Natural Products |
| HY-N14131 | Cyclothialidine D | 194276-78-3 | Natural Products |
| HY-N14132 | Cyclothialidine E | 194276-79-4 | Natural Products |
| HY-N14133 | Enaminomycin A | 68330-49-4 | Natural Products |
| HY-N14134 | Deoxyfrenolicin | 10023-11-7 | Natural Products |
| HY-N14135 | Cystothiazole A | 207399-36-8 | Natural Products |
| HY-N14136 | Cinnatriacetin A | 244277-14-3 | Natural Products |
| HY-N14137 | Cinnatriacetin B | 244277-15-4 | Natural Products |
| HY-N14138 | Diolmycin A1 | 150408-69-8 | Natural Products |
| HY-N14139 | Dioxamycin | 134861-62-4 | Natural Products |
| HY-N1414 | (E)-3',6-Disinapoylsucrose | 139891-98-8 | Natural Products |
| HY-N14140 | Dioxolamycin | 91432-46-1 | Natural Products |
| HY-N14141 | Citreamicin γ | 128999-31-5 | Natural Products |
| HY-N14142 | Citreamicin ξ | 1092776-20-9 | Natural Products |
| HY-N14143 | Citreamicin η | 128969-88-0 | Natural Products |
| HY-N14144 | Cremimycin | 182285-29-6 | Natural Products |
| HY-N14145 | Collinone | 343315-22-0 | Natural Products |
| HY-N14149 | Cystothiazole B | 207399-38-0 | Natural Products |
| HY-N1414A | 3′,6-Disinapoylsucrose | 76656-80-9 | Natural Products |
| HY-N1414R | (E)-3',6-Disinapoylsucrose (Standard) | 139891-98-8 | Reference Standards |
| HY-N1415 | β-Caryophyllene | 87-44-5 | Natural Products |
| HY-N14150 | Darlucin A | 162341-15-3 | Natural Products |
| HY-N14151 | Darlucin B | 162341-16-4 | Natural Products |
| HY-N14152 | Desertomycin B | 143629-44-1 | Natural Products |
| HY-N14153 | Enaminomycin B | 68245-17-0 | Natural Products |
| HY-N14154 | Enaminomycin C | 68245-16-9 | Natural Products |
| HY-N14155 | Epelmycin A | 107807-25-0 | Natural Products |
| HY-N14156 | Epelmycin B | 107807-24-9 | Natural Products |
| HY-N14157 | Epelmycin C | 107807-23-8 | Natural Products |
| HY-N14158 | Epelmycin D | 130852-65-2 | Natural Products |
| HY-N14159 | Epelmycin E | 76264-93-2 | Natural Products |
| HY-N1415R | β-Caryophyllene (Standard) | 87-44-5 | Reference Standards |
| HY-N1415S | β-Caryophyllene-d2 | 2006272-96-2 | Isotope-Labeled Compounds |
| HY-N1415S1 | β-Caryophyllene-13C,d2 | Isotope-Labeled Compounds | |
| HY-N1416 | Pogostone | 23800-56-8 | Natural Products |
| HY-N14160 | Diaporthin | 10532-39-5 | Natural Products |
| HY-N14161 | Diazaquinomycin A | 87614-40-2 | Natural Products |
| HY-N14162 | Dihydroabikoviromycin | 38704-36-8 | Natural Products |
| HY-N14163 | Diperamycin | 220766-06-3 | Natural Products |
| HY-N14164 | Echinoserine | 167324-03-0 | Natural Products |
| HY-N14165 | Endusamycin | 100242-41-9 | Natural Products |
| HY-N14166 | Empedopeptin | 87551-98-2 | Natural Products |
| HY-N14167 | Ekatetrone | 12794-19-3 | Natural Products |
| HY-N14168 | Ashimycin A | 123482-11-1 | Natural Products |
| HY-N1416R | Pogostone (Standard) | 23800-56-8 | Reference Standards |
| HY-N1417 | Sesamol | 533-31-3 | Natural Products |
| HY-N14170 | Ashimycin B | 123482-12-2 | Natural Products |
| HY-N14171 | Epicorazine A | 62256-05-7 | Natural Products |
| HY-N14172 | Epicorazine B | 69176-72-3 | Natural Products |
| HY-N14173 | Epiderstatin | 126602-16-2 | Natural Products |
| HY-N14174 | Epithienamycin A | 63582-78-5 | Natural Products |
| HY-N14175 | Epithienamycin C | 63599-16-6 | Natural Products |
| HY-N14176 | Cyathin A3 | 38598-35-5 | Natural Products |
| HY-N14177 | Cyathin A4 | 12626-14-1 | Natural Products |
| HY-N14178 | Cyclacidin | 749-18-8 | Natural Products |
| HY-N14179 | Cytovaricin | 79553-45-0 | Natural Products |
| HY-N1417R | Sesamol (Standard) | 533-31-3 | Reference Standards |
| HY-N1418 | (S)-(-)-Tetrahydroberberine | 5096-57-1 | Natural Products |
| HY-N14180 | 6-Deoxyilludin M | 112953-12-5 | Natural Products |
| HY-N14181 | Ditrisarubicin A | 87399-21-1 | Natural Products |
| HY-N14182 | Asparenomycin A | 76466-24-5 | Natural Products |
| HY-N14183 | Asparenomycin B | 79366-72-6 | Natural Products |
| HY-N14185 | Asparenomycin C | 81018-71-5 | Natural Products |
| HY-N14186 | Asperaldin | 561297-46-9 | Natural Products |
| HY-N14187 | Aspergillic acid | 490-02-8 | Natural Products |
| HY-N14189 | Hynapene A | 155111-89-0 | Natural Products |
| HY-N1418A | (R)-(+)-Tetrahydroberberine | 2086-96-6 | Natural Products |
| HY-N1419 | Vaccarin | 53452-16-7 | Natural Products |
| HY-N14193 | Estatin B | 106396-24-1 | Natural Products |
| HY-N14194 | Esterastin | 67655-93-0 | Natural Products |
| HY-N14197 | Hynapene B | 155111-88-9 | Natural Products |
| HY-N14198 | Hynapene C | 155111-90-3 | Natural Products |
| HY-N1419R | Vaccarin (Standard) | 53452-16-7 | Reference Standards |
| HY-N1420 | Rhamnose | 3615-41-6 | Natural Products |
| HY-N14200 | Maridomycin II | 35908-45-3 | Natural Products |
| HY-N14201 | Maridomycin IV | 35942-56-4 | Natural Products |
| HY-N14202 | Maridomycin V | 35942-57-5 | Natural Products |
| HY-N14203 | Maridomycin VI | 35775-66-7 | Natural Products |
| HY-N14205 | Cytosporin A | 175521-93-4 | Natural Products |
| HY-N14206 | Cytosporin B | 175413-74-8 | Natural Products |
| HY-N14207 | Cytosporin C | 175521-92-3 | Natural Products |
| HY-N14209 | Epithienamycin D | 65322-98-7 | Natural Products |
| HY-N1420A | Rhamnose (monohydrate) | 10030-85-0 | Natural Products |
| HY-N1420AR | Rhamnose (monohydrate) (Standard) | 10030-85-0 | Reference Standards |
| HY-N1420AS | Rhamnose-13C (monohydrate) | 478511-48-7 | Isotope-Labeled Compounds |
| HY-N1420AS2 | Rhamnose-13C-2 (monohydrate) | 478511-54-5 | Isotope-Labeled Compounds |
| HY-N1420R | Rhamnose (Standard) | 3615-41-6 | Reference Standards |
| HY-N14210 | Epithienamycin F | 79057-45-7 | Natural Products |
| HY-N14217 | Eulicin | 534-76-9 | Natural Products |
| HY-N14218 | Eurystatin A | 137563-63-4 | Natural Products |
| HY-N14219 | Enactin Ⅴa | 130640-31-2 | Natural Products |
| HY-N1422 | Hecogenin | 467-55-0 | Natural Products |
| HY-N14220 | Epoformin | 52146-62-0 | Natural Products |
| HY-N14221 | Eponemycin | 126509-46-4 | Natural Products |
| HY-N14222 | Epopromycin A | 153540-55-7 | Natural Products |
| HY-N14224 | Enteromycin | 3552-16-7 | Natural Products |
| HY-N14225 | Fumifungin | 110231-33-9 | Natural Products |
| HY-N14226 | Eurystatin B | 137563-64-5 | Natural Products |
| HY-N1422R | Hecogenin (Standard) | 467-55-0 | Reference Standards |
| HY-N1423 | Glycocholic acid | 475-31-0 | Natural Products |
| HY-N14230 | Everninomicin D | 39340-46-0 | Natural Products |
| HY-N14232 | Inactone | 487-34-3 | Natural Products |
| HY-N14233 | Inosamycin A | 91421-97-5 | Natural Products |
| HY-N14234 | Isohematinic acid | 86408-37-9 | Natural Products |
| HY-N14236 | Epopromycin B | 153540-56-8 | Natural Products |
| HY-N14237 | Epoxyquinomicin A | 175448-31-4 | Natural Products |
| HY-N14238 | Epoxyquinomicin B | 175448-32-5 | Natural Products |
| HY-N14239 | Jietacin A | 109766-61-2 | Natural Products |
| HY-N1423A | Glycocholic acid (sodium) | 863-57-0 | Natural Products |
| HY-N1423AR | Glycocholic acid (sodium) (Standard) | 863-57-0 | Reference Standards |
| HY-N1423B | Glycocholic acid (hydrate) | 1192657-83-2 | Natural Products |
| HY-N1423R | Glycocholic acid (Standard) | 475-31-0 | Reference Standards |
| HY-N1423S | Glycocholic acid-d4 | 1201918-15-1 | Isotope-Labeled Compounds |
| HY-N1423S1 | Glycocholic acid-d5 | 2170091-95-7 | Isotope-Labeled Compounds |
| HY-N1424 | Glycoursodeoxycholic acid | 64480-66-6 | Natural Products |
| HY-N14242 | Jietacin B | 109766-62-3 | Natural Products |
| HY-N14246 | Exfoliamycin | 148084-37-1 | Natural Products |
| HY-N14247 | Exfoliazone | 132627-73-7 | Natural Products |
| HY-N14248 | Melithiazole A | 170894-30-1 | Natural Products |
| HY-N14249 | Melithiazole B | 170894-31-2 | Natural Products |
| HY-N1424R | Glycoursodeoxycholic acid (Standard) | 64480-66-6 | Reference Standards |
| HY-N1424S | Glycoursodeoxycholic Acid-d4 | 2044276-17-5 | Isotope-Labeled Compounds |
| HY-N1425 | Tiliroside | 20316-62-5 | Natural Products |
| HY-N14250 | Melithiazole C | 214420-47-0 | Natural Products |
| HY-N14251 | Melithiazole K | 248938-47-8 | Natural Products |
| HY-N14252 | Melithiazole N | 248938-54-7 | Natural Products |
| HY-N14253 | cis-2-Amino-1-hydroxycyclobutane-1-acetic acid | 108428-42-8 | Natural Products |
| HY-N14254 | Hypelcin A-Ⅰ | 93397-17-2 | Natural Products |
| HY-N14256 | Amycin B | 129313-99-1 | Natural Products |
| HY-N14257 | Andrimid | 108868-95-7 | Natural Products |
| HY-N14258 | Kerriamycin A | 98474-20-5 | Natural Products |
| HY-N14259 | Kerriamycin C | 98495-38-6 | Natural Products |
| HY-N1425R | Tiliroside (Standard) | 20316-62-5 | Reference Standards |
| HY-N1426 | Raspberry ketone | 5471-51-2 | Natural Products |
| HY-N14260 | Hypelcin A-II | 93397-16-1 | Natural Products |
| HY-N14261 | Angiolam A | 99267-41-1 | Natural Products |
| HY-N14262 | Kinamycin A | 35303-12-9 | Natural Products |
| HY-N14263 | Kirrothricin | 79190-00-4 | Natural Products |
| HY-N14264 | Kistamicin A | 155683-50-4 | Natural Products |
| HY-N14265 | Kistamicin B | 155683-51-5 | Natural Products |
| HY-N14266 | Hypelcin A-IV | 93397-15-0 | Natural Products |
| HY-N14268 | Ezomycin A1 | 39422-19-0 | Natural Products |
| HY-N14269 | Ezomycin A2 | 54328-22-2 | Natural Products |
| HY-N1426R | Raspberry ketone (Standard) | 5471-51-2 | Reference Standards |
| HY-N1427 | Glycodeoxycholate (Sodium) | 16409-34-0 | Natural Products |
| HY-N14274 | Miyakamide A1 | 497252-38-7 | Natural Products |
| HY-N14275 | Miyakamide A2 | 497252-39-8 | Natural Products |
| HY-N14276 | Miyakamide B1 | 497182-82-8 | Natural Products |
| HY-N14277 | Miyakamide B2 | 497182-83-9 | Natural Products |
| HY-N1427A | Glycodeoxycholic acid (monohydrate) | 1079043-81-4 | Natural Products |
| HY-N1427AR | Glycodeoxycholic acid (monohydrate) (Standard) | 1079043-81-4 | Reference Standards |
| HY-N1427R | Glycodeoxycholate (Sodium) (Standard) | 16409-34-0 | Reference Standards |
| HY-N1428 | Citric acid | 77-92-9 | Natural Products |
| HY-N14282 | Ezomycin B2 | 57973-16-7 | Natural Products |
| HY-N14283 | Ezomycin D2 | 57973-11-2 | Natural Products |
| HY-N14284 | Mniopetal A | 158760-98-6 | Natural Products |
| HY-N14285 | Mniopetal B | 158760-99-7 | Natural Products |
| HY-N14286 | Mniopetal C | 158761-00-3 | Natural Products |
| HY-N14287 | Mniopetal D | 158761-01-4 | Natural Products |
| HY-N14288 | Mniopetal E | 158761-02-5 | Natural Products |
| HY-N14289 | Mniopetal F | 158761-03-6 | Natural Products |
| HY-N1428A | Citric acid (monohydrate) | 5949-29-1 | Biochemical Assay Reagents |
| HY-N1428AR | Citric acid (monohydrate) (Standard) | 5949-29-1 | Reference Standards |
| HY-N1428C | Ferric citrate | 3522-50-7 | Reference compound |
| HY-N1428CR | Ferric citrate (Standard) | 3522-50-7 | Reference Standards |
| HY-N1428R | Citric acid (standard) | 77-92-9 | Reference Standards |
| HY-N1428S | Citric acid-d4 | 147664-83-3 | Isotope-Labeled Compounds |
| HY-N1428S1 | Citric acid-13C6 | 287389-42-8 | Isotope-Labeled Compounds |
| HY-N1428S3 | Citric acid-13C3 | 302912-06-7 | Isotope-Labeled Compounds |
| HY-N1428S6 | Citric acid-d4-1 | Isotope-Labeled Compounds | |
| HY-N1429 | Taurochenodeoxycholic acid (sodium) | 6009-98-9 | Natural Products |
| HY-N1429R | Taurochenodeoxycholic acid (sodium) (Standard) | 6009-98-9 | Reference Standards |
| HY-N1429S | Taurochenodeoxycholic acid-d9 (sodium) | 2483832-00-2 | Isotope-Labeled Compounds |
| HY-N1429S1 | Taurochenodeoxycholic acid-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-N1429S2 | Taurochenodeoxycholic acid-d4-1 (sodium) | Isotope-Labeled Compounds | |
| HY-N1430 | Oxyresveratrol | 29700-22-9 | Natural Products |
| HY-N14301 | Aquayamycin | 26055-63-0 | Natural Products |
| HY-N14304 | Asperlicin | 93413-04-8 | Natural Products |
| HY-N14306 | Aspersitin | 86996-89-6 | Natural Products |
| HY-N14308 | Aspiculamycin | 2096-42-6 | Natural Products |
| HY-N14309 | Astechrome | 75310-10-0 | Natural Products |
| HY-N1430R | Oxyresveratrol (Standard) | 29700-22-9 | Reference Standards |
| HY-N1431 | Tabersonine | 4429-63-4 | Natural Products |
| HY-N14317 | Feigrisolide A | 313949-16-5 | Natural Products |
| HY-N14318 | Feigrisolide B | 313949-17-6 | Natural Products |
| HY-N14319 | Feigrisolide C | 313949-18-7 | Natural Products |
| HY-N1431A | Tabersonine (hydrochloride) | 29479-00-3 | Natural Products |
| HY-N1432 | Lirioprolioside B | 182284-68-0 | Natural Products |
| HY-N14320 | Lactaroviolin | 85-33-6 | Natural Products |
| HY-N14321 | Feigrisolide D | 313949-19-8 | Natural Products |
| HY-N14322 | Mollisin | 667-92-5 | Natural Products |
| HY-N14323 | Madindoline A | 184877-64-3 | Natural Products |
| HY-N14325 | Madindoline B | 184877-65-4 | Natural Products |
| HY-N14327 | Ferensimycin B | 135501-80-3 | Natural Products |
| HY-N14329 | Maniwamycin B | 122547-71-1 | Natural Products |
| HY-N1433 | Phytolaccagenin | 1802-12-6 | Natural Products |
| HY-N14330 | Fibrostatin A | 91776-42-0 | Natural Products |
| HY-N14331 | Fibrostatin B | 91776-48-6 | Natural Products |
| HY-N14332 | Fibrostatin D | 91776-46-4 | Natural Products |
| HY-N14333 | Halomicin A | 56411-51-9 | Natural Products |
| HY-N14334 | Halomicin B | 54356-09-1 | Natural Products |
| HY-N14335 | Halomicin C | 64419-06-3 | Natural Products |
| HY-N14336 | Halomicin D | 56413-94-6 | Natural Products |
| HY-N14338 | Sannamycin L | 83946-32-1 | Natural Products |
| HY-N14339 | Fibrostatin E | 91776-44-2 | Natural Products |
| HY-N1433R | Phytolaccagenin (Standard) | 1802-12-6 | Reference Standards |
| HY-N1434 | Methyl p-coumarate | 3943-97-3 | Natural Products |
| HY-N14340 | Fibrostatin F | 91776-45-3 | Natural Products |
| HY-N14341 | Mannosyl glucosaminide | 14510-04-4 | Natural Products |
| HY-N14342 | Manumycin E | 156250-43-0 | Natural Products |
| HY-N14343 | Manumycin F | 156317-47-4 | Natural Products |
| HY-N14344 | Manumycin G | 156250-44-1 | Natural Products |
| HY-N14345 | Marcellomycin | 63710-10-1 | Natural Products |
| HY-N14348 | Astepyrone | 86925-92-0 | Natural Products |
| HY-N14349 | Asterriquinone | 60696-52-8 | Natural Products |
| HY-N1435 | Oroxin B | 114482-86-9 | Natural Products |
| HY-N14350 | 2'''-Hydroxychlorothricin | 111810-18-5 | Natural Products |
| HY-N14351 | Ferrocin A | 114550-08-2 | Natural Products |
| HY-N14353 | Papulacandins A | 61036-46-2 | Natural Products |
| HY-N14354 | Ferrocin B | 114562-40-2 | Natural Products |
| HY-N14359 | Megovalicin B | 89759-26-2 | Natural Products |
| HY-N1435R | Oroxin B (Standard) | 114482-86-9 | Reference Standards |
| HY-N1436 | L-(+)-Abrine | 526-31-8 | Natural Products |
| HY-N14360 | Megovalicin H | 115932-37-1 | Natural Products |
| HY-N14363 | Fistupyrone | 315193-05-6 | Natural Products |
| HY-N14364 | Flavipucine | 38473-18-6 | Natural Products |
| HY-N14365 | Sannamycin J | 83997-42-6 | Natural Products |
| HY-N14366 | Fleephilone | 183239-76-1 | Natural Products |
| HY-N14367 | Fluoropolyoxin L | 50355-67-4 | Natural Products |
| HY-N1437 | Hydroxycitric acid | 6205-14-7 | Natural Products |
| HY-N14370 | Menoxymycin A | 160492-65-9 | Natural Products |
| HY-N14371 | Menoxymycin B | 160523-76-2 | Natural Products |
| HY-N14372 | Methymycin | 497-72-3 | Natural Products |
| HY-N14373 | Mycelianamide | 22775-52-6 | Natural Products |
| HY-N14374 | Mycoplanecin B | 81018-84-0 | Natural Products |
| HY-N14375 | Mycoplanecin C | 81018-83-9 | Natural Products |
| HY-N1438 | Hydroxygenkwanin | 20243-59-8 | Natural Products |
| HY-N14380 | Sannamycin K | 83919-30-6 | Natural Products |
| HY-N14381 | Leptofuranin A | 183017-80-3 | Natural Products |
| HY-N14382 | Leptofuranin B | 183017-81-4 | Natural Products |
| HY-N14383 | Leptofuranin C | 183017-82-5 | Natural Products |
| HY-N14384 | Leptofuranin D | 183017-83-6 | Natural Products |
| HY-N14386 | Istamycin Y0 | 73491-61-9 | Natural Products |
| HY-N1438R | Hydroxygenkwanin (Standard) | 20243-59-8 | Reference Standards |
| HY-N1439 | Methyl gypsogenin-3-O-glucuronide | 96553-02-5 | Natural Products |
| HY-N14390 | Asticolorin A | 93376-70-6 | Natural Products |
| HY-N14391 | Asticolorin B | 93376-71-7 | Natural Products |
| HY-N14392 | Fluoropolyoxin M | 50355-68-5 | Natural Products |
| HY-N14393 | Fomecin A | 1403-56-1 | Natural Products |
| HY-N14394 | Fusicoccin H | 50906-51-9 | Natural Products |
| HY-N14395 | Formadicin A | 99150-60-4 | Natural Products |
| HY-N14396 | Sannamycin F | 83931-91-3 | Natural Products |
| HY-N14398 | Sannamycin E | 73051-92-0 | Natural Products |
| HY-N14399 | Fortimicin B | 54783-95-8 | Natural Products |
| HY-N1440 | Koumine | 1358-76-5 | Natural Products |
| HY-N14401 | Salfredin B11 | 165467-63-0 | Natural Products |
| HY-N14402 | Mycoplanecin D | 89355-38-4 | Natural Products |
| HY-N14404 | Fosfadecin | 120909-50-4 | Natural Products |
| HY-N14408 | Fosfazinomycin B | 87423-11-8 | Natural Products |
| HY-N14409 | Mycoversilin | 88527-18-8 | Natural Products |
| HY-N1440R | Koumine (Standard) | 1358-76-5 | Reference Standards |
| HY-N1441 | Afzelin | 482-39-3 | Natural Products |
| HY-N14410 | Clecarmycin C | 136427-31-1 | Natural Products |
| HY-N144101 | SARS-CoV MPro-IN-2 | 81418-42-0 | Natural Products |
| HY-N14411 | Myxovirescin A | 85279-97-6 | Natural Products |
| HY-N144114 | P-gp inhibitor 2 | 2408406-89-1 | Reference compound |
| HY-N14412 | Napyradiomycin A2 | 111216-62-7 | Natural Products |
| HY-N14413 | Narbomycin | 6036-25-5 | Natural Products |
| HY-N14415 | Cochleamycin A | 134769-19-0 | Natural Products |
| HY-N14416 | Parvodicin A | 110882-81-0 | Natural Products |
| HY-N14418 | Parvodicin B1 | 110882-82-1 | Natural Products |
| HY-N14419 | Salfredin C3 | 139542-58-8 | Natural Products |
| HY-N1441R | Afzelin (Standard) | 482-39-3 | Reference Standards |
| HY-N1442 | Acid orange 7 | 633-96-5 | Dye Reagents |
| HY-N14420 | Parvodicin B2 | 110882-83-2 | Natural Products |
| HY-N14422 | Collismycin B | 158792-25-7 | Natural Products |
| HY-N14423 | Concanamycin D | 144450-34-0 | Natural Products |
| HY-N14425 | Concanamycin E | 144450-35-1 | Natural Products |
| HY-N14426 | Concanamycin F | 144539-92-4 | Natural Products |
| HY-N14427 | Concanamycin G | 144730-82-5 | Natural Products |
| HY-N14428 | Fosfocytocin | 126986-25-2 | Natural Products |
| HY-N14429 | Fredericamycin A | 80455-68-1 | Natural Products |
| HY-N1442R | Acid orange 7 (Standard) | 633-96-5 | Dye Reagents |
| HY-N1443 | Demethylcantharidate (disodium) | 129-67-9 | Natural Products |
| HY-N14431 | Salfredin C2 | 139542-57-7 | Natural Products |
| HY-N14432 | Fujianmycin A | 96695-57-7 | Natural Products |
| HY-N14433 | Fumigatin | 484-89-9 | Natural Products |
| HY-N14434 | Pradimicin B | 117704-66-2 | Natural Products |
| HY-N14435 | Pradimicin Q | 141869-53-6 | Natural Products |
| HY-N14436 | Pradimicin Tl | 149598-64-1 | Natural Products |
| HY-N14437 | Pradimicin T2 | 149598-63-0 | Natural Products |
| HY-N14438 | Furaquinocin A | 125108-66-9 | Natural Products |
| HY-N14439 | Furaquinocin B | 125224-54-6 | Natural Products |
| HY-N1444 | Complanatuside | 116183-66-5 | Natural Products |
| HY-N14440 | Furaquinocin C | 134984-98-8 | Natural Products |
| HY-N14445 | Sakyomicin D | 86413-77-6 | Natural Products |
| HY-N14447 | Salfredin A3 | 139542-53-3 | Natural Products |
| HY-N14449 | Salfredin A4 | 139542-54-4 | Natural Products |
| HY-N1444R | Complanatuside (Standard) | 116183-66-5 | Reference Standards |
| HY-N1445 | Isoquercitrin | 482-35-9 | Natural Products |
| HY-N14450 | Salfredin A7 | 139542-55-5 | Natural Products |
| HY-N14451 | Salfredin C1 | 139542-56-6 | Natural Products |
| HY-N1445R | Isoquercitrin (Standard) | 482-35-9 | Reference Standards |
| HY-N1446 | Oleic acid | 112-80-1 | Natural Products |
| HY-N14469 | Sakyomicin C | 86413-76-5 | Natural Products |
| HY-N1446A | Glycerol Monoleate | 25496-72-4 | Reference compound |
| HY-N1446AR | Glycerol Monoleate (Standard) | 25496-72-4 | Reference Standards |
| HY-N1446B | Sodium oleate | 143-19-1 | Natural Products |
| HY-N1446BR | Sodium oleate (Standard) | 143-19-1 | Reference Standards |
| HY-N1446C | Sorbitan monooleate | 1338-43-8 | Reference compound |
| HY-N1446R | Oleic acid (Standard) | 112-80-1 | Reference Standards |
| HY-N1446S | Oleic acid-13C | 82005-44-5 | Isotope-Labeled Compounds |
| HY-N1446S1 | Oleic acid-d2 | 5711-29-5 | Isotope-Labeled Compounds |
| HY-N1446S2 | Oleic acid-13C18 | 287100-82-7 | Isotope-Labeled Compounds |
| HY-N1446S3 | Oleic acid-d17 | 223487-44-3 | Isotope-Labeled Compounds |
| HY-N1446S4 | Oleic acid-13C-1 | 2483735-58-4 | Isotope-Labeled Compounds |
| HY-N1446S5 | Oleic acid-d9 | 2687960-84-3 | Isotope-Labeled Compounds |
| HY-N1447 | Ganoderic acid A | 81907-62-2 | Natural Products |
| HY-N14471 | Fusacandin A | 166407-33-6 | Natural Products |
| HY-N14472 | Fusacandin B | 166407-34-7 | Natural Products |
| HY-N14473 | Fusarin C | 79748-81-5 | Natural Products |
| HY-N14474 | Fusarubin | 1702-77-8 | Natural Products |
| HY-N14475 | Sakyomicin B | 86470-27-1 | Natural Products |
| HY-N14477 | Saframycin Mx2 | 113036-79-6 | Natural Products |
| HY-N14478 | Saframycin Mx1 | 113036-78-5 | Natural Products |
| HY-N1447R | Ganoderic acid A (Standard) | 81907-62-2 | Reference Standards |
| HY-N1448 | Vincetoxicoside B | 22007-72-3 | Natural Products |
| HY-N14480 | Phenelfamycins A | 118498-91-2 | Natural Products |
| HY-N14482 | Phenelfamycins D | 118498-94-5 | Natural Products |
| HY-N14483 | Phenelfamycins C | 118498-93-4 | Natural Products |
| HY-N14485 | Nebramycin Ⅳ | 51736-76-6 | Natural Products |
| HY-N14486 | Neihumicin | 111451-12-8 | Natural Products |
| HY-N14487 | Nemotin | 502-12-5 | Natural Products |
| HY-N14488 | Nemotinic acid | 539-98-0 | Natural Products |
| HY-N14489 | Neocopiamycin A | 89989-28-6 | Natural Products |
| HY-N1448R | Vincetoxicoside B (Standard) | 22007-72-3 | Reference Standards |
| HY-N1449 | Neonuezhenide | 96382-91-1 | Natural Products |
| HY-N14490 | Coumamidine γ1 | 121634-35-3 | Natural Products |
| HY-N14491 | Coumamidine γ2 | 121634-34-2 | Natural Products |
| HY-N14492 | Coumermycin A2 | 3130-60-7 | Natural Products |
| HY-N14494 | Neoviridogrisein Ⅰ | 66002-39-9 | Natural Products |
| HY-N14495 | Nidulal | 185853-14-9 | Natural Products |
| HY-N14496 | Nisamycin | 150829-93-9 | Natural Products |
| HY-N14497 | Nocardicyclin A | 199173-81-4 | Natural Products |
| HY-N14499 | Saframycin H | 92569-01-2 | Natural Products |
| HY-N1450 | Aristolochic acid C | 4849-90-5 | Natural Products |
| HY-N14502 | Gambierol | 146763-62-4 | Natural Products |
| HY-N14506 | Gibbestatin B | 89687-34-3 | Natural Products |
| HY-N1450R | Aristolochic acid C (Standard) | 4849-90-5 | Reference Standards |
| HY-N1451 | Betulonic acid | 4481-62-3 | Natural Products |
| HY-N14513 | Pyrrolomycin A | 79763-01-2 | Natural Products |
| HY-N14514 | Gentamicin X2 | 36889-17-5 | Natural Products |
| HY-N14515 | Saframycin G | 92569-02-3 | Natural Products |
| HY-N14516 | Saframycin F | 92569-03-4 | Natural Products |
| HY-N1451R | Betulonic acid (Standard) | 4481-62-3 | Reference Standards |
| HY-N14522 | Gilvocarcin E | 80937-34-4 | Natural Products |
| HY-N14523 | Gilvusmycin | 195052-09-6 | Natural Products |
| HY-N14524 | Gladiolic acid | 478-05-7 | Natural Products |
| HY-N14525 | Glisoprenin A | 144376-62-5 | Natural Products |
| HY-N14526 | Octacosamicin A | 122005-25-8 | Natural Products |
| HY-N14527 | Octacosamicin B | 122005-24-7 | Natural Products |
| HY-N14528 | Oganomycin A | 75794-94-4 | Natural Products |
| HY-N14529 | Oganomycin B | 75794-96-6 | Natural Products |
| HY-N1453 | Hypocrellin B | 123940-54-5 | Natural Products |
| HY-N14530 | Cremeomycin | 11050-22-9 | Natural Products |
| HY-N14532 | Pyrrolomycin E | 87376-16-7 | Natural Products |
| HY-N14538 | Saframycin E | 66082-31-3 | Natural Products |
| HY-N14539 | Pyrromycin | 668-17-7 | Natural Products |
| HY-N1453R | Hypocrellin B (Standard) | 123940-54-5 | Reference Standards |
| HY-N1454 | Apigenin-7-glucuronide | 29741-09-1 | Natural Products |
| HY-N14541 | Saframycin B | 66082-28-8 | Natural Products |
| HY-N14542 | Oleficin | 12764-54-4 | Natural Products |
| HY-N14543 | Olivomycin A | 6988-58-5 | Natural Products |
| HY-N14544 | Orchinol | 41060-20-2 | Natural Products |
| HY-N14545 | Oxamicetin | 52665-75-5 | Natural Products |
| HY-N14546 | Oxirapentyn | 88205-90-7 | Natural Products |
| HY-N14547 | Crotocin | 21284-11-7 | Natural Products |
| HY-N14548 | Cryptosporiopsin | 25707-30-6 | Natural Products |
| HY-N14549 | Cycloepoxydon | 193481-66-2 | Natural Products |
| HY-N1454R | Apigenin-7-glucuronide (Standard) | 29741-09-1 | Reference Standards |
| HY-N1455 | Falcarinol | 21852-80-2 | Natural Products |
| HY-N14550 | Cyclogregatin | 120167-25-1 | Natural Products |
| HY-N14551 | Roseorubicin B | 70559-01-2 | Natural Products |
| HY-N14552 | Quadrilineatin | 642-27-3 | Natural Products |
| HY-N14560 | Cyclopaldic acid | 477-99-6 | Natural Products |
| HY-N14561 | Cyclophellitol | 126661-83-4 | Natural Products |
| HY-N14562 | Cyclo (D-Pro-L-Val) | 156617-55-9 | Natural Products |
| HY-N14563 | Cycloviracin B1 | 142382-45-4 | Natural Products |
| HY-N14564 | Cycloviracin B2 | 142382-46-5 | Natural Products |
| HY-N14565 | Cymbimicin A | 200563-97-9 | Natural Products |
| HY-N14566 | Cymbimicin B | 200564-07-4 | Natural Products |
| HY-N14567 | Cytochalasin F | 36084-18-1 | Natural Products |
| HY-N14568 | Cytochalasin G | 54874-57-6 | Natural Products |
| HY-N14569 | Cytochalasin L | 79637-87-9 | Natural Products |
| HY-N1457 | Chrysosplenetin | 603-56-5 | Natural Products |
| HY-N14571 | Quinomycin B | 13602-52-3 | Natural Products |
| HY-N14572 | Roseorubicin A | 70559-00-1 | Natural Products |
| HY-N14573 | Glisoprenin B | 144376-63-6 | Natural Products |
| HY-N14574 | Glisoprenin C | 205594-88-3 | Natural Products |
| HY-N14578 | Roselipin 2B | 232258-27-4 | Natural Products |
| HY-N14579 | Racemomycin D | 3776-36-1 | Natural Products |
| HY-N1458 | Isoschaftoside | 52012-29-0 | Natural Products |
| HY-N14580 | Roselipin 2A | 232258-26-3 | Natural Products |
| HY-N14581 | Roselipin 1A | 232258-17-2 | Natural Products |
| HY-N14582 | Glomosporin | 288631-37-8 | Natural Products |
| HY-N14583 | Glucoallosamidin A | 136236-41-4 | Natural Products |
| HY-N14584 | Roselipin 1B | 232258-18-3 | Natural Products |
| HY-N14585 | Ramulosin | 29914-01-0 | Natural Products |
| HY-N14586 | Roridin J | 74072-83-6 | Natural Products |
| HY-N14587 | Oxypyrrolnitrin | 15345-51-4 | Natural Products |
| HY-N14588 | Pacidamycin 2 | 121264-06-0 | Natural Products |
| HY-N14589 | Resorcinomycin A | 100234-70-6 | Natural Products |
| HY-N1458R | Isoschaftoside (Standard) | 52012-29-0 | Reference Standards |
| HY-N1459 | Campesterol | 474-62-4 | Natural Products |
| HY-N14593 | Roridin D | 14682-29-2 | Natural Products |
| HY-N14594 | Glucoallosamidin B | 136236-42-5 | Natural Products |
| HY-N14595 | Resorcinomycin B | 100234-69-3 | Natural Products |
| HY-N14596 | Glucolipsin A | 222613-92-5 | Natural Products |
| HY-N14597 | Glucolipsin B | 222613-93-6 | Natural Products |
| HY-N14598 | Glucopiericidin B | 108073-61-6 | Natural Products |
| HY-N14599 | Resorthiomycin | 126651-92-1 | Natural Products |
| HY-N1459A | (S)-Campesterol | 4651-51-8 | Natural Products |
| HY-N1459AS | (S)-Campesterol-d6 | 2260669-13-2 | Isotope-Labeled Compounds |
| HY-N1459R | Campesterol (Standard) | 474-62-4 | Reference Standards |
| HY-N1459S | (24Rac)-Campesterol-d7 | 2483832-11-5 | Isotope-Labeled Compounds |
| HY-N14600 | Stambomycin A | 1263082-06-9 | Natural Products |
| HY-N14601 | Respinomycin A1 | 138843-19-3 | Natural Products |
| HY-N14602 | Rifamycin W | 53904-81-7 | Natural Products |
| HY-N14603 | Chandrananimycin A | 664355-12-8 | Natural Products |
| HY-N14604 | Chandrananimycin B | 664355-13-9 | Natural Products |
| HY-N14605 | Chandrananimycin C | 664355-11-7 | Natural Products |
| HY-N14606 | Pacidamycin 3 | 121280-49-7 | Natural Products |
| HY-N14607 | Pacidamycin 5 | 122855-43-0 | Natural Products |
| HY-N14608 | Pacidamycin D | 287107-95-3 | Natural Products |
| HY-N14609 | Respinomycin A2 | 151233-04-4 | Natural Products |
| HY-N1461 | Dihydrodaidzein | 17238-05-0 | Natural Products |
| HY-N14610 | Grahamimycin B | 883434-90-0 | Natural Products |
| HY-N14611 | Pyrazomycin Ⅱ | 41855-21-4 | Natural Products |
| HY-N14612 | Griseochelin | 91920-88-6 | Natural Products |
| HY-N14613 | Rhodomycin B | 1404-52-0 | Natural Products |
| HY-N14614 | Pyripyropene B | 151519-44-7 | Natural Products |
| HY-N14615 | Pyrisulfoxin A | 187337-07-1 | Natural Products |
| HY-N14616 | Reumycin | 5016-18-2 | Natural Products |
| HY-N14617 | Rhodirubin A | 64253-73-2 | Natural Products |
| HY-N14619 | Rhodirubin B | 64502-82-5 | Natural Products |
| HY-N1461R | Dihydrodaidzein (Standard) | 17238-05-0 | Reference Standards |
| HY-N1462 | Atractyloside (potassium salt) | 102130-43-8 | Natural Products |
| HY-N14621 | Harzialacton A | 321868-49-9 | Natural Products |
| HY-N14623 | Paulomycin B | 81988-76-3 | Natural Products |
| HY-N14624 | Pelagiomicin B | 173485-81-9 | Natural Products |
| HY-N14625 | Harziphilone | 183239-75-0 | Natural Products |
| HY-N14626 | Pelagiomicin C | 173485-82-0 | Natural Products |
| HY-N14627 | Liposidomycin A | 99751-55-0 | Natural Products |
| HY-N14628 | Liposidomycin B | 99751-53-8 | Natural Products |
| HY-N14629 | Liposidomycin C | 99751-54-9 | Natural Products |
| HY-N1462R | Atractyloside (potassium salt) (Standard) | 102130-43-8 | Reference Standards |
| HY-N1463 | Luteolin 7-O-glucuronide | 29741-10-4 | Natural Products |
| HY-N14630 | Lividomycin B | 37636-51-4 | Natural Products |
| HY-N14632 | Louisianin A | 171784-03-5 | Natural Products |
| HY-N14633 | Louisianin B | 1192169-18-8 | Natural Products |
| HY-N14634 | Louisianin C | 171784-05-7 | Natural Products |
| HY-N14635 | Paeciloquinone A | 162797-33-3 | Natural Products |
| HY-N14636 | Paeciloquinone B | 162797-34-4 | Natural Products |
| HY-N14637 | Paeciloquinone C | 92439-42-4 | Natural Products |
| HY-N14638 | Paeciloquinone D | 162797-35-5 | Natural Products |
| HY-N14639 | Paeciloquinone E | 162797-36-6 | Natural Products |
| HY-N1463R | Luteolin 7-O-glucuronide (Standard) | 29741-10-4 | Reference Standards |
| HY-N14640 | Paeciloquinone F | 162797-37-7 | Natural Products |
| HY-N14641 | Panclicin A | 160669-37-4 | Natural Products |
| HY-N14642 | Panclicin B | 160700-42-5 | Natural Products |
| HY-N14643 | Panclicin C | 160669-43-2 | Natural Products |
| HY-N14644 | Hazimycin 5 | 84894-71-3 | Natural Products |
| HY-N14646 | Panclicin D | 160669-44-3 | Natural Products |
| HY-N14647 | Panclicin E | 160669-45-4 | Natural Products |
| HY-N14648 | Purpactin B | 133806-60-7 | Natural Products |
| HY-N14649 | Purpactin C | 133806-61-8 | Natural Products |
| HY-N1464A | Aristolone | 25274-27-5 | Natural Products |
| HY-N1465 | Aristolochic acid D | 17413-38-6 | Natural Products |
| HY-N14650 | Hazimycin 6 | 84885-57-4 | Natural Products |
| HY-N14651 | Glucosylquestiomycin | 218150-62-0 | Natural Products |
| HY-N14652 | Glycocinnasperimicin D | 99260-73-8 | Natural Products |
| HY-N14653 | Glysperin A | 78213-56-6 | Natural Products |
| HY-N14654 | Glysperin B | 78213-55-5 | Natural Products |
| HY-N14655 | Paulomenol A | 94739-81-8 | Natural Products |
| HY-N14656 | Paulomenol B | 97670-28-5 | Natural Products |
| HY-N14657 | Paulomycin A2 | 101411-68-1 | Natural Products |
| HY-N14658 | Phosmidosine B | 146425-23-2 | Natural Products |
| HY-N14659 | Pilatin | 119525-97-2 | Natural Products |
| HY-N1465R | Aristolochic acid D (Standard) | 17413-38-6 | Reference Standards |
| HY-N14660 | Granaticin B | 19879-03-9 | Natural Products |
| HY-N14661 | Granaticinic acid | 71203-17-3 | Natural Products |
| HY-N14662 | Griseolic acid B | 98890-01-8 | Natural Products |
| HY-N14663 | Griseolic acid C | 100242-49-7 | Natural Products |
| HY-N14664 | Actithiazic acid | 539-35-5 | Natural Products |
| HY-N14665 | Atrovenetin | 2582-86-7 | Natural Products |
| HY-N14666 | Agrocybin | 544-44-5 | Natural Products |
| HY-N14667 | Cladospolide A | 77663-54-8 | Natural Products |
| HY-N14668 | Cladospolide B | 96443-55-9 | Natural Products |
| HY-N14669 | Cladospolide D | 371229-61-7 | Natural Products |
| HY-N1467 | (-)-α-Terpineol | 10482-56-1 | Natural Products |
| HY-N14670 | Pentenocin A | 249283-62-3 | Natural Products |
| HY-N14671 | Hedamycin | 11048-97-8 | Natural Products |
| HY-N14672 | Pentenocin B | 249283-63-4 | Natural Products |
| HY-N14673 | Helvecardin A | 119979-33-8 | Natural Products |
| HY-N14674 | Permetin A | 71888-70-5 | Natural Products |
| HY-N14675 | Helvecardin B | 119979-34-9 | Natural Products |
| HY-N14676 | Phenochalasin B | 207679-46-7 | Natural Products |
| HY-N14677 | Pillaromycin A | 30361-37-6 | Natural Products |
| HY-N14678 | Piloquinone | 25414-26-0 | Natural Products |
| HY-N14679 | Pinselin | 476-53-9 | Natural Products |
| HY-N1468 | Agarotetrol | 69809-22-9 | Natural Products |
| HY-N14680 | Glysperin C | 78213-54-4 | Natural Products |
| HY-N14681 | Griseorhodin A | 11048-91-2 | Natural Products |
| HY-N14682 | Helvolinic acid | 10072-61-4 | Natural Products |
| HY-N14683 | Griseusin A | 59554-11-9 | Natural Products |
| HY-N14684 | Griseusin B | 59554-12-0 | Natural Products |
| HY-N14685 | Heptaibin | 291311-47-2 | Natural Products |
| HY-N14686 | Phencomycin | 146615-53-4 | Natural Products |
| HY-N14687 | Herbicidin B | 55353-32-7 | Natural Products |
| HY-N14688 | Phenylpyropene B | 556013-83-3 | Natural Products |
| HY-N14689 | Hibarimicin D | 208588-87-8 | Natural Products |
| HY-N1468R | Agarotetrol (Standard) | 69809-22-9 | Reference Standards |
| HY-N1469 | Kaurenoic acid | 6730-83-2 | Natural Products |
| HY-N14690 | Piperazinomycin | 83858-82-6 | Natural Products |
| HY-N14691 | Platenomycin C3 | 35908-44-2 | Natural Products |
| HY-N14692 | Pluracidomycin A1 | 82138-64-5 | Natural Products |
| HY-N14693 | Pluracidomycin B | 82138-65-6 | Natural Products |
| HY-N14694 | Pluracidomycin C1 | 82138-66-7 | Natural Products |
| HY-N14696 | Cytochalasin M | 79648-73-0 | Natural Products |
| HY-N14697 | Cytorhodin X | 133914-58-6 | Natural Products |
| HY-N14698 | Cytotrienin A | 208527-57-5 | Natural Products |
| HY-N14699 | Diphenicillin | 304-43-8 | Natural Products |
| HY-N1469R | Kaurenoic acid (Standard) | 6730-83-2 | Reference Standards |
| HY-N1470 | Plantagoside | 78708-33-5 | Natural Products |
| HY-N14701 | 2-Hydroxygentamicin A3 | 78874-52-9 | Natural Products |
| HY-N14702 | 2-Hydroxygentamicin B | 78874-50-7 | Natural Products |
| HY-N14703 | 2-Hydroxygentamicin B1 | 78874-51-8 | Natural Products |
| HY-N14704 | 2-Hydroxygentamicin C1 | 60609-40-7 | Natural Products |
| HY-N14705 | 2-Hydroxygentamicin C2 | 60768-15-2 | Natural Products |
| HY-N14706 | Kibdelin A | 103528-50-3 | Natural Products |
| HY-N14707 | Kibdelin B | 103528-49-0 | Natural Products |
| HY-N14708 | Kibdelin C1 | 103549-47-9 | Natural Products |
| HY-N14709 | Kibdelin C2 | 105997-85-1 | Natural Products |
| HY-N1470R | Plantagoside (Standard) | 78708-33-5 | Reference Standards |
| HY-N1471 | Liquiritin apioside | 74639-14-8 | Natural Products |
| HY-N14710 | Kibdelin D | 105997-86-2 | Natural Products |
| HY-N14711 | Himalomycin A | 701915-10-8 | Natural Products |
| HY-N14713 | Gualamycin | 161017-23-8 | Natural Products |
| HY-N14714 | Gunacin | 73341-70-5 | Natural Products |
| HY-N14715 | Gypsetin | 155114-38-8 | Natural Products |
| HY-N14716 | Haematocin | 262425-39-8 | Natural Products |
| HY-N14717 | Polymyxin M | 6683-17-6 | Natural Products |
| HY-N14718 | Porothramycin A | 110652-73-8 | Natural Products |
| HY-N14719 | Porothramycin B | 110652-72-7 | Natural Products |
| HY-N1471R | Liquiritin apioside (Standard) | 74639-14-8 | Reference Standards |
| HY-N1472 | Levistolide A | 88182-33-6 | Natural Products |
| HY-N14721 | Erabulenol A | 20887-73-4 | Natural Products |
| HY-N14722 | Lactonamycin | 182234-02-2 | Natural Products |
| HY-N14726 | Primocarcin | 3750-26-3 | Natural Products |
| HY-N14728 | Homoalanosine | 114707-36-7 | Natural Products |
| HY-N14733 | 31-Homorifamycin W | 157049-51-9 | Natural Products |
| HY-N14734 | Disorazol A | 158181-47-6 | Natural Products |
| HY-N14735 | Dotriacolide | 80994-06-5 | Natural Products |
| HY-N14736 | Drosophilin | 484-67-3 | Natural Products |
| HY-N14737 | Dunaimycin A1 | 140221-72-3 | Natural Products |
| HY-N14738 | Dutomycin | 146663-67-4 | Natural Products |
| HY-N14739 | Dykellic acid | 1097679-78-1 | Natural Products |
| HY-N1474 | Picfeltarraenin IA | 97230-47-2 | Natural Products |
| HY-N14740 | Lanopylin A1 | 608135-01-9 | Natural Products |
| HY-N14741 | Lanopylin A2 | 679411-84-8 | Natural Products |
| HY-N14743 | Lanopylin B1 | 608135-02-0 | Natural Products |
| HY-N14744 | Lanopylin B2 | 679411-86-0 | Natural Products |
| HY-N14745 | Elaiomycin | 23315-05-1 | Natural Products |
| HY-N14746 | Elizabethin | 78361-81-6 | Natural Products |
| HY-N14747 | Elloramycin | 97218-42-3 | Natural Products |
| HY-N14748 | Elsamicin B | 97068-31-0 | Natural Products |
| HY-N14749 | Emerin | 40581-18-8 | Natural Products |
| HY-N1474R | Picfeltarraenin IA (Standard) | 97230-47-2 | Reference Standards |
| HY-N1475 | Nicotiflorin | 17650-84-9 | Natural Products |
| HY-N14750 | Emimycin | 3735-46-4 | Natural Products |
| HY-N14752 | Hydroxymycotrienin A | 178550-61-3 | Natural Products |
| HY-N14753 | Juglomycin A | 38637-88-6 | Natural Products |
| HY-N14754 | Juglomycin B | 38637-89-7 | Natural Products |
| HY-N14755 | Juvenimicin A2 | 61417-47-8 | Natural Products |
| HY-N14756 | 6"'-Deamino-6"'-hydroxyneomycin B | 78524-73-9 | Natural Products |
| HY-N14757 | Hydantocidin | 130607-26-0 | Natural Products |
| HY-N14758 | 6"'-Deamino-6"'-hydroxyparomomycin I | 78524-72-8 | Natural Products |
| HY-N14759 | Matlystatin B | 140923-32-6 | Natural Products |
| HY-N1475R | Nicotiflorin (Standard) | 17650-84-9 | Reference Standards |
| HY-N1476 | Heterophyllin B | 145459-19-4 | Natural Products |
| HY-N14760 | Leucomycin A9 | 18361-49-4 | Natural Products |
| HY-N14761 | Matlystatin D | 140638-25-1 | Natural Products |
| HY-N14762 | Leucomycin V | 22875-15-6 | Natural Products |
| HY-N14763 | 3'-O-Decarbamoylirumamycin | 99486-52-9 | Natural Products |
| HY-N14764 | 2-Hydroxyaclacinomycin A | 79127-36-9 | Natural Products |
| HY-N14765 | 7-Demethylnaphterpin | 137109-43-4 | Natural Products |
| HY-N14767 | Naphthablin | 167568-51-6 | Natural Products |
| HY-N14768 | O-Demethylpaulomycin A | 113603-74-0 | Natural Products |
| HY-N14769 | 2-Hydroxyaclacinomycin B | 85819-82-5 | Natural Products |
| HY-N1477 | Dencichine | 5302-45-4 | Natural Products |
| HY-N14770 | Matlystatin E | 140638-26-2 | Natural Products |
| HY-N14771 | Matlystatin F | 140667-42-1 | Natural Products |
| HY-N14772 | Laccaridione A | 320369-80-0 | Natural Products |
| HY-N14773 | Laccaridione B | 320369-81-1 | Natural Products |
| HY-N14774 | Lactoquinomycin B | 101342-94-3 | Natural Products |
| HY-N14775 | Lavanduquinocin | 167114-85-4 | Natural Products |
| HY-N14776 | 11-Demethyltomaymycin | 55511-85-8 | Natural Products |
| HY-N14777 | Hydroxyakalone | 182056-35-5 | Natural Products |
| HY-N14779 | Mureidomycin A | 114797-04-5 | Natural Products |
| HY-N1478 | Gardenoside | 24512-62-7 | Natural Products |
| HY-N14780 | Pochonin D | 544712-82-5 | Natural Products |
| HY-N14781 | 10-Decarbamoyloxy-9-dehydromitomycin B | 74148-44-0 | Natural Products |
| HY-N14782 | 10-Decarbomethoxyaclacinomycin A | 76264-91-0 | Natural Products |
| HY-N14783 | Decarestrictin M | 144161-38-6 | Natural Products |
| HY-N14784 | Dechloromycorrhizin A | 161815-17-4 | Natural Products |
| HY-N14785 | Deflectin 1a | 79495-61-7 | Natural Products |
| HY-N14786 | 2-Hydroxy-5-iminoazacyclopent-3-ene | 71765-74-7 | Natural Products |
| HY-N14787 | Basidalin | 82501-56-2 | Natural Products |
| HY-N14788 | Cephemimycin | 34279-51-1 | Natural Products |
| HY-N1479 | Polygalic acid | 1260-04-4 | Natural Products |
| HY-N14790 | Mureidomycin B | 114797-05-6 | Natural Products |
| HY-N14795 | Leucomentin-5 | 300662-10-6 | Natural Products |
| HY-N14796 | Leucomentin-6 | 300662-28-6 | Natural Products |
| HY-N14797 | Macquarimicin A | 165561-14-8 | Natural Products |
| HY-N14798 | Macquarimicin B | 165561-13-7 | Natural Products |
| HY-N14799 | Mycobacillin | 18524-67-9 | Natural Products |
| HY-N1479R | Polygalic acid (Standard) | 1260-04-4 | Reference Standards |
| HY-N1480 | (-)-Fucose | 2438-80-4 | Natural Products |
| HY-N14800 | 5-Hydroxymethylblasticidin S | 123067-52-7 | Natural Products |
| HY-N14803 | Nanaomycin B | 52934-85-7 | Natural Products |
| HY-N1480R | (-)-Fucose (Standard) | 2438-80-4 | Reference Standards |
| HY-N1480S | (-)-Fucose-13C | 83379-38-8 | Isotope-Labeled Compounds |
| HY-N1480S1 | (-)-Fucose-13C-1 | 83379-37-7 | Isotope-Labeled Compounds |
| HY-N1480S2 | (-)-Fucose-13C-2 | 478518-50-2 | Isotope-Labeled Compounds |
| HY-N1480S3 | (-)-Fucose-13C-3 | 478518-51-3 | Isotope-Labeled Compounds |
| HY-N1481 | Methyl linoleate | 112-63-0 | Natural Products |
| HY-N14815 | Nanaomycin D | 60325-08-8 | Natural Products |
| HY-N14818 | O-Acetylbenzeneamidinocarboxylic acid | 82744-16-9 | Natural Products |
| HY-N14819 | Defucogilvocarcin V | 80155-95-9 | Natural Products |
| HY-N1481R | Methyl linoleate (Standard) | 112-63-0 | Reference Standards |
| HY-N1481S | Linoleic Acid-d11 methyl ester | Isotope-Labeled Compounds | |
| HY-N1482 | Methyl palmitate | 112-39-0 | Natural Products |
| HY-N14820 | Kurasoin A | 182232-62-8 | Natural Products |
| HY-N14822 | 4-O-Demethyl-11-deoxydoxorubicin | 81382-05-0 | Natural Products |
| HY-N14823 | Demethylmacrocin | 79404-98-1 | Natural Products |
| HY-N14825 | Erythroskyrine | 4987-27-3 | Natural Products |
| HY-N14826 | Nanaomycin E | 72660-52-7 | Natural Products |
| HY-N14829 | Naphthoquinomycin A | 101190-62-9 | Natural Products |
| HY-N1482R | Methyl palmitate (Standard) | 112-39-0 | Reference Standards |
| HY-N1482S | Methyl palmitate-13C16 | Isotope-Labeled Compounds | |
| HY-N1482S1 | Methyl palmitate-d31 | 29848-79-1 | Isotope-Labeled Compounds |
| HY-N1483 | Guanfu base A | 1394-48-5 | Natural Products |
| HY-N14830 | 3-Hydroxyrifamycin S | 75922-14-4 | Natural Products |
| HY-N14833 | Naphthoquinomycin B | 101190-61-8 | Natural Products |
| HY-N14836 | Macquarimicin C | 165561-12-6 | Natural Products |
| HY-N14837 | Lymphostin | 191474-39-2 | Natural Products |
| HY-N14838 | Neoenactin A | 88231-85-0 | Natural Products |
| HY-N14839 | Neoenactin B2 | 88231-87-2 | Natural Products |
| HY-N1483A | Guanfu base A (hydrochloride) | 618094-85-2 | Natural Products |
| HY-N1484 | 7beta-Hydroxylathyrol | 34208-98-5 | Natural Products |
| HY-N14840 | 1-Hydroxysulfurmycin A | 79234-80-3 | Natural Products |
| HY-N14841 | Naphthyridinomycin | 54913-26-7 | Natural Products |
| HY-N14844 | Napyradiomycin C2 | 103106-19-0 | Natural Products |
| HY-N14845 | Napsamycin A | 126049-03-4 | Natural Products |
| HY-N14847 | 1-Hydroxyauramycin B | 79206-72-7 | Natural Products |
| HY-N14849 | 1-Hydroxyauramycin A | 79217-17-7 | Natural Products |
| HY-N1485 | Cycloastragenol | 78574-94-4 | Natural Products |
| HY-N14850 | Napsamycin B | 144408-86-6 | Natural Products |
| HY-N14851 | Napsamycin C | 144379-26-0 | Natural Products |
| HY-N14852 | Napsamycin D | 144379-27-1 | Natural Products |
| HY-N14853 | Ossamycin | 2057463-74-6 | Natural Products |
| HY-N14859 | 4-Hydroxybaumycinol A1 | 78919-31-0 | Natural Products |
| HY-N1485R | Cycloastragenol (Standard) | 78574-94-4 | Reference Standards |
| HY-N1486 | Ursonic acid | 6246-46-4 | Natural Products |
| HY-N14860 | Milbemycin β3 | 56198-39-1 | Natural Products |
| HY-N1486R | Ursonic acid (Standard) | 6246-46-4 | Reference Standards |
| HY-N1487 | Oleanonic acid | 17990-42-0 | Natural Products |
| HY-N14870 | Ostreogrycin B3 | 31508-69-7 | Natural Products |
| HY-N14877 | Enactin Ia | 130640-30-1 | Natural Products |
| HY-N14878 | Enactin Ⅰb | 137252-26-7 | Natural Products |
| HY-N14879 | Asticolorin C | 93395-44-9 | Natural Products |
| HY-N1487R | Oleanonic acid (Standard) | 17990-42-0 | Reference Standards |
| HY-N1488 | 14-Deoxy-17-hydroxyandrographolide | 869384-82-7 | Natural Products |
| HY-N14880 | Oudenone | 31323-50-9 | Natural Products |
| HY-N14887 | Phleomycin E | 11031-13-3 | Natural Products |
| HY-N14888 | Phyllosinol | 24292-29-3 | Natural Products |
| HY-N1489 | 14-Deoxy-11,12-didehydroandrographiside | 141973-41-3 | Natural Products |
| HY-N14891 | Pristinamycin ⅠC | 28979-74-0 | Natural Products |
| HY-N14892 | Cetoniacytone A | 496775-48-5 | Natural Products |
| HY-N14893 | Cetoniacytone B | 496775-49-6 | Natural Products |
| HY-N14894 | Promothiocin B | 156737-06-3 | Natural Products |
| HY-N14895 | Chitinovorin A | 95041-98-8 | Natural Products |
| HY-N14896 | Chitinovorin C | 95230-98-1 | Natural Products |
| HY-N1490 | 14-Deoxy-11,12-didehydroandrographolide | 42895-58-9 | Natural Products |
| HY-N14900 | Milbemycin β1 | 51596-16-8 | Natural Products |
| HY-N14902 | Mimosamycin | 59493-94-6 | Natural Products |
| HY-N14905 | α-Prumycin hydrochloride | 54612-75-8 | Natural Products |
| HY-N14909 | Actamycin | 76045-67-5 | Natural Products |
| HY-N1490R | 14-Deoxy-11,12-didehydroandrographolide (Standard) | 42895-58-9 | Reference Standards |
| HY-N1491 | 14-Deoxy-11-hydroxyandrographolide | 160242-09-1 | Natural Products |
| HY-N14910 | Actiketal | 133658-47-6 | Natural Products |
| HY-N14911 | Actinoplanone A | 115655-86-2 | Natural Products |
| HY-N14912 | β-Prumycin hydrochloride | 54612-74-7 | Natural Products |
| HY-N14913 | Adenomycin | 76174-56-6 | Natural Products |
| HY-N14914 | Adiposin | 83764-11-8 | Natural Products |
| HY-N14915 | Adxanthromycin A | 223740-97-4 | Natural Products |
| HY-N14916 | Quinomycin C | 11001-74-4 | Natural Products |
| HY-N1492 | 14-Deoxy-12-hydroxyandrographolide | 219721-33-2 | Natural Products |
| HY-N14922 | Nikkomycin Lx | 242149-96-8 | Natural Products |
| HY-N14923 | Nikkomycin Lz | 242149-97-9 | Natural Products |
| HY-N14925 | Citrinin hydrate | 157643-56-6 | Natural Products |
| HY-N14927 | Phepropeptin A | 396729-23-0 | Natural Products |
| HY-N14928 | Phepropeptin B | 396729-24-1 | Natural Products |
| HY-N14929 | Phepropeptin C | 396729-25-2 | Natural Products |
| HY-N14930 | Aeruginoic acid | 27501-91-3 | Natural Products |
| HY-N14931 | Aestivophoenin A | 171864-91-8 | Natural Products |
| HY-N14932 | Aggreceride A | 19207-26-2 | Natural Products |
| HY-N14933 | Aggreceride B | 104700-85-8 | Natural Products |
| HY-N14934 | Aggreceride C | 104700-86-9 | Natural Products |
| HY-N14935 | Agrobactin | 70393-50-9 | Natural Products |
| HY-N14936 | AK-toxin Ⅰ | 85146-09-4 | Natural Products |
| HY-N14937 | Albaflavenone | 157078-47-2 | Natural Products |
| HY-N14938 | Albocycline K3 | 178114-31-3 | Natural Products |
| HY-N1494 | (+)-14-Deoxy-ε-caesalpin | 279683-46-4 | Natural Products |
| HY-N14940 | Phepropeptin D | 396729-26-3 | Natural Products |
| HY-N1495 | Maltopentaose | 34620-76-3 | Natural Products |
| HY-N14957 | Clavicoronic acid | 139748-98-4 | Natural Products |
| HY-N14958 | Dedesosaminyl-5-O-mycaminosyl-10,11-dihydromycinamicin IV | 83883-27-6 | Natural Products |
| HY-N14959 | Deacetylravidomycin N-oxide | 114494-30-3 | Natural Products |
| HY-N1495R | Maltopentaose (Standard) | 34620-76-3 | Reference Standards |
| HY-N1496 | 15,16-Di-O-acetyldarutoside | 1188282-02-1 | Natural Products |
| HY-N14960 | Clavariopsin A | 227083-47-8 | Natural Products |
| HY-N14961 | Clavariopsin B | 227083-48-9 | Natural Products |
| HY-N14964 | Epihygromycin | 75081-92-4 | Natural Products |
| HY-N14967 | Epicillin | 26774-90-3 | Natural Products |
| HY-N14968 | Enniatin F | 144446-20-8 | Natural Products |
| HY-N1497 | Plumbagin | 481-42-5 | Natural Products |
| HY-N14972 | 3,6-Dihydroxyindoxazene | 86004-57-1 | Natural Products |
| HY-N14973 | Epoxyquinomicin D | 200496-86-2 | Natural Products |
| HY-N14974 | Ericamycin | 11052-01-0 | Natural Products |
| HY-N14975 | 3,4-Dimethoxytropolone | 69432-64-0 | Natural Products |
| HY-N14977 | Epoxyquinomicin C | 200496-85-1 | Natural Products |
| HY-N14978 | Eurocidin D | 130433-01-1 | Natural Products |
| HY-N14979 | Dermostatin A | 51053-36-2 | Natural Products |
| HY-N1497R | Plumbagin (Standard) | 481-42-5 | Reference Standards |
| HY-N1498 | 15,18-Dihydroxyabieta-8,11,13-trien-7-one | 213329-45-4 | Natural Products |
| HY-N14980 | Dermostatin B | 51141-40-3 | Natural Products |
| HY-N14981 | Eurocidin E | 130433-02-2 | Natural Products |
| HY-N14982 | Ferrimycin A1 | 15319-50-3 | Natural Products |
| HY-N14986 | Methylenomycin A | 52775-76-5 | Natural Products |
| HY-N14987 | Methylenomycin B | 52775-77-6 | Natural Products |
| HY-N14989 | Fluostatin A | 160219-74-9 | Natural Products |
| HY-N14989A | Fluostatin A (sodium) | 209673-93-8 | Natural Products |
| HY-N1499 | Nystose | 13133-07-8 | Natural Products |
| HY-N14990 | Pneumocandin C0 | 144074-96-4 | Natural Products |
| HY-N14992 | Melleolide L | 298702-67-7 | Natural Products |
| HY-N14995 | Frenolicin | 10023-07-1 | Natural Products |
| HY-N14997 | Fulvoplumierin | 20867-01-0 | Natural Products |
| HY-N14998 | Damavaricin D | 59556-95-5 | Natural Products |
| HY-N14999 | Decatromicin A | 235097-63-9 | Natural Products |
| HY-N1499R | Nystose (Standard) | 13133-07-8 | Reference Standards |
| HY-N1500 | Pulegone | 89-82-7 | Natural Products |
| HY-N15000 | Lipomycin β | 51053-41-9 | Natural Products |
| HY-N15001 | Gabaculine | 59556-18-2 | Natural Products |
| HY-N15004 | Galactostatin | 107537-94-0 | Natural Products |
| HY-N15005 | Espicufolin | 182232-96-8 | Natural Products |
| HY-N15007 | 6-Ethoxyethyl-5-hydroxy-2,7-dime-thoxy-1,4-naphtoquinone | 86343-22-8 | Natural Products |
| HY-N15009 | Kynapcin-13 | 476337-32-3 | Natural Products |
| HY-N1500R | Pulegone (Standard) | 89-82-7 | Reference Standards |
| HY-N1500S1 | Pulegone-d8 | Isotope-Labeled Compounds | |
| HY-N1501 | Beta-asarone | 5273-86-9 | Natural Products |
| HY-N15010 | Kynapcin-28 | 476337-33-4 | Natural Products |
| HY-N15011 | Ganoderic acid W | 86377-49-3 | Natural Products |
| HY-N15012 | 6-O-Demethyl-5-deoxyfusarubin | 132899-05-9 | Natural Products |
| HY-N15013 | 7-Deoxyloganin | 26660-57-1 | Natural Products |
| HY-N15014 | Deoxyradicinin | 84413-76-3 | Natural Products |
| HY-N15015 | Dephostatin | 151606-30-3 | Natural Products |
| HY-N15016 | 4-Deoxybostrycin | 21879-83-4 | Natural Products |
| HY-N15017 | Katanosin A | 116103-86-7 | Natural Products |
| HY-N15019 | Glycothiohexide α | 158446-31-2 | Natural Products |
| HY-N1501R | Beta-asarone (Standard) | 5273-86-9 | Reference Standards |
| HY-N1502 | Carboxyatractyloside (tripotassium) | 77228-71-8 | Natural Products |
| HY-N15020 | Izumenolide | 76265-39-9 | Natural Products |
| HY-N15021 | Azinothricin | 101342-90-9 | Natural Products |
| HY-N15022 | Azirinomycin | 31772-89-1 | Natural Products |
| HY-N15023 | Azoxybacilin | 157998-96-4 | Natural Products |
| HY-N15024 | Eupenoxide | 89773-19-3 | Natural Products |
| HY-N15025 | Hydroxynybomycin | 63582-81-0 | Natural Products |
| HY-N15026 | 13-Hydroxyglucopiericidin A | 132150-13-1 | Natural Products |
| HY-N15027 | Istamycin B | 72523-64-9 | Natural Products |
| HY-N15028 | Depsidomycin | 131956-33-7 | Natural Products |
| HY-N15029 | Destomycin A | 14918-35-5 | Natural Products |
| HY-N1503 | Methyl deacetylasperulosidate | 52613-28-2 | Natural Products |
| HY-N15030 | Diatretyne Ⅰ | 544-04-7 | Natural Products |
| HY-N15031 | Fumarprotocetraric acid | 489-50-9 | Natural Products |
| HY-N15032 | Espinomycin A3 | 35867-32-4 | Natural Products |
| HY-N15033 | Ganoderic acid U | 86377-51-7 | Natural Products |
| HY-N15034 | 7-Hydroxyguanine | 16870-91-0 | Natural Products |
| HY-N15035 | Bis(N-methylthioformohydroxamate)nickel (II) | 31541-90-9 | Natural Products |
| HY-N15037 | Flavomycoin | 77814-07-4 | Natural Products |
| HY-N15038 | Haloquinone | 80902-01-8 | Natural Products |
| HY-N15039 | 5-Hydroxymethyltubercidin | 49558-38-5 | Natural Products |
| HY-N1503R | Methyl deacetylasperulosidate (Standard) | 52613-28-2 | Reference Standards |
| HY-N1504 | Loureirin B | 119425-90-0 | Natural Products |
| HY-N15041 | Hitachimycin | 77642-19-4 | Natural Products |
| HY-N15042 | 9-Hydroxyoudemansin A | 225937-85-9 | Natural Products |
| HY-N15044 | Badione A | 90295-66-2 | Natural Products |
| HY-N15046 | Barminomycin I | 108147-17-7 | Natural Products |
| HY-N15047 | Barminomycin II | 108089-33-4 | Natural Products |
| HY-N15049 | Cefminox | 84305-41-9 | Natural Products |
| HY-N1504R | Loureirin B (Standard) | 119425-90-0 | Reference Standards |
| HY-N1505 | Loureirin A | 119425-89-7 | Natural Products |
| HY-N15050 | Cervicarcin | 18700-78-2 | Natural Products |
| HY-N15051 | Harveynone | 142435-66-3 | Natural Products |
| HY-N15052 | Monorden C | 544712-80-3 | Natural Products |
| HY-N15054 | 17-O-Demethylgeldanamycin | 52762-28-4 | Natural Products |
| HY-N15056 | Chainin | 38264-25-4 | Natural Products |
| HY-N15057 | Chivosazol A | 169181-40-2 | Natural Products |
| HY-N15058 | Chlorogentisylquinone | 333344-08-4 | Natural Products |
| HY-N15059 | Cissetin | 691407-97-3 | Natural Products |
| HY-N1505R | Loureirin A (Standard) | 119425-89-7 | Reference Standards |
| HY-N1506 | Ganodermanontriol | 106518-63-2 | Natural Products |
| HY-N15060 | 2-Hydroxybutirosin | 59867-75-3 | Natural Products |
| HY-N15062 | 2-Hydroxymethylclavam | 66036-39-3 | Natural Products |
| HY-N15063 | 10-Hydroxyundeca-2,4,6,8-tetraynamide | 83475-37-0 | Natural Products |
| HY-N15066 | 16-Hydroxyroridin L-2 | 87292-18-0 | Natural Products |
| HY-N15068 | 1-Hydroxyoxaunomycin | 145165-10-2 | Natural Products |
| HY-N1506R | Ganodermanontriol (Standard) | 106518-63-2 | Reference Standards |
| HY-N1507 | Tracheloside | 33464-71-0 | Natural Products |
| HY-N15070 | Polyozellin | 197703-46-1 | Natural Products |
| HY-N15075 | Espinomycin A2 | 40867-12-7 | Natural Products |
| HY-N15076 | Herbimycin B | 76207-83-5 | Natural Products |
| HY-N15077 | 11-Deacetoxywortmannin | 31652-69-4 | Natural Products |
| HY-N15078 | 4-Chlorothreonine | 142698-80-4 | Natural Products |
| HY-N15079 | Arphamenine B | 88465-81-0 | Natural Products |
| HY-N1507R | Tracheloside (Standard) | 33464-71-0 | Reference Standards |
| HY-N1508 | Ecliptasaponin A | 78285-90-2 | Natural Products |
| HY-N15080 | S-2,3-Dicarboxyaziridine | 57528-68-4 | Natural Products |
| HY-N15082 | Hypnophilin | 80677-96-9 | Natural Products |
| HY-N15083 | Iodinin | 68-81-5 | Natural Products |
| HY-N15084 | Isocycloheximide | 6746-42-5 | Natural Products |
| HY-N15085 | Leucomycin A6 | 18361-48-3 | Natural Products |
| HY-N15086 | Leucomycin U | 31642-61-2 | Natural Products |
| HY-N15087 | Lunatoic acid A | 65745-48-4 | Natural Products |
| HY-N15088 | Lunatoic acid B | 65745-49-5 | Natural Products |
| HY-N15089 | Melleolide M | 264229-82-5 | Natural Products |
| HY-N1508R | Ecliptasaponin A (Standard) | 78285-90-2 | Reference Standards |
| HY-N15095 | Aplasmomycin | 61230-25-9 | Natural Products |
| HY-N15097 | Dihydrocompactin | 78366-44-6 | Natural Products |
| HY-N1510 | Kaempferol 3-O-gentiobioside | 22149-35-5 | Natural Products |
| HY-N15100 | Pristinamycin ⅡB | 21102-49-8 | Natural Products |
| HY-N15101 | Rifamycin L | 26117-02-2 | Natural Products |
| HY-N15103 | Hydroxymycotrienin B | 178550-62-4 | Natural Products |
| HY-N15104 | 11-Deoxy-13-deoxodaunorubicin | 71800-92-5 | Natural Products |
| HY-N15106 | 11-Deoxy-13-dihydrodaunorubicin | 71800-90-3 | Natural Products |
| HY-N1510R | Kaempferol 3-O-gentiobioside (Standard) | 22149-35-5 | Reference Standards |
| HY-N1511 | Ganoderic acid D | 108340-60-9 | Natural Products |
| HY-N1511R | Ganoderic acid D (Standard) | 108340-60-9 | Reference Standards |
| HY-N1512 | Ganoderic acid E | 98665-14-6 | Natural Products |
| HY-N15124 | 1-Deamino-1-hydroxysagamicin | 72614-86-9 | Natural Products |
| HY-N15125 | 1-Deamino-1-hydroxygentamicin C2 | 72854-56-9 | Natural Products |
| HY-N15126 | 1-Deamino-1-hydroxygentamicin C1a | 66065-96-1 | Natural Products |
| HY-N15127 | 3-O-Demethyl-2'-N-glylfortimicin B | 71640-65-8 | Natural Products |
| HY-N15128 | 7β,8β-Epoxyroridin H | 64687-85-0 | Natural Products |
| HY-N15129 | 7β,8β-2′,3′-Diepoxyroridin H | 64687-84-9 | Natural Products |
| HY-N1513 | Ganoderic acid H | 98665-19-1 | Natural Products |
| HY-N15130 | Cerpegin | 129748-28-3 | Natural Products |
| HY-N15131 | 4-(Indol-3-yl)-(3E)-buten-2-one | 57598-80-8 | Natural Products |
| HY-N15132 | Stephalonine N | 2376321-20-7 | Natural Products |
| HY-N15133 | Solanacol | 953389-72-5 | Natural Products |
| HY-N15135 | Arabinoxylan (Medium viscosity) | 9040-27-1 | Natural Products |
| HY-N15136 | Isomorellinol | 149655-53-8 | Natural Products |
| HY-N15137 | Calycopterin | 481-52-7 | Natural Products |
| HY-N15138 | Sativanone | 70561-31-8 | Natural Products |
| HY-N1514 | Ganoderenic acid B | 100665-41-6 | Natural Products |
| HY-N15142 | Furcellaran | 9000-21-9 | Natural Products |
| HY-N15144 | Cyanidin-3-O-sophoroside (chloride) | 38820-68-7 | Natural Products |
| HY-N15145 | Lucyoside E | 91174-22-0 | Natural Products |
| HY-N15146 | Aralia-saponin I | 289649-54-3 | Natural Products |
| HY-N15147 | Panax saponin C | 51542-56-4 | Natural Products |
| HY-N15148 | Disialyllactose | 38598-36-6 | Natural Products |
| HY-N1514R | Ganoderenic acid B (Standard) | 100665-41-6 | Reference Standards |
| HY-N1515 | Ganoderenic acid C | 100665-42-7 | Natural Products |
| HY-N15152 | Isoaesculioside D | 1184581-59-6 | Natural Products |
| HY-N15154 | Tasiamide B | 587014-85-5 | Natural Products |
| HY-N15155 | Vitexin 7-O-β-D-glucopyranoside | 35109-95-6 | Natural Products |
| HY-N15156 | Thiotaurine | 2937-54-4 | Natural Products |
| HY-N15159 | Cladophorol A | 146776-30-9 | Natural Products |
| HY-N1516 | Ganoderenic acid D | 100665-43-8 | Natural Products |
| HY-N15169 | BG-136 | Natural Products | |
| HY-N1516A | (Z)-Ganoderenic acid D | 1910062-63-3 | Natural Products |
| HY-N1516R | Ganoderenic acid D (Standard) | 100665-43-8 | Reference Standards |
| HY-N1517 | Ganoderic acid C2 | 103773-62-2 | Natural Products |
| HY-N15176 | Bisucaberin | 112972-60-8 | Natural Products |
| HY-N15177 | Δ9-THCB | 60008-00-6 | Natural Products |
| HY-N15179 | Minosaminomycin | 51746-09-9 | Natural Products |
| HY-N1517A | (Rac)-Ganoderic acid C2 | 98296-48-1 | Natural Products |
| HY-N1517R | Ganoderic acid C2 (Standard) | 103773-62-2 | Reference Standards |
| HY-N1518 | Rauvoyunine C | 1211543-01-9 | Natural Products |
| HY-N15180 | Corynantheidine | 23407-35-4 | Natural Products |
| HY-N15181 | Fluostatin B | 158906-40-2 | Natural Products |
| HY-N15182 | 4-Trehalosamine | 51855-99-3 | Natural Products |
| HY-N15183 | Aselacin C | 156223-08-4 | Natural Products |
| HY-N15184 | Benanomicin B | 116249-66-2 | Natural Products |
| HY-N15185 | Pyrenophorin | 5739-85-5 | Natural Products |
| HY-N15186 | Gymnoascolide A | 865092-05-3 | Natural Products |
| HY-N15187 | Acronycidine | 521-43-7 | Natural Products |
| HY-N15188 | hemi-Oxanthromicin A | 91161-78-3 | Natural Products |
| HY-N1519 | Ravenine | 20105-22-0 | Natural Products |
| HY-N15190 | Sesaminol | 74061-79-3 | Natural Products |
| HY-N15193 | Cystocholic acid | 73386-01-3 | Natural Products |
| HY-N15196 | Andrographolide-lipoic acid | 1167601-06-0 | Natural Products |
| HY-N1520 | Rediocide A | 280565-85-7 | Natural Products |
| HY-N15206 | (3R,5R)-1-(4-Hydroxy-3-methoxyphenyl)-7-phenylheptane-3,5-diol | 460052-56-6 | Natural Products |
| HY-N15207 | (3R,5R)-1-(4-Hydroxyphenyl)-7-phenyl-3,5-heptanediol | 112494-44-7 | Natural Products |
| HY-N15208 | (3S,5S)-1-(4-Hydroxy-3-methoxyphenyl)-7-phenyl-3,5-heptanediol | 1172102-24-7 | Natural Products |
| HY-N15209 | 2β-Methoxy-2-deethoxy-8-O-deacylphantomolin-8-O-tiglinate | 102934-36-1 | Natural Products |
| HY-N1521 | Rehmannic acid | 467-81-2 | Natural Products |
| HY-N15211 | 3′-Hydroxytectoridin | 285565-82-4 | Natural Products |
| HY-N15212 | Methyl 20(21)-dehydrolucidenate A | 852936-70-0 | Natural Products |
| HY-N15215 | Antiviral agent 64 | 1004319-60-1 | Natural Products |
| HY-N15216 | Ganolucidic acid B | 98683-75-1 | Natural Products |
| HY-N15217 | Antiviral agent 65 | 1004319-61-2 | Natural Products |
| HY-N15218 | Akebia saponin F | 39524-17-9 | Natural Products |
| HY-N15219 | 6-Hydroxygenistein-7-O-β-D-glucopyranoside | 198135-88-5 | Natural Products |
| HY-N1522 | Rengynic acid | 517883-38-4 | Natural Products |
| HY-N15220 | Dipsacus saponin X | 146100-01-8 | Natural Products |
| HY-N15221 | 12-Acetoxyganoderic acid D | 2374206-92-3 | Natural Products |
| HY-N15222 | Toralactone-9-O-β-D-glucopyranoside | 1011710-89-6 | Natural Products |
| HY-N15223 | [(2E,4E)-Octadienoyl]-N-isobutylamide | 23512-47-2 | Natural Products |
| HY-N15224 | 15-Hydroxy-3,11,23-trioxolanost-8,20-dien-26-oic acid | 1309931-88-1 | Natural Products |
| HY-N15225 | 12β-Hydroxyganoderenic acid B | 1309931-84-7 | Natural Products |
| HY-N15226 | Butyrolactone Ia | 942986-92-7 | Natural Products |
| HY-N15227 | (+)-N-Methylhernovine | 5550-65-2 | Natural Products |
| HY-N15229 | Resinacein L | 2259327-01-8 | Natural Products |
| HY-N1523 | Rengyol | 93675-85-5 | Natural Products |
| HY-N15230 | Torososide B | 243835-63-4 | Natural Products |
| HY-N15231 | Dipsacus saponin XII | 149558-32-7 | Natural Products |
| HY-N15233 | Demethylflavasperone 10-O-β-D-glucopyranoside | 1015476-85-3 | Natural Products |
| HY-N15237 | Allyl β-lactoside | 52211-61-7 | Natural Products |
| HY-N1524 | Quinovic acid | 465-74-7 | Natural Products |
| HY-N15244 | (+)-Strigone | 151716-20-0 | Natural Products |
| HY-N15245 | (+)-Sorgomol | 1011730-11-2 | Natural Products |
| HY-N1525 | Quinovic acid 3-O-(6-deoxy-β-D-glucopyranoside) 28-O-β-D-glucopyranosyl ester | 124727-10-2 | Natural Products |
| HY-N15255 | 5-S-Cysteinyldopamine | 99558-89-1 | Natural Products |
| HY-N1526 | Quinovic acid 3-O-beta-D-glucoside | 79955-41-2 | Natural Products |
| HY-N15262 | Schinlignan B | 77881-08-4 | Natural Products |
| HY-N15264 | Azaspirene | 461644-34-8 | Natural Products |
| HY-N15265 | Piperettine | 583-34-6 | Natural Products |
| HY-N15266 | Mukonidine | 24949-00-6 | Natural Products |
| HY-N15267 | Ovalitenone | 64280-22-4 | Natural Products |
| HY-N15268 | Koenine | 28200-63-7 | Natural Products |
| HY-N15269 | Cyperol | 20084-99-5 | Natural Products |
| HY-N1527 | Quinovic acid 3-O-α-L-rhamnopyranoside | 104055-76-7 | Natural Products |
| HY-N15270 | S-Secoantioquine | 93767-29-4 | Natural Products |
| HY-N15271 | Oxopurpureine | 32845-27-5 | Natural Products |
| HY-N15272 | Artocarpesin | 3162-09-2 | Natural Products |
| HY-N15277 | Deoxyshikonofuran | 104056-81-7 | Natural Products |
| HY-N1528 | Quinovic acid 3-O-β-D-quinovopyranoside | 107870-05-3 | Natural Products |
| HY-N15280 | Terrestrimine | 1778735-31-1 | Natural Products |
| HY-N15281 | Khellol | 478-79-5 | Natural Products |
| HY-N15282 | Broussoflavonol G | 128341-11-7 | Natural Products |
| HY-N15283 | Baculiferin A | 1141448-57-8 | Natural Products |
| HY-N15288 | Cavipetin C | 128552-90-9 | Natural Products |
| HY-N15289 | Malyngamide K | 96845-21-5 | Natural Products |
| HY-N1529 | Gomisin M1 | 82467-50-3 | Natural Products |
| HY-N15291 | Divinatorin A | 611228-04-7 | Natural Products |
| HY-N15292 | Scutebarbolide G | 2691877-88-8 | Natural Products |
| HY-N15293 | Sesamolinol | 100016-94-2 | Natural Products |
| HY-N15294 | 3β-Hydroxy-27-p-Z-coumaroyloxyurs-12-en-28-oic acid | Natural Products | |
| HY-N15295 | 3-Acetylnerbowdine | 100196-22-3 | Natural Products |
| HY-N15296 | Piperdial | 100288-36-6 | Natural Products |
| HY-N15297 | Isotenulin | 10092-04-3 | Natural Products |
| HY-N15298 | Turricolol E | 101392-12-5 | Natural Products |
| HY-N15299 | iso-C15:0 3-OH | 60834-18-6 | Natural Products |
| HY-N15300 | Acremorin E | Natural Products | |
| HY-N15301 | Nocarnickelamide B | Natural Products | |
| HY-N15302 | Ostamycin A | Natural Products | |
| HY-N15303 | Goyazensolide | 60066-35-5 | Natural Products |
| HY-N15304 | Ent-17α,18-dihydroxy-kauran-19-oic acid | 141947-35-5 | Natural Products |
| HY-N15305 | Ferolin | 39380-12-6 | Natural Products |
| HY-N15306 | Boerelasin E | Natural Products | |
| HY-N15307 | Trigraecum | 38070-97-2 | Natural Products |
| HY-N15308 | Kanjone | 1094-12-8 | Natural Products |
| HY-N15309 | Torvoside C | 185012-38-8 | Natural Products |
| HY-N1531 | Randaiol | 87562-14-9 | Natural Products |
| HY-N15310 | Dimerum acid | 26912-16-3 | Natural Products |
| HY-N15312 | (4Z)-4-Nonenal | 2277-15-8 | Natural Products |
| HY-N15313 | Siegesbeckiol | 141947-34-4 | Natural Products |
| HY-N15314 | Syringolin A | 212115-96-3 | Natural Products |
| HY-N15315 | Triptriolide | 137131-18-1 | Natural Products |
| HY-N15316 | cis-9,cis-12-Heptadecadienoic acid | 29203-97-2 | Natural Products |
| HY-N1532 | Raucaffricine | 31282-07-2 | Natural Products |
| HY-N15320 | Schidigera-genin B | 267003-21-4 | Natural Products |
| HY-N15321 | Norselic acid B | 1190954-39-2 | Natural Products |
| HY-N15322 | Polyandric acid A | 1282509-78-7 | Natural Products |
| HY-N15323 | Samioside | 360768-68-9 | Natural Products |
| HY-N15324 | (+)-Cocsuline | 26279-88-9 | Natural Products |
| HY-N15325 | Demethylbatatasin IV | 113276-63-4 | Natural Products |
| HY-N1533 | 28-O-β-D-Glucopyranosyl pomolic acid | 83725-24-0 | Natural Products |
| HY-N15330 | Aspecioside | 101915-75-7 | Natural Products |
| HY-N15331 | Mecambrine | 1093-07-8 | Natural Products |
| HY-N15332 | Virgaureasaponin 1 | 112515-98-7 | Natural Products |
| HY-N15333 | β-Terpinyl acetate | Natural Products | |
| HY-N15334 | Tricrozarin A | 107817-60-7 | Natural Products |
| HY-N15335 | Anti-inflammatory agent 98 | 1175517-20-0 | Natural Products |
| HY-N15336 | Tschimganin | 38970-49-9 | Natural Products |
| HY-N15337 | Vineomycin A1 | 78164-00-8 | Natural Products |
| HY-N15338 | Phyllalbine | 4540-25-4 | Natural Products |
| HY-N15339 | Convolamine | 500-56-1 | Natural Products |
| HY-N1534 | Ponasterone A | 13408-56-5 | Natural Products |
| HY-N15340 | 1-Oleoyl-2-linoleoyl-sn-glycerol | 91125-76-7 | Natural Products |
| HY-N15342 | Tschimganidin | 39380-16-0 | Natural Products |
| HY-N15343 | Albiducin A | 2222286-14-6 | Natural Products |
| HY-N15344 | Euryachin E | Natural Products | |
| HY-N15345 | Menominin A | Natural Products | |
| HY-N15346 | Menominin B | Natural Products | |
| HY-N15347 | Talaromyketide B | Natural Products | |
| HY-N15348 | Aphidicolins B32 | Natural Products | |
| HY-N15349 | Nocapyrone Q | 1558013-79-8 | Natural Products |
| HY-N1535 | Ponicidin | 52617-37-5 | Natural Products |
| HY-N15350 | Demethylblasticidin S | 63257-29-4 | Natural Products |
| HY-N15351 | Flavokermesic acid | 18499-84-8 | Natural Products |
| HY-N15352 | C20 Sphingomyelin (d18:1/20:1) | 222403-67-0 | Natural Products |
| HY-N15353 | 1-Palmitoyl-2-linoleoyl-sn-glycerol | 51621-26-2 | Natural Products |
| HY-N15354 | Jujubasaponin IV | 146445-93-4 | Natural Products |
| HY-N15355 | Jujubasaponin VI | 146445-94-5 | Natural Products |
| HY-N15356 | 9-Oxooctadecanedioic acid | 2489590-40-9 | Natural Products |
| HY-N15357 | Falcarindiol 3-acetate | 22526-53-0 | Natural Products |
| HY-N15358 | 15:0-18:1 DG | 67889-40-1 | Natural Products |
| HY-N15359 | Germicidin C | 919288-75-8 | Natural Products |
| HY-N1536 | Porsone | 56222-03-8 | Natural Products |
| HY-N15360 | Isophytyl acetate | 58425-36-8 | Natural Products |
| HY-N15362 | 5α-Pregnane-3β,17α,20α-triol | 570-50-3 | Natural Products |
| HY-N15363 | 5-Pregnene-3β,17a,20a-triol | 85202-13-7 | Natural Products |
| HY-N15364 | Imidazoleacetic acid riboside | 29605-99-0 | Natural Products |
| HY-N15365 | Antcin B | 163597-25-9 | Natural Products |
| HY-N15366 | N-Acetoxy-IQ | 115722-78-6 | Natural Products |
| HY-N15367 | Aklaviketone | 116235-59-7 | Natural Products |
| HY-N15368 | Pradimicinone I | 116276-03-0 | Natural Products |
| HY-N15369 | 3′-GMP | 117-68-0 | Natural Products |
| HY-N1537 | Preisocalamendiol | 25645-19-6 | Natural Products |
| HY-N15370 | Morellin | 1183-12-6 | Natural Products |
| HY-N15371 | Barbinine | 123497-99-4 | Natural Products |
| HY-N15372 | Heritonin | Natural Products | |
| HY-N15373 | Abrusoside A | 124962-06-7 | Natural Products |
| HY-N15374 | Hypercalin B | 125583-45-1 | Natural Products |
| HY-N15375 | Trichomycin B | 12699-00-2 | Natural Products |
| HY-N15376 | 12-Hydroxydihydrochelirubine | 131984-77-5 | Natural Products |
| HY-N15377 | 2,6-Dimethoxy-4-hydroxyacetophenone | 13246-14-5 | Natural Products |
| HY-N15378 | β-Carotene-15,15'-epoxide | 132541-62-9 | Natural Products |
| HY-N15379 | Catharine | 1355-31-3 | Natural Products |
| HY-N1538 | (+)-Piperitol-3,3-dimethylallyl ether | 157659-20-6 | Natural Products |
| HY-N15380 | 4,4′-Secalonic acid D | 2265910-52-7 | Natural Products |
| HY-N15381 | Taxine A | 1361-49-5 | Natural Products |
| HY-N15382 | Prebetanin | 13798-16-8 | Natural Products |
| HY-N15383 | Bakankosin | 1398-17-0 | Natural Products |
| HY-N15385 | Hericenone D | 137592-04-2 | Natural Products |
| HY-N15386 | Hericenone I | 1094030-08-6 | Natural Products |
| HY-N15387 | Hericenone J | 1094030-09-7 | Natural Products |
| HY-N15388 | Hericenone A | 126654-52-2 | Natural Products |
| HY-N15389 | Noformicin | 155-38-4 | Natural Products |
| HY-N1539 | Preschisanartanin B | 1033288-92-4 | Natural Products |
| HY-N15390 | Cerexin B1 | 70943-81-6 | Natural Products |
| HY-N15391 | 1-Hydroxy-2-nonyn-4-one | 81474-56-8 | Natural Products |
| HY-N15392 | Lactonamycin Z | 709032-67-7 | Natural Products |
| HY-N15393 | Cerexin B4 | 70943-84-9 | Natural Products |
| HY-N15394 | Cerexin D4 | 70943-88-3 | Natural Products |
| HY-N15395 | Dermadin | 12698-52-1 | Natural Products |
| HY-N15396 | Exophilin A | 172703-87-6 | Natural Products |
| HY-N15398 | Chaetoglobosin E | 55945-74-9 | Natural Products |
| HY-N1540 | Preskimmianin | 38695-41-9 | Natural Products |
| HY-N15400 | Velloquercetin | 139955-63-8 | Natural Products |
| HY-N15401 | Alpinine | 14028-90-1 | Natural Products |
| HY-N15402 | Porritoxin | 143114-82-3 | Natural Products |
| HY-N15403 | Acetylcaranine | 14383-07-4 | Natural Products |
| HY-N15407 | Asparagoside A | 14835-43-9 | Natural Products |
| HY-N15408 | Terminaline | 15112-49-9 | Natural Products |
| HY-N15409 | Epoxymurin A | 151484-64-9 | Natural Products |
| HY-N1541 | prim-O-Glucosylangelicain | 85889-15-2 | Natural Products |
| HY-N15410 | β-Cotonefuran | 161748-46-5 | Natural Products |
| HY-N15411 | Helminthosporol | 1619-29-0 | Natural Products |
| HY-N15412 | Cabreuvin | 1621-61-0 | Natural Products |
| HY-N15413 | Thalidasine | 16623-56-6 | Natural Products |
| HY-N15414 | Demethoxykanugin | 1668-33-3 | Natural Products |
| HY-N15415 | Zaluzanin C | 16838-87-2 | Natural Products |
| HY-N15416 | Palmarin | 17226-41-4 | Natural Products |
| HY-N15417 | 1,13-Tridecanolide | 1725-04-8 | Natural Products |
| HY-N15418 | Mikanolide | 17928-61-9 | Natural Products |
| HY-N15419 | Acutumidine | 18145-26-1 | Natural Products |
| HY-N1542 | Prionitin | 117469-56-4 | Natural Products |
| HY-N15420 | Leucomycin A7 | 18361-47-2 | Natural Products |
| HY-N15421 | Leucomycin A8 | 18361-50-7 | Natural Products |
| HY-N15422 | Glucoputranjivin | 18432-16-1 | Natural Products |
| HY-N15423 | Acrophylline | 18904-40-0 | Natural Products |
| HY-N15424 | Himachalol | 1891-45-8 | Natural Products |
| HY-N15425 | 11β-Hydroxy-17α-methyltestosterone | 1043-10-3 | Natural Products |
| HY-N15426 | Herbicidal agent 9 | 19467-61-9 | Natural Products |
| HY-N1543 | Procumbide | 20486-27-5 | Natural Products |
| HY-N1544 | Prometaphanine | 6858-85-1 | Natural Products |
| HY-N15440 | Mutatochrome | 515-06-0 | Natural Products |
| HY-N15443 | Mevalocidin | 887028-34-4 | Natural Products |
| HY-N15444 | Bullatenone | 493-71-0 | Natural Products |
| HY-N15446 | Siamine | 60352-12-7 | Natural Products |
| HY-N15447 | Visnaginone | 484-27-5 | Natural Products |
| HY-N15448 | Dihydrosamidin | 6005-18-1 | Natural Products |
| HY-N15449 | Vicanicin | 33211-22-2 | Natural Products |
| HY-N1545 | Prostephanaberrine | 105608-27-3 | Natural Products |
| HY-N15450 | Undulatine | 6882-09-3 | Natural Products |
| HY-N15451 | Deoxytopsentin | 112515-42-1 | Natural Products |
| HY-N15452 | Eseramine | 6091-57-2 | Natural Products |
| HY-N15453 | Asperenone | 18810-05-4 | Natural Products |
| HY-N15454 | Altenuisol | 1188382-26-4 | Natural Products |
| HY-N15456 | Cryptolepinone | 178884-07-6 | Natural Products |
| HY-N1546 | Protoplumericin A | 80396-57-2 | Natural Products |
| HY-N1547 | Prudomestin | 3443-28-5 | Natural Products |
| HY-N15473 | Isopaucifloral F | 1001259-00-2 | Natural Products |
| HY-N1547R | Prudomestin (Standard) | 3443-28-5 | Reference Standards |
| HY-N1548 | Prunasin | 99-18-3 | Natural Products |
| HY-N1549 | Prunin | 529-55-5 | Natural Products |
| HY-N15496 | Fusaproliferin | 152469-17-5 | Natural Products |
| HY-N1550 | Przewalskin | 119400-87-2 | Natural Products |
| HY-N15500 | Trichodermoside | 3074780-91-6 | Natural Products |
| HY-N15501 | Trichaspside F | 3075431-03-4 | Natural Products |
| HY-N15502 | Cycloneroside A | 3075431-04-5 | Natural Products |
| HY-N15503 | Cycloneroside B | 3075431-05-6 | Natural Products |
| HY-N15504 | Cycloneroside C | 3075431-06-7 | Natural Products |
| HY-N15505 | Cycloneroside D | 3075431-07-8 | Natural Products |
| HY-N15506 | Cycloneroside E | 3075431-08-9 | Natural Products |
| HY-N15507 | Harzianoside A | 3075431-09-0 | Natural Products |
| HY-N15508 | Harzianoside B | 3075431-10-3 | Natural Products |
| HY-N15509 | Harzianol K | 3038319-61-5 | Natural Products |
| HY-N1551 | Przewaquinone A | 76843-23-7 | Natural Products |
| HY-N15510 | Harzianol J | 2671032-64-5 | Natural Products |
| HY-N15522 | Bi-magnolignan | 2883117-61-9 | Natural Products |
| HY-N1553 | Pseudolaric acid D | 115028-67-6 | Natural Products |
| HY-N1555 | Pseudotaraxasterol | 464-98-2 | Biochemical Assay Reagents |
| HY-N1556 | Psidial A | 1207181-35-8 | Natural Products |
| HY-N1557 | Ptelatoside B | 90852-99-6 | Natural Products |
| HY-N1558 | Pterisolic acid A | 1401419-85-9 | Natural Products |
| HY-N1559 | Pterisolic acid C | 1401419-87-1 | Natural Products |
| HY-N1561 | Pterisolic acid E | 1401419-89-3 | Natural Products |
| HY-N1562 | Pterisolic acid F | 1401419-90-6 | Natural Products |
| HY-N1563 | Pterodondiol | 60132-35-6 | Natural Products |
| HY-N1564 | Pterodontic acid | 185845-89-0 | Natural Products |
| HY-N1565 | Pterokaurane R | 67349-43-3 | Natural Products |
| HY-N1566 | Pterokaurene L3 | 77658-38-9 | Natural Products |
| HY-N1567 | Pterolactam | 38072-88-7 | Natural Products |
| HY-N1568 | Pterolactone A | 74730-10-2 | Natural Products |
| HY-N1569 | Pteroside D | 35943-38-5 | Natural Products |
| HY-N1570 | Pterosin B | 34175-96-7 | Natural Products |
| HY-N1570R | Pterosin B (Standard) | 34175-96-7 | Reference Standards |
| HY-N1571 | Pterosin D | 34169-70-5 | Natural Products |
| HY-N1572 | Pterosin D 3-O-glucoside | 84299-80-9 | Natural Products |
| HY-N1573 | Pterosin Z | 34169-69-2 | Natural Products |
| HY-N1574 | Puerol A | 152784-32-2 | Natural Products |
| HY-N1575 | Podocarpusflavone B | 23624-21-7 | Natural Products |
| HY-N1576 | p-Vinylphenyl O-beta-D-glucopyranoside | 62470-46-6 | Natural Products |
| HY-N1577 | Pyrocatechol monoglucoside | 2400-71-7 | Natural Products |
| HY-N1578 | Pyrocincholic acid methyl ester | 107160-24-7 | Natural Products |
| HY-N1579 | Pyrogallol | 87-66-1 | Natural Products |
| HY-N1579R | Pyrogallol (Standard) | 87-66-1 | Reference Standards |
| HY-N1580 | Pyrroside B | 116271-35-3 | Natural Products |
| HY-N1581 | Quassin | 76-78-8 | Natural Products |
| HY-N1581R | Quassin (Standard) | 76-78-8 | Reference Standards |
| HY-N1582 | Quercetin 3,4′-dimethyl ether | 33429-83-3 | Natural Products |
| HY-N1583 | Quercetin 3-O-robinobioside | 52525-35-6 | Natural Products |
| HY-N1584 | Halofuginone | 55837-20-2 | Natural Products |
| HY-N1584A | Halofuginone (hydrobromide) | 64924-67-0 | Natural Products |
| HY-N1584AR | Halofuginone (hydrobromide) (Standard) | 64924-67-0 | Reference Standards |
| HY-N1584B | Halofuginone (hydrochloride) | 1217623-74-9 | Reference compound |
| HY-N1584BR | Halofuginone (hydrochloride) (Standard) | 1217623-74-9 | Reference Standards |
| HY-N1584C | Halofuginone (lactate) | 82186-71-8 | Reference compound |
| HY-N1584R | Halofuginone (Standard) | 55837-20-2 | Reference Standards |
| HY-N1585 | 15-Demethylplumieride | 132586-69-7 | Natural Products |
| HY-N1586 | 15-Deoxoeucosterol | 81241-53-4 | Natural Products |
| HY-N1587 | 15-Dihydroepioxylubimin | 129214-59-1 | Natural Products |
| HY-N1588 | 15-Hydroxy-7-oxodehydroabietic acid | 95416-25-4 | Natural Products |
| HY-N1589 | 15-Hydroxydehydroabietic acid | 54113-95-0 | Natural Products |
| HY-N1590 | 8β,18-Dihydroxysandaracopimar-15-ene | 73002-86-5 | Natural Products |
| HY-N1591 | 15-Methoxymkapwanin | 1309920-99-7 | Natural Products |
| HY-N1592 | 15-Methoxypatagonic acid | 115783-35-2 | Natural Products |
| HY-N1593 | 15-Methoxypinusolidic acid | 769928-72-5 | Natural Products |
| HY-N1594 | 15-Nor-14-oxolabda-8(17),12E-Diene-18-oic acid | 1039673-32-9 | Natural Products |
| HY-N1595 | 16-Acetoxy-7-O-acetylhorminone | 269742-39-4 | Natural Products |
| HY-N1596 | Ent-16α,17-dihydroxykauran-3-one | 135683-73-7 | Natural Products |
| HY-N1597 | (19Z)-Normacusine B | 124096-81-7 | Natural Products |
| HY-N1598 | (E)-16-Epi-normacusine B | 126640-98-0 | Natural Products |
| HY-N1599 | 16-Epivoacarpine | 114027-38-2 | Natural Products |
| HY-N1600 | 16(R/S)-Hydroxy-3,13Z-kolavadien-15,16-olide-2-one | 165459-53-0 | Natural Products |
| HY-N1601 | 2β,6β,15α-Trihydroxy-ent-kaur-16-ene | 53452-32-7 | Natural Products |
| HY-N1602 | 16-Nor-15-oxodehydroabietic acid | 200813-31-6 | Natural Products |
| HY-N1603 | 16-o-Acetyldarutigenol | 1188282-01-0 | Natural Products |
| HY-N1604 | O-Methyl-Δ14-vincanol | 112237-71-5 | Natural Products |
| HY-N1605 | 17α-Neriifolin | 7044-31-7 | Natural Products |
| HY-N1606 | 17α-Thevebioside | 114613-59-1 | Natural Products |
| HY-N1607 | 18-Nor-4,15-dihydroxyabieta-8,11,13-trien-7-one | 213329-46-5 | Natural Products |
| HY-N1608 | 18-Norabieta-8,11,13-trien-4α-ol | 22478-65-5 | Natural Products |
| HY-N1609 | 18-Nor-abieta-8,11,13-triene-4,15-diol | 203455-81-6 | Natural Products |
| HY-N1610 | 19(S)-Hydroxyconopharyngine | 16790-93-5 | Natural Products |
| HY-N1611 | 19,20-(E)-Vallesamine | 3368-87-4 | Natural Products |
| HY-N1612 | 19-Hydroxybaccatin III | 78432-78-7 | Natural Products |
| HY-N1613 | 1-Acetyltagitinin A | 60547-63-9 | Natural Products |
| HY-N1614 | 1α-Hydroxytorilin | 887147-75-3 | Natural Products |
| HY-N1615 | 1beta-Hydroxy-beta-eudesmol | 83217-89-4 | Natural Products |
| HY-N1616 | 1β-Hydroxyeuscaphic acid | 120211-98-5 | Natural Products |
| HY-N1617 | 1beta-Hydroxytorilin | 509078-16-4 | Natural Products |
| HY-N1618 | 1-Cinnamoyl-3-hydroxypyrrolidine | 1344876-77-2 | Natural Products |
| HY-N1619 | N-Cinnamoylpyrrole | 252248-89-8 | Natural Products |
| HY-N1620 | 1-Cinnamoylpyrrolidine | 52438-21-8 | Natural Products |
| HY-N1621 | 1-Deacetylnimbolinin B | 76689-98-0 | Natural Products |
| HY-N1622 | 1-Dehydroxy-23-deoxojessic acid | 149252-87-9 | Natural Products |
| HY-N1623 | 1-Hydroxy-2,3,4,7-tetramethoxyxanthone | 14103-09-4 | Natural Products |
| HY-N1624 | 1-Hydroxy-2,3,5-trimethoxyxanthone | 22804-49-5 | Natural Products |
| HY-N1625 | 1-Hydroxy-2-methylanthraquinone | 6268-09-3 | Natural Products |
| HY-N1626 | 1β-Hydroxy-2-oxopomolic acid | 217466-37-0 | Natural Products |
| HY-N1627 | 2-Prenyl-1-naphthol | 16274-34-3 | Natural Products |
| HY-N1628 | 1β-Hydroxybaccatin I | 30244-37-2 | Natural Products |
| HY-N1629 | 1-Hydroxycanthin-6-one | 80787-59-3 | Natural Products |
| HY-N1631 | 1-Hydroxyrutecarpine | 53600-24-1 | Natural Products |
| HY-N1633 | 1-Methoxycarbonyl-β-carboline | 3464-66-2 | Natural Products |
| HY-N1634 | Anagyroidisoflavone A | 221002-11-5 | Natural Products |
| HY-N1635 | 1-Methoxyindole-3-carboxylic acid | 91913-76-7 | Natural Products |
| HY-N1636 | 1-Methyl-2-nonyl-4(1H)-quinolone | 68353-24-2 | Natural Products |
| HY-N1637 | 1-Methyl-2-pentyl-4(1H)-quinolinone | 22048-98-2 | Natural Products |
| HY-N1638 | 1-Methyl-2-undecyl-4(1H)-quinolone | 59443-02-6 | Natural Products |
| HY-N1639 | 1-Decarboxy-3-oxo-ceanothic acid | 214150-74-0 | Natural Products |
| HY-N1640 | 1-O-Deacetyl-2α-hydroxykhayanolide E | 1189801-51-1 | Natural Products |
| HY-N1641 | 1-O-Deacetylkhayanolide E | 1007387-95-2 | Natural Products |
| HY-N1642 | 1-O-Methyljatamanin D | 54656-47-2 | Natural Products |
| HY-N1643 | 2-[(1H-Indol-3-ylcarbonyl)amino]benzoic acid | 171817-95-1 | Natural Products |
| HY-N1644 | 2,16,19-Kauranetriol 2-O-β-D-allopyranoside | 195723-38-7 | Natural Products |
| HY-N1645 | 2,16-Kauranediol | 34302-37-9 | Natural Products |
| HY-N1646 | 2,16-Kauranediol 2-O-β-D-allopyranoside | 474893-07-7 | Natural Products |
| HY-N1647 | 2',3',6-Trihydroxy-2,4-dimethoxybenzophenone | 219861-73-1 | Natural Products |
| HY-N1648 | 2,2,5,5-Tetramethylcyclohexane-1,4-dione | 86838-54-2 | Natural Products |
| HY-N1649 | 2,3,2'',3''-Tetrahydroochnaflavone | 678138-59-5 | Natural Products |
| HY-N1650 | Pygenic acid B | 89786-83-4 | Natural Products |
| HY-N1651 | 2,3',4,6-Tetrahydroxybenzophenone | 26271-33-0 | Natural Products |
| HY-N1652 | 2,3,8-Tri-O-methylellagic acid | 1617-49-8 | Natural Products |
| HY-N1653 | 2,3-Dehydrokievitone | 74161-25-4 | Natural Products |
| HY-N1654 | 2',3'-Dehydrosalannol | 97411-50-2 | Natural Products |
| HY-N1655 | 2,3-Dihydroamentoflavone 7,4'-dimethyl ether | 873999-88-3 | Natural Products |
| HY-N1656 | Podocarpus flavanone | 110382-42-8 | Natural Products |
| HY-N1657 | 2,3-Dihydrohinokiflavone | 34292-87-0 | Natural Products |
| HY-N1658 | 2,3-Dihydroisoginkgetin | 828923-27-9 | Natural Products |
| HY-N1659 | 2,3-Dihydropodocarpusflavone A | 852875-96-8 | Natural Products |
| HY-N1660 | 2,3-Dihydrosciadopitysin | 34421-19-7 | Reference compound |
| HY-N1661 | 2α,3β-Dihydroxypterodontic acid | 185821-32-3 | Natural Products |
| HY-N1662 | 2,4,6,6-Tetramethyl-3(6H)-pyridinone | 203524-64-5 | Natural Products |
| HY-N1663 | 2',4',6'-Trimethoxyacetophenone | 832-58-6 | Natural Products |
| HY-N1664 | 2',4'-Dihydroxy-2,3',6'-trimethoxychalcone | 100079-39-8 | Natural Products |
| HY-N1665 | 2',4'-Dihydroxy-3',6'-dimethoxychalcone | 129724-43-2 | Natural Products |
| HY-N1666 | 2',4'-Dihydroxy-3,7':4,8'-diepoxylign-7-ene | 666250-52-8 | Natural Products |
| HY-N1667 | 2',4'-Dihydroxy-6'-Methoxyacetophenone | 3602-54-8 | Natural Products |
| HY-N1668 | 2,4-Dihydroxyphenylacetic acid | 614-82-4 | Natural Products |
| HY-N1669 | 2'',4''-Di-O-(E-p-Coumaroyl)afzelin | 163434-73-9 | Natural Products |
| HY-N1670 | 2'',4''-Di-O-(Z-p-Coumaroyl)afzelin | 205534-17-4 | Natural Products |
| HY-N1671 | 2',5,6',7-Tetraacetoxyflavanone | 80604-17-7 | Natural Products |
| HY-N1672 | 5,7,2′,6′-Tetrahydroxyflavanone | 80604-16-6 | Natural Products |
| HY-N1673 | 2,5-Dihydroxybenzaldehyde | 1194-98-5 | Natural Products |
| HY-N1673R | 2,5-Dihydroxybenzaldehyde (Standard) | 1194-98-5 | Reference Standards |
| HY-N1674 | 2,6,16-Kauranetriol | 41530-90-9 | Natural Products |
| HY-N1675 | 2,6,16-Kauranetriol 2-O-beta-D-allopyranoside | 195735-16-1 | Natural Products |
| HY-N1676 | 2′,3,5,6′,7-Pentahydroxyflavanone | 80366-15-0 | Natural Products |
| HY-N1677 | 2,6-Dimethoxy-1,4-benzoquinone | 530-55-2 | Natural Products |
| HY-N1678 | 2,6-Dimethoxy-1-acetonylquinol | 2215-96-5 | Natural Products |
| HY-N1679 | 2,6-Dimethyl-3,7-octadiene-2,6-diol | 51276-34-7 | Natural Products |
| HY-N1680 | 3,7-Dimethyloct-1-ene-3,6,7-triol | 73815-21-1 | Natural Products |
| HY-N1681 | 2,7-Dihydrohomoerysotrine | 51095-85-3 | Natural Products |
| HY-N1682 | 2,7-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one | 69804-59-7 | Natural Products |
| HY-N1683 | 20(S),24(S)-Dihydroxydammar-25-en-3-one | 75069-59-9 | Natural Products |
| HY-N1684 | 20-Deoxyingenol 3-angelate | 75567-38-3 | Natural Products |
| HY-N1685 | 20-Hydroxy-3-oxo-28-lupanoic acid | 93372-87-3 | Natural Products |
| HY-N1686 | 20S,24R-Epoxydammar-12,25-diol-3-one | 25279-15-6 | Natural Products |
| HY-N1687 | 21,24-Epoxycycloartane-3,25-diol | 125305-73-9 | Natural Products |
| HY-N1688 | 24-Norhopa-4(23),22(29)-diene-3β,6β-diol | 194613-74-6 | Natural Products |
| HY-N1689 | 21-Deoxyneridienone B | 924910-83-8 | Natural Products |
| HY-N1690 | 21-epi-Serratenediol | 1449-06-5 | Natural Products |
| HY-N1692 | 22-Dehydroclerosterol | 26315-07-1 | Natural Products |
| HY-N1693 | 22-Dehydroclerosterol glucoside | 143815-99-0 | Natural Products |
| HY-N1694 | 22-Dehydroclerosteryl acetate | 28594-00-5 | Natural Products |
| HY-N1695 | Demethylregelin | 173991-81-6 | Natural Products |
| HY-N1696 | 23-Deoxojessic acid | 215609-93-1 | Natural Products |
| HY-N1697 | 23-Hydroxybetulin | 84414-40-4 | Natural Products |
| HY-N1698 | 23-Hydroxymangiferonic acid | 232266-08-9 | Natural Products |
| HY-N1699 | 24R,25-Dihydroxycycloartan-3-one | 155060-48-3 | Natural Products |
| HY-N1700 | 24,25-Dihydroxydammar-20-en-3-one | 63543-53-3 | Natural Products |
| HY-N1701 | 24,25-Epoxydammar-20(21)-en-3-one | 63543-52-2 | Natural Products |
| HY-N1702 | 24,25-Epoxytirucall-7-en-3,23-dione | 890928-81-1 | Natural Products |
| HY-N1703 | 24-Methylenecycloartanol | 1449-09-8 | Natural Products |
| HY-N1704 | 24-Methylenecycloartanol acetate | 1259-94-5 | Natural Products |
| HY-N1705 | 25-Hydroxycycloart-23-en-3-one | 148044-47-7 | Natural Products |
| HY-N1706 | 26-Nor-8-oxo-alpha-onocerin | 125124-68-7 | Natural Products |
| HY-N1707 | 27-Hydroxymangiferolic acid | 17983-82-3 | Natural Products |
| HY-N1708 | 27-Hydroxymangiferonic acid | 5132-66-1 | Natural Products |
| HY-N1710 | 28-Deoxonimbolide | 126005-94-5 | Natural Products |
| HY-N1711 | 28-Hydroxy-3-oxoolean-12-en-29-oic acid | 381691-22-1 | Natural Products |
| HY-N1712 | 29-Hydroxyfriedelan-3-one | 39903-21-4 | Natural Products |
| HY-N1713 | 29-Nor-20-oxolupeol | 19891-85-1 | Natural Products |
| HY-N1714 | 29-Norcycloartan-23-ene-3beta,25-diol | 115040-04-5 | Natural Products |
| HY-N1715 | 2-Acetoxy-3-deacetoxycaesaldekarin e | 18326-06-2 | Natural Products |
| HY-N1716 | 2′′-Acetylastragalin | 1206734-95-3 | Natural Products |
| HY-N1717 | 2-Acetylbenzoic acid | 577-56-0 | Natural Products |
| HY-N1718 | 2α,3β,24-Trihydroxyurs-12-en-28-oic acid | 143839-02-5 | Natural Products |
| HY-N1719 | Isoarjunolic acid | 102519-34-6 | Natural Products |
| HY-N1720 | 2α,3α,24-Trihydroxyolean-12-en-28-oic acid | 150821-16-2 | Natural Products |
| HY-N1721 | 2β-Hydroxykolavelool | 221466-42-8 | Natural Products |
| HY-N1722 | (–)-Erythro-saccharinic acid lactone | 18465-71-9 | Natural Products |
| HY-N1723 | 2-Deacetoxytaxinine B | 191547-12-3 | Natural Products |
| HY-N1724 | Concanamycin A | 80890-47-7 | Natural Products |
| HY-N1725 | 2-Desoxy-4-epi-pulchellin | 122872-03-1 | Natural Products |
| HY-N1726 | cis-Burchellin | 57457-99-5 | Natural Products |
| HY-N1727 | 2-Epitormentic acid | 119725-19-8 | Natural Products |
| HY-N1728 | 2-Ethyl-2,6,6-trimethylpiperidin-4-one | 133568-79-3 | Natural Products |
| HY-N1729 | 2α-Hydroxy-1,8-cineole | 60761-00-4 | Natural Products |
| HY-N1730 | 2-Hydroxy-3,4,5,6-tetramethoxychalcone | 219298-74-5 | Natural Products |
| HY-N1731 | 2′-Hydroxy-5′-methoxyacetophenone | 705-15-7 | Biochemical Assay Reagents |
| HY-N1732 | 2-Hydroxy-7-O-methylscillascillin | 52096-50-1 | Natural Products |
| HY-N1733 | 2′-Hydroxydaidzein | 7678-85-5 | Natural Products |
| HY-N1734 | 2-Hydroxydiplopterol | 1193250-54-2 | Natural Products |
| HY-N1735 | 2′-Hydroxygenistein | 1156-78-1 | Natural Products |
| HY-N1736 | 2-Hydroxynaringenin | 58124-18-8 | Natural Products |
| HY-N1737 | 2-Hydroxytetracosanoic acid ethyl ester | 124111-47-3 | Natural Products |
| HY-N1738 | 2-Methoxystypandrone | 85122-21-0 | Natural Products |
| HY-N1739 | Tectoquinone | 84-54-8 | Natural Products |
| HY-N1739R | Tectoquinone (Standard) | 84-54-8 | Reference Standards |
| HY-N1740 | 2''-O-Acetylsprengerinin C | 1220707-33-4 | Natural Products |
| HY-N1741 | Tutin,6-acetate | 2749-28-2 | Natural Products |
| HY-N1742 | 2''-O-Coumaroyljuglanin | 67214-05-5 | Natural Products |
| HY-N1743 | 1-(4-Hydroxy-2-methoxyphenyl)-3-(4-hydroxy-3-prenylphenyl) | 376362-03-7 | Natural Products |
| HY-N1744 | 4,4'-Dihydroxy-2',6'-dimethoxychalcone | 123316-64-3 | Natural Products |
| HY-N1745 | 2'-O-Methylisoliquiritigenin | 51828-10-5 | Natural Products |
| HY-N1745A | 3-Deoxysappanchalcone | 112408-67-0 | Natural Products |
| HY-N1746 | (2S)-2'-Methoxykurarinone | 270249-38-2 | Natural Products |
| HY-N1747 | 2'-O-Methylperlatolic acid | 38968-07-9 | Natural Products |
| HY-N1748 | 2-Oxokolavelool | 221466-41-7 | Natural Products |
| HY-N1750 | 3-(2,4-Dihydroxyphenyl)propanoic acid | 5631-68-5 | Natural Products |
| HY-N1750R | 3-(2,4-Dihydroxyphenyl)propanoic acid (Standard) | 5631-68-5 | Reference Standards |
| HY-N1751 | (Rac)-Phytene-1,2-diol | 438536-34-6 | Natural Products |
| HY-N1753 | 3-(4-Hydroxyphenyl)-1-propanol | 10210-17-0 | Reference compound |
| HY-N1754 | 3-(4-Methoxyphenyl)-1-(pyrrol-1-yl)propan-1-one | 448905-82-6 | Natural Products |
| HY-N1755 | 3-(Hydroxymethyl)cyclopentanol | 1007125-14-5 | Natural Products |
| HY-N1756 | 3-(Hydroxymethyl)cyclopentanone | 113681-11-1 | Natural Products |
| HY-N1757 | 3,10-Dihydroxy-5,11-dielmenthadiene-4,9-dione | 106623-23-8 | Natural Products |
| HY-N1759 | 3,11,12-Trihydroxyspirovetiv-1(10)-en-2-one | 220328-04-1 | Natural Products |
| HY-N1760 | 3β, 19α-Dihydroxy-6-oxo-urs-12-en-23-al-28-oic acid | 261768-88-1 | Natural Products |
| HY-N1762 | 3α,22β-Dihydroxyolean-12-en-29-oic acid | 808769-54-2 | Natural Products |
| HY-N1763 | 3,2'-epi-Larixinol | 1207671-28-0 | Natural Products |
| HY-N1764 | 3,4,4',7-Tetrahydroxyflavan | 38412-82-7 | Natural Products |
| HY-N1765 | L-Praziquanamine | 99746-73-3 | Reference compound |
| HY-N1766 | 3',4',5',3,5,6,7-Heptamethoxyflavone | 17245-30-6 | Natural Products |
| HY-N1767 | trans-3,4,5-Trimethoxycinnamyl alcohol | 30273-62-2 | Natural Products |
| HY-N1768 | (2S)-3',4',7-Trimethoxyflavan | 116384-26-0 | Natural Products |
| HY-N1769 | 3,4-Diacetoxycinnamamide | 129488-34-2 | Natural Products |
| HY-N1770 | 12-Hydroxysapriparaquinone | 142763-37-9 | Natural Products |
| HY-N1772 | (3S,4S)-3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one | 1220891-22-4 | Natural Products |
| HY-N1773 | 5,7,3'-Tri-O-methyl (-)-epicatechin | 97914-19-7 | Natural Products |
| HY-N1774 | 3,4'-Dihydroxy-3',5'-dimethoxypropiophenone | 136196-47-9 | Natural Products |
| HY-N1775 | 3',4'-Dihydroxyacetophenone | 1197-09-7 | Natural Products |
| HY-N1777 | 3,4-Dimethoxybenzamide | 1521-41-1 | Natural Products |
| HY-N1777R | 3,4-Dimethoxybenzamide (Standard) | 1521-41-1 | Reference Standards |
| HY-N1778 | 3,4-Dimethoxycinnamic acid | 2316-26-9 | Natural Products |
| HY-N1778A | (E)-3,4-Dimethoxycinnamic acid | 14737-89-4 | Natural Products |
| HY-N1779 | (E)-3,4-Dimethoxycinnamyl alcohol | 40918-90-9 | Natural Products |
| HY-N1780 | 3,4-Dimethoxyphenol | 2033-89-8 | Natural Products |
| HY-N1780R | 3,4-Dimethoxyphenol (Standard) | 2033-89-8 | Reference Standards |
| HY-N1781 | 3,4-Dimethoxyphenyl beta-D-glucoside | 84812-00-0 | Natural Products |
| HY-N1782 | 3,4-O-Isopropylidene-shikimic acid | 183075-03-8 | Natural Products |
| HY-N1783 | (24E)-3,4-Secocucurbita-4,24-diene-3,26,29-trioic acid | 329975-47-5 | Natural Products |
| HY-N1784 | 3',5,5',7-Tetrahydroxy-4',6-dimethoxyflavone | 125537-92-0 | Natural Products |
| HY-N1785 | Hibiscetin heptamethyl ether | 21634-52-6 | Natural Products |
| HY-N1789 | Kaempferol-7,4'-dimethyl ether | 15486-33-6 | Natural Products |
| HY-N1790 | 6-Dehydrocerevisterol | 14858-07-2 | Natural Products |
| HY-N1791 | 3,5-Diprenyl-4-hydroxybenzaldehyde | 52275-04-4 | Natural Products |
| HY-N1792 | 3,6,19,23-Tetrahydroxy-12-ursen-28-oic acid | 91095-51-1 | Natural Products |
| HY-N1793 | 3,6,19-Trihydroxy-23-oxo-12-ursen-28-oic acid | 131984-82-2 | Natural Products |
| HY-N1794 | 3,6-Dimethoxyapigenin | 22697-65-0 | Natural Products |
| HY-N1795 | 3,7,16-Trihydroxystigmast-5-ene | 289056-24-2 | Natural Products |
| HY-N1796 | Populigenin | 103553-98-6 | Natural Products |
| HY-N1797 | 3,7-Di-O-methylducheside A | 136133-08-9 | Natural Products |
| HY-N1798 | Quercetin 3,7-dimethyl ether | 2068-02-2 | Natural Products |
| HY-N1799 | 3,8''-Biapigenin | 101140-06-1 | Natural Products |
| HY-N1800 | 3,3'-Di-O-methylellagic acid-4'-O-β-D-glucopyranoside | 51803-68-0 | Natural Products |
| HY-N1801 | 30-Hydroxylup-20(29)-en-3-one | 72944-06-0 | Natural Products |
| HY-N1802 | 30-Oxolupeol | 64181-07-3 | Natural Products |
| HY-N1803 | 3-Acetoxy-11-ursen-28,13-olide | 35959-08-1 | Natural Products |
| HY-N1804 | 3-Acetoxy-24-hydroxydammara-20,25-diene | 143519-04-4 | Natural Products |
| HY-N1805 | 3-Acetoxy-4,7(11)-cadinadien-8-one | 104975-02-2 | Natural Products |
| HY-N1806 | 3-Acetoxy-4-cadinen-8-one | 923950-05-4 | Natural Products |
| HY-N1807 | (E)-3-Acetoxy-5-methoxystilbene | 71144-78-0 | Natural Products |
| HY-N1808 | 3-Acetoxy-8(17),13E-labdadien-15-oic acid | 63399-37-1 | Natural Products |
| HY-N1809 | 3a-Epiburchellin | 155551-61-4 | Natural Products |
| HY-N1810 | Ditigloylteloidine | 7159-86-6 | Natural Products |
| HY-N1811 | 3α-Angeloyloxypterokaurene L3 | 79406-11-4 | Natural Products |
| HY-N1812 | 3α-Cinnamoyloxypterokaurene L3 | 79406-13-6 | Natural Products |
| HY-N1813 | Isoanwuweizic acid | 129724-83-0 | Natural Products |
| HY-N1814 | 3β-Hydroxyurs-11-en-28,13β-olide | 35959-05-8 | Natural Products |
| HY-N1815 | 3-Chloro-4-hydroxy-2-piperidone | 174204-83-2 | Natural Products |
| HY-N1816 | 3-Dehydro-15-deoxoeucosterol | 81678-46-8 | Natural Products |
| HY-N1817 | Demethoxypiplartine | 130263-10-4 | Natural Products |
| HY-N1818 | Deoxysappanone B | 113122-54-6 | Natural Products |
| HY-N1819 | 3-Deoxyzinnolide | 17811-32-4 | Natural Products |
| HY-N1820 | 3α-Akebonoic acid | 104777-61-9 | Natural Products |
| HY-N1821 | 3-Epicabraleadiol | 19942-04-2 | Natural Products |
| HY-N1822 | 3-epi-Cabraleahydroxylactone | 35833-72-8 | Natural Products |
| HY-N1823 | Pygenic acid A | 52213-27-1 | Natural Products |
| HY-N1824 | 3-Epiglochidiol | 29028-10-2 | Natural Products |
| HY-N1825 | 3-Epiglochidiol diacetate | 6587-37-7 | Natural Products |
| HY-N1826 | Epikatonic acid | 76035-62-6 | Natural Products |
| HY-N1827 | 3-epi-Maslinic acid | 26563-68-8 | Natural Products |
| HY-N1829 | 3-Epiturraeanthin | 22415-24-3 | Natural Products |
| HY-N1830 | 3-Epiwilsonine | 39024-15-2 | Natural Products |
| HY-N1831 | 3-Eudesmene-1beta,11-diol | 658062-22-7 | Natural Products |
| HY-N1832 | 3-Furfuryl 2-pyrrolecarboxylate | 119767-00-9 | Natural Products |
| HY-N1833 | 3'-Geranyl-3-prenyl-2',4',5,7-tetrahydroxyflavone | 1334309-44-2 | Natural Products |
| HY-N1834 | 3-Geranyl-4-methoxybenzoic acid | 246266-38-6 | Natural Products |
| HY-N1835 | 3'-Hydroxy-3,9-dihydroeucomin | 107585-75-1 | Natural Products |
| HY-N1836 | 3-Acetonyl-3-hydroxyoxindole | 33417-17-3 | Natural Products |
| HY-N1837 | 3-Hydroxy-4,15-dinor-1(5)-xanthen-12,8-olide | 1093207-99-8 | Natural Products |
| HY-N1838 | Dehydromaackiain | 59901-98-3 | Natural Products |
| HY-N1839 | 3-Hydroxybakuchiol | 178765-54-3 | Natural Products |
| HY-N1840 | 3-Hydroxycatalponol | 265644-24-4 | Natural Products |
| HY-N1841 | Rocaglamide D | 189322-67-6 | Natural Products |
| HY-N1842 | 3-Hydroxysarpagine | 857297-90-6 | Natural Products |
| HY-N1843 | 3-Isomangostin hydrate | 26063-96-7 | Natural Products |
| HY-N1845 | 3-Methoxy-4,5-methylenedioxycinnamaldehyde | 74683-19-5 | Natural Products |
| HY-N1846 | 3-Methoxy-5-heneicosylphenol | 126882-76-6 | Natural Products |
| HY-N1847 | 3'-Methoxydaidzein | 21913-98-4 | Natural Products |
| HY-N1848 | 3-Methoxyfuran | 3420-57-3 | Natural Products |
| HY-N1849 | 3'-Methoxyrocaglamide | 189322-69-8 | Natural Products |
| HY-N1850 | 3'-Methyl-4-O-methylhelichrysetin | 109471-13-8 | Natural Products |
| HY-N1851 | 3'-Methylflavokawin | 1044743-35-2 | Natural Products |
| HY-N1852 | 3-O-(E)-Coumaroylbetulin | 144424-80-6 | Natural Products |
| HY-N1854 | Pinobanksin 3-acetate | 52117-69-8 | Natural Products |
| HY-N1855 | 3-O-Caffeoyloleanolic acid | 97534-10-6 | Natural Products |
| HY-N1858 | 3-O-Methylducheside A | 62218-23-9 | Natural Products |
| HY-N1859 | 3'-O-Methylorobol | 36190-95-1 | Natural Products |
| HY-N1860 | 3-O-Methylquercetin | 1486-70-0 | Natural Products |
| HY-N1861 | 3-O-Methylquercetin tetraacetate | 1486-69-7 | Natural Products |
| HY-N1862 | 3-O-Methyltirotundin | 1021945-29-8 | Natural Products |
| HY-N1863 | 3-p-(E)-Coumaroyloleanolic acid | 151334-06-4 | Natural Products |
| HY-N1864 | 3-O-trans-p-Coumaroyltormentic acid | 121064-78-6 | Natural Products |
| HY-N1865 | 3-Oxotirucalla-7,24-dien-21-oic acid | 82464-35-5 | Natural Products |
| HY-N1866 | N-(3-Phenylpropanoyl)pyrrole | 112448-69-8 | Natural Products |
| HY-N1867 | trans-Cinnamyl alcohol | 4407-36-7 | Natural Products |
| HY-N1868 | 3-Prenyl-2,4,6-trihydroxybenzophenone | 93796-20-4 | Natural Products |
| HY-N1869 | 4(15),11-Oppositadien-1-ol | 70389-96-7 | Natural Products |
| HY-N1870 | 1β-Hydroxy-4(15),5E,10(14)-germacratriene | 81968-62-9 | Natural Products |
| HY-N1871 | 4-(2-Hydroxy-1-methoxyethyl)-1,2-benzenediol | 577976-26-2 | Natural Products |
| HY-N1872 | 4-(3,4-Dihydroxyphenyl)butan-2-one | 61152-62-3 | Natural Products |
| HY-N1873 | (E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol | 69768-97-4 | Natural Products |
| HY-N1874 | (E)-4-(3,4-Dimethoxyphenyl)but-3-ene-1,2-diol | 164661-12-5 | Natural Products |
| HY-N1875 | 4-(Ethoxymethyl)phenol | 57726-26-8 | Natural Products |
| HY-N1876 | Aromadendrane-4β,10α-diol | 70051-38-6 | Natural Products |
| HY-N1877 | 4',4'''-Di-O-methylcupressuflavone | 74336-91-7 | Natural Products |
| HY-N1878 | 4,5-Diepipsidial A | 1219603-97-0 | Natural Products |
| HY-N1879 | 4,5-Dihydroblumenol A | 155418-97-6 | Natural Products |
| HY-N1881 | 4',5-Dihydroxyflavone | 6665-67-4 | Natural Products |
| HY-N1882 | 4,5-Dimethoxycanthin-6-one | 18110-87-7 | Natural Products |
| HY-N1883 | Epoxyarteannuinic acid | 92466-31-4 | Natural Products |
| HY-N1884 | 4',7-Di-O-methylnaringenin | 29424-96-2 | Natural Products |
| HY-N1885 | 4alpha,8beta-Dihydroxyeudesm-7(11)-en-12,8-olide | 1231208-53-9 | Natural Products |
| HY-N1886 | Catalpanp-1 | 56473-67-7 | Natural Products |
| HY-N1887 | 4-Allylcatechol | 1126-61-0 | Natural Products |
| HY-N1888 | Rospiglioside aglycon | 55102-39-1 | Natural Products |
| HY-N1889 | 4-Cadinen-7-ol | 217650-27-6 | Natural Products |
| HY-N1890 | 4'-Demethoxypiperlotine C | 807372-38-9 | Natural Products |
| HY-N1891 | 4'-Demethyl-3,9-dihydroeucomin | 107585-77-3 | Natural Products |
| HY-N1892 | 4'-Demethyleucomin | 34818-83-2 | Natural Products |
| HY-N1893 | 4-epi-Alyxialactone | 132339-37-8 | Natural Products |
| HY-N1894 | 4-Epicommunic acid | 83945-57-7 | Natural Products |
| HY-N1895 | 4-epi-Isoinuviscolide | 68832-39-3 | Natural Products |
| HY-N1896 | 4-Hydroxy-1,10-secocadin-5-ene-1,10-dione | 226904-40-1 | Natural Products |
| HY-N1897 | 4-Hydroxy-11,12,13-trinor-5-eudesmen-7-one | 133369-42-3 | Natural Products |
| HY-N1899 | p-Hydroxy-5,6-dehydrokawain | 39986-86-2 | Natural Products |
| HY-N1900 | 4-Hydroxycephalotaxine | 84567-08-8 | Natural Products |
| HY-N1901 | (E)-p-Coumaramide | 194940-15-3 | Natural Products |
| HY-N1902 | 4-Hydroxyphenylacetic acid | 156-38-7 | Natural Products |
| HY-N1902R | 4-Hydroxyphenylacetic acid (Standard) | 156-38-7 | Reference Standards |
| HY-N1902S | 4-Hydroxyphenylacetic acid-d6 | 100287-06-7 | Isotope-Labeled Compounds |
| HY-N1902S1 | 4-Hydroxyphenylacetic acid-d4 | Isotope-Labeled Compounds | |
| HY-N1903 | NSC 648342 | 120278-25-3 | Natural Products |
| HY-N1904 | 4′-Hydroxywogonin | 57096-02-3 | Natural Products |
| HY-N1905 | 4-Methoxy-β-carboline-1-carboxylic acid methylester | 60807-25-2 | Natural Products |
| HY-N1906 | 4-Methoxy-1-methylquinolin-2-one | 32262-18-3 | Natural Products |
| HY-N1907 | 4-O-Demethylisokadsurenin D | 89104-59-6 | Natural Products |
| HY-N1908 | 4-O-Demethylkadsurenin D | 127179-70-8 | Natural Products |
| HY-N1909 | 4-O-Galloylbergenin | 82958-45-0 | Natural Products |
| HY-N1910 | 4'-O-Methylbavachalcone | 20784-60-5 | Natural Products |
| HY-N1911 | 4-O-Methylhelichrysetin | 56121-44-9 | Natural Products |
| HY-N1912 | Andropanolide | 869807-57-8 | Natural Products |
| HY-N1913 | Danshensu | 76822-21-4 | Natural Products |
| HY-N1913A | Danshensu (sodium) | 81075-52-7 | Natural Products |
| HY-N1914 | Ergothioneine | 497-30-3 | Natural Products |
| HY-N1914R | Ergothioneine (Standard) | 497-30-3 | Reference Standards |
| HY-N1914S | Ergothioneine-d3 | 1356933-89-5 | Isotope-Labeled Compounds |
| HY-N1914S1 | Ergothioneine-d9 | Isotope-Labeled Compounds | |
| HY-N1915 | Cellohexaose | 2478-35-5 | Natural Products |
| HY-N1916 | Coniferyl ferulate | 63644-62-2 | Natural Products |
| HY-N1917 | Alpha-Solamarine | 20318-30-3 | Natural Products |
| HY-N1918 | (+)-Adonifoline | 115712-88-4 | Natural Products |
| HY-N1919 | Ajmalicine | 483-04-5 | Natural Products |
| HY-N1919A | Ajmalicine (hydrochloride) | 4373-34-6 | Natural Products |
| HY-N1919R | Ajmalicine (Standard) | 483-04-5 | Reference Standards |
| HY-N1920S | DL-Menthone-d8 | 244023-68-5 | Isotope-Labeled Compounds |
| HY-N1921 | Edpetiline | 32685-93-1 | Natural Products |
| HY-N1921R | Edpetiline (Standard) | 32685-93-1 | Reference Standards |
| HY-N1922 | Mesaconine | 6792-09-2 | Natural Products |
| HY-N1923 | Hypaconine | 63238-68-6 | Natural Products |
| HY-N1924 | Crassicauline A | 79592-91-9 | Natural Products |
| HY-N1924R | Crassicauline A (Standard) | 79592-91-9 | Reference Standards |
| HY-N1925 | Tea polyphenol | 84650-60-2 | Natural Products |
| HY-N1926 | Dihydrocoumarin | 119-84-6 | Natural Products |
| HY-N1926R | Dihydrocoumarin (Standard) | 119-84-6 | Reference Standards |
| HY-N1927 | Menisdaurin | 67765-58-6 | Natural Products |
| HY-N1930 | (-)-Hinesol | 23811-08-7 | Natural Products |
| HY-N1931 | Epifriedelanol | 16844-71-6 | Natural Products |
| HY-N1932 | Bayogenin | 6989-24-8 | Natural Products |
| HY-N1932R | Bayogenin (Standard) | 6989-24-8 | Reference Standards |
| HY-N1933 | Allocryptopine | 485-91-6 | Natural Products |
| HY-N1933R | Allocryptopine (Standard) | 485-91-6 | Reference Standards |
| HY-N1934 | Dihydroberberine | 483-15-8 | Natural Products |
| HY-N1934R | Dihydroberberine (Standard) | 483-15-8 | Reference Standards |
| HY-N1936 | α-Spinasterol-3-O-β-D-glucoside | 1745-36-4 | Natural Products |
| HY-N1937 | Pristimerin | 1258-84-0 | Natural Products |
| HY-N1937R | Pristimerin (Standard) | 1258-84-0 | Reference Standards |
| HY-N1938 | D(+)-Raffinose (pentahydrate) | 17629-30-0 | Natural Products |
| HY-N1939 | Icariside I | 56725-99-6 | Natural Products |
| HY-N1939R | Icariside I (Standard) | 56725-99-6 | Reference Standards |
| HY-N1940 | β-Anhydroicaritin | 38226-86-7 | Natural Products |
| HY-N1941 | Isosinensetin | 17290-70-9 | Natural Products |
| HY-N1942 | 5-O-Demethylnobiletin | 2174-59-6 | Natural Products |
| HY-N1942R | 5-O-Demethylnobiletin (Standard) | 2174-59-6 | Reference Standards |
| HY-N1943 | Ailanthone | 981-15-7 | Natural Products |
| HY-N1944 | Nerolidol,98%(isomers mixture) | 7212-44-4 | Natural Products |
| HY-N1944A | cis-Nerolidol | 3790-78-1 | Natural Products |
| HY-N1944AR | cis-Nerolidol (Standard) | 3790-78-1 | Reference Standards |
| HY-N1944R | Nerolidol (Standard) | 7212-44-4 | Reference Standards |
| HY-N1944S | Nerolidol-d4 | Isotope-Labeled Compounds | |
| HY-N1945 | Bonvalotidine A | 929019-25-0 | Natural Products |
| HY-N1946 | Chasmanine | 5066-78-4 | Natural Products |
| HY-N1947 | Ligurobustoside N | 583058-07-5 | Natural Products |
| HY-N1948 | Mitoridine | 3911-19-1 | Natural Products |
| HY-N1949 | Homoplantaginin | 17680-84-1 | Natural Products |
| HY-N1949R | Homoplantaginin (Standard) | 17680-84-1 | Reference Standards |
| HY-N1950 | Hispidulin | 1447-88-7 | Natural Products |
| HY-N1950R | Hispidulin (Standard) | 1447-88-7 | Reference Standards |
| HY-N1951 | Miltirone | 27210-57-7 | Natural Products |
| HY-N1952 | Isoeugenol | 97-54-1 | Natural Products |
| HY-N1952A | cis-Isoeugenol | 5912-86-7 | Natural Products |
| HY-N1952R | Isoeugenol (Standard) | 97-54-1 | Reference Standards |
| HY-N1952S | Isoeugenol-d3 | 1668553-92-1 | Isotope-Labeled Compounds |
| HY-N1953 | Clove oil | 8000-34-8 | Biochemical Assay Reagents |
| HY-N1955 | Protostemotinine | 169534-85-4 | Natural Products |
| HY-N1956 | Rubiadin-1-methyl ether | 7460-43-7 | Natural Products |
| HY-N1957 | Gamma-Mangostin | 31271-07-5 | Natural Products |
| HY-N1957R | Gamma-Mangostin (Standard) | 31271-07-5 | Reference Standards |
| HY-N1958 | Syringaresinol diglucoside | 66791-77-3 | Natural Products |
| HY-N1958R | Syringaresinol diglucoside (Standard) | 66791-77-3 | Reference Standards |
| HY-N1959 | Cannabisin A | 130508-46-2 | Reference compound |
| HY-N1961 | Ophiopogonin B | 38971-41-4 | Natural Products |
| HY-N1962 | Ophiopojaponin C | 911819-08-4 | Natural Products |
| HY-N1963 | Curzerene | 17910-09-7 | Natural Products |
| HY-N1963R | Curzerene (Standard) | 17910-09-7 | Reference Standards |
| HY-N1964 | Gibberellic acid | 77-06-5 | Natural Products |
| HY-N1964R | Gibberellic acid (Standard) | 77-06-5 | Reference Standards |
| HY-N1965 | Gaultherin | 490-67-5 | Natural Products |
| HY-N1965R | Gaultherin (Standard) | 490-67-5 | Reference Standards |
| HY-N1966 | (E)-Osmundacetone | 123694-03-1 | Natural Products |
| HY-N1966R | (E)-Osmundacetone (Standard) | 123694-03-1 | Reference Standards |
| HY-N1967 | Dihydrocurcumin | 76474-56-1 | Natural Products |
| HY-N1968 | Quercetin-3-O-β-D-glucose-7-O-β-D-gentiobiosiden | 60778-02-1 | Natural Products |
| HY-N1969 | 3,3'-Di-O-methylellagic acid | 2239-88-5 | Natural Products |
| HY-N1970 | 5,7-Dihydroxychromone | 31721-94-5 | Natural Products |
| HY-N1970R | 5,7-Dihydroxychromone (Standard) | 31721-94-5 | Reference Standards |
| HY-N1972 | Sennoside C | 37271-16-2 | Natural Products |
| HY-N1972R | Sennoside C (Standard) | 37271-16-2 | Reference Standards |
| HY-N1973 | Sennoside D | 37271-17-3 | Natural Products |
| HY-N1973R | Sennoside D (Standard) | 37271-17-3 | Reference Standards |
| HY-N1974 | Fuziline | 80665-72-1 | Natural Products |
| HY-N1974R | Fuziline (Standard) | 80665-72-1 | Reference Standards |
| HY-N1975 | Ethyl phenethyl acetal | 2556-10-7 | Natural Products |
| HY-N1976 | (+)-(3R,8S)-Falcarindiol | 225110-25-8 | Natural Products |
| HY-N1977 | Podophyllotoxin glucoside | 16481-54-2 | Natural Products |
| HY-N1978 | 3'-Methoxypuerarin | 117047-07-1 | Natural Products |
| HY-N1978R | 3'-Methoxypuerarin (Standard) | 117047-07-1 | Reference Standards |
| HY-N1979 | 4'-Methoxypuerarin | 92117-94-7 | Natural Products |
| HY-N1980 | 3'-Hydroxypuerarin | 117060-54-5 | Natural Products |
| HY-N1980R | 3'-Hydroxypuerarin (Standard) | 117060-54-5 | Reference Standards |
| HY-N1981 | Triolein | 122-32-7 | Natural Products |
| HY-N1981R | Triolein (Standard) | 122-32-7 | Reference Standards |
| HY-N1981S | Triolein-13C3 | 82005-46-7 | Isotope-Labeled Compounds |
| HY-N1981S1 | Triolein-d5 | 60892-83-3 | Isotope-Labeled Compounds |
| HY-N1982 | Denudatine | 26166-37-0 | Natural Products |
| HY-N1983 | Caudatin | 38395-02-7 | Natural Products |
| HY-N1983R | Caudatin (Standard) | 38395-02-7 | Reference Standards |
| HY-N1984 | Artemisic acid | 80286-58-4 | Natural Products |
| HY-N1984R | Artemisic acid (Standard) | 80286-58-4 | Reference Standards |
| HY-N1985 | Acetylastragaloside I | 84687-47-8 | Natural Products |
| HY-N1986 | Cucurbitacin D | 3877-86-9 | Natural Products |
| HY-N1986R | Cucurbitacin D (Standard) | 3877-86-9 | Reference Standards |
| HY-N1987 | Cucurbitacin IIb | 50298-90-3 | Natural Products |
| HY-N1987R | Cucurbitacin IIb (Standard) | 50298-90-3 | Reference Standards |
| HY-N1988 | Cucurbitacin IIa | 58546-34-2 | Natural Products |
| HY-N1988R | Cucurbitacin IIa (Standard) | 58546-34-2 | Reference Standards |
| HY-N1989 | Bacoside A | 11028-00-5 | Natural Products |
| HY-N1990 | Gypenoside XLIX | 94987-08-3 | Natural Products |
| HY-N1990R | Gypenoside XLIX (Standard) | 94987-08-3 | Reference Standards |
| HY-N1991 | Platicodigenin | 22327-82-8 | Natural Products |
| HY-N1992 | Theaflavin 3,3'-digallate | 30462-35-2 | Natural Products |
| HY-N1992R | Theaflavin 3,3'-digallate (Standard) | 30462-35-2 | Reference Standards |
| HY-N1993 | 5-Methyl-7-methoxyisoflavone | 82517-12-2 | Natural Products |
| HY-N1994 | Swertianine | 20882-75-1 | Natural Products |
| HY-N1995 | Methylswertianin | 22172-17-4 | Natural Products |
| HY-N1996 | Chebulagic acid | 23094-71-5 | Natural Products |
| HY-N1996R | Chebulagic acid (Standard) | 23094-71-5 | Reference Standards |
| HY-N1997 | Pyromeconic acid | 496-63-9 | Natural Products |
| HY-N1999 | Wilfordine | 37239-51-3 | Natural Products |
| HY-N2000 | Bellidifolin | 2798-25-6 | Natural Products |
| HY-N2001 | Araloside X | 344911-90-6 | Natural Products |
| HY-N2002 | Araloside VII | 340982-22-1 | Natural Products |
| HY-N2003 | D-Tetrahydropalmatine | 3520-14-7 | Natural Products |
| HY-N2004 | Isoborneol | 124-76-5 | Natural Products |
| HY-N2004R | Isoborneol (Standard) | 124-76-5 | Reference Standards |
| HY-N2005 | Cycleanine | 518-94-5 | Natural Products |
| HY-N2006 | Ganoderic acid B | 81907-61-1 | Natural Products |
| HY-N2006R | Ganoderic acid B (Standard) | 81907-61-1 | Reference Standards |
| HY-N2007 | Veratric acid | 93-07-2 | Natural Products |
| HY-N2007R | Veratric acid (Standard) | 93-07-2 | Reference Standards |
| HY-N2007S | Veratric acid-d6 | 1162658-12-9 | Isotope-Labeled Compounds |
| HY-N2008 | Luteolin 5-O-glucoside | 20344-46-1 | Natural Products |
| HY-N2009 | 3-O-Methylgallic acid | 3934-84-7 | Natural Products |
| HY-N2010 | Methyl gallate | 99-24-1 | Natural Products |
| HY-N2010R | Methyl gallate (Standard) | 99-24-1 | Reference Standards |
| HY-N2011 | Octyl gallate | 1034-01-1 | Natural Products |
| HY-N2011R | Octyl gallate (Standard) | 1034-01-1 | Reference Standards |
| HY-N2012 | 7-Hydroxyaristolochic acid A | 79185-75-4 | Natural Products |
| HY-N2013 | Aristolactam I | 13395-02-3 | Natural Products |
| HY-N2013R | Aristolactam I (Standard) | 13395-02-3 | Reference Standards |
| HY-N2014 | Verbenalin | 548-37-8 | Natural Products |
| HY-N2014R | Verbenalin (Standard) | 548-37-8 | Reference Standards |
| HY-N2015 | Hastatoside | 50816-24-5 | Natural Products |
| HY-N2015R | Hastatoside (Standard) | 50816-24-5 | Reference Standards |
| HY-N2016 | Arteannuin B | 50906-56-4 | Natural Products |
| HY-N2017 | Maoecrystal A | 96850-30-5 | Natural Products |
| HY-N2018 | α-D-Xylose | 6763-34-4 | Natural Products |
| HY-N2019 | Chaetocin | 28097-03-2 | Natural Products |
| HY-N2020 | Anacardic Acid | 16611-84-0 | Natural Products |
| HY-N2020R | Anacardic Acid (Standard) | 16611-84-0 | Reference Standards |
| HY-N2021 | Phosphoramidon | 36357-77-4 | Natural Products |
| HY-N2021A | Phosphoramidon (disodium) | 164204-38-0 | Natural Products |
| HY-N2021AR | Phosphoramidon (Disodium) (Standard) | 164204-38-0 | Reference Standards |
| HY-N2021B | Phosphoramidon (sodium) | 119942-99-3 | Biochemical Assay Reagents |
| HY-N2022 | Castanospermine | 79831-76-8 | Natural Products |
| HY-N2024 | Maltose | 69-79-4 | Natural Products |
| HY-N2024A | Maltose monohydrate | 6363-53-7 | Natural Products |
| HY-N2024AR | Maltose monohydrate (Standard) | 6363-53-7 | Reference Standards |
| HY-N2024AS | Maltose monohydrate-d14 | Isotope-Labeled Compounds | |
| HY-N2024AS1 | Maltose monohydrate-13C12 | Isotope-Labeled Compounds | |
| HY-N2024AS2 | Maltose monohydrate-13C | Isotope-Labeled Compounds | |
| HY-N2024B | Maltose solution, 20% in H2O | 69-79-4 | Biochemical Assay Reagents |
| HY-N2024R | Maltose (Standard) | 69-79-4 | Reference Standards |
| HY-N2025 | Oroxin A | 57396-78-8 | Natural Products |
| HY-N2025R | Oroxin A (Standard) | 57396-78-8 | Reference Standards |
| HY-N2026 | Propylparaben | 94-13-3 | Natural Products |
| HY-N2026A | Propylparaben (sodium) | 35285-69-9 | Natural Products |
| HY-N2026AR | Propylparaben (sodium) (Standard) | 35285-69-9 | Reference Standards |
| HY-N2026R | Propylparaben (Standard) | 94-13-3 | Reference Standards |
| HY-N2026S | Propylparaben-d7 | 1246820-92-7 | Isotope-Labeled Compounds |
| HY-N2026S1 | Propylparaben-d4 | 1219802-67-1 | Isotope-Labeled Compounds |
| HY-N2027 | Taurochenodeoxycholic acid | 516-35-8 | Natural Products |
| HY-N2027R | Taurochenodeoxycholic acid (Standard) | 516-35-8 | Reference Standards |
| HY-N2027S | Taurochenodeoxycholic acid-d4 (sodium) | 2410279-85-3 | Isotope-Labeled Compounds |
| HY-N2028 | Demethylwedelolactone | 6468-55-9 | Natural Products |
| HY-N2028A | Demethylwedelolactone (Sulfate) | 1318240-80-0 | Natural Products |
| HY-N2030 | Perakine | 4382-56-3 | Natural Products |
| HY-N2031 | Parishin | 62499-28-9 | Natural Products |
| HY-N2031R | Parishin (Standard) | 62499-28-9 | Reference Standards |
| HY-N2033 | Chebulinic acid | 18942-26-2 | Natural Products |
| HY-N2033R | Chebulinic acid (Standard) | 18942-26-2 | Reference Standards |
| HY-N2034 | Dehydrodicentrine | 19843-03-9 | Natural Products |
| HY-N2035 | Moslosooflavone | 3570-62-5 | Natural Products |
| HY-N2035R | Moslosooflavone (Standard) | 3570-62-5 | Reference Standards |
| HY-N2036 | Mosloflavone | 740-33-0 | Natural Products |
| HY-N2037 | Higenamine | 5843-65-2 | Natural Products |
| HY-N2037A | Higenamine (hydrochloride) | 11041-94-4 | Natural Products |
| HY-N2037AR | Higenamine (hydrochloride) (Standard) | 11041-94-4 | Reference Standards |
| HY-N2037AS | Higenamine-d4 (hydrochloride) | 2249814-84-2 | Isotope-Labeled Compounds |
| HY-N2037AS1 | Higenamine-d4-1 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-N2037B | (S)-Higenamine | 22672-77-1 | Reference compound |
| HY-N2037C | (S)-Higenamine (hydrobromide) | 105990-27-0 | Reference compound |
| HY-N2038 | 3,5,6,7,8,3',4'-Heptemthoxyflavone | 1178-24-1 | Natural Products |
| HY-N2038R | 3,?5,?6,?7,?8,?3',?4'-?Heptemthoxyflavone (Standard) | 1178-24-1 | Reference Standards |
| HY-N2039 | 20(R)-Ginsenoside Rg2 | 80952-72-3 | Natural Products |
| HY-N2039R | 20(R)-Ginsenoside Rg2 (Standard) | 80952-72-3 | Reference Standards |
| HY-N2040 | (20R)-Protopanaxadiol | 7755-01-3 | Natural Products |
| HY-N2041 | Myristic acid | 544-63-8 | Natural Products |
| HY-N2041R | Myristic acid (Standard) | 544-63-8 | Reference Standards |
| HY-N2041S | Myristic acid-d27 | 60658-41-5 | Isotope-Labeled Compounds |
| HY-N2041S1 | Myristic acid-d2 | 30719-21-2 | Isotope-Labeled Compounds |
| HY-N2041S2 | Myristic acid-13C | 57677-52-8 | Isotope-Labeled Compounds |
| HY-N2041S3 | Myristic acid-d3 | 62217-71-4 | Isotope-Labeled Compounds |
| HY-N2041S4 | Myristic acid-13C3 | 202114-49-6 | Isotope-Labeled Compounds |
| HY-N2041S5 | Myristic acid-d1 | 358730-97-9 | Isotope-Labeled Compounds |
| HY-N2041S6 | Myristic acid-d5 | 327077-03-2 | Isotope-Labeled Compounds |
| HY-N2041S7 | Myristic acid-d7 | Isotope-Labeled Compounds | |
| HY-N2043 | Huperzine B | 103548-82-9 | Natural Products |
| HY-N2043R | Huperzine B (Standard) | 103548-82-9 | Reference Standards |
| HY-N2044 | Methyl 3,4,5-trimethoxybenzoate | 1916-07-0 | Natural Products |
| HY-N2044S | Methyl 3,4,5-trimethoxybenzoate-d9 | 1182838-07-8 | Isotope-Labeled Compounds |
| HY-N2045 | Musk ketone | 81-14-1 | Natural Products |
| HY-N2045R | Musk ketone (Standard) | 81-14-1 | Reference Standards |
| HY-N2046 | Jujuboside D | 194851-84-8 | Natural Products |
| HY-N2047 | Jujuboside B1 | 68144-21-8 | Natural Products |
| HY-N2048 | 2,2':5',2''-Terthiophene | 1081-34-1 | Natural Products |
| HY-N2048R | 2,2':5',2''-Terthiophene (Standard) | 1081-34-1 | Reference Standards |
| HY-N2049 | 20(R)-Notoginsenoside R2 | 948046-15-9 | Natural Products |
| HY-N2050 | 1,3,5,8-Tetrahydroxyxanthone | 2980-32-7 | Natural Products |
| HY-N2051 | Zeylenone | 193410-84-3 | Natural Products |
| HY-N2052 | (-)-Zeylenol | 78804-17-8 | Natural Products |
| HY-N2053 | Physalin L | 113146-74-0 | Natural Products |
| HY-N2054 | Kaempferol 4'-glucoside | 52222-74-9 | Natural Products |
| HY-N2055 | Kaempferol 3-O-sophoroside | 19895-95-5 | Natural Products |
| HY-N2056 | 11-Keto-beta-boswellic acid | 17019-92-0 | Natural Products |
| HY-N2056R | 11-Keto-beta-boswellic acid (Standard) | 17019-92-0 | Reference Standards |
| HY-N2057 | Steviol | 471-80-7 | Natural Products |
| HY-N2057R | Steviol (Standard) | 471-80-7 | Reference Standards |
| HY-N2058 | Neogambogic acid | 93772-31-7 | Natural Products |
| HY-N2059 | Santalol | 11031-45-1 | Natural Products |
| HY-N2060 | Evocarpine | 15266-38-3 | Natural Products |
| HY-N2061 | Lindenenol | 26146-27-0 | Natural Products |
| HY-N2062A | (±)-10-Nitrocamptothecin | 104195-61-1 | Natural Products |
| HY-N2063 | 12-Ethyl-9-hydroxycamptothecin | 119577-28-5 | Natural Products |
| HY-N2064 | Racanisodamine | 17659-49-3 | Natural Products |
| HY-N2065 | Withaferin A | 5119-48-2 | Natural Products |
| HY-N2065R | Withaferin A (Standard) | 5119-48-2 | Reference Standards |
| HY-N2067 | Vanillyl alcohol | 498-00-0 | Natural Products |
| HY-N2067R | Vanillyl alcohol (Standard) | 498-00-0 | Reference Standards |
| HY-N2068 | Didymin | 14259-47-3 | Natural Products |
| HY-N2068R | Didymin (Standard) | 14259-47-3 | Reference Standards |
| HY-N2070 | Acevaltrate | 25161-41-5 | Natural Products |
| HY-N2071 | Cedrol | 77-53-2 | Natural Products |
| HY-N2071R | Cedrol (Standard) | 77-53-2 | Reference Standards |
| HY-N2072 | Crocetin | 27876-94-4 | Natural Products |
| HY-N2072R | Crocetin (Standard) | 27876-94-4 | Reference Standards |
| HY-N2073 | Ethyl linolenate | 1191-41-9 | Natural Products |
| HY-N2073R | Ethyl linolenate (Standard) | 1191-41-9 | Reference Standards |
| HY-N2073S | Ethyl linolenate-d5 | 203633-16-3 | Isotope-Labeled Compounds |
| HY-N2074 | Picrinine | 4684-32-6 | Natural Products |
| HY-N2074R | Picrinine (Standard) | 4684-32-6 | Reference Standards |
| HY-N2075 | 3-Acetyl-beta-boswellic acid | 5968-70-7 | Natural Products |
| HY-N2075R | 3-Acetyl-beta-boswellic acid (Standard) | 5968-70-7 | Reference Standards |
| HY-N2076 | Cephaeline (hydrochloride) | 3738-70-3 | Natural Products |
| HY-N2077 | Heteroclitin D | 140369-76-2 | Natural Products |
| HY-N2078 | Yamogenin | 512-06-1 | Natural Products |
| HY-N2078R | Yamogenin (Standard) | 512-06-1 | Reference Standards |
| HY-N2079 | (-)-Securinine | 5610-40-2 | Natural Products |
| HY-N2079R | (-)-Securinine (Standard) | 5610-40-2 | Reference Standards |
| HY-N2080 | Songorine | 509-24-0 | Natural Products |
| HY-N2081 | Skimmianine | 83-95-4 | Natural Products |
| HY-N2081R | Skimmianine (Standard) | 83-95-4 | Reference Standards |
| HY-N2082 | Isorhamnetin 3-O-galactoside | 6743-92-6 | Natural Products |
| HY-N2083 | Handelin | 62687-22-3 | Natural Products |
| HY-N2084 | Perillartine | 30950-27-7 | Natural Products |
| HY-N2085 | L-Perillaldehyde | 18031-40-8 | Natural Products |
| HY-N2085R | L-Perillaldehyde (Standard) | 18031-40-8 | Reference Standards |
| HY-N2086 | Ethyl palmitate | 628-97-7 | Natural Products |
| HY-N2086R | Ethyl palmitate (Standard) | 628-97-7 | Reference Standards |
| HY-N2086S | Ethyl palmitate-d31 | 1215721-57-5 | Isotope-Labeled Compounds |
| HY-N2087 | Ligupurpuroside A | 147396-01-8 | Natural Products |
| HY-N2088 | Ligupurpuroside B | 147396-02-9 | Natural Products |
| HY-N2089 | Ligupurpuroside C | 1194056-33-1 | Natural Products |
| HY-N2090 | Ligupurpuroside D | 1194056-35-3 | Natural Products |
| HY-N2091 | cis-Ligupurpuroside B | 350588-96-4 | Natural Products |
| HY-N2092 | Atractylodinol | 61642-89-5 | Natural Products |
| HY-N2093 | Vicine | 152-93-2 | Natural Products |
| HY-N2093R | Vicine (Standard) | 152-93-2 | Reference Standards |
| HY-N2094 | Genipin 1-β-D-gentiobioside | 29307-60-6 | Natural Products |
| HY-N2095 | Atractylone | 6989-21-5 | Natural Products |
| HY-N2096 | Kavain | 3155-48-4 | Natural Products |
| HY-N2096R | Kavain (Standard) | 3155-48-4 | Reference Standards |
| HY-N2097 | Cimigenoside | 27994-11-2 | Natural Products |
| HY-N2097R | Cimigenoside (Standard) | 27994-11-2 | Reference Standards |
| HY-N2098 | Obtusifolin | 477-85-0 | Natural Products |
| HY-N2098R | Obtusifolin (Standard) | 477-85-0 | Reference Standards |
| HY-N2099 | Onjisaponin B | 35906-36-6 | Natural Products |
| HY-N2100 | 6'-O-beta-D-Glucosylgentiopicroside | 115713-06-9 | Natural Products |
| HY-N2101 | Benzoyloxypaeoniflorin | 72896-40-3 | Natural Products |
| HY-N2102 | Tenacissoside I | 191729-44-9 | Natural Products |
| HY-N2103 | Tenacissoside G | 191729-43-8 | Natural Products |
| HY-N2104 | Daurinoline | 2831-75-6 | Natural Products |
| HY-N2105 | (-)-Dicentrine | 28832-07-7 | Natural Products |
| HY-N2106 | Dehydroevodiamine | 67909-49-3 | Natural Products |
| HY-N2107 | Physion 8-O-β-D-glucoside | 26296-54-8 | Natural Products |
| HY-N2108 | 7-Ethylcamptothecin | 78287-27-1 | Natural Products |
| HY-N2108R | 7-Ethylcamptothecin (Standard) | 78287-27-1 | Reference Standards |
| HY-N2109 | Macranthoidin A | 140360-29-8 | Natural Products |
| HY-N2109R | Macranthoidin A (Standard) | 140360-29-8 | Reference Standards |
| HY-N2110 | Phellopterin | 2543-94-4 | Natural Products |
| HY-N2110R | Phellopterin (Standard) | 2543-94-4 | Reference Standards |
| HY-N2111 | Momordicoside A | 75801-95-5 | Natural Products |
| HY-N2112 | Glaucocalyxin A | 79498-31-0 | Natural Products |
| HY-N2113 | Glaucocalyxin B | 80508-81-2 | Natural Products |
| HY-N2114 | Sedanolide | 6415-59-4 | Natural Products |
| HY-N2115 | Araloside A | 7518-22-1 | Natural Products |
| HY-N2115R | Araloside A (Standard) | 7518-22-1 | Reference Standards |
| HY-N2116 | Ginkgolic acid C17:1 | 111047-30-4 | Natural Products |
| HY-N2116R | Ginkgolic acid C17:1 (Standard) | 111047-30-4 | Reference Standards |
| HY-N2117 | Isoginkgetin | 548-19-6 | Natural Products |
| HY-N2117R | Isoginkgetin (Standard) | 548-19-6 | Reference Standards |
| HY-N2118 | Bilobetin | 521-32-4 | Natural Products |
| HY-N2118R | Bilobetin (Standard) | 521-32-4 | Reference Standards |
| HY-N2119 | Sciadopitysin | 521-34-6 | Natural Products |
| HY-N2119R | Sciadopitysin (Standard) | 521-34-6 | Reference Standards |
| HY-N2120 | Dichotomitin | 88509-91-5 | Natural Products |
| HY-N2122 | Neoisoliquiritin | 59122-93-9 | Natural Products |
| HY-N2123 | Neoliquiritin | 5088-75-5 | Natural Products |
| HY-N2123R | Neoliquiritin (Standard) | 5088-75-5 | Reference Standards |
| HY-N2124 | Parishin B | 174972-79-3 | Natural Products |
| HY-N2124R | Parishin B (Standard) | 174972-79-3 | Reference Standards |
| HY-N2125 | Parishin C | 174972-80-6 | Natural Products |
| HY-N2125R | Parishin C (Standard) | 174972-80-6 | Reference Standards |
| HY-N2126 | Parishin E | 952068-57-4 | Natural Products |
| HY-N2126R | Parishin E (Standard) | 952068-57-4 | Reference Standards |
| HY-N2127 | Pinostrobin | 480-37-5 | Natural Products |
| HY-N2128 | Nigakinone | 18110-86-6 | Natural Products |
| HY-N2129 | N-Nornuciferine | 4846-19-9 | Natural Products |
| HY-N2131 | Isosakuranetin | 480-43-3 | Natural Products |
| HY-N2132 | Flavokawain B | 1775-97-9 | Natural Products |
| HY-N2132R | Flavokawain B (Standard) | 1775-97-9 | Reference Standards |
| HY-N2133 | Fallaxsaponin A | 1287702-60-6 | Natural Products |
| HY-N2134 | Mirificin | 103654-50-8 | Natural Products |
| HY-N2135 | Puerarin 6''-O-Xyloside | 114240-18-5 | Natural Products |
| HY-N2135R | Puerarin 6''-O-Xyloside (Standard) | 114240-18-5 | Reference Standards |
| HY-N2136 | Cochinchinenin A | 1057666-04-2 | Natural Products |
| HY-N2138 | Buddlejasaponin IVb | 152580-79-5 | Natural Products |
| HY-N2139 | Protopseudohypericin | 54328-09-5 | Natural Products |
| HY-N2140 | Herpetone | 951677-22-8 | Natural Products |
| HY-N2141 | Pseudoaspidin | 478-28-4 | Natural Products |
| HY-N2142 | 3-O-beta-Allopyranosyl-(1->4)-beta-oleandropyranosyl-11-O-isobutyryl-12-O-acetyltenacigenin B | 1260252-18-3 | Natural Products |
| HY-N2143 | Fumitremorgin C | 118974-02-0 | Natural Products |
| HY-N2144 | 7,4'-Di-O-methylapigenin | 5128-44-9 | Natural Products |
| HY-N2144R | 7,4'-Di-O-methylapigenin (Standard) | 5128-44-9 | Reference Standards |
| HY-N2145 | 4',7-Dimethoxyisoflavone | 1157-39-7 | Natural Products |
| HY-N2145S | 4',7-Dimethoxyisoflavone-d6 | Isotope-Labeled Compounds | |
| HY-N2146 | Combretastatin A4 | 117048-59-6 | Natural Products |
| HY-N2147 | Phorbol | 17673-25-5 | Natural Products |
| HY-N2148 | Cytosporone B | 321661-62-5 | Natural Products |
| HY-N2148R | Cytosporone B (Standard) | 321661-62-5 | Reference Standards |
| HY-N2149 | Tomatidine | 77-59-8 | Natural Products |
| HY-N2149A | Tomatidine (hydrochloride) | 6192-62-7 | Natural Products |
| HY-N2150 | Psammaplin A | 110659-91-1 | Natural Products |
| HY-N2151 | Rhodojaponin II | 26116-89-2 | Natural Products |
| HY-N2151R | Rhodojaponin II (Standard) | 26116-89-2 | Reference Standards |
| HY-N2152 | Rhodojaponin III | 26342-66-5 | Natural Products |
| HY-N2153 | Apigenin-7-O-(2G-rhamnosyl)gentiobioside | 174284-20-9 | Natural Products |
| HY-N2154 | Rhodojaponin V | 37720-86-8 | Natural Products |
| HY-N2155 | Tubuloside A | 112516-05-9 | Natural Products |
| HY-N2155R | Tubuloside A (Standard) | 112516-05-9 | Reference Standards |
| HY-N2156 | Paeonolide | 72520-92-4 | Natural Products |
| HY-N2156R | Paeonolide (Standard) | 72520-92-4 | Reference Standards |
| HY-N2157 | Pteryxin | 13161-75-6 | Natural Products |
| HY-N2158 | 7-O-Methylmangiferin | 31002-12-7 | Natural Products |
| HY-N2159 | Lancerin | 81991-99-3 | Natural Products |
| HY-N2159R | Lancerin (Standard) | 81991-99-3 | Reference Standards |
| HY-N2160 | 6'''-Feruloylspinosin | 77690-92-7 | Natural Products |
| HY-N2161 | Apiopaeonoside | 100291-86-9 | Natural Products |
| HY-N2162 | 12-Epinapelline | 110064-71-6 | Natural Products |
| HY-N2163 | Mudanpioside C | 172760-03-1 | Natural Products |
| HY-N2164 | 3-Deoxyaconitine | 3175-95-9 | Natural Products |
| HY-N2165 | Vicenin 2 | 23666-13-9 | Natural Products |
| HY-N2165R | Vicenin 2 (Standard) | 23666-13-9 | Reference Standards |
| HY-N2166 | Tomatine | 17406-45-0 | Natural Products |
| HY-N2166A | Tomatine (hydrochloride) | 17605-83-3 | Reference compound |
| HY-N2167 | Sibiricose A5 | 107912-97-0 | Natural Products |
| HY-N2167R | Sibiricose A5 (Standard) | 107912-97-0 | Reference Standards |
| HY-N2168 | Pinoresinol 4-O-β-D-glucopyranoside | 69251-96-3 | Natural Products |
| HY-N2168R | Pinoresinol 4-O-β-D-glucopyranoside (Standard) | 69251-96-3 | Reference Standards |
| HY-N2169 | Polygalasaponin V | 162857-65-0 | Natural Products |
| HY-N2170 | Acetylshengmanol Arabinoside | 402513-88-6 | Natural Products |
| HY-N2171 | Sibiricaxanthone B | 241125-81-5 | Natural Products |
| HY-N2172 | Sibiricose A6 | 241125-75-7 | Natural Products |
| HY-N2173 | Forsythoside E | 93675-88-8 | Natural Products |
| HY-N2174 | Ophiogenin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside | 128502-94-3 | Natural Products |
| HY-N2175 | Cixiophiopogon A | 288143-27-1 | Natural Products |
| HY-N2176 | S-(+)-Marmesin | 13849-08-6 | Natural Products |
| HY-N2176A | (±)-Marmesin | 13710-70-8 | Natural Products |
| HY-N2176R | S-(+)-Marmesin (Standard) | 13849-08-6 | Reference Standards |
| HY-N2177 | 3-Dehydrotrametenolic acid | 29220-16-4 | Natural Products |
| HY-N2178 | Saikosaponin F | 62687-63-2 | Natural Products |
| HY-N2179 | Hypaphorine | 487-58-1 | Natural Products |
| HY-N2180 | Pinoresinol dimethyl ether | 29106-36-3 | Natural Products |
| HY-N2180R | Pinoresinol dimethyl ether (Standard) | 29106-36-3 | Reference Standards |
| HY-N2181 | Acetylshikonin | 24502-78-1 | Natural Products |
| HY-N2181A | DL-Acetylshikonin | 54984-93-9 | Natural Products |
| HY-N2182 | Episyringaresinol 4'-O-β-D-glncopyranoside | 137038-13-2 | Natural Products |
| HY-N2182R | Episyringaresinol 4'-O-β-D-glncopyranoside (Standard) | 137038-13-2 | Reference Standards |
| HY-N2183 | Baimaside | 18609-17-1 | Natural Products |
| HY-N2183R | Baimaside (Standard) | 18609-17-1 | Reference Standards |
| HY-N2184 | Furanodienone | 24268-41-5 | Natural Products |
| HY-N2185 | (5R,6E)-5-Hydroxy-1,7-diphenyl-6-hepten-3-one | 87095-74-7 | Natural Products |
| HY-N2185R | (5R,6E)-5-Hydroxy-1,7-diphenyl-6-hepten-3-one (Standard) | 87095-74-7 | Reference Standards |
| HY-N2186 | Leucoside | 27661-51-4 | Natural Products |
| HY-N2186R | Leucoside (Standard) | 27661-51-4 | Reference Standards |
| HY-N2187 | Deoxyshikonin | 43043-74-9 | Natural Products |
| HY-N2188 | Beta-Acetoxyisovalerylshikonin | 69091-17-4 | Natural Products |
| HY-N2189 | Swertisin | 6991-10-2 | Natural Products |
| HY-N2189R | Swertisin (Standard) | 6991-10-2 | Reference Standards |
| HY-N2190 | Hederagenin 28-O-beta-D-glucopyranosyl ester | 53931-25-2 | Natural Products |
| HY-N2191 | Ecliptasaponin D | 206756-04-9 | Natural Products |
| HY-N2192 | Swertianolin | 23445-00-3 | Natural Products |
| HY-N2192R | Swertianolin (Standard) | 23445-00-3 | Reference Standards |
| HY-N2193 | Hirsutine | 7729-23-9 | Natural Products |
| HY-N2194 | Bergamottin | 7380-40-7 | Natural Products |
| HY-N2194R | Bergamottin (Standard) | 7380-40-7 | Reference Standards |
| HY-N2195 | Nootkatone | 4674-50-4 | Natural Products |
| HY-N2195R | Nootkatone (Standard) | 4674-50-4 | Reference Standards |
| HY-N2196 | Ajugasterone C | 23044-80-6 | Natural Products |
| HY-N2197 | Hirsuteine | 35467-43-7 | Natural Products |
| HY-N2198 | Podocarpusflavone A | 22136-74-9 | Natural Products |
| HY-N2199 | Sotetsuflavone | 2608-21-1 | Natural Products |
| HY-N2200 | Precyasterone | 27335-85-9 | Natural Products |
| HY-N2201 | Pseudoginsenoside RT1 | 98474-74-9 | Natural Products |
| HY-N2202 | Vitexin caffeate | 73815-15-3 | Natural Products |
| HY-N2203 | Vitexin2''-O-p-coumarate | 59282-55-2 | Natural Products |
| HY-N2203A | Vitexin2''-O-p-trans-coumarate | 1229437-79-9 | Natural Products |
| HY-N2204 | Swertiajaponin | 6980-25-2 | Natural Products |
| HY-N2205 | Esculentoside H | 66656-92-6 | Natural Products |
| HY-N2207 | rel-(8R,8'R)-Dimethyl-(7S,7'R)-bis(3,4-methylenedioxyphenyl)tetrahydro-furan | 178740-32-4 | Natural Products |
| HY-N2208 | 4-Hydroxylonchocarpin | 56083-03-5 | Natural Products |
| HY-N2208A | Isobavachromene | 52801-22-6 | Natural Products |
| HY-N2209 | Angeloylgomisin H | 66056-22-2 | Natural Products |
| HY-N2210 | 5,7,4'-Trihydroxy-8-Methylflavanone | 916917-28-7 | Natural Products |
| HY-N2211 | Picfeltarraenin IB | 97230-46-1 | Natural Products |
| HY-N2211R | Picfeltarraenin IB (Standard) | 97230-46-1 | Reference Standards |
| HY-N2212 | Arctigenin 4'-O-β-gentiobioside | 41682-24-0 | Natural Products |
| HY-N2213 | Matairesinol 4′-O-β-D-glucopyranoside | 106647-14-7 | Natural Products |
| HY-N2214 | 7-O-Methylaloeresin A | 329361-25-3 | Natural Products |
| HY-N2215 | Aloeresin D | 105317-67-7 | Natural Products |
| HY-N2215R | Aloeresin D (Standard) | 105317-67-7 | Reference Standards |
| HY-N2216 | Polygalasaponin XXXI | 79103-90-5 | Natural Products |
| HY-N2217 | Rotundic acid | 20137-37-5 | Natural Products |
| HY-N2217R | Rotundic acid (Standard) | 20137-37-5 | Reference Standards |
| HY-N2218 | Jionoside B1 | 120406-37-3 | Natural Products |
| HY-N2219 | Picfeltarraegenin X | 1391826-61-1 | Natural Products |
| HY-N2220 | 6-Formyl-isoophiopogonanone A | 116291-82-8 | Natural Products |
| HY-N2221 | Ganoderal A | 104700-98-3 | Natural Products |
| HY-N2222 | Epigomisin O | 73036-31-4 | Natural Products |
| HY-N2223 | Ganoderol B | 104700-96-1 | Natural Products |
| HY-N2224 | Guaijaverin | 22255-13-6 | Natural Products |
| HY-N2224R | Guaijaverin (Standard) | 22255-13-6 | Reference Standards |
| HY-N2225 | Isorhamnetin-3-O-sophoroside-7-O-rhamnoside | 41328-75-0 | Natural Products |
| HY-N2226 | Kaempferol 3-sophoroside 7-rhamnoside | 93098-79-4 | Natural Products |
| HY-N2227 | Isorhamnetin 3-glucoside-7-rhamnoside | 17331-71-4 | Natural Products |
| HY-N2228 | (-)-Epigallocatechin-3-(3''-O-methyl) gallate | 83104-87-4 | Natural Products |
| HY-N2229 | Rhapontigenin | 500-65-2 | Natural Products |
| HY-N2229R | Rhapontigenin (Standard) | 500-65-2 | Reference Standards |
| HY-N2230 | N-p-trans-Coumaroyltyramine | 36417-86-4 | Natural Products |
| HY-N2230R | N-p-trans-Coumaroyltyramine (Standard) | 36417-86-4 | Reference Standards |
| HY-N2231 | N-trans-p-coumaroyloctopamine | 66648-45-1 | Natural Products |
| HY-N2232 | N-Feruloyloctopamine | 66648-44-0 | Natural Products |
| HY-N2233 | Rhapontigenin 3'-O-glucoside | 94356-22-6 | Natural Products |
| HY-N2234 | Ganolactone B | 1028449-53-7 | Natural Products |
| HY-N2235 | Gomisin O | 72960-22-6 | Natural Products |
| HY-N2236 | Dipsanoside B | 889678-64-2 | Natural Products |
| HY-N2237 | Piceatannol 3'-O-glucoside | 94356-26-0 | Natural Products |
| HY-N2237R | Piceatannol 3'-O-glucoside (Standard) | 94356-26-0 | Reference Standards |
| HY-N2238 | Dipsanoside A | 889678-62-0 | Natural Products |
| HY-N2239 | 6-Methoxykaempferol 3-O-Rutinoside | 403861-33-6 | Natural Products |
| HY-N2240 | Eupalinolide K | 108657-10-9 | Natural Products |
| HY-N2241 | Hosenkoside F | 160896-45-7 | Natural Products |
| HY-N2242 | Hosenkoside G | 160896-46-8 | Natural Products |
| HY-N2243 | Hosenkoside K | 160896-49-1 | Natural Products |
| HY-N2243R | Hosenkoside K (Standard) | 160896-49-1 | Reference Standards |
| HY-N2244 | Hosenkoside M | 161016-51-9 | Natural Products |
| HY-N2245 | Schisandrone | 98619-25-1 | Natural Products |
| HY-N2246 | Gomisin H | 66056-20-0 | Natural Products |
| HY-N2247 | Guaiacin | 36531-08-5 | Natural Products |
| HY-N2247A | (+)-Guaiacin | 88547-66-4 | Natural Products |
| HY-N2249 | Hosenkoside A | 156791-82-1 | Natural Products |
| HY-N2249R | Hosenkoside A (Standard) | 156791-82-1 | Reference Standards |
| HY-N2250 | Hosenkoside B | 156764-82-8 | Natural Products |
| HY-N2250R | Hosenkoside B (Standard) | 156764-82-8 | Reference Standards |
| HY-N2251 | Hosenkoside C | 156764-83-9 | Natural Products |
| HY-N2251R | Hosenkoside C (Standard) | 156764-83-9 | Reference Standards |
| HY-N2252 | Licarin A | 51020-86-1 | Natural Products |
| HY-N2253 | Neoruscogenin | 17676-33-4 | Natural Products |
| HY-N2253R | Neoruscogenin (Standard) | 17676-33-4 | Reference Standards |
| HY-N2254 | (-)-Oxypeucedanin hydrate | 133164-11-1 | Natural Products |
| HY-N2255 | Crebanine | 25127-29-1 | Natural Products |
| HY-N2258 | Poncirin | 14941-08-3 | Natural Products |
| HY-N2258R | Poncirin (Standard) | 14941-08-3 | Reference Standards |
| HY-N2259 | Curcumenol | 19431-84-6 | Natural Products |
| HY-N2260 | Cephaeline (dihydrochloride) | 5853-29-2 | Natural Products |
| HY-N2260R | Cephaeline (dihydrochloride) (Standard) | 5853-29-2 | Reference Standards |
| HY-N2261 | Ipecoside | 15401-60-2 | Natural Products |
| HY-N2262 | 8-Geranyloxypsoralen | 7437-55-0 | Natural Products |
| HY-N2262R | 8-Geranyloxypsoralen (Standard) | 7437-55-0 | Reference Standards |
| HY-N2263 | Skimmin | 93-39-0 | Natural Products |
| HY-N2264 | Wulignan A1 | 117047-76-4 | Natural Products |
| HY-N2265 | Angeloyl-(+)-gomisin K3 | 1023744-69-5 | Natural Products |
| HY-N2266 | Benzoylgomisin O | 130783-32-3 | Natural Products |
| HY-N2267 | (+)-Schisandrin B | 82467-52-5 | Natural Products |
| HY-N2268 | Gymnemagenin | 22467-07-8 | Natural Products |
| HY-N2268R | Gymnemagenin (Standard) | 22467-07-8 | Reference Standards |
| HY-N2269 | p-Hydroxyphenethyl anisate | 87932-34-1 | Natural Products |
| HY-N2270 | Chicanine | 78919-28-5 | Natural Products |
| HY-N2271 | Angeloylgomisin O | 83864-69-1 | Natural Products |
| HY-N2272 | Cnidilin | 14348-22-2 | Natural Products |
| HY-N2273 | Gymnestrogenin | 19942-02-0 | Natural Products |
| HY-N2274 | 23-Hydroxylongispinogenin | 42483-24-9 | Natural Products |
| HY-N2275 | 21-O-Tigloylgymnemagenin | 1581276-63-2 | Natural Products |
| HY-N2276 | Nodakenetin | 495-32-9 | Natural Products |
| HY-N2277 | 3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone | 1694587-15-9 | Natural Products |
| HY-N2278 | Kushenol A | 99217-63-7 | Natural Products |
| HY-N2279 | Kurarinone | 34981-26-5 | Natural Products |
| HY-N2280 | Baohuoside V | 118544-18-6 | Natural Products |
| HY-N2281 | Leachianone A | 97938-31-3 | Natural Products |
| HY-N2282 | Zingiberen Newsaponin | 91653-50-8 | Natural Products |
| HY-N2283 | Deltonin | 55659-75-1 | Natural Products |
| HY-N2284 | Sophoflavescenol | 216450-65-6 | Natural Products |
| HY-N2285 | Fabiatrin | 18309-73-4 | Natural Products |
| HY-N2286 | Kushenol I | 99119-69-4 | Natural Products |
| HY-N2287 | Cimifugin 4'-O-β-D-glucopyranoside | 1632110-81-6 | Reference compound |
| HY-N2288 | Euonymine | 33458-82-1 | Natural Products |
| HY-N2289 | 2''-O-Rhamnosylicariside II | 135293-13-9 | Natural Products |
| HY-N2290 | Baohuoside VII | 119730-89-1 | Natural Products |
| HY-N2291 | Rebaudioside G | 127345-21-5 | Natural Products |
| HY-N2292 | Kinsenoside | 151870-74-5 | Natural Products |
| HY-N2293 | Chamigrenal | 19912-84-6 | Natural Products |
| HY-N2295 | 6"-O-Apiosyl-5-O-Methylvisammioside | 139446-82-5 | Natural Products |
| HY-N2296 | (2R,3R)-3,7-Dihydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)chroman-4-one | 204935-85-3 | Natural Products |
| HY-N2297 | Kaji-ichigoside F1 | 95298-47-8 | Natural Products |
| HY-N2297R | Kaji-ichigoside F1 (Standard) | 95298-47-8 | Reference Standards |
| HY-N2298 | Camellianin A | 109232-77-1 | Natural Products |
| HY-N2299 | Morusinol | 62949-93-3 | Natural Products |
| HY-N2300 | Kuwanon A | 62949-77-3 | Natural Products |
| HY-N2301 | Pleuromutilin | 125-65-5 | Natural Products |
| HY-N2301R | Pleuromutilin (Standard) | 125-65-5 | Reference Standards |
| HY-N2302 | Fucoxanthin | 3351-86-8 | Natural Products |
| HY-N2302R | Fucoxanthin (Standard) | 3351-86-8 | Reference Standards |
| HY-N2303 | Eriocalyxin B | 84745-95-9 | Natural Products |
| HY-N2304 | 3-O-Methyl-6β-naltrexone | 65150-66-5 | Reference compound |
| HY-N2304A | Methyl-6-alpha-Naltrexol | 116388-85-3 | Reference compound |
| HY-N2306 | Aclacinomycin A | 57576-44-0 | Dye Reagents |
| HY-N2306A | Aclacinomycin A (hydrochloride) | 75443-99-1 | Natural Products |
| HY-N2306R | Aclacinomycin A (Standard) | 57576-44-0 | Reference Standards |
| HY-N2307A | Lirinidine | 54383-28-7 | Natural Products |
| HY-N2309 | Kainic acid | 487-79-6 | Natural Products |
| HY-N2309A | Kainic acid (hydrate) | 58002-62-3 | Reference compound |
| HY-N2311 | Ibotenic acid | 2552-55-8 | Natural Products |
| HY-N2311R | Ibotenic acid (Standard) | 2552-55-8 | Reference Standards |
| HY-N2312 | Mogrol | 88930-15-8 | Natural Products |
| HY-N2312R | Mogrol (Standard) | 88930-15-8 | Reference Standards |
| HY-N2317 | Di-O-demethylcurcumin | 60831-46-1 | Natural Products |
| HY-N2318 | Podocarpic acid | 5947-49-9 | Natural Products |
| HY-N2318R | Podocarpic acid (Standard) | 5947-49-9 | Reference Standards |
| HY-N2319 | Dihydroergocristine (mesylate) | 24730-10-7 | Reference compound |
| HY-N2319R | Dihydroergocristine (mesylate) (Standard) | 24730-10-7 | Reference Standards |
| HY-N2320 | Physostigmine (hemisulfate) | 64-47-1 | Reference compound |
| HY-N2321 | Salsolinol-1-carboxylic acid | 57256-34-5 | Natural Products |
| HY-N2322 | Khasianine | 32449-98-2 | Natural Products |
| HY-N2322R | Khasianine (Standard) | 32449-98-2 | Reference Standards |
| HY-N2323 | 4'-Demethylpodophyllotoxin | 40505-27-9 | Natural Products |
| HY-N2324 | Paulownin | 13040-46-5 | Natural Products |
| HY-N2325 | D-(+)-Cellobiose | 528-50-7 | Natural Products |
| HY-N2325R | D-(+)-Cellobiose (Standard) | 528-50-7 | Reference Standards |
| HY-N2325S | D-(+)-Cellobiose-13C | Isotope-Labeled Compounds | |
| HY-N2326 | (±)-Anatoxin A (fumarate) | 1219922-30-1 | Reference compound |
| HY-N2327 | Oleamide | 301-02-0 | Natural Products |
| HY-N2327A | 9(E)-Octadecenamide | 4303-70-2 | Natural Products |
| HY-N2327R | Oleamide (Standard) | 301-02-0 | Reference Standards |
| HY-N2329 | Piperlongumine | 20069-09-4 | Natural Products |
| HY-N2330 | Lipstatin | 96829-59-3 | Reference compound |
| HY-N2330R | Lipstatin (Standard) | 96829-59-3 | Reference Standards |
| HY-N2331 | Proscillaridin A | 466-06-8 | Natural Products |
| HY-N2331R | Proscillaridin A (Standard) | 466-06-8 | Reference Standards |
| HY-N2332A | Methyllycaconitine citrate | 351344-10-0 | Reference compound |
| HY-N2333 | Resiniferatoxin | 57444-62-9 | Natural Products |
| HY-N2334 | Glycochenodeoxycholic acid | 640-79-9 | Natural Products |
| HY-N2334A | Glycochenodeoxycholic acid sodium salt | 16564-43-5 | Natural Products |
| HY-N2334AR | Glycochenodeoxycholic acid sodium salt (Standard) | 16564-43-5 | Reference Standards |
| HY-N2334AS | Glycochenodeoxycholic acid-d7 (sodium) | Isotope-Labeled Compounds | |
| HY-N2334R | Glycochenodeoxycholic acid (Standard) | 640-79-9 | Reference Standards |
| HY-N2334S | Glycochenodeoxycholic acid-d4 | 1201918-16-2 | Isotope-Labeled Compounds |
| HY-N2335 | Coumestrol | 479-13-0 | Natural Products |
| HY-N2335R | Coumestrol (Standard) | 479-13-0 | Reference Standards |
| HY-N2336 | Rosmarinic acid (racemate) | 537-15-5 | Natural Products |
| HY-N2337 | 11beta-Hydroxyprogesterone | 600-57-7 | Natural Products |
| HY-N2338 | Cholesterol myristate | 1989-52-2 | Natural Products |
| HY-N2339 | Cholesteryl behenate | 61510-09-6 | Natural Products |
| HY-N2340 | D-(+)-Melezitose | 597-12-6 | Natural Products |
| HY-N2340A | D-(+)-Melezitose (hydrate) | 207511-10-2 | Natural Products |
| HY-N2341 | Palmitelaidic Acid | 10030-73-6 | Natural Products |
| HY-N2341S | Palmitelaidic acid-d13 | 2692623-91-7 | Isotope-Labeled Compounds |
| HY-N2342 | Procyanidin C1 | 37064-30-5 | Natural Products |
| HY-N2342R | Procyanidin C1 (Standard) | 37064-30-5 | Reference Standards |
| HY-N2343 | Procyanidin A2 | 41743-41-3 | Natural Products |
| HY-N2343R | Procyanidin A2 (Standard) | 41743-41-3 | Reference Standards |
| HY-N2344 | Procyanidin A1 | 103883-03-0 | Natural Products |
| HY-N2344R | Procyanidin A1 (Standard) | 103883-03-0 | Reference Standards |
| HY-N2345 | Procyanidin B3 | 23567-23-9 | Natural Products |
| HY-N2345R | Procyanidin B3 (Standard) | 23567-23-9 | Reference Standards |
| HY-N2346 | Tubulysin E | 309935-58-8 | Natural Products |
| HY-N2347 | Tubulysin C | 205304-88-7 | Natural Products |
| HY-N2348 | Tubulysin D | 309935-57-7 | Natural Products |
| HY-N2349S | Melengestrol-d5 | Isotope-Labeled Compounds | |
| HY-N2350 | Cynaropicrin | 35730-78-0 | Natural Products |
| HY-N2350R | Cynaropicrin (Standard) | 35730-78-0 | Reference Standards |
| HY-N2351 | Paeonoside | 20309-70-0 | Natural Products |
| HY-N2352 | Laurolitsine | 5890-18-6 | Natural Products |
| HY-N2352A | Laurolitsine (hydrochloride) | Natural Products | |
| HY-N2353 | Arabinose | 147-81-9 | Natural Products |
| HY-N2353R | Arabinose (Standard) | 147-81-9 | Reference Standards |
| HY-N2353S | Arabinose-1-13C | 70849-23-9 | Isotope-Labeled Compounds |
| HY-N2353S1 | Arabinose-d1 | 77583-92-7 | Isotope-Labeled Compounds |
| HY-N2353S2 | Arabinose-d1-1 | 288846-87-7 | Isotope-Labeled Compounds |
| HY-N2355 | Solasurine | 27028-76-8 | Natural Products |
| HY-N2357 | Eudesmin | 526-06-7 | Natural Products |
| HY-N2358 | Blumeatin | 118024-26-3 | Natural Products |
| HY-N2359 | Chelerythrine | 34316-15-9 | Natural Products |
| HY-N2360 | Hinokiflavone | 19202-36-9 | Natural Products |
| HY-N2361 | N-Benzyllinoleamide | 18286-71-0 | Natural Products |
| HY-N2362 | DL-Alanine | 302-72-7 | Reference compound |
| HY-N2362R | DL-Alanine (Standard) | 302-72-7 | Reference Standards |
| HY-N2362S | DL-Alanine-13C-1 | 102029-81-2 | Isotope-Labeled Compounds |
| HY-N2362S1 | DL-Alanine-13C-3 | 131157-42-1 | Isotope-Labeled Compounds |
| HY-N2362S2 | DL-Alanine-d3 | 53795-94-1 | Isotope-Labeled Compounds |
| HY-N2362S5 | DL-Alanine-15N | 71261-64-8 | Isotope-Labeled Compounds |
| HY-N2362S8 | DL-Alanine-d7 | Isotope-Labeled Compounds | |
| HY-N2362S9 | DL-Alanine-13C2,15N | 221080-39-3 | Isotope-Labeled Compounds |
| HY-N2364 | Arecoline | 63-75-2 | Natural Products |
| HY-N2365 | Macamide B | 74058-71-2 | Natural Products |
| HY-N2365R | Macamide B (Standard) | 74058-71-2 | Reference Standards |
| HY-N2368 | Arecaidine | 499-04-7 | Natural Products |
| HY-N2368A | Arecaidine (hydrochloride) | 6018-28-6 | Natural Products |
| HY-N2368B | Arecaidine (hydrobromide) | 6013-57-6 | Reference compound |
| HY-N2369 | Chelidonine | 476-32-4 | Natural Products |
| HY-N2369A | Chelidonine (hydrochloride) | 4312-31-6 | Natural Products |
| HY-N2369B | (-)-Chelidonine | 88200-01-5 | Natural Products |
| HY-N2369R | Chelidonine (Standard) | 476-32-4 | Reference Standards |
| HY-N2370 | 24-Hydroxycholesterol | 30271-38-6 | Natural Products |
| HY-N2371 | 27-Hydroxycholesterol | 20380-11-4 | Natural Products |
| HY-N2372 | Fraxinol | 486-28-2 | Natural Products |
| HY-N2372R | Fraxinol (Standard) | 486-28-2 | Reference Standards |
| HY-N2373 | Palmaturbine | 16176-68-4 | Natural Products |
| HY-N2373A | Palmaturbine (hydroxide) | Natural Products | |
| HY-N2374 | Eupatorin | 855-96-9 | Natural Products |
| HY-N2374R | Eupatorin (Standard) | 855-96-9 | Reference Standards |
| HY-N2375 | L-Quebrachitol | 642-38-6 | Natural Products |
| HY-N2376 | Chrysin-7-O-glucuronide | 35775-49-6 | Natural Products |
| HY-N2376R | Chrysin-7-O-glucuronide (Standard) | 35775-49-6 | Reference Standards |
| HY-N2377 | Allosecurinine | 884-68-4 | Natural Products |
| HY-N2378 | (2R,3S)-3-Phenylisoserine hydrochloride | 132201-32-2 | Peptides |
| HY-N2380 | N-Benzoyl-(2R,3S)-3-phenylisoserine | 132201-33-3 | Natural Products |
| HY-N2381 | Menthone | 10458-14-7 | Natural Products |
| HY-N2381R | Menthone (Standard) | 10458-14-7 | Reference Standards |
| HY-N2382 | Polyphyllin H | 81917-50-2 | Natural Products |
| HY-N2383 | Validamine | 32780-32-8 | Natural Products |
| HY-N2384 | Febrifugine | 24159-07-7 | Natural Products |
| HY-N2384A | Febrifugine (dihydrochloride) | 32434-42-7 | Natural Products |
| HY-N2385 | N-Benzyloctadecenamide | 101762-87-2 | Natural Products |
| HY-N2386 | Polyphyllin E | 76296-73-6 | Natural Products |
| HY-N2387 | Pinosylvin | 22139-77-1 | Natural Products |
| HY-N2387R | Pinosylvin (Standard) | 22139-77-1 | Reference Standards |
| HY-N2388 | Auraptene | 495-02-3 | Natural Products |
| HY-N2388R | Auraptene (Standard) | 495-02-3 | Reference Standards |
| HY-N2389 | Formosanin C | 50773-42-7 | Natural Products |
| HY-N2389R | Formosanin C (Standard) | 50773-42-7 | Reference Standards |
| HY-N2391 | p-Hydroxycinnamic acid | 7400-08-0 | Natural Products |
| HY-N2392 | Kukoamine A | 75288-96-9 | Natural Products |
| HY-N2392R | Kukoamine A (Standard) | 75288-96-9 | Reference Standards |
| HY-N2392S | Kukoamine A-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-N2393 | Kukoamine B | 164991-67-7 | Natural Products |
| HY-N2393A | Kukoamine B (mesylate) | 1375179-86-4 | Natural Products |
| HY-N2393R | Kukoamine B (Standard) | 164991-67-7 | Reference Standards |
| HY-N2393S | Kukoamine B-d5 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-N2394 | Emodin-1-O-β-D-glucopyranoside | 38840-23-2 | Natural Products |
| HY-N2395 | Chrysophanol 8-O-glucoside | 13241-28-6 | Natural Products |
| HY-N2395R | Chrysophanol 8-O-glucoside (Standard) | 13241-28-6 | Reference Standards |
| HY-N2396 | N-(3-Methoxybenzyl-(9z,12z)-octadecadienamide | 883715-22-8 | Reference compound |
| HY-N2397 | 9''-Methyl salvianolate B | 1167424-31-8 | Natural Products |
| HY-N2398 | Rehmapicroside | 104056-82-8 | Natural Products |
| HY-N2399 | Diffractaic acid | 436-32-8 | Natural Products |
| HY-N2400 | Rehmannioside C | 81720-07-2 | Natural Products |
| HY-N2401 | Baldrinal | 18234-46-3 | Natural Products |
| HY-N2403 | Dihydrolycorine | 6271-21-2 | Natural Products |
| HY-N2406 | Dihydrocaffeic acid | 1078-61-1 | Natural Products |
| HY-N2406R | Dihydrocaffeic acid (Standard) | 1078-61-1 | Reference Standards |
| HY-N2408 | 4α-Phorbol | 26241-63-4 | Natural Products |
| HY-N2409 | Delphinidin (chloride) | 528-53-0 | Natural Products |
| HY-N2409R | Delphinidin (chloride) (Standard) | 528-53-0 | Reference Standards |
| HY-N2410 | N-trans-Feruloyltyramine | 66648-43-9 | Natural Products |
| HY-N2410R | N-trans-Feruloyltyramine (Standard) | 66648-43-9 | Reference Standards |
| HY-N2411 | Geissoschizine methyl ether | 60314-89-8 | Natural Products |
| HY-N2412 | Irisolidone | 2345-17-7 | Natural Products |
| HY-N2413 | Gomisin D | 60546-10-3 | Natural Products |
| HY-N2414 | Periplogenin | 514-39-6 | Natural Products |
| HY-N2415 | Podophyllotoxone | 477-49-6 | Natural Products |
| HY-N2416 | Taccalonolide A | 108885-68-3 | Natural Products |
| HY-N2417 | Stearyl glycyrrhetinate | 13832-70-7 | Natural Products |
| HY-N2418 | Homoarbutin | 25712-94-1 | Natural Products |
| HY-N2419 | Erythrodiol | 545-48-2 | Natural Products |
| HY-N2419R | Erythrodiol (Standard) | 545-48-2 | Reference Standards |
| HY-N2420 | Flavokawain A | 3420-72-2 | Natural Products |
| HY-N2421 | Sequoyitol | 523-92-2 | Natural Products |
| HY-N2422 | 7,2′-Dihydroxy-3′,4′-dimethoxyisoflavan 7-O-β-D-glucoside | 94367-43-8 | Natural Products |
| HY-N2423 | Sinigrin (hydrate) | 64550-88-5 | Natural Products |
| HY-N2424 | Flavone | 525-82-6 | Natural Products |
| HY-N2424R | Flavone (Standard) | 525-82-6 | Reference Standards |
| HY-N2425 | Rhodiosin | 86831-54-1 | Natural Products |
| HY-N2425R | Rhodiosin (Standard) | 86831-54-1 | Reference Standards |
| HY-N2426 | Clerodendrin | 119738-57-7 | Natural Products |
| HY-N2426R | Clerodendrin (Standard) | 119738-57-7 | Reference Standards |
| HY-N2427 | Adamantane | 281-23-2 | Natural Products |
| HY-N2427R | Adamantane (Standard) | 281-23-2 | Reference Standards |
| HY-N2427S | Adamantane-d16 | 30470-60-1 | Isotope-Labeled Compounds |
| HY-N2428 | N-(3-Methoxybenzyl)Palmitamide | 847361-96-0 | Natural Products |
| HY-N2429 | Sphondin | 483-66-9 | Natural Products |
| HY-N2431 | 16-Methoxystrychnine | 5096-72-0 | Natural Products |
| HY-N2432 | Paederoside | 20547-45-9 | Natural Products |
| HY-N2433 | Paederosidic acid methyl ester | 122413-01-8 | Natural Products |
| HY-N2434 | [10]-Shogaol | 36752-54-2 | Natural Products |
| HY-N2434R | [10]-Shogaol (Standard) | 36752-54-2 | Reference Standards |
| HY-N2435 | [8]-Shogaol | 36700-45-5 | Natural Products |
| HY-N2435R | [8]-Shogaol (Standard) | 36700-45-5 | Reference Standards |
| HY-N2436 | 2,3-Dihydroxysuccinic acid | 526-83-0 | Biochemical Assay Reagents |
| HY-N2436R | 2,3-Dihydroxysuccinic acid (Standard) | 526-83-0 | Reference Standards |
| HY-N2437 | Methylophiopogonanone A | 74805-92-8 | Natural Products |
| HY-N2437R | Methylophiopogonanone A (Standard) | 74805-92-8 | Reference Standards |
| HY-N2438 | Methylophiopogonanone B | 74805-91-7 | Natural Products |
| HY-N2439 | Methyl isoeugenol | 93-16-3 | Natural Products |
| HY-N2439R | Methyl isoeugenol (Standard) | 93-16-3 | Reference Standards |
| HY-N2440 | Gypenoside A | 157752-01-7 | Natural Products |
| HY-N2441 | Methylophiopogonone A | 74805-90-6 | Natural Products |
| HY-N2441R | Methylophiopogonone A (Standard) | 74805-90-6 | Reference Standards |
| HY-N2442 | Methylophiopogonone B | 74805-89-3 | Natural Products |
| HY-N2443 | Tribuloside | 22153-44-2 | Natural Products |
| HY-N2444 | Bacosine | 198014-94-7 | Natural Products |
| HY-N2445 | Flavokawain C | 37308-75-1 | Natural Products |
| HY-N2445R | Flavokawain C (Standard) | 37308-75-1 | Reference Standards |
| HY-N2446 | Kakuol | 18607-90-4 | Natural Products |
| HY-N2447 | Amarogentin | 21018-84-8 | Natural Products |
| HY-N2447R | Amarogentin (Standard) | 21018-84-8 | Reference Standards |
| HY-N2448 | Lindleyin | 59282-56-3 | Natural Products |
| HY-N2450 | Sulforaphene | 592-95-0 | Natural Products |
| HY-N2451 | Aloe-emodin-8-O-β-D-glucopyranoside | 33037-46-6 | Natural Products |
| HY-N2451R | Aloe-emodin-8-O-β-D-glucopyranoside (Standard) | 33037-46-6 | Reference Standards |
| HY-N2452 | Cochinchinenin C | 956103-79-0 | Natural Products |
| HY-N2453 | Convallatoxin | 508-75-8 | Natural Products |
| HY-N2453R | Convallatoxin (Standard) | 508-75-8 | Reference Standards |
| HY-N2454 | β-Elemonic acid | 28282-25-9 | Natural Products |
| HY-N2454R | β-Elemonic acid (Standard) | 28282-25-9 | Reference Standards |
| HY-N2456 | Mogroside IV-E | 88915-64-4 | Natural Products |
| HY-N2458 | Ganoderic acid G | 98665-22-6 | Natural Products |
| HY-N2459 | Peonidin (chloride) | 134-01-0 | Natural Products |
| HY-N2459R | Peonidin (chloride) (Standard) | 134-01-0 | Reference Standards |
| HY-N2460 | Aloesin | 30861-27-9 | Natural Products |
| HY-N2461 | Ganoderic acid C6 | 105742-76-5 | Natural Products |
| HY-N2463 | Kushenol E | 99119-72-9 | Natural Products |
| HY-N2464 | Maltotetraose | 34612-38-9 | Natural Products |
| HY-N2464R | Maltotetraose (Standard) | 34612-38-9 | Reference Standards |
| HY-N2465 | Methylsticin | 495-85-2 | Natural Products |
| HY-N2465R | Methylsticin (Standard) | 495-85-2 | Reference Standards |
| HY-N2466 | Melanotan I | 75921-69-6 | Peptides |
| HY-N2466A | Melanotan I (acetate) | 1566590-77-9 | Peptides |
| HY-N2468 | Xylobiose | 6860-47-5 | Natural Products |
| HY-N2469 | Xylotriose | 47592-59-6 | Natural Products |
| HY-N2470 | Myricetin 3-O-(3''-O-galloyl)-α-L-rhamnopyranoside | 143202-36-2 | Natural Products |
| HY-N2471 | Aristolindiquinone | 86533-36-0 | Natural Products |
| HY-N2472 | Medicagenic acid | 599-07-5 | Natural Products |
| HY-N2472R | Medicagenic acid (Standard) | 599-07-5 | Reference Standards |
| HY-N2473 | Methylnissolin-3-O-glucoside | 94367-42-7 | Natural Products |
| HY-N2473R | Methylnissolin-3-O-glucoside (Standard) | 94367-42-7 | Reference Standards |
| HY-N2475 | Lappaol A | 62333-08-8 | Natural Products |
| HY-N2476 | Adynerin | 35109-93-4 | Natural Products |
| HY-N2477 | Taraxerol | 127-22-0 | Natural Products |
| HY-N2477R | Taraxerol (Standard) | 127-22-0 | Reference Standards |
| HY-N2478 | Taraxasteryl acetate | 6426-43-3 | Natural Products |
| HY-N2478R | Taraxasteryl acetate (Standard) | 6426-43-3 | Reference Standards |
| HY-N2481 | Oroxylin A-7-O-glucuronide | 36948-76-2 | Natural Products |
| HY-N2481R | Oroxylin A-7-O-glucuronide (Standard) | 36948-76-2 | Reference Standards |
| HY-N2482 | Guvacine | 498-96-4 | Natural Products |
| HY-N2482A | Guvacine (hydrobromide) | 6027-92-5 | Natural Products |
| HY-N2483 | Hydroprotopine | 128397-41-1 | Natural Products |
| HY-N2484 | Methylnissolin | 73340-41-7 | Natural Products |
| HY-N2485 | 4'-Methoxyresveratrol | 33626-08-3 | Natural Products |
| HY-N2485R | 4'-Methoxyresveratrol (Standard) | 33626-08-3 | Reference Standards |
| HY-N2486 | Desoxyrhaponticin | 30197-14-9 | Natural Products |
| HY-N2486R | Desoxyrhaponticin (Standard) | 30197-14-9 | Reference Standards |
| HY-N2487 | 5-Hydroxy-7-acetoxyflavone | 6674-40-4 | Reference compound |
| HY-N2488 | Demethylsuberosin | 21422-04-8 | Natural Products |
| HY-N2489 | 5α-Hydroxy-laxogenin | 56786-63-1 | Reference compound |
| HY-N2490 | Dehydrotrametenolic acid | 6879-05-6 | Natural Products |
| HY-N2491 | Deoxyelephantopin | 29307-03-7 | Natural Products |
| HY-N2492 | (E)-Methyl 4-coumarate | 19367-38-5 | Natural Products |
| HY-N2492R | (E)-Methyl 4-coumarate (Standard) | 19367-38-5 | Reference Standards |
| HY-N2493 | Lawsone | 83-72-7 | Natural Products |
| HY-N2493S | Lawsone-d4 | Isotope-Labeled Compounds | |
| HY-N2494 | Hydroxyevodiamine | 1238-43-3 | Natural Products |
| HY-N2495 | Isomucronulatol | 52250-35-8 | Natural Products |
| HY-N2495A | (R)-Isomucronulatol | 64474-51-7 | Natural Products |
| HY-N2496 | Apigenin 7-O-malonylglucoside | 86546-87-4 | Natural Products |
| HY-N2497 | Isoliquiritin apioside | 120926-46-7 | Natural Products |
| HY-N2497R | Isoliquiritin apioside (Standard) | 120926-46-7 | Reference Standards |
| HY-N2498 | Glomeratose A | 202471-84-9 | Natural Products |
| HY-N2499 | Dehydrotumulosic acid | 6754-16-1 | Natural Products |
| HY-N2499R | Dehydrotumulosic acid (Standard) | 6754-16-1 | Reference Standards |
| HY-N2500 | Deoxypodophyllotoxin | 19186-35-7 | Natural Products |
| HY-N2501 | Sodium Demethylcantharidate | 13114-29-9 | Natural Products |
| HY-N2502 | Tetradehydropodophyllotoxin | 42123-27-3 | Natural Products |
| HY-N2503 | Ginsenoside F4 | 181225-33-2 | Natural Products |
| HY-N2504 | Ginsenoside Rk2 | 364779-14-6 | Natural Products |
| HY-N2505 | Iristectorigenin A | 39012-01-6 | Natural Products |
| HY-N2506 | Ginsenoside Ra1 | 83459-41-0 | Natural Products |
| HY-N2509 | Iristectorigenin B | 86849-77-6 | Natural Products |
| HY-N2510 | Myristicin | 607-91-0 | Natural Products |
| HY-N2510R | Myristicin (Standard) | 607-91-0 | Reference Standards |
| HY-N2511 | Trimyristin | 555-45-3 | Natural Products |
| HY-N2511R | Trimyristin (Standard) | 555-45-3 | Reference Standards |
| HY-N2511S | Trimyristin--d15 | 1219804-94-0 | Isotope-Labeled Compounds |
| HY-N2512 | 1-Monomyristin | 589-68-4 | Natural Products |
| HY-N2513 | β-Boswellic acid | 631-69-6 | Natural Products |
| HY-N2513R | β-Boswellic acid (Standard) | 631-69-6 | Reference Standards |
| HY-N2514 | α-Lactose | 14641-93-1 | Natural Products |
| HY-N2515 | Ginsenoside Rk1 | 494753-69-4 | Natural Products |
| HY-N2515R | Ginsenoside Rk1 (Standard) | 494753-69-4 | Reference Standards |
| HY-N2516 | Ginsenoside Rd2 | 83480-64-2 | Natural Products |
| HY-N2517 | Dihydroevocarpine | 15266-35-0 | Natural Products |
| HY-N2518 | Agnuside | 11027-63-7 | Natural Products |
| HY-N2518R | Agnuside (Standard) | 11027-63-7 | Reference Standards |
| HY-N2519 | (E)-Coniferin | 124151-33-3 | Natural Products |
| HY-N2521 | Tetramethylcurcumin | 52328-97-9 | Natural Products |
| HY-N2522 | Carboxyatractyloside (dipotassium) | 33286-30-5 | Natural Products |
| HY-N2522R | Carboxyatractyloside (dipotassium) (Standard) | 33286-30-5 | Reference Standards |
| HY-N2523 | Gigantol isomer-1 | 67884-30-4 | Natural Products |
| HY-N2524 | Camelliaside A | 135095-52-2 | Natural Products |
| HY-N2524R | Camelliaside A (Standard) | 135095-52-2 | Reference Standards |
| HY-N2525 | Teucvidin | 53625-15-3 | Natural Products |
| HY-N2526 | Nervonic acid | 506-37-6 | Natural Products |
| HY-N2526R | Nervonic acid (Standard) | 506-37-6 | Reference Standards |
| HY-N2528 | Usnic acid (sodium) | 34769-44-3 | Natural Products |
| HY-N2529 | Sophoranone | 23057-55-8 | Natural Products |
| HY-N2530 | Notoginsenoside Fa | 88100-04-3 | Natural Products |
| HY-N2530R | Notoginsenoside Fa (Standard) | 88100-04-3 | Reference Standards |
| HY-N2531 | Notoginsenoside Fc | 88122-52-5 | Natural Products |
| HY-N2532 | Diphyllin | 22055-22-7 | Natural Products |
| HY-N2533 | Cyanidin 3-sambubioside (chloride) | 33012-73-6 | Natural Products |
| HY-N2533R | Cyanidin 3-sambubioside (chloride) (Standard) | 33012-73-6 | Reference Standards |
| HY-N2534 | Karanjin | 521-88-0 | Natural Products |
| HY-N2534R | Karanjin (Standard) | 521-88-0 | Reference Standards |
| HY-N2535 | Coniferaldehyde | 458-36-6 | Natural Products |
| HY-N2535R | Coniferaldehyde (Standard) | 458-36-6 | Reference Standards |
| HY-N2540 | (±)-Pinocembrin | 68745-38-0 | Natural Products |
| HY-N2540R | (±)-Pinocembrin (Standard) | 68745-38-0 | Reference Standards |
| HY-N2541 | Gymnemic acid I | 122168-40-5 | Natural Products |
| HY-N2542 | Tubeimoside III | 115810-13-4 | Natural Products |
| HY-N2542R | Tubeimoside III (Standard) | 115810-13-4 | Reference Standards |
| HY-N2543 | Damascenone | 23696-85-7 | Natural Products |
| HY-N2543R | Damascenone (Standard) | 23696-85-7 | Reference Standards |
| HY-N2544 | Dehydroglaucine | 22212-26-6 | Natural Products |
| HY-N2545 | Tenacissoside X | 875057-87-7 | Natural Products |
| HY-N2546 | (+)-Dehydroabietic acid | 1231-75-0 | Natural Products |
| HY-N2547 | Steviolbioside | 41093-60-1 | Natural Products |
| HY-N2547R | Steviolbioside (Standard) | 41093-60-1 | Reference Standards |
| HY-N2548 | Turkesterone | 41451-87-0 | Natural Products |
| HY-N2548R | Turkesterone (Standard) | 41451-87-0 | Reference Standards |
| HY-N2549 | (±)-Abscisic acid | 14375-45-2 | Natural Products |
| HY-N2549A | (±)-trans-Abscisic acid | 2228-72-0 | Natural Products |
| HY-N2550 | (+)-Coclaurine | 2196-60-3 | Natural Products |
| HY-N2550A | (+)-Coclaurine (hydrochloride) | 19894-19-0 | Reference compound |
| HY-N2551 | Vitamin U (chloride) | 1115-84-0 | Natural Products |
| HY-N2552 | Vitamin K5 (hydrochloride) | 130-24-5 | Reference compound |
| HY-N2552R | Vitamin K5 (hydrochloride) (Standard) | 130-24-5 | Reference Standards |
| HY-N2553 | 4-Deoxypyridoxine 5'-phosphate | 883-84-1 | Reference compound |
| HY-N2554 | Osthenol | 484-14-0 | Natural Products |
| HY-N2555 | Tilianin | 4291-60-5 | Natural Products |
| HY-N2555R | Tilianin (Standard) | 4291-60-5 | Reference Standards |
| HY-N2556 | Tirucallol | 514-46-5 | Natural Products |
| HY-N2558 | Murrayone | 19668-69-0 | Natural Products |
| HY-N2559 | Maltohexaose | 34620-77-4 | Natural Products |
| HY-N2560 | Senecionine | 130-01-8 | Natural Products |
| HY-N2560R | Senecionine (Standard) | 130-01-8 | Reference Standards |
| HY-N2561 | Seneciphylline N-Oxide | 38710-26-8 | Natural Products |
| HY-N2561A | Spartioidine N-oxide | 121123-61-3 | Natural Products |
| HY-N2561AR | Spartioidine N-oxide (Standard) | 121123-61-3 | Reference Standards |
| HY-N2562 | Norwogonin | 4443-09-8 | Natural Products |
| HY-N2563 | Neocnidilide | 4567-33-3 | Natural Products |
| HY-N2564 | Isomagnolol | 87688-90-2 | Natural Products |
| HY-N2565 | Rosamultin | 88515-58-6 | Natural Products |
| HY-N2566 | Euscaphic acid | 53155-25-2 | Natural Products |
| HY-N2567 | (±)-Decursinol | 5993-18-0 | Natural Products |
| HY-N2570 | Corytuberine | 517-56-6 | Natural Products |
| HY-N2571 | Corydine | 476-69-7 | Natural Products |
| HY-N2572 | Nepetin | 520-11-6 | Natural Products |
| HY-N2572R | Nepetin (Standard) | 520-11-6 | Reference Standards |
| HY-N2573 | Corydalmine | 30413-84-4 | Natural Products |
| HY-N2573A | Corydalmine (hydrochloride) | 2428393-60-4 | Reference compound |
| HY-N2574 | Gitogenin | 511-96-6 | Natural Products |
| HY-N2574R | Gitogenin (Standard) | 511-96-6 | Reference Standards |
| HY-N2575 | Hypocrellin A | 77029-83-5 | Natural Products |
| HY-N2575R | Hypocrellin A (Standard) | 77029-83-5 | Reference Standards |
| HY-N2576 | 7-hydroxy-1-Naphthalenesulfonic acid potassium salt | 30252-40-5 | Biochemical Assay Reagents |
| HY-N2577 | 1F-Fructofuranosylnystose | 59432-60-9 | Natural Products |
| HY-N2579 | 1-Kestose | 470-69-9 | Natural Products |
| HY-N2579R | 1-Kestose (Standard) | 470-69-9 | Reference Standards |
| HY-N2580 | Zinc Phytate | 63903-51-5 | Natural Products |
| HY-N2581 | Phytic acid (sodium salt) | 14306-25-3 | Natural Products |
| HY-N2581R | Phytic acid (sodium salt) (Standard) | 14306-25-3 | Reference Standards |
| HY-N2582 | Calcium Phytate | 3615-82-5 | Natural Products |
| HY-N2583 | Isobornyl acetate | 125-12-2 | Natural Products |
| HY-N2583R | Isobornyl acetate (Standard) | 125-12-2 | Reference Standards |
| HY-N2584 | (2S)-Isoxanthohumol | 70872-29-6 | Natural Products |
| HY-N2584A | Isoxanthohumol | 521-48-2 | Natural Products |
| HY-N2584AR | Isoxanthohumol (Standard) | 521-48-2 | Reference Standards |
| HY-N2585 | Isodeoxyelephantopin | 38927-54-7 | Natural Products |
| HY-N2586 | Tenuifoliside C | 139726-37-7 | Natural Products |
| HY-N2587 | Irigenin | 548-76-5 | Natural Products |
| HY-N2587R | Irigenin (Standard) | 548-76-5 | Reference Standards |
| HY-N2589 | Isosaponarin | 19416-87-6 | Natural Products |
| HY-N2590 | Lupenone | 1617-70-5 | Natural Products |
| HY-N2591 | Isocorydine | 475-67-2 | Natural Products |
| HY-N2591A | Isocorydine (hydrochloride) | 13552-72-2 | Reference compound |
| HY-N2592 | Isobutylshikonin | 52438-12-7 | Natural Products |
| HY-N2593 | Isorhapontigenin | 32507-66-7 | Natural Products |
| HY-N2593R | Isorhapontigenin (Standard) | 32507-66-7 | Reference Standards |
| HY-N2594 | Isoforsythiaside | 1357910-26-9 | Natural Products |
| HY-N2596 | Isoscabertopin | 439923-16-7 | Natural Products |
| HY-N2597 | Prunetin | 552-59-0 | Natural Products |
| HY-N2598 | Methyl oleate | 112-62-9 | Natural Products |
| HY-N2598R | Methyl oleate (Standard) | 112-62-9 | Reference Standards |
| HY-N2599 | Taraxerol acetate | 2189-80-2 | Natural Products |
| HY-N2600 | Kuwanon H | 76472-87-2 | Natural Products |
| HY-N2600R | Kuwanon H (Standard) | 76472-87-2 | Reference Standards |
| HY-N2601 | Bayogenin 3-O-β-D-glucopyranoside | 104513-86-2 | Natural Products |
| HY-N2602 | Sanggenol L | 329319-20-2 | Natural Products |
| HY-N2603 | Saikosaponin H | 91990-63-5 | Natural Products |
| HY-N2604 | Loureirin C | 116384-24-8 | Natural Products |
| HY-N2605 | Camelliaside B | 131573-90-5 | Natural Products |
| HY-N2605R | Camelliaside B (Standard) | 131573-90-5 | Reference Standards |
| HY-N2606 | Bernardioside A | 121368-52-3 | Natural Products |
| HY-N2607 | Sanggenone H | 86450-80-8 | Natural Products |
| HY-N2608 | 7-O-Ethylmorroniside | 945721-10-8 | Natural Products |
| HY-N2609 | 7,4'-Dihydroxyflavone | 2196-14-7 | Natural Products |
| HY-N2610 | 14-Formyldihydrorutaecarpine | 68353-23-1 | Natural Products |
| HY-N2611 | Deacylmetaplexigenin | 3513-04-0 | Natural Products |
| HY-N2612 | O-Methyldauricine | 2202-17-7 | Natural Products |
| HY-N2616 | Vomicine | 125-15-5 | Natural Products |
| HY-N2616R | Vomicine (Standard) | 125-15-5 | Reference Standards |
| HY-N2618 | 3-O-Acetyloleanolic acid | 4339-72-4 | Natural Products |
| HY-N2620 | Rutaevin | 33237-37-5 | Natural Products |
| HY-N2621 | Evodol | 22318-10-1 | Natural Products |
| HY-N2622 | Oxypeucedanin hydrate | 2643-85-8 | Natural Products |
| HY-N2623 | Alloimperatorin | 642-05-7 | Natural Products |
| HY-N2624 | Liguiritigenin-7-O-D-apiosyl-4'-O-D-glucoside | 199796-12-8 | Natural Products |
| HY-N2625 | Harmalol | 525-57-5 | Reference compound |
| HY-N2625A | Harmalol (hydrochloride) | 6028-07-5 | Natural Products |
| HY-N2625AR | Harmalol (hydrochloride) (Standard) | 6028-07-5 | Reference Standards |
| HY-N2626 | Epimedoside A | 39012-04-9 | Natural Products |
| HY-N2627 | Isorhamnetin 3-O-robinobioside | 53584-69-3 | Natural Products |
| HY-N2628 | Erigeroside | 59219-76-0 | Natural Products |
| HY-N2632 | Uvarigrin | 200563-11-7 | Natural Products |
| HY-N2634 | Uvarigranol B | 164204-79-9 | Natural Products |
| HY-N2635 | Uvarigranol C | 172104-04-0 | Natural Products |
| HY-N2637 | Yibeinoside A | 98985-24-1 | Natural Products |
| HY-N2638 | Ilexsaponin A | 108524-93-2 | Natural Products |
| HY-N2638R | Ilexsaponin A (Standard) | 108524-93-2 | Reference Standards |
| HY-N2639 | Macatrichocarpin A | 1038753-13-7 | Natural Products |
| HY-N2640 | 4-O-Methylsappanol | 104778-16-7 | Natural Products |
| HY-N2641 | Dihydrotamarixetin | 70411-27-7 | Reference compound |
| HY-N2642 | 4'-O-trans-p-Coumaroylmussaenoside | 1246012-27-0 | Natural Products |
| HY-N2643 | 4-Oxobedfordiaic acid | 68799-38-2 | Natural Products |
| HY-N2644 | 4-Oxododecanedioic acid | 30828-09-2 | Natural Products |
| HY-N2645 | 7-Methoxy-5-benzofuranpropanol | 118930-92-0 | Natural Products |
| HY-N2646 | 5-Heptadec-cis-8-enylresorcinol | 52483-19-9 | Natural Products |
| HY-N2647 | 5,19-Epoxy-25-methoxycucurbita-6,23-dien-3-ol | 81910-39-6 | Natural Products |
| HY-N2648 | 5,5'-Dimethoxylariciresinol | 116498-58-9 | Natural Products |
| HY-N2649 | 5,5'-Dimethoxylariciresinol 4-O-glucoside | 154418-16-3 | Natural Products |
| HY-N2651 | 5,7,3'-Trihydroxy-4'-Methoxy-8-prenylflavanone | 1268140-15-3 | Natural Products |
| HY-N2652 | 5,7,3'-Trihydroxy-6,4',5'-trimethoxyflavanone | 310888-07-4 | Natural Products |
| HY-N2653 | 5,7,4-Trihydroxy-3,6-dimethoxy-3-prenylflavone | 959421-20-6 | Natural Products |
| HY-N2654 | 3-Hydroxy-4',5,7-trimethoxyflavanone | 76792-94-4 | Natural Products |
| HY-N2655 | 5,7,4'-Tri-O-methylcatechin | 105330-59-4 | Natural Products |
| HY-N2656 | 5,7,8-Trimethoxycoumarin | 60796-65-8 | Natural Products |
| HY-N2657 | Flavone, 5,7-dihydroxy-3,4',8-trimethoxy-, diacetate | 5128-43-8 | Natural Products |
| HY-N2658 | 5,7-Diacetoxy-8-methoxyflavone | 23246-80-2 | Natural Products |
| HY-N2659 | 5,7-Diacetoxyflavone | 6665-78-7 | Natural Products |
| HY-N2661 | 5,7-Dihydroxy-3,4',8-trimethoxyflavone | 1570-09-8 | Natural Products |
| HY-N2662 | 6-Methoxywogonin | 3162-45-6 | Natural Products |
| HY-N2663 | 5,8,4'-Trihydroxy-7-methoxyflavone 8-O-glucoside | 710952-13-9 | Natural Products |
| HY-N2664 | 5-Acetoxy-7-hydroxyflavone | 132351-58-7 | Natural Products |
| HY-N2665 | 5-Acetoxymatairesinol dimethyl ether | 74892-45-8 | Natural Products |
| HY-N2666 | 5α-Hydroxycostic acid | 132185-83-2 | Natural Products |
| HY-N2667 | 5β-Hydroxycostic acid | 132185-84-3 | Natural Products |
| HY-N2669 | 5'-Demethylaquillochin | 305364-91-4 | Natural Products |
| HY-N2670 | 5-Deoxycajanin | 7622-53-9 | Natural Products |
| HY-N2671 | 5-Epilithospermoside | 84799-31-5 | Natural Products |
| HY-N2672 | Glutinol | 545-24-4 | Natural Products |
| HY-N2673 | 5-Heptadecylresorcinol | 41442-57-3 | Natural Products |
| HY-N2674 | 5-Hydroxy-1-methoxyxanthone | 27770-13-4 | Natural Products |
| HY-N2675 | 5-Hydroxypyrrolidin-2-one | 62312-55-4 | Natural Products |
| HY-N2676 | 7-O-Methyldihydrowogonin | 113981-49-0 | Natural Products |
| HY-N2677 | 5-Hydroxy-7-acetoxy-8-methoxyflavone | 95480-80-1 | Natural Products |
| HY-N2678 | 5-Hydroxymethyl-7-methoxybenzofuran | 831222-78-7 | Natural Products |
| HY-N2679 | 2-(1-Hydroxy-1-methylethyl)-4-methoxyfuro-[3,2-g]benzopyran-7-one | 54087-32-0 | Natural Products |
| HY-N2681 | (±)-5'-Methoxylariciresinol | 105256-12-0 | Natural Products |
| HY-N2682 | (7R,8S)-Dehydrodiconiferyl alcohol | 155836-29-6 | Natural Products |
| HY-N2682A | (E)-Dehydrodiconiferyl alcohol | 528814-97-3 | Natural Products |
| HY-N2682B | Dehydrodiconiferyl alcohol | 4263-87-0 | Natural Products |
| HY-N2683 | 5-O-Methylnaringenin | 61775-19-7 | Natural Products |
| HY-N2684 | 5''-O-Syringoylkelampayoside A | 1014974-98-1 | Natural Products |
| HY-N2685 | 5-Pentacosylresorcinol | 70110-61-1 | Natural Products |
| HY-N2686 | 5'-Prenylaliarin | 1246926-09-9 | Natural Products |
| HY-N2687 | 5-n-Tricosylresorcinol | 70110-60-0 | Natural Products |
| HY-N2688 | 6,7-Dihydroneridienone A | 72959-46-7 | Natural Products |
| HY-N2689 | (R)-6',7'-Dihydroxybergamottin | 264234-05-1 | Natural Products |
| HY-N2690 | 6',7'-Dihydroxybergamottin acetonide | 684217-08-1 | Natural Products |
| HY-N2691 | 6,8-Cyclo-1,4-eudesmanediol | 213769-80-3 | Natural Products |
| HY-N2692 | 6,8-Diprenylgenistein | 51225-28-6 | Natural Products |
| HY-N2693 | 6,8-Diprenylorobol | 66777-70-6 | Natural Products |
| HY-N2694 | 6,9,10-Trihydroxy-7-megastigmen-3-one | 476682-97-0 | Natural Products |
| HY-N2695 | 6-Acetonyldihydrochelerythrine | 22864-92-2 | Natural Products |
| HY-N2696 | 6-Acetonyldihydrosanguinarine | 37687-34-6 | Natural Products |
| HY-N2697 | 6-Acetonyl-N-methyldihydrodecarine | 1253740-09-8 | Natural Products |
| HY-N2698 | 6-Acetyl-2,2-dimethylchroman-4-one | 68799-41-7 | Natural Products |
| HY-N2699 | 6alpha-Hydroxymaackiain | 61218-44-8 | Natural Products |
| HY-N2700 | 6a-Hydroxymedicarpin | 61135-92-0 | Natural Products |
| HY-N2701 | 6α-Hydroxynidorellol | 70387-38-1 | Natural Products |
| HY-N2702 | 6-Benzoyl-5,7-dihydroxy-2,2-dimethylchromane | 86606-14-6 | Natural Products |
| HY-N2703 | 6β-Hydroxyipolamiide | 87797-84-0 | Natural Products |
| HY-N2705 | Stigmast-4-en-6β-ol-3-one | 36450-02-9 | Natural Products |
| HY-N2706 | 6-Deoxy-9α-hydroxycedrodorin | 247036-52-8 | Natural Products |
| HY-N2707 | 6-Deoxyjacareubin | 16265-56-8 | Natural Products |
| HY-N2708 | 6-epi-8-O-Acetylharpagide | 97169-44-3 | Natural Products |
| HY-N2709 | 6-Epidemethylesquirolin D | 165074-00-0 | Natural Products |
| HY-N2710 | 6-Epiharpagide | 86362-16-5 | Natural Products |
| HY-N2711 | Curvifloruside F | 1151862-67-7 | Natural Products |
| HY-N2712 | 6''-O-trans-Feruloylcatalpol | 770721-33-0 | Natural Products |
| HY-N2713 | 10-Carboxylinalool | 28420-25-9 | Natural Products |
| HY-N2714 | 6-Hydroxyrubiadin | 87686-86-0 | Natural Products |
| HY-N2715 | 6-Methoxynaringenin | 94942-49-1 | Natural Products |
| HY-N2715A | (2R)-6-Methoxynaringenin | 1212075-61-0 | Natural Products |
| HY-N2716 | 6-O-(3'',4''-Dimethoxycinnamoyl)catalpol | 147714-71-4 | Natural Products |
| HY-N2717 | Kaempferol-3-O-β-D-6''-acetylglucoside | 118169-27-0 | Natural Products |
| HY-N2718 | 6-O-Acetylcoriatin | 1432063-63-2 | Natural Products |
| HY-N2719 | 6-O-Benzoylphlorigidoside B | 1246012-24-7 | Natural Products |
| HY-N2720 | 6-O-Caffeoylarbutin | 136172-60-6 | Natural Products |
| HY-N2721 | 6'-O-Cinnamoyl-8-epikingisidic acid | 1403984-03-1 | Natural Products |
| HY-N2722 | 6-O-Cinnamoylcatalpol | 136807-41-5 | Natural Products |
| HY-N2723 | 6-O-Feruloylglucose | 137887-25-3 | Natural Products |
| HY-N2724 | 6-O-Methylcerevisterol | 126060-09-1 | Natural Products |
| HY-N2725 | Derwentioside B | 1016987-87-3 | Natural Products |
| HY-N2726 | 6'-O-p-Hydroxybenzoylcatalposide | 355143-38-3 | Natural Products |
| HY-N2728 | 6-O-Syringoylajugol | 144049-72-9 | Natural Products |
| HY-N2729 | 6-O-trans-Cinnamoylphlorigidoside B | 1246012-25-8 | Natural Products |
| HY-N2731 | 6-O-Vanilloylajugol | 124168-04-3 | Natural Products |
| HY-N2732 | 6-Prenylapigenin | 68097-13-2 | Natural Products |
| HY-N2733 | 7,2',4'-Trihydroxy-5-methoxy-3-arylcoumarin | 1092952-62-9 | Natural Products |
| HY-N2734 | 2',7-Dihydroxy-5,8-dimethoxyflavanone | 1351338-14-1 | Natural Products |
| HY-N2735 | 7,3',4'-Trihydroxy-3-benzyl-2H-chromene | 1111897-60-9 | Natural Products |
| HY-N2736 | 3′,4′,7-Trihydroxyflavone | 2150-11-0 | Natural Products |
| HY-N2737 | 7,3'-Dihydroxy-4'-methoxyflavan | 162290-05-3 | Natural Products |
| HY-N2738 | (2S)-7,4'-Dihydroxy-3'-prenylflavan | 376361-96-5 | Natural Products |
| HY-N2740 | Agalloside | 221257-06-3 | Natural Products |
| HY-N2741 | Vitexin B-1 | 357645-16-0 | Natural Products |
| HY-N2743 | (3β,7α,22E)-Stigmasta-5,22-diene-3,7-diol | 64998-19-2 | Natural Products |
| HY-N2744 | 7beta-Hydroxyrutaecarpine | 163815-35-8 | Natural Products |
| HY-N2745 | 7-Geranyloxy-5-methoxycoumarin | 1432075-68-7 | Natural Products |
| HY-N2746 | 7-O-Geranylscopoletin | 28587-43-1 | Natural Products |
| HY-N2747 | 2(S)-7-Hydroxy-5,8,2'-trimethoxyflavanone | 100079-34-3 | Natural Products |
| HY-N2748 | 7-Hydroxy-3-prenylcoumarin | 86654-26-4 | Natural Products |
| HY-N2749 | 7-Hydroxy-5,8-dimethoxyflavanone | 54377-24-1 | Natural Products |
| HY-N2750 | 7-Hydroxy-6-methoxy-3-prenylcoumarin | 299159-90-3 | Natural Products |
| HY-N2751 | 7-Hydroxydarutigenol | 1188281-99-3 | Natural Products |
| HY-N2752 | 7-O-Acetyl-4-O-demethylpolysyphorin | 89706-39-8 | Natural Products |
| HY-N2753 | 7-Acetoxybonducellpin C | 197781-86-5 | Natural Products |
| HY-N2754 | Sternbin | 51857-11-5 | Natural Products |
| HY-N2755 | 7-O-Methylporiol | 206560-99-8 | Natural Products |
| HY-N2756 | Amentoflavone 7,4',7'',4'''-tetramethyl ether | 3778-25-4 | Natural Products |
| HY-N2757 | 7-Ketositosterol | 2034-74-4 | Natural Products |
| HY-N2758 | 7-Oxohinokinin | 130837-92-2 | Natural Products |
| HY-N2759 | 7-O-Isopentenyl-γ-fagarine | 23417-92-7 | Natural Products |
| HY-N2760 | Sandaracopimaradien-3β-ol | 4728-30-7 | Natural Products |
| HY-N2761 | 8(14),15-Isopimaradiene-3,18-diol | 59219-64-6 | Natural Products |
| HY-N2762 | Labda-8(17),13(14)-dien-15,16-olide | 83324-51-0 | Natural Products |
| HY-N2763 | 8,3'-Diprenylapigenin | 955135-37-2 | Natural Products |
| HY-N2764 | 8,9-Didehydro-7-hydroxydolichodial | 97856-19-4 | Natural Products |
| HY-N2765 | 1,9-Pentadecadiene-4,6-diyne-3,8-diol, 8-acetate | 41682-30-8 | Natural Products |
| HY-N2766 | 8alpha-Hydroxy-alpha-gurjunene | 70206-70-1 | Natural Products |
| HY-N2767 | Naphtho[1,2-b]furan, 2-propenoic acid deriv. | 104021-39-8 | Natural Products |
| HY-N2768 | 8-Benzoyl-5,7-dihydroxy-2,2-dimethylchromane | 63565-07-1 | Natural Products |
| HY-N2769 | 9β-Hydroxy-ageraphorone | 97372-53-7 | Natural Products |
| HY-N2771 | 8-Epicrepiside E | 93395-30-3 | Natural Products |
| HY-N2772 | 8-Epideoxyloganic acid | 88668-99-9 | Natural Products |
| HY-N2773 | 8-Geranyloxy-5,7-dimethoxycoumarin | 1228175-65-2 | Natural Products |
| HY-N2774 | 8-Hydroxy-3,5,7,3',4',5'-hexamethoxyflavone | 202846-95-5 | Natural Products |
| HY-N2775 | 8-Hydroxy-5-O-beta-D-glucosylpsoralen | 425680-98-4 | Natural Products |
| HY-N2776 | 8-Hydroxydigitoxigenin | 1049674-06-7 | Natural Products |
| HY-N2777 | 8-Hydroxyhyperforin 8,1-hemiacetal | 59014-02-7 | Natural Products |
| HY-N2778 | 8-Hydroxyodoroside A | 176519-75-8 | Natural Products |
| HY-N2779 | 8-Lavandulylkaempferol | 883859-83-4 | Natural Products |
| HY-N2781 | 8-O-Acetyltorilolone | 20482-21-7 | Natural Products |
| HY-N2782 | 8-O-Demethyl-7-O-methyl-3,9-dihydropunctatin | 93078-83-2 | Natural Products |
| HY-N2783 | 8'-Oxo-6-hydroxydihydrophaseic acid | 1388075-44-2 | Natural Products |
| HY-N2784 | 8-Prenyldaidzein | 135384-00-8 | Natural Products |
| HY-N2785 | Desmethylicaritin | 28610-31-3 | Natural Products |
| HY-N2786 | 8-Prenylluteone | 125002-91-7 | Natural Products |
| HY-N2787 | 8-Prenylnaringenin | 53846-50-7 | Natural Products |
| HY-N2788 | 9(11),12-Oleanadien-3-ol | 94530-87-7 | Natural Products |
| HY-N2789 | (9Z)-9,17-Octadecadiene-12,14-diyne-1,11,16-triol | 211238-60-7 | Natural Products |
| HY-N2790 | 9α,13α-Epidioxyabiet-8(14)-en-18-oic acid | 116499-73-1 | Natural Products |
| HY-N2791 | 9,13-Epidioxy-8(14)-abieten-18-oic acid | 5309-35-3 | Natural Products |
| HY-N2793 | 9-Epiblumenol B | 22841-42-5 | Natural Products |
| HY-N2794 | 9-Hydroxy-α-lapachone | 22333-58-0 | Natural Products |
| HY-N2795 | 9-Hydroxycalabaxanthone | 35349-68-9 | Reference compound |
| HY-N2797 | 9-Methoxy-α-lapachone | 35241-80-6 | Natural Products |
| HY-N2798 | Lariciresinol-4,4'-dimethyl ether-9-acetate | 73354-15-1 | Natural Products |
| HY-N2799 | 9-O-Feruloyl-5,5'-dimethoxylariciresinol | 166322-14-1 | Natural Products |
| HY-N2800 | 9-O-Feruloyllariciresinol | 60337-67-9 | Natural Products |
| HY-N2801 | 9-O-Methyl-4-hydroxyboeravinone B | 333798-10-0 | Natural Products |
| HY-N2802 | Euptox A | 79491-71-7 | Natural Products |
| HY-N2803 | 9-Oxo-2,7-bisaboladien-15-oic acid | 93888-59-6 | Natural Products |
| HY-N2804 | 9-Oxoageraphorone | 105181-06-4 | Natural Products |
| HY-N2805 | 9-Oxonerolidol | 58865-88-6 | Natural Products |
| HY-N2806 | Abiesinol F | 1190070-91-7 | Natural Products |
| HY-N2807 | Acanthoside B | 7374-79-0 | Natural Products |
| HY-N2808 | Acantrifoic acid A | 654663-85-1 | Natural Products |
| HY-N2809 | Acantrifoside E | 645414-25-1 | Natural Products |
| HY-N2810 | Acetylcephalotaxine | 24274-60-0 | Natural Products |
| HY-N2811 | Acetyldihydromicromelin A | 94285-22-0 | Natural Products |
| HY-N2812 | Epipodophyllotoxin acetate | 1180-35-4 | Natural Products |
| HY-N2813 | Acetylisocupressic acid | 52992-82-2 | Natural Products |
| HY-N2814 | Acetylsventenic acid | 126737-42-6 | Natural Products |
| HY-N2815 | Ursolic acid acetate | 7372-30-7 | Natural Products |
| HY-N2817 | Acuminatin | 41744-39-2 | Natural Products |
| HY-N2820 | Adynerigenin beta-neritrioside | 88721-09-9 | Natural Products |
| HY-N2821 | (+)-Afzelechin | 2545-00-8 | Natural Products |
| HY-N2822 | Agathadiol diacetate | 24022-13-7 | Natural Products |
| HY-N2823 | Agatharesinol | 7288-11-1 | Natural Products |
| HY-N2824 | Agatharesinol acetonide | 800389-33-7 | Natural Products |
| HY-N2825 | Agatholal | 3650-31-5 | Natural Products |
| HY-N2826 | Aglaine B | 177262-32-7 | Natural Products |
| HY-N2827 | Aglain C | 177468-85-8 | Natural Products |
| HY-N2828 | Aglaxiflorin D | 269739-78-8 | Natural Products |
| HY-N2829 | Aglinin A | 246868-97-3 | Natural Products |
| HY-N2830 | Agrimonolide | 21499-24-1 | Natural Products |
| HY-N2831 | Agrimonolide 6-O-β-D-glucoside | 126223-29-8 | Natural Products |
| HY-N2832 | Agrocybenine | 178764-92-6 | Natural Products |
| HY-N2834 | Akuammiline | 1897-26-3 | Natural Products |
| HY-N2835 | Alboctalol | 62394-00-7 | Natural Products |
| HY-N2836 | Alepterolic acid | 63399-38-2 | Natural Products |
| HY-N2837 | Aliarin | 84294-77-9 | Natural Products |
| HY-N2838 | Alismol | 87827-55-2 | Natural Products |
| HY-N2839 | Allamandicin | 51838-83-6 | Natural Products |
| HY-N2840 | Allitol | 488-44-8 | Natural Products |
| HY-N2840R | Allitol (Standard) | 488-44-8 | Reference Standards |
| HY-N2840S | Allitol-13C | Isotope-Labeled Compounds | |
| HY-N2841 | Alnusdiol | 56973-51-4 | Natural Products |
| HY-N2842 | α-Amyrin acetate | 863-76-3 | Natural Products |
| HY-N2843 | α-Amyrin palmitate | 22255-10-3 | Natural Products |
| HY-N2845 | Tsugalactone | 85699-62-3 | Natural Products |
| HY-N2846 | α-Epoxydihydroartemisinic acid | 380487-65-0 | Natural Products |
| HY-N2847 | alpha-Isowighteone | 65388-03-6 | Natural Products |
| HY-N2848 | α-Lapachone | 4707-33-9 | Natural Products |
| HY-N2849 | alpha-Onocerol | 511-01-3 | Natural Products |
| HY-N2850 | α-Spinasterol acetate | 4651-46-1 | Natural Products |
| HY-N2851 | α-Spinasterone | 23455-44-9 | Natural Products |
| HY-N2852 | α-Terthienylmethanol | 13059-93-3 | Natural Products |
| HY-N2853 | D-α-Tocopherylquinone | 7559-04-8 | Natural Products |
| HY-N2853R | D-α-Tocopherylquinone (Standard) | 7559-04-8 | Reference Standards |
| HY-N2854 | α-Viniferin | 62218-13-7 | Natural Products |
| HY-N2855 | Alphitolic acid | 19533-92-7 | Natural Products |
| HY-N2856 | Alpiniaterpene A | 1448667-05-7 | Natural Products |
| HY-N2857 | Alpinumisoflavone | 34086-50-5 | Natural Products |
| HY-N2858 | Alpinumisoflavone acetate | 86989-18-6 | Natural Products |
| HY-N2859 | Alstolenine | 85769-33-1 | Natural Products |
| HY-N2860 | Alstonic acid A | 1159579-44-8 | Natural Products |
| HY-N2861 | Alstonic acid B | 1159579-45-9 | Natural Products |
| HY-N2862 | Alstoyunine E | 1188932-15-1 | Natural Products |
| HY-N2863 | Goniothalenol | 65408-91-5 | Natural Products |
| HY-N2864 | Amaronol A | 226560-96-9 | Natural Products |
| HY-N2865 | Amaronol B | 226561-02-0 | Natural Products |
| HY-N2866 | Andrographidine C | 113963-39-6 | Natural Products |
| HY-N2867 | Andrographiside | 82209-76-5 | Natural Products |
| HY-N2868 | Andropanoside | 82209-72-1 | Natural Products |
| HY-N2870 | Angeloylisogomisin O | 83864-70-4 | Natural Products |
| HY-N2871 | Angophorol | 133442-54-3 | Natural Products |
| HY-N2872 | Angustin A | 1415795-50-4 | Natural Products |
| HY-N2873 | Angustin B | 1415795-51-5 | Natural Products |
| HY-N2874 | Anhydroglycinol | 67685-22-7 | Natural Products |
| HY-N2875 | Anhydrotuberosin | 41347-49-3 | Natural Products |
| HY-N2876 | Anisofolin A | 83529-71-9 | Natural Products |
| HY-N2877 | Annonacin | 111035-65-5 | Natural Products |
| HY-N2878 | Antiarol rutinoside | 261351-23-9 | Natural Products |
| HY-N2880 | Antiquorin | 125356-08-3 | Natural Products |
| HY-N2881 | Antirhine | 16049-28-8 | Natural Products |
| HY-N2882 | Apigenin-4'-α-L-rhamnoside | 133538-77-9 | Natural Products |
| HY-N2883 | Salipurpin | 28757-27-9 | Reference compound |
| HY-N2884 | Apigenin 5-O-neohesperidoside | 850630-40-9 | Natural Products |
| HY-N2885 | Apocynol A | 358721-33-2 | Natural Products |
| HY-N2886 | Aporeine | 2030-53-7 | Natural Products |
| HY-N2887 | Araliadiol | 1354638-93-9 | Natural Products |
| HY-N2888 | Araneosol | 50461-86-4 | Natural Products |
| HY-N2890 | Arillatose B | 137941-45-8 | Natural Products |
| HY-N2891 | Aristolactam A II | 53948-07-5 | Reference compound |
| HY-N2892 | Aristolactam A IIIa | 97399-91-2 | Natural Products |
| HY-N2893 | Cepharanone B | 53948-09-7 | Natural Products |
| HY-N2894 | Piperolactam A | 112501-42-5 | Natural Products |
| HY-N2895 | Arjunic acid | 31298-06-3 | Natural Products |
| HY-N2896 | Arjunolic acid | 465-00-9 | Natural Products |
| HY-N2897 | Dihydrokaempferol | 480-20-6 | Natural Products |
| HY-N2897R | Dihydrokaempferol (Standard) | 480-20-6 | Reference Standards |
| HY-N2898 | Artanin | 96917-26-9 | Natural Products |
| HY-N2899 | Arteannuin M | 207446-90-0 | Natural Products |
| HY-N2901 | Artemetin acetate | 95135-98-1 | Natural Products |
| HY-N2902 | Artocarpin | 7608-44-8 | Natural Products |
| HY-N2903 | Artoheterophyllin B | 1174017-37-8 | Natural Products |
| HY-N2904 | Ascleposide E | 325686-49-5 | Natural Products |
| HY-N2905 | Aurantiamide acetate | 56121-42-7 | Natural Products |
| HY-N2906 | Limonianin | 119309-02-3 | Natural Products |
| HY-N2907 | Atranorin | 479-20-9 | Natural Products |
| HY-N2907R | Atranorin (Standard) | 479-20-9 | Reference Standards |
| HY-N2908 | Atraric acid | 4707-47-5 | Natural Products |
| HY-N2908R | Atraric acid (Standard) | 4707-47-5 | Reference Standards |
| HY-N2909 | Aurantiamide | 58115-31-4 | Natural Products |
| HY-N2910 | Auraptenol | 1221-43-8 | Natural Products |
| HY-N2911 | Auriculasin | 60297-37-2 | Natural Products |
| HY-N2912 | Axillaridine A | 128255-16-3 | Natural Products |
| HY-N2913 | Ayanin | 572-32-7 | Natural Products |
| HY-N2914 | (±)-Balanophonin | 118916-57-7 | Natural Products |
| HY-N2915 | Barbacarpan | 213912-46-0 | Natural Products |
| HY-N2916 | Barbinervic acid | 64199-78-6 | Natural Products |
| HY-N2917 | Barpisoflavone A | 101691-27-4 | Natural Products |
| HY-N2918 | Bauerenol acetate | 17020-04-1 | Natural Products |
| HY-N2919 | Bergenin pentaacetate | 14531-47-6 | Natural Products |
| HY-N2920 | β-Amyrenonol | 38242-02-3 | Natural Products |
| HY-N2921 | β-Amyrenonol acetate | 5356-56-9 | Natural Products |
| HY-N2922 | β-Amyrin | 559-70-6 | Natural Products |
| HY-N2922R | β-Amyrin (Standard) | 559-70-6 | Reference Standards |
| HY-N2923 | β-Amyrin acetate | 1616-93-9 | Natural Products |
| HY-N2924 | β-Amyrin palmitate | 5973-06-8 | Natural Products |
| HY-N2925 | β-Amyrone | 638-97-1 | Natural Products |
| HY-N2926 | β-Carboline-1-propionic acid | 89915-39-9 | Natural Products |
| HY-N2927 | Costic acid | 3650-43-9 | Natural Products |
| HY-N2928 | β-Dihydroplumericinic acid | 59204-61-4 | Natural Products |
| HY-N2929 | β-Hydroxypropiovanillone | 2196-18-1 | Natural Products |
| HY-N2930 | β-Peltoboykinolic acid | 24778-48-1 | Natural Products |
| HY-N2931 | β-Rotunol | 24405-57-0 | Natural Products |
| HY-N2932 | β-Yohimbine | 549-84-8 | Natural Products |
| HY-N2933 | Betulalbuside A | 64776-96-1 | Natural Products |
| HY-N2934 | Betulin caffeate | 89130-86-9 | Natural Products |
| HY-N2935 | Betulin palmitate | 582315-55-7 | Natural Products |
| HY-N2936 | Bi-linderone | 1227375-09-8 | Natural Products |
| HY-N2937 | Biondinin C | 55511-08-5 | Natural Products |
| HY-N2938 | Biorobin | 17297-56-2 | Natural Products |
| HY-N2939 | Bis-5,5-Nortrachelogenin | 870480-56-1 | Natural Products |
| HY-N2940 | Bisandrographolide A | 160498-00-0 | Natural Products |
| HY-N2941 | Bisandrographolide C | 160498-02-2 | Reference compound |
| HY-N2943 | Blumeatin B | 79995-67-8 | Natural Products |
| HY-N2944 | Blumenol B | 36151-01-6 | Natural Products |
| HY-N2945 | Byzantionoside B | 135820-80-3 | Natural Products |
| HY-N2946 | Boehmenan D | 57296-22-7 | Natural Products |
| HY-N2947 | Boeravinone B | 114567-34-9 | Natural Products |
| HY-N2947R | Boeravinone B (Standard) | 114567-34-9 | Reference Standards |
| HY-N2948 | Boeravinone E | 137787-00-9 | Natural Products |
| HY-N2949 | Bonducellpin D | 197781-85-4 | Natural Products |
| HY-N2950 | Bongardol | 123690-76-6 | Natural Products |
| HY-N2951 | Borapetoside B | 104901-05-5 | Natural Products |
| HY-N2952 | Borapetoside D | 151200-48-5 | Natural Products |
| HY-N2953 | Borapetoside E | 151200-49-6 | Natural Products |
| HY-N2954 | Borapetoside F | 151200-50-9 | Natural Products |
| HY-N2955 | Borreriagenin | 249916-07-2 | Natural Products |
| HY-N2956 | Bourjotinolone A | 6985-35-9 | Natural Products |
| HY-N2957 | Brachynoside heptaacetate | 144765-80-0 | Natural Products |
| HY-N2958 | Braylin | 6054-10-0 | Natural Products |
| HY-N2959 | Brevilin A | 16503-32-5 | Natural Products |
| HY-N2959R | Brevilin A (Standard) | 16503-32-5 | Reference Standards |
| HY-N2960 | Broussonin A | 73731-87-0 | Natural Products |
| HY-N2961 | Broussonin B | 73731-86-9 | Natural Products |
| HY-N2962 | Broussonin C | 76045-49-3 | Natural Products |
| HY-N2963 | Broussonin E | 90902-21-9 | Natural Products |
| HY-N2964 | BR-xanthone A | 112649-48-6 | Natural Products |
| HY-N2965 | Bryonolic acid | 24480-45-3 | Natural Products |
| HY-N2966 | Buergerinin B | 919769-83-8 | Natural Products |
| HY-N2967 | Buergerinin G | 263764-83-6 | Natural Products |
| HY-N2968 | Bullatantriol | 99933-32-1 | Natural Products |
| HY-N2969 | Bulleyanin | 123043-54-9 | Natural Products |
| HY-N2970 | Burchellin | 38276-59-4 | Natural Products |
| HY-N2971 | Buxbodine B | 390362-51-3 | Natural Products |
| HY-N2973 | 9-epi-Blumenol C β-D-glucopyranoside | 189109-45-3 | Natural Products |
| HY-N2974 | Caboxine A | 53851-13-1 | Natural Products |
| HY-N2975 | Cabraleadiol | 67253-01-4 | Natural Products |
| HY-N2976 | Cabraleadiol monoacetate | 35833-62-6 | Natural Products |
| HY-N29777 | Cabraleahydroxylactone | 35833-69-3 | Natural Products |
| HY-N2978 | Cabraleahydroxylactone, acetate | 35833-70-6 | Natural Products |
| HY-N2979 | Cabralealactone | 19865-87-3 | Natural Products |
| HY-N2980 | Ocotillone | 35761-54-7 | Natural Products |
| HY-N2981 | Caesalmin B | 352658-23-2 | Natural Products |
| HY-N2982 | Caesalmin E | 204185-91-1 | Natural Products |
| HY-N2983 | Cajanin | 32884-36-9 | Natural Products |
| HY-N2984 | Calanolide E | 142566-61-8 | Natural Products |
| HY-N2987 | (-)-Holostyligone | 887501-28-2 | Natural Products |
| HY-N2988 | Schisanwilsonin C | 1181216-83-0 | Natural Products |
| HY-N2988A | Benzoylgomisin P | 129445-43-8 | Natural Products |
| HY-N2989 | 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid | 168293-14-9 | Natural Products |
| HY-N2990 | 16α-Hydroxydehydrotrametenolic acid | 176390-66-2 | Natural Products |
| HY-N2991 | Dehydropachymic acid | 77012-31-8 | Natural Products |
| HY-N2991R | Dehydropachymic acid (Standard) | 77012-31-8 | Reference Standards |
| HY-N2992 | 16α-Hydroxytrametenolic acid | 176390-68-4 | Natural Products |
| HY-N2993 | Polyporenic acid C | 465-18-9 | Natural Products |
| HY-N2994 | 3-O-Acetyl-16α-hydroxytrametenolic acid | 168293-13-8 | Natural Products |
| HY-N2995 | Poricoic acid A | 137551-38-3 | Natural Products |
| HY-N2996 | Ganodermanondiol | 107900-76-5 | Natural Products |
| HY-N2997 | Ganoderic acid LM2 | 508182-41-0 | Natural Products |
| HY-N2998 | Ganoderenic acid A | 100665-40-5 | Natural Products |
| HY-N2998R | Ganoderenic acid A (Standard) | 100665-40-5 | Reference Standards |
| HY-N2999 | Ganoderic acid I | 98665-20-4 | Natural Products |
| HY-N3000 | 6-Methoxydihydrosanguinarine | 72401-54-8 | Natural Products |
| HY-N3001 | Isolinderalactone | 957-66-4 | Natural Products |
| HY-N3002 | α-Arbutin | 84380-01-8 | Natural Products |
| HY-N3002R | α-Arbutin (Standard) | 84380-01-8 | Reference Standards |
| HY-N3003 | Darutigenol | 5940-00-1 | Natural Products |
| HY-N3004 | Cyperotundone | 3466-15-7 | Natural Products |
| HY-N3005 | Britannin | 33627-28-0 | Natural Products |
| HY-N3006 | Sakuranetin | 2957-21-3 | Natural Products |
| HY-N3007 | Naringenin chalcone | 73692-50-9 | Natural Products |
| HY-N3007A | (E)-Naringenin chalcone | 25515-46-2 | Natural Products |
| HY-N3007R | Naringenin chalcone (Standard) | 73692-50-9 | Reference Standards |
| HY-N3009 | Secoxyloganin | 58822-47-2 | Natural Products |
| HY-N3009R | Secoxyloganin (Standard) | 58822-47-2 | Reference Standards |
| HY-N3010 | Salviaflaside | 178895-25-5 | Natural Products |
| HY-N3010R | Salviaflaside (Standard) | 178895-25-5 | Reference Standards |
| HY-N3011 | Iridin | 491-74-7 | Natural Products |
| HY-N3011R | Iridin (Standard) | 491-74-7 | Reference Standards |
| HY-N3012 | Isovalerylshikonin | 52387-14-1 | Natural Products |
| HY-N3013 | Bruceine B | 25514-29-8 | Natural Products |
| HY-N3014 | Bruceine D | 21499-66-1 | Natural Products |
| HY-N3015 | Bruceine E | 21586-90-3 | Natural Products |
| HY-N3016 | Rupestonic acid | 83161-56-2 | Natural Products |
| HY-N3017 | Artemitin | 479-90-3 | Natural Products |
| HY-N3017R | Artemitin (Standard) | 479-90-3 | Reference Standards |
| HY-N3018 | Isomaltose | 499-40-1 | Natural Products |
| HY-N3020 | Brandioside | 133393-81-4 | Natural Products |
| HY-N3021 | D-chiro-Inositol | 643-12-9 | Natural Products |
| HY-N3023 | 3,4-Dihydroxybenzylamine (hydrobromide) | 16290-26-9 | Reference compound |
| HY-N3025 | Zinc sulfate (heptahydrate) | 7446-20-0 | Reference compound |
| HY-N3026 | Soyasaponin Ab | 118194-13-1 | Natural Products |
| HY-N3027 | Soyasaponin Aa | 117230-33-8 | Natural Products |
| HY-N3027R | Soyasaponin Aa (Standard) | 117230-33-8 | Reference Standards |
| HY-N3028 | Taccalonolide B | 108885-69-4 | Natural Products |
| HY-N3029 | Noreugenin | 1013-69-0 | Natural Products |
| HY-N3030 | Sylvestroside I | 71431-22-6 | Natural Products |
| HY-N3031 | Grosvenorine | 156980-60-8 | Natural Products |
| HY-N3031R | Grosvenorine (Standard) | 156980-60-8 | Reference Standards |
| HY-N3033 | N-Benzyllinolenamide | 883715-18-2 | Natural Products |
| HY-N3035 | Tetrahydroepiberberine | 38853-67-7 | Natural Products |
| HY-N3036 | (Rac)-Isovalerylshikonin | 76549-35-4 | Natural Products |
| HY-N3037 | 3-O-Acetyl-α-boswellic acid | 89913-60-0 | Natural Products |
| HY-N3037R | 3-O-Acetyl-α-boswellic acid (Standard) | 89913-60-0 | Reference Standards |
| HY-N3038 | Polygonal | 72537-20-3 | Natural Products |
| HY-N3039 | p-Menthane-1,3,8-triol | 155348-06-4 | Natural Products |
| HY-N3040 | p-Menth-8-ene-1,2-diol | 57457-97-3 | Natural Products |
| HY-N3041 | Plumieride | 511-89-7 | Natural Products |
| HY-N3042 | Platyphyllonol | 41137-85-3 | Natural Products |
| HY-N3043 | Platyphyllenone | 56973-65-0 | Natural Products |
| HY-N3044 | Piscidinol A | 100198-09-2 | Natural Products |
| HY-N3045 | (S,S)-Pisatin | 20186-22-5 | Natural Products |
| HY-N3046 | Piptocarphin A | 76248-63-0 | Natural Products |
| HY-N3047 | Piperolactam C | 116064-76-7 | Natural Products |
| HY-N3048 | Piperlotine D | 958296-13-4 | Natural Products |
| HY-N3049 | Piperlotine C | 886989-88-4 | Natural Products |
| HY-N3050 | Isocolumbin | 471-54-5 | Natural Products |
| HY-N3051 | Piperlotine A | 389572-70-7 | Natural Products |
| HY-N3052 | Piperitol | 52151-92-5 | Natural Products |
| HY-N3053 | Piperenone | 57625-31-7 | Natural Products |
| HY-N3054 | Pinusolidic acid | 40433-82-7 | Natural Products |
| HY-N3055 | Pinusolide | 31685-80-0 | Natural Products |
| HY-N3056 | Pinosylvin monomethyl ether | 35302-70-6 | Natural Products |
| HY-N3056R | Pinosylvin monomethyl ether (Standard) | 35302-70-6 | Reference Standards |
| HY-N3057 | Pinostrobin chalcone | 18956-15-5 | Natural Products |
| HY-N3057R | Pinostrobin chalcone (Standard) | 18956-15-5 | Reference Standards |
| HY-N3058 | Pinostilbenoside | 58762-96-2 | Natural Products |
| HY-N3059 | Pinostilbene | 42438-89-1 | Natural Products |
| HY-N3059R | Pinostilbene (Standard) | 42438-89-1 | Reference Standards |
| HY-N3060 | (S)-5,7-Diacetoxyflavanone | 111441-88-4 | Natural Products |
| HY-N3061 | Pinocembrin, 7-acetate | 109592-60-1 | Natural Products |
| HY-N3062 | Pinobanksin | 548-82-3 | Natural Products |
| HY-N3063 | Pimaric acid | 127-27-5 | Reference compound |
| HY-N3065 | Pierreione B | 1292766-21-2 | Natural Products |
| HY-N3067 | Picrasin B acetate | 30315-04-9 | Natural Products |
| HY-N3068 | Picrasin B | 26121-56-2 | Reference compound |
| HY-N3071 | Picrasidine I | 100234-59-1 | Natural Products |
| HY-N3072 | Picraline | 2671-32-1 | Natural Products |
| HY-N3073 | Picralinal | 20045-06-1 | Natural Products |
| HY-N3074 | Hexahydrofarnesyl acetone | 502-69-2 | Natural Products |
| HY-N3074R | Hexahydrofarnesyl acetone (Standard) | 502-69-2 | Reference Standards |
| HY-N3075 | Phytol | 150-86-7 | Natural Products |
| HY-N3075R | Phytol (Standard) | 150-86-7 | Reference Standards |
| HY-N3076 | Phyllostine | 27270-89-9 | Natural Products |
| HY-N3077 | Phyllostadimer A | 638203-32-4 | Natural Products |
| HY-N3078 | p-Hydroxyphenethyl trans-ferulate | 84873-15-4 | Natural Products |
| HY-N3079 | Phlorin | 28217-60-9 | Natural Products |
| HY-N3080 | Phlorigidoside B | 288248-46-4 | Natural Products |
| HY-N3081 | Phloracetophenone 4'-O-glucoside | 5027-30-5 | Natural Products |
| HY-N3082 | Phlegmanol C | 1260-05-5 | Natural Products |
| HY-N3083 | Phenylalanine betaine | 56755-22-7 | Natural Products |
| HY-N3084 | Phellochin | 115334-04-8 | Natural Products |
| HY-N3085 | Phellamurin | 52589-11-4 | Natural Products |
| HY-N3086 | Phebalosin | 6545-99-9 | Natural Products |
| HY-N3087 | Phaseollin | 13401-40-6 | Natural Products |
| HY-N3088 | Phaseollidin hydrate | 76122-57-1 | Natural Products |
| HY-N3089 | Phaseollidin | 37831-70-2 | Natural Products |
| HY-N3090 | Peucedanol | 46992-81-8 | Natural Products |
| HY-N3091 | Persiconin | 28978-03-2 | Natural Products |
| HY-N3092 | Perilloxin | 263249-77-0 | Natural Products |
| HY-N3093 | Periglaucine B | 1025023-05-5 | Natural Products |
| HY-N3094 | Periglaucine A | 1025023-04-4 | Natural Products |
| HY-N3095 | Peraksine | 15527-80-7 | Natural Products |
| HY-N3096 | Penduletin | 569-80-2 | Natural Products |
| HY-N3097 | Pellitorine | 18836-52-7 | Natural Products |
| HY-N3097R | Pellitorine (Standard) | 18836-52-7 | Reference Standards |
| HY-N3098 | Pelirine | 30435-26-8 | Natural Products |
| HY-N3099 | Pedicin | 521-51-7 | Natural Products |
| HY-N3100 | Pedatisectine F | 206757-32-6 | Natural Products |
| HY-N3101 | Pedalitin | 22384-63-0 | Natural Products |
| HY-N3102 | p-Coumaryl alcohol | 3690-05-9 | Natural Products |
| HY-N3102A | (E)-p-Coumaryl alcohol | 20649-40-5 | Reference compound |
| HY-N3103 | p-Coumaric Acid Ethyl Ester | 7362-39-2 | Reference compound |
| HY-N3103R | p-Coumaric Acid Ethyl Ester (Standard) | 7362-39-2 | Reference Standards |
| HY-N3104 | Paxiphylline E | 1092555-03-7 | Natural Products |
| HY-N3105 | Paxiphylline D | 1092555-02-6 | Natural Products |
| HY-N3106 | Pashanone | 42438-78-8 | Natural Products |
| HY-N3107 | Paniculoside III | 60129-65-9 | Natural Products |
| HY-N3108 | Paniculoside II | 60129-64-8 | Natural Products |
| HY-N3109 | Paniculoside I | 60129-63-7 | Natural Products |
| HY-N3110 | Paniculidine C | 97399-95-6 | Natural Products |
| HY-N3111 | Paniculidine B | 97399-94-5 | Natural Products |
| HY-N3112 | Paniculidine A | 97399-93-4 | Natural Products |
| HY-N3113 | Panaxyne | 122855-49-6 | Natural Products |
| HY-N3114 | Panaxydiol | 63910-76-9 | Natural Products |
| HY-N3115 | Palbinone | 139954-00-0 | Natural Products |
| HY-N3116 | Paeonilactone C | 98751-77-0 | Natural Products |
| HY-N3117 | Paeonilactone B | 98751-78-1 | Natural Products |
| HY-N3118 | Paeonilactone A | 98751-79-2 | Natural Products |
| HY-N3119 | Paeoniflorigenone | 80454-42-8 | Natural Products |
| HY-N3120 | Padmatin | 80453-44-7 | Natural Products |
| HY-N3121 | Pachypodol | 33708-72-4 | Natural Products |
| HY-N3121R | Pachypodol (Standard) | 33708-72-4 | Reference Standards |
| HY-N3122 | Pachyaximine A | 128255-08-3 | Natural Products |
| HY-N3123 | Oxychelerythrine | 28342-33-8 | Natural Products |
| HY-N3125 | Osajin | 482-53-1 | Natural Products |
| HY-N3126 | Orsellinic acid | 480-64-8 | Natural Products |
| HY-N3126R | Orsellinic acid (Standard) | 480-64-8 | Reference Standards |
| HY-N3127 | Orobol | 480-23-9 | Natural Products |
| HY-N3128 | Orientanol A | 190381-82-9 | Natural Products |
| HY-N3129 | Oplopanon | 1911-78-0 | Natural Products |
| HY-N3131 | Ophiopogonanone F | 588706-67-6 | Natural Products |
| HY-N3132 | Ophiopogonanone E | 588706-66-5 | Natural Products |
| HY-N3133 | Ophiopogonanone C | 477336-75-7 | Natural Products |
| HY-N3134 | Onitisin | 53823-03-3 | Natural Products |
| HY-N3135 | Onitin 2'-O-glucoside | 76947-60-9 | Natural Products |
| HY-N3136 | Onitin | 53823-02-2 | Natural Products |
| HY-N3137 | O-Methylpallidine | 27510-33-4 | Natural Products |
| HY-N3138 | Ombuoside | 20188-85-6 | Natural Products |
| HY-N3139 | Ombuin | 529-40-8 | Natural Products |
| HY-N3140 | Olivil monoacetate | 1016974-78-9 | Natural Products |
| HY-N3141 | Olivil | 2955-23-9 | Natural Products |
| HY-N3142 | Oleuropeic acid 8-O-glucoside | 865887-46-3 | Natural Products |
| HY-N3143 | Oleuropeic acid | 5027-76-9 | Natural Products |
| HY-N3144 | Oleoside | 178600-68-5 | Natural Products |
| HY-N3145 | Oleonuezhenide | 112693-21-7 | Natural Products |
| HY-N3146 | Olean-12-ene-3β,24-diol | 119318-15-9 | Natural Products |
| HY-N3147 | Olean-12-ene-3,11-dione | 2935-32-2 | Natural Products |
| HY-N3148 | Olean-12-ene-3,11-diol | 5282-14-4 | Natural Products |
| HY-N3149 | (E)-2-Hydroxycinnamaldehyde | 60125-23-7 | Natural Products |
| HY-N3149A | 2-Hydroxycinnamaldehyde | 3541-42-2 | Natural Products |
| HY-N3150 | Ohchinin acetate | 67023-81-8 | Natural Products |
| HY-N3151 | Ohchinin | 67023-80-7 | Natural Products |
| HY-N3152 | O-Geranylconiferyl alcohol | 129350-09-0 | Natural Products |
| HY-N3154 | Odorinol | 72755-22-7 | Natural Products |
| HY-N3155 | Odorine | 72755-20-5 | Natural Products |
| HY-N3156 | Odoratone | 16962-90-6 | Natural Products |
| HY-N3157 | Odonicin | 51419-51-3 | Natural Products |
| HY-N3158 | O-Demethylforbexanthone | 92609-77-3 | Natural Products |
| HY-N3159 | Octadecyl caffeate | 69573-60-0 | Natural Products |
| HY-N3160 | Erythrinasinate B | 101959-37-9 | Natural Products |
| HY-N3161 | Ocotillone Ⅰ | 22549-21-9 | Natural Products |
| HY-N3162 | Obtucarbamate B | 20913-18-2 | Natural Products |
| HY-N3163 | Obtucarbamate A | 6935-99-5 | Natural Products |
| HY-N3164 | Oblongine | 60008-01-7 | Natural Products |
| HY-N3166 | Onitisin 2'-O-glucoside | 62043-53-2 | Natural Products |
| HY-N3167 | Nyasicoside | 111518-94-6 | Natural Products |
| HY-N3168 | Nyasicol 1,2-acetonide | 1432057-64-1 | Natural Products |
| HY-N3169 | Nyasicol | 111518-95-7 | Natural Products |
| HY-N3170 | N-p-Coumaroyl-N'-caffeoylputrescine | 1138156-77-0 | Natural Products |
| HY-N3171 | Nortrachelogenin | 34444-37-6 | Natural Products |
| HY-N3171A | (+)-Nortrachelogenin | 61521-74-2 | Natural Products |
| HY-N3174 | (2R)-Norpterosin B | 1226892-20-1 | Natural Products |
| HY-N3175 | Norlichexanthone | 20716-98-7 | Natural Products |
| HY-N3176 | Norkhellol | 4439-68-3 | Natural Products |
| HY-N3177 | Norglaucine (hydrochloride) | 39945-41-0 | Natural Products |
| HY-N3179 | Norcepharadione B | 57576-41-7 | Natural Products |
| HY-N3180 | Norbraylin | 60796-64-7 | Natural Products |
| HY-N3181 | Nodosin | 10391-09-0 | Natural Products |
| HY-N3182 | N-Methylnuciferine | 754919-24-9 | Natural Products |
| HY-N3182A | N-Methylnuciferine (iodide) | 53098-68-3 | Natural Products |
| HY-N3183 | N-Methyllindcarpine | 14028-97-8 | Natural Products |
| HY-N3184 | N-Methylflindersine | 50333-13-6 | Natural Products |
| HY-N3185 | N-Methylcalycinine | 86537-66-8 | Natural Products |
| HY-N3186 | N-Methoxyanhydrovobasinediol | 125180-42-9 | Natural Products |
| HY-N3187 | Nimbin | 5945-86-8 | Natural Products |
| HY-N3188 | Niloticin | 115404-57-4 | Natural Products |
| HY-N3189 | Nigrolineaxanthone V | 864516-31-4 | Natural Products |
| HY-N3190 | Nigracin | 18463-25-7 | Natural Products |
| HY-N3191 | N-trans-Feruloyl-3-methyldopamine | 78510-19-7 | Natural Products |
| HY-N3192 | Nervogenic acid | 17622-86-5 | Natural Products |
| HY-N3193 | Neritaloside | 465-13-4 | Natural Products |
| HY-N3194 | Neridienone B | 61671-56-5 | Natural Products |
| HY-N3195 | Neotuberostemonone | 954379-68-1 | Natural Products |
| HY-N3196 | Neotuberostemonine | 143120-46-1 | Natural Products |
| HY-N3197 | Neostenine | 477953-07-4 | Natural Products |
| HY-N3198A | Sophoramine | 6882-66-2 | Natural Products |
| HY-N3199 | Neorauflavene | 53734-75-1 | Natural Products |
| HY-N3200 | Neorauflavane | 53734-74-0 | Natural Products |
| HY-N3201 | Neoprzewaquinone A | 630057-39-5 | Natural Products |
| HY-N3202 | Neolitsine | 2466-42-4 | Natural Products |
| HY-N3203 | Neolinine | 112515-37-4 | Natural Products |
| HY-N3204 | Neoechinulin A | 51551-29-2 | Natural Products |
| HY-N3205 | Neochamaejasmin B | 90411-12-4 | Natural Products |
| HY-N3205A | Isoneochamaejasmin A | 871319-96-9 | Natural Products |
| HY-N3206 | Neobyakangelicol | 35214-82-5 | Natural Products |
| HY-N3207 | Nemoralisin C | 1443421-84-8 | Natural Products |
| HY-N3208 | Nemoralisin | 942480-13-9 | Natural Products |
| HY-N3209 | Nelumol A | 77836-86-3 | Natural Products |
| HY-N3210 | Nb-Demethylechitamine | 60048-88-6 | Natural Products |
| HY-N3211 | N-cis-Feruloyl tyramine | 80510-09-4 | Natural Products |
| HY-N3212 | Naringenin trimethyl ether | 38302-15-7 | Natural Products |
| HY-N3213 | Naringenin triacetate | 3682-04-0 | Natural Products |
| HY-N3214 | Naringenin-4',7-diacetate | 18196-13-9 | Natural Products |
| HY-N3215 | Nagilactone C | 24338-53-2 | Natural Products |
| HY-N3216 | Nagilactone B | 19891-51-1 | Natural Products |
| HY-N3217 | N1-Methoxymethyl picrinine | 1158845-78-3 | Natural Products |
| HY-N3218 | N1,N10-Bis(p-coumaroyl)spermidine | 114916-05-1 | Natural Products |
| HY-N3220 | Myricetin 3-O-galactoside | 15648-86-9 | Natural Products |
| HY-N3221 | Myriceric acid C | 162059-94-1 | Natural Products |
| HY-N3222 | Myriceric acid B | 55497-79-5 | Natural Products |
| HY-N3223 | Myricanone | 32492-74-3 | Natural Products |
| HY-N3224 | Myricanol triacetate | 34509-52-9 | Natural Products |
| HY-N3225 | Myricanol | 33606-81-4 | Natural Products |
| HY-N3226 | Myricananin A | 1079941-35-7 | Natural Products |
| HY-N3227 | Myricadiol | 17884-88-7 | Natural Products |
| HY-N3228 | Myrianthic acid | 89786-84-5 | Natural Products |
| HY-N3229 | Mussaenoside | 64421-27-8 | Natural Products |
| HY-N3230 | Murpanicin | 88478-44-8 | Natural Products |
| HY-N3231 | Murraol | 109741-38-0 | Natural Products |
| HY-N3232 | Murrangatin diacetate | 51650-59-0 | Natural Products |
| HY-N3233 | Murrangatin | 37126-91-3 | Natural Products |
| HY-N3234 | Murralongin | 53011-72-6 | Natural Products |
| HY-N3235 | Mupinensisone | 152253-67-3 | Natural Products |
| HY-N3236 | Mullilam diol | 36150-04-6 | Natural Products |
| HY-N3237 | Mulberrofuran H | 89199-99-5 | Natural Products |
| HY-N3238 | Mulberrofuran G pentaacetate | 99217-75-1 | Natural Products |
| HY-N3239 | Mulberrofuran G | 87085-00-5 | Natural Products |
| HY-N3241 | Mucrolidin | 227471-20-7 | Natural Products |
| HY-N3242 | Moronic acid | 6713-27-5 | Natural Products |
| HY-N3243 | Moracin P | 102841-46-3 | Natural Products |
| HY-N3244 | Moracin O | 123702-97-6 | Natural Products |
| HY-N3245 | Moracin C | 69120-06-5 | Natural Products |
| HY-N3246 | Morachalcone A | 76472-88-3 | Natural Products |
| HY-N3247 | Monomethyl kolavate | 24513-41-5 | Natural Products |
| HY-N3248 | Momordicoside G | 81371-54-2 | Natural Products |
| HY-N3249 | Momor-cerebroside I | 606125-07-9 | Natural Products |
| HY-N3251 | (S)-Moluccanin | 121700-26-3 | Natural Products |
| HY-N3252 | Mirandin B | 62163-24-0 | Natural Products |
| HY-N3253 | Mirabijalone D | 485811-84-5 | Natural Products |
| HY-N3254 | Minumicrolin | 88546-96-7 | Natural Products |
| HY-N3255 | Minecoside | 51005-44-8 | Natural Products |
| HY-N3256 | Millewanin H | 874303-34-1 | Natural Products |
| HY-N3257 | Millewanin G | 874303-33-0 | Natural Products |
| HY-N3258 | Micromelin | 15085-71-9 | Natural Products |
| HY-N3259 | Micranoic acid A | 659738-08-6 | Natural Products |
| HY-N3260 | Methyllucidone | 19956-54-8 | Natural Products |
| HY-N3261 | Methyllinderone | 3984-73-4 | Natural Products |
| HY-N3262 | Methylisopelletierine | 18747-42-7 | Natural Products |
| HY-N3263 | Methyleugenolglycol | 26509-45-5 | Natural Products |
| HY-N3264 | Methyl vanillate glucoside | 72500-11-9 | Natural Products |
| HY-N3265 | Methyl sinapate | 20733-94-2 | Natural Products |
| HY-N3266 | Methyl rosmarinate | 99353-00-1 | Natural Products |
| HY-N3267 | Methyl pseudolarate B | 82508-34-7 | Natural Products |
| HY-N3268 | Methyl pseudolarate A | 82508-33-6 | Natural Products |
| HY-N3269 | Methyl p-hydroxyphenyllactate | 51095-47-7 | Natural Products |
| HY-N3270 | Methyl orsellinate | 3187-58-4 | Natural Products |
| HY-N3271 | Methyl lycernuate A | 56218-46-3 | Natural Products |
| HY-N3272 | Methyl levulinate | 624-45-3 | Natural Products |
| HY-N3272R | Methyl levulinate (Standard) | 624-45-3 | Reference Standards |
| HY-N3273 | Methyl isodrimeninol | 442851-27-6 | Natural Products |
| HY-N3274 | Methyl isocostate | 132342-55-3 | Natural Products |
| HY-N3275 | Methyl eichlerianate | 56421-12-6 | Natural Products |
| HY-N3276 | Methyl dodovisate A | 1246937-33-6 | Natural Products |
| HY-N3277 | Methyl dodonate A acetate | 349487-98-5 | Natural Products |
| HY-N3278 | Methyl dodonate A | 349534-70-9 | Natural Products |
| HY-N3279 | Methyl N1-demethoxycarbonylchanofruticosinate | 80151-89-9 | Natural Products |
| HY-N3280 | Methyl clerodermate | 67650-47-9 | Natural Products |
| HY-N3281 | Methyl chanofruticosinate | 14050-92-1 | Natural Products |
| HY-N3282 | Methyl β-D-fructoside | 13403-14-0 | Natural Products |
| HY-N3283 | 6-Methylhydroxyangolensate | 22255-07-8 | Natural Products |
| HY-N3285 | Methyl 6-acetoxyangolensate | 16566-88-4 | Natural Products |
| HY-N3287 | Methyl 3-hydroxy-4,5-dimethoxybenzoate | 83011-43-2 | Natural Products |
| HY-N3288 | Methyl carbazole-3-carboxylate | 97931-41-4 | Natural Products |
| HY-N3289 | Methyl 3,4,5-trimethoxycinnamate | 7560-49-8 | Natural Products |
| HY-N3289A | (E)-Methyl 3,4,5-trimethoxycinnamate | 20329-96-8 | Natural Products |
| HY-N3290 | Methyl p-methoxyhydrocinnamate | 15823-04-8 | Natural Products |
| HY-N3291 | Methyl-3-(2,4-dihydroxy phenyl) propanoate | 17422-90-1 | Natural Products |
| HY-N3292 | Metasequoic acid A | 113626-22-5 | Natural Products |
| HY-N3293 | Metasequirin D | 1264694-96-3 | Natural Products |
| HY-N3294 | Mesuol | 16981-20-7 | Natural Products |
| HY-N3295 | Mesuaxanthone A | 3561-81-7 | Natural Products |
| HY-N3296 | Meridinol | 120051-54-9 | Natural Products |
| HY-N3297 | Meranzin (hydrate) | 5875-49-0 | Natural Products |
| HY-N3297R | Meranzin (hydrate) (Standard) | 5875-49-0 | Reference Standards |
| HY-N3298 | Meranzin | 23971-42-8 | Natural Products |
| HY-N3298R | Meranzin (Standard) | 23971-42-8 | Reference Standards |
| HY-N3299 | Meloscandonine | 28645-27-4 | Natural Products |
| HY-N3300 | Mellein | 480-33-1 | Natural Products |
| HY-N3300A | (+)-Mellein | 62623-84-1 | Natural Products |
| HY-N3301 | Melilotigenin C | 188970-21-0 | Natural Products |
| HY-N3302 | Melilotigenin B | 91269-84-0 | Natural Products |
| HY-N3303 | Meliasenin B | 1221262-77-6 | Natural Products |
| HY-N3304 | 7-Megastigmene-3,5,6,9-tetraol | 276870-26-9 | Natural Products |
| HY-N3305 | Megastigm-7-ene-3,5,6,9-tetraol | 680617-50-9 | Natural Products |
| HY-N3306 | Megastigm-7-ene-3,4,6,9-tetrol | 180164-14-1 | Natural Products |
| HY-N3307 | (+)-Medioresinol | 40957-99-1 | Natural Products |
| HY-N3308 | Medicarpin | 32383-76-9 | Natural Products |
| HY-N3309 | Mearnsitrin | 30484-88-9 | Natural Products |
| HY-N3310 | Mearnsetin | 16805-10-0 | Natural Products |
| HY-N3312 | Matairesinol | 580-72-3 | Natural Products |
| HY-N3312R | Matairesinol (Standard) | 580-72-3 | Reference Standards |
| HY-N3314 | Massoniresinol | 96087-10-4 | Natural Products |
| HY-N3315 | Massonianoside B | 188300-19-8 | Natural Products |
| HY-N3316 | Martynoside | 67884-12-2 | Natural Products |
| HY-N3317 | Marsformoxide B | 2111-46-8 | Natural Products |
| HY-N3319 | Marmin acetonide | 320624-68-8 | Natural Products |
| HY-N3320 | Marmin | 14957-38-1 | Natural Products |
| HY-N3321 | Maoyerabdosin | 90468-72-7 | Natural Products |
| HY-N3322 | Maoecrystal B | 96850-29-2 | Natural Products |
| HY-N3323 | Mannioside A | 1038922-95-0 | Natural Products |
| HY-N3324 | Mangostanol | 184587-72-2 | Natural Products |
| HY-N3326 | Mangiferolic acid | 4184-34-3 | Natural Products |
| HY-N3327 | Mallorepine | 767-98-6 | Natural Products |
| HY-N3328 | Malic acid 4-Me ester | 66178-02-7 | Natural Products |
| HY-N3329 | Magnoloside A | 113557-95-2 | Natural Products |
| HY-N3330 | Magnolignan C | 93697-42-8 | Natural Products |
| HY-N3331 | Magnolignan A | 93673-81-5 | Natural Products |
| HY-N3332 | Magnolianin | 147663-91-0 | Natural Products |
| HY-N3333 | Magnaldehyde D | 93753-33-4 | Natural Products |
| HY-N3334 | Maglifloenone | 82427-77-8 | Natural Products |
| HY-N3336 | Macrocarpal N | 221899-21-4 | Natural Products |
| HY-N3337 | Macrocarpal L | 327601-97-8 | Natural Products |
| HY-N3338 | Macrocarpal K | 218290-59-6 | Natural Products |
| HY-N3339 | Macrocarpal J | 179603-47-5 | Reference compound |
| HY-N3340 | Macrocarpal I | 179388-54-6 | Natural Products |
| HY-N3341 | Macrocarpal H | 179388-53-5 | Natural Products |
| HY-N3342 | Macrocarpal E | 142628-54-4 | Natural Products |
| HY-N3343 | Macrocarpal D | 142647-71-0 | Natural Products |
| HY-N3344 | Macrocarpal C | 142628-53-3 | Natural Products |
| HY-N3345 | Macrocarpal B | 142698-60-0 | Natural Products |
| HY-N3346 | Macrocarpal A | 132951-90-7 | Natural Products |
| HY-N3347 | Macurin | 519-34-6 | Natural Products |
| HY-N3348 | Lyoniside | 34425-25-7 | Natural Products |
| HY-N3349 | Lyoniresinol | 14464-90-5 | Natural Products |
| HY-N3349A | (-)-Lyoniresinol | 31768-94-2 | Natural Products |
| HY-N3350 | Lycoclavanol | 13956-51-9 | Natural Products |
| HY-N3352 | Lycernuic acid A | 53755-77-4 | Natural Products |
| HY-N3353 | Luteone | 41743-56-0 | Natural Products |
| HY-N3354 | Lupiwighteone | 104691-86-3 | Natural Products |
| HY-N3355 | Lupeolic acid | 87355-32-6 | Natural Products |
| HY-N3356 | Lupeol palmitate | 32214-80-5 | Natural Products |
| HY-N3357 | Caffeoxylupeol | 103917-26-6 | Natural Products |
| HY-N3358 | Lupeol β-hydroxyoctadecanoate | 108885-61-6 | Natural Products |
| HY-N3359 | Lupanine | 550-90-3 | Natural Products |
| HY-N3359A | Lupanine (perchlorate) | 7400-11-5 | Natural Products |
| HY-N3359B | Lupanine (hydrochloride) | 1025-39-4 | Natural Products |
| HY-N3360 | Lupalbigenin | 76754-24-0 | Natural Products |
| HY-N3361 | (3β,4α)-Lup-20(29)-ene-3,23-diol | 163060-07-9 | Natural Products |
| HY-N3363 | Lup-20(29)-ene-2alpha,3beta-diol | 61448-03-1 | Natural Products |
| HY-N3364 | Lucidone | 19956-53-7 | Natural Products |
| HY-N3365 | Lophanthoidin F | 120462-46-6 | Natural Products |
| HY-N3366 | Lophanthoidin E | 120462-45-5 | Natural Products |
| HY-N3367 | Lophanthoidin B | 120462-42-2 | Natural Products |
| HY-N3368 | Longistylumphylline A | 857672-34-5 | Natural Products |
| HY-N3369 | Longistylin C | 64125-60-6 | Natural Products |
| HY-N3370 | Longipedlactone J | 1011762-93-8 | Natural Products |
| HY-N3371 | Longikaurin E | 77949-42-9 | Natural Products |
| HY-N3372 | Longifloroside A | 175556-08-8 | Natural Products |
| HY-N3373 | Loganetin | 29748-10-5 | Natural Products |
| HY-N3373R | Loganetin (Standard) | 29748-10-5 | Reference Standards |
| HY-N3374 | Lochnerine | 522-47-4 | Natural Products |
| HY-N3375 | Litseglutine B | 25368-01-8 | Natural Products |
| HY-N3376 | Liriodenine | 475-75-2 | Natural Products |
| HY-N3377 | Liriodendrin | 573-44-4 | Natural Products |
| HY-N3378 | Lipiferolide | 41059-80-7 | Natural Products |
| HY-N3379 | Linderone | 1782-79-2 | Natural Products |
| HY-N3380 | Linderaspirone A | 1235126-46-1 | Natural Products |
| HY-N3381 | Limonol | 989-61-7 | Natural Products |
| HY-N3382 | Shihulimonin A | 99026-99-0 | Natural Products |
| HY-N3383 | Ligustroside | 35897-92-8 | Natural Products |
| HY-N3384 | Ligucyperonol | 105108-20-1 | Natural Products |
| HY-N3385 | Licorisoflavan A | 129314-37-0 | Natural Products |
| HY-N3386 | Licoricone | 51847-92-8 | Natural Products |
| HY-N3387 | Licoricidin | 30508-27-1 | Natural Products |
| HY-N3388 | Licoisoflavone B | 66056-30-2 | Natural Products |
| HY-N3389 | Licoisoflavone A | 66056-19-7 | Natural Products |
| HY-N3389A | (S)-Licoisoflavone A | 164163-92-2 | Natural Products |
| HY-N3390 | Liangshanin A | 122717-54-8 | Natural Products |
| HY-N3391 | Leuconolam | 93710-27-1 | Natural Products |
| HY-N3392 | Lethedoside A | 221289-20-9 | Natural Products |
| HY-N3393 | Lethedioside A | 221289-31-2 | Natural Products |
| HY-N3394 | Lecanoric acid | 480-56-8 | Natural Products |
| HY-N3395 | Leachianone G | 152464-78-3 | Natural Products |
| HY-N3396 | Laxiracemosin H | 1241871-28-2 | Natural Products |
| HY-N3397 | Lauterine | 28200-65-9 | Natural Products |
| HY-N3398 | Lauroscholtzine | 2169-44-0 | Natural Products |
| HY-N3400 | Lasiodonin | 38602-52-7 | Natural Products |
| HY-N3401 | Lasiodiplodin | 32885-81-7 | Natural Products |
| HY-N3402 | Larixinol | 101046-79-1 | Natural Products |
| HY-N3403 | Lariciresinol dimethyl ether | 67560-68-3 | Natural Products |
| HY-N3404 | Lariciresinol acetate | 79114-77-5 | Natural Products |
| HY-N3405 | Lariciresinol | 27003-73-2 | Natural Products |
| HY-N3406 | Lansiumarin C | 205115-75-9 | Natural Products |
| HY-N3407 | Lancifolin C | 74048-71-8 | Natural Products |
| HY-N3408 | Lamiide | 27856-54-8 | Natural Products |
| HY-N3409 | Ladanein | 10176-71-3 | Natural Products |
| HY-N3410 | Lacinilene C | 41653-72-9 | Natural Products |
| HY-N3411 | Labd-13(E)-ene-8α,15-diol | 10267-31-9 | Natural Products |
| HY-N3413 | Kushenol X | 254886-77-6 | Natural Products |
| HY-N3414 | Kushenol L | 101236-50-4 | Natural Products |
| HY-N3415 | Kumatakenin | 3301-49-3 | Natural Products |
| HY-N3416 | Koumine N-oxide | 113900-75-7 | Natural Products |
| HY-N3417 | Kongensin A | 885315-96-8 | Natural Products |
| HY-N3419 | Kobusone | 24173-71-5 | Natural Products |
| HY-N3420 | Koaburaside monomethyl ether | 41514-64-1 | Natural Products |
| HY-N3421 | Koaburaside | 41653-73-0 | Natural Products |
| HY-N3422 | (+)-cis-Khellactone | 24144-61-4 | Natural Products |
| HY-N3422A | (rac)-Khellactone | 518-76-3 | Natural Products |
| HY-N3424 | Kelampayoside A | 87562-76-3 | Natural Products |
| HY-N3425 | Kazinol U | 1238116-48-7 | Natural Products |
| HY-N3426 | Kazinol B | 99624-27-8 | Natural Products |
| HY-N3427 | Karavilagenin A | 912329-03-4 | Natural Products |
| HY-N3428 | Kamebanin | 39388-57-3 | Natural Products |
| HY-N3429 | Kaerophyllin | 75590-33-9 | Natural Products |
| HY-N3430 | Kaempferol tetraacetate | 16274-11-6 | Natural Products |
| HY-N3431 | Kaempferol-7-O-rhamnoside | 20196-89-8 | Natural Products |
| HY-N3431A | Aromadendrin 7-O-rhamnoside | 69135-41-7 | Natural Products |
| HY-N3432 | 3-Hydroxy-5,7,4′-trimethoxyflavone | 1098-92-6 | Reference compound |
| HY-N3433 | Kaempferol 3-O-arabinoside | 99882-10-7 | Natural Products |
| HY-N3434 | Kaempferol 3,7,4'-trimethyl ether | 15486-34-7 | Natural Products |
| HY-N3435 | Kaempferol 3,4',7-triacetate | 143724-69-0 | Natural Products |
| HY-N3436 | Kadsurin A | 99340-07-5 | Natural Products |
| HY-N3437 | Kadsuric acid | 62393-88-8 | Natural Products |
| HY-N3438 | Kadsurenin D | 140669-89-2 | Natural Products |
| HY-N3439 | Junipediol B 8-O-glucoside | 188894-19-1 | Natural Products |
| HY-N3440 | Junipediol B | 144881-19-6 | Natural Products |
| HY-N3441 | Junipediol A | 86548-91-6 | Natural Products |
| HY-N3442 | Juglanin | 5041-67-8 | Natural Products |
| HY-N3443 | Jolkinol A | 62820-11-5 | Natural Products |
| HY-N3444 | Jangomolide | 93767-25-0 | Natural Products |
| HY-N3445 | Jaceidin triacetate | 14397-69-4 | Natural Products |
| HY-N3446 | IVHD-valtrate | 28325-56-6 | Natural Products |
| HY-N3447 | Itol A | 1033747-78-2 | Natural Products |
| HY-N3448 | Isowigtheone | 68436-47-5 | Natural Products |
| HY-N3449 | Isovouacapenol C | 455255-15-9 | Natural Products |
| HY-N3450 | Isotschimgin | 62356-47-2 | Natural Products |
| HY-N3451 | Isothymusin | 98755-25-0 | Natural Products |
| HY-N3452 | Isotetrandrine N2'-oxide | 70191-83-2 | Natural Products |
| HY-N3453 | Isotaxiresinol 9,9'-acetonide | 252333-72-5 | Natural Products |
| HY-N3454 | Isotaxiresinol | 26194-57-0 | Natural Products |
| HY-N3455 | Isotachioside | 31427-08-4 | Natural Products |
| HY-N3456 | Isosaxalin | 55481-86-2 | Natural Products |
| HY-N3457 | Isosativan | 60102-29-6 | Natural Products |
| HY-N3458 | Isosalvipuberulin | 115321-32-9 | Natural Products |
| HY-N3458A | Dugesin B | 760973-66-8 | Natural Products |
| HY-N3459 | Isosalicifolin | 156974-99-1 | Natural Products |
| HY-N3460 | Isorhoifolin | 552-57-8 | Natural Products |
| HY-N3460R | Isorhoifolin (Standard) | 552-57-8 | Reference Standards |
| HY-N3461 | Isorauhimbine | 483-09-0 | Natural Products |
| HY-N3462 | Isopteleine | 2181-84-2 | Natural Products |
| HY-N3463 | Isopimaric acid | 5835-26-7 | Natural Products |
| HY-N3464 | Isopedicin | 4431-42-9 | Natural Products |
| HY-N3465 | Isonormangostin | 15404-80-5 | Natural Products |
| HY-N3466 | Isomurralonginol acetate | 139115-59-6 | Natural Products |
| HY-N3468 | Isomerazin | 1088-17-1 | Natural Products |
| HY-N3468R | Isomerazin (Standard) | 1088-17-1 | Reference Standards |
| HY-N3469 | Isomedicarpin | 74560-05-7 | Natural Products |
| HY-N3470 | Isomartynoside | 94410-22-7 | Natural Products |
| HY-N3471 | Isomangiferolic acid | 13878-92-7 | Natural Products |
| HY-N3472 | Isomagnolone | 155709-41-4 | Natural Products |
| HY-N3473 | Isomaculosidine | 518-96-7 | Natural Products |
| HY-N3474 | Isolicoflavonol | 94805-83-1 | Natural Products |
| HY-N3475 | 9,9'-O-Isopropyllidene-isolariciresinol | 252333-71-4 | Natural Products |
| HY-N3476 | Isokaempferide | 1592-70-7 | Natural Products |
| HY-N3477 | Isokadsurenin D | 147976-35-0 | Natural Products |
| HY-N3478 | Isohyenanchin | 19417-00-6 | Natural Products |
| HY-N3479 | Isohemiphloin | 3682-02-8 | Natural Products |
| HY-N3480 | Isogosferol | 53319-52-1 | Natural Products |
| HY-N3481 | Isogomisin O | 83916-76-1 | Natural Products |
| HY-N3482 | Isogarciniaxanthone E | 659747-28-1 | Natural Products |
| HY-N3484 | Isoerysenegalensein E | 478158-77-9 | Natural Products |
| HY-N3485 | Isoelemicin | 5273-85-8 | Natural Products |
| HY-N3486 | Isodunnianol | 139726-30-0 | Natural Products |
| HY-N3487 | Isodorsmanin A | 118266-99-2 | Natural Products |
| HY-N3488 | Isodiospyrin | 20175-84-2 | Natural Products |
| HY-N3489 | Isodihydrofutoquinol B | 62499-71-2 | Natural Products |
| HY-N3490 | Isodihydrofutoquinol A | 62560-95-6 | Natural Products |
| HY-N3491 | Isodictamnine | 484-74-2 | Natural Products |
| HY-N3492 | Isoderrone | 121747-89-5 | Natural Products |
| HY-N3493 | Isocupressic acid | 1909-91-7 | Natural Products |
| HY-N3494 | γ-Costic acid | 69978-82-1 | Natural Products |
| HY-N3496 | Isochandalone | 121747-90-8 | Natural Products |
| HY-N3497 | Isochamaejasmin | 93859-63-3 | Natural Products |
| HY-N3498 | 7-Isocarapanaubine | 17391-09-2 | Natural Products |
| HY-N3499 | Isocalamendiol | 25330-21-6 | Natural Products |
| HY-N3500 | Ganoderic acid D2 | 97653-94-6 | Natural Products |
| HY-N3501 | Deacetyl Ganoderic Acid F | 100665-44-9 | Natural Products |
| HY-N3502 | 20(21)-Dehydrolucidenic acid A | 852936-69-7 | Natural Products |
| HY-N3503 | Ganoderlactone D | 1801934-15-5 | Natural Products |
| HY-N3504 | Ophiopogonin D' | 65604-80-0 | Natural Products |
| HY-N3505 | 14-Hydroxy sprengerinin C | 1111088-89-1 | Natural Products |
| HY-N3506 | Wilfortrine | 37239-48-8 | Natural Products |
| HY-N3507 | Euojaponine D | 128397-42-2 | Natural Products |
| HY-N3508 | Hyponine D | 259823-31-9 | Natural Products |
| HY-N3509 | Hyponine E | 226975-99-1 | Natural Products |
| HY-N3510 | Peritassine A | 262601-67-2 | Natural Products |
| HY-N3511 | Triptonine B | 168009-85-6 | Natural Products |
| HY-N3512 | Wilfornine A | 345954-00-9 | Natural Products |
| HY-N3513 | Mulberrin | 62949-79-5 | Natural Products |
| HY-N3513R | Mulberrin (Standard) | 62949-79-5 | Reference Standards |
| HY-N3514 | Kuwanon E | 68401-05-8 | Natural Products |
| HY-N3515 | Multicaulisin | 286461-76-5 | Natural Products |
| HY-N3516 | Oxyresveratrol 2-O-β-D-glucopyranoside | 392274-22-5 | Natural Products |
| HY-N3517 | Oxyresveratrol 3'-O-β-D-glucopyranoside | 144525-40-6 | Natural Products |
| HY-N3518 | Mulberroside F | 193483-95-3 | Natural Products |
| HY-N3519 | Platycodin D3 | 67884-03-1 | Natural Products |
| HY-N3520 | Deapi-platycodin D3 | 67884-05-3 | Natural Products |
| HY-N3521 | Platycoside G1 | 849758-42-5 | Natural Products |
| HY-N3522 | Platycoside E | 237068-41-6 | Natural Products |
| HY-N3523 | 3-O-Beta-D-Glucopyranosylplatycodigenin | 38337-25-6 | Natural Products |
| HY-N3524 | Calycanthoside | 483-91-0 | Natural Products |
| HY-N3525 | Calyciphylline A | 596799-30-3 | Natural Products |
| HY-N3526 | Calyxamine B | 150710-72-8 | Natural Products |
| HY-N3527 | Calyxin B | 164991-53-1 | Natural Products |
| HY-N3528 | Camaric acid | 146450-83-1 | Natural Products |
| HY-N3532 | Cannabisin F | 163136-19-4 | Natural Products |
| HY-N3534 | β-Cannabispiranol | 64052-90-0 | Natural Products |
| HY-N3535 | Canniprene | 70677-47-3 | Natural Products |
| HY-N3536 | Canthin-6-one | 479-43-6 | Natural Products |
| HY-N3537 | Canusesnol A | 816456-90-3 | Natural Products |
| HY-N3538 | Carabrolactone A | 1187925-30-9 | Natural Products |
| HY-N3539 | Carabrolactone B | 1187925-31-0 | Natural Products |
| HY-N3540 | Caraphenol A | 354553-35-8 | Natural Products |
| HY-N3541 | Cardenolide B-1 | 1318158-89-2 | Natural Products |
| HY-N3542 | Carpachromene | 57498-96-1 | Natural Products |
| HY-N3543 | Caryolane-1,9β-diol | 155485-76-0 | Natural Products |
| HY-N3544 | Caryophyllene oxide | 1139-30-6 | Natural Products |
| HY-N3544R | Caryophyllene oxide (Standard) | 1139-30-6 | Reference Standards |
| HY-N3545 | Casegravol | 74474-76-3 | Natural Products |
| HY-N3546 | Cassiachromone | 28955-30-8 | Natural Products |
| HY-N3547 | Cassyfiline | 4030-51-7 | Natural Products |
| HY-N3548 | Catalpalactone | 1585-68-8 | Natural Products |
| HY-N3549 | Catalpin | 1390-72-3 | Natural Products |
| HY-N3550 | Catalponol | 34168-56-4 | Natural Products |
| HY-N3552 | Catalposide | 6736-85-2 | Natural Products |
| HY-N3553 | Catechin 3-O-α-L-rhamnopyranoside | 103630-03-1 | Reference compound |
| HY-N3554 | Catechin-7-O-β-D-xylopyranoside | 42830-48-8 | Natural Products |
| HY-N3555 | (+)-Catechin pentaacetate | 16198-01-9 | Natural Products |
| HY-N3556 | Caulilexin C | 30536-48-2 | Natural Products |
| HY-N3557 | Cauloside A | 17184-21-3 | Natural Products |
| HY-N3558 | Ceanothic acid | 21302-79-4 | Natural Products |
| HY-N3559 | Emmolic acid, acetate | 119533-63-0 | Natural Products |
| HY-N3560 | Cedeodarin | 31076-39-8 | Natural Products |
| HY-N3561 | Cedrelone | 1254-85-9 | Natural Products |
| HY-N3562 | Cedrin | 75513-81-4 | Natural Products |
| HY-N3563 | Celaphanol A | 244204-40-8 | Natural Products |
| HY-N3564 | Centrolobol | 30359-01-4 | Natural Products |
| HY-N3565 | Cephalocyclidin A | 421583-14-4 | Natural Products |
| HY-N3566 | Cepharadione A | 55610-01-0 | Natural Products |
| HY-N3567 | Cerberic acid B | 1309362-77-3 | Natural Products |
| HY-N3568 | Cerberidol | 126594-64-7 | Natural Products |
| HY-N3569 | Cerbinal | 65597-42-4 | Natural Products |
| HY-N3570 | Cerebroside B | 88642-46-0 | Natural Products |
| HY-N3571 | Cerevisterol | 516-37-0 | Natural Products |
| HY-N3572 | Chinensine B | 849245-34-7 | Natural Products |
| HY-N3573 | Chlorahololide D | 943136-39-8 | Natural Products |
| HY-N3574 | Chloramultilide B | 1000995-47-0 | Natural Products |
| HY-N3575 | Henriol A | 1000995-48-1 | Natural Products |
| HY-N3576 | Henriol B | 1000995-49-2 | Natural Products |
| HY-N3577 | Chlorantholide A | 1372558-33-2 | Natural Products |
| HY-N3578 | Chlorantholide B | 1372558-34-3 | Natural Products |
| HY-N3579 | Chlorantholide C | 1372558-35-4 | Natural Products |
| HY-N3580 | Chlorantholide D | 1253106-58-9 | Natural Products |
| HY-N3581 | Chlorantholide E | 1372558-36-5 | Natural Products |
| HY-N3582 | Enhydrin chlorohydrin | 38230-99-8 | Natural Products |
| HY-N3583 | Chlorouvedalin | 24694-80-2 | Natural Products |
| HY-N3584 | Paris saponin VII | 68124-04-9 | Natural Products |
| HY-N3584R | Paris saponin VII (Standard) | 68124-04-9 | Reference Standards |
| HY-N3585 | Chrysothol | 911714-91-5 | Natural Products |
| HY-N3586 | Cimidahurinine | 142542-89-0 | Natural Products |
| HY-N3587 | Cimiside B | 152685-91-1 | Natural Products |
| HY-N3588 | Cinnamyl cinnamate | 122-69-0 | Natural Products |
| HY-N3589 | Cinnzeylanol | 62394-04-1 | Natural Products |
| HY-N3590 | cis-3,4-Dihydroxy-β-ionone | 875666-39-0 | Natural Products |
| HY-N3591 | cis-Methylisoeugenol | 6380-24-1 | Natural Products |
| HY-N3592 | Citreorosein | 481-73-2 | Natural Products |
| HY-N3593 | Clausine Z | 866111-14-0 | Natural Products |
| HY-N3594 | Clauszoline M | 187110-72-1 | Natural Products |
| HY-N3595 | Cleomiscosin A | 76948-72-6 | Natural Products |
| HY-N3596 | Cleomiscosin C | 84575-10-0 | Reference compound |
| HY-N3597 | Clerodenoside A | 164022-75-7 | Natural Products |
| HY-N3598 | Cleroindicin B | 107389-91-3 | Natural Products |
| HY-N3600 | Cleroindicin D | 189264-45-7 | Natural Products |
| HY-N3601 | (±)-Cleroindicin E | 165197-71-7 | Natural Products |
| HY-N3602 | Cleroindicin F | 189264-47-9 | Natural Products |
| HY-N3602A | rel-Cleroindicin F | 94535-01-0 | Natural Products |
| HY-N3603 | Clerosterol glucoside | 123621-00-1 | Natural Products |
| HY-N3604 | Clovanediol | 2649-64-1 | Natural Products |
| HY-N3605 | Clovanediol diacetate | 2649-68-5 | Natural Products |
| HY-N3606 | Cnidioside B methyl ester | 158500-59-5 | Natural Products |
| HY-N3607 | Coccineone B | 135626-13-0 | Natural Products |
| HY-N3608 | Coccinic acid | 107783-45-9 | Natural Products |
| HY-N3609 | Coclauril | 127350-68-9 | Natural Products |
| HY-N3610 | Coclaurine | 486-39-5 | Natural Products |
| HY-N3611 | Codaphniphylline | 14694-15-6 | Natural Products |
| HY-N3612 | Communic acid | 2761-77-5 | Natural Products |
| HY-N3612A | trans-Communic acid | 10178-32-2 | Natural Products |
| HY-N3613 | Conduritol A | 526-87-4 | Natural Products |
| HY-N3614 | Confluentic acid | 6009-12-7 | Natural Products |
| HY-N3615 | Confluentin | 585534-03-8 | Natural Products |
| HY-N3616 | trans-Coniferyl aldehyde | 20649-42-7 | Natural Products |
| HY-N3617 | Coniferin | 531-29-3 | Natural Products |
| HY-N3617R | Coniferin (Standard) | 531-29-3 | Reference Standards |
| HY-N3618 | Conopharyngine | 76-98-2 | Natural Products |
| HY-N3619 | Conophylline | 142741-24-0 | Natural Products |
| HY-N3620 | Epiquinamine | 464-86-8 | Natural Products |
| HY-N3621 | Corchoionol C | 189351-15-3 | Natural Products |
| HY-N3622 | Corchoionoside C | 185414-25-9 | Natural Products |
| HY-N3623 | Corianin | 35481-77-7 | Natural Products |
| HY-N3624 | Coriatin | 91653-75-7 | Natural Products |
| HY-N3625 | Coronalolic acid | 268214-52-4 | Natural Products |
| HY-N3626 | Coronalolide | 268214-51-3 | Natural Products |
| HY-N3627 | Coronalolide methyl este | 268214-50-2 | Natural Products |
| HY-N3628 | Coronarin A | 119188-33-9 | Natural Products |
| HY-N3629 | Coronarin B | 119188-38-4 | Natural Products |
| HY-N3630 | Coronarin D | 119188-37-3 | Natural Products |
| HY-N3631 | Ethoxycoronarin D | 138965-89-6 | Natural Products |
| HY-N3632 | Methoxycoronarin D | 157528-81-9 | Natural Products |
| HY-N3633 | Coronarin E | 117591-81-8 | Natural Products |
| HY-N3634 | Corylifol C | 775351-91-2 | Natural Products |
| HY-N3635 | Corymbol | 7047-54-3 | Natural Products |
| HY-N3636 | (-)-Corypalmine | 6018-40-2 | Natural Products |
| HY-N3637 | Cotoin | 479-21-0 | Natural Products |
| HY-N3638 | Coumurrayin | 17245-25-9 | Natural Products |
| HY-N3639 | Crassanine | 16790-92-4 | Natural Products |
| HY-N3640 | Crenatine | 26585-14-8 | Natural Products |
| HY-N3641 | Creticoside C | 53452-34-9 | Natural Products |
| HY-N3642 | Cristacarpin | 74515-47-2 | Natural Products |
| HY-N3643 | Cryptomeridiol | 4666-84-6 | Natural Products |
| HY-N3644 | Cryptomeridiol 11-rhamnoside | 349112-30-7 | Natural Products |
| HY-N3645 | Cucumegastigmane I | 929881-46-9 | Natural Products |
| HY-N3646 | Cudratricusxanthone A | 740810-42-8 | Natural Products |
| HY-N3647 | Cudraxanthone D | 96552-41-9 | Natural Products |
| HY-N3648 | Cudraxanthone L | 135541-40-1 | Natural Products |
| HY-N3649 | Cuniloside B | 1187303-40-7 | Natural Products |
| HY-N3651 | Curzerenone | 20493-56-5 | Natural Products |
| HY-N3652 | Cuspidiol | 51593-96-5 | Natural Products |
| HY-N3653 | C-Veratroylglycol | 168293-10-5 | Natural Products |
| HY-N3654 | Cyclo(l-Pro-d-Leu) | 36238-67-2 | Natural Products |
| HY-N3655 | Cyclo(D-Phe-L-Pro) | 26488-24-4 | Natural Products |
| HY-N3657 | Cycloart-23-ene-3β,25-diol | 14599-48-5 | Natural Products |
| HY-N3658 | Cycloart-25-ene-3β,24-diol | 10388-48-4 | Natural Products |
| HY-N3660 | (24S)-Cycloartane-3,24,25-triol 24,25-acetonide | 57576-31-5 | Natural Products |
| HY-N3661 | (24S)-Cycloartane-3β,24,25-triol | 57576-29-1 | Natural Products |
| HY-N3662 | Cycloartanol | 4657-58-3 | Natural Products |
| HY-N3664 | Cyclocerberidol | 126594-66-9 | Natural Products |
| HY-N3665 | Cyclocommunol | 145643-96-5 | Natural Products |
| HY-N3666 | Cycloeucalenol | 469-39-6 | Natural Products |
| HY-N3667 | Cycloheterophyllin | 36545-53-6 | Natural Products |
| HY-N3668 | Cyclomorusin | 62596-34-3 | Natural Products |
| HY-N3669 | Cyclomusalenone | 30452-60-9 | Natural Products |
| HY-N3670 | Cycloolivil | 3064-05-9 | Natural Products |
| HY-N3671 | Cycloshizukaol A | 150033-85-5 | Natural Products |
| HY-N3672 | Cynatratoside A | 97399-96-7 | Natural Products |
| HY-N3674 | Dalbergioidin | 30368-42-4 | Natural Products |
| HY-N3675 | Dammar-20(21)-en-3,24,25-triol | 55050-69-6 | Natural Products |
| HY-N3676 | Dammaradienyl acetate | 52914-31-5 | Natural Products |
| HY-N3677 | Dammarenediol II | 14351-29-2 | Natural Products |
| HY-N3678 | Dammarenediol II 3-O-caffeate | 171438-55-4 | Natural Products |
| HY-N3679 | Danshenol C | 910856-25-6 | Natural Products |
| HY-N3680 | Danshenxinkun A | 65907-75-7 | Natural Products |
| HY-N3681 | Daphmacropodine | 39729-21-0 | Natural Products |
| HY-N3682 | Daphnilongeranin A | 874201-05-5 | Natural Products |
| HY-N3683 | Daphnilongeranin C | 750649-07-1 | Natural Products |
| HY-N3684 | Daphnilongeridine | 922522-15-4 | Natural Products |
| HY-N3685 | Daphniyunnine A | 881388-87-0 | Natural Products |
| HY-N3686 | D-Arabitol | 488-82-4 | Natural Products |
| HY-N3686A | DL-Arabitol | 2152-56-9 | Biochemical Assay Reagents |
| HY-N3686R | D-Arabitol (Standard) | 488-82-4 | Reference Standards |
| HY-N3686S | D-Arabitol-13C | Isotope-Labeled Compounds | |
| HY-N3686S1 | D-Arabitol-13C-1 | Isotope-Labeled Compounds | |
| HY-N3686S2 | D-Arabitol-13C-2 | Isotope-Labeled Compounds | |
| HY-N3687 | Dasycarpol | 202343-57-5 | Natural Products |
| HY-N3688 | Daturabietatriene | 65894-41-9 | Natural Products |
| HY-N3689 | Daturametelin I | 904667-65-8 | Natural Products |
| HY-N3692 | Daurichromenic acid | 82003-90-5 | Natural Products |
| HY-N3693 | De-4′-O-methylyangambin | 149250-48-6 | Natural Products |
| HY-N3694 | Deacetylnimbin | 18609-16-0 | Natural Products |
| HY-N3695 | 6-Deacetylnimbinene | 912545-53-0 | Natural Products |
| HY-N3696 | Deacetylpseudolaric acid A | 82508-37-0 | Natural Products |
| HY-N3697 | Demethoxydeacetoxypseudolaric acid B | 82508-36-9 | Natural Products |
| HY-N3698 | Deacetylsalannin | 1110-56-1 | Natural Products |
| HY-N3699 | Deacetylxylopic acid | 6619-95-0 | Natural Products |
| HY-N3700 | Decarine | 54354-62-0 | Natural Products |
| HY-N3701 | Decursidate | 272122-56-2 | Natural Products |
| HY-N3702 | Dehydroabietinol | 3772-55-2 | Natural Products |
| HY-N3704 | Δ16-Dehydroadynerigenin β-D-digitaloside | 52628-62-3 | Natural Products |
| HY-N3705 | Dehydroadynerigenin glucosyldigitaloside | 144223-70-1 | Natural Products |
| HY-N3706 | Dehydro-α-lapachone | 15297-92-4 | Natural Products |
| HY-N3707 | Dehydroborapetoside B | 1221178-16-0 | Natural Products |
| HY-N3708 | Dehydrochromolaenin | 20013-76-7 | Natural Products |
| HY-N3709 | Dehydrocrebanine | 77784-22-6 | Natural Products |
| HY-N3710 | Dehydrocrenatidine | 65236-62-6 | Natural Products |
| HY-N3711 | Dehydrocrenatine | 26585-13-7 | Natural Products |
| HY-N3712 | Dehydrodeguelin | 3466-23-7 | Natural Products |
| HY-N3713 | Dehydro-δ-tocopherol | 802909-72-4 | Natural Products |
| HY-N3714 | Dehydroespeletone | 51995-99-4 | Natural Products |
| HY-N3715 | Dehydroformouregine | 107633-69-2 | Natural Products |
| HY-N3716 | Dehydroglyasperin D | 517885-72-2 | Natural Products |
| HY-N3717 | (7E)-7,8-Dehydroheliobuphthalmin | 103001-05-4 | Natural Products |
| HY-N3718 | 6a,12a-Dehydro-α-toxicarol | 59086-93-0 | Natural Products |
| HY-N3719 | δ-Amyrin acetate | 51361-60-5 | Natural Products |
| HY-N3720 | Demethoxycapillarisin | 61854-36-2 | Natural Products |
| HY-N3721 | Demethylcephalotaxinone | 51020-45-2 | Natural Products |
| HY-N3722 | O-Demethylmurrayanine | 123497-84-7 | Natural Products |
| HY-N3723 | Demethylsonchifolin | 956384-55-7 | Natural Products |
| HY-N3725 | Demethylvestitol | 65332-45-8 | Natural Products |
| HY-N3726 | Dendocarbin A | 350986-74-2 | Natural Products |
| HY-N3727 | Denudadione C | 61240-34-4 | Natural Products |
| HY-N3728 | Denudanolide A | 288259-72-3 | Natural Products |
| HY-N3729 | (-)-Denudatin B | 87402-88-8 | Natural Products |
| HY-N3730 | De-O-methylacetovanillochromene | 67667-62-3 | Natural Products |
| HY-N3732 | Daphlongamine H | 1147716-90-2 | Natural Products |
| HY-N3733 | Deoxylapachol | 3568-90-9 | Natural Products |
| HY-N3734 | Deoxyneocryptotanshinone | 27468-20-8 | Natural Products |
| HY-N3735 | Deoxyvasicinone | 530-53-0 | Natural Products |
| HY-N3736 | Derrisisoflavone B | 246870-75-7 | Natural Products |
| HY-N3737 | Derrone | 76166-59-1 | Natural Products |
| HY-N3738 | Demethoxycentaureidin | 22934-99-2 | Natural Products |
| HY-N3739 | Diacetonamine | 625-04-7 | Natural Products |
| HY-N3741 | Didrovaltrate | 18296-45-2 | Natural Products |
| HY-N3742 | Dihydroajugapitin | 87480-84-0 | Natural Products |
| HY-N3743 | Erythrivarone A | 63807-90-9 | Natural Products |
| HY-N3745 | (-)-(7R, 8S)-dihydrodehydrodiconiferyl alcohol | 126253-41-6 | Natural Products |
| HY-N3746 | Dihydroepistephamiersine 6-acetate | 57361-74-7 | Natural Products |
| HY-N3747 | Dihydromicromelin B | 94285-06-0 | Natural Products |
| HY-N3748 | Dihydromorin | 18422-83-8 | Natural Products |
| HY-N3749 | Dihydroniloticin | 115334-05-9 | Natural Products |
| HY-N3750 | Dihydroobovatin | 104055-79-0 | Natural Products |
| HY-N3751 | Dihydrooxoepistephamiersine | 51804-69-4 | Natural Products |
| HY-N3752 | Dihydroperaksine | 16100-84-8 | Natural Products |
| HY-N3753 | Dihydropinosylvin | 14531-52-3 | Natural Products |
| HY-N3754 | Dihydropinosylvin monomethyl ether | 17635-59-5 | Natural Products |
| HY-N3755 | Dihydroresveratrol | 58436-28-5 | Natural Products |
| HY-N3755R | Dihydroresveratrol (Standard) | 58436-28-5 | Reference Standards |
| HY-N3756 | Dihydroresveratrol 3-O-glucoside | 100432-87-9 | Natural Products |
| HY-N3757 | (+)-Dihydrorobinetin | 4382-33-6 | Natural Products |
| HY-N3758 | Dihydrosesamin | 83708-70-7 | Natural Products |
| HY-N3760 | Dimeric coniferyl acetate | 184046-40-0 | Natural Products |
| HY-N3761 | Dimethylmatairesinol | 25488-59-9 | Natural Products |
| HY-N3762 | Di-O-methylbergenin | 33815-57-5 | Natural Products |
| HY-N3763 | Di-O-methylcrenatin | 64121-98-8 | Natural Products |
| HY-N3764 | Diosbulbin C | 20086-07-1 | Natural Products |
| HY-N3765 | Diosbulbin D | 66756-57-8 | Natural Products |
| HY-N3766 | Diosbulbin G | 67567-15-1 | Natural Products |
| HY-N3767 | Diosbulbin J | 1187951-06-9 | Natural Products |
| HY-N3768 | Diosbulbin L | 1236285-87-2 | Natural Products |
| HY-N3769 | Dipterocarpol | 471-69-2 | Natural Products |
| HY-N3770 | (E)-Docosyl caffeate | 28593-92-2 | Natural Products |
| HY-N3771 | Dodonaflavonol | 1392213-93-2 | Natural Products |
| HY-N3772 | Dodonolide | 349534-73-2 | Natural Products |
| HY-N3773 | Dodoviscin A | 1372527-25-7 | Natural Products |
| HY-N3774 | Dodoviscin H | 1372527-39-3 | Natural Products |
| HY-N3775 | Dodoviscin I | 1372527-40-6 | Natural Products |
| HY-N3776 | Dorsmanin A | 162229-27-8 | Natural Products |
| HY-N3777 | Drahebenine | 1399049-43-4 | Natural Products |
| HY-N3778 | Dregeoside A11 | 89020-11-1 | Natural Products |
| HY-N3779 | Dregeoside Aa1 | 20230-41-5 | Natural Products |
| HY-N3780 | Dregeoside Da1 | 98665-65-7 | Natural Products |
| HY-N3781 | Dregeoside Ga1 | 98665-66-8 | Natural Products |
| HY-N3782 | Drevogenin A | 10163-83-4 | Natural Products |
| HY-N3783 | Drim-7-ene-11,12-diol acetonide | 213552-47-7 | Natural Products |
| HY-N3784 | Drimiopsin C | 773850-90-1 | Natural Products |
| HY-N3785 | Drimiopsin D | 773850-91-2 | Natural Products |
| HY-N3786 | Drupacine | 49686-57-9 | Natural Products |
| HY-N3787 | Ducheside A | 176665-78-4 | Natural Products |
| HY-N3788 | Dulcioic acid | 78516-69-5 | Natural Products |
| HY-N3789 | Dunnianol | 139726-29-7 | Natural Products |
| HY-N3790 | Durantoside I | 53526-67-3 | Natural Products |
| HY-N3791 | Durantoside II | 53526-66-2 | Natural Products |
| HY-N3792 | 20-Hydroxyecdysone 2,3:20,22-diacetonide | 22798-98-7 | Natural Products |
| HY-N3793 | Ecdysterone 20,22-monoacetonide | 22798-96-5 | Natural Products |
| HY-N3794 | Echinophyllin C | 310433-44-4 | Natural Products |
| HY-N3795 | Thiophene E | 64165-98-6 | Natural Products |
| HY-N3796 | Echinulin | 1859-87-6 | Natural Products |
| HY-N3797A | Echitamine (chloride) | 6878-36-0 | Natural Products |
| HY-N3798 | Effusanin A | 30220-43-0 | Natural Products |
| HY-N3799 | Ehretioside B | 156368-84-2 | Natural Products |
| HY-N3800 | Eichlerialactone | 2202-01-9 | Natural Products |
| HY-N3801 | Eichlerianic acid | 56421-13-7 | Natural Products |
| HY-N3802 | Eleutheroside C | 15486-24-5 | Natural Products |
| HY-N3803 | trans-Communol | 10178-31-1 | Natural Products |
| HY-N3804 | enantio-7(11)-Eudesmen-4-ol | 186374-63-0 | Natural Products |
| HY-N3805 | Encecalin | 20628-09-5 | Natural Products |
| HY-N3806 | Enniatin B | 917-13-5 | Natural Products |
| HY-N3807 | Enniatin B1 | 19914-20-6 | Natural Products |
| HY-N3808 | (4α,11β,15β)-11,15-Dihydroxykaur-16-en-19-oic acid | 57719-76-3 | Natural Products |
| HY-N3809 | ent-11,16-Epoxy-15-hydroxykauran-19-oic acid | 77658-46-9 | Natural Products |
| HY-N3810 | ent-11α-Hydroxy-15-oxokaur-16-en-19-oic acid | 57719-81-0 | Natural Products |
| HY-N3811 | ent-11β-Hydroxyatis-16-ene-3,14-dione | 1092103-22-4 | Natural Products |
| HY-N3812 | ent-14,16-Epoxy-8-pimarene-3,15-diol | 1188281-98-2 | Natural Products |
| HY-N3813 | ent-16α,17-Dihydroxyatisan-3-one | 112523-91-8 | Natural Products |
| HY-N3814 | ent-16β,17-Dihydroxykauran-19-oic acid | 3301-61-9 | Natural Products |
| HY-N3815 | ent-16-Kaurene-3b,15b,18-triol | 921211-29-2 | Natural Products |
| HY-N3816 | ent-17-Hydroxykaur-15-en-19-oic acid | 35030-38-7 | Natural Products |
| HY-N3817 | ent-3beta-Cinnamoyloxykaur-16-en-19-oic acid | 79406-10-3 | Natural Products |
| HY-N3818 | ent-3β-Hydroxykaur-16-en-19-oic acid | 66556-91-0 | Natural Products |
| HY-N3819 | ent-3Beta-Tigloyloxykaur-16-en-19-oic acid | 79406-09-0 | Natural Products |
| HY-N3820 | 3-Oxokauran-17-oic acid | 151561-88-5 | Natural Products |
| HY-N3821 | ent-7α,9-Dihydroxy-15-oxokaur-16-en-19,6β-olide | 59885-89-1 | Natural Products |
| HY-N3822 | ent-9-Hydroxy-15-oxo-16-kauren-19-oic acid | 77658-39-0 | Natural Products |
| HY-N3823 | ent-9-Hydroxy-15-oxo-19-kauranoic acid | 77658-45-8 | Natural Products |
| HY-N3824 | ent-Atisane-3β,16α,17-triol | 115783-44-3 | Natural Products |
| HY-N3825 | ent-Kaurane-3α,16β,17-triol | 130855-22-0 | Natural Products |
| HY-N3827 | Epicatechin pentaacetate | 20194-41-6 | Natural Products |
| HY-N3828 | epi-Eriocalyxin A | 191545-24-1 | Natural Products |
| HY-N3829 | epi-Eudesmol | 15051-81-7 | Natural Products |
| HY-N3830 | Epiguajadial B | 1411629-26-9 | Natural Products |
| HY-N3831 | Epimedokoreanin B | 161068-53-7 | Natural Products |
| HY-N3832 | Epinortrachelogenin | 125072-69-7 | Natural Products |
| HY-N3833 | Epipterosin L | 52611-75-3 | Natural Products |
| HY-N3834 | Epipterosin L 2'-O-glucoside | 61117-89-3 | Natural Products |
| HY-N3835 | trans-1,4-Dihydroxycyclohexaneacetic acid | 1310146-00-9 | Natural Products |
| HY-N3836 | Epistephamiersine | 52389-15-8 | Natural Products |
| HY-N3837 | Epitaraxerol | 20460-33-7 | Natural Products |
| HY-N3838 | Epitulipinolide diepoxide | 39815-40-2 | Natural Products |
| HY-N3839 | epi-Vogeloside | 118627-52-4 | Natural Products |
| HY-N3840 | Epoxyparvinolide | 102227-61-2 | Natural Products |
| HY-N3841 | ε-Viniferin | 62218-08-0 | Natural Products |
| HY-N3841A | δ-Viniferin | 681293-15-2 | Natural Products |
| HY-N3841R | ε-?Viniferin (Standard) | 62218-08-0 | Reference Standards |
| HY-N3842 | Ergosta-4,6,8(14),22-tetraen-3-one | 19254-69-4 | Natural Products |
| HY-N3844 | Ergosta-7,22-dien-3-one | 32507-77-0 | Natural Products |
| HY-N3845 | Ergosterol peroxide | 2061-64-5 | Natural Products |
| HY-N3846 | Ergosterol peroxide glucoside | 140447-22-9 | Natural Products |
| HY-N3847 | Eriodictyol-7-O-glucoside | 38965-51-4 | Natural Products |
| HY-N3848 | Ermanin | 20869-95-8 | Natural Products |
| HY-N3849 | Ervamycine | 27773-39-3 | Natural Products |
| HY-N3850 | Erysenegalensein E | 154992-17-3 | Natural Products |
| HY-N3851 | Erysotramidine | 52358-58-4 | Natural Products |
| HY-N3853 | Erysubin A | 221150-18-1 | Natural Products |
| HY-N3854 | Erysubin B | 221150-19-2 | Natural Products |
| HY-N3855 | Erythrabyssin II | 77263-06-0 | Natural Products |
| HY-N3856 | Erythrartine | 51666-26-3 | Natural Products |
| HY-N3857 | Erythrinin C | 63807-85-2 | Natural Products |
| HY-N3858 | Erythristemine | 28619-41-2 | Natural Products |
| HY-N3859 | Erythro-1-phenylpropane-1,2-diol | 40421-52-1 | Natural Products |
| HY-N3860 | Erythrocentauric acid | 90921-13-4 | Natural Products |
| HY-N3861 | Erythrocentaurin | 50276-98-7 | Natural Products |
| HY-N3862 | Erythrodiol 3-O-palmitate | 19833-13-7 | Natural Products |
| HY-N3863 | erythro-Guaiacylglycerol | 38916-91-5 | Natural Products |
| HY-N3864 | erythro-Guaiacylglycerol β-coniferyl ether | 890317-92-7 | Natural Products |
| HY-N3865 | Erythroxytriol P | 7121-99-5 | Natural Products |
| HY-N3866 | Esculentic acid | 103974-74-9 | Natural Products |
| HY-N3867 | Ethyl 2,4,6-trihydroxybenzoate | 90536-74-6 | Natural Products |
| HY-N3868 | Ethyl 2,4-dihydroxyphenylacetate | 67828-62-0 | Natural Products |
| HY-N3869 | Ethyl-p-methoxyhydrocinnamate | 22767-72-2 | Natural Products |
| HY-N3870 | Ethyl β-fructofuranoside | 1820-84-4 | Natural Products |
| HY-N3871 | Ethyl β-D-ribo-hexopyranosid-3-ulose | 104953-08-4 | Natural Products |
| HY-N3872 | Ethyl β-D-glucopyranoside | 3198-49-0 | Natural Products |
| HY-N3873 | Ethyl p-hydroxyphenyllactate | 62517-34-4 | Natural Products |
| HY-N3875 | Ethyllucidone | 1195233-59-0 | Natural Products |
| HY-N3876 | Eucalyptin | 3122-88-1 | Natural Products |
| HY-N3877 | Eucalyptone | 172617-99-1 | Natural Products |
| HY-N3878 | Eucamalol | 145544-91-8 | Natural Products |
| HY-N3879 | Eudesm-4(14)-ene-3α,11-diol | 113773-90-3 | Natural Products |
| HY-N3880 | Eugenol rutinoside | 138772-01-7 | Natural Products |
| HY-N3881 | Euphroside | 76994-07-5 | Natural Products |
| HY-N3882 | Eurycarpin A | 166547-20-2 | Natural Products |
| HY-N3883 | Euxanthone | 529-61-3 | Natural Products |
| HY-N3884 | Evodosin A | 1291053-38-7 | Natural Products |
| HY-N3885 | Evofolin B | 1961305-60-1 | Natural Products |
| HY-N3886 | Evofolin C | 163634-05-7 | Natural Products |
| HY-N3887 | Evoxine | 522-11-2 | Natural Products |
| HY-N3889 | Excisanin B | 78536-36-4 | Natural Products |
| HY-N3890 | Exoticin | 13364-94-8 | Natural Products |
| HY-N3891 | Fargesone A | 116424-69-2 | Natural Products |
| HY-N3892 | Fargesone B | 116424-70-5 | Natural Products |
| HY-N3893 | Farrerol 7-O-β-D-glucopyranoside | 885044-12-2 | Natural Products |
| HY-N3894 | Ferulamide | 61012-31-5 | Natural Products |
| HY-N3895 | Ficaprenol-11 | 26296-50-4 | Natural Products |
| HY-N3896 | Ficusin A | 173429-83-9 | Natural Products |
| HY-N3897 | Flavaprin | 53846-49-4 | Natural Products |
| HY-N3898 | Floribundone 1 | 118555-84-3 | Natural Products |
| HY-N3899 | Foliamenthic acid | 26187-80-4 | Natural Products |
| HY-N3900 | Tsugacetal | 101312-79-2 | Natural Products |
| HY-N3901 | Forrestin A (rabdosia) | 152175-76-3 | Natural Products |
| HY-N3902 | Forskolin G | 473981-11-2 | Natural Products |
| HY-N3903 | Forskolin J | 81873-08-7 | Natural Products |
| HY-N3904 | Fortuneine | 87340-25-8 | Natural Products |
| HY-N3905 | Fragransin A2 | 112652-46-7 | Natural Products |
| HY-N3906 | Fraxamoside | 326594-34-7 | Natural Products |
| HY-N3907 | Fraxidin | 525-21-3 | Natural Products |
| HY-N3908 | Fraxiresinol 1-O-glucoside | 89199-94-0 | Natural Products |
| HY-N3909 | Friedelinol | 5085-72-3 | Natural Products |
| HY-N3910 | Fuegin | 6750-10-3 | Natural Products |
| HY-N3911 | Fupenzic acid | 119725-20-1 | Natural Products |
| HY-N3912 | Furomollugin | 61658-41-1 | Natural Products |
| HY-N3913 | Furowanin A | 911004-72-3 | Natural Products |
| HY-N3914 | Futoenone | 19913-01-0 | Natural Products |
| HY-N3915 | Futoquinol | 28178-92-9 | Natural Products |
| HY-N3916 | Galanolactone | 115753-79-2 | Natural Products |
| HY-N3917 | γ-Diasarone | 80434-33-9 | Natural Products |
| HY-N3918 | γ-Fagarine | 524-15-2 | Natural Products |
| HY-N3919 | γ-Methoxyisoeugenol | 63644-71-3 | Natural Products |
| HY-N3920 | Gancaonin G | 126716-34-5 | Natural Products |
| HY-N3921 | Gancaonin I | 126716-36-7 | Natural Products |
| HY-N3922 | Gancaonin M | 129145-51-3 | Natural Products |
| HY-N3923 | Ganoderic acid S1 | 104759-35-5 | Natural Products |
| HY-N3924 | Ganoderiol F | 114567-47-4 | Natural Products |
| HY-N3925 | Ganoderol A | 104700-97-2 | Natural Products |
| HY-N3926 | Garbanzol | 1226-22-8 | Natural Products |
| HY-N3928 | Garciniaxanthone E | 173294-74-1 | Natural Products |
| HY-N3929 | Gardenine | 139682-36-3 | Natural Products |
| HY-N3931 | Gardneramine | 34274-91-4 | Natural Products |
| HY-N3932 | Garjasmin | 144868-43-9 | Natural Products |
| HY-N3933 | Gelomulide A | 122537-59-1 | Natural Products |
| HY-N3934 | Gelomulide B | 122537-60-4 | Natural Products |
| HY-N3935 | Gelomulide N | 1005212-02-1 | Natural Products |
| HY-N3936 | Gelomuloside A | 149998-38-9 | Natural Products |
| HY-N3937 | Gelomuloside B | 149998-39-0 | Natural Products |
| HY-N3938 | Gelsemiol | 110414-77-2 | Natural Products |
| HY-N3939 | Gelsempervine A | 865187-17-3 | Natural Products |
| HY-N3940 | Gelsevirine | 38990-03-3 | Natural Products |
| HY-N3942 | Glabranine | 41983-91-9 | Natural Products |
| HY-N3943 | Glabrene | 60008-03-9 | Natural Products |
| HY-N3944 | Glaucin B | 115458-73-6 | Natural Products |
| HY-N3945 | Glaucine | 475-81-0 | Natural Products |
| HY-N3945R | Glaucine (Standard) | 475-81-0 | Reference Standards |
| HY-N3946 | Glaucogenin C mono-D-thevetoside | 849201-84-9 | Natural Products |
| HY-N3947 | Glepidotin B | 87440-56-0 | Natural Products |
| HY-N3948 | Globularin | 1399-49-1 | Natural Products |
| HY-N3949 | Glochicoccin D | 927812-23-5 | Natural Products |
| HY-N3950 | Glochidiol | 6610-56-6 | Natural Products |
| HY-N3951 | Glochidone | 6610-55-5 | Natural Products |
| HY-N3952 | Glochidonol | 23963-54-4 | Natural Products |
| HY-N3953 | Glucosyringic acid | 33228-65-8 | Natural Products |
| HY-N3954 | Glutinyl acetate | 6426-44-4 | Natural Products |
| HY-N3955 | Alnusenone | 508-09-8 | Natural Products |
| HY-N3956 | Glyasperin A | 142474-52-0 | Natural Products |
| HY-N3957 | 1-(26-Hydroxyhexacosanoyl)-glycerol | 177602-14-1 | Natural Products |
| HY-N3958 | Glycosolone | 67879-81-6 | Natural Products |
| HY-N3959 | Glycozolinine | 5257-08-9 | Natural Products |
| HY-N3960 | Glycyrin | 66056-18-6 | Natural Products |
| HY-N3961 | Neoglycyrol | 23013-84-5 | Natural Products |
| HY-N3962 | Glycyrrhisoflavone | 116709-70-7 | Natural Products |
| HY-N3962R | Glycyrrhisoflavone (Standard) | 116709-70-7 | Reference Standards |
| HY-N3963 | Gomisin M2 | 82425-45-4 | Natural Products |
| HY-N3964 | Goniodiol | 96422-52-5 | Natural Products |
| HY-N3965 | Goniodiol 7-acetate | 96422-53-6 | Natural Products |
| HY-N3966 | Goniodiol 8-acetate | 144429-71-0 | Natural Products |
| HY-N3967 | Goniopypyrone | 129578-07-0 | Natural Products |
| HY-N3968 | Goniothalamin | 17303-67-2 | Natural Products |
| HY-N3969 | Goniotriol | 96405-62-8 | Natural Products |
| HY-N3970 | Gopherenediol | 916236-79-8 | Natural Products |
| HY-N3971 | Grandiflorenic acid | 22338-67-6 | Natural Products |
| HY-N3972 | Grandifloric acid | 22338-69-8 | Natural Products |
| HY-N3973 | Grandifloroside | 61186-24-1 | Natural Products |
| HY-N3974 | Griffipavixanthone | 219649-95-3 | Natural Products |
| HY-N3975 | Griffithazanone A | 240122-30-9 | Natural Products |
| HY-N3977 | Grifolic acid | 80557-12-6 | Natural Products |
| HY-N3978 | Griselinoside | 71035-06-8 | Natural Products |
| HY-N3979 | Grossamide | 80510-06-1 | Natural Products |
| HY-N3980 | Guaiol | 489-86-1 | Natural Products |
| HY-N3980R | Guaiol (Standard) | 489-86-1 | Reference Standards |
| HY-N3981 | Guajadial | 959860-49-2 | Natural Products |
| HY-N3982 | Guajadial B | 1414455-03-0 | Natural Products |
| HY-N3983 | Gynosaponin I | 1207861-69-5 | Natural Products |
| HY-N3984 | Gynuramide II | 295803-03-1 | Natural Products |
| HY-N3985 | Gyrophoric acid | 548-89-0 | Natural Products |
| HY-N3986 | Hainanmurpanin | 95360-22-8 | Natural Products |
| HY-N3987 | Hancinone C | 111843-10-8 | Natural Products |
| HY-N3988 | Hannokinol | 79120-40-4 | Natural Products |
| HY-N3989 | Haplopine | 5876-17-5 | Natural Products |
| HY-N3990 | Hardwickiic acid | 1782-65-6 | Natural Products |
| HY-N3991 | 14β-Benzoyloxy-2-deacetylbaccatin VI | 705973-69-9 | Natural Products |
| HY-N3994 | 16α,17α-Epoxyprogesterone | 1097-51-4 | Natural Products |
| HY-N3995 | 5β-Dihydrocortisol | 1482-50-4 | Natural Products |
| HY-N3995R | 5β-Dihydrocortisol (Standard) | 1482-50-4 | Reference Standards |
| HY-N3995S | 5β-Dihydrocortisol-d6 | Isotope-Labeled Compounds | |
| HY-N3997 | Nostosin G | 3033950-58-9 | Natural Products |
| HY-N3999 | Venuloside A | 1609278-97-8 | Natural Products |
| HY-N4000 | Digitonin | 11024-24-1 | Natural Products |
| HY-N4001 | Isoboonein acetate | 99891-77-7 | Natural Products |
| HY-N4002 | Isoboonein | 99946-04-0 | Natural Products |
| HY-N4003 | Isobonducellin | 610778-85-3 | Natural Products |
| HY-N4004 | Isoapetalic acid | 34366-34-2 | Natural Products |
| HY-N4005 | Isoastilbin | 54081-48-0 | Natural Products |
| HY-N4006 | Isoangustone A | 129280-34-8 | Natural Products |
| HY-N4008 | Iriflophenone 3-C-glucoside | 104669-02-5 | Natural Products |
| HY-N4008R | Iriflophenone 3-C-glucoside (Standard) | 104669-02-5 | Reference Standards |
| HY-N4009 | Iriflophenone 2-O-α-rhamnoside | 943989-68-2 | Natural Products |
| HY-N4010 | Iriflophenone | 52591-10-3 | Natural Products |
| HY-N4011 | Irenolone | 149184-19-0 | Natural Products |
| HY-N4013 | Imbricatoloic acid | 6832-60-6 | Natural Products |
| HY-N4014 | Ilicol | 72715-02-7 | Natural Products |
| HY-N4015 | Ilicic acid | 4586-68-9 | Natural Products |
| HY-N4016 | Ikshusterol 3-O-glucoside | 112137-81-2 | Natural Products |
| HY-N4017 | Ikshusterol | 34427-61-7 | Natural Products |
| HY-N4018 | Ifflaiamine | 31520-95-3 | Natural Products |
| HY-N4019 | Maohuoside A | 128988-55-6 | Natural Products |
| HY-N4020 | Icariside E5 | 126176-79-2 | Natural Products |
| HY-N4022 | Hyuganin D | 77331-76-1 | Natural Products |
| HY-N4023 | Hythiemoside A | 853267-91-1 | Natural Products |
| HY-N4024 | Hyptadienic acid | 128397-09-1 | Natural Products |
| HY-N4025 | (+)-Hydroxytuberosone | 95456-43-2 | Natural Products |
| HY-N4027 | Hydrangenol 8-O-glucoside | 67600-94-6 | Natural Products |
| HY-N4028 | Hydrangenol | 480-47-7 | Natural Products |
| HY-N4029 | Humulene oxide II | 19888-34-7 | Natural Products |
| HY-N4030 | Humantenmine | 82354-38-9 | Natural Products |
| HY-N4031 | Humantenine | 82375-29-9 | Natural Products |
| HY-N4032 | Humantenidine | 114027-39-3 | Natural Products |
| HY-N4033 | Horminone | 21887-01-4 | Natural Products |
| HY-N4034 | Hopane-3β,22-diol | 22149-65-1 | Natural Products |
| HY-N4035 | Hop-17(21)-en-3-ol | 564-14-7 | Natural Products |
| HY-N4036 | Honyucitrin | 114542-44-8 | Natural Products |
| HY-N4037 | Homopterocarpin | 606-91-7 | Natural Products |
| HY-N4040 | Homalomenol A | 145400-03-9 | Natural Products |
| HY-N4042 | Hirsutenone | 41137-87-5 | Natural Products |
| HY-N4043 | Hirsutanonol 5-O-β-D-glucopyranoside | 93915-36-7 | Natural Products |
| HY-N4044 | Hirsutanonol | 41137-86-4 | Natural Products |
| HY-N4045 | Hierochin D | 155759-02-7 | Natural Products |
| HY-N4046 | Hexacosyl (E)-ferulate | 63034-29-7 | Natural Products |
| HY-N4047 | Heveaflavone | 23132-13-0 | Natural Products |
| HY-N4048 | Heudelotinone | 133453-58-4 | Natural Products |
| HY-N4049 | Heteronoside | 852638-61-0 | Natural Products |
| HY-N4050 | Heraclenol acetonide | 64790-68-7 | Natural Products |
| HY-N4051 | 3"-O-β-D-Glucopyranosyl-(2"R)-heraclenol | 32207-10-6 | Natural Products |
| HY-N4052 | Heraclenol | 31575-93-6 | Natural Products |
| HY-N4052A | (±)-Heraclenol | 118407-74-2 | Natural Products |
| HY-N4053 | Heraclenin | 2880-49-1 | Natural Products |
| HY-N4054 | Henryoside | 72021-23-9 | Natural Products |
| HY-N4055 | Hennadiol | 20065-99-0 | Natural Products |
| HY-N4056 | Hemiphroside B | 165338-28-3 | Natural Products |
| HY-N4057 | Hemiphroside A | 165338-27-2 | Natural Products |
| HY-N4058 | Helichrysetin | 62014-87-3 | Natural Products |
| HY-N4058R | Helichrysetin (Standard) | 62014-87-3 | Reference Standards |
| HY-N4059 | Hedyotisol B | 95839-45-5 | Natural Products |
| HY-N4060 | Hedyotisol A | 95732-59-5 | Natural Products |
| HY-N4061 | Hedycoronen A | 1383441-73-3 | Natural Products |
| HY-N4062 | Hedychenone | 56324-54-0 | Natural Products |
| HY-N4063 | Hedragonic acid | 466-02-4 | Natural Products |
| HY-N4064 | Hederagonic acid | 466-01-3 | Natural Products |
| HY-N4065 | Hebeirubescensin H | 887333-30-4 | Natural Products |
| HY-N4066 | Hautriwaic acid | 18411-75-1 | Natural Products |
| HY-N4067 | Isochenodeoxycholic acid | 566-24-5 | Reference compound |
| HY-N4068 | Glucoraphanin | 21414-41-5 | Natural Products |
| HY-N4068R | Glucoraphanin (Standard) | 21414-41-5 | Reference Standards |
| HY-N4069 | Lupinalbin A | 98094-87-2 | Natural Products |
| HY-N4070 | 6"-O-Acetylgenistin | 73566-30-0 | Natural Products |
| HY-N4071 | 6"-O-Acetyldaidzin | 71385-83-6 | Natural Products |
| HY-N4072 | 6''-O-Acetylglycitin | 134859-96-4 | Natural Products |
| HY-N4073 | 6"-O-Malonyldaidzin | 124590-31-4 | Natural Products |
| HY-N4074 | 6"-O-Malonylglycitin | 137705-39-6 | Natural Products |
| HY-N4075 | O-Desmethylangolensin | 21255-69-6 | Natural Products |
| HY-N4075R | O-Desmethylangolensin (Standard) | 21255-69-6 | Reference Standards |
| HY-N4080 | Cyclobuxine D | 2241-90-9 | Natural Products |
| HY-N4081 | Dracorhodin | 643-56-1 | Natural Products |
| HY-N4082 | Neotriptophenolide | 81827-74-9 | Natural Products |
| HY-N4084 | Thonningianin A | 271579-11-4 | Natural Products |
| HY-N4085 | Vitexin 4'-glucoside | 38950-94-6 | Natural Products |
| HY-N4087 | Platycodin D2 | 66663-90-9 | Natural Products |
| HY-N4088 | Pseudolaric acid A-O-β-D-glucopyranoside | 98891-44-2 | Natural Products |
| HY-N4088R | Pseudolaric acid A-O-β-D-glucopyranoside (Standard) | 98891-44-2 | Reference Standards |
| HY-N4089 | Quercetin 3-gentiobioside | 7431-83-6 | Natural Products |
| HY-N4089R | Quercetin 3-gentiobioside (Standard) | 7431-83-6 | Reference Standards |
| HY-N4090 | Vicenin 3 | 59914-91-9 | Natural Products |
| HY-N4090R | Vicenin 3 (Standard) | 59914-91-9 | Reference Standards |
| HY-N4091 | Tinnevellin glucoside | 80358-06-1 | Natural Products |
| HY-N4092 | Shanziside | 29836-27-9 | Natural Products |
| HY-N4092R | Shanziside (Standard) | 29836-27-9 | Reference Standards |
| HY-N4093 | Astringin | 29884-49-9 | Natural Products |
| HY-N4093R | Astringin (Standard) | 29884-49-9 | Reference Standards |
| HY-N4094 | Morellic acid | 5304-71-2 | Natural Products |
| HY-N4094R | Morellic acid (Standard) | 5304-71-2 | Reference Standards |
| HY-N4095 | Brevifolincarboxylic acid | 18490-95-4 | Natural Products |
| HY-N4095R | Brevifolincarboxylic acid (Standard) | 18490-95-4 | Reference Standards |
| HY-N4096 | Tsugaric acid A | 174391-64-1 | Natural Products |
| HY-N4096R | Tsugaric acid A (Standard) | 174391-64-1 | Reference Standards |
| HY-N4097 | Incensole | 22419-74-5 | Natural Products |
| HY-N4097R | Incensole (Standard) | 22419-74-5 | Reference Standards |
| HY-N4098 | Incensole Acetate | 34701-53-6 | Natural Products |
| HY-N4098R | Incensole Acetate (Standard) | 34701-53-6 | Reference Standards |
| HY-N4099 | Luteolin-3-O-beta-D-glucuronide | 53527-42-7 | Natural Products |
| HY-N4099R | Luteolin-3-O-beta-D-glucuronide (Standard) | 53527-42-7 | Reference Standards |
| HY-N4100 | Trilobatin | 4192-90-9 | Natural Products |
| HY-N4100R | Trilobatin (Standard) | 4192-90-9 | Reference Standards |
| HY-N4101 | Styraxlignolide F | 823214-06-8 | Natural Products |
| HY-N4102 | 5,7-Dihydroxy-4-methylcoumarin | 2107-76-8 | Natural Products |
| HY-N4102R | 5,7-Dihydroxy-4-methylcoumarin (Standard) | 2107-76-8 | Reference Standards |
| HY-N4103 | Fucosterol | 17605-67-3 | Natural Products |
| HY-N4103A | Δ5-Avenasterol | 18472-36-1 | Natural Products |
| HY-N4103R | Fucosterol (Standard) | 17605-67-3 | Reference Standards |
| HY-N4104 | Agaric acid | 666-99-9 | Natural Products |
| HY-N4104R | Agaric acid (Standard) | 666-99-9 | Reference Standards |
| HY-N4106 | Dihydroartemisinic acid | 85031-59-0 | Natural Products |
| HY-N4107 | Phyllanthin | 10351-88-9 | Natural Products |
| HY-N4107R | Phyllanthin (Standard) | 10351-88-9 | Reference Standards |
| HY-N4108 | Hypophyllanthin | 33676-00-5 | Natural Products |
| HY-N4108R | Hypophyllanthin (Standard) | 33676-00-5 | Reference Standards |
| HY-N4109 | Decursinol | 23458-02-8 | Natural Products |
| HY-N4109R | Decursinol (Standard) | 23458-02-8 | Reference Standards |
| HY-N4110 | Friedelin | 559-74-0 | Natural Products |
| HY-N4110R | Friedelin (Standard) | 559-74-0 | Reference Standards |
| HY-N4111 | Wushanicaritin | 521-45-9 | Natural Products |
| HY-N4112 | L-Fucitol | 13074-06-1 | Natural Products |
| HY-N4113 | Glycycoumarin | 94805-82-0 | Natural Products |
| HY-N4113R | Glycycoumarin (Standard) | 94805-82-0 | Reference Standards |
| HY-N4114 | Picrocrocin | 138-55-6 | Natural Products |
| HY-N4114R | Picrocrocin (Standard) | 138-55-6 | Reference Standards |
| HY-N4115 | Syrosingopine | 84-36-6 | Reference compound |
| HY-N4116 | Xanthyletin | 553-19-5 | Natural Products |
| HY-N4117 | Hamamelitannin | 469-32-9 | Natural Products |
| HY-N4118 | Cephaeline | 483-17-0 | Natural Products |
| HY-N4119 | Neoeriocitrin | 13241-32-2 | Natural Products |
| HY-N4119R | Neoeriocitrin (Standard) | 13241-32-2 | Reference Standards |
| HY-N4121 | Isocurcumenol | 24063-71-6 | Natural Products |
| HY-N4122 | Neodiosmin | 38665-01-9 | Natural Products |
| HY-N4122R | Neodiosmin (Standard) | 38665-01-9 | Reference Standards |
| HY-N4123 | Orcinol gentiobioside | 164991-86-0 | Natural Products |
| HY-N4124 | Poricoic acid B | 137551-39-4 | Natural Products |
| HY-N4125 | Dehydroeburicoic acid monoacetate | 77035-42-8 | Natural Products |
| HY-N4126 | 6-Demethoxytangeretin | 6601-66-7 | Natural Products |
| HY-N4127 | 3'-Demethylnobiletin | 112448-39-2 | Natural Products |
| HY-N4128 | 4''-methyloxy-Daidzin | 1195968-02-5 | Natural Products |
| HY-N4129 | 4''-methyloxy-Genistin | 950910-16-4 | Natural Products |
| HY-N4130 | 25S-Inokosterone | 19595-18-7 | Natural Products |
| HY-N4131 | 25R-Inokosterone | 19682-38-3 | Natural Products |
| HY-N4132 | 17-Hydroxyisolathyrol | 93551-00-9 | Natural Products |
| HY-N4133 | Ciwujianoside A1 | 120768-65-2 | Reference compound |
| HY-N4134 | Ciwujianoside C3 | 114906-74-0 | Natural Products |
| HY-N4135 | Acanthopanaxoside B | 915792-03-9 | Natural Products |
| HY-N4136 | Lonicerin | 25694-72-8 | Natural Products |
| HY-N4136R | Lonicerin (Standard) | 25694-72-8 | Reference Standards |
| HY-N4137 | Tormentic acid | 13850-16-3 | Natural Products |
| HY-N4137R | Tormentic acid (Standard) | 13850-16-3 | Reference Standards |
| HY-N4139 | Protohypericin | 548-03-8 | Natural Products |
| HY-N4142 | Cyanidin-3-O-galactoside (chloride) | 27661-36-5 | Natural Products |
| HY-N4142R | Cyanidin-3-O-galactoside (chloride) (Standard) | 27661-36-5 | Reference Standards |
| HY-N4143 | Cyanidin 3-arabinoside | 27214-72-8 | Natural Products |
| HY-N4144 | Cyanidin 3-xyloside | 29761-24-8 | Natural Products |
| HY-N4146 | Proanthocyanidin A4 | 111466-29-6 | Natural Products |
| HY-N4146R | Proanthocyanidin A4 (Standard) | 111466-29-6 | Reference Standards |
| HY-N4147 | Eleutheroside D | 79484-75-6 | Natural Products |
| HY-N4148 | Purpureaside C | 108648-07-3 | Natural Products |
| HY-N4149 | Quercetagetin | 90-18-6 | Natural Products |
| HY-N4149R | Quercetagetin (Standard) | 90-18-6 | Reference Standards |
| HY-N4150 | Quercetagitrin | 548-75-4 | Natural Products |
| HY-N4150R | Quercetagitrin (Standard) | 548-75-4 | Reference Standards |
| HY-N4151 | Chrysophanein | 4839-60-5 | Natural Products |
| HY-N4153 | 1-Methyl-2, 8-dihydroxy3-carboxy-9, 10-anthraquinone | 1401414-53-6 | Natural Products |
| HY-N4155 | 2α,19α-Dihydroxy-3-oxo-urs-12-en-28-oic acid | 176983-21-4 | Natural Products |
| HY-N4156 | Pteropodine | 5629-60-7 | Natural Products |
| HY-N4157 | Isopteropodine | 5171-37-9 | Natural Products |
| HY-N4157R | Isopteropodine (Standard) | 5171-37-9 | Reference Standards |
| HY-N4160 | Aflavazole | 2043963-70-6 | Natural Products |
| HY-N4161 | Euparin | 532-48-9 | Natural Products |
| HY-N4162 | 3-Oxo-21α-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone | 1260173-73-6 | Natural Products |
| HY-N4163 | Acoforestinine | 110011-77-3 | Natural Products |
| HY-N4164 | Schinifoline | 80554-58-1 | Natural Products |
| HY-N4165 | Arnidiol | 6750-30-7 | Natural Products |
| HY-N4167 | 3-O-Methylgalangin | 6665-74-3 | Natural Products |
| HY-N4168 | 3-O-Caffeoylquinic acid methyl ester | 123483-19-2 | Natural Products |
| HY-N4168A | Neochlorogenic acid methyl ester | 123410-65-1 | Natural Products |
| HY-N4168B | Methyl chlorogenate | 29708-87-0 | Natural Products |
| HY-N4169 | Trametenolic acid | 24160-36-9 | Natural Products |
| HY-N4170 | Chebulic acid | 23725-05-5 | Natural Products |
| HY-N4171 | Dihydrocucurbitacin B | 13201-14-4 | Natural Products |
| HY-N4172 | Tectorigenin 7-O-Xylosyl Glucoside | 231288-19-0 | Natural Products |
| HY-N4173 | 8-Oxoepiberberine | 19716-60-0 | Reference compound |
| HY-N4173R | 8-Oxoepiberberine (Standard) | 19716-60-0 | Reference Standards |
| HY-N4174 | Raddeanoside 20 | 335354-79-5 | Natural Products |
| HY-N4175 | Cucurbitacin A | 6040-19-3 | Natural Products |
| HY-N4176 | Ginkgolide K | 153355-70-5 | Natural Products |
| HY-N4177 | Rubrofusarin gentiobioside | 24577-90-0 | Natural Products |
| HY-N4178 | Isopropylidenylacetyl-marmesin | 35178-20-2 | Natural Products |
| HY-N4179 | Aurantio-obtusin β-D-glucoside | 129025-96-3 | Natural Products |
| HY-N4180 | Pennogenin 3-O-beta-chacotrioside | 55916-52-4 | Natural Products |
| HY-N4181 | Kanzonol C | 151135-82-9 | Natural Products |
| HY-N4182 | Licochalcone E | 864232-34-8 | Natural Products |
| HY-N4183 | Licoflavone C | 72357-31-4 | Natural Products |
| HY-N4184 | Licoflavone B | 91433-17-9 | Natural Products |
| HY-N4185 | Licoflavone A | 61153-77-3 | Natural Products |
| HY-N4186 | Glabrolide | 10401-33-9 | Natural Products |
| HY-N4187 | Licochalcone D | 144506-15-0 | Natural Products |
| HY-N4188 | N-Benzyloctadecanamide | 5327-45-7 | Natural Products |
| HY-N4189 | Isocucurbitacin B | 17278-28-3 | Natural Products |
| HY-N4190 | Britannilactone diacetate | 1286694-67-4 | Natural Products |
| HY-N4191 | Isorosmanol | 93780-80-4 | Natural Products |
| HY-N4192 | Toringin | 1329-10-8 | Natural Products |
| HY-N4193 | Glabrol | 59870-65-4 | Natural Products |
| HY-N4194 | Glabrone | 60008-02-8 | Natural Products |
| HY-N4195 | Resveratroloside | 38963-95-0 | Natural Products |
| HY-N4196 | 4-(4'-Hydroxyphenyl)-2-butanone4'-O-β-D-(2''-O-galloyl-6''-O-p-coumaroyl)glucopyranoside | 105274-16-6 | Natural Products |
| HY-N4198 | 1'''-O-β-D-Glucopyranosylformoside | 148245-77-6 | Natural Products |
| HY-N4200 | S-Dihydrodaidzein | 879559-75-8 | Natural Products |
| HY-N4201 | β-Hydroxyisovalerylshikonin | 7415-78-3 | Natural Products |
| HY-N4202 | Dihydrorotenone | 6659-45-6 | Natural Products |
| HY-N4203 | Isopropyl ferulate | 59831-94-6 | Natural Products |
| HY-N4204 | Daidzein diacetate | 3682-01-7 | Reference compound |
| HY-N4205 | Tetrahydropiperine | 23434-88-0 | Natural Products |
| HY-N4205R | Tetrahydropiperine (Standard) | 23434-88-0 | Reference Standards |
| HY-N4206 | Leptomerine | 22048-97-1 | Natural Products |
| HY-N4207 | Cnidicin | 14348-21-1 | Natural Products |
| HY-N4207R | Cnidicin (Standard) | 14348-21-1 | Reference Standards |
| HY-N4208 | Taccalonolide AJ | 2230777-09-8 | Reference compound |
| HY-N4209 | 3α-Dihydrocadambine | 54483-84-0 | Natural Products |
| HY-N4210 | Yadanziolide A | 95258-14-3 | Natural Products |
| HY-N4211 | Saikosaponin E | 64340-44-9 | Natural Products |
| HY-N4212 | Astraganoside | 1011711-05-9 | Natural Products |
| HY-N4213 | Anemarrhenasaponin I | 163047-21-0 | Natural Products |
| HY-N4214 | Isoastragaloside IV | 136033-55-1 | Natural Products |
| HY-N4215 | 11(α)-Methoxysaikosaponin F | 104109-37-7 | Natural Products |
| HY-N4216 | Saikosaponin G | 99365-19-2 | Natural Products |
| HY-N4217 | Saikosaponin I | 103629-71-6 | Natural Products |
| HY-N4218 | Saikosaponin B4 | 58558-09-1 | Natural Products |
| HY-N4219 | Saikosaponin B3 | 58316-42-0 | Natural Products |
| HY-N4220 | Cistanoside F | 97411-47-7 | Natural Products |
| HY-N4221 | 6'-O-Cinnamoyl harpagide | 1245572-24-0 | Natural Products |
| HY-N4222 | Acetyl Perisesaccharide C | 110764-09-5 | Natural Products |
| HY-N4223 | Sibirioside A | 173046-19-0 | Natural Products |
| HY-N4224 | Neoastragaloside I | 1324005-51-7 | Natural Products |
| HY-N4225 | Aaptamine | 85547-22-4 | Natural Products |
| HY-N4226 | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | 3719-45-7 | Natural Products |
| HY-N4226R | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid (Standard) | 3719-45-7 | Reference Standards |
| HY-N4227 | Conicasterol | 76758-18-4 | Natural Products |
| HY-N4229 | Clematomandshurica saponin C | 916649-92-8 | Natural Products |
| HY-N4230 | Clematomandshurica saponin B | 916649-91-7 | Natural Products |
| HY-N4231 | Lucyoside B | 91174-19-5 | Natural Products |
| HY-N4232 | Clematichinenoside AR | 761425-93-8 | Natural Products |
| HY-N4233 | Bisabolangelone | 30557-81-4 | Natural Products |
| HY-N4234 | Angelol K | 169736-93-0 | Natural Products |
| HY-N4235 | Angelol B | 83156-04-1 | Natural Products |
| HY-N4236 | Angelol A | 19625-17-3 | Natural Products |
| HY-N4237 | Saikogenin D | 5573-16-0 | Natural Products |
| HY-N4238 | Dehydrocorydaline (nitrate) | 13005-09-9 | Natural Products |
| HY-N4240 | Dihydropalmatine | 26067-60-7 | Natural Products |
| HY-N4241 | Kauran-18-oic acid, 16,17,19-trihydroxy-, (4α)- | 308821-59-2 | Natural Products |
| HY-N4243 | Neocurdione | 108944-67-8 | Natural Products |
| HY-N4244 | Kakkalide | 58274-56-9 | Natural Products |
| HY-N4245 | Siegesmethyletheric acid | 196399-16-3 | Natural Products |
| HY-N4246 | Bacopaside I | 382148-47-2 | Natural Products |
| HY-N4246R | Bacopaside I (Standard) | 382148-47-2 | Reference Standards |
| HY-N4247 | Kuwanon G | 75629-19-5 | Natural Products |
| HY-N4247R | Kuwanon G (Standard) | 75629-19-5 | Reference Standards |
| HY-N4248 | Perisesaccharide C | 1311473-28-5 | Natural Products |
| HY-N4249 | Perisesaccharide B | 1095261-93-0 | Natural Products |
| HY-N4250 | Periplocoside N | 39946-41-3 | Natural Products |
| HY-N4251 | Periplocoside M | 116782-73-1 | Natural Products |
| HY-N4252 | Periplocymarin | 32476-67-8 | Natural Products |
| HY-N4253 | Kudinoside D | 173792-61-5 | Natural Products |
| HY-N4255 | Resibufagin | 20987-24-0 | Natural Products |
| HY-N4257 | Yadanzioside A | 95258-15-4 | Natural Products |
| HY-N4258 | Panasenoside | 31512-06-8 | Natural Products |
| HY-N4259 | Ginsenoside Ra3 | 90985-77-6 | Natural Products |
| HY-N4260 | Ginsenoside Ra2 | 83459-42-1 | Natural Products |
| HY-N4261 | Dehydronuciferine | 7630-74-2 | Natural Products |
| HY-N4262 | Ginsenoside Rh7 | 343780-68-7 | Natural Products |
| HY-N4263 | 5,6-Didehydroginsenoside Rd | 1268459-68-2 | Natural Products |
| HY-N4264 | Vinaginsenoside R3 | 156012-92-9 | Natural Products |
| HY-N4265 | Vinaginsenoside R4 | 156009-80-2 | Natural Products |
| HY-N4266 | Vinaginsenoside R8 | 156042-22-7 | Natural Products |
| HY-N4267 | Yangambin | 13060-14-5 | Natural Products |
| HY-N4268 | Tenuifoliside B | 139726-36-6 | Natural Products |
| HY-N4269 | Sargentol | 623928-18-7 | Natural Products |
| HY-N4270 | Pseudoprotogracillin | 637349-03-2 | Natural Products |
| HY-N4271 | Protogracillin | 54848-30-5 | Natural Products |
| HY-N4272 | Protodeltonin | 94992-08-2 | Natural Products |
| HY-N4273 | Oxyimperatorin | 35740-18-2 | Natural Products |
| HY-N4273R | Oxyimperatorin (Standard) | 35740-18-2 | Reference Standards |
| HY-N4274 | Ophiopogonoside A | 791849-22-4 | Natural Products |
| HY-N4275 | Oleaside A | 69686-84-6 | Natural Products |
| HY-N4276 | Nortracheloside | 33464-78-7 | Natural Products |
| HY-N4277 | Methyl protogracillin | 54522-53-1 | Natural Products |
| HY-N4278 | Huangjiangsu A | 1026020-27-8 | Reference compound |
| HY-N4279 | Gentisin | 437-50-3 | Natural Products |
| HY-N4280 | 7,8-Dimethoxycoumarin | 2445-80-9 | Natural Products |
| HY-N4282 | 8-Hydroxy-7-methoxycoumarin | 19492-03-6 | Natural Products |
| HY-N4283 | Coniferyl alcohol | 458-35-5 | Natural Products |
| HY-N4283A | (E)-Coniferyl alcohol | 32811-40-8 | Natural Products |
| HY-N4284 | Angelicolide | 90826-58-7 | Natural Products |
| HY-N4285 | Negletein | 29550-13-8 | Natural Products |
| HY-N4286 | 4-Methyldaphnetin | 2107-77-9 | Natural Products |
| HY-N4287 | Nordalbergin | 482-82-6 | Natural Products |
| HY-N4288 | 4-Methylesculetin | 529-84-0 | Natural Products |
| HY-N4289 | 3-Epiursolic Acid | 989-30-0 | Natural Products |
| HY-N4289R | 3-Epiursolic Acid (Standard) | 989-30-0 | Reference Standards |
| HY-N4290 | 3-Epioleanolic acid | 25499-90-5 | Natural Products |
| HY-N4291 | 1,7-Dihydroxy-2,3-methylenedioxyxanthone | 183210-63-1 | Natural Products |
| HY-N4292 | 3,8-Dihydroxy-2,4,6-trimethoxyxanthone | 65008-17-5 | Natural Products |
| HY-N4293 | 1,2,3,7-Tetramethoxyxanthone | 22804-52-0 | Natural Products |
| HY-N4294 | Arjungenin | 58880-25-4 | Natural Products |
| HY-N4294R | Arjungenin (Standard) | 58880-25-4 | Reference Standards |
| HY-N4295 | Bacopaside V | 620592-16-7 | Natural Products |
| HY-N4296 | Isosakuranin | 491-69-0 | Natural Products |
| HY-N4297 | Baicalin methyl ester | 82475-03-4 | Natural Products |
| HY-N4298 | Epitheaflagallin 3-O-gallate | 102067-92-5 | Natural Products |
| HY-N4299 | Caesappanin C | 1913319-59-1 | Natural Products |
| HY-N4300 | 4'-O-Methylochnaflavone | 49619-87-6 | Natural Products |
| HY-N4301 | Monensin B | 30485-16-6 | Natural Products |
| HY-N4302 | Monensin | 17090-79-8 | Natural Products |
| HY-N4303 | 5-Ethoxy-10-Gingerol | 121771-98-0 | Reference compound |
| HY-N4304 | Gambogellic acid | 173867-04-4 | Natural Products |
| HY-N4305 | Notoginsenoside FP2 | 1004988-75-3 | Natural Products |
| HY-N4306 | Sarracenin | 59653-37-1 | Natural Products |
| HY-N4307 | Laetanine | 72361-67-2 | Natural Products |
| HY-N4308 | Hexamethylquercetagetin | 1251-84-9 | Natural Products |
| HY-N4309 | Lotusine | 6871-67-6 | Natural Products |
| HY-N4309A | Lotusine (hydroxide) | 3721-76-4 | Natural Products |
| HY-N4310 | Taxifolin 7-O-rhamnoside | 137592-12-2 | Natural Products |
| HY-N4311 | 2,3,4,5-Tetracaffeoyl-D-Glucaric acid | 1419478-52-6 | Natural Products |
| HY-N4312 | Bryodulcosigenin | 88930-16-9 | Natural Products |
| HY-N4313 | Eriosematin | 168010-17-1 | Natural Products |
| HY-N4314 | Scutellarein tetramethyl ether | 1168-42-9 | Natural Products |
| HY-N4314R | Scutellarein tetramethyl ether (Standard) | 1168-42-9 | Reference Standards |
| HY-N4315 | Pomiferin | 572-03-2 | Natural Products |
| HY-N4316 | Flemiphilippinin A | 140366-64-9 | Natural Products |
| HY-N4317 | Ethoxysanguinarine | 28342-31-6 | Natural Products |
| HY-N4318 | Graveobioside A | 506410-53-3 | Natural Products |
| HY-N4319 | Jasminoside B | 214125-04-9 | Natural Products |
| HY-N4320 | 3-Feruloyl-1-Sinapoyl sucrose | 98942-06-4 | Natural Products |
| HY-N4321 | Glucotropaeolin (potassium) | 5115-71-9 | Natural Products |
| HY-N4321R | Glucotropaeolin (potassium) (Standard) | 5115-71-9 | Reference Standards |
| HY-N4322 | Decursinol angelate | 130848-06-5 | Natural Products |
| HY-N4322R | Decursinol angelate (Standard) | 130848-06-5 | Reference Standards |
| HY-N4323 | 14-Deoxyandrographolide | 4176-97-0 | Natural Products |
| HY-N4323R | 14-Deoxyandrographolide (Standard) | 4176-97-0 | Reference Standards |
| HY-N4324 | cis-p-Menthan-1,8-diol | 565-48-0 | Natural Products |
| HY-N4325 | Onjisaponin Z | 1078708-72-1 | Natural Products |
| HY-N4326 | 14,15 β-Dihydroxyklaineanone | 137359-82-1 | Natural Products |
| HY-N4327 | Eurycomalactone | 23062-24-0 | Natural Products |
| HY-N4328 | Pasakbumin B | 138809-10-6 | Natural Products |
| HY-N4330 | Rivulariapeptolides 1155 | Natural Products | |
| HY-N4331 | Rivulariapeptolides 1185 | Natural Products | |
| HY-N4332 | Rivulariapeptolides 1121 | Natural Products | |
| HY-N4333 | Rivulariapeptolides 988 | Natural Products | |
| HY-N5001 | Euphorbia Factor L2 | 218916-51-9 | Natural Products |
| HY-N5002 | (+)-Viroallosecurinine | 1857-30-3 | Natural Products |
| HY-N5005 | Guanfu base H | 4758-99-0 | Natural Products |
| HY-N5006 | Guanfu base G | 78969-72-9 | Natural Products |
| HY-N5007 | Galgravin | 528-63-2 | Natural Products |
| HY-N5008 | Macranthoside B | 146100-02-9 | Natural Products |
| HY-N5009 | Thermopsine | 486-90-8 | Natural Products |
| HY-N5010 | Nepitrin | 569-90-4 | Natural Products |
| HY-N5010R | Nepitrin (Standard) | 569-90-4 | Reference Standards |
| HY-N5011 | 5,7-Dimethoxyflavone | 21392-57-4 | Natural Products |
| HY-N5011R | 5,7-Dimethoxyflavone (Standard) | 21392-57-4 | Reference Standards |
| HY-N5012 | Eurycomanone | 84633-29-4 | Natural Products |
| HY-N5012R | Eurycomanone (Standard) | 84633-29-4 | Reference Standards |
| HY-N5013 | Robustaflavone | 49620-13-5 | Natural Products |
| HY-N5014 | Liensinine (perchlorate) | 2385-63-9 | Natural Products |
| HY-N5015 | Rosmanol | 80225-53-2 | Natural Products |
| HY-N5015R | Rosmanol (Standard) | 80225-53-2 | Reference Standards |
| HY-N5016 | Guvacoline (hydrochloride) | 6197-39-3 | Natural Products |
| HY-N5018 | Nepodin | 3785-24-8 | Natural Products |
| HY-N5018R | Nepodin (Standard) | 3785-24-8 | Reference Standards |
| HY-N5019 | Notoginsenoside S | 575446-95-6 | Natural Products |
| HY-N5020 | Carabrone | 1748-81-8 | Natural Products |
| HY-N5021 | Anhydrosafflor yellow B | 184840-84-4 | Natural Products |
| HY-N5022 | Evolitrine | 523-66-0 | Natural Products |
| HY-N5023 | Veraguensin | 19950-55-1 | Natural Products |
| HY-N5024 | Gambogenic acid | 173932-75-7 | Natural Products |
| HY-N5025 | Bullatine A | 1354-84-3 | Natural Products |
| HY-N5027 | Oxyberberine | 549-21-3 | Natural Products |
| HY-N5028 | Enmein | 3776-39-4 | Natural Products |
| HY-N5029 | Isofebrifugine | 32434-44-9 | Natural Products |
| HY-N5030 | 8-Hydroxy-3,5,6,7,3',4'-hexamethoxyflavone | 1000415-56-4 | Natural Products |
| HY-N5031 | Mulberrofuran Q | 101383-35-1 | Natural Products |
| HY-N5032 | 7Z-Trifostigmanoside I | 1018898-17-3 | Natural Products |
| HY-N5033 | 17-Hydroxy sprengerinin C | 1029017-75-1 | Natural Products |
| HY-N5034 | Phosphorylethanolamine | 1071-23-4 | Natural Products |
| HY-N5034R | Phosphorylethanolamine (Standard) | 1071-23-4 | Reference Standards |
| HY-N5034S | Phosphorylethanolamine-d4 | 1169692-38-9 | Isotope-Labeled Compounds |
| HY-N5035 | Moscatin | 108335-06-4 | Natural Products |
| HY-N5036 | Ilexsaponin B3 | 109008-26-6 | Natural Products |
| HY-N5037 | Ilexoside D | 109008-27-7 | Natural Products |
| HY-N5038 | Mauritianin | 109008-28-8 | Natural Products |
| HY-N5039 | 1,2-O-Dilinoleoyl-3-O-Beta-D-Galactopyranosylracglycerol | 111187-15-6 | Natural Products |
| HY-N5040 | Ilexhainanoside D | 1137648-52-2 | Natural Products |
| HY-N5041 | 9'''-Methyl salvianolate B | 1167424-32-9 | Natural Products |
| HY-N5042 | Forsythoside I | 1177581-50-8 | Natural Products |
| HY-N5043 | Forsythoside H | 1178974-85-0 | Natural Products |
| HY-N5045 | Jionoside A1 | 120444-60-2 | Natural Products |
| HY-N5046 | 27-O-Acetyl-withaferin A | 1214886-35-7 | Natural Products |
| HY-N5047 | Orientin-2''-O-p-trans-coumarate | 1229437-75-5 | Natural Products |
| HY-N5048 | Galloylpaeoniflorin | 122965-41-7 | Natural Products |
| HY-N5049 | Alcesefoliside | 124151-38-8 | Natural Products |
| HY-N5050 | OJV-VI | 125150-67-6 | Natural Products |
| HY-N5051 | 25(S)-Ruscogenin-1-O-α-L-rhamnopyranosyl (1→2)-β-D-xylopyranoside | 125225-63-0 | Natural Products |
| HY-N5052 | Asiaticoside B | 125265-68-1 | Natural Products |
| HY-N5052R | Asiaticoside B (Standard) | 125265-68-1 | Reference Standards |
| HY-N5053 | Periplogenin 3-[O-β-glucopyranosyl-(1→4)-β-sarmentopyranoside] | 1253421-94-1 | Natural Products |
| HY-N5054 | (R)-5,7-Dimethoxyflavanone | 1277188-85-8 | Natural Products |
| HY-N5055 | Saponin C, from Liriope muscari | 130551-41-6 | Natural Products |
| HY-N5055R | Saponin C, from Liriope muscari (Standard) | 130551-41-6 | Reference Standards |
| HY-N5056 | DL-Goitrin | 13190-34-6 | Natural Products |
| HY-N5056R | DL-Goitrin (Standard) | 13190-34-6 | Reference Standards |
| HY-N5057 | Przewalskinic acid A | 136112-75-9 | Natural Products |
| HY-N5058 | Dehydroeffusol | 137319-34-7 | Natural Products |
| HY-N5059 | Monnieriside G | 1401799-34-5 | Natural Products |
| HY-N5060 | Estragole | 140-67-0 | Natural Products |
| HY-N5060R | Estragole (Standard) | 140-67-0 | Reference Standards |
| HY-N5060S | Estragole-d4 | 1335401-40-5 | Isotope-Labeled Compounds |
| HY-N5061 | Rotundatin | 144506-16-1 | Natural Products |
| HY-N5062 | 7,22,25-Stigmastatrienol | 14485-48-4 | Natural Products |
| HY-N5063 | Plantainoside D | 147331-98-4 | Natural Products |
| HY-N5064 | Bacoside A3 | 157408-08-7 | Natural Products |
| HY-N5064R | Bacoside A3 (Standard) | 157408-08-7 | Reference Standards |
| HY-N5065 | Gentiournoside D | 157722-21-9 | Natural Products |
| HY-N5067 | Rhodiocyanoside A | 168433-86-1 | Natural Products |
| HY-N5068 | Isorhamnetin 7-O-α-L-rhamnoside | 17331-72-5 | Natural Products |
| HY-N5069 | 2,3-Didehydrosomnifericin | 173614-88-5 | Natural Products |
| HY-N5070 | Depressine | 176182-06-2 | Natural Products |
| HY-N5071 | Clematichinenoside C | 177912-24-2 | Natural Products |
| HY-N5072 | Desmethylglycitein | 17817-31-1 | Natural Products |
| HY-N5073 | Vitexin-4''-O-glucoside | 178468-00-3 | Natural Products |
| HY-N5074 | Terrestrosin D | 179464-23-4 | Natural Products |
| HY-N5075 | Quercetin 3-O-glucoside-7-O-rhamnoside | 18016-58-5 | Natural Products |
| HY-N5076 | Picfeltarraenin IV | 184288-35-5 | Natural Products |
| HY-N5077 | Sinapine | 18696-26-9 | Natural Products |
| HY-N5077B | Sinapine (hydroxide) | 122-30-5 | Natural Products |
| HY-N5078 | Terrestrosin K | 193605-07-1 | Natural Products |
| HY-N5079 | Lotaustralin | 1973415-50-7 | Natural Products |
| HY-N5080 | Isoscoparin | 20013-23-4 | Natural Products |
| HY-N5081 | 1αH,5αH-Guaia-6-ene-4β,10β-diol | 2013537-81-8 | Natural Products |
| HY-N5082 | Homodihydrocapsaicin I | 20279-06-5 | Natural Products |
| HY-N5083 | Saponarin | 20310-89-8 | Natural Products |
| HY-N5083R | Saponarin (Standard) | 20310-89-8 | Reference Standards |
| HY-N5084 | Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside | 205370-59-8 | Natural Products |
| HY-N5085 | Nudicaucin B | 211557-36-7 | Natural Products |
| HY-N5086 | Picroside IV | 211567-04-3 | Natural Products |
| HY-N5087 | Nudicaucin A | 211815-97-3 | Natural Products |
| HY-N5088 | 26-Deoxycimicifugoside | 214146-75-5 | Natural Products |
| HY-N5089 | (+)-Balanophonin | 215319-47-4 | Natural Products |
| HY-N5091 | Physcion 8-O-β-D-glucopyranoside | 23451-01-6 | Natural Products |
| HY-N5092 | 7-Methylcoumarin | 2445-83-2 | Natural Products |
| HY-N5092R | 7-Methylcoumarin (Standard) | 2445-83-2 | Reference Standards |
| HY-N5093 | Glucodigifucoside | 2446-63-1 | Natural Products |
| HY-N5094 | 6'-O-β-Apiofuranosylsweroside | 266678-59-5 | Natural Products |
| HY-N5095 | Eupteleasaponin I | 290809-29-9 | Natural Products |
| HY-N5096 | Sophorabioside | 2945-88-2 | Natural Products |
| HY-N5097 | 13-Oxo-9E,11E-octadecadienoic acid | 29623-29-8 | Natural Products |
| HY-N5098 | Arenobufagin 3-hemisuberate | 30219-16-0 | Natural Products |
| HY-N5099 | N-Vanillyldecanamide | 31078-36-1 | Natural Products |
| HY-N5100 | Isodemethylwedelolactone | 350681-33-3 | Natural Products |
| HY-N5101 | Kobusin | 36150-23-9 | Natural Products |
| HY-N5102 | D-(+)-Fucose | 3615-37-0 | Natural Products |
| HY-N5102R | D-(+)-Fucose (Standard) | 3615-37-0 | Reference Standards |
| HY-N5103 | Genistein 7,4'-di-O-β-D-glucoside | 36190-98-4 | Natural Products |
| HY-N5104 | Clemaphenol A | 362606-60-8 | Natural Products |
| HY-N5105 | Scarlet 808 | 3789-75-1 | Natural Products |
| HY-N5106 | (E)-Flavokawain A | 37951-13-6 | Natural Products |
| HY-N5106R | (E)-Flavokawain A (Standard) | 37951-13-6 | Reference Standards |
| HY-N5107 | Epimagnolin A | 41689-51-4 | Natural Products |
| HY-N5108 | 4β,12-Dihydroxyguaian-6,10-diene | 461644-90-6 | Natural Products |
| HY-N5109 | Cheilanthifoline | 483-44-3 | Natural Products |
| HY-N5110 | Marmesinin | 495-30-7 | Natural Products |
| HY-N5111 | Aloe-emodin-3-(hydroxymethyl)-O-β-D-glucopyranoside | 50488-89-6 | Natural Products |
| HY-N5112 | (Rac)-Arnebin 1 | 5162-01-6 | Natural Products |
| HY-N5112A | β,β-Dimethylacrylalkannin | 34539-65-6 | Natural Products |
| HY-N5112B | β,β-Dimethylacrylshikonin | 24502-79-2 | Natural Products |
| HY-N5113 | 6α-Chloro-5β-hydroxywithaferin A | 52329-20-1 | Natural Products |
| HY-N5114 | Isovitexin 2''-O-arabinoside | 53382-71-1 | Natural Products |
| HY-N5115 | Neosmitilbin | 54081-47-9 | Natural Products |
| HY-N5116 | Neoisoastilbin | 54141-72-9 | Natural Products |
| HY-N5117 | Kaempferol 3-sophoroside-7-glucoside | 55136-76-0 | Natural Products |
| HY-N5118 | Chimonanthine | 5545-89-1 | Natural Products |
| HY-N5119 | Kaempferol-3-O-(2''-O-β-D-glucopyl)-β-D-rutinoside | 55696-58-7 | Natural Products |
| HY-N5120 | Dihydrowithaferin A | 5589-41-3 | Natural Products |
| HY-N5121 | Calycanthine | 595-05-1 | Natural Products |
| HY-N5122 | Vindolinine | 5980-02-9 | Natural Products |
| HY-N5123 | α-L-Rhamnose | 6014-42-2 | Natural Products |
| HY-N5124 | Meloside A | 60767-80-8 | Natural Products |
| HY-N5125 | 2-Hydroxy-1-methoxyanthraquinone | 6170-06-5 | Natural Products |
| HY-N5126 | Juncusol | 62023-90-9 | Natural Products |
| HY-N5127 | Nonacosane | 630-03-5 | Natural Products |
| HY-N5127R | Nonacosane (Standard) | 630-03-5 | Reference Standards |
| HY-N5128 | Apigenin6-C-α-L-arabinopyranosyl-8-C-β-D-xylopyranoside | 677021-30-6 | Natural Products |
| HY-N5129 | Genistein 7-O-β-D-glucopyranoside-4'-O-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside] | 70404-42-1 | Natural Products |
| HY-N5130 | Effusol | 73166-28-6 | Natural Products |
| HY-N5131 | 3β-Methoxy-2,3-dihydrowithaferin A | 73365-94-3 | Natural Products |
| HY-N5132 | (-)-Fenchone | 7787-20-4 | Natural Products |
| HY-N5132R | (-)-Fenchone (Standard) | 7787-20-4 | Reference Standards |
| HY-N5133 | Clovin | 81970-00-5 | Natural Products |
| HY-N5134 | 5'-Guanylic acid | 85-32-5 | Natural Products |
| HY-N5134R | 5'-Guanylic acid (Standard) | 85-32-5 | Reference Standards |
| HY-N5134S1 | 5'-Guanylic acid-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-N5134S2 | 5'-Guanylic acid-15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-N5134S3 | 5'-Guanylic acid-d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-N5134S4 | 5'-Guanylic acid-15N5,d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-N5134S5 | 5'-Guanylic acid-13C10,15N5 (dilithium) | 2483830-56-2 | Isotope-Labeled Compounds |
| HY-N5135 | Liriopesides B | 87425-34-1 | Natural Products |
| HY-N5135R | Liriopesides B (Standard) | 87425-34-1 | Reference Standards |
| HY-N5136 | 25(R,S)-Ruscogenin | 874485-32-2 | Natural Products |
| HY-N5137 | L-Borneol 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside | 88700-35-0 | Natural Products |
| HY-N5138 | Odoratisol A | 891182-93-7 | Natural Products |
| HY-N5139 | Lecithins, egg | 93685-90-6 | Natural Products |
| HY-N5140 | Bacopaside X | 94443-88-6 | Natural Products |
| HY-N5140R | Bacopaside X (Standard) | 94443-88-6 | Reference Standards |
| HY-N5141 | Isoscoparin-2′′O-glucoside | 97605-25-9 | Natural Products |
| HY-N5142 | α-Terpineol | 98-55-5 | Natural Products |
| HY-N5142R | α-Terpineol (Standard) | 98-55-5 | Reference Standards |
| HY-N5142S | α-Terpineol-d3 | 203633-12-9 | Isotope-Labeled Compounds |
| HY-N5142S1 | α-Terpineol-d6 | 1263090-98-7 | Isotope-Labeled Compounds |
| HY-N5143 | (2R)-3α,7,4'-Trihydroxy-5-methoxy-8-prenylflavanone | 1966944-04-6 | Natural Products |
| HY-N5146 | Ophiopogonside A | 2423917-90-0 | Natural Products |
| HY-N5148 | Vaccarin E | 2252345-81-4 | Natural Products |
| HY-N5152 | (2′S)-4′-O-β-D-apiofuranosyl-(1→6)-O-β-D-glucopyranosylvisamminol | 2254096-97-2 | Natural Products |
| HY-N5153 | 12β-Acetoxyganoderic Acid θ | 2374206-90-1 | Natural Products |
| HY-N5154 | Sanggenon W | 2226467-12-3 | Natural Products |
| HY-N5158B | (5S)-Neosamine C | 108864-61-5 | Natural Products |
| HY-N5159 | Ampullosporin A | 197960-94-4 | Natural Products |
| HY-N5160 | Arborcandin A | 223465-76-7 | Natural Products |
| HY-N5161 | Arborcandin B | 223465-78-9 | Natural Products |
| HY-N5162 | Arborcandin C | 223465-77-8 | Natural Products |
| HY-N5163 | Arborcandin D | 223465-79-0 | Natural Products |
| HY-N5164 | Arborcandin E | 223465-80-3 | Natural Products |
| HY-N5165 | Arborcandin F | 223465-81-4 | Natural Products |
| HY-N5166 | Ardeemin | 148441-25-2 | Natural Products |
| HY-N5167 | Argimicin A | 321846-46-2 | Natural Products |
| HY-N5168 | Argimicin B | 663910-32-5 | Natural Products |
| HY-N5169 | Argimicin C | 663910-33-6 | Natural Products |
| HY-N5170 | Aselacin A | 156223-06-2 | Natural Products |
| HY-N5171 | Aselacin B | 156223-07-3 | Natural Products |
| HY-N5172 | Actinoidin A | 60382-78-7 | Natural Products |
| HY-N5173 | Aibellin | 151036-29-2 | Natural Products |
| HY-N5174 | Azetomycin II | 59481-55-9 | Natural Products |
| HY-N5175 | Cephaibol A | 304911-38-4 | Natural Products |
| HY-N5176 | Cephaibol B | 304911-39-5 | Natural Products |
| HY-N5177 | Cephaibol D | 280774-64-3 | Natural Products |
| HY-N5178 | Chloropeptin I | 160219-64-7 | Natural Products |
| HY-N5179 | Chloropeptin II | 69598-75-0 | Natural Products |
| HY-N5180 | Chymostatin A | 51759-76-3 | Natural Products |
| HY-N5182 | Chymostatin B | 51759-77-4 | Natural Products |
| HY-N5183 | Chymostatin C | 51759-78-5 | Natural Products |
| HY-N5185 | Cyclothiazomycin | 133352-26-8 | Natural Products |
| HY-N5186 | Cypemycin | 154277-21-1 | Natural Products |
| HY-N5187 | Edeine A1 | 27656-72-0 | Natural Products |
| HY-N5188 | Emerimicin III | 52931-42-7 | Natural Products |
| HY-N5189 | Emerimicin IV | 52931-43-8 | Natural Products |
| HY-N5190 | Enamidonin | 2271109-33-0 | Natural Products |
| HY-N5191 | Epidermin | 99165-17-0 | Natural Products |
| HY-N5192 | Galacardin A | 137801-55-9 | Natural Products |
| HY-N5193 | Galacardin B | 137801-54-8 | Natural Products |
| HY-N5194 | Lipohexin | 193751-58-5 | Natural Products |
| HY-N5197 | Dapdiamide A | 1196054-26-8 | Natural Products |
| HY-N5202 | Aspochalasin A | 72363-48-5 | Natural Products |
| HY-N5203 | Ala0-Actagardine | 223465-14-3 | Natural Products |
| HY-N5204 | Clavalanine | 74758-63-7 | Natural Products |
| HY-N6002 | 3'-Hydroxypterostilbene | 475231-21-1 | Natural Products |
| HY-N6004 | (Rac)-Shikonin | 54952-43-1 | Natural Products |
| HY-N6005 | Methyl caffeate | 3843-74-1 | Natural Products |
| HY-N6005A | (E)-Methyl caffeate | 67667-67-8 | Biochemical Assay Reagents |
| HY-N6006 | 1,3,6-Tri-O-galloyl-beta-D-glucose | 18483-17-5 | Natural Products |
| HY-N6006R | 1,3,6-Tri-O-galloyl-beta-D-glucose (Standard) | 18483-17-5 | Reference Standards |
| HY-N6007 | Chrysosplenol D | 14965-20-9 | Natural Products |
| HY-N6008 | 7-O-Methyl morroniside | 41679-97-4 | Natural Products |
| HY-N6008A | 7β-O-Methylmorroniside | 119943-46-3 | Natural Products |
| HY-N6009 | 8-Deoxygartanin | 33390-41-9 | Natural Products |
| HY-N6010 | 8-Hydroxybergapten | 1603-47-0 | Natural Products |
| HY-N6011 | 9-Methoxycamptothecin | 39026-92-1 | Natural Products |
| HY-N6012 | (-)-Alkannin | 517-88-4 | Natural Products |
| HY-N6013 | Aloin(mixture of A&B) | 8015-61-0 | Natural Products |
| HY-N6014 | Asperosaponin IV | 126778-93-6 | Natural Products |
| HY-N6015 | Bacopasaponin C | 178064-13-6 | Natural Products |
| HY-N6015R | Bacopasaponin C (Standard) | 178064-13-6 | Reference Standards |
| HY-N6016 | Bacopaside II | 382146-66-9 | Natural Products |
| HY-N6016R | Bacopaside II (Standard) | 382146-66-9 | Reference Standards |
| HY-N6017 | Bakkenolide A | 19906-72-0 | Natural Products |
| HY-N6018 | Beta-Eudesmol | 473-15-4 | Natural Products |
| HY-N6020 | (-)-Butin | 492-14-8 | Natural Products |
| HY-N6020A | (+)-Butin | 74628-42-5 | Natural Products |
| HY-N6020B | Butin | 21913-99-5 | Natural Products |
| HY-N6022 | Byakangelicin | 482-25-7 | Natural Products |
| HY-N6023 | Thermopsoside | 19993-32-9 | Natural Products |
| HY-N6025 | Clemastanin B | 112747-98-5 | Natural Products |
| HY-N6027 | Cyclosporin C | 59787-61-0 | Natural Products |
| HY-N6028 | Darutoside | 59219-65-7 | Natural Products |
| HY-N6028R | Darutoside (Standard) | 59219-65-7 | Reference Standards |
| HY-N6029 | Dehydroevodiamine (hydrochloride) | 111664-82-5 | Natural Products |
| HY-N6030 | (Rac)-Dencichine | 7554-90-7 | Natural Products |
| HY-N6031 | Dendrophenol | 108853-14-1 | Natural Products |
| HY-N6032 | Esculentoside B | 60820-94-2 | Natural Products |
| HY-N6033 | Ferruginol | 514-62-5 | Natural Products |
| HY-N6036 | Ganoderic acid F | 98665-15-7 | Natural Products |
| HY-N6036R | Ganoderic acid F (Standard) | 98665-15-7 | Reference Standards |
| HY-N6037 | Gardenin B | 2798-20-1 | Natural Products |
| HY-N6037R | Gardenin B (Standard) | 2798-20-1 | Reference Standards |
| HY-N6038 | Gartanin | 33390-42-0 | Natural Products |
| HY-N6038R | Gartanin (Standard) | 33390-42-0 | Reference Standards |
| HY-N6039 | Gentianine | 439-89-4 | Natural Products |
| HY-N6040 | Helicianeoide A | 496066-82-1 | Natural Products |
| HY-N6041 | Helicianeoide B | 496066-89-8 | Natural Products |
| HY-N6042 | Hernandezine | 6681-13-6 | Natural Products |
| HY-N6043 | Hydroxytyrosol acetate | 69039-02-7 | Natural Products |
| HY-N6044 | Isoanhydroicaritin | 28610-30-2 | Natural Products |
| HY-N6045 | Isotetrandrine | 477-57-6 | Natural Products |
| HY-N6046 | Kamebakaurin | 73981-34-7 | Natural Products |
| HY-N6047 | Lancifodilactone C | 663176-26-9 | Natural Products |
| HY-N6048 | Lancifodilactone F | 850878-47-6 | Natural Products |
| HY-N6049 | Lup-20(29)-en-28-oic acid | 848784-85-0 | Natural Products |
| HY-N6050 | Lycorenine | 477-19-0 | Natural Products |
| HY-N6051 | (-)-Maackiain | 2035-15-6 | Natural Products |
| HY-N6051R | (-)-Maackiain (Standard) | 2035-15-6 | Reference Standards |
| HY-N6052 | (+)-Medicarpin | 33983-39-0 | Natural Products |
| HY-N6054 | Niranthin | 50656-77-4 | Natural Products |
| HY-N6054R | Niranthin (Standard) | 50656-77-4 | Reference Standards |
| HY-N6055 | Nuezhenidic acid | 183238-67-7 | Natural Products |
| HY-N6057 | Obtusin | 70588-05-5 | Natural Products |
| HY-N6058 | (3β)-3-[(O-β-D-Glucopyranosyl-(1→3)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-α-L-arabinopyranosyl)oxy]olean-12-en-28-oic acid | 103956-33-8 | Natural Products |
| HY-N6059 | Ophiopogonanone A | 75239-63-3 | Natural Products |
| HY-N6060 | Ophiopogonanone B | 1316759-83-7 | Natural Products |
| HY-N6061 | Ophiopogonin C | 65586-25-6 | Natural Products |
| HY-N6063 | (+)-Peusedanol | 20516-23-8 | Natural Products |
| HY-N6063R | (+)-Peusedanol (Standard) | 20516-23-8 | Reference Standards |
| HY-N6064 | Polygalacin D | 66663-91-0 | Natural Products |
| HY-N6065 | Praeruptorin A | 73069-27-9 | Natural Products |
| HY-N6065R | Praeruptorin A (Standard) | 73069-27-9 | Reference Standards |
| HY-N6066 | Praeruptorin E | 78478-28-1 | Natural Products |
| HY-N6066R | Praeruptorin E (Standard) | 78478-28-1 | Reference Standards |
| HY-N6067 | Primin | 15121-94-5 | Natural Products |
| HY-N6068 | Pulsatilla saponin H | 68027-14-5 | Natural Products |
| HY-N6069 | Raspberry ketone glucoside | 38963-94-9 | Natural Products |
| HY-N6070 | Ricinoleic acid (purity≥85%) | 141-22-0 | Natural Products |
| HY-N6070A | Ricinoleic acid (purity≥99%) | 141-22-0 | Reference compound |
| HY-N6070AR | Ricinoleic acid (purity≥99%) (Standard) | 141-22-0 | Reference Standards |
| HY-N6070R | Ricinoleic acid (purity≥85%) (Standard) | 141-22-0 | Reference Standards |
| HY-N6071 | Secoisolariciresinol | 29388-59-8 | Natural Products |
| HY-N6071R | Secoisolariciresinol (Standard) | 29388-59-8 | Reference Standards |
| HY-N6072 | Seco-neokadsuranic acid A | 124817-74-9 | Natural Products |
| HY-N6073 | Soyasapogenol A | 508-01-0 | Natural Products |
| HY-N6073R | Soyasapogenol A (Standard) | 508-01-0 | Reference Standards |
| HY-N6074 | Soyasapogenol B | 595-15-3 | Natural Products |
| HY-N6074R | Soyasapogenol B (Standard) | 595-15-3 | Reference Standards |
| HY-N6075 | Specneuzhenide | 449733-84-0 | Natural Products |
| HY-N6076 | Tenuifoliside A | 139726-35-5 | Natural Products |
| HY-N6077 | Thalidezine | 18251-36-0 | Natural Products |
| HY-N6078 | Thalrugosaminine | 22226-73-9 | Natural Products |
| HY-N6079 | Timosaponin A1 | 68422-00-4 | Natural Products |
| HY-N6080 | Tripterifordin | 139122-81-9 | Natural Products |
| HY-N6081 | Hypocrellin C | 149457-83-0 | Natural Products |
| HY-N6082 | Rhein 8-Glucoside | 34298-86-7 | Natural Products |
| HY-N6082R | Rhein 8-Glucoside (Standard) | 34298-86-7 | Reference Standards |
| HY-N6084 | Humulone | 26472-41-3 | Natural Products |
| HY-N6085 | N-Caffeoylputrescine,(E)- | 29554-26-5 | Natural Products |
| HY-N6086 | Angelic anhydride | 94487-74-8 | Natural Products |
| HY-N6087 | meso-Dihydroguaiaretic acid | 66322-34-7 | Natural Products |
| HY-N6087R | meso-Dihydroguaiaretic acid (Standard) | 66322-34-7 | Reference Standards |
| HY-N6088 | Isoginsenoside Rh3 | 166040-90-0 | Natural Products |
| HY-N6095 | Nocarimidazole A | 1818218-33-5 | Reference compound |
| HY-N6097 | Amauromine | 88360-87-6 | Natural Products |
| HY-N6149 | 2-Isobutoxyaniline | 104065-95-4 | Reference compound |
| HY-N6181 | Terrelumamide A | 1802497-05-7 | Natural Products |
| HY-N6217 | F-14329 | 942195-19-9 | Natural Products |
| HY-N6237 | Aspulvinone O | 914071-54-8 | Natural Products |
| HY-N6242 | Angelicide | 92935-94-9 | Natural Products |
| HY-N6243 | Veratrosine | 475-00-3 | Natural Products |
| HY-N6244 | Isolindleyin | 87075-18-1 | Natural Products |
| HY-N6245 | Daphylloside | 14260-99-2 | Natural Products |
| HY-N6246 | Asperulosidic Acid | 25368-11-0 | Natural Products |
| HY-N6246R | Asperulosidic Acid (Standard) | 25368-11-0 | Reference Standards |
| HY-N6247 | Fuscaxanthone C | 15404-76-9 | Natural Products |
| HY-N6248 | Cowaxanthone B | 212842-64-3 | Natural Products |
| HY-N6249 | Feretoside | 27530-67-2 | Natural Products |
| HY-N6250 | Isomucronulatol 7-O-glucoside | 136087-29-1 | Natural Products |
| HY-N6251 | Cratoxylone | 149155-01-1 | Natural Products |
| HY-N6252 | Gypenoside XLVI | 94705-70-1 | Natural Products |
| HY-N6253 | Pinoresinol | 487-36-5 | Natural Products |
| HY-N6253R | Pinoresinol (Standard) | 487-36-5 | Reference Standards |
| HY-N6254 | Moluccanin | 116521-73-4 | Natural Products |
| HY-N6255 | Ilexgenin A | 108524-94-3 | Natural Products |
| HY-N6256 | Ilexsaponin B2 | 108906-69-0 | Natural Products |
| HY-N6257 | Cafestol | 469-83-0 | Natural Products |
| HY-N6257R | Cafestol (Standard) | 469-83-0 | Reference Standards |
| HY-N6258 | Kahweol | 6894-43-5 | Natural Products |
| HY-N6258R | Kahweol (Standard) | 6894-43-5 | Reference Standards |
| HY-N6259 | 5,7,3'-Trihydroxy-6,4',5'-trimethoxyflavone | 78417-26-2 | Natural Products |
| HY-N6259R | 5,?7,?3'-?Trihydroxy-?6,?4',?5'-?trimethoxyflavone (Standard) | 78417-26-2 | Reference Standards |
| HY-N6260 | 4-O-beta-Glucopyranosyl-cis-coumaric acid | 117405-48-8 | Natural Products |
| HY-N6261 | Epimagnolin B | 1134188-26-3 | Natural Products |
| HY-N6262 | 20(S),24(R)-Ocotillol | 69926-31-4 | Natural Products |
| HY-N6263 | EGCG Octaacetate | 148707-39-5 | Reference compound |
| HY-N6264 | 26-Deoxyactein | 264624-38-6 | Natural Products |
| HY-N6264R | 26-Deoxyactein (Standard) | 264624-38-6 | Reference Standards |
| HY-N6265 | Cauloside F | 60451-47-0 | Natural Products |
| HY-N6294 | Monocerin | 30270-60-1 | Natural Products |
| HY-N6310 | Talaromycesone A | 1658474-60-2 | Natural Products |
| HY-N6570 | Alisol C | 30489-27-1 | Natural Products |
| HY-N6571 | Spinorhamnoside | 864271-19-2 | Natural Products |
| HY-N6572 | Sutchuenmedin A | 1197194-31-2 | Natural Products |
| HY-N6573 | Bufarenogin | 17008-65-0 | Natural Products |
| HY-N6574 | Marinobufogenin | 470-42-8 | Natural Products |
| HY-N6575 | 7β-Hydroxybufalin | 20143-97-9 | Natural Products |
| HY-N6576 | Hellebrigenin | 465-90-7 | Natural Products |
| HY-N6577 | Astragaloside VI | 84687-45-6 | Natural Products |
| HY-N6578 | 3-epi-Isocucurbitacin B | 89647-62-1 | Natural Products |
| HY-N6579 | Arvenin I | 65247-27-0 | Natural Products |
| HY-N6580 | Ginsenoside Rg4 | 126223-28-7 | Natural Products |
| HY-N6581 | Notoginsenoside T5 | 769932-34-5 | Natural Products |
| HY-N6582 | Flavokawin C | 56798-34-6 | Natural Products |
| HY-N6583 | Licoflavonol | 60197-60-6 | Natural Products |
| HY-N6584 | Saikogenin A | 5092-09-1 | Natural Products |
| HY-N6585 | 4'-O-Methylvitexin | 2326-34-3 | Natural Products |
| HY-N6587 | Betulinic acid methyl ester | 2259-06-5 | Natural Products |
| HY-N6588 | 3,4,5-Tricaffeoylquinic acid | 86632-03-3 | Natural Products |
| HY-N6590 | Tenuifoliose A | 139682-01-2 | Natural Products |
| HY-N6591 | Tenuifoliose H | 147742-13-0 | Natural Products |
| HY-N6592 | Tenuifoliose I | 147742-14-1 | Natural Products |
| HY-N6593 | Arillanin A | 154287-47-5 | Natural Products |
| HY-N6595 | Lucidone A | 97653-92-4 | Natural Products |
| HY-N6596 | 7-Hydroxy-4H-chromen-4-one | 59887-89-7 | Natural Products |
| HY-N6597 | 3'-Methoxyapiin | 33579-63-4 | Natural Products |
| HY-N6598 | 4-Feruloylquinic acid | 2613-86-7 | Natural Products |
| HY-N6599 | 3-Feruloylquinic acid | 1899-29-2 | Natural Products |
| HY-N6600 | Octadecane | 593-45-3 | Reference compound |
| HY-N6600S | Octadecane-d38 | 16416-31-2 | Isotope-Labeled Compounds |
| HY-N6601 | Pomolic acid | 13849-91-7 | Natural Products |
| HY-N6602 | α-Solanine | 20562-02-1 | Natural Products |
| HY-N6602R | α-Solanine (Standard) | 20562-02-1 | Reference Standards |
| HY-N6604 | Apigenin 7-O-sophoroside | 52073-83-3 | Natural Products |
| HY-N6605 | Kaempferol 3-O-β-D-galactopyranoside | 23627-87-4 | Natural Products |
| HY-N6606 | Delphinidin-3-O-galactoside (chloride) | 28500-00-7 | Natural Products |
| HY-N6606R | Delphinidin-3-O-galactoside (chloride) (Standard) | 28500-00-7 | Reference Standards |
| HY-N6607 | Tryptanthrin | 13220-57-0 | Natural Products |
| HY-N6607R | Tryptanthrin (Standard) | 13220-57-0 | Reference Standards |
| HY-N6608 | Physostigmine | 57-47-6 | Natural Products |
| HY-N6608S | Physostigmine-d3 | 1217704-11-4 | Isotope-Labeled Compounds |
| HY-N6609 | Magnocurarine | 6801-40-7 | Natural Products |
| HY-N6609A | (Rac)-Magnocurarin (chloride) | 2365275-47-2 | Natural Products |
| HY-N6610 | Protoanemonene | 108-28-1 | Natural Products |
| HY-N6611 | Chimaphilin | 482-70-2 | Natural Products |
| HY-N6612 | D-Glucuronic acid | 6556-12-3 | Natural Products |
| HY-N6612A | D-Glucuronic acid (sodium) salt (monohydrate) | 207300-70-7 | Natural Products |
| HY-N6612B | Glucuronic acid (sodium) | 7182-77-6 | Reference compound |
| HY-N6612R | D-Glucuronic acid (Standard) | 6556-12-3 | Reference Standards |
| HY-N6613 | Polygalacturonic acid | 25990-10-7 | Natural Products |
| HY-N6614 | L-Galactose | 15572-79-9 | Biochemical Assay Reagents |
| HY-N6614S1 | L-Galactose-13C-1 | Isotope-Labeled Compounds | |
| HY-N6615 | Aflatoxin B1 | 1162-65-8 | Natural Products |
| HY-N6615R | Aflatoxin B1 (Standard) | 1162-65-8 | Reference Standards |
| HY-N6615S | Aflatoxin B1-13C17 | 1217449-45-0 | Isotope-Labeled Compounds |
| HY-N6616 | Pinocembrin-7-O-β-D-glucopyranoside | 75829-43-5 | Natural Products |
| HY-N6616R | Pinocembrin-7-O-β-D-glucopyranoside (Standard) | 75829-43-5 | Reference Standards |
| HY-N6617 | Norswertianolin | 54954-12-0 | Natural Products |
| HY-N6618 | DL-Mannitol | 87-78-5 | Natural Products |
| HY-N6618S | DL-Mannitol-13C | 132144-93-5 | Isotope-Labeled Compounds |
| HY-N6619 | Lycoramine (hydrobromide) | 89505-76-0 | Natural Products |
| HY-N6619A | Lycoramine | 21133-52-8 | Natural Products |
| HY-N6621 | Hippeastrine | 477-17-8 | Natural Products |
| HY-N6621A | Hippeastrine (hydrobromide) | 22352-41-6 | Natural Products |
| HY-N6622 | Tazettine | 507-79-9 | Natural Products |
| HY-N6623 | Malvidin-3-galactoside (chloride) | 30113-37-2 | Natural Products |
| HY-N6623R | Malvidin-3-galactoside (chloride) (Standard) | 30113-37-2 | Reference Standards |
| HY-N6624 | Skullcapflavone II | 55084-08-7 | Natural Products |
| HY-N6625 | Chlorothalonil | 1897-45-6 | Reference compound |
| HY-N6625R | Chlorothalonil (Standard) | 1897-45-6 | Reference Standards |
| HY-N6625S | Chlorothalonil-13C2 | 2767332-24-9 | Isotope-Labeled Compounds |
| HY-N6626 | Pyraclostrobin | 175013-18-0 | Reference compound |
| HY-N6626R | Pyraclostrobin (Standard) | 175013-18-0 | Reference Standards |
| HY-N6628 | 6,2'-Dihydroxyflavone | 92439-20-8 | Reference compound |
| HY-N6629 | 3'-Methoxyflavonol | 76666-32-5 | Natural Products |
| HY-N6629R | 3'-Methoxyflavonol (Standard) | 76666-32-5 | Reference Standards |
| HY-N6630 | 6-Methylflavone | 29976-75-8 | Natural Products |
| HY-N6631 | 7-Methoxyisoflavone | 1621-56-3 | Reference compound |
| HY-N6634 | Araloside C | 55446-15-6 | Natural Products |
| HY-N6635 | trans-Nerolidol | 40716-66-3 | Natural Products |
| HY-N6635R | trans-Nerolidol (Standard) | 40716-66-3 | Reference Standards |
| HY-N6636 | Valencene | 4630-07-3 | Natural Products |
| HY-N6636R | Valencene (Standard) | 4630-07-3 | Reference Standards |
| HY-N6637 | Senecionine N-oxide | 13268-67-2 | Natural Products |
| HY-N6637S | Senecionine N-oxide-d3 | Isotope-Labeled Compounds | |
| HY-N6638 | Retrorsine | 480-54-6 | Natural Products |
| HY-N6638R | Retrorsine (Standard) | 480-54-6 | Reference Standards |
| HY-N6639 | 3-O-Acetyl-20-Hydroxyecdysone | 22961-68-8 | Natural Products |
| HY-N6640 | 2-O-Acetyl-20-hydroxyecdysone | 19536-25-5 | Natural Products |
| HY-N6641 | Monascin | 21516-68-7 | Natural Products |
| HY-N6641R | Monascin (Standard) | 21516-68-7 | Reference Standards |
| HY-N6642 | Ankaflavin | 50980-32-0 | Natural Products |
| HY-N6643 | Rubropunctamine | 514-66-9 | Natural Products |
| HY-N6644 | Crocin III | 55750-85-1 | Natural Products |
| HY-N6644R | Crocin III (Standard) | 55750-85-1 | Reference Standards |
| HY-N6645 | 6-Acetyldepheline | 1310693-07-2 | Natural Products |
| HY-N6647 | Luteolin-7-rutinoside | 20633-84-5 | Natural Products |
| HY-N6648 | Cirsimaritin | 6601-62-3 | Natural Products |
| HY-N6650 | Isotanshinone IIA | 20958-15-0 | Natural Products |
| HY-N6652 | 1-beta-D-Arabinofuranosyluracil | 3083-77-0 | Natural Products |
| HY-N6652R | 1-beta-D-Arabinofuranosyluracil (Standard) | 3083-77-0 | Reference Standards |
| HY-N6653 | Lentinan | 37339-90-5 | Natural Products |
| HY-N6654 | Syringyl Alcohol | 530-56-3 | Reference compound |
| HY-N6655 | DL-Methionine methylsulfonium (chloride) | 3493-12-7 | Natural Products |
| HY-N6656 | 6-Hydroxycoumarin | 6093-68-1 | Natural Products |
| HY-N6657 | 7-Hydroxy-4-methyl-8-nitrocoumarin | 19037-69-5 | Reference compound |
| HY-N6658 | 6-Hydroxy-4-methylcoumarin | 2373-31-1 | Reference compound |
| HY-N6660 | Trisdecanoin | 621-71-6 | Natural Products |
| HY-N6660R | Trisdecanoin (Standard) | 621-71-6 | Reference Standards |
| HY-N6661 | Verbenone | 1196-01-6 | Natural Products |
| HY-N6661R | Verbenone (Standard) | 1196-01-6 | Reference Standards |
| HY-N6662 | (+)-Longifolene | 475-20-7 | Natural Products |
| HY-N6662S | (+)-Longifolene-13C,d2 | Isotope-Labeled Compounds | |
| HY-N6663 | 3-Carene | 13466-78-9 | Natural Products |
| HY-N6663R | 3-Carene (Standard) | 13466-78-9 | Reference Standards |
| HY-N6664 | Gum arabic | 9000-01-5 | Natural Products |
| HY-N6665 | Cefquinome (sulfate) | 118443-89-3 | Reference compound |
| HY-N6665A | Cefquinome | 84957-30-2 | Reference compound |
| HY-N6665R | Cefquinome (sulfate) (Standard) | 118443-89-3 | Reference Standards |
| HY-N6666 | Vidarabine (monohydrate) | 24356-66-9 | Reference compound |
| HY-N6666R | Vidarabine (monohydrate) (Standard) | 24356-66-9 | Reference Standards |
| HY-N6667 | Glucovanillin | 494-08-6 | Natural Products |
| HY-N6669 | Methyl 3-O-methylgallate | 3934-86-9 | Natural Products |
| HY-N6670 | Cefotetan | 69712-56-7 | Reference compound |
| HY-N6670R | Cefotetan (Standard) | 69712-56-7 | Reference Standards |
| HY-N6672 | Caulophylline B | 1359978-55-4 | Natural Products |
| HY-N6673 | Okanin | 484-76-4 | Natural Products |
| HY-N6674 | Diazepinomicin | 733035-26-2 | Reference compound |
| HY-N6675 | Gardenia yellow | 94238-00-3 | Natural Products |
| HY-N6677 | β-Apo-8'-carotenal | 1107-26-2 | Natural Products |
| HY-N6678 | Zearalanone | 5975-78-0 | Natural Products |
| HY-N6678R | Zearalanone (Standard) | 5975-78-0 | Reference Standards |
| HY-N6678S | (Rac)-Zearalanone-d6 | 1795020-90-4 | Isotope-Labeled Compounds |
| HY-N6679 | (R)-10,11-Dehydrocurvularin | 1095588-70-7 | Natural Products |
| HY-N6679A | 10,11-Dehydrocurvularin | 21178-57-4 | Natural Products |
| HY-N6680 | Virginiamycin S1 | 23152-29-6 | Natural Products |
| HY-N6680R | Virginiamycin S1 (Standard) | 23152-29-6 | Reference Standards |
| HY-N6681 | 15-Acetoxyscirpenol | 2623-22-5 | Natural Products |
| HY-N6682 | Cytochalasin D | 22144-77-0 | Natural Products |
| HY-N6683 | 15-Acetyl-deoxynivalenol | 88337-96-6 | Natural Products |
| HY-N6683R | 15-Acetyl-deoxynivalenol (Standard) | 88337-96-6 | Reference Standards |
| HY-N6683S1 | 15-Acetyl-deoxynivalenol-13C17 | 911392-39-7 | Isotope-Labeled Compounds |
| HY-N6684 | Deoxynivalenol | 51481-10-8 | Natural Products |
| HY-N6684R | Deoxynivalenol (Standard) | 51481-10-8 | Reference Standards |
| HY-N6685 | 3-Acetyldeoxynivalenol | 50722-38-8 | Natural Products |
| HY-N6685R | 3-Acetyldeoxynivalenol (Standard) | 50722-38-8 | Reference Standards |
| HY-N6685S1 | 3-Acetyldeoxynivalenol-13C17 | 1217476-81-7 | Isotope-Labeled Compounds |
| HY-N6686 | Virginiamycin M1 | 21411-53-0 | Natural Products |
| HY-N6686R | Virginiamycin M1 (Standard) | 21411-53-0 | Reference Standards |
| HY-N6687 | Calcimycin | 52665-69-7 | Natural Products |
| HY-N6687A | Calcimycin (hemicalcium salt) | 59450-89-4 | Natural Products |
| HY-N6687B | Calcimycin (hemimagnesium) | 72124-77-7 | Reference compound |
| HY-N6687R | Calcimycin (Standard) | 52665-69-7 | Reference Standards |
| HY-N6688 | Verruculogen | 12771-72-1 | Natural Products |
| HY-N6689 | Destruxin A | 6686-70-0 | Natural Products |
| HY-N6690 | Destruxin B | 2503-26-6 | Natural Products |
| HY-N6691 | Veratridine | 71-62-5 | Natural Products |
| HY-N6691R | Veratridine (Standard) | 71-62-5 | Reference Standards |
| HY-N6692 | Diacetoxyscirpenol | 2270-40-8 | Natural Products |
| HY-N6692S | Diacetoxyscirpenol-13C19 | Isotope-Labeled Compounds | |
| HY-N6693 | Valinomycin | 2001-95-8 | Natural Products |
| HY-N6694 | 4-Bromo A23187 | 76455-48-6 | Reference compound |
| HY-N6695 | Aflatoxicol | 29611-03-8 | Natural Products |
| HY-N6696 | Aflatoxin B2 | 7220-81-7 | Natural Products |
| HY-N6696S | Aflatoxin B2-13C17 | 1217470-98-8 | Isotope-Labeled Compounds |
| HY-N6697 | Aflatoxin G1 | 1165-39-5 | Natural Products |
| HY-N6697S | Aflatoxin G1-13C17 | 1217444-07-9 | Isotope-Labeled Compounds |
| HY-N6698 | Aflatoxin G2 | 7241-98-7 | Natural Products |
| HY-N6698S | Aflatoxin G2-13C17 | 1217462-49-1 | Isotope-Labeled Compounds |
| HY-N6699 | Aflatoxin M1 | 6795-23-9 | Natural Products |
| HY-N6699S | Aflatoxin M1-13C17 | 2707441-97-0 | Isotope-Labeled Compounds |
| HY-N6700 | Aflatoxin M2 | 6885-57-0 | Natural Products |
| HY-N6700R | Aflatoxin M2 (Standard) | 6885-57-0 | Reference Standards |
| HY-N6700S | Aflatoxin M2-13C17 | Isotope-Labeled Compounds | |
| HY-N6701 | Dihydrocytochalasin B | 39156-67-7 | Natural Products |
| HY-N6702 | Enniatin A | 2503-13-1 | Natural Products |
| HY-N6703 | ar-Turmerone | 532-65-0 | Natural Products |
| HY-N6703R | ar-Turmerone (Standard) | 532-65-0 | Reference Standards |
| HY-N6703S | ar-Turmerone-d3 | Isotope-Labeled Compounds | |
| HY-N6704 | Enniatin A1 | 4530-21-6 | Natural Products |
| HY-N6705 | Tropodithietic acid | 750590-18-2 | Natural Products |
| HY-N6706 | Enniatin complex | 11113-62-5 | Natural Products |
| HY-N6707 | Triacsin C | 76896-80-5 | Natural Products |
| HY-N6708 | Alamethicin | 27061-78-5 | Natural Products |
| HY-N6709 | Zeranol | 26538-44-3 | Natural Products |
| HY-N6710 | α-Zearalenol | 36455-72-8 | Reference compound |
| HY-N6710R | α-Zearalenol (Standard) | 36455-72-8 | Reference Standards |
| HY-N6710S | α-Zearalenol-d4 | 1778734-73-8 | Isotope-Labeled Compounds |
| HY-N6711 | Equisetin | 57749-43-6 | Natural Products |
| HY-N6711A | epi-Equisetin | 255377-45-8 | Natural Products |
| HY-N6712 | Thiolutin | 87-11-6 | Natural Products |
| HY-N6712R | Thiolutin (Standard) | 87-11-6 | Reference Standards |
| HY-N6713 | (-)-Altenuene | 889101-41-1 | Natural Products |
| HY-N6713A | Altenuene | 29752-43-0 | Natural Products |
| HY-N6713AS | Altenuene-d3 | 2757575-86-1 | Isotope-Labeled Compounds |
| HY-N6714 | Alternariol | 641-38-3 | Natural Products |
| HY-N6714R | Alternariol (Standard) | 641-38-3 | Reference Standards |
| HY-N6714S2 | Alternariol-13C14 | Isotope-Labeled Compounds | |
| HY-N6715 | Tenuazonic acid | 610-88-8 | Natural Products |
| HY-N6715R | Tenuazonic acid (Standard) | 610-88-8 | Reference Standards |
| HY-N6715S | Tenuazonic acid-13C10 | Isotope-Labeled Compounds | |
| HY-N6716 | Filipin complex | 11078-21-0 | Dye Reagents |
| HY-N6717 | Tentoxin | 28540-82-1 | Natural Products |
| HY-N6718 | Filipin III | 480-49-9 | Natural Products |
| HY-N6719 | Fumonisin B1 | 116355-83-0 | Natural Products |
| HY-N6719S | Fumonisin B1-13C34 | 1217458-62-2 | Isotope-Labeled Compounds |
| HY-N6720 | T-2 Triol | 34114-98-2 | Natural Products |
| HY-N6721 | T-2 Tetraol | 34114-99-3 | Natural Products |
| HY-N6722 | Swainsonine | 72741-87-8 | Natural Products |
| HY-N6723 | Fumonisin B2 | 116355-84-1 | Natural Products |
| HY-N6723S | Fumonisin B2-13C34 | 1217481-36-1 | Isotope-Labeled Compounds |
| HY-N6724 | Altertoxin I | 56258-32-3 | Natural Products |
| HY-N6725 | Sterigmatocystine | 10048-13-2 | Natural Products |
| HY-N6725R | Sterigmatocystine (Standard) | 10048-13-2 | Reference Standards |
| HY-N6725S | Sterigmatocystine-13C18 | Isotope-Labeled Compounds | |
| HY-N6726 | Fumonisin B3 | 1422359-85-0 | Natural Products |
| HY-N6726R | Fumonisin B3 (Standard) | 1422359-85-0 | Reference Standards |
| HY-N6726S | Fumonisin B3-13C34 | 2819816-90-3 | Isotope-Labeled Compounds |
| HY-N6726S1 | Fumonisin B3-13C34-1 | 1217494-88-6 | Isotope-Labeled Compounds |
| HY-N6727 | Gliotoxin | 67-99-2 | Natural Products |
| HY-N6728 | Helvolic acid | 29400-42-8 | Natural Products |
| HY-N6729 | HT-2 Toxin | 26934-87-2 | Natural Products |
| HY-N6729S2 | HT-2 Toxin-13C22 | 1486469-92-4 | Isotope-Labeled Compounds |
| HY-N6730 | Hydrolyzed Fumonisin B1 | 145040-09-1 | Natural Products |
| HY-N6731 | Hydrolyzed Fumonisin B2 | 147985-10-2 | Natural Products |
| HY-N6732 | K-252a | 99533-80-9 | Natural Products |
| HY-N6733 | Aphidicolin | 38966-21-1 | Natural Products |
| HY-N6733R | Aphidicolin (Standard) | 38966-21-1 | Reference Standards |
| HY-N6734 | K-252b | 99570-78-2 | Natural Products |
| HY-N6735 | Apicidin | 183506-66-3 | Natural Products |
| HY-N6736 | K-252c | 85753-43-1 | Natural Products |
| HY-N6737 | Aureothricin | 574-95-8 | Natural Products |
| HY-N6738 | Bafilomycin B1 | 88899-56-3 | Natural Products |
| HY-N6739 | Beauvericin | 26048-05-5 | Natural Products |
| HY-N6739R | Beauvericin (Standard) | 26048-05-5 | Reference Standards |
| HY-N6739S | Beauvericin-13C45 | Isotope-Labeled Compounds | |
| HY-N6740 | Beta-Zearalanol | 42422-68-4 | Natural Products |
| HY-N6740R | Beta-Zearalanol (Standard) | 42422-68-4 | Reference Standards |
| HY-N6740S | β-Zearalanol-d4 | 1778735-09-3 | Isotope-Labeled Compounds |
| HY-N6741 | β-Zearalenol | 71030-11-0 | Natural Products |
| HY-N6741R | β-Zearalenol (Standard) | 71030-11-0 | Reference Standards |
| HY-N6742 | Borrelidin | 7184-60-3 | Natural Products |
| HY-N6743 | Cercosporin | 35082-49-6 | Natural Products |
| HY-N6744 | Chaetoglobosin A | 50335-03-0 | Natural Products |
| HY-N6745 | Citreoviridin | 25425-12-1 | Natural Products |
| HY-N6745S | Citreoviridin-13C23 | Isotope-Labeled Compounds | |
| HY-N6746 | Citrinin | 518-75-2 | Natural Products |
| HY-N6746R | Citrinin (Standard) | 518-75-2 | Reference Standards |
| HY-N6746S1 | Citrinin-13C13 | Isotope-Labeled Compounds | |
| HY-N6747 | Stauprimide | 154589-96-5 | Reference compound |
| HY-N6748 | Roquefortine C | 58735-64-1 | Natural Products |
| HY-N6769 | Radicicol | 12772-57-5 | Natural Products |
| HY-N6770 | Curvularin | 10140-70-2 | Natural Products |
| HY-N6771 | Cyclopiazonic acid | 18172-33-3 | Natural Products |
| HY-N6771R | Cyclopiazonic acid (Standard) | 18172-33-3 | Reference Standards |
| HY-N6772 | Cytochalasin E | 36011-19-5 | Natural Products |
| HY-N6772R | Cytochalasin E (Standard) | 36011-19-5 | Reference Standards |
| HY-N6773 | Cytochalasin A | 14110-64-6 | Natural Products |
| HY-N6773R | Cytochalasin A (Standard) | 14110-64-6 | Reference Standards |
| HY-N6774 | Cytochalasin C | 22144-76-9 | Natural Products |
| HY-N6775 | Sonolisib | 502632-66-8 | Reference compound |
| HY-N6776 | Penitrem A | 12627-35-9 | Natural Products |
| HY-N6776R | Penitrem A (Standard) | 12627-35-9 | Reference Standards |
| HY-N6777 | Penicillic acid | 90-65-3 | Reference compound |
| HY-N6777R | Penicillic acid (Standard) | 90-65-3 | Reference Standards |
| HY-N6778 | Paxilline | 57186-25-1 | Natural Products |
| HY-N6779 | Patulin | 149-29-1 | Natural Products |
| HY-N6779R | Patulin (Standard) | 149-29-1 | Reference Standards |
| HY-N6779S | Patulin-13C7 | 1353867-99-8 | Isotope-Labeled Compounds |
| HY-N6780 | Ophiobolin B | 5601-74-1 | Natural Products |
| HY-N6781 | Ophiobolin A | 4611-05-6 | Natural Products |
| HY-N6782 | Oligomycin | 1404-19-9 | Natural Products |
| HY-N6783 | Oligomycin C | 11052-72-5 | Natural Products |
| HY-N6784 | Oligomycin B | 11050-94-5 | Natural Products |
| HY-N6785 | Okadaic acid | 78111-17-8 | Natural Products |
| HY-N6785A | Okadaic acid (sodium) | 209266-80-8 | Reference compound |
| HY-N6786 | Ochratoxin B | 4825-86-9 | Natural Products |
| HY-N6786R | Ochratoxin B (Standard) | 4825-86-9 | Reference Standards |
| HY-N6786S | Ochratoxin B-13C20 | Isotope-Labeled Compounds | |
| HY-N6787 | 5,6-Dihydro-5-methyluracil | 696-04-8 | Natural Products |
| HY-N6787R | 5,6-Dihydro-5-methyluracil (Standard) | 696-04-8 | Reference Standards |
| HY-N6787S | 5,6-Dihydro-5-methyluracil-d6 | 334473-42-6 | Isotope-Labeled Compounds |
| HY-N6789 | KT5720 | 108068-98-0 | Reference compound |
| HY-N6790 | Nonactin | 6833-84-7 | Natural Products |
| HY-N6791 | KT5823 | 126643-37-6 | Reference compound |
| HY-N6792 | T-2 Toxin | 21259-20-1 | Natural Products |
| HY-N6792S | T-2 Toxin-13C24 | Isotope-Labeled Compounds | |
| HY-N6793 | Phomopsin A | 64925-80-0 | Natural Products |
| HY-N6794 | 10Z-Hymenialdisine | 82005-12-7 | Natural Products |
| HY-N6795 | Leptomycin A | 87081-36-5 | Natural Products |
| HY-N6796 | Manumycin A | 52665-74-4 | Natural Products |
| HY-N6797 | Meleagrin | 71751-77-4 | Natural Products |
| HY-N6798 | Myriocin | 35891-70-4 | Natural Products |
| HY-N6798R | Myriocin (Standard) | 35891-70-4 | Reference Standards |
| HY-N6799 | Neosolaniol | 36519-25-2 | Natural Products |
| HY-N6799R | Neosolaniol (Standard) | 36519-25-2 | Reference Standards |
| HY-N6800 | Netropsin | 1438-30-8 | Natural Products |
| HY-N6800A | Netropsin (dihydrochloride) | 18133-22-7 | Reference compound |
| HY-N6801 | Nivalenol | 23282-20-4 | Natural Products |
| HY-N6801R | Nivalenol (Standard) | 23282-20-4 | Reference Standards |
| HY-N6801S | Nivalenol-13C15 | 911392-40-0 | Isotope-Labeled Compounds |
| HY-N6802 | Tigloylgomisin H | 66069-55-4 | Natural Products |
| HY-N6803 | Polygalaxanthone XI | 857859-82-6 | Natural Products |
| HY-N6804 | Diammonium Glycyrrhizinate | 79165-06-3 | Natural Products |
| HY-N6805 | Isoeugenol acetate | 93-29-8 | Natural Products |
| HY-N6805A | (E)-Isoeugenol acetate | 5912-87-8 | Natural Products |
| HY-N6805R | Isoeugenol acetate (Standard) | 93-29-8 | Reference Standards |
| HY-N6806 | Timosaponin B III | 142759-74-8 | Natural Products |
| HY-N6807 | Elemicin | 487-11-6 | Natural Products |
| HY-N6807S | Elemicin-d3 | Isotope-Labeled Compounds | |
| HY-N6808 | Rebaudioside B | 58543-17-2 | Natural Products |
| HY-N6808R | Rebaudioside B (Standard) | 58543-17-2 | Reference Standards |
| HY-N6810 | Thymol | 89-83-8 | Natural Products |
| HY-N6810R | Thymol (Standard) | 89-83-8 | Reference Standards |
| HY-N6810S | Thymol-d13 | 1219798-93-2 | Isotope-Labeled Compounds |
| HY-N6811 | 1-Octacosanol | 557-61-9 | Natural Products |
| HY-N6812 | Karacoline | 39089-30-0 | Natural Products |
| HY-N6814 | Mogroside IIe | 88901-38-6 | Natural Products |
| HY-N6815 | Isomogroside V | 1126032-65-2 | Natural Products |
| HY-N6815R | Isomogroside V (Standard) | 1126032-65-2 | Reference Standards |
| HY-N6816 | Ludaconitine | 82144-72-7 | Natural Products |
| HY-N6817 | Isoagarotetrol | 104060-61-9 | Natural Products |
| HY-N6818 | 5,7,4'-Trimethoxyflavone | 5631-70-9 | Natural Products |
| HY-N6818R | 5,?7,?4'-?Trimethoxyflavone (Standard) | 5631-70-9 | Reference Standards |
| HY-N6819 | Iristectorin B | 94396-09-5 | Natural Products |
| HY-N6820 | Iristectorin A | 37744-61-9 | Natural Products |
| HY-N6821 | 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | 129499-78-1 | Reference compound |
| HY-N6821R | 2-O-α-D-Glucopyranosyl-L-ascorbic Acid (Standard) | 129499-78-1 | Reference Standards |
| HY-N6822 | Triglochinic acid | 31795-12-7 | Natural Products |
| HY-N6824 | Hydroxy-β-sanshool | 97465-69-5 | Natural Products |
| HY-N6825 | Hydroxy-α-sanshool | 83883-10-7 | Natural Products |
| HY-N6825R | Hydroxy-α-sanshool (Standard) | 83883-10-7 | Reference Standards |
| HY-N6826 | Asatone | 38451-63-7 | Natural Products |
| HY-N6827 | Usaramine N-oxide | 117020-54-9 | Natural Products |
| HY-N6827R | Usaramine N-oxide (Standard) | 117020-54-9 | Reference Standards |
| HY-N6828 | Monocrotaline N-Oxide | 35337-98-5 | Natural Products |
| HY-N6828R | Monocrotaline N-Oxide (Standard) | 35337-98-5 | Reference Standards |
| HY-N6829 | Retusin | 1245-15-4 | Natural Products |
| HY-N6829R | Retusin (Standard) | 1245-15-4 | Reference Standards |
| HY-N6831 | Xylohexaose | 49694-21-5 | Natural Products |
| HY-N6832 | Rebaudioside N | 1220616-46-5 | Natural Products |
| HY-N6832R | Rebaudioside N (Standard) | 1220616-46-5 | Reference Standards |
| HY-N6833 | Rebaudioside M | 1220616-44-3 | Natural Products |
| HY-N6833R | Rebaudioside M (Standard) | 1220616-44-3 | Reference Standards |
| HY-N6834 | Fructo-oligosaccharide DP10/GF9 | 118150-64-4 | Natural Products |
| HY-N6835 | Fructo-oligosaccharide DP9/GF8 | 143625-74-5 | Natural Products |
| HY-N6836 | Fructo-oligosaccharide DP8/GF7 | 62512-21-4 | Natural Products |
| HY-N6837 | Fructo-oligosaccharide DP7/GF6 | 62512-20-3 | Natural Products |
| HY-N6838 | 1,1,1,1-Kestohexaose | 62512-19-0 | Natural Products |
| HY-N6839 | 1,4-b-D-Xylopentaose | 49694-20-4 | Natural Products |
| HY-N6840 | Xylotetraose | 22416-58-6 | Natural Products |
| HY-N6841 | Rhodiolin | 86831-53-0 | Natural Products |
| HY-N6842 | ArnicolideC | 34532-67-7 | Natural Products |
| HY-N6843 | Arnicolide D | 34532-68-8 | Natural Products |
| HY-N6844 | 8,9-Epoxy-3-isobutyryloxy-10-(2-methylbutanoyl)thymol | 22518-07-6 | Natural Products |
| HY-N6845 | 3-Isomangostin | 19275-46-8 | Natural Products |
| HY-N6846 | 10-Isobutyryloxy-8,9-epoxythymol isobutyrate | 22518-06-5 | Natural Products |
| HY-N6847 | 5,6,7,40-Tetrahydroxyisoflavone-6,7-di-o-b-D-glucopyranoside | 1219001-04-3 | Natural Products |
| HY-N6848 | Acetylseneciphylline N-oxide | 123844-00-8 | Reference compound |
| HY-N6849 | InteriotherinA | 181701-06-4 | Natural Products |
| HY-N6850 | Calenduloside E | 26020-14-4 | Natural Products |
| HY-N6851 | Glycyrrhetic acid 3-O-β-D-glucuronide | 34096-83-8 | Natural Products |
| HY-N6852 | 11-Oxomogroside IIe | 918972-06-2 | Natural Products |
| HY-N6853 | Mogroside I E1 | 88901-39-7 | Natural Products |
| HY-N6854 | Mogroside I A1 | 88901-46-6 | Natural Products |
| HY-N6854A | 3α-Hydroxymogroside IA1 | Reference compound | |
| HY-N6855 | Mogroside IIA1 | 88901-44-4 | Natural Products |
| HY-N6856 | 4-Hydroxycoumarin | 1076-38-6 | Natural Products |
| HY-N6856R | 4-Hydroxycoumarin (Standard) | 1076-38-6 | Reference Standards |
| HY-N6857 | Armepavine | 524-20-9 | Natural Products |
| HY-N6857A | (+)-Armepavine | 14400-96-5 | Natural Products |
| HY-N6857C | (±)-Armepavine (hydrochloride) | 13944-21-3 | Reference compound |
| HY-N6857R | Armepavine (Standard) | 524-20-9 | Reference Standards |
| HY-N6858 | 4-Hydroxyisoleucine | 781658-23-9 | Natural Products |
| HY-N6858R | 4-Hydroxyisoleucine (Standard) | 781658-23-9 | Reference Standards |
| HY-N6859 | Lucidenic acid LM1 | 364622-33-3 | Natural Products |
| HY-N6860 | Lucidenic acid C | 95311-96-9 | Natural Products |
| HY-N6861 | Lucidenic acid B | 95311-95-8 | Natural Products |
| HY-N6862 | Lucideric acid A | 95311-94-7 | Natural Products |
| HY-N6864 | Isovanillic acid | 645-08-9 | Natural Products |
| HY-N6865 | Groenlandicine | 38691-95-1 | Natural Products |
| HY-N6866 | Gomisin N | 69176-52-9 | Natural Products |
| HY-N6867 | Ganoderenic acid E | 110241-23-1 | Natural Products |
| HY-N6868 | Dimethyl lithospermate B | 875313-64-7 | Natural Products |
| HY-N6869 | Dehydroabietic acid | 1740-19-8 | Natural Products |
| HY-N6869R | Dehydroabietic acid (Standard) | 1740-19-8 | Reference Standards |
| HY-N6871 | Abietic acid | 514-10-3 | Natural Products |
| HY-N6872 | Actein | 18642-44-9 | Natural Products |
| HY-N6872R | Actein (Standard) | 18642-44-9 | Reference Standards |
| HY-N6873 | GL3 | 60037-39-0 | Natural Products |
| HY-N6874 | Ligustrosidic acid | 96382-89-7 | Natural Products |
| HY-N6875 | Oleuropeinic acid | 96382-90-0 | Natural Products |
| HY-N6876 | Secologanoside | 59472-23-0 | Natural Products |
| HY-N6876R | Secologanoside (Standard) | 59472-23-0 | Reference Standards |
| HY-N6877 | Purpurogallin carboxylic acid | 5146-12-3 | Natural Products |
| HY-N6878 | Cauloside D | 12672-45-6 | Natural Products |
| HY-N6879 | DiosMetin 7-O-β-D-Glucuronide | 35110-20-4 | Natural Products |
| HY-N6879R | DiosMetin 7-O-β-D-Glucuronide (Standard) | 35110-20-4 | Reference Standards |
| HY-N6880 | Rabdosiin | 263397-69-9 | Natural Products |
| HY-N6880A | (-)-Rabdosiin | 119152-54-4 | Natural Products |
| HY-N6881 | Gypenoside XIII | 80325-22-0 | Natural Products |
| HY-N6882 | Genistein 8-c-glucoside | 66026-80-0 | Natural Products |
| HY-N6883 | 6-Methoxytricin | 76015-42-4 | Natural Products |
| HY-N6884 | Bixin | 6983-79-5 | Natural Products |
| HY-N6884R | Bixin (Standard) | 6983-79-5 | Reference Standards |
| HY-N6885 | Puerarin-4'-O-β-D-glucopyranoside | 117047-08-2 | Natural Products |
| HY-N6886 | Rebaudioside J | 1313049-59-0 | Natural Products |
| HY-N6887 | Rebaudioside F | 438045-89-7 | Natural Products |
| HY-N6888 | Rebaudioside E | 63279-14-1 | Natural Products |
| HY-N6888R | Rebaudioside E (Standard) | 63279-14-1 | Reference Standards |
| HY-N6889 | Rebaudioside I | 1220616-34-1 | Natural Products |
| HY-N6890 | Tarasaponin VI | 59252-95-8 | Natural Products |
| HY-N6891 | Hamaudol | 735-46-6 | Natural Products |
| HY-N6892 | 3'-O-Acetylhamaudol | 30358-88-4 | Natural Products |
| HY-N6893 | Ergolide | 54999-07-4 | Natural Products |
| HY-N6894 | Pseudocoptisine (acetate) | 30426-66-5 | Natural Products |
| HY-N6894A | Pseudocoptisine (chloride) | 30044-78-1 | Natural Products |
| HY-N6895 | Violanthin | 40581-17-7 | Natural Products |
| HY-N6896 | Isoviolanthin | 40788-84-9 | Natural Products |
| HY-N6896R | Isoviolanthin (Standard) | 40788-84-9 | Reference Standards |
| HY-N6897 | Podecdysone B | 22612-27-7 | Natural Products |
| HY-N6898 | 3-O-Acetylbufotalin | 4029-69-0 | Reference compound |
| HY-N6899 | Crocetine dimethyl ester | 5892-54-6 | Reference compound |
| HY-N6901 | Luteolin 7-sulfate | 56857-57-9 | Natural Products |
| HY-N6902 | Linderene acetate | 26146-28-1 | Natural Products |
| HY-N6903 | Geoside | 585-90-0 | Natural Products |
| HY-N6904 | Crocetin monomethyl ester | 25368-09-6 | Natural Products |
| HY-N6904R | Crocetin monomethyl ester (Standard) | 25368-09-6 | Reference Standards |
| HY-N6905 | Acetylarenobufagin | 184673-79-8 | Natural Products |
| HY-N6906 | Oleuroside | 116383-31-4 | Natural Products |
| HY-N6906R | Oleuroside (Standard) | 116383-31-4 | Reference Standards |
| HY-N6907 | Dahurinol | 38908-87-1 | Natural Products |
| HY-N6908 | Continentalic acid | 19889-23-7 | Natural Products |
| HY-N6908R | Continentalic acid (Standard) | 19889-23-7 | Reference Standards |
| HY-N6909 | Neochebulagic acid | 28196-46-5 | Natural Products |
| HY-N6910 | Pseudolaric Acid C2 | 82508-35-8 | Natural Products |
| HY-N6911 | Licorice-saponin H2 | 118441-85-3 | Natural Products |
| HY-N6911A | 18α-Glycyrrhizic acid | 83896-44-0 | Natural Products |
| HY-N6911B | Licorice-saponin H2 (ammonium) | 2484765-33-3 | Natural Products |
| HY-N6912 | Regelidine | 114542-54-0 | Natural Products |
| HY-N6913 | 3α-Hydroxymogrol | 1343402-73-2 | Natural Products |
| HY-N6914 | Nortanshinone | 97399-70-7 | Natural Products |
| HY-N6915 | Mogroside II-A | 1613527-65-3 | Natural Products |
| HY-N6916 | Siraitic Acid B | 183374-16-5 | Natural Products |
| HY-N6917 | Siraitic Acid A | 183374-15-4 | Natural Products |
| HY-N6918 | Steviol-19-O-glucoside | 1185737-16-9 | Natural Products |
| HY-N6919 | Cauloside C | 20853-58-1 | Natural Products |
| HY-N6920 | 11-Oxomogroside IIIE | 2096516-68-4 | Natural Products |
| HY-N6920R | 11-Oxomogroside IIIE (Standard) | 2096516-68-4 | Reference Standards |
| HY-N6921 | 11-Oxomogroside III | 952481-53-7 | Natural Products |
| HY-N6922 | Danshenxinkun B | 65907-76-8 | Natural Products |
| HY-N6923 | N-(3-Methoxybenzyl)oleamide | 883715-21-7 | Natural Products |
| HY-N6924 | Zingibroside R1 | 80930-74-1 | Natural Products |
| HY-N6925 | Scutellarin methyl ester | 119262-68-9 | Natural Products |
| HY-N6926 | 1,3,5-Tricaffeoylquinic acid | 1073897-80-9 | Natural Products |
| HY-N6927 | Isoforskolin | 64657-21-2 | Natural Products |
| HY-N6927R | Isoforskolin (Standard) | 64657-21-2 | Reference Standards |
| HY-N6928 | Mogroside III-E | 88901-37-5 | Natural Products |
| HY-N6928R | Mogroside III-E (Standard) | 88901-37-5 | Reference Standards |
| HY-N6929 | Angelic acid | 565-63-9 | Natural Products |
| HY-N6929R | Angelic acid (Standard) | 565-63-9 | Reference Standards |
| HY-N6930 | Shikonofuran A | 85022-66-8 | Natural Products |
| HY-N6931 | Usaramine | 15503-87-4 | Natural Products |
| HY-N6931R | Usaramine (Standard) | 15503-87-4 | Reference Standards |
| HY-N6932 | Voacamine | 3371-85-5 | Natural Products |
| HY-N6933 | 1-Triacontanol | 593-50-0 | Natural Products |
| HY-N6935 | Sennidin B | 517-44-2 | Natural Products |
| HY-N6935R | Sennidin B (Standard) | 517-44-2 | Reference Standards |
| HY-N6936 | Sennidin A | 641-12-3 | Natural Products |
| HY-N6936R | Sennidin A (Standard) | 641-12-3 | Reference Standards |
| HY-N6937 | (R,R)-Secoisolariciresinol diglucoside | 158932-33-3 | Natural Products |
| HY-N6937R | (R,R)-Secoisolariciresinol diglucoside (Standard) | 158932-33-3 | Reference Standards |
| HY-N6937S1 | (R,R)-Secoisolariciresinol diglucoside-d6 | Isotope-Labeled Compounds | |
| HY-N6938 | Pseudolaric acid B β-D-glucoside | 98891-41-9 | Natural Products |
| HY-N6939 | Pseudolaric Acid B | 82508-31-4 | Natural Products |
| HY-N6939R | Pseudolaric Acid B (Standard) | 82508-31-4 | Reference Standards |
| HY-N6940 | Prosapogenin A | 19057-67-1 | Natural Products |
| HY-N6940R | Prosapogenin A (Standard) | 19057-67-1 | Reference Standards |
| HY-N6941 | Angelicain | 49624-66-0 | Natural Products |
| HY-N6942 | Mogroside IV-A | 88901-41-1 | Natural Products |
| HY-N6945 | Mogroside IV | 89590-95-4 | Natural Products |
| HY-N6945R | Mogroside IV (Standard) | 89590-95-4 | Reference Standards |
| HY-N6946 | Mitraphylline | 509-80-8 | Natural Products |
| HY-N6946R | Mitraphylline (Standard) | 509-80-8 | Reference Standards |
| HY-N6947 | Lutein | 127-40-2 | Natural Products |
| HY-N6947R | Lutein (Standard) | 127-40-2 | Reference Standards |
| HY-N6948 | Linalyl acetate | 115-95-7 | Natural Products |
| HY-N6948R | Linalyl acetate (Standard) | 115-95-7 | Reference Standards |
| HY-N6948S | Linalyl acetate-d6 | Isotope-Labeled Compounds | |
| HY-N6949 | Juglone | 481-39-0 | Natural Products |
| HY-N6949R | Juglone (Standard) | 481-39-0 | Reference Standards |
| HY-N6950 | Hederacolchiside A1 | 106577-39-3 | Natural Products |
| HY-N6950R | Hederacolchiside A1 (Standard) | 106577-39-3 | Reference Standards |
| HY-N6951 | Guaiazulene | 489-84-9 | Natural Products |
| HY-N6951R | Guaiazulene (Standard) | 489-84-9 | Reference Standards |
| HY-N6952 | Geraniol | 106-24-1 | Natural Products |
| HY-N6952R | Geraniol (Standard) | 106-24-1 | Reference Standards |
| HY-N6953 | Garcinone D | 107390-08-9 | Natural Products |
| HY-N6953R | Garcinone D (Standard) | 107390-08-9 | Reference Standards |
| HY-N6954 | Garcinone C | 76996-27-5 | Natural Products |
| HY-N6954R | Garcinone C (Standard) | 76996-27-5 | Reference Standards |
| HY-N6955 | Eupalinilide B | 757202-08-7 | Natural Products |
| HY-N6956 | 5-MethoxyPinocembroside | 1450878-89-3 | Natural Products |
| HY-N6957 | 8-Keto-berberine | 81397-08-2 | Reference compound |
| HY-N6958 | 2-O-β-D-Glucopyranosyl-L-ascorbic acid | 562043-82-7 | Natural Products |
| HY-N6960 | L-Stepholidine | 16562-13-3 | Natural Products |
| HY-N6961 | Lapachol | 84-79-7 | Natural Products |
| HY-N6961R | Lapachol (Standard) | 84-79-7 | Reference Standards |
| HY-N6962 | α-Spinasterol | 481-18-5 | Natural Products |
| HY-N6963 | Choerospondin | 81202-36-0 | Natural Products |
| HY-N6964 | Quercetin 3-O-β-D-(6''-p-coumaroyl)glucopyranosyl(1→2)-α-L-rhamnopyranoside | 143061-65-8 | Natural Products |
| HY-N6965 | Kaempferol-3-O-(6'''-trans-p-coumaroyl-2''-glucosyl)rhamnoside | 111957-48-3 | Natural Products |
| HY-N6966 | Ethyl Caffeate | 102-37-4 | Natural Products |
| HY-N6966A | Ethyl trans-caffeate | 66648-50-8 | Natural Products |
| HY-N6967 | Levomenol | 23089-26-1 | Natural Products |
| HY-N6967R | Levomenol (Standard) | 23089-26-1 | Reference Standards |
| HY-N6968 | α-Humulene | 6753-98-6 | Natural Products |
| HY-N6968R | α-Humulene (Standard) | 6753-98-6 | Reference Standards |
| HY-N6969 | Dicentrine | 517-66-8 | Natural Products |
| HY-N6969A | Dicentrine (hydrochloride) | 5742-03-0 | Natural Products |
| HY-N6970 | Araloside V | 340963-86-2 | Natural Products |
| HY-N6971 | Cimiracemoside C | 256925-92-5 | Natural Products |
| HY-N6971R | Cimiracemoside C (Standard) | 256925-92-5 | Reference Standards |
| HY-N6972 | Cepharanthine | 481-49-2 | Natural Products |
| HY-N6972R | Cepharanthine (Standard) | 481-49-2 | Reference Standards |
| HY-N6973 | Boldine | 476-70-0 | Natural Products |
| HY-N6973R | Boldine (Standard) | 476-70-0 | Reference Standards |
| HY-N6974 | Ascr#2 | 946524-24-9 | Natural Products |
| HY-N6975 | Glyasperin D | 142561-10-2 | Natural Products |
| HY-N6976 | Ascr#8 | 1172120-40-9 | Natural Products |
| HY-N6977 | Ascr#3 | 946524-26-1 | Natural Products |
| HY-N6978 | Ascr#5 | 1086696-26-5 | Natural Products |
| HY-N6979 | Crustecdysone | 5289-74-7 | Natural Products |
| HY-N6979R | Crustecdysone (Standard) | 5289-74-7 | Reference Standards |
| HY-N6980 | Licorice glycoside C2 | 202657-55-4 | Natural Products |
| HY-N6981 | Methyl Glycyrrhizate | 104191-95-9 | Reference compound |
| HY-N6982 | Licoricesaponin A3 | 118325-22-7 | Natural Products |
| HY-N6983 | Licoricesaponin G2 | 118441-84-2 | Natural Products |
| HY-N6984 | Glycyroside | 125310-04-5 | Natural Products |
| HY-N6985 | Baccatin III | 27548-93-2 | Natural Products |
| HY-N6985R | Baccatin III (Standard) | 27548-93-2 | Reference Standards |
| HY-N6986 | Liquiritigenin-7-O-β-D-glucopyranosyl-(1→2)-β-D-apiofuranoside | 135432-48-3 | Natural Products |
| HY-N6987 | Licraside | 29913-71-1 | Natural Products |
| HY-N6988 | Cimigenol | 3779-59-7 | Natural Products |
| HY-N6989 | Isoglycycoumarin | 117038-82-1 | Natural Products |
| HY-N6990 | Anhydrosecoisolariciresinol | 29388-33-8 | Natural Products |
| HY-N6991 | 11-Deoxymogroside IIIE | 1793003-47-0 | Natural Products |
| HY-N6992 | Dulcoside A | 64432-06-0 | Natural Products |
| HY-N6992R | Dulcoside A (Standard) | 64432-06-0 | Reference Standards |
| HY-N6993 | 25-O-Methylalisol A | 155801-00-6 | Natural Products |
| HY-N6994 | Isoasatone A | 67451-73-4 | Natural Products |
| HY-N6995 | Marrubiin | 465-92-9 | Natural Products |
| HY-N6995R | Marrubiin (Standard) | 465-92-9 | Reference Standards |
| HY-N6996 | Methyl Eugenol | 93-15-2 | Natural Products |
| HY-N6996R | Methyl Eugenol (Standard) | 93-15-2 | Reference Standards |
| HY-N6996S | Methyl Eugenol-13C,d3 | Isotope-Labeled Compounds | |
| HY-N6997 | Ceratamine A | 634151-15-8 | Natural Products |
| HY-N6998 | Paederosidic acid | 18842-98-3 | Natural Products |
| HY-N7000 | Perillyl alcohol | 536-59-4 | Natural Products |
| HY-N7000R | Perillyl alcohol (Standard) | 536-59-4 | Reference Standards |
| HY-N7002 | Nagarine | 41849-35-8 | Natural Products |
| HY-N7003 | 28-Demethyl-β-amyrone | 73493-60-4 | Natural Products |
| HY-N7004 | Arborine | 6873-15-0 | Natural Products |
| HY-N7005 | Clitorin | 55804-74-5 | Natural Products |
| HY-N7006 | Timosaponin C | 185432-00-2 | Natural Products |
| HY-N7007 | Sclareol glycol | 55881-96-4 | Natural Products |
| HY-N7007R | Sclareol glycol (Standard) | 55881-96-4 | Reference Standards |
| HY-N7008 | Fructo-oligosaccharide DP11/GF10 | 137405-36-8 | Natural Products |
| HY-N7009 | Fructo-oligosaccharide DP12/GF11 | 137405-40-4 | Natural Products |
| HY-N7010 | (-)-Corynoxidine | 57906-85-1 | Natural Products |
| HY-N7011 | Epicorynoxidine | 58000-48-9 | Natural Products |
| HY-N7012 | 7,3',4'-Tri-O-methylluteolin | 29080-58-8 | Natural Products |
| HY-N7013 | Hydroxy-Epsilon-Sanshool | 252193-26-3 | Natural Products |
| HY-N7014 | Hydroxyl-γ-isosanshool | 127514-62-9 | Natural Products |
| HY-N7015 | Zerumbone | 471-05-6 | Natural Products |
| HY-N7015R | Zerumbone (Standard) | 471-05-6 | Reference Standards |
| HY-N7017 | 19-Oxocinobufagin | 24512-59-2 | Natural Products |
| HY-N7018 | 20-Hydroxyganoderic Acid G | 400604-12-8 | Natural Products |
| HY-N7019 | 19-Hydroxybufalin | 39844-86-5 | Natural Products |
| HY-N7020 | Cinobufaginol | 6691-83-4 | Natural Products |
| HY-N7021 | 12-Hydroxyganoderic Acid D | 942950-96-1 | Natural Products |
| HY-N7022 | Eclalbasaponin I | 158511-59-2 | Natural Products |
| HY-N7022R | Eclalbasaponin I (Standard) | 158511-59-2 | Reference Standards |
| HY-N7023 | 7-Prenyloxycoumarin | 10387-50-5 | Natural Products |
| HY-N7024 | Quercetin 3-O-(6''-galloyl)-β-D-galactopyranoside | 53171-28-1 | Natural Products |
| HY-N7025 | Suavissimoside R1 | 95645-51-5 | Natural Products |
| HY-N7026 | Celosin I | 1807732-38-2 | Natural Products |
| HY-N7027 | Macrozamin | 6327-93-1 | Natural Products |
| HY-N7027R | Macrozamin (Standard) | 6327-93-1 | Reference Standards |
| HY-N7028 | Withanolide A | 32911-62-9 | Natural Products |
| HY-N7028R | Withanolide A (Standard) | 32911-62-9 | Reference Standards |
| HY-N7029 | 3',4',5',5,7-Pentamethoxyflavone | 53350-26-8 | Natural Products |
| HY-N7030 | 5,7,3',4'-Tetramethoxyflavone | 855-97-0 | Natural Products |
| HY-N7031 | (±)-Vasicine | 6159-56-4 | Natural Products |
| HY-N7031R | (±)?-?Vasicine (Standard) | 6159-56-4 | Reference Standards |
| HY-N7032 | Uridine 5′-diphosphoglucose (disodium salt) | 28053-08-9 | Natural Products |
| HY-N7032S | Uridine 5′-diphosphoglucose-13C (disodium) | 478529-38-3 | Isotope-Labeled Compounds |
| HY-N7032S1 | Uridine 5′-diphosphoglucose-13C6 (disodium) | 2483735-04-0 | Isotope-Labeled Compounds |
| HY-N7033 | UDP-glucuronic acid (trisodium) | 63700-19-6 | Reference compound |
| HY-N7033R | UDP-glucuronic acid (trisodium) (Standard) | 63700-19-6 | Reference Standards |
| HY-N7034 | Magnolioside | 20186-29-2 | Natural Products |
| HY-N7035 | Wogonin 7-O-beta-D-glucuronide methyl ester | 82475-01-2 | Natural Products |
| HY-N7036 | Rhamnetin | 90-19-7 | Natural Products |
| HY-N7036R | Rhamnetin (Standard) | 90-19-7 | Reference Standards |
| HY-N7037 | Osthol hydrate | 69219-24-5 | Natural Products |
| HY-N7038 | Phytohemagglutinin | 9008-97-3 | Natural Products |
| HY-N7038A | Phytohemagglutinin P | Natural Products | |
| HY-N7039 | Mogroside IA-(1-3)-glucopyranoside | Natural Products | |
| HY-N7040 | 11-Deoxymogroside IIE | Natural Products | |
| HY-N7041 | 11-Oxomogroside IIa | Natural Products | |
| HY-N7043 | Isosilybin A | 142796-21-2 | Natural Products |
| HY-N7043R | Isosilybin A (Standard) | 142796-21-2 | Reference Standards |
| HY-N7044 | Vitexin (arginine) | Natural Products | |
| HY-N7045 | Isosilybin B | 142796-22-3 | Natural Products |
| HY-N7045R | Isosilybin B (Standard) | 142796-22-3 | Reference Standards |
| HY-N7046 | Silybin B | 142797-34-0 | Natural Products |
| HY-N7046R | Silybin B (Standard) | 142797-34-0 | Reference Standards |
| HY-N7046S | Silybin B-d3 | Isotope-Labeled Compounds | |
| HY-N7047 | 8-Epidiosbulbin E acetate | 91095-48-6 | Natural Products |
| HY-N7049 | Tubulysin F | 368870-67-1 | Natural Products |
| HY-N7050 | Tubulysin G | 799822-08-5 | Natural Products |
| HY-N7051 | Tubulysin H | 799822-09-6 | Natural Products |
| HY-N7052 | Tubulysin I | 799822-10-9 | Natural Products |
| HY-N7053 | Tubulysin M | 936691-46-2 | Natural Products |
| HY-N7054 | Volemitol | 488-38-0 | Natural Products |
| HY-N7055 | Trierucin | 2752-99-0 | Natural Products |
| HY-N7056 | 4'-Hydroxychalcone | 2657-25-2 | Natural Products |
| HY-N7057 | Nonanoic acid | 112-05-0 | Natural Products |
| HY-N7057R | Nonanoic acid (Standard) | 112-05-0 | Reference Standards |
| HY-N7057S | Nonanoic acid-d17 | 130348-94-6 | Isotope-Labeled Compounds |
| HY-N7057S1 | Nonanoic acid-d3 | 134646-27-8 | Isotope-Labeled Compounds |
| HY-N7057S2 | Nonanoic acid-d4 | 1219795-27-3 | Isotope-Labeled Compounds |
| HY-N7057S3 | Nonanoic acid-d2 | 62689-94-5 | Isotope-Labeled Compounds |
| HY-N7058 | cis-Jasmone | 488-10-8 | Natural Products |
| HY-N7058A | trans-Jasmone | 6261-18-3 | Natural Products |
| HY-N7058R | cis-?Jasmone (Standard) | 488-10-8 | Reference Standards |
| HY-N7058S | cis-Jasmone-d2 | Isotope-Labeled Compounds | |
| HY-N7059 | Lactobionic acid | 96-82-2 | Natural Products |
| HY-N7060 | Helicin | 618-65-5 | Natural Products |
| HY-N7061 | Tropine | 120-29-6 | Natural Products |
| HY-N7061R | Tropine (Standard) | 120-29-6 | Reference Standards |
| HY-N7062 | JNJ-1661010 | 681136-29-8 | Reference compound |
| HY-N7063 | Nerol | 106-25-2 | Natural Products |
| HY-N7063R | Nerol (Standard) | 106-25-2 | Reference Standards |
| HY-N7063S | Nerol-d2 | 32637-85-7 | Isotope-Labeled Compounds |
| HY-N7063S1 | Nerol-d6 | 66063-45-4 | Isotope-Labeled Compounds |
| HY-N7064 | Iminostilbene | 256-96-2 | Reference compound |
| HY-N7064R | Iminostilbene (Standard) | 256-96-2 | Reference Standards |
| HY-N7064S | Iminostilbene-d4 | Isotope-Labeled Compounds | |
| HY-N7065 | Dihydralazine (sulfate) | 7327-87-9 | Reference compound |
| HY-N7065R | Dihydralazine (sulfate) (Standard) | 7327-87-9 | Reference Standards |
| HY-N7066 | Difloxacin (hydrochloride) | 91296-86-5 | Reference compound |
| HY-N7066R | Difloxacin (hydrochloride) (Standard) | 91296-86-5 | Reference Standards |
| HY-N7067 | Revaprazan (hydrochloride) | 178307-42-1 | Reference compound |
| HY-N7068 | Mupirocin (calcium hydrate) | 115074-43-6 | Natural Products |
| HY-N7068R | Mupirocin (calcium hydrate) (Standard) | 115074-43-6 | Reference Standards |
| HY-N7069 | 4-Isopropylbenzyl alcohol | 536-60-7 | Natural Products |
| HY-N7069R | 4-Isopropylbenzyl alcohol (Standard) | 536-60-7 | Reference Standards |
| HY-N7070 | Geranyl acetate | 105-87-3 | Natural Products |
| HY-N7070R | Geranyl acetate (Standard) | 105-87-3 | Reference Standards |
| HY-N7071 | Maduramicin | 79356-08-4 | Reference compound |
| HY-N7071A | Maduramicin (ammonium) | 84878-61-5 | Natural Products |
| HY-N7071AR | Maduramicin (ammonium) (Standard) | 84878-61-5 | Reference Standards |
| HY-N7072 | Grape seed extract | 84929-27-1 | Natural Products |
| HY-N7073 | Silymarin | 65666-07-1 | Natural Products |
| HY-N7074 | Lanolin | 8006-54-0 | Natural Products |
| HY-N7075 | Inulin | 9005-80-5 | Natural Products |
| HY-N7076 | Aleuritic acid | 533-87-9 | Natural Products |
| HY-N7076R | Aleuritic acid (Standard) | 533-87-9 | Reference Standards |
| HY-N7078 | Spiculisporic acid | 469-77-2 | Natural Products |
| HY-N7079 | Erythorbic acid | 89-65-6 | Natural Products |
| HY-N7079A | Sodium erythorbate | 6381-77-7 | Natural Products |
| HY-N7079R | Erythorbic acid (Standard) | 89-65-6 | Reference Standards |
| HY-N7080 | Dihydroferulic acid | 1135-23-5 | Natural Products |
| HY-N7080R | Dihydroferulic acid (Standard) | 1135-23-5 | Reference Standards |
| HY-N7082 | D-Arabinose | 28697-53-2 | Natural Products |
| HY-N7082R | D-?Arabinose (Standard) | 28697-53-2 | Reference Standards |
| HY-N7082S | D-Arabinose-13C5 | Isotope-Labeled Compounds | |
| HY-N7083 | Citral | 5392-40-5 | Natural Products |
| HY-N7083R | Citral (Standard) | 5392-40-5 | Reference Standards |
| HY-N7084 | Methyl dihydrojasmonate | 24851-98-7 | Natural Products |
| HY-N7084R | Methyl dihydrojasmonate (Standard) | 24851-98-7 | Reference Standards |
| HY-N7085 | Citropten | 487-06-9 | Natural Products |
| HY-N7085R | Citropten (Standard) | 487-06-9 | Reference Standards |
| HY-N7086 | 1,3,5-Trimethylpyrazole | 1072-91-9 | Reference compound |
| HY-N7088 | Raffinose | 512-69-6 | Natural Products |
| HY-N7088R | Raffinose (Standard) | 512-69-6 | Reference Standards |
| HY-N7089 | Benzoyleneurea | 86-96-4 | Reference compound |
| HY-N7090 | Benzyl cinnamate | 103-41-3 | Natural Products |
| HY-N7090R | Benzyl cinnamate (Standard) | 103-41-3 | Reference Standards |
| HY-N7090S | Benzyl cinnamate-d5 | 347840-02-2 | Isotope-Labeled Compounds |
| HY-N7091 | Atrazine | 1912-24-9 | Reference compound |
| HY-N7091R | Atrazine (Standard) | 1912-24-9 | Reference Standards |
| HY-N7091S | Atrazine-15N | 287476-17-9 | Isotope-Labeled Compounds |
| HY-N7091S1 | Atrazine-13C3,15N3 | Isotope-Labeled Compounds | |
| HY-N7091S2 | Atrazine-d5 | 163165-75-1 | Isotope-Labeled Compounds |
| HY-N7092 | D-Fructose | 57-48-7 | Natural Products |
| HY-N7092A | L-(+)-Fructose, 95% | 7776-48-9 | Natural Products |
| HY-N7092AS | L-Fructose-1-13C | Isotope-Labeled Compounds | |
| HY-N7092R | D-Fructose (Standard) | 57-48-7 | Reference Standards |
| HY-N7092S | D-Fructose-13C6 | 201595-65-5 | Isotope-Labeled Compounds |
| HY-N7092S1 | D-Fructose-13C | 108311-21-3 | Isotope-Labeled Compounds |
| HY-N7092S10 | D-Fructose-d7 | Isotope-Labeled Compounds | |
| HY-N7092S11 | D-Fructose-d-1 | Isotope-Labeled Compounds | |
| HY-N7092S13 | D-Fructose-13C6,d7 | Isotope-Labeled Compounds | |
| HY-N7092S14 | D-Fructose-d-2 | 80599-66-2 | Isotope-Labeled Compounds |
| HY-N7092S16 | D-Fructose-d2 | 285979-75-1 | Isotope-Labeled Compounds |
| HY-N7092S18 | D-Fructose-d2-1 | 478518-48-8 | Isotope-Labeled Compounds |
| HY-N7092S2 | D-Fructose-13C-1 | 117013-19-1 | Isotope-Labeled Compounds |
| HY-N7092S20 | D(-)-Fructose-18O-1 | Isotope-Labeled Compounds | |
| HY-N7092S21 | D-Fructose-18O-2 | Isotope-Labeled Compounds | |
| HY-N7092S22 | D-Fructose-13C3 | Isotope-Labeled Compounds | |
| HY-N7092S23 | D-Fructose-13C3-1 | Isotope-Labeled Compounds | |
| HY-N7092S24 | D-Fructose-13C4 | Isotope-Labeled Compounds | |
| HY-N7092S3 | D-Fructose-13C2 | 2483736-14-5 | Isotope-Labeled Compounds |
| HY-N7092S4 | D-Fructose-3-13C | 249928-59-4 | Isotope-Labeled Compounds |
| HY-N7092S5 | D-Fructose-4-13C | 84270-09-7 | Isotope-Labeled Compounds |
| HY-N7092S6 | D-Fructose-5-13C | 635325-97-2 | Isotope-Labeled Compounds |
| HY-N7092S7 | D-Fructose-6-13C | 287100-63-4 | Isotope-Labeled Compounds |
| HY-N7092S8 | D-Fructose-d | 374089-83-5 | Isotope-Labeled Compounds |
| HY-N7092S9 | D-Fructose-d4 | 478518-49-9 | Isotope-Labeled Compounds |
| HY-N7093 | Furaneol | 3658-77-3 | Natural Products |
| HY-N7093R | Furaneol (Standard) | 3658-77-3 | Reference Standards |
| HY-N7095 | Ceftezole | 26973-24-0 | Reference compound |
| HY-N7096 | Ceftezole (sodium) | 41136-22-5 | Reference compound |
| HY-N7096R | Ceftezole (sodium) (Standard) | 41136-22-5 | Reference Standards |
| HY-N7097 | Sulbenicillin (disodium) | 28002-18-8 | Reference compound |
| HY-N7098 | Dihydrojasmone | 1128-08-1 | Natural Products |
| HY-N7099 | Cue-lure | 3572-06-3 | Reference compound |
| HY-N7099R | Cue-lure (Standard) | 3572-06-3 | Reference Standards |
| HY-N7100 | Ethyl chrysanthemate | 97-41-6 | Reference compound |
| HY-N7101 | Cefpodoxime Proxetil | 87239-81-4 | Reference compound |
| HY-N7101R | Cefpodoxime Proxetil (Standard) | 87239-81-4 | Reference Standards |
| HY-N7101S1 | Cefpodoxime Proxetil-d6 | Isotope-Labeled Compounds | |
| HY-N7102 | Ceftiofur | 80370-57-6 | Reference compound |
| HY-N7102R | Ceftiofur (Standard) | 80370-57-6 | Reference Standards |
| HY-N7103 | Ethyl oleate | 111-62-6 | Natural Products |
| HY-N7103R | Ethyl oleate (Standard) | 111-62-6 | Reference Standards |
| HY-N7104 | Lactitol | 585-86-4 | Reference compound |
| HY-N7104R | Lactitol (Standard) | 585-86-4 | Reference Standards |
| HY-N7105 | γ-Decalactone | 706-14-9 | Natural Products |
| HY-N7105R | γ-Decalactone (Standard) | 706-14-9 | Reference Standards |
| HY-N7105S | γ-Decalactone-d7 | 1104979-33-0 | Isotope-Labeled Compounds |
| HY-N7106 | Dimethyl phthalate | 131-11-3 | Natural Products |
| HY-N7106R | Dimethyl phthalate (Standard) | 131-11-3 | Reference Standards |
| HY-N7106S | Dimethyl phthalate (Ring-d4) | 93951-89-4 | Isotope-Labeled Compounds |
| HY-N7106S1 | Dimethyl phthalate-d6 | 85448-30-2 | Isotope-Labeled Compounds |
| HY-N7107 | Fenchyl alcohol | 1632-73-1 | Natural Products |
| HY-N7107A | (+)-Fenchyl alcohol | 2217-02-9 | Reference compound |
| HY-N7108 | 7-Hydroxyflavone | 6665-86-7 | Natural Products |
| HY-N7108R | 7-Hydroxyflavone (Standard) | 6665-86-7 | Reference Standards |
| HY-N7109 | Erucic acid | 112-86-7 | Natural Products |
| HY-N7109B | Erucic acid (sodium) | 14488-85-8 | Natural Products |
| HY-N7109R | Erucic acid (Standard) | 112-86-7 | Reference Standards |
| HY-N7110 | 6-Hydroxyflavone | 6665-83-4 | Natural Products |
| HY-N7111 | Sultamicillin (tosylate) | 83105-70-8 | Reference compound |
| HY-N7111R | Sultamicillin (tosylate) (Standard) | 83105-70-8 | Reference Standards |
| HY-N7112 | Leucomycin | 1392-21-8 | Natural Products |
| HY-N7112A | Leucomycin (tartrate) | 37280-56-1 | Natural Products |
| HY-N7113 | Squalane | 111-01-3 | Natural Products |
| HY-N7113R | Squalane (Standard) | 111-01-3 | Reference Standards |
| HY-N7113S | Squalane-d62 | 16514-83-3 | Isotope-Labeled Compounds |
| HY-N7114 | Chloramphenicol succinate | 3544-94-3 | Reference compound |
| HY-N7114A | Chloramphenicol succinate (sodium) | 982-57-0 | Natural Products |
| HY-N7114AR | Chloramphenicol succinate (sodium) (Standard) | 982-57-0 | Reference Standards |
| HY-N7115 | Sultamicillin | 76497-13-7 | Reference compound |
| HY-N7115R | Sultamicillin (Standard) | 76497-13-7 | Reference Standards |
| HY-N7116 | Lawsone methyl ether | 2348-82-5 | Natural Products |
| HY-N7117 | 1,4-Cineole | 470-67-7 | Natural Products |
| HY-N7117R | 1,4-Cineole (Standard) | 470-67-7 | Reference Standards |
| HY-N7118 | Clindamycin (hydrochloride monohydrate) | 58207-19-5 | Reference compound |
| HY-N7118R | Clindamycin (hydrochloride monohydrate) (Standard) | 58207-19-5 | Reference Standards |
| HY-N7119 | Cimicifugoside | 66176-93-0 | Natural Products |
| HY-N7120 | Penicillin G procaine (hydrate) | 6130-64-9 | Reference compound |
| HY-N7120R | Penicillin G procaine (hydrate) (Standard) | 6130-64-9 | Reference Standards |
| HY-N7121 | Erythromycin estolate | 3521-62-8 | Natural Products |
| HY-N7121R | Erythromycin estolate (Standard) | 3521-62-8 | Reference Standards |
| HY-N7122 | Thymopentin | 69558-55-0 | Natural Products |
| HY-N7122A | Thymopentin (acetate) | 89318-88-7 | Natural Products |
| HY-N7123 | Sulfacetamide | 144-80-9 | Reference compound |
| HY-N7123R | Sulfacetamide (Standard) | 144-80-9 | Reference Standards |
| HY-N7123S | Sulfacetamide-d4 | Isotope-Labeled Compounds | |
| HY-N7123S1 | Sulfacetamide-13C6 | Isotope-Labeled Compounds | |
| HY-N7124 | Benzyl acetate | 140-11-4 | Natural Products |
| HY-N7124R | Benzyl acetate (Standard) | 140-11-4 | Reference Standards |
| HY-N7124S | Benzyl acetate-d5 | 1398065-57-0 | Isotope-Labeled Compounds |
| HY-N7125 | Cinnamyl acetate | 103-54-8 | Natural Products |
| HY-N7125R | Cinnamyl acetate (Standard) | 103-54-8 | Reference Standards |
| HY-N7125S | Cinnamyl acetate-13C2 | 1083053-34-2 | Isotope-Labeled Compounds |
| HY-N7126 | Citronellal | 106-23-0 | Natural Products |
| HY-N7126R | Citronellal (Standard) | 106-23-0 | Reference Standards |
| HY-N7127 | (E)-m-Coumaric acid | 14755-02-3 | Natural Products |
| HY-N7127R | (E)-m-Coumaric acid (Standard) | 14755-02-3 | Reference Standards |
| HY-N7128 | Flavanone | 487-26-3 | Reference compound |
| HY-N7128R | Flavanone (Standard) | 487-26-3 | Reference Standards |
| HY-N7129 | Cinnamylideneacetic acid | 1552-94-9 | Natural Products |
| HY-N7130 | Thioisonicotinamide | 2196-13-6 | Reference compound |
| HY-N7131 | Coumarin 6 | 38215-36-0 | Dye Reagents |
| HY-N7132 | Menthyl acetate | 2623-23-6 | Natural Products |
| HY-N7132R | Menthyl acetate (Standard) | 2623-23-6 | Reference Standards |
| HY-N7133 | Diphenylamine hydrochloride | 537-67-7 | Natural Products |
| HY-N7135 | Tropolone | 533-75-5 | Natural Products |
| HY-N7136 | α-Terpinyl acetate | 80-26-2 | Natural Products |
| HY-N7136R | α-?Terpinyl acetate (Standard) | 80-26-2 | Reference Standards |
| HY-N7137 | Norgestrel | 6533-00-2 | Reference compound |
| HY-N7137R | Norgestrel (Standard) | 6533-00-2 | Reference Standards |
| HY-N7137S | Norgestrel-d5 | 2015995-56-7 | Isotope-Labeled Compounds |
| HY-N7138 | 2-(Phosphonooxy)benzoic acid | 6064-83-1 | Reference compound |
| HY-N7139 | Penicillin G | 61-33-6 | Reference compound |
| HY-N7139A | Penicillin G benzathine | 1538-09-6 | Reference compound |
| HY-N7139B | Penicillin G benzathine (tetrahydrate) | 41372-02-5 | Reference compound |
| HY-N7139BR | Penicillin G benzathine (tetrahydrate) (Standard) | 41372-02-5 | Reference Standards |
| HY-N7139S1 | Penicillin G-d7 (potassium salt) | 352323-25-2 | Isotope-Labeled Compounds |
| HY-N7140 | Gamma-Linolenic acid | 506-26-3 | Natural Products |
| HY-N7140R | Gamma-Linolenic acid (Standard) | 506-26-3 | Reference Standards |
| HY-N7141 | Spiramycin I | 24916-50-5 | Natural Products |
| HY-N7141R | Spiramycin I (Standard) | 24916-50-5 | Reference Standards |
| HY-N7142 | DL-Norepinephrine (hydrochloride) | 55-27-6 | Natural Products |
| HY-N7142S | DL-Norepinephrine-d6 (hydrochloride) | 1219803-04-9 | Isotope-Labeled Compounds |
| HY-N7142S1 | DL-Norepinephrine-d3 (hydrochloride) | 1392208-07-9 | Isotope-Labeled Compounds |
| HY-N7143 | Monobutyl phthalate | 131-70-4 | Natural Products |
| HY-N7143R | Monobutyl phthalate (Standard) | 131-70-4 | Reference Standards |
| HY-N7143S | Monobutyl phthalate-d4 | 478954-81-3 | Isotope-Labeled Compounds |
| HY-N7144A | Citronellyl acetate | 150-84-5 | Natural Products |
| HY-N7144AR | Citronellyl acetate (Standard) | 150-84-5 | Reference Standards |
| HY-N7145 | Bombykol | 765-17-3 | Natural Products |
| HY-N7147 | Irisquinone | 56495-82-0 | Natural Products |
| HY-N7148 | γ-Tocopherol | 54-28-4 | Natural Products |
| HY-N7148A | (±)-γ-Tocopherol | 7616-22-0 | Natural Products |
| HY-N7148R | γ-Tocopherol (Standard) | 54-28-4 | Reference Standards |
| HY-N7148S | α-Vitamin E-d6 | 113892-08-3 | Isotope-Labeled Compounds |
| HY-N7148S1 | γ-Tocopherol-d4 | 1329652-13-2 | Isotope-Labeled Compounds |
| HY-N7150 | Tricetin 3',4',5'-trimethyl ether | 18103-42-9 | Natural Products |
| HY-N7151 | Aurachin D | 108354-13-8 | Natural Products |
| HY-N7151R | Aurachin D (Standard) | 108354-13-8 | Reference Standards |
| HY-N7152 | 6-Dehydrogingerdione | 76060-35-0 | Natural Products |
| HY-N7153 | 10-Hydroxycanthin-6-one | 86293-41-6 | Natural Products |
| HY-N7154 | 2,3-O-Isopropylidenyl euscaphic acid | 220880-90-0 | Natural Products |
| HY-N7155 | 2,4,7-Trihydroxy-9,10-dihydrophenanthrene | 70205-52-6 | Natural Products |
| HY-N7156 | 2,3,4'-Trihydroxy-3',5'-dimethoxypropiophenone | 33900-74-2 | Natural Products |
| HY-N7157 | 2-2'-(Hydroxytetracosanoylamino)-octadecane-1,3,4-triol tetraacetate | 340702-68-3 | Natural Products |
| HY-N7158 | Elasticamide | 154801-30-6 | Natural Products |
| HY-N7160 | 2-Hydroxy-3-methylanthraquinone | 17241-40-6 | Natural Products |
| HY-N7161 | 3-O-(2'E,4'E-Decadienoyl)-ingenol | 466663-11-6 | Natural Products |
| HY-N7162 | 3-O-Acetyl-11-hydroxy-beta-boswellic acid | 146019-25-2 | Natural Products |
| HY-N7163 | (2S)-5,7,3',5'-Tetrahydroxyflavanone | 160436-10-2 | Natural Products |
| HY-N7164 | 3-Oxo-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone | 828935-47-3 | Natural Products |
| HY-N7165 | 3-O-cis-p-Coumaroyl maslinic acid | 69297-40-1 | Natural Products |
| HY-N7165A | 3-β-O-(trans-p-Coumaroyl)maslinic acid | 35482-91-8 | Natural Products |
| HY-N7166 | 3-O-(2'E,4'Z-Decadienoyl)ingenol | 84680-59-1 | Natural Products |
| HY-N7167 | 6''-O-Acetylisovitexin | 1223097-20-8 | Natural Products |
| HY-N7168 | 3-O-(2'E ,4'E-Decadienoyl)-20-O-acetylingenol | 466663-12-7 | Natural Products |
| HY-N7168A | 3-O-(2'E ,4'Z-Decadienoyl)-20-O-acetylingenol | 158850-76-1 | Natural Products |
| HY-N7170 | (-)-6β-Hydroxy-5β,8β,9β,10α-cleroda-3,13-dien-16,15-olid-18-oic acid | 771493-42-6 | Natural Products |
| HY-N7171 | 4,4'-Di-O-methylellagic acid | 3374-77-4 | Natural Products |
| HY-N7173 | 7-Methoxy-β-carboline-1-propionic acid | 137756-13-9 | Natural Products |
| HY-N7175 | 5,8-Epidioxyergosta-6,9(11),22-trien-3-ol | 86363-50-0 | Natural Products |
| HY-N7176 | Kaempferol 3-O-β-D-glucuronide | 22688-78-4 | Natural Products |
| HY-N7176R | Kaempferol 3-O-β-D-glucuronide (Standard) | 22688-78-4 | Reference Standards |
| HY-N7177 | Hydroxytanshinone IIA | 18887-18-8 | Natural Products |
| HY-N7178 | Abieta-8,11,13-triene-7α,15,18-triol | 337527-10-3 | Natural Products |
| HY-N7179 | 7-Hydroxy-5-methoxycoumarin | 3067-10-5 | Natural Products |
| HY-N7180 | 6β-Hydroxystigmasta-4,22-dien-3-one | 36450-01-8 | Natural Products |
| HY-N7181 | 7,3'-Dihydroxy-5'-methoxyisoflavone | 947611-61-2 | Natural Products |
| HY-N7182 | 9,10-Dimethoxycanthin-6-one | 155861-51-1 | Natural Products |
| HY-N7183 | 9-Hydroxycanthin-6-one | 138544-91-9 | Natural Products |
| HY-N7188 | CJ-21,058 | 405072-57-3 | Natural Products |
| HY-N7189 | Yadanzioside C | 95258-16-5 | Natural Products |
| HY-N7190 | Yadanzioside F | 95258-11-0 | Natural Products |
| HY-N7191 | Yadanzioside G | 95258-17-6 | Natural Products |
| HY-N7194 | Yadanzioside L | 99132-97-5 | Natural Products |
| HY-N7195 | 12-Deoxywithastramonolide | 60124-17-6 | Natural Products |
| HY-N7195R | 12-Deoxywithastramonolide (Standard) | 60124-17-6 | Reference Standards |
| HY-N7196 | Myrtucommulone A | 54247-21-1 | Natural Products |
| HY-N7199 | (Rac)-Hydnocarpin | 51419-48-8 | Natural Products |
| HY-N7200 | Ginnol | 2606-50-0 | Natural Products |
| HY-N7202 | Angulatin A | 139979-81-0 | Natural Products |
| HY-N7203 | N-Caffeoyl O-methyltyramine | 189307-47-9 | Natural Products |
| HY-N7203R | N-Caffeoyl O-methyltyramine (Standard) | 189307-47-9 | Reference Standards |
| HY-N7204 | 4-Hydroxyderricin | 55912-03-3 | Natural Products |
| HY-N7205 | Glaucocalyxin D | 140671-02-9 | Natural Products |
| HY-N7206 | 5-O-Methylvisamminol | 80681-42-1 | Natural Products |
| HY-N7206R | 5-O-Methylvisamminol (Standard) | 80681-42-1 | Reference Standards |
| HY-N7207 | 11-Methoxyyangonin | 2743-14-8 | Natural Products |
| HY-N7214 | Termitomycamide E | 1177258-62-6 | Natural Products |
| HY-N7215 | Jatrophone | 29444-03-9 | Natural Products |
| HY-N7216 | Altromycin A | 128439-47-4 | Natural Products |
| HY-N7218 | Lysolipin I | 59113-57-4 | Natural Products |
| HY-N7219 | Aloeresin A | 74545-79-2 | Natural Products |
| HY-N7221 | Janthitrem G | 90986-51-9 | Natural Products |
| HY-N7222 | Janthitrem F | 90986-52-0 | Natural Products |
| HY-N7223 | Lappaol F | 69394-17-8 | Natural Products |
| HY-N7224 | N-Formylfortimicin A | 74228-81-2 | Natural Products |
| HY-N7225 | Yuanhuacine | 60195-70-2 | Natural Products |
| HY-N7227 | Anonaine | 1862-41-5 | Natural Products |
| HY-N7228 | Rabdosin C | 82460-75-1 | Natural Products |
| HY-N7229 | Rabdosin B | 84304-92-7 | Natural Products |
| HY-N7230 | Rabdosin A | 84304-91-6 | Natural Products |
| HY-N7231 | Licoricesaponin E2 | 119417-96-8 | Natural Products |
| HY-N7232 | Limocrocin | 24112-57-0 | Natural Products |
| HY-N7234 | Sarasinoside C1 | 114066-51-2 | Natural Products |
| HY-N7235 | Lanatoside E | 20460-30-4 | Natural Products |
| HY-N7236 | Pervicoside B | 96157-95-8 | Natural Products |
| HY-N7237 | Stichloroside B1 | 78244-74-3 | Natural Products |
| HY-N7240 | (Rac)-Juvenile hormone III | 24198-95-6 | Reference compound |
| HY-N7240S | (Rac)-Juvenile Hormone III-d3 | 951116-89-5 | Isotope-Labeled Compounds |
| HY-N7241 | Saudin | 94978-16-2 | Natural Products |
| HY-N7242 | Plicacetin | 43043-15-8 | Natural Products |
| HY-N7247 | Thiochrome | 92-35-3 | Reference compound |
| HY-N7247R | Thiochrome (Standard) | 92-35-3 | Reference Standards |
| HY-N7250 | (+)-trans-Isolimonene | 5113-87-1 | Natural Products |
| HY-N7251 | Stachartin A | 1978388-54-3 | Natural Products |
| HY-N7252 | Daphnin | 486-55-5 | Natural Products |
| HY-N7252R | Daphnin (Standard) | 486-55-5 | Reference Standards |
| HY-N7253 | Nardoeudesmol A | 1445952-30-6 | Natural Products |
| HY-N7255 | Cycloartenol | 469-38-5 | Natural Products |
| HY-N7255R | Cycloartenol (Standard) | 469-38-5 | Reference Standards |
| HY-N7256 | Dihydrocephalomannine | 159001-25-9 | Natural Products |
| HY-N7257 | Glucosinalbate | 19253-84-0 | Natural Products |
| HY-N7257A | Glucosinalbate (potassium) | 16411-05-5 | Natural Products |
| HY-N7258 | Neohesperidose | 17074-02-1 | Natural Products |
| HY-N7259 | (+)-Isomenthone | 1196-31-2 | Natural Products |
| HY-N7259A | (-)-Isomenthone | 18309-28-9 | Natural Products |
| HY-N7259B | (±)-Isomenthone | 491-07-6 | Natural Products |
| HY-N7260 | Aphadilactone B | 1522004-68-7 | Natural Products |
| HY-N7262 | Hydroxyvalerenic acid | 1619-16-5 | Natural Products |
| HY-N7262R | Hydroxyvalerenic acid (Standard) | 1619-16-5 | Reference Standards |
| HY-N7263 | Galanthamine N-Oxide | 134332-50-6 | Natural Products |
| HY-N7264 | 7α-Hydroxycholesterol | 566-26-7 | Natural Products |
| HY-N7264S | 7α-Hydroxycholesterol-d7 | 349553-94-2 | Isotope-Labeled Compounds |
| HY-N7265 | Epi-galantamine | 1668-85-5 | Natural Products |
| HY-N7266 | Obtusifoliol | 16910-32-0 | Natural Products |
| HY-N7267 | 31-Norlanostenol | 16910-39-7 | Natural Products |
| HY-N7268 | Solanidiene | 26516-51-8 | Natural Products |
| HY-N7269 | Luteolin 7-diglucuronide | 96400-45-2 | Natural Products |
| HY-N7269R | Luteolin 7-diglucuronide (Standard) | 96400-45-2 | Reference Standards |
| HY-N7270 | Apigenin-7-diglucuronide | 74696-01-8 | Natural Products |
| HY-N7271 | Solanidine | 80-78-4 | Natural Products |
| HY-N7271R | Solanidine (Standard) | 80-78-4 | Reference Standards |
| HY-N7272 | Cirsimarin | 13020-19-4 | Natural Products |
| HY-N7272R | Cirsimarin (Standard) | 13020-19-4 | Reference Standards |
| HY-N7273 | Soyasaponin III | 55304-02-4 | Natural Products |
| HY-N7275 | Di-O-methyldemethoxycurcumin | 824951-60-2 | Natural Products |
| HY-N7276 | 7α-Galloyloxysweroside | 2222365-75-3 | Natural Products |
| HY-N7276A | 7β-Galloyloxysweroside | 2222365-76-4 | Natural Products |
| HY-N7277 | Delgrandine | 145237-05-4 | Natural Products |
| HY-N7278 | Mudanpioside J | 262350-52-7 | Natural Products |
| HY-N7279 | Epiaschantin | 41689-50-3 | Natural Products |
| HY-N7281 | Aphadilactone C | 1522004-70-1 | Natural Products |
| HY-N7284 | Traxillaside | 149415-62-3 | Natural Products |
| HY-N7285 | Otophylloside F | 250217-73-3 | Natural Products |
| HY-N7287 | (+)-Matairesinol | 148409-36-3 | Natural Products |
| HY-N7288 | Trilepisflavan | 1443218-16-3 | Natural Products |
| HY-N7289 | Taxuspine B | 157414-05-6 | Natural Products |
| HY-N7290 | Cedrelopsin | 19397-28-5 | Natural Products |
| HY-N7291 | Tryprostatin A | 171864-80-5 | Natural Products |
| HY-N7292 | Bakkenolide B | 18455-98-6 | Natural Products |
| HY-N7293 | Bakkenolide D | 18456-03-6 | Natural Products |
| HY-N7294 | Taxuspine W | 181309-92-2 | Natural Products |
| HY-N7296 | Derrisisoflavone H | 2172624-65-4 | Natural Products |
| HY-N7297 | Derrisisoflavone K | 2172624-68-7 | Natural Products |
| HY-N7298 | Derrisisoflavone J | 2172624-67-6 | Natural Products |
| HY-N7299 | Derrisisoflavone I | 2172624-66-5 | Natural Products |
| HY-N7300 | Otophylloside T | 1642306-14-6 | Natural Products |
| HY-N7302 | Anthracophyllone | 1801750-22-0 | Natural Products |
| HY-N7304 | Jatrophane I | 210108-85-3 | Natural Products |
| HY-N7305 | Jatrophane 5 | 210108-89-7 | Natural Products |
| HY-N7306 | Jatrophane VI | 210108-90-0 | Natural Products |
| HY-N7307 | Pachybasin | 2549-78-2 | Natural Products |
| HY-N7309 | Benzoylgomisin H | 66056-23-3 | Natural Products |
| HY-N7310 | Gomisin E | 72960-21-5 | Natural Products |
| HY-N7311 | Bonducellpin C | 197781-84-3 | Natural Products |
| HY-N7312 | Ditryptophenaline | 64947-43-9 | Natural Products |
| HY-N7313 | Macrocarpal O | 327622-65-1 | Natural Products |
| HY-N7314 | Asebogenin | 520-42-3 | Natural Products |
| HY-N7315 | Agavasaponin C | 56316-35-9 | Natural Products |
| HY-N7316 | Frangulin B | 14101-04-3 | Natural Products |
| HY-N7319 | Dodovislactone B | 1616683-55-6 | Natural Products |
| HY-N7321 | Eucomol | 17934-12-2 | Natural Products |
| HY-N7321A | (R)-Eucomol | 118204-64-1 | Natural Products |
| HY-N7322 | Swietemahalactone | 1514669-21-6 | Natural Products |
| HY-N7323 | Artemyriantholide D | 421558-76-1 | Natural Products |
| HY-N7324 | Dehydroperilloxin | 263241-09-4 | Natural Products |
| HY-N7325 | Valerosidate | 29505-31-5 | Natural Products |
| HY-N7326 | Latinone | 79157-36-1 | Natural Products |
| HY-N7327 | Ochnaflavone | 50276-96-5 | Natural Products |
| HY-N7328 | Lanatoside B | 17575-21-2 | Natural Products |
| HY-N7329 | Corymbosin | 18103-41-8 | Natural Products |
| HY-N7330 | Integracin B | 224186-05-4 | Natural Products |
| HY-N7331 | Ciwujiatone | 218901-26-9 | Natural Products |
| HY-N7332 | Pepluanin A | 670257-89-3 | Natural Products |
| HY-N7333 | epi-Syringaresinol | 51152-20-6 | Natural Products |
| HY-N7334 | Yunaconitoline | 259099-25-7 | Natural Products |
| HY-N7335 | Dehydroglyasperin C | 199331-35-6 | Natural Products |
| HY-N7336 | Wedelialactone A | 175862-40-5 | Natural Products |
| HY-N7337 | Dibritannilactone B | 1829580-18-8 | Natural Products |
| HY-N7338 | Yadanziolide C | 95258-12-1 | Natural Products |
| HY-N7340 | Withaperuvin C | 81644-34-0 | Natural Products |
| HY-N7341 | 8-Deacetylyunaconitine | 93460-55-0 | Natural Products |
| HY-N7342 | Valeriotriate B | 862255-64-9 | Natural Products |
| HY-N7343 | Pregomisin | 66280-26-0 | Natural Products |
| HY-N7344 | Futokadsurin C | 852459-91-7 | Natural Products |
| HY-N7345 | Schizandriside | 71222-06-5 | Natural Products |
| HY-N7346 | Lucidadiol | 252351-95-4 | Natural Products |
| HY-N7347 | (-)-Hydroxycitric acid lactone | 27750-13-6 | Natural Products |
| HY-N7347R | (-)-Hydroxycitric acid lactone (Standard) | 27750-13-6 | Reference Standards |
| HY-N7348 | Taxezopidine G | 205440-22-8 | Natural Products |
| HY-N7349 | N-Methyltaxol C | 153083-53-5 | Natural Products |
| HY-N7353 | Stachartin C | 1978388-56-5 | Natural Products |
| HY-N7354 | Quininic acid | 86-68-0 | Natural Products |
| HY-N7355 | 9-Deacetyltaxinine E | 284672-78-2 | Natural Products |
| HY-N7359 | Securitinine | 13861-71-7 | Natural Products |
| HY-N7363 | Isolongifolene | 1135-66-6 | Natural Products |
| HY-N7364 | (E)-β-Farnesene | 18794-84-8 | Natural Products |
| HY-N7364R | (E)-β-Farnesene (Standard) | 18794-84-8 | Reference Standards |
| HY-N7364S | (E)-β-Farnesene-d6 | 1092965-77-9 | Isotope-Labeled Compounds |
| HY-N7365 | Spathulatol | 1373888-27-7 | Natural Products |
| HY-N7366 | Taxachitriene A | 167906-74-3 | Natural Products |
| HY-N7368 | Hibifolin | 55366-56-8 | Natural Products |
| HY-N7368R | Hibifolin (Standard) | 55366-56-8 | Reference Standards |
| HY-N7369 | Hybridaphniphylline A | 1467083-07-3 | Natural Products |
| HY-N7370 | Hybridaphniphylline B | 1467083-09-5 | Natural Products |
| HY-N7372 | Licoisoflavanone | 66067-26-3 | Natural Products |
| HY-N7374 | Cyperin | 33716-82-4 | Natural Products |
| HY-N7377 | Butyl isobutyl phthalate | 17851-53-5 | Natural Products |
| HY-N7378 | N-Hydroxypipecolic acid | 115819-92-6 | Natural Products |
| HY-N7378A | N-Hydroxypipecolic acid (potassium) | 2253632-01-6 | Natural Products |
| HY-N7384A | Vitamin B15 (hemicalcium) | 20310-61-6 | Natural Products |
| HY-N7385 | Nudol | 86630-46-8 | Natural Products |
| HY-N7386A | D-Erythrose 4-phosphate (sodium) | 103302-15-4 | Reference compound |
| HY-N7387 | 3-Oxocholic acid | 2304-89-4 | Natural Products |
| HY-N7387R | 3-Oxocholic acid (Standard) | 2304-89-4 | Reference Standards |
| HY-N7389A | GDP-D-mannose (disodium) | 103301-73-1 | Natural Products |
| HY-N7389B | GDP-α-D-mannose (disodium) | 148296-46-2 | Reference compound |
| HY-N7390 | Cholesterol glucuronide | 17435-78-8 | Natural Products |
| HY-N7392 | Acetoacetyl-CoA | 1420-36-6 | Biochemical Assay Reagents |
| HY-N7393 | Isomalt | 64519-82-0 | Natural Products |
| HY-N7393R | Isomalt (Standard) | 64519-82-0 | Reference Standards |
| HY-N7394A | (-)-Zuonin A | 84709-25-1 | Natural Products |
| HY-N7395 | Cyclic ADP-ribose | 119340-53-3 | Natural Products |
| HY-N7395A | Cyclic ADP-ribose (ammonium) | Natural Products | |
| HY-N7396 | UMP-morpholidate | 27908-36-7 | Reference compound |
| HY-N7397 | Forsythoside F | 94130-58-2 | Natural Products |
| HY-N7398 | 2-Pentylfuran | 3777-69-3 | Natural Products |
| HY-N7398R | 2-Pentylfuran (Standard) | 3777-69-3 | Reference Standards |
| HY-N7398S | 2-Pentylfuran-13C2 | Isotope-Labeled Compounds | |
| HY-N7399 | Dipalmitin | 26657-95-4 | Natural Products |
| HY-N7400 | Phaseoloidin | 118555-82-1 | Natural Products |
| HY-N7401 | Entadamide-A-β-D-glucopyranoside | 138916-58-2 | Natural Products |
| HY-N7402 | Hexyl hexanoate | 6378-65-0 | Natural Products |
| HY-N7403 | N-(3-Phenylpropionyl)glycine | 56613-60-6 | Natural Products |
| HY-N7403R | N-(3-Phenylpropionyl)glycine (Standard) | 56613-60-6 | Reference Standards |
| HY-N7403S | N-(3-Phenylpropionyl)glycine-d2 | 1219795-43-3 | Isotope-Labeled Compounds |
| HY-N7404 | Nε,Nε,Nε-Trimethyllysine (chloride) | 55528-53-5 | Natural Products |
| HY-N7404S | Nε,Nε,Nε-Trimethyllysine-d9 (chloride) | Isotope-Labeled Compounds | |
| HY-N7421 | Smilagenin acetate | 4947-75-5 | Reference compound |
| HY-N7422 | Kauran-16,17-diol | 16836-31-0 | Natural Products |
| HY-N7423 | Methyl isoferulate | 16980-82-8 | Natural Products |
| HY-N7426 | 3-Deoxyglucosone | 4084-27-9 | Natural Products |
| HY-N7427 | 2-(2',3',4'-Trihydroxybutyl)quinoxaline | 42015-38-3 | Natural Products |
| HY-N7428 | 1-(2-Quinoxalinyl)-1,2,3,4-butanetetrol | 80840-09-1 | Natural Products |
| HY-N7430 | 3-O-Methylellagic acid | 51768-38-8 | Natural Products |
| HY-N7432 | DIMBOA | 15893-52-4 | Natural Products |
| HY-N7432R | DIMBOA (Standard) | 15893-52-4 | Reference Standards |
| HY-N7433 | 4,6-O-Ethylidene-α-D-glucose | 13224-99-2 | Natural Products |
| HY-N7434 | N-Nitrosodiethylamine | 55-18-5 | Natural Products |
| HY-N7434R | N-Nitrosodiethylamine (Standard) | 55-18-5 | Reference Standards |
| HY-N7434S | N-Nitrosodiethylamine-d4 | 1346603-41-5 | Isotope-Labeled Compounds |
| HY-N7434S1 | N-Nitrosodiethylamine-d10 | 1219794-54-3 | Isotope-Labeled Compounds |
| HY-N7435 | Massoia lactone | 54814-64-1 | Natural Products |
| HY-N7436 | Methyl propyl disulfide | 2179-60-4 | Natural Products |
| HY-N7436R | Methyl propyl disulfide (Standard) | 2179-60-4 | Reference Standards |
| HY-N7436S | Methyl propyl disulfide-d3 | 1335436-28-6 | Isotope-Labeled Compounds |
| HY-N7437 | Akuammidine | 639-36-1 | Natural Products |
| HY-N7438 | Mogroside VI A | 2146088-13-1 | Natural Products |
| HY-N7439 | Mogroside VI B | 2149606-17-5 | Natural Products |
| HY-N7443 | Gibberellin A1 | 545-97-1 | Natural Products |
| HY-N7443R | Gibberellin A1 (Standard) | 545-97-1 | Reference Standards |
| HY-N7445 | Platyphylline | 480-78-4 | Natural Products |
| HY-N7448 | 5-Deoxystrigol | 151716-18-6 | Natural Products |
| HY-N7449 | Neamine | 3947-65-7 | Reference compound |
| HY-N7450 | Icariside D2 | 38954-02-8 | Natural Products |
| HY-N7452 | Coumermycin A1 | 4434-05-3 | Reference compound |
| HY-N7454 | Anhydroerythromycin A | 23893-13-2 | Natural Products |
| HY-N7454R | Anhydroerythromycin A (Standard) | 23893-13-2 | Reference Standards |
| HY-N7456 | Otophylloside O | 1326583-08-7 | Natural Products |
| HY-N7457 | Decinnamoyltaxinine J | 84652-33-5 | Natural Products |
| HY-N7459 | Sakurasosaponin | 59527-84-3 | Natural Products |
| HY-N7460 | 7-Deacetoxytaxinine J | 18457-45-9 | Natural Products |
| HY-N7462 | Norarmepavine | 3195-01-5 | Natural Products |
| HY-N7463 | Serrin A | 845959-98-0 | Natural Products |
| HY-N7464 | Jolkinolide E | 54494-34-7 | Natural Products |
| HY-N7465 | Wallicoside | 88797-59-5 | Natural Products |
| HY-N7467 | Taxuspine X | 194782-02-0 | Natural Products |
| HY-N7468 | Daphnicyclidin D | 385384-24-7 | Natural Products |
| HY-N7470 | Daphnicyclidin F | 385384-26-9 | Natural Products |
| HY-N7471 | Daphnicyclidin I | 1467083-10-8 | Natural Products |
| HY-N7472 | Daphnicyclidin H | 385384-29-2 | Natural Products |
| HY-N7475 | Taxinine J | 18457-46-0 | Natural Products |
| HY-N7476 | Colominic acid (sodium salt) | 70431-34-4 | Natural Products |
| HY-N7477 | Rauvovertine A | 2055073-75-9 | Natural Products |
| HY-N7478 | Glycoperine | 55740-45-9 | Natural Products |
| HY-N7479 | Giffonin R | 1966183-72-1 | Natural Products |
| HY-N7480A | Quinolactacin A1 | 815576-68-2 | Natural Products |
| HY-N7481 | Tupichinol A | 497142-88-8 | Natural Products |
| HY-N7483 | 1-Dehydroxybaccatin IV | 57672-78-3 | Natural Products |
| HY-N7484 | (−)-Voacangarine | 545-84-6 | Natural Products |
| HY-N7485 | Gomisin K1 | 75629-20-8 | Natural Products |
| HY-N7486 | Chamaejasmenin B | 89595-71-1 | Natural Products |
| HY-N7488 | Visnadine | 477-32-7 | Natural Products |
| HY-N7489 | β-Hederin | 35790-95-5 | Natural Products |
| HY-N7491 | Verticilide | 693778-57-3 | Natural Products |
| HY-N7491A | Ent-(+)-Verticilide | 2056011-05-1 | Peptides |
| HY-N7493 | N-acetyldopamine | 2494-12-4 | Natural Products |
| HY-N7494 | Pentacosane | 629-99-2 | Natural Products |
| HY-N7494R | Pentacosane (Standard) | 629-99-2 | Reference Standards |
| HY-N7494S | Pentacosane-d52 | 121578-13-0 | Isotope-Labeled Compounds |
| HY-N7495 | all-trans-Anhydro Retinol | 1224-78-8 | Natural Products |
| HY-N7495R | all-trans-Anhydro Retinol (Standard) | 1224-78-8 | Reference Standards |
| HY-N7496 | Odoroside A | 12738-19-1 | Natural Products |
| HY-N7497 | Protoescigenin | 20853-07-0 | Natural Products |
| HY-N7497R | Protoescigenin (Standard) | 20853-07-0 | Reference Standards |
| HY-N7498 | Oxypalmatine | 19716-59-7 | Natural Products |
| HY-N7499 | Sibiricaxanthone A | 241125-76-8 | Natural Products |
| HY-N7501 | Isoformononetin | 486-63-5 | Natural Products |
| HY-N7501R | Isoformononetin (Standard) | 486-63-5 | Reference Standards |
| HY-N7501S | Isoformononetin-d3 | Isotope-Labeled Compounds | |
| HY-N7502 | 2-(Hydroxymethyl)anthraquinone | 17241-59-7 | Natural Products |
| HY-N7503 | Psoralenoside | 905954-17-8 | Natural Products |
| HY-N7504 | Isopsoralenoside | 905954-18-9 | Natural Products |
| HY-N7505 | Norchelerythrine | 6900-99-8 | Natural Products |
| HY-N7506 | 13-Hydroxyisobakuchiol | 178765-49-6 | Natural Products |
| HY-N7507 | Sempervirine | 549-92-8 | Natural Products |
| HY-N7507A | Sempervirine (nitrate) | 17994-15-9 | Natural Products |
| HY-N7508 | Humantenirine | 82375-30-2 | Natural Products |
| HY-N7509 | 2,3-Dihydroxy-4-methoxyacetophenone | 708-53-2 | Natural Products |
| HY-N7510 | 12-O-Methylcarnosic acid | 62201-71-2 | Natural Products |
| HY-N7510R | 12-O-Methylcarnosic acid (Standard) | 62201-71-2 | Reference Standards |
| HY-N7511 | O-Nornuciferine | 3153-55-7 | Natural Products |
| HY-N7512 | Asimilobine | 6871-21-2 | Natural Products |
| HY-N7513 | Homovanillyl alcohol | 2380-78-1 | Natural Products |
| HY-N7513R | Homovanillyl alcohol (Standard) | 2380-78-1 | Reference Standards |
| HY-N7514 | Strictosidinic acid | 150148-81-5 | Natural Products |
| HY-N7515 | Pinocembrin chalcone | 4197-97-1 | Natural Products |
| HY-N7515A | (E)-Pinocembrin chalcone | 82451-30-7 | Natural Products |
| HY-N7516 | 4'-Hydroxy-2,4-dimethoxychalcone | 151135-64-7 | Natural Products |
| HY-N7517 | Adenosine 5′-monophosphoramidate (sodium) | 102029-68-5 | Natural Products |
| HY-N7518 | Eulophiol | 87402-72-0 | Natural Products |
| HY-N7521 | Procyanidin C2 | 37064-31-6 | Natural Products |
| HY-N7522 | Salvianolic acid E | 142998-46-7 | Natural Products |
| HY-N7523 | Neoxanthin | 14660-91-4 | Natural Products |
| HY-N7523R | Neoxanthin (Standard) | 14660-91-4 | Reference Standards |
| HY-N7524 | Gnetulin | 152340-24-4 | Natural Products |
| HY-N7525 | Machigline | 87264-30-0 | Natural Products |
| HY-N7526 | Naphthazarin | 475-38-7 | Natural Products |
| HY-N7527 | Baccatin VI | 57672-79-4 | Natural Products |
| HY-N7529 | Siastatin B | 54795-58-3 | Natural Products |
| HY-N7530 | Kopsine | 559-48-8 | Natural Products |
| HY-N7532 | Yadanzioside I | 99132-95-3 | Natural Products |
| HY-N7533 | Carpalasionin | 83150-97-4 | Natural Products |
| HY-N7534 | (+)-Epipinoresinol | 24404-50-0 | Natural Products |
| HY-N7534A | (-)-Epipinoresinol | 10061-38-8 | Natural Products |
| HY-N7535 | Chlorovaltrate K | 96801-92-2 | Natural Products |
| HY-N7536 | Voacangine | 510-22-5 | Natural Products |
| HY-N7537 | Manassantin A | 88497-87-4 | Natural Products |
| HY-N7538 | Dealanylalahopcin | 96565-32-1 | Natural Products |
| HY-N7539 | Cognac oil | 8016-21-5 | Natural Products |
| HY-N7541 | Antrodin A | 656830-24-9 | Natural Products |
| HY-N7541R | Antrodin A (Standard) | 656830-24-9 | Reference Standards |
| HY-N7542 | Praeroside II | 86940-46-7 | Natural Products |
| HY-N7543 | Schisantherin D | 64917-82-4 | Natural Products |
| HY-N7545 | Protorubradirin | 122525-61-5 | Natural Products |
| HY-N7546 | Agavoside C' | 58546-17-1 | Natural Products |
| HY-N7549 | Dehydrobruceantin | 53662-98-9 | Natural Products |
| HY-N7550 | Latrunculin M | 122876-49-7 | Natural Products |
| HY-N7551 | Neocaesalpin L | 952473-86-8 | Natural Products |
| HY-N7552 | Isodaphnoretin B | 944824-29-7 | Natural Products |
| HY-N7555 | Valeriotetrate C | 904891-20-9 | Natural Products |
| HY-N7556 | Phyperunolide E | 1198400-52-0 | Natural Products |
| HY-N7557 | (E)-2'-Hydroxy-3,4-dimethoxychalcone | 79140-20-8 | Reference compound |
| HY-N7559 | 7β-Acetoxytaxuspine C | 256347-91-8 | Natural Products |
| HY-N7560 | Safranal | 116-26-7 | Natural Products |
| HY-N7560R | Safranal (Standard) | 116-26-7 | Reference Standards |
| HY-N7561 | Sagittatoside C | 118525-37-4 | Natural Products |
| HY-N7562 | Ustusolate E | 1175543-06-2 | Natural Products |
| HY-N7563 | α-Toxicarol | 82-09-7 | Natural Products |
| HY-N7564 | Methylliberine | 51168-26-4 | Natural Products |
| HY-N7567 | Axinysone A | 1114491-57-4 | Natural Products |
| HY-N7569 | Demethoxyfumitremorgin C | 111768-16-2 | Natural Products |
| HY-N7571 | Tatsinine | 90038-21-4 | Natural Products |
| HY-N7572 | Eupatoriopicrin | 6856-01-5 | Natural Products |
| HY-N7573 | 2-Deacetoxy-taxinine J | 119347-14-7 | Natural Products |
| HY-N7574 | WS9326A | 125774-71-2 | Natural Products |
| HY-N7575 | Lacto-N-fucopentaose II | 21973-23-9 | Natural Products |
| HY-N7576 | Anemarrhenasaponin Ia | 221317-02-8 | Natural Products |
| HY-N7579 | Lehmbachol D | 913556-40-8 | Natural Products |
| HY-N7580 | Chrysocauloflavone I | 899789-51-6 | Natural Products |
| HY-N7581 | 23-Acetylshengmanol 3-O-β-D-xylopyranoside | 62498-88-8 | Natural Products |
| HY-N7582 | Cimicifugoside H-2 | 161097-77-4 | Natural Products |
| HY-N7583 | Norcaesalpinin E | 854038-96-3 | Natural Products |
| HY-N7585 | Ustusolate C | 1188398-15-3 | Natural Products |
| HY-N7586 | Tigloylgomisin P | 69176-51-8 | Natural Products |
| HY-N7587 | Chlorophorin | 537-41-7 | Natural Products |
| HY-N7588 | Acetylvirolin | 916264-22-7 | Natural Products |
| HY-N7589 | Demethylcarolignan E | 873694-46-3 | Natural Products |
| HY-N7590 | Foresticine | 91794-15-9 | Natural Products |
| HY-N7591 | Millepachine | 1393922-01-4 | Natural Products |
| HY-N7592 | Arjunetin | 31297-79-7 | Natural Products |
| HY-N7592R | Arjunetin (Standard) | 31297-79-7 | Reference Standards |
| HY-N7593 | Tectoruside | 38784-73-5 | Natural Products |
| HY-N7594 | Senecionine acetate | 126642-77-1 | Natural Products |
| HY-N7595 | Microhelenin C | 63569-07-3 | Natural Products |
| HY-N7596 | Isoverticine | 23496-43-7 | Natural Products |
| HY-N7597 | Epimedoside | 106441-31-0 | Natural Products |
| HY-N7598 | Chrysophanol-1-O-β-gentiobioside | 54944-38-6 | Natural Products |
| HY-N7599 | Chrysophanol triglucoside | 120181-07-9 | Natural Products |
| HY-N7600 | Zhebeirine | 143120-47-2 | Natural Products |
| HY-N7601 | Benzoylalbiflorin | 184103-78-4 | Natural Products |
| HY-N7602 | 10-Hydroxy majoroside | 259753-12-3 | Natural Products |
| HY-N7603 | Rubrofusarin triglucoside | 245724-07-6 | Natural Products |
| HY-N7604 | Isorubrofusarin-6-O-β-gentiobioside | 200127-93-1 | Natural Products |
| HY-N7605 | 11-epi-mogroside V | 2146088-12-0 | Natural Products |
| HY-N7606 | (Rac)-β-Chamigrenic acid | 1174388-31-8 | Natural Products |
| HY-N7607 | Quercetin-3-O-D-glucosyl]-(1-2)-L-rhamnoside | 143016-74-4 | Natural Products |
| HY-N7608 | Beiwutine | 76918-93-9 | Natural Products |
| HY-N7609 | Kipukasin D | 948574-00-3 | Oligonucleotides |
| HY-N7610 | Acetylalkannin | 34232-27-4 | Natural Products |
| HY-N7611 | 7-Prenyloxyaromadendrin | 78876-50-3 | Natural Products |
| HY-N7612 | N-Desmethyl Galanthamine | 41303-74-6 | Natural Products |
| HY-N7613 | 6''-O-Acetylsaikosaponin A | 64340-46-1 | Natural Products |
| HY-N7614 | Anemarrhenasaponin A2 | 117210-12-5 | Natural Products |
| HY-N7615 | Momordin IIc | 96990-19-1 | Natural Products |
| HY-N7616 | Oleanolic acid-3-O-glucosyl(1-2)xylyl(1-3)glucosiduronic acid | 1447508-78-2 | Natural Products |
| HY-N7617 | Toralactone | 41743-74-2 | Natural Products |
| HY-N7617R | Toralactone (Standard) | 41743-74-2 | Reference Standards |
| HY-N7618 | 8-Methyl Chrysophanol | 3300-25-2 | Natural Products |
| HY-N7619 | Xanthopurpurin | 518-83-2 | Natural Products |
| HY-N7620 | Bryonamide B | 5942-25-6 | Natural Products |
| HY-N7621 | Bryonamide A | 75268-14-3 | Natural Products |
| HY-N7622 | Acetylatractylodinol | 61582-39-6 | Natural Products |
| HY-N7623 | Ursonic acid methyl ester | 989-72-0 | Reference compound |
| HY-N7624 | Methyl oleanonate | 1721-58-0 | Natural Products |
| HY-N7625 | N-Formylcytisine | 53007-06-0 | Natural Products |
| HY-N7626 | Eleutherol | 480-00-2 | Natural Products |
| HY-N7627 | Regaloside C | 117591-85-2 | Natural Products |
| HY-N7628 | Cassiaside C | 119170-52-4 | Natural Products |
| HY-N7629 | Lactiflorin | 1361049-59-3 | Natural Products |
| HY-N7630 | Rehmapicrogenin | 135447-39-1 | Natural Products |
| HY-N7631 | Combretol | 5084-19-5 | Natural Products |
| HY-N7632 | 5-Desmethylsinensetin | 21763-80-4 | Natural Products |
| HY-N7633 | Regaloside D | 120601-66-3 | Natural Products |
| HY-N7634 | Tectol | 24449-39-6 | Natural Products |
| HY-N7635 | Oleanolic acid 28-O-β-D-glucopyranoside | 14162-53-9 | Natural Products |
| HY-N7636 | Persicogenin | 28590-40-1 | Natural Products |
| HY-N7637 | Tubuloside B | 112516-04-8 | Natural Products |
| HY-N7638 | Dihydrolapachenole | 20213-26-7 | Natural Products |
| HY-N7639 | Paeoniflorin sulfite | 1146967-98-7 | Natural Products |
| HY-N7640 | Deoxylimonin | 989-23-1 | Natural Products |
| HY-N7640R | Deoxylimonin (Standard) | 989-23-1 | Reference Standards |
| HY-N7641 | 3',4',7-Trimethoxyquercetin | 6068-80-0 | Natural Products |
| HY-N7642 | Oxysanguinarine | 548-30-1 | Natural Products |
| HY-N7643 | Comanthoside B | 70938-60-2 | Natural Products |
| HY-N7644 | Comanthoside A | 70938-59-9 | Natural Products |
| HY-N7645 | Prunetrin | 154-36-9 | Natural Products |
| HY-N7646 | Curculigoside B | 143601-09-6 | Natural Products |
| HY-N7647 | Methyl brevifolincarboxylate | 154702-76-8 | Natural Products |
| HY-N7648 | Atherosperminine | 5531-98-6 | Natural Products |
| HY-N7649 | Rhombifoline | 529-78-2 | Natural Products |
| HY-N7650 | Dihydroseselin | 2221-66-1 | Natural Products |
| HY-N7651 | Neoanhydropodophyllol | 62287-47-2 | Natural Products |
| HY-N7652 | Terminolic acid | 564-13-6 | Natural Products |
| HY-N7653 | Azaleatin | 529-51-1 | Natural Products |
| HY-N7654 | (-)-Epipodophyllotoxin | 4375-07-9 | Natural Products |
| HY-N7655 | 7-O-Methylbiochanin A | 34086-51-6 | Natural Products |
| HY-N7656 | 5,7,8-Trimethoxyflavone | 23050-38-6 | Natural Products |
| HY-N7657 | L-octaguluronic acid (octasodium salt) | 862694-88-0 | Natural Products |
| HY-N7659 | Glucobrassicin | 4356-52-9 | Natural Products |
| HY-N7659A | Glucobrassicin (potassium) | 143231-38-3 | Natural Products |
| HY-N7661 | 4β-Hydroxywithanolide E | 54334-04-2 | Natural Products |
| HY-N7662 | L-heptaguluronic acid (heptasodium salt) | 862694-87-9 | Natural Products |
| HY-N7664 | Isotheaflavin | 31701-93-6 | Natural Products |
| HY-N7665 | Prosaikogenin G | 99365-23-8 | Natural Products |
| HY-N7666 | Prosaikogenin F | 99365-20-5 | Natural Products |
| HY-N7667 | Prosaikogenin D | 103629-72-7 | Natural Products |
| HY-N7668 | Neotheaflavin | 36451-14-6 | Natural Products |
| HY-N7669 | Taccalonolide C | 117803-96-0 | Natural Products |
| HY-N7670 | Saikogenin F | 14356-59-3 | Natural Products |
| HY-N7671 | Euphorbetin | 35897-99-5 | Natural Products |
| HY-N7672 | Isoeuphorbetin | 50886-61-8 | Natural Products |
| HY-N7673 | Gymnoside III | 899430-03-6 | Natural Products |
| HY-N7674 | Angoline | 21080-31-9 | Natural Products |
| HY-N7674A | Angoline (hydrochloride) | 1071676-04-4 | Natural Products |
| HY-N7675 | Flavanomarein | 577-38-8 | Natural Products |
| HY-N7675A | (2R)-Flavanomarein | 56389-87-8 | Natural Products |
| HY-N7676 | Marein | 535-96-6 | Natural Products |
| HY-N7677 | Isookanin | 1036-49-3 | Natural Products |
| HY-N7678 | Gypenoside LXXV | 110261-98-8 | Natural Products |
| HY-N7679 | Stachyanthuside A | 864779-30-6 | Natural Products |
| HY-N7680 | Neopuerarin A | 1150314-34-3 | Natural Products |
| HY-N7680A | Neopuerarin B | 1150314-39-8 | Natural Products |
| HY-N7681 | Taxifolin 7-O-β-D-glucoside | 14292-40-1 | Natural Products |
| HY-N7682 | β-Tomatine | 17406-46-1 | Natural Products |
| HY-N7683 | Prunetin 5-O-β-D-glucopyranoside | 89595-66-4 | Natural Products |
| HY-N7684 | Picropodophyllone | 477-48-5 | Natural Products |
| HY-N7685 | Podophyllol | 78339-51-2 | Reference compound |
| HY-N7686 | Paeoniflorgenin | 697300-41-7 | Reference compound |
| HY-N7687 | Caulophyllogenin | 52936-64-8 | Natural Products |
| HY-N7688 | Regaloside B | 114420-67-6 | Natural Products |
| HY-N7689 | Mexoticin | 18196-00-4 | Natural Products |
| HY-N7690 | 3,5,7,3′,4′-Pentamethoxyflavone | 1247-97-8 | Natural Products |
| HY-N7691 | 3,29-O-Dibenzoyloxykarounidiol | 389122-01-4 | Natural Products |
| HY-N7692 | Polyporusterone A | 141360-88-5 | Natural Products |
| HY-N7693 | Polyporusterone B | 141360-89-6 | Natural Products |
| HY-N7694 | Isotoosendanin | 97871-44-8 | Natural Products |
| HY-N7695 | Physalin B | 23133-56-4 | Natural Products |
| HY-N7696 | Physalin F | 57423-71-9 | Natural Products |
| HY-N7697 | Chitotetraose (tetrahydrochloride) | 117399-50-5 | Natural Products |
| HY-N7697A | Chitopentaose (pentahydrochloride) | 117467-64-8 | Natural Products |
| HY-N7697B | Chitobiose (dihydrochloride) | 115350-24-8 | Natural Products |
| HY-N7697BR | Chitobiose (dihydrochloride) (Standard) | 115350-24-8 | Reference Standards |
| HY-N7697C | Chitohexaose (hexahydrochloride) | 127171-88-4 | Natural Products |
| HY-N7697D | Chitoheptaose (heptahydrochloride) | 127171-89-5 | Reference compound |
| HY-N7697E | Chitotriose (trihydrochloride) | 117436-78-9 | Natural Products |
| HY-N7697F | Chitobiose | 577-76-4 | Natural Products |
| HY-N7697R | Chitotetraose (tetrahydrochloride) (Standard) | 117399-50-5 | Reference Standards |
| HY-N7698 | Tetra-N-acetylchitotetraose | 2706-65-2 | Reference compound |
| HY-N7698A | Penta-N-acetylchitopentaose | 36467-68-2 | Reference compound |
| HY-N7698B | Hexa-N-acetylchitohexaose | 38854-46-5 | Reference compound |
| HY-N7699 | D-Dimannuronic acid | 34044-53-6 | Natural Products |
| HY-N7699A | D-Trimannuronic acid | 66754-13-0 | Natural Products |
| HY-N7699B | D-Tetramannuronic acid | 149511-34-2 | Natural Products |
| HY-N7699C | D-Pentamannuronic acid | 183668-50-0 | Natural Products |
| HY-N7699D | D-Hexamannuronic acid | 183668-52-2 | Natural Products |
| HY-N7699E | D-Heptamannuronic acid | 862694-97-1 | Natural Products |
| HY-N7699F | D-Octamannuronic acid | 862694-98-2 | Natural Products |
| HY-N7699G | D-Nonamannuronic acid | 862694-99-3 | Natural Products |
| HY-N7699H | D-Dimannuronic acid (sodium) | Natural Products | |
| HY-N7700 | Guluronic acid | 15769-56-9 | Reference compound |
| HY-N7700A | Guluronic acid (sodium) | Reference compound | |
| HY-N7700C | L-Guluronic acid (sodium salt) | 32510-76-2 | Natural Products |
| HY-N7701 | L-Diguluronic acid | 34044-54-7 | Natural Products |
| HY-N7701A | L-Triguluronic acid | 66754-14-1 | Reference compound |
| HY-N7701B | L-Tetraguluronic acid | 149511-37-5 | Reference compound |
| HY-N7701C | L-Pentaguluronic acid | 183668-72-6 | Reference compound |
| HY-N7701D | L-Hexaguluronic acid | 183668-74-8 | Reference compound |
| HY-N7701E | L-Diguluronic acid (disodium) | 1883438-76-3 | Natural Products |
| HY-N7702 | N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide | 883715-23-9 | Natural Products |
| HY-N7703 | D-Mannuronic acid (sodium) | 921-56-2 | Natural Products |
| HY-N7704 | Debenzoylpaeoniflorgenin | 1429403-79-1 | Natural Products |
| HY-N7705 | Isoescin Ie | 1613506-28-7 | Natural Products |
| HY-N7706 | Escin Ie | 1613506-26-5 | Natural Products |
| HY-N7707 | Sandacanol | 28219-61-6 | Reference compound |
| HY-N7708 | Lycodoline | 6900-92-1 | Natural Products |
| HY-N7709 | Cinchonain IIb | 85022-68-0 | Natural Products |
| HY-N7710 | FF-MAS | 64284-64-6 | Natural Products |
| HY-N7711 | 5-Epicanadensene | 220384-17-8 | Natural Products |
| HY-N7715 | Ferulic acid acyl-β-D-glucoside | 7196-71-6 | Natural Products |
| HY-N7717 | (-)-N-methylcoclaurine | 5096-70-8 | Natural Products |
| HY-N7718 | (−)-Rugulosin | 21884-45-7 | Natural Products |
| HY-N7719 | Oosporein | 475-54-7 | Natural Products |
| HY-N7719R | Oosporein (Standard) | 475-54-7 | Reference Standards |
| HY-N7722 | Demethyl Calyciphylline A | 1584236-34-9 | Natural Products |
| HY-N7724 | Cedrusin | 75775-36-9 | Natural Products |
| HY-N7727 | Gallocatechin gallate | 5127-64-0 | Natural Products |
| HY-N7729 | Sekikaic acid | 607-11-4 | Natural Products |
| HY-N7731 | (±)-Lavandulol | 58461-27-1 | Natural Products |
| HY-N7731A | (-)-Lavandulol | 498-16-8 | Natural Products |
| HY-N7731R | (±)-Lavandulol (Standard) | 58461-27-1 | Reference Standards |
| HY-N7732 | Peucedanol 3'-O-glucoside | 65891-61-4 | Natural Products |
| HY-N7733 | Fasciculic acid A | 126906-00-1 | Natural Products |
| HY-N7734 | 2,7-Dideacetoxytaxinine J | 115810-14-5 | Natural Products |
| HY-N7736 | Furan fatty acid F5 | 57818-37-8 | Natural Products |
| HY-N7737 | Furan fatty acid F6 | 57818-36-7 | Natural Products |
| HY-N7740 | Adenosine 2',5'-diphosphate (sodium) | 154146-84-6 | Natural Products |
| HY-N7741 | Isozaluzanin C | 67667-64-5 | Natural Products |
| HY-N7745 | Glucosylsphingosine | 52050-17-6 | Natural Products |
| HY-N7745S | Glucosylsphingosine-d7 | 2315262-29-2 | Isotope-Labeled Compounds |
| HY-N7745S1 | Glucosylsphingosine-d5 | Isotope-Labeled Compounds | |
| HY-N7745S2 | Glucosylsphingosine-13C6 | 299172-48-8 | Isotope-Labeled Compounds |
| HY-N7747 | Sceptrin (dihydrochloride) | 79703-25-6 | Natural Products |
| HY-N7748A | Epi-cryptoacetalide | 132152-57-9 | Natural Products |
| HY-N7751 | Isotanshinone II | 98249-39-9 | Natural Products |
| HY-N7752 | 3α-Hydroxytanshinone IIA | 97399-71-8 | Natural Products |
| HY-N7753 | Hydroxymethylenetanshiquinone | 83145-47-5 | Natural Products |
| HY-N7755 | Estradiol 3-(β-D-Glucuronide) (sodium) | 14982-12-8 | Natural Products |
| HY-N7756 | 2-Deacetoxydecinnamoyltaxinine J | 87193-98-4 | Natural Products |
| HY-N7759 | Peucedanol 7-O-glucoside | 65853-04-5 | Natural Products |
| HY-N7760 | Neosalvianen | 790673-00-6 | Natural Products |
| HY-N7761 | Trijuganone B | 126979-84-8 | Natural Products |
| HY-N7762 | Chrysanthellin A | 73039-13-1 | Natural Products |
| HY-N7763 | Casuarictin | 79786-00-8 | Natural Products |
| HY-N7765 | Oenothein B | 104987-36-2 | Natural Products |
| HY-N7766 | Rubropunctatin | 514-67-0 | Natural Products |
| HY-N7768 | β-Ergocryptine | 20315-46-2 | Natural Products |
| HY-N7771 | Spartioidine | 520-59-2 | Natural Products |
| HY-N7771R | Spartioidine (Standard) | 520-59-2 | Reference Standards |
| HY-N7774 | Echinatine N-oxide | 20267-93-0 | Natural Products |
| HY-N7776 | 7-Xylosyl-10-Deacetyltaxol B | 90332-64-2 | Natural Products |
| HY-N7777 | 7-Xylosyl-10-Deacetyltaxol C | 90332-65-3 | Natural Products |
| HY-N7778 | 3-Hydroxy-(28-4-coumaroyloxy)lup-20(29)-en-27-oic acid | 85540-98-3 | Natural Products |
| HY-N7780 | Aflatrem | 70553-75-2 | Natural Products |
| HY-N7781 | (-)-(E)-Guggulsterone | 39025-24-6 | Natural Products |
| HY-N7781R | (-)-(E)-Guggulsterone (Standard) | 39025-24-6 | Reference Standards |
| HY-N7782 | Arborinone | 25465-81-0 | Natural Products |
| HY-N7784 | Liriodenine methiodide | 55974-07-7 | Natural Products |
| HY-N7785 | N-Demethyl-α-obscurine | 34399-44-5 | Natural Products |
| HY-N7788 | cis-2-Dodecenoic acid | 55928-65-9 | Natural Products |
| HY-N7790 | Citrusinol | 112516-43-5 | Natural Products |
| HY-N7791 | Kushenol O | 102390-91-0 | Natural Products |
| HY-N7792 | Baptifoline | 732-50-3 | Natural Products |
| HY-N7795 | 16,23-Oxidoalisol B | 169326-06-1 | Natural Products |
| HY-N7798 | Pennogenin | 507-89-1 | Natural Products |
| HY-N7800 | Himbacine | 6879-74-9 | Natural Products |
| HY-N7801 | (±)5-HEPE | 83952-40-3 | Natural Products |
| HY-N7803 | De-O-Methyllasiodiplodin | 32885-82-8 | Natural Products |
| HY-N7804 | 4'-O-Methylcoumestrol | 1690-62-6 | Natural Products |
| HY-N7806 | 7,3'-Di-O-Methylorobol | 104668-88-4 | Natural Products |
| HY-N7807 | (±)-5,7-Dimethyltocol | 493-35-6 | Natural Products |
| HY-N7811 | 2-Hydroxytetracosanoic acid | 544-57-0 | Natural Products |
| HY-N7813 | 1,2-Dipalmitoyl-3-oleoylglycerol | 1867-91-0 | Natural Products |
| HY-N7814 | 2-Hydroxypalmitic acid | 764-67-0 | Natural Products |
| HY-N7814R | 2-Hydroxypalmitic acid (Standard) | 764-67-0 | Reference Standards |
| HY-N7814S | 2-Hydroxypalmitic acid-d30 | 2692623-90-6 | Isotope-Labeled Compounds |
| HY-N7815 | 3-Hydroxytridecanoic acid | 32602-69-0 | Natural Products |
| HY-N7816 | trans-Methylkhellactone | 23733-92-8 | Natural Products |
| HY-N7819 | Pristane | 1921-70-6 | Natural Products |
| HY-N7819S | Pristane-d40 | 16416-35-6 | Isotope-Labeled Compounds |
| HY-N7821 | Aphidicolin 17-acetate | 51103-57-2 | Natural Products |
| HY-N7823 | Phorbol 13-acetate | 32752-29-7 | Natural Products |
| HY-N7824 | 15-Methylpalmitic acid | 1603-03-8 | Biochemical Assay Reagents |
| HY-N7825 | Gomisin L1 | 82425-43-2 | Natural Products |
| HY-N7830 | 7α,15-Dihydroxydehydroabietic acid | 155205-64-4 | Natural Products |
| HY-N7831 | N-Oleoyl alanine | 745733-78-2 | Natural Products |
| HY-N7832 | Petunidin-3-O-glucoside (chloride) | 6988-81-4 | Natural Products |
| HY-N7832A | Petunidin-3-O-galactoside (chloride) | 28500-02-9 | Natural Products |
| HY-N7832R | Petunidin-3-O-glucoside (chloride) (Standard) | 6988-81-4 | Reference Standards |
| HY-N7833 | Heneicosapentaenoic acid | 24257-10-1 | Biochemical Assay Reagents |
| HY-N7833S | Heneicosapentaenoic acid-d6 | 2692624-13-6 | Isotope-Labeled Compounds |
| HY-N7835 | Methyl dotriacontanoate | 41755-79-7 | Natural Products |
| HY-N7839 | cis-Methylkhellactone | 20107-13-5 | Natural Products |
| HY-N7842 | 17-Methylstearic acid | 2724-59-6 | Biochemical Assay Reagents |
| HY-N7843 | (+)-8-Methoxyisolariciresinol | 136082-41-2 | Natural Products |
| HY-N7844 | N6-Benzyladenosine | 4294-16-0 | Natural Products |
| HY-N7844S | N6-Benzyladenosine-d5 | Isotope-Labeled Compounds | |
| HY-N7848 | Linoleamide | 3999-01-7 | Natural Products |
| HY-N7848R | Linoleamide (Standard) | 3999-01-7 | Reference Standards |
| HY-N7850 | 6PGD-IN-1 | 5539-66-2 | Natural Products |
| HY-N7851 | Terpineol | 8000-41-7 | Natural Products |
| HY-N7854 | Anacardic acid diene | 103904-74-1 | Natural Products |
| HY-N7856 | 3-Oxooctadecanoic acid | 16694-29-4 | Natural Products |
| HY-N7857 | 19(R)-Hydroxy-prostaglandin F2α | 64625-53-2 | Natural Products |
| HY-N7858 | cis-Parinaric acid | 593-38-4 | Natural Products |
| HY-N7859 | 1,3-Dioleoyl-2-myristoyl glycerol | 158298-95-4 | Natural Products |
| HY-N7860 | Δ2-cis Eicosenoic acid | 93772-82-8 | Natural Products |
| HY-N7861 | Methyl elaidate | 1937-62-8 | Biochemical Assay Reagents |
| HY-N7861R | Methyl elaidate (Standard) | 1937-62-8 | Reference Standards |
| HY-N7862 | Tridocosahexaenoin | 11094-59-0 | Natural Products |
| HY-N7862R | Tridocosahexaenoin (Standard) | 11094-59-0 | Reference Standards |
| HY-N7864 | Osbond acid | 25182-74-5 | Biochemical Assay Reagents |
| HY-N7865 | 1,2-Palmitolein-3-olein | 107196-42-9 | Natural Products |
| HY-N7866 | 2-Hydroxytricosanoic acid | 2718-37-8 | Natural Products |
| HY-N7867 | Taxifolin 3′-O-β-D-glucoside | 31106-05-5 | Natural Products |
| HY-N7868 | Methyl tricosanoate | 2433-97-8 | Biochemical Assay Reagents |
| HY-N7868R | Methyl tricosanoate (Standard) | 2433-97-8 | Reference Standards |
| HY-N7871 | Angulatin K | 1631992-80-7 | Natural Products |
| HY-N7875 | Celangulin | 116159-73-0 | Natural Products |
| HY-N7878 | Tectorigenin sodium sulfonate | 807636-25-5 | Natural Products |
| HY-N7880 | Salvianolic acid Y | 1638738-76-7 | Natural Products |
| HY-N7881 | 1,2,4,5-Tetrachloro-3,6-dimethoxybenzene | 944-78-5 | Natural Products |
| HY-N7882 | Ptaquiloside | 87625-62-5 | Natural Products |
| HY-N7885 | (25R)-Spirost-4-ene-3,12-dione | 6875-60-1 | Natural Products |
| HY-N7887 | Cassiaside | 13709-03-0 | Natural Products |
| HY-N7889 | Syringetin-3-O-rutinoside | 53430-50-5 | Natural Products |
| HY-N7893 | Ebracteolata cpd B | 83459-37-4 | Natural Products |
| HY-N7894 | 3-Hydroxymorindone | 80368-74-7 | Natural Products |
| HY-N7895 | Secologanic acid | 60077-46-5 | Natural Products |
| HY-N7897 | Myrrhone | 183551-83-9 | Natural Products |
| HY-N7898 | Epipinoresinol-4'-O-β-D-glucoside | 24404-49-7 | Natural Products |
| HY-N7899 | 11-Deoxymogroside V | 1707161-17-8 | Natural Products |
| HY-N7900 | Malvidin 3,5-diglucoside (chloride) | 16727-30-3 | Natural Products |
| HY-N7902 | 6''-O-Xylosylglycitin | 231288-18-9 | Natural Products |
| HY-N7903 | Complanatoside B | 142473-99-2 | Natural Products |
| HY-N7904 | Laricitrin 3-O-glucoside | 39986-90-8 | Natural Products |
| HY-N7905 | Myricetin 3'-glucoside | 520-14-9 | Natural Products |
| HY-N7906 | Myricetin 3-O-glucoside | 19833-12-6 | Natural Products |
| HY-N7907 | Myricetin-3-O-β-D-xylopyranosyl-(1→2)-β-D-glucopyranoside | 142449-93-2 | Natural Products |
| HY-N7909 | 1-Octacosanoyl glyceride | 71035-02-4 | Natural Products |
| HY-N7910 | Stachyose | 470-55-3 | Natural Products |
| HY-N7910R | Stachyose (Standard) | 470-55-3 | Reference Standards |
| HY-N7912 | Pterosin A | 35910-16-8 | Natural Products |
| HY-N7915 | Nepasaikosaponin K | 405229-61-0 | Natural Products |
| HY-N7916 | (-)-Menthone | 14073-97-3 | Natural Products |
| HY-N7916R | (-)-Menthone (Standard) | 14073-97-3 | Reference Standards |
| HY-N7918 | 17β-Tenacigenin B | 863767-79-7 | Natural Products |
| HY-N7919 | Celosin H | 1623405-28-6 | Natural Products |
| HY-N7921 | Urolithin M6 | 1006683-97-1 | Natural Products |
| HY-N7922 | Urolithin M5 | 91485-02-8 | Natural Products |
| HY-N7924 | Astragenol | 86541-79-9 | Natural Products |
| HY-N7926 | Pentadecane | 629-62-9 | Natural Products |
| HY-N7926R | Pentadecane (Standard) | 629-62-9 | Reference Standards |
| HY-N7926S | Pentadecane-d32 | 36340-20-2 | Isotope-Labeled Compounds |
| HY-N7927 | (-)-Terpinen-4-ol | 20126-76-5 | Natural Products |
| HY-N7927R | (-)-Terpinen-4-ol (Standard) | 20126-76-5 | Reference Standards |
| HY-N7928 | Nonadecane | 629-92-5 | Natural Products |
| HY-N7928R | Nonadecane (Standard) | 629-92-5 | Reference Standards |
| HY-N7928S | n-Nonadecane-d40 | 39756-36-0 | Isotope-Labeled Compounds |
| HY-N7929 | 5-Feruloylquinic acid | 40242-06-6 | Natural Products |
| HY-N7929R | 5-Feruloylquinic acid (Standard) | 40242-06-6 | Reference Standards |
| HY-N7930 | Crenulatin | 63026-02-8 | Natural Products |
| HY-N7931 | Regaloside A | 114420-66-5 | Natural Products |
| HY-N7932 | Kaempferol 3-O-α-L-rhamnopyranosyl(2,1)-α-L-rhamnopyranoside | 142451-65-8 | Natural Products |
| HY-N7933 | Tetracosane | 646-31-1 | Natural Products |
| HY-N7933R | Tetracosane (Standard) | 646-31-1 | Reference Standards |
| HY-N7933S | Tetracosane-d50 | 16416-32-3 | Isotope-Labeled Compounds |
| HY-N7934 | Trachelogenin | 34209-69-3 | Natural Products |
| HY-N7935 | Procyanidin B5 | 12798-57-1 | Natural Products |
| HY-N7937 | γ-Asarone | 5353-15-1 | Natural Products |
| HY-N7938 | Fructo-oligosaccharide DP13 | 137405-37-9 | Natural Products |
| HY-N7939 | Celangulin XIX | 403505-80-6 | Natural Products |
| HY-N7940 | 6-Aldehydoisoophiopogonone B | 112500-89-7 | Natural Products |
| HY-N7942 | 6-Aldehydoisoophiopogonone A | 112500-90-0 | Natural Products |
| HY-N7944 | Eucommiol | 55930-44-4 | Natural Products |
| HY-N7945 | 6-Hydroxykaempferol 3-O-β-rutinoside-6-O-β-D-glucoside | 145134-63-0 | Natural Products |
| HY-N7948 | Isomaltotetraose | 35997-20-7 | Natural Products |
| HY-N7948R | Isomaltotetraose (Standard) | 35997-20-7 | Reference Standards |
| HY-N7950 | 16-Oxoalisol A | 124515-98-6 | Natural Products |
| HY-N7951 | Aristolochic acid III | 7267-92-7 | Natural Products |
| HY-N7952 | Achyranthoside D | 168009-91-4 | Natural Products |
| HY-N7953 | 1,2-Dioleoyl-3-linoleoyl-rac-glycerol | 2190-20-7 | Natural Products |
| HY-N7954 | Neopanaxadiol | 1203590-03-7 | Natural Products |
| HY-N7957 | Pratensein-7-O-β-D-glucopyranoside | 36191-03-4 | Natural Products |
| HY-N7958 | Gomisin F | 62956-47-2 | Natural Products |
| HY-N7960 | (2S)-Pteroside A | 35910-15-7 | Natural Products |
| HY-N7961 | (E/Z)-Ginkgolic acid C17:2 | 102811-39-2 | Natural Products |
| HY-N7962 | Cornoside | 40661-45-8 | Natural Products |
| HY-N7963 | 1-O-Galloyl-2-O-cinnamoyl-glucose | 791836-69-6 | Natural Products |
| HY-N7965 | Methyl kakuol | 70342-29-9 | Natural Products |
| HY-N7966 | Bacopaside N2 | 871706-75-1 | Natural Products |
| HY-N7968 | Angenomalin | 18199-64-9 | Natural Products |
| HY-N7969 | Odoriflavene | 101153-41-7 | Natural Products |
| HY-N7971 | 2-Hydroxy-1-Methoxyaporphine | 33770-27-3 | Natural Products |
| HY-N7972 | 19-Oxocinobufotalin | 24512-60-5 | Natural Products |
| HY-N7974 | Kizuta saponin K11 | 97240-03-4 | Natural Products |
| HY-N7975 | Lucidin 3-O-glucoside | 22255-29-4 | Natural Products |
| HY-N7976 | Quercetin 3-O-neohesperidoside | 32453-36-4 | Natural Products |
| HY-N7977 | Lucidone B | 97653-93-5 | Natural Products |
| HY-N7980 | Rubipodanone A | 2170211-22-8 | Natural Products |
| HY-N7981 | Pratensein | 2284-31-3 | Natural Products |
| HY-N7982 | (+)-Pinoresinol monomethyl ether O-β-D-glucoside | 74957-57-6 | Natural Products |
| HY-N7985 | Pendulone | 69359-09-7 | Natural Products |
| HY-N7986 | Dihydromollugin | 60657-93-4 | Natural Products |
| HY-N7989 | Quercetin 3-O-(6''-O-galloyl)-β-D-glucoside | 56316-75-7 | Natural Products |
| HY-N7990 | Scheffoleoside A | 160669-23-8 | Natural Products |
| HY-N7991 | Rubiayannone A | 517918-25-1 | Natural Products |
| HY-N7992 | Myricetin-3-O-rutinoside | 41093-68-9 | Natural Products |
| HY-N7993 | Manghaslin | 55696-57-6 | Natural Products |
| HY-N7994 | Hellebrigenol | 508-79-2 | Natural Products |
| HY-N7996 | Matairesinoside | 23202-85-9 | Natural Products |
| HY-N8005 | 11-Dehydroxyisomogroside V | 1628293-32-2 | Natural Products |
| HY-N8007 | Quercetin 3-O-Glc-(1→2)-Rha-7-O-Rha | 138989-37-4 | Natural Products |
| HY-N8008 | Wallichoside | 60657-36-5 | Natural Products |
| HY-N8009 | Rebaudioside O | 1220616-48-7 | Natural Products |
| HY-N8011 | 25(R)-3β,17α-Dihydroxy-5α-spirostan-6-one 3-O-α-D-rhamnopyranosyl-(1→2)-β-D-glucopyranoside | 143051-94-9 | Natural Products |
| HY-N8012 | Multinoside A | 59262-54-3 | Natural Products |
| HY-N8015 | Octanal | 124-13-0 | Natural Products |
| HY-N8015R | Octanal (Standard) | 124-13-0 | Reference Standards |
| HY-N8015S | Octanal-d16 | 1219794-66-7 | Isotope-Labeled Compounds |
| HY-N8015S2 | Octanal-d4 | 1335401-91-6 | Isotope-Labeled Compounds |
| HY-N8016 | Nonanal | 124-19-6 | Natural Products |
| HY-N8016R | Nonanal (Standard) | 124-19-6 | Reference Standards |
| HY-N8016S | Nonanal-d18 | 1466552-36-2 | Isotope-Labeled Compounds |
| HY-N8016S1 | Nonanal-d4 | 1335401-96-1 | Isotope-Labeled Compounds |
| HY-N8016S2 | Nonanal-d2 | 1335435-50-1 | Isotope-Labeled Compounds |
| HY-N8018 | Leucosceptoside A | 83529-62-8 | Natural Products |
| HY-N8021 | Epipinoresinol-4-O-β-glucoside | 74983-66-7 | Natural Products |
| HY-N8022 | Lucidin primeveroside | 29706-59-0 | Natural Products |
| HY-N8024 | Rubinaphthin A | 448962-05-8 | Natural Products |
| HY-N8025 | Nephthenol | 53915-41-6 | Natural Products |
| HY-N8026 | Colutehydroquinone | 181311-16-0 | Natural Products |
| HY-N8028 | Quercetin 3-O-sambubioside | 83048-35-5 | Natural Products |
| HY-N8029 | 6-Hydroxyapigenin 6-O-β-D-glucoside-7-O-β-D-glucuronide | 1146045-40-0 | Natural Products |
| HY-N8030 | Pseudoginsenoside Rg3 | 1012886-99-5 | Natural Products |
| HY-N8033 | Deglucohellebrin | 20300-44-1 | Natural Products |
| HY-N8034 | Glychionide A | 119152-50-0 | Natural Products |
| HY-N8034R | Glychionide A (Standard) | 119152-50-0 | Reference Standards |
| HY-N8038 | Isoanthricin | 69222-20-4 | Natural Products |
| HY-N8039 | Ganoderic acid T-Q | 112430-66-7 | Natural Products |
| HY-N8040 | Demethoxymatteucinol | 56297-79-1 | Natural Products |
| HY-N8041 | Mogroside III A2 | 88901-43-3 | Natural Products |
| HY-N8042 | Erigeside I | 224824-74-2 | Natural Products |
| HY-N8045 | Methyl ricinoleate | 141-24-2 | Biochemical Assay Reagents |
| HY-N8045R | Methyl ricinoleate (Standard) | 141-24-2 | Reference Standards |
| HY-N8046 | Gardoside | 54835-76-6 | Natural Products |
| HY-N8047 | 5-Hydroxy-7-(4'-hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone | 79559-61-8 | Natural Products |
| HY-N8052 | (-)-Antofine | 32671-82-2 | Natural Products |
| HY-N8054 | 1-Hydroxypinoresinol 1-O-β-D-glucoside | 81495-71-8 | Natural Products |
| HY-N8055 | Bancroftinone | 14964-98-8 | Natural Products |
| HY-N8059 | Fructo-oligosaccharide DP14 | 137405-38-0 | Natural Products |
| HY-N8060 | Orotidine 5′-monophosphate | 2149-82-8 | Natural Products |
| HY-N8060A | Orotidine 5′-monophosphate (trisodium) | 68244-58-6 | Natural Products |
| HY-N8063 | γ-Glutamylornithine | 56523-61-6 | Natural Products |
| HY-N8064 | Methyl cis-15-tetracosenoate | 2733-88-2 | Biochemical Assay Reagents |
| HY-N8066 | Chitobiose octaacetate | 41670-99-9 | Natural Products |
| HY-N8067 | Terbufoxon sulfoxide | 56165-57-2 | Natural Products |
| HY-N8068 | Dihydrooroxylin A | 18956-18-8 | Natural Products |
| HY-N8070 | 13-O-Cinnamoylbaccatin III | 220932-65-0 | Natural Products |
| HY-N8082 | Stearyl gallate | 10361-12-3 | Reference compound |
| HY-N8083 | Icariside B1 | 109062-00-2 | Natural Products |
| HY-N8084 | Epimedin B1 | 133137-58-3 | Natural Products |
| HY-N8085 | Icariside F2 | 115009-57-9 | Natural Products |
| HY-N8086 | Korepimedoside C | 205445-00-7 | Natural Products |
| HY-N8087 | Epimedin K | 174286-13-6 | Natural Products |
| HY-N8088 | Neolancerin | 117221-65-5 | Natural Products |
| HY-N8089 | Bis(dihydrochelerythrinyl)amine | 165393-48-6 | Natural Products |
| HY-N8090 | (3β,7β,12β,20Z)-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid | 1961358-02-0 | Natural Products |
| HY-N8091 | Lehmannine | 58480-54-9 | Natural Products |
| HY-N8092 | Kushenol B | 99217-64-8 | Natural Products |
| HY-N8093 | 2-Methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-O-α-rhamnosyl-(1→2)-β-D-glucoside | 87686-87-1 | Natural Products |
| HY-N8094 | Kushenol M | 101236-51-5 | Natural Products |
| HY-N8095 | Kushenol N | 102490-65-3 | Natural Products |
| HY-N8096 | Raddeanoside R17 | 824401-07-2 | Natural Products |
| HY-N8097 | Kushenol W | 254886-76-5 | Natural Products |
| HY-N8098 | Pulchinenoside E2 | 244202-36-6 | Natural Products |
| HY-N8100 | 2-Methyl-1,3,6-trihydroxy-9,10-anthraquinone 3-O-α-rhamnosyl-(1→2)-β-glucoside | 87686-88-2 | Natural Products |
| HY-N8101 | Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate | 90685-26-0 | Natural Products |
| HY-N8102 | Echinocystic acid 28-O-β-D-glucoside | 99633-30-4 | Natural Products |
| HY-N8103 | Heishuixiecaoline A | 1469493-85-3 | Natural Products |
| HY-N8104 | 15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid | 1961358-01-9 | Natural Products |
| HY-N8105 | Protoneogracillin | 191334-50-6 | Natural Products |
| HY-N8106 | 7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid | 942936-54-1 | Natural Products |
| HY-N8107 | Matairesinol monoglucoside | 34446-06-5 | Natural Products |
| HY-N8108 | Sterebin E | 114343-74-7 | Natural Products |
| HY-N8109 | 4'-Methoxyagarotetrol | 123278-01-3 | Natural Products |
| HY-N8110 | 8-Chloro-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydrochromone | 626236-06-4 | Natural Products |
| HY-N8111 | Huzhangoside B | 94795-70-7 | Natural Products |
| HY-N8112 | Polygalasaponin LII | 162857-62-7 | Natural Products |
| HY-N8113 | 3-(β-D-Glucopyranosyloxy)-1,6-dihydroxy-2-methyl-9,10-anthracenedione | 125906-49-2 | Natural Products |
| HY-N8114 | 2-Naphthalenecarboxylic acid, 4-(D-glucopyranosyloxy)-1-hydroxy-3-(3-hydroxy-3-methylbutyl)-, methyl ester | 125906-48-1 | Natural Products |
| HY-N8115 | S-(4-Hydroxybenzyl)glutathione | 129636-38-0 | Natural Products |
| HY-N8116 | Leonloside D | 20830-84-6 | Natural Products |
| HY-N8117 | Bisabolol oxide A | 22567-36-8 | Natural Products |
| HY-N8117R | Bisabolol oxide A (Standard) | 22567-36-8 | Reference Standards |
| HY-N8118 | Euphorbia factor L7b | 93550-95-9 | Natural Products |
| HY-N8119 | Euphorbia factor L8 | 218916-53-1 | Natural Products |
| HY-N8120 | Bisabolone oxide A | 22567-38-0 | Natural Products |
| HY-N8121 | Euphorbia factor L7a | 93550-94-8 | Natural Products |
| HY-N8122 | 24-Methylenecycloartanyl ferulate | 469-36-3 | Natural Products |
| HY-N8123 | 6,7-Dimethoxy-2-(2-phenylethyl)chromone | 84294-87-1 | Natural Products |
| HY-N8124 | 1,4-Dihydroxy-2-carbomethoxy-3-prenylnaphthalene-1-O-β-D-glucopyranoside | 1415729-43-9 | Natural Products |
| HY-N8125 | Rhaponticin 2′′-O-gallate | 94356-24-8 | Natural Products |
| HY-N8126 | Emodin 6-O-β-D-glucoside | 34298-85-6 | Natural Products |
| HY-N8127 | (1(10)E,2R*,4R*)-2-Methoxy-8,12-epoxygermacra-1(10),7,11-trien-6-one | 75412-95-2 | Natural Products |
| HY-N8128 | Rutarensin | 119179-04-3 | Natural Products |
| HY-N8129 | Rhaponticin 6′′-O-gallate | 94356-23-7 | Natural Products |
| HY-N8130 | 9-Methoxymyrrhone | 1809980-22-0 | Natural Products |
| HY-N8131 | Pangelin | 33783-80-1 | Natural Products |
| HY-N8132 | 2,4,6-Trichlorol-3-methyl-5-methoxy-phenol 1-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside | 1447969-66-5 | Natural Products |
| HY-N8133 | 5-O-(3'-O-Glucosylcaffeoyl)quinic acid | 1629852-63-6 | Natural Products |
| HY-N8134 | 2-Methoxy-5-acetoxy-fruranogermacr-1(10)-en-6-one | 1809980-25-3 | Natural Products |
| HY-N8135 | Sterebin A | 107647-14-3 | Natural Products |
| HY-N8136 | Volvalerenic acid A | 1247014-34-1 | Natural Products |
| HY-N8137 | Cucurbitacin Q1 | 99530-82-2 | Natural Products |
| HY-N8138 | (-)-Isobicyclogermacrenal | 73256-82-3 | Natural Products |
| HY-N8139 | 2-Amino-3-carboxy-1,4-naphthoquinone | 173043-38-4 | Natural Products |
| HY-N8140 | Methoxyeugenol 4-O-rutinoside | 903519-86-8 | Natural Products |
| HY-N8141 | Regaloside H | 126239-77-8 | Natural Products |
| HY-N8142 | 6-Hydroxy-2-phenethylchromone | 84294-90-6 | Natural Products |
| HY-N8143 | Emodin-1-O-β-gentiobioside | 849789-95-3 | Natural Products |
| HY-N8144 | Niga-ichigoside F1 | 95262-48-9 | Natural Products |
| HY-N8145 | Gingerglycolipid A | 145937-22-0 | Natural Products |
| HY-N8146 | Bruceantinol | 53729-52-5 | Natural Products |
| HY-N8147 | 11-Oxomogroside IV | 2096516-32-2 | Natural Products |
| HY-N8148 | Cassiaside B | 119170-51-3 | Natural Products |
| HY-N8149 | Eupalinolide H | 1402067-83-7 | Natural Products |
| HY-N8150 | Hythiemoside B | 853267-90-0 | Natural Products |
| HY-N8151 | Sanguisorbigenin | 6812-98-2 | Natural Products |
| HY-N8152 | Randialic acid B | 14021-14-8 | Natural Products |
| HY-N8153 | Glycosmisic acid | 443908-19-8 | Natural Products |
| HY-N8154 | Tortoside A | 190655-16-4 | Natural Products |
| HY-N8155 | Regaloside F | 120601-65-2 | Natural Products |
| HY-N8156 | Soyasapogenol C | 595-14-2 | Natural Products |
| HY-N8157 | 4'-O-Methylpyridoxine | 1464-33-1 | Natural Products |
| HY-N8158 | Gomisin S | 119239-49-5 | Natural Products |
| HY-N8159 | Gomisin U | 135095-46-4 | Natural Products |
| HY-N8160 | Dehydrocurdione | 38230-32-9 | Natural Products |
| HY-N8161 | Kaempferol-3,7-di-O-β-glucoside | 25615-14-9 | Natural Products |
| HY-N8162 | Soyasapogenol D | 65892-76-4 | Natural Products |
| HY-N8163 | Kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside | 476617-49-9 | Natural Products |
| HY-N8164 | 19α-Hydroxyasiatic acid | 70868-78-9 | Natural Products |
| HY-N8165 | Kaempferol 3-O-rutinoside 7-O-glucoside | 34336-18-0 | Natural Products |
| HY-N8166 | Celosin J | 1623405-29-7 | Natural Products |
| HY-N8167 | Plantanone B | 55780-30-8 | Natural Products |
| HY-N8168 | LPRP-Et-97543 | 84638-48-2 | Natural Products |
| HY-N8169 | 10-O-Trans-p-methoxycinnamoylcatalpol | 201605-27-8 | Natural Products |
| HY-N8170 | 4',2-Dihydroxy-4,6-dimethoxydihydrochalcone | 151752-07-7 | Natural Products |
| HY-N8171 | Lagotisoide D | 834155-36-1 | Natural Products |
| HY-N8172 | (+)-Secoisolariciresinol | 145265-02-7 | Natural Products |
| HY-N8172R | (+)-Secoisolariciresinol (Standard) | 145265-02-7 | Reference Standards |
| HY-N8173 | Valtrate hydrine B4 | 18296-48-5 | Natural Products |
| HY-N8174 | Valeriandoid F | 1427162-60-4 | Natural Products |
| HY-N8175 | 3'-O-Methylbatatasin III | 101330-69-2 | Natural Products |
| HY-N8176 | Arundinin | 148225-38-1 | Natural Products |
| HY-N8177 | Bletilloside A | 2292159-89-6 | Natural Products |
| HY-N8178 | (R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone | 849727-88-4 | Natural Products |
| HY-N8180 | Silyamandin | 1009565-36-9 | Natural Products |
| HY-N8181 | 1,3-Linolein-2-Olein | 2190-22-9 | Natural Products |
| HY-N8182 | Bletilol B | 147235-17-4 | Natural Products |
| HY-N8183 | Shancigusin I | 1435488-35-9 | Natural Products |
| HY-N8184 | 4,4'-Dihydroxy-2,6-dimethoxydihydrochalcone | 151752-08-8 | Natural Products |
| HY-N8185 | Loureiriol | 479195-44-3 | Natural Products |
| HY-N8186 | (3R)-7,4’-Dihydrohomoisoflavanone | 1178893-64-5 | Natural Products |
| HY-N8187 | Eupalinolide O | 2170228-67-6 | Natural Products |
| HY-N8188 | Dehydrojuncusol | 117824-04-1 | Natural Products |
| HY-N8189 | Loureirin D | 119425-91-1 | Natural Products |
| HY-N8190 | 6-Hydroxykaempferol 3-O-β-D-glucoside | 145134-61-8 | Natural Products |
| HY-N8191 | 5,6,7,4'-Tetrahydroxyflavonol 3-O-rutinoside | 205527-00-0 | Natural Products |
| HY-N8192 | 5-Hydroxy-3-(4-hydroxybenzyl)-7-methoxychroman-4-one | 108001-32-7 | Natural Products |
| HY-N8193 | Brassicin | 6743-96-0 | Natural Products |
| HY-N8194 | Syringetin-3-O-glucoside | 40039-49-4 | Natural Products |
| HY-N8195 | Quercetin 3-O-sophoroside-7-O-rhamnoside | 64828-40-6 | Natural Products |
| HY-N8196 | Isorhamnetin 3,7-di-O-β-D-glucopyranoside | 6758-51-6 | Natural Products |
| HY-N8197 | Epigambogic acid | 887606-04-4 | Natural Products |
| HY-N8198 | Ardisiacrispin B | 112766-96-8 | Natural Products |
| HY-N8199 | Ardisicrenoside A | 160824-52-2 | Natural Products |
| HY-N8200 | Cassiaside B2 | 218155-40-9 | Natural Products |
| HY-N8201 | Rheumone B | 2095596-67-9 | Natural Products |
| HY-N8202 | Hemiphloin | 71963-94-5 | Natural Products |
| HY-N8203 | 4'-Hydroxy-6,7,8,3'-tetramethoxyflavonol | 1879030-01-9 | Natural Products |
| HY-N8204 | Siaresinolic acid 28-O-β-D-glucopyranosyl ester | 155653-86-4 | Natural Products |
| HY-N8205 | Hispidulin 4'-O-β-D-glucopyranoside | 244285-12-9 | Natural Products |
| HY-N8206 | Chrysophanol tetraglucoside | 120181-08-0 | Natural Products |
| HY-N8207 | Gypenoside LI | 94987-10-7 | Natural Products |
| HY-N8208 | Sibiricose A1 | 139726-40-2 | Natural Products |
| HY-N8209 | (+)-Medioresinol Di-O-β-D-glucopyranoside | 88142-63-6 | Natural Products |
| HY-N8210 | Homoeriodictyol | 446-71-9 | Reference compound |
| HY-N8210R | Homoeriodictyol (Standard) | 446-71-9 | Reference Standards |
| HY-N8211 | Gypenoside L | 94987-09-4 | Natural Products |
| HY-N8212 | Isofutoquinol A | 62499-70-1 | Natural Products |
| HY-N8213 | Rapanone | 573-40-0 | Natural Products |
| HY-N8214 | Isorhamnetin 3-O-β-D-glucose-7-O-β-D-gentiobioside | 60778-00-9 | Natural Products |
| HY-N8215 | Achyranthoside C | 168009-90-3 | Natural Products |
| HY-N8216 | Bacopaside IV | 155545-03-2 | Natural Products |
| HY-N8217 | 4-O-Cinnamoylquinic acid | 5509-70-6 | Natural Products |
| HY-N8218 | Homoeriodictyol 7-O-β-D-glucoside | 14982-11-7 | Natural Products |
| HY-N8219 | Isoarundinin II | 151538-56-6 | Natural Products |
| HY-N8220 | 2-(2-Phenylethyl)chromone | 61828-53-3 | Natural Products |
| HY-N8221 | Homoembelin | 38363-99-4 | Natural Products |
| HY-N8222 | Bacopaside N1 | 871706-74-0 | Natural Products |
| HY-N8223 | Viscumneoside III | 118985-27-6 | Natural Products |
| HY-N8224 | 5-O-Cinnamoylquinic acid | 5515-82-2 | Natural Products |
| HY-N8224A | (E)-5-O-Cinnamoylquinic acid | 6470-68-4 | Natural Products |
| HY-N8225 | Manassantin B | 88497-88-5 | Natural Products |
| HY-N8227 | Szechenyin A | Natural Products | |
| HY-N8228 | 17-Hydroxyneomatrine | 2306139-04-6 | Natural Products |
| HY-N8229 | 7β,15α,20-Trihydroxy-3,11,23-trioxo-5α-lanosta-8-en-26-oic acid | 2374206-89-8 | Natural Products |
| HY-N8235 | Virgaureagenin F | 2226630-77-7 | Natural Products |
| HY-N8239 | Cepharanoline | 27686-34-6 | Natural Products |
| HY-N8241 | N-trans-Caffeoyltyramine | 103188-48-3 | Natural Products |
| HY-N8243 | Coreopsin | 499-29-6 | Natural Products |
| HY-N8245 | 2',3'-cGMP (sodium) | 15718-49-7 | Natural Products |
| HY-N8246 | 2',3'-cUMP (sodium) | 15718-50-0 | Natural Products |
| HY-N8248 | Eleutherin | 478-36-4 | Natural Products |
| HY-N8248A | (-)-Eleutherin | 22768-95-2 | Natural Products |
| HY-N8249 | Cynandione A | 168706-29-4 | Natural Products |
| HY-N8251 | Cyclocurcumin | 153127-42-5 | Natural Products |
| HY-N8252 | Xanthoquinodin A1 | 151063-27-3 | Natural Products |
| HY-N8253 | Spiraeoside | 20229-56-5 | Natural Products |
| HY-N8253R | Spiraeoside (Standard) | 20229-56-5 | Reference Standards |
| HY-N8253S | Quercetin 4'-Glucoside-d3 | Isotope-Labeled Compounds | |
| HY-N8254 | Haginin A | 74174-29-1 | Natural Products |
| HY-N8256 | (–)-Mycousnine | 77480-55-8 | Natural Products |
| HY-N8257 | Dehydrobruceine A | 73435-47-9 | Natural Products |
| HY-N8258 | Aszonapyrone A | 83103-08-6 | Natural Products |
| HY-N8259 | Obovatol | 83864-78-2 | Natural Products |
| HY-N8260 | Angeloylgomisin Q | 72561-28-5 | Natural Products |
| HY-N8261 | Amicoumacin B | 77674-99-8 | Natural Products |
| HY-N8262 | Dehydrocorybulbine (chloride) | 59870-72-3 | Natural Products |
| HY-N8263 | Nepetoidin B | 55486-06-1 | Natural Products |
| HY-N8264 | Moringin | 73255-40-0 | Natural Products |
| HY-N8265 | Abyssinone V | 77263-11-7 | Natural Products |
| HY-N8266 | 10-Deacetylcephalomannine | 76429-85-1 | Natural Products |
| HY-N8267 | Territrem A | 70407-19-1 | Natural Products |
| HY-N8268 | Nordeoxycholic acid | 53608-86-9 | Natural Products |
| HY-N8268R | Nordeoxycholic acid (Standard) | 53608-86-9 | Reference Standards |
| HY-N8269 | Rivularin | 70028-59-0 | Natural Products |
| HY-N8270 | Physalin H | 70241-09-7 | Natural Products |
| HY-N8271 | Galeopsin | 76475-16-6 | Natural Products |
| HY-N8272 | Neocyclomorusin | 62596-35-4 | Natural Products |
| HY-N8274 | Flavidin | 83924-98-5 | Natural Products |
| HY-N8276 | Ro 3-1314 | 2012-14-8 | Reference compound |
| HY-N8277 | Kdo2-Lipid A (ammonium) | 1246298-62-3 | Natural Products |
| HY-N8278 | Dermatan (sulphate sodium) | 54328-33-5 | Natural Products |
| HY-N8279 | β-1,3-1,4-Glucanase | 62213-14-3 | Enzyme |
| HY-N8280 | IKD-8344 | 129046-69-1 | Natural Products |
| HY-N8281 | Daldinone A | 479669-74-4 | Natural Products |
| HY-N8282 | Flavoglaucin | 523-73-9 | Natural Products |
| HY-N8283 | Euchrestaflavanone B | 87402-91-3 | Natural Products |
| HY-N8284 | Tomentosin | 33649-15-9 | Natural Products |
| HY-N8285 | Sporogen AO-1 | 88418-12-6 | Natural Products |
| HY-N8286 | Anigorufone | 56252-32-5 | Reference compound |
| HY-N8287 | Oxaline | 55623-37-5 | Natural Products |
| HY-N8288 | Momordicoside F1 | 81348-81-4 | Natural Products |
| HY-N8289 | Nudiposide | 62058-46-2 | Natural Products |
| HY-N8290 | Lactupicrin | 65725-11-3 | Natural Products |
| HY-N8290R | Lactupicrin (Standard) | 65725-11-3 | Reference Standards |
| HY-N8292 | 7-(2'-Deoxyadenosin-N6-yl)aristolactam I | 127191-86-0 | Natural Products |
| HY-N8293 | Eupalinolide I | 1402067-84-8 | Natural Products |
| HY-N8294 | Kadsulignan L | 163660-06-8 | Natural Products |
| HY-N8295 | Leucomycin A13 | 78897-52-6 | Natural Products |
| HY-N8296 | Saccharocarcin A | 158475-32-2 | Natural Products |
| HY-N8297 | Pueroside B | 100692-54-4 | Natural Products |
| HY-N8298 | Taxezopidine L | 219749-76-5 | Natural Products |
| HY-N8300 | Rupesin E | 924901-58-6 | Natural Products |
| HY-N8301 | Ilicicolin F | 22738-98-3 | Natural Products |
| HY-N8302 | Cassythicine | 5890-28-8 | Natural Products |
| HY-N8303 | Gardenin A | 21187-73-5 | Natural Products |
| HY-N8304 | Shegansu B | 291535-65-4 | Natural Products |
| HY-N8305 | Gentianose | 25954-44-3 | Natural Products |
| HY-N8306 | Isojacareubin | 50597-93-8 | Natural Products |
| HY-N8307 | Syringaresinol | 487-35-4 | Natural Products |
| HY-N8308 | Momordicoside I aglycone | 81910-41-0 | Natural Products |
| HY-N8309 | Luteolin-4'-O-glucoside | 6920-38-3 | Natural Products |
| HY-N8309R | Luteolin-4'-O-glucoside (Standard) | 6920-38-3 | Reference Standards |
| HY-N8311 | Goshonoside F5 | 90851-28-8 | Natural Products |
| HY-N8312 | Bakkenolide IIIa | 915289-60-0 | Natural Products |
| HY-N8313 | Kielcorin | 64280-48-4 | Natural Products |
| HY-N8314 | 8-Epiloganic acid | 82509-41-9 | Natural Products |
| HY-N8315 | Echitovenidine | 7222-35-7 | Natural Products |
| HY-N8316 | Rugulotrosin A | 685135-81-3 | Natural Products |
| HY-N8317 | Rubicordifolin | 849699-55-4 | Natural Products |
| HY-N8318 | Luteolin-3′,7-diglucoside | 52187-80-1 | Natural Products |
| HY-N8319 | Leojaponin | 864817-63-0 | Natural Products |
| HY-N8320 | Tricin 5-gucoside | 32769-00-9 | Biochemical Assay Reagents |
| HY-N8321 | 5-O-Caffeoylshikimic acid | 73263-62-4 | Natural Products |
| HY-N8321R | 5-O-Caffeoylshikimic acid (Standard) | 73263-62-4 | Reference Standards |
| HY-N8322 | Erioside | 75872-12-7 | Natural Products |
| HY-N8323 | erythro-Guaiacylglycerol β-Sinapyl Ether 7-O-Glucoside | 412029-03-9 | Natural Products |
| HY-N8324 | Glabralide C | 2170388-85-7 | Natural Products |
| HY-N8325 | Phomosine D | 874918-37-3 | Natural Products |
| HY-N8326 | Maltononaose | 6471-60-9 | Natural Products |
| HY-N8328 | Trigonosin F | 1262842-73-8 | Natural Products |
| HY-N8329 | AS-2077715 | 1637356-98-9 | Natural Products |
| HY-N8330 | Cryptofolione | 160098-78-2 | Natural Products |
| HY-N8331 | Terpendole I | 167612-17-1 | Natural Products |
| HY-N8332 | Bile extract | 8008-63-7 | Biochemical Assay Reagents |
| HY-N8333 | Lepimectin A4 | 171249-05-1 | Natural Products |
| HY-N8334 | Stachybotrysin B | 2098376-42-0 | Natural Products |
| HY-N8336 | IT-143A | 183485-32-7 | Natural Products |
| HY-N8337 | IT-143B | 183485-34-9 | Natural Products |
| HY-N8338 | Pancixanthone A | 174232-30-5 | Natural Products |
| HY-N8339 | Decatromicin B | 235097-64-0 | Natural Products |
| HY-N8340 | Luvangetin | 483-92-1 | Natural Products |
| HY-N8341 | Alphitonin | 493-36-7 | Natural Products |
| HY-N8342 | Rhamnazin | 552-54-5 | Natural Products |
| HY-N8343 | Arjunglucoside I | 62319-70-4 | Natural Products |
| HY-N8344 | Frangulin A | 521-62-0 | Natural Products |
| HY-N8345 | Isocudraniaxanthone B | 199851-52-0 | Natural Products |
| HY-N8346 | 8-Oxocoptisine | 19716-61-1 | Natural Products |
| HY-N8347 | Dalbergin | 482-83-7 | Natural Products |
| HY-N8348 | Multiflorenol | 2270-62-4 | Natural Products |
| HY-N8349 | 19,20-Epoxycytochalasin D | 191349-10-7 | Natural Products |
| HY-N8351 | Vobtusine | 19772-79-3 | Natural Products |
| HY-N8352 | Baicalein 6-O-glucoside | 28279-72-3 | Natural Products |
| HY-N8353 | Stachybotramide | 149598-71-0 | Natural Products |
| HY-N8354 | 6',7'-Dihydroxybergamottin | 145414-76-2 | Natural Products |
| HY-N8355 | Beauveriolide I | 154491-55-1 | Natural Products |
| HY-N8356 | 13-cis-Vitamin A palmitate | 26771-20-0 | Natural Products |
| HY-N8356A | 9-cis-Vitamin A palmitate | 34356-29-1 | Natural Products |
| HY-N8357 | Vitamin D3 octanoate | 927822-16-0 | Natural Products |
| HY-N8357R | Vitamin D3 octanoate (Standard) | 927822-16-0 | Reference Standards |
| HY-N8358 | Carpinontriol B | 473451-73-9 | Natural Products |
| HY-N8359 | Questinol | 35688-09-6 | Natural Products |
| HY-N8360 | Citromycin | 37209-30-6 | Natural Products |
| HY-N8361 | Glycoborinine | 233279-39-5 | Natural Products |
| HY-N8362 | 1-Isomangostin | 19275-44-6 | Natural Products |
| HY-N8363 | Isoscutellarein | 41440-05-5 | Natural Products |
| HY-N8364 | Evoxanthine | 477-82-7 | Natural Products |
| HY-N8365 | Alpha-D-Glucose 1,6-bisphosphate (tetrapotassium) | 91183-87-8 | Natural Products |
| HY-N8366 | Alloisoimperatorin | 35214-83-6 | Natural Products |
| HY-N8367 | Vitexolide D | 1788090-69-6 | Natural Products |
| HY-N8368 | Neotripterifordin | 149249-32-1 | Natural Products |
| HY-N8371 | Shizukaol B | 142279-40-1 | Natural Products |
| HY-N8372 | Nalanthalide | 145603-76-5 | Natural Products |
| HY-N8373 | Beauvericin A | 165467-50-5 | Natural Products |
| HY-N8374 | Pheanthine | 1263-79-2 | Natural Products |
| HY-N8375 | Sieboldin | 18777-73-6 | Natural Products |
| HY-N8376 | Fustin | 20725-03-5 | Natural Products |
| HY-N8377 | Capsiate | 205687-01-0 | Natural Products |
| HY-N8378 | Clonostachydiol | 2205018-06-8 | Natural Products |
| HY-N8379 | Morolic acid | 559-68-2 | Natural Products |
| HY-N8380 | (-)-Latifolin | 10154-42-4 | Natural Products |
| HY-N8381 | Berkeleylactone E | 122211-62-5 | Natural Products |
| HY-N8382 | Chalepensin | 13164-03-9 | Natural Products |
| HY-N8383 | Butyrolactone V | 1151509-01-1 | Natural Products |
| HY-N8385 | 19,20-Epoxycytochalasin C | 189351-79-9 | Natural Products |
| HY-N8386 | Berkeleylactone F | 2095114-72-8 | Natural Products |
| HY-N8387 | Neogrifolin | 23665-96-5 | Natural Products |
| HY-N8388 | Collinin | 34465-83-3 | Natural Products |
| HY-N8389 | Globulol | 489-41-8 | Natural Products |
| HY-N8390 | 3-Epidehydropachymic acid | 168293-15-0 | Natural Products |
| HY-N8391 | Hydroxysulochrin | 581068-64-6 | Natural Products |
| HY-N8393 | Ascr#18 | 1355681-10-5 | Natural Products |
| HY-N8394 | Eupatolide | 6750-25-0 | Natural Products |
| HY-N8395 | Tunicamycin V | 66054-36-2 | Natural Products |
| HY-N8398 | n-Octyl caffeate | 478392-41-5 | Natural Products |
| HY-N8399 | Yadanziolide B | 95258-13-2 | Natural Products |
| HY-N8400 | Roridin L2 | 85124-22-7 | Natural Products |
| HY-N8401 | Musellactone | 907583-51-1 | Natural Products |
| HY-N8402 | Germacrone 4,5-epoxide | 92691-35-5 | Natural Products |
| HY-N8403 | Vibralactone B | 1093230-95-5 | Natural Products |
| HY-N8404 | Chlorahololide C | 1007859-25-7 | Natural Products |
| HY-N8405 | Isolimonexic acid | 73904-93-5 | Natural Products |
| HY-N8406 | Monomethylsulochrin | 10056-14-1 | Natural Products |
| HY-N8407 | Carminic acid | 1260-17-9 | Dye Reagents |
| HY-N8407R | Carminic acid (Standard) | 1260-17-9 | Dye Reagents |
| HY-N8408 | Peonidin 3,5-diglucoside | 132-37-6 | Natural Products |
| HY-N8409 | FD-838 | 110341-78-1 | Natural Products |
| HY-N8410 | Momordicoside P | 1011726-62-7 | Natural Products |
| HY-N8411 | Aromadendrene | 489-39-4 | Natural Products |
| HY-N8411R | Aromadendrene (Standard) | 489-39-4 | Reference Standards |
| HY-N8412 | 4-O-Methylbutein | 13323-67-6 | Natural Products |
| HY-N8413 | Chlojaponilactone B | 1449382-91-5 | Natural Products |
| HY-N8414 | Dehydrogeijerin | 16850-91-2 | Natural Products |
| HY-N8415 | Hispanone | 82462-67-7 | Natural Products |
| HY-N8416 | (-)-Isosclerone | 137494-04-3 | Natural Products |
| HY-N8417 | Buddlenoid A | 142750-32-1 | Natural Products |
| HY-N8418 | Cearoin | 52811-37-7 | Natural Products |
| HY-N8419 | Retronecine | 480-85-3 | Natural Products |
| HY-N8420 | Thalifoline | 21796-15-6 | Natural Products |
| HY-N8422 | 1(10)-Aristolen-2-one | 28398-06-3 | Natural Products |
| HY-N8423 | α-Amyrin | 638-95-9 | Natural Products |
| HY-N8423R | α-Amyrin (Standard) | 638-95-9 | Reference Standards |
| HY-N8424 | 1,5,6-Trihydroxy-3-methoxyxanthone | 50868-52-5 | Natural Products |
| HY-N8425 | Octacosanoic acid | 506-48-9 | Natural Products |
| HY-N8425R | Octacosanoic acid (Standard) | 506-48-9 | Reference Standards |
| HY-N8426 | 4'-O-Methylnyasol | 79004-25-4 | Natural Products |
| HY-N8427 | Bisacurone | 120681-81-4 | Natural Products |
| HY-N8428 | Canophyllal | 14440-40-5 | Natural Products |
| HY-N8429 | Prehelminthosporol | 1619-13-2 | Natural Products |
| HY-N8430 | Poricoic acid AM | 151200-92-9 | Natural Products |
| HY-N8431 | 5-Geranoxy-7-methoxycoumarin | 7380-39-4 | Natural Products |
| HY-N8432 | Dipyrithione | 3696-28-4 | Natural Products |
| HY-N8433 | Dhurrin | 499-20-7 | Natural Products |
| HY-N8434 | Cinnamyl caffeate | 115610-32-7 | Natural Products |
| HY-N8435 | Desoxo-narchinol A | 53859-06-6 | Natural Products |
| HY-N8438 | Methyl tetracosanoate | 2442-49-1 | Natural Products |
| HY-N8438R | Methyl tetracosanoate (Standard) | 2442-49-1 | Reference Standards |
| HY-N8438S | Methyl tetracosanoate-d4 | 2692624-16-9 | Isotope-Labeled Compounds |
| HY-N8439 | Questiomycin A | 1916-59-2 | Natural Products |
| HY-N8440 | Gibberellin A4 | 468-44-0 | Natural Products |
| HY-N8440S1 | Gibberellin A4-d2 | Isotope-Labeled Compounds | |
| HY-N8441 | Neriifolin | 466-07-9 | Natural Products |
| HY-N8442 | Drimenol | 468-68-8 | Natural Products |
| HY-N8443 | Isoaltenuene | 126671-80-5 | Natural Products |
| HY-N8443S | Isoaltenuene-d6 | Isotope-Labeled Compounds | |
| HY-N8444 | Triptoquinone A | 142950-86-5 | Natural Products |
| HY-N8445 | Glucoerucin (potassium) | 15592-37-7 | Natural Products |
| HY-N8446 | (E/Z)-Geranylacetone | 689-67-8 | Biochemical Assay Reagents |
| HY-N8447 | 3'-O-Methylmurraol | 1891097-17-8 | Natural Products |
| HY-N8448 | 3,4-Di-O-caffeoyl quinic acid methyl ester | 114637-83-1 | Natural Products |
| HY-N8449 | Ailanthoidol | 156398-61-7 | Natural Products |
| HY-N8450 | 3-Acetylpinobanksin-7-methyl ether | 139906-49-3 | Natural Products |
| HY-N8451 | Melissic acid | 506-50-3 | Biochemical Assay Reagents |
| HY-N8452 | Noroxyhydrastinine | 21796-14-5 | Natural Products |
| HY-N8453 | Macranthoin G | 159934-13-1 | Natural Products |
| HY-N8455 | Isocudraniaxanthone A | 197447-26-0 | Natural Products |
| HY-N8458 | Cryogenine | 10308-13-1 | Natural Products |
| HY-N8459 | α-Cembrenediol | 57605-80-8 | Natural Products |
| HY-N8460 | Cortisol sulfate | 1253-43-6 | Natural Products |
| HY-N8460A | Cortisol sulfate (sodium) | 1852-36-4 | Reference compound |
| HY-N8461 | Reuterin | 2134-29-4 | Natural Products |
| HY-N8461R | Reuterin (Standard) | 2134-29-4 | Reference Standards |
| HY-N8462 | 6-O-Nicotinoylscutebarbatine G | 1206805-30-2 | Natural Products |
| HY-N8464 | Juncuenin D | 1161681-24-8 | Natural Products |
| HY-N8465 | Noracronycine | 13161-79-0 | Natural Products |
| HY-N8466 | (-)-Lyoniresinol 9'-O-glucoside | 143236-02-6 | Natural Products |
| HY-N8469 | cis-5-Dodecenoic acid | 2430-94-6 | Natural Products |
| HY-N8469R | cis-5-Dodecenoic acid (Standard) | 2430-94-6 | Reference Standards |
| HY-N8470 | Steffimycin B | 54526-94-2 | Natural Products |
| HY-N8471 | Niazinin | 147821-57-6 | Natural Products |
| HY-N8472 | Chrodrimanin B | 132196-54-4 | Natural Products |
| HY-N8473 | Pericosine A | 200335-68-8 | Natural Products |
| HY-N8474 | Pyrenocine A | 76868-97-8 | Natural Products |
| HY-N8475 | 6-Deoxyisojacareubin | 26486-92-0 | Natural Products |
| HY-N8476 | Sahandol | 1452398-07-0 | Natural Products |
| HY-N8477 | Isolupalbigenin | 162616-70-8 | Natural Products |
| HY-N8478 | 7-Hydroxycadalene | 2102-75-2 | Natural Products |
| HY-N8480 | Atractylochromene | 203443-33-8 | Natural Products |
| HY-N8481 | 3,6-Dihydroxyflavone | 108238-41-1 | Natural Products |
| HY-N8482 | Zinnol | 148717-78-6 | Natural Products |
| HY-N8483 | Eprinomectin B1a | 133305-88-1 | Natural Products |
| HY-N8484 | Eprinomectin B1b | 133305-89-2 | Natural Products |
| HY-N8485 | Pungiolide A | 130395-54-9 | Natural Products |
| HY-N8487 | 7-Methoxyflavone | 22395-22-8 | Natural Products |
| HY-N8488 | Anhydro-6-epiophiobolin A | 90411-20-4 | Natural Products |
| HY-N8488A | Anhydroophiobolin A | 6026-65-9 | Natural Products |
| HY-N8489 | 1-Methoxyphaseollidin | 65428-13-9 | Natural Products |
| HY-N8490 | Eicosyl ferulate | 133882-79-8 | Natural Products |
| HY-N8491A | (+)-Dihydrocarvone | 5524-05-0 | Natural Products |
| HY-N8491B | (-)-Dihydrocarveol | 20549-47-7 | Natural Products |
| HY-N8492 | Monascorubrin | 13283-90-4 | Natural Products |
| HY-N8494 | ent-Kauran-17,19-dioic acid | 60761-79-7 | Natural Products |
| HY-N8495 | 4'-Hydroxyflavanone | 6515-37-3 | Natural Products |
| HY-N8495R | 4'-Hydroxyflavanone (Standard) | 6515-37-3 | Reference Standards |
| HY-N8496 | Clinopodiside A | 142809-89-0 | Natural Products |
| HY-N8497 | Leoidin | 105350-54-7 | Natural Products |
| HY-N8498 | GKK1032B | 358375-11-8 | Natural Products |
| HY-N8499 | Sporothriolide | 154799-92-5 | Natural Products |
| HY-N8500 | Aristolochic acid Ia | 38965-71-8 | Natural Products |
| HY-N8501 | Emestrin | 97816-62-1 | Natural Products |
| HY-N8502 | Urdamycin A | 98474-21-6 | Dye Reagents |
| HY-N8503 | Niazimicin | 147821-49-6 | Natural Products |
| HY-N8504 | Neoaureothin | 59795-94-7 | Biochemical Assay Reagents |
| HY-N8505 | Lobelanine | 579-21-5 | Natural Products |
| HY-N8508 | Myrothecine A | 910292-40-9 | Natural Products |
| HY-N8510 | Anemarrhena B | 1627521-95-2 | Natural Products |
| HY-N8511 | Acremine I | 1110661-29-4 | Natural Products |
| HY-N8512 | Asperfuran | 129277-10-7 | Natural Products |
| HY-N8513 | Brevicompanine B | 215121-47-4 | Natural Products |
| HY-N8515 | UDP-3-O-acyl-GlcNAc | 108636-29-9 | Natural Products |
| HY-N8515B | UDP-3-O-acyl-GlcNAc (diammonium) | Natural Products | |
| HY-N8515C | UDP-3-O-acyl-GlcNAc (disodium) | Natural Products | |
| HY-N8517 | Malabaricone B | 63335-24-0 | Natural Products |
| HY-N8518 | Malabaricone C | 63335-25-1 | Natural Products |
| HY-N8519 | Urdamycin B | 104542-46-3 | Natural Products |
| HY-N8520 | Variculanol | 135513-21-2 | Natural Products |
| HY-N8521 | 6-O-Methacrylate | 950685-51-5 | Natural Products |
| HY-N8522 | 9,10-Dihydroxystearic acid | 120-87-6 | Natural Products |
| HY-N8523 | Vibralactone D | 1251748-32-9 | Natural Products |
| HY-N8525 | 3'-O-Acetylthymidine | 21090-30-2 | Natural Products |
| HY-N8526 | Himbosine | 15448-14-3 | Natural Products |
| HY-N8530 | Conodurine | 2665-57-8 | Natural Products |
| HY-N8531 | 4α-Methylcholesterol | 15073-00-4 | Natural Products |
| HY-N8532 | (1’S)-Dehydropestalotin | 330582-38-2 | Natural Products |
| HY-N8533 | Sodium Camptothecin | 25387-67-1 | Natural Products |
| HY-N8534 | Neophytadiene | 504-96-1 | Natural Products |
| HY-N8535 | Massarigenin C | 496926-08-0 | Natural Products |
| HY-N8537 | Enfumafungin | 260979-95-1 | Natural Products |
| HY-N8537R | Enfumafungin (Standard) | 260979-95-1 | Reference Standards |
| HY-N8539 | (–)-Himgaline | 16585-08-3 | Natural Products |
| HY-N8541 | Endocrocin | 481-70-9 | Natural Products |
| HY-N8543 | Gliocladic acid | 82425-48-7 | Natural Products |
| HY-N8547A | (Rac)-Sclerone | 19638-58-5 | Natural Products |
| HY-N8548 | Fellutanine A | 175414-35-4 | Natural Products |
| HY-N8549A | 5-Dihydrocortisone | 28423-48-5 | Natural Products |
| HY-N8550 | Cortolone | 516-42-7 | Natural Products |
| HY-N8550S | Cortolone-d5 | Isotope-Labeled Compounds | |
| HY-N8551 | (5E)-7-Oxozeaenol | 1198574-97-8 | Natural Products |
| HY-N8552 | Banksialactone A | 1135775-06-2 | Natural Products |
| HY-N8554 | 5''-O-Acetyljuglanin | 885697-82-5 | Natural Products |
| HY-N8555 | ent-Kaurane-16β,19,20-triol | 167898-32-0 | Natural Products |
| HY-N8556 | 3,4,5-Trimethoxyphenyl-(6'-O-galloyl)-O-β-D-glucopyranoside | 109206-94-2 | Natural Products |
| HY-N8557 | 1,5-Dihydroxyxanthone | 14686-65-8 | Natural Products |
| HY-N8558 | Senkyunolide N | 140694-58-2 | Natural Products |
| HY-N8558A | Senkyunolide J | 94530-86-6 | Natural Products |
| HY-N8559 | Aloesone | 40738-40-7 | Natural Products |
| HY-N8560 | 3,5,7,15-Tetraacetoxy-9-nicotinoyloxy-6(17),11-jatrophadien-14-one | 244277-75-6 | Natural Products |
| HY-N8563A | (E)-Masticadienonic acid | 66052-86-6 | Natural Products |
| HY-N8571 | 6-Methoxyflavonol | 93176-00-2 | Natural Products |
| HY-N8572 | 3',4'-Dimethoxyflavone | 4143-62-8 | Natural Products |
| HY-N8573 | β-Phellandrene | 555-10-2 | Natural Products |
| HY-N8573S | β-Phellandrene-d2 | 1335436-61-7 | Isotope-Labeled Compounds |
| HY-N8574 | 1-Heptacosanol | 2004-39-9 | Biochemical Assay Reagents |
| HY-N8575 | (1S)-Chrysanthemolactone | 14087-71-9 | Natural Products |
| HY-N8575A | (1R)-Chrysanthemolactone | 14087-70-8 | Natural Products |
| HY-N8576 | 8-Acetyl-7-methoxycoumarin | 89019-07-8 | Natural Products |
| HY-N8577 | 2,4-Dihydroxy-3-methoxyacetophenone | 62615-26-3 | Natural Products |
| HY-N8578 | Luteolin 7,3′-di-O-glucuronide | 53965-08-5 | Natural Products |
| HY-N8579 | Eugenyl benzoate | 531-26-0 | Natural Products |
| HY-N8580 | Hydrocotarnine (hydrobromide) | 5985-00-2 | Natural Products |
| HY-N8581 | 5,5'-Dimethoxysecoisolariciresinol | 1002106-91-3 | Natural Products |
| HY-N8582 | Momordicine V | 1012315-36-4 | Natural Products |
| HY-N8583 | 6α,16,18-Trihydroxycleroda-3(4),13(14)-dien-15,16-olide | 1017233-48-5 | Natural Products |
| HY-N8584 | (20S,25S)-20,25-Epoxy-25-methoxy-24,24-dimethyl-26,27-dinordammaran-3-one | 1020074-97-8 | Natural Products |
| HY-N8585 | Neoprocurcumenol | 102130-91-6 | Natural Products |
| HY-N8586 | Rehmaglutin D | 103744-84-9 | Natural Products |
| HY-N8587 | Kadsuric acid 3-Me ester | 1041070-16-9 | Natural Products |
| HY-N8588 | Methyl ganoderate C6 | 105742-81-2 | Natural Products |
| HY-N8589 | (-)-Epiafzelechin-3-O-gallate | 108907-43-3 | Natural Products |
| HY-N8590 | Ilexgenin B | 109008-39-1 | Natural Products |
| HY-N8591 | cis-Dehydroosthol | 109741-40-4 | Natural Products |
| HY-N8593 | Undecane | 1120-21-4 | Natural Products |
| HY-N8593R | Undecane (Standard) | 1120-21-4 | Reference Standards |
| HY-N8593S | Undecane-d24 | 164858-54-2 | Isotope-Labeled Compounds |
| HY-N8594 | ∆14-Vincamenine | 112219-48-4 | Natural Products |
| HY-N8595 | 2(S)-5,7,2'-Trihydroxy-8-methoxyflavanone | 112408-71-6 | Natural Products |
| HY-N8597 | Boeravinone A | 114567-33-8 | Natural Products |
| HY-N8598 | Caulophine | 1159989-19-1 | Natural Products |
| HY-N8599 | Cichoriin | 531-58-8 | Natural Products |
| HY-N8600 | 7,8,3′,4′-Tetrahydroxyflavone | 3440-24-2 | Natural Products |
| HY-N8601 | 2-Picenecarboxylic acid | 118172-80-8 | Natural Products |
| HY-N8602 | Ganoderenic acid F | 120462-47-7 | Natural Products |
| HY-N8603 | Desacetyldoronine | 120481-77-8 | Natural Products |
| HY-N8604 | Methyl 4-O-caffeoylquinate | 123372-74-7 | Natural Products |
| HY-N8605 | Arisanlactone D | 1234186-01-6 | Natural Products |
| HY-N8606 | N-Acetylciprofloxacin | 93594-20-8 | Natural Products |
| HY-N8607 | 3"-O-Acetylplatyconic acid A | 1256935-28-0 | Natural Products |
| HY-N8608 | 2''-O-Acetyl-platyconic acid A | 1256935-30-4 | Natural Products |
| HY-N8609 | Uralsaponin C | 1262326-46-4 | Natural Products |
| HY-N8610 | Uralsaponin D | 1262489-44-0 | Natural Products |
| HY-N8611 | Specioside B | 126589-95-5 | Natural Products |
| HY-N8612 | 4,9-Dimethoxycanthin-6-one | 1270001-72-3 | Natural Products |
| HY-N8613 | Gancaonin N | 129145-52-4 | Natural Products |
| HY-N8614 | Peucedanocoumarin I | 130464-55-0 | Natural Products |
| HY-N8615 | Peucedanocoumarin II | 130464-56-1 | Natural Products |
| HY-N8616 | 21,23:24,25-Diepoxy-21,23-dimethoxytirucall-7-en-3-one | 1351617-74-7 | Natural Products |
| HY-N8617 | Trijuganone C | 135247-94-8 | Natural Products |
| HY-N8618 | Erythro-guaiacylglycerol-β-O-4'-dihydroconiferyl alcohol | 135820-77-8 | Natural Products |
| HY-N8619 | Minimolide F | 1367351-41-4 | Natural Products |
| HY-N8620 | 9-Methoxycanthin-6-one-N-oxide | 137739-74-3 | Natural Products |
| HY-N8621 | (11S)-(-)-Hydroxyjasmonic acid | 140447-14-9 | Natural Products |
| HY-N8622 | Heteroclitin C | 140460-42-0 | Natural Products |
| HY-N8622A | Heteroclitin B | 140461-47-8 | Natural Products |
| HY-N8623 | Trachelanthamine | 14140-18-2 | Natural Products |
| HY-N8624 | Ethyl 3,4-dicaffeoylquinate | 143051-73-4 | Natural Products |
| HY-N8625 | 5,8-Dihydroxypsoralen | 14348-23-3 | Natural Products |
| HY-N8626 | 8-(7-Hydroxy-3,7-dimethyl-2,5-octadienyloxy)psoralen | 144398-34-5 | Natural Products |
| HY-N8627 | (7S,8S)-3-Methoxy-3',7-epoxy-8,4'-oxyneoligna-4,9,9'-triol | 144881-21-0 | Natural Products |
| HY-N8629 | Boeravinone O | 1449384-21-7 | Natural Products |
| HY-N8630 | Oleacein | 149183-75-5 | Natural Products |
| HY-N8631 | O-Acetylschisantherin L | 149998-51-6 | Natural Products |
| HY-N8632 | Qianhucoumarin A | 150135-35-6 | Natural Products |
| HY-N8633 | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphoinositol | 1331751-28-0 | Natural Products |
| HY-N8634 | Methyl 5-O-feruloylquinate | 154461-64-0 | Natural Products |
| HY-N8635 | Alisol E 23-acetate | 155301-58-9 | Natural Products |
| HY-N8636 | Rabdoternin F | 155977-87-0 | Natural Products |
| HY-N8637 | Qianhucoumarin E | 156041-02-0 | Natural Products |
| HY-N8638 | 3,4-Secotirucalla-4(28,7,24-triene-3),26-dioic acid | 159623-48-0 | Natural Products |
| HY-N8639 | Chrysin 8-C-β-D-glucoside | 160880-89-7 | Natural Products |
| HY-N8640 | 5,7-Dimethoxy-3′,4′-methylenedioxyflavan-3-ol | 162602-04-2 | Natural Products |
| HY-N8641 | Kadsulignan N | 163564-58-7 | Natural Products |
| HY-N8642 | N9-Methylharman | 16498-64-9 | Natural Products |
| HY-N8643 | Dihydropedicin | 169234-89-3 | Natural Products |
| HY-N8644 | Florosenine | 16958-30-8 | Natural Products |
| HY-N8645 | Floridanine | 16958-31-9 | Natural Products |
| HY-N8646 | Isodonal | 16964-56-0 | Natural Products |
| HY-N8647 | Naringin 4'-glucoside | 17257-21-5 | Natural Products |
| HY-N8648 | Brevicornin | 173792-49-9 | Natural Products |
| HY-N8649 | (±)-Sigmoidin A | 176046-04-1 | Natural Products |
| HY-N8650 | 4-O-Caffeoylshikimic acid | 180842-65-3 | Natural Products |
| HY-N8652 | 25-Anhydrocimigenol-3-O-β-D-xylopyranoside | 181765-11-7 | Natural Products |
| HY-N8653 | 11α,12α-Epoxy-3β,23-dihydroxy-30-norolean-20(29)-en-28 | 186140-36-3 | Natural Products |
| HY-N8654 | Artoindonesianin B 1 | 936006-11-0 | Natural Products |
| HY-N8655 | Sarracine N-oxide | 19038-27-8 | Natural Products |
| HY-N8656 | Glycyrrhiza-flavonol A | 197304-01-1 | Natural Products |
| HY-N8657 | Pyrocurzerenone | 20013-75-6 | Natural Products |
| HY-N8658 | Epinodosin | 20086-60-6 | Natural Products |
| HY-N8659 | Uzarin | 20231-81-6 | Natural Products |
| HY-N8660 | Cimicifugic acid B | 205114-66-5 | Natural Products |
| HY-N8661 | Fenfangjine G | 205533-81-9 | Natural Products |
| HY-N8662 | Primulic acid II | 208599-88-6 | Natural Products |
| HY-N8663 | Nilgirine | 21009-05-2 | Natural Products |
| HY-N8664 | 11(S),16(R)-Dihydroxyoctadeca-9Z,17-diene12,14-diyn-1-yl acetate | 213905-35-2 | Natural Products |
| HY-N8665 | 1,7-Dihydroxy-4-methoxyxanthone | 87339-76-2 | Natural Products |
| HY-N8666 | 15,16-Epoxy-12-hydroxylabda-8(17),13(16),14-triene | 216011-55-1 | Natural Products |
| HY-N8667 | 7-Epi-5-eudesmene-1beta,11-diol | 87261-77-6 | Natural Products |
| HY-N8668 | Eudesmane K | 86917-79-5 | Natural Products |
| HY-N8669 | Curcolonol | 217817-09-9 | Natural Products |
| HY-N8670 | 3-Hydroxy-12-oleanene-23,28-dioic acid | 226562-47-6 | Natural Products |
| HY-N8671 | Withanoside V | 256520-90-8 | Natural Products |
| HY-N8671R | Withanoside V (Standard) | 256520-90-8 | Reference Standards |
| HY-N8672 | 4-Methoxyglucobrassicin | 83327-21-3 | Natural Products |
| HY-N8673 | 3-(4-Hydroxybenzylidene)-5-hydroxy-7-methoxychroman-4-one | 259653-54-8 | Natural Products |
| HY-N8674 | Dihydroisotanshinone II | 260397-58-8 | Natural Products |
| HY-N8675 | Olivil-4'-O-β-glucopyranoside | 76880-93-8 | Natural Products |
| HY-N8676 | Antiproliferative agent-29 | 263844-79-7 | Natural Products |
| HY-N8677 | Antiproliferative agent-28 | 263844-80-0 | Natural Products |
| HY-N8678 | Thonningianin B | 271579-12-5 | Natural Products |
| HY-N8679 | Physalin C | 27503-33-9 | Natural Products |
| HY-N8680 | 12-Hydroxy-2,3-dihydroeuparin | 68776-42-1 | Natural Products |
| HY-N8681 | 9-Angeloylretronecine N-oxide | 27773-86-0 | Natural Products |
| HY-N8682 | Macrophylline | 27841-97-0 | Natural Products |
| HY-N8683 | 25-O-Methylcimigenol-3-O-D-xylopyranoside | 27994-13-4 | Natural Products |
| HY-N8684 | Chrysin 6-C-glucoside | 28368-57-2 | Natural Products |
| HY-N8685 | Quercetin 3,4′-diglucoside | 29125-80-2 | Natural Products |
| HY-N8686 | Pandamarilactonine B | 303008-81-3 | Natural Products |
| HY-N8689 | 4-Epi-curcumenol | 350602-21-0 | Natural Products |
| HY-N8690 | 4,2'-Dihydroxy-4'-methoxychalcone | 63529-06-6 | Natural Products |
| HY-N8691 | 2',6'-Dihydroxy-4'-methoxydihydrochalcone | 35241-55-5 | Natural Products |
| HY-N8692 | Dihydrobaicalein | 35683-17-1 | Natural Products |
| HY-N8693 | Withanoside IV | 362472-81-9 | Natural Products |
| HY-N8694 | Obtusafuran methyl ether | 40357-59-3 | Natural Products |
| HY-N8695 | 1β-Hydroxybufalin | 366004-27-5 | Natural Products |
| HY-N8697 | 6-epi-Angustifolin | 369390-94-3 | Natural Products |
| HY-N8698 | Picein | 530-14-3 | Natural Products |
| HY-N8698R | Picein (Standard) | 530-14-3 | Reference Standards |
| HY-N8700 | Pterocarpadiol A | 2055882-21-6 | Natural Products |
| HY-N8701 | Melliferone | 377724-68-0 | Natural Products |
| HY-N8702 | 2,5-Dihydroxy-1-methoxyxanthone | 173220-32-1 | Natural Products |
| HY-N8704 | Methyl 4-prenyloxycinnamate | 81053-49-8 | Natural Products |
| HY-N8706 | Hydrangetin | 485-90-5 | Natural Products |
| HY-N8707 | Homobutein | 34000-39-0 | Natural Products |
| HY-N8708 | Bryonolol | 39765-50-9 | Natural Products |
| HY-N8709 | Onetine | 41451-67-6 | Natural Products |
| HY-N8710 | Shinjulactone L | 4283-49-2 | Natural Products |
| HY-N8712 | Umckalin | 43053-62-9 | Natural Products |
| HY-N8712R | Umckalin (Standard) | 43053-62-9 | Reference Standards |
| HY-N8713 | 4-Methyl-6-phenyl-2H-pyranone | 4467-30-5 | Natural Products |
| HY-N8714 | Interiotherin C | 460090-65-7 | Natural Products |
| HY-N8715 | Cimilactone A | 468733-06-4 | Natural Products |
| HY-N8718 | Izalpinin | 480-14-8 | Natural Products |
| HY-N8719 | Pratol | 487-24-1 | Natural Products |
| HY-N8721 | Nemorensine | 50906-96-2 | Natural Products |
| HY-N8722 | Datiscetin | 480-15-9 | Natural Products |
| HY-N8723 | (1′S,2′S)-Nicotine-1'-oxide | 51095-86-4 | Natural Products |
| HY-N8723S | (1′S,2′S)-Nicotine-1'-oxide-d3 | Isotope-Labeled Compounds | |
| HY-N8724 | Lamalbid | 52212-87-0 | Natural Products |
| HY-N8725 | (2-Methylbutyryl)shikonin | 52387-15-2 | Natural Products |
| HY-N8726 | Neophellamuretin | 52589-20-5 | Natural Products |
| HY-N8727 | Isomorellic acid | 5262-69-1 | Natural Products |
| HY-N8728 | Aposcopolamine | 535-26-2 | Natural Products |
| HY-N8728R | Aposcopolamine (Standard) | 535-26-2 | Reference Standards |
| HY-N8730 | 7,8,3′,4′-Tetramethoxyflavone | 65548-55-2 | Natural Products |
| HY-N8731 | Lutein dipalmitate | 547-17-1 | Natural Products |
| HY-N8732 | 1,7-Dimethoxy-2,3-methylenedioxyxanthone | 145523-71-3 | Natural Products |
| HY-N8733 | p-Menth-1-ene-3,6-diol | 4031-55-4 | Natural Products |
| HY-N8734 | Florilenalin | 54964-49-7 | Natural Products |
| HY-N8735 | k-Strophanthoside | 33279-57-1 | Natural Products |
| HY-N8736 | Eicosanyl (E)-caffeate | 28593-90-0 | Natural Products |
| HY-N8737 | Desrhamnosylmartynoside | 136055-64-6 | Natural Products |
| HY-N8738 | Myrciaphenone A | 26089-54-3 | Natural Products |
| HY-N8739 | 2-Hydroxyxanthone | 1915-98-6 | Natural Products |
| HY-N8740 | ent-16β,17-Dihydroxy-9(11)-kauren-19-oic acid | 55483-24-4 | Natural Products |
| HY-N8741 | Datiscin | 16310-92-2 | Natural Products |
| HY-N8742 | Geraldol | 21511-25-1 | Natural Products |
| HY-N8744 | Vestitol | 56701-24-7 | Natural Products |
| HY-N8745 | α-Peltatin | 568-53-6 | Natural Products |
| HY-N8746 | threo-1-(4-Hydroxy-3-methoxyphenyl)propane-1,2-diol | 848031-94-7 | Natural Products |
| HY-N8747 | Vitexin 2''-O-(4'''-O-acetyl)rhamnoside | 80537-98-0 | Natural Products |
| HY-N8748 | 2-Geranyl-4-isobutyrylphloroglucinol | 72008-03-8 | Natural Products |
| HY-N8749 | 2-Methyl-4-isobutyrylphloroglucinol | 69480-03-1 | Natural Products |
| HY-N8750 | 5-Acetyl-2-(1-hydroxy-1-methylethyl)benzofuran | 64165-99-7 | Natural Products |
| HY-N8751 | 4-Hydroxy-2,6,6-trimethyl-1-cyclohexenecarboxylic acid | 62218-55-7 | Natural Products |
| HY-N8753 | 3-(β-D-Glucopyranosyloxy)-2-hydroxybenzoic acid methyl ester | 53827-68-2 | Natural Products |
| HY-N8754 | (7S)-Dalbergiphenol | 52811-31-1 | Natural Products |
| HY-N8755 | Chikusetsusaponin Ib | 59252-87-8 | Natural Products |
| HY-N8756 | 3-Hydroxybisabola-1,10-dien-9-one | 129673-86-5 | Natural Products |
| HY-N8757 | Dihydropyrocurzerenone | 59462-26-9 | Natural Products |
| HY-N8758 | α-Onocerin diacetate | 34434-99-6 | Natural Products |
| HY-N8759 | Vogeloside | 60077-47-6 | Natural Products |
| HY-N8760 | Batatasin IV | 60347-67-3 | Natural Products |
| HY-N8761 | Kihadanin A | 125276-62-2 | Natural Products |
| HY-N8762 | 3,9-Dihydroxypterocarpan | 61135-91-9 | Natural Products |
| HY-N8763 | Ciwujianoside E | 114912-36-6 | Natural Products |
| HY-N8764 | Decaffeoylacteoside | 61548-34-3 | Natural Products |
| HY-N8765 | Methyl 2-(5-acetyl-2,3-dihydrobenzofuran-2-yl)propenoate | 617722-55-1 | Natural Products |
| HY-N8766 | Dehydrodiconiferyl alcohol 4-O-β-D-glucopyranoside | 107870-88-2 | Natural Products |
| HY-N8767 | Methyl 2-(6-acetyl-5-hydroxy-2,3-dihydrobenzofuran-2-yl)propenoate | 617722-56-2 | Natural Products |
| HY-N8768 | 3alpha-Acetoxy-20(29)-lupene-23,28-dioic acid | 83725-41-1 | Natural Products |
| HY-N8769 | Demethoxy-7-O-methylcapillarisin | 61854-37-3 | Natural Products |
| HY-N8770 | 5,6-Dimethoxy-2-isopropenylbenzofuran | 34293-09-9 | Natural Products |
| HY-N8773 | 3,5,7-Trihydroxychromone | 31721-95-6 | Natural Products |
| HY-N8774 | 1-Hydroxy-9-methoxycanthin-6-one | 622408-85-9 | Natural Products |
| HY-N8776 | 11-Hydroxybisabola-1,3,5-trien-9-one | 61235-23-2 | Natural Products |
| HY-N8777 | Diversoside | 55062-36-7 | Natural Products |
| HY-N8778 | Intermedin B | 127214-87-3 | Natural Products |
| HY-N8779 | 3-(4-Hydroxy-3,5-dimethoxyphenyl)-1,2-propanediol | 22805-15-8 | Natural Products |
| HY-N8780 | 3,5,7-Trihydroxy-3',4',5'-trimethoxyflavone | 146132-95-8 | Natural Products |
| HY-N8781 | Tetrahymanol | 2130-17-8 | Natural Products |
| HY-N8782 | 4,6,7-Trimethoxy-5-methylcoumarin | 62615-63-8 | Natural Products |
| HY-N8783 | Kuwanon B | 62949-78-4 | Natural Products |
| HY-N8784 | 5-Hydroxycanthin-6-one | 64118-73-6 | Natural Products |
| HY-N8785 | Arvenin II | 65247-28-1 | Natural Products |
| HY-N8786 | 2,4,4'-Trihydroxydihydrochalcone | 15097-74-2 | Natural Products |
| HY-N8787 | Angustifolin | 66548-01-4 | Natural Products |
| HY-N8788 | Baicalein 7-O-β-D-ethylglucuronide | 675624-38-1 | Natural Products |
| HY-N8789 | 2-Hydroxymethyl-3-hydroxyanthraquinone | 68243-30-1 | Natural Products |
| HY-N8790 | 24-Methylenecycloartanone | 1449-08-7 | Natural Products |
| HY-N8791 | Qianhucoumarin G | 68692-61-5 | Natural Products |
| HY-N8792 | 15-Hydroxypinusolidic acid | 691009-85-5 | Natural Products |
| HY-N8793 | Hesperetin 5-β-D-glucopyranoside | 69651-80-5 | Natural Products |
| HY-N8794 | Rhapontisterone B | 698975-64-3 | Natural Products |
| HY-N8795 | 2-Hydroxyplatyphyllide | 72145-19-8 | Natural Products |
| HY-N8796 | 2',4'-Dihydroxy-4,6'-diMethoxydihydrochalcone | 75679-58-2 | Natural Products |
| HY-N8797 | Methyl 1-hydroxy-4-oxocyclohexaneacetate | 81053-14-7 | Natural Products |
| HY-N8798 | Arteannuin A | 82442-48-6 | Natural Products |
| HY-N8799 | (Z)-Aldosecologanin (Centauroside) | 82474-97-3 | Natural Products |
| HY-N8800 | 3α-Hydroxytirucalla-7,24-dien-21-oic acid | 82509-40-8 | Natural Products |
| HY-N8801 | Anhydrodihydro artemisinin | 82596-30-3 | Natural Products |
| HY-N8802 | (-)-Epicatechin 3-(3-O-methylgallate) | 83104-86-3 | Natural Products |
| HY-N8803 | Isocarlinoside | 83151-90-0 | Natural Products |
| HY-N8804 | Shatavarin IV | 84633-34-1 | Natural Products |
| HY-N8805 | Nortrachelogenin-8'-O-β-glucoside | 858127-38-5 | Natural Products |
| HY-N8806 | Daphniyunnine B | 881388-88-1 | Natural Products |
| HY-N8807 | Platycoside K | 899447-64-4 | Natural Products |
| HY-N8808 | 10-O-Coumaroyl-10-O-deacetylasperuloside | 903519-82-4 | Natural Products |
| HY-N8809 | 25-O-ethylcimigenol-3-O-beta-D-xylopyranoside | 914086-57-0 | Natural Products |
| HY-N8810 | Platycoside M1 | 917482-67-8 | Natural Products |
| HY-N8811 | Acetyl 11α-methoxy-β-boswellic acid | 918548-43-3 | Natural Products |
| HY-N8812 | 19-[(β-D-Glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide | 919120-78-8 | Natural Products |
| HY-N8813 | Glucoliquiritin | 93446-18-5 | Natural Products |
| HY-N8814 | Parisyunnanoside B | 945865-37-2 | Natural Products |
| HY-N8815 | Kuwanol A | 96562-91-3 | Natural Products |
| HY-N8816 | Stipuleanoside R2 | 96627-72-4 | Natural Products |
| HY-N8817 | Decuroside V | 96648-59-8 | Natural Products |
| HY-N8818 | 3-Acetoxytirucalla-7,24-dien-21-oic acid | 98166-55-3 | Natural Products |
| HY-N8819 | Methyl ganoderate H | 98665-11-3 | Natural Products |
| HY-N8821 | 1-(4-Hydroxybenzoyl)glucose | 25545-07-7 | Natural Products |
| HY-N8822 | 2'-Methoxyflavone | 19725-47-4 | Natural Products |
| HY-N8824 | Maackiaflavanone | 156162-10-6 | Natural Products |
| HY-N8826 | 1,7-Diphenyl-4-hepten-3-one | 79559-59-4 | Natural Products |
| HY-N8827 | Sophoracarpan A | 1674359-82-0 | Natural Products |
| HY-N8828 | 6''-O-Acetylsaikosaponin D | 64340-45-0 | Natural Products |
| HY-N8829 | (-)-Myrtenol | 19894-97-4 | Biochemical Assay Reagents |
| HY-N8830 | Selina-4(14),7(11)-dien-8-one | 54707-47-0 | Natural Products |
| HY-N8831 | Daidzein-4',7-diglucoside | 53681-67-7 | Natural Products |
| HY-N8832 | Matsukaze-lactone | 3153-73-9 | Natural Products |
| HY-N8834 | 7-Neohesperidosides | 28383-41-7 | Natural Products |
| HY-N8835 | Cannabisin D | 144506-19-4 | Natural Products |
| HY-N8836 | Sanggenon K | 86450-77-3 | Natural Products |
| HY-N8837 | Trifloroside | 53823-10-2 | Natural Products |
| HY-N8838 | Platycoside M3 | 917482-69-0 | Natural Products |
| HY-N8839 | Momordicine II | 91590-75-9 | Natural Products |
| HY-N8840 | Laricitrin | 53472-37-0 | Natural Products |
| HY-N8841 | Daidzein-7-O-glucuronide | 38482-80-3 | Natural Products |
| HY-N8842 | 8,8''-Bibaicalein | 135309-02-3 | Natural Products |
| HY-N8843 | Mollisorin A | 72704-04-2 | Natural Products |
| HY-N8844 | 2''-O-Galloylquercitrin | 80229-08-9 | Natural Products |
| HY-N8845 | Myzodendrone | 101705-37-7 | Natural Products |
| HY-N8846 | dl-Aloesol | 104871-04-7 | Natural Products |
| HY-N8847 | α-Ionone | 127-41-3 | Natural Products |
| HY-N8847R | α-Ionone (Standard) | 127-41-3 | Reference Standards |
| HY-N8847S | α-Ionone-13C3 | 130015-00-8 | Isotope-Labeled Compounds |
| HY-N8849 | 4-Methyl-6,7-methylenedioxycoumarin | 15071-04-2 | Natural Products |
| HY-N8850 | Angelol G | 83199-38-6 | Natural Products |
| HY-N8851 | trans-3'-O-Benzoyl-4'-O-methylkhellactone | 23733-95-1 | Natural Products |
| HY-N8852 | 6-Methoxyflavanone | 3034-04-6 | Natural Products |
| HY-N8853 | Victoxinine | 39965-06-5 | Natural Products |
| HY-N8854 | Pueroside C | 112343-16-5 | Natural Products |
| HY-N8855 | 7-Hydroxy-2,2-dimethylchromene | 19012-97-6 | Natural Products |
| HY-N8856 | Angelol M | 1092952-64-1 | Natural Products |
| HY-N8857 | Parvifolixanthone A | 906794-56-7 | Natural Products |
| HY-N8859 | Isoiridogermanal | 86293-25-6 | Natural Products |
| HY-N8861 | Isoflavidinin | 85734-02-7 | Natural Products |
| HY-N8862 | Anti-inflammatory agent 69 | 80514-14-3 | Natural Products |
| HY-N8863 | 6-Hydroxy-1,2,3,7-tetramethoxyxanthone | 64756-87-2 | Natural Products |
| HY-N8864 | Isosativenediol | 57079-92-2 | Natural Products |
| HY-N8865 | 2-Deacetyltaxuspine X | 259678-73-4 | Natural Products |
| HY-N8866 | 3,2'-Dihydroxy-4,4'-dimethoxychalcone | 2567-65-9 | Natural Products |
| HY-N8867 | 13-Deacetyltaxachitriene A | 239800-99-8 | Natural Products |
| HY-N8868 | Hemiphroside B nonaacetate | 132302-25-1 | Natural Products |
| HY-N8869 | 2-Deacetyltaxachitriene A | 214769-96-7 | Natural Products |
| HY-N8870 | Physapruin A | 155178-03-3 | Natural Products |
| HY-N8871 | Rauvovertine B | 2055073-72-6 | Natural Products |
| HY-N8872 | Arjunglucoside II | 62369-72-6 | Natural Products |
| HY-N8873 | Silychristin B | 879325-58-3 | Natural Products |
| HY-N8874 | Pueroside A | 100692-52-2 | Natural Products |
| HY-N8875 | Scillascilloside B-1 | 2023822-41-3 | Natural Products |
| HY-N8876 | Paucinervin A | 1243249-16-2 | Natural Products |
| HY-N8877 | Kaempferol 3-O-rhamninoside | 83170-31-4 | Natural Products |
| HY-N8878 | Latisxanthone C | 197447-32-8 | Natural Products |
| HY-N8879 | Wilforol A | 167882-66-8 | Natural Products |
| HY-N8880 | Caohuoside E | 174286-23-8 | Natural Products |
| HY-N8881 | Ethyl(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate | 60263-06-1 | Natural Products |
| HY-N8882 | Oleoside 11-methyl ester | 60539-23-3 | Natural Products |
| HY-N8883 | 6-Epiphysalin G | 76045-38-0 | Natural Products |
| HY-N8884 | Coelonin | 82344-82-9 | Natural Products |
| HY-N8885 | Walsuralactam A | 1370556-82-3 | Natural Products |
| HY-N8886 | Galanganone B | 1922129-43-8 | Natural Products |
| HY-N8887 | ent-17-Hydroxykaura-9(11),15-dien-19-oic acid | 1588516-88-4 | Natural Products |
| HY-N8888 | 10,11-Dihydro-24-hydroxyaflavinine | 171569-81-6 | Natural Products |
| HY-N8889 | Persianone | 170894-20-9 | Natural Products |
| HY-N8890 | Demissidine | 474-08-8 | Natural Products |
| HY-N8891 | 1,2,5-Trihydroxyxanthone | 156640-23-2 | Natural Products |
| HY-N8892 | Triptinin B | 189389-05-7 | Natural Products |
| HY-N8893 | 1,2,3,10-Tetramethoxy-9-(2-hydroxy-4,5-dimethoxybenzyloxy)oxoaporphine | 872729-33-4 | Natural Products |
| HY-N8894 | (-)-Isolariciresinol 9'-O-glucoside | 143236-04-8 | Natural Products |
| HY-N8895 | Onjixanthone II | 136083-93-7 | Natural Products |
| HY-N8896 | Ursolic aldehyde | 19132-81-1 | Natural Products |
| HY-N8897 | Ugaxanthone | 13179-11-8 | Natural Products |
| HY-N8898 | 3''-Galloylquercitrin | 503446-90-0 | Natural Products |
| HY-N8899 | Daidzein-4'-glucoside | 58970-69-7 | Natural Products |
| HY-N8900 | Vernolide B | 618860-58-5 | Natural Products |
| HY-N8901 | 20-Gluco-ginsenoside-Rf | 68406-27-9 | Natural Products |
| HY-N8903 | Mumefural | 222973-44-6 | Natural Products |
| HY-N8904 | Carasiphenol C | 868168-04-1 | Natural Products |
| HY-N8905 | Withanolide C | 108030-78-0 | Natural Products |
| HY-N8907 | 3'-Hydroxydehydroaglaiastatin | 259143-58-3 | Natural Products |
| HY-N8908 | 2α,9α,11-Trihydroxy-6-oxodrim-7-ene | 1175543-03-9 | Natural Products |
| HY-N8909 | 3Alaph-Tigloyloxypterokaurene L3 | 1588516-87-3 | Natural Products |
| HY-N8910 | (7R)-Methoxy-8-epi-matairesinol | 198827-23-5 | Natural Products |
| HY-N8911 | Dihydrodaidzin | 121927-96-6 | Natural Products |
| HY-N8913 | Iristectorene B | 156791-81-0 | Natural Products |
| HY-N8914 | Isoshinanolone | 39626-91-0 | Natural Products |
| HY-N8915 | Deoxyflindissone | 107176-31-8 | Natural Products |
| HY-N8916 | Coulteropine | 6014-62-6 | Natural Products |
| HY-N8917 | (3R)-7-hydroxy-3-(4-hydroxybenzyl)chromane | 1180504-64-6 | Natural Products |
| HY-N8918 | Undulatoside A | 58108-99-9 | Natural Products |
| HY-N8919 | N-trans-Sinapoyltyramine | 200125-11-7 | Natural Products |
| HY-N8920 | Syringetin | 4423-37-4 | Natural Products |
| HY-N8921 | Methoxyanigorufone | 56252-05-2 | Natural Products |
| HY-N8922 | Platycodin A | 66779-34-8 | Natural Products |
| HY-N8923 | Angelol H | 83247-73-8 | Natural Products |
| HY-N8924 | Carasinol D | 1072797-66-0 | Natural Products |
| HY-N8925 | Glyasperin F | 145382-61-2 | Natural Products |
| HY-N8926 | Caraganaphenol A | 174916-31-5 | Natural Products |
| HY-N8927 | 4'-O-Demethylbroussonin A | 376361-97-6 | Natural Products |
| HY-N8928 | 2''-O-Galloylmyricitrin | 56939-52-7 | Natural Products |
| HY-N8929 | Carasinol B | 777857-86-0 | Natural Products |
| HY-N8930 | Eupatorin-5-methyl ether | 21764-09-0 | Natural Products |
| HY-N8931 | Monomethyl lithospermate | 933054-33-2 | Natural Products |
| HY-N8933 | Glucolimnanthin | 111810-95-8 | Natural Products |
| HY-N8934 | 6β-Hydroxytomentosin | 1232676-22-0 | Natural Products |
| HY-N8935 | Eucamalduside A | 1287220-29-4 | Natural Products |
| HY-N8936 | Narchinol B | 1356822-09-7 | Natural Products |
| HY-N8938 | Jasminoid A | 1459784-57-6 | Natural Products |
| HY-N8939 | Desmethylrocaglamide | 146408-78-8 | Natural Products |
| HY-N8940 | 1-O-Acetyl-6-O-isobutyrylbritannilactone | 1613152-34-3 | Natural Products |
| HY-N8941 | Hydramicromelin D | 1623437-86-4 | Natural Products |
| HY-N8942 | (S)-17-Hydroxy-18,20-ene-neogrifolin | 1630936-42-3 | Natural Products |
| HY-N8943 | Otophylloside B 4'''-O-β-D-oleandropyranoside | 168001-54-5 | Natural Products |
| HY-N8944 | Otophylloside B 4'''-O-β-D-cymaropyranoside | 171422-85-8 | Natural Products |
| HY-N8945 | Meliasendanin D | 1820034-05-6 | Natural Products |
| HY-N8946 | 1-O-Acetyl-6alpha-O-(2-methylbutyryl)britannilactone | 1932687-71-2 | Natural Products |
| HY-N8947 | Glyurallin A | 199331-36-7 | Natural Products |
| HY-N8948 | Forsythenside A | 202721-09-3 | Natural Products |
| HY-N8950 | Phlogacanthoside A | 830347-18-7 | Natural Products |
| HY-N8951 | 3,4-Dihydroxybisabola-1,10-diene | 129673-87-6 | Natural Products |
| HY-N8953 | Bisacurone C | 127214-86-2 | Natural Products |
| HY-N8954 | Kaempferol 7-O-neohesperidoside | 17353-03-6 | Natural Products |
| HY-N8955 | Maritimein | 490-54-0 | Natural Products |
| HY-N8956 | Pachysamine M | 1253202-75-3 | Natural Products |
| HY-N8958 | Deacetylorientalide | 1258517-59-7 | Natural Products |
| HY-N8959 | 9-O-Ethyldeacetylorientalide | 1258517-60-0 | Natural Products |
| HY-N8960 | 1-Hydroxybisabola-2,10-dien-4-one | 1213251-45-6 | Natural Products |
| HY-N8961 | 10-O-Ethylcannabitriol | 1259515-25-7 | Natural Products |
| HY-N8962 | Physcion 8-O-rutinoside | 129393-21-1 | Natural Products |
| HY-N8964 | Sophoraflavanone H | 136997-68-7 | Natural Products |
| HY-N8965 | Scandine N-oxide | 140701-69-5 | Natural Products |
| HY-N8966 | Saropyrone | 159650-12-1 | Natural Products |
| HY-N8967 | 8-Glucosyl-5,7-dihydroxy-2-(1-methylpropyl)chromone | 188818-27-1 | Natural Products |
| HY-N8968 | Scillascillol | 2023822-39-9 | Natural Products |
| HY-N8969 | Rauvovertine C | 2055073-74-8 | Natural Products |
| HY-N8970 | Carmichaenine A | 2065228-59-1 | Natural Products |
| HY-N8971 | Bauer-7-ene-3β,16α-diol | 214351-30-1 | Natural Products |
| HY-N8972 | Nudifloside D | 454212-54-5 | Natural Products |
| HY-N8973 | 2,7-Dimethyl-1,4-dihydroxynaphthalene 1-O-glucoside | 839711-70-5 | Natural Products |
| HY-N8974 | Jasmoside | 97763-17-2 | Natural Products |
| HY-N8975 | Antitumor agent-137 | 105955-04-2 | Natural Products |
| HY-N8976 | 7-(4-Hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one | 79559-60-7 | Natural Products |
| HY-N8977 | 4-O-Methylgrifolic acid | 118040-60-1 | Natural Products |
| HY-N8979 | Kanshone A | 115356-18-8 | Natural Products |
| HY-N8980 | Ambocin | 108044-05-9 | Natural Products |
| HY-N8981 | Bisabola-2,10-diene-1,9-dione | 107439-25-8 | Natural Products |
| HY-N8982 | Heraclenol 3'-O-[beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside] | 765316-44-7 | Natural Products |
| HY-N8984 | Kanshone B | 115370-61-1 | Natural Products |
| HY-N8985 | 3'-Methoxymirificin | 1297609-29-0 | Natural Products |
| HY-N8986 | Momordicoside X | 1333321-50-8 | Natural Products |
| HY-N8987 | (3β,7β)-3,7,23,24-Tetrahydroxycucurbita-5,25-dien-19-al | 1446447-97-7 | Natural Products |
| HY-N8988 | 3-Methoxymollugin | 154706-44-2 | Natural Products |
| HY-N8989 | (1,5E,11E)-Tridecatriene-7,9-diyne-3,4-diacetate | 201012-14-8 | Natural Products |
| HY-N8990 | Aristola-1(10),8-dien-2-one | 22391-34-0 | Natural Products |
| HY-N8991 | Isohomoarbutin | 25162-30-5 | Natural Products |
| HY-N8992 | Nudifloside B | 297740-98-8 | Natural Products |
| HY-N8994 | 3-Hydroxy-4',5-dimethoxystilbene | 58436-29-6 | Natural Products |
| HY-N8995 | Bruceoside A | 63306-30-9 | Natural Products |
| HY-N8996 | (+)-Isoajmaline | 6989-79-3 | Natural Products |
| HY-N8997 | 5-Hydroxy-1,7-diphenyl-4E,6E-dien-3-heptanone | 87095-77-0 | Natural Products |
| HY-N8998 | Sophoraflavanone I | 136997-69-8 | Natural Products |
| HY-N8999 | Thalrugosidine | 33954-34-6 | Natural Products |
| HY-N9000 | Loganic acid 6′-O-β-D-glucoside | 176226-39-4 | Natural Products |
| HY-N9001 | Cadensin D | 102349-35-9 | Natural Products |
| HY-N9003 | Dihydroprehelminthosporol | 118069-95-7 | Natural Products |
| HY-N9004 | Khayalenoid E | 1220508-29-1 | Natural Products |
| HY-N9005 | Dysolenticin J | 1337973-08-6 | Natural Products |
| HY-N9006 | Amooracetal | 1351617-73-6 | Natural Products |
| HY-N9007 | Isojasminin | 135378-08-4 | Natural Products |
| HY-N9008 | 4''-Hydroxyisojasminin | 135378-09-5 | Natural Products |
| HY-N9009 | 1-Hydroxymethyl-β-carboline glucoside | 1408311-12-5 | Natural Products |
| HY-N9010 | Chartarlactam A | 1528745-88-1 | Natural Products |
| HY-N9011 | 16-Oxo-11-anhydroalisol A | 156338-93-1 | Natural Products |
| HY-N9012 | 2-Hydroxy-5-(2-hydroxy-4-methoxybenzyl)-4-methoxybenzaldehyde | 953427-66-2 | Natural Products |
| HY-N9013 | Flavidinin | 83925-00-2 | Natural Products |
| HY-N9014 | Bisdehydroneotuberostemonine | 160333-27-7 | Natural Products |
| HY-N9015 | Phlogacantholide B | 830347-16-5 | Natural Products |
| HY-N9016 | 8(17),12E,14-Labdatrien-20-oic acid | 1639257-36-5 | Natural Products |
| HY-N9017 | 12E,14-Labdadien-20,8β-olide | 1639257-37-6 | Natural Products |
| HY-N9018 | 4-(6-Methyl-4-oxohept-5-en-2-yl)cyclohex-2-en-1-one | 170380-68-4 | Natural Products |
| HY-N9019 | 1,4-Epidioxybisabola-2,10-dien-9-one | 170380-69-5 | Natural Products |
| HY-N9020 | Curcumaromin C | 1810034-40-2 | Natural Products |
| HY-N9021 | Isoleojaponin | 1840966-49-5 | Natural Products |
| HY-N9022 | (S)-1-(4-Hydroxy-2,2-dimethylchroman-6-yl)ethanone | 1890153-71-5 | Natural Products |
| HY-N9025 | ent-6,9-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyranosyl ester | 81263-98-1 | Natural Products |
| HY-N9026 | Stachartin B | 1978388-55-4 | Natural Products |
| HY-N9027 | Bruceantinoside A | 79439-85-3 | Natural Products |
| HY-N9028 | Scillascillone | 2023822-40-2 | Natural Products |
| HY-N9029 | Carmichaenine B | 2065228-60-4 | Natural Products |
| HY-N9030 | Carmichaenine C | 2065228-61-5 | Natural Products |
| HY-N9031 | Carmichaenine D | 2065228-62-6 | Natural Products |
| HY-N9032 | Carmichaenine E | 2065228-63-7 | Natural Products |
| HY-N9033 | 9-Deacetyl-9-benzoyl-10-debenzoyl-4β,20-epoxytaxchinin A | 227011-48-5 | Natural Products |
| HY-N9035 | 20-Deacetyltaxuspine X | 284672-76-0 | Natural Products |
| HY-N9036 | Drechslerine A | 405157-84-8 | Natural Products |
| HY-N9039 | Syringetin 3-O-galactoside | 55025-56-4 | Natural Products |
| HY-N9040 | 6β-Angeloyloxy-1β,10β-epoxy-9-oxo-furaneremophilane | 59780-08-4 | Natural Products |
| HY-N9041 | Pyranojacareubin | 78343-62-1 | Natural Products |
| HY-N9042 | 3-Acetylyunaconitine | 80787-51-5 | Natural Products |
| HY-N9043 | Tasumatrol L | 847835-17-0 | Natural Products |
| HY-N9044 | ent-14,15-Dinor-13-oxolabda-8(17),11-dien-18-oic acid | 875585-30-1 | Natural Products |
| HY-N9045 | 7-Prenyljacareubin | 94513-60-7 | Natural Products |
| HY-N9046 | Citroside A | 120330-44-1 | Natural Products |
| HY-N9047 | Marumoside A | 1309604-34-9 | Natural Products |
| HY-N9048 | 12α-Methoxygrandiflorenic acid | 135383-94-7 | Natural Products |
| HY-N9049 | 5-O-Methyldalbergiphenol | 1499946-35-8 | Natural Products |
| HY-N9050 | Hotrienol | 20053-88-7 | Natural Products |
| HY-N9051 | 6-Prenylquercetin-3-Me ether | 151649-34-2 | Natural Products |
| HY-N9052 | Dehydroaglaiastatin | 155595-93-0 | Natural Products |
| HY-N9053 | Wedeliatrilolactone A | 156993-29-2 | Natural Products |
| HY-N9056 | Pterocarpadiol C | 2055882-22-7 | Natural Products |
| HY-N9057 | Pterocarpadiol D | 2055882-23-8 | Natural Products |
| HY-N9058 | 6-Formyl-1,2,9,10-tetramethoxy-6a,7-dehydroaporphine | 2101836-45-5 | Natural Products |
| HY-N9060 | Dehydrohautriwaic acid | 51905-84-1 | Natural Products |
| HY-N9061 | Withanolide S | 63139-16-2 | Natural Products |
| HY-N9062 | Cannabispirenone A | 63213-00-3 | Natural Products |
| HY-N9063 | Demethylluvangetin | 64652-10-4 | Natural Products |
| HY-N9064 | Parvifuran | 69470-93-5 | Natural Products |
| HY-N9065 | 12-Oxograndiflorenic acid | 74284-42-7 | Natural Products |
| HY-N9066 | Chilenine | 71700-15-7 | Natural Products |
| HY-N9067 | Sanggenofuran B | 1017277-40-5 | Natural Products |
| HY-N9068 | Alterlactone | 1030376-89-6 | Natural Products |
| HY-N9069 | 1-O-Methylnataloe-emodin | 103392-51-4 | Natural Products |
| HY-N9070 | Taxumairol R | 244167-04-2 | Natural Products |
| HY-N9071 | 5-Allyl-3-methoxy-6-methyl-7-(3,4,5-trimethoxyphenyl)bicyclo[3.2.1]oct-3-ene-2,8-dione | 106894-43-3 | Natural Products |
| HY-N9072 | Lucidioline | 22594-91-8 | Natural Products |
| HY-N9073 | 1,7-Dihydroxyacridone | 112649-95-3 | Natural Products |
| HY-N9074 | Shizukanolide H | 1136932-34-7 | Natural Products |
| HY-N9075 | 9-(4′-Hydroxyphenyl)-2-methoxyphenalen-1-one | 204134-70-3 | Natural Products |
| HY-N9076 | Triptocalline A | 201534-10-3 | Natural Products |
| HY-N9077 | 11-Dehydroxygrevilloside B | 197307-49-6 | Natural Products |
| HY-N9078 | 9alpha,11,12-Trihydroxydrim-7-en-6-one | 192566-65-7 | Natural Products |
| HY-N9079 | 8alpha-(2-Methylacryloyloxy)hirsutinolide | 188293-70-1 | Natural Products |
| HY-N9081 | 6β-Hydroxyhispanone | 170711-93-0 | Natural Products |
| HY-N9082 | Taxachitriene B | 167906-75-4 | Natural Products |
| HY-N9083 | 8α-Hydroxy-α-gurjunene | 1674359-84-2 | Natural Products |
| HY-N9084 | 9-Hydroxyeriobofuran | 167278-41-3 | Natural Products |
| HY-N9085 | Neuchromenin | 180964-26-5 | Natural Products |
| HY-N9086 | Poriol | 14348-16-4 | Natural Products |
| HY-N9086A | (rac)-Poriol | 70460-58-1 | Natural Products |
| HY-N9087 | Filicenol B | 145103-37-3 | Natural Products |
| HY-N9088 | 2,3-Dihydro-12,13-dihydroxyeuparin | 135531-75-8 | Natural Products |
| HY-N9089 | Suavioside A | 133740-37-1 | Natural Products |
| HY-N9090 | erythro-1-(4-Hydroxy-3-methoxyphenyl)propane-1,2-diol | 1280602-81-4 | Natural Products |
| HY-N9091 | 9α,11-Dihydroxydrim-7-en-6-one | 127681-58-7 | Natural Products |
| HY-N9092 | Geranyl ferulate | 1206615-69-1 | Natural Products |
| HY-N9093 | (3R,5R)-3,5-Diacetoxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane | 1269839-26-0 | Natural Products |
| HY-N9094 | 8α-Acetoxyarglabin | 126829-70-7 | Natural Products |
| HY-N9095 | Curculigoside C | 851713-74-1 | Natural Products |
| HY-N9096 | Gentiside B | 1225022-67-2 | Natural Products |
| HY-N9097 | Niazirin | 122001-32-5 | Natural Products |
| HY-N9098 | 2-(4-Hydroxyphenyl)-6-methyl-2,3-dihydro-4H-pyran-4-one | 1167483-18-2 | Natural Products |
| HY-N9099 | 3-(4-Hydroxyphenyl)propan-2-one | 117614-84-3 | Natural Products |
| HY-N9101 | 4,4'-Dihydroxy-3,3',9-trimethoxy-9,9'-epoxylignan | 1206464-65-4 | Natural Products |
| HY-N9102 | 1-(3,4-Dihydroxyphenyl)-7-(4-hydroxyphenyl)hept-6-en-3-ol | 1206788-61-5 | Natural Products |
| HY-N9103 | Norpterosin B glucoside | 1226785-88-1 | Natural Products |
| HY-N9104 | ent-Labda-8(17),13Z-diene-15,16,19-triol 19-O-glucoside | 1245636-01-4 | Natural Products |
| HY-N9105 | 5,7,4'-Trihydroxy-3',5'-di(3-methylbut-2-enyl)-3,6-dimethoxyflavone | 1246926-08-8 | Natural Products |
| HY-N9106 | 3′-Methoxydaidzin | 200127-80-6 | Natural Products |
| HY-N9107 | Fisetinidin (chloride) | 2948-76-7 | Natural Products |
| HY-N9108 | 4-Hydroxybenzaldehyde rhamnoside | 88086-86-6 | Natural Products |
| HY-N9110 | 7,3′,4′-Tri-O-methyleriodictyol | 70987-96-1 | Natural Products |
| HY-N9111 | Bisabola-3,10-dien-2-one | 61432-71-1 | Natural Products |
| HY-N9112 | Eriodictyol 7, 3'-dimethyl ether | 54352-60-2 | Natural Products |
| HY-N9113 | 1,3,5,6-Tetrahydroxyxanthone | 5084-31-1 | Natural Products |
| HY-N9114 | Mesuaxanthone B | 5042-03-5 | Natural Products |
| HY-N9115 | Plathymenin | 492-12-6 | Natural Products |
| HY-N9116 | Unedone | 1199815-09-2 | Natural Products |
| HY-N9117 | Prehelminthosporolactone | 118101-72-7 | Natural Products |
| HY-N9118 | (E)-8α-Hydroxylabda-13(16),14-dien-19-yl coumarate | 117254-98-5 | Natural Products |
| HY-N9121 | 8β-(4-Acetoxy-5-hydroxytigloyloxy)costunolide | 109770-86-7 | Natural Products |
| HY-N9122 | 4'-Hydroxypiptocarphin A | 103994-39-4 | Natural Products |
| HY-N9123 | Rhoeadine | 2718-25-4 | Natural Products |
| HY-N9124 | Goshonoside F1 | 90851-24-4 | Natural Products |
| HY-N9125 | Adoxosidic acid | 84375-46-2 | Natural Products |
| HY-N9126 | Hopeyhopin | 63975-56-4 | Natural Products |
| HY-N9127 | Hydroxyanigorufone | 56252-02-9 | Natural Products |
| HY-N9128 | Medicarpin 3-O-glucoside | 52766-70-8 | Natural Products |
| HY-N9129 | Cinnamyl isoferulate | 115610-31-6 | Natural Products |
| HY-N9130 | Indicine | 480-82-0 | Natural Products |
| HY-N9131 | 6-Methylgenistein | 97575-49-0 | Natural Products |
| HY-N9133 | 4-Hydroxymethylphenol 1-O-rhamnoside | 478314-67-9 | Natural Products |
| HY-N9134 | 5-O-Methylgenistein | 4569-98-6 | Natural Products |
| HY-N9135 | Quercetin 3,3'-dimethyl ether | 4382-17-6 | Natural Products |
| HY-N9136 | 2',6'-Dihydroxy-4,4'-dimethoxychalcone | 20621-49-2 | Natural Products |
| HY-N9137 | 2α-Hydroxy-8β-(2-methylbutyryloxy)costunolide | 128286-87-3 | Natural Products |
| HY-N9138 | Tovopyrifolin C | 34211-53-5 | Natural Products |
| HY-N9139 | Gelidoside | 128420-44-0 | Natural Products |
| HY-N9140 | Hulupinic acid | 1891-42-5 | Natural Products |
| HY-N9141 | Nantenine | 2565-01-7 | Natural Products |
| HY-N9142 | Ergosterol glucoside | 130155-33-8 | Natural Products |
| HY-N9143 | Decinnamoyltaxagifine | 130394-69-3 | Natural Products |
| HY-N9144 | ent-3β,18-Dihydroxylabda-8(17),13E-dien-15-oic acid | 99624-39-2 | Natural Products |
| HY-N9145 | 1beta,10beta-Epoxydehydroleucodin | 130858-00-3 | Natural Products |
| HY-N9146 | 3,5-Dimethoxy-3'-hydroxybibenzyl | 168281-05-8 | Natural Products |
| HY-N9147 | 1-Hydroxy-N-methylacridone | 16584-54-6 | Natural Products |
| HY-N9148 | Aphagranin A | 1318173-53-3 | Natural Products |
| HY-N9149 | Cryptanoside A | 98570-81-1 | Natural Products |
| HY-N9150 | Shizukaol A | 131984-98-0 | Natural Products |
| HY-N9151 | (4->2)-Abeo-16-hydroxycleroda-2,13-dien-15,16-olide-3-al | 935293-70-2 | Natural Products |
| HY-N9152 | Parvifolixanthone B | 906794-57-8 | Natural Products |
| HY-N9153 | erythro-Guaiacylglycerol-β-O-4’-sinapyl ether | 877875-96-2 | Natural Products |
| HY-N9153A | Guaiacylglycerol-8-O-4'-(sinapyl alcohol) ether | 905726-70-7 | Natural Products |
| HY-N9154 | 6-Dehydroxy-8-hydroxygaleopsinolone | 87440-66-2 | Natural Products |
| HY-N9155 | 10-Deacetylyunnanxane | 1333323-17-3 | Natural Products |
| HY-N9156 | Methyl 1,6-dihydroxy-3-methylxanthone-8-carboxylate | 85003-85-6 | Natural Products |
| HY-N9158 | 15,16-Dinor-8(17),11-labdadien-13-one | 76497-69-3 | Natural Products |
| HY-N9159 | Piptocarphin F | 76215-53-7 | Natural Products |
| HY-N9160 | ent-3β-Angeloyloxykaur-16-en-19-oic acid | 74635-61-3 | Natural Products |
| HY-N9161 | Echitoveniline | 72855-79-9 | Natural Products |
| HY-N9162 | 2α-Hydroxyeupatolide 8-O-angelate | 72229-39-1 | Natural Products |
| HY-N9163 | Uncarine A | 6899-73-6 | Natural Products |
| HY-N9164 | Hecubine | 62874-52-6 | Natural Products |
| HY-N9165 | 15,16-Epoxy-12R-hydroxylabda-8(17),13(16),14-triene | 61597-55-5 | Natural Products |
| HY-N9166 | erythro-Guaiacylglycerol-β-O-4'-dehydrodisinapyl ether | 613684-55-2 | Natural Products |
| HY-N9167 | 6α-Hydroxyhispanone | 596814-48-1 | Natural Products |
| HY-N9169 | 8β-(4-Hydroxytigloyloxy)ovatifolin | 554449-27-3 | Natural Products |
| HY-N9170 | Lup-20(29)-ene-3β,11β-diol | 49776-92-3 | Natural Products |
| HY-N9171 | Musellarin A | 477565-36-9 | Natural Products |
| HY-N9172 | Eupaglehnin C | 476630-49-6 | Natural Products |
| HY-N9173 | Cupressuflavone | 3952-18-9 | Natural Products |
| HY-N9174 | 5,7,3',4'-Tetrahydroxy-3-methoxy-8,5'-diprenylflavone | 1353676-65-9 | Natural Products |
| HY-N9175 | 4α,6α-Dihydroxyeudesm-11(13)-en-12,8β-olide | 35001-19-5 | Natural Products |
| HY-N9176 | 15,16-Epoxy-15-ethoxy-6β,13-dihydroxylabd-8-en-7-one | 1374328-47-8 | Natural Products |
| HY-N9177 | 3',4'-Dihydroxy-2-O-methylanigorufone | 1392307-42-4 | Natural Products |
| HY-N9178 | Nudifloside C | 297740-99-9 | Natural Products |
| HY-N9179 | 3′,4′,5′,5,6,7-Hexamethoxyflavone | 29043-07-0 | Natural Products |
| HY-N9180 | 8α-Methacryloyloxy-13-ethoxyvernojalcanolide | 142891-14-3 | Natural Products |
| HY-N9182 | Zeaxanthin dipalmitate | 144-67-2 | Natural Products |
| HY-N9183 | Diarylcomosol III | 1452487-93-2 | Natural Products |
| HY-N9184 | Furano(2'',3'',7,6)-4'-hydroxyflavanone | 1454619-70-5 | Natural Products |
| HY-N9186 | Bakkenolide Db | 226711-23-5 | Natural Products |
| HY-N9187 | 1α,4β,10β-Trihydroxyguaia-2,11(13)-dien-12,6α-olide | 221148-94-3 | Natural Products |
| HY-N9188 | 3-(2,4-Dihydroxybenzyl)-5-hydroxy-7,8-dimethoxy-6-methylchroman-4-one | 149180-48-3 | Natural Products |
| HY-N9189 | 5,8,9,14-Tetraacetoxy-3-benzoyloxy-10,15-dihydroxypepluane | 219916-77-5 | Natural Products |
| HY-N9191 | p-Hydroxyphenethyl vanillate | 1539303-03-1 | Natural Products |
| HY-N9192 | 2,2-Dimethyl-8-prenylchromene 6-carboxylic acid | 151731-50-9 | Natural Products |
| HY-N9193 | 2',4',5'-Trimethoxy-2'',2''-dimethylpyrano[5'',6'':6,7]isoflavone | 211799-56-3 | Natural Products |
| HY-N9194 | 5-Methoxycanthin-6-one | 15071-56-4 | Natural Products |
| HY-N9195 | 4-Hydroxy-3-(3-methyl-2-butenoyl)-5-(3-methyl-2-butenyl)benzoic acid | 155051-85-7 | Natural Products |
| HY-N9196 | Pinobanksin 3-O-propionate | 126394-70-5 | Natural Products |
| HY-N9198 | 13-O-Ethylpiptocarphol | 202522-40-5 | Natural Products |
| HY-N9199 | 6β,19-Dihydroxyurs-12-en-3-oxo-28-oic acid | 194027-11-7 | Natural Products |
| HY-N9200 | 3-Phenyl-1,2-dihydroacenaphthylene-1,2-diol | 193892-33-0 | Natural Products |
| HY-N9201 | 8beta-Methoxyatractylenolide I | 193694-24-5 | Natural Products |
| HY-N9202 | Galanganone A | 1922129-42-7 | Natural Products |
| HY-N9203 | Pinobanksin 5-methyl ether | 119309-36-3 | Natural Products |
| HY-N9205 | 5-Acetyltaxachitriene A | 187988-48-3 | Natural Products |
| HY-N9206 | Kimcuongin | 1872403-23-0 | Natural Products |
| HY-N9207 | Germanicol acetate | 10483-91-7 | Natural Products |
| HY-N9208 | Sarmentocymarin | 98633-61-5 | Natural Products |
| HY-N9209 | Cinalbicol | 69904-85-4 | Natural Products |
| HY-N9210 | 1,2,3-Tri-O-methyl-7,8-methyleneflavellagic acid | 69251-99-6 | Natural Products |
| HY-N9211 | Norpterosin C | 64890-70-6 | Natural Products |
| HY-N9212 | trans-2,3-Dihydro-3-hydroxyeuparin | 64185-57-5 | Natural Products |
| HY-N9213 | 1-Methoxyallocryptopine | 56743-52-3 | Natural Products |
| HY-N9214 | 1-Oxobakkenolide S | 18456-02-5 | Natural Products |
| HY-N9215 | 1-Oxo-4-hydroxy-2-en-4-ethylcyclohexa-5,8-olide | 55604-88-1 | Natural Products |
| HY-N9216 | 3,4-seco-Olean-12-en-4-ol-3,28-dioic acid | 182249-69-0 | Natural Products |
| HY-N9217 | 3,5-Dihydroxy-1,7-bis(3,4-dihydroxyphenyl)heptane | 408324-01-6 | Natural Products |
| HY-N9218 | Quinovic acid 3-O-(3',4'-O-isopropylidene)-β-D-fucopyranoside | 182132-59-8 | Natural Products |
| HY-N9219 | 2,5-Dihydroxyxanthone | 35040-32-5 | Natural Products |
| HY-N9220 | 6-Epi-albassitriol | 178456-58-1 | Natural Products |
| HY-N9221 | Bakkenolide III | 24909-95-3 | Natural Products |
| HY-N9222 | 9-Deacetyl-9-benzoyl-10-debenzoyltaxchinin A | 172486-22-5 | Natural Products |
| HY-N9223 | Ketohakonanol | 18004-20-1 | Natural Products |
| HY-N9224 | 5-Acetyl-6-hydroxy-2-(1-hydroxy-1-methylethyl)benzofuran | 173992-05-7 | Natural Products |
| HY-N9225 | 4',4'''-Di-O-methylisochamaejasmin | 1620921-68-7 | Natural Products |
| HY-N9226 | Glucocheirolin | 15592-36-6 | Natural Products |
| HY-N9227 | 7,13-Dideacetyl-9,10-didebenzoyltaxchinin C | 156497-25-5 | Natural Products |
| HY-N9228 | 5,7,3',4'-Tetrahydroxy-3-methoxy-8-geranylflavone | 1605304-56-0 | Natural Products |
| HY-N9230 | Isocuparenal | 16982-01-7 | Natural Products |
| HY-N9231 | 4'-O-Methylirenolone | 159853-36-8 | Natural Products |
| HY-N9232 | Rutaevin 7-acetate | 62306-81-4 | Natural Products |
| HY-N9233 | Schisandrin C epoxide | 81345-36-0 | Natural Products |
| HY-N9234 | Taxcultine | 153415-46-4 | Natural Products |
| HY-N9235 | Wilforlide A acetate | 84104-80-3 | Natural Products |
| HY-N9236 | Virgatic acid | 14356-51-5 | Natural Products |
| HY-N9237 | 2,3-Di(3',4'-methylenedioxybenzyl)-2-buten-4-olide | 137809-97-3 | Natural Products |
| HY-N9238 | 3'',4''-Di-O-acetyl-2'',6''-di-O-p-coumaroylastragalin | 137018-33-8 | Natural Products |
| HY-N9239 | Turmeronol A | 131651-37-1 | Natural Products |
| HY-N9240 | Acerogenin G | 130233-83-9 | Natural Products |
| HY-N9241 | 3-Hydroxy-7-methoxyflavone | 7478-60-6 | Natural Products |
| HY-N9241R | 3-Hydroxy-7-methoxyflavone (Standard) | 7478-60-6 | Reference Standards |
| HY-N9242 | Isoficusin A | 1914963-20-4 | Natural Products |
| HY-N9243 | 5-Hydroxy-1,7-bis(4-hydroxyphenyl)heptan-3-yl acetate | 1269839-24-8 | Natural Products |
| HY-N9244 | Filic-3-en-25-al | 147850-78-0 | Natural Products |
| HY-N9246 | 4'-Methoxyflavanone | 97005-76-0 | Natural Products |
| HY-N9248 | 6-Hydroxywogonin | 76844-70-7 | Natural Products |
| HY-N9250 | Gentiside J | 1238837-50-7 | Natural Products |
| HY-N9251 | Cyclo(Ile-Ala) | 90821-99-1 | Natural Products |
| HY-N9251R | Cyclo(Ile-Ala) (Standard) | 90821-99-1 | Reference Standards |
| HY-N9253 | 2,2-Dimethyl-6-phenylpyrano[3,4-b]pyran-8-one | 1153624-36-2 | Natural Products |
| HY-N9254 | Demethoxyisodaphneticin | 121587-20-0 | Natural Products |
| HY-N9256 | 5,7-Dihydroxy-3',4',5'-trimethoxyflavanone | 62252-10-2 | Natural Products |
| HY-N9257 | 8-Hydroxypinoresinol4,4'-di-O-β-D-glucopyranoside | 112747-99-6 | Natural Products |
| HY-N9258 | p-Vinylphenyl O-β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside | 112047-91-3 | Natural Products |
| HY-N9259 | Cnidimol A | 103629-80-7 | Natural Products |
| HY-N9260 | 4E-Deacetylchromolaenide 4'-O-acetate | 104736-09-6 | Natural Products |
| HY-N9261 | 3-(3-Hydroxy-3-methylbutanyl)-2,4,6-trihydroxybenzophenone | 1432062-53-7 | Natural Products |
| HY-N9262 | 2α,7β,13α-Triacetoxy-5α-cinnamoyloxy-9β-hydroxy-2(3→20)abeotaxa-4(20),11-dien-10-one | 322471-42-1 | Natural Products |
| HY-N9263 | Diacetylpiptocarphol | 101628-29-9 | Natural Products |
| HY-N9264 | trans-2,3-Dihydro-3-ethoxyeuparin | 1015698-14-2 | Natural Products |
| HY-N9265 | 3-(1,1-Dimethylallyl)-8-hydroxy-7-methoxycoumarin | 61899-42-1 | Natural Products |
| HY-N9267 | Erigeside C | 112667-09-1 | Natural Products |
| HY-N9268 | 8β-Tigloyloxyreynosin | 80368-31-6 | Natural Products |
| HY-N9269 | 1,7-Dihydroxy-2,3-dimethoxyxanthone | 78405-33-1 | Natural Products |
| HY-N9270 | 3-Epichromolaenide | 89913-53-1 | Natural Products |
| HY-N9271 | Grifolin | 6903-07-7 | Natural Products |
| HY-N9271R | Grifolin (Standard) | 6903-07-7 | Reference Standards |
| HY-N9272 | 2-Methyl-4-(2-methylbutyryl)phloroglucinol | 124598-11-4 | Natural Products |
| HY-N9273 | Taraxasterone | 6786-16-9 | Natural Products |
| HY-N9274 | 3-Hydroxy-3-(4-hydroxyphenyl)-lactic acid | 100201-57-8 | Natural Products |
| HY-N9275 | Isopicropodophyllin | 60660-50-6 | Natural Products |
| HY-N9277 | β-Furoyleupatolide | 114437-24-0 | Natural Products |
| HY-N9278 | 8beta-(2-Hydroxy-2-methyl-3-oxobutyryloxy)glucozaluzanin C | 93395-31-4 | Natural Products |
| HY-N9279 | Dehydromonocrotaline | 23291-96-5 | Natural Products |
| HY-N9280 | ent-11α-Hydroxyabieta-8(14),13(15)-dien-16,12α-olide | 130466-20-5 | Natural Products |
| HY-N9282 | 8alpha-(2-Methylacryloyloxy)-1-O-methylhirsutinolide 13-O-acetate | 883872-71-7 | Natural Products |
| HY-N9283 | 1,2-Diacetoxy-4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzofuran | 146905-24-0 | Natural Products |
| HY-N9284 | 5,19-Epoxy-19R,25-dimethoxycucurbita-6,23-dien-3-ol | 85372-72-1 | Natural Products |
| HY-N9285 | 1-(3-(1-Hydroxy-3-methylbutyl)-4-methoxyphenyl)ethan-1-one | 148044-44-4 | Natural Products |
| HY-N9286 | 7,4'-Dihydroxy-8-methylflavan | 82925-55-1 | Natural Products |
| HY-N9287 | Breyniaionoside A | 823182-23-6 | Natural Products |
| HY-N9288 | 8-(6-Hydroperoxy-3,7-dimethyl-2,7-octadienyloxy)psoralen | 151121-39-0 | Natural Products |
| HY-N9289 | Vitedoin A | 819861-40-0 | Natural Products |
| HY-N9290 | ent-6,9-Dihydroxy-15-oxo-16-kauren-19-oic acid | 81264-00-8 | Natural Products |
| HY-N9291 | 4-(trans)-Acetyl-3,6,8-trihydroxy-3-methyldihydronaphthalenone | 263368-91-8 | Natural Products |
| HY-N9292 | Friedelin-3,4-lactone | 29621-75-8 | Natural Products |
| HY-N9293 | Jasminin | 30164-93-3 | Natural Products |
| HY-N9294 | 2',4'-Dihydroxy-7-methoxy-8-prenylflavan | 331954-16-6 | Natural Products |
| HY-N9295 | 3,4-Seco-4(23),20(29)-lupadiene-3,28-dioic acid | 36138-41-7 | Natural Products |
| HY-N9297 | Oxyphyllenone A | 363610-34-8 | Natural Products |
| HY-N9298 | 3,5-Dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane | 408324-00-5 | Natural Products |
| HY-N9299 | Alnusone | 52330-11-7 | Natural Products |
| HY-N9300 | 1,6-Dihydro-4,7-epoxy-1-methoxy-3,4-methylenedioxy-6-oxo-3,8-lignan | 57430-03-2 | Natural Products |
| HY-N9301 | 11,12-Dihydro-7-hydroxyhedychenone | 60149-07-7 | Natural Products |
| HY-N9302 | Chromolaenide | 66148-25-2 | Natural Products |
| HY-N9303 | 1,6-Dihydro-4,7'-Epoxy-1-Methoxy-3',4'-Methylenedioxy-6-Oxo-3,8'-Lignan | 67920-48-3 | Natural Products |
| HY-N9304 | Fern-7-en-19α-ol | 70588-12-4 | Natural Products |
| HY-N9305 | Obolactone | 712272-88-3 | Natural Products |
| HY-N9306 | 11-Hydroxydrim-7-en-6-one | 74635-87-3 | Natural Products |
| HY-N9307A | (S)-8-Acetoxy-15,16-epoxy-8,9-secolabda-13(16),14-diene-7,9-dione | 76497-89-7 | Natural Products |
| HY-N9308 | Delta-Caesalpin | 7716-14-5 | Natural Products |
| HY-N9309 | 2,6-Dimethyl-3-O-methyl-4-(2-methylbutyryl)phloroglucinol | 97761-91-6 | Natural Products |
| HY-N9310 | 6-Deoxy-3-O-methyl-beta-allopyranosyl(1-4)-beta-cymaronic acid delta-lactone | 19131-13-6 | Natural Products |
| HY-N9311 | 2,3-Dihydroxy-4-methoxybenzoic acid | 3934-81-4 | Natural Products |
| HY-N9312 | Ganoderic acid J | 100440-26-4 | Natural Products |
| HY-N9314 | Camellianin B | 109232-76-0 | Natural Products |
| HY-N9315 | Episappanol | 111254-18-3 | Natural Products |
| HY-N9316 | 3'-Deoxy-4-O-methylsappanol | 112408-68-1 | Natural Products |
| HY-N9317 | Tangshenoside I | 117278-74-7 | Natural Products |
| HY-N9318 | 4'-Demethyldehydropodophyllotoxin | 117669-31-5 | Natural Products |
| HY-N9319 | Fulvotomentoside A | 150107-44-1 | Natural Products |
| HY-N9320 | 13,21-Dihydroeurycomanone | 129587-06-0 | Natural Products |
| HY-N9321 | Cathayanon H | 1303438-51-8 | Natural Products |
| HY-N9322 | Bergaptol O-β-D-glucopyranoside | 131623-13-7 | Natural Products |
| HY-N9324 | Ilexoside O | 136552-23-3 | Natural Products |
| HY-N9325 | Pasakbumin D | 138874-44-9 | Natural Products |
| HY-N9326 | Uralenol | 139163-15-8 | Natural Products |
| HY-N9327 | 3,11,15,23-Tetraoxo-27ξ-lanosta-8,16-dien-26-oic acid | 1427189-02-3 | Natural Products |
| HY-N9328 | Tarasaponin IV | 156980-31-3 | Natural Products |
| HY-N9329 | Glicoricone | 161099-37-2 | Natural Products |
| HY-N9330 | Broussoflavonol F | 162558-94-3 | Natural Products |
| HY-N9331 | Cimicifugoside H-1 | 163046-73-9 | Natural Products |
| HY-N9332 | Kalopanax saponin G | 171370-50-6 | Natural Products |
| HY-N9333 | Wistin | 19046-26-5 | Natural Products |
| HY-N9334 | Tetrahydroxymethoxychalcone | 197227-39-7 | Natural Products |
| HY-N9335 | Myrciacetin | 203734-35-4 | Natural Products |
| HY-N9337 | Amaroswerin | 21233-18-1 | Natural Products |
| HY-N9338 | Guattegaumerine | 21446-35-5 | Natural Products |
| HY-N9339 | Norglaucine | 21848-62-4 | Natural Products |
| HY-N9340 | Hypoglaunine D | 220751-00-8 | Natural Products |
| HY-N9341 | Norswertianin | 22172-15-2 | Natural Products |
| HY-N9343 | Kulactone | 22611-36-5 | Natural Products |
| HY-N9344 | Wilfordinine D | 256937-98-1 | Natural Products |
| HY-N9345 | (2α,3β)-Olean-12-ene-2,3-diol | 26926-98-7 | Natural Products |
| HY-N9346 | Phlorigidoside C | 276691-32-8 | Natural Products |
| HY-N9347 | Stepharine | 2810-21-1 | Natural Products |
| HY-N9348A | Glucoraphenin (potassium) | 108844-81-1 | Natural Products |
| HY-N9349 | Malvidin-3-O-arabinoside (chloride) | 28500-04-1 | Natural Products |
| HY-N9350 | Ganoderic acid ε | 294674-05-8 | Natural Products |
| HY-N9351 | Cleistanthin B | 30021-77-3 | Natural Products |
| HY-N9352 | Cantleyoside | 32455-46-2 | Natural Products |
| HY-N9354A | (+)-Saxalin | 125517-45-5 | Natural Products |
| HY-N9355 | (+)-N-Formylnorglaucine | 371196-16-6 | Natural Products |
| HY-N9356 | Oxocrebanine | 38826-42-5 | Natural Products |
| HY-N9357 | Granilin | 40737-97-1 | Natural Products |
| HY-N9358 | Argentinogenin | 4236-48-0 | Natural Products |
| HY-N9359 | Toddaculin | 4335-12-0 | Natural Products |
| HY-N9362 | Emodinanthrone | 491-60-1 | Natural Products |
| HY-N9362R | Emodinanthrone (Standard) | 491-60-1 | Reference Standards |
| HY-N9363 | Corymbiferin | 5042-09-1 | Natural Products |
| HY-N9364 | Iso-oxypeucedanin | 5058-15-1 | Natural Products |
| HY-N9366 | Tumulosic acid | 508-24-7 | Natural Products |
| HY-N9368 | Luteolin-7-O-α-L-arabinopyranosyl (1→6)-β-D-glucopyranoside | 52714-82-6 | Natural Products |
| HY-N9369 | Verbascose | 546-62-3 | Natural Products |
| HY-N9370 | Isobellidifolin | 552-00-1 | Natural Products |
| HY-N9371 | Crocin IV | 57710-64-2 | Natural Products |
| HY-N9371R | Crocin IV (Standard) | 57710-64-2 | Reference Standards |
| HY-N9372 | Crocetin β-D-glucopyranoside | 58050-17-2 | Natural Products |
| HY-N9373 | Bacoside A2 | 58798-95-1 | Natural Products |
| HY-N9374 | Bufotenidine | 487-91-2 | Natural Products |
| HY-N9375 | Kakkanin | 63770-91-2 | Natural Products |
| HY-N9376 | Kansuinine E | 672945-84-5 | Natural Products |
| HY-N9377 | Platyconic acid A | 68051-23-0 | Natural Products |
| HY-N9378 | 3-Oxobetulin | 7020-34-0 | Natural Products |
| HY-N9379 | Fissistigine A | 70420-58-5 | Natural Products |
| HY-N9381 | Kaempferol 3,4'-diglucoside | 71939-16-7 | Natural Products |
| HY-N9383 | 6''-Acetylhyperin | 72659-75-7 | Natural Products |
| HY-N9384 | 13-Dehydroxyindaconitine | 77757-14-3 | Natural Products |
| HY-N9385 | Proprotogracillin | 78229-03-5 | Natural Products |
| HY-N9386 | Tellimagrandin II | 81571-72-4 | Natural Products |
| HY-N9387 | Macarangioside D | 819870-23-0 | Natural Products |
| HY-N9388 | Andrograpanin | 82209-74-3 | Natural Products |
| HY-N9388R | Andrograpanin (Standard) | 82209-74-3 | Reference Standards |
| HY-N9390 | Wilforlide B | 84104-70-1 | Natural Products |
| HY-N9391 | 7,3′,5′-Trihydroxyflavanone | 847375-46-6 | Natural Products |
| HY-N9392 | Stemonidine | 85700-47-6 | Natural Products |
| HY-N9394 | (+)-Norlirioferine | 86941-27-7 | Natural Products |
| HY-N9395 | Dihydroarteannuin B | 87206-33-5 | Natural Products |
| HY-N9396 | Nasunin | 28463-30-1 | Natural Products |
| HY-N9397 | Quercetin 3-O-(6''-O-malonyl)-β-D-glucoside | 96862-01-0 | Natural Products |
| HY-N9397R | Quercetin 3-O-(6''-O-malonyl)-β-D-glucoside (Standard) | 96862-01-0 | Reference Standards |
| HY-N9398 | 3β,6α,12β-Dammar-E-20(22)-ene-3,6,12,25-tetraol | 97744-95-1 | Natural Products |
| HY-N9400 | Lucidenic acid F | 98665-18-0 | Natural Products |
| HY-N9401 | Azedarachol | 99305-11-0 | Natural Products |
| HY-N9402 | Prosaikogenin A | 99365-21-6 | Natural Products |
| HY-N9403 | Prosaikogenin H | 99365-22-7 | Natural Products |
| HY-N9404 | 6-Benzoylheteratisine | 99759-48-5 | Natural Products |
| HY-N9406 | Maltooctaose | 66567-45-1 | Natural Products |
| HY-N9407 | Guvacine ethyl ester | 18513-76-3 | Natural Products |
| HY-N9408 | Furostan, β-D-glucopyranoside deriv | 117457-34-8 | Natural Products |
| HY-N9410 | Lysophosphatidylcholine 18:2 | 22252-07-9 | Natural Products |
| HY-N9410S | Lysophosphatidylcholine 18:2-d9 | 2162167-92-0 | Isotope-Labeled Compounds |
| HY-N9412 | 4-O-Methyl-D-glucuronic acid | 4120-73-4 | Natural Products |
| HY-N9413 | γ-Glutamyl-S-allylcysteine | 91216-95-4 | Natural Products |
| HY-N9414 | Acetoxyvalerenic acid | 84638-55-1 | Natural Products |
| HY-N9414R | Acetoxyvalerenic acid (Standard) | 84638-55-1 | Reference Standards |
| HY-N9417 | 2,3-Dihydroxyisovaleric acid | 1756-18-9 | Natural Products |
| HY-N9418 | Gibberellin A5 | 561-56-8 | Natural Products |
| HY-N9418R | Gibberellin A5 (Standard) | 561-56-8 | Reference Standards |
| HY-N9422 | Adenosine 3'-phosphate 5'-phosphosulfate (triethylamine) | 936827-87-1 | Natural Products |
| HY-N9425 | Caprazamycin | 327164-11-4 | Natural Products |
| HY-N9429 | 6-Deoxy-D-glucose | 7658-08-4 | Natural Products |
| HY-N9434 | 5,7,2',6'-Tetrahydroxyflavone | 82475-00-1 | Natural Products |
| HY-N9435 | 28-Homobrassinolide | 82373-95-3 | Natural Products |
| HY-N9437 | Betulin diacetate | 1721-69-3 | Natural Products |
| HY-N9438 | Lactucin | 1891-29-8 | Natural Products |
| HY-N9438R | Lactucin (Standard) | 1891-29-8 | Reference Standards |
| HY-N9439 | 6-O-β-D-Galactopyranosyl-D-galactose | 5077-31-6 | Natural Products |
| HY-N9441 | Ascr#7 | 1139837-37-8 | Natural Products |
| HY-N9442 | Ancymidol | 12771-68-5 | Biochemical Assay Reagents |
| HY-N9442R | Ancymidol (Standard) | 12771-68-5 | Reference Standards |
| HY-N9443 | (12β)-20-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-one | 1123845-41-9 | Natural Products |
| HY-N9444 | 1,3-Dipalmitoyl-2-linoleoylglycerol | 2442-56-0 | Natural Products |
| HY-N9445 | Lacto-N-neotetraose | 13007-32-4 | Natural Products |
| HY-N9446 | H-Asn(glcnac-beta-D)-OH | 2776-93-4 | Natural Products |
| HY-N9447 | Norbergenin | 79595-97-4 | Natural Products |
| HY-N9448 | Lacto-N-tetraose | 14116-68-8 | Natural Products |
| HY-N9448R | Lacto-N-tetraose (Standard) | 14116-68-8 | Reference Standards |
| HY-N9451 | Ginger extract | 84696-15-1 | Natural Products |
| HY-N9452 | Capsaicin β-D-glucopyranoside | 153409-16-6 | Natural Products |
| HY-N9453 | 5α-Cholesta-7,24-dien-3β-ol | 651-54-7 | Natural Products |
| HY-N9453S | 5α-Cholesta-7,24-dien-3β-ol-d6 | 2260669-18-7 | Isotope-Labeled Compounds |
| HY-N9454 | Garcinoic acid | 91893-83-3 | Natural Products |
| HY-N9456 | 14-Anhydrodigitoxigenin | 4321-20-4 | Natural Products |
| HY-N9457 | Norcholic acid | 60696-62-0 | Natural Products |
| HY-N9457R | Norcholic acid (Standard) | 60696-62-0 | Reference Standards |
| HY-N9459 | 2-Amino-2-deoxyglucose (hydrochloride) | 1078691-95-8 | Natural Products |
| HY-N9460 | Sibiromycin | 12684-33-2 | Natural Products |
| HY-N9468 | Gentamicin C2a | 59751-72-3 | Natural Products |
| HY-N9470 | λ-Carrageenan | 9064-57-7 | Natural Products |
| HY-N9474 | Mevalonic acid 5-pyrophosphate (tetralithium) | 108869-00-7 | Natural Products |
| HY-N9475 | Betulonaldehyde | 4439-98-9 | Natural Products |
| HY-N9477 | Betulinic aldehyde oxime | 25613-12-1 | Natural Products |
| HY-N9478 | Sumaresinolic acid | 559-64-8 | Natural Products |
| HY-N9480 | Vinaxanthone | 133293-89-7 | Natural Products |
| HY-N9481 | Lipoteichoic acid | 56411-57-5 | Natural Products |
| HY-N9483 | 7-Keto-DHEA | 566-19-8 | Natural Products |
| HY-N9484 | Menthofuran | 494-90-6 | Natural Products |
| HY-N9484S | Menthofuran-13C2 | Isotope-Labeled Compounds | |
| HY-N9485 | 25(R)-Hydroxyprotopanaxadiol | 83349-37-5 | Natural Products |
| HY-N9486 | 2-Hydroxyeupatolide | 72229-33-5 | Natural Products |
| HY-N9487 | (R)-(-)-α-Phellandrene | 4221-98-1 | Natural Products |
| HY-N9488 | Girinimbine | 23095-44-5 | Natural Products |
| HY-N9489 | Phoyunnanin E | 886747-60-0 | Natural Products |
| HY-N9490 | Phytolaccagenic acid | 54928-05-1 | Natural Products |
| HY-N9491 | Charantadiol A | 1220890-23-2 | Natural Products |
| HY-N9492 | (+)-2-Carene | 4497-92-1 | Natural Products |
| HY-N9493 | Chrysanthemol | 5617-92-5 | Natural Products |
| HY-N9494 | 6-O-Nicotiylbarbatin C | 1015776-92-7 | Natural Products |
| HY-N9495 | (-)-trans-Myrtanol | 53369-17-8 | Natural Products |
| HY-N9496 | Piperitone | 89-81-6 | Natural Products |
| HY-N9496R | Piperitone (Standard) | 89-81-6 | Reference Standards |
| HY-N9497 | Galactinol | 3687-64-7 | Biochemical Assay Reagents |
| HY-N9498 | 3,5-Dihydroxy-4-methoxybenzoic acid | 4319-02-2 | Natural Products |
| HY-N9499 | 3-Methoxyflavone | 7245-02-5 | Natural Products |
| HY-N9499R | 3-Methoxyflavone (Standard) | 7245-02-5 | Reference Standards |
| HY-N9501 | Retronecine N-oxide | 6870-33-3 | Natural Products |
| HY-N9502 | Linalool oxide | 60047-17-8 | Natural Products |
| HY-N9502R | Linalool oxide (Standard) | 60047-17-8 | Reference Standards |
| HY-N9503 | Carvacryl acetate | 6380-28-5 | Natural Products |
| HY-N9504 | Polyschistine A | 96562-88-8 | Natural Products |
| HY-N9506 | Anisatin | 5230-87-5 | Natural Products |
| HY-N9507 | Picrasidine Q | 101219-61-8 | Natural Products |
| HY-N9508 | Perilla ketone | 553-84-4 | Natural Products |
| HY-N9509 | Erucifoline | 40158-95-0 | Natural Products |
| HY-N9511 | Jacobine N-oxide | 38710-25-7 | Natural Products |
| HY-N9512 | Lycopsamine N-oxide | 95462-15-0 | Natural Products |
| HY-N9512S | Lycopsamine N-oxide-d3 | Isotope-Labeled Compounds | |
| HY-N9513 | Echimidine N-oxide | 41093-89-4 | Natural Products |
| HY-N9515 | Diallyl tetrasulfide | 2444-49-7 | Natural Products |
| HY-N9516 | Taurodehydrocholic acid | 517-37-3 | Natural Products |
| HY-N9517 | QS 7 | 208933-54-4 | Natural Products |
| HY-N9520 | 1-Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone | 120693-52-9 | Natural Products |
| HY-N9521 | 3-O-β-D-Glucopyranosyl(1→2)-[a-Lrhamnopyranosyl(1→3)]-β-D-glucopyranosyl 28-O-β-D-glucuronopyranoside | 110081-91-9 | Natural Products |
| HY-N9522 | β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate | 51161-58-1 | Natural Products |
| HY-N9523 | Gosferol | 37551-62-5 | Natural Products |
| HY-N9524 | Ilexoside XLVIII | 129095-76-7 | Natural Products |
| HY-N9525 | Limocitrin 3-β-D-glucose | 38836-51-0 | Natural Products |
| HY-N9526 | Lyciumin B | 125756-66-3 | Natural Products |
| HY-N9527 | Poricoic acid BM | 1815623-74-5 | Natural Products |
| HY-N9528 | Lyciumin A | 125708-06-7 | Natural Products |
| HY-N9529 | Kaempferol 3-O-(2′′-O-α-rhamnosyl-6′′-O-malonyl-β-glucoside) | 528606-92-0 | Natural Products |
| HY-N9530 | 1-Methyl-2-[(4Z,7Z)-4,7-tridecadienyl]-4(1H)-quinolone | 120693-53-0 | Natural Products |
| HY-N9531 | 3'-Hydroxyxanthyletin | 165900-08-3 | Natural Products |
| HY-N9532 | Isobyakangelicol | 35214-81-4 | Natural Products |
| HY-N9533 | 16R-Hydroxy-3-oxolanosta7,9(11),24-trien-21-oic acid | 862109-64-6 | Natural Products |
| HY-N9534 | Xylopine | 517-71-5 | Natural Products |
| HY-N9535 | tert-OMe-byakangelicin | 79638-04-3 | Natural Products |
| HY-N9535A | (R)-tert-OMe-byakangelicin | 89560-97-4 | Natural Products |
| HY-N9536 | Cinnamtannin A2 | 86631-38-1 | Natural Products |
| HY-N9537 | Napelline | 5008-52-6 | Natural Products |
| HY-N9538 | 8-(3-Ethoxy-2-hydroxy-3-methylbutyloxy)psoralen | 55481-87-3 | Natural Products |
| HY-N9540 | Methyl citrate | 26163-61-1 | Natural Products |
| HY-N9541 | Chaetoglobosin Vb | 1399690-75-5 | Natural Products |
| HY-N9542 | Dimethyl Citric acid | 53798-97-3 | Natural Products |
| HY-N9550 | Chrysogine | 14422-59-4 | Natural Products |
| HY-N9551 | Eriodictyol chalcone | 14917-41-0 | Natural Products |
| HY-N9561 | Vanicoside B | 155179-21-8 | Natural Products |
| HY-N9562 | Avenacoside B | 35920-91-3 | Natural Products |
| HY-N9572 | Cadambine | 54422-49-0 | Natural Products |
| HY-N9581 | Apocynoside I | 358721-31-0 | Natural Products |
| HY-N9583 | (S)-4-Methoxydalbergione | 2543-95-5 | Natural Products |
| HY-N9585 | Lutonarin | 35450-86-3 | Natural Products |
| HY-N9587 | Tricin 7-O-β-D-glucopyranoside | 32769-01-0 | Natural Products |
| HY-N9588 | Pedaliin | 22860-72-6 | Natural Products |
| HY-N9595 | Bracteatin | 3260-50-2 | Natural Products |
| HY-N9596 | Stigmasta-4,22-dien-3-one | 20817-72-5 | Natural Products |
| HY-N9599 | Roridin A | 14729-29-4 | Natural Products |
| HY-N9600 | Dotriacontane | 544-85-4 | Natural Products |
| HY-N9600R | Dotriacontane (Standard) | 544-85-4 | Reference Standards |
| HY-N9600S | Dotriacontane-d66 | 62369-68-0 | Isotope-Labeled Compounds |
| HY-N9602 | 6,7,4'-Trihydroxyflavanone | 189689-31-4 | Natural Products |
| HY-N9604 | Andrastin C | 174232-44-1 | Natural Products |
| HY-N9608 | 6-Ketocholestanol | 1175-06-0 | Natural Products |
| HY-N9610 | Coenzyme Q6 | 1065-31-2 | Natural Products |
| HY-N9615 | Azadiradione | 26241-51-0 | Natural Products |
| HY-N9625 | Violaxanthin | 126-29-4 | Natural Products |
| HY-N9625R | Violaxanthin (Standard) | 126-29-4 | Reference Standards |
| HY-N9626 | Cuparene | 16982-00-6 | Natural Products |
| HY-N9629 | Cyclooctatin | 139552-97-9 | Natural Products |
| HY-N9630 | Qianhucoumarin C | 152615-15-1 | Natural Products |
| HY-N9633 | Oxyphyllacinol | 87657-77-0 | Natural Products |
| HY-N9647 | Dalbinol | 41993-79-7 | Natural Products |
| HY-N9650 | Mesuagin | 21721-08-4 | Natural Products |
| HY-N9667 | Stilbostemin N | 1000676-45-8 | Natural Products |
| HY-N9668 | 6-Hydroxyisosativan | 2172624-69-8 | Natural Products |
| HY-N9669 | Epimedonin I | 2222285-83-6 | Natural Products |
| HY-N9670 | Epimedonin J | 2222285-84-7 | Natural Products |
| HY-N9675 | (+)-Hannokinol | 408324-76-5 | Natural Products |
| HY-N9676 | Kaempferol 3-O-(2'',4''-di-acetyl-3''-cis-p-coumaroyl-6''-trans-p-coumaroyl)-β-D-glucopyranoside | 349545-02-4 | Natural Products |
| HY-N9680 | Coenzyme Q8 | 2394-68-5 | Enzyme |
| HY-N9682 | Syringopicroside | 29118-80-7 | Natural Products |
| HY-N9685 | Digitoxose | 527-52-6 | Natural Products |
| HY-N9686 | Caffeoyl-CoA | 53034-79-0 | Natural Products |
| HY-N9687 | 7-Angeloylretronecine | 6029-82-9 | Natural Products |
| HY-N9688 | Jacoumaric acid | 63303-42-4 | Natural Products |
| HY-N9690 | Longistyline A | 64095-60-9 | Natural Products |
| HY-N9691 | Curcumene | 644-30-4 | Natural Products |
| HY-N9693 | Gibberellin A8 | 7044-72-6 | Natural Products |
| HY-N9694 | Essential oils, Melaleuca alternifolia | 68647-73-4 | Natural Products |
| HY-N9695 | 2,6-Dihydroxy-4-methoxyacetophenone | 7507-89-3 | Natural Products |
| HY-N9697 | 2-Methoxy-1H-phenalen-1-one | 51652-39-2 | Natural Products |
| HY-N9698 | 1,5-Diphenyl-2-penten-1-one | 39686-51-6 | Natural Products |
| HY-N9699 | 8α-Hydroxyhirsutinolide | 1394156-45-6 | Natural Products |
| HY-N9701 | 7′,8′-Dihydroobolactone | 1240403-82-0 | Natural Products |
| HY-N9702 | n-Butyl-β-D-fructopyranoside | 67884-27-9 | Natural Products |
| HY-N9703 | 15,16-Dihydroxy-9Z,12Z-octadecadienoic acid | 140129-22-2 | Natural Products |
| HY-N9704 | n-Tritriacontan-16,18-dione | 24514-86-1 | Natural Products |
| HY-N9705 | Aspergillon A | 2239299-08-0 | Natural Products |
| HY-N9709 | 5-Hydroxysophoranone | 90686-12-7 | Natural Products |
| HY-N9710 | Bis(methylthio)gliotoxin | 74149-38-5 | Natural Products |
| HY-N9711 | 1-Methoxyberberine chloride | 29133-52-6 | Natural Products |
| HY-N9712 | Phomaligol A | 152204-32-5 | Natural Products |
| HY-N9713 | Dihydroxyaflavinine | 76410-56-5 | Natural Products |
| HY-N9714 | 4-Hydroxyalternariol-9-methyl ether | 959417-17-5 | Natural Products |
| HY-N9716 | Primeverose | 26531-85-1 | Natural Products |
| HY-N9720 | Herbarin | 36379-67-6 | Natural Products |
| HY-N9721 | Methyl 8-hydroxy-3-(2-methoxy-2-oxoethyl)-6-methyl-9-oxo-9H-furo[3,4-b]chromene-1-carboxylate | 96287-41-1 | Natural Products |
| HY-N9723 | 5-O-Ethylcleroindicin D | 488138-32-5 | Natural Products |
| HY-N9725 | 16-Hydroxycleroda-3,13-dien-15,16-olide | 141979-19-3 | Natural Products |
| HY-N9727 | 2-(2,4-Dihydroxyphenyl)-6-hydroxybenzofuran | 67736-22-5 | Natural Products |
| HY-N9728 | 3-Hydroxychimaphilin | 33253-99-5 | Natural Products |
| HY-N9729 | Ethyl chlorogenate | 425408-42-0 | Natural Products |
| HY-N9730 | Methyl 2α-hydroxyhardwickiate | 50428-93-8 | Natural Products |
| HY-N9732 | 3,4-Dihydroxy-2-methoxyxanthone | 6702-55-2 | Natural Products |
| HY-N9733 | 2-Methoxyanofinic acid | 179457-70-6 | Natural Products |
| HY-N9734 | 3α-Cinnamoyloxy-9β,17-dihydroxy-ent-kaur-15-en-19-oic acid | 2186648-60-0 | Natural Products |
| HY-N9735 | 8-Hydroxy-9,10-diisobutyryloxythymol | 22518-08-7 | Natural Products |
| HY-N9736 | 6,4'-Dihydroxy-7-methoxyflavanone | 189689-32-5 | Natural Products |
| HY-N9737 | (−)-Acutumine | 17088-50-5 | Natural Products |
| HY-N9738 | 14β,16β-Dihydroxy-3β-(β-D-glucopyranosyloxy)-5α-bufa-20,22-dienolide | 1323952-04-0 | Natural Products |
| HY-N9739 | (2S)-6,4'-Dihydroxy-7-methoxyflavan | 202463-50-1 | Natural Products |
| HY-N9744 | Polypodine B 20,22-acetonide | 159858-85-2 | Natural Products |
| HY-N9746 | (R)-4-Methoxydalbergione | 4646-86-0 | Natural Products |
| HY-N9747 | Alnusonol | 52330-12-8 | Natural Products |
| HY-N9751 | β-Guaiene | 88-84-6 | Natural Products |
| HY-N9753 | Tsukubamycin B | 104987-30-6 | Natural Products |
| HY-N9755 | 1-O-Methylemodin | 3775-08-4 | Natural Products |
| HY-N9758 | Hedysarimcoumestan B | 899436-04-5 | Natural Products |
| HY-N9760 | Dictysine | 67256-05-7 | Natural Products |
| HY-N9761 | Murrayanine | 723-97-7 | Natural Products |
| HY-N9763 | Cinchonain Ib | 85022-69-1 | Natural Products |
| HY-N9766 | Jasminoside | 82451-18-1 | Natural Products |
| HY-N9768 | (10E,12E)-9-Oxo-10,12-octadecadienoic acid | 54232-58-5 | Natural Products |
| HY-N9769 | (+)-Dalbergiphenol | 82358-44-9 | Natural Products |
| HY-N9774 | (3β,20S)-Pregn-5-ene-3,17,20-triol | 903-67-3 | Natural Products |
| HY-N9775 | 3'',4''-Di-O-p-Coumaroylquercitrin | 437615-43-5 | Natural Products |
| HY-N9777 | Procyanidin B-5 3,3'-di-O-gallate | 106533-60-2 | Natural Products |
| HY-N9780 | Cinnamolide | 23599-47-5 | Natural Products |
| HY-N9781 | Cassamedine | 16408-75-6 | Natural Products |
| HY-N9785 | 1-O-trans-p-Coumaroylglycerol | 106055-11-2 | Natural Products |
| HY-N9786 | Phoyunbene C | 886747-63-3 | Natural Products |
| HY-N9787 | 16-Hentriacontanone | 502-73-8 | Natural Products |
| HY-N9788 | 3′,3′′′-Binaringenin | 145399-99-1 | Natural Products |
| HY-N9790 | Procyanidin B2 3,3'-di-O-gallate | 79907-44-1 | Natural Products |
| HY-N9791 | Rubanthrone A | 441764-20-1 | Natural Products |
| HY-N9792 | 7-Ketoisodrimenin | 73036-54-1 | Natural Products |
| HY-N9793 | Dehydrojuncuenin B | 1161681-28-2 | Natural Products |
| HY-N9794 | Isoboldine | 3019-51-0 | Natural Products |
| HY-N9795 | (+)-Maackiain | 23513-53-3 | Natural Products |
| HY-N9796 | Lycernuic ketone C | 53800-21-8 | Natural Products |
| HY-N9798 | Ugandenial A | 1175880-15-5 | Natural Products |
| HY-N9802 | n-Butyl-β-D-fructofuranoside | 80971-60-4 | Natural Products |
| HY-N9803 | Taxilluside A | 1661914-46-0 | Natural Products |
| HY-N9806 | 3',3'''-Biapigenin | 151455-26-4 | Natural Products |
| HY-N9810 | Jasamplexoside C | 147742-02-7 | Natural Products |
| HY-N9811 | Hydroxytyrosol 4-O-glucoside | 54695-80-6 | Natural Products |
| HY-N9812 | 2,3-Dimethoxyxanthone | 42833-49-8 | Natural Products |
| HY-N9813 | 1-(3,4,5-Trihydroxypentanoyl)-β-carboline | 180995-40-8 | Natural Products |
| HY-N9814 | Shanciol B | 208106-53-0 | Natural Products |
| HY-N9818 | 10-Hydroxyligstroside | 35897-94-0 | Natural Products |
| HY-N9820 | Linaroside | 53452-12-3 | Natural Products |
| HY-N9823 | Leeaoside | 1015063-56-5 | Natural Products |
| HY-N9824 | 10-Hydroxyoleoside dimethyl ester | 91679-27-5 | Natural Products |
| HY-N9825 | Delicaflavone | 343569-15-3 | Natural Products |
| HY-N9828 | Lantanilic acid | 60657-41-2 | Natural Products |
| HY-N9829 | Methyl lucidenate E2 | 98665-12-4 | Natural Products |
| HY-N9830 | 7β-Hydroxycucurbitacin B | 1135141-79-5 | Natural Products |
| HY-N9834 | Aureusidin | 38216-54-5 | Natural Products |
| HY-N9837 | Methyl lucidenate L | 110267-46-4 | Natural Products |
| HY-N9840 | (R)-Perillaldehyde | 5503-12-8 | Natural Products |
| HY-N9842 | Violanone | 52250-38-1 | Natural Products |
| HY-N9843 | Methyl ganoderenate D | 748136-03-0 | Natural Products |
| HY-N9847 | Phochinenin I | 1070883-77-0 | Natural Products |
| HY-N9849 | 8-Hydroxythymol | 4478-33-5 | Natural Products |
| HY-N9850 | Pomegralignan | 1562492-32-3 | Natural Products |
| HY-N9851 | 10-Hydroxyoleoside 11-methyl ester | 131836-11-8 | Natural Products |
| HY-N9852 | Cryptomerin B | 22012-98-2 | Natural Products |
| HY-N9853 | Methyl lucidenate A | 105742-79-8 | Natural Products |
| HY-N9854 | Icariside E4 | 126253-42-7 | Natural Products |
| HY-N9855 | Convallagenin B | 17934-59-7 | Natural Products |
| HY-N9856 | Juncusol 2-O-glucoside | 175094-14-1 | Natural Products |
| HY-N9857 | Betulinic acid palmitate | 19833-15-9 | Natural Products |
| HY-N9859 | 6,6'-Di-O-sinapoylsucrose | 1068661-35-7 | Natural Products |
| HY-N9860 | (9Z,11E)-13-Hydroxy-9,11-octadecadienoic acid ethyl ester | 947529-92-2 | Natural Products |
| HY-N9861 | Kayaflavone | 481-45-8 | Natural Products |
| HY-N9862 | Ethyl brevifolincarboxylate | 107646-82-2 | Natural Products |
| HY-N9863 | (7R,8R)-Dihydrodehydrodiconiferyl alcohol 9-O-β-D-glucoside | 351346-10-6 | Natural Products |
| HY-N9866 | Grasshopper ketone | 41703-38-2 | Natural Products |
| HY-N9867 | Gnetifolin E | 140671-07-4 | Natural Products |
| HY-N9871 | (6R,9S)-3-Oxo-α-ionol β-D-glucopyranoside | 159813-37-3 | Natural Products |
| HY-N9872 | Quercetin 4′-O-D-galactoside | 381728-34-3 | Natural Products |
| HY-N9873 | Hancinone | 104013-61-8 | Natural Products |
| HY-N9874 | 2,6-Dihydroxy-3-methyl4-methoxyacetophenone | 69480-06-4 | Natural Products |
| HY-N9875 | Juncusol 7-O-glucoside | 175094-15-2 | Natural Products |
| HY-N9879 | Thalibealine | 351531-39-0 | Natural Products |
| HY-N9880 | Tamarixin | 27542-39-8 | Natural Products |
| HY-N9881 | Heynic acid | 88478-14-2 | Natural Products |
| HY-N9882 | Petiolin F | 1204251-10-4 | Natural Products |
| HY-N9884 | (-)-Galbelgin | 10569-12-7 | Natural Products |
| HY-N9886 | Platanoside | 133740-25-7 | Natural Products |
| HY-N9887 | Magnosalin | 81861-74-7 | Natural Products |
| HY-N9888 | 1,6,2',3',6'-O-Pentaacetyl-3-O-trans-p-coumaroylsucrose | 138213-63-5 | Natural Products |
| HY-N9890 | 3-O-(6'-O-Galloyl)-β-D-glucopyranosylmaltol | 163397-38-4 | Natural Products |
| HY-N9891 | 12-Dehydrogingerdione | 99742-05-9 | Natural Products |
| HY-N9892 | Guttiferone G | 666174-75-0 | Natural Products |
| HY-N9895 | 3,5-Dicaffeoyl-epi-quinic acid | 879305-14-3 | Natural Products |
| HY-N9896 | Anhydronotoptol | 88206-51-3 | Natural Products |
| HY-N9897 | N-Benzylheptadecanamide | 883715-19-3 | Natural Products |
| HY-N9898 | Sinocrassoside C1 | 909803-26-5 | Natural Products |
| HY-N9900 | Demethyldaphnoretin-7-O-glucoside | 438578-91-7 | Natural Products |
| HY-N9902 | Rutinose | 90-74-4 | Biochemical Assay Reagents |
| HY-N9903 | Tetrahydrodehydrodiconiferyl alcohol | 5234-70-8 | Natural Products |
| HY-N9908 | 2-Oxopomolic acid | 54963-52-9 | Natural Products |
| HY-N9909 | 7,8,3',4'-Tetrahydroxyflavanone | 489-73-6 | Natural Products |
| HY-N9910 | Visamminol | 492-52-4 | Natural Products |
| HY-N9911 | 1,5-Anhydro-D-mannitol | 492-93-3 | Natural Products |
| HY-N9912 | Physalin D | 54980-22-2 | Natural Products |
| HY-N9914 | D-Psicose | 551-68-8 | Biochemical Assay Reagents |
| HY-N9914R | D-Psicose (Standard) | 551-68-8 | Reference Standards |
| HY-N9914S | D-Psicose-d | 53685-24-8 | Isotope-Labeled Compounds |
| HY-N9916 | 8,3′,4′-Trihydroxyflavone-7-O-β-D-glucopyranoside | 925701-05-9 | Natural Products |
| HY-N9917 | Galloylalbiflorin | 929042-36-4 | Natural Products |
| HY-N9919 | Glyasperin C | 142474-53-1 | Natural Products |
| HY-N9920 | Quercetin 7-O-rutinoside | 147714-62-3 | Natural Products |
| HY-N9921 | Antcin A | 163597-24-8 | Natural Products |
| HY-N9922 | Alashinol G | 58139-12-1 | Natural Products |
| HY-N9923 | 2-C-Methyl-D-erythritol 4-phosphate | 206440-72-4 | Natural Products |
| HY-N9924 | Glucoerucin | 21973-56-8 | Natural Products |
| HY-N9925 | Plantaginin | 26046-94-6 | Natural Products |
| HY-N9926 | Pluviatolide | 28115-68-6 | Natural Products |
| HY-N9928 | Echinenone | 432-68-8 | Natural Products |
| HY-N9929 | Docosane | 629-97-0 | Natural Products |
| HY-N9929R | Docosane (Standard) | 629-97-0 | Reference Standards |
| HY-N9929S | Docosane-d46 | 260411-88-9 | Isotope-Labeled Compounds |
| HY-N9930 | Effusanin B | 76470-16-1 | Natural Products |
| HY-N9933 | Tauro-β-muricholic acid | 25696-60-0 | Natural Products |
| HY-N9933S | Tauro-β-muricholic acid-d4-1 (sodium) | Isotope-Labeled Compounds | |
| HY-N9934 | (-)-3-Dehydroshikimic acid | 2922-42-1 | Biochemical Assay Reagents |
| HY-N9934R | (-)-3-Dehydroshikimic acid (Standard) | 2922-42-1 | Reference Standards |
| HY-N9936 | Saikosaponin S5 | 102934-42-9 | Natural Products |
| HY-N9941 | 2,8-Dihydroxyadenine | 30377-37-8 | Natural Products |
| HY-N9942 | Physalin A | 23027-91-0 | Natural Products |
| HY-N9944 | 3-Oxo-4,6-choladien-24-oic acid | 88179-71-9 | Natural Products |
| HY-N9944R | 3-Oxo-4,6-choladien-24-oic acid (Standard) | 88179-71-9 | Reference Standards |
| HY-N9945 | 3-Oxo-7-hydroxychol-4-enoic acid | 14772-95-3 | Natural Products |
| HY-N9947 | Methyl-6-gingerol | 23513-10-2 | Natural Products |
| HY-N9947A | (rac)-Methyl-6-gingerol | 61914-52-1 | Natural Products |
| HY-N9949 | Sparteine | 24915-04-6 | Natural Products |
| HY-N9950 | α-D-altro-3-Heptulofuranose | 25545-06-6 | Natural Products |
| HY-N9953 | Chrysophanol 8-O-β-D-(6′-O-galloyl)glucopyranoside | 266997-57-3 | Natural Products |
| HY-N9954 | Isoharringtonine | 26833-86-3 | Natural Products |
| HY-N9955 | Isonardosinone | 27062-01-7 | Natural Products |
| HY-N9959 | Isoengeletin | 30987-58-7 | Natural Products |
| HY-N9960 | α-Isopropylmalate | 3237-44-3 | Natural Products |
| HY-N9960R | α-Isopropylmalate (Standard) | 3237-44-3 | Reference Standards |
| HY-N9961 | 2-Hydroxyl emodin-1-methyl ether | 346434-45-5 | Natural Products |
| HY-N9965 | 2'-Fucosyllactose | 41263-94-9 | Natural Products |
| HY-N9966 | Sanggenol O | 426211-27-0 | Natural Products |
| HY-N9968 | Cucurbitacin C | 5988-76-1 | Natural Products |
| HY-N9969 | Lupulone C | 613683-50-4 | Natural Products |
| HY-N9971 | Hentriacontane | 630-04-6 | Natural Products |
| HY-N9971R | Hentriacontane (Standard) | 630-04-6 | Reference Standards |
| HY-N9973 | Malabaricone A | 63335-23-9 | Natural Products |
| HY-N9974 | Lappaol C | 64855-00-1 | Natural Products |
| HY-N9975 | 4'',5''-Dehydroisopsoralidin | 65639-51-2 | Natural Products |
| HY-N9977 | Dihydrocatalpol | 6736-86-3 | Natural Products |
| HY-N9981 | 5β-Hydroxybufotalin | 74531-99-0 | Natural Products |
| HY-N9983 | Effusanin E | 76470-15-0 | Natural Products |
| HY-N9987 | 11β,13-Dihydrolactucin | 83117-63-9 | Natural Products |
| HY-N9989 | Brachyoside B | 86764-12-7 | Natural Products |
| HY-N9991 | 5-Hydroxy-3,7-dimethoxyflavone | 70786-48-0 | Natural Products |
| HY-N9994 | Pinofuranoxin A | Natural Products | |
| HY-N9995 | Methyl 11,14,17-eicosatrienoate | 55682-88-7 | Natural Products |
| HY-N9996 | Isohericerin | 140381-53-9 | Natural Products |
| HY-N9998 | Hirudonucleodisulfide A | 1072789-37-7 | Natural Products |
| HY-NP001 | Cationic Bovine Serum Albumin | Biochemical Assay Reagents | |
| HY-NP002 | BSA Standard Solution (5mg/mL) | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP002A | Goat Serum Albumin | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP002B | Rabbit Serum Albumin | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP002C | Rabbit Serum Albumin (globulin free) | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP002D | Bovine Serum Albumin (Biotinylated) | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP002E | Porcine Serum Albumin | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP002H | Porcine Serum Albumin (globulin free) | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP002I | Sheep Serum Albumin | 9048-46-8 | Biochemical Assay Reagents |
| HY-NP003 | Collagen, Type II, from bovine snout membrane | 9007-34-5 | Biochemical Assay Reagents |
| HY-NP004 | Cobra Venom Factor | Biochemical Assay Reagents | |
| HY-NP005 | Avidin, chiken egg white | 1405-69-2 | Biochemical Assay Reagents |
| HY-NP006 | Protein A | 308083-69-4 | Biochemical Assay Reagents |
| HY-NP007 | Myoglobin | 100684-32-0 | Biochemical Assay Reagents |
| HY-NP008 | β-Lactoglobulin | 9045-23-2 | Biochemical Assay Reagents |
| HY-NP009 | α-Lactalbumin | 9051-29-0 | Biochemical Assay Reagents |
| HY-NP010 | Collagen, rat tail | 9007-34-5 | Biochemical Assay Reagents |
| HY-NP011 | Holo-Human transferrin | Biochemical Assay Reagents | |
| HY-NP011A | Apo-Human transferrin (suitable for cell culture) | Biochemical Assay Reagents | |
| HY-NP012 | Low density lipoprotein (human) | Biochemical Assay Reagents | |
| HY-NP013 | Oxidized low density lipoprotein (mouse) | Biochemical Assay Reagents | |
| HY-NP0131 | Griffonia (Bandeiraea) Simplicifolia Lectin I (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0132 | Griffonia Simplicifolia Lectin I Isolectin B4 (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0133 | Jacalin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0134 | Lens Culinaris Agglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0135 | Lotus Tetragonolobus Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0136 | Lycopersicon esculentum (Tomato) Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0137 | Maackia Amurensis Lectin I (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0138 | Peanut Agglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0139 | Phaseolus Vulgaris Erythroagglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP014 | Protein A-PE | Biochemical Assay Reagents | |
| HY-NP0140 | Phaseolus Vulgaris Leucoagglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0141 | Ricinus Communis Agglutinin I (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0142 | Sambucus Nigra Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0143 | Soybean Agglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0144 | Succinylated Wheat Germ Agglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0145 | Ulex Europaeus Agglutinin I (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0146 | Vicia Villosa Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0147 | Wheat Germ Agglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0148 | Wisteria Floribunda Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0149 | Sambucus Nigra Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP015 | SLT/SLT-IIe (O139) protein | Biochemical Assay Reagents | |
| HY-NP0150 | Griffonia (Bandeiraea) Simplicifolia Lectin II (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0151 | Jacalin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0152 | Wheat Germ Agglutinin (Peroxidase) | Biochemical Assay Reagents | |
| HY-NP0153 | Concanavalin A (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP0154 | Dolichos Biflorus Agglutinin (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP0155 | Griffonia (Bandeiraea) Simplicifolia Lectin I (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP0156 | Peanut Agglutinin (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP0157 | Ricinus Communis Agglutinin I (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP0158 | Ulex Europaeus Agglutinin I (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP0159 | Wheat Germ Agglutinin (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP016 | Brucella bacterial protein | Biochemical Assay Reagents | |
| HY-NP0160 | Succinylated Wheat Germ Agglutinin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0161 | Galanthus Nivalis Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP0162 | Aleuria Aurantia Lectin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0163 | Erythrina Cristagalli Lectin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0164 | Galanthus Nivalis Lectin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0165 | Peanut Agglutinin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0166 | Sambucus Nigra Lectin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0167 | Soybean Agglutinin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0168 | Ulex Europaeus Agglutinin I (Agarose) | Biochemical Assay Reagents | |
| HY-NP0169 | Vicia Villosa Lectin (Agarose) | Biochemical Assay Reagents | |
| HY-NP017 | Prostate specific antigen protein (human) | Biochemical Assay Reagents | |
| HY-NP0170 | Wheat Germ Agglutinin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0171 | Wisteria Floribunda Lectin (Agarose) | Biochemical Assay Reagents | |
| HY-NP0172 | Ricinus Communis Agglutinin I (Agarose) | Biochemical Assay Reagents | |
| HY-NP0173 | Aleuria Aurantia Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0174 | Concanavalin A (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0175 | Datura Stramonium Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0176 | Dolichos Biflorus Agglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0177 | Erythrina Cristagalli Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0178 | Griffonia Simplicifolia Lectin I Isolectin B4 (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0179 | Jacalin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP018 | Bovine fibrinogen (from plasma) | Biochemical Assay Reagents | |
| HY-NP0180 | Lens Culinaris Agglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0181 | Maackia Amurensis Lectin II (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0182 | Peanut Agglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0183 | Phaseolus Vulgaris Erythroagglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0184 | Phaseolus Vulgaris Leucoagglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0185 | Pisum Sativum Agglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0186 | Ricinus Communis Agglutinin I (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0187 | Solanum Tuberosum (Potato) Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0188 | Soybean Agglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0189 | Succinylated Wheat Germ Agglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP019 | Agkistrodon halys batroxobin | Biochemical Assay Reagents | |
| HY-NP0190 | Ulex Europaeus Agglutinin I (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0191 | Vicia Villosa Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0192 | Wheat Germ Agglutinin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0193 | Wisteria Floribunda Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP0194 | C1q Protein (human) | Biochemical Assay Reagents | |
| HY-NP0194A | C1q Protein (Mouse) | Biochemical Assay Reagents | |
| HY-NP020 | E.coli DH-5 alpha Bacterial protein | Biochemical Assay Reagents | |
| HY-NP021 | Human D-dimer protein | Biochemical Assay Reagents | |
| HY-NP022 | Mycobacterium bovis bacterial protein | Biochemical Assay Reagents | |
| HY-NP023 | Lactoferrin (human) | Biochemical Assay Reagents | |
| HY-NP024 | Snake poison protein | Biochemical Assay Reagents | |
| HY-NP025 | E.coli Bacterial protein | Biochemical Assay Reagents | |
| HY-NP026 | Spirulina C-phycocyanin | Biochemical Assay Reagents | |
| HY-NP027 | Human Serum Albumin-Cy3 | Biochemical Assay Reagents | |
| HY-NP028 | Keyhole Limpet Hemocyanin-FITC | Biochemical Assay Reagents | |
| HY-NP029 | Human Serum Albumin-RBITC | Biochemical Assay Reagents | |
| HY-NP030 | Ovalbumin-PE | Biochemical Assay Reagents | |
| HY-NP031 | Human Serum Albumin-AF555 | Biochemical Assay Reagents | |
| HY-NP032 | Human Serum Albumin-Cy5 | Biochemical Assay Reagents | |
| HY-NP033 | Bovine Serum Albumin-HRP | Biochemical Assay Reagents | |
| HY-NP034 | Bovine Serum Albumin-AF350 | Biochemical Assay Reagents | |
| HY-NP035 | Ovalbumin-FITC | Biochemical Assay Reagents | |
| HY-NP036 | Pig Insulin-PE | Biochemical Assay Reagents | |
| HY-NP037 | Avidin-HRP | Biochemical Assay Reagents | |
| HY-NP038 | Bovine Serum Albumin-AF405 | Biochemical Assay Reagents | |
| HY-NP039 | Bovine Serum Albumin-APC | Biochemical Assay Reagents | |
| HY-NP040 | Bovine Serum Albumin-RBITC | Biochemical Assay Reagents | |
| HY-NP041 | Bovine Serum Albumin-PE | Biochemical Assay Reagents | |
| HY-NP042 | Protein A-Cy3 | Biochemical Assay Reagents | |
| HY-NP043 | Avidin-Cy3 | Biochemical Assay Reagents | |
| HY-NP044 | Concanacalin A-AF594 | Biochemical Assay Reagents | |
| HY-NP045 | Protein A-RBITC | Biochemical Assay Reagents | |
| HY-NP046 | Human Serum Albumin-Biotin | Biochemical Assay Reagents | |
| HY-NP047 | Bovine Serum Albumin-Cy7 | Biochemical Assay Reagents | |
| HY-NP048 | Bovine Serum Albumin-AF647 | Biochemical Assay Reagents | |
| HY-NP049 | Avidin-FITC | Biochemical Assay Reagents | |
| HY-NP050 | Human Serum Albumin-AF647 | Biochemical Assay Reagents | |
| HY-NP051 | Bovine Serum Albumin-FITC | Biochemical Assay Reagents | |
| HY-NP052 | Ovalbumin-Biotin | Biochemical Assay Reagents | |
| HY-NP053 | Ovalbumin-APC | Biochemical Assay Reagents | |
| HY-NP054 | Human Serum Albumin-APC | Biochemical Assay Reagents | |
| HY-NP055 | Ovalbumin-Cy5 | Biochemical Assay Reagents | |
| HY-NP056 | Ovalbumin-AF488 | Biochemical Assay Reagents | |
| HY-NP057 | Ovalbumin-AF555 | Biochemical Assay Reagents | |
| HY-NP058 | Ovalbumin-AF594 | Biochemical Assay Reagents | |
| HY-NP059 | Ovalbumin-AF647 | Biochemical Assay Reagents | |
| HY-NP060 | Human Serum Albumin-AF488 | Biochemical Assay Reagents | |
| HY-NP061 | Bovine Serum Albumin-AF750 | Biochemical Assay Reagents | |
| HY-NP062 | Bovine Serum Albumin-Cy5.5 | Biochemical Assay Reagents | |
| HY-NP063 | Aleuria Aurantia Lectin | Biochemical Assay Reagents | |
| HY-NP064 | Bauhinia Purpurea Lectin | Biochemical Assay Reagents | |
| HY-NP065 | Datura Stramonium Lectin | Biochemical Assay Reagents | |
| HY-NP066 | Erythrina Cristagalli Lectin | Biochemical Assay Reagents | |
| HY-NP067 | Galanthus Nivalis Lectin | Biochemical Assay Reagents | |
| HY-NP068 | Griffonia (Bandeiraea) Simplicifolia Lectin I | Biochemical Assay Reagents | |
| HY-NP069 | Griffonia (Bandeiraea) Simplicifolia Lectin II | Biochemical Assay Reagents | |
| HY-NP070 | Lotus tetragonolobus lectin | Biochemical Assay Reagents | |
| HY-NP071 | Lycopersicon esculentum (Tomato) Lectin | Biochemical Assay Reagents | |
| HY-NP072 | Maackia Amurensis Lectin I | Biochemical Assay Reagents | |
| HY-NP073 | Maackia Amurensis Lectin II | Biochemical Assay Reagents | |
| HY-NP074 | Maclura Pomifera Lectin | Biochemical Assay Reagents | |
| HY-NP075 | Narcissus Pseudonarcissus (Daffodil) Lectin | Biochemical Assay Reagents | |
| HY-NP076 | Phaseolus Vulgaris Erythroagglutinin | Biochemical Assay Reagents | |
| HY-NP077 | Phaseolus vulgaris leucoagglutinin | Biochemical Assay Reagents | |
| HY-NP077A | Phaseolus vulgaris Lectin-P | Biochemical Assay Reagents | |
| HY-NP077B | Phaseolus vulgaris Lectin-M | Biochemical Assay Reagents | |
| HY-NP078 | Pisum Sativum Agglutinin | Biochemical Assay Reagents | |
| HY-NP078A | Pisum Sativum Agglutinin (FITC) | Biochemical Assay Reagents | |
| HY-NP079 | Ricinus Communis Agglutinin I | Biochemical Assay Reagents | |
| HY-NP080 | Sambucus Nigra Lectin | Biochemical Assay Reagents | |
| HY-NP081 | Solanum Tuberosum (Potato) Lectin | Biochemical Assay Reagents | |
| HY-NP082 | Vicia Villosa Lectin | Biochemical Assay Reagents | |
| HY-NP083 | Wisteria Floribunda Lectin | Biochemical Assay Reagents | |
| HY-NP083A | Wisteria Floribunda Lectin (Biotin) | Biochemical Assay Reagents | |
| HY-NP084 | Dolichos Biflorus Agglutinin | Biochemical Assay Reagents | |
| HY-NP085 | Griffonia Simplicifolia Lectin I Isolectin B4 | Biochemical Assay Reagents | |
| HY-NP086 | Jacalin | Biochemical Assay Reagents | |
| HY-NP087 | Lens Culinaris Agglutinin | Biochemical Assay Reagents | |
| HY-NP089 | Soybean Agglutinin | Biochemical Assay Reagents | |
| HY-NP090 | Ulex Europaeus Agglutinin I | Biochemical Assay Reagents | |
| HY-NP090A | Ulex Europaeus Agglutinin I (peroxidase) | Biochemical Assay Reagents | |
| HY-NP091 | Wheat Germ Agglutinin | Biochemical Assay Reagents | |
| HY-NP092 | Sambucus Nigra Lectin (CY3) | Biochemical Assay Reagents | |
| HY-NP093 | Peanut Agglutinin (CY3) | Biochemical Assay Reagents | |
| HY-NP094 | Sambucus Nigra Lectin (CY5) | Biochemical Assay Reagents | |
| HY-NP095 | Aleuria Aurantia Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP096 | Concanavalin A (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP097 | Datura Stramonium Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP098 | Dolichos Biflorus Agglutinin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP099 | Erythrina Cristagalli Lectin (Fluorescein) | Biochemical Assay Reagents | |
| HY-NP101 | Highly purified Type I collagen, from bovine skin | Biochemical Assay Reagents | |
| HY-NP102 | Highly purified Type II collagen, from bovine articular cartilage | Biochemical Assay Reagents | |
| HY-NP103 | Highly purified Type III collagen, from bovine skin | Biochemical Assay Reagents | |
| HY-NP104 | Highly purified Type V collagen, from bovine amnion | Biochemical Assay Reagents | |
| HY-NP105 | Highly purified Type IX collagen, from bovine articular cartilage | Biochemical Assay Reagents | |
| HY-NP106 | Highly purified Type XI collagen, from bovine articular cartilage | Biochemical Assay Reagents | |
| HY-NP107 | Highly purified Type I collagen, from rat skin | Biochemical Assay Reagents | |
| HY-NP108 | Highly purified type II collagen, from rat sternal cartilage | Biochemical Assay Reagents | |
| HY-NP109 | Highly purified type I collagen, from mouse skin | Biochemical Assay Reagents | |
| HY-NP110 | Highly purified Type II collagen, from mouse sternal cartilage | Biochemical Assay Reagents | |
| HY-NP111 | Highly purified Type V collagen, from mouse intestine | Biochemical Assay Reagents | |
| HY-NP112 | Highly purified Type I collagen, from chick skin | Biochemical Assay Reagents | |
| HY-NP113 | Highly purified Type II collagen, from chick sternal cartilage | Biochemical Assay Reagents | |
| HY-NP114 | Highly purified Type IX collagen, from chick articular cartilage | Biochemical Assay Reagents | |
| HY-NP115 | Highly purified Type XI collagen, from chick articular cartilage | Biochemical Assay Reagents | |
| HY-NP116 | Highly purified Type I collagen, from human placenta | Biochemical Assay Reagents | |
| HY-NP117 | Highly purified Type II collagen, from human sternal cartilage | Biochemical Assay Reagents | |
| HY-NP118 | Highly purified Type III collagen, from human placenta | Biochemical Assay Reagents | |
| HY-NP119 | Highly purified Type V collagen, from human amnion | Biochemical Assay Reagents | |
| HY-NP120 | Highly purified Type V collagen, from human placenta | Biochemical Assay Reagents | |
| HY-NP121 | Highly purified Type XI collagen, from human sternal cartilage | Biochemical Assay Reagents | |
| HY-NP122 | Highly purified Type I collagen, from porcine skin | Biochemical Assay Reagents | |
| HY-NP123 | Highly purified Type II collagen, from porcine articular cartilage | Biochemical Assay Reagents | |
| HY-NP124 | Highly purified Type III collagen, from porcine skin | Biochemical Assay Reagents | |
| HY-NP125 | Highly purified Type IX collagen, from porcine articular cartilage | Biochemical Assay Reagents | |
| HY-NP126 | Highly purified Type XI collagen, from porcine articular cartilage | Biochemical Assay Reagents | |
| HY-NP127 | Highly purified Type I collagen, from canine skin | Biochemical Assay Reagents | |
| HY-NP128 | Highly purified Type I collagen, from rabbit skin | Biochemical Assay Reagents | |
| HY-NP129 | Highly purified Type II collagen, from sheep articular cartilage | Biochemical Assay Reagents | |
| HY-NP130 | Highly purified Type II collagen, from goat articular cartilage | Biochemical Assay Reagents | |
| HY-NP131 | Recombinant Humanized Type III Collagen (30-40kDa) | Biochemical Assay Reagents | |
| HY-NP132 | Recombinant Humanized Type III Collagen 28.6kDa | Biochemical Assay Reagents | |
| HY-NP132A | Recombinant humanized type III collagen (MW 55900) | Biochemical Assay Reagents | |
| HY-NP133A | NP-KLH,Type II | Biochemical Assay Reagents | |
| HY-NP134 | Flagellin from S. typhimurium | Biochemical Assay Reagents | |
| HY-NP135 | Oxidized low density lipoprotein (Human) | Biochemical Assay Reagents | |
| HY-NP136 | Myelin basic protein (human) | Natural Products | |
| HY-NP137 | NP-PE (Phycoerythrin) | Biochemical Assay Reagents | |
| HY-NP138 | NP-OVAL (Ovalbumin) | Biochemical Assay Reagents | |
| HY-NP139 | Mouse Laminin | Biochemical Assay Reagents | |
| HY-NP141 | NP-BSA | Biochemical Assay Reagents | |
| HY-NP142 | Methamphetamine-BSA | Biochemical Assay Reagents | |
| HY-NP143 | Nerve Growth Factor 2.5S,murine submaxillary gland | 93928-24-6 | Biochemical Assay Reagents |
| HY-NP144 | Nerve Growth Factor 7S,murine submaxillary gland | 93928-24-6 | Biochemical Assay Reagents |
| HY-NP145 | Epidermal Growth Factor,murine submaxillary gland | 62229-50-9 | Biochemical Assay Reagents |
| HY-NP146 | Peanut Agglutinin (CY5) | Biochemical Assay Reagents | |
| HY-NP147 | Phaseolus Vulgaris Leucoagglutinin (Rhodamine) | Biochemical Assay Reagents | |
| HY-NP148 | Lycopersicon esculentum (Tomato) Lectin (Biotin) | Biochemical Assay Reagents | |
| HY-NP149 | Galanthus Nivalis Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP150 | Maackia Amurensis Lectin I (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP151 | Griffonia Simplicifolia Lectin I (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP152 | Griffonia Simplicifolia Lectin II (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP153 | Lotus Tetragonolobus Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP154 | Narcissus Pseudonarcissus (Daffodil) Lectin (Biotinylated) | Biochemical Assay Reagents | |
| HY-NP155 | Histone (calf thymus) | 9064-47-5 | Biochemical Assay Reagents |
| HY-NP156 | Type I Collagen, for cell culture, from Bovine | Biochemical Assay Reagents | |
| HY-NP156A | Type I Collagen, for cell culture, from Porcine | Biochemical Assay Reagents | |
| HY-NP157 | Type I Collagen, T Cell Grade, from Bovine | Biochemical Assay Reagents | |
| HY-NP157A | Type I Collagen, T Cell Grade, from Chick | Biochemical Assay Reagents | |
| HY-NP157B | Type I Collagen, T Cell Grade, from Human | Biochemical Assay Reagents | |
| HY-NP157C | Type I Collagen, T Cell Grade, from Mouse | Biochemical Assay Reagents | |
| HY-NP157D | Type I Collagen, T Cell Grade, from Porcine | Biochemical Assay Reagents | |
| HY-NP157E | Type I Collagen, T Cell Grade, from Rat | Biochemical Assay Reagents | |
| HY-NP158 | Type II Collagen, T Cell Grade, from Bovine | Biochemical Assay Reagents | |
| HY-NP158A | Type II Collagen, T Cell Grade, from Chick | Biochemical Assay Reagents | |
| HY-NP158B | Type II Collagen, T Cell Grade, from Human | Biochemical Assay Reagents | |
| HY-NP158C | Type II Collagen, T Cell Grade, from Monkey | Biochemical Assay Reagents | |
| HY-NP158D | Type II Collagen, T Cell Grade, from Mouse | Biochemical Assay Reagents | |
| HY-NP158E | Type II Collagen, T Cell Grade, from Porcine | Biochemical Assay Reagents | |
| HY-NP158H | Type II Collagen, T Cell Grade, from Rat | Biochemical Assay Reagents | |
| HY-NP159 | House Dust Mite Extract, from D.farinae | Biochemical Assay Reagents | |
| HY-NP159A | House Dust Mite Extract, from D.pteronyssinus | Biochemical Assay Reagents | |
| HY-NP160 | Recombinant Humanized Type I Collagen | Biochemical Assay Reagents | |
| HY-NP161 | Mussel Adhesive Protein | Biochemical Assay Reagents | |
| HY-NP162 | Recombinant Humanized Type XVII Collagen | Biochemical Assay Reagents | |
| HY-NP163 | Wheat germ agglutinin-AF350 | Biochemical Assay Reagents | |
| HY-NP163A | Wheat germ agglutinin-AF488 | Biochemical Assay Reagents | |
| HY-NP163B | Wheat germ agglutinin-AF532 | Biochemical Assay Reagents | |
| HY-NP163C | Wheat germ agglutinin-AF555 | Biochemical Assay Reagents | |
| HY-NP163D | Wheat germ agglutinin-AF594 | Biochemical Assay Reagents | |
| HY-NP163E | Wheat germ agglutinin-AF647 | Biochemical Assay Reagents | |
| HY-NP163H | Wheat germ agglutinin-AF750 | Biochemical Assay Reagents | |
| HY-NP164 | Concanavalin A-HRP | Biochemical Assay Reagents | |
| HY-NP164A | Concanavalin A-Cy5.5 | Biochemical Assay Reagents | |
| HY-NP164B | Concanavalin A-AF488 | Biochemical Assay Reagents | |
| HY-NP165 | Advanced glycation end products | Biochemical Assay Reagents | |
| HY-NP166 | Fibrinogen from human plasma | Biochemical Assay Reagents | |
| HY-NP167 | Fibrinogen from rat plasma | Biochemical Assay Reagents | |
| HY-NP170 | Holo Transferrin (Bovine) | Biochemical Assay Reagents | |
| HY-NP171 | DSPE-PCB | Biochemical Assay Reagents | |
| HY-NP175 | Collagen (bovine skin) | 9064-67-9 | Biochemical Assay Reagents |
| HY-NP186 | Helix pomatia Agglutinin | Biochemical Assay Reagents | |
| HY-NP186A | Helix pomatia Agglutinin (Biotin) | Biochemical Assay Reagents | |
| HY-NP187 | Phytolacca americana Lectin | Biochemical Assay Reagents | |
| HY-NP188 | Lycopersicon esculentum (Tomato) Lectin (FITC) | Biochemical Assay Reagents | |
| HY-NP189 | Human Immunoglobulin G | Biochemical Assay Reagents | |
| HY-NP191 | Human Immunoglobulin M | Biochemical Assay Reagents | |
| HY-NP192 | Sericin | Biochemical Assay Reagents | |
| HY-O0004 | Collagenase I, from Clostridium histolyticum | 9001-12-1 | Enzyme |
| HY-P0001 | Thymus factor X | 78310-77-7 | Biochemical Assay Reagents |
| HY-P0002 | Protirelin | 24305-27-9 | Peptides |
| HY-P0002A | Protirelin (acetate) | 120876-23-5 | Peptides |
| HY-P0003 | Nesiritide | 124584-08-3 | Peptides |
| HY-P0003A | Nesiritide (acetate) | 1684439-46-0 | Peptides |
| HY-P0004 | Lysipressin | 50-57-7 | Peptides |
| HY-P0004A | Lysipressin (acetate) | 83968-49-4 | Peptides |
| HY-P0004R | Lysipressin (Standard) | 50-57-7 | Reference Standards |
| HY-P0006 | Eledoisin | 69-25-0 | Peptides |
| HY-P0007 | Elcatonin | 60731-46-6 | Peptides |
| HY-P0009 | Cetrorelix | 120287-85-6 | Peptides |
| HY-P0009A | Cetrorelix (Acetate) | 145672-81-7 | Peptides |
| HY-P0009B | Cetrorelix (diacetate) | 130143-01-0 | Peptides |
| HY-P0009S1 | Cetrorelix-d10 | Isotope-Labeled Compounds | |
| HY-P0012 | Aviptadil | 40077-57-4 | Peptides |
| HY-P0012A | Aviptadil (acetate) | 1444827-29-5 | Peptides |
| HY-P0013 | Antide | 112568-12-4 | Peptides |
| HY-P0013A | Antide (acetate) | 625092-10-6 | Peptides |
| HY-P0014 | Liraglutide | 204656-20-2 | Reference compound |
| HY-P0014A | Liraglutide (acetate) | 1997361-86-0 | Peptides |
| HY-P0014AS | Liraglutide-d8 (tetraTFA) | Isotope-Labeled Compounds | |
| HY-P0014S1 | Liraglutide-13C5,15N (TFA) | Isotope-Labeled Compounds | |
| HY-P0014S2 | Liraglutide-13C6,15N (TFA) | Isotope-Labeled Compounds | |
| HY-P0017 | Aprotinin | 9087-70-1 | Natural Products |
| HY-P0018 | Pepstatin | 26305-03-3 | Peptides |
| HY-P0018A | Pepstatin (Trifluoroacetate) | Peptides | |
| HY-P0018B | Pepstatin Ammonium | Peptides | |
| HY-P0018C | Pepstatin (acetate) | 28575-34-0 | Peptides |
| HY-P0018R | Pepstatin (Standard) | 26305-03-3 | Reference Standards |
| HY-P0019 | Z-Gly-Gly-Arg-AMC | 66216-78-2 | Dye Reagents |
| HY-P0019A | Z-Gly-Gly-Arg-AMC (acetate) | 2070009-61-7 | Dye Reagents |
| HY-P0019B | Z-Gly-Gly-Arg-AMC (TFA) | 66216-79-3 | Dye Reagents |
| HY-P0020 | Tos-Gly-Pro-Arg-ANBA-IPA | 99700-50-2 | Peptides |
| HY-P0020A | Tos-Gly-Pro-Arg-ANBA-IPA (acetate) | 2070009-46-8 | Peptides |
| HY-P0021 | D-Lys(Z)-Pro-Arg-pNA | 108963-69-5 | Dye Reagents |
| HY-P0021A | D-Lys(Z)-Pro-Arg-pNA (diacetate) | 108963-70-8 | Dye Reagents |
| HY-P0022 | pGlu-Pro-Arg-MNA | 130835-45-9 | Peptides |
| HY-P0022A | pGlu-Pro-Arg-MNA (monoacetate) | 2070009-26-4 | Peptides |
| HY-P0023 | Cyclo(-RGDfK) | 161552-03-0 | Peptides |
| HY-P0023A | Cyclo(-RGDfK) (TFA) | 500577-51-5 | Peptides |
| HY-P0024 | Veldoreotide | 252845-37-7 | Peptides |
| HY-P0024A | Veldoreotide (TFA) | 2126831-23-8 | Peptides |
| HY-P0025 | NIM811 | 143205-42-9 | Reference compound |
| HY-P0027 | Jasplakinolide | 102396-24-7 | Natural Products |
| HY-P0028 | Phalloidin | 17466-45-4 | Dye Reagents |
| HY-P0030 | 5-Tamra-DRVYIHP | Peptides | |
| HY-P0031 | Cyclo(RADfK) | 756500-23-9 | Peptides |
| HY-P0033 | Argireline | 616204-22-9 | Peptides |
| HY-P0033A | Argireline (acetate) | 2484708-86-1 | Peptides |
| HY-P0034 | Ac-DEVD-CMK | 285570-60-7 | Peptides |
| HY-P0034A | Ac-DEVD-CMK (TFA) | Peptides | |
| HY-P0035 | Insulin (human) | 11061-68-0 | Peptides |
| HY-P0035A | Insulin solution (human) | 11061-68-0 | Peptides |
| HY-P0036 | Octreotide | 83150-76-9 | Peptides |
| HY-P0036B | Octreotide (pamoate) | 135467-16-2 | Peptides |
| HY-P0036S2 | Octreotide-d8 | 1240797-41-4 | Isotope-Labeled Compounds |
| HY-P0036S3 | Octreotide-13C9,15N | Isotope-Labeled Compounds | |
| HY-P0036S4 | Octreotide-d8 (acetate) | Isotope-Labeled Compounds | |
| HY-P0037 | Org-30850 | 136208-71-4 | Peptides |
| HY-P0039 | BIM-26226 | 136207-23-3 | Peptides |
| HY-P0041 | F992 | 162277-99-8 | Peptides |
| HY-P0041A | F992 (TFA) | Peptides | |
| HY-P0045 | Palmitoyl pentapeptide 4 | 214047-00-4 | Peptides |
| HY-P0046 | Glycyl-L-histidyl-L-lysine | 49557-75-7 | Peptides |
| HY-P0047 | Palmitoyl Tripeptide-1 | 147732-56-7 | Peptides |
| HY-P0047A | Palmitoyl Tripeptide-1 (hydrochloride) | 2757690-14-3 | Peptides |
| HY-P0048 | (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH | 52435-06-0 | Peptides |
| HY-P0049 | Argipressin | 113-79-1 | Peptides |
| HY-P0049A | Argipressin (diacetate) | 75499-44-4 | Peptides |
| HY-P0051 | Lecirelin | 61012-19-9 | Peptides |
| HY-P0052 | Enfuvirtide | 159519-65-0 | Peptides |
| HY-P0052A | Enfuvirtide (acetate) | 914454-00-5 | Peptides |
| HY-P0053 | Fertirelin | 38234-21-8 | Peptides |
| HY-P0053A | Fertirelin (acetate) | 66002-66-2 | Peptides |
| HY-P0054 | GLP-1(7-36), amide (acetate) | 1119517-19-9 | Peptides |
| HY-P0054A | GLP-1(7-36), amide | 107444-51-9 | Peptides |
| HY-P0054B | GLP-1(7-36), amide (TFA) | Peptides | |
| HY-P0055 | GLP-1(7-37) | 106612-94-6 | Peptides |
| HY-P0055A | GLP-1(7-37) (acetate) | 1450806-98-0 | Peptides |
| HY-P0056 | Histrelin | 76712-82-8 | Peptides |
| HY-P0056A | Histrelin (acetate) | 220810-26-4 | Peptides |
| HY-P0058 | Pramlintide | 151126-32-8 | Peptides |
| HY-P0058A | Pramlintide (TFA) | Peptides | |
| HY-P0058B | Pramlintide (acetate) | 187887-46-3 | Peptides |
| HY-P0059 | Teriparatide | 52232-67-4 | Reference compound |
| HY-P0059A | Teriparatide (acetate hydrate) | 99294-94-7 | Reference compound |
| HY-P0060 | Tetracosactide | 16960-16-0 | Peptides |
| HY-P0060A | Tetracosactide (acetate) | 60189-34-6 | Peptides |
| HY-P0061 | Vapreotide | 103222-11-3 | Peptides |
| HY-P0061A | Vapreotide (acetate) | 849479-74-9 | Peptides |
| HY-P0061B | Vapreotide (diacetate) | 936560-75-7 | Peptides |
| HY-P0062 | Ziconotide | 107452-89-1 | Peptides |
| HY-P0062A | Ziconotide (TFA) | Peptides | |
| HY-P0062B | Ziconotide (acetate) | 914454-03-8 | Peptides |
| HY-P0063 | Copper tripeptide | 89030-95-5 | Peptides |
| HY-P0063A | Copper tripeptide (acetate) | 300801-03-0 | Peptides |
| HY-P0064 | Palmitoyl Tetrapeptide-3 | 221227-05-0 | Peptides |
| HY-P0065 | Acetyl octapeptide-1 | 868844-74-0 | Peptides |
| HY-P0066 | Contulakin G | 229180-41-0 | Peptides |
| HY-P0068 | Aminocandin | 227472-48-2 | Peptides |
| HY-P0069 | D-JNKI-1 | 1445179-97-4 | Peptides |
| HY-P0069A | L-JNKI-1 | Peptides | |
| HY-P0070 | Thymus peptide C | 316791-23-8 | Peptides |
| HY-P0072 | Microcystin-LR | 101043-37-2 | Natural Products |
| HY-P0073 | Tyr-Gly-Gly-Phe-Met-OH | 58569-55-4 | Peptides |
| HY-P0074 | GPRP | 67869-62-9 | Peptides |
| HY-P0074A | GPRP (acetate) | 157009-81-9 | Peptides |
| HY-P0076 | TAK-448 | 1234319-68-6 | Peptides |
| HY-P0076A | TAK-448 (acetate) | 1470374-22-1 | Peptides |
| HY-P0078 | TRAP-6 | 141136-83-6 | Peptides |
| HY-P0079 | Neuromedin N | 92169-45-4 | Peptides |
| HY-P0080 | Novokinin | 358738-77-9 | Peptides |
| HY-P0080A | Novokinin (TFA) | 1262750-59-3 | Peptides |
| HY-P0081 | Bax inhibitor peptide V5 | 579492-81-2 | Reference compound |
| HY-P0082 | Glucagon (1-29), bovine, human | 16941-32-5 | Peptides |
| HY-P0082A | Glucagon (1-29), bovine, human (hydrochloride) | 28270-04-4 | Peptides |
| HY-P0082F | Glucagon (1-29), FAM-labeled | Peptides | |
| HY-P0083 | Ornipressin | 3397-23-7 | Peptides |
| HY-P0083A | Ornipressin (acetate) | 914453-98-8 | Peptides |
| HY-P0084 | Cyclic somatostatin | 38916-34-6 | Peptides |
| HY-P0084R | Cyclic somatostatin (Standard) | 38916-34-6 | Reference Standards |
| HY-P0085 | Splenopentin (diacetate) | 105184-37-0 | Peptides |
| HY-P0088 | Porcine dynorphin A(1-13) | 72957-38-1 | Peptides |
| HY-P0089 | Human growth hormone-releasing factor | 83930-13-6 | Peptides |
| HY-P0089A | Human growth hormone-releasing factor (TFA) | Peptides | |
| HY-P0090 | Calcitonin (salmon) | 47931-85-1 | Peptides |
| HY-P0090A | Calcitonin (salmon) (acetate) | 158000-61-4 | Peptides |
| HY-P0090S | Calcitonin-13C6,15N4 (salmon) (TFA) | Isotope-Labeled Compounds | |
| HY-P0091 | Thymalfasin | 62304-98-7 | Peptides |
| HY-P0092 | Cecropin B | 80451-05-4 | Peptides |
| HY-P0093 | Sincalide | 25126-32-3 | Peptides |
| HY-P0093A | Sincalide (ammonium) | 70706-98-8 | Peptides |
| HY-P0095 | Acetyl tetrapeptide-5 | 820959-17-9 | Peptides |
| HY-P0096 | Decapeptide-12 | 137665-91-9 | Peptides |
| HY-P0097 | Nonapeptide-1 | 158563-45-2 | Peptides |
| HY-P0097A | Nonapeptide-1 (acetate salt) | Peptides | |
| HY-P0098 | [D-Ala2]leucine-enkephalin | 64963-01-5 | Peptides |
| HY-P0099 | Pentapeptide-3 | 135679-88-8 | Peptides |
| HY-P0100 | AHK | 126828-32-8 | Peptides |
| HY-P0101A | Palmitoyl dipeptide-5 diaminohydroxybutyrate | 794590-33-3 | Peptides |
| HY-P0102 | Dipeptide diaminobutyroyl benzylamide (diacetate) | 823202-99-9 | Peptides |
| HY-P0103 | Myristoyl pentapeptide-17 | 959610-30-1 | Peptides |
| HY-P0104 | Palmitoyl tripeptide-38 | 1447824-23-8 | Peptides |
| HY-P0107 | RC-3095 | 138147-78-1 | Peptides |
| HY-P0107A | RC-3095 (TFA) | 1217463-61-0 | Peptides |
| HY-P0108 | Angiotensin II 5-valine | 58-49-1 | Peptides |
| HY-P0109 | (S,S)-Z-FA-FMK | 105637-38-5 | Peptides |
| HY-P0109A | Z-FA-FMK | 197855-65-5 | Reference compound |
| HY-P0110 | (Iso)-Z-VAD(OMe)-FMK | 634911-81-2 | Peptides |
| HY-P0111 | Z-WEHD-FMK | 210345-00-9 | Peptides |
| HY-P0117 | Tat-NR2B9c | 500992-11-0 | Peptides |
| HY-P0117A | Tat-NR2B9c (TFA) | 1834571-04-8 | Peptides |
| HY-P0118 | Disitertide | 272105-42-7 | Peptides |
| HY-P0118A | Disitertide (TFA) | Peptides | |
| HY-P0118B | Disitertide (diammonium) | Peptides | |
| HY-P0119 | Lixisenatide | 320367-13-3 | Peptides |
| HY-P0119A | Lixisenatide (acetate) | 1997361-87-1 | Peptides |
| HY-P0120 | Dulaglutide | 923950-08-7 | Peptides |
| HY-P0121 | ReACp53 | Peptides | |
| HY-P0122 | iRGD peptide | 1392278-76-0 | Peptides |
| HY-P0122B | iRGD peptide 1 (TFA) | Peptides | |
| HY-P0123 | SPACE peptide | 1621717-95-0 | Peptides |
| HY-P0125 | Elamipretide | 736992-21-5 | Peptides |
| HY-P0125A | Elamipretide (TFA) | 1606994-55-1 | Peptides |
| HY-P0125B | Elamipretide (triacetate) | 1849610-71-4 | Peptides |
| HY-P0128 | β-Amyloid (25-35) | 131602-53-4 | Peptides |
| HY-P0128A | β-Amyloid (25-35), HFIP-treated | 131602-53-4 | Peptides |
| HY-P0128F | FITC-β-Amyloid (25-35) | Peptides | |
| HY-P0128F1 | FITC-β-Ala-β-Amyloid (25-35） | Peptides | |
| HY-P0129 | PLP (139-151) | 131334-43-5 | Peptides |
| HY-P0131 | Laminin (925-933) | 110590-60-8 | Peptides |
| HY-P0131A | Laminin (925-933)(TFA) | 2828432-44-4 | Peptides |
| HY-P0132 | YIGSR | 110590-64-2 | Peptides |
| HY-P0133 | (Arg)9 | 143413-47-2 | Peptides |
| HY-P0133A | (Arg)9 (TFA) | 2283335-13-5 | Peptides |
| HY-P0133B | (Arg)9 (acetate) | Peptides | |
| HY-P0135 | Penta lysine | 19431-21-1 | Peptides |
| HY-P0136 | SAMS | 125911-68-4 | Peptides |
| HY-P0136AF | FAM-SAMS (TFA) | Peptides | |
| HY-P0136F | FAM-SAMS | Peptides | |
| HY-P0137 | CEF1, Influenza Matrix Protein M1 (58-66) | 141368-69-6 | Peptides |
| HY-P0138 | MART-1 (26-35) (human) | 156251-01-3 | Peptides |
| HY-P0138A | MART-1 (26-35) (human) (TFA) | Peptides | |
| HY-P0139 | Gap 27 | 198284-64-9 | Peptides |
| HY-P0141 | Akt/SKG Substrate Peptide | 276680-69-4 | Peptides |
| HY-P0141A | Akt/SKG Substrate Peptide (TFA) | Peptides | |
| HY-P0142 | DT-3 | 329306-46-9 | Peptides |
| HY-P0142A | DT-3 (acetate) | Peptides | |
| HY-P0143 | Leucylarginylproline | 133943-59-6 | Peptides |
| HY-P0144 | Thrombospondin-1 (1016-1023) (human, bovine, mouse) | 149234-04-8 | Peptides |
| HY-P0148 | Gly6 | 3887-13-6 | Peptides |
| HY-P0148A | Gly6 (hydrochloride) | 71176-49-3 | Peptides |
| HY-P0149 | Katacalcin | 85916-47-8 | Peptides |
| HY-P0149A | Katacalcin (TFA) | Peptides | |
| HY-P0150 | Glucagon (19-29), human | 64790-15-4 | Peptides |
| HY-P0151 | SN50 | 213546-53-3 | Peptides |
| HY-P0154 | Epsilon-V1-2 | 182683-50-7 | Peptides |
| HY-P0162 | HCV-IN-4 | 2058080-25-2 | Peptides |
| HY-P0163 | Gramicidin | 1405-97-6 | Natural Products |
| HY-P0165 | Taspoglutide | 275371-94-3 | Peptides |
| HY-P0165B | Taspoglutide (acetate) | 1022150-16-8 | Peptides |
| HY-P0168 | Cibinetide | 1208243-50-8 | Peptides |
| HY-P0170 | TB500 | 885340-08-9 | Peptides |
| HY-P0171 | Motixafortide | 664334-36-5 | Peptides |
| HY-P0172 | ATI-2341 | 1337878-62-2 | Peptides |
| HY-P0172A | ATI-2341 (TFA) | Peptides | |
| HY-P0173 | Chlorotoxin(linear) | Peptides | |
| HY-P0173A | Chlorotoxin | 163515-35-3 | Peptides |
| HY-P0173B | Chlorotoxin (TFA) | Peptides | |
| HY-P0175 | 740 Y-P | 1236188-16-1 | Peptides |
| HY-P0175A | 740 Y-P (TFA) | Peptides | |
| HY-P0176 | PACAP (1-27), human, ovine, rat | 127317-03-7 | Peptides |
| HY-P0176A | PACAP (1-27), human, ovine, rat (TFA) | Peptides | |
| HY-P0177 | 123C4 | 2034159-30-1 | Peptides |
| HY-P0178 | LXW7 | 1313004-77-1 | Peptides |
| HY-P0178A | LXW7 (TFA) | Peptides | |
| HY-P0179 | β-Casomorphin, bovine | 72122-62-4 | Peptides |
| HY-P0179A | β-Casomorphin, bovine (TFA) | Peptides | |
| HY-P0181 | Microtubule-associated protein tau (26-44) | Peptides | |
| HY-P0182 | NH2-KLGADTDGEQDQHMTYGGQ-COOH | Peptides | |
| HY-P0183 | Nociceptin | 170713-75-4 | Peptides |
| HY-P0184 | Camstatin | 1002295-95-5 | Peptides |
| HY-P0184A | Camstatin (TFA) | Peptides | |
| HY-P0185 | Endomorphin 1 | 189388-22-5 | Peptides |
| HY-P0185A | Endomorphin 1 (acetate) | 1276123-71-7 | Peptides |
| HY-P0186 | Endomorphin 2 | 141801-26-5 | Peptides |
| HY-P0186A | Endomorphin 2 (TFA) | 1276124-00-5 | Peptides |
| HY-P0187 | Senktide | 106128-89-6 | Reference compound |
| HY-P0188 | ω-Conotoxin MVIIC | 147794-23-8 | Peptides |
| HY-P0188A | ω-Conotoxin MVIIC (TFA) | Peptides | |
| HY-P0189 | ω-Conotoxin GVIA | 106375-28-4 | Peptides |
| HY-P0189A | ω-Conotoxin GVIA (TFA) | Peptides | |
| HY-P0190 | Iberiotoxin | 129203-60-7 | Peptides |
| HY-P0190A | Iberiotoxin (TFA) | Peptides | |
| HY-P0191 | Charybdotoxin | 95751-30-7 | Peptides |
| HY-P0191A | Charybdotoxin (TFA) | Peptides | |
| HY-P0194 | NocII | 188119-47-3 | Peptides |
| HY-P0194A | NocII (TFA) | Peptides | |
| HY-P0195 | Bombesin | 31362-50-2 | Peptides |
| HY-P0196 | Cholecystokinin Octapeptide, desulfated | 25679-24-7 | Peptides |
| HY-P0196A | Cholecystokinin Octapeptide, desulfated (TFA) | 171486-94-5 | Peptides |
| HY-P0197 | Neurokinin A | 86933-74-6 | Peptides |
| HY-P0197A | Neurokinin A (TFA) | 2828433-19-6 | Peptides |
| HY-P0198 | Neuropeptide Y (human,rat,mouse) | 90880-35-6 | Peptides |
| HY-P0198A | Neuropeptide Y (human,rat,mouse) (TFA) | Peptides | |
| HY-P0198B | [D-Arg25]-Neuropeptide Y (human) | Peptides | |
| HY-P0199 | Pancreatic Polypeptide, human | 75976-10-2 | Peptides |
| HY-P0200 | RR-SRC | 81156-93-6 | Peptides |
| HY-P0201 | Substance P | 33507-63-0 | Peptides |
| HY-P0201A | Substance P (TFA) | 148470-19-3 | Peptides |
| HY-P0201AF | Substance P, FAM-labeled (TFA) | Peptides | |
| HY-P0201F | Substance P, FAM-labeled | Peptides | |
| HY-P0202 | Endothelin 1 (swine, human) | 117399-94-7 | Peptides |
| HY-P0202A | Endothelin 1 (swine, human) (TFA) | 394693-38-0 | Peptides |
| HY-P0203 | α-CGRP (mouse, rat) | 83651-90-5 | Peptides |
| HY-P0203A | α-CGRP (mouse, rat) (TFA) | Peptides | |
| HY-P0203B | β-CGRP (mouse) | Peptides | |
| HY-P0204 | Endothelin-3, human, mouse, rabbit, rat | 117399-93-6 | Peptides |
| HY-P0204A | Endothelin-3, human, mouse, rabbit, rat (TFA) | Peptides | |
| HY-P0205 | Saralasin | 34273-10-4 | Peptides |
| HY-P0205A | Saralasin (acetate hydrate) | 39698-78-7 | Peptides |
| HY-P0205B | Saralasin (TFA) | Peptides | |
| HY-P0206 | Bradykinin | 58-82-2 | Peptides |
| HY-P0206A | Bradykinin (acetate) | 6846-03-3 | Peptides |
| HY-P0206F | biotin-Bradykinin | 477319-71-4 | Peptides |
| HY-P0207 | Endothelin-2 (49-69), human | 123562-20-9 | Peptides |
| HY-P0207A | Endothelin-2 (49-69), human (TFA) | Peptides | |
| HY-P0208 | [Leu31,Pro34]-Neuropeptide Y (porcine) | 125580-28-1 | Peptides |
| HY-P0209 | Rat CGRP-(8-37) | 129121-73-9 | Peptides |
| HY-P0210 | DAMGO | 78123-71-4 | Peptides |
| HY-P0210B | DAMGO (TFA) | 950492-85-0 | Peptides |
| HY-P0211 | [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) | 93965-89-0 | Peptides |
| HY-P0212 | Neuropeptide Y, porcine | 83589-17-7 | Peptides |
| HY-P0212A | Neuropeptide Y, porcine (TFA) | Peptides | |
| HY-P0214 | Autocamtide-2-related inhibitory peptide | 167114-91-2 | Peptides |
| HY-P0214A | Autocamtide-2-related inhibitory peptide (TFA) | Peptides | |
| HY-P0215 | Autocamtide-2-related inhibitory peptide, myristoylated | 201422-04-0 | Peptides |
| HY-P0215A | Autocamtide-2-related inhibitory peptide, myristoylated (TFA) | Peptides | |
| HY-P0216 | A 779 | 159432-28-7 | Peptides |
| HY-P0217 | Microcystin-RR | 111755-37-4 | Peptides |
| HY-P0218 | Microcystin YR | 101064-48-6 | Peptides |
| HY-P0219 | Microcystin-LA | 96180-79-9 | Peptides |
| HY-P0220 | PACAP (6-38), human, ovine, rat | 143748-18-9 | Peptides |
| HY-P0220A | PACAP (6-38), human, ovine, rat (TFA) | Peptides | |
| HY-P0221 | PACAP (1-38), human, ovine, rat | 137061-48-4 | Peptides |
| HY-P0221A | PACAP (1-38), human, ovine, rat (TFA) | Peptides | |
| HY-P0221B | PACAP (1-38) free acid (TFA) | Peptides | |
| HY-P0221C | PACAP (1-38) free acid | 129405-61-4 | Peptides |
| HY-P0222 | PKI(5-24) | 99534-03-9 | Peptides |
| HY-P0222A | PKI(5-24) (TFA) | Peptides | |
| HY-P0223 | FLAG peptide | 98849-88-8 | Peptides |
| HY-P0223A | FLAG peptide (TFA) | Peptides | |
| HY-P0224 | N-Formyl-Met-Leu-Phe | 59880-97-6 | Peptides |
| HY-P0225 | Autocamtide 2 | 129198-88-5 | Peptides |
| HY-P0226 | TFLLR-NH2 | 197794-83-5 | Peptides |
| HY-P0226A | TFLLR-NH2(TFA) | 1313730-19-6 | Peptides |
| HY-P0227 | SHU 9119 | 168482-23-3 | Peptides |
| HY-P0228 | PKA RII peptide | 113873-67-9 | Peptides |
| HY-P0228A | PKA RII peptide (TFA) | Peptides | |
| HY-P0229 | Ribonuclease T1, Aspergillus oryzae | 9026-12-4 | Enzyme |
| HY-P0229A | Ribonuclease T1 (animal free) | 9026-12-4 | Enzyme |
| HY-P0230 | Teixobactin | 1613225-53-8 | Peptides |
| HY-P0231 | AZP-531 | 1088543-62-7 | Peptides |
| HY-P0232 | Fmoc-Thr[GalNAc(Ac)3-α-D]-OH | 116783-35-8 | Peptides |
| HY-P0233 | Melittin | 20449-79-0 | Peptides |
| HY-P0233A | Melittin (TFA) | Peptides | |
| HY-P0234 | Neurotensin | 39379-15-2 | Peptides |
| HY-P0235 | CDK2 | 255064-79-0 | Peptides |
| HY-P0236 | Neurokinin A(4-10) | 97559-35-8 | Peptides |
| HY-P0236A | Neurokinin A(4-10) (TFA) | Peptides | |
| HY-P0237 | KKI-5 | 97145-43-2 | Peptides |
| HY-P0237A | KKI-5 (TFA) | Peptides | |
| HY-P0238 | Gastrin-Releasing Peptide, human | 93755-85-2 | Peptides |
| HY-P0239 | HA Peptide | 92000-76-5 | Peptides |
| HY-P0239A | HA Peptide (TFA) | Peptides | |
| HY-P0240 | Tuftsin | 9063-57-4 | Peptides |
| HY-P0240A | Tuftsin (diacetate) | 72103-53-8 | Peptides |
| HY-P0241 | Neuromedin B | 87096-84-2 | Peptides |
| HY-P0242 | Neurokinin B | 86933-75-7 | Peptides |
| HY-P0242A | Neurokinin B (TFA) | 101536-55-4 | Peptides |
| HY-P0243 | Luteinizing Hormone Releasing Hormone (LH-RH), salmon | 86073-88-3 | Peptides |
| HY-P0244 | Dermorphin | 77614-16-5 | Peptides |
| HY-P0244A | Dermorphin (TFA) | 78331-26-7 | Peptides |
| HY-P0245 | Speract | 76901-59-2 | Peptides |
| HY-P0246 | Mastoparan | 72093-21-1 | Peptides |
| HY-P0248 | Kemptide | 65189-71-1 | Peptides |
| HY-P0248F | Kemptide, 5-FAM labeled | 1161072-61-2 | Peptides |
| HY-P0249 | Phe-Met-Arg-Phe, amide | 64190-70-1 | Peptides |
| HY-P0249A | Phe-Met-Arg-Phe amide (trifluoroacetate) | 159237-99-7 | Peptides |
| HY-P0249B | Phe-Met-Arg-Phe, amide (acetate) | 152165-14-5 | Peptides |
| HY-P0250 | Kassinin | 63968-82-1 | Peptides |
| HY-P0251 | Neurotensin(8-13) | 60482-95-3 | Peptides |
| HY-P0251A | Neurotensin(8-13) (TFA) | 2952825-79-3 | Peptides |
| HY-P0252 | α-MSH | 581-05-5 | Peptides |
| HY-P0252A | α-MSH (TFA) | 171869-93-5 | Peptides |
| HY-P0252B | α-MSH (free acid) | 10466-28-1 | Peptides |
| HY-P0253 | Xenopsin | 51827-01-1 | Peptides |
| HY-P0253A | Xenopsin (TFA) | Peptides | |
| HY-P0254 | Kisspeptin-10, human | 374675-21-5 | Peptides |
| HY-P0254A | Kisspeptin-10, human (TFA) | Peptides | |
| HY-P0255 | Physalaemin | 2507-24-6 | Natural Products |
| HY-P0256 | Apamin | 24345-16-2 | Peptides |
| HY-P0256A | Apamin (TFA) | Peptides | |
| HY-P0257 | Astressin | 170809-51-5 | Peptides |
| HY-P0258 | Mas7 | 145854-59-7 | Peptides |
| HY-P0259 | Xenin | 144092-28-4 | Peptides |
| HY-P0260 | p2Ca | 142606-55-1 | Peptides |
| HY-P0261 | Indolicidin | 140896-21-5 | Peptides |
| HY-P0261A | Indolicidin (acetate) | Peptides | |
| HY-P0261B | Indolicidin (TFA) | Peptides | |
| HY-P0262 | Galantide | 138579-66-5 | Reference compound |
| HY-P0262A | Galantide (TFA) | Peptides | |
| HY-P0263 | Dermaseptin | 136212-91-4 | Peptides |
| HY-P0263A | Dermaseptin (TFA) | 646451-06-1 | Peptides |
| HY-P0263R | Dermaseptin (Standard) | 136212-91-4 | Reference Standards |
| HY-P0264 | Exendin(9-39) amide | 133514-43-9 | Reference compound |
| HY-P0264A | Exendin(9-39) amide (acetate) | 2051593-46-3 | Peptides |
| HY-P0265A | β-Amyloid (1-40) (human) (TFA) | Peptides | |
| HY-P0265AS | β-Amyloid-15N (1-40) (TFA) | Isotope-Labeled Compounds | |
| HY-P0265F | Biotin-Ahx-β-Amyloid (1-40) | 1802086-72-1 | Peptides |
| HY-P0266 | N-Acetyl-Ser-Asp-Lys-Pro | 127103-11-1 | Peptides |
| HY-P0266A | N-Acetyl-Ser-Asp-Lys-Pro (TFA) | Peptides | |
| HY-P0266B | N-Acetyl-Ser-Asp-Lys-Pro (acetate) | Peptides | |
| HY-P0267 | Melanotan (MT)-II | 121062-08-6 | Peptides |
| HY-P0268 | Myomodulin | 110570-93-9 | Peptides |
| HY-P0269 | Magainin 1 | 108433-99-4 | Peptides |
| HY-P0269A | Magainin 1 (TFA) | Peptides | |
| HY-P0270 | Magainin 2 | 108433-95-0 | Peptides |
| HY-P0271 | Syntide 2 | 108334-68-5 | Peptides |
| HY-P0271A | Syntide 2 (TFA) | Peptides | |
| HY-P0272 | Peptide T | 106362-32-7 | Peptides |
| HY-P0272A | Peptide T (TFA) | 1610056-01-3 | Peptides |
| HY-P0273 | Histatin 5 | 115966-68-2 | Peptides |
| HY-P0273A | Histatin 5 (TFA) | Peptides | |
| HY-P0274 | PGLa | 102068-15-5 | Peptides |
| HY-P0274A | PGLa (TFA) | Peptides | |
| HY-P0275 | Proctolin | 57966-42-4 | Peptides |
| HY-P0276 | GIP, human | 100040-31-1 | Peptides |
| HY-P0276A | GIP, human (TFA) | Peptides | |
| HY-P0277 | Carcinoembryonic antigen peptide 1 | 168635-85-6 | Peptides |
| HY-P0278 | RGD | 99896-85-2 | Peptides |
| HY-P0278A | RGD (Trifluoroacetate) | 2378808-45-6 | Peptides |
| HY-P0279 | Systemin | 137181-56-7 | Peptides |
| HY-P0280 | MUC5AC motif peptide | 244049-41-0 | Peptides |
| HY-P0281 | TAT | 191936-91-1 | Peptides |
| HY-P0281A | TAT (TFA) | Peptides | |
| HY-P0282 | TAT peptide | Peptides | |
| HY-P0282A | TAT peptide (TFA) | Peptides | |
| HY-P0283 | Protease-Activated Receptor-2, amide | 190383-13-2 | Peptides |
| HY-P0284 | C-telopeptide | 162929-64-8 | Peptides |
| HY-P0285 | Rabies Virus Glycoprotein | Peptides | |
| HY-P0285A | Rabies Virus Glycoprotein (TFA) | Peptides | |
| HY-P0286 | OVA Peptide (323-339) | 92915-79-2 | Peptides |
| HY-P0286F | Biotin-OVA (323-339) | Peptides | |
| HY-P0286F1 | FITC-OVA (323-339) | Peptides | |
| HY-P0286F1A | FITC-OVA (323-339) (TFA) | Dye Reagents | |
| HY-P0287 | QL9 | 159646-83-0 | Peptides |
| HY-P0287A | QL9 (TFA) | Peptides | |
| HY-P0288 | [Leu5]-Enkephalin | 58822-25-6 | Peptides |
| HY-P0288A | [Leu5]-Enkephalin (TFA) | 73563-78-7 | Peptides |
| HY-P0289 | CEF3 | 199727-62-3 | Peptides |
| HY-P0290 | GRGDSP | 91037-75-1 | Peptides |
| HY-P0290A | GRGDSP (TFA) | Peptides | |
| HY-P0291 | Kemptide (Phospho-Ser5) | Peptides | |
| HY-P0293 | FMRF | 74012-06-9 | Peptides |
| HY-P0294 | Hexa-His | 64134-30-1 | Peptides |
| HY-P0294A | Hexa-His (TFA) | 1456728-20-3 | Peptides |
| HY-P0295 | Gly-Arg-Gly-Asp-Ser | 96426-21-0 | Peptides |
| HY-P0295A | Gly-Arg-Gly-Asp-Ser (TFA) | 2828433-23-2 | Peptides |
| HY-P0296 | Gly-Phe-Arg | 121822-47-7 | Peptides |
| HY-P0297 | Protease-Activated Receptor-4 | 245443-52-1 | Peptides |
| HY-P0298 | [Des-Arg9]-Bradykinin | 15958-92-6 | Peptides |
| HY-P0298A | [Des-Arg9]-Bradykinin (acetate) | 23827-91-0 | Peptides |
| HY-P0299 | LSKL, Inhibitor of Thrombospondin (TSP-1) | 283609-79-0 | Peptides |
| HY-P0299A | LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) | 2828433-17-4 | Peptides |
| HY-P0300 | Bak BH3 | 300349-67-1 | Peptides |
| HY-P0300F | Bak BH3 (72-87), TAMRA-labeled | Peptides | |
| HY-P0301 | SLLK, Control Peptide for TSP1 Inhibitor | 2918768-29-1 | Peptides |
| HY-P0301A | SLLK, Control Peptide for TSP1 Inhibitor(TFA) | Peptides | |
| HY-P0302 | HEX3 | 688805-40-5 | Peptides |
| HY-P0303 | Crustacean cardioactive peptide，free acid | 309247-84-5 | Peptides |
| HY-P0304 | CEF4 | 199727-68-9 | Peptides |
| HY-P0305 | PrP (106-126) | 148439-49-0 | Peptides |
| HY-P0306 | Fibronectin Adhesion-promoting Peptide | 125720-21-0 | Peptides |
| HY-P0306A | Fibronectin Adhesion-promoting Peptide (TFA) | Peptides | |
| HY-P0307 | Antennapedia Peptide | 188842-14-0 | Peptides |
| HY-P0307A | Antennapedia Peptide (TFA) | Peptides | |
| HY-P0308 | [Glu1]-Fibrinopeptide B | 103213-49-6 | Peptides |
| HY-P0309 | Arg-Gly-Glu-Ser | 93674-97-6 | Peptides |
| HY-P0309A | Arg-Gly-Glu-Ser (TFA) | Peptides | |
| HY-P0310 | SV40 large T antigen NLS | 163815-24-5 | Peptides |
| HY-P0311 | LAH4 | 184776-51-0 | Peptides |
| HY-P0311A | LAH4 (TFA) | Peptides | |
| HY-P0312 | c-Myc Peptide (TFA) | 2918768-02-0 | Peptides |
| HY-P0313 | CEF6 | 913545-15-0 | Peptides |
| HY-P0314 | Arg-Gly-Asp-Cys | 109292-46-8 | Peptides |
| HY-P0314A | Arg-Gly-Asp-Cys (TFA) | 2171504-22-4 | Peptides |
| HY-P0315 | Crosstide | 171783-05-4 | Peptides |
| HY-P0315F | Biotin-Crosstide | 923949-90-0 | Peptides |
| HY-P0316 | TP508 | 121341-81-9 | Peptides |
| HY-P0316A | TP508 (TFA) | Peptides | |
| HY-P0317 | Interleukin (IL)-6 Receptor | Peptides | |
| HY-P0318 | Hemorphin-7 | 152685-85-3 | Peptides |
| HY-P0319 | 3X FLAG peptide | 402750-12-3 | Peptides |
| HY-P0319A | 3X FLAG peptide (TFA) | Peptides | |
| HY-P0320 | EGF Receptor Substrate 2 (Phospho-Tyr5) | 149261-42-7 | Peptides |
| HY-P0320A | EGF Receptor Substrate 2 (Phospho-Tyr5) (TFA) | Peptides | |
| HY-P0320B | EGF Receptor Substrate 2 (Phospho-Tyr5) (acetate) | Peptides | |
| HY-P0321 | Asp-Asp-Asp-Asp-Asp | 124219-00-7 | Peptides |
| HY-P0322 | GRGDSPK | 111119-28-9 | Peptides |
| HY-P0322A | GRGDSPK (TFA) | Peptides | |
| HY-P0323 | GP(33-41) | 161928-86-5 | Peptides |
| HY-P0323A | GP(33-41) (TFA) | Peptides | |
| HY-P0324 | Parasin I | 219552-69-9 | Peptides |
| HY-P0324A | Parasin I (TFA) | Peptides | |
| HY-P0325 | V5 Epitope Tag Peptide (TFA) | Peptides | |
| HY-P0326 | S Tag Peptide | 7429-70-1 | Peptides |
| HY-P0327 | T7 Tag Peptide | 245445-88-9 | Peptides |
| HY-P0327A | T7 Tag Peptide (TFA) | Peptides | |
| HY-P0328 | VSV-G tag Peptide | 103425-05-4 | Peptides |
| HY-P0329 | X-press Tag Peptide | 339988-16-8 | Peptides |
| HY-P1000 | TRAP-14 | 137339-65-2 | Peptides |
| HY-P10000 | Peptide YY (PYY) (3-36), Human | 123583-37-9 | Peptides |
| HY-P10001 | Z-IETD-pNA | 348079-18-5 | Peptides |
| HY-P10002 | EWFW-ACC | Peptides | |
| HY-P10002A | EWFW-ACC (TFA) | Peptides | |
| HY-P10003 | iso-VQA-ACC | Peptides | |
| HY-P10003A | iso-VQA-ACC (TFA) | Peptides | |
| HY-P10003B | iso-VQA-ACC (acetate) | Peptides | |
| HY-P10004 | Z-Ala-Ala-Asp-CMK | 183284-21-1 | Peptides |
| HY-P10005 | D-Val-Gly-Arg-pNA | Peptides | |
| HY-P10006 | Leumorphin, human | 88846-98-4 | Peptides |
| HY-P10007 | Z-Gly-Pro-Phe-Leu-CHO | 159659-05-9 | Peptides |
| HY-P1001 | Ac-DEVD-CHO | 169332-60-9 | Reference compound |
| HY-P10012 | Pendetide | 148805-91-8 | Peptides |
| HY-P10013 | Codactide | 22572-04-9 | Peptides |
| HY-P10014 | Bibapcitide | 153507-46-1 | Peptides |
| HY-P10015 | Orenetide | 1124168-43-9 | Peptides |
| HY-P10018 | Bamadutide | 1596343-09-7 | Peptides |
| HY-P10019 | Pegsebrenatide | 2243292-26-2 | Peptides |
| HY-P1002 | Suc-Leu-Leu-Val-Tyr-AMC | 94367-21-2 | Dye Reagents |
| HY-P10020 | Alrefimotide | 1331848-79-3 | Peptides |
| HY-P10021 | Tapderimotide | 1221082-45-6 | Peptides |
| HY-P10022 | Riletamotide | 524061-04-9 | Peptides |
| HY-P10023 | Evuzamitide | 1420048-58-3 | Peptides |
| HY-P10025 | ω-Conotoxin CVID | 247207-64-3 | Peptides |
| HY-P10026 | Nisotirostide | 2663844-45-7 | Peptides |
| HY-P10027 | Clovibactin | 2247194-77-8 | Peptides |
| HY-P10027A | Clovibactin (TFA) | Peptides | |
| HY-P10028 | DC432 | 2388988-70-1 | Peptides |
| HY-P10029 | Sakura-6 | 2490708-79-5 | Peptides |
| HY-P1003 | Ac-DEVD-AMC | 169332-61-0 | Dye Reagents |
| HY-P10030 | DPLG3 | 1801379-22-5 | Peptides |
| HY-P10031 | SAR441255 | Peptides | |
| HY-P10031A | SAR441255 (TFA) | Peptides | |
| HY-P10032 | NN1177 | Peptides | |
| HY-P10032A | NN1177 (TFA) | Peptides | |
| HY-P10033 | SFTI-1 | 245080-24-4 | Peptides |
| HY-P10034 | Pheromonotropin (pseudaletia separata) | 141281-40-5 | Peptides |
| HY-P10035 | β Amyloid(28-35) human | 182945-56-8 | Peptides |
| HY-P10036 | G-Subtide | 910804-03-4 | Peptides |
| HY-P10037 | β Amyloid(17-28) human | Peptides | |
| HY-P10038 | mP6 | 2700321-79-3 | Peptides |
| HY-P10039 | β Amyloid (1-16) rat | 1123154-43-7 | Peptides |
| HY-P1004 | Luciferase | 9014-00-0 | Dye Reagents |
| HY-P10040 | (Gln22)β-Amyloid (1-40) human | Peptides | |
| HY-P10041 | Obestatin(11-23)mouse, rat | 938193-98-7 | Peptides |
| HY-P10042 | S6K Substrate | Peptides | |
| HY-P10043 | MMP-1 Substrate | 150956-93-7 | Peptides |
| HY-P10044 | IGF1Rtide | 172615-51-9 | Peptides |
| HY-P10045 | Integrin signaling inhibitor, mP13 | 1335046-19-9 | Peptides |
| HY-P10046 | [Deamino-Pen1,Val4,D-Arg8]-vasopressin | 64158-84-5 | Peptides |
| HY-P10047 | PKItide | 126370-52-3 | Peptides |
| HY-P10048 | TAT-JIP | 1623722-15-5 | Peptides |
| HY-P10049 | TAT-TCL1-Akt-in | 1073630-46-2 | Peptides |
| HY-P1004A | Luciferase, firefly | 61970-00-1 | Dye Reagents |
| HY-P1005 | Ac-DEVD-AFC | 201608-14-2 | Dye Reagents |
| HY-P10050 | Calpain substrate | 728005-83-2 | Peptides |
| HY-P10051 | Cyclorasin 9A5 | 1782098-79-6 | Peptides |
| HY-P10051A | Cyclorasin 9A5 (TFA) | Peptides | |
| HY-P10052 | CBO-P11 | 612096-46-5 | Peptides |
| HY-P10053 | sPLA2-IIA Inhibitor | 236394-37-9 | Peptides |
| HY-P10054 | SGKtide | 171782-99-3 | Peptides |
| HY-P10055 | PSMA targeting peptide | 2042750-71-8 | Peptides |
| HY-P10055A | PSMA targeting peptide (TFA) | Peptides | |
| HY-P10056 | HEP-1 | 174641-44-2 | Peptides |
| HY-P10057 | cpm-1285 | 300349-97-7 | Peptides |
| HY-P10058 | cpm-1285m | Peptides | |
| HY-P10059 | Boc-Val-Gly-Arg-βNA | 64309-42-8 | Peptides |
| HY-P1006 | Ac-DEVD-pNA | 189950-66-1 | Reference compound |
| HY-P10060 | Boc-Val-Gly-Arg-AMC | 113865-80-8 | Peptides |
| HY-P10061 | Cathepsin K inhibitor 4 | Peptides | |
| HY-P10062 | Hylambatin | 80890-46-6 | Peptides |
| HY-P10063 | Cionin | 126985-56-6 | Peptides |
| HY-P10064 | Akt Substrate | 312752-00-4 | Peptides |
| HY-P10065 | RKLLW-NH2 | 289480-71-3 | Peptides |
| HY-P10066 | Menin-MLL inhibitor 31 | 2863656-86-2 | Peptides |
| HY-P10068 | LAH5 | 476169-12-7 | Peptides |
| HY-P10068A | LAH5 (TFA) | Peptides | |
| HY-P10069 | Ac-pSar12-OH | 2313534-24-4 | Peptides |
| HY-P1007 | Z-VEID-FMK | 210344-96-0 | Peptides |
| HY-P10070 | Ac-pSar16-OH | Peptides | |
| HY-P10071 | CaMKII inhibitory peptide KIIN | 508181-45-1 | Peptides |
| HY-P10072 | MK2-IN-5 | 474713-20-7 | Peptides |
| HY-P10072A | MK2-IN-5 (acetate) | Peptides | |
| HY-P10073 | Calpain-1 substrate, fluorogenic | 636566-40-0 | Peptides |
| HY-P10074 | TAT-MEK1 | 566872-16-0 | Peptides |
| HY-P10076 | TAT-JBD20 | Peptides | |
| HY-P10077 | GL189 | 552337-94-7 | Peptides |
| HY-P10078 | pTH (39-84) (human) | 90880-43-6 | Peptides |
| HY-P10079 | Xenopus orexin A | 254757-77-2 | Peptides |
| HY-P1008 | Z-VDVAD-FMK | 210344-92-6 | Peptides |
| HY-P10080 | Xenopus orexin B | 254757-78-3 | Peptides |
| HY-P10081 | CTP-NBD | 1268513-27-4 | Peptides |
| HY-P10082 | Ac-VETD-AMC | 1135686-24-6 | Peptides |
| HY-P10083 | Ac-VQVD-pNA | 189684-55-7 | Peptides |
| HY-P10084 | Ac-VAD-pNA | 154564-07-5 | Peptides |
| HY-P10085 | PKC-ε translocation inhibitor peptide | Peptides | |
| HY-P10086 | TREM-1 inhibitory peptide GF9 | 1289375-12-7 | Peptides |
| HY-P10087 | Mouse TREM-1 SCHOOL peptide | 1292755-24-8 | Peptides |
| HY-P10088 | Mouse TREM-1 SCHOOL peptide, control | Peptides | |
| HY-P10089 | TREM-1 inhibitory peptide M3 | Peptides | |
| HY-P1008A | Z-VDVA-(DL-Asp)-FMK | 1926163-61-2 | Peptides |
| HY-P1009 | Z-YVAD-FMK | 210344-97-1 | Peptides |
| HY-P10090 | Apoptin-derived peptide | 2232156-31-7 | Peptides |
| HY-P10091 | CD24/Siglec-10 blocking peptide, CSBP | Peptides | |
| HY-P10092 | SP6 | Peptides | |
| HY-P10093 | Penetratin-PI3Kγ(126-150) | Peptides | |
| HY-P10094 | β-Ala-Gly-Arg-pNA | 858971-42-3 | Peptides |
| HY-P10095 | D-Val-Phe-Lys-CMK | 75590-17-9 | Peptides |
| HY-P10096 | STAT3-IN-22, negative control | 286465-27-8 | Peptides |
| HY-P10097 | Flt2₋11 | 329189-44-8 | Peptides |
| HY-P10098 | PKA Substrate | 121932-31-8 | Peptides |
| HY-P10099 | STAT3-IN-21, cell-permeable, negative control | 400628-17-3 | Peptides |
| HY-P1010 | Z-LEHD-FMK | 210345-04-3 | Peptides |
| HY-P10100 | RS Repeat peptide | Peptides | |
| HY-P10101 | APT STAT3, scrambled | Peptides | |
| HY-P10102 | Kp7-6 | 629628-53-1 | Peptides |
| HY-P10103 | Smac-N7 peptide | 401913-57-3 | Peptides |
| HY-P10104 | Smac-N7, Penetratin conjugated | Peptides | |
| HY-P10105 | TCL1(10-24) | 835655-37-3 | Peptides |
| HY-P10106 | TAT-PAK18 inhibitory peptide | Peptides | |
| HY-P10107 | TAT-PAK18 R192A | Peptides | |
| HY-P10108 | Hexokinase II VDAC binding domain peptide, cell-permeable | Peptides | |
| HY-P10109 | G6PI 325-339 (human) | 1174631-35-6 | Peptides |
| HY-P10109A | G6PI 325-339 (human) (hydrochloride) | Peptides | |
| HY-P1010A | Z-LEHD-FMK (TFA) | 524746-03-0 | Peptides |
| HY-P1011 | Neuropeptide Y (13-36), porcine | 113662-54-7 | Peptides |
| HY-P10110 | retro-inverso TAT-Beclin 1 (D-amino acid) | Peptides | |
| HY-P10111 | Histone H3K9me3 (1-15) | 951011-30-6 | Peptides |
| HY-P10111A | Histone H3K9me3 (1-15) (TFA) | Peptides | |
| HY-P10113 | STAT3-IN-23 | 286465-26-7 | Peptides |
| HY-P10114 | STAT3-IN-24, cell-permeable | 400628-16-2 | Peptides |
| HY-P10115 | APT STAT3 | 1345420-96-3 | Peptides |
| HY-P10116 | APTSTAT3-9R, scrambled | Peptides | |
| HY-P10117 | Cathepsin K inhibitor 5 | 448945-62-8 | Peptides |
| HY-P10118 | Cathepsin L-IN-3 | 478164-48-6 | Peptides |
| HY-P10119 | PDGFR Y1021 peptide (non-phosphorylation) | 205173-94-0 | Peptides |
| HY-P1012 | [Sar9,Met(O2)11]-Substance P | 110880-55-2 | Peptides |
| HY-P10126 | Osteocalcin, bovine | Peptides | |
| HY-P10128 | GE11 | 875142-25-9 | Peptides |
| HY-P1012A | [Sar9,Met(O2)11]-Substance P (TFA) | 2828433-10-7 | Peptides |
| HY-P1013 | Deltorphin 2 | 122752-16-3 | Peptides |
| HY-P10131 | 3BP-3940 | 2803421-14-7 | Peptides |
| HY-P10132 | PRDX3(103-112), human | 847447-01-2 | Peptides |
| HY-P10133 | PRDX3(103-112) SO3 modified, human | 847447-04-5 | Peptides |
| HY-P10134 | Salivaricin B | 335080-41-6 | Peptides |
| HY-P10135 | RES-701-1 | 151308-34-8 | Peptides |
| HY-P10136 | IA9 | Peptides | |
| HY-P10136A | IA9 (TFA) | Peptides | |
| HY-P10137 | Satoreotide | 1801415-23-5 | Peptides |
| HY-P10138 | human GIP(3-30), amide | 1884226-05-4 | Peptides |
| HY-P10138A | human GIP(3-30), amide (TFA) | Peptides | |
| HY-P10139 | Dnp-PLGLWAr-NH2 | 121282-17-5 | Peptides |
| HY-P1013A | Deltorphin 2 (TFA) | Peptides | |
| HY-P1014 | HCGRP-(8-37) | 119911-68-1 | Peptides |
| HY-P10140 | JNK-IN-15, Cell-Permeable | Peptides | |
| HY-P10141 | JNK-IN-15, Cell-Permeable, Negative Control | Peptides | |
| HY-P10142 | Ac-YEVD-AMC | 1631716-11-4 | Peptides |
| HY-P10143 | MMP-2/MMP-9 Substrate | 98992-65-5 | Peptides |
| HY-P10144 | Ac-Orn-Phe-Arg-AMC | Peptides | |
| HY-P10145 | Ac-LEVD-pNA | 189684-49-9 | Peptides |
| HY-P10146 | Ac-LETD-CHO | Peptides | |
| HY-P10147 | Ac-LDESD-AMC | Peptides | |
| HY-P10148 | N-Acetyl [Leu28, Leu31] neuropeptide Y (24–36) | 155709-24-3 | Peptides |
| HY-P10149 | Ac-IEPD-CHO | 352520-90-2 | Peptides |
| HY-P1015 | VIP(Guinea pig) | 96886-24-7 | Peptides |
| HY-P10150 | IN-2-LF | 749879-64-9 | Peptides |
| HY-P10151 | PD 156252 | 175592-65-1 | Peptides |
| HY-P10152 | INF7 | 185462-59-3 | Peptides |
| HY-P10153 | gH625 | 1360823-60-4 | Peptides |
| HY-P10155 | VT5 | 352653-12-4 | Peptides |
| HY-P10156 | MAP17 | 1613241-14-7 | Peptides |
| HY-P10157 | ARF(1-22) | 1027629-94-2 | Peptides |
| HY-P10158 | PMAP-36 | 154338-08-6 | Peptides |
| HY-P10159 | DJK-5 | 1809102-71-3 | Peptides |
| HY-P1015A | VIP(Guinea pig) (TFA) | Peptides | |
| HY-P1016 | BQ-3020 | 143113-45-5 | Peptides |
| HY-P10160 | Cathelicidin-2 (chicken) | 1149347-67-0 | Peptides |
| HY-P10161 | Ac-DMQD-pNA | 907589-02-0 | Peptides |
| HY-P10162 | Ac-DMQD-AMC | 355137-38-1 | Peptides |
| HY-P10163 | α-Secretase Substrate II, Fluorogenic | Peptides | |
| HY-P10164 | Pen-N3 | Peptides | |
| HY-P10165 | MLCK Peptide | 209251-64-9 | Peptides |
| HY-P10166 | MLCK Peptide, control | 209251-66-1 | Peptides |
| HY-P10167 | 11R-CaN-AID | 650603-03-5 | Peptides |
| HY-P10168 | 11R-CaN-CON | Peptides | |
| HY-P10169 | Acetyl-Calpastatin(184-210)(human), Negative Control | Peptides | |
| HY-P1016B | BQ-3020 (ammonium) | Peptides | |
| HY-P1017 | MDL 29913 | 135721-56-1 | Peptides |
| HY-P10172 | Abz-SDK(Dnp)P-OH | 860313-53-7 | Peptides |
| HY-P10173 | Abz-LFK(Dnp)-OH | 1217437-30-3 | Peptides |
| HY-P10174 | ADAM-17 Substrate | Peptides | |
| HY-P10174A | ADAM-17 Substrate (TFA) | Peptides | |
| HY-P10175 | Acetalin-1 | 152274-67-4 | Peptides |
| HY-P10176 | Acetalin-2 | 152274-66-3 | Peptides |
| HY-P10177 | Acetalin-3 | 152274-65-2 | Peptides |
| HY-P10178 | Myristoylated ARF6 (2-13) | Peptides | |
| HY-P10179 | ARF6 (2-13) | 1026775-53-0 | Peptides |
| HY-P1018 | IRL 1038 | 144602-02-8 | Peptides |
| HY-P10180 | β-Amyloid/A4 Protein Precusor (319-335) | 148914-01-6 | Peptides |
| HY-P10181 | Acetyl angiotensinogen (1-14), human | 104180-27-0 | Peptides |
| HY-P10182 | Angiotensin III antipeptide | 133605-55-7 | Peptides |
| HY-P10183 | CD36 Peptide P (139-155), Cys conjugated | 143257-74-3 | Peptides |
| HY-P10184 | CD36 Peptide P (93-110), Cys conjugated | 143257-75-4 | Peptides |
| HY-P10185 | Antiflammin 3 | 118850-73-0 | Peptides |
| HY-P10186 | Myristoylated ARF6 (2-13), scrambled | Peptides | |
| HY-P10187 | α-Casein (90-96) | 83471-49-2 | Peptides |
| HY-P10188 | apoB (4372-4392) | 255822-48-1 | Peptides |
| HY-P10189 | α-Secretase Substrate, Fluorogenic | Peptides | |
| HY-P1019 | [Ala1,3,11,15]-Endothelin (53-63) | 121204-87-3 | Peptides |
| HY-P10190 | CADY | 1369966-01-7 | Peptides |
| HY-P10191 | β-Secretase Substrate-1, Fluorogenic | Peptides | |
| HY-P10196 | DABCYL-SEVNLDAEF-EDANS | 1802078-36-9 | Peptides |
| HY-P10197 | DABCYL-VNLDAE-EDANS | 1802078-37-0 | Peptides |
| HY-P10198 | Cbz-Lys-Lys-PABA-AMC (diTFA) | 1616957-48-2 | Peptides |
| HY-P1019A | [Ala1,3,11,15]-Endothelin (53-63) (TFA) | Peptides | |
| HY-P1020 | Nocistatin(human) | 212609-11-5 | Peptides |
| HY-P10200 | CP7-FP13-2 | 3032621-32-9 | Peptides |
| HY-P10201 | Ac-GpYLPQTV-NH2 | 1349616-70-1 | Peptides |
| HY-P10201A | Ac-GpYLPQTV-NH2 (acetate) | Peptides | |
| HY-P10202 | 5-FAM-GpYLPQTV-NH2 | 769166-98-5 | Peptides |
| HY-P10202A | 5-FAM-GpYLPQTV-NH2 (TFA) | Peptides | |
| HY-P10203 | μ/κ/δ opioid receptor agonist 1 | Peptides | |
| HY-P10204 | FZD7 antagonist 1 | 2416664-25-8 | Peptides |
| HY-P10208 | RKH | Peptides | |
| HY-P10208A | RKH (acetate) | Peptides | |
| HY-P10209 | Cilagicin | Peptides | |
| HY-P1020A | Nocistatin(human) (TFA) | Peptides | |
| HY-P1021 | Peptide YY (PYY) (3-36), porcine | 126339-09-1 | Peptides |
| HY-P10210 | Paenilagicin | Peptides | |
| HY-P10211 | Virgilagicin | Peptides | |
| HY-P10212 | AVLX-125 | 1786434-31-8 | Peptides |
| HY-P10213 | CbZ-Ala-Ala-Ala-Ala | 13883-42-6 | Peptides |
| HY-P10215 | Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 | Peptides | |
| HY-P10216 | CAQK peptide | 2088281-24-5 | Peptides |
| HY-P10217 | PD-1/PD-L1-IN-42 | Peptides | |
| HY-P10218 | MANS peptide | 479482-23-0 | Peptides |
| HY-P10218A | MANS peptide (TFA) | Peptides | |
| HY-P10219 | Brevicidine analog 22 | Peptides | |
| HY-P1021A | Peptide YY (PYY) (3-36), porcine (TFA) | Peptides | |
| HY-P1022 | Kisspeptin-54(human) | 374683-24-6 | Peptides |
| HY-P10220 | NOTA-COG1410 | 2914099-35-5 | Peptides |
| HY-P10221A | Cyclo(CKLIIF) (TFA) | Peptides | |
| HY-P10222 | Cyclo(CRLLIF) | Peptides | |
| HY-P10223 | Cyclo(CRVIIF) | Peptides | |
| HY-P10224 | G7-18NATE | 936728-13-1 | Peptides |
| HY-P10224A | G7-18NATE (TFA) | Peptides | |
| HY-P10226 | PGD97 | 2717490-36-1 | Peptides |
| HY-P10227 | Xelafaslatide | 2040964-58-5 | Peptides |
| HY-P10228 | S-Thanatin | 1027105-06-1 | Peptides |
| HY-P10229 | RALF1 peptide | Peptides | |
| HY-P1022A | Kisspeptin-54(human) (TFA) | Peptides | |
| HY-P1023 | VIP(6-28)(human, rat, porcine, bovine) | 69698-54-0 | Peptides |
| HY-P10230 | Sublancin | 207410-26-2 | Peptides |
| HY-P10231 | Ac-Phe-Thiaphe-OH | 108906-59-8 | Peptides |
| HY-P10232 | Hynic-toc | 257943-19-4 | Peptides |
| HY-P10233 | SAAP 148 | Peptides | |
| HY-P10233A | SAAP 148 (TFA) | Peptides | |
| HY-P10234 | Poneratoxin | 137084-94-7 | Peptides |
| HY-P10234A | Poneratoxin (acetate) | Peptides | |
| HY-P10235 | Cyclic AC253 | Peptides | |
| HY-P10236 | Ac-WEHD-pNA | 1135248-58-6 | Peptides |
| HY-P10237 | Calcitonin (chicken) | 100016-62-4 | Peptides |
| HY-P10238 | MYBMIM | Peptides | |
| HY-P10239 | Tyr3-Octreotate | 302794-43-0 | Peptides |
| HY-P10239A | Tyr3-Octreotate (acetate) | Peptides | |
| HY-P1024 | GLP-2(1-33)(human) | 223460-79-5 | Peptides |
| HY-P10240 | Ac-WVAD-AMC | 219661-33-3 | Peptides |
| HY-P10241 | Ac-LEHD-CHO | 319494-38-7 | Peptides |
| HY-P10242 | Myostatin inhibitory peptide 7 | 1621169-56-9 | Peptides |
| HY-P10242A | Myostatin inhibitory peptide 7 (TFA) | Peptides | |
| HY-P10243 | Ac-VAD-CMK | 216008-80-9 | Peptides |
| HY-P10244 | Ac-YVAD-FMK | 350021-87-3 | Peptides |
| HY-P10244F | Biotin-YVAD-FMK | Peptides | |
| HY-P10245 | Fusion glycoprotein (92-106) | 406477-46-1 | Peptides |
| HY-P10246 | Hemoglobin (64-76) | 139644-18-1 | Peptides |
| HY-P10247 | Amyloid precursor C-terminal peptide | 201293-38-1 | Peptides |
| HY-P10248 | Atriopeptin I (rat, mouse) | 89139-53-7 | Peptides |
| HY-P10249 | HIV gp120 (254-274) | 113944-46-0 | Peptides |
| HY-P1025 | M40 | 143896-17-7 | Reference compound |
| HY-P10250 | HIV gp120 (308-331) | 115416-08-5 | Peptides |
| HY-P10251 | HIV gp120 (318-327) | 147841-68-7 | Peptides |
| HY-P10252 | HIV gp120 (421-438) | 129318-38-3 | Peptides |
| HY-P10253 | Homo-phytochelatin | 118026-35-0 | Peptides |
| HY-P10254 | Iso-phytochelatin 2 (Glu) | 162966-04-3 | Peptides |
| HY-P10255 | K90-114TAT | Peptides | |
| HY-P10256 | Kiss2 peptide | 1111070-93-9 | Peptides |
| HY-P10256A | Kiss2 peptide (acetate) | Peptides | |
| HY-P10257 | KR-12 (human) | 1218951-51-9 | Peptides |
| HY-P10258 | KRES peptide | 867376-23-6 | Peptides |
| HY-P10259 | BNP(1-32), porcine | 117345-87-6 | Peptides |
| HY-P1025A | M40 (TFA) | Peptides | |
| HY-P1026 | NFAT Inhibitor-1 | 249537-73-3 | Peptides |
| HY-P10260 | BNP(7-32), porcine | 114547-28-3 | Peptides |
| HY-P10261 | Collagen binding peptide | 94040-53-6 | Peptides |
| HY-P10262 | LL-37-Cys | Peptides | |
| HY-P10263 | MAGE-1 nonapeptide | 144449-86-5 | Peptides |
| HY-P10264 | MAGE-3 peptide | 154652-68-3 | Peptides |
| HY-P10265 | Melanostatin, frog | 134709-16-3 | Peptides |
| HY-P10266 | Myristoyl tripeptide-1 | 748816-12-8 | Peptides |
| HY-P10267 | Neuromedin (B-30) | 98537-35-0 | Peptides |
| HY-P10268 | Neuropeptide K (human, porcine, rat) | 96827-05-3 | Peptides |
| HY-P10269 | Bofanglutide | 2668298-70-0 | Peptides |
| HY-P1027 | LEP(116-130)(mouse) | 258276-95-8 | Peptides |
| HY-P10270 | PDGFR Y1021 peptide (phosphorylation) | 147428-10-2 | Peptides |
| HY-P10271 | RG7697 | Peptides | |
| HY-P10272 | Rusfertide | 1628323-80-7 | Peptides |
| HY-P10273 | DOTA-Octreotide | 209277-09-8 | Peptides |
| HY-P10273A | DOTA-Octreotide (TFA) | Peptides | |
| HY-P10274 | CM05 | Peptides | |
| HY-P10275 | Tat-NTS peptide | Peptides | |
| HY-P10276 | Ac-VAD-AFC | Peptides | |
| HY-P10278 | Anantin | 133658-45-4 | Peptides |
| HY-P10279 | Anaritide | 95896-08-5 | Peptides |
| HY-P1028 | Hexa-D-arginine | 673202-67-0 | Peptides |
| HY-P10280 | ATR kinase substrate peptide | Peptides | |
| HY-P10281 | RW3 | 359632-11-4 | Peptides |
| HY-P10282 | Synapsin I-(3-13) | Peptides | |
| HY-P10283 | S1H | Peptides | |
| HY-P10284 | S7 | 853248-13-2 | Peptides |
| HY-P10285 | d-KLA Peptide | 286380-05-0 | Peptides |
| HY-P10286 | Phage-derived 12/1 peptide | 186180-20-1 | Peptides |
| HY-P10287 | Neuropeptide W-30 (human) | 383415-80-3 | Peptides |
| HY-P10289 | Neuropeptide W-30 (rat) | 383415-90-5 | Peptides |
| HY-P1028A | Hexa-D-arginine (TFA) | 958204-56-3 | Peptides |
| HY-P1029 | MLCK inhibitor peptide 18 | 224579-74-2 | Reference compound |
| HY-P10290 | Neuropeptide Y (human) (free acid) | 99575-89-0 | Peptides |
| HY-P10291 | [Pro34]Neuropeptide Y, porcine | 128768-54-7 | Peptides |
| HY-P10292 | NOTA-Pep-1L | Peptides | |
| HY-P10293 | NQEQVSP | 372135-74-5 | Peptides |
| HY-P10294 | Oligopeptide P11-4 | 593266-60-5 | Peptides |
| HY-P10295 | p53 (232-240) | 155314-26-4 | Peptides |
| HY-P10296 | p60 (217–225) | 153147-67-2 | Peptides |
| HY-P10297 | PLP (190-209) | 165549-59-7 | Peptides |
| HY-P10299 | Calcitonin, porcine | 12321-44-7 | Peptides |
| HY-P1030 | Hemokinin 1 (mouse) | 208041-90-1 | Peptides |
| HY-P10300 | CXCL8 (54-72) | Peptides | |
| HY-P10301 | CXCL9(74-103) | Peptides | |
| HY-P10302 | GLP-1R/GIPR agonist-1 | Peptides | |
| HY-P10302A | GLP-1R/GIPR agonist-1 (soduim) | Peptides | |
| HY-P10303 | Cyclo[Arg-Gly-Asp-D-Phe-Lys(Azide)] | 2767993-86-0 | Peptides |
| HY-P10304 | Cyclo(Arg-Pro) | 74838-83-8 | Peptides |
| HY-P10304A | Cyclo(Arg-Pro) (TFA) | Peptides | |
| HY-P10304C | Cyclo(L-Pro-D-Arg) | 181961-24-0 | Peptides |
| HY-P10305 | Visepegenatide | 2641081-54-9 | Peptides |
| HY-P10306 | Cys-LL37 | Peptides | |
| HY-P10307 | DOTA-ubiquicidin (29–41) | Peptides | |
| HY-P10308 | [(Cys(Bzl)84,Glu(OBzl)85)]CD4 (81-92) | 124699-95-2 | Peptides |
| HY-P10309 | [Nle8,18,Tyr34]-pTH (3-34) amide (human) | 120527-89-1 | Peptides |
| HY-P1031 | [bAla8]-Neurokinin A(4-10) | 122063-01-8 | Peptides |
| HY-P10310 | F9170 | 2305092-66-2 | Peptides |
| HY-P10312 | SPN009 | Peptides | |
| HY-P10313 | [Nle8,18,Tyr34]-pTH (3-34) amide (bovine) | 64297-16-1 | Peptides |
| HY-P10314 | [Leu144]-PLP (139-151) | 202462-61-1 | Peptides |
| HY-P10315 | [Gln144]-PLP (139-151) | 170033-42-8 | Peptides |
| HY-P10316 | CaMKI(299-320) | 205598-38-5 | Peptides |
| HY-P10317 | Suc-YVAD-AMC | 201860-29-9 | Peptides |
| HY-P10318 | SHR-2042 | Peptides | |
| HY-P10319 | RI-STAD-2 | Peptides | |
| HY-P1032 | Angiotensin I (human, mouse, rat) | 484-42-4 | Peptides |
| HY-P10320 | T3 Peptide | Peptides | |
| HY-P10321 | HBP08 | 2490442-13-0 | Peptides |
| HY-P10322 | Z-IETD-R110 | Peptides | |
| HY-P10323 | T7 Peptide | Peptides | |
| HY-P10324 | TAT-p16 | Peptides | |
| HY-P10325 | Kalata B7 | 339532-29-5 | Peptides |
| HY-P10326 | Z-ATAD-FMK | 1416658-51-9 | Peptides |
| HY-P10327 | PP18 | Peptides | |
| HY-P10328 | Vasoactive intestinal contractor | 138863-63-5 | Peptides |
| HY-P10329 | KK14(R) | 2415098-35-8 | Peptides |
| HY-P1032F | Biotinyl-Angiotensin I (human, mouse, rat) | 1815618-04-2 | Peptides |
| HY-P1032S | Angiotensin I-13C19,15N3 (human, mouse, rat) | 2226467-14-5 | Isotope-Labeled Compounds |
| HY-P1032S2 | Angiotensin I-13C6,15N (human, mouse, rat) (TFA) | Isotope-Labeled Compounds | |
| HY-P1033 | [Pyr1]-Apelin-13 | 217082-60-5 | Peptides |
| HY-P10331 | KSL 128114 | 2757292-12-7 | Peptides |
| HY-P10332 | WL 47 dimer | Peptides | |
| HY-P10333 | LIH383 | 2866266-58-0 | Peptides |
| HY-P10335 | SPARC (119-122) (mouse) | 155149-79-4 | Peptides |
| HY-P10336 | Serpinin | 1383743-23-4 | Peptides |
| HY-P10337 | OXM-7 | Peptides | |
| HY-P10338 | LZ1 peptide | 1423743-97-8 | Peptides |
| HY-P10339 | SMCY peptide | 169312-12-3 | Peptides |
| HY-P1033S | [Pyr1]-Apelin-13, Gly(15N) (TFA) | Isotope-Labeled Compounds | |
| HY-P1033S1 | [Pyr1]-Apelin-13, Pro(13C5,15N) (TFA) | Isotope-Labeled Compounds | |
| HY-P1034 | DAPTA | 106362-34-9 | Peptides |
| HY-P10341 | ZP3022 | Peptides | |
| HY-P10342 | Soystatin | 510725-34-5 | Peptides |
| HY-P10343 | Soybean peptide QRPR | 125585-15-1 | Peptides |
| HY-P10344 | MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 | 932391-88-3 | Peptides |
| HY-P10345 | OP-145 | 732984-81-5 | Peptides |
| HY-P10346 | smMLCK peptide | 172960-20-2 | Peptides |
| HY-P10349 | Pap12-6 | Peptides | |
| HY-P1035 | Neuropeptide W-23 (human) | 383415-79-0 | Peptides |
| HY-P10350 | PapRIV | Peptides | |
| HY-P10352 | Pediocin PA 1 | 111745-56-3 | Peptides |
| HY-P10352A | Pediocin PA 1 (TFA) | Peptides | |
| HY-P10353 | d-(RYTVELA) | 868844-53-5 | Peptides |
| HY-P10354 | SPA4 | 1343908-95-1 | Peptides |
| HY-P10355 | Suc-AFK-AMC (acetate) | 117756-27-1 | Peptides |
| HY-P10356 | T100-Mut | Peptides | |
| HY-P10357 | TAT-CBD3 | 1355359-36-2 | Peptides |
| HY-P10358 | TAT-CBD3A6K | 1505463-57-9 | Peptides |
| HY-P10358A | TAT-CBD3A6K (acetate) | Peptides | |
| HY-P10359 | TAT-QFNP12 | Peptides | |
| HY-P1035A | Neuropeptide W-23 (human) (TFA) | Peptides | |
| HY-P1036 | Compstatin | 206645-99-0 | Peptides |
| HY-P10360 | Tat-βsyn-degron | 2816095-52-8 | Peptides |
| HY-P10361 | Temporin-GHc | 2755770-49-9 | Peptides |
| HY-P10362 | Temporin-GHd | 2755770-50-2 | Peptides |
| HY-P10363 | Tiger17 | 1647121-94-5 | Peptides |
| HY-P10364 | Ubiquicidin(29-41) | 216867-99-1 | Peptides |
| HY-P10365 | VPM-p15 | Peptides | |
| HY-P10366 | WEYIPNV | 652969-14-7 | Peptides |
| HY-P10367 | Ziptide | 518069-98-2 | Peptides |
| HY-P10368 | P110 heptapeptide | 1411976-18-5 | Peptides |
| HY-P10369 | Betiatide | 103725-47-9 | Peptides |
| HY-P1036A | Compstatin (TFA) | Peptides | |
| HY-P1037 | Motilin (26-47), human, porcine | 52906-92-0 | Peptides |
| HY-P10370 | d-(KLAKLAK)2, Proapoptotic Peptide | 721397-24-6 | Peptides |
| HY-P10371 | PKHB1 | 1505523-99-8 | Peptides |
| HY-P10372 | pFYN peptide | Peptides | |
| HY-P10373 | pJAK2(1001–1013) | 1259928-08-9 | Peptides |
| HY-P10374 | Pep42 | 900518-62-9 | Peptides |
| HY-P10375 | BMS-986189 | 1629665-96-8 | Peptides |
| HY-P10377 | GUB03385 | Peptides | |
| HY-P10378 | GPR10 agonist 1 | Peptides | |
| HY-P10379 | palm-PrRP31 | Peptides | |
| HY-P1038 | [SER140]-PLP(139-151) | 122018-58-0 | Peptides |
| HY-P10380 | palm11-PrRP31 | Peptides | |
| HY-P10381 | palm11-TTDS-PrRP31 | Peptides | |
| HY-P10382 | M133 peptide | Peptides | |
| HY-P10383 | SPSB2-iNOS inhibitory cyclic peptide-1 | 1621616-13-4 | Peptides |
| HY-P10383A | SPSB2-iNOS inhibitory cyclic peptide-1 (TFA) | Peptides | |
| HY-P10384 | SPSB2-iNOS inhibitory cyclic peptide-2 | 1989528-33-7 | Peptides |
| HY-P10384A | SPSB2-iNOS inhibitory cyclic peptide-2 (TFA) | Peptides | |
| HY-P10385 | SPSB2-iNOS inhibitory cyclic peptide-3 | 2244164-71-2 | Peptides |
| HY-P10385A | SPSB2-iNOS inhibitory cyclic peptide-3 (TFA) | Peptides | |
| HY-P10386 | 155H1 | Peptides | |
| HY-P10387 | RSM3 | Peptides | |
| HY-P10387A | RSM3 (TFA) | Peptides | |
| HY-P10388 | TAX2 peptide | Peptides | |
| HY-P10389 | Globomycin derivative G2A | Peptides | |
| HY-P1038A | [SER140]-PLP(139-151) (TFA) | Peptides | |
| HY-P1039 | R18 | 211364-78-2 | Peptides |
| HY-P10390 | Insecticidal agent 11 | 1798816-86-0 | Peptides |
| HY-P10391 | Ser-Ala-Pro | 403694-80-4 | Peptides |
| HY-P10392 | aStAx-35R | 1418863-17-8 | Peptides |
| HY-P10392AF | fStAx-35R (TFA) | Peptides | |
| HY-P10392B | aStAx-35R (TFA) | Peptides | |
| HY-P10393 | ERα17p | 938077-77-1 | Peptides |
| HY-P10394 | DP32 | 2376306-14-6 | Peptides |
| HY-P10395 | DP50 | Peptides | |
| HY-P10396 | Elf18 | 849352-44-9 | Peptides |
| HY-P10397 | YHIEPV | 2243939-21-9 | Peptides |
| HY-P10398 | 5-FAM-TEGEARGSVILLK(5-TAMRA)K-NH2 (TFA) | Peptides | |
| HY-P10399 | KGYY15 | 1690215-31-6 | Peptides |
| HY-P1039A | R18 (TFA) | Peptides | |
| HY-P10400 | AtPep1 | 902781-11-7 | Peptides |
| HY-P10401 | TAT-GluR6-9c | Peptides | |
| HY-P10402 | BMAP 28 (bovine) | 939963-76-5 | Peptides |
| HY-P10403 | IGFBP-3 peptide | 319426-26-1 | Peptides |
| HY-P10404 | PDpep1.3 | 2942277-55-4 | Peptides |
| HY-P10405 | TAT-D1 peptide | Peptides | |
| HY-P10406 | 5-FAM-LPETGG | Peptides | |
| HY-P10407 | BM30 | 2606862-05-7 | Peptides |
| HY-P10408 | Candidalysin | 1906866-53-2 | Peptides |
| HY-P10409 | SHLP2 | 1191923-93-9 | Peptides |
| HY-P10410 | AEC5 | 2035042-31-8 | Peptides |
| HY-P10411 | BING | 2396407-35-3 | Peptides |
| HY-P10412 | A11 | 2412926-30-6 | Peptides |
| HY-P10413 | SHBG(141–161) | Peptides | |
| HY-P10414 | Klotho-derived peptide 1 | Peptides | |
| HY-P10414A | Klotho-derived peptide 1 (hydrochloride) | Peptides | |
| HY-P10415 | EPI-X4 | 930280-31-2 | Peptides |
| HY-P10416 | Q14 | Peptides | |
| HY-P10417 | RTDLDSLRTYTL | 222557-93-9 | Peptides |
| HY-P10418 | VGN50 | Peptides | |
| HY-P10419 | Zebrafish Kisspeptin-1 | 1071873-79-4 | Peptides |
| HY-P10420 | RS17 | 2415545-08-1 | Peptides |
| HY-P10421 | PKCδ substrate | 915155-20-3 | Peptides |
| HY-P10422 | Multi-Leu peptide | 1413058-07-7 | Peptides |
| HY-P10424 | OPBP-1 | Peptides | |
| HY-P10425 | T2857W | Peptides | |
| HY-P10426 | cyclo(CLLFVY) | 1446322-73-1 | Peptides |
| HY-P10427 | DV1 | Peptides | |
| HY-P10428 | E6AP-mimicking peptide | Peptides | |
| HY-P10429 | RCP168 | Peptides | |
| HY-P1043 | NGR peptide | 651328-78-8 | Peptides |
| HY-P10430 | Stalk peptide | Peptides | |
| HY-P10431 | Hc-CATH | 1801534-21-3 | Peptides |
| HY-P10432 | SHAAGtide | 510732-22-6 | Peptides |
| HY-P10433 | EGFRvIII peptide | 916850-24-3 | Peptides |
| HY-P10434 | BRC4wt | Peptides | |
| HY-P10435 | KEMPFPKYPVEP | 1393589-51-9 | Peptides |
| HY-P10436 | Braftide | 2411851-64-2 | Peptides |
| HY-P10437 | VIRIP | 339332-64-8 | Peptides |
| HY-P10438 | Tat-braftide | Peptides | |
| HY-P10439 | CVRARTR | 2349354-64-7 | Peptides |
| HY-P1043A | NGR peptide (Trifluoroacetate) | Peptides | |
| HY-P1044 | Spinorphin | 137201-62-8 | Natural Products |
| HY-P10440 | Cdk5i peptide | 2298317-00-5 | Peptides |
| HY-P10441 | S-palm P0(180–199) | 1240687-76-6 | Peptides |
| HY-P10441A | S-palm P0(180–199) (TFA) | Peptides | |
| HY-P10442 | Cinnamosyn | Peptides | |
| HY-P10443 | ppTG20 | 380480-75-1 | Peptides |
| HY-P10444 | DOTA Conjugated JM#21 derivative 7 | 3033865-40-3 | Peptides |
| HY-P10445 | TAT-PiET | 3036046-03-1 | Peptides |
| HY-P10446 | TAT-PiET-PROTAC | Peptides | |
| HY-P10447 | Plipastatin A1 | 103651-09-8 | Peptides |
| HY-P10448 | Boc-Leu-Gly-Arg-pNA (acetate) | 176786-91-7 | Peptides |
| HY-P10449 | M2 Peptide | Peptides | |
| HY-P1044A | Spinorphin (TFA) | 2828433-21-0 | Natural Products |
| HY-P1045 | 187-1, N-WASP inhibitor | 380488-27-7 | Peptides |
| HY-P10450 | (Asp)2-Rhodamine 110 | 220846-62-8 | Peptides |
| HY-P10452 | Ac-LEVDGWK(Dnp)-NH2 | 400727-81-3 | Peptides |
| HY-P10453 | Myr5A peptide | Peptides | |
| HY-P10454 | (Z-IETD)2-Rh 110 | Peptides | |
| HY-P10455 | Cys-Pexiganan (TFA) | Peptides | |
| HY-P10456 | [Leu144,Arg147]-PLP (139-151) | 188859-65-6 | Peptides |
| HY-P10457 | 15-Hydroxy prostaglandin dehydrogenase blocking peptide | Peptides | |
| HY-P10458 | 5-Lipoxygenase blocking peptide | Peptides | |
| HY-P1045A | 187-1, N-WASP inhibitor (TFA) | Peptides | |
| HY-P1046 | β-Amyloid (1-15) | 183745-81-5 | Peptides |
| HY-P10461 | Abz-Val-Ala-Asp-Nva-Arg-Asp-Arg-Gln-EDDnp | 1042405-14-0 | Peptides |
| HY-P10462 | SAP15 | 1403753-45-6 | Peptides |
| HY-P10463 | ssK36 | Peptides | |
| HY-P10464 | Tat-AKAP79 (326-336) | Peptides | |
| HY-P10465 | TRPV1-Tat | Peptides | |
| HY-P10467 | ALPS1 peptide from ArfGAP1 | Peptides | |
| HY-P10468 | 5-FAM-TEGEARGSVILLK(5-TAMRA)K-NH2 | Peptides | |
| HY-P10469 | NBD-2 | Peptides | |
| HY-P1047 | β-Sheet Breaker Peptide iAβ5 | 182912-74-9 | Peptides |
| HY-P10471 | MPSD | 134248-85-4 | Peptides |
| HY-P10471A | MPSD (TFA) | Peptides | |
| HY-P10471B | Ala-MPSD | 136561-67-6 | Peptides |
| HY-P10471C | Ala-MPSD (TFA) | Peptides | |
| HY-P10472 | Azaline B | 134457-28-6 | Peptides |
| HY-P10473 | CPN-351 | 3057171-63-5 | Peptides |
| HY-P10473A | CPN-351 (TFA) | Peptides | |
| HY-P10474 | RYTVELA | 1200829-06-6 | Peptides |
| HY-P10476 | Myostatin inhibitory peptide 2 | 1621169-52-5 | Peptides |
| HY-P10476A | Myostatin inhibitory peptide 2 (TFA) | Peptides | |
| HY-P10477 | CT-08 | 1000770-96-6 | Peptides |
| HY-P1048 | Myelin Basic Protein (MBP) (68-82), guinea pig | 98474-59-0 | Peptides |
| HY-P10485 | Glp-Asn-Pro-AMC | 291752-43-7 | Reference compound |
| HY-P10486 | AIP-II | 200010-31-7 | Peptides |
| HY-P10487 | APP669-711 | Peptides | |
| HY-P10488 | cycFWRPW | 2116533-34-5 | Peptides |
| HY-P10489 | Kisspeptin-14 human | 374675-19-1 | Peptides |
| HY-P10490 | (D-His(Bzl)6)-LHRH (1-7) (free acid) | 1926163-27-0 | Peptides |
| HY-P10491 | MAGE A4 (230-239) | 252875-61-9 | Peptides |
| HY-P10492 | Tregitope 289 | Peptides | |
| HY-P10493 | NY-ESO-1 (157-165) peptide | 202815-17-6 | Peptides |
| HY-P10493A | NY-ESO-1 (157-165) peptide (TFA) | Peptides | |
| HY-P10494 | FEFEFKFK | 883746-83-6 | Peptides |
| HY-P10495 | GPR110 peptide agonist P12 | 1778685-49-6 | Peptides |
| HY-P10495A | GPR110 peptide agonist P12 (acetate) | Peptides | |
| HY-P10496 | MAGE-A1-derived peptide | 160213-30-9 | Peptides |
| HY-P10496A | MAGE-A1-derived peptide (acetate) | Peptides | |
| HY-P10497 | EBV BZLF1 (190-197) | 200124-17-0 | Peptides |
| HY-P10498 | [Des-Tyr1]-gamma-Endorphin | 67810-56-4 | Peptides |
| HY-P10499 | [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) | 141055-85-8 | Peptides |
| HY-P1050 | COG 133 | 514200-66-9 | Peptides |
| HY-P10500 | NX210 | 216682-41-6 | Peptides |
| HY-P10501 | FRα-targeting peptide C7 | 2159055-74-8 | Peptides |
| HY-P10501A | FRα-targeting peptide C7 (TFA) | Peptides | |
| HY-P10502 | L57 | 2378836-93-0 | Peptides |
| HY-P10503 | S2-16 | 672333-56-1 | Peptides |
| HY-P10504 | C-Terminally encoded peptide 1 | Peptides | |
| HY-P10505 | Tau conotoxin CnVA | 1436463-45-4 | Peptides |
| HY-P10506 | CMX-8933 | 146877-90-9 | Peptides |
| HY-P10507 | MART-1 nonamer antigen | 204060-43-5 | Peptides |
| HY-P10508 | Pantinin-1 | 2383114-96-1 | Peptides |
| HY-P10509 | IE1 peptide | 127902-44-7 | Peptides |
| HY-P1050A | COG 133 (TFA) | 2828432-37-5 | Peptides |
| HY-P1051 | β-Amyloid (12-28) | 107015-83-8 | Peptides |
| HY-P10510 | R5 peptide | 380488-45-9 | Peptides |
| HY-P10511 | Pantinin-3 | 2383115-06-6 | Peptides |
| HY-P10512 | BDC2.5 mimotope | 1370451-15-2 | Peptides |
| HY-P10513 | AcrAP1 | Peptides | |
| HY-P10514 | Transportan 10 | 678980-64-8 | Peptides |
| HY-P10515 | AcrAP2 | Peptides | |
| HY-P10516 | BRC4 peptide | Peptides | |
| HY-P10517 | Sifuvirtide | 857094-21-4 | Peptides |
| HY-P10517A | Sifuvirtide (acetate) | Peptides | |
| HY-P10518 | Anoplin | 321352-67-4 | Peptides |
| HY-P10519 | Brevicidine | 2676889-05-5 | Peptides |
| HY-P1051A | β-Amyloid (12-28) (TFA) | Peptides | |
| HY-P1052 | Myelin Basic Protein(87-99) | 118506-26-6 | Peptides |
| HY-P10520 | RWmix | Peptides | |
| HY-P10521 | Apolipoprotein KV domain (67-77) | 515170-17-9 | Peptides |
| HY-P10522 | MBP Ac1-9 | 106128-97-6 | Peptides |
| HY-P10525 | MBP Ac1-9 (4Y) | 167278-49-1 | Peptides |
| HY-P10526 | CRAMP (1-39) | Peptides | |
| HY-P10527 | CSK substrate | Peptides | |
| HY-P10528 | Echinotocin | 1219926-10-9 | Peptides |
| HY-P10529 | Ganglioside GM1-binding peptides p3 | 247185-97-3 | Peptides |
| HY-P1052A | Myelin Basic Protein(87-99) (TFA) | Peptides | |
| HY-P1053 | β-Amyloid (10-20) | 152286-31-2 | Peptides |
| HY-P10530 | Nrf2 (69-84) | 1364173-77-2 | Peptides |
| HY-P10531 | ALFA-tag | 2413353-86-1 | Peptides |
| HY-P10532 | Myelin basic protein, MBP (68-86) | 121196-80-3 | Peptides |
| HY-P10533 | Cysteine peptide | 845727-64-2 | Peptides |
| HY-P10534 | ccβ | 873582-78-6 | Peptides |
| HY-P10535 | AAV-8 NSL epitope | 872141-81-6 | Peptides |
| HY-P10536 | Temporin SHF | 1802175-40-1 | Peptides |
| HY-P10538 | Balteatide | 1630816-52-2 | Peptides |
| HY-P10539 | Hp1404 | 2249769-83-1 | Peptides |
| HY-P1054 | pep2-EVKI | 1315378-67-6 | Peptides |
| HY-P10540 | Pantinin-2 | 2383115-01-1 | Peptides |
| HY-P10541 | HSP70/DnaK substrate peptide | 156343-40-7 | Peptides |
| HY-P10542 | Dodecapeptide AR71 | 1247945-70-5 | Peptides |
| HY-P10543 | SMRT peptide | 857026-08-5 | Peptides |
| HY-P10544 | Humanized anti-tac (HAT) binding peptide | 223744-37-4 | Peptides |
| HY-P10545 | [D-His26]-Neuropeptide Y, human, rat | Peptides | |
| HY-P10546 | Polyalanine peptide | Peptides | |
| HY-P10547 | Macropin | 1382853-39-5 | Peptides |
| HY-P10548 | Cyclic L27-11 | 1221423-80-8 | Peptides |
| HY-P10549 | NGFFFamide | 1219926-09-6 | Peptides |
| HY-P10550 | VGB4 | Peptides | |
| HY-P10551 | Apo A-I mimetic 5A peptide | Peptides | |
| HY-P10552 | pCXCL8-1aa | Peptides | |
| HY-P10553 | ARF(26–44), cell-permeable | 935732-44-8 | Peptides |
| HY-P10554 | Myhc-α(334–352) | 171675-09-5 | Peptides |
| HY-P10555 | (D-Arg2, Sar 4)-Dermorphin (1-4) | 90549-86-3 | Peptides |
| HY-P10556 | (KFF)3K | 622402-94-2 | Peptides |
| HY-P10557 | DAG peptide | Peptides | |
| HY-P10559 | (RXR)4XB | 879010-15-8 | Peptides |
| HY-P10560 | M918 | 955937-87-8 | Peptides |
| HY-P10561 | CPK peptide | Peptides | |
| HY-P10562 | BMV Gag-(7−25) | 312613-48-2 | Peptides |
| HY-P10563 | Noraramtide | 2580150-96-3 | Peptides |
| HY-P10564 | Pardaxin P 4 | 134940-98-0 | Peptides |
| HY-P10565 | (RFR)4XB | 1139931-15-9 | Peptides |
| HY-P10566 | BCOR(498-514), biotinylated | Peptides | |
| HY-P10567 | Pip6a | Peptides | |
| HY-P10569 | Biotin HER-2 substrate peptide | Peptides | |
| HY-P10570 | [Nle20] H4 peptide (16−23) | 2042178-19-6 | Peptides |
| HY-P10571 | GPS1573 | 2445822-54-6 | Peptides |
| HY-P10572 | HG1 Toxin | Peptides | |
| HY-P10574 | Phosphorylated CHKtide | Peptides | |
| HY-P10577 | RAG8 peptide | Peptides | |
| HY-P10578 | SEN 304 | Peptides | |
| HY-P10579 | 123B9 | 2225868-19-7 | Peptides |
| HY-P10580 | Vasculotide | 1359657-45-6 | Peptides |
| HY-P10580A | Vasculotide (TFA) | Peptides | |
| HY-P10581A | SIIVFEKL (TFA) | Peptides | |
| HY-P10582A | SIYNFEKL (TFA) | Peptides | |
| HY-P10586 | Macrophage-activating lipopeptide 2 | 250718-44-6 | Peptides |
| HY-P10586A | Macrophage-activating lipopeptide 2 (TFA) | Peptides | |
| HY-P10587 | Icotrokinra | 2763602-16-8 | Peptides |
| HY-P10588 | WIN 66306 | 151928-32-4 | Peptides |
| HY-P10589 | Phomopsinamine A | 89085-54-1 | Peptides |
| HY-P10590 | Talogreptide mesaroxetan | 1801418-23-4 | Peptides |
| HY-P10591 | Olatorepatide | 2675496-01-0 | Peptides |
| HY-P10593 | Influenza A NP (383-391) (HLA-B27) | 126779-14-4 | Peptides |
| HY-P10594 | Myr-Arf1(2–17) | 143244-89-7 | Peptides |
| HY-P10595 | Antho-Rwamide II | 118904-15-7 | Peptides |
| HY-P10596 | Lasioglossin-III | 1242413-05-3 | Peptides |
| HY-P10597 | Angiotensin II type 1 receptor (181-187) | 275359-37-0 | Peptides |
| HY-P10598 | BIMAX1 | 1105053-45-9 | Peptides |
| HY-P10598A | BIMAX1 (acetate) | Peptides | |
| HY-P10599 | Scyliorhinin I | 103425-21-4 | Peptides |
| HY-P1060 | LPYFD-NH2 | 700361-48-4 | Peptides |
| HY-P10600 | BIMAX2 | 1105053-46-0 | Peptides |
| HY-P10600A | BIMAX2 (acetate) | Peptides | |
| HY-P10601 | αs1-CN f(143–149) | 916608-63-4 | Peptides |
| HY-P10602 | PKA Regulatory Subunit II Substrate | 103659-06-9 | Peptides |
| HY-P10603 | SP1 | 858602-44-5 | Peptides |
| HY-P10604 | SP2 | 678138-45-9 | Peptides |
| HY-P10605 | GSK3β-peptide | 496856-73-6 | Peptides |
| HY-P10606 | CK1tide | Peptides | |
| HY-P10607 | IALYLQQNW | 610268-80-9 | Peptides |
| HY-P10608 | KK4A peptide | 851626-94-3 | Peptides |
| HY-P10609 | Btk substrate peptide | Peptides | |
| HY-P1060A | LPYFD-NH2 (TFA) | Peptides | |
| HY-P1061 | Colivelin | 867021-83-8 | Peptides |
| HY-P10610 | Peptide 234CM | 155314-25-3 | Peptides |
| HY-P10611 | [D-Ser14]-Humanin | 570382-85-3 | Peptides |
| HY-P10612 | Tetanus toxin peptide | 143651-00-7 | Peptides |
| HY-P10613 | RERMS | 148914-08-3 | Peptides |
| HY-P10614 | Bid BH3 peptide | 300349-78-4 | Peptides |
| HY-P10615 | Abz-YGGRASDQ-EDDnp | Peptides | |
| HY-P10616 | Salusin-α | 624735-22-4 | Peptides |
| HY-P10617 | Salusin-β | 624735-23-5 | Peptides |
| HY-P10618 | BTM-P1 | 845623-61-2 | Peptides |
| HY-P10619 | [Tyr6,D-Phe7,D-His9]-Substance P (6-11) | 145194-26-9 | Peptides |
| HY-P1061A | Colivelin (TFA) | 2803948-60-7 | Peptides |
| HY-P1062 | Lauryl-LF 11 | 832729-14-3 | Peptides |
| HY-P10620 | GGGYK-Biotin | Peptides | |
| HY-P10621 | SHLP-1 | Peptides | |
| HY-P10622 | SHLP-3 | Peptides | |
| HY-P10623 | SHLP-4 | 1191923-94-0 | Peptides |
| HY-P10624 | SHLP-5 | 1191923-95-1 | Peptides |
| HY-P10625 | SHLP-6 | 368431-25-8 | Peptides |
| HY-P10626 | Nanodisc scaffold peptide | Peptides | |
| HY-P10627 | SOD1 (147-153) human | 2760733-01-3 | Peptides |
| HY-P10628 | β Amyloid (1-14), human | Peptides | |
| HY-P10629 | PSMα2 | 1092844-32-0 | Peptides |
| HY-P1062A | Lauryl-LF 11 (TFA) | Peptides | |
| HY-P1063 | LF11 | 832729-13-2 | Peptides |
| HY-P10630 | Pep63 | 1781242-18-9 | Peptides |
| HY-P10631 | gp96-II | Peptides | |
| HY-P10632 | HiBiT tag | 1628912-54-8 | Peptides |
| HY-P10633 | SmBiT Tag | 1628913-44-9 | Peptides |
| HY-P10634 | P17 Peptide | 846546-36-9 | Peptides |
| HY-P10635 | TKD (450-463) | 403668-80-4 | Peptides |
| HY-P10636 | Nictide | 1159973-22-4 | Peptides |
| HY-P10637 | Orcokinin | 145344-97-4 | Peptides |
| HY-P10638 | TAT-CN21 | Peptides | |
| HY-P10638A | TAT-CN21 (scrambled) | Peptides | |
| HY-P10639 | C5aR2 agonist P32 | 2097449-46-0 | Peptides |
| HY-P10639A | C5aR2 agonist P32 (acetate) | Peptides | |
| HY-P1063A | LF11 (TFA) | Peptides | |
| HY-P1064 | Apelin-36(human) | 252642-12-9 | Peptides |
| HY-P10640 | [Sar1,Thr8]-Angiotensin II | 53632-49-8 | Peptides |
| HY-P10641 | Heart-homing peptide | 876460-72-9 | Peptides |
| HY-P10641A | Heart-homing peptide (TFA) | Peptides | |
| HY-P10643 | Skeletal muscle-targeted peptide MSP | 216763-24-5 | Peptides |
| HY-P10644 | CPP9 | 1831064-63-1 | Peptides |
| HY-P10644A | CPP9 (TFA) | Peptides | |
| HY-P10645 | T9 peptide | 1098005-45-8 | Peptides |
| HY-P10646 | Muscle homing peptide M12 | 2896181-32-9 | Peptides |
| HY-P10648 | Herceptide | 3027722-28-4 | Peptides |
| HY-P10649 | CPP12 | Peptides | |
| HY-P10649A | CPP12 (TFA) | Peptides | |
| HY-P1064A | Apelin-36(human) (TFA) | Peptides | |
| HY-P1065 | Apelin-36(rat, mouse) | 230299-95-3 | Peptides |
| HY-P10650 | FAM49B (190-198) mouse | 1588388-60-6 | Peptides |
| HY-P10651 | Lifeact peptide | 1158186-08-3 | Peptides |
| HY-P10652 | hsBCL9CT-24 | 2094604-98-3 | Peptides |
| HY-P10653 | C5A | 811418-15-2 | Peptides |
| HY-P10654 | RhTx | 2861260-80-0 | Peptides |
| HY-P10655 | Caloxin 1C2 | Peptides | |
| HY-P10656 | Ac-DEVDD-TPP | 2950171-24-9 | Peptides |
| HY-P10657 | Ac-DEMEEC-OH | 208921-05-5 | Peptides |
| HY-P10658 | ARF1 (2-17) | 143228-35-7 | Peptides |
| HY-P10659 | Self-assembling peptide pY1 | Peptides | |
| HY-P1065A | Apelin-36(rat, mouse) (TFA) | Peptides | |
| HY-P1066 | Apelin-17(human, bovine) | 217082-57-0 | Peptides |
| HY-P10660 | CMV pp65 (415-429) | 207847-44-7 | Peptides |
| HY-P10661 | L-KYFIL | Peptides | |
| HY-P10662 | HLA-B*0801-binding EBV peptide | 139143-28-5 | Peptides |
| HY-P10663 | EBV EBNA3A (379-387) | 160790-25-0 | Peptides |
| HY-P10664 | EBV EBNA3B (416-424) | 147138-29-2 | Peptides |
| HY-P10665 | pYEEI | Peptides | |
| HY-P10666 | Ac-VDQQD-pNA | 189684-52-4 | Peptides |
| HY-P10667 | Ac-MRGDH-NH2 | Peptides | |
| HY-P10668 | Ac-EVKKQR-pNA | 410532-54-6 | Peptides |
| HY-P10669 | NDI-Lyso | 2999646-19-2 | Peptides |
| HY-P1066A | Apelin-17(human, bovine) (TFA) | Peptides | |
| HY-P1067 | Enterostatin(human,mouse,rat) | 117830-79-2 | Peptides |
| HY-P10670 | CLE25 Peptide | 911319-15-8 | Peptides |
| HY-P10671 | WVSAV | Peptides | |
| HY-P10672 | SEI144 | Peptides | |
| HY-P10673 | KwFwLL-NH2 | 942266-38-8 | Peptides |
| HY-P10674 | QMT-CBT | Peptides | |
| HY-P10675 | Peptide K | Peptides | |
| HY-P10676 | cMCF02A | Peptides | |
| HY-P10677 | HB-3-20 | Peptides | |
| HY-P10678 | d-KYFIL | Peptides | |
| HY-P10679 | GPLGLAGGWGERDGS | 1449337-90-9 | Peptides |
| HY-P1067A | Enterostatin(human,mouse,rat) (TFA) | Peptides | |
| HY-P1068 | Lysozyme | 9001-63-2 | Enzyme |
| HY-P10680 | TFE-IDAtp1-LinA | Peptides | |
| HY-P10681 | Crabrolin | 93207-22-8 | Peptides |
| HY-P10682 | PuroA | 639459-67-9 | Peptides |
| HY-P10683 | RAWVAWR-NH2 | 646044-31-7 | Peptides |
| HY-P10684 | Polyphemusin II | 125139-68-6 | Peptides |
| HY-P10685 | T-22 | 147658-54-6 | Peptides |
| HY-P10686 | CH401 peptide | 503027-61-0 | Peptides |
| HY-P10687 | H3B10-27(13/17αF) | Peptides | |
| HY-P10688 | NQK-Q8 peptide | 2445453-91-6 | Peptides |
| HY-P10689 | NQK-A8 peptide | Peptides | |
| HY-P1068A | Recombinant human lysozyme (plant expression) | 9001-63-2 | Enzyme |
| HY-P1068B | Lysozyme, Human Neutrophil | Enzyme | |
| HY-P10690 | CCHa1 peptide | Peptides | |
| HY-P10691 | P-113D | 348641-28-1 | Peptides |
| HY-P10692 | HB-107 | 135154-02-8 | Peptides |
| HY-P10693 | CZEN-002 | 942626-41-7 | Peptides |
| HY-P10694 | IDR-HH2 | 1214699-22-5 | Peptides |
| HY-P10695 | Bac8c | 1391837-43-6 | Peptides |
| HY-P10696 | C16G2 | 2154327-48-5 | Peptides |
| HY-P10697 | VH4127 | Peptides | |
| HY-P10698 | VH-N412 | 1801681-81-1 | Peptides |
| HY-P10699 | MAX1 | 487036-63-5 | Peptides |
| HY-P1070 | Amylin, amide, human | 122384-88-7 | Peptides |
| HY-P10700 | RO7196472 | 2097285-98-6 | Peptides |
| HY-P10701 | Q11 peptide | 581799-39-5 | Peptides |
| HY-P10702 | SAF-p1 | 292605-65-3 | Peptides |
| HY-P10703 | SAF-p2 | 292605-66-4 | Peptides |
| HY-P10704 | C16Y | 640756-12-3 | Peptides |
| HY-P10705 | KGFRWR | Peptides | |
| HY-P10706 | Ac-ILVAGK-NH2 | 1588764-53-7 | Peptides |
| HY-P10707 | Tpp-CAQK | Peptides | |
| HY-P10707A | Tpp-CAQK (TFA) | Peptides | |
| HY-P10708 | SVS-1 peptide | 1370453-04-5 | Peptides |
| HY-P10708A | SVS-1 peptide (acetate) | Peptides | |
| HY-P10709 | CREKA peptide | 847058-45-1 | Peptides |
| HY-P1070A | Amylin, amide, human (TFA) | Peptides | |
| HY-P1071 | α-CGRP(human) | 90954-53-3 | Peptides |
| HY-P10710 | BMP-4 | 1629625-47-3 | Peptides |
| HY-P10711 | ALA-A2 peptide | Peptides | |
| HY-P10712 | Nap-GFFY | 1242159-03-0 | Peptides |
| HY-P10713 | PTZ-GFFY | 1421688-61-0 | Peptides |
| HY-P10714 | Ub4ix | 2396736-46-0 | Peptides |
| HY-P10715 | Fmoc-KCRGDK | Peptides | |
| HY-P10716 | Exendin-P5 | Peptides | |
| HY-P10718 | IMG-2005 | 1229954-79-3 | Peptides |
| HY-P10719 | Pepinh-MYD | 1421052-89-2 | Peptides |
| HY-P10719A | Pepinh-MYD (TFA) | Peptides | |
| HY-P1071A | α-CGRP(human) (TFA) | Peptides | |
| HY-P1072 | PHM-27 (human) | 87403-73-4 | Peptides |
| HY-P10720 | C-Type Natriuretic Peptide (1-53), Porcine, Rat,mouse | 129405-72-7 | Peptides |
| HY-P10721 | Plectasin | Peptides | |
| HY-P10722 | Efpegerglucagon | 2766774-81-4 | Peptides |
| HY-P10723 | IL-23R inhibitor peptide-1 | 2894052-23-2 | Peptides |
| HY-P10724 | fMIFL | 112275-26-0 | Peptides |
| HY-P10728 | B7-33 | 1818415-56-3 | Peptides |
| HY-P10729 | DOTA-Bombesin (1-14) | 593287-40-2 | Peptides |
| HY-P1073 | ProTx-I | 484598-35-8 | Peptides |
| HY-P10730 | DOTA-Lanreotide | 213187-44-1 | Peptides |
| HY-P10731 | DOTA-NAPamide | 935886-72-9 | Peptides |
| HY-P10732 | DOTA-cyclo(RGDfK) | 909024-55-1 | Peptides |
| HY-P10733 | LAH4-L1 | 882690-68-8 | Peptides |
| HY-P10734 | NODAGA-RGD | 1321510-77-3 | Peptides |
| HY-P10735 | GIP (mouse) | 181591-59-3 | Peptides |
| HY-P10736 | AMG133 peptide payload | Peptides | |
| HY-P10736A | AMG133 peptide payload (TFA) | Peptides | |
| HY-P10737 | CGGK | 1253739-14-8 | Peptides |
| HY-P10737A | CGGK (acetate) | Peptides | |
| HY-P10738 | N-Formyl-MMYALF | 863418-59-1 | Peptides |
| HY-P10738A | N-Formyl-MMYALF (TFA) | Peptides | |
| HY-P10739 | WYRGRL | 1021155-39-4 | Peptides |
| HY-P1074 | SNX-482 | 203460-30-4 | Peptides |
| HY-P10740 | CBP-1018 | 2923068-30-6 | Peptides |
| HY-P10741 | DOTA-EB-TATE | Peptides | |
| HY-P10742 | CBX-12 | Peptides | |
| HY-P10743 | BQ7876 | Peptides | |
| HY-P10744 | BQ7859 | Peptides | |
| HY-P10745 | Petrelintide | 2766385-23-1 | Peptides |
| HY-P10745A | Petrelintide (acetate) | Peptides | |
| HY-P10746 | EB1002 | 2770688-48-5 | Peptides |
| HY-P1075 | CALP3 | 261969-05-5 | Peptides |
| HY-P10757 | DTX-P7 | Peptides | |
| HY-P10758 | Alkyne-βAG-TOCA | Peptides | |
| HY-P10759 | DTS-201 (sodium) | 372491-73-1 | Peptides |
| HY-P1075A | CALP3 (TFA) | Peptides | |
| HY-P1076 | CALP2 | 261969-04-4 | Peptides |
| HY-P10760 | PhAc-ALGP-Dox | 1616592-31-4 | Peptides |
| HY-P10761 | DPI-4452 | 2941391-49-5 | Peptides |
| HY-P10762 | CBP-1008 | 2082631-84-1 | Peptides |
| HY-P10765 | DTS-108 | 951792-83-9 | Peptides |
| HY-P10766 | Nva-VYIHPF | 51988-72-8 | Peptides |
| HY-P10767 | MD01-67 | 2468971-42-6 | Peptides |
| HY-P10768 | Ro 25-1553 | 159427-08-4 | Peptides |
| HY-P10769 | MOTS-c (mouse) | Peptides | |
| HY-P1076A | CALP2 (TFA) | Peptides | |
| HY-P1077 | CALP1 | 145224-99-3 | Peptides |
| HY-P10770 | P-ESBP-DOX | Peptides | |
| HY-P10772 | L2P4 | Peptides | |
| HY-P10773 | CTP-amiodarone | Peptides | |
| HY-P10775 | BT1769 | Peptides | |
| HY-P10776 | RNS peptide | 901117-08-6 | Peptides |
| HY-P10777 | ANG1009 | 1220637-65-9 | Peptides |
| HY-P10778 | me4 Peptide | Peptides | |
| HY-P10779 | flg22Pst | 2268675-54-1 | Peptides |
| HY-P1077A | CALP1 (TFA) | Peptides | |
| HY-P1078 | Huwentoxin XVI | 1600543-88-1 | Peptides |
| HY-P10780 | RFRP-3 (mouse) | Peptides | |
| HY-P10781 | PSMA-D5 | 3056440-83-3 | Peptides |
| HY-P10782 | Pt(IV)-M13 | Peptides | |
| HY-P10783 | BGC0222 | Peptides | |
| HY-P10785 | Iturin A-2 | 83785-07-3 | Peptides |
| HY-P10786 | LinTT1 peptide | 2031154-77-3 | Peptides |
| HY-P10787 | tLyP-1 peptide | 1354801-55-0 | Peptides |
| HY-P10788 | CK3 peptide | 1801552-75-9 | Peptides |
| HY-P10789 | P160 peptide | 362043-77-4 | Peptides |
| HY-P1078A | Huwentoxin XVI (TFA) | Peptides | |
| HY-P1079 | ω-Agatoxin TK | 158484-42-5 | Peptides |
| HY-P10790 | "Breast cancer targeting peptide 18–4" | 1332850-08-4 | Peptides |
| HY-P10791 | YYLLVR | 3060796-96-2 | Peptides |
| HY-P10792 | HER2-targeted peptide H6F | 1644155-35-0 | Peptides |
| HY-P10793 | Cyclic(YCDGFYACYMDV) | 535959-77-4 | Peptides |
| HY-P10794 | LH2 peptide | Peptides | |
| HY-P10795 | NK-2 | 280138-31-0 | Peptides |
| HY-P10796 | YARA peptide | Peptides | |
| HY-P10797 | TAT-N24 | Peptides | |
| HY-P10798 | Eloralintide | 2883634-40-8 | Peptides |
| HY-P10798A | Eloralintide (sodium) | Peptides | |
| HY-P10799 | SLAFVDVLN | Peptides | |
| HY-P1080 | ω-Agatoxin IVA | 145017-83-0 | Peptides |
| HY-P10800 | T20-M | Peptides | |
| HY-P10801 | mC46 peptide | Peptides | |
| HY-P10802 | ER-DRI | Peptides | |
| HY-P10803 | FLDKFNHEAEDLFYQSSL | Peptides | |
| HY-P10804 | PIH | Peptides | |
| HY-P10805 | Capsid assembly inhibitor | 865292-94-0 | Peptides |
| HY-P10806 | kCAL01 | 1364717-03-2 | Peptides |
| HY-P10808 | RSRGVFF | Peptides | |
| HY-P10809 | VAMP | Peptides | |
| HY-P1080A | ω-Agatoxin IVA (TFA) | Peptides | |
| HY-P1081 | Acetyl-Calpastatin(184-210)(human) | 123714-50-1 | Peptides |
| HY-P10810 | QPH-FR | Peptides | |
| HY-P10811 | Na+-Ca2+ Exchanger | Peptides | |
| HY-P10812 | CP61 | 1631984-43-4 | Peptides |
| HY-P10813 | ZLIRTLHEWY | Peptides | |
| HY-P10814 | MciZ (B. subtilis) | Peptides | |
| HY-P10815 | IP3RCYT | Peptides | |
| HY-P10816 | PACE4 Inhibitory peptide C23 | 1426656-94-1 | Peptides |
| HY-P10817 | Corza6 | Peptides | |
| HY-P10818 | Polyglutamine binding peptide 1 | 274914-75-9 | Peptides |
| HY-P10819 | S9-CMC1 (TFA) | Peptides | |
| HY-P1081A | Acetyl-Calpastatin(184-210)(human) (TFA) | Peptides | |
| HY-P1082 | Gap 26 | 197250-15-0 | Peptides |
| HY-P10820 | N36Mut(e,g) | Peptides | |
| HY-P10821 | Myr-Tat-PKCβII | Peptides | |
| HY-P10822 | ED11 | 1593480-56-8 | Peptides |
| HY-P10823 | RI-OR2 | 1219627-58-3 | Peptides |
| HY-P10824 | RI-OR2-TAT | 1430219-69-4 | Peptides |
| HY-P10825 | p21PBP | Peptides | |
| HY-P10826 | PD-1/PD-L1 inhibitory peptide C8 | Peptides | |
| HY-P10827 | PIC1 PA | 1356469-36-7 | Peptides |
| HY-P10828 | MAPI | 1260620-30-1 | Peptides |
| HY-P10829 | MLH40 | Peptides | |
| HY-P1082A | Gap 26 (TFA) | Peptides | |
| HY-P1083 | Dynamin inhibitory peptide | 251634-21-6 | Peptides |
| HY-P10830 | AT1R epitope | 161146-12-9 | Peptides |
| HY-P10831 | GNQWFI | 853995-60-5 | Peptides |
| HY-P10832 | ATWLPPRAANLLMAAS | 1228447-26-4 | Peptides |
| HY-P10833 | C-VGB3 | Peptides | |
| HY-P10834 | NYAD-13 | 1042980-96-0 | Peptides |
| HY-P10835 | LAG-3 cyclic peptide inhibitor C25 | Peptides | |
| HY-P10836 | DN59 | 869011-94-9 | Peptides |
| HY-P10837 | LAG-3 cyclic peptide inhibitor 12 | Peptides | |
| HY-P10838 | PL120131 | Peptides | |
| HY-P10839 | NBD peptide | 371915-62-7 | Peptides |
| HY-P1083A | Dynamin inhibitory peptide (TFA) | Peptides | |
| HY-P1084 | β-Pompilidotoxin | 216064-36-7 | Peptides |
| HY-P10840 | Tkip | 716361-65-8 | Peptides |
| HY-P10841 | CyPep-1 | 1319804-91-5 | Peptides |
| HY-P10842 | d-GLP-2 E33A | Peptides | |
| HY-P10843 | R4K1 | Peptides | |
| HY-P10844 | ANK peptide | 929207-58-9 | Peptides |
| HY-P10845 | KRL74 | 2423969-43-9 | Peptides |
| HY-P10846 | HYNIC-CTP | Peptides | |
| HY-P10847 | KS-58 | 2549046-46-8 | Peptides |
| HY-P10848 | RJPXD33 | Peptides | |
| HY-P10849 | IP3RPEP6 | 3061802-23-8 | Peptides |
| HY-P1084A | β-Pompilidotoxin (TFA) | Peptides | |
| HY-P1085 | Epidermal Growth Factor Receptor Peptide (985-996) | 96249-43-3 | Peptides |
| HY-P10850 | PIYLGGVFQ | Peptides | |
| HY-P10851 | HVEM(14-39) | Peptides | |
| HY-P10852 | TAT-MKK3b | 928163-65-9 | Peptides |
| HY-P10853 | Bacilotetrin C analogue | Peptides | |
| HY-P10854 | TAT-N15 | 2415370-74-8 | Peptides |
| HY-P10855 | S1b3inL1 | 3027437-21-1 | Peptides |
| HY-P10856 | CPI1 | Peptides | |
| HY-P10857 | Microcin J25 | 145538-47-2 | Peptides |
| HY-P10858 | UCI-1 | Peptides | |
| HY-P1086 | Cadherin Peptide, avian | 127650-08-2 | Peptides |
| HY-P10860 | cMCoFx1 | 2853605-24-8 | Peptides |
| HY-P10861 | RI-AG03 | Peptides | |
| HY-P10862 | AH-D peptide | Peptides | |
| HY-P10868 | Pegtarazimod | 2056232-82-5 | Peptides |
| HY-P10869 | dCNP | Peptides | |
| HY-P1087 | Adrenorphin | 88377-68-8 | Reference compound |
| HY-P10870 | Pep1-DNP conjugate 9 | Peptides | |
| HY-P10871 | cTEV6-2 | Peptides | |
| HY-P10872 | P315V3 | Peptides | |
| HY-P10873 | ST-CY14 | Peptides | |
| HY-P10874 | SMR efflux inhibitor | Peptides | |
| HY-P10875 | HL2-m5 | 2130846-15-8 | Peptides |
| HY-P10876 | mcK6A1 | Peptides | |
| HY-P10877 | Bicyclic UK18 | 1393680-45-9 | Peptides |
| HY-P10878 | UK140 | Peptides | |
| HY-P1088 | [Ser25] Protein Kinase C (19-31) | 136795-05-6 | Peptides |
| HY-P10881 | Ganipatide | 2758595-29-6 | Peptides |
| HY-P10882 | Gletimbetasin | 921944-96-9 | Peptides |
| HY-P10883 | Lutetate tezuvotide tetraxetan | Peptides | |
| HY-P10884 | Lead-bamzireotide navoxetan | Peptides | |
| HY-P10885 | Lead-lapemelanotide zapixetan | Peptides | |
| HY-P10886 | Zifogaptide | 1465809-36-2 | Peptides |
| HY-P10887 | Pegevongitide | 2988012-71-9 | Peptides |
| HY-P10888 | GPC3 targeting peptide 1 | 3066113-41-2 | Peptides |
| HY-P10889 | CNI103 | 2366279-86-7 | Peptides |
| HY-P1089 | Cytochrome c-pigeon (88-104) | 86579-06-8 | Peptides |
| HY-P10892 | Nectin-4 targeting bicycle peptide 59 | 2378594-54-6 | Peptides |
| HY-P10893 | BCY8234 | 2922478-12-2 | Peptides |
| HY-P10894 | mUNO | 2283322-63-2 | Peptides |
| HY-P10895 | HR97 (TFA) | Peptides | |
| HY-P10896 | NOTA-P2-RM26 | 1446005-10-2 | Peptides |
| HY-P10897 | SjDX5-271 | 2767993-76-8 | Peptides |
| HY-P10898 | GeX-2 | 2900996-95-2 | Peptides |
| HY-P10899 | ETTAC-2 | Peptides | |
| HY-P1090 | Hemopressin(rat) | 568588-77-2 | Peptides |
| HY-P10900 | 2x HA tag peptide | 1005489-48-4 | Peptides |
| HY-P10902 | Lorutengitide | 2559326-61-1 | Peptides |
| HY-P10904 | Vezocolmitide | 51486-77-2 | Peptides |
| HY-P10905 | Tezuvotide tetraxetan | Peptides | |
| HY-P10906 | Talovirtide | 2868285-05-4 | Peptides |
| HY-P10907 | Zaloganan | 2759007-66-2 | Peptides |
| HY-P10908 | H-20 | 3020015-02-2 | Reference compound |
| HY-P10909 | Canvuparatide | 2925554-87-4 | Peptides |
| HY-P1090A | Hemopressin(rat) (TFA) | 1431329-47-3 | Peptides |
| HY-P1091 | Hemopressin (human, mouse) | 1314035-51-2 | Peptides |
| HY-P10910 | Vensemaglutide | 2919344-88-8 | Peptides |
| HY-P10911 | IETP2 | 2314338-36-6 | Peptides |
| HY-P10912 | Lapemelanotide zapixetan | Peptides | |
| HY-P10913 | HYNIC-UBI29-41 | 1186217-15-1 | Peptides |
| HY-P10914 | D-CopA3 | 1426227-11-3 | Peptides |
| HY-P10915 | Linear daptomycin | 883991-21-7 | Peptides |
| HY-P10916 | Micafungin metabolite M1 | 539823-80-8 | Peptides |
| HY-P10918 | F11R peptide (TFA) | Peptides | |
| HY-P1091A | Hemopressin(human, mouse) (TFA) | 1431329-48-4 | Peptides |
| HY-P1092 | Ac-IEPD-AFC | 1135417-31-0 | Peptides |
| HY-P10920 | DOTAMTATE | 2415661-92-4 | Peptides |
| HY-P10922 | Cathepsin E substrate e | 1246741-19-4 | Peptides |
| HY-P10923 | KYS-1 | 592544-81-5 | Peptides |
| HY-P10924 | Roseltide rT1 | 2206692-95-5 | Peptides |
| HY-P10925 | I-66 | 3044032-95-0 | Peptides |
| HY-P10925A | I-67 | Peptides | |
| HY-P10926 | MH42 | 2950154-05-7 | Peptides |
| HY-P10927 | BRP | Peptides | |
| HY-P10929 | Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH | 2460751-66-8 | Natural Products |
| HY-P1093 | Ac-LEHD-AFC | 210345-03-2 | Dye Reagents |
| HY-P10930 | wrwyar-NH2 (TFA) | Peptides | |
| HY-P10930A | wrwycr-NH2 (TFA) | Peptides | |
| HY-P10931 | RAD21 (356–395) | Peptides | |
| HY-P10931A | RAD21 (356–395) (TFA) | Peptides | |
| HY-P10931F | RAD21 (356–395), biotin labeled | Dye Reagents | |
| HY-P10932 | pGk13a | Peptides | |
| HY-P10933 | PRO20 | Peptides | |
| HY-P10935 | Amilo-5MER | 1860001-61-1 | Peptides |
| HY-P10935A | Amilo-5MER (TFA) | Peptides | |
| HY-P10936 | AQP4 (201-220) | 2104700-59-4 | Peptides |
| HY-P10936A | AQP4 (201-220) (TFA) | Peptides | |
| HY-P10937 | AQP4 (205-215) | 2891466-35-4 | Peptides |
| HY-P10937A | AQP4 (205-215) (TFA) | Peptides | |
| HY-P10938 | LP17 (human) | 887973-05-9 | Peptides |
| HY-P10939 | Ac-DMLD-CMK | 2588354-33-8 | Peptides |
| HY-P1094 | AZ-10417808 | 331645-84-2 | Reference compound |
| HY-P10940 | Ac-RFAAKAA-COOH | 845727-63-1 | Peptides |
| HY-P10944 | Unlabeled FXX489 | 3076330-05-4 | Peptides |
| HY-P10945 | FAP targeting peptide for FXX489 | 3076328-74-7 | Peptides |
| HY-P10946 | FAP targeting peptide-PEG2 conjugate | 3076328-71-4 | Peptides |
| HY-P1095 | Ivachtin | 745046-84-8 | Reference compound |
| HY-P1096 | A71623 | 130408-77-4 | Reference compound |
| HY-P1097 | Gastrin I, human | 10047-33-3 | Reference compound |
| HY-P1097F | Biotin-Gastrin-1, human (1-17) | 663625-43-2 | Peptides |
| HY-P1098 | Ac2-26 | 151988-33-9 | Peptides |
| HY-P1098A | Ac2-26 (TFA) | Peptides | |
| HY-P1098B | Ac2-26 (ammonium) | Peptides | |
| HY-P1099 | Ac2-12 | 256447-08-2 | Peptides |
| HY-P1099A | Ac2-12 (TFA) | Peptides | |
| HY-P1100 | PM102 | 1234564-95-4 | Peptides |
| HY-P1102 | TC14012 | 368874-34-4 | Peptides |
| HY-P1102A | TC14012 (TFA) | Peptides | |
| HY-P1103 | CTCE-9908 | 1030384-98-5 | Peptides |
| HY-P1103A | CTCE-9908 (TFA) | Peptides | |
| HY-P1104 | FC131 | 606968-52-9 | Peptides |
| HY-P1104A | FC131 (TFA) | 842166-42-1 | Peptides |
| HY-P1105 | GaTx2 | 194665-85-5 | Reference compound |
| HY-P1106 | K41498 | 434938-41-7 | Peptides |
| HY-P1106A | K41498 (TFA) | Peptides | |
| HY-P1107 | Antisauvagine-30 | 220673-95-0 | Reference compound |
| HY-P1107A | Antisauvagine-30 (TFA) | Reference compound | |
| HY-P1108 | Astressin 2B | 681260-70-8 | Peptides |
| HY-P1108A | Astressin 2B (TFA) | Peptides | |
| HY-P1110 | AF12198 | 185413-30-3 | Peptides |
| HY-P1111 | Lyn peptide inhibitor | 222018-18-0 | Reference compound |
| HY-P1111A | Lyn peptide inhibitor (TFA) | Reference compound | |
| HY-P1112 | Sarafotoxin S6a | 126738-34-9 | Peptides |
| HY-P1112A | Sarafotoxin S6a (TFA) | Peptides | |
| HY-P1113 | Phospho-Glycogen Synthase Peptide-2(substrate) | 851366-97-7 | Reference compound |
| HY-P1113A | Phospho-Glycogen Synthase Peptide-2(substrate) (TFA) | Reference compound | |
| HY-P1114 | 2B-(SP) | 186901-17-7 | Peptides |
| HY-P1114A | 2B-(SP) (TFA) | Peptides | |
| HY-P1115 | AKTide-2T | 324029-01-8 | Peptides |
| HY-P1115A | AKTide-2T (TFA) | Peptides | |
| HY-P1116 | PBP10 | 794466-43-6 | Peptides |
| HY-P1116A | PBP10 (TFA) | Peptides | |
| HY-P1117 | MMK1 | 271246-66-3 | Reference compound |
| HY-P1117A | MMK1 (TFA) | Reference compound | |
| HY-P1118 | Ac9-25 | 284040-76-2 | Peptides |
| HY-P1118A | Ac9-25 (TFA) | Peptides | |
| HY-P1119 | WRW4 | 878557-55-2 | Peptides |
| HY-P1119A | WRW4 (TFA) | Peptides | |
| HY-P1120 | WKYMVm | 187986-17-0 | Peptides |
| HY-P1120A | WKYMVm (TFA) | 1313730-09-4 | Peptides |
| HY-P1121 | WKYMVM-NH2 | 187986-11-4 | Peptides |
| HY-P1121A | WKYMVM-NH2 (TFA) | 1435781-74-0 | Peptides |
| HY-P1122 | Cyclosporin H | 83602-39-5 | Peptides |
| HY-P1123 | MEDICA16 | 87272-20-6 | Reference compound |
| HY-P1123R | MEDICA16 (Standard) | 87272-20-6 | Reference Standards |
| HY-P1124 | AS2034178 (free base) | 1030846-42-4 | Reference compound |
| HY-P1125 | 4-CMTB | 300851-67-6 | Reference compound |
| HY-P1126 | Dolastatin 15 | 123884-00-4 | Peptides |
| HY-P1127 | Galanin (1-30), human | 119418-04-1 | Peptides |
| HY-P1128 | Galanin (swine) | 88813-36-9 | Peptides |
| HY-P1128A | Galanin (swine) (TFA) | Peptides | |
| HY-P1129 | AR-M1896 | 367518-31-8 | Peptides |
| HY-P1130 | M871 | 908844-75-7 | Peptides |
| HY-P1131 | M617 | 860790-38-1 | Peptides |
| HY-P1131A | M617 (TFA) | Peptides | |
| HY-P1132 | Galanin (1-29)(rat, mouse) | 114547-31-8 | Peptides |
| HY-P1132A | Galanin (1-29)(rat, mouse) (TFA) | Peptides | |
| HY-P1133 | Galanin (2-29) (rat) | 141696-11-9 | Peptides |
| HY-P1134 | Galanin (1-15) (porcine, rat) | 112747-70-3 | Peptides |
| HY-P1135 | M1145 | 1172089-00-7 | Peptides |
| HY-P1135A | M1145 (TFA) | Peptides | |
| HY-P1136 | Gap19 | 1507930-57-5 | Peptides |
| HY-P1136A | Gap19 (TFA) | Peptides | |
| HY-P1136B | TAT-Gap19 | 1507930-54-2 | Peptides |
| HY-P1136C | TAT-Gap19 (TFA) | Peptides | |
| HY-P1137 | 10Panx | 955091-53-9 | Peptides |
| HY-P1138 | Scrambled 10Panx | 1315378-72-3 | Reference compound |
| HY-P1139 | Cortistatin-8 | 485803-62-1 | Reference compound |
| HY-P1141 | GLP-1(9-36)amide | 161748-29-4 | Peptides |
| HY-P1141A | GLP-1(9-36)amide (TFA) | Peptides | |
| HY-P1142 | GLP-2(rat) | 195262-56-7 | Peptides |
| HY-P1142A | GLP-2(rat) (TFA) | Peptides | |
| HY-P1142S | GLP-2(rat) (Ala-13C3,15N) | Isotope-Labeled Compounds | |
| HY-P1142S1 | GLP-2(rat) (Ala-13C3,15N) (TFA) | Isotope-Labeled Compounds | |
| HY-P1143 | [Des-His1,Glu9]-Glucagon amide | 110084-95-2 | Peptides |
| HY-P1143A | [Des-His1,Glu9]-Glucagon amide (TFA) | Peptides | |
| HY-P1144 | Oxyntomodulin (bovine, porcine) | 62340-29-8 | Peptides |
| HY-P1144A | Oxyntomodulin (bovine, porcine) (TFA) | Peptides | |
| HY-P1145 | Glucagon-like peptide 1 (1-37), human | 87805-34-3 | Peptides |
| HY-P1145A | Glucagon-like peptide 1 (1-37), human (TFA) | Peptides | |
| HY-P1146 | Semax | 80714-61-0 | Peptides |
| HY-P1146A | Semax (acetate) | 2828433-33-4 | Peptides |
| HY-P1149 | Epitalon | 307297-39-8 | Peptides |
| HY-P1149A | Epitalon (TFA) | Peptides | |
| HY-P1155 | GRF (1-29) amide (rat) | 91826-20-9 | Peptides |
| HY-P1156 | Insulin(cattle) | 11070-73-8 | Peptides |
| HY-P1157 | Exendin derivative 1 | Peptides | |
| HY-P1158 | [Ala2,8,9,11,19,22,24,25,27,28]-VIP | 866552-34-3 | Peptides |
| HY-P1159 | [D-p-Cl-Phe6,Leu17]-VIP | 102805-45-8 | Peptides |
| HY-P1159A | [D-p-Cl-Phe6,Leu17]-VIP (TFA) | Peptides | |
| HY-P1160 | Bay 55-9837 | 463930-25-8 | Peptides |
| HY-P1160A | Bay 55-9837 (TFA) | Peptides | |
| HY-P1162 | (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin | 73168-24-8 | Peptides |
| HY-P1163 | D[LEU4,LYS8]-VP | 42061-33-6 | Peptides |
| HY-P1163A | D[LEU4,LYS8]-VP (TFA) | Peptides | |
| HY-P1164 | Urotensin II (114-124), human | 251293-28-4 | Peptides |
| HY-P1164A | Urotensin II (114-124), human (TFA) | Peptides | |
| HY-P1165 | Urotensin II-related peptide | 342878-90-4 | Peptides |
| HY-P1166 | UFP-803 | 879497-82-2 | Peptides |
| HY-P1166A | UFP-803 (TFA) | Peptides | |
| HY-P1167 | [Orn5]-URP | 782485-03-4 | Peptides |
| HY-P1167A | [Orn5]-URP (TFA) | Peptides | |
| HY-P1168 | [Orn8]-Urotensin II (human) | 479065-85-5 | Peptides |
| HY-P1169 | Ac-IETD-AFC | 211990-57-7 | Dye Reagents |
| HY-P1170 | N-terminally acetylated Leu-enkephalin | 2703746-32-9 | Peptides |
| HY-P1171 | N-terminally acetylated Endomorphin-1 | 936000-56-5 | Peptides |
| HY-P1172 | TCS 184 | 1315378-71-2 | Peptides |
| HY-P1172A | TCS 184 (TFA) | Peptides | |
| HY-P1173 | L803-mts | 706785-93-5 | Peptides |
| HY-P1174 | GnRH Associated Peptide (GAP) (1-13), human | 100111-07-7 | Peptides |
| HY-P1175 | L-R4W2 | 206350-79-0 | Peptides |
| HY-P1175A | L-R4W2 (TFA) | Peptides | |
| HY-P1176 | NTR 368 | 197230-90-3 | Peptides |
| HY-P1176A | NTR 368 (TFA) | Peptides | |
| HY-P1178 | Cyclotraxin B | 1203586-72-4 | Peptides |
| HY-P1178A | Cyclotraxin B (TFA) | Peptides | |
| HY-P1179 | Guanylin(human) | 183200-12-6 | Peptides |
| HY-P1179A | Guanylin(human) (TFA) | Peptides | |
| HY-P1180 | Pam3CSK4 | 112208-00-1 | Peptides |
| HY-P1180A | Pam3CSK4 (TFA) | 112208-01-2 | Peptides |
| HY-P1180B | Pam3CSK4 (trihydrochloride) | 112208-04-5 | Biochemical Assay Reagents |
| HY-P1181 | Pam2CSK4 | 868247-72-7 | Peptides |
| HY-P1181A | Pam2CSK4 (TFA) | Peptides | |
| HY-P1183 | Locustatachykinin I | 126985-97-5 | Peptides |
| HY-P1183A | Locustatachykinin I (TFA) | Peptides | |
| HY-P1184 | HNGF6A | 1093111-54-6 | Peptides |
| HY-P1184A | HNGF6A (TFA) | Peptides | |
| HY-P1185 | Antagonist G | 115150-59-9 | Peptides |
| HY-P1185A | Antagonist G (TFA) | Peptides | |
| HY-P1186 | Eledoisin Related Peptide | 2990-43-4 | Peptides |
| HY-P1187 | HSDVHK-NH2 | 848644-86-0 | Peptides |
| HY-P1187A | HSDVHK-NH2 (TFA) | Peptides | |
| HY-P1188 | LDV-FITC | 1207610-07-8 | Peptides |
| HY-P1188A | LDV-FITC (TFA) | Peptides | |
| HY-P1189 | Echistatin | 154303-05-6 | Peptides |
| HY-P1189A | Echistatin (TFA) | Peptides | |
| HY-P1190 | c-JUN peptide | 610273-01-3 | Peptides |
| HY-P1191 | JIP-1(153-163) | 438567-88-5 | Peptides |
| HY-P1191A | JIP-1(153-163) (TFA) | Peptides | |
| HY-P1192 | GR-73632 | 133156-06-6 | Peptides |
| HY-P1193 | GR 82334 | 129623-01-4 | Peptides |
| HY-P1194 | Spantide I | 91224-37-2 | Peptides |
| HY-P1194A | Spantide I (TFA) | Peptides | |
| HY-P1194B | [D-Pro2] Spantide I (TFA) | Peptides | |
| HY-P1195 | PDZ1 Domain inhibitor peptide | 1315378-73-4 | Peptides |
| HY-P1195A | PDZ1 Domain inhibitor peptide (TFA) | Peptides | |
| HY-P1196 | Kisspeptin 234 | 1145998-81-7 | Peptides |
| HY-P1196A | Kisspeptin 234 (TFA) | 1848962-29-7 | Peptides |
| HY-P1197 | Kisspeptin-10 (mouse, rat) | 478507-53-8 | Peptides |
| HY-P1197A | Kisspeptin-10 (mouse, rat) (TFA) | Peptides | |
| HY-P1198 | Hemokinin 1, human | 491851-53-7 | Peptides |
| HY-P1198A | Hemokinin 1, human (TFA) | Peptides | |
| HY-P1199 | pp60 c-src (521-533) (phosphorylated) | 149299-77-4 | Peptides |
| HY-P1200 | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH | 159439-02-8 | Peptides |
| HY-P1200A | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH (TFA) | Peptides | |
| HY-P1201 | Cyclosomatostatin | 84211-54-1 | Peptides |
| HY-P1201A | Cyclosomatostatin (TFA) | Peptides | |
| HY-P1202 | CYN 154806 | 183658-72-2 | Peptides |
| HY-P1202A | CYN 154806 (TFA) | 2828432-46-6 | Peptides |
| HY-P1203 | BIM-23056 | 150155-61-6 | Peptides |
| HY-P1203A | BIM-23056 (TFA) | 1426173-61-6 | Peptides |
| HY-P1204 | [Ala17]-MCH | 359784-84-2 | Peptides |
| HY-P1204A | [Ala17]-MCH (TFA) | Peptides | |
| HY-P1205 | MCH(human, mouse, rat) | 128315-56-0 | Peptides |
| HY-P1205A | MCH(human, mouse, rat) (TFA) | Peptides | |
| HY-P1206 | CH 275 | 174688-78-9 | Peptides |
| HY-P1207 | BIM 23052 | 133073-82-2 | Peptides |
| HY-P1208 | PG-931 | 667430-81-1 | Peptides |
| HY-P1208A | PG-931 (TFA) | Peptides | |
| HY-P1209 | PG106 | 944111-22-2 | Peptides |
| HY-P1209A | PG106 (TFA) | Peptides | |
| HY-P1210 | Lys-γ3-MSH(human) | 156159-18-1 | Peptides |
| HY-P1210A | Lys-γ3-MSH(human) (TFA) | Peptides | |
| HY-P1211 | Adrenocorticotropic Hormone (ACTH) (1-39), human | 12279-41-3 | Peptides |
| HY-P1211B | Adrenocorticotropic Hormone (ACTH) (1-39), human (acetate) | Peptides | |
| HY-P1212 | Cortistatin 14 (mouse, rat) | 193829-96-8 | Peptides |
| HY-P1213 | JKC363 | 436083-30-6 | Peptides |
| HY-P1213A | JKC363 (TFA) | Peptides | |
| HY-P1214 | γ1-MSH | 72629-65-3 | Peptides |
| HY-P1214A | γ1-MSH (TFA) | Peptides | |
| HY-P1215 | HS024 | 212370-59-7 | Peptides |
| HY-P1215A | HS024 (TFA) | Peptides | |
| HY-P1216 | HS014 | 207678-81-7 | Peptides |
| HY-P1216A | HS014 (TFA) | Peptides | |
| HY-P1217 | [D-Trp8]-γ-MSH | 321351-81-9 | Peptides |
| HY-P1217A | [D-Trp8]-γ-MSH (TFA) | Peptides | |
| HY-P1218 | Phrixotoxin 3 | 880886-00-0 | Peptides |
| HY-P1218A | Phrixotoxin 3 (TFA) | Peptides | |
| HY-P1218B | Phrixotoxin 3-NH2 (TFA) | Peptides | |
| HY-P1219 | Jingzhaotoxin-III | 925463-91-8 | Peptides |
| HY-P1220 | Huwentoxin-IV | 526224-73-7 | Peptides |
| HY-P1220A | Huwentoxin-IV (TFA) | Peptides | |
| HY-P1221 | ProTx II | 484598-36-9 | Peptides |
| HY-P1221A | ProTx II (TFA) | Peptides | |
| HY-P1222 | LL-37, human | 154947-66-7 | Peptides |
| HY-P1222A | LL-37, human (TFA) | Peptides | |
| HY-P1222B | LL-37, human (acetate) | Peptides | |
| HY-P1223 | Exendin-3/4 (59-86) | 1263874-37-8 | Peptides |
| HY-P1224 | HAEGTFTSDVS | 864915-61-7 | Peptides |
| HY-P1225 | {Val1}-Exendin-3/4 | Peptides | |
| HY-P1226 | HAEGTFTSD | 926018-45-3 | Peptides |
| HY-P1227 | SDV-Exendin-3/4 | Peptides | |
| HY-P1228 | HAEGTFT | 926018-95-3 | Peptides |
| HY-P1229 | FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | Peptides | |
| HY-P1230 | HAEGT | 852155-81-8 | Peptides |
| HY-P1231 | GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | Peptides | |
| HY-P1232 | HAE | 64111-99-5 | Peptides |
| HY-P1233 | ANQ-11125 | 153966-48-4 | Peptides |
| HY-P1233A | ANQ-11125 (TFA) | Peptides | |
| HY-P1235 | Carperitide | 89213-87-6 | Peptides |
| HY-P1235A | Carperitide (acetate) | 1366000-58-9 | Peptides |
| HY-P1236 | Atrial Natriuretic Peptide (ANP) (1-28), rat, mouse | 88898-17-3 | Peptides |
| HY-P1236A | Atrial Natriuretic Peptide (ANP) (1-28), rat, mouse (TFA) | Peptides | |
| HY-P1237 | C-Type Natriuretic Peptide (CNP) (1-22), human | 127869-51-6 | Peptides |
| HY-P1237A | C-Type Natriuretic Peptide (CNP) (1-22), human (TFA) | 1966153-17-2 | Peptides |
| HY-P1238 | Neuromedin U, rat | 117505-80-3 | Peptides |
| HY-P1238A | Neuromedin U, rat (TFA) | Peptides | |
| HY-P1239 | Neuromedin S(rat) | 843782-19-4 | Peptides |
| HY-P1239A | Neuromedin S(rat) (TFA) | Peptides | |
| HY-P1240 | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat | 149635-73-4 | Peptides |
| HY-P1240A | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA) | Peptides | |
| HY-P1240B | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate) | Peptides | |
| HY-P1241 | BAM(8-22) | 412961-36-5 | Peptides |
| HY-P1241A | BAM(8-22) (TFA) | Peptides | |
| HY-P1242 | NEP(1-40) | 475221-20-6 | Peptides |
| HY-P1242A | NEP(1-40) (TFA) | Peptides | |
| HY-P1242B | NEP(1-40), N-terminal uncapped | Peptides | |
| HY-P1243 | C3bot(154-182) | 1246280-79-4 | Peptides |
| HY-P1243A | C3bot(154-182) (TFA) | Peptides | |
| HY-P1244 | Secretin (33-59), rat | 121028-49-7 | Peptides |
| HY-P1244A | Secretin (33-59), rat (TFA) | Peptides | |
| HY-P1245 | Neuropeptide SF (human) | 192387-39-6 | Peptides |
| HY-P1245A | Neuropeptide SF (human) (acetate) | 2924824-03-1 | Peptides |
| HY-P1246 | Neuropeptide AF (human) | 192387-38-5 | Peptides |
| HY-P1247 | Calcineurin autoinhibitory peptide | 148067-21-4 | Peptides |
| HY-P1247A | Calcineurin autoinhibitory peptide (TFA) | Peptides | |
| HY-P1248 | Neuropeptide FF | 99566-27-5 | Peptides |
| HY-P1249 | Neuropeptide SF(mouse,rat) | 230960-31-3 | Peptides |
| HY-P1249A | Neuropeptide SF(mouse,rat) (TFA) | Peptides | |
| HY-P1250 | RFRP-3(human) | 311309-27-0 | Peptides |
| HY-P1250A | RFRP-3(human) (TFA) | Peptides | |
| HY-P1252 | Parathyroid Hormone (1-34), bovine | 12583-68-5 | Peptides |
| HY-P1252A | Parathyroid Hormone (1-34), bovine (TFA) | Peptides | |
| HY-P1253 | α-Endorphin (human) | 59004-96-5 | Peptides |
| HY-P1254 | Beta-Lipotropin (1-10), porcine | 77875-68-4 | Peptides |
| HY-P1255 | Kinetensin | 103131-69-7 | Peptides |
| HY-P1256 | JMV 449 | 139026-66-7 | Peptides |
| HY-P1256C | JMV 449 (acetate) | 141863-45-8 | Peptides |
| HY-P1257 | Xenin-8 | 117442-28-1 | Peptides |
| HY-P1257A | Xenin-8 (TFA) | Peptides | |
| HY-P1258 | PSI | 158442-41-2 | Peptides |
| HY-P1258A | PSI (TFA) | Peptides | |
| HY-P1259 | PR-39 | 139637-11-9 | Peptides |
| HY-P1259A | PR-39 (TFA) | Peptides | |
| HY-P1260 | FSLLRY-NH2 | 245329-02-6 | Peptides |
| HY-P1260A | FSLLRY-NH2 (TFA) | Peptides | |
| HY-P1261 | Parstatin(mouse) | 1065756-01-5 | Peptides |
| HY-P1261A | Parstatin(mouse) (TFA) | Peptides | |
| HY-P1262 | Parstatin(human) | 1065755-99-8 | Peptides |
| HY-P1262A | Parstatin(human) (TFA) | Peptides | |
| HY-P1263 | tcY-NH2 | 327177-34-4 | Peptides |
| HY-P1263A | tcY-NH2 (TFA) | 1262750-73-1 | Peptides |
| HY-P1264 | α-Bungarotoxin | 11032-79-4 | Peptides |
| HY-P1264F | α-Bungarotoxin, FITC labeled | Peptides | |
| HY-P1264F1 | Biotin-α-Bungarotoxin | Peptides | |
| HY-P1266 | α-Conotoxin EI | 170663-33-9 | Peptides |
| HY-P1267 | α-Conotoxin PnIA | 705300-84-1 | Peptides |
| HY-P1267A | α-Conotoxin PnIA (TFA) | Peptides | |
| HY-P1268 | α-Conotoxin PIA | 669050-68-4 | Peptides |
| HY-P1268A | α-Conotoxin PIA (TFA) | Peptides | |
| HY-P1269 | α-Conotoxin AuIB | 216299-21-7 | Peptides |
| HY-P1269A | α-Conotoxin AuIB (TFA) | Peptides | |
| HY-P1270 | α-Conotoxin Im-I | 156467-85-5 | Peptides |
| HY-P1271 | Catestatin | 142211-96-9 | Peptides |
| HY-P1271A | Catestatin (TFA) | Peptides | |
| HY-P1274 | ShK-Dap22 | 220384-25-8 | Peptides |
| HY-P1275 | Tertiapin-Q | 910044-56-3 | Reference compound |
| HY-P1276 | Men 10376 | 135306-85-3 | Peptides |
| HY-P1276A | Men 10376 (TFA) | Peptides | |
| HY-P1277 | GR 94800 | 141636-65-9 | Peptides |
| HY-P1277A | GR 94800 (TFA) | Peptides | |
| HY-P1278 | GR 64349 | 137593-52-3 | Peptides |
| HY-P1278A | GR 64349 (TFA) | Peptides | |
| HY-P1279 | [Lys5,MeLeu9,Nle10]-NKA(4-10) | 137565-28-7 | Peptides |
| HY-P1279A | [Lys5,MeLeu9,Nle10]-NKA(4-10) (TFA) | Peptides | |
| HY-P1280 | Margatoxin | 145808-47-5 | Peptides |
| HY-P1280A | Margatoxin (TFA) | Peptides | |
| HY-P1281 | Kaliotoxin | 145199-73-1 | Peptides |
| HY-P1282 | Agitoxin-2 | 168147-41-9 | Peptides |
| HY-P1282A | Agitoxin-2 (TFA) | Peptides | |
| HY-P1284 | ZIP | 863987-12-6 | Peptides |
| HY-P1284A | ZIP (TFA) | Peptides | |
| HY-P1285 | Conantokin R | 202925-60-8 | Peptides |
| HY-P1286 | PKC β pseudosubstrate | 172308-76-8 | Peptides |
| HY-P1286A | PKC β pseudosubstrate (TFA) | Peptides | |
| HY-P1287 | Conantokin-T | 127476-26-0 | Peptides |
| HY-P1288 | Protein Kinase C (530-558) | 122613-29-0 | Peptides |
| HY-P1289 | [Ala113]MBP(104-118) | 99026-78-5 | Peptides |
| HY-P1289A | [Ala107]MBP(104-118) | 99026-77-4 | Peptides |
| HY-P1289B | [Ala107]MBP(104-118) (TFA) | Peptides | |
| HY-P1289C | [Ala113]MBP(104-118) (TFA) | Peptides | |
| HY-P1290 | PKA Inhibitor Fragment (6-22) amide | 121932-06-7 | Peptides |
| HY-P1290A | PKA Inhibitor Fragment (6-22) amide (TFA) | Peptides | |
| HY-P1291 | PKI 14-22 amide,myristoylated | 201422-03-9 | Peptides |
| HY-P1291A | PKI 14-22 amide,myristoylated (TFA) | Peptides | |
| HY-P1292 | PKG inhibitor peptide | 82801-73-8 | Peptides |
| HY-P1292A | PKG inhibitor peptide (TFA) | Peptides | |
| HY-P1293 | Conantokin G | 93438-65-4 | Peptides |
| HY-P1293A | Conantokin G (TFA) | Peptides | |
| HY-P1294 | α-Helical CRF(9-41) | 90880-23-2 | Peptides |
| HY-P1294A | α-Helical CRF(9-41) (TFA) | Peptides | |
| HY-P1295 | Urocortin, human | 176591-49-4 | Peptides |
| HY-P1296 | Urocortin, rat | 171543-83-2 | Peptides |
| HY-P1296A | Urocortin, rat (TFA) | Peptides | |
| HY-P1297 | CRF(6-33)(human) | 120066-38-8 | Peptides |
| HY-P1297A | CRF(6-33)(human) (TFA) | Peptides | |
| HY-P1298 | Sauvagine | 74434-59-6 | Peptides |
| HY-P1298A | Sauvagine (TFA) | Peptides | |
| HY-P1299 | UFP-101 | 849024-68-6 | Peptides |
| HY-P1299A | UFP-101 (TFA) | Peptides | |
| HY-P1300 | [(pF)Phe4]Nociceptin(1-13)NH2 | 380620-88-2 | Peptides |
| HY-P1300A | [(pF)Phe4]Nociceptin(1-13)NH2 (TFA) | Peptides | |
| HY-P1301 | [Arg14,Lys15]Nociceptin | 236098-40-1 | Peptides |
| HY-P1301A | [Arg14,Lys15]Nociceptin (TFA) | Peptides | |
| HY-P1302 | Orphanin FQ(1-11) | 178249-41-7 | Peptides |
| HY-P1302A | Orphanin FQ(1-11) (TFA) | Peptides | |
| HY-P1303 | CART(62-76)(human,rat) | 210978-19-1 | Peptides |
| HY-P1303A | CART(62-76)(human,rat) (TFA) | Peptides | |
| HY-P1304 | CART(55-102)(human) | 214050-22-3 | Peptides |
| HY-P1304A | CART(55-102)(human) (TFA) | Peptides | |
| HY-P1305 | CART(55-102)(rat) | 209615-79-2 | Peptides |
| HY-P1305A | CART(55-102)(rat) (TFA) | Peptides | |
| HY-P1306 | Obestatin(rat) | 869705-22-6 | Peptides |
| HY-P1306A | Obestatin(rat) (TFA) | 1312186-27-8 | Peptides |
| HY-P1308 | SLIGRL-NH2 | 171436-38-7 | Peptides |
| HY-P1308A | SLIGRL-NH2 (TFA) | 2828432-39-7 | Peptides |
| HY-P1309 | PAR-4 Agonist Peptide, amide | 352017-71-1 | Peptides |
| HY-P1309A | PAR-4 Agonist Peptide, amide (TFA) | 1228078-65-6 | Peptides |
| HY-P1310 | VKGILS-NH2 | 942413-05-0 | Peptides |
| HY-P1310A | VKGILS-NH2 (TFA) | 2828432-41-1 | Peptides |
| HY-P1311 | RLLFT-NH2 | 447408-68-6 | Peptides |
| HY-P1311A | RLLFT-NH2 (TFA) | Peptides | |
| HY-P1312 | LRGILS-NH2 | 245329-01-5 | Peptides |
| HY-P1312A | LRGILS-NH2 (TFA) | Peptides | |
| HY-P1313 | PAR 4 (1-6) (human) | 225779-44-2 | Peptides |
| HY-P1313A | PAR 4 (1-6) (TFA) | Peptides | |
| HY-P1314 | 2-Furoyl-LIGRLO-amide | 729589-58-6 | Peptides |
| HY-P1314A | 2-Furoyl-LIGRLO-amide (TFA) | 2468029-34-5 | Peptides |
| HY-P1315 | Papain inhibitor | 70195-20-9 | Peptides |
| HY-P1316 | Ac-RYYRWK-NH2 | 200959-47-3 | Peptides |
| HY-P1316A | Ac-RYYRWK-NH2 (TFA) | 408305-09-9 | Peptides |
| HY-P1317 | Nociceptin (1-13), amide | 178064-02-3 | Peptides |
| HY-P1317A | Nociceptin (1-13), amide (TFA) | Peptides | |
| HY-P1318 | Ac-RYYRIK-NH2 | 200959-48-4 | Peptides |
| HY-P1318A | Ac-RYYRIK-NH2 (TFA) | Peptides | |
| HY-P1319 | Nociceptin(1-7) | 178249-42-8 | Peptides |
| HY-P1319A | Nociceptin(1-7) (TFA) | Peptides | |
| HY-P1320 | [Nphe1]Nociceptin(1-13)NH2 | 267234-08-2 | Peptides |
| HY-P1320A | [Nphe1]Nociceptin(1-13)NH2 (TFA) | Peptides | |
| HY-P1321 | GR231118 | 158859-98-4 | Peptides |
| HY-P1321A | GR231118 (TFA) | Peptides | |
| HY-P1322 | [D-Trp34]-Neuropeptide Y | 153549-84-9 | Peptides |
| HY-P1322A | [D-Trp34]-Neuropeptide Y (TFA) | Peptides | |
| HY-P1323 | [Leu31,Pro34]-Neuropeptide Y (human,rat) | 132699-73-1 | Peptides |
| HY-P1323A | [Leu31,Pro34]-Neuropeptide Y(human,rat,mouse) (TFA) | Peptides | |
| HY-P1324 | [cPP1-7,NPY19-23,Ala31,Aib32,Gln34]-hPancreatic Polypeptide | 313988-89-5 | Peptides |
| HY-P1324A | [cPP1-7,NPY19-23,Ala31,Aib32,Gln34]-hPancreatic polypeptide (TFA) | Peptides | |
| HY-P1325 | BWX 46 | 172997-92-1 | Peptides |
| HY-P1328 | TAT-14 | 1362661-34-4 | Peptides |
| HY-P1328A | TAT-14 (TFA) | Peptides | |
| HY-P1329 | CTOP | 103429-31-8 | Peptides |
| HY-P1329A | CTOP (TFA) | Peptides | |
| HY-P1330 | Purotoxin 1 | 1396322-38-5 | Peptides |
| HY-P1331 | BAM-22P | 76622-26-9 | Peptides |
| HY-P1332 | DSLET | 75644-90-5 | Peptides |
| HY-P1333 | Dynorphin A | 80448-90-4 | Peptides |
| HY-P1333A | Dynorphin A (TFA) | Peptides | |
| HY-P1334 | DPDPE | 88373-73-3 | Peptides |
| HY-P1334A | DPDPE (TFA) | 172888-59-4 | Peptides |
| HY-P1335 | CTAP | 103429-32-9 | Peptides |
| HY-P1335A | CTAP (TFA) | Peptides | |
| HY-P1336 | Deltorphin I | 122752-15-2 | Peptides |
| HY-P1337 | Dynorphin B (1-13) | 83335-41-5 | Peptides |
| HY-P1337A | Dynorphin B (1-13) (TFA) | Peptides | |
| HY-P1338 | PL-017 | 83397-56-2 | Peptides |
| HY-P1338A | PL-017 (TFA) | Peptides | |
| HY-P1339 | Orexin B, human | 205640-91-1 | Peptides |
| HY-P1339A | Orexin B, human (TFA) | Peptides | |
| HY-P1339B | Orexin B, human (acetate) | Peptides | |
| HY-P1340 | [Ala11,D-Leu15]-Orexin B(human) | 532932-99-3 | Peptides |
| HY-P1340A | [Ala11,D-Leu15]-Orexin B(human) (TFA) | Peptides | |
| HY-P1341 | OXA(17-33) | 343268-91-7 | Peptides |
| HY-P1341A | OXA(17-33) (TFA) | Peptides | |
| HY-P1342 | Prosaptide Tx14(A) | 196391-82-9 | Peptides |
| HY-P1342A | Prosaptide Tx14(A) (TFA) | Peptides | |
| HY-P1343 | Frog 26RFa | 881640-56-8 | Peptides |
| HY-P1344 | DAPK Substrate Peptide | 386769-53-5 | Peptides |
| HY-P1344A | DAPK Substrate Peptide (TFA) | Peptides | |
| HY-P1345 | TLQP-21 | 869988-94-3 | Peptides |
| HY-P1345A | TLQP-21 (TFA) | Peptides | |
| HY-P1346 | APETx2 | 713544-47-9 | Peptides |
| HY-P1346A | APETx2 (TFA) | Peptides | |
| HY-P1347 | RETF-4NA | 1160928-63-1 | Peptides |
| HY-P1347A | RETF-4NA (TFA) | Peptides | |
| HY-P1348 | GLP-1 moiety from Dulaglutide | 1197810-60-8 | Peptides |
| HY-P1349 | Orexin B, rat, mouse | 202801-92-1 | Peptides |
| HY-P1349A | Orexin B, rat, mouse (TFA) | Peptides | |
| HY-P1350 | H-Lys-Trp-Lys-OH | 38579-27-0 | Peptides |
| HY-P1351 | Angiopep-2-Cys | 906480-09-9 | Peptides |
| HY-P1354 | Cyclosporin A-Derivative 2 | 156047-45-9 | Peptides |
| HY-P1355 | Cyclosporin A-Derivative 1 | 1487360-85-9 | Peptides |
| HY-P1355A | Cyclosporin A-Derivative 1 (Free base) | 286852-20-8 | Peptides |
| HY-P1358 | Alisporivir intermediate-1 | 882506-05-0 | Peptides |
| HY-P1360 | H-D-MeAla-EtVaI-VaI-MeLeu-AIa-D-AIa-MeLeu-MeLeu-MeVaI-MeBmt(OAc)-Abu-O-CH2-CH2-NHMe | 1038781-13-3 | Peptides |
| HY-P1362 | β-Amyloid (42-1), human | 317366-82-8 | Peptides |
| HY-P1362A | β-Amyloid (42-1), human (TFA) | Peptides | |
| HY-P1362F | Cy5-β-Amyloid (42-1), human | Dye Reagents | |
| HY-P1362FA | Cy5-β-Amyloid (42-1), human (Tris) | Dye Reagents | |
| HY-P1363 | β-Amyloid (1-42), human (TFA) | Peptides | |
| HY-P1363A | β-Amyloid (1-42), human | 107761-42-2 | Peptides |
| HY-P1363B | β-Amyloid (1-42), human, HFIP-treated | 107761-42-2 | Peptides |
| HY-P1363F1 | Biotin-β-Amyloid (1-42), human (TFA) | Peptides | |
| HY-P1363F3 | 5-FAM-β-Amyloid (1-42), human (Tris) | Peptides | |
| HY-P1363S | β-Amyloid-15N (1-42), human (TFA) | Isotope-Labeled Compounds | |
| HY-P1365 | α-Conotoxin MII | 175735-93-0 | Peptides |
| HY-P1365A | α-Conotoxin MII (TFA) | Peptides | |
| HY-P1366 | des-Gln14-Ghrelin | 293735-04-3 | Peptides |
| HY-P1366A | des-Gln14-Ghrelin (TFA) | Peptides | |
| HY-P1368 | Stressin I | Peptides | |
| HY-P1368A | Stressin I (TFA) | Peptides | |
| HY-P1369 | DynaMin inhibitory peptide, myristoylated | 251634-22-7 | Peptides |
| HY-P1369A | DynaMin inhibitory peptide, myristoylated (TFA) | Peptides | |
| HY-P1372 | PKC ζ pseudosubstrate | Peptides | |
| HY-P1373 | Neuronostatin-13 (human) | 1096485-24-3 | Peptides |
| HY-P1374 | SYSMEHFRWGKPS | 2320573-08-6 | Peptides |
| HY-P1375 | [D-Trp7,9,10]-Substance P | 89430-38-6 | Peptides |
| HY-P1375A | [D-Trp7,9,10]-Substance P (TFA) | Peptides | |
| HY-P1376 | G-Protein antagonist peptide | 143675-79-0 | Peptides |
| HY-P1376A | G-Protein antagonist peptide (TFA) | Peptides | |
| HY-P1377 | Caffeic acid-pYEEIE | 507471-72-9 | Peptides |
| HY-P1377A | Caffeic acid-pYEEIE (TFA) | Peptides | |
| HY-P1378 | β-Amyloid (1-43)(human) | 134500-80-4 | Peptides |
| HY-P1378A | β-Amyloid (1-43)(human) (TFA) | Peptides | |
| HY-P1379 | C14TKL-1 | 1423381-12-7 | Peptides |
| HY-P1379A | C14TKL-1 (acetate) | Peptides | |
| HY-P1380A | Difopein (TFA) | Peptides | |
| HY-P1382 | Rac1 Inhibitor W56 | 1095179-01-3 | Peptides |
| HY-P1382A | Rac1 Inhibitor W56 (TFA) | Peptides | |
| HY-P1383 | Rac1 Inhibitor F56, control peptide | 1315378-77-8 | Peptides |
| HY-P1383A | Rac1 Inhibitor F56, control peptide (TFA) | Peptides | |
| HY-P1387 | β-Amyloid (1-40) (rat) | 144409-98-3 | Peptides |
| HY-P1388 | β-Amyloid (1-42), (rat/mouse) | 166090-74-0 | Peptides |
| HY-P1388A | β-Amyloid (1-42), (rat/mouse) (TFA) | Peptides | |
| HY-P1389 | Neuropeptide S (human) | 412938-67-1 | Peptides |
| HY-P1389A | Neuropeptide S (human) (TFA) | Peptides | |
| HY-P1390 | d[Cha4]-AVP | 500170-27-4 | Peptides |
| HY-P1390A | d[Cha4]-AVP (TFA) | Peptides | |
| HY-P1391 | ZIP(Scrambled) | 908012-18-0 | Peptides |
| HY-P1391A | ZIP(Scrambled) (TFA) | Peptides | |
| HY-P1393 | AC 187 | 151804-77-2 | Peptides |
| HY-P1393A | AC 187 (TFA) | Peptides | |
| HY-P1396 | GRK2i | 148505-03-7 | Peptides |
| HY-P1396A | GRK2i (TFA) | Peptides | |
| HY-P1397 | RVD-Hpα | 1193362-76-3 | Peptides |
| HY-P1397A | RVD-Hpα (TFA) | 1431329-51-9 | Peptides |
| HY-P1398 | Compstatin control peptide | 301544-78-5 | Peptides |
| HY-P1398A | Compstatin control peptide (TFA) | Peptides | |
| HY-P1399 | Pep2m, myristoylated | 1423381-07-0 | Peptides |
| HY-P1399A | Pep2m, myristoylated (TFA) | Peptides | |
| HY-P1401 | Protein Kinase C (19-36) | 113731-96-7 | Peptides |
| HY-P1402 | [Glu27]-PKC (19-36) | 309247-49-2 | Peptides |
| HY-P1403 | Tertiapin LQ | Peptides | |
| HY-P1404 | R8-T198wt | 2305815-72-7 | Peptides |
| HY-P1405 | Pam3CSK4-Biotin | 1429504-10-8 | Peptides |
| HY-P1407 | Z-VRPR-FMK (TFA) | Peptides | |
| HY-P1408 | Obtustatin | 404882-00-4 | Peptides |
| HY-P1408A | Obtustatin (triacetate) | Peptides | |
| HY-P1409 | ADWX 1 | Peptides | |
| HY-P1409A | ADWX 1 (TFA) | Peptides | |
| HY-P1410 | GsMTx4 | 1209500-46-8 | Peptides |
| HY-P1410A | GsMTx4 (TFA) | Peptides | |
| HY-P1410B | D-GsMTx4 | Peptides | |
| HY-P1410C | D-GsMTx4 (TFA) | Peptides | |
| HY-P1411 | Psalmotoxin 1 | 880107-52-8 | Peptides |
| HY-P1411A | Psalmotoxin 1 (TFA) | Peptides | |
| HY-P1415 | Norleual | 334994-34-2 | Peptides |
| HY-P1415A | Norleual (TFA) | Peptides | |
| HY-P1416 | Foxy-5 | 881188-51-8 | Peptides |
| HY-P1416A | Foxy-5 (TFA) | Peptides | |
| HY-P1418 | DPC-AJ1951 | 943519-33-3 | Peptides |
| HY-P1418A | DPC-AJ1951 (TFA) | Peptides | |
| HY-P1419 | AP 811 | 124833-45-0 | Peptides |
| HY-P1419A | AP 811 (acetate) | Peptides | |
| HY-P1420 | TAT-cyclo-CLLFVY | 1446322-66-2 | Peptides |
| HY-P1420A | TAT-cyclo-CLLFVY (TFA) | Peptides | |
| HY-P1421 | Obestatin(human) | 1081110-72-6 | Peptides |
| HY-P1421A | Obestatin(human) (TFA) | Peptides | |
| HY-P1422 | Spadin | 1270083-24-3 | Peptides |
| HY-P1422A | Spadin (TFA) | Peptides | |
| HY-P1423 | BA 1 | 183241-31-8 | Peptides |
| HY-P1423A | BA 1 (TFA) | Peptides | |
| HY-P1424 | Lei-Dab7 | 1061556-49-7 | Peptides |
| HY-P1424A | Lei-Dab7 (TFA) | Peptides | |
| HY-P1425 | (Z-LL)2 ketone | 313664-40-3 | Peptides |
| HY-P1426 | AmmTX3 | Peptides | |
| HY-P1426A | AmmTX3 (TFA) | Peptides | |
| HY-P1427 | Guangxitoxin 1E | 1233152-82-3 | Peptides |
| HY-P1427A | Guangxitoxin 1E (TFA) | Peptides | |
| HY-P1428 | RFRP-1(human) | 311309-25-8 | Peptides |
| HY-P1428A | RFRP-1(human) (TFA) | Peptides | |
| HY-P1430 | 11R-VIVIT | 592517-80-1 | Peptides |
| HY-P1430A | 11R-VIVIT (TFA) | Peptides | |
| HY-P1432 | K-(D-1-Nal)-FwLL-NH2 | 1394288-22-2 | Peptides |
| HY-P1432A | K-(D-1-Nal)-FwLL-NH2 (TFA) | Peptides | |
| HY-P1434 | [Pro3]-GIP (mouse) | Peptides | |
| HY-P1435 | NoxA1ds | 1435893-78-9 | Peptides |
| HY-P1435A | NoxA1ds (TFA) | Peptides | |
| HY-P1436 | Acetyl-pepstatin | 11076-29-2 | Peptides |
| HY-P1437 | Neuropeptide S (mouse) | 412938-74-0 | Peptides |
| HY-P1437A | Neuropeptide S(Mouse) (TFA) | Peptides | |
| HY-P1438 | Neuropeptide S(Rat) | 412938-75-1 | Peptides |
| HY-P1438A | Neuropeptide S(Rat) (TFA) | Peptides | |
| HY-P1439 | RS 09 | 1449566-36-2 | Peptides |
| HY-P1439A | RS 09 (TFA) | Peptides | |
| HY-P1440 | BeKm-1 | 524962-01-4 | Peptides |
| HY-P1440A | BeKm-1 (TFA) | Peptides | |
| HY-P1441 | Mambalgin 1 | 1609937-15-6 | Peptides |
| HY-P1441A | Mambalgin 1 (TFA) | Peptides | |
| HY-P1442 | AdTx1 | Peptides | |
| HY-P1443 | OD1 | Peptides | |
| HY-P1444 | Acein | 2022202-76-0 | Peptides |
| HY-P1445 | HAEGTFTSDVSSYLE | 926018-57-7 | Peptides |
| HY-P1446 | Cholera toxin | 9012-63-9 | Reference compound |
| HY-P1447 | Exendin-3/4 (64-86) | Peptides | |
| HY-P1448 | Ac-Leu-Arg-AMC | 929621-79-4 | Dye Reagents |
| HY-P1449 | Boc-Gly-Gly-Phe-Gly-OH | 187794-49-6 | Peptides |
| HY-P1449A | Boc-Gly-Gly-Phe-Gly-OH (TFA) | 2450273-39-7 | Peptides |
| HY-P1452A | RNAIII-inhibiting peptide(TFA) | 2703745-76-8 | Peptides |
| HY-P1453 | CMD178 | Peptides | |
| HY-P1453A | CMD178 (TFA) | Peptides | |
| HY-P1454 | Fz7-21 | 2247635-23-8 | Peptides |
| HY-P1454A | Fz7-21 (TFA) | Peptides | |
| HY-P1454B | Fz7-21S | 2247635-24-9 | Peptides |
| HY-P1455 | Adrenomedullin (AM) (1-52), human | 148498-78-6 | Peptides |
| HY-P1455A | Adrenomedullin (AM) (1-52), human (TFA) | Peptides | |
| HY-P1457 | Adrenomedullin (AM) (13-52), human | 154765-05-6 | Peptides |
| HY-P1459 | Sphistin Synthetic Peptide(12-38,Fitc in N-Terminal-Fluorescently Labeled Peptide) | Peptides | |
| HY-P1460 | His-[D-2-ME-Trp]-Ala | Peptides | |
| HY-P1463 | Calcitonin, eel | 57014-02-5 | Peptides |
| HY-P1463A | Calcitonin, eel (TFA) | Peptides | |
| HY-P1464 | Amylin, amide, rat | 124447-81-0 | Peptides |
| HY-P1465 | Secretin (28-54), human | 108153-74-8 | Peptides |
| HY-P1465A | Secretin (28-54), human (TFA) | Peptides | |
| HY-P1466 | β-Amyloid (1-16) | 131580-10-4 | Peptides |
| HY-P1467 | [Met5]-Enkephalin, amide | 60117-17-1 | Peptides |
| HY-P1467A | [Met5]-Enkephalin, amide (TFA) | 2918768-28-0 | Peptides |
| HY-P1468 | β-Amyloid (1-28) | 109770-29-8 | Peptides |
| HY-P1468F | Biotin-β-amyloid (1-28) | Peptides | |
| HY-P1468F1 | 5-FAM-β-Amyloid (1-28) | Peptides | |
| HY-P1469 | Bradykinin (1-6) | 23815-88-5 | Peptides |
| HY-P1470 | [Leu5]-Enkephalin, amide | 60117-24-0 | Peptides |
| HY-P1471 | Adrenomedullin (AM) (22-52), human | 159899-65-7 | Peptides |
| HY-P1471A | Adrenomedullin (AM) (22-52), human (TFA) | Peptides | |
| HY-P1473 | Amylin (8-37), rat | 138398-61-5 | Peptides |
| HY-P1474 | β-Amyloid (22-35) | 144189-71-9 | Peptides |
| HY-P1474A | β-Amyloid (22-35) (TFA) | Peptides | |
| HY-P1475 | C-Peptide, dog | 39016-05-2 | Peptides |
| HY-P1476 | Adrenocorticotropic Hormone (ACTH) (18-39), human | 53917-42-3 | Peptides |
| HY-P1476A | Adrenocorticotropic Hormone (ACTH) (18-39), human (TFA) | 73724-75-1 | Peptides |
| HY-P1477 | Adrenocorticotropic Hormone (ACTH) (1-39), rat | 77465-10-2 | Peptides |
| HY-P1477A | Adrenocorticotropic Hormone (ACTH) (1-39), rat (TFA) | Peptides | |
| HY-P1478 | Adrenocorticotropic Hormone (ACTH) (4-10), human | 4037-01-8 | Peptides |
| HY-P1479 | Calmodulin-Dependent Protein Kinase II (290-309) | 115044-69-4 | Peptides |
| HY-P1479A | Calmodulin-Dependent Protein Kinase II(290-309) (acetate) | Peptides | |
| HY-P1480 | Neuropeptide Y (13-36), amide, human | 122341-40-6 | Peptides |
| HY-P1481 | β-Casomorphin, human | 102029-74-3 | Peptides |
| HY-P1481A | β-Casomorphin, human (TFA) | Peptides | |
| HY-P1482 | α-Factor Mating Pheromone, yeast | 59401-28-4 | Peptides |
| HY-P1482A | α-Factor Mating Pheromone, yeast (TFA) | Peptides | |
| HY-P1482R | α-Factor Mating Pheromone, yeast (Standard) | 59401-28-4 | Reference Standards |
| HY-P1483 | Urotensin II, mouse | 405137-01-1 | Peptides |
| HY-P1483A | Urotensin II, mouse (TFA) | Peptides | |
| HY-P1483B | Urotensin II, mouse (acetate) | Peptides | |
| HY-P1484 | Bradykinin (1-7) | 23815-87-4 | Peptides |
| HY-P1485 | Substance P(1-7) | 68060-49-1 | Peptides |
| HY-P1485A | Substance P(1-7) (TFA) | 2828433-22-1 | Peptides |
| HY-P1486 | Angiotensinogen (1-14), human | 104180-23-6 | Peptides |
| HY-P1486A | Angiotensinogen (1-14), human (TFA) | Peptides | |
| HY-P1487 | Pressinoic Acid | 35748-51-7 | Peptides |
| HY-P1488 | Bradykinin (1-5) | 23815-89-6 | Peptides |
| HY-P1489 | OVA Peptide(257-264) | 138831-86-4 | Peptides |
| HY-P1489A | OVA Peptide(257-264) (TFA) | 1262751-08-5 | Peptides |
| HY-P1489B | OVA Peptide(257-264) (acetate salt) | Peptides | |
| HY-P1489F | FAM-OVA (257-264) | Peptides | |
| HY-P1490 | Bradykinin (2-9) | 16875-11-9 | Peptides |
| HY-P1491 | HIV-1 TAT (48-60) | 220408-24-2 | Peptides |
| HY-P1492 | Substance P (7-11) | 51165-05-0 | Peptides |
| HY-P1493 | Fibrinopeptide B, human | 36204-23-6 | Peptides |
| HY-P1493A | Fibrinopeptide B, human (TFA) | Peptides | |
| HY-P1494 | Substance P (1-9) | 57468-17-4 | Peptides |
| HY-P1495 | Small Cardioactive Peptide B (SCPB) | 84746-43-0 | Peptides |
| HY-P1496 | Leucokinin VIII | 2703746-05-6 | Peptides |
| HY-P1497 | Bradykinin (1-3) | 23815-91-0 | Peptides |
| HY-P1498 | Substance P, Free Acid | 71977-09-8 | Peptides |
| HY-P1499 | Somatostatin-28 (1-14) | 79243-10-0 | Peptides |
| HY-P1501 | δ-Sleep Inducing Peptide | 62568-57-4 | Peptides |
| HY-P1501A | δ-Sleep Inducing Peptide (acetate) | Peptides | |
| HY-P1502 | β-Endorphin, human | 61214-51-5 | Reference compound |
| HY-P1502F | Biocytin-β-endorphin, human | Peptides | |
| HY-P1503 | ACTH (4-11) | 67224-41-3 | Peptides |
| HY-P1504 | β-Melanocyte Stimulating Hormone (MSH), human | 17908-57-5 | Peptides |
| HY-P1504A | β-Melanocyte Stimulating Hormone (MSH), human (TFA) | Peptides | |
| HY-P1505 | C3a (70-77) | 63555-63-5 | Peptides |
| HY-P1505A | C3a (70-77) (TFA) | Peptides | |
| HY-P1506 | [Nle11]-Substance P | 57462-42-7 | Peptides |
| HY-P1507 | Fibrinogen Binding Inhibitor Peptide | 89105-94-2 | Peptides |
| HY-P1508 | Bactenecin | 116229-36-8 | Peptides |
| HY-P1508A | Bactenecin (TFA) | Peptides | |
| HY-P1509 | Rhodopsin Epitope Tag | 102099-07-0 | Peptides |
| HY-P1510 | β-Amyloid (1-11) | 190436-05-6 | Peptides |
| HY-P1511 | PACAP-Related Peptide (PRP), human | Peptides | |
| HY-P1512 | Antioxidant peptide A | 159147-88-3 | Peptides |
| HY-P1512A | Antioxidant peptide A (TFA) | Peptides | |
| HY-P1513 | LL-37 scrambled peptide | Peptides | |
| HY-P1513A | LL-37 scrambled peptide (acetate) | Peptides | |
| HY-P1514 | Peptide YY (PYY), human | 118997-30-1 | Peptides |
| HY-P1515 | Angiotensin II (3-8), human | 12676-15-2 | Peptides |
| HY-P1515A | Angiotensin II (3-8), human (TFA) | Peptides | |
| HY-P1516 | Angiogenin (108-122) | 112173-49-6 | Peptides |
| HY-P1516A | Angiogenin (108-122) (TFA) | Peptides | |
| HY-P1517 | β-Amyloid (31-35) | 149385-65-9 | Peptides |
| HY-P1518 | Adrenocorticotropic Hormone (ACTH) (1-10), human | 2791-05-1 | Peptides |
| HY-P1519 | Brain Natriuretic Peptide (1-32), rat | 133448-20-1 | Peptides |
| HY-P1519B | Brain Natriuretic Peptide (1-32), rat (acetate) | Peptides | |
| HY-P1520 | Prolactin Releasing Peptide (1-31), human | 215510-22-8 | Peptides |
| HY-P1520A | Prolactin Releasing Peptide (1-31), human (acetate) | Peptides | |
| HY-P1521 | β-Amyloid (15-21) | 365537-52-6 | Peptides |
| HY-P1522 | β-Amyloid (29-40) | 184865-04-1 | Peptides |
| HY-P1523 | Leptin (22-56), human | 183598-56-3 | Peptides |
| HY-P1524 | β-Amyloid (1-14),mouse,rat | Peptides | |
| HY-P1525 | Melanin Concentrating Hormone, salmon | 87218-84-6 | Peptides |
| HY-P1525A | Melanin Concentrating Hormone, salmon (TFA) | Peptides | |
| HY-P1526 | ANP [Des18-22] 4-23 amide (rat) | 111863-73-1 | Peptides |
| HY-P1527 | Bim BH3 | 505070-06-4 | Peptides |
| HY-P1528 | Autocamtide 2, amide | Peptides | |
| HY-P1529 | Thyrotropin-Releasing Hormone (TRH), Free Acid | 24769-58-2 | Natural Products |
| HY-P1530 | Prolactin Releasing Peptide (12-31), human | 235433-36-0 | Peptides |
| HY-P1531 | γ-1-Melanocyte Stimulating Hormone (MSH), amide | 72629-65-3 | Peptides |
| HY-P1532 | Pancreatic Polypeptide, rat | 90419-12-8 | Peptides |
| HY-P1533 | CRF, bovine | 92307-52-3 | Peptides |
| HY-P1533A | CRF, bovine (TFA) | Peptides | |
| HY-P1534 | Adrenomedullin (1-50), rat | Peptides | |
| HY-P1535 | Secretin, porcine | 17034-34-3 | Peptides |
| HY-P1535A | Secretin, porcine (TFA) | Peptides | |
| HY-P1536 | Thrombin Receptor Activator for Peptide 5 (TRAP-5) | 141685-53-2 | Peptides |
| HY-P1537 | Pancreatic Polypeptide, bovine | 179986-89-1 | Peptides |
| HY-P1538 | Fibrinopeptide A, human | 25422-31-5 | Peptides |
| HY-P1538A | Fibrinopeptide A, human (TFA) | 61533-47-9 | Peptides |
| HY-P1539 | Cecropin A | 80451-04-3 | Peptides |
| HY-P1539A | Cecropin A (TFA) | Peptides | |
| HY-P1540 | Angiotensin III, human, mouse | 13602-53-4 | Peptides |
| HY-P1540A | Angiotensin III, human, mouse (TFA) | Peptides | |
| HY-P1541 | Motilin, canine | 85490-53-5 | Peptides |
| HY-P1542 | Urotensin I | 83930-33-0 | Peptides |
| HY-P1542B | Urotensin I (TFA) | Peptides | |
| HY-P1543 | Exendin-3 | 130357-25-4 | Peptides |
| HY-P1544 | Cerebellin | 94071-26-8 | Peptides |
| HY-P1545 | ACTH (1-17) | 7266-47-9 | Peptides |
| HY-P1545A | ACTH (1-17) (TFA) | Peptides | |
| HY-P1546 | Bombinin-Like Peptide (BLP-1) | 138220-00-5 | Peptides |
| HY-P1547 | Somatostatin-25 | 76461-17-1 | Peptides |
| HY-P1548 | β-CGRP, human | 101462-82-2 | Peptides |
| HY-P1548A | β-CGRP, human (TFA) | Peptides | |
| HY-P1548B | β-CGRP, human (acetate) | Peptides | |
| HY-P1555 | ACTH (1-13) | 22006-64-0 | Peptides |
| HY-P1556 | Vasonatrin Peptide (VNP) | 141676-35-9 | Peptides |
| HY-P1556A | Vasonatrin Peptide (VNP) (TFA) | Peptides | |
| HY-P1557 | Somatostatin-28 (1-12) | 81286-16-0 | Peptides |
| HY-P1558 | ACTH (11-24) | 4237-93-8 | Peptides |
| HY-P1558A | ACTH (11-24) (acetate) | Peptides | |
| HY-P1558B | ACTH (11-24) (hexaacetate) | 79190-56-0 | Peptides |
| HY-P1559 | GRGDSPC | 91575-26-7 | Peptides |
| HY-P1559A | GRGDSPC (TFA) | Peptides | |
| HY-P1560 | Allergen Gal d 4 (46-61), chicken | 62982-31-4 | Peptides |
| HY-P1561 | PKG Substrate | 81187-14-6 | Peptides |
| HY-P1562 | PUMA BH3 | Peptides | |
| HY-P1562A | PUMA BH3 (TFA) | Peptides | |
| HY-P1563 | Osteogenic Growth Peptide, OGP | 132996-61-3 | Peptides |
| HY-P1564 | [Sar1, Ile8]-Angiotensin II | 37827-06-8 | Peptides |
| HY-P1564A | [Sar1, Ile8]-Angiotensin II (TFA) | Peptides | |
| HY-P1565 | Transdermal Peptide Disulfide | 888486-23-5 | Peptides |
| HY-P1565A | Transdermal Peptide Disulfide (TFA) | Peptides | |
| HY-P1566 | MPG, HIV related | 395069-92-8 | Peptides |
| HY-P1567 | β-Amyloid (10-35), amide | 181427-66-7 | Peptides |
| HY-P1568 | Flagelin 22 | 304642-91-9 | Peptides |
| HY-P1568A | Flagelin 22 (TFA) | Peptides | |
| HY-P1569 | LCMV gp33-41 | 151705-84-9 | Peptides |
| HY-P1569A | LCMV gp33-41 (TFA) | Peptides | |
| HY-P1571 | Nucleoprotein (396-404) | 158475-79-7 | Peptides |
| HY-P1571A | Nucleoprotein (396-404) (TFA) | Peptides | |
| HY-P1572 | Handle region peptide, rat | 749227-53-0 | Peptides |
| HY-P1573 | Brain Natriuretic Peptide-45, rat | 123337-89-3 | Peptides |
| HY-P1573A | Brain Natriuretic Peptide-45, rat (TFA) | Peptides | |
| HY-P1574 | [Arg8]-Vasotocin | 113-80-4 | Peptides |
| HY-P1574A | [Arg8]-Vasotocin (TFA) | Peptides | |
| HY-P1575 | TAT (48-57) | 253141-50-3 | Peptides |
| HY-P1575A | TAT (48-57) (TFA) | Peptides | |
| HY-P1576 | AMARA peptide | 163560-19-8 | Peptides |
| HY-P1576A | AMARA peptide (TFA) | Peptides | |
| HY-P1577 | Dermorphin Analog | 115814-08-9 | Peptides |
| HY-P1578 | Galanin (1-16), mouse, porcine, rat | 125118-77-6 | Peptides |
| HY-P1578A | Galanin (1-16), mouse, porcine, rat (TFA) | Peptides | |
| HY-P1580 | PA (224-233), Influenza | 271573-27-4 | Peptides |
| HY-P1581 | Ceratotoxin A | 150671-04-8 | Peptides |
| HY-P1582 | ACTH (1-14) | 25696-21-3 | Peptides |
| HY-P1582A | ACTH (1-14) (TFA) | Peptides | |
| HY-P1583 | MARK Substrate | 847991-34-8 | Peptides |
| HY-P1584 | Nucleoprotein (118-126) | 124454-83-7 | Peptides |
| HY-P1585 | Gp100 (25-33), human | 212370-40-6 | Peptides |
| HY-P1585A | Gp100 (25-33), human (TFA) | Peptides | |
| HY-P1586 | HIV-1 Rev (34-50) | 141237-50-5 | Peptides |
| HY-P1587 | IRBP (1-20), human | 298202-25-2 | Peptides |
| HY-P1587A | IRBP (1-20), human (TFA) | Peptides | |
| HY-P1588 | Scyliorhinin II | 112748-19-3 | Peptides |
| HY-P1589 | β-catenin peptide | 265669-37-2 | Peptides |
| HY-P1590 | Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9) | 247171-44-4 | Peptides |
| HY-P1591 | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | 71901-21-8 | Peptides |
| HY-P1591A | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys (TFA) | 2918767-97-0 | Peptides |
| HY-P1592 | G3-C12 | 848301-94-0 | Peptides |
| HY-P1592A | G3-C12 (TFA) | Peptides | |
| HY-P1593 | Mini Gastrin I, human | 54405-27-5 | Peptides |
| HY-P1593A | Mini Gastrin I, human (TFA) | Peptides | |
| HY-P1594 | Dynorphin A (1-10) | 79994-24-4 | Peptides |
| HY-P1594A | Dynorphin A (1-10) (TFA) | Peptides | |
| HY-P1595 | CREBtide | 149155-45-3 | Peptides |
| HY-P1595A | CREBtide (TFA) | Peptides | |
| HY-P1596 | Gluten Exorphin C | 142479-62-7 | Peptides |
| HY-P1597 | Malantide | 86555-35-3 | Peptides |
| HY-P1597A | Malantide (TFA) | Peptides | |
| HY-P1598 | GroES mobile loop | Peptides | |
| HY-P1599 | Valorphin | 144313-54-2 | Reference compound |
| HY-P1600 | Tyr-Somatostatin-14 | 58100-03-1 | Peptides |
| HY-P1601 | Neuropeptide Y(29-64) | 303052-45-1 | Peptides |
| HY-P1602 | Apidaecin IB | 123276-94-8 | Reference compound |
| HY-P1603 | ACTH (22-39) | 37548-29-1 | Peptides |
| HY-P1604 | ATX-II | 60748-45-0 | Peptides |
| HY-P1604A | ATX-II (TFA) | Peptides | |
| HY-P1607 | Nisin | 1414-45-5 | Peptides |
| HY-P1610 | Asudemotide | 1018833-53-8 | Peptides |
| HY-P1612 | Hormaomycin | 121548-21-8 | Peptides |
| HY-P1613 | Cyclo(Arg-Gly-Asp-D-Phe-Val) | 137813-35-5 | Peptides |
| HY-P1613A | Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) | 199807-33-5 | Peptides |
| HY-P1615 | Cenupatide | 1006388-38-0 | Peptides |
| HY-P1617 | LY 190388 | 105496-35-3 | Peptides |
| HY-P1618 | LY-281217 | 105027-75-6 | Peptides |
| HY-P1619 | ICI 186756 | 95500-67-7 | Reference compound |
| HY-P1624 | Teduglutide | 197922-42-2 | Peptides |
| HY-P1624A | Teduglutide (TFA) | Peptides | |
| HY-P1625 | Daeatal | 103614-28-4 | Peptides |
| HY-P1626 | Acetyl tetrapeptide-15 | 928007-64-1 | Peptides |
| HY-P1628 | Ganirelix | 124904-93-4 | Peptides |
| HY-P1629 | Temporin A | 188713-69-1 | Peptides |
| HY-P1630 | Buforin II | 172998-24-2 | Peptides |
| HY-P1631 | Polyphemusin I | 125139-67-5 | Peptides |
| HY-P1632 | Tachyplesin I | 118231-04-2 | Peptides |
| HY-P1632A | Tachyplesin I (TFA) | Peptides | |
| HY-P1633 | Protegrin-1 | 168831-77-4 | Peptides |
| HY-P1635 | Pepsin | 9001-75-6 | Enzyme |
| HY-P1636 | Hirudin (54-65) | 485816-48-6 | Peptides |
| HY-P1636A | Hirudin (54-65) (TFA) | Peptides | |
| HY-P1638 | Isariin A | 10409-85-5 | Peptides |
| HY-P1640 | (Trp63,Trp64)-C3a(63-77) | 130154-64-2 | Peptides |
| HY-P1645 | Papain | 9001-73-4 | Natural Products |
| HY-P1649 | SPR741 | 1179330-52-9 | Peptides |
| HY-P1649A | SPR741 (TFA) | Peptides | |
| HY-P1649B | SPR741 (acetate) | Peptides | |
| HY-P1651 | SOR-C13 | 1187852-48-7 | Peptides |
| HY-P1651A | SOR-C13 (TFA) | Peptides | |
| HY-P1651B | SOR-C13 (acetate) | Peptides | |
| HY-P1654 | A20FMDV2 | 932699-03-1 | Peptides |
| HY-P1662 | GLGPNPCRKKCYKRDFLGR | Peptides | |
| HY-P1663 | ATWLPPR Peptide | 272121-15-0 | Peptides |
| HY-P1663A | ATWLPPR Peptide (TFA) | Reference compound | |
| HY-P1674 | Murepavadin | 944252-63-5 | Peptides |
| HY-P1674A | Murepavadin (TFA) | Peptides | |
| HY-P1675A | Acetyl-PHF6 amide (TFA) | Peptides | |
| HY-P1676 | cyclo(RLsKDK) | 1975145-82-4 | Peptides |
| HY-P1676A | cyclo(RLsKDK) (TFA) | Peptides | |
| HY-P1680 | Astin C | 148057-23-2 | Peptides |
| HY-P1681 | GpTx-1 | 1661050-12-9 | Peptides |
| HY-P1681A | GpTx-1 (TFA) | Peptides | |
| HY-P1682 | Balixafortide | 1051366-32-5 | Peptides |
| HY-P1682A | Balixafortide (TFA) | Peptides | |
| HY-P1684 | Peptide P60 | 1319725-20-6 | Peptides |
| HY-P1685 | Ranatensin | 29451-71-6 | Peptides |
| HY-P1687 | Siomycin A | 12656-09-6 | Reference compound |
| HY-P1691 | Leucopyrokinin | 104052-00-8 | Peptides |
| HY-P1694 | B4148 | 103412-37-9 | Peptides |
| HY-P1695 | Cinnamycin | 110655-58-8 | Reference compound |
| HY-P1698 | Reltecimod | 1447799-33-8 | Peptides |
| HY-P1698B | Reltecimod (TFA) | Peptides | |
| HY-P1699 | Aurantimycin A | 162478-50-4 | Reference compound |
| HY-P1700 | BCMA72-80 | 2293841-58-2 | Peptides |
| HY-P1701 | Morphiceptin | 74135-04-9 | Peptides |
| HY-P1702 | GR83895 | 152323-73-4 | Reference compound |
| HY-P1703 | Avellanin B | 110297-46-6 | Natural Products |
| HY-P1704 | Cyclosporin E | 63798-73-2 | Peptides |
| HY-P1707A | Tau protein (592-597), human (TFA) | 2703746-44-3 | Peptides |
| HY-P1708 | Enopeptin A | 139601-96-0 | Reference compound |
| HY-P1709 | Protactin | 141912-59-6 | Reference compound |
| HY-P1710 | ARL 15849XX | 152548-39-5 | Reference compound |
| HY-P1711 | L 366763 | 154447-41-3 | Reference compound |
| HY-P1714 | Apraglutide | 1295353-98-8 | Peptides |
| HY-P1714A | Apraglutide (TFA) | Peptides | |
| HY-P1716 | Neuropeptide DF2 | 149471-11-4 | Peptides |
| HY-P1717 | AMY-101 | 1427001-89-5 | Peptides |
| HY-P1717A | AMY-101 (TFA) | 1789738-04-0 | Peptides |
| HY-P1717B | AMY-101 (acetate) | Peptides | |
| HY-P1720 | Telomycin | 19246-24-3 | Reference compound |
| HY-P1721 | NPC 17731 | 147267-10-5 | Peptides |
| HY-P1722 | Spantide II | 129176-97-2 | Peptides |
| HY-P1723 | Spexin | 1370290-58-6 | Peptides |
| HY-P1723A | Spexin (TFA) | Peptides | |
| HY-P1725 | Leucomyosuppressin | 106884-19-9 | Reference compound |
| HY-P1726 | MSG606 | 1416983-77-1 | Peptides |
| HY-P1726A | MSG606 (TFA) | Peptides | |
| HY-P1727 | Super-TDU | 1599441-71-0 | Peptides |
| HY-P1727A | Super-TDU (TFA) | Peptides | |
| HY-P1728 | Super-TDU (1-31) | Peptides | |
| HY-P1728A | Super-TDU (1-31) (TFA) | Peptides | |
| HY-P1729 | M-2420 | 310427-95-3 | Peptides |
| HY-P1730 | Nuclear pore complex protein Nup98 (315-360) | Peptides | |
| HY-P1732 | Transportan | 203716-10-3 | Peptides |
| HY-P1733 | BMf-BH3 | Peptides | |
| HY-P1734 | Ac-MBP (1-11) | 125366-42-9 | Peptides |
| HY-P1735 | Moth Cytochrome C (MCC) (88-103) | 108273-68-3 | Peptides |
| HY-P1736 | Influenza HA (126-138) | 207349-63-1 | Peptides |
| HY-P1737 | Conopressin S | 111317-90-9 | Peptides |
| HY-P1738 | [Sar9] Substance P | 77128-75-7 | Peptides |
| HY-P1739 | ACTH (34-39) | 69454-10-0 | Peptides |
| HY-P1740 | RGD peptide (GRGDNP) | 114681-65-1 | Peptides |
| HY-P1740A | RGD peptide (GRGDNP) (TFA) | Peptides | |
| HY-P1741 | Fibrinogen-Binding Peptide | 137235-80-4 | Peptides |
| HY-P1741A | Fibrinogen-Binding Peptide (TFA) | Peptides | |
| HY-P1742 | Gluten Exorphin B5 | 68382-18-3 | Peptides |
| HY-P1743 | Acyl Carrier Protein (ACP) (65-74) | 66851-75-0 | Peptides |
| HY-P1744 | N-Formyl-Met-Leu-Phe-Lys | 67247-11-4 | Peptides |
| HY-P1745 | InsB (9-23) | 163364-16-7 | Peptides |
| HY-P1746 | Protein Kinase C (19-31) | 121545-65-1 | Peptides |
| HY-P1746A | Protein Kinase C (19-31) (TFA) | Peptides | |
| HY-P1747 | Pneumadin, rat | 130918-90-0 | Reference compound |
| HY-P1748 | Thermolysin, Bacillus thermoproteolyticus rokko | 9073-78-3 | Enzyme |
| HY-P1749 | Influenza HA (307-319) | 528526-85-4 | Peptides |
| HY-P1750 | Shepherdin (79-87) | 861224-28-4 | Peptides |
| HY-P1750A | Shepherdin (79-87) (TFA) | Peptides | |
| HY-P1751 | Ceratotoxin B | 150671-05-9 | Peptides |
| HY-P1752 | Urocortin II, human | 351999-18-3 | Peptides |
| HY-P1752A | Urocortin II, human (TFA) | Peptides | |
| HY-P1753 | VIR-165 | 943790-62-3 | Peptides |
| HY-P1754 | Tetanus toxin (830-843) | 119260-99-0 | Peptides |
| HY-P1754A | Tetanus toxin (830-843) (TFA) | Peptides | |
| HY-P1755 | p53 (17-26) | 488118-64-5 | Peptides |
| HY-P1755F | p53 (17-26), FITC labeled | Peptides | |
| HY-P1756 | N-Formyl-Met-Ala-Ser | 17351-32-5 | Peptides |
| HY-P1757 | HIV p17 Gag (77-85) | 147468-65-3 | Peptides |
| HY-P1758 | IFN-α Receptor Recognition Peptide 1 | 153840-64-3 | Peptides |
| HY-P1759 | N-CBZ-Phe-Arg-AMC | 65147-22-0 | Peptides |
| HY-P1759B | N-CBZ-Phe-Arg-AMC (TFA) | Peptides | |
| HY-P1760 | Allatostatin IV | 123338-13-6 | Peptides |
| HY-P1761 | Prepro VIP (111-122), human | 123025-94-5 | Peptides |
| HY-P1762 | Influenza NP (147-155) | 132326-72-8 | Peptides |
| HY-P1762A | Influenza NP (147-155) (TFA) | Peptides | |
| HY-P1763 | Urechistachykinin II | 149097-04-1 | Peptides |
| HY-P1764 | Secretoneurin, rat | 149146-12-3 | Peptides |
| HY-P1765 | Galanin (1-19), human | 136005-51-1 | Peptides |
| HY-P1766 | Adrenomedullin (11-50), rat | 163648-32-6 | Peptides |
| HY-P1767 | Prepro VIP (81-122), human | 111366-38-2 | Peptides |
| HY-P1768 | Urechistachykinin I | 149097-03-0 | Peptides |
| HY-P1769 | Angiotensin II (5-8), human | 34233-50-6 | Peptides |
| HY-P1770 | Adrenomedullin (16-31), human | 318480-38-5 | Peptides |
| HY-P1770A | Adrenomedullin (16-31), human (TFA) | Peptides | |
| HY-P1771 | OVA G4 peptide | 148274-82-2 | Peptides |
| HY-P1771A | OVA G4 peptide (TFA) | Peptides | |
| HY-P1772 | β-Amyloid (1-17) | 186319-72-2 | Peptides |
| HY-P1773 | IGF-I (30-41) | 82177-09-1 | Peptides |
| HY-P1773A | IGF-I (30-41) (TFA) | Peptides | |
| HY-P1774 | Hepatitis B Virus Core (128-140) | 160015-13-4 | Peptides |
| HY-P1775 | Carbonic anhydrase, Bovine erythrocytes | 9001-03-0 | Enzyme |
| HY-P1775A | Carbonic anhydrase (isoenzyme) | 9001-03-0 | Enzyme |
| HY-P1776 | [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) | 141171-54-2 | Peptides |
| HY-P1777 | IGF-I (24-41) | 135861-49-3 | Peptides |
| HY-P1777A | IGF-I (24-41) (TFA) | Peptides | |
| HY-P1778 | HPV16 E7 (86-93) | 160212-93-1 | Peptides |
| HY-P1778A | HPV16 E7 (86-93) (TFA) | Peptides | |
| HY-P1779 | β-Casomorphin (1-5), bovine | 72122-63-5 | Peptides |
| HY-P1779A | β-Casomorphin (1-5), bovine (TFA) | 2828433-20-9 | Peptides |
| HY-P1780 | CEF20 | 153045-21-7 | Peptides |
| HY-P1781 | Peptide C105Y | 247572-63-0 | Peptides |
| HY-P1781A | Peptide C105Y (TFA) | Peptides | |
| HY-P1782 | Calcitonin (8-32), salmon | 155069-90-2 | Peptides |
| HY-P1783 | M2e, human | 251359-24-7 | Peptides |
| HY-P1783A | M2e, human (TFA) | Peptides | |
| HY-P1784 | Secretin, canine | 110786-77-1 | Peptides |
| HY-P1785 | Abl Cytosolic Substrate | 168202-46-8 | Peptides |
| HY-P1786 | Allatostatin II | 123374-34-5 | Peptides |
| HY-P1787 | β-Amyloid (4-10) | 477284-32-5 | Peptides |
| HY-P1788 | Influenza A NP(366-374) Strain A/PR/8/35 | 132326-73-9 | Peptides |
| HY-P1789 | CTTHWGFTLC, CYCLIC | 244082-19-7 | Peptides |
| HY-P1789A | CTTHWGFTLC, CYCLIC (TFA) | Peptides | |
| HY-P1790 | Axltide | 143364-95-8 | Peptides |
| HY-P1791 | Lactoferrin (17-41) | 146897-68-9 | Peptides |
| HY-P1791B | Lactoferrin (17-41) (acetate) | 2828433-30-1 | Peptides |
| HY-P1792 | Angiotensin II (1-4), human | 52580-29-7 | Peptides |
| HY-P1792A | Angiotensin II (1-4), human (TFA) | Peptides | |
| HY-P1793 | α-Casein (90-95) | 83471-50-5 | Peptides |
| HY-P1793A | α-Casein (90-95) (TFA) | Peptides | |
| HY-P1794 | G280-9 | 156761-76-1 | Peptides |
| HY-P1795 | Boc-FLFLF | 148182-34-7 | Peptides |
| HY-P1796 | Gp100 (619-627) | 187987-68-4 | Peptides |
| HY-P1796A | Gp100 (619-627) (acetate) | Peptides | |
| HY-P1797A | Sakamototide substrate peptide (TFA) | Peptides | |
| HY-P1798 | Platelet Factor 4 (58-70), human | 82989-21-7 | Peptides |
| HY-P1799 | [pTyr5] EGFR (988-993) | 159453-08-4 | Peptides |
| HY-P1799A | [pTyr5] EGFR (988-993) (TFA) | Peptides | |
| HY-P1800 | Caerulein, desulfated | 20994-83-6 | Peptides |
| HY-P1800A | Caerulein, desulfated (TFA) | Peptides | |
| HY-P1801 | Cys-TAT(47-57) | 583836-55-9 | Peptides |
| HY-P1801A | Cys-TAT(47-57) (TFA) | Peptides | |
| HY-P1803 | Protein Kinase C Peptide Substrate | 120253-69-2 | Peptides |
| HY-P1804 | SIYRY | 178561-37-0 | Peptides |
| HY-P1805 | Calmodulin Binding Peptide 1 | 104041-80-7 | Peptides |
| HY-P1806 | Gastrin I (1-14), human | 100940-57-6 | Peptides |
| HY-P1806A | Gastrin I (1-14), human (TFA) | Peptides | |
| HY-P1807 | Mast Cell Degranulating Peptide HR-2 | 80388-04-1 | Peptides |
| HY-P1808 | LGnRH-III, lamprey | 147859-97-0 | Peptides |
| HY-P1809 | Velmupressin | 1647119-61-6 | Peptides |
| HY-P1809A | Velmupressin (acetate) | 1647120-04-4 | Peptides |
| HY-P1810 | c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm | 1647119-71-8 | Peptides |
| HY-P1811 | Iα52 | 137756-45-7 | Peptides |
| HY-P1812 | AUNP-12 | 1353563-85-5 | Peptides |
| HY-P1812A | AUNP-12 (TFA) | Peptides | |
| HY-P1813 | PSA1 (141-150) | 160215-60-1 | Peptides |
| HY-P1814 | TLQP-30 | 922704-13-0 | Peptides |
| HY-P1815 | C-Type Natriuretic Peptide (1-53), human | 141294-77-1 | Peptides |
| HY-P1815A | C-Type Natriuretic Peptide (1-53), human (TFA) | Peptides | |
| HY-P1816 | Fibronectin CS1 Peptide | 136466-51-8 | Peptides |
| HY-P1817 | PACAP-38 (16-38), human, mouse, rat | 144025-82-1 | Peptides |
| HY-P1818 | Neuropeptide Y (22-36) | 119019-65-7 | Peptides |
| HY-P1819 | N-Acetyl-α-Endorphin | 88264-63-5 | Peptides |
| HY-P1820 | SNAP-25 (187-203) | 216568-37-5 | Peptides |
| HY-P1821 | Myelin Basic Protein | 126768-94-3 | Peptides |
| HY-P1821A | Myelin Basic Protein (TFA) | Peptides | |
| HY-P1822 | BDC2.5 mimotope 1040-31 | 329696-49-3 | Peptides |
| HY-P1822A | BDC2.5 mimotope 1040-31 (TFA) | Peptides | |
| HY-P1823 | C-Reactive Protein (CRP) (174-185) | 147516-85-6 | Peptides |
| HY-P1824 | C-Reactive Protein (CRP) (201-206) | 130348-99-1 | Peptides |
| HY-P1825 | TNF-α (10-36), human | 144796-70-3 | Peptides |
| HY-P1825A | TNF-α (10-36), human (TFA) | Peptides | |
| HY-P1826 | CLIP (86-100) | 648881-58-7 | Peptides |
| HY-P1826A | CLIP (86-100) (TFA) | Peptides | |
| HY-P1827 | mTRP-2 (180-188) | 219312-69-3 | Peptides |
| HY-P1828 | EGFRvIII peptide (PEPvIII) | 129112-17-0 | Peptides |
| HY-P1828A | EGFRvIII peptide (PEPvIII) (TFA) | Peptides | |
| HY-P1829 | Angiotensin I/II (1-6) | 47896-63-9 | Peptides |
| HY-P1829A | Angiotensin I/II (1-6) (TFA) | Peptides | |
| HY-P1831 | Proadrenomedullin (1-20), human | 150238-87-2 | Peptides |
| HY-P1832 | PTD-p65-P1 Peptide | Peptides | |
| HY-P1832A | PTD-p65-P1 Peptide (TFA) | Peptides | |
| HY-P1833 | Egg Laying Hormone, aplysia | 117680-39-4 | Peptides |
| HY-P1834 | MARCKS Peptide(151-175), Phosphorylated | Peptides | |
| HY-P1835 | CEF8, Influenza Virus NP (383-391) | 142479-13-8 | Peptides |
| HY-P1836 | C-Reactive Protein (CRP) (77-82) | 130349-01-8 | Peptides |
| HY-P1837 | Influenza HA (518-526) | 186302-15-8 | Peptides |
| HY-P1838 | Proadrenomedullin (45-92), human | 166798-69-2 | Peptides |
| HY-P1839 | Angiotensin I/II (1-5) | 58442-64-1 | Peptides |
| HY-P1839A | Angiotensin I/II (1-5) (TFA) | Peptides | |
| HY-P1840 | Galanin Receptor Ligand M35 | 142846-71-7 | Peptides |
| HY-P1840A | Galanin Receptor Ligand M35 (TFA) | Peptides | |
| HY-P1841 | Glucagon-Like Peptide (GLP) II, human | 89750-15-2 | Peptides |
| HY-P1842 | MAGE-A3 (195-203) | 171066-85-6 | Peptides |
| HY-P1843 | Glycoprotein (276-286) | 160543-97-5 | Peptides |
| HY-P1844 | Chemerin-9 (149-157) | 676367-27-4 | Peptides |
| HY-P1844A | Chemerin-9 (149-157) (TFA) | Peptides | |
| HY-P1845 | PACAP-38 (31-38), human, mouse, rat | 138764-85-9 | Peptides |
| HY-P1845A | PACAP-38 (31-38), human, mouse, rat (TFA) | Peptides | |
| HY-P1846 | Jagged-1 (188-204) | 219127-21-6 | Peptides |
| HY-P1846A | Jagged-1 (188-204) (TFA) | Peptides | |
| HY-P1847 | IKKγ NBD Inhibitory Peptide | 372146-18-4 | Peptides |
| HY-P1847A | IKKγ NBD Inhibitory Peptide (TFA) | Peptides | |
| HY-P1848 | Pep-1 (uncapped) | 395069-86-0 | Peptides |
| HY-P1849 | JAG-1, scrambled | 402941-23-5 | Peptides |
| HY-P1849A | JAG-1, scrambled (TFA) | Peptides | |
| HY-P1850 | β-Amyloid (1-20) | 186319-68-6 | Peptides |
| HY-P1850A | β-Amyloid (1-20) (acetate) | Peptides | |
| HY-P1851 | AGA-(C8R) HNG17, humanin derivative | 875910-01-3 | Peptides |
| HY-P1851A | AGA-(C8R) HNG17, humanin derivative (TFA) | Peptides | |
| HY-P1852 | TIP 39, Tuberoinfundibular Neuropeptide | 277302-47-3 | Peptides |
| HY-P1853 | Abz-FR-K(Dnp)-P-OH | 500799-61-1 | Peptides |
| HY-P1854 | β-Amyloid (1-9) | 147529-30-4 | Peptides |
| HY-P1855 | HER2/neu (654-662) GP2 | 160790-21-6 | Peptides |
| HY-P1856 | Proinsulin C-peptide (human) | 33017-11-7 | Peptides |
| HY-P1857 | CEF7, Influenza Virus NP (380-388) | 147100-46-7 | Peptides |
| HY-P1858 | Urocortin III, mouse | 357952-10-4 | Peptides |
| HY-P1858A | Urocortin III, mouse (TFA) | Peptides | |
| HY-P1859 | MCA-SEVNLDAEFR-K(Dnp)-RR, amide | 438625-61-7 | Peptides |
| HY-P1860 | TNF-α (31-45), human | 144796-71-4 | Peptides |
| HY-P1860A | TNF-α (31-45), human (TFA) | Peptides | |
| HY-P1861 | Interphotoreceptor Retinoid Binding Protein Fragment (IRBP) | 211426-18-5 | Peptides |
| HY-P1861A | Interphotoreceptor Retinoid Binding Protein Fragment (IRBP) (TFA) | Peptides | |
| HY-P1862 | HSV-gB2 (498-505) | 149997-91-1 | Peptides |
| HY-P1863 | α-Neoendorphin (1-8) | 83339-89-3 | Peptides |
| HY-P1866 | β-Endorphin, equine | 79495-86-6 | Peptides |
| HY-P1866A | β-Endorphin, equine (TFA) | Peptides | |
| HY-P1867 | β-Amyloid (1-34) | 186359-65-9 | Peptides |
| HY-P1868 | α2β1 Integrin Ligand Peptide | 134580-64-6 | Peptides |
| HY-P1868A | α2β1 Integrin Ligand Peptide (TFA) | Peptides | |
| HY-P1869 | Neuropeptide EI, rat | 125934-45-4 | Peptides |
| HY-P1870 | OVA sequence (323-336) | 92915-80-5 | Peptides |
| HY-P1871 | Amylin (IAPP), feline | 213779-12-5 | Peptides |
| HY-P1871A | Amylin (IAPP), feline (TFA) | Peptides | |
| HY-P1872 | OV-1, sheep | 326855-45-2 | Peptides |
| HY-P1873 | Phosphorylase Kinase β-Subunit Fragment (420-436) | 150829-21-3 | Peptides |
| HY-P1874 | Calmodulin-Dependent Protein Kinase II (281-309) | 116826-37-0 | Peptides |
| HY-P1875 | TNF-α (46-65), human | 144796-72-5 | Peptides |
| HY-P1875A | TNF-α (46-65), human (TFA) | Peptides | |
| HY-P1876 | NLS (PKKKRKV) | 95088-49-6 | Peptides |
| HY-P1876A | NLS (PKKKRKV) (TFA) | Peptides | |
| HY-P1876B | NLS (PKKKRKV) (hydrochloride) | Peptides | |
| HY-P1877 | SV40 T-Ag-derived NLS peptide | 105425-98-7 | Peptides |
| HY-P1877A | SV40 T-Ag-derived NLS peptide (TFA) | Peptides | |
| HY-P1878 | Proinsulin C-Peptide (55-89), human | 11097-48-6 | Peptides |
| HY-P1879 | β-Amyloid (18-28) | 112163-49-2 | Peptides |
| HY-P1880 | β-Amyloid (12-20) | 134649-29-9 | Peptides |
| HY-P1881 | HPV16-E711-20 epitope | 160040-04-0 | Peptides |
| HY-P1882 | Type A Allatostatin I | 123209-95-0 | Peptides |
| HY-P1883 | Bacterial Sortase Substrate III, Abz/DNP | 2857862-12-3 | Peptides |
| HY-P1883A | Bacterial Sortase Substrate III, Abz/DNP (TFA) | Peptides | |
| HY-P1884 | LL-37, acetylated,amidated | Peptides | |
| HY-P1885 | HIV gag peptide (197-205) | 214978-47-9 | Peptides |
| HY-P1886 | Kv3, Channel Containing Protein (567-585) | Peptides | |
| HY-P1887 | p5 Ligand for Dnak and DnaJ | 209518-24-1 | Peptides |
| HY-P1888 | HIF-1 alpha (556-574) | 1201633-99-9 | Peptides |
| HY-P1888A | HIF-1 alpha (556-574) (TFA) | Peptides | |
| HY-P1889 | Bim BH3, Peptide IV | 721885-31-0 | Peptides |
| HY-P1889A | Bim BH3, Peptide IV (TFA) | Peptides | |
| HY-P1890 | CEF14, EBV Rta Protein (28-37) | 216862-58-7 | Peptides |
| HY-P1891 | β-Amyloid (22-40) | 1206779-25-0 | Peptides |
| HY-P1892 | Competence-Stimulating Peptide-12261 | 1235882-91-3 | Peptides |
| HY-P1893 | β-Amyloid (11-22) | 885323-98-8 | Peptides |
| HY-P1894 | β-Amyloid Protein Precursor 770 (135-155) | 315229-44-8 | Peptides |
| HY-P1895 | β-Amyloid (33-40) | 634204-57-2 | Peptides |
| HY-P1896 | Hsp70-derived octapeptide | 736171-62-3 | Peptides |
| HY-P1897 | Fibronectin Active Fragment Control | 97461-84-2 | Peptides |
| HY-P1898 | β-Amyloid (13-27) | 148270-13-7 | Peptides |
| HY-P1899 | Smcy HY Peptide (738-746) | 207113-06-2 | Peptides |
| HY-P1900 | SEB Domain (152-161) | 210229-94-0 | Peptides |
| HY-P1900A | SEB Domain (152-161) (TFA) | Peptides | |
| HY-P1901 | Insulin alpha-chain (1-13) | 872036-64-1 | Peptides |
| HY-P1902 | Cardiotoxin Analog (CTX) IV (6-12) | 115722-23-1 | Peptides |
| HY-P1902A | Cardiotoxin Analog (CTX) IV (6-12) (TFA) | 2918768-05-3 | Peptides |
| HY-P1903 | β-Amyloid (35-42) | 183292-41-3 | Peptides |
| HY-P1904 | Phe-Met-Arg-Phe Like Peptide, Snail Helix aspersa | 98495-35-3 | Peptides |
| HY-P1905 | [Gln8]-C517 (LH-RH), chicken | 47922-48-5 | Peptides |
| HY-P1906 | [pThr3]-CDK5 Substrate | 1670273-47-8 | Peptides |
| HY-P1906A | [pThr3]-CDK5 Substrate (TFA) | Peptides | |
| HY-P1907 | Human Papillomavirus (HPV) E7 protein (49-57) | 151812-18-9 | Peptides |
| HY-P1908 | sgp91 ds-tat Peptide 2, scrambled | Peptides | |
| HY-P1909 | Casein Kinase Substrates 3 | 154444-97-0 | Peptides |
| HY-P1910 | BDC2.5 mimotope 1040-51 | 329696-50-6 | Peptides |
| HY-P1911 | CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156) | 254110-79-7 | Peptides |
| HY-P1912 | Alpha 1(I) Collagen (614-639), human | 210905-12-7 | Peptides |
| HY-P1913 | Calcitonin Gene Related Peptide (CGRP) II, rat | 99889-63-1 | Peptides |
| HY-P1913A | Calcitonin Gene Related Peptide (CGRP) II, rat (TFA) | Peptides | |
| HY-P1914 | NY-BR-1 p904 (A2) | 347142-73-8 | Peptides |
| HY-P1915 | 26Rfa, Hypothalamic Peptide, human | 600171-68-4 | Peptides |
| HY-P1916 | FliC, Serotype a (427-441), S.paratyphi A | 857678-38-7 | Peptides |
| HY-P1917 | Uty HY Peptide (246-254) | 261172-28-5 | Peptides |
| HY-P1917A | Uty HY Peptide (246-254) (TFA) | Peptides | |
| HY-P1918 | Activated Protein C (390-404), human | 146340-20-7 | Peptides |
| HY-P1918A | Activated Protein C (390-404), human (TFA) | Peptides | |
| HY-P1919 | [Asp371]-Tyrosinase (369-377), human | 168650-46-2 | Peptides |
| HY-P1920 | CEF19, Epstein-Barr Virus latent NA-3A (458-466) | 157876-41-0 | Peptides |
| HY-P1921 | YRGDS Fibronectin Fragment | 134282-68-1 | Peptides |
| HY-P1922 | γ-2-MSH (41-58), amide | 799841-81-9 | Peptides |
| HY-P1923 | L-Asparaginase | 9015-68-3 | Enzyme |
| HY-P1924 | IRBP(651-670) human, mouse | 1977546-93-2 | Peptides |
| HY-P1924A | IRBP(651-670) human, mouse (TFA) | Peptides | |
| HY-P1925A | GO-203 (TFA) | 1222186-26-6 | Peptides |
| HY-P1925B | L-GO-203 (TFA) | Peptides | |
| HY-P1926 | A-54556A | 95398-45-1 | Peptides |
| HY-P1928 | Humanin | 330936-69-1 | Peptides |
| HY-P1929 | Bivalirudin | 128270-60-0 | Peptides |
| HY-P1930 | Risuteganib | 1307293-62-4 | Peptides |
| HY-P1930A | Risuteganib (hydrochloride) | Peptides | |
| HY-P1931 | Antiflammin-1 | 118850-71-8 | Peptides |
| HY-P1932 | Cortistatin-14 | 186901-48-4 | Peptides |
| HY-P1932A | Cortistatin-14 (TFA) | Peptides | |
| HY-P1933 | [pSer2, pSer5, pSer7]-CTD | Peptides | |
| HY-P1933A | [pSer2, pSer5, pSer7]-CTD (TFA) | Peptides | |
| HY-P1934 | Cyclo(Phe-Pro) | 14705-60-3 | Peptides |
| HY-P1934A | Cyclo(L-Phe-L-Pro) | 3705-26-8 | Peptides |
| HY-P1934AR | Cyclo(L-Phe-L-Pro) (Standard) | 3705-26-8 | Reference Standards |
| HY-P1935 | Cyclo(Ala-Pro) | 36357-32-1 | Peptides |
| HY-P1936 | Cyclo(Gly-L-Pro) | 3705-27-9 | Natural Products |
| HY-P1937 | Cyclo(-Met-Pro) | 53049-06-2 | Peptides |
| HY-P1938 | Cyclo(L-Pro-L-Val) | 2854-40-2 | Natural Products |
| HY-P1938R | Cyclo(L-Pro-L-Val) (Standard) | 2854-40-2 | Reference Standards |
| HY-P1939 | Cyclo(L-Leu-L-Pro) | 2873-36-1 | Peptides |
| HY-P1940 | Maculosin | 4549-02-4 | Peptides |
| HY-P1940R | Maculosin (Standard) | 4549-02-4 | Reference Standards |
| HY-P1944 | Apelin-13 | 217082-58-1 | Peptides |
| HY-P1944A | Apelin-13 (TFA) | Peptides | |
| HY-P1948 | Thioredoxin reductase peptide | 950890-23-0 | Peptides |
| HY-P1948A | Thioredoxin reductase peptide (TFA) | Peptides | |
| HY-P1949 | Cyclic MKEY | Peptides | |
| HY-P1949A | Cyclic MKEY (TFA) | Peptides | |
| HY-P1952 | µ-Conotoxin-CnIIIC | 936616-33-0 | Peptides |
| HY-P1952A | µ-Conotoxin-CnIIIC (acetate) | Peptides | |
| HY-P1954 | Epinecidin-1 | 1131706-77-8 | Peptides |
| HY-P1954A | Epinecidin-1 (TFA) | Peptides | |
| HY-P1955 | Etelcalcetide | 1262780-97-1 | Peptides |
| HY-P1955A | Etelcalcetide (hydrochloride) | 1334237-71-6 | Peptides |
| HY-P1956 | Human serum albumin | 70024-90-7 | Biochemical Assay Reagents |
| HY-P1956A | Human serum albumin (Cell culture grade, Endotoxin<0.125 EU/mg) | 70024-90-7 | Biochemical Assay Reagents |
| HY-P1957 | Dihydrocyclosporin A | 59865-15-5 | Peptides |
| HY-P1958 | Histone H4 (2-21) | 667899-73-2 | Peptides |
| HY-P1959 | Lanreotide | 108736-35-2 | Peptides |
| HY-P1959A | Lanreotide (acetate) | 2378114-72-6 | Peptides |
| HY-P1959B | Lanreotide (diTFA) | 1024499-83-9 | Peptides |
| HY-P1962 | β-Secretase inhibitor | 350228-37-4 | Peptides |
| HY-P1963 | Ac-IEVDIDVEH (TFA) | Peptides | |
| HY-P1964 | Ac-IEVDIDVE (TFA) | Peptides | |
| HY-P1965 | Ac-IEVDIDV (TFA) | Peptides | |
| HY-P1966 | Ac-IEVDID (TFA) | Peptides | |
| HY-P1967 | Ac-VDID (TFA) | Peptides | |
| HY-P1973 | Cyclosporin B | 63775-95-1 | Peptides |
| HY-P1974 | FR 901379 | 144371-88-0 | Peptides |
| HY-P1975 | Aureobasidin A | 127785-64-2 | Peptides |
| HY-P1978 | CysHHC10 | 1408311-03-4 | Peptides |
| HY-P1978A | CysHHC10 (TFA) | Peptides | |
| HY-P1980 | A-71915 (TFA) | Peptides | |
| HY-P1984 | Alphostatin | 90119-88-3 | Peptides |
| HY-P1985A | Notch 1 (TFA) | Peptides | |
| HY-P1986 | Z-DEVD-AFC | 1135416-11-3 | Dye Reagents |
| HY-P1987 | Mast cell degranulating peptide (28-49) | 65636-54-6 | Peptides |
| HY-P1988 | JMV 179 | 119386-87-7 | Peptides |
| HY-P1991 | Isariin D | 80111-97-3 | Peptides |
| HY-P1992 | Isariin B | 80111-95-1 | Peptides |
| HY-P1994 | JMV 167 | 120775-49-7 | Peptides |
| HY-P1996 | Tiplimotide | 178823-49-9 | Peptides |
| HY-P1997 | Ferrichrome Iron-free | 34787-28-5 | Biochemical Assay Reagents |
| HY-P1998 | Pepsinostreptin | 51724-57-3 | Natural Products |
| HY-P1999 | α-Gliadin (43-49) | 107936-65-2 | Peptides |
| HY-P2000 | Septide | 79775-19-2 | Peptides |
| HY-P2004 | FFAGLDD | 2703745-70-2 | Peptides |
| HY-P2004A | FFAGLDD (TFA) | Peptides | |
| HY-P2005 | Malformin C | 59926-78-2 | Peptides |
| HY-P2006 | Abecomotide | 907596-50-3 | Peptides |
| HY-P2008 | Boc-Ile-Glu-Gly-Arg-AMC | 65147-06-0 | Peptides |
| HY-P2009 | Orfamide B | 939960-35-7 | Biochemical Assay Reagents |
| HY-P2011 | Cephabacin M4 | 99313-74-3 | Peptides |
| HY-P2012 | TRP-601 | 1094569-02-4 | Peptides |
| HY-P2014 | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,Tyr-NH29)-Vasotocin | 114056-26-7 | Peptides |
| HY-P2015 | Diacetylsplenopentine | 91418-71-2 | Reference compound |
| HY-P2015A | Diacetylsplenopentin (hydrochloride) | 122402-38-4 | Reference compound |
| HY-P2016 | Ac-Nle-Pro-Nle-Asp-AMC | 355140-49-7 | Peptides |
| HY-P2018 | FK 33-824 | 64854-64-4 | Peptides |
| HY-P2019 | Levitide | 114281-19-5 | Peptides |
| HY-P2020 | Berninamycin A | 58798-97-3 | Peptides |
| HY-P2021 | BMS 180742 | 138828-04-3 | Peptides |
| HY-P2023 | Hirugen | 121822-23-9 | Peptides |
| HY-P2024 | CP-85339 | 119625-53-5 | Peptides |
| HY-P2025 | JMV 236 | 113137-57-8 | Peptides |
| HY-P2026 | A 71915 | 132956-87-7 | Peptides |
| HY-P2028 | BIM 21009 | 106881-54-3 | Peptides |
| HY-P2031 | Phallacidin | 26645-35-2 | Peptides |
| HY-P2032 | Cyclochlorotine | 12663-46-6 | Peptides |
| HY-P2033 | Nostopeptin B | 185980-89-6 | Natural Products |
| HY-P2034 | Cargutocin | 33605-67-3 | Peptides |
| HY-P2036 | FSL-1 | 322455-70-9 | Peptides |
| HY-P2036A | FSL-1 (TFA) | Peptides | |
| HY-P2037 | FW 34-569 | 70021-31-7 | Peptides |
| HY-P2038 | Cephabacin M6 | 99313-73-2 | Peptides |
| HY-P2039 | Retrobradykinin | 5991-13-9 | Peptides |
| HY-P2040 | Nodularin | 118399-22-7 | Peptides |
| HY-P2042 | SALMF amide 1 | 134439-73-9 | Peptides |
| HY-P2043 | Cyanopeptolin 954 | 866718-63-0 | Peptides |
| HY-P2045 | RA-VII | 86229-97-2 | Peptides |
| HY-P2046 | β-Endorphin (rat) | 309246-19-3 | Peptides |
| HY-P2047 | Lavendomycin | 82987-09-5 | Peptides |
| HY-P2048 | MOTS-c (human) | 1627580-64-6 | Peptides |
| HY-P2048A | MOTS-c(human) (acetate) | Peptides | |
| HY-P2052 | AWL 60 | 140716-14-9 | Peptides |
| HY-P2054 | Mvt-101 | 125552-93-4 | Peptides |
| HY-P2055 | A-57696 | 125598-87-0 | Peptides |
| HY-P2057 | PD 142893 | 143037-36-9 | Peptides |
| HY-P2060 | CGP 44099 | 128856-81-5 | Peptides |
| HY-P2061 | Leualacin | 128140-12-5 | Peptides |
| HY-P2064 | Lariatin A | 732286-09-8 | Peptides |
| HY-P2065 | Ac-VEID-AMC | 219137-97-0 | Dye Reagents |
| HY-P2067 | Argtide | 138111-66-7 | Peptides |
| HY-P2070 | Aspartocin D | 1211953-97-7 | Peptides |
| HY-P2072 | GF109 | 79873-93-1 | Peptides |
| HY-P2073 | Cyclo(δ-Ala-L-Val) | 25516-00-1 | Peptides |
| HY-P2075 | EMD 55068 | 126784-34-7 | Peptides |
| HY-P2076 | Dusquetide | 931395-42-5 | Peptides |
| HY-P2076A | Dusquetide (TFA) | Peptides | |
| HY-P2077 | L-366948 | 127819-97-0 | Peptides |
| HY-P2080 | GIP (1-30) amide,human | 198624-01-0 | Peptides |
| HY-P2080B | GIP (1-30) amide,human (acetate) | Peptides | |
| HY-P2080C | GIP (1-30)-Myr | Peptides | |
| HY-P2081 | Delicious peptide | 73984-05-1 | Peptides |
| HY-P2082 | [D-pGlu1,D-Phe2,D-NaI3,6]-Gn-RH | 78255-70-6 | Peptides |
| HY-P2083 | WWamide-2 | 149636-88-4 | Peptides |
| HY-P2084 | WWamide-1 | 149665-72-5 | Peptides |
| HY-P2085 | WWamide-3 | 149636-89-5 | Peptides |
| HY-P2087 | Bassianolide | 64763-82-2 | Natural Products |
| HY-P2088 | TANDEM | 63478-55-7 | Peptides |
| HY-P2089 | Dnp-PYAYWMR | 135662-06-5 | Peptides |
| HY-P2090 | Angiopeptin | 113294-82-9 | Peptides |
| HY-P2090A | Angiopeptin (TFA) | 2478421-60-0 | Peptides |
| HY-P2091 | Ac-YVAD-pNA | 149231-66-3 | Peptides |
| HY-P2092 | Cyclo(L-leucyl-L-tryptophyl) | 15136-34-2 | Peptides |
| HY-P2093 | S961 | 1083433-49-1 | Peptides |
| HY-P2093A | S961 (TFA) | Peptides | |
| HY-P2093B | S961 (acetate) | Peptides | |
| HY-P2096 | Hexapeptide-11 | 161258-30-6 | Peptides |
| HY-P2097 | L-363564 | 86153-46-0 | Peptides |
| HY-P2098 | Alamethicin F 50 | 56165-93-6 | Peptides |
| HY-P2101 | Micropeptin 478A | 186368-49-0 | Peptides |
| HY-P2106 | Elabela(19-32) | 1886973-05-2 | Peptides |
| HY-P2106A | Elabela(19-32) (TFA) | Peptides | |
| HY-P2109 | JMV-1645 | 284037-77-0 | Peptides |
| HY-P2110 | RS-18286 | 109458-76-6 | Peptides |
| HY-P2112 | DOTA-NOC | 619300-53-7 | Peptides |
| HY-P2113 | ORG-2766 | 50913-82-1 | Peptides |
| HY-P2114 | IT9302 | 173959-12-1 | Peptides |
| HY-P2118 | NPC-567 | 109333-26-8 | Peptides |
| HY-P2120 | Pseudobactin A | 79438-64-5 | Peptides |
| HY-P2121 | JMV 176 | 119068-32-5 | Peptides |
| HY-P2123A | Colistin A (sulfate hydrate) | Peptides | |
| HY-P2124 | Cyclo(L-Trp-L-Trp) | 20829-55-4 | Peptides |
| HY-P2124R | Cyclo(L-Trp-L-Trp) (Standard) | 20829-55-4 | Reference Standards |
| HY-P2130 | SR 42128 | 98092-14-9 | Peptides |
| HY-P2134 | YSDSPSTST | 130007-45-3 | Peptides |
| HY-P2136 | COG1410 | 878009-24-6 | Peptides |
| HY-P2136F | Biotin-COG1410 (TFA) | Peptides | |
| HY-P2138 | U-85548E | 124020-62-8 | Peptides |
| HY-P2141 | TRV-120027 | 1234510-46-3 | Peptides |
| HY-P2141A | TRV-120027 (TFA) | Peptides | |
| HY-P2145 | Extracellular death factor | 960129-66-2 | Peptides |
| HY-P2147 | Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-Ome | 93287-54-8 | Peptides |
| HY-P2148 | P-113 | 190673-58-6 | Peptides |
| HY-P2149 | Concanavalin A | 11028-71-0 | Biochemical Assay Reagents |
| HY-P2149A | Concanavalin A (agarose) | 11028-71-0 | Biochemical Assay Reagents |
| HY-P2150 | Cortistatin-29 | 1815618-17-7 | Peptides |
| HY-P2155 | BigLEN(rat) | 369377-66-2 | Peptides |
| HY-P2155A | BigLEN(rat) (TFA) | Peptides | |
| HY-P2157 | Ras Inhibitory Peptide | 159088-48-9 | Peptides |
| HY-P2159 | Dynorphin A (1-8) | 75790-53-3 | Peptides |
| HY-P2161 | TAK-683 | 872719-49-8 | Peptides |
| HY-P2161A | TAK-683 (TFA) | Peptides | |
| HY-P2161B | TAK-683 (acetate) | Peptides | |
| HY-P2162 | Kemptamide | 89315-28-6 | Peptides |
| HY-P2164 | PHPFHFFVYK | 75645-19-1 | Peptides |
| HY-P2165 | N-acetyl CCK-(26-30) amide | 89911-69-3 | Peptides |
| HY-P2166 | MMP3 inhibitor 3 | 158841-76-0 | Peptides |
| HY-P2166A | MMP3 inhibitor 3 (TFA) | Peptides | |
| HY-P2168 | Demoxytocin | 113-78-0 | Peptides |
| HY-P2169 | Small cardioactive peptide A | 98035-79-1 | Peptides |
| HY-P2170 | XMP-629 | 316805-65-9 | Peptides |
| HY-P2171 | CCP peptide | 277748-59-1 | Peptides |
| HY-P2171A | CCP peptide (TFA) | Peptides | |
| HY-P2176 | Z-LRGG-AMC | 167698-68-2 | Peptides |
| HY-P2178 | Dihydrochlamydocin analog-1 | 157618-75-2 | Peptides |
| HY-P2179 | MMP-1/MMP-9 Substrate, Fluorogenic | 150956-92-6 | Peptides |
| HY-P2183 | PEN(mouse) | 1236955-25-1 | Peptides |
| HY-P2183A | PEN(mouse) (TFA) | Peptides | |
| HY-P2185 | NFF-3 | 158584-09-9 | Dye Reagents |
| HY-P2185A | NFF-3 (TFA) | Peptides | |
| HY-P2191 | KISS1-305 | 872717-97-0 | Peptides |
| HY-P2192 | JMV-320 | 130582-10-4 | Reference compound |
| HY-P2193 | TAT-amide | 697226-52-1 | Peptides |
| HY-P2193A | TAT-amide (TFA) | Peptides | |
| HY-P2194 | AtPep3 | 902781-14-0 | Peptides |
| HY-P2194A | AtPep3 (TFA) | Peptides | |
| HY-P2196 | ELA-32(human) | 1680205-79-1 | Peptides |
| HY-P2196A | ELA-32(human) (TFA) | Peptides | |
| HY-P2197 | ELA-11(human) | 1784687-32-6 | Peptides |
| HY-P2197A | ELA-11(human) (TFA) | Peptides | |
| HY-P2198 | PAMP-12(human, porcine) | 196305-05-2 | Peptides |
| HY-P2198A | PAMP-12(human, porcine) (TFA) | Peptides | |
| HY-P2199 | SNF 9007 | 137415-20-4 | Peptides |
| HY-P2200 | Siamycin I | 164802-68-0 | Reference compound |
| HY-P2202 | Desferriferribactin | 140198-04-5 | Reference compound |
| HY-P2203 | SAHM1 | 2050906-89-1 | Peptides |
| HY-P2203A | SAHM1 (TFA) | Peptides | |
| HY-P2205 | EMD 55450 | 126657-82-7 | Peptides |
| HY-P2206 | Zelkovamycin | 221197-33-7 | Peptides |
| HY-P2207 | Sinapultide | 138531-07-4 | Peptides |
| HY-P2207A | Sinapultide (TFA) | 2828433-25-4 | Peptides |
| HY-P2208 | Z-IETD-AFC | 219138-02-0 | Dye Reagents |
| HY-P2210 | BigLEN(mouse) | 501036-69-7 | Peptides |
| HY-P2210A | BigLEN(mouse) (TFA) | Peptides | |
| HY-P2212 | (Asn1,Val5)-Angiotensin II | 53-73-6 | Peptides |
| HY-P2213 | GPLGIAGQ | 109053-09-0 | Peptides |
| HY-P2213A | GPLGIAGQ (TFA) | Peptides | |
| HY-P2217 | Aclerastide | 227803-63-6 | Peptides |
| HY-P2218 | Anditixafortide | 1821136-83-7 | Peptides |
| HY-P2219 | CGGRGD | 1260223-44-6 | Peptides |
| HY-P2219A | CGGRGD (TFA) | Peptides | |
| HY-P2221 | Glepaglutide | 914009-86-2 | Peptides |
| HY-P2221B | Glepaglutide (acetate) | Peptides | |
| HY-P2222 | DX600 | 478188-26-0 | Peptides |
| HY-P2222A | DX600 (TFA) | Peptides | |
| HY-P2223 | Hypeptin | 124883-38-1 | Peptides |
| HY-P2228 | Chlamydocin | 53342-16-8 | Peptides |
| HY-P2229 | Ilatreotide | 119719-11-8 | Peptides |
| HY-P2230 | Angstrom6 | 220334-14-5 | Peptides |
| HY-P2231 | Cotadutide | 1686108-82-6 | Peptides |
| HY-P2231A | Cotadutide (acetate) | Peptides | |
| HY-P2232 | Conalbumin | 1391-06-6 | Biochemical Assay Reagents |
| HY-P2233 | Globomycin | 67076-74-8 | Peptides |
| HY-P2237 | Boc-Leu-Gly-Arg-AMC | 65147-09-3 | Peptides |
| HY-P2242A | RO27-3225 (TFA) | Peptides | |
| HY-P2243 | D-JBD19 | 954134-42-0 | Peptides |
| HY-P2243A | D-JBD19 (TFA) | Peptides | |
| HY-P2244 | YAP-TEAD-IN-1 | 1659305-78-8 | Peptides |
| HY-P2244A | YAP-TEAD-IN-1 (TFA) | 1659305-79-9 | Peptides |
| HY-P2246 | JTP10-△-TATi (TFA) | Peptides | |
| HY-P2247 | JTP10-△-R9 (TFA) | Peptides | |
| HY-P2248 | ELA-14 negative control | 1885873-44-8 | Peptides |
| HY-P2249 | ELA-21 (human) | 2245073-05-4 | Peptides |
| HY-P2250 | ELA RR>GG | Peptides | |
| HY-P2251 | T-peptide | 2022956-62-1 | Peptides |
| HY-P2252 | H3K27(Me) (15-34) | Peptides | |
| HY-P2253 | H3K27(Me2) (15-34) | Peptides | |
| HY-P2254 | H3K27(Me3) (15-34) | Peptides | |
| HY-P2255 | H3K4(Me) (1-20) | Peptides | |
| HY-P2256 | H3K4(Me2) (1-20) | Peptides | |
| HY-P2257 | H3K4(Me3) (1-20) | Peptides | |
| HY-P2258 | Histone H3 (1-34) | Peptides | |
| HY-P2259 | TAT-GluA2 3Y | 1404188-93-7 | Peptides |
| HY-P2260 | Tat-beclin 1 | 1423821-88-8 | Peptides |
| HY-P2260A | Tat-beclin 1 (TFA) | Peptides | |
| HY-P2260B | Tat-beclin 1 scrambled | Peptides | |
| HY-P2260C | Tat-beclin 1 scrambled (TFA) | Peptides | |
| HY-P2261 | STAD 2 | 1542100-77-5 | Peptides |
| HY-P2263 | KLD-12 | 800379-47-9 | Peptides |
| HY-P2263A | KLD-12 (TFA) | Peptides | |
| HY-P2264 | KYL peptide | 676657-00-4 | Peptides |
| HY-P2265 | SAH-SOS1A | 1652561-87-9 | Peptides |
| HY-P2265A | SAH-SOS1A (TFA) | 2896737-31-6 | Peptides |
| HY-P2266 | SAH-EZH2 | 1453222-26-8 | Peptides |
| HY-P2267 | LDV | 1155866-55-9 | Peptides |
| HY-P2268 | RAGE antagonist peptide | 1092460-91-7 | Peptides |
| HY-P2268A | RAGE antagonist peptide (TFA) | Peptides | |
| HY-P2269 | MAIT-203 | Peptides | |
| HY-P2269A | MAIT-203 (acetate) | Peptides | |
| HY-P2270 | Phalloidin-TRITC | 915013-10-4 | Dye Reagents |
| HY-P2271 | MM 54 | 1313027-43-8 | Peptides |
| HY-P2272 | NLS-StAx-h | 2872559-21-0 | Peptides |
| HY-P2272A | NLS-StAx-h (TFA) | Peptides | |
| HY-P2273 | Calcitonin (human) | 21215-62-3 | Peptides |
| HY-P2274 | Argifin | 243975-37-3 | Peptides |
| HY-P2274R | Argifin (Standard) | 243975-37-3 | Reference Standards |
| HY-P2275 | Peptide5 | 916977-43-0 | Peptides |
| HY-P2275B | Peptide5 (TFA) | Peptides | |
| HY-P2276 | Pep2-8 | 1541011-97-5 | Peptides |
| HY-P2276A | Pep2-8 (TFA) | Peptides | |
| HY-P2277 | PEN (rat) | 569364-13-2 | Peptides |
| HY-P2277A | PEN (rat) (TFA) | Peptides | |
| HY-P2278 | PEN (human) | 597578-70-6 | Peptides |
| HY-P2279 | Parathyroid hormone (1-34) (rat) | 98614-76-7 | Peptides |
| HY-P2279A | Parathyroid hormone (1-34) (rat) (acetate) | Peptides | |
| HY-P2280 | TAT-P110 | 2247617-97-4 | Peptides |
| HY-P2281 | Atrial natriuretic factor (1-28) (human, porcine) | 91917-63-4 | Peptides |
| HY-P2281A | Atrial natriuretic factor (1-28) (human, porcine) (TFA) | Peptides | |
| HY-P2282 | APTSTAT3-9R | Peptides | |
| HY-P2283 | β-Amyloid (1-37) (human) | 186359-67-1 | Peptides |
| HY-P2284 | AD 01 | 959961-23-0 | Peptides |
| HY-P2285 | AC 253 | 151804-79-4 | Peptides |
| HY-P2286 | D-3 | 1967815-98-0 | Peptides |
| HY-P2287 | Cortagine | Peptides | |
| HY-P2288 | WL47 | Peptides | |
| HY-P2288A | WL47 (TFA) | Peptides | |
| HY-P2289 | β-defesin 1 (pig) | Peptides | |
| HY-P2289A | β-defesin 1 (pig) (TFA) | Peptides | |
| HY-P2291 | Beta-defensin 103 isoform X1, pig | Peptides | |
| HY-P2291A | Beta-defensin 103 isoform X1, pig (TFA) | Peptides | |
| HY-P2292 | Omiganan, FITC labeled | Peptides | |
| HY-P2292A | Omiganan, FITC labeled (TFA) | Peptides | |
| HY-P2293 | Luteinizing hormone (human) | 39341-83-8 | Peptides |
| HY-P2294 | pm26TGF-β1 peptide | Peptides | |
| HY-P2294A | pm26TGF-β1 peptide (TFA) | Peptides | |
| HY-P2295 | Dabcyl-KTSAVLQSGFRKME-Edans (TFA) | Peptides | |
| HY-P2296 | Abz-FRLKGGAPIKGV-EDDNP (TFA) | Peptides | |
| HY-P2297 | TfR-T12 | 344618-30-0 | Peptides |
| HY-P2297A | TfR-T12 (TFA) | Peptides | |
| HY-P2298 | TAT-P4-(DATC5)2 | Peptides | |
| HY-P2298A | TAT-P4-(DATC5)2 (TFA) | Peptides | |
| HY-P2299 | Protein E7(43-62) | 143853-58-1 | Peptides |
| HY-P2299A | Protein E7(43-62) (TFA) | Peptides | |
| HY-P2300 | Cyclo(Arg-Gly-Asp-D-Phe-Cys) | 862772-11-0 | Peptides |
| HY-P2300A | Cyclo(Arg-Gly-Asp-D-Phe-Cys) (TFA) | Peptides | |
| HY-P2302 | Defensin HNP-3 human | 136661-76-2 | Peptides |
| HY-P2307 | Tat-NR2Baa | 847829-41-8 | Peptides |
| HY-P2307A | Tat-NR2Baa (TFA) | Peptides | |
| HY-P2310 | Defensin HNP-1 human | 148093-65-6 | Peptides |
| HY-P2310A | Defensin HNP-1 human (TFA) | Peptides | |
| HY-P2311 | Defensin HNP-2 human | 120721-97-3 | Peptides |
| HY-P2313 | Human β-defensin-2 | 372146-20-8 | Peptides |
| HY-P2314 | HAIYPRH (hydrochloride) | Peptides | |
| HY-P2315 | Human β-defensin-1 | 452274-53-2 | Peptides |
| HY-P2317 | Cecropin P1, porcine | 125667-96-1 | Peptides |
| HY-P2317A | Cecropin P1, porcine (acetate) | Peptides | |
| HY-P2318 | Bac2A (TFA) | 231306-42-6 | Peptides |
| HY-P2319 | OVA-E1 peptide | 153316-01-9 | Peptides |
| HY-P2319A | OVA-E1 peptide (TFA) | 1262750-80-0 | Peptides |
| HY-P2320 | IDR-1 | 940291-10-1 | Peptides |
| HY-P2321 | TRAP-6 amide | 141923-40-2 | Peptides |
| HY-P2321A | TRAP-6 amide (TFA) | 1426807-16-0 | Peptides |
| HY-P2322 | Iturin A | 52229-90-0 | Peptides |
| HY-P2323 | Lactoferricin B (4-14), bovine (TFA) | Peptides | |
| HY-P2324 | Gramicidin A | 11029-61-1 | Peptides |
| HY-P2324A | Gramicidin A (TFA) | Peptides | |
| HY-P2325 | Exoenzyme C3, clostridium botulinum | 58319-92-9 | Enzyme |
| HY-P2328 | Gramicidin C | 9062-61-7 | Peptides |
| HY-P2329 | Lysostaphin | 9011-93-2 | Enzyme |
| HY-P2331 | Actagardin | 59165-34-3 | Peptides |
| HY-P2333 | LCKLSL | 533902-29-3 | Peptides |
| HY-P2333A | LCKLSL (hydrochloride) | Peptides | |
| HY-P2336 | CCZ01048 | Peptides | |
| HY-P2336A | CCZ01048 (TFA) | Peptides | |
| HY-P2341 | Angiopep-2 (hydrochloride) | Peptides | |
| HY-P2342 | Angiopep-Bim BH3 (hydrochloride) | Peptides | |
| HY-P2343 | BH3 (hydrochloride) | Peptides | |
| HY-P2344 | HIV Protease Substrate 1 | 223769-59-3 | Peptides |
| HY-P2344A | HIV Protease Substrate 1 (TFA) | Peptides | |
| HY-P2352 | Fetuin, Fetal Bovine Serum | 9014-81-7 | Biochemical Assay Reagents |
| HY-P2355 | {Boc}-Phe-Leu-Phe-Leu-Phe | 66556-73-8 | Peptides |
| HY-P2355A | {Boc}-Phe-Leu-Phe-Leu-Phe (TFA) | Peptides | |
| HY-P2357 | MI-1544 | 87565-51-3 | Peptides |
| HY-P2358 | PSMα3 | 1001405-52-2 | Peptides |
| HY-P2358A | PSMα3 (TFA) | Peptides | |
| HY-P2360 | G12 | 162550-82-5 | Peptides |
| HY-P2360A | G12 (TFA) | Peptides | |
| HY-P2361 | S12 | 257872-93-8 | Peptides |
| HY-P2363 | Leucinostatin K | 109539-57-3 | Peptides |
| HY-P2365 | Histatin-8 | 127637-03-0 | Peptides |
| HY-P2366 | Teprotide | 35115-60-7 | Peptides |
| HY-P2370 | CH-66 | 139890-66-7 | Peptides |
| HY-P2372 | P60v-src(137-157) | 131023-24-0 | Peptides |
| HY-P2373 | Nattokinase, Natto fermentation | 133876-92-3 | Enzyme |
| HY-P2374 | Ac-DMQD-CHO | 259199-63-8 | Peptides |
| HY-P2376 | Arg-Phe-Asp-Ser | 102567-19-1 | Peptides |
| HY-P2377 | Ac-YVAD-AFC | 219137-85-6 | Dye Reagents |
| HY-P2378 | Neuromedin U-25 (human) | 312306-89-1 | Peptides |
| HY-P2379 | His-Cys-Lys-Phe-Trp-Trp | 172546-75-7 | Peptides |
| HY-P2380 | PAR3 (1-6) (human) | 320347-28-2 | Peptides |
| HY-P2381 | Sar-Arg-Val-Tyr-Val-His-NH2 | 2410957-04-7 | Peptides |
| HY-P2382 | TRV120056 | 40678-47-5 | Peptides |
| HY-P2384 | Fmoc-Glu(OtBu)-Ser(psi(Me,Me)pro)-OH | 909115-33-9 | Peptides |
| HY-P2385 | Fmoc-Val-Ser(psi(Me,Me)pro)-OH | 186023-49-4 | Peptides |
| HY-P2386 | Fmoc-Ala-Ser(psi(Me,Me)pro)-OH | 252554-78-2 | Peptides |
| HY-P2387 | Fmoc-Tyr(tBu)-Ser(psi(Me,Me)pro)-OH | 878797-09-2 | Peptides |
| HY-P2388 | Fmoc-Lys(Boc)-Thr(psi(Me,Me)pro)-OH | 911838-56-7 | Peptides |
| HY-P2389 | Fmoc-Lys(Boc)-Ser(psi(Me,Me)pro)-OH | 957780-54-0 | Peptides |
| HY-P2390 | Fmoc-Leu-Ser(psi(Me,Me)pro)-OH | 339531-50-9 | Peptides |
| HY-P2391 | Fmoc-Gln(Trt)-Ser(psi(Me,Me)pro)-OH | 1821378-64-6 | Peptides |
| HY-P2392 | Fmoc-Ala-Thr(psi(Me,Me)pro)-OH | 252554-79-3 | Peptides |
| HY-P2393 | Fmoc-Val-Thr(psi(Me,Me)pro)-OH | 168216-05-5 | Peptides |
| HY-P2394 | Fmoc-Ser(tBu)-Thr(psi(Me,Me)pro)-OH | 1266350-99-5 | Peptides |
| HY-P2395 | Fmoc-Tyr(tBu)-Thr(psi(Me,Me)pro)-OH | 920519-31-9 | Peptides |
| HY-P2396 | Fmoc-Ile-Thr(psi(Me,Me)pro)-OH | 957780-52-8 | Peptides |
| HY-P2397 | Fmoc-Asn(Trt)-Thr(psi(Me,Me)pro)-OH | 957780-59-5 | Peptides |
| HY-P2398 | Fmoc-Phe-Ser(psi(Me,Me)pro)-OH | 878797-01-4 | Peptides |
| HY-P2399 | Fmoc-Glu(OtBu)-Thr(psi(Me,Me)pro)-OH | 957780-56-2 | Peptides |
| HY-P2400 | Fmoc-Leu-Thr(psi(Me,Me)pro)-OH | 955048-89-2 | Peptides |
| HY-P2401 | Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH | 920519-33-1 | Peptides |
| HY-P2402 | Fmoc-Gly-Thr(psi(Me,Me)pro)-OH | 1262308-49-5 | Peptides |
| HY-P2403 | Fmoc-Asp(OtBu)-Ser(psi(Me,Me)pro)-OH | 955048-92-7 | Peptides |
| HY-P2404 | Fmoc-Asp(OtBu)-Thr(psi(Me,Me)pro)-OH | 920519-32-0 | Peptides |
| HY-P2405 | Fmoc-Gly-Ser(psi(Me,Me)pro)-OH | 1095952-22-9 | Peptides |
| HY-P2407 | Fmoc-Ser(tBu)-Ser(psi(Me,Me)pro)-OH | 1000164-43-1 | Peptides |
| HY-P2408 | Fmoc-Trp(Boc)-Thr(psi(Me,Me)pro)-OH | 936707-21-0 | Peptides |
| HY-P2409 | Fmoc-Phe-Thr(psi(Me,Me)pro)-OH | 1196703-48-6 | Peptides |
| HY-P2410 | Fmoc-Ile-Ser(psi(Me,Me)pro)-OH | 1147996-34-6 | Peptides |
| HY-P2411 | Fmoc-Gln(Trt)-Thr(psi(Me,Me)pro)-OH | 1572725-72-4 | Peptides |
| HY-P2412 | Fmoc-Trp(Boc)-Ser(psi(Me,Me)pro)-OH | 908601-15-0 | Peptides |
| HY-P2413 | Ac-PPPHPHARIK-NH2 | 957791-38-7 | Reference compound |
| HY-P2414 | MMP-13 Substrate | 1872435-02-3 | Peptides |
| HY-P2414A | MMP-13 Substrate (TFA) | Peptides | |
| HY-P2416 | Gastrin I, rat | 81123-06-0 | Peptides |
| HY-P2419 | [Ala6]-LHRH | 51278-35-4 | Peptides |
| HY-P2422 | Ser-Asp-Gly-Arg-Gly | 108608-63-5 | Peptides |
| HY-P2424 | Cholecystokinin-J | 144396-38-3 | Peptides |
| HY-P2426 | (D-Trp12,Tyr34)-pTH (7-34) amide (bovine) | 118102-98-0 | Peptides |
| HY-P2428 | RI-61 | 95034-26-7 | Reference compound |
| HY-P2429 | N,N-Diallyl-Tyr-Aib-Aib-Phe-Leu | 92535-15-4 | Peptides |
| HY-P2433 | SNF-8814 | 137442-16-1 | Peptides |
| HY-P2434 | AP102 | 846569-60-6 | Peptides |
| HY-P2435 | Bz-Nle-Lys-Arg-Arg-AMC | 863975-32-0 | Peptides |
| HY-P2436 | L-659837 | 125989-10-8 | Peptides |
| HY-P2438 | Thr8-saralasin | 74127-89-2 | Reference compound |
| HY-P2439 | MEN 10208 | 129781-07-3 | Peptides |
| HY-P2442 | Bombolitin V | 95648-98-9 | Peptides |
| HY-P2444 | Platelet factor 4 (59-70) | 88145-47-5 | Peptides |
| HY-P2446 | ORG 30276 | 83539-08-6 | Peptides |
| HY-P2450 | Leucinostatin A | 76600-38-9 | Natural Products |
| HY-P2452 | Vitronectin (367-378) | 1217344-74-5 | Peptides |
| HY-P2453 | MBP (90-106) | Peptides | |
| HY-P2454 | CSP1 | 172889-49-5 | Peptides |
| HY-P2455 | LLO (91-99) | 137856-41-8 | Peptides |
| HY-P2456 | MBP MAPK Substrate | 138028-00-9 | Peptides |
| HY-P2457 | rCRAMP (rat) | 376364-38-4 | Peptides |
| HY-P2458 | CAP18 (rabbit) | 152742-15-9 | Peptides |
| HY-P2459 | MOG (35-55), human | 163158-19-8 | Peptides |
| HY-P2460 | SMAP-29 | 172485-26-6 | Peptides |
| HY-P2461 | MOG (89-113), human | 218291-36-2 | Peptides |
| HY-P2462 | Ac-Arg-Gly-Lys(Ac)-AMC | 660846-97-9 | Peptides |
| HY-P2463 | Fequesetide | 476014-70-7 | Peptides |
| HY-P2464 | Myosin H Chain Fragment, mouse | Peptides | |
| HY-P2464A | Myosin H Chain Fragment, mouse (acetate) | Peptides | |
| HY-P2465 | Histone H3 (1-35) | 135990-31-7 | Peptides |
| HY-P2465A | Histone H3 (1-35) (TFA) | Peptides | |
| HY-P2466 | Bax BH3 peptide (55-74), wild type | 299946-20-6 | Peptides |
| HY-P2467 | Biotin-TAT (47-57) | 1231898-25-1 | Peptides |
| HY-P2468 | BAD (103-127) (human) | 331762-68-6 | Peptides |
| HY-P2469 | Brain Natriuretic Peptide-45, mouse | 1816939-52-2 | Peptides |
| HY-P2470 | Human PD-L1 inhibitor II | 2135542-85-5 | Peptides |
| HY-P2471 | Neurogranin (48-76), mouse | Peptides | |
| HY-P2472 | Orphan GPCR SP9155 agonist P550 (mouse, rat) | 600171-70-8 | Peptides |
| HY-P2473 | Neurogranin (48-76), human | Peptides | |
| HY-P2474 | Human PD-L1 inhibitor I | 2135542-86-6 | Peptides |
| HY-P2475 | [Pro9]-Substance P | 104486-69-3 | Peptides |
| HY-P2476 | Peripheral Myelin P0 Protein (180-199), mouse | 147450-30-4 | Peptides |
| HY-P2477 | Human PD-L1 inhibitor IV | 2135542-83-3 | Peptides |
| HY-P2478 | Human PD-L1 inhibitor V | 2815311-61-4 | Peptides |
| HY-P2478A | Human PD-L1 inhibitor V (TFA) | Peptides | |
| HY-P2479 | Peripheral Myelin Protein P2 (53-78), bovine | 81628-50-4 | Peptides |
| HY-P2480 | Histone H1-derived Peptide | 889112-06-5 | Peptides |
| HY-P2482 | TD-1 | 918629-48-8 | Peptides |
| HY-P2483 | Octaarginine | 148796-86-5 | Peptides |
| HY-P2483A | Octaarginine (TFA) | Peptides | |
| HY-P2490 | Acetyl-Hirudin (54-65) (sulfated) | 125441-00-1 | Peptides |
| HY-P2491 | Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled | 1815618-06-4 | Peptides |
| HY-P2492 | Renin FRET Substrate I | 142988-22-5 | Peptides |
| HY-P2493 | (Cys47)-HIV-1 tat Protein (47-57) | 627079-23-6 | Peptides |
| HY-P2494 | OVA (55-62) | 151992-56-2 | Peptides |
| HY-P2495 | OVA (241-270) | 2648610-97-1 | Peptides |
| HY-P2495A | OVA (241-270) (TFA) | Peptides | |
| HY-P2496 | Endothelin 1 (swine, human), Alexa Fluor 488-labeled | Peptides | |
| HY-P2497 | Exendin (5-39) | 196109-27-0 | Peptides |
| HY-P2498 | Cathepsin D and E FRET Substrate | 839730-93-7 | Peptides |
| HY-P2498A | Cathepsin D and E FRET Substrate (acetate) | Peptides | |
| HY-P2499 | BAD (103-127) (human), FAM-labeled | Peptides | |
| HY-P2500 | (Arg)9, FAM-labeled | Peptides | |
| HY-P2501 | Amylin (8-37), human | 135702-23-7 | Peptides |
| HY-P2502 | Hepatitis Virus C NS3 Protease Inhibitor 2 | 208939-95-1 | Peptides |
| HY-P2503 | EGFR Protein Tyrosine Kinase Substrate | 945830-38-6 | Peptides |
| HY-P2504 | Syk Kinase Peptide Substrate, Biotin labeled | Peptides | |
| HY-P2505 | Syk Kinase Peptide Substrate | 865778-47-8 | Peptides |
| HY-P2506 | Gp100 (25-33), mouse | 212370-36-0 | Peptides |
| HY-P2506A | Gp100 (25-33), mouse (TFA) | Peptides | |
| HY-P2507 | NY-ESO-1 (87-111) | 508230-31-7 | Peptides |
| HY-P2508 | MUC1, mucin core | 149205-73-2 | Peptides |
| HY-P2509 | Histone H2A (1-20) | Peptides | |
| HY-P2510 | Parathyroid Hormone (1-34), human, biotinylated | Peptides | |
| HY-P2511 | Insulin β Chain Peptide (15-23) | 247044-67-3 | Peptides |
| HY-P2512 | Phytochelatin 2 (PC2) | 95014-75-8 | Peptides |
| HY-P2512A | Phytochelatin 2 (PC2) (TFA) | 1426828-27-4 | Peptides |
| HY-P2513 | Src Optimal Peptide Substrate | 168202-45-7 | Peptides |
| HY-P2514 | TET 830 modified/T-helper epitope from tetanus toxoid | 410527-75-2 | Peptides |
| HY-P2515 | Transcriptional Intermediary Factor 2 (TIF2) (740-753) | 359821-54-8 | Peptides |
| HY-P2516 | Tau Peptide (275-305) (Repeat 2 domain) | 330456-25-2 | Peptides |
| HY-P2517 | Scrambled TRAP Fragment | 1348418-97-2 | Peptides |
| HY-P2518 | Protease-Activated Receptor-1, PAR-1 Agonist | 141136-85-8 | Peptides |
| HY-P2518A | Protease-Activated Receptor-1, PAR-1 Agonist (TFA) | Peptides | |
| HY-P2519 | Protease-Activated Receptor-3 (PAR-3) (1-6), human | 1872435-09-0 | Peptides |
| HY-P2519A | Protease-Activated Receptor-3 (PAR-3) (1-6), human (TFA) | Peptides | |
| HY-P2520 | Influenza HA (110-119) | 132031-50-6 | Peptides |
| HY-P2521 | NS2 (114-121), Influenza | 184763-32-4 | Peptides |
| HY-P2522 | Competence-Stimulating Peptide-2 (CSP-2) | 1174553-84-4 | Peptides |
| HY-P2523 | Temporin L | 188713-81-7 | Peptides |
| HY-P2524 | MAGE-3 (271-279) | 160295-81-8 | Peptides |
| HY-P2525 | GAD65 (206-220) | 245124-26-9 | Peptides |
| HY-P2526 | LyP-1 | 454487-07-1 | Peptides |
| HY-P2526A | LyP-1 (TFA) | Peptides | |
| HY-P2527 | Tyrosinase-related Protein 2 (TRP-2) (181-188) | 187671-49-4 | Peptides |
| HY-P2528 | Enhanced Green Fluorescent Protein (EGFP) (200-208) | 323198-39-6 | Peptides |
| HY-P2529 | Penetratin | 940866-75-1 | Peptides |
| HY-P2530 | KALA | 187987-64-0 | Peptides |
| HY-P2531 | OVA (329-337) | 276889-40-8 | Peptides |
| HY-P2532 | Integrin Binding Peptide | 278792-07-7 | Peptides |
| HY-P2533 | Proinsulin C-Peptide (31-63), porcine | 28152-90-1 | Peptides |
| HY-P2534 | C-Peptide 2, rat | 41594-08-5 | Peptides |
| HY-P2535 | Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human | Peptides | |
| HY-P2536 | Mca-Ala-Pro-Lys(Dnp)-OH | 305336-82-7 | Dye Reagents |
| HY-P2537 | Apelin-12 | 229961-08-4 | Peptides |
| HY-P2538 | Big Endothelin-1 (1-38), human | 120796-97-6 | Peptides |
| HY-P2539 | Big Endothelin-1 (1-39), porcine | 120796-99-8 | Peptides |
| HY-P2540 | Leptin (93-105), human | 200436-43-7 | Peptides |
| HY-P2541 | GIP (1-30) amide, porcine | 134846-93-8 | Peptides |
| HY-P2541A | GIP (1-30) amide, porcine (TFA) | Peptides | |
| HY-P2542 | GIP (3-42), human | 1802086-25-4 | Peptides |
| HY-P2543 | Neuropeptide Y (3-36) (human, rat) | 150138-78-6 | Peptides |
| HY-P2544 | [Lys8, Lys9]-Neurotensin (8-13) | 139026-64-5 | Peptides |
| HY-P2545 | [Tyr1]-Somatostatin-14 | 59481-23-1 | Peptides |
| HY-P2546 | Biotin-Substance P | 87468-58-4 | Peptides |
| HY-P2547 | Tyrosine Kinase Peptide 1 | 173691-86-6 | Peptides |
| HY-P2547A | Tyrosine Kinase Peptide 1 (acetate) | Peptides | |
| HY-P2548 | pp60 (v-SRC) Autophosphorylation Site, Phosphorylated | 176042-83-4 | Peptides |
| HY-P2549 | Biotin-β-Amyloid (1-40) | 183906-14-1 | Peptides |
| HY-P2550 | β-Amyloid (1-40), FAM-labeled | 1678416-08-4 | Peptides |
| HY-P2550A | β-Amyloid (1-40), FAM-labeled (TFA) | Peptides | |
| HY-P2551 | Biotin-β-Amyloid (17-40) | Peptides | |
| HY-P2552 | Histone H3 (1-21) | 873215-29-3 | Peptides |
| HY-P2553 | Histone H3 (116-136), C116-136 | 917103-17-4 | Peptides |
| HY-P2554 | Histone H3 (1-25), amide | 1373320-65-0 | Peptides |
| HY-P2555 | Histone H3 (23-34) | 2130981-29-0 | Peptides |
| HY-P2556 | Histone H3 (21-44) | 1373516-71-2 | Peptides |
| HY-P2557 | Histone H3 (5-23) | 330198-01-1 | Peptides |
| HY-P2558 | GSK3 Substrate, α, β subunit | Peptides | |
| HY-P2559 | CDK7/9 tide | Peptides | |
| HY-P2560 | LCMV GP (61-80) | 232598-19-5 | Peptides |
| HY-P2561 | Influenza Matrix Protein (61-72) | 1286245-45-1 | Peptides |
| HY-P2562 | β-Amyloid (1-38), mouse, rat | 186359-66-0 | Peptides |
| HY-P2563 | [Tyr(P)4] Angiotensin II | 129785-85-9 | Peptides |
| HY-P2564 | Human PD-L1 inhibitor III | 2135542-84-4 | Peptides |
| HY-P2565 | Pepinh-TRIF (TFA) | Peptides | |
| HY-P2569 | Malformin A1 | 3022-92-2 | Peptides |
| HY-P2572 | Deltakephalin | 85286-38-0 | Peptides |
| HY-P2573 | Suc-AAPF-pNA | 70967-97-4 | Peptides |
| HY-P2576 | Polistes mastoparan | 74129-19-4 | Peptides |
| HY-P2578 | PHYD protein, Arabidopsis | 158379-16-9 | Peptides |
| HY-P2579 | Dafphedyn | 111846-43-6 | Peptides |
| HY-P2582 | KRAKAKTTKKR | 118675-77-7 | Peptides |
| HY-P2585 | Sporidesmolide V | 127072-57-5 | Peptides |
| HY-P2588 | Osteocalcin (human) | 136461-80-8 | Peptides |
| HY-P2590 | Tnrnflrfamide | 113611-68-0 | Peptides |
| HY-P2592 | Ro 23-7014 | 113714-78-6 | Peptides |
| HY-P2595 | SKF 103784 | 111372-60-2 | Peptides |
| HY-P2596 | BC 197 | 115295-08-4 | Peptides |
| HY-P2599 | A83586C | 116364-81-9 | Peptides |
| HY-P2600 | Laminin B1 (1363-1383) | 112761-58-7 | Peptides |
| HY-P2601A | Tyr-α-CGRP (human) (TFA) | Reference compound | |
| HY-P2602 | α-Casozepine | 117592-45-7 | Peptides |
| HY-P2603 | Bz-Dab(NBD)-AwFpP-Nle-NH2 | 161238-74-0 | Peptides |
| HY-P2605 | Tuna AI | 117620-76-5 | Peptides |
| HY-P2606 | Antiflammin 2 | 118850-72-9 | Peptides |
| HY-P2608 | DNP-Pro-Leu-Ala-Leu-Trp-Ala-Arg-OH | 135662-04-3 | Peptides |
| HY-P2609F | PACAP (1-38), amide, Biotin-labeled | Peptides | |
| HY-P2610 | Ac-VEID-pNA | 189684-54-6 | Peptides |
| HY-P2612 | WP9QY | 199999-60-5 | Peptides |
| HY-P2612A | WP9QY (TFA) | Peptides | |
| HY-P2614 | Mca-DEVDAP-K(Dnp)-OH | 189696-20-6 | Dye Reagents |
| HY-P2615 | Ac-VDVAD-AFC | 210344-94-8 | Dye Reagents |
| HY-P2615A | Ac-VDVAD-AFC (TFA) | Dye Reagents | |
| HY-P2616 | Mca-YVADAP-Lys(Dnp)-OH | 189696-01-3 | Dye Reagents |
| HY-P2616A | Mca-YVADAP-Lys(Dnp)-OH (TFA) | Peptides | |
| HY-P2617 | Ac-WEHD-AFC | 210344-99-3 | Peptides |
| HY-P2617A | Ac-WEHD-AFC (TFA) | Peptides | |
| HY-P2618 | Pro-Phe-Arg-AMC (acetate) | 2237216-30-5 | Peptides |
| HY-P2620 | Ac-LETD-AFC | 210345-02-1 | Dye Reagents |
| HY-P2624 | st-Ht31 | 188425-80-1 | Peptides |
| HY-P2624A | st-Ht31 (ammonium) | Peptides | |
| HY-P2625 | GLP-2(3-33) | 275801-62-2 | Peptides |
| HY-P2625S | GLP-2(3-33) (Leu-13C6,15N) | Isotope-Labeled Compounds | |
| HY-P2625S1 | GLP-2(3-33) (Leu-13C6,15N) (TFA) | Isotope-Labeled Compounds | |
| HY-P2626 | [D-Ala2]-Met-Enkephalin | 61370-87-4 | Peptides |
| HY-P2627 | CCK (27-33) | 47910-79-2 | Peptides |
| HY-P2628 | Dabcyl-YVADAPV-EDANS | 161877-70-9 | Dye Reagents |
| HY-P2630 | Suc-YVAD-pNA | 208264-84-0 | Peptides |
| HY-P2631 | EC119 | 742091-99-2 | Peptides |
| HY-P2632 | RAD16-I | 289042-25-7 | Peptides |
| HY-P2632A | RAD16-I (hydrochloride) | 2100275-49-6 | Peptides |
| HY-P2633 | Dentonin | 400090-20-2 | Peptides |
| HY-P2633A | Dentonin (TFA) | Peptides | |
| HY-P2634 | Acetyl pentapeptide-1 | 97530-32-0 | Peptides |
| HY-P2635 | RGDSPASSKP | 91575-25-6 | Peptides |
| HY-P2636 | Cholecystokinin Precursor (24-32) (rat) | 99291-20-0 | Peptides |
| HY-P2638 | Cholecystokinin (27-32)-amide | 86367-90-0 | Peptides |
| HY-P2641 | Peptide 74 | 132116-39-3 | Peptides |
| HY-P2642 | Peptide 78 | 132116-62-2 | Peptides |
| HY-P2643 | Angiotensin I/II (4-8) | 52530-60-6 | Peptides |
| HY-P2648 | Suc-Ala-Ala-Pro-Leu-pNA | 70968-04-6 | Peptides |
| HY-P2651 | Dansyl-D-Ala-Gly-Phe(pNO2)-Gly | 83960-27-4 | Peptides |
| HY-P2655 | Antho-RFamide | 107535-01-3 | Peptides |
| HY-P2656 | β-Defensin-4 (human) | 370570-43-7 | Peptides |
| HY-P2657 | Verucopeptin | 138067-14-8 | Peptides |
| HY-P2658 | [Des-Tyr1]-Met-Enkephalin | 61370-88-5 | Peptides |
| HY-P2660 | Gly-Asp-Asp-Asp-Asp-Lys-β-naphthylamide | 70023-02-8 | Peptides |
| HY-P2661 | FA-Leu-Gly-Pro-Ala-OH | 78832-65-2 | Peptides |
| HY-P2663 | Acetyl tetrapeptide-2 | 757942-88-4 | Peptides |
| HY-P2664 | MeOSuc-AAPM-PNA | 70967-91-8 | Biochemical Assay Reagents |
| HY-P2665 | Lymphocyte activating pentapeptide | 120484-65-3 | Peptides |
| HY-P2668 | Cdk5 Substrate | 164669-07-2 | Peptides |
| HY-P2669 | Boc-YPGFL(O-tBu) | 179124-36-8 | Peptides |
| HY-P2670 | SN50M | 201608-17-5 | Peptides |
| HY-P2671 | [Leu15]-Gastrin I (human) | 39024-57-2 | Peptides |
| HY-P2673 | Lys-Arg-Thr-Leu-Arg-Arg | 121284-21-7 | Peptides |
| HY-P2673A | Lys-Arg-Thr-Leu-Arg-Arg (acetate) | Peptides | |
| HY-P2676 | Enkephalin(1-3) | 21778-69-8 | Peptides |
| HY-P2677 | CCK (26-31) (sulfated) | 89911-65-9 | Peptides |
| HY-P2678 | CCK (26-31) (non-sulfated) | 89911-64-8 | Peptides |
| HY-P2682 | MMP-8/MMP-26 Fluorogenic substrate | 135662-05-4 | Peptides |
| HY-P2685 | MeOSuc-Ala-Ala-Pro-Val-pNA | 70967-90-7 | Dye Reagents |
| HY-P2686 | Acetyl angiotensinogen (1-14), porcine | 66641-26-7 | Peptides |
| HY-P2687 | Ularitide | 118812-69-4 | Peptides |
| HY-P2689 | DNP-PLGMWSR | 135662-07-6 | Peptides |
| HY-P2692A | DT-2 | 1220985-78-3 | Peptides |
| HY-P2692B | DT-2 (acetate) | Peptides | |
| HY-P2695 | STh | 118447-40-8 | Peptides |
| HY-P2697 | PA22-2 (free acid) | 123063-31-0 | Peptides |
| HY-P2698 | 1-Alaninechlamydocin | 141446-96-0 | Peptides |
| HY-P2699 | ω-Grammotoxin SIA | 152617-90-8 | Peptides |
| HY-P2700 | µ-Conotoxin GIIIB | 140678-12-2 | Peptides |
| HY-P2702 | Helodormin | 89468-62-2 | Peptides |
| HY-P2703 | Peptide YY (pig) | 81858-94-8 | Peptides |
| HY-P2705 | Mastoparan X | 72093-22-2 | Peptides |
| HY-P2706 | Granuliberin R | 64704-41-2 | Peptides |
| HY-P2707 | α-Dendrotoxin | 74504-53-3 | Peptides |
| HY-P2708 | H-Gly-Pro-Arg-Pro-NH2 | 126047-75-4 | Peptides |
| HY-P2709 | Rigin | 77727-17-4 | Peptides |
| HY-P2710 | Noxiustoxin | 85205-49-8 | Peptides |
| HY-P2712 | Chemerin-9, mouse | 686324-96-9 | Peptides |
| HY-P2713 | OM99-2 | 314266-76-7 | Peptides |
| HY-P2713A | OM99-2 (TFA) | 2504147-81-1 | Peptides |
| HY-P2714 | SEVNLDAEFR | 186142-28-9 | Peptides |
| HY-P2715 | Boc-Leu-Ser-Thr-Arg-AMC | 73554-93-5 | Peptides |
| HY-P2716 | Mca-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(Dnp)-NH2 | 158584-08-8 | Peptides |
| HY-P2717 | Ac-YVAD-AMC | 149231-65-2 | Peptides |
| HY-P2718 | Z-Gly-Pro-Gly-Gly-Pro-Ala-OH | 13075-38-2 | Peptides |
| HY-P2719 | Fibronectin Type III Connecting Segment Fragment 1-25 | 107978-77-8 | Peptides |
| HY-P2723 | Dextran sucrase | 9032-14-8 | Enzyme |
| HY-P2724 | Purine nucleoside phosphorylase, Microorganism | 9030-21-1 | Enzyme |
| HY-P2724A | Purine nucleoside phosphorylase, Bacillus sp. | 9030-21-1 | Enzyme |
| HY-P2725 | Glycerol dehydrogenase | 9028-14-2 | Enzyme |
| HY-P2726 | Aldolase, Rabbit muscle | 9024-52-6 | Enzyme |
| HY-P2727 | Chondroitinase ABC | 9024-13-9 | Enzyme |
| HY-P2728 | Antithrombin III, human plasma | 90170-80-2 | Enzyme |
| HY-P2728A | Murine Antithrombin III | Enzyme | |
| HY-P2729 | Subtilisin | 9014-01-1 | Enzyme |
| HY-P2733 | Glycerol-3-phosphate oxidase, E. coli | 9046-28-0 | Enzyme |
| HY-P2733A | Glycerol 3-phosphate Oxidase, Pedio coccus sp. | 9046-28-0 | Enzyme |
| HY-P2733B | Glycerol 3-phosphate Oxidase, Aerococcus viridans | 9046-28-0 | Enzyme |
| HY-P2733C | Glycerol-3-phosphate oxidase, microorganism | 9046-28-0 | Enzyme |
| HY-P2734 | Phosphorylase a, rabbit muscle | 9032-10-4 | Enzyme |
| HY-P2735 | Phosphorylase b | 9012-69-5 | Enzyme |
| HY-P2736 | Amidase | 9012-56-0 | Enzyme |
| HY-P2738 | Collagen, Type I, from bovine achilles tendon | 9007-34-5 | Biochemical Assay Reagents |
| HY-P2739 | Citrate synthase | 9027-96-7 | Enzyme |
| HY-P2740 | Alcohol dehydrogenase, Saccharomyces cerevisiae | 9031-72-5 | Enzyme |
| HY-P2740A | (R)-Alcohol dehydrogenase | 9028-12-0 | Enzyme |
| HY-P2740B | Alcohol dehydrogenase, yeast | 9031-72-5 | Enzyme |
| HY-P2741 | Maltose phosphorylase | 9030-19-7 | Enzyme |
| HY-P2742 | Ascorbate oxidase, Cucurbit sp. | 9029-44-1 | Enzyme |
| HY-P2742A | L-Ascorbate oxidase, Cucumber | 9029-44-1 | Enzyme |
| HY-P2742B | Ascorbate oxidase, acremonium sp | 9029-44-1 | Enzyme |
| HY-P2743 | Choline oxidase | 9028-67-5 | Enzyme |
| HY-P2744 | Ribulose bisphosphate carboxylase | 9027-23-0 | Enzyme |
| HY-P2745 | Glycerophosphocholine phosphodiesterase | 9025-85-8 | Enzyme |
| HY-P2746 | Carboxypeptidase B, Porcine pancreas | 9025-24-5 | Enzyme |
| HY-P2747 | Aconitate hydratase, pig heart | 9024-25-3 | Enzyme |
| HY-P2749 | Glutamine synthetase | 9023-70-5 | Enzyme |
| HY-P2750 | Cathepsin D | 9025-26-7 | Enzyme |
| HY-P2750A | Cathepsin D, Human Liver | Enzyme | |
| HY-P2751 | Elastase, Human leukocytes | 9004-06-2 | Enzyme |
| HY-P2752 | Lipoprotein lipase, Pseudomonas sp | 9004-02-8 | Enzyme |
| HY-P2753 | Sucrose phosphorylase | 9074-06-0 | Enzyme |
| HY-P2754 | Micrococcal nuclease | 9013-53-0 | Enzyme |
| HY-P2755 | Xanthine oxidase, Microorganism | 9002-17-9 | Enzyme |
| HY-P2755A | Xanthine oxidase, bovine milk | 9002-17-9 | Enzyme |
| HY-P2756 | Alcohol oxidase | 9073-63-6 | Enzyme |
| HY-P2757 | Phosphorylase kinase | 9001-88-1 | Enzyme |
| HY-P2758 | Diamine oxidase | 9001-53-0 | Enzyme |
| HY-P2759 | Thioredoxin reductase | 9074-14-0 | Enzyme |
| HY-P2760 | Glutaminase | 9001-47-2 | Enzyme |
| HY-P2761 | Glucokinase | 9001-36-9 | Enzyme |
| HY-P2762 | α-Amylase from Aspergillus oryzae | 9001-19-8 | Enzyme |
| HY-P2763 | beta-Glucanase | 9074-98-0 | Enzyme |
| HY-P2764 | Apyrase | 9000-95-7 | Enzyme |
| HY-P2765 | Glycerol phosphate dehydrogenase, rabbit muscle | 9075-65-4 | Enzyme |
| HY-P2766 | Trehalase | 9025-52-9 | Enzyme |
| HY-P2766A | Trehalase, Microorganism | 9025-52-9 | Enzyme |
| HY-P2767 | Urease, Jack bean | 9002-13-5 | Enzyme |
| HY-P2768 | Leucine dehydrogenase, Microorganism | 9082-71-7 | Enzyme |
| HY-P2769 | Agarase | 37288-57-6 | Enzyme |
| HY-P2769A | Thermostable β-Agarase | 37288-57-6 | Enzyme |
| HY-P2770 | β-Amylase, Bacilus subtilis | 9000-91-3 | Enzyme |
| HY-P2771 | Pectinesterase | 9025-98-3 | Enzyme |
| HY-P2772 | Restrictocin | 1406-72-0 | Enzyme |
| HY-P2773 | Nuclease S1, Aspergillus oryzae | 37288-25-8 | Enzyme |
| HY-P2774 | Glyoxalase I | 9033-12-9 | Enzyme |
| HY-P2775 | β-Glucosidase, almond | 9001-22-3 | Enzyme |
| HY-P2776 | Hexokinase, microorganism | 9001-51-8 | Enzyme |
| HY-P2776A | Hexokinase, Yeast | 9001-51-8 | Enzyme |
| HY-P2776B | Hexokinase, Bacillus sp. | 9001-51-8 | Enzyme |
| HY-P2777 | Ceruloplasmin | 9031-37-2 | Enzyme |
| HY-P2779 | Microsomal aminopeptidase, Microorganism | 9054-63-1 | Enzyme |
| HY-P2780 | Cathepsin B, Bovine spleen | 9047-22-7 | Enzyme |
| HY-P2780A | Cathepsin B, Human Liver | Enzyme | |
| HY-P2781 | 3′,5′-Cyclic nucleotide phosphodiesterase | 9040-59-9 | Enzyme |
| HY-P2783 | Destruxin B2 | 79386-00-8 | Natural Products |
| HY-P2784 | [Tyr8]-Substance P | 55614-10-3 | Peptides |
| HY-P2785 | Phrixotoxin-1 | 221872-97-5 | Peptides |
| HY-P2785A | Phrixotoxin-1 (TFA) | Peptides | |
| HY-P2786A | Phrixotoxin 2 | 741738-57-8 | Peptides |
| HY-P2787 | Pro-Phe-Phe | 164257-32-3 | Peptides |
| HY-P2788 | Hyp-Phe-Phe | 2493080-84-3 | Peptides |
| HY-P2791 | Tertiapin (reduced) | 58694-52-3 | Peptides |
| HY-P2792 | Beauveriolide III | 221111-70-2 | Peptides |
| HY-P2793 | Uperolein | 55601-63-3 | Peptides |
| HY-P2794 | G0775 | 2098663-92-2 | Peptides |
| HY-P2795 | Kallikrein, Porcine pancreas | 9001-01-8 | Enzyme |
| HY-P2796 | Pyruvate decarboxylase | 9001-04-1 | Enzyme |
| HY-P2797 | Chitinase, Serratia marcescens | 9001-06-3 | Enzyme |
| HY-P2797A | Chitinase, Streptomyces griseus | 9001-06-3 | Enzyme |
| HY-P2797B | Chitinase | 9001-06-3 | Enzyme |
| HY-P2798 | Cholinesterase, Horse serum | 9001-08-5 | Enzyme |
| HY-P2799 | Creatine phosphokinase, Rabbit muscle | 9001-15-4 | Enzyme |
| HY-P2799A | Creatine Kinase (CPK/CK), Bovine Heart | 9001-15-4 | Enzyme |
| HY-P2799B | Creatine Kinase (CK/CPK), Porcine Heart | 9001-15-4 | Enzyme |
| HY-P2799C | Creatine Kinase BB (CK-BB) Isoenzyme, Porcine Brain | 9001-15-4 | Enzyme |
| HY-P2799D | Creatine Kinase MB (rCK-MB), Recombinant Human | 9001-15-4 | Enzyme |
| HY-P2799E | Creatine Kinase MM (CK-MM), Human Skeletal Muscle | 9001-15-4 | Enzyme |
| HY-P2799H | Creatine kinase-MB, Human heart | 9001-15-4 | Enzyme |
| HY-P2800 | Diaphorase, Recombinant microorganisms | 9001-18-7 | Enzyme |
| HY-P2800A | Diaphorase, clostridium sp. | 9001-18-7 | Enzyme |
| HY-P2802 | α-Glucosidase, Yeast | 9001-42-7 | Enzyme |
| HY-P2802A | α-Glucosidase, bacillus stearothermophilus | 9001-42-7 | Enzyme |
| HY-P2802B | α-Glucosidase, rice | 9001-42-7 | Enzyme |
| HY-P2803 | Beta-glucuronidase (Escherichia coli) | 9001-45-0 | Enzyme |
| HY-P2803A | Beta-glucuronidase (bovine liver) | 9001-45-0 | Enzyme |
| HY-P2803B | Beta-glucuronidase (helix pomatia) | 9001-45-0 | Enzyme |
| HY-P2804 | GAPDH, rabbit muscle | 9001-50-7 | Enzyme |
| HY-P2806 | Pyruvate Kinase, Microorganism | 9001-59-6 | Enzyme |
| HY-P2806A | Pyruvate Kinase (PK),Rabbit Muscle | 9001-59-6 | Enzyme |
| HY-P2807 | L-Lactate dehydrogenase, Microorganism | 9001-60-9 | Enzyme |
| HY-P2807A | Lactate Dehydrogenase (LDH), Porcine Heart | 9001-60-9 | Enzyme |
| HY-P2807B | Lactate Dehydrogenase 1 (LDH-1), Human Erythrocytes | 9001-60-9 | Enzyme |
| HY-P2807C | Lactate Dehydrogenase 2 (LDH-2), Human Erythrocytes | 9001-60-9 | Enzyme |
| HY-P2807D | Lactate Dehydrogenase 3 (LDH-3), Human Erythrocytes | 9001-60-9 | Enzyme |
| HY-P2807E | Lactate Dehydrogenase 4 (LDH-4), Human Liver | 9001-60-9 | Enzyme |
| HY-P2807F | Lactate Dehydrogenase (LDH), Bovine Heart | 9001-60-9 | Enzyme |
| HY-P2807G | Lactate Dehydrogenase (LDH), Chicken Heart | 9001-60-9 | Enzyme |
| HY-P2807H | Lactate Dehydrogenase 5 (LDH-5), Human Liver | 9001-60-9 | Enzyme |
| HY-P2807I | L-Lactate Dehydrogenase, rabbit muscle | 9001-60-9 | Enzyme |
| HY-P2807J | L-Lactate Dehydrogenase (L-LDH), pig muscle | 9001-60-9 | Enzyme |
| HY-P2807K | L-Lactate Dehydrogenase, bovine muscle | 9001-60-9 | Enzyme |
| HY-P2808 | 4-Phytase | 9001-89-2 | Enzyme |
| HY-P2809 | Malic dehydrogenase, microorganism | 9001-64-3 | Enzyme |
| HY-P2810 | Rennin | 9001-98-3 | Enzyme |
| HY-P2812 | Phospholipase D, Streptomyces chromofuscus | 9001-87-0 | Enzyme |
| HY-P2812A | Phospholipase D, peanut | 9001-87-0 | Enzyme |
| HY-P2812B | Phospholipase D, cabbage | 9001-87-0 | Enzyme |
| HY-P2813 | Hirudin | 8001-27-2 | Peptides |
| HY-P2815 | Creatinine deiminase | 37289-15-9 | Enzyme |
| HY-P2816 | Xylanase | 37278-89-0 | Enzyme |
| HY-P2817 | Phospholipase C | 9001-86-9 | Enzyme |
| HY-P2818 | Alkaline phosphatase, Bovine intestine | 9001-78-9 | Enzyme |
| HY-P2818A | Alkaline phosphatase, Escherichia coli | 9001-78-9 | Enzyme |
| HY-P2818B | Alkaline phosphatase, Chicken Intestine | 9001-78-9 | Enzyme |
| HY-P2818C | Alkaline phosphatase, microorganism | 9001-78-9 | Enzyme |
| HY-P2818D | Alkaline phosphatase, Human liver | 9001-78-9 | Enzyme |
| HY-P2819 | Phosphofructokinase 1 | 9001-80-3 | Enzyme |
| HY-P2819A | Phosphofructokinase,Bacillus stearothermophilus | 9001-80-3 | Enzyme |
| HY-P2820 | Phosphoglucomutase, Rabbit muscle | 9001-81-4 | Enzyme |
| HY-P2821 | Plasminogen, Human plasma | 9001-91-6 | Enzyme |
| HY-P2821A | Bovine Plasminogen | 9001-91-6 | Enzyme |
| HY-P2821B | Murine Plasminogen | 9001-91-6 | Enzyme |
| HY-P2822 | Phosphoglycerate kinase, yeast | 9001-83-6 | Enzyme |
| HY-P2824 | Streptokinase, β-hemolytic streptococcus (Lancefield Group C) | 9002-01-1 | Enzyme |
| HY-P2825 | Tyrosine decarboxylase, Microorganism | 9002-09-9 | Enzyme |
| HY-P2826 | alpha 1-Antitrypsin | 9041-92-3 | Enzyme |
| HY-P2827 | Acetyl-CoA synthetase | 9012-31-1 | Enzyme |
| HY-P2828 | [Des-Pro2]-Bradykinin | 80943-05-1 | Peptides |
| HY-P2830 | Complement factor D | 37213-56-2 | Enzyme |
| HY-P2831 | Esterase, pig liver | 9016-18-6 | Enzyme |
| HY-P2832 | Acyl coenzyme A synthetase | 9013-18-7 | Enzyme |
| HY-P2833 | Glutathione Peroxidase | 9013-66-5 | Enzyme |
| HY-P2834 | Penicillin amidase, E. coli | 9014-06-6 | Enzyme |
| HY-P2835 | Alginate lyase | 9024-15-1 | Enzyme |
| HY-P2836 | (R)-Mandelonitrile lyase | 9024-43-5 | Enzyme |
| HY-P2837 | Oxaloacetate decarboxylase | 9024-98-0 | Enzyme |
| HY-P2838 | Creatininase, Microorganism | 9025-13-2 | Enzyme |
| HY-P2839 | Heparinase | 9025-39-2 | Enzyme |
| HY-P2840 | Dextranase, Trichoderma reesei | 9025-70-1 | Enzyme |
| HY-P2841 | Elastin from pig | 9007-58-3 | Biochemical Assay Reagents |
| HY-P2841A | Elastin from bovine | 9007-58-3 | Peptides |
| HY-P2842 | Aminopeptidase | 9031-94-1 | Enzyme |
| HY-P2843 | Citrate lyase | 9012-83-3 | Enzyme |
| HY-P2844 | Polynucleotide kinase | 37211-65-7 | Enzyme |
| HY-P2847 | Urocortin II, mouse | 330648-32-3 | Peptides |
| HY-P2848 | Cholesterol oxidase, Microorganism | 9028-76-6 | Enzyme |
| HY-P2848A | Cholesterol oxidase, rhodococcus sp | 9028-76-6 | Enzyme |
| HY-P2853 | Hemocyanin | 9013-72-3 | Biochemical Assay Reagents |
| HY-P2854 | Alanine dehydrogenase, expressed in E. coli | 9029-06-5 | Enzyme |
| HY-P2855 | Phenylpyruvate tautomerase | 9023-54-5 | Enzyme |
| HY-P2856 | Phosphatidylinositol phosphodiesterase | 37288-19-0 | Enzyme |
| HY-P2857 | Amyloglucosidase, Aspergillus niger | 9032-08-0 | Enzyme |
| HY-P2857A | Glucoamylase, Rhizopus sp. | 9032-08-0 | Enzyme |
| HY-P2858 | β-Mannosidase | 9025-43-8 | Enzyme |
| HY-P2859 | Chitosanase | 51570-20-8 | Enzyme |
| HY-P2860 | Acetylcholinesterase, Fly head | 9000-81-1 | Enzyme |
| HY-P2860A | Acetylcholinesterase, Electric eel | 9000-81-1 | Enzyme |
| HY-P2861 | Sarcosine oxidase, Bacillus | 9029-22-5 | Enzyme |
| HY-P2862 | Enolase | 9014-08-8 | Enzyme |
| HY-P2863 | Deoxyribonuclease II | 9025-64-3 | Enzyme |
| HY-P2864 | Rhodanese | 9026-04-4 | Enzyme |
| HY-P2865 | Guanylate kinase | 9026-59-9 | Enzyme |
| HY-P2866 | β-N-Acetylhexosaminidase, Streptococcus pneumoniae | 9012-33-3 | Enzyme |
| HY-P2866A | β-N-Acetylhexosaminidase, Porcine kidney | 9012-33-3 | Enzyme |
| HY-P2867 | Phosphodiesterase II, Bovine Spleen | 9068-54-6 | Enzyme |
| HY-P2868 | Galactosyltransferase | 9031-68-9 | Enzyme |
| HY-P2869 | β-Galactosidase, E. coli | 9031-11-2 | Enzyme |
| HY-P2869A | β1-3 Galactosidase | 9031-11-2 | Enzyme |
| HY-P2869B | β1-4 Galactosidase, E. coli | 9031-11-2 | Enzyme |
| HY-P2869C | β1-3,4 Galactosidase | 9031-11-2 | Enzyme |
| HY-P2869D | β1-3,6 Galactosidase, Xanthomonas manihotis | 9031-11-2 | Enzyme |
| HY-P2869E | β1-3,4,6 Galactosidase | 9031-11-2 | Enzyme |
| HY-P2869I | β-D-Galactosidase, Sweet almond | 9031-11-2 | Enzyme |
| HY-P2871 | α-Galactosidase, Aspergillus niger | 9025-35-8 | Enzyme |
| HY-P2871A | α1-3,6 Galactosidase, Xanthomonas manihotis | 9025-35-8 | Enzyme |
| HY-P2871B | α1-3,4,6 Galactosidase | 9025-35-8 | Enzyme |
| HY-P2872 | Thioglucosidase | 9025-38-1 | Enzyme |
| HY-P2874 | Prolidase | 9025-32-5 | Enzyme |
| HY-P2875 | Hemicellulase | 9025-56-3 | Enzyme |
| HY-P2876 | Tryptophanase | 9024-00-4 | Enzyme |
| HY-P2877 | Tannase | 9025-71-2 | Enzyme |
| HY-P2878 | Phosphodiesterase I | 9025-82-5 | Enzyme |
| HY-P2879 | Cholesterol esterase, Pseudomonas | 9026-00-0 | Enzyme |
| HY-P2879A | Cholesterol esterase, Porcine pancreas | 9026-00-0 | Enzyme |
| HY-P2879B | Cholesterol esterase, Candida cylindracea | 9026-00-0 | Enzyme |
| HY-P2879C | Cholesterol esterase, schizophyllum commune | Enzyme | |
| HY-P2880 | PHI-27 (porcine) | 80458-29-3 | Peptides |
| HY-P2881 | Nucleoside diphosphate kinase | 9026-51-1 | Enzyme |
| HY-P2886 | Ribose-5-phosphate isomerase | 9023-83-0 | Enzyme |
| HY-P2887 | Acetate kinase (ACK) | 9027-42-3 | Enzyme |
| HY-P2888 | Bilirubin oxidase | 80619-01-8 | Enzyme |
| HY-P2888A | Bilirubin oxidase, bacillus cereus | 80619-01-8 | Enzyme |
| HY-P2888B | Bilirubin oxidase, Magnaporthe oryzae | Enzyme | |
| HY-P2888C | Bilirubin oxidase, Bacillus pumilus | Enzyme | |
| HY-P2889 | Pyranose oxidase, Coriolus sp. | 37250-80-9 | Enzyme |
| HY-P2890 | Laccase, Microorganisms | 80498-15-3 | Enzyme |
| HY-P2890A | Laccase, Recombinant Microbial (High activity) | 80498-15-3 | Enzyme |
| HY-P2891 | Pyruvate Oxidase, Microorganisms | 9001-96-1 | Enzyme |
| HY-P2891A | Pyruvate oxidase, Aerococcus viridans | 9001-96-1 | Enzyme |
| HY-P2892 | Fumarase | 9032-88-6 | Enzyme |
| HY-P2893 | Creatinase, Actinobacteria | 37340-58-2 | Enzyme |
| HY-P2893A | Creatinase (Recombinant) | 37340-58-2 | Enzyme |
| HY-P2893B | Creatinase, microorganism | 37340-58-2 | Enzyme |
| HY-P2895 | Clostripain | 9028-00-6 | Enzyme |
| HY-P2896 | Bromoperoxidase | 69279-19-2 | Enzyme |
| HY-P2897 | D-Lactate dehydrogenase, Microorganism | 9028-36-8 | Enzyme |
| HY-P2898 | Chondroitinase C | 60184-91-0 | Enzyme |
| HY-P2901 | 3α-Hydroxysteroid Dehydrogenase, Microorganism | 9028-56-2 | Enzyme |
| HY-P2902 | Glucose oxidase | 9001-37-0 | Enzyme |
| HY-P2906 | Cytochrome P450 reductase | 9039-06-9 | Enzyme |
| HY-P2907 | Formate dehydrogenase | 9028-85-7 | Enzyme |
| HY-P2909 | Formaldehyde dehydrogenase, Pseudomonas sp | 9028-84-6 | Enzyme |
| HY-P2910 | Galactose Oxidase, Dactylium dendroides | 9028-79-9 | Enzyme |
| HY-P2911 | Glutamate dehydrogenase (NAD(P)) | 9029-12-3 | Enzyme |
| HY-P2912 | Glutamate dehydrogenase (NADP) | 9029-11-2 | Enzyme |
| HY-P2913 | Vitronectin | 83380-82-9 | Biochemical Assay Reagents |
| HY-P2914 | Carnitine acetyltransferase | 9029-90-7 | Enzyme |
| HY-P2915 | Protocatechuate 3,4-dioxygenase | 9029-47-4 | Enzyme |
| HY-P2916 | Thymidine phosphorylase | 9030-23-3 | Enzyme |
| HY-P2917 | Glycerol kinase, microorganism | 9030-66-4 | Enzyme |
| HY-P2917A | Glycerol kinase, Cellulomonas sp. | 9030-66-4 | Enzyme |
| HY-P2917B | Glycerol kinase, Flavobacterium meningosepticum | 9030-66-4 | Enzyme |
| HY-P2918 | Phosphoglucose Isomerase, Rabbit muscle | 9001-41-6 | Enzyme |
| HY-P2918A | Phosphoglucose isomerase, bacillus stearothermophilus | 9001-41-6 | Enzyme |
| HY-P2918B | Phosphoglucose isomerase, Baker's Yeast | 9001-41-6 | Enzyme |
| HY-P2919 | Rennet | 9042-08-4 | Enzyme |
| HY-P2920 | Protamine from salmon | 9012-00-4 | Biochemical Assay Reagents |
| HY-P2921 | Urate oxidase, Microorganism | 9002-12-4 | Enzyme |
| HY-P2921A | Uricase, Bacillus fastidious | 9002-12-4 | Enzyme |
| HY-P2921B | Uricase, Arthrobacter globiformis | 9002-12-4 | Enzyme |
| HY-P2921C | Uricase (Recombinant) | 9002-12-4 | Enzyme |
| HY-P2921D | Uricase, candida utilis | 9002-12-4 | Enzyme |
| HY-P2922 | Cathepsin C | 9032-68-2 | Enzyme |
| HY-P2923 | Cathepsin L | 60616-82-2 | Enzyme |
| HY-P2926 | Formamidopyrimidine-DNA glycosidase | 78783-53-6 | Enzyme |
| HY-P2927 | Protein disulfide isomerase | 37318-49-3 | Enzyme |
| HY-P2928 | Aeromonas proteolytica aminopeptidase | 37288-67-8 | Enzyme |
| HY-P2929 | PNGase F | 83534-39-8 | Enzyme |
| HY-P2929A | PNGase F-Fast | 83534-39-8 | Enzyme |
| HY-P2930 | Peptidylprolyl isomerase | 95076-93-0 | Enzyme |
| HY-P2931 | Triosephosphate isomerase | 9023-78-3 | Enzyme |
| HY-P2932 | Cholecystokinin | 9011-97-6 | Peptides |
| HY-P2932A | Cholecystokinin-33 (free acid) | Peptides | |
| HY-P2933 | Activated protein C | 42617-41-4 | Enzyme |
| HY-P2935 | Glutamic acid protease | 137010-42-5 | Enzyme |
| HY-P2936 | Sphingomyelin phosphodiesterase, Streptomyces sp. | 9031-54-3 | Enzyme |
| HY-P2937 | DNA polymerase | 9012-90-2 | Enzyme |
| HY-P2938 | γ-Glutamyl hydrolase | 9074-87-7 | Enzyme |
| HY-P2939 | Chondroitinase AC | 9047-57-8 | Enzyme |
| HY-P2940 | NADase | 9032-65-9 | Enzyme |
| HY-P2942 | Chymotrypsinogen | 9035-75-0 | Biochemical Assay Reagents |
| HY-P2943 | Phosphate acetyltransferase | 9029-91-8 | Enzyme |
| HY-P2944 | Ferredoxin-NADP reductase | 9029-33-8 | Enzyme |
| HY-P2946 | Chondroitinase B | 52227-83-5 | Enzyme |
| HY-P2947 | ALDH | 9028-88-0 | Enzyme |
| HY-P2948 | Protein serine/threonine kinase | 9026-43-1 | Enzyme |
| HY-P2949 | Pandinotoxin Kα | 185529-64-0 | Peptides |
| HY-P2950 | α-Mannosidase | 9025-42-7 | Enzyme |
| HY-P2950A | α1-6 Mannosidase, Xanthomonas phaseoli | 9025-42-7 | Enzyme |
| HY-P2950B | α-(1-2,3,6) Mannosidase | 9025-42-7 | Enzyme |
| HY-P2951 | Phenylalanine ammonia-lyase | 9024-28-6 | Enzyme |
| HY-P2952 | Myokinase, Microorganism | 9013-02-9 | Enzyme |
| HY-P2953 | Heparitin sulfate lyase | 37290-86-1 | Enzyme |
| HY-P2954 | Polymyxin deacylase | 111174-43-7 | Enzyme |
| HY-P2955 | Heparinase II | 149371-12-0 | Enzyme |
| HY-P2956 | Fructose 5-dehydrogenase (acceptor) | 37250-85-4 | Enzyme |
| HY-P2957 | Hyaluronate lyase | 37259-53-3 | Enzyme |
| HY-P2958 | Choloylglycine hydrolase | 37289-07-9 | Enzyme |
| HY-P2959 | Menhaden oil, crude source of omega-3 fatty acids | 8002-50-4 | Biochemical Assay Reagents |
| HY-P2960 | Aminoacylase | 9012-37-7 | Enzyme |
| HY-P2961 | Glutathione S-transferase | 50812-37-8 | Enzyme |
| HY-P2962 | Transglutaminase, Streptoverticillium mobaraense | 80146-85-6 | Enzyme |
| HY-P2963 | Nuclease P1 | 54576-84-0 | Enzyme |
| HY-P2964 | Phenylalanine dehydrogenase | 69403-12-9 | Enzyme |
| HY-P2965 | L-Lysine α-oxidase | 70132-14-8 | Enzyme |
| HY-P2966 | Protein-arginine deiminase | 75536-80-0 | Enzyme |
| HY-P2968 | Bacterial α-Amylase | 9000-85-5 | Enzyme |
| HY-P2969 | Complement factor I | 80295-66-5 | Enzyme |
| HY-P2970 | Stem bromelain | 37189-34-7 | Enzyme |
| HY-P2972 | Sulfatase, Helix pomatia | 9068-67-1 | Enzyme |
| HY-P2973 | Aspergillopepsin I | 9025-49-4 | Enzyme |
| HY-P2974 | Elastase, Porcine pancreas | 39445-21-1 | Enzyme |
| HY-P2975 | Laminin β2 (Engelbreth-Holm-Swarm murine sarcoma basement membrane) | 114956-81-9 | Biochemical Assay Reagents |
| HY-P2976 | Lipoxygenase, general | 9029-60-1 | Enzyme |
| HY-P2977 | N-Acetylneuraminate lyase (CgNal) | 9027-60-5 | Enzyme |
| HY-P2978 | Alpha 1 Antichymotrypsin, Human Plasma | 141176-92-3 | Enzyme |
| HY-P2979 | Invertase, baker's yeast (S. cerevisiae) | 9001-57-4 | Enzyme |
| HY-P2979A | Invertase, candida sp. | 9001-57-4 | Enzyme |
| HY-P2980 | Carboxypeptidase A, Bovine pancreas | 11075-17-5 | Enzyme |
| HY-P2981 | Carboxypeptidase C | 9046-67-7 | Enzyme |
| HY-P2982 | Ceramide 1-phosphate | 128543-23-7 | Natural Products |
| HY-P2983 | Angiotensin-converting enzyme | 9015-82-1 | Enzyme |
| HY-P2984 | Adenosine triphosphatase | 9000-83-3 | Enzyme |
| HY-P2985 | Alanine aminotransferase, Porcine heart | 9000-86-6 | Enzyme |
| HY-P2985A | Alanine aminotransferase, Human liver | 9000-86-6 | Enzyme |
| HY-P2986 | D-Amino acid oxidase (Immobilized) | 9000-88-8 | Enzyme |
| HY-P2987 | L-Amino acid oxidase | 9000-89-9 | Enzyme |
| HY-P2988 | Neuraminidase, Microorganism | 9001-67-6 | Enzyme |
| HY-P2988A | α2-3,6 Neuraminidase, Bifidobacterium infantis | 9001-67-6 | Enzyme |
| HY-P2988B | Neuraminidase, arthrobacter ureafaciens | 9001-67-6 | Enzyme |
| HY-P2989 | Pyruvate carboxylase | 9014-19-1 | Enzyme |
| HY-P2990 | Enteropeptidase | 9014-74-8 | Enzyme |
| HY-P2991 | Galactose 1-phosphate uridylyltransferase | 9016-11-9 | Enzyme |
| HY-P2992 | Inorganic pyrophosphatase, Saccharomyces cerevisiae | 9024-82-2 | Enzyme |
| HY-P2993 | Isocitrate dehydrogenase, Porcine heart | 9028-48-2 | Enzyme |
| HY-P2993A | Isocitrate dehydrogenase, Microorganism | 9028-48-2 | Enzyme |
| HY-P2994 | 3-Hydroxybutyrate dehydrogenase | 9028-38-0 | Enzyme |
| HY-P2995 | Hemoglobin | 9008-02-0 | Biochemical Assay Reagents |
| HY-P2996 | NAD(P)H-Nitrate reductase | 9029-27-0 | Enzyme |
| HY-P2996A | Nitrate Reductase, Arabidopsis thaliana | 9029-27-0 | Enzyme |
| HY-P2996B | Nitrate Reductase (NAD[P]H), Pichia Pastoris (recombinant) | 9029-27-0 | Enzyme |
| HY-P2997 | γ-glutamyltransferase, Porcine kidney | 9046-27-9 | Enzyme |
| HY-P2997A | γ-glutamyltransferase, Human liver | 9046-27-9 | Enzyme |
| HY-P2998 | β-Lactamase | 9073-60-3 | Enzyme |
| HY-P2999 | Endo-β-N-acetylglucosaminidase | 37278-88-9 | Enzyme |
| HY-P3000 | myo-Inositol dehydrogenase | 9028-25-5 | Enzyme |
| HY-P3001 | Malate dehydrogenase (oxaloacetate-decarboxylating, NADP+) | 9028-47-1 | Enzyme |
| HY-P3003 | Cereulide | 157232-64-9 | Peptides |
| HY-P3003S | Cereulide-13C6 | 1487375-69-8 | Isotope-Labeled Compounds |
| HY-P3004 | Endo-1,3-β-glucanase | 9025-37-0 | Enzyme |
| HY-P3005 | T4 DNA ligase | 9015-85-4 | Enzyme |
| HY-P3006 | Des-Leu10-angiotensin I | 34273-12-6 | Peptides |
| HY-P3008 | Submandibular mucin | 84195-52-8 | Biochemical Assay Reagents |
| HY-P3009 | Factor Xa | 9002-05-5 | Enzyme |
| HY-P3009A | Canine Factor Xa | 9002-05-5 | Enzyme |
| HY-P3009B | Porcine Factor Xa | 9002-05-5 | Enzyme |
| HY-P3009C | Rabbit Factor Xa | 9002-05-5 | Enzyme |
| HY-P3009D | Rat Factor Xa | 9002-05-5 | Enzyme |
| HY-P3012 | Cathepsin G | 107200-92-0 | Biochemical Assay Reagents |
| HY-P3014 | Hongotoxin-1 | Peptides | |
| HY-P3016 | Aspartate aminotransferase, Genetically engineered bacteria | 9000-97-9 | Enzyme |
| HY-P3016A | Glutamate oxaloacetate aminotransferase, porcine heart | 9000-97-9 | Enzyme |
| HY-P3016B | Aspartate aminotransferase, Human liver | 9000-97-9 | Enzyme |
| HY-P3017 | Endo-1,4-β-xylanase | 9025-57-4 | Enzyme |
| HY-P3018 | Uridine-5'-diphosphoglucose pyrophosphorylase | 9026-22-6 | Enzyme |
| HY-P3019 | Urocortin III (human) | 357952-09-1 | Peptides |
| HY-P3021 | Human milk lysozyme | 12671-19-1 | Enzyme |
| HY-P3023 | Mutanolysin | 55466-22-3 | Enzyme |
| HY-P3025 | Salmine sulfate | 53597-25-4 | Biochemical Assay Reagents |
| HY-P3026 | Bowman-birk inhibitor | 37330-34-0 | Peptides |
| HY-P3028 | Ficain | 9001-33-6 | Enzyme |
| HY-P3029 | Phospholipase A2 | 9001-84-7 | Enzyme |
| HY-P3029A | Phospholipase A2, Crotalus adamanteus Venom | 9001-84-7 | Enzyme |
| HY-P3030 | CPN-219 | 2240202-02-0 | Peptides |
| HY-P3035 | Corazonin | 122929-08-2 | Peptides |
| HY-P3037 | Imperatoxin A | 172451-37-5 | Peptides |
| HY-P3037A | Imperatoxin A (TFA) | Peptides | |
| HY-P3038 | SDZ 90-215 | 129816-38-2 | Peptides |
| HY-P3040 | PHI-27 (rat) | 96849-38-6 | Peptides |
| HY-P3040A | PHI-27 (rat) (TFA) | Peptides | |
| HY-P3041 | Chromostatin (bovine) | 133633-11-1 | Peptides |
| HY-P3042 | Chymostatin | 9076-44-2 | Peptides |
| HY-P3043 | Bilaid A | 2393865-97-7 | Peptides |
| HY-P3044 | Bilaid A1e | 2393866-02-7 | Peptides |
| HY-P3045 | Bilaid B | 2393866-06-1 | Peptides |
| HY-P3047 | Acetyl decapeptide-3 | 935288-50-9 | Peptides |
| HY-P3050 | Helospectin II | 93585-83-2 | Peptides |
| HY-P3051 | CKS-17 | 99273-04-8 | Peptides |
| HY-P3052 | RGDV | 93674-99-8 | Peptides |
| HY-P3053 | Helospectin I | 93438-37-0 | Peptides |
| HY-P3054 | S6 peptide | 93674-74-9 | Peptides |
| HY-P3055 | Dendrotoxin-I | 107950-33-4 | Peptides |
| HY-P3055A | Dendrotoxin-I (TFA) | Peptides | |
| HY-P3056 | GHRF, ovine | 94948-82-0 | Peptides |
| HY-P3057 | [D-Trp11]-Neurotensin | 73634-68-1 | Peptides |
| HY-P3058 | Ederimotide | 852243-39-1 | Peptides |
| HY-P3060 | Atriopeptin II (rat, mouse) | 89139-54-8 | Peptides |
| HY-P3061 | [Hyp3]-Bradykinin | 37642-65-2 | Peptides |
| HY-P3062 | [Tyr11]-Somatostatin | 59481-27-5 | Peptides |
| HY-P3063 | α-Conotoxin SI | 115797-06-3 | Peptides |
| HY-P3064 | Scyllatoxin | 142948-19-4 | Peptides |
| HY-P3065 | Calcicludine | 178036-64-1 | Peptides |
| HY-P3066 | SKF 100398 | 77453-01-1 | Peptides |
| HY-P3068 | ACTH (1-16) (human) | 5576-42-1 | Peptides |
| HY-P3069 | γ-Neuropeptide (rabbit) | 114882-65-4 | Peptides |
| HY-P3070 | H2-D b restricted epitopes VSV Nucleoprotein (52-59) | 132326-74-0 | Peptides |
| HY-P3071 | ShK toxin | 172450-46-3 | Peptides |
| HY-P3072 | Mastoparan 17 | 145854-61-1 | Peptides |
| HY-P3073 | Myelin Basic Protein (1-11) | 106128-98-7 | Peptides |
| HY-P3075 | pTH-Related Protein (1-34) (human,mouse,rat) | 112540-82-6 | Peptides |
| HY-P3078 | Amphomycin | 1402-82-0 | Peptides |
| HY-P3082 | SKF 106760 | 126053-71-2 | Peptides |
| HY-P3083 | N-Myristoyl-Lys-Arg-Thr-Leu-Arg | 125678-68-4 | Peptides |
| HY-P3084 | Human follicular gonadotropin releasing peptide | 107873-08-5 | Peptides |
| HY-P3087 | Tyr-W-MIF-1 | 144450-13-5 | Peptides |
| HY-P3089 | Dendrotoxin K | 119128-61-9 | Peptides |
| HY-P3089A | Dendrotoxin K (TFA) | Peptides | |
| HY-P3090 | [D-Asp3]-Microcystin-LR | 120011-66-7 | Peptides |
| HY-P3092 | Phyllomedusin | 26145-48-2 | Peptides |
| HY-P3095 | α-Latrotoxin | 65988-34-3 | Peptides |
| HY-P3098 | Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH2 | 256394-94-2 | Dye Reagents |
| HY-P3099 | Uroguanylin (human) | 154525-25-4 | Peptides |
| HY-P3099A | Uroguanylin (human) (TFA) | Peptides | |
| HY-P3100 | Orfamide A | 939960-34-6 | Peptides |
| HY-P3101 | GLP-1(28-36)amide | 1225021-13-5 | Peptides |
| HY-P3101A | GLP-1(28-36)amide (TFA) | Peptides | |
| HY-P3102 | GLP-1(32-36)amide | 1417302-71-6 | Peptides |
| HY-P3102A | GLP-1(32-36)amide (TFA) | Peptides | |
| HY-P3103 | PINT-87aa | Peptides | |
| HY-P3103A | PINT-87aa (TFA) | Peptides | |
| HY-P3106 | (Z-Ala-Ala-Ala-Ala)2Rh110 | 149695-85-2 | Peptides |
| HY-P3107 | Homodestcardin | 917382-84-4 | Peptides |
| HY-P3108 | Alamandine | 1176306-10-7 | Peptides |
| HY-P3109 | Sporidesmolide II | 3200-75-7 | Peptides |
| HY-P3110 | Ac-DNLD-AMC | 958001-92-8 | Dye Reagents |
| HY-P3111 | Slotoxin | Peptides | |
| HY-P3112 | ICI 216140 | 124001-41-8 | Peptides |
| HY-P3115 | Ac-LEVD-AFC | 1092077-23-0 | Peptides |
| HY-P3116 | Thiocoraline | 173046-02-1 | Peptides |
| HY-P3117 | PACAP (6-27) (human, ovine, rat) | 136134-68-4 | Peptides |
| HY-P3118 | Bz-IEGR-pNA (acetate) | 1325307-57-0 | Peptides |
| HY-P3119 | Desotamide | 194660-14-5 | Peptides |
| HY-P3120 | Mca-Pro-Leu-Ala-Cys(Mob)-Trp-Ala-Arg-Dap(Dnp)-NH2 | 1926163-82-7 | Dye Reagents |
| HY-P3121 | Caprooyl-tetrapeptide-3 (acetate) | 1012317-71-3 | Peptides |
| HY-P3123 | Dnp-RPLALWRS | 172666-82-9 | Peptides |
| HY-P3124 | BIM-23190 | 182153-96-4 | Peptides |
| HY-P3124A | BIM-23190 (hydrochloride) | Peptides | |
| HY-P3126 | Suc-Ile-Glu(γ-pip)-Gly-Arg-pNA (hydrochloride) | 1379822-04-4 | Peptides |
| HY-P3129 | KRAS G13D peptide, 25 mer | 145019-94-9 | Peptides |
| HY-P3130 | Stresscopin-related peptide (human) | 348626-74-4 | Peptides |
| HY-P3134 | CPN-267 | 2241236-26-8 | Peptides |
| HY-P3134A | CPN-267 (TFA) | Peptides | |
| HY-P3136 | TRV055 | 25849-90-5 | Peptides |
| HY-P3136A | TRV055 (hydrochloride) | Peptides | |
| HY-P3137 | TRV056 | 812644-79-4 | Peptides |
| HY-P3138 | (Sar1)-Angiotensin II | 51833-69-3 | Peptides |
| HY-P3139 | TPP-1 | 2426685-25-6 | Peptides |
| HY-P3139A | TPP-1 (TFA) | Peptides | |
| HY-P3140 | α-Synuclein (61-75) | 440645-08-9 | Peptides |
| HY-P3140A | α-Synuclein (61-75) (TFA) | Peptides | |
| HY-P3141 | STIEEQAKTFLDKFNHEAEDLFYQSSLASWN | Peptides | |
| HY-P3142 | NMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQ | Peptides | |
| HY-P3143 | BMSpep-57 | 1629655-80-6 | Peptides |
| HY-P3143A | BMSpep-57 (hydrochloride) | Peptides | |
| HY-P3145 | Astin A | 151201-75-1 | Peptides |
| HY-P3146 | FTISADTSK | 1431957-73-1 | Peptides |
| HY-P3146A | FTISADTSK (acetate) | Peptides | |
| HY-P3146S | FTISADTSK-13C6,15N2 (TFA) | Isotope-Labeled Compounds | |
| HY-P3147 | IYPTNGYTR | 1431957-72-0 | Peptides |
| HY-P3147A | IYPTNGYTR (acetate) | Peptides | |
| HY-P3148 | Astin B | 151201-76-2 | Natural Products |
| HY-P3149 | LEESGGGLVQPGGSMK | 2096980-79-7 | Peptides |
| HY-P3149A | LEESGGGLVQPGGSMK (TFA) | Peptides | |
| HY-P3149B | LEESGGGLVQPGGSMK (acetate) | Peptides | |
| HY-P3150 | Recombinant Proteinase K | Enzyme | |
| HY-P3151 | Gliadin p31-43 | 176326-01-5 | Peptides |
| HY-P3151A | Gliadin p31-43 (TFA) | Peptides | |
| HY-P3152 | Streptavidin | 9013-20-1 | Biochemical Assay Reagents |
| HY-P3153 | Cathepsin K | 94716-09-3 | Enzyme |
| HY-P3155 | Ac-hMCH(6-16)-NH2 | 353486-32-5 | Peptides |
| HY-P3156 | Syringomycin E | 124888-22-8 | Peptides |
| HY-P3158 | TCTDSTNCYKAT | 1621188-94-0 | Peptides |
| HY-P3159 | VPM peptide | 1428885-83-9 | Peptides |
| HY-P3159A | VPM peptide (TFA) | Peptides | |
| HY-P3160 | Fibronectin | 86088-83-7 | Biochemical Assay Reagents |
| HY-P3160B | Fibronectin, human | 86088-83-7 | Enzyme |
| HY-P3160C | Fibronectin, bovine | 86088-83-7 | Biochemical Assay Reagents |
| HY-P3161 | Lactoferrin from Bovine milk | 936541-36-5 | Biochemical Assay Reagents |
| HY-P3162 | (Ala13)-Apelin-13 | 568565-11-7 | Peptides |
| HY-P3162A | (Ala13)-Apelin-13 (TFA) | Peptides | |
| HY-P3163 | Hexapeptide-9 | 885024-94-2 | Peptides |
| HY-P3164 | Acetyl tetrapeptide-9 | 928006-50-2 | Peptides |
| HY-P3169 | a-Helical Corticotropin Releasing Factor (9-41) | 99658-03-4 | Peptides |
| HY-P3170 | β-Alanine-pyruvate transaminase | 61461-61-8 | Enzyme |
| HY-P3172A | Haptoglobin, Phenotype 2-2, Human Plasma | 9087-69-8 | Enzyme |
| HY-P3173 | Pullulanase | 9075-68-7 | Enzyme |
| HY-P3174 | Pyroglutamate aminopeptidase I | 9075-21-2 | Enzyme |
| HY-P3175 | Phosphogluconate dehydrogenase (NADP, decarboxylating) | 9073-95-4 | Enzyme |
| HY-P3176 | Motilin, human, porcine | 9072-41-7 | Peptides |
| HY-P3178 | Pyrimidine nucleoside phosphorylase | 9055-35-0 | Enzyme |
| HY-P3179 | 1,3-β-Glucanase | 9044-93-3 | Enzyme |
| HY-P3180 | Hemoglobin S | 9035-22-7 | Biochemical Assay Reagents |
| HY-P3182 | NADH oxidase | 9032-21-7 | Enzyme |
| HY-P3183 | Organophosphorus acid anhydrolase | 9032-18-2 | Enzyme |
| HY-P3185 | beta-Galactose dehydrogenase | 9028-54-0 | Enzyme |
| HY-P3186 | Glucose dehydrogenase, recombinant Microorganisms | 9028-53-9 | Enzyme |
| HY-P3186A | NAD-dependent Glucose dehydrogenase | 9028-53-9 | Enzyme |
| HY-P3187 | Exo-1,4-β-xylosidase | 9025-53-0 | Enzyme |
| HY-P3188 | Nitrilase | 9024-90-2 | Enzyme |
| HY-P3189 | Mannitol dehydrogenase | 9001-65-4 | Enzyme |
| HY-P3190 | Arginase, Microorganism | 9000-96-8 | Enzyme |
| HY-P3193 | Cyclic nona-L-arginine (TFA) | Peptides | |
| HY-P3193A | Cyclic nona-L-arginine (hydrochloride) | Peptides | |
| HY-P3199 | PKCβII Peptide Inhibitor I | 862502-26-9 | Peptides |
| HY-P3201 | PKCζ/ι pseudosubstrate inhibitor | 799764-07-1 | Peptides |
| HY-P3202 | Matrix metalloproteinase 3 | 79955-99-0 | Enzyme |
| HY-P3203 | DSTYSLSSTLTLSK | 177792-42-6 | Peptides |
| HY-P3203A | DSTYSLSSTLTLSK (TFA) | Peptides | |
| HY-P3204 | POT-4 | 934461-40-2 | Peptides |
| HY-P3204A | POT-4 (TFA) | Peptides | |
| HY-P3205 | Lysyl endopeptidase, Achromobacter sp | 123175-82-6 | Enzyme |
| HY-P3206 | Serum thymic factor | 63958-90-7 | Peptides |
| HY-P3206A | Serum thymic factor (acetate) | 125117-65-9 | Peptides |
| HY-P3207A | DLPLTFGGGTK (TFA) | Peptides | |
| HY-P3207S | DLPLTFGGGT-Lys-13C6,15N2 (TFA) | Isotope-Labeled Compounds | |
| HY-P3208 | Endoproteinase Lys-C | 72561-05-8 | Enzyme |
| HY-P3208A | Endoproteinase Lys-C (Tag-free) | 72561-05-8 | Enzyme |
| HY-P3208B | Endoproteinase Lys-C (MS grade) | 72561-05-8 | Enzyme |
| HY-P3209 | Des-Arg9-[Leu8]-Bradykinin (acetate) | 115035-45-5 | Peptides |
| HY-P3211 | Nangibotide | 2014384-91-7 | Peptides |
| HY-P3211A | Nangibotide (TFA) | Peptides | |
| HY-P3211B | Nangibotide scrambled peptide | Peptides | |
| HY-P3212 | Allo-aca | Peptides | |
| HY-P3212A | Allo-aca (TFA) | Peptides | |
| HY-P3213 | Dp[Tyr(methyl)2,Arg8]-Vasopressin | 67269-08-3 | Peptides |
| HY-P3214 | Myosin light chain kinase fragment 11-19 amide | 119386-39-9 | Peptides |
| HY-P3215 | Oxytocin parallel dimer | 19645-28-4 | Peptides |
| HY-P3215A | Oxytocin parallel dimer (TFA) | Peptides | |
| HY-P3216 | Oxytocin free acid | 4248-64-0 | Peptides |
| HY-P3216B | Oxytocin free acid (TFA) | Peptides | |
| HY-P3217 | [Asp5]-Oxytocin | 65907-78-0 | Peptides |
| HY-P3217A | [Asp5]-Oxytocin (acetate) | Peptides | |
| HY-P3218 | [Glu4]-Oxytocin | 4314-67-4 | Peptides |
| HY-P3218A | [Glu4]-Oxytocin (acetate) | Peptides | |
| HY-P3219 | N-Acetyloxytocin | 10551-48-1 | Peptides |
| HY-P3220 | [D-Asn5]-Oxytocin | 5754-53-0 | Peptides |
| HY-P3221 | [Leu3]-Oxytocin | 4294-11-5 | Peptides |
| HY-P3222 | Oxytocin antiparallel dimer | 20054-93-7 | Peptides |
| HY-P3222A | Oxytocin antiparallel dimer (TFA) | Peptides | |
| HY-P3223 | Biphalin (TFA) | 126872-95-5 | Peptides |
| HY-P3225 | (D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P (acetate) | 143077-65-0 | Peptides |
| HY-P3226 | JB-1 | 147819-32-7 | Peptides |
| HY-P3227 | Cyclo(Ala-Arg-Gly-Asp-Mamb) | 153381-95-4 | Peptides |
| HY-P3229 | SN52 | 1071173-56-2 | Peptides |
| HY-P3232 | B 9430 | 180981-09-3 | Peptides |
| HY-P3234 | Ac-ESMD-CHO | 191338-87-1 | Peptides |
| HY-P3235 | E-76 | 1926163-13-4 | Peptides |
| HY-P3236 | N-Acetyl-Ile-Glu-Pro-Asp-p-nitroanilide | 216757-29-8 | Peptides |
| HY-P3239 | Belantamab mafodotin | 2050232-20-5 | ADC Related |
| HY-P3242 | Mad1 (6-21) | 880150-82-3 | Peptides |
| HY-P3242A | Mad1 (6-21) (TFA) | Peptides | |
| HY-P3244 | D-KLVFFA | 342877-55-8 | Peptides |
| HY-P3245 | HXR9 | 917953-08-3 | Peptides |
| HY-P3245A | HXR9 (hydrochloride) | Peptides | |
| HY-P3247 | [D-Ala2]-GIP (human) | 444073-04-5 | Peptides |
| HY-P3248 | J5 peptide | 444305-16-2 | Peptides |
| HY-P3252A | Pegcetacoplan (acetate) | Peptides | |
| HY-P3255 | DA-JC4 | 2315504-40-4 | Peptides |
| HY-P3257A | ADP-specific glucokinase, pyrococcus furiosus | 173585-07-4 | Enzyme |
| HY-P3257B | ADP-Specific glucokinase, thermococcus litoralis | Enzyme | |
| HY-P3258 | SP-10 | 882157-88-2 | Peptides |
| HY-P3259 | AY254 | 2093408-03-6 | Peptides |
| HY-P3260 | 5′-Nucleotidase, Microorganism | 9027-73-0 | Enzyme |
| HY-P3261 | Inulinase | 9025-67-6 | Enzyme |
| HY-P3263 | Glutamate oxidase | 39346-34-4 | Enzyme |
| HY-P3267 | Holo-Bovine Transferrin | 11096-37-0 | Biochemical Assay Reagents |
| HY-P3267A | Apo-Bovine Transferrin | 11096-37-0 | Biochemical Assay Reagents |
| HY-P3269 | Calciseptin | 178805-91-9 | Peptides |
| HY-P3270 | Capreomycin | 11003-38-6 | Peptides |
| HY-P3275 | β-Amyloid (17-40) | 156790-69-1 | Peptides |
| HY-P3277 | KRpep-2d | 2098181-84-9 | Peptides |
| HY-P3277A | KRpep-2d (TFA) | Peptides | |
| HY-P3278 | Caloxin 2A1 | 350670-85-8 | Peptides |
| HY-P3278A | Caloxin 2A1 (TFA) | Peptides | |
| HY-P3279 | EPQpYEEIPIYL | 147612-86-0 | Peptides |
| HY-P3280 | γ-Glu-Gly | 1948-29-4 | Peptides |
| HY-P3280A | γ-Glu-Gly (TFA) | Peptides | |
| HY-P3281 | FGL peptide | 499993-62-3 | Peptides |
| HY-P3282 | MM 419447 | 1092457-78-7 | Peptides |
| HY-P3284 | Mastoparan M (tetraacetate) | 79396-78-4 | Peptides |
| HY-P3287 | UL75 (14-42)，Human herpesvirus 5 | Peptides | |
| HY-P3291 | Dapiglutide | 2296814-85-0 | Peptides |
| HY-P3293 | Lonodelestat | 906547-89-5 | Peptides |
| HY-P3293A | Lonodelestat (TFA) | Peptides | |
| HY-P3294 | Onzigolide | 778630-77-6 | Peptides |
| HY-P3301 | SDKPDMAEIEKFDKSK | 1339864-27-5 | Peptides |
| HY-P3302 | Sialylglycopeptide | 189035-43-6 | Peptides |
| HY-P3304 | MR 409 | 1445155-39-4 | Peptides |
| HY-P3305 | NBD-LLLLpY | 2883234-17-9 | Peptides |
| HY-P3307 | Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2 | 2858785-68-7 | Peptides |
| HY-P3314 | Nendratareotide | 2251119-65-8 | Peptides |
| HY-P3315 | Onilcamotide | 1164096-85-8 | Peptides |
| HY-P3316 | OSK-1 | 183815-75-0 | Peptides |
| HY-P3317 | Azaline | 134457-26-4 | Peptides |
| HY-P3318 | Boc-Phe-Leu-Phe-Leu-Phe | 73572-58-4 | Peptides |
| HY-P3319 | β-Neuroprotectin | 127634-29-1 | Peptides |
| HY-P3320 | Phytochelatin 3 | 86220-45-3 | Peptides |
| HY-P3320A | Phytochelatin 3 (TFA) | Peptides | |
| HY-P3321 | Phytochelatin 4 | 99465-98-2 | Peptides |
| HY-P3321A | Phytochelatin 4 (TFA) | Peptides | |
| HY-P3322 | Phytochelatin 5 | 99465-97-1 | Peptides |
| HY-P3322A | Phytochelatin 5 (TFA) | Peptides | |
| HY-P3323 | Phytochelatin 6 | 99478-30-5 | Peptides |
| HY-P3323A | Phytochelatin 6 (TFA) | Peptides | |
| HY-P3325 | P8RI | 2147724-76-1 | Peptides |
| HY-P3326 | Targeting the bacterial sliding clamp peptide 46 | 2756997-82-5 | Peptides |
| HY-P3328 | MDP1 | Peptides | |
| HY-P3328A | MDP1 (acetate) | Peptides | |
| HY-P3332 | 3x DYKDDDDK Tag | 921765-76-6 | Peptides |
| HY-P3332A | 3x DYKDDDDK Tag (TFA) | Peptides | |
| HY-P3333 | KSPWFTTL | 153049-05-9 | Peptides |
| HY-P3333A | KSPWFTTL (TFA) | Peptides | |
| HY-P3338 | Cyclosporin A-Derivative 3 | 121584-34-7 | Peptides |
| HY-P3340 | Leptin (116-130) | 189224-35-9 | Peptides |
| HY-P3341 | OB3 | 259535-56-3 | Peptides |
| HY-P3342 | [D-Leu-4]-OB3 | 289056-32-2 | Peptides |
| HY-P3343A | hFSH-β-(33-53) (TFA) | Peptides | |
| HY-P3346 | NH2-c[X-R-L-S-X]-K-G-P-(D-1Nal) | 2891469-80-8 | Reference compound |
| HY-P3347 | NH2-c[X-R-L-S-X]-K-G-P-(D-2Nal) | 2891469-81-9 | Peptides |
| HY-P3348 | c[Arg-Arg-Arg-Arg-Dip-Dip-Dip] | 2619853-87-9 | Peptides |
| HY-P3349 | c[Arg-Arg-Arg-Arg-Nal-Nal-Nal] | 2619854-01-0 | Peptides |
| HY-P3350 | LS-BF1 | 2892148-58-0 | Peptides |
| HY-P3351 | ASP5286 | 935735-70-9 | Peptides |
| HY-P3354 | p3Ysh-3 | Peptides | |
| HY-P3355 | p-fin4 | 2883747-74-6 | Peptides |
| HY-P3356 | Cyclotheonellazole A | 2094993-48-1 | Reference compound |
| HY-P3358 | Antitumor agent-39 | 159255-72-8 | Peptides |
| HY-P3359 | Y4R agonist-1 | 2757328-51-9 | Peptides |
| HY-P3360 | Y4R agonist-2 | 2757328-63-3 | Peptides |
| HY-P3361 | IDR-1018 | 1453221-07-2 | Peptides |
| HY-P3362 | Ac-IETD-AMC | 348079-17-4 | Dye Reagents |
| HY-P3363 | Z-DEVD-AMC | Dye Reagents | |
| HY-P3364 | Ac-QPKK(Ac)-AMC | 1387005-23-3 | Peptides |
| HY-P3365 | Cecropin D | 83652-32-8 | Peptides |
| HY-P3366 | Ecnoglutide | 2459531-73-6 | Peptides |
| HY-P3369 | Gersizangitide | 2417491-82-6 | Peptides |
| HY-P3371 | Ifinatamab deruxtecan | 2484870-92-8 | ADC Related |
| HY-P3375 | Mazdutide | 2259884-03-0 | Peptides |
| HY-P3375A | Mazdutide (TFA) | Peptides | |
| HY-P3376 | Riminkefon | 2168572-99-2 | Peptides |
| HY-P3377 | Rimtoregtide | 2251722-35-5 | Peptides |
| HY-P3383 | Peceleganan | 850761-47-6 | Peptides |
| HY-P3383A | Peceleganan (acetate) | Peptides | |
| HY-P3384 | Pezadeftide | 1907724-92-8 | Peptides |
| HY-P3385 | Rilunermin alfa | 2254278-53-8 | Inhibitory Antibodies |
| HY-P3386 | Selcopintide | 2130912-34-2 | Peptides |
| HY-P3386A | Selcopintide (acetate) | Peptides | |
| HY-P3388 | Utreglutide | 2460862-12-6 | Peptides |
| HY-P3392 | Zilganersen | 2305355-56-8 | Reference compound |
| HY-P3392A | Zilganersen (sodium) | 2305355-64-8 | Oligonucleotides |
| HY-P3393 | Efrilacedase alfa | 2642552-02-9 | Inhibitory Antibodies |
| HY-P3394 | Cholera toxin B subunit, from vibrio cholerae | 131096-89-4 | Biochemical Assay Reagents |
| HY-P3395 | Catestatin (human) | 197151-46-5 | Peptides |
| HY-P3397 | JV-1-36 | 221377-79-3 | Peptides |
| HY-P3397A | JV-1-36 (acetate) | Peptides | |
| HY-P3400 | LP17 | 887255-16-5 | Peptides |
| HY-P3400A | LP17 (TFA) | Peptides | |
| HY-P3401 | GHGVYGHGVYGHGPYGHGPYGHGLYW | 2231617-62-0 | Peptides |
| HY-P34013 | Urinary Trypsin Inhibitor Fragment | 164859-77-2 | Biochemical Assay Reagents |
| HY-P3412 | MMI-0100 | 1039342-24-9 | Peptides |
| HY-P3413 | H-Glu-Pro-Leu-Gln-Leu-Lys-Met-OH | 683750-83-6 | Peptides |
| HY-P3413A | H-Glu-Pro-Leu-Gln-Leu-Lys-Met-OH (acetate) | Peptides | |
| HY-P3414 | Proteasome-activating peptide 1 | 1565763-62-3 | Peptides |
| HY-P3414A | Proteasome-activating peptide 1 (TFA) | Peptides | |
| HY-P3417 | Amp1EP9 | Peptides | |
| HY-P3418 | CKLF1-C27 | 891861-48-6 | Peptides |
| HY-P3418A | CKLF1-C27 (TFA) | Peptides | |
| HY-P3419 | PAMP-12 (unmodified) | 929905-12-4 | Peptides |
| HY-P3419A | PAMP-12 (unmodified) (TFA) | Peptides | |
| HY-P3420 | NH2-ASK-COOH | 866128-65-6 | Peptides |
| HY-P3421 | NH2-SSK-COOH | 352276-62-1 | Peptides |
| HY-P3422 | NH2-AKA-COOH | 33062-84-9 | Peptides |
| HY-P3423 | NH2-KAA-COOH | 34385-54-1 | Peptides |
| HY-P3424 | NH2-AKK-COOH | 158837-92-4 | Peptides |
| HY-P3425 | AGPV | 154485-78-6 | Peptides |
| HY-P3425A | AGPV (TFA) | Peptides | |
| HY-P3426 | BACE1-IN-10 | 2799658-44-7 | Peptides |
| HY-P3429 | SAMβA | 2429946-75-6 | Peptides |
| HY-P3429A | SAMβA (TFA) | Peptides | |
| HY-P3430 | JM3A | Peptides | |
| HY-P3431 | VSGLNPSLWSIFGLQFILLWLVSGSRHYLW | 2279952-25-7 | Peptides |
| HY-P3431A | VSGLNPSLWSIFGLQFILLWLVSGSRHYLW (TFA) | Peptides | |
| HY-P3432 | DfTat | 2035480-78-3 | Peptides |
| HY-P3433 | Sarafotoxin S6b | 120972-53-4 | Peptides |
| HY-P3434 | Ac-FEID-CMK | Peptides | |
| HY-P3434A | Ac-FEID-CMK (TFA) | Peptides | |
| HY-P3436 | WLSEAGPVVTVRALRGTGSW | 771479-86-8 | Peptides |
| HY-P3436A | WLSEAGPVVTVRALRGTGSW (TFA) | Peptides | |
| HY-P3438 | PRRVRLK | 2088834-66-4 | Peptides |
| HY-P3438A | PRRVRLK (acetate) | Peptides | |
| HY-P3440 | WL12 | 1886057-64-2 | Peptides |
| HY-P3441 | 3BP-4089 | 2581199-35-9 | Peptides |
| HY-P3441A | 3BP-4089 (TFA) | Peptides | |
| HY-P3443 | Peanut agglutinin | Dye Reagents | |
| HY-P3444 | CD31 | 161374-99-8 | Peptides |
| HY-P3444A | CD31 (TFA) | Peptides | |
| HY-P3445 | Anrikefon | 2269511-95-5 | Peptides |
| HY-P3445A | Anrikefon (acetate) | 2584931-05-3 | Peptides |
| HY-P3446A | Big Gastrin I (human) (TFA) | Peptides | |
| HY-P3448 | Certepetide | 2580154-02-3 | Peptides |
| HY-P3449 | Dazdotuftide | 2522933-44-2 | Peptides |
| HY-P3449A | Dazdotuftide (TFA) | 2522933-45-3 | Peptides |
| HY-P3450 | Erepdekinra | 2641313-47-3 | Peptides |
| HY-P3451 | Lefleuganan | 2233558-98-8 | Peptides |
| HY-P3452 | Tetrapeptide-30 | 1036207-61-0 | Peptides |
| HY-P3455 | Ac-SVVVRT-NH2 | 1401804-69-0 | Peptides |
| HY-P3459 | Tet-213 | 1260528-09-3 | Peptides |
| HY-P3459A | Tet-213 (TFA) | Peptides | |
| HY-P3460 | TDSRCVIGLYHPPLQVY | 887973-01-5 | Peptides |
| HY-P3460A | TDSRCVIGLYHPPLQVY (TFA) | Peptides | |
| HY-P3461 | Argadin | 289665-92-5 | Peptides |
| HY-P3462 | Cagrilintide | 1415456-99-3 | Peptides |
| HY-P3462A | Cagrilintide (acetate) | Peptides | |
| HY-P3463 | Beinaglutide | 123475-27-4 | Peptides |
| HY-P3464 | RERHNGWRKSVLMVSYGFYVP | Peptides | |
| HY-P3465 | Bulevirtide | 2012558-47-1 | Peptides |
| HY-P3466 | Nisin Z | 137061-46-2 | Peptides |
| HY-P3467 | (Thr4,Gly7)-Oxytocin | 60786-59-6 | Peptides |
| HY-P3469 | Dasiglucagon | 1544300-84-6 | Peptides |
| HY-P3469A | Dasiglucagon (acetate) | Peptides | |
| HY-P3472 | Cyclo(IP) | 57089-60-8 | Peptides |
| HY-P3473 | Evybactin | Peptides | |
| HY-P3475 | Mca-VDQMDGW-K(Dnp)-NH2 | Dye Reagents | |
| HY-P3476 | Mca-VDQVDGW-Lys(Dnp)-NH2 | Peptides | |
| HY-P3477 | Mca-PLA-Nva-Dap(Dnp)-AR-NH2 | 256394-92-0 | Dye Reagents |
| HY-P3479 | Insulin (swine) | 12584-58-6 | Peptides |
| HY-P3480 | H-Trp-Phe-Tyr-Ser(PO3H2)-Pro-Arg-pNA | 202739-41-1 | Peptides |
| HY-P3484 | Dnp-PLGLWA-DArg-NH2 (TFA) | Dye Reagents | |
| HY-P3485 | GAGGVGKSAL | 199477-18-4 | Peptides |
| HY-P3486 | GADGVGKSAL | 199477-24-2 | Peptides |
| HY-P3487 | GAGGVGKSA | 1223335-84-9 | Peptides |
| HY-P3488 | GADGVGKSA | 2032119-68-7 | Peptides |
| HY-P3489 | β-Corticotropin (swine) | 12427-33-7 | Peptides |
| HY-P3491 | Pegloxenatide | 2420483-82-3 | Peptides |
| HY-P3492 | SARS-CoV-2-IN-34 | 3029103-37-2 | Peptides |
| HY-P3494 | Hepcidin-25 (human) | 1356390-47-0 | Peptides |
| HY-P3496 | Pep19-2.5 | 1322711-38-5 | Peptides |
| HY-P3497 | Fmoc-Cys-Asp10 | 2407782-70-9 | Peptides |
| HY-P3497A | Fmoc-Cys-Asp10 (TFA) | Peptides | |
| HY-P3498 | Elsiglutide | 914009-84-0 | Peptides |
| HY-P3499 | Dolcanatide | 1092457-65-2 | Peptides |
| HY-P3501 | Fexapotide | 492447-54-8 | Peptides |
| HY-P3501A | Fexapotide (TFA) | Peptides | |
| HY-P3502 | Zilucoplan | 1841136-73-9 | Peptides |
| HY-P3502A | Zilucoplan (TFA) | Peptides | |
| HY-P3502B | Zilucoplan (PEG2) | Peptides | |
| HY-P3503 | Vosoritide | 1480724-61-5 | Peptides |
| HY-P3503A | Vosoritide (acetate) | Peptides | |
| HY-P3506 | Retatrutide | 2381089-83-2 | Peptides |
| HY-P3506A | Retatrutide (TFA) | Peptides | |
| HY-P3506B | Retatrutide (acetate) | Peptides | |
| HY-P3507 | Dalazatide | 1081110-69-1 | Peptides |
| HY-P3507A | Dalazatide (TFA) | Peptides | |
| HY-P3508 | PNC-27 | 1159861-00-3 | Peptides |
| HY-P3508A | PNC-27 (acetate) | Peptides | |
| HY-P3509 | PNC-28 | 392661-17-5 | Peptides |
| HY-P3509A | PNC-28 (acetate) | Peptides | |
| HY-P3511 | Friulimicin D | 302327-42-0 | Peptides |
| HY-P3512 | Iseganan | 257277-05-7 | Peptides |
| HY-P3513 | β-Neo-Endorphin | 77739-21-0 | Peptides |
| HY-P3513A | β-Neo-Endorphin (acetate) | 78658-39-6 | Peptides |
| HY-P3515 | β-Lipotropin (61-69) | 59481-79-7 | Peptides |
| HY-P3516 | Barusiban | 285571-64-4 | Peptides |
| HY-P3517 | β-Endorphin (6-31), human | 77761-27-4 | Peptides |
| HY-P3519 | ACV Tripeptide | 32467-88-2 | Peptides |
| HY-P3519A | ACV Tripeptide (TFA) | Peptides | |
| HY-P3520 | SDGR | 97461-82-0 | Peptides |
| HY-P3521 | RGDT | 93675-01-5 | Peptides |
| HY-P3522 | REDV | 107978-83-6 | Peptides |
| HY-P3522A | REDV (TFA) | Peptides | |
| HY-P3523 | KGDS | 93674-95-4 | Peptides |
| HY-P3524 | GRGESP | 99896-88-5 | Peptides |
| HY-P3525 | G-Pen-GRGDSPCA | 126716-28-7 | Peptides |
| HY-P3526 | YQEAFRRFFGPV | 129356-77-0 | Peptides |
| HY-P3528 | GPR | 47295-77-2 | Peptides |
| HY-P3529 | G-{d-Arg}-GDSPASSK | 133640-14-9 | Peptides |
| HY-P3530 | G-{d-Arg}-GDSP | 111844-21-4 | Peptides |
| HY-P3531 | Fibrinogen γ-chain (397-411) | 80755-86-8 | Peptides |
| HY-P3532 | [Glp1]-FGL peptide (acetate) | Peptides | |
| HY-P3533 | EILEVPST | 239075-62-8 | Peptides |
| HY-P3534 | EILDV (human, bovine, rat) | 150525-67-0 | Peptides |
| HY-P3537 | AGDV | 99896-90-9 | Peptides |
| HY-P3538 | Corticotropin-releasing hormone | 9015-71-8 | Peptides |
| HY-P3539 | Exendin-4 (3-39) | 196109-31-6 | Peptides |
| HY-P3540 | Y-{d-Trp}-GFM-NH2 | 73459-29-7 | Peptides |
| HY-P3541 | Dirucotide | 152074-97-0 | Peptides |
| HY-P3542 | Des His1, Glu8 Exendin-4 | Peptides | |
| HY-P3543 | T-kinin | 86030-63-9 | Peptides |
| HY-P35433 | Tifuvirtide | 251562-00-2 | Peptides |
| HY-P3544 | Lys-[Hyp3]-Bradykinin | 113662-39-8 | Peptides |
| HY-P3545 | 5-Valine-angiotensin I | 484-43-5 | Peptides |
| HY-P3546 | [DPen2, Pen5] Enkephalin | 88373-72-2 | Peptides |
| HY-P3547 | (D-Met2,Pro5)-Enkephalinamide | 63307-63-1 | Peptides |
| HY-P3548 | [D-Ala2]-Met-Enkephalinamide | 61090-95-7 | Peptides |
| HY-P3549 | [D-Ala2] Leu-Enkephalinamide | 65189-64-2 | Peptides |
| HY-P3550 | β-Lipotropin (60-65) | 60117-19-3 | Peptides |
| HY-P3551 | [Ala2] Met-Enkephalinamide | 64240-07-9 | Peptides |
| HY-P3553 | Alsactide | 34765-96-3 | Peptides |
| HY-P3554 | Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl | 129988-00-7 | Peptides |
| HY-P3555 | D-Ala-Gly-Phe-Met-NH2 | 82948-89-8 | Peptides |
| HY-P3555A | D-Ala-Gly-Phe-Met-NH2 (monoacetate) | 100929-65-5 | Peptides |
| HY-P3556 | Benzoyl-Phe-Ala-Arg | 89020-38-2 | Peptides |
| HY-P3557 | Mibenratide | 1239011-83-6 | Peptides |
| HY-P3557A | Mibenratide (TFA) | Peptides | |
| HY-P3558 | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met | 67746-47-8 | Peptides |
| HY-P3559 | Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | 72601-97-9 | Peptides |
| HY-P3560 | Edratide | 433922-67-9 | Peptides |
| HY-P3561 | Agouti-related Protein (AGRP) (83-132) Amide (human) | Peptides | |
| HY-P3561A | Agouti-related Protein (AGRP) (83-132) Amide (human) (TFA) | Peptides | |
| HY-P3562 | PL-3994 | 952295-80-6 | Peptides |
| HY-P3563 | [Lys4] Sarafotoxin S6c | 1219444-22-0 | Peptides |
| HY-P3564 | (D-Ser1)-ACTH (1-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) | 18067-65-7 | Peptides |
| HY-P3565 | Sarafotoxin S6d | 1446991-36-1 | Peptides |
| HY-P3566 | (D-Lys16)-ACTH (1-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) | 494750-52-6 | Peptides |
| HY-P3567 | (p-Iodo-Phe7)-ACTH (4-10) | 159600-82-5 | Peptides |
| HY-P3568 | Adipokinetic hormone (Gryllus bimaculatus) | 113800-65-0 | Peptides |
| HY-P3569 | [D-Val22, Phe33] Big Endothelin-1 (16-38), human | 1206769-73-4 | Peptides |
| HY-P3570 | Adipokinetic hormone II (Locusta migratoria) | 98968-94-6 | Peptides |
| HY-P3571 | [Ala2] Endothelin-3, human | 2243207-08-9 | Peptides |
| HY-P3572 | Adipokinetic hormone I (Locusta migratoria) | 61627-67-6 | Peptides |
| HY-P3574 | Biotinyl-Obestatin, rat | 1815618-11-1 | Peptides |
| HY-P3575 | Arg34GLP-1(7-34) (human) | 204521-68-6 | Peptides |
| HY-P3576 | Biotin-Gastrin Releasing Peptide, human | Peptides | |
| HY-P3577 | [Tyr0] Gastric Inhibitory Peptide (23-42), human | 121765-67-1 | Peptides |
| HY-P3578 | Gastric Inhibitory Polypeptide (1-30), porcine | 134875-67-5 | Peptides |
| HY-P3579 | Gastric Inhibitory Peptide, porcine | 11063-17-5 | Peptides |
| HY-P3580 | Acetyl Gastric Inhibitory Peptide (human) | 299898-33-2 | Peptides |
| HY-P3580A | Acetyl Gastric Inhibitory Peptide (human) (TFA) | Peptides | |
| HY-P3581 | PE 22-28 | 1801959-12-5 | Peptides |
| HY-P3582 | sGnRH-A | 96497-82-4 | Peptides |
| HY-P3582A | sGnRH-A (acetate) | Peptides | |
| HY-P3583 | (Des-Gly10,D-Arg6,Pro-NHEt9)-LHRH II (chicken) | 145940-57-4 | Peptides |
| HY-P3584 | (Pro3) GIP, human | 299898-52-5 | Peptides |
| HY-P3584A | (Pro3) GIP, human (TFA) | Peptides | |
| HY-P3585 | Epobis | 915091-83-7 | Peptides |
| HY-P3586 | HKPao | 859216-15-2 | Peptides |
| HY-P3587 | FNLPLGNYKKP | 211362-82-2 | Peptides |
| HY-P3588 | N-Acetyl semax amidate | 2920938-90-3 | Peptides |
| HY-P3590 | PQDVKFP | 153299-82-2 | Peptides |
| HY-P3591 | YMRF-NH2 | 83903-32-6 | Peptides |
| HY-P3592 | YLPLRF-NH2 | Peptides | |
| HY-P3593 | LPLRF-NH2 | 88280-21-1 | Peptides |
| HY-P3594 | [His1,Nle27] GHRF (1-32), amide, human | 94034-78-3 | Peptides |
| HY-P3595 | GHRF, porcine | 88384-73-0 | Peptides |
| HY-P3596 | GHRF, mouse | 125199-49-7 | Peptides |
| HY-P3597 | Urocortin III (mouse) (free acid) | Peptides | |
| HY-P3598 | Substance P(1-4) | 57468-16-3 | Peptides |
| HY-P3599 | P-T-P-S-NH2 | 121269-85-0 | Peptides |
| HY-P3600 | FIZZ-1 (32-51) (mouse) | Peptides | |
| HY-P3601 | Brain Derived Basic Fibroblast Growth Factor (1-24) | 211362-85-5 | Peptides |
| HY-P3602 | C3 Peptide P16 | 99027-06-2 | Peptides |
| HY-P3603 | a-TGF (34-43), rat | 95596-38-6 | Peptides |
| HY-P3604 | LH-RH II (chicken) | 91097-16-4 | Peptides |
| HY-P3605 | GnRH Associated Peptide (25-53), human | 106061-19-2 | Peptides |
| HY-P3606 | GnRH Associated Peptide (1-24), human | 148943-65-1 | Peptides |
| HY-P3607 | GHRF, bovine | 88894-91-1 | Peptides |
| HY-P3608 | [Des-His1,Glu9] Glucagon | 110121-11-4 | Peptides |
| HY-P3609 | CR 665 | 228546-92-7 | Peptides |
| HY-P3610 | [Ala18] Endothelin-1, human | Peptides | |
| HY-P3611 | Valosin (porcine) | 99510-37-9 | Peptides |
| HY-P3612 | CTCE-0214 | 577782-52-6 | Peptides |
| HY-P3614 | [Ala3,11,18, Nle7] Endothelin-1, human | Peptides | |
| HY-P3615 | [Asn18] Endothelin-1, human | 309245-97-4 | Peptides |
| HY-P3616 | Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide | Peptides | |
| HY-P3617 | Glucagon (22-29) | 32204-93-6 | Peptides |
| HY-P3618 | Cortistatin-29 (reduced) | Peptides | |
| HY-P3619 | (Tyr0)-C-Peptide (dog) | 101135-67-5 | Peptides |
| HY-P3620 | (Tyr0)-C-Peptide (human) | 57327-90-9 | Peptides |
| HY-P3621 | Biotinyl-Glucagon (1-29), human, bovine, porcine | Peptides | |
| HY-P3622 | (Ser8)-GLP-1 (7-36) amide, human | 215777-46-1 | Peptides |
| HY-P3623 | Biotin-Glucagon-Like Peptide 1 (7-36) amide, human | Peptides | |
| HY-P3624 | Cenderitide | 507289-11-4 | Peptides |
| HY-P3625 | Dynorphin (2-17), amide (porcine) | 161874-98-2 | Peptides |
| HY-P3626 | Astodrimer | 1379746-42-5 | Peptides |
| HY-P3627 | Nagrestipen | 166089-33-4 | Peptides |
| HY-P3628 | Dynorphin (2-17) (porcine) | 83608-80-4 | Peptides |
| HY-P3629 | Dynorphin B 29 (pig) | 84376-30-7 | Peptides |
| HY-P3630 | Stick Insect Hypertrehalosaemic Factor II | 102067-93-6 | Peptides |
| HY-P3631 | SALMF amide 2 | 134439-74-0 | Peptides |
| HY-P3632 | [DAla2, DArg6] Dynorphin A, (1-13) (porcine) | 75921-88-9 | Peptides |
| HY-P3633 | Locustatachykinin II | 126985-98-6 | Peptides |
| HY-P3634 | [DAla2] Dynorphin A (1-13), amide (porcine) | 79985-43-6 | Peptides |
| HY-P3635 | Cockroach Myoactive Peptide II | 93240-39-2 | Peptides |
| HY-P3636 | Cockroach Myoactive Peptide I | 93208-51-6 | Peptides |
| HY-P3637 | AVSEHQLLHDKGKSIQDLRRRFFLHHLI-{Aib}-EIHTAYRFGG | 2640019-27-6 | Peptides |
| HY-P3639 | SYLQDSVPDSFQD | 320341-56-8 | Peptides |
| HY-P3640 | MAGE-3 Antigen (167-176) (human) | 178243-46-4 | Peptides |
| HY-P3641 | Kisspeptin 13 | 374675-18-0 | Peptides |
| HY-P3641A | Kisspeptin 13 (TFA) | Peptides | |
| HY-P3644 | EEKLIVVAF | 188818-21-5 | Peptides |
| HY-P3645 | (Nle4)-α-MSH | 64887-70-3 | Peptides |
| HY-P3646 | [DAla2] Dynorphin A (1-9) (porcine) | 95673-38-4 | Peptides |
| HY-P3647 | [DPro10] Dynorphin A (1-11), porcine | 94596-26-6 | Peptides |
| HY-P3647A | [DPro10] Dynorphin A (1-11), porcine (hydrochloride) | Peptides | |
| HY-P3648 | Ala-Ala-Pro-Val-chloromethylketone | 90105-47-8 | Peptides |
| HY-P3649 | D-Val-Leu-Lys-chloromethylketone | 75590-15-7 | Peptides |
| HY-P3650 | Cholecystokinin (1-21) | 101831-07-6 | Peptides |
| HY-P3651 | Cholecystokinin (26-33) (free acid) | 103974-46-5 | Peptides |
| HY-P3652 | Cholecystokinin-33 (swine) | 67256-27-3 | Peptides |
| HY-P3653 | α-Conotoxin M I | 88217-10-1 | Peptides |
| HY-P3654 | α-Conotoxin S IA | 135190-31-7 | Peptides |
| HY-P3655 | Agelenin | 142582-60-3 | Peptides |
| HY-P3656 | Kaliotoxin (1-37) | 150769-72-5 | Peptides |
| HY-P3657A | Biotin-KKKRKV (acetate) | Peptides | |
| HY-P3658 | [Lys0]γ1-MSH | 78859-45-7 | Peptides |
| HY-P3659 | (D-Phe7)-α-MSH | 92937-43-4 | Peptides |
| HY-P3662 | Ac-[Nle4,D-Phe7]-α-MSH (4-10)-NH2 | 82188-67-8 | Peptides |
| HY-P3663 | [Lys8] LH-RH | 35544-05-9 | Peptides |
| HY-P3664 | [D-Phe2,D-Ala6]-LH-RH | 54784-44-0 | Peptides |
| HY-P3665A | RIVTSEEVIIRDS (TFA) | Peptides | |
| HY-P3666 | [D-Phe2,6, Pro3]-LH-RH | 64789-67-9 | Peptides |
| HY-P3668 | [D-Lys6]-LH-RH | 52671-12-2 | Peptides |
| HY-P3669 | Gly-Gly-Phe-Gly | 200427-88-9 | Peptides |
| HY-P3670 | [D-Leu6, Val7]-LH-RH (1-9) Ethyl Amide | Peptides | |
| HY-P3671 | [D-Glp1,D-Phe2,D-Trp3,6]-LH-RH | 68059-94-9 | Peptides |
| HY-P3672 | [D-Ala6]-LH-RH | 51230-19-4 | Peptides |
| HY-P3673 | Lamprey LH-RH I | 102634-23-1 | Peptides |
| HY-P3674 | LH-RH (7-10) | 38482-71-2 | Peptides |
| HY-P3675 | LH-RH (4-10) | 51776-33-1 | Peptides |
| HY-P3676 | Neuropeptide Y (3-36) (porcine) | 143863-88-1 | Peptides |
| HY-P3677 | Neuropeptide Y (2-36) (porcine) | 102961-52-4 | Peptides |
| HY-P3678 | Neuropeptide Y (18-36) (porcine) | 114495-97-5 | Peptides |
| HY-P3679 | Neuropeptide Y (1-24) (human) | 131448-51-6 | Peptides |
| HY-P3680 | [Nle13]-Motilin | 55524-56-6 | Peptides |
| HY-P3682 | w-Conotoxin SVIB | 150433-82-2 | Peptides |
| HY-P3683 | a-Helical Corticotropin Releasing Factor (12-41) | 158535-55-8 | Peptides |
| HY-P3684 | [DPro5] Corticotropin Releasing Factor, human, rat | 195628-97-8 | Peptides |
| HY-P3684A | [DPro5] Corticotropin Releasing Factor, human, rat (TFA) | Peptides | |
| HY-P3685 | [Met(O)21] Corticotropin Releasing Factor, ovine | Peptides | |
| HY-P3687 | [Tyr0] Corticotropin Releasing Factor, ovine | 83930-34-1 | Peptides |
| HY-P3688 | β-Amyloid (1-38) | 131438-74-9 | Peptides |
| HY-P3689 | [Tyr22] Calcitonin Gene Related Peptide, (22-37), rat | 198277-54-2 | Peptides |
| HY-P3690 | Ac-Leu-Leu-Norleucinol | 148333-42-0 | Peptides |
| HY-P3691 | CART (1-39), Human, Rat | Peptides | |
| HY-P3692 | CART (55-76), rat | 1815618-15-5 | Peptides |
| HY-P3695 | VSPPLTLGQLLS | 1206896-24-3 | Peptides |
| HY-P3695A | VSPPLTLGQLLS (TFA) | Peptides | |
| HY-P3699 | TNO003 | 202273-56-1 | Peptides |
| HY-P3700 | QATVGDVNTDRPGLLDLKY | 204510-59-8 | Peptides |
| HY-P3701 | [Ala 353, 367]Presenilin 1 (349-361) | Peptides | |
| HY-P3702 | CEDAEVFKDSMVPGEK | Peptides | |
| HY-P3703 | H-Val-Thr-Cys-Gly-OH | 131204-46-1 | Peptides |
| HY-P3704 | Enterostatin (rat) | 117137-85-6 | Peptides |
| HY-P3705 | VIHS | 309247-91-4 | Peptides |
| HY-P3706 | VGVRVR | 309247-90-3 | Peptides |
| HY-P3707 | Tumor targeted pro-apoptotic peptide | 1926163-30-5 | Peptides |
| HY-P3708 | TRAF6 control peptide | 852690-80-3 | Peptides |
| HY-P3709 | TRAF6 peptide | 852805-92-6 | Peptides |
| HY-P3709A | TRAF6 peptide (TFA) | Peptides | |
| HY-P3710 | Ser-Ala-alloresact | 140653-27-6 | Peptides |
| HY-P3711 | SPAI-1 | 131359-77-8 | Peptides |
| HY-P3712 | Cardioexcitatory peptide 1 | 127122-98-9 | Peptides |
| HY-P3713 | Presenilin 1 (349-361) | 956004-39-0 | Peptides |
| HY-P3714 | p-Aminophenylacetyl-tuftsin | 63147-94-4 | Peptides |
| HY-P3715 | OVA peptide | 141312-45-0 | Peptides |
| HY-P3716 | H(-Asn-Pro-Asn-Ala)2-OH | 110713-84-3 | Peptides |
| HY-P3717 | Targefrin | 3031514-44-7 | Peptides |
| HY-P3718 | MOG peptide (79-96) rat | 356038-17-0 | Peptides |
| HY-P3719 | MOG(35-55) amide, mouse, rat | 2022956-48-3 | Peptides |
| HY-P3720 | YEQLRNSRA | 321914-26-5 | Peptides |
| HY-P3721 | Miraculin (1-20) | 198694-37-0 | Peptides |
| HY-P3722 | Mca-PLAQAV-Dpa-RSSSR-NH2 | 192723-42-5 | Peptides |
| HY-P3722A | Mca-PLAQAV-Dpa-RSSSR-NH2 (TFA) | Peptides | |
| HY-P3723 | MBP (83-99) | 178823-45-5 | Peptides |
| HY-P3724 | MBP (146-170) | 604803-17-0 | Peptides |
| HY-P3725 | H-Leu-Ser-Phe(NO2)-Nle-Ala-OMe (TFA) | 99764-63-3 | Peptides |
| HY-P3726 | Lys-Gln-Ala-Gly-Asp-Val | 80755-87-9 | Peptides |
| HY-P3727 | Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr | 75813-50-2 | Peptides |
| HY-P3728 | Interleukin II (60-70) | 800379-41-3 | Peptides |
| HY-P3729 | Ac-Lys-D-Ala-D-Ala-OH | 28845-97-8 | Peptides |
| HY-P3730 | Cdk2/Cyclin Inhibitory Peptide I | 237392-84-6 | Peptides |
| HY-P3731 | Cdk2/Cyclin Inhibitory Peptide II | 237392-85-7 | Peptides |
| HY-P3732 | RGD-4C | 332179-76-7 | Peptides |
| HY-P3733 | Big Endothelin-1 (22-38), human | 124932-61-2 | Peptides |
| HY-P3734 | Big Endothelin-2 (1-38), human | 142191-53-5 | Peptides |
| HY-P3735 | Bone Gla Protein (45-49) | 85679-70-5 | Peptides |
| HY-P3736 | Myelopeptide-2 | 137833-31-9 | Peptides |
| HY-P3737 | Osteocalcin (37-49), human | 89458-24-2 | Peptides |
| HY-P3738 | Osteocalcin (7-19) (human) | 120944-72-1 | Peptides |
| HY-P3739 | [pGlu4]-Myelin Basic Protein (4-14) | 136132-68-8 | Peptides |
| HY-P3740 | Osteocalcin 30-43 Fragment | Peptides | |
| HY-P3741 | [Ala9,10, Lys11,12] Glycogen Synthase (1-12) | 105802-84-4 | Peptides |
| HY-P3742 | Tyrosinase (192-200), human mouse | 170294-35-6 | Peptides |
| HY-P3743 | p60c-src Substrate | 165190-42-1 | Peptides |
| HY-P3744 | pp60v-src Autophosphorylation site | 81493-98-3 | Peptides |
| HY-P3745 | H1-7 (histone H1 phosphorylation site), PKA Substrate | 65189-70-0 | Peptides |
| HY-P3746 | Pentigetide | 62087-72-3 | Peptides |
| HY-P3747 | Hemagglutinin (48-68) | 115721-95-4 | Peptides |
| HY-P3748 | Casein Kinase II Receptor Peptide | 198481-81-1 | Peptides |
| HY-P3749 | Mca-(ala7,lys(dnp)9)-bradykinin | 323577-36-2 | Dye Reagents |
| HY-P3750 | Methionyl-Lysyl-Bradykinin | 550-19-6 | Peptides |
| HY-P3751 | [Tyr8] Bradykinin | 32222-00-7 | Peptides |
| HY-P3752 | Gly-Ala-Tyr | 92327-84-9 | Peptides |
| HY-P3753 | Phe-Leu-Glu-Glu-Val | 61037-79-4 | Peptides |
| HY-P3754 | Experimental allergic encephalitogenic peptide (human) | 29705-92-8 | Peptides |
| HY-P3755 | Ephrin-A2-selective YSA-peptide | 532441-10-4 | Peptides |
| HY-P3756 | EPO mimetic peptide-1 | 186526-28-3 | Peptides |
| HY-P3757 | H-D-Tyr-Val-Gly-OH | 86030-52-6 | Peptides |
| HY-P3758 | BNP (1-21), Pro (Human) | 286373-49-7 | Peptides |
| HY-P3759 | BNP (22-46), Pro (Human) | Peptides | |
| HY-P3760 | H-Pro-Phe-Thr-Arg-Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu-His-Leu-OH | 158879-51-7 | Peptides |
| HY-P3761 | Ac-Tyr-Val-Lys-Asp-aldehyde | 147821-01-0 | Peptides |
| HY-P3762 | ANP (1-30), frog | 309245-16-7 | Peptides |
| HY-P3763 | Atrial Natriuretic Peptide (7-28), human, canine | 128746-58-7 | Peptides |
| HY-P3764 | Protein kinase C substrate | 105802-82-2 | Peptides |
| HY-P3765 | Auriculin A | 91421-87-3 | Peptides |
| HY-P3766 | Protein kinase C (alpha) peptide (TFA) | 159939-84-1 | Peptides |
| HY-P3767 | Auriculin B | 90052-57-6 | Peptides |
| HY-P3769 | Prepro-ANF (56-92), human | 112199-06-1 | Peptides |
| HY-P3770 | Phosphate acceptor peptide | 93511-94-5 | Peptides |
| HY-P3771 | p60c-src substrate II, phosphorylated | 284660-72-6 | Peptides |
| HY-P3772 | [Mpr7, DAla9] ANP (7-28), amide, rat | 112926-01-9 | Peptides |
| HY-P3773 | p60c-src substrate II | 168781-78-0 | Peptides |
| HY-P3774 | [Tyr8]-Atrial Natriuretic Peptide (5-27), rat | 108703-67-9 | Peptides |
| HY-P3775 | a-Bag Cell Peptide (1-7) | 87549-54-0 | Peptides |
| HY-P3776 | a-Bag Cell Peptide (1-8) | 87549-53-9 | Peptides |
| HY-P3777 | β-Bag cell peptide | 109024-47-7 | Peptides |
| HY-P3778 | γ-Bag cell peptide | 109024-48-8 | Peptides |
| HY-P3779 | Amyloid 17-42 | 155178-13-5 | Peptides |
| HY-P3780 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (36-42) | 1802078-25-6 | Peptides |
| HY-P3781 | (Met(O)35)-Amyloid β-Protein (1-42) | Peptides | |
| HY-P3782 | (Met(O2)35)-Amyloid β-Protein (1-42) | Peptides | |
| HY-P3783 | (Nle35)-Amyloid β-Protein (1-42) (ammonium) | Peptides | |
| HY-P3784 | FKKSFKL-NH2 | 137168-33-3 | Peptides |
| HY-P3785 | PKI(5-22)amide | 100853-58-5 | Peptides |
| HY-P3786 | H-Arg-Gly-Tyr-Ala-Leu-Gly-OH | 59587-24-5 | Peptides |
| HY-P3787 | Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 157382-69-9 | Peptides |
| HY-P3788 | Ac-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 168135-79-3 | Peptides |
| HY-P3789 | Prolactin-Releasing Peptide (12-31), rat | 222988-10-5 | Peptides |
| HY-P3790 | T-F-Q-A-Y-P-L-R-E-A | 117592-22-0 | Peptides |
| HY-P3791 | N-Succinyl-Ile-Ile-Trp-AMC | 133525-12-9 | Dye Reagents |
| HY-P3792 | Mca-Pro-Leu-Gly-Pro-D-Lys(Dnp) | 185698-23-1 | Peptides |
| HY-P3793 | Amyloid β-Protein (33-42) (TFA) | Peptides | |
| HY-P3794 | Glu-Ala-Leu-Phe-Gln-pNA | 198551-00-7 | Peptides |
| HY-P3795 | G2-Peptide | 361443-81-4 | Peptides |
| HY-P3796 | Agalactoglyco peptide | 361443-82-5 | Peptides |
| HY-P3797 | Furin Substrate | 174838-79-0 | Peptides |
| HY-P3798 | Eglin c (41-49) | 122299-11-0 | Peptides |
| HY-P3799 | [Glp6] Substance P (6-11) | 61123-13-5 | Peptides |
| HY-P3800 | [Glp5] Substance P (5-11) | 56104-22-4 | Peptides |
| HY-P3801 | [Glp5,(Me)Phe8,Sar9] Substance P (5-11) | 77128-69-9 | Peptides |
| HY-P3802 | [D-Trp2,7,9] Substance P | 100930-11-8 | Peptides |
| HY-P3803 | [D-Pro4,D-Trp7,9] Substance P (4-11) | 81039-85-2 | Peptides |
| HY-P3805 | [D-Pro4,D-Trp7,9,Nle11] Substance P (4-11) | 89430-34-2 | Peptides |
| HY-P3806 | [D-Pro4,D-Trp7,9,10] Substance P (4-11) | 86917-57-9 | Peptides |
| HY-P3808 | [D-Pro2,D-Trp7,9] Substance P | 80434-86-2 | Peptides |
| HY-P3809 | [D-Pro2,D-Phe7,D-Trp9] Substance P | 77275-70-8 | Peptides |
| HY-P3810 | Caspofungin impurity A | 1202167-57-4 | Peptides |
| HY-P3811 | Autocamtide-3 | 142828-10-2 | Peptides |
| HY-P3811A | Autocamtide-3 (acetate) | Peptides | |
| HY-P3812 | Woodtide | 634592-23-7 | Peptides |
| HY-P3813 | Tyrosinase (206-214), human | 166188-11-0 | Peptides |
| HY-P3814 | S6 Kinase Substrate Peptide 32 | Peptides | |
| HY-P3815 | Casein Kinase 2 Substrate Peptide | 132176-35-3 | Peptides |
| HY-P3816 | PKCε Inhibitor Scramble Peptide | 813416-34-1 | Peptides |
| HY-P3817 | Des-[Gly77,His78] Myelin Basic Protein (68-84), bovine | 98474-60-3 | Peptides |
| HY-P3818 | PKCδ Peptide Substrate | 813416-46-5 | Peptides |
| HY-P3819 | Delta (Phospho) Sleep Inducing Peptide | 70754-23-3 | Peptides |
| HY-P3820 | [Dehydro-Pro4] Substance P (4-11) | Peptides | |
| HY-P3822 | PRMT5-IN-23 | Peptides | |
| HY-P3823 | Asp-Asp-Asp-Asp-Asp-Asp | 145224-96-0 | Peptides |
| HY-P3823A | Asp-Asp-Asp-Asp-Asp-Asp (TFA) | Peptides | |
| HY-P3824 | Red pigment-concentrating hormone | 37933-92-9 | Peptides |
| HY-P3825 | Crustacean cardioactive peptide | 107090-96-0 | Peptides |
| HY-P3826 | Chromogranin A (324-337), human | 115136-18-0 | Peptides |
| HY-P3827 | Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly | 104914-40-1 | Peptides |
| HY-P3828 | Biotin-myelin basic protein (94-102) | 923949-88-6 | Peptides |
| HY-P3829 | Beacon (47-73) | 681153-68-4 | Peptides |
| HY-P3830 | Beacon (30-73) | Peptides | |
| HY-P3831 | β-Interleukin II (44-56) | 309247-07-2 | Peptides |
| HY-P3832 | Antifreeze Polypeptide 6 (winter flounder) | 122604-16-4 | Peptides |
| HY-P3833 | Yp537 | 166664-90-0 | Peptides |
| HY-P3833A | Yp537 (TFA) | Peptides | |
| HY-P3834 | Antiarrhythmic peptide (cattle atrium) | 81771-37-1 | Peptides |
| HY-P3835 | Mating Factor α (1-6) | 65418-88-4 | Peptides |
| HY-P3836 | [His7] Corazonin | 138968-27-1 | Peptides |
| HY-P3837 | Xenopsin-Related Peptide 2 | 117442-29-2 | Peptides |
| HY-P3838 | Protein Kinase C (gamma) Peptide | 309247-51-6 | Peptides |
| HY-P3839 | Nocistatin | 207392-60-7 | Peptides |
| HY-P3840 | Head activator neuropeptide | 79943-68-3 | Peptides |
| HY-P3841 | Protein Kinase C (beta) Peptide | 309247-50-5 | Peptides |
| HY-P3842 | Protein Kinase C (661-671) | 149839-93-0 | Peptides |
| HY-P3843 | Neuropeptide AF (cattle) | 99588-52-0 | Peptides |
| HY-P3844 | Biotinyl-neuropeptide W-23 (human) | 1815618-09-7 | Peptides |
| HY-P3845 | (Gly22)-Amyloid β-Protein (1-42) | 1802086-23-2 | Peptides |
| HY-P3846 | (Glu20)-Amyloid β-Protein (1-42) | 1802086-22-1 | Peptides |
| HY-P3847 | Tyr0-Neurokinin B | 131019-53-9 | Peptides |
| HY-P3848 | Tyr0-Neurokinin A | 116868-93-0 | Peptides |
| HY-P3849 | [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) | 149270-28-0 | Peptides |
| HY-P3850 | (D-Pro2,D-Trp6,8,Nle10)-Neurokinin B | 109212-72-8 | Peptides |
| HY-P3851 | (β-Ala8)-Neurokinin A (4-10) | 127633-71-0 | Peptides |
| HY-P3852 | Neurokinin Receptor (393-407), rat | 153607-26-2 | Peptides |
| HY-P3853 | GR 87389 | 141663-86-7 | Peptides |
| HY-P3854 | GR 83074 | 141636-44-4 | Peptides |
| HY-P3855 | Endokinin D | 566151-48-2 | Peptides |
| HY-P3856 | Endokinin C | 347837-74-5 | Peptides |
| HY-P3857 | Carassin | 133950-47-7 | Peptides |
| HY-P3858 | (D-Asp1)-Amyloid β-Protein (1-42) | 1802086-19-6 | Peptides |
| HY-P3859 | Cys-Gly-Lys-Arg-Amyloid β-Protein (1-42) | 1802086-21-0 | Peptides |
| HY-P3860 | Biotinyl-Amyloid β-Protein (1-42) (ammonium) | Peptides | |
| HY-P3861 | Biotin-NeurokininA | Peptides | |
| HY-P3862 | [MePhe7]-Neurokinin B | 110880-53-0 | Peptides |
| HY-P3863 | Pancreastatin (swine) | 106477-83-2 | Peptides |
| HY-P3864 | Pancreastatin (37-52), human | 133605-57-9 | Peptides |
| HY-P3865 | Pancreastatin (33-49), porcine | 106507-61-3 | Peptides |
| HY-P3866 | [Asu1,6]-Oxytocin | 14317-68-1 | Peptides |
| HY-P3867 | Hypocretin (70-98), human | 1129545-33-0 | Peptides |
| HY-P3868A | QEQLERALNSS (TFA) | Peptides | |
| HY-P3869 | [D-Arg2]Dermorphin-(1-4) amide | 100304-60-7 | Peptides |
| HY-P3870 | DALDA | 118476-85-0 | Peptides |
| HY-P3870A | DALDA (acetate) | Peptides | |
| HY-P3870B | DALDA (TFA) | Peptides | |
| HY-P3871 | Peptide F, bovine | 75718-92-2 | Peptides |
| HY-P3872 | Peptide B, bovine | 87713-86-8 | Peptides |
| HY-P3873 | Neuropeptide FF (5-8) | 152050-35-6 | Peptides |
| HY-P3874 | Peptide E | 78355-50-7 | Peptides |
| HY-P3875 | [Arg-15,20,21,Leu17]-PACAP-Gly-Lys-Arg-NH2 | 176785-25-4 | Peptides |
| HY-P3876 | (Pro34)-Peptide YY (human) | 179986-93-7 | Peptides |
| HY-P3877 | (Leu31,Pro34)-Peptide YY (human) | 179986-95-9 | Peptides |
| HY-P3877A | (Leu31,Pro34)-Peptide YY (human) (TFA) | Peptides | |
| HY-P3878 | Renin substrate 1 | 791068-69-4 | Peptides |
| HY-P3879 | Protein Kinase C (660-673) | 149839-94-1 | Peptides |
| HY-P3880 | (D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P | 84676-91-5 | Peptides |
| HY-P3881 | (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P | 115760-58-2 | Peptides |
| HY-P3882 | Fmoc-Ala-Glu-Gln-Lys-NH2 | Peptides | |
| HY-P3883 | [DAla4] Substance P (4-11) | 81381-50-2 | Peptides |
| HY-P3884 | Arylomycin A2 | 459844-20-3 | Peptides |
| HY-P3885 | Substance P (alligator) | 113516-47-5 | Peptides |
| HY-P3886 | Substance P-Gly-Lys-Arg | 123148-51-6 | Peptides |
| HY-P3887 | MLGFFQQPKPR-NH2 | 1802883-75-5 | Peptides |
| HY-P3888 | Gly-Leu-Met-NH2 | 4652-64-6 | Peptides |
| HY-P3889 | Substance P (6-11) | 51165-07-2 | Peptides |
| HY-P3890 | Substance P (5-11) | 51165-09-4 | Peptides |
| HY-P3890A | Substance P (5-11) (TFA) | Peptides | |
| HY-P3891 | Substance P (4-11) | 53749-60-3 | Peptides |
| HY-P3892 | Protein Kinase C (19-35) Peptide | 309247-48-1 | Peptides |
| HY-P3893 | PSTAIR | 126675-53-4 | Peptides |
| HY-P3894 | P34cdc2 Kinase Fragment | 309247-52-7 | Peptides |
| HY-P3895 | Substance P (3-11) | 51165-11-8 | Peptides |
| HY-P3896 | Substance P (2-11) | 53749-61-4 | Peptides |
| HY-P3897 | [Tyr12] Somatostatin 28 (1-14) | 198276-46-9 | Peptides |
| HY-P3898 | Tyr-Somatostatin-28 | 86649-84-5 | Peptides |
| HY-P3899 | [Nle8] Somatostatin (1-28) | 84768-30-9 | Peptides |
| HY-P3899A | [Nle8] Somatostatin (1-28) (TFA) | Peptides | |
| HY-P3900 | [Tyr0,D-Trp8] Somatostatin | 99341-94-3 | Peptides |
| HY-P3901 | [Leu8,D-Trp22,Tyr25] Somatostatin-28 | 77909-99-0 | Peptides |
| HY-P3902 | [D-Trp8] Somatostatin-14 | 58976-46-8 | Peptides |
| HY-P3903 | [D-Trp8,Tyr11] Somatostatin | 75176-06-6 | Peptides |
| HY-P3904 | P34cdc2 Kinase Substrate Peptide | 135546-44-0 | Peptides |
| HY-P3905 | [Glp5,Sar9] Substance P (5-11) | 77128-78-0 | Peptides |
| HY-P3906 | Melittin (free acid) | 123168-46-7 | Peptides |
| HY-P3907 | Kemptide (amide) | 70691-36-0 | Peptides |
| HY-P3908 | FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium) | Peptides | |
| HY-P3910 | [Val4] Angiotensin III | 100900-28-5 | Peptides |
| HY-P3911 | CAP 37 (20-44) | 151679-59-3 | Peptides |
| HY-P3912 | Endotoxin inhibitor | 147396-10-9 | Peptides |
| HY-P3912A | Endotoxin inhibitor (TFA) | Peptides | |
| HY-P3913 | Acetyl-Adhesin (1025-1044) amide | 320350-56-9 | Peptides |
| HY-P3914 | Cecropin A (1-7)-Melittin A (2-9) | 157606-25-2 | Peptides |
| HY-P3915 | Esculentin 1A | 1350828-38-4 | Peptides |
| HY-P3916 | GVLSNVIGYLKKLGTGALNAVLKQ | 136831-50-0 | Peptides |
| HY-P3917 | Lactoferricin B (4-14), bovine | 183476-25-7 | Peptides |
| HY-P3918 | EGF-R (661-681) T669 Peptide | 137348-21-1 | Peptides |
| HY-P3919 | Adrenotensin (human) | 166546-72-1 | Peptides |
| HY-P3920 | Cys-Kemptide | 309247-46-9 | Peptides |
| HY-P3921 | Casein Kinase II Substrate | 95651-74-4 | Peptides |
| HY-P3922 | [Gly11] Substance P | Peptides | |
| HY-P3923 | Agouti-Related Protein (25-51) (human) | 209460-61-7 | Peptides |
| HY-P3924 | Agouti-Related Protein (54-82) (human) | 209460-63-9 | Peptides |
| HY-P3925 | [His11]Substance P | Peptides | |
| HY-P3926 | Amylin (8-37) (human) | 309244-90-4 | Peptides |
| HY-P3927 | [MePhe8,Sar9] Substance P | 77128-76-8 | Peptides |
| HY-P3929 | PKI (14-24)amide | 100853-61-0 | Peptides |
| HY-P3929A | PKI (14-24)amide (TFA) | 1293946-39-0 | Peptides |
| HY-P3930 | PKI (5-24),amide | 100891-36-9 | Peptides |
| HY-P3931 | Histone H2b(29-35) | 71937-87-6 | Peptides |
| HY-P3932 | [Sar4] Substance P (4-11) | Peptides | |
| HY-P3933 | [Tyr8,Nle11] Substance P | 71890-48-7 | Peptides |
| HY-P3934 | HIV Protease Substrate I | 124077-63-0 | Peptides |
| HY-P3935 | Arg-Gly-Tyr-Ser-Leu-Gly | 59587-18-7 | Peptides |
| HY-P3936 | Endotoxin Substrate | 68223-96-1 | Peptides |
| HY-P3938 | Suc-Ala-Ala-Pro-Gly-pNA | 72682-68-9 | Peptides |
| HY-P3939 | Suc-Ala-Ala-Pro-Trp-pNA | Peptides | |
| HY-P3940 | Ac-MBP (4-14) Peptide | 138250-62-1 | Peptides |
| HY-P3941 | Ala-Arg-Arg-Pro-Glu-Gly-Arg-Thr-Trp-Ala-Gln-Pro-Gly-Tyr | 309247-45-8 | Peptides |
| HY-P3942 | SDP116 | Peptides | |
| HY-P3943 | Calmodulin Dependent Protein Kinase Substrate Analog | 123067-01-6 | Peptides |
| HY-P3944 | Calmodulin Dependent Protein Kinase Substrate | 82801-68-1 | Peptides |
| HY-P3945 | Prolactin-Releasing Peptide (12-31), bovine | 209466-90-0 | Peptides |
| HY-P3946 | Prolactin-Releasing Peptide (1-31), bovine | Peptides | |
| HY-P3947 | Fluorescent Substrate for Subtillsin | 147471-56-5 | Peptides |
| HY-P3948 | Fluorescent Substrate for Pro-Specific Proteases | 142689-23-4 | Peptides |
| HY-P3949 | Fluorescent Substrate for Glu-Specific Proteases | 143147-75-5 | Peptides |
| HY-P3950 | Fluorescent Substrate for Asp-Specific Proteases | 143147-74-4 | Peptides |
| HY-P3951 | Fluorescent HIV Substrate | 1426174-10-8 | Peptides |
| HY-P3952 | (D-Trp8,D-Cys14)-Somatostatin-14 | 61950-59-2 | Peptides |
| HY-P3953 | Wy 41747 | 68463-41-2 | Peptides |
| HY-P3954 | Somatostatin-28 (sheep, human rat mouse) | 73032-94-7 | Peptides |
| HY-P3955 | RC-160 [Lys(Boc)] | 139668-78-3 | Peptides |
| HY-P3956 | Prosomatostatin (1-32), porcine | 99694-34-5 | Peptides |
| HY-P3957 | Urotensin II, teleost fish | 9047-55-6 | Peptides |
| HY-P3958 | BIM-23027 | 78981-49-4 | Peptides |
| HY-P3959 | (Tyr0)-Urocortin, rat | 187111-93-9 | Peptides |
| HY-P3960 | (Glu2)-TRH | 85541-78-2 | Peptides |
| HY-P3961 | [Tyr0] Thymus Factor | 81478-67-3 | Peptides |
| HY-P3962 | [Phe2]-TRH | 34783-35-2 | Peptides |
| HY-P3963 | Thymus Factor | 62036-77-5 | Peptides |
| HY-P3964 | TRH Precursor Peptide | 128578-17-6 | Peptides |
| HY-P3965 | 16-38-Thymosin β4 (cattle) | 113318-05-1 | Peptides |
| HY-P3965A | 16-38-Thymosin β4 (cattle) (TFA) | Peptides | |
| HY-P3966 | Thymosin β10Arg | 88160-82-1 | Peptides |
| HY-P3967 | Thymopoietin i/ii (29-41) (bovine) | 56795-64-3 | Peptides |
| HY-P3968 | Thrombospondin-1 (1016-1021) (human, bovine, mouse) | 149234-06-0 | Peptides |
| HY-P3969 | Prepro-TRH-(160-169) | 122018-91-1 | Peptides |
| HY-P3970 | KRFK | 162290-78-0 | Peptides |
| HY-P3970A | KRFK (TFA) | Peptides | |
| HY-P3970C | KQFK | 162290-88-2 | Peptides |
| HY-P3970D | KQFK (TFA) | Peptides | |
| HY-P3971 | H-Leu-Ser-Lys-Leu-OH | 162559-45-7 | Peptides |
| HY-P3972 | H-ILE-ARG-VAL-VAL-MET-OH | 149234-05-9 | Peptides |
| HY-P3973 | Thrombostatin cont-1 | 929555-19-1 | Peptides |
| HY-P3974 | Semastatin-5B | 929555-17-9 | Peptides |
| HY-P3975 | Glp-His-Pro-Gly-NH2 | 41880-59-5 | Peptides |
| HY-P3976 | Lactalbumin B (50-53) Alpha [Lactorphin Alpha], bovine | 198284-23-0 | Peptides |
| HY-P3977 | ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) | 1036763-00-4 | Peptides |
| HY-P3978 | ACTH (4-9) | 56236-83-0 | Peptides |
| HY-P3979 | Defensin HNP 4 | Peptides | |
| HY-P3980 | HIV-1, HIV-2 Protease Substrate | 149639-49-6 | Peptides |
| HY-P3981 | Defensin NP-3A | 134090-73-6 | Peptides |
| HY-P3982 | CKLF1-C19 | 960358-79-6 | Peptides |
| HY-P3983 | [Cys(Bzl)84] CD (81-92) | 123380-68-7 | Peptides |
| HY-P3984 | Tyr-ACTH (4-9) | 129813-57-6 | Peptides |
| HY-P3985 | Bradykinin potentiator B | 30892-86-5 | Peptides |
| HY-P3990 | Coibamide A | 1029227-48-2 | Peptides |
| HY-P3991 | Bradykinin potentiator C | 30953-20-9 | Peptides |
| HY-P3992 | 5-FAM-Dyrktide | Peptides | |
| HY-P3993 | (Gly14)-Humanin (human) | 330936-70-4 | Peptides |
| HY-P3993A | (Gly14)-Humanin (human) (acetate) | Peptides | |
| HY-P3994 | [3,5 Diiodo-Tyr7] Peptide T | 128551-40-6 | Peptides |
| HY-P3995 | Scospondistatin | 929555-18-0 | Peptides |
| HY-P3996 | Properdistatin | 945373-85-3 | Peptides |
| HY-P3997 | Papilostatin-2 | 929555-13-5 | Peptides |
| HY-P3998 | Fibulostatin 6.3 | 929555-10-2 | Peptides |
| HY-P3999 | Fibulostatin 6.2 | 945373-84-2 | Peptides |
| HY-P4000 | Cartilostatin 1 | 929555-05-5 | Peptides |
| HY-P4001 | Adamtsostatin 4 | 929554-73-4 | Peptides |
| HY-P4002 | Adamtsostatin 18 | 929554-95-0 | Peptides |
| HY-P4003 | Adamtsostatin 16 | 929554-90-5 | Peptides |
| HY-P4004 | PAR-4 (1-6) amide (human) | 245443-51-0 | Peptides |
| HY-P4005 | Ala-Leu-Ala-Leu | 84676-48-2 | Peptides |
| HY-P4006 | [Pmp1,Tyr(OEt)2] AVP | 112453-06-2 | Peptides |
| HY-P4007 | [Pmp1,DTyr(OEt)2,Val4,Cit8] Vasopressin | 1426174-49-3 | Peptides |
| HY-P4008 | [Deamino-4-valine, 8-D-arginine]-Vasopressin | 43157-23-9 | Peptides |
| HY-P4009 | [Lys8] Vasopressin Desglycinamide | 32215-99-9 | Peptides |
| HY-P4010 | Desamino(D-3-(3′-pyridyl)-Ala2,Arg8)-Vasopressin | 136105-89-0 | Peptides |
| HY-P4011 | [1,6-Aminosuberic acid]-arginine-Vasotocin | 35375-13-4 | Peptides |
| HY-P4012 | [Asu1,6-Arg8]Vasopressin | 40944-53-4 | Peptides |
| HY-P4013 | [Arg15,20,21, Leu17] VIP-Gly-Lys-Arg-NH2 | 186844-13-3 | Peptides |
| HY-P4014 | HSDAVFTDNYTRLRRQLAVRRYLNSILN-NH2 | 735327-71-6 | Peptides |
| HY-P4015 | VIP (1-12), human, porcine, rat, ovine | 120928-03-2 | Peptides |
| HY-P4016 | Semastatin 5A.2 | 929555-16-8 | Peptides |
| HY-P4017 | Semastatin 5A.1 | 929555-15-7 | Peptides |
| HY-P4018 | HIV Protease Substrate IV | 128340-47-6 | Peptides |
| HY-P4019 | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | 121822-32-0 | Peptides |
| HY-P4020 | 2F5 epitope | 470704-11-1 | Peptides |
| HY-P4021 | Mca-KKEDVV-Abu-CS-Abu-S-(NO2)F-KK-NH2 | 396665-80-8 | Peptides |
| HY-P4022 | Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-OH | 291297-58-0 | Peptides |
| HY-P4023 | Mca-KKEDVV-Abu-C | 290836-22-5 | Peptides |
| HY-P4024 | KKEDVV-Abu-CS-Abu-SYKK-NH2 | 396096-62-1 | Peptides |
| HY-P4025 | ELDKWA | 152051-21-3 | Peptides |
| HY-P4026 | K(biotinyl)-KEDVV-Abu-CS-Abu-SYKK-NH2 | 396679-25-7 | Peptides |
| HY-P4027 | HCV-1 e2 Protein (554-569) | 290362-31-1 | Peptides |
| HY-P4027A | HCV-1 e2 Protein (554-569) (TFA) | Peptides | |
| HY-P4028 | Herpes virus inhibitor 1 | 103424-73-3 | Peptides |
| HY-P4029 | HCV-1 e2 Protein (484-499) | 161012-10-8 | Peptides |
| HY-P4030 | Herpes virus inhibitor 2 | 103424-74-4 | Peptides |
| HY-P4031 | HCV Peptide (131-140) | 160926-86-3 | Peptides |
| HY-P4032 | HCV Peptide (35-44) | 160214-01-7 | Peptides |
| HY-P4033 | HCV Peptide (257-266) | 199533-16-9 | Peptides |
| HY-P4035 | HCV NS4A Protein (18-40) (JT strain) | 188427-41-0 | Peptides |
| HY-P4036 | HCV Core Protein (59-68) | 160187-72-4 | Peptides |
| HY-P4037 | HCV Core Protein (107-114) | 160187-74-6 | Peptides |
| HY-P4038 | Hepatitis C Virus S5A/5B | 191529-67-6 | Peptides |
| HY-P4039 | Ac-EEVVAC-pNA | 389868-12-6 | Dye Reagents |
| HY-P4040 | Ac-D-DGla-LI-Cha-C | 208940-40-3 | Peptides |
| HY-P4041 | [Ala127] Hepatitis B Virus Pre-S Region (120-131) | 171089-50-2 | Peptides |
| HY-P4042 | Hepatitis B Virus Receptor Binding Fragment | 114495-85-1 | Peptides |
| HY-P4043 | Hepatitis b virus pre-s region (120-145) | 104504-34-9 | Peptides |
| HY-P4044 | HBV Seq2 aa:28-39 | 168417-72-9 | Peptides |
| HY-P4045 | HBV Seq2 aa:208-216 | 160214-63-1 | Peptides |
| HY-P4046 | HBV Seq2 aa:179-186 | 337464-42-3 | Peptides |
| HY-P4047 | Cyclo(RGDfK(Mal)) | 1228992-90-2 | Peptides |
| HY-P4048 | HBV Seq1 aa:93-100 | Peptides | |
| HY-P4049 | HBV Seq1 aa:63-71 | 189323-64-6 | Peptides |
| HY-P4050 | HBV Seq1 aa:18-27 | 147820-47-1 | Peptides |
| HY-P4051 | HBV Seq1 aa:141-151 | 147318-53-4 | Peptides |
| HY-P4052 | Pinealon | 175175-23-2 | Peptides |
| HY-P4053 | Dalargin | 81733-79-1 | Peptides |
| HY-P4054 | IEIK 13 | 1426415-02-2 | Peptides |
| HY-P4055 | GP120, HIV-1 MN | Peptides | |
| HY-P4056 | CIGB-300 | 1072877-99-6 | Peptides |
| HY-P4056A | CIGB-300 (acetate) | Peptides | |
| HY-P4058 | Calcitonin gene-related peptide (free acid) | 83652-28-2 | Peptides |
| HY-P4060 | Pancreatic polypeptide | 59763-91-6 | Peptides |
| HY-P4060A | Pancreatic polypeptide (TFA) | Peptides | |
| HY-P4062 | Insulin peglispro | 1200440-65-8 | Peptides |
| HY-P4063 | Pegylated synthetic human c-peptide | 1350661-05-0 | Peptides |
| HY-P4066 | Emfilermin | 159075-60-2 | Peptides |
| HY-P4070 | Insulin icodec | 1188379-43-2 | Peptides |
| HY-P4071 | OH-CATH | Peptides | |
| HY-P4072 | (D)-PPA 1 | 1620813-53-7 | Peptides |
| HY-P4072A | (D)-PPA 1 (TFA) | Peptides | |
| HY-P4073 | ANG1005 | 1075214-55-9 | Peptides |
| HY-P4074 | Anti-BetaGamma | Peptides | |
| HY-P4075 | Antennapedia Leader Peptide (CT) | 379733-69-4 | Peptides |
| HY-P4076 | MPG peptides, Pβ | 791642-10-9 | Peptides |
| HY-P4077 | Antennapedia Peptide, amide | 214556-79-3 | Peptides |
| HY-P4078 | (Arg)9 biotin labeled | Peptides | |
| HY-P4079 | hCT(18-32) | 769175-01-1 | Peptides |
| HY-P4080 | MPG peptides, Pα | 1392498-36-0 | Peptides |
| HY-P4081 | plsl | Peptides | |
| HY-P4082 | ErbB-2-binding peptide | 562791-56-4 | Peptides |
| HY-P4083 | (Arg)9,TAMRA-labeled | Peptides | |
| HY-P4084 | KLA seq | 406482-85-7 | Peptides |
| HY-P4084A | KLA seq (acetate) | Peptides | |
| HY-P4085 | AGR | 945245-90-9 | Peptides |
| HY-P4086 | Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) | 1678417-57-6 | Peptides |
| HY-P4087 | Cys(Npys)-(Arg)9 | 1417221-06-7 | Peptides |
| HY-P4088 | LyP-2 | 850859-24-4 | Peptides |
| HY-P4089 | REA | 945245-82-9 | Peptides |
| HY-P4090 | CPP2 | 1313390-49-6 | Peptides |
| HY-P4091 | LSD | 945245-76-1 | Peptides |
| HY-P4091A | LSD (acetate) | Peptides | |
| HY-P4092 | HN-1 | 386223-83-2 | Peptides |
| HY-P4093 | Cys-Penetratin | 209323-98-8 | Peptides |
| HY-P4094 | CTP | 1052692-86-0 | Peptides |
| HY-P4095 | NoxaBH3 | Peptides | |
| HY-P4096 | HAP-1 | 329004-38-8 | Peptides |
| HY-P4097 | 293P-1 | 1465746-23-9 | Peptides |
| HY-P4098 | SynB1 | 1207092-86-1 | Peptides |
| HY-P4099 | Cys(Npys)-(D-Arg)9 | Peptides | |
| HY-P4100 | Cyclic SSTR agonist octreotide | Peptides | |
| HY-P4101 | Cys(Npys)-TAT (47-57) | Peptides | |
| HY-P4102 | Cyclic PSAP peptide | 1810853-35-0 | Peptides |
| HY-P4103 | Cys(Npys)-TAT (47-57), FAM-labeled | Peptides | |
| HY-P4104 | pVEC (Cadherin-5) | 383430-30-6 | Peptides |
| HY-P4105 | TAT (47-57), TAMRA-labeled | Peptides | |
| HY-P4106 | Tat-GluR23Y, scrambled | 1404188-94-8 | Peptides |
| HY-P4106A | Tat-GluR23Y, scrambled (TFA) | Peptides | |
| HY-P4107 | Bilaid C | 2393866-13-0 | Peptides |
| HY-P4108 | TAT-HA2 Fusion Peptide | 923954-79-4 | Peptides |
| HY-P4109 | vMIP-II (1-21) | 265650-93-9 | Peptides |
| HY-P4109A | vMIP-II (1-21) (TFA) | Peptides | |
| HY-P4110 | TAT-NSF222 Fusion Peptide | Peptides | |
| HY-P4111 | Peptide R | 1318232-11-9 | Peptides |
| HY-P4111A | Peptide R (TFA) | Peptides | |
| HY-P4112 | TAT-NSF222scr Fusion Polypeptide, scrambled | Peptides | |
| HY-P4113 | TAT-NSF700 Fusion Peptide | Peptides | |
| HY-P4114 | TAT-NSF700scr | Peptides | |
| HY-P4115 | CooP | 1192864-27-9 | Peptides |
| HY-P4116 | pH-Low Insertion Peptide | 2293160-09-3 | Peptides |
| HY-P4116A | pH-Low Insertion Peptide (TFA) | Peptides | |
| HY-P4117 | Penetratin-Arg | 474634-55-4 | Peptides |
| HY-P4118 | EB1 peptide | 952754-66-4 | Peptides |
| HY-P4119 | Pep-1-Cysteamine | 863608-35-9 | Peptides |
| HY-P4119A | Pep-1-Cysteamine (TFA) | Peptides | |
| HY-P4120 | MHV EPTM | 2583513-76-0 | Peptides |
| HY-P4121 | L17E | 1898254-09-5 | Peptides |
| HY-P4122 | TAT (47-57), FAM-labeled | 1676104-81-6 | Peptides |
| HY-P4123 | TAT (47-57) GGG-Cys(Npys) | 1231898-26-2 | Peptides |
| HY-P4124 | Pepinh-Control | Peptides | |
| HY-P4125 | FITC-LC-TAT (47-57) | Peptides | |
| HY-P4126 | Suc-Ala-Ala-Pro-Val-AMC | 113277-37-5 | Peptides |
| HY-P4127 | M65 | 1872440-65-7 | Peptides |
| HY-P4127A | M65 TFA | Peptides | |
| HY-P4128 | LL-37 SKE | 1072128-56-3 | Peptides |
| HY-P4129 | Rabies Virus Matrix Protein Fragment(RV-MAT) | 1023648-37-4 | Peptides |
| HY-P4130 | MPS-Gαi2 | 1180485-56-6 | Peptides |
| HY-P4131 | MPS-Gαi3 | 439223-21-9 | Peptides |
| HY-P4132 | Membrane-Permeable Sequence, MPS | 1231898-22-8 | Peptides |
| HY-P4133 | MEK1 Derived Peptide Inhibitor 1 | 355367-87-2 | Peptides |
| HY-P4134 | Lipid Membrane Translocating Peptide | 333757-44-1 | Peptides |
| HY-P4135 | FITC-LC-Antennapedia Peptide | Peptides | |
| HY-P4136 | Myristoyl-MEK1 Derived Peptide Inhibitor 1 | 427884-64-8 | Peptides |
| HY-P4137 | Cys(Npys) Antennapedia Peptide, amide | 220337-24-6 | Peptides |
| HY-P4138 | Antennapedia Peptide FAM-labeled | Peptides | |
| HY-P4139 | activable cell-penetrating peptide (ACCP) | Peptides | |
| HY-P4144 | Onvitrelin ucalontide | 1174415-90-7 | Peptides |
| HY-P4145 | Quazomotide | 935395-33-8 | Peptides |
| HY-P4146 | Survodutide | 2805997-46-8 | Peptides |
| HY-P4146A | Survodutide (TFA) | Peptides | |
| HY-P4147 | Ac-IHIHIQI-NH2 | 1582727-85-2 | Peptides |
| HY-P4148 | Vorumotide | 935395-34-9 | Peptides |
| HY-P4149 | Imsamotide | 2130836-27-8 | Peptides |
| HY-P4151 | Marlumotide | 952720-86-4 | Peptides |
| HY-P4152 | Etimumotide | 1431550-68-3 | Peptides |
| HY-P4153 | Enlicitide (chloride) | 2407527-16-4 | Peptides |
| HY-P4154 | Bevonescein | 2276787-79-0 | Peptides |
| HY-P4155 | SSA antigenic peptide | Peptides | |
| HY-P4156 | VLVNTFCDSCIPKTYWNLGY (TFA) | Peptides | |
| HY-P4157 | FOXO4-DRI | 2460055-10-9 | Peptides |
| HY-P4157A | FOXO4-DRI (acetate) | Peptides | |
| HY-P4159 | Endothelin-1 (1-31) (Human) | 133972-52-8 | Peptides |
| HY-P4159A | Endothelin-1 (1-31) (Human) (TFA) | Peptides | |
| HY-P4159B | Endothelin-1 (1-31) (Human) (acetate) | Peptides | |
| HY-P4160 | PDC31 | 634586-40-6 | Peptides |
| HY-P4161 | KWWCRW | 292148-25-5 | Peptides |
| HY-P4166 | Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar | 2857963-60-9 | Peptides |
| HY-P4182 | Schistoflrfamide | 121801-61-4 | Peptides |
| HY-P4184 | Isotocin | 550-21-0 | Peptides |
| HY-P4184A | Isotocin (acetate) | Peptides | |
| HY-P4190 | Fsh receptor-binding inhibitor fragment(bi-10) | 163973-98-6 | Peptides |
| HY-P4191 | Met-RANTES (human) | 1883816-50-9 | Peptides |
| HY-P4191A | Met-RANTES (human) (acetate) | Peptides | |
| HY-P4192 | Fomc-Gly-Gly-Phe-Gly-OH | 1817857-75-2 | Peptides |
| HY-P4193 | AH1 | 181272-91-3 | Peptides |
| HY-P4195 | [K15,R16,L27]VIP(1-7)/GRF(8-27) | 201995-58-6 | Peptides |
| HY-P4195A | [K15,R16,L27]VIP(1-7)/GRF(8-27) (acetate) | Peptides | |
| HY-P4196 | Met-Enkephalin-Arg-Phe | 73024-95-0 | Peptides |
| HY-P4198 | Fmoc-N(Me)-Sar10 | 2375600-56-7 | Peptides |
| HY-P4201 | JKC 301 | 136553-96-3 | Peptides |
| HY-P4202 | Suc-Ala-Glu-Pro-Phe-pNA | 128802-76-6 | Dye Reagents |
| HY-P4202A | Suc-Ala-Glu-Pro-Phe-pNA (TFA) | Dye Reagents | |
| HY-P4204 | Ranalexin | 155761-99-2 | Peptides |
| HY-P4205 | Aminopeptidase N Ligand (CD13) NGR peptide | 760947-20-4 | Peptides |
| HY-P4209 | Boc-GRR-AMC | 113866-14-1 | Peptides |
| HY-P4209A | Boc-GRR-AMC (TFA) | Peptides | |
| HY-P4210 | Sulanemadlin | 1451199-98-6 | Peptides |
| HY-P4211 | PSM-β | Peptides | |
| HY-P4217 | Z-Gly-Pro-Arg-AMC (hydrochloride) | 201928-42-9 | Peptides |
| HY-P4222 | IETD-CHO | 886462-83-5 | Peptides |
| HY-P4222A | IETD-CHO (TFA) | Peptides | |
| HY-P4223 | Acetyl neurotensin (8-13) | 74853-69-3 | Peptides |
| HY-P4225 | H-Glu-Tyr-Glu-OH | 32140-46-8 | Peptides |
| HY-P4226 | H-Glu-Val-OH | 5879-06-1 | Peptides |
| HY-P4227A | WRVYEKC(dnp)ALK (tetraTFA) | Peptides | |
| HY-P4228 | (3,5-Diiodo-Tyr1,D-Ala2,N-Me-Phe4,glycinol5)-Enkephalin | 103213-42-9 | Peptides |
| HY-P4229 | ([D8]Val7,10)-C-Peptide (human) | 1802078-41-6 | Isotope-Labeled Compounds |
| HY-P4230 | Glycylalanylglycine | 16422-05-2 | Peptides |
| HY-P4231 | H-Gly-Ala-Hyp-OH | 22028-81-5 | Peptides |
| HY-P4232 | H-Gly-Arg-Ala-Asp-Ser-Pro-OH | 99896-86-3 | Peptides |
| HY-P4233 | H-Gly-Arg-Gly-Asp-Ser-NH2 | 143648-02-6 | Peptides |
| HY-P4234 | H-Gly-Asp-Gly-OH | 10517-27-8 | Peptides |
| HY-P4235 | H-Gly-Cys-Gly-OH | 88440-55-5 | Peptides |
| HY-P4236 | Gly-d-Phe | 34258-14-5 | Peptides |
| HY-P4237 | [8-L-arginine] deaminovasopressin | 25255-33-8 | Peptides |
| HY-P4238 | Biotinyl-ε-aminocaproyl-PPACK | 131104-10-4 | Peptides |
| HY-P4239 | H-AAAAAA-OH | 10576-91-7 | Peptides |
| HY-P4240 | N2-L-Alanylasparagine | 31796-57-3 | Peptides |
| HY-P4241 | Alanyl-D-isoglutamine | 45159-25-9 | Peptides |
| HY-P4242 | Ala-Gly-Ala | 37460-22-3 | Peptides |
| HY-P4243 | Dansyl-Glu-Gly-Arg-Chloromethylketone | 69024-84-6 | Peptides |
| HY-P4243A | Dansyl-Glu-Gly-Arg-Chloromethylketone (TFA) | Peptides | |
| HY-P4244 | Ala-Ser | 3303-41-1 | Peptides |
| HY-P4245 | D-Pro-Phe-Arg-Chloromethylketone | 88546-74-1 | Peptides |
| HY-P4246 | Ala-Trp-Ala | 126310-63-2 | Peptides |
| HY-P4247 | Hexaarginine | 96337-25-6 | Peptides |
| HY-P4248 | H-Gly-Cys-OH | 57281-78-4 | Peptides |
| HY-P4249 | Gly-Gly-Arg | 54944-27-3 | Peptides |
| HY-P4250 | Arg-Arg-Arg-Arg | 26791-46-8 | Peptides |
| HY-P4250A | Arg-Arg-Arg-Arg (acetate) | Peptides | |
| HY-P4251 | Gly-Phe-Gly-Aldehyde semicarbazone | 102579-48-6 | Peptides |
| HY-P4252 | Arginylaspartic acid | 15706-88-4 | Peptides |
| HY-P4253 | Arginyl-Glutamine | 2483-17-2 | Peptides |
| HY-P4254 | H-Gly-Glu-pNA | 201735-59-3 | Peptides |
| HY-P4255 | H-His-Phe-OH | 16874-81-0 | Peptides |
| HY-P4256 | Arg-Glu | 15706-89-5 | Peptides |
| HY-P4257 | L-Isoleucyl-L-arginine | 55715-01-0 | Peptides |
| HY-P4258 | Arg-Gly-Asp-Ser-Pro | 110697-44-4 | Peptides |
| HY-P4259 | Hirullin P18 | 131147-81-4 | Peptides |
| HY-P4260 | LPP Tripeptide | 121305-26-8 | Peptides |
| HY-P4261 | L-Arginylglycine | 2418-67-9 | Peptides |
| HY-P4262 | H-Leu-Trp-OH | 5156-22-9 | Peptides |
| HY-P4263 | Glycylglycylalanine | 19729-30-7 | Peptides |
| HY-P4265 | Arg-His-NH2 | 244765-93-3 | Peptides |
| HY-P4266 | Arginylisoleucine | 62632-70-6 | Peptides |
| HY-P4267 | H-Gly-Gly-Arg-Ser-Pro-Ala-Met-Pro-Glu-OH | 2022956-40-5 | Peptides |
| HY-P4268 | Arg-Leu | 1188-24-5 | Peptides |
| HY-P4269 | Glycylglycylcysteine | 95416-30-1 | Peptides |
| HY-P4270 | Met-Arg-Phe-Ala | 67368-29-0 | Peptides |
| HY-P4271 | H-Gly-Gly-Lys-OH | 10236-53-0 | Peptides |
| HY-P4272 | Tetraproline | 21866-90-0 | Peptides |
| HY-P4273 | H-Gly-Gly-Met-OH | 17343-02-1 | Peptides |
| HY-P4274 | Arginylmethionine | 45243-23-0 | Peptides |
| HY-P4275 | Glycylglycinamide | 20238-94-2 | Peptides |
| HY-P4276 | Arg-Trp | 25615-38-7 | Peptides |
| HY-P4277 | N,S-Bis-Fmoc-Glutathione | 149438-56-2 | Peptides |
| HY-P4277A | N,S-Bis-Fmoc-Glutathione (TFA) | Peptides | |
| HY-P4278 | H-Gly-His-Arg-Pro-NH2 | 209623-54-1 | Peptides |
| HY-P4279 | Ovalbumin (154-159) | 1370698-94-4 | Peptides |
| HY-P4280 | Arg-Tyr | 74863-12-0 | Peptides |
| HY-P4281 | Ovotransferrin (328-332) | 1226776-54-0 | Peptides |
| HY-P4282 | Asn-Val | 145314-87-0 | Peptides |
| HY-P4283 | Glycylhistidylglycine | 7758-33-0 | Peptides |
| HY-P4284 | Z-GGF-CMK | 35172-59-9 | Peptides |
| HY-P4285 | β-Aspartylalanine | 13110-25-3 | Peptides |
| HY-P4286 | H-Gly-Leu-Phe-OH | 103213-38-3 | Peptides |
| HY-P4287 | H-Gly-Lys-Gly-OH | 45214-22-0 | Peptides |
| HY-P4288 | Beta-Asp-His | 20223-80-7 | Peptides |
| HY-P4290 | Antiulcer Agent 2 | 111543-77-2 | Peptides |
| HY-P4291 | Z-Leu-Leu-Tyr-COCHO | 204649-66-1 | Peptides |
| HY-P4292 | H-Gly-Pro-Gly-NH2 | 141497-12-3 | Peptides |
| HY-P4293 | Z-Leu-Tyr-Chloromethylketone | 56979-35-2 | Peptides |
| HY-P4294 | H-Gly-Pro-Gly-OH | 2441-63-6 | Peptides |
| HY-P4295 | Z-Phe-Ala-diazomethylketone | 71732-53-1 | Peptides |
| HY-P4296 | H-Gly-Sar-Sar-OH | 57836-11-0 | Peptides |
| HY-P4297 | Anti-inflammatory agent 37 | 2640-07-5 | Peptides |
| HY-P4299 | Tri-aspartic acid | 107208-63-9 | Peptides |
| HY-P4300 | H-Gly-Trp-Gly-OH | 23067-32-5 | Peptides |
| HY-P4301 | Di-aspartic acid | 58471-53-7 | Peptides |
| HY-P4302 | Z-FK-ck | 118253-05-7 | Peptides |
| HY-P4303 | H-Gly-Trp-βNA | 164802-32-8 | Peptides |
| HY-P4305 | Asp-Lys | 5891-51-0 | Peptides |
| HY-P4306 | Z-Phe-Phe-Diazomethylketone | 65178-14-5 | Peptides |
| HY-P4307 | Antioxidant agent-9 | 71835-79-5 | Peptides |
| HY-P4308 | Z-Pro-Pro-aldehyde-dimethyl acetal | 170116-63-9 | Peptides |
| HY-P4309 | H-Gly-Tyr-Gly-OH | 6099-08-7 | Peptides |
| HY-P4310 | Boc-Val-Leu-Lys-AMC | 73554-84-4 | Peptides |
| HY-P4311 | H-His-Glu-OH | 53634-28-9 | Peptides |
| HY-P4312 | Boc-Leu-Lys-Arg-AMC | 109358-47-6 | Peptides |
| HY-P4313 | Asp-Val | 13433-04-0 | Peptides |
| HY-P4314 | Boc-Gly-Lys-Arg-AMC | 109358-48-7 | Peptides |
| HY-P4315 | Histidylmethionine | 2488-11-1 | Peptides |
| HY-P4316 | Cys(NPys)-D{Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg}-NH2 | 1676104-79-2 | Peptides |
| HY-P4317 | H-His-Trp-OH | 23403-90-9 | Peptides |
| HY-P4318 | HHV-2 Envelope Glycoprotein G (552-574) | 2022956-63-2 | Peptides |
| HY-P4319 | Boc-Glu-Lys-Lys-AMC | 73554-85-5 | Peptides |
| HY-P4320 | Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge:cys1-cys10) | 166184-23-2 | Peptides |
| HY-P4321 | H-Ile-His-OH | 97284-12-3 | Peptides |
| HY-P4322 | H-Ile-Lys-Val-Ala-Val-OH | 131167-89-0 | Peptides |
| HY-P4323 | Boc-Gln-Arg-Arg-AMC | 109376-05-8 | Peptides |
| HY-P4323A | Boc-Gln-Arg-Arg-AMC (acetate) | 2223665-74-3 | Peptides |
| HY-P4324 | Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 | 110590-61-9 | Peptides |
| HY-P4325 | Hirudin (55-65) (sulfated) | 109528-50-9 | Peptides |
| HY-P4326 | Boc-Val-Pro-Arg-AMC | 65147-04-8 | Peptides |
| HY-P4327 | Hispidalin | 2243219-67-0 | Peptides |
| HY-P4331 | Boc-Gln-Gly-Arg-AMC | 113865-85-3 | Peptides |
| HY-P4332 | Boc-Glu(OBzl)-Ala-Arg-AMC | 113866-16-3 | Peptides |
| HY-P4333 | Boc-Glu(OBzl)-Gly-Arg-AMC | 73554-94-6 | Peptides |
| HY-P4334 | Bz-RGFFL-4MβNA | 99112-24-0 | Peptides |
| HY-P4335 | Bz-RGFFP-4MβNA | 782432-03-5 | Peptides |
| HY-P4336 | Dansyl-Ala-Arg | 87687-46-5 | Peptides |
| HY-P4337 | Dansyl-Gly-Cys-Val-Leu-Ser | 143744-88-1 | Peptides |
| HY-P4337A | Dansyl-Gly-Cys-Val-Leu-Ser (TFA) | Peptides | |
| HY-P4338 | Glutaryl-Gly-Arg-AMC | 65147-16-2 | Peptides |
| HY-P4339 | Ala-Phe-Lys-AMC | 120928-02-1 | Peptides |
| HY-P4340 | Arg-Arg-AMC | 263843-55-6 | Peptides |
| HY-P4340A | Arg-Arg-AMC (acetate) | Peptides | |
| HY-P4341 | D-Val-Leu-Lys-AMC | 148168-23-4 | Peptides |
| HY-P4342 | Gly-Arg-AMC | 65147-19-5 | Peptides |
| HY-P4343 | Lys(Abz)-Pro-Pro-pNA | 219138-18-8 | Peptides |
| HY-P4344 | Met-Gly-Pro-AMC | 1926163-52-1 | Peptides |
| HY-P4345 | Pro-Arg-AMC | 546103-85-9 | Peptides |
| HY-P4346 | MeOSuc-Ala-Ala-Pro-Met-AMC | 201853-55-6 | Peptides |
| HY-P4347 | MeOSuc-Ala-Phe-Lys-AMC (TFA) | 201853-92-1 | Peptides |
| HY-P4348 | MeOSuc-Gly-Leu-Phe-AMC | 201854-05-9 | Peptides |
| HY-P4349 | Pyr-Arg-Thr-Lys-Arg-AMC | 155575-02-3 | Peptides |
| HY-P4349A | Pyr-Arg-Thr-Lys-Arg-AMC (TFA) | 1255501-99-5 | Peptides |
| HY-P4350 | Suc-Ala-Ala-Ala-AMC | 73617-90-0 | Peptides |
| HY-P4351 | HIV-1 gag Protein p24 (194-210) | 141281-67-6 | Peptides |
| HY-P4352 | HIV-2 Peptide | 172486-63-4 | Peptides |
| HY-P4353 | D-{Ala-Ala-Ala} | 1114-94-9 | Peptides |
| HY-P4354 | D-{Met-Met} | 89680-20-6 | Peptides |
| HY-P4355 | D-Ala-Ala | 1115-78-2 | Peptides |
| HY-P4356 | D-Met-Met | 89680-17-1 | Peptides |
| HY-P4357 | D-{Ala-Ala-Ala-Ala-Ala} | 10491-09-5 | Peptides |
| HY-P4358 | LAAVSDLNPNAPR | 415684-36-5 | Peptides |
| HY-P4359 | Suc-AEPF-AMC | 142997-30-6 | Peptides |
| HY-P4360 | Suc-Ala-Phe-Lys-AMC | 73207-91-7 | Peptides |
| HY-P4361 | Suc-Ala-Phe-Pro-Phe-pNA | 128802-73-3 | Peptides |
| HY-P4362 | Suc-Ala-Pro-Ala-AMC | 88467-44-1 | Peptides |
| HY-P4363 | Suc-GPLGP-AMC | 72698-36-3 | Peptides |
| HY-P4364 | Suc-Phe-Leu-Phe-4MβNA | 201982-89-0 | Peptides |
| HY-P4365 | D-Pro-Pro-Glu | 1021646-82-1 | Peptides |
| HY-P4366 | Tos-Gly-Pro-Lys-AMC | 128202-25-5 | Peptides |
| HY-P4367 | TRH-AMC | 190836-86-3 | Peptides |
| HY-P4368 | Z-APF-CMK | 217658-18-9 | Peptides |
| HY-P4369 | Z-Arg-Arg-AMC | 88937-61-5 | Peptides |
| HY-P4370 | Hepcidin-20 (human) | 342790-23-2 | Peptides |
| HY-P4371 | Hel 13-5 | 177942-21-1 | Peptides |
| HY-P4371A | Hel 13-5 (TFA) | Peptides | |
| HY-P4372 | Hepcidin-22 (human) | 342790-22-1 | Peptides |
| HY-P4373 | Hepcidin-1 (mouse) | 1676104-75-8 | Peptides |
| HY-P4373A | Hepcidin-1 (mouse) (TFA) | Peptides | |
| HY-P4374 | H-Leu-Asn-OH | 14608-81-2 | Peptides |
| HY-P4375 | Gln-Glu | 88830-90-4 | Peptides |
| HY-P4376 | Gamma-Glu-Abu | 16869-42-4 | Peptides |
| HY-P4376A | Gamma-Glu-Abu (TFA) | Peptides | |
| HY-P4377 | H-Leu-Asp-OH | 32949-40-9 | Peptides |
| HY-P4378 | H-Leu-Gly-βNA | 100930-00-5 | Peptides |
| HY-P4379 | Gamma-Glu-D-Glu | 6931-86-8 | Peptides |
| HY-P4381 | γ-Glu-Gly-Gly | 13640-39-6 | Peptides |
| HY-P4382 | H-Leu-His-OH | 38062-72-5 | Peptides |
| HY-P4383 | H-Leu-Leu-Ala-OH | 20274-80-0 | Peptides |
| HY-P4384 | H-Leu-Ser-OH | 6209-12-7 | Peptides |
| HY-P4385 | (Asn10,Leu11,D-Trp12)-pTH-Related Protein (7-34) amide (human, mouse, rat) | 129622-68-0 | Peptides |
| HY-P4386 | (Asp28)-Exenatide | 1678417-24-7 | Peptides |
| HY-P4387 | H-Leu-Ser-Phe-OH | 40290-77-5 | Peptides |
| HY-P4388 | Z-Arg-Leu-Arg-Gly-Gly-AMC | 167698-69-3 | Peptides |
| HY-P4388A | Z-Arg-Leu-Arg-Gly-Gly-AMC (acetate) | Peptides | |
| HY-P4389 | (Asp28)-Glucagon (1-29) (human, rat, porcine) | 1037751-81-7 | Peptides |
| HY-P4390 | Z-Leu-Leu-Arg-AMC | 90468-17-0 | Peptides |
| HY-P4391 | (Asp37)-Amyloid β-Protein (1-42) | 1875128-79-2 | Peptides |
| HY-P4392 | Z-VAD-AMC | 219137-91-4 | Peptides |
| HY-P4393 | H-Leu-Trp-Met-Arg-OH | 67368-23-4 | Peptides |
| HY-P4395 | (Asp76)-pTH (39-84) (human) | 79804-72-1 | Peptides |
| HY-P4396 | H-Lys-Arg-OH | 29586-66-1 | Peptides |
| HY-P4397 | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin | 115499-13-3 | Peptides |
| HY-P4398 | (Cys(Acm)6,12)-Orexin A (human, mouse, rat) | 2022974-96-3 | Peptides |
| HY-P4399 | Z-Gly-Gly-Leu-AMC | 97792-39-7 | Peptides |
| HY-P4400 | Z-VDVAD-AFC | 219138-08-6 | Peptides |
| HY-P4401 | Z-VEID-AFC | 219138-06-4 | Peptides |
| HY-P4402 | D-Ile-Phe-Lys-pNA | 76626-41-0 | Peptides |
| HY-P4403 | Z-DEVD-R110 | 223538-61-2 | Peptides |
| HY-P4404 | Abz-GIVRAK(Dnp) | 827044-38-2 | Peptides |
| HY-P4405 | (D-Ala2)-GRF (1-29) amide (human) | 89453-59-8 | Peptides |
| HY-P4406 | Abz-AGLA-Nba | 100307-95-7 | Peptides |
| HY-P4407 | (D-Asn28)-Exenatide | 2022972-66-1 | Peptides |
| HY-P4408 | Ac-Arg-Gly-Lys-AMC | 660846-99-1 | Peptides |
| HY-P4409 | (Des-Ala3)-GHRP-2 | 290312-22-0 | Peptides |
| HY-P4410 | (D-Asp28)-Exenatide | 2022972-67-2 | Peptides |
| HY-P4411 | (Des-acetyl)-α-MSH | 53697-27-1 | Peptides |
| HY-P4412 | H-Lys-Asp-OH | 20556-18-7 | Peptides |
| HY-P4413 | (Des-Glu5)-ACTH (1-24) (human, bovine, rat) | 1815617-95-8 | Peptides |
| HY-P4414 | (Des-Bromo)-Neuropeptide B (1-23) (human) | 434897-64-0 | Peptides |
| HY-P4415 | H-Lys-Gly-OH | 7563-03-3 | Peptides |
| HY-P4416 | Ac-Gly-Ala-Lys(Ac)-AMC | 577969-56-3 | Peptides |
| HY-P4417 | Ac-IEPD-AMC | 216757-33-4 | Peptides |
| HY-P4417A | Ac-IEPD-AMC (TFA) | Peptides | |
| HY-P4419 | Boc-Asp(OBzl)-Pro-Arg-AMC | 113866-00-5 | Peptides |
| HY-P4419A | Boc-Asp(OBzl)-Pro-Arg-AMC (acetate) | Peptides | |
| HY-P4420 | H-Lys-Trp-OH | 50674-18-5 | Peptides |
| HY-P4423 | H-Lys-Val-OH | 20556-11-0 | Peptides |
| HY-P4424 | H-Met-Arg-OH | 60461-10-1 | Peptides |
| HY-P4425 | Gly-Phe-AMC | 201852-70-2 | Peptides |
| HY-P4426 | Lys-Pro-AMC | 133066-53-2 | Peptides |
| HY-P4426A | Lys-Pro-AMC (diTFA) | Peptides | |
| HY-P4427 | Z-VAN-AMC | 245036-58-2 | Peptides |
| HY-P4428 | Z-Val-Lys-Met-AMC | 141223-71-4 | Peptides |
| HY-P4428A | Z-Val-Lys-Met-AMC (TFA) | Peptides | |
| HY-P4429 | Z-YVAD-AFC | 201608-13-1 | Peptides |
| HY-P4430 | H-Met-Asn-OH | 36261-61-7 | Peptides |
| HY-P4431 | H-Met-Asp-OH | 14595-65-4 | Peptides |
| HY-P4432 | (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (salmon) | 88848-87-7 | Peptides |
| HY-P4433 | H-Met-D-Met-OH | 89680-18-2 | Peptides |
| HY-P4434 | H-Met-Glu-OH | 14517-44-3 | Peptides |
| HY-P4435 | H-Met-His-OH | 14486-12-5 | Peptides |
| HY-P4436 | H-Met-Lys-OH | 45214-88-8 | Peptides |
| HY-P4437 | H-Met-Phe-OH | 14492-14-9 | Peptides |
| HY-P4438 | H-Met-Thr-OH | 40883-16-7 | Peptides |
| HY-P4439 | H-Met-Val-OH | 14486-13-6 | Peptides |
| HY-P4440 | (Des-Gly10,Des-Ser4,D-Leu6,Pro-NHEt9)-LHRH | 267878-61-5 | Peptides |
| HY-P4441 | (Des-Gly10,D-His2,D-His(Bzl)6,Pro-NHEt9)-LHRH | 134009-10-2 | Peptides |
| HY-P4442 | (Des-Gly10,D-His2,D-Trp6,Pro-NHEt9)-LHRH | 1872435-01-2 | Peptides |
| HY-P4443 | Ac-GAK-AMC | 1926163-46-3 | Peptides |
| HY-P4445 | (Des-Gly10,D-Leu6,Orn8,Pro-NHEt9)-LHRH | 1051970-61-6 | Peptides |
| HY-P4447 | (Des-Gly10,D-Pyr1,D-Leu6,Pro-NHEt9)-LHRH | 1926163-26-9 | Peptides |
| HY-P4448 | Ac-Gly-Pro-AFC | 886993-02-8 | Peptides |
| HY-P4449 | Ac-VRPR-AMC | 919515-51-8 | Peptides |
| HY-P4449A | Ac-VRPR-AMC (TFA) | Peptides | |
| HY-P4450 | Homoglutathione | 18710-27-5 | Peptides |
| HY-P4451 | TRAP-5 amide | 141923-41-3 | Peptides |
| HY-P4452 | PRL 2915 | 209006-18-8 | Peptides |
| HY-P4453 | Boc-Ala-Ala-Asp-pNA | 201732-83-4 | Peptides |
| HY-P4454 | Goserelin EP Impurity E | 147688-42-4 | Peptides |
| HY-P4455 | Boc-AAG-pNA | 90037-94-8 | Peptides |
| HY-P4456 | (Des-His6)-ACTH (1-24) (human, bovine, rat) | 1926163-11-2 | Peptides |
| HY-P4457 | Leuprolide Acetate EP Impurity D | 1926163-25-8 | Peptides |
| HY-P4458 | Boc-QAR-pNA | 1926163-47-4 | Peptides |
| HY-P4459 | (Des-Gly2)-Exenatide | 1678416-78-8 | Peptides |
| HY-P4460 | AAA-pNA | 60354-61-2 | Peptides |
| HY-P4461 | Ala-Ala-Pro-pNA | 99524-09-1 | Peptides |
| HY-P4462 | D-Leu-Thr-Arg-pNA | 122630-72-2 | Peptides |
| HY-P4463 | (Des-Pyr1)-LHRH | 38280-53-4 | Peptides |
| HY-P4464 | Ala-Phe-Pro-pNA | 201732-35-6 | Peptides |
| HY-P4464A | Ala-Phe-Pro-pNA (TFA) | Peptides | |
| HY-P4465 | Gly-Arg-pNA | 103192-40-1 | Peptides |
| HY-P4466 | Arg-Val-(Nle-p-nitro)-Phe-Glu-Ala-Nle-NH2 | 130877-92-8 | Peptides |
| HY-P4467 | (Des-Pyr1,Des-Gly10,D-Leu6,Pro-NHEt9)-LHRH | 1642799-35-6 | Peptides |
| HY-P4468 | Lys-Ala-pNA | 115846-24-7 | Peptides |
| HY-P4469 | PRL 3195 | 341519-04-8 | Peptides |
| HY-P4470 | Phe-Pro-Ala-pNA | 201738-99-0 | Peptides |
| HY-P4471 | p-Hydroxyhippuryl-His-Leu | 77697-23-5 | Peptides |
| HY-P4472 | H-Phe-Asp-OH | 22828-05-3 | Peptides |
| HY-P4473 | H-Phe-Ile-OH | 22951-94-6 | Peptides |
| HY-P4474 | Pz-Pro-Leu-Gly-Pro-d-Arg | 17011-78-8 | Peptides |
| HY-P4475 | Sar-Pro-Arg-pNA | 77695-30-8 | Peptides |
| HY-P4476 | Suc-AAPA-pNA | 72682-69-0 | Peptides |
| HY-P4477 | Suc-AAPR-pNA | 131068-47-8 | Peptides |
| HY-P4478 | H-Phe-Met-OH | 15080-84-9 | Peptides |
| HY-P4479 | H-Phe-Phe-Phe-OH | 2578-81-6 | Peptides |
| HY-P4480 | H-Phe-Phe-Phe-Phe-OH | 2667-02-9 | Peptides |
| HY-P4481 | H-Phe-Phe-Phe-Phe-Phe-OH | 65757-10-0 | Peptides |
| HY-P4482 | Suc-AAPE-pNA | 108929-37-9 | Peptides |
| HY-P4483 | H-Pro-Arg-OH | 2418-74-8 | Peptides |
| HY-P4484 | Suc-AAPK-pNA | 108929-39-1 | Peptides |
| HY-P4485 | H-Pro-Asn-OH | 107856-82-6 | Peptides |
| HY-P4486 | H-Pro-Gly-Pro-OH | 7561-51-5 | Peptides |
| HY-P4487 | H-Pro-Pro-Asp-NH2 | 850440-85-6 | Peptides |
| HY-P4488 | H-Pro-Pro-Gln-OH | 856170-98-4 | Peptides |
| HY-P4489 | Suc-AAPM-pNA | 72682-73-6 | Peptides |
| HY-P4490 | Suc-Ala-Pro-pNA | 95632-46-5 | Peptides |
| HY-P4491 | Suc-Leu-Leu-Val-Tyr-pNA | 1926163-44-1 | Peptides |
| HY-P4492 | Suc-Phe-Leu-Phe-SBzl | 80651-94-1 | Peptides |
| HY-P4493 | (Des-Ser3)-ACTH (1-24) (human, bovine, rat) | 1926163-12-3 | Peptides |
| HY-P4494 | Suc-Val-Pro-Phe-pNA | 95192-11-3 | Peptides |
| HY-P4495 | H-Pro-Pro-Pro-OH | 19285-44-0 | Peptides |
| HY-P4496 | Tos-Gly-Pro-Lys-pNA | 73392-19-5 | Peptides |
| HY-P4497 | Prolylserine | 71835-80-8 | Peptides |
| HY-P4498 | Z-Ala-Pro-pNA | 66382-56-7 | Peptides |
| HY-P4499 | H-Ser-Ala-OH | 6403-17-4 | Peptides |
| HY-P4500 | Z-Arg-Arg-pNA | 122630-71-1 | Peptides |
| HY-P4501 | H-Ser-Asp-OH | 2543-31-9 | Peptides |
| HY-P4502 | (Des-Thr5)-Glucagon | 1802078-27-8 | Peptides |
| HY-P4503 | (D-His1)-Exenatide | 1678417-09-8 | Peptides |
| HY-P4504 | (Des-Thr7)-Glucagon | 1802078-28-9 | Peptides |
| HY-P4505 | H-Ser-Gln-OH | 94421-66-6 | Peptides |
| HY-P4508 | SIGSLAK | 115918-58-6 | Peptides |
| HY-P4509 | H-Ser-Phe-OH | 16875-28-8 | Peptides |
| HY-P4510 | SLSLSPG | 943235-75-4 | Peptides |
| HY-P4511 | Serylleucine | 6665-16-3 | Peptides |
| HY-P4512 | H-Ser-Ser-OH | 6620-95-7 | Peptides |
| HY-P4513 | H-Ser-Ser-Ser-OH | 6620-98-0 | Peptides |
| HY-P4514 | Z-Gly-Gly-Arg-βNA | 17278-97-6 | Peptides |
| HY-P4515 | Z-Phe-Arg-pNA | 117761-01-0 | Peptides |
| HY-P4516 | Z-Phe-Leu-Glu-pNA | 104634-10-8 | Peptides |
| HY-P4517 | Z-Tyr-Lys-Arg-pNA | 108318-36-1 | Peptides |
| HY-P4518 | Z-Val-Gly-Arg-pNA | 78333-16-1 | Peptides |
| HY-P4519 | Ac-Lys(Ac)-D-Ala-D-Lactic acid | 65882-12-4 | Peptides |
| HY-P4520 | (Trp4)-Kemptide | 80224-16-4 | Peptides |
| HY-P4521 | Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt | 99828-55-4 | Peptides |
| HY-P4522 | Bz-Ala-Arg | 71448-11-8 | Peptides |
| HY-P4522A | Bz-Ala-Arg (TFA) | Peptides | |
| HY-P4523 | FA-Ala-Arg | 76079-06-6 | Peptides |
| HY-P4524 | FA-Phe-Phe | 83661-95-4 | Peptides |
| HY-P4525 | Ala-Ala-Ala-Ala | 926-79-4 | Peptides |
| HY-P4526 | Ala-Ala-OMe | 24326-09-8 | Peptides |
| HY-P4527 | Ala-Ala-βNA | 20724-07-6 | Peptides |
| HY-P4528 | Ala-Phe-Pro-βNA | 749831-27-4 | Peptides |
| HY-P4529 | β-Asp-Leu | 14650-26-1 | Peptides |
| HY-P4530 | D-Ala-Gly-Gly-OH | 77286-90-9 | Peptides |
| HY-P4531 | H-Ser-Tyr-OH | 21435-27-8 | Peptides |
| HY-P4532 | Ac-Leu-Val-Lys-Aldehyde | 147600-40-6 | Peptides |
| HY-P4533 | H-Thr-Ala-OH | 56217-50-6 | Peptides |
| HY-P4534 | (D-His2,D-Trp6)-LHRH | 321709-34-6 | Peptides |
| HY-P4535 | Ac-Trp-Glu-His-Asp-Aldehyde | 189275-71-6 | Peptides |
| HY-P4536 | (D-Leu6)-LHRH (1-8) | 112642-14-5 | Peptides |
| HY-P4537 | H-Thr-Arg-OH | 13448-26-5 | Peptides |
| HY-P4538 | (D-Leu6,Pro-NHEt9)-LHRH (4-9) | 202333-85-5 | Peptides |
| HY-P4539 | H-Thr-Asp-OH | 108320-97-4 | Peptides |
| HY-P4540 | (D-Leu7)-LHRH | 53728-75-9 | Peptides |
| HY-P4541 | (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) | 124199-90-2 | Peptides |
| HY-P4542 | (D-Phe12,Nle21,38,α-Me-Leu37)-CRF (12-41) (human, rat) | 150646-45-0 | Peptides |
| HY-P4543 | HIV-IN petide | 167875-35-6 | Peptides |
| HY-P4544 | Z-Val-Arg-Pro-DL-Arg-Fluoromethylketone | 1926163-57-6 | Peptides |
| HY-P4545 | Abz-Gly-p-nitro-Phe-Pro-OH | 67482-93-3 | Peptides |
| HY-P4546 | Abz-Ser-Pro-3-nitro-Tyr | 553644-01-2 | Peptides |
| HY-P4547 | Ac-Trp-Glu-His-Asp-AMC | 189275-74-9 | Peptides |
| HY-P4548 | Boc-Arg-Val-Arg-Arg-AMC (hydrochloride) | 136132-77-9 | Peptides |
| HY-P4549 | H-D-Ala-D-Ala-D-Ala-D-Ala-OH | 926-78-3 | Peptides |
| HY-P4550 | H-Hyp-Gly-OH | 7672-35-7 | Peptides |
| HY-P4551 | Hippuryl-His-Leu-OH | 31373-65-6 | Peptides |
| HY-P4552 | Hippuryl-Phe-Arg-OH | 73167-83-6 | Peptides |
| HY-P4553 | H-Met-Pro-OH | 59227-86-0 | Peptides |
| HY-P4554 | H-Phe-Arg-OH | 1238-09-1 | Peptides |
| HY-P4555 | (D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide | 340821-13-8 | Peptides |
| HY-P4556 | H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe | 50572-79-7 | Peptides |
| HY-P4557 | H-Phe-Leu-Glu-Glu-Leu-OH | 69729-06-2 | Peptides |
| HY-P4558 | H-Pro-Lys-OH | 71227-70-8 | Peptides |
| HY-P4558A | H-Pro-Lys-OH (TFA) | Peptides | |
| HY-P4559 | H-Pro-Met-OH | 52899-08-8 | Peptides |
| HY-P4560 | H-Pro-Phe-OH | 13589-02-1 | Peptides |
| HY-P4561 | H-Pro-Thr-Glu-Phe-p-nitro-Phe-Arg-Leu-OH | 90331-82-1 | Peptides |
| HY-P4562 | (D-Phe7)-Somatostatin-14 | 64813-74-7 | Peptides |
| HY-P4563 | (D-Ser4)-LHRH | 103065-82-3 | Peptides |
| HY-P4564 | (D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH | 1926163-38-3 | Peptides |
| HY-P4565 | Phe-Arg-Arg-Gly | 642080-61-3 | Peptides |
| HY-P4566 | H-Pro-Val-OH | 52899-09-9 | Peptides |
| HY-P4567 | (D-Ser4,D-Trp6)-LHRH | 102992-39-2 | Peptides |
| HY-P4568 | (D-Ser4,D-Ser(tBu)6,Azagly10)-LHRH | 1926163-39-4 | Peptides |
| HY-P4569 | H-Ser-Pro-OH | 23827-93-2 | Peptides |
| HY-P4570 | (D-Ser6,Azagly10)-LHRH | 65807-03-6 | Peptides |
| HY-P4571 | (D-Trp6)-LHRH (1-6) amide | 1217367-73-1 | Peptides |
| HY-P4572 | (D-Trp6)-LHRH (free acid) | 129418-54-8 | Peptides |
| HY-P4573 | (D-Trp6)-LHRH (2-10) | 108787-46-8 | Peptides |
| HY-P4574 | VPLSLYSG | 425632-67-3 | Peptides |
| HY-P4575 | (D-Trp6)-LHRH-Leu-Arg-Pro-Gly amide | 1926163-16-7 | Peptides |
| HY-P4576 | Methoxycarbonyl-D-Nle-Gly-Arg-pNA | 104186-68-7 | Peptides |
| HY-P4577 | (D-Tyr5,D-Ser(tBu)6,Azagly10)-LHRH | 1426173-74-1 | Peptides |
| HY-P4578 | (D-Trp6,D-Leu7)-LHRH | 321709-37-9 | Peptides |
| HY-P4579 | Pyr-Phe-OH | 21282-12-2 | Peptides |
| HY-P4580 | Suc-Ala-Ala-Pro-Phe-SBzl | 80651-95-2 | Peptides |
| HY-P4581 | Suc-Ala-Leu-Pro-Phe-pNA | 128802-78-8 | Peptides |
| HY-P4582 | Suc-Phe-Ala-Ala-Phe-pNA | 110906-89-3 | Peptides |
| HY-P4583 | Suc-Val-Pro-Phe-SBzl | 95192-51-1 | Peptides |
| HY-P4584 | TRH-βNA | 73644-58-3 | Peptides |
| HY-P4585 | (Gln22)-Amyloid β-Protein (1-42) | 147335-12-4 | Peptides |
| HY-P4586 | (D-Tyr5,D-Trp6)-LHRH | 321709-35-7 | Peptides |
| HY-P4587 | (Glu13,17,20)-Osteocalcin (1-46) (mouse) | 1802086-27-6 | Peptides |
| HY-P4588 | (Glu17,21,24)-Osteocalcin (1-49) (human) | 1927927-11-4 | Peptides |
| HY-P4590 | (Glu20)-Glucagon (1-29) (human, rat, porcine) | 2022956-46-1 | Peptides |
| HY-P4592 | (Glu24)-Glucagon (1-29) (human, rat, porcine) | 308356-99-2 | Peptides |
| HY-P4593 | Z-Gly-Pro-Arg-4MβNA | 66647-41-4 | Peptides |
| HY-P4594 | Z-Phe-His-Leu | 28458-19-7 | Peptides |
| HY-P4595 | H-Glu-Tyr-OH | 3422-39-7 | Peptides |
| HY-P4596 | H-Gly-Arg-OH | 18635-55-7 | Peptides |
| HY-P4596S | H-Gly-Arg-OH (Arg-13C6,15N4) | Isotope-Labeled Compounds | |
| HY-P4596S1 | H-Gly-Arg-OH (Arg-13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-P4597 | (H-Cys-Phe-OH)2 (disulfide bond) | 62130-80-7 | Peptides |
| HY-P4598 | H-His-Asp-OH | 41658-60-0 | Peptides |
| HY-P4599 | H-His-His-OH | 306-14-9 | Peptides |
| HY-P4600 | H-Ala-Arg-OH | 16709-12-9 | Peptides |
| HY-P4601 | β-Asp-Phe | 13433-10-8 | Peptides |
| HY-P4601A | β-Asp-Phe (TFA) | Peptides | |
| HY-P4602 | (H-Cys-Tyr-OH)2 | 7369-94-0 | Peptides |
| HY-P4603 | H-Asp-Ala-OH | 13433-02-8 | Peptides |
| HY-P4604 | H-His-Lys-OH | 37700-85-9 | Peptides |
| HY-P4605 | (Ile8)-Oxytocin | 362-39-0 | Peptides |
| HY-P4605A | (Ile8)-Oxytocin (acetate) | Peptides | |
| HY-P4606 | (Ile5,Trp23,Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat) | 181057-31-8 | Peptides |
| HY-P4607 | H-Lys-Ala-OH | 17043-71-9 | Peptides |
| HY-P4608 | H-Phe-Ser-OH | 16053-39-7 | Peptides |
| HY-P4609 | H-Pro-Trp-OH | 35310-39-5 | Peptides |
| HY-P4610 | H-Trp-Tyr-OH | 19653-76-0 | Peptides |
| HY-P4611 | Z-Pro-Ala | 14030-00-3 | Peptides |
| HY-P4612 | Z-Pro-Pro | 7360-23-8 | Peptides |
| HY-P4614 | (Lys(Ac)5,8,12,16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) | 2022956-65-4 | Peptides |
| HY-P4615 | Cyclo(-Glu-Glu) | 16691-00-2 | Peptides |
| HY-P4616 | (Lys(Ac)12)-Histone H4 (1-21)-Gly-Gly-Lys(biotinyl) | 2022956-66-5 | Peptides |
| HY-P4617 | Cyclo(-Leu-Phe) | 7280-77-5 | Peptides |
| HY-P4619 | H-Thr-Glu-OH | 54532-73-9 | Peptides |
| HY-P4620 | (Lys(Me)24)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) | 2022956-70-1 | Peptides |
| HY-P4621 | Ala-Ala-Gln | 290312-62-8 | Peptides |
| HY-P4622 | H-Thr-Gly-OH | 686-44-2 | Peptides |
| HY-P4623 | Penta-alanine | 10183-34-3 | Peptides |
| HY-P4624 | H-Thr-Met-OH | 90729-28-5 | Peptides |
| HY-P4625 | Ala-d-Gln | 281660-34-2 | Peptides |
| HY-P4626 | H-Thr-Phe-OH | 16875-27-7 | Peptides |
| HY-P4627 | (Lys(Me)29)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) | 1622085-04-4 | Peptides |
| HY-P4628 | TPNQRQNVC | 2022956-41-6 | Peptides |
| HY-P4629 | d-Ala-Gln | 205252-36-4 | Peptides |
| HY-P4630 | H-Thr-Pro-OH | 46398-79-2 | Peptides |
| HY-P4631 | Tryptophylalanine | 24046-71-7 | Peptides |
| HY-P4632 | H-γ-Glu-Leu-OH | 2566-39-4 | Peptides |
| HY-P4633 | γ-Glu-Tyr | 7432-23-7 | Peptides |
| HY-P4634 | (Lys(Me)327)-Histone H3 (21-44)-Gly-Lys(biotinyl) | 2022956-67-6 | Peptides |
| HY-P4635 | H-Trp-Arg-OH | 88831-09-8 | Peptides |
| HY-P4636 | (Lys(Me)34)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide | 2022956-71-2 | Peptides |
| HY-P4637 | Ile-Phe | 22951-98-0 | Peptides |
| HY-P4638 | (Lys(Me)39)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide | 2022956-73-4 | Peptides |
| HY-P4639 | H-Trp-Asn-OH | 175027-11-9 | Peptides |
| HY-P4640 | (Lys22)-Amyloid β-Protein (1-42) | 383200-59-7 | Peptides |
| HY-P4641 | H-Trp-Phe-OH | 6686-02-8 | Peptides |
| HY-P4643 | H-Trp-Met-OH | 21438-63-1 | Peptides |
| HY-P4644 | Tryptophylleucine | 13123-35-8 | Peptides |
| HY-P4645 | Mca-Pro-Leu | 140430-55-3 | Peptides |
| HY-P4646 | N-L-Tryptophylserine | 133101-40-3 | Peptides |
| HY-P4647 | Tryptophyltryptophan | 20696-60-0 | Peptides |
| HY-P4648 | H-Trp-Trp-Trp-OH | 59005-82-2 | Peptides |
| HY-P4650 | Tyrosylhistidine | 3788-44-1 | Peptides |
| HY-P4651 | H-Tyr-Ile-Gly-Ser-Arg-NH2 | 110590-65-3 | Peptides |
| HY-P4652 | H-Tyr-Ile-OH | 40829-32-1 | Peptides |
| HY-P4653 | YLADGDLHSDGPGR | 415684-38-7 | Peptides |
| HY-P4654 | H-Tyr-Lys-OH | 54925-88-1 | Peptides |
| HY-P4655 | Tyrosyltryptophan | 60815-41-0 | Peptides |
| HY-P4656 | Tyrosylvaline | 17355-09-8 | Peptides |
| HY-P4657 | Human Growth Hormone (1-43) | 96827-07-5 | Peptides |
| HY-P4658 | H-Val-Ala-pNA | 87810-63-7 | Peptides |
| HY-P4659 | H-Val-Arg-OH | 37682-75-0 | Peptides |
| HY-P4660 | H-Val-Asp-OH | 20556-16-5 | Peptides |
| HY-P4661 | H-Val-Gln-OH | 42854-54-6 | Peptides |
| HY-P4662 | Valylglutamic acid | 3062-07-5 | Peptides |
| HY-P4663 | Val-Gly-Ser-Glu | 61756-22-7 | Peptides |
| HY-P4664 | VHLTP | 93913-38-3 | Peptides |
| HY-P4666 | Valylhistidine | 13589-07-6 | Peptides |
| HY-P4667 | VLHDDLLEA | 204931-32-8 | Peptides |
| HY-P4668 | Valylleucine | 3989-97-7 | Peptides |
| HY-P4668A | Valylleucine (TFA) | 27530-02-5 | Peptides |
| HY-P4669 | LM-030 | 1122484-55-2 | Peptides |
| HY-P4670 | L-Valine p-nitroanilide | 52084-13-6 | Peptides |
| HY-P4671 | Nle-Arg-Phe-NH2 (acetate) | 104809-29-2 | Peptides |
| HY-P4672 | (Met(O)27)-Glucagon (1-29) (human, rat, porcine) | 75217-63-9 | Peptides |
| HY-P4673 | (Nle8,18,Tyr34)-pTH (1-34) (human) | 78041-34-6 | Peptides |
| HY-P4675 | LHRH (free acid) | 35263-73-1 | Peptides |
| HY-P4676 | Lys-(Des-Arg9,Leu8)-Bradykinin | 71800-37-8 | Peptides |
| HY-P4677 | GP100 (209–217) | 162558-10-3 | Peptides |
| HY-P4678 | (Phe2,Orn8)-Oxytocin | 2480-41-3 | Peptides |
| HY-P4678A | (Phe2,Orn8)-Oxytocin (acetate) | Peptides | |
| HY-P4679 | (N-Me-Tyr1,N-Me-Arg7,D-Leu-NHEt8)-Dynorphin A (1-8) | 103613-84-9 | Peptides |
| HY-P4680 | (Phe13,Tyr19)-MCH (human, mouse, rat) | 160201-86-5 | Peptides |
| HY-P4681 | (Phe2,Nle4)-ACTH (1-24) (human, bovine, rat) | 97773-00-7 | Peptides |
| HY-P4682 | Neuromedin U-25 (porcine) | 98395-76-7 | Peptides |
| HY-P4683 | (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin | 129520-65-6 | Peptides |
| HY-P4683A | (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin (acetate) | Peptides | |
| HY-P4684 | Osteostatin | 138949-73-2 | Peptides |
| HY-P4685 | (Sar1,Ile4,8)-Angiotensin II | 185461-45-4 | Peptides |
| HY-P4686 | (Ser(PO3H2)202,Thr(PO3H2)205)-Tau Peptide (194-213) | 2022956-55-2 | Peptides |
| HY-P4687 | (Ser(Ac)3)-Ghrelin (mouse, rat) | 321974-76-9 | Peptides |
| HY-P4688 | (Ser(Ac)4,D-Ser(tBu)6,Azagly10)-LHRH | 1926163-83-8 | Peptides |
| HY-P4689 | Prolactin-Releasing Peptide (1-31) (rat) | 215510-06-8 | Peptides |
| HY-P4690 | pTH (13-34) (human) | 81306-64-1 | Peptides |
| HY-P4691 | (Ser(PO3H2)396,404)-Tau Peptide (379-408) | 2022956-60-9 | Peptides |
| HY-P4692 | pTH (1-44) (human) | 85568-24-7 | Peptides |
| HY-P4693 | (Ser(tBu)6,Azagly10)-LHRH | 184686-52-0 | Peptides |
| HY-P4695 | (Thr(PO3H2)231)-Tau Peptide (225-237) | 1670270-09-3 | Peptides |
| HY-P4696 | pTH (3-34) (bovine) | 51257-86-4 | Peptides |
| HY-P4697 | pTH (44-68) (human) | 64421-69-8 | Peptides |
| HY-P4697A | pTH (44-68) (human) (TFA) | Peptides | |
| HY-P4698 | Tri-valine | 28130-13-4 | Peptides |
| HY-P4699 | (Thr17)-c-Jun (11-23) | 2243207-05-6 | Peptides |
| HY-P4700 | pTH (53-84) (human) | 89439-30-5 | Peptides |
| HY-P4701 | pTH-Related Protein (1-34) amide (human, mouse, rat) | 112955-31-4 | Peptides |
| HY-P4703 | Hydrin 1′ | 148440-73-7 | Peptides |
| HY-P4704 | α-Synuclein (61-95) (human) | 154040-19-4 | Peptides |
| HY-P4704A | α-Synuclein (61-95) (human) (TFA) | Peptides | |
| HY-P4705 | Hymenistatin I | 129536-23-8 | Peptides |
| HY-P4706 | Boc-Ala-Ala-pNA | 50439-35-5 | Peptides |
| HY-P4707 | (Trp6)-LHRH | 156126-74-8 | Peptides |
| HY-P4708 | Excitin 1 | 17136-25-3 | Peptides |
| HY-P4709 | (Trp7,β-Ala8)-Neurokinin A (4-10) | 132041-95-3 | Peptides |
| HY-P4710 | (Tyr1)-pTH (1-34) (human) | 213779-10-3 | Peptides |
| HY-P4711 | N-β-Alanyl-β-alanine | 2140-53-6 | Peptides |
| HY-P4714 | (Tyr27)-α-CGRP (27-37) (canine, mouse, rat) | 124501-79-7 | Peptides |
| HY-P4715 | (Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat) | 213779-11-4 | Peptides |
| HY-P4716 | Boc-D-Trp(For)-OH | 64905-10-8 | Peptides |
| HY-P4717 | IFN-γ Antagonist 1 | 158040-83-6 | Peptides |
| HY-P4717A | IFN-γ Antagonist 1 (acetate) | Peptides | |
| HY-P4719 | (Val2)-Amyloid β-Protein (1-6) | 727727-66-4 | Peptides |
| HY-P4720 | Interleukin-6 fragment (human) | 145990-81-4 | Peptides |
| HY-P4721 | Succinyl-(Pro58,D-Glu65)-Hirudin (56-65) (sulfated) | 131791-98-5 | Peptides |
| HY-P4723 | Intermedin (human) | 1188922-20-4 | Peptides |
| HY-P4724 | (β-Asp28)-Exenatide | 2022972-68-3 | Peptides |
| HY-P4725 | Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH2 | 133233-38-2 | Peptides |
| HY-P4727 | (β-Asp5)-Delta-Sleep Inducing Peptide | 82602-88-8 | Peptides |
| HY-P4728 | Intermedin (rat) | 1816940-00-7 | Peptides |
| HY-P4730 | (β-D-Asp28)-Exenatide | 2022976-04-9 | Peptides |
| HY-P4731 | Kisspeptin-54 (27-54) (human) | 1135442-77-1 | Peptides |
| HY-P4732 | 5-FAM-Amylin (human) | 1678414-71-5 | Peptides |
| HY-P4733 | Lactoferrin (322-329) (human) | 496808-32-3 | Peptides |
| HY-P4734 | 5-FAM-LL-37 (scrambled) | 2022972-73-0 | Peptides |
| HY-P4735 | 5-FAM-Woodtide | 1566528-51-5 | Peptides |
| HY-P4736 | Leptin (116-130) (human) | 2243207-12-5 | Peptides |
| HY-P4737 | FITC-YVADAPK(Dnp) | 1926163-32-7 | Peptides |
| HY-P4739 | LHRH (1-5) (free acid) | 52434-75-0 | Peptides |
| HY-P4740 | β-Amyloid (35-25) | 147740-73-6 | Peptides |
| HY-P4741 | LL-37 (37-1) | 2022972-70-7 | Peptides |
| HY-P4742 | 6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK) | 1927927-42-1 | Peptides |
| HY-P4742A | 6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK) (TFA) | Peptides | |
| HY-P4743 | FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) | 2022956-64-3 | Peptides |
| HY-P4744 | LL-37 amide | 597562-32-8 | Peptides |
| HY-P4744A | LL-37 amide (TFA) | Peptides | |
| HY-P4745 | hMCH-1R antagonist 1 | 353487-64-6 | Peptides |
| HY-P4746 | LL-37 FKR | 913736-94-4 | Peptides |
| HY-P4747 | LL-37 GKE | 913736-92-2 | Peptides |
| HY-P4748 | LL-21 | 740800-39-9 | Peptides |
| HY-P4749 | Prion Protein (106-126) (human) (scrambled) | 150469-23-1 | Peptides |
| HY-P4750 | Acetyl-(D-Arg2)-GRF (1-29) amide (human) | 93942-91-7 | Peptides |
| HY-P4751 | LL-37 RKS | 672345-61-8 | Peptides |
| HY-P4752 | KWKHGAEIVYKSPVV-{S(GlcNAc-β-D)}-GDTSPRHLSNVK-{K(biotinyl)}-NH2 | 2022974-40-7 | Peptides |
| HY-P4753 | Met(O)14-Exenatide | 1678417-38-3 | Peptides |
| HY-P4754 | Microtubule-Associated Protein (142-161) (human) | 565227-74-9 | Peptides |
| HY-P4755 | N-((RS)-2-Hydroxy-propyl)-Val-Leu-anilide | 282726-24-3 | Peptides |
| HY-P4756 | N-(2-Carbamoyl-ethyl)-Val-Leu-anilide | 282725-67-1 | Peptides |
| HY-P4757 | N1-Glutathionyl-spermidine disulfide | 108081-77-2 | Peptides |
| HY-P4758 | N-2-Cyanoethyl-Val-Leu-anilide | 194351-52-5 | Peptides |
| HY-P4759 | (D-His2)-Goserelin | 1926163-37-2 | Peptides |
| HY-P4760 | (Diacetyl)-α-MSH | 71952-90-4 | Peptides |
| HY-P4761 | N-2-Hydroxyethyl-Val-Leu-anilide | 194351-53-6 | Peptides |
| HY-P4762 | (TYR34)-PTH (7-34) AMIDE (BOVINE) | 86292-93-5 | Peptides |
| HY-P4763 | Neuromedin U-8 (porcine) | 98395-75-6 | Peptides |
| HY-P4764 | Ac-(d-Arg)-CEH-(d-Phe)-RWC-NH2 | 819048-44-7 | Peptides |
| HY-P4765 | Neuropeptide Y-Lys(biotinyl) (free acid) (human, rat) | 1927927-12-5 | Peptides |
| HY-P4766 | Adrenomedullin (porcine) | 912862-96-5 | Peptides |
| HY-P4767 | Amylin (1-13) (human) | 198328-30-2 | Peptides |
| HY-P4772 | Me-CO-Lys(Cbo)-Gly-Arg-pNA | 96559-87-4 | Peptides |
| HY-P4773 | HSV-1 Protease substrate | 396716-24-8 | Peptides |
| HY-P4774 | Angiotensinogen (1-14) porcine | 20845-02-7 | Peptides |
| HY-P4776 | Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) | 202463-00-1 | Peptides |
| HY-P4777 | Dabcyl-RGVVNASSRLA-Edans | 163265-38-1 | Peptides |
| HY-P4778 | Neurotensin (1-8) | 80887-44-1 | Peptides |
| HY-P4779 | Acetyl-ACTH (2-24) (human, bovine, rat) | 1815617-98-1 | Peptides |
| HY-P4780 | Glu(EDANS)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(DABCYL) | 1914987-47-5 | Peptides |
| HY-P4782 | Acetyl-ACTH (3-24) (human, bovine, rat) | 1815617-99-2 | Peptides |
| HY-P4784 | Acetyl-ACTH (4-24) (human, bovine, rat) | 1815618-00-8 | Peptides |
| HY-P4785 | Acetyl-Amylin (8-37) (human) | 178603-79-7 | Peptides |
| HY-P4786 | Acetyl-ACTH (7-24) (human, bovine, rat) | 1815618-01-9 | Peptides |
| HY-P4787 | Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH2 | 400716-78-1 | Peptides |
| HY-P4788 | Acetyl-Amyloid β-Protein (1-6) amide | 903883-22-7 | Peptides |
| HY-P4789 | N-Me-Val-Leu-anilide | 194351-54-7 | Peptides |
| HY-P4790 | Acetyl-Exenatide | 305815-28-5 | Peptides |
| HY-P4791 | Orexin A (1-15) (free acid) | 2022956-49-4 | Peptides |
| HY-P4792 | Orexin A (16-33) | 1374694-00-4 | Peptides |
| HY-P4793 | Acetyl-Heme-Binding Protein 1 (1-21) (human) | 946571-77-3 | Peptides |
| HY-P4794 | Osteoblast-Adhesive Peptide | 193613-75-1 | Peptides |
| HY-P4795 | Acetyl-Hirudin (55-65) (sulfated) | 125441-01-2 | Peptides |
| HY-P4796 | Oxyntomodulin (human, mouse, rat) | 159002-68-3 | Peptides |
| HY-P4798 | Osteostatin (1-5) amide (human, bovine, dog, horse, mouse, rabbit, rat) | 155918-12-0 | Peptides |
| HY-P4799 | LL-37 KR20 | 672333-78-7 | Peptides |
| HY-P4800 | Osteostatin (human) | 137348-10-8 | Peptides |
| HY-P4801 | PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) | 160489-86-1 | Peptides |
| HY-P4802 | Pam3-Cys-Ala-Gly | 117858-54-5 | Peptides |
| HY-P4803 | PAR-2 (1-6) (human) | 202933-49-1 | Peptides |
| HY-P4805 | Peptide YY (13-36) (canine, mouse, porcine, rat) | 86895-09-2 | Peptides |
| HY-P4806 | Perisulfakinin | 125131-58-0 | Peptides |
| HY-P4807 | Pheromone Biosynthesis Activating Neuropeptide (Helicoverpa assulta, Heliothis zea) | 122071-54-9 | Peptides |
| HY-P4808 | PHF6 | 329897-62-3 | Peptides |
| HY-P4808A | PHF6 (TFA) | Peptides | |
| HY-P4809 | Polybia-MP1 | 872043-01-1 | Peptides |
| HY-P4810 | Polyphemusin II-Derived Peptide | 229030-20-0 | Peptides |
| HY-P4811 | Prepro-Atrial Natriuretic Factor (26-55) (human) | 112160-82-4 | Peptides |
| HY-P4812 | Prepro-von Willebrand factor (641-650) (bovine) | 143470-36-4 | Peptides |
| HY-P4813 | Preptin (rat) | 315197-73-0 | Peptides |
| HY-P4814 | Proadrenomedullin (1-20) (rat) | 167699-60-7 | Peptides |
| HY-P4815 | Prokineticin 2 Isoform 2 (human) | 423206-00-2 | Peptides |
| HY-P4816 | Pseudin-2 | 388602-02-6 | Peptides |
| HY-P4817 | Human PTH-(1-31) | 157938-23-3 | Peptides |
| HY-P4818 | Human PTH-(1-31) amide | 173833-08-4 | Peptides |
| HY-P4819 | Acetyl-PHF4 amide | 2022956-50-7 | Peptides |
| HY-P4820 | SYNV-cyclo(CGGYF) | Peptides | |
| HY-P4820A | SYNV-cyclo(CGGYF) (TFA) | Peptides | |
| HY-P4821 | pTH (1-34) amide (human) | 83139-29-1 | Peptides |
| HY-P4822 | Acetyl-PHF5 amide | 1190970-24-1 | Peptides |
| HY-P4823 | pTH (1-37) (human) | 136799-54-7 | Peptides |
| HY-P4824 | Acetyl-PHF6KE amide | 1079892-79-7 | Peptides |
| HY-P4825 | pTH (1-38) (human) | 78232-94-7 | Peptides |
| HY-P4826 | Acetyl-PHF6QV amide | 2022956-52-9 | Peptides |
| HY-P4827 | pTH (1-84) (dog) | 521986-14-1 | Peptides |
| HY-P4828 | Acetyl-PHF6YA amide | 885610-34-4 | Peptides |
| HY-P4829 | pTH (1-84) (rat) | 521986-16-3 | Peptides |
| HY-P4830 | Acetyl-Tau Peptide (244-274) (Repeat 1 Domain) | 2022956-56-3 | Peptides |
| HY-P4831 | Acetyl-β-Endorphin (human) | 80102-04-1 | Peptides |
| HY-P4832 | Acetyl-Tau Peptide (273-284) amide | 1684399-52-7 | Peptides |
| HY-P4833 | Ac-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH2 | 1092658-86-0 | Peptides |
| HY-P4834 | Acetyl-α-MSH (11-13) | 57899-96-4 | Peptides |
| HY-P4835 | pTH (2-34) (human) | 247902-18-7 | Peptides |
| HY-P4836 | LL-37 FK-13 | 717919-68-1 | Peptides |
| HY-P4836A | LL-37 FK-13 (TFA) | Peptides | |
| HY-P4837 | Ac-Lys-D-Ala-D-lactic acid | 220341-79-7 | Peptides |
| HY-P4838 | pTH (2-38) (human) | 154765-04-5 | Peptides |
| HY-P4839 | GLP-2 (1-34) (human) | 99120-49-7 | Peptides |
| HY-P4840 | Ac-Phe-Lys-OH | 14287-21-9 | Peptides |
| HY-P4841 | GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat) | 1802086-70-9 | Peptides |
| HY-P4842 | pTH (28-48) (human) | 83286-22-0 | Peptides |
| HY-P4843 | Gastric Inhibitory Polypeptide (6-30) amide (human) | 1139691-72-7 | Peptides |
| HY-P4844 | Ac-Phe-Phe-OH | 10030-31-6 | Peptides |
| HY-P4845 | pTH (7-84) (human) | 406610-86-4 | Peptides |
| HY-P4846 | Ac-Pro-Gly-Pro-OH | 292171-04-1 | Peptides |
| HY-P4847 | pTH (73-84) (human) | 321957-35-1 | Peptides |
| HY-P4848 | Dermcidin-1L (human) | 478898-18-9 | Peptides |
| HY-P4849 | pTH-Related Protein (1-37) (human, mouse, rat) | 206010-80-2 | Peptides |
| HY-P4850 | Ac-Pro-Leu-Gly-OH | 89626-38-0 | Peptides |
| HY-P4851 | Adipokinetic hormone (Manduca sexta) | 99886-31-4 | Peptides |
| HY-P4852 | ACTH (2-24) (human, bovine, rat) | 67654-32-4 | Peptides |
| HY-P4853 | Adrenomedullin (rat) | 161383-47-7 | Peptides |
| HY-P4854 | Ac-Val-Tyr-Lys-NH2 | 884009-99-8 | Peptides |
| HY-P4855 | CRAMP (mouse) | 376364-36-2 | Peptides |
| HY-P4856 | pTH-Related Protein (1-40) (human, mouse, rat) | 120298-73-9 | Peptides |
| HY-P4857 | pTH-Related Protein (7-34) amide (human, mouse, rat) | 115695-30-2 | Peptides |
| HY-P4858 | C-Peptide 1 (rat) | 41475-27-8 | Peptides |
| HY-P4859 | Pyr-Gly | 29227-88-1 | Peptides |
| HY-P4860 | Adropin (34-76) (human, mouse, rat) | 1802086-30-1 | Peptides |
| HY-P4861 | Biotinyl-Ahx-Amyloid β-Protein (1-42) | 1872440-40-8 | Peptides |
| HY-P4862 | Biotinyl-pTH (1-34) (human) | 213779-14-7 | Peptides |
| HY-P4863 | Biotinyl-Amylin (human) | 1678415-18-3 | Peptides |
| HY-P4864 | Biotinyl-ACTH (1-39) (human) | 1816258-26-0 | Peptides |
| HY-P4865 | β Amyloid (3-40) | 157884-70-3 | Peptides |
| HY-P4866 | Q-Peptide | 1361235-89-3 | Peptides |
| HY-P4867 | β Amyloid (1-42) (scrambled) | 1678415-52-5 | Peptides |
| HY-P4868 | β Amyloid (1-39) | 115427-62-8 | Peptides |
| HY-P4869 | Biotin-KRpep-2d (acetate) | Peptides | |
| HY-P4870 | β Amyloid (11-42) | 157802-70-5 | Peptides |
| HY-P4872 | Alarin (human) | 909409-86-5 | Peptides |
| HY-P4873 | Amylin (20-29) (human) | 118068-30-7 | Peptides |
| HY-P4874 | ACTH (7-38) (human) | 68563-24-6 | Peptides |
| HY-P4878 | 5-TAMRA-Amyloid β-Protein (1-40) | 1802087-81-5 | Peptides |
| HY-P4879 | Amyloid β-Protein (1-12) | 142047-91-4 | Peptides |
| HY-P4881 | Amyloid β-Protein (1-24) | 138648-77-8 | Peptides |
| HY-P4882 | (Pyr3)-Amyloid β-Protein (3-42) | 183449-57-2 | Peptides |
| HY-P4882A | (Pyr3)-Amyloid β-Protein (3-42) (TFA) | Peptides | |
| HY-P4883 | Amyloid β-Protein (16-22) | 153247-41-7 | Peptides |
| HY-P4884 | Amyloid β-Protein (1-46) | 285554-31-6 | Peptides |
| HY-P4885 | Glp-amyloid-β (3-40) peptide (human) | 161818-04-8 | Peptides |
| HY-P4886 | Amyloid β-Protein (3-42) | 157884-74-7 | Peptides |
| HY-P4886A | Amyloid β-Protein (3-42) (TFA) | Peptides | |
| HY-P4887 | Amyloid β-Protein (1-6) | 214550-64-8 | Peptides |
| HY-P4888 | (Pyr11)-Amyloid β-Protein (11-40) | 192377-94-9 | Peptides |
| HY-P4889 | (Gly22)-amyloid beta-protein(1-40) | 175010-18-1 | Peptides |
| HY-P4890 | Relaxin H3 (human) | 1158181-62-4 | Peptides |
| HY-P4890A | Relaxin H3 (human) (TFA) | Peptides | |
| HY-P4891 | Angiotensin (1-12) (human) | 136865-09-3 | Peptides |
| HY-P4892 | Amyloid β-Protein (4-42) | 157884-72-5 | Peptides |
| HY-P4893 | (Gln22,Asn23)-Amyloid β-Protein (1-40) | 374796-75-5 | Peptides |
| HY-P4894 | Amyloid β-Protein (5-42) | 1678415-97-8 | Peptides |
| HY-P4895 | (d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin | 77327-45-8 | Peptides |
| HY-P4896 | FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro | 2022956-44-9 | Peptides |
| HY-P4897 | [Gly9-OH]-Atosiban | 168102-69-0 | Peptides |
| HY-P4898 | Anthopleurin-A | Peptides | |
| HY-P4898A | Anthopleurin-A (TFA) | Peptides | |
| HY-P4899 | RE(EDANS)EVNLDAEFK(DABCYL)R | 310427-94-2 | Peptides |
| HY-P4900 | Fluorescein-6-carbonyl-Asp(OMe)-Glu(OMe)-Val-DL-Asp(OMe)-fluoromethylketone | 1926163-65-6 | Peptides |
| HY-P4901 | Fluorescein-6-carbonyl-Tyr-Val-Ala-DL-Asp(OMe)-fluoromethylketone | 1926163-69-0 | Peptides |
| HY-P4902 | Retrocyclin-1 | 724760-19-4 | Peptides |
| HY-P4903 | RGD-targeted Proapoptotic Peptide | 2243207-09-0 | Peptides |
| HY-P4904 | RFRP-3 (rat) | 420088-80-8 | Peptides |
| HY-P4905 | Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH2 | 891198-38-2 | Peptides |
| HY-P4906 | Atrial Natriuretic Factor (5-27) (human) | 98929-56-7 | Peptides |
| HY-P4907 | RGD Negative Control | 756500-24-0 | Peptides |
| HY-P4908 | S-(1,2-Dicarboxyethyl)glutathione | 1115-52-2 | Peptides |
| HY-P4909 | Autoinducing Peptide I | 200010-29-3 | Peptides |
| HY-P4910 | Baceridin | 1622872-91-6 | Peptides |
| HY-P4911 | SDF-1α (human) | 1268129-65-2 | Peptides |
| HY-P4911A | SDF-1α (human) (TFA) | Peptides | |
| HY-P4912 | Big Endothelin-1 (rat) | 2243219-82-9 | Peptides |
| HY-P4913 | Secretin (5-27) (porcine) | 19665-15-7 | Peptides |
| HY-P4914 | Sex Pheromone Inhibitor iPD1 | 120116-56-5 | Peptides |
| HY-P4915 | Big Endothelin-3 (22-41) amide (human) | 174283-52-4 | Peptides |
| HY-P4916 | Somatostatin-14 (3-14) | 54518-51-3 | Peptides |
| HY-P4917 | Somatostatin-14 (reduced) | 40958-31-4 | Peptides |
| HY-P4917A | Somatostatin-14 (reduced) (TFA) | Peptides | |
| HY-P4919 | Mca-SEVNLDAEFK(Dnp) | 1802078-31-4 | Peptides |
| HY-P4920 | Mca-SEVNLDAEFK(Dnp)-NH2 | 1802078-32-5 | Peptides |
| HY-P4921 | Suc-Gly-Pro-pNA | 115846-45-2 | Peptides |
| HY-P4923 | Tau Peptide (1-16) (human) | 2022956-53-0 | Peptides |
| HY-P4924 | Tau Peptide (244-274) (Repeat 1 Domain) | 330456-24-1 | Peptides |
| HY-P4925 | Biotinyl-(Arg8)-Vasopressin | 126703-17-1 | Peptides |
| HY-P4926 | Mca-SEVKMDAEFRK(Dnp)RR-NH2 | 1802078-33-6 | Peptides |
| HY-P4927 | Tau Peptide (245-274) (Repeat 1 Domain) | 1428134-39-7 | Peptides |
| HY-P4928 | Biotinyl-Amylin (mouse, rat) | 1678414-88-4 | Peptides |
| HY-P4928A | Biotinyl-Amylin (mouse, rat) (TFA) | Peptides | |
| HY-P4929 | Biotinyl-(Gln1)-Orexin A (human, mouse, rat) | 2022973-13-1 | Peptides |
| HY-P4931 | Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 | 720710-69-0 | Peptides |
| HY-P4931A | Mca-KPLGL-Dap(Dnp)-AR-NH2 (TFA) | 1392300-20-7 | Peptides |
| HY-P4933 | Tau Peptide (255-314) (Repeat 2 Domain) (human) | 2022995-68-0 | Peptides |
| HY-P4934 | Biotinyl-BNP-32 (human) | 1816258-27-1 | Peptides |
| HY-P4935 | Tau Peptide (268-282) | 330456-37-6 | Peptides |
| HY-P4937 | NBD-Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys-(DMC)-NH2 | 945414-97-1 | Peptides |
| HY-P4939 | Biotinyl-KR-12 (human) | 2022956-47-2 | Peptides |
| HY-P4940 | Abz-Val-Asn-Leu-Asp-Ala-Glu-EDDnp | 1007306-20-8 | Peptides |
| HY-P4941 | Biotinyl-α-CGRP (mouse, rat) | 1816258-61-3 | Peptides |
| HY-P4942 | Biotinyl-Somatostatin-14 | 145251-83-8 | Peptides |
| HY-P4943 | Tau Peptide (273-284) | 1663490-91-2 | Peptides |
| HY-P4945 | Biotinyl-(εAhx)-Gly-Arg-Gly-Asp-Ser | 2022956-45-0 | Peptides |
| HY-P4946 | Biotinyl-α-CGRP (human) | 1816258-60-2 | Peptides |
| HY-P4949 | Tau Peptide (274-288) | 330456-39-8 | Peptides |
| HY-P4955 | H-Ala-Val-OH | 3303-45-5 | Peptides |
| HY-P4957 | Octreotide dimer (parallel) | 1926163-80-5 | Peptides |
| HY-P4959 | Tau Peptide (277-291) | 330456-40-1 | Peptides |
| HY-P4960 | Tau Peptide (294-305) (human) | 1428135-29-8 | Peptides |
| HY-P4961 | Tau Peptide (295-309) | 330456-46-7 | Peptides |
| HY-P4962 | Tau Peptide (298-312) | 330456-47-8 | Peptides |
| HY-P4963 | Tau Peptide (301-315) | 330456-48-9 | Peptides |
| HY-P4964 | Tau Peptide (304-318) | 330456-49-0 | Peptides |
| HY-P4965 | Tau Peptide (306-317) | 1003007-59-7 | Peptides |
| HY-P4966 | Tau Peptide (306-336) (Repeat 3 Domain) | 330456-26-3 | Peptides |
| HY-P4967 | Tau Peptide (307-321) | 330456-50-3 | Peptides |
| HY-P4968 | Tau Peptide (337-368) (Repeat 4 Domain) | 330456-27-4 | Peptides |
| HY-P4969 | Tau Peptide (379-408) | 1246357-53-8 | Peptides |
| HY-P4971 | C5a Anaphylatoxin (human) | 1816940-05-2 | Peptides |
| HY-P4972 | Tau Peptide (45-73) (Exon 2/Insert 1 Domain) | 2022956-54-1 | Peptides |
| HY-P4973 | Calcitonin (rat) | 11118-25-5 | Peptides |
| HY-P4974 | Tau Peptide (512-525) amide | 2022956-61-0 | Peptides |
| HY-P4975 | CART (61-102) (rat) | 209615-75-8 | Peptides |
| HY-P4976 | TGF α (1-50) (rat) | 89899-53-6 | Peptides |
| HY-P4977 | Tau Peptide (74-102) (Exon 3/Insert 2 Domain) | 1322695-34-0 | Peptides |
| HY-P4978 | CBP501 Affinity Peptide | 1351804-17-5 | Peptides |
| HY-P4979 | Cdc25A (80-93) (human) | 851538-67-5 | Peptides |
| HY-P4980 | Acetyl-Lys5-octreotide | 173606-11-6 | Peptides |
| HY-P4984 | Toxic Shock Syndrome Toxin-1 (TSST-1) (58-78) | 137593-46-5 | Peptides |
| HY-P4985 | γ3-MSH | 72629-64-2 | Peptides |
| HY-P4986 | ACTH (6-9) | 4289-02-5 | Peptides |
| HY-P4987 | TRAP-7 | 145229-76-1 | Peptides |
| HY-P4989 | Type A Allatostatin III | 123209-96-1 | Peptides |
| HY-P4990 | Pro8-Oxytocin | 24327-19-3 | Peptides |
| HY-P4990A | Pro8-Oxytocin (TFA) | Peptides | |
| HY-P4992 | Tyr-(D-Dab4,Arg5,D-Trp8)-cyclo-Somatostatin-14 (4-11) | 496849-46-8 | Peptides |
| HY-P4994 | Val9-Oxytocin | 1021701-88-1 | Peptides |
| HY-P4997 | Tyr-Uroguanylin (mouse, rat) | 1926163-29-2 | Peptides |
| HY-P4998 | Chemotactic Domain of Elastin | 92899-39-3 | Peptides |
| HY-P5000 | Cholecystokinin Octapeptide (1-2) (desulfated) | 22840-03-5 | Peptides |
| HY-P5001 | iso-TRAP-6 | 150242-29-8 | Peptides |
| HY-P5003 | Collagen Type II Fragment | 144703-90-2 | Peptides |
| HY-P5005 | VIPhyb | 125093-93-8 | Peptides |
| HY-P5006 | (d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin | 176714-12-8 | Peptides |
| HY-P5007 | Copeptin (human) | 78362-34-2 | Peptides |
| HY-P5008 | Cbz-Asn-Gly-OH | 56675-97-9 | Peptides |
| HY-P5009 | Copeptin (rat) | 86280-64-0 | Peptides |
| HY-P5010 | (D-Arg8)-Inotocin | 745816-74-4 | Peptides |
| HY-P5011 | Cortistatin-17 (human) | 189450-19-9 | Peptides |
| HY-P5012 | Cbz-Glu-Gly-OH | 1634-89-5 | Peptides |
| HY-P5014 | Cortistatin-29 (human) | 1815618-16-6 | Peptides |
| HY-P5016 | CRAMP-18 (mouse) | 256639-17-5 | Peptides |
| HY-P5016A | CRAMP-18 (mouse) (acetate) | Peptides | |
| HY-P5017 | (Val3,Pro8)-Oxytocin | 2134138-89-7 | Peptides |
| HY-P5018 | NOTA-AE105 | 1820563-84-5 | Peptides |
| HY-P5020 | Crotalicidin | 1818372-26-7 | Peptides |
| HY-P5021 | Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) | 756500-22-8 | Peptides |
| HY-P5022 | Cullin-Associated NEDD8-Dissociated Protein 1 (548-566) | 2243207-02-3 | Peptides |
| HY-P5023 | Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) | 1193347-53-3 | Peptides |
| HY-P5023A | Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) (TFA) | Peptides | |
| HY-P5024 | Cbz-Ile-Pro-OH | 13211-37-5 | Peptides |
| HY-P5025 | Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) | 1392269-21-4 | Peptides |
| HY-P5027 | Cbz-Lys-Arg-pNA | 108318-37-2 | Peptides |
| HY-P5028 | Cyclo(His-Phe) | 56586-95-9 | Peptides |
| HY-P5028A | Cyclo(His-Phe) (TFA) | 147600-13-3 | Peptides |
| HY-P5029 | Cyclo(Asp-Asp) | 35309-53-6 | Peptides |
| HY-P5030 | Cyclo(Met-Met) | 73037-51-1 | Peptides |
| HY-P5031 | Cyclo(D-Ala-Val) | 15136-27-3 | Peptides |
| HY-P5032 | Cyclo(D-His-Pro) | 75685-88-0 | Peptides |
| HY-P5033 | Cyclo(Gly-His) | 15266-88-3 | Peptides |
| HY-P5034 | Cyclo(D-Leu-D-Pro) | 274680-11-4 | Peptides |
| HY-P5034A | Cyclo(L-Leu-D-Pro) | 32510-93-3 | Peptides |
| HY-P5035 | Cyclo(Gly-Arg-Gly-Glu-Ser-Pro) | 2022956-43-8 | Peptides |
| HY-P5036 | Cyclo(D-Trp-Tyr) | 852955-00-1 | Peptides |
| HY-P5037 | Fmoc-Gly-Pro-Hyp-OH | 185213-75-6 | Peptides |
| HY-P5037A | Fmoc-Gly-Pro-Hyp-OH (TFA) | Peptides | |
| HY-P5038 | Cyclo(Gly-Arg-Gly-Asp-Ser-Pro) | 135432-37-0 | Peptides |
| HY-P5040 | Cbz-Pro-Leu-Gly-OH | 7801-38-9 | Peptides |
| HY-P5041 | α-Synuclein (34-45) (human) | 2170181-52-7 | Peptides |
| HY-P5042 | Cbz-Tyr-Ala-OH | 23018-09-9 | Peptides |
| HY-P5043 | α-Synuclein (67-78) (human) | 2243206-99-5 | Peptides |
| HY-P5044 | α-Synuclein (45-54) (human) | 2243206-98-4 | Peptides |
| HY-P5045 | Fmoc-Thr(GalNAc(Ac)3-β-D)-OH | 133575-43-6 | Peptides |
| HY-P5046 | α-Synuclein (71-82) (human) | 332867-16-0 | Peptides |
| HY-P5049 | β-MSH (monkey) | 17750-75-3 | Peptides |
| HY-P5050 | Cyclo(Pro-Thr) | 227777-31-3 | Peptides |
| HY-P5051 | Isorugulosuvine | 6521-48-8 | Peptides |
| HY-P5053 | Galacto-RGD | 922175-70-0 | Peptides |
| HY-P5054 | Galanin (1-13)-Neuropeptide Y (25-36) amide | 147138-51-0 | Peptides |
| HY-P5055 | Gastrin I (human) (sulfated) | 19361-51-4 | Peptides |
| HY-P5056 | Galanin message associated peptide (1-41) amide | 132699-74-2 | Peptides |
| HY-P5057 | 5-FAM-LL-37 | 2243219-81-8 | Peptides |
| HY-P5057A | 5-FAM-LL-37 (TFA) | Peptides | |
| HY-P5057B | 5-FAM-Ahx-LL-37 (TFA) | Peptides | |
| HY-P5058 | Cyclolinopeptide B | 193139-41-2 | Peptides |
| HY-P5059 | Dendroaspis Natriuretic Peptide | 255721-52-9 | Peptides |
| HY-P5060 | PAR-1 (1-6) (mouse, rat) | 140436-67-5 | Peptides |
| HY-P5061 | Dynorphin A (1-13) amide | 79515-34-7 | Peptides |
| HY-P5062 | DEC-RVRK-CMK | 534615-50-4 | Peptides |
| HY-P5062A | DEC-RVRK-CMK (TFA) | Peptides | |
| HY-P5063 | Galanin-Like Peptide (human) | 245114-99-2 | Peptides |
| HY-P5064 | Galanin-Like Peptide (porcine) | 245114-96-9 | Peptides |
| HY-P5065 | Galanin-Like Peptide (rat) | 245114-97-0 | Peptides |
| HY-P5067 | EAK16-II | 157675-61-1 | Peptides |
| HY-P5069 | Glutathione diethyl ester | 97451-40-6 | Peptides |
| HY-P5069A | Glutathione diethyl ester (TFA) | Peptides | |
| HY-P5070 | Gluten Exorphin A5 | 142155-24-6 | Peptides |
| HY-P5071 | EcAMP3 | 2243219-65-8 | Peptides |
| HY-P5072 | GRP (14-27) (human, porcine, canine) | 81608-29-9 | Peptides |
| HY-P5074 | GRPP (human) | 1132745-52-8 | Peptides |
| HY-P5076 | Biotinyl-LL-37 | 2243219-80-7 | Peptides |
| HY-P5077 | Guanylin (mouse, rat) | 145257-03-0 | Peptides |
| HY-P5077A | Guanylin (mouse, rat) (TFA) | Peptides | |
| HY-P5078 | NPNA hexamer | 114332-71-7 | Peptides |
| HY-P5079 | LGLLLRHLRHHSNLLANI | 222557-92-8 | Peptides |
| HY-P5080 | Big Endothelin-2 (human) | 151853-67-7 | Peptides |
| HY-P5081 | Endotrophin (Mus musculus) | 1678414-54-4 | Peptides |
| HY-P5082 | α-Synuclein 4554W | 2243207-00-1 | Peptides |
| HY-P5083 | Lys-Phe-Glu-Arg-Gln | 115084-19-0 | Peptides |
| HY-P5084 | Neuromedin S (human) | 1138204-27-9 | Peptides |
| HY-P5085 | Acetyl-Octreotide | 83795-61-3 | Peptides |
| HY-P5086 | H-Gly-Arg-NH2 | 24326-03-2 | Peptides |
| HY-P5087 | Histone H3 (1-20) | 380598-30-1 | Peptides |
| HY-P5089 | Enterotoxin STp (E. coli) | 115474-04-9 | Peptides |
| HY-P5089A | Enterotoxin STp (E. coli) (TFA) | Peptides | |
| HY-P5090 | Exendin-4 (1-8) | 1802078-29-0 | Peptides |
| HY-P5091 | FA-Phe-Ala-OH | 83803-17-2 | Peptides |
| HY-P5092 | FA-Glu-Glu-OH | 1374423-90-1 | Peptides |
| HY-P5093 | Cecropin B (free acid) | 203265-23-0 | Peptides |
| HY-P5094 | FA-Gly-Phe-Leu | 390766-88-8 | Peptides |
| HY-P5095 | FGF basic (93-110) (human, bovine) | 1807793-49-2 | Peptides |
| HY-P5096 | FITC-β-Ala-Amyloid β-Protein (1-42) | 1802087-77-9 | Peptides |
| HY-P5097 | γ-Glutamylhistidine | 37460-15-4 | Peptides |
| HY-P5098 | E(c(RGDfK))2 | 250612-47-6 | Peptides |
| HY-P5100 | Glu-Glu-Leu | 189080-99-7 | Peptides |
| HY-P5101 | Glu-Glu-βNA | 23645-15-0 | Peptides |
| HY-P5103 | Glu-Ser | 5875-38-7 | Peptides |
| HY-P5104 | Glu-Thr-Tyr-Ser-Lys | 76021-78-8 | Peptides |
| HY-P5106 | α-Synuclein (32-37) (human) | 865377-33-9 | Peptides |
| HY-P5107 | Low molecular weight protamine | 121052-30-0 | Peptides |
| HY-P5109 | Minigastrin | 60748-07-4 | Peptides |
| HY-P5110 | TLQP-21 (human) | 1259837-37-0 | Peptides |
| HY-P5111 | Myristoyl-(Lys12,27,28)-VIP-Gly-Gly-Thr (free acid) | 2243219-86-3 | Peptides |
| HY-P5112 | Azido-PEG3-DYKDDDDK | 2243206-95-1 | Peptides |
| HY-P5113 | Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide | 2243207-10-3 | Peptides |
| HY-P5114 | Maurocalcine | 269745-22-4 | Peptides |
| HY-P5114A | Maurocalcine (TFA) | Peptides | |
| HY-P5115 | (Lys(Me,Me)27)-Histone H3 (21-44)-Gly-Lys(Biotinyl) | 2243207-11-4 | Peptides |
| HY-P5117 | TAT-CIRP | Peptides | |
| HY-P5118 | Tat-peptide 190-208 | Peptides | |
| HY-P5118A | Tat-peptide 190-208 (TFA) | Peptides | |
| HY-P5119 | Tat-peptide control 168-189 | Peptides | |
| HY-P5119A | Tat-peptide control 168-189 (TFA) | Peptides | |
| HY-P5121 | γ-Fibrinogen 377-395 | 957792-67-5 | Peptides |
| HY-P5121A | γ-Fibrinogen 377-395 (TFA) | Peptides | |
| HY-P5122 | Z-LEED-FMK | 1135688-38-8 | Peptides |
| HY-P5123 | Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg | Peptides | |
| HY-P5123A | Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg (TFA) | Peptides | |
| HY-P5124 | β-Amyloid peptide(16-20) | 153247-40-6 | Peptides |
| HY-P5125 | Z-Arg-SBzl | 88253-86-5 | Peptides |
| HY-P5125A | Z-Arg-SBzl (TFA) | Peptides | |
| HY-P5126 | DOTA-LM3 | 1192362-32-5 | Peptides |
| HY-P5126A | DOTA-LM3 (TFA) | Peptides | |
| HY-P5127 | CNP-38 | Peptides | |
| HY-P5128 | DOTA-JR11 | 1039726-31-2 | Peptides |
| HY-P5129 | ASB20123 | Peptides | |
| HY-P5130 | Big endothelin-1 (rat 1-39) | Peptides | |
| HY-P5133 | Synstatin (92-119) | 1259384-47-8 | Peptides |
| HY-P5140 | ω-Tbo-IT1 | Peptides | |
| HY-P5141 | µ-Conotoxin KIIIA | 884469-67-4 | Peptides |
| HY-P5141A | µ-Conotoxin KIIIA (TFA) | Peptides | |
| HY-P5142 | ω-Hexatoxin-Hv1a | 193981-10-1 | Peptides |
| HY-P5143 | ω-Conotoxin SO3 | 441284-32-8 | Peptides |
| HY-P5144 | Aah II | Peptides | |
| HY-P5145 | μ-Conotoxin PIIIA | 184840-20-8 | Peptides |
| HY-P5146 | α-Conotoxin PeIA | 866876-88-2 | Peptides |
| HY-P5147 | α-Conotoxin GID | 547741-78-6 | Peptides |
| HY-P5148 | α-Conotoxin BuIA | 846539-62-6 | Peptides |
| HY-P5149 | αC-Conotoxin PrXA | Peptides | |
| HY-P5151 | LiTx3 | Peptides | |
| HY-P5152 | Scorpion toxin Tf2 | Peptides | |
| HY-P5153 | ProTx-III | Peptides | |
| HY-P5154 | Tamapin | Peptides | |
| HY-P5154A | Tamapin (TFA) | Peptides | |
| HY-P5155 | Stromatoxin 1 | 741738-59-0 | Peptides |
| HY-P5156 | BDS-I | 207621-38-3 | Peptides |
| HY-P5157 | BmP02 | Peptides | |
| HY-P5158 | Conopeptide rho-TIA | 381725-58-2 | Peptides |
| HY-P5159 | Crotamine | Peptides | |
| HY-P5159A | Crotamine (TFA) | Peptides | |
| HY-P5160 | Phlotoxin-1 | Peptides | |
| HY-P5161 | FC382K10W15 | Peptides | |
| HY-P5161A | FC382K10W15 (TFA) | Peptides | |
| HY-P5162 | Dc1a | Peptides | |
| HY-P5163 | NMB-1 | 2843557-76-4 | Peptides |
| HY-P5164 | GrTx1 | Peptides | |
| HY-P5165 | Maurotoxin | 188240-41-7 | Peptides |
| HY-P5166 | Lys-Conopressin-G | 111317-91-0 | Peptides |
| HY-P5167 | GsAF-1 | 518309-03-0 | Peptides |
| HY-P5168AS | GPSVFPLAPSSK-13C6,15N2 (TFA) | Isotope-Labeled Compounds | |
| HY-P5168S | GPSVFPLAPSSK-13C6,15N2 | Isotope-Labeled Compounds | |
| HY-P5169 | LVGRQLEEFL (mouse) | 608513-82-2 | Peptides |
| HY-P5169A | LVGRQLEEFL (mouse) (TFA) | Peptides | |
| HY-P5170 | CLIVILSPFVKT (TFA) | Peptides | |
| HY-P5171 | MDGCEL | 881188-48-3 | Peptides |
| HY-P5172 | MitTx-alpha | Peptides | |
| HY-P5174 | MitTx | Peptides | |
| HY-P5175 | Muscarinic toxin 7 | Peptides | |
| HY-P5176 | Latartoxin-1a | Peptides | |
| HY-P5177 | GsAF-II | Peptides | |
| HY-P5179 | Huwentoxin I | 769973-37-7 | Peptides |
| HY-P5180 | Hainantoxin-III | 1809149-40-3 | Peptides |
| HY-P5182 | HsTX1 | 201948-00-7 | Peptides |
| HY-P5182A | HsTX1 (TFA) | Peptides | |
| HY-P5183 | Hm1a | Peptides | |
| HY-P5184 | Hainantoxin-IV | 651782-02-4 | Peptides |
| HY-P5188A | Waglerin-1 | 145038-84-2 | Peptides |
| HY-P5189A | His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 (TFA) | Peptides | |
| HY-P5190S | RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE | Isotope-Labeled Compounds | |
| HY-P5190S1 | RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE (TFA) | Isotope-Labeled Compounds | |
| HY-P5192 | KRAS G12D(8-16) | 199476-92-1 | Peptides |
| HY-P5201S | VTSEGAGLQLQK-13C6,15N2 | Isotope-Labeled Compounds | |
| HY-P5201S1 | VTSEGAGLQLQK-13C6,15N2 (TFA) | Isotope-Labeled Compounds | |
| HY-P5202 | H-Gly-Gly-Arg-AMC | 104086-87-5 | Peptides |
| HY-P5203 | Enterocin K1 | 2764845-22-7 | Peptides |
| HY-P5204 | Enterocin Hybrid 1 | 2764845-25-0 | Peptides |
| HY-P5205 | Garvicin KS, GakA | 2098351-24-5 | Peptides |
| HY-P5206 | Garvicin KS, GakB | 2098351-25-6 | Peptides |
| HY-P5207 | Garvicin KS, GakC | 2098351-26-7 | Peptides |
| HY-P5208 | CBLB 612 | 1039381-80-0 | Peptides |
| HY-P5213 | Vasopressin Dimer (parallel) (TFA) | Peptides | |
| HY-P5214 | Vasopressin Dimer (anti-parallel) (TFA) | Peptides | |
| HY-P5215 | LfcinB 17–28 (TFA) | Peptides | |
| HY-P5217 | CSTSMLKAC (disulfide) | Peptides | |
| HY-P5218 | Acetyl dipeptide-3 aminohexanoate | 1176133-78-0 | Peptides |
| HY-P5219 | Acetyl heptapeptide-4 | 1459206-66-6 | Peptides |
| HY-P5220 | Acetyl hexapeptide-1 | 448944-47-6 | Peptides |
| HY-P5220A | Acetyl hexapeptide-1 (acetate) | 2828433-36-7 | Peptides |
| HY-P5221 | Acetyl hexapeptide-37 | 1447824-16-9 | Peptides |
| HY-P5222 | Angio-S | 1114970-34-1 | Peptides |
| HY-P5223 | Hexapeptide-42 | 197771-66-7 | Peptides |
| HY-P5224 | Lipospondin | Peptides | |
| HY-P5225 | Acetyl hexapeptide-38 | 1400634-44-7 | Peptides |
| HY-P5226 | Palmitoyl tripeptide-8 | 936544-53-5 | Peptides |
| HY-P5227 | Acetyl hexapeptide-49 | 1969409-70-8 | Peptides |
| HY-P5228 | KSDSC | 2439064-83-0 | Peptides |
| HY-P5228A | KSDSC (TFA) | Peptides | |
| HY-P5229 | IHRIC | 2439064-86-3 | Peptides |
| HY-P5229A | IHRIC (TFA) | Peptides | |
| HY-P5230 | Manganese tripeptide-1 | 611182-15-1 | Peptides |
| HY-P5231 | Pentapeptide-31 | 1232137-75-5 | Peptides |
| HY-P5232 | Tetrapeptide-21 | 960608-17-7 | Peptides |
| HY-P5233 | Acetyltetrapeptide 11 | 928006-88-6 | Peptides |
| HY-P5234 | Tetrapeptide-26 | 1234463-61-6 | Peptides |
| HY-P5235 | Myristoyl hexapeptide-16 | 959610-54-9 | Peptides |
| HY-P5236 | Acetyl tetrapeptide-22 | 1295648-76-8 | Peptides |
| HY-P5237 | Tetrapeptide-4 | 960608-16-6 | Peptides |
| HY-P5238 | Trifluoroacetyl tripeptide-2 | 64577-63-5 | Peptides |
| HY-P5239 | Myristoyl pentapeptide-4 | 1392416-25-9 | Peptides |
| HY-P5240 | Acetyl tripeptide-30 citrulline | 2098345-00-5 | Peptides |
| HY-P5241 | Acetylarginyltryptophyl diphenylglycine | 1334583-93-5 | Peptides |
| HY-P5242 | Tripeptide-10 citrulline | 960531-53-7 | Peptides |
| HY-P5243 | Copper tripeptide-3 | 767286-83-9 | Peptides |
| HY-P5244 | Tripeptide-32 | 1185583-20-3 | Peptides |
| HY-P5245 | Ac-KLKKTETQ-NH2 | 934812-87-0 | Peptides |
| HY-P5247 | Palmitoyl tetrapeptide-20 | Peptides | |
| HY-P5247A | Palmitoyl tetrapeptide-20 (TFA) | Peptides | |
| HY-P5248 | Tetrapeptide-1 | 1632354-04-1 | Peptides |
| HY-P5249 | KLKKTETQ | 1054611-00-5 | Peptides |
| HY-P5250 | Palmitoyl tripeptide-5 | 623172-55-4 | Peptides |
| HY-P5251 | Oligopeptide-68 | 1206525-47-4 | Peptides |
| HY-P5252 | Diaminopropionoyl tripeptide-33 | 1199495-15-2 | Peptides |
| HY-P5253 | Octapeptide-2 | 1374396-34-5 | Peptides |
| HY-P5254 | Hexapeptide-3 | 1205679-02-2 | Peptides |
| HY-P5255 | Oligopeptide-10 | 466691-40-7 | Peptides |
| HY-P5256 | Oligopeptide-20 | 948884-07-9 | Peptides |
| HY-P5257 | Oligopeptide-24 | 1018685-16-9 | Peptides |
| HY-P5258 | Oligopeptide-41 | Peptides | |
| HY-P5259 | Oligopeptide-6 | Peptides | |
| HY-P5260 | Oligopeptide-74 | Peptides | |
| HY-P5261 | SA1-III | 2673230-58-3 | Peptides |
| HY-P5262 | Tripeptide-10 | 515835-71-9 | Peptides |
| HY-P5263 | YYRADDA | 1082226-36-5 | Peptides |
| HY-P5264 | Tripeptide-8 | Peptides | |
| HY-P5265 | Tetrapeptide | 31008-44-3 | Peptides |
| HY-P5267 | Palmitoyl dipeptide-7 | 911813-90-6 | Peptides |
| HY-P5268 | Palmitoyl hexapeptide-14 | 891498-01-4 | Peptides |
| HY-P5269 | Palmitoyl tetrapeptide-10 | 887140-79-6 | Peptides |
| HY-P5270 | Hexapeptide-12 | 70592-18-6 | Peptides |
| HY-P5271 | Influenza hemagglutinin (HA) epitope | 92000-72-1 | Peptides |
| HY-P5272 | Histatin-3 (TFA) | 112844-49-2 | Peptides |
| HY-P5273 | FLAG-Cys | 844869-12-1 | Peptides |
| HY-P5274 | BACE1 (485-501) | 300584-87-6 | Peptides |
| HY-P5275 | Tripeptide-41 | 1093241-16-7 | Peptides |
| HY-P5276 | Human membrane-bound PD-L1 polypeptide | 1831010-13-9 | Peptides |
| HY-P5277 | TAT-GluN2BCTM | 1587742-50-4 | Peptides |
| HY-P5278 | Z-Gly-Arg-Thiobenzyl ester | 130698-88-3 | Peptides |
| HY-P5279 | Palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine | 2228114-98-3 | Peptides |
| HY-P5280 | Ac-KQL-AMC | 1104011-51-9 | Peptides |
| HY-P5281 | TAT-GluN2B | 1587636-62-1 | Peptides |
| HY-P5282 | ApoA-I mimetic peptide | 221882-20-8 | Peptides |
| HY-P5283 | rTAT | 849431-85-2 | Peptides |
| HY-P5284 | RALA peptide | 1613231-49-4 | Peptides |
| HY-P5285 | Lunasin | 496823-34-8 | Peptides |
| HY-P5286 | BMAP-27 | 184870-30-2 | Peptides |
| HY-P5287 | cRGDfK-thioacetyl ester | 393781-65-2 | Peptides |
| HY-P5287A | cRGDfK-thioacetyl ester (TFA) | Peptides | |
| HY-P5288 | BMAP-28 | 184870-31-3 | Peptides |
| HY-P5290 | HYNIC-PSMA | 2213408-17-2 | Peptides |
| HY-P5291 | CPF-7 | 103238-06-8 | Peptides |
| HY-P5292 | HYNIC-iPSMA | 2192215-74-8 | Peptides |
| HY-P5292A | HYNIC-iPSMA (TFA) | 2375849-11-7 | Peptides |
| HY-P5293 | Acetyl sh-heptapeptide-1 | 1356845-72-1 | Peptides |
| HY-P5294 | YLLEMLWRL | 203515-09-7 | Peptides |
| HY-P5295 | Cy3-Ova (323-339) | Peptides | |
| HY-P5296 | Dabsyl-Leu-Gly-Gly-Gly-Ala-Edans | 949898-96-8 | Peptides |
| HY-P5297 | DOTA-CXCR4-L | Peptides | |
| HY-P5299 | Fmoc-Gly-Gly-OSu | 114726-49-7 | Peptides |
| HY-P5300 | YNPCVMYL (Thioester: Cys4-Leu8) | Peptides | |
| HY-P5300A | YNPCVMYL (Thioester: Cys4-Leu8) (TFA) | Peptides | |
| HY-P5304A | RTQLLWTPAAPTAMA (TFA) | Peptides | |
| HY-P5305A | GAD65(247-266) epitope (TFA) | Peptides | |
| HY-P5306 | α-Conotoxin TxID | 1496617-64-1 | Peptides |
| HY-P5307 | Peptide A5K | Peptides | |
| HY-P5307A | Peptide A5K (acetate) | Peptides | |
| HY-P5308 | β-Amyloid (1-19) (acetate) | Peptides | |
| HY-P5309 | (Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide | Peptides | |
| HY-P5309A | (Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide (TFA) | Peptides | |
| HY-P5310 | VPSTPPTPSPSTPPTPSPS | Peptides | |
| HY-P5310A | VPSTPPTPSPSTPPTPSPS (TFA) | Peptides | |
| HY-P5312 | Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr | Peptides | |
| HY-P5312A | Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr (acetate) | Peptides | |
| HY-P5313 | Abz-Nle-Lys-Arg-Arg-Ser-3-(NO2)Tyr | Peptides | |
| HY-P5313A | Abz-Nle-Lys-Arg-Arg-Ser-3-(NO2)Tyr (acetate) | Peptides | |
| HY-P5314 | OK2 | Peptides | |
| HY-P5315 | eNOS pT495 decoy peptide | 2769088-82-4 | Peptides |
| HY-P5316 | MHLWAAK | Peptides | |
| HY-P5316A | MHLWAAK (TFA) | Peptides | |
| HY-P5317 | MAQAAEYYR | Peptides | |
| HY-P5317A | MAQAAEYYR (TFA) | Peptides | |
| HY-P5318 | MDYYFEER | Peptides | |
| HY-P5318A | MDYYFEER (TFA) | Peptides | |
| HY-P5319 | MCaE12A | Peptides | |
| HY-P5320 | TAT-BH4 (Bcl-xL) | Peptides | |
| HY-P5320A | TAT-BH4 (Bcl-xL) (TFA) | Peptides | |
| HY-P5321 | bFGF (119-126) | 152051-61-1 | Peptides |
| HY-P5322 | Thrombospondin (TSP-1)-derived CD36 binding motif | 138849-26-0 | Peptides |
| HY-P5323 | Dabcyl-AGHDAHASET-Edans | Peptides | |
| HY-P5324 | Bad BH3 (mouse) | 505070-07-5 | Peptides |
| HY-P5325 | Bid BH3 (80-99) | 505070-05-3 | Peptides |
| HY-P5325F | Bid BH3 (80-99), FAM labeled | Peptides | |
| HY-P5326 | EDANS-CO-CH2-CH2-CO-ALERMFLSFP-Dap(DABCYL)OH | Peptides | |
| HY-P5327 | r8 Bid BH3 | Peptides | |
| HY-P5328 | Noxa A BH3 | 505070-09-7 | Peptides |
| HY-P5329 | r8-Gly-Noxa A BH3 | Peptides | |
| HY-P5330 | Noxa B BH3 | 505070-10-0 | Peptides |
| HY-P5331 | [Asn23]-beta-Amyloid (1-42), iowa mutation | Peptides | |
| HY-P5332 | Aβ1-14-εK-HBsAg3 Th | Peptides | |
| HY-P5333 | Aβ1-14-εK-KKK-MvF5 Th | Peptides | |
| HY-P5333A | Aβ1-14-εK-KKK-MvF5 Th (acetate) | Peptides | |
| HY-P5334 | AADvac 1 | 2307465-24-1 | Peptides |
| HY-P5334A | AADvac 1 (TFA) | Peptides | |
| HY-P5336 | μ-Conotoxin Sx IIIA | 1400096-00-5 | Peptides |
| HY-P5337 | Myristoyl tetrapeptide Ala-Ala-Pro-Val | 1616261-46-1 | Peptides |
| HY-P5338 | H-Ala-Hyp-OH | 76400-25-4 | Peptides |
| HY-P5339 | Humanin C8A-HN | 330936-71-5 | Peptides |
| HY-P5340 | Amyloid-Forming peptide GNNQQNY | 339091-39-3 | Peptides |
| HY-P5341 | Bik BH3 | 505070-08-6 | Peptides |
| HY-P5342 | Hrk BH3 | 1644272-97-8 | Peptides |
| HY-P5343 | p53 CBS | 721963-21-9 | Peptides |
| HY-P5344 | Dabcyl-LNKRLLHETQ-Edans | Peptides | |
| HY-P5345 | KLA peptide | 184240-26-4 | Peptides |
| HY-P5346 | Smac-based peptide | 411230-24-5 | Peptides |
| HY-P5347 | Biotin-YVAD-CMK | 402474-75-3 | Peptides |
| HY-P5348 | Ac-LEHD-pNA | 921771-40-6 | Peptides |
| HY-P5349 | 4N1K peptide | 178921-95-4 | Peptides |
| HY-P5350 | FN-A208 fusion peptide | 809281-07-0 | Peptides |
| HY-P5351 | Hyaluronan-binding peptide, biotin labeled | Peptides | |
| HY-P5351A | Hyaluronan-binding peptide, biotin labeled (TFA) | Peptides | |
| HY-P5352 | Hyaluronan-IN-1 | 299157-43-0 | Peptides |
| HY-P5353 | PA22-2 | 131435-36-4 | Peptides |
| HY-P5354 | FRETS-VWF73 | Peptides | |
| HY-P5355 | Z-Gly-Gly-Arg-AFC | 76409-80-8 | Peptides |
| HY-P5356 | H-D-Val-Leu-Lys-AFC | 97055-77-1 | Peptides |
| HY-P5357 | SFNGGP-NH2 | 261521-21-5 | Peptides |
| HY-P5358 | YFLLRNP | 149440-16-4 | Peptides |
| HY-P5359 | FLLRN | 141136-84-7 | Peptides |
| HY-P5360 | TFLLRN-NH2 | 244095-36-1 | Peptides |
| HY-P5361 | β-Amyloid (40-1) | 144409-99-4 | Peptides |
| HY-P5362 | NODAGA-LM3 | Peptides | |
| HY-P5362A | NODAGA-LM3 (TFA) | Peptides | |
| HY-P5363 | PAP 248-286 | Peptides | |
| HY-P5363A | PAP 248-286 (acetate) | Peptides | |
| HY-P5364 | B8R 20-27 | 848642-31-9 | Peptides |
| HY-P5365 | [Asn23] β-Amyloid (1-40), Iowa mutation | 374796-72-2 | Peptides |
| HY-P5366 | PEP1 | Peptides | |
| HY-P5367 | 5-FAM-PMDM6 | Peptides | |
| HY-P5368 | [Arg6]-β-Amyloid (1-40), england mutation | 1802084-26-9 | Peptides |
| HY-P5369 | [Arg6]-β-Amyloid (1-42), england mutation | Peptides | |
| HY-P5370 | Scrambled β-amyloid (1-40) | 1678415-68-3 | Peptides |
| HY-P5371 | TFLLRNPNDK-NH2 | 145229-90-9 | Peptides |
| HY-P5372 | Ala-parafluoroPhe-Arg-Cha-Cit-Tyr-NH2 | 211190-38-4 | Peptides |
| HY-P5373 | Ser-parafluoroPhe-Aad-Leu-Arg-Asn-Pro-NH2 | 237409-87-9 | Peptides |
| HY-P5374 | MeOSuc-AAPV-AFC | 125791-90-4 | Peptides |
| HY-P5375 | O-Linked GlcNAc transferase substrate | 954381-93-2 | Peptides |
| HY-P5376 | MeO-Suc-Arg-Pro-Tyr-pNA | 82564-18-9 | Peptides |
| HY-P5377 | Abz-HPGGPQ-EDDnp | 221055-89-6 | Peptides |
| HY-P5378 | Ac-KQKLR-AMC | 1135686-31-5 | Peptides |
| HY-P5379 | Calpastatin subdomain B | 128578-18-7 | Peptides |
| HY-P5380 | TNO211 | 193475-71-7 | Peptides |
| HY-P5381 | gp91 ds-tat | 329902-61-6 | Peptides |
| HY-P5384 | sgp91 ds-tat | Peptides | |
| HY-P5385 | Renin substrate, angiotensinogen (1-14), rat | 110200-37-8 | Peptides |
| HY-P5386 | H-d-Val-Leu-Arg-AFC | Peptides | |
| HY-P5387 | Connexin mimetic peptide 40,37GAP26 | 514787-21-4 | Peptides |
| HY-P5388 | Renin inhibitor peptide,rat | 115290-00-1 | Peptides |
| HY-P5389 | Connexin mimetic peptide 40GAP27 | 403858-30-0 | Peptides |
| HY-P5390 | GIP, rat | Peptides | |
| HY-P5390A | GIP, rat (TFA) | Peptides | |
| HY-P5391 | LL-37(17-32) | 717919-61-4 | Peptides |
| HY-P5392 | Apelin-16, human, bovine | 942905-20-6 | Peptides |
| HY-P5392A | Apelin-16, human, bovine (acetate) | Peptides | |
| HY-P5394 | Dby HY Peptide (608-622), mouse | 288855-20-9 | Peptides |
| HY-P5395 | TAT-GluR23A Fusion Peptide | Peptides | |
| HY-P5396 | GAD65 (524-543) | 152468-44-5 | Peptides |
| HY-P5397 | IRBP derived peptide, R16 | 145821-83-6 | Peptides |
| HY-P5397A | IRBP derived peptide, R16 (acetate) | Peptides | |
| HY-P5398 | HR2-18 | 742695-60-9 | Peptides |
| HY-P5400 | OVA (257-264), scrambled | 1213245-88-5 | Peptides |
| HY-P5401 | SAP1 | 2416761-73-2 | Peptides |
| HY-P5404 | SAP6 | 2568001-51-2 | Peptides |
| HY-P5405 | dTAT-HA2 | Peptides | |
| HY-P5406 | OVA-A2 Peptide | 149755-57-7 | Peptides |
| HY-P5407 | HD5 | 798569-33-2 | Peptides |
| HY-P5408 | OVA-Q4H7 Peptide | 923926-96-9 | Peptides |
| HY-P5410 | OVA-Q4 Peptide | 148274-85-5 | Peptides |
| HY-P5411 | OVA-T4 Peptide | 148274-88-8 | Peptides |
| HY-P5412 | LLO (190-201) | 331941-87-8 | Peptides |
| HY-P5413 | [Lys3]-Bombesin | 66839-66-5 | Peptides |
| HY-P5415 | DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | 127134-13-8 | Peptides |
| HY-P5416 | GGASCCLYCRCH | 1401180-68-4 | Peptides |
| HY-P5417 | Pancreastatin | 113817-19-9 | Peptides |
| HY-P5419 | WAAG-3R | Peptides | |
| HY-P5419A | WAAG-3R (TFA) | Peptides | |
| HY-P5420 | PSTi8 | 2434805-63-5 | Peptides |
| HY-P5421 | Caloxin 1B1 | Peptides | |
| HY-P5422 | Caloxin 3A1 | Peptides | |
| HY-P5423 | GALA | 107658-43-5 | Peptides |
| HY-P5423A | GALA (TFA) | Peptides | |
| HY-P5424 | RyR1(3614-3643) | Peptides | |
| HY-P5425 | Tetanus Toxin (830–844) | 126779-13-3 | Peptides |
| HY-P5425A | Tetanus Toxin (830–844) (TFA) | Peptides | |
| HY-P5426 | Abl protein tyrosine kinase substrate | 1377320-37-0 | Peptides |
| HY-P5427 | EAC3I | 209004-76-2 | Peptides |
| HY-P5428 | Cdc2 kinase substrate | 956004-38-9 | Peptides |
| HY-P5429 | DNA-PK Substrate | 146064-85-9 | Peptides |
| HY-P5430 | DYRKtide | 2250228-51-2 | Peptides |
| HY-P5431 | Insulin receptor (1142-1153), pTyr1150 | 134177-41-6 | Peptides |
| HY-P5432 | IRAK-4 Peptide substrate | 2837877-90-2 | Peptides |
| HY-P5433 | IRS1-derived peptide | 865778-50-3 | Peptides |
| HY-P5433F | IRS-1 Peptide, FAM labeled | 1600503-54-5 | Peptides |
| HY-P5434 | Jak3tide | 926279-93-8 | Peptides |
| HY-P5435 | LKBtide | 835653-81-1 | Peptides |
| HY-P5436 | SK-MLCK M13 | 99268-57-2 | Peptides |
| HY-P5437 | PKCε (85-92) | 207111-98-6 | Peptides |
| HY-P5438 | Srctide | Peptides | |
| HY-P5438F | FAM-Srctide | Peptides | |
| HY-P5439 | Epsilon-V1-2, Cys-conjugated | Peptides | |
| HY-P5440 | ERKtide | 287721-17-9 | Peptides |
| HY-P5441 | KRpTIRR | 261159-34-6 | Peptides |
| HY-P5441A | KRpTIRR (acetate) | Peptides | |
| HY-P5442 | MOG (44-54), mouse, human, rat | 507233-91-2 | Peptides |
| HY-P5443 | Pyrrhocoricin | 224569-84-0 | Peptides |
| HY-P5444 | Drosocin | 149924-99-2 | Peptides |
| HY-P5445 | Neurogranin 28-43 | 146554-17-8 | Peptides |
| HY-P5446 | BMAP-18 | 1245798-31-5 | Peptides |
| HY-P5447 | RRLIEDAEpYAARG | 118447-68-0 | Peptides |
| HY-P5448 | MOG (92–106), mouse, rat | 159507-82-1 | Peptides |
| HY-P5449 | p70 S6 Kinase substrate | 171783-08-7 | Peptides |
| HY-P5450 | PDKtide | Peptides | |
| HY-P5451 | PLP (178-191) | 172228-98-7 | Peptides |
| HY-P5452 | PKCd (8-17) | 379711-25-8 | Peptides |
| HY-P5453 | CFP10 (71–85) | 646997-09-3 | Peptides |
| HY-P5454 | RS Domain derived peptide | 182570-72-5 | Peptides |
| HY-P5455 | S3 Fragment | Peptides | |
| HY-P5456 | KRPpSQRHGSKY-NH2 | 338949-46-5 | Peptides |
| HY-P5457 | BMP-2 Epitope (73-92) | 500719-13-1 | Peptides |
| HY-P5458 | SRC-1 (686-700) | 394658-24-3 | Peptides |
| HY-P5459 | Elafin(human) | Peptides | |
| HY-P5461 | CHRG01 | 646038-39-3 | Peptides |
| HY-P5462 | PLP (180-199) | 165549-58-6 | Peptides |
| HY-P5462A | PLP (180-199) (TFA) | Peptides | |
| HY-P5463 | C18G | 138555-82-5 | Peptides |
| HY-P5464 | SRC-1 NR box peptide | 227929-80-8 | Peptides |
| HY-P5465 | Lactoferricin H, Lactotransferrin (37-61), human | 192198-43-9 | Peptides |
| HY-P5466 | S6(229-239) | 105802-81-1 | Peptides |
| HY-P5467 | S6(229-239), Amide, biotinalyted | Peptides | |
| HY-P5468 | NRC-16 | 1642796-54-0 | Peptides |
| HY-P5469 | WRW4-OH | 722541-91-5 | Peptides |
| HY-P5470 | LMP2A (426-434) | 152274-91-4 | Peptides |
| HY-P5471 | Melan-A/MART-1 analog | 204060-45-7 | Peptides |
| HY-P5472 | Tumour-associated MUC1 epitope | 129437-45-2 | Peptides |
| HY-P5473 | EA2 | 562082-63-7 | Peptides |
| HY-P5474 | PMAP-23 | 350019-43-1 | Peptides |
| HY-P5475 | BMLF1 (280–288) | 183719-29-1 | Peptides |
| HY-P5476 | Influenza virus NP (44-52) | 152647-27-3 | Peptides |
| HY-P5477 | Influenza virus NP (266-274) | 152647-29-5 | Peptides |
| HY-P5478 | Influenza virus PA (46-54) | 318273-25-5 | Peptides |
| HY-P5479 | EE epitope | 221216-83-7 | Peptides |
| HY-P5480 | Keap1-Nrf2-IN-16 | 1362661-40-2 | Peptides |
| HY-P5481 | DABCYL-LPETG-EDANS | 1807943-24-3 | Peptides |
| HY-P5482 | Epstein-barr virus BRLF1 (134-142) | 216862-59-8 | Peptides |
| HY-P5483 | Retro-indolicidin | 267890-59-5 | Peptides |
| HY-P5484 | SMAP-18 | 1629248-30-1 | Peptides |
| HY-P5485 | Dabcyl-QALPETGEE-Edans | 271798-75-5 | Peptides |
| HY-P5486 | Tet-20 | 1299291-79-4 | Peptides |
| HY-P5487 | GluR23Y | 696659-27-5 | Peptides |
| HY-P5488 | BDC2.5 Mimotope 1040-63 | 329696-53-9 | Peptides |
| HY-P5489 | IGRP(206-214) | 849069-99-4 | Peptides |
| HY-P5490 | Spexin-2 (53-70), human,mouse,rat | 1370290-59-7 | Peptides |
| HY-P5491 | 3X HA Tag | Peptides | |
| HY-P5492 | Delta-hemolysin | 74838-20-3 | Peptides |
| HY-P5492A | Delta-hemolysin (TFA) | Peptides | |
| HY-P5493 | D-Arg-[Hyp3,Thi5,8,D-Phe7]-Bradykinin | 103412-42-6 | Peptides |
| HY-P5494 | DPc10 | Peptides | |
| HY-P5495 | Uroguanylin-15 (Rat) | 219486-69-8 | Peptides |
| HY-P5496 | AAV2 Epitope | 872141-80-5 | Peptides |
| HY-P5497 | C34 peptide | Peptides | |
| HY-P5498 | N36 peptide | Peptides | |
| HY-P5499 | CMV pp65(13-27) | 357643-84-6 | Peptides |
| HY-P5500 | Peptide P1 | 959780-73-5 | Peptides |
| HY-P5501 | Influenza A NP (366-374) | 145253-17-4 | Peptides |
| HY-P5502 | Influenza NP (311-325) | 1225029-27-5 | Peptides |
| HY-P5503 | Pol (476-484), HIV-1 RT Epitope | 139079-41-7 | Peptides |
| HY-P5505 | LCMV-derived p13 epitope | 474105-11-8 | Peptides |
| HY-P5506 | C5a Receptor agonist, W5Cha | 144555-23-7 | Peptides |
| HY-P5507 | ERK2 Substrate | 947688-38-2 | Peptides |
| HY-P5508 | MUC5AC-13 | 869012-67-9 | Peptides |
| HY-P5509 | C5aR1 antagonist peptide | 230968-98-6 | Peptides |
| HY-P5510 | Ac-Asp-Glu-Asp(EDANS)-Glu-Glu-Abu-ψ-(COO)Ala-Ser-Lys(DABCYL)-NH2 | 188530-20-3 | Peptides |
| HY-P5511 | MUC5AC-3/13 | 869012-68-0 | Peptides |
| HY-P5512 | MUC5AC-3 | 869012-66-8 | Peptides |
| HY-P5513 | Aquaporin-2 (254-267), pSER261, human | 1643595-65-6 | Peptides |
| HY-P5514 | NF(N-Me)GA(N-Me)IL | 409085-42-3 | Peptides |
| HY-P5515 | F(N-Me)GA(N-Me)IL | 409085-40-1 | Peptides |
| HY-P5516 | SNNF(N-Me)GA(N-Me)IL | 409085-44-5 | Peptides |
| HY-P5517 | SNNF(N-Me)GA(N-Me)ILSS | 409085-46-7 | Peptides |
| HY-P5518 | [Des-Arg10]-HOE I40 | 1054763-33-5 | Peptides |
| HY-P5519 | [Thr28, Nle31]-Cholecystokinin (25-33), sulfated | 77568-41-3 | Peptides |
| HY-P5520 | GB-6 | 2413262-74-3 | Peptides |
| HY-P5521 | mLR12 | Peptides | |
| HY-P5522 | TriDAP | 877462-71-0 | Peptides |
| HY-P5523 | iE-DAP | 592520-07-5 | Peptides |
| HY-P5524 | C12-iE-DAP | 1269619-57-9 | Peptides |
| HY-P5525 | AC3-I, myristoylated | Peptides | |
| HY-P5526 | CCK1-specific peptide substrate | Peptides | |
| HY-P5527F | FAM-CSKtide | Peptides | |
| HY-P5528 | 2Abz-SLGRKIQIK(Dnp)-NH2 | Peptides | |
| HY-P5529 | 2Abz-GLQRALEI-Lys(Dnp)-NH2 | Peptides | |
| HY-P5530 | 2Abz-SVARTLLV-Lys(Dnp)-NH2 | Peptides | |
| HY-P5531 | beta-Casein phosphopeptide | 183582-09-4 | Peptides |
| HY-P5533 | CRT | 2414254-70-7 | Peptides |
| HY-P5534 | Enavermotide | 524060-93-3 | Peptides |
| HY-P5535 | Invopressin | 1488411-60-4 | Peptides |
| HY-P5536 | Irucalantide | 1631160-47-8 | Peptides |
| HY-P5537S | ETTVFENLPEK-13C11,15N2 (TFA) | Isotope-Labeled Compounds | |
| HY-P5538S | EPYFGYSGAFK-13C9,15N3 (TFA) | Isotope-Labeled Compounds | |
| HY-P5539 | Omramotide | 2306406-71-1 | Peptides |
| HY-P5540 | Oximbomotide | 2306406-51-7 | Peptides |
| HY-P5541 | Sucantomotide | 2378651-62-6 | Peptides |
| HY-P5542 | Vicatertide | 1251838-01-3 | Peptides |
| HY-P5544 | M-TriDAP | 60230-21-9 | Peptides |
| HY-P5544A | M-TriDAP (TFA) | Peptides | |
| HY-P5545 | Lynronne-1 | Peptides | |
| HY-P5546 | Lynronne-2 | Peptides | |
| HY-P5547 | Lynronne-3 | Peptides | |
| HY-P5548 | CaLL | 1228093-67-1 | Peptides |
| HY-P5549 | Hb 98–114 | Peptides | |
| HY-P5550 | Urumin | 2215863-74-2 | Peptides |
| HY-P5551 | TLN-58 | Peptides | |
| HY-P5552 | Melimine | Peptides | |
| HY-P5553 | cPcAMP1/26 | Peptides | |
| HY-P5554 | cOB1 phermone | 163193-68-8 | Peptides |
| HY-P5555 | LMW peptide | 1818202-23-1 | Peptides |
| HY-P5556 | KAMP-19 | 1404488-98-7 | Peptides |
| HY-P5557 | TP4 (Nile tilapia piscidin) | 1429184-62-2 | Peptides |
| HY-P5558 | KLTWQELYQLKYKGI | 917760-16-8 | Peptides |
| HY-P5559 | ND1-YL2 | 2582803-80-1 | Peptides |
| HY-P5560 | PP13 | 1099486-04-0 | Peptides |
| HY-P5561 | Aurein 2.2 | 302343-04-0 | Peptides |
| HY-P5562 | PP102 | Peptides | |
| HY-P5563 | PP113 | Peptides | |
| HY-P5564 | BTL peptide | 1021461-47-1 | Peptides |
| HY-P5565 | RP-1 | 239114-03-5 | Peptides |
| HY-P5566 | GLK-19 | 1225014-04-9 | Peptides |
| HY-P5567 | GLR-19 | 1225014-05-0 | Peptides |
| HY-P5568 | Siamycin III | 152835-17-1 | Peptides |
| HY-P5569 | SP-B peptide | 865714-65-4 | Peptides |
| HY-P5570 | Aurein 2.3 | 302343-06-2 | Peptides |
| HY-P5571 | Aurein 2.4 | 302343-07-3 | Peptides |
| HY-P5572 | Aurein 2.5 | 302343-09-5 | Peptides |
| HY-P5573 | Aurein 2.6 | 302343-10-8 | Peptides |
| HY-P5574 | Aurein 3.1 | 302343-11-9 | Peptides |
| HY-P5575 | Aurein 3.2 | 302343-14-2 | Peptides |
| HY-P5576 | Aurein 3.3 | 302343-15-3 | Peptides |
| HY-P5577 | Aurein 5.2 | 302343-22-2 | Peptides |
| HY-P5578 | A8SGLP-1 | 753024-08-7 | Peptides |
| HY-P5578A | A8SGLP-1 (TFA) | Peptides | |
| HY-P5579 | Alloferon 2 | 347884-62-2 | Peptides |
| HY-P5580 | Dermaseptin-B3 | 210890-55-4 | Peptides |
| HY-P5581 | Alloferon 1 | 347884-61-1 | Peptides |
| HY-P5582 | Combi-1 | 143459-88-5 | Peptides |
| HY-P5583 | Dermaseptin-B9 | 1235883-50-7 | Peptides |
| HY-P5584 | Heliomicin | 391977-03-0 | Peptides |
| HY-P5585 | Dermaseptin-B4 | 210890-56-5 | Peptides |
| HY-P5586 | Dermaseptin-B5 | 210890-57-6 | Peptides |
| HY-P5587 | Dermaseptin-S5 | 151896-16-1 | Peptides |
| HY-P5588 | Dermaseptin-S4 | 151896-15-0 | Peptides |
| HY-P5589 | Plantaricin A | 131463-18-8 | Peptides |
| HY-P5590 | Dermaseptin-S3 | 151896-14-9 | Peptides |
| HY-P5591 | PAF26 | Peptides | |
| HY-P5592 | Temporin B | 188713-70-4 | Peptides |
| HY-P5592A | Temporin B (acetate) | Peptides | |
| HY-P5593 | Dermaseptin-S2 | 151896-13-8 | Peptides |
| HY-P5594 | Dermaseptin-S1 | 136033-70-0 | Peptides |
| HY-P5595 | Temporin C | 188713-72-6 | Peptides |
| HY-P5596 | Combi-2 | Peptides | |
| HY-P5597 | Temporin F | 188713-77-1 | Peptides |
| HY-P5598 | Temporin G | 188713-78-2 | Peptides |
| HY-P5599 | Temporin K | 188713-80-6 | Peptides |
| HY-P5600 | The K4 peptide | 1163064-86-5 | Peptides |
| HY-P5601 | Thanatin | 214542-43-5 | Peptides |
| HY-P5601A | Thanatin (TFA) | Peptides | |
| HY-P5602 | Mastoparan B | 137354-65-5 | Peptides |
| HY-P5603 | Bovine neutrophil beta-defensin 12 | 455257-02-0 | Peptides |
| HY-P5604 | Maximin 1 | 479664-79-4 | Peptides |
| HY-P5605 | Maximin 2 | 853262-54-1 | Peptides |
| HY-P5606 | Maximin 3 | 634600-23-0 | Peptides |
| HY-P5607 | Bombinin | Peptides | |
| HY-P5608 | Maximin 4 | 853262-55-2 | Peptides |
| HY-P5609 | Maximin 5 | 634600-61-6 | Peptides |
| HY-P5610 | Maximin Hv | Peptides | |
| HY-P5611 | Maximin 7 | 853262-56-3 | Peptides |
| HY-P5612 | Maximin 8 | 853262-57-4 | Peptides |
| HY-P5613 | XT-1 | 398143-78-7 | Peptides |
| HY-P5614 | Maximin 9 | 853262-58-5 | Peptides |
| HY-P5615 | XT-2 peptide | 1235883-67-6 | Peptides |
| HY-P5616 | Maximin H1 | 853262-60-9 | Peptides |
| HY-P5617 | Cathepsin G(1-5) | 129633-72-3 | Peptides |
| HY-P5618 | Maximin H2 | Peptides | |
| HY-P5619 | Maximin H3 | 853262-62-1 | Peptides |
| HY-P5620 | DFTamP1 | 2415653-64-2 | Peptides |
| HY-P5621 | Maximin 63 | Peptides | |
| HY-P5622 | Hs-1 | 1799386-27-8 | Peptides |
| HY-P5623 | RVG | 115136-25-9 | Peptides |
| HY-P5623A | RVG-Cys | 1186105-01-0 | Peptides |
| HY-P5623A1 | RVG-Cys (acetate) | Peptides | |
| HY-P5623B | RVG (TFA) | Peptides | |
| HY-P5624 | Gallin | Peptides | |
| HY-P5625 | ROAD-1 | Peptides | |
| HY-P5626 | Seabream hepcidin | Peptides | |
| HY-P5627 | XT-4 | 398143-81-2 | Peptides |
| HY-P5628 | Termicin | Peptides | |
| HY-P5629 | MCF | 579474-25-2 | Peptides |
| HY-P5630 | Aeschna defensin | Peptides | |
| HY-P5631 | Rabbit neutrophil peptide 3b | Peptides | |
| HY-P5632 | Bovine tracheal antimicrobial peptide | Peptides | |
| HY-P5633 | Bombinin-like peptide 2 | 138220-01-6 | Peptides |
| HY-P5634 | Bombinin-like peptide 3 | 138220-02-7 | Peptides |
| HY-P5635 | Bombinin-like peptide 4 | 138220-03-8 | Peptides |
| HY-P5636 | Bombinin-like peptide 7 | 138657-70-2 | Peptides |
| HY-P5637 | Tur1A | Peptides | |
| HY-P5638 | FLGFVGQALNALLGKL-NH2 | 2268718-85-8 | Peptides |
| HY-P5639 | Gageotetrin A | 1536405-78-3 | Peptides |
| HY-P5640 | Tritrpticin | 179264-81-4 | Peptides |
| HY-P5641 | Pleurocidin | 190324-47-1 | Peptides |
| HY-P5642 | Retrocyclin-101 | 536757-16-1 | Peptides |
| HY-P5643 | Retrocyclin-2 | 724760-20-7 | Peptides |
| HY-P5644 | Retrocyclin-3 | 724760-21-8 | Peptides |
| HY-P5645 | LEAP-2 | 1683582-94-6 | Peptides |
| HY-P5646 | Gageotetrin C | 1536405-84-1 | Peptides |
| HY-P5647 | PhD1 | Peptides | |
| HY-P5648 | PhD2 | Peptides | |
| HY-P5649 | PhD3 | Peptides | |
| HY-P5650 | Bombolitin I | 95648-97-8 | Peptides |
| HY-P5651 | PhD4 | Peptides | |
| HY-P5652 | Bombolitin II | 95732-43-7 | Peptides |
| HY-P5653 | Bombolitin III | 95732-42-6 | Peptides |
| HY-P5654 | Bombolitin IV | 95753-40-5 | Peptides |
| HY-P5655 | Maximin H4 | Peptides | |
| HY-P5656 | Brevinin-1Ea | 156793-64-5 | Peptides |
| HY-P5657 | Maximin H5 | 495395-61-4 | Peptides |
| HY-P5658 | Brevinin-1E | 150050-01-4 | Peptides |
| HY-P5659 | Brevinin-1 | 145963-49-1 | Peptides |
| HY-P5660 | Brevinin-2 | 145963-50-4 | Peptides |
| HY-P5661 | Maximin H7 | 853262-65-4 | Peptides |
| HY-P5662 | Brevinin-2EC | 156549-28-9 | Peptides |
| HY-P5663 | Bombinin H-BO1 | Peptides | |
| HY-P5664 | Maximin S4 | 847871-00-5 | Peptides |
| HY-P5665 | Bombinin-BO1 | Peptides | |
| HY-P5666 | Maximin 15 | Peptides | |
| HY-P5667 | VP7 (31-40) peptide | 152687-39-3 | Peptides |
| HY-P5667A | VP7 (31-40) peptide (acetate) | Peptides | |
| HY-P5668 | Maximin 28 | Peptides | |
| HY-P5670 | Maximin 31 | Peptides | |
| HY-P5671 | Maximin 32 | Peptides | |
| HY-P5672 | Maximin 39 | Peptides | |
| HY-P5673 | Bombinin H1 | Peptides | |
| HY-P5674 | Bombinin H2 | 152846-09-8 | Peptides |
| HY-P5675 | Bombinin H7 | Peptides | |
| HY-P5676 | Bombinin H3 | Peptides | |
| HY-P5677 | Bombinin H5 | 325686-32-6 | Peptides |
| HY-P5678 | Bombinin H4 | Peptides | |
| HY-P5680 | SpHistin | Peptides | |
| HY-P5681 | Human α-Defensin 6 | Peptides | |
| HY-P5682 | Maximin 41 | Peptides | |
| HY-P5683 | Maximin 45 | Peptides | |
| HY-P5684 | Maximin H39 | Peptides | |
| HY-P5685 | Maximin 49 | Peptides | |
| HY-P5686 | Maximin 78 | Peptides | |
| HY-P5687 | Im5 | Peptides | |
| HY-P5688 | Maximin 68 | Peptides | |
| HY-P5689 | Maximin 42 | Peptides | |
| HY-P5690 | Distinctin | 857394-09-3 | Peptides |
| HY-P5691 | P1 | 675123-75-8 | Peptides |
| HY-P5692 | Maximin 77 | Peptides | |
| HY-P5693 | HBA(111–142) | Peptides | |
| HY-P5694 | Human α-defensin 5 | Peptides | |
| HY-P5695 | GP-2B | Peptides | |
| HY-P5696 | Xenopsin precursor fragment | 108460-66-8 | Peptides |
| HY-P5697 | Tilapia piscidin 3 | 2026639-29-0 | Peptides |
| HY-P5698 | Cyclopetide 1 | 82081-23-0 | Peptides |
| HY-P5699 | Cyclopetide 2 | 748142-26-9 | Peptides |
| HY-P5700 | SAAP Fraction 3 | 172617-19-5 | Peptides |
| HY-P5701 | EP2 | 749252-78-6 | Peptides |
| HY-P5702 | EP3 | 749252-79-7 | Peptides |
| HY-P5703 | EP5-1 | Peptides | |
| HY-P5704 | K11 | 1398109-79-9 | Peptides |
| HY-P5705 | Gageotetrin B | 1536405-81-8 | Peptides |
| HY-P5706 | HG2 | Peptides | |
| HY-P5707 | Gramicidin B | 4422-52-0 | Peptides |
| HY-P5708 | Adenoregulin | 149260-68-4 | Peptides |
| HY-P5709 | HG4 | Peptides | |
| HY-P5710 | LCI peptide | Peptides | |
| HY-P5711 | NEMURI | Peptides | |
| HY-P5712 | Gramicidin S | 113-73-5 | Peptides |
| HY-P5713 | Des(8-14)brevinin-1PMa | Peptides | |
| HY-P5714 | Abaecin | 123997-18-2 | Peptides |
| HY-P5715 | Im6 | Peptides | |
| HY-P5717 | Peptide 12d | 1427516-66-2 | Peptides |
| HY-P5718 | Brevinin-1PMa | Peptides | |
| HY-P5719 | Andropin | Peptides | |
| HY-P5720 | Peptide 5e | 908065-89-4 | Peptides |
| HY-P5721 | Apidaecin IA | 123081-48-1 | Peptides |
| HY-P5722 | Peptide 5f | 908065-90-7 | Peptides |
| HY-P5723 | Api137 | 1428789-03-0 | Peptides |
| HY-P5723A | Api137 (TFA) | Peptides | |
| HY-P5724 | Nv-CATH | Peptides | |
| HY-P5725 | Aurein 2.1 | 1240116-47-5 | Peptides |
| HY-P5726 | Aurein 1.2 | 302343-01-7 | Peptides |
| HY-P5727 | HR1 | 80533-94-4 | Peptides |
| HY-P5728 | Aurein 1.1 | 302343-00-6 | Peptides |
| HY-P5729 | LL-25 | 740800-35-5 | Peptides |
| HY-P5730 | Peptide 5g | 908065-91-8 | Peptides |
| HY-P5731 | Bac7(1-35) | Peptides | |
| HY-P5734 | Bactenecin 5 | Peptides | |
| HY-P5735 | Bactenecin 7 | 123938-70-5 | Peptides |
| HY-P5736 | Bass hepcidin | Peptides | |
| HY-P5737 | ASP-1 | Peptides | |
| HY-P5738 | Palicourein | 331714-57-9 | Peptides |
| HY-P5739 | Mram 8 | 1803183-45-0 | Peptides |
| HY-P5741 | IPL344 | 877120-59-7 | Peptides |
| HY-P5742 | ELAAWCRWGFLLALLPPGIAG | 1443436-78-9 | Peptides |
| HY-P5742A | ELAAWCRWGFLLALLPPGIAG (TFA) | Peptides | |
| HY-P5743 | IRGRILHDGAYSLTLQGLGIH | 1443436-79-0 | Peptides |
| HY-P5743A | IRGRILHDGAYSLTLQGLGIH (TFA) | Peptides | |
| HY-P5744 | SPPHPSPAFSPAFDNLYYWDQ | 1443436-80-3 | Peptides |
| HY-P5744A | SPPHPSPAFSPAFDNLYYWDQ (TFA) | Peptides | |
| HY-P5745 | TYVPANASL | 921621-38-7 | Peptides |
| HY-P5745A | TYVPANASL (TFA) | Peptides | |
| HY-P5746 | Suicin 65 | Peptides | |
| HY-P5747 | Glycocin F | Peptides | |
| HY-P5748 | Bac5(1-25) | 170917-43-8 | Peptides |
| HY-P5750 | Hypertrehalosemic neuropeptide (Nauphoeta cinerea) | 106018-36-4 | Peptides |
| HY-P5751 | Cyclo(Ile-Val) | 104068-43-1 | Natural Products |
| HY-P5753 | JB-95 | 1873323-60-4 | Peptides |
| HY-P5753A | JB-95 (acetate) | Peptides | |
| HY-P5754 | TAT-NEP1-40 | Peptides | |
| HY-P5754A | TAT-NEP1-40 (TFA) | Peptides | |
| HY-P5754B | TAT-NEP1-40 (acetate) | Peptides | |
| HY-P5755 | SWELYYPLRANL-NH2 | Peptides | |
| HY-P5755A | SWELYYPLRANL-NH2 (TFA) | Peptides | |
| HY-P5756 | CSD-CH2(1,8)-NH2 | 3032600-19-1 | Peptides |
| HY-P5758 | His 11 | 620927-23-3 | Peptides |
| HY-P5758A | His 11 (TFA) | Peptides | |
| HY-P5762 | Phoenixin-14 | 1415039-79-0 | Peptides |
| HY-P5762A | Phoenixin-14 (TFA) | Peptides | |
| HY-P5763 | Phoenixin-20 | 1415039-77-8 | Peptides |
| HY-P5763A | Phoenixin-20 (TFA) | Peptides | |
| HY-P5765 | Galanin (1-13)-spantide I | 143868-20-6 | Peptides |
| HY-P5766 | AChRα(97-116) | 663154-30-1 | Peptides |
| HY-P5766A | AChRα(97-116) (TFA) | Peptides | |
| HY-P5768 | WSHPQFEKWSHPQFEK | 2771233-98-6 | Peptides |
| HY-P5768A | WSHPQFEKWSHPQFEK (TFA) | Peptides | |
| HY-P5770 | Jingzhaotoxin-V | Peptides | |
| HY-P5771 | Jingzhaotoxin-IX | Peptides | |
| HY-P5772 | Jingzhaotoxin-II | Peptides | |
| HY-P5773 | Jingzhaotoxin-34 | Peptides | |
| HY-P5780 | π-TRTX-Hm3a | Peptides | |
| HY-P5781 | δ-Theraphotoxin-Hm1b | Peptides | |
| HY-P5782 | δ-Theraphotoxin-Hm1a toxin | Peptides | |
| HY-P5783 | δ-Buthitoxin-Hj2a | Peptides | |
| HY-P5784 | δ-Buthitoxin-Hj1a | Peptides | |
| HY-P5785 | Heteropodatoxin-2 | 741730-12-1 | Peptides |
| HY-P5785A | Heteropodatoxin-2 (TFA) | Peptides | |
| HY-P5786 | Heteropodatoxin-1 | Peptides | |
| HY-P5788 | Hemitoxin | Peptides | |
| HY-P5790 | μ-TRTX-Hd1a | Peptides | |
| HY-P5791 | Haplotoxin-2 | Peptides | |
| HY-P5792 | Atrial natriuretic peptide (3-28) (human) | 102686-43-1 | Peptides |
| HY-P5793 | GTx1-15 | Peptides | |
| HY-P5795 | GsAF-I | Peptides | |
| HY-P5796 | FS-2 | Peptides | |
| HY-P5797 | Fasciculin-II | 95506-56-2 | Peptides |
| HY-P5798 | Fasciculin-I | Peptides | |
| HY-P5799 | ω-Conotoxin MVIID | Peptides | |
| HY-P5800 | Phlo1b | Peptides | |
| HY-P5801 | Phlo1a | Peptides | |
| HY-P5802 | ω-Conotoxin FVIA | Peptides | |
| HY-P5803 | Pardaxin P5 | 67995-63-5 | Peptides |
| HY-P5803A | Pardaxin P5 (TFA) | Peptides | |
| HY-P5804 | ω-Conotoxin CVIF | Peptides | |
| HY-P5805 | ω-Conotoxin CVIE | Peptides | |
| HY-P5806 | Ergtoxin-1 | 304436-85-9 | Peptides |
| HY-P5807 | Cn2 toxin | Peptides | |
| HY-P5807A | Cn2 toxin (TFA) | Peptides | |
| HY-P5808 | Iota-conotoxin RXIA | 1042682-52-9 | Peptides |
| HY-P5808A | Iota-conotoxin RXIA (TFA) | Peptides | |
| HY-P5809 | Pe1b | Peptides | |
| HY-P5810 | Ceratotoxin-2 | 880885-98-3 | Peptides |
| HY-P5811 | Ceratotoxin-1 | Peptides | |
| HY-P5812 | IDR 1002 | 1224095-25-3 | Peptides |
| HY-P5813 | Cd1a | Peptides | |
| HY-P5815 | GLP-1 (1-36) amide (human, rat) | 99658-04-5 | Peptides |
| HY-P5815A | GLP-1 (1-36) amide (human, rat) (TFA) | Peptides | |
| HY-P5816 | BmK-M1 | Peptides | |
| HY-P5817 | ω-Conotoxin CVIB | 325164-09-8 | Peptides |
| HY-P5818 | BDS-II | Peptides | |
| HY-P5819 | xStAx-VHLL | Peptides | |
| HY-P5819A | xStAx-VHLL (TFA) | Peptides | |
| HY-P5820 | ω-Conotoxin Bu8 | Peptides | |
| HY-P5821 | ω-Conotoxin CVIA | 325164-06-5 | Peptides |
| HY-P5822 | ω-Conotoxin CnVIIA | 760212-36-0 | Peptides |
| HY-P5823 | Azemiopsin | 1391936-86-9 | Peptides |
| HY-P5824 | Anthopleurin-C | Peptides | |
| HY-P5825 | κM-Conotoxin RIIIK | 740843-55-4 | Peptides |
| HY-P5826 | Dynorphin B (1-9) | 126050-26-8 | Peptides |
| HY-P5827 | SBP1 peptide | 2416761-69-6 | Peptides |
| HY-P5828 | κM-Conotoxin RIIIJ | Peptides | |
| HY-P5829A | CRAMP (140-173) (mouse) (TFA) | Peptides | |
| HY-P5830 | Biotin-DEVD-CHO | 178603-73-1 | Peptides |
| HY-P5831 | Biotin-H10 | Peptides | |
| HY-P5832 | BMP2-derived peptide | 836606-84-9 | Peptides |
| HY-P5833 | κ-Bungarotoxin | 124511-67-7 | Peptides |
| HY-P5834 | Boc-AEVD-CHO | 220094-15-5 | Peptides |
| HY-P5835 | δ-Dendrotoxin | 189201-23-8 | Peptides |
| HY-P5836 | Citrullinated LL-37 1cit | Peptides | |
| HY-P5837 | Citrullinated LL-37 2cit | Peptides | |
| HY-P5838 | Citrullinated LL-37 5cit | Peptides | |
| HY-P5839 | α-Conotoxin MrIC | 1417816-41-1 | Peptides |
| HY-P5840 | Cyclo(RGDyC) | 1206475-79-7 | Peptides |
| HY-P5840A | Cyclo(RGDyC) (TFA) | Peptides | |
| HY-P5841 | α-Conotoxin LtIA | Peptides | |
| HY-P5842 | Citrullinated LL-37 3cit | Peptides | |
| HY-P5843 | Citrullinated LL-37 4cit | Peptides | |
| HY-P5844 | α-Conotoxin AuIA | 216299-20-6 | Peptides |
| HY-P5845 | α-Conotoxin RgIA | 876728-23-3 | Peptides |
| HY-P5846 | Muscarinic toxin 3 | 873336-87-9 | Peptides |
| HY-P5847 | α-Conotoxin GIC | 757236-92-3 | Peptides |
| HY-P5848 | αO-Conotoxin GeXIVA | 2010167-25-4 | Peptides |
| HY-P5849 | αA-Conotoxin OIVA | 878027-87-3 | Peptides |
| HY-P5850 | α-Conotoxin Bt1.8 | Peptides | |
| HY-P5851 | AaHI | 820981-26-8 | Peptides |
| HY-P5852 | α-Conotoxin EIIB | Peptides | |
| HY-P5853 | Aam-KTX | Peptides | |
| HY-P5854 | Aa1 toxin | Peptides | |
| HY-P5855 | μ-Conotoxin SxIIIC | Peptides | |
| HY-P5856 | αA-Conotoxin PIVA | 171439-59-1 | Peptides |
| HY-P5857 | MmTx2 toxin | Peptides | |
| HY-P5858 | µ-Conotoxin SIIIA | 877860-32-7 | Peptides |
| HY-P5859 | α-Pompilidotoxin | 202075-91-0 | Peptides |
| HY-P5860 | MmTx1 toxin | Peptides | |
| HY-P5861 | µ-Conotoxin BuIIIC | 1400096-08-3 | Peptides |
| HY-P5862 | µ-Conotoxin BuIIIB | 1400096-06-1 | Peptides |
| HY-P5863 | Mambalgin-2 | Peptides | |
| HY-P5864 | µ-Conotoxin BuIIIA | Peptides | |
| HY-P5865 | Tap1a | Peptides | |
| HY-P5866 | Allatotropin | 120928-88-3 | Peptides |
| HY-P5868 | mHuwentoxin-IV | Peptides | |
| HY-P5869 | Kurtoxin | Peptides | |
| HY-P5870 | KTX-Sp2 | Peptides | |
| HY-P5871 | Jingzhaotoxin-XII | Peptides | |
| HY-P5871A | Jingzhaotoxin-XII (TFA) | Peptides | |
| HY-P5872 | Jingzhaotoxin XI | Peptides | |
| HY-P5873 | Jingzhaotoxin-X | Peptides | |
| HY-P5874 | Myr-TAT-CBD3 | Peptides | |
| HY-P5875 | P4pal10 | 1021346-05-3 | Peptides |
| HY-P5875A | P4pal10 (TFA) | Peptides | |
| HY-P5876 | Proadrenomedullin (N-20) (bovine, porcine) | Peptides | |
| HY-P5877 | ɛPKC(85–92),Myristoylated | 1072301-79-1 | Peptides |
| HY-P5878 | RG33 Peptide | Peptides | |
| HY-P5881 | PKCα (C2-4) inhibitor peptide | Peptides | |
| HY-P5883 | TAT-M2NX | 2126166-03-6 | Peptides |
| HY-P5884 | PKCθ pseudosubstrate peptide inhibitor,myristoylated | Peptides | |
| HY-P5884A | PKCθ pseudosubstrate peptide inhibitor,myristoylated (TFA) | Peptides | |
| HY-P5885 | PKCη pseudosubstrate inhibitor,myristoylated | 908012-19-1 | Peptides |
| HY-P5886 | PKC 20-28,myristoylated | Peptides | |
| HY-P5887 | Tertiapin-RQ | Peptides | |
| HY-P5888 | PKCε inhibitor peptide,myristoylated | Peptides | |
| HY-P5889 | Thrombin receptor peptide ligand | 287964-20-9 | Peptides |
| HY-P5890 | YVAD-CHO | 153604-27-4 | Peptides |
| HY-P5891 | TAT-SAMβA | Peptides | |
| HY-P5892 | β-Endorphin (1-27) (human) | 76622-84-9 | Peptides |
| HY-P5894 | human GALP (3-32) | Peptides | |
| HY-P5896 | Ala5-Galanin (2-11) | 859843-84-8 | Peptides |
| HY-P5899 | Mambalgin-3 | Peptides | |
| HY-P5900 | m3-Huwentoxin IV | Peptides | |
| HY-P5901 | ChTX-Lq2 | Peptides | |
| HY-P5902 | ω-conotoxin MoVIA | Peptides | |
| HY-P5903 | FGF acidic I (102-111) (bovine brain) | 198542-00-6 | Peptides |
| HY-P5904 | Caveolin-1 (82-101) amide (human, mouse, rat) | 2757108-69-1 | Peptides |
| HY-P5905 | Citrullinated amyloid-β (1-42) peptide (human) | Peptides | |
| HY-P5906 | Citrullinated amyloid-β (1-40) peptide (human) | Peptides | |
| HY-P5907 | Helianorphin-19 | 2883653-86-7 | Peptides |
| HY-P5908 | DEALA-Hyp-YIPD | Peptides | |
| HY-P5908F | FAM-DEALA-Hyp-YIPD | Peptides | |
| HY-P5909 | Keap1-Nrf2 probe | 2430031-36-8 | Peptides |
| HY-P5909F | FITC-labelled Keap1-Nrf2 probe | Peptides | |
| HY-P5910 | Azurin p28 peptide | 897026-25-4 | Peptides |
| HY-P5910A | Azurin p28 peptide (TFA) | Peptides | |
| HY-P5911 | GluN1(359-378) | Peptides | |
| HY-P5912 | GluN1(356-385) | Peptides | |
| HY-P5913 | [Tyr6]-Angiotensin II | 52634-95-4 | Peptides |
| HY-P5914 | Wasabi Receptor Toxin | 2569291-86-5 | Peptides |
| HY-P5914A | Wasabi Receptor Toxin (TFA) | Peptides | |
| HY-P5915 | FAM-DEALA-Hyp-YIPMDDDFQLRSF-NH2 | Peptides | |
| HY-P5916 | VSTx-3 | Peptides | |
| HY-P5917 | Vm24-toxin | 1373890-79-9 | Peptides |
| HY-P5918 | Galanin-B2 | 944087-28-9 | Peptides |
| HY-P5919 | Ala-D-γ-Glu-Lys-D-Ala-D-Ala | 2614-55-3 | Peptides |
| HY-P5920 | Urotoxin | Peptides | |
| HY-P5921 | Tityustoxin-Kα | 152618-71-8 | Peptides |
| HY-P5922 | PTD2 | Peptides | |
| HY-P5923 | E70K | Peptides | |
| HY-P5924 | L-K6L9 | 507238-92-8 | Peptides |
| HY-P5924A | D-K6L9 | 426264-61-1 | Peptides |
| HY-P5925 | Ssm spooky toxin | Peptides | |
| HY-P5925A | Ssm spooky toxin (TFA) | Peptides | |
| HY-P5929 | VnP-16 | Peptides | |
| HY-P5930 | HOXB7 8–25 | Peptides | |
| HY-P5931 | Spinoxin | 752984-66-0 | Peptides |
| HY-P5932 | Maculatin 1.1 (TFA) | Peptides | |
| HY-P5936 | Ac-AAVALLPAVLLALLAP-DEVD-CHO | 201608-15-3 | Peptides |
| HY-P5937 | Caerin 1.1 (TFA) | Peptides | |
| HY-P5938 | Ac-AAVALLPAVLLALLAP-YVAD-CHO | 201608-12-0 | Peptides |
| HY-P5939 | Angiotensinogen (1-13) (human) | 82048-97-3 | Peptides |
| HY-P5940 | β-Amyloid precursor protein (96-110), cyclized (human) | 289634-54-4 | Peptides |
| HY-P5941 | Bilaid C1 | 2393866-15-2 | Peptides |
| HY-P5942 | Pterinotoxin-2 | Peptides | |
| HY-P5943 | Pterinotoxin-1 | Peptides | |
| HY-P5944 | Deamino-pterinotoxin-1 | Peptides | |
| HY-P5945 | β-Amyloid (1-8, A2V) | Peptides | |
| HY-P5946 | β-Amyloid (1-8) | 659739-33-0 | Peptides |
| HY-P5947 | Tat-HA-NR2B9c | Peptides | |
| HY-P5949 | AMPR-22 | 2569135-98-2 | Peptides |
| HY-P5950 | ACTH (6-24) (human) | 33512-65-1 | Peptides |
| HY-P5951 | Adrenomedullin (1-12) (human) | 161206-81-1 | Peptides |
| HY-P5952 | Bilaid B1 | 2393866-07-2 | Peptides |
| HY-P5954 | PLTX-II | Peptides | |
| HY-P5955 | Ac-AAVALLPAVLLALLAP-LEVD-CHO | 886462-82-4 | Peptides |
| HY-P5956 | Ac-AAVALLPAVLLALLAP-LEHD-CHO | 623948-42-5 | Peptides |
| HY-P5957 | Omphalotin A | 186511-50-2 | Peptides |
| HY-P5959 | PTBP1 α3-helix derived peptide P1 (TFA) | Peptides | |
| HY-P5960 | PTBP1-RNA-binding inhibitor P6 (TFA) | Peptides | |
| HY-P5961 | Chktide | 289652-77-3 | Peptides |
| HY-P5962 | Fmoc-Gly-Pro-Hyp(OtBu)-OH (TFA) | Peptides | |
| HY-P5963 | Lib2-1 | 2983116-47-6 | Peptides |
| HY-P5964 | K1 peptide | 2973365-72-7 | Peptides |
| HY-P5964A | K1 peptide (TFA) | Peptides | |
| HY-P5965 | BiP substrate | 1421316-16-6 | Peptides |
| HY-P5966 | Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse | 507233-87-6 | Peptides |
| HY-P5967 | Acetly-β Amyloid(15-20), Amide | 189064-06-0 | Peptides |
| HY-P5968 | [Ala28]-β Amyloid(25-35) | 173993-86-7 | Peptides |
| HY-P5969 | Cys-V5 Peptide | 922704-46-9 | Peptides |
| HY-P5970 | DABCYL-TNF-α-EDANS (-4 to +6) (human) | 396716-14-6 | Peptides |
| HY-P5971 | TCMCB07 | 1456699-27-6 | Peptides |
| HY-P5971A | TCMCB07 (TFA) | Peptides | |
| HY-P5972 | GRP20–29, frog | 136058-54-3 | Peptides |
| HY-P5974 | Z-YVAD-pNA | 154564-23-5 | Peptides |
| HY-P5975 | Z-Leu-Leu-Leu-fluoromethyl ketone | 371167-61-2 | Peptides |
| HY-P5976 | Suc-Arg-Pro-Phe-His-Leu-Leu-Val-Tyr-AMC | 76524-84-0 | Peptides |
| HY-P5977 | STE-MEK1(13) | 566872-15-9 | Peptides |
| HY-P5978 | Atriopeptin III (rat) | 90817-13-3 | Peptides |
| HY-P5979 | LRRKtide | 1071466-49-3 | Peptides |
| HY-P5981 | Chromozym t-PA | 137051-68-4 | Peptides |
| HY-P5982 | PTPσ Inhibitor, ISP | Peptides | |
| HY-P5983 | Ac-VEID-AFC | 210345-01-0 | Peptides |
| HY-P5984 | Thioether-cyclized helix B peptide, CHBP | 1453840-35-1 | Peptides |
| HY-P5984A | Thioether-cyclized helix B peptide, CHBP (TFA) | Peptides | |
| HY-P5985 | mSIRK | 593267-11-9 | Peptides |
| HY-P5986 | mSIRK (L9A) | Peptides | |
| HY-P5987 | Calmodulin Kinase IINtide, Myristoylated | Peptides | |
| HY-P5988 | N-myristoyl-RKRTLRRL | 152246-40-7 | Peptides |
| HY-P5989 | Calpain inhibitor V | 912476-54-1 | Peptides |
| HY-P5990 | Prostate Specific Antigen Substrate | 380225-52-5 | Peptides |
| HY-P5991 | K-Casein (106-116),bovine | 103951-35-5 | Peptides |
| HY-P5992 | Factor VIIa substrate | 161572-31-2 | Peptides |
| HY-P5993 | MeOSuc-Ala-Ala-Pro-Val-4-MNA | 72252-91-6 | Peptides |
| HY-P5994 | MeOSuc-AAPF-CMK | 137259-05-3 | Peptides |
| HY-P5995 | MeOSuc-AAPA-CMK | Peptides | |
| HY-P5996 | MCA-Gly-Asp-Ala-Glu-pTyr-Ala-Ala-Lys(DNP)-Arg-NH2 | Peptides | |
| HY-P5997 | XQ2B | 2104728-28-9 | Peptides |
| HY-P5998 | Myosin Light Chain Kinase Substrate (smooth muscle) | 119386-41-3 | Peptides |
| HY-P5999 | Z-FG-NHO-Bz | 118292-22-1 | Peptides |
| HY-P6008 | Myoregulin | Peptides | |
| HY-P6008A | Myoregulin (TFA) | Peptides | |
| HY-P6009 | Cys-αvβ6-BP | Peptides | |
| HY-P6009A | Cys-αvβ6-BP (TFA) | Peptides | |
| HY-P6010 | αvβ6-BP | Peptides | |
| HY-P6010A | αvβ6-BP (TFA) | Peptides | |
| HY-P6011 | GMPRGA | 2059978-58-2 | Peptides |
| HY-P6011A | GMPRGA (TFA) | Peptides | |
| HY-P6012 | SAIRGA | 2059978-63-9 | Peptides |
| HY-P6012A | SAIRGA (TFA) | Peptides | |
| HY-P6013 | wt hMLN | Peptides | |
| HY-P6013A | wt hMLN (TFA) | Peptides | |
| HY-P6022 | G4RGDSP, integrin-binding peptide | 774577-43-4 | Peptides |
| HY-P6023 | D-Leu-Pro-Arg-Rh110-D-Pro | Peptides | |
| HY-P6023A | D-Leu-Pro-Arg-Rh110-D-Pro (TFA) | Peptides | |
| HY-P6023B | D-Leu-Pro-Arg-Rh110-D-Pro (acetate) | Peptides | |
| HY-P6027 | H-D-CHA-Ala-Arg-pNA | 143556-06-3 | Peptides |
| HY-P6027A | H-D-CHA-Ala-Arg-pNA (diacetate) | Peptides | |
| HY-P6028 | GSNKSKPK-NH2 | Peptides | |
| HY-P6028A | GSNKSKPK-NH2 (TFA) | Peptides | |
| HY-P6053 | KK-103 | 2775287-98-2 | Peptides |
| HY-P6079 | Ac-IHIHIYI-NH2 | 2156606-61-8 | Peptides |
| HY-P6079A | Ac-IHIHIYI-NH2 (TFA) | Peptides | |
| HY-P6083 | RTSPSSR | 1995062-44-6 | Peptides |
| HY-P6176 | JLB2-110c | 3032608-72-0 | Peptides |
| HY-P6177 | SGP8 | 855790-98-6 | Peptides |
| HY-P6183 | LXJ-02 | 2672508-37-9 | Peptides |
| HY-P6285 | Z-TPE-2DEVD | 1426396-40-8 | Peptides |
| HY-P6292 | KS-133 | 2724212-01-3 | Peptides |
| HY-P6292A | KS-133 (TFA) | Peptides | |
| HY-P6293 | Heterophyllin A | 145459-18-3 | Natural Products |
| HY-P6294 | Pseudostellarin G | 156525-71-2 | Natural Products |
| HY-P6299 | MAX8 | 944792-75-0 | Peptides |
| HY-P6303 | Gly-Glu-Gly | 50997-16-5 | Peptides |
| HY-P6306 | CS-6253 | 1627911-44-7 | Peptides |
| HY-P6306A | CS-6253 (TFA) | Peptides | |
| HY-P6312 | ESAT6 Epitope | 183273-40-7 | Peptides |
| HY-P6322 | Azide-RRRRRRRR (TFA) | Peptides | |
| HY-P6351 | c(avb6)-DOTA (TFA) | Peptides | |
| HY-P6355 | CAP1-6D | Peptides | |
| HY-P6365 | APL180 (TFA) | Peptides | |
| HY-P6365A | APL180 | 388566-97-0 | Peptides |
| HY-P6365B | APP-018 | 452782-06-8 | Peptides |
| HY-P6372 | SDZ 280-446 | 129893-84-1 | Peptides |
| HY-P6374 | IIQLPEIVVV (TFA) | Peptides | |
| HY-P6421S | LGPLVEQG-Arg(13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-P6422S | LAVYQAGA-Arg(13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-P6423S | CLAVYQAGA-Arg(13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-P6424S | LGADMEDVCG-Arg(13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-P6425S | LCADMEDV-Arg(13C6,15N4) (TFA) | Isotope-Labeled Compounds | |
| HY-P6437 | Drp1 peptide inhibitor P110 | 2770267-63-3 | Peptides |
| HY-P6438 | Alkyne-cRGD | 2665674-77-9 | Peptides |
| HY-P6440 | Met-12 | 1242964-46-0 | Peptides |
| HY-P6441 | KP-6 | 2102414-23-1 | Peptides |
| HY-P6443 | NTPA (TFA) | Peptides | |
| HY-P700001 | IL-4R alpha, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700002 | Tenascin/Tnc, Mouse (His-Myc) | Recombinant Proteins | |
| HY-P700002A | Tenascin/Tnc, Mouse (His-Myc, Solution) | Recombinant Proteins | |
| HY-P700003 | DCIP-1/CXCL3, Mouse (CHO) | Recombinant Proteins | |
| HY-P700004 | PAEP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700006 | PSMA, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P700007 | MMP-14, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700008 | Cadherin-1/CD324, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P700009 | CCL24/Eotaxin-2, Rat | Recombinant Proteins | |
| HY-P70001 | CTLA-4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P700010 | Flap endonuclease 1/FEN-1, Human (His, Myc) | Recombinant Proteins | |
| HY-P700011 | Klotho, Human (CHO, His) | Recombinant Proteins | |
| HY-P700012AF | Animal-Free 4-1BBL/TNFSF9, Human (His) | Recombinant Proteins | |
| HY-P700014AF | Animal-Free AITRL/TNFSF18, Human (His) | Recombinant Proteins | |
| HY-P700015AF | Animal-Free Annexin A5/ANXA5, Human (His) | Recombinant Proteins | |
| HY-P700016AF | Animal-Free APRIL/TNFSF13, Human (His) | Recombinant Proteins | |
| HY-P700017AF | Animal-Free BAFF/TNFSF13B, Human (His) | Recombinant Proteins | |
| HY-P700018AF | Animal-Free beta-NGF, Human (His) | Recombinant Proteins | |
| HY-P700019AF | Animal-Free BMP-10, Human (His) | Recombinant Proteins | |
| HY-P70002 | BAR/Phosphinothricin N-acetyltransferase, Streptomyces hygroscopicus | Recombinant Proteins | |
| HY-P700020AF | Animal-Free GDF-11/BMP-11, Human (His) | Recombinant Proteins | |
| HY-P700021AF | Animal-Free BMP-12/GDF-7, Human (His) | Recombinant Proteins | |
| HY-P700022AF | Animal-Free BMP-13/GDF-6, Human (His) | Recombinant Proteins | |
| HY-P700023AF | Animal-Free GDF-5, Human (His) | Recombinant Proteins | |
| HY-P700024AF | Animal-Free BMP-15, Human (His) | Recombinant Proteins | |
| HY-P700025AF | Animal-Free Nodal, Human (His) | Recombinant Proteins | |
| HY-P700026AF | Animal-Free BMP-3, Human (His) | Recombinant Proteins | |
| HY-P700027AF | Animal-Free BMP-4, Human (His) | Recombinant Proteins | |
| HY-P700028AF | Animal-Free BMP-5, Human (His) | Recombinant Proteins | |
| HY-P700029AF | Animal-Free BMP-6, Human (His) | Recombinant Proteins | |
| HY-P70003 | DPEP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700030AF | Animal-Free BMP-7, Human (His) | Recombinant Proteins | |
| HY-P700031AF | Animal-Free BMP-8a, Human (His) | Recombinant Proteins | |
| HY-P700032AF | Animal-Free BMP-8b, Human (His) | Recombinant Proteins | |
| HY-P700033AF | Animal-Free GDF-2/BMP-9, Human (His) | Recombinant Proteins | |
| HY-P700034AF | Animal-Free MCP-1/CCL2, Human (His) | Recombinant Proteins | |
| HY-P700035AF | Animal-Free CD70, Human (His) | Recombinant Proteins | |
| HY-P700036AF | Animal-Free CD30 Ligand/TNFSF8, Human (His) | Recombinant Proteins | |
| HY-P700037AF | Animal-Free EpCAM/TROP1, Human (His) | Recombinant Proteins | |
| HY-P700038AF | Animal-Free CDNF, Human (His) | Recombinant Proteins | |
| HY-P700039AF | Animal-Free CHI3L1, Human (His) | Recombinant Proteins | |
| HY-P70004 | CD36, Human (HEK293, Fc ) | Recombinant Proteins | |
| HY-P700040AF | Animal-Free GRO-alpha/CXCL1, Human (His) | Recombinant Proteins | |
| HY-P700041AF | Animal-Free IP-10/CXCL10, Human (His) | Recombinant Proteins | |
| HY-P700042AF | Animal-Free I-TAC/CXCL11, Human (His) | Recombinant Proteins | |
| HY-P700043AF | Animal-Free SDF-1 alpha/CXCL12, Human (His) | Recombinant Proteins | |
| HY-P700044AF | Animal-Free BCA-1/CXCL13, Human (His) | Recombinant Proteins | |
| HY-P700045AF | Animal-Free GRO-beta/CXCL2, Human (His) | Recombinant Proteins | |
| HY-P700046AF | Animal-Free PF-4/CXCL4, Human (His) | Recombinant Proteins | |
| HY-P700047AF | Animal-Free ENA-78/CXCL5, Human (His) | Recombinant Proteins | |
| HY-P700048AF | Animal-Free GCP-2/CXCL6, Human (His) | Recombinant Proteins | |
| HY-P700049AF | Animal-Free NAP-2/CXCL7, Human (His) | Recombinant Proteins | |
| HY-P70005 | CTRB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700050AF | Animal-Free MIG/CXCL9, Human (His) | Recombinant Proteins | |
| HY-P700051AF | Animal-Free EGF, Human (His) | Recombinant Proteins | |
| HY-P700052AF | Animal-Free Fas Ligand, Human (His) | Recombinant Proteins | |
| HY-P700053AF | Animal-Free FGF-1, Human (His) | Recombinant Proteins | |
| HY-P700054AF | Animal-Free FGF-11 isoform 1, Human (His) | Recombinant Proteins | |
| HY-P700055AF | Animal-Free FGF-11 isoform 2, Human (His) | Recombinant Proteins | |
| HY-P700056AF | Animal-Free FGF-12, Human (His) | Recombinant Proteins | |
| HY-P700057AF | Animal-Free FGF-13, Human (His) | Recombinant Proteins | |
| HY-P700058AF | Animal-Free FGF-14, Human (His) | Recombinant Proteins | |
| HY-P700059AF | Animal-Free FGF-16, Human (His) | Recombinant Proteins | |
| HY-P70006 | Desmin/DES, Human (His) | Recombinant Proteins | |
| HY-P700060AF | Animal-Free FGF-17, Human (His) | Recombinant Proteins | |
| HY-P700061AF | Animal-Free FGF-18, Human (His) | Recombinant Proteins | |
| HY-P700062AF | Animal-Free FGF-20, Human (His) | Recombinant Proteins | |
| HY-P700063AF | Animal-Free FGF-22, Human (His) | Recombinant Proteins | |
| HY-P700064AF | Animal-Free FGF-23, Human (His) | Recombinant Proteins | |
| HY-P700065AF | Animal-Free FGF-3, Human (His) | Recombinant Proteins | |
| HY-P700066AF | Animal-Free FGF-4, Human (His) | Recombinant Proteins | |
| HY-P700067AF | Animal-Free FGF-5, Human (His) | Recombinant Proteins | |
| HY-P700068AF | Animal-Free FGF-6, Human (His) | Recombinant Proteins | |
| HY-P700069AF | Animal-Free FGF-8a, Human (His) | Recombinant Proteins | |
| HY-P70007 | Cyclophilin A, Mouse (solution) | Recombinant Proteins | |
| HY-P700070AF | Animal-Free FGF-8b, Human/Mouse (His) | Recombinant Proteins | |
| HY-P700071AF | Animal-Free FGF-9, Human (His) | Recombinant Proteins | |
| HY-P700072 | FLT3LG, Human | Recombinant Proteins | |
| HY-P700072AF | Animal-Free FLT3LG, Human (His) | Recombinant Proteins | |
| HY-P700073AF | Animal-Free Galectin-10, Human (His) | Recombinant Proteins | |
| HY-P700074AF | Animal-Free Galectin-12, Human (His) | Recombinant Proteins | |
| HY-P700075AF | Animal-Free Galectin-13, Human (His) | Recombinant Proteins | |
| HY-P700076AF | Animal-Free Galectin-14/LGALS14, Human (His) | Recombinant Proteins | |
| HY-P700077AF | Animal-Free Galectin-16, Human (His) | Recombinant Proteins | |
| HY-P700078AF | Animal-Free Galectin-2/LGALS2, Human (His) | Recombinant Proteins | |
| HY-P700079AF | Animal-Free Galectin-3/LGALS3, Human (His) | Recombinant Proteins | |
| HY-P70007A | Cyclophilin A, Mouse | Recombinant Proteins | |
| HY-P70008 | MIG/CXCL9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700080AF | Animal-Free Galectin-7/LGALS7, Human (His) | Recombinant Proteins | |
| HY-P700081AF | Animal-Free Galectin-8/LGALS8, Human (His) | Recombinant Proteins | |
| HY-P700082AF | Animal-Free Galectin-9/LGALS9, Human (His) | Recombinant Proteins | |
| HY-P700083AF | Animal-Free G-CSF, Human (His) | Recombinant Proteins | |
| HY-P700084AF | Animal-Free GDNF, Human (His) | Recombinant Proteins | |
| HY-P700085AF | Animal-Free Intrinsic Factor/GIF, Human (His) | Recombinant Proteins | |
| HY-P700086AF | Animal-Free GM-CSF, Human (His) | Recombinant Proteins | |
| HY-P700087AF | Animal-Free HDGF, Human (His) | Recombinant Proteins | |
| HY-P700088AF | Animal-Free HMGB2/HMG-2, Human (His) | Recombinant Proteins | |
| HY-P700089AF | Animal-Free IFN-alpha 1/IFNA13, Human (His) | Recombinant Proteins | |
| HY-P70009 | Collagen alpha-1(IX) chain/COL9A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700090AF | Animal-Free IFN-beta, Human (His) | Recombinant Proteins | |
| HY-P700091AF | Animal-Free IFN-gamma, Human (His) | Recombinant Proteins | |
| HY-P700092AF | Animal-Free IFN-omega 1, Human (His) | Recombinant Proteins | |
| HY-P700093AF | Animal-Free IGF-I/IGF-1, Human (His) | Recombinant Proteins | |
| HY-P700094AF | Animal-Free IGF2, Human (His) | Recombinant Proteins | |
| HY-P700095AF | Animal-Free IL-1 alpha, Human (His) | Recombinant Proteins | |
| HY-P700096AF | Animal-Free IL-1 beta, Human (His) | Recombinant Proteins | |
| HY-P700097AF | Animal-Free IL-10, Human (His) | Recombinant Proteins | |
| HY-P700098AF | Animal-Free IL-11, Human (His) | Recombinant Proteins | |
| HY-P700099AF | Animal-Free IL-12 alpha, Human (His) | Recombinant Proteins | |
| HY-P7001 | FGF-1, Human | Recombinant Proteins | |
| HY-P70010 | CD73/5'-Nucleotidase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700100AF | Animal-Free IL-12 beta, Human (His) | Recombinant Proteins | |
| HY-P700101AF | Animal-Free IL-12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700102AF | Animal-Free IL-13, Human (His) | Recombinant Proteins | |
| HY-P700103AF | Animal-Free IL-16, Human (His) | Recombinant Proteins | |
| HY-P700104AF | Animal-Free IL-17A, Human (His) | Recombinant Proteins | |
| HY-P700105AF | Animal-Free IL-17B, Human (His) | Recombinant Proteins | |
| HY-P700106AF | Animal-Free IL-17D, Human (His) | Recombinant Proteins | |
| HY-P700107AF | Animal-Free IL-17F, Human (His) | Recombinant Proteins | |
| HY-P700108AF | Animal-Free IL-18, Human (His) | Recombinant Proteins | |
| HY-P700109AF | Animal-Free IL-19, Human (His) | Recombinant Proteins | |
| HY-P70011 | Cyclophilin B/PPIB, Human (HEK293, C-His, solution) | Recombinant Proteins | |
| HY-P700110AF | Animal-Free IL-1RA/IL-1RN, Human (His) | Recombinant Proteins | |
| HY-P700111AF | Animal-Free IL-20, Human (His) | Recombinant Proteins | |
| HY-P700112AF | Animal-Free IL-21, Human (His) | Recombinant Proteins | |
| HY-P700113AF | Animal-Free IL-22, Human (His) | Recombinant Proteins | |
| HY-P700114AF | Animal-Free IL-23 alpha, Human (His) | Recombinant Proteins | |
| HY-P700115AF | Animal-Free IL-24, Human (His) | Recombinant Proteins | |
| HY-P700116AF | Animal-Free IL-25/IL-17E, Human (His) | Recombinant Proteins | |
| HY-P700117AF | Animal-Free IL-26/AK155, Human (His) | Recombinant Proteins | |
| HY-P700118AF | Animal-Free IL-27 beta/EBI3, Human (His) | Recombinant Proteins | |
| HY-P700119AF | Animal-Free IFN-lambda 2/IL-28A, Human (His) | Recombinant Proteins | |
| HY-P70011A | Cyclophilin B/PPIB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70012 | Thymidylate, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700120AF | Animal-Free IFN-lambda 3/IL-28B, Human (His) | Recombinant Proteins | |
| HY-P700121AF | Animal-Free IFN-lambda 1/IL-29, Human (His) | Recombinant Proteins | |
| HY-P700122AF | Animal-Free IL-30/IL-27A, Human (His) | Recombinant Proteins | |
| HY-P700123AF | Animal-Free IL-31, Human (His) | Recombinant Proteins | |
| HY-P700124AF | Animal-Free IL-32 alpha, Human (His) | Recombinant Proteins | |
| HY-P700125AF | Animal-Free IL-34, Human (His) | Recombinant Proteins | |
| HY-P700126AF | Animal-Free IL-36 alpha/IL-1F6, Human (His) | Recombinant Proteins | |
| HY-P700127AF | Animal-Free IL-36RN, Human (His) | Recombinant Proteins | |
| HY-P700128AF | Animal-Free IL-37 Protein, Human (His) | Recombinant Proteins | |
| HY-P700129AF | Animal-Free IL-1F10/IL-38, Human (His) | Recombinant Proteins | |
| HY-P70013 | CRHBP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700130AF | Animal-Free IL-4, Human (His) | Recombinant Proteins | |
| HY-P700131AF | Animal-Free IL-5, Human (His) | Recombinant Proteins | |
| HY-P700132AF | Animal-Free IL-7, Human (His) | Recombinant Proteins | |
| HY-P700133AF | Animal-Free IL-8/CXCL8, Human (His) | Recombinant Proteins | |
| HY-P700134AF | Animal-Free IL-9, Human (His) | Recombinant Proteins | |
| HY-P700135AF | Animal-Free LIF, Human (His) | Recombinant Proteins | |
| HY-P700136AF | Animal-Free LIGHT/TNFSF14, Human (His) | Recombinant Proteins | |
| HY-P700137AF | Animal-Free M-CSF, Human (His) | Recombinant Proteins | |
| HY-P700138AF | Animal-Free MDK, Human (His) | Recombinant Proteins | |
| HY-P700139AF | Animal-Free MMP-2, Human (His) | Recombinant Proteins | |
| HY-P70014 | CDK2, Human (His) | Recombinant Proteins | |
| HY-P700142AF | Animal-Free Neurturin, Human (His) | Recombinant Proteins | |
| HY-P700143AF | Animal-Free Noggin, Human (His) | Recombinant Proteins | |
| HY-P700144AF | Animal-Free PGA5, Human (His) | Recombinant Proteins | |
| HY-P700145AF | Animal-Free Pleiotrophin, Human (His) | Recombinant Proteins | |
| HY-P700146AF | Animal-Free AGER, Human (His) | Recombinant Proteins | |
| HY-P700147AF | Animal-Free RANK L/TNFSF11, Human (His) | Recombinant Proteins | |
| HY-P700148AF | Animal-Free SCF, Human (His) | Recombinant Proteins | |
| HY-P700149AF | Animal-Free TGF alpha/TGFA, Human (His) | Recombinant Proteins | |
| HY-P70015 | B18R, Vaccinia virus (HEK293, His) | Recombinant Proteins | |
| HY-P700150AF | Animal-Free TGF beta 1/TGFB1, Human (His) | Recombinant Proteins | |
| HY-P700151AF | Animal-Free TGF beta 2/TGFB2, Human (His) | Recombinant Proteins | |
| HY-P700152AF | Animal-Free TGF beta 3/TGFB3, Human (His) | Recombinant Proteins | |
| HY-P700153AF | Animal-Free TL1A/TNFSF15, Human (His) | Recombinant Proteins | |
| HY-P700154AF | Animal-Free TNF-beta/TNFSF1, Human (His) | Recombinant Proteins | |
| HY-P700155AF | Animal-Free TPO/Thrombopoietin, Human (His) | Recombinant Proteins | |
| HY-P700156AF | Animal-Free TWEAK/TNFSF12, Human (His) | Recombinant Proteins | |
| HY-P700157AF | Animal-Free VEGF165, Human (His) | Recombinant Proteins | |
| HY-P700158AF | Animal-Free BDNF, Human/Mouse (His) | Recombinant Proteins | |
| HY-P700159AF | Animal-Free Activin A, Human/Mouse/Rat (His) | Recombinant Proteins | |
| HY-P70016 | AZGP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700160AF | Animal-Free 4-1BBL/TNFSF9, Mouse (His) | Recombinant Proteins | |
| HY-P700161AF | Animal-Free BAFF/TNFSF13B, Mouse (His) | Recombinant Proteins | |
| HY-P700162AF | Animal-Free beta-NGF, Mouse (His) | Recombinant Proteins | |
| HY-P700163AF | Animal-Free BMP-4, Mouse (His) | Recombinant Proteins | |
| HY-P700164AF | Animal-Free MCP-1/CCL2, Mouse (His) | Recombinant Proteins | |
| HY-P700165AF | Animal-Free CCL4, Mouse (His) | Recombinant Proteins | |
| HY-P700166AF | Animal-Free CDNF, Mouse (His) | Recombinant Proteins | |
| HY-P700167AF | Animal-Free GRO-alpha/CXCL1, Mouse (His) | Recombinant Proteins | |
| HY-P700168AF | Animal-Free IP-10/CRG-2/CXCL10, Mouse (His) | Recombinant Proteins | |
| HY-P700169AF | Animal-Free I-TAC/CXCL11, Mouse (His) | Recombinant Proteins | |
| HY-P70017 | CD26/Dipeptidyl Peptidase 4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700170AF | Animal-Free CXCL16, Mouse (His) | Recombinant Proteins | |
| HY-P700171AF | Animal-Free MIP-2/CXCL2, Mouse (His) | Recombinant Proteins | |
| HY-P700172AF | Animal-Free DCIP-1/CXCL3, Mouse (His) | Recombinant Proteins | |
| HY-P700173AF | Animal-Free LIX/CXCL5, Mouse (His) | Recombinant Proteins | |
| HY-P700174AF | Animal-Free NAP-2/CXCL7, Mouse (His) | Recombinant Proteins | |
| HY-P700175AF | Animal-Free NAP-2/CXCL7, Mouse (62a.a, His) | Recombinant Proteins | |
| HY-P700176AF | Animal-Free Fas Ligand, Mouse (His) | Recombinant Proteins | |
| HY-P700177AF | Animal-Free FLT3LG, Mouse (His) | Recombinant Proteins | |
| HY-P700178AF | Animal-Free G-CSF, Mouse (His) | Recombinant Proteins | |
| HY-P700179AF | Animal-Free GDNF, Mouse (His) | Recombinant Proteins | |
| HY-P70018 | Collagen alpha-1(VIII) chain/COL8A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700180AF | Animal-Free GM-CSF, Mouse (His) | Recombinant Proteins | |
| HY-P700181AF | Animal-Free HDGF, Mouse (His) | Recombinant Proteins | |
| HY-P700182AF | Animal-Free HMGB1/HMG-1, Mouse (His) | Recombinant Proteins | |
| HY-P700183AF | Animal-Free IFN alpha 1/IFNA1, Mouse (His) | Recombinant Proteins | |
| HY-P700184AF | Animal-Free IFN-gamma, Mouse (His) | Recombinant Proteins | |
| HY-P700185AF | Animal-Free IGF-II, Mouse (His) | Recombinant Proteins | |
| HY-P700186AF | Animal-Free IL-1 alpha, Mouse (His) | Recombinant Proteins | |
| HY-P700187AF | Animal-Free IL-1 beta, Mouse (His) | Recombinant Proteins | |
| HY-P700188AF | Animal-Free IL-10, Mouse (His) | Recombinant Proteins | |
| HY-P700189AF | Animal-Free IL-11, Mouse (His) | Recombinant Proteins | |
| HY-P70019 | DCK/Deoxycytidine kinase, Human (His-T7) | Recombinant Proteins | |
| HY-P700190AF | Animal-Free IL-12 alpha, Mouse (His) | Recombinant Proteins | |
| HY-P700191AF | Animal-Free IL-12 beta, Mouse (His) | Recombinant Proteins | |
| HY-P700192AF | Animal-Free IL-13, Mouse (His) | Recombinant Proteins | |
| HY-P700193AF | Animal-Free IL-15, Mouse (His) | Recombinant Proteins | |
| HY-P700194AF | Animal-Free IL-17A, Mouse (His) | Recombinant Proteins | |
| HY-P700195AF | Animal-Free IL-17F, Mouse (His) | Recombinant Proteins | |
| HY-P700196AF | Animal-Free IL-19, Mouse (His) | Recombinant Proteins | |
| HY-P700197AF | Animal-Free IL-1RA/IL-1RN, Mouse (His) | Recombinant Proteins | |
| HY-P700198AF | Animal-Free IL-20 Protein, Mouse (His) | Recombinant Proteins | |
| HY-P700199AF | Animal-Free IL-21, Mouse (His) | Recombinant Proteins | |
| HY-P7002 | Amphiregulin, Human (HEK293) | Recombinant Proteins | |
| HY-P70020 | Cystatin D/CST5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700200AF | Animal-Free IL-24, Mouse (His) | Recombinant Proteins | |
| HY-P700201AF | Animal-Free IL-25/IL-17E, Mouse (His) | Recombinant Proteins | |
| HY-P700202AF | Animal-Free IL-27 beta EBI3, Mouse (His) | Recombinant Proteins | |
| HY-P700203AF | Animal-Free IFN-lambda 2/IL-28A, Mouse (His) | Recombinant Proteins | |
| HY-P700204AF | Animal-Free IFN-lambda 3/IL-28B, Mouse (His) | Recombinant Proteins | |
| HY-P700205AF | Animal-Free IL-3, Mouse (His) | Recombinant Proteins | |
| HY-P700206AF | Animal-Free IL-30/IL-27A, Mouse (His) | Recombinant Proteins | |
| HY-P700207AF | Animal-Free IL-31, Mouse (His) | Recombinant Proteins | |
| HY-P700208AF | Animal-Free IL-33, Mouse (His) | Recombinant Proteins | |
| HY-P700209AF | Animal-Free IL-34, Mouse (His) | Recombinant Proteins | |
| HY-P70021 | Decorin/PGS2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700210AF | Animal-Free IL-36 alpha/IL-1F6, Mouse (His) | Recombinant Proteins | |
| HY-P700211AF | Animal-Free IL-36 gamma/IL-1F9, Mouse (His) | Recombinant Proteins | |
| HY-P700212AF | Animal-Free IL-36RN, Mouse (His) | Recombinant Proteins | |
| HY-P700213AF | Animal-Free IL-1F10/IL-38, Mouse (His) | Recombinant Proteins | |
| HY-P700214AF | Animal-Free IL-4, Mouse (His) | Recombinant Proteins | |
| HY-P700215AF | Animal-Free IL-5, Mouse (His) | Recombinant Proteins | |
| HY-P700216AF | Animal-Free IL-6, Mouse (His) | Recombinant Proteins | |
| HY-P700217AF | Animal-Free IL-7, Mouse (His) | Recombinant Proteins | |
| HY-P700218AF | Animal-Free IL-9, Mouse (His) | Recombinant Proteins | |
| HY-P700219AF | Animal-Free SDF-1 alpha/CXCL12, Mouse (His) | Recombinant Proteins | |
| HY-P70022 | CD38, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P700220AF | Animal-Free LIF, Mouse (His) | Recombinant Proteins | |
| HY-P700221AF | Animal-Free LIGHT/TNFSF14, Mouse (His) | Recombinant Proteins | |
| HY-P700222AF | Animal-Free M-CSF, Mouse (His) | Recombinant Proteins | |
| HY-P700223AF | Animal-Free Midkine, Mouse (His) | Recombinant Proteins | |
| HY-P700224AF | Animal-Free Neurturin, Mouse (His) | Recombinant Proteins | |
| HY-P700225AF | Animal-Free OX40 Ligand/TNFSF4, Mouse (His) | Recombinant Proteins | |
| HY-P700226AF | Animal-Free RANK L/TNFSF11, Mouse (His) | Recombinant Proteins | |
| HY-P700227AF | Animal-Free TGF beta 1/TGFB1, Mouse (His) | Recombinant Proteins | |
| HY-P700228AF | Animal-Free TNF beta, Mouse (His) | Recombinant Proteins | |
| HY-P700229AF | Animal-Free TNFRSF12A, Mouse (His) | Recombinant Proteins | |
| HY-P70023 | CD30/TNFRSF8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700230AF | Animal-Free BMP-4, Pig (His) | Recombinant Proteins | |
| HY-P700231AF | Animal-Free MCP-1/CCL2, Pig (His) | Recombinant Proteins | |
| HY-P700232AF | Animal-Free IP-10/CXCL10, Pig (His) | Recombinant Proteins | |
| HY-P700233AF | Animal-Free I-TAC/CXCL11, Pig (His) | Recombinant Proteins | |
| HY-P700234AF | Animal-Free CXCL13, Pig (His) | Recombinant Proteins | |
| HY-P700235AF | Animal-Free MIG/CXCL9, Pig (His) | Recombinant Proteins | |
| HY-P700236AF | Animal-Free EGF, Pig (His) | Recombinant Proteins | |
| HY-P700237AF | Animal-Free FGF-2, Pig (His) | Recombinant Proteins | |
| HY-P700238AF | Animal-Free FLT3LG, Pig (His) | Recombinant Proteins | |
| HY-P700239AF | Animal-Free GM-CSF, Pig (His) | Recombinant Proteins | |
| HY-P70024 | HPD/HPPDase, Human (His) | Recombinant Proteins | |
| HY-P700240AF | Animal-Free IFN-gamma, Pig (His) | Recombinant Proteins | |
| HY-P700241AF | Animal-Free IGF-I, Pig (His) | Recombinant Proteins | |
| HY-P700242AF | Animal-Free IL-1 alpha/IL-1F1, Pig (His) | Recombinant Proteins | |
| HY-P700243AF | Animal-Free IL-1 beta, Pig (His) | Recombinant Proteins | |
| HY-P700244AF | Animal-Free IL-10, Pig (His) | Recombinant Proteins | |
| HY-P700245AF | Animal-Free IL-15, Pig (His) | Recombinant Proteins | |
| HY-P700246AF | Animal-Free IL-17A, Pig (His) | Recombinant Proteins | |
| HY-P700247AF | Animal-Free IL-2, Pig (His) | Recombinant Proteins | |
| HY-P700248AF | Animal-Free IL-4, Pig (His) | Recombinant Proteins | |
| HY-P700249AF | Animal-Free IL-6, Pig (His) | Recombinant Proteins | |
| HY-P70025 | Cystathionine gamma-lyase/CTH, Human | Recombinant Proteins | |
| HY-P700250AF | Animal-Free IL-8/CXCL8, Pig (His) | Recombinant Proteins | |
| HY-P700251AF | Animal-Free TGF beta 1/TGFB1, Pig (His) | Recombinant Proteins | |
| HY-P700252AF | Animal-Free TNF-alpha/TNFSF2, Pig (His) | Recombinant Proteins | |
| HY-P700253 | DHH, Human (His-GST, Myc) | Recombinant Proteins | |
| HY-P700253AF | Animal-Free RSPO1/R-spondin-1, Human (243a.a, HEK293, His, SUMO) | Recombinant Proteins | |
| HY-P700254 | IL-1 beta, Human (N-His) | Recombinant Proteins | |
| HY-P700255 | RSPO1/R-spondin-1, Mouse (189aa, His) | Recombinant Proteins | |
| HY-P700256 | IGFBP-1, Mouse (SUMO, His) | Recombinant Proteins | |
| HY-P700257 | Ki67/MKI67, Human (His) | Recombinant Proteins | |
| HY-P700258 | SMYD3, Human (His-Myc) | Recombinant Proteins | |
| HY-P700259 | "RANKL/TNFSF11, Mouse (CHO, His) " | Recombinant Proteins | |
| HY-P70026 | dUTPase/DUT, Human | Recombinant Proteins | |
| HY-P700260 | Aminopeptidase P1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700261 | Prolactin, Mouse (His) | Recombinant Proteins | |
| HY-P700262 | "R-spondin 3, Human (HEK293, His) " | Recombinant Proteins | |
| HY-P700263 | TNFR-1/CD120a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700264 | TNFR-1/CD120a, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P700265 | Fructose-bisphosphate aldolase A/ALDOA, Human (His) | Recombinant Proteins | |
| HY-P700266 | MCP-5/CCL12, Mouse (P. pastoris, His) | Recombinant Proteins | |
| HY-P700268 | RHEB, Human (sf9, N-His) | Recombinant Proteins | |
| HY-P700271 | BCAS2, Human (N-GST) | Recombinant Proteins | |
| HY-P700275 | PPAR gamma, Human (C-His, solution) | Recombinant Proteins | |
| HY-P700279 | KGF-2/FGF-10, Human (N-His) | Recombinant Proteins | |
| HY-P70028 | CD68, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P700280 | CXCL14/BRAK, Rat (N-His) | Recombinant Proteins | |
| HY-P700281 | CCL6, Rat (N-His) | Recombinant Proteins | |
| HY-P700282 | FGF-1, Mouse (N-His) | Recombinant Proteins | |
| HY-P700283 | TNF-alpha/TNFSF2, Pig (N-His) | Recombinant Proteins | |
| HY-P700285 | CCL11, Rhesus macaque (N-His) | Recombinant Proteins | |
| HY-P700286 | Noggin, Mouse (HEK293) | Recombinant Proteins | |
| HY-P700287 | FGF-17, Human | Recombinant Proteins | |
| HY-P700288 | FGF-4, Human (136a.a) | Recombinant Proteins | |
| HY-P700289 | "FGF-1, Human (154a.a) " | Recombinant Proteins | |
| HY-P70029 | Basigin/CD147, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700290 | "IL-1 alpha, Human (HEK293, Fc) " | Recombinant Proteins | |
| HY-P700291 | TNF-alpha/TNFSF2, Human (177a.a, His) | Recombinant Proteins | |
| HY-P700292 | Prolactin, Human | Recombinant Proteins | |
| HY-P700293 | GDF-15, Mouse (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P700294 | IL-21, Mouse (His) | Recombinant Proteins | |
| HY-P700297 | Semaphorin-3A/SEMA3A, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P7003 | BAFF/TNFSF13B, Human (CHO) | Recombinant Proteins | |
| HY-P70030 | CHI3L1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700300 | Ribonuclease R (rnr), E.coli (His) | Recombinant Proteins | |
| HY-P700301 | Galectin-2/LGALS2, Human (GST) | Recombinant Proteins | |
| HY-P700302 | FcRH5/FcRL5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700303 | Bcl-2-like 11, Human (His) | Recombinant Proteins | |
| HY-P700304 | 14-3-3 beta, Human (His) | Recombinant Proteins | |
| HY-P700306 | OX40 Ligand/TNFSF4, Human (HEK293) | Recombinant Proteins | |
| HY-P700308 | Stratifin, Human (N-His, C-Myc) | Recombinant Proteins | |
| HY-P700309 | SAA1, Mouse (His) | Recombinant Proteins | |
| HY-P70031 | CFHR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700311 | Sorcin/SRI, Human (E.coli, GST) | Recombinant Proteins | |
| HY-P700312 | T4 gp32, T4 phage (His, Myc) | Recombinant Proteins | |
| HY-P700313 | Wnt4, Human (HEK293, C-hFc) | Recombinant Proteins | |
| HY-P700320 | Protein A (His) | Recombinant Proteins | |
| HY-P700321 | Protein G, Staphylococcus aureus (His) | Recombinant Proteins | |
| HY-P70033 | CTRL-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700331 | Protein A/G, Staphylococcus aureus (His) | Recombinant Proteins | |
| HY-P70034 | CDKN2C, Human (His) | Recombinant Proteins | |
| HY-P70035 | ECE-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70036 | Afamin/AFM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70036B | Afamin/AFM, Human (587a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70037 | CDKN1B, Human (His) | Recombinant Proteins | |
| HY-P700378 | ACKR2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70038 | Deoxyhypusine synthase/DHS, Human (His) | Recombinant Proteins | |
| HY-P700380 | ACKR1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P700381 | Glutathione S-transferase kappa 1/GSTK1, Human (GST) | Recombinant Proteins | |
| HY-P700382 | Galectin-8/LGALS8, Human (GST) | Recombinant Proteins | |
| HY-P700383 | PEX19, Human (GST) | Recombinant Proteins | |
| HY-P700384 | RGS17, Human (GST) | Recombinant Proteins | |
| HY-P700385 | YcbX, E.coli (GST) | Recombinant Proteins | |
| HY-P700386 | YTFE, E.coli (GST) | Recombinant Proteins | |
| HY-P700387 | LDCC, E.coli (His) | Recombinant Proteins | |
| HY-P700388 | HP-0175, Helicobacter pylori (GST) | Recombinant Proteins | |
| HY-P700389 | Protein E7, HPV (N-His, C-His) | Recombinant Proteins | |
| HY-P70039 | CTCF, Human | Recombinant Proteins | |
| HY-P700390 | GPD1L, Human (GST) | Recombinant Proteins | |
| HY-P700391 | SINHCAF, Human (GST) | Recombinant Proteins | |
| HY-P700392 | UBAC1, Human (GST) | Recombinant Proteins | |
| HY-P700393 | BZW2, Human (GST) | Recombinant Proteins | |
| HY-P700394 | Alkaline Phosphatase/ALPI, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P700395 | Alkaline Phosphatase/ALPI, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P700396 | ANGPT2/Angiopoietin-2, Dog (HEK293, His) | Recombinant Proteins | |
| HY-P700398 | C5AR1-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700399 | CCR4-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7004 | FGF basic/bFGF, Human (146a.a) | Recombinant Proteins | |
| HY-P70040 | BLK, Human (His) | Recombinant Proteins | |
| HY-P700400 | CCR8-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700401 | CD24-Nanoparticle, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700402 | CD44, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P700403 | Claudin-18/CLDN18.2-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700404 | Claudin-18/CLDN18.2-VLP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700405 | Claudin-4/CLDN4-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700406 | Claudin-6/CLDN6-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700407 | Claudin-9/CLDN9-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700408 | CNR1-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700409 | EGFR, Human (621a.a, HEK293, N-His, C-Myc) | Recombinant Proteins | |
| HY-P70041 | Cyclin-H/CCNH, Human (His) | Recombinant Proteins | |
| HY-P700410 | ENPP-3, Human (828a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700411 | GCGR, Human (HEK293, N-His, C-Myc) | Recombinant Proteins | |
| HY-P700413 | Growth Hormone R/GHR, Human (Biotinylated, HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P700414 | Glypican-3/GPC3, Human (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P700415 | GUCY2C/Guanylyl cyclase C, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P700417 | L1CAM, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P700418 | LIFR, Human (HEK293, hFc-Flag) | Recombinant Proteins | |
| HY-P700419 | TNF-beta/TNFSF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70042 | CRISP-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700420 | MAGEA4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700421 | Tau-F/2N4R, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700422 | PNS-Tau/MAPT, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700423 | Tau-A/MAPT, Macaca mulatta (HEK293, His) | Recombinant Proteins | |
| HY-P700424 | Tau-A/SC1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P700425 | MIF, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700426 | Mesothelin, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700427 | NRG1-beta 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700428 | Plexin B1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P700429 | Semaphorin-4D/SEMA4D, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P70043 | TYRO3/DTK, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P700430 | SSTR2-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700431 | TFPI, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P700432 | TNFRSF11B/OPG, Human (HEK293, hFc-Flag) | Recombinant Proteins | |
| HY-P700433 | CD30/TNFRSF8, Human (HEK293, N-His, C-Myc) | Recombinant Proteins | |
| HY-P700434 | CD30 Ligand/TNFSF8, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P700435 | 4-1BBL/TNFSF9, Human (HEK293, hFc-Myc) | Recombinant Proteins | |
| HY-P700436 | FGFR-1 beta, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700438 | ENPP-3, Macaca fascicularis (HEK293, His) | Recombinant Proteins | |
| HY-P700439 | CD44, Macaca fascicularis (HEK293, His) | Recombinant Proteins | |
| HY-P70044 | CD38, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P700440 | Claudin-18/CLDN18.2-VLP, Macaca fascicularis (HEK293, His) | Recombinant Proteins | |
| HY-P700441 | DNAM-1, Human (HEK293, hFc, Myc) | Recombinant Proteins | |
| HY-P700442 | MERTK, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700443 | RSPO1/R-spondin-1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700444 | CD20/MS4A1-VLP, Dog (HEK293, His) | Recombinant Proteins | |
| HY-P700445 | ACE2, Paguma larvata (HEK293, hFc) | Recombinant Proteins | |
| HY-P700446 | MERTK, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700448 | CD276/B7-H3, Human (HEK293, Myc-hFc) | Recombinant Proteins | |
| HY-P700449 | GFRAL, Mouse (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P70045 | Claudin-18/CLDN18.1, Human (His) | Recombinant Proteins | |
| HY-P700450 | IGFL1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700451 | ZG16B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700452 | HVEM/TNFRSF14, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700453 | BAFFR/TNFRSF13C, Human (HEK293, hFc-Flag) | Recombinant Proteins | |
| HY-P700454 | IGFLR1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P700455 | ACE2, Human (Biotinylated, HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P700456 | Delta-like 3/DLL3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700457 | GPRC5D-VLP, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P700458 | ULBP1, Human (Biotinylated, HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P700459 | BAFF/TNFSF13B, Human (Biotinylated, HEK293, hFc-Avi) | Recombinant Proteins | |
| HY-P70046 | B2M/Beta-2-microglobulin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700460 | Endothelin-1/EDN1, Human (GST) | Recombinant Proteins | |
| HY-P700461 | TNF-alpha/TNFSF2, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700462 | IL-12 Protein, Human (HEK293, His, Flag) | Recombinant Proteins | |
| HY-P700463 | LIV-1/SLC39A6, Human (Baculovirus, His) | Recombinant Proteins | |
| HY-P700464 | CD93/C1qR1, Macaca fascicularis (HEK293, His) | Recombinant Proteins | |
| HY-P700467 | TPBG/5T4, Cynomolgus (HEK293, N-His, C-Myc) | Recombinant Proteins | |
| HY-P700468 | GLP1R, Human (HEK293, N-His, C-Myc) | Recombinant Proteins | |
| HY-P700469 | DSG3, Human (Sf9, His) | Recombinant Proteins | |
| HY-P70047 | Peptidyl-prolyl cis-trans isomerase A/CYPA, Human | Recombinant Proteins | |
| HY-P700470 | TMEFF2/Tomoregulin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700471 | CEACAM6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700472 | Claudin-3/CLDN3-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700473 | LY6G6D, Macaca fascicularis (P. pastoris, His) | Recombinant Proteins | |
| HY-P700474 | TGF beta 1/TGFB1, Oncorhynchus mykiss (P. pastoris, His) | Recombinant Proteins | |
| HY-P700475 | IGF2, Human (GST) | Recombinant Proteins | |
| HY-P700476 | FGF basic/bFGF, Bovine (His) | Recombinant Proteins | |
| HY-P700477 | FGF basic/bFGF, Bovine (P. pastoris, N-His) | Recombinant Proteins | |
| HY-P700478 | IGF-I/IGF-1, Human (P. pastoris, N-His) | Recombinant Proteins | |
| HY-P700479 | FGF basic/bFGF, Human (P. pastoris, N-His) | Recombinant Proteins | |
| HY-P70047A | Peptidyl-prolyl cis-trans isomerase A/CYPA, Human | Recombinant Proteins | |
| HY-P70048 | PIN/DYNLL1, Human (His) | Recombinant Proteins | |
| HY-P700480 | FGF-5, Human (GST) | Recombinant Proteins | |
| HY-P700481 | TDGF1, Human (GST) | Recombinant Proteins | |
| HY-P700483 | TGF beta 1/TGFB1, Xenopus laevis (P. pastoris, His) | Recombinant Proteins | |
| HY-P700484 | FGFR-3, Human (P. pastoris, N-His) | Recombinant Proteins | |
| HY-P700485 | EPS15, Human (His) | Recombinant Proteins | |
| HY-P700487 | FGF2, Chicken (N-His, C-Myc) | Recombinant Proteins | |
| HY-P700488 | HDGF, Mouse (P. pastoris, N-His, C-Myc) | Recombinant Proteins | |
| HY-P700489 | TDGF1P3, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P70049 | CXADR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700492 | IGFL1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P700493 | FGF-23, Rat (P. pastoris, His) | Recombinant Proteins | |
| HY-P700494 | FGF-22, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700495 | HO-1, Mouse (His) | Recombinant Proteins | |
| HY-P700496 | VEGF-A, Rabbit (His-SUMO) | Recombinant Proteins | |
| HY-P700497 | VEGF-A, Rabbit (P. pastoris, His) | Recombinant Proteins | |
| HY-P700498 | MSTN, Cat (HEK293, His) | Recombinant Proteins | |
| HY-P700499 | DFFA, Human (GST) | Recombinant Proteins | |
| HY-P7004AF | Animal-Free FGF basic/bFGF, Human (154a.a,) | Recombinant Proteins | |
| HY-P7005 | Betacellulin, Human | Recombinant Proteins | |
| HY-P70050 | CRADD, Human | Recombinant Proteins | |
| HY-P700500 | OX40 Ligand/TNFSF4, Rabbit (HEK293, hFc) | Recombinant Proteins | |
| HY-P700501 | OX40 Ligand/TNFSF4, Rabbit (P. pastoris, His-Myc) | Recombinant Proteins | |
| HY-P700502 | APAF1, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700503 | TRIM24, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700504 | TNF-alpha/TNFSF2, Marmota monax (Baculovirus, His) | Recombinant Proteins | |
| HY-P700505 | DR6/TNFRSF21, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700506 | EIF3G, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700507 | TNF-alpha/TNFSF2, Human (P. pastoris, C-His) | Recombinant Proteins | |
| HY-P700508 | GM-CSF, Human (P.pastoris, N-His) | Recombinant Proteins | |
| HY-P700509 | TFF1, Human (P. pastoris, N-His) | Recombinant Proteins | |
| HY-P70051 | Aminopeptidase N/APN, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700510 | TNF-alpha/TNFSF2, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P700511 | CSF1R, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P700512 | GM-CSF, Bovine (P. pastoris, His-Myc) | Recombinant Proteins | |
| HY-P700513 | MIF, Human (N-His, C-Myc) | Recombinant Proteins | |
| HY-P700514 | USF1, Human (His) | Recombinant Proteins | |
| HY-P700515 | TNF-alpha/TNFSF2, Sheep (GST) | Recombinant Proteins | |
| HY-P700516 | TNF-alpha/TNFSF2, Sheep (P. pastoris, His) | Recombinant Proteins | |
| HY-P700517 | MIF, Mouse (P. pastoris, His) | Recombinant Proteins | |
| HY-P700518 | 4-1BBL/TNFSF9, Human (His) | Recombinant Proteins | |
| HY-P700519 | EIF1, Human (GST) | Recombinant Proteins | |
| HY-P70052 | CXADR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P700520 | Fas Ligand, Human (His) | Recombinant Proteins | |
| HY-P700521 | Fas Ligand, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P700522 | TNF-alpha/TNFSF2, Bovine (His) | Recombinant Proteins | |
| HY-P700523 | TFF3, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700524 | SRSF1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700526 | EIF4A2, Human (GST) | Recombinant Proteins | |
| HY-P700527 | TFF3, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700528 | G-CSFR/CD114, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P700529 | AIF1, Bovine (N-His, C-Myc) | Recombinant Proteins | |
| HY-P70053 | Cytochrome c/CYCS, Human (His) | Recombinant Proteins | |
| HY-P700530 | GDF-2/BMP-9, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700531 | BAFF/TNFSF13B, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700532 | IP-10/CXCL10, Human (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P700533 | IP-10/CXCL10, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700534 | MIP-2/CXCL2, Mouse (His) | Recombinant Proteins | |
| HY-P700536 | CXCR2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700537 | ACKR3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700539 | CXCR3, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P700539A | CXCR3, Human (C-His) | Recombinant Proteins | |
| HY-P70054 | Contactin-2/CNTN2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700540 | CCR5, Mouse (P. pastoris, His) | Recombinant Proteins | |
| HY-P700541 | CCR2, Mouse (N-His, C-Myc) | Recombinant Proteins | |
| HY-P700543 | CCR8, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700544 | CCR9, Human (GST) | Recombinant Proteins | |
| HY-P700545 | MIP-4/CCL18, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700546 | CXCR4, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P700547 | BCA-1/CXCL13, Rat (His-GST) | Recombinant Proteins | |
| HY-P700548 | CXCL16, Mouse (His) | Recombinant Proteins | |
| HY-P700549 | MIP-3 alpha/CCL20, Rhesus macaque (GST) | Recombinant Proteins | |
| HY-P70055 | CFHR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700550 | MIP-3 alpha/CCL20, Bovine (His-SUMO) | Recombinant Proteins | |
| HY-P700551 | MIP-3 alpha/CCL20, Bovine (P. pastoris, His) | Recombinant Proteins | |
| HY-P700552 | TARC/CCL17, Dog (HEK293, His) | Recombinant Proteins | |
| HY-P700553 | MIG/CXCL9, Rabbit (His-SUMO) | Recombinant Proteins | |
| HY-P700554 | CD40L/CD154/TRAP, Rabbit (P. pastoris, His) | Recombinant Proteins | |
| HY-P700555 | CD40L/CD154/TRAP, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700556 | BMP-2, Human/Mouse/Rat (P. pastoris, His) | Recombinant Proteins | |
| HY-P700557 | ACVR2B, Human (P. pastoris, N-His) | Recombinant Proteins | |
| HY-P700558 | GRO-alpha/CXCL1, Human (His) | Recombinant Proteins | |
| HY-P700559 | GRO-alpha/CXCL1, Mouse (His) | Recombinant Proteins | |
| HY-P70056 | CHRNB3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700560 | ANGPT1/Angiopoietin-1, Rat (P. pastoris, His) | Recombinant Proteins | |
| HY-P700561 | ANGPTL8/Angiopoietin-like 8, Mouse (P. pastoris, His) | Recombinant Proteins | |
| HY-P700562 | ANGPTL4/Angiopoietin-related 4, Human (GST) | Recombinant Proteins | |
| HY-P700563 | Natriuretic peptides A/NPPA, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700564 | Galanin, Human (N-His, C-Myc) | Recombinant Proteins | |
| HY-P700565 | Coagulation factor VII/F7, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700566 | EIF5, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700567 | PLA2G7, Mouse (Baculovirus, N-His, C-Myc) | Recombinant Proteins | |
| HY-P700568 | PLA2G7, Mouse (HEK293, N-His, C-Myc) | Recombinant Proteins | |
| HY-P70057 | TYRO3/DTK, Human (388a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700570 | CDKN1A, Human (GST) | Recombinant Proteins | |
| HY-P700571 | MMP-10, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700572 | MMP-9, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700573 | MMP-2, Rat (P. pastoris, His) | Recombinant Proteins | |
| HY-P700574 | MMP-7, Rat (P. pastoris, His) | Recombinant Proteins | |
| HY-P700575 | PAK4, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700576 | AK1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700577 | Creatine kinase M-type/CKM, Mouse (His) | Recombinant Proteins | |
| HY-P700578 | PKLR, Rat (P. pastoris, His) | Recombinant Proteins | |
| HY-P700579 | CAMKIV/CAMK4, Rat (His) | Recombinant Proteins | |
| HY-P70058 | Clusterin/APOJ, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700580 | HK1/Hexokinase-1, Human (His) | Recombinant Proteins | |
| HY-P700581 | HK1/Hexokinase-1, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700583 | JAK1, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700584 | DCK/Deoxycytidine kinase, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700585 | AXL, Human (D266N, HEK293, His) | Recombinant Proteins | |
| HY-P700586 | AXL, Human (D266N, HEK293, hFc) | Recombinant Proteins | |
| HY-P700589 | MAP2K4, Human (P. pastoris, His-GST) | Recombinant Proteins | |
| HY-P70059 | ECH1, Human (His) | Recombinant Proteins | |
| HY-P700591 | GSK-3 beta, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700592 | MAP2K6, Human (Baculovirus, His) | Recombinant Proteins | |
| HY-P700593 | MAP3K1, Mouse (His) | Recombinant Proteins | |
| HY-P700594 | MERTK, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P700595 | PRPS1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P700597 | PIP4K2B, Human (His) | Recombinant Proteins | |
| HY-P700598 | BTK, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700599 | Coagulation Factor XII/F12, Pig (P. pastoris, His) | Recombinant Proteins | |
| HY-P7006 | BMP-2, Human/Mouse/Rat | Recombinant Proteins | |
| HY-P70060 | BTN1A1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P700600 | Hygromycin-B kinase/HPH, E.coli (P. pastoris, His) | Recombinant Proteins | |
| HY-P700601 | TSLP, Human (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P700603 | GUCY2C/Guanylyl cyclase C, Mouse (HEK293, N-His, C-Myc) | Recombinant Proteins | |
| HY-P700604 | HGF, Human (HEK293) | Recombinant Proteins | |
| HY-P700605 | DHH, Human | Recombinant Proteins | |
| HY-P700606 | BACE1, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P700607 | LILRA6/CD85b/ILT8, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P700609 | Ephrin-B1/EFNB1, Human (HEK293, C-hFc) | Recombinant Proteins | |
| HY-P70061 | Angiopoietin-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P700610 | GH/Somatotropin, Human (N-His, C-Avi) | Recombinant Proteins | |
| HY-P700611 | IFN-gamma R1/CD119, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P700612 | TNF-beta/TNFSF1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700613 | NGFR, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700614 | Calcitonin/CALCA, Human (P. pastoris, His-SUMO) | Recombinant Proteins | |
| HY-P700615 | TCTP/TPT1, Human | Recombinant Proteins | |
| HY-P700616 | ANO1/Anoctamin-1, Human (N-His, C-Myc) | Recombinant Proteins | |
| HY-P700617 | PCSK6, Human (His) | Recombinant Proteins | |
| HY-P700618 | SHP-2, Human (T253M, Q257L, His) | Recombinant Proteins | |
| HY-P700619 | Prostatic acid Phosphatase/ACPP, Human (HEK293, GFP-His) | Recombinant Proteins | |
| HY-P70062 | Cystatin M/CST6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700620 | Prostatic acid Phosphatase/ACPP-VLP, Human (386a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700621 | PCSK6, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700622 | PPT1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700623 | TCTP/TPT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700624 | RIPK2, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P700625 | ADI, Metamycoplasma hominis (HEK293, His) | Recombinant Proteins | |
| HY-P700626 | BLMH/Bleomycin Hydrolase, Mouse (P. pastoris, His) | Recombinant Proteins | |
| HY-P700627 | DBI, Mouse (P. pastoris, His) | Recombinant Proteins | |
| HY-P700628 | LASB, Pseudomonas aeruginosa (P. pastoris, His) | Recombinant Proteins | |
| HY-P700629 | CYP102A1, Priestia megaterium (P. pastoris, His) | Recombinant Proteins | |
| HY-P70063 | Clusterin-like 1/CLUL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700630 | FGF2, Chicken (His) | Recombinant Proteins | |
| HY-P700631 | FAM3B, Human (His) | Recombinant Proteins | |
| HY-P700632 | IL-17A, Pig (N-His, C-Myc) | Recombinant Proteins | |
| HY-P700633 | ANGPTL8/Angiopoietin-like 8, Mouse (H40A, Q44A, Q47A, His) | Recombinant Proteins | |
| HY-P700634 | Hepcidin/HAMP, Mouse (GST) | Recombinant Proteins | |
| HY-P700635 | FGFR-1 alpha, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P700636 | CNR2-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P700637 | CRELD2, Human (329a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700638 | METTL11A, Human (His) | Recombinant Proteins | |
| HY-P700639 | IL-10R alpha, Human (HEK293) | Recombinant Proteins | |
| HY-P70064 | Carbonic Anhydrase 9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700641 | SF20/MYDGF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700644 | Angiogenin, Human (His) | Recombinant Proteins | |
| HY-P700645 | SIRP beta 1, Human (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P700646 | ALDH1A2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P700649 | IL-2, Rat (145a.a, HEK293, C-His) | Recombinant Proteins | |
| HY-P70065 | AOC3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700651 | Alpha-Fetoprotein, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700652 | Alpha-Fetoprotein, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700653 | Alkaline Phosphatase/ALPI, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P700654 | AMIGO2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700655 | ANGPTL4/Angiopoietin-related 4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700656 | CMG-2/ANTXR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700657 | Annexin A1/ANXA1, Cynomolgus (His) | Recombinant Proteins | |
| HY-P700658 | APLN/Apelin, Mouse (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P700659 | APLP-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70066 | CDO1/Cysteine dioxygenase type 1, Human (His) | Recombinant Proteins | |
| HY-P700660 | Apolipoprotein H/APOH, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700661 | APRIL/TNFSF13 Trimer, Human (Biotinylated, HEK293, Flag, His-Avi) | Recombinant Proteins | |
| HY-P700662 | BCAM, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700663 | BCMA/TNFRSF17, Human (FITC, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700664 | Cadherin-17, Human (Biotinylated, 765a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700665 | GDF-15, Human (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P700666 | BSP2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700667 | BST2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700668 | CD163, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700669 | CD163, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70067 | Collectin-11/CL-K1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700670 | CD200, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700671 | Melanotransferrin/CD228, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700672 | CD229/SLAMF3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700673 | CD30/TNFRSF8, Cynomolgus (HEK293, C-His) | Recombinant Proteins | |
| HY-P700674 | CD300a/LMIR1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700675 | CD31/PECAM-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700676 | CD36, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700677 | CD3D-CD3E Heterodimer, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P700678 | CD3E-CD3G Heterodimer, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P700679 | CD43, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70068 | Chlorite Dismutase/Cld, Dechloromonas aromatica (His) | Recombinant Proteins | |
| HY-P700680 | CD46, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700681 | CD46, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700682 | CD47, Cynomolgus/Rhesus Macaque (HEK293, C-His) | Recombinant Proteins | |
| HY-P700683 | CD59, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700684 | CD6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700685 | CD69, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700686 | CD96, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700687 | CDCP1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P700688 | Cadherin-17, Human (765a.a, HEK293, hFc) | Recombinant Proteins | |
| HY-P700689 | Cadherin-17, Human (328a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70069 | CDNF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700690 | Cadherin-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700691 | Claudin-6/CLDN6-VLP, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P700692 | Claudin-6/CLDN6-VLP, Mouse (HEK293) | Recombinant Proteins | |
| HY-P700693 | CLEC14A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700694 | Dectin-1/CLEC7A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P700695 | Coagulation Factor III/F3, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700696 | C1s/Complement component C1s, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700697 | C2/Complement C2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700698 | HSP10/EPF, Goat/Human/Mouse (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P700699 | HSP10/EPF, Goat/Human/Mouse (His-Avi) | Recombinant Proteins | |
| HY-P7006A | BMP-2, Human/Mouse/Rat (His) | Recombinant Proteins | |
| HY-P7006AF | Animal-Free BMP-2, Human/Mouse/Rat (His) | Recombinant Proteins | |
| HY-P7006B | BMP-2, Human/Mouse/Rat (Tag Free) | Recombinant Proteins | |
| HY-P7007 | BMP-4, Human | Recombinant Proteins | |
| HY-P70070 | CDO, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700700 | CRTAM/CD355, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700701 | CCN2/CTGF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700702 | Fractalkine/CX3CL1, Cynomolgus (317a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700703 | PF-4/CXCL4, Human (His-Avi) | Recombinant Proteins | |
| HY-P700704 | DKK-1 C terminal Domain, Human (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P700705 | DKK-1 N terminal Domain, Human (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P700706 | DLK-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700707 | DR3/TNFRSF25, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700708 | Cadherin-1/CD324, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700709 | ENPP-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70071 | TPBG/5T4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700710 | ENPP-3, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700711 | EPHA10, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700712 | EphA2, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P700713 | EphA2, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700714 | EphA3, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700715 | EPHA5, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700716 | EphB2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700717 | MPZL2, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700718 | MPZL2, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P700719 | FGF-21, Human (Biotinylated, HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P70072 | CPA2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700720 | FGFR-1 beta (IIIc), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700721 | FGL2, Human (HEK293, His-Avi, Flag) | Recombinant Proteins | |
| HY-P700722 | FLT3, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P700723 | GAS6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700724 | GAS6, Human (630a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700725 | G-CSFR/CD114, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700726 | GDF-15, Canine (His) | Recombinant Proteins | |
| HY-P700727 | GDF-15, Rat (His) | Recombinant Proteins | |
| HY-P700728 | GFRAL, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700729 | GGT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700730 | GM-CSF R alpha, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700731 | GPRC5D-VLP, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P700732 | GPVI, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700733 | HER4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700734 | HGFA/HGF Activator, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700735 | HLA-G Complex, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700736 | IgE, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700737 | IgG2C Fc, Mouse (HEK293) | Recombinant Proteins | |
| HY-P700738 | IGSF11, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700739 | IL-1 alpha, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70074 | CD38, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700740 | IL-10, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700741 | IL-10R alpha, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700742 | IL-18BP, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700743 | IL-22, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700744 | IL-22R alpha 1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700745 | IL-23, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700746 | IL-23R, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700747 | IL-3R alpha/CD123, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700748 | IL-4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700749 | IL-6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70075 | CD30/TNFRSF8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700750 | Integrin alpha 10 beta 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700751 | Integrin alpha 10 beta 1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700752 | Integrin alpha 2 beta 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700753 | Integrin alpha 2 beta 1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700754 | Integrin alpha 2B beta 3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700755 | Integrin alpha 5 beta 1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700756 | Integrin alpha A1 beta 1 Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700757 | Integrin alpha A1 beta 1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700758 | Integrin alpha L beta 2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700759 | Integrin alpha M beta 2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70076 | DAND1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700760 | Integrin alpha V beta 3, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P700761 | Integrin alpha V beta 3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700762 | Integrin alpha V beta 6 Protein, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700763 | Integrin alpha V beta 8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700764 | Integrin alpha 6 beta 1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700765 | Integrin alpha V beta 3 Protein, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700766 | Integrin alpha V beta 5 Protein, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700767 | Integrin alpha V beta 8 Protein, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700768 | ITGB6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700769 | ITGB6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70077 | CD38, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P700770 | KRT19, Canine (His) | Recombinant Proteins | |
| HY-P700771 | KIR3DL2/CD158k, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P700772 | Plasma kallikrein/KLKB1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700773 | Kremen-2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700774 | LAMP5, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700775 | LAMP5/BAD-LAMP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700777 | LILRA6/CD85b/ILT-8, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700778 | LILRB1/CD85j/ILT2, Rhesus macaque (HEK293, C-His) | Recombinant Proteins | |
| HY-P700779 | LILRB4/CD85k/ILT3, Human (Biotinylated, Domain 1, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70078 | Carboxypeptidase A4/CPA4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700780 | LILRB4/CD85k/ILT3, Human (Domain 1, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700781 | LILRB5/CD85c/LIR-8, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700782 | LRG1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700783 | LRP-10, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700784 | LRRN1/NLRR-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700785 | TGF beta 2/TGFB2, Human (HEK293, Avi) | Recombinant Proteins | |
| HY-P700786 | TGF beta 3/TGFB3, Human (HEK293, Avi) | Recombinant Proteins | |
| HY-P700787 | MCP-1/CCL2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700788 | M-CSF, Human (Biotinylated, HEK293, C-His-Avi) | Recombinant Proteins | |
| HY-P700789 | M-CSF, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70079 | Coronin-6/CORO6, Human (His) | Recombinant Proteins | |
| HY-P700790 | MICA, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P700791 | MDK/Midkine, Human (His-Avi) | Recombinant Proteins | |
| HY-P700792 | MIF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700793 | MMP-8, Cynomolgus (447a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700794 | Mesothelin, Human (411a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700795 | Mucin-1/MUC1 Isoform Y, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P700796 | NKG2A-CD94 Heterodimer, Cynomolgus (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P700797 | NKG2C-CD94 Heterodimer, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700798 | NKG2C-CD94 Heterodimer, Cynomolgus (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P700799 | NKG2C/CD159c, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7007A | BMP-4, Human (His) | Recombinant Proteins | |
| HY-P7008 | BMP-7, Human | Recombinant Proteins | |
| HY-P70080 | CLM9/CD300g, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700800 | NKG2C/CD159c, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700801 | NKG2C/CD159c, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P700802 | Nogo Receptor/NgR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700803 | Notch 3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700804 | Notch 3, Human (HEK293, C-His-Avi) | Recombinant Proteins | |
| HY-P700805 | OSM, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700806 | OSMR beta, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700808 | PD-1, Mouse (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P700809 | PDGF R alpha, Cynomolgus (501a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70081 | CRELD2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700810 | PDGF R beta, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700811 | PLAU/uPA, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700812 | PLXNA1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700813 | PLXNA1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700814 | Prolactin R, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700815 | CD162/PSGL-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700816 | CD162/PSGL-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700818 | PVRIG, Mouse (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P700819 | PVRIG, Mouse (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P70082 | L-xylulose reductase/DCXR, Human (His) | Recombinant Proteins | |
| HY-P700820 | S100B, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P700821 | Alpha-2-Antiplasmin/Serpin F2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700822 | SEZ6/BSRP-C, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700823 | SFRP2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700824 | SCG3/Secretogranin-3, Cynomolgus (449a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700825 | Siglec-6, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700826 | SIRP alpha V8/CD172a, Human (Biotinylated, S44L, S50T, I52T, H54R, V57A, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700827 | SIRP Beta 1, Human (Biotinylated, HEK293, C-His-Avi) | Recombinant Proteins | |
| HY-P700828 | SLAMF6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700829 | SOST, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70083 | CADM3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700830 | SPARC, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700831 | Endosialin/CD248, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700832 | PLXDC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700833 | Tenascin/Tnc, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700834 | Tenascin/Tnc, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700835 | TLR3, Cynomolgus (681a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700836 | TREML1, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P700837 | TM4SF1-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P700838 | TNFRSF1A, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700839 | TL1A/TNFSF15, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700840 | TPBG/5T4, Human (FITC, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700841 | TFRC, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700842 | TSLPR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700843 | uPAR, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700844 | uPAR, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700845 | uPAR, Human (Domain 2&3 , HEK293, His) | Recombinant Proteins | |
| HY-P700846 | uPAR, Human (Domain 1, HEK293, His) | Recombinant Proteins | |
| HY-P700847 | uPAR, Human (Domain 3, HEK293, His) | Recombinant Proteins | |
| HY-P700848 | uPAR, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700849 | uPAR, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70085 | CADM1/IGSF4A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700850 | VEGFR-2, Human (Biotinylated, HEK293, mFc) | Recombinant Proteins | |
| HY-P700852 | ANGPTL7/Angiopoietin-related 7, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700853 | Apolipoprotein E/APOE4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700854 | CD7, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700855 | CD96, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700856 | DLK-1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700857 | GARP&Latent TGF Beta 2 Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700858 | IL-2R gamma/CD132, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700859 | IL-3, Cynomolgus (His) | Recombinant Proteins | |
| HY-P700860 | LDLR, Human (HEK293, Avi-His) | Recombinant Proteins | |
| HY-P700861 | RANTES/CCL5, Human (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P700862 | Complement C5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700863 | DKK-1, Human (89a.a, HEK293, mFc) | Recombinant Proteins | |
| HY-P700864 | GARP&Latent TGF Beta 1 Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700865 | GARP&Latent TGF Beta 1 Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700866 | GDF-15, Cynomolgus (His) | Recombinant Proteins | |
| HY-P700867 | GYPA/CD235a, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700868 | GRP-10, Canine (HEK293, hFc) | Recombinant Proteins | |
| HY-P700869 | IGF2R, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70087 | DTD1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700870 | IGF2R, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700871 | IGF2R, Human (Domain 1-3, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700872 | IL-22R alpha 1 & IL-10R beta, Human (Biotinylated, HEK293, hFc-Avi) | Recombinant Proteins | |
| HY-P700873 | MFAP4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700874 | MRC2, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700875 | MRC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700876 | MXRA8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700877 | MXRA8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700878 | PGF, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700879 | PLVAP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70088 | CES3/CES1D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700880 | CD276/B7-H3, Human (Biotinylated, HEK293, C-His-Avi) | Recombinant Proteins | |
| HY-P700881 | CLEC4C, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P700882 | Carbonic Anhydrase 9, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700884 | DKK-1 C terminal, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P700885 | DKK-1 N terminal, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P700887 | HER2/CD340, Cynomolgus (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P700889 | IL-23R, Cynomolgus (HEK293, C-His) | Recombinant Proteins | |
| HY-P70089 | Cytoglobin/Histoglobin, Human (His) | Recombinant Proteins | |
| HY-P700890 | Latent TGF beta 3/Latent TGFB3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700891 | Lgr5/GPR49, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P700892 | LRRC15, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700893 | MMP-9, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700894 | PD-L2, Cynomolgus/Rhesus macaque (HEK293, C-His) | Recombinant Proteins | |
| HY-P700895 | Siglec-2/CD22, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P700896 | TIM-4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700897 | uPAR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700898 | CD20/MS4A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700899 | ADORA2A-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P7008A | BMP-7, Human (His) | Recombinant Proteins | |
| HY-P7009 | Collagen Alpha-1(XVIII) Chain/Endostatin, Human (P.pastoris) | Recombinant Proteins | |
| HY-P70090 | CD3 epsilon, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P700901 | HLA-A*0201 AFP Complex, Human (Biotinylated, FMNKFIYEI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700902 | HLA-A*0201 AFP Complex, Human (Biotinylated, PLFQVPEPV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700903 | HLA-A*0203 AFP Complex, Human (Biotinylated, FMNKFIYEI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700904 | HLA-A*0203 AFP Complex, Human (FMNKFIYEI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700905 | HLA-A*0203 AFP Complex Tetramer, Human (FMNKFIYEI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700906 | HLA-A*0101 CT83 Complex, Human (NTDNNLAVY, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700907 | HLA-A*0101 CT83 Complex Tetramer, Human (NTDNNLAVY, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700908 | HLA-A*0101 DSG3 Complex, Human (NTDNNLAVY, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700909 | HLA-A*2402 GP100 Intron 4 Complex, Human (Biotinylated, VYFFLPDHL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70091 | CD3 delta, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P700910 | HLA-A*2402 GP100 Intron 4 Complex, Human (VYFFLPDHL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700911 | HLA-A*0201 HBV Complex, Human (Biotinylated, FLLTRILTI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700912 | HLA-A*0201 HBV Complex, Human (FLLTRILTI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700913 | HLA-A*0201 HBV Complex Tetramer, Human (FLLTRILTI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700914 | HLA-A*0201 HPV16 E6 Complex, Human (KLPQLCTEL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700915 | HLA-A*0201 HPV16 E6 Complex Tetramer, Human (KLPQLCTEL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700916 | HLA-A*0201 HPV16 E7 complex, Human (Biotinylated, YMLDLQPET, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700917 | HLA-A*0201 HPV16 E7 complex, Human (YMLDLQPET, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700918 | HLA-A*0201 HPV16 E7 complex Tetramer, Human (YMLDLQPET, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700919 | HLA-A*1101 KRAS G12A Complex, Human (Biotinylated, VVVGAAGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70092 | CTHRC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700920 | HLA-A*1101 KRAS G12A Complex, Human (VVVGAAGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700921 | HLA-A*1101 KRAS G12C Complex, Human (Biotinylated, VVVGACGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700922 | HLA-A*1101 KRAS G12C Complex, Human (VVVGACGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700923 | HLA-A*1101 KRAS G12R Complex, Human (Biotinylated, VVVGARGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700924 | HLA-A*1101 KRAS G12R Complex, Human (VVVGAAGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700925 | HLA-A*1101 KRAS G12S Complex, Human (Biotinylated, VVVGASGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700926 | HLA-A*1101 KRAS G12S Complex, Human (VVVGASGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700927 | HLA-A*0301 KRAS G12V Complex, Human (Biotinylated, VVGAVGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700928 | HLA-A*0301 KRAS G12V Complex, Human (VVGAVGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700929 | HLA-A*1101 KRAS WT Complex, Human (Biotinylated, VVVGAGGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70093 | DCN1-like 1/DCUN1D1, Human (His) | Recombinant Proteins | |
| HY-P700930 | HLA-A*1101 KRAS WT Complex, Human (VVVGAGGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700931 | HLA-A*1101 KRAS WT Complex Tetramer, Human (VVVGAGGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700932 | HLA-A*1101 LMP2 Complex, Human (Biotinylated, SSCSSCPLTK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700933 | HLA-A*1101 LMP2 Complex, Human (SSCSSCPLTK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700934 | HLA-A*1101 LMP2 Complex Tetramer, Human (SSCSSCPLTK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700935 | HLA-A*0101 MAGE-A3 Complex, Human (Biotinylated, EVDPIGHLY, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700936 | HLA-A*0101 MAGE-A3 Complex Tetramer, Human (EVDPIGHLY, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700937 | HLA-A*2402 MAGE-A3 Complex, Human (Biotinylated, IMPKAGLLI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700938 | HLA-A*2402 MAGE-A3 Complex, Human (IMPKAGLLI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700939 | HLA-A*2402 MAGE-A3 Complex Tetramer, Human (IMPKAGLLI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70094 | COL21A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700940 | HLA-A*0201 MART-1 Complex, Human (ELAGIGILTV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700941 | HLA-A*0201 MART-1 Complex Tetramer, Human (ELAGIGILTV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700942 | HLA-A*0201 NY-ESO-1 complex, Human (SLLMWITQV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700943 | HLA-A*0201 NY-ESO-1 complex Tetramer, Human (SLLMWITQV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700944 | HLA-A*0201 Survivin Complex, Human (Biotinylated, LMLGEFLKL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700945 | HLA-A*2402 Survivin 2B Complex, Human (Biotinylated, AYACNTSTL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700946 | HLA-A*2402 Survivin 2B Complex, Human (AYACNTSTL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700947 | HLA-A*2402 Survivin 2B Complex Tetramer, Human (AYACNTSTL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700948 | Adiponectin/Acrp30, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700949 | Alkaline Phosphatase/ALPP, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70095 | DCBLD2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700950 | Alkaline Phosphatase/ALPG, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700951 | Alkaline Phosphatase/ALPG, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700952 | Alkaline Phosphatase/ALPG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700953 | AMHR2/MISRII, Human (HEK293) | Recombinant Proteins | |
| HY-P700954 | ANGPTL3/Angiopoietin-like 3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700955 | ANGPTL7/Angiopoietin-related 7, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700956 | ENPP-1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700957 | BPIFA1, Human | Recombinant Proteins | |
| HY-P700958 | BTN2A2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P700959 | Complement C5/C5a, Human (His) | Recombinant Proteins | |
| HY-P70096 | COQ7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700960 | CA125, Human (Biotinylated, 685a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700961 | CA125, Human (685a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700962 | CADM3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700963 | Eotaxin/CCL11, Human (His) | Recombinant Proteins | |
| HY-P700964 | CCL24/Eotaxin-2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700965 | CCR8, Cynomolgus (HEK293, mFc) | Recombinant Proteins | |
| HY-P700966 | CD44, Human (242a.a, HEK293, hFc) | Recombinant Proteins | |
| HY-P700967 | CD44, Human (242a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700968 | CD45, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700969 | CDCP1, Human (339a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70097 | Copine-1/CPNE1, Human (His) | Recombinant Proteins | |
| HY-P700970 | Cadherin-17, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P700971 | Cadherin-17, Human (215a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700972 | Cadherin-17, Human (Biotinylated, 328a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700973 | CDH19, Human (Flag-MBP) | Recombinant Proteins | |
| HY-P700974 | Cadherin-3, Cynomolgus (547a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700975 | CEACAM8/CD66b, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P700976 | CKAP4, Human (His) | Recombinant Proteins | |
| HY-P700977 | C-MPL, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700978 | Coagulation Factor XI/F11, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700979 | C-Reactive, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70098 | CTRC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700981 | PF-4/CXCL4, Human (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P700982 | Delta-like 3/DLL3, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P700983 | Delta-like 3/DLL3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700984 | TAFA5/FAM19A5, Human (His) | Recombinant Proteins | |
| HY-P700985 | TAFA5/FAM19A5, Mouse (His) | Recombinant Proteins | |
| HY-P700986 | FGFR-2 beta (IIIb), Human (HEK293, Avi) | Recombinant Proteins | |
| HY-P700987 | FGL2, Human (Biotinylated, HEK293, His-Avi, Flag) | Recombinant Proteins | |
| HY-P700988 | FGL2, Mouse (Biotinylated, HEK293, His-Avi, Flag) | Recombinant Proteins | |
| HY-P700989 | FGL2, Rat (Biotinylated, HEK293, His-Avi, Flag) | Recombinant Proteins | |
| HY-P70099 | Chemerin/RARRES2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P700990 | FGL2, Mouse (HEK293, His-Avi, Flag) | Recombinant Proteins | |
| HY-P700991 | Fibronectin, Human (314a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700992 | Fibronectin, Human (571a.a, HEK293, His) | Recombinant Proteins | |
| HY-P700995 | FNDC1, Human (His) | Recombinant Proteins | |
| HY-P700996 | Galectin-3/LGALS3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P700997 | GFRAL, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P700998 | GPRC5D-VLP, Mouse (HEK293) | Recombinant Proteins | |
| HY-P700999 | GUCY2C/Guanylyl cyclase C, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7010 | Epigen, Human | Recombinant Proteins | |
| HY-P70100 | Collectin-11/CL-K1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701000 | GUCY2C/Guanylyl cyclase C, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701001 | HLA-G Complex, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701002 | PE-Labeled HLA-G Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701003 | Hemopexin, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701004 | HSP70/HSPA1A, Human (E110D, His) | Recombinant Proteins | |
| HY-P701005 | HTRA1, Human (His) | Recombinant Proteins | |
| HY-P701006 | IFN-gamma, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701007 | IL-11, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701008 | IL-12, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701009 | IL-12 beta, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70101 | Dectin-1/CLEC7A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701010 | IL-18BP, Cynomolgus (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P701011 | IL-23R, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P701012 | IL-25/IL-17E, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701013 | IL-27R alpha/TCCR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701014 | IL-9, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701015 | Integrin alpha V beta 3, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701017 | LILRB1/CD85j/ILT2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701018 | LILRB4/CD85k/ILT3, Human (Biotinylated, 141a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701019 | LRIG1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70102 | CFHR5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701020 | LRRC15, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P701021 | LY6G6F, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701022 | DEC-205/CD205, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701023 | MICB, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701024 | MDK/Midkine, Human (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P701025 | MDK/Midkine, Mouse (His) | Recombinant Proteins | |
| HY-P701026 | NCAM-1/CD56, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701027 | NLRP3, Human (GST) | Recombinant Proteins | |
| HY-P701028 | Notch 4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P701029 | NTS1/NTSR1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70103 | CNDP2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P701030 | PADI4, Human (Biotinylated, His) | Recombinant Proteins | |
| HY-P701032 | PTP4A1, Human (His) | Recombinant Proteins | |
| HY-P701033 | PTP4A3, Human (His) | Recombinant Proteins | |
| HY-P701034 | WFDC1/PS20, Cynomolgus (His) | Recombinant Proteins | |
| HY-P701035 | RGM-C, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701036 | Siglec-15, Cynomolgus (Biotinylated, 263a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701037 | Siglec-3/CD33, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701038 | Siglec-5, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701039 | Siglec-5, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70104 | Dermatopontin/DPT, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P701040 | Siglec-9, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701041 | Syndecan-1/CD138, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P701042 | TIM-1/KIM-1/HAVCR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701043 | Thymidine kinase 1/TK1, Canine (His) | Recombinant Proteins | |
| HY-P701045 | TWEAK/TNFSF12, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701046 | TL1A/TNFSF15, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701047 | TL1A/TNFSF15, Cynomolgus/Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P701048 | TL1A/TNFSF15, Human (180a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701049 | TPBG/5T4, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P70105 | DMP-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701050 | TPSAB1, Cynomolgus (His) | Recombinant Proteins | |
| HY-P701051 | Apolipoprotein E/APOE3, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701052 | PTPRC/CD45RABC, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701053 | IFN-alpha 1/IFNA1, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P701054 | TREML1, Human (147a.a, HEK293, hFc) | Recombinant Proteins | |
| HY-P701055 | ULBP2/NKG2DL2, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701056 | ACAN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701057 | CSPG4/MCSP, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701058 | FGL2, Cynomolgus (Biotinylated, HEK293, His-Avi, Flag) | Recombinant Proteins | |
| HY-P701059 | FGL2, Cynomolgus (HEK293, His-Avi, Flag) | Recombinant Proteins | |
| HY-P70106 | CCN2/CTGF, Human (HEK293) | Recombinant Proteins | |
| HY-P701060 | IFNAR2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701061 | IGF2R, Human (Domain 1-7, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701062 | IL-22R alpha 1 & IL-10R beta, Human (HEK293, hFc-Avi) | Recombinant Proteins | |
| HY-P701063 | Integrin alpha V beta 3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701064 | LILRB4/CD85k/ILT3 Domain 1+hinge, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701065 | LILRB4/CD85k/ILT3 Domain 1+hinge, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701066 | MD2, Cynomolgus (His) | Recombinant Proteins | |
| HY-P701067 | MD2, Human (His) | Recombinant Proteins | |
| HY-P701068 | PKA/PRKACA, Canine (His) | Recombinant Proteins | |
| HY-P701069 | SP-17, Human (His) | Recombinant Proteins | |
| HY-P70107 | CGREF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701070 | SP-17, Mouse (His) | Recombinant Proteins | |
| HY-P701071 | Osteopontin/OPN, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701072 | TENM2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701073 | Tubby, Human (His) | Recombinant Proteins | |
| HY-P701074 | Tulp1, Human (His) | Recombinant Proteins | |
| HY-P701075 | NKp46/NCR1, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P701076 | AG-2, Mouse (His) | Recombinant Proteins | |
| HY-P701077 | FGL1, Human (Biotinylated, 242a.a, HEK293, hFc) | Recombinant Proteins | |
| HY-P701078 | FGL2, Human (HEK293, hFc-Flag) | Recombinant Proteins | |
| HY-P70108 | BSSP-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701080 | Latent TGF beta 3/Latent TGFB3, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P701081 | Neogenin, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701082 | Lipocalin-2/NGAL, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701083 | Siglec-10, Cynomolgus (HEK293, His, solution) | Recombinant Proteins | |
| HY-P701084 | TNF RII/TNFRSF1B, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P701085 | AGER, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701086 | HLA-C*0304 KRAS G12D Complex, Human (Biotinylated, GADGVGKSAL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701087 | HLA-C*0304 KRAS G12D Complex, Human (GADGVGKSAL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701088 | HLA-C*0304 KRAS G12D Complex Tetramer, Human (GADGVGKSAL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701089 | FITC-Labeled HLA-A*1101 KRAS WT Complex, Human (VVVGAGGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70109 | CDCP1, Human (312a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701090 | HLA-A*0201 PRAME complex, Human (SLLQHLIGL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701091 | HLA-A*0201 PRAME complex Tetramer, Human (SLLQHLIGL, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P701092 | FGF-21, Human (181a.a) | Recombinant Proteins | |
| HY-P701093 | IL-4, Mouse (HEK293) | Recombinant Proteins | |
| HY-P701094 | Apolipoprotein E/APOE2, Human (R154S, R176C, HEK293, C-His) | Recombinant Proteins | |
| HY-P701095 | IFN-alpha 2b/IFNA2, Human (His) | Recombinant Proteins | |
| HY-P701096 | Apolipoprotein E/APOE, Rat (His) | Recombinant Proteins | |
| HY-P701097 | STAT3, Human (His-Sumo) | Recombinant Proteins | |
| HY-P701098 | STAT3, Human (Full Length, His) | Recombinant Proteins | |
| HY-P701099 | Intelectin-1/ITLN1, Human (N-His, C-Myc) | Recombinant Proteins | |
| HY-P7010A | Epigen, Human (CHO) | Recombinant Proteins | |
| HY-P7010B | Epigen, Human (E. coli) | Recombinant Proteins | |
| HY-P7011 | Epiregulin, Human | Recombinant Proteins | |
| HY-P70110 | DC-SIGN/CD209, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701100 | SHH, Mouse (HEK293) | Recombinant Proteins | |
| HY-P701101 | M-CSF, Human (CHO, Tag Free) | Recombinant Proteins | |
| HY-P701102 | Janus kinase 2/JAK2, Human (381aa, His) | Recombinant Proteins | |
| HY-P701103 | MSP/MST1, Mouse (C677A, HEK293) | Recombinant Proteins | |
| HY-P701105 | RIZ1, Human (His) | Recombinant Proteins | |
| HY-P701106 | ER alpha/ESR1, Human (P. pastoris, N-His) | Recombinant Proteins | |
| HY-P701109 | Cortactin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70111 | Delta-like 4/DLL4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701113 | alpha Actinin 4/ACTN4, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P701114 | TAGLN2, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P701118 | NIP30 Protein, Human (His) | Recombinant Proteins | |
| HY-P70112 | Dipeptidyl peptidase 3/DPP3, Human (His) | Recombinant Proteins | |
| HY-P70113 | CLIC5, Human (His) | Recombinant Proteins | |
| HY-P701131 | RAB5C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701135 | PICALM Recombinant,Human(HEK293,C-His) | Recombinant Proteins | |
| HY-P701136 | Dynamitin (DCTN2), Human (HEK293, His) | Recombinant Proteins | |
| HY-P701139 | HNF4A, Human (His, solution) | Recombinant Proteins | |
| HY-P701139A | HNF4A, Human (His) | Recombinant Proteins | |
| HY-P70114 | B3GAT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70115 | EDAR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P701153 | EBP50/SLC9A3R1, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P701153A | EBP50/SLC9A3R1 Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701154 | U1A/SNRPA, Human(HEK293, C-6*His) | Recombinant Proteins | |
| HY-P70116 | Cornulin, Human (His) | Recombinant Proteins | |
| HY-P701163 | NASP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701170 | FOXO3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701179 | FUBP1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70118 | CLEC4E, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701180 | PPM1H, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70119 | Histone chaperone ASF1A/ASF1A, Human (T7-His) | Recombinant Proteins | |
| HY-P701199 | CSRP3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7012 | FGF-21, Human | Recombinant Proteins | |
| HY-P70120 | CLIC4/Chloride intracellular channel 4, Human (His) | Recombinant Proteins | |
| HY-P70121 | TPBG/5T4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P701216 | Prothrombin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701217 | PTGR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70122 | SARS-CoV-2 PLpro | Recombinant Proteins | |
| HY-P701224 | BMI1, Human (His) | Recombinant Proteins | |
| HY-P701226 | HNRNPM, Human (N-His) | Recombinant Proteins | |
| HY-P701227 | CEBPA, Human (His) | Recombinant Proteins | |
| HY-P701228 | TFEB, Human (N-His) | Recombinant Proteins | |
| HY-P70123 | Angiopoietin-2, Rhesus macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P701230 | NFKBIE/IKB epsilon, Human (His) | Recombinant Proteins | |
| HY-P701234 | HER4, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P701235 | Cas9, S. pyogenes (NLS) | Recombinant Proteins | |
| HY-P701236 | Virus-Like Particles (VLPs) isotype control (HEK293) | Recombinant Proteins | |
| HY-P701237 | PDGF-BB, Bovine | Recombinant Proteins | |
| HY-P701238 | FGF basic, Salmon | Recombinant Proteins | |
| HY-P701239AF | Animal-Free SUMO Protease , Saccharomyces cerevisiae (His) | Recombinant Proteins | |
| HY-P70124 | CSF1R, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701240 | Insulin, Bovine | Recombinant Proteins | |
| HY-P701241 | IGF-I, Salmon | Recombinant Proteins | |
| HY-P701242 | Heat Stable FGF basic/bFGF, Human | Recombinant Proteins | |
| HY-P701243 | CD19, Human (FITC, HEK293, His) | Recombinant Proteins | |
| HY-P701244 | LacI WT, E.coli (His) | Recombinant Proteins | |
| HY-P701245 | Granzyme B/GZMB, Mouse (HEK293) | Recombinant Proteins | |
| HY-P701246 | ATG10, Human (GST) | Recombinant Proteins | |
| HY-P701247 | Cathepsin C/DPPI, Mouse (Inactive, His-Myc) | Recombinant Proteins | |
| HY-P701249 | KEAP1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P70125 | CD276/B7-H3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701251 | M-CSF, Human (Tag free, HEK293) | Recombinant Proteins | |
| HY-P701252 | RPRD1B, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P701253 | NEK7, Human (His-SUMO) | Recombinant Proteins | |
| HY-P701254 | CD72, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701256 | PE-Labeled HLA-A*0201 NY-ESO-1 Complex Tetramer, Human (SLLMWITQC, HEK293) | Recombinant Proteins | |
| HY-P701258 | PE-Labeled HLA-A*0201 HPV16 E7 Complex, Human (YMLDLQPET, HEK293) | Recombinant Proteins | |
| HY-P701259 | PE-Labeled Mesothelin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70126 | CD276/B7-H3, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P701260 | FITC-Labeled EpCAM/TROP1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701261 | FITC-Labeled EpCAM/TROP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701262 | FITC-Labeled Siglec-3/CD33, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701263 | FITC-Labeled HGFR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701264 | FITC-Labeled VEGFR-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701265 | FITC-Labeled CD30/TNFRSF8, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701266 | FITC-Labeled CD47, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701267 | FITC-labeled EGFR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701268 | FITC-Labeled HER2/CD340, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701269 | FITC-Labeled CD5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70127 | SARS-CoV-2 NSP1 (His) | Recombinant Proteins | |
| HY-P701270 | FITC-Labeled CEACAM5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701271 | FITC-Labeled CEACAM5, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P701272 | FITC-Labeled CD98, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701273 | FITC-Labeled CD7, Human (HEK293, Llama IgG2b Fc) | Recombinant Proteins | |
| HY-P701274 | FITC-Labeled CD7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701275 | FITC-Labeled CD7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701276 | FITC-Labeled CD37, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701277 | FITC-Labeled CD99, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701278 | FITC-Labeled FOLR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701279 | FITC-Labeled VEGF165, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70128 | SARS-CoV-2 NSP2 (His) | Recombinant Proteins | |
| HY-P701280 | FITC-Labeled CD72, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701281 | FITC-labeled HER3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701282 | FITC-labeled GUCY2C/Guanylyl cyclase C, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701283 | FITC-labeled GUCY2C/Guanylyl cyclase C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701284 | FITC-Labeled NKG2D/CD314, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701285 | FITC-Labeled IL-3R alpha/CD123, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701286 | FITC-Labeled CD38, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701287 | FITC-Labeled CD70 Trimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P701288 | Siglec-2/CD22, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P701289 | FITC-Labeled Basigin/CD147, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70129 | SARS-CoV-2 NSP7 (His) | Recombinant Proteins | |
| HY-P701290 | FITC-Labeled FLT3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701293 | PE-labeled Glypican-3/GPC3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701294 | PE-Labeled SIRP alpha/CD172a, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701295 | FITC-labeled BCMA/TNFRSF17, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701296 | FITC-labeled BCMA/TNFRSF17, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701297 | FITC-Labeled uPAR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701298 | FITC-Labeled IL-15R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701299 | PE-Labeled IL-15R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7013 | FGF-23, Human | Recombinant Proteins | |
| HY-P70130 | SARS-CoV-2 NSP8 (His) | Recombinant Proteins | |
| HY-P701300 | PE-Labeled HLA-A*1101 KRAS Complex, Human (VVGADGVGK, HEK293) | Recombinant Proteins | |
| HY-P701301 | PE-Labeled HLA-A*1101 KRAS Complex, Human (VVGAGGVGK, HEK293) | Recombinant Proteins | |
| HY-P701302 | FITC-Labeled CD276/B7-H3, Human (435a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P701303 | TFRC, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P701305 | FITC-Labeled IL-1RAcP/IL-1 R3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701306 | FITC-Labeled Delta-like 3/DLL3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701307 | FITC-Labeled ROBO1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701308 | PYCARD, Human (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P701309 | Delta-like 4/DLL4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70131 | SARS-CoV-2 NSP10 (His) | Recombinant Proteins | |
| HY-P701310 | FABP7, Human | Recombinant Proteins | |
| HY-P701311 | Laminin 521, Human | Recombinant Proteins | |
| HY-P701311AF | Animal-Free Laminin 521, Human | Recombinant Proteins | |
| HY-P701312 | T-PA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P701313 | MCR-1, E.coli (Cell-Free, His-SUMO) | Recombinant Proteins | |
| HY-P701314 | NAMPT, Mouse | Recombinant Proteins | |
| HY-P701315 | NAMPT, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P701316 | TFAM, Mouse (His, Myc) | Recombinant Proteins | |
| HY-P701317 | TFAM, Human (His) | Recombinant Proteins | |
| HY-P701318 | NNMT, Human (GST) | Recombinant Proteins | |
| HY-P701319 | gp130/IL6ST, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70132 | SARS-CoV-2 Guanine-N7 methyltransferase (His) | Recombinant Proteins | |
| HY-P701320 | Optineurin, Human (sf9, His) | Recombinant Proteins | |
| HY-P701321 | Src, Human (His) | Recombinant Proteins | |
| HY-P701323 | TWEAK/TNFSF12, Mouse (204a.a, HEK293, rFc) | Recombinant Proteins | |
| HY-P701324 | SMOC1, Human (408a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701325 | THBS1, Mouse (His) | Recombinant Proteins | |
| HY-P701326 | APCDD1, Human (466a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P701327 | NOV/CCN3, Human (sf9, His) | Recombinant Proteins | |
| HY-P701328 | BID, Mouse (His) | Recombinant Proteins | |
| HY-P70133 | CELA3A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701330 | Cadherin-6/KCAD, Human (562a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701331 | vacA, Helicobacter pylori (His) | Recombinant Proteins | |
| HY-P701332 | ACAT2, Human (His, Myc) | Recombinant Proteins | |
| HY-P701335 | Neurotrophin-4, Human (His) | Recombinant Proteins | |
| HY-P701336 | PPAR gamma, Human | Recombinant Proteins | |
| HY-P701337 | BCAT1, Human | Recombinant Proteins | |
| HY-P701338 | BCAT1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701339 | BCAT2, Human | Recombinant Proteins | |
| HY-P70134 | Secretogranin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701340 | BCAT2, Human (His, Strep) | Recombinant Proteins | |
| HY-P701341 | Caspase-3/CASP3, Human | Recombinant Proteins | |
| HY-P701342 | Caspase-3/CASP3, Human (His, Strep) | Recombinant Proteins | |
| HY-P701343 | DHFR, Human | Recombinant Proteins | |
| HY-P701346 | UbcH6/UBE2E1, Human (Sf9) | Recombinant Proteins | |
| HY-P701347 | UbcH6/UBE2E1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701348 | UbcH7/UBE2L3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701349 | USP2, Human | Recombinant Proteins | |
| HY-P70135 | CHRDL2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P701350 | UBE2C, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701351 | PSAT1, Human | Recombinant Proteins | |
| HY-P701352 | PSAT1, Human (N-His) | Recombinant Proteins | |
| HY-P701353 | UBE1L2/UBA6, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701355 | bABCC1, Bovine (HEK293, GFP, Strep, His) | Recombinant Proteins | |
| HY-P701357 | ABCA1, Human (HEK293, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P701358 | ATG9B, Human (HEK293, FLAG) | Recombinant Proteins | |
| HY-P701359 | ATG9B, Human (HEK293, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P70136 | CYB5B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701360 | CDK12-CCNK Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P701361 | CDK12-CCNK Heterodimer, Human (Sf9, GST, FLAG) | Recombinant Proteins | |
| HY-P701362 | CDK15-CCNY Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P701363 | CDK19-CCNC-MED12, Human (Sf9) | Recombinant Proteins | |
| HY-P701364 | CDK3-CCNE1 Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P701365 | CDK3-CCNE1 Heterodimer, Human (Sf9, GST, FLAG, His) | Recombinant Proteins | |
| HY-P701366 | CDK6-CCND1 Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P701368 | CDK6-CCND2 Heterodimer, Human (Sf9, GST, FLAG, His) | Recombinant Proteins | |
| HY-P701369 | CDK6-CCND3 Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P70137 | Cystatin B/CSTB, Mouse (His) | Recombinant Proteins | |
| HY-P701370 | CDK6-CCND3 Heterodimer, Human (Sf9, GST, His) | Recombinant Proteins | |
| HY-P701371 | CDK7-CCNH-MNAT1, Human (Sf9) | Recombinant Proteins | |
| HY-P701373 | CDK8-CCNC-MED12, Human (Sf9, GST, FLAG, His) | Recombinant Proteins | |
| HY-P701374 | CDK9-CCNK Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P701375 | CDK9-CCNK Heterodimer, Human (Sf9, GST, FLAG) | Recombinant Proteins | |
| HY-P701376 | CDK9-CCNT1 Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P701377 | CDK9-CCNT2 Heterodimer, Human (Sf9) | Recombinant Proteins | |
| HY-P701378 | KIF11, Human | Recombinant Proteins | |
| HY-P701379 | KIF11, Human (His) | Recombinant Proteins | |
| HY-P70138 | DLK-1, Human (S260N, HEK293, His) | Recombinant Proteins | |
| HY-P701380 | KIFC1, Human | Recombinant Proteins | |
| HY-P701381 | KIFC1, Human (His) | Recombinant Proteins | |
| HY-P701382 | TRPA1, Human (HEK293, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P701383 | Mucolipin-1/MCOLN1, Human (HEK293, Strep, FLAG) | Recombinant Proteins | |
| HY-P701385 | HSPA2, Human (His) | Recombinant Proteins | |
| HY-P701386 | HSPBP1, Human | Recombinant Proteins | |
| HY-P701387 | HSPBP1, Human (E88G, His) | Recombinant Proteins | |
| HY-P701388 | PSMG3, Human | Recombinant Proteins | |
| HY-P701389 | PSMG3, Human (His, Strep) | Recombinant Proteins | |
| HY-P70139 | Stromelysin-1/MMP-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701390 | PSMG4, Human | Recombinant Proteins | |
| HY-P701391 | PSMG4, Human (His, Strep) | Recombinant Proteins | |
| HY-P701396 | PXR, Human | Recombinant Proteins | |
| HY-P701397 | PXR, Human (His) | Recombinant Proteins | |
| HY-P701398 | RGS14, Human | Recombinant Proteins | |
| HY-P701399 | RGS14, Human (His) | Recombinant Proteins | |
| HY-P7014 | FGF-4, Human | Recombinant Proteins | |
| HY-P70140 | MECR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701400 | RORa, Human (Sf9) | Recombinant Proteins | |
| HY-P701401 | RORa, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701402 | RXRB, Human | Recombinant Proteins | |
| HY-P701403 | RXRB, Human (His) | Recombinant Proteins | |
| HY-P701404 | LXR-α, Human | Recombinant Proteins | |
| HY-P701405 | LXR-α, Human (His) | Recombinant Proteins | |
| HY-P701406 | UCHL5, Human | Recombinant Proteins | |
| HY-P70141 | NAD kinase/NADK, Human (His) | Recombinant Proteins | |
| HY-P701410 | USP15, Human (sf9, GST) | Recombinant Proteins | |
| HY-P701411 | USP15, Human (sf9) | Recombinant Proteins | |
| HY-P701412 | USP16, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701413 | USP16, Human (Sf9) | Recombinant Proteins | |
| HY-P701417 | USP44, Human | Recombinant Proteins | |
| HY-P701418 | USP46, Human (His, GST) | Recombinant Proteins | |
| HY-P701419 | USP46, Human | Recombinant Proteins | |
| HY-P70142 | Spondin-2/SPON2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701420 | USP47, Human (Sf9, His, FLAG) | Recombinant Proteins | |
| HY-P701421 | USP47, Human (Sf9, FLAG) | Recombinant Proteins | |
| HY-P701422 | USP48, Human (Sf9, FLAG) | Recombinant Proteins | |
| HY-P701423 | USP50, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701424 | USP50, Human (Sf9) | Recombinant Proteins | |
| HY-P701425 | USP51, Human (Sf9, His, FLAG) | Recombinant Proteins | |
| HY-P701426 | USP51, Human (Sf9) | Recombinant Proteins | |
| HY-P701427 | USP53, Human (His, GST) | Recombinant Proteins | |
| HY-P701428 | USP53, Human | Recombinant Proteins | |
| HY-P701429 | USP6, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70142A | Spondin-2/SPON2, Human (Q9BUD6, HEK293, His) | Recombinant Proteins | |
| HY-P70143 | Kallikrein-10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701430 | USP6, Human (Sf9) | Recombinant Proteins | |
| HY-P701431 | USP9X, Human (GST) | Recombinant Proteins | |
| HY-P701432 | USP9X, Human | Recombinant Proteins | |
| HY-P701433 | USP9Y, Human (GST) | Recombinant Proteins | |
| HY-P701434 | USP9Y, Human | Recombinant Proteins | |
| HY-P701435 | VCPIP1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701436 | VCPIP1, Human (Sf9) | Recombinant Proteins | |
| HY-P701437 | COPS5, Human | Recombinant Proteins | |
| HY-P701439 | EIF3S5, Human (GST) | Recombinant Proteins | |
| HY-P70144 | Kallikrein-1, Human (244a.a, HEK293, His, solution) | Recombinant Proteins | |
| HY-P701441 | USP21, Human | Recombinant Proteins | |
| HY-P701442 | USP21, Human (GST) | Recombinant Proteins | |
| HY-P701443 | USP22, Human (Sf9) | Recombinant Proteins | |
| HY-P701444 | USP25, Human | Recombinant Proteins | |
| HY-P701445 | USP25, Human (His) | Recombinant Proteins | |
| HY-P701446 | USP28, Human (Sf9) | Recombinant Proteins | |
| HY-P701447 | USP28, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701448 | USP29, Human (Sf9) | Recombinant Proteins | |
| HY-P701449 | USP29, Human (Sf9, FLAG) | Recombinant Proteins | |
| HY-P70145 | MMP-9, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P701450 | USP30, Human (Sf9) | Recombinant Proteins | |
| HY-P701451 | USP30, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701454 | USP37, Human (Sf9) | Recombinant Proteins | |
| HY-P701455 | USP37, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701456 | ALG13, Human | Recombinant Proteins | |
| HY-P701457 | ALG13, Human (His) | Recombinant Proteins | |
| HY-P701458 | AMSH, Human | Recombinant Proteins | |
| HY-P701459 | AMSHLP, Human (His) | Recombinant Proteins | |
| HY-P70145A | MMP-9, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70146 | Ketohexokinase/KHK, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701460 | ATXN3L, Human (Sf9, FLAG) | Recombinant Proteins | |
| HY-P701461 | ATXN3L, Human (Sf9, His, FLAG) | Recombinant Proteins | |
| HY-P701462 | BAP1, Human | Recombinant Proteins | |
| HY-P701463 | BAP1, Human (His) | Recombinant Proteins | |
| HY-P701465 | OTUD7B, Human (Sf9) | Recombinant Proteins | |
| HY-P701466 | OTUD7B, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701467 | PSMD7, Human (Sf9) | Recombinant Proteins | |
| HY-P701468 | SENP3, Human | Recombinant Proteins | |
| HY-P701469 | SENP3, Human (GST) | Recombinant Proteins | |
| HY-P70147 | Neuropilin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701470 | SENP5, Human | Recombinant Proteins | |
| HY-P701471 | SENP5, Human (GST) | Recombinant Proteins | |
| HY-P701472 | SENP6, Human (sf9) | Recombinant Proteins | |
| HY-P701473 | SENP6, Human (GST) | Recombinant Proteins | |
| HY-P701474 | JOSD1, Human | Recombinant Proteins | |
| HY-P701475 | JOSD1, Human (GST) | Recombinant Proteins | |
| HY-P701476 | JOSD2, Human | Recombinant Proteins | |
| HY-P701477 | AMSH-LP, Human | Recombinant Proteins | |
| HY-P701478 | MPND, Human | Recombinant Proteins | |
| HY-P701479 | MPND, Human (GST) | Recombinant Proteins | |
| HY-P70148 | Mesothelin, Human (303a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701482 | OTUD2, Human | Recombinant Proteins | |
| HY-P701483 | OTUD5, Human (His, FLAG) | Recombinant Proteins | |
| HY-P701484 | OTUD6A, Human | Recombinant Proteins | |
| HY-P701485 | ZRANB1, Human (Sf9) | Recombinant Proteins | |
| HY-P701486 | ZRANB1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701487 | UB2E3, Human (Sf9) | Recombinant Proteins | |
| HY-P701488 | UB2E2, Human (Sf9) | Recombinant Proteins | |
| HY-P701489 | UB2V1, Human (Sf9) | Recombinant Proteins | |
| HY-P70149 | ISG15/UCRP, Human (His) | Recombinant Proteins | |
| HY-P701490 | UB2E3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701491 | UB2Q1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701492 | UFC1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701493 | UBE2O, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701494 | UBE2O, Human (Sf9) | Recombinant Proteins | |
| HY-P701495 | UB2Q2, Human (Sf9) | Recombinant Proteins | |
| HY-P701496 | UB2E2, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701497 | UE2NL, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701498 | UE2NL, Human (Sf9) | Recombinant Proteins | |
| HY-P701499 | UEVLD, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P70149A | ISG15/UCRP, Human (His) | Recombinant Proteins | |
| HY-P70150 | GSTP1, Human | Recombinant Proteins | |
| HY-P701500 | UEVLD, Human (Sf9) | Recombinant Proteins | |
| HY-P701501 | UB2V1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701502 | TRIM2, Human (GST) | Recombinant Proteins | |
| HY-P701503 | TRIM2, Human | Recombinant Proteins | |
| HY-P701504 | TRIM3, Human (GST) | Recombinant Proteins | |
| HY-P701505 | TRIM3, Human | Recombinant Proteins | |
| HY-P70151 | ESM-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701512 | SMURF2, Human (His) | Recombinant Proteins | |
| HY-P701513 | SMURF2, Human | Recombinant Proteins | |
| HY-P701514 | TCEB3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701515 | TCEB3, Human (Sf9) | Recombinant Proteins | |
| HY-P701516 | UHRF2, Human (His, SUMO) | Recombinant Proteins | |
| HY-P701517 | DCAF16, Human (Sf9) | Recombinant Proteins | |
| HY-P701518 | DCAF16, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701519 | DCAF15, Human (Sf9) | Recombinant Proteins | |
| HY-P70152 | EIF4E, Human | Recombinant Proteins | |
| HY-P701520 | DCAF15-DDB1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701521 | DCAF7, Human (Sf9) | Recombinant Proteins | |
| HY-P701522 | DTX3, Human | Recombinant Proteins | |
| HY-P701523 | DTX3, Human (GST) | Recombinant Proteins | |
| HY-P701524 | GZF1, Human (Sf9) | Recombinant Proteins | |
| HY-P701525 | GZF1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701526 | HACE1, Human (His) | Recombinant Proteins | |
| HY-P701527 | HERC2, Human (His) | Recombinant Proteins | |
| HY-P701528 | HLTF, Human | Recombinant Proteins | |
| HY-P701529 | HLTF, Human (His) | Recombinant Proteins | |
| HY-P70153 | KRAS Protein, Human (G12S, His) | Recombinant Proteins | |
| HY-P701530 | ANKFY1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701531 | ARMC5, Human (Sf9) | Recombinant Proteins | |
| HY-P701532 | ARMC5, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701533 | BACH2, Human (Sf9) | Recombinant Proteins | |
| HY-P701534 | BACH2, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701535 | BRAP, Human | Recombinant Proteins | |
| HY-P701536 | BTBD11, Human (Sf9) | Recombinant Proteins | |
| HY-P701537 | BTBD11, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701538 | BTBD9, Human (Sf9) | Recombinant Proteins | |
| HY-P701539 | BTBD9, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P70154 | EpCAM/TROP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701540 | CHFR, Human | Recombinant Proteins | |
| HY-P701541 | CHFR, Human (His) | Recombinant Proteins | |
| HY-P701542 | RFPL3, Human | Recombinant Proteins | |
| HY-P701543 | RFPL3, Human (His) | Recombinant Proteins | |
| HY-P701544 | RNF113A, Human | Recombinant Proteins | |
| HY-P701545 | RNF113A, Human (His) | Recombinant Proteins | |
| HY-P701546 | RNF113B, Human | Recombinant Proteins | |
| HY-P701547 | RNF113B, Human (His) | Recombinant Proteins | |
| HY-P701548 | RNF114, Human | Recombinant Proteins | |
| HY-P701549 | RNF114, Human (GST) | Recombinant Proteins | |
| HY-P70155 | EpCAM/TROP1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701550 | RNF11, Human | Recombinant Proteins | |
| HY-P701551 | RNF11, Human (His) | Recombinant Proteins | |
| HY-P701552 | RNF135, Human | Recombinant Proteins | |
| HY-P701553 | RNF135, Human (His) | Recombinant Proteins | |
| HY-P701554 | RNF141, Human | Recombinant Proteins | |
| HY-P701555 | RNF141, Human (His) | Recombinant Proteins | |
| HY-P701556 | RNF146, Human | Recombinant Proteins | |
| HY-P701557 | RNF146, Human (His) | Recombinant Proteins | |
| HY-P701558 | RNF14, Human | Recombinant Proteins | |
| HY-P701559 | RNF14, Human (His) | Recombinant Proteins | |
| HY-P70156 | Lactoferrin/LTF, Human (691a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701560 | RNF181, Human | Recombinant Proteins | |
| HY-P701561 | RNF181, Human (His) | Recombinant Proteins | |
| HY-P701562 | RNF216, Human | Recombinant Proteins | |
| HY-P701563 | RNF216, Human (His) | Recombinant Proteins | |
| HY-P701564 | RNF8, Human | Recombinant Proteins | |
| HY-P701565 | RNF8, Human (His) | Recombinant Proteins | |
| HY-P701566 | SF3B3, Human (Sf9) | Recombinant Proteins | |
| HY-P701567 | SF3B3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701568 | SH3RF3, Human | Recombinant Proteins | |
| HY-P701569 | SH3RF3, Human (His) | Recombinant Proteins | |
| HY-P70157 | MICA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701570 | IPP, Human (Sf9) | Recombinant Proteins | |
| HY-P701571 | IPP, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701572 | IVNS1ABP, Human (Sf9) | Recombinant Proteins | |
| HY-P701573 | IVNS1ABP, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701574 | KBTBD11, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701575 | KBTBD2, Human (Sf9) | Recombinant Proteins | |
| HY-P701576 | KBTBD2, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701577 | KBTBD6, Human (Sf9) | Recombinant Proteins | |
| HY-P701578 | KBTBD7, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701579 | KBTBD8, Human (Sf9) | Recombinant Proteins | |
| HY-P701580 | KBTBD8, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701581 | KCTD1, Human (Sf9) | Recombinant Proteins | |
| HY-P701582 | KCTD1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701583 | KLHL21, Human (Sf9) | Recombinant Proteins | |
| HY-P701584 | KLHL21, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701585 | KLHL3, Human (Sf9) | Recombinant Proteins | |
| HY-P701586 | KLHL3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701587 | KLHL42, Human (Sf9) | Recombinant Proteins | |
| HY-P701588 | KLHL42, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701589 | KMT2D, Human | Recombinant Proteins | |
| HY-P70159 | Galectin-14/LGALS14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701590 | KMT2D, Human (GST) | Recombinant Proteins | |
| HY-P701591 | LONRF2, Human | Recombinant Proteins | |
| HY-P701592 | LONRF2, Human (His) | Recombinant Proteins | |
| HY-P701593 | MDM2, Human | Recombinant Proteins | |
| HY-P701594 | MDM2, Human (His) | Recombinant Proteins | |
| HY-P701595 | NEDD4L, Human | Recombinant Proteins | |
| HY-P701596 | NEDD4L, Human (His) | Recombinant Proteins | |
| HY-P701597 | NOSIP, Human | Recombinant Proteins | |
| HY-P701598 | NOSIP, Human (His) | Recombinant Proteins | |
| HY-P701599 | ZBTB7B, Human (Sf9) | Recombinant Proteins | |
| HY-P7015A | G-CSF, Human (CHO) | Recombinant Proteins | |
| HY-P7016 | GM-CSF, Human (CHO) | Recombinant Proteins | |
| HY-P70160 | Gastrotropin/FABP6, Human (His) | Recombinant Proteins | |
| HY-P701600 | ZBTB7B, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701601 | ZFAND3, Human (Sf9) | Recombinant Proteins | |
| HY-P701602 | ZFAND3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701603 | ZFAND5, Human (Sf9) | Recombinant Proteins | |
| HY-P701604 | ZFAND5, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P701605 | EIF4A1, Human | Recombinant Proteins | |
| HY-P701606 | EIF4A1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701607 | EXOSC2, Human | Recombinant Proteins | |
| HY-P701608 | EXOSC2, Human (His, Strep) | Recombinant Proteins | |
| HY-P701609 | SIRT3, Human | Recombinant Proteins | |
| HY-P70161 | LYVE-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701610 | SIRT3, Human (His, SUMO) | Recombinant Proteins | |
| HY-P701611 | BPTF, Human | Recombinant Proteins | |
| HY-P701612 | BPTF, Human (His) | Recombinant Proteins | |
| HY-P701613 | CECR2, Human (His) | Recombinant Proteins | |
| HY-P701614 | WDHD1, Human (HEK293, FLAG) | Recombinant Proteins | |
| HY-P701615 | WDHD1, Human (HEK293, His, Strep) | Recombinant Proteins | |
| HY-P701616 | PHF8, Human | Recombinant Proteins | |
| HY-P701617 | PHF8, Human (His) | Recombinant Proteins | |
| HY-P701618 | JMJD2A, Human | Recombinant Proteins | |
| HY-P701619 | JMJD2A, Human (His) | Recombinant Proteins | |
| HY-P70162 | ILT6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701620 | JMJD2D, Human | Recombinant Proteins | |
| HY-P701621 | KDM2A, Human | Recombinant Proteins | |
| HY-P701622 | KDM2A, Human (His) | Recombinant Proteins | |
| HY-P701623 | KDM8, Human | Recombinant Proteins | |
| HY-P701624 | KDM8, Human (His) | Recombinant Proteins | |
| HY-P701625 | MYST1, Human | Recombinant Proteins | |
| HY-P701627 | GRM5, Human (His) | Recombinant Proteins | |
| HY-P701629 | P2Y1, Human (Sf9, FLAG) | Recombinant Proteins | |
| HY-P70163 | Kallikrein-7, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P701630 | P2Y1, Human (Sf9, FLAG, His) | Recombinant Proteins | |
| HY-P701631 | TNKS1, Human (His) | Recombinant Proteins | |
| HY-P701632 | TNKS1, Human | Recombinant Proteins | |
| HY-P701633 | SLK, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701635 | SRPK2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701637 | SYK, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701638 | SYK, Human (Sf9) | Recombinant Proteins | |
| HY-P701639 | TAB1, Human (His) | Recombinant Proteins | |
| HY-P70164 | Ephrin-A1/EFNA1, Human (164a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701640 | TAB1, Human | Recombinant Proteins | |
| HY-P701641 | TAOK2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701643 | TEC, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701644 | TEC, Human (Sf9) | Recombinant Proteins | |
| HY-P701645 | TNIK, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701646 | TNIK, Human (Sf9) | Recombinant Proteins | |
| HY-P701647 | TSSK1, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701649 | TSSK2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70165 | MANSC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701651 | TSSK4, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701652 | TSSK4, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701653 | TTK, Human (Sf9, GST, FLAG) | Recombinant Proteins | |
| HY-P701654 | TTK, Human (K857G, Sf9, FLAG) | Recombinant Proteins | |
| HY-P701655 | TXK Protein, Human (Sf9, 268a.a, His, GST) | Recombinant Proteins | |
| HY-P701658 | CK1d, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701659 | CK1γ3, Human (Sf9) | Recombinant Proteins | |
| HY-P70166 | LRG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701660 | CK1γ3, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701661 | CKS1, Human | Recombinant Proteins | |
| HY-P701662 | CKS2, Human | Recombinant Proteins | |
| HY-P701664 | CLK2, Human (GST) | Recombinant Proteins | |
| HY-P701667 | DYRK1A, Human | Recombinant Proteins | |
| HY-P701668 | DYRK1A, Human (His) | Recombinant Proteins | |
| HY-P70167 | ENPP-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701672 | DYRK2, Human (GST) | Recombinant Proteins | |
| HY-P701673 | DYRK4, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701674 | DYRK4, Human (Sf9, His, FLAG) | Recombinant Proteins | |
| HY-P701676 | EEF2K, Human (GST) | Recombinant Proteins | |
| HY-P701678 | ERK1, Human (GST) | Recombinant Proteins | |
| HY-P701679 | ERK3, Human (L290V) | Recombinant Proteins | |
| HY-P70168 | LILRB2/CD85d/ILT-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701680 | ERK3, Human (L290V, His) | Recombinant Proteins | |
| HY-P701682 | FAK1, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701684 | FGR, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701686 | FIP1L1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701690 | GSK3α, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701691 | HCK, Human (Q523E, Q524E, Q525I, Sf9) | Recombinant Proteins | |
| HY-P701692 | HCK, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701693 | HIPK1, Human (Sf9) | Recombinant Proteins | |
| HY-P701694 | HIPK1, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701698 | HIPK3, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P7016A | GM-CSF, Human | Recombinant Proteins | |
| HY-P7016B | GM-CSF, Human (P.pastoris) | Recombinant Proteins | |
| HY-P7016C | GM-CSF, Human (His) | Recombinant Proteins | |
| HY-P7017 | HB-EGF, Human | Recombinant Proteins | |
| HY-P70170 | Fetuin A/AHSG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701700 | HIPK4, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701705 | ASK1, Human (His) | Recombinant Proteins | |
| HY-P701706 | AURA, Human (Sf9) | Recombinant Proteins | |
| HY-P70171 | Galectin-3/LGALS3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701710 | AURC, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701711 | BMX, Human (Sf9) | Recombinant Proteins | |
| HY-P701712 | BMX, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701713 | BRDT, Human | Recombinant Proteins | |
| HY-P701714 | BRDT, Human (His, SUMO) | Recombinant Proteins | |
| HY-P701716 | BRSK1, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701718 | BRSK2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70172 | Mucin-15/MUC15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701720 | CaMKII delta/CAMK2D, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701722 | CAMKK1, Human (Sf9) | Recombinant Proteins | |
| HY-P701723 | CAMKK1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701725 | VRK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701726 | Wee1, Human (Sf9) | Recombinant Proteins | |
| HY-P701727 | Wee1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701729 | WEE2, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701730 | P38β, Human (Sf9) | Recombinant Proteins | |
| HY-P701731 | P38β, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701732 | PAK6, Human | Recombinant Proteins | |
| HY-P701733 | PAK6, Human (His) | Recombinant Proteins | |
| HY-P701735 | PASK, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701737 | PDK4, Human (GST) | Recombinant Proteins | |
| HY-P701738 | PDPK1, Human (Sf9) | Recombinant Proteins | |
| HY-P701739 | PDPK1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P70174 | NKp46/NCR1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701740 | PHKG2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701742 | PI4KB, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701744 | PIK3R3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701745 | PIM1, Human | Recombinant Proteins | |
| HY-P701746 | PIM2, Human | Recombinant Proteins | |
| HY-P701747 | PIM2, Human (His) | Recombinant Proteins | |
| HY-P701749 | PIM3, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70175 | LRG1, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P701750 | PIP4K2C, Human | Recombinant Proteins | |
| HY-P701752 | PK3C3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701753 | PKACα, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701754 | PKCz, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701755 | PRKCZ, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701756 | PNCK, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701757 | PNCK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701759 | PRKG2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70176 | Insulin-like 3/INSL3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701761 | PRKX, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701763 | PXK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701764 | RCK, Human (His) | Recombinant Proteins | |
| HY-P701766 | RIOK2, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701768 | RIPK1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701769 | ROCK1, Human (Sf9) | Recombinant Proteins | |
| HY-P701770 | ROCK1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701771 | RSK1, Human (Sf9) | Recombinant Proteins | |
| HY-P701772 | RSK1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701773 | RSK2, Human | Recombinant Proteins | |
| HY-P701774 | RSK2, Human (His) | Recombinant Proteins | |
| HY-P701776 | SBK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P70178 | FLT3, Human (HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P701780 | SCYL3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701782 | SGK2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701783 | SGK, Human (Sf9) | Recombinant Proteins | |
| HY-P701784 | SGK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701786 | IKKβ, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701788 | IKKε, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701789 | IRAK1, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70179 | LILRB1/CD85j/ILT2, Human (435a.a, HEK293, His) | Recombinant Proteins | |
| HY-P701790 | JNK3, Human | Recombinant Proteins | |
| HY-P701791 | JNK3, Human (His) | Recombinant Proteins | |
| HY-P701792 | LIMK1, Human (D460N, Sf9) | Recombinant Proteins | |
| HY-P701793 | LIMK1, Human (D460N, Sf9, His) | Recombinant Proteins | |
| HY-P701795 | LTK, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701797 | MAK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P7018 | IGF-I/IGF-1, Human (70a.a) | Recombinant Proteins | |
| HY-P70180 | GPVI, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P701801 | MAP4K6, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701803 | MAPK4, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P701804 | MAPKAPK2, Human | Recombinant Proteins | |
| HY-P701805 | MAPKAPK2, Human (His) | Recombinant Proteins | |
| HY-P701806 | MARK1, Human | Recombinant Proteins | |
| HY-P701807 | MARK1, Human (His) | Recombinant Proteins | |
| HY-P701808 | MARK4, Human | Recombinant Proteins | |
| HY-P701809 | MARK4, Human (His) | Recombinant Proteins | |
| HY-P70181 | Leptin, Carassius auratus (P.pastoris, His) | Recombinant Proteins | |
| HY-P701810 | MELK, Human | Recombinant Proteins | |
| HY-P701811 | MELK, Human (His) | Recombinant Proteins | |
| HY-P701813 | MKNK1, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701814 | MKNK2, Human | Recombinant Proteins | |
| HY-P701815 | MKNK2, Human (His) | Recombinant Proteins | |
| HY-P701817 | MRCKα, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701819 | MSK1, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70182 | LILRB1/CD85j/ILT2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P701821 | MST2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701822 | NEK2, Human (T175A) | Recombinant Proteins | |
| HY-P701823 | NEK2, Human (T175A, His) | Recombinant Proteins | |
| HY-P701825 | NEK6, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701827 | NEK9, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P70183 | Fetuin A/AHSG, Macaca mulatta (HEK293, His) | Recombinant Proteins | |
| HY-P701831 | YSK, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P701833 | GPR158, Human (HEK293, GFP, FLAG, His) | Recombinant Proteins | |
| HY-P701834 | hERG, Human (HEK293, GFP, His) | Recombinant Proteins | |
| HY-P701835 | VKOR1, Human (HEK293, GFP, His) | Recombinant Proteins | |
| HY-P701838 | P371, Human (L573F, Sf9, FLAG) | Recombinant Proteins | |
| HY-P701839 | ubiquitin, Human (His) | Recombinant Proteins | |
| HY-P70184 | HVEM/TNFRSF14, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P701840 | SPIN4, Human (His) | Recombinant Proteins | |
| HY-P701841 | SPIN4, Human | Recombinant Proteins | |
| HY-P701842 | SNAP23, Human (His, Strep) | Recombinant Proteins | |
| HY-P701843 | SNAP23, Human | Recombinant Proteins | |
| HY-P701845 | clpB, E.coli (K476C) | Recombinant Proteins | |
| HY-P701846 | clpB, E.coli (K476C, His) | Recombinant Proteins | |
| HY-P701847 | GEMIN6, Human | Recombinant Proteins | |
| HY-P701848 | GEMIN6, Human (His, Strep) | Recombinant Proteins | |
| HY-P701849 | GMNN, Human | Recombinant Proteins | |
| HY-P70185 | Neuropilin-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701850 | GMNN, Human (His, Strep) | Recombinant Proteins | |
| HY-P701851 | gp15, Escherichia phage T7 (His, Strep) | Recombinant Proteins | |
| HY-P701853 | APC, Human (His) | Recombinant Proteins | |
| HY-P701854 | PMF1, Human | Recombinant Proteins | |
| HY-P701855 | PMF1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701856 | MTCP1, Human | Recombinant Proteins | |
| HY-P701857 | MTCP1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701858 | Thermostable xylanase, E.coli (His) | Recombinant Proteins | |
| HY-P70186 | IL-4R alpha/CD124, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701861 | SPR, Human (His) | Recombinant Proteins | |
| HY-P701862 | SPR, Human | Recombinant Proteins | |
| HY-P701863 | TKT, Human (His) | Recombinant Proteins | |
| HY-P701864 | TKT, Human | Recombinant Proteins | |
| HY-P701865 | TRIP13, Human (His, Strep) | Recombinant Proteins | |
| HY-P701866 | TRIP13, Human | Recombinant Proteins | |
| HY-P701867 | ClpC1 NTD, Mycobacterium tuberculosis | Recombinant Proteins | |
| HY-P701868 | ClpC1 NTD, Mycobacterium tuberculosis (His) | Recombinant Proteins | |
| HY-P701869 | Purine nucleoside phosphorylase, Thermus thermophilus | Recombinant Proteins | |
| HY-P70187 | ICOS, Rhesus macaque (HEK293,Fc) | Recombinant Proteins | |
| HY-P701870 | Purine nucleoside phosphorylase, Thermus thermophilus (His) | Recombinant Proteins | |
| HY-P701871 | GRE3, Saccharomyces cerevisiae | Recombinant Proteins | |
| HY-P701872 | GRE3, Saccharomyces cerevisiae (His) | Recombinant Proteins | |
| HY-P701873 | DPP8, Human (Sf9) | Recombinant Proteins | |
| HY-P701874 | DPP8, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701875 | eltD, Mycolicibacterium smegmatis 155 | Recombinant Proteins | |
| HY-P701876 | eltD, Mycolicibacterium smegmatis 155 (His, Strep) | Recombinant Proteins | |
| HY-P701877 | EXOSC5, Human | Recombinant Proteins | |
| HY-P701878 | EXOSC5, Human (His, Strep) | Recombinant Proteins | |
| HY-P701879 | EXOSC8, Human | Recombinant Proteins | |
| HY-P70188 | Nectin-4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P701880 | EXOSC8, Human (His, Strep) | Recombinant Proteins | |
| HY-P701881 | FASN, Human (Sf9) | Recombinant Proteins | |
| HY-P701882 | FASN, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701883 | fbaA, Shigella flexneri | Recombinant Proteins | |
| HY-P701884 | fbaA, Shigella flexneri (His) | Recombinant Proteins | |
| HY-P701885 | FNTA, Human | Recombinant Proteins | |
| HY-P701886 | FNTA, Human (His, Strep) | Recombinant Proteins | |
| HY-P701888 | FTO, Human (His) | Recombinant Proteins | |
| HY-P701889 | Galactokinase, Thermus thermophilus | Recombinant Proteins | |
| HY-P70189 | EGFR vIII, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701890 | Galactokinase, Thermus thermophilus (His) | Recombinant Proteins | |
| HY-P701891 | Beta-galactosidase, Saccharolobus solfataricus | Recombinant Proteins | |
| HY-P701892 | Beta-galactosidase, Saccharolobus solfataricus (FLAG, His) | Recombinant Proteins | |
| HY-P701893 | GALNS, Human (Sf9) | Recombinant Proteins | |
| HY-P701894 | GALNS, Human (Sf9, His) | Recombinant Proteins | |
| HY-P701895 | gdh2, Saccharolobus solfataricus | Recombinant Proteins | |
| HY-P701896 | gdh2, Saccharolobus solfataricus (His, Strep) | Recombinant Proteins | |
| HY-P701897 | glycogen phosphorylase, Pyrococcus furiosus | Recombinant Proteins | |
| HY-P701898 | glycogen phosphorylase, Pyrococcus furiosus (His) | Recombinant Proteins | |
| HY-P701899 | Glycosyltransferase, Citrus clementina | Recombinant Proteins | |
| HY-P7019 | IGF2, Human | Recombinant Proteins | |
| HY-P70190 | Galectin-8/LGALS8, Human | Recombinant Proteins | |
| HY-P701900 | Glycosyltransferase, Citrus clementina (His) | Recombinant Proteins | |
| HY-P701901 | GNPDA2, Human | Recombinant Proteins | |
| HY-P701902 | GNPDA2, Human (His) | Recombinant Proteins | |
| HY-P701903 | Dit, Bacillus phage SPP1 | Recombinant Proteins | |
| HY-P701904 | Dit, Bacillus phage SPP1 (FLAG, His) | Recombinant Proteins | |
| HY-P701905 | gucD, Bacillus subtilis | Recombinant Proteins | |
| HY-P701906 | gucD, Bacillus subtilis (His, Strep) | Recombinant Proteins | |
| HY-P701907 | gyrB, E.coli (Y5S, N198D) | Recombinant Proteins | |
| HY-P701908 | gyrB, E.coli (Y5S, N198D, His) | Recombinant Proteins | |
| HY-P701909 | hDDC, Human | Recombinant Proteins | |
| HY-P70191 | Lefty-A/TGF-beta 4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701910 | hDDC, Human (His, Strep) | Recombinant Proteins | |
| HY-P701911 | hflC, E.coli | Recombinant Proteins | |
| HY-P701912 | hflC, E.coli (His) | Recombinant Proteins | |
| HY-P701914 | GLUD1, Human | Recombinant Proteins | |
| HY-P701915 | GLUD1, Human (His) | Recombinant Proteins | |
| HY-P701916 | hydB, Pyrococcus furiosus | Recombinant Proteins | |
| HY-P701917 | hydB, Pyrococcus furiosus (His) | Recombinant Proteins | |
| HY-P701918 | hydG, Pyrococcus furiosus | Recombinant Proteins | |
| HY-P701919 | hydG, Pyrococcus furiosus (His) | Recombinant Proteins | |
| HY-P70192 | GFRA2/GDNFR-alpha-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701920 | 3C protease, Human rhinovirus 14 | Recombinant Proteins | |
| HY-P701921 | 3C protease, Human rhinovirus 14 (GST) | Recombinant Proteins | |
| HY-P701922 | ACSS2, Human | Recombinant Proteins | |
| HY-P701923 | ACSS2, Human (His) | Recombinant Proteins | |
| HY-P701924 | ADH1A, Human | Recombinant Proteins | |
| HY-P701925 | ADH1A, Human (His) | Recombinant Proteins | |
| HY-P701926 | ADH4, Human | Recombinant Proteins | |
| HY-P701927 | ADH4, Human (GST) | Recombinant Proteins | |
| HY-P701928 | ADH4, Saccharomyces cerevisiae | Recombinant Proteins | |
| HY-P701929 | ADH4, Saccharomyces cerevisiae (His, Strep) | Recombinant Proteins | |
| HY-P70193 | Ephrin-A4/EFNA4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P701930 | ADH5, Human (His) | Recombinant Proteins | |
| HY-P701931 | ADH6, Human | Recombinant Proteins | |
| HY-P701932 | ADH6, Human (GST) | Recombinant Proteins | |
| HY-P701933 | ADH II, Zymomonas mobilis subsp. mobilis | Recombinant Proteins | |
| HY-P701934 | ADH II, Zymomonas mobilis subsp. mobilis (His, Strep) | Recombinant Proteins | |
| HY-P701935 | ADH1C, Human | Recombinant Proteins | |
| HY-P701936 | ADH, Sulfurisphaera tokodaii | Recombinant Proteins | |
| HY-P701937 | ADH, Drosophila melanogaster | Recombinant Proteins | |
| HY-P701938 | ADH, Sulfurisphaera tokodaii (His, Strep) | Recombinant Proteins | |
| HY-P701939 | ADH, Drosophila melanogaster (His, Strep) | Recombinant Proteins | |
| HY-P70194 | Ephrin-A5/EFNA5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P701940 | aKMT, Sulfolobus islandicus | Recombinant Proteins | |
| HY-P701941 | aKMT, Sulfolobus islandicus (His, Strep) | Recombinant Proteins | |
| HY-P701942 | L-arabinose isomerase, Bacillus subtilis | Recombinant Proteins | |
| HY-P701943 | L-arabinose isomerase, Bacillus subtilis (His) | Recombinant Proteins | |
| HY-P701944 | Cephalosporin C deacetylase, Bacillus subtilis | Recombinant Proteins | |
| HY-P701945 | CHAC1, Human (Strep) | Recombinant Proteins | |
| HY-P701946 | CHAC1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701949 | panD, Corynebacterium jeikeium | Recombinant Proteins | |
| HY-P70195 | Ephrin-A3/EFNA3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P701950 | panD, Corynebacterium jeikeium (FLAG, His) | Recombinant Proteins | |
| HY-P701951 | PARP14, Human | Recombinant Proteins | |
| HY-P701952 | PARP14, Human (His, Strep) | Recombinant Proteins | |
| HY-P701953 | PARP15, Human (His) | Recombinant Proteins | |
| HY-P701956 | patZ, E.coli | Recombinant Proteins | |
| HY-P701957 | patZ, E.coli (His, Strep) | Recombinant Proteins | |
| HY-P701958 | PBP1A, Mycobacterium tuberculosis | Recombinant Proteins | |
| HY-P701959 | PBP1A, Mycobacterium tuberculosis (His) | Recombinant Proteins | |
| HY-P70196 | IL-13R alpha 1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P701960 | PDE4D, Human | Recombinant Proteins | |
| HY-P701961 | PDE4D, Human (His) | Recombinant Proteins | |
| HY-P701962 | PGAM1, Human | Recombinant Proteins | |
| HY-P701963 | PGAM1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701964 | Phospholipase C, Bacillus cereus | Recombinant Proteins | |
| HY-P701965 | Phospholipase C, Bacillus cereus (His) | Recombinant Proteins | |
| HY-P701966 | PKCi, Human (H114A) | Recombinant Proteins | |
| HY-P701967 | PKCi, Human (H114A, His) | Recombinant Proteins | |
| HY-P701968 | PRIM1, Human | Recombinant Proteins | |
| HY-P701969 | PRIM1, Human (His, Strep) | Recombinant Proteins | |
| HY-P70197 | IMPA2, Human (His) | Recombinant Proteins | |
| HY-P701970 | PTPRG, Human | Recombinant Proteins | |
| HY-P701971 | PTPRG, Human (His) | Recombinant Proteins | |
| HY-P701972 | Aldose-reductase, Human | Recombinant Proteins | |
| HY-P701973 | Aldose-reductase, Human (His) | Recombinant Proteins | |
| HY-P701974 | RRAS2, Human | Recombinant Proteins | |
| HY-P701975 | RRAS2, Human (His, Strep) | Recombinant Proteins | |
| HY-P701976 | SHMT2, Human | Recombinant Proteins | |
| HY-P701977 | SHMT2, Human (His) | Recombinant Proteins | |
| HY-P701979 | kshB, Mycobacterium tuberculosis | Recombinant Proteins | |
| HY-P70198 | LSM1, Human (His) | Recombinant Proteins | |
| HY-P701980 | kshB, Mycobacterium tuberculosis (His) | Recombinant Proteins | |
| HY-P701981 | MCD, Human | Recombinant Proteins | |
| HY-P701982 | MCD, Human (His) | Recombinant Proteins | |
| HY-P701983 | metK, Shigella sonnei (His) | Recombinant Proteins | |
| HY-P701984 | MGLL, Human | Recombinant Proteins | |
| HY-P701985 | MGLL, Human (His) | Recombinant Proteins | |
| HY-P701987 | MMP-13, Human (His) | Recombinant Proteins | |
| HY-P701988 | NIT2, Arabidopsis thaliana | Recombinant Proteins | |
| HY-P701989 | NIT2, Arabidopsis thaliana (His) | Recombinant Proteins | |
| HY-P70199 | HMGB3/HMG-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P701990 | YPR1, Saccharomyces cerevisiae | Recombinant Proteins | |
| HY-P701991 | YPR1, Saccharomyces cerevisiae (His, Strep) | Recombinant Proteins | |
| HY-P701992 | λPP, Escherichia phage lambda (His, FLAG) | Recombinant Proteins | |
| HY-P701993 | Sox2, Human | Recombinant Proteins | |
| HY-P701994 | PYHIN1, Human (FLAG) | Recombinant Proteins | |
| HY-P701995 | PYHIN1, Human (His, Strep) | Recombinant Proteins | |
| HY-P701996 | IFI16, Human (FLAG) | Recombinant Proteins | |
| HY-P701997 | IFI16, Human (His, Strep) | Recombinant Proteins | |
| HY-P701998 | LGP2, Human (HEK293, FLAG) | Recombinant Proteins | |
| HY-P701999 | LGP2, Human (HEK293, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P7020 | IGFBP-3, Human | Recombinant Proteins | |
| HY-P702000 | LRRFIP1, Human (FLAG) | Recombinant Proteins | |
| HY-P702001 | LRRFIP1, Human (His, Strep) | Recombinant Proteins | |
| HY-P702002 | MRE11A, Human (His, GST) | Recombinant Proteins | |
| HY-P702003 | NLRP5, Human (Sf9) | Recombinant Proteins | |
| HY-P702005 | NLRP6, Human (Sf9) | Recombinant Proteins | |
| HY-P702006 | SLC15A2, Human (HEK293, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702007 | SLC19A1, Human (Sf9, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P702008 | SLC35A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702009 | SLC14A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P70201 | FLRT2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702010 | SLC30A10, Human (Sf9, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P702012 | SLC35F2, Human (Sf9, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P702013 | SLC19A2, Human (Sf9, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P702014 | SLC25A45, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702015 | SLC30A3, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702016 | SLC11A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702017 | SLC11A2, Human (HEK293, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702018 | SLC15A2, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702019 | SLC21A3, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P70202 | HAI-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702020 | SLC25A5, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702021 | SLC16A2, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702022 | SLC12A2, Human (HEK293, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P702023 | SLC46A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702025 | SLC15A2, Human (Sf9, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P702027 | SLC17A3, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702028 | SLC25A46, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702029 | SLC29A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P70203 | LRRTM2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702030 | SLC29A2, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702031 | SLC30A2, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702033 | SLC30A10, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702034 | SLC35A2, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702035 | SLC37A4, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702036 | SLC38A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702038 | SLC20A2, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702039 | SLC51B, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702040 | SLC52A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702041 | SLC52A3, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702042 | SLC44A1, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702043 | SLC30A4, Human (Sf9, His, Strep, FLAG) | Recombinant Proteins | |
| HY-P702044 | SLC25A37, Human (Sf9, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P702046 | CIAO1, Human | Recombinant Proteins | |
| HY-P702047 | CIAO1, Human (His, Strep) | Recombinant Proteins | |
| HY-P702048 | CRKL, Human | Recombinant Proteins | |
| HY-P702049 | CRKL, Human (His, Strep) | Recombinant Proteins | |
| HY-P70205 | Progonadoliberin-2/GNRH II, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702050 | CHMP4B, Human | Recombinant Proteins | |
| HY-P702051 | CHMP4B, Human (His, Strep) | Recombinant Proteins | |
| HY-P702052 | CHMP6, Human | Recombinant Proteins | |
| HY-P702053 | CHMP6, Human (His, Strep) | Recombinant Proteins | |
| HY-P702054 | Vps29, Human | Recombinant Proteins | |
| HY-P702055 | Vps29, Human (His, Strep) | Recombinant Proteins | |
| HY-P702056 | MYD88, Human | Recombinant Proteins | |
| HY-P702057 | MYD88, Human (His, GST) | Recombinant Proteins | |
| HY-P702058 | BRPF3, Human | Recombinant Proteins | |
| HY-P702059 | BRPF3, Human (His) | Recombinant Proteins | |
| HY-P702060 | VP40, Zaire ebolavirus (H269L) | Recombinant Proteins | |
| HY-P702061 | p30, African swine fever virus | Recombinant Proteins | |
| HY-P702062 | USP11, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P702063 | USP11, Human (Sf9) | Recombinant Proteins | |
| HY-P702064 | UB2L5, Human (Sf9) | Recombinant Proteins | |
| HY-P702065 | UB2D3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P702066 | UB2L5, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P702067 | TRIM16, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P70206A | Maleylacetoacetate isomerase/GSTZ1, Human (N-His) | Recombinant Proteins | |
| HY-P70207 | EIF1B, Human (His) | Recombinant Proteins | |
| HY-P702070 | CUL5, Human (Sf9) | Recombinant Proteins | |
| HY-P702071 | CUL5, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P702072 | DTX3L, Human | Recombinant Proteins | |
| HY-P702073 | DTX3L, Human (His) | Recombinant Proteins | |
| HY-P702074 | WHSC1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P702075 | PELI2, Human | Recombinant Proteins | |
| HY-P702076 | RBCK1, Human | Recombinant Proteins | |
| HY-P702077 | RBCK1, Human (His) | Recombinant Proteins | |
| HY-P702078 | RNF4, Human | Recombinant Proteins | |
| HY-P702079 | RNF4, Human (GST) | Recombinant Proteins | |
| HY-P70208 | GAS7, Human (His) | Recombinant Proteins | |
| HY-P702080 | ZNRF2, Human | Recombinant Proteins | |
| HY-P702081 | ZNRF2, Human (His) | Recombinant Proteins | |
| HY-P702082 | KDM6B, Human (Sf9) | Recombinant Proteins | |
| HY-P702083 | KDM6B, Human (Sf9, His) | Recombinant Proteins | |
| HY-P702085 | PRKD1, Human (Sf9) | Recombinant Proteins | |
| HY-P702086 | PRKD1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P702087 | frxA, Pyrococcus furiosus | Recombinant Proteins | |
| HY-P702088 | frxA, Pyrococcus furiosus (His) | Recombinant Proteins | |
| HY-P702089 | Menin, Human | Recombinant Proteins | |
| HY-P70209 | EDF1/MBF1, Human (His) | Recombinant Proteins | |
| HY-P702090 | Menin, Human (His) | Recombinant Proteins | |
| HY-P702091 | speA, Shewanella putrefaciens (FLAG, His) | Recombinant Proteins | |
| HY-P702092 | speA, Shewanella putrefaciens | Recombinant Proteins | |
| HY-P702093 | SSDA1, Ketogulonicigenium vulgare (His) | Recombinant Proteins | |
| HY-P702094 | SSDA1, Ketogulonicigenium vulgare | Recombinant Proteins | |
| HY-P702095 | TAL, Rhodotorula glutinis (FLAG, His) | Recombinant Proteins | |
| HY-P702096 | tdc, Levilactobacillus brevis (FLAG, His) | Recombinant Proteins | |
| HY-P702097 | tdc, Levilactobacillus brevis | Recombinant Proteins | |
| HY-P702098 | treS, Thermus thermophilus (FLAG, His) | Recombinant Proteins | |
| HY-P702099 | treS, Thermus thermophilus | Recombinant Proteins | |
| HY-P7021 | IGFBP-5, Human | Recombinant Proteins | |
| HY-P70210 | Frizzled-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P702100 | treY, Arthrobacter ramosus (FLAG, His) | Recombinant Proteins | |
| HY-P702101 | treY, Arthrobacter ramosus | Recombinant Proteins | |
| HY-P702102 | treZ, Arthrobacter ramosus (FLAG, His) | Recombinant Proteins | |
| HY-P702103 | treZ, Arthrobacter ramosus | Recombinant Proteins | |
| HY-P702104 | Urethanase, Lysinibacillus fusiformis (FLAG, His) | Recombinant Proteins | |
| HY-P702105 | Phytanoyl-CoA dioxygenase, Actinophytocola oryzae | Recombinant Proteins | |
| HY-P702106 | Phytanoyl-CoA dioxygenase, Actinophytocola oryzae (His) | Recombinant Proteins | |
| HY-P702107 | Cyclopentanone monooxygenase, Rhodococcus sp. S2-17 | Recombinant Proteins | |
| HY-P702108 | Cyclopentanone monooxygenase, Rhodococcus sp. S2-17 (His) | Recombinant Proteins | |
| HY-P702109 | dai, Aeribacillus pallidus | Recombinant Proteins | |
| HY-P70211 | GGCT, Human (His) | Recombinant Proteins | |
| HY-P702110 | dai, Aeribacillus pallidus (FLAG, His) | Recombinant Proteins | |
| HY-P702113 | Epoxide hydrolases, Sinorhizobium fredii | Recombinant Proteins | |
| HY-P702114 | Epoxide hydrolases, Sinorhizobium fredii (His) | Recombinant Proteins | |
| HY-P702115 | Esterase, Enterobacter asburiae | Recombinant Proteins | |
| HY-P702116 | Esterase, Enterobacter asburiae (His) | Recombinant Proteins | |
| HY-P702119 | FDH1, Candida boidinii | Recombinant Proteins | |
| HY-P70212 | GADD45B, Human (His) | Recombinant Proteins | |
| HY-P702120 | FDH1, Candida boidinii (His) | Recombinant Proteins | |
| HY-P702121 | fum, Corynebacterium glutamicum | Recombinant Proteins | |
| HY-P702122 | fum, Corynebacterium glutamicum (His) | Recombinant Proteins | |
| HY-P702123 | GOX2015, Gluconobacter oxydans | Recombinant Proteins | |
| HY-P702124 | GOX2015, Gluconobacter oxydans (His, Strep) | Recombinant Proteins | |
| HY-P702125 | gyaR, Thermoanaerobacter ethanolicus | Recombinant Proteins | |
| HY-P702126 | gyaR, Thermoanaerobacter ethanolicus (His, Strep) | Recombinant Proteins | |
| HY-P702127 | POLG, Hepatitis C virus genotype 1b | Recombinant Proteins | |
| HY-P702128 | POLG, Hepatitis C virus genotype 1b (His) | Recombinant Proteins | |
| HY-P702129 | HELPY, Helicobacter pylori (T380A) | Recombinant Proteins | |
| HY-P70213 | Gankyrin/PSMD10, Human | Recombinant Proteins | |
| HY-P702130 | HELPY, Helicobacter pylori (T380A, His) | Recombinant Proteins | |
| HY-P702131 | COLAER_02088, Collinsella aerofaciens | Recombinant Proteins | |
| HY-P702132 | COLAER_02088, Collinsella aerofaciens (T189V, V207M, GST) | Recombinant Proteins | |
| HY-P702133 | ADH-HT, Geobacillus stearothermophilus | Recombinant Proteins | |
| HY-P702134 | ADH-HT, Geobacillus stearothermophilus (His, Strep) | Recombinant Proteins | |
| HY-P702135 | D-hydantoinase, Arthrobacter crystallopoietes (His) | Recombinant Proteins | |
| HY-P702136 | Acetylornithine Deacylase, Shigella sonnei | Recombinant Proteins | |
| HY-P702137 | Acetylornithine Deacylase, Shigella sonnei (His) | Recombinant Proteins | |
| HY-P702138 | ADH, Geobacillus stearothermophilus | Recombinant Proteins | |
| HY-P702139 | ADH, Geobacillus stearothermophilus (His, Strep) | Recombinant Proteins | |
| HY-P70214 | IDH1, Human (HEK293, His, Solution) | Recombinant Proteins | |
| HY-P702140 | adhT, Geobacillus stearothermophilus | Recombinant Proteins | |
| HY-P702141 | adhT, Geobacillus stearothermophilus (His, Strep) | Recombinant Proteins | |
| HY-P702144 | Alcohol dehydrogenase, Lentilactobacillus curieae | Recombinant Proteins | |
| HY-P702145 | Alcohol dehydrogenase, Lentilactobacillus curieae (His) | Recombinant Proteins | |
| HY-P702146 | Aldehyde reductase, Gluconobacter oxydans | Recombinant Proteins | |
| HY-P702147 | Aldehyde reductase, Gluconobacter oxydans (His) | Recombinant Proteins | |
| HY-P702148 | Alpha amylase, Bacillus licheniformis | Recombinant Proteins | |
| HY-P702149 | Alpha amylase, Bacillus licheniformis (His) | Recombinant Proteins | |
| HY-P70214A | IDH1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70215 | Coagulation Factor X/F10, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702151 | araA, Anoxybacillus flavithermus | Recombinant Proteins | |
| HY-P702152 | araA, Geobacillus stearothermophilus (His) | Recombinant Proteins | |
| HY-P702153 | araA, Anoxybacillus flavithermus (His, CL7) | Recombinant Proteins | |
| HY-P702154 | birA, E.coli (His) | Recombinant Proteins | |
| HY-P702155 | Catalase, Bacillus | Recombinant Proteins | |
| HY-P702156 | Catalase, Bacillus (FLAG, His) | Recombinant Proteins | |
| HY-P702157 | PpSQ1_00405, Pseudomonas putida | Recombinant Proteins | |
| HY-P702158 | PpSQ1_00405, Pseudomonas putida (His, Strep) | Recombinant Proteins | |
| HY-P702159 | pulB, Pullulanibacillus naganoensis | Recombinant Proteins | |
| HY-P702160 | pulB, Pullulanibacillus naganoensis (FLAG, His) | Recombinant Proteins | |
| HY-P702161 | Hyoscyamine 6 beta-hydroxylase, Hyoscyamus niger | Recombinant Proteins | |
| HY-P702162 | ido, Bacillus thuringiensis | Recombinant Proteins | |
| HY-P702163 | ido, Bacillus thuringiensis (FLAG, His) | Recombinant Proteins | |
| HY-P702164 | inuB, Bacillus licheniformis | Recombinant Proteins | |
| HY-P702165 | inuB, Bacillus licheniformis (His) | Recombinant Proteins | |
| HY-P702166 | LCC, Unknown prokaryotic organism | Recombinant Proteins | |
| HY-P702167 | LCC, Unknown prokaryotic organism (His) | Recombinant Proteins | |
| HY-P702168 | leucyl aminopeptidase, Geobacillus kaustophilus | Recombinant Proteins | |
| HY-P702169 | leucyl aminopeptidase, Geobacillus kaustophilus (His) | Recombinant Proteins | |
| HY-P70216A | Legumain, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P70217 | Lymphocyte antigen 6H/LY6H, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702170 | lipoxygenase, Pseudomonas aeruginosa | Recombinant Proteins | |
| HY-P702171 | lipoxygenase, Pseudomonas aeruginosa (FLAG, His) | Recombinant Proteins | |
| HY-P702172 | maiA, Serratia marcescens | Recombinant Proteins | |
| HY-P702173 | maiA, Serratia marcescens (FLAG, His) | Recombinant Proteins | |
| HY-P702174 | Beta-mannanase, Lonsdalea quercina | Recombinant Proteins | |
| HY-P702176 | MDO, Mycobacterium sp. (His) | Recombinant Proteins | |
| HY-P702177 | monomeric sarcosine oxidase, Bacillus sp. | Recombinant Proteins | |
| HY-P702178 | monomeric sarcosine oxidase, Bacillus sp. (His) | Recombinant Proteins | |
| HY-P702179 | NADH dehydrogenase, Gluconobacter oxydans | Recombinant Proteins | |
| HY-P70218 | GADD45G/DDIT2, Human (His) | Recombinant Proteins | |
| HY-P702180 | NADH dehydrogenase type II, Gluconobacter oxydans | Recombinant Proteins | |
| HY-P702181 | NADH dehydrogenase type II, Gluconobacter oxydans (His) | Recombinant Proteins | |
| HY-P702183 | nitA, Rhodococcus rhodochrous | Recombinant Proteins | |
| HY-P702184 | DDX41, Human (FLAG) | Recombinant Proteins | |
| HY-P702185 | DDX41, Human (His, Strep, Flag) | Recombinant Proteins | |
| HY-P702186 | AIM2, Human | Recombinant Proteins | |
| HY-P702187 | AIM2, Human (His) | Recombinant Proteins | |
| HY-P702188 | NLRP1, Human | Recombinant Proteins | |
| HY-P702189 | NLRP1, Human (His) | Recombinant Proteins | |
| HY-P70219 | LYPD3/C4.4A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702190 | PL-PRO, 2019-nCoV (His) | Recombinant Proteins | |
| HY-P702191 | BRPF1, Human | Recombinant Proteins | |
| HY-P702192 | BRPF1, Human (His) | Recombinant Proteins | |
| HY-P702199 | ADIPOR1, Human (Cell-Free) | Recombinant Proteins | |
| HY-P7022 | IFN-alpha 2a/IFNA2, Human (R46K) | Recombinant Proteins | |
| HY-P70220 | MPZL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702202 | ADORA1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702203 | ADRA2A-VLPs, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702206 | ADRB2, Human (Cell-Free, His, SUMO) | Recombinant Proteins | |
| HY-P702207 | ADTRP, Human (Cell-Free, His, Myc) | Recombinant Proteins | |
| HY-P70221 | Acyl-protein thioesterase 2/LYPLA2, Human (His) | Recombinant Proteins | |
| HY-P702211 | APH1A, Human (Cell-Free, His, SUMO) | Recombinant Proteins | |
| HY-P702215 | AQP4, Mouse (Cell-Free) | Recombinant Proteins | |
| HY-P702216 | AQP4, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702219 | ATP1B1, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702220 | ATP5J2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702227 | C5AR2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70222Y | GDF-11/BMP-11, Human (HEK293, solution) | Recombinant Proteins | |
| HY-P70223 | Lymphocyte antigen 86/LY86, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70224 | GGPS1, Human (His) | Recombinant Proteins | |
| HY-P702243 | CD9, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702247 | Claudin-18/CLDN18.1-VLP, Human (HEK293, mCherry) | Recombinant Proteins | |
| HY-P70225 | LDHA, Human (His) | Recombinant Proteins | |
| HY-P702250 | CMKLR1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702255 | CNR2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702257 | CXCR2, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702258 | CXCR4-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70226 | Coagulation factor XIII A/F13A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702263 | DHCR7, Bovine (Cell-Free, His) | Recombinant Proteins | |
| HY-P702265 | DSC3/Desmocollin-3, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P70227 | HGPRT, Human (His) | Recombinant Proteins | |
| HY-P702279 | CD64, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70228 | Kanamycin kinase type II/NEO, Klebsiella pneumoniae | Recombinant Proteins | |
| HY-P702283 | FZD3, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702285 | GIPR, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702289 | glycoprotein B/gB, HHV-2 (Cell-Free, His) | Recombinant Proteins | |
| HY-P70229 | LALBA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702290 | glycoprotein B/gB, HHV-7 (Cell-Free, His) | Recombinant Proteins | |
| HY-P702291 | glycoprotein C/gC, HHV-2 (Cell-Free, His) | Recombinant Proteins | |
| HY-P702292 | glycoprotein D/gD, HHV-2 (Cell-Free, His) | Recombinant Proteins | |
| HY-P702293 | glycoprotein E/gE, HHV-2 (Cell-Free, His) | Recombinant Proteins | |
| HY-P702297 | glycoprotein G/gG, HHV-1 (Cell-Free, His) | Recombinant Proteins | |
| HY-P702298 | GNRHR2, Rhesus Macaque (Cell-Free, His) | Recombinant Proteins | |
| HY-P7023 | IFN-alpha 2b/IFNA2, Human | Recombinant Proteins | |
| HY-P70230 | Haptoglobin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702302 | GPR146, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702308 | GPR65, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70231 | Coagulation factor IX/F9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702315 | Hemagglutinin glycoprotein, Measles virus (Cell-Free, His) | Recombinant Proteins | |
| HY-P70232 | Kras4B Protein, Human (G12C, His) | Recombinant Proteins | |
| HY-P702322 | HRH3-VLPs, Human (HEK293, GFP) | Recombinant Proteins | |
| HY-P702323 | HRH3-VLPs, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70233 | Kras4B, Human (His) | Recombinant Proteins | |
| HY-P702330 | Hypothetical membrane spanning, Coxiella burnetii (Cell-Free, His) | Recombinant Proteins | |
| HY-P702332 | Hypothetical membrane spanning, Coxiella burnetii (Cell-Free, GST) | Recombinant Proteins | |
| HY-P702333 | IFI27L2A, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702334 | IGSF1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70233A | Kras4B, Human (N-His) | Recombinant Proteins | |
| HY-P70234 | Kras4B Protein, Human (G12V, His) | Recombinant Proteins | |
| HY-P70235 | LDLR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702352 | KDELR2, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702356 | Large envelope, HBV-D (Cell-Free, His) | Recombinant Proteins | |
| HY-P70236 | Latent TGF beta 1/TGFB1, Human (C33S, HEK293, His) | Recombinant Proteins | |
| HY-P702365 | MARCH2, Human (Cell-Free, His, SUMO) | Recombinant Proteins | |
| HY-P70237 | FSH, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P702371 | MC1R-VLPs, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702374 | Mucolipin-1/MCOLN1 Protein, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702377 | MFN2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702378 | MG281, Mycoplasma genitalium (Cell-Free, His) | Recombinant Proteins | |
| HY-P702379 | MGST2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70238 | FSH beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702380 | MRGPRX2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702384 | NAD2, Psoroptes ovis (Cell-Free, His) | Recombinant Proteins | |
| HY-P702385 | NINJ1, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702389 | NPY2R, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70239 | GLP-1/GCG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702395 | Oleosin L, Sesamum indicum (Cell-Free, His) | Recombinant Proteins | |
| HY-P702396 | Oleosin, Glycine max (Cell-Free, His) | Recombinant Proteins | |
| HY-P702398 | OPN1LW, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P7024 | IFN-beta, Human (HEK293) | Recombinant Proteins | |
| HY-P70240 | Somatoliberin/GHRH, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P702402 | OPRD1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702403 | OPRM1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70241 | IFN-alpha 1/IFNA13, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702415 | Polyprotein orf1a, SARS coronavirus MA15 (Cell-Free, His) | Recombinant Proteins | |
| HY-P70242 | Hemoglobin subunit zeta/HBAZ, Human (His) | Recombinant Proteins | |
| HY-P702421 | Replicase 1AB polyprotein, SARS-CoV (Cell-Free, His) | Recombinant Proteins | |
| HY-P702425 | RNF5, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70243 | Myoglobin, Human (His) | Recombinant Proteins | |
| HY-P702435 | SLC23A2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70244 | Hemopexin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702440 | SLC26A4-VLPs, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702442 | SLC30A8, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702444 | SLC7A11, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702447 | SMPD2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P70244A | Hemopexin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70245 | Ferritin light chain/FTL, Human (His) | Recombinant Proteins | |
| HY-P70246 | Ferritin heavy chain/FTH1, Human | Recombinant Proteins | |
| HY-P70247 | LacI, E.coli (Q360QC, His) | Recombinant Proteins | |
| HY-P702477 | TRPV3, Human (Cell-Free, His, Flag) | Recombinant Proteins | |
| HY-P702478 | TSPO, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P702479 | TYR/Tyrosinase, Mouse (Cell-Free, His) | Recombinant Proteins | |
| HY-P70248 | ER alpha/ESR1, Human (His) | Recombinant Proteins | |
| HY-P702489 | UPK2, Human (Cell-Free, His, SUMO) | Recombinant Proteins | |
| HY-P70249 | Plasma kallikrein/KLKB1, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P702493 | SPINK1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P702494 | GPT1, Human (His) | Recombinant Proteins | |
| HY-P702495 | BIRC5, Human (His-SUMO) | Recombinant Proteins | |
| HY-P702496 | Glial fibrillary acidic, Human (432a.a, His) | Recombinant Proteins | |
| HY-P702498 | ADAM10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70249A | Plasma kallikrein/KLKB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7025 | IFN-gamma, Human | Recombinant Proteins | |
| HY-P70250 | MMP-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702501 | Agrin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702502 | Amphiregulin, Mouse | Recombinant Proteins | |
| HY-P702506 | TDGF1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702508 | Enterokinase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702509 | FGF-23, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70250A | MMP-1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70251 | IgG3 Fc, Mouse (HEK293) | Recombinant Proteins | |
| HY-P702512 | ICAM-5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70252 | LCAT, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702520 | LRP-1 Cluster II, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702522 | MAG/Siglec-4a, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702523 | Matriptase/ST14 Catalytic Domain, Human (His) | Recombinant Proteins | |
| HY-P702524 | Matriptase/ST14 Catalytic Domain, Mouse (His) | Recombinant Proteins | |
| HY-P702525 | OGN/Osteoglycin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702526 | MIP-3 beta/CCL19, Human | Recombinant Proteins | |
| HY-P702527 | MMP-13, Human (HEK293) | Recombinant Proteins | |
| HY-P702528 | CD206/MMR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702529 | APPBP1-UBA3/NEDD8 E1, Human | Recombinant Proteins | |
| HY-P70253 | Granzyme B/GZMB, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P702533 | Neuregulin-1/NRG1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702534 | Neuropilin-1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702535 | Neurotrophin-3, Human (HEK293) | Recombinant Proteins | |
| HY-P702536 | Nidogen-1/Entactin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702537 | Neurotrophin-4, Human (HEK293) | Recombinant Proteins | |
| HY-P70253A | Granzyme B/GZMB, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P70254 | HER2/CD340, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702540 | Proinsulin, Human (His) | Recombinant Proteins | |
| HY-P702542 | RET, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702544 | ROBO1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702549 | sFRP-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70255 | Myeloperoxidase/MPO, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702553 | SREC-I/SCARF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702558 | ULBP3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702559 | Large envelope, HBV-C (P.pastoris, 180a.a, His) | Recombinant Proteins | |
| HY-P70256 | FABP3, Human (His) | Recombinant Proteins | |
| HY-P702562 | PTHrP, Human (His) | Recombinant Proteins | |
| HY-P702563 | Thrombospondin-2, Mouse (His) | Recombinant Proteins | |
| HY-P702564 | Thrombospondin-2, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P702565 | USP10, Human (Sf9) | Recombinant Proteins | |
| HY-P702568 | Growth Hormone R/GHR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702569 | TL1A/TNFSF15, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P702569A | TL1A/TNFSF15 Protein, Human (Biotinylated, HEK293, Avi-His, solution) | Recombinant Proteins | |
| HY-P70257 | Integrin beta-1/CD29, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702570 | TRADD, Human (His) | Recombinant Proteins | |
| HY-P702571 | TL1A/TNFSF15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702572 | PPAR gamma, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P702573 | Annexin A5/ANXA5, Mouse (His, Myc) | Recombinant Proteins | |
| HY-P702574 | MLKL, Human (His) | Recombinant Proteins | |
| HY-P702575 | BCL6, Human | Recombinant Proteins | |
| HY-P702576 | YTHDF2, Human (His) | Recombinant Proteins | |
| HY-P702577 | GGPS1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702578 | Sialidase-2, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P702579 | FGG/Fibrinogen gamma chain, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P70258 | Beta-glucuronidase/GUSB, E.coli (N-His, solution) | Recombinant Proteins | |
| HY-P702580 | HRH1, Human (His) | Recombinant Proteins | |
| HY-P702581 | Alkaline Phosphatase/ALPG, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702582 | LY6D, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P702583 | DDX5, Human (His, Myc) | Recombinant Proteins | |
| HY-P702584 | USP10, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P702585 | PARP2, Human (sf9, His) | Recombinant Proteins | |
| HY-P702586 | IL-6, Rabbit (P.pastoris, His) | Recombinant Proteins | |
| HY-P702587 | Beta-ketoacyl-ACP reductase, E.coli (His, Myc) | Recombinant Proteins | |
| HY-P702588 | SARS-CoV-2 S1 (Delta, B.1.617.2, His) | Recombinant Proteins | |
| HY-P702589 | JUN, Human (His, Myc) | Recombinant Proteins | |
| HY-P70259 | LDHA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702590 | FcRH5/FcRL5, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P702591 | PTBP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702592 | IRF5, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P702593 | ODC1, Human (His-SUMO, Myc) | Recombinant Proteins | |
| HY-P702594 | CCR6-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702595 | TM4SF1-VLP, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P702596 | Claudin-6/CLDN6-VLP, Human (HEK293, GFP) | Recombinant Proteins | |
| HY-P702597 | CCR9-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702598 | Mucin-2/MUC2, Human (His) | Recombinant Proteins | |
| HY-P702599 | Mucin-2/MUC2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P7025A | IFN-gamma, Human (CHO) | Recombinant Proteins | |
| HY-P7026 | IFN-lambda 1/IL-29, Human | Recombinant Proteins | |
| HY-P70260 | Enolase 1/ENO1, Human (His, solution) | Recombinant Proteins | |
| HY-P702600 | USP21, Human (356a.a) | Recombinant Proteins | |
| HY-P702601 | CDK6, Human (Sf9, His-Avi) | Recombinant Proteins | |
| HY-P702602 | EphA8, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P702603 | USP7, Human (His) | Recombinant Proteins | |
| HY-P702604 | USP7, Human | Recombinant Proteins | |
| HY-P702605 | CFP-10, Mycobacterium tuberculosis (His) | Recombinant Proteins | |
| HY-P702606 | CCR4, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702608 | AK2, Human (GST) | Recombinant Proteins | |
| HY-P70260A | Enolase 1/ENO1, Human (C-His) | Recombinant Proteins | |
| HY-P70261 | GH/Somatotropin, Mouse | Recombinant Proteins | |
| HY-P702610 | Annexin A4, Human (His-SUMO, Myc) | Recombinant Proteins | |
| HY-P702611 | Arylsulfatase B/ARSB, Human (His-SUMO) | Recombinant Proteins | |
| HY-P702612 | Arylsulfatase B/ARSB, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P702613 | ASIP/Agouti, Human (His, Myc) | Recombinant Proteins | |
| HY-P702614 | Bax, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P702615 | Collagen XV alpha 1/COL15A1, Human (His) | Recombinant Proteins | |
| HY-P702616 | Versican Isoform V0, Human (His, B2M, Myc) | Recombinant Proteins | |
| HY-P702617 | DGKA, Human (sf9, His, Myc) | Recombinant Proteins | |
| HY-P70262 | Gastric lipase, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P702620 | PKC iota, Human (Sf9, His) | Recombinant Proteins | |
| HY-P702621 | Integrin alpha 6 beta 1, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P702622 | LY6G6D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702624 | GFRAL, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702626 | Integrin alpha V beta 1, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P702628 | Wnt6, Mouse (His, SUMO) | Recombinant Proteins | |
| HY-P702629 | DLK2, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P70262A | Gastric lipase, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P702630 | FUS, Human (His, Myc) | Recombinant Proteins | |
| HY-P702631 | AKT1, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P702632 | AKT2, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P702633 | AKT3, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P702634 | MRCKG, Human (sf9) | Recombinant Proteins | |
| HY-P702635 | MRCKβ, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702636 | CIT, Human (sf9) | Recombinant Proteins | |
| HY-P702637 | PRKACB, Human (sf9) | Recombinant Proteins | |
| HY-P702638 | PRKACG, Human (sf9) | Recombinant Proteins | |
| HY-P702639 | PRKCB, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70263A | M-CSF, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P70264 | FABP1/L-FABP, Human (N-His) | Recombinant Proteins | |
| HY-P702640 | PRKCG, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702641 | PRKCA, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702642 | PRKCD, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702643 | PRKCH, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702644 | PRKCE, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702645 | PRKCI, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702646 | GPX4, Human (His) | Recombinant Proteins | |
| HY-P702647 | PRKG1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702648 | PKN1, Human (sf9, His, Flag) | Recombinant Proteins | |
| HY-P702649 | PKN2, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P70264A | FABP1/L-FABP, Human (His, solution) | Recombinant Proteins | |
| HY-P70265 | LDHB, Human (His) | Recombinant Proteins | |
| HY-P702650 | RPS6KA4, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P702651 | RPS6KA6, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702652 | CAMKIV/CAMK4, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702653 | CAMK1 delta, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702654 | CAMK1 alpha, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P702655 | CaMKII beta/CAMK2B, Human (Q13554-1, sf9, GST) | Recombinant Proteins | |
| HY-P702656 | NUAK1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702657 | DAPK1, Human (289a.a, sf9, GST) | Recombinant Proteins | |
| HY-P702658 | DAPK2, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P702659 | STK17A, Human (sf9) | Recombinant Proteins | |
| HY-P70266 | Kallikrein-3/PSA, Human (244a.a, HEK293, His) | Recombinant Proteins | |
| HY-P702660 | DCLK1, Human (739a.a, sf9, GST) | Recombinant Proteins | |
| HY-P702661 | DCLK2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702662 | MAPKAPK2, Human (323a.a) | Recombinant Proteins | |
| HY-P702663 | MAPKAPK3, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P702664 | MAPKAPK5, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702665 | PHKG1, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P702666 | CSNK1E, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702667 | CSNK1G2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702668 | CSNK1A1, Human (sf9, His, Strep) | Recombinant Proteins | |
| HY-P702669 | CSNK1G1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70267 | Fumarate hydratase/FH, Human | Recombinant Proteins | |
| HY-P702670 | CSNK1A1L, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P702671 | CDK1-CCNA2, Human (sf9, GST, His) | Recombinant Proteins | |
| HY-P702672 | AURKA, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702673 | CDK1-CCNE1, Human (sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P702674 | CDK1-CCNE2, Human (sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P702675 | CDK2-CCNA2, Human (sf9, GST, His) | Recombinant Proteins | |
| HY-P702676 | CDK2-CCND1, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702677 | CDK2-CCNE1, Human (sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P702678 | CDK2-CCNE2, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702679 | CDK2-CCNO, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P70268 | MMP-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702680 | CDK3-CCNC, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702681 | CDK3-CCNE2, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702682 | CDK4-CCND1, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702683 | CDK4-CCND2, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702684 | CDK4-CCND3, Human (sf9, GST, His) | Recombinant Proteins | |
| HY-P702685 | CDK5-p25, Human (sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P702686 | CDK5-p35, Human (sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P702687 | CDK6-CCND1 Heterodimer, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702688 | CDK7-CCNH-MNAT1, Human (sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P702689 | CDK9-CCNT1, Human (sf9, GST, His) | Recombinant Proteins | |
| HY-P70269 | HMBS/Porphobilinogen deaminase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702690 | CDK9-CCNT2, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702691 | CD117/c-kit, Human (P10721-1, sf9) | Recombinant Proteins | |
| HY-P702692 | CDK12-CCNT1, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702693 | CDK13-CCNK, Human (sf9, GST, Flag) | Recombinant Proteins | |
| HY-P702694 | CDK13-CCNT1, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702695 | CDK15-CCNY, Human (sf9, GST, Flag) | Recombinant Proteins | |
| HY-P702696 | CDK16-CCNY, Human (sf9, GST, Flag) | Recombinant Proteins | |
| HY-P702697 | CDK17-CCNY, Human (sf9, GST, Flag) | Recombinant Proteins | |
| HY-P702698 | CDK18-CCNY, Human (sf9, GST, Flag) | Recombinant Proteins | |
| HY-P702699 | CDK19-CCNC-MED12, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P70269A | HMBS/Porphobilinogen deaminase, Human (N-His) | Recombinant Proteins | |
| HY-P70269Y | HMBS/Porphobilinogen deaminase, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P7027 | IL-1 alpha, Human | Recombinant Proteins | |
| HY-P70270 | GST, Schistosoma Japonicum | Recombinant Proteins | |
| HY-P702700 | NTRK3, Human (Biotinylated, sf9, His, Avi) | Recombinant Proteins | |
| HY-P702701 | MUSK, Human (O15146-1, sf9, His, GST) | Recombinant Proteins | |
| HY-P702702 | TYRO3, Human (Biotinylated, sf9, Flag, Avi) | Recombinant Proteins | |
| HY-P702703 | AXL, Human (Biotinylated, sf9, GST, Avi) | Recombinant Proteins | |
| HY-P702704 | MERTK, Human (Biotinylated, sf9, Flag, Avi) | Recombinant Proteins | |
| HY-P702705 | TIE-2, Human (Biotinylated, sf9, Avi) | Recombinant Proteins | |
| HY-P702706 | EphA1, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P702707 | EphA3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702708 | EphA7, Human (sf9) | Recombinant Proteins | |
| HY-P702709 | EphB1, Human | Recombinant Proteins | |
| HY-P70271 | Gamma-enolase/Enolase 2, Human (His) | Recombinant Proteins | |
| HY-P702710 | EphB2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702711 | EphB3, Human (sf9) | Recombinant Proteins | |
| HY-P702712 | RET, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702713 | DDR2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702714 | ROS1, Human (sf9, His) | Recombinant Proteins | |
| HY-P702715 | ALK, Human (L1196M, Biotinylated, sf9, Avi) | Recombinant Proteins | |
| HY-P702716 | ABL1, Human (sf9) | Recombinant Proteins | |
| HY-P702717 | PTK2B, Human (sf9) | Recombinant Proteins | |
| HY-P702718 | FER, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702719 | FES, Human (His) | Recombinant Proteins | |
| HY-P70272 | Hemoglobin subunit theta-1/HBQ1, Human (His) | Recombinant Proteins | |
| HY-P702720 | Janus kinase 2/JAK2, Human (sf9) | Recombinant Proteins | |
| HY-P702721 | JAK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702722 | TYK2, Human (Biotinylated, sf9, His, Flag, Avi) | Recombinant Proteins | |
| HY-P702723 | Lck, Human (Biotinylated, sf9, Avi) | Recombinant Proteins | |
| HY-P702724 | Src, Human (sf9, His, Flag) | Recombinant Proteins | |
| HY-P702725 | YES1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702726 | Brk/PTK6, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P702727 | FYN, Human (Biotinylated, sf9, His, Flag, Avi) | Recombinant Proteins | |
| HY-P702728 | SYK, Human (Biotinylated, sf9, Avi) | Recombinant Proteins | |
| HY-P702729 | ZAP70, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P70273 | Galectin-1/LGALS1, Human (His) | Recombinant Proteins | |
| HY-P702730 | BTK, Human (Biotinylated, sf9, His, Avi) | Recombinant Proteins | |
| HY-P702731 | ITK, Human (620a.a, sf9, GST) | Recombinant Proteins | |
| HY-P702732 | IRAK4, Human (307a.a, sf9, His) | Recombinant Proteins | |
| HY-P702733 | RAF1, Human (Y340D,Y341D, sf9, His, GST) | Recombinant Proteins | |
| HY-P702734 | GSK3B, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702735 | MAPK1/ERK2, Human (Flag, His) | Recombinant Proteins | |
| HY-P702736 | CDK1-CCNB1, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702737 | TLK2, Human (749a.a, sf9, His, GST) | Recombinant Proteins | |
| HY-P702739 | NEK2, Human (Active) | Recombinant Proteins | |
| HY-P70273AF | Animal-Free Galectin-1/LGALS1, Human (His) | Recombinant Proteins | |
| HY-P70274 | HMGB1/HMG-1, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P702740 | NEK7, Human (His) | Recombinant Proteins | |
| HY-P702741 | CSNK2A1, Human (His) | Recombinant Proteins | |
| HY-P702742 | MAP4K1, Human (sf9) | Recombinant Proteins | |
| HY-P702743 | MAP4K4, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702744 | STK4, Human (His) | Recombinant Proteins | |
| HY-P702745 | PAK2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702746 | PAK3, Human (sf9) | Recombinant Proteins | |
| HY-P702747 | PAK4, Human (His) | Recombinant Proteins | |
| HY-P702748 | PAK5, Human | Recombinant Proteins | |
| HY-P702749 | TAOK1, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P70274A | HMGB1/HMG-1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70275 | FBP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702750 | MST3/STK24, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702751 | EGFR, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702752 | ERBB4, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702753 | CSF1R, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702754 | FLT3, Human (Biotinylated, sf9, His, Avi) | Recombinant Proteins | |
| HY-P702755 | CDK10-CCNM, Human (sf9, GST, Flag) | Recombinant Proteins | |
| HY-P702756 | PDGF R beta, Human (Biotinylated, sf9, His, Avi) | Recombinant Proteins | |
| HY-P702757 | VEGFR-2, Human (1355a.a, sf9, GST) | Recombinant Proteins | |
| HY-P702758 | FGFR-1 alpha, Human (Biotinylated, sf9, Flag, Avi) | Recombinant Proteins | |
| HY-P702759 | FGFR-2, Human (Biotinylated, sf9, Avi) | Recombinant Proteins | |
| HY-P70276 | HO-1, Human | Recombinant Proteins | |
| HY-P702760 | FGFR-3, Human (sf9, His, Strep) | Recombinant Proteins | |
| HY-P702761 | FGFR-4, Human (Biotinylated, sf9, Avi) | Recombinant Proteins | |
| HY-P702762 | NTRK1/TrkA-I, Human (Biotinylated, sf9, Flag, Avi) | Recombinant Proteins | |
| HY-P702763 | NTRK2/TrkB, Human (Biotinylated, sf9, Flag, Avi) | Recombinant Proteins | |
| HY-P702764 | CBLC, Human (sf9) | Recombinant Proteins | |
| HY-P702765 | SPHK1/Sphingosine Kinase 1, Human (sf9, 363a.a) | Recombinant Proteins | |
| HY-P702766 | IRF3, Human (His) | Recombinant Proteins | |
| HY-P702767 | MOG, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P702768 | MOG, Mouse (N-His) | Recombinant Proteins | |
| HY-P702769 | uPAR, Human (GST) | Recombinant Proteins | |
| HY-P70277 | Leukotriene A4 Hydrolase/LTA4H, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702770 | NLRP3, Human (1-536a.a, His) | Recombinant Proteins | |
| HY-P702771 | RPLP0, Mouse (His, SUMO, Myc) | Recombinant Proteins | |
| HY-P702772 | MAGP-2/MFAP5, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P702773 | RNASEH1, Human (His) | Recombinant Proteins | |
| HY-P702774 | SIRT3, Mouse (His, Myc) | Recombinant Proteins | |
| HY-P702775 | Envelop VLP Control (HEK293) | Recombinant Proteins | |
| HY-P702776 | MYCN, Human (Sf9, His) | Recombinant Proteins | |
| HY-P702777 | RAD51, Human (His) | Recombinant Proteins | |
| HY-P702778 | beta-NGF, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702779 | CDK1, Human (sf9) | Recombinant Proteins | |
| HY-P70278 | Ig Lambda Constant 2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702781 | NR3C1, Human (His) | Recombinant Proteins | |
| HY-P702782 | MTFP1, Human (GST) | Recombinant Proteins | |
| HY-P702783 | TDG, Human (His) | Recombinant Proteins | |
| HY-P702784 | OXCT1, Human (His) | Recombinant Proteins | |
| HY-P702786 | FOXC1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P702787 | Trypsin inhibitor DE-3, Erythrina caffra (P. pastoris, His) | Recombinant Proteins | |
| HY-P70279 | Esterase D/FGH, Human (His) | Recombinant Proteins | |
| HY-P702790 | RNF7, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P702791 | RNF7, Human (GST) | Recombinant Proteins | |
| HY-P702792 | CRIP1, Human (GST) | Recombinant Proteins | |
| HY-P702793 | CNR2-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702794 | CPA3, Human (His) | Recombinant Proteins | |
| HY-P702795 | CPA3, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P702796 | EsxA, Mycobacterium tuberculosis (His, Myc) | Recombinant Proteins | |
| HY-P702797 | EsxB, Mycobacterium tuberculosis (His) | Recombinant Proteins | |
| HY-P702798 | CYP7A1, Human (His) | Recombinant Proteins | |
| HY-P702799 | IMPDH2, Human (His) | Recombinant Proteins | |
| HY-P7028 | IL-1 beta, Human | Recombinant Proteins | |
| HY-P70280 | Granzyme D/GZMD, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702800 | GIPR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702801 | GIPR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702802 | GIPR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P702803 | GIPR, Cynomolgus (P.pastoris, His) | Recombinant Proteins | |
| HY-P702804 | SENP6, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702805 | AANAT, Human (His-GST) | Recombinant Proteins | |
| HY-P702806 | PRKN, Human (His, SUMO) | Recombinant Proteins | |
| HY-P702807 | PRKN, Human (sf9, His, Myc) | Recombinant Proteins | |
| HY-P70281 | MBL2/COLEC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702810 | PRKN, Mouse (GST) | Recombinant Proteins | |
| HY-P702811 | Granzyme K, Human (His) | Recombinant Proteins | |
| HY-P702812 | Granzyme K, Mouse (His, Myc) | Recombinant Proteins | |
| HY-P702815 | RNF8, Human (sf9, His, Myc) | Recombinant Proteins | |
| HY-P702817 | Cereblon-DDB1-Cul4A-Rbx1 Complex, Human (HEK293, Flag, His) | Recombinant Proteins | |
| HY-P702818 | CRBN, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P702819 | Complement C3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70282 | Myeloperoxidase/MPO, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702820 | CRBN, Human (His) | Recombinant Proteins | |
| HY-P702821 | SARS-COV-2 S trimer (XBB.1.16, HEK293, His) | Recombinant Proteins | |
| HY-P702822 | YBX1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P702823 | ADH5, Human | Recombinant Proteins | |
| HY-P702824 | PNO1, Human (His) | Recombinant Proteins | |
| HY-P702825 | CRBN-DDB1, Human (sf9, His, Avi) | Recombinant Proteins | |
| HY-P702826 | CRBN-DDB1-CUL4A-RBX1 Complex, Human (sf9, His, Avi) | Recombinant Proteins | |
| HY-P702827 | ELAVL1, Human (Flag) | Recombinant Proteins | |
| HY-P702829 | KEAP1, Mouse (His, SUMO) | Recombinant Proteins | |
| HY-P70283 | G6PD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702830 | CCR5, Human (HEK293, Flag, His, Strep) | Recombinant Proteins | |
| HY-P702831 | EGFR, Human (C797S, T790M, L858R, sf9, GST) | Recombinant Proteins | |
| HY-P702832 | EGFR, Human (T790M, L858R, sf9, Strep, GST, His) | Recombinant Proteins | |
| HY-P702834 | MBP, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P702835 | STAT6, Human (Phosphorylated, 536a.a, His) | Recombinant Proteins | |
| HY-P702835A | STAT6, Human (536a.a, His) | Recombinant Proteins | |
| HY-P702836 | RIPK1, Mouse (His) | Recombinant Proteins | |
| HY-P702837 | PDGF-DD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702838 | USP1, Human (His) | Recombinant Proteins | |
| HY-P702839 | "Peptide Ready HLA-E*01:03&B2M Monomer, Human (HEK293, His, Avi) " | Recombinant Proteins | |
| HY-P70284 | FABP2/I-FABP, Human (His) | Recombinant Proteins | |
| HY-P702840 | Peptide Ready HLA-A*02:01&B2M Monomer, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P702841 | MAP2K4, Human (Sf9) | Recombinant Proteins | |
| HY-P702842 | GDF-8, Human (His) | Recombinant Proteins | |
| HY-P702843 | PPAR alpha, Mouse (His) | Recombinant Proteins | |
| HY-P702844 | NF2L2, Mouse (His) | Recombinant Proteins | |
| HY-P702845 | PKM2, Human | Recombinant Proteins | |
| HY-P702846 | TARC/CCL17, Dog (Biotinylated, MBP, His-Avi) | Recombinant Proteins | |
| HY-P702847 | MGP, Human (His) | Recombinant Proteins | |
| HY-P702848 | SARS-CoV-2 S (R683A, R685A, K986P, V987P, HEK293, His) | Recombinant Proteins | |
| HY-P702849 | IGFBP-1 Protein, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70285 | Promotilin/MLN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702850 | CRBN-DDB1 Protein, Human (Biotinylated, sf9, Avi) | Recombinant Proteins | |
| HY-P702851 | CRBN-DDB1 Protein, Human (sf9, Avi) | Recombinant Proteins | |
| HY-P702853 | Wnt5a, Human (His) | Recombinant Proteins | |
| HY-P702854 | AKT2, Mouse (His, Myc) | Recombinant Proteins | |
| HY-P702855 | LDHC, Human (sf9, His) | Recombinant Proteins | |
| HY-P702856 | G3BP1, Human (466a.a, His) | Recombinant Proteins | |
| HY-P702857 | Haptoglobin, Mouse (His) | Recombinant Proteins | |
| HY-P702858 | HDAC8, Human (sf9) | Recombinant Proteins | |
| HY-P702859 | Protein E7, HPV18 (His) | Recombinant Proteins | |
| HY-P70286 | IL-1R1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P702860 | CDK4 Protein, Human (His, Avi) | Recombinant Proteins | |
| HY-P702861 | ATP6V0D1, Human (GST) | Recombinant Proteins | |
| HY-P702862 | GAK, Human (GST) | Recombinant Proteins | |
| HY-P702863 | HSD17B4, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P702864 | FOS, Human (His, Myc) | Recombinant Proteins | |
| HY-P702865 | FCN2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P702866 | PARP3, Human (His, Strep) | Recombinant Proteins | |
| HY-P702867 | AURKA-INCENP Heterodimer, Human (sf9, GST, His, Strep) | Recombinant Proteins | |
| HY-P702868 | PARP6, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P702869 | PGAM5, Human (His) | Recombinant Proteins | |
| HY-P70287 | Glial fibrillary acidic, Human (His) | Recombinant Proteins | |
| HY-P702870 | REG-3 beta/REG3B, Mouse | Recombinant Proteins | |
| HY-P702871 | NFE2L2, Mouse (His) | Recombinant Proteins | |
| HY-P702872 | LASP1, Human (His) | Recombinant Proteins | |
| HY-P702873 | LASP1, Mouse (His) | Recombinant Proteins | |
| HY-P702874 | GDF-8, Human/Mouse/Rat (109a.a, HEK293) | Recombinant Proteins | |
| HY-P702875 | KDM5A, Human (sf9, Flag) | Recombinant Proteins | |
| HY-P702876 | BRD3, Human (BD2, His) | Recombinant Proteins | |
| HY-P702877 | BRD3, Human (BD2, GST) | Recombinant Proteins | |
| HY-P702878 | FXR, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702879 | WWP1, Human (sf9, Flag) | Recombinant Proteins | |
| HY-P70288 | MIF, Human (His, solution) | Recombinant Proteins | |
| HY-P702880 | WDR5, Human (sf9, His) | Recombinant Proteins | |
| HY-P702881 | WDR5, Human (Biotinylated, sf9, Avi, His) | Recombinant Proteins | |
| HY-P702882 | SARM1, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P702883 | JMJD6, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702884 | OTUD6B, Human (His, FLAG) | Recombinant Proteins | |
| HY-P702885 | CDK12-CCNK, Human (658-1490,sf9, GST) | Recombinant Proteins | |
| HY-P702886 | CDK12-CCNK, Human (696-1082, sf9, GST) | Recombinant Proteins | |
| HY-P702887 | MLL3-WDR5-Ash2L-RbBP5-DPY30, Human (His) | Recombinant Proteins | |
| HY-P702888 | CBL, Human (GST) | Recombinant Proteins | |
| HY-P702889 | PLK3 Polo Box Domain, Human (MBP, His) | Recombinant Proteins | |
| HY-P70288A | MIF, Human (N-His) | Recombinant Proteins | |
| HY-P70288AF | Animal-Free MIF, Human (His) | Recombinant Proteins | |
| HY-P70289 | HCLS1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702890 | CREBBP, Human (His) | Recombinant Proteins | |
| HY-P702891 | CREBBP, Human (GST) | Recombinant Proteins | |
| HY-P702892 | EP300, Human (His) | Recombinant Proteins | |
| HY-P702893 | PRMT2, Human (sf9, Flag) | Recombinant Proteins | |
| HY-P702894 | PI3 kinase (p110β/p85α), Human (sf9, Flag ) | Recombinant Proteins | |
| HY-P702895 | PPP2CA-PPP2R1A, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702896 | AMPK gamma 1/beta 1/alpha 1, Human (sf9, His) | Recombinant Proteins | |
| HY-P702897 | PTPRM, Human (GST) | Recombinant Proteins | |
| HY-P702898 | TAF1, Human (BD2, His) | Recombinant Proteins | |
| HY-P702899 | TAF1, Human (BD1, His) | Recombinant Proteins | |
| HY-P7029 | IL-1RA/IL-1RN, Human | Recombinant Proteins | |
| HY-P70290 | Neutrophil cytosol factor 1, Human (His) | Recombinant Proteins | |
| HY-P702900 | TAF1, Human (BD1+BD2, GST) | Recombinant Proteins | |
| HY-P702901 | TAF1, Human (BD2, GST) | Recombinant Proteins | |
| HY-P702902 | JARID1C, Human (sf9, Flag) | Recombinant Proteins | |
| HY-P702904 | PCAF, Human (His) | Recombinant Proteins | |
| HY-P702905 | MEKK2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702906 | SIRT2, Human (His) | Recombinant Proteins | |
| HY-P702907 | CDK19-CCNC, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702908 | SIRT4, Human (GST) | Recombinant Proteins | |
| HY-P702909 | TBK1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70291 | Insulysin/IDE, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702910 | PRMT7, Human (sf9, Flag) | Recombinant Proteins | |
| HY-P702911 | NSD3, Human (GST) | Recombinant Proteins | |
| HY-P702912 | METTL3, Human (sf9, FLAG) | Recombinant Proteins | |
| HY-P702913 | SPHK2, Human (sf9, His) | Recombinant Proteins | |
| HY-P702914 | TET1, Human (sf9, FLAG) | Recombinant Proteins | |
| HY-P702915 | LOXL4, Human (His) | Recombinant Proteins | |
| HY-P702916 | TTBK1, Human (sf9, GST, His) | Recombinant Proteins | |
| HY-P702917 | DPY30, Human (His) | Recombinant Proteins | |
| HY-P702918 | FBXL10, Human (sf9, FLAG) | Recombinant Proteins | |
| HY-P702919 | IDO2, Mouse (His) | Recombinant Proteins | |
| HY-P70292 | ETS1/EWSR2, Human (His) | Recombinant Proteins | |
| HY-P702920 | CDK11A-CCND3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702921 | BRAF, Human (sf9, GST, His) | Recombinant Proteins | |
| HY-P702922 | ATG16L1 Protein, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P702923 | CDK8-CCNK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702924 | CDK9-CCNK, Human (sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P702925 | CDK14-CCNY, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702926 | MYT1, Human (sf9, His) | Recombinant Proteins | |
| HY-P702927 | ARAF, Human (Y301D/Y302D, sf9, GST) | Recombinant Proteins | |
| HY-P702928 | BUB1-BUB3, Human (sf9, GST, Flag) | Recombinant Proteins | |
| HY-P702929 | MLK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70293 | FABP4, Human (His) | Recombinant Proteins | |
| HY-P702930 | CDK18-CCNY, Human (sf9,GST) | Recombinant Proteins | |
| HY-P702931 | ROCK2, Human (sf9, His) | Recombinant Proteins | |
| HY-P702932 | AAK1, Human (His) | Recombinant Proteins | |
| HY-P702933 | AAK1, Human (sf9, His) | Recombinant Proteins | |
| HY-P702934 | MAPK15, Human (sf9, GST, StrepII) | Recombinant Proteins | |
| HY-P702935 | RIPK1, Rat (sf9, GST) | Recombinant Proteins | |
| HY-P702936 | RIPK1, Cynomolgus (sf9, GST) | Recombinant Proteins | |
| HY-P702937 | RIPK1, Canine (sf9, GST) | Recombinant Proteins | |
| HY-P702938 | SIK3, Human (sf9, GST, StrepII) | Recombinant Proteins | |
| HY-P702939 | BRAF, Human (G466V, sf9, GST) | Recombinant Proteins | |
| HY-P70294 | Glutamine synthetase/GLUL, Human (His) | Recombinant Proteins | |
| HY-P702940 | CCNA2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702941 | CDK8, Human ( Unactive, sf9, GST) | Recombinant Proteins | |
| HY-P702942 | ERF1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702943 | HSPA9, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702944 | IRS1, Human (GST) | Recombinant Proteins | |
| HY-P702945 | CDK14, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702946 | RB1, Human (GST) | Recombinant Proteins | |
| HY-P702947 | UBA2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702948 | BCKDK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702949 | NDR1, Human (Unactive, sf9, GST) | Recombinant Proteins | |
| HY-P70295 | Ezrin/EZR, Human | Recombinant Proteins | |
| HY-P702950 | PTK9L, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702951 | KDM4C, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702952 | SIRT6, Human (GST) | Recombinant Proteins | |
| HY-P702953 | ATR, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702954 | BAD, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702955 | BUB1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702956 | CCNC, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702957 | CCND3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702958 | CDKN3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702959 | CREBBP, Human (1319-1710, GST) | Recombinant Proteins | |
| HY-P70296 | FOLR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702960 | CREBBP, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702961 | CTNNA1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702962 | EIF2S1, Human (His) | Recombinant Proteins | |
| HY-P702963 | EP300, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702964 | GRB7, Human (GST) | Recombinant Proteins | |
| HY-P702965 | HSD17B10, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702966 | PRMT2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702967 | INCENP, Human (sf9, His) | Recombinant Proteins | |
| HY-P702968 | ING1, Human (sf9, His) | Recombinant Proteins | |
| HY-P702969 | SMAD5, Human (GST) | Recombinant Proteins | |
| HY-P70297 | 15-PGDH/HPGD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P702970 | MEF2A, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702971 | NFATC1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702972 | NFKB2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702973 | PDE6D, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702974 | PDE6B, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702975 | PFKFB2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702976 | PIK3R2, Human (sf9, His) | Recombinant Proteins | |
| HY-P702977 | POR, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702978 | AMPK (gamma 1/beta 1/alpha 2), Human (Inactive, sf9, His) | Recombinant Proteins | |
| HY-P702979 | AMPKG1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70298 | Histatin-3/HTN3, Human | Recombinant Proteins | |
| HY-P702980 | PRKAR1B, Human (sf9, His) | Recombinant Proteins | |
| HY-P702981 | PTEN, Human (GST) | Recombinant Proteins | |
| HY-P702982 | RANGAP1, Human (His) | Recombinant Proteins | |
| HY-P702983 | RELB, Human (sf9, His) | Recombinant Proteins | |
| HY-P702984 | RGS1, Human (His) | Recombinant Proteins | |
| HY-P702985 | SNCB, Human (His) | Recombinant Proteins | |
| HY-P702986 | STAT2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702987 | STAT5A Protein, Human (sf9, His) | Recombinant Proteins | |
| HY-P702988 | STK9, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702989 | p73 beta, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70299 | NME1/NDPKA, Human (His) | Recombinant Proteins | |
| HY-P702990 | p73 gamma, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702991 | p73 alpha, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702992 | TRAF1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702993 | TRAF2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702995 | 14-3-3 zeta, Human (GST) | Recombinant Proteins | |
| HY-P702996 | 14-3-3 zeta, Human (sf9, His) | Recombinant Proteins | |
| HY-P702997 | 14-3-3 zeta, Human | Recombinant Proteins | |
| HY-P702998 | IKBKG, Human (sf9, GST) | Recombinant Proteins | |
| HY-P702999 | CDK10, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7029A | IL-1RA/IL-1RN, Human (HEK293) | Recombinant Proteins | |
| HY-P7030 | IL-10, Human | Recombinant Proteins | |
| HY-P70300 | Glucosamine (N-acetyl)-6-Sulfatase/GNS, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703000 | FADD, Human (His) | Recombinant Proteins | |
| HY-P703001 | RIOK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703002 | CCNK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703003 | PRPF4B, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703004 | GNA14, Human (GST) | Recombinant Proteins | |
| HY-P703005 | PPM1F, Human (GST) | Recombinant Proteins | |
| HY-P703006 | CCNO, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703007 | FRS3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703008 | KAT7, Human (Active, K277Q, sf9, GST) | Recombinant Proteins | |
| HY-P703009 | KAT7, Human (Active, K277R, sf9, GST) | Recombinant Proteins | |
| HY-P70301 | Mucin-1/MUC1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703010 | IRAK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703011 | AATK, Mouse (sf9, GST) | Recombinant Proteins | |
| HY-P703012 | 14-3-3 theta, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P703013 | 14-3-3 zeta, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P703014 | LMTK2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703015 | SIRT2, Human (GST) | Recombinant Proteins | |
| HY-P703016 | TRIM32, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703017 | TPX2, Human (sf9, His) | Recombinant Proteins | |
| HY-P703018 | PHLPP2, Human (GST) | Recombinant Proteins | |
| HY-P703019 | SGK3, Human (Inactive, sf9, GST) | Recombinant Proteins | |
| HY-P70302 | Kallikrein-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703020 | JNK1, Mouse (Inactive, GST) | Recombinant Proteins | |
| HY-P703021 | PRPF19, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703022 | PAD1, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P703023 | NRBP1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703024 | CAB39, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703025 | AMPKG3, Human (sf9, GST, His) | Recombinant Proteins | |
| HY-P703026 | PRMT7, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703027 | FANCL, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703028 | STYK1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703029 | METTL3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70303 | Beta-galactosidase/GLB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703030 | CAMKK1, Rat (F230G, sf9, GST) | Recombinant Proteins | |
| HY-P703031 | KDM5B, Mouse (sf9, GST) | Recombinant Proteins | |
| HY-P703032 | TRIB1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703033 | p70S6KL1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703034 | SETDB2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703035 | LOXL3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703036 | PLCD4, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703037 | CCNQ, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703038 | HTRA3, Human (His) | Recombinant Proteins | |
| HY-P703039 | CDK20, Mouse (sf9, GST) | Recombinant Proteins | |
| HY-P70304 | NCK1, Human (His) | Recombinant Proteins | |
| HY-P703040 | TP53RK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703041 | UHMK1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703042 | UBE2U, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703043 | PIP5K3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703044 | ADCK5, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703045 | Tubulin Beta, Human (GST) | Recombinant Proteins | |
| HY-P703046 | KDM1B, Mouse (sf9, GST) | Recombinant Proteins | |
| HY-P703047 | CCNY, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703048 | STK32A, Mouse (sf9, GST) | Recombinant Proteins | |
| HY-P703049 | KSR2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P70305 | IL-4R alpha/CD124, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P703050 | METTL2A, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703051 | CDKL4, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703052 | PAD6, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703053 | LMTK3, Mouse (sf9, GST) | Recombinant Proteins | |
| HY-P703054 | ASK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703055 | UBE2D2, Xenopus (His) | Recombinant Proteins | |
| HY-P703056 | PNMT, Dog (Active, sf9, GST) | Recombinant Proteins | |
| HY-P703057 | CDK11A, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703058 | ACKA, Bacteria (GST) | Recombinant Proteins | |
| HY-P703059 | ACKA, Bacteria (His) | Recombinant Proteins | |
| HY-P70306 | MGMT, Human (His) | Recombinant Proteins | |
| HY-P703060 | GFP, Bacteria (His) | Recombinant Proteins | |
| HY-P703061 | RIPK1,Cynomolgus (Active, sf9, GST) | Recombinant Proteins | |
| HY-P703062 | colE7, E. coli (His) | Recombinant Proteins | |
| HY-P703063 | RIPK1, Dog (Active, 1-327, sf9, GST) | Recombinant Proteins | |
| HY-P703064 | Y1BFP, other (His) | Recombinant Proteins | |
| HY-P703065 | BFP, other (His) | Recombinant Proteins | |
| HY-P703066 | HtrA, Streptococcus (S234A, His) | Recombinant Proteins | |
| HY-P703067 | RED, other (His) | Recombinant Proteins | |
| HY-P703068 | RFP, Discosoma sp. (His) | Recombinant Proteins | |
| HY-P703069 | HDAC10, Human (His) | Recombinant Proteins | |
| HY-P70307 | Fumarylacetoacetase/FAH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703070 | Uridylate Kinase, Human (His) | Recombinant Proteins | |
| HY-P703071 | SETDB1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P703072 | WNK1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703073 | GBA/Glucosylceramidase, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P703074 | NPR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703075 | FASN, Human (Sf9, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703076 | Caspase-1/CASP1, Human (Active, T388A, His) | Recombinant Proteins | |
| HY-P703077 | SLC12A2, Human (HEK293, His, Strep, GFP) | Recombinant Proteins | |
| HY-P703078 | IRAK4, Mouse (His) | Recombinant Proteins | |
| HY-P703079 | DNASE1L3, Human (His) | Recombinant Proteins | |
| HY-P70308 | HOXB4, Human (His) | Recombinant Proteins | |
| HY-P703080 | PD-L1, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P703081 | G-CSF, Rhesus Macaque | Recombinant Proteins | |
| HY-P703082 | MAVS, Human (His-SUMO) | Recombinant Proteins | |
| HY-P703083 | HSP90AA1, Human (His, Avi) | Recombinant Proteins | |
| HY-P703084 | ABCA2, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703086 | GRK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703087 | AGTR2, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703088 | AVPR2, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703089 | BAK1, Human | Recombinant Proteins | |
| HY-P70309 | Galectin-3/LGALS3, Human | Recombinant Proteins | |
| HY-P703091 | BRCA1, Human | Recombinant Proteins | |
| HY-P703092 | BRCA2, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703093 | CALB1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703094 | S100G, Human (His, Strep) | Recombinant Proteins | |
| HY-P703095 | CBFA2T3, Human (His, Strep) | Recombinant Proteins | |
| HY-P703096 | CCNB1, Human (His, CL7) | Recombinant Proteins | |
| HY-P703097 | CCNB1, Human | Recombinant Proteins | |
| HY-P703098 | CCNT1, Human | Recombinant Proteins | |
| HY-P703099 | CDX2, Human (His, Strep) | Recombinant Proteins | |
| HY-P7030A | IL-10, Human (CHO) | Recombinant Proteins | |
| HY-P7031 | IL-11, Human | Recombinant Proteins | |
| HY-P70310 | EGR1/ZNF225, Human (His) | Recombinant Proteins | |
| HY-P703100 | CENPE, Human | Recombinant Proteins | |
| HY-P703101 | CFTR, Human (HEK293) | Recombinant Proteins | |
| HY-P703102 | M1R, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703103 | CHRM2, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703104 | M2R, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703106 | CLC1, Human (HEK293) | Recombinant Proteins | |
| HY-P703107 | LT4R1, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703108 | ABCC2, Human (HEK293) | Recombinant Proteins | |
| HY-P703109 | ABCC2, Human (HEK293, E1462Q) | Recombinant Proteins | |
| HY-P70311 | Activin A, Human/Mouse/Rat (HEK293) | Recombinant Proteins | |
| HY-P703111 | DHX9, Human (His) | Recombinant Proteins | |
| HY-P703112 | DHX9, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703113 | DLG4, Human (HEK293, Biotinylated) | Recombinant Proteins | |
| HY-P703114 | DLG4, Human (Biotinylated) | Recombinant Proteins | |
| HY-P703115 | DPAGT1, Human (Sf9) | Recombinant Proteins | |
| HY-P703116 | DRD2, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703117 | DRD3, Human (sf9, Flag, His) | Recombinant Proteins | |
| HY-P703118 | EBF1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703119 | GPR183, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P70311A | Activin A, Human (406a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70311AF | Animal-Free Activin A, Human/Mouse/Rat | Recombinant Proteins | |
| HY-P70311G | GMP Activin A, Human/Mouse/Rat (HEK293) | Recombinant Proteins | |
| HY-P70312 | L-selectin/CD62L, Mouse (294a.a, HEK293, C-Fc-His) | Recombinant Proteins | |
| HY-P703120 | EGR2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703121 | ELF3, Human (His, Strep) | Recombinant Proteins | |
| HY-P703122 | ETV4, Human (His, Strep) | Recombinant Proteins | |
| HY-P703123 | ETV6, Human (His, Strep) | Recombinant Proteins | |
| HY-P703124 | PRDM3, Human | Recombinant Proteins | |
| HY-P703125 | PAR2, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703126 | FLI1, Human | Recombinant Proteins | |
| HY-P703127 | FLI1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703128 | NR5A1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703129 | XRCC6, Human (Flag) | Recombinant Proteins | |
| HY-P70313 | LBP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703130 | GABRA1-GABRB2-GABRG2, Human (HEK293, Strep) | Recombinant Proteins | |
| HY-P703131 | GABRA5/GABRB3, Human (HEK293, His, Strep) | Recombinant Proteins | |
| HY-P703132 | GABRR1, Human (HEK293, twin-Strep) | Recombinant Proteins | |
| HY-P703133 | GATA2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703134 | NR6A1, Human | Recombinant Proteins | |
| HY-P703137 | GRK5, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703138 | GPS1, Human (Sf9) | Recombinant Proteins | |
| HY-P703139 | GRM1, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P70314 | Erythropoietin receptor/EpoR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703140 | GRM2, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703141 | GSPT1, Human (Sf9, Biotinylated) | Recombinant Proteins | |
| HY-P703142 | H2BC4, Human | Recombinant Proteins | |
| HY-P703143 | Histone H3, Human | Recombinant Proteins | |
| HY-P703144 | Histone H3, Human (K27M) | Recombinant Proteins | |
| HY-P703145 | Histone H3, Human (G34R) | Recombinant Proteins | |
| HY-P703146 | Histone H3, Human (G34V) | Recombinant Proteins | |
| HY-P703147 | Histone H3, Human (His) | Recombinant Proteins | |
| HY-P703148 | HSPA1L, Human (His, Strep) | Recombinant Proteins | |
| HY-P703149 | 5HT2A, Human (S162K, M164W, Sf9, Flag, His) | Recombinant Proteins | |
| HY-P70315 | Follistatin/FST, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703150 | 5HT2A, Human (L247A, L371A, Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703151 | IMPDH1, Human | Recombinant Proteins | |
| HY-P703152 | IRF1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703153 | ITGB7, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703154 | KCNA3, Human (HEK293, GFP, Strep, His) | Recombinant Proteins | |
| HY-P703155 | KCNA3-KCAB2, Human (Sf9, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703156 | KCNA3-KCAB2, Human (Sf9, His, Strep, Flag, H451N) | Recombinant Proteins | |
| HY-P703157 | KCNA3, Human (HEK293) | Recombinant Proteins | |
| HY-P703158 | KCNJ2, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703159 | TASK-1, Human (Insect cell) | Recombinant Proteins | |
| HY-P70316 | Elafin/Trappin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703160 | MAGEA8, Human (His, Strep) | Recombinant Proteins | |
| HY-P703161 | MC4R, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703162 | MAP3K4, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703163 | Menin, Human (His, M327I) | Recombinant Proteins | |
| HY-P703164 | Menin, Human (His, M327V) | Recombinant Proteins | |
| HY-P703165 | Menin, Human (His, T349M) | Recombinant Proteins | |
| HY-P703166 | Menin, Human (His, G331R) | Recombinant Proteins | |
| HY-P703167 | MYLK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703168 | NONO, Human (His, Strep) | Recombinant Proteins | |
| HY-P703169 | NPY1R, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P70317 | Kallikrein-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703170 | NVL, Human | Recombinant Proteins | |
| HY-P703171 | OXYR, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703172 | P2X3, Human (HEK293) | Recombinant Proteins | |
| HY-P703173 | PGM3, Human | Recombinant Proteins | |
| HY-P703174 | ABCB1, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703175 | ABCB1, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703176 | PIK3C2B, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P703177 | PIK3C2G, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703178 | PPP2R5A, Human (His, Strep) | Recombinant Proteins | |
| HY-P703179 | MAPK7, Human | Recombinant Proteins | |
| HY-P70318 | MAG/Siglec-4a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703180 | P2ER3, Human (Sf9, Flag, GFP, His) | Recombinant Proteins | |
| HY-P703181 | PE2R4, Human (Sf9) | Recombinant Proteins | |
| HY-P703182 | PYCR1, Human | Recombinant Proteins | |
| HY-P703183 | RAB27A, Human (His) | Recombinant Proteins | |
| HY-P703184 | RBBP8, Human (His, Strep) | Recombinant Proteins | |
| HY-P703185 | RLBP1, Human | Recombinant Proteins | |
| HY-P703187 | RNF4, Human (Biotinylated) | Recombinant Proteins | |
| HY-P703188 | RNF4, Human | Recombinant Proteins | |
| HY-P703189 | RNF4, Human (Biotinylated, G120-I190) | Recombinant Proteins | |
| HY-P70319 | MAG/Siglec-4a, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703190 | CLIP1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703191 | SCN10A, Human (HEK293, Flag, Strep) | Recombinant Proteins | |
| HY-P703193 | SFSWAP, Human (His, Strep) | Recombinant Proteins | |
| HY-P703194 | EAAT3, Human (HEK293, His, Strep, GFP) | Recombinant Proteins | |
| HY-P703195 | SLC1A3, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703196 | ASCT2, Human (Sf9) | Recombinant Proteins | |
| HY-P703197 | GLUT1, Human (Sf9, His, N45T, E329Q) | Recombinant Proteins | |
| HY-P703198 | GLUT1, Human (Sf9, His, N45T) | Recombinant Proteins | |
| HY-P703199 | GLUT1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P70319A | MAG/Siglec-4a, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P7031A | IL-11 Protein, Human (CHO) | Recombinant Proteins | |
| HY-P7032 | IL-12, Human (HEK293) | Recombinant Proteins | |
| HY-P70320 | GPD1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703200 | GLUT3, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703203 | SLC2A5, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703204 | SLC4A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703205 | SLC4A1, Human (Sf9) | Recombinant Proteins | |
| HY-P703206 | SLC5A1, Human (HEK293) | Recombinant Proteins | |
| HY-P703207 | SLC5A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703208 | GAT1, Human (HEK293) | Recombinant Proteins | |
| HY-P703209 | SERT, Human (HEK293) | Recombinant Proteins | |
| HY-P70321 | EphA1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703210 | SERT, Human (HEK293, Strep) | Recombinant Proteins | |
| HY-P703211 | GlyT1, Human (HEK293, His, GFP) | Recombinant Proteins | |
| HY-P703212 | NTCP, Human (HEK293) | Recombinant Proteins | |
| HY-P703214 | SLC12A1, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703215 | SLC12A3, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703216 | KCC1, Human (HEK293) | Recombinant Proteins | |
| HY-P703217 | KCC1, Human (HEK293, Strep, His) | Recombinant Proteins | |
| HY-P703218 | KCC1, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703219 | SLC15A1, Human (HEK293, Strep, His) | Recombinant Proteins | |
| HY-P70322 | HER3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703220 | SMO, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703221 | HSPA13, Human (His, Strep) | Recombinant Proteins | |
| HY-P703222 | HNF1A, Human (His, Strep) | Recombinant Proteins | |
| HY-P703223 | TCF4, Human (His, Strep) | Recombinant Proteins | |
| HY-P703224 | TERF2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703225 | THRB, Human (His, Strep) | Recombinant Proteins | |
| HY-P703226 | HSP90B1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703228 | TRPC3, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703229 | TRPC6, Human (HEK293, Flag, His, Strep) | Recombinant Proteins | |
| HY-P70323 | HER3, Human (312a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P703230 | UCP1, Human (HEK293, Strep, Flag) | Recombinant Proteins | |
| HY-P703231 | UCK2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703232 | USP4, Human (Sf9, His, Flag) | Recombinant Proteins | |
| HY-P703234 | KAT6A, Human (Biotinylated) | Recombinant Proteins | |
| HY-P703235 | GLRA3, Human (Sf9, Strep) | Recombinant Proteins | |
| HY-P703236 | NUP214, Human (His, Strep) | Recombinant Proteins | |
| HY-P703237 | CUL5-RBX1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703238 | CUL5-RBX2, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703239 | CUL5-RBX2, Human (Sf9, His, Strep, Neddylated) | Recombinant Proteins | |
| HY-P70324 | KEL/Kelch-like 41, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P703240 | TAF15, Human (His, Strep) | Recombinant Proteins | |
| HY-P703241 | SPOP, Human | Recombinant Proteins | |
| HY-P703242 | CUL1-RBX1, Human (Sf9) | Recombinant Proteins | |
| HY-P703243 | CUL1-RBX1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703244 | CUL2-RBX1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703245 | CUL3-RBX1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703246 | CUL4A-RBX1, Human (Sf9) | Recombinant Proteins | |
| HY-P703247 | TEAD2, Human (Sf9, , Depalmitoylated) | Recombinant Proteins | |
| HY-P703248 | TEAD2, Human (Sf9, Biotinylated, Depalmitoylated) | Recombinant Proteins | |
| HY-P703249 | TEAD2, Human (Sf9, His, Depalmitoylated, Strep) | Recombinant Proteins | |
| HY-P70324A | KEL/Kelch-like 41, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70325 | IL-4R alpha/CD124, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P703250 | MAP4K3, Human (Sf9, GST, Flag) | Recombinant Proteins | |
| HY-P703251 | ABCB11, Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P703252 | SLC4A4, Human (HEK293, His, Strep, GFP) | Recombinant Proteins | |
| HY-P703253 | ARHGEF7, Human (His, Strep) | Recombinant Proteins | |
| HY-P703254 | RAB29, Human (GST) | Recombinant Proteins | |
| HY-P703256 | SLC7A7-SLC3A2, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703257 | MAP3K6, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703258 | LATS1-MOB1A-1-MST2, Human (Sf9, His, GST, Strep) | Recombinant Proteins | |
| HY-P703259 | SLC16A3-BSG2, Human (Sf9, His) | Recombinant Proteins | |
| HY-P70326 | GADD45A/DDDIT-1, Human (His) | Recombinant Proteins | |
| HY-P703260 | CNOT9, Human (His, Strep) | Recombinant Proteins | |
| HY-P703261 | KCNQ4, Human (HEK293) | Recombinant Proteins | |
| HY-P703262 | CYTH2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703263 | GPR52, Human (HEK293, Flag, His) | Recombinant Proteins | |
| HY-P703265 | RECQ4, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703266 | ABCG2, Human (HEK293) | Recombinant Proteins | |
| HY-P703267 | ABCG2, Human (HEK293, E211Q) | Recombinant Proteins | |
| HY-P703268 | QKI, Human (His, Strep) | Recombinant Proteins | |
| HY-P703269 | PICK1, Human (Biotinylated) | Recombinant Proteins | |
| HY-P703270 | DCAF1, Human (Sf9) | Recombinant Proteins | |
| HY-P703271 | DCAF1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703272 | ZEB2, Human | Recombinant Proteins | |
| HY-P703273 | USP52, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703274 | USP3, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P703275 | KCC3, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703276 | KCC3, Human (HEK293) | Recombinant Proteins | |
| HY-P703277 | KCC3, Human (HEK293, Strep, His) | Recombinant Proteins | |
| HY-P703278 | PDCD6IP, Human (His, Strep) | Recombinant Proteins | |
| HY-P703279 | ABCC5, Human (HEK293) | Recombinant Proteins | |
| HY-P70327A | LMW-PTP/ACP1, Human (C-His) | Recombinant Proteins | |
| HY-P70328 | Myelin P0/MPZ, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703280 | SIGMAR1, Human (Sf9) | Recombinant Proteins | |
| HY-P703281 | IRF9, Human (His) | Recombinant Proteins | |
| HY-P703282 | IRF9, Human (Insect cell, His, Strep) | Recombinant Proteins | |
| HY-P703283 | IRF9, Human (His, Strep) | Recombinant Proteins | |
| HY-P703284 | ATG7, Human (Sf9) | Recombinant Proteins | |
| HY-P703285 | DNPH1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703286 | KCC4, Human (HEK293) | Recombinant Proteins | |
| HY-P703287 | KCC4, Human (HEK293, Strep, His) | Recombinant Proteins | |
| HY-P703288 | SLC12A7, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P70329 | Fas/CD95, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703290 | PLK4, Human | Recombinant Proteins | |
| HY-P703291 | NUP50, Human (His, Strep) | Recombinant Proteins | |
| HY-P703292 | SEC24A, Human (Sf9, Biotinylated) | Recombinant Proteins | |
| HY-P703293 | GPR75, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703295 | U2AF2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703296 | IRF9, Mouse | Recombinant Proteins | |
| HY-P703297 | UBCH7, Mouse | Recombinant Proteins | |
| HY-P703298 | UBCH7, Mouse (His) | Recombinant Proteins | |
| HY-P703299 | CPEB3, Human (His, Strep) | Recombinant Proteins | |
| HY-P7032G | GMP IL-12, Human (HEK293) | Recombinant Proteins | |
| HY-P7033 | IL-13, Human (CHO) | Recombinant Proteins | |
| HY-P70330 | Fas/CD95, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703300 | NT5C2, Human | Recombinant Proteins | |
| HY-P703301 | DNAJC9, Human (His, Strep) | Recombinant Proteins | |
| HY-P703302 | OTUD3, Human | Recombinant Proteins | |
| HY-P703303 | SMG6, Human (His, Strep) | Recombinant Proteins | |
| HY-P703304 | ABCB10, Human (HEK293, Flag, His, E659Q) | Recombinant Proteins | |
| HY-P703305 | ABCB10, Human (HEK293, Flag, His, N229A) | Recombinant Proteins | |
| HY-P703306 | ABCB10, Human (HEK293, Flag, His, N407A) | Recombinant Proteins | |
| HY-P703307 | ABCB10, Human (HEK293, Flag, His, N229A, F398A) | Recombinant Proteins | |
| HY-P703308 | ABCB10, Human (HEK293, Flag, His, N229A, N407A) | Recombinant Proteins | |
| HY-P703309 | ABCA6, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P70331 | HSP40/DNAJB1, Human (His) | Recombinant Proteins | |
| HY-P703310 | KLHDC2, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703311 | PANX1, Human (HEK293) | Recombinant Proteins | |
| HY-P703312 | ABTB2, Human (Sf9) | Recombinant Proteins | |
| HY-P703313 | SAMHD1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703314 | ULK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703315 | DCAF4, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703316 | SLC17A5, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703317 | TMEM97, Human (Sf9) | Recombinant Proteins | |
| HY-P703318 | DBNL, Human (HEK293, His, Strep) | Recombinant Proteins | |
| HY-P703319 | ZBTB7A, Human (His) | Recombinant Proteins | |
| HY-P70332 | HMGB2/HMG-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703320 | RhCG, Human (HEK293) | Recombinant Proteins | |
| HY-P703322 | CPSF73, Human | Recombinant Proteins | |
| HY-P703323 | MYO3A, Human (Sf9, His, GST, Strep) | Recombinant Proteins | |
| HY-P703324 | SLC38A2, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703325 | DGCR8, Human (His, Strep) | Recombinant Proteins | |
| HY-P703326 | PUS7, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703327 | EGLN1, Human (His) | Recombinant Proteins | |
| HY-P703328 | MINDY2, Human (GST) | Recombinant Proteins | |
| HY-P703329 | TRPM4, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P70333 | FKBP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703330 | TRPM7, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703331 | CEP55, Human (His, Strep) | Recombinant Proteins | |
| HY-P703332 | CEP55, Human | Recombinant Proteins | |
| HY-P703333 | PI4K2B, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703334 | ABCF3, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703335 | PI4K2A, Human (His, GST) | Recombinant Proteins | |
| HY-P703336 | RBM38, Human (His) | Recombinant Proteins | |
| HY-P703337 | NLRP2, Human (Sf9) | Recombinant Proteins | |
| HY-P703338 | MINDY1, Human (GST) | Recombinant Proteins | |
| HY-P703339 | ADCK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P70334 | Grancalcin/GCA, Human (His) | Recombinant Proteins | |
| HY-P703343 | GPR158, Human (775a.a, HEK293) | Recombinant Proteins | |
| HY-P703344 | GPR158, Human (HEK293) | Recombinant Proteins | |
| HY-P703345 | KLHL14, Human (Sf9) | Recombinant Proteins | |
| HY-P703346 | KLHL14, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703347 | USP36, Human (His, GST) | Recombinant Proteins | |
| HY-P703348 | SUGP1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703349 | Cope1, Mouse (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P70335 | IMPA1, Human (His) | Recombinant Proteins | |
| HY-P703351 | CHT, Human (HEK293, Strep, His) | Recombinant Proteins | |
| HY-P703352 | ATG101, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703353 | SLC22A23, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703354 | BCORL1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703355 | PRDM16, Human | Recombinant Proteins | |
| HY-P703356 | CNT3, Human (Sf9, Strep, His) | Recombinant Proteins | |
| HY-P703357 | NOD2, Human (Sf9, Strep, Flag) | Recombinant Proteins | |
| HY-P703358 | SOX17, Human | Recombinant Proteins | |
| HY-P703359 | PPP1CB, Human (His) | Recombinant Proteins | |
| HY-P70336 | EphA2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703360 | WNK4, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703361 | Lonp1, Mouse | Recombinant Proteins | |
| HY-P703362 | DPP3, Mouse (His, Strep) | Recombinant Proteins | |
| HY-P703363 | DCAF10-DDB1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703364 | GRHL2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703365 | DCAF11-DDB1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703366 | KIF18A, Human | Recombinant Proteins | |
| HY-P703367 | TMEM175, Human (HEK293) | Recombinant Proteins | |
| HY-P703368 | TMEM175, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703369 | CARD11, Human (His, Strep) | Recombinant Proteins | |
| HY-P70337 | EphA8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703370 | MAP3K21, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703373 | HDGFL2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703374 | AIFM2, Human (Strep) | Recombinant Proteins | |
| HY-P703376 | OTULIN, Human (His, GST) | Recombinant Proteins | |
| HY-P703377 | STRADA, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703378 | SPSB4, Human (His) | Recombinant Proteins | |
| HY-P703379 | DPP3, Rat (His, Strep) | Recombinant Proteins | |
| HY-P70338 | IL-35, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703380 | SLC26A9, Human (HEK293) | Recombinant Proteins | |
| HY-P703382 | SLC22A12, Human (HEK293) | Recombinant Proteins | |
| HY-P703383 | SLC15A4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703384 | SLC15A4, Human (HEK293, StrepⅡ, His) | Recombinant Proteins | |
| HY-P703385 | MSI2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703386 | GRK7, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703387 | SLC34A3, Human (HEK293, His, Strep, Flag) | Recombinant Proteins | |
| HY-P703388 | NLRP4, Human (Insect cell, His, Strep, MBP) | Recombinant Proteins | |
| HY-P703389 | NLRP4, Human (Sf9, His, Strep, MBP) | Recombinant Proteins | |
| HY-P70339 | AHSG/Fetuin-A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703390 | HSCB, Human (His, Strep) | Recombinant Proteins | |
| HY-P703391 | GPR155, Human (Sf9) | Recombinant Proteins | |
| HY-P703392 | GPR155, Human (Sf9, GFP, Strep, His) | Recombinant Proteins | |
| HY-P703393 | MOSPD2, Human | Recombinant Proteins | |
| HY-P703394 | SLC5A8, Human (HEK293) | Recombinant Proteins | |
| HY-P703395 | DCP2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703396 | STKLD1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703397 | NSMCE1, Human | Recombinant Proteins | |
| HY-P703398 | NSMCE1, Human (His) | Recombinant Proteins | |
| HY-P703399 | NLRP7, Human (Sf9, His, Strep, MBP) | Recombinant Proteins | |
| HY-P7034 | IL-15, Human | Recombinant Proteins | |
| HY-P70340 | nAChRα5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703400 | STK32A, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703401 | cGAS, MOUSE | Recombinant Proteins | |
| HY-P703402 | cGAS, MOUSE (Biotinylated) | Recombinant Proteins | |
| HY-P703403 | CERS6, Human (HEK293, His, Strep) | Recombinant Proteins | |
| HY-P703404 | DHHC20, Human (Sf9) | Recombinant Proteins | |
| HY-P703405 | STK32C, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703406 | NaCT, Human (Sf9) | Recombinant Proteins | |
| HY-P703407 | TRAP1, Rat (646a.a) | Recombinant Proteins | |
| HY-P703408 | TRAP1, Human (His) | Recombinant Proteins | |
| HY-P703409 | TRAP1, Rat | Recombinant Proteins | |
| HY-P70341 | MIF, Mouse (His) | Recombinant Proteins | |
| HY-P703410 | NLRP9, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703411 | MYLK4, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703412 | SLC26A5, Human (HEK293) | Recombinant Proteins | |
| HY-P703413 | SLC26A5, Human (HEK293, GFP, strep, His) | Recombinant Proteins | |
| HY-P703414 | USP27X, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703415 | AKR1A1, Sus scrofa | Recombinant Proteins | |
| HY-P703416 | UfSP1, Human | Recombinant Proteins | |
| HY-P703417 | TRIm72, Human | Recombinant Proteins | |
| HY-P703418 | TRIM72, Human (His) | Recombinant Proteins | |
| HY-P703419 | FABP9, Human | Recombinant Proteins | |
| HY-P70341AF | Animal-Free MIF, Mouse (His) | Recombinant Proteins | |
| HY-P70342 | MMP-12, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703420 | FABP12, Human | Recombinant Proteins | |
| HY-P703421 | SPT16, Arabidopsis thaliana | Recombinant Proteins | |
| HY-P703422 | EIF4E1, Human | Recombinant Proteins | |
| HY-P703423 | CAK1, Saccharomyces cerevisiae (Sf9, GST, His) | Recombinant Proteins | |
| HY-P703424 | TSI3, Pseudomonas aeruginosa (His, Strep) | Recombinant Proteins | |
| HY-P703425 | serB2, Mycobacterium tuberculosis | Recombinant Proteins | |
| HY-P703426 | kshA, Mycobacterium tuberculosis (His, Strep) | Recombinant Proteins | |
| HY-P703427 | Nitroreductase, Bacillus subtilis (strain 168) (His) | Recombinant Proteins | |
| HY-P703428 | birA, Bacillus subtilis (His) | Recombinant Proteins | |
| HY-P703429 | phoA, E.coli | Recombinant Proteins | |
| HY-P70343 | Glypican-1/GPC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703430 | ulp1, Schizosaccharomyces pombe (His) | Recombinant Proteins | |
| HY-P703431 | D15, Escherichia phage T5 | Recombinant Proteins | |
| HY-P703432 | Xylose reductase, Neurospora crassa | Recombinant Proteins | |
| HY-P703433 | srtA Protein, S. aureus | Recombinant Proteins | |
| HY-P703434 | srtA, Staphylococcus aureus (His) | Recombinant Proteins | |
| HY-P703435 | DRE1C, Rice | Recombinant Proteins | |
| HY-P703436 | PAS, Pichia pastoris | Recombinant Proteins | |
| HY-P703437 | OsHSL1, Rice (HEK293, Flag) | Recombinant Proteins | |
| HY-P703438 | hemA, Rhodobacter capsulatus | Recombinant Proteins | |
| HY-P703439 | RAD51, Pyrococcus furiosus(del R288-G301) | Recombinant Proteins | |
| HY-P70344 | FOLR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703440 | RAD51, Pyrococcus furiosus | Recombinant Proteins | |
| HY-P703441 | treS, Mycobacterium tuberculosis | Recombinant Proteins | |
| HY-P703442 | icl1, Mycobacterium tuberculosis | Recombinant Proteins | |
| HY-P703443 | dps, Listeria monocytogenes serovar 1/2a (His) | Recombinant Proteins | |
| HY-P703444 | nanA, Staphylococcus haemolyticus | Recombinant Proteins | |
| HY-P703445 | susB, Bacteroides thetaiotaomicron | Recombinant Proteins | |
| HY-P703446 | susB, Bacteroides thetaiotaomicron (His, Strep) | Recombinant Proteins | |
| HY-P703447 | BT_4683, Bacteroides thetaiotaomicron (His) | Recombinant Proteins | |
| HY-P703448 | BT_1622, Bacteroides thetaiotaomicron (His) | Recombinant Proteins | |
| HY-P703449 | BT_1636, Bacteroides thetaiotaomicron (His) | Recombinant Proteins | |
| HY-P70345 | TNFRSF3/LTBR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703450 | LapB, Human | Recombinant Proteins | |
| HY-P703451 | hemO, Rhodopseudomonas palustris | Recombinant Proteins | |
| HY-P703452 | hemO, Rhodopseudomonas palustris (His) | Recombinant Proteins | |
| HY-P703453 | D13, Monkeypox virus (His, Strep) | Recombinant Proteins | |
| HY-P703454 | hdhA, E.coli (His, Strep) | Recombinant Proteins | |
| HY-P703455 | fimG, E.coli (His) | Recombinant Proteins | |
| HY-P703456 | ADH1, Geobacillus thermodenitrificans (His, Strep) | Recombinant Proteins | |
| HY-P703457 | ADH2, Geobacillus thermodenitrificans | Recombinant Proteins | |
| HY-P703458 | Histone-H2B, Xenopus laevis | Recombinant Proteins | |
| HY-P703459 | CDK2/CCNE2, Sus scrofa (Sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P70346 | HLP2/HPCAL1, Human (His) | Recombinant Proteins | |
| HY-P703460 | Histone-H3, Xenopus laevis | Recombinant Proteins | |
| HY-P703461 | KLHDC2/EloB/EloC, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703462 | VSD4-NaV1.7-NaVPas, Human (HEK293, Flag, Strep) | Recombinant Proteins | |
| HY-P703463 | AURB/INCENP, Human (Sf9, GST(AURKB), His, Strep (INCENP)) | Recombinant Proteins | |
| HY-P703464 | DCAF12/DDB1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703465 | KMT9a/KMT9b, Human (His) | Recombinant Proteins | |
| HY-P703466 | p85/p110, Human (Sf9, Biotinylated, H1047R) | Recombinant Proteins | |
| HY-P703467 | p85/p110, Human (Sf9, Biotinylated) | Recombinant Proteins | |
| HY-P703468 | p85/p110, Human (Sf9, Biotinylated, E542K) | Recombinant Proteins | |
| HY-P703469 | p85/p110, Human (Sf9, Biotinylated, E545K) | Recombinant Proteins | |
| HY-P70347 | Collagen alpha-1(XVIII) chain/COL18A1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703470 | p85/p110, Human (Sf9, Biotinylated, N345K) | Recombinant Proteins | |
| HY-P703471 | p85/p110, Human (Sf9, Biotinylated, P539R) | Recombinant Proteins | |
| HY-P703472 | DCAF16-DDB1, Human (Sf9, Biotinylated) | Recombinant Proteins | |
| HY-P703473 | SKP1-SKP2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703474 | SKP1-SKP2, Human | Recombinant Proteins | |
| HY-P703475 | CDK2/CCNE1, Sus scrofa (Sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P703476 | CALM3, Tetronarce californica | Recombinant Proteins | |
| HY-P703477 | mTSH, Mouse (HEK293) | Recombinant Proteins | |
| HY-P703478 | VEGF165, Human (HEK293, Strep, His) | Recombinant Proteins | |
| HY-P703479 | APJ/MSP1D1 (Nanodisc), Human (Sf9, Flag, His) | Recombinant Proteins | |
| HY-P70348 | Flap endonuclease 1/FEN-1, Human | Recombinant Proteins | |
| HY-P703480 | metB, Staphylococcus aureus (His, Strep) | Recombinant Proteins | |
| HY-P703481 | MT-RNR1, Human (His, GST) | Recombinant Proteins | |
| HY-P703482 | rLuc, Human (His, Strep) | Recombinant Proteins | |
| HY-P703483 | SBK2, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703484 | IGKC, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703485 | ScFv16, Mouse (Sf9) | Recombinant Proteins | |
| HY-P703486 | aerA | Recombinant Proteins | |
| HY-P703487 | Ferritin, Penaeus japonicus (His) | Recombinant Proteins | |
| HY-P703488 | HKR3, Human (His, Strep) | Recombinant Proteins | |
| HY-P703489 | ideS, Streptococcus pyogenes | Recombinant Proteins | |
| HY-P70349 | MDH1, Human (His) | Recombinant Proteins | |
| HY-P703490 | MIZ1, Chlorocebus sabaeus (His, Strep) | Recombinant Proteins | |
| HY-P703491 | BIRC8, Human (GST) | Recombinant Proteins | |
| HY-P703492 | Carbonyl reductase, Bacillus sp. (His) | Recombinant Proteins | |
| HY-P703493 | Short chain dehydrogenase, Lentilactobacillus buchneri (His) | Recombinant Proteins | |
| HY-P703494 | Carboxylesterase, Thermobifida fusca | Recombinant Proteins | |
| HY-P703495 | Carboxylesterase, Thermobifida fusca (His) | Recombinant Proteins | |
| HY-P703496 | Cas9, Streptococcus pyogenes serotype M1 | Recombinant Proteins | |
| HY-P703497 | dapb2, Pseudoxanthomonas mexicana (Flag, His) | Recombinant Proteins | |
| HY-P703499 | Epoxide hydrolase, Bacillus gobiensis (His) | Recombinant Proteins | |
| HY-P7035 | IL-16, Human | Recombinant Proteins | |
| HY-P70350 | MDH2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703500 | FDH, Pseudomonas sp. | Recombinant Proteins | |
| HY-P703501 | FDH, Pseudomonas sp. (His, Strep) | Recombinant Proteins | |
| HY-P703502 | FDH, Pseudomonas sp. (His, Strep) | Recombinant Proteins | |
| HY-P703503 | FDH1, Yeast (His) | Recombinant Proteins | |
| HY-P703504 | FDH1, Yeast (His, Strep) | Recombinant Proteins | |
| HY-P703505 | Peptide deformylase, S. aureus (His, SUMO) | Recombinant Proteins | |
| HY-P703506 | DNA polymerase, Pyrococcus woesei (His) | Recombinant Proteins | |
| HY-P703507 | Halohydrin epoxidase A, Tistrella mobilis (His) | Recombinant Proteins | |
| HY-P703508 | Heparinase, Flavobacterium hibernum (His, Strep) | Recombinant Proteins | |
| HY-P703509 | ideZ, SEZ | Recombinant Proteins | |
| HY-P70351 | MMP-9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703510 | inuB, Human (His) | Recombinant Proteins | |
| HY-P703511 | lipoxygenase, Pseudomonas aeruginosa (Flag, His, CL7) | Recombinant Proteins | |
| HY-P703512 | Lysine decarboxylase, Klebsiella pneumoniae IS43 (His) | Recombinant Proteins | |
| HY-P703513 | malQ, Thermus thermophilus (Flag, His) | Recombinant Proteins | |
| HY-P703514 | MDH, Human (His, Strep) | Recombinant Proteins | |
| HY-P703515 | nitA, Rhodococcus rhodochrous (His) | Recombinant Proteins | |
| HY-P703516 | Nitrilase, S. wittichii (His) | Recombinant Proteins | |
| HY-P703517 | Nitrilase, Alcaligenes sp. EGD-AK7 (His) | Recombinant Proteins | |
| HY-P703518 | Nitrilase, Human (His) | Recombinant Proteins | |
| HY-P703519 | PET hydrolase, Thermobifida alba (His, Strep) | Recombinant Proteins | |
| HY-P70351A | MMP-9, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P70352 | GLP1R, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703520 | PET hydrolase, Thermobifida cellulosilytica (His, Strep) | Recombinant Proteins | |
| HY-P703521 | PET hydrolase, Thermobifida alba (261a.a, His, Strep) | Recombinant Proteins | |
| HY-P703522 | PET hydrolase, Thermobifida fusca (His, Strep) | Recombinant Proteins | |
| HY-P703523 | DTE, Pseudomonas cichorii (His, Myc) | Recombinant Proteins | |
| HY-P703524 | Polyphosphate glucokinase-5R, Thermobifida fusca | Recombinant Proteins | |
| HY-P703525 | IGF2BP3, Human (His) | Recombinant Proteins | |
| HY-P703526 | ACVR2B, Human | Recombinant Proteins | |
| HY-P703527 | xynG1, Paenibacillus sp. (His, Strep) | Recombinant Proteins | |
| HY-P703528 | NCP N, SARS-CoV-2 (His) | Recombinant Proteins | |
| HY-P703529 | NCP N, SARS-CoV-2 (N269-K369) | Recombinant Proteins | |
| HY-P70353 | NAMPT, Human (His) | Recombinant Proteins | |
| HY-P703530 | NCP N, SARS-CoV-2 (N48-A173) | Recombinant Proteins | |
| HY-P703531 | NCP N, SARS-CoV-2 (Sf9, His, Flag) | Recombinant Proteins | |
| HY-P703532 | NSP16-NSP10, SARS-CoV-2 | Recombinant Proteins | |
| HY-P703533 | NSP16-NSP10, Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) (His) | Recombinant Proteins | |
| HY-P703534 | NSP3, SARS-CoV-2 (A1-F372) | Recombinant Proteins | |
| HY-P703535 | NSP3, SARS-CoV-2 (A1-T183) | Recombinant Proteins | |
| HY-P703536 | NSP3, SARS-CoV-2 (His) | Recombinant Proteins | |
| HY-P703537 | NSP3, SARS-CoV-2 (I388-R745) | Recombinant Proteins | |
| HY-P703538 | NSP3, SARS-CoV-2 (E746-K1083) | Recombinant Proteins | |
| HY-P703539 | NSP7, SARS-CoV-2 (His) | Recombinant Proteins | |
| HY-P70354 | KIR2DL3, Human (EK293, His) | Recombinant Proteins | |
| HY-P703540 | NSP8, SARS-CoV-2 | Recombinant Proteins | |
| HY-P703541 | NSP8, SARS-CoV-2 (His, Flag) | Recombinant Proteins | |
| HY-P703542 | NSP9, SARS-CoV-2 (His) | Recombinant Proteins | |
| HY-P703543 | SARS-CoV-2 RdRP Protein (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703544 | Spike glycoProtein, SARS-CoV-2 (Sf9, His) | Recombinant Proteins | |
| HY-P703545 | Spike glycoProtein, SARS-CoV-2 (HEK293, Strep, His) | Recombinant Proteins | |
| HY-P703547 | HCVNS5B, HCV | Recombinant Proteins | |
| HY-P703548 | pp1a, AIBV (His) | Recombinant Proteins | |
| HY-P703549 | BRAF, Human (Flag) | Recombinant Proteins | |
| HY-P70355 | EIF1AX, Human (His) | Recombinant Proteins | |
| HY-P703550 | CASP6, Human | Recombinant Proteins | |
| HY-P703551 | Cyclin A2, Human | Recombinant Proteins | |
| HY-P703552 | CDK11p58, Human (Sf9) | Recombinant Proteins | |
| HY-P703553 | CDK3, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P703554 | CDK3-CCNC, Human (Sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P703555 | CDK3-CCNE2, Human (Sf9, GST, Flag, His) | Recombinant Proteins | |
| HY-P703556 | CDK7, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P703557 | CDK8, Human (Sf9) | Recombinant Proteins | |
| HY-P703558 | CDK9, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P703559 | DCAF16-DDB1-CUL4A-RBX1, Human (Sf9) | Recombinant Proteins | |
| HY-P70356 | IL-11, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P703560 | DCAF2-DDB1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703561 | DCAF8-DDB1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703562 | DCAF9/DDB1, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703563 | DDB1, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703564 | DNMT1, Human | Recombinant Proteins | |
| HY-P703565 | DNMT1, Human (Sf9, GST, Flag) | Recombinant Proteins | |
| HY-P703566 | ETF1, Human | Recombinant Proteins | |
| HY-P703568 | GPRK4, Human (Sf9) | Recombinant Proteins | |
| HY-P70357 | IGFBP-6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703570 | HSP90, Human (Biotinylated) | Recombinant Proteins | |
| HY-P703571 | HSP90b, Human (Sf9) | Recombinant Proteins | |
| HY-P703572 | HSP90b, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703573 | IRS1, Human (His, Strep) | Recombinant Proteins | |
| HY-P703574 | MAT2A, Human | Recombinant Proteins | |
| HY-P703575 | CDK17-CCNY, Human (Sf9, GST, Flag) | Recombinant Proteins | |
| HY-P703576 | CDK18-CCNY, Human (Sf9, GST, Flag) | Recombinant Proteins | |
| HY-P703577 | PDE7A1, Human | Recombinant Proteins | |
| HY-P703578 | PDK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703579 | STAT6, Human (sf9, His, Strep) | Recombinant Proteins | |
| HY-P70358 | Galectin-7/LGALS7, Human | Recombinant Proteins | |
| HY-P703580 | PIK3CA, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703581 | PK3CD/p85, Human (Sf9, His, Strep, GST) | Recombinant Proteins | |
| HY-P703583 | PIK3R1-PIK3CA, Human (Sf9) | Recombinant Proteins | |
| HY-P703584 | PREP, Human | Recombinant Proteins | |
| HY-P703585 | MAP2K1, Human (Sf9, Flag) | Recombinant Proteins | |
| HY-P703586 | MEK1, Human (Inactive, Sf9, His) | Recombinant Proteins | |
| HY-P703587 | MAP2K3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703588 | RB1, Human (Strep) | Recombinant Proteins | |
| HY-P703589 | KDM5A, Human | Recombinant Proteins | |
| HY-P70359 | GLIPR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703590 | RPS6KB2, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703591 | TAK1, Human (Sf9) | Recombinant Proteins | |
| HY-P703592 | TNFAIP3, Human (His, GST) | Recombinant Proteins | |
| HY-P703593 | TNFAIP3, Human (GST, His) | Recombinant Proteins | |
| HY-P703594 | UBE3A, Human (His) | Recombinant Proteins | |
| HY-P703595 | BRPF1, Human | Recombinant Proteins | |
| HY-P703596 | BRD3, Human (His) | Recombinant Proteins | |
| HY-P703597 | CDC7, Human (His) | Recombinant Proteins | |
| HY-P703598 | CDK13, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P703599 | CDK13-CCNK, Human (Sf9, GST, Flag) | Recombinant Proteins | |
| HY-P7036 | IL-17A, Human | Recombinant Proteins | |
| HY-P70360 | Glutathione synthetase/GSS, Human (His) | Recombinant Proteins | |
| HY-P703600 | CDK13-CCNT1, Human (Sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P703601 | UBA3/APPBP1, Human (Sf9) | Recombinant Proteins | |
| HY-P703602 | PKMYT1, Human | Recombinant Proteins | |
| HY-P703603 | STK17B, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703604 | SETDB1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703605 | FXR, Human | Recombinant Proteins | |
| HY-P703606 | FXR, Human (His, Strep) | Recombinant Proteins | |
| HY-P703607 | SAE2, Human | Recombinant Proteins | |
| HY-P703608 | SAE2, Human (His, Strep) | Recombinant Proteins | |
| HY-P703609 | BCKDK, Human | Recombinant Proteins | |
| HY-P70361 | INPP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703610 | BCKDK, Human (His, Strep) | Recombinant Proteins | |
| HY-P703611 | ERN2, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703612 | POLQ, Human (Sf9, Biotinylated, His) | Recombinant Proteins | |
| HY-P703613 | WWP1, Human (His) | Recombinant Proteins | |
| HY-P703614 | WWP1, Human | Recombinant Proteins | |
| HY-P703615 | WDR5, Human | Recombinant Proteins | |
| HY-P703616 | STK38, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703617 | PTK9L, Human | Recombinant Proteins | |
| HY-P703618 | PTK9L, Human (His, Strep) | Recombinant Proteins | |
| HY-P703619 | JMJD2C, Human | Recombinant Proteins | |
| HY-P70362 | MTHFS, Human (His) | Recombinant Proteins | |
| HY-P703620 | SARM1, Human | Recombinant Proteins | |
| HY-P703621 | JMJD6, Human (His, Strep) | Recombinant Proteins | |
| HY-P703622 | PARP7, Human (His) | Recombinant Proteins | |
| HY-P703623 | UHRF1, Human (His) | Recombinant Proteins | |
| HY-P703624 | UHRF1, Human | Recombinant Proteins | |
| HY-P703625 | UBE2J1, Human | Recombinant Proteins | |
| HY-P703626 | Sirt6, Human (His) | Recombinant Proteins | |
| HY-P703627 | OTUD6B, Human (Flag) | Recombinant Proteins | |
| HY-P703629 | CDK12-CCNT1, Human (Sf9, GST, His, Flag) | Recombinant Proteins | |
| HY-P70363 | TNFRSF3/LTBR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P703630 | BIKE, Human (His, Strep) | Recombinant Proteins | |
| HY-P703632 | SCYL1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703633 | METTL14-METTL3, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P703634 | KMT2C, Human | Recombinant Proteins | |
| HY-P703635 | EHMT1, Human (His) | Recombinant Proteins | |
| HY-P703636 | EHMT1, Human | Recombinant Proteins | |
| HY-P703637 | PEAK1, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703638 | TSSK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703639 | POMK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P70364 | METAP2/Methionine aminopeptidase 2, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703641 | DPP9, Human (Sf9) | Recombinant Proteins | |
| HY-P703642 | TBCK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703644 | LRRK2, Human (Sf9, GST, G2019S) | Recombinant Proteins | |
| HY-P703645 | STK35, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703646 | Tnnt2, Mouse (His, Flag) | Recombinant Proteins | |
| HY-P703647 | Rab10, Mouse (His) | Recombinant Proteins | |
| HY-P703648 | LIPA, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P703649 | THRA, Human (His) | Recombinant Proteins | |
| HY-P70365 | Galactokinase/GALK1, Human (His) | Recombinant Proteins | |
| HY-P703650 | OGT, Human (His) | Recombinant Proteins | |
| HY-P703651 | USP8, Human (sf9) | Recombinant Proteins | |
| HY-P703652 | USP8, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P703653 | Galectin 9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703656 | Galectin-1/LGALS1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703657 | Galectin 1, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P70366 | MeCP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703663 | Fibronectin, Human (91a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703665 | Collagen II/COL2A1, Human (aa 1242-1487, HEK293, His) | Recombinant Proteins | |
| HY-P703668 | Fibronectin/FN1, Human | Recombinant Proteins | |
| HY-P70367 | Glypican-3/GPC3, Human (HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P703671 | USP14, Human | Recombinant Proteins | |
| HY-P703672 | USP14, Human (399a.a, His) | Recombinant Proteins | |
| HY-P703673 | USP5, Human (His) | Recombinant Proteins | |
| HY-P703674 | IL-13, Canine (HEK293, hFc) | Recombinant Proteins | |
| HY-P703678 | IL-23R, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P703679 | SEZ6, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P70367A | Glypican-3/GPC3 Protein, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70368 | HDGF, Human (His) | Recombinant Proteins | |
| HY-P703680 | Musk (muscle, skeletal receptor tyrosine-protein kinase), Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703681 | RIIB/ACVR2B, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703682 | uPAR/PLAUR, Rat (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703683 | RIIA/ACVR2A, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703684 | NPR1/NPRA, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703685 | GIPR, Cynomolgus (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703686 | IL1R1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703688 | CD2/SRBC, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703689 | IL-13 R alpha 1/IL13RA1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70369 | Lumican/LUM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703690 | RNF43, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703691 | Serum Albumin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703693 | EMMPRIN/CD147, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703694 | Integrin alpha 2 beta 1 (ITGA2&ITGB1) Heterodimer, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703695 | IFN-gamma R1/CD119, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P703696 | IL-7 R alpha&TSLPR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703697 | CLEC11a/SCGF-alpha, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703698 | NPR1/NPRA, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P703699 | FcRn, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7037 | IL-2, Human | Recombinant Proteins | |
| HY-P70370 | Lumican/LUM, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703700 | NPR1/NPRA, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P703701 | NPR1/NPRA, Cynomolgus (HEK293, mFc) | Recombinant Proteins | |
| HY-P703702 | FSH, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703703 | NPR1/NPRA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703704 | NPR1/NPRA, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703705 | HLA-A*02:01&B2M&HIV Gag (SLYNTVATL) Monomer, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703706 | RIIB/ACVR2B, Human/Cynomolgus (HEK293, hFAvi) | Recombinant Proteins | |
| HY-P703707 | RIIB/ACVR2B, Human/Cynomolgus (HEK293, mFc) | Recombinant Proteins | |
| HY-P703708 | c-MPL/Thrombopoietin R, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703709 | LY6G6D, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P70371 | Importin alpha-1/KPNA2, Human (His) | Recombinant Proteins | |
| HY-P703710 | Mouse&Chimeric Integrin alpha V beta 6 (ITGAV&ITGB6) Heterodimer, Mouse&Human (HEK293, His) | Recombinant Proteins | |
| HY-P703712 | H-2K(b)&B2M&OVA (SIINFEKL) Monomer, Mouse (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703713 | CD300LG/Nepmucin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703714 | FSH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703716 | OX40 Ligand/TNFSF4, Cynomolgus/Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P703717 | OX40/TNFRSF4/CD134, Cynomolgus/Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P703718 | IL-31, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703719 | CDCP1, Cynomolgus (HEK293, C-His) | Recombinant Proteins | |
| HY-P70372 | Ribonuclease UK114/HRSP12, Human (His) | Recombinant Proteins | |
| HY-P703720 | ASGR1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703721 | MERTK/Mer, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703722 | MSLN/Mesothelin, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703723 | CD228/MFI2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703724 | CD98, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703725 | CD98, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703726 | CD98, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703727 | FcRH5/FcRL5, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703728 | HGFR, Mouse (907a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703729 | OSMR-GPL fusion, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70373 | Ephrin-A1/EFNA1, Mouse (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P703730 | Oncostatin M/OSM, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703731 | CD6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703732 | EPHA5, Cynomolgus (518a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703733 | BTN2A1&BTN3A1 complex, Human (HEK293, His, Flag) | Recombinant Proteins | |
| HY-P703734 | CA2/Carbonic anhydrase II, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703735 | ficolin 1/FCN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703736 | PRAK, Human (Sf9, Strep) | Recombinant Proteins | |
| HY-P703737 | N Cadherin Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703738 | LY6G6D Protein, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703739 | PDGFA, Canine (Yeast, His) | Recombinant Proteins | |
| HY-P70374 | Ephrin-B1/EFNB1, Mouse (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P703740 | Coagulation Factor II Protein, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703741 | HRG/HPRG Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703742 | Fibronectin (1266-1356), Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703743 | SMR3B Protein, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P703744 | CD8 alpha&beta Heterodimer, Human (HEK293, His, Flag) | Recombinant Proteins | |
| HY-P703745 | N Cadherin Protein, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703746 | Integrin alpha 8 beta 1 (ITGA8&ITGB1) Heterodimer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703747 | EMMPRIN/CD147, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703749 | Hamster FGF21 Protein, Hamster (HEK293, His) | Recombinant Proteins | |
| HY-P70375 | Ephrin-A3/EFNA3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703750 | gp130/CD130/IL-6 R beta, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P703751 | IL-1R3/IL-1 RAcP, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703752 | ICAM-1/CD54, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703753 | CEACAM-8/CD66b, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703754 | OSMR Protein, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703755 | Oncostatin M/OSM Protein, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703756 | EPO/Erythropoietin Protein, Human (HEK293) | Recombinant Proteins | |
| HY-P703757 | BAFF/TNFSF13B, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P703758 | ROR2/NTRKR2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703759 | FSHB, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70376 | Ephrin-A4/EFNA4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703760 | CD117, Cynomolgus/Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P703761 | CCL24, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703763 | Hyaluronidase 2/HYAL2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703764 | CDH3/Cadherin 3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703766 | BTLA, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703767 | LTK, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703768 | FGF-9, Canine (HEK293, mFc) | Recombinant Proteins | |
| HY-P70377 | Ephrin-B2/EFNB2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703770 | Complement factor I, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703771 | M1R, Monkeypox virus (HEK293, His) | Recombinant Proteins | |
| HY-P703772 | Aminopeptidase P2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703773 | Integrin alpha V beta 3, Mouse (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703774 | AGER, Cynomolgus (331a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703775 | A35R, Monkeypox virus (HEK293, His) | Recombinant Proteins | |
| HY-P703776 | CA12/Carbonic anhydrase XII, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703777 | IL-21R, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703778 | IL-18R alpha, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703779 | IGFBP2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70378 | Ephrin-B2/EFNB2, Mouse (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P703780 | ICAM-1/CD54, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703781 | ENPP-2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703782 | Glycoprotein/G, HRSV (232a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703783 | DDT, Cynomolgus (His) | Recombinant Proteins | |
| HY-P703784 | Integrin alpha V beta 3, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703785 | Aminopeptidase P2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703786 | DDT, Canine (His) | Recombinant Proteins | |
| HY-P703787 | CEACAM6, Cynomolgus (286a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703788 | A29, Monkeypox virus (His) | Recombinant Proteins | |
| HY-P703789 | A30, Monkeypox virus (HEK293, His) | Recombinant Proteins | |
| HY-P70379 | Ephrin-A5/EFNA5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703790 | E8L, Monkeypox virus (His) | Recombinant Proteins | |
| HY-P703791 | SLAMF7/CRACC, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703792 | L1R, Monkeypox virus (His) | Recombinant Proteins | |
| HY-P703793 | Complement factor I, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703794 | GBA/glucocerebrosidase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703796 | DPPIV/CD26, Cynomolgus/Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7037A | IL-2, Human (CHO) | Recombinant Proteins | |
| HY-P7037AF | Animal-Free IL-2, Human (His) | Recombinant Proteins | |
| HY-P7037B | IL-2, Human (His) | Recombinant Proteins | |
| HY-P7037G | GMP IL-2, Human (Tag Free) | Recombinant Proteins | |
| HY-P7038 | IL-21, Human | Recombinant Proteins | |
| HY-P70380 | METAP1/Methionine aminopeptidase 1, Human | Recombinant Proteins | |
| HY-P703800 | HGFR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703802 | Nectin-4, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P703804 | MME, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703805 | DKK1, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P703809 | CD157, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70381 | EphB1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703812 | PADI4, Cynomolgus (His) | Recombinant Proteins | |
| HY-P703815 | TYRO3/DTK, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703816 | PDGF R beta, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703817 | Carbonic Anhydrase 9, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703819 | RANKL/TNFSF11, Mouse (247a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70382 | EphA4, Human (HEK293) | Recombinant Proteins | |
| HY-P703820 | TAG-72, Canine (His) | Recombinant Proteins | |
| HY-P703821 | NKp46/NCR1, Human (Biotinylated, HEK293, His, solution) | Recombinant Proteins | |
| HY-P703823 | CD200R1, Cynomolgus (243a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703825 | CD64, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703827 | ALK, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P703829 | AGR-2, Human (His) | Recombinant Proteins | |
| HY-P70383 | Inhibin beta C chain/INHBC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703833 | DDT, Mouse (His) | Recombinant Proteins | |
| HY-P703834 | DDT, Human (His) | Recombinant Proteins | |
| HY-P703839 | IL-1 beta, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P70384 | GFRA1/GDNFR-alpha-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703840 | IGFBP-3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703844 | Neuropilin-1, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P703845 | BACE1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703846 | IL-2R alpha/CD25, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703849 | Angiopoietin-2, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P70385 | JAM-B/CD322, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703850 | TNFRSF10C, Human (213a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703851 | Legumain, Human (416a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703852 | NTRK2/TrkB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703853 | KIR3DL3/CD158z, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703855 | PD-L1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P703856 | SIRP alpha V5/CD172a, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703857 | LIF, Cynomolgus, (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703858 | SLC34A2-VLP, Cynomolgus (HEK293, His, Strep) | Recombinant Proteins | |
| HY-P70386 | FAM3B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703860 | Latent TGF beta 1/TGFB1, Cynomolgus (HEK293,His) | Recombinant Proteins | |
| HY-P703861 | TPO/Thrombopoietin, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P703862 | VEGFR-2, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703867 | Ferret CD4, Ferret (HEK293, His) | Recombinant Proteins | |
| HY-P703868 | Ferret CD8 alpha, Ferret (HEK293, His) | Recombinant Proteins | |
| HY-P703869 | Ferret TNF-alphaFerret | Recombinant Proteins | |
| HY-P70387 | Glia maturation factor beta/GMFB, Human (His) | Recombinant Proteins | |
| HY-P703870 | HMPV, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703871 | glycoprotein D/gD, HSV-2 (HEK293, His) | Recombinant Proteins | |
| HY-P703872 | BAFFR/TNFRSF13C, Human (HEK293, His, Fc) | Recombinant Proteins | |
| HY-P703873 | BAFFR/TNFRSF13C, Human (Biotinylated, HEK293, hFc, Avi) | Recombinant Proteins | |
| HY-P703874 | BID, Human (N-G&P) | Recombinant Proteins | |
| HY-P703875 | BMP-4, Human (HEK293, E399D) | Recombinant Proteins | |
| HY-P703876 | BMPR1A/ALK-3, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703877 | B7-2/CD86, Human (Biotinylated, HEK293, hFc, Avi) | Recombinant Proteins | |
| HY-P703878 | B7-2/CD86, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703879 | CD9-VLP, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P70388 | MAX, Human (His) | Recombinant Proteins | |
| HY-P703880 | CD9-Nanodisc, Human (HEK293, His, GFP) | Recombinant Proteins | |
| HY-P703881 | C1qR1/CD93, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703882 | C1qR1/CD93, Human (559a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703883 | CD96, Human (Biotinylated, HEK293, hFc, Avi) | Recombinant Proteins | |
| HY-P703884 | CEACAM5, Human (685a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703885 | CEACAM6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703886 | Carboxylesterase 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703887 | Claudin-4/CLDN4-VLP, Human (HEK293,Flag) | Recombinant Proteins | |
| HY-P703888 | Claudin-4/CLDN4-Nanodisc, Human (HEK293,His, Strep) | Recombinant Proteins | |
| HY-P703889 | Claudin-6-Nanodisc, Human (HEK293, GFP, His) | Recombinant Proteins | |
| HY-P70389 | Neurocalcin-delta/NCALD, Human (His) | Recombinant Proteins | |
| HY-P703890 | Claudin-9/CLDN9-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P703891 | Claudin-9/CLDN9-Nanodisc, Human (HEK293, Biotinylated,His, Avi) | Recombinant Proteins | |
| HY-P703892 | CLEC12A/MICL, Human (HEK293, Biotinylated, Avi, Fc) | Recombinant Proteins | |
| HY-P703894 | Carboxypeptidase B1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703895 | TDGF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703896 | CRTAM/CD355, Human (HEK293, Biotinylated, His) | Recombinant Proteins | |
| HY-P703898 | DUSP3, Human (Sf9) | Recombinant Proteins | |
| HY-P703899 | HER4, Human, (HEK293, hFc) | Recombinant Proteins | |
| HY-P7038A | IL-21, Human(E. coli) | Recombinant Proteins | |
| HY-P7038G | GMP IL-21, Human | Recombinant Proteins | |
| HY-P7039 | IL-22, Human | Recombinant Proteins | |
| HY-P70390 | Lysozyme C/LYZ, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703901 | Erythropoietin/EPO, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703902 | Fc epsilon RIA/FCER1A, Human (HEK293,His) | Recombinant Proteins | |
| HY-P703903 | Fc epsilon RIA/FCER1A, Human (HEK293) | Recombinant Proteins | |
| HY-P703904 | IGF2R, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703905 | IGFBP-7, Human (HEK293, K95R, His) | Recombinant Proteins | |
| HY-P703906 | IGFBP-7, Human (HEK293, Biotinylated, hFc, Avi) | Recombinant Proteins | |
| HY-P703907 | TAOK3, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P703908 | NA/Neuraminidase, Influenza B (EPI1868374, HEK293, His) | Recombinant Proteins | |
| HY-P703909 | ACVR2B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70390A | Lysozyme C/LYZ, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70391 | HLA-A*0201 AFP complex, Human (FMNKFIYEI, HEK293, His) | Recombinant Proteins | |
| HY-P703910 | CD99L2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703911 | gp130/IL6ST, Mouse (599a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703912 | CD166/ALCAM, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703913 | gp130/IL6ST, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P703914 | IL-25/IL-17E, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P703915 | TIE-2, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P703916 | IGFBP1, Rhesus (HEK293, His) | Recombinant Proteins | |
| HY-P703918 | CD30 Ligand/TNFSF8, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P703919 | CD30 Ligand/TNFSF8, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70392 | HLA-A*0201 GP100 complex, Human (IMDQVPFSV, HEK293, His) | Recombinant Proteins | |
| HY-P703920 | Fas/CD95, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P703921 | IL-23 Receptor, Cynomolgus, (HEK293, hFc) | Recombinant Proteins | |
| HY-P703922 | Erythropoietin receptor/EpoR, Cynomolgus, (HEK293, His) | Recombinant Proteins | |
| HY-P703923 | NPR1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703924 | p38 gamma/MAPK12, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P703925 | METAP2/Methionine aminopeptidase 2, Human (Sf9, C-His) | Recombinant Proteins | |
| HY-P703926 | CNDP2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P703927 | RIB/ALK-4, Mouse (Activin, 344a.a, HEK293, Fc ) | Recombinant Proteins | |
| HY-P703928 | BMP-1, Human (C-His) | Recombinant Proteins | |
| HY-P703929 | CCR5, Human (Sf9, Flag-His) | Recombinant Proteins | |
| HY-P70393 | HLA-A*0201 HPV16 E7 complex, Human (YMLDLQPET, HEK293, His) | Recombinant Proteins | |
| HY-P703930 | SLC44A1, Human (Sf9) | Recombinant Proteins | |
| HY-P703931 | "Delta-like protein 3/DLL3, Human (Biotinylated, HEK293, His, Avi) " | Recombinant Proteins | |
| HY-P703932 | PE-Labeled Delta-like protein 3/DLL3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703933 | Delta-like protein 3/DLL3, Human (128a.a, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703934 | "Delta-like protein 3/DLL3, Human (Biotinylated, 169a.a, HEK293, His, Avi) " | Recombinant Proteins | |
| HY-P703936 | SLC22A23, Human (HEK293, His, MBP, Flag) | Recombinant Proteins | |
| HY-P703937 | hERG, Human (HEK293) | Recombinant Proteins | |
| HY-P703938 | MMP-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703939 | cGAS, Human (362a.a, His) | Recombinant Proteins | |
| HY-P70394 | HLA-A*0201 NY-ESO-1 complex Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703940 | Granzyme B/GZMB, Human (227a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703941 | TXNIP, Human (His, B2M) | Recombinant Proteins | |
| HY-P703942 | GPX4, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703943 | HK2, Human (Sf9, His) | Recombinant Proteins | |
| HY-P703944 | OX1R, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P703945 | SOD3, Human (His) | Recombinant Proteins | |
| HY-P703946 | CD109/CPAMD7, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703947 | BMPR-II, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703948 | Coagulation Factor XI/F11, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P703949 | RGM-C, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70395 | HLA-A*0201 WT-1 complex Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703950 | CLM-5, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703951 | BAFFR/TNFRSF13C, Cynomolgus/Rhesus Macaque (HEK293, hFc) | Recombinant Proteins | |
| HY-P703952 | IL-4R alpha/CD124, Cynomolgus (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P703953 | CLEC4A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703954 | IL-4R alpha/CD124, Canine (208a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703955 | FCRL2, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P703956 | ACVR2B, Human/Cynomolgus (Biotinylated, HEK293, mFc) | Recombinant Proteins | |
| HY-P703957 | FcRH5/FcRL5, Human (106a.a, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703958 | MUSK, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703959 | MUSK, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70396 | Grb2, Human (His) | Recombinant Proteins | |
| HY-P703960 | VEGF-DD, Human (117a.a, HEK293, His) | Recombinant Proteins | |
| HY-P703961 | RGM-C, Human (Biotinylated, HEK293, Avi) | Recombinant Proteins | |
| HY-P703962 | IL-1 beta, Cynomolgus (Biotinylated, His, Avi) | Recombinant Proteins | |
| HY-P703963 | CLEC5A/MDL-1, Mouse (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703964 | FITC-Labeled Angiopoietin-2, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703965 | GIPR, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703966 | PTK7, Mouse (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703967 | PTK7, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703968 | IL-1 beta, Mouse (Biotinylated, His, Avi) | Recombinant Proteins | |
| HY-P703969 | IL-1 beta, Mouse (His, Avi) | Recombinant Proteins | |
| HY-P70397 | Hemoglobin subunit alpha/HBA1, Human (His) | Recombinant Proteins | |
| HY-P703970 | PTK7, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703971 | VEGF110, Human (HEK293) | Recombinant Proteins | |
| HY-P703972 | CLEC9A, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P703973 | CLEC5A/MDL-1, Mouse (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703974 | IL-13R alpha 2, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703975 | IL-22R alpha 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P703976 | CD2, Human (185a.a, Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703977 | ACVR2A/Activin RIIA, Human/Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703978 | Serum Albumin/ALB, Human (HEK293, V418M, T420A, E505G, V547A) | Recombinant Proteins | |
| HY-P703979 | Serum Albumin/ALB, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P70398 | LRIG1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P703980 | Cadherin-1/CD324, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703981 | GDF-2/BMP-9, Human (HEK293) | Recombinant Proteins | |
| HY-P703982 | GIPR, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703983 | Mesothelin, Human (112a.a, Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703984 | FGFR-3 alpha (IIIb), Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P703985 | NCAM-1/CD56, Human (699a.a, Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703986 | CD23/Fc epsilon RII, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703987 | GCGR, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703988 | DPP3, Rat (His) | Recombinant Proteins | |
| HY-P703989 | DPP3, Mouse (His) | Recombinant Proteins | |
| HY-P70399 | Jagged-1/JAG1 Protein, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P703990 | GIPR, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703991 | GIPR, Human (HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703992 | GCGR, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P703993 | IFNAR1, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703994 | Activin A, Human (Biotinylated, HEK293, Avi) | Recombinant Proteins | |
| HY-P703995 | ACVR2A/Activin RIIA, Human/Cynomolgus (Biotinylated, HEK293, hFc, Avi) | Recombinant Proteins | |
| HY-P703996 | IFN-alpha/beta R2, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703997 | IFN-alpha/beta R2, Mouse (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P703999 | DRD2, Human (His, Myc) | Recombinant Proteins | |
| HY-P7039A | IL-22, Human (HEK293) | Recombinant Proteins | |
| HY-P7039C | IL-22, Human (His) | Recombinant Proteins | |
| HY-P7040 | IL-3, Human | Recombinant Proteins | |
| HY-P70400 | Hepcidin/HAMP, Human (GST) | Recombinant Proteins | |
| HY-P704000 | LATS1, Human (His, Myc) | Recombinant Proteins | |
| HY-P704001 | SCP2, Human (GST) | Recombinant Proteins | |
| HY-P704002 | ASK3, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P704003 | CDK4, Human (sf9, His, Flag, Avi) | Recombinant Proteins | |
| HY-P704004 | SLC22A6, Human (HEK293, His, MBP, FLAG) | Recombinant Proteins | |
| HY-P704006 | Pellino-1, Human | Recombinant Proteins | |
| HY-P704008 | MAPK1/ERK2, Human (Inactive, GST) | Recombinant Proteins | |
| HY-P704009 | Cathepsin C/DPPI, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70401 | Neuropilin-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704010 | CCN1/Cyr61, Mouse (His) | Recombinant Proteins | |
| HY-P704011 | MEK1, Human (Active, Sf9, His) | Recombinant Proteins | |
| HY-P704012 | CHRM2, Human (His) | Recombinant Proteins | |
| HY-P704013 | HK2, Mouse (Sf9, His) | Recombinant Proteins | |
| HY-P704014 | NAMPT, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P704015 | Latent GDF-8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704016 | EIF2AK2, Human (Active, Sf9, GST) | Recombinant Proteins | |
| HY-P704017 | Cathepsin C/DPPI, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704018 | Cathepsin C/DPPI, Mouse (Active, HEK293, His) | Recombinant Proteins | |
| HY-P70402 | Ephrin-B1/EFNB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704020 | GZMA/Granzyme A, Mouse (His) | Recombinant Proteins | |
| HY-P704021 | Dihydroorotate Dehydrogenase, Human (C-His) | Recombinant Proteins | |
| HY-P704022 | Galectin-7/LGALS7, Human (His) | Recombinant Proteins | |
| HY-P704023 | NEK2, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P704024 | HDAC6, Human (Sf9, His) | Recombinant Proteins | |
| HY-P704025 | BTK, Human (Sf9, GST) | Recombinant Proteins | |
| HY-P704026 | BTK, Human (Sf9, GST, C481S) | Recombinant Proteins | |
| HY-P704027 | BTK, Human (Sf9, GST, M437R) | Recombinant Proteins | |
| HY-P704028 | BTK, Human (Sf9, GST, T316A) | Recombinant Proteins | |
| HY-P704029 | BTK, Human (Sf9, GST, T474I) | Recombinant Proteins | |
| HY-P70403 | FKBP3, Human (His) | Recombinant Proteins | |
| HY-P704030 | BTK, Human (Sf9, GST, T474S) | Recombinant Proteins | |
| HY-P704031 | ECM1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704032 | CSDE1, Mouse (His) | Recombinant Proteins | |
| HY-P704033 | CHRNA7, Human (His) | Recombinant Proteins | |
| HY-P704034 | Caspase-3/CASP3, Mouse (His, Myc) | Recombinant Proteins | |
| HY-P704035 | Dectin-1/CLEC7A, Human (HEK293) | Recombinant Proteins | |
| HY-P704036 | Dectin-1/CLEC7A Protein, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P704037 | KAT7, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P704038 | FASN, Human (His) | Recombinant Proteins | |
| HY-P704039 | TERT, Human (His) | Recombinant Proteins | |
| HY-P70404 | N-acetylgalactosamine kinase/GALK2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704040 | KMO, Human (His) | Recombinant Proteins | |
| HY-P704041 | SFTPC, Human (GST) | Recombinant Proteins | |
| HY-P704042 | "SFTPC, Human (P.pastoris, His) " | Recombinant Proteins | |
| HY-P704043 | SFTPC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704044 | Cry2 Protein, Mouse (His) | Recombinant Proteins | |
| HY-P704045 | RORC, Mouse (P. pastoris, His) | Recombinant Proteins | |
| HY-P704046 | Bmal1, Arnt3, Brain and muscle ARNT-like 1 | Recombinant Proteins | |
| HY-P704047 | GSDME, Human (His) | Recombinant Proteins | |
| HY-P704048 | ACVR2B, Human (His, GST) | Recombinant Proteins | |
| HY-P704049 | GSDMD, Human (His) | Recombinant Proteins | |
| HY-P70405 | FKBP4, Human (His) | Recombinant Proteins | |
| HY-P704050 | gp41 antigen 2, HIV-1 (His） | Recombinant Proteins | |
| HY-P704051 | "p24, HIV-1 (His) " | Recombinant Proteins | |
| HY-P704052 | omp1, other (His, Myc) | Recombinant Proteins | |
| HY-P704053 | omp1A, other (His, SUMO) | Recombinant Proteins | |
| HY-P704054 | omp1B, other (His, Myc) | Recombinant Proteins | |
| HY-P704055 | omp1C, other (His, Myc) | Recombinant Proteins | |
| HY-P704056 | PDK4 Protein, Mouse (221a.a, His ) | Recombinant Proteins | |
| HY-P704057 | Vpr, HIV-1 group M subtype K (His, Myc) | Recombinant Proteins | |
| HY-P704058 | Vif ,HIV-1 group M subtype B | Recombinant Proteins | |
| HY-P704059 | Rev,HIV-1 group M subtype C (GST) | Recombinant Proteins | |
| HY-P70406 | HSF2, Human (His) | Recombinant Proteins | |
| HY-P704060 | Vpr Protein, HIV-1 group M subtype C (His, Myc) | Recombinant Proteins | |
| HY-P704061 | Vpr, HIV-1 group M subtype G | Recombinant Proteins | |
| HY-P704062 | COL4A1, Human (His) | Recombinant Proteins | |
| HY-P704063 | "Integrin alpha V beta 1 (ITGAV&ITGB1) Heterodimer, Human (HEK293, His, Avi) " | Recombinant Proteins | |
| HY-P704064 | MAP2K4, Human (Sf9, His, StrepⅡ, GST) | Recombinant Proteins | |
| HY-P704065 | MYC, Human (His) | Recombinant Proteins | |
| HY-P704066 | MYC, Human (C-His) | Recombinant Proteins | |
| HY-P704067 | Vitronectin, Human (417a.a) | Recombinant Proteins | |
| HY-P704068 | glycoprotein D/gD, HSV-1 (HEK293, His) | Recombinant Proteins | |
| HY-P704069 | Integrin alpha-V, Human (158a.a, His) | Recombinant Proteins | |
| HY-P70407 | ITIH3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704070 | CHMP4B, Human (GST) | Recombinant Proteins | |
| HY-P704071 | PDHA1, Human (His, GST) | Recombinant Proteins | |
| HY-P704072 | PDHA1, Human (His, Myc) | Recombinant Proteins | |
| HY-P704073 | PDHA1, Human (GST) | Recombinant Proteins | |
| HY-P704074 | CHMP1B, Human (GST) | Recombinant Proteins | |
| HY-P704075 | PNPLA3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704076 | PNPLA3, Human (I148M, sf9, His) | Recombinant Proteins | |
| HY-P704077 | Lymphotactin/XCL1, Mouse | Recombinant Proteins | |
| HY-P704078 | Endothelin-3/EDN3, Human (P. pastoris, His, Myc) | Recombinant Proteins | |
| HY-P704079 | UBE2N/Ubc13, Human (sf9) | Recombinant Proteins | |
| HY-P70408 | IGFBP-5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704080 | Enterotoxin type E, S. aureus (HEK293, His, Myc) | Recombinant Proteins | |
| HY-P704081 | NCL, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704082 | UBE2V2, Human (sf9, His,strep) | Recombinant Proteins | |
| HY-P704083 | UBE2V2, Human | Recombinant Proteins | |
| HY-P704084 | UBE2V2, Human (sf9) | Recombinant Proteins | |
| HY-P704085 | IDH1, Human (R132H, His) | Recombinant Proteins | |
| HY-P704086 | IDH1, Human (His) | Recombinant Proteins | |
| HY-P704087 | KLRG1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704088 | AKT1, Human (S473D, sf9, His, GST) | Recombinant Proteins | |
| HY-P704089 | GNAI2, Mouse (His) | Recombinant Proteins | |
| HY-P70409 | Erythropoietin/EPO, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704090 | IgG2 Fc, Human (HEK293) | Recombinant Proteins | |
| HY-P704092 | VEGF206, Human (His) | Recombinant Proteins | |
| HY-P704093 | DDR1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704094 | APJ-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P704095 | SARS-COV-2 S trimer (BA.2, HEK293, His) | Recombinant Proteins | |
| HY-P704096 | VAV1, Human (GST) | Recombinant Proteins | |
| HY-P704097 | HDAC11, Human (His) | Recombinant Proteins | |
| HY-P704098 | MLC1, Chicken | Recombinant Proteins | |
| HY-P704099 | Serum Albumin/ALB, Chicken (His, Myc) | Recombinant Proteins | |
| HY-P7040A | IL-3, Human (CHO) | Recombinant Proteins | |
| HY-P7041 | IL-33, Human | Recombinant Proteins | |
| HY-P70410 | MGAT2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704100 | AADAC, Human (His) | Recombinant Proteins | |
| HY-P704102 | VAT1L, Human (His) | Recombinant Proteins | |
| HY-P704103 | CD3D-CD3E Heterodimer, Cynomolgus (HEK293, His, flag) | Recombinant Proteins | |
| HY-P704104 | HSP90AA1, Human (sf9, His) | Recombinant Proteins | |
| HY-P704105 | MYL12A, Human (His) | Recombinant Proteins | |
| HY-P704106 | MYL9, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P704107 | MYL12B, Human (His) | Recombinant Proteins | |
| HY-P704108 | DPEP3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704109 | KAAG1, Human (His) | Recombinant Proteins | |
| HY-P70411 | Hyaluronidase-1/HYAL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704110 | Mucin-13, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704111 | HA/Hemagglutinin, H1N1 (EPI2397519, sf9, His) | Recombinant Proteins | |
| HY-P704112 | CCR8-VLP, Human (Flag, His, Strep) | Recombinant Proteins | |
| HY-P704113 | HA/Hemagglutinin, H3N2 (HEK293, His) | Recombinant Proteins | |
| HY-P704114 | HA/Hemagglutinin , Influenza B (EPI1868375, HEK293,His) | Recombinant Proteins | |
| HY-P704115 | ITPRIPL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704116 | EDNRA, Human (His) | Recombinant Proteins | |
| HY-P704117 | SLC34A2, Human (HEK293, His, mFc) | Recombinant Proteins | |
| HY-P704118 | ADAMTS14, Human (His) | Recombinant Proteins | |
| HY-P704119 | PLGF-3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70411A | Hyaluronidase-1/HYAL1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70412 | Follistatin-like 1/FSTL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704120 | LGR4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704121 | MAOB, Human (Sf9, His) | Recombinant Proteins | |
| HY-P704122 | MAOA, Human (Active, Sf9, His) | Recombinant Proteins | |
| HY-P704123 | NR3C1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704124 | LYPD1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704125 | SMN1, Human (His) | Recombinant Proteins | |
| HY-P704126 | NODAL, Human | Recombinant Proteins | |
| HY-P704127 | MASP1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704128 | PDE4A, Human (Sf9, His) | Recombinant Proteins | |
| HY-P704129 | "SEZ6L2/BSRP-A, Human (Biotinylated, HEK293, His, Avi) " | Recombinant Proteins | |
| HY-P70413 | MPF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704130 | IL-22, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P704131 | MMP-14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704132 | CBX5, Human (His, Myc) | Recombinant Proteins | |
| HY-P704133 | IL-22, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P704134 | IL-22, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P704135 | FGF-1, Human (Biotinylated, His, Avi) | Recombinant Proteins | |
| HY-P704136 | ALK-7, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704137 | ALK-7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704138 | LRG1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P704139 | LSR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70414 | LSAMP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704140 | IL-6, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704141 | Cadherin-17, Human (105a.a, HEK293, mFc) | Recombinant Proteins | |
| HY-P704142 | CD79, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704143 | NPR1/NPRA, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704144 | IL-22, Pig (HEK293, His) | Recombinant Proteins | |
| HY-P704145 | CEACAM6, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704146 | IL-31R alpha, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704147 | Cadherin-6/KCAD, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704148 | FABP3, Human | Recombinant Proteins | |
| HY-P704149 | ALK-7, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P70415 | EIF4EBP1, Human (His) | Recombinant Proteins | |
| HY-P704150 | ROBO1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704151 | TRBC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704152 | TRBC2, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704153 | TRBC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704154 | TRDC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704155 | TMEM119, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P704156 | EMAP-II, Human (His) | Recombinant Proteins | |
| HY-P704157 | RNF182, Human (His) | Recombinant Proteins | |
| HY-P704158 | SLC1A5, Human (HEK293, His, TrxA) | Recombinant Proteins | |
| HY-P704159 | STEAP1, Human (HEK293, His, Twin-Strep) | Recombinant Proteins | |
| HY-P70416 | EIF4EBP2, Human (His) | Recombinant Proteins | |
| HY-P704160 | Gremlin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704161 | PADI3, Human (Sf9, His) | Recombinant Proteins | |
| HY-P704162 | OLFML3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704163 | NPTX2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704164 | Neurogranin, Human (His) | Recombinant Proteins | |
| HY-P704165 | PLD6, Human | Recombinant Proteins | |
| HY-P704166 | ATP6, Human (His) | Recombinant Proteins | |
| HY-P704167 | FGF-20, Mouse (His) | Recombinant Proteins | |
| HY-P704168 | MARCHF1, Human (His) | Recombinant Proteins | |
| HY-P704169 | SLC25A4, Human (His) | Recombinant Proteins | |
| HY-P70417 | GAMT, Human (His) | Recombinant Proteins | |
| HY-P704170 | Integrin alpha V beta 7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704171 | Integrin alpha V beta 7, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704172 | TYK2, Human (Active, sf9, His) | Recombinant Proteins | |
| HY-P704173 | FLT3 Ligand, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704174 | EphA2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P704175 | Glypican-4/GPC4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704176 | NTN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704177 | KRAS, Human (Active, G13D, His) | Recombinant Proteins | |
| HY-P704178 | Mucin-1/MUC1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704179 | P5CS, Human | Recombinant Proteins | |
| HY-P70418 | UDP-glucose 4-epimerase/GALE, Human (His) | Recombinant Proteins | |
| HY-P704180 | SLC16A3, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P704181 | Decorin/PGS2, Bovine (His) | Recombinant Proteins | |
| HY-P704182 | SPRR4, Mouse (His) | Recombinant Proteins | |
| HY-P704183 | ATP2A1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P704184 | ZBP1, Mouse (HEK293, His, Flag) | Recombinant Proteins | |
| HY-P704185 | Gastrin-71, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704187 | AHR, Human (His) | Recombinant Proteins | |
| HY-P704188 | ZBP1, Human (His, Myc) | Recombinant Proteins | |
| HY-P704189 | SLC39A1, Human (GST) | Recombinant Proteins | |
| HY-P70419 | LRRC32, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704190 | DOT1L, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P704191 | SLC40A1, Human (HEK293) | Recombinant Proteins | |
| HY-P704192 | PLY, Streptococcus pneumoniae serotype 4 | Recombinant Proteins | |
| HY-P704193 | SOS1, (Active, sf9, His) | Recombinant Proteins | |
| HY-P704194 | GPBAR1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P704195 | CSNK1E, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P704196 | FOXC1, Human (C-His) | Recombinant Proteins | |
| HY-P704197 | EGFR, Human (L861Q, Active, sf9, GST) | Recombinant Proteins | |
| HY-P704198 | Zaire ebolavirus VP30 (His) | Recombinant Proteins | |
| HY-P704199 | PPP1CB, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P7042 | IL-4, Human (CHO) | Recombinant Proteins | |
| HY-P704200 | RIPK1, Mouse (C-His) | Recombinant Proteins | |
| HY-P704201 | IL-39, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704202 | VCAM-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704203 | Ara h 1, Arachis hypogaea (His) | Recombinant Proteins | |
| HY-P704204 | CDKN1A, Mouse (His) | Recombinant Proteins | |
| HY-P70421 | IL-23, Mouse (Sf9) | Recombinant Proteins | |
| HY-P70422 | G-CSF, Human | Recombinant Proteins | |
| HY-P70425 | IL-11 Protein, Human (P.pastoris) | Recombinant Proteins | |
| HY-P70426A | TNF alpha/TNFSF2, Human (His) | Recombinant Proteins | |
| HY-P70426AF | Animal-Free TNF-alpha/TNFSF2, Human (His) | Recombinant Proteins | |
| HY-P70426G | GMP TNF-alpha/TNFSF2, Human | Recombinant Proteins | |
| HY-P70428 | BAFF/TNFSF13B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7043 | IL-5, Human | Recombinant Proteins | |
| HY-P70433 | TGF beta 1/TGFB1 LAP, Human (HEK293) | Recombinant Proteins | |
| HY-P70434 | CD3D-CD3E Heterodimer, Human (HEK293, Fc-Flag&Fc-His) | Recombinant Proteins | |
| HY-P70439 | FGF-2, Mouse (154a.a) | Recombinant Proteins | |
| HY-P7043A | IL-5, Human (CHO) | Recombinant Proteins | |
| HY-P7044 | IL-6, Human | Recombinant Proteins | |
| HY-P70440 | FGF basic/bFGF, Human (157a.a) | Recombinant Proteins | |
| HY-P70440G | GMP FGF basic/bFGF, Human | Recombinant Proteins | |
| HY-P70445 | IL-4, Human | Recombinant Proteins | |
| HY-P70448 | Siglec-10, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70449 | Beta-NGF, Human (120a.a) | Recombinant Proteins | |
| HY-P7044A | IL-6, Human (CHO) | Recombinant Proteins | |
| HY-P7044AF | Animal-Free IL-6, Human (His) | Recombinant Proteins | |
| HY-P7044B | IL-6, Human (N-His) | Recombinant Proteins | |
| HY-P7044G | GMP IL-6, Human | Recombinant Proteins | |
| HY-P7045 | IL-7, Human | Recombinant Proteins | |
| HY-P70450 | RANTES/CCL5, Human | Recombinant Proteins | |
| HY-P70452 | Wnt3a, Mouse (His) | Recombinant Proteins | |
| HY-P70453A | Wnt3a, Human (His) | Recombinant Proteins | |
| HY-P70453B | Wnt3a Surrogate, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70453C | Wnt3a Surrogate, Human (HEK293, C-hFc) | Recombinant Proteins | |
| HY-P70453D | Wnt3a Surrogate, Human (HEK293, N-hFc) | Recombinant Proteins | |
| HY-P70454G | GMP IL-1 alpha, Human | Recombinant Proteins | |
| HY-P70455 | IL-37, Human | Recombinant Proteins | |
| HY-P70456 | Neurotrophin-3, Human | Recombinant Proteins | |
| HY-P70456AF | Animal-Free Neurotrophin-3, Human | Recombinant Proteins | |
| HY-P70457 | TROP-2, Human (248a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70458A | VEGF165, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7046 | IL-9, Human (CHO) | Recombinant Proteins | |
| HY-P70460 | IL-13, Mouse | Recombinant Proteins | |
| HY-P70461 | IL-3R alpha/CD123, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70463 | I-309/CCL1, Human | Recombinant Proteins | |
| HY-P70465 | OSM, Human (His) | Recombinant Proteins | |
| HY-P70465G | GMP OSM, Human (His) | Recombinant Proteins | |
| HY-P70466 | PVRIG, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70467 | SHH, Human | Recombinant Proteins | |
| HY-P70468 | IL-3R alpha/CD123, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70469 | SDF-1 alpha/CXCL12, Human | Recombinant Proteins | |
| HY-P70470 | GAS6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70471 | RBP4, Human | Recombinant Proteins | |
| HY-P70473 | FGF-21, Human (His) | Recombinant Proteins | |
| HY-P70473AF | Animal-Free FGF-21, Human (His) | Recombinant Proteins | |
| HY-P70475 | IL-33, Human (His) | Recombinant Proteins | |
| HY-P70475AF | Animal-Free IL-33, Human (His) | Recombinant Proteins | |
| HY-P70476 | CD200, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70478 | Fc gamma RIIA/CD32a, Human (183a.a, H167R, HEK293, His) | Recombinant Proteins | |
| HY-P7047A | KGF/FGF-7, Human (CHO) | Recombinant Proteins | |
| HY-P7048 | KGF-2/FGF-10, Human (169a.a) | Recombinant Proteins | |
| HY-P70482 | TIM-3/HAVCR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70483 | IFNAR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70484 | SIRP alpha/CD172a, Human (CAA71403, HEK293, His) | Recombinant Proteins | |
| HY-P70485 | Vitronectin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70485G | GMP Vitronectin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70486 | CD28, Human/Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P70487 | Glypican-3/GPC3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70487G | GMP Glypican-3/GPC3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70488 | M-CSF, Human (223a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70489 | HVEM/TNFRSF14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7049 | LIF, Human | Recombinant Proteins | |
| HY-P70491 | Fc gamma RIIB/CD32b, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70492 | CD73/5'-Nucleotidase, Human (T376A, M379T, HEK293, His) | Recombinant Proteins | |
| HY-P70493 | M-CSF, Rat (HEK293) | Recombinant Proteins | |
| HY-P70494 | Nectin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70495 | VEGF-DD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70496 | Semaphorin-5A/SEMA5A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70497 | CD7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70498 | Serpin F1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70498A | Serpin F1, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P70499 | Osteopontin/OPN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7050 | M-CSF, Human | Recombinant Proteins | |
| HY-P70500 | Transthyretin/TTR, Human (127a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70501 | VEGF-CC, Human (196a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70502 | Vanin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70503 | VSIG2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70504 | Adiponectin/Acrp30, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70505 | CD19, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70506 | CD3 epsilon, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70507 | CD44, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70508 | GRO-alpha/CXCL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70509 | PRTN3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70509A | PRTN3, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7050A | M-CSF, Human (CHO) | Recombinant Proteins | |
| HY-P70510 | SAA1, Human (His) | Recombinant Proteins | |
| HY-P70511 | TFF1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70512 | TPBG/5T4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70513 | DKK-1, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P70515 | IL-6R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70516 | TNF RII/TNFRSF1B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70517 | IL-10, Mouse | Recombinant Proteins | |
| HY-P70519 | VEGF121, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7051A | Noggin, Human (CHO) | Recombinant Proteins | |
| HY-P7052 | OSM, Human (227a.a) | Recombinant Proteins | |
| HY-P70524 | NRG1-beta 1, Human (245a.a) | Recombinant Proteins | |
| HY-P70525 | PD-1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70527 | IL-17A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70528 | SCF, Mouse | Recombinant Proteins | |
| HY-P70528AF | Animal-Free SCF, Mouse | Recombinant Proteins | |
| HY-P7052A | OSM, Human (209a.a) | Recombinant Proteins | |
| HY-P7052B | "OSM, Human (227a.a, His) " | Recombinant Proteins | |
| HY-P7053 | TNFRSF11B/OPG, Human (CHO, Fc) | Recombinant Proteins | |
| HY-P70530 | Beta-NGF, Mouse (110a.a) | Recombinant Proteins | |
| HY-P70530A | Beta-NGF, Mouse (110a.a, His) | Recombinant Proteins | |
| HY-P70531 | S100A8, Human (C-His) | Recombinant Proteins | |
| HY-P70531A | S100A8, Human (N-His) | Recombinant Proteins | |
| HY-P70532 | S100A9, Human | Recombinant Proteins | |
| HY-P70532A | S100A9, Human (His) | Recombinant Proteins | |
| HY-P70533 | FGF-8b, Human/Mouse | Recombinant Proteins | |
| HY-P70534 | TREM-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70535 | Galectin-9/LGALS9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70536 | TNF RII/TNFRSF1B, Human (183a.a, HEK293, mFc) | Recombinant Proteins | |
| HY-P70537 | CD4, Human (365a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70538 | Rnase 3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70539 | IL-9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7054 | PEDF, Human | Recombinant Proteins | |
| HY-P70540 | IL-17F, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70541 | CD79B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70542 | Noggin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70543 | TGF beta 1/TGFB1, Human (HEK293) | Recombinant Proteins | |
| HY-P70543G | GMP TGF beta 1/TGFB1, Human (CHO) | Recombinant Proteins | |
| HY-P70544 | FLT3LG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70544G | GMP FLT3LG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70545 | PCSK9, Human (HEK293, V474I, G670E, His) | Recombinant Proteins | |
| HY-P70545A | PCSK9, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70546 | PCSK9, Human (Biotinylated, V474I, G670E, HEK293, His-HA-Avi) | Recombinant Proteins | |
| HY-P70547 | PD-1, Cynomolgus (143a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P70548 | PSMA, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70548A | PSMA, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P70549 | OX40/TNFRSF4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7055 | PDGF-BB, Human | Recombinant Proteins | |
| HY-P70550 | CD137/4-1BB, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P70551 | NKG2A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70552 | VEGFR-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70553 | M-CSF, Mouse (HEK293) | Recombinant Proteins | |
| HY-P70554 | G-CSF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70555 | SCF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70556 | IL-2R gamma/CD132, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70557 | RSPO3/R-spondin-3, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P70558 | Noggin, Human (HEK293) | Recombinant Proteins | |
| HY-P70558G | GMP Noggin, Human (HEK293) | Recombinant Proteins | |
| HY-P7055A | PDGF-BB, Human (P.pastoris) | Recombinant Proteins | |
| HY-P7055B | PDGF-BB, Human (His) | Recombinant Proteins | |
| HY-P7055G | GMP PDGF-BB, Human | Recombinant Proteins | |
| HY-P7056 | SCF, Human (P.pastoris) | Recombinant Proteins | |
| HY-P70560 | Siglec-2/CD22, Human (668a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P70561 | HGF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70562 | NKp46/NCR1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70563 | FLT3LG, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70564 | PD-L1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70566 | IL-7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70567 | GM-CSF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70567G | GMP GM-CSF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70568 | IL-13, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70569 | IL-8/CXCL8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7057 | TSLP, Human | Recombinant Proteins | |
| HY-P70570 | HMGB1/HMG-1, Human | Recombinant Proteins | |
| HY-P70571 | TNF-alpha/TNFSF2, Mouse (147a.a) | Recombinant Proteins | |
| HY-P70573 | IRF5, Human | Recombinant Proteins | |
| HY-P70574 | STAT3, Human (His) | Recombinant Proteins | |
| HY-P70576 | IL-3, Human (His) | Recombinant Proteins | |
| HY-P70576AF | Animal-Free IL-3, Human (His) | Recombinant Proteins | |
| HY-P70576G | GMP IL-3, Human (His) | Recombinant Proteins | |
| HY-P70577 | SNCA, Human | Recombinant Proteins | |
| HY-P70578 | Amphiregulin, Human | Recombinant Proteins | |
| HY-P70579 | MICA, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7058 | TNF-alpha/TNFSF2, Human | Recombinant Proteins | |
| HY-P70581 | MYDGF, Human (His) | Recombinant Proteins | |
| HY-P70583 | FGF-19, Human (His) | Recombinant Proteins | |
| HY-P70583AF | Animal-Free FGF-19, Human (His) | Recombinant Proteins | |
| HY-P70584 | Serpin F1, Mouse (375a.a) | Recombinant Proteins | |
| HY-P70586 | IL-1beta, Human (solution) | Recombinant Proteins | |
| HY-P70586G | GMP IL-1 beta, Human | Recombinant Proteins | |
| HY-P70587 | IL-17D, Human | Recombinant Proteins | |
| HY-P70589 | Tau-F/2N4R, Human | Recombinant Proteins | |
| HY-P7058A | TNF-alpha/TNFSF2, Human (P.pastoris) | Recombinant Proteins | |
| HY-P70590 | EGF, Mouse (His) | Recombinant Proteins | |
| HY-P70590A | EGF, Mouse (N-His) | Recombinant Proteins | |
| HY-P70590AF | Animal-Free EGF, Mouse (His) | Recombinant Proteins | |
| HY-P70591 | IL-18, Human | Recombinant Proteins | |
| HY-P70591A | IL-18, Human (N-His) | Recombinant Proteins | |
| HY-P70591G | GMP IL-18, Human | Recombinant Proteins | |
| HY-P70593 | Fibronectin, Human | Recombinant Proteins | |
| HY-P70593G | GMP Fibronectin, Human | Recombinant Proteins | |
| HY-P70597 | KGF/FGF-7, Human | Recombinant Proteins | |
| HY-P70597G | GMP KGF/FGF-7, Human | Recombinant Proteins | |
| HY-P70598 | PDGF-AA, Human | Recombinant Proteins | |
| HY-P70599 | PKM2, Human (530a.a, His) | Recombinant Proteins | |
| HY-P7060 | NT 13 | 117928-93-5 | Peptides |
| HY-P70600 | FGF basic/bFGF, Human (K128N, solution) | Recombinant Proteins | |
| HY-P70600A | FGF basic/bFGF, Human (K128N) | Recombinant Proteins | |
| HY-P70601 | FCRN-B2M, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70602 | CCN2/CTGF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70603 | IL-1RL2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70604 | IL-23, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P70606 | Kallikrein-3/PSA Protein, Human (237a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70608 | EGFR vIII, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70609 | CD40L/CD154/TRAP, Human (HEK293) | Recombinant Proteins | |
| HY-P70609G | GMP CD40L/CD154/TRAP, Human (HEK293) | Recombinant Proteins | |
| HY-P7061 | ALX 40-4C | 143413-49-4 | Peptides |
| HY-P70610 | IFN-gamma, Human (HEK293) | Recombinant Proteins | |
| HY-P70610G | GMP IFN-gamma, Human (HEK293) | Recombinant Proteins | |
| HY-P70612 | IL-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70613 | EGFR, Human (621a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70614 | CD28, Mouse (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P70615 | ST2/IL1RL1, Human (310a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70616 | Nectin-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70617 | IL-12 beta, Human (HEK293) | Recombinant Proteins | |
| HY-P70618 | PF-4/CXCL4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7061A | ALX 40-4C (Trifluoroacetate) | Peptides | |
| HY-P7062 | IL-3, Mouse | Recombinant Proteins | |
| HY-P70620 | Transferrin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70622 | OX40 Ligand/TNFSF4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70623 | GM-CSF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70624 | TIGIT, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70625 | IL-1RL2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70626 | TSLP, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70627 | HGF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70627G | GMP HGF , Human (HEK293, His) | Recombinant Proteins | |
| HY-P70628 | IL-2R alpha/CD25, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7062A | IL-3, Mouse | Recombinant Proteins | |
| HY-P7063 | IL-6, Mouse | Recombinant Proteins | |
| HY-P70631 | IL-2R beta/CD122, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70632 | PD-L1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70633 | PD-L1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70635 | VEGFR-2, Human (745a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P70636 | VEGFR-1, Human (730a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P70637 | TPO/Thrombopoietin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70637A | TPO/Thrombopoietin, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70637G | GMP TPO/Thrombopoietin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70638 | VEGF164, Rat (P.pastoris) | Recombinant Proteins | |
| HY-P70639 | PD-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7063A | IL-6, Mouse (His) | Recombinant Proteins | |
| HY-P7064 | SCF, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P70640 | PD-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70642 | IL-18, Mouse (His) | Recombinant Proteins | |
| HY-P70642AF | Animal-Free IL-18, Mouse (His) | Recombinant Proteins | |
| HY-P70643 | IL-21, Mouse (122a.a) | Recombinant Proteins | |
| HY-P70644 | IL-4, Mouse | Recombinant Proteins | |
| HY-P70646AF | Animal-Free IL-2, Mouse (His) | Recombinant Proteins | |
| HY-P70647 | IL-12R beta 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70648 | TGF beta 1/TGFB1, Mouse/Rat (HEK293) | Recombinant Proteins | |
| HY-P70649 | TGF beta 2/TGFB2, Mouse/Rat (HEK293) | Recombinant Proteins | |
| HY-P7065 | FGF-1, Mouse | Recombinant Proteins | |
| HY-P70651 | B7-1/CD80, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70652 | CD276/B7-H3, Human (433a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70653 | IL-4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70655 | IL-15R alpha & IL-15, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70656 | FCRN-B2M, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70657 | PD-L1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70658 | Lipocalin-2/NGAL, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70658A | Lipocalin-2/NGAL, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P70659 | S100B, Human (His) | Recombinant Proteins | |
| HY-P7066 | FGF-2, Mouse (145a.a) | Recombinant Proteins | |
| HY-P70660 | SNCA, Mouse | Recombinant Proteins | |
| HY-P70663 | PD-L1, Human (HEK293, Flag) | Recombinant Proteins | |
| HY-P70664 | Irisin, Human/Mouse/Rat (HEK293, His) | Recombinant Proteins | |
| HY-P70665 | Irisin, Human/Mouse/Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P70666 | IL-12, Mouse (HEK293) | Recombinant Proteins | |
| HY-P70667 | IFN-gamma, Mouse (HEK293) | Recombinant Proteins | |
| HY-P70668 | IFN-gamma, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70669 | CD64, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7067 | EGF, Mouse | Recombinant Proteins | |
| HY-P70670 | IL-36 gamma/IL-1F9, Human | Recombinant Proteins | |
| HY-P70672 | PD-L1, Human (221a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P70673 | KGF/FGF-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70674 | MBL2/COLEC1, Mouse (HEK293) | Recombinant Proteins | |
| HY-P70675 | CEACAM5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70676 | PD-1, Cynomolgus (147a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70677 | TIGIT, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70678 | 4-1BB/TNFRSF9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70679 | IDO-1, Human (His) | Recombinant Proteins | |
| HY-P7068 | G-CSF, Mouse (CHO) | Recombinant Proteins | |
| HY-P70680 | IL-23R, Human (330a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P70681 | 4-1BB/TNFRSF9, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70682 | CD3 epsilon, Human (104a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P70683 | GITR, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P70684 | CTLA-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70685 | IL-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70686 | TPO/Thrombopoietin, Mouse (335a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70686A | TPO/Thrombopoietin, Mouse (335a.a, HEK293, C-His) | Recombinant Proteins | |
| HY-P70687 | NCAM-1/CD56, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70688 | NKG2D/CD314, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7069 | GM-CSF, Mouse (CHO) | Recombinant Proteins | |
| HY-P70691 | CTLA-4, Human (HEK293, GST) | Recombinant Proteins | |
| HY-P70692 | IL-10R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70693 | IL-2R gamma/CD132, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70694 | FGF-4, Human (153a.a) | Recombinant Proteins | |
| HY-P70696 | Galectin-9/LGALS9, Human (GST) | Recombinant Proteins | |
| HY-P70697 | TNF-alpha/TNFSF2, Rat | Recombinant Proteins | |
| HY-P70698 | IGF-I/IGF-1, Mouse (His) | Recombinant Proteins | |
| HY-P70698A | IGF-I/IGF-1, Mouse (N-His) | Recombinant Proteins | |
| HY-P70698AF | Animal-Free IGF-I/IGF-1, Mouse (His) | Recombinant Proteins | |
| HY-P70699 | PDGF-BB, Mouse (His) | Recombinant Proteins | |
| HY-P70699A | PDGF-BB, Mouse (C-His) | Recombinant Proteins | |
| HY-P7070 | IGF-I/IGF-1, Mouse | Recombinant Proteins | |
| HY-P70700 | TMEM173, Human (Sumo-His) | Recombinant Proteins | |
| HY-P70700A | TMEM173, Human (N-Sumo-His) | Recombinant Proteins | |
| HY-P70701 | Claudin-18/CLDN18.2, Human (His) | Recombinant Proteins | |
| HY-P70702 | IL-36 alpha/IL-1F6, Human | Recombinant Proteins | |
| HY-P70703 | TSLP, Cynomolgus (His) | Recombinant Proteins | |
| HY-P70704 | Leptin, Mouse | Recombinant Proteins | |
| HY-P70704A | Leptin, Mouse (His) | Recombinant Proteins | |
| HY-P70705 | Fc gamma RIIIA/CD16a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70706 | CTLA-4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70708 | Fc gamma RIII/CD16, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70709 | IL-23, Mouse (HEK293) | Recombinant Proteins | |
| HY-P7071 | IFN-gamma, Mouse | Recombinant Proteins | |
| HY-P70710 | IL-4R alpha/CD124, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70711 | Fc gamma RIIA/CD32a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70712 | IL-4R alpha/CD124, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70713 | NKG2A-CD94 Heterodimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P70714 | HGFR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70715 | HGFR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70716 | TREM-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70717 | SOST, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70718 | IL-2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P70719 | SIRP beta 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7072 | IL-1 alpha, Mouse | Recombinant Proteins | |
| HY-P70720 | CD24, Human (S44T, HEK293, Fc) | Recombinant Proteins | |
| HY-P70721 | PD-L1, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P70722 | LAG-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70723 | LAG-3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70724 | Thrombomodulin, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70724A | Thrombomodulin, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70725 | THBS1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70726 | IGFBP-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70727 | CD39, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70728 | TROP-2, Human (187a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7073 | IL-1 beta, Mouse | Recombinant Proteins | |
| HY-P70730 | BAFF/TNFSF13B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70731 | CD38, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70731A | CD38, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70732 | ROR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70733 | APRIL/TNFSF13 Trimer , Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P70733A | APRIL/TNFSF13 Trimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P70734 | PD-L2, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70735 | LAG-3, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70736 | IL-23, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70737 | FGL1, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70737A | FGL1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70738 | Siglec-15, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70739 | Siglec-9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7073A | IL-1 beta, Mouse (CHO) | Recombinant Proteins | |
| HY-P70740 | FGL1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70740A | FGL1, Human (HEK293, mFc, solution) | Recombinant Proteins | |
| HY-P70742 | Siglec-15, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70743 | Siglec-15, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70744 | Siglec-15, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70745 | Prolactin, Sheep (HEK293, His) | Recombinant Proteins | |
| HY-P70746 | IL-5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70748 | IL-1RL2 Protein, Mouse (A158V, HEK293, His) | Recombinant Proteins | |
| HY-P70749 | PLGF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7074A | IL-10, Mouse (CHO) | Recombinant Proteins | |
| HY-P70750 | IL-4, Human (HEK293) | Recombinant Proteins | |
| HY-P70750G | GMP IL-4, Human (HEK293) | Recombinant Proteins | |
| HY-P70751 | IL-10, Human (HEK293) | Recombinant Proteins | |
| HY-P70752 | CD99, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70753 | IL-17A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70754 | CD300a/LMIR1, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P70755 | IL-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70755G | GMP IL-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70756 | SOST, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70757 | SCF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70757G | GMP SCF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70758 | IL-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70758G | GMP IL-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70759 | HER2/CD340, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7075A | IL-11, Mouse (HEK293) | Recombinant Proteins | |
| HY-P70760 | IL-18, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70760G | GMP IL-18, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70761 | VEGF164, Mouse (164a.a, P.pastoris) | Recombinant Proteins | |
| HY-P70763 | IgG1, Mouse (HEK293) | Recombinant Proteins | |
| HY-P70764 | IL-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70765 | IL-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70766 | PD-1, Human (147a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70767 | Siglec-15, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P70768 | CD79B, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70769 | ACE2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7076A | IL-13, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P7077 | IL-2, Mouse | Recombinant Proteins | |
| HY-P70770 | TROP-2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P70771 | IgG4 Fc, Human (HEK293) | Recombinant Proteins | |
| HY-P70775 | IL-2 Protein, Human (C145S) | Recombinant Proteins | |
| HY-P70776G | GMP IL-15, Human | Recombinant Proteins | |
| HY-P70778 | BCMA/TNFRSF17, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70779 | IL-13, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P7078 | IL-21, Mouse (129a.a) | Recombinant Proteins | |
| HY-P70780 | GAS6, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70780A | GAS6, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70781 | SCF, Human | Recombinant Proteins | |
| HY-P70783 | LR3 IGF-I/IGF-1, Human (83a.a, E51R) | Recombinant Proteins | |
| HY-P70783G | GMP LR3 IGF-I/IGF-1, Human (83a.a, E51R) | Recombinant Proteins | |
| HY-P70785 | Noggin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70788 | IGF-I/IGF-1, Human (G49-A118) | Recombinant Proteins | |
| HY-P7079 | IL-22, Mouse | Recombinant Proteins | |
| HY-P70790 | EphB2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70791 | ER beta/ESR2, Human (His) | Recombinant Proteins | |
| HY-P70792 | PLGF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70793 | TrkB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70794 | TSLP R, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70795 | B7-2/CD86, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70796 | IgG1, Human (D239E, L241M, HEK293) | Recombinant Proteins | |
| HY-P70796A | IgG1 Protein, Human (D239E, L241E, HEK293) | Recombinant Proteins | |
| HY-P70797 | Semaphorin-3A/SEMA3A, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P70799 | PD-1, Human (C93S, HEK293, His) | Recombinant Proteins | |
| HY-P7079A | IL-22, Mouse (His) | Recombinant Proteins | |
| HY-P7079AF | Animal-Free IL-22, Mouse (His) | Recombinant Proteins | |
| HY-P7080 | IL-4, Mouse (CHO) | Recombinant Proteins | |
| HY-P70800 | TNF-alpha/TNFSF2, Rabbit | Recombinant Proteins | |
| HY-P70801 | TNFRSF1A, Human (His) | Recombinant Proteins | |
| HY-P70803 | P-selectin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70805 | TNFRSF11B/OPG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70806 | TRAIL R2/TNFRSF10B, Human (127a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70807 | PVR/CD155, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70808 | CD40L/CD154/TRAP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70809 | CD24, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7081 | IL-5, Mouse | Recombinant Proteins | |
| HY-P70810 | Carbonic Anhydrase 14, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70811 | IL-13, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70812 | TIM-3/HAVCR2, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P70813 | OX40/TNFRSF4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70815 | TNFRSF10C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70816 | BAFF/TNFSF13B, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70817 | FGFR-3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70818 | TSLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7081A | IL-5, Mouse (CHO) | Recombinant Proteins | |
| HY-P7082 | IL-7, Mouse (CHO) | Recombinant Proteins | |
| HY-P70820 | CD47, Mouse (140a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70821 | TRAIL R2/TNFRSF10B, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P70822 | GITR, Human (T45A, HEK293, mFc) | Recombinant Proteins | |
| HY-P70823 | TSLPR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70824 | CD3 epsilon 1-27 peptide, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70825 | PDGF-AA, Human (His) | Recombinant Proteins | |
| HY-P70826 | TIM-3/HAVCR2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70827 | BCMA/TNFRSF17, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P70829 | DNAM-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7083 | IL-9, Mouse (CHO) | Recombinant Proteins | |
| HY-P70830 | Cathepsin B, Human (His) | Recombinant Proteins | |
| HY-P70831 | GALNT3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70832 | HABP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70833 | INSL4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70834 | INPP5A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70835 | GNMT, Human (His) | Recombinant Proteins | |
| HY-P70836 | GPNMB/Osteoactivin, Human (465a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70837 | KPNB1, Human (His) | Recombinant Proteins | |
| HY-P70838 | HEPACAM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70839 | MORF4L2, Human (His) | Recombinant Proteins | |
| HY-P7084 | LIF, Mouse | Recombinant Proteins | |
| HY-P70840 | KARS, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70841 | HER4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70842 | EphA7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70843 | NEDD8, Human | Recombinant Proteins | |
| HY-P70844 | HSPB2, Human (His) | Recombinant Proteins | |
| HY-P70845 | MOG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70845A | MOG, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70846 | MIA, Human (His) | Recombinant Proteins | |
| HY-P70846A | MIA, Human (N-His) | Recombinant Proteins | |
| HY-P70847 | IA2, Human (293a.a, His, solution) | Recombinant Proteins | |
| HY-P70847A | IA2, Human (293a.a, N-His) | Recombinant Proteins | |
| HY-P70848 | IA2, Human (His) | Recombinant Proteins | |
| HY-P70849 | IZUMO4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7085 | M-CSF, Mouse | Recombinant Proteins | |
| HY-P70850 | Growth Hormone R/GHR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70851 | LGALSL, Human (His) | Recombinant Proteins | |
| HY-P70852 | MAdCAM1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70853 | LACTB2, Human (GST) | Recombinant Proteins | |
| HY-P70854 | IGSF11, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70855 | MARCO, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70856 | Mesothelin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70857 | HER3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70858 | IGFBP-7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70859 | Follistatin-like 1/FSTL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7085A | M-CSF, Mouse (CHO) | Recombinant Proteins | |
| HY-P7086 | Noggin, Mouse (CHO) | Recombinant Proteins | |
| HY-P70860 | IL-11R alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70861 | GABARAP, Human (GST) | Recombinant Proteins | |
| HY-P70862 | METAP1D/Methionine aminopeptidase 1D, Human (His) | Recombinant Proteins | |
| HY-P70863 | IDO-2, Human (His) | Recombinant Proteins | |
| HY-P70864 | ILDR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70865 | IMPA3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70866 | Kirrel1/NEPH1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70867 | GALNT7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70868 | LYG2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70869 | TMPRSS11B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7087 | PDGF-BB, Mouse | Recombinant Proteins | |
| HY-P70870 | MDP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70871 | LAIR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70872 | Glypican-3/GPC3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70873 | GPIHBP1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70874 | MGL2/CD301b, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70875 | LILRA2/CD85h/ILT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70876 | LRRC25, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70877 | GALNTL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70878 | EDIL3, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70878A | EDIL3, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70879 | GOLM1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7088 | TPO/Thrombopoietin, Mouse (CHO) | Recombinant Proteins | |
| HY-P70880 | Nectin-4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70881 | FCGRT-B2M Heterodimer, Cynomolgus (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P70882 | FAM172A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70883 | Kallikrein-7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70884 | Hemopexin, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P70884A | Hemopexin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70885 | FAM3C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70886 | NDRG1, Human (His) | Recombinant Proteins | |
| HY-P70887 | Kallikrein-6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70888 | GCDH, Human (His) | Recombinant Proteins | |
| HY-P70889 | ESAM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7088A | TPO/Thrombopoietin, Mouse (HEK293) | Recombinant Proteins | |
| HY-P70890 | FAM3D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70891 | ERP27, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70892 | IL-17RA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70893 | ERO1L, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70894 | LRRC3B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70896 | ERMAP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70897A | Legumain, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P70898 | KLF6, Human | Recombinant Proteins | |
| HY-P70899 | GPA33, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7089A | TRAIL/TNFSF10, Mouse (His) | Recombinant Proteins | |
| HY-P7089AF | Animal-Free TRAIL/TNFSF10, Mouse (His) | Recombinant Proteins | |
| HY-P7090 | TNF-alpha/TNFSF2, Mouse (156a.a) | Recombinant Proteins | |
| HY-P70900 | EpCAM/TROP1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70901 | TXNDC4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70902 | GGACT, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70903 | IDI2, Human (His) | Recombinant Proteins | |
| HY-P70903A | IDI2, Human (C-His) | Recombinant Proteins | |
| HY-P70904 | ITPase, Human (His) | Recombinant Proteins | |
| HY-P70905 | EPT1, Human (GST) | Recombinant Proteins | |
| HY-P70906 | HCFC2, Mouse (His) | Recombinant Proteins | |
| HY-P70907 | Envelope glycoprotein gp120, HIV (Q9DKG6, HEK293, His) | Recombinant Proteins | |
| HY-P70908 | EXTL2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70909 | MAP1LC3B, Human | Recombinant Proteins | |
| HY-P7090A | TNF-alpha/TNFSF2, Mouse (P. pastoris) | Recombinant Proteins | |
| HY-P7091 | FGF-2, Rat | Recombinant Proteins | |
| HY-P70910 | EIF5A2, Human (His) | Recombinant Proteins | |
| HY-P70911 | Lacritin, Human (His) | Recombinant Proteins | |
| HY-P70912 | HDHD2, Human (His) | Recombinant Proteins | |
| HY-P70913 | GABARAPL1/GEC-1, Human (His) | Recombinant Proteins | |
| HY-P70914 | LMAN2L, Human (295a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70915 | Frizzled-8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70916 | MAP1LC3A, Human (His) | Recombinant Proteins | |
| HY-P70917 | MOB1A, Human (His) | Recombinant Proteins | |
| HY-P70918 | FZD2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70919 | MYOZ2, Human (His) | Recombinant Proteins | |
| HY-P7092 | EGF, Rat | Recombinant Proteins | |
| HY-P70921 | MBIP, Human (His) | Recombinant Proteins | |
| HY-P70922 | NECAP2, Human (His) | Recombinant Proteins | |
| HY-P70923 | IL1RAPL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70924 | FLRT3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70925 | FLRT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70926 | LMCD1, Human (His) | Recombinant Proteins | |
| HY-P70927 | ESM-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70928 | Glypican-1/GPC1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70929 | HSPB7, Human (His) | Recombinant Proteins | |
| HY-P7092A | EGF, Rat (CHO) | Recombinant Proteins | |
| HY-P7092Y | EGF, Rat (Tag Free, Solution) | Recombinant Proteins | |
| HY-P70930 | Fetuin B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70931 | MAPKSP1, Human (His) | Recombinant Proteins | |
| HY-P70932 | HAO1, Human (Trx-His) | Recombinant Proteins | |
| HY-P70933 | HSPB8, Human (His) | Recombinant Proteins | |
| HY-P70934 | Kallikrein-13, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70935 | EPDR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70936 | EPCR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70937 | MINPP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70938 | ITM2B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70939 | Kallikrein-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70939A | Kallikrein-5, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7093A | G-CSF, Rat (HEK293) | Recombinant Proteins | |
| HY-P7094 | GM-CSF, Rat (CHO) | Recombinant Proteins | |
| HY-P70940 | MOB4, Human (His) | Recombinant Proteins | |
| HY-P70941 | FIS1, Human (His) | Recombinant Proteins | |
| HY-P70942 | HDGF2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70943 | HYOU1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70944 | LSM4, Human (His) | Recombinant Proteins | |
| HY-P70945 | HSPB11, Human (His) | Recombinant Proteins | |
| HY-P70946 | LRP-12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70947 | Kallikrein-4, Human (H197Q, HEK293, His) | Recombinant Proteins | |
| HY-P70948 | JAM-A/CD321, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70949 | FKBP7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7095 | IFN-gamma, Rat | Recombinant Proteins | |
| HY-P70950 | IGF2BP2, Human (T7-His) | Recombinant Proteins | |
| HY-P70951 | HVEM/TNFRSF14, Rhesus macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P70952 | IFNAR1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70953 | GFER, Human (His) | Recombinant Proteins | |
| HY-P70953A | GFER, Human (N-His) | Recombinant Proteins | |
| HY-P70954 | GM2A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70955 | GMPR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70956 | Kininogen-1, Human (409a.a, HEK293, His) | Recombinant Proteins | |
| HY-P70957 | MAN1B1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70958 | Mer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70959 | NANS, Human (His) | Recombinant Proteins | |
| HY-P7095A | IFN-gamma, Rat (CHO) | Recombinant Proteins | |
| HY-P7096 | IL-1 alpha, Rat (CHO) | Recombinant Proteins | |
| HY-P70960 | Siglec-5, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70961 | PVRIG, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P70962 | VISTA/B7-H5, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P70963 | SECTM1A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P70964 | PD-L2, Rhesus macaque/Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P70965 | Otolin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70966 | PCSK9, Macaca nemestrina (HEK293, His) | Recombinant Proteins | |
| HY-P70967 | NRG1-beta 1, Human (246a.a, His) | Recombinant Proteins | |
| HY-P70968 | OGG1, Human | Recombinant Proteins | |
| HY-P70969 | SULT1A1, Human (His) | Recombinant Proteins | |
| HY-P7097 | IL-1 beta, Rat | Recombinant Proteins | |
| HY-P70970 | Serpin B6, Human (Trx-His) | Recombinant Proteins | |
| HY-P70971 | QPRTase, Human (His) | Recombinant Proteins | |
| HY-P70972 | PNLIPRP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70973 | SHMT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70974 | SUMO2, Human (His) | Recombinant Proteins | |
| HY-P70975 | Serpin A5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70976 | TIM-4/TIMD-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70977 | SULT1B1, Human (His) | Recombinant Proteins | |
| HY-P70978 | Kappa-Casein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7097A | IL-1 beta, Rat (His) | Recombinant Proteins | |
| HY-P7098 | IL-10, Rat | Recombinant Proteins | |
| HY-P70980 | TPP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70981 | OBFC1, Human (His) | Recombinant Proteins | |
| HY-P70982 | WIF-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70983 | VISTA/B7-H5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70984 | PSG9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70985 | SAA2, Human (His) | Recombinant Proteins | |
| HY-P70986 | SP-D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70987 | PPP1R1A, Human (His) | Recombinant Proteins | |
| HY-P70988 | CD31/PECAM-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P70989 | TSLP R, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7098A | IL-10, Rat (CHO) | Recombinant Proteins | |
| HY-P70990 | PADI4, Human (His) | Recombinant Proteins | |
| HY-P70991 | PLRP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70992 | PEPD, Human | Recombinant Proteins | |
| HY-P70993 | PLA2G7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70994 | Vinculin, Human | Recombinant Proteins | |
| HY-P70995 | Syndecan-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P70997 | SUMO1, Human (His) | Recombinant Proteins | |
| HY-P70998 | UBE2D3, Human | Recombinant Proteins | |
| HY-P70999 | Vasorin, Human (552a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71000 | ZWINT/ZW10 interactor, Human (His) | Recombinant Proteins | |
| HY-P71001 | SULT1A2, Human (His) | Recombinant Proteins | |
| HY-P71002 | NRCAM, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71003 | RGMA, Human (His) | Recombinant Proteins | |
| HY-P71004 | PRAP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71005 | SLAMF9, Mouse (L224P, HEK293, His) | Recombinant Proteins | |
| HY-P71006 | VSIG4, Mouse (168a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71007 | TIGIT, Cynomolgus (HEK293, C-hFc) | Recombinant Proteins | |
| HY-P71008 | PD-L1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P71009 | TIGIT, Mouse (118a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P71010 | PSD95, Rat (His) | Recombinant Proteins | |
| HY-P71011A | SULT2B1, Human (311a.a, C-His) | Recombinant Proteins | |
| HY-P71012 | SULT1C2, Human (His) | Recombinant Proteins | |
| HY-P71013 | UPK2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71014 | Syntenin-1, Human (C-His) | Recombinant Proteins | |
| HY-P71014A | Syntenin-1, Human (N-His) | Recombinant Proteins | |
| HY-P71015 | RNASET2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71017 | TNFRSF11B/OPG, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71019 | PDCD5, Human (His) | Recombinant Proteins | |
| HY-P7102 | IL-5, Rat | Recombinant Proteins | |
| HY-P71020 | UBE2L6, Human (His) | Recombinant Proteins | |
| HY-P71021 | PMM2, Human (His) | Recombinant Proteins | |
| HY-P71022 | PP1MG, Human (His) | Recombinant Proteins | |
| HY-P71023 | Siglec-5, Human (HEK293, His-Flag-Fc) | Recombinant Proteins | |
| HY-P71024 | STX7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71025 | YKT6, Human (His) | Recombinant Proteins | |
| HY-P71026 | SDC4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71028 | ZNHIT1, Human (His) | Recombinant Proteins | |
| HY-P71029 | PPIH, Human (His) | Recombinant Proteins | |
| HY-P7102A | IL-5, Rat (CHO) | Recombinant Proteins | |
| HY-P71030 | TGOLN2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71031 | Siglec-6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71032 | Syntaxin-6, Human | Recombinant Proteins | |
| HY-P71033 | SGTA, Human (His) | Recombinant Proteins | |
| HY-P71034 | Persephin, Human | Recombinant Proteins | |
| HY-P71035 | SPINK4, Human (60a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71036 | HPGDS, Human | Recombinant Proteins | |
| HY-P71037 | ZG16, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71038 | SH2D1A, Human (His) | Recombinant Proteins | |
| HY-P71039 | Serpin I2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7103A | IL-6, Rat (HEK293) | Recombinant Proteins | |
| HY-P71040 | SCO1, Human (GST) | Recombinant Proteins | |
| HY-P71041 | ACAT2, Human (Trx-His) | Recombinant Proteins | |
| HY-P71042 | SCGN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71043 | SNCG, Human | Recombinant Proteins | |
| HY-P71044 | VAPB, Human (His) | Recombinant Proteins | |
| HY-P71045 | VNN2/Vanin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71046 | TXNDC12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71047 | ZBED1, Human (His) | Recombinant Proteins | |
| HY-P71048 | SOD1, Human (His) | Recombinant Proteins | |
| HY-P71048A | SOD1, Human (N-His) | Recombinant Proteins | |
| HY-P71049 | PGK1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71050 | PLAU/uPA, Human (411a.a, HEK293, His, solution) | Recombinant Proteins | |
| HY-P71051 | T-PA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71052 | Renin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71053 | SPINK1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71054 | Serpin A3, Human (K267R, HEK293, His) | Recombinant Proteins | |
| HY-P71055 | TIMP-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71056 | TGF beta 1/TGFB1, Human (Biotinylated, HEK293, N-Avi) | Recombinant Proteins | |
| HY-P71058 | PDYN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71059 | Prolactin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71060 | PTH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71061 | VIP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71062 | PPY, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71063 | NPY, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71065 | PIGR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71066 | PMP2, Human (His) | Recombinant Proteins | |
| HY-P71067 | Pentraxin 2/SAP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71068 | Vitamin D-binding/GC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71069 | TFRC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7107 | SCF, Rat (P.pastoris) | Recombinant Proteins | |
| HY-P71070 | TDT, Human (His) | Recombinant Proteins | |
| HY-P71071 | PLA2G1B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71072 | TFF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71073 | SOD2/Mn-SOD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71074 | Thymidine kinase 1/TK1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71075 | TUBB4A, Human (His) | Recombinant Proteins | |
| HY-P71076 | S100A8-S100A9 Heterodimer, Human (His, solution) | Recombinant Proteins | |
| HY-P71076A | S100A8-S100A9 Heterodimer, Human (C-6His) | Recombinant Proteins | |
| HY-P71077 | Serpin E1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71078 | REG-1 alpha/REG1A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71079 | Serpin A7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7107A | SCF, Rat (HEK293) | Recombinant Proteins | |
| HY-P7108 | TNF-alpha/TNFSF2, Rat (P.pastoris) | Recombinant Proteins | |
| HY-P71080 | UROD, Human (His) | Recombinant Proteins | |
| HY-P71081 | Renin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71082 | S100A6, Human (His) | Recombinant Proteins | |
| HY-P71083 | TPM3, Human | Recombinant Proteins | |
| HY-P71084 | S100A4, Mouse (His) | Recombinant Proteins | |
| HY-P71085 | Serpin E2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71086 | SPARC, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71087 | P4HB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71088 | UQCRH, Human (GST) | Recombinant Proteins | |
| HY-P71089 | Rnase 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71089Y | Rnase 1, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P7109 | EGF, Human | Recombinant Proteins | |
| HY-P71090 | PFKM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71091 | SLAMF2/CD48, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P71092 | QDPR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71093 | RBP1, Human | Recombinant Proteins | |
| HY-P71094 | SPARC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71095 | TROP-2, Human (187a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P71096 | UCHL1 Protein, Human (His) | Recombinant Proteins | |
| HY-P71097 | TrpA, E.coli | Recombinant Proteins | |
| HY-P71098 | Tryptophan Synthase, E.coli (His) | Recombinant Proteins | |
| HY-P71099 | TrpB, E.coli (His) | Recombinant Proteins | |
| HY-P7109G | GMP EGF, Human | Recombinant Proteins | |
| HY-P7110 | VEGF165, Human (P.pastoris) | Recombinant Proteins | |
| HY-P71100 | Oncomodulin-1, Human (His) | Recombinant Proteins | |
| HY-P71101 | UBB, Human | Recombinant Proteins | |
| HY-P71102 | Tau-D/0N4R, Human (133a.a, His) | Recombinant Proteins | |
| HY-P71103 | PRKAR1A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71104 | RBP3, Human (His) | Recombinant Proteins | |
| HY-P71105 | UROIIIS, Human (His) | Recombinant Proteins | |
| HY-P71106 | PSG2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71107 | Uteroglobin/SCGB1A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71108 | PRPS2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71109 | ODC1, Human (HEK293, His-T7) | Recombinant Proteins | |
| HY-P7110A | VEGF165, Human (HEK293) | Recombinant Proteins | |
| HY-P7110G | GMP VEGF165, Human | Recombinant Proteins | |
| HY-P7111 | FLT3LG, Human (CHO) | Recombinant Proteins | |
| HY-P71110 | TIMP-1, Mouse (HEK293) | Recombinant Proteins | |
| HY-P71111 | Pentraxin 2/SAP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71112 | TDGF1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71113 | PDIA4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71115 | UCHL3, Human (His) | Recombinant Proteins | |
| HY-P71116 | ST6GAL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71117 | TIMP-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71118 | PFKFB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71119 | NPPB, Human (His, solution) | Recombinant Proteins | |
| HY-P71119A | NPPB, Human (His) | Recombinant Proteins | |
| HY-P7112 | PTH, Human | Recombinant Proteins | |
| HY-P71120 | NPPB, Human (76a.a, Flag-His) | Recombinant Proteins | |
| HY-P71121 | Stathmin, Human (C-His) | Recombinant Proteins | |
| HY-P71121A | Stathmin, Human (His) | Recombinant Proteins | |
| HY-P71122 | NPR3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71124 | NFKB1, Human (His) | Recombinant Proteins | |
| HY-P71125 | TPSB2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71126 | TNFRII, Human (174a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71127 | Tissue Factor, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71128 | TAC1, Human (His) | Recombinant Proteins | |
| HY-P71129 | PVALB, Human (His) | Recombinant Proteins | |
| HY-P7113 | 4-1BBL/TNFSF9, Human | Recombinant Proteins | |
| HY-P71130 | SCF, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P71131 | Tryptase beta-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71132 | TGM2/Transglutaminase 2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71132A | TGM2/Transglutaminase 2, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P71133 | Serpin E1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71134 | WARS, Human (His) | Recombinant Proteins | |
| HY-P71135 | NFYA, Human | Recombinant Proteins | |
| HY-P71136 | YY1, Human (His) | Recombinant Proteins | |
| HY-P71137 | TIMP-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71137A | TIMP-2, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P71138 | S100P, Human (His) | Recombinant Proteins | |
| HY-P71138A | S100P, Human (N-His) | Recombinant Proteins | |
| HY-P71139 | SP-10/ACRV1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7114 | RSPO1/R-spondin-1, Human (CHO, His) | Recombinant Proteins | |
| HY-P71140 | S100A4, Human (C-His) | Recombinant Proteins | |
| HY-P71140A | S100A4, Human (C/N-His) | Recombinant Proteins | |
| HY-P71141 | SHP-1, Human (His) | Recombinant Proteins | |
| HY-P71142 | Serpin B3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71143 | Serpin A4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71144 | PBLD, Human (His) | Recombinant Proteins | |
| HY-P71145 | PRDX6, Human (His) | Recombinant Proteins | |
| HY-P71146 | PRDX5/Peroxiredoxin-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71147 | PRDX3, Human | Recombinant Proteins | |
| HY-P71149 | NOV/CCN3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7115 | TPO/Thrombopoietin, Human (CHO, His) | Recombinant Proteins | |
| HY-P71150 | DUSP3, Human (His) | Recombinant Proteins | |
| HY-P71151 | LMAN2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71153 | Neuroplastin, Human (192a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71154 | Neurotrimin, Human (283a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71155 | Neurturin, Human | Recombinant Proteins | |
| HY-P71156 | Lipocalin-2/NGAL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71157 | Nogo Receptor/NgR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71158 | Nogo Receptor/NgR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71159 | RTN4RL1/NgR3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7116 | BDNF, Human (CHO) | Recombinant Proteins | |
| HY-P71160 | NHP2, Human (His) | Recombinant Proteins | |
| HY-P71161 | NHP2L1, Human (His) | Recombinant Proteins | |
| HY-P71162 | NIP7, Human (His) | Recombinant Proteins | |
| HY-P71163 | ULBP1/RAET1I, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71164 | NKG2DL2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71165 | NLGN4X, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71166 | NOTCH1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71167 | NOTCH2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71168 | NPDC-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71169 | NPTX1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7116A | BDNF, Human | Recombinant Proteins | |
| HY-P7116G | GMP BDNF, Human | Recombinant Proteins | |
| HY-P7117 | TGF beta 1/TGFB1, Rat/Mouse (HEK293) | Recombinant Proteins | |
| HY-P71171A | NRG1-beta 1, Human (CHO) | Recombinant Proteins | |
| HY-P71172 | NRN1L, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71173 | NTAL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71174 | NTAQ1, Human (GST) | Recombinant Proteins | |
| HY-P71175 | NTNG1, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P71176 | NTNG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71177 | Nucleobindin-2, Human | Recombinant Proteins | |
| HY-P71178 | NXPH1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71179 | OLFM4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7118 | TGF beta 1/TGFB1, Human (CHO) | Recombinant Proteins | |
| HY-P71180 | LOX-1/OLR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71181 | Osteocrin, Human (His) | Recombinant Proteins | |
| HY-P71182 | OTUB2, Human (GST) | Recombinant Proteins | |
| HY-P71183 | PACSIN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71184 | PACSIN2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71185 | PAFAHB, Human (His) | Recombinant Proteins | |
| HY-P71186 | PAP, Human (His) | Recombinant Proteins | |
| HY-P71187 | PCDH1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71188 | PCDH10, Human (L405P, HEK293, His) | Recombinant Proteins | |
| HY-P71189 | PCSK9, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P71189A | PCSK9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7119 | TGF beta 2/TGFB2, Human | Recombinant Proteins | |
| HY-P71190 | PDCD10, Human | Recombinant Proteins | |
| HY-P71191 | PDCD4, Human (His) | Recombinant Proteins | |
| HY-P71192 | PDIA5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71193 | PDIA6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71194 | PDILT, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71195 | PEA15, Human | Recombinant Proteins | |
| HY-P71196 | Periostin, Human (758a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71197 | PFDN2, Human (His) | Recombinant Proteins | |
| HY-P71198 | PFDN4, Human (His) | Recombinant Proteins | |
| HY-P71199 | PFKFB3, Human (His) | Recombinant Proteins | |
| HY-P7120 | TGF beta 3/TGFB3, Human/Mouse/Rat (HEK293) | Recombinant Proteins | |
| HY-P71200 | PGCP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71201 | PGM2, Human (His) | Recombinant Proteins | |
| HY-P71202 | PHLDA2, Human (His) | Recombinant Proteins | |
| HY-P71203 | PHS, Human (His) | Recombinant Proteins | |
| HY-P71204 | PIK3IP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71205 | PIN4, Human (His) | Recombinant Proteins | |
| HY-P71206 | PIP4K2A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71207 | PITPNA, Human (His) | Recombinant Proteins | |
| HY-P71208 | PKCE, Human (His) | Recombinant Proteins | |
| HY-P71209 | PKI-beta, Human (His) | Recombinant Proteins | |
| HY-P7121 | HGF, Human (CHO) | Recombinant Proteins | |
| HY-P71210 | PKLR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71211 | PLA2G16, Human (His) | Recombinant Proteins | |
| HY-P71212 | PLA2G1B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71213 | Pleiotrophin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71214 | PLXDC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71215 | PLXDC2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71216 | PMM1, Human (His) | Recombinant Proteins | |
| HY-P71217 | PMVK, Human (His) | Recombinant Proteins | |
| HY-P71218 | Podoplanin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71219 | Podoplanin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P71220 | POLD2, Human (His) | Recombinant Proteins | |
| HY-P71221 | POMGNT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71222 | PPC-DC, Human (His) | Recombinant Proteins | |
| HY-P71222A | PPC-DC, Human (His, solution) | Recombinant Proteins | |
| HY-P71223 | PPIC, Human (Trx-His) | Recombinant Proteins | |
| HY-P71224 | PPID, Human (His, solution) | Recombinant Proteins | |
| HY-P71224A | PPID, Human (His) | Recombinant Proteins | |
| HY-P71225 | PPIE, Human (His) | Recombinant Proteins | |
| HY-P71226 | PPIL1, Human (His) | Recombinant Proteins | |
| HY-P71227 | PPM1A, Human (His) | Recombinant Proteins | |
| HY-P71228 | PPP1CC, Human (His) | Recombinant Proteins | |
| HY-P71229 | PPP1R14A, Human (His) | Recombinant Proteins | |
| HY-P7123 | FGF-18, Human | Recombinant Proteins | |
| HY-P71230 | PPT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71231 | PRDX1, Human (His) | Recombinant Proteins | |
| HY-P71232 | PRDX4, Human (His) | Recombinant Proteins | |
| HY-P71233 | PRG3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71234 | PRKG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71235 | Prolactin R, Mouse (210a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71236 | PRND, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71237 | Profilin-2, Human | Recombinant Proteins | |
| HY-P71238 | PS-beta-G-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71239 | PSG3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7124 | FGF-18, Rat | Recombinant Proteins | |
| HY-P71240 | PSMA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71241 | PSP, Human (His) | Recombinant Proteins | |
| HY-P71242 | PTGDS, Human (His, solution) | Recombinant Proteins | |
| HY-P71242A | PTGDS, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P71244 | PTH1R, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71245 | PTP4A2, Human (His) | Recombinant Proteins | |
| HY-P71246 | PTX3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71247 | PVRIG, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71248 | PVRIG, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P71249 | RBP2, Human | Recombinant Proteins | |
| HY-P7125 | 4-1BB/TNFRSF9, Human | Recombinant Proteins | |
| HY-P71250 | RBP5, Human | Recombinant Proteins | |
| HY-P71251A | RBP7, Human (His) | Recombinant Proteins | |
| HY-P71252 | RCN2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71253 | RCN3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71254 | REG-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71255 | REG-3 gamma/REG3G, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71256 | REG-3 gamma/REG3G, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71257 | REG-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71258 | RELT, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71259 | Resistin, Human (His) | Recombinant Proteins | |
| HY-P7126 | Adiponectin/Acrp30, Human (CHO) | Recombinant Proteins | |
| HY-P71260 | RHEB, Human (GST) | Recombinant Proteins | |
| HY-P71261 | RNASE6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71262 | ROBO4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71263 | ROR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71264 | RPE, Human (His) | Recombinant Proteins | |
| HY-P71265 | RPS19, Human | Recombinant Proteins | |
| HY-P71266 | RPS7, Human (His) | Recombinant Proteins | |
| HY-P71267 | RRM2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71268 | RTBDN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71269 | S100A11, Mouse (His) | Recombinant Proteins | |
| HY-P7127 | Adiponectin/Acrp30, Human (HEK293) | Recombinant Proteins | |
| HY-P71270 | S100A12, Human | Recombinant Proteins | |
| HY-P71271 | S100A13, Human | Recombinant Proteins | |
| HY-P71272 | S100A15A, Mouse | Recombinant Proteins | |
| HY-P71272A | S100A15A, Mouse (solution) | Recombinant Proteins | |
| HY-P71273 | S100A16 , Human | Recombinant Proteins | |
| HY-P71274 | S100A7, Human | Recombinant Proteins | |
| HY-P71275 | S100A8, Rat (His) | Recombinant Proteins | |
| HY-P71276 | S100B, Mouse (His) | Recombinant Proteins | |
| HY-P71277 | SAA4, Human (His) | Recombinant Proteins | |
| HY-P71278 | SCARB2/LIMP-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71279 | SCG3/Secretogranin-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71280 | SCLY, Human (His) | Recombinant Proteins | |
| HY-P71281 | SECTM1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71282 | Semaphorin-3C/SEMA3C, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P71282A | Semaphorin-3C/SEMA3C, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P71283 | Semaphorin-4A/SEMA4A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71284 | Semaphorin-4B/SEMA4B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71285 | Semaphorin-4C/SEMA4C, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P71286 | Semaphorin-4G/SEMA4G, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71287 | Semenogelin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71288 | SENP2, Human | Recombinant Proteins | |
| HY-P71289 | SENP7, Human | Recombinant Proteins | |
| HY-P7129 | Adiponectin/Acrp30, Mouse (227a.a) | Recombinant Proteins | |
| HY-P71290 | SENP8, Human (His) | Recombinant Proteins | |
| HY-P71291 | SEPHS1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71292 | Serpin A10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71293 | Serpin D1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71294 | Serpin E2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71295 | Alpha-2-Antiplasmin/Serpin F2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71297 | Serpin G1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71298 | Serpin H1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71299 | Vaspin, Human (GST) | Recombinant Proteins | |
| HY-P7130 | BAFFR/TNFRSF13C, Human | Recombinant Proteins | |
| HY-P71300 | Vaspin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71301 | Serpin A1c, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71302 | Serpin A3N, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71303 | Serpin B1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71304 | Serpin B12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71306 | Serpin B9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71307 | SGSH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71308 | CARKL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71309 | SIAE, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7131 | BCA-1/CXCL13, Human | Recombinant Proteins | |
| HY-P71310 | Sialidase-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71311 | Siglec-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71312 | Siglec-8, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71313 | Siglec-8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71314 | Siglec-E, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P71315 | SIRP beta 2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71316 | SIRP gamma, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71317 | SLAMF6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71318 | SLAMF8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71319 | SLAMF8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7132 | BCMA/TNFRSF17, Human | Recombinant Proteins | |
| HY-P71320 | SLP-76, Human (His-T7) | Recombinant Proteins | |
| HY-P71323 | SMAD3, Human (Flag-His) | Recombinant Proteins | |
| HY-P71324 | SMAD4, Human (His) | Recombinant Proteins | |
| HY-P71325 | SMPDL3A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71326 | SNAP-alpha, Human (His) | Recombinant Proteins | |
| HY-P71327 | SNCA, Human (His) | Recombinant Proteins | |
| HY-P71328 | SORD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71329 | SP-D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7133 | BD-1, Human | Recombinant Proteins | |
| HY-P71330 | SPESP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71331 | SPINK7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71332 | ST6GALNAC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71333 | ST6GALNAC2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71334 | ST8SIA1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71335 | STAT1, Human | Recombinant Proteins | |
| HY-P71336 | STAT5B, Human (His) | Recombinant Proteins | |
| HY-P71337 | STAT6, Human (His) | Recombinant Proteins | |
| HY-P71338 | STC1/Stanniocalcin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71339 | Stratifin, Human | Recombinant Proteins | |
| HY-P7134 | BD-1, Rat | Recombinant Proteins | |
| HY-P71340 | STUB1, Human | Recombinant Proteins | |
| HY-P71341 | SULT1A3, Human (His) | Recombinant Proteins | |
| HY-P71341A | SULT1A3, Human (N-His) | Recombinant Proteins | |
| HY-P71342 | SULT1C4, Human (His) | Recombinant Proteins | |
| HY-P71343 | SULT2A1, Human (His) | Recombinant Proteins | |
| HY-P71344 | SULT4A1, Human | Recombinant Proteins | |
| HY-P71345 | SUMF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71346 | SUMO3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71347 | SWSAP1, Human (His) | Recombinant Proteins | |
| HY-P71348 | Syntaxin-8, Human | Recombinant Proteins | |
| HY-P71349 | Tachykinin-3, Human (His) | Recombinant Proteins | |
| HY-P7135 | BD-2, Human | Recombinant Proteins | |
| HY-P71350 | TAFA4, Human (His) | Recombinant Proteins | |
| HY-P71351 | TALDO1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71352 | Testican 3/SPOCK3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71354 | TFF2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71355 | TFF2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71356 | TFF3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71357 | TFIIB, Human (GST) | Recombinant Proteins | |
| HY-P71358 | TFPI2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71358A | TFPI2, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P71359 | THOP1, Human (His) | Recombinant Proteins | |
| HY-P7136 | BD-2, Mouse | Recombinant Proteins | |
| HY-P71360 | THSD1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71361 | Thymopoietin, Human (His) | Recombinant Proteins | |
| HY-P71362 | TIE-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71363 | TIGIT, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P71364 | TIM, Human (His) | Recombinant Proteins | |
| HY-P71365 | TIM-1/KIM-1/HAVCR, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P71366 | TIM-14, S.cerevisiae | Recombinant Proteins | |
| HY-P71367 | TIM-16, S. cerevisiae | Recombinant Proteins | |
| HY-P71368 | TIMP-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71369 | TINAGL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7137 | BD-3, Human | Recombinant Proteins | |
| HY-P71370 | TMIGD2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71371 | TMX2, Human (His) | Recombinant Proteins | |
| HY-P71372 | Troponin C/TNNC1, Human (His) | Recombinant Proteins | |
| HY-P71372A | Troponin C/TNNC1, Human (N-His) | Recombinant Proteins | |
| HY-P71373 | TOLLIP, Human (His) | Recombinant Proteins | |
| HY-P71374 | TPBG/5T4, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P71375 | TPH2, Human (His) | Recombinant Proteins | |
| HY-P71376 | TPK1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71377 | TPSAB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71378 | TRAIL R2/TNFRSF10B, Mouse (HEK293, Avi-His) | Recombinant Proteins | |
| HY-P71379 | TRAT1, Human (His) | Recombinant Proteins | |
| HY-P7138 | BD-3, Mouse | Recombinant Proteins | |
| HY-P71380 | TREM-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71381 | TREM-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71382 | TREML1, Human (147a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71383 | TREML2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71384 | TREML2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71385 | TRIM5, Human (His) | Recombinant Proteins | |
| HY-P71385A | TRIM5, Human (N-His) | Recombinant Proteins | |
| HY-P71386 | TrkC, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71387 | TROP-2, Mouse (246a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71388 | TROP-2, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P71389 | TSLP R, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7139 | BD-3, Rat | Recombinant Proteins | |
| HY-P71390 | TSTA3, Human (His) | Recombinant Proteins | |
| HY-P71391 | TWSG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71392 | TXLNA, Human (His) | Recombinant Proteins | |
| HY-P71393 | TXN2, Human (His) | Recombinant Proteins | |
| HY-P71394 | TXNDC15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71395 | UBA5, Human (His) | Recombinant Proteins | |
| HY-P71396 | UBAP1, Human (His) | Recombinant Proteins | |
| HY-P71397 | UBE2A, Human (GST-His) | Recombinant Proteins | |
| HY-P71398 | UBE2B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71399 | UBE2D1, Human (GST) | Recombinant Proteins | |
| HY-P7140 | BD-4, Human | Recombinant Proteins | |
| HY-P71400 | UBE2D4, Human (GST) | Recombinant Proteins | |
| HY-P71401 | UBE2G2, Human (GST) | Recombinant Proteins | |
| HY-P71402 | UBE2H, Human (GST) | Recombinant Proteins | |
| HY-P71403 | UBE2I, Human (GST) | Recombinant Proteins | |
| HY-P71404 | UBE2J2, Human (GST) | Recombinant Proteins | |
| HY-P71405 | UBE2K, Human (GST) | Recombinant Proteins | |
| HY-P71406 | UBE2M, Human | Recombinant Proteins | |
| HY-P71407 | UBE2R2, Human (His) | Recombinant Proteins | |
| HY-P71408 | UBE2S, Human (GST) | Recombinant Proteins | |
| HY-P71409 | UBE2T, Human (His) | Recombinant Proteins | |
| HY-P7141 | BD-4, Rat | Recombinant Proteins | |
| HY-P71410 | UBE2V1, Human (His) | Recombinant Proteins | |
| HY-P71411 | UBE2V2, Human (His) | Recombinant Proteins | |
| HY-P71412 | UBE2Z, Human (His) | Recombinant Proteins | |
| HY-P71413 | UCMA, Human | Recombinant Proteins | |
| HY-P71414 | UGRP1, Human | Recombinant Proteins | |
| HY-P71415 | ULBP1/RAET1I, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71416 | UPP1, Human (His) | Recombinant Proteins | |
| HY-P71417 | UPRT, Human (His) | Recombinant Proteins | |
| HY-P71418 | USP14, Human (His) | Recombinant Proteins | |
| HY-P71419 | Uteroglobin/SCGB1A1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7142 | Betacellulin/BTC, Mouse (HEK293) | Recombinant Proteins | |
| HY-P71420 | VCP, Human (His) | Recombinant Proteins | |
| HY-P71421 | VEGFR-2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P71422 | VMO1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71423 | VSIG4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71424 | VSIG4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71425 | VSIG8, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P71426 | VSIG8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71427 | VSNL1, Human (His) | Recombinant Proteins | |
| HY-P71428 | VSTM1, Human (119a.a, HEK293, His) | Recombinant Proteins | |
| HY-P71429 | VSTM2A, Human ( E84K, HEK293, His) | Recombinant Proteins | |
| HY-P7143 | CCL6, Mouse | Recombinant Proteins | |
| HY-P71430 | WBP1, Human (His) | Recombinant Proteins | |
| HY-P71431 | WBP2, Human (His) | Recombinant Proteins | |
| HY-P71432 | HE4/WFDC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71433 | WIBG, Human (His) | Recombinant Proteins | |
| HY-P71434 | Lymphotactin/XCL1, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P71435 | XPNPEP3, Human (His) | Recombinant Proteins | |
| HY-P71436 | ZBP1, Human (His) | Recombinant Proteins | |
| HY-P71437 | ZBTB17, Human (His) | Recombinant Proteins | |
| HY-P71438 | ZBTB9, Human (His) | Recombinant Proteins | |
| HY-P71439 | ZMYND19, Human (His) | Recombinant Proteins | |
| HY-P7144 | CD40L/CD154/TRAP, Human | Recombinant Proteins | |
| HY-P71440 | ZNF100, Human (His) | Recombinant Proteins | |
| HY-P71441 | ZNF70, Human (His) | Recombinant Proteins | |
| HY-P71442 | ZNF75A, Human (His) | Recombinant Proteins | |
| HY-P71443 | VSTM5, Human (His) | Recombinant Proteins | |
| HY-P71444 | COL4A1, Human (GST) | Recombinant Proteins | |
| HY-P71445 | CPS1/CPSase I, Human (Sf9, His) | Recombinant Proteins | |
| HY-P71446 | Endothelin-1/EDN1, Rat (His-KSI) | Recombinant Proteins | |
| HY-P71447 | GABRB2, Human (His) | Recombinant Proteins | |
| HY-P71448 | ITGBL1, Human (Myc, His) | Recombinant Proteins | |
| HY-P71449 | Neuropeptide B, Human (GST) | Recombinant Proteins | |
| HY-P7145 | CNTF, Human (HEK293) | Recombinant Proteins | |
| HY-P71450 | STC2/Stanniocalcin-2, Mouse | Recombinant Proteins | |
| HY-P71451 | TPP2, Human (Myc, His) | Recombinant Proteins | |
| HY-P71452 | Murinoglobulin-1/Mug1, Mouse (His) | Recombinant Proteins | |
| HY-P71453 | YebF, E.coli (Myc, His) | Recombinant Proteins | |
| HY-P71454 | Leukocidin-F subunit/LukF, S. aureus (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71455 | SVMP, Crotalus adamanteus (His) | Recombinant Proteins | |
| HY-P71456 | PRSS3/Trypsin-3, Human (His) | Recombinant Proteins | |
| HY-P71457 | Dxr/DXP reductoisomerase, E.coli (Myc, His) | Recombinant Proteins | |
| HY-P71458 | PpsA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71459 | Beta-lactamase CTX-M-1/Bla, E.coli (His) | Recombinant Proteins | |
| HY-P7146 | CNTF, Human | Recombinant Proteins | |
| HY-P71460 | GltI/YbeJ, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71461 | GFP, Aequorea victoria (His) | Recombinant Proteins | |
| HY-P71462 | Lithostathine-1/Reg1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71463 | HLA-DMA, Human (His) | Recombinant Proteins | |
| HY-P71464 | Peroxiredoxin-2/PRDX2, Human (His) | Recombinant Proteins | |
| HY-P71465 | Enterotoxin type C-2, S. aureus | Recombinant Proteins | |
| HY-P71466 | Cytosine deaminase/CodA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71467 | Pal, Legionella pneumophila (His-SUMO) | Recombinant Proteins | |
| HY-P71468 | Cathelicidin-4/CATHL4, Bovine (His-SUMO) | Recombinant Proteins | |
| HY-P71469 | Cardiac troponin I/Tnni3, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P7147 | CNTF, Mouse | Recombinant Proteins | |
| HY-P71470 | Ribonuclease J/RnJ, Synechocystis sp. (His-SUMO) | Recombinant Proteins | |
| HY-P71471 | HADHB, Human (GST) | Recombinant Proteins | |
| HY-P71472 | Hydrophobin-1/HFB1 Protein, Hypocrea jecorina (His-SUMO) | Recombinant Proteins | |
| HY-P71473 | CS6 fimbrial subunit B/cssB, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71474 | Protease 7/OmpT, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71475 | Propionate kinase/TdcD, E.coli (Myc, His) | Recombinant Proteins | |
| HY-P71476 | MecA, S. aureus (His-SUMO) | Recombinant Proteins | |
| HY-P71477 | FkpA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71478 | Fusion glycoprotein F0/F, HRSV (His, B2M) | Recombinant Proteins | |
| HY-P71479 | AlkB, E.coli (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P7148 | CNTF, Rat | Recombinant Proteins | |
| HY-P71480 | Anionic trypsin, Dog (His-SUMO) | Recombinant Proteins | |
| HY-P71481 | Outer membrane porin C/OmpC, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71482 | MutT, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71483 | Protease 7/OmpT, E.coli (His) | Recombinant Proteins | |
| HY-P71484 | Exfoliative toxin A, S. aureus (His) | Recombinant Proteins | |
| HY-P71485 | Gamma-hemolysin component A, S. aureus (Myc, His) | Recombinant Proteins | |
| HY-P71486 | Enterotoxin type G, S. aureus (His-SUMO) | Recombinant Proteins | |
| HY-P71487 | HtpG, E.coli | Recombinant Proteins | |
| HY-P71488 | LpxC, E.coli (His) | Recombinant Proteins | |
| HY-P71489 | RecF/UvrF, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P7148A | CNTF, Rat (His) | Recombinant Proteins | |
| HY-P7149 | Cardiotrophin-1/CTF1, Human (CHO) | Recombinant Proteins | |
| HY-P71490 | RecR, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71491 | RuvA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71492 | TalB, E.coli (Myc, His) | Recombinant Proteins | |
| HY-P71493 | Outer membrane A/OmpA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71494 | Outer membrane X/OmpX, E.coli (Myc, His) | Recombinant Proteins | |
| HY-P71495 | FtsZ, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71496 | Thioredoxin-1/TRXA, E.coli (His) | Recombinant Proteins | |
| HY-P71497 | DNA-binding HU-alpha, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71498 | NlpD, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71499 | MBP/MalE, E.coli (Myc, His) | Recombinant Proteins | |
| HY-P7150 | Cardiotrophin-1/CTF1, Mouse (HEK293) | Recombinant Proteins | |
| HY-P71500 | TsaE, E.coli | Recombinant Proteins | |
| HY-P71501 | PPIase A, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71502 | Exopolyphosphatase/PPX, E.coli (His) | Recombinant Proteins | |
| HY-P71503 | Major urinary 6, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71504 | Type-1A pilin/fimA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71505 | HLA-DRB1, Human (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71506 | Major urinary 11, Mouse (His) | Recombinant Proteins | |
| HY-P71507 | Cationic trypsin, Dog (His-SUMO) | Recombinant Proteins | |
| HY-P71508 | TSST-1, S. aureus (His-SUMO) | Recombinant Proteins | |
| HY-P71509 | Enterotoxin type A, S. aureus (His) | Recombinant Proteins | |
| HY-P7151 | CXCL16, Mouse | Recombinant Proteins | |
| HY-P71511 | Gamma-GCS, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71512 | RecO, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71513 | RuvB, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71514 | RuvC, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71515 | BamA, E.coli (Myc, His) | Recombinant Proteins | |
| HY-P71516 | Exopolyphosphatase/PPX, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71517 | Hygromycin-B kinase/HPH, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71518 | H2-D1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71519 | LacI, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P7152 | CXCL3/CINC-2 alpha, Rat (CHO) | Recombinant Proteins | |
| HY-P71520 | TetR, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71520A | TetR, E.coli (His) | Recombinant Proteins | |
| HY-P71521 | Rnls, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71522 | IIdD Protein, E.coli (His) | Recombinant Proteins | |
| HY-P71523 | GhrA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71524 | Lipoate-protein ligase A/LplA, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71525 | Minor allergen Can f 2, Dog (His-SUMO) | Recombinant Proteins | |
| HY-P71526 | FGF-15, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71527 | ZWINT/ZW10 interactor, Human (GST) | Recombinant Proteins | |
| HY-P71528 | LUXS, E.coli (His) | Recombinant Proteins | |
| HY-P71529 | ST3GAL3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P7153 | DCIP-1/CXCL3, Mouse | Recombinant Proteins | |
| HY-P71530 | PAK1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71532 | MYBPC3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71532A | MYBPC3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71533 | KYAT1, Human (His) | Recombinant Proteins | |
| HY-P71534 | DDX39B, Human (GST) | Recombinant Proteins | |
| HY-P71535 | TEAD4, Human (His) | Recombinant Proteins | |
| HY-P71536 | SMAD2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71537 | TRAP1, Human (GST) | Recombinant Proteins | |
| HY-P71538 | AIMP2, Human (His) | Recombinant Proteins | |
| HY-P71539 | Lymphocyte antigen 6E/LY6E, Human (His-SUMO) | Recombinant Proteins | |
| HY-P7154 | DKK-1, Mouse (CHO) | Recombinant Proteins | |
| HY-P71540 | MAD2L1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71541 | ASAH1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71542 | DCTN1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71543 | DNASE1L3, Human (GST) | Recombinant Proteins | |
| HY-P71544 | MLANA, Human (His, B2M) | Recombinant Proteins | |
| HY-P71545 | MORC3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71546 | DPYSL3, Human (His) | Recombinant Proteins | |
| HY-P71547 | CRMP1, Human | Recombinant Proteins | |
| HY-P71548 | JMJD1C, Human (His-SUMO-Myc) | Recombinant Proteins | |
| HY-P71549 | STK11, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71550 | ATP5MG, Bovine (Myc, His) | Recombinant Proteins | |
| HY-P71551 | PAG-1, Bovine (His) | Recombinant Proteins | |
| HY-P71552 | Complement C3/C3a, Bovine (His-SUMO) | Recombinant Proteins | |
| HY-P71553 | PLBD2, Mouse (His) | Recombinant Proteins | |
| HY-P71554 | Pollen allergen Phl p 5b, Phleum pratense (His-SUMO) | Recombinant Proteins | |
| HY-P71555 | CDTB, E.coli (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71556 | ygiS, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P71557 | PLBD2, Rat (His-SUMO) | Recombinant Proteins | |
| HY-P71558 | FBXO48, Human (His) | Recombinant Proteins | |
| HY-P71559 | NAALADL2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P7155A | DKK-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7155B | DKK-1, Human (HEK293) | Recombinant Proteins | |
| HY-P7156 | EMAP-II, Human | Recombinant Proteins | |
| HY-P71560 | SMUG1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71561 | CMRF35-like molecule 1, Rat (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71562 | CT83, Human (His, B2M) | Recombinant Proteins | |
| HY-P71563 | HCDH, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71564 | Semaphorin-3A/SEMA3A, Rat (His) | Recombinant Proteins | |
| HY-P71565 | FCRL6, Human (His) | Recombinant Proteins | |
| HY-P71566 | AE-binding 1/Aebp1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71567 | OGDC-E, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71568 | MUSK, Mouse (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71569 | METRNL/Meteorin-like, Human (His-SUMO) | Recombinant Proteins | |
| HY-P7157 | ENA-78/CXCL5, Human (HEK293) | Recombinant Proteins | |
| HY-P71570 | TRIM21, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71571 | GFER, Rat (His-SUMO) | Recombinant Proteins | |
| HY-P71572 | SH3PXD2A, Human (Myc, His) | Recombinant Proteins | |
| HY-P71573 | Allergen Fel d 4, Cat (His-SUMO) | Recombinant Proteins | |
| HY-P71574 | Nucleophosmin/Npm1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71575 | ETFR-2/TEAD-4, Mouse | Recombinant Proteins | |
| HY-P71576 | ATG14, Human (Myc, His) | Recombinant Proteins | |
| HY-P71577 | EIF3M, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71578 | MCR-1, E.coli (364a.a, His-SUMO) | Recombinant Proteins | |
| HY-P71579 | TFIIF-associating CTD phosphatase, Mouse (Myc, His) | Recombinant Proteins | |
| HY-P7158 | ENA-78/CXCL5, Human | Recombinant Proteins | |
| HY-P71580 | GFRAL, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71581 | Clumping factor A, S. aureus | Recombinant Proteins | |
| HY-P71582 | PNLIP/Pancreatic lipase, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71583 | LAMTOR1, Human (His) | Recombinant Proteins | |
| HY-P71584 | ALKAL1, Human (His, B2M) | Recombinant Proteins | |
| HY-P71585 | KDM3B, Human (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71587 | Nmes1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71588 | CHD1L, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71589 | IFN-epsilon, Human (His) | Recombinant Proteins | |
| HY-P7159 | Eotaxin/CCL11, Human | Recombinant Proteins | |
| HY-P71590 | Kallikrein-14, Mouse (His) | Recombinant Proteins | |
| HY-P71591 | cGB-PDE, Mouse (Myc, His) | Recombinant Proteins | |
| HY-P71592 | Sap130, Mouse (His) | Recombinant Proteins | |
| HY-P71593 | Frataxin/FXN, Cynomolgus (His) | Recombinant Proteins | |
| HY-P71594 | SRPX2, Mouse (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71595 | CD300LF, Human (His) | Recombinant Proteins | |
| HY-P71596 | SIRT1, Human (His) | Recombinant Proteins | |
| HY-P71597 | cGAS, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71598 | NLRP3, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71599 | DENND1A, Human (His-SUMO) | Recombinant Proteins | |
| HY-P7160 | Eotaxin/CCL11, Mouse | Recombinant Proteins | |
| HY-P71600 | PNPLA2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71601 | IL-1F10/IL-38, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71601Y | IL-1F10/IL-38, Mouse (His-SUMO, solution) | Recombinant Proteins | |
| HY-P71602 | Langerin/CD207, Mouse (His) | Recombinant Proteins | |
| HY-P71603 | SELM, Human | Recombinant Proteins | |
| HY-P71604 | Transmembrane protease serine 4, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71605 | SCGB3A2, Mouse (His, GST) | Recombinant Proteins | |
| HY-P71606 | Lysyl oxidase homolog 4, Mouse (His) | Recombinant Proteins | |
| HY-P71607 | KLRG1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71608 | TGS1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71609 | TXNDC5, Human (GST) | Recombinant Proteins | |
| HY-P7161 | CCL24/Eotaxin-2, Human | Recombinant Proteins | |
| HY-P71610 | Outer membrane porin C/OmpC, E.coli (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71612 | RBM14, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71613 | Placenta-expressed transcript 1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71614 | PDK3, Mouse (His) | Recombinant Proteins | |
| HY-P71615 | PDGF-DD, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71617 | METRNL/Meteorin-like, Mouse (His) | Recombinant Proteins | |
| HY-P71618 | KRT35, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71619 | SYNGAP1, Human (His) | Recombinant Proteins | |
| HY-P71620 | PNKP, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71621 | Tissue alpha-L-Fucosidase, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P71622 | WDR77, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71623 | SOST, Rat (Myc, His) | Recombinant Proteins | |
| HY-P71624 | Staphopain B, S. aureus (GST) | Recombinant Proteins | |
| HY-P71625 | PARK7/DJ-1, Human (GST) | Recombinant Proteins | |
| HY-P71626 | TEAD3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71627 | AMELX, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71628 | FOXP3, Human (His) | Recombinant Proteins | |
| HY-P71629 | Collectrin/TMEM27, Mouse (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P7163 | Eotaxin-3/CCL26, Human | Recombinant Proteins | |
| HY-P71630 | IL-5, Pig (His) | Recombinant Proteins | |
| HY-P71631 | PITHD1, Human (Myc, His) | Recombinant Proteins | |
| HY-P71632 | LHPP, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71633 | Jagged-1/JAG1, Mouse (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71635 | SNTG1, Human (Myc, His) | Recombinant Proteins | |
| HY-P71636 | CD367/CLEC4A, Mouse (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71637 | TRIM5, Human (His, B2M) | Recombinant Proteins | |
| HY-P71638 | Elastase IIIB/CELA3B, Mouse (Myc, His) | Recombinant Proteins | |
| HY-P71639 | CORS26, Mouse (Myc, His) | Recombinant Proteins | |
| HY-P7164 | Erythropoietin/EPO, Human (CHO) | Recombinant Proteins | |
| HY-P71640 | RPS10P5, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71641 | IFIH1, Human (His) | Recombinant Proteins | |
| HY-P71642 | Acetyl-CoA synthetase 1/AceCS, Mouse (His) | Recombinant Proteins | |
| HY-P71643 | SAE1, Human (GST) | Recombinant Proteins | |
| HY-P71644 | TRMT112, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71645 | AK3, Human (Myc, His) | Recombinant Proteins | |
| HY-P71646 | PLXNA1, Human (His) | Recombinant Proteins | |
| HY-P71647 | CHID1, Human (His) | Recombinant Proteins | |
| HY-P71648 | C1QTNF3/CTRP3, Human (His) | Recombinant Proteins | |
| HY-P71649 | GSDMC, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71650 | Cytosolic beta-Glucosidase/GBA3, Human (GST) | Recombinant Proteins | |
| HY-P71651 | DDX19A, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71652 | ANGPTL2/Angiopoietin-like 2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71653 | PLA2G2D, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71654 | ERVW-1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71655 | Hydroxyacid oxidase 1 Protein, Mouse (His) | Recombinant Proteins | |
| HY-P71656 | Wnt8b, Mouse (Myc, His-SUMO) | Recombinant Proteins | |
| HY-P71657 | IL-18, Dog (His) | Recombinant Proteins | |
| HY-P71658 | OARD1, Human (Myc, His) | Recombinant Proteins | |
| HY-P71659 | USH1C, Human (His-SUMO) | Recombinant Proteins | |
| HY-P7166 | Exodus-2/CCL21, Human | Recombinant Proteins | |
| HY-P71660 | ARL2BP, Human (GST) | Recombinant Proteins | |
| HY-P71661 | RUVBL2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P71662 | CD8 alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71663 | EphA3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71664 | FCGRT, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71666 | GUCY2C/Guanylyl cyclase C, Rat (HEK293, Myc, His) | Recombinant Proteins | |
| HY-P71667 | HLA-G, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71668 | KRT18, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71669 | PAEP, Human (HEK293, Myc, His) | Recombinant Proteins | |
| HY-P7167 | 6Ckine/CCL21B, Mouse | Recombinant Proteins | |
| HY-P71670 | QPCT, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71670A | QPCT, Mouse (His) | Recombinant Proteins | |
| HY-P71671 | Transthyretin/TTR, Cynomolgus (HEK293, His, Myc) | Recombinant Proteins | |
| HY-P71672 | ZP3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71673 | ZYX, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71674 | Semaphorin-3F/SEMA3F, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71675 | VSIG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P71676 | PDCE2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71677 | FAM20C, Human (HEK293, Myc, His) | Recombinant Proteins | |
| HY-P71678 | FAM167A, Human (HEK293, Myc, His) | Recombinant Proteins | |
| HY-P71679 | CLEC4C, Human (HEK293, His, Myc) | Recombinant Proteins | |
| HY-P7168 | Fas/CD95, Human (HEK293) | Recombinant Proteins | |
| HY-P71680 | Glucose-6-phosphate isomerase, Human (His) | Recombinant Proteins | |
| HY-P71681 | FAU, Human (GST) | Recombinant Proteins | |
| HY-P71682 | 14-3-3 eta, Human (GST) | Recombinant Proteins | |
| HY-P71683 | RPS13, Human (GST) | Recombinant Proteins | |
| HY-P71685 | ABL1, Human (GST) | Recombinant Proteins | |
| HY-P71687 | RANK/TNFRSF11A, Human (His) | Recombinant Proteins | |
| HY-P71688 | HGF Protein, Rat (GST) | Recombinant Proteins | |
| HY-P71689 | 30S Ribosomal S4/RPS4, E.coli (His) | Recombinant Proteins | |
| HY-P7169 | Fas/CD95, Human | Recombinant Proteins | |
| HY-P71690 | GLO2/Glyoxalase II, Human (GST) | Recombinant Proteins | |
| HY-P71691 | TNC, Human (His) | Recombinant Proteins | |
| HY-P71692 | Alkaline Phosphatase/ALPI, Human (His) | Recombinant Proteins | |
| HY-P71693 | Vinculin, Human (GST) | Recombinant Proteins | |
| HY-P71694 | MetC, E.coli (His) | Recombinant Proteins | |
| HY-P71695 | SPEA, E.coli (His) | Recombinant Proteins | |
| HY-P71696 | HLA-DPB1, Human (His) | Recombinant Proteins | |
| HY-P71697 | HLA-DPA1, Human (His) | Recombinant Proteins | |
| HY-P71698 | TTN, Human (His) | Recombinant Proteins | |
| HY-P71699 | HLA-B, Human (His) | Recombinant Proteins | |
| HY-P71699A | HLA-B, Human (N-His) | Recombinant Proteins | |
| HY-P7170 | KGF-2/FGF-10, Mouse | Recombinant Proteins | |
| HY-P71700 | HLA-C, Human (His) | Recombinant Proteins | |
| HY-P71701 | CTSF, Human (His) | Recombinant Proteins | |
| HY-P71702 | Calcitonin/CALCA, Human (GST) | Recombinant Proteins | |
| HY-P71703 | p53, Rat (His) | Recombinant Proteins | |
| HY-P71704 | NrdD, E.coli (His) | Recombinant Proteins | |
| HY-P71705 | Transcription termination factor Rho, E.coli (His) | Recombinant Proteins | |
| HY-P71707 | KAT5, Human (His) | Recombinant Proteins | |
| HY-P71708 | Caspase-8/CASP8 subunit p18, Human (His) | Recombinant Proteins | |
| HY-P71709 | NAD(P)H-flavin reductase, E.coli (His) | Recombinant Proteins | |
| HY-P7171 | FGF-18, Mouse | Recombinant Proteins | |
| HY-P71710 | Serum Albumin/ALB, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71711 | Serum Albumin/ALB, Cynomolgus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71712 | Muellerian-inhibiting factor/AMH, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71713 | Annexin A1/ANXA1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71714 | Annexin A13/ANXA13, Dog (P.pastoris, His) | Recombinant Proteins | |
| HY-P71715 | ApoA-IV, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71716 | ATP5F1B, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71717 | Apoptosis inhibitor 4/Birc5, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71718 | C1QA, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71719 | Complement C5a anaphylatoxin, Pig (P.pastoris, His) | Recombinant Proteins | |
| HY-P7172 | FGF-19, Human | Recombinant Proteins | |
| HY-P71720 | CA12/Carbonic Anhydrase 12, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71721 | Calreticulin/CALR, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71721Y | Calreticulin/CALR, Mouse (P.pastoris, His, solution) | Recombinant Proteins | |
| HY-P71722 | Calreticulin/CALR, Pig (P.pastoris, His) | Recombinant Proteins | |
| HY-P71724 | CD59, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71725 | Cadherin-3, Pig (P.pastoris) | Recombinant Proteins | |
| HY-P71726 | Complement Factor D/Adipsin, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71727 | CHGA, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71728 | CYP21A2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71729 | DCD, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P7172A | FGF-19, Human (Flag) | Recombinant Proteins | |
| HY-P7173 | FGF-21, Mouse | Recombinant Proteins | |
| HY-P71730 | EDNRA, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71731 | EIF4G1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71732 | Erythropoietin/EPO, Pig (P.pastoris, His) | Recombinant Proteins | |
| HY-P71733 | ERG, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71734 | FLG, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71735 | FXN, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71736 | Vitamin D-binding/GC, Human (P.pastoris, His-SUMOstar) | Recombinant Proteins | |
| HY-P71737 | GDI2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71738 | Glucose-6-phosphate isomerase, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71739 | EGLP/GPX5, Pig (P.pastoris, Myc, His) | Recombinant Proteins | |
| HY-P7174 | FGF-6, Human | Recombinant Proteins | |
| HY-P71740 | GSTP1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71741 | GYPA/CD235a, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71742 | HSPA5/GRP-78, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71742Y | HSPA5/GRP-78, Mouse (P.pastoris, His, solution) | Recombinant Proteins | |
| HY-P71743 | IDO-2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71744 | Immunoglobulin J chain Protein, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71745 | IL-15, Rhesus macaque (P.pastoris, His) | Recombinant Proteins | |
| HY-P71746 | IL-2R beta/CD122, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71747 | IRF3, Mouse (P.pastoris, Myc, His) | Recombinant Proteins | |
| HY-P71748 | Plasma kallikrein/KLKB1, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71750 | LCP1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71751 | LY6G6D, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71752 | PNS-Tau/MAPT, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71753 | Tau-A/SC1, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71754 | Myoglobin, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71755 | Monoglyceride lipase, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71756 | MICAL2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71757 | MME, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71758 | CD20/MS4A1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P7176 | KGF/FGF-7, Mouse | Recombinant Proteins | |
| HY-P71760 | NCL, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71761 | Acyl carrier/ACP, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71762 | NES, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71763 | Nidogen-1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71765 | NR4A2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71766 | OXT, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71767 | Peptide deformylase, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71768 | PLP phosphatase, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71769 | PHPT1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P7177 | FGF-9, Human | Recombinant Proteins | |
| HY-P71770 | PNLIPRP1, Dog (P.pastoris, His) | Recombinant Proteins | |
| HY-P71773 | Trypsin, Pig (P.pastoris, His) | Recombinant Proteins | |
| HY-P71774 | Anionic trypsin-2, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71775 | PSCA, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71776 | Prothymosin alpha, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71777 | PTPRZ1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71778 | RCVRN, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71779 | S100A8, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P7178 | FGF-9, Rat | Recombinant Proteins | |
| HY-P71780 | Serum amyloid A, Cat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71781 | SAG, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71782 | Syndecan-1/CD138, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P71784 | SMARCA4, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71785 | SOCS1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71786 | Osteopontin/OPN, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71787 | SPRR2B, Human (P.pastoris, Myc, His) | Recombinant Proteins | |
| HY-P71788 | TARDBP, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71789 | TCN1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P7179 | FGF basic/bFGF, Bovine | Recombinant Proteins | |
| HY-P71791 | TRIM21, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71792 | TYR, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71794 | IL-4, Cynomolgus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71795 | Hydrophobin-2/HFB2 Protein, Trichoderma reesei (P.pastoris) | Recombinant Proteins | |
| HY-P71796 | Lymphocyte antigen 6C1/LY6C1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71797 | Major urinary 2, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71798 | Interferon tau-1/IFNT1, Bovine (P.pastoris, His) | Recombinant Proteins | |
| HY-P71799 | HE/Hemagglutinin-esterase, Bovine (P.pastoris, His) | Recombinant Proteins | |
| HY-P7180 | Fractalkine/CX3CL1, Human | Recombinant Proteins | |
| HY-P71800 | PhoP, E.coli (P.pastoris, Myc, His) | Recombinant Proteins | |
| HY-P71801 | Lymphocyte antigen 6G/LY6G, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P71802 | Carboxylesterase 1C, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71803 | 26 kDa secreted antigen/TES-26, Canine (P.pastoris, His) | Recombinant Proteins | |
| HY-P71804 | Beta-lactamase TEM/Bla, E.coli (P.pastoris, His) | Recombinant Proteins | |
| HY-P71805 | Insulin-1/Ins1, Mouse (P.pastoris, Myc, His) | Recombinant Proteins | |
| HY-P71805Y | Insulin-1/Ins1 Protein, Mouse (P.pastoris, Myc, His, solution) | Recombinant Proteins | |
| HY-P71806 | Gamma-hemolysin component B, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71807 | Enterotoxin type H, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71808 | Enterotoxin type B, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71809 | Serum amyloid A-3/Saa3, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71810 | Odorant-binding/OBP, Bovine (P.pastoris) | Recombinant Proteins | |
| HY-P71811 | FimH, E.coli (P.pastoris, His) | Recombinant Proteins | |
| HY-P71812 | LolA, E.coli (P.pastoris, His) | Recombinant Proteins | |
| HY-P71813 | Trigger factor, E.coli (P.pastoris, His) | Recombinant Proteins | |
| HY-P71814 | PODXL, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71815 | KIR2DS3, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71816 | DPYSL2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71817 | UAP1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71818 | MAdCAM1, Human (P.pastoris, His-Myc) | Recombinant Proteins | |
| HY-P71819 | ELAVL3, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P7182 | GDNF, Human | Recombinant Proteins | |
| HY-P71820 | RCN1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71821 | PTK7, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71822 | GCKR, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71823 | KIR2DS1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71824 | HSP70/DnaK, E. coli (P.pastoris, His) | Recombinant Proteins | |
| HY-P71825 | Alpha-hemolysin, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71826 | Angiogenin-4, Mouse (P.pastoris His-SUMOstar) | Recombinant Proteins | |
| HY-P71827 | Adiponectin/Acrp30, Bovine (P.pastoris, His) | Recombinant Proteins | |
| HY-P71828 | MCT/SACOL1244, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71829 | Clumping factor A, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P7182A | GDNF, Human (His) | Recombinant Proteins | |
| HY-P7183 | GH/Somatotropin, Human | Recombinant Proteins | |
| HY-P71830 | Lymphocyte antigen 6E/LY6E, Mouse (P.pastoris, His, SUMO) | Recombinant Proteins | |
| HY-P71831 | Azoreductase/NQO1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71832 | Kallikrein-8, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71833 | Arginase-1/ARG1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71834 | Chemotaxis inhibitory, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71835 | Gamma-hemolysin component C, S. aureus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71836 | CEMP1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71837 | S100A7A, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71838 | BPHL, Human (P.pastoris, His-Myc) | Recombinant Proteins | |
| HY-P7184 | GM-CSF, Rhesus macaque | Recombinant Proteins | |
| HY-P71840 | DST, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71841 | Serpin A3N, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71842 | ZG16B, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71843 | Plexin domain-containing 1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71844 | PGLYRP2/PGRP-L, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71845 | CD3 gamma, Cynomolgus (P.pastoris, His) | Recombinant Proteins | |
| HY-P71848 | BAG-3, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P7185 | Granzyme B/GZMB, Mouse (CHO) | Recombinant Proteins | |
| HY-P71850 | KCIP-1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71850Y | KCIP-1 , Mouse (P.pastoris, His, solution) | Recombinant Proteins | |
| HY-P71851 | ACSS1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71852 | Delta-like 3/DLL3, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71853 | RIPK3, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P71854 | MINPP1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71855 | RIPK3, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P71858A | IL-3, Rhesus macaque (His) | Recombinant Proteins | |
| HY-P71859 | IL-4, Rhesus macaque | Recombinant Proteins | |
| HY-P7186 | GRO-alpha/CXCL1, Mouse (CHO) | Recombinant Proteins | |
| HY-P71866 | IL-1 alpha, Rhesus macaque | Recombinant Proteins | |
| HY-P7187 | GRO-alpha/CXCL1, Human | Recombinant Proteins | |
| HY-P71876A | IL-1RN, Horse (His) | Recombinant Proteins | |
| HY-P71877 | CSF3, Rhesus macaque | Recombinant Proteins | |
| HY-P71878 | CXCL17, Human | Recombinant Proteins | |
| HY-P7188 | GRO-alpha/CXCL1, Mouse | Recombinant Proteins | |
| HY-P71883A | IP-10/CXCL10, Rhesus macaque (His) | Recombinant Proteins | |
| HY-P71885 | PF-4/CXCL4, Mouse | Recombinant Proteins | |
| HY-P71886 | I-TAC/CXCL11, Mouse | Recombinant Proteins | |
| HY-P71887A | CXCL14/BRAK, Mouse (His) | Recombinant Proteins | |
| HY-P71889 | CCL4, Mouse | Recombinant Proteins | |
| HY-P7189 | GRO-alpha/CXCL1, Rat | Recombinant Proteins | |
| HY-P71890 | RANTES/CCL5, Mouse | Recombinant Proteins | |
| HY-P71891A | TARC/CCL17, Mouse (His) | Recombinant Proteins | |
| HY-P71892 | CCL21C, Mouse | Recombinant Proteins | |
| HY-P71893 | TECK/CCL25, Mouse | Recombinant Proteins | |
| HY-P71894 | CTACK/CCL27, Mouse | Recombinant Proteins | |
| HY-P71897 | CXCL17, Rat | Recombinant Proteins | |
| HY-P71898 | MIP-1 alpha/CCL3, Rat | Recombinant Proteins | |
| HY-P71899 | CCL4, Rat | Recombinant Proteins | |
| HY-P7190 | GRO-beta/CXCL2, Human | Recombinant Proteins | |
| HY-P71901 | CCL11, Rat | Recombinant Proteins | |
| HY-P71902 | TARC/CCL17, Rat (His) | Recombinant Proteins | |
| HY-P71903 | MCP-5/CCL12, Rat | Recombinant Proteins | |
| HY-P71904A | CXCL8, Rhesus macaque (His) | Recombinant Proteins | |
| HY-P71905A | FGF-17, Human (His) | Recombinant Proteins | |
| HY-P71908A | Neuritin, Human (N-His) | Recombinant Proteins | |
| HY-P7191 | GRO-beta/CXCL2, Rat | Recombinant Proteins | |
| HY-P71913 | TL1A/TNFSF15, Human | Recombinant Proteins | |
| HY-P71916A | Prolactin, Rat (His) | Recombinant Proteins | |
| HY-P71917 | P4HB, Human (His) | Recombinant Proteins | |
| HY-P71918A | NAD-ME, Human (N-His) | Recombinant Proteins | |
| HY-P7192 | GRO-gamma/CXCL3, Human (CHO) | Recombinant Proteins | |
| HY-P71922A | Streptokinase G, Streptococcus sp. (His) | Recombinant Proteins | |
| HY-P71924 | Cardiotrophin-1/CTF1, Rat | Recombinant Proteins | |
| HY-P71925A | SCGB1A1, Rat (His) | Recombinant Proteins | |
| HY-P71928 | TFF1, Human | Recombinant Proteins | |
| HY-P71929A | TFF2, Human (His) | Recombinant Proteins | |
| HY-P7193 | GRO-gamma/CXCL3, Human | Recombinant Proteins | |
| HY-P71930A | TMSB4X, Human (His) | Recombinant Proteins | |
| HY-P71933 | Uteroglobin/SCGB1A1, Human | Recombinant Proteins | |
| HY-P71935A | FABP1/L-FABP, Mouse (His) | Recombinant Proteins | |
| HY-P71936A | SCGB1A1, Mouse (His) | Recombinant Proteins | |
| HY-P7194 | HB-EGF, Mouse | Recombinant Proteins | |
| HY-P71940A | ARMET/MANF, Human (His) | Recombinant Proteins | |
| HY-P71947A | XCL1, Rat (His) | Recombinant Proteins | |
| HY-P7195 | HCC-1/CCL14, Human | Recombinant Proteins | |
| HY-P71959A | FGF-12, Human (181a.a, His) | Recombinant Proteins | |
| HY-P7196 | HCC-4/CCL16, Human (CHO) | Recombinant Proteins | |
| HY-P71963 | IL-17RA, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P71965 | IL-36RN, Human | Recombinant Proteins | |
| HY-P7197 | HCC-4/CCL16, Human | Recombinant Proteins | |
| HY-P71978 | IL-15R alpha, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P7198 | I-309/CCL1, Human (CHO) | Recombinant Proteins | |
| HY-P71981 | TL1A/TNFSF15, Human (O95150-2, HEK293, His) | Recombinant Proteins | |
| HY-P71986 | CTLA-4, Guinea pig (P.pastoris, His) | Recombinant Proteins | |
| HY-P71991 | CTLA-4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P71992 | HVEM/TNFRSF14, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P71995 | TIM-3/HAVCR2, Mouse (HEK 293, hFc) | Recombinant Proteins | |
| HY-P72007 | NRG1-beta 1, Human (65a.a, His) | Recombinant Proteins | |
| HY-P72009 | YUAB, Bacillus subtilis (Cell-Free, His-SUMO) | Recombinant Proteins | |
| HY-P7201 | IFN-omega 1, Human | Recombinant Proteins | |
| HY-P72010 | OMA1, Human (Cell-Free, His-SUMO) | Recombinant Proteins | |
| HY-P72011 | SLC31A1, Human (Cell-Free, His-SUMO) | Recombinant Proteins | |
| HY-P72014 | CLEC4C, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72015 | TROP-2, Human (248a.a, HEK293, hFc) | Recombinant Proteins | |
| HY-P72018 | NKG2D/CD314, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72019 | Siglec-2/CD22, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72020 | CD46, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72021 | Siglec-3/CD33, Human (HEK293, Fc-Myc) | Recombinant Proteins | |
| HY-P72022 | SLAMF2/CD48, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72023 | ULBP1/RAET1I, Human (HEK293, Fc-Myc) | Recombinant Proteins | |
| HY-P72024 | Growth Hormone R/GHR, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72025 | TNFRII, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72026 | Transthyretin/TTR, Human (HEK293, Fc-Myc) | Recombinant Proteins | |
| HY-P72028 | CD40L/CD154/TRAP, Human (HEK293, hFc-Flag) | Recombinant Proteins | |
| HY-P72028A | CD40L/CD154/TRAP, Human (HEK293, N-hFc) | Recombinant Proteins | |
| HY-P72029 | ACE2, Macaca fascicularis (HEK293, hFc) | Recombinant Proteins | |
| HY-P7203 | IGF-I/IGF-1, Rat | Recombinant Proteins | |
| HY-P72030 | BTLA/CD272, Human (HEK293, hFc-Myc) | Recombinant Proteins | |
| HY-P72031 | RBP4, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72031A | RBP4, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P72032 | SECTM1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72033 | LIGHT/TNFSF14, Human (HEK293, hFC-Myc) | Recombinant Proteins | |
| HY-P72034 | SARS-CoV-2 Nucleocapsid, Human (His) | Recombinant Proteins | |
| HY-P72035 | SARS-CoV-2 S glycoprotein (HEK293, His, Flag) | Recombinant Proteins | |
| HY-P72036 | SARS-CoV-2 S glycoprotein (D614G, HEK293, His) | Recombinant Proteins | |
| HY-P72037 | SARS-CoV-2 S glycoprotein (P.pastoris, His, SUMO) | Recombinant Proteins | |
| HY-P72038 | SARS-CoV-2 S glycoprotein (HEK293, His-mFc) | Recombinant Proteins | |
| HY-P72039 | SARS-CoV-2 S glycoprotein (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P7204 | IHH, Human | Recombinant Proteins | |
| HY-P72040 | SARS-CoV-2 S glycoprotein (V367F, HEK293, His) | Recombinant Proteins | |
| HY-P72041 | SARS-CoV-2 S glycoprotein (G476S, HEK293, His) | Recombinant Proteins | |
| HY-P72042 | SARS-CoV-2 S glycoprotein (V483A, HEK293, His) | Recombinant Proteins | |
| HY-P72043 | TMPRSS2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72044 | TMPRSS2, Human (R255Q, HEK293, His) | Recombinant Proteins | |
| HY-P72045 | SARS-CoV S (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P72047 | APT, Streptococcus pyogenes serotype M1 (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72048 | BTK, Human (Sf9, His) | Recombinant Proteins | |
| HY-P72049 | CYP51, Mycobacterium tuberculosis (sf9, His) | Recombinant Proteins | |
| HY-P7205 | IL-1 beta, Human (CHO) | Recombinant Proteins | |
| HY-P72050 | GSTP1, Cricetulus longicaudatus (sf9, His-Myc) | Recombinant Proteins | |
| HY-P72051 | HSP90AA1, Sus scrofa (Sf9, His) | Recombinant Proteins | |
| HY-P72052 | KRT8, Human (sf9, His-Myc) | Recombinant Proteins | |
| HY-P72053 | PKM2, Mouse (Baculovirus, His) | Recombinant Proteins | |
| HY-P72054 | RCVRN, Human (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72055 | Serpin A5, Mouse (Baculovirus, His) | Recombinant Proteins | |
| HY-P72056 | TRA2B, Human (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72057 | PLY, Streptococcus pneumoniae serotype 4 (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72057A | PLY, Streptococcus pneumoniae serotype 4 (N-His) | Recombinant Proteins | |
| HY-P72058A | Enterotoxin type E, S. aureus (His) | Recombinant Proteins | |
| HY-P72059 | Enterotoxin type A, S. aureus (sf9, His-Myc) | Recombinant Proteins | |
| HY-P7206 | IL-1 beta, Pig | Recombinant Proteins | |
| HY-P72060 | ACPS, Streptococcus pyogenes serotype M28 (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72060A | ACPS, Streptococcus pyogenes serotype M28 (His) | Recombinant Proteins | |
| HY-P72061 | ADAM12, Mouse (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72062 | NEU2, Cricetulus griseus (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72063 | NRROS, Human (Baculovirus, His-Myc) | Recombinant Proteins | |
| HY-P72064 | LIMS1, Mouse (Baculovirus, His) | Recombinant Proteins | |
| HY-P72065 | PAK5, Human (Baculovirus, His) | Recombinant Proteins | |
| HY-P72066 | ISCU, Human (Sf9, His) | Recombinant Proteins | |
| HY-P72068 | ABAT, Human (His, SUMO, Myc) | Recombinant Proteins | |
| HY-P72069 | ABCC1, Human (His) | Recombinant Proteins | |
| HY-P7207 | IL-1 beta, Rhesus macaque | Recombinant Proteins | |
| HY-P72070 | ACLY, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72071 | ADH1B, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72072 | SPEB, E.coli (His-SUMO) | Recombinant Proteins | |
| HY-P72073 | AHCY, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72074 | AICDA, Mouse (His-Myc) | Recombinant Proteins | |
| HY-P72075 | AIF1, Mouse (His) | Recombinant Proteins | |
| HY-P72076 | ALOX12, Human (His) | Recombinant Proteins | |
| HY-P72077 | Muellerian-inhibiting factor/AMH, Mouse | Recombinant Proteins | |
| HY-P72078 | Annexin A1/ANXA1, Mouse (His) | Recombinant Proteins | |
| HY-P72079 | Annexin A4/ANXA4, Mouse (His-Myc) | Recombinant Proteins | |
| HY-P7208 | IL-12, Mouse (CHO) | Recombinant Proteins | |
| HY-P72080 | APOBEC3A, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72081 | APOC3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72082 | Apolipoprotein C-III/APOC3, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72083 | Apolipoprotein E/APOE, Rabbit (His-SUMO) | Recombinant Proteins | |
| HY-P72084 | Apolipoprotein E/APOE, Rabbit (His-B2M, Myc) | Recombinant Proteins | |
| HY-P72085 | AQP1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72086 | AQP1, Human (GST) | Recombinant Proteins | |
| HY-P72087 | AQP4, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72087A | AQP4, Human (His) | Recombinant Proteins | |
| HY-P72088 | Androgen receptor, Human (His-SUMO, Myc) | Recombinant Proteins | |
| HY-P72089 | ARF1, Human (His-GST, Myc) | Recombinant Proteins | |
| HY-P7209 | IL-17F, Human | Recombinant Proteins | |
| HY-P72090 | Arginase-2/ARG2, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72091 | ASGR2/ASGPR2, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72092 | ASPH, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72093 | ASPN, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72094 | ATP2A2, Human (His) | Recombinant Proteins | |
| HY-P72095 | ATP5F1A, Human (His) | Recombinant Proteins | |
| HY-P72096 | ATP5F1A, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72097 | ATP5D, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72098 | ATP5D, Human (His) | Recombinant Proteins | |
| HY-P72099 | ATP6AP2, Human (His) | Recombinant Proteins | |
| HY-P7210 | IL-18, Rat | Recombinant Proteins | |
| HY-P72100 | ATP6AP2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72101 | BCL2, Mouse (His) | Recombinant Proteins | |
| HY-P72102 | BCL6, Human (GST) | Recombinant Proteins | |
| HY-P72103 | BGLAP, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72104 | BGLAP, Rat (GST) | Recombinant Proteins | |
| HY-P72105 | BLM, Mouse (His-Myc) | Recombinant Proteins | |
| HY-P72107 | BRCC36, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72108 | C1QA, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72109 | CACNA2D1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P7211 | IL-18BP, Human (CHO) | Recombinant Proteins | |
| HY-P72110 | CALML3, Human (GST) | Recombinant Proteins | |
| HY-P72111 | Calreticulin/CALR, Human (His) | Recombinant Proteins | |
| HY-P72112 | Calreticulin/CALR, Mouse (GST) | Recombinant Proteins | |
| HY-P72113 | CAPN1, Human (His) | Recombinant Proteins | |
| HY-P72114 | CAPN1, Mouse (His) | Recombinant Proteins | |
| HY-P72115 | CAPN2, Human (His) | Recombinant Proteins | |
| HY-P72116 | CAPZA2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72117 | Caspase-1/CASP1 p20, Human (GST) | Recombinant Proteins | |
| HY-P72118 | CBS, Human (His) | Recombinant Proteins | |
| HY-P72119 | CCND1, Human (His) | Recombinant Proteins | |
| HY-P7212 | IL-19, Human | Recombinant Proteins | |
| HY-P72120 | CCT2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72121 | CD40L/CD154/TRAP, Rhesus macaque (His) | Recombinant Proteins | |
| HY-P72122 | CD40L/CD154/TRAP, Rabbit (His) | Recombinant Proteins | |
| HY-P72123 | CD52, Human (His) | Recombinant Proteins | |
| HY-P72124 | CD63, Mouse (GST) | Recombinant Proteins | |
| HY-P72126 | CD81, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72127 | CDR2, Human (His) | Recombinant Proteins | |
| HY-P72128 | CEACAM1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72129 | CEACAM1, Human | Recombinant Proteins | |
| HY-P72129A | CEACAM1, Human (N-His) | Recombinant Proteins | |
| HY-P7213 | IL-19, Mouse | Recombinant Proteins | |
| HY-P72130 | CEACAM3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72131 | CEACAM6, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72132 | CEACAM7, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72133 | CEACAM8/CD66b, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72134 | CEBP delta/CEBPD, Human (His-Myc) | Recombinant Proteins | |
| HY-P72135 | CELA2A, Human (His) | Recombinant Proteins | |
| HY-P72136 | CELA2A, Mouse (His) | Recombinant Proteins | |
| HY-P72137 | Complement Factor B/CFB Protein, Mouse (His) | Recombinant Proteins | |
| HY-P72138 | CHRM1, Rat (His) | Recombinant Proteins | |
| HY-P72139 | CHRNA1, Human (His) | Recombinant Proteins | |
| HY-P7214 | IL-20, Human | Recombinant Proteins | |
| HY-P72140 | CHRNA1, Human (His-Trx) | Recombinant Proteins | |
| HY-P72141 | CHRNA1, Mouse (His) | Recombinant Proteins | |
| HY-P72142 | CHRNA1, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72143 | CHRNA1, Tetronarce californica (His-SUMO) | Recombinant Proteins | |
| HY-P72144 | CHRNA3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72145 | CIRBP, Mouse (His) | Recombinant Proteins | |
| HY-P72146 | Claudin-3/CLDN3, Human (His-B2M) | Recombinant Proteins | |
| HY-P72147 | COL4A2, Human (His) | Recombinant Proteins | |
| HY-P72148 | COL4A3, Human (His) | Recombinant Proteins | |
| HY-P72149 | COMT, Human (His) | Recombinant Proteins | |
| HY-P7215 | IL-2R alpha/CD25, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P72150 | COX4I1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72151 | CSAD, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72152 | CSNK1E, Human (His) | Recombinant Proteins | |
| HY-P72153 | CCN2/CTGF, Human (His) | Recombinant Proteins | |
| HY-P72154 | CCN2/CTGF, Mouse (GST) | Recombinant Proteins | |
| HY-P72155 | Cathepsin D, Cricetulus griseus (His-SUMO) | Recombinant Proteins | |
| HY-P72157 | Cathepsin K, Mouse (His) | Recombinant Proteins | |
| HY-P72158 | Cathepsin K, Rat (His) | Recombinant Proteins | |
| HY-P72159 | CXCR4, Human (N-His-SUMO, C-Myc) | Recombinant Proteins | |
| HY-P7216 | IL-3, Canine | Recombinant Proteins | |
| HY-P72160 | CXCR4, Human (GST) | Recombinant Proteins | |
| HY-P72161 | CYBB/Nox2, Human (His) | Recombinant Proteins | |
| HY-P72162 | CYGB, Rat (His-Myc) | Recombinant Proteins | |
| HY-P72163 | CYP11B2, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72164 | CYP21A2, Human (His) | Recombinant Proteins | |
| HY-P72165 | ERG11, Saccharomyces cerevisiae (GST) | Recombinant Proteins | |
| HY-P72166 | DBI, Human (103a.a, His) | Recombinant Proteins | |
| HY-P72167 | DBI, Mouse (His-Myc) | Recombinant Proteins | |
| HY-P72168 | DCT, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72169 | DCT, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P7217 | IL-31, Human | Recombinant Proteins | |
| HY-P72170 | DDX58, Human (His) | Recombinant Proteins | |
| HY-P72171 | DEFA1, Human (GST) | Recombinant Proteins | |
| HY-P72172 | DENR, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72174 | DSG3, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72175 | DSG3, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72176 | DSP, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72177 | TMK, Bacillus anthracis (His) | Recombinant Proteins | |
| HY-P72178 | EEF1A1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72179 | ELANE, Human (GST) | Recombinant Proteins | |
| HY-P7218 | IL-33, Mouse | Recombinant Proteins | |
| HY-P72180 | ELAVL4, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72181 | EN1, Gallus gallus (His-B2M) | Recombinant Proteins | |
| HY-P72182 | Enolase 1/ENO1, Mouse (His) | Recombinant Proteins | |
| HY-P72183 | EpCAM/TROP1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72184 | EPHX1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72185 | Erythropoietin, Horse (His-SUMO) | Recombinant Proteins | |
| HY-P72186 | Erythropoietin, Cynomolgus (His-SUMO) | Recombinant Proteins | |
| HY-P72187 | Erythropoietin/EPO, Pig (His-B2M) | Recombinant Proteins | |
| HY-P72188 | Coagulation Factor XI/F11, Human (His) | Recombinant Proteins | |
| HY-P72189 | Coagulation Factor XII/F12, Pig (His) | Recombinant Proteins | |
| HY-P7219 | IL-4, Porcine (CHO) | Recombinant Proteins | |
| HY-P72190 | FANCC, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72191 | Fc epsilon RIA/FCER1A, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72192 | FCGRT, Human (GST) | Recombinant Proteins | |
| HY-P72193 | FDFT1, Human (His) | Recombinant Proteins | |
| HY-P72194 | FGA, Human (His) | Recombinant Proteins | |
| HY-P72195 | FGF-23, Rat (His) | Recombinant Proteins | |
| HY-P72196 | FGFR-3, Human (His-B2M) | Recombinant Proteins | |
| HY-P72197 | FOXM1, Human (His, SUMO-Myc) | Recombinant Proteins | |
| HY-P72198 | FSHR, Human (His) | Recombinant Proteins | |
| HY-P72199 | FXN, Mouse (His) | Recombinant Proteins | |
| HY-P7220 | IL-4R alpha/CD124, Human (HEK293) | Recombinant Proteins | |
| HY-P72200 | FXN, Rat | Recombinant Proteins | |
| HY-P72201 | GAPDH, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72202 | Vitamin D-binding/GC, Human (His) | Recombinant Proteins | |
| HY-P72203 | GFAP, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72204 | Growth Hormone R/GHR, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72205 | GJA1, Human (His) | Recombinant Proteins | |
| HY-P72206 | GLP1R, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72207 | GNAO1, Mouse (His) | Recombinant Proteins | |
| HY-P72208 | GNAZ, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72209 | GOLM1, Human (His) | Recombinant Proteins | |
| HY-P72209A | GOLM1, Human (His, Solution) | Recombinant Proteins | |
| HY-P72210 | Glucose-6-phosphate isomerase, Mouse (His-B2M) | Recombinant Proteins | |
| HY-P72211 | EGLP/GPX5, Pig (His-Myc) | Recombinant Proteins | |
| HY-P72212 | GLXR, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P72214 | GSTP1, Cricetulus longicaudatus (His-Myc) | Recombinant Proteins | |
| HY-P72215 | GSTP1, Human (His) | Recombinant Proteins | |
| HY-P72217 | GSTP1, Rat (His) | Recombinant Proteins | |
| HY-P72218 | GYPA/CD235a, Human (GST) | Recombinant Proteins | |
| HY-P72219 | GYPA/CD235a, Human (His) | Recombinant Proteins | |
| HY-P7222 | IL-6, Rhesus macaque | Recombinant Proteins | |
| HY-P72220 | GZMA/Granzyme A, Mouse (His-B2M) | Recombinant Proteins | |
| HY-P72221 | HAMP, Larimichthys crocea | Recombinant Proteins | |
| HY-P72222 | HAS2, Mouse (His) | Recombinant Proteins | |
| HY-P72224 | HDAC6, Human (His) | Recombinant Proteins | |
| HY-P72225 | HIST1H2BM, Mouse (His) | Recombinant Proteins | |
| HY-P72226 | HJURP, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72227 | HLA-G, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72228 | HMGCR, Human (His) | Recombinant Proteins | |
| HY-P72229 | HNRNPA1, Human (His) | Recombinant Proteins | |
| HY-P7223 | IL-6R alpha, Human (CHO) | Recombinant Proteins | |
| HY-P72230 | HNRNPA2B1, Human (His-B2M) | Recombinant Proteins | |
| HY-P72231 | HNRNPA2B1, Human (GST) | Recombinant Proteins | |
| HY-P72232 | HNRNPA2B1, Mouse (His-SUMO, Myc) | Recombinant Proteins | |
| HY-P72233 | HNRNPH1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72234 | HNRNPM, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72235 | HPSE, Rat (His-Myc) | Recombinant Proteins | |
| HY-P72236 | Hemopexin, Rat (His) | Recombinant Proteins | |
| HY-P72237 | HSD11B1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72238 | HSP90AA1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72239 | HSPA5/GRP-78, Human (His) | Recombinant Proteins | |
| HY-P7224 | IL-8/CXCL8, Human | Recombinant Proteins | |
| HY-P72240 | IAPP, Human (GST) | Recombinant Proteins | |
| HY-P72241 | IBSP, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72242 | IDUA, Human (His) | Recombinant Proteins | |
| HY-P72243 | IFN-alpha 14/IFNA14, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72244 | IFN-alpha 6/IFNA6, Human (His-Myc) | Recombinant Proteins | |
| HY-P72245 | IFN-gamma, Sheep (His) | Recombinant Proteins | |
| HY-P72246 | IFN-omega 1, Bovine (His-SUMO) | Recombinant Proteins | |
| HY-P7225 | IP-10/CXCL10, Rat (HEK293) | Recombinant Proteins | |
| HY-P72256 | IGF-I R, Human (His) | Recombinant Proteins | |
| HY-P72257 | Cellular tumor antigen P53/TP53, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72258 | Melanoma antigen preferentially/PRAME, Human (His) | Recombinant Proteins | |
| HY-P72259 | Protein E7, HPV16 (His) | Recombinant Proteins | |
| HY-P7226 | IP-10/CXCL10, Human | Recombinant Proteins | |
| HY-P72260 | Protein E6, HPV16 (His) | Recombinant Proteins | |
| HY-P72261 | Wilms tumor/WT1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72262 | Histone deacetylase 1/HDAC1, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72263 | NUP210, Human (His) | Recombinant Proteins | |
| HY-P72264 | TPM2, Human (His) | Recombinant Proteins | |
| HY-P72265 | Neurofilament light polypeptide/NEFL, Human (His-SUMO, myc) | Recombinant Proteins | |
| HY-P72266 | Frataxin/FXN, Human (His, Myc) | Recombinant Proteins | |
| HY-P72267 | HGFR, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72268 | Nucleoprotein/NP, HCoV-NL63 (Sf9, His, myc) | Recombinant Proteins | |
| HY-P72269 | HCoV-OC43 Spike/S, HCoV-OC43 (Sf9, His, myc) | Recombinant Proteins | |
| HY-P7227 | IP-10/CRG-2/CXCL10, Mouse | Recombinant Proteins | |
| HY-P72270 | Toll-like receptor 8/TLR8, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72271 | TRAC, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72272 | CBR1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72273 | MUSK, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72274 | Islet cell autoantigen 1/ICA1, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72275 | Cardiac phospholamban/PLN, Human (P.pastoris, GST) | Recombinant Proteins | |
| HY-P72276 | Reelin/RELN, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72279 | Outer membrane F/OmpF, E.coli (His, myc) | Recombinant Proteins | |
| HY-P7228 | I-TAC/CXCL11, Human (HEK293) | Recombinant Proteins | |
| HY-P72280 | VEGF-A, Pig (His) | Recombinant Proteins | |
| HY-P72280AF | Animal-Free VEGF, Pig (His) | Recombinant Proteins | |
| HY-P72281 | Cathepsin W/CTSW, Mouse (His, Myc) | Recombinant Proteins | |
| HY-P72282 | Nucleolar transcription factor 1/UBTF, Human (His-SUMO) | Recombinant Proteins | |
| HY-P72283 | Nucleoprotein/NP, Influenza B virus (His-SUMO) | Recombinant Proteins | |
| HY-P72284 | Nucleoprotein/NP, Influenza A virus H1N1 (His-SUMO) | Recombinant Proteins | |
| HY-P72285 | Nucleoprotein/NP, Influenza A virus H3N2 (His-SUMO) | Recombinant Proteins | |
| HY-P72286 | Outer membrane C/OmpC, Klebsiella pneumoniae (His, myc) | Recombinant Proteins | |
| HY-P72287 | Prolactin, Pig (His-SUMO) | Recombinant Proteins | |
| HY-P72288 | HLA-A, Human (His) | Recombinant Proteins | |
| HY-P72289 | Leukocyte elastase inhibitor/SERPINB1, Pig (His, myc) | Recombinant Proteins | |
| HY-P7229 | I-TAC/CXCL11, Human | Recombinant Proteins | |
| HY-P72290 | Chymase/CMA1, Mouse (His) | Recombinant Proteins | |
| HY-P72291 | Clumping factor B, S. aureus (His) | Recombinant Proteins | |
| HY-P72292 | Vitamin D-binding/GC, Mouse (His) | Recombinant Proteins | |
| HY-P72293 | Group XV phospholipase A2/Pla2g15, Mouse (His, myc) | Recombinant Proteins | |
| HY-P72294 | 40S Ribosomal S3/RPS3, Human (His) | Recombinant Proteins | |
| HY-P72295 | Inhibin alpha chain/INHA, Bovine (His-SUMO) | Recombinant Proteins | |
| HY-P72296 | DNA helicase II/uvrD, E.coli | Recombinant Proteins | |
| HY-P72297 | Apolipoprotein M/APOM, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P72298 | CDK5, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72300 | Protein L1/VACWR088, Vaccinia virus (Sf9, His, myc) | Recombinant Proteins | |
| HY-P72301 | Protein L1/L1R, Vaccinia virus (Sf9, His, myc) | Recombinant Proteins | |
| HY-P72302 | Intermediate capsid VP6, Rotavirus A (sf9, His, Myc) | Recombinant Proteins | |
| HY-P72302A | Intermediate capsid VP6, Rotavirus A (sf9, His) | Recombinant Proteins | |
| HY-P72303 | Atrial natriuretic peptide receptor 2/NPR2, Human (His) | Recombinant Proteins | |
| HY-P72305 | Neurofilament light polypeptide/NEFL, Mouse (His) | Recombinant Proteins | |
| HY-P72307 | Major capsid VP1, Murine polyomavirus (Sf9, His) | Recombinant Proteins | |
| HY-P72308 | NFE2L2, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P72309 | Lanosterol synthase/LSS, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P7231 | LD78-beta/CCL3L1, Human | Recombinant Proteins | |
| HY-P7232 | Leptin, Human | Recombinant Proteins | |
| HY-P72328 | H2AC4, Human | Recombinant Proteins | |
| HY-P72329 | H2BC11, Human | Recombinant Proteins | |
| HY-P7232A | Leptin, Human (His) | Recombinant Proteins | |
| HY-P7233 | Leptin, Rat | Recombinant Proteins | |
| HY-P72330 | Histone H2A, Xenopus laevis | Recombinant Proteins | |
| HY-P72331 | Histone H2B 1.1, Xenopus laevis | Recombinant Proteins | |
| HY-P72332 | Histone H3, Human | Recombinant Proteins | |
| HY-P72333 | Histone H3, Xenopus laevis (135a.a) | Recombinant Proteins | |
| HY-P72334 | Histone H3, Xenopus laevis (98a.a, His) | Recombinant Proteins | |
| HY-P72335 | Histone H3, Human (98a.a, His) | Recombinant Proteins | |
| HY-P72336 | Histone H4, Human/Xenopus laevis | Recombinant Proteins | |
| HY-P72337 | cGAS, Human (His) | Recombinant Proteins | |
| HY-P72338 | OGG1, Human (His) | Recombinant Proteins | |
| HY-P72338A | OGG1, Human (N-His) | Recombinant Proteins | |
| HY-P7233A | Leptin, Rat (His) | Recombinant Proteins | |
| HY-P7234 | Lymphotactin/XCL1, Human | Recombinant Proteins | |
| HY-P72341 | B7-H4, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72342 | BCMA/TNFRSF17, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72343 | BTN1A1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72344 | BTN2A2, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72345 | BTN3A1/CD277, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72346 | BTN3A2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72347 | CA125, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72348 | Carbonic Anhydrase 9, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72349 | IL-3R alpha/CD123, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P7235 | MCP-1/CCL2, Mouse (HEK293) | Recombinant Proteins | |
| HY-P72350 | Basigin/CD147, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72351 | Siglec-2/CD22, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72352 | CD24, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72353 | CD28, Human/Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72354 | CD30/TNFRSF8, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72355 | CD36, Mouse (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72356 | CD38, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72358 | CD40L/CD154/TRAP, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72359 | CD47, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P7236 | MCP-1/CCL2, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P72360 | CD52, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72361 | CD7, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72362 | CEACAM5, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72363 | CTLA-4, Human (Biotinylated, HEK293, hFc-Avi) | Recombinant Proteins | |
| HY-P72364 | CXADR, Mouse (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72367 | EpCAM/TROP1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72368 | FCRN-B2M, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72369 | FGL1, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P7237 | MCP-1/CCL2, Human | Recombinant Proteins | |
| HY-P72370 | Fibronectin, Human (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P72371 | FOLR1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72372 | Frizzled-8, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72373 | Glypican-3/GPC3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72374 | HER2/CD340, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72375 | HER3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72376 | HGFR, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72377 | HLA-A*0201 GP100 complex, Human (Biotinylated, IMDQVPFSV, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72378 | IGFBP-5, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72379 | IgG1, Human (Biotinylated, HEK293, Avi) | Recombinant Proteins | |
| HY-P7238 | MCP-2/CCL8, Human | Recombinant Proteins | |
| HY-P72380 | IL-1 alpha, Human (Biotinylated, HEK293, Avi) | Recombinant Proteins | |
| HY-P72381 | IL-13R alpha 1, Mouse (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72382 | IL-13, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72383 | "IL-17C, Human (Biotinylated, HEK293, His-Avi)" | Recombinant Proteins | |
| HY-P72385 | IL-2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72386 | IL-2R beta/CD122, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72387 | IL-5, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72388 | IL-6R alpha, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72389 | LAG-3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7239 | MCP-2/CCL8, Mouse | Recombinant Proteins | |
| HY-P72390 | LAIR1, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72391 | LAIR2, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72392 | LDLR, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72393 | LILRA3/CD85e/ILT6, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72394 | LILRA5/CD85f, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72395 | LILRB1/CD85j/ILT2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72396 | LILRB2/CD85d/ILT-4, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72397 | MAdCAM1, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72398 | Mesothelin, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72399 | Mucin-1/MUC1, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P7240 | MCP-3/CCL7, Human (CHO) | Recombinant Proteins | |
| HY-P72400 | Nectin-2/CD112, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72401 | Nectin-4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72403 | Neuropilin-1, Human (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72404 | OX40/TNFRSF4, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72405 | PCSK9, Human (Biotinylated, V474I, G670E, HEK293, Avi) | Recombinant Proteins | |
| HY-P72406 | PD-1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72407 | PD-L2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72408 | P-selectin, Mouse (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72409 | PVRIG, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72410 | ROR1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72411 | Siglec-10, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P72412 | SIRP alpha/CD172a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72413 | CD150/SLAMF1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72414 | CD84/SLAMF5, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72415 | SLAMF6, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72416 | CRACC/SLAMF7, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72418 | TIGIT, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72419 | TIM-3/HAVCR2, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P7242 | MCP-3/CCL7, Human | Recombinant Proteins | |
| HY-P72420 | TNF RII/TNFRSF1B, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72421 | TPBG/5T4, Human (HEK293, Avi-His) | Recombinant Proteins | |
| HY-P72425 | GDF-9, Human (GST) | Recombinant Proteins | |
| HY-P72426 | BMP-15, Human (His, Myc) | Recombinant Proteins | |
| HY-P72426A | BMP-15, Human (His, Myc, soluition) | Recombinant Proteins | |
| HY-P72427 | VSIG8, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P72427A | VSIG8, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P72428 | VISTA/B7-H5, Mouse (159a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72429 | VEGFR-2, Mouse (743a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P7243 | MCP-3/CCL7, Mouse | Recombinant Proteins | |
| HY-P72430 | VEGF-DD, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72431 | VEGF-BB, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72432 | VCAM-1/CD106, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72433 | uPAR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72434 | TNFRSF12A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72435 | TNFRSF12A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72436 | TrkB, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72438 | TREM-2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72439 | TRAILR4/TNFRSF10D, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7244 | MCP-3/CCL7, Rat | Recombinant Proteins | |
| HY-P72440 | TRAIL R1/TNFRSF10A, Human (216a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72442 | BAFF/TNFSF13B, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P72443 | TNF RI/TNFRSF1A, Mouse | Recombinant Proteins | |
| HY-P72444 | TNF RII/TNFRSF1B, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P72445 | TMED1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72446 | TL1A/TNFSF15, Mouse | Recombinant Proteins | |
| HY-P72447 | TIM-3/HAVCR2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72448 | TIM-3/HAVCR2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72449 | TIGIT, Mouse (110a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7245 | MCP-4/CCL13, Human | Recombinant Proteins | |
| HY-P72450 | TIE-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72451 | Thrombomodulin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72452 | TGFBR3/TGF-beta RIII, Mouse (763a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72453 | TGFBR1/ALK-5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72454 | TGFBR1/ALK-5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72455 | TFRC, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72456 | TCblR/CD320, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72457 | TNFRSF13B, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72458 | TNFRSF13B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72459 | ST2/IL1RL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7246 | MCP-5/CCL12, Mouse (CHO) | Recombinant Proteins | |
| HY-P72460 | CRACC/SLAMF7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72461 | CRACC/SLAMF7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72463 | CD84/SLAMF5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72464 | CD229/SLAMF3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72465 | CD229/SLAMF3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72466 | SLAMF2/CD48, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72467 | CD150/SLAMF1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72468 | SIRP alpha/CD172a, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72469 | SIRP alpha/CD172a, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7247 | M-CSF, Rat (CHO) | Recombinant Proteins | |
| HY-P72470 | Siglec-F, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72471 | Siglec-5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72472 | Siglec-3/CD33, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P72473 | Siglec-3/CD33, Mouse (G236R, HEK293, His) | Recombinant Proteins | |
| HY-P72474 | Siglec-2/CD22, Mouse (AAA02562.1, HEK293, His) | Recombinant Proteins | |
| HY-P72474A | Siglec-2/CD22, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72475 | Siglec-15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72476 | Siglec-10, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72477 | Serpin A8/Angiotensinogen, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P72478 | Semaphorin-4D/SEMA4D, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72479 | Syndecan-1/CD138, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7248 | MDC/CCL22, Mouse (His) | Recombinant Proteins | |
| HY-P72480 | SCF, Rat (His) | Recombinant Proteins | |
| HY-P72481 | S100A2, Human | Recombinant Proteins | |
| HY-P72482 | S100A11, Human | Recombinant Proteins | |
| HY-P72483 | RANK/TNFRSF11A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72484 | RANK/TNFRSF11A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72485 | CD162/PSGL-1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72486 | PSG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72486A | PSG1 Protein, Human (HEK 293, hFc) | Recombinant Proteins | |
| HY-P72487 | HB-EGF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72488 | pro-Beta-NGF, Human (223a.a) | Recombinant Proteins | |
| HY-P72489 | BDNF, Human (R125A, R127A, R128A) | Recombinant Proteins | |
| HY-P72489Y | BDNF, Human (R125A, R127A, R128A, solution) | Recombinant Proteins | |
| HY-P7249 | MDC/CCL22, Rat | Recombinant Proteins | |
| HY-P72490 | CD31/PECAM-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72491 | PD-L2, Mouse (200a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P72492 | PD-L2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72493 | PD-L2, Rhesus macaque/Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72494 | PDGF R beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72495 | PDGF R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72496 | PDGF R alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72497 | OX40 Ligand/TNFSF4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72498 | OX40 Ligand/TNFSF4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72499 | OX40/TNFRSF4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7250 | MEC/CCL28, Human | Recombinant Proteins | |
| HY-P72500 | OSMR beta, Human (712a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72501 | NKp80/KLRF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72502 | NKp44/NCR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72503 | NKG2D/CD314, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72504 | NKG2D/CD314, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72505A | MME, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P72506 | NKp30/NCR3, Human (120a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72507 | MMP-8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72508 | Ki67/MKI67 Protein, Human (GST) | Recombinant Proteins | |
| HY-P72509 | CSF1R, Human (498a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7251 | MEC/CCL28, Mouse | Recombinant Proteins | |
| HY-P72510 | TIM-3/HAVCR2, Marmoset (HEK293, His) | Recombinant Proteins | |
| HY-P72512 | LRRC15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72514 | CD300a/LMIR1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72515 | LIMPII/SR-B2, Mouse (406a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72516 | IFN-zeta/Limitin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72517 | LILRB5/CD85c/LIR-8, Human (433a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72518 | LILRB4/CD85k/ILT3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72519 | LILRB4/CD85k/ILT3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7252 | MEC/CCL28, Rat | Recombinant Proteins | |
| HY-P72520 | LILRB1/CD85j/ILT2, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P72521 | LILRA5/CD85f, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72522 | LIGHT/TNFSF14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72523 | Leptin R/LEPR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72524 | Leptin R/LEPR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72525 | LAMP2/CD107b, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72526 | LAMP1/CD107a, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72527 | LAIR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72528 | LAIR1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P72529 | LAIR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7253 | MIG/CXCL9, Human | Recombinant Proteins | |
| HY-P72530 | LAG-3, Cynomolgus (428a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72533 | ITGA5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72534 | Irisin, Human/Mouse/Rat (HEK293, N-His) | Recombinant Proteins | |
| HY-P72535 | Integrin alpha V beta 8 Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72536 | CD127/IL-7RA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72537 | CD127/IL-7RA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72538 | IL-6R alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72539 | IL-5R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7254 | MIP-1 alpha/CCL3, Human (CHO) | Recombinant Proteins | |
| HY-P72540 | IL-5R alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72541 | IL-4R alpha/CD124, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72542 | IL-3R alpha/CD123, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72544 | IL-36 gamma/IL-1F9, Mouse | Recombinant Proteins | |
| HY-P72545 | IL-36 beta/IL-1F8, Human | Recombinant Proteins | |
| HY-P72546 | IL-36 beta/IL-1F8, Mouse | Recombinant Proteins | |
| HY-P72547 | IL-36 alpha/IL-1F6, Mouse | Recombinant Proteins | |
| HY-P72548 | IL-33, Rhesus macaque (His) | Recombinant Proteins | |
| HY-P72549 | IL-2R beta/CD122, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7255 | MIP-1 alpha/CCL3, Mouse (HEK293) | Recombinant Proteins | |
| HY-P72550 | IL-2R alpha/CD25, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72551 | IFN-lambda 1/IL-29, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72552 | IFN-lambda 3/IL-28B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72553 | IFN-lambda 2/IL-28A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72554 | IL-27, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72555 | IL-25/IL-17E, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72556 | IL-23R, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72557 | IL-22BP/IL-22RA2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72559 | IL-21R, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7256 | MIP-1 alpha/CCL3, Human | Recombinant Proteins | |
| HY-P72560 | IL-21R, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72561 | IL-20R beta Protein, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72562 | IL-20R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72564 | IL-2, Human (L100F, R101D, L105V, I106V, I112F, HEK293, His) | Recombinant Proteins | |
| HY-P72565 | IL-1RAcP/IL-1 R3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72566 | IL-1RA/IL-1RN, Mouse | Recombinant Proteins | |
| HY-P72567 | IL-1R2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72568 | IL-1R2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72569 | IL-1R1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7256AF | Animal-Free MIP-1 alpha/CCL3, Human (His) | Recombinant Proteins | |
| HY-P7257 | CCL4, Human | Recombinant Proteins | |
| HY-P72570 | IL-1F10/IL-38, Human | Recombinant Proteins | |
| HY-P72571 | IL-1 beta, Cavia porcellus (His) | Recombinant Proteins | |
| HY-P72572 | IL-1 alpha, Rat | Recombinant Proteins | |
| HY-P72573 | IL-18R beta/IL-1R7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72574 | IL-18BP, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72575 | IL-18BP, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72576 | IL-17RE, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72577 | IL-17RE, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72578 | IL-17RD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72579 | IL-17RD, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7258 | MIP-2/CXCL2, Mouse | Recombinant Proteins | |
| HY-P72580 | IL-17RC, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72581 | IL-17RB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72582 | IL-17RB, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72583 | IL-17RA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72584 | IL-17F, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72585 | IL-17F, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72586 | IL-17F, Human (HEK293) | Recombinant Proteins | |
| HY-P72587 | IL-17C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72588 | IL-17B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72589 | IL-17A/F Heterodimer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7258A | MIP-2/CXCL2, Mouse (HEK293) | Recombinant Proteins | |
| HY-P7259 | MPIF-1/CCL23, Human (99a.a, CHO) | Recombinant Proteins | |
| HY-P72590 | IL-16, Mouse (His) | Recombinant Proteins | |
| HY-P72590AF | Animal-Free IL-16, Mouse (His) | Recombinant Proteins | |
| HY-P72592 | IL-15R alpha, Human (142a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P72594 | IL-13R alpha 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72595 | IL-13, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72596 | IL-12R beta 2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72597 | IL-12 beta, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72598 | IL-12, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72599 | IL-10R beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7260 | MIP-3 alpha/CCL20, Human (CHO) | Recombinant Proteins | |
| HY-P72600 | IgG3 Fc, Human (HEK293) | Recombinant Proteins | |
| HY-P72602 | IgG2B Fc, Mouse (HEK293) | Recombinant Proteins | |
| HY-P72603 | IgG2A Fc, Mouse (HEK293) | Recombinant Proteins | |
| HY-P72604 | IgG2A Fc, Rat (HEK293) | Recombinant Proteins | |
| HY-P72605 | IgG2 Fc, Human (V161M, S257A, HEK293) | Recombinant Proteins | |
| HY-P72606 | IGF-I R, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72608 | IGFBP-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72609 | Ig kappa, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7261 | MIP-3 alpha/CCL20, Rat (HEK293) | Recombinant Proteins | |
| HY-P72610 | IFN-omega 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72611 | IFN-gamma R1/CD119, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72612 | IFN-gamma R1/CD119, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P72612A | IFN-gamma R1/CD119, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72613 | IFN-alpha/beta R2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72614 | IFN-alpha 6/IFNA6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72615 | IFN-alpha 4/IFNA4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72616 | IDO-1, Mouse (His) | Recombinant Proteins | |
| HY-P72618 | ICOS, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72619 | ICOS, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7262 | MIP-3 alpha/CCL20, Human | Recombinant Proteins | |
| HY-P72620 | ICAM-2/CD102, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72621 | ICAM-1/CD54, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72622 | ICAM-1/CD54, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P72624 | HGFR, Human (495a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72625 | HER3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72625A | HER3, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P72626 | HER2/CD340, Rat (His) | Recombinant Proteins | |
| HY-P72628 | Glypican-3/GPC3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72629 | GM-CSF, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7263 | MIP-3 alpha/CCL20, Mouse | Recombinant Proteins | |
| HY-P72631 | GITR, Mouse (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P72632 | GDF-8, Human/Mouse/Rat (HEK293) | Recombinant Proteins | |
| HY-P72633 | GDF-5, Human | Recombinant Proteins | |
| HY-P72634 | G-CSFR/CD114, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72635 | Grancalcin/GCA, Human (GST) | Recombinant Proteins | |
| HY-P72636 | GARP&Latent TGF Beta-1 Complex, Human (HEK293, His, Strep) | Recombinant Proteins | |
| HY-P72637 | Galectin-9/LGALS9, Mouse (GST) | Recombinant Proteins | |
| HY-P72638 | Galectin-4/LGALS4, Human (His) | Recombinant Proteins | |
| HY-P72638AF | Animal-Free Galectin-4/LGALS4, Human (His) | Recombinant Proteins | |
| HY-P72639 | GABARAP, Human (His, Fc) | Recombinant Proteins | |
| HY-P7264 | MIP-3 beta/CCL19, Mouse | Recombinant Proteins | |
| HY-P72640 | Follistatin-like 1/FSTL1, Human (His) | Recombinant Proteins | |
| HY-P72641 | FIBP, Human | Recombinant Proteins | |
| HY-P72642 | FGL1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72643 | FGFRL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72644 | FGFR-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72645 | FGFR-2 alpha (IIIc), Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72646 | FGFR-2 beta (IIIb), Human (HEK293, His) | Recombinant Proteins | |
| HY-P72647 | FGFR-2 beta (IIIc), Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72649 | FGF-4, Mouse | Recombinant Proteins | |
| HY-P7264A | MIP-3 beta/CCL19, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P7265 | MIP-4/CCL18, Human | Recombinant Proteins | |
| HY-P72650 | FGF-21, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72651 | FGF-21, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72652 | FGF-17, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72653 | FGF-17, Mouse (His) | Recombinant Proteins | |
| HY-P72654 | FGF-12, Human | Recombinant Proteins | |
| HY-P72655 | FCRL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72656 | FCRL1, Mouse (203a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72657 | FCAR/CD89, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72658 | Fas Ligand, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72658A | Fas Ligand, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72659 | FAP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72659A | FAP, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P7266 | MIP-5/CCL15, Human | Recombinant Proteins | |
| HY-P72660 | FABP5, Human (His) | Recombinant Proteins | |
| HY-P72661 | E-selectin/CD62E, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72662 | Ephrin-A1/EFNA1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72663 | EDA2R/XEDAR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72664 | DR6/TNFRSF21, Mouse (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P72665 | DR6/TNFRSF21, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72666 | DR3/TNFRSF25, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72667 | Dermatopontin/DPT, Human (HEK293, Fc, His) | Recombinant Proteins | |
| HY-P72668 | DNAM-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72669 | DNAM-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7267 | NAP-2/CXCL7, Human (CHO) | Recombinant Proteins | |
| HY-P72673 | DDR2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72674 | CXCR4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72675 | MIG/CXCL9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72676 | NAP-2/CXCL7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72677 | GCP-2/CXCL6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72678 | GRO-gamma/CXCL3, Human (His) | Recombinant Proteins | |
| HY-P72678AF | Animal-Free GRO-gamma/CXCL3, Human (His) | Recombinant Proteins | |
| HY-P7268 | NAP-2/CXCL7, Human | Recombinant Proteins | |
| HY-P72681 | CXCL16, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72682 | CXCL15, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72683 | CXCL14/BRAK, Human | Recombinant Proteins | |
| HY-P72684 | GRO-alpha/CXCL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72685 | Fractalkine/CX3CL1, Human (315a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72686 | Fractalkine/CX3CL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72688 | Cystatin C/CST3, Human (HEK293) | Recombinant Proteins | |
| HY-P72689 | CLEC10A/CD301, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7269 | NAP-2/CXCL7, Rat | Recombinant Proteins | |
| HY-P72690 | CFHR4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72691 | CFHR3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72692 | CEACAM8/CD66b, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72693 | CEACAM5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72694 | CEACAM3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72695 | CEACAM1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72697 | CD99L2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72698 | CD96, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72699 | CD96, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7270 | Neuroserpin, Human (CHO) | Recombinant Proteins | |
| HY-P72700 | CD94, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72701 | CD9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72702 | CD8 beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72703 | CD83, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72704 | CD83, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72705 | CD82, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72706 | CD81, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72707 | CD79B, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72708 | CD79B, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P72709 | CD79A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7271 | NGFR, Human (HEK293) | Recombinant Proteins | |
| HY-P72710 | CD74, Mouse (160a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72711 | CD72, Human (Trx, His) | Recombinant Proteins | |
| HY-P72712 | CD7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72713 | CD69, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72714 | CD64, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72715 | CD63, Human/Cynomolgus (HEK293, N-His) | Recombinant Proteins | |
| HY-P72716 | CD6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72717 | CD5L, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72718 | CD5L, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72719 | CD59, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7272 | Neurotrophin-4, Human | Recombinant Proteins | |
| HY-P72720 | CD58, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72721 | CD55/DAF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72722 | CD5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72723 | CD46, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72724 | CD40, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72725 | CD40, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72726 | CD3D-CD3E Heterodimer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72727 | CD3D-CD3E Heterodimer, Cynomolgus (HEK293, Fc-Flag&Fc-His) | Recombinant Proteins | |
| HY-P72728 | CD3 delta, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72729 | CD39L1/ENTPD2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7273 | NT-4, Mouse | Recombinant Proteins | |
| HY-P72730 | CD39L1/ENTPD2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72732 | CD38, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72733 | CD36, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72734 | CD34, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72735 | Fc gamma RIIB/CD32b, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72736 | CD316/IGSF8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72737 | CD31/PECAM-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72738 | CD300a/LMIR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72739 | CD299, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P7274 | OSM, Mouse (HEK293) | Recombinant Proteins | |
| HY-P72740 | CD70, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72741 | CD70, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72741AF | Animal-Free CD70, Mouse (His) | Recombinant Proteins | |
| HY-P72742 | CD27/TNFRSF7, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72743 | CD27/TNFRSF7, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72744 | CD27/TNFRSF7, Rhesus macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P72745 | 2B4/CD244, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72746 | 2B4/CD244, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72747 | CD24, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P72748 | CD23/Fc epsilon RII, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72749 | CD200R1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7275 | OSM, Mouse | Recombinant Proteins | |
| HY-P72750 | CD161, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72751 | Basigin/CD147, Mouse (304a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72752 | CD117/c-kit, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72756 | 6Ckine/CCL21A, Mouse | Recombinant Proteins | |
| HY-P72757 | MCP-1/CCL2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72759 | MIP-4/CCL18, Human (His) | Recombinant Proteins | |
| HY-P72762 | BTNL6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72763 | BTN3A1/CD277, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72764 | BAFFR/TNFRSF13C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72766 | B7-2/CD86, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P72767 | B7-1/CD80, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72768 | B7-1/CD80, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P72769 | Activin RIA, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7277 | PDGF-AA, Mouse | Recombinant Proteins | |
| HY-P72770 | CRACC/SLAMF7, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P72772 | IL-17A, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72773 | AITRL/TNFSF18, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P72774 | CD300LB, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P72775 | VEGF120, Mouse | Recombinant Proteins | |
| HY-P72776 | Thymosin beta 4, Human | Recombinant Proteins | |
| HY-P72777 | TAFA2/FAM19A2, Human | Recombinant Proteins | |
| HY-P72778 | Streptavidin | Recombinant Proteins | |
| HY-P72779 | TRAIL R2/TNFRSF10B, Human | Recombinant Proteins | |
| HY-P7278 | PDGF-BB, Rat | Recombinant Proteins | |
| HY-P72780 | Staphylokinase, S. aureus | Recombinant Proteins | |
| HY-P72781 | SDF-1 beta/CXCL12, Rat | Recombinant Proteins | |
| HY-P72782 | SDF-1 beta/CXCL12, Mouse | Recombinant Proteins | |
| HY-P72783 | S100A1 Protein, Human (His) | Recombinant Proteins | |
| HY-P72783A | S100A1, Human (C-His) | Recombinant Proteins | |
| HY-P72784 | RSPO1/R-spondin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72784A | RSPO1/R-spondin-1, Human (125a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72785 | CDKN2A, Human | Recombinant Proteins | |
| HY-P72786 | MPIF-1/CCL23, Human (99a.a) | Recombinant Proteins | |
| HY-P7278A | PDGF-BB, Rat (His) | Recombinant Proteins | |
| HY-P7279 | PDGF-CC, Human (HEK293) | Recombinant Proteins | |
| HY-P72790 | MDC/CCL22, Human | Recombinant Proteins | |
| HY-P72791 | LIX/CXCL5, Mouse | Recombinant Proteins | |
| HY-P72792 | IL-7, Human (CHO, His) | Recombinant Proteins | |
| HY-P72793 | IL-22, Mouse (CHO) | Recombinant Proteins | |
| HY-P72794 | IL-17RD, Mouse (CHO) | Recombinant Proteins | |
| HY-P72795 | IL-13, Human | Recombinant Proteins | |
| HY-P72796 | IFN-alpha 1b/IFNA13, Human | Recombinant Proteins | |
| HY-P72797 | HMGB1/HMG-1, Human (His) | Recombinant Proteins | |
| HY-P72797AF | Animal-Free HMGB1/HMG-1, Human (His) | Recombinant Proteins | |
| HY-P72798 | Histone H3, Human (His) | Recombinant Proteins | |
| HY-P72799 | Hirudin, Poecilobdella viridis (P. pastoris) | Recombinant Proteins | |
| HY-P7280 | PDGF-DD, Human (CHO) | Recombinant Proteins | |
| HY-P72800 | HA/Hemagglutinin, H1N1 (sf9, His) | Recombinant Proteins | |
| HY-P72801 | GMF-beta, Mouse | Recombinant Proteins | |
| HY-P72802 | FLT3LG, Macaca nemestrina | Recombinant Proteins | |
| HY-P72803 | FGF-13, Human | Recombinant Proteins | |
| HY-P72805 | BNP, Human | Recombinant Proteins | |
| HY-P72806 | TNFRSF3/LTBR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72807 | ACE2, Human (Biotinylated, sf9, His-Avi) | Recombinant Proteins | |
| HY-P72808 | ACE2, Human (sf9, His) | Recombinant Proteins | |
| HY-P72809 | ACE2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7281 | PF-4/CXCL4, Human (HEK293) | Recombinant Proteins | |
| HY-P72810 | ACE2, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P72811 | Acetylcholinesterase/ACHE, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72812 | Activin RIA, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72813 | ACVR2B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72814 | ADAM12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72815 | ADAM17/TACE, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72816 | AIM2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P72817 | AKT3, Mouse (sf9) | Recombinant Proteins | |
| HY-P72818 | ALK-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72819 | ACVRL1/ALK1, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P7282 | RANTES/CCL5, Human (HEK293) | Recombinant Proteins | |
| HY-P72820 | ALK-1, Rat (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72821 | Alkaline Phosphatase/ALPI, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72822 | Alkaline Phosphatase/ALPI, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72823 | Alpha-2-macroglobulin, Human (sf9, His) | Recombinant Proteins | |
| HY-P72824 | Aminopeptidase A, Human (sf9, His) | Recombinant Proteins | |
| HY-P72825 | Aminopeptidase A, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P72826 | Aminopeptidase A, Rat (sf9, His) | Recombinant Proteins | |
| HY-P72827 | Angiopoietin-2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72828 | Angiopoietin-2, Human (CHO, His) | Recombinant Proteins | |
| HY-P72829 | Angiopoietin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72830 | Angiopoietin-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72831 | Antithrombin III/Serpin C1, Human (432a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72832 | Apolipoprotein A-I/APOA1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72833 | Apolipoprotein A-I/APOA1, Mouse (246a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P72834 | Amyloid Precursor/APP-751, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72835 | AGO2/Argonaute-2, Human (sf9, His) | Recombinant Proteins | |
| HY-P72836 | ASAM/CLMP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72837 | ASAM/CLMP, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72839 | B7-H6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72840 | BACE1, Human (HEK293) | Recombinant Proteins | |
| HY-P72842 | BACE1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72843 | BACE1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72844 | BCAM, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72845 | BCAM, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72846 | Bcl-XL, Mouse (His) | Recombinant Proteins | |
| HY-P72846A | Bcl-XL, Mouse (C-His) | Recombinant Proteins | |
| HY-P72847 | BCMA/TNFRSF17, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72849 | BCMA/TNFRSF17, Mouse (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P7285 | SDF-1 alpha/CXCL12, Mouse | Recombinant Proteins | |
| HY-P72850 | BCMA/TNFRSF17, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72852 | BID, Mouse (His-GST) | Recombinant Proteins | |
| HY-P72853 | BLK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P72854 | BMP-2, Zebrafish | Recombinant Proteins | |
| HY-P72855 | BMPR-II, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72856 | Brk, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P72857 | Biotinidase/BTD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72859 | Butyrylcholinesterase/BCHE, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7286 | SDF-1 alpha/CXCL12, Rat | Recombinant Proteins | |
| HY-P72860 | Carbonic Anhydrase 2, Human (C-His, Solution) | Recombinant Proteins | |
| HY-P72860A | Carbonic Anhydrase 2, Human (C-His) | Recombinant Proteins | |
| HY-P72861 | Carbonic Anhydrase 2, Mouse (His) | Recombinant Proteins | |
| HY-P72862 | Carbonic Anhydrase 4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72863 | Carbonic Anhydrase 9, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72864 | Carbonic Anhydrase 10, Human (HEK293) | Recombinant Proteins | |
| HY-P72865 | Carbonic Anhydrase 10, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72866 | CA12/Carbonic Anhydrase 12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72867 | Carbonic Anhydrase 14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72868 | Carboxypeptidase A1/CPA1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72869 | Carboxypeptidase B1/CPB1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7287 | SDF-1 beta/CXCL12, Human (72a.a) | Recombinant Proteins | |
| HY-P72870 | Cardiotrophin-1/CTF1, Human (HEK293) | Recombinant Proteins | |
| HY-P72871 | Cardiotrophin-1/CTF1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72872 | Casein Kinase I alpha, Human (sf9, GST) | Recombinant Proteins | |
| HY-P72873 | Casein Kinase I gamma-2, Human (sf9, His) | Recombinant Proteins | |
| HY-P72875 | Exodus-2/CCL21, Human (sf9) | Recombinant Proteins | |
| HY-P72876 | MME, Human (HEK293) | Recombinant Proteins | |
| HY-P72876A | MME, Human (HEK293) | Recombinant Proteins | |
| HY-P72877 | MME, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72878 | MME, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72879 | CD117/c-Kit, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7288 | SHH, Mouse (CHO) | Recombinant Proteins | |
| HY-P72880 | CD117/c-Kit, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72884 | 4-1BB/TNFRSF9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72885 | Fc gamma RIIIA/CD16a, Human (F176V, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72886 | CD2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72887 | CD200, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72889 | CD200, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72890 | CD21, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72892 | CD31/PECAM-1, Human | Recombinant Proteins | |
| HY-P72894 | CD36, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72895 | CD36, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72896 | CD38, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P72897 | CD38, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P72898 | CD39, Mouse (His) | Recombinant Proteins | |
| HY-P72899 | CD3E-CD3G Heterodimer, Human (HEK293, Fc-Flag & mFc) | Recombinant Proteins | |
| HY-P7290 | SHH, Mouse | Recombinant Proteins | |
| HY-P72900 | CD4, Ferret (HEK293, His) | Recombinant Proteins | |
| HY-P72901 | CD4, Human (183a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72902 | CD4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72904 | CD4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72905 | CD4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72907 | CD40L/CD154/TRAP, Human (His) | Recombinant Proteins | |
| HY-P72907AF | Animal-Free CD40L/CD154/TRAP, Human (His) | Recombinant Proteins | |
| HY-P72908 | CD40L/CD154/TRAP, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72909 | CD40, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P7291 | SPARC, Human | Recombinant Proteins | |
| HY-P72910 | CD40, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72911 | CD40, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72913 | PTPRC/CD45R0, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72914 | CD45, Mouse (sf9) | Recombinant Proteins | |
| HY-P72915 | CD45, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P72916 | CD45, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72917 | CD47, Human (HEK293) | Recombinant Proteins | |
| HY-P72918 | CD47, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72919 | SLAMF2/CD48, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7292 | TARC/CCL17, Human | Recombinant Proteins | |
| HY-P72920 | CD5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72921 | ICAM-3/CD50, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72922 | CD6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72923 | CD6, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72924 | CD6, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72925 | CD64, Human (CHO, C-His) | Recombinant Proteins | |
| HY-P72926 | CD64, Human (Biotinylated, 272a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72927 | CD64, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72928 | CD70, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P72929 | CD70, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7293 | TARC/CCL17, Mouse (70a.a) | Recombinant Proteins | |
| HY-P72930 | CD70, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72931 | CD74, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72932 | CEACAM1, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72933 | CLPS, Human (sf9, His) | Recombinant Proteins | |
| HY-P72934 | HGFR, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P72935 | HGFR, Cynomolgus/Rhesus Macaque (HEK293) | Recombinant Proteins | |
| HY-P72936 | HGFR, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P72937 | HGFR, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P72938 | HGFR, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P7294 | TECK/CCL25, Human | Recombinant Proteins | |
| HY-P72940 | HGFR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72941 | HGFR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72942 | HGFR, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P72943 | CNTF, Human (His) | Recombinant Proteins | |
| HY-P72943AF | Animal-Free CNTF, Human (His) | Recombinant Proteins | |
| HY-P72944 | Coagulation Factor II/F2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72945 | COMP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72946 | Complement factor H/CFH, Human (372a.a, HEK293, His) | Recombinant Proteins | |
| HY-P72947 | Contactin-3/CNTN3, Human (N708D, HEK293, Fc) | Recombinant Proteins | |
| HY-P72948 | CSF1R, Human (HEK293) | Recombinant Proteins | |
| HY-P72949 | CSF1R, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P7295 | TFF3, Human | Recombinant Proteins | |
| HY-P72950 | CSF1R, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P72951 | CSF1R, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72952 | CSF1R, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72953 | CSF1R, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P72954 | CSF1R, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P72955 | CSF1R, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72955A | CSF1R, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P72956 | CSK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P72957 | CSK, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P72958 | CTLA-4, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P72959 | CTLA-4, Human (HEK293) | Recombinant Proteins | |
| HY-P7296 | TGF alpha/TGFA, Human (CHO) | Recombinant Proteins | |
| HY-P72961 | CXCL16, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72962 | Cyclin A1, Human (sf9, His) | Recombinant Proteins | |
| HY-P72963 | Cyclin E, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P72964 | Cyclin E, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P72965 | Cystatin B/CSTB, Human (His) | Recombinant Proteins | |
| HY-P72966 | Cystatin C/CST3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72967 | Dectin-2/CLEC6A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72968 | DKK-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72969 | DKK-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72970 | Delta-like 1/DLL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72970A | Delta-like 1/DLL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72971 | Delta-like 1/DLL1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P72972 | Delta-like 4/DLL4, Human (HEK293) | Recombinant Proteins | |
| HY-P72974 | DNase I, Human (HEK293, His) | Recombinant Proteins | |
| HY-P72975 | CD26/Dipeptidyl Peptidase 4, Human (HEK293) | Recombinant Proteins | |
| HY-P72976 | CD26/Dipeptidyl Peptidase 4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72977 | TRAIL R2/TNFRSF10B, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72979 | DR6/TNFRSF21, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P72980 | EGF, Canine (P.pastoris) | Recombinant Proteins | |
| HY-P72981 | EGF, Canine (His) | Recombinant Proteins | |
| HY-P72982 | EGF, Human (HEK293, N-hFc, solution) | Recombinant Proteins | |
| HY-P72982A | EGF, Human (HEK293, N-hFc) | Recombinant Proteins | |
| HY-P72983 | EGF, Mouse (HEK293) | Recombinant Proteins | |
| HY-P72984 | EGF, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P72985 | EGF, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72986 | EGFR, Canine (sf9, His) | Recombinant Proteins | |
| HY-P72987 | EGFR, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P72988 | EGFR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72989 | EGFR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P72990 | EGFR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P72991 | EphA2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P72992 | EphA2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P72993 | EphA4, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P72994 | EphA4, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P72995 | EphA4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P72997 | EphB1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P72998 | EphB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73000 | EphB2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73001 | EphB2, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73002 | EphB4, Human (HEK293) | Recombinant Proteins | |
| HY-P73003 | EphB4, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73004 | EphB4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73005 | EphB4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73006 | Ephrin-A3/EFNA3, Human (HEK293) | Recombinant Proteins | |
| HY-P73006A | Ephrin-A3/EFNA3, Human (HEK293, Tag Free) | Recombinant Proteins | |
| HY-P73007 | Ephrin-A3/EFNA3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73009 | Ephrin-A3/EFNA3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7301 | NAP-2/CXCL7, Rat (CHO) | Recombinant Proteins | |
| HY-P73010 | Ephrin-A4/EFNA4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73011 | Ephrin-A4/EFNA4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73012 | Ephrin-A5/EFNA5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73013 | Ephrin-A5/EFNA5, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73014 | Ephrin-A5/EFNA5, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73015 | Ephrin-B2/EFNB2, Human (HEK293) | Recombinant Proteins | |
| HY-P73016 | Ephrin-B2/EFNB2, Human (HEK293, His, Fc, solution) | Recombinant Proteins | |
| HY-P73016A | Ephrin-B2/EFNB2, Human (HEK293, His, Fc) | Recombinant Proteins | |
| HY-P73017 | Ephrin-B2/EFNB2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73018 | Ephrin-B2/EFNB2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73019 | Ephrin-B2/EFNB2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7302 | TNF-alpha/TNFSF2, Bovine | Recombinant Proteins | |
| HY-P73020 | Ephrin-B2/EFNB2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73021 | Ephrin B3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73022 | Ephrin B3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73024 | Ephrin-A1/EFNA1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73025 | Ephrin-A1/EFNA1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73026 | Ephrin-B1/EFNB1, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73027 | Ephrin-B1/EFNB1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73028 | Ephrin-B1/EFNB1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73029 | Ephrin-B1/EFNB1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7303 | TNF-alpha/TNFSF2, Rhesus macaque | Recombinant Proteins | |
| HY-P73030 | Ephrin-B1/EFNB1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73031 | Epiregulin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73032 | EPOR-CD131 Heterodimer, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73033 | Erythropoietin receptor/EpoR, Mouse (sf9, Fc) | Recombinant Proteins | |
| HY-P73034 | Erythropoietin receptor/EpoR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73035 | HER4, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73036 | HER4, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73037 | HER4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73038 | Erythropoietin/EPO, Mouse (HEK293, solution) | Recombinant Proteins | |
| HY-P73038A | Erythropoietin/EPO, Mouse (HEK293) | Recombinant Proteins | |
| HY-P7304 | TNF-beta/TNFSF1, Human | Recombinant Proteins | |
| HY-P73040 | Erythropoietin, Rat (sf9, His) | Recombinant Proteins | |
| HY-P73041 | E-Selectin/CD62E, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73042 | E-Selectin/CD62E, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73043 | E-Selectin/CD62E, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73044 | E-Selectin/CD62E, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73045 | Coagulation Factor VII/F7, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P73046 | Coagulation Factor XI/F11, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73047 | Fas/CD95, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73048 | Fas/CD95, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73049 | Fas/CD95, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7305 | TNFRSF1A, Human (CHO) | Recombinant Proteins | |
| HY-P73050 | FES, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73051 | FGF-18, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73052 | FGF-2, Mouse (His) | Recombinant Proteins | |
| HY-P73052AF | Animal-Free FGF-2, Mouse (His) | Recombinant Proteins | |
| HY-P73053 | FGF-9, Human (HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P73053A | FGF-9, Human (HEK293, N-hFc) | Recombinant Proteins | |
| HY-P73054 | FGFR-1 beta, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73055 | FGFR-1 beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73056 | FGFR-3, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73057 | FGFR-4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73059 | FGFR-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7306 | TRAIL/TNFSF10, Human | Recombinant Proteins | |
| HY-P73060 | FGFR-4, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73061 | FGFR-4, Rat (HEK293, Fc, Solution) | Recombinant Proteins | |
| HY-P73061A | FGFR-4, Rat (HEK293, C-hFc) | Recombinant Proteins | |
| HY-P73062 | Fumarate Hydratase/FH, Human (His) | Recombinant Proteins | |
| HY-P73063 | Fibronectin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73064 | VEGFR-1, Human (328a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P73065 | VEGFR-1, Human (328a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73066 | FLT3LG, Human (sf9, His) | Recombinant Proteins | |
| HY-P73067 | FLT3LG, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73068 | Follistatin/FST, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73069 | Follistatin/FST, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7306A | TRAIL/TNFSF10, Human (N-His) | Recombinant Proteins | |
| HY-P7306AF | Animal-Free TRAIL/TNFSF10, Human (His) | Recombinant Proteins | |
| HY-P7307 | TRAIL R2/TNFRSF10B, Human (HEK293) | Recombinant Proteins | |
| HY-P73071 | Galectin-7/LGALS7, Human (GST) | Recombinant Proteins | |
| HY-P73072 | Galectin-1/LGALS1, Human | Recombinant Proteins | |
| HY-P73073 | G-CSF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73074 | GDNF, Human (HEK293) | Recombinant Proteins | |
| HY-P73075 | GDNF, Rat (sf9, His) | Recombinant Proteins | |
| HY-P73076 | GITR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73077 | GLA/alpha-Galactosidase A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73078 | Glypican-3/GPC3, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73079 | Glypican-5/GPC5, Human (sf9, His) | Recombinant Proteins | |
| HY-P7308 | TrkA, Human (HEK293) | Recombinant Proteins | |
| HY-P73081 | GM-CSF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73082 | GM-CSF, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73083 | GM-CSF R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73085 | GH/Somatotropin, Human (His) | Recombinant Proteins | |
| HY-P73086 | Growth Hormone R/GHR, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73087 | Growth Hormone R/GHR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73088 | Growth Hormone R/GHR, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73089 | Growth Hormone R/GHR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7309 | TWEAK/TNFSF12, Human (CHO) | Recombinant Proteins | |
| HY-P73090 | GSK-3 beta, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73091 | HAI-1, Human (His) | Recombinant Proteins | |
| HY-P73092 | HAI-1, Mouse (Fc) | Recombinant Proteins | |
| HY-P73093 | HB-EGF, Human (sf9) | Recombinant Proteins | |
| HY-P73094 | HER2/CD340, Human (HEK293) | Recombinant Proteins | |
| HY-P73095 | HER2/CD340, Human (Domain 4, HEK293, His) | Recombinant Proteins | |
| HY-P73097 | HER2/CD340 Protein, Rat (HEK293) | Recombinant Proteins | |
| HY-P73099 | HEXA/Hexosaminidase A, Human (sf9, His) | Recombinant Proteins | |
| HY-P73101 | HGF, Rat (HEK293) | Recombinant Proteins | |
| HY-P73102 | HMGB1/HMG-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73103 | HMGB1/HMG-1, Human (102a.a, His) | Recombinant Proteins | |
| HY-P73104 | HMGB1/HMG-1, Mouse (HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P73104A | HMGB1/HMG-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73105 | HSP70/HSPA1B, Human (SF9, His) | Recombinant Proteins | |
| HY-P73108 | HVEM/TNFRSF14, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P7311 | VEGF164, Rat (CHO) | Recombinant Proteins | |
| HY-P73112 | ICAM-1/CD54, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73113 | ICAM-1/CD54, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73114 | ICAM-1/CD54, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73115 | ICAM-2/CD102, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73116 | ICAM-2/CD102, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73117 | ICAM-2/CD102, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73119 | B7-H2/ICOSLG, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P7312 | VEGF164, Mouse | Recombinant Proteins | |
| HY-P73120 | B7-H2/ICOSLG, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73121 | IDO-1, Human | Recombinant Proteins | |
| HY-P73122 | IFN-alpha 13/IFNA13, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P73123 | IFN-alpha 13/IFNA13, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P73124 | IFN-alpha 13/IFNA13, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73125 | IFN-alpha 13/IFNA13, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73127 | IFNAR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73128 | IFN-beta, Human (CHO) | Recombinant Proteins | |
| HY-P73129 | IFN-beta, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7313 | VEGF-CC, Human (116a.a, HEK293) | Recombinant Proteins | |
| HY-P73130 | IFN-beta, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73131 | IFN-beta Protein, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73132 | IFN-beta, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P73133 | IFN-gamma R1/CD119, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73134 | IFN-omega 1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73136 | IGF-I/IGF-1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P73137 | IGF-I R, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73138 | IGFBP-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7313A | VEGF-CC, Human (116a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7314 | VEGF-D, Human (HEK293) | Recombinant Proteins | |
| HY-P73140 | IGFBP-5, Human (sf9, His) | Recombinant Proteins | |
| HY-P73141 | IGFBP-6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73142 | IGFBP-7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73143 | IgG1, Human (C103S, HEK293) | Recombinant Proteins | |
| HY-P73145 | IL-1 alpha, Human (HEK293) | Recombinant Proteins | |
| HY-P73146 | IL-1 beta, Canine | Recombinant Proteins | |
| HY-P73146A | IL-1 beta, Canine (Tag free) | Recombinant Proteins | |
| HY-P73148 | IL-1 beta, Feline | Recombinant Proteins | |
| HY-P73149 | IL-1 beta, Human (E6K, His) | Recombinant Proteins | |
| HY-P73150 | IL-1 beta, Rabbit | Recombinant Proteins | |
| HY-P73151 | IL-1R9/IL1RAPL2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73152 | IL-10, Feline | Recombinant Proteins | |
| HY-P73153 | IL-10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73154 | IL-10, Pig | Recombinant Proteins | |
| HY-P73155 | IL-11, Mouse | Recombinant Proteins | |
| HY-P73156 | GMP IL-12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73157 | IL-12, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73158 | IL-12, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73159 | IL-12, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7316 | EGFR, Human (621a.a, Sf9, His) | Recombinant Proteins | |
| HY-P73160 | IL-12 beta, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73161 | IL-12 beta, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73162 | IL-12 beta, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73164 | IL-12 beta, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73165 | IL-13, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P73166 | IL-13, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P73168 | IL-13, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73169 | IL-16, Human (His) | Recombinant Proteins | |
| HY-P7317 | 4-1BB/TNFRSF9, Human (CHO, Fc) | Recombinant Proteins | |
| HY-P73170 | IL-17A, Canine | Recombinant Proteins | |
| HY-P73171 | IL-17A, Human (CHO) | Recombinant Proteins | |
| HY-P73172 | IL-17A, Human (T26A, sf9, His) | Recombinant Proteins | |
| HY-P73174 | IL-17A, Mouse | Recombinant Proteins | |
| HY-P73174A | IL-17A, Mouse (E. coli) | Recombinant Proteins | |
| HY-P73175 | IL-17A, Rabbit (solution) | Recombinant Proteins | |
| HY-P73175A | IL-17A, Rabbit | Recombinant Proteins | |
| HY-P73176 | IL-17A, Rabbit (sf9, His) | Recombinant Proteins | |
| HY-P73177 | IL-17A, Rhesus macaque (sf9) | Recombinant Proteins | |
| HY-P7318 | AITRL/TNFSF18, Human | Recombinant Proteins | |
| HY-P73181 | IL-18, Mouse (solution) | Recombinant Proteins | |
| HY-P73182 | IL-18, Rhesus Macaque (His) | Recombinant Proteins | |
| HY-P73183 | IL-19, Human (sf9, His) | Recombinant Proteins | |
| HY-P73184 | IL-19, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73185 | IL-1R1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73187 | IL-1RA/IL-1RN, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73188 | IL-2, Canine (C147S) | Recombinant Proteins | |
| HY-P7319 | AITRL/TNFSF18, Mouse | Recombinant Proteins | |
| HY-P73191 | IL-21R, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73192 | IL-22, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P73193 | IL-23, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73194 | IL-23 Protein, Marmoset (HEK293, His) | Recombinant Proteins | |
| HY-P73195 | IL-23, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73196 | IL-23R, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73197 | IL-23R, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73198 | IL-25/IL-17E, Mouse (His) | Recombinant Proteins | |
| HY-P73198A | IL-25/IL-17E, Mouse (N-His) | Recombinant Proteins | |
| HY-P73199 | IL-27, Human (CHO, His) | Recombinant Proteins | |
| HY-P7320 | APRIL/TNFSF13, Mouse | Recombinant Proteins | |
| HY-P73200 | IL-27, Mouse (228a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73200A | IL-27, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P73200Y | IL-27, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73201 | IFN-lambda 3/IL-28B, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P73202 | IFN-lambda 1/IL-29, Human (HEK293) | Recombinant Proteins | |
| HY-P73207 | IL-3, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73208 | IL-3, Rat (sf9, His) | Recombinant Proteins | |
| HY-P73209 | IL-31, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7321 | B7-1/CD80, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73210 | IL-33, Canine | Recombinant Proteins | |
| HY-P73211 | IL-34, Human (CHO, His) | Recombinant Proteins | |
| HY-P73212 | IL-34, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73214 | IL-4, Canine | Recombinant Proteins | |
| HY-P73215 | IL-4 Protein, Mouse (Q136D, Y139D, sf9, His) | Recombinant Proteins | |
| HY-P73217 | IL-4R alpha/CD124 Protein, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73218 | IL-5, Canine (sf9, His) | Recombinant Proteins | |
| HY-P73219 | IL-5, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P7322 | B7-2/CD86, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73220 | IL-6, Pig | Recombinant Proteins | |
| HY-P73221 | IL-6R, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P73222 | IL-6R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73224 | IL-6R, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73225 | IL-6R, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P73226 | IL-7, Mouse | Recombinant Proteins | |
| HY-P73227 | IL-7, Rat | Recombinant Proteins | |
| HY-P73227A | IL-7, Rat | Recombinant Proteins | |
| HY-P73228 | IL-9, Human (sf9, His) | Recombinant Proteins | |
| HY-P73229 | IL-9 Protein, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73230 | IL-9, Rat (sf9, His) | Recombinant Proteins | |
| HY-P73231 | NA/Neuraminidase, Influenza A H1N1 (HEK293) | Recombinant Proteins | |
| HY-P73232 | HA/Hemagglutinin, Influenza A H1N1 (HEK293, His) | Recombinant Proteins | |
| HY-P73233 | NA/Neuraminidase, Influenza A H3N2 (HEK293) | Recombinant Proteins | |
| HY-P73234 | HA/Hemagglutinin, Influenza A H3N2 (sf9, His) | Recombinant Proteins | |
| HY-P73235 | HA/Hemagglutinin, Influenza A H3N2 (HEK293, His) | Recombinant Proteins | |
| HY-P73236 | NA/Neuraminidase, Influenza A H3N2 (N294S, HEK293) | Recombinant Proteins | |
| HY-P73237 | NA/Neuraminidase, Influenza A H3N2 (R292K, HEK293) | Recombinant Proteins | |
| HY-P73238 | HA/Hemagglutinin, Influenza A H5N1 (sf9, His) | Recombinant Proteins | |
| HY-P73239 | NA/Neuraminidase, Influenza A H5N1 (H255Y, HEK293) | Recombinant Proteins | |
| HY-P7324 | B7-H2/ICOSLG, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73240 | HA1/Hemagglutinin, Influenza B (sf9, His) | Recombinant Proteins | |
| HY-P73241 | Activin A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73242 | INHBB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73243 | Insulin, Human (P.pastoris) | Recombinant Proteins | |
| HY-P73244 | Insulin R/CD220, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73245 | IFN-alpha 1/IFNA13, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P73246 | IFN-alpha 2b/IFNA2, Human (P.pastoris) | Recombinant Proteins | |
| HY-P73247 | IFN-alpha 2/IFNA2, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P73248 | IFN-alpha 2/IFNA2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73249 | IFN-alpha B/IFNA8, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P73249A | IFN-alpha B/IFNA8, Cynomolgus (HEK293, C-mFc) | Recombinant Proteins | |
| HY-P7325 | B7-H2/ICOSLG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73252 | IFN-gamma, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73254 | IFN-gamma, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73255 | IRAK4, Human (sf9, His) | Recombinant Proteins | |
| HY-P73256 | IRE1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73258 | Jagged-1/JAG1 Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73259 | JAM-B/CD322, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7326 | CD276/B7-H3, Human (435a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P73260 | JAM-B/CD322, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73261 | JAM-B/CD322, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73262 | Kallikrein-1, Human (240a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73263 | Kallikrein-11, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73265 | Kallikrein-8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73266 | Kininogen-1, Human (626a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73267 | Kininogen-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73268 | Latexin, Mouse (His) | Recombinant Proteins | |
| HY-P73269 | Lck, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7327 | CD276/B7-H3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73270 | LDHA, Mouse (His) | Recombinant Proteins | |
| HY-P73271 | LDHA, Rat (His) | Recombinant Proteins | |
| HY-P73272 | LDLR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73273 | Leptin R/LEPR, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73275 | Leukotriene A4 Hydrolase/LTA4H, Human (sf9, His) | Recombinant Proteins | |
| HY-P73276 | LIF, Human (HEK293) | Recombinant Proteins | |
| HY-P73277 | LIF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73278 | LIF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73279 | LIF, Mouse (HEK293) | Recombinant Proteins | |
| HY-P7328 | Betacellulin, Human (HEK293) | Recombinant Proteins | |
| HY-P73280 | LIF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73281 | LIGHT/TNFSF14, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73282 | LOK, Human (His) | Recombinant Proteins | |
| HY-P73283 | Lyn, Human (sf9, GST) | Recombinant Proteins | |
| HY-P73287 | M-CSF, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P73289 | Mer, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P7329 | Betacellulin/BTC, Mouse (N-His) | Recombinant Proteins | |
| HY-P73290 | MERS-CoV Spike/S1 (1297a.a, sf9, His) | Recombinant Proteins | |
| HY-P73291 | MERS-CoV Spike/S1 (725a.a, sf9, His) | Recombinant Proteins | |
| HY-P73293 | MICB, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73294 | MICB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73295 | MDK, Human (sf9) | Recombinant Proteins | |
| HY-P73296 | MMP-2, Human (HEK293) | Recombinant Proteins | |
| HY-P73297 | Stromelysin-1/MMP-3, Human | Recombinant Proteins | |
| HY-P73298 | MMP-8, Human (HEK293) | Recombinant Proteins | |
| HY-P7330 | FGF basic/bFGF, Human (145a.a) | Recombinant Proteins | |
| HY-P73300 | MMP-9, Human (HEK293) | Recombinant Proteins | |
| HY-P73301 | MMP-9, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73302 | N-Cadherin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73303 | SF20/MYDGF, Mouse | Recombinant Proteins | |
| HY-P73304 | NRG1-beta 2, Human | Recombinant Proteins | |
| HY-P73305 | DKK-1, Rat (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73305A | DKK-1, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P73306 | Nectin-3/CD113, Human (400a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73307 | Nectin-2/CD112, Human (HEK293) | Recombinant Proteins | |
| HY-P73309 | Neuropilin-1, Human (Biotinylated, HEK293, His-Avi, solution) | Recombinant Proteins | |
| HY-P7330A | FGF basic/bFGF, Human (145a.a, His) | Recombinant Proteins | |
| HY-P7331 | FGF basic/bFGF, Human (154a.a) | Recombinant Proteins | |
| HY-P73310 | Neuropilin-1, Human (V179A, HEK293, Fc) | Recombinant Proteins | |
| HY-P73312 | Neuropilin-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73313 | Neuropilin-2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73314 | Neuropilin-2, Human (855a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73315 | Neuropilin-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73316 | Beta-NGF, Human (CHO) | Recombinant Proteins | |
| HY-P73317 | Beta-NGF, Mouse (CHO) | Recombinant Proteins | |
| HY-P73318 | NGFR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73319 | NKG2D/CD314, Human (sf9, His) | Recombinant Proteins | |
| HY-P7331A | FGF basic/bFGF, Human (154a.a, His) | Recombinant Proteins | |
| HY-P7331AF | Animal-Free FGF basic/bFGF, Human (154a.a, His) | Recombinant Proteins | |
| HY-P7332 | BMP-3B/GDF10, Human (His) | Recombinant Proteins | |
| HY-P73322 | Noggin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73323 | Noggin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73324 | NOTCH1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73326 | NRG1-alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73327 | NRG1-alpha, Human (65a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P73328 | NRG1-beta 1, Human (HEK293) | Recombinant Proteins | |
| HY-P73329 | NRG1-beta 1, Human (245a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P7333 | CD19, Human (CHO, Fc) | Recombinant Proteins | |
| HY-P73330 | NRG1-beta 1, Human (71a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P73331 | OSM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73332 | TNFRSF11B/OPG, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73334 | p38 delta/MAPK13, Human (sf9, GST) | Recombinant Proteins | |
| HY-P73335 | p38 alpha/MAPK14, Human (Activated, sf9, His) | Recombinant Proteins | |
| HY-P73336 | Serpin E1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73337 | PARP, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P7334 | CD28, Human/Cynomolgus/Rhesus Macaque (HEK293, hFc) | Recombinant Proteins | |
| HY-P73340 | PCSK9, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73341 | PD-1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P73342 | PD-1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P73342A | PD-1, Canine (HEK293, C-His) | Recombinant Proteins | |
| HY-P73344 | PD-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73345 | PD-1, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73347 | PD-1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73348 | PD-1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73349 | PD-1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7335 | CD47, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73350 | PD-1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P73351 | PDGF-BB, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P73352 | PDGF-BB, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P73353 | PDGF-CC, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73354 | PDGF-CC, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73356 | PDGF R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7336 | CD47, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73360 | PDGF R beta, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73361 | PD-L1, Human (HEK293) | Recombinant Proteins | |
| HY-P73364 | PD-L1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73365 | PD-L1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73369 | PD-L2, Mouse (219a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7337 | DCIP-1/CXCL3, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P73370 | PD-L2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73371 | PD-L2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73372 | Serpin F1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73373 | Periostin Protein, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73374 | Peroxiredoxin-2/PRDX2, Human (sf9, His) | Recombinant Proteins | |
| HY-P73375 | PRDX5/Peroxiredoxin-5, Mouse (His) | Recombinant Proteins | |
| HY-P73376 | PGD, Human (His) | Recombinant Proteins | |
| HY-P73377 | PIGR, Human (G365S, HEK293, His) | Recombinant Proteins | |
| HY-P73378 | Podoplanin, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73379 | Podoplanin, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P7338 | DHH, Human (C23II) | Recombinant Proteins | |
| HY-P73380 | Prolactin, Human (SF9, His) | Recombinant Proteins | |
| HY-P73381 | Prolactin, Mouse (Sf9, His) | Recombinant Proteins | |
| HY-P73383 | P-Selectin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73385 | P-Selectin, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73386 | RANKL/TNFSF11, Human (HEK293) | Recombinant Proteins | |
| HY-P73387 | RANKL/TNFSF11, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P73388 | RANKL/TNFSF11, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7339 | DHH, Mouse | Recombinant Proteins | |
| HY-P73390 | ROR1, Human (sf9, His) | Recombinant Proteins | |
| HY-P73391 | S100B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73392 | SARS-CoV S (S577A, sf9, His) | Recombinant Proteins | |
| HY-P73393 | SARS-CoV S RBD (HEK293, Fc) | Recombinant Proteins | |
| HY-P73394 | SARS-CoV S1 (sf9, His) | Recombinant Proteins | |
| HY-P73395 | SARS-CoV S1 (HEK293, Fc) | Recombinant Proteins | |
| HY-P73396 | SARS-CoV-2 S RBD (HEK293) | Recombinant Proteins | |
| HY-P73397 | SARS-CoV-2 S RBD (HEK293, Fc) | Recombinant Proteins | |
| HY-P73398 | SARS-CoV-2 S RBD (A435S, HEK293, His) | Recombinant Proteins | |
| HY-P73399 | SARS-CoV-2 S RBD (F342L, HEK293, His) | Recombinant Proteins | |
| HY-P7340 | EGFR, Human (621a.a, CHO, His) | Recombinant Proteins | |
| HY-P73400 | SARS-CoV-2 S RBD (K458R, HEK293, His) | Recombinant Proteins | |
| HY-P73401 | SARS-CoV-2 S RBD (V367F, HEK293, His) | Recombinant Proteins | |
| HY-P73402 | SARS-CoV-2 S RBD (V483A, HEK293, His) | Recombinant Proteins | |
| HY-P73403 | SARS-CoV-2 S RBD (W436R, HEK293,His) | Recombinant Proteins | |
| HY-P73404 | SARS-CoV-2 S RBD (223a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73405 | SARS-CoV-2 S RBD (V367F, HEK293, Fc) | Recombinant Proteins | |
| HY-P73406 | SARS-CoV-2 S RBD (HEK293, mFc) | Recombinant Proteins | |
| HY-P73407 | SARS-CoV-2 S RBD (HEK293, rFc) | Recombinant Proteins | |
| HY-P73408 | SARS-CoV-2 S1 (sf9, His) | Recombinant Proteins | |
| HY-P73409 | SARS-CoV-2 S1 (HEK293, His) | Recombinant Proteins | |
| HY-P7341 | Enterokinase, Bovine (P.pastoris, His) | Recombinant Proteins | |
| HY-P73410 | SCF, Human (sf9, His) | Recombinant Proteins | |
| HY-P73411 | SDF-1 beta/CXCL12, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73412 | Serpin A3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73413 | SFRP1, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P73414 | SLPI, Human (107a.a, Sf9, His) | Recombinant Proteins | |
| HY-P73414A | SLPI, Human (107a.a, sf9, His, solution) | Recombinant Proteins | |
| HY-P73416 | SMAC/Diablo, Human (His) | Recombinant Proteins | |
| HY-P73417 | SHH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73418 | SHH, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7341AF | Animal-Free Enterokinase, Bovine (His) | Recombinant Proteins | |
| HY-P73420 | SPARC, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73422 | Src, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73423 | Src, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P73424 | SDC4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73425 | TFPI, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73425A | TFPI, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P73426 | Latent TGF beta 1/TGFB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73428 | TGFBR2/TGF-beta RII, Human (sf9, His) | Recombinant Proteins | |
| HY-P7342AF | Animal-Free KGF-2/FGF-10, Human (His) | Recombinant Proteins | |
| HY-P7343 | FGF-12, Human (177 a.a) | Recombinant Proteins | |
| HY-P73430 | TGFBR2/TGF-beta RII, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73431 | Thioredoxin/TXN, Human (Solution) | Recombinant Proteins | |
| HY-P73431A | Thioredoxin/TXN, Human | Recombinant Proteins | |
| HY-P73432 | Thioredoxin/TRX, Mouse | Recombinant Proteins | |
| HY-P73432A | Thioredoxin/TRX, Mouse (N-His) | Recombinant Proteins | |
| HY-P73434 | TIE-2, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73435 | TIE-2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73436 | TIE-2, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P73437 | TIE-2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73438 | TIE-2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7344 | FGF-16, Human (CHO) | Recombinant Proteins | |
| HY-P73441 | TIMP-1, Rat (HEK293) | Recombinant Proteins | |
| HY-P73442 | TIMP-2, Human (HEK293) | Recombinant Proteins | |
| HY-P73443 | TNF-alpha/TNFSF2, Canine | Recombinant Proteins | |
| HY-P73444 | TNF-alpha/TNFSF2, Cynomolgus | Recombinant Proteins | |
| HY-P73444A | TNF-alpha/TNFSF2, Cynomolgus (N-His) | Recombinant Proteins | |
| HY-P73445 | TNF-alpha/TNFSF2, Ferret | Recombinant Proteins | |
| HY-P73449 | TNF RI/TNFRSF1A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7345 | FGF-21, Human (CHO, His) | Recombinant Proteins | |
| HY-P73450 | TNF RI/TNFRSF1A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73451 | T-PA, Human (HEK293) | Recombinant Proteins | |
| HY-P73453 | Transferrin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73454 | Transferrin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73456 | TrkA, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P73457 | TrkA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73458 | TrkA, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73459 | TrkA, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73460 | TrkA, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73461 | TrkB, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P73462 | TrkB, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73464 | TrkC, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73465 | TrkC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73466 | UCHL1, Mouse (His) | Recombinant Proteins | |
| HY-P73467 | PLAU/uPA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73468 | VCAM-1/CD106, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73469 | VCAM-1/CD106, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P7346A | FGF-8e, Human (193a.a) | Recombinant Proteins | |
| HY-P7347 | FGF-8a, Human | Recombinant Proteins | |
| HY-P73470 | VCAM-1/CD106, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73471 | VEGF121, Human (HEK293) | Recombinant Proteins | |
| HY-P73473 | VEGF-AA, Canine (HEK293) | Recombinant Proteins | |
| HY-P73474 | VEGF-DD, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73475 | VEGF-DD, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73476 | VEGFR-2, Human (327a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P73477 | VEGFR-2, Human (208a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P7348 | FGF-8c, Mouse | Recombinant Proteins | |
| HY-P73481 | VEGFR-2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73482 | VISTA/B7-H5, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P73484 | Vitronectin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73485 | XIAP, Human (Avi) | Recombinant Proteins | |
| HY-P73486 | YES1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73489 | ACE2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7348A | FGF-8c, Mouse (His) | Recombinant Proteins | |
| HY-P7349 | FGF-8e, Human | Recombinant Proteins | |
| HY-P73495 | CD117/c-kit, Human (P10721-2, HEK293, His) | Recombinant Proteins | |
| HY-P73498 | CD3D-CD3E Heterodimer, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P73499A | CD40, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7349A | FGF-8e, Human (N-His) | Recombinant Proteins | |
| HY-P7350 | FGF-8f, Human | Recombinant Proteins | |
| HY-P73506 | CD84/SLAMF5, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73506A | CD84/SLAMF5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73507 | CDH16, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73510 | CSF1R, Human (HEK293, C-His-Avi) | Recombinant Proteins | |
| HY-P73517 | EGFR, Human (Biotinylated, 621a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7352 | FGF-9, Mouse (His, solution) | Recombinant Proteins | |
| HY-P73521 | Erythropoietin receptor/EpoR, Human (HEK293 , Fc) | Recombinant Proteins | |
| HY-P73522 | FCRN-B2M Heterodimer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73523 | G-CSF, Human (HEK293) | Recombinant Proteins | |
| HY-P73526 | Serpin G1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73529 | VEGF-CC, Human (125a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7352A | FGF-9, Mouse (N-His) | Recombinant Proteins | |
| HY-P73530 | VEGFR-2, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P73531 | CD14, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73533 | Zika virus Membrane (HEK293, Fc) | Recombinant Proteins | |
| HY-P73534 | Zika virus E/Envelope (T366A, Q367G, W391R, L397R, sf9, His) | Recombinant Proteins | |
| HY-P73535 | Zika virus E/Envelope (Domain III, P.pastoris, His) | Recombinant Proteins | |
| HY-P73536 | Zika virus E/Envelope (Domain I, His-MBP) | Recombinant Proteins | |
| HY-P73537 | XIAP, Human (His) | Recombinant Proteins | |
| HY-P73538 | XG/Xg blood group, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73539 | XG/Xg blood group, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7354 | FLT3LG, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P73540 | WARS, Human (sf9, His) | Recombinant Proteins | |
| HY-P73541 | Von Willebrand Factor/vWF, Human (CHO, His) | Recombinant Proteins | |
| HY-P73542 | Vitamin D Receptor/VDR, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73543 | Vitamin D Receptor/VDR, Human (sf9, His) | Recombinant Proteins | |
| HY-P73544 | VISTA/B7-H5, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P73545 | VISTA/B7-H5, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P73546 | VISTA/B7-H5, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73547 | VISTA/B7-H5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73549 | Vinculin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7355 | Fractalkine/CX3CL1, Human (S199N, CHO) | Recombinant Proteins | |
| HY-P73550 | Vinculin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73551 | Vimentin, Human (sf9, His) | Recombinant Proteins | |
| HY-P73552 | VEGFR-1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73553 | VEGFR-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73554 | VEGFR-1, Human (756a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73556 | VEGF145, Human (HEK293, solution) | Recombinant Proteins | |
| HY-P73557 | VE-Cadherin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73559 | VE-Cadherin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73560A | VE-Cadherin, Human (HEK293, C-His-Fc) | Recombinant Proteins | |
| HY-P73561 | PLAU/uPA, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73562 | UNG, Human (His) | Recombinant Proteins | |
| HY-P73563 | Tyrosine Hydroxylase, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73564 | Tyrosine Hydroxylase, Human (sf9, His) | Recombinant Proteins | |
| HY-P73565 | Tubulin cofactor A, Human | Recombinant Proteins | |
| HY-P73565A | Tubulin cofactor A, Human (Tag Free) | Recombinant Proteins | |
| HY-P73566 | Tryptophan Hydroxylase 1/TPH-1, Human (His) | Recombinant Proteins | |
| HY-P73568 | TRP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73570 | TROY/TNFRSF19, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73571 | TROY/TNFRSF19, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73572 | TROY/TNFRSF19, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73573 | TROY/TNFRSF19, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73574 | TrkB, Rat (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73574A | TrkB, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P73575 | TrkB, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73576 | TrkB, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P73577 | TrkA, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P73578 | TrkA, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P7358 | Adiponectin/Acrp30, Mouse (144a.a) | Recombinant Proteins | |
| HY-P73580 | Transthyretin/TTR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73581 | Transferrin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73582 | TPO/Thyroid peroxidase, Human (A257S, T725P, sf9, His) | Recombinant Proteins | |
| HY-P73583 | T-PA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73584 | TOP1, Human (765a.a, sf9, His) | Recombinant Proteins | |
| HY-P73585 | TOP1, Human (575a.a, sf9, His) | Recombinant Proteins | |
| HY-P73586 | TLR4, Human (sf9, His) | Recombinant Proteins | |
| HY-P73589 | TLR2, Rat (sf9, His) | Recombinant Proteins | |
| HY-P7359 | GDNF, Mouse (CHO) | Recombinant Proteins | |
| HY-P73590 | TLR2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73591 | TLR2, Human (sf9, His) | Recombinant Proteins | |
| HY-P73592 | Tissue Factor, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73594 | Tissue Factor, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P73596 | TIMP-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73597 | TIMP-1, Human (HEK293) | Recombinant Proteins | |
| HY-P7360 | GH/Somatotropin, Human (CHO) | Recombinant Proteins | |
| HY-P73601 | TIM-1/KIM-1/HAVCR, Rat (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73602 | TIM-1/KIM-1/HAVCR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73604 | TIM-1/KIM-1/HAVCR, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73605 | TIM-1/KIM-1/HAVCR, Human (HEK293) | Recombinant Proteins | |
| HY-P73606 | TIM-1/KIM-1/HAVCR, Human (270a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73607 | TIM-1/KIM-1/HAVCR, Human (135a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73608 | TIM-1/KIM-1/HAVCR, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P73609 | TIM-1/KIM-1/HAVCR, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P7361 | GM-CSF, Mouse | Recombinant Proteins | |
| HY-P73610 | TIE-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73612 | Thrombin Receptor/PAR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73613 | TGF beta 2/TGFB2, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P73613A | TGF beta 2/TGFB2, Rhesus Macaque (HEK293, C-His) | Recombinant Proteins | |
| HY-P73614 | TGF beta 2/TGFB2, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P73615 | Latent TGF beta 1/TGFB1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73615A | Latent TGF beta 1/TGFB1, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P73616 | TGF beta 1/TGFB1 LAP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73617 | TGF beta 1/TGFB1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P73618 | Fetal-tau/0N3R, Human (His, solution) | Recombinant Proteins | |
| HY-P73618A | Fetal-tau/0N3R, Human (His) | Recombinant Proteins | |
| HY-P73619 | Tapasin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7361A | GM-CSF, Mouse (His) | Recombinant Proteins | |
| HY-P7362 | Glia maturation factor beta/GMFB, Human | Recombinant Proteins | |
| HY-P73620 | Syntaxin-7, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73622 | Syntaxin-3, Human (His) | Recombinant Proteins | |
| HY-P73623 | Syndecan-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73624 | Syndecan-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73625 | Syndecan-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73628 | STAT1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73628Y | STAT1, Human (sf9, His-GST, solution) | Recombinant Proteins | |
| HY-P73629 | SSB, Human (sf9, His) | Recombinant Proteins | |
| HY-P7363 | GRO-alpha/CXCL1, Human (CHO) | Recombinant Proteins | |
| HY-P73630 | SSB, Human (His) | Recombinant Proteins | |
| HY-P73630A | SSB, Human | Recombinant Proteins | |
| HY-P73631 | SPHK1/Sphingosine Kinase 1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73632 | Sphingomyelin Synthase 2/SGMS2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73633 | SOCS3, Human (His-Trx) | Recombinant Proteins | |
| HY-P73634 | SNAP25, Human (His) | Recombinant Proteins | |
| HY-P73635 | SMNDC1/SPF30, Human (His) | Recombinant Proteins | |
| HY-P73636 | SMAD3, Human/Mouse/Rat (sf9, His-GST) | Recombinant Proteins | |
| HY-P73637 | SMAD2, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P73639 | Siglec-3/CD33, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73640 | Siglec-3/CD33, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73641 | Siglec-3/CD33, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73642 | Siglec-3/CD33, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P73643 | Siglec-3/CD33, Human (HEK293) | Recombinant Proteins | |
| HY-P73644 | Siglec-3/CD33, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73646 | Siglec-2/CD22, Mouse (690a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P73648 | Siglec-2/CD22, Human (512a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73649 | SHP-1, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P7365 | NRG1-beta 1, Human | Recombinant Proteins | |
| HY-P73650 | Shiga toxin 2B, E. coli (His) | Recombinant Proteins | |
| HY-P73651 | Serpin A8/Angiotensinogen, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73652 | Serpin A8/Angiotensinogen, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73653 | Serpin A8/Angiotensinogen, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73654 | Serpin G1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73655 | Serpin E1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73656 | Serpin A7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73657 | Serpin A6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73658 | Serpin A6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73659 | Serpin A6, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7366 | HVEM/TNFRSF14, Human (Sf9, Fc) | Recombinant Proteins | |
| HY-P73661 | SDF-1 alpha/CXCL12, Human (His) | Recombinant Proteins | |
| HY-P73662 | SCF, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73663 | SARS-CoV-2 S2 (sf9, Fc) | Recombinant Proteins | |
| HY-P73664 | SARS-CoV-2 S RBD (sf9, His) | Recombinant Proteins | |
| HY-P73665 | SARS-CoV-2 S RBD (N354D, HEK293, His) | Recombinant Proteins | |
| HY-P73666 | SARS-CoV-2 ME (His) | Recombinant Proteins | |
| HY-P73667 | SARS-CoV S2 (sf9, His) | Recombinant Proteins | |
| HY-P73668 | SARS-CoV S RBD (sf9, His) | Recombinant Proteins | |
| HY-P73669 | SARS-CoV S RBD (sf9, Fc) | Recombinant Proteins | |
| HY-P7367 | IFN-gamma R2, Human (CHO) | Recombinant Proteins | |
| HY-P73671 | S100A8, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73672 | RYK, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73673 | RPE, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73674 | RISC, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73675 | RISC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73676 | RhoA, Human (sf9, His) | Recombinant Proteins | |
| HY-P73677 | RFK, Human (His) | Recombinant Proteins | |
| HY-P73678 | RET, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73679 | RET, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7368 | IGFBP-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73680 | Resistin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73681 | RelA/NFkB p65, Human (GST) | Recombinant Proteins | |
| HY-P73682 | RANK L/TNFSF11, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P73684 | PTS, Human (His) | Recombinant Proteins | |
| HY-P73685 | PTP1B, Human (His) | Recombinant Proteins | |
| HY-P73686 | PTH, Human (GST) | Recombinant Proteins | |
| HY-P73687 | P-Selectin, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P73688 | P-Selectin, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P73689 | P-Selectin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7369 | IGFBP-4, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P73690 | P-Selectin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73692 | Prolyl Endopeptidase/PREP, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73693 | Prolactin R, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73694 | Prolactin R, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73696 | Prolactin R, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73697 | Profilin-4, Human (His) | Recombinant Proteins | |
| HY-P73698 | Profilin-2, Human (His) | Recombinant Proteins | |
| HY-P73699 | PRKD3/nPKC nu, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7370 | IL-12, Rat (CHO) | Recombinant Proteins | |
| HY-P73700 | PRAC, Human (His-SUMO) | Recombinant Proteins | |
| HY-P73701 | PPAR gamma, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73702 | Pollen allergen Phl p 5, Phleum pratense | Recombinant Proteins | |
| HY-P73703 | Pollen allergen Phl p 2, Phleum pratense (HEK293, His) | Recombinant Proteins | |
| HY-P73704 | Podoplanin, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73705 | PLP-C beta, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73706 | PLK1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73707 | Pleckstrin, Human (His) | Recombinant Proteins | |
| HY-P73708 | PIST, Human (His) | Recombinant Proteins | |
| HY-P73709 | PGD2 Synthase/PTGDS, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7371 | IL-15, Human (His) | Recombinant Proteins | |
| HY-P73710 | PGD2 Synthase/PTGDS, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73711 | PRDX5/Peroxiredoxin-5, Human (His) | Recombinant Proteins | |
| HY-P73712 | Peroxiredoxin-2/PRDX2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73713 | PRDX1, Mouse (His) | Recombinant Proteins | |
| HY-P73714 | Pentraxin 3/TSG-14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73715 | Pentraxin 2/SAP, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73716 | PD-L1, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73717 | PD-L1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P73718 | PDK1, Human (sf9, His) | Recombinant Proteins | |
| HY-P73719 | PDGF-CC, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P7371AF | Animal-Free IL-15, Human (His) | Recombinant Proteins | |
| HY-P7372 | IL-17A, Mouse (CHO) | Recombinant Proteins | |
| HY-P73720 | PDGF-AA, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P73721 | PDGF R alpha, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73722 | PDGF R alpha, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73724 | PD-1, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73725 | PD-1, Cynomolgus (Biotinylated, 143a.a, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P73727 | PD-1, Canine (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P73728 | PCSK9, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73729 | PCNA, Human (sf9, His) | Recombinant Proteins | |
| HY-P7373 | IL-17A, Human (CHO, His) | Recombinant Proteins | |
| HY-P73730 | PARM-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73731 | PAM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73732 | PAM, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73733 | PAH, Human (D415N, sf9, His) | Recombinant Proteins | |
| HY-P73734 | p63/TP73L, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73736 | Olfactory Marker/OMP, Human (His) | Recombinant Proteins | |
| HY-P73737 | OAF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73738 | NS1, Dengue virus 4 (HEK293, His) | Recombinant Proteins | |
| HY-P73739 | NS1, Dengue virus 3 (HEK293, His) | Recombinant Proteins | |
| HY-P7374 | IL-2R alpha/CD25, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73740 | NS1, Dengue virus 2 (HEK293, His) | Recombinant Proteins | |
| HY-P73741 | NRAS, Human (His, solution) | Recombinant Proteins | |
| HY-P73741A | NRAS, Human (N-His) | Recombinant Proteins | |
| HY-P73742 | NOTCH1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73743 | Neurotensin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73744 | NRG1-beta 2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73745 | NRG1-beta 2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73746 | Neprilysin/CD10, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73749 | NCAM-1/CD56, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73750 | N-Cadherin, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73753 | NAGA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73754 | NA/Neuraminidase, Influenza B (EPI529344, sf9, His) | Recombinant Proteins | |
| HY-P73755 | NA/Neuraminidase, Influenza B (AAA43749, HEK293, His) | Recombinant Proteins | |
| HY-P73756 | NA/Neuraminidase, Influenza B (4CPL_A, HEK293) | Recombinant Proteins | |
| HY-P73757 | NA/Neuraminidase, H5N1 (AEO89183, HEK293, His) | Recombinant Proteins | |
| HY-P73758 | NA/Neuraminidase, H5N1 (ABU94738, sf9, His) | Recombinant Proteins | |
| HY-P73759 | NA/Neuraminidase, H3N2 (QGZ99158, HEK293, His) | Recombinant Proteins | |
| HY-P73760 | NA/Neuraminidase, H3N2 (Q75VQ4, HEK293, His) | Recombinant Proteins | |
| HY-P73761 | NA/Neuraminidase, H3N2 (H274Y, ACN50232, HEK293) | Recombinant Proteins | |
| HY-P73762 | NA/Neuraminidase, H3N2 (EPI675797, sf9, His) | Recombinant Proteins | |
| HY-P73763 | NA/Neuraminidase, H3N2 (EPI675797, HEK293, His) | Recombinant Proteins | |
| HY-P73764 | NA/Neuraminidase, H3N2 (E119V, ACN50232, HEK293) | Recombinant Proteins | |
| HY-P73765 | NA/Neuraminidase, H3N2 (AVG71505, sf9, His) | Recombinant Proteins | |
| HY-P73766 | NA/Neuraminidase, H3N2 (AFG72176, HEK293, His) | Recombinant Proteins | |
| HY-P73767 | NA/Neuraminidase, H3N2 (AFG71945, HEK293, His) | Recombinant Proteins | |
| HY-P73768 | NA/Neuraminidase, H3N2 (AEG65596, HEK293, His) | Recombinant Proteins | |
| HY-P73769 | NA/Neuraminidase, H3N2 (ADT79152, HEK293, His) | Recombinant Proteins | |
| HY-P7377 | IL-6R alpha, Human (Sf9) | Recombinant Proteins | |
| HY-P73770 | NA/Neuraminidase, H3N2 (ACN50232, HEK293, His) | Recombinant Proteins | |
| HY-P73771 | NA/Neuraminidase, H3N2 (ACN50232, HEK293) | Recombinant Proteins | |
| HY-P73772 | NA/Neuraminidase, H3N2 (ACF36533, HEK293, His) | Recombinant Proteins | |
| HY-P73773 | NA/Neuraminidase, H3N2 (ABO44071, HEK293, His) | Recombinant Proteins | |
| HY-P73774 | NA/Neuraminidase, H1N1 (QEM24782, sf9, His) | Recombinant Proteins | |
| HY-P73775 | NA/Neuraminidase, H1N1 (QEM24761, sf9, His) | Recombinant Proteins | |
| HY-P73776 | NA/Neuraminidase, H1N1 (P03469, HEK293, His) | Recombinant Proteins | |
| HY-P73777 | NA/Neuraminidase, H1N1 (P03469, HEK293) | Recombinant Proteins | |
| HY-P73778 | NA/Neuraminidase, H1N1 (P03468, HEK293) | Recombinant Proteins | |
| HY-P73779 | NA/Neuraminidase, H1N1 (N295S, ACP41107, HEK293) | Recombinant Proteins | |
| HY-P7378 | IL-6, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P73780 | NA/Neuraminidase, H1N1 (H275Y, ACP41107, HEK293) | Recombinant Proteins | |
| HY-P73781 | NA/Neuraminidase, H1N1 (EPI859652, sf9, His) | Recombinant Proteins | |
| HY-P73782 | NA/Neuraminidase, H1N1 (EPI859651, HEK293, His) | Recombinant Proteins | |
| HY-P73783 | NA/Neuraminidase, H1N1 (EPI1799927, sf9, His) | Recombinant Proteins | |
| HY-P73784 | NA/Neuraminidase, H1N1 (AYV62750, HEK293, His) | Recombinant Proteins | |
| HY-P73785 | NA/Neuraminidase, H1N1 (ATB53863, HEK293, His) | Recombinant Proteins | |
| HY-P73786 | NA/Neuraminidase, H1N1 (AQS19400, HEK293, His) | Recombinant Proteins | |
| HY-P73787 | NA/Neuraminidase, H1N1 (AKM14549, HEK293, His) | Recombinant Proteins | |
| HY-P73788 | NA/Neuraminidase, H1N1 (AKJ83184, HEK293, His) | Recombinant Proteins | |
| HY-P73789 | NA/Neuraminidase, H1N1 (AIE51967, HEK293, His) | Recombinant Proteins | |
| HY-P7379 | IL-8/CXCL8, Human (CHO) | Recombinant Proteins | |
| HY-P73790 | NA/Neuraminidase, H1N1 (ACP41107, sf9, His) | Recombinant Proteins | |
| HY-P73791 | NA/Neuraminidase, H1N1 (ACP41107, HEK293, Fc) | Recombinant Proteins | |
| HY-P73792 | NA/Neuraminidase, H1N1 (ACM51249, HEK293, His) | Recombinant Proteins | |
| HY-P73793 | NA/Neuraminidase, H1N1 (ACF41870, HEK293, His) | Recombinant Proteins | |
| HY-P73794 | NA/Neuraminidase, H1N1 (ABR28848, HEK293, His) | Recombinant Proteins | |
| HY-P73795 | NA/Neuraminidase, H1N1 (ABQ53689, HEK293, His) | Recombinant Proteins | |
| HY-P73796 | NA/Neuraminidase, H1N1 (ABO38354, HEK293, His) | Recombinant Proteins | |
| HY-P73797 | NA/Neuraminidase, H1N1 (ABO38057, HEK293, His) | Recombinant Proteins | |
| HY-P73798 | NA/Neuraminidase, H1N1 (ABD95342, HEK293, His) | Recombinant Proteins | |
| HY-P73799 | NA/Neuraminidase, H1N1 (AAF77044, HEK293, His) | Recombinant Proteins | |
| HY-P7380 | IL-8/CXCL8, Human (72a.a) | Recombinant Proteins | |
| HY-P73802 | Mucin-1/MUC1, Human (HEK293) | Recombinant Proteins | |
| HY-P73803 | MSH2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73804 | MPZL3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73805 | MOG, Mouse (His) | Recombinant Proteins | |
| HY-P73806 | Moesin, Human (His) | Recombinant Proteins | |
| HY-P73807 | MMP-9, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73808 | MMP-8, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73809 | MMP-8, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P7381 | Kallikrein-11, Human (Sf9) | Recombinant Proteins | |
| HY-P73810 | MMP-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73811 | MKK6, Human (S207D, T211D, sf9, His-GST) | Recombinant Proteins | |
| HY-P73811A | MKK6, Human (S207D, T211D, sf9, His) | Recombinant Proteins | |
| HY-P73812 | MIP-5/CCL15, Human (68a.a, His) | Recombinant Proteins | |
| HY-P73813 | MIP-3 alpha/CCL20, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73814 | MIP-3 alpha/CCL20, Human (His) | Recombinant Proteins | |
| HY-P73815 | MFG-E8, Human (sf9, His) | Recombinant Proteins | |
| HY-P73816 | MFG-E8, Human (Biotinylated, sf9, His-Avi) | Recombinant Proteins | |
| HY-P73818 | MPF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73819 | Mesothelin, Human (285a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P7382 | KGF/FGF-7, Human (N-His) | Recombinant Proteins | |
| HY-P73820 | Mer, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73821 | Mer, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73822 | Mer, Human (sf9) | Recombinant Proteins | |
| HY-P73823 | Mer, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P73824 | Mer, Human (HEK293) | Recombinant Proteins | |
| HY-P73825 | MEK1, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P73827 | M-CSF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73829 | M-CSF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7383 | LIX/CXCL5, Mouse (74a.a, CHO) | Recombinant Proteins | |
| HY-P73830 | M-CSF, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P73831 | M-CSF, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P73832 | MAX, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73833 | MAG/Siglec-4a, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73834 | Lysozyme 2/LYZL2, Human (sf9, His) | Recombinant Proteins | |
| HY-P73835 | LOX-1/OLR1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73836 | LOX-1/OLR1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73837 | LIGHT/TNFSF14, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73837A | LIGHT/TNFSF14, Mouse (sf9, His, solution) | Recombinant Proteins | |
| HY-P73838 | LDLR, Mouse (Biotinylated, A23V, C27G, HEK293, His) | Recombinant Proteins | |
| HY-P73839 | Layilin/LAYN, Human (220a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73840 | Layilin/LAYN, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73841 | Latexin, Human (His) | Recombinant Proteins | |
| HY-P73842 | Latexin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73843 | LAG-3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73844 | LAG-3, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73846 | Ku70-Ku80 Heterodimer, Human (sf9, His) | Recombinant Proteins | |
| HY-P73847 | Kallikrein-11, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73848 | JNK1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P73849 | JAM-C/CD323, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7385 | Serpin B5/Maspin, Human (375 a.a) | Recombinant Proteins | |
| HY-P73850 | JAM-C/CD323, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73851 | JAM-C/CD323, Human (HEK293) | Recombinant Proteins | |
| HY-P73852 | JAM-B/CD322, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73853 | JAM-A/CD321, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73854 | JAM-A/CD321, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73855 | JAM-A/CD321 Protein, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73856 | IVD, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P73857 | IVD, Human (sf9, His) | Recombinant Proteins | |
| HY-P73858 | IRE1, Human (sf9) | Recombinant Proteins | |
| HY-P73859 | Intrinsic Factor/GIF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7385A | Serpin B5/Maspin, Human (His) | Recombinant Proteins | |
| HY-P7386 | M-CSF, Rat | Recombinant Proteins | |
| HY-P73860 | IFN-alpha B/IFNA8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73861 | IFN-alpha B/IFNA8, Human (HEK293) | Recombinant Proteins | |
| HY-P73863 | Integrin alpha X beta 2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73864 | Integrin alpha X beta 2, Human (HEK293, Flag, His) | Recombinant Proteins | |
| HY-P73865 | Integrin alpha V beta 8 Protein, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73867 | Integrin alpha V beta 6 Protein, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P73868 | Integrin alpha V beta 3 Protein, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73868A | Integrin alpha V beta 3, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P73869 | Integrin alpha 8 beta 1, Human (HEK293, Flag, His) | Recombinant Proteins | |
| HY-P73869A | Integrin alpha 8 beta 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7387 | MIF, Human | Recombinant Proteins | |
| HY-P73870 | Integrin alpha 6 beta 4, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P73871 | Integrin alpha 6 beta 1, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P73872 | Integrin alpha 5 beta 1, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P73873 | Insulin R/CD220, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P73873A | Insulin R/CD220, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P73874 | IL-8/CXCL8, Human (72a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73875 | IL-8/CXCL8, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73876 | IL-6R, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73878 | IL-5, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P7388 | MIF, Mouse | Recombinant Proteins | |
| HY-P73880 | IL-35, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P73882 | IL-35, Human (HEK293, His, hFc-Flag) | Recombinant Proteins | |
| HY-P73883 | IL-33, Cynomolgus | Recombinant Proteins | |
| HY-P73884 | IL-32, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73885 | IL-23R, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73886 | IL-23R, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73887 | IL-23 Protein, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P73888 | IL-21R, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P73889 | IL-21R, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73892 | IL-20, Rat | Recombinant Proteins | |
| HY-P73894 | IL-1RA/IL-1RN, Rat (His, solution) | Recombinant Proteins | |
| HY-P73894A | IL-1RA/IL-1RN, Rat (C-His) | Recombinant Proteins | |
| HY-P73895 | IL-1R9/IL1RAPL2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73897 | IL-12, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P73898 | IL-12, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73900 | IL-1 beta, Rat (268a.a, His) | Recombinant Proteins | |
| HY-P73901 | IgG1, Mouse (HEK293, C102S) | Recombinant Proteins | |
| HY-P73903 | IgG1, Human (CHO, C103S) | Recombinant Proteins | |
| HY-P73904 | IgG, Rabbit (T185A, N284S, HEK293) | Recombinant Proteins | |
| HY-P73905 | IGFBP-6, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73906 | IGF2, Human (P.pastoris) | Recombinant Proteins | |
| HY-P73907 | IgE, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73908 | IFN-alpha 13/IFNA13, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P73909 | ICAM-1/CD54, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7391 | NANOG, Human (His-SUMO) | Recombinant Proteins | |
| HY-P73910 | ICAM-1/CD54, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73911 | ICAM-1/CD54, Human (HEK293) | Recombinant Proteins | |
| HY-P73912 | ICA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73913 | I-309/CCL1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73914 | I-309/CCL1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73915 | HSPA8/HSC70, Human (His, Solution) | Recombinant Proteins | |
| HY-P73915A | HSPA8/HSC70, Human (N-His) | Recombinant Proteins | |
| HY-P73916 | HSP60, Mouse (His, solution) | Recombinant Proteins | |
| HY-P73916A | HSP60, Mouse (N-His) | Recombinant Proteins | |
| HY-P73917 | HSP60, Human (His-GST) | Recombinant Proteins | |
| HY-P73918 | HSF1, Human (His) | Recombinant Proteins | |
| HY-P73919 | HRAS, Human (sf9, His) | Recombinant Proteins | |
| HY-P73920 | HNRNPR, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P73921 | p24, HIV-1 (BAH97658, His) | Recombinant Proteins | |
| HY-P73922 | p24, HIV-1 (ACI05538, His) | Recombinant Proteins | |
| HY-P73923 | p24, HIV-1 (AAB61122, His) | Recombinant Proteins | |
| HY-P73924 | p24, HIV-1 (AAB50258, His) | Recombinant Proteins | |
| HY-P73925 | p24, HIV-1 (AAA44868, His) | Recombinant Proteins | |
| HY-P73926 | Histo-blood group ABO/ABO, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73928 | HGF, Mouse (HEK293) | Recombinant Proteins | |
| HY-P73929 | HER2/CD340, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P73929A | HER2/CD340, Mouse (HEK293, N-His) | Recombinant Proteins | |
| HY-P7393 | Otoraplin/OTOR, Human (CHO) | Recombinant Proteins | |
| HY-P73930 | HER2/CD340, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P73931 | HER2/CD340, Human (Biotinylated, 173a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73933 | HARS/HisRS, Human (sf9, His) | Recombinant Proteins | |
| HY-P73934 | Haptoglobin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P73935 | HA/Hemagglutinin, Influenza B (EPI529345, sf9, His) | Recombinant Proteins | |
| HY-P73936 | HA/Hemagglutinin, Influenza B (EPI1394970, HEK293, His) | Recombinant Proteins | |
| HY-P73937 | HA/Hemagglutinin, Influenza B (AXB73995, HEK293, His) | Recombinant Proteins | |
| HY-P73938 | HA/Hemagglutinin, Influenza B (AGX21754, HEK293, His) | Recombinant Proteins | |
| HY-P73939 | HA1/Hemagglutinin, Influenza B (AGI64446, HEK293, His) | Recombinant Proteins | |
| HY-P7394 | OX40/TNFRSF4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73940 | HA/Hemagglutinin, Influenza B (AGB07680, sf9, His) | Recombinant Proteins | |
| HY-P73941 | HA/Hemagglutinin, Influenza B (AFT64423, sf9, His) | Recombinant Proteins | |
| HY-P73942 | HA/Hemagglutinin, Influenza B (AFP83206, HEK293, His) | Recombinant Proteins | |
| HY-P73943 | HA/Hemagglutinin, Influenza B (ACO05957, HEK293, His) | Recombinant Proteins | |
| HY-P73944 | HA1/Hemagglutinin, Influenza B (ACO05957, HEK293, His) | Recombinant Proteins | |
| HY-P73945 | HA1/Hemagglutinin, Influenza B (ACN29383, HEK293, His) | Recombinant Proteins | |
| HY-P73946 | HA/Hemagglutinin, Influenza B (ACN29380, sf9, His) | Recombinant Proteins | |
| HY-P73947 | HA/Hemagglutinin, Influenza B (ACN29380, sf9) | Recombinant Proteins | |
| HY-P73948 | HA/Hemagglutinin, Influenza B (ACN29380, HEK293, His) | Recombinant Proteins | |
| HY-P73949 | HA/Hemagglutinin, Influenza B (ACA33493, HEK293, Fc) | Recombinant Proteins | |
| HY-P7395 | PD-1, Human (CHO, Fc) | Recombinant Proteins | |
| HY-P73950 | HA/Hemagglutinin, Influenza B (ACA33493, HEK293, His) | Recombinant Proteins | |
| HY-P73951 | HA1/Hemagglutinin, Influenza B (ACA33493, HEK293, His) | Recombinant Proteins | |
| HY-P73952 | HA/Hemagglutinin, Influenza B (ABL77299, HEK293, His) | Recombinant Proteins | |
| HY-P73953 | HA/Hemagglutinin, Influenza B (ABL77244, sf9, His) | Recombinant Proteins | |
| HY-P73954 | HA1/Hemagglutinin, Influenza B (ABL77244, HEK293, His) | Recombinant Proteins | |
| HY-P73955 | HA/Hemagglutinin, Influenza B (ABF21279, HEK293, His) | Recombinant Proteins | |
| HY-P73956 | HA/Hemagglutinin, Influenza B (AAA43701, HEK293, His) | Recombinant Proteins | |
| HY-P73957 | HA/Hemagglutinin, Influenza B (A4D5Q0, sf9, His) | Recombinant Proteins | |
| HY-P73958 | HA/Hemagglutinin, H7N9 (EPI443034, sf9, His) | Recombinant Proteins | |
| HY-P73959 | HA/Hemagglutinin, H7N9 (EPI440701, sf9, His) | Recombinant Proteins | |
| HY-P7396 | PD-1, Human (143a.a, HEK293, His) | Recombinant Proteins | |
| HY-P73960 | HA/Hemagglutinin, H7N9 (EPI440701, HEK293, His) | Recombinant Proteins | |
| HY-P73961 | HA1/Hemagglutinin, H7N9 (EPI440701, sf9, His) | Recombinant Proteins | |
| HY-P73962 | HA1/Hemagglutinin, H7N9 (EPI440701, HEK293, His) | Recombinant Proteins | |
| HY-P73963 | HA/Hemagglutinin, H7N9 (EPI439507, sf9, His) | Recombinant Proteins | |
| HY-P73964 | HA/Hemagglutinin, H7N9 (EPI439507, HEK293, His) | Recombinant Proteins | |
| HY-P73965 | HA1/Hemagglutinin, H7N9 (AHA11500, HEK293, His) | Recombinant Proteins | |
| HY-P73966 | HA1/Hemagglutinin, H7N9 (AGJ51953, HEK293, His) | Recombinant Proteins | |
| HY-P73967 | HA/Hemagglutinin, H7N9 (AGI60301, sf9, His) | Recombinant Proteins | |
| HY-P73968 | HA/Hemagglutinin, H7N9 (AGI60301, HEK293, His) | Recombinant Proteins | |
| HY-P73969 | HA1/Hemagglutinin, H7N9 (AGI60301, HEK293, His) | Recombinant Proteins | |
| HY-P7397 | PD-L1, Human (CHO, Fc) | Recombinant Proteins | |
| HY-P73970 | HA1/Hemagglutinin, H5N8 (P11135, HEK293, His) | Recombinant Proteins | |
| HY-P73971 | HA/Hemagglutinin, H5N8 (EPI547678, sf9, His) | Recombinant Proteins | |
| HY-P73972 | HA/Hemagglutinin, H5N8 (EPI544756, sf9, His) | Recombinant Proteins | |
| HY-P73973 | HA/Hemagglutinin, H5N8 (AHL21419, sf9, His) | Recombinant Proteins | |
| HY-P73974 | HA/Hemagglutinin, H5N8 (AHL21407, sf9, His) | Recombinant Proteins | |
| HY-P73975 | HA/Hemagglutinin, H5N8 (ABI85117, sf9, His) | Recombinant Proteins | |
| HY-P73976 | HA/Hemagglutinin, H5N8 (AAP72011, HEK293, His) | Recombinant Proteins | |
| HY-P73977 | HA1/Hemagglutinin, H5N8 (AAP72011, HEK293, His) | Recombinant Proteins | |
| HY-P73978 | HA1/Hemagglutinin, H5N1 (Q9Q0U6, HEK293, His) | Recombinant Proteins | |
| HY-P73979 | HA1/Hemagglutinin, H5N1 (Q692M2, HEK293, His) | Recombinant Proteins | |
| HY-P7398 | PD-L1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P73980 | HA1/Hemagglutinin, H5N1 (H8PF45, HEK293, His) | Recombinant Proteins | |
| HY-P73981 | HA/Hemagglutinin, H5N1 (Biotinylated, AAT73273, sf9, His) | Recombinant Proteins | |
| HY-P73982 | HA/Hemagglutinin, H5N1 (Biotinylated, ABJ96775, HEK293, His) | Recombinant Proteins | |
| HY-P73983 | HA1/Hemagglutinin, H5N1 (Biotinylated, ABJ96775, HEK293, His) | Recombinant Proteins | |
| HY-P73984 | HA1/Hemagglutinin, H5N1 (BAD89305, HEK293, His) | Recombinant Proteins | |
| HY-P73985 | HA/Hemagglutinin, H5N1 (AGC13463, sf9, His) | Recombinant Proteins | |
| HY-P73986 | HA1/Hemagglutinin, H5N1 (AGC13463, HEK293, His) | Recombinant Proteins | |
| HY-P73987 | HA1/Hemagglutinin, H5N1 (ADM95445, HEK293, His) | Recombinant Proteins | |
| HY-P73988 | HA1/Hemagglutinin, H5N1 (ADF83651, HEK293, His) | Recombinant Proteins | |
| HY-P73989 | HA1/Hemagglutinin, H5N1 (ACZ36881, HEK293, His) | Recombinant Proteins | |
| HY-P7399 | PD-L2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P73990 | HA1/Hemagglutinin, H5N1 (ACT15357, HEK293, His) | Recombinant Proteins | |
| HY-P73991 | HA1/Hemagglutinin, H5N1 (ACO07033, HEK293, His) | Recombinant Proteins | |
| HY-P73992 | HA1/Hemagglutinin, H5N1 (ACJ68614, HEK293, His) | Recombinant Proteins | |
| HY-P73993 | HA/Hemagglutinin, H5N1 (ACJ26242, HEK293, His) | Recombinant Proteins | |
| HY-P73994 | HA1/Hemagglutinin, H5N1 (ACI06185, HEK293, His) | Recombinant Proteins | |
| HY-P73995 | HA1/Hemagglutinin, H5N1 (ACI06178, HEK293, His) | Recombinant Proteins | |
| HY-P73996 | HA1/Hemagglutinin, H5N1 (ACA47835, HEK293, His) | Recombinant Proteins | |
| HY-P73997 | HA1/Hemagglutinin, H5N1 (ABQ45850, HEK293, His) | Recombinant Proteins | |
| HY-P73998 | HA1/Hemagglutinin, H5N1 (ABP96850, HEK293, His) | Recombinant Proteins | |
| HY-P73999 | HA1/Hemagglutinin, H5N1 (ABP51975, S28W, HEK293, His) | Recombinant Proteins | |
| HY-P7400 | HB-EGF, Human (CHO) | Recombinant Proteins | |
| HY-P74000 | HA1/Hemagglutinin, H5N1 (ABJ96777, HEK293, His) | Recombinant Proteins | |
| HY-P74001 | HA1/Hemagglutinin, H5N1 (ABJ96698, HEK293, His) | Recombinant Proteins | |
| HY-P74002 | HA1/Hemagglutinin, H5N1 (ABG81039, HEK293, His) | Recombinant Proteins | |
| HY-P74003 | HA1/Hemagglutinin, H5N1 (ABG67978, HEK293, His) | Recombinant Proteins | |
| HY-P74004 | HA1/Hemagglutinin, H5N1 (ABF93441, HEK293, His) | Recombinant Proteins | |
| HY-P74005 | HA1/Hemagglutinin, H5N1 (ABD28180, HEK293, His) | Recombinant Proteins | |
| HY-P74006 | HA1/Hemagglutinin, H5N1 (ABD28180, HEK293) | Recombinant Proteins | |
| HY-P74007 | HA1/Hemagglutinin, H5N1 (AAW80717, HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74008 | HA/Hemagglutinin, H5N1 (AAT76166, sf9, His) | Recombinant Proteins | |
| HY-P74009 | HA1/Hemagglutinin, H5N1 (AAF02306, HEK293, His) | Recombinant Proteins | |
| HY-P7401 | PVR/CD155, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74010 | HA1/Hemagglutinin, H5N1 (AAC32099, HEK293, His) | Recombinant Proteins | |
| HY-P74011 | HA1/Hemagglutinin, H5N1 (ABJ96775, HEK293, His) | Recombinant Proteins | |
| HY-P74012 | HA1/Hemagglutinin, H3N2 (AGL07159, HEK293, His) | Recombinant Proteins | |
| HY-P74013 | HA1/Hemagglutinin, H3N2 (AGB08328, HEK293, His) | Recombinant Proteins | |
| HY-P74014 | HA/Hemagglutinin, H3N2 (AFM72872, sf9, His) | Recombinant Proteins | |
| HY-P74016 | HA1/Hemagglutinin, H3N2 (ACS71642, HEK293, His) | Recombinant Proteins | |
| HY-P74017 | HA1/Hemagglutinin, H3N2 (ACF54576, HEK293, His) | Recombinant Proteins | |
| HY-P74018 | HA1/Hemagglutinin, H3N2 (ABX10525, HEK293, His) | Recombinant Proteins | |
| HY-P74019 | HA1/Hemagglutinin, H3N2 (ABW23353, HEK293, His) | Recombinant Proteins | |
| HY-P74020 | HA1/Hemagglutinin, H3N2 (AAA43178, HEK293, His) | Recombinant Proteins | |
| HY-P74021 | HA/Hemagglutinin, H2N2 (AAY28987, HEK293, His) | Recombinant Proteins | |
| HY-P74022 | HA1/Hemagglutinin, H2N2 (AAO46269, HEK293, His) | Recombinant Proteins | |
| HY-P74023 | HA/Hemagglutinin, H2N2 (AAA43185, HEK293, His) | Recombinant Proteins | |
| HY-P74024 | HA1/Hemagglutinin, H1N2 (ACD85231, HEK293, His) | Recombinant Proteins | |
| HY-P74025 | HA1/Hemagglutinin, H1N2 (ABQ42444, HEK293, His) | Recombinant Proteins | |
| HY-P74026 | HA1/Hemagglutinin, H1N2 (AAY28987, HEK293, His) | Recombinant Proteins | |
| HY-P74027 | HA/Hemagglutinin, H1N1 (QHN72768, HEK293, His) | Recombinant Proteins | |
| HY-P74028 | HA/Hemagglutinin, H1N1 (QEM24709, sf9, His) | Recombinant Proteins | |
| HY-P74029 | HA/Hemagglutinin, H1N1 (QEM24690, sf9, His) | Recombinant Proteins | |
| HY-P7403 | SDF-1 alpha/CXCL12, Mouse (68a.a, CHO) | Recombinant Proteins | |
| HY-P74030 | HA/Hemagglutinin, H1N1 (QEM24690, HEK293, His) | Recombinant Proteins | |
| HY-P74031 | HA/Hemagglutinin, H1N1 (QEM24688, HEK293, His) | Recombinant Proteins | |
| HY-P74032 | HA/Hemagglutinin, H1N1 (QEM24663, sf9, His) | Recombinant Proteins | |
| HY-P74033 | HA1/Hemagglutinin, H1N1 (P03453, HEK293, His) | Recombinant Proteins | |
| HY-P74034 | HA/Hemagglutinin, H1N1 (P03452, sf9, His) | Recombinant Proteins | |
| HY-P74035 | HA/Hemagglutinin, H1N1 (EPI944618, HEK293, His) | Recombinant Proteins | |
| HY-P74036 | HA/Hemagglutinin, H1N1 (EPI1312566, HEK293, His) | Recombinant Proteins | |
| HY-P74037 | HA/Hemagglutinin, H1N1 (EPI1017503, HEK293, His) | Recombinant Proteins | |
| HY-P74038 | HA/Hemagglutinin, H1N1 (Biotinylated, ACP41953.1, HEK293, His) | Recombinant Proteins | |
| HY-P74039 | HA/Hemagglutinin, H1N1 (Biotinylated, ACP41105, sf9, His) | Recombinant Proteins | |
| HY-P74040 | HA/Hemagglutinin, H1N1 (BAK23277, HEK293, His) | Recombinant Proteins | |
| HY-P74041 | HA/Hemagglutinin, H1N1 (APT36456, HEK293, His) | Recombinant Proteins | |
| HY-P74042 | HA/Hemagglutinin, H1N1 (APC57869, sf9, His) | Recombinant Proteins | |
| HY-P74043 | HA/Hemagglutinin, H1N1 (APC57869, HEK293, His) | Recombinant Proteins | |
| HY-P74044 | HA/Hemagglutinin, H1N1 (AMY16048, HEK293, His) | Recombinant Proteins | |
| HY-P74045 | HA/Hemagglutinin, H1N1 (ALZ46477, HEK293, His) | Recombinant Proteins | |
| HY-P74046 | HA/Hemagglutinin, H1N1 (AKM14547, HEK293, His) | Recombinant Proteins | |
| HY-P74047 | HA/Hemagglutinin, H1N1 (AKJ81829, HEK293, His) | Recombinant Proteins | |
| HY-P74048 | HA/Hemagglutinin, H1N1 (AGL04329, HEK293, His) | Recombinant Proteins | |
| HY-P74049 | HA/Hemagglutinin, H1N1 (AFR76582, HEK293, His) | Recombinant Proteins | |
| HY-P7405 | SIRP alpha/CD172a, Human (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P74050 | HA/Hemagglutinin, H1N1 (AFR76227, HEK293, His) | Recombinant Proteins | |
| HY-P74051 | HA/Hemagglutinin, H1N1 (AFR75881, HEK293, His) | Recombinant Proteins | |
| HY-P74052 | HA/Hemagglutinin, H1N1 (AEX38474, HEK293, His) | Recombinant Proteins | |
| HY-P74053 | HA/Hemagglutinin, H1N1 (AEI30056, HEK293, His) | Recombinant Proteins | |
| HY-P74054 | HA/Hemagglutinin, H1N1 (ACV49556, HEK293, His) | Recombinant Proteins | |
| HY-P74055 | HA/Hemagglutinin, H1N1 (ACU80014, sf9, His) | Recombinant Proteins | |
| HY-P74056 | HA/Hemagglutinin, H1N1 (ACU80014, HEK293, His) | Recombinant Proteins | |
| HY-P74057 | HA1/Hemagglutinin, H1N1 (ACR38870, HEK293, His) | Recombinant Proteins | |
| HY-P74058 | HA/Hemagglutinin, H1N1 (ACR15621, sf9, His) | Recombinant Proteins | |
| HY-P74059 | HA/Hemagglutinin, H1N1 (ACR08536,sf9, His) | Recombinant Proteins | |
| HY-P7406 | SIRP alpha/CD172a, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74060 | HA/Hemagglutinin, H1N1 (ACQ89903,sf9, His) | Recombinant Proteins | |
| HY-P74061 | HA/Hemagglutinin, H1N1 (ACQ63286, HEK293, His) | Recombinant Proteins | |
| HY-P74062 | HA/Hemagglutinin, H1N1 (ACP41953, sf9, His) | Recombinant Proteins | |
| HY-P74063 | HA/Hemagglutinin, H1N1 (ACP41953, HEK293, His) | Recombinant Proteins | |
| HY-P74064 | HA/Hemagglutinin, H1N1 (ACP41935, sf9, His) | Recombinant Proteins | |
| HY-P74065 | HA/Hemagglutinin, H1N1 (ACP41105.1, sf9 ,His) | Recombinant Proteins | |
| HY-P74066 | HA/Hemagglutinin, H1N1 (ACN67524, sf9, His) | Recombinant Proteins | |
| HY-P74067 | HA/Hemagglutinin, H1N1 (ACF41933, sf9, His) | Recombinant Proteins | |
| HY-P74068 | HA/Hemagglutinin, H1N1 (ACF41867, sf9, His) | Recombinant Proteins | |
| HY-P74069 | HA/Hemagglutinin, H1N1 (ACF41867, HEK293, His) | Recombinant Proteins | |
| HY-P7407 | SHH, Human (C24II) | Recombinant Proteins | |
| HY-P74070 | HA/Hemagglutinin, H1N1 (ABW71481, HEK293, His) | Recombinant Proteins | |
| HY-P74071 | HA/Hemagglutinin, H1N1 (ABV25642, HEK293, His) | Recombinant Proteins | |
| HY-P74072 | HA/Hemagglutinin, H1N1 (ABU99109, sf9, His) | Recombinant Proteins | |
| HY-P74073 | HA/Hemagglutinin, H1N1 (ABQ44416, sf9, His) | Recombinant Proteins | |
| HY-P74074 | HA/Hemagglutinin, H1N1 (ABP49481, sf9, His) | Recombinant Proteins | |
| HY-P74075 | HA/Hemagglutinin, H1N1 (ABP49327, HEK293, His) | Recombinant Proteins | |
| HY-P74076 | HA/Hemagglutinin, H1N1 (ABK57093, HEK293, His) | Recombinant Proteins | |
| HY-P74077 | HA/Hemagglutinin, H1N1 (ABI19015, HEK293, His) | Recombinant Proteins | |
| HY-P74078 | HA/Hemagglutinin, H1N1 (ABF21274, sf9, His) | Recombinant Proteins | |
| HY-P74079 | HA/Hemagglutinin, H1N1 (ABF21274, HEK293, His) | Recombinant Proteins | |
| HY-P7408 | SHH, Human (C24IVI) | Recombinant Proteins | |
| HY-P74080 | HA/Hemagglutinin, H1N1 (ABD77807, sf9, His) | Recombinant Proteins | |
| HY-P74081 | HA/Hemagglutinin, H1N1 (ABD62843, sf9, His) | Recombinant Proteins | |
| HY-P74082 | HA/Hemagglutinin, H1N1 (ABD59849, HEK293, His) | Recombinant Proteins | |
| HY-P74083 | HA/Hemagglutinin, H1N1 (ABD15258, HEK293, His) | Recombinant Proteins | |
| HY-P74084 | HA/Hemagglutinin, H1N1 (AAL87868, HEK293, His) | Recombinant Proteins | |
| HY-P74085 | HA1/Hemagglutinin, H1N1 (AAD17219, HEK293, His) | Recombinant Proteins | |
| HY-P74086 | HA/Hemagglutinin, H1N1 (AAA67183, HEK293, His) | Recombinant Proteins | |
| HY-P74087 | HA/Hemagglutinin, H1N1 (ADD64203, HEK293, His) | Recombinant Proteins | |
| HY-P74088 | HA/Hemagglutinin, H1N1 (ACU13097, HEK293, His) | Recombinant Proteins | |
| HY-P74089 | HA/Hemagglutinin, H1N1 (ACR15621, HEK293, His) | Recombinant Proteins | |
| HY-P7409 | SHH, Mouse (C25II) | Recombinant Proteins | |
| HY-P74090 | HA/Hemagglutinin, H1N1 (ACP41934, HEK293, His) | Recombinant Proteins | |
| HY-P74091 | HA/Hemagglutinin, H1N1 (ACP41105, HEK293, His) | Recombinant Proteins | |
| HY-P74092 | HA/Hemagglutinin, H1N1 (AAD17229, HEK293, His) | Recombinant Proteins | |
| HY-P74093 | HA/Hemagglutinin, H1N1 (528a.a, ACF54598, HEK293, His) | Recombinant Proteins | |
| HY-P74094 | HA/Hemagglutinin, H1N1 (ACA28844, HEK293, His) | Recombinant Proteins | |
| HY-P74095 | HA/Hemagglutinin, H1N1 (ABW40422, HEK293, His) | Recombinant Proteins | |
| HY-P74096 | HA/Hemagglutinin, H1N1 (528a.a, ABU99109, HEK293, His) | Recombinant Proteins | |
| HY-P74097 | HA/Hemagglutinin, H1N1 (ABD77675, HEK293, His) | Recombinant Proteins | |
| HY-P74098 | HA/Hemagglutinin, H1N1 (AAP34324, HEK293, His) | Recombinant Proteins | |
| HY-P74099 | HA/Hemagglutinin, H1N1 (ACF41933, HEK293, His) | Recombinant Proteins | |
| HY-P7410 | SP-D, Human (HEK293) | Recombinant Proteins | |
| HY-P74100 | HA/Hemagglutinin, H1N1 (ACF54598, HEK293, His) | Recombinant Proteins | |
| HY-P74101 | HA1/Hemagglutinin, H1N1 (ADD64203, HEK293, His) | Recombinant Proteins | |
| HY-P74102 | HA1/Hemagglutinin, H1N1 (ACU13097, HEK293, His) | Recombinant Proteins | |
| HY-P74103 | HA1/Hemagglutinin, H1N1 (ACR15621, HEK293, His) | Recombinant Proteins | |
| HY-P74104 | HA1/Hemagglutinin, H1N1 (ACP41934, HEK293, His) | Recombinant Proteins | |
| HY-P74105 | HA1/Hemagglutinin, H1N1 (ACP41105, HEK293, His) | Recombinant Proteins | |
| HY-P74106 | HA1/Hemagglutinin, H1N1 (ACF41933, HEK293, His) | Recombinant Proteins | |
| HY-P74107 | HA1/Hemagglutinin, H1N1 (AAD17229, HEK293, His) | Recombinant Proteins | |
| HY-P74108 | HA1/Hemagglutinin, H1N1 (ACF54598, HEK293, His) | Recombinant Proteins | |
| HY-P74109 | HA1/Hemagglutinin, H1N1 (ACA28844, HEK293, His) | Recombinant Proteins | |
| HY-P7411 | TGF alpha/TGFA, Human | Recombinant Proteins | |
| HY-P74110 | HA1/Hemagglutinin, H1N1 (ABW40422, HEK293, His) | Recombinant Proteins | |
| HY-P74111 | HA/Hemagglutinin, H1N1 (ABU99109, HEK293, His) | Recombinant Proteins | |
| HY-P74112 | HA1/Hemagglutinin, H1N1 (ABD77675, HEK293, His) | Recombinant Proteins | |
| HY-P74113 | HA1/Hemagglutinin, H1N1 (AAP34324, HEK293, His) | Recombinant Proteins | |
| HY-P74114 | GSK-3 beta, Human (sf9, His) | Recombinant Proteins | |
| HY-P74115 | Granzyme H/GZMH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74116 | GPA33, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74118 | envelope glycoprotein gp120, HIV-1 (ACY40659, HEK293, His) | Recombinant Proteins | |
| HY-P74119 | envelope glycoprotein gp120, HIV-1 (AFM77980, HEK293, His) | Recombinant Proteins | |
| HY-P74120 | envelope glycoprotein gp120, HIV-1 (AAC57427, HEK293 , His) | Recombinant Proteins | |
| HY-P74121 | envelope glycoprotein gp120, HIV-1 (AAA44191, HEK293 , His) | Recombinant Proteins | |
| HY-P74122 | Glypican-3/GPC3, Human (S495A, HEK293, Fc) | Recombinant Proteins | |
| HY-P74124 | glycoprotein/G, HRSV (HEK293, His) | Recombinant Proteins | |
| HY-P74125 | GIP, Human (HEK293, hFc, solution) | Recombinant Proteins | |
| HY-P74125A | GIP, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74126 | GFER, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74126A | GFER, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74128 | GARS, Human (sf9, His) | Recombinant Proteins | |
| HY-P74129 | GAPDH, Mouse (His) | Recombinant Proteins | |
| HY-P74130 | Galectin-1/LGALS1, Rat | Recombinant Proteins | |
| HY-P74131 | Galectin-1/LGALS1, Mouse | Recombinant Proteins | |
| HY-P74132 | Galanin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74133 | FSH, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74134 | Frizzled-6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74135 | Frizzled-6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74136 | Frizzled-5, Mouse (CHO, Fc) | Recombinant Proteins | |
| HY-P74138 | Frizzled-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74139 | Frizzled-5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7414 | TIGIT, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74140 | Frizzled-4/CD344, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74141 | Frizzled-4/CD344, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74142 | Frizzled-4/CD344, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74143 | Frizzled-4/CD344, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74144 | Frizzled-10/CD350, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74145 | Frizzled-10/CD350, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74146 | Frizzled-10/CD350, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74147 | Frizzled-10/CD350, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74148 | Follistatin/FST, Mouse (CHO, Fc) | Recombinant Proteins | |
| HY-P7415 | TIM-3/HAVCR2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74150 | FLT3LG, Rat (sf9, His) | Recombinant Proteins | |
| HY-P74151 | FLT3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74153 | FGFR-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74156 | Fas Ligand, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P74157 | Fas Ligand, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P74158 | Fas Ligand, Human (148a.a, P.pastoris, His) | Recombinant Proteins | |
| HY-P7416 | TNF-alpha/TNFSF2, Human (His) | Recombinant Proteins | |
| HY-P74160 | E-Selectin/CD62E, Mouse (HEK293) | Recombinant Proteins | |
| HY-P74161 | E-Selectin/CD62E, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74162 | E-Selectin/CD62E, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74164 | ESD, Human (His) | Recombinant Proteins | |
| HY-P74165 | ESAM, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74166 | ESAM, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74169 | ERH, Human (N-His) | Recombinant Proteins | |
| HY-P7417 | TNF-alpha/TNFSF2, Mouse (His) | Recombinant Proteins | |
| HY-P74171 | EphB4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74172 | EpCAM/TROP1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74173 | EpCAM/TROP1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74175 | ENSA, Human (His) | Recombinant Proteins | |
| HY-P74177 | EGFR, Human (621a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P74179 | EED, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P7417AF | Animal-Free TNF-alpha/TNFSF2, Mouse (His) | Recombinant Proteins | |
| HY-P74180 | EDNRB/Endothelin R Type B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74181 | EDNRB/Endothelin R Type B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74182 | ECD, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74183 | E2/Envelope, Hepatitis C virus (AAC15723, HEK293, His) | Recombinant Proteins | |
| HY-P74184 | E2/Envelope, Hepatitis C virus (BAA03581, HEK293, His) | Recombinant Proteins | |
| HY-P74185 | E2/Envelope, Hepatitis C virus (278a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74186 | E/Envelope, West Nile Virus Lineage 2 (120a.a, P.pastoris, His) | Recombinant Proteins | |
| HY-P74187 | E/Envelope, West Nile Virus Lineage 2 (109a.a, P.pastoris, His) | Recombinant Proteins | |
| HY-P74188 | E/Envelope, West Nile virus Lineage 1 (120a.a, P.pastoris, His) | Recombinant Proteins | |
| HY-P74189 | E/Envelope, West Nile Virus Lineage 1 (109a.a, P.pastoris, His) | Recombinant Proteins | |
| HY-P7419 | Vaspin, Human | Recombinant Proteins | |
| HY-P74190 | E/Envelope, Dengue virus 4 (395a.a, sf9, His) | Recombinant Proteins | |
| HY-P74191 | E/Envelope, Dengue virus 4 (101a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74192 | E/Envelope, Dengue virus 3 (429a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74193 | E/Envelope, Dengue virus 2 (103a.a, P.pastoris, His) | Recombinant Proteins | |
| HY-P74194 | E/Envelope, Dengue virus 2 (429a.a, sf9, His) | Recombinant Proteins | |
| HY-P74195 | E/Envelope, Dengue virus 2 (399a.a, T76R, Q77E, W101R, L107R, sf9, His) | Recombinant Proteins | |
| HY-P74196 | E/Envelope, Dengue virus 2 (102a.a, P.pastoris, His) | Recombinant Proteins | |
| HY-P74197 | E/Envelope, Dengue virus 1 (101a.a, sf9, His) | Recombinant Proteins | |
| HY-P74198 | E/Envelope, Dengue virus 1 (101a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7420 | VEGF121, Human (120 a.a) | Recombinant Proteins | |
| HY-P74200 | DEP-1/CD148, Human (341a.a, His) | Recombinant Proteins | |
| HY-P74201 | Dectin-2/CLEC6A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74202 | Decorin/PGS2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74203 | DEC-205/CD205, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74204 | DDC, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74205 | DC-SIGN/CD209, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P74206 | DC-SIGN/CD209, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P74207 | DBT, Human (sf9, His) | Recombinant Proteins | |
| HY-P74209 | Cystatin C/CST3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7421 | VEGF164, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P74210 | CYP3A4, Human (His) | Recombinant Proteins | |
| HY-P74211 | Cyclophilin F/PPIF, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74211A | Cyclophilin F/PPIF Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74212 | Cyclophilin A, Mouse (His) | Recombinant Proteins | |
| HY-P74214 | Cyclin E, Human (sf9) | Recombinant Proteins | |
| HY-P74215 | CTLA-4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74216 | CTLA-4, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74218 | CROT, Human (V474L, sf9, His) | Recombinant Proteins | |
| HY-P74219 | C-Reactive, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7422 | Thioredoxin/TXN, Human (His) | Recombinant Proteins | |
| HY-P74220 | C-Reactive, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74221 | C-Reactive, Human (HEK293, solution) | Recombinant Proteins | |
| HY-P74221A | C-Reactive, Human (HEK293) | Recombinant Proteins | |
| HY-P74222 | COX-2, Human (sf9, His) | Recombinant Proteins | |
| HY-P74223 | Contactin-2/CNTN2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74224 | Contactin-1/CNTN1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74225 | Contactin-1/CNTN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74226 | Contactin-3/CNTN3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74227 | Contactin-3/CNTN3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74228 | Contactin-3/CNTN3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74229 | Contactin-3/CNTN3, Human (N708D, HEK293, His) | Recombinant Proteins | |
| HY-P74230 | COMT, Human (sf9, His) | Recombinant Proteins | |
| HY-P74232 | Complement factor H/CFH, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74234 | Cofilin-2, Human (His) | Recombinant Proteins | |
| HY-P74235 | Cochlin/COCH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74236 | Coagulation Factor XIV/PROC, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74237 | Coagulation Factor XIV/PROC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74238 | Coagulation factor XIII B/F13B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74239 | Coagulation Factor VII/F7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7424 | RANKL/TNFSF11, Human | Recombinant Proteins | |
| HY-P74240 | Coagulation Factor IX/F9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74241 | Coagulation Factor II/F2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74242 | CNTF, Mouse (His) | Recombinant Proteins | |
| HY-P74242AF | Animal-Free CNTF, Mouse (His) | Recombinant Proteins | |
| HY-P74243 | C-MPL, Rat (sf9, His) | Recombinant Proteins | |
| HY-P74244 | C-MPL, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74246 | CLM9/CD300g, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74247 | CLM9/CD300g, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74248 | CLM9/CD300g, Human (HEK293) | Recombinant Proteins | |
| HY-P7425 | RANK L/TNFSF11, Mouse | Recombinant Proteins | |
| HY-P74250 | Claudin-11/CLDN11, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74251 | Citrate Synthase/CS, Human (sf9, His) | Recombinant Proteins | |
| HY-P74252 | Chymase/CMA1, Human (sf9, His) | Recombinant Proteins | |
| HY-P74253 | Chk1, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P74254 | CEBP gamma/CEBPG, Human (His) | Recombinant Proteins | |
| HY-P74257 | CDK1-CCNE1 Heterodimer, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74258 | CDC42, Human (GST) | Recombinant Proteins | |
| HY-P74259 | CD8A-CD8B Heterodimer, Mouse (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P7425B | RANK L/TNFSF11, Mouse (HEK293, N-His) | Recombinant Proteins | |
| HY-P7425C | RANKL/TNFSF11, Mouse (HEK293, His, Flag) | Recombinant Proteins | |
| HY-P7426 | TGFBR2/TGF-beta RII, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74260 | CD83, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74262 | CD81, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74263 | CD81, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74264 | CD81, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74265 | CD8 beta, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74266 | CD8 beta, Human (HEK293) | Recombinant Proteins | |
| HY-P74267 | CD8 alpha, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74268 | CD8 alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74269 | CD8 alpha, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7427 | TGFBR2/TGF-beta RII, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74270 | CD8 alpha, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P74272 | CD73/5'-Nucleotidase, Human (T376A, HEK293, Fc) | Recombinant Proteins | |
| HY-P74273 | CD7, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74274 | CD69, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74275 | CD69, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74276 | CD68, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74277 | CD68, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74278 | CD68, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74279 | CD68, Human (sf9, His) | Recombinant Proteins | |
| HY-P7428 | TGFBR2/TGF-beta RII, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74280 | CD63, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74281 | CD63, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74283 | CD5, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74284 | CD5, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74286 | CD5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74287 | CD5, Human (Biotinylated , HEK293, His-Avi) | Recombinant Proteins | |
| HY-P74289 | CD47, Mouse (HEK293, solution) | Recombinant Proteins | |
| HY-P74289A | CD47, Mouse (HEK293) | Recombinant Proteins | |
| HY-P7429 | SARS-CoV-2 3C-likease (His) | Recombinant Proteins | |
| HY-P74290 | PTPRC/CD45RAB, Human (529a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74291 | CD44, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74293 | CD44, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74295 | CD40, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74296 | CD40, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74298 | CD40, Mouse (Biotinylated , HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7429A | SARS-CoV-2 3C-likease (N-His) | Recombinant Proteins | |
| HY-P74300 | CD4, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P74301 | CD3D-CD3E Heterodimer, Human (HEK293) | Recombinant Proteins | |
| HY-P74302 | CD36, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74303 | CD36, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74304 | CD34, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74305 | CD34, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74306 | CD34, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74309 | CD28, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7431 | SARS-CoV-2 S RBD (194a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74310 | CD28, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74311 | CD28, Mouse (Biotinylated , HEK293, His) | Recombinant Proteins | |
| HY-P74313 | CD28, Human/Cynomolgus/Rhesus Macaque (HEK293) | Recombinant Proteins | |
| HY-P74314 | CD276/B7-H3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74315 | CD276/B7-H3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74318 | CD24, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7431A | SARS-CoV-2 S RBD (194a.a, HEK293, C-His) | Recombinant Proteins | |
| HY-P7432 | SARS-CoV-2 S RBD-SD1 (HEK293, mFc) | Recombinant Proteins | |
| HY-P74320 | CD23/Fc epsilon RII, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74321 | CD23/Fc epsilon RII, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74322 | CD2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74323 | CD2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74324 | CD2, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P74325 | CD2, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P74326 | CD1D-B2M Heterodimer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74327A | CD1D Protein | Recombinant Proteins | |
| HY-P74328 | CD19, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7433 | SARS-CoV-2 S RBD-SD1 (HEK293, His) | Recombinant Proteins | |
| HY-P74330 | CD19, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74331 | CD14, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74332 | CD14, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74333 | CD14, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74335 | 4-1BB/TNFRSF9, Mouse (isoform 2, HEK293, Fc) | Recombinant Proteins | |
| HY-P74336 | CD117/c-kit, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P74337 | CD117/c-kit, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74338 | CD117/c-kit, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74339 | CD117/c-kit, Human (P10721-2, HEK293, Fc) | Recombinant Proteins | |
| HY-P7434 | SARS-CoV-2 S1 (HEK293, mFc) | Recombinant Proteins | |
| HY-P74341 | CD117/c-kit, Human (141a.a, His) | Recombinant Proteins | |
| HY-P74342 | CCL4, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P74343 | CBLC, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74344 | Cathepsin E, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74345 | Cathepsin B, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74346 | Cathepsin A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74347 | Caspase-7/CASP7, Human (His) | Recombinant Proteins | |
| HY-P74349 | CASK, Human (sf9) | Recombinant Proteins | |
| HY-P7435 | SARS-CoV-2 S1 (HEK293, Fc) | Recombinant Proteins | |
| HY-P74350 | CART, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74351 | CART, Human (HEK293) | Recombinant Proteins | |
| HY-P74352 | Carboxyl Ester Lipase/CEL, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74354 | Capsid, Hepatitis B Virus (His) | Recombinant Proteins | |
| HY-P74355 | CANT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74356 | CANT1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74357 | Can f 6, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P74359 | Calcitonin R, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P7436 | SARS-CoV-2 S1 (HEK293) | Recombinant Proteins | |
| HY-P74360 | Cadherin-8, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74361 | Cadherin-8, Rat (HEK293) | Recombinant Proteins | |
| HY-P74362 | Cadherin-13, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74363 | Cadherin-13, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74364 | Cadherin-13, Rat (HEK293) | Recombinant Proteins | |
| HY-P74365 | Cadherin-13, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74366 | Cadherin-13, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74367 | Cadherin-1/CD324, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74368 | Cadherin-1/CD324, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7437 | Nucleocapsid (His) | Recombinant Proteins | |
| HY-P74370 | Cadherin-1/CD324, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74371 | C7/Complement component C7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74371A | C7/Complement component C7, Human (HEK293, C-10*His) | Recombinant Proteins | |
| HY-P74372 | C7/Complement component C7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74373 | C6/Complement component C6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74374 | C2/Complement C2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74375 | C2/Complement C2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74376 | C2/Complement C2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74377 | C1D, Human (His) | Recombinant Proteins | |
| HY-P74379 | BMP-4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7438 | Nucleocapsid NTD domain, Virus (His) | Recombinant Proteins | |
| HY-P74380 | BIN1, Human (His) | Recombinant Proteins | |
| HY-P74381 | beta-Catenin, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P74382 | beta-Catenin, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74383 | BDNF, Mouse (R129A, R130A, HEK293, His, Solution)) | Recombinant Proteins | |
| HY-P74383A | BDNF, Mouse (R129A, R130A, HEK293, C-His) | Recombinant Proteins | |
| HY-P74387 | Basigin/CD147, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74388 | Basigin/CD147, Human (HEK293) | Recombinant Proteins | |
| HY-P7439 | Nucleocapsid CTD domain, Virus (His) | Recombinant Proteins | |
| HY-P74390 | BAMBI/NMA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74391 | BAMBI/NMA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74392 | BAMBI/NMA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74393 | B7-H4, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74394 | B7-H4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74395 | B7-H4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74398 | B7-1/CD80, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74402 | B2M/Beta-2 microglobulin, Rat (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74403 | B2M/Beta-2 microglobulin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74404 | B2M/Beta-2 microglobulin, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74405 | Azoreductase/NQO1, Human (His) | Recombinant Proteins | |
| HY-P74405A | Azoreductase/NQO1, Human | Recombinant Proteins | |
| HY-P74406 | AXL, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74407 | AXL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74408 | ATF2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74409 | ART3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7441 | ACE2, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74410 | Apolipoprotein H/APOH, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74411 | Angiopoietin-4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74412 | Angiopoietin-1, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74412A | Angiopoietin-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74413 | Muellerian-inhibiting factor/AMH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74415 | Alkaline Phosphatase/ALPL, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74416 | Alkaline Phosphatase/ALPL, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74417 | ALK-7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74419 | Aldolase B, Human (GST) | Recombinant Proteins | |
| HY-P74419A | Aldolase B, Human (N-GST) | Recombinant Proteins | |
| HY-P7442 | ACE2, Human (HEK293, hFc, solution) | Recombinant Proteins | |
| HY-P74420 | AKT2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74421 | AKT1, Human (sf9, His) | Recombinant Proteins | |
| HY-P74422 | AGO3, Human (sf9, His) | Recombinant Proteins | |
| HY-P74423 | AGO2/Argonaute-2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74423Y | AGO2/Argonaute-2, Mouse (sf9, His, solution) | Recombinant Proteins | |
| HY-P74424 | AGO1, Human (sf9, His) | Recombinant Proteins | |
| HY-P74425 | AGER, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74426 | Adrenomedullin/ADM, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74427 | Adenylate Kinase 1/AK1, Rat (His) | Recombinant Proteins | |
| HY-P74428 | Adenylate Kinase 1/AK1, Human (His) | Recombinant Proteins | |
| HY-P74429 | Adenosine Deaminase/ADA, Human (sf9, His) | Recombinant Proteins | |
| HY-P7443 | ACE2, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P74430 | ACPP/Prostatic Acid Phosphatase, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74431 | Aconitase 2/ACO2, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P74432 | Aconitase 2/ACO2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74433 | ACE2, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74434 | ACE2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74435 | AACS, Human (sf9, His) | Recombinant Proteins | |
| HY-P74436 | 15 Lipoxygenase 2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74437 | 15 Lipoxygenase 2, Human (sf9) | Recombinant Proteins | |
| HY-P74438 | 14-3-3 sigma, Mouse | Recombinant Proteins | |
| HY-P74439 | 14-3-3 beta, Human (GST) | Recombinant Proteins | |
| HY-P7444 | MASP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74440 | 14-3-3 beta, Human | Recombinant Proteins | |
| HY-P74441 | Lymphocyte antigen 86/MD-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74441A | Lymphocyte antigen 86/MD-1, Mouse (HEK293, C-6*His) | Recombinant Proteins | |
| HY-P74442 | IGF-I R, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74443 | SARS-CoV-2 Nucleocapsid (Omicron, B.1.1.529, His) | Recombinant Proteins | |
| HY-P74443A | SARS-CoV-2 Nucleocapsid (Omicron, B.1.1.529, N-His) | Recombinant Proteins | |
| HY-P74444 | SARS-CoV-2 S (Omicron, B.1.1.529, His) | Recombinant Proteins | |
| HY-P74445 | SARS-CoV-2 S1 (Omicron, B.1.1.529, His, solution) | Recombinant Proteins | |
| HY-P74445A | SARS-CoV-2 S1 (Omicron, B.1.1.529, C-His) | Recombinant Proteins | |
| HY-P74446 | SARS-CoV-2 S RBD (Biotinylated, Omicron, B.1.1.529, His-Avi) | Recombinant Proteins | |
| HY-P74447 | SARS-CoV-2 S RBD (Omicron, B.1.1.529, His) | Recombinant Proteins | |
| HY-P74448 | HA/Hemagglutinin, H9N2 (Q9ICY5, HEK293, His) | Recombinant Proteins | |
| HY-P74449 | HA1/Hemagglutinin, H9N2 (Q9ICY5, HEK293, His) | Recombinant Proteins | |
| HY-P7445 | 14-3-3 epsilon, Human (GST) | Recombinant Proteins | |
| HY-P74450 | HA/Hemagglutinin, H9N2 (AAO46082, HEK293, His) | Recombinant Proteins | |
| HY-P74451 | HA1/Hemagglutinin, H9N2 (AAO46082, HEK293, His) | Recombinant Proteins | |
| HY-P74452 | HA/Hemagglutinin, H9N2 (AAF00701, HEK293, His) | Recombinant Proteins | |
| HY-P74453 | HA1/Hemagglutinin, H9N2 (AAF00701, HEK293, His) | Recombinant Proteins | |
| HY-P74454 | Zika virus NS1 (sf9, His) | Recombinant Proteins | |
| HY-P74455 | Zika virus NS1 (HEK293, His) | Recombinant Proteins | |
| HY-P74456 | Zika virus E/Envelope (HEK293, His) | Recombinant Proteins | |
| HY-P74457 | Zika virus E/Envelope (97a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P74458 | Zika virus E/Envelope (438a.a, sf9, His) | Recombinant Proteins | |
| HY-P74459 | Zika virus E/Envelope (107a.a, sf9, His) | Recombinant Proteins | |
| HY-P7446 | 4-1BBL/TNFSF9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74460 | Zika virus E/Envelope (107a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P74461 | XCL2/SCM-1 beta, Human (sf9, His) | Recombinant Proteins | |
| HY-P74463 | WIF-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74464 | West Nile Virus NS1 (HEK293, His) | Recombinant Proteins | |
| HY-P74466 | VEGFR-3/FLT4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74467 | VEGFR-3/FLT4, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P74468 | VEGFR-3/FLT4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74469 | VEGFR-3/FLT4, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P7447 | 4-1BB/TNFRSF9, Mouse (HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P74470 | VEGFR-2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74471 | VEGFR-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74472 | VEGFR-2, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P74473 | VEGFR-2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P74474 | VEGF-CC, Mouse/Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74475 | VEGF-CC, Mouse/Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74478 | USP7, Human (sf9) | Recombinant Proteins | |
| HY-P74479 | USP5, Human (sf9, His) | Recombinant Proteins | |
| HY-P7447A | 4-1BB/TNFRSF9, Mouse (HEK293, C-hFc) | Recombinant Proteins | |
| HY-P7448 | CD73/5'-Nucleotidase, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74481 | UNC5B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74482 | UNC5B, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74483 | UCHL1, Rat (His) | Recombinant Proteins | |
| HY-P74484 | UBASH3B/STS1, Human (His) | Recombinant Proteins | |
| HY-P74485 | UBA1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74486 | TSHR, Human (sf9, His) | Recombinant Proteins | |
| HY-P74488 | TROP-2, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P7449 | CD73/5'-Nucleotidase, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74490 | TROP-2, Human (HEK293, His-hFc) | Recombinant Proteins | |
| HY-P74491 | TRIB3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P74492 | TRIB2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74493 | TRF1, Human (sf9, His) | Recombinant Proteins | |
| HY-P74494 | Transferrin, Pig (HEK293, His) | Recombinant Proteins | |
| HY-P74495 | Transferrin, Pig (HEK293, hFc) | Recombinant Proteins | |
| HY-P74497 | TRAIL R2/TNFRSF10B, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74498 | TRAIL R2/TNFRSF10B, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7450 | PGD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74500 | TRAIL R1/TNFRSF10A, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74502 | TPM1, Human (His) | Recombinant Proteins | |
| HY-P74503 | AITRL/TNFSF18, Human (sf9, His) | Recombinant Proteins | |
| HY-P74504 | TNFRSF1A, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74505 | TNFRSF1A, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74506 | TNFRSF13B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74507 | TM4SF2/TSPAN7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74508 | TL1A/TNFSF15, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74509 | TIM-3/HAVCR2, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P7451 | MCAD, Human (His) | Recombinant Proteins | |
| HY-P74510 | TIM-1/KIM-1/HAVCR, Rhesus Macaque (HEK293) | Recombinant Proteins | |
| HY-P74512 | TIM-1/KIM-1/HAVCR, Rhesus Macaque (116a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74513 | TIGIT, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74514 | Thy1/CD90, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74515 | Thy1/CD90, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74516 | Thy1/CD90, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74517 | Thy1/CD90, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74518 | Thy1/CD90, Human (HEK293) | Recombinant Proteins | |
| HY-P74519 | Thrombomodulin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7452 | ACOT13, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74521 | TGFBR3/TGF-beta RIII, Human (sf9, His) | Recombinant Proteins | |
| HY-P74522 | TGFBR1/ALK-5, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74523 | TGFBR1/ALK-5, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74525 | TGFBI, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74525A | TGFBI, Human(HEK293, His) | Recombinant Proteins | |
| HY-P74526 | TFRC, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74527 | TFPI2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74527A | TFPI2, Mouse (189a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74528 | TFPI2, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P74529 | TFF3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7453 | ACTB, Human (His) | Recombinant Proteins | |
| HY-P74530 | TCL1A, Human (His) | Recombinant Proteins | |
| HY-P74531 | TARC/CCL17, Human (sf9, His) | Recombinant Proteins | |
| HY-P74532 | TARC/CCL17, Human (sf9) | Recombinant Proteins | |
| HY-P74533A | Synaptotagmin Protein, Human (N-His) | Recombinant Proteins | |
| HY-P74534 | SUC2, Saccharomyces cerevisiae (P.pastoris, His) | Recombinant Proteins | |
| HY-P74535 | STXBP3, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74536 | STIM1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74537 | SRP54, Human (sf9, His) | Recombinant Proteins | |
| HY-P74538 | SOD2/Mn-SOD, Human | Recombinant Proteins | |
| HY-P74539 | SMAD5, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P74540 | SMAD5, Mouse (sf9) | Recombinant Proteins | |
| HY-P74541 | SLAMF2/CD48, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74542 | SLAMF2/CD48, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P74543 | SLAMF2/CD48, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74545 | SIRT5, Human (Flag) | Recombinant Proteins | |
| HY-P74546 | SIRP alpha/CD172a, Human (G75A, HEK293, His) | Recombinant Proteins | |
| HY-P74547 | SIGIRR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74548 | SIAE, Human (sf9, His) | Recombinant Proteins | |
| HY-P74549 | SHP-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7455 | ACVR2A/Activin RIIA, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74550 | SFRP4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74551 | SFRP4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74552 | SFRP4, Human (CHO, His) | Recombinant Proteins | |
| HY-P74553 | SFRP2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74554 | SFRP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74555 | Serpin A1b, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74556 | Serpin A1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74557 | Serpin F1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74558 | Serpin A3N, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74559 | Semaphorin-5A/SEMA5A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7455A | ACVR2A/Activin RIIA, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7456 | ACVR2B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74560 | Semaphorin-5A/SEMA5A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74561 | Semaphorin-4D/SEMA4D, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74562 | Semaphorin-4D/SEMA4D, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74563 | Semaphorin-4D/SEMA4D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74565 | Semaphorin-4D/SEMA4D, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74566 | Semaphorin-3A/SEMA3A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74568 | SCG3/Secretogranin-3, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74569 | SDF-1, Canine | Recombinant Proteins | |
| HY-P7457 | ACY3, Human (His) | Recombinant Proteins | |
| HY-P74570 | SBDS, Human (His) | Recombinant Proteins | |
| HY-P74571 | SARS-CoV-2 S2 (sf9, His) | Recombinant Proteins | |
| HY-P74572 | SARS-CoV-2 S2 (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P74573 | SARS-CoV-2 S1 (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P74574 | SARS-CoV-2 S1 (305a.a, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P74575 | SARS-CoV-2 S1 (D614G, HEK293, His) | Recombinant Proteins | |
| HY-P74576 | SARS-CoV-2 S1 (D614G, HEK293, Fc) | Recombinant Proteins | |
| HY-P74577 | SARS-CoV-2 S1 (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P74578 | SARS-CoV-2 S (sf9, His) | Recombinant Proteins | |
| HY-P74579 | SARS-CoV-2 RDRP (sf9, His) | Recombinant Proteins | |
| HY-P7458 | ACYP1, Human (His) | Recombinant Proteins | |
| HY-P74580 | SARS-CoV-2 NSP3 (sf9, His) | Recombinant Proteins | |
| HY-P74581 | SARS-CoV Plpro/papain-like protease (His) | Recombinant Proteins | |
| HY-P74582 | SARS-CoV Nucleoprotein/NP (sf9, His) | Recombinant Proteins | |
| HY-P74583 | S100A9, Mouse (His) | Recombinant Proteins | |
| HY-P74584 | S100A6, Mouse | Recombinant Proteins | |
| HY-P74585 | S100A2, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74586 | S100A10, Human (His) | Recombinant Proteins | |
| HY-P74587 | S100A1, Mouse (His) | Recombinant Proteins | |
| HY-P74588 | S100A1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74589 | S100A1, Human | Recombinant Proteins | |
| HY-P7459 | Acylphosphatase-2/ACYP2, Human (GST) | Recombinant Proteins | |
| HY-P74590 | RYBP, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74591 | RRM1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74592 | RPE, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74593 | RP2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P74594 | ROM1, Human (His) | Recombinant Proteins | |
| HY-P74595 | ROBO2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74596 | RGS5, Human (His) | Recombinant Proteins | |
| HY-P74597 | REG-4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74598 | RBP4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74599 | RBP4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7460 | ADAMDEC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74600 | RBBP4, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74601 | RBBP4, Human (sf9, His) | Recombinant Proteins | |
| HY-P74602 | RANTES/CCL5, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P74603 | RAMP3, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74604 | AGER, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74605 | AGER, Human (HEK293) | Recombinant Proteins | |
| HY-P74606 | RACK1, Human (His-MBP) | Recombinant Proteins | |
| HY-P74607 | RAC2, Human (His) | Recombinant Proteins | |
| HY-P74608 | RAC1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P74609 | RAB2, Mouse (His) | Recombinant Proteins | |
| HY-P7461 | Adiponectin/Acrp30, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74610 | RAB11B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74613 | PR-Set7, Human | Recombinant Proteins | |
| HY-P74614 | Protein S/PROS1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74615 | Protein Kinase D2/PRKD2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74616 | Prokineticin-1/EG-VEGF, Human (sf9, His) | Recombinant Proteins | |
| HY-P74617 | Progranulin/PGRN, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74618 | Progranulin/PGRN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74618A | Progranulin/PGRN, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P74619 | PRNP/CD230, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74619A | PRNP/CD230, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P7462 | ADPRH/ARH1, Human (His) | Recombinant Proteins | |
| HY-P74620 | PRC1, Human (sf9, His) | Recombinant Proteins | |
| HY-P74621 | PRAK/MAPKAPK5, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74622 | Porcine circovirus 2 Capsid (sf9, His) | Recombinant Proteins | |
| HY-P74623 | PON3, Human (S50N, sf9, His) | Recombinant Proteins | |
| HY-P74624 | Podoplanin, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P74625 | PLTP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74626 | PLGF, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P74627 | PLGF-1, Human | Recombinant Proteins | |
| HY-P74627A | PLGF-1, Human (N-His) | Recombinant Proteins | |
| HY-P74628 | PLA2G2A, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P74629 | PKM2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P7463 | Alpha-Fetoprotein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74630 | PKC iota, Human (sf9, GST) | Recombinant Proteins | |
| HY-P74631 | PIGR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74632 | PIG3, Human (His) | Recombinant Proteins | |
| HY-P74633A | PHGDH, Human (C-His) | Recombinant Proteins | |
| HY-P74634 | PGK1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74635 | PFKM, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74636 | PFKFB3, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74637 | pfHPRT, P. falciparum (His) | Recombinant Proteins | |
| HY-P74638 | Periostin, Human (781a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74639 | PDK4, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P7464 | Alpha-Fetoprotein, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74640 | PDGF-CC, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P74641 | PDGF-BB, Rhesus Macaque (P.pastoris, His) | Recombinant Proteins | |
| HY-P74642 | PDGF-BB, Canine (P.pastoris, His) | Recombinant Proteins | |
| HY-P74643 | PDGF-AA, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P74644 | PDGF R beta, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74645 | PDGF R alpha, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74647 | PDE2A, Human (sf9, His) | Recombinant Proteins | |
| HY-P74648 | PDE1C, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74649 | PCBP1, Human (His) | Recombinant Proteins | |
| HY-P7465 | AG-2, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74650 | PC4/SUB1, Human (His) | Recombinant Proteins | |
| HY-P74651 | PAX8, Human (His) | Recombinant Proteins | |
| HY-P74652 | PARP1, Human (sf9, His) | Recombinant Proteins | |
| HY-P74653 | PARK7/DJ-1, Human (His) | Recombinant Proteins | |
| HY-P74654 | PAK3, Human (sf9, His) | Recombinant Proteins | |
| HY-P74655 | p67phox, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74656 | p67phox, Human (sf9) | Recombinant Proteins | |
| HY-P74658 | P4HB, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74659 | p19INK4d, Human (His) | Recombinant Proteins | |
| HY-P7465A | AG-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7466 | AGR3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74660 | OX40 Ligand/TNFSF4, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74661 | TNFRSF11B/OPG, Rhesus Macaque (hFc) | Recombinant Proteins | |
| HY-P74662 | OSM, Human (HEK293) | Recombinant Proteins | |
| HY-P74664 | OGN/Osteoglycin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74665 | Nucleoside phosphorylase/PNP, Human (His) | Recombinant Proteins | |
| HY-P74666 | Nucleoprotein/NP, Influenza B (EPI1649065, sf9, His) | Recombinant Proteins | |
| HY-P74667 | Nucleoprotein/NP, Influenza B (EPI1368865, sf9, His) | Recombinant Proteins | |
| HY-P74668 | Nucleoprotein/NP, Influenza B (ACF54251, sf9, His) | Recombinant Proteins | |
| HY-P74669 | Nucleoprotein/NP, H3N2 (P22435, sf9, His) | Recombinant Proteins | |
| HY-P7467 | AGER, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74670 | Nucleoprotein/NP, H3N2 (EPI541652, sf9, His) | Recombinant Proteins | |
| HY-P74671 | Nucleoprotein/NP, H3N2 (EPI1698482, sf9, His) | Recombinant Proteins | |
| HY-P74672 | Nucleoprotein/NP, H3N2 (EPI1395762, sf9, His) | Recombinant Proteins | |
| HY-P74673 | Nucleoprotein/NP, H3N2 (AFM71861, sf9, His) | Recombinant Proteins | |
| HY-P74674 | Nucleoprotein/NP, H2N2 (P21433, sf9, His) | Recombinant Proteins | |
| HY-P74675 | Nucleoprotein/NP, H1N1 (Q5UEW0, sf9, His) | Recombinant Proteins | |
| HY-P74676 | Nucleoprotein/NP, H1N1 (I116M, AAM75159, sf9, His) | Recombinant Proteins | |
| HY-P74677 | Nucleoprotein/NP, H1N1 (EPI1716625, sf9, His) | Recombinant Proteins | |
| HY-P74678 | Nucleoprotein/NP, H1N1 (EPI1617976, sf9, His) | Recombinant Proteins | |
| HY-P74679 | Nucleoprotein/NP, H1N1 (ACS94534, sf9, His) | Recombinant Proteins | |
| HY-P7468 | AGR3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74680 | Nucleophosmin/Npm1, Human (193a.a, His, soultion) | Recombinant Proteins | |
| HY-P74680A | Nucleophosmin/Npm1, Human (193a.a, His) | Recombinant Proteins | |
| HY-P74681 | Nucleophosmin/Npm1, Human (150a.a, His) | Recombinant Proteins | |
| HY-P74682 | Neuregulin-2/NRG2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74683 | NOTCH4, Human (sf9, His) | Recombinant Proteins | |
| HY-P74684 | Non-structural 1/NS1, H1N1 (His) | Recombinant Proteins | |
| HY-P74685 | NKp44/NCR2, Human (Biotinylated, 169a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7469 | AKR1C2, Human | Recombinant Proteins | |
| HY-P74690 | NKG2A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74691 | NKG2A, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P74692 | Niemann Pick C2/NPC2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74693 | Niemann Pick C2/NPC2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74694 | Niemann Pick C2/NPC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74695 | Niemann Pick C1/NPC1, Human (His) | Recombinant Proteins | |
| HY-P74696 | Nicastrin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74697 | Nicastrin, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P74698 | Nicastrin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74699 | NGFR, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P7470 | AKR1C4, Human (His) | Recombinant Proteins | |
| HY-P74700 | NGFR, Rabbit (HEK293, hFc) | Recombinant Proteins | |
| HY-P74701 | Neurotrimin, Human (312a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74702 | Neurotrimin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74703 | Neuroserpin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74704 | Neuroligin-1/NLGN1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74704A | Neuroligin-1NLGN1, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P74705 | NLGN1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P74706 | Neurofascin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74706A | Neurofascin, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P74707 | Neurofascin, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74708 | Neurofascin, Human (Biotinylated, HEK293, hFc) | Recombinant Proteins | |
| HY-P74709 | Neuregulin-1/NRG1, Canine (HEK293) | Recombinant Proteins | |
| HY-P7471 | ALCAM/CD166, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74710 | Neuregulin-1/NRG1, Canine (65a.a, HEK293, mFc) | Recombinant Proteins | |
| HY-P74711 | Neuregulin-1/NRG1, Canine (65a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74712 | Neuregulin-1/NRG1, Canine (222a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74713 | Neuregulin-1/NRG1, Canine (222a.a, HEK293, hFc) | Recombinant Proteins | |
| HY-P74714 | NA/Neuraminidase, H9N2 (Q9ICY2, HEK293, His) | Recombinant Proteins | |
| HY-P74715 | NA/Neuraminidase, H9N2 (AAD49001, HEK293, His) | Recombinant Proteins | |
| HY-P74716 | NA/Neuraminidase, H7N9 (EPI439509, HEK293, His) | Recombinant Proteins | |
| HY-P74717 | NA/Neuraminidase, H7N9 (EPI439509, HEK293) | Recombinant Proteins | |
| HY-P74718 | NA/Neuraminidase, H7N9 (EPI439487, HEK293, His) | Recombinant Proteins | |
| HY-P74719 | NA/Neuraminidase, H7N9 (Biotinylated, EPI439509, HEK293, His) | Recombinant Proteins | |
| HY-P7472 | ALCAM/CD166, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74720 | NA/Neuraminidase, H7N7 (AAR11367, HEK293, His) | Recombinant Proteins | |
| HY-P74721 | NA/Neuraminidase, H7N7 (AAR11367, HEK293) | Recombinant Proteins | |
| HY-P74722 | NA/Neuraminidase, H4N6 (ABI47998, sf9, His) | Recombinant Proteins | |
| HY-P74723 | NA/Neuraminidase, H4N6 (ABI47998, HEK293) | Recombinant Proteins | |
| HY-P74724 | NA/Neuraminidase, H1N2 (QAX25989, HEK293, His) | Recombinant Proteins | |
| HY-P74725 | NA/Neuraminidase, H1N2 (CCQ71972, HEK293, His) | Recombinant Proteins | |
| HY-P74726 | NA/Neuraminidase, H1N2 (APQ31966, HEK293, His) | Recombinant Proteins | |
| HY-P74727 | NA/Neuraminidase, H1N2 (AGA19317, HEK293, His) | Recombinant Proteins | |
| HY-P74728 | NA/Neuraminidase, H1N2 (ADR51655, HEK293, His) | Recombinant Proteins | |
| HY-P74729 | NA/Neuraminidase, H1N2 (AAL87886, HEK293, His) | Recombinant Proteins | |
| HY-P7473 | ADH7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74730 | NA/Neuraminidase, H12N5 (ABB88113, HEK293) | Recombinant Proteins | |
| HY-P74731 | NA/Neuraminidase, H10N8 (AFJ19054, sf9, His) | Recombinant Proteins | |
| HY-P74732 | Neuraminidase, C.perfringens (His) | Recombinant Proteins | |
| HY-P74733 | NEU2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74734 | NEIL1, Human (His) | Recombinant Proteins | |
| HY-P74735 | Nectin-2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74736 | NBL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74737 | NBL1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74738 | NARS, Human (sf9, His) | Recombinant Proteins | |
| HY-P74739 | MVK, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P7474 | ALDH1A1, Human (His) | Recombinant Proteins | |
| HY-P74740 | MTH1, Human (His) | Recombinant Proteins | |
| HY-P74741 | MST4/STK26, Human (sf9, GST) | Recombinant Proteins | |
| HY-P74742 | MST1/STK4, Human (sf9, His) | Recombinant Proteins | |
| HY-P74743 | MRAP, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74744 | MMP-12, Human | Recombinant Proteins | |
| HY-P74745 | MKK6, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74746 | MKK6, Human (sf9) | Recombinant Proteins | |
| HY-P74748 | MKK6, Human (S207D, T211D, sf9) | Recombinant Proteins | |
| HY-P7475 | ALDH1A2, Human (His) | Recombinant Proteins | |
| HY-P74750 | MERS-CoV Spike/S2 (sf9, His) | Recombinant Proteins | |
| HY-P74751 | MERS-CoV Spike/S1 (HEK293, His) | Recombinant Proteins | |
| HY-P74752 | MERS-CoV Spike/S RBD (sf9, Fc) | Recombinant Proteins | |
| HY-P74753 | MERS-CoV Spike/S RBD (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P74754 | MERS-CoV Nucleoprotein/NP (sf9, His) | Recombinant Proteins | |
| HY-P74756 | MDM4/MDMX, Human (His) | Recombinant Proteins | |
| HY-P74757 | MDH1, Rat (His) | Recombinant Proteins | |
| HY-P74758 | MCP-1/CCL2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74759 | Matrix 1/M1, H7N9 (EPI439506, His) | Recombinant Proteins | |
| HY-P7476 | ALDH1A3, Human (His) | Recombinant Proteins | |
| HY-P74760 | Matrix 1/M1, H3N2 (AFM71858, His) | Recombinant Proteins | |
| HY-P74761 | Matrix 1/M1, H1N1 (Q8BAC3, His) | Recombinant Proteins | |
| HY-P74762 | Matrix 1/M1, H1N1 (NP_040978, His) | Recombinant Proteins | |
| HY-P74763 | MAPKAPK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P74764 | LYVE-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74766 | L-selectin/CD62L, Mouse (3332a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74767 | L-selectin/CD62L, Human (CHO, His) | Recombinant Proteins | |
| HY-P74768 | L-selectin/CD62L, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74769 | LOXL2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7477 | ALDH3A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74770 | LOXL2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74771 | LOXL2, Human (CHO, His) | Recombinant Proteins | |
| HY-P74772 | Lon Protease, E. coli (His) | Recombinant Proteins | |
| HY-P74773 | LMW-PTP/ACP1, Human (GST) | Recombinant Proteins | |
| HY-P74774 | Lipocalin-2/NGAL, Rat (sf9, His) | Recombinant Proteins | |
| HY-P74776 | Leukotriene A4 Hydrolase/LTA4H, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P74777 | Layilin/LAYN, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74778 | Layilin/LAYN, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74779 | Layilin/LAYN, Rat (HEK293) | Recombinant Proteins | |
| HY-P7478 | Aldolase C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74780 | LAP3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74781 | LAMP2/CD107b, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74782 | LAMP1/CD107a, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74783 | LAIR1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74784 | LAIR1, Human (144a.a, HEK293, hFc) | Recombinant Proteins | |
| HY-P74786 | LAIR1, Human (Biotinylated, 144a.a, HEK293, His) | Recombinant Proteins | |
| HY-P74788 | LAG-3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74789 | Lactoferrin/LTF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7479 | Aldose 1-epimerase/GALM, Human (His) | Recombinant Proteins | |
| HY-P74790 | Lactoferrin/LTF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74791 | L1CAM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74792 | KIR2DL1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74793 | KIR2DL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74795 | ITK, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P74796 | ITK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P74797 | IP-10/CXCL10, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P74798 | ING4, Human (His) | Recombinant Proteins | |
| HY-P74799 | IL-8/CXCL8, Canine | Recombinant Proteins | |
| HY-P7480 | ALK-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74800 | IL-5R alpha, Human (Q01344-2, HEK293, His) | Recombinant Proteins | |
| HY-P74801 | IL-4R alpha/CD124 Protein, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74803 | IL-36 beta/IL-1F8, Human (His) | Recombinant Proteins | |
| HY-P74803AF | Animal-Free IL-36 beta/IL-1F8, Human (His) | Recombinant Proteins | |
| HY-P74804 | IL-31 Protein, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74805 | IL-2R gamma/CD132, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74806 | IL-2R gamma/CD132, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P74807 | IL-2R gamma/CD132, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74809 | IL-2R alpha/CD25, Rat (sf9, His) | Recombinant Proteins | |
| HY-P7481 | ACVRL1/ALK1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74811 | IL-2R alpha/CD25, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P74812 | IL-25/IL-17E, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74813 | IL-25/IL-17E, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74814 | IL-23 Protein, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74816 | IL-23, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P74817 | IL-21, Rat (sf9, His) | Recombinant Proteins | |
| HY-P74818 | IL-21, Rat | Recombinant Proteins | |
| HY-P74819 | IL-21, Canine | Recombinant Proteins | |
| HY-P7482 | Activin RIA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74820 | IL-1R2, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P74821 | IL-1R1, Rat (HEK293, His-mFc) | Recombinant Proteins | |
| HY-P74822 | IL-1R1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74823 | IL-1R1, Human (HEK293) | Recombinant Proteins | |
| HY-P74825 | IL-17RA, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74826 | IL-17RA Protein, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P74827 | IL-17RA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74829 | IL-17F, Rat (sf9, His) | Recombinant Proteins | |
| HY-P74829A | IL-17F, Rat (sf9, His) | Recombinant Proteins | |
| HY-P7483 | BMPR1A/ALK-3, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74831 | IL-17F Protein, Mouse | Recombinant Proteins | |
| HY-P74832 | IL-17A/F Heterodimer, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P74833 | IL-17A, Cynomolgus (sf9) | Recombinant Proteins | |
| HY-P74834 | IL-12R beta 2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74835 | IL-12 beta, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74836 | IL-12 beta, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P74837 | IL-10R beta, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74838 | IL-10R beta, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P74839 | IL-10R beta, Human (HEK293, His-hFc) | Recombinant Proteins | |
| HY-P7484 | BMPR1A/ALK-3, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P74842 | IgJ, Human (His) | Recombinant Proteins | |
| HY-P74843 | IGF-I/IGF-1, Mouse (P.pastoris) | Recombinant Proteins | |
| HY-P74844 | IGFBP-7, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74845 | IGFBP-4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74846 | IGFBP-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74847 | IGFBP-2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74848 | IGFBP-1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P74849 | IGFBP-1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P7485 | Activin RIB/ALK-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74850 | IGF2BP2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74851 | IFN-lambda 3/IL-28B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74852 | IFN-gamma R2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74855 | IFN-gamma R1/CD119, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74857 | IFN-gamma Protein, Ferret (HEK293, His) | Recombinant Proteins | |
| HY-P74859 | IFNAR1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7486 | Activin RIB/ALK-4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P74860 | IFN-alpha/beta R2, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P74861 | IFN-alpha/beta R2, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P74862A | IFN-alpha/beta R2 Protein, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P74863 | IFN-alpha B/IFNA8, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P74864 | IFN-alpha 1/IFNA1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74864A | IFN-alpha 1/IFNA1, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P74865 | IFN-alpha 1/IFNA1, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P74866 | IFN-alpha 1/IFNA1, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P74867 | IdeS, Streptococcus pyogenes (His, solution) | Recombinant Proteins | |
| HY-P74867A | IdeS, Streptococcus pyogenes (N-His) | Recombinant Proteins | |
| HY-P74868 | ICOS, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74869 | ICAM-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7487 | Alkaline Phosphatase/ALPP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74870 | ICAM-5, Human (539a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P74871 | ICAM-5, Human (101a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P74872 | ICAM-3/CD50, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P74873 | ICAM-1/CD54, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P74874 | Human IL-23 alpha & Mouse IL-12 beta Heterodimer (HEK293, His) | Recombinant Proteins | |
| HY-P74875 | Human cytomegalovirus Glycoprotein B/gB (HEK293) | Recombinant Proteins | |
| HY-P74876 | HTRA2/OMI, Human (His) | Recombinant Proteins | |
| HY-P74877 | HSP70/HSPA1A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74878 | HSP27/HSPB1, Human (His) | Recombinant Proteins | |
| HY-P74879 | HOXA1, Human (His) | Recombinant Proteins | |
| HY-P7487A | Alkaline Phosphatase/ALPP, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7488 | AIF1, Human (C-His) | Recombinant Proteins | |
| HY-P74880 | HN1, Mouse (His) | Recombinant Proteins | |
| HY-P74881 | HK3/Hexokinase-3, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74882 | gp36, HIV-2 (His-MBP) | Recombinant Proteins | |
| HY-P74883 | gp140, HIV-1 (647a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P74884 | gp140, HIV-1 (627a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P74885 | envelope glycoprotein gp160, HIV-1 (AAT67478, HEK293, His) | Recombinant Proteins | |
| HY-P74887 | Histone H1, Human (His) | Recombinant Proteins | |
| HY-P74888 | HIF-1 alpha, Human (His) | Recombinant Proteins | |
| HY-P74889 | HGF, Canine (HEK293) | Recombinant Proteins | |
| HY-P7488A | AIF1, Human (N-His) | Recombinant Proteins | |
| HY-P7489 | Alpha 1-Microglobulin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74890 | HEXB/Hexosaminidase B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74891 | HER3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74892 | HER3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74893 | HER3, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P74895 | HER2/CD340, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74896 | HER2/CD340 Protein, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P74897 | HER2/CD340, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P74898 | NS3 protease, HCV (GST) | Recombinant Proteins | |
| HY-P74899 | Envelope Glycoprotein E1, HCV (HEK293, His) | Recombinant Proteins | |
| HY-P7490 | Orm2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74900 | Hendra virus Glycoprotein/GP (HEK293, Fc) | Recombinant Proteins | |
| HY-P74901 | Hemopexin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P74903 | HA/Hemagglutinin, H1N1 (Y108F, S340Q, I341R, Q342E, S343T, ACP41105, sf9, His) | Recombinant Proteins | |
| HY-P74904 | HA/Hemagglutinin, H1N1 (Y108F, ACP41105, sf9, His) | Recombinant Proteins | |
| HY-P74905 | HA/Hemagglutinin, H3N2 (Y108F, ACS71642, sf9, His) | Recombinant Proteins | |
| HY-P74906 | HA1/Hemagglutinin, Influenza B (EPI529345, HEK293, His) | Recombinant Proteins | |
| HY-P74907 | HA1/Hemagglutinin, Influenza B (EPI483156, HEK293, His) | Recombinant Proteins | |
| HY-P74908 | HA1/Hemagglutinin, Influenza B (EPI354025, HEK293, His) | Recombinant Proteins | |
| HY-P74909 | HA1/Hemagglutinin, Influenza B (EPI346478, HEK293, His) | Recombinant Proteins | |
| HY-P7491 | Serpin A1a, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P74910 | HA1/Hemagglutinin, Influenza B (AFT64423, HEK293, His) | Recombinant Proteins | |
| HY-P74911 | HA1/Hemagglutinin, Influenza B (ACF54213, HEK293, His) | Recombinant Proteins | |
| HY-P74912 | HA1/Hemagglutinin, Influenza B (ABL77255, HEK293, His) | Recombinant Proteins | |
| HY-P74913 | HA1/Hemagglutinin, Influenza B (ABL77101, HEK293, His) | Recombinant Proteins | |
| HY-P74914 | HA1/Hemagglutinin, Influenza B (ABF21280, HEK293, His) | Recombinant Proteins | |
| HY-P74915 | HA1/Hemagglutinin, H9N5 (ABB87950, HEK293, His) | Recombinant Proteins | |
| HY-P74916 | HA1/Hemagglutinin, H9N2 (ADC41863, HEK293, His) | Recombinant Proteins | |
| HY-P74917 | HA1/Hemagglutinin, H9N2 (ADC41853, HEK293, His) | Recombinant Proteins | |
| HY-P74918 | HA1/Hemagglutinin, H9N1 (Q20PC1, HEK293, His) | Recombinant Proteins | |
| HY-P74919 | HA1/Hemagglutinin, H8N4 (ABB87729, HEK293, His) | Recombinant Proteins | |
| HY-P7492 | Alpha-Galactosidase A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74920 | HA1/Hemagglutinin, H7N8 (EPI182113, HEK293, His) | Recombinant Proteins | |
| HY-P74921 | HA1/Hemagglutinin, H7N7 (AAR02640, HEK293, His) | Recombinant Proteins | |
| HY-P74922 | HA1/Hemagglutinin, H7N7 (AAR02639, HEK293, His) | Recombinant Proteins | |
| HY-P74923 | HA1/Hemagglutinin, H7N3 (ACA25329, HEK293, His) | Recombinant Proteins | |
| HY-P74924 | HA1/Hemagglutinin, H7N2 (ACS68445, HEK293, His) | Recombinant Proteins | |
| HY-P74925 | HA1/Hemagglutinin, H7N1 (CAD38286, HEK293, His) | Recombinant Proteins | |
| HY-P74926 | HA1/Hemagglutinin, H6N8 (ABO52049, HEK293, His) | Recombinant Proteins | |
| HY-P74927 | HA1/Hemagglutinin, H6N6 (AEF59343, HEK293, His) | Recombinant Proteins | |
| HY-P74928 | HA1/Hemagglutinin, H6N5 (ABI84516, HEK293, His) | Recombinant Proteins | |
| HY-P74929 | HA1/Hemagglutinin, H6N2 (AFJ19048, HEK293, His) | Recombinant Proteins | |
| HY-P7493 | PARVA/alpha-Parvin, Human (His) | Recombinant Proteins | |
| HY-P74930 | HA1/Hemagglutinin, H6N2 (ADG44842, HEK293, His) | Recombinant Proteins | |
| HY-P74931 | HA1/Hemagglutinin, H5N9 (ABR37720, HEK293, His) | Recombinant Proteins | |
| HY-P74932 | HA1/Hemagglutinin, H5N8 (EPI547678, HEK293, His) | Recombinant Proteins | |
| HY-P74933 | HA1/Hemagglutinin, H5N8 (EPI544756, HEK293, His) | Recombinant Proteins | |
| HY-P74934 | HA1/Hemagglutinin, H5N8 (AIU46063, HEK293, His) | Recombinant Proteins | |
| HY-P74935 | HA1/Hemagglutinin, H5N8 (AHM24058, HEK293, His) | Recombinant Proteins | |
| HY-P74936 | HA1/Hemagglutinin, H5N8 (AHM24057, HEK293, His) | Recombinant Proteins | |
| HY-P74937 | HA1/Hemagglutinin, H5N8 (AHL21419, HEK293, His) | Recombinant Proteins | |
| HY-P74938 | HA1/Hemagglutinin, H5N8 (AHL21407, HEK293, His) | Recombinant Proteins | |
| HY-P74939 | HA1/Hemagglutinin, H5N8 (AFK13933, HEK293, His) | Recombinant Proteins | |
| HY-P7494 | Ameloblastin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74940 | HA1/Hemagglutinin, H5N6 (EPI533583, HEK293, His) | Recombinant Proteins | |
| HY-P74941 | HA1/Hemagglutinin, H5N6 (EPI530054, HEK293, His) | Recombinant Proteins | |
| HY-P74942 | HA1/Hemagglutinin, H5N6 (AIA24403, HEK293, His) | Recombinant Proteins | |
| HY-P74943 | HA1/Hemagglutinin, H5N3 (BAG07130, HEK293, His) | Recombinant Proteins | |
| HY-P74944 | HA1/Hemagglutinin, H5N2 (AKG52687, HEK293, His) | Recombinant Proteins | |
| HY-P74945 | HA1/Hemagglutinin, H5N2 (ACF47563, HEK293, His) | Recombinant Proteins | |
| HY-P74946 | HA1/Hemagglutinin, H5N2 (ABQ24010, HEK293, His) | Recombinant Proteins | |
| HY-P74947 | HA1/Hemagglutinin, H5N1 (AEO89181, HEK293, His) | Recombinant Proteins | |
| HY-P74948 | HA1/Hemagglutinin, H4N8 (P19695, HEK293, His) | Recombinant Proteins | |
| HY-P74949 | HA1/Hemagglutinin, H4N6 (ABI47995, HEK293, His) | Recombinant Proteins | |
| HY-P7495 | AMIGO2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74950 | HA1/Hemagglutinin, H4N6 (AAG17429, HEK293, His) | Recombinant Proteins | |
| HY-P74951 | HA1/Hemagglutinin, H4N2 (ADN78261, HEK293, His) | Recombinant Proteins | |
| HY-P74952 | HA1/Hemagglutinin, H3N2 (EPI552125, HEK293, His) | Recombinant Proteins | |
| HY-P74953 | HA1/Hemagglutinin, H3N2 (EPI541659, HEK293, His) | Recombinant Proteins | |
| HY-P74954 | HA1/Hemagglutinin, H3N2 (EPI348478, HEK293, His) | Recombinant Proteins | |
| HY-P74955 | HA1/Hemagglutinin, H3N2 (EPI189220, HEK293, His) | Recombinant Proteins | |
| HY-P74956 | HA1/Hemagglutinin, H3N2 (BAA08716, HEK293, His) | Recombinant Proteins | |
| HY-P74957 | HA1/Hemagglutinin, H3N2 (AIU46093, HEK293, His) | Recombinant Proteins | |
| HY-P74958 | HA1/Hemagglutinin, H3N2 (AIU46089, HEK293, His) | Recombinant Proteins | |
| HY-P74959 | HA1/Hemagglutinin, H3N2 (AIU46065, HEK293, His) | Recombinant Proteins | |
| HY-P7496 | AMIGO2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P74960 | HA1/Hemagglutinin, H3N2 (AIU46063, HEK293, His) | Recombinant Proteins | |
| HY-P74961 | HA1/Hemagglutinin, H3N2 (AIU46048, HEK293, His) | Recombinant Proteins | |
| HY-P74962 | HA1/Hemagglutinin, H3N2 (AIU46036, HEK293, His) | Recombinant Proteins | |
| HY-P74964 | HA1/Hemagglutinin, H3N2 (AGC13545, HEK293, His) | Recombinant Proteins | |
| HY-P74965 | HA1/Hemagglutinin, H3N2 (AFR61003, HEK293, His) | Recombinant Proteins | |
| HY-P74966 | HA1/Hemagglutinin, H3N2 (AFM72872, HEK293, His) | Recombinant Proteins | |
| HY-P74967 | HA1/Hemagglutinin, H3N2 (AFM72164, HEK293, His) | Recombinant Proteins | |
| HY-P74968 | HA1/Hemagglutinin, H3N2 (AFM71967, HEK293, His) | Recombinant Proteins | |
| HY-P74969 | HA1/Hemagglutinin, H3N2 (AFM71912, HEK293, His) | Recombinant Proteins | |
| HY-P7497 | ABP1/AOC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74970 | HA1/Hemagglutinin, H3N2 (AFM71868, HEK293, His) | Recombinant Proteins | |
| HY-P74971 | HA1/Hemagglutinin, H3N2 (AFM71754, HEK293, His) | Recombinant Proteins | |
| HY-P74972 | HA1/Hemagglutinin, H3N2 (ACO95259, HEK293, His) | Recombinant Proteins | |
| HY-P74973 | HA1/Hemagglutinin, H3N2 (ABW80975, HEK293, His) | Recombinant Proteins | |
| HY-P74974 | HA1/Hemagglutinin, H3N2 (ABE73115, HEK293, His) | Recombinant Proteins | |
| HY-P74975 | HA1/Hemagglutinin, H3N2 (ABB54514, HEK293, His) | Recombinant Proteins | |
| HY-P74976 | HA1/Hemagglutinin, H3N2 (AAL62329, HEK293, His) | Recombinant Proteins | |
| HY-P74977 | HA1/Hemagglutinin, H3N2 (AAK51718, HEK293, His) | Recombinant Proteins | |
| HY-P74978 | HA1/Hemagglutinin, H3N2 (AAB69838, HEK293, His) | Recombinant Proteins | |
| HY-P74979 | HA1/Hemagglutinin, H3N2 (AAA87553, HEK293, His) | Recombinant Proteins | |
| HY-P7498 | Aminopeptidase P1, Human (His) | Recombinant Proteins | |
| HY-P74980 | HA1/Hemagglutinin, H3N1 (ACS71642, HEK293, His) | Recombinant Proteins | |
| HY-P74981 | HA1/Hemagglutinin, H1N9 (ABK40634, HEK293, His) | Recombinant Proteins | |
| HY-P74982 | HA1/Hemagglutinin, H1N8 (ACT83229, HEK293, His) | Recombinant Proteins | |
| HY-P74983 | HA1/Hemagglutinin, H1N3 (ABB20429, HEK293, His) | Recombinant Proteins | |
| HY-P74984 | HA1/Hemagglutinin, H1N1 (EPI859651, HEK293, His) | Recombinant Proteins | |
| HY-P74985 | HA1/Hemagglutinin, H1N1 (ACU80014, HEK293, His) | Recombinant Proteins | |
| HY-P74986 | HA1/Hemagglutinin, H1N1 (ACQ89903, HEK293, His) | Recombinant Proteins | |
| HY-P74987 | HA1/Hemagglutinin, H1N1 (ACP41935, HEK293, His) | Recombinant Proteins | |
| HY-P74988 | HA1/Hemagglutinin, H1N1 (ACN67524, HEK293, His) | Recombinant Proteins | |
| HY-P74989 | HA1/Hemagglutinin, H1N1 (ACF41867, HEK293, His) | Recombinant Proteins | |
| HY-P7499 | Aminopeptidase P2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P74990 | HA1/Hemagglutinin, H1N1 (ACA33723, HEK293, His) | Recombinant Proteins | |
| HY-P74991 | HA1/Hemagglutinin, H1N1 (ABQ44416, HEK293, His) | Recombinant Proteins | |
| HY-P74992 | HA1/Hemagglutinin, H1N1 (ABD77807, HEK293, His) | Recombinant Proteins | |
| HY-P74993 | HA1/Hemagglutinin, H1N1 (ABD62843, HEK293, His) | Recombinant Proteins | |
| HY-P74994 | HA1/Hemagglutinin, H1N1 (AAF87275, HEK293, His) | Recombinant Proteins | |
| HY-P74995 | HA1/Hemagglutinin, H1N1 (A4U7A6, HEK293, His) | Recombinant Proteins | |
| HY-P74996 | HA1/Hemagglutinin, H18N11 (AGX84934, HEK293, His) | Recombinant Proteins | |
| HY-P74997 | HA1/Hemagglutinin, H16N3 (AAV91217, HEK293, His) | Recombinant Proteins | |
| HY-P74998 | HA1/Hemagglutinin, H15N8 (ABB88132, HEK293, His) | Recombinant Proteins | |
| HY-P74999 | HA1/Hemagglutinin, H15N2 (ABB90704, HEK293, His) | Recombinant Proteins | |
| HY-P7500 | AMY2B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75000 | HA1/Hemagglutinin, H14N5 (P26136, HEK293, His) | Recombinant Proteins | |
| HY-P75001 | HA1/Hemagglutinin, H13N8 (AAV91212, HEK293, His) | Recombinant Proteins | |
| HY-P75002 | HA1/Hemagglutinin, H13N6 (AAV91213, HEK293, His) | Recombinant Proteins | |
| HY-P75003 | HA1/Hemagglutinin, H12N5 (ABB88110, HEK293, His) | Recombinant Proteins | |
| HY-P75004 | HA1/Hemagglutinin, H12N3 (ACV86810, HEK293, His) | Recombinant Proteins | |
| HY-P75005 | HA1/Hemagglutinin, H12N1 (ABB88099, HEK293, His) | Recombinant Proteins | |
| HY-P75006 | HA1/Hemagglutinin, H11N2 (ADD21478, HEK293, His) | Recombinant Proteins | |
| HY-P75007 | HA1/Hemagglutinin, H10N9 (ABI84469, HEK293, His) | Recombinant Proteins | |
| HY-P75008 | HA1/Hemagglutinin, H10N8 (EPI497477, HEK293, His) | Recombinant Proteins | |
| HY-P75009 | HA1/Hemagglutinin, H10N7 (ADH96304, HEK293, His) | Recombinant Proteins | |
| HY-P7501 | Amyloid Precursor/APP-695, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75010 | HA/Hemagglutinin, Influenza B (EPI529345, sf9) | Recombinant Proteins | |
| HY-P75011 | HA/Hemagglutinin, Influenza B (AGB07680, sf9) | Recombinant Proteins | |
| HY-P75012 | HA/Hemagglutinin, H9N2 (ADC41863, sf9, His) | Recombinant Proteins | |
| HY-P75013 | HA/Hemagglutinin, H9N2 (ADC41853, sf9, His) | Recombinant Proteins | |
| HY-P75014 | HA/Hemagglutinin, H9N2 (AAO46079, sf9, His) | Recombinant Proteins | |
| HY-P75015 | HA1/Hemagglutinin, H9N2 (AAO46079, HEK293, His) | Recombinant Proteins | |
| HY-P75016 | HA/Hemagglutinin, H9N1 (Q20PC1, sf9, His) | Recombinant Proteins | |
| HY-P75017 | HA/Hemagglutinin, H7N7 (ACL12085, sf9, His) | Recombinant Proteins | |
| HY-P75018 | HA/Hemagglutinin, H7N7 (AAR02640, sf9, His) | Recombinant Proteins | |
| HY-P75019 | HA/Hemagglutinin, H7N7 (AAR02639, sf9, His) | Recombinant Proteins | |
| HY-P7502 | APLP-1, Human (171a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75020 | HA/Hemagglutinin, H7N2 (ACS68445, sf9, His) | Recombinant Proteins | |
| HY-P75021 | HA/Hemagglutinin, H6N8 (ABO52049, sf9, His) | Recombinant Proteins | |
| HY-P75022 | HA1/Hemagglutinin, H6N1 (CAC84981, HEK293, His) | Recombinant Proteins | |
| HY-P75023 | HA1/Hemagglutinin, H6N1 (ACE81692, HEK293, His) | Recombinant Proteins | |
| HY-P75024 | HA/Hemagglutinin, H5N9 (ABR37720, sf9, His) | Recombinant Proteins | |
| HY-P75025 | HA/Hemagglutinin, H5N6 (EPI533583, sf9, His) | Recombinant Proteins | |
| HY-P75026 | HA/Hemagglutinin, H5N6 (EPI530054, sf9, His) | Recombinant Proteins | |
| HY-P75027 | HA/Hemagglutinin, H5N6 (AKS48023, sf9, His) | Recombinant Proteins | |
| HY-P75028 | HA/Hemagglutinin, H5N6 (AIA24403, sf9, His) | Recombinant Proteins | |
| HY-P75029 | HA/Hemagglutinin, H5N3 (BAG07130, HEK293, His) | Recombinant Proteins | |
| HY-P7503 | Angiogenin, Human | Recombinant Proteins | |
| HY-P75030 | HA/Hemagglutinin, H5N1 (Q9Q0U6, sf9, His) | Recombinant Proteins | |
| HY-P75031 | HA/Hemagglutinin, H5N1 (Q207Z6, sf9, His) | Recombinant Proteins | |
| HY-P75032 | HA/Hemagglutinin, H5N1 (G2U0T8, HEK293, His) | Recombinant Proteins | |
| HY-P75033 | HA/Hemagglutinin, H5N1 (BAD89305, HEK293, His) | Recombinant Proteins | |
| HY-P75034 | HA/Hemagglutinin, H5N1 (AJY79342, HEK293, His) | Recombinant Proteins | |
| HY-P75035 | HA/Hemagglutinin, H5N1 (AGM16225, HEK293, His) | Recombinant Proteins | |
| HY-P75037 | HA/Hemagglutinin, H5N1 (AEO89181, sf9, His) | Recombinant Proteins | |
| HY-P75039 | HA/Hemagglutinin, H5N1 (ADF83651, HEK293, His) | Recombinant Proteins | |
| HY-P7504 | ANGPTL3/Angiopoietin-like 3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75040 | HA/Hemagglutinin, H5N1 (ACZ48508, HEK293, His) | Recombinant Proteins | |
| HY-P75041 | HA/Hemagglutinin, H5N1 (ACZ36881, HEK293, His) | Recombinant Proteins | |
| HY-P75042 | HA/Hemagglutinin, H5N1 (ACT15357, HEK293, His) | Recombinant Proteins | |
| HY-P75043 | HA/Hemagglutinin, H5N1 (ACO07033, sf9, His) | Recombinant Proteins | |
| HY-P75044 | HA/Hemagglutinin, H5N1 (ACO07033, HEK293, His) | Recombinant Proteins | |
| HY-P75045 | HA/Hemagglutinin, H5N1 (ACL28277, sf9, His) | Recombinant Proteins | |
| HY-P75046 | HA/Hemagglutinin, H5N1 (ACL28277, HEK293, His) | Recombinant Proteins | |
| HY-P75047 | HA/Hemagglutinin, H5N1 (ACL11932, HEK293, His) | Recombinant Proteins | |
| HY-P75048 | HA/Hemagglutinin, H5N1 (ACJ68614, HEK293, His) | Recombinant Proteins | |
| HY-P7505 | ANGPTL3/Angiopoietin-like 3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75050 | HA/Hemagglutinin, H5N1 (ACI06178, sf9, His) | Recombinant Proteins | |
| HY-P75051 | HA/Hemagglutinin, H5N1 (ACI06178, HEK293, His) | Recombinant Proteins | |
| HY-P75052 | HA/Hemagglutinin, H5N1 (ACA47835, HEK293, His) | Recombinant Proteins | |
| HY-P75053 | HA/Hemagglutinin, H5N1 (ABW06108, HEK293, His) | Recombinant Proteins | |
| HY-P75054 | HA/Hemagglutinin, H5N1 (ABR10842, HEK293, His) | Recombinant Proteins | |
| HY-P75055 | HA/Hemagglutinin, H5N1 (ABQ45850, sf9, His) | Recombinant Proteins | |
| HY-P75056 | HA/Hemagglutinin, H5N1 (ABQ45850, HEK293, His) | Recombinant Proteins | |
| HY-P75057 | HA/Hemagglutinin, H5N1 (ABP96850, HEK293, His) | Recombinant Proteins | |
| HY-P75058 | HA/Hemagglutinin, H5N1 (ABP96845, HEK293, His) | Recombinant Proteins | |
| HY-P75059 | HA/Hemagglutinin, H5N1 (ABP51975, S28W, HEK293, His) | Recombinant Proteins | |
| HY-P7506 | ANGPTL8/Angiopoietin-like 8, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75060 | HA/Hemagglutinin, H5N1 (ABJ96777, HEK293, His) | Recombinant Proteins | |
| HY-P75061 | HA/Hemagglutinin, H5N1 (ABJ96775, HEK293, His) | Recombinant Proteins | |
| HY-P75062 | HA/Hemagglutinin, H5N1 (ABJ96698, HEK293, His) | Recombinant Proteins | |
| HY-P75063 | HA/Hemagglutinin, H5N1 (ABF93441, sf9, His) | Recombinant Proteins | |
| HY-P75064 | HA/Hemagglutinin, H5N1 (ABD73284, HEK293, His) | Recombinant Proteins | |
| HY-P75065 | HA/Hemagglutinin, H5N1 (ABD28180, HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75066 | HA/Hemagglutinin, H5N1 (ABD28180, HEK293, His) | Recombinant Proteins | |
| HY-P75067 | HA/Hemagglutinin, H5N1 (AAW80717, HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75068 | HA/Hemagglutinin, H5N1 (AAT73273, sf9, His) | Recombinant Proteins | |
| HY-P75069 | HA/Hemagglutinin, H5N1 (AAT73273, HEK293, His) | Recombinant Proteins | |
| HY-P7507 | ANGPTL4/Angiopoietin-related 4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75070 | HA/Hemagglutinin, H5N1 (AAF02306, HEK293, His) | Recombinant Proteins | |
| HY-P75071 | HA/Hemagglutinin, H5N1 (AAC32099, HEK293, His) | Recombinant Proteins | |
| HY-P75072 | HA/Hemagglutinin, H5N1 (A150V, ABD28180, sf9, His) | Recombinant Proteins | |
| HY-P75073 | HA/Hemagglutinin, H4N6 (ABI47995, HEK293, His) | Recombinant Proteins | |
| HY-P75074 | HA/Hemagglutinin, H4N6 (AAG17429, HEK293, His) | Recombinant Proteins | |
| HY-P75075 | HA/Hemagglutinin, H4N2 (ADN78261, sf9, His) | Recombinant Proteins | |
| HY-P75076 | HA/Hemagglutinin, H3N2 (Q91MA7, HEK293, His) | Recombinant Proteins | |
| HY-P75077 | HA/Hemagglutinin, H3N2 (P03438, sf9, His) | Recombinant Proteins | |
| HY-P75078 | HA/Hemagglutinin, H3N2 (P03438, HEK293, His) | Recombinant Proteins | |
| HY-P75079 | HA/Hemagglutinin, H3N2 (P03437, sf9, His) | Recombinant Proteins | |
| HY-P7508 | ANGPTL4/Angiopoietin-related 4, Mouse (HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P75080 | HA/Hemagglutinin, H3N2 (EPI653201, sf9, His) | Recombinant Proteins | |
| HY-P75081 | HA/Hemagglutinin, H3N2 (EPI552125, sf9, His) | Recombinant Proteins | |
| HY-P75082 | HA/Hemagglutinin, H3N2 (EPI541659, sf9, His) | Recombinant Proteins | |
| HY-P75083 | HA/Hemagglutinin, H3N2 (EPI537015, sf9, His) | Recombinant Proteins | |
| HY-P75084 | HA/Hemagglutinin, H3N2 (EPI1698489, HEK293, His) | Recombinant Proteins | |
| HY-P75085 | HA/Hemagglutinin, H3N2 (EPI1341068, HEK293, His) | Recombinant Proteins | |
| HY-P75086 | HA/Hemagglutinin, H3N2 (BAP27935, HEK293, His) | Recombinant Proteins | |
| HY-P75087 | HA/Hemagglutinin, H3N2 (AXQ12067, HEK293, His) | Recombinant Proteins | |
| HY-P75088 | HA/Hemagglutinin, H3N2 (Avi15186, HEK293, His) | Recombinant Proteins | |
| HY-P75089 | HA/Hemagglutinin, H3N2 (AMY16172, HEK293, His) | Recombinant Proteins | |
| HY-P7508A | ANGPTL4/Angiopoietin-related 4, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P7509 | ANGPTL7/Angiopoietin-related 7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75090 | HA/Hemagglutinin, H3N2 (AIZ95441, HEK293, His) | Recombinant Proteins | |
| HY-P75091 | HA/Hemagglutinin, H3N2 (AIU46093, sf9, His) | Recombinant Proteins | |
| HY-P75092 | HA/Hemagglutinin, H3N2 (AIU46089, sf9, His) | Recombinant Proteins | |
| HY-P75093 | HA/Hemagglutinin, H3N2 (AIU46065, sf9, His) | Recombinant Proteins | |
| HY-P75094 | HA/Hemagglutinin, H3N2 (AIU46063, sf9, His) | Recombinant Proteins | |
| HY-P75095 | HA/Hemagglutinin, H3N2 (AIU46048, sf9, His) | Recombinant Proteins | |
| HY-P75096 | HA/Hemagglutinin, H3N2 (AIU46036, sf9, His) | Recombinant Proteins | |
| HY-P75097 | HA/Hemagglutinin, H3N2 (AGG53108, HEK293, His) | Recombinant Proteins | |
| HY-P75098 | HA/Hemagglutinin, H3N2 (AGB08328, sf9, His) | Recombinant Proteins | |
| HY-P75099 | HA/Hemagglutinin, H3N2 (AFU10042, HEK293, His) | Recombinant Proteins | |
| HY-P7510 | Angiopoietin-2, Human (222a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75100 | HA/Hemagglutinin, H3N2 (AFR76481, HEK293, His) | Recombinant Proteins | |
| HY-P75101 | HA/Hemagglutinin, H3N2 (AFR42694, sf9, His) | Recombinant Proteins | |
| HY-P75103 | HA/Hemagglutinin, H3N2 (AFM72164, sf9, His) | Recombinant Proteins | |
| HY-P75104 | HA/Hemagglutinin, H3N2 (ADI52838, sf9, His) | Recombinant Proteins | |
| HY-P75105 | HA/Hemagglutinin, H3N2 (ACS71642, HEK293, His) | Recombinant Proteins | |
| HY-P75106 | HA/Hemagglutinin, H3N2 (ACO95259, sf9, His) | Recombinant Proteins | |
| HY-P75107 | HA/Hemagglutinin, H3N2 (ACN50256, sf9, His) | Recombinant Proteins | |
| HY-P75108 | HA/Hemagglutinin, H3N2 (ACJ73757, HEK293, His) | Recombinant Proteins | |
| HY-P75109 | HA/Hemagglutinin, H3N2 (ACF54576, sf9, His) | Recombinant Proteins | |
| HY-P7511 | ASB13, Human (His) | Recombinant Proteins | |
| HY-P75110 | HA/Hemagglutinin, H3N2 (ACF54576, HEK293, His) | Recombinant Proteins | |
| HY-P75111 | HA/Hemagglutinin, H3N2 (ABX10525, sf9, His) | Recombinant Proteins | |
| HY-P75112 | HA/Hemagglutinin, H3N2 (ABW80975, sf9, His) | Recombinant Proteins | |
| HY-P75113 | HA/Hemagglutinin, H3N2 (ABW23353, sf9, His) | Recombinant Proteins | |
| HY-P75114 | HA/Hemagglutinin, H3N2 (ABW23353, HEK293, His) | Recombinant Proteins | |
| HY-P75115 | HA/Hemagglutinin, H3N2 (ABD62833, HEK293, His) | Recombinant Proteins | |
| HY-P75116 | HA/Hemagglutinin, H3N2 (AAA87553, sf9, His) | Recombinant Proteins | |
| HY-P75117 | HA/Hemagglutinin, H3N2 (AAA43178, HEK293, His) | Recombinant Proteins | |
| HY-P75118 | HA/Hemagglutinin, H3N2 ( EPI189220, sf9, His) | Recombinant Proteins | |
| HY-P75119 | HA/Hemagglutinin, H3N1 (AFR76416, HEK293, His) | Recombinant Proteins | |
| HY-P7512 | Annexin A1/ANXA1, Human | Recombinant Proteins | |
| HY-P75120 | HA/Hemagglutinin, H3N1 (ACS71642, sf9, His) | Recombinant Proteins | |
| HY-P75121 | HA/Hemagglutinin, H3N1 (ABD85122, HEK293, His) | Recombinant Proteins | |
| HY-P75122 | HA/Hemagglutinin, H1N9 (ABK40634, sf9, His) | Recombinant Proteins | |
| HY-P75123 | HA/Hemagglutinin, H1N3 (ABB20429, sf9, His) | Recombinant Proteins | |
| HY-P75124 | HA/Hemagglutinin, H1N3 (ABB20429, HEK293, His) | Recombinant Proteins | |
| HY-P75125 | HA/Hemagglutinin, H1N2 (BAG49619, HEK293, His) | Recombinant Proteins | |
| HY-P75126 | HA/Hemagglutinin, H1N2 (AKJ81614, HEK293, His) | Recombinant Proteins | |
| HY-P75127 | HA/Hemagglutinin, H1N2 (AKJ81567, HEK293, His) | Recombinant Proteins | |
| HY-P75128 | HA/Hemagglutinin, H1N2 (AKJ80792, HEK293, His) | Recombinant Proteins | |
| HY-P75129 | HA/Hemagglutinin, H1N2 (AIE50626, HEK293, His) | Recombinant Proteins | |
| HY-P7513 | Annexin A10/ANXA10, Human | Recombinant Proteins | |
| HY-P75130 | HA/Hemagglutinin, H1N2 (AHW83238, HEK293, His) | Recombinant Proteins | |
| HY-P75131 | HA/Hemagglutinin, H1N2 (AHB21075, HEK293, His) | Recombinant Proteins | |
| HY-P75132 | HA/Hemagglutinin, H1N2 (AEC23333, HEK293, His) | Recombinant Proteins | |
| HY-P75133 | HA/Hemagglutinin, H1N2 (ACO07051, HEK293, His) | Recombinant Proteins | |
| HY-P75134 | HA/Hemagglutinin, H1N2 (ABQ42444, HEK293, His) | Recombinant Proteins | |
| HY-P75135 | HA/Hemagglutinin, H18N11 (AGX84934, sf9, His) | Recombinant Proteins | |
| HY-P75136 | HA/Hemagglutinin, H13N8 (AAV91212, sf9, His) | Recombinant Proteins | |
| HY-P75137 | HA/Hemagglutinin, H13N8 (AAV91212, HEK293, His) | Recombinant Proteins | |
| HY-P75138 | HA/Hemagglutinin, H12N5 (ABB88110, HEK293, His) | Recombinant Proteins | |
| HY-P75139 | HA/Hemagglutinin, H10N9 (ABI84469, sf9, His) | Recombinant Proteins | |
| HY-P7514 | Annexin A13/ANXA13, Human | Recombinant Proteins | |
| HY-P75140 | HA/Hemagglutinin, H10N9 (ABI84469, HEK293, His) | Recombinant Proteins | |
| HY-P75141 | HA/Hemagglutinin, H10N8 (EPI497477, sf9, His) | Recombinant Proteins | |
| HY-P75142 | HA/Hemagglutinin, H9N2 (AAO46082, sf9, His) | Recombinant Proteins | |
| HY-P75143 | HE4/WFDC2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75144 | HDAC8, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75148 | HCC-1/CCL14, Human (74a.a, His) | Recombinant Proteins | |
| HY-P75149 | HCC-1/CCL14, Human (66a.a, His) | Recombinant Proteins | |
| HY-P7515 | Annexin A2/ANXA2, Human | Recombinant Proteins | |
| HY-P75150 | HBP1, Human (His) | Recombinant Proteins | |
| HY-P75151 | GYPA/CD235a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75152 | GSTM2, Human (His, solution) | Recombinant Proteins | |
| HY-P75152A | GSTM2, Human (N-His) | Recombinant Proteins | |
| HY-P75153 | GSTA1, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75153A | GSTA1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P75154 | MIP-2/CXCL2, Mouse (His-SUMO) | Recombinant Proteins | |
| HY-P75156 | GRIK2, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75158 | GPT, Rat (sf9, His) | Recombinant Proteins | |
| HY-P75159 | envelope glycoprotein gp120, SIV (ADN41251, HEK293, His) | Recombinant Proteins | |
| HY-P7516 | Annexin A3/ANXA3, Human | Recombinant Proteins | |
| HY-P75160 | GM2A, Human (sf9, His) | Recombinant Proteins | |
| HY-P75161 | HCMV Glycoprotein B/gB (HEK293, Fc) | Recombinant Proteins | |
| HY-P75162 | GLO1/Glyoxalase I, Mouse (His) | Recombinant Proteins | |
| HY-P75163 | GITR, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75164 | GITR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75165 | GITR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75166 | GITR, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P75169 | GDNF, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P7517 | Annexin A5/ANXA5, Human (solution) | Recombinant Proteins | |
| HY-P75170 | GDF-15, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P75171 | GDF-15, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75172 | GBP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75173 | GASP-1/WFIKKN2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75174 | GAS6, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75174A | GAS6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75175 | GAP43, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75176 | Galectin-9/LGALS9, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75177 | GAD2/GAD65, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P75178 | GAD2/GAD65, Mouse (sf9) | Recombinant Proteins | |
| HY-P75179 | GAD2/GAD65, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7517A | Annexin A5/ANXA5, Human | Recombinant Proteins | |
| HY-P7518 | Annexin A6/ANXA6, Human (His) | Recombinant Proteins | |
| HY-P75180 | GAD1/GAD67, Human (sf9, His) | Recombinant Proteins | |
| HY-P75181 | FUT8, Human (sf9, His) | Recombinant Proteins | |
| HY-P75182 | Fusion glycoprotein F0/F, HRSV (sf9, His) | Recombinant Proteins | |
| HY-P75183 | FLT3, Human (T227M, HEK293, His) | Recombinant Proteins | |
| HY-P75184 | FLT3, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75185 | Flagellin, Listeria monocytogenes (His) | Recombinant Proteins | |
| HY-P75186 | Fibromodulin, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75187 | FHIT, Human (His) | Recombinant Proteins | |
| HY-P75188 | FGL1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75189 | FGL1, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P7519 | Annexin A7/ANXA7, Human | Recombinant Proteins | |
| HY-P75190 | FGFR-4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75191 | FGFR-4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75192 | FGF-18, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75193 | FGF-14, Human (isoform 1B) | Recombinant Proteins | |
| HY-P75194 | FGF-1, Canine | Recombinant Proteins | |
| HY-P75195 | Fetuin B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75196 | FDPS, Mouse (His) | Recombinant Proteins | |
| HY-P75197 | FDPS, Human (His) | Recombinant Proteins | |
| HY-P75199 | FCGRT-B2M Heterodimer, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7520 | Annexin A8/ANXA8, Human | Recombinant Proteins | |
| HY-P75200 | FCGRT-B2M Heterodimer, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75202 | Fc gamma RIIIB/CD16b, Human (NA2, CHO, His) | Recombinant Proteins | |
| HY-P75204 | Fc gamma RIIIB/CD16b, Human (Biotinylated, NA2) | Recombinant Proteins | |
| HY-P75207 | Fc gamma RIIIA/CD16a, Human (CHO, His) | Recombinant Proteins | |
| HY-P75209 | Fc gamma RIIIA/CD16a, Human (F176V, HEK293, His) | Recombinant Proteins | |
| HY-P7521 | TEM8/ANTXR1, Human | Recombinant Proteins | |
| HY-P75210 | Fc gamma RIIIA/CD16a, Human (F176V, CHO, His) | Recombinant Proteins | |
| HY-P75211 | Fc gamma RIIB/CD32b, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P75212 | Fc epsilon RIA/FCER1A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75214 | FABP5, Human | Recombinant Proteins | |
| HY-P75215 | FABP4, Mouse (His) | Recombinant Proteins | |
| HY-P75217 | FABP4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75218 | FABP3, Mouse | Recombinant Proteins | |
| HY-P75219 | ESM-1, Human (sf9, His) | Recombinant Proteins | |
| HY-P7522 | APBA3, Human (His) | Recombinant Proteins | |
| HY-P75220 | E-selectin/CD62E, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75221 | E-selectin/CD62E, Cynomolgus (HEK293, hFc) | Recombinant Proteins | |
| HY-P75222 | Erythropoietin, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75223 | MAPK1/ERK2, Human (sf9, His) | Recombinant Proteins | |
| HY-P75224 | Epstein-Barr virus Glycoprotein gp350/GP350 (sf9, His) | Recombinant Proteins | |
| HY-P75225 | Epstein-Barr virus Glycoprotein gp350/GP350 (HEK293, His) | Recombinant Proteins | |
| HY-P75226 | Epiregulin, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P75227 | EPHX2, Human (sf9, His) | Recombinant Proteins | |
| HY-P75228 | Ephrin B3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75229 | Ephrin B3, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P7523 | APE, Human | Recombinant Proteins | |
| HY-P75230 | Ephrin-B2/EFNB2, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75231 | Ephrin-B2/EFNB2, Canine (HEK293, hFc) | Recombinant Proteins | |
| HY-P75232 | Ephrin-A5/EFNA5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75234 | Ephrin-A1/EFNA1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75235 | EphB2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75236 | EphB2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75237 | EphB2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75238 | EphA4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75239 | EphA4, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7524 | Apolipoprotein B-100/APOB, Human (His, solution) | Recombinant Proteins | |
| HY-P75240 | EphA2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75241 | EphA1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75242 | EphA1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75244 | EPCR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75245 | EPCR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75246 | EPCR, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P75247 | EPCR, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75248 | envelope glycoprotein gp120, SIV (508a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75249 | envelope glycoprotein gp120, SIV (461a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7524A | Apolipoprotein B-100/APOB, Human (His) | Recombinant Proteins | |
| HY-P7525 | Apolipoprotein A-I/APOA1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75250 | Enterovirus D68 VP4 (sf9, Fc) | Recombinant Proteins | |
| HY-P75251 | Enterovirus D68 VP1 (sf9, Fc) | Recombinant Proteins | |
| HY-P75252 | Enoyl-ACP Reductase, E. coli (His) | Recombinant Proteins | |
| HY-P75253 | Enolase 1/ENO1, Rat (His) | Recombinant Proteins | |
| HY-P75255 | EIF5, Human (His) | Recombinant Proteins | |
| HY-P75256 | EGFR, Rhesus Macaque (sf9, His) | Recombinant Proteins | |
| HY-P75257 | EGFR, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75258 | EGFR, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75259 | EGFR, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P7526 | Apolipoprotein A-I/APOA1, Human | Recombinant Proteins | |
| HY-P75260 | EGFR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75261 | EDAR, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75262 | EDAR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75263 | EDAR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75264 | ECM1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75265 | ECM1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75266 | ECE-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75267 | ECE-2, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75268 | Ebola virus Glycoprotein/GP (QDA39862, HEK293, His) | Recombinant Proteins | |
| HY-P75269 | Ebola virus Glycoprotein/GP (Q7T9D9, HEK293, His) | Recombinant Proteins | |
| HY-P7527 | Apolipoprotein A-II/APOA2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75270 | Ebola virus Glycoprotein/GP (Q7T9D9, sf9, His) | Recombinant Proteins | |
| HY-P75271 | Ebola virus Glycoprotein/GP (Q05320, sf9, His) | Recombinant Proteins | |
| HY-P75272 | Ebola virus Glycoprotein/GP (AIE11917, HEK293, His) | Recombinant Proteins | |
| HY-P75273 | Ebola virus Glycoprotein/GP (AHX24649, sf9, His) | Recombinant Proteins | |
| HY-P75274 | Ebola virus Glycoprotein/GP (AHX24649, HEK293, His) | Recombinant Proteins | |
| HY-P75275 | EB3/MAPRE3, Human (His) | Recombinant Proteins | |
| HY-P75276 | E2/Envelope 2, Chikungunya virus (sf9, His) | Recombinant Proteins | |
| HY-P75277 | DR6/TNFRSF21, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75278 | DR6/TNFRSF21, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75279 | DR6/TNFRSF21, Human (HEK293) | Recombinant Proteins | |
| HY-P7528 | ApoA-IV, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75280 | DPP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75281 | DPP10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75282 | Doublecortin/DCX, Human (His) | Recombinant Proteins | |
| HY-P75283 | DOT1L, Human | Recombinant Proteins | |
| HY-P75286 | DLAT, Human (sf9, His) | Recombinant Proteins | |
| HY-P75287 | DKK-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75289 | Der p 23, Dermatophagoides pteronyssinus (HEK293, His) | Recombinant Proteins | |
| HY-P7529 | APOC2, Human (His, solution) | Recombinant Proteins | |
| HY-P75290 | NS1, Dengue virus 1 (HEK293, His) | Recombinant Proteins | |
| HY-P75291 | Dengue virus Capsid (His) | Recombinant Proteins | |
| HY-P75292 | Delta-like protein 4/DLL4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75293 | Delta-like protein 4/DLL4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75294 | Delta-like 4/DLL4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75295 | Delta-like 1/DLL1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75296 | Dectin-1/CLEC7A, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75296A | Dectin-1/CLEC7A Protein, Mouse (HEK293) | Recombinant Proteins | |
| HY-P75297 | DDR2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75298 | DDR2, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P75299 | DDR1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7529A | APOC2, Human (His) | Recombinant Proteins | |
| HY-P75300 | DDR1, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P75301 | DDR1, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P75302 | DDR1, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75303 | DDR1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75304 | DDR1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75305 | DDR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75306 | DcR3/TNFRSF6B, Human (sf9, hFc) | Recombinant Proteins | |
| HY-P75307 | DCLK1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75308 | DCLK1, Human (sf9) | Recombinant Proteins | |
| HY-P75309 | DARS, Human (His) | Recombinant Proteins | |
| HY-P7530A | APOD, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7531 | Apolipoprotein E/APOE3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75310 | DAP10, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P75311 | DAG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75313 | CXCL16, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75314 | CXCL16, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75315 | CXCL14/BRAK, Human (Biotinylated) | Recombinant Proteins | |
| HY-P75316 | CUTC, Human (His) | Recombinant Proteins | |
| HY-P75317 | CTLA-4, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7532 | Apolipoprotein E/APOE, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75320 | CTLA-4, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75321 | CTLA-4, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75322 | CSK, Mouse (sf9) | Recombinant Proteins | |
| HY-P75323 | CSF1R, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75324 | CSF1R, Human (430a.a, sf9, His-GST) | Recombinant Proteins | |
| HY-P75326 | CSF1R, Human (271a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75327 | CSF1R, Human (214a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75328 | Cas9, S. pyogenes (sf9, NLS, His) | Recombinant Proteins | |
| HY-P75329 | TDGF1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7533 | Apolipoprotein H/APOH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75330 | TDGF1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75331 | CRIPT, Human (His) | Recombinant Proteins | |
| HY-P75332 | Complement C3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75333 | Collagen alpha-1(II) chain/COL2A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75334 | CLPS, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75335 | CLEC1B/CLEC-2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75336 | CLEC1B/CLEC-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75336A | CLEC1B/CLEC-2, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P75337 | CLEC-1/CLEC1A, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75338 | CLEC-1/CLEC1A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75339 | CLEC-1/CLEC1A, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P75340 | Creatine kinase M-type/CKM, Human (His) | Recombinant Proteins | |
| HY-P75341 | CG alpha, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P75342 | CG alpha, Human (HEK293) | Recombinant Proteins | |
| HY-P75344 | CHL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75345 | CHL1, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P75346 | CHL1, Mouse (HEK293) | Recombinant Proteins | |
| HY-P75347 | CHL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75348 | CHEK2, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P75349 | CHEK2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7534A | Apolipoprotein H/APOH, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7535 | Clusterin/APOJ, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P75350 | Cerberus 1/CER1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75351 | Centrin-2, Human (His) | Recombinant Proteins | |
| HY-P75352 | Centrin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75353 | CENPB, Human (sf9, His) | Recombinant Proteins | |
| HY-P75355 | CEACAM5, Human (Biotinylated, HEK293, C-His) | Recombinant Proteins | |
| HY-P75356 | CEACAM5, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75358 | CEACAM1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7536 | Apolipoprotein M/APOM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75360 | CEACAM1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75361 | CDK7-CCNH-MNAT1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75362 | CDC37, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P75363 | CDC37, Mouse (sf9) | Recombinant Proteins | |
| HY-P75364 | CDC37, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75365 | CD99, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75366 | CD99, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75367 | CD98, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75368 | CD98, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75369 | CD97, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7536A | Apolipoprotein M/APOM, Human (166a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7537 | BCL2, Human (His) | Recombinant Proteins | |
| HY-P75370 | CD97, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75371 | CD96, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75373 | CD93/C1qR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75375 | CD83, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75376 | CD83, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75377 | CD83, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75378 | CD81, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75379 | CD81, Rat (HEK293) | Recombinant Proteins | |
| HY-P7538 | APRIL/TNFSF13, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75380 | CD8 alpha, Ferret (HEK293, His) | Recombinant Proteins | |
| HY-P75381 | CD8 alpha, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P75383 | CD79A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75385 | CD79, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75386 | CD79, Human (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P75386A | CD79, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75387 | CD70, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P75388 | CD64, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7539 | APT-1/LYPLA1, Human (His) | Recombinant Proteins | |
| HY-P75390 | CD59, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75391 | CD59, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75392 | CD58, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75394 | CD55/DAF, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75396 | CD53, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75397 | CD52, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75398 | CD52, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75399 | CD52, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P7540 | ARC, Human | Recombinant Proteins | |
| HY-P75401 | CD47, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75402 | CD47, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75403 | CD43, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75404 | CD43, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75405 | CD40L/CD154/TRAP, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75406 | CD40L/CD154/TRAP, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75407 | CD40L/CD154/TRAP, Canine (HEK293) | Recombinant Proteins | |
| HY-P75408 | CD40, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75409 | CD40, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7541 | Arginase-1/ARG1, Human (C-His) | Recombinant Proteins | |
| HY-P75410 | CD40, Canine (P.pastoris, His) | Recombinant Proteins | |
| HY-P75411 | CD40, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75412 | CD40, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75413 | CD40, Canine (HEK293) | Recombinant Proteins | |
| HY-P75414 | CD3E-CD3G Heterodimer, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75415 | CD3D-CD3E Heterodimer, Mouse (HEK293, Flag-His) | Recombinant Proteins | |
| HY-P75416 | CD3D-CD3E Heterodimer, Mouse (HEK293) | Recombinant Proteins | |
| HY-P75417 | CD39, Human (sf9, His) | Recombinant Proteins | |
| HY-P75418 | CD37, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P7541A | Arginase-1/ARG1, Human (N-His) | Recombinant Proteins | |
| HY-P7542 | Serpin A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75421 | CD30/TNFRSF8, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75422 | CD30/TNFRSF8, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75424 | CD28, Human/Cynomolgus/Rhesus Macaque (HEK293, C-His) | Recombinant Proteins | |
| HY-P75427 | CD27/TNFRSF7, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75428 | CD26/Dipeptidyl Peptidase 4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75429 | CD26/Dipeptidyl Peptidase 4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75430 | Siglec-2/CD22, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75431 | Siglec-2/CD22, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75432 | CD200, Human (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P75433 | CD20/MS4A1, Cynomolgus (85a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75434 | CD2, Cynomolgus/Rhesus Macaque (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75434A | CD2, Cynomolgus/Rhesus Macaque (HEK293, C-His) | Recombinant Proteins | |
| HY-P75435 | CD2, Cynomolgus/Rhesus Macaque (HEK293, hFc) | Recombinant Proteins | |
| HY-P75436 | CD1D, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75437 | CD1D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75438 | CD1B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75439 | CD19, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7544 | IFN-alpha 2/IFNA2, Mouse | Recombinant Proteins | |
| HY-P75441 | CD160, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75444 | CD14, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75445 | CD14, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75446 | CD105/Endoglin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75446A | CD105/Endoglin, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P75447 | MEC/CCL28, Human (His) | Recombinant Proteins | |
| HY-P75448 | Cathepsin Z/CTSZ, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75449 | Carboxypeptidase B2/CPB2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7544A | "IFN-alpha 2/IFNA2, Mouse (His) " | Recombinant Proteins | |
| HY-P75450 | Carboxypeptidase B2/CPB2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75452 | Carboxypeptidase A2/CPA2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75454 | Carbonic Anhydrase 9, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75455 | Carbonic Anhydrase 9, Canine (HEK293, hFc) | Recombinant Proteins | |
| HY-P75457 | CAMKIV/CAMK4, Mouse (sf9) | Recombinant Proteins | |
| HY-P75459 | Calsequestrin 1, Human | Recombinant Proteins | |
| HY-P75460 | Calnexin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75461 | CALM2, Human (His) | Recombinant Proteins | |
| HY-P75462 | CADM1/IGSF4A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75463 | C1s-A subcomponent, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75464 | C1QB, Human (sf9, His) | Recombinant Proteins | |
| HY-P75465 | C1orf33/MRTO4, Human (His) | Recombinant Proteins | |
| HY-P75466 | BTLA/CD272, Rat (HEK293, mFc) | Recombinant Proteins | |
| HY-P75467 | BTLA/CD272, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P75468 | BST2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75469 | BST2, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P75470 | Brk, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75471 | BNIP3L, Human | Recombinant Proteins | |
| HY-P75472 | BMP-5, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P75473 | BMF, Human (His) | Recombinant Proteins | |
| HY-P75474 | BLNK, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75475 | BirA, E. coli (His-MBP) | Recombinant Proteins | |
| HY-P75476 | Alpha 1-Microglobulin, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P75477 | Biglycan, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75478 | Betacellulin/BTC, Mouse (HEK293, His-hFc) | Recombinant Proteins | |
| HY-P75479 | BCAM, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75480 | Basigin/CD147, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75481 | Basigin/CD147, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75483 | B7-H6, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75484 | B7-H6, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75485 | B7-H4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75486 | B7-H2/ICOSLG, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75487 | B7-H2/ICOSLG, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75489 | B7-2/CD86, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75495 | B7-1/CD80, Macaca nemestrina (HEK293, hFc) | Recombinant Proteins | |
| HY-P75496 | B7-1/CD80, Macaca nemestrina (HEK293, His) | Recombinant Proteins | |
| HY-P75497 | ATL3, Human (His) | Recombinant Proteins | |
| HY-P75498 | ASGR1/ASGPR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75499 | Arylsulfatase A/ARSA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75500 | ARHI, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75501 | Argininosuccinate lyase, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75502 | ARF5, Human (His) | Recombinant Proteins | |
| HY-P75503 | Apolipoprotein A-I/APOA1, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75503A | Apolipoprotein A-I/APOA1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75504 | Apolipoprotein L/APOL1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75505 | Annexin A8/ANXA8, Human (His) | Recombinant Proteins | |
| HY-P75506 | ANGPTL7/Angiopoietin-related 7, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75507 | ANGPTL7/Angiopoietin-related 7, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75508 | ANGPTL7/Angiopoietin-related 7, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75509 | Angiopoietin-2, Dog (HEK293, His) | Recombinant Proteins | |
| HY-P75511 | Amyloid Precursor/Beta-APP40, Human (His-GST) | Recombinant Proteins | |
| HY-P75514 | Aminoacylase-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75516 | ALK-1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75517 | Alanyl-tRNA synthetase, Human (sf9, His) | Recombinant Proteins | |
| HY-P75519 | AKT3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75520 | AKR1C2, Human (His) | Recombinant Proteins | |
| HY-P75521 | AKR1B1, Human (His) | Recombinant Proteins | |
| HY-P75523 | AGRP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75524 | AGRP, Mouse (50a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P75525 | AGRP, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75526 | AGRP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75527 | AGRP, Human (48a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P75528 | AGRP, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75529 | ADK/Adenosine Kinase, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75530 | ADK/Adenosine Kinase, Human (HEK293) | Recombinant Proteins | |
| HY-P75531 | ADAM9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75532 | ADAM8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75533 | ADAM15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75533A | ADAM15, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P75534 | ADAM15, Human (CHO, His) | Recombinant Proteins | |
| HY-P75535 | ACVR2B, Mouse (HEK293, His-hFc) | Recombinant Proteins | |
| HY-P75536 | ACVR2B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75537 | ACVR2A/Activin RIIA, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75538 | ACVR1, Rat (HEK293, hFc) | Recombinant Proteins | |
| HY-P75539 | ACVR1, Mouse (HEK293, His-hFc) | Recombinant Proteins | |
| HY-P75540 | ACP5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75541 | ACOX1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75542 | ACK1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75543 | ACAT2, Rat (His) | Recombinant Proteins | |
| HY-P75544 | A1BG/Alpha-1B-Glycoprotein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75545 | 6Ckine/CCL21A, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75546 | 6Ckine/CCL21A, Mouse (sf9) | Recombinant Proteins | |
| HY-P75547 | 15-PGDH/HPGD, Human (His) | Recombinant Proteins | |
| HY-P75547A | 15-PGDH/HPGD, Human (C-His) | Recombinant Proteins | |
| HY-P75548 | 14-3-3 theta, Human (GST) | Recombinant Proteins | |
| HY-P75548A | 14-3-3 theta, Human (His) | Recombinant Proteins | |
| HY-P75549 | 14-3-3 epsilon, Mouse (His) | Recombinant Proteins | |
| HY-P75550 | 14-3-3 beta, Cynomolgus | Recombinant Proteins | |
| HY-P75551 | LSD1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75552 | TIM-4/TIMD-4, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75553 | Chemerin/RARRES2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75554 | Chemerin/RARRES2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75555 | 15-PGDH/HPGD, Mouse (His) | Recombinant Proteins | |
| HY-P75558 | ACAA1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75559 | acnB, E. coli | Recombinant Proteins | |
| HY-P75560 | Aconitase 1/ACO1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75561 | ACP5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75562 | ACVR2A/Activin RIIA, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75563 | ACVR2A/Activin RIIA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75564 | ADAM15, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75565 | ADSL/Adenylosuccinate Lyase, Human (His) | Recombinant Proteins | |
| HY-P75566 | AGRP, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75567 | AARS1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75567Y | AARS1, Mouse (sf9, His, solution) | Recombinant Proteins | |
| HY-P75568 | ALDH3A1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75569 | ALK-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75570 | ALK-1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P75571 | Activin RIB/ALK-4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75572 | Activin RIB/ALK-4, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75573 | ALK-7, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75574 | Allergin-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75575 | Allergin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75576 | Aminoacylase-1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75577 | ANGPTL2/Angiopoietin-like 2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75578 | ANGPTL2/Angiopoietin-like 2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75580 | ANGPTL3/Angiopoietin-like 3, Human (sf9, His) | Recombinant Proteins | |
| HY-P75581 | Antithrombin III/Serpin C1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75582 | APLP-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75583 | ARF3, Human (His) | Recombinant Proteins | |
| HY-P75584 | Artemin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75585 | ATOX1, Human (His) | Recombinant Proteins | |
| HY-P75586 | ATP1B1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75587 | ATP1B2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75588 | BACE2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75589 | BAFF/TNFSF13B, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75590 | BCL2A1, Human (His) | Recombinant Proteins | |
| HY-P75591 | BCMA/TNFRSF17, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75592 | B2M/Beta-2 microglobulin, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75594 | BMPR1A/ALK-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75596 | BOLA1, Human (His) | Recombinant Proteins | |
| HY-P75597 | BVES, Human (GST) | Recombinant Proteins | |
| HY-P75598 | CADM1/IGSF4A, Mouse (Q8R5M8-2, HEK293, His) | Recombinant Proteins | |
| HY-P75599 | CADM2/IGSF4D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75600 | CALCB, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P75601 | CAPG, Human | Recombinant Proteins | |
| HY-P75602 | CARKL, Human (sf9) | Recombinant Proteins | |
| HY-P75604 | CASPR2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75605 | CBR3, Human (His) | Recombinant Proteins | |
| HY-P75606 | Eotaxin-3/CCL26, Human (sf9) | Recombinant Proteins | |
| HY-P75607 | Neprilysin/CD10, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75608 | CD131, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75609 | CD137/4-1BB, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75610 | CD137/4-1BB, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75611 | CD146/MCAM, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75612 | CD146/MCAM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75613 | CD146/MCAM, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75614 | PVR/CD155, Human (HEK293) | Recombinant Proteins | |
| HY-P75617 | CD164, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75618 | CD164, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75619 | ALCAM/CD166, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75620 | ALCAM/CD166, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75621 | Fc gamma RIIIA/CD16a, Rat (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75621A | Fc gamma RIIIA/CD16a, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P75622 | CD200R1, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75624 | CD200R1, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75625 | CD200R1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75626 | CD22, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75627 | CD22, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75629 | IL-2R alpha/CD25, Rhesus Macaque (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P75630 | CD27/TNFRSF7, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P75632 | CD27/TNFRSF7, Human (sf9, His) | Recombinant Proteins | |
| HY-P75633 | CD27/TNFRSF7, Human (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P75634 | CD27/TNFRSF7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75637 | CD302/CLEC13A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75638 | CD302/CLEC13A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75639 | CD30 Ligand/TNFSF8, Rat (HEK293) | Recombinant Proteins | |
| HY-P75640 | CD30 Ligand/TNFSF8, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75642 | Fc gamma RIIA/CD32a, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P75644 | Fc gamma RIIA/CD32a, Human (H167R, HEK293, Fc) | Recombinant Proteins | |
| HY-P75645 | Fc gamma RIIA/CD32a, Human (H167R, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P75647 | Fc gamma RIIA/CD32a, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75649 | Fc gamma RIIB/CD32b, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P75651 | Siglec-3/CD33, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75652 | Siglec-3/CD33, Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75653 | CD36, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75654 | CD3D, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75655 | CD55/DAF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75658 | CD79B, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75659 | CD79B, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75660 | FCAR/CD89, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75661 | CD93/C1qR1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75663 | CD98, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75664 | CD98, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75665 | CDCP1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75667 | N-Cadherin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75668 | CDK1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75669 | CDK1, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P75670 | CDNF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75671 | CEACAM6, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75672 | Chk1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75673 | CHN1, Human (sf9) | Recombinant Proteins | |
| HY-P75674 | CHN1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75675 | CIB2, Human (His) | Recombinant Proteins | |
| HY-P75675A | CIB2, Human (N-His) | Recombinant Proteins | |
| HY-P75676 | CLEC10A/CD301, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75677 | CLEC4F/CLECSF13, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75679 | CMBL, Human (His) | Recombinant Proteins | |
| HY-P75680 | CNPY3/PRAT4A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75681 | CNTN4/Contactin-4, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75682 | Cofilin-1, Human (His) | Recombinant Proteins | |
| HY-P75683 | COL4A3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75684 | COL6A3, Human (HEK293) | Recombinant Proteins | |
| HY-P75685 | COL6A3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75686 | COX5B, Human (His) | Recombinant Proteins | |
| HY-P75687 | CRABP1, Human | Recombinant Proteins | |
| HY-P75688 | CRABP2, Human (His) | Recombinant Proteins | |
| HY-P75689 | CRABP2, Mouse (His) | Recombinant Proteins | |
| HY-P75691 | CSEN, Human (His) | Recombinant Proteins | |
| HY-P75692 | G-CSFR/CD114, Human (HEK293) | Recombinant Proteins | |
| HY-P75694 | G-CSFR/CD114, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75695 | CSRP1, Mouse (His) | Recombinant Proteins | |
| HY-P75696 | CXCL16, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75697 | CXCL16, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75698 | NAP-2/CXCL7, Mouse (His) | Recombinant Proteins | |
| HY-P75699 | NAP-2/CXCL7, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75700 | NAP-2/CXCL7, Rat (P.pastoris, His) | Recombinant Proteins | |
| HY-P75701 | DDOST, Human | Recombinant Proteins | |
| HY-P75702 | DDR2, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75703 | DDR2, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75704 | NS5, Dengue virus 2 (His) | Recombinant Proteins | |
| HY-P75705 | DERP1, Dermatophagoides pteronyssinus (HEK293, His) | Recombinant Proteins | |
| HY-P75706 | DERP1, Dermatophagoides pteronyssinus (C132A, N150E, HEK293, His) | Recombinant Proteins | |
| HY-P75707 | DKK-1, Rhesus Macaque (N256Q, HEK293, His) | Recombinant Proteins | |
| HY-P75708 | DKK-1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75709 | DLST, Human (sf9, His) | Recombinant Proteins | |
| HY-P75710 | DMBT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75711 | DNMT2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75712 | DPP2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75713 | DPYS, Human (sf9) | Recombinant Proteins | |
| HY-P75714 | DPYS, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75715 | Ebola virus Glycoprotein/GP1 (ACI28624, sf9, His) | Recombinant Proteins | |
| HY-P75716 | Ebola virus VP40/Matrix VP40 (B8XCM9, His) | Recombinant Proteins | |
| HY-P75717 | Ebola virus Glycoprotein/GP1 (468a.a, Q7T9D9, sf9, His) | Recombinant Proteins | |
| HY-P75718 | Ebola virus Glycoprotein/GP1 (468a.a, Q7T9D9, HEK293, His) | Recombinant Proteins | |
| HY-P75719 | Ebola virus VP40/Matrix VP40 (YP_138522, His-MBP) | Recombinant Proteins | |
| HY-P75720 | Ebola virus VP40/Matrix VP40 (Q5XX06, His) | Recombinant Proteins | |
| HY-P75721 | Ebola virus Glycoprotein/GP1 (AHX24649, HEK293, His) | Recombinant Proteins | |
| HY-P75722 | Ebola virus NP/Nucleoprotein (His) | Recombinant Proteins | |
| HY-P75723 | Ebola virus VP40/Matrix VP40 (AHX24648, His-MBP) | Recombinant Proteins | |
| HY-P75724 | Ebola virus NP/Nucleoprotein (378a.a, Q5XX08, His) | Recombinant Proteins | |
| HY-P75725 | Ebola virus NP/Nucleoprotein (109a.a, Q5XX08, His) | Recombinant Proteins | |
| HY-P75726 | EBP1, Human (His) | Recombinant Proteins | |
| HY-P75727 | EDA2R/XEDAR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75728 | EDA2R/XEDAR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75729 | EDA2R/XEDAR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75730 | EGFL7/VE-Statin, Human (sf9, His) | Recombinant Proteins | |
| HY-P75731 | EGFL7/VE-Statin, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75732 | Enolase 3/ENO3, Human (His) | Recombinant Proteins | |
| HY-P75733 | ENPP-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75734 | ENPP-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75736 | EpCAM/TROP1, Rhesus Macaque (HEK293) | Recombinant Proteins | |
| HY-P75737 | EpCAM/TROP1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75738 | EphA3, Mouse (sf9) | Recombinant Proteins | |
| HY-P75739 | EphA3, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P75740 | EphA3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75741 | EphA3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75742 | EphA3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75743 | EphA3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75744 | EphA6, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75745 | EphA6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75746 | EphA7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75747 | EphB1, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P75748 | EphB1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75749 | EphB3, Mouse (508a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75750 | EphB3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75751 | EphB6, Human (HEK293) | Recombinant Proteins | |
| HY-P75752 | EphB6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75753 | EphB6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75754 | EphB6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75755 | Ephrin A5, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75756 | ERAP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75757 | EVI2A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75759 | FAP, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75760 | FCGRT-B2M Heterodimer, Rat (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75760A | FCGRT-B2M Heterodimer, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P75761 | FCGRT-B2M Heterodimer, Rat (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75762 | FGF-21, Hamster (HEK293, His) | Recombinant Proteins | |
| HY-P75763 | FGFR-1 alpha (IIIb), Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75764 | FGFR-1 alpha (IIIb), Human (HEK293, His) | Recombinant Proteins | |
| HY-P75765 | FGFR-1 beta (IIIb), Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75766 | FGFR-1 beta (IIIb), Human (HEK293, His) | Recombinant Proteins | |
| HY-P75767 | FGFR-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75768 | FGFR-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75769 | FGFR-1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75770 | FGFR-1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75771 | FGL1, Rat (sf9, His) | Recombinant Proteins | |
| HY-P75772 | FGG/Fibrinogen gamma chain, Human (P.pastoris) | Recombinant Proteins | |
| HY-P75775 | FOLR1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75776 | FOLR1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75777 | Fractalkine/CX3CL1, Canine (HEK293) | Recombinant Proteins | |
| HY-P75778 | Fractalkine/CX3CL1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75779 | Fractalkine/CX3CL1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75780 | FRZB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75781 | Follistatin-like 1/FSTL1, Rat (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75781A | Follistatin-like 1/FSTL1 Protein, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P75782 | FUCA1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75783 | FUT8, Hamster (sf9, His) | Recombinant Proteins | |
| HY-P75784 | G6B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75785 | G6B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75786 | GBA/Glucosylceramidase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75787 | GBP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75788 | BMP-3B/GDF10, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75790 | Glucokinase/GCK, Human | Recombinant Proteins | |
| HY-P75791 | GMPR, Human (His) | Recombinant Proteins | |
| HY-P75792 | gp130/IL6ST, Human (HEK293) | Recombinant Proteins | |
| HY-P75794 | gp130/IL6ST, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75795 | gp130/IL6ST, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75796 | GPR56, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75797 | GPT2, Rat (sf9, His) | Recombinant Proteins | |
| HY-P75798 | GPX7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75799 | GRK6, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75800 | GSTK1, Human | Recombinant Proteins | |
| HY-P75801 | GSTM5, Human (N-His) | Recombinant Proteins | |
| HY-P75802 | GSTT2B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75803 | HE4/WFDC2, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75804 | HER2/CD340, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P75805 | HER2/CD340, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75806 | HER2/CD340, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75807 | HER2/CD340, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75808 | HEXB/Hexosaminidase B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75809 | HGF, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P75810 | HMGN3, Human (His) | Recombinant Proteins | |
| HY-P75811 | HNMT, Human (His) | Recombinant Proteins | |
| HY-P75812 | glycoprotein/G, HRSV (sf9, His) | Recombinant Proteins | |
| HY-P75813 | glycoprotein/G, HRSV (93% Homology, HEK293, His) | Recombinant Proteins | |
| HY-P75814 | Glycoprotein/G, HRSV (95% Homology, HEK293, His) | Recombinant Proteins | |
| HY-P75815 | Fusion glycoprotein F0/F, HRSV (P11209, sf9, His) | Recombinant Proteins | |
| HY-P75816 | Fusion glycoprotein F0/F, HRSV (AFX60213, sf9, His) | Recombinant Proteins | |
| HY-P75817 | Fusion glycoprotein F0/F, HRSV (AHX57537, sf9, His) | Recombinant Proteins | |
| HY-P75818 | glycoprotein/G, HRSV (258a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75819 | ICOS, Rhesus Macaque (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P75820 | IFI30, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75821 | IFN-alpha 4/IFNA4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75822 | IFN-alpha 4/IFNA4, Human (sf9, His) | Recombinant Proteins | |
| HY-P75824 | IFN-gamma R1/CD119, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75825 | IL-10R alpha, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75827 | IL-13R alpha 2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75829 | IL-13R alpha 2, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75830 | IL-13R alpha 2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75831 | IL-13R alpha 2, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75832 | IL-13R alpha 2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75833 | IL-13R alpha 2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75834 | IL-13R alpha 2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75835 | IL-17B Protein, Mouse (sf9, Fc) | Recombinant Proteins | |
| HY-P75836 | IL-17C Protein, Human (sf9, Fc) | Recombinant Proteins | |
| HY-P75837 | IL-17RC, Human (sf9, His) | Recombinant Proteins | |
| HY-P75839 | IL-17RD, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75840 | IL-17RD, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P75841 | IL-18BP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75842 | IL-18R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75843 | IL-18R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75845 | IL-18R alpha, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75846 | IL-18R alpha, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75847 | IL-18R alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75848 | IL-18RAP, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75849 | IL-1R2, Human (HEK293) | Recombinant Proteins | |
| HY-P75852 | IL-1R2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75853 | IL-1RA/IL-1RN, Cynomolgus (His) | Recombinant Proteins | |
| HY-P75854 | IL-22BP/IL-22RA2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75855 | IL-22BP/IL-22RA2, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P75857 | IL-23R, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75858 | IL-25/IL-17E, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75859 | IL-31R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75860 | IL-31R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75861 | IL-36 gamma/IL-1F9, Human (His) | Recombinant Proteins | |
| HY-P75861AF | Animal-Free IL-36 gamma/IL-1F9, Human (His) | Recombinant Proteins | |
| HY-P75862 | IL-3R alpha/CD123 Protein, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75864 | IL-5R alpha, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75865 | IL-8/CXCL8, Rhesus Macaque | Recombinant Proteins | |
| HY-P75866 | LILRB4/CD85k/ILT3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75867 | HA/Hemagglutinin, H10N3 (BAF46762, sf9, His) | Recombinant Proteins | |
| HY-P75868 | HA/Hemagglutinin, H10N3 (BAF46762, HEK293, His) | Recombinant Proteins | |
| HY-P75869 | HA1/Hemagglutinin, H10N3 (BAF46762, HEK293, His) | Recombinant Proteins | |
| HY-P75870 | HA1/Hemagglutinin, H10N3 (AGO87051, HEK293, His) | Recombinant Proteins | |
| HY-P75871 | HA/Hemagglutinin, H10N3 (ACT84107, sf9, His) | Recombinant Proteins | |
| HY-P75872 | HA1/Hemagglutinin, H10N3 (ACT84107, HEK293, His) | Recombinant Proteins | |
| HY-P75873 | HA/Hemagglutinin, H10N7 (ADH96304, sf9, His) | Recombinant Proteins | |
| HY-P75874 | HA1/Hemagglutinin, H10N8 (AFJ19053, HEK293, His) | Recombinant Proteins | |
| HY-P75875 | HA1/Hemagglutinin, H11N6 (AGB50949, HEK293, His) | Recombinant Proteins | |
| HY-P75876 | HA1/Hemagglutinin, H3N8 (ACE81938, HEK293, His) | Recombinant Proteins | |
| HY-P75877 | HA1/Hemagglutinin, H3N8 (ACE81938, sf9, His) | Recombinant Proteins | |
| HY-P75878 | HA/Hemagglutinin, H4N8 (P19695, HEK293, His) | Recombinant Proteins | |
| HY-P75879 | HA/Hemagglutinin Protein, H5N1 (ABP51975, S28W, sf9, His) | Recombinant Proteins | |
| HY-P75880 | HA/Hemagglutinin, H5N2 (ACF47563, HEK293, His) | Recombinant Proteins | |
| HY-P75881 | HA/Hemagglutinin, H5N2 (AKG52687, sf9, His) | Recombinant Proteins | |
| HY-P75882 | HA/Hemagglutinin, H6N1 (ACE81692, HEK293, His) | Recombinant Proteins | |
| HY-P75883 | HA/Hemagglutinin, H7N3 (CAF33017, sf9, His) | Recombinant Proteins | |
| HY-P75884 | HA1/Hemagglutinin, H7N3 (CAF33017, HEK293, His) | Recombinant Proteins | |
| HY-P75885 | Nucleocapsid/NP, H7N9 (AHZ59787, sf9, His) | Recombinant Proteins | |
| HY-P75886 | Nucleocapsid/NP, H7N9 (R4NE06, sf9, His) | Recombinant Proteins | |
| HY-P75887 | ING5, Human (His) | Recombinant Proteins | |
| HY-P75888 | INHBE, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75889 | IFN-alpha 2/IFNA2, Rhesus Macaque (P.pastoris) | Recombinant Proteins | |
| HY-P75890 | IFN-alpha 2/IFNA2, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75891 | IFN-alpha 2/IFNA2, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75892 | IFN-alpha 5/IFNA5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75893 | IFN-alpha 5/IFNA5, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P75894 | ITCH/AIP4, Human (solution) | Recombinant Proteins | |
| HY-P75894A | ITCH/AIP4, Human | Recombinant Proteins | |
| HY-P75895 | JAML/AMICA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75896 | JTB, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75897 | KEAP1, Human (sf9) | Recombinant Proteins | |
| HY-P75897Y | KEAP1, Human (sf9, solution) | Recombinant Proteins | |
| HY-P75899 | KEAP1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75900 | KIAA0101, Human (His) | Recombinant Proteins | |
| HY-P75901 | KIR2DL3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75903 | KYNU/Kynureninase, Human (sf9, His) | Recombinant Proteins | |
| HY-P75904 | KYNU/Kynureninase, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75905 | LCN1/Lipocalin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75906 | LECT1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75907 | LIFR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75909 | LILRA5/CD85f, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75910 | LILRA5/CD85f, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75912 | LILRB3/CD85a, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75913 | LILRB3/CD85a, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P75914 | LILRB3/CD85a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75915 | LSM3, Human (His) | Recombinant Proteins | |
| HY-P75916 | LSP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75917 | TNFRSF3/LTBR, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P75918 | TNFRSF3/LTBR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P75919 | LTC4S, Human (sf9, His) | Recombinant Proteins | |
| HY-P75920 | Lymphocyte antigen 6A-2/LY6A, Mouse (His) | Recombinant Proteins | |
| HY-P75921 | MAP3K8/TPL-2, Human (sf9, GST) | Recombinant Proteins | |
| HY-P75923 | MCP-2/CCL8, Human (SUMO) | Recombinant Proteins | |
| HY-P75924 | MERS-CoV Spike/S RBD (sf9, His) | Recombinant Proteins | |
| HY-P75925 | METAP2/Methionine aminopeptidase 2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75926 | METTL1, Human (His) | Recombinant Proteins | |
| HY-P75927 | MGAT5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75928 | MICA, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P75929 | MMP-19, Human | Recombinant Proteins | |
| HY-P75930 | MTSS1, Human (His) | Recombinant Proteins | |
| HY-P75931 | Myocilin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75932 | NCAM-1/CD56, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P75932A | NCAM-1/CD56 Protein, Human (HEK293, His-Avi, Biotinylated) | Recombinant Proteins | |
| HY-P75933 | NCAM-1/CD56, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P75934 | Kilon/NEGR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75935 | NEK7, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75936 | NELL2, Human (sf9, His) | Recombinant Proteins | |
| HY-P75937 | NETO1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75938 | Neurolysin, Human (His) | Recombinant Proteins | |
| HY-P75939 | KLRB1F/CD161f, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P75940 | NKG2D/CD314, Rhesus Macaque (sf9, His) | Recombinant Proteins | |
| HY-P75941 | NMNAT1, Human (sf9, His) | Recombinant Proteins | |
| HY-P75942 | NNT1/CLC, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75943 | Neuregulin-3/NRG3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75944 | Neuregulin-3/NRG3, Human (61a.a, HEK293, His) | Recombinant Proteins | |
| HY-P75945 | NRXN3/Neurexin-3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75946 | NRXN3/Neurexin-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75947 | NUDC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75948 | OMGP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75950 | GPNMB/Osteoactivin, Human (Isoform 2, HEK293, His) | Recombinant Proteins | |
| HY-P75951 | GPNMB/Osteoactivin, Human (Isoform 2, HEK293, Fc) | Recombinant Proteins | |
| HY-P75952 | OTUB1, Human (His) | Recombinant Proteins | |
| HY-P75953 | OX40/TNFRSF4, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P75954 | OX40/TNFRSF4, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75956 | PCDH7, Human (sf9, His) | Recombinant Proteins | |
| HY-P75957 | PCK2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75958 | PCSK9, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P75960 | PDE1B, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75961 | PDE3A, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75962 | PDE9A, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75963 | PDE9A, Human (His) | Recombinant Proteins | |
| HY-P75964 | PDGFAA, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P75965 | PDGFAA, Canine (P.pastoris, His) | Recombinant Proteins | |
| HY-P75966 | PDGF-BB, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P75966A | PDGF-BB Protein, Cynomolgus (HEK293, mFc) | Recombinant Proteins | |
| HY-P75969 | PEAR1, Rat (sf9, His) | Recombinant Proteins | |
| HY-P75970 | Pellino-1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75971 | PFKP, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P75972 | PGK2, Human (sf9, His) | Recombinant Proteins | |
| HY-P75974 | PHOSPHO1, Human (His) | Recombinant Proteins | |
| HY-P75975 | PHPT1, Human (His) | Recombinant Proteins | |
| HY-P75977 | PLA2G2A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75978 | PNLIP/Pancreatic lipase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75979 | PPM1A, Mouse (His) | Recombinant Proteins | |
| HY-P75980 | PRELP, Human (HEK293) | Recombinant Proteins | |
| HY-P75981 | PRELP, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75982 | PRKAR1A, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P75983 | PRMT6, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P75984 | PRSS2/Trypsin-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P75985 | PRSS3/Trypsin-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75986 | PSG1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75988 | PSMA3, Human (His) | Recombinant Proteins | |
| HY-P75989 | PSMB6, Mouse (His) | Recombinant Proteins | |
| HY-P75990 | PSME1, Human (His) | Recombinant Proteins | |
| HY-P75991 | PSME2, Human (His) | Recombinant Proteins | |
| HY-P75992 | PTMA, Human (GST) | Recombinant Proteins | |
| HY-P75993 | RAB1B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75994 | RAB27B, Human (HEK293) | Recombinant Proteins | |
| HY-P75995 | RAB27B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P75996 | RAB27B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P75997 | RAB6A, Human (His) | Recombinant Proteins | |
| HY-P75998 | RAB7A, Rat (His, solution) | Recombinant Proteins | |
| HY-P75998A | RAB7A, Rat (N-His) | Recombinant Proteins | |
| HY-P75999 | RANKL/TNFSF11, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76000 | RBP4, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76001 | RBP4, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P76002 | REG-3 alpha/REG3A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76003 | REG-3 beta/REG3B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76005 | RVFV-L (His) | Recombinant Proteins | |
| HY-P76006 | RNASET2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76007 | RNF43, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76008 | RNF43, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76009 | ROBO4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76011 | RSK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76012 | RSPO1/R-spondin-1, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P76013 | RSPO2/R-spondin-2, Mouse (Fc) | Recombinant Proteins | |
| HY-P76016 | RUVBL1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76017 | S100A3, Mouse (His) | Recombinant Proteins | |
| HY-P76018 | S100A5, Mouse (His) | Recombinant Proteins | |
| HY-P76019 | SARS-CoV S RBD (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P7602 | Arginase-1/ARG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76020 | SARS-CoV S1 (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P76021 | SARS-CoV-2 Plpro/Papain-like protease (His) | Recombinant Proteins | |
| HY-P76022 | SARS-CoV-2 S RBD (A344S, HEK293, His) | Recombinant Proteins | |
| HY-P76023 | SARS-CoV-2 S RBD (A352S, HEK293, His) | Recombinant Proteins | |
| HY-P76024 | SARS-CoV-2 S RBD (A372T, HEK293, His) | Recombinant Proteins | |
| HY-P76025 | SARS-CoV-2 S RBD (F377L, HEK293, His) | Recombinant Proteins | |
| HY-P76026 | SARS-CoV-2 S RBD (I472V, HEK293, His) | Recombinant Proteins | |
| HY-P76027 | SARS-CoV-2 S RBD (K417N, HEK293, His) | Recombinant Proteins | |
| HY-P76028 | SARS-CoV-2 S RBD (K444R, HEK293, His) | Recombinant Proteins | |
| HY-P76029 | SARS-CoV-2 S RBD (K458Q, HEK293, His) | Recombinant Proteins | |
| HY-P7603 | Arginase-2/ARG2, Human (His) | Recombinant Proteins | |
| HY-P76030 | SARS-CoV-2 S RBD (L452R, HEK293, His) | Recombinant Proteins | |
| HY-P76031 | SARS-CoV-2 S RBD (N439K, HEK293, His) | Recombinant Proteins | |
| HY-P76032 | SARS-CoV-2 S RBD (N440K, HEK293, His) | Recombinant Proteins | |
| HY-P76033 | SARS-CoV-2 S RBD (N501Y, HEK293, His) | Recombinant Proteins | |
| HY-P76034 | SARS-CoV-2 S RBD (P521R, HEK293, His) | Recombinant Proteins | |
| HY-P76035 | SARS-CoV-2 S RBD (Q414E, HEK293, His) | Recombinant Proteins | |
| HY-P76036 | SARS-CoV-2 S RBD (Q414R, HEK293, His) | Recombinant Proteins | |
| HY-P76037 | SARS-CoV-2 S RBD (S359N, HEK293, His) | Recombinant Proteins | |
| HY-P76038 | SARS-CoV-2 S RBD (T393P, HEK293, His) | Recombinant Proteins | |
| HY-P76039 | SARS-CoV-2 S RBD (V341I, HEK293, His) | Recombinant Proteins | |
| HY-P7604 | AKR1C3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76040 | SARS-CoV-2 S RBD (V445F, HEK293, His) | Recombinant Proteins | |
| HY-P76041 | SARS-CoV-2 S RBD (V483I, HEK293, His) | Recombinant Proteins | |
| HY-P76042 | SARS-CoV-2 S RBD (Y508H, HEK293, His) | Recombinant Proteins | |
| HY-P76043 | SARS-CoV-2 S RBD (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P76044 | SARS-CoV-2 S RBD (Biotinylated, sf9, Avi-His) | Recombinant Proteins | |
| HY-P76045 | SARS-CoV-2 S RBD (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P76046 | SARS-CoV-2 S RBD (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76047 | SARS-CoV-2 S1 NTD (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P76048 | SARS-CoV-2 S1 (N234Q, HEK293, His) | Recombinant Proteins | |
| HY-P76049 | SBDS, Mouse (His) | Recombinant Proteins | |
| HY-P7605 | ARMET/MANF, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76050 | SCGN, Human (His) | Recombinant Proteins | |
| HY-P76051 | SCN2B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76052 | SCN2B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76054 | SDF-2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76055 | Semaphorin-4A/SEMA4A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76056 | Semaphorin-4A/SEMA4A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76057 | Semaphorin-6A/SEMA6A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76058 | Serglycin/SRGN, Human (HEK293, His-Myc) | Recombinant Proteins | |
| HY-P76059 | Serglycin/SRGN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7606 | ARRB1/Beta-Arrestin 1, Human (His) | Recombinant Proteins | |
| HY-P76060 | Serpin A11, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76061 | Serpin B6b, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76062 | SETD7, Human (His) | Recombinant Proteins | |
| HY-P76063 | SGK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76064 | SIGIRR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76065 | SIGIRR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76068 | SIRP alpha V8/CD172a, Human (AAH38510, HEK293, His) | Recombinant Proteins | |
| HY-P76069 | SIRP alpha V8/CD172a, Human (AAH38510, HEK293, Fc) | Recombinant Proteins | |
| HY-P7607 | Artemin, Human | Recombinant Proteins | |
| HY-P76071 | SIRP alpha/CD172a, Mouse (BAA20376, HEK293, Fc) | Recombinant Proteins | |
| HY-P76072 | SIRP alpha/CD172a, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76073 | SIRP alpha/CD172a, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76074 | CD150/SLAMF1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76075 | CD150/SLAMF1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76076 | SLAMF6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76077 | SLITRK1, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P76078 | SLITRK1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76079 | SMYD2, Human (sf9, His) | Recombinant Proteins | |
| HY-P7608 | Arylsulfatase A/ARSA, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P76080 | SMYD3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76084 | SPINK4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76085 | SPINK4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76086 | SR-BI/SCARB1, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P76087 | SR-BI/SCARB1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76089 | ssPA, E. coli (His) | Recombinant Proteins | |
| HY-P7608A | Arylsulfatase A/ARSA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7609 | ASAM/CLMP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76090 | ST2/IL1RL1, Human (HEK293) | Recombinant Proteins | |
| HY-P76091 | ST2/IL1RL1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76093 | ST2/IL1RL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76094 | ST6GAL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76095 | STC2/Stanniocalcin-2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76096 | STC2/Stanniocalcin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76097 | STK16, Human (His) | Recombinant Proteins | |
| HY-P76098 | STK40, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76099 | SULT1E1, Human (His) | Recombinant Proteins | |
| HY-P76099A | SULT1E1, Human (N-His) | Recombinant Proteins | |
| HY-P7610 | ASGR1/ASGPR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76101 | Syndecan-1/CD138, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76102A | TCN2/Transcobalamin-2, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P76103 | TCPTP, Human (sf9, solution) | Recombinant Proteins | |
| HY-P76103A | TCPTP, Human (sf9) | Recombinant Proteins | |
| HY-P76104 | TCPTP, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76105 | Thy1/CD90, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76108 | TNF RII/TNFRSF1B, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7611 | GOT1, Human (His) | Recombinant Proteins | |
| HY-P76110 | AITRL/TNFSF18, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76111 | TPM4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76112 | TPP1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76114Y | TGM2/Transglutaminase 2, Human (sf9, His, solution) | Recombinant Proteins | |
| HY-P76115 | TrkA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76116 | TrkA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76117 | TSPAN8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76118 | TSPAN8, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76119A | UCHL3, Mouse (His, solution) | Recombinant Proteins | |
| HY-P7612 | Fibrillin-1/Asprosin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76120 | UNC5B, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76121 | VAMP3, Human (His) | Recombinant Proteins | |
| HY-P76122 | VEGF164, Rat (sf9) | Recombinant Proteins | |
| HY-P76124 | VHL, Human (His) | Recombinant Proteins | |
| HY-P76125 | VLDLR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76126 | VNN1/Vanin-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76127 | VNN1/Vanin-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76128 | VIPR2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76129 | Zika virus E/Envelope (HEK293, His) | Recombinant Proteins | |
| HY-P76129A | Zika virus E/Envelope (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7613 | ASS1, Human (His) | Recombinant Proteins | |
| HY-P76130 | Zika virus NS5 (sf9, His) | Recombinant Proteins | |
| HY-P76131 | AARSD1, Human (His) | Recombinant Proteins | |
| HY-P76132 | ABHD14B, Human (His) | Recombinant Proteins | |
| HY-P76133 | ABHD4, Human (sf9, His) | Recombinant Proteins | |
| HY-P76134 | SMPD1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76134A | SMPD1, Mouse (sf9, C-His) | Recombinant Proteins | |
| HY-P76135 | ADAMTSL1/Punctin, Human (sf9, His) | Recombinant Proteins | |
| HY-P76136 | AHSP, Human | Recombinant Proteins | |
| HY-P76137 | AKR1A1, Human (His) | Recombinant Proteins | |
| HY-P76138 | ALDH4A1, Human (sf9) | Recombinant Proteins | |
| HY-P76139 | ALDH4A1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P7614 | ASXL1, Human (GST) | Recombinant Proteins | |
| HY-P76140 | ALDH7A1, Human (His) | Recombinant Proteins | |
| HY-P76141 | AMPK gamma 1/beta 1/alpha 1 Heterotrimer, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76142 | AMPK gamma 1/beta 1/alpha 2 Heterotrimer, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76143 | AMPK gamma 1/beta 2/alpha 1 Heterotrimer, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76144 | AMPK gamma 1/beta 2/alpha 2 Heterotrimer, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76145 | Angiopoietin-1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76146 | Angiopoietin-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76147 | Angiopoietin-2, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76148 | Angiopoietin-2, Cynomolgus/Rhesus Macaque (222a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76149 | Angiopoietin-2, Cynomolgus/Rhesus Macaque (495a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7615 | ATF1, Human (His) | Recombinant Proteins | |
| HY-P76150 | ANP32A, Human (His) | Recombinant Proteins | |
| HY-P76151 | CMG-2/ANTXR2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76152 | CMG-2/ANTXR2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76153 | CMG-2/ANTXR2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76154 | APCDD1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76155 | APOA1BP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76156 | ARL2BP, Human (His) | Recombinant Proteins | |
| HY-P76157 | ASF1B, Human (sf9, His) | Recombinant Proteins | |
| HY-P76158 | AspF6, Neosartorya fumigata (His) | Recombinant Proteins | |
| HY-P76159 | ATP6V1F, Human (GST) | Recombinant Proteins | |
| HY-P76159A | ATP6V1F, Human | Recombinant Proteins | |
| HY-P76160 | B3GNT2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76163 | BBOX1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76164 | BCA-1/CXCL13, Cynomolgus (His) | Recombinant Proteins | |
| HY-P76165 | BCL2L12, Human (GST) | Recombinant Proteins | |
| HY-P76166 | BCMA/TNFRSF17, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76167 | BCMA/TNFRSF17, Rhesus Macaque (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P76168 | Amyloid Precursor/Beta-APP42, Human (His-GST) | Recombinant Proteins | |
| HY-P76169 | Alpha 1-Microglobulin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7617 | ATG3, Human | Recombinant Proteins | |
| HY-P76170 | BLMH/Bleomycin Hydrolase, Mouse (His) | Recombinant Proteins | |
| HY-P76171 | BLOC1S2, Human | Recombinant Proteins | |
| HY-P76171A | BLOC1S2, Human (GST) | Recombinant Proteins | |
| HY-P76172 | BLVRB, Human (His) | Recombinant Proteins | |
| HY-P76173 | BMPR1A/ALK-3, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76174 | BMPRIB/ALK-6, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76175 | BMPRIB/ALK-6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76176 | BMPRIB/ALK-6, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76177 | BPHL, Human (His) | Recombinant Proteins | |
| HY-P76178 | BPIFB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76179 | BTN3A1/CD277, Human (HEK293) | Recombinant Proteins | |
| HY-P7618 | ATG4A, Human (His) | Recombinant Proteins | |
| HY-P76182 | BTN3A1/CD277, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76185 | HABP1/C1QBP, Mouse (His) | Recombinant Proteins | |
| HY-P76187 | CADM4/IGSF4C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76188 | CADM4/IGSF4C, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76189 | CADM4/IGSF4C, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7619 | ATG4C, Human (His) | Recombinant Proteins | |
| HY-P76191 | CAMKI gamma/CAMK1G, Human (sf9, His, GST) | Recombinant Proteins | |
| HY-P76192 | CES2/carboxylesterase 2, Human (HEK293,C-His) | Recombinant Proteins | |
| HY-P76192A | CES2/carboxylesterase 2 , Human (HEK293,C-His,Solution) | Recombinant Proteins | |
| HY-P76193 | CES2/carboxylesterase 2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76194 | 6Ckine/CCL21, Rhesus Macaque (sf9) | Recombinant Proteins | |
| HY-P76195 | CD131, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76196 | CD133/PROM1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76197 | CD133/PROM1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76199 | CD137/4-1BB, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7620 | ATG5, Human | Recombinant Proteins | |
| HY-P76200 | CD137/4-1BB, Rhesus Macaque (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76201 | CD146/MCAM, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76202 | Basigin/CD147, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76204 | CD157, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76205 | CD157, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76207 | Fc gamma RIII/CD16, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P76208 | CD1A-B2M Heterodimer, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76209 | CD1B-B2M Heterodimer, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7621 | ABCB5, Human (Trx) | Recombinant Proteins | |
| HY-P76210 | CD1C-B2M Heterodimer, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76211 | CD200, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76212 | CD200, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76213 | DNAM-1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76214 | DNAM-1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76216 | CD27/TNFRSF7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76219 | CD299, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76219A | CD299, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P7622 | AXL, Human (415a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76220 | CD3 zeta/CD247, Human (His) | Recombinant Proteins | |
| HY-P76222 | CD300c, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76223 | CD300e, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76224 | CD30 Ligand/TNFSF8, Human (HEK293) | Recombinant Proteins | |
| HY-P76225 | CD30 Ligand/TNFSF8, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P76226 | TCblR/CD320, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76228 | Fc gamma RIIA/CD32a, Human (Biotinylated, H167R, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7623 | AXL, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76230 | Fc gamma RIIA/CD32a, Human (CHO, His) | Recombinant Proteins | |
| HY-P76233 | Fc gamma RIIA/CD32a, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76235 | Fc gamma RIIB/CD32b, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76237 | CD3E-CD3G Heterodimer, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7624 | Azurocidin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76240 | CD52, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76241 | CD55/DAF, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76242 | CD59, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76243 | CD63, Human/Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76244 | CD81, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76245 | CD83, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76246 | CD83, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76247 | CDKL2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76248 | CDNF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7625 | B2M/Beta-2-microglobulin, Human (His) | Recombinant Proteins | |
| HY-P76250 | CECR1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76254 | CHIT1/Chitotriosidase-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76256 | CHODL, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76257 | CHST11, Human (sf9, His) | Recombinant Proteins | |
| HY-P76258 | CHST15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76259 | CHST3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7626 | B3GAT3, Human (His) | Recombinant Proteins | |
| HY-P76260 | TRIP10/CIP4, Human (sf9, His) | Recombinant Proteins | |
| HY-P76261 | CIRBP, Human (His) | Recombinant Proteins | |
| HY-P76262 | CISD1, Human (His) | Recombinant Proteins | |
| HY-P76263 | CSNK2A1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76264 | CKMT1A, Human (sf9, His) | Recombinant Proteins | |
| HY-P76265 | CLEC10A/CD301, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76266 | CLEC10A/CD301, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76267 | CLEC12A/MICL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76268 | CLEC4F/CLECSF13, Rat (HEK293) | Recombinant Proteins | |
| HY-P76269 | CLEC5A/MDL-1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7627 | B3GNT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76270 | CLEC9A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76271 | CLSTN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76272 | CNDP1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76273 | CNPY3/PRAT4A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76274 | CNPY3/PRAT4A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76275 | CNTFR alpha, Human (sf9, His) | Recombinant Proteins | |
| HY-P76276 | CNTFR alpha, Rat (sf9, His) | Recombinant Proteins | |
| HY-P76277 | CNTN4/Contactin-4, Human (sf9, His) | Recombinant Proteins | |
| HY-P76278 | CNTN6/Contactin-6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76279 | CL-P1/COLEC12, Rat (sf9, His) | Recombinant Proteins | |
| HY-P7628 | B4GALT1, Human (HEK293, Y285L, His) | Recombinant Proteins | |
| HY-P76280 | Coxsackievirus A16 VP1 (295a.a, sf9, Fc) | Recombinant Proteins | |
| HY-P76281 | Coxsackievirus A16 VP4 (68a.a, sf9, Fc) | Recombinant Proteins | |
| HY-P76282 | CPLX2/Complexin-2, Human (His) | Recombinant Proteins | |
| HY-P76283 | HSP10/EPF, Human (His) | Recombinant Proteins | |
| HY-P76284 | CREB3L1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76285 | CRELD1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76286 | CRELD1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76287 | CRELD1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76288 | CRELD2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76289 | CRELD2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7629 | B4GALT3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76290 | CRIP2, Human (sf9) | Recombinant Proteins | |
| HY-P76291 | CRIP2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76292 | CRISP-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76293 | CRISP-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76294 | CSF1R, Rhesus Macaque (C378R, HEK293, Fc) | Recombinant Proteins | |
| HY-P76295 | CSF1R, Rhesus Macaque (C378R, HEK293, His) | Recombinant Proteins | |
| HY-P76296 | CK2 alpha/CSNK2A2, Human (sf9) | Recombinant Proteins | |
| HY-P76297 | CK2 alpha/CSNK2A2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76298 | CSRP1, Human (His) | Recombinant Proteins | |
| HY-P76299 | CTHRC1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7630 | B4GALT4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76300 | CYTL1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P76301 | DSC2/Desmocollin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76301A | DSC2/Desmocollin-2, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P76302 | DSC2/Desmocollin-2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76303 | DSC2/Desmocollin-2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76305 | DPEP2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76306 | DPEP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76307 | DUSP14, Human (His) | Recombinant Proteins | |
| HY-P76308 | DYRK3, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76309 | Ebola virus VP24 (YP_003815439, His) | Recombinant Proteins | |
| HY-P7631 | B7-H6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76310 | Ebola virus VP24 (AHX24653, His) | Recombinant Proteins | |
| HY-P76311 | ECSIT, Human (His) | Recombinant Proteins | |
| HY-P76312 | EDA2R/XEDAR, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76313 | EDA2R/XEDAR, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76314 | EEF1E1, Human (His) | Recombinant Proteins | |
| HY-P76315 | EGFL6, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76316 | EGFL6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76317 | CD39L4/ENTPD5, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76319 | EphA7, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7632 | B7-1/CD80, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76320 | EphA7, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76321 | Ephrin-A5/EFNA5, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76322 | Ephrin-A5/EFNA5, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76323 | DSPG3/Epiphycan, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76324 | ETHE1, Human (His) | Recombinant Proteins | |
| HY-P76325 | EXOSC9, Human (sf9, His) | Recombinant Proteins | |
| HY-P76326 | FAM20B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76328 | FAM3D, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76329 | FAM3D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7633 | B7-1/CD80, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76330 | Fas/CD95, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P76331 | Fas/CD95, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76332 | FGF-1, Cynomolgus | Recombinant Proteins | |
| HY-P76333 | FGFR-2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76334 | FGFR-2 alpha (IIIb), Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76335 | FGFR-2 beta (IIIc), Human (267a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76336 | FGFR-2 alpha (IIIb), Human (HEK293, His) | Recombinant Proteins | |
| HY-P76337 | FGFR-2 alpha (IIIc), Human (HEK293, His) | Recombinant Proteins | |
| HY-P76338 | FGFR-2 alpha (IIIc), Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P76339 | FGFR-2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7634 | B7-1/CD80, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76340 | FGFR-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76341 | FGFR-3, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76342 | FGFR-3, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76343 | FGFRL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76344 | FKBP11, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76345 | FKBP12, Human (His) | Recombinant Proteins | |
| HY-P76346 | FKBP12, Mouse (His) | Recombinant Proteins | |
| HY-P76348 | FOLR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76349 | FSTL3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7635 | B7-2/CD86, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76350 | FSTL5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76351 | FSTL5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76352 | FTCD, Human (sf9, His) | Recombinant Proteins | |
| HY-P76353 | GABARAPL2/GATE-16, Human (His) | Recombinant Proteins | |
| HY-P76354 | GALNT10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76355 | GALNT2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76356 | Gastrokine 1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76357 | GCDH, Human (sf9, His) | Recombinant Proteins | |
| HY-P76358 | GCSH, Human (His) | Recombinant Proteins | |
| HY-P76359 | GFPT1, Human | Recombinant Proteins | |
| HY-P7636 | B7-2/CD86, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76360 | GFRA1/GDNFR-alpha-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76361 | GGT5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76362 | GITR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76363 | Gliomedin, Human (HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P76363A | Gliomedin, Human (HEK293, N-hFc) | Recombinant Proteins | |
| HY-P76364 | GLIPR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76365 | GLTP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76366 | GRX1/Glutaredoxin 1, Human (His) | Recombinant Proteins | |
| HY-P76367 | GMFG, Human (His) | Recombinant Proteins | |
| HY-P76368 | GNG13, Human (His) | Recombinant Proteins | |
| HY-P76369 | GNGT1, Human (His) | Recombinant Proteins | |
| HY-P7637 | B7-2/CD86, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76370 | gp130/IL6ST, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76371 | gp130/IL6ST, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76374 | gp130/IL6ST, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76375 | gp130/IL6ST, Rat (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P76377 | GZMA/Granzyme A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76379 | HAPLN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7638 | B7-2/CD86, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76380 | HGFA/HGF Activator, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76381 | HIST2H2BE, Human | Recombinant Proteins | |
| HY-P76382 | HIST3H2A, Human | Recombinant Proteins | |
| HY-P76383 | envelope glycoprotein gp160, HIV-1 (ADD25380, HEK293, His) | Recombinant Proteins | |
| HY-P76384 | HCoV-229E Spike/S (APT69883, sf9, His) | Recombinant Proteins | |
| HY-P76385 | HCoV-229E Spike/S1 (APT69883, HEK293, His) | Recombinant Proteins | |
| HY-P76386 | HCoV-OC43 Spike/S (AVR40344, sf9, His) | Recombinant Proteins | |
| HY-P76387 | HCoV-OC43 Spike/S2 (AVR40344, sf9, His) | Recombinant Proteins | |
| HY-P76388 | HCoV-HKU1 Spike/S1 (Q5MQD0, HEK293, His) | Recombinant Proteins | |
| HY-P76389 | Enterovirus 71 VP0 (sf9, His-GST) | Recombinant Proteins | |
| HY-P7639 | CD276/B7-H3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76390 | envelope glycoprotein gp120, HIV-1 (AAC31819, HEK293, His) | Recombinant Proteins | |
| HY-P76391 | HAdV-E fiber (sf9, His) | Recombinant Proteins | |
| HY-P76393 | B7-H2/ICOSLG, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76394 | B7-H2/ICOSLG, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76396 | ICOS, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P76397 | ICOS Protein, Mouse (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P76399 | IDS/Iduronate 2-sulfatase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7640 | B7-H4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76400 | IFN-alpha 14/IFNA14, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76401 | IFN-alpha 14/IFNA14, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76403 | IFN-alpha 4/IFNA4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76404 | IFN-alpha 7/IFNA7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76405 | IFN-alpha 7/IFNA7, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P76406 | IFNAR1, Rhesus Macaque (HEK293) | Recombinant Proteins | |
| HY-P76407 | IFNAR1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76409 | IGFBP-2, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7641 | B7-H4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76410 | IGFBP-5, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76411 | IGSF11, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76412 | IGSF3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76414 | IL-10R beta, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76415 | IL-11, Cynomolgus | Recombinant Proteins | |
| HY-P76416 | IL-11R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76417 | IL-13R alpha 1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76418 | IL-17A, Marmoset | Recombinant Proteins | |
| HY-P76419 | IL-17RB, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7642 | B7-H4, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76421 | IL-17RB, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76423 | IL-18R alpha, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76424 | IL-18R alpha, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76425 | IL-18R beta/IL-1R7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76427 | IL-1F10/IL-38, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P76428 | IL-20R beta Protein, Human (sf9, His) | Recombinant Proteins | |
| HY-P76429 | IL-20R beta, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7643 | B7-H4, Rhesus macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76430 | IL-21R, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76431 | IL-21R Protein, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76432 | IL-23 alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76433 | CD127/IL-7RA, Human (I66T, V138I, HEK293, Fc) | Recombinant Proteins | |
| HY-P76436 | CD127/IL-7RA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76437 | IL-9R, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76438 | ILKAP/PP2C delta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7644 | BPI, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76440 | LILRB4/CD85k/ILT3, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76441 | LILRB4/CD85k/ILT3, Human (237a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P76442 | HA/Hemagglutinin, H10N8 (EPI497477, sf9) | Recombinant Proteins | |
| HY-P76443 | HA1/Hemagglutinin, H11N2 (AAY85533, HEK293, His) | Recombinant Proteins | |
| HY-P76444 | HA1/Hemagglutinin, H13N6 (AAV91213, sf9, His) | Recombinant Proteins | |
| HY-P76445 | HA/Hemagglutinin, H16N3 (AAV91217, sf9, His) | Recombinant Proteins | |
| HY-P76446 | HA/Hemagglutinin, H16N3 (AAV91217, HEK293, His) | Recombinant Proteins | |
| HY-P76447 | HA/Hemagglutinin, H1N1 (ACP41105, sf9) | Recombinant Proteins | |
| HY-P76448 | Non-structural 2/NS2, H1N1 (His) | Recombinant Proteins | |
| HY-P76449 | HA1/Hemagglutinin, H4N4 (Q0A4G1, HEK293, His) | Recombinant Proteins | |
| HY-P7645 | BIRC5, Human | Recombinant Proteins | |
| HY-P76450 | HA/Hemagglutinin, H6N2 (AFJ19048, sf9, His) | Recombinant Proteins | |
| HY-P76451 | HA/Hemagglutinin, H6N2 (ADG44842, sf9, His) | Recombinant Proteins | |
| HY-P76452 | HA/Hemagglutinin, H7N8 (ACR59554, sf9, His) | Recombinant Proteins | |
| HY-P76453 | HA/Hemagglutinin, H9N5 (ABB87950, sf9, His) | Recombinant Proteins | |
| HY-P76454 | HA/Hemagglutinin, H9N8 (ABH12262, sf9, His) | Recombinant Proteins | |
| HY-P76455 | INSL6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76456 | IFN-alpha 10/IFNA10, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76457 | IFN-alpha 10/IFNA10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76459 | IFN-alpha 5/IFNA5 Protein, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7646 | BAFFR/TNFRSF13C, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76460 | IFN-alpha 5/IFNA5, Mouse (P.pastoris, His) | Recombinant Proteins | |
| HY-P76461 | IFN-alpha 5/IFNA5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76462 | IFN-alpha 5/IFNA5, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76462A | IFN-alpha 5/IFNA5, Rat (HEK293, C-His) | Recombinant Proteins | |
| HY-P76464 | JAML/AMICA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76465 | JAML/AMICA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76466 | Kallikrein-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76467 | Kirrel1/NEPH1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76468 | Kirrel1/NEPH1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76469 | KLC2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P7647 | BAG-2, Human (His) | Recombinant Proteins | |
| HY-P76470 | KLHL2, Human (His) | Recombinant Proteins | |
| HY-P76471 | KREMEN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76474 | LOX-1/OLR1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76475 | LRP-10, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76476 | LRP-10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76477 | LRP-11, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76478 | LRPAP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76478A | LRPAP1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P76479 | LRPAP1, Mouse (HEK293, His, Solution) | Recombinant Proteins | |
| HY-P76479A | LRPAP1, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P7648 | BCAM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76480 | LRRC15, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76481 | LRRTM4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76482 | TNFSF3/Lymphotoxin Beta, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P76483 | LYPD3/C4.4A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76484 | MAGOH, Human (His) | Recombinant Proteins | |
| HY-P76485 | MAN1A2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76488 | MBL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76489 | MCP-1/CCL2, Mouse (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P7649 | BCAS2, Human (His, T7) | Recombinant Proteins | |
| HY-P76490 | MEGF10, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76491 | MEGF10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76492 | MESDC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76493 | Meteorin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76494 | MAGP-2/MFAP5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76494A | MAGP-2/MFAP5, Human (His-SUMO) | Recombinant Proteins | |
| HY-P76495 | Melanotransferrin/CD228, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76496 | Melanotransferrin/CD228, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76497 | MID1IP1, Human (His) | Recombinant Proteins | |
| HY-P76498 | MMP-26, Human | Recombinant Proteins | |
| HY-P7650 | Bcl-2-like 1, Human (His) | Recombinant Proteins | |
| HY-P76500 | MSRB3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76501 | MSRB3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76502 | MSRB3, Human (His) | Recombinant Proteins | |
| HY-P76504 | NAPG, Human (His) | Recombinant Proteins | |
| HY-P76505 | OCAM/NCAM2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76506 | OCAM/NCAM2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76507 | Nectin-2/CD112, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76508 | NEGR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76509 | NEK3, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P7651 | Bax, Human (His) | Recombinant Proteins | |
| HY-P76510 | Neuroligin-3/NLGN3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76512 | NKG2D/CD314, Human (CHO, Fc) | Recombinant Proteins | |
| HY-P76513 | NKG2D/CD314, Mouse (sf9, Fc) | Recombinant Proteins | |
| HY-P76514 | NKp46/NCR1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76515 | NLGN4X, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76517 | NLK/Nemo Like Kinase, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76519 | NOTCH2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76520 | NOV/CCN3, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P76522 | NPTXR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76523 | NRBF2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76524 | Neuregulin-4/NRG4, Human | Recombinant Proteins | |
| HY-P76525 | NUDT5, Human (His) | Recombinant Proteins | |
| HY-P76526 | NXPH1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76527 | OMGP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76528 | OBCAM/OPCML, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76529 | Osteomodulin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7653 | Bcl-2-like 2, Human (His) | Recombinant Proteins | |
| HY-P76530 | Osteomodulin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76531 | OSTM1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76532 | p38 gamma/MAPK12, Human (sf9) | Recombinant Proteins | |
| HY-P76533 | p38 gamma/MAPK12, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76534 | p53R2, Human (His) | Recombinant Proteins | |
| HY-P76536 | PCTAIRE1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76537 | PDRG1, Human (His) | Recombinant Proteins | |
| HY-P76538 | Pepsinogen C/PGC, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76539 | PF4V1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7654 | BCMA/TNFRSF17, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76540 | PFDN1, Human (His) | Recombinant Proteins | |
| HY-P76541 | PFDN1, Mouse (His) | Recombinant Proteins | |
| HY-P76542 | PFDN5, Human (His) | Recombinant Proteins | |
| HY-P76543 | PGLYRP1/PGRP-S, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76544 | PHYH, Human | Recombinant Proteins | |
| HY-P76545 | PILR-alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76546 | PIN1, Human | Recombinant Proteins | |
| HY-P76549 | PLA2G2D, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7655 | BCMA/TNFRSF17, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P76550 | PLK1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76551 | PRMT3, Human (His) | Recombinant Proteins | |
| HY-P76552 | PRTN3, Human (S203A, HEK293, His) | Recombinant Proteins | |
| HY-P76553 | PSAP/Prosaposin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76554 | PSME3, Human (His) | Recombinant Proteins | |
| HY-P76554A | PSME3, Human (N-His) | Recombinant Proteins | |
| HY-P76555 | PTP alpha/PTPRA, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76556 | PTPMT1, Human (His) | Recombinant Proteins | |
| HY-P76557 | PTPN12, Human | Recombinant Proteins | |
| HY-P76558 | PTPN12, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76559 | PTRH2, Human (His) | Recombinant Proteins | |
| HY-P7656 | BCMA/TNFRSF17, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76560 | QPCT, Human (sf9, His) | Recombinant Proteins | |
| HY-P76561 | RAB31, Human (His) | Recombinant Proteins | |
| HY-P76562 | RANK/TNFRSF11A, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76563 | RANK/TNFRSF11A, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76564 | RBKS, Human (His) | Recombinant Proteins | |
| HY-P76565 | REG-1 beta/REG1B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76566 | REG-2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76568 | REG-3 alpha/REG3A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76569 | REG-3 alpha/REG3A, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76570 | REG-3 alpha/REG3A, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76571 | REG-3 delta/REG3D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76572 | RGMA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76573 | RGMB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76574 | RPN2/Ribophorin II, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76575 | RPN2/Ribophorin II, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76576 | glycoprotein/G1, RVFV (sf9, His) | Recombinant Proteins | |
| HY-P76577 | glycoprotein/G2, RVFV (sf9, His) | Recombinant Proteins | |
| HY-P76578 | RIOK1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76579 | RIZ1, Human | Recombinant Proteins | |
| HY-P7658 | BDH1, Human (His) | Recombinant Proteins | |
| HY-P76580 | RIZ1, Human (GST) | Recombinant Proteins | |
| HY-P76581 | RPLP1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76582 | RSPO2/R-Spondin 2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76583 | S100A13, Mouse (His) | Recombinant Proteins | |
| HY-P76583A | S100A13 Protein, Mouse (N-His) | Recombinant Proteins | |
| HY-P76584 | S100A14, Human (His) | Recombinant Proteins | |
| HY-P76584A | S100A14 Protein, Human (His) | Recombinant Proteins | |
| HY-P76585 | S100A3, Human (His-MBP) | Recombinant Proteins | |
| HY-P76586 | S100A8, Human (sf9, His) | Recombinant Proteins | |
| HY-P76587 | S100A9, Human (sf9, His) | Recombinant Proteins | |
| HY-P76588 | S6K1/RPS6KB1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76589 | SARS-CoV-2 3CLpro/3C-like protease (sf9, His) | Recombinant Proteins | |
| HY-P7659 | BDH2, Human (His) | Recombinant Proteins | |
| HY-P76590 | SARS-CoV-2 3CLpro/3C-like protease (His-Avi) | Recombinant Proteins | |
| HY-P76591 | SARS-CoV-2 3CLpro/3C-like protease (sf9, His-Avi) | Recombinant Proteins | |
| HY-P76592 | SARS-CoV-2 NSP9 (His-Avi) | Recombinant Proteins | |
| HY-P76593 | SARS-CoV-2 S RBD (A348S, HEK293, His) | Recombinant Proteins | |
| HY-P76594 | SARS-CoV-2 S RBD (A372S, HEK293, His) | Recombinant Proteins | |
| HY-P76595 | SARS-CoV-2 S RBD (A475V, HEK293, His) | Recombinant Proteins | |
| HY-P76596 | SARS-CoV-2 S RBD (A520S, HEK293, His) | Recombinant Proteins | |
| HY-P76597 | SARS-CoV-2 S RBD (A520V, HEK293, His) | Recombinant Proteins | |
| HY-P76598 | SARS-CoV-2 S RBD (A522S, HEK293, His) | Recombinant Proteins | |
| HY-P76599 | SARS-CoV-2 S RBD (A522V, HEK293, His) | Recombinant Proteins | |
| HY-P7660 | Beta-NGF, Human (HEK293) | Recombinant Proteins | |
| HY-P76600 | SARS-CoV-2 S RBD (D405V, Q414A, HEK293, His) | Recombinant Proteins | |
| HY-P76601 | SARS-CoV-2 S RBD (E406Q, HEK293, His) | Recombinant Proteins | |
| HY-P76602 | SARS-CoV-2 S RBD (E471Q, HEK293, His) | Recombinant Proteins | |
| HY-P76603 | SARS-CoV-2 S RBD (F338L, HEK293, His) | Recombinant Proteins | |
| HY-P76604 | SARS-CoV-2 S RBD (F456E, HEK293, His) | Recombinant Proteins | |
| HY-P76605 | SARS-CoV-2 S RBD (F456L, HEK293, His) | Recombinant Proteins | |
| HY-P76606 | SARS-CoV-2 S RBD (F486S, HEK293, His) | Recombinant Proteins | |
| HY-P76607 | SARS-CoV-2 S RBD (F490L, HEK293, His) | Recombinant Proteins | |
| HY-P76608 | SARS-CoV-2 S RBD (F490S, HEK293, His) | Recombinant Proteins | |
| HY-P76609 | SARS-CoV-2 S RBD (G446S, HEK293, His) | Recombinant Proteins | |
| HY-P7661 | Beta-NGF, Mouse (120a.a) | Recombinant Proteins | |
| HY-P76610 | SARS-CoV-2 S RBD (G446V, HEK293, His) | Recombinant Proteins | |
| HY-P76611 | SARS-CoV-2 S RBD (G482S, HEK293, His) | Recombinant Proteins | |
| HY-P76612 | SARS-CoV-2 S RBD (K378N, HEK293, His) | Recombinant Proteins | |
| HY-P76613 | SARS-CoV-2 S RBD (K378R, HEK293, His) | Recombinant Proteins | |
| HY-P76614 | SARS-CoV-2 S RBD (L455F, HEK293, His) | Recombinant Proteins | |
| HY-P76615 | SARS-CoV-2 S RBD (N487R, HEK293, His) | Recombinant Proteins | |
| HY-P76616 | SARS-CoV-2 S RBD (P337S, HEK293, His) | Recombinant Proteins | |
| HY-P76617 | SARS-CoV-2 S RBD (P384L, HEK293, His) | Recombinant Proteins | |
| HY-P76618 | SARS-CoV-2 S RBD (P479S, HEK293, His) | Recombinant Proteins | |
| HY-P76619 | SARS-CoV-2 S RBD (P521S, HEK293, His) | Recombinant Proteins | |
| HY-P7662 | BID, Human | Recombinant Proteins | |
| HY-P76620 | SARS-CoV-2 S RBD (Q409E, HEK293, His) | Recombinant Proteins | |
| HY-P76621 | SARS-CoV-2 S RBD (R408I, HEK293, His) | Recombinant Proteins | |
| HY-P76622 | SARS-CoV-2 S RBD (S477I, HEK293, His) | Recombinant Proteins | |
| HY-P76623 | SARS-CoV-2 S RBD (S477R, HEK293, His) | Recombinant Proteins | |
| HY-P76624 | SARS-CoV-2 S RBD (S494P, HEK293, His) | Recombinant Proteins | |
| HY-P76625 | SARS-CoV-2 S RBD (T385A, HEK293, His) | Recombinant Proteins | |
| HY-P76626 | SARS-CoV-2 S RBD (T478I, HEK293, His) | Recombinant Proteins | |
| HY-P76627 | SARS-CoV-2 S RBD (V395I, HEK293, His) | Recombinant Proteins | |
| HY-P76628 | SARS-CoV-2 S RBD (V503F, HEK293, His) | Recombinant Proteins | |
| HY-P76629 | SARS-CoV-2 S1 NTD (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7663 | Biglycan, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76630 | SARS-CoV-2 S (D614G, sf9, His) | Recombinant Proteins | |
| HY-P76631 | SARS-CoV-2 S (Mutated, HEK293, His) | Recombinant Proteins | |
| HY-P76632 | SARS-CoV-2 S (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P76633 | SARS-CoV-2 S2 (HEK293, Fc) | Recombinant Proteins | |
| HY-P76634 | SCN3B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76635 | SCN3B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76636 | SDF-2, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76637 | SDPR, Mouse (His) | Recombinant Proteins | |
| HY-P76638 | L-Selectin/CD62L, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76639 | Serpin A10, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7664 | Biliverdin Reductase A/BLVRA, Human (C-His) | Recombinant Proteins | |
| HY-P76640 | Serpin B6, Human (sf9, His) | Recombinant Proteins | |
| HY-P76641 | Serpin B8, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76642 | Siglec-10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76643 | DC-SIGN/CD209, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76644 | SKP1, Human (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P76645 | SLAMF6, Human (HEK293) | Recombinant Proteins | |
| HY-P76646 | SLAMF6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76649 | SMOC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7665 | BPGM, Human (His) | Recombinant Proteins | |
| HY-P76650 | SorCS1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76651 | SPARCL1, Mouse (650a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76652 | SPARCL1, Mouse (283a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76653 | SPINK2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76654 | Testican 1/SPOCK1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76655 | Testican 3/SPOCK3, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76656 | SR-BI/SCARB1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76657 | SR-BI/SCARB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76658 | SR-BI/SCARB1, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P76659 | SRPK3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7666 | FABP7, Human (His) | Recombinant Proteins | |
| HY-P76660 | ST2/IL1RL1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76661 | ST2/IL1RL1, Mouse (332a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P76662 | ST2/IL1RL1, Mouse (332a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76663 | ST6GAL1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76664 | STAT4, Human (sf9, His) | Recombinant Proteins | |
| HY-P76665 | Statherin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76666 | SULT2B1, Human (364a.a, His) | Recombinant Proteins | |
| HY-P76667 | TARC/CCL17, Rhesus Macaque (sf9, His) | Recombinant Proteins | |
| HY-P76668 | IL-27R alpha/TCCR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76669 | TCPTP, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P7667 | BLNK, Human (His) | Recombinant Proteins | |
| HY-P76671 | Tetranectin/CLEC3B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76672 | TPO/Thrombopoietin, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76673 | TIE-2, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76674 | TIGIT, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76675 | TLE3, Human (GST) | Recombinant Proteins | |
| HY-P76676 | TLK1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76677 | TM4SF2/TSPAN7, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76678 | TMED9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76679 | TMED9, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7668 | PRCP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76680 | TMPRSS11D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76681 | TMX1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76682 | TNFAIP8, Human (His) | Recombinant Proteins | |
| HY-P76683 | TNFRII, Human (257a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76684 | TMEFF1/Tomoregulin-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76685 | TSC22/TSC22D1, Human (His) | Recombinant Proteins | |
| HY-P76686 | TSPAN31, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76687 | UBASH3A, Human (His) | Recombinant Proteins | |
| HY-P76688A | UBE2F, Human (His, Solution) | Recombinant Proteins | |
| HY-P76689 | UCHL3, Rat (His) | Recombinant Proteins | |
| HY-P7669 | BMPR-II, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76690 | ULBP4/RAET1E, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76691 | ULBP4/RAET1E, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76692 | UNC5H1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76693 | UNC5H1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76694 | VSNL1, Human | Recombinant Proteins | |
| HY-P76697 | VSIG2, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76699 | VSIG4, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P7670 | BNIP3/NIP3, Human (His) | Recombinant Proteins | |
| HY-P76700 | VTI1A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76701 | VTI1A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76702 | CHI3L1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76703 | PSMA, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76704 | 4-1BBL/TNFSF9, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76705 | 4-1BBL/TNFSF9, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76706 | ABHD10, Human (sf9, His) | Recombinant Proteins | |
| HY-P76708 | ACBD6, Human (sf9, His) | Recombinant Proteins | |
| HY-P76709 | ACBD7, Human (His) | Recombinant Proteins | |
| HY-P7671 | BOC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76710 | SMPD1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76711 | envelope glycoprotein gp64, AcmNPV (HEK293, His) | Recombinant Proteins | |
| HY-P76712 | envelope glycoprotein gp64, AcmNPV (sf9, His) | Recombinant Proteins | |
| HY-P76713 | ACPL2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76714 | ACVR1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76715 | ACVR1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P76716 | AK3L1, Human (sf9) | Recombinant Proteins | |
| HY-P76717 | AK3L1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76718 | Activin RIB/ALK-4, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76719 | Allergin-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7672 | BMPG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76720 | Alpha-2-Antiplasmin/Serpin F2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76721 | Alpha-2-Antiplasmin/Serpin F2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76722 | AMY2A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76723 | AMY2A, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76724 | AMY2A, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76725 | Amelotin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76726 | ANGPTL3/Angiopoietin-like 3, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P76727 | ANGPTL5/Angiopoietin-like 5, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76728 | AP-2 gamma/TFAP2C, Human (His) | Recombinant Proteins | |
| HY-P76729 | APEG1, Human (His) | Recombinant Proteins | |
| HY-P7673 | BST2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76730 | ARL6IP6, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76731 | ARMET/MANF, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76733 | ARP3/ACTR3, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76734 | ART1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76735 | ASAH2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76736 | ASGR2/ASGPR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76737 | AGA/Aspartylglucosaminidase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76738 | B3GALT5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76739 | B3GALT5, Human (sf9, His) | Recombinant Proteins | |
| HY-P7674 | BSP2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76740 | B3GALTL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76741 | B3GNT6, Human (sf9, His) | Recombinant Proteins | |
| HY-P76742 | B7-H6, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76743 | B7-H6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76744 | BAFFR/TNFRSF13C, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76745 | BAFFR/TNFRSF13C, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76746 | BCCIP, Human (sf9) | Recombinant Proteins | |
| HY-P76747 | BCCIP, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76748 | BLOT5, Blomia tropicalis (P.pastoris, His) | Recombinant Proteins | |
| HY-P76749 | BPIFA2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7675 | BAI3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76750 | BPIFA2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76751 | BTLA/CD272, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76752 | BTLA/CD272, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76753 | CA5A, Human (His) | Recombinant Proteins | |
| HY-P76754 | CABP5, Human (His) | Recombinant Proteins | |
| HY-P76755 | Cadherin-17, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76756 | CADM3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76757 | CADM3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76758 | CADM3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76759 | Calcineurin A/PPP3CA, Human (sf9, His) | Recombinant Proteins | |
| HY-P7676 | BCAN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76760 | CALML5, Human (His) | Recombinant Proteins | |
| HY-P76761 | CaMKII alpha/CAMK2A, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76762 | CaMKII beta/CAMK2B, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76764 | Can f 1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P76765 | Carbonic Anhydrase VIII/CA8, Mouse (His) | Recombinant Proteins | |
| HY-P76766 | CARHSP1, Human (His) | Recombinant Proteins | |
| HY-P76766A | CARHSP1 , Human | Recombinant Proteins | |
| HY-P76767 | CBFB, Human (His) | Recombinant Proteins | |
| HY-P76768 | CCDC47, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76769 | IL-2R beta/CD122, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P7677 | BIN2, Human (His) | Recombinant Proteins | |
| HY-P76771 | IL-2R beta/CD122, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76772 | IL-2R beta/CD122, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76773 | IL-2R beta/CD122, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76774 | PVR/CD155, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76775 | CD160, Rhesus Macaque (HEK293) | Recombinant Proteins | |
| HY-P76776 | ALCAM/CD166, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76777 | ALCAM/CD166, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76778 | CD1D1-B2M Heterodimer, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76779 | CD1D2-B2M Heterodimer, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7678 | BTLA/CD272, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76780 | CD200R1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76781 | CD204/MSR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76782 | CD204/MSR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76783 | CD204/MSR1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76784 | CD204/MSR1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76785 | IL-2R alpha/CD25, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P76786 | IL-2R alpha/CD25, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76787 | IL-2R alpha/CD25, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76788 | CD3 epsilon, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76789 | CD3 epsilon, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7679 | BTLA/CD272, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76791 | CD3 epsilon, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76792 | CD30/TNFRSF8, Cynomolgus (194a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76793 | CD300LF, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76795 | CD302/CLEC13A, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76796 | CD302/CLEC13A, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76797 | TCblR/CD320, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76798 | TCblR/CD320, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76799 | Fc gamma RIIB/CD32b, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7680 | BTN1A1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76800 | Fc gamma RIIB/CD32b, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76801 | CD39, Cynomolgus/Rhesus Macaque (sf9, His) | Recombinant Proteins | |
| HY-P76802 | CD3D-CD3E Heterodimer, Rhesus Macaque (hFc) | Recombinant Proteins | |
| HY-P76803 | CD3D, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76805 | CD42c/GP1BB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76806 | CD53, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76807 | CD53, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76808 | CD58, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76809 | CD59a, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7681 | BTN2A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76810 | CD63, Pig (HEK293, Fc) | Recombinant Proteins | |
| HY-P76812 | CD82, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76813 | CD99L2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76814 | CD99L2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76816 | CEACAM19, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76817 | CEACAM5, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76818 | CEP57, Human (His) | Recombinant Proteins | |
| HY-P7682 | BTN2A2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76820 | CGB7, Human (sf9, His) | Recombinant Proteins | |
| HY-P76821 | CHODL, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76822 | CHODL, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76823 | CHST5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76824A | cIAP1/BIRC2, Human (Avi) | Recombinant Proteins | |
| HY-P76825 | CK2 alpha/CSNK2A1, Mouse (sf9) | Recombinant Proteins | |
| HY-P76826 | CK2 alpha/CSNK2A1, Mouse (sf9, His-GST) | Recombinant Proteins | |
| HY-P76827 | CKMT2, Rat (His) | Recombinant Proteins | |
| HY-P76827A | CKMT2, Rat (His, Solution) | Recombinant Proteins | |
| HY-P76828 | CLEC14A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76829 | CLEC14A, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7683 | BTN3A1/CD277, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76830 | CLEC2B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76831 | OCIL/CLEC2D, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76832 | CLEC3A, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P76833 | CD367/CLEC4A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76834 | CLEC4D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76835 | CLEC4D, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76836 | CLEC4D, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76837 | CNDP2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76838 | CNKSR3, Human (sf9, GST) | Recombinant Proteins | |
| HY-P76839 | CNPY2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7684 | BTN3A2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76840 | PRAT4B/CNPY4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76841 | CNTN5/Contactin-5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76842 | CNTN5/Contactin-5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76843 | COASY, Human (His) | Recombinant Proteins | |
| HY-P76844 | COL4A3BP, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76845 | CL-L1/COLEC10, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76846 | COMMD9, Human (His) | Recombinant Proteins | |
| HY-P76847 | COPZ1, Human/Mouse/Rat (His) | Recombinant Proteins | |
| HY-P76848 | CPLX3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76849 | CSAG1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7685 | BTN3A3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76850 | CSNK1G1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76851 | Cystatin-8/CST8, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76852 | CTRB1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P76853 | PF-4/CXCL4, Human | Recombinant Proteins | |
| HY-P76854 | CXCL7, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76855 | CXCL7, Cynomolgus/Rhesus Macaque (P.pastoris, His) | Recombinant Proteins | |
| HY-P76856 | CYB5R1, Human (His) | Recombinant Proteins | |
| HY-P76857 | CD19, Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76858 | DAPK1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76859 | DCBLD1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7686 | BTNL2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76860 | TNFRSF10C, Human (210a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76863 | TRAILR4/TNFRSF10D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76864 | TRAILR4/TNFRSF10D, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76865 | TRAILR4/TNFRSF10D, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76866 | DCUN1D2, Human (His) | Recombinant Proteins | |
| HY-P76867 | DDR2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76868 | DDR2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76869 | DDR2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7687 | BTNL9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76870 | DEFA3/Defensin alpha 3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76871 | DHRS9, Human (His) | Recombinant Proteins | |
| HY-P76872 | Delta-like 4/DLL4, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76873 | DNAJC30, Human (His) | Recombinant Proteins | |
| HY-P76874 | Dopamine beta-Hydroxylase, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76875 | CD26/Dipeptidyl Peptidase 4, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P76876 | CD26/Dipeptidyl Peptidase 4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76877 | CD26/Dipeptidyl Peptidase 4, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76878 | Draxin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76879 | Nucleoprotein/NP, DcCoV (sf9, His) | Recombinant Proteins | |
| HY-P7688 | BUP-1, Human (His) | Recombinant Proteins | |
| HY-P76880 | DYDC2, Human (His) | Recombinant Proteins | |
| HY-P76881 | EBAG9, Human (His) | Recombinant Proteins | |
| HY-P76882 | Ebola virus Glycoprotein/GP-RBD (ACI28624, HEK293, Fc) | Recombinant Proteins | |
| HY-P76884 | Ebola virus Glycoprotein/GP1 (Q7T9D9, sf9, His) | Recombinant Proteins | |
| HY-P76885 | Ebola virus Glycoprotein/GP1 (Q7T9D9, HEK293, His) | Recombinant Proteins | |
| HY-P76886 | Ebola virus Glycoprotein/GP RBD (Q7T9D9, HEK293, Fc) | Recombinant Proteins | |
| HY-P76887 | Ebola virus Glycoprotein/GP1 (AHX24649, sf9, His) | Recombinant Proteins | |
| HY-P76888 | Ebola virus Glycoprotein/GP RBD (AHX24649, HEK293, Fc) | Recombinant Proteins | |
| HY-P76889 | Ebola virus Glycoprotein/GP RBD (AHX24649, HEK293, His) | Recombinant Proteins | |
| HY-P7689 | BTN1A1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76890 | Ebola virus Glycoprotein/GP2 (AHX24649, HEK293, Fc) | Recombinant Proteins | |
| HY-P76891 | Ebola virus VP40/Matrix VP40 (AHX24648, His) | Recombinant Proteins | |
| HY-P76892 | Ebola virus Glycoprotein/GP RBD (Q05320, HEK293, Fc) | Recombinant Proteins | |
| HY-P76893 | Ebola virus Glycoprotein/GP RBD (AAC54887, HEK293) | Recombinant Proteins | |
| HY-P76894 | Ebola virus Glycoprotein/GP RBD (Q05320, HEK293, His) | Recombinant Proteins | |
| HY-P76895 | EDAR, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76896 | EDAR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76897 | EDEM2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76898 | EEF1B2, Human (His) | Recombinant Proteins | |
| HY-P7690 | Butyrylcholinesterase/BCHE, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76901 | EIF3K, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76902 | ENPP-7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76903 | CD39L1/ENTPD2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76904 | ENTPD3, Human (sf9, His) | Recombinant Proteins | |
| HY-P76905 | ENTPD5, Human (sf9, His) | Recombinant Proteins | |
| HY-P76906 | EPCR, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76907 | EPCR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76908 | EphA4, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76909 | EphA4, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7691 | CD93/C1qR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76910 | Ephrin-A2/EFNA2, Mouse (HEK293) | Recombinant Proteins | |
| HY-P76911 | Ephrin-A2/EFNA2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76912 | Ephrin-A2/EFNA2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76913 | FAM171B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76914 | FAM171B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76915 | FACA/FANCA, Human (sf9, His) | Recombinant Proteins | |
| HY-P76916 | FcgR4/CD16-2, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P76917 | FcgR4/CD16-2, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P76918 | FcgR4/CD16-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76919 | FCGRT-B2M Heterodimer, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7692 | HABP1/C1QBP, Human (His) | Recombinant Proteins | |
| HY-P76920 | FCGRT-B2M Heterodimer, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76921 | FCGRT-B2M Heterodimer, Cynomolgus (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P76923 | FCRL1, Mouse (Q8R4Y0-2, HEK293, His) | Recombinant Proteins | |
| HY-P76924 | FCRL2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76924A | FCRL2, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P76925 | FGF-12, Canine | Recombinant Proteins | |
| HY-P76926 | FGFBP3, Human (sf9, His) | Recombinant Proteins | |
| HY-P76927 | FGFR1OP, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76928 | FGFR-4, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76929 | FGFR-4, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7693 | C1QTNF1/CTRP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76930 | Ficolin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76931 | FKBP14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76932 | FKBP7, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76934 | FLRT2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76935 | FNDC4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76936 | FOLR1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76937 | FOLR1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P76938 | Fractalkine/CX3CL1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76939 | Fractalkine/CX3CL1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7694 | PRADC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76940 | FUOM/Fucose Mutarotase, Human (His) | Recombinant Proteins | |
| HY-P76941 | FUT10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76942 | GABARAP, Human (His-MBP) | Recombinant Proteins | |
| HY-P76943 | Galectin-8/LGALS8, Rat (GST) | Recombinant Proteins | |
| HY-P76943A | Galectin-8/LGALS8, Rat (His) | Recombinant Proteins | |
| HY-P76944 | GCAP1, Human (sf9) | Recombinant Proteins | |
| HY-P76945 | GCAP1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76946 | MAP4K2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76947 | GFOD2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76948 | GFRA1/GDNFR-alpha-1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76949 | GFRA1/GDNFR-alpha-1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7695 | Complement C5/C5a, Mouse | Recombinant Proteins | |
| HY-P76950 | GFRA2/GDNFR-alpha-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76951 | GFRA3/GDNFR-alpha-3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76952 | GFRA3/GDNFR-alpha-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76953 | GGH/Glutamyl hydrolase gamma, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76954 | GLT25D2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76955 | GLT8D2, Human (sf9, His) | Recombinant Proteins | |
| HY-P76956 | Glycophorin C/GYPC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76958 | GPHA2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76959 | GPHA2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7695A | Complement C5/C5a, Mouse (His) | Recombinant Proteins | |
| HY-P7696 | CA125, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76960 | GPR114, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76961 | GPR133, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76962 | HAAO, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P76963 | HAAO, Rat (His) | Recombinant Proteins | |
| HY-P76964 | HAI-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76965 | Nucleocapsid/NP, HTNV (sf9, His) | Recombinant Proteins | |
| HY-P76966 | USH1C, Human (His) | Recombinant Proteins | |
| HY-P76967 | HER3, Rhesus Macaque (HEK293) | Recombinant Proteins | |
| HY-P76968 | HER3, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76969 | HER3, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7697 | Cadherin-1/CD324, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76970 | HHLA2 Protein, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P76971 | HHLA2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76972 | Gag-Pol polyprotein, HIV (440a.a, His) | Recombinant Proteins | |
| HY-P76973 | Gag-Pol polyprotein, HIV (560a.a, His) | Recombinant Proteins | |
| HY-P76974 | HS3ST1, Human (sf9, His) | Recombinant Proteins | |
| HY-P76975 | HSD17B14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76976 | HCoV-229E Nucleoprotein/NP (NP_073556, His) | Recombinant Proteins | |
| HY-P76977 | Nucleoprotein/NP, HCoV (YP_173242, His) | Recombinant Proteins | |
| HY-P76978 | HCoV-NL63 Spike/S1 (HEK293, His) | Recombinant Proteins | |
| HY-P76979 | HCoV-OC43 Spike/S1 (HEK293, His) | Recombinant Proteins | |
| HY-P7698 | Cadherin-11, Human (HEK293, His) | Recombinant Proteins | |
| HY-P76980 | HCMV Glycoprotein B/gB (676a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P76981 | HIV-1 gp140 (646a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P76983 | IFN-alpha 4/IFNA4, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P76984 | CD316/IGSF8, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76985 | CD316/IGSF8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P76986 | IKB beta/NFKBIB, Human (His) | Recombinant Proteins | |
| HY-P76987 | IL-10R alpha, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76988 | IL-10R alpha, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76989 | IL-13R alpha 2, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P7699 | Cadherin-17, Human (765a.a, HEK293, His) | Recombinant Proteins | |
| HY-P76990 | IL-13R alpha 2, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P76991 | IL-17RA, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P76992 | IL-17RA, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P76993 | IL-18R alpha, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P76994 | IL-18R alpha, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76995 | IL-1R1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P76996 | IL-1R1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P76997 | IL-1R2, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P76998 | IL1RAPL1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P76999 | IL-20R beta Protein, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7700 | Cadherin-3, Human (630a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77000 | IL-20R beta, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77001 | IL-22R alpha 1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77002 | IL-22R alpha 1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77003 | IL-24, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77004 | IL-24, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77005 | IFN-lambda 2/IL-28A, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P77006 | IL-31, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77007 | IL-36RN, Mouse | Recombinant Proteins | |
| HY-P77009 | IL-4R, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P7701 | Cadherin-3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77010 | IL-4R, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77011 | CD127/IL-7RA, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77012 | CD127/IL-7RA, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77013 | HA/Hemagglutinin, H11N2 (AAY85533, sf9, His) | Recombinant Proteins | |
| HY-P77014 | HA/Hemagglutinin, H11N2 (AAY85533, HEK293, His) | Recombinant Proteins | |
| HY-P77015 | HA/Hemagglutinin, H11N2 (ADD21478, sf9, His) | Recombinant Proteins | |
| HY-P77016 | HA/Hemagglutinin, H11N9 (ABB87228, HEK293, His) | Recombinant Proteins | |
| HY-P77017 | HA1/Hemagglutinin, H11N9 (ABB87228, HEK293, His) | Recombinant Proteins | |
| HY-P77018 | HA/Hemagglutinin, H12N1 (ABB88099, HEK293, His) | Recombinant Proteins | |
| HY-P77019 | HA/Hemagglutinin, H12N1 (ABB88099, sf9, His) | Recombinant Proteins | |
| HY-P7702 | Cadherin-6/KCAD, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77020 | HA/Hemagglutinin, H14N5 (P26136, sf9, His) | Recombinant Proteins | |
| HY-P77021 | HA/Hemagglutinin, H15N2 (ABB90704, sf9, His) | Recombinant Proteins | |
| HY-P77022 | HA/Hemagglutinin, H15N8 (ABB88132, HEK293, His) | Recombinant Proteins | |
| HY-P77023 | HA/Hemagglutinin, H17N10 (AFC35418, sf9, His) | Recombinant Proteins | |
| HY-P77024 | HA1/Hemagglutinin, H17N10 (AFC35418, HEK293, His) | Recombinant Proteins | |
| HY-P77025 | HA/Hemagglutinin, H1N1 (Biotinylated, ACP41105.1, sf9) | Recombinant Proteins | |
| HY-P77026 | HA/Hemagglutinin, H3N2 (ACN50256, sf9) | Recombinant Proteins | |
| HY-P77027 | HA/Hemagglutinin, H3N2 (ACS71642, sf9) | Recombinant Proteins | |
| HY-P77028 | HA/Hemagglutinin, H3N2 (EPI541659, sf9) | Recombinant Proteins | |
| HY-P77029 | HA/Hemagglutinin, H4N4 (ABB87495, sf9, His) | Recombinant Proteins | |
| HY-P7703 | Cadherin-6/KCAD, Human (594a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77031 | HA/Hemagglutinin, H6N4 (CAC84244, sf9, His) | Recombinant Proteins | |
| HY-P77032 | HA/Hemagglutinin, H6N4 (CAC84244, HEK293, His) | Recombinant Proteins | |
| HY-P77033 | HA/Hemagglutinin, H8N4 (ABB87729, sf9, His) | Recombinant Proteins | |
| HY-P77034 | HA/Hemagglutinin, H8N4 (ABB87729, HEK293, His) | Recombinant Proteins | |
| HY-P77035 | IZUMO1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77037 | Cadherin-6/KCAD, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77038 | Cadherin-6/KCAD, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77039 | KIAA1279, Human (sf9) | Recombinant Proteins | |
| HY-P7704 | Cadherin-8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77040 | KIAA1279, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77041 | KIR2DL5/CD158f, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77042 | KIR3DL3/CD158z, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77043 | KIRREL2/NEPH3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77044 | KIRREL2/NEPH3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77045 | KIRREL3/NEPH2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77046 | KIRREL3/NEPH2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77047 | Kallikrein-15, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77048 | Kallikrein-15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77048A | Kallikrein-15, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7705 | Calcineurin B, Human (His) | Recombinant Proteins | |
| HY-P77050 | LAIR2, Human (HEK293) | Recombinant Proteins | |
| HY-P77053 | LAMTOR2, Human (His) | Recombinant Proteins | |
| HY-P77054 | Layilin/LAYN, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77055 | Layilin/LAYN, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77056 | LCN8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77057 | LDLRAD3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77057A | LDLRAD3 , Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P77058 | LIFR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77059 | LIFR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7706 | CALCB, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P77060 | LIFR, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77061 | LIFR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77062 | LILRA5/CD85f, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77063 | LILRA5/CD85f, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77064 | LILRB3/CD85a, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77064A | LILRB3/CD85a, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P77065 | Livin/BIRC7, Human (His) | Recombinant Proteins | |
| HY-P77066 | LPAL2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77067 | LRRN3/NLRR-3, Human (sf9, His) | Recombinant Proteins | |
| HY-P77068 | LRRTM3, Mouse (CHO, His) | Recombinant Proteins | |
| HY-P77069 | LRRTM4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7707 | Calcitonin/CALCA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77070 | LYG1, Human (sf9, His) | Recombinant Proteins | |
| HY-P77071 | Lymphotactin/XCL1, Canine (sf9, His) | Recombinant Proteins | |
| HY-P77072 | Lymphotactin/XCL1, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P77073 | Neuraminidase, M.viridifaciens (His) | Recombinant Proteins | |
| HY-P77074 | MAB21L2, Human (His) | Recombinant Proteins | |
| HY-P77075 | Glycoprotein B/gB, CyCMV (HEK293, Fc) | Recombinant Proteins | |
| HY-P77076 | SCGB2A1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77077 | Marapsin/Pancreasin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77078 | Mast Cell Protease-1/MCPT-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77079 | MBL1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P7708 | Calcitonin/CALCA, Human (His, solution) | Recombinant Proteins | |
| HY-P77080 | MCEMP1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77081 | MD-2/LY96, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77082 | MDGA2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77083 | Meprin alpha/MEP1A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77084 | Meprin alpha/MEP1A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77085 | MFAP3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77086 | MIG/CXCL9, Rhesus Macaque | Recombinant Proteins | |
| HY-P77087 | MMGT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77088 | MPIF-1/CCL23, Human (P.pastoris, His) | Recombinant Proteins | |
| HY-P77089 | MPIF-1/CCL23, Human (His) | Recombinant Proteins | |
| HY-P7708A | Calcitonin/CALCA, Human (His) | Recombinant Proteins | |
| HY-P7709 | Calmegin/CLGN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77090 | MRPL44, Human (sf9, His) | Recombinant Proteins | |
| HY-P77091 | MUCL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77092 | Syntaxin-BP1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77093 | MUSTN1, Human (His) | Recombinant Proteins | |
| HY-P77094 | MZB1/PERP1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77095 | MZB1/PERP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77096 | NAA10/ARD1, Human (sf9) | Recombinant Proteins | |
| HY-P77097 | NAA10/ARD1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77098 | NAALADL1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77099 | NCKIPSD, Human (His) | Recombinant Proteins | |
| HY-P7710 | Calmodulin, Human | Recombinant Proteins | |
| HY-P77100 | NGFR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77101 | NGFR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77102 | NGL-1/LRRC4C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77103 | NGL-1/LRRC4C, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77104 | Ninjurin-1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77105 | NKG2A, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77106 | NKp30/NCR3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77107 | NOTCH2NL, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77108 | NUDT2, Human (His) | Recombinant Proteins | |
| HY-P77109 | NUP210, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7711 | Calnexin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77110 | NXPH1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77111 | OBP2B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77112 | OBP2B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77114 | OBCAM/OPCML, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77115 | OBCAM/OPCML, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77116 | GPNMB/Osteoactivin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77117 | OSTM1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77118 | OTUB2, Human (His) | Recombinant Proteins | |
| HY-P77119 | OXSR1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P7712 | Calreticulin-3/CALR3, Human | Recombinant Proteins | |
| HY-P77120 | ADCYAP1R1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77120A | ADCYAP1R1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P77122 | PBK/TOPK, Human (sf9, His) | Recombinant Proteins | |
| HY-P77123 | PDGF R beta, Human (HEK293, C-His-Avi) | Recombinant Proteins | |
| HY-P77124 | PDGF R beta, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77127 | PDGF R beta, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77128 | PDGF R beta, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77129 | PDGF R beta, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7713 | Calumenin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77130 | PDZD11, Human (His) | Recombinant Proteins | |
| HY-P77131 | Pepsinogen C/PGC, Human (His) | Recombinant Proteins | |
| HY-P77132 | Pepsinogen C/PGC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77133 | PEX11A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77134 | PfLDH, P. falciparum (His) | Recombinant Proteins | |
| HY-P77135 | Pepsinogen A4/PGA4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77136 | Pepsinogen A4/PGA4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77137 | PGLYRP4/PGRP-I beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77138 | PLA2G2E, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77139 | PIK3IP1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7714 | CAMKI alpha/CAMK1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77140 | PILR-alpha, Human (HEK293) | Recombinant Proteins | |
| HY-P77141 | PILR-alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77142 | PILR-alpha, Human (178a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77143 | PILR-beta, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77144 | PLA2G12B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77145 | PLAC9, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77147 | Placental Lactogen/CSH1, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77148 | PLBD2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77149 | PLRP2, Human (sf9, His) | Recombinant Proteins | |
| HY-P7715 | CAMKI delta/CAMK1D, Human (GST) | Recombinant Proteins | |
| HY-P77151 | PPIL2, Human (His) | Recombinant Proteins | |
| HY-P77153 | Prostasin/PRSS8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77154 | Prostasin/PRSS8, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P77155 | Prostasin/PRSS8, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77156 | PRPS2, Human (His) | Recombinant Proteins | |
| HY-P77157 | PRRG2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77158 | PRTFDC1, Human (His) | Recombinant Proteins | |
| HY-P77159 | PSAP/Prosaposin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7716 | Carbonic Anhydrase 12, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77160 | PSAP/Prosaposin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77161 | PSG6, Human (sf9, His) | Recombinant Proteins | |
| HY-P77162 | CD162/PSGL-1, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P77163 | CD162/PSGL-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77164 | CD162/PSGL-1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P77165 | CD162/PSGL-1, Mouse (HEK293) | Recombinant Proteins | |
| HY-P77167 | PTK9, Human | Recombinant Proteins | |
| HY-P77168 | PTK9, Human (His-GST) | Recombinant Proteins | |
| HY-P77169 | PTP4A2, Human (GST) | Recombinant Proteins | |
| HY-P7717 | Carbonic Anhydrase 4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77170 | PTP-MEG2/PTPN9, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77171 | RBP4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77172 | R-Cadherin/CDH4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77173 | REG1A, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77174 | REG4, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77175 | REG4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77176 | RLN1/Relaxin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77177 | RCN3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77178 | RGMB, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77179 | RKIP/PEBP1, Human | Recombinant Proteins | |
| HY-P7718 | Carbonic Anhydrase 1, Human (His) | Recombinant Proteins | |
| HY-P77180 | RON/MSPR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77180A | RON/MSPR, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P77181 | RP105/CD180, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77182 | RP105/CD180, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77183 | RP105/CD180, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77186 | SARS-CoV-2 S RBD (G476S, HEK293, His) | Recombinant Proteins | |
| HY-P77187 | SARS-CoV-2 S RBD (N370S, HEK293, His) | Recombinant Proteins | |
| HY-P77188 | SARS-CoV-2 S RBD (S477N, HEK293, His) | Recombinant Proteins | |
| HY-P77189 | SARS-CoV-2 S RBD (Y453F, HEK293, His) | Recombinant Proteins | |
| HY-P7718A | Carbonic Anhydrase 1, Human (C-His) | Recombinant Proteins | |
| HY-P7719 | Carbonic Anhydrase 3, Human (His) | Recombinant Proteins | |
| HY-P77190 | SARS-CoV-2 S RBD (Y505C, HEK293, His) | Recombinant Proteins | |
| HY-P77191 | SARS-CoV-2 S1 (Biotinylated, HEK293, Avi-His) | Recombinant Proteins | |
| HY-P77192 | HIN-1/SCGB3A1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77194 | Semaphorin-4D/SEMA4D, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77195 | Serpin A3C, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77196 | SERPINB10, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P77197 | Serpin B12, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P77198 | Serpin B4, Human (sf9, His) | Recombinant Proteins | |
| HY-P77199 | Serpin D1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7720 | Carbonic Anhydrase 4, Human (His) | Recombinant Proteins | |
| HY-P77200 | SEZ6L2/BSRP-A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77202 | CRACC/SLAMF7, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P77203 | CRACC/SLAMF7, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77205 | CRACC/SLAMF7, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77206 | SLC27A4/FATP4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77207 | SLITRK4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77208 | SLITRK6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77209 | SMPDL3A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7721 | Carbonic Anhydrase 5B, Human (His) | Recombinant Proteins | |
| HY-P77210 | Sorcin/SRI, Human (sf9) | Recombinant Proteins | |
| HY-P77211 | Sorcin/SRI, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77212 | SPG21, Human (sf9, His) | Recombinant Proteins | |
| HY-P77213 | SPG21, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P77214 | SPG3A/ATL1, Human (sf9, His) | Recombinant Proteins | |
| HY-P77215 | SRFBP1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77216 | Stomatin/STOM, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77217 | SUSD4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77218 | SUV420H2, Human (His) | Recombinant Proteins | |
| HY-P77219 | Syndecan-1/CD138, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P7722 | Carbonic Anhydrase 7, Human (His) | Recombinant Proteins | |
| HY-P77220 | T Plastin/PLS3, Human (His) | Recombinant Proteins | |
| HY-P77221 | TAFA2/FAM19A2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77222 | TAOK3, Human (sf9, His) | Recombinant Proteins | |
| HY-P77223 | IL-27R alpha/TCCR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77224 | TCTP/TPT1, Human (His) | Recombinant Proteins | |
| HY-P77225 | TECTB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77226 | TEM8/ANTXR1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77227 | TFPI, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77228 | TFPI, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77229 | TGFBR2/TGF-beta RII, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7723 | Carbonic Anhydrase 8, Human (His) | Recombinant Proteins | |
| HY-P77230 | THOP1, Mouse (sf9, His) | Recombinant Proteins | |
| HY-P77231 | THSD1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77232 | TIE-2, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77235 | TIGIT, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P77236 | TIM-4/TIMD-4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77238 | TM2D1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7724 | Carbonic Anhydrase 10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77240 | TMED1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77241 | TMED1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77242 | TMED4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77243 | TMED4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77244 | TMEM156, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77245 | TMEM25, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77246 | Collectrin/TMEM27, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77247 | TMIGD1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77248 | TMIGD1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77249 | TMIGD2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7725 | Carbonic Anhydrase 10, Human (His) | Recombinant Proteins | |
| HY-P77250 | TMP21/p23, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77251 | TMUB2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77252 | TMEFF1/Tomoregulin-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77253 | TPPP2, Human (His) | Recombinant Proteins | |
| HY-P77254 | TPPP3, Human (His) | Recombinant Proteins | |
| HY-P77255 | TPST1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77256 | TRAIL/TNFSF10, Rhesus Macaque | Recombinant Proteins | |
| HY-P77257 | Transglutaminase 3/TGM3, Human (sf9, His) | Recombinant Proteins | |
| HY-P77258 | TRXR1/TXNRD1, Human (His) | Recombinant Proteins | |
| HY-P77258A | TRXR1/TXNRD1, Human (N-His) | Recombinant Proteins | |
| HY-P77259 | TSC22/TSC22D1, Mouse (His) | Recombinant Proteins | |
| HY-P7726 | Carbonic Anhydrase 13, Human (His) | Recombinant Proteins | |
| HY-P77260 | TSPAN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77261 | TSPAN1, Human (HEK293, rFc) | Recombinant Proteins | |
| HY-P77262 | TSPAN1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77263 | TWEAK/TNFSF12, Human/Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77264 | TWEAK/TNFSF12, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77265 | TWEAK/TNFSF12, Mouse (HEK293, rFc) | Recombinant Proteins | |
| HY-P77266 | TWEAK/TNFSF12, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77267 | TWSG1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77268 | TXNDC17, Human | Recombinant Proteins | |
| HY-P77269 | TXNL4A, Human (His) | Recombinant Proteins | |
| HY-P77270 | TXNL4B, Human (His) | Recombinant Proteins | |
| HY-P77271 | UBE2G1, Human | Recombinant Proteins | |
| HY-P77272 | UBE2W, Human (His) | Recombinant Proteins | |
| HY-P77273 | UMP-CMP kinase/CMPK1, Human (sf9, His, solution) | Recombinant Proteins | |
| HY-P77273A | UMP-CMP kinase/CMPK1, Human (sf9, His) | Recombinant Proteins | |
| HY-P77275 | uPAR, Mouse (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P77276 | uPAR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77277 | USP46, Human/Mouse (sf9) | Recombinant Proteins | |
| HY-P77278 | USP46, Human/Mouse (sf9, SUMO) | Recombinant Proteins | |
| HY-P77279 | VEGF183, Human (sf9) | Recombinant Proteins | |
| HY-P7728 | Carbonic Anhydrase 14, Mouse (His) | Recombinant Proteins | |
| HY-P77280 | VMO1, Human (HEK293) | Recombinant Proteins | |
| HY-P77281 | VMO1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77282 | VSTM1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77285 | ZG16, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77286 | DAPK3/ZIPK, Human (sf9, GST) | Recombinant Proteins | |
| HY-P77287 | 4-1BBL/TNFSF9, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77288 | 4-1BBL/TNFSF9, Cynomolgus (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77289 | ACVR1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P7729 | Carbonic Anhydrase 11, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77290 | ACVR2B, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P77291 | ACVR2B, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77292 | ACVR2B, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77293 | ADAM8, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77294 | Activin RIB/ALK-4, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77295 | ANGPTL1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P77296 | ARMET/MANF, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77297 | ART4/CD297, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77298 | ART4/CD297, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77299 | ART4/CD297, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7730 | Carboxylesterase 1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77300 | ART4/CD297, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77301 | ART4/CD297, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77302 | AspF9, Neosartorya fumigata (HEK293, His) | Recombinant Proteins | |
| HY-P77303 | Betacellulin/BTC, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77304 | BLOT1, Blomia tropicalis (P.pastoris, His) | Recombinant Proteins | |
| HY-P77305 | BLOT2, Blomia tropicalis (HEK293, His) | Recombinant Proteins | |
| HY-P77306 | Blot21, Blomia tropicalis (His) | Recombinant Proteins | |
| HY-P77307 | Blot21, Blomia tropicalis (HEK293, His) | Recombinant Proteins | |
| HY-P77308 | ABL1, Human (sf9, GST) | Recombinant Proteins | |
| HY-P77309 | Cadherin-17, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P7731 | Carboxylesterase 5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77310 | Can f 4, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P77311 | CCDC47, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77312 | Fc gamma RIII/CD16, Rhesus Macaque (His-Avi) | Recombinant Proteins | |
| HY-P77313 | Fc gamma RIII/CD16, Rhesus Macaque (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77314 | Fc gamma RIII/CD16, Rhesus Macaque (His) | Recombinant Proteins | |
| HY-P77315 | CD164, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77316 | CD1E-B2M Heterodimer, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77317 | CD200R4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77318 | CD200R4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77319 | CD200R1L, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7732 | Carboxypeptidase A1/CPA1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77320 | CD3 epsilon, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P77321 | CD30L, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77322 | CD30L, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77323 | CD42c/GP1BB, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77324 | CD64, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P77325 | CD84/SLAMF5, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77326 | CD84/SLAMF5, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77329 | Cadherin-18, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7733 | Carboxypeptidase A2/CPA2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77330 | CEACAM6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77331 | CKAP1/TBCB, Human (His) | Recombinant Proteins | |
| HY-P77332 | CD367/CLEC4A, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77333 | CLEC4A3, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77334 | CLEC4A3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77335 | CLEC4B2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77336 | CLEC4E, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77336A | CLEC4E, Rhesus Macaque (HEK293, N-hFc) | Recombinant Proteins | |
| HY-P77337 | CLEC5A/MDL-1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77338 | CLEC5A/MDL-1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77339 | CNPY4/PRAT4B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7734 | Carboxypeptidase B1/CPB1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77340 | CL-L1/COLEC10, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77341 | CL-P1/COLEC12, Rhesus Macaque (sf9, His) | Recombinant Proteins | |
| HY-P77342 | COX4NB, Human (His) | Recombinant Proteins | |
| HY-P77343 | CST9L, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77344 | CSTL1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77345 | CTLA-4, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77347 | PD-L1, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77348 | PD-L1, Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7735 | Carboxypeptidase B2/CPB2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77350 | DEFB127, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77351 | DERP5, Dermatophagoides pteronyssinus (His) | Recombinant Proteins | |
| HY-P77352 | DR6/TNFRSF21, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77353 | EDA2R/XEDAR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77354 | EDA2R/XEDAR, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77355 | EFNB2A, zebrafish (HEK293, Fc) | Recombinant Proteins | |
| HY-P77356 | EFNB2A, zebrafish (HEK293, His) | Recombinant Proteins | |
| HY-P77357 | ENPP-3, Rhesus Macaque (sf9, His) | Recombinant Proteins | |
| HY-P77358 | ENPP-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77359 | EphB1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7736 | Carboxypeptidase E/CPE, Human (HEK293 His) | Recombinant Proteins | |
| HY-P77360 | EphB1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77361 | EphB6, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77363 | FCAMR/CD351, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77365 | FGF-14, Canine | Recombinant Proteins | |
| HY-P77366 | FGL1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77367 | FGL1, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P77368 | Ficolin-1, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7737 | Carboxypeptidase M/CPM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77370 | IFITM3/Fragilis, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77371 | GFRA1/GDNFR-alpha-1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P77372 | GFRA3/GDNFR-alpha-3, Human (HEK293, His-Fc) | Recombinant Proteins | |
| HY-P77373 | GFRA3/GDNFR-alpha-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77374 | gp130/IL6ST, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77375 | gp130/IL6ST, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77376 | HEMK2, Human (His) | Recombinant Proteins | |
| HY-P77377 | Hemojuvelin, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P77378 | HEPACAM2, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77379 | HEPACAM2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7738 | Carboxypeptidase M/CPM, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77380 | HPRG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77381 | HPRG, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77382 | Nucleoprotein/NP, HCoV-NL63 (His) | Recombinant Proteins | |
| HY-P77383 | HCoV-NL63 Spike/S (APF29071, sf9, His) | Recombinant Proteins | |
| HY-P77384 | HCoV-OC43 Hemagglutinin esterase (HEK293, His) | Recombinant Proteins | |
| HY-P77385 | HCoV-OC43 Nucleoprotein/NP (His) | Recombinant Proteins | |
| HY-P77386 | HCoV-HKU1 Spike (Q0ZME7, sf9, His) | Recombinant Proteins | |
| HY-P77387 | HCoV-HKU1 Spike/S1 (Q0ZME7, HEK293, His) | Recombinant Proteins | |
| HY-P77388 | Encapsidation IVa2, HAdV-B (sf9, His) | Recombinant Proteins | |
| HY-P77389 | Hemagglutinin-neuraminidase, HPIV-4b (sf9, His) | Recombinant Proteins | |
| HY-P7739 | Cardiotrophin-1/CTF1, Human (His) | Recombinant Proteins | |
| HY-P77390 | IFN-alpha 14/IFNA14, Rhesus Macaque (P.pastoris, His) | Recombinant Proteins | |
| HY-P77391 | IFN-alpha 4/IFNA4, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77392 | IFN-alpha/beta R2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77393 | IGFBP-4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77394 | IGFBP-5, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77395 | IGFL2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77395A | IGFL2, Human (HEK293, N-hFc) | Recombinant Proteins | |
| HY-P77396 | IGFLR1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77397 | IL-11R alpha, Canine (HEK293) | Recombinant Proteins | |
| HY-P77398 | IL-11R alpha, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P77399 | IL-11R alpha, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P7740 | Carnosine Dipeptidase 1/CNDP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77400 | IL-11R alpha, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77401 | IL-12 alpha, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77402 | IL-12 beta, Marmoset (HEK293, Fc) | Recombinant Proteins | |
| HY-P77403 | IL-13R alpha 1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77404 | IL-17RB, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77405 | IL-17RB, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77406 | IL-18R alpha, Rhesus macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77407 | IL-18R alpha, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77408 | IL-18RAP, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77409 | IL-18RAP, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7741 | Casein Kinase I gamma-2, Human (His) | Recombinant Proteins | |
| HY-P77410 | IL-1R2, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77411 | IL-1RAcP/IL-1 R3, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77412 | IL-1RAcP/IL-1 R3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77413 | IL-1RAcP/IL-1 R3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77417 | IL-1RAcP/IL-1 R3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77419 | IL-20R alpha, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7742 | Caspase-10/CASP10, Human (His) | Recombinant Proteins | |
| HY-P77421 | IL-20R beta, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77422 | IL-20R beta, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77423 | IL-22R alpha 1, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P77424 | IL-22R alpha 1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P77425 | CD127/IL-7RA, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77426 | HA/Hemagglutinin Protein, H5N1 (R339G, S341R, sf9, His) | Recombinant Proteins | |
| HY-P77427 | IP6K1/IHPK1, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77429 | K-Cadherin/CDH6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7743 | Caspase-14/CASP14, Human (His) | Recombinant Proteins | |
| HY-P77430 | KCT2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77431 | Kallikrein-4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77432 | Klrb1a, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77433 | FGFBP2, Human (sf9, His) | Recombinant Proteins | |
| HY-P77434 | LAMP2/CD107b, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77435 | LAMP3/CD208, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77436 | LAMP3/CD208, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77437 | Langerin/CD207, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77438 | Legumain, Pig (416a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7744 | Catalase, Human | Recombinant Proteins | |
| HY-P77440 | LILRA1/LIR-6/CD85i, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77441 | LILRA4/ILT-7/CD85g, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77443 | LILRB5/CD85c/LIR-8, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77444 | PLA2G7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77445 | TNFRSF3/LTBR, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77447 | METTL11A, Human | Recombinant Proteins | |
| HY-P77448 | METTL11A, Human (GST) | Recombinant Proteins | |
| HY-P77449 | MOB4A/MOB1B, Human (His) | Recombinant Proteins | |
| HY-P7744A | Catalase, Human (His) | Recombinant Proteins | |
| HY-P7745 | Cathepsin A, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P77450 | NAALADL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77452 | NKp30/NCR3, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77453 | NKp80/KLRF1, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77454 | NOV/CCN3, Rhesus Macaque (sf9, His) | Recombinant Proteins | |
| HY-P77455 | NT5C3A/NT5C3, Human | Recombinant Proteins | |
| HY-P77457 | OX40 Ligand/TNFSF4, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77458 | OX40 Ligand/TNFSF4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77459 | OX40 Ligand/TNFSF4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7745A | Cathepsin A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77460 | OX40 Ligand/TNFSF4, Mouse (HEK293, rFc) | Recombinant Proteins | |
| HY-P77461 | PANP/C12orf53, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77462 | PCSK1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77463 | PILR-beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77464 | PNLIPRP1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77465 | PRL2A1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77466 | PRL8A4, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77467 | FPRP/PTGFRN, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77468 | Nectin-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77469 | Nectin-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7747 | Cathepsin B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77470 | Nectin-1, Rat (HEK293, Fc) | Recombinant Proteins | |
| HY-P77471 | Nectin-1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77472 | REG1A, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77473 | REG1A, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77474 | REG1B, Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77475 | REG1B, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77476 | RCN3, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P77477 | SARS-CoV-2 S RBD (G485S, HEK293, His) | Recombinant Proteins | |
| HY-P77478 | SARS-CoV-2 S RBD (N481D, HEK293, His) | Recombinant Proteins | |
| HY-P77479 | SARS-CoV-2 S RBD (P499R, HEK293, His) | Recombinant Proteins | |
| HY-P7748 | Cathepsin D, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P77480 | SARS-CoV-2 S (Biotinylated, sf9, Avi-His) | Recombinant Proteins | |
| HY-P77481 | SARS-CoV-2 S2 (HEK293, His) | Recombinant Proteins | |
| HY-P77482 | L-selectin/CD62L, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77483 | L-selectin/CD62L, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77484 | Serpina1d, Mouse (HEK293) | Recombinant Proteins | |
| HY-P77485 | Serpina1d, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77486 | Serpina1d, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77488 | SIRP gamma, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77489 | SIRP gamma, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7748A | Cathepsin D, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7749 | Cathepsin D, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77490A | SIRP beta, Mouse (HEK293, C-His) | Recombinant Proteins | |
| HY-P77491 | SMR3B, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77492 | SMR3B, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77493 | Somatostatin R1/SSR1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77494 | SP-D, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77495 | TM4SF2/TSPAN7, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77496 | TM4SF2/TSPAN7, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77497 | TM4SF2/TSPAN7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77498 | TNF RII/TNFRSF1B, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P7750 | Cathepsin E, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77500 | TNFRH3/TNFRSF26, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77502 | ULBP-6/RAET1L, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77503 | ULBP-6/RAET1L, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77504 | VRK1, Human (sf9) | Recombinant Proteins | |
| HY-P77506 | Brorin/VWC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77507 | WWP2, Human (sf9, His-GST) | Recombinant Proteins | |
| HY-P77508 | XTP3TPA, Human (His) | Recombinant Proteins | |
| HY-P77509 | PD-1, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7751 | Cathepsin E, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77510 | IL-4, Human (Biotinylated) | Recombinant Proteins | |
| HY-P77511 | IL-12, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77514 | C-Reactive, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P77515 | Insulin R/CD220, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77516 | M-CSF, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P77517 | CD4, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77518 | Cadherin-1/CD324, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77519 | CD8 beta, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P7752 | Cathepsin H, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77520 | CD8 alpha, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77521 | FAP, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77522 | DR3/TNFRSF25, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77523 | B7-1/CD80, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77524 | CD34, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77525 | CD34, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77526 | IgG1, Human (Biotinylated, C103S, HEK293) | Recombinant Proteins | |
| HY-P77527 | CD19, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77528 | PD-L2, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77529 | SCF, Mouse (Biotinylated, sf9, His) | Recombinant Proteins | |
| HY-P7753 | Cathepsin L1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77530 | IgG2A Fc, Mouse (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P77531 | EpCAM/TROP1, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77532 | EpCAM/TROP1, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77533 | HER2/CD340, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77534 | CD73/5'-Nucleotidase, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77535 | HER2/CD340, Human (Biotinylated, Domain 4, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77536 | Siglec-3/CD33, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77537 | Siglec-2/CD22, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77538 | CD276/B7-H3, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77539 | Siglec-2/CD22, Human (Biotinylated, 512a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7754 | Cathepsin L1, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P77540 | Complement C5/C5a, Mouse (Biotinylated) | Recombinant Proteins | |
| HY-P77541 | B7-H4, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77542 | TIE-2, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77543 | TNF-alpha/TNFSF2, Cynomolgus (Biotinylated) | Recombinant Proteins | |
| HY-P77544 | ENSA, Human (Biotinylated, His) | Recombinant Proteins | |
| HY-P77545 | EphB4, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77546 | Mesothelin, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77547 | MPF, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77548 | Glypican-3/GPC3, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77549 | FGFR-4, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7754A | Cathepsin L1, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7755 | Cathepsin L2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77553 | Fc gamma RIIIA/CD16a, Human (Biotinylated, F176V, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77554 | HER3, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77555 | ASGR1/ASGPR1, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77556 | Neuraminidase/NA, H5N1 (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77558 | ADAM8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77559 | AMCase/CHIA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7755A | Cathepsin L2, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P7756 | Cathepsin S, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77560 | AMHR2/MISRII, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77561 | Annexin A2/ANXA2, Mouse (His) | Recombinant Proteins | |
| HY-P77562 | Apolipoprotein A-II/APOA2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77563 | APLN/Apelin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77564 | APRIL/TNFSF13 Trimer, Cynomolgus (HEK293, His-Flag-Avi) | Recombinant Proteins | |
| HY-P77565 | ASPH, Mouse (His) | Recombinant Proteins | |
| HY-P77566 | ASTL/SAS1B, Mouse (His) | Recombinant Proteins | |
| HY-P77567 | AXL, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77569 | BACE1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7757 | Cathepsin S, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77570 | BAFFR/TNFRSF13C, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77571 | BAFF/TNFSF13B Trimer, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77572 | BAFF/TNFSF13B, Cynomolgus (Biotinylated, HEK293, His-Flag-Avi) | Recombinant Proteins | |
| HY-P77573 | 4-1BB/TNFRSF9, Cynomolgus/Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77574 | 4-1BB/TNFRSF9, Mouse (isoform 2, HEK293, His) | Recombinant Proteins | |
| HY-P77578 | CD276/B7-H3, Human (217a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P7758 | Cathepsin Z/CTSZ, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P77581 | BTN3A1/CD277, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77582 | BTN3A1/CD277, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77583 | CYTL1, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P77584 | CYTL1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77585 | Carbonic Anhydrase 9, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77586 | Calcitonin/CALCA, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77587 | Calcitonin/CALCA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77588 | EpCAM/TROP1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77589 | CCR2b-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P7758A | Cathepsin Z/CTSZ Protein, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7759 | TARC/CCL17, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77590 | CCR2b-VLP, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P77591 | IL-2R gamma/CD132, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77592 | CD161, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77593 | CD161, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77594 | IL-2R beta/CD122, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77596 | CD24-VLP, Cynomolgus (HEK293) | Recombinant Proteins | |
| HY-P77597 | CD24, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77598 | CD24, Cynomolgus (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77599 | CD200R1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7760 | CCL24/Eotaxin-2, Mouse | Recombinant Proteins | |
| HY-P77600 | CD200R1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77601 | CD200R1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77602 | CD21, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77603 | CD3D-CD3E Heterodimer, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77604 | CD3D-CD3E Heterodimer, Cynomolgus (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77605 | CD3E-CD3G Heterodimer, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77606 | CD3E-CD3G Heterodimer, Cynomolgus (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77607 | CD3 epsilon 1-27 peptide, Cynomolgus (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P77608 | CD3 epsilon 1-27 peptide, Cynomolgus (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P77609 | CD3E-CD3G Heterodimer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7761 | RANTES/CCL5, Rat (His) | Recombinant Proteins | |
| HY-P77610 | CD3D-CD3E Heterodimer, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77611 | CD3E-CD3G Heterodimer, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77612 | CD3D-CD3E Heterodimer, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P77613 | CD3E-CD3G Heterodimer, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P77614 | CD3D-CD3E Heterodimer, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77616 | CD4, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77617 | CD55/DAF, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77618 | CD5, Rhesus Macaque (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77618A | CD5, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77619 | CD5, Rhesus Macaque (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7762 | CCDC134, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77620 | CD70, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77621 | CD28, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P77622 | CD28, Canine (HEK293, mFc) | Recombinant Proteins | |
| HY-P77623 | CD99, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77624 | CD1A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77625 | CDCP1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77626 | CDCP1, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77627 | Cadherin-17, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77628 | Cadherin-11, Human (564a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77629 | CEACAM8/CD66b, Human (285a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7763 | HCC-1/CCL14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77630 | CEACAM1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77631 | CLEC12A/MICL, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77632 | CLEC5A/MDL-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77633 | CLEC12A/MICL, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77634 | CLEC12A/MICL, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P77635 | SARS-CoV-2 S1 (Biotinylated, Omicron, B.1.1.529, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77636 | CRTAM/CD355, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77637 | C-Reactive, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77638 | CSF1R, Cynomolgus (498a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77639 | DDR1, Mouse (394a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7764 | MCP-1/CCL2, Mouse | Recombinant Proteins | |
| HY-P77640 | DKK-3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77641 | Delta-like 3/DLL3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77642 | Delta-like 3/DLL3, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77643 | EMAP-II, Mouse (His) | Recombinant Proteins | |
| HY-P77644 | ECSCR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77645 | Ephrin-B2/EFNB2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77646 | EphB4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77648 | EphA10, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7765 | MPIF-1/CCL23, Human (75a.a) | Recombinant Proteins | |
| HY-P77652 | FcRH5/FcRL5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77653 | FGFR-2 beta (IIIb), Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77654 | FGFR-1 beta (IIIc), Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77655 | FGFR-3 alpha (IIIb), Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77656 | FGFR-3 alpha (IIIb), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77657 | FGFR-3 beta (IIIb), Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77658 | FGFR-3 beta (IIIb), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77659 | FGFR-1 alpha (IIIc), Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7766 | CCL24/Eotaxin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77660 | FGFR-1 alpha (IIIc), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77661 | FGFR-2 beta (IIIb), Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77662 | FGFR-3 alpha (IIIb), Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77663 | Fc gamma RIII/CD16, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77664 | FOLR1, Cynomolgus/Rhesus Macaque (209a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77669 | GARP&Latent TGF beta Complex, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7767 | CTACK/CCL27, Human | Recombinant Proteins | |
| HY-P77670 | GARP&Latent TGF beta Complex, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77671 | GARP (Y137H)&Latent TGF Beta Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77672 | GARP (S138G)&Latent TGF Beta Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77673 | GARP (G139N)&Latent TGF Beta Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77674 | GARP&Latent TGF Beta Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77675 | GARP&Latent TGF beta Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77676 | GARP (Mutated)&Latent TGF Beta Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77677 | GARP&Latent TGF beta Complex, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77678 | GARP&Latent TGF beta Complex, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77679 | GUCY2C/Guanylyl cyclase C, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7767A | CTACK/CCL27, Human (His) | Recombinant Proteins | |
| HY-P7768 | MIP-1 alpha/CCL3, Mouse (His) | Recombinant Proteins | |
| HY-P77680 | GUCY2C/Guanylyl cyclase C, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P77681 | GDF-15, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77682 | GDF-15, Cynomolgus (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77683 | GFRAL, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77684 | Galectin-3/LGALS3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77686 | CD42c/GP1BB, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77687 | HLA-G Complex Tetramer, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77688 | HLA-G Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77689 | HLA-G Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7768AF | Animal-Free MIP-1 alpha/CCL3, Mouse (His) | Recombinant Proteins | |
| HY-P7769 | LD78-beta/CCL3L1, Human (HEK293 His) | Recombinant Proteins | |
| HY-P77690 | HLA-G Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77691 | HLA-G Complex Tetramer, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77692 | HLA-G Complex Tetramer, Rhesus Macaque (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77693 | TMPRSS1/HPN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77694 | IgE, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77695 | IgE, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77696 | IgE, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77697 | TMEM219/IGFBP-3R, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77698 | IL-1 Rrp2/IL-1 R6, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77699 | IL-15R alpha & IL-15, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7770 | MCP-2/CCL8, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77700 | IL-15R alpha & IL-15 Protein, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77701 | IL-1R2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77702 | IL-12, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77703 | Cynomolgus IL-23 alpha & Mouse IL-12 beta Heterodimer (HEK293, His) | Recombinant Proteins | |
| HY-P77704 | IL-23 alpha (170a.a) & IL-12 beta (306a.a) Heterodimer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77707 | IL-17A/F Heterodimer, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77708 | IL-17A/F Heterodimer, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77709 | IL-18BP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7771 | MCP-2/CCL8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77710 | IL-18R alpha, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77711 | IL-18R alpha, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77712 | Human IL-23 alpha & Mouse IL-12 beta Heterodimer (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77713 | IL-17A/F Heterodimer, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77714 | IL-21R, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77715 | IL-2R beta & IL-2R gamma Heterodimer, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77716 | Integrin alpha 2B beta 3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77718 | Integrin alpha 5 beta 1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77719 | Integrin alpha V beta 3 Protein, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7772 | CCL9/10/MIP-1 gamma, Mouse | Recombinant Proteins | |
| HY-P77720 | Integrin alpha V beta 5 Protein, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77721 | Integrin alpha V beta 6 Protein, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77721A | Integrin alpha V beta 6 Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77722 | Integrin alpha V beta 8 Protein, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77723 | Integrin alpha V beta 6, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77724 | Integrin alpha V beta 6, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77725 | Integrin alpha V beta 8, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77727 | Cas9, S. pyogenes (His) | Recombinant Proteins | |
| HY-P77728 | GMP-Cas9, S. pyogenes (His) | Recombinant Proteins | |
| HY-P77729 | KIR2DL5/CD158f, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7773 | CCND2, Human (His) | Recombinant Proteins | |
| HY-P77730 | KIR2DL5/CD158f, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77731 | Kallikrein-5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77731A | Kallikrein-5, Mouse (271a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77732 | L1CAM, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77733 | LAMP5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77735 | LDLR, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77736 | LILRA4/ILT-7/CD85g, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77737 | LILRB2/CD85d/ILT-4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77738 | LILRB4/CD85k/ILT3, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77739 | LILRB2/CD85d/ILT-4, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P7774 | Semaphorin-4D/SEMA4D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77740 | LILRB1/CD85j/ILT2, Rhesus Macaque (474a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P77741 | LILRB4/CD85k/ILT3, Human (Domain1&2, HEK293, His) | Recombinant Proteins | |
| HY-P77743 | LILRB4/CD85k/ILT3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77744 | LILRB4/CD85k/ILT3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77745 | MANSC1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77746 | MFAP4, Mouse (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P77747 | MCEMP1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77748 | MAdCAM1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77749 | MFG-E8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7775 | ICAM-2/CD102, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77750 | HLA-A*0201 MAGE-A4 Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77751 | HLA-A*0201 MAGE-A4 Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77752 | HLA-A*0201 MAGE-A4 Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77753 | HLA-A*0201 GP100 Complex, Human (YLEPGPVTA, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77754 | HLA-A*0201 GP100 Complex, Human (Biotinylated, YLEPGPVTA, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77755 | HLA-A*0201 GP100 Complex Tetramer, Human (YLEPGPVTA, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77756 | HLA-A*0201 NY-ESO-1 Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77757 | HLA-A*0201 NY-ESO-1 Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77758 | HLA-E*0103 Complex Protein, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77759 | HLA-E*0103 Complex Protein, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7776 | CD105/Endoglin, Human (Trx-His) | Recombinant Proteins | |
| HY-P77760 | HLA-E*0103 Complex Tetramer Protein, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77761 | HLA-E*0103 Complex Tetramer Protein, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77762 | HLA-A*0201 AFP Complex Tetramer, Human (FMNKFIYEI, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77763 | HLA-A*0201 AFP Complex, Human (PLFQVPEPV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77764 | HLA-A*0201 AFP Complex Tetramer, Human (PLFQVPEPV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77765 | HLA-A*0201 NY-ESO-1 Complex, Human (Biotinylated, SLLMWITQV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77766 | HLA-A*0201 LMP2 Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77767 | HLA-A*0201 LMP2 Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77768 | HLA-A*0201 LMP2 Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77769 | HLA-A*0201 Survivin Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7777 | VCAM-1/CD106, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77770 | HLA-A*0201 Survivin Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77771 | Chimeric HLA-A*0201 LMP2, Human&Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77772 | Chimeric HLA-A*0201 LMP2 Tetramer, Human&Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77773 | Chimeric HLA-A*0201 WT-1 Complex, Human&Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77774 | Chimeric HLA-A*0201 WT-1 Complex Tetramer, Human&Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77775 | HLA-A*0201 P53 R175H Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77776 | HLA-A*0201 P53 R175H Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77777 | HLA-A*0201 P53 R175H Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77778 | HLA-A*0201 P53 WT Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77779 | HLA-A*0201 P53 WT Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7778 | LAMP1/CD107a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77780 | HLA-A*0201 P53 WT Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77781 | HLA-A*0301 KRAS G12V Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77782 | HLA-A*0301 KRAS G12V Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77783 | HLA-A*1101 KRAS G12D, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77784 | HLA-A*1101 KRAS G12D Complex, Human (Biotinylated, VVVGADGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77785 | HLA-A*1101 KRAS G12D Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77786 | HLA-A*1101 KRAS G12V Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77787 | HLA-A*1101 KRAS G12V Complex, Human (Biotinylated, VVGAVGVGK, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77788 | HLA-A*1101 KRAS G12V Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77789 | HLA-A*0301 KRAS WT, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7779 | LAMP1/CD107a, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77790 | HLA-A*0301 KRAS WT, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77791 | HLA-A*0301 KRAS WT Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77792 | HLA-A*0201 WT-1 Complex, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77793 | HLA-A*0201 WT-1 Complex, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77794 | HLA-A*0201 WT-1 Complex Tetramer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77796 | Mesothelin, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77797 | Mesothelin, Cynomolgus (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P77798 | Mesothelin, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P77799 | MASP2, Cynomolgus (His) | Recombinant Proteins | |
| HY-P7780 | Nectin-2/CD112, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77800 | MASP2, Mouse (His) | Recombinant Proteins | |
| HY-P77801 | MASP2, Rat (His) | Recombinant Proteins | |
| HY-P77802 | MASP2, Rat (Biotinylated, His) | Recombinant Proteins | |
| HY-P77803 | NKG2A-CD94 Heterodimer, Human (HEK293, Fc-Flag) | Recombinant Proteins | |
| HY-P77804 | NKG2A-CD94 Heterodimer, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P77805 | NKG2A-CD94 Heterodimer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77806 | NKG2A-CD94 Heterodimer, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77807 | NKG2C-CD94 Heterodimer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77808 | NKG2A-CD94 Heterodimer, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P77809 | NKG2C/CD159c, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7781 | Nectin-2/CD112, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77810 | NKp46/NCR1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77811 | NKp30/NCR3, Human (120a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P77812 | NKp30/NCR3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77813 | NKp30/NCR3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77816 | SARS-CoV-2 NSP7-NSP8 Heterodimer (His) | Recombinant Proteins | |
| HY-P77817 | NTS, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77818 | Periostin, Human (815a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77819 | PD-L1, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7782 | Nectin-3/CD113, Human (309a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77821 | PLD4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77822 | Prolactin R, Canine (HEK293, Fc) | Recombinant Proteins | |
| HY-P77823 | PSMP, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77824 | PTPRC/CD45RABC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77825 | ROR1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P77826 | ROR2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77827 | ROR2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77828 | ROR2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77829 | S100A9, Cynomolgus (His) | Recombinant Proteins | |
| HY-P7783 | GM-CSF R alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77830 | S100A9, Canine (His) | Recombinant Proteins | |
| HY-P77831 | SARS Plpro/papain-like protease (His-Avi) | Recombinant Proteins | |
| HY-P77832 | Semaphorin-4D/SEMA4D, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77833 | CSPG5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77834 | CSPG5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77835 | SFRP2, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P77835A | SFRP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77836 | SIRP alpha V2/CD172a, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77837 | SIRP alpha V2/CD172a, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77838 | SIRP Beta 1, Human (isoform 3, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77839 | SIRP Beta 1, Human (Biotinylated, isoform 3, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7784 | IL-2R beta/CD122, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77840 | SIRP alpha V2/CD172a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77841 | SIRP alpha V3, Human (H54L, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77842 | SIRP alpha V3, Human (Biotinylated, H54L, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77843 | SIRP alpha V4/CD172a, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77844 | SIRP alpha V4/CD172a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77845 | SIRP alpha V6/CD172a, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77846 | SIRP alpha V6/CD172a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77847 | SIRP alpha V8/CD172a, Human (S44L, S50T, I52T, H54R, V57A, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77849 | ST3GAL4, Human (HEK293, His-HA) | Recombinant Proteins | |
| HY-P7785 | CD127/IL-7RA, Human (HEK293, Fc-His) | Recombinant Proteins | |
| HY-P77851 | Syndecan-1/CD138, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77852 | Syndecan-1/CD138, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77853 | Syndecan-1/CD138, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77854 | TMEM106B, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77855 | TFRC, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77856 | TGF beta 1/TGFB1, Rhesus Macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77857 | TGF alpha/TGFA, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77859 | TLR3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7786 | CD14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77860 | TREM-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77861 | TROP-2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77863 | TYRO3/DTK, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77864 | VEGF-C, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77865 | VEGF-C, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77867 | ADAM9, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P77867A | ADAM9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77868 | Amphiregulin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77869 | AMCase/CHIA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7787 | Tissue Factor, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77870 | AMHR2/MISRII, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77871 | AMIGO2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77872 | Apolipoprotein A-V/APOA5, Mouse (His) | Recombinant Proteins | |
| HY-P77873 | APCDD1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77874 | APLN/Apelin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77875 | AXL, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77876 | AXL, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77877 | AXL, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77878 | AXL, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77879 | VISTA/B7-H5, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7787A | Tissue Factor, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7788 | CD150/SLAMF1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77883 | IL-2R beta/CD122, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77884 | CD163, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77886 | CD37, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77887 | CD43, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77888 | CD164, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77889 | FPRP/PTGFRN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7789 | PVR/CD155, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77890 | FPRP/PTGFRN, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77891 | CDCP1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77892 | CDCP1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77893 | CDCP1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77894 | Cadherin-3, Human (547a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77895 | Cadherin-17, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77896 | Chordin-like 1/CHRDL1, Human (His, solution) | Recombinant Proteins | |
| HY-P77896A | Chordin-like 1/CHRDL1, Human (N-His) | Recombinant Proteins | |
| HY-P77897 | CHODL, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77898 | Complement Factor D/Adipsin, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77899 | Claudin-6/CLDN6-VLP, Human (HEK293, solution) | Recombinant Proteins | |
| HY-P77899A | Claudin-6/CLDN6, Human (HEK 293) | Recombinant Proteins | |
| HY-P7790 | PVR/CD155, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77900 | Claudin-6/CLDN6-VLP, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P77901 | OCIL/CLEC2D, Human (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P77902 | OCIL/CLEC2D, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P77903 | CLEC12A/MICL, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77904 | CLEC9A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77905 | CLEC12A/MICL, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77906 | CLEC5A/MDL-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77907 | CRTAM/CD355, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77909 | GM-CSF R alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7791 | CD157, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77910 | CXCL16, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77911 | BCA-1/CXCL13, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77912 | BCA-1/CXCL13, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77913 | DNAM-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77914 | DLK-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77915 | DLK-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77916 | Delta-like 3/DLL3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77917 | DSG2/Desmoglein-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77918 | DSG2/Desmoglein-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77919 | ECSCR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7792 | CD157, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77920 | Fibulin-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77921 | Fibulin-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77923 | ENPP-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77924 | ENPP-3, Human (828a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77925 | ENPP-3, Human (Biotinylated, 828a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77926 | ENPP-3, Human (110a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77927 | ENPP-3, Human (Biotinylated, 110a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77928 | ENPP-3, Human (318a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77929 | EPHA10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7793 | CD157, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77930 | EPHA5, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77931 | EphB3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77932 | EPHA5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77934 | FAP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77935 | FOLR2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77936 | FOLR4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77937 | FOLR2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77938 | FOLR4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77939 | TL1A/TNFSF15, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7794 | CD158d/KIR2DL4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77940 | FSH beta, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77941 | FSTL3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77942 | GUCY2C/Guanylyl cyclase C, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77943 | GUCY2C/Guanylyl cyclase C, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77944 | GUCY2C/Guanylyl cyclase C, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77945 | GDF-15, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77945A | GDF-15, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P77946 | GDF-15, Mouse (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P77947 | GFRAL, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77948 | GIP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77949 | GIP, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7795 | CD160, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P77951 | CD42b/GP1BA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77952 | GPVI, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77953 | CD42a/GP9, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77954 | GYPA/CD235a, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77955 | VSIG1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77956 | GYPA/CD235a, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77957 | Glypican-2/GPC2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77958 | GPRC5D-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P77959 | GPRC5D-VLP, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P7796 | CD160, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77960 | HGFA/HGF Activator, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77961 | Hepsin/HPN, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77962 | TMEM219/IGFBP-3R, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77963 | IL-20 Protein, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77964 | IL-20 Protein, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77965 | IL-20R alpha, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77966 | IL-33, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P77967 | IL-22R alpha 1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77968 | IL-31R alpha, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77969 | IL-22R alpha 1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7797 | CD160, Rhesus macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P77970 | KIR2DL2/CD158b1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77971 | KIR2DL2/CD158b1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77972 | Klotho beta, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77973 | Plasma kallikrein/KLKB1, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P77973A | Plasma kallikrein/KLKB1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77974 | KLRG1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77975 | KIR3DL2/CD158k, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77976 | Kremen-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77977 | Kremen-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77978 | LAMP5/BAD-LAMP, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P77979 | LCAT, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7798 | CD160, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77980 | LILRB1/CD85j/ILT2 (Domain1&2), Human (HEK293, His) | Recombinant Proteins | |
| HY-P77981 | LILRB1/CD85j/ILT2, Human (346a.a, HEK293, His) | Recombinant Proteins | |
| HY-P77982 | LILRB1/CD85j/ILT2, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P77983 | LILRA2/CD85h/ILT1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77984 | LILRA3/CD85e/ILT6, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77985 | LILRB1/CD85j/ILT2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77986 | LOX-1/OLR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77987 | LRG1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77988 | LRIG1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77989 | LRP-5, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P7799 | CD160, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77990 | LRP-6, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P77991 | LRRC52, Human (HEK293, His) | Recombinant Proteins | |
| HY-P77992 | DEC-205/CD205, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77993 | MFAP4, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P77994 | MAGP-2/MFAP5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P77995 | MBP, Mouse (His) | Recombinant Proteins | |
| HY-P77996 | MEPE/OF45, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P77997 | MICA, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P77998 | MICA, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7800 | CD162/PSGL-1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78002 | C-MPL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78003 | C-MPL, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78004 | MARCO, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78005 | MASP2, Human (His) | Recombinant Proteins | |
| HY-P78006 | NKG2C/CD159c, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78007 | NKp46/NCR1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78008 | NKp46/NCR1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78009 | Notch3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7801 | CD177, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78010 | Notch 3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78011 | OSCAR, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78012 | OSCAR, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78013 | PSCA, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78014 | PGLYRP1/PGRP-S, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78015 | PIP/GCDFP-15, Human (His) | Recombinant Proteins | |
| HY-P78016 | Prokineticin-1/EG-VEGF, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78017 | PLAU/uPA, Mouse (HEK293, C-His-Avi) | Recombinant Proteins | |
| HY-P78018 | PLAU/uPA, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78019 | PLD4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7802 | Thioredoxin/TXN, E.coli (His) | Recombinant Proteins | |
| HY-P78020 | Endoglycan/PODXL2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78021 | Endoglycan/PODXL2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78022 | PILR-alpha, Human (178a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P78023 | PRNP/CD230, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78024 | WFDC1/PS20, Human (His) | Recombinant Proteins | |
| HY-P78025 | WFDC1/PS20, Mouse (His) | Recombinant Proteins | |
| HY-P78026 | PSMA, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78027 | PSMP, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78028 | RGM-C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78029 | RGM-C, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7803 | PKM2, Human (420 a.a, His) | Recombinant Proteins | |
| HY-P78030 | RNF43, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78031 | ROBO4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78032 | ROR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78033 | Semaphorin-7A/SEMA7A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78034 | Semaphorin-4B/SEMA4B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78035 | Semaphorin-7A/SEMA7A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78035A | Semaphorin-7A/SEMA7A, Mouse (HEK293, C-6His) | Recombinant Proteins | |
| HY-P78036 | SEZ6/BSRP-C, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78037 | SEZ6/BSRP-C, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78038 | SEZ6L2//BSRP-A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78039 | Siglec-9, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7804 | KRAS, Human (G12C, His) | Recombinant Proteins | |
| HY-P78040 | Siglec-9, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78041 | SLPI, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78042 | Endosialin/CD248, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78043 | Endosialin/CD248, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78044 | THSD7A, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78045 | TPO/Thyroid Peroxidase, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78046 | TSLP, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78047 | TSLP, Cynomolgus (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78049 | VLDLR, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7804A | KRAS, Human (G13C, His) | Recombinant Proteins | |
| HY-P7805 | KRAS, Human (G12V, His) | Recombinant Proteins | |
| HY-P78050 | VSTM5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78051 | WISP1/CCN4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78052 | 2B4/CD244, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78053 | TPBG/5T4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78054 | ACE2, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78055 | ACE2, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78056 | ALCAM/CD166, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78057 | ALCAM/CD166, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78058 | ALCAM/CD166, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78059 | ANGPTL3/Angiopoietin-like 3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7805A | KRAS, Human (G13V, His) | Recombinant Proteins | |
| HY-P7806 | Fc gamma RIIIA/CD16a, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78060 | ANGPTL2/Angiopoietin-like 2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78061 | Angiopoietin-2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78062 | Apolipoprotein E/APOE3, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78063 | B7-1/CD80, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78064 | B7-2/CD86, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78065 | BAFFR/TNFRSF13C, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78066 | BAFF/TNFSF13B Trimer, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78067 | 4-1BB/TNFRSF9, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78068 | 4-1BB/TNFRSF9, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78069 | 4-1BBL/TNFSF9 Trimer, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P7807 | CRTAM/CD355, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78070 | BCMA/TNFRSF17, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78071 | BCMA/TNFRSF17 Trimer, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78072 | BCMA/TNFRSF17, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78073 | B7-H4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78074 | CD276/B7-H3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78075 | B7-H2/ICOSLG, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78076 | B7-H6, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78077 | Serum Albumin/ALB, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78078 | BTLA/CD272, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7808 | CD7, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78080 | BTN3A1/CD277, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78081 | CEACAM6, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78082 | PVR/CD155, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P78083 | IL-2R gamma/CD132, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78084 | PVR/CD155, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78085 | CD161, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78086 | CD20/MS4A1, Human (His-Avi) | Recombinant Proteins | |
| HY-P78088 | CD24, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P78089 | CD3 epsilon 1-27 peptide, Human (Biotinylated, HEK293, hFc-Avi) | Recombinant Proteins | |
| HY-P7809 | BTNL4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78090 | CD4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78091 | CD40, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78092 | IL-2R alpha/CD25, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78093 | CD5, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78094 | CD47, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P78095 | CD47, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78096 | CD28, Human/Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78097 | CD94, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78098 | CD93/C1qR1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78099 | Fc gamma RIIIA/CD16a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7810 | CD137/4-1BB, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P78100 | Fc gamma RIIA/CD32a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78101 | CDCP1, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78102 | CD40L/CD154/TRAP, Human (Biotinylated, HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78103 | CD70 Trimer, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78104 | CCN2/CTGF, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78105 | Claudin-18/CLDN18.2-VLP, Human (Biotinylated, HEK293) | Recombinant Proteins | |
| HY-P78106 | SARS-CoV-2 S Trimer (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78107 | SARS-CoV-2 S RBD (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78108 | SARS-CoV-2 S1 (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78109 | CSF1R, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7811 | Fibrillin-1/Asprosin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78110 | GM-CSF R alpha, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78111 | Nucleocapsid CTD domain, Virus (His-Avi) | Recombinant Proteins | |
| HY-P78112 | CTLA-4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78113 | Fractalkine/CX3CL1, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78114 | DNAM-1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78115 | Delta-like 3/DLL3, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78116 | Delta-like 4/DLL4, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78117 | EGFR vIII, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78118 | EGFR, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78119 | E-selectin/CD62E, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7812 | DKK-3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78120 | FAP, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78121 | FAP, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78122 | Fc gamma RIIIB/CD16b, Human (Biotinylated, NA2, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78123 | KGF-2/FGF-10, Human (Biotinylated) | Recombinant Proteins | |
| HY-P78124 | FGFR-3 alpha (IIIc), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78125 | FGFR-2 alpha (IIIb), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78126 | FGFR-3 beta (IIIc), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78127 | FGFR-4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78128 | FGL1, Human (Biotinylated, 242a.a, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78129 | FGFR-2 beta (IIIb), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7813 | Complement Factor B/CFB, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78130 | FGFR-2 beta (IIIc), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78131 | FGFR-2 alpha (IIIc), Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78133 | AITRL/TNFSF18 Trimer, Human (Biotinylated, HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78134 | GDF-15, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P78135 | GFRAL, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78136 | GPA33, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78137 | GITR, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78138 | HER2/CD340, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78139 | HMGB1/HMG-1, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7814 | DFF45/ICAD, Human (His) | Recombinant Proteins | |
| HY-P78140 | IFN-gamma, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78141 | IFNAR1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78142 | IGF-I R, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78143 | IL-1 beta, Human (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P78144 | IL-10, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78145 | IL-1RL2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78146 | IL-1RAcP/IL-1 R3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78147 | IL-17RA, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78148 | IL-21, Human (His-Avi) | Recombinant Proteins | |
| HY-P78149 | IL-21, Mouse (Biotinylated, His-Avi) | Recombinant Proteins | |
| HY-P7815 | Tetranectin/CLEC3B, Human (181a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78150 | IL-22, Mouse (His-Avi) | Recombinant Proteins | |
| HY-P78151 | IL-2, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78152 | IL-23 alpha, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78153 | IL-4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78154 | IL-15R alpha, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78155 | IL-5, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78156 | IL-18BP, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78157 | IL-17A, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78158 | IL-17A, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78159 | IL-17F, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7816 | CHI3L2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78160 | IL-17F, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78161 | IL-17RA, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78162 | IL-5R alpha, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78163 | IL-13R alpha 1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78164 | KGF/FGF-7, Human (Biotinylated, His) | Recombinant Proteins | |
| HY-P78165 | KIR2DL1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78166 | KIR2DL3, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78167 | KIR3DL3/CD158z, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78168 | TGF beta 1/TGFB1 LAP, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78169 | LILRA1/LIR-6/CD85i, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7817 | Prostatic acid phosphatase/ACPP, Human (354a.a, HEK293, His, solution) | Recombinant Proteins | |
| HY-P78170 | LILRA6/CD85b/ILT-8, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78171 | LILRB3/CD85a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78172 | LRRC15, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78173 | MCP-1/CCL2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78174 | MICB, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78175 | MMP-9, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78176 | Mesothelin, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78177 | Mesothelin, Mouse (Biotinylated, 303a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78178 | CA125, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78179 | Nectin-1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7817A | Prostatic acid phosphatase/ACPP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7818 | CPVL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78180 | Nectin-3/CD113, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78181 | Nectin-4 IgV domain, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78182 | NKG2A, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78183 | NKG2D/CD314, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78184 | NOTCH1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78185 | NOTCH2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78186 | SARS-CoV-2 Nucleocapsid NTD domain (His-Avi) | Recombinant Proteins | |
| HY-P78187 | OSM, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78188 | OX40/TNFRSF4, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P78189 | "OX40/TNFRSF4, Human (Biotinylated, HEK293, His-Avi)" | Recombinant Proteins | |
| HY-P7819 | Langerin/CD207, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78190 | OX40/TNFRSF4, Mouse (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78191 | PD-1, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78192 | PD-L1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78193 | PDGF R alpha, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78194 | PDGF R beta, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78195 | PLAU/uPA, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78196 | CD45, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78197 | RGMA, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78198 | SARS-CoV S RBD (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78199 | SARS-CoV S1 RBD (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7820 | Corneodesmosin/CDSN, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78200 | SARS-CoV S1 RBD (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78201 | P-Selectin, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78202 | Semaphorin-4D/SEMA4D, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78203 | Siglec-5, Human (Biotinylated, HEK293, Fc) | Recombinant Proteins | |
| HY-P78204 | Siglec-8, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78205 | Siglec-10, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78206 | Siglec-10, Human (Biotinylated, R119A, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78207 | MAG/Siglec-4a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78208 | Siglec-15, Mouse (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78209 | SOST, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78210 | SIRP gamma, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78211 | SIRP alpha/CD172a, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78212 | TFPI, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78213 | Mature TGF beta 1/TGFB1, Human (Biotinylated, HEK293, Avi) | Recombinant Proteins | |
| HY-P78214 | Latent TGF beta 1/TGFB1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78215 | TGFBR2/TGF-beta RII, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78216 | TIGIT, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78217 | TIM-3/HAVCR2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78218 | TNF-alpha/TNFSF2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78219 | TRAIL R1/TNFRSF10A, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7822 | Cerberus 1/CER1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78220 | TRAIL R2/TNFRSF10B, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78221 | TRAILR4/TNFRSF10D, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78222 | TREM-2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78223 | TROP-2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78224 | TSLP, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78225 | TSLP, Human (Biotinylated, R127A, R130A, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78226 | NKG2DL2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78227 | ULBP1/RAET1I, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78228 | VEGF121, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78229 | VEGF165, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7823 | CEACAM21, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78230 | VEGFR-1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78231 | VEGFR-2, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78232 | EIF5A, Human (His) | Recombinant Proteins | |
| HY-P78233 | ACE2, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78234 | Adiponectin/Acrp30, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78236 | ALCAM/CD166, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78237 | ANGPTL4/Angiopoietin-related 4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78238 | Apolipoprotein A-I/APOA1, Mouse (240a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P78239 | Apolipoprotein E/APOE, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7824 | Complement C8G, Human (His) | Recombinant Proteins | |
| HY-P78240 | B2M/Beta-2 microglobulin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78243 | BCMA/TNFRSF17, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78244 | Serum Albumin/ALB, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78245 | Serum Albumin/ALB, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78246 | BTLA/CD272, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78247 | Complement C3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78248 | CCL24/Eotaxin-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78249 | RANTES/CCL5, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7824A | Complement C8G, Human (N-6*His) | Recombinant Proteins | |
| HY-P7825 | CEACAM7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78250 | CCL24/Eotaxin-2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78255 | CD24, Mouse (27a.a, HEK293, mFc) | Recombinant Proteins | |
| HY-P78256 | CD27/TNFRSF7, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P78258 | CD43, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78261 | CD7, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78262 | CD74, Mouse (224a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78263 | CD79B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78265 | Fc gamma RIIA/CD32a, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78266 | CD300a/LMIR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78268 | CDCP1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78269 | CD3 epsilon, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P7827 | Creatine kinase M-type/CKM, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78270 | CHODL, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78271 | CD40L/CD154/TRAP Trimer, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78273 | Complement Factor D/Adipsin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78274 | CD367/CLEC4A, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78275 | SARS-CoV-2 3CLpro/3C-like protease | Recombinant Proteins | |
| HY-P78275A | SARS-CoV-2 3CLpro/3C-like protease (Tag Free) | Recombinant Proteins | |
| HY-P78276 | SARS-COV-2 Nucleocapsid (His-Avi) | Recombinant Proteins | |
| HY-P78277 | SARS-COV-2 Nucleocapsid (Bioytinylated, His-Avi) | Recombinant Proteins | |
| HY-P78278 | SARS-CoV-2 S RBD (N501Y, K417N, E484K, HEK293, His) | Recombinant Proteins | |
| HY-P78279 | SARS-COV-2 S1 (N501Y, K417N, E484K, HEK293, His) | Recombinant Proteins | |
| HY-P7828 | ACE2, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P78280 | SARS-COV-2 S1 NTD (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78281 | SARS-COV-2 S1 (N501Y, HEK293, His) | Recombinant Proteins | |
| HY-P78282 | SARS-COV-2 S Trimer (HEK293, Fc) | Recombinant Proteins | |
| HY-P78283 | SARS-COV-2 S RBD (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78284 | SARS-COV-2 S Trimer (D614G, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78285 | SARS-COV-2 S1 (D614G, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78286 | SARS-COV-2 S Trimer (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78287 | SARS-COV-2 S1 (670a.a, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78288 | CXCL16, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78289 | PF-4/CXCL4, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7829 | Cutinase, Thermobifida Fusca (His) | Recombinant Proteins | |
| HY-P78291 | DSG3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78293 | EphA4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78294 | EphB3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78296 | Fas/CD95, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78299 | AITRL/TNFSF18, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7830 | Complement factor H/CFH, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78301 | Galectin-1/LGALS1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78302 | Progranulin/PGRN, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78306 | ICOS, Mouse (C137S, C138S, HEK293, His) | Recombinant Proteins | |
| HY-P78307 | ICOS, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78308 | IFNAR1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78309 | IFNAR1, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7831 | CD47, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P78311 | IL-1RAcP/IL-1 R3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78312 | IL-2, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78313 | IL-3, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78314 | IL-5, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78315 | IL-17B, Mouse (His) | Recombinant Proteins | |
| HY-P78315AF | Animal-Free IL-17B, Mouse (His) | Recombinant Proteins | |
| HY-P78316 | IL-18RAP, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78319 | IL-9 Protein, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7832 | CD27/TNFRSF7, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P78320 | IL-17A, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78321 | IL-17F, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78322 | JAM-A/CD321, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78323 | LAIR2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78324 | LIF, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78325 | LILRB1/CD85j/ILT2, Rhesus macaque (440a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P78328 | MMP-8, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78329 | Lipocalin-2/NGAL, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7833 | CD19, Cynomolgus/Rhesus Macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P78330 | NKG2D/CD314, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78331 | NKp46/NCR1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78332 | Periostin, Mouse (Q62009-2, HEK293, His) | Recombinant Proteins | |
| HY-P78333 | OSMR beta, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78334 | OX40/TNFRSF4, Mouse (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78335 | PSCA Protein, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78336 | PSCA, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78337 | PLGF, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78338 | PGLYRP1/PGRP-S, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7834 | B7-1/CD80, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P78340 | PLA2G1B, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78341 | PILR-alpha, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78342 | Pleiotrophin, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78343 | PVRIG, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P78344 | RSPO1/R-spondin-1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78345 | Pentraxin 2/SAP, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78346 | SARS-CoV S RBD (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78347 | SARS-CoV S1 (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78348 | SARS-CoV S1 (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78349 | P-Selectin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7835 | B7-2/CD86, Cynomolgus/Rhesus Macaque (HEK293, hFc) | Recombinant Proteins | |
| HY-P78350 | Semaphorin-3A/SEMA3A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78352 | SCG3/Secretogranin-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78353 | Siglec-15, Cynomolgus (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78354 | Siglec-5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78358 | Osteopontin/OPN, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78359 | TFF1, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7836 | CD73/5'-Nucleotidase, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78360 | Latent TGF beta 1/TGFB1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78361 | TGM2/Transglutaminase 2, Mouse (His) | Recombinant Proteins | |
| HY-P78362 | TLR3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78363 | TRAIL R2/TNFRSF10B, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78364 | TROP-2, Rat (246a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78366 | 2B4/CD244, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78367 | BTN3A2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78368 | Claudin-18/CLDN18.2-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P78369 | FITC-Labeled Mesothelin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P7837 | CD40, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P78370 | Mesothelin, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78371 | FITC-Labeled Mesothelin, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78372 | Nectin-2/CD112, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78373 | Nectin-4, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78374 | Nectin-4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78375 | Nectin-4, Human (IgV, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78376 | RANKL/TNFSF11, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78377 | VEGF121, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78378 | VEGF165, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78379 | ANGPTL3/Angiopoietin-like 3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7838 | CTLA-4, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78380 | ANGPTL2/Angiopoietin-like 2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78381 | Angiopoietin-2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78382 | B7-1/CD80, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78383 | B7-2/CD86, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78384 | BAFF/TNFSF13B, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78385 | BAFF/TNFSF13B, Human (HEK293, Fc-Flag) | Recombinant Proteins | |
| HY-P78386 | 4-1BB/TNFRSF9, Human (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78387 | CLEC4C, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78388 | BCMA/TNFRSF17, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78389 | BCMA/TNFRSF17 Trimer, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7839 | BCMA/TNFRSF17, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P78390 | B7-H4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78391 | CD276/B7-H3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78392 | B7-H2/ICOSLG, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78393 | Serum Albumin/ALB, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78394 | BTLA/CD272, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78395 | BTN1A1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78396 | Carbonic Anhydrase 9, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78397 | CEACAM6, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78398 | PTK7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78399 | RANTES/CCL5, Human (His-SUMO) | Recombinant Proteins | |
| HY-P78400 | PVR/CD155, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78401 | IL-2R gamma/CD132, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78402 | PVR/CD155, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78403 | CD160, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78404 | CD24, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78405 | CD30 Ligand/TNFSF8, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78406 | CD30/TNFRSF8, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78407 | Siglec-3/CD33, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78408 | FITC-Labeled Siglec-3/CD33, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78409 | CD36, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7840A | CLIC1, Human (N-His) | Recombinant Proteins | |
| HY-P7841 | Delta-like 1/DLL1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78410 | CD4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78411 | CD52, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78412 | IL-2R alpha/CD25, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78413 | CD5, Human (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78414 | CD7, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78415 | CD79B, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78416 | CD28, Human/Cynomolgus/Rhesus Macaque (HEK293, mFc) | Recombinant Proteins | |
| HY-P78417 | CD28, Human/Cynomolgus/Rhesus Macaque (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78418 | CD84/SLAMF5, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78419 | CD8 alpha, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7842 | CCN1/Cyr61, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78420 | CD96, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78421 | CD94, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78422 | Fc gamma RIIIA/CD16a, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78423 | Fc gamma RIIA/CD32a, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78424 | Fc gamma RIIB/CD32b, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78425 | CD40L/CD154/TRAP Trimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78427 | M-CSF, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78429 | DNAM-1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7843 | CLIC2/XAP121, Human (His) | Recombinant Proteins | |
| HY-P78430 | DKK-1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78431 | CD105/Endoglin, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78432 | EGFR vIII, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78433 | EGFR vIII, Human (FITC, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78434 | PE-Labeled EGFR vIII, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78435 | EGFR, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78436 | EGFR, Human (FITC, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78437 | E-Selectin/CD62E, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78438 | Fc gamma RIIIB/CD16b, Human (NA2, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78439 | FGFR-3 alpha (IIIc), Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7844 | Angiopoietin-2, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78440 | FGFR-3 beta (IIIc), Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78441 | FGFR-4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78442 | FGF-21, Human (HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P78443 | FGL1, Human (HEK293, 242a.a, His-Avi) | Recombinant Proteins | |
| HY-P78445 | FOLR1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78446 | CD64, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78447 | TL1A/TNFSF15 Trimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78447A | TL1A/TNFSF15 Protein, Human (161a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78448 | AITRL/TNFSF18 Trimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78449 | GFRAL, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7845 | Chitinase-like 3/YM1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78450 | GPA33, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78451 | HER2/CD340, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78452 | HER3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78453 | HER2/CD340, Human (Domain 4, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78454 | HER4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78455 | HLA-G, Human (C66S, His-Avi) | Recombinant Proteins | |
| HY-P78456 | IFN-gamma, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78457 | IFNAR1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78458 | IGF-I R, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78459 | IL-1 beta, Human (His-Avi) | Recombinant Proteins | |
| HY-P78459A | IL-1 beta, Human (C-His) | Recombinant Proteins | |
| HY-P7846 | BRD4, Human (His-Flag) | Recombinant Proteins | |
| HY-P78460 | IL-10, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78461 | IL-13, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78462 | IL-1RL2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78463 | IL-1RAcP/IL-1 R3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78464 | IL-10R alpha, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78465 | IL-3, Human (His-Avi) | Recombinant Proteins | |
| HY-P78466 | IL-4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78467 | IL-5, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78468 | IL-15R alpha, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78469 | IL-17C, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7847 | CutA, Human (His) | Recombinant Proteins | |
| HY-P78470 | IL-23R, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78471 | IL-5R alpha, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78472 | IL-6R alpha, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78473 | KIR2DL1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78474 | KIR2DL3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78475 | KIR3DL3/CD158z, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78476 | LAIR1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78477 | LIGHT/TNFSF14 Trimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78478 | LILRB2/CD85d/ILT-4, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78479 | LILRA1/LIR-6/CD85i, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7848 | Fc gamma RIIIB/CD16b, Human (NA2, HEK293, His) | Recombinant Proteins | |
| HY-P78480 | LILRA4/ILT-7/CD85g, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78481 | LILRA5/CD85f, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78482 | LILRA6/CD85b/ILT-8, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78483 | LILRB2/CD85d/ILT-4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78484 | LILRB3/CD85a, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78485 | LILRB5/CD85c/LIR-8, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78486 | LRRC15, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78487 | CD229/SLAMF3, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78488 | MCP-1/CCL2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78489 | Mer, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P7849 | CREG1/CREG, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78490 | HGFR, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78491 | MICB, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78492 | MMP-9, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78493 | CA125, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78494 | Nectin-1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78495 | Nectin-2/CD112, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78496 | Nectin-3/CD113, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78497 | NKG2A, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78498 | NKG2D/CD314, Human (HEK293, Fc-Flag) | Recombinant Proteins | |
| HY-P78499 | NKG2A, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7850 | CDK2AP2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78500 | NKG2D/CD314, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78501 | NOTCH1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78502 | OSM, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78503 | OX40/TNFRSF4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78504 | OX40 Ligand/TNFSF4 Trimer, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78505 | PD-L2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78506 | PDGF R alpha, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78508 | RGMA, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7851 | Cystatin F/CST7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78510 | ROR1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78511 | P-Selectin, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78512 | Semaphorin-4D/SEMA4D, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78513 | Siglec-8, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78514 | Siglec-10, Human (R119A, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78515 | Siglec-15, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78516 | Siglec-10, Human (HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78517 | CRACC/SLAMF7, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78518 | CRACC/SLAMF7, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78519 | SOST, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7852 | CREG1/CREG, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78520 | SIRP Beta 1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78521 | SIRP gamma, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78522 | TFPI, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78523 | TFRC, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78524 | TGFBR2/TGF-beta RII, Human (HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P78525 | TGFBR1/ALK-5, Human (HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P78526 | TNF RII/TNFRSF1B, Human (235a.a, HEK293, mFc) | Recombinant Proteins | |
| HY-P78527 | TNF-alpha/TNFSF2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78527A | TNF-alpha/TNFSF2 Protein, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78528 | TRAIL/TNFSF10, Human (HEK293, His-Flag) | Recombinant Proteins | |
| HY-P78529 | TRAIL R1/TNFRSF10A, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7853 | Cystatin F/CST7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78530 | TRAIL R2/TNFRSF10B, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78531 | TRAILR4/TNFRSF10D, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78532 | TSLP, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78533 | TSLP, Human (R127A, R130A, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78534 | NKG2DL2, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78535 | ULBP1/RAET1I, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78536 | VEGFR-2, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78537 | VEGFR-1, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78538 | VEGFR-3/FLT4, Human (HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78540 | FITC-Labeled CD70, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78541 | Siglec-2/CD22, Human (FITC, HEK293, Fc) | Recombinant Proteins | |
| HY-P78542 | Apolipoprotein E/APOE4, Human (C130R, HEK293, Fc, solution) | Recombinant Proteins | |
| HY-P78542A | Apolipoprotein E/APOE4, Human (C130R, HEK293, Fc) | Recombinant Proteins | |
| HY-P78543 | CD20/MS4A1-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P78544 | CD24-VLP, Human (HEK293) | Recombinant Proteins | |
| HY-P78545 | Complement Factor D/Adipsin, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78546 | ICOS, Human (C136S, C137S, HEK293, His) | Recombinant Proteins | |
| HY-P78547 | IL-1RL2 Protein, Human (C154S, C262S, HEK293, His) | Recombinant Proteins | |
| HY-P78548 | SLPI, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78549 | GMP IL-4, Human | Recombinant Proteins | |
| HY-P7855 | CRTAM/CD355, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78550 | GMP IL-7, Human | Recombinant Proteins | |
| HY-P78551 | GMP IL-2 Protein, Human (solution) | Recombinant Proteins | |
| HY-P78552 | GMP IFN-gamma, Human | Recombinant Proteins | |
| HY-P78553 | SIRP alpha/CD172a, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78555 | COMMD8, Human (N-His) | Recombinant Proteins | |
| HY-P78556 | IL-17A, Rat (His) | Recombinant Proteins | |
| HY-P78557 | IL-13, Cotton Rat (His) | Recombinant Proteins | |
| HY-P78558 | IL-15R alpha & IL-15, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7856 | PDCD8/AIFM1, Human (His) | Recombinant Proteins | |
| HY-P78561 | CD47, Human (Biotinylated, HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P78565 | TSLP, Cynomolgus (R127A, R130S, HEK293, His) | Recombinant Proteins | |
| HY-P78567 | TRAIL R2/TNFRSF10B, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78568 | TIE-2, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78569 | LIV-1/SLC39A6, Cynomolgus (Sf9, His) | Recombinant Proteins | |
| HY-P7857 | CLIC3, Human (His) | Recombinant Proteins | |
| HY-P78571 | Siglec-10, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78573 | PTK7, Cynomolgus/Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P78575 | PADI2, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P78576 | NKG2A, Cynomolgus/Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P78579 | CD20/MS4A1-VLP, Cynomolgus (297a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7858 | Cytochrome b5/CYB5A, Human (His) | Recombinant Proteins | |
| HY-P78581 | Mer, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P78583 | MARCO, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78584 | Latent TGF beta 1/TGFB1, Cynomolgus (C33S, HEK293, His) | Recombinant Proteins | |
| HY-P78585 | IL-1 beta, Cynomolgus (His) | Recombinant Proteins | |
| HY-P78586 | IGF-I R, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78587 | GPA33, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78589 | FGL1, Cynomolgus (HEK293, mFc) | Recombinant Proteins | |
| HY-P7859 | Beta-galactosidase/GLB1, E.coli | Recombinant Proteins | |
| HY-P78590 | CLEC4C, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78591 | IL-8/CXCL8, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78592 | Tissue Factor, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78595 | Complement C5/C5a, Cynomolgus | Recombinant Proteins | |
| HY-P7860 | Coagulation Factor X/F10, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78602 | TIGIT, Rabbit (HEK293, Fc) | Recombinant Proteins | |
| HY-P78603 | PTK7, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P78608 | IL-5, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P7861 | Complement Factor D/Adipsin, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78616 | LIV-1/SLC39A6, Rat (Sf9, His) | Recombinant Proteins | |
| HY-P78617 | ROR1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P78619 | PTK7, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P7861A | Complement Factor D/Adipsin, Human (HEK293, His, Solution) | Recombinant Proteins | |
| HY-P7862 | Complement C3/C3a, Human | Recombinant Proteins | |
| HY-P78620 | Mesothelin, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P78621 | LIF, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P78622 | FAP, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P78624 | Fc gamma RIIA/CD32a, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P78625 | B2M/Beta-2 microglobulin, Rat (99a.a, HEK293, His) | Recombinant Proteins | |
| HY-P7863 | Complement C3/C3a, Mouse | Recombinant Proteins | |
| HY-P78633 | PD-L1, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P78634 | IL-3R alpha/CD123, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P78635 | IL-2R beta/CD122, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P7864 | Complement C5/C5a, Human | Recombinant Proteins | |
| HY-P78640 | GITR, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P78645 | FITC-Labeled LILRB4/CD85k/ILT3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78646 | FITC-Labeled LILRB4/CD85k/ILT3, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78648 | FITC-Labeled NCAM-1/CD56, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7865 | Cystatin C/CST3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78650 | FITC-Labeled CD38, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78651 | FITC-Labeled Angiopoietin-2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78653 | FITC-Labeled CLEC12A/MICL, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P78656 | LAG-3, Marmoset (HEK293, His) | Recombinant Proteins | |
| HY-P78657 | TYRO3/DTK, Human (Q261H, HEK293, Fc) | Recombinant Proteins | |
| HY-P78658 | TSLP, Human (R127A, R130A, HEK293, His) | Recombinant Proteins | |
| HY-P78659 | TSLP, Human (R127A, R130A, HEK293, mFc) | Recombinant Proteins | |
| HY-P7866 | Cystatin S/CST4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78660 | CD96, Human (C110S, HEK293, His) | Recombinant Proteins | |
| HY-P78663 | PCSK9, Human (D374Y, HEK293, His) | Recombinant Proteins | |
| HY-P78664 | LBP, Human (I465F, HEK293, His) | Recombinant Proteins | |
| HY-P78668 | TGF beta 1/TGFB1 LAP, Human (HEK293, N-His) | Recombinant Proteins | |
| HY-P7867 | Cystatin SN/CST1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78672 | IFN-alpha 2b/IFNA2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78673 | ICOS Protein, Mouse (C137S, C138S, HEK293, Fc) | Recombinant Proteins | |
| HY-P78674 | Glypican-3/GPC3, Human (S359F, HEK293, His) | Recombinant Proteins | |
| HY-P78675 | FGF-23, Human (R179Q, HEK293, His) | Recombinant Proteins | |
| HY-P78676 | Fc gamma RIIIA/CD16a, Human (F176V, HEK293, SUMO-His) | Recombinant Proteins | |
| HY-P78677 | Fc gamma RIIIA/CD16a, Human (F176V, HEK293, His-HSA) | Recombinant Proteins | |
| HY-P7868 | Cystatin A/CSTA, Human (His) | Recombinant Proteins | |
| HY-P78680 | HER2/CD340, Human (S310Y, HEK293, His) | Recombinant Proteins | |
| HY-P78681 | DKK-3, Human (R335G, HEK293, His) | Recombinant Proteins | |
| HY-P78682 | Cathepsin B, Human (L26V, HEK293, His) | Recombinant Proteins | |
| HY-P78688 | PLGF, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P7869 | CG alpha, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78691 | OV16, Onchocerca volvulus (GST) | Recombinant Proteins | |
| HY-P78693 | AMHR2/MISRII, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78694 | Galectin-4, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78695 | LRRC15, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78697 | VEGFR-2, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P78699 | IL-13R alpha 1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7870 | CGA-CGB3 Heterodimer, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78700 | IgG2B Fc, Llama | Recombinant Proteins | |
| HY-P78703 | Gastrin-71, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P78704 | EpCAM/TROP1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78705 | ENPP-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7871 | Placental Lactogen/CSH1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78711 | CD47, Mouse (HEK293, hFc) | Recombinant Proteins | |
| HY-P78712 | CD117/c-kit, Mouse (495a.a, HEK293, Fc) | Recombinant Proteins | |
| HY-P78713 | CCN2/CTGF, Rhesus macaque (HEK293, His) | Recombinant Proteins | |
| HY-P78716 | GITR, Cynomolgus (HEK293, Fc) | Recombinant Proteins | |
| HY-P78717 | ADAM17/TACE, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78719 | IL-15, Mouse (HEK293, Fc) | Recombinant Proteins | |
| HY-P7872 | Alpha-crystallin A chain/CRYAA, Human (His) | Recombinant Proteins | |
| HY-P78720 | LAG-3, Mouse (419a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78721 | PTPRD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78722 | FZD2, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78723 | IGF-I R, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78724 | IGF-I R, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P78726 | Growth Hormone R/GHR, Rhesus macaque (HEK293, Fc) | Recombinant Proteins | |
| HY-P78728 | CBLB/RNF56, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7873 | Alpha-crystallin B chain/CRYAB, Human (His) | Recombinant Proteins | |
| HY-P78730 | Frizzled-7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78732 | CD133/PROM1-VLP, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78733 | Mucin-1/MUC1, Human (269a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78734 | Mucin-1/MUC1, Human (120a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78736 | CD206/MMR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78737 | Serum Albumin/ALB, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P78738 | PADI2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78739 | JAK1, Human (sf9, His) | Recombinant Proteins | |
| HY-P7874 | C-Reactive, Human (His) | Recombinant Proteins | |
| HY-P78740 | Mucin-1/MUC1, Human (357a.a, sf9, Fc) | Recombinant Proteins | |
| HY-P78742 | GUCY2C/Guanylyl cyclase C, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78744 | MUC-17, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78745 | Netrin receptor DCC/DCC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78746 | Carbonic Anhydrase 2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78747 | Furin/PCSK3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78749 | LIV-1/SLC39A6, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7875 | Serum Albumin/ALB, Human (P.pastoris) | Recombinant Proteins | |
| HY-P78750 | ZNRF3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78753 | CD3 gamma, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78756 | CEACAM5, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78757 | Plexin B2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7876 | Complement Factor D/Adipsin, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78760 | IL-13, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P78761 | PTK7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78763 | Coagulation factor VII/F7, Human (406a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78764 | NCAM-1/CD56, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78765 | USAG-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78766 | FOLR3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78767 | PADI2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78767A | PADI2, Mouse (HEK293, N-His) | Recombinant Proteins | |
| HY-P78769 | Cadherin-10/CDH10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7877 | Fructose-bisphosphate aldolase A/ALDOA, Human (His, solution) | Recombinant Proteins | |
| HY-P78770 | Cadherin-9/CDH9, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78771 | AG-2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78772 | IFN-alpha/beta R2, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78773 | Sortilin/SORT1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78774 | Mucin-1/MUC1, Human (HEK293, mFc) | Recombinant Proteins | |
| HY-P78776 | GAPDH, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78778 | LSECtin/CLEC4G, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78779 | Neuropilin-1, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P78783 | Transferrin R2, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P7879 | CD3D, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7880 | Alkaline Phosphatase/ALPL, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78804 | SOST, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P78808 | SIRP alphaV8/CD172a, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78810 | Protein L, Finegoldia magna (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78813 | VEGF165 Protein, Human (Biotinylated, HEK293, Avi) | Recombinant Proteins | |
| HY-P7882 | CD2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78824 | PCSK9, Human (Biotinylated, HEK293, D374Y, His-Avi) | Recombinant Proteins | |
| HY-P7883 | DNA polymerase beta, Human (His) | Recombinant Proteins | |
| HY-P78832 | NKp46/NCR1, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78833 | Mucin-1/MUC1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7884 | CD45, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P7885 | Decorin/PGS2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78850 | LILRA2/CD85h/ILT1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78854 | IL-6, Human (Biotinylated) | Recombinant Proteins | |
| HY-P78855 | IL-4R alpha/CD124, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78858 | IL-2, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P7886 | Collagen alpha-1(III) chain/COL3A, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P78860 | IL-15, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78868 | GM-CSF, Human (HEK293) | Recombinant Proteins | |
| HY-P78869 | Growth Hormone R/GHR, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7887 | CD45, Human (552a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78872 | VEGFR-3/FLT4, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78874 | CD3 epsilon, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78879 | Fc gamma RIIIA/CD16a, Cynomolgus (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7888 | PTPRC/CD45R0, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78881 | Fc gamma RIIIB/CD16b, Human (Biotinylated, NA1, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78882 | Her2/CD340, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P7889 | PTPRC/CD45RA, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78890 | CTLA-4, Human (Biotinylated, HEK293, mFc-Avi) | Recombinant Proteins | |
| HY-P78894 | CEACAM1, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78897 | CD8 alpha, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7890 | Complement factor H/CFH, Human (431a.a, HEK293, His) | Recombinant Proteins | |
| HY-P78900 | LILRB1/CD85j/ILT2, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78904 | TFRC, Cynomolgus (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78908 | CD47, Human (Biotinylated, HEK293, hFc-Avi) | Recombinant Proteins | |
| HY-P78909 | CD36, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P7890A | Complement factor H/CFH, Human (431a.a, HEK293, C-His) | Recombinant Proteins | |
| HY-P7891 | Cystatin SA/CST2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78913 | CD24, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78917 | CD19, Human (Biotinylated, Fc) | Recombinant Proteins | |
| HY-P7892 | Cryptic, Human (HEK293, His) | Recombinant Proteins | |
| HY-P7893 | CG beta 3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78930 | CD276/B7-H3, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78933 | 4-1BBL/TNFSF9, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78934 | CD40L/CD154/TRAP, Human (Biotinylated, HEK293, Fc-Avi) | Recombinant Proteins | |
| HY-P78936 | VISTA/B7-H5, Human (Biotinylated, HEK293, His-Avi) | Recombinant Proteins | |
| HY-P78937 | Fractalkine/CX3CL1, Human (Biotinylated, HEK293, His) | Recombinant Proteins | |
| HY-P78938 | T4 ligase, T4 phage (His) | Recombinant Proteins | |
| HY-P78939 | T4 gp32, T4 phage (His) | Recombinant Proteins | |
| HY-P7894 | SARS-CoV-2 PP1ab (His-MBP) | Recombinant Proteins | |
| HY-P78940 | T4 DNA Polymerase, T4 phage (His) | Recombinant Proteins | |
| HY-P78942 | Bst DNA Polymerase, Geobacillus stearothermophilus (His) | Recombinant Proteins | |
| HY-P78943 | FPG, E.coli (His) | Recombinant Proteins | |
| HY-P78944 | UDG, E.coli (His) | Recombinant Proteins | |
| HY-P78945 | ENDO VIII, E. coli (His) | Recombinant Proteins | |
| HY-P78946 | TDT, Bos taurus (His) | Recombinant Proteins | |
| HY-P78947 | EXO I, E. coli (His) | Recombinant Proteins | |
| HY-P78948 | VCAM-1/CD106, Human (Biotinylated, HEK293, hFc) | Recombinant Proteins | |
| HY-P78949 | HIFI Dna polymerase, Thermococcus kodakarensis | Recombinant Proteins | |
| HY-P7895 | Clusterin/APOJ, Human (HEK293, His) | Recombinant Proteins | |
| HY-P78950 | ALAS2, Human (His) | Recombinant Proteins | |
| HY-P78955 | NucA, S. marcescens | Recombinant Proteins | |
| HY-P7896 | CD20/MS4A1, Human (Trx-His, Solution) | Recombinant Proteins | |
| HY-P7896A | CD20/MS4A1, Human (Trx-His) | Recombinant Proteins | |
| HY-P7897 | Creatine kinase B-type/CKB, Human (His) | Recombinant Proteins | |
| HY-P7898 | D-amino-acid oxidase/DAO, Human (His) | Recombinant Proteins | |
| HY-P78986 | ACAT1, Human (His) | Recombinant Proteins | |
| HY-P78986A | ACAT1, Human | Recombinant Proteins | |
| HY-P7899 | Aminopeptidase N/APN, Human (HEK293, His, solution) | Recombinant Proteins | |
| HY-P78999 | PSAT1, Human (His) | Recombinant Proteins | |
| HY-P7899A | Aminopeptidase N/APN, Human ((HEK293, His) | Recombinant Proteins | |
| HY-P79001 | Crlf1, Mouse ( HEK293, His, solution) | Recombinant Proteins | |
| HY-P790010 | Peroxiredoxin-1, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P790012 | PPAR-gamma, Human (P37231-2, His) | Recombinant Proteins | |
| HY-P790016 | GBP4, mouse (HEK293, His) | Recombinant Proteins | |
| HY-P790035 | DNase1L3, Mouse (His) | Recombinant Proteins | |
| HY-P790057 | LAG-3, Canine (HEK293, Flag, His) | Recombinant Proteins | |
| HY-P790059 | NOX4, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P790073 | FBLN1, Human (HEK293, His, Myc) | Recombinant Proteins | |
| HY-P790076 | PRDX6, Mouse (His) | Recombinant Proteins | |
| HY-P790077 | GRPR, Human (Cell-free, Twin-Strep) | Recombinant Proteins | |
| HY-P790083 | CXCR2, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P790088 | HSPA5, Human (sf9, His) | Recombinant Proteins | |
| HY-P790095 | CARM1, Human (His) | Recombinant Proteins | |
| HY-P790098 | PSMD14, Mouse (His) | Recombinant Proteins | |
| HY-P790108 | NLRP3, Human (His) | Recombinant Proteins | |
| HY-P79018 | TYR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P79037 | MERS-CoV Spike/S1 (CHO, hFc) | Recombinant Proteins | |
| HY-P79064 | Endo S2, S. pyogenes (His) | Recombinant Proteins | |
| HY-P79077 | BMP-3, Human | Recombinant Proteins | |
| HY-P79079 | Galectin-3/LGALS3, Mouse | Recombinant Proteins | |
| HY-P79080 | Nodal, Mouse | Recombinant Proteins | |
| HY-P79083 | Ecotin, E. coli (His) | Recombinant Proteins | |
| HY-P79087 | GM-CSF, Canine | Recombinant Proteins | |
| HY-P79088 | IL-6, Canine | Recombinant Proteins | |
| HY-P79097 | MMP-16, Human (I152N, His) | Recombinant Proteins | |
| HY-P79099 | TNF-alpha/TNFSF2, Equine | Recombinant Proteins | |
| HY-P79101 | IL-6, Equine | Recombinant Proteins | |
| HY-P79104 | PRDC/GREM2, Mouse | Recombinant Proteins | |
| HY-P79111 | SCF, Canine | Recombinant Proteins | |
| HY-P79114 | Lipocalin-2/NGAL, Cynomolgus (CHO, His) | Recombinant Proteins | |
| HY-P79115 | Frizzled-9, Mouse (HEK293, mFc) | Recombinant Proteins | |
| HY-P79117 | IL-4, Bovine | Recombinant Proteins | |
| HY-P79122 | Serum Amyloid A-1, Mouse | Recombinant Proteins | |
| HY-P79124 | Norrin, Human | Recombinant Proteins | |
| HY-P79126 | HO-2/HMOX2, Human (His) | Recombinant Proteins | |
| HY-P79127 | Siglec-11, Human (E84A, K145Q, CHO, hFc) | Recombinant Proteins | |
| HY-P79131 | Norrin, Mouse | Recombinant Proteins | |
| HY-P79135 | Stabilin-2, Human (His) | Recombinant Proteins | |
| HY-P79138 | PSP94/MSMB, Human (His) | Recombinant Proteins | |
| HY-P79142 | KIR3DS1/CD158e2, Human (CHO) | Recombinant Proteins | |
| HY-P79144 | ADAMTS13, Human (CHO, His) | Recombinant Proteins | |
| HY-P79151A | TEV Protease, Tobacco etch virus (S2256N, C-His) | Recombinant Proteins | |
| HY-P79165A | TNF-alpha/TNFSF2, Guinea (N-His) | Recombinant Proteins | |
| HY-P79168 | Hyaluronan Lyase, S. agActiae (His) | Recombinant Proteins | |
| HY-P79169 | TAFA1/FAM19A1, Human | Recombinant Proteins | |
| HY-P79173 | NOTCH1, Mouse (CHO, mFc) | Recombinant Proteins | |
| HY-P79178 | IL-8/CXCL8, Porcine | Recombinant Proteins | |
| HY-P79181 | Heparan Sulfate-6-O-Sulfotransferase-3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P79193 | Fractalkine/CX3CL1, Rat | Recombinant Proteins | |
| HY-P79197 | Heparinase I, B. thetaiotaomicron (His) | Recombinant Proteins | |
| HY-P79202 | IL-18/IL-1F4, Porcine | Recombinant Proteins | |
| HY-P79208 | LEDGF p52, Human | Recombinant Proteins | |
| HY-P79211 | Heparinase III, P. heparinus (His) | Recombinant Proteins | |
| HY-P79214 | Frizzled-7, Human (CHO, hFc) | Recombinant Proteins | |
| HY-P79219 | Toxin B/TcdB, C. difficile (His) | Recombinant Proteins | |
| HY-P79221 | Heparinase II, P. heparinus (His) | Recombinant Proteins | |
| HY-P79222 | Osteopontin/OPN, Rat (CHO, His) | Recombinant Proteins | |
| HY-P79228 | Furin/PCSK3, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P79236 | Agrin, Human (CHO, His) | Recombinant Proteins | |
| HY-P79242 | O-GlcNAcase/OGA, B. thetaiotaomicron (His) | Recombinant Proteins | |
| HY-P79243 | IL-1 alpha/IL-1F1, Pig | Recombinant Proteins | |
| HY-P79244 | Chondroitinase ABC, P. vulgaris (His) | Recombinant Proteins | |
| HY-P79250 | MCV-type II Chemokine-like, Virus | Recombinant Proteins | |
| HY-P79256 | GM-CSF, Pig | Recombinant Proteins | |
| HY-P79264 | CTACK/CCL27, Mouse | Recombinant Proteins | |
| HY-P79268 | IL-10, Canine | Recombinant Proteins | |
| HY-P79277 | Acetylcholinesterase/ACHE, Human (CHO, His) | Recombinant Proteins | |
| HY-P79280 | IFN-gamma, Feline | Recombinant Proteins | |
| HY-P79286 | Nicotinamide N-Methyltransferase/NNMT, Human (His) | Recombinant Proteins | |
| HY-P79293 | IL-1RA/IL-1F3, Porcine | Recombinant Proteins | |
| HY-P79295 | IFN-gamma, Canine | Recombinant Proteins | |
| HY-P79308 | Lgr5/GPR49, Human (CHO, hFc) | Recombinant Proteins | |
| HY-P79310 | PPA1, S. cerevisiae (His) | Recombinant Proteins | |
| HY-P79326 | IL-17A, Rat (CHO) | Recombinant Proteins | |
| HY-P79328 | HTRA/Protease Do Protein, E. coli (His) | Recombinant Proteins | |
| HY-P79333 | BMP-13/GDF-6, Mouse | Recombinant Proteins | |
| HY-P79343 | Agrin, Human (1073a.a, CHO, His) | Recombinant Proteins | |
| HY-P79348 | Periostin/OSF-2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P79356 | PNGase F, F. meningosepticum (His) | Recombinant Proteins | |
| HY-P79357 | Notum, Human (C330S, CHO, His) | Recombinant Proteins | |
| HY-P79362 | IL-10, Virus | Recombinant Proteins | |
| HY-P79369 | CCN2/CTGF, Rat (HEK293) | Recombinant Proteins | |
| HY-P79382 | BTNL8, Human (HEK293, hFc) | Recombinant Proteins | |
| HY-P79398 | FABP5, Mouse (His) | Recombinant Proteins | |
| HY-P79408 | Calcium-sensing R/CaSR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P79419 | Midkine, Mouse | Recombinant Proteins | |
| HY-P79429 | IFN-gamma, Porcine | Recombinant Proteins | |
| HY-P79432 | GM-CSF, Feline (M36I, T56A, K126N) | Recombinant Proteins | |
| HY-P79448 | UBE2R1/CDC34, Human (Sf9, His, Strep) | Recombinant Proteins | |
| HY-P79449 | UbcH5b/UBE2D2, Human | Recombinant Proteins | |
| HY-P79451 | UbcH7/UBE2L3, Human | Recombinant Proteins | |
| HY-P79452 | UBE2N/Ubc13, Human (sf9, His, Strep) | Recombinant Proteins | |
| HY-P79454 | ISG15 E1/UBE1L, Human (sf9, His, Strep) | Recombinant Proteins | |
| HY-P79456 | Ataxin-3, Human (His) | Recombinant Proteins | |
| HY-P79457 | USP2 Catalytic Domain, Human (His) | Recombinant Proteins | |
| HY-P79459 | SENP1 Catalytic Domain, Human (His) | Recombinant Proteins | |
| HY-P7989 | Janus kinase 2/JAK2, Human (His) | Recombinant Proteins | |
| HY-P7991 | IFN-lambda 2/IL-28A, Mouse (HEK293, His, solution) | Recombinant Proteins | |
| HY-P7991A | IFN-lambda 2/IL-28A, Mouse (HEK293, N-His) | Recombinant Proteins | |
| HY-P7992 | ACE/CD143, Human (His) | Recombinant Proteins | |
| HY-P7993A | Cathepsin B, Human (HEK293, C-His) | Recombinant Proteins | |
| HY-P7996 | PPAR alpha, Human (His) | Recombinant Proteins | |
| HY-P7999 | PPAR gamma, Human (His) | Recombinant Proteins | |
| HY-P7S0152 | RORC, Human (His, SUMO) | Recombinant Proteins | |
| HY-P7S0185 | CHUK, Human (Sf9, His, GST) | Recombinant Proteins | |
| HY-P7S0363 | PPARD, Human (HEK293, His) | Recombinant Proteins | |
| HY-P80001 | 53BP1 Antibody | Antibodies | |
| HY-P80002 | ABCG2 Antibody | Antibodies | |
| HY-P80003 | ACE2 Antibody | Antibodies | |
| HY-P80004 | Adiponectin Antibody | Antibodies | |
| HY-P80005 | Adiponectin receptor protein 1 Antibody | Antibodies | |
| HY-P80006 | AIF Antibody (YA636) | Antibodies | |
| HY-P80007 | AKT1 Antibody (YA834) | Antibodies | |
| HY-P80008 | AKT1 Antibody (YA634) | Antibodies | |
| HY-P80009 | AKT1/2/3 Antibody | Antibodies | |
| HY-P8001 | HRP-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P80010 | Albumin Antibody | Antibodies | |
| HY-P80011 | ALIX Antibody | Antibodies | |
| HY-P80012 | Alkaline Phosphatase Antibody | Antibodies | |
| HY-P80013 | ALKBH1 Antibody | Antibodies | |
| HY-P80014 | Androgen receptor Antibody | Antibodies | |
| HY-P80015 | Annexin A2 Antibody | Antibodies | |
| HY-P80016 | APC Antibody | Antibodies | |
| HY-P80017 | APC6 Antibody | Antibodies | |
| HY-P80018 | A-RAF Antibody | Antibodies | |
| HY-P80019 | Arginase-1 Antibody | Antibodies | |
| HY-P8002 | Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P80020 | ASK1 Antibody (YA609) | Antibodies | |
| HY-P80021 | Atg12 Antibody | Antibodies | |
| HY-P80022 | ATG5 Antibody | Antibodies | |
| HY-P80023 | ATM Antibody | Antibodies | |
| HY-P80024 | ATRX Antibody | Antibodies | |
| HY-P80025 | Bad Antibody | Antibodies | |
| HY-P80026 | Bak Antibody (YA592) | Antibodies | |
| HY-P80027 | BAX Antibody (YA825) | Antibodies | |
| HY-P80028 | Bax Antibody (YA591) | Antibodies | |
| HY-P80029 | Bcl-2 Antibody | Antibodies | |
| HY-P8003 | Alexa Fluor® 594-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P80030 | Bcl-XL Antibody | Antibodies | |
| HY-P80031 | Bid Antibody | Antibodies | |
| HY-P80032 | Bim Antibody | Antibodies | |
| HY-P80033 | BMAL1 Antibody | Antibodies | |
| HY-P80034 | Bmi1 Antibody | Antibodies | |
| HY-P80035 | BNIP3 Antibody | Antibodies | |
| HY-P80036 | B-Raf Antibody | Antibodies | |
| HY-P80037 | BRD2 Antibody | Antibodies | |
| HY-P80038 | BrdU Antibody (YA578) | Antibodies | |
| HY-P80039 | BRG1 Antibody | Antibodies | |
| HY-P8004 | HRP-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P80040 | Calbindin Antibody | Antibodies | |
| HY-P80041 | Calnexin Antibody (YA573) | Antibodies | |
| HY-P80042 | Calpastatin Antibody | Antibodies | |
| HY-P80043 | Calreticulin Antibody | Antibodies | |
| HY-P80044 | Caspase-10 Antibody | Antibodies | |
| HY-P80045 | Caspase-14 Antibody | Antibodies | |
| HY-P80046 | Caspase-3 Antibody | Antibodies | |
| HY-P80047 | Caspase-6 Antibody | Antibodies | |
| HY-P80048 | Caspase-6 p18 Antibody | Antibodies | |
| HY-P80049 | Caspase-8 Antibody | Antibodies | |
| HY-P8005 | Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P80050 | Caspase-9 Antibody | Antibodies | |
| HY-P80051 | Catalase Antibody (YA552) | Antibodies | |
| HY-P80052 | Catalase Antibody (YA811) | Antibodies | |
| HY-P80053 | Caveolin-1 Antibody | Antibodies | |
| HY-P80054 | CD133 Antibody | Antibodies | |
| HY-P80055 | CD4 Antibody | Antibodies | |
| HY-P80056 | CD40 Antibody | Antibodies | |
| HY-P80057 | CD40L Antibody | Antibodies | |
| HY-P80058 | CD41 Antibody | Antibodies | |
| HY-P80059 | CD42a Antibody | Antibodies | |
| HY-P8006 | Alexa Fluor® 594-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P80060 | CD42b Antibody | Antibodies | |
| HY-P80061 | CD43 Antibody | Antibodies | |
| HY-P80062 | CD44 Antibody | Antibodies | |
| HY-P80063 | CD45 Antibody (YA533) | Antibodies | |
| HY-P80064 | CD46 Antibody | Antibodies | |
| HY-P80065 | CD47 Antibody | Antibodies | |
| HY-P80066 | CD68 Antibody (YA798) | Antibodies | |
| HY-P80067 | CD68 Antibody (YA529) | Antibodies | |
| HY-P80068 | CD9 Antibody (YA524) | Antibodies | |
| HY-P80069 | CD90 Antibody | Antibodies | |
| HY-P80070 | CD99 Antibody | Antibodies | |
| HY-P80071 | CDC23 Antibody | Antibodies | |
| HY-P80072 | Cdc25B Antibody | Antibodies | |
| HY-P80073 | Cdc27 Antibody | Antibodies | |
| HY-P80075 | CDC42EP1 Antibody | Antibodies | |
| HY-P80076 | Cdk2 Antibody | Antibodies | |
| HY-P80077 | Cdk4 Antibody | Antibodies | |
| HY-P80078 | Cdk5 Antibody | Antibodies | |
| HY-P80079 | Cdk6 Antibody | Antibodies | |
| HY-P80080 | CDT1 Antibody | Antibodies | |
| HY-P80081 | c-Fos Antibody (YA506) | Antibodies | |
| HY-P80082 | Chk1 Antibody (YA505) | Antibodies | |
| HY-P80083 | Chk2 Antibody | Antibodies | |
| HY-P80084 | c-Jun Antibody | Antibodies | |
| HY-P80085 | c-Kit Antibody (YA502) | Antibodies | |
| HY-P80086 | Clathrin heavy chain Antibody | Antibodies | |
| HY-P80087 | CNPase Antibody | Antibodies | |
| HY-P80088 | Cortactin Antibody | Antibodies | |
| HY-P80089 | COX IV Antibody | Antibodies | |
| HY-P80090 | COX2 Antibody | Antibodies | |
| HY-P80091 | COX2/Cyclooxygenase 2 Antibody | Antibodies | |
| HY-P80092 | CREB Antibody | Antibodies | |
| HY-P80093 | c-Rel Antibody | Antibodies | |
| HY-P80094 | Ctip1 Antibody | Antibodies | |
| HY-P80095 | Ctip2 Antibody | Antibodies | |
| HY-P80096 | Cyclin A2 Antibody | Antibodies | |
| HY-P80097 | Cyclin B1 Antibody (YA486) | Antibodies | |
| HY-P80098 | Cyclin D1 Antibody (YA485) | Antibodies | |
| HY-P80099 | Cyclin D3 Antibody | Antibodies | |
| HY-P80100 | Cyclin E1 Antibody (YA483) | Antibodies | |
| HY-P80101 | Cyclophilin A Antibody | Antibodies | |
| HY-P80102 | Cytochrome C Antibody | Antibodies | |
| HY-P80103 | Desmin Antibody | Antibodies | |
| HY-P80104 | DNA-PKcs/PRKDC Antibody | Antibodies | |
| HY-P80105 | DNMT1 Antibody (YA781) | Antibodies | |
| HY-P80106 | Dnmt1 Antibody (YA476) | Antibodies | |
| HY-P80107 | Dnmt3a Antibody | Antibodies | |
| HY-P80108 | Doublecortin Antibody | Antibodies | |
| HY-P80109 | DR5 Antibody | Antibodies | |
| HY-P80110 | Drosha Antibody | Antibodies | |
| HY-P80111 | DYKDDDDK Tag (FLAG) Antibody | Antibodies | |
| HY-P80111A | Flag Tag Antibody (HRP) (YA873) | Antibodies | |
| HY-P80112 | E-Cadherin Antibody (YA778) | Antibodies | |
| HY-P80113 | E-Cadherin Antibody (YA470) | Antibodies | |
| HY-P80114 | EEA1 Antibody | Antibodies | |
| HY-P80115 | EGF Antibody | Antibodies | |
| HY-P80116 | EGFR Antibody | Antibodies | |
| HY-P80117 | EGR1 Antibody | Antibodies | |
| HY-P80118 | eIF4E Antibody | Antibodies | |
| HY-P80119 | eIF4EBP1 Antibody | Antibodies | |
| HY-P80120 | Epac1 Antibody | Antibodies | |
| HY-P80121 | EpCAM Antibody (YA772) | Antibodies | |
| HY-P80122 | ERK5 Antibody | Antibodies | |
| HY-P80123 | ERp72 Antibody | Antibodies | |
| HY-P80124 | FABP4 Antibody | Antibodies | |
| HY-P80125 | FAK Antibody | Antibodies | |
| HY-P80126 | Fas/CD95 Antibody | Antibodies | |
| HY-P80127 | Fascin Antibody (YA445) | Antibodies | |
| HY-P80128 | Fatty Acid Synthase Antibody | Antibodies | |
| HY-P80129 | Filamin A Antibody | Antibodies | |
| HY-P80130 | FIP200 Antibody | Antibodies | |
| HY-P80131 | FosB Antibody | Antibodies | |
| HY-P80132 | FOXO1A Antibody | Antibodies | |
| HY-P80134 | FOXO4 Antibody | Antibodies | |
| HY-P80135 | FOXP3 Antibody | Antibodies | |
| HY-P80136 | GABARAP Antibody | Antibodies | |
| HY-P80137 | GAPDH Antibody | Antibodies | |
| HY-P80138 | GCN2 Antibody | Antibodies | |
| HY-P80139 | GFAP Antibody (YA755) | Antibodies | |
| HY-P80140 | GFAP Antibody (YA416) | Antibodies | |
| HY-P80141 | GFP Antibody | Antibodies | |
| HY-P80142 | Gli1 Antibody | Antibodies | |
| HY-P80143 | Glucocorticoid Receptor alpha Antibody | Antibodies | |
| HY-P80145 | Glycogen synthase Antibody | Antibodies | |
| HY-P80146 | GPX1 Antibody | Antibodies | |
| HY-P80147 | GRB2 Antibody | Antibodies | |
| HY-P80148 | GST-Tag Antibody HRP Conjugated | Antibodies | |
| HY-P80148A | GST-Tag Antibody | Antibodies | |
| HY-P80149 | HDAC1 Antibody | Antibodies | |
| HY-P80150 | HDAC10 Antibody | Antibodies | |
| HY-P80151 | HDAC2 Antibody | Antibodies | |
| HY-P80152 | HDAC3 Antibody | Antibodies | |
| HY-P80153 | HDAC4 Antibody | Antibodies | |
| HY-P80154 | HDAC6 Antibody | Antibodies | |
| HY-P80155 | Hes1 Antibody | Antibodies | |
| HY-P80157 | Histone H1.0 Antibody | Antibodies | |
| HY-P80158 | Histone H1.2 Antibody | Antibodies | |
| HY-P80159 | Histone H2A(acetyl K9) Antibody | Antibodies | |
| HY-P80160 | Histone H2A (hydroxyl Y39) Antibody | Antibodies | |
| HY-P80161 | Histone H2A.X Antibody | Antibodies | |
| HY-P80162 | Histone H2A.Z Antibody | Antibodies | |
| HY-P80163 | Histone H2B Antibody | Antibodies | |
| HY-P80164 | Histone H2B (acetyl K20) Antibody | Antibodies | |
| HY-P80165 | Histone H2B (mono methyl R79) Antibody | Antibodies | |
| HY-P80166 | Histone H3 Antibody | Antibodies | |
| HY-P80167 | Histone H3 (acetyl K14) Antibody | Antibodies | |
| HY-P80168 | Histone H3 (acetyl K18) Antibody | Antibodies | |
| HY-P80169 | Histone H3 (acetyl K27) Antibody | Antibodies | |
| HY-P80170 | Histone H3 (acetyl K56) Antibody | Antibodies | |
| HY-P80171 | Histone H3 (di methyl K9) Antibody | Antibodies | |
| HY-P80172 | Histone H3 (mono methyl K18) Antibody | Antibodies | |
| HY-P80173 | Histone H3 (mono methyl K36)Antibody | Antibodies | |
| HY-P80174 | Histone H3 (mono methyl R2)Antibody | Antibodies | |
| HY-P80175 | Histone H3 (mono+di+tri methyl K79) Antibody | Antibodies | |
| HY-P80176 | Histone H3 (tri methyl K9) Antibody | Antibodies | |
| HY-P80177 | Histone H3.3 Antibody | Antibodies | |
| HY-P80178 | Histone H4 Antibody | Antibodies | |
| HY-P80179 | Histone H4 (acetyl K16) Antibody | Antibodies | |
| HY-P80180 | Histone H4 (acetyl K8) Antibody | Antibodies | |
| HY-P80181 | Histone H4 (tri methyl K20) Antibody | Antibodies | |
| HY-P80182 | Histone H4 (acetyl K5) Antibody | Antibodies | |
| HY-P80183 | HMGB1 Antibody | Antibodies | |
| HY-P80184 | HSP60 Antibody | Antibodies | |
| HY-P80185 | Hsp70 Antibody (YA359) | Antibodies | |
| HY-P80186 | Hsp90 alpha Antibody | Antibodies | |
| HY-P80187 | Hsp90 beta Antibody | Antibodies | |
| HY-P80188 | Huntingtin Antibody | Antibodies | |
| HY-P80189A | IL-6 Antibody (YA3428) | Antibodies | |
| HY-P80190 | Insulin Antibody | Antibodies | |
| HY-P80191 | Insulin degrading enzyme Antibody | Antibodies | |
| HY-P80192 | Insulin Receptor Beta Antibody | Antibodies | |
| HY-P80193 | Insulin Receptor R Antibody | Antibodies | |
| HY-P80194 | ISG15 Antibody | Antibodies | |
| HY-P80195 | Jagged1 Antibody | Antibodies | |
| HY-P80196 | JAK1 Antibody | Antibodies | |
| HY-P80197 | JNK1+JNK2+JNK3 Antibody | Antibodies | |
| HY-P80198 | JNK1+JNK3 Antibody | Antibodies | |
| HY-P80199 | JNK2 Antibody | Antibodies | |
| HY-P80200 | JunB Antibody | Antibodies | |
| HY-P80201 | KLF4 Antibody | Antibodies | |
| HY-P80202 | Ku70 Antibody (YA715) | Antibodies | |
| HY-P80203 | Ku80 Antibody | Antibodies | |
| HY-P80204 | Lamin A/C Antibody | Antibodies | |
| HY-P80205 | Lamin B1 Antibody | Antibodies | |
| HY-P80206 | LAMP1 Antibody | Antibodies | |
| HY-P80206A | LAMP1 Antibody (YA3434) | Antibodies | |
| HY-P80207 | LAMP2 Antibody (YA713) | Antibodies | |
| HY-P80208 | LAMP2a Antibody | Antibodies | |
| HY-P80209 | LC3B Antibody (YA308) | Antibodies | |
| HY-P80210 | LIN28A Antibody | Antibodies | |
| HY-P80211 | Lin28B Antibody | Antibodies | |
| HY-P80212 | LRP6 Antibody | Antibodies | |
| HY-P80213 | MAPK14 Antibody | Antibodies | |
| HY-P80214 | MAPKAP Kinase 2 Antibody | Antibodies | |
| HY-P80215 | MCM2 Antibody | Antibodies | |
| HY-P80216 | MCU Antibody | Antibodies | |
| HY-P80217 | MEK1 Antibody | Antibodies | |
| HY-P80218 | MEK1/2 Antibody | Antibodies | |
| HY-P80219 | Met (C-Met) Antibody | Antibodies | |
| HY-P80220 | Metabotropic glutamate receptor 5 Antibody | Antibodies | |
| HY-P80221 | Methionine Aminopeptidase 2 Antibody | Antibodies | |
| HY-P80222 | Methylmalonyl Coenzyme A mutase Antibody | Antibodies | |
| HY-P80223 | METTL3 Antibody | Antibodies | |
| HY-P80224 | MGMT Antibody | Antibodies | |
| HY-P80225 | MiTF Antibody | Antibodies | |
| HY-P80226 | MLH1 Antibody | Antibodies | |
| HY-P80227 | MLKL Antibody | Antibodies | |
| HY-P80228 | Moesin Antibody | Antibodies | |
| HY-P80229 | Mre11 Antibody | Antibodies | |
| HY-P80230 | Mst2 Antibody | Antibodies | |
| HY-P80231 | mTOR Antibody (YA281) | Antibodies | |
| HY-P80232 | Myc-tag Antibody | Antibodies | |
| HY-P80232A | Myc Tag Antibody(HRP) (YA866) | Antibodies | |
| HY-P80233 | MyD88 Antibody (YA280) | Antibodies | |
| HY-P80234 | Myosin heavy chain Antibody | Antibodies | |
| HY-P80235 | Myosin Light Chain 2 Antibody | Antibodies | |
| HY-P80236 | Myosin light chain kinase Antibody | Antibodies | |
| HY-P80237 | Nanog Antibody | Antibodies | |
| HY-P80239 | NDRG1 Antibody | Antibodies | |
| HY-P80240 | NEDD8 Antibody | Antibodies | |
| HY-P80241 | NeuN Antibody | Antibodies | |
| HY-P80242 | NFAT1 Antibody | Antibodies | |
| HY-P80243 | NFAT2 Antibody | Antibodies | |
| HY-P80244 | NF-KB p105/p50 Antibody | Antibodies | |
| HY-P80245 | NF-KB p65 Antibody | Antibodies | |
| HY-P80246 | NLRP3 Antibody | Antibodies | |
| HY-P80247 | NMDAR1 Antibody | Antibodies | |
| HY-P80248 | NMDAR2A Antibody | Antibodies | |
| HY-P80249 | nNOS Antibody | Antibodies | |
| HY-P80250 | NQO1 Antibody (YA697) | Antibodies | |
| HY-P80251 | NQO1 Antibody (YA261) | Antibodies | |
| HY-P80252 | Nucleolin Antibody | Antibodies | |
| HY-P80253 | NUMB Antibody | Antibodies | |
| HY-P80254 | OGT Antibody | Antibodies | |
| HY-P80255 | OPA1 Antibody | Antibodies | |
| HY-P80256 | p27 KIP 1 Antibody | Antibodies | |
| HY-P80257 | p53 Antibody (YA250) | Antibodies | |
| HY-P80258 | p53 (acetyl K382) Antibody | Antibodies | |
| HY-P80259 | p53 DINP1 Antibody | Antibodies | |
| HY-P80260 | p53 (acetyl K370)Antibody | Antibodies | |
| HY-P80261 | Pan-Actin Antibody | Antibodies | |
| HY-P80262 | Pan-Cadherin Antibody | Antibodies | |
| HY-P80263 | PARP1 Antibody | Antibodies | |
| HY-P80265 | PARP2 Antibody | Antibodies | |
| HY-P80266 | Paxillin Antibody | Antibodies | |
| HY-P80267 | PCK1 Antibody | Antibodies | |
| HY-P80268 | PCNA Antibody | Antibodies | |
| HY-P80269 | PDCD4 Antibody | Antibodies | |
| HY-P80270 | PDIA2 Antibody | Antibodies | |
| HY-P80271 | PDIA6 Antibody | Antibodies | |
| HY-P80272 | PDK1 Antibody | Antibodies | |
| HY-P80273 | PD-L1 Antibody | Antibodies | |
| HY-P80274 | PDX1 Antibody | Antibodies | |
| HY-P80275 | PFKFB3 Antibody | Antibodies | |
| HY-P80276 | Phospho-AKT1(Ser473) Antibody | Antibodies | |
| HY-P80277 | Phospho-Glycogen synthase 1 (S641) Antibody | Antibodies | |
| HY-P80278 | Phospho-PDGFR beta (Y740) Antibody | Antibodies | |
| HY-P80279 | Phospho-PKC alpha (T638) Antibody | Antibodies | |
| HY-P80280 | Phospho-PKC zeta (T560) Antibody | Antibodies | |
| HY-P80281 | Phospho-STAT3 (Ser727) Antibody | Antibodies | |
| HY-P80282 | Phospho-STAT3 (Tyr705) Antibody (YA146) | Antibodies | |
| HY-P80283 | PKR Antibody | Antibodies | |
| HY-P80284 | PP2A alpha + beta Antibody | Antibodies | |
| HY-P80285 | PSD95 Antibody | Antibodies | |
| HY-P80286 | PTEN Antibody | Antibodies | |
| HY-P80287 | PU.1/SPI1 Antibody (YA118) | Antibodies | |
| HY-P80288 | PU.1/SPI1 Antibody (YA117) | Antibodies | |
| HY-P80289 | PUMA Antibody | Antibodies | |
| HY-P80290 | PYK2 Antibody (YA115) | Antibodies | |
| HY-P80291 | Pyruvate Dehydrogenase E1 beta subunit Antibody | Antibodies | |
| HY-P80292 | Pyruvate Dehydrogenase E2 Antibody | Antibodies | |
| HY-P80293 | Rab5 Antibody | Antibodies | |
| HY-P80294 | RAB5C Antibody | Antibodies | |
| HY-P80295 | RAB7 Antibody | Antibodies | |
| HY-P80296 | RAB8A Antibody | Antibodies | |
| HY-P80297 | Rad51 Antibody | Antibodies | |
| HY-P80298 | Ras Antibody | Antibodies | |
| HY-P80299 | RASA1 Antibody | Antibodies | |
| HY-P80300 | Rb Antibody | Antibodies | |
| HY-P80301 | RbAP48 Antibody | Antibodies | |
| HY-P80302 | RbBP5 Antibody | Antibodies | |
| HY-P80303 | RBM3 Antibody | Antibodies | |
| HY-P80304 | RBP4 Antibody | Antibodies | |
| HY-P80305 | RBPJK Antibody | Antibodies | |
| HY-P80306 | RelB Antibody | Antibodies | |
| HY-P80307 | Ret Antibody | Antibodies | |
| HY-P80308 | Retinoic Acid Receptor alpha Antibody | Antibodies | |
| HY-P80309 | Retinoid X Receptor alpha Antibody | Antibodies | |
| HY-P80310 | RHEB Antibody | Antibodies | |
| HY-P80311 | RhoA Antibody (YA093) | Antibodies | |
| HY-P80312 | RICTOR Antibody | Antibodies | |
| HY-P80313 | RIP Antibody | Antibodies | |
| HY-P80314 | ROCK1 Antibody | Antibodies | |
| HY-P80315 | RSK1 p90 Antibody (YA088) | Antibodies | |
| HY-P80316 | RUNX2 Antibody | Antibodies | |
| HY-P80317 | S100A4 Antibody | Antibodies | |
| HY-P80318 | SDHA Antibody | Antibodies | |
| HY-P80319 | SIRT1 Antibody | Antibodies | |
| HY-P80320 | SIRT2 Antibody | Antibodies | |
| HY-P80321 | SIRT5 Antibody | Antibodies | |
| HY-P80322 | SIRT6 Antibody | Antibodies | |
| HY-P80323 | Smad1 Antibody | Antibodies | |
| HY-P80324 | Smad2 Antibody | Antibodies | |
| HY-P80325 | Smad3 Antibody | Antibodies | |
| HY-P80326 | Smad4 Antibody | Antibodies | |
| HY-P80327 | Smad5 Antibody | Antibodies | |
| HY-P80328 | SOCS2 Antibody | Antibodies | |
| HY-P80329 | SOD2 Antibody (YA071) | Antibodies | |
| HY-P80330 | SOX1 Antibody | Antibodies | |
| HY-P80331 | SOX10 Antibody | Antibodies | |
| HY-P80332 | SOX11 Antibody | Antibodies | |
| HY-P80333 | SOX18 Antibody | Antibodies | |
| HY-P80334 | SOX2 Antibody | Antibodies | |
| HY-P80335 | SOX9 Antibody | Antibodies | |
| HY-P80336 | SP1 Antibody | Antibodies | |
| HY-P80337 | SPHK1 Antibody | Antibodies | |
| HY-P80338 | Src Antibody | Antibodies | |
| HY-P80339 | SRC1 Antibody | Antibodies | |
| HY-P80340 | STAT1 Antibody (YA059) | Antibodies | |
| HY-P80341 | STAT1 Antibody (YA667) | Antibodies | |
| HY-P80342 | STAT1 alpha Antibody | Antibodies | |
| HY-P80343 | STAT2 Antibody (YA057) | Antibodies | |
| HY-P80344 | STAT3 Antibody (YA056) | Antibodies | |
| HY-P80345 | STAT5a Antibody | Antibodies | |
| HY-P80346 | STAT5b Antibody | Antibodies | |
| HY-P80347 | STAT6 Antibody | Antibodies | |
| HY-P80348 | Stathmin 1 Antibody (YA049) | Antibodies | |
| HY-P80349 | Stathmin 1 Antibody (YA050) | Antibodies | |
| HY-P80350 | STING Antibody (YA048) | Antibodies | |
| HY-P80351 | SUMO1 Antibody (YA046) | Antibodies | |
| HY-P80352 | Survivin Antibody (YA045) | Antibodies | |
| HY-P80353 | SUZ12 Antibody | Antibodies | |
| HY-P80354 | Synaptophysin Antibody (YA043) | Antibodies | |
| HY-P80355 | TAK1 Antibody (YA042) | Antibodies | |
| HY-P80356 | TIMP2 Antibody | Antibodies | |
| HY-P80357 | TRAF2 Antibody | Antibodies | |
| HY-P80358 | TrkA Antibody | Antibodies | |
| HY-P80359 | TrkA+B+C Antibody | Antibodies | |
| HY-P80360 | TrkB Antibody | Antibodies | |
| HY-P80361 | TXNIP Antibody | Antibodies | |
| HY-P80362 | Tyrosine Hydroxylase Antibody | Antibodies | |
| HY-P80363 | Ubiquitin Antibody (YA022) | Antibodies | |
| HY-P80364 | Ubiquitin D Antibody | Antibodies | |
| HY-P80365 | Ubiquitin-like modifier-activating enzyme 1 Antibody | Antibodies | |
| HY-P80366 | ULK1 Antibody | Antibodies | |
| HY-P80367 | V5-tag Antibody | Antibodies | |
| HY-P80368 | VASP Antibody | Antibodies | |
| HY-P80369 | VDAC1 Antibody | Antibodies | |
| HY-P80370 | VEGF Receptor 2 Antibody | Antibodies | |
| HY-P80371 | Vimentin Antibody | Antibodies | |
| HY-P80372 | Vinculin Antibody | Antibodies | |
| HY-P80373 | WDR5 Antibody | Antibodies | |
| HY-P80374 | YAP1 Antibody | Antibodies | |
| HY-P80375 | YB1 Antibody (YA004) | Antibodies | |
| HY-P80376 | AMPK alpha 1 Antibody (YA624) | Antibodies | |
| HY-P80377 | AMPK alpha 2 Antibody (YA833) | Antibodies | |
| HY-P80378 | Aryl hydrocarbon Receptor Antibody | Antibodies | |
| HY-P80379 | ATF6 Antibody (YA831) | Antibodies | |
| HY-P80380 | ATP citrate lyase Antibody | Antibodies | |
| HY-P80382 | Carbonic Anhydrase I Antibody | Antibodies | |
| HY-P80383 | Cathepsin B Antibody | Antibodies | |
| HY-P80384 | Cathepsin D Antibody | Antibodies | |
| HY-P80385 | CCR2 Antibody | Antibodies | |
| HY-P80386 | CD38 Antibody | Antibodies | |
| HY-P80387 | CD73 Antibody (YA528) | Antibodies | |
| HY-P80388 | CD73 Antibody (YA797) | Antibodies | |
| HY-P80389 | Cdk7 Antibody | Antibodies | |
| HY-P80390 | Dynamin 1 Antibody | Antibodies | |
| HY-P80391 | ERK1 Antibody | Antibodies | |
| HY-P80392 | Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187) Antibody (YA455) | Antibodies | |
| HY-P80393 | ERK1/2 Antibody | Antibodies | |
| HY-P80394 | ERK2 Antibody | Antibodies | |
| HY-P80395 | FGFR1 Antibody | Antibodies | |
| HY-P80396 | FGFR1 Oncogene Partner Antibody | Antibodies | |
| HY-P80397 | FGFR2 Antibody | Antibodies | |
| HY-P80398 | FGFR2/CD332 Antibody | Antibodies | |
| HY-P80399 | FGFR3 Antibody | Antibodies | |
| HY-P80400 | FKBP12 Antibody | Antibodies | |
| HY-P80401 | FKBP51 Antibody | Antibodies | |
| HY-P80402 | FKBP52 Antibody | Antibodies | |
| HY-P80403 | Galectin 1 Antibody | Antibodies | |
| HY-P80404 | Galectin 3 Antibody | Antibodies | |
| HY-P80405 | Glucosidase 2 subunit beta Antibody | Antibodies | |
| HY-P80406 | GLUT2 Antibody | Antibodies | |
| HY-P80407 | Glutamate receptor 1 Antibody | Antibodies | |
| HY-P80408 | Glutamine Synthetase Antibody (YA751) | Antibodies | |
| HY-P80410 | Glutathione Peroxidase 1 Antibody (YA404) | Antibodies | |
| HY-P80411 | Glutathione Synthetase Antibody | Antibodies | |
| HY-P80412 | HSP70 Antibody (YA728) | Antibodies | |
| HY-P80413 | IKK alpha Antibody | Antibodies | |
| HY-P80414 | IKK alpha + IKK beta Antibody | Antibodies | |
| HY-P80415 | IKK gamma Antibody | Antibodies | |
| HY-P80416 | Integrin alpha 5 Antibody | Antibodies | |
| HY-P80417 | Integrin alpha V Antibody | Antibodies | |
| HY-P80418 | Integrin beta 1 Antibody | Antibodies | |
| HY-P80419 | Integrin beta 3 Antibody | Antibodies | |
| HY-P80420 | IRAK-1 Antibody | Antibodies | |
| HY-P80421 | JAK2 Antibody (YA721) | Antibodies | |
| HY-P80422 | Lactate Dehydrogenase Antibody | Antibodies | |
| HY-P80423 | LXR alpha Antibody | Antibodies | |
| HY-P80424 | MMP3 Antibody | Antibodies | |
| HY-P80425 | MMP9 Antibody (YA285) | Antibodies | |
| HY-P80426 | Notch 1 Antibody | Antibodies | |
| HY-P80427 | Phospholipase C gamma 1 Antibody | Antibodies | |
| HY-P80428 | PKA 2 beta (regulatory subunit)Antibody | Antibodies | |
| HY-P80429 | PKA R2 Antibody | Antibodies | |
| HY-P80430 | PKC alpha Antibody | Antibodies | |
| HY-P80431 | PKC beta 1 Antibody | Antibodies | |
| HY-P80432 | PKC beta 2 Antibody | Antibodies | |
| HY-P80433 | PKC delta Antibody | Antibodies | |
| HY-P80434 | PKC epsilon Antibody | Antibodies | |
| HY-P80435 | PKC gamma Antibody | Antibodies | |
| HY-P80436 | PPAR gamma Antibody (YA122) | Antibodies | |
| HY-P80437 | Proteasome 20S LMP7 Antibody | Antibodies | |
| HY-P80438 | Beta Actin Antibody | Antibodies | |
| HY-P80439 | Laminin beta 1 Antibody | Antibodies | |
| HY-P80440 | Oct-4 Antibody | Antibodies | |
| HY-P80441 | Argonaute 2 Antibody (YA612) | Antibodies | |
| HY-P80443 | Calpain 1 Antibody | Antibodies | |
| HY-P80444 | Calpain 2 Antibody | Antibodies | |
| HY-P80445 | CaMKII alpha Antibody | Antibodies | |
| HY-P80446 | CD19 Antibody | Antibodies | |
| HY-P80447 | CD31 Antibody | Antibodies | |
| HY-P80448 | Cleaved PARP Antibody | Antibodies | |
| HY-P80449 | Cytochrome P450 17A1 Antibody | Antibodies | |
| HY-P80450 | GPX4 Antibody | Antibodies | |
| HY-P80451 | Phospho-AMPK alpha 1 (Ser496) Antibody (YA226) | Antibodies | |
| HY-P80452 | Phospho-AMPK alpha 2(Ser345) Antibody | Antibodies | |
| HY-P80453 | Phospho-ATM (S1981) Antibody | Antibodies | |
| HY-P80454 | Phospho-BTK(Y223) Antibody | Antibodies | |
| HY-P80455 | Phospho-Chk1 (Ser296) Antibody | Antibodies | |
| HY-P80456 | Phospho-c-Jun(Ser63) Antibody | Antibodies | |
| HY-P80457 | Phospho-Creb (Ser133) Antibody | Antibodies | |
| HY-P80458 | Phospho-EGFR (Tyr1068) Antibody (YA204) | Antibodies | |
| HY-P80459 | Phospho-eIF4G (Ser1108) Antibody | Antibodies | |
| HY-P80460 | Phospho-FAK (Tyr397) Antibody | Antibodies | |
| HY-P80461 | Phospho-FOXO3a(Ser253) Antibody | Antibodies | |
| HY-P80462 | Phospho-GSK3 beta(Ser 9) Antibody | Antibodies | |
| HY-P80463 | Phospho-Histone H2A.X (Ser139) Antibody (YA190) | Antibodies | |
| HY-P80464 | Phospho-Hormone sensitive lipase (Ser853) Antibody | Antibodies | |
| HY-P80465 | Phospho-Hsp27 (Ser82) Antibody (YA187) | Antibodies | |
| HY-P80466 | Phospho-IKB alpha (Ser32) Antibody (YA183) | Antibodies | |
| HY-P80467 | Phospho-JAK2 (Tyr1007+Tyr1008) Antibody | Antibodies | |
| HY-P80468 | Phospho-MLKL (Ser345) Antibody | Antibodies | |
| HY-P80469 | Phospho-mTOR (Ser2448) Antibody (YA691) | Antibodies | |
| HY-P80470 | Phospho-NF-κB p65 (Ser529) Antibody | Antibodies | |
| HY-P80471 | Phospho-Nrf2 (Ser40) Antibody (YA168) | Antibodies | |
| HY-P80472 | Phospho-p53 (Ser392) Antibody | Antibodies | |
| HY-P80473 | Phospho-p95/NBS1 (Ser343) Antibody | Antibodies | |
| HY-P80474 | Phospho-PLK1 (Thr210) Antibody | Antibodies | |
| HY-P80475 | Phospho-PTEN (Ser380) Antibody | Antibodies | |
| HY-P80476 | Phospho-Rb (Ser807) Antibody | Antibodies | |
| HY-P80477 | Phospho-Smad3 (Ser423/Ser425) Antibody | Antibodies | |
| HY-P80478 | Phospho-STAT1 (Ser727) Antibody (YA148) | Antibodies | |
| HY-P80479 | Phospho-Stat5 (Tyr694) Antibody | Antibodies | |
| HY-P80480 | Phospho-Tau (Ser396) Antibody | Antibodies | |
| HY-P80481 | Phospho-YAP1 (Ser127) Antibody (YA137) | Antibodies | |
| HY-P80482 | Acetyl CoA Carboxylase 1 (ACC1) Antibody | Antibodies | |
| HY-P80483 | Acetyl CoA synthetase Antibody | Antibodies | |
| HY-P80484 | alpha smooth muscle ActinAntibody | Antibodies | |
| HY-P80485 | alpha Tubulin (acetyl K40) Antibody | Antibodies | |
| HY-P80486 | ATF4 Antibody (YA605) | Antibodies | |
| HY-P80487 | beta Tubulin Antibody | Antibodies | |
| HY-P80488 | Beta-Catenin Antibody | Antibodies | |
| HY-P80489 | BRCA1 Antibody (YA819) | Antibodies | |
| HY-P80490 | C/EBP Beta Antibody | Antibodies | |
| HY-P80491 | E2F1 Antibody | Antibodies | |
| HY-P80492 | EIF2A Antibody | Antibodies | |
| HY-P80493 | Fibronectin Antibody | Antibodies | |
| HY-P80494 | Glucose Transporter GLUT1 Antibody | Antibodies | |
| HY-P80495 | Glucose Transporter GLUT4 Antibody (YA753) | Antibodies | |
| HY-P80496 | GRP78 BiP Antibody | Antibodies | |
| HY-P80497 | GSK3 beta Antibody (YA397) | Antibodies | |
| HY-P80498 | Hamartin Antibody | Antibodies | |
| HY-P80499 | Heme Oxygenase 1 Antibody | Antibodies | |
| HY-P80500 | HER2 Antibody | Antibodies | |
| HY-P80501 | Iba1 Antibody | Antibodies | |
| HY-P80502 | ICAM1 Antibody (YA725) | Antibodies | |
| HY-P80503 | IL-1 beta Antibody (YA345) | Antibodies | |
| HY-P80504 | IRF3 Antibody | Antibodies | |
| HY-P80505 | Ki67 Antibody (YA717) | Antibodies | |
| HY-P80506 | Ki67 Antibody (YA322) | Antibodies | |
| HY-P80507 | KMT6/EZH2 Antibody | Antibodies | |
| HY-P80508 | MCL1 Antibody | Antibodies | |
| HY-P80509 | MMP2 Antibody | Antibodies | |
| HY-P80510 | PDGFR alpha Antibody | Antibodies | |
| HY-P80511 | Phospho-c-Myc(Ser62) Antibody | Antibodies | |
| HY-P80512 | Phospho-Met Antibody (YA175) | Antibodies | |
| HY-P80513 | Phospho-SHP2 (Tyr542) Antibody | Antibodies | |
| HY-P80514 | Phospho-Src (Tyr419) Antibody | Antibodies | |
| HY-P80516 | PI 3 Kinase p85 alpha Antibody | Antibodies | |
| HY-P80517 | pVHL Antibody | Antibodies | |
| HY-P80518 | SQSTM1/p62 Antibody (YA669) | Antibodies | |
| HY-P80519 | TBK1 Antibody (YA662) | Antibodies | |
| HY-P80520 | TCF7L2/TCF4 Antibody | Antibodies | |
| HY-P80521 | TGF beta 1 Antibody | Antibodies | |
| HY-P80522 | TMS1 Antibody | Antibodies | |
| HY-P80523 | xCT Antibody (YA652) | Antibodies | |
| HY-P80524 | ZAP70 Antibody (YP4051) | Antibodies | |
| HY-P80525 | 14-3-3 eta Antibody (YA838) | Antibodies | |
| HY-P80526 | 4E BP1 Antibody | Antibodies | |
| HY-P80527 | ABCB5 Antibody (YA836) | Antibodies | |
| HY-P80528 | Acetyl Coenzyme A Carboxylase Antibody | Antibodies | |
| HY-P80529 | Acetyl-Histone H3 (Lys14) Antibody | Antibodies | |
| HY-P80530 | Acetyl-Histone H3 (Lys27) Antibody | Antibodies | |
| HY-P80531 | Acetyl-Histone H3 (Lys4) Antibody | Antibodies | |
| HY-P80532 | Acetyl-p53 (Lys370) Antibody | Antibodies | |
| HY-P80533 | Adipose Triglyceride Lipase Antibody | Antibodies | |
| HY-P80534 | AIF Antibody (YA835) | Antibodies | |
| HY-P80535 | AKT1/AKT2/AKT3 Antibody | Antibodies | |
| HY-P80536 | ALDH1A1 Antibody | Antibodies | |
| HY-P80537 | alpha 1 Sodium Potassium ATPase Antibody | Antibodies | |
| HY-P80538 | alpha Tubulin Antibody | Antibodies | |
| HY-P80539 | AMPK alpha 1 Antibody | Antibodies | |
| HY-P80540 | AMPK alpha 2 Antibody (YA623) | Antibodies | |
| HY-P80541 | AMPK alpha Antibody | Antibodies | |
| HY-P80542 | AMPK beta 1 Antibody | Antibodies | |
| HY-P80543 | AMPK gamma 1 Antibody | Antibodies | |
| HY-P80544 | Annexin A1 Antibody (YA832) | Antibodies | |
| HY-P80545 | APG5L Antibody | Antibodies | |
| HY-P80546 | Argonaute 2 Antibody | Antibodies | |
| HY-P80547 | Aromatase Antibody | Antibodies | |
| HY-P80548 | ASC Antibody | Antibodies | |
| HY-P80549 | ASK1 Antibody | Antibodies | |
| HY-P80550 | Asparagine Synthetase Antibody | Antibodies | |
| HY-P80551 | ASS1 Antibody | Antibodies | |
| HY-P80552 | ATF2 Antibody | Antibodies | |
| HY-P80553 | ATF4 Antibody | Antibodies | |
| HY-P80554 | ATF6 Antibody (YA604) | Antibodies | |
| HY-P80555 | ATG10 Antibody | Antibodies | |
| HY-P80556 | ATG3 Antibody | Antibodies | |
| HY-P80557 | ATG4A Antibody | Antibodies | |
| HY-P80558 | ATG4C Antibody | Antibodies | |
| HY-P80559 | ATG7 Antibody | Antibodies | |
| HY-P80560 | ATP Citrate Lyase Antibody (YA829) | Antibodies | |
| HY-P80561 | Aurora A Antibody (YA827) | Antibodies | |
| HY-P80562 | Aurora B Antibody | Antibodies | |
| HY-P80563 | Bak Antibody | Antibodies | |
| HY-P80564 | Bax Antibody (YA826) | Antibodies | |
| HY-P80565 | Bcl2 Antibody (YA824) | Antibodies | |
| HY-P80566 | Bcl2 Antibody | Antibodies | |
| HY-P80567 | BDNF Antibody | Antibodies | |
| HY-P80568 | Beclin 1 Antibody | Antibodies | |
| HY-P80569 | beta Arrestin 1 Antibody (YA822) | Antibodies | |
| HY-P80570 | beta III Tubulin Antibody | Antibodies | |
| HY-P80571 | BNIP3L Antibody | Antibodies | |
| HY-P80572 | BRAF Antibody | Antibodies | |
| HY-P80573 | BRCA1 Antibody | Antibodies | |
| HY-P80575 | BRG1 Antibody (YA817) | Antibodies | |
| HY-P80576 | BTK Antibody (YA816) | Antibodies | |
| HY-P80577 | C3 Antibody | Antibodies | |
| HY-P80578 | Calnexin Antibody | Antibodies | |
| HY-P80579 | Calumenin Antibody (YA813) | Antibodies | |
| HY-P80580 | CaMK1 Antibody | Antibodies | |
| HY-P80581 | CAP2 Antibody | Antibodies | |
| HY-P80582 | CARD9 Antibody | Antibodies | |
| HY-P80583 | CARM1 Antibody (YA812) | Antibodies | |
| HY-P80584 | CARS Antibody | Antibodies | |
| HY-P80585 | Casein Kinase 1 alpha Antibody | Antibodies | |
| HY-P80586 | Casein Kinase 2 beta Antibody | Antibodies | |
| HY-P80587 | Caspase 1 Antibody | Antibodies | |
| HY-P80588 | Caspase 11 Antibody | Antibodies | |
| HY-P80589 | Caspase 7 Antibody | Antibodies | |
| HY-P80590 | CBR1 Antibody (YA810) | Antibodies | |
| HY-P80591 | CD105 Antibody | Antibodies | |
| HY-P80592 | CD11b Antibody | Antibodies | |
| HY-P80593 | CD127 Antibody | Antibodies | |
| HY-P80594 | CD133 Antibody (YA809) | Antibodies | |
| HY-P80595 | CD146 Antibody | Antibodies | |
| HY-P80596 | CD147 Antibody | Antibodies | |
| HY-P80597 | CD19 Antibody (YA807) | Antibodies | |
| HY-P80598 | CD3 epsilon Antibody | Antibodies | |
| HY-P80599 | CD31 Antibody (YA806) | Antibodies | |
| HY-P80600 | CD3D Antibody | Antibodies | |
| HY-P80601 | CD3G Antibody | Antibodies | |
| HY-P80602 | CD44 Antibody (YA801) | Antibodies | |
| HY-P80603 | CD45 Antibody (YA800) | Antibodies | |
| HY-P80604 | CD63 Antibody | Antibodies | |
| HY-P80605 | CD68 Antibody (YA799) | Antibodies | |
| HY-P80606 | CD79a Antibody | Antibodies | |
| HY-P80607 | CD8 alpha Antibody | Antibodies | |
| HY-P80608 | CD81 Antibody | Antibodies | |
| HY-P80609 | CD86 Antibody | Antibodies | |
| HY-P80610 | CD9 Antibody | Antibodies | |
| HY-P80611 | CDK1 Antibody | Antibodies | |
| HY-P80612 | CDK16 Antibody | Antibodies | |
| HY-P80613 | CDK5 Antibody (YA796) | Antibodies | |
| HY-P80614 | CDK9 Antibody | Antibodies | |
| HY-P80615 | CDKN2A Antibody | Antibodies | |
| HY-P80616 | c-Fos Antibody | Antibodies | |
| HY-P80617 | Chk1 Antibody | Antibodies | |
| HY-P80618 | cIAP2 Antibody (YA795) | Antibodies | |
| HY-P80619 | c-Kit Antibody | Antibodies | |
| HY-P80620 | CKMT1 Antibody (YA794) | Antibodies | |
| HY-P80621 | CKMT2 Antibody (YA793) | Antibodies | |
| HY-P80622 | Cleaved-Caspase 1 Antibody | Antibodies | |
| HY-P80623 | Cleaved-Caspase 3 p12 Antibody | Antibodies | |
| HY-P80624 | Cleaved-Caspase 8 Antibody | Antibodies | |
| HY-P80625 | Cleaved-PARP1 Antibody | Antibodies | |
| HY-P80626 | c-Myc Antibody | Antibodies | |
| HY-P80626A | c-Myc Antibody (YA3476) | Antibodies | |
| HY-P80627 | Collagen I alpha 2 Antibody | Antibodies | |
| HY-P80628 | Connexin 43 Antibody | Antibodies | |
| HY-P80629 | Creatine Kinase B type Antibody (YA492) | Antibodies | |
| HY-P80630 | CRK Antibody (YA790) | Antibodies | |
| HY-P80631 | Cyclin A1 Antibody | Antibodies | |
| HY-P80632 | Cyclin B1 Antibody | Antibodies | |
| HY-P80633 | Cyclin D1 Antibody | Antibodies | |
| HY-P80634 | Cyclin D2 Antibody (YA789) | Antibodies | |
| HY-P80635 | Cyclin E1 Antibody | Antibodies | |
| HY-P80636 | Cyclin H Antibody (YA788) | Antibodies | |
| HY-P80637 | Cyclin H Antibody | Antibodies | |
| HY-P80638 | Cyclophilin B Antibody (YA787) | Antibodies | |
| HY-P80639 | Cystatin C Antibody | Antibodies | |
| HY-P80640 | Cytochrome P450 17A1 Antibody (YA786) | Antibodies | |
| HY-P80641 | DDB1 Antibody (YA785) | Antibodies | |
| HY-P80642 | DDX3 Antibody (YA784) | Antibodies | |
| HY-P80643 | DiMethyl-Histone H3 Antibody (YA783) | Antibodies | |
| HY-P80644 | DRP1 Antibody | Antibodies | |
| HY-P80645 | DUSP1 Antibody | Antibodies | |
| HY-P80646 | DUSP3 Antibody | Antibodies | |
| HY-P80647 | Eg5 Antibody (YA776) | Antibodies | |
| HY-P80648 | EGFR Antibody (YA775) | Antibodies | |
| HY-P80649 | eIF1A Antibody | Antibodies | |
| HY-P80650 | eIF4A1 Antibody (YA774) | Antibodies | |
| HY-P80651 | eIF4B Antibody | Antibodies | |
| HY-P80652 | eIF4G1 Antibody | Antibodies | |
| HY-P80653 | eIF5A Antibody | Antibodies | |
| HY-P80654 | Elongation Factor 1A1 Antibody | Antibodies | |
| HY-P80655 | ENO1 Antibody (YA773) | Antibodies | |
| HY-P80656 | eNOS Antibody | Antibodies | |
| HY-P80657 | EpCAM Antibody (YA458) | Antibodies | |
| HY-P80658 | HER2 Antibody (YA771) | Antibodies | |
| HY-P80659 | ErbB 3 Antibody | Antibodies | |
| HY-P80660 | ErbB 4 Antibody | Antibodies | |
| HY-P80661 | ERCC1 Antibody (YA770) | Antibodies | |
| HY-P80662 | Estrogen Receptor alpha Antibody (YA768) | Antibodies | |
| HY-P80663 | Estrogen Receptor alpha Antibody | Antibodies | |
| HY-P80664 | Ezrin Antibody (YA767) | Antibodies | |
| HY-P80665 | F4/80 Antibody | Antibodies | |
| HY-P80666 | Fas Antibody | Antibodies | |
| HY-P80667 | Fascin Antibody | Antibodies | |
| HY-P80668 | Fatty Acid Synthase Antibody (YA766) | Antibodies | |
| HY-P80669 | FEN1 Antibody (YA765) | Antibodies | |
| HY-P80670 | Ferritin Heavy Chain Antibody | Antibodies | |
| HY-P80671 | FGF2 Antibody | Antibodies | |
| HY-P80672 | FH Antibody (YA763) | Antibodies | |
| HY-P80673 | Fibrillarin Antibody | Antibodies | |
| HY-P80674 | Fibronectin Antibody (YA762) | Antibodies | |
| HY-P80675 | Flotillin 1 Antibody (YA760) | Antibodies | |
| HY-P80676 | FOXO1 Antibody | Antibodies | |
| HY-P80677 | FOXO3 Antibody | Antibodies | |
| HY-P80678 | FOXP3 Antibody (YA759) | Antibodies | |
| HY-P80679 | FSP1 Antibody | Antibodies | |
| HY-P80680 | FTO Antibody | Antibodies | |
| HY-P80681 | FYN Antibody | Antibodies | |
| HY-P80682 | GAD65 Antibody (YA758) | Antibodies | |
| HY-P80683 | gamma Catenin Antibody | Antibodies | |
| HY-P80684 | gamma Tubulin Antibody | Antibodies | |
| HY-P80685 | GATA6 Antibody (YA757) | Antibodies | |
| HY-P80686 | GFAP Antibody (YA756) | Antibodies | |
| HY-P80687 | Glucocorticoid Receptor Antibody | Antibodies | |
| HY-P80688 | Glucose 6 Phosphate Dehydrogenase Antibody | Antibodies | |
| HY-P80689 | Glucose Transporter GLUT4 Antibody | Antibodies | |
| HY-P80690 | Glutaminase Antibody | Antibodies | |
| HY-P80691 | Glutamine Synthetase Antibody (YA405) | Antibodies | |
| HY-P80692 | Glutathione Peroxidase 4 Antibody | Antibodies | |
| HY-P80693 | Glutathione Reductase Antibody | Antibodies | |
| HY-P80694 | Glycogen Synthase 1 Antibody | Antibodies | |
| HY-P80695 | GRB2 Antibody (YA748) | Antibodies | |
| HY-P80696 | GRP78 BiP Antibody (YA746) | Antibodies | |
| HY-P80697 | GSDME Antibody | Antibodies | |
| HY-P80698 | GSK3 beta Antibody (YA744) | Antibodies | |
| HY-P80699 | HDAC2 Antibody (YA742) | Antibodies | |
| HY-P80700 | HDAC4 Antibody (YA741) | Antibodies | |
| HY-P80701 | HDAC6 Antibody (YA740) | Antibodies | |
| HY-P80702 | Hexokinase I Antibody (YA739) | Antibodies | |
| HY-P80703 | Hexokinase II Antibody | Antibodies | |
| HY-P80704 | HIF1 alpha Antibody | Antibodies | |
| HY-P80705 | HIF1 beta Antibody | Antibodies | |
| HY-P80706 | Histone H2B Antibody (YA737) | Antibodies | |
| HY-P80707 | HP1 gamma Antibody (YA733) | Antibodies | |
| HY-P80708 | Hsc70 Antibody | Antibodies | |
| HY-P80709 | Hsp27 Antibody (YA732) | Antibodies | |
| HY-P80710 | Hsp40 Antibody | Antibodies | |
| HY-P80711 | Hsp60 Antibody (YA730) | Antibodies | |
| HY-P80712 | Hsp70 1A Antibody (YA727) | Antibodies | |
| HY-P80713 | Hsp70 1B Antibody | Antibodies | |
| HY-P80714 | Hsp90 alpha/beta Antibody | Antibodies | |
| HY-P80715 | HtrA2 Antibody (YA726) | Antibodies | |
| HY-P80716 | ICAM1 Antibody (YA352) | Antibodies | |
| HY-P80717 | IGF1 Receptor Antibody | Antibodies | |
| HY-P80718 | IKB alpha Antibody | Antibodies | |
| HY-P80719 | IKK beta Antibody | Antibodies | |
| HY-P80720 | IL-1 beta Antibody | Antibodies | |
| HY-P80721 | IL-18 Antibody | Antibodies | |
| HY-P80722 | IL-4 Antibody | Antibodies | |
| HY-P80723 | IL-6 Antibody | Antibodies | |
| HY-P80724 | IMP3 Antibody | Antibodies | |
| HY-P80725 | iNOS Antibody | Antibodies | |
| HY-P80726 | JAK1 Antibody (YA722) | Antibodies | |
| HY-P80727 | JAK2 Antibody (YA330) | Antibodies | |
| HY-P80728 | JNK Antibody | Antibodies | |
| HY-P80729 | JNK1 Antibody (YA720) | Antibodies | |
| HY-P80730 | KAP1 Antibody (YA719) | Antibodies | |
| HY-P80731 | KDM1A Antibody (YA718) | Antibodies | |
| HY-P80732 | Keap1 Antibody | Antibodies | |
| HY-P80733 | KGF Antibody | Antibodies | |
| HY-P80734 | Ki67 Antibody (YA001) | Antibodies | |
| HY-P80735 | KLF4 Antibody (YA716) | Antibodies | |
| HY-P80736 | Ku70 Antibody (YA319) | Antibodies | |
| HY-P80737 | Ku80 Antibody (YA714) | Antibodies | |
| HY-P80738 | Lactate Dehydrogenase A Antibody | Antibodies | |
| HY-P80739 | Lactate Dehydrogenase C Antibody | Antibodies | |
| HY-P80740 | LAMP2 Antibody (YA310) | Antibodies | |
| HY-P80741 | LC3A/B Antibody | Antibodies | |
| HY-P80742 | LC3B Antibody | Antibodies | |
| HY-P80743 | Lck Antibody (YA712) | Antibodies | |
| HY-P80744 | LIN28A Antibody (YA711) | Antibodies | |
| HY-P80745 | Liver Arginase Antibody | Antibodies | |
| HY-P80746 | LRP1 Antibody | Antibodies | |
| HY-P80747 | Lyn Antibody (YA707) | Antibodies | |
| HY-P80748 | Lysozyme Antibody | Antibodies | |
| HY-P80749 | MCM2 Antibody (YA705) | Antibodies | |
| HY-P80750 | M-CSF Antibody | Antibodies | |
| HY-P80751 | Mitofusin 1 Antibody | Antibodies | |
| HY-P80752 | Mitofusin 2 Antibody | Antibodies | |
| HY-P80753 | MLH1 Antibody (YA703) | Antibodies | |
| HY-P80754 | MMP1 Antibody | Antibodies | |
| HY-P80754A | MMP1 Antibody(YA3394) | Antibodies | |
| HY-P80755 | MMP12 Antibody | Antibodies | |
| HY-P80756 | MMP9 Antibody | Antibodies | |
| HY-P80757 | Mouse IgG Isotype Control | Antibodies | |
| HY-P80758 | MSR1 Antibody | Antibodies | |
| HY-P80759 | mTOR Antibody | Antibodies | |
| HY-P80760 | MyD88 Antibody | Antibodies | |
| HY-P80761 | N Cadherin Antibody | Antibodies | |
| HY-P80762 | NADPH Oxidase 4 Antibody | Antibodies | |
| HY-P80763 | NF-KB p100 Antibody | Antibodies | |
| HY-P80764 | NF-KB p105 Antibody (YA700) | Antibodies | |
| HY-P80765 | NF-KB p65 Antibody | Antibodies | |
| HY-P80766 | NLRP3 Antibody | Antibodies | |
| HY-P80767 | Noggin Antibody (YA698) | Antibodies | |
| HY-P80768 | Notch1 Antibody | Antibodies | |
| HY-P80769 | Nrf1 Antibody | Antibodies | |
| HY-P80770 | Oct-4 Antibody | Antibodies | |
| HY-P80771 | Osteopontin Antibody | Antibodies | |
| HY-P80772 | P Glycoprotein Antibody | Antibodies | |
| HY-P80773 | p21 Antibody (YA254) | Antibodies | |
| HY-P80774 | p21 Antibody | Antibodies | |
| HY-P80774A | p21 Antibody (YA3460) | Antibodies | |
| HY-P80775 | p300 Antibody | Antibodies | |
| HY-P80776 | p38 Antibody (YA696) | Antibodies | |
| HY-P80776A | Phospho-p38 (Thr180+Tyr182) Antibody | Antibodies | |
| HY-P80777 | p38 Antibody | Antibodies | |
| HY-P80778 | PAK2 Antibody (YA695) | Antibodies | |
| HY-P80779 | Parkin Antibody | Antibodies | |
| HY-P80780 | PARP1 Antibody (YA245) | Antibodies | |
| HY-P80781 | PERK Antibody | Antibodies | |
| HY-P80782 | Peroxiredoxin 1 Antibody (YA692) | Antibodies | |
| HY-P80783 | PGC1 alpha Antibody | Antibodies | |
| HY-P80784 | PGK1 Antibody | Antibodies | |
| HY-P80784A | PGK1 Antibody (YA862) | Antibodies | |
| HY-P80785 | PGP9.5 Antibody | Antibodies | |
| HY-P80786 | Phospho-4E BP1 (Thr46) Antibody | Antibodies | |
| HY-P80787 | Phospho-Acetyl Coenzyme A Carboxylase (Ser79) Antibody | Antibodies | |
| HY-P80788 | Phospho-AKT1 (Ser473) Antibody | Antibodies | |
| HY-P80789 | Phospho-AKT (Thr308) Antibody | Antibodies | |
| HY-P80790 | Phospho-AMPK alpha 1 (Ser496) Antibody | Antibodies | |
| HY-P80791 | Phospho-AMPK alpha 2 (Thr172) Antibody | Antibodies | |
| HY-P80792 | Phospho-ASK1 (Ser966) Antibody | Antibodies | |
| HY-P80793 | Phospho-ATF2 (Thr71) Antibody | Antibodies | |
| HY-P80794 | Phospho-BRAF (Thr401) Antibody | Antibodies | |
| HY-P80795 | Phospho-CD18 (Ser745) Antibody | Antibodies | |
| HY-P80796 | Phospho-CDK1 (Tyr15) Antibody | Antibodies | |
| HY-P80797 | Phospho-CDK1/2/3 (Thr14) Antibody | Antibodies | |
| HY-P80798 | Phospho-CDK2 (Tyr15) Antibody | Antibodies | |
| HY-P80799 | Phospho-Chk2 (Thr68) Antibody | Antibodies | |
| HY-P80800 | Phospho-c-Jun (Ser243) Antibody | Antibodies | |
| HY-P80801 | Phospho-c-Jun (Ser63) Antibody | Antibodies | |
| HY-P80802 | Phospho-c-Jun (Ser73) Antibody | Antibodies | |
| HY-P80803 | Phospho-c-Met (Tyr1349) Antibody | Antibodies | |
| HY-P80804 | Phospho-c-Myc (Ser62) Antibody | Antibodies | |
| HY-P80805 | Phospho-CREB (Ser133) Antibody (YA209) | Antibodies | |
| HY-P80806 | Phospho-Cyclin B1 (Ser126) Antibody | Antibodies | |
| HY-P80807 | Phospho-Cyclin E1 (Thr395) Antibody | Antibodies | |
| HY-P80808 | Phospho-EGFR (Tyr1068) Antibody | Antibodies | |
| HY-P80809 | Phospho-EGFR (Tyr1092) Antibody | Antibodies | |
| HY-P80810 | Phospho-EGFR (Tyr1173) Antibody | Antibodies | |
| HY-P80811 | Phospho-eIF2A (Ser51) Antibody | Antibodies | |
| HY-P80812 | Phospho-eIF4E (Ser209) Antibody | Antibodies | |
| HY-P80813 | Phospho-ERK1/2 (Thr202/Thr185) Antibody | Antibodies | |
| HY-P80814 | Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187) Antibody | Antibodies | |
| HY-P80815 | Phospho-ERK1/2 (Tyr204/Tyr187) Antibody | Antibodies | |
| HY-P80816 | Phospho-FAK (Tyr576) Antibody | Antibodies | |
| HY-P80817 | Phospho-FOXO3A (Ser253) Antibody | Antibodies | |
| HY-P80818 | Phospho-GAB1 (Tyr627) Antibody | Antibodies | |
| HY-P80819 | Phospho-GSK3 (Tyr216/Tyr279) Antibody | Antibodies | |
| HY-P80820 | Phospho-GSK3 beta (Ser9) Antibody | Antibodies | |
| HY-P80821 | Phospho-Histone H2A.X (Ser139) Antibody (YA191) | Antibodies | |
| HY-P80822 | Phospho-HSF1 (Ser303/Ser307) Antibody | Antibodies | |
| HY-P80823 | Phospho-Hsp27 (Ser78) Antibody | Antibodies | |
| HY-P80824 | Phospho-Hsp27 (Ser82) Antibody | Antibodies | |
| HY-P80825 | Phospho-IGF1 Receptor (Tyr1166) Antibody | Antibodies | |
| HY-P80826 | Phospho-IKB alpha (Ser32) Antibody (YA185) | Antibodies | |
| HY-P80827 | Phospho-IKB alpha (Ser36) Antibody | Antibodies | |
| HY-P80828 | Phospho-IRE1 (Ser724) Antibody | Antibodies | |
| HY-P80829 | Phospho-JAK2 (Tyr1007/1008) Antibody | Antibodies | |
| HY-P80830 | Phospho-JNK (Thr183) Antibody | Antibodies | |
| HY-P80831 | Phospho-JNK1 (Thr183/Tyr185) Antibody | Antibodies | |
| HY-P80832 | Phospho-MEK1 (Ser298) Antibody | Antibodies | |
| HY-P80833 | Phospho-MEK1 (Thr292) Antibody | Antibodies | |
| HY-P80834 | Phospho-MEK4 (Ser80) Antibody | Antibodies | |
| HY-P80835 | Phospho-MSK1 (Ser360) Antibody | Antibodies | |
| HY-P80836 | Phospho-MSK1 (Ser376) Antibody | Antibodies | |
| HY-P80837 | Phospho-mTOR (Ser2448) Antibody (YA171) | Antibodies | |
| HY-P80838 | Phospho-mTOR (Ser2481) Antibody | Antibodies | |
| HY-P80839 | Phospho-NF-KB p65 (Ser536) Antibody | Antibodies | |
| HY-P80840 | Phospho-NF-KB p65 (Thr254) Antibody | Antibodies | |
| HY-P80841 | Phospho-Nrf2 (Ser40) Antibody (YA169) | Antibodies | |
| HY-P80842 | Phospho-p38 (Thr180/Tyr182) Antibody | Antibodies | |
| HY-P80843 | Phospho-p53 (Ser37) Antibody | Antibodies | |
| HY-P80844 | Phospho-p53 (Ser6) Antibody | Antibodies | |
| HY-P80846 | Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199) Antibody | Antibodies | |
| HY-P80847 | Phospho-PKA RII alpha (Ser99) Antibody | Antibodies | |
| HY-P80848 | Phospho-RSK1 p90 (Ser380) Antibody | Antibodies | |
| HY-P80849 | Phospho-RSK1 p90 (Thr359/Ser363) Antibody | Antibodies | |
| HY-P80850 | Phospho-RSK2 (Ser227) Antibody | Antibodies | |
| HY-P80851 | Phospho-RSK4 (Ser232) Antibody | Antibodies | |
| HY-P80852 | Phospho-Smad1 (Ser463/Ser465) Antibody | Antibodies | |
| HY-P80853 | Phospho-Smad2 (Ser250) Antibody | Antibodies | |
| HY-P80854 | Phospho-Smad3 (Ser423/425) Antibody | Antibodies | |
| HY-P80854A | Phospho-Smad3 (Ser423/425) Antibody (YA3477) | Antibodies | |
| HY-P80855 | Phospho-STAT1 (Ser727) Antibody (YA149) | Antibodies | |
| HY-P80856 | Phospho-STAT1 (Tyr701) Antibody | Antibodies | |
| HY-P80857 | Phospho-STAT3 (Tyr705) Antibody | Antibodies | |
| HY-P80858 | Phospho-TAK1 (Ser439) Antibody | Antibodies | |
| HY-P80859 | Phospho-Tau (Ser198) Antibody | Antibodies | |
| HY-P80860 | Phospho-Tau (Ser404) Antibody | Antibodies | |
| HY-P80861 | Phospho-Tau (Thr181) Antibody | Antibodies | |
| HY-P80862 | Phospho-TrkA/B (Tyr490/Tyr516) Antibody | Antibodies | |
| HY-P80863 | Phospho-Vimentin (Ser56) Antibody | Antibodies | |
| HY-P80864 | Phospho-YAP1 (Ser127) Antibody (YA136) | Antibodies | |
| HY-P80865 | PI3 Kinase p110 gamma Antibody (YA690) | Antibodies | |
| HY-P80866 | PI3 Kinase p55 gamma Antibody | Antibodies | |
| HY-P80867 | PI3 Kinase p85 alpha Antibody (YA689) | Antibodies | |
| HY-P80868 | PI3 Kinase p85 beta Antibody (YA688) | Antibodies | |
| HY-P80869 | PKC eta Antibody | Antibodies | |
| HY-P80870 | PKM2 Antibody | Antibodies | |
| HY-P80871 | PPAR alpha Antibody | Antibodies | |
| HY-P80872 | PPAR gamma Antibody | Antibodies | |
| HY-P80873 | PPP4C Antibody (YA687) | Antibodies | |
| HY-P80874 | PRMT1 Antibody (YA686) | Antibodies | |
| HY-P80875 | PRMT6 Antibody (YA685) | Antibodies | |
| HY-P80876 | Proteasome beta 8 Antibody (YA684) | Antibodies | |
| HY-P80877 | PYK2 Antibody (YA682) | Antibodies | |
| HY-P80878 | Pyruvate Dehydrogenase E1 alpha Antibody (YA681) | Antibodies | |
| HY-P80879 | Rabbit IgG Isotype Control | Antibodies | |
| HY-P80880 | Raf1 Antibody | Antibodies | |
| HY-P80881 | RhoA Antibody | Antibodies | |
| HY-P80882 | RhoA/B/C Antibody | Antibodies | |
| HY-P80883 | RNA Polymerase II Subunit B1 Antibody | Antibodies | |
| HY-P80884 | RPA70 Antibody (YA678) | Antibodies | |
| HY-P80885 | RPS6 Antibody (YA677) | Antibodies | |
| HY-P80886 | RSK1 p90 Antibody (YA676) | Antibodies | |
| HY-P80887 | RSK3 Antibody | Antibodies | |
| HY-P80888 | RUNX Antibody | Antibodies | |
| HY-P80889 | S100A10 Antibody (YA675) | Antibodies | |
| HY-P80890 | S100A6 Antibody (YA674) | Antibodies | |
| HY-P80891 | S100B Antibody | Antibodies | |
| HY-P80892 | SIRT3 Antibody | Antibodies | |
| HY-P80893 | Smad2/3 Antibody | Antibodies | |
| HY-P80894 | SMC1A Antibody (YA673) | Antibodies | |
| HY-P80895 | SMYD1 Antibody (YA672) | Antibodies | |
| HY-P80896 | SMYD4 Antibody (YA671) | Antibodies | |
| HY-P80897 | SOCS1 Antibody | Antibodies | |
| HY-P80898 | SOD2 Antibody (YA670) | Antibodies | |
| HY-P80899 | SQSTM1/p62 Antibody (YA062) | Antibodies | |
| HY-P80900 | SREBP1 Antibody | Antibodies | |
| HY-P80901 | SSB Antibody (YA668) | Antibodies | |
| HY-P80902 | STAT3 Antibody (YA666) | Antibodies | |
| HY-P80903 | STAT4 Antibody | Antibodies | |
| HY-P80904 | STAT5 Antibody | Antibodies | |
| HY-P80904A | STAT5 Antibody | Antibodies | |
| HY-P80905 | SUMO1 Antibody (YA047) | Antibodies | |
| HY-P80906 | Survivin Antibody (YA665) | Antibodies | |
| HY-P80907 | Synaptophysin Antibody (YA664) | Antibodies | |
| HY-P80908 | TAK1 Antibody (YA663) | Antibodies | |
| HY-P80909 | Tau Antibody | Antibodies | |
| HY-P80910 | TBK1 Antibody (YA040) | Antibodies | |
| HY-P80911 | TGF alpha Antibody | Antibodies | |
| HY-P80912 | Thioredoxin Antibody | Antibodies | |
| HY-P80913 | Thioredoxin Reductase 2 Antibody (YA661) | Antibodies | |
| HY-P80914 | TNF alpha Antibody | Antibodies | |
| HY-P80915 | TNF Receptor 2 Antibody | Antibodies | |
| HY-P80916 | TNFRSF10B Antibody (YA660) | Antibodies | |
| HY-P80917 | Toll-Like Receptor 3 Antibody | Antibodies | |
| HY-P80918 | Toll-Like Receptor 4 Antibody | Antibodies | |
| HY-P80919 | TRAF6 Antibody | Antibodies | |
| HY-P80920 | TREM2 Antibody | Antibodies | |
| HY-P80921 | TRIM21 Antibody (YA658) | Antibodies | |
| HY-P80922 | TriMethyl-Histone H3 (Lys27) Antibody | Antibodies | |
| HY-P80923 | Trk B Antibody | Antibodies | |
| HY-P80924 | TSG101 Antibody | Antibodies | |
| HY-P80925 | Ubiquitin Antibody | Antibodies | |
| HY-P80926 | USP7 Antibody (YA657) | Antibodies | |
| HY-P80927 | VCAM1 Antibody | Antibodies | |
| HY-P80928 | VEGF Receptor 1 Antibody | Antibodies | |
| HY-P80929 | VEGFA Antibody | Antibodies | |
| HY-P80930 | Vitamin D Binding Protein Antibody | Antibodies | |
| HY-P80931 | WDR77 Antibody (YA655) | Antibodies | |
| HY-P80933 | Wnt5a Antibody | Antibodies | |
| HY-P80934 | Wnt5b Antibody (YA653) | Antibodies | |
| HY-P80935 | xCT Antibody (YA006) | Antibodies | |
| HY-P80936 | YB1 Antibody | Antibodies | |
| HY-P80937 | ZAP70 Antibody (YA651) | Antibodies | |
| HY-P80938 | p53 Antibody | Antibodies | |
| HY-P80939 | MYSM1 Antibody | Antibodies | |
| HY-P80940 | STING Antibody | Antibodies | |
| HY-P80941 | Phospho-Histone H2A.X (Ser139) Antibody | Antibodies | |
| HY-P80942 | GLO1 Antibody | Antibodies | |
| HY-P80943 | TCTP Antibody | Antibodies | |
| HY-P80944 | S100A11 Antibody | Antibodies | |
| HY-P80945 | Annexin VI Antibody | Antibodies | |
| HY-P80947 | Anti-6X His-tag (C-terminal) Antibody | Antibodies | |
| HY-P80947A | His Tag Antibody (HRP) (YA877) | Antibodies | |
| HY-P80948 | Anti-HA tag Antibody | Antibodies | |
| HY-P80948A | HA Tag Antibody (HRP) (YA876) | Antibodies | |
| HY-P80948B | HA tag Antibody (YA3393) | Antibodies | |
| HY-P80949 | Goat Anti-Mouse IgG H&L (Biotin) | Antibodies | |
| HY-P80950 | Goat Anti-Mouse IgG H&L (FITC) | Antibodies | |
| HY-P80951 | Goat Anti-Rabbit IgG H&L (FITC) | Antibodies | |
| HY-P80952 | Alexa Fluor® 647-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P80953 | Goat Anti-Rabbit IgG H&L (Biotin) | Antibodies | |
| HY-P80954 | GAPDH Antibody (YA848) | Antibodies | |
| HY-P80954A | GAPDH Antibody (HRP) (YA874) | Antibodies | |
| HY-P80955 | beta Tubulin Antibody (YA839) | Antibodies | |
| HY-P80955A | beta Tubulin Antibody (HRP) (YA865) | Antibodies | |
| HY-P80956 | Transferrin Antibody (YA840) | Antibodies | |
| HY-P80957 | VGluT1 Antibody | Antibodies | |
| HY-P80958 | SATB2 Antibody | Antibodies | |
| HY-P80959 | 6X His Tag Antibody | Antibodies | |
| HY-P80960 | CDC37 Antibody | Antibodies | |
| HY-P80961 | Phospho-CDC37 (Ser13) Antibody | Antibodies | |
| HY-P80962 | Phospho-CDC37 (Ser13) Antibody (YA219) | Antibodies | |
| HY-P80963 | Anoctamin 1 Antibody | Antibodies | |
| HY-P80964 | Cleaved-Caspase 9 Antibody | Antibodies | |
| HY-P80965 | Anti-FOXP3 Antibody | Antibodies | |
| HY-P80966 | CD161 Antibody | Antibodies | |
| HY-P80967 | S1PR4 Antibody | Antibodies | |
| HY-P80968 | HMGCS2 Antibody | Antibodies | |
| HY-P80969 | IBSP Antibody | Antibodies | |
| HY-P80970 | FMRP Antibody | Antibodies | |
| HY-P80971 | Aurora A Antibody | Antibodies | |
| HY-P80972 | PLK1 Antibody | Antibodies | |
| HY-P80973 | Thymidylate Synthase Antibody | Antibodies | |
| HY-P80974 | FOXA2 Antibody | Antibodies | |
| HY-P80975 | RPA32 Antibody (YA679) | Antibodies | |
| HY-P80976 | BRD4 Antibody | Antibodies | |
| HY-P80977 | FACL4 Antibody | Antibodies | |
| HY-P80978 | PAX6 Antibody | Antibodies | |
| HY-P80979 | HOPX Antibody | Antibodies | |
| HY-P80980 | TOP2A Antibody | Antibodies | |
| HY-P80981 | CD64 Antibody | Antibodies | |
| HY-P80982 | Cytokeratin 20 Antibody | Antibodies | |
| HY-P80983 | CDX2 Antibody | Antibodies | |
| HY-P80984 | Cytokeratin 5 Antibody | Antibodies | |
| HY-P80985 | CEACAM1 Antibody | Antibodies | |
| HY-P80986 | Villin Antibody | Antibodies | |
| HY-P80987 | Mucin 2 Antibody | Antibodies | |
| HY-P80988 | Mucin 5AC Antibody | Antibodies | |
| HY-P80989 | Gastric Mucin Antibody | Antibodies | |
| HY-P80990 | Mucin 5B Antibody | Antibodies | |
| HY-P80991 | Mucin 16 Antibody | Antibodies | |
| HY-P80992 | CDKN2A/p16INK4a Antibody | Antibodies | |
| HY-P80993 | Beta Actin Antibody HRP Conjugated | Antibodies | |
| HY-P80994 | Anti-Lactate Dehydrogenase A Antibody | Antibodies | |
| HY-P80995 | IDH1 Antibody | Antibodies | |
| HY-P80996 | p38 MAPK Antibody | Antibodies | |
| HY-P80998 | Cyclin B2 Antibody | Antibodies | |
| HY-P81000 | Transferrin Receptor 1 Antibody | Antibodies | |
| HY-P81002 | FDFT1 Antibody | Antibodies | |
| HY-P81003 | CDKN2C Antibody | Antibodies | |
| HY-P81004 | FXR1 Antibody | Antibodies | |
| HY-P81005 | Alexa Fluor® 555-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P81006 | Alexa Fluor® 555-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P81007 | TRITC-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P81008 | TRITC-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P81013 | Alexa Fluor® 647-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P81014 | Alexa Fluor® 405-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P81015 | Alexa Fluor® 405-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P81016 | Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P81017 | Cy3-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P81018 | Cy5-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P81019 | Cy5-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P81020 | Cy7-conjugated AffiniPure Goat Anti-Mouse IgG H&L | Antibodies | |
| HY-P81021 | Cy7-conjugated AffiniPure Goat Anti-Rabbit IgG H&L | Antibodies | |
| HY-P81022 | Phospho-IRF3 (Ser386) Antibody | Antibodies | |
| HY-P81023 | CHRNA9 Antibody | Antibodies | |
| HY-P81024 | AmCyan Tag Antibody (YA864) | Antibodies | |
| HY-P81025 | COX IV Antibody (YA867) | Antibodies | |
| HY-P81026 | DsbA Tag Antibody (YA868) | Antibodies | |
| HY-P81027 | Dynactin Subunit 1 Antibody (YA869) | Antibodies | |
| HY-P81028 | E2 Tag Antibody (YA870) | Antibodies | |
| HY-P81029 | ECFP Tag Antibody (YA871) | Antibodies | |
| HY-P81030 | EYFP Tag Antibody (YA872) | Antibodies | |
| HY-P81031 | VSV G tag Antibody (YA875) | Antibodies | |
| HY-P81032 | HSV Tag Antibody (YA878) | Antibodies | |
| HY-P81033 | MBP Tag Antibody (YA879) | Antibodies | |
| HY-P81034 | mOrange Tag Antibody (YA880) | Antibodies | |
| HY-P81035 | Plant Actin Antibody (YA881) | Antibodies | |
| HY-P81036 | RFP Tag Antibody (YA882) | Antibodies | |
| HY-P81037 | S Tag Antibody (YA883) | Antibodies | |
| HY-P81038 | SRT Tag Antibody (YA884) | Antibodies | |
| HY-P81039 | Strep-Tag II Antibody (YA885) | Antibodies | |
| HY-P81040 | T7 Tag Antibody (YA886) | Antibodies | |
| HY-P81041 | TAP Tag Antibody (YA887) | Antibodies | |
| HY-P81042 | Trx Tag Antibody (YA888) | Antibodies | |
| HY-P81043 | HE4 Antibody | Antibodies | |
| HY-P81044 | MUC16 Antibody | Antibodies | |
| HY-P81045 | Thrombomodulin Antibody (YA891) | Antibodies | |
| HY-P81046 | Thrombomodulin Antibody (YA892) | Antibodies | |
| HY-P81047 | Collagen II Antibody | Antibodies | |
| HY-P81047A | Collagen II Antibody(YA3550) | Antibodies | |
| HY-P81048 | Collagen VI Antibody (YA893) | Antibodies | |
| HY-P81049 | Phospho-NFKB1 (Ser337) Antibody | Antibodies | |
| HY-P81050 | Phospho-HSF1 (Ser326) Antibody(YA894) | Antibodies | |
| HY-P81051 | Nrf2 Antibody(YA895) | Antibodies | |
| HY-P81052 | HSF1 Antibody (YA896) | Antibodies | |
| HY-P81053 | MAP2 Antibody | Antibodies | |
| HY-P81054 | DXd Antibody (YA897) | Antibodies | |
| HY-P81055 | DM1 Antibody (YA898) | Antibodies | |
| HY-P81056 | MMAE Antibody (YA899) | Antibodies | |
| HY-P81057 | MMAF Antibody (YA900) | Antibodies | |
| HY-P81058 | Salbutamol Antibody (YA901) | Antibodies | |
| HY-P81059 | Malachite green Antibody (Biotin) (YA902) | Antibodies | |
| HY-P81060 | Quinolones Antibody (YA903) | Antibodies | |
| HY-P81061 | Clenbuterol Antibody (YA904) | Antibodies | |
| HY-P81062 | Sudan I Antibody (YA905) | Antibodies | |
| HY-P81063 | Sulfadimidine Antibody (YA906) | Antibodies | |
| HY-P81064 | Neomycin Antibody (YA907) | Antibodies | |
| HY-P81065 | Phospho-ULK1 (Ser556) Antibody | Antibodies | |
| HY-P81066 | Peroxiredoxin 3 Antibody | Antibodies | |
| HY-P81067 | HBcAg Antibody | Antibodies | |
| HY-P81068 | CIDEC Antibody | Antibodies | |
| HY-P81068A | CIDEC Antibody | Antibodies | |
| HY-P81070 | DLAT Antibody (YA912) | Antibodies | |
| HY-P81071 | DLST Antibody | Antibodies | |
| HY-P81072 | LIAS Antibody | Antibodies | |
| HY-P81073 | NK1R Antibody | Antibodies | |
| HY-P81074 | FOXO1 Antibody | Antibodies | |
| HY-P81075 | CTLA4 Antibody | Antibodies | |
| HY-P81076 | HBsAg Antibody (YA913) | Antibodies | |
| HY-P81077 | AFP Antibody (YA914) | Antibodies | |
| HY-P81078 | AFP Antibody (YA915) | Antibodies | |
| HY-P81080 | CEA Antibody (YA917) | Antibodies | |
| HY-P81082 | Fbx32 Antibody (YA919) | Antibodies | |
| HY-P81083 | ADGRE1 (F4/80) Antibody (YA920) | Antibodies | |
| HY-P81084 | ACE Antibody | Antibodies | |
| HY-P81085 | ADRB2 Antibody | Antibodies | |
| HY-P81086 | RAGE Antibody | Antibodies | |
| HY-P81086A | RAGE Antibody(YA3549) | Antibodies | |
| HY-P81087 | AGEs Antibody | Antibodies | |
| HY-P81088 | ACAN Antibody | Antibodies | |
| HY-P81089 | CXCR4 Antibody | Antibodies | |
| HY-P81091 | Beta casein Antibody | Antibodies | |
| HY-P81092 | DRD2 Antibody | Antibodies | |
| HY-P81093 | BMP2 Antibody | Antibodies | |
| HY-P81094 | Calponin 1 Antibody | Antibodies | |
| HY-P81095 | Caspase-12 Antibody | Antibodies | |
| HY-P81096 | CD14 Antibody | Antibodies | |
| HY-P81097 | CD144/VE Cadherin Antibody | Antibodies | |
| HY-P81098 | CD34 Antibody | Antibodies | |
| HY-P81099 | Calcitonin Antibody | Antibodies | |
| HY-P81100 | ChAT Antibody | Antibodies | |
| HY-P81101 | Collagen III Antibody | Antibodies | |
| HY-P81102 | Collagen X Antibody | Antibodies | |
| HY-P81103 | CTGF Antibody | Antibodies | |
| HY-P81106 | IL-8/CXCL8 Antibody | Antibodies | |
| HY-P81107 | Growth hormone receptor Antibody | Antibodies | |
| HY-P81110 | TERT Antibody | Antibodies | |
| HY-P81110A | TERT Antibody (YA3439) | Antibodies | |
| HY-P81111 | IFN gamma Antibody | Antibodies | |
| HY-P81112 | IGF 1 Antibody | Antibodies | |
| HY-P81113 | IL-10 Antibody | Antibodies | |
| HY-P81114 | IL17A Antibody | Antibodies | |
| HY-P81115 | IL-1 alpha Antibody | Antibodies | |
| HY-P81116 | IRS1 Antibody | Antibodies | |
| HY-P81117 | MMP7 Antibody | Antibodies | |
| HY-P81118 | MRP2 Antibody | Antibodies | |
| HY-P81119 | MTNR1A Antibody | Antibodies | |
| HY-P81120 | Nestin Antibody | Antibodies | |
| HY-P81121 | NGF Antibody | Antibodies | |
| HY-P81123 | OPG Antibody | Antibodies | |
| HY-P81124 | RANKL/CD254 Antibody | Antibodies | |
| HY-P81125 | SP7/Osterix Antibody | Antibodies | |
| HY-P81127 | PKA alpha + beta Antibody | Antibodies | |
| HY-P81128 | SCF Antibody | Antibodies | |
| HY-P81130 | Substance P Antibody | Antibodies | |
| HY-P81131 | TGF beta Receptor II Antibody | Antibodies | |
| HY-P81132 | CD90/Thy-1 Antibody | Antibodies | |
| HY-P81133 | TIMP-1 Antibody | Antibodies | |
| HY-P81134 | TLR2 Antibody | Antibodies | |
| HY-P81135 | SNAI1 Antibody | Antibodies | |
| HY-P81136 | Aquaporin 5 Antibody | Antibodies | |
| HY-P81137 | APOA1 Antibody | Antibodies | |
| HY-P81138 | CD166 Antibody | Antibodies | |
| HY-P81140 | 8-OHdG (DNA/RNA Damage) Antibody | Antibodies | |
| HY-P81141 | Casein Antibody | Antibodies | |
| HY-P81142 | Muscarinic Acetylcholine receptor M3 Antibody | Antibodies | |
| HY-P81143 | CCR7 Antibody | Antibodies | |
| HY-P81144 | Cardiac Troponin I/TNNC1 Antibody | Antibodies | |
| HY-P81145 | Oxytocin R Antibody | Antibodies | |
| HY-P81148 | CD8 Antibody | Antibodies | |
| HY-P81150 | GPR30 Antibody | Antibodies | |
| HY-P81153 | HIF 2 alpha Antibody | Antibodies | |
| HY-P81154 | CXCL10/IP10 Antibody | Antibodies | |
| HY-P81155 | Occludin/OCLN Antibody | Antibodies | |
| HY-P81156 | phospho-ERK1 + 2 (Thr183/Tyr185) Antibody | Antibodies | |
| HY-P81157 | Shh Antibody | Antibodies | |
| HY-P81158 | CXCR2 Antibody | Antibodies | |
| HY-P81160 | GLP-1R Antibody | Antibodies | |
| HY-P81161 | CEBP-alpha Antibody | Antibodies | |
| HY-P81162 | PI3 Kinase p110 alpha/PIK3CA Antibody | Antibodies | |
| HY-P81162A | PI3 Kinase p110 alpha/PIK3CA Antibody | Antibodies | |
| HY-P81163 | Cathepsin K Antibody | Antibodies | |
| HY-P81164 | Pan Cytokeratin Antibody | Antibodies | |
| HY-P81165 | Dopamine Transporter Antibody | Antibodies | |
| HY-P81166 | ox-LDL Antibody | Antibodies | |
| HY-P81167 | CPT1A Antibody | Antibodies | |
| HY-P81169A | PD-1 Antibody(YA3401) | Antibodies | |
| HY-P81171 | MCP1 Antibody | Antibodies | |
| HY-P81172 | LOX 1 Antibody | Antibodies | |
| HY-P81173 | TWIST Antibody | Antibodies | |
| HY-P81175 | MyoD1/Myf3 Antibody | Antibodies | |
| HY-P81176 | CD11c Antibody | Antibodies | |
| HY-P81177 | CD163 Antibody | Antibodies | |
| HY-P81179 | CXCL5 Antibody | Antibodies | |
| HY-P81181 | CK18 Antibody | Antibodies | |
| HY-P81183 | Cytokeratin 19 Antibody | Antibodies | |
| HY-P81183A | Cytokeratin 19 Antibody(PBS only) | Antibodies | |
| HY-P81184 | CD80 Antibody (YA3386) | Antibodies | |
| HY-P81185 | C5b-9 Antibody | Antibodies | |
| HY-P81186 | TIM 1 Antibody | Antibodies | |
| HY-P81188 | CXCR3 Antibody | Antibodies | |
| HY-P81189 | Myogenin Antibody | Antibodies | |
| HY-P81190 | Phospho-PERK (Thr980) Antibody | Antibodies | |
| HY-P81191 | Phospho-eNOS (Ser1177) Antibody | Antibodies | |
| HY-P81192 | StAR Antibody | Antibodies | |
| HY-P81193 | ADAMTS5 Antibody | Antibodies | |
| HY-P81194 | EPX Antibody | Antibodies | |
| HY-P81195 | NOX2 Antibody | Antibodies | |
| HY-P81196 | HSD3B1 Antibody | Antibodies | |
| HY-P81197 | HMGCR Antibody | Antibodies | |
| HY-P81198 | AXL Antibody | Antibodies | |
| HY-P81201 | Collagen IV Antibody | Antibodies | |
| HY-P81202 | CD16 Antibody | Antibodies | |
| HY-P81203 | Vitamin D Receptor Antibody | Antibodies | |
| HY-P81204 | Alpha-ENaC Antibody | Antibodies | |
| HY-P81205 | CAMKK2 Antibody | Antibodies | |
| HY-P81206 | SRD5A2 Antibody | Antibodies | |
| HY-P81207 | TNMD Antibody | Antibodies | |
| HY-P81208 | 4 Hydroxynonenal Antibody | Antibodies | |
| HY-P81209 | S6K1 Antibody | Antibodies | |
| HY-P81210 | phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody | Antibodies | |
| HY-P81211 | phospho-PI3 Kinase p110 beta (Ser1070) Antibody | Antibodies | |
| HY-P81214 | MRC1 Antibody | Antibodies | |
| HY-P81215 | Neutrophil Elastase Antibody | Antibodies | |
| HY-P81216 | 3-Nitrotyrosine Antibody | Antibodies | |
| HY-P81217 | Osteocalcin Antibody | Antibodies | |
| HY-P81218 | SLC40A1 Antibody | Antibodies | |
| HY-P81219 | MPO Antibody | Antibodies | |
| HY-P81219A | MPO Antibody(YA3392) | Antibodies | |
| HY-P81222A | Claudin 1Antibody(YA3551) | Antibodies | |
| HY-P81223 | CYP11A1 Antibody | Antibodies | |
| HY-P81225 | GPR43 Antibody | Antibodies | |
| HY-P81227 | Collagen I Antibody | Antibodies | |
| HY-P81228 | SOD1 Antibody | Antibodies | |
| HY-P81230 | GSDMD Antibody | Antibodies | |
| HY-P81231 | Occludin Antibody | Antibodies | |
| HY-P81232 | Caspase-1 Antibody | Antibodies | |
| HY-P81233 | DDIT3 Antibody | Antibodies | |
| HY-P81234 | Ki-67 Antibody | Antibodies | |
| HY-P81236 | ATG10 Antibody | Antibodies | |
| HY-P81237 | Wnt10a Antibody | Antibodies | |
| HY-P81238 | Phospho-NF-κB p65 (Ser536) Antibody | Antibodies | |
| HY-P81240 | IL-19 Antibody | Antibodies | |
| HY-P81241 | Leptin Antibody | Antibodies | |
| HY-P81242 | Glucagon Antibody | Antibodies | |
| HY-P81243 | F2 Antibody | Antibodies | |
| HY-P81244 | CYP2E1 Antibody | Antibodies | |
| HY-P81245 | CYP1A2 Antibody | Antibodies | |
| HY-P81246 | DGAT1 Antibody | Antibodies | |
| HY-P81248 | SN38 Antibody (YA923) | Antibodies | |
| HY-P81250 | Cytokeratin 19 Antibody (YA924) | Antibodies | |
| HY-P81251 | CASP4 Antibody | Antibodies | |
| HY-P81252 | Caspase-5 p20 Antibody | Antibodies | |
| HY-P81253 | Myoglobin Antibody (YA925) | Antibodies | |
| HY-P81254 | Beta Actin (Fruit Fly) Antibody | Antibodies | |
| HY-P81256 | Acetyl-Histone H4 Antibody (YA926) | Antibodies | |
| HY-P81256A | Acetyl-Histone H4 Antibody (YA927) | Antibodies | |
| HY-P81257 | ALDH2 Antibody (YA928) | Antibodies | |
| HY-P81257A | ALDH2 Antibody (YA929) | Antibodies | |
| HY-P81258 | alpha Skeletal Muscle Actin Antibody (YA930) | Antibodies | |
| HY-P81258A | alpha Skeletal Muscle Actin Antibody (YA931) | Antibodies | |
| HY-P81259 | BAG1 Antibody (YA932) | Antibodies | |
| HY-P81259A | BAG1 Antibody (YA933) | Antibodies | |
| HY-P81260 | beta 2 Microglobulin Antibody (YA934) | Antibodies | |
| HY-P81260A | beta 2 Microglobulin Antibody (YA935) | Antibodies | |
| HY-P81261 | beta Catenin Antibody (YA936) | Antibodies | |
| HY-P81261A | beta Catenin Antibody (YA937) | Antibodies | |
| HY-P81261B | beta Catenin Antibody (YA938) | Antibodies | |
| HY-P81262 | C Reactive Protein Antibody (YA939) | Antibodies | |
| HY-P81262A | C Reactive Protein Antibody (YA940) | Antibodies | |
| HY-P81262B | C Reactive Protein Antibody (YA941) | Antibodies | |
| HY-P81263 | CAMKIV Antibody (YA942) | Antibodies | |
| HY-P81263A | CAMKIV Antibody (YA943) | Antibodies | |
| HY-P81264 | CHD3 Antibody (YA944) | Antibodies | |
| HY-P81264A | CHD3 Antibody (YA945) | Antibodies | |
| HY-P81265 | CHD4 Antibody (YA946) | Antibodies | |
| HY-P81265A | CHD4 Antibody (YA947) | Antibodies | |
| HY-P81266 | Cytokeratin 16 Antibody (YA948) | Antibodies | |
| HY-P81266A | Cytokeratin 16 Antibody (YA949) | Antibodies | |
| HY-P81267 | Cytokeratin 7 Antibody (YA950) | Antibodies | |
| HY-P81267A | Cytokeratin 7 Antibody (YA951) | Antibodies | |
| HY-P81267B | Cytokeratin 7 Antibody (YA952) | Antibodies | |
| HY-P81268 | Cytokeratin pan Antibody (YA953) | Antibodies | |
| HY-P81268A | Cytokeratin pan Antibody (YA954) | Antibodies | |
| HY-P81269 | DBC 1 Antibody (YA955) | Antibodies | |
| HY-P81269A | DBC 1 Antibody (YA956) | Antibodies | |
| HY-P81270 | DNA PKcs Antibody (YA957) | Antibodies | |
| HY-P81270A | DNA PKcs Antibody (YA958) | Antibodies | |
| HY-P81270B | DNA PKcs Antibody (YA959) | Antibodies | |
| HY-P81271 | E Cadherin Antibody | Antibodies | |
| HY-P81272 | Elongation factor 2 Antibody (YA962) | Antibodies | |
| HY-P81272A | Elongation factor 2 Antibody (YA963) | Antibodies | |
| HY-P81272B | Elongation factor 2 Antibody (YA964) | Antibodies | |
| HY-P81273 | FABP1 Antibody (YA965) | Antibodies | |
| HY-P81273B | FABP1 Antibody (YA967) | Antibodies | |
| HY-P81274 | FABP3 Antibody (YA968) | Antibodies | |
| HY-P81274A | FABP3 Antibody (YA969) | Antibodies | |
| HY-P81274B | FABP3 Antibody (YA970) | Antibodies | |
| HY-P81275 | Ferritin Light Chain Antibody (YA971) | Antibodies | |
| HY-P81275A | Ferritin Light Chain Antibody (YA972) | Antibodies | |
| HY-P81276 | FYB Antibody (YA973) | Antibodies | |
| HY-P81276B | FYB Antibody (YA974) | Antibodies | |
| HY-P81277 | GST3 Antibody (YA975) | Antibodies | |
| HY-P81277A | GST3 Antibody (YA976) | Antibodies | |
| HY-P81278 | HARS Antibody (YA977) | Antibodies | |
| HY-P81278B | HARS Antibody (YA978) | Antibodies | |
| HY-P81279 | hnRNP U Antibody (YA979) | Antibodies | |
| HY-P81279A | hnRNP U Antibody (YA980) | Antibodies | |
| HY-P81280 | HP1 alpha Antibody (YA981) | Antibodies | |
| HY-P81280A | HP1 alpha Antibody (YA982) | Antibodies | |
| HY-P81280B | HP1 alpha Antibody (YA983) | Antibodies | |
| HY-P81281 | Human Serum Albumin Antibody (YA984) | Antibodies | |
| HY-P81281A | Human Serum Albumin Antibody (YA985) | Antibodies | |
| HY-P81282 | Ikaros Antibody (YA987) | Antibodies | |
| HY-P81282A | Ikaros Antibody (YA988) | Antibodies | |
| HY-P81283 | Lamin B2 Antibody (YA989) | Antibodies | |
| HY-P81283A | Lamin B2 Antibody (YA990) | Antibodies | |
| HY-P81284 | Lipocalin 2 Antibody (YA991) | Antibodies | |
| HY-P81284A | Lipocalin 2 Antibody (YA992) | Antibodies | |
| HY-P81285 | LPP Antibody (YA993) | Antibodies | |
| HY-P81285A | LPP Antibody (YA994) | Antibodies | |
| HY-P81286 | LYRIC Antibody (YA995) | Antibodies | |
| HY-P81286A | LYRIC Antibody (YA996) | Antibodies | |
| HY-P81287 | MonoMethyl-Histone H3 Antibody (YA997) | Antibodies | |
| HY-P81287A | MonoMethyl-Histone H3 Antibody (YA998) | Antibodies | |
| HY-P81288 | Natriuretic Peptides B Antibody (YA999) | Antibodies | |
| HY-P81288A | Natriuretic Peptides B Antibody (YA1000) | Antibodies | |
| HY-P81288B | Natriuretic Peptides B Antibody (YA1001) | Antibodies | |
| HY-P81289 | NM23A Antibody (YA1002) | Antibodies | |
| HY-P81289A | NM23A Antibody (YA1003) | Antibodies | |
| HY-P81290 | NSE Antibody (YA1004) | Antibodies | |
| HY-P81290A | NSE Antibody (YA1005) | Antibodies | |
| HY-P81290B | NSE Antibody (YA1006) | Antibodies | |
| HY-P81290C | NSE Antibody (YA1007) | Antibodies | |
| HY-P81291 | Nucleophosmin Antibody (YA1008) | Antibodies | |
| HY-P81291A | Nucleophosmin Antibody (YA1009) | Antibodies | |
| HY-P81292 | NUP98 Antibody (YA1010) | Antibodies | |
| HY-P81292A | NUP98 Antibody (YA1011) | Antibodies | |
| HY-P81293 | Olig2 Antibody (YA1012) | Antibodies | |
| HY-P81293A | Olig2 Antibody (YA1013) | Antibodies | |
| HY-P81294 | Phospho-CBL (Tyr774) Antibody (YA1014) | Antibodies | |
| HY-P81294A | Phospho-CBL (Ser669) Antibody (YA1015) | Antibodies | |
| HY-P81295 | Phospho-CDC6 (Ser106) Antibody (YA1016) | Antibodies | |
| HY-P81295A | Phospho-CDC6 (Ser54) Antibody (YA1017) | Antibodies | |
| HY-P81296 | Phospho-delta 1 Catenin (Tyr228) Antibody (YA1018) | Antibodies | |
| HY-P81296A | Phospho-delta 1 Catenin (Ser268) Antibody (YA1019) | Antibodies | |
| HY-P81296B | Phospho-delta 1 Catenin (Thr916) Antibody (YA1020) | Antibodies | |
| HY-P81297 | Phospho-LAT (Tyr191) Antibody (YA1021) | Antibodies | |
| HY-P81297A | Phospho-LAT (Tyr200) Antibody (YA1022) | Antibodies | |
| HY-P81298 | Phospho-PKC alpha (Ser657) Antibody (YA1023) | Antibodies | |
| HY-P81298A | Phospho-PKC alpha (Thr638) Antibody (YA1024) | Antibodies | |
| HY-P81299 | Phospho-PKR (Thr451) Antibody (YA1025) | Antibodies | |
| HY-P81299A | Phospho-PKR (Thr446) Antibody (YA1026) | Antibodies | |
| HY-P81300 | Phospho-PTP1B (Ser352) Antibody (YA1027) | Antibodies | |
| HY-P81300A | Phospho-PTP1B (Ser378) Antibody (YA1028) | Antibodies | |
| HY-P81301 | Phospho-Rb (Thr356) Antibody (YA1029) | Antibodies | |
| HY-P81301A | Phospho-Rb (Ser780) Antibody (YA1030) | Antibodies | |
| HY-P81301B | Phospho-Rb (Ser811) Antibody (YA1031) | Antibodies | |
| HY-P81301C | Phospho-Rb (Ser608) Antibody (YA1032) | Antibodies | |
| HY-P81301D | Phospho-Rb (Thr252) Antibody (YA1033) | Antibodies | |
| HY-P81302 | Phospho-Rb2 p130 (Ser952) Antibody (YA1034) | Antibodies | |
| HY-P81302A | Phospho-Rb2 p130 (Thr986) Antibody (YA1035) | Antibodies | |
| HY-P81303 | Phospho-SIRT1 (Ser47) Antibody (YA1036) | Antibodies | |
| HY-P81303A | Phospho-SIRT1 (Thr530) Antibody (YA1037) | Antibodies | |
| HY-P81304 | Placental Alkaline Phosphatase Antibody (YA1038) | Antibodies | |
| HY-P81304A | Placental Alkaline Phosphatase Antibody (YA1039) | Antibodies | |
| HY-P81305 | PP1C alpha Antibody (YA1040) | Antibodies | |
| HY-P81305A | PP1C alpha Antibody (YA1041) | Antibodies | |
| HY-P81306 | SAFB1 Antibody (YA1042) | Antibodies | |
| HY-P81306A | SAFB1 Antibody (YA1043) | Antibodies | |
| HY-P81307 | SHP1 Antibody (YA1044) | Antibodies | |
| HY-P81307A | SHP1 Antibody (YA1045) | Antibodies | |
| HY-P81308 | SMARCC1 Antibody (YA1046) | Antibodies | |
| HY-P81308A | SMARCC1 Antibody (YA1047) | Antibodies | |
| HY-P81309 | SUMO2/3 Antibody (YA1048) | Antibodies | |
| HY-P81309A | SUMO2/3 Antibody (YA1049) | Antibodies | |
| HY-P81310 | Syntenin 1 Antibody (YA1050) | Antibodies | |
| HY-P81310A | Syntenin 1 Antibody (YA1051) | Antibodies | |
| HY-P81311 | TBL1XR1 Antibody (YA1052) | Antibodies | |
| HY-P81311A | TBL1XR1 Antibody (YA1053) | Antibodies | |
| HY-P81312 | Transcription Initiation Factor IIB Antibody (YA1054) | Antibodies | |
| HY-P81312A | Transcription Initiation Factor IIB Antibody (YA1055) | Antibodies | |
| HY-P81313 | UHRF1 Antibody (YA1056) | Antibodies | |
| HY-P81313A | UHRF1 Antibody (YA1057) | Antibodies | |
| HY-P81314 | XRCC1 Antibody (YA1058) | Antibodies | |
| HY-P81314A | XRCC1 Antibody (YA1059) | Antibodies | |
| HY-P81315 | Anthrax Protective gen Antibody (YA1060) | Antibodies | |
| HY-P81316 | CKM Antibody (YA1061) | Antibodies | |
| HY-P81317 | Human IgM Antibody (YA1062) | Antibodies | |
| HY-P81318 | KDM5C Antibody (YA1063) | Antibodies | |
| HY-P81319 | JMJD6 Antibody (YA1064) | Antibodies | |
| HY-P81320 | TBL1X Antibody (YA1065) | Antibodies | |
| HY-P81321 | TRIM33 Antibody (YA1066) | Antibodies | |
| HY-P81322 | GTF2H1 Antibody (YA1067) | Antibodies | |
| HY-P81323 | PP1C gamma Antibody (YA1068) | Antibodies | |
| HY-P81324 | PPP5C Antibody (YA1069) | Antibodies | |
| HY-P81325 | CRTC1 Antibody (YA1070) | Antibodies | |
| HY-P81326 | ALDH3A2 Antibody (YA1071) | Antibodies | |
| HY-P81327 | ATIC Antibody (YA1072) | Antibodies | |
| HY-P81328 | Switch Associated Protein 70 Antibody (YA1073) | Antibodies | |
| HY-P81329 | Phostensin Antibody (YA1074) | Antibodies | |
| HY-P81330 | Rad23B Antibody (YA1075) | Antibodies | |
| HY-P81331 | GADD45A Antibody (YA1076) | Antibodies | |
| HY-P81332 | ntpII Antibody (YA1077) | Antibodies | |
| HY-P81333 | GRAP2 Antibody (YA1078) | Antibodies | |
| HY-P81334 | 4E BP2 Antibody (YA1079) | Antibodies | |
| HY-P81335 | 4E BP3 Antibody (YA1080) | Antibodies | |
| HY-P81336 | Wnt3 Antibody (YA1081) | Antibodies | |
| HY-P81337 | XRCC4 Antibody (YA1082) | Antibodies | |
| HY-P81338 | Aldose Reductase Antibody (YA1083) | Antibodies | |
| HY-P81339 | TBLR1 Antibody (YA1084) | Antibodies | |
| HY-P81340 | Mannose Phosphate Isomerase Antibody (YA1085) | Antibodies | |
| HY-P81341 | AMACR Antibody (YA1086) | Antibodies | |
| HY-P81342 | Rad9 Antibody (YA1087) | Antibodies | |
| HY-P81343 | MAP2K6 Antibody (YA1088) | Antibodies | |
| HY-P81344 | LSP1 Antibody (YA1089) | Antibodies | |
| HY-P81345 | FAP Antibody (YA1090) | Antibodies | |
| HY-P81346 | 15 Lipoxygenase 1 Antibody (YA1091) | Antibodies | |
| HY-P81347 | CD28 Antibody (YA1092) | Antibodies | |
| HY-P81348 | PHLPP2 Antibody (YA1093) | Antibodies | |
| HY-P81349 | CD39 Antibody (YA1094) | Antibodies | |
| HY-P81350 | Luteinizing Hormone beta Antibody (YA1095) | Antibodies | |
| HY-P81351 | 15 PGDH Antibody (YA1096) | Antibodies | |
| HY-P81352 | 5T4 Antibody (YA1097) | Antibodies | |
| HY-P81353 | LYPD3 Antibody (YA1098) | Antibodies | |
| HY-P81354 | Folate Binding Protein Antibody (YA1099) | Antibodies | |
| HY-P81355 | PODXL Antibody (YA1100) | Antibodies | |
| HY-P81356 | PRDM1/Blimp1 Antibody (YA1101) | Antibodies | |
| HY-P81357 | FOXA1 Antibody (YA1102) | Antibodies | |
| HY-P81358 | AACT Antibody (YA1103) | Antibodies | |
| HY-P81359 | FOXC1 Antibody (YA1104) | Antibodies | |
| HY-P81360 | MAGEA1 Antibody (YA1105) | Antibodies | |
| HY-P81361 | PRKCQ Antibody (YA1106) | Antibodies | |
| HY-P81362 | FOXJ1 Antibody (YA1107) | Antibodies | |
| HY-P81363 | ABHD5 Antibody (YA1108) | Antibodies | |
| HY-P81364 | MAGEA3 Antibody (YA1109) | Antibodies | |
| HY-P81365 | SLC45A3 Antibody (YA1110) | Antibodies | |
| HY-P81366 | CD48 Antibody (YA1111) | Antibodies | |
| HY-P81367 | FOXM1 Antibody (YA1112) | Antibodies | |
| HY-P81368 | AKR1B10 Antibody (YA1113) | Antibodies | |
| HY-P81369 | MAGEC2 Antibody (YA1114) | Antibodies | |
| HY-P81370 | CD53 Antibody (YA1115) | Antibodies | |
| HY-P81371 | PU.1/SPI1 Antibody (YA1116) | Antibodies | |
| HY-P81372 | MAGP2 Antibody (YA1117) | Antibodies | |
| HY-P81373 | CD69 Antibody (YA1118) | Antibodies | |
| HY-P81374 | FUBP1 Antibody (YA1119) | Antibodies | |
| HY-P81375 | ALDH3A1 Antibody (YA1120) | Antibodies | |
| HY-P81376 | QSOX1 Antibody (YA1121) | Antibodies | |
| HY-P81377 | alpha 1-Antitrypsin Antibody (YA1122) | Antibodies | |
| HY-P81378 | MAP4K4/NIK Antibody (YA1123) | Antibodies | |
| HY-P81379 | RBX1 Antibody (YA1124) | Antibodies | |
| HY-P81380 | alpha 1 Spectrin Antibody (YA1125) | Antibodies | |
| HY-P81381 | MASH1/Achaete-scute homolog 1 Antibody (YA1126) | Antibodies | |
| HY-P81382 | Galectin 9 Antibody (YA1127) | Antibodies | |
| HY-P81383 | CD79B Antibody (YA1128) | Antibodies | |
| HY-P81384 | RON Antibody (YA1129) | Antibodies | |
| HY-P81385 | Amyloid Precursor Protein Antibody (YA1130) | Antibodies | |
| HY-P81386 | TPSB2 Antibody (YA1131) | Antibodies | |
| HY-P81387 | GCET2 Antibody (YA1132) | Antibodies | |
| HY-P81388 | CD82 Antibody (YA1133) | Antibodies | |
| HY-P81389 | Annexin A10 Antibody (YA1134) | Antibodies | |
| HY-P81390 | ROR2 Antibody (YA1135) | Antibodies | |
| HY-P81391 | GDA Antibody (YA1136) | Antibodies | |
| HY-P81392 | MCM3 Antibody (YA1137) | Antibodies | |
| HY-P81393 | Annexin VII Antibody (YA1138) | Antibodies | |
| HY-P81394 | Geminin Antibody (YA1139) | Antibodies | |
| HY-P81395 | MCM5 Antibody (YA1140) | Antibodies | |
| HY-P81396 | RUNX3 Antibody (YA1141) | Antibodies | |
| HY-P81397 | Transcription Factor AP 2 gamma Antibody (YA1142) | Antibodies | |
| HY-P81398 | Ionotropic Glutamate Receptor 2 Antibody (YA1143) | Antibodies | |
| HY-P81399 | CD97 Antibody (YA1144) | Antibodies | |
| HY-P81400 | Aquaporin 3 Antibody (YA1145) | Antibodies | |
| HY-P81401 | MCM6 Antibody (YA1146) | Antibodies | |
| HY-P81402 | SA2 Antibody (YA1147) | Antibodies | |
| HY-P81403 | CDA Antibody (YA1148) | Antibodies | |
| HY-P81404 | Aquaporin 1 Antibody (YA1149) | Antibodies | |
| HY-P81405 | SAGE1 Antibody (YA1150) | Antibodies | |
| HY-P81406 | Glycophorin A Antibody (YA1151) | Antibodies | |
| HY-P81407 | CDC7 Antibody (YA1152) | Antibodies | |
| HY-P81408 | ZEB1 Antibody (YA1153) | Antibodies | |
| HY-P81409 | SATB1 Antibody (YA1154) | Antibodies | |
| HY-P81410 | MEF2B Antibody (YA1155) | Antibodies | |
| HY-P81411 | Glycophorin C Antibody (YA1156) | Antibodies | |
| HY-P81412 | Mesothelin Antibody (YA1157) | Antibodies | |
| HY-P81413 | ARID1A Antibody (YA1158) | Antibodies | |
| HY-P81414 | GPNMB Antibody (YA1159) | Antibodies | |
| HY-P81415 | Scavenging Receptor SR-BI Antibody (YA1160) | Antibodies | |
| HY-P81416 | CENPF Antibody (YA1161) | Antibodies | |
| HY-P81417 | Granulin Antibody (YA1162) | Antibodies | |
| HY-P81418 | SCD1 Antibody (YA1163) | Antibodies | |
| HY-P81419 | Claudin 5 Antibody (YA1164) | Antibodies | |
| HY-P81420 | GRB7 Antibody (YA1165) | Antibodies | |
| HY-P81421 | MRP4 Antibody (YA1166) | Antibodies | |
| HY-P81422 | SCGN Antibody (YA1167) | Antibodies | |
| HY-P81423 | Serum Amyloid A Antibody (YA1168) | Antibodies | |
| HY-P81424 | Claudin 8 Antibody (YA1169) | Antibodies | |
| HY-P81425 | S100A8 Antibody (YA1170) | Antibodies | |
| HY-P81426 | SF3B3 Antibody (YA1171) | Antibodies | |
| HY-P81427 | B7H4 Antibody (YA1172) | Antibodies | |
| HY-P81428 | Hemoglobin subunit alpha Antibody (YA1173) | Antibodies | |
| HY-P81429 | CLEC4C Antibody (YA1174) | Antibodies | |
| HY-P81430 | Myoglobin Antibody (YA1175) | Antibodies | |
| HY-P81431 | Baf180 Antibody (YA1176) | Antibodies | |
| HY-P81432 | SLAMF7/CS1 Antibody (YA1177) | Antibodies | |
| HY-P81433 | c-Maf Antibody (YA1178) | Antibodies | |
| HY-P81434 | BANK1 Antibody (YA1179) | Antibodies | |
| HY-P81435 | SLC1A5/ASCT2 Antibody (YA1180) | Antibodies | |
| HY-P81436 | HLA-DP Antibody (YA1181) | Antibodies | |
| HY-P81437 | SLC34A2 Antibody (YA1182) | Antibodies | |
| HY-P81438 | Nampt Antibody (YA1183) | Antibodies | |
| HY-P81439 | CRX Antibody (YA1184) | Antibodies | |
| HY-P81440 | HMGA1 Antibody (YA1185) | Antibodies | |
| HY-P81441 | HMGA2 Antibody (YA1186) | Antibodies | |
| HY-P81442 | SLC39A6 Antibody (YA1187) | Antibodies | |
| HY-P81443 | Bcl10 Antibody (YA1188) | Antibodies | |
| HY-P81445 | HNF 4 alpha Antibody (YA1190) | Antibodies | |
| HY-P81446 | Placental lactogen Antibody (YA1191) | Antibodies | |
| HY-P81447 | NCR1 Antibody (YA1192) | Antibodies | |
| HY-P81448 | SLC7A5/LAT1 Antibody (YA1193) | Antibodies | |
| HY-P81449 | hnRNP K Antibody (YA1194) | Antibodies | |
| HY-P81450 | Smoothelin Antibody (YA1195) | Antibodies | |
| HY-P81451 | Nectin 2 Antibody (YA1196) | Antibodies | |
| HY-P81452 | Somatostatin Receptor 2 Antibody (YA1197) | Antibodies | |
| HY-P81453 | HOXB13 Antibody (YA1198) | Antibodies | |
| HY-P81454 | SOX17 Antibody (YA1199) | Antibodies | |
| HY-P81455 | HRPT2/Parafibromin Antibody (YA1200) | Antibodies | |
| HY-P81456 | Cyclin D3/CCND3 Antibody (YA1201) | Antibodies | |
| HY-P81457 | SPARC Antibody (YA1202) | Antibodies | |
| HY-P81458 | Brk/PTK6 Antibody (YA1203) | Antibodies | |
| HY-P81459 | SPINK1 Antibody (YA1204) | Antibodies | |
| HY-P81460 | NR0B1/DAX1 Antibody (YA1205) | Antibodies | |
| HY-P81461 | TAGLN/Transgelin Antibody (YA1206) | Antibodies | |
| HY-P81462 | URI1 Antibody (YA1207) | Antibodies | |
| HY-P81463 | DDX4 Antibody (YA1208) | Antibodies | |
| HY-P81464 | NFE2 Antibody (YA1209) | Antibodies | |
| HY-P81465 | DEK Antibody (YA1210) | Antibodies | |
| HY-P81466 | TARC/CCL17 Antibody (YA1211) | Antibodies | |
| HY-P81467 | ICOS Antibody (YA1212) | Antibodies | |
| HY-P81468 | C1QA Antibody (YA1213) | Antibodies | |
| HY-P81469 | Nkx2.2 Antibody (YA1214) | Antibodies | |
| HY-P81470 | Desmoglein 3 Antibody (YA1215) | Antibodies | |
| HY-P81471 | CAST Antibody (YA1216) | Antibodies | |
| HY-P81472 | T-bet / Tbx21 Antibody (YA1217) | Antibodies | |
| HY-P81473 | IGJ Antibody (YA1218) | Antibodies | |
| HY-P81474 | NKX6.1 Antibody (YA1219) | Antibodies | |
| HY-P81475 | TCF3 / E2A Antibody (YA1220) | Antibodies | |
| HY-P81476 | Calpain Small Subunit 1 Antibody (YA1221) | Antibodies | |
| HY-P81477 | DGKZ Antibody (YA1222) | Antibodies | |
| HY-P81478 | NR2F2 Antibody (YA1223) | Antibodies | |
| HY-P81479 | Nuclear Matrix Protein p84 Antibody (YA1224) | Antibodies | |
| HY-P81480 | IL-4I1/LAO Antibody (YA1225) | Antibodies | |
| HY-P81481 | DMRT1 Antibody (YA1226) | Antibodies | |
| HY-P81482 | Obestatin Antibody (YA1227) | Antibodies | |
| HY-P81483 | IL-5 Receptor alpha Antibody (YA1228) | Antibodies | |
| HY-P81484 | TIA1 Antibody (YA1229) | Antibodies | |
| HY-P81485 | Ornithine Carbamoyltransferase/OTC Antibody (YA1230) | Antibodies | |
| HY-P81486 | DPEP1/MDP Antibody (YA1231) | Antibodies | |
| HY-P81487 | Inhibin alpha Antibody (YA1232) | Antibodies | |
| HY-P81488 | TNS4/CTEN Antibody (YA1233) | Antibodies | |
| HY-P81489 | P cadherin Antibody (YA1234) | Antibodies | |
| HY-P81490 | DPEP3 Antibody (YA1235) | Antibodies | |
| HY-P81491 | INPP4B Antibody (YA1236) | Antibodies | |
| HY-P81492 | TN-X Antibody (YA1237) | Antibodies | |
| HY-P81493 | TRBC1 Antibody (YA1238) | Antibodies | |
| HY-P81494 | EDG1 Antibody (YA1239) | Antibodies | |
| HY-P81495 | p73 Antibody (YA1240) | Antibodies | |
| HY-P81496 | INSL3 Antibody (YA1241) | Antibodies | |
| HY-P81497 | Trefoil Factor 3 Antibody (YA1242) | Antibodies | |
| HY-P81498 | CD103 Antibody (YA1243) | Antibodies | |
| HY-P81499 | Islet 1 Antibody (YA1244) | Antibodies | |
| HY-P81500 | p75 NGF Receptor Antibody (YA1245) | Antibodies | |
| HY-P81501 | KIR2DL3 Antibody (YA1246) | Antibodies | |
| HY-P81502 | TRP1 Antibody (YA1247) | Antibodies | |
| HY-P81503 | Pancreatic Lipase Antibody (YA1248) | Antibodies | |
| HY-P81504 | Parvalbumin Antibody (YA1249) | Antibodies | |
| HY-P81505 | TRP2 Antibody (YA1250) | Antibodies | |
| HY-P81506 | ENT1 Antibody (YA1251) | Antibodies | |
| HY-P81507 | TSH Receptor/TSH-R Antibody (YA1252) | Antibodies | |
| HY-P81508 | CD13 Antibody (YA1253) | Antibodies | |
| HY-P81509 | CD134/OX40L Recepter Antibody (YA1254) | Antibodies | |
| HY-P81510 | Laminin gamma 1 Antibody (YA1255) | Antibodies | |
| HY-P81511 | PBK Antibody (YA1256) | Antibodies | |
| HY-P81512 | uPAR Antibody (YA1257) | Antibodies | |
| HY-P81512A | uPAR Antibody | Antibodies | |
| HY-P81513 | CD163L1 Antibody (YA1258) | Antibodies | |
| HY-P81514 | Uroplakin II/UPII Antibody (YA1259) | Antibodies | |
| HY-P81515 | Sialoadhesin/CD169 Antibody (YA1260) | Antibodies | |
| HY-P81516 | LILRB1 Antibody (YA1261) | Antibodies | |
| HY-P81517 | LY75 Antibody (YA1262) | Antibodies | |
| HY-P81518 | LINE-1 ORF1p Antibody (YA1263) | Antibodies | |
| HY-P81519 | FBP1 Antibody (YA1264) | Antibodies | |
| HY-P81520 | PDCD6/ALG-2 Antibody (YA1265) | Antibodies | |
| HY-P81521 | Langerin Antibody (YA1266) | Antibodies | |
| HY-P81522 | CD22 Antibody (YA1267) | Antibodies | |
| HY-P81523 | liver FABP Antibody (YA1268) | Antibodies | |
| HY-P81524 | VIPR1 Antibody (YA1269) | Antibodies | |
| HY-P81525 | Fbxw7 Antibody (YA1270) | Antibodies | |
| HY-P81526 | VPAC2 Antibody (YA1271) | Antibodies | |
| HY-P81527 | FCRL4 Antibody (YA1272) | Antibodies | |
| HY-P81528 | LMO2 Antibody (YA1273) | Antibodies | |
| HY-P81529 | DPP4/CD26 Antibody (YA1274) | Antibodies | |
| HY-P81530 | LPCAT1 Antibody (YA1275) | Antibodies | |
| HY-P81531 | VISTA Antibody (YA1276) | Antibodies | |
| HY-P81532 | PEG10 Antibody (YA1277) | Antibodies | |
| HY-P81533 | CD27 Antibody (YA1278) | Antibodies | |
| HY-P81534 | CD276 Antibody (YA1279) | Antibodies | |
| HY-P81535 | Periostin Antibody (YA1280) | Antibodies | |
| HY-P81536 | Bcl6 Antibody (YA1281) | Antibodies | |
| HY-P81537 | CD74 Antibody (YA1282) | Antibodies | |
| HY-P81538 | FOXP1 Antibody (YA1283) | Antibodies | |
| HY-P81539 | p-RIPK1(S166) Antibody (YA1284) | Antibodies | |
| HY-P81545 | J-chain Antibody (YA1290) | Antibodies | |
| HY-P81546 | CCR6 Antibody (YA1291) | Antibodies | |
| HY-P81547 | Alpha B Crystallin Antibody (YA1292) | Antibodies | |
| HY-P81548 | CD169 Antibody (YA1293) | Antibodies | |
| HY-P81549 | Ataxin 3 Antibody (YA1294) | Antibodies | |
| HY-P81550 | C4.4A/LYPD3 Antibody (YA1295) | Antibodies | |
| HY-P81551 | CD23 Antibody (YA1296) | Antibodies | |
| HY-P81553 | ASGPR Antibody (YA1298) | Antibodies | |
| HY-P81554 | CSF-1R Antibody (YA1299) | Antibodies | |
| HY-P81555 | LOX1 Antibody (YA1300) | Antibodies | |
| HY-P81556 | Caldesmon/CDM Antibody (YA1301) | Antibodies | |
| HY-P81557 | DPEP1 Antibody (YA1302) | Antibodies | |
| HY-P81558 | CD20 Antibody (YA1303) | Antibodies | |
| HY-P81560 | CD58 Antibody (YA1305) | Antibodies | |
| HY-P81561 | CRALBP Antibody (YA1306) | Antibodies | |
| HY-P81562 | CD21 Antibody (YA1307) | Antibodies | |
| HY-P81563 | CD33 Antibody (YA1308) | Antibodies | |
| HY-P81564 | ALOX15 Antibody (YA1309) | Antibodies | |
| HY-P81565 | Keratin 15 Antibody (YA1310) | Antibodies | |
| HY-P81566 | Cofilin 1 Antibody (YA1311) | Antibodies | |
| HY-P81567 | PDCD2 Antibody (YA1312) | Antibodies | |
| HY-P81568 | CD10 Antibody (YA1313) | Antibodies | |
| HY-P81569 | CBP Tag Antibody (YA1314) | Antibodies | |
| HY-P81570 | GABA A Receptor alpha 1 Antibody (YA1315) | Antibodies | |
| HY-P81571 | CD50 Antibody (YA1316) | Antibodies | |
| HY-P81572 | S100A2 Antibody | Antibodies | |
| HY-P81573 | SFTPA1 + SFTPA2 Antibody (YA1318) | Antibodies | |
| HY-P81574 | Keratin 6 Antibody (YA1319) | Antibodies | |
| HY-P81575 | BAP31 Antibody (YA1320) | Antibodies | |
| HY-P81576 | SMARCD1 Antibody (YA1321) | Antibodies | |
| HY-P81577 | CD168 Antibody (YA1322) | Antibodies | |
| HY-P81578 | CDK8 Antibody (YA1323) | Antibodies | |
| HY-P81579 | FOXL2 Antibody (YA1324) | Antibodies | |
| HY-P81580 | CENP-A Antibody (YA1325) | Antibodies | |
| HY-P81581 | Granzyme B Antibody (YA1326) | Antibodies | |
| HY-P81582 | CD15 Antibody (YA1327) | Antibodies | |
| HY-P81583 | CD35 Antibody (YA1328) | Antibodies | |
| HY-P81584 | 4-1BB Ligand Antibody (YA1329) | Antibodies | |
| HY-P81585 | NDUFB10 Antibody (YA1330) | Antibodies | |
| HY-P81586 | NDUFB11 Antibody (YA1331) | Antibodies | |
| HY-P81587 | SKP2 Antibody (YA1332) | Antibodies | |
| HY-P81588 | GITR Antibody (YA1333) | Antibodies | |
| HY-P81589 | USP22 Antibody (YA1334) | Antibodies | |
| HY-P81590 | NDUFB2 Antibody (YA1335) | Antibodies | |
| HY-P81591 | USP28 Antibody (YA1336) | Antibodies | |
| HY-P81592 | AMHR2 Antibody (YA1337) | Antibodies | |
| HY-P81593 | NDUFB4 Antibody (YA1338) | Antibodies | |
| HY-P81594 | EPHA2 Antibody (YA1339) | Antibodies | |
| HY-P81595 | NDUFB9 Antibody (YA1340) | Antibodies | |
| HY-P81596 | MALT1 Antibody (YA1341) | Antibodies | |
| HY-P81597 | HVEM Antibody (YA1342) | Antibodies | |
| HY-P81598 | NDUFC2 Antibody (YA1343) | Antibodies | |
| HY-P81599 | RNF8 Antibody (YA1344) | Antibodies | |
| HY-P81600 | TAX1BP3 Antibody (YA1345) | Antibodies | |
| HY-P81601 | NDUFS3 Antibody (YA1346) | Antibodies | |
| HY-P81602 | NDUFS6 Antibody (YA1347) | Antibodies | |
| HY-P81603 | PD-L2 Antibody (YA1348) | Antibodies | |
| HY-P81604 | Factor X Antibody (YA1349) | Antibodies | |
| HY-P81606 | Claudin 4 Antibody (YA1351) | Antibodies | |
| HY-P81607 | NDUFS8 Antibody (YA1352) | Antibodies | |
| HY-P81608 | Factor IX Antibody (YA1353) | Antibodies | |
| HY-P81609 | B7H6 Antibody (YA1354) | Antibodies | |
| HY-P81610 | NEAS Antibody (YA1355) | Antibodies | |
| HY-P81611 | BAFFR Antibody (YA1356) | Antibodies | |
| HY-P81612 | gamma Sarcoglycan Antibody (YA1357) | Antibodies | |
| HY-P81613 | NEK4 Antibody (YA1358) | Antibodies | |
| HY-P81614 | BCL2L1 Antibody (YA1359) | Antibodies | |
| HY-P81615 | NEK7 Antibody (YA1360) | Antibodies | |
| HY-P81616 | SIRP alpha Antibody (YA1361) | Antibodies | |
| HY-P81617 | NEK9 Antibody (YA1362) | Antibodies | |
| HY-P81618 | PAK1 Antibody (YA1363) | Antibodies | |
| HY-P81619 | BTLA Antibody (YA1364) | Antibodies | |
| HY-P81620 | NELFE Antibody (YA1365) | Antibodies | |
| HY-P81621 | BTN3A1 Antibody (YA1366) | Antibodies | |
| HY-P81622 | PAK3 Antibody (YA1367) | Antibodies | |
| HY-P81623 | CA9 Antibody (YA1368) | Antibodies | |
| HY-P81624 | Nesprin1 Antibody (YA1369) | Antibodies | |
| HY-P81625 | CD171 Antibody (YA1370) | Antibodies | |
| HY-P81626 | Nesprin3 Antibody (YA1371) | Antibodies | |
| HY-P81627 | CB1 Antibody | Antibodies | |
| HY-P81628 | CCR8 Antibody (YA1373) | Antibodies | |
| HY-P81629 | IL-6R Antibody | Antibodies | |
| HY-P81630 | CD200 Antibody (YA1375) | Antibodies | |
| HY-P81631 | KMT5A Antibody (YA1376) | Antibodies | |
| HY-P81632 | IL-13RA1 Antibody (YA1377) | Antibodies | |
| HY-P81633 | Neurofilament Heavy Polypeptide Antibody (YA1378) | Antibodies | |
| HY-P81634 | IL-17RA Antibody (YA1379) | Antibodies | |
| HY-P81635 | TOMM20 Antibody (YA1380) | Antibodies | |
| HY-P81636 | Natriuretic Peptides A Antibody (YA1381) | Antibodies | |
| HY-P81637 | 2B4 Antibody (YA1382) | Antibodies | |
| HY-P81638 | Neurogranin Antibody (YA1383) | Antibodies | |
| HY-P81639 | TRIM56 Antibody (YA1384) | Antibodies | |
| HY-P81640 | TACI Antibody (YA1385) | Antibodies | |
| HY-P81641 | NF2 Antibody (YA1386) | Antibodies | |
| HY-P81642 | MYBBP1A Antibody (YA1387) | Antibodies | |
| HY-P81643 | VEGF Receptor2 Antibody | Antibodies | |
| HY-P81644 | Phospho-NFAT2 (Ser237) Antibody (YA1389) | Antibodies | |
| HY-P81645 | CD30 Antibody (YA1390) | Antibodies | |
| HY-P81646 | KSR1 Antibody (YA1391) | Antibodies | |
| HY-P81647 | NFIB Antibody (YA1392) | Antibodies | |
| HY-P81648 | CD37 Antibody (YA1393) | Antibodies | |
| HY-P81649 | Phospho-PKC (Ser660) Antibody (YA1394) | Antibodies | |
| HY-P81650 | PDK2 Antibody (YA1395) | Antibodies | |
| HY-P81651 | NFYA Antibody (YA1396) | Antibodies | |
| HY-P81652 | Nicastrin Antibody (YA1397) | Antibodies | |
| HY-P81653 | BAG2 Antibody (YA1398) | Antibodies | |
| HY-P81654 | Niemann Pick C2 Antibody (YA1399) | Antibodies | |
| HY-P81655 | FRS2 Antibody (YA1400) | Antibodies | |
| HY-P81656 | NIT1 Antibody (YA1401) | Antibodies | |
| HY-P81657 | KMT4 Antibody (YA1402) | Antibodies | |
| HY-P81658 | SLC12A1 Antibody (YA1403) | Antibodies | |
| HY-P81659 | CD5 Antibody (YA1404) | Antibodies | |
| HY-P81660 | CD7 Antibody (YA1405) | Antibodies | |
| HY-P81661 | NONO Antibody (YA1406) | Antibodies | |
| HY-P81662 | GCLM Antibody (YA1407) | Antibodies | |
| HY-P81663 | SLC31A1 Antibody (YA1408) | Antibodies | |
| HY-P81664 | CD70 Antibody (YA1409) | Antibodies | |
| HY-P81665 | Nodal Antibody (YA1410) | Antibodies | |
| HY-P81666 | PGC1 beta Antibody (YA1411) | Antibodies | |
| HY-P81667 | SNAP25 Antibody (YA1412) | Antibodies | |
| HY-P81668 | B7-1 Antibody (YA1413) | Antibodies | |
| HY-P81669 | Nogo B Receptor Antibody (YA1414) | Antibodies | |
| HY-P81670 | KPNA2 Antibody (YA1415) | Antibodies | |
| HY-P81671 | NOLC1 Antibody (YA1416) | Antibodies | |
| HY-P81672 | MVP Antibody (YA1417) | Antibodies | |
| HY-P81673 | VAMP2 Antibody (YA1418) | Antibodies | |
| HY-P81674 | CLEC12A Antibody (YA1419) | Antibodies | |
| HY-P81675 | Nogo Antibody (YA1420) | Antibodies | |
| HY-P81676 | Nova1 Antibody (YA1421) | Antibodies | |
| HY-P81677 | KLRG1 Antibody (YA1422) | Antibodies | |
| HY-P81678 | MELK Antibody (YA1423) | Antibodies | |
| HY-P81679 | XBP1 Antibody (YA1424) | Antibodies | |
| HY-P81680 | NEFL Antibody (YA1425) | Antibodies | |
| HY-P81681 | NR1D1 Antibody (YA1426) | Antibodies | |
| HY-P81682 | LMAN1 Antibody (YA1427) | Antibodies | |
| HY-P81683 | ADAM9 Antibody (YA1428) | Antibodies | |
| HY-P81684 | YTHDF1 Antibody (YA1429) | Antibodies | |
| HY-P81685 | FGF1 Antibody (YA1430) | Antibodies | |
| HY-P81687 | NRG3 Antibody (YA1432) | Antibodies | |
| HY-P81688 | TARBP2 Antibody (YA1433) | Antibodies | |
| HY-P81689 | PGF Antibody (YA1434) | Antibodies | |
| HY-P81690 | NTH1 Antibody (YA1435) | Antibodies | |
| HY-P81691 | DNAM1 Antibody (YA1436) | Antibodies | |
| HY-P81692 | THO Complex Subunit 1 Antibody (YA1437) | Antibodies | |
| HY-P81693 | MEF2C Antibody (YA1438) | Antibodies | |
| HY-P81694 | Flotillin 2 Antibody (YA1439) | Antibodies | |
| HY-P81695 | Phospho-Nucleolin (Thr84) Antibody (YA1440) | Antibodies | |
| HY-P81696 | Furin Antibody (YA1441) | Antibodies | |
| HY-P81697 | FAP Antibody (YA1442) | Antibodies | |
| HY-P81698 | Peroxiredoxin 4 Antibody (YA1443) | Antibodies | |
| HY-P81699 | NTPCR Antibody (YA1444) | Antibodies | |
| HY-P81700 | HIF2 alpha Antibody (YA1445) | Antibodies | |
| HY-P81701 | GPRC5D Antibody (YA1446) | Antibodies | |
| HY-P81702 | DDAH2 Antibody (YA1447) | Antibodies | |
| HY-P81703 | TIM3 Antibody (YA1448) | Antibodies | |
| HY-P81704 | HES5 Antibody (YA1449) | Antibodies | |
| HY-P81705 | NUDT19 Antibody (YA1450) | Antibodies | |
| HY-P81706 | B7H2 Antibody (YA1451) | Antibodies | |
| HY-P81707 | Parathyroid Hormone Receptor 1 Antibody (YA1452) | Antibodies | |
| HY-P81708 | NUDT9 Antibody (YA1453) | Antibodies | |
| HY-P81709 | IL-2 Antibody (YA1454) | Antibodies | |
| HY-P81710 | Nuf2 Antibody (YA1455) | Antibodies | |
| HY-P81711 | PSGL1 Antibody (YA1456) | Antibodies | |
| HY-P81712 | IL-2RA Antibody (YA1457) | Antibodies | |
| HY-P81713 | CD123 Antibody (YA1458) | Antibodies | |
| HY-P81714 | ApoA2 Antibody (YA1459) | Antibodies | |
| HY-P81715 | NUP107 Antibody (YA1460) | Antibodies | |
| HY-P81716 | LAG3 Antibody (YA1461) | Antibodies | |
| HY-P81717 | NUR77 Antibody (YA1462) | Antibodies | |
| HY-P81718 | IL-23 alpha Antibody (YA1463) | Antibodies | |
| HY-P81719 | MICA Antibody (YA1464) | Antibodies | |
| HY-P81720 | N WASP Antibody (YA1465) | Antibodies | |
| HY-P81721 | MICB Antibody (YA1466) | Antibodies | |
| HY-P81722 | BDKRB2 Antibody (YA1467) | Antibodies | |
| HY-P81723 | NXF1 Antibody (YA1468) | Antibodies | |
| HY-P81724 | ALDH1A2 Antibody (YA1469) | Antibodies | |
| HY-P81725 | H Cadherin Antibody (YA1470) | Antibodies | |
| HY-P81726 | NKp30 Antibody (YA1471) | Antibodies | |
| HY-P81727 | NTB-A Antibody (YA1472) | Antibodies | |
| HY-P81728 | LIN28 Antibody (YA1473) | Antibodies | |
| HY-P81729 | Olfactory Marker Protein Antibody (YA1474) | Antibodies | |
| HY-P81730 | OX40L Antibody (YA1475) | Antibodies | |
| HY-P81731 | Cadherin 16 Antibody (YA1476) | Antibodies | |
| HY-P81732 | ORP1 Antibody (YA1477) | Antibodies | |
| HY-P81733 | ORP150 Antibody (YA1478) | Antibodies | |
| HY-P81734 | PSCA Antibody (YA1479) | Antibodies | |
| HY-P81735 | Thyroid Peroxidase Antibody (YA1480) | Antibodies | |
| HY-P81736 | APAF1 Antibody (YA1481) | Antibodies | |
| HY-P81737 | SELP Antibody (YA1482) | Antibodies | |
| HY-P81738 | OTUB1 Antibody (YA1483) | Antibodies | |
| HY-P81739 | Phospho-alpha Synuclein (Ser129) Antibody (YA1484) | Antibodies | |
| HY-P81740 | CD155 Antibody (YA1485) | Antibodies | |
| HY-P81741 | ROR1 Antibody (YA1486) | Antibodies | |
| HY-P81742 | HLA DRB1 Antibody (YA1487) | Antibodies | |
| HY-P81743 | p150 CAF1 Antibody (YA1488) | Antibodies | |
| HY-P81744 | Trk A Antibody (YA1489) | Antibodies | |
| HY-P81745 | CD138 Antibody (YA1490) | Antibodies | |
| HY-P81746 | MyoD1/Myf3 Antibody | Antibodies | |
| HY-P81747 | CS1 Antibody (YA1492) | Antibodies | |
| HY-P81748 | Cytokeratin 15 Antibody (YA1493) | Antibodies | |
| HY-P81749 | Phospho-p27 Kip 1 (Ser10) Antibody (YA1494) | Antibodies | |
| HY-P81749A | Phospho-p27 Kip 1 (Ser10) Antibody (YA1494) | Antibodies | |
| HY-P81750 | Firefly Luciferase Antibody (YA1495) | Antibodies | |
| HY-P81751 | TROP2 Antibody (YA1496) | Antibodies | |
| HY-P81752 | TIGIT Antibody (YA1497) | Antibodies | |
| HY-P81753 | Fos B Antibody (YA1498) | Antibodies | |
| HY-P81754 | IGF2R Antibody (YA1499) | Antibodies | |
| HY-P81755 | p40 Antibody (YA1500) | Antibodies | |
| HY-P81756 | BCMA Antibody (YA1501) | Antibodies | |
| HY-P81757 | T Box Protein 21 Antibody (YA1502) | Antibodies | |
| HY-P81758 | P4HB Antibody (YA1503) | Antibodies | |
| HY-P81759 | OX40 Antibody (YA1504) | Antibodies | |
| HY-P81760 | C4A Antibody (YA1505) | Antibodies | |
| HY-P81761 | 4-1BB Antibody (YA1506) | Antibodies | |
| HY-P81762 | TNFSF12 Antibody (YA1507) | Antibodies | |
| HY-P81763 | Transcription Factor E3 Antibody (YA1508) | Antibodies | |
| HY-P81764 | GRM5 Antibody (YA1509) | Antibodies | |
| HY-P81765 | BAFF Antibody (YA1510) | Antibodies | |
| HY-P81766 | p60 Katanin Antibody (YA1511) | Antibodies | |
| HY-P81767 | LIGHT Antibody (YA1512) | Antibodies | |
| HY-P81768 | Phospho-STAT5(Tyr694) Antibody (YA1513) | Antibodies | |
| HY-P81769 | S6K2 Antibody (YA1514) | Antibodies | |
| HY-P81770 | GITR-L Antibody (YA1515) | Antibodies | |
| HY-P81771 | ApoE Antibody (YA1516) | Antibodies | |
| HY-P81772 | EPHA3 Antibody (YA1517) | Antibodies | |
| HY-P81773 | Claudin 18.2 Antibody | Antibodies | |
| HY-P81774 | Raptor Antibody (YA1519) | Antibodies | |
| HY-P81775 | p95/NBS1 Antibody (YA1520) | Antibodies | |
| HY-P81776 | PABPN1 Antibody (YA1521) | Antibodies | |
| HY-P81777 | PRKRA Antibody (YA1522) | Antibodies | |
| HY-P81778 | HIP1 Antibody (YA1523) | Antibodies | |
| HY-P81779 | PAI1 Antibody (YA1524) | Antibodies | |
| HY-P81780 | SGK1 Antibody (YA1525) | Antibodies | |
| HY-P81781 | Nuclear Mitotic Apparatus Protein 1 Antibody (YA1526) | Antibodies | |
| HY-P81782 | Oct-2 Antibody (YA1527) | Antibodies | |
| HY-P81783 | PAIP1 Antibody (YA1528) | Antibodies | |
| HY-P81784 | Endo G Antibody (YA1529) | Antibodies | |
| HY-P81785 | Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Antibody (YA1530) | Antibodies | |
| HY-P81786 | p63 Antibody (YA1531) | Antibodies | |
| HY-P81787 | Uteroglobin Antibody (YA1532) | Antibodies | |
| HY-P81788 | Mast Cell Tryptase Antibody (YA1533) | Antibodies | |
| HY-P81789 | Versican Core Protein Antibody (YA1534) | Antibodies | |
| HY-P81790 | P-Cadherin Antibody (YA1535) | Antibodies | |
| HY-P81791 | PAR6 Antibody (YA1536) | Antibodies | |
| HY-P81792 | Prostate Specific Antigen Antibody (YA1537) | Antibodies | |
| HY-P81793 | CD36 Antibody (YA1538) | Antibodies | |
| HY-P81794 | Phospho-Parvin alpha (Ser8) Antibody (YA1539) | Antibodies | |
| HY-P81795 | Insulin Receptor Antibody (YA1540) | Antibodies | |
| HY-P81796 | NPR3 Antibody (YA1541) | Antibodies | |
| HY-P81797 | SAMHD1 Antibody (YA1542) | Antibodies | |
| HY-P81798 | PCBP2 Antibody (YA1543) | Antibodies | |
| HY-P81799 | SEC23A Antibody (YA1544) | Antibodies | |
| HY-P81800 | PCGF6 Antibody (YA1545) | Antibodies | |
| HY-P81801 | VPS26 Antibody (YA1546) | Antibodies | |
| HY-P81802 | PCK2 Antibody (YA1547) | Antibodies | |
| HY-P81803 | Laminin alpha 3 Antibody (YA1548) | Antibodies | |
| HY-P81804 | PCPTP1 Antibody (YA1549) | Antibodies | |
| HY-P81805 | PCSK9 Antibody (YA1550) | Antibodies | |
| HY-P81806 | PIWIL1 Antibody (YA1551) | Antibodies | |
| HY-P81807 | VAMP8 Antibody (YA1552) | Antibodies | |
| HY-P81808 | PDE1B Antibody (YA1553) | Antibodies | |
| HY-P81809 | CRM1 Antibody (YA1554) | Antibodies | |
| HY-P81810 | DNA Nucleotidylexotransferase Antibody (YA1555) | Antibodies | |
| HY-P81811 | PDGF B Antibody (YA1556) | Antibodies | |
| HY-P81812 | Caspase 6 Antibody (YA1557) | Antibodies | |
| HY-P81813 | ELOVL5 Antibody (YA1558) | Antibodies | |
| HY-P81814 | Intestinal Alkaline Phosphatase Antibody (YA1559) | Antibodies | |
| HY-P81815 | Interferon beta Antibody (YA1560) | Antibodies | |
| HY-P81816 | Calsequestrin 1 Antibody (YA1561) | Antibodies | |
| HY-P81817 | ADAM17 Antibody (YA1562) | Antibodies | |
| HY-P81818 | CDKN2A/p14ARF Antibody (YA1563) | Antibodies | |
| HY-P81819 | KDM5A Antibody (YA1564) | Antibodies | |
| HY-P81820 | PDLIM1 Antibody (YA1565) | Antibodies | |
| HY-P81821 | PDLIM7 Antibody (YA1566) | Antibodies | |
| HY-P81822 | BUB1 Antibody (YA1567) | Antibodies | |
| HY-P81823 | GATA4 Antibody (YA1568) | Antibodies | |
| HY-P81824 | PDPK1 Antibody (YA1569) | Antibodies | |
| HY-P81825 | Gelsolin Antibody (YA1570) | Antibodies | |
| HY-P81826 | PDZK1 Antibody (YA1571) | Antibodies | |
| HY-P81827 | PEF1 Antibody (YA1572) | Antibodies | |
| HY-P81828 | Matrin 3 Antibody (YA1573) | Antibodies | |
| HY-P81829 | Retinoic Acid Receptor beta Antibody (YA1574) | Antibodies | |
| HY-P81830 | Pellino 1 Antibody (YA1575) | Antibodies | |
| HY-P81831 | Lipoprotein Lipase Antibody (YA1576) | Antibodies | |
| HY-P81832 | UFM1 Antibody (YA1577) | Antibodies | |
| HY-P81833 | PEPD Antibody (YA1578) | Antibodies | |
| HY-P81834 | ZNF364 Antibody (YA1579) | Antibodies | |
| HY-P81835 | SDHB Antibody (YA1580) | Antibodies | |
| HY-P81836 | CD52 Antibody (YA1581) | Antibodies | |
| HY-P81837 | Midkine Antibody (YA1582) | Antibodies | |
| HY-P81838 | MRP1 Antibody (YA1583) | Antibodies | |
| HY-P81839 | PD-L2 Antibody (YA1584) | Antibodies | |
| HY-P81839A | PD-L2 Antibody (YA3391) | Antibodies | |
| HY-P81840 | Peroxiredoxin 2 Antibody (YA1585) | Antibodies | |
| HY-P81841 | Prolactin Antibody (YA1586) | Antibodies | |
| HY-P81842 | GATA1 Antibody (YA1587) | Antibodies | |
| HY-P81843 | FGFR4 Antibody (YA1588) | Antibodies | |
| HY-P81844 | IGFBP2 Antibody (YA1589) | Antibodies | |
| HY-P81845 | MMP14 Antibody (YA1590) | Antibodies | |
| HY-P81846 | Peroxiredoxin 5 Antibody (YA1591) | Antibodies | |
| HY-P81847 | Angiopoietin 1 Antibody (YA1592) | Antibodies | |
| HY-P81847A | Angiopoietin 1 Antibody | Antibodies | |
| HY-P81848 | Plexin A1 Antibody (YA1593) | Antibodies | |
| HY-P81849 | PEX11B Antibody (YA1594) | Antibodies | |
| HY-P81850 | NAT10 Antibody (YA1595) | Antibodies | |
| HY-P81851 | IP3 Receptor Antibody (YA1596) | Antibodies | |
| HY-P81852 | PFKL Antibody (YA1597) | Antibodies | |
| HY-P81853 | Angiopoietin 2 Antibody (YA1598) | Antibodies | |
| HY-P81854 | PFKP Antibody (YA1599) | Antibodies | |
| HY-P81855 | TNFAIP8 Antibody (YA1600) | Antibodies | |
| HY-P81856 | Heparanase 1 Antibody (YA1601) | Antibodies | |
| HY-P81858 | PGM1 Antibody (YA1603) | Antibodies | |
| HY-P81859 | Sprouty 2 Antibody (YA1604) | Antibodies | |
| HY-P81860 | Presenilin 2 Antibody (YA1605) | Antibodies | |
| HY-P81861 | LOXL2 Antibody (YA1606) | Antibodies | |
| HY-P81862 | RANK Antibody (YA1607) | Antibodies | |
| HY-P81863 | Tryptophan tRNA Ligase Antibody (YA1608) | Antibodies | |
| HY-P81864 | TRPM8 Antibody (YA1609) | Antibodies | |
| HY-P81865 | PHAPI2 Antibody (YA1610) | Antibodies | |
| HY-P81866 | IKK epsilon Antibody (YA1611) | Antibodies | |
| HY-P81867 | PHD3 Antibody (YA1612) | Antibodies | |
| HY-P81868 | GNB2 Antibody (YA1613) | Antibodies | |
| HY-P81869 | Cathepsin S Antibody (YA1614) | Antibodies | |
| HY-P81870 | CD32B Antibody (YA1615) | Antibodies | |
| HY-P81871 | PHLDA1 Antibody (YA1616) | Antibodies | |
| HY-P81872 | PI3 Kinase p110 delta Antibody (YA1617) | Antibodies | |
| HY-P81873 | Phospho-Phospholamban (Ser16) Antibody (YA1618) | Antibodies | |
| HY-P81874 | POMC Antibody (YA1619) | Antibodies | |
| HY-P81875 | MYH11 Antibody (YA1620) | Antibodies | |
| HY-P81876 | TAF3 Antibody (YA1621) | Antibodies | |
| HY-P81877 | Phospholamban Antibody (YA1622) | Antibodies | |
| HY-P81878 | Phospho-MLKL (Ser358) Antibody (YA1623) | Antibodies | |
| HY-P81879 | IL-13 Receptor alpha 1 Antibody (YA1624) | Antibodies | |
| HY-P81880 | Importin 9 Antibody (YA1625) | Antibodies | |
| HY-P81881 | Phospholipase C beta 1 Antibody (YA1626) | Antibodies | |
| HY-P81882 | TXNIP Antibody (YA1627) | Antibodies | |
| HY-P81883 | PMP70 Antibody (YA1628) | Antibodies | |
| HY-P81884 | Mast Cell Chymase Antibody (YA1629) | Antibodies | |
| HY-P81885 | NAPSIN A Antibody (YA1630) | Antibodies | |
| HY-P81886 | Factor XIIIa Antibody (YA1631) | Antibodies | |
| HY-P81887 | PICK1 Antibody (YA1632) | Antibodies | |
| HY-P81888 | ATP Synthase C Antibody (YA1633) | Antibodies | |
| HY-P81889 | C1QB Antibody (YA1634) | Antibodies | |
| HY-P81890 | PIN1 Antibody (YA1635) | Antibodies | |
| HY-P81891 | MGST1 Antibody (YA1636) | Antibodies | |
| HY-P81892 | ATOH1 Antibody (YA1637) | Antibodies | |
| HY-P81893 | Serotonin Transporter Antibody (YA1638) | Antibodies | |
| HY-P81894 | ARFRP1 Antibody (YA1639) | Antibodies | |
| HY-P81895 | CD2 Antibody (YA1640) | Antibodies | |
| HY-P81896 | PIN4 Antibody (YA1641) | Antibodies | |
| HY-P81897 | Netrin 1 Antibody (YA1642) | Antibodies | |
| HY-P81898 | SHP2 Antibody (YA1643) | Antibodies | |
| HY-P81899 | PIP5K1C Antibody (YA1644) | Antibodies | |
| HY-P81900 | MC4R Antibody (YA1645) | Antibodies | |
| HY-P81901 | OXGR1 Antibody (YA1646) | Antibodies | |
| HY-P81902 | PIST Antibody (YA1647) | Antibodies | |
| HY-P81903 | MSP Antibody (YA1648) | Antibodies | |
| HY-P81904 | NOXA2 Antibody (YA1649) | Antibodies | |
| HY-P81905 | ATG13 Antibody (YA1650) | Antibodies | |
| HY-P81906 | DAP12 Antibody (YA1651) | Antibodies | |
| HY-P81907 | CRABP2 Antibody (YA1652) | Antibodies | |
| HY-P81908 | CENPA Antibody (YA1653) | Antibodies | |
| HY-P81909 | DARC Antibody (YA1654) | Antibodies | |
| HY-P81910 | beta Defensin 1 Antibody (YA1655) | Antibodies | |
| HY-P81911 | Niemann Pick C1 Like 1 Antibody (YA1656) | Antibodies | |
| HY-P81912 | WTAP Antibody (YA1657) | Antibodies | |
| HY-P81913 | ADAR1 Antibody (YA1658) | Antibodies | |
| HY-P81914 | PKD1 Antibody (YA1659) | Antibodies | |
| HY-P81915 | Integrin alpha 9 Antibody (YA1660) | Antibodies | |
| HY-P81916 | CPS1 Antibody (YA1661) | Antibodies | |
| HY-P81917 | Phospho-PRKD2 (Ser876) Antibody (YA1662) | Antibodies | |
| HY-P81918 | TRMT2A Antibody (YA1663) | Antibodies | |
| HY-P81919 | PKN1 Antibody (YA1664) | Antibodies | |
| HY-P81920 | MYO7A Antibody (YA1665) | Antibodies | |
| HY-P81921 | PON1 Antibody (YA1666) | Antibodies | |
| HY-P81922 | ROCK2 Antibody (YA1667) | Antibodies | |
| HY-P81923 | FHL1 Antibody (YA1668) | Antibodies | |
| HY-P81924 | MOV10 Antibody (YA1669) | Antibodies | |
| HY-P81925 | CCL19 Antibody (YA1670) | Antibodies | |
| HY-P81926 | NUP153 Antibody (YA1671) | Antibodies | |
| HY-P81927 | PLSCR3 Antibody (YA1672) | Antibodies | |
| HY-P81928 | Menin Antibody (YA1673) | Antibodies | |
| HY-P81929 | PERP Antibody (YA1674) | Antibodies | |
| HY-P81930 | CLPP Antibody (YA1675) | Antibodies | |
| HY-P81931 | PMCA1 Antibody (YA1676) | Antibodies | |
| HY-P81932 | Inhibin beta B Antibody (YA1677) | Antibodies | |
| HY-P81933 | PML Protein Antibody (YA1678) | Antibodies | |
| HY-P81934 | COPS8 Antibody (YA1679) | Antibodies | |
| HY-P81935 | POLDIP2 Antibody (YA1680) | Antibodies | |
| HY-P81936 | Rad50 Antibody (YA1681) | Antibodies | |
| HY-P81937 | Mammaglobin A Antibody (YA1682) | Antibodies | |
| HY-P81938 | Cas9 SA Antibody (YA1683) | Antibodies | |
| HY-P81939 | RNA Polymerases I/II/III Subunit ABC1 Antibody (YA1684) | Antibodies | |
| HY-P81940 | ENDOGL1 Antibody (YA1685) | Antibodies | |
| HY-P81941 | LIM Kinase 1 Antibody (YA1686) | Antibodies | |
| HY-P81942 | PEDF Antibody (YA1687) | Antibodies | |
| HY-P81943 | PON2 Antibody (YA1688) | Antibodies | |
| HY-P81944 | SynGAP Antibody (YA1689) | Antibodies | |
| HY-P81945 | POT1 Antibody (YA1690) | Antibodies | |
| HY-P81946 | P2Y6 Antibody (YA1691) | Antibodies | |
| HY-P81947 | MAD2L1 Antibody (YA1692) | Antibodies | |
| HY-P81948 | PP2A alpha/beta Antibody (YA1693) | Antibodies | |
| HY-P81949 | Lipoamide Dehydrogenase Antibody (YA1694) | Antibodies | |
| HY-P81950 | MBD3 Antibody (YA1695) | Antibodies | |
| HY-P81951 | PAH Antibody (YA1696) | Antibodies | |
| HY-P81952 | Uroplakin 3A Antibody (YA1697) | Antibodies | |
| HY-P81953 | PPM1G Antibody (YA1698) | Antibodies | |
| HY-P81954 | ABCE1 Antibody (YA1699) | Antibodies | |
| HY-P81955 | PP1C alpha/beta Antibody (YA1700) | Antibodies | |
| HY-P81956 | Cytokeratin 6 Antibody (YA1701) | Antibodies | |
| HY-P81957 | Desmocollin 3 Antibody (YA1702) | Antibodies | |
| HY-P81958 | PP1C beta Antibody (YA1703) | Antibodies | |
| HY-P81959 | T Cell Leukemia/Lymphoma Protein 1A Antibody (YA1704) | Antibodies | |
| HY-P81960 | PPP2R5D Antibody (YA1705) | Antibodies | |
| HY-P81961 | Prostatic Acid Phosphatase Antibody (YA1706) | Antibodies | |
| HY-P81962 | PTF1A Antibody (YA1707) | Antibodies | |
| HY-P81963 | PPP2R5E Antibody (YA1708) | Antibodies | |
| HY-P81964 | LI Cadherin Antibody (YA1709) | Antibodies | |
| HY-P81965 | Neurofascin Antibody (YA1710) | Antibodies | |
| HY-P81966 | PRAME Antibody (YA1711) | Antibodies | |
| HY-P81967 | SNX5 Antibody (YA1712) | Antibodies | |
| HY-P81968 | Phospho-PRC1 (Thr481) Antibody (YA1713) | Antibodies | |
| HY-P81969 | PDE4D Antibody (YA1714) | Antibodies | |
| HY-P81970 | Fructose 6 Phosphate Kinase Antibody (YA1715) | Antibodies | |
| HY-P81971 | PRC1 Antibody (YA1716) | Antibodies | |
| HY-P81972 | PFDN5 Antibody (YA1717) | Antibodies | |
| HY-P81973 | POLD1 Antibody (YA1718) | Antibodies | |
| HY-P81974 | Prealbumin Antibody (YA1719) | Antibodies | |
| HY-P81975 | SLP2 Antibody (YA1720) | Antibodies | |
| HY-P81976 | WIPI1 Antibody (YA1721) | Antibodies | |
| HY-P81977 | Presenilin 1 Antibody (YA1722) | Antibodies | |
| HY-P81978 | ASH2L Antibody (YA1723) | Antibodies | |
| HY-P81979 | HNF 1 beta Antibody (YA1724) | Antibodies | |
| HY-P81980 | Prion Protein Antibody (YA1725) | Antibodies | |
| HY-P81981 | PKA C gamma Antibody (YA1726) | Antibodies | |
| HY-P81982 | PGD Antibody (YA1727) | Antibodies | |
| HY-P81983 | MMP17 Antibody (YA1728) | Antibodies | |
| HY-P81984 | PREB Antibody (YA1729) | Antibodies | |
| HY-P81985 | PKD2 Antibody (YA1730) | Antibodies | |
| HY-P81986 | PRMT3 Antibody (YA1731) | Antibodies | |
| HY-P81987 | TREX1 Antibody (YA1732) | Antibodies | |
| HY-P81988 | GABA B Receptor 2 Antibody (YA1733) | Antibodies | |
| HY-P81989 | PRMT7 Antibody (YA1734) | Antibodies | |
| HY-P81990 | KAT13A Antibody (YA1735) | Antibodies | |
| HY-P81991 | Phospho-Progesterone Receptor (Ser190) Antibody (YA1736) | Antibodies | |
| HY-P81992 | KAT1 Antibody (YA1737) | Antibodies | |
| HY-P81993 | Hsc70 Interacting Protein HIP Antibody (YA1738) | Antibodies | |
| HY-P81994 | Prostaglandin D Synthase Antibody (YA1739) | Antibodies | |
| HY-P81995 | BANF1 Antibody (YA1740) | Antibodies | |
| HY-P81996 | Prostaglandin E Synthase Antibody (YA1741) | Antibodies | |
| HY-P81997 | Dopamine Receptor D3 Antibody (YA1742) | Antibodies | |
| HY-P81998 | Pirh2 Antibody (YA1743) | Antibodies | |
| HY-P81999 | Proteasome alpha 2 Antibody (YA1744) | Antibodies | |
| HY-P82000 | GIT1 Antibody (YA1745) | Antibodies | |
| HY-P82001 | ZHX2 Antibody (YA1746) | Antibodies | |
| HY-P82002 | Proteasome beta 9 Antibody (YA1747) | Antibodies | |
| HY-P82003 | CRTC3 Antibody (YA1748) | Antibodies | |
| HY-P82004 | Proteasome alpha 6 Antibody (YA1749) | Antibodies | |
| HY-P82005 | DKC1 Antibody (YA1750) | Antibodies | |
| HY-P82006 | PKA RI alpha Antibody (YA1751) | Antibodies | |
| HY-P82007 | RPS19 Antibody (YA1752) | Antibodies | |
| HY-P82008 | Prothrombin Antibody (YA1753) | Antibodies | |
| HY-P82009 | PROX1 Antibody (YA1754) | Antibodies | |
| HY-P82010 | Actin Related Protein 3 Antibody (YA1755) | Antibodies | |
| HY-P82011 | MSH6 Antibody (YA1756) | Antibodies | |
| HY-P82012 | PRPF4 Antibody (YA1757) | Antibodies | |
| HY-P82013 | GABA A Receptor beta 2 Antibody (YA1758) | Antibodies | |
| HY-P82014 | PRPF8 Antibody (YA1759) | Antibodies | |
| HY-P82015 | U1A Antibody (YA1760) | Antibodies | |
| HY-P82016 | PRSS8 Antibody (YA1761) | Antibodies | |
| HY-P82017 | Cytokeratin 4 Antibody (YA1762) | Antibodies | |
| HY-P82018 | PSF1 Antibody (YA1763) | Antibodies | |
| HY-P82019 | PSMA Antibody (YA1764) | Antibodies | |
| HY-P82020 | PSMA4 Antibody (YA1765) | Antibodies | |
| HY-P82021 | PSME1 Antibody (YA1766) | Antibodies | |
| HY-P82022 | PSMB10 Antibody (YA1767) | Antibodies | |
| HY-P82023 | PSMC5 Antibody (YA1768) | Antibodies | |
| HY-P82024 | CXCL11 Antibody (YA1769) | Antibodies | |
| HY-P82025 | PSS2 Antibody (YA1770) | Antibodies | |
| HY-P82026 | E2F6 Antibody (YA1771) | Antibodies | |
| HY-P82027 | PMS2 Antibody (YA1772) | Antibodies | |
| HY-P82028 | PTN Antibody (YA1773) | Antibodies | |
| HY-P82029 | MSH2 Antibody (YA1774) | Antibodies | |
| HY-P82030 | EB3 Antibody (YA1775) | Antibodies | |
| HY-P82031 | PTP1B Antibody (YA1776) | Antibodies | |
| HY-P82032 | AMF Antibody (YA1777) | Antibodies | |
| HY-P82033 | MEIS2 Antibody (YA1778) | Antibodies | |
| HY-P82034 | Anterior Gradient 2 Antibody (YA1779) | Antibodies | |
| HY-P82035 | Sprouty 4 Antibody (YA1780) | Antibodies | |
| HY-P82036 | PUM1 Antibody (YA1781) | Antibodies | |
| HY-P82037 | Caveolin 1 Antibody (YA1782) | Antibodies | |
| HY-P82038 | PUS1 Antibody (YA1783) | Antibodies | |
| HY-P82039 | PWP1 Antibody (YA1784) | Antibodies | |
| HY-P82040 | PBR Antibody (YA1785) | Antibodies | |
| HY-P82041 | Pyrophosphatase 1 Antibody (YA1786) | Antibodies | |
| HY-P82042 | LRG1 Antibody (YA1787) | Antibodies | |
| HY-P82043 | QK1 Antibody (YA1788) | Antibodies | |
| HY-P82044 | Rab10 Antibody (YA1789) | Antibodies | |
| HY-P82045 | DNA Ligase I Antibody (YA1790) | Antibodies | |
| HY-P82046 | Rab22A Antibody (YA1791) | Antibodies | |
| HY-P82047 | Rab45 Antibody (YA1792) | Antibodies | |
| HY-P82048 | ERp29 Antibody (YA1793) | Antibodies | |
| HY-P82049 | ATAD2 Antibody (YA1794) | Antibodies | |
| HY-P82050 | GABA Transporter 1 Antibody (YA1795) | Antibodies | |
| HY-P82051 | Profilin 1 Antibody (YA1796) | Antibodies | |
| HY-P82052 | RYBP Antibody (YA1797) | Antibodies | |
| HY-P82053 | Rab7B Antibody (YA1798) | Antibodies | |
| HY-P82054 | PARK7/DJ1 Antibody (YA1799) | Antibodies | |
| HY-P82055 | Rab9 Antibody (YA1800) | Antibodies | |
| HY-P82056 | HBEGF Antibody (YA1801) | Antibodies | |
| HY-P82057 | Rac3 Antibody (YA1802) | Antibodies | |
| HY-P82058 | eIF2B5 Antibody (YA1803) | Antibodies | |
| HY-P82059 | RACK1 Antibody (YA1804) | Antibodies | |
| HY-P82060 | Cenexin1 Antibody (YA1805) | Antibodies | |
| HY-P82061 | Dnmt3b Antibody (YA1806) | Antibodies | |
| HY-P82062 | GAD67 Antibody (YA1807) | Antibodies | |
| HY-P82063 | Rad51D Antibody (YA1808) | Antibodies | |
| HY-P82064 | Glypican 1 Antibody (YA1809) | Antibodies | |
| HY-P82065 | Radixin Antibody (YA1810) | Antibodies | |
| HY-P82066 | USP9X Antibody (YA1811) | Antibodies | |
| HY-P82067 | PLGF Antibody (YA1812) | Antibodies | |
| HY-P82068 | CoREST Antibody (YA1813) | Antibodies | |
| HY-P82069 | TrpC1 Antibody (YA1814) | Antibodies | |
| HY-P82070 | RAIDD Antibody (YA1815) | Antibodies | |
| HY-P82071 | RALB Antibody (YA1816) | Antibodies | |
| HY-P82072 | E1 Ubiquitin Activating Enzyme Antibody (YA1817) | Antibodies | |
| HY-P82073 | RAMP1 Antibody (YA1818) | Antibodies | |
| HY-P82074 | Band 3 Antibody (YA1819) | Antibodies | |
| HY-P82075 | GM130 Antibody (YA1820) | Antibodies | |
| HY-P82075A | GM130 Antibody (YA3462) | Antibodies | |
| HY-P82076 | Ran Antibody (YA1821) | Antibodies | |
| HY-P82077 | eIF4A3 Antibody (YA1822) | Antibodies | |
| HY-P82078 | Phospho-DNA PKcs (Ser2056) Antibody (YA1823) | Antibodies | |
| HY-P82079 | RAP1 Antibody (YA1824) | Antibodies | |
| HY-P82080 | SEC61A Antibody (YA1825) | Antibodies | |
| HY-P82081 | RAP1GAP Antibody (YA1826) | Antibodies | |
| HY-P82082 | Calmodulin Antibody (YA1827) | Antibodies | |
| HY-P82083 | Syntrophin alpha 1 Antibody (YA1828) | Antibodies | |
| HY-P82084 | Annexin V Antibody (YA1829) | Antibodies | |
| HY-P82085 | GTPase NRAS Antibody (YA1830) | Antibodies | |
| HY-P82086 | Neuropilin 1 Antibody (YA1831) | Antibodies | |
| HY-P82087 | Troponin I Antibody (YA1832) | Antibodies | |
| HY-P82088 | GTPase HRAS Antibody (YA1833) | Antibodies | |
| HY-P82089 | RASSF2 Antibody (YA1834) | Antibodies | |
| HY-P82090 | CEBPB Antibody (YA1835) | Antibodies | |
| HY-P82091 | Cytochrome P450 1B1 Antibody (YA1836) | Antibodies | |
| HY-P82092 | RAVER2 Antibody (YA1837) | Antibodies | |
| HY-P82093 | hnRNP Q Antibody (YA1838) | Antibodies | |
| HY-P82094 | CD41 Antibody (YA1839) | Antibodies | |
| HY-P82095 | Syntaxin 1B Antibody (YA1840) | Antibodies | |
| HY-P82096 | ABCG1 Antibody (YA1841) | Antibodies | |
| HY-P82097 | LGR5 Antibody (YA1842) | Antibodies | |
| HY-P82098 | RBBP4 Antibody (YA1843) | Antibodies | |
| HY-P82099 | R Cadherin Antibody (YA1844) | Antibodies | |
| HY-P82100 | Transferrin Receptor 2 Antibody (YA1845) | Antibodies | |
| HY-P82101 | USP11 Antibody (YA1846) | Antibodies | |
| HY-P82102 | SAE1 Antibody (YA1847) | Antibodies | |
| HY-P82103 | REA Antibody (YA1848) | Antibodies | |
| HY-P82104 | Syntaxin 4 Antibody (YA1849) | Antibodies | |
| HY-P82105 | REEP2 Antibody (YA1850) | Antibodies | |
| HY-P82106 | DKK3 Antibody (YA1851) | Antibodies | |
| HY-P82107 | Rel B Antibody (YA1852) | Antibodies | |
| HY-P82108 | PRMT5 Antibody (YA1853) | Antibodies | |
| HY-P82109 | p16 ARC Antibody (YA1854) | Antibodies | |
| HY-P82110 | Relaxin 2 Antibody (YA1855) | Antibodies | |
| HY-P82111 | Intra Acrosomal Protein Antibody (YA1856) | Antibodies | |
| HY-P82112 | Cytokeratin 10 Antibody (YA1857) | Antibodies | |
| HY-P82113 | RENT1 Antibody (YA1858) | Antibodies | |
| HY-P82114 | Destrin Antibody (YA1859) | Antibodies | |
| HY-P82115 | Retinoic Acid Receptor gamma Antibody (YA1860) | Antibodies | |
| HY-P82116 | Sulfotransferase 2A1 Antibody (YA1861) | Antibodies | |
| HY-P82117 | GSK3 alpha/beta Antibody (YA1862) | Antibodies | |
| HY-P82118 | RhoGDI Antibody (YA1863) | Antibodies | |
| HY-P82119 | Phospho-Synapsin I (Ser9) Antibody (YA1864) | Antibodies | |
| HY-P82120 | Complex III Subunit 5 Antibody (YA1865) | Antibodies | |
| HY-P82121 | Progesterone Receptor Antibody (YA1866) | Antibodies | |
| HY-P82122 | IRAK2 Antibody (YA1867) | Antibodies | |
| HY-P82123 | Phospho-Presenilin 1 (Ser310) Antibody (YA1868) | Antibodies | |
| HY-P82124 | RKIP Antibody (YA1869) | Antibodies | |
| HY-P82125 | RNA Helicase A Antibody (YA1870) | Antibodies | |
| HY-P82126 | IKK alpha/beta Antibody (YA1871) | Antibodies | |
| HY-P82127 | Cellubrevin Antibody (YA1872) | Antibodies | |
| HY-P82128 | C4 Binding Protein Antibody (YA1873) | Antibodies | |
| HY-P82129 | hnRNP C1/C2 Antibody (YA1874) | Antibodies | |
| HY-P82130 | FHL2 Antibody (YA1875) | Antibodies | |
| HY-P82131 | Cytokeratin 14 Antibody (YA1876) | Antibodies | |
| HY-P82132 | GEF H1 Antibody (YA1877) | Antibodies | |
| HY-P82133 | Phospho-Presenilin 2 (Ser330) Antibody (YA1878) | Antibodies | |
| HY-P82134 | KA1 Antibody (YA1879) | Antibodies | |
| HY-P82135 | RPL10A Antibody (YA1880) | Antibodies | |
| HY-P82136 | Rab25 Antibody (YA1881) | Antibodies | |
| HY-P82137 | KMT1B Antibody (YA1882) | Antibodies | |
| HY-P82138 | RRM1 Antibody (YA1883) | Antibodies | |
| HY-P82139 | IRF5 Antibody (YA1884) | Antibodies | |
| HY-P82140 | RRM2 Antibody (YA1885) | Antibodies | |
| HY-P82141 | RRP4 Antibody (YA1886) | Antibodies | |
| HY-P82142 | Exocyst Complex Component 3 Antibody (YA1887) | Antibodies | |
| HY-P82143 | Phospho-MDM2 (Ser166) Antibody (YA1888) | Antibodies | |
| HY-P82144 | GluA4 Antibody (YA1889) | Antibodies | |
| HY-P82145 | Phospho-S6K2 (Ser371) Antibody (YA1890) | Antibodies | |
| HY-P82146 | MIB1 Antibody (YA1891) | Antibodies | |
| HY-P82147 | Estrogen Receptor beta Antibody (YA1892) | Antibodies | |
| HY-P82148 | ApoL1 Antibody (YA1893) | Antibodies | |
| HY-P82149 | S100 alpha9 Antibody (YA1894) | Antibodies | |
| HY-P82150 | Tetranectin Antibody (YA1895) | Antibodies | |
| HY-P82151 | Fibrinogen gamma Chain Antibody (YA1896) | Antibodies | |
| HY-P82152 | Yes1 Antibody (YA1897) | Antibodies | |
| HY-P82153 | Synapsin 2 Antibody (YA1898) | Antibodies | |
| HY-P82154 | Sall4 Antibody (YA1899) | Antibodies | |
| HY-P82155 | RanGAP1 Antibody (YA1900) | Antibodies | |
| HY-P82156 | SAMD9 Antibody (YA1901) | Antibodies | |
| HY-P82157 | Hex Antibody (YA1902) | Antibodies | |
| HY-P82158 | Sarcomeric alpha Actinin Antibody (YA1903) | Antibodies | |
| HY-P82159 | ILF3 Antibody (YA1904) | Antibodies | |
| HY-P82160 | SC35 Antibody (YA1905) | Antibodies | |
| HY-P82161 | SCAI Antibody (YA1906) | Antibodies | |
| HY-P82162 | HIF1AN Antibody (YA1907) | Antibodies | |
| HY-P82163 | SCARB1 Antibody (YA1908) | Antibodies | |
| HY-P82164 | Lipin 1 Antibody (YA1909) | Antibodies | |
| HY-P82165 | NEK2 Antibody (YA1910) | Antibodies | |
| HY-P82166 | SCIN Antibody (YA1911) | Antibodies | |
| HY-P82167 | MIF Antibody (YA1912) | Antibodies | |
| HY-P82168 | HIPK2 Antibody (YA1913) | Antibodies | |
| HY-P82169 | BACE1 Antibody (YA1914) | Antibodies | |
| HY-P82170 | SENP1 Antibody (YA1915) | Antibodies | |
| HY-P82171 | Secretory Phospholipase A2 Antibody (YA1916) | Antibodies | |
| HY-P82172 | Securin Antibody (YA1917) | Antibodies | |
| HY-P82173 | Nucleostemin Antibody (YA1918) | Antibodies | |
| HY-P82174 | SEH1L Antibody (YA1919) | Antibodies | |
| HY-P82175 | KAT13D Antibody (YA1920) | Antibodies | |
| HY-P82176 | Annexin IV Antibody (YA1921) | Antibodies | |
| HY-P82177 | Semaphorin 4D Antibody (YA1922) | Antibodies | |
| HY-P82178 | IRF9 Antibody (YA1923) | Antibodies | |
| HY-P82179 | SEP15 Antibody (YA1924) | Antibodies | |
| HY-P82180 | PDGFR beta Antibody (YA1925) | Antibodies | |
| HY-P82181 | EGR2 Antibody (YA1926) | Antibodies | |
| HY-P82182 | Septin 7 Antibody (YA1927) | Antibodies | |
| HY-P82183 | CDK5RAP3 Antibody (YA1928) | Antibodies | |
| HY-P82184 | Complex III Subunit 2 Antibody (YA1929) | Antibodies | |
| HY-P82185 | Frizzled 9 Antibody (YA1930) | Antibodies | |
| HY-P82186 | SERCA2 ATPase Antibody (YA1931) | Antibodies | |
| HY-P82187 | Toll-Like Receptor 2 Antibody (YA1932) | Antibodies | |
| HY-P82188 | HuR Antibody (YA1933) | Antibodies | |
| HY-P82189 | SESN2 Antibody (YA1934) | Antibodies | |
| HY-P82190 | SET Antibody (YA1935) | Antibodies | |
| HY-P82191 | SF2 Antibody (YA1936) | Antibodies | |
| HY-P82192 | 5 Lipoxygenase Antibody (YA1937) | Antibodies | |
| HY-P82193 | EBF1 Antibody (YA1938) | Antibodies | |
| HY-P82194 | OS9 Antibody (YA1939) | Antibodies | |
| HY-P82195 | SFPQ Antibody (YA1940) | Antibodies | |
| HY-P82196 | CRMP1 Antibody (YA1941) | Antibodies | |
| HY-P82197 | Plastin L Antibody (YA1942) | Antibodies | |
| HY-P82198 | SFRP4 Antibody (YA1943) | Antibodies | |
| HY-P82199 | ILF2 Antibody (YA1944) | Antibodies | |
| HY-P82200 | Galectin 7 Antibody (YA1945) | Antibodies | |
| HY-P82201 | SGSM1 Antibody (YA1946) | Antibodies | |
| HY-P82202 | NDUFB8 Antibody (YA1947) | Antibodies | |
| HY-P82203 | Alcohol Dehydrogenase Antibody (YA1948) | Antibodies | |
| HY-P82204 | 14-3-3 Antibody (YA1949) | Antibodies | |
| HY-P82205 | SH2D1A Antibody (YA1950) | Antibodies | |
| HY-P82206 | TAB1 Antibody (YA1951) | Antibodies | |
| HY-P82207 | GRIM19 Antibody (YA1952) | Antibodies | |
| HY-P82208 | SNX9 Antibody (YA1953) | Antibodies | |
| HY-P82209 | Transcriptional Enhancer Factor TEF 1 Antibody (YA1954) | Antibodies | |
| HY-P82210 | 14-3-3 theta Antibody (YA1955) | Antibodies | |
| HY-P82211 | GLI3 Antibody (YA1956) | Antibodies | |
| HY-P82212 | Xanthine Oxidase Antibody (YA1957) | Antibodies | |
| HY-P82213 | SODD Antibody (YA1958) | Antibodies | |
| HY-P82214 | 67kDa Laminin Receptor Antibody (YA1959) | Antibodies | |
| HY-P82215 | CD89 Antibody (YA1960) | Antibodies | |
| HY-P82216 | Neurofilament light polypeptide Antibody (YA1961) | Antibodies | |
| HY-P82217 | CDX1 Antibody (YA1962) | Antibodies | |
| HY-P82218 | AAMP Antibody (YA1963) | Antibodies | |
| HY-P82219 | ABAT Antibody (YA1964) | Antibodies | |
| HY-P82220 | GDF3 Antibody (YA1965) | Antibodies | |
| HY-P82221 | GATAD2A Antibody (YA1966) | Antibodies | |
| HY-P82222 | ACADM Antibody (YA1967) | Antibodies | |
| HY-P82223 | PAG1 Antibody (YA1968) | Antibodies | |
| HY-P82224 | ACADS Antibody (YA1969) | Antibodies | |
| HY-P82225 | EHD1 Antibody (YA1970) | Antibodies | |
| HY-P82226 | ACAT1 Antibody (YA1971) | Antibodies | |
| HY-P82227 | NUDEL Antibody (YA1972) | Antibodies | |
| HY-P82228 | LHX2 Antibody (YA1973) | Antibodies | |
| HY-P82229 | SKP1 Antibody (YA1974) | Antibodies | |
| HY-P82230 | CNTN2 Antibody (YA1975) | Antibodies | |
| HY-P82231 | Collagen XI alpha 1 Antibody (YA1976) | Antibodies | |
| HY-P82232 | SLAMF6 Antibody (YA1977) | Antibodies | |
| HY-P82233 | Ubiquitin Conjugating Enzyme E2 N Antibody (YA1978) | Antibodies | |
| HY-P82234 | ACOX1 Antibody (YA1979) | Antibodies | |
| HY-P82235 | SERPING1 Antibody (YA1980) | Antibodies | |
| HY-P82236 | SLBP Antibody (YA1981) | Antibodies | |
| HY-P82237 | Carbonic Anhydrase 1 Antibody (YA1982) | Antibodies | |
| HY-P82238 | ACSS2 Antibody (YA1983) | Antibodies | |
| HY-P82239 | XRCC3 Antibody (YA1984) | Antibodies | |
| HY-P82240 | SLC25A12 Antibody (YA1985) | Antibodies | |
| HY-P82241 | TNPO3 Antibody (YA1986) | Antibodies | |
| HY-P82242 | SMG1 Antibody (YA1987) | Antibodies | |
| HY-P82243 | SLC27A4 Antibody (YA1988) | Antibodies | |
| HY-P82244 | Activin A Receptor Type IB Antibody (YA1989) | Antibodies | |
| HY-P82245 | Dynactin Subunit 5 Antibody (YA1990) | Antibodies | |
| HY-P82246 | SLCO5A1 Antibody (YA1991) | Antibodies | |
| HY-P82247 | FMO3 Antibody (YA1992) | Antibodies | |
| HY-P82248 | SMAC Antibody (YA1993) | Antibodies | |
| HY-P82249 | Activin Receptor Type IA Antibody (YA1994) | Antibodies | |
| HY-P82250 | RanBP9 Antibody (YA1995) | Antibodies | |
| HY-P82251 | Human kappa Light Chain Antibody (YA1996) | Antibodies | |
| HY-P82252 | ACTN3 Antibody (YA1997) | Antibodies | |
| HY-P82253 | ADH5 Antibody (YA1998) | Antibodies | |
| HY-P82254 | p60 CAF1 Antibody (YA1999) | Antibodies | |
| HY-P82255 | DPD Antibody (YA2000) | Antibodies | |
| HY-P82256 | Syntaxin 1A Antibody (YA2001) | Antibodies | |
| HY-P82257 | ADAMTS13 Antibody (YA2002) | Antibodies | |
| HY-P82258 | SMYD3 Antibody (YA2003) | Antibodies | |
| HY-P82259 | Elongation factor 1 gamma Antibody (YA2004) | Antibodies | |
| HY-P82260 | Adrenodoxin Antibody (YA2005) | Antibodies | |
| HY-P82261 | CBFB Antibody (YA2006) | Antibodies | |
| HY-P82262 | ADRM1 Antibody (YA2007) | Antibodies | |
| HY-P82263 | SNAP29 Antibody (YA2008) | Antibodies | |
| HY-P82264 | Estrogen Related Receptor gamma Antibody (YA2009) | Antibodies | |
| HY-P82265 | Protein Jumonji Antibody (YA2010) | Antibodies | |
| HY-P82266 | AdSS 2 Antibody (YA2011) | Antibodies | |
| HY-P82267 | MFF Antibody (YA2012) | Antibodies | |
| HY-P82268 | SMARCA5 Antibody (YA2013) | Antibodies | |
| HY-P82269 | COMT Antibody (YA2014) | Antibodies | |
| HY-P82270 | AER61 Antibody (YA2015) | Antibodies | |
| HY-P82271 | ANGPTL3 Antibody (YA2016) | Antibodies | |
| HY-P82272 | AF10 Antibody (YA2017) | Antibodies | |
| HY-P82273 | SMARCB1 Antibody (YA2018) | Antibodies | |
| HY-P82274 | MC1R Antibody (YA2019) | Antibodies | |
| HY-P82275 | AGXT Antibody (YA2020) | Antibodies | |
| HY-P82276 | WRN Antibody (YA2021) | Antibodies | |
| HY-P82277 | SUN1 Antibody (YA2022) | Antibodies | |
| HY-P82278 | AHA1 Antibody (YA2023) | Antibodies | |
| HY-P82279 | SENP2 Antibody (YA2024) | Antibodies | |
| HY-P82280 | SUN2 Antibody (YA2025) | Antibodies | |
| HY-P82281 | SNRPD3 Antibody (YA2026) | Antibodies | |
| HY-P82282 | FRA1 Antibody (YA2027) | Antibodies | |
| HY-P82283 | ALAS2 Antibody (YA2028) | Antibodies | |
| HY-P82284 | ATP7B Antibody (YA2029) | Antibodies | |
| HY-P82285 | CTBP1 Antibody (YA2030) | Antibodies | |
| HY-P82286 | ALDH1L1 Antibody (YA2031) | Antibodies | |
| HY-P82287 | Somatostatin Receptor 3 Antibody (YA2032) | Antibodies | |
| HY-P82288 | IGF2BP2 Antibody (YA2033) | Antibodies | |
| HY-P82289 | ALDH7A1 Antibody (YA2034) | Antibodies | |
| HY-P82290 | Tomoregulin 2 Antibody (YA2035) | Antibodies | |
| HY-P82291 | Monoamine Oxidase A Antibody (YA2036) | Antibodies | |
| HY-P82292 | ALDOA Antibody (YA2037) | Antibodies | |
| HY-P82293 | 12 Lipoxygenase Antibody (YA2038) | Antibodies | |
| HY-P82294 | Monoamine Oxidase B Antibody (YA2039) | Antibodies | |
| HY-P82295 | Glucokinase Antibody (YA2040) | Antibodies | |
| HY-P82296 | OGA Antibody (YA2041) | Antibodies | |
| HY-P82297 | ApoH Antibody (YA2042) | Antibodies | |
| HY-P82298 | Spermine Synthase Antibody (YA2043) | Antibodies | |
| HY-P82299 | SNX1 Antibody (YA2044) | Antibodies | |
| HY-P82300 | MYF5 Antibody (YA2045) | Antibodies | |
| HY-P82301 | SPINK5 Antibody (YA2046) | Antibodies | |
| HY-P82302 | ALKBH2 Antibody (YA2047) | Antibodies | |
| HY-P82303 | BMP6 Antibody (YA2048) | Antibodies | |
| HY-P82304 | SPON2 Antibody (YA2049) | Antibodies | |
| HY-P82305 | ALKBH4 Antibody (YA2050) | Antibodies | |
| HY-P82306 | MAGE1 Antibody (YA2051) | Antibodies | |
| HY-P82307 | Frizzled 8 Antibody (YA2052) | Antibodies | |
| HY-P82308 | AGPS Antibody (YA2053) | Antibodies | |
| HY-P82309 | SPOP Antibody (YA2054) | Antibodies | |
| HY-P82310 | EN1 Antibody (YA2055) | Antibodies | |
| HY-P82311 | VAMP1 Antibody (YA2056) | Antibodies | |
| HY-P82312 | CTNNA1 Antibody (YA2057) | Antibodies | |
| HY-P82313 | FE65 Antibody (YA2058) | Antibodies | |
| HY-P82314 | alpha 1a Adrenergic Receptor Antibody (YA2059) | Antibodies | |
| HY-P82315 | PCB Antibody (YA2060) | Antibodies | |
| HY-P82316 | BACH1 Antibody (YA2061) | Antibodies | |
| HY-P82317 | alpha Actinin 4 Antibody (YA2062) | Antibodies | |
| HY-P82318 | SRP72 Antibody (YA2063) | Antibodies | |
| HY-P82319 | FAAH1 Antibody (YA2064) | Antibodies | |
| HY-P82320 | SSX2IP Antibody (YA2065) | Antibodies | |
| HY-P82321 | Triosephosphate Isomerase Antibody (YA2066) | Antibodies | |
| HY-P82322 | alpha Internexin Antibody (YA2067) | Antibodies | |
| HY-P82323 | alpha Sarcoglycan Antibody (YA2068) | Antibodies | |
| HY-P82324 | Fibrinogen alpha Chain Antibody (YA2069) | Antibodies | |
| HY-P82325 | Lactate Dehydrogenase B Antibody (YA2070) | Antibodies | |
| HY-P82326 | CD66b Antibody (YA2071) | Antibodies | |
| HY-P82327 | NDUFS4 Antibody (YA2072) | Antibodies | |
| HY-P82328 | alpha Synuclein Antibody (YA2073) | Antibodies | |
| HY-P82329 | Interferon gamma Receptor 1 Antibody (YA2074) | Antibodies | |
| HY-P82330 | ALS2CR8 Antibody (YA2075) | Antibodies | |
| HY-P82331 | KARS Antibody (YA2076) | Antibodies | |
| HY-P82332 | Staufen Antibody (YA2077) | Antibodies | |
| HY-P82333 | Galactosidase alpha Antibody (YA2078) | Antibodies | |
| HY-P82334 | Aly Antibody (YA2079) | Antibodies | |
| HY-P82335 | STIP1 Antibody (YA2080) | Antibodies | |
| HY-P82336 | Phospho-Glutamate Receptor 1 (AMPA Subtype) (Ser845) Antibody (YA2081) | Antibodies | |
| HY-P82337 | MDH1 Antibody (YA2082) | Antibodies | |
| HY-P82338 | STK3 Antibody (YA2083) | Antibodies | |
| HY-P82339 | ATP1B1 Antibody (YA2084) | Antibodies | |
| HY-P82340 | STK33 Antibody (YA2085) | Antibodies | |
| HY-P82341 | HLTF Antibody (YA2086) | Antibodies | |
| HY-P82342 | Cytochrome P450 4A Antibody (YA2087) | Antibodies | |
| HY-P82343 | Striatin 4 Antibody (YA2088) | Antibodies | |
| HY-P82344 | MT ND1 Antibody (YA2089) | Antibodies | |
| HY-P82345 | Angiopoietin Like 4 Antibody (YA2090) | Antibodies | |
| HY-P82346 | IMPDH2 Antibody (YA2091) | Antibodies | |
| HY-P82347 | Stromal Interaction Molecule 1 Antibody (YA2092) | Antibodies | |
| HY-P82348 | MYL9 Antibody (YA2093) | Antibodies | |
| HY-P82349 | ACE Antibody | Antibodies | |
| HY-P82350 | GSTO1 Antibody (YA2095) | Antibodies | |
| HY-P82351 | STUB1 Antibody (YA2096) | Antibodies | |
| HY-P82352 | Angiotensinogen Antibody (YA2097) | Antibodies | |
| HY-P82353 | Mitochondrial Fission 1 Protein Antibody (YA2098) | Antibodies | |
| HY-P82354 | Cyclophilin 40 Antibody (YA2099) | Antibodies | |
| HY-P82355 | Exportin 5 Antibody (YA2100) | Antibodies | |
| HY-P82356 | Transcription Factor 21 Antibody (YA2101) | Antibodies | |
| HY-P82357 | Syntaxin 3 Antibody (YA2102) | Antibodies | |
| HY-P82358 | Zinc Alpha 2 Glycoprotein Antibody (YA2103) | Antibodies | |
| HY-P82359 | MARK2 Antibody (YA2104) | Antibodies | |
| HY-P82360 | alpha COP I Antibody (YA2105) | Antibodies | |
| HY-P82361 | CXCR5 Antibody (YA2106) | Antibodies | |
| HY-P82362 | Pulmonary Surfactant Associated Protein D Antibody (YA2107) | Antibodies | |
| HY-P82363 | GSC Antibody (YA2108) | Antibodies | |
| HY-P82364 | AP2 alpha Antibody (YA2109) | Antibodies | |
| HY-P82365 | Baf57 Antibody (YA2110) | Antibodies | |
| HY-P82366 | TOMM22 Antibody (YA2111) | Antibodies | |
| HY-P82367 | FANCA Antibody (YA2112) | Antibodies | |
| HY-P82368 | Phospho-AP2M1 (Thr156) Antibody (YA2113) | Antibodies | |
| HY-P82369 | Syndecan 3 Antibody (YA2114) | Antibodies | |
| HY-P82370 | PSMD4 Antibody (YA2115) | Antibodies | |
| HY-P82371 | IKZF3 Antibody (YA2116) | Antibodies | |
| HY-P82372 | AP3M1 Antibody (YA2117) | Antibodies | |
| HY-P82373 | PEN2 Antibody (YA2118) | Antibodies | |
| HY-P82374 | Syntaxin 16 Antibody (YA2119) | Antibodies | |
| HY-P82375 | APE1 Antibody (YA2120) | Antibodies | |
| HY-P82376 | Cytochrome P450 24A1 Antibody (YA2121) | Antibodies | |
| HY-P82377 | Transcriptional Enhancer Factor TEF Antibody (YA2122) | Antibodies | |
| HY-P82378 | ODC1 Antibody (YA2123) | Antibodies | |
| HY-P82379 | Synaptophysin Like Protein 1 Antibody (YA2124) | Antibodies | |
| HY-P82380 | Cardiac Troponin C Antibody (YA2125) | Antibodies | |
| HY-P82381 | TINF2 Antibody (YA2126) | Antibodies | |
| HY-P82382 | DDB2 Antibody (YA2127) | Antibodies | |
| HY-P82383 | ApoER2 Antibody (YA2128) | Antibodies | |
| HY-P82384 | CEND1 Antibody (YA2129) | Antibodies | |
| HY-P82385 | TROP2 Antibody (YA2130) | Antibodies | |
| HY-P82386 | APPBP1 Antibody (YA2131) | Antibodies | |
| HY-P82387 | AP2S1 Antibody (YA2132) | Antibodies | |
| HY-P82388 | CLASP1 Antibody (YA2133) | Antibodies | |
| HY-P82389 | TAF15 Antibody (YA2134) | Antibodies | |
| HY-P82390 | APPL Antibody (YA2135) | Antibodies | |
| HY-P82391 | SAM68 Antibody (YA2136) | Antibodies | |
| HY-P82392 | SRP54 Antibody (YA2137) | Antibodies | |
| HY-P82393 | Aprataxin Antibody (YA2138) | Antibodies | |
| HY-P82394 | TAF1C Antibody (YA2139) | Antibodies | |
| HY-P82395 | Kininogen 1 Antibody (YA2140) | Antibodies | |
| HY-P82396 | TAGAP Antibody (YA2141) | Antibodies | |
| HY-P82397 | Aquaporin 2 Antibody (YA2142) | Antibodies | |
| HY-P82398 | KHSRP Antibody (YA2143) | Antibodies | |
| HY-P82399 | T Box Transcription Factor T Antibody (YA2144) | Antibodies | |
| HY-P82400 | PLEKHA1 Antibody (YA2145) | Antibodies | |
| HY-P82401 | ARFGEF2 Antibody (YA2146) | Antibodies | |
| HY-P82402 | Guanylyl Cyclase beta 1 Antibody (YA2147) | Antibodies | |
| HY-P82403 | CBS Antibody (YA2148) | Antibodies | |
| HY-P82404 | ARHGAP25 Antibody (YA2149) | Antibodies | |
| HY-P82405 | MARK3 Antibody (YA2150) | Antibodies | |
| HY-P82406 | Aconitase 2 Antibody (YA2151) | Antibodies | |
| HY-P82407 | ARPC2 Antibody (YA2152) | Antibodies | |
| HY-P82408 | Glutathione Peroxidase 2 Antibody (YA2153) | Antibodies | |
| HY-P82409 | T Box Protein 3 Antibody (YA2154) | Antibodies | |
| HY-P82410 | Artemin Antibody (YA2155) | Antibodies | |
| HY-P82411 | PGAM1 Antibody (YA2156) | Antibodies | |
| HY-P82412 | SERCA1 ATPase Antibody (YA2157) | Antibodies | |
| HY-P82413 | TCEA1 Antibody (YA2158) | Antibodies | |
| HY-P82414 | ERAP1 Antibody (YA2159) | Antibodies | |
| HY-P82415 | DIAPH1 Antibody (YA2160) | Antibodies | |
| HY-P82416 | VAV1 Antibody (YA2161) | Antibodies | |
| HY-P82417 | Aryl Hydrocarbon Receptor Antibody (YA2162) | Antibodies | |
| HY-P82418 | Cytochrome P450 27A1 Antibody (YA2163) | Antibodies | |
| HY-P82419 | AP-A Antibody (YA2164) | Antibodies | |
| HY-P82420 | RNF40 Antibody (YA2165) | Antibodies | |
| HY-P82421 | Cytochrome P450 2C9 Antibody (YA2166) | Antibodies | |
| HY-P82422 | Transcription Factor 7 Like 2 Antibody (YA2167) | Antibodies | |
| HY-P82423 | c-Myb Antibody (YA2168) | Antibodies | |
| HY-P82424 | SRSF3 Antibody (YA2169) | Antibodies | |
| HY-P82425 | AS160 Antibody (YA2170) | Antibodies | |
| HY-P82426 | MCM7 Antibody (YA2171) | Antibodies | |
| HY-P82427 | TDP 43 Antibody (YA2172) | Antibodies | |
| HY-P82428 | Pentraxin 3 Antibody (YA2173) | Antibodies | |
| HY-P82429 | TRIB3 Antibody (YA2174) | Antibodies | |
| HY-P82430 | Aspartate Aminotransferase Antibody (YA2175) | Antibodies | |
| HY-P82431 | Ephrin Receptor B1 Antibody (YA2176) | Antibodies | |
| HY-P82432 | Ataxin 1 Antibody (YA2177) | Antibodies | |
| HY-P82433 | ATE1 Antibody (YA2178) | Antibodies | |
| HY-P82434 | NDUFAF1 Antibody (YA2179) | Antibodies | |
| HY-P82435 | BUB3 Antibody (YA2180) | Antibodies | |
| HY-P82436 | Tec Antibody (YA2181) | Antibodies | |
| HY-P82437 | RHOQ Antibody (YA2182) | Antibodies | |
| HY-P82438 | Tropomyosin alpha 1 Chain Antibody (YA2183) | Antibodies | |
| HY-P82439 | ATF5 Antibody (YA2184) | Antibodies | |
| HY-P82440 | TPPP Antibody (YA2185) | Antibodies | |
| HY-P82441 | Galectin 8 Antibody (YA2186) | Antibodies | |
| HY-P82442 | ATG16L1 Antibody (YA2187) | Antibodies | |
| HY-P82443 | GSTK1 Antibody (YA2188) | Antibodies | |
| HY-P82444 | GTPBP4 Antibody (YA2189) | Antibodies | |
| HY-P82445 | Cpn10 Antibody (YA2190) | Antibodies | |
| HY-P82446 | COPS3 Antibody (YA2191) | Antibodies | |
| HY-P82447 | Thioredoxin 2 Antibody (YA2192) | Antibodies | |
| HY-P82448 | Glycodelin Antibody (YA2193) | Antibodies | |
| HY-P82449 | SMN Antibody (YA2194) | Antibodies | |
| HY-P82450 | Thymidine Kinase Antibody (YA2195) | Antibodies | |
| HY-P82451 | Human IgG2 Antibody (YA2196) | Antibodies | |
| HY-P82452 | Lysophospholipase 1 Antibody (YA2197) | Antibodies | |
| HY-P82454 | Thyroglobulin Antibody (YA2199) | Antibodies | |
| HY-P82455 | TIAM2 Antibody (YA2200) | Antibodies | |
| HY-P82456 | ATP1B3 Antibody (YA2201) | Antibodies | |
| HY-P82457 | Cullin 2 Antibody (YA2202) | Antibodies | |
| HY-P82458 | ApoF Antibody (YA2203) | Antibodies | |
| HY-P82459 | TIMELESS Antibody (YA2204) | Antibodies | |
| HY-P82460 | ATP5G Antibody (YA2205) | Antibodies | |
| HY-P82461 | Rab27A Antibody (YA2206) | Antibodies | |
| HY-P82462 | TIMM44 Antibody (YA2207) | Antibodies | |
| HY-P82463 | ATP6V0D1 Antibody (YA2208) | Antibodies | |
| HY-P82464 | Transmembrane Protein 161B Antibody (YA2209) | Antibodies | |
| HY-P82465 | OTX2 Antibody (YA2210) | Antibodies | |
| HY-P82466 | ATP6V1A Antibody (YA2211) | Antibodies | |
| HY-P82467 | BOB1 Antibody (YA2212) | Antibodies | |
| HY-P82468 | WNK1 Antibody (YA2213) | Antibodies | |
| HY-P82469 | ATPB Antibody (YA2214) | Antibodies | |
| HY-P82470 | Transmembrane Protein 192 Antibody (YA2215) | Antibodies | |
| HY-P82471 | SAA4 Antibody (YA2216) | Antibodies | |
| HY-P82472 | PIAS1 Antibody (YA2217) | Antibodies | |
| HY-P82473 | ENTPD5 Antibody (YA2218) | Antibodies | |
| HY-P82474 | AVEN Antibody (YA2219) | Antibodies | |
| HY-P82475 | Transmembrane Protein 30B Antibody (YA2220) | Antibodies | |
| HY-P82476 | U2AF2 Antibody (YA2221) | Antibodies | |
| HY-P82477 | Axin 2 Antibody (YA2222) | Antibodies | |
| HY-P82478 | Transmembrane Protein 43 Antibody (YA2223) | Antibodies | |
| HY-P82479 | WSTF Antibody (YA2224) | Antibodies | |
| HY-P82480 | Transmembrane Protein 85 Antibody (YA2225) | Antibodies | |
| HY-P82481 | AZI2 Antibody (YA2226) | Antibodies | |
| HY-P82482 | CENPC Antibody (YA2227) | Antibodies | |
| HY-P82483 | Transmembrane Protein 9B Antibody (YA2228) | Antibodies | |
| HY-P82484 | Max Dimerization Protein 3 Antibody (YA2229) | Antibodies | |
| HY-P82485 | KAT8 Antibody (YA2230) | Antibodies | |
| HY-P82486 | TNFAIP3 Antibody (YA2231) | Antibodies | |
| HY-P82487 | CT A Antibody (YA2232) | Antibodies | |
| HY-P82488 | Emi1 Antibody (YA2233) | Antibodies | |
| HY-P82489 | Tensin 4 Antibody (YA2234) | Antibodies | |
| HY-P82490 | Hsf2 Antibody (YA2235) | Antibodies | |
| HY-P82491 | CHD1L Antibody (YA2236) | Antibodies | |
| HY-P82492 | Topoisomerase I Antibody (YA2237) | Antibodies | |
| HY-P82493 | TCP 1 alpha Antibody (YA2238) | Antibodies | |
| HY-P82494 | GOLPH4 Antibody (YA2239) | Antibodies | |
| HY-P82495 | BAG3 Antibody (YA2240) | Antibodies | |
| HY-P82496 | Thrombopoietin Receptor Antibody (YA2241) | Antibodies | |
| HY-P82497 | GCDFP 15 Antibody (YA2242) | Antibodies | |
| HY-P82498 | ELMO1 Antibody (YA2243) | Antibodies | |
| HY-P82499 | TPP1 Antibody (YA2244) | Antibodies | |
| HY-P82500 | Cripto 1 Antibody (YA2245) | Antibodies | |
| HY-P82501 | Gephyrin Antibody (YA2246) | Antibodies | |
| HY-P82502 | CLSTN1 Antibody (YA2247) | Antibodies | |
| HY-P82503 | TAX1BP1 Antibody (YA2248) | Antibodies | |
| HY-P82504 | GABA A Receptor alpha 5 Antibody (YA2249) | Antibodies | |
| HY-P82505 | PSMD14 Antibody (YA2250) | Antibodies | |
| HY-P82506 | BAT3 Antibody (YA2251) | Antibodies | |
| HY-P82507 | DDX6 Antibody (YA2252) | Antibodies | |
| HY-P82508 | BAT5 Antibody (YA2253) | Antibodies | |
| HY-P82509 | Septin 2 Antibody (YA2254) | Antibodies | |
| HY-P82510 | Transglutaminase 2 Antibody (YA2255) | Antibodies | |
| HY-P82511 | SF3B1 Antibody (YA2256) | Antibodies | |
| HY-P82512 | Translin Associated Protein X Antibody (YA2257) | Antibodies | |
| HY-P82513 | APRIL Antibody (YA2258) | Antibodies | |
| HY-P82514 | Cytochrome P450 26A1 Antibody (YA2259) | Antibodies | |
| HY-P82515 | CD83 Antibody (YA2260) | Antibodies | |
| HY-P82516 | GABA A Receptor beta 1 Antibody (YA2261) | Antibodies | |
| HY-P82517 | ICAD Antibody (YA2262) | Antibodies | |
| HY-P82518 | TRIF Antibody (YA2263) | Antibodies | |
| HY-P82519 | Cellular Apoptosis Susceptibility Antibody (YA2264) | Antibodies | |
| HY-P82520 | UAP1 Antibody (YA2265) | Antibodies | |
| HY-P82521 | GPA33 Antibody (YA2266) | Antibodies | |
| HY-P82522 | beta IV Tubulin Antibody (YA2267) | Antibodies | |
| HY-P82523 | TGFBI Antibody (YA2268) | Antibodies | |
| HY-P82524 | TRIM23 Antibody (YA2269) | Antibodies | |
| HY-P82525 | EWSR1 Antibody (YA2270) | Antibodies | |
| HY-P82526 | IRS2 Antibody (YA2271) | Antibodies | |
| HY-P82527 | Rab4 Antibody (YA2272) | Antibodies | |
| HY-P82528 | TRIM24 Antibody (YA2273) | Antibodies | |
| HY-P82529 | Lactoferrin Antibody (YA2274) | Antibodies | |
| HY-P82530 | BIN1 Antibody (YA2275) | Antibodies | |
| HY-P82531 | TRADD Antibody (YA2276) | Antibodies | |
| HY-P82532 | Wilms Tumor Protein Antibody (YA2277) | Antibodies | |
| HY-P82533 | TRIM25 Antibody (YA2278) | Antibodies | |
| HY-P82534 | MBD2 Antibody (YA2279) | Antibodies | |
| HY-P82535 | DUSP6 Antibody (YA2280) | Antibodies | |
| HY-P82536 | TFG Antibody (YA2281) | Antibodies | |
| HY-P82537 | BLNK Antibody (YA2282) | Antibodies | |
| HY-P82538 | ERR alpha Antibody (YA2283) | Antibodies | |
| HY-P82539 | TrpV5 Antibody (YA2284) | Antibodies | |
| HY-P82540 | BMP4 Antibody (YA2285) | Antibodies | |
| HY-P82541 | TRUB2 Antibody (YA2286) | Antibodies | |
| HY-P82542 | NQO2 Antibody (YA2287) | Antibodies | |
| HY-P82543 | Olfactomedin 4 Antibody (YA2288) | Antibodies | |
| HY-P82544 | Bok Antibody (YA2289) | Antibodies | |
| HY-P82545 | Niemann Pick C1 Antibody (YA2290) | Antibodies | |
| HY-P82546 | TLE1 Antibody (YA2291) | Antibodies | |
| HY-P82547 | Bora Antibody (YA2292) | Antibodies | |
| HY-P82549 | BRAT1 Antibody (YA2294) | Antibodies | |
| HY-P82550 | alpha 1-adaptin Antibody (YA2295) | Antibodies | |
| HY-P82551 | Calmegin Antibody (YA2296) | Antibodies | |
| HY-P82552 | Thyroid Transcription Factor 1 Antibody (YA2297) | Antibodies | |
| HY-P82553 | BRCC36 Antibody (YA2298) | Antibodies | |
| HY-P82554 | Desmoglein 2 Antibody (YA2299) | Antibodies | |
| HY-P82555 | XLF Antibody (YA2300) | Antibodies | |
| HY-P82556 | PSMA1 Antibody (YA2301) | Antibodies | |
| HY-P82557 | Cytochrome P450 2E1 Antibody (YA2302) | Antibodies | |
| HY-P82558 | Transcription Termination Factor 2 Antibody (YA2303) | Antibodies | |
| HY-P82559 | Telomeric Repeat Binding Factor 2 Antibody (YA2304) | Antibodies | |
| HY-P82560 | BTF3 Antibody (YA2305) | Antibodies | |
| HY-P82561 | ATP5F1A Antibody (YA2306) | Antibodies | |
| HY-P82562 | Biglycan Antibody (YA2307) | Antibodies | |
| HY-P82563 | GSTM1 Antibody (YA2308) | Antibodies | |
| HY-P82564 | TXNDC9 Antibody (YA2309) | Antibodies | |
| HY-P82565 | SorLA Antibody (YA2310) | Antibodies | |
| HY-P82566 | GC1q R Antibody (YA2311) | Antibodies | |
| HY-P82567 | Thioredoxin Like Protein 1 Antibody (YA2312) | Antibodies | |
| HY-P82569 | RNase L Antibody (YA2314) | Antibodies | |
| HY-P82570 | Thioredoxin Reductase 1 Antibody (YA2315) | Antibodies | |
| HY-P82571 | 4 1BBL Antibody (YA2316) | Antibodies | |
| HY-P82572 | NKX3.1 Antibody (YA2317) | Antibodies | |
| HY-P82573 | DDX58 Antibody (YA2318) | Antibodies | |
| HY-P82574 | C3orf38 Antibody (YA2319) | Antibodies | |
| HY-P82575 | CCT2 Antibody (YA2320) | Antibodies | |
| HY-P82576 | TR AP Antibody (YA2321) | Antibodies | |
| HY-P82577 | COUP TF1 Antibody (YA2322) | Antibodies | |
| HY-P82578 | Epac2 Antibody (YA2323) | Antibodies | |
| HY-P82579 | PHF8 Antibody (YA2324) | Antibodies | |
| HY-P82580 | C9orf167 Antibody (YA2325) | Antibodies | |
| HY-P82581 | U1C Antibody (YA2326) | Antibodies | |
| HY-P82582 | TRP1 Antibody (YA2327) | Antibodies | |
| HY-P82583 | Liver Carboxylesterase 1 Antibody (YA2328) | Antibodies | |
| HY-P82584 | UBA2 Antibody (YA2329) | Antibodies | |
| HY-P82585 | MTH1 Antibody (YA2330) | Antibodies | |
| HY-P82586 | NCX1 Antibody (YA2331) | Antibodies | |
| HY-P82587 | Caldesmon Antibody (YA2332) | Antibodies | |
| HY-P82588 | Ubiquitin Conjugating Enzyme E2 D3 Antibody (YA2333) | Antibodies | |
| HY-P82589 | Claudin 11 Antibody (YA2334) | Antibodies | |
| HY-P82590 | GRASP65 Antibody (YA2335) | Antibodies | |
| HY-P82591 | Calretinin Antibody (YA2336) | Antibodies | |
| HY-P82592 | CaMKII delta Antibody (YA2337) | Antibodies | |
| HY-P82593 | AKR1C3 Antibody (YA2338) | Antibodies | |
| HY-P82594 | UCHL5 Antibody (YA2339) | Antibodies | |
| HY-P82595 | SMC4 Antibody (YA2340) | Antibodies | |
| HY-P82596 | NR0B1 Antibody (YA2341) | Antibodies | |
| HY-P82597 | DLX5 Antibody (YA2342) | Antibodies | |
| HY-P82598 | HAUS7 Antibody (YA2343) | Antibodies | |
| HY-P82599 | CaMKII beta Antibody (YA2344) | Antibodies | |
| HY-P82600 | Activin Receptor Type IIB Antibody (YA2345) | Antibodies | |
| HY-P82601 | Transgelin Antibody (YA2346) | Antibodies | |
| HY-P82602 | UFC1 Antibody (YA2347) | Antibodies | |
| HY-P82603 | ApoC1 Antibody (YA2348) | Antibodies | |
| HY-P82604 | KLF10 Antibody (YA2349) | Antibodies | |
| HY-P82605 | Phospho-Cannabinoid Receptor I (Ser316) Antibody (YA2350) | Antibodies | |
| HY-P82606 | RING1 Antibody (YA2351) | Antibodies | |
| HY-P82607 | UFD1 Antibody (YA2352) | Antibodies | |
| HY-P82608 | PER2 Antibody (YA2353) | Antibodies | |
| HY-P82609 | RGS18 Antibody (YA2354) | Antibodies | |
| HY-P82610 | ULK3 Antibody (YA2355) | Antibodies | |
| HY-P82611 | Transmembrane Protease Serine 2 Antibody (YA2356) | Antibodies | |
| HY-P82612 | CPEB1 Antibody (YA2357) | Antibodies | |
| HY-P82613 | Complex III Subunit 7 Antibody (YA2358) | Antibodies | |
| HY-P82614 | EDG3 Antibody (YA2359) | Antibodies | |
| HY-P82615 | Oxytocin Receptor Antibody (YA2360) | Antibodies | |
| HY-P82616 | IL-2 Receptor alpha Antibody (YA2361) | Antibodies | |
| HY-P82617 | USP10 Antibody (YA2362) | Antibodies | |
| HY-P82618 | KLC1 Antibody (YA2363) | Antibodies | |
| HY-P82619 | MRC2 Antibody (YA2364) | Antibodies | |
| HY-P82620 | EAAT3 Antibody (YA2365) | Antibodies | |
| HY-P82621 | Caspase 10 Antibody (YA2366) | Antibodies | |
| HY-P82622 | USP13 Antibody (YA2367) | Antibodies | |
| HY-P82623 | MST1 Antibody (YA2368) | Antibodies | |
| HY-P82624 | NeuroD2 Antibody (YA2369) | Antibodies | |
| HY-P82625 | NPHS2 Antibody (YA2370) | Antibodies | |
| HY-P82626 | NUDC Antibody (YA2371) | Antibodies | |
| HY-P82627 | SMURF2 Antibody (YA2372) | Antibodies | |
| HY-P82628 | EHMT2 Antibody (YA2373) | Antibodies | |
| HY-P82629 | Pyruvate Dehydrogenase E1 beta Antibody (YA2374) | Antibodies | |
| HY-P82630 | VCP Antibody (YA2375) | Antibodies | |
| HY-P82631 | CD239 Antibody (YA2376) | Antibodies | |
| HY-P82632 | Estrogen Inducible Protein pS2 Antibody (YA2377) | Antibodies | |
| HY-P82633 | Cullin 1 Antibody (YA2378) | Antibodies | |
| HY-P82634 | Desmoplakin Antibody (YA2379) | Antibodies | |
| HY-P82635 | Cathelicidin Antibody (YA2380) | Antibodies | |
| HY-P82636 | BMP15 Antibody (YA2381) | Antibodies | |
| HY-P82637 | Cathepsin Z Antibody (YA2382) | Antibodies | |
| HY-P82638 | RANTES Antibody (YA2383) | Antibodies | |
| HY-P82639 | PSMA2 Antibody (YA2384) | Antibodies | |
| HY-P82640 | VEGFD Antibody (YA2385) | Antibodies | |
| HY-P82641 | PSMA3 Antibody (YA2386) | Antibodies | |
| HY-P82642 | Caveolin 2 Antibody (YA2387) | Antibodies | |
| HY-P82643 | IQGAP1 Antibody (YA2388) | Antibodies | |
| HY-P82644 | USO1 Antibody (YA2389) | Antibodies | |
| HY-P82645 | TIMM50 Antibody (YA2390) | Antibodies | |
| HY-P82646 | TRPM7 Antibody (YA2391) | Antibodies | |
| HY-P82647 | CBL Antibody (YA2392) | Antibodies | |
| HY-P82648 | BPR Antibody (YA2393) | Antibodies | |
| HY-P82649 | SHC Antibody (YA2394) | Antibodies | |
| HY-P82650 | CBR3 Antibody (YA2395) | Antibodies | |
| HY-P82651 | NEK6 Antibody (YA2396) | Antibodies | |
| HY-P82652 | WAPL Antibody (YA2397) | Antibodies | |
| HY-P82653 | Integrin alpha L Antibody (YA2398) | Antibodies | |
| HY-P82654 | MDA5 Antibody (YA2399) | Antibodies | |
| HY-P82655 | Leukotriene A4 Hydrolase Antibody (YA2400) | Antibodies | |
| HY-P82656 | TAB3 Antibody (YA2401) | Antibodies | |
| HY-P82657 | Vitronectin Antibody (YA2402) | Antibodies | |
| HY-P82658 | RNA Polymerase beta Antibody (YA2403) | Antibodies | |
| HY-P82659 | Phospho-c Myb (Ser11) Antibody (YA2404) | Antibodies | |
| HY-P82660 | Nogo Receptor Antibody (YA2405) | Antibodies | |
| HY-P82661 | von Willebrand Factor Antibody (YA2406) | Antibodies | |
| HY-P82662 | RORB Antibody (YA2407) | Antibodies | |
| HY-P82663 | Interferon Regulatory Factor 4 Antibody (YA2408) | Antibodies | |
| HY-P82664 | VPS41 Antibody (YA2409) | Antibodies | |
| HY-P82665 | IGFBP1 Antibody (YA2410) | Antibodies | |
| HY-P82666 | Prolactin Receptor Antibody (YA2411) | Antibodies | |
| HY-P82667 | CD226 Antibody (YA2412) | Antibodies | |
| HY-P82668 | VPS4A Antibody (YA2413) | Antibodies | |
| HY-P82669 | MCAK Antibody (YA2414) | Antibodies | |
| HY-P82670 | HB9 Antibody (YA2415) | Antibodies | |
| HY-P82671 | WAVE 1 Antibody (YA2416) | Antibodies | |
| HY-P82672 | WDR1 Antibody (YA2417) | Antibodies | |
| HY-P82673 | GABA B Receptor 1 Antibody (YA2418) | Antibodies | |
| HY-P82674 | Scramblase 1 Antibody (YA2419) | Antibodies | |
| HY-P82675 | Superoxide Dismutase 3 Antibody (YA2420) | Antibodies | |
| HY-P82676 | Wnt16 Antibody (YA2421) | Antibodies | |
| HY-P82677 | Chromogranin B Antibody (YA2422) | Antibodies | |
| HY-P82678 | CBX2 Antibody (YA2423) | Antibodies | |
| HY-P82679 | Wnt2b Antibody (YA2424) | Antibodies | |
| HY-P82680 | Phospho-CD3 zeta (Tyr142) Antibody (YA2425) | Antibodies | |
| HY-P82681 | SLC22A1 Antibody (YA2426) | Antibodies | |
| HY-P82682 | SNAP23 Antibody (YA2427) | Antibodies | |
| HY-P82683 | DOPA Decarboxylase Antibody (YA2428) | Antibodies | |
| HY-P82684 | XIAP Antibody (YA2429) | Antibodies | |
| HY-P82685 | DISC1 Antibody (YA2430) | Antibodies | |
| HY-P82686 | PHD2 Antibody (YA2431) | Antibodies | |
| HY-P82687 | G3BP Antibody (YA2432) | Antibodies | |
| HY-P82688 | HLA DQA1 Antibody (YA2433) | Antibodies | |
| HY-P82689 | XPD Antibody (YA2434) | Antibodies | |
| HY-P82690 | Neuronatin Antibody (YA2435) | Antibodies | |
| HY-P82691 | BMF Antibody (YA2436) | Antibodies | |
| HY-P82692 | VPS11 Antibody (YA2437) | Antibodies | |
| HY-P82693 | MEIS1 Antibody (YA2438) | Antibodies | |
| HY-P82694 | Y14 Antibody (YA2439) | Antibodies | |
| HY-P82695 | CD55 Antibody (YA2440) | Antibodies | |
| HY-P82696 | MBD1 Antibody (YA2441) | Antibodies | |
| HY-P82697 | ENT2 Antibody (YA2442) | Antibodies | |
| HY-P82698 | Carbonic Anhydrase 9Rabbit mAb Antibody (YA2443) | Antibodies | |
| HY-P82699 | NrCAM Antibody (YA2444) | Antibodies | |
| HY-P82700 | VPS18 Antibody (YA2445) | Antibodies | |
| HY-P82701 | YY1 Antibody (YA2446) | Antibodies | |
| HY-P82702 | RNA Polymerase II Subunit B3 Antibody (YA2447) | Antibodies | |
| HY-P82703 | Fibulin 5 Antibody (YA2448) | Antibodies | |
| HY-P82704 | MAD1L1 Antibody (YA2449) | Antibodies | |
| HY-P82705 | CDC25 Antibody (YA2450) | Antibodies | |
| HY-P82706 | Glypican 3 Antibody (YA2451) | Antibodies | |
| HY-P82707 | Cystathionase Antibody (YA2452) | Antibodies | |
| HY-P82708 | ZNF160 Antibody (YA2453) | Antibodies | |
| HY-P82709 | IRAK1 Antibody (YA2454) | Antibodies | |
| HY-P82710 | PAR2 Antibody (YA2455) | Antibodies | |
| HY-P82711 | Tight Junction Protein ZO 3 Antibody (YA2456) | Antibodies | |
| HY-P82712 | ALK-1 Antibody (YA2457) | Antibodies | |
| HY-P82713 | MAG Antibody (YA2458) | Antibodies | |
| HY-P82714 | ZYX Antibody (YA2459) | Antibodies | |
| HY-P82715 | Butyrylcholinesterase Antibody (YA2460) | Antibodies | |
| HY-P82716 | Protein C Antibody (YA2461) | Antibodies | |
| HY-P82717 | ATP1A3 Antibody (YA2462) | Antibodies | |
| HY-P82718 | IRF7 Antibody (YA2463) | Antibodies | |
| HY-P82719 | Dynamin 2 Antibody (YA2464) | Antibodies | |
| HY-P82720 | Surfeit Locus Protein 4 Antibody (YA2465) | Antibodies | |
| HY-P82721 | JAK3 Antibody (YA2466) | Antibodies | |
| HY-P82722 | CRABP1 Antibody (YA2467) | Antibodies | |
| HY-P82723 | ATG4B Antibody (YA2468) | Antibodies | |
| HY-P82723A | ATG4B Antibody (YA2468) | Antibodies | |
| HY-P82724 | Legumain Antibody (YA2469) | Antibodies | |
| HY-P82725 | DDX39B Antibody (YA2470) | Antibodies | |
| HY-P82726 | Tissue Factor Antibody (YA2471) | Antibodies | |
| HY-P82727 | NR5A2 Antibody (YA2472) | Antibodies | |
| HY-P82728 | Renalase Antibody (YA2473) | Antibodies | |
| HY-P82729 | CDT2 Antibody (YA2474) | Antibodies | |
| HY-P82730 | PIAS1/2 Antibody (YA2475) | Antibodies | |
| HY-P82731 | Actin Regulatory Protein CAPG Antibody (YA2476) | Antibodies | |
| HY-P82732 | CECR5 Antibody (YA2477) | Antibodies | |
| HY-P82733 | SF3A3 Antibody (YA2478) | Antibodies | |
| HY-P82734 | EAAT1 Antibody (YA2479) | Antibodies | |
| HY-P82735 | CELF2 Antibody (YA2480) | Antibodies | |
| HY-P82736 | RYK Antibody (YA2481) | Antibodies | |
| HY-P82737 | EAAT2 Antibody (YA2482) | Antibodies | |
| HY-P82738 | CENPE Antibody (YA2483) | Antibodies | |
| HY-P82739 | hnRNP A1 Antibody (YA2484) | Antibodies | |
| HY-P82740 | ACAP2 Antibody (YA2485) | Antibodies | |
| HY-P82741 | Carboxypeptidase A1/A2/B Antibody (YA2486) | Antibodies | |
| HY-P82742 | CGBP Antibody (YA2487) | Antibodies | |
| HY-P82743 | Involucrin Antibody (YA2488) | Antibodies | |
| HY-P82744 | DDX17 Antibody (YA2489) | Antibodies | |
| HY-P82745 | CBX4 Antibody (YA2490) | Antibodies | |
| HY-P82746 | GDNF Antibody (YA2491) | Antibodies | |
| HY-P82747 | NAP1L1 Antibody (YA2492) | Antibodies | |
| HY-P82748 | Leptin Receptor Antibody (YA2493) | Antibodies | |
| HY-P82749 | ETS1 Antibody (YA2494) | Antibodies | |
| HY-P82750 | alpha A Crystallin Antibody (YA2495) | Antibodies | |
| HY-P82751 | Chromogranin A Antibody (YA2496) | Antibodies | |
| HY-P82752 | CRMP5 Antibody (YA2497) | Antibodies | |
| HY-P82753 | Phospho-KIF22 (Ser427) Antibody (YA2498) | Antibodies | |
| HY-P82754 | GATA3 Antibody (YA2499) | Antibodies | |
| HY-P82755 | cIAP1 Antibody (YA2500) | Antibodies | |
| HY-P82756 | ZBTB7A Antibody (YA2501) | Antibodies | |
| HY-P82757 | PIM1 Antibody (YA2502) | Antibodies | |
| HY-P82758 | CIP4 Antibody (YA2503) | Antibodies | |
| HY-P82759 | NDUFB1 Antibody (YA2504) | Antibodies | |
| HY-P82760 | PAF1 Antibody (YA2505) | Antibodies | |
| HY-P82761 | CIRBP Antibody (YA2506) | Antibodies | |
| HY-P82762 | IFRD1 Antibody (YA2507) | Antibodies | |
| HY-P82763 | Calcineurin A Antibody (YA2508) | Antibodies | |
| HY-P82764 | EBP1 Antibody (YA2509) | Antibodies | |
| HY-P82765 | NEDD4 Antibody (YA2510) | Antibodies | |
| HY-P82766 | CD26 Antibody (YA2511) | Antibodies | |
| HY-P82767 | Claudin 3 Antibody (YA2512) | Antibodies | |
| HY-P82768 | OR1A1 Antibody (YA2513) | Antibodies | |
| HY-P82769 | Toll-Like Receptor 7 Antibody (YA2514) | Antibodies | |
| HY-P82770 | VAV3 Antibody (YA2515) | Antibodies | |
| HY-P82771 | FIG4 Antibody (YA2516) | Antibodies | |
| HY-P82772 | CLIC4 Antibody (YA2517) | Antibodies | |
| HY-P82773 | Ly6A/E Antibody (YA2518) | Antibodies | |
| HY-P82774 | GRP94 Antibody (YA2519) | Antibodies | |
| HY-P82775 | RBM43 Antibody (YA2520) | Antibodies | |
| HY-P82776 | CLPTM1 Antibody (YA2521) | Antibodies | |
| HY-P82777 | Tyrosinase Antibody (YA2522) | Antibodies | |
| HY-P82778 | CAD Antibody (YA2523) | Antibodies | |
| HY-P82779 | Elongation Factor Ts Antibody (YA2524) | Antibodies | |
| HY-P82780 | Clusterin alpha Chain Antibody (YA2525) | Antibodies | |
| HY-P82781 | Syndecan 1 Antibody (YA2526) | Antibodies | |
| HY-P82782 | Neurogenin 2 Antibody (YA2527) | Antibodies | |
| HY-P82783 | SF20 Antibody (YA2528) | Antibodies | |
| HY-P82784 | Neurofilament Medium Antibody (YA2529) | Antibodies | |
| HY-P82785 | COG6 Antibody (YA2530) | Antibodies | |
| HY-P82786 | LGR6 Antibody (YA2531) | Antibodies | |
| HY-P82787 | Coilin Antibody (YA2532) | Antibodies | |
| HY-P82788 | Collagen VI alpha 1 Antibody (YA2533) | Antibodies | |
| HY-P82789 | Cytokeratin 17 Antibody (YA2534) | Antibodies | |
| HY-P82790 | NDUFS1 Antibody (YA2535) | Antibodies | |
| HY-P82791 | KDM4B Antibody (YA2536) | Antibodies | |
| HY-P82792 | Cyclooxygenase 1 Antibody (YA2537) | Antibodies | |
| HY-P82793 | Perilipin 1 Antibody (YA2538) | Antibodies | |
| HY-P82794 | WAS Antibody (YA2539) | Antibodies | |
| HY-P82795 | PACSIN3 Antibody (YA2540) | Antibodies | |
| HY-P82796 | Cyclooxygenase 2 Antibody (YA2541) | Antibodies | |
| HY-P82797 | IP10 Antibody (YA2542) | Antibodies | |
| HY-P82798 | Kaiso Antibody (YA2543) | Antibodies | |
| HY-P82799 | NUP62CL Antibody (YA2544) | Antibodies | |
| HY-P82800 | Haptoglobin Antibody (YA2545) | Antibodies | |
| HY-P82801 | RASGRP1 Antibody (YA2546) | Antibodies | |
| HY-P82802 | Cathepsin L/V/K/H Antibody (YA2547) | Antibodies | |
| HY-P82803 | E1B AP5 Antibody (YA2548) | Antibodies | |
| HY-P82804 | BHMT Antibody (YA2549) | Antibodies | |
| HY-P82805 | COX5B Antibody (YA2550) | Antibodies | |
| HY-P82806 | SMC3 Antibody (YA2551) | Antibodies | |
| HY-P82807 | TRIM29 Antibody (YA2552) | Antibodies | |
| HY-P82808 | NOXA Antibody (YA2553) | Antibodies | |
| HY-P82809 | CPSF6 Antibody (YA2554) | Antibodies | |
| HY-P82810 | BMP7 Antibody (YA2555) | Antibodies | |
| HY-P82811 | Poliovirus Receptor Antibody (YA2556) | Antibodies | |
| HY-P82812 | Notch4 Antibody (YA2557) | Antibodies | |
| HY-P82813 | Salivary alpha Amylase Antibody (YA2558) | Antibodies | |
| HY-P82814 | CCL4 beta Antibody (YA2559) | Antibodies | |
| HY-P82815 | BCAR1 Antibody (YA2560) | Antibodies | |
| HY-P82816 | HOXA13 Antibody (YA2561) | Antibodies | |
| HY-P82817 | VPS24 Antibody (YA2562) | Antibodies | |
| HY-P82818 | CRMP3 Antibody (YA2563) | Antibodies | |
| HY-P82819 | Fetal Hemoglobin Antibody (YA2564) | Antibodies | |
| HY-P82820 | CSHL1 Antibody (YA2565) | Antibodies | |
| HY-P82821 | ApoB Antibody (YA2566) | Antibodies | |
| HY-P82822 | Lysosome Membrane Protein 2 Antibody (YA2567) | Antibodies | |
| HY-P82823 | Phospho-Amyloid Precursor Protein (Thr743) Antibody (YA2568) | Antibodies | |
| HY-P82824 | MAGOH Antibody (YA2569) | Antibodies | |
| HY-P82825 | CTCF Antibody (YA2570) | Antibodies | |
| HY-P82826 | SMCHD1 Antibody (YA2571) | Antibodies | |
| HY-P82827 | Phospho-CDK1/2 (Thr14) Antibody (YA2572) | Antibodies | |
| HY-P82828 | Thyroid Hormone Receptor alpha Antibody (YA2573) | Antibodies | |
| HY-P82829 | CTP Synthase Antibody (YA2574) | Antibodies | |
| HY-P82830 | NCF1 Antibody (YA2575) | Antibodies | |
| HY-P82831 | TP53BP2 Antibody (YA2576) | Antibodies | |
| HY-P82832 | CrkL Antibody (YA2577) | Antibodies | |
| HY-P82833 | Cullin 3 Antibody (YA2578) | Antibodies | |
| HY-P82834 | Phospho-E Cadherin (Ser838/Ser840) Antibody (YA2579) | Antibodies | |
| HY-P82835 | ApoM Antibody (YA2580) | Antibodies | |
| HY-P82836 | Phospho-Elongation Factor 2 (Thr56/Thr58) Antibody (YA2581) | Antibodies | |
| HY-P82837 | Collagen X alpha 1 Antibody (YA2582) | Antibodies | |
| HY-P82838 | Cullin 4A/4B Antibody (YA2583) | Antibodies | |
| HY-P82839 | ApoD Antibody (YA2584) | Antibodies | |
| HY-P82840 | Cullin 5 Antibody (YA2585) | Antibodies | |
| HY-P82841 | PUM2 Antibody (YA2586) | Antibodies | |
| HY-P82842 | CYB5R3 Antibody (YA2587) | Antibodies | |
| HY-P82843 | DcR2 Antibody (YA2588) | Antibodies | |
| HY-P82844 | TIRAP Antibody (YA2589) | Antibodies | |
| HY-P82845 | Phospho-Filamin A/B (Ser2152/Ser2107) Antibody (YA2590) | Antibodies | |
| HY-P82846 | hHR23A Antibody (YA2591) | Antibodies | |
| HY-P82847 | ApoA4 Antibody (YA2592) | Antibodies | |
| HY-P82848 | Phospho-GATA3 (Ser308) Antibody (YA2593) | Antibodies | |
| HY-P82849 | Cyclin E2 Antibody (YA2594) | Antibodies | |
| HY-P82850 | Phospho-Glucocorticoid Receptor (Ser226) Antibody (YA2595) | Antibodies | |
| HY-P82851 | CITED2 Antibody (YA2596) | Antibodies | |
| HY-P82852 | PAX5 Antibody (YA2597) | Antibodies | |
| HY-P82853 | Uracil DNA Glycosylase Antibody (YA2598) | Antibodies | |
| HY-P82854 | Phospho-Hormone Sensitive Lipase (Ser855) Antibody (YA2599) | Antibodies | |
| HY-P82855 | Cyclin T1 Antibody (YA2600) | Antibodies | |
| HY-P82856 | MBNL1 Antibody (YA2601) | Antibodies | |
| HY-P82857 | Cyclophilin F Antibody (YA2602) | Antibodies | |
| HY-P82858 | PAR4 Antibody (YA2603) | Antibodies | |
| HY-P82859 | Phospho-Rac1/CDC42 (Ser71) Antibody (YA2604) | Antibodies | |
| HY-P82860 | CYFIP1 Antibody (YA2605) | Antibodies | |
| HY-P82861 | Phospho-Jun/JunD (Ser73/Ser100) Antibody (YA2606) | Antibodies | |
| HY-P82862 | Adenosine Deaminase Antibody (YA2607) | Antibodies | |
| HY-P82863 | Hsp47 Antibody (YA2608) | Antibodies | |
| HY-P82864 | CDCA5 Antibody (YA2609) | Antibodies | |
| HY-P82865 | Muscarinic Acetylcholine Receptor M2 Antibody (YA2610) | Antibodies | |
| HY-P82866 | Cytochrome C Oxidase subunit Vic Antibody (YA2611) | Antibodies | |
| HY-P82867 | HLA B Antibody (YA2612) | Antibodies | |
| HY-P82868 | Hsp110 Antibody (YA2613) | Antibodies | |
| HY-P82869 | Phospho-Moesin (Thr558) Antibody (YA2614) | Antibodies | |
| HY-P82870 | CARD11 Antibody (YA2615) | Antibodies | |
| HY-P82871 | Nicotinic Acetylcholine Receptor alpha 4 Antibody (YA2616) | Antibodies | |
| HY-P82872 | HspB8 Antibody (YA2617) | Antibodies | |
| HY-P82873 | Phospho-NDRG1 (Ser330) Antibody (YA2618) | Antibodies | |
| HY-P82874 | Cytochrome P450 Reductase Antibody (YA2619) | Antibodies | |
| HY-P82875 | Syntaxin Binding Protein 1 Antibody (YA2620) | Antibodies | |
| HY-P82876 | SUMO4 Antibody (YA2621) | Antibodies | |
| HY-P82877 | Phospho-Nucleophosmin (Thr199) Antibody (YA2622) | Antibodies | |
| HY-P82878 | ITCH Antibody (YA2623) | Antibodies | |
| HY-P82879 | CDC25C Antibody (YA2624) | Antibodies | |
| HY-P82880 | Hsp75 Antibody (YA2625) | Antibodies | |
| HY-P82881 | CDC6 Antibody (YA2626) | Antibodies | |
| HY-P82882 | VEGFB Antibody (YA2627) | Antibodies | |
| HY-P82883 | Phospho-PKC delta (Ser299) Antibody (YA2628) | Antibodies | |
| HY-P82884 | 14-3-3 epsilon Antibody (YA2629) | Antibodies | |
| HY-P82885 | EDD Antibody (YA2630) | Antibodies | |
| HY-P82886 | Phospho-PKC zeta/lambda (Thr410/Thr412) Antibody (YA2631) | Antibodies | |
| HY-P82887 | Phospho-PML Protein (Ser518) Antibody (YA2632) | Antibodies | |
| HY-P82888 | MEKK3 Antibody (YA2633) | Antibodies | |
| HY-P82889 | GGT1 Antibody (YA2634) | Antibodies | |
| HY-P82890 | Phospho-Cytokeratin 8 (Ser23) Antibody (YA2635) | Antibodies | |
| HY-P82891 | Phospho-PTS (Ser19) Antibody (YA2636) | Antibodies | |
| HY-P82892 | Collagen VI alpha 1/2/3 Antibody (YA2637) | Antibodies | |
| HY-P82893 | D4 GDI Antibody (YA2638) | Antibodies | |
| HY-P82894 | SLAMF1 Antibody (YA2639) | Antibodies | |
| HY-P82895 | Phospho-Rad17 (Ser656) Antibody (YA2640) | Antibodies | |
| HY-P82896 | DAP1 Antibody (YA2641) | Antibodies | |
| HY-P82897 | RCC1 Antibody (YA2642) | Antibodies | |
| HY-P82898 | DAPK2 Antibody (YA2643) | Antibodies | |
| HY-P82899 | DARPP32 Antibody (YA2644) | Antibodies | |
| HY-P82900 | IL-17 Receptor A Antibody (YA2645) | Antibodies | |
| HY-P82901 | DAZAP1 Antibody (YA2646) | Antibodies | |
| HY-P82902 | MEK7 Antibody (YA2647) | Antibodies | |
| HY-P82903 | NR2E1 Antibody (YA2648) | Antibodies | |
| HY-P82904 | Pannexin 1 Antibody (YA2649) | Antibodies | |
| HY-P82905 | ADAM15 Antibody (YA2650) | Antibodies | |
| HY-P82906 | ATF7 Antibody (YA2651) | Antibodies | |
| HY-P82907 | DBF4 Antibody (YA2652) | Antibodies | |
| HY-P82908 | KIF4A Antibody (YA2653) | Antibodies | |
| HY-P82909 | 14-3-3 sigma Antibody (YA2654) | Antibodies | |
| HY-P82910 | DCAMKL1 Antibody (YA2655) | Antibodies | |
| HY-P82911 | Phospho-Src (Tyr530) Antibody (YA2656) | Antibodies | |
| HY-P82912 | Ephrin A1 Antibody (YA2657) | Antibodies | |
| HY-P82913 | DCI Antibody (YA2658) | Antibodies | |
| HY-P82914 | Nicotinic Acetylcholine Receptor alpha 5 Antibody (YA2659) | Antibodies | |
| HY-P82915 | Phospho-TAOK1/2/3 (Ser181/Ser181/Ser177) Antibody (YA2660) | Antibodies | |
| HY-P82916 | DDAH1 Antibody (YA2661) | Antibodies | |
| HY-P82917 | IRF6 Antibody (YA2662) | Antibodies | |
| HY-P82918 | DDX21 Antibody (YA2663) | Antibodies | |
| HY-P82919 | WIF1 Antibody (YA2664) | Antibodies | |
| HY-P82920 | Cytokeratin 1 Antibody (YA2665) | Antibodies | |
| HY-P82921 | DDX5 Antibody (YA2666) | Antibodies | |
| HY-P82922 | CTRL Antibody (YA2667) | Antibodies | |
| HY-P82923 | 14-3-3 gamma Antibody (YA2668) | Antibodies | |
| HY-P82924 | Glucose Transporter GLUT2 Antibody (YA2669) | Antibodies | |
| HY-P82925 | Thromboxane A Synthase Antibody (YA2670) | Antibodies | |
| HY-P82926 | Cytokeratin 2e Antibody (YA2671) | Antibodies | |
| HY-P82927 | FGF19 Antibody (YA2672) | Antibodies | |
| HY-P82928 | A RAF Antibody (YA2673) | Antibodies | |
| HY-P82929 | E2F2 Antibody (YA2674) | Antibodies | |
| HY-P82930 | AKR1C1/AKR1C2 Antibody (YA2675) | Antibodies | |
| HY-P82931 | CD266 Antibody (YA2676) | Antibodies | |
| HY-P82932 | FHIT Antibody (YA2677) | Antibodies | |
| HY-P82933 | Gemin 3 Antibody (YA2678) | Antibodies | |
| HY-P82934 | Phospho-PKC zeta (Thr560) Antibody (YA2679) | Antibodies | |
| HY-P82935 | DGCR8 Antibody (YA2680) | Antibodies | |
| HY-P82936 | FOXF1 Antibody (YA2681) | Antibodies | |
| HY-P82937 | MMP11 Antibody (YA2682) | Antibodies | |
| HY-P82938 | PSAP Antibody (YA2683) | Antibodies | |
| HY-P82939 | ACTL6A Antibody (YA2684) | Antibodies | |
| HY-P82940 | RuvB Like 1 Antibody (YA2685) | Antibodies | |
| HY-P82941 | ACTR1B Antibody (YA2686) | Antibodies | |
| HY-P82942 | HOXB4 Antibody (YA2687) | Antibodies | |
| HY-P82943 | Phospho-Dishevelled 2 (Ser143) Antibody (YA2688) | Antibodies | |
| HY-P82944 | ADK Antibody (YA2689) | Antibodies | |
| HY-P82945 | Stanniocalcin 1 Antibody (YA2690) | Antibodies | |
| HY-P82946 | AK2 Antibody (YA2691) | Antibodies | |
| HY-P82947 | EBI3 Antibody (YA2692) | Antibodies | |
| HY-P82948 | AK3L1 Antibody (YA2693) | Antibodies | |
| HY-P82949 | Phospholipase C beta 3 Antibody (YA2694) | Antibodies | |
| HY-P82950 | Cytokeratin 13 Antibody (YA2695) | Antibodies | |
| HY-P82951 | AKAP95 Antibody (YA2696) | Antibodies | |
| HY-P82952 | DLX4 Antibody (YA2697) | Antibodies | |
| HY-P82953 | LHX3 Antibody (YA2698) | Antibodies | |
| HY-P82954 | DNA Ligase IV Antibody (YA2699) | Antibodies | |
| HY-P82955 | Adiponectin Receptor 1 Antibody (YA2700) | Antibodies | |
| HY-P82956 | HRH3 Antibody (YA2701) | Antibodies | |
| HY-P82957 | DNAJA4 Antibody (YA2702) | Antibodies | |
| HY-P82958 | FLAP Antibody (YA2703) | Antibodies | |
| HY-P82959 | DNAJB6 Antibody (YA2704) | Antibodies | |
| HY-P82960 | GRIK2 Antibody (YA2705) | Antibodies | |
| HY-P82961 | DKK1 Antibody (YA2706) | Antibodies | |
| HY-P82962 | AMSH Antibody (YA2707) | Antibodies | |
| HY-P82963 | MCM4 Antibody (YA2708) | Antibodies | |
| HY-P82964 | MYL2 Antibody (YA2709) | Antibodies | |
| HY-P82965 | DOCK2 Antibody (YA2710) | Antibodies | |
| HY-P82966 | Annexin 2 Antibody (YA2711) | Antibodies | |
| HY-P82967 | ABCF1 Antibody (YA2712) | Antibodies | |
| HY-P82968 | DOCK8 Antibody (YA2713) | Antibodies | |
| HY-P82969 | Annexin 4 Antibody (YA2714) | Antibodies | |
| HY-P82970 | CPT2 Antibody (YA2715) | Antibodies | |
| HY-P82971 | Rad52 Antibody (YA2716) | Antibodies | |
| HY-P82972 | DOHH Antibody (YA2717) | Antibodies | |
| HY-P82973 | FRA2 Antibody (YA2718) | Antibodies | |
| HY-P82974 | Cardiac Troponin T Antibody (YA2719) | Antibodies | |
| HY-P82975 | Phospho-RPA2 (Thr21) Antibody (YA2720) | Antibodies | |
| HY-P82976 | DPS1 Antibody (YA2721) | Antibodies | |
| HY-P82977 | APLP2 Antibody (YA2722) | Antibodies | |
| HY-P82978 | ZNF217 Antibody (YA2723) | Antibodies | |
| HY-P82979 | DYNLL1 Antibody (YA2724) | Antibodies | |
| HY-P82980 | Actin Related Protein 2 Antibody (YA2725) | Antibodies | |
| HY-P82981 | Olig1 Antibody (YA2726) | Antibodies | |
| HY-P82982 | Renin Antibody (YA2727) | Antibodies | |
| HY-P82983 | E2F4 Antibody (YA2728) | Antibodies | |
| HY-P82984 | Kallikrein 2 Antibody (YA2729) | Antibodies | |
| HY-P82985 | PIAS2 Antibody (YA2730) | Antibodies | |
| HY-P82986 | SAP97 Antibody (YA2731) | Antibodies | |
| HY-P82987 | ApoA Antibody (YA2732) | Antibodies | |
| HY-P82988 | BAP1 Antibody (YA2733) | Antibodies | |
| HY-P82989 | Ubiquitin Conjugating Enzyme E2 C Antibody (YA2734) | Antibodies | |
| HY-P82990 | BarX1 Antibody (YA2735) | Antibodies | |
| HY-P82991 | M6PR Antibody (YA2736) | Antibodies | |
| HY-P82992 | BCKDK Antibody (YA2737) | Antibodies | |
| HY-P82993 | MUC13 Antibody (YA2738) | Antibodies | |
| HY-P82994 | SESN1 Antibody (YA2739) | Antibodies | |
| HY-P82995 | Bcl2 L14 Antibody (YA2740) | Antibodies | |
| HY-P82996 | BGAT Antibody (YA2741) | Antibodies | |
| HY-P82997 | CSK Antibody (YA2742) | Antibodies | |
| HY-P82998 | Bcl2 A1 Antibody (YA2743) | Antibodies | |
| HY-P82999 | MADCAM1 Antibody (YA2744) | Antibodies | |
| HY-P83000 | eIF3B Antibody (YA2745) | Antibodies | |
| HY-P83001 | Bcr Antibody (YA2746) | Antibodies | |
| HY-P83002 | GOLPH2 Antibody (YA2747) | Antibodies | |
| HY-P83003 | DNAJA1 Antibody (YA2748) | Antibodies | |
| HY-P83004 | Tryptophan 5 Hydroxylase 1 Antibody (YA2749) | Antibodies | |
| HY-P83005 | PIM2 Antibody (YA2750) | Antibodies | |
| HY-P83006 | beta Dystroglycan Antibody (YA2751) | Antibodies | |
| HY-P83007 | Hippocalcin Antibody (YA2752) | Antibodies | |
| HY-P83008 | IL-12 beta Antibody (YA2753) | Antibodies | |
| HY-P83009 | PLTP Antibody (YA2754) | Antibodies | |
| HY-P83010 | RPS3 Antibody (YA2755) | Antibodies | |
| HY-P83011 | PR3 Antibody (YA2756) | Antibodies | |
| HY-P83012 | BUBR1 Antibody (YA2757) | Antibodies | |
| HY-P83013 | ELK1 Antibody (YA2758) | Antibodies | |
| HY-P83014 | Collagen XVII alpha 1 Antibody (YA2759) | Antibodies | |
| HY-P83015 | Cystatin A Antibody (YA2760) | Antibodies | |
| HY-P83016 | CAB39 Antibody (YA2761) | Antibodies | |
| HY-P83017 | Dynactin Subunit 3 Antibody (YA2762) | Antibodies | |
| HY-P83018 | EMAP II Antibody (YA2763) | Antibodies | |
| HY-P83019 | Cadherin 10 Antibody (YA2764) | Antibodies | |
| HY-P83020 | Emerin Antibody (YA2765) | Antibodies | |
| HY-P83021 | DP1 Antibody (YA2766) | Antibodies | |
| HY-P83022 | GATA2/3 Antibody (YA2767) | Antibodies | |
| HY-P83023 | ENO3 Antibody (YA2768) | Antibodies | |
| HY-P83024 | KIFAP3 Antibody (YA2769) | Antibodies | |
| HY-P83025 | ENSA Antibody (YA2770) | Antibodies | |
| HY-P83026 | Tropomodulin 2 Antibody (YA2771) | Antibodies | |
| HY-P83027 | Cleaved-Caspase 2 Antibody (YA2772) | Antibodies | |
| HY-P83028 | CDC123 Antibody (YA2773) | Antibodies | |
| HY-P83029 | p75 NGF Receptor Antibody (YA2774) | Antibodies | |
| HY-P83030 | CCL21 Antibody (YA2775) | Antibodies | |
| HY-P83031 | EPS15R Antibody (YA2776) | Antibodies | |
| HY-P83032 | CRMP4 Antibody (YA2777) | Antibodies | |
| HY-P83033 | Epsin 1 Antibody (YA2778) | Antibodies | |
| HY-P83034 | CD229 Antibody (YA2779) | Antibodies | |
| HY-P83035 | Inhibin beta A Antibody (YA2780) | Antibodies | |
| HY-P83036 | ETAA1 Antibody (YA2781) | Antibodies | |
| HY-P83037 | HIRA Antibody (YA2782) | Antibodies | |
| HY-P83038 | DNA Polymerase gamma Antibody (YA2783) | Antibodies | |
| HY-P83039 | ESE1 Antibody (YA2784) | Antibodies | |
| HY-P83040 | XPO4 Antibody (YA2785) | Antibodies | |
| HY-P83041 | CDC34 Antibody (YA2786) | Antibodies | |
| HY-P83042 | Extracellular Matrix Protein 1 Antibody (YA2787) | Antibodies | |
| HY-P83043 | FABP2 Antibody (YA2788) | Antibodies | |
| HY-P83044 | PIK3C3 Antibody (YA2789) | Antibodies | |
| HY-P83045 | CHX10 Antibody (YA2790) | Antibodies | |
| HY-P83046 | Factor D Antibody (YA2791) | Antibodies | |
| HY-P83047 | NAIP Antibody (YA2792) | Antibodies | |
| HY-P83048 | FADD Antibody (YA2793) | Antibodies | |
| HY-P83049 | Transcription Factor 7 Like 1 Antibody (YA2794) | Antibodies | |
| HY-P83050 | Activin Receptor Type IIA Antibody (YA2795) | Antibodies | |
| HY-P83051 | HTR7 Antibody (YA2796) | Antibodies | |
| HY-P83052 | CEP55 Antibody (YA2797) | Antibodies | |
| HY-P83053 | DAP Kinase 1 Antibody (YA2798) | Antibodies | |
| HY-P83054 | FAM50A Antibody (YA2799) | Antibodies | |
| HY-P83055 | Somatostatin Receptor 5 Antibody (YA2800) | Antibodies | |
| HY-P83056 | FAM98B Antibody (YA2801) | Antibodies | |
| HY-P83057 | Citrate Synthetase Antibody (YA2802) | Antibodies | |
| HY-P83058 | FKBP38 Antibody (YA2803) | Antibodies | |
| HY-P83059 | FANCB Antibody (YA2804) | Antibodies | |
| HY-P83060 | HAPLN1 Antibody (YA2805) | Antibodies | |
| HY-P83061 | CUG BP1 Antibody (YA2806) | Antibodies | |
| HY-P83062 | CLIC1 Antibody (YA2807) | Antibodies | |
| HY-P83063 | TRAF4 Antibody (YA2808) | Antibodies | |
| HY-P83064 | Transcription Factor 4 Antibody (YA2809) | Antibodies | |
| HY-P83065 | CLIP170 Antibody (YA2810) | Antibodies | |
| HY-P83066 | UCHL3 Antibody (YA2811) | Antibodies | |
| HY-P83067 | KDM2A Antibody (YA2812) | Antibodies | |
| HY-P83068 | Oncostatin M Antibody (YA2813) | Antibodies | |
| HY-P83069 | CLPX Antibody (YA2814) | Antibodies | |
| HY-P83070 | Musashi 1 Antibody (YA2815) | Antibodies | |
| HY-P83071 | GLB1 Antibody (YA2816) | Antibodies | |
| HY-P83072 | FDPS Antibody (YA2817) | Antibodies | |
| HY-P83073 | PAX2 Antibody (YA2818) | Antibodies | |
| HY-P83074 | RhoGAP Antibody (YA2819) | Antibodies | |
| HY-P83075 | FES Antibody (YA2820) | Antibodies | |
| HY-P83076 | LRRK2 Antibody (YA2821) | Antibodies | |
| HY-P83076A | Phospho-LRRK2(Ser935) Antibody | Recombinant Proteins | |
| HY-P83077 | Cofilin Antibody (YA2822) | Antibodies | |
| HY-P83078 | PI 3 Kinase p150 Antibody (YA2823) | Antibodies | |
| HY-P83079 | Fetuin A Antibody (YA2824) | Antibodies | |
| HY-P83080 | TRAM2 Antibody (YA2825) | Antibodies | |
| HY-P83081 | eIF3E Antibody (YA2826) | Antibodies | |
| HY-P83082 | SPAK Antibody (YA2827) | Antibodies | |
| HY-P83083 | CSDE1 Antibody (YA2828) | Antibodies | |
| HY-P83084 | Melanocyte Protein PMEL Antibody (YA2829) | Antibodies | |
| HY-P83085 | SLC22A3 Antibody (YA2830) | Antibodies | |
| HY-P83086 | Fibulin 1 Antibody (YA2831) | Antibodies | |
| HY-P83087 | SHIP1 Antibody (YA2832) | Antibodies | |
| HY-P83088 | CSNK2A1 Antibody (YA2833) | Antibodies | |
| HY-P83089 | Phospholipase A2 Activator Protein Antibody (YA2834) | Antibodies | |
| HY-P83090 | CTBP2 Antibody (YA2835) | Antibodies | |
| HY-P83091 | ARF5 Antibody (YA2836) | Antibodies | |
| HY-P83092 | FLI1 Antibody (YA2837) | Antibodies | |
| HY-P83093 | Phospho-Smad5 (Ser463/465) Antibody (YA2838) | Antibodies | |
| HY-P83094 | HMGN2 Antibody (YA2839) | Antibodies | |
| HY-P83095 | ABI2 Antibody (YA2840) | Antibodies | |
| HY-P83096 | FNTA Antibody (YA2841) | Antibodies | |
| HY-P83097 | ERG Antibody (YA2842) | Antibodies | |
| HY-P83098 | HLA F Antibody (YA2843) | Antibodies | |
| HY-P83099 | FNTB Antibody (YA2844) | Antibodies | |
| HY-P83100 | ID1 Antibody (YA2845) | Antibodies | |
| HY-P83101 | Neurocan Antibody (YA2846) | Antibodies | |
| HY-P83102 | Follistatin Antibody (YA2847) | Antibodies | |
| HY-P83103 | PYGO2 Antibody (YA2848) | Antibodies | |
| HY-P83104 | Cystatin B Antibody (YA2849) | Antibodies | |
| HY-P83105 | Aconitase 1 Antibody (YA2850) | Antibodies | |
| HY-P83106 | Cytokeratin 9 Antibody (YA2851) | Antibodies | |
| HY-P83107 | DAB2 Antibody (YA2852) | Antibodies | |
| HY-P83108 | beta Glucuronidase Antibody (YA2853) | Antibodies | |
| HY-P83109 | Daxx Antibody (YA2854) | Antibodies | |
| HY-P83110 | CHMP2B Antibody (YA2855) | Antibodies | |
| HY-P83111 | Phospho-PP2A alpha (Tyr307) Antibody (YA2856) | Antibodies | |
| HY-P83112 | MYH7B Antibody (YA2857) | Antibodies | |
| HY-P83113 | DENN Antibody (YA2858) | Antibodies | |
| HY-P83114 | RPL7A Antibody (YA2859) | Antibodies | |
| HY-P83115 | Fragilis Antibody (YA2860) | Antibodies | |
| HY-P83116 | DGKA Antibody (YA2861) | Antibodies | |
| HY-P83117 | GOT2 Antibody (YA2862) | Antibodies | |
| HY-P83118 | FRAT1 Antibody (YA2863) | Antibodies | |
| HY-P83119 | LCAT Antibody (YA2864) | Antibodies | |
| HY-P83120 | TNFRSF19 Antibody (YA2865) | Antibodies | |
| HY-P83121 | Cubilin Antibody (YA2866) | Antibodies | |
| HY-P83122 | DLX3 Antibody (YA2867) | Antibodies | |
| HY-P83123 | DOK1 Antibody (YA2868) | Antibodies | |
| HY-P83124 | Caveolin 3 Antibody (YA2869) | Antibodies | |
| HY-P83125 | DNAJC12 Antibody (YA2870) | Antibodies | |
| HY-P83126 | Kir2.1 Antibody (YA2871) | Antibodies | |
| HY-P83127 | GAA Antibody (YA2872) | Antibodies | |
| HY-P83128 | Desmoglein 1 Antibody (YA2873) | Antibodies | |
| HY-P83129 | DTYMK Antibody (YA2874) | Antibodies | |
| HY-P83130 | SNAP alpha Antibody (YA2875) | Antibodies | |
| HY-P83131 | LRP2 Antibody (YA2876) | Antibodies | |
| HY-P83132 | Ephrin Receptor B3 Antibody (YA2877) | Antibodies | |
| HY-P83133 | GNA13 Antibody (YA2878) | Antibodies | |
| HY-P83134 | Elongation Factor 1A2 Antibody (YA2879) | Antibodies | |
| HY-P83135 | RNF20 Antibody (YA2880) | Antibodies | |
| HY-P83136 | RACGAP1 Antibody (YA2881) | Antibodies | |
| HY-P83137 | GABARAPL2 Antibody (YA2882) | Antibodies | |
| HY-P83138 | EFEMP1 Antibody (YA2883) | Antibodies | |
| HY-P83139 | HDAC11 Antibody (YA2884) | Antibodies | |
| HY-P83140 | LGI1 Antibody (YA2885) | Antibodies | |
| HY-P83141 | Tat SF1 Antibody (YA2886) | Antibodies | |
| HY-P83142 | Entactin Antibody (YA2887) | Antibodies | |
| HY-P83143 | PEX19 Antibody (YA2888) | Antibodies | |
| HY-P83144 | Kallikrein 5 Antibody (YA2889) | Antibodies | |
| HY-P83145 | PKN2 Antibody (YA2890) | Antibodies | |
| HY-P83146 | GAP43 Antibody (YA2891) | Antibodies | |
| HY-P83147 | Ephrin Receptor B4 Antibody (YA2892) | Antibodies | |
| HY-P83148 | Arginase 2 Antibody (YA2893) | Antibodies | |
| HY-P83149 | C10orf63 Antibody (YA2894) | Antibodies | |
| HY-P83150 | Epoxide Hydrolase 1 Antibody (YA2895) | Antibodies | |
| HY-P83151 | SETD7 Antibody (YA2896) | Antibodies | |
| HY-P83152 | VPS28 Antibody (YA2897) | Antibodies | |
| HY-P83153 | GCLC Antibody (YA2898) | Antibodies | |
| HY-P83154 | Glycerol Kinase Antibody (YA2899) | Antibodies | |
| HY-P83155 | KAT2A Antibody (YA2900) | Antibodies | |
| HY-P83156 | ERCC8 Antibody (YA2901) | Antibodies | |
| HY-P83157 | PTBP2 Antibody (YA2902) | Antibodies | |
| HY-P83158 | GDF15 Antibody (YA2903) | Antibodies | |
| HY-P83159 | SPT5 Antibody (YA2904) | Antibodies | |
| HY-P83160 | EYA2 Antibody (YA2905) | Antibodies | |
| HY-P83161 | Gemin 2 Antibody (YA2906) | Antibodies | |
| HY-P83162 | HOXA5 Antibody (YA2907) | Antibodies | |
| HY-P83163 | GEN1 Antibody (YA2908) | Antibodies | |
| HY-P83164 | HOXA9 Antibody (YA2909) | Antibodies | |
| HY-P83165 | FADS1 Antibody (YA2910) | Antibodies | |
| HY-P83166 | IL-32 Antibody (YA2911) | Antibodies | |
| HY-P83167 | GFPT1 Antibody (YA2912) | Antibodies | |
| HY-P83168 | ANPR B Antibody (YA2913) | Antibodies | |
| HY-P83169 | GFPT2 Antibody (YA2914) | Antibodies | |
| HY-P83170 | Plectin Antibody (YA2915) | Antibodies | |
| HY-P83171 | ETV6 Antibody (YA2916) | Antibodies | |
| HY-P83172 | GNE Antibody (YA2917) | Antibodies | |
| HY-P83173 | PLA2G2A Antibody (YA2918) | Antibodies | |
| HY-P83174 | Protein S Antibody (YA2919) | Antibodies | |
| HY-P83175 | FKBP6 Antibody (YA2920) | Antibodies | |
| HY-P83176 | TACC3 Antibody (YA2921) | Antibodies | |
| HY-P83177 | Glucose Transporter GLUT3 Antibody (YA2922) | Antibodies | |
| HY-P83178 | CCL19 beta Antibody (YA2923) | Antibodies | |
| HY-P83179 | WDR4 Antibody (YA2924) | Antibodies | |
| HY-P83180 | GALT Antibody (YA2925) | Antibodies | |
| HY-P83181 | MAT2A Antibody (YA2926) | Antibodies | |
| HY-P83182 | PCBP1 Antibody (YA2927) | Antibodies | |
| HY-P83183 | Glutathione S Transferase mu 1 Antibody (YA2928) | Antibodies | |
| HY-P83184 | CCL23 Antibody (YA2929) | Antibodies | |
| HY-P83185 | GBP1 Antibody (YA2930) | Antibodies | |
| HY-P83186 | PRSS2 Antibody (YA2931) | Antibodies | |
| HY-P83187 | PDE4B Antibody (YA2932) | Antibodies | |
| HY-P83188 | Talin 2 Antibody (YA2933) | Antibodies | |
| HY-P83189 | ATP1A2 Antibody (YA2934) | Antibodies | |
| HY-P83190 | Torsin 1A Antibody (YA2935) | Antibodies | |
| HY-P83191 | GlyT2 Antibody (YA2936) | Antibodies | |
| HY-P83192 | Guanylyl Cyclase alpha 1 Antibody (YA2937) | Antibodies | |
| HY-P83193 | GNAQ Antibody (YA2938) | Antibodies | |
| HY-P83194 | NLK Antibody (YA2939) | Antibodies | |
| HY-P83195 | HLA A Antibody (YA2940) | Antibodies | |
| HY-P83196 | Jagged 2 Antibody (YA2941) | Antibodies | |
| HY-P83197 | GMEB1 Antibody (YA2942) | Antibodies | |
| HY-P83198 | ACVR1 Antibody (YA2943) | Antibodies | |
| HY-P83199 | GNAI2 Antibody (YA2944) | Antibodies | |
| HY-P83200 | GNB3 Antibody (YA2945) | Antibodies | |
| HY-P83201 | Monoacylglycerol Lipase Antibody (YA2946) | Antibodies | |
| HY-P83202 | HspA12A Antibody (YA2947) | Antibodies | |
| HY-P83203 | GOLGA1 Antibody (YA2948) | Antibodies | |
| HY-P83204 | GRK2 Antibody (YA2949) | Antibodies | |
| HY-P83205 | Trefoil Factor 2 Antibody (YA2950) | Antibodies | |
| HY-P83206 | GPR37 Antibody (YA2951) | Antibodies | |
| HY-P83207 | GRK6 Antibody (YA2952) | Antibodies | |
| HY-P83208 | LMO4 Antibody (YA2953) | Antibodies | |
| HY-P83209 | p57 Kip2 Antibody (YA2954) | Antibodies | |
| HY-P83210 | GRSF1 Antibody (YA2955) | Antibodies | |
| HY-P83211 | TAF1 Antibody (YA2956) | Antibodies | |
| HY-P83212 | RDC1 Antibody (YA2957) | Antibodies | |
| HY-P83213 | GPD2 Antibody (YA2958) | Antibodies | |
| HY-P83214 | HCE Antibody (YA2959) | Antibodies | |
| HY-P83215 | Connexin 32 Antibody (YA2960) | Antibodies | |
| HY-P83216 | GPR182 Antibody (YA2961) | Antibodies | |
| HY-P83217 | PELP1 Antibody (YA2962) | Antibodies | |
| HY-P83218 | Tyrosine Protein Kinase HCK Antibody (YA2963) | Antibodies | |
| HY-P83219 | GPRC5B Antibody (YA2964) | Antibodies | |
| HY-P83220 | ATRIP Antibody (YA2965) | Antibodies | |
| HY-P83221 | MERTK Antibody (YA2966) | Antibodies | |
| HY-P83222 | HDAC9 Antibody (YA2967) | Antibodies | |
| HY-P83223 | NME2 Antibody (YA2968) | Antibodies | |
| HY-P83224 | HDLBP Antibody (YA2969) | Antibodies | |
| HY-P83225 | Caspr2 Antibody (YA2970) | Antibodies | |
| HY-P83226 | GSK3 alpha Antibody (YA2971) | Antibodies | |
| HY-P83227 | ATP4B Antibody (YA2972) | Antibodies | |
| HY-P83228 | Wnt2 Antibody (YA2973) | Antibodies | |
| HY-P83229 | PITX3 Antibody (YA2974) | Antibodies | |
| HY-P83230 | HIF Prolyl Hydroxylases Antibody (YA2975) | Antibodies | |
| HY-P83231 | Rab11A Antibody (YA2976) | Antibodies | |
| HY-P83232 | Metabotropic Glutamate Receptor 3 Antibody (YA2977) | Antibodies | |
| HY-P83233 | GSTA3 Antibody (YA2978) | Antibodies | |
| HY-P83234 | Dynamin 3 Antibody (YA2979) | Antibodies | |
| HY-P83235 | HADHA Antibody (YA2980) | Antibodies | |
| HY-P83236 | CETP Antibody (YA2981) | Antibodies | |
| HY-P83237 | MCJ Antibody (YA2982) | Antibodies | |
| HY-P83238 | HINT1 Antibody (YA2983) | Antibodies | |
| HY-P83239 | Complement factor B Antibody (YA2984) | Antibodies | |
| HY-P83240 | Rad21 Antibody (YA2985) | Antibodies | |
| HY-P83241 | CD1C Antibody (YA2986) | Antibodies | |
| HY-P83242 | HJURP Antibody (YA2987) | Antibodies | |
| HY-P83243 | HKDC1 Antibody (YA2988) | Antibodies | |
| HY-P83244 | PDE2A Antibody (YA2989) | Antibodies | |
| HY-P83245 | HLF Antibody (YA2990) | Antibodies | |
| HY-P83246 | EG VEGF Antibody (YA2991) | Antibodies | |
| HY-P83247 | HMG4 Antibody (YA2992) | Antibodies | |
| HY-P83248 | gamma Adaptin Antibody (YA2993) | Antibodies | |
| HY-P83249 | HDAC8 Antibody (YA2994) | Antibodies | |
| HY-P83250 | HMGB2 Antibody (YA2995) | Antibodies | |
| HY-P83251 | Tenascin Antibody (YA2996) | Antibodies | |
| HY-P83252 | Nucleoporin p62 Antibody (YA2997) | Antibodies | |
| HY-P83253 | DMAP1 Antibody (YA2998) | Antibodies | |
| HY-P83254 | alpha/beta Synuclein Antibody (YA2999) | Antibodies | |
| HY-P83255 | HPRT Antibody (YA3000) | Antibodies | |
| HY-P83256 | CTNNA3 Antibody (YA3001) | Antibodies | |
| HY-P83257 | CC2D1A Antibody (YA3002) | Antibodies | |
| HY-P83258 | HspA14 Antibody (YA3003) | Antibodies | |
| HY-P83259 | Cytokeratin 12 Antibody (YA3004) | Antibodies | |
| HY-P83260 | Cytokeratin 8 Antibody (YA3005) | Antibodies | |
| HY-P83261 | Histone H1.3 Antibody (YA3006) | Antibodies | |
| HY-P83262 | ICAM2 Antibody (YA3007) | Antibodies | |
| HY-P83263 | Histone H2A Antibody (YA3008) | Antibodies | |
| HY-P83264 | ICAM3 Antibody (YA3009) | Antibodies | |
| HY-P83265 | beta II Tubulin Antibody (YA3010) | Antibodies | |
| HY-P83266 | Ihh Antibody (YA3011) | Antibodies | |
| HY-P83267 | IKB epsilon Antibody (YA3012) | Antibodies | |
| HY-P83268 | Renilla Luciferase Antibody (YA3013) | Antibodies | |
| HY-P83269 | IL-1 Receptor Accessory Protein Antibody (YA3014) | Antibodies | |
| HY-P83270 | IL-26 Antibody (YA3015) | Antibodies | |
| HY-P83271 | ARF6 Antibody (YA3016) | Antibodies | |
| HY-P83272 | HOXB9 Antibody (YA3017) | Antibodies | |
| HY-P83273 | ING1 Antibody (YA3018) | Antibodies | |
| HY-P83274 | HLA C Antibody (YA3019) | Antibodies | |
| HY-P83275 | Integrin alpha 6 Antibody (YA3020) | Antibodies | |
| HY-P83276 | ALAS1 Antibody (YA3021) | Antibodies | |
| HY-P83277 | IQGAP2 Antibody (YA3022) | Antibodies | |
| HY-P83278 | Loricrin Antibody (YA3023) | Antibodies | |
| HY-P83279 | HMGCL Antibody (YA3024) | Antibodies | |
| HY-P83280 | Junctional Adhesion Molecule 1 Antibody (YA3025) | Antibodies | |
| HY-P83281 | Glutamate Dehydrogenase 1 Antibody (YA3026) | Antibodies | |
| HY-P83282 | KAT7 Antibody (YA3027) | Antibodies | |
| HY-P83283 | PHOX2B Antibody (YA3028) | Antibodies | |
| HY-P83284 | hnRNP G Antibody (YA3029) | Antibodies | |
| HY-P83285 | MMP8 Antibody (YA3030) | Antibodies | |
| HY-P83286 | hnRNP G T Antibody (YA3031) | Antibodies | |
| HY-P83287 | KMT6 Antibody (YA3032) | Antibodies | |
| HY-P83288 | Phospho-GCN2 (Thr899) Antibody (YA3033) | Antibodies | |
| HY-P83289 | hnRNP M Antibody (YA3034) | Antibodies | |
| HY-P83290 | Homer1 Antibody (YA3035) | Antibodies | |
| HY-P83291 | Dysferlin Antibody (YA3036) | Antibodies | |
| HY-P83292 | Tuberin Antibody (YA3037) | Antibodies | |
| HY-P83293 | LIG1 Antibody (YA3038) | Antibodies | |
| HY-P83294 | LINE 1 ORF1p Antibody (YA3039) | Antibodies | |
| HY-P83295 | MelanA Antibody (YA3040) | Antibodies | |
| HY-P83296 | Phospho-alpha Tubulin (Tyr272) Antibody (YA3041) | Antibodies | |
| HY-P83297 | HPDL Antibody (YA3042) | Antibodies | |
| HY-P83298 | LLGL1 Antibody (YA3043) | Antibodies | |
| HY-P83299 | Acetyl-Histone H2A Antibody (YA3044) | Antibodies | |
| HY-P83300 | Musashi 2 Antibody (YA3045) | Antibodies | |
| HY-P83301 | MonoMethyl-Histone H4 Antibody (YA3046) | Antibodies | |
| HY-P83302 | LTK Antibody (YA3047) | Antibodies | |
| HY-P83303 | HSD17B1 Antibody (YA3048) | Antibodies | |
| HY-P83304 | Phospho-Histone H1.4 (Thr17) Antibody (YA3049) | Antibodies | |
| HY-P83305 | MAP3K4 Antibody (YA3050) | Antibodies | |
| HY-P83306 | Integrin alpha E Antibody (YA3051) | Antibodies | |
| HY-P83307 | IRAKM Antibody (YA3052) | Antibodies | |
| HY-P83308 | RALBP1 Antibody (YA3053) | Antibodies | |
| HY-P83309 | GARS Antibody (YA3054) | Antibodies | |
| HY-P83310 | ME2 Antibody (YA3055) | Antibodies | |
| HY-P83311 | HspA2 Antibody (YA3056) | Antibodies | |
| HY-P83312 | Meckelin Antibody (YA3057) | Antibodies | |
| HY-P83313 | PRPF19 Antibody (YA3058) | Antibodies | |
| HY-P83314 | MEK2 Antibody (YA3059) | Antibodies | |
| HY-P83315 | HuC/HuD Antibody (YA3060) | Antibodies | |
| HY-P83316 | HMBS Antibody (YA3061) | Antibodies | |
| HY-P83317 | Phospho-PDGFR beta (Tyr740) Antibody (YA3062) | Antibodies | |
| HY-P83318 | MAD2L1 Binding Protein Antibody (YA3063) | Antibodies | |
| HY-P83319 | ICOS Ligand Antibody (YA3064) | Antibodies | |
| HY-P83320 | IDH2 Antibody (YA3065) | Antibodies | |
| HY-P83321 | IFITM1 Antibody (YA3066) | Antibodies | |
| HY-P83322 | Rad18 Antibody (YA3067) | Antibodies | |
| HY-P83323 | BPI Antibody (YA3068) | Antibodies | |
| HY-P83324 | IFT88 Antibody (YA3069) | Antibodies | |
| HY-P83325 | MAPKAP Kinase 3 Antibody (YA3070) | Antibodies | |
| HY-P83326 | IGF2BP1 Antibody (YA3071) | Antibodies | |
| HY-P83327 | WAVE 2 Antibody (YA3072) | Antibodies | |
| HY-P83328 | MLLT6 Antibody (YA3073) | Antibodies | |
| HY-P83329 | NSD3 Antibody (YA3074) | Antibodies | |
| HY-P83330 | KCNA1 Antibody (YA3075) | Antibodies | |
| HY-P83331 | IGFBP6 Antibody (YA3076) | Antibodies | |
| HY-P83332 | MPP1 Antibody (YA3077) | Antibodies | |
| HY-P83333 | AKAP14 Antibody (YA3078) | Antibodies | |
| HY-P83334 | IGFBP7 Antibody (YA3079) | Antibodies | |
| HY-P83335 | MRAS Antibody (YA3080) | Antibodies | |
| HY-P83336 | ATG9A Antibody (YA3081) | Antibodies | |
| HY-P83337 | MRPS18B Antibody (YA3082) | Antibodies | |
| HY-P83338 | Phospho-Paxillin (Tyr118) Antibody (YA3083) | Antibodies | |
| HY-P83339 | HLA DR Antibody (YA3084) | Antibodies | |
| HY-P83340 | MTAP Antibody (YA3085) | Antibodies | |
| HY-P83341 | Mucin 1 Antibody (YA3086) | Antibodies | |
| HY-P83342 | Phospho-JunD (Ser255) Antibody (YA3087) | Antibodies | |
| HY-P83343 | IKB beta Antibody (YA3088) | Antibodies | |
| HY-P83344 | Phospho-SHIP1 (Tyr1020) Antibody (YA3089) | Antibodies | |
| HY-P83345 | AGTR2 Antibody (YA3090) | Antibodies | |
| HY-P83346 | Jagged 1 Antibody (YA3091) | Antibodies | |
| HY-P83347 | IL-11 Receptor alpha Antibody (YA3092) | Antibodies | |
| HY-P83348 | MVK Antibody (YA3093) | Antibodies | |
| HY-P83349 | NDEL1 Antibody (YA3094) | Antibodies | |
| HY-P83350 | IL-1 Receptor Antagonist Protein Antibody (YA3095) | Antibodies | |
| HY-P83351 | Phospho-beta Catenin (Ser33/Ser37) Antibody (YA3096) | Antibodies | |
| HY-P83352 | NDUFS2 Antibody (YA3097) | Antibodies | |
| HY-P83353 | Cytokeratin 6A Antibody (YA3098) | Antibodies | |
| HY-P83354 | Phospho-Bad (Ser112) Antibody (YA3099) | Antibodies | |
| HY-P83355 | Indoleamine 2,3-dioxygenase Antibody (YA3100) | Antibodies | |
| HY-P83356 | INMT Antibody (YA3101) | Antibodies | |
| HY-P83357 | FANCD2 Antibody (YA3102) | Antibodies | |
| HY-P83358 | Phospho-p95 (Ser343) Antibody (YA3103) | Antibodies | |
| HY-P83359 | ITPA Antibody (YA3104) | Antibodies | |
| HY-P83360 | NgR3 Antibody (YA3105) | Antibodies | |
| HY-P83361 | AP2M1 Antibody (YA3106) | Antibodies | |
| HY-P83362 | Integrin alpha 2 Antibody (YA3107) | Antibodies | |
| HY-P83363 | Integrin beta 5 Antibody (YA3108) | Antibodies | |
| HY-P83364 | PPP1R1A Antibody (YA3109) | Antibodies | |
| HY-P83365 | NME3 Antibody (YA3110) | Antibodies | |
| HY-P83366 | Integrin Linked ILK Antibody (YA3111) | Antibodies | |
| HY-P83367 | Interferon alpha/beta Receptor 1 Antibody (YA3112) | Antibodies | |
| HY-P83368 | MYH9 Antibody (YA3113) | Antibodies | |
| HY-P83369 | MYH10 Antibody (YA3114) | Antibodies | |
| HY-P83370 | IRAK4 Antibody (YA3115) | Antibodies | |
| HY-P83371 | NOP10 Antibody (YA3116) | Antibodies | |
| HY-P83372 | delta Opioid Receptor Antibody (YA3117) | Antibodies | |
| HY-P83373 | IRF1 Antibody (YA3118) | Antibodies | |
| HY-P83374 | CCR9 Antibody (YA3119) | Antibodies | |
| HY-P83375 | NSDHL Antibody (YA3120) | Antibodies | |
| HY-P83376 | IRF8 Antibody (YA3121) | Antibodies | |
| HY-P83377 | Integrin beta 6 Antibody (YA3122) | Antibodies | |
| HY-P83378 | NUP155 Antibody (YA3123) | Antibodies | |
| HY-P83379 | AGO3 Antibody (YA3124) | Antibodies | |
| HY-P83380 | ITPK1 Antibody (YA3125) | Antibodies | |
| HY-P83381 | NUP50 Antibody (YA3126) | Antibodies | |
| HY-P83382 | Optineurin Antibody (YA3127) | Antibodies | |
| HY-P83383 | ORAI3 Antibody (YA3128) | Antibodies | |
| HY-P83384 | OTX1 Antibody (YA3129) | Antibodies | |
| HY-P83385 | IRF2 Antibody (YA3130) | Antibodies | |
| HY-P83386 | p23 Antibody (YA3131) | Antibodies | |
| HY-P83387 | kappa Opioid Receptor Antibody (YA3132) | Antibodies | |
| HY-P83388 | MYLK Antibody (YA3133) | Antibodies | |
| HY-P83389 | KCTD21 Antibody (YA3134) | Antibodies | |
| HY-P83390 | P2Y12 Antibody (YA3135) | Antibodies | |
| HY-P83391 | ATF1 Antibody (YA3136) | Antibodies | |
| HY-P83392 | KCTD3 Antibody (YA3137) | Antibodies | |
| HY-P83393 | KCTD9 Antibody (YA3138) | Antibodies | |
| HY-P83394 | NCF4 Antibody (YA3139) | Antibodies | |
| HY-P83395 | MEK5 Antibody (YA3140) | Antibodies | |
| HY-P83396 | KIF5B Antibody (YA3141) | Antibodies | |
| HY-P83397 | KIFC1 Antibody (YA3142) | Antibodies | |
| HY-P83398 | MMP13 Antibody (YA3143) | Antibodies | |
| HY-P83399 | Killin Antibody (YA3144) | Antibodies | |
| HY-P83400 | PAX9 Antibody (YA3145) | Antibodies | |
| HY-P83401 | HDAC7 Antibody (YA3146) | Antibodies | |
| HY-P83402 | KRIT1 Antibody (YA3147) | Antibodies | |
| HY-P83403 | LYVE1 Antibody (YA3148) | Antibodies | |
| HY-P83404 | L1CAM Antibody (YA3149) | Antibodies | |
| HY-P83405 | JNK3 Antibody (YA3150) | Antibodies | |
| HY-P83406 | Lamin B Receptor Antibody (YA3151) | Antibodies | |
| HY-P83407 | PAX7 Antibody (YA3152) | Antibodies | |
| HY-P83408 | LOX Antibody (YA3153) | Antibodies | |
| HY-P83409 | Peroxiredoxin 6 Antibody (YA3154) | Antibodies | |
| HY-P83410 | GRP75 Antibody (YA3155) | Antibodies | |
| HY-P83411 | PF4 Antibody (YA3156) | Antibodies | |
| HY-P83412 | ORAI1 Antibody (YA3157) | Antibodies | |
| HY-P83413 | CDC45 Antibody (YA3158) | Antibodies | |
| HY-P83414 | JAB1 Antibody (YA3159) | Antibodies | |
| HY-P83415 | CDC5 Antibody (YA3160) | Antibodies | |
| HY-P83416 | LAT Antibody (YA3161) | Antibodies | |
| HY-P83417 | PKC theta Antibody (YA3162) | Antibodies | |
| HY-P83418 | Pleckstrin Antibody (YA3163) | Antibodies | |
| HY-P83419 | LEF1 Antibody (YA3164) | Antibodies | |
| HY-P83420 | PMF 1 Antibody (YA3165) | Antibodies | |
| HY-P83421 | Steroidogenic Factor 1 Antibody (YA3166) | Antibodies | |
| HY-P83422 | PNKP Antibody (YA3167) | Antibodies | |
| HY-P83423 | CDC40 Antibody (YA3168) | Antibodies | |
| HY-P83424 | LGALS14 Antibody (YA3169) | Antibodies | |
| HY-P83425 | POLG Antibody (YA3170) | Antibodies | |
| HY-P83426 | LGALS3BP Antibody (YA3171) | Antibodies | |
| HY-P83427 | HspA4 Antibody (YA3172) | Antibodies | |
| HY-P83428 | LIS1 Antibody (YA3173) | Antibodies | |
| HY-P83429 | Hsp20 Antibody (YA3174) | Antibodies | |
| HY-P83430 | PPCEL Antibody (YA3175) | Antibodies | |
| HY-P83431 | CDCA3 Antibody (YA3176) | Antibodies | |
| HY-P83432 | PPCS Antibody (YA3177) | Antibodies | |
| HY-P83433 | PAX8 Antibody (YA3178) | Antibodies | |
| HY-P83434 | PRAS40 Antibody (YA3179) | Antibodies | |
| HY-P83435 | Caspase 14 Antibody (YA3180) | Antibodies | |
| HY-P83436 | Phospho-ATM (Ser1981) Antibody (YA3181) | Antibodies | |
| HY-P83437 | LRRC15 Antibody (YA3182) | Antibodies | |
| HY-P83438 | Prohibitin Antibody (YA3183) | Antibodies | |
| HY-P83439 | Protein CASP Antibody (YA3184) | Antibodies | |
| HY-P83440 | Polycomb Protein SUZ12 Antibody (YA3185) | Antibodies | |
| HY-P83441 | Macro H2A.1 Antibody (YA3186) | Antibodies | |
| HY-P83442 | PSD93 Antibody (YA3187) | Antibodies | |
| HY-P83443 | SDF1 Antibody (YA3188) | Antibodies | |
| HY-P83444 | PTBP1 Antibody (YA3189) | Antibodies | |
| HY-P83445 | MAD2L2 Antibody (YA3190) | Antibodies | |
| HY-P83446 | ZNRF2 Antibody (YA3191) | Antibodies | |
| HY-P83447 | IGF2 Antibody (YA3192) | Antibodies | |
| HY-P83448 | PTP4A2 Antibody (YA3193) | Antibodies | |
| HY-P83449 | MAPK6 Antibody (YA3194) | Antibodies | |
| HY-P83450 | mGluR1 Antibody (YA3195) | Antibodies | |
| HY-P83451 | MetRS Antibody (YA3196) | Antibodies | |
| HY-P83452 | FUS Antibody (YA3197) | Antibodies | |
| HY-P83453 | MAS1L Antibody (YA3198) | Antibodies | |
| HY-P83454 | MAT1A Antibody (YA3199) | Antibodies | |
| HY-P83455 | MYH6 Antibody (YA3200) | Antibodies | |
| HY-P83456 | Integrin alpha 4 Antibody (YA3201) | Antibodies | |
| HY-P83457 | EBP50 Antibody (YA3202) | Antibodies | |
| HY-P83458 | ABL2 Antibody (YA3203) | Antibodies | |
| HY-P83459 | Aquaporin 4 Antibody (YA3204) | Antibodies | |
| HY-P83459A | Aquaporin 4 Antibody | Antibodies | |
| HY-P83460 | M-CSF Receptor Antibody (YA3205) | Antibodies | |
| HY-P83461 | Tissue Type Plasminogen Activator Antibody (YA3206) | Antibodies | |
| HY-P83462 | MDH2 Antibody (YA3207) | Antibodies | |
| HY-P83463 | RAP80 Antibody (YA3208) | Antibodies | |
| HY-P83464 | MEF2A Antibody (YA3209) | Antibodies | |
| HY-P83465 | S100P Antibody (YA3210) | Antibodies | |
| HY-P83466 | RGS6 Antibody (YA3211) | Antibodies | |
| HY-P83467 | RRAS Antibody (YA3212) | Antibodies | |
| HY-P83468 | FTCD Antibody (YA3213) | Antibodies | |
| HY-P83469 | MEK3 Antibody (YA3214) | Antibodies | |
| HY-P83470 | MEKK2 Antibody (YA3215) | Antibodies | |
| HY-P83471 | RNF14 Antibody (YA3216) | Antibodies | |
| HY-P83472 | T Box Brain Protein 1 Antibody (YA3217) | Antibodies | |
| HY-P83473 | Metabotropic Glutamate Receptor 2 Antibody (YA3218) | Antibodies | |
| HY-P83474 | RPS20 Antibody (YA3219) | Antibodies | |
| HY-P83475 | RPS8 Antibody (YA3220) | Antibodies | |
| HY-P83476 | NG2 Antibody (YA3221) | Antibodies | |
| HY-P83477 | NCAM1 Antibody (YA3222) | Antibodies | |
| HY-P83478 | MGST3 Antibody (YA3223) | Antibodies | |
| HY-P83479 | Dystrophin Antibody (YA3224) | Antibodies | |
| HY-P83480 | HLA G Antibody (YA3225) | Antibodies | |
| HY-P83481 | SARA Antibody (YA3226) | Antibodies | |
| HY-P83482 | SBDS Antibody (YA3227) | Antibodies | |
| HY-P83483 | TGOLN2 Antibody (YA3228) | Antibodies | |
| HY-P83484 | SEC24D Antibody (YA3229) | Antibodies | |
| HY-P83485 | Mitochondrial Ribosomal Protein L11 Antibody (YA3230) | Antibodies | |
| HY-P83486 | Mitofilin Antibody (YA3231) | Antibodies | |
| HY-P83487 | Semaphorin 7A Antibody (YA3232) | Antibodies | |
| HY-P83488 | MKLP1 Antibody (YA3233) | Antibodies | |
| HY-P83489 | Septin 8 Antibody (YA3234) | Antibodies | |
| HY-P83490 | MLD Antibody (YA3235) | Antibodies | |
| HY-P83491 | Serine Racemase Antibody (YA3236) | Antibodies | |
| HY-P83492 | MLK3 Antibody (YA3237) | Antibodies | |
| HY-P83493 | SFT Antibody (YA3238) | Antibodies | |
| HY-P83494 | TERF1 Antibody (YA3239) | Antibodies | |
| HY-P83495 | MMP26 Antibody (YA3240) | Antibodies | |
| HY-P83496 | SMARCA2 Antibody (YA3241) | Antibodies | |
| HY-P83497 | Mint3 Antibody (YA3242) | Antibodies | |
| HY-P83498 | Sortilin Antibody (YA3243) | Antibodies | |
| HY-P83499 | Monocarboxylic Acid Transporter 1 Antibody (YA3244) | Antibodies | |
| HY-P83500 | MRPS26 Antibody (YA3245) | Antibodies | |
| HY-P83501 | MRPS31 Antibody (YA3246) | Antibodies | |
| HY-P83502 | MS2 Antibody (YA3247) | Antibodies | |
| HY-P83503 | uPA Antibody (YA3248) | Antibodies | |
| HY-P83504 | MS4A14 Antibody (YA3249) | Antibodies | |
| HY-P83505 | CD32 Antibody (YA3250) | Antibodies | |
| HY-P83506 | CD59 Antibody (YA3251) | Antibodies | |
| HY-P83507 | MSRB3 Antibody (YA3252) | Antibodies | |
| HY-P83508 | MST4 Antibody (YA3253) | Antibodies | |
| HY-P83509 | MTCO2 Antibody (YA3254) | Antibodies | |
| HY-P83510 | Endothelin Receptor B Antibody (YA3255) | Antibodies | |
| HY-P83511 | SV40 T Antigen Antibody (YA3256) | Antibodies | |
| HY-P83512 | GBA Antibody (YA3257) | Antibodies | |
| HY-P83513 | MTHFR Antibody (YA3258) | Antibodies | |
| HY-P83514 | TAOK1 Antibody (YA3259) | Antibodies | |
| HY-P83515 | TATA Box Binding Protein Antibody (YA3260) | Antibodies | |
| HY-P83516 | MTX3 Antibody (YA3261) | Antibodies | |
| HY-P83517 | Metalloproteinase Inhibitor 2 Antibody (YA3262) | Antibodies | |
| HY-P83518 | Dynein Light Chain Tctex Type 1 Antibody (YA3263) | Antibodies | |
| HY-P83519 | Mucin 4 Antibody (YA3264) | Antibodies | |
| HY-P83520 | Toll-Like Receptor 5 Antibody (YA3265) | Antibodies | |
| HY-P83521 | Transcription Factor EB Antibody (YA3266) | Antibodies | |
| HY-P83522 | Growth Hormone 1 Antibody (YA3267) | Antibodies | |
| HY-P83523 | General Transcription Factor II I Antibody (YA3268) | Antibodies | |
| HY-P83524 | Rhodopsin Antibody (YA3269) | Antibodies | |
| HY-P83525 | Dopamine Receptor D1 Antibody (YA3270) | Antibodies | |
| HY-P83526 | Myelin Basic Protein Antibody (YA3271) | Antibodies | |
| HY-P83527 | Tissue Factor Pathway Inhibitor Antibody (YA3272) | Antibodies | |
| HY-P83528 | HLA DPB1 Antibody (YA3273) | Antibodies | |
| HY-P83529 | CD62P Antibody (YA3274) | Antibodies | |
| HY-P83530 | Thrombospondin 1 Antibody (YA3275) | Antibodies | |
| HY-P83531 | FGF21 Antibody (YA3276) | Antibodies | |
| HY-P83532 | MOG Antibody (YA3277) | Antibodies | |
| HY-P83533 | Myelin Protein Zero Antibody (YA3278) | Antibodies | |
| HY-P83534 | CREB Regulated Transcription Coactivator 2 Antibody (YA3279) | Antibodies | |
| HY-P83535 | Integrin beta 4 Antibody (YA3280) | Antibodies | |
| HY-P83536 | NeuroD1 Antibody (YA3281) | Antibodies | |
| HY-P83537 | MYO19 Antibody (YA3282) | Antibodies | |
| HY-P83538 | TPMT Antibody (YA3283) | Antibodies | |
| HY-P83539 | MYO1B Antibody (YA3284) | Antibodies | |
| HY-P83540 | TPX2 Antibody (YA3285) | Antibodies | |
| HY-P83541 | N4BP1 Antibody (YA3286) | Antibodies | |
| HY-P83542 | TRAPPC2 Antibody (YA3287) | Antibodies | |
| HY-P83543 | NAT1 Antibody (YA3288) | Antibodies | |
| HY-P83544 | NCAPH2 Antibody (YA3289) | Antibodies | |
| HY-P83545 | Rac Antibody (YA3290) | Antibodies | |
| HY-P83546 | NCE2 Antibody (YA3291) | Antibodies | |
| HY-P83547 | ADAM10 Antibody (YA3292) | Antibodies | |
| HY-P83548 | NCK2 Antibody (YA3293) | Antibodies | |
| HY-P83549 | NCK1 Antibody (YA3294) | Antibodies | |
| HY-P83550 | NDRG2 Antibody (YA3295) | Antibodies | |
| HY-P83551 | NEDD8 Activating Enzyme E1C Antibody (YA3296) | Antibodies | |
| HY-P83552 | NDUFA1 Antibody (YA3297) | Antibodies | |
| HY-P83554 | Ubiquitin 60S Ribosomal Protein L40 Antibody (YA3299) | Antibodies | |
| HY-P83555 | ERp57 Antibody (YA3300) | Antibodies | |
| HY-P83556 | SUMO Conjugating Enzyme UBC9 Antibody (YA3301) | Antibodies | |
| HY-P83557 | NDUFAF4 Antibody (YA3302) | Antibodies | |
| HY-P83558 | Ubiquitin Conjugating Enzyme E2 L3 Antibody (YA3303) | Antibodies | |
| HY-P83559 | NDUFAF5 Antibody (YA3304) | Antibodies | |
| HY-P83560 | Alpha-2-Macroglobulin Antibody (YA3305) | Antibodies | |
| HY-P83561 | Ubiquitin Protein Ligase E3A Antibody (YA3306) | Antibodies | |
| HY-P83562 | G-CSF Antibody (YA3307) | Antibodies | |
| HY-P83563 | Ubiquitin Conjugation Factor E4 B Antibody (YA3308) | Antibodies | |
| HY-P83564 | USF1 Antibody (YA3309) | Antibodies | |
| HY-P83565 | RPE65 Antibody (YA3310) | Antibodies | |
| HY-P83566 | SFRP1 Antibody (YA3311) | Antibodies | |
| HY-P83567 | VAV2 Antibody (YA3312) | Antibodies | |
| HY-P83568 | SOS1 Antibody (YA3313) | Antibodies | |
| HY-P83569 | VPS35 Antibody (YA3314) | Antibodies | |
| HY-P83570 | WWOX Antibody (YA3315) | Antibodies | |
| HY-P83571 | S100A1 Antibody (YA3316) | Antibodies | |
| HY-P83572 | YTHDC2 Antibody (YA3317) | Antibodies | |
| HY-P83573 | Drebrin Antibody (YA3318) | Antibodies | |
| HY-P83574 | DAP kinase 3 Antibody (YA3319) | Antibodies | |
| HY-P83575 | GCET1 Antibody (YA3320) | Antibodies | |
| HY-P83576 | Toll-Like Receptor 9 Antibody (YA3321) | Antibodies | |
| HY-P83577 | MHC Class I Antibody (YA3322) | Antibodies | |
| HY-P83578 | MEK3/MEK6 Antibody (YA3323) | Antibodies | |
| HY-P83579 | MEF2A/MEF2C Antibody (YA3324) | Antibodies | |
| HY-P83580 | PHD1 Antibody (YA3325) | Antibodies | |
| HY-P83581 | delta Sarcoglycan Antibody (YA3326) | Antibodies | |
| HY-P83582 | Human IgG4 Antibody (YA3327) | Antibodies | |
| HY-P83583 | USP14 Antibody (YA3328) | Antibodies | |
| HY-P83584 | BNIP1 Antibody (YA3329) | Antibodies | |
| HY-P83585 | RING2 Antibody (YA3330) | Antibodies | |
| HY-P83586 | KDM4A Antibody (YA3331) | Antibodies | |
| HY-P83587 | Hydroxyl-Histone H2A Antibody (YA3332) | Antibodies | |
| HY-P83588 | Phospho-PAK4/5/6 (Ser474/Ser560/Ser602) Antibody (YA3333) | Antibodies | |
| HY-P83589 | Lymphotoxin alpha Antibody (YA3334) | Antibodies | |
| HY-P83590 | DHFR Antibody (YA3335) | Antibodies | |
| HY-P83591 | Cyclin A1/A2 Antibody (YA3336) | Antibodies | |
| HY-P83592 | DAZL Antibody (YA3337) | Antibodies | |
| HY-P83593 | PRPF31 Antibody (YA3338) | Antibodies | |
| HY-P83594 | HEC1 Antibody (YA3339) | Antibodies | |
| HY-P83595 | Reelin Antibody (YA3340) | Antibodies | |
| HY-P83596 | Adenosine A1 Receptor Antibody (YA3341) | Antibodies | |
| HY-P83597 | Prostaglandin E Receptor EP2 Antibody (YA3342) | Antibodies | |
| HY-P83598 | ERAB Antibody (YA3343) | Antibodies | |
| HY-P83599 | MTA2 Antibody (YA3344) | Antibodies | |
| HY-P83600 | TBP Like 1 Antibody (YA3345) | Antibodies | |
| HY-P83601 | ITK Antibody (YA3346) | Antibodies | |
| HY-P83602 | alpha Fodrin Antibody (YA3347) | Antibodies | |
| HY-P83603 | Reptin Antibody (YA3348) | Antibodies | |
| HY-P83604 | ApoC3 Antibody (YA3349) | Antibodies | |
| HY-P83605 | CRCP Antibody (YA3350) | Antibodies | |
| HY-P83606 | CEACAM6 Antibody (YA3351) | Antibodies | |
| HY-P83607 | Antithrombin III Antibody (YA3352) | Antibodies | |
| HY-P83608 | Mitochondrial Ferritin Antibody (YA3353) | Antibodies | |
| HY-P83609 | ORM2 Antibody (YA3354) | Antibodies | |
| HY-P83610 | Klotho Antibody (YA3355) | Antibodies | |
| HY-P83611 | OGG1 Antibody (YA3356) | Antibodies | |
| HY-P83612 | BST2 Antibody (YA3357) | Antibodies | |
| HY-P83613 | Angiotensin II Type 1 Receptor Antibody (YA3358) | Antibodies | |
| HY-P83614 | CD209 Antibody (YA3359) | Antibodies | |
| HY-P83615 | mtTFA Antibody (YA3360) | Antibodies | |
| HY-P83616 | Factor H Antibody (YA3361) | Antibodies | |
| HY-P83617 | Carbonic Anhydrase 2 Antibody (YA3362) | Antibodies | |
| HY-P83618 | Plasma Kallikrein Antibody (YA3363) | Antibodies | |
| HY-P83619 | HTR2C Antibody (YA3364) | Antibodies | |
| HY-P83620 | Cytochrome P450 3A4 Antibody (YA3365) | Antibodies | |
| HY-P83621 | KIF3A Antibody (YA3366) | Antibodies | |
| HY-P83622 | DDR2 Antibody (YA3367) | Antibodies | |
| HY-P83623 | mSin3A Antibody (YA3368) | Antibodies | |
| HY-P83624 | AMBP Antibody (YA3369) | Antibodies | |
| HY-P83625 | CRMP2 Antibody (YA3370) | Antibodies | |
| HY-P83626 | Caspr1 Antibody (YA3371) | Antibodies | |
| HY-P83627 | ZIC 1 Antibody (YA3372) | Antibodies | |
| HY-P83628 | G-CSF Receptor Antibody (YA3373) | Antibodies | |
| HY-P83629 | Dynein Intermediate Chain 1 Antibody (YA3374) | Antibodies | |
| HY-P83630 | EDG2 Antibody (YA3375) | Antibodies | |
| HY-P83631 | HSD11B1 Antibody (YA3376) | Antibodies | |
| HY-P83632 | GAL4 Antibody (YA3377) | Antibodies | |
| HY-P83633 | DNA Polymerase beta Antibody (YA3378) | Antibodies | |
| HY-P83634 | CD1a Antibody (YA3379) | Antibodies | |
| HY-P83635 | RES Antibody (YA3380) | Antibodies | |
| HY-P83636 | Hemopexin Antibody (YA3381) | Antibodies | |
| HY-P83637 | KAT9 Antibody (YA3382) | Antibodies | |
| HY-P83638 | KDM1B Antibody (YA3383) | Antibodies | |
| HY-P83639 | Cytochrome P450 2D6 Antibody (YA3384) | Antibodies | |
| HY-P83640 | Ephrin B2 Antibody (YA3385) | Antibodies | |
| HY-P83642 | DM4 Antibody | Antibodies | |
| HY-P83644 | Phospho-PKM2(Tyr105)Antibody | Antibodies | |
| HY-P83646 | Goat Anti-Rabbit IgG Antibody | Antibodies | |
| HY-P83647 | DHCR7 Antibody | Antibodies | |
| HY-P83648 | Goat Anti-Human IgG H&L (AF594) | Antibodies | |
| HY-P83649 | Goat Anti-Human IgG H&L (FITC) | Antibodies | |
| HY-P83652 | Goat Anti-Mouse/Rabbit lgG(H&L)-HRP (Ready to use) | Antibodies | |
| HY-P83653 | CD11c Antibody | Antibodies | |
| HY-P83656 | IL-23R Antibody | Antibodies | |
| HY-P83657 | MPZ Antibody | Antibodies | |
| HY-P83658 | CTSE Antibody | Antibodies | |
| HY-P83660 | LILRB4/CD85k Antibody(YA3395) | Antibodies | |
| HY-P83661 | IL-3RB Antibody(YA3396) | Antibodies | |
| HY-P83662 | Goat Anti-Human IgG H&L (HRP) | Antibodies | |
| HY-P83663 | BSA Antibody(YA3397) | Antibodies | |
| HY-P83666M | Human CD235 Antibody (APC) | Antibodies | |
| HY-P83667 | Phospho-ATF4 (Ser219) Antibody | Antibodies | |
| HY-P83668 | CHRNA7 Antibody | Antibodies | |
| HY-P83669 | delta Tubulin Antibody | Antibodies | |
| HY-P83670 | Chenodeoxycholic acid Antibody | Antibodies | |
| HY-P83671 | Cholic acid Antibody | Antibodies | |
| HY-P83672 | Corticosterone Antibody | Antibodies | |
| HY-P83673 | Cortisol Antibody | Antibodies | |
| HY-P83674 | DHEA Antibody | Antibodies | |
| HY-P83675 | Enrofloxacin Antibody | Antibodies | |
| HY-P83676 | FITC Antibody | Antibodies | |
| HY-P83677 | Folic acid Antibody | Antibodies | |
| HY-P83678 | Gentamicin Antibody | Antibodies | |
| HY-P83679 | Kanamycin Antibody | Antibodies | |
| HY-P83680 | Ofloxacin Antibody | Antibodies | |
| HY-P83681 | Ractopamine Antibody | Antibodies | |
| HY-P83682 | Sulfametoxydiazine Antibody | Antibodies | |
| HY-P83683 | Testosterone Antibody | Antibodies | |
| HY-P83684 | The metabolite of furaltadone Antibody | Antibodies | |
| HY-P83685 | The metabolite of furazolidone Antibody | Antibodies | |
| HY-P83686 | The metabolite of nitrofurazone Antibody | Antibodies | |
| HY-P83687 | Abscisic acid Antibody | Antibodies | |
| HY-P83688 | Estradiol Antibody | Antibodies | |
| HY-P83689 | CD147 Antibody(YA3422) | Antibodies | |
| HY-P83690 | CD11b Antibody | Antibodies | |
| HY-P83691 | Eribulin Antibody | Antibodies | |
| HY-P83692 | CXCR3 Antibody (YA3426) | Antibodies | |
| HY-P83693 | ALKBH5 Antibody (YA3429) | Antibodies | |
| HY-P83694 | ZO-1 Antibody | Antibodies | |
| HY-P83695 | CHMP6 Antibody | Antibodies | |
| HY-P83696 | Cytochrome P450 4A/CYP4A11 Antibody (YA3431) | Antibodies | |
| HY-P83697 | 6X His-tag Antibody (YA3432) | Antibodies | |
| HY-P83698 | Ovalbumin Antibody (YA3433) | Antibodies | |
| HY-P83700 | Phospho-Tau (Ser202/Thr205) Antibody | Antibodies | |
| HY-P83701 | HLA E Antibody (YA3437) | Antibodies | |
| HY-P83702 | Cytokeratin 17 Antibody (YA3438) | Antibodies | |
| HY-P83703 | CDC42 Antibody (YA3440) | Antibodies | |
| HY-P83704 | Transcription factor AP2 alpha Antibody (YA3441) | Antibodies | |
| HY-P83705 | MDM2 Antibody | Antibodies | |
| HY-P83706 | GSDMD Antibody | Antibodies | |
| HY-P83707M | Human CD138 Antibody (PE) | Antibodies | |
| HY-P83708M | Human CD73 Antibody (PE) | Antibodies | |
| HY-P83709 | m6A Antibody (YA3446) | Antibodies | |
| HY-P83710M | Rat Anti-Mouse CD86 Antibody (FITC) | Antibodies | |
| HY-P83711M | Armenian Hamster Anti-Mouse CD80 Antibody (PE) | Antibodies | |
| HY-P83712M | Rat Anti-Mouse CD16/32 Antibody (FITC) | Antibodies | |
| HY-P83713M | Armenian Hamster Anti-Mouse CD11c Antibody (APC) | Antibodies | |
| HY-P83714M | Rat Anti-Mouse CD206 Antibody (APC) | Antibodies | |
| HY-P83715M | Rat Anti-Mouse F4/80 Antibody (PE) | Antibodies | |
| HY-P83716 | Alpha-dystroglycan Antibody | Antibodies | |
| HY-P83717 | LDLR Antibody（YA3452） | Antibodies | |
| HY-P83718 | PSMB1 Antibody | Antibodies | |
| HY-P83719 | PSMB5/MB1 Antibody | Antibodies | |
| HY-P83720 | CD5 Antibody (YA3453) | Antibodies | |
| HY-P83721 | WTAP Antibody | Antibodies | |
| HY-P83722 | NME4 Antibody(YA3454) | Antibodies | |
| HY-P83724 | Wnt3a Antibody | Antibodies | |
| HY-P83725 | ATG4C Antibody(YA3456) | Antibodies | |
| HY-P83727 | Mouse Anti-Human IgG Fc | Antibodies | |
| HY-P83728 | PGC1 alpha+beta Antibody(YA3458) | Antibodies | |
| HY-P83729 | ZBED4 Antibody | Antibodies | |
| HY-P83730 | Beta Actin Antibody(YA3459) | Antibodies | |
| HY-P83731 | Gli1 Antibody | Antibodies | |
| HY-P83732 | NR0B2 Antibody | Antibodies | |
| HY-P83733 | Acetylated-Lysine Antibody (YA3463) | Antibodies | |
| HY-P83734 | S100A9 Antibody (YA3464) | Antibodies | |
| HY-P83735M | Mouse Anti-Human CD45 Antibody (AF647) | Antibodies | |
| HY-P83736 | MPO Antibody (YA3466) | Antibodies | |
| HY-P83737 | PDGF Receptor beta Antibody(YA3467) | Antibodies | |
| HY-P83738 | Rabbit Anti-Rat IgG H&L (HRP) | Antibodies | |
| HY-P83739 | alpha smooth muscle Actin Antibody(YA3468) | Antibodies | |
| HY-P83740 | Bcl2 Antibody (YA3469) | Antibodies | |
| HY-P83741 | EpCAM Antibody (YA3470) | Antibodies | |
| HY-P83742 | SLC12A1 Antibody (YA3471) | Antibodies | |
| HY-P83743 | Nephrin Antibody (YA3472) | Antibodies | |
| HY-P83744 | Donkey Anti-Goat IgG H&L(AF680) | Antibodies | |
| HY-P83745 | Donkey Anti-Rabbit IgG H&L(PE) | Antibodies | |
| HY-P83746 | LRP2/Megalin Antibody(YA3473) | Antibodies | |
| HY-P83747 | mCherry Antibody(YA3474) | Antibodies | |
| HY-P83748 | Digoxigenin Antibody(HRP)(YA3475) | Antibodies | |
| HY-P83748A | Digoxigenin Antibody(YA3475) | Antibodies | |
| HY-P83749 | Phospho-Tyrosine Antibody(YA3552) | Antibodies | |
| HY-P83750 | Thrombospondin 1 Antibody (YA3553) | Antibodies | |
| HY-P83751 | Goat Anti-Rat IgG H&L (HRP) | Antibodies | |
| HY-P83752 | Rabbit Anti-Human IgG H&L (FITC) | Antibodies | |
| HY-P83753 | beta Amyloid 1-40 Antibody (YA3554) | Antibodies | |
| HY-P83754 | beta Amyloid 1-42 Antibody (YA3555) | Antibodies | |
| HY-P83755 | beta Amyloid Antibody (YA3556) | Antibodies | |
| HY-P83756 | CD4 Antibody (YA3557) | Antibodies | |
| HY-P83757 | Cas9 SP Antibody (YA3558) | Antibodies | |
| HY-P83758 | ROR gamma T Antibody (YA3559) | Antibodies | |
| HY-P83759 | DUSP4 Antibody | Antibodies | |
| HY-P83760 | MICA+MICB Antibody (YA3560) | Antibodies | |
| HY-P83761 | Phospho-HER2(Tyr1221/Tyr1222) Antibody | Antibodies | |
| HY-P83762 | alpha Actinin Antibody(YA3561) | Antibodies | |
| HY-P83763 | EIF2S1 Antibody(YA3562) | Antibodies | |
| HY-P83764 | pan Cytokeratin Antibody(YA3563) | Antibodies | |
| HY-P83765 | K Cadherin Antibody(YA3564) | Antibodies | |
| HY-P83766 | eRF3a Antibody | Antibodies | |
| HY-P83767 | Phospho-S6 Ribosomal Protein (Ser235/Ser236) Antibody | Antibodies | |
| HY-P83768 | CD11c Antibody(YA3565) | Antibodies | |
| HY-P83769 | SLFN11 Antibody | Antibodies | |
| HY-P83770 | DLL3 Antibody(YA3566) | Antibodies | |
| HY-P83771 | Phospho-Smad1/5/9 (S463/S465/S467)Antibody(YA3567) | Antibodies | |
| HY-P83772 | Phospho-SMAD2 (S465+467)Antibody(YA3568) | Antibodies | |
| HY-P83773 | CFTR Antibody(YA3569) | Antibodies | |
| HY-P83774 | Phospho-MAPKAPK2 (Thr334) Antibody | Antibodies | |
| HY-P83775 | HNF 4 alpha Antibody (YA3571) | Antibodies | |
| HY-P83776 | Goat Anti-Human IgG H&L (AF488) | Antibodies | |
| HY-P83777 | SYP121 Antibody | Antibodies | |
| HY-P83778 | Phospho-Tau (T217) Antibody (YA3476) | Antibodies | |
| HY-P83779 | Phospho-Tau (T231) Antibody (YA3477) | Antibodies | |
| HY-P83780 | OPN3 Antibody | Antibodies | |
| HY-P83781 | Mouse anti Human Kappa Light Chain | Reference compound | |
| HY-P9801 | Anti-Spike-RBD mAb | Inhibitory Antibodies | |
| HY-P9802 | Anti-Spike-RBD Single Domain mAb | Inhibitory Antibodies | |
| HY-P9803 | Anti-SARS-80R mAb | Inhibitory Antibodies | |
| HY-P9804 | Anti-MERS-2E6 mAb | Inhibitory Antibodies | |
| HY-P9805 | Anti-MERS-3A1 mAb | Inhibitory Antibodies | |
| HY-P9806 | Anti-MERS-D12 mAb | Inhibitory Antibodies | |
| HY-P9807 | Anti-SARS-CoV-2 Spike mAb (CR3022) | Inhibitory Antibodies | |
| HY-P990001 | Anti-Mouse IL-10 Antibody (JES5-2A5) | Inhibitory Antibodies | |
| HY-P990002 | Anti-Mouse CD117/c-Kit Antibody (2B8) | Inhibitory Antibodies | |
| HY-P990004 | Anti-Mouse TIM-3 Antibody (B8.2C12) | Inhibitory Antibodies | |
| HY-P990005 | Mouse IgG2a Fc, Isotype Control | Inhibitory Antibodies | |
| HY-P990006 | Duvakitug | 2750005-84-4 | Inhibitory Antibodies |
| HY-P990007 | Tulisokibart | 2648504-55-4 | Inhibitory Antibodies |
| HY-P990008 | Atrosab | 1365659-05-7 | Inhibitory Antibodies |
| HY-P990009 | Nisevokitug | 2649854-92-0 | Inhibitory Antibodies |
| HY-P99001 | Human IgG1 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P990010 | Devextinetug | 2609642-90-0 | Inhibitory Antibodies |
| HY-P990011 | Sabirnetug | 2747959-38-0 | Inhibitory Antibodies |
| HY-P990012 | Vamikibart | 2744320-12-3 | Inhibitory Antibodies |
| HY-P990013 | Gulgafafusp alfa | 2642374-02-3 | Inhibitory Antibodies |
| HY-P990014 | Danburstotug | 2307144-65-4 | Inhibitory Antibodies |
| HY-P990015 | Tobevibart | 2645440-65-7 | Inhibitory Antibodies |
| HY-P990016 | Temtokibart | 2639874-57-8 | Inhibitory Antibodies |
| HY-P990017 | Englumafusp alfa | 2417199-08-5 | Inhibitory Antibodies |
| HY-P990018 | Boserolimab | 2444297-08-7 | Inhibitory Antibodies |
| HY-P990019 | Epacmarstobart | 2518200-89-8 | Inhibitory Antibodies |
| HY-P99002 | Human IgG2 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P990020 | Eglatoprutug | 2518200-21-8 | Inhibitory Antibodies |
| HY-P990021 | Calpurbatug | 2635404-72-5 | Inhibitory Antibodies |
| HY-P990022 | Prafnosbart | 2566473-71-8 | Inhibitory Antibodies |
| HY-P990023 | Bempikibart | 2622254-57-1 | Inhibitory Antibodies |
| HY-P990024 | Casdozokitug | 2643331-37-5 | Inhibitory Antibodies |
| HY-P990025 | Empasiprubart | 2579031-19-7 | Inhibitory Antibodies |
| HY-P990026 | Ulviprubart | 2569434-60-0 | Inhibitory Antibodies |
| HY-P990027 | Izeltabart | 2642078-60-0 | Inhibitory Antibodies |
| HY-P990028 | Raludotatug | 2610074-56-9 | Inhibitory Antibodies |
| HY-P99003 | Human IgG4 (S228P) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P990030 | Ralzapastotug | 2581724-89-0 | Inhibitory Antibodies |
| HY-P990031 | Dargistotug | 2649362-29-6 | Inhibitory Antibodies |
| HY-P990032 | Belrestotug | 2574438-65-4 | Inhibitory Antibodies |
| HY-P990033 | Anzurstobart | 2543693-10-1 | Inhibitory Antibodies |
| HY-P990034 | Pateclizumab | 1202526-59-7 | Inhibitory Antibodies |
| HY-P990036 | Dazukibart | 2639474-65-8 | Inhibitory Antibodies |
| HY-P990037 | Erzotabart | 2430792-01-9 | Inhibitory Antibodies |
| HY-P990038 | Eurestobart | 2682847-53-4 | Inhibitory Antibodies |
| HY-P990039 | Falbikitug | 2740565-02-8 | Inhibitory Antibodies |
| HY-P99004 | hMC1R agonist 1 | 3028881-87-7 | Reference compound |
| HY-P990040 | Exlinkibart | 2642171-64-8 | Inhibitory Antibodies |
| HY-P990041 | Firastotug | 2750031-14-0 | Inhibitory Antibodies |
| HY-P990042 | Gotistobart | 2226344-78-9 | Inhibitory Antibodies |
| HY-P990043 | Iluzanebart | 2733621-19-5 | Inhibitory Antibodies |
| HY-P990044 | Dalnicastobart | 2642171-59-1 | Inhibitory Antibodies |
| HY-P990045 | Lixudebart | 2749515-10-2 | Inhibitory Antibodies |
| HY-P990046 | Tuparstobart | 2649466-03-3 | Inhibitory Antibodies |
| HY-P990047 | Maridebart | 2761478-99-1 | Inhibitory Antibodies |
| HY-P990048 | Muzastotug | 2750031-18-4 | Inhibitory Antibodies |
| HY-P990049 | Becotatug | 2648260-93-7 | Inhibitory Antibodies |
| HY-P990051 | Delpacibart | 2653183-66-3 | Inhibitory Antibodies |
| HY-P990052 | Simaravibart | 2657609-23-7 | Inhibitory Antibodies |
| HY-P990053 | Nelistotug | 2645437-82-5 | Inhibitory Antibodies |
| HY-P990054 | Eramkafusp Alfa | Inhibitory Antibodies | |
| HY-P990055 | Nezutatug | 2673271-78-6 | Inhibitory Antibodies |
| HY-P990056 | Oberotatug | 2641919-35-7 | Inhibitory Antibodies |
| HY-P990057 | Picankibart | 2622900-74-5 | Inhibitory Antibodies |
| HY-P990058 | Varokibart | 2643349-04-4 | Inhibitory Antibodies |
| HY-P990059 | Puxitatug | 2760250-47-1 | Inhibitory Antibodies |
| HY-P99006 | Amatuximab | 931402-35-6 | Inhibitory Antibodies |
| HY-P990060 | Denecimig | 2488745-86-2 | Inhibitory Antibodies |
| HY-P990061 | Polzastobart | 2640981-19-5 | Inhibitory Antibodies |
| HY-P990062 | Freneslerbart | 2453195-94-1 | Inhibitory Antibodies |
| HY-P990063 | Mevonlerbart | 2453195-99-6 | Inhibitory Antibodies |
| HY-P990064 | Umesolerbart | 2456307-11-0 | Inhibitory Antibodies |
| HY-P990065 | Bremzalerbart | 2456307-07-4 | Inhibitory Antibodies |
| HY-P990066 | Atisnolerbart | 2456308-79-3 | Inhibitory Antibodies |
| HY-P990067 | Evunzekibart | 2639688-77-8 | Inhibitory Antibodies |
| HY-P990068 | Perenostobart | 2643331-31-9 | Inhibitory Antibodies |
| HY-P990069 | Linavonkibart | 2640981-30-0 | Inhibitory Antibodies |
| HY-P99007 | Aprutumab | 1634620-63-5 | Inhibitory Antibodies |
| HY-P990070 | Zigakibart | 2642175-46-8 | Inhibitory Antibodies |
| HY-P990071 | Fepixnebart | 2489584-93-0 | Inhibitory Antibodies |
| HY-P990072 | Lipustobart | 2639481-06-2 | Inhibitory Antibodies |
| HY-P990073 | Davutamig | 2648058-48-2 | Inhibitory Antibodies |
| HY-P990074 | Enlonstobart | 2651230-53-2 | Inhibitory Antibodies |
| HY-P990076 | Lorukafusp alfa | 2131168-99-3 | Inhibitory Antibodies |
| HY-P990077 | Pidilizumab | 1036730-42-3 | Inhibitory Antibodies |
| HY-P990078 | Remternetug | 2571940-41-3 | Inhibitory Antibodies |
| HY-P990079 | Renvistobart | 2725062-35-9 | Inhibitory Antibodies |
| HY-P99008 | Atibuclimab | 2417175-94-9 | Inhibitory Antibodies |
| HY-P990080 | Sovipostobart | 2649371-19-5 | Inhibitory Antibodies |
| HY-P990081 | Oloctinebart | 2669063-84-5 | Inhibitory Antibodies |
| HY-P990082 | Suvemcitug | 1610010-57-5 | Inhibitory Antibodies |
| HY-P990083 | Tegoprubart | 2628092-47-5 | Inhibitory Antibodies |
| HY-P990084 | Veligrotug | 2728655-31-8 | Inhibitory Antibodies |
| HY-P990085 | Verzistobart | 2649466-18-0 | Inhibitory Antibodies |
| HY-P990086 | Vopikitug | 2733581-99-0 | Inhibitory Antibodies |
| HY-P990087 | Zovostotug | 2756228-84-7 | Inhibitory Antibodies |
| HY-P990088 | Sotiburafusp alfa | 2637466-37-4 | Inhibitory Antibodies |
| HY-P990089 | Patecibart | 2642374-04-5 | Inhibitory Antibodies |
| HY-P99009 | Batoclimab | 2187430-05-1 | Inhibitory Antibodies |
| HY-P990090 | Rademikibart | 2648260-80-2 | Inhibitory Antibodies |
| HY-P990091 | Riliprubart | 2756228-76-7 | Inhibitory Antibodies |
| HY-P990092 | Rolistobart | 2723442-10-0 | Inhibitory Antibodies |
| HY-P990093 | Stapokibart | 2734715-10-5 | Inhibitory Antibodies |
| HY-P990094 | Trabikibart | 2643974-98-3 | Inhibitory Antibodies |
| HY-P990095 | Vonsetamig | 2408319-33-3 | Inhibitory Antibodies |
| HY-P990096 | Human IgG1 lambda2, Isotype Control | Inhibitory Antibodies | |
| HY-P9901 | Ipilimumab | 477202-00-9 | Inhibitory Antibodies |
| HY-P99010 | Bemarituzumab | 1952272-74-0 | Inhibitory Antibodies |
| HY-P990100 | Human IgG1(E356D/M358L) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P990104 | Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) | Inhibitory Antibodies | |
| HY-P990106 | Anti-Mouse VEGFR-2 Antibody (DC101) | Inhibitory Antibodies | |
| HY-P990107 | Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) | Inhibitory Antibodies | |
| HY-P99010A | Bemarituzumab (FUT8-KO) | Inhibitory Antibodies | |
| HY-P99011 | Cibisatamab | 1855925-27-7 | Inhibitory Antibodies |
| HY-P990110 | Lecanemab (Mouse IGG2a) | Inhibitory Antibodies | |
| HY-P990111 | BMS-986325 (anti-CD40) | Inhibitory Antibodies | |
| HY-P990113 | Anti-Rat TCR gamma/delta Antibody (V65) | Inhibitory Antibodies | |
| HY-P990114 | Anti-Canine PD-L1/B7-H1 Antibody (JC071) | Inhibitory Antibodies | |
| HY-P990115 | Anti-Mouse OX40/CD134 Antibody (OX-86) | Inhibitory Antibodies | |
| HY-P990116 | Anti-Mouse osteopontin/SPP1 Antibody (103D6) | Inhibitory Antibodies | |
| HY-P990117 | Anti-Mouse/Rat/Human Osteopontin/SPP1 Antibody (MPIIIB10) | Inhibitory Antibodies | |
| HY-P990118 | Anti-Mouse Ly6G Antibody (1A8) | Inhibitory Antibodies | |
| HY-P990119 | Anti-Mouse Kappa Immunoglobulin Light Chain Antibody (HB-58) | Inhibitory Antibodies | |
| HY-P99012 | Clazakizumab | 1236278-28-6 | Inhibitory Antibodies |
| HY-P990120 | Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) | Inhibitory Antibodies | |
| HY-P990121 | Anti-Mouse IL-4 Antibody (11B11) | Inhibitory Antibodies | |
| HY-P990122 | Anti-Rat IL-4 Antibody (OX-81) | Inhibitory Antibodies | |
| HY-P990123 | Anti-Mouse ICOSL/CD275 Antibody (HK5.3) | Inhibitory Antibodies | |
| HY-P990124 | Anti-Mouse GITR Antibody (DTA-1) | Inhibitory Antibodies | |
| HY-P990125 | Anti-Mouse (CSF1R/CD115) Antibody (AFS98) | Inhibitory Antibodies | |
| HY-P990126 | Anti-Rat CD8α Antibody (OX-8) | Inhibitory Antibodies | |
| HY-P990127 | Anti-Mouse CD80/B7-1 Antibody (RM80) | Inhibitory Antibodies | |
| HY-P990128 | Anti-Rat CD80/B7-1 Antibody (3H5) | Inhibitory Antibodies | |
| HY-P990129 | Anti-Mouse CD71/TfR1 Antibody (8D3) | Inhibitory Antibodies | |
| HY-P99013 | Codrituzumab | 1365267-33-9 | Inhibitory Antibodies |
| HY-P990130 | Anti-Mouse/Rat CD71/TfR1 Antibody (OX-26) | Inhibitory Antibodies | |
| HY-P990131 | Anti-Mouse CD47/IAP Antibody (MIAP301) | Inhibitory Antibodies | |
| HY-P990132 | Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410) | Inhibitory Antibodies | |
| HY-P990133 | Anti-Monkey/Human CD40L/CD154 Antibody (5C8) | Inhibitory Antibodies | |
| HY-P990134 | Anti-Mouse CD40L/CD154 Antibody (MR-1) | Inhibitory Antibodies | |
| HY-P990135 | Anti-Rat CD4 Antibody (OX-38) | Inhibitory Antibodies | |
| HY-P990136 | Anti-Monkey/Human CD28 Antibody (CD28.2) | Inhibitory Antibodies | |
| HY-P990137 | Anti-Rat CD28 Antibody (JJ319) | Inhibitory Antibodies | |
| HY-P990138 | Anti-Monkey/Human CD20 Antibody (2H7) | Inhibitory Antibodies | |
| HY-P990139 | Anti-Mouse CD20 Antibody (AISB12) | Inhibitory Antibodies | |
| HY-P99014 | Cusatuzumab | 1864871-20-4 | Inhibitory Antibodies |
| HY-P990140 | Anti-Rat β-2-Microglobulin Antibody (4C9) | Inhibitory Antibodies | |
| HY-P990141 | Anti-Mouse Vβ8 TCR Antibody (F23.1) | Inhibitory Antibodies | |
| HY-P990142 | Anti-Mouse Vβ4 TCR Antibody (KT4) | Inhibitory Antibodies | |
| HY-P990143 | Anti-Mouse/Rat/Bovine VLDL-R Antibody (IgG-6A6) | Inhibitory Antibodies | |
| HY-P990144 | Anti-Mouse/Human VLA-4/CD49d Antibody (PS/2) | Inhibitory Antibodies | |
| HY-P990145 | Anti-Mouse VISTA Antibody (13F3) | Inhibitory Antibodies | |
| HY-P990146 | Anti-Mouse/Rat/Human v-H-Ras Antibody (Y13-238) | Inhibitory Antibodies | |
| HY-P990147 | Anti-Mouse VEGFR-2 Antibody (DC101-Mouse IgG2a) | Inhibitory Antibodies | |
| HY-P990148 | Anti-Mouse VEGF-A Antibody (2G11-2A05) | Inhibitory Antibodies | |
| HY-P990149 | Anti-Mouse/Human TYRP1 Antibody (TA99) | Inhibitory Antibodies | |
| HY-P99015 | Dacetuzumab | 880486-59-9 | Inhibitory Antibodies |
| HY-P990150 | Anti-Mouse TSLP Antibody (28F12) | Inhibitory Antibodies | |
| HY-P990151 | Anti-Mouse TL1A/TNFSF15 Antibody (5G4.6) | Inhibitory Antibodies | |
| HY-P990152 | Anti-Mouse TIM-4 Antibody (RMT4-54) | Inhibitory Antibodies | |
| HY-P990153 | Anti-Mouse TIM-2 Antibody (RMT2-29) | Inhibitory Antibodies | |
| HY-P990154 | Anti-Mouse TIM-1/CD365 Antibody (3B3) | Inhibitory Antibodies | |
| HY-P990155 | Anti-Mouse TIGIT Antibody (1G9) | Inhibitory Antibodies | |
| HY-P990156 | Anti-Mouse Thy1.1/CD90.1 Antibody (19E12) | Inhibitory Antibodies | |
| HY-P990157 | Anti-Mouse Thy1/CD90 Antibody (M5/49.4.1) | Inhibitory Antibodies | |
| HY-P990158 | Anti-Mouse Ter-119 Antibody (TER-119) | Inhibitory Antibodies | |
| HY-P990159 | Anti-Mouse TCRβ Antibody (HB218) | Inhibitory Antibodies | |
| HY-P99016 | Enfortumab | 1448664-46-7 | Inhibitory Antibodies |
| HY-P990160 | Anti-Rat TCR alpha/beta Antibody (R73) | Inhibitory Antibodies | |
| HY-P990161 | Anti-Mouse TCR Vγ1.1/Cr4 Antibody (2.11) | Inhibitory Antibodies | |
| HY-P990162 | Anti-Mouse T15 VH and T15 VL regions of IgM Antibody (HB33) | Inhibitory Antibodies | |
| HY-P990163 | Anti-Mouse Siglec-H Antibody (440c) | Inhibitory Antibodies | |
| HY-P990164 | Anti-Mouse RGMb Antibody (307.9D1) | Inhibitory Antibodies | |
| HY-P990165 | Anti-Mouse RANKL/CD254 Antibody (IK22/5) | Inhibitory Antibodies | |
| HY-P990166 | Anti-Mouse PSGL-1/CD162 Antibody (4RA10) | Inhibitory Antibodies | |
| HY-P990167 | Anti-Mouse/Human PrP/prion protein Antibody (TW1) | Inhibitory Antibodies | |
| HY-P990168 | Anti-Mouse Podoplanin/glycoprotein 38 Antibody (8.1.1) | Inhibitory Antibodies | |
| HY-P990169 | Anti-Mouse/Human phosphorylated PD-1/CD279 Antibody (407.6G12) | Inhibitory Antibodies | |
| HY-P99016A | Enfortumab vedotin-ejfv | 1346452-25-2 | ADC Related |
| HY-P99016B | Enfortumab vedotin-ejfv (solution) | 1346452-25-2 | ADC Related |
| HY-P99017 | Eptinezumab | 1644539-04-7 | Inhibitory Antibodies |
| HY-P990170 | Anti-Mouse PD-L2/B7-DC Antibody (TY25) | Inhibitory Antibodies | |
| HY-P990171 | Anti-Mouse PD-L1/B7-H1 (LALA-PG) Antibody (10F.9G2) | Inhibitory Antibodies | |
| HY-P990172 | Anti-Mouse PD-L1/B7-H1 (D265A) Antibody (10F.9G2) | Inhibitory Antibodies | |
| HY-P990173 | Anti-Mouse/Rat/Human PD-L1 Antibody (368A.4H1) | Inhibitory Antibodies | |
| HY-P990174 | Anti-Mouse Pan-endothelial Cell Antigen/MECA-32 Antibody (MECA-32) | Inhibitory Antibodies | |
| HY-P990175 | Anti-Mouse OX40L/CD134L Antibody (RM134L) | Inhibitory Antibodies | |
| HY-P990176 | Anti-Mouse OX40/CD134 (LALA-PG) Antibody (OX86) | Inhibitory Antibodies | |
| HY-P990177 | Anti-Mouse Notch4 Antibody (HMN4-14) | Inhibitory Antibodies | |
| HY-P990178 | Anti-Mouse NKG2D/CD314 Antibody (CX5) | Inhibitory Antibodies | |
| HY-P990179 | Anti-Mouse NKG2AB6 Antibody (16A11) | Inhibitory Antibodies | |
| HY-P99018 | Etokimab | 2022981-44-6 | Inhibitory Antibodies |
| HY-P990180 | Anti-Mouse NKG2A/C/E Antibody (20D5) | Inhibitory Antibodies | |
| HY-P990181 | Anti-Mouse myeloperoxidase/MPO Antibody (6G4) | Inhibitory Antibodies | |
| HY-P990182 | Mouse IgG2b (LALA-PG) kappa, isotype control | Inhibitory Antibodies | |
| HY-P990183 | Mouse IgG2a (D265A) kappa, isotype control | Inhibitory Antibodies | |
| HY-P990184 | Anti-Mouse MHC Class II (βchain) Antibody (KL277) | Inhibitory Antibodies | |
| HY-P990185 | Anti-Mouse/Rat MHC Class II (I-Ek/RT1-D) Antibody (14-4-4S) | Inhibitory Antibodies | |
| HY-P990186 | Anti-Mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7) Antibody (10-3.6.2) | Inhibitory Antibodies | |
| HY-P990187 | Anti-Mouse MHC Class II (I-A/I-E) Antibody (M5/114) | Inhibitory Antibodies | |
| HY-P990188 | Anti-Mouse MHC class II (I-A) Antibody (Y-3P) | Inhibitory Antibodies | |
| HY-P990189 | Anti-Monkey/Human MHC class II (HLA-DR) Antibody (L243) | Inhibitory Antibodies | |
| HY-P99019 | Fremanezumab | 1655501-53-3 | Inhibitory Antibodies |
| HY-P990190 | Anti-Swine MHC Class I (SLAd) Antibody (74-11-10) | Inhibitory Antibodies | |
| HY-P990191 | Anti-Mouse MHC Class I (H-2Kk, H-2Dk) Antibody (15-3-1S (HB-13)) | Inhibitory Antibodies | |
| HY-P990192 | Anti-Mouse MHC Class I (H-2Kk) Antibody (AF3-12.1.3) | Inhibitory Antibodies | |
| HY-P990193 | Anti-Mouse MHC Class I (H-2Kd, H-2Dd) Antibody (34-1-2S) | Inhibitory Antibodies | |
| HY-P990194 | Anti-Mouse MHC Class I (H-2Kd) Antibody (HB-159) | Inhibitory Antibodies | |
| HY-P990195 | Anti-Mouse MHC Class I (H-2) Antibody (M1/42.3.9.8) | Inhibitory Antibodies | |
| HY-P990196 | Anti-Monkey/Human MDR-1/CD243 Antibody (UIC2) | Inhibitory Antibodies | |
| HY-P990197 | Anti-Mouse MAdCAM-1 Antibody (MECA-367) | Inhibitory Antibodies | |
| HY-P990198 | Anti-Mouse/Human Mac-2/Galectin-3 Antibody (TIB-166) | Inhibitory Antibodies | |
| HY-P990199 | Anti-Mouse Ly6G/Ly6C Antibody (NIMP-R14) | Inhibitory Antibodies | |
| HY-P9902 | Pembrolizumab | 1374853-91-4 | Inhibitory Antibodies |
| HY-P99020 | Fresolimumab | 948564-73-6 | Inhibitory Antibodies |
| HY-P990200 | Anti-Mouse Ly6C Antibody (Monts 1) | Inhibitory Antibodies | |
| HY-P990201 | Anti-Mouse L-Selectin/CD62L Antibody (Mel-14) | Inhibitory Antibodies | |
| HY-P990202 | Anti-Mouse/Rat/Human LRP1/CD91 Antibody (11H4) | Inhibitory Antibodies | |
| HY-P990203 | Anti-Mouse LPAM-1/Integrin α4β7 Antibody (DATK32) | Inhibitory Antibodies | |
| HY-P990204 | Anti-Mouse LAG-3 (D265A) Antibody (C9B7W) | Inhibitory Antibodies | |
| HY-P990205 | Anti-Mouse/Human KLRG-1 Antibody (2F1) | Inhibitory Antibodies | |
| HY-P990206 | Anti-Mouse Jagged 2 Antibody (HMJ2-1) | Inhibitory Antibodies | |
| HY-P990207 | Anti-Mouse/Human Integrin β7 Antibody (FIB504) | Inhibitory Antibodies | |
| HY-P990208 | Anti-Mouse IL-9 Antibody (9C1) | Inhibitory Antibodies | |
| HY-P990209 | Anti-Mouse IL-7Rα/CD127 Antibody (A7R34) | Inhibitory Antibodies | |
| HY-P99021 | Galcanezumab | 1578199-75-3 | Inhibitory Antibodies |
| HY-P990210 | Anti-Mouse/Human IL-7 Antibody (M25) | Inhibitory Antibodies | |
| HY-P990211 | Anti-Mouse IL-6R Antibody (15A7) | Inhibitory Antibodies | |
| HY-P990212 | Anti-Mouse IL-6 Antibody (MP5-20F3) | Inhibitory Antibodies | |
| HY-P990213 | Anti-Mouse/Human IL-5 Antibody (TRFK5) | Inhibitory Antibodies | |
| HY-P990214 | Anti-Mouse IL-3 Antibody (MP2-8F8) | Inhibitory Antibodies | |
| HY-P990215 | Anti-Mouse IL-27 p28 Antibody (MM27.7B1) | Inhibitory Antibodies | |
| HY-P990216 | Anti-Mouse IL-25 Antibody (2C3) | Inhibitory Antibodies | |
| HY-P990217 | Anti-Mouse IL-23 p19 Antibody (G23-8) | Inhibitory Antibodies | |
| HY-P990218 | Anti-Mouse IL-21R Antibody (4A9) | Inhibitory Antibodies | |
| HY-P990219 | Anti-Mouse IL-2 Antibody (JES6-1A12) | Inhibitory Antibodies | |
| HY-P99022 | Gantenerumab | 1043556-46-2 | Inhibitory Antibodies |
| HY-P990220 | Anti-Mouse IL-18 Antibody (YIGIF74-1G7) | Inhibitory Antibodies | |
| HY-P990221 | Anti-Mouse IL-17F Antibody (MM17F8F5.1A9) | Inhibitory Antibodies | |
| HY-P990222 | Anti-Mouse/Rat IL-17A Antibody (17F3) | Inhibitory Antibodies | |
| HY-P990223 | Anti-Mouse IL-15 Antibody (AIO.3) | Inhibitory Antibodies | |
| HY-P990224 | Anti-Mouse IL-12 p75 Antibody (R2-9A5) | Inhibitory Antibodies | |
| HY-P990225 | Anti-Mouse IL-12 p40 Antibody (C17.8) | Inhibitory Antibodies | |
| HY-P990226 | Anti-Mouse IL-12 p35 Antibody (C18.2) | Inhibitory Antibodies | |
| HY-P990227 | Anti-Mouse IL-12 Antibody (R1-5D9) | Inhibitory Antibodies | |
| HY-P990228 | Anti-Mouse IL-10R/CD210 Antibody (1B1.3A) | Inhibitory Antibodies | |
| HY-P990229 | Anti-Rat IgG2b Antibody (RG7/11.1) | Inhibitory Antibodies | |
| HY-P99023 | Girentuximab | 916138-87-9 | Inhibitory Antibodies |
| HY-P990230 | Anti-Rat IgG2a Antibody (RG7/1.30) | Inhibitory Antibodies | |
| HY-P990231 | Anti-Rat IgG1 Antibody (RG11/39.4) | Inhibitory Antibodies | |
| HY-P990232 | Anti-Mouse IFNγRα/CD119 Antibody (2E2) | Inhibitory Antibodies | |
| HY-P990233 | Anti-Mouse IFNγR/CD119 Antibody (GR-20) | Inhibitory Antibodies | |
| HY-P990234 | Anti-Mouse ICOSL/CD275 (LALA-PG) Antibody (HK5.3) | Inhibitory Antibodies | |
| HY-P990235 | Anti-Mouse ICOSL/CD275 (D265A) Antibody (HK5.3) | Inhibitory Antibodies | |
| HY-P990236 | Anti-Mouse/Rat/Monkey/Human ICOS/CD278 Antibody (C398.4A) | Inhibitory Antibodies | |
| HY-P990237 | Anti-Mouse ICOS Antibody (7E.17G9) | Inhibitory Antibodies | |
| HY-P990238 | Anti-Human/Rat HER2 (neu) Antibody (7.16.4) | Inhibitory Antibodies | |
| HY-P990239 | Anti-Human/Mouse GRP78 Antibody (N88) | Inhibitory Antibodies | |
| HY-P99024 | Glofitamab | 2229047-91-8 | Inhibitory Antibodies |
| HY-P990240 | Anti-Mouse GITR (LALA-PG) Antibody (DTA-1) | Inhibitory Antibodies | |
| HY-P990241 | Anti-Mouse GITR (D265A) Antibody (DTA-1) | Inhibitory Antibodies | |
| HY-P990242 | Anti-Mouse Galectin-9 Antibody (RG9-1) | Inhibitory Antibodies | |
| HY-P990243 | Anti-Mouse FGL-1 Antibody (177R4) | Inhibitory Antibodies | |
| HY-P990244 | Anti-Rat FcRn heavy chain heterodimers Antibody (2G3) | Inhibitory Antibodies | |
| HY-P990245 | Anti-Mouse FAP Antibody (73.3) | Inhibitory Antibodies | |
| HY-P990246 | Anti-Mouse F4/80 Antibody (CI:A3-1) | Inhibitory Antibodies | |
| HY-P990247 | Anti-Mouse E-selectin/CD62E Antibody (9A9) | Inhibitory Antibodies | |
| HY-P990248 | Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) | Inhibitory Antibodies | |
| HY-P990249 | Anti-Mouse DR5/CD262 Antibody (MD5-1) | Inhibitory Antibodies | |
| HY-P99025 | Lebrikizumab | 953400-68-5 | Inhibitory Antibodies |
| HY-P990250 | Anti-Mouse DKK3 Antibody (DKK3-4.22) | Inhibitory Antibodies | |
| HY-P990251 | Anti-Human/Mouse denatured collagen type-I Antibody (XL313) | Inhibitory Antibodies | |
| HY-P990252 | Anti-Mouse Delta-like protein 4/DLL4 Antibody (HMD4-2) | Inhibitory Antibodies | |
| HY-P990253 | Anti-Mouse Delta-like protein 1/DLL1 Antibody (HMD1-5) | Inhibitory Antibodies | |
| HY-P990254 | Anti-Mouse CXCR3/CD183 Antibody (CXCR3-173) | Inhibitory Antibodies | |
| HY-P990255 | Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) | Inhibitory Antibodies | |
| HY-P990256 | Anti-Mouse CTLA-4/CD152 (LALA-PG) Antibody (9D9) | Inhibitory Antibodies | |
| HY-P990257 | Anti-Mouse CSF1 Antibody (5A1) | Inhibitory Antibodies | |
| HY-P990258 | Anti-Mouse CLEC9A/CD370 Antibody (7H11) | Inhibitory Antibodies | |
| HY-P990259 | Anti-Mouse CD96 Antibody (3.3) | Inhibitory Antibodies | |
| HY-P99026 | Lemzoparlimab | 2377483-71-9 | Inhibitory Antibodies |
| HY-P990260 | Anti-Mouse CD86/B7-2 Antibody (GL-1) | Inhibitory Antibodies | |
| HY-P990261 | Anti-Mouse CD83 Antibody (Michel-17) | Inhibitory Antibodies | |
| HY-P990262 | Anti-Mouse CD8 Antibody (HB-129) | Inhibitory Antibodies | |
| HY-P990263 | Anti-Mouse CD73 Antibody (TY/23) | Inhibitory Antibodies | |
| HY-P990264 | Anti-Mouse CD70 Antibody (FR70) | Inhibitory Antibodies | |
| HY-P990265 | Anti-Mouse CD69 Antibody (CD69.2.2) | Inhibitory Antibodies | |
| HY-P990266 | Anti-Mouse CD48 Antibody (HM48-1) | Inhibitory Antibodies | |
| HY-P990267 | Anti-Mouse CD45RB Antibody (MB23G2) | Inhibitory Antibodies | |
| HY-P990268 | Anti-Mouse CD45.2 Antibody (104.2) | Inhibitory Antibodies | |
| HY-P990269 | Anti-Mouse CD40L/CD154 (LALA-PG) Antibody (MR-1) | Inhibitory Antibodies | |
| HY-P99027 | Ieramilimab | 2137049-37-5 | Inhibitory Antibodies |
| HY-P990270 | Anti-Mouse CD40L/CD154 (D265A) Antibody (MR-1) | Inhibitory Antibodies | |
| HY-P990272 | Anti-Mouse CD3ε Antibody (KT3) | Inhibitory Antibodies | |
| HY-P990273 | Anti-Mouse CD38 Antibody (NIMR5) | Inhibitory Antibodies | |
| HY-P990274 | Anti-Canine CD34 Antibody (1H6) | Inhibitory Antibodies | |
| HY-P990275 | Anti-Mouse CD326/EpCAM Antibody (G8.8) | Inhibitory Antibodies | |
| HY-P990276 | Anti-Mouse CD317/BST2 Antibody (927) | Inhibitory Antibodies | |
| HY-P990277 | Anti-Mouse CD31/PECAM-1 Antibody (390) | Inhibitory Antibodies | |
| HY-P990278 | Anti-Mouse CD29 Antibody (KMI6) | Inhibitory Antibodies | |
| HY-P990279 | Anti-Mouse CD276/B7-H3 Antibody (MJ18) | Inhibitory Antibodies | |
| HY-P99028 | Ibalizumab | 680188-33-4 | Inhibitory Antibodies |
| HY-P990280 | Anti-Mouse CD27 Antibody (RM27-3E5) | Inhibitory Antibodies | |
| HY-P990281 | Anti-Mouse CD25/IL-2Rα Antibody (PC-61.5.3) | Inhibitory Antibodies | |
| HY-P990282 | Anti-Mouse CD24 Antibody (M1/69) | Inhibitory Antibodies | |
| HY-P990283 | Anti-Mouse CD22 Antibody (Cy34.1) | Inhibitory Antibodies | |
| HY-P990284 | Anti-Mouse CD205 Antibody (NLDC-145) | Inhibitory Antibodies | |
| HY-P990285 | Anti-Mouse CD200 Antibody (OX-90) | Inhibitory Antibodies | |
| HY-P990286 | Anti-Rat CD2 Antibody (OX-34) | Inhibitory Antibodies | |
| HY-P990287 | Anti-Mouse CD1d Antibody (19G11) | Inhibitory Antibodies | |
| HY-P990288 | Anti-Mouse CD18 Antibody (M18/2) | Inhibitory Antibodies | |
| HY-P990289 | Anti-Mouse CD172a Antibody (P84) | Inhibitory Antibodies | |
| HY-P99029 | Magrolimab | 2169232-81-7 | Inhibitory Antibodies |
| HY-P990290 | Anti-Mouse CD16/CD32 (LALA-PG) Antibody (2.4G2) | Inhibitory Antibodies | |
| HY-P990291 | Anti-Mouse CD16.2 Antibody (9E9) | Inhibitory Antibodies | |
| HY-P990292 | Anti-Mouse CD132 (common γ chain) Antibody (3E12) | Inhibitory Antibodies | |
| HY-P990293 | Anti-Mouse CD122/IL-2Rβ Antibody (5H4) | Inhibitory Antibodies | |
| HY-P990294 | Anti-Mouse CD106/VCAM-1 Antibody (M/K-2.7) | Inhibitory Antibodies | |
| HY-P990295 | Anti-Mouse CD103 Antibody (M290) | Inhibitory Antibodies | |
| HY-P990296 | Anti-Mouse CCR3/CD193 Antibody (6S2-19-4) | Inhibitory Antibodies | |
| HY-P990297 | Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5) | Inhibitory Antibodies | |
| HY-P990298 | Anti-Mouse BTLA/CD272 Antibody (6A6) | Inhibitory Antibodies | |
| HY-P990299 | Anti-Mouse B220 Antibody (RA3.3A1/6.1) | Inhibitory Antibodies | |
| HY-P9902A | Pembrolizumab (anti-PD-1) | Inhibitory Antibodies | |
| HY-P9903 | Nivolumab | 946414-94-4 | Inhibitory Antibodies |
| HY-P99030 | Margetuximab | 1350624-75-7 | Inhibitory Antibodies |
| HY-P990300 | anti-Phosphotyrosine Antibody (4G10) | Inhibitory Antibodies | |
| HY-P990301 | Anti-Human/Mouse/Rat Amyloid-beta Antibody (MOAB-2) | Inhibitory Antibodies | |
| HY-P990302 | Anti-Human/Rat/Fish AChR Antibody (Mab35) | Inhibitory Antibodies | |
| HY-P990303 | Anti-Mouse 2C TCR Antibody (1B2) | Inhibitory Antibodies | |
| HY-P990304 | Anti-Mouse 4-1BBL/CD137L Antibody (TKS-1) | Inhibitory Antibodies | |
| HY-P990304A | Anti-Mouse 4-1BBL/CD137L Antibody (TKS-1-Mouse IgG2a) | Inhibitory Antibodies | |
| HY-P990304B | Anti-Mouse 4-1BBL/CD137L (D265A) Antibody (TKS-1) | Inhibitory Antibodies | |
| HY-P990304C | Anti-Mouse 4-1BBL/CD137L (LALA-PG) Antibody (TKS-1) | Inhibitory Antibodies | |
| HY-P990305 | Polyclonal Armenian hamster IgG, Isotype Control | Inhibitory Antibodies | |
| HY-P99031 | Mavrilimumab | 1085337-57-0 | Inhibitory Antibodies |
| HY-P990310 | 19G9 | Inhibitory Antibodies | |
| HY-P990311 | AB-25E9 | Inhibitory Antibodies | |
| HY-P990312 | ABT-325 | Inhibitory Antibodies | |
| HY-P990313 | ABX-IL8 | Inhibitory Antibodies | |
| HY-P990314 | AFM24 | Inhibitory Antibodies | |
| HY-P990315 | Anti-ENPP3/CD203c Antibody (AGS-16C3F antibody) | Inhibitory Antibodies | |
| HY-P990317 | AGS-67E | Inhibitory Antibodies | |
| HY-P990318 | Alacizumab | 934216-54-3 | Inhibitory Antibodies |
| HY-P990319 | ALT-100 (Human IgG4) | Inhibitory Antibodies | |
| HY-P99032 | Monalizumab | 1228763-95-8 | Inhibitory Antibodies |
| HY-P990320 | ALT-836 (TNX-832) | Inhibitory Antibodies | |
| HY-P990321 | AMG-108 | Inhibitory Antibodies | |
| HY-P990322 | AMG-811 | Inhibitory Antibodies | |
| HY-P990323 | Anti-158P1D7 Antibody | Inhibitory Antibodies | |
| HY-P990324 | Anti-AA2AR/Adenosine A2aR Antibody (3F6-9G5) | Inhibitory Antibodies | |
| HY-P990325 | Anti-ABCB5 Antibody | Inhibitory Antibodies | |
| HY-P990326 | Anti-ACVR2A Antibody (Ab-14E1) | Inhibitory Antibodies | |
| HY-P990327 | Anti-ACVR2B Antibody | Inhibitory Antibodies | |
| HY-P990328 | Anti-AGER/RAGE Antibody (XT-M4) | Inhibitory Antibodies | |
| HY-P990329 | Anti-Albumin Antibody | Inhibitory Antibodies | |
| HY-P99033 | Mosunetuzumab | 1905409-39-3 | Inhibitory Antibodies |
| HY-P990331 | Anti-ALP Antibody | Inhibitory Antibodies | |
| HY-P990332 | Anti-Amyloid Beta Antibody (CNTO 2125) | Inhibitory Antibodies | |
| HY-P990333 | Anti-Amyloid Beta Antibody (DLX212) | Inhibitory Antibodies | |
| HY-P990334 | Anti-ANGPT2 Antibody | Inhibitory Antibodies | |
| HY-P990335 | Anti-ANGPTL4 Antibody | Inhibitory Antibodies | |
| HY-P990336 | Anti-ANGPTL8 Antibody | Inhibitory Antibodies | |
| HY-P990337 | Anti-ANO1/TMEM16A Antibody | Inhibitory Antibodies | |
| HY-P990338 | Anti-ASIC1 Antibody | Inhibitory Antibodies | |
| HY-P990339 | Anti-AXL/UFO Antibody (ORY012) | Inhibitory Antibodies | |
| HY-P99034 | Moxetumomab | 1622075-65-3 | Inhibitory Antibodies |
| HY-P990340 | Anti-B7-H3/CD276 Antibody | Inhibitory Antibodies | |
| HY-P990341 | Anti-B7-H4/VTCN1 Antibody | Inhibitory Antibodies | |
| HY-P990342 | Anti-B7-H6/NCR3LG1 Antibody | Inhibitory Antibodies | |
| HY-P990343 | Anti-BACE1 Antibody | Inhibitory Antibodies | |
| HY-P990344 | Anti-Bcl-2 Antibody | Inhibitory Antibodies | |
| HY-P990345 | Anti-BST2/CD317 Antibody | Inhibitory Antibodies | |
| HY-P990346 | Anti-CAPRIN1 Antibody | Inhibitory Antibodies | |
| HY-P990347 | Anti-CD151 Antibody | Inhibitory Antibodies | |
| HY-P990348 | Anti-CD163 Antibody (OR2805) | Inhibitory Antibodies | |
| HY-P990349 | Anti-CD19 Antibody | Inhibitory Antibodies | |
| HY-P99035 | Naptumomab | 1412892-09-1 | Inhibitory Antibodies |
| HY-P990350 | Anti-CD20 Antibody | Inhibitory Antibodies | |
| HY-P990351 | Anti-CD34 Antibody | Inhibitory Antibodies | |
| HY-P990352 | Anti-CD36 Antibody | Inhibitory Antibodies | |
| HY-P990353 | Anti-CD4 Antibody (TRX1) | Inhibitory Antibodies | |
| HY-P990354 | Anti-CD48 Antibody | Inhibitory Antibodies | |
| HY-P990355 | Anti-CD5 Antibody | Inhibitory Antibodies | |
| HY-P990356 | Anti-CD59 Antibody | Inhibitory Antibodies | |
| HY-P990357 | Anti-CD69 Antibody | Inhibitory Antibodies | |
| HY-P990358 | Anti-CD7 Antibody | Inhibitory Antibodies | |
| HY-P990359 | Anti-CD83 Antibody | Inhibitory Antibodies | |
| HY-P99036 | Nesvacumab | 1296818-77-3 | Inhibitory Antibodies |
| HY-P990360 | Anti-CD9 Antibody | Inhibitory Antibodies | |
| HY-P990361 | Anti-CDCP1/CD318 Antibody (38 E11) | Inhibitory Antibodies | |
| HY-P990362 | Anti-CDH1/E-cadherin/CD324 Antibody | Inhibitory Antibodies | |
| HY-P990363 | Anti-CDH17/Cadherin-17 Antibody (PTA001_A4) | Inhibitory Antibodies | |
| HY-P990364 | Anti-CEACAM1/CD66a Antibody | Inhibitory Antibodies | |
| HY-P990365 | Anti-CEACAM5/CEA/CD66e Antibody | Inhibitory Antibodies | |
| HY-P990366 | Anti-CHI3L1 Antibody | Inhibitory Antibodies | |
| HY-P990368 | Anti-CLDN6 Antibody (AB1-11) | Inhibitory Antibodies | |
| HY-P990369 | Anti-CLDN6 Antibody (AB3-7) | Inhibitory Antibodies | |
| HY-P99037 | Nipocalimab | 2211985-36-1 | Inhibitory Antibodies |
| HY-P990372 | Anti-CLEC14A Antibody | Inhibitory Antibodies | |
| HY-P990373 | Anti-CLEC4C Antibody | Inhibitory Antibodies | |
| HY-P990374 | Anti-CLEC7A Antibody | Inhibitory Antibodies | |
| HY-P990376 | Anti-Complement C5aR1 Antibody | Inhibitory Antibodies | |
| HY-P990377 | Anti-Complement Factor B Antibody | Inhibitory Antibodies | |
| HY-P990378 | Anti-Complement Factor P/Properdin Antibody | Inhibitory Antibodies | |
| HY-P990379 | Anti-c-RET Antibody | Inhibitory Antibodies | |
| HY-P99038 | Odronextamab | 1801338-64-6 | Inhibitory Antibodies |
| HY-P990380 | Anti-CRTAM/CD355 Antibody | Inhibitory Antibodies | |
| HY-P990381 | Anti-CSF2/GM-CSF Antibody | Inhibitory Antibodies | |
| HY-P990384 | Anti-CSF3R/G-CSFR Antibody | Inhibitory Antibodies | |
| HY-P990385 | Anti-CTLA-4/CD152 Antibody | Inhibitory Antibodies | |
| HY-P990386 | Anti-CTLA-8/IL-17a Antibody | Inhibitory Antibodies | |
| HY-P990387 | Anti-CTSS/Cathepsin S Antibody (Fsn0503h) | Inhibitory Antibodies | |
| HY-P990388 | Anti-CXADR Antibody | Inhibitory Antibodies | |
| HY-P990389 | Anti-CXC-ELR Antibody | Inhibitory Antibodies | |
| HY-P99039 | Oleclumab | 1803176-05-7 | Inhibitory Antibodies |
| HY-P990390 | Anti-CXCL12/SDF1a Antibody | Inhibitory Antibodies | |
| HY-P990391 | Anti-CXCL4/PF4 Antibody | Inhibitory Antibodies | |
| HY-P990392 | Anti-CXCL8/IL-8 Antibody | Inhibitory Antibodies | |
| HY-P990393 | Anti-CXCL9 Antibody | Inhibitory Antibodies | |
| HY-P990394 | Anti-CXCR3/GPR9/CD183 Antibody | Inhibitory Antibodies | |
| HY-P990395 | Anti-CXCR4/CD184 Antibody | Inhibitory Antibodies | |
| HY-P990396 | Anti-CYR61/CCN1 Antibody | Inhibitory Antibodies | |
| HY-P990397 | Anti-DCBLD2/ESDN Antibody (FA19-1) | Inhibitory Antibodies | |
| HY-P990398 | Anti-DC-SIGN/CD209 Antibody | Inhibitory Antibodies | |
| HY-P9904 | Atezolizumab | 1380723-44-3 | Inhibitory Antibodies |
| HY-P99040 | Onvatilimab | 1969313-51-6 | Inhibitory Antibodies |
| HY-P990400 | Anti-DDR1/CD167a Antibody | Inhibitory Antibodies | |
| HY-P990401 | Anti-DLL3 Antibody | Inhibitory Antibodies | |
| HY-P990402 | Anti-DLL4 Antibody | Inhibitory Antibodies | |
| HY-P990403 | Anti-DSG3 Antibody | Inhibitory Antibodies | |
| HY-P990404 | Anti-EphA2 Antibody | Inhibitory Antibodies | |
| HY-P990405 | Anti-EphB2 Antibody | Inhibitory Antibodies | |
| HY-P990406 | Anti-EphB4 Antibody | Inhibitory Antibodies | |
| HY-P990407 | Anti-EPOR Antibody | Inhibitory Antibodies | |
| HY-P990408 | Anti-ERBB1/EGFR/HER1 Antibody | Inhibitory Antibodies | |
| HY-P990409 | Anti-ERBB1/EGFR/HER1 Antibody (7A7) | Inhibitory Antibodies | |
| HY-P99041 | Panitumumab | 339177-26-3 | Inhibitory Antibodies |
| HY-P990410 | Anti-ERG Antibody | Inhibitory Antibodies | |
| HY-P990411 | Anti-F3/Factor III/Tissue Factor/CD142 Antibody | Inhibitory Antibodies | |
| HY-P990412 | Anti-F8/Factor VIII Antibody | Inhibitory Antibodies | |
| HY-P990413 | Anti-Fc gamma R1 Antibody | Inhibitory Antibodies | |
| HY-P990414 | Anti-FGF19 Antibody (1A6) | Inhibitory Antibodies | |
| HY-P990415 | Anti-FGFR1/CD331 Antibody | Inhibitory Antibodies | |
| HY-P990417 | Anti-FOLR1/FRA Antibody | Inhibitory Antibodies | |
| HY-P990418 | Anti-FZD7 Antibody | Inhibitory Antibodies | |
| HY-P990419 | Anti-GAD65 Antibody | Inhibitory Antibodies | |
| HY-P99041A | Panitumumab (anti-EGFR) | Inhibitory Antibodies | |
| HY-P99042 | Polatuzumab | 2279068-37-8 | Inhibitory Antibodies |
| HY-P990421 | Anti-GOLM1 Antibody | Inhibitory Antibodies | |
| HY-P990423 | Anti-GPC2/Glypican 2 Antibody | Inhibitory Antibodies | |
| HY-P990424 | Anti-GPR44/PTGDR2/CD294 Antibody | Inhibitory Antibodies | |
| HY-P990425 | Anti-GPR73/PROKR1 Antibody | Inhibitory Antibodies | |
| HY-P990426 | Anti-GREM1/Gremlin Antibody | Inhibitory Antibodies | |
| HY-P990427 | Anti-Haptoglobin Antibody | Inhibitory Antibodies | |
| HY-P990429 | Anti-Hepcidin/HAMP Antibody | Inhibitory Antibodies | |
| HY-P99043 | Rovalpituzumab | 1613313-01-1 | Inhibitory Antibodies |
| HY-P990430 | Anti-HGF/SF Antibody (TAK-701) | Inhibitory Antibodies | |
| HY-P990431 | Anti-HGFA Antibody | Inhibitory Antibodies | |
| HY-P990432 | Anti-HGFR/c-Met Antibody | Inhibitory Antibodies | |
| HY-P990433 | Anti-Histone H2B Antibody | Inhibitory Antibodies | |
| HY-P990434 | Anti-Histone H3 Antibody | Inhibitory Antibodies | |
| HY-P990435 | Anti-Histone H4 Antibody | Inhibitory Antibodies | |
| HY-P990436 | Anti-ICAM3/CD50 Antibody | Inhibitory Antibodies | |
| HY-P990437 | Anti-IDO2 Antibody | Inhibitory Antibodies | |
| HY-P990438 | Anti-IFNa1 Antibody | Inhibitory Antibodies | |
| HY-P990439 | Anti-IFNAR1 Antibody | Inhibitory Antibodies | |
| HY-P99044 | Sabatolimab | 2252262-24-9 | Inhibitory Antibodies |
| HY-P990440 | Anti-IGF1R/CD221 Antibody | Inhibitory Antibodies | |
| HY-P990441 | Anti-IGF-2 Antibody (DX-2647) | Inhibitory Antibodies | |
| HY-P990442 | Anti-IL-13 Antibody (CNTO 607) | Inhibitory Antibodies | |
| HY-P990443 | Anti-IL-13 Antibody (H2L6) | Inhibitory Antibodies | |
| HY-P990444 | Anti-IL-13 Antibody (M1295) | Inhibitory Antibodies | |
| HY-P990445 | Anti-IL-13Ra2/CD213a2 | Inhibitory Antibodies | |
| HY-P990446 | Anti-IL-15 Antibody (DISC0280) | Inhibitory Antibodies | |
| HY-P990447 | Anti-IL-20 Antibody | Inhibitory Antibodies | |
| HY-P990448 | Anti-IL-20Ra Antibody | Inhibitory Antibodies | |
| HY-P990449 | Anti-IL-21 Antibody | Inhibitory Antibodies | |
| HY-P99045 | Sacituzumab | 1796566-95-4 | Inhibitory Antibodies |
| HY-P990451 | Anti-IL-3Ra/CD123 Antibody (SNG-CD123A) | Inhibitory Antibodies | |
| HY-P990452 | Anti-IL-5 Antibody | Inhibitory Antibodies | |
| HY-P990453 | Anti-IL-6/IFNb2 Antibody | Inhibitory Antibodies | |
| HY-P990454 | Anti-INHBB/Activin B Antibody | Inhibitory Antibodies | |
| HY-P990455 | Anti-Integrin a11/ITAG11 Antibody | Inhibitory Antibodies | |
| HY-P990456 | Anti-Integrin b7/ITGB7 Antibody | Inhibitory Antibodies | |
| HY-P990457 | Anti-KID3 Antibody | Inhibitory Antibodies | |
| HY-P990458 | Anti-KIR2DL1/CD158a Antibody | Inhibitory Antibodies | |
| HY-P990459 | Anti-KLK5/Kallikrein 5 Antibody | Inhibitory Antibodies | |
| HY-P99046 | Selicrelumab | 1622140-49-1 | Inhibitory Antibodies |
| HY-P990460 | Anti-LAP Antibody | Inhibitory Antibodies | |
| HY-P990461 | Anti-LIF Antibody (MSC-1) | Inhibitory Antibodies | |
| HY-P990462 | Anti-LILRB4/ILT3/CD85k Antibody | Inhibitory Antibodies | |
| HY-P990463 | Anti-MAGEA3 Antibody | Inhibitory Antibodies | |
| HY-P990464 | Anti-Matriptase Antibody | Inhibitory Antibodies | |
| HY-P990465 | Anti-Meflin Antibody | Inhibitory Antibodies | |
| HY-P990466 | Anti-Mesothelin Antibody | Inhibitory Antibodies | |
| HY-P990467 | Anti-MICB Antibody | Inhibitory Antibodies | |
| HY-P990468 | Anti-MMP9 Antibody | Inhibitory Antibodies | |
| HY-P990469 | Anti-MPL/TPOR/CD110 Antibody (TA136) | Inhibitory Antibodies | |
| HY-P99047 | Simtuzumab | 1318075-13-6 | Inhibitory Antibodies |
| HY-P990470 | Anti-MRC2/CD280 Antibody | Inhibitory Antibodies | |
| HY-P990471 | Anti-MSPR/RON/CD136 Antibody | Inhibitory Antibodies | |
| HY-P990472 | Anti-MSPR/RON/CD136 Antibody (H5B14) | Inhibitory Antibodies | |
| HY-P990473 | Anti-MUSK Antibody | Inhibitory Antibodies | |
| HY-P990474 | Anti-NGF/bNGF Antibody | Inhibitory Antibodies | |
| HY-P990475 | Anti-Nogo Receptor/NgR Antibody | Inhibitory Antibodies | |
| HY-P990476 | Anti-NOTCH1 Antibody | Inhibitory Antibodies | |
| HY-P990477 | Anti-NOTCH3 Antibody | Inhibitory Antibodies | |
| HY-P990478 | Anti-Orai1 Antibody | Inhibitory Antibodies | |
| HY-P990479 | Anti-OX2R/CD200R1 Antibody | Inhibitory Antibodies | |
| HY-P99048 | Sintilimab | 2072873-06-2 | Inhibitory Antibodies |
| HY-P990480 | Anti-oxLDL Antibody | Inhibitory Antibodies | |
| HY-P990481 | Anti-PACAP38 Antibody | Inhibitory Antibodies | |
| HY-P990482 | Anti-PAR2 Antibody | Inhibitory Antibodies | |
| HY-P990483 | Anti-PAR2 Antibody (PAR650097) | Inhibitory Antibodies | |
| HY-P990484 | Anti-PCLA Antibody | Inhibitory Antibodies | |
| HY-P990485 | Anti-PCSK9 Antibody | Inhibitory Antibodies | |
| HY-P990486 | Anti-PDCD1/PD-1/CD279 Antibody | Inhibitory Antibodies | |
| HY-P990487 | Anti-PDGFB Antibody (MOR-8457) | Inhibitory Antibodies | |
| HY-P990488 | Anti-PDGFC/VEGFE Antibody | Inhibitory Antibodies | |
| HY-P990489 | Anti-PDGFRB/CD140b Antibody (IMC-2C5) | Inhibitory Antibodies | |
| HY-P99048A | Sintilimab (Anti-PD-1) | Inhibitory Antibodies | |
| HY-P99049 | Sotigalimab | 2305607-45-6 | Inhibitory Antibodies |
| HY-P990490 | Anti-PGLYRP1/PGRP-S Antibody | Inhibitory Antibodies | |
| HY-P990491 | Anti-PLA2G1B Antibody | Inhibitory Antibodies | |
| HY-P990492 | Anti-PMEL Antibody | Inhibitory Antibodies | |
| HY-P990493 | Anti-Polyubiquitin Antibody | Inhibitory Antibodies | |
| HY-P990494 | Anti-PROM1/CD133 Antibody | Inhibitory Antibodies | |
| HY-P990495 | Anti-PTPRC/CD45 Antibody | Inhibitory Antibodies | |
| HY-P990496 | Anti-PVRIG Antibody (COM701) | Inhibitory Antibodies | |
| HY-P990497 | Anti-RAMP3 Antibody | Inhibitory Antibodies | |
| HY-P990498 | Anti-RGMC/HFE2 Antibody (DISC-0974) | Inhibitory Antibodies | |
| HY-P990499 | Anti-RHD/CD240d Antibody | Inhibitory Antibodies | |
| HY-P9905 | Cetuximab | 205923-56-4 | Inhibitory Antibodies |
| HY-P99050 | Sutimlimab | 2049079-64-1 | Inhibitory Antibodies |
| HY-P990500 | Anti-ROBO1 Antibody | Inhibitory Antibodies | |
| HY-P990501 | Anti-RSPO1 Antibody | Inhibitory Antibodies | |
| HY-P990502 | Anti-SCN11a/Nav1.9 Antibody | Inhibitory Antibodies | |
| HY-P990503 | Anti-SCN9a/Nav1.7 Antibody | Inhibitory Antibodies | |
| HY-P990504 | Anti-SERPINE1 Antibody | Inhibitory Antibodies | |
| HY-P990505 | Anti-Siglec-15/CD33L3 Antibody | Inhibitory Antibodies | |
| HY-P990506 | Anti-Siglec-2/CD22 Antibody (NCI m971) | Inhibitory Antibodies | |
| HY-P990507 | Anti-Siglec-2/CD22 Antibody (NCI m972) | Inhibitory Antibodies | |
| HY-P99051 | Tinurilimab | 2226224-30-0 | Inhibitory Antibodies |
| HY-P990510 | Anti-SLC40A1 Antibody | Inhibitory Antibodies | |
| HY-P990512 | Anti-Sphingosine-1-phosphate Antibody | Inhibitory Antibodies | |
| HY-P990513 | Anti-STOP1 Antibody | Inhibitory Antibodies | |
| HY-P990514 | Anti-TAT226 Antibody | Inhibitory Antibodies | |
| HY-P990515 | Anti-TCR Antibody (NKTT320) | Inhibitory Antibodies | |
| HY-P990516 | Anti-TEM7R/PLXDC2 Antibody | Inhibitory Antibodies | |
| HY-P990517 | Anti-TGFb1 Antibody | Inhibitory Antibodies | |
| HY-P990518 | Anti-TIE2/CD202b Antibody | Inhibitory Antibodies | |
| HY-P990519 | Anti-TLR3/CD283 Antibody (CNTO5429) | Inhibitory Antibodies | |
| HY-P99052 | Tislelizumab | 1858168-59-8 | Inhibitory Antibodies |
| HY-P990520 | Anti-TLR7 Antibody | Inhibitory Antibodies | |
| HY-P990521 | Anti-TM4SF1 Antibody | Inhibitory Antibodies | |
| HY-P990522 | Anti-TMEFF1/Tomoregulin-1 Antibody | Inhibitory Antibodies | |
| HY-P990523 | Anti-TMEFF2 Antibody | Inhibitory Antibodies | |
| HY-P990524 | Anti-TMPRSS2 Antibody | Inhibitory Antibodies | |
| HY-P990525 | Anti-TNFRSF18/GITR/CD357 Antibody | Inhibitory Antibodies | |
| HY-P990526 | Anti-TNFRSF21/DR6/CD358 Antibody | Inhibitory Antibodies | |
| HY-P990527 | Anti-TNFRSF5/CD40 Antibody | Inhibitory Antibodies | |
| HY-P990528 | Anti-TNFRSF7/CD27 Antibody | Inhibitory Antibodies | |
| HY-P990529 | Anti-TNFSF2/TNFa Antibody | Inhibitory Antibodies | |
| HY-P99053 | Tralokinumab | 1044515-88-9 | Inhibitory Antibodies |
| HY-P990530 | Anti-TNFSF2/TNFa Antibody (hMAK195) | Inhibitory Antibodies | |
| HY-P990531 | Anti-TNFSF9/4-1BBL Antibody | Inhibitory Antibodies | |
| HY-P990532 | Anti-TPBG Antibody | Inhibitory Antibodies | |
| HY-P990533 | Anti-TPSAB1 Antibody | Inhibitory Antibodies | |
| HY-P990534 | Anti-TSHR Antibody (K1-70) | Inhibitory Antibodies | |
| HY-P990535 | Anti-TSLP Antibody | Inhibitory Antibodies | |
| HY-P990536 | Anti-TSPAN8 Antibody | Inhibitory Antibodies | |
| HY-P990537 | Anti-VCAM1/CD106 Antibody | Inhibitory Antibodies | |
| HY-P990538 | Anti-VEGF Antibody | Inhibitory Antibodies | |
| HY-P99054 | Tusamitamab | 2349294-95-5 | Inhibitory Antibodies |
| HY-P990540 | Anti-VEGFB Antibody (CSL346) | Inhibitory Antibodies | |
| HY-P990541 | Anti-VEGFR1/FLT1 Antibody | Inhibitory Antibodies | |
| HY-P990542 | Anti-VEGFR2/KDR/CD309 Antibody | Inhibitory Antibodies | |
| HY-P990543 | Anti-VEGFR2/KDR/CD309 Antibody (AT001) | Inhibitory Antibodies | |
| HY-P990544 | Anti-vWF Antibody | Inhibitory Antibodies | |
| HY-P990545 | ANX005 | Inhibitory Antibodies | |
| HY-P990546 | Apamistamab | Inhibitory Antibodies | |
| HY-P990547 | APX-007 | Inhibitory Antibodies | |
| HY-P990549 | ASK-8007 | Inhibitory Antibodies | |
| HY-P99055 | Urelumab | 934823-49-1 | Inhibitory Antibodies |
| HY-P990550 | ATH3G10 | Inhibitory Antibodies | |
| HY-P990551 | Atinumab (NG-101) | 1226761-65-4 | Inhibitory Antibodies |
| HY-P990552 | ATN-658 | Inhibitory Antibodies | |
| HY-P990554 | BHQ-880 | Inhibitory Antibodies | |
| HY-P990555 | BI-765063 | Inhibitory Antibodies | |
| HY-P990558 | BMS-986021 | Inhibitory Antibodies | |
| HY-P990559 | BMS-986178 | Inhibitory Antibodies | |
| HY-P99056 | Utomilumab | 1417318-27-4 | Inhibitory Antibodies |
| HY-P990560 | BNC-101 | Inhibitory Antibodies | |
| HY-P990561 | BT-063 | Inhibitory Antibodies | |
| HY-P990562 | CAT-2200 | Inhibitory Antibodies | |
| HY-P990563 | CDP-484 | Inhibitory Antibodies | |
| HY-P990564 | Senlizumab | 336128-48-4 | Inhibitory Antibodies |
| HY-P990566 | CDX-1401 | 1587257-96-2 | Inhibitory Antibodies |
| HY-P990567 | Citatuzumab | Inhibitory Antibodies | |
| HY-P990568 | CLN-619 | Inhibitory Antibodies | |
| HY-P990569 | CM-24 | 1783801-93-3 | Inhibitory Antibodies |
| HY-P99057 | Varlilumab | 1393344-72-3 | Inhibitory Antibodies |
| HY-P990570 | CMAB008 | Inhibitory Antibodies | |
| HY-P990571 | Coltuximab | Inhibitory Antibodies | |
| HY-P990572 | DCBY02 | Inhibitory Antibodies | |
| HY-P990573 | DEDN6526A (RG-7636) | Inhibitory Antibodies | |
| HY-P990574 | Derlotuximab | 340013-96-9 | Inhibitory Antibodies |
| HY-P990575 | DFRF4539A (RG-7598) | Inhibitory Antibodies | |
| HY-P990578 | Anti-GPR20 Antibody | Inhibitory Antibodies | |
| HY-P990579 | Anti-CLDN6 Antibody (DS-9606A antibody) | Inhibitory Antibodies | |
| HY-P99057A | Varlilumab (anti-CD27) | 1393344-72-3 | Inhibitory Antibodies |
| HY-P99058 | Zolbetuximab | 1496553-00-4 | Inhibitory Antibodies |
| HY-P990581 | ELB-031 | Inhibitory Antibodies | |
| HY-P990585 | ESBA-105 | Inhibitory Antibodies | |
| HY-P990586 | FG-3246 (FOR46) | Inhibitory Antibodies | |
| HY-P990587 | FR104 | Inhibitory Antibodies | |
| HY-P990589 | GBR-900 | Inhibitory Antibodies | |
| HY-P990590 | GFB-024 | Inhibitory Antibodies | |
| HY-P990591 | GSK-1070806 | Inhibitory Antibodies | |
| HY-P990592 | GSK-3050002 | Inhibitory Antibodies | |
| HY-P990593 | GSK-4381562 | Inhibitory Antibodies | |
| HY-P990594 | GSK-679586 | Inhibitory Antibodies | |
| HY-P990595 | GSK-933776 | Inhibitory Antibodies | |
| HY-P990596 | Hersintuzumab | Inhibitory Antibodies | |
| HY-P990597 | HuGAL-F2 | Inhibitory Antibodies | |
| HY-P990598 | Adakitug | 2231258-73-2 | Inhibitory Antibodies |
| HY-P990599 | Ibritumomab | Inhibitory Antibodies | |
| HY-P9906 | Bevacizumab | 216974-75-3 | Inhibitory Antibodies |
| HY-P990600 | Icatolimab | 2236068-83-8 | Inhibitory Antibodies |
| HY-P990601 | ICT-01 | Inhibitory Antibodies | |
| HY-P990602 | IMA-026 | 1038541-65-9 | Inhibitory Antibodies |
| HY-P990603 | IMC-C103C | Inhibitory Antibodies | |
| HY-P990604 | Anti-ADAM9 Antibody (MGA021) | Inhibitory Antibodies | |
| HY-P990605 | Anti-CD33 Antibody | Inhibitory Antibodies | |
| HY-P990606 | IMMU-114 | Inhibitory Antibodies | |
| HY-P990607 | Indatuximab | Inhibitory Antibodies | |
| HY-P990608 | Alpitatug | 2921676-05-1 | Inhibitory Antibodies |
| HY-P990609 | KHK-2866 | 1832713-21-9 | Inhibitory Antibodies |
| HY-P990610 | KHK-2898 | Inhibitory Antibodies | |
| HY-P990611 | KRN-330 | Inhibitory Antibodies | |
| HY-P990612 | LGN-523 (AML-01) | Inhibitory Antibodies | |
| HY-P990613 | LIV-1205 (CBA-1205) | Inhibitory Antibodies | |
| HY-P990614 | LK-1 | Inhibitory Antibodies | |
| HY-P990615 | Anti-c-Kit Antibody (LMJ729) | Inhibitory Antibodies | |
| HY-P990616 | LY2525623 | Inhibitory Antibodies | |
| HY-P990617 | LY2787106 | Inhibitory Antibodies | |
| HY-P990618 | LY2928057 | Inhibitory Antibodies | |
| HY-P990619 | LY3022855 | Inhibitory Antibodies | |
| HY-P990620 | LY3022856 | Inhibitory Antibodies | |
| HY-P990621 | LY3022859 (IMC-TR1) | Inhibitory Antibodies | |
| HY-P990622 | MB-311 | Inhibitory Antibodies | |
| HY-P990623 | MDX-1105 | Inhibitory Antibodies | |
| HY-P990624 | MEDI-2045 | Inhibitory Antibodies | |
| HY-P990625 | MEDI-3617 | 1415642-51-1 | Inhibitory Antibodies |
| HY-P990627 | Anti-EphA2 Antibody (1C1) | Inhibitory Antibodies | |
| HY-P990628 | MEDI-570 | 2179209-59-5 | Inhibitory Antibodies |
| HY-P990629 | MEDI-578 | Inhibitory Antibodies | |
| HY-P990630 | Anti-LY75/CD205 Antibody (MEN1309) | Inhibitory Antibodies | |
| HY-P990631 | Mibavademab | 2305770-44-7 | Inhibitory Antibodies |
| HY-P990632 | MVT-5873 | 2362015-67-4 | Inhibitory Antibodies |
| HY-P990633 | NC-318 (5G-12) | Inhibitory Antibodies | |
| HY-P990634 | NEO-201 | Inhibitory Antibodies | |
| HY-P990635 | NGM-120 | Inhibitory Antibodies | |
| HY-P990636 | NGM-313 | Inhibitory Antibodies | |
| HY-P990637 | NGM-621 | Inhibitory Antibodies | |
| HY-P990638 | NI-0701 | Inhibitory Antibodies | |
| HY-P990639 | NI-0801 | Inhibitory Antibodies | |
| HY-P990641 | NTX-1088 | Inhibitory Antibodies | |
| HY-P990642 | Oportuzumab | Inhibitory Antibodies | |
| HY-P990643 | OS-2966 | Inhibitory Antibodies | |
| HY-P990644 | PDL-241 | Inhibitory Antibodies | |
| HY-P990645 | PF-03732010 | 2070913-84-5 | Inhibitory Antibodies |
| HY-P990646 | Anti-TPBG Antibody (PF-06263507) | Inhibitory Antibodies | |
| HY-P990647 | PF-06342674 | Inhibitory Antibodies | |
| HY-P990649 | PF-5212374 (TRU-015) | 1169717-01-4 | Inhibitory Antibodies |
| HY-P990650 | PY159 | Inhibitory Antibodies | |
| HY-P990651 | PY314 | Inhibitory Antibodies | |
| HY-P990653 | R707 | Inhibitory Antibodies | |
| HY-P990654 | Radretumab | 1253180-81-2 | Inhibitory Antibodies |
| HY-P990656 | RG-6125 | Inhibitory Antibodies | |
| HY-P990657 | RG-7212 (RO5458640) | Inhibitory Antibodies | |
| HY-P990658 | RG-7652 | Inhibitory Antibodies | |
| HY-P990659 | Anti-LY6E Antibody (MLYE4489A) | Inhibitory Antibodies | |
| HY-P990660 | RGX-019 | Inhibitory Antibodies | |
| HY-P990661 | SAIT-301 | Inhibitory Antibodies | |
| HY-P990662 | Sapelizumab | 1535963-91-7 | Inhibitory Antibodies |
| HY-P990664 | Anti-Melanotransferrin/CD228 Antibody | Inhibitory Antibodies | |
| HY-P990665 | Anti-SLAMF6 Antibody (h20F3ec) | Inhibitory Antibodies | |
| HY-P990667 | STX-100 | 1439902-67-6 | Inhibitory Antibodies |
| HY-P990668 | TOL-101 | Inhibitory Antibodies | |
| HY-P990669 | Torudokimab | 2241728-76-5 | Inhibitory Antibodies |
| HY-P990670 | TTX-030 | 2935496-38-9 | Inhibitory Antibodies |
| HY-P990672 | U3-1784 | Inhibitory Antibodies | |
| HY-P990673 | Vandortuzumab | Inhibitory Antibodies | |
| HY-P990674 | VB1-050 | Inhibitory Antibodies | |
| HY-P990675 | VGX-100 | Inhibitory Antibodies | |
| HY-P990676 | VIB-9600 | Inhibitory Antibodies | |
| HY-P990677 | VLST-002 | Inhibitory Antibodies | |
| HY-P990678 | Vonlerizumab | 1638935-72-4 | Inhibitory Antibodies |
| HY-P990679 | Rat IgG2a kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P990680 | Anti-Mouse CD40 Antibody (FGK4.5/FGK45) | Inhibitory Antibodies | |
| HY-P990682 | Rat IgG2b kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P990683 | Satumomab | 144058-40-2 | Inhibitory Antibodies |
| HY-P990684 | Tacatuzumab | Inhibitory Antibodies | |
| HY-P990685 | Romiplostim | 267639-76-9 | Inhibitory Antibodies |
| HY-P990686 | Ispectamab | Inhibitory Antibodies | |
| HY-P990687 | Luveltamab | Inhibitory Antibodies | |
| HY-P990688 | Xaluritamig | 2559056-68-5 | Inhibitory Antibodies |
| HY-P990689 | Zifibancimig | 2517939-46-5 | Inhibitory Antibodies |
| HY-P990690 | Volrustomig | 2407760-40-9 | Inhibitory Antibodies |
| HY-P990691 | Vilamakitug | 2458202-06-5 | Inhibitory Antibodies |
| HY-P990692 | Ciduvectamig | 2412587-62-1 | Inhibitory Antibodies |
| HY-P990693 | Tarperprumig | 2630946-41-5 | Inhibitory Antibodies |
| HY-P990694 | Zeripatamig | 2607644-43-7 | Inhibitory Antibodies |
| HY-P990695 | Lunaxafusp | 2642197-17-7 | Inhibitory Antibodies |
| HY-P990696 | Resugosbart | 2647412-09-5 | Inhibitory Antibodies |
| HY-P990697 | Anvatabart | 2636710-06-8 | Inhibitory Antibodies |
| HY-P990698 | Umizortamig | 2599198-83-9 | Inhibitory Antibodies |
| HY-P990699 | Riltovetbart | 2641479-65-2 | Inhibitory Antibodies |
| HY-P9906A | Bevacizumab (PBS) | 216974-75-3 | Inhibitory Antibodies |
| HY-P9907 | Trastuzumab | 180288-69-1 | Inhibitory Antibodies |
| HY-P990700 | Tobemstomig | 2648839-43-2 | Inhibitory Antibodies |
| HY-P990701 | Lomvastomig | 2648840-52-0 | Inhibitory Antibodies |
| HY-P990702 | Pradusinstobart | 2642171-66-0 | Inhibitory Antibodies |
| HY-P990703 | Porustobart | 2649372-91-6 | Inhibitory Antibodies |
| HY-P990704 | Rilvegostomig | 2640305-01-5 | Inhibitory Antibodies |
| HY-P990705 | Gorivitug | 2765086-18-6 | Inhibitory Antibodies |
| HY-P990706 | Povetacicept | 2490217-42-8 | Inhibitory Antibodies |
| HY-P990707 | Maplirpacept | 2631667-06-4 | Inhibitory Antibodies |
| HY-P990708 | Bizaxofusp | 1236019-35-4 | Inhibitory Antibodies |
| HY-P990710 | Acimtamig | 2738880-26-5 | Inhibitory Antibodies |
| HY-P990711 | Canrivitug | Inhibitory Antibodies | |
| HY-P990712 | Ersodetug | 2410976-61-1 | Inhibitory Antibodies |
| HY-P990713 | Nolavetbart | 2750248-93-0 | Inhibitory Antibodies |
| HY-P990714 | Obertamig | 2750126-32-8 | Inhibitory Antibodies |
| HY-P990715 | Ozekibart | 2539847-03-3 | Inhibitory Antibodies |
| HY-P990716 | Sabestomig | 2648346-74-9 | Inhibitory Antibodies |
| HY-P990717 | Brenetafusp | 2736407-54-6 | Inhibitory Antibodies |
| HY-P990718 | Cemavafusp | 2711705-98-3 | Inhibitory Antibodies |
| HY-P990719 | Efbalropendekin alfa | 2736449-62-8 | Inhibitory Antibodies |
| HY-P990720 | Elritercept | 2727114-26-1 | Inhibitory Antibodies |
| HY-P990721 | Inpegsomatropin | 2656386-75-1 | Inhibitory Antibodies |
| HY-P990722 | Danvilostomig | 2599198-80-6 | Inhibitory Antibodies |
| HY-P990723 | Timdarpacept | 2749520-17-8 | Inhibitory Antibodies |
| HY-P990724 | Tividenofusp alfa | 2641020-57-5 | Inhibitory Antibodies |
| HY-P990725 | Nisfevitug | Inhibitory Antibodies | |
| HY-P990726 | Abiprubart | 2765071-95-0 | Inhibitory Antibodies |
| HY-P990727 | Alextatug | 2768264-93-1 | Inhibitory Antibodies |
| HY-P990728 | Bezetabart | 2763746-69-4 | Inhibitory Antibodies |
| HY-P990729 | Budoprutug | 2720478-38-4 | Inhibitory Antibodies |
| HY-P990730 | Cabotamig | 2755301-09-6 | Inhibitory Antibodies |
| HY-P990731 | Canvircept | 2833647-10-0 | Inhibitory Antibodies |
| HY-P990732 | Cepeprubart | 2769758-59-8 | Inhibitory Antibodies |
| HY-P990733 | Cibotercept | 2769700-97-0 | Inhibitory Antibodies |
| HY-P990734 | Coramitug | 2626841-92-5 | Inhibitory Antibodies |
| HY-P990735 | Donzakimig | 2765066-99-5 | Inhibitory Antibodies |
| HY-P990736 | Efercoleukin alfa | 2760549-52-6 | Inhibitory Antibodies |
| HY-P990737 | Eltrekibart | 2484883-56-7 | Inhibitory Antibodies |
| HY-P990738 | Enristomig | 2539845-73-1 | Inhibitory Antibodies |
| HY-P990739 | Evalstotug | 2460399-39-5 | Inhibitory Antibodies |
| HY-P990740 | Fanastomig | 2761795-00-8 | Inhibitory Antibodies |
| HY-P990741 | Galvokimig | 2648456-30-6 | Inhibitory Antibodies |
| HY-P990742 | Givastomig | 2762499-30-7 | Inhibitory Antibodies |
| HY-P990743 | Gruticibart | 2704554-77-6 | Inhibitory Antibodies |
| HY-P990744 | Ibentatug | 2767983-94-6 | Inhibitory Antibodies |
| HY-P990745 | Izastobart | 2769937-42-8 | Inhibitory Antibodies |
| HY-P990746 | Lancastotug | 2768355-20-8 | Inhibitory Antibodies |
| HY-P990747 | Lumrotatug | 2760318-99-6 | Inhibitory Antibodies |
| HY-P990748 | Lunsekimig | 2770858-49-4 | Inhibitory Antibodies |
| HY-P990749 | Luvagrobart | 2768355-18-4 | Inhibitory Antibodies |
| HY-P990750 | Negalstobart | 2360418-68-2 | Inhibitory Antibodies |
| HY-P990751 | Nelmastobart | 2669823-48-5 | Inhibitory Antibodies |
| HY-P990752 | Nezastomig | 2657613-60-8 | Inhibitory Antibodies |
| HY-P990753 | Omoprubart | 2763342-87-4 | Inhibitory Antibodies |
| HY-P990754 | Opelkibart | 2771389-44-5 | Inhibitory Antibodies |
| HY-P990755 | Pamvatamig | 2750004-05-6 | Inhibitory Antibodies |
| HY-P990756 | Pemivibart | 2858673-18-2 | Inhibitory Antibodies |
| HY-P990757 | Ragistomig | 2763222-58-6 | Inhibitory Antibodies |
| HY-P990758 | Reflocibart | 2642578-92-3 | Inhibitory Antibodies |
| HY-P990759 | Rezetamig | 2795115-07-8 | Inhibitory Antibodies |
| HY-P990760 | Rezorstobart | 2762201-86-3 | Inhibitory Antibodies |
| HY-P990761 | Roconkibart | 2638480-59-6 | Inhibitory Antibodies |
| HY-P990762 | Seniprutug | 2484772-72-5 | Inhibitory Antibodies |
| HY-P990763 | Sifarobocept | 2760175-31-1 | Inhibitory Antibodies |
| HY-P990764 | Sigvotatug | 2764774-90-3 | Inhibitory Antibodies |
| HY-P990765 | Silevimig | 2618667-99-3 | Inhibitory Antibodies |
| HY-P990766 | Sipavibart | 2768288-97-5 | Inhibitory Antibodies |
| HY-P990767 | Solrikitug | 2768721-24-8 | Inhibitory Antibodies |
| HY-P990768 | Timcevibart | 2857862-27-0 | Inhibitory Antibodies |
| HY-P990769 | Traxivitug | 2770852-89-4 | Inhibitory Antibodies |
| HY-P990770 | Ucenprubart | 2414559-57-0 | Inhibitory Antibodies |
| HY-P990771 | Uprevstobart | 2762201-85-2 | Inhibitory Antibodies |
| HY-P990772 | Usilnetug | 2770861-19-1 | Inhibitory Antibodies |
| HY-P990773 | Venanprubart | 2635407-50-8 | Inhibitory Antibodies |
| HY-P990774 | Verekitug | 2768386-15-6 | Inhibitory Antibodies |
| HY-P990775 | Vilastobart | 2760549-50-4 | Inhibitory Antibodies |
| HY-P990776 | Vimekofusp | 2771192-33-5 | Inhibitory Antibodies |
| HY-P990777 | Vipalanebart | 2642173-04-2 | Inhibitory Antibodies |
| HY-P990778 | Xirestomig | 2756879-35-1 | Inhibitory Antibodies |
| HY-P990780 | Zeleciment | 2725863-34-1 | Inhibitory Antibodies |
| HY-P990781 | Suciraslimab | 2415439-63-1 | Inhibitory Antibodies |
| HY-P990782 | Efzofitimod | 2566615-11-8 | Inhibitory Antibodies |
| HY-P990785 | Etentamig | 2490552-52-6 | Inhibitory Antibodies |
| HY-P990786 | Anti-FLT3 Antibody (AGS62P) | Inhibitory Antibodies | |
| HY-P990788 | Anti-Mouse PD-1 Antibody (29F.1A12) | Inhibitory Antibodies | |
| HY-P990789 | Anti-Mouse CTLA-4 Antibody (9H10) | Inhibitory Antibodies | |
| HY-P990790 | Anti-Mouse CD8α Antibody (2.43) | Inhibitory Antibodies | |
| HY-P990791 | Anti-Mouse CD71/TfR1 Antibody (R17 217.1.3) | Inhibitory Antibodies | |
| HY-P990792 | Anti-Mouse CD4 Antibody (GK1.5) | Inhibitory Antibodies | |
| HY-P990793 | Anti-Mouse CD28 Antibody (D665) | Inhibitory Antibodies | |
| HY-P990794 | Anti-Mouse TNF-alpha/TNFSF2 Antibody (XT3.11) | Inhibitory Antibodies | |
| HY-P990795 | Anti-Mouse osteopontin/SPP1 Antibody (100D3) | Inhibitory Antibodies | |
| HY-P990796 | Anti-Mouse IL-2 Antibody (S4B6-1) | Inhibitory Antibodies | |
| HY-P990797 | Anti-Mouse IFN gamma Antibody (R4-6A2) | Inhibitory Antibodies | |
| HY-P990798 | Anti-Mouse IFN gamma Antibody (XMG1.2) | Inhibitory Antibodies | |
| HY-P9907A | Trastuzumab (anti-HER2) | 180288-69-1 | Inhibitory Antibodies |
| HY-P9908 | Adalimumab | 331731-18-1 | Inhibitory Antibodies |
| HY-P990800 | Anti-Mouse IL-4 Antibody (BVD6-24G2) | Inhibitory Antibodies | |
| HY-P990801 | Anti-Mouse CD11a/LFA-1α Antibody (M17/4) | Inhibitory Antibodies | |
| HY-P990802 | Anti-Mouse CD3ε Antibody (145-2C11) | Inhibitory Antibodies | |
| HY-P990803 | Anti-Mouse CD28 Antibody (PV-1) | Inhibitory Antibodies | |
| HY-P990804 | Anti-Mouse NKG2D/CD314 Antibody (HMG2D) | Inhibitory Antibodies | |
| HY-P990805 | Anti-Human/Mouse GRP78 Antibody (C38) | Inhibitory Antibodies | |
| HY-P990806 | Anti-Mouse CD20 Antibody (MB20-11) | Inhibitory Antibodies | |
| HY-P990807 | Anti-Mouse CD1d Antibody (20H2 (HB323)) | Inhibitory Antibodies | |
| HY-P990808 | Anti-Mouse CD122/IL-2Rβ Antibody (TM-Beta 1) | Inhibitory Antibodies | |
| HY-P990809 | Anti-Mouse 4-1BB/CD137 Antibody (LOB12.3) | Inhibitory Antibodies | |
| HY-P990810 | Anti-LCMV Nucleoprotein Antibody (VL-4) | Inhibitory Antibodies | |
| HY-P990811 | Anti-Influenza A virus NP Antibody (H16-L10-4R5 (HB-65)) | Inhibitory Antibodies | |
| HY-P990812 | Anti-Mouse myeloperoxidase/MPO Antibody (6D1) | Inhibitory Antibodies | |
| HY-P990813 | Anti-Mouse Nonclassical MHC Class I molecule Qa-1b Antibody (4C2.4A7.5H11) | Inhibitory Antibodies | |
| HY-P990814 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope B, SARS2-34) | Inhibitory Antibodies | |
| HY-P990815 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope A, SARS2-01) | Inhibitory Antibodies | |
| HY-P990816 | Anti-SARS-CoV-2 S protein Antibody (NTD, SARS2-29) | Inhibitory Antibodies | |
| HY-P990817 | Anti-West Nile/dengue virus E protein Antibody (E60) | Inhibitory Antibodies | |
| HY-P990818 | Anti-Rat FcRn heavy chain heterodimers Antibody (1G3) | Inhibitory Antibodies | |
| HY-P990819 | Anti-Rat CD28 Antibody (JJ316) | Inhibitory Antibodies | |
| HY-P990820 | Anti-Mouse TIM-4 Antibody (RMT4-53) | Inhibitory Antibodies | |
| HY-P990821 | Anti-Mouse TIM-3 Antibody (RMT3-23) | Inhibitory Antibodies | |
| HY-P990822 | Anti-Mouse TIM-1/CD365 Antibody (3D10) | Inhibitory Antibodies | |
| HY-P990823 | Anti-Mouse PD-L1/B7-H1 Antibody (10F.2H11) | Inhibitory Antibodies | |
| HY-P990824 | Anti-Mouse PD-1 Antibody (J43) | Inhibitory Antibodies | |
| HY-P990825 | Anti-Chikungunya virus E2 Antibody (CHK-265) | Inhibitory Antibodies | |
| HY-P990826 | Anti-YB-1 Antibody (21A3) | Inhibitory Antibodies | |
| HY-P990827 | Anti-TROP-2 Antibody (Pr1E11) | Inhibitory Antibodies | |
| HY-P990828 | Anti-PD-L1/B7-H1 Antibody (29E.2A3) | Inhibitory Antibodies | |
| HY-P990829 | Anti-NKG2D/CD314 Antibody (1D11) | Inhibitory Antibodies | |
| HY-P990830 | Anti-MUC16 Antibody (VK8) | Inhibitory Antibodies | |
| HY-P990831 | Anti-MUC1/CD227 Antibody (C595 (NCRC48)) | Inhibitory Antibodies | |
| HY-P990832 | Anti-MHC Class I Antibody (W6/32) | Inhibitory Antibodies | |
| HY-P990833 | Anti-Mesothelin Antibody (YP218) | Inhibitory Antibodies | |
| HY-P990834 | Anti-MAGEC2/CT10 Antibody (LX-CT10.5) | Inhibitory Antibodies | |
| HY-P990835 | Anti-LFA-1α/CD11a Antibody (TS-1/22.1.1.13) | Inhibitory Antibodies | |
| HY-P990836 | Anti-IL-9 Antibody (MH9A4) | Inhibitory Antibodies | |
| HY-P990837 | Anti-IL-4 Antibody (MP4-25D2) | Inhibitory Antibodies | |
| HY-P990838 | Anti-IL-12 p70 Antibody (20C2) | Inhibitory Antibodies | |
| HY-P990839 | Anti-IFNγ Antibody (B133.5) | Inhibitory Antibodies | |
| HY-P990840 | Anti-GPC3 Antibody (YP7) | Inhibitory Antibodies | |
| HY-P990841 | Anti-pan-Glypican Antibody (HS20) | Inhibitory Antibodies | |
| HY-P990842 | Anti-GPC-2 Antibody (CT3) | Inhibitory Antibodies | |
| HY-P990843 | Anti-Glycophorin A (type M) Antibody (6A7M) | Inhibitory Antibodies | |
| HY-P990844 | Anti-GC1q R/C1QBP Antibody (60.11) | Inhibitory Antibodies | |
| HY-P990845 | Anti-Ganglioside GD2 Antibody (14G2a) | Inhibitory Antibodies | |
| HY-P990846 | Anti-Fy3 Antibody (MIMA-29) | Inhibitory Antibodies | |
| HY-P990847 | Anti-E-Selectin Antibody (CL2) | Inhibitory Antibodies | |
| HY-P990848 | Anti-CTLA-4/CD152 Antibody (BN13) | Inhibitory Antibodies | |
| HY-P990849 | Anti-CSF1R/CD115 Antibody (2-4A5-4) | Inhibitory Antibodies | |
| HY-P990850 | Anti-c-myc Antibody (9E10) | Inhibitory Antibodies | |
| HY-P990851 | Anti-c-Kit/CD117 Antibody (SR-1) | Inhibitory Antibodies | |
| HY-P990852 | Anti-CEACAM7 Antibody (P3-7B) | Inhibitory Antibodies | |
| HY-P990853 | Anti-CEACAM5 Antibody (4H11-8) | Inhibitory Antibodies | |
| HY-P990854 | Anti-CEACAM1/3/5/6/8 Antibody (6G5j) | Inhibitory Antibodies | |
| HY-P990855 | Anti-CD8α Antibody (OKT-8) | Inhibitory Antibodies | |
| HY-P990856 | Anti-CD71 Antibody (OKT-9) | Inhibitory Antibodies | |
| HY-P990857 | Anti-CD54/ICAM-1 Antibody (R6-5-D6) | Inhibitory Antibodies | |
| HY-P990858 | Anti-CD47 Antibody (B6.H12) | Inhibitory Antibodies | |
| HY-P990859 | Anti-CD44 Antibody (Hermes-1) | Inhibitory Antibodies | |
| HY-P990860 | Anti-CD40 Antibody (G28.5) | Inhibitory Antibodies | |
| HY-P990861 | Anti-CD4 Antibody (OKT-4) | Inhibitory Antibodies | |
| HY-P990862 | Anti-CD326/EpCAM Antibody (Ber-EP4) | Inhibitory Antibodies | |
| HY-P990863 | Anti-CD32/FcγRIIA Antibody (IV.3) | Inhibitory Antibodies | |
| HY-P990864 | Anti-CD3 Antibody (OKT-3) | Inhibitory Antibodies | |
| HY-P990865 | Anti-CD28 Antibody (9.3) | Inhibitory Antibodies | |
| HY-P990866 | Anti-CD25/IL-2Rα Antibody (7G7B6) | Inhibitory Antibodies | |
| HY-P990867 | Anti-CD220/Insulin Receptor Antibody (IR 83-22) | Inhibitory Antibodies | |
| HY-P990868 | Anti-CD2 Antibody (CB.219) | Inhibitory Antibodies | |
| HY-P990869 | Anti-CD1a Antibody (OKT-6) | Inhibitory Antibodies | |
| HY-P990870 | Anti-CD19 Antibody (4G7) | Inhibitory Antibodies | |
| HY-P990871 | Anti-CD11a/LFA-1α Antibody (R7-1) | Inhibitory Antibodies | |
| HY-P990872 | Anti-CA19-9 Antibody (1116-NS-19-9) | Inhibitory Antibodies | |
| HY-P990873 | Anti-BRCA1 Antibody (BR64) | Inhibitory Antibodies | |
| HY-P990874 | Anti-HIV gp120 Antibody (55-36) | Inhibitory Antibodies | |
| HY-P990875 | Anti-TIM-1/KIM-1/CD365 Antibody (2.70.2) | Inhibitory Antibodies | |
| HY-P990876 | Afimkibart | 2911580-96-4 | Inhibitory Antibodies |
| HY-P990894 | Anti-DM1 antibody(14E3) (Rabbit mAb) | ADC Related | |
| HY-P990896 | FZ-A038 | Inhibitory Antibodies | |
| HY-P990897 | Aldastotug | 2865844-59-1 | Inhibitory Antibodies |
| HY-P990898 | Amlenetug | 2850367-41-6 | Inhibitory Antibodies |
| HY-P990899 | Amostomig | 2889449-09-4 | Inhibitory Antibodies |
| HY-P9909 | Ustekinumab | 815610-63-0 | Inhibitory Antibodies |
| HY-P990900 | Ansipastobart | 2829250-32-8 | Inhibitory Antibodies |
| HY-P990901 | Aplitabart | 2796349-94-3 | Inhibitory Antibodies |
| HY-P990902 | Atigotatug | 2733581-82-1 | Inhibitory Antibodies |
| HY-P990903 | Avitotamig | 2577961-36-3 | Inhibitory Antibodies |
| HY-P990904 | Azirkitug | 2837169-12-5 | Inhibitory Antibodies |
| HY-P990905 | Bexatamig | 2871775-98-1 | Inhibitory Antibodies |
| HY-P990906 | Bosakitug | 2762183-23-1 | Inhibitory Antibodies |
| HY-P990907 | Brivekimig | 2834733-45-6 | Inhibitory Antibodies |
| HY-P990908 | Cafelkibart | 2851855-89-3 | Inhibitory Antibodies |
| HY-P990909 | Calotatug | 2254097-05-5 | Inhibitory Antibodies |
| HY-P990910 | Comekibart | 2833673-47-3 | Inhibitory Antibodies |
| HY-P990911 | Crebankitug | 2893793-17-2 | Inhibitory Antibodies |
| HY-P990912 | Cugrastomig | 2852680-10-3 | Inhibitory Antibodies |
| HY-P990913 | Dalmitamig | 2765077-69-6 | Inhibitory Antibodies |
| HY-P990914 | Denikitug | 2865822-82-6 | Inhibitory Antibodies |
| HY-P990915 | Dibotatug | 2842038-48-4 | Inhibitory Antibodies |
| HY-P990916 | Donitabart | 2888594-15-6 | Inhibitory Antibodies |
| HY-P990917 | Ebrasodebart | 2572467-73-1 | Inhibitory Antibodies |
| HY-P990918 | Emiltatug | 2855971-15-0 | Inhibitory Antibodies |
| HY-P990919 | Gimistotug | 2768487-95-0 | Inhibitory Antibodies |
| HY-P990920 | Gocatamig | 2851862-91-2 | Inhibitory Antibodies |
| HY-P990921 | Imelciment | 2845128-03-0 | Inhibitory Antibodies |
| HY-P990922 | Indenebart | 2864437-88-5 | Inhibitory Antibodies |
| HY-P990923 | Lanerkitug | 2839417-54-6 | Inhibitory Antibodies |
| HY-P990924 | Libevitug | 2817665-64-6 | Inhibitory Antibodies |
| HY-P990925 | Linclatamig | 2885203-43-8 | Inhibitory Antibodies |
| HY-P990926 | Lumistobart | 2851923-91-4 | Inhibitory Antibodies |
| HY-P990927 | Micvotabart | 2867549-73-1 | Inhibitory Antibodies |
| HY-P990928 | Mipletamig | 2839556-21-5 | Inhibitory Antibodies |
| HY-P990929 | Misitatug | 2767203-01-8 | Inhibitory Antibodies |
| HY-P990930 | Mozistobart | 2852752-92-0 | Inhibitory Antibodies |
| HY-P990931 | Navenibart | 2803430-16-0 | Inhibitory Antibodies |
| HY-P990932 | Obrixtamig | 2851943-09-2 | Inhibitory Antibodies |
| HY-P990933 | Ocankitug | 2803351-66-6 | Inhibitory Antibodies |
| HY-P990934 | Olintatug | 2851870-28-3 | Inhibitory Antibodies |
| HY-P990935 | Opugotamig | 2779564-38-2 | Inhibitory Antibodies |
| HY-P990936 | Ozureprubart | 2823332-50-7 | Inhibitory Antibodies |
| HY-P990937 | Pacibekitug | 2948444-06-0 | Inhibitory Antibodies |
| HY-P990938 | Pegrizeprument | 2829316-24-5 | Inhibitory Antibodies |
| HY-P990939 | Podentamig | 2851863-52-8 | Inhibitory Antibodies |
| HY-P990940 | Precemtabart | 2883118-92-9 | Inhibitory Antibodies |
| HY-P990941 | Rinatabart | 2853518-94-0 | Inhibitory Antibodies |
| HY-P990942 | Samatatug | 2861288-57-3 | Inhibitory Antibodies |
| HY-P990943 | Siltartoxatug | 2841700-23-8 | Inhibitory Antibodies |
| HY-P990944 | Sonavibart | 2769699-23-0 | Inhibitory Antibodies |
| HY-P990945 | Tazlestobart | 2850355-80-3 | Inhibitory Antibodies |
| HY-P990946 | Tecotabart | 2823329-10-6 | Inhibitory Antibodies |
| HY-P990947 | Tilatamig | 2868265-50-1 | Inhibitory Antibodies |
| HY-P990948 | Trosunilimab | 2550297-60-2 | Inhibitory Antibodies |
| HY-P990949 | Umikibart | 2851478-58-3 | Inhibitory Antibodies |
| HY-P990950 | Vebanvibart | 2937321-40-7 | Inhibitory Antibodies |
| HY-P990951 | Vixticibart | 2845128-05-2 | Inhibitory Antibodies |
| HY-P990952 | Zaltenibart | 2527079-60-1 | Inhibitory Antibodies |
| HY-P990953 | Zubotamig | 2640279-10-1 | Inhibitory Antibodies |
| HY-P990954 | Amulirafusp alfa | 2850355-94-9 | Inhibitory Antibodies |
| HY-P990955 | Ebribafusp alfa | 2839652-75-2 | Inhibitory Antibodies |
| HY-P990956 | Etakafusp alfa | 2852680-28-3 | Inhibitory Antibodies |
| HY-P990957 | Ficerafusp alfa | 2764727-44-6 | Inhibitory Antibodies |
| HY-P990958 | Invikafusp alfa | 2894138-60-2 | Inhibitory Antibodies |
| HY-P990959 | Lesigercept | 2878448-12-3 | Inhibitory Antibodies |
| HY-P990960 | Lucorafusp alfa | 2769742-99-4 | Inhibitory Antibodies |
| HY-P990961 | Palverafusp alfa | 2850355-87-0 | Inhibitory Antibodies |
| HY-P990962 | Vislarafusp alfa | 2850355-96-1 | Inhibitory Antibodies |
| HY-P990963 | Albipagrastim alfa | 2817686-50-1 | Inhibitory Antibodies |
| HY-P990964 | Efimosfermin alfa | 2765640-39-7 | Inhibitory Antibodies |
| HY-P990965 | Efparepoetin alfa | 2761347-19-5 | Inhibitory Antibodies |
| HY-P990966 | Redalsomatropin alfa | 2793441-31-1 | Inhibitory Antibodies |
| HY-P990967 | Sonefpeglutide | 2854391-99-2 | Inhibitory Antibodies |
| HY-P990968 | Alcestobart | 2888563-73-1 | Inhibitory Antibodies |
| HY-P990969 | Amtabafusp alfa | 2839531-84-7 | Inhibitory Antibodies |
| HY-P990970 | Armocibart | 2857858-84-3 | Inhibitory Antibodies |
| HY-P990971 | Atenastobart | 2817644-49-6 | Inhibitory Antibodies |
| HY-P990972 | Azerutamig | 2920336-42-9 | Inhibitory Antibodies |
| HY-P990973 | Betinukibart | 2744274-11-9 | Inhibitory Antibodies |
| HY-P990974 | Bezeotermin alfa | 2935496-94-7 | Inhibitory Antibodies |
| HY-P990975 | Birinkibart | 2894136-82-2 | Inhibitory Antibodies |
| HY-P990976 | Brivestobart | 2786639-04-9 | Inhibitory Antibodies |
| HY-P990977 | Bulumtatug | 2862919-81-9 | Inhibitory Antibodies |
| HY-P990978 | Caxmotabart | 2930815-95-3 | Inhibitory Antibodies |
| HY-P990979 | Ciletatug | 2897622-41-0 | Inhibitory Antibodies |
| HY-P990980 | Cizutamig | 2919209-65-5 | Inhibitory Antibodies |
| HY-P990981 | Clesitamig | 2930861-48-4 | Inhibitory Antibodies |
| HY-P990982 | Denrakibart | 2922866-66-6 | Inhibitory Antibodies |
| HY-P990983 | Drotokibart | 2925270-26-2 | Inhibitory Antibodies |
| HY-P990984 | Eclutatug | 2922054-25-7 | Inhibitory Antibodies |
| HY-P990985 | Efarindodekin alfa | 2922072-00 | Inhibitory Antibodies |
| HY-P990986 | Efdelikofusp alfa | 2922216-49-5 | Inhibitory Antibodies |
| HY-P990987 | Efdoralprin alfa | 2539844-42-1 | Inhibitory Antibodies |
| HY-P990988 | Efgitasialase alfa | 2891502-37-5 | Inhibitory Antibodies |
| HY-P990989 | Efmedaglutide alfa | 2919801-97-9 | Inhibitory Antibodies |
| HY-P990990 | Efsubaglutide alfa | 2803875-75-2 | Inhibitory Antibodies |
| HY-P990991 | Efsudenermin alfa | 2769701-94-0 | Inhibitory Antibodies |
| HY-P990992 | Efzilonkofusp alfa | 2922216-50-8 | Inhibitory Antibodies |
| HY-P990993 | Emugrobart | 2922218-19-5 | Inhibitory Antibodies |
| HY-P990994 | Emunkitug | 2916519-48-5 | Inhibitory Antibodies |
| HY-P990995 | Etalanetug | 2690265-18-8 | Inhibitory Antibodies |
| HY-P990996 | Felmetatug | 2924808-29-5 | Inhibitory Antibodies |
| HY-P990997 | Gacovetug | 2935485-57-5 | Inhibitory Antibodies |
| HY-P990998 | Greziprubart | 2894136-80-0 | Inhibitory Antibodies |
| HY-P990999 | Imeroprubart | 2919582-96-8 | Inhibitory Antibodies |
| HY-P9910 | Obinutuzumab | 949142-50-1 | Inhibitory Antibodies |
| HY-P99100 | Visugromab | 2556646-63-8 | Inhibitory Antibodies |
| HY-P991000 | Imneskibart | 2919583-43-8 | Inhibitory Antibodies |
| HY-P991001 | Imzokitug | 2883771-61-5 | Inhibitory Antibodies |
| HY-P991002 | Indemakitug | 2856372-57-9 | Inhibitory Antibodies |
| HY-P991003 | Ingitamig | 2839572-09-5 | Inhibitory Antibodies |
| HY-P991004 | Itanistomig | 2923687-56-1 | Inhibitory Antibodies |
| HY-P991005 | Larnefpendekin alfa | 2877653-03-5 | Inhibitory Antibodies |
| HY-P991006 | Lofacimig | 2857858-76-3 | Inhibitory Antibodies |
| HY-P991007 | Lotivibart | 2851892-98-1 | Inhibitory Antibodies |
| HY-P991008 | Lunlekitug | 2640257-30-1 | Inhibitory Antibodies |
| HY-P991009 | Mavrostobart | 2928515-12-0 | Inhibitory Antibodies |
| HY-P99101 | Vobramitamab | 2490556-50-6 | Inhibitory Antibodies |
| HY-P991010 | Nebokitug | 2922315-59-9 | Inhibitory Antibodies |
| HY-P991011 | Nivisnebart | 2923556-87-8 | Inhibitory Antibodies |
| HY-P991012 | Nuvustotug | 2916519-49-6 | Inhibitory Antibodies |
| HY-P991013 | Omectatug | 2867393-44-8 | Inhibitory Antibodies |
| HY-P991014 | Pamlectabart | 2925692-65-3 | Inhibitory Antibodies |
| HY-P991015 | Pasritamig | 2921676-04-0 | Inhibitory Antibodies |
| HY-P991016 | Peluntamig | 2928515-21-1 | Inhibitory Antibodies |
| HY-P991017 | Produvofusp | 2925698-93-5 | Inhibitory Antibodies |
| HY-P991018 | Posnafusp alfa | 2797073-53-9 | Inhibitory Antibodies |
| HY-P991019 | Recibokibart | 2744274-17-5 | Inhibitory Antibodies |
| HY-P99102 | Zinlirvimab | 2417213-75-1 | Inhibitory Antibodies |
| HY-P991020 | Remzistotug | 2920425-39-2 | Inhibitory Antibodies |
| HY-P991021 | Rilogrotug | 2894138-72-6 | Inhibitory Antibodies |
| HY-P991022 | Ruxoprubart | 2842046-67-5 | Inhibitory Antibodies |
| HY-P991023 | Safimestomig | 2911590-72-0 | Inhibitory Antibodies |
| HY-P991024 | Solabafusp alfa | 2918752-58-4 | Inhibitory Antibodies |
| HY-P991025 | Solnerstotug | 2927399-38-8 | Inhibitory Antibodies |
| HY-P991026 | Sonesitatug | 2883771-43-3 | Inhibitory Antibodies |
| HY-P991027 | Spevatamig | 2928515-36-8 | Inhibitory Antibodies |
| HY-P991028 | Surovatamig | 2892667-02-4 | Inhibitory Antibodies |
| HY-P991029 | Sutacimig | 2933972-64-4 | Inhibitory Antibodies |
| HY-P99103 | Bebtelovimab | 2578319-11-4 | Inhibitory Antibodies |
| HY-P991030 | Tabirafusp alfa | 2839527-15-8 | Inhibitory Antibodies |
| HY-P991031 | Telikibart | 2618667-96-0 | Inhibitory Antibodies |
| HY-P991032 | Tizetatug | 2938864-87-8 | Inhibitory Antibodies |
| HY-P991033 | Tovecimig | 2923284-73-3 | Inhibitory Antibodies |
| HY-P991034 | Trevotamig | 2920215-79-6 | Inhibitory Antibodies |
| HY-P991035 | Turenkibart | 2761187-73-7 | Inhibitory Antibodies |
| HY-P991036 | Velinotamig | 2848586-49-0 | Inhibitory Antibodies |
| HY-P991037 | Verenafusp alfa | 2699034-69-8 | Inhibitory Antibodies |
| HY-P991038 | Zadoprubart | 2904575-77-3 | Inhibitory Antibodies |
| HY-P991039 | Zamubafusp alfa | 2937458-25-6 | Inhibitory Antibodies |
| HY-P99104 | Plutavimab | 2529854-88-2 | Inhibitory Antibodies |
| HY-P991040 | hu14.18 (K322A) | Inhibitory Antibodies | |
| HY-P991041 | Anti-SEZ6 Antibody (SC17) | Inhibitory Antibodies | |
| HY-P991042 | Anti-IGFBP2 Antibody (M14) | Inhibitory Antibodies | |
| HY-P991044 | Anti-Mouse CD3E Antibody (1E11.D) | Inhibitory Antibodies | |
| HY-P991045 | Donanemab (Mouse IgG2a) | Inhibitory Antibodies | |
| HY-P991046 | Donanemab (Mouse IgG2b) | Inhibitory Antibodies | |
| HY-P991047 | Anti-CD71/TfR1 Antibody | Inhibitory Antibodies | |
| HY-P991048 | AMG-820 | 2243120-07-0 | Inhibitory Antibodies |
| HY-P991049 | Atrosimab | Inhibitory Antibodies | |
| HY-P99105 | Anselamimab | 2414866-63-8 | Inhibitory Antibodies |
| HY-P991050 | Procizumab | Inhibitory Antibodies | |
| HY-P991051 | GSK-2330811 | Inhibitory Antibodies | |
| HY-P991052 | GSK-3174998 | 2089398-68-3 | Inhibitory Antibodies |
| HY-P991054 | CR-8020 | 1422526-93-9 | Inhibitory Antibodies |
| HY-P991055 | Forimtamig | 2649379-96-2 | Inhibitory Antibodies |
| HY-P991057 | STI-6643 | 2376730-61-7 | Inhibitory Antibodies |
| HY-P991058 | Zimistobart | 2829290-06-2 | Inhibitory Antibodies |
| HY-P991059 | VIS-410 | 2043950-09-8 | Inhibitory Antibodies |
| HY-P99106 | Acrixolimab | 2506324-29-2 | Inhibitory Antibodies |
| HY-P991060 | Cergutuzumab | 1622305-37-6 | Inhibitory Antibodies |
| HY-P991061 | CHS-114 | Inhibitory Antibodies | |
| HY-P991062 | Gentulizumab | Inhibitory Antibodies | |
| HY-P991063 | GEN-1053 | 2733575-82-9 | Inhibitory Antibodies |
| HY-P991064 | Lafuvitug | 2743342-91-6 | Inhibitory Antibodies |
| HY-P991065 | Ichorcumab | 2589583-20-8 | Inhibitory Antibodies |
| HY-P991066 | ARGX-119 | 2966023-63-0 | Inhibitory Antibodies |
| HY-P991067 | Vensobafusp alfa | 2724922-85-2 | Inhibitory Antibodies |
| HY-P991068 | hT84.66-M5A | Inhibitory Antibodies | |
| HY-P991069 | VRC-01 | 1412901-55-3 | Inhibitory Antibodies |
| HY-P991070 | ADG-106 | Inhibitory Antibodies | |
| HY-P991071 | AK-001 | Inhibitory Antibodies | |
| HY-P991072 | MB-66 | Inhibitory Antibodies | |
| HY-P991073 | MEDI-1814 | Inhibitory Antibodies | |
| HY-P991075 | ALT-100 (Human IgG1) | Inhibitory Antibodies | |
| HY-P991076 | Entolimod | 951628-22-1 | Inhibitory Antibodies |
| HY-P991077 | Nogapendekin alfa inbakicept | 1850381-92-8 | Inhibitory Antibodies |
| HY-P991078 | Anti-Mouse PD-1 (LALA-PG) Antibody (RMP1-14) | Inhibitory Antibodies | |
| HY-P991079 | Anti-Mouse PD-1 Antibody (D265A) Antibody (RMP1-14) | Inhibitory Antibodies | |
| HY-P99107A | Brentuximab vedotin (solution) | 914088-09-8 | ADC Related |
| HY-P99108 | Penpulimab | 2350298-92-7 | Inhibitory Antibodies |
| HY-P991080 | Anti-SLC44A4 Antibody | Inhibitory Antibodies | |
| HY-P991081 | VHH antibody (His tag), Isotype Control | Inhibitory Antibodies | |
| HY-P991082 | Anti-LAMP1/CD107a Antibody | Inhibitory Antibodies | |
| HY-P991083 | MAS825 | Inhibitory Antibodies | |
| HY-P991084 | TQB-2858 | Inhibitory Antibodies | |
| HY-P991085 | HX009 | Inhibitory Antibodies | |
| HY-P991086 | MGD010 | Inhibitory Antibodies | |
| HY-P991087 | RO7122290 | Inhibitory Antibodies | |
| HY-P991088 | HPN536 | Inhibitory Antibodies | |
| HY-P991089 | GEN-1044 | Inhibitory Antibodies | |
| HY-P99109 | Zimberelimab | 2259860-24-5 | Inhibitory Antibodies |
| HY-P991090 | YH32367 | Inhibitory Antibodies | |
| HY-P991091 | COVA322 | Inhibitory Antibodies | |
| HY-P991092 | IBI-334 | Inhibitory Antibodies | |
| HY-P991093 | NGM-707 | Inhibitory Antibodies | |
| HY-P991095 | ALG.APV-527 | Inhibitory Antibodies | |
| HY-P991097 | PM-8002 | Inhibitory Antibodies | |
| HY-P991098 | Anti-TrkB/NTRK2 Antibody | Inhibitory Antibodies | |
| HY-P991099 | Anti-GLP1R Antibody | Inhibitory Antibodies | |
| HY-P9911 | Vedolizumab | 943609-66-3 | Inhibitory Antibodies |
| HY-P99110 | Lanadelumab | 1426055-14-2 | Inhibitory Antibodies |
| HY-P991100 | Anti-CDH17/Cadherin-17 Antibody (10C12) | Inhibitory Antibodies | |
| HY-P991101 | Anti-Amyloid Beta Antibody (scFv59) | Inhibitory Antibodies | |
| HY-P991102 | Anti-MUC17 Antibody | Inhibitory Antibodies | |
| HY-P991103 | Anti-IL-25 Antibody | Inhibitory Antibodies | |
| HY-P991104 | Anti-EMMPRIN/CD147 Antibody | Inhibitory Antibodies | |
| HY-P991105 | Anti-Clathrin Heavy Chain Antibody | Inhibitory Antibodies | |
| HY-P991106 | IMC-D11 | Inhibitory Antibodies | |
| HY-P991107 | Anti-Dysadherin Antibody | Inhibitory Antibodies | |
| HY-P991108 | Anti-CDH6/K-Cadherin Antibody | Inhibitory Antibodies | |
| HY-P991109 | Anti-EFNA4 Antibody | Inhibitory Antibodies | |
| HY-P99111 | Golimumab | 476181-74-5 | Inhibitory Antibodies |
| HY-P991110 | Anti-Mouse CD25 Antibody (7D4) | Inhibitory Antibodies | |
| HY-P991111 | Anti-Mouse TIGIT Antibody (10A7) | Inhibitory Antibodies | |
| HY-P991112 | Anti-Mouse CD8α Antibody (YTS169.4) | Inhibitory Antibodies | |
| HY-P991113 | Abazistobart | 3002062-67-8 | Inhibitory Antibodies |
| HY-P991114 | Adezkibart | 2921564-55-6 | Inhibitory Antibodies |
| HY-P991115 | Adimanebart | 3011838-77-7 | Inhibitory Antibodies |
| HY-P991116 | Amdokitug | 3012586-05-6 | Inhibitory Antibodies |
| HY-P991117 | Amrecibart | 3008610-20-3 | Inhibitory Antibodies |
| HY-P991118 | Arumakimig | 3018901-76-0 | Inhibitory Antibodies |
| HY-P991119 | Balekafusp alfa | 2866185-77-3 | Inhibitory Antibodies |
| HY-P99112 | Satralizumab | 1535963-91-7 | Inhibitory Antibodies |
| HY-P991120 | Balertatug | 3010940-29-8 | Inhibitory Antibodies |
| HY-P991121 | Baloncibart | 2988795-75-9 | Inhibitory Antibodies |
| HY-P991122 | Besufetamig | 3037124-22-1 | Inhibitory Antibodies |
| HY-P991123 | Bocunebart | 2984605-64-1 | Inhibitory Antibodies |
| HY-P991124 | Cenvacibart | 3008610-21-4 | Inhibitory Antibodies |
| HY-P991125 | Cenzestotug | 3014361-58-8 | Inhibitory Antibodies |
| HY-P991126 | Ciltistotug | 3014361-59-9 | Inhibitory Antibodies |
| HY-P991127 | Claseprubart | 2922766-89-8 | Inhibitory Antibodies |
| HY-P991128 | Cliramitug | 2965214-50-8 | Inhibitory Antibodies |
| HY-P991129 | Crusekitug | 2956768-50-4 | Inhibitory Antibodies |
| HY-P99113 | Inebilizumab | 1299440-37-1 | Inhibitory Antibodies |
| HY-P991130 | Dalidnetug | 2991369-43-6 | Inhibitory Antibodies |
| HY-P991131 | Daretabart | 3011830-62-6 | Inhibitory Antibodies |
| HY-P991132 | Efclarofusp alfa | 3053638-35-7 | Inhibitory Antibodies |
| HY-P991133 | Efranarelaxin alfa | 2969217-22-7 | Inhibitory Antibodies |
| HY-P991134 | Elegrobart | 2832924-76-0 | Inhibitory Antibodies |
| HY-P991135 | Enzelkitug | 2999644-88-9 | Inhibitory Antibodies |
| HY-P991136 | Etuptamig | 3009874-10-3 | Inhibitory Antibodies |
| HY-P991137 | Exerenibart | 2996101-49-4 | Inhibitory Antibodies |
| HY-P991138 | Firsekibart | 2981430-39-9 | Inhibitory Antibodies |
| HY-P991139 | Futermestotug | 3014361-57-7 | Inhibitory Antibodies |
| HY-P99113A | Inebilizumab (FUT8-KO) | Inhibitory Antibodies | |
| HY-P99114 | Sugemalimab | 2256084-03-2 | Inhibitory Antibodies |
| HY-P991140 | Garetatug | 3023285-05-1 | Inhibitory Antibodies |
| HY-P991141 | Inlecitug | 2997627-68-4 | Inhibitory Antibodies |
| HY-P991142 | Isuventatug | 2986317-23-9 | Inhibitory Antibodies |
| HY-P991143 | Ixotatug | 3018936-99-4 | Inhibitory Antibodies |
| HY-P991144 | Lasrekibart | 3021525-26-5 | Inhibitory Antibodies |
| HY-P991145 | Laventatug | 3009829-91-5 | Inhibitory Antibodies |
| HY-P991146 | Lecankitug | 2923284-76-6 | Inhibitory Antibodies |
| HY-P991147 | Ledostomig | 2769743-01-1 | Inhibitory Antibodies |
| HY-P991148 | Moflerafusp alfa | 2983848-20-8 | Inhibitory Antibodies |
| HY-P991149 | Nesfrotamig | 2966936-23-0 | Inhibitory Antibodies |
| HY-P99115 | Envafolimab | 2102192-68-5 | Inhibitory Antibodies |
| HY-P991150 | Ompekimig | 2981477-39-6 | Inhibitory Antibodies |
| HY-P991151 | Opamtistomig | 2923499-76-5 | Inhibitory Antibodies |
| HY-P991152 | Oturkibart | 2956767-43-2 | Inhibitory Antibodies |
| HY-P991153 | Potravitug | 2923558-06-7 | Inhibitory Antibodies |
| HY-P991154 | Pumitamig | 2999726-97-3 | Inhibitory Antibodies |
| HY-P991155 | Ramantamig | 2988886-91-3 | Inhibitory Antibodies |
| HY-P991156 | Rapaprutug | 2994192-38-8 | Inhibitory Antibodies |
| HY-P991157 | Retavibart | 3023741-03-6 | Inhibitory Antibodies |
| HY-P991158 | Rinvatercept | 2996105-98-5 | Inhibitory Antibodies |
| HY-P991159 | Ruzaltatug | 2981438-63-3 | Inhibitory Antibodies |
| HY-P99116 | Faricimab | 1607793-29-2 | Inhibitory Antibodies |
| HY-P991160 | Suvonstobart | 2983834-87-1 | Inhibitory Antibodies |
| HY-P991161 | Tanruprubart | 2065212-40-8 | Inhibitory Antibodies |
| HY-P991162 | Tilrekimig | 2981469-90-1 | Inhibitory Antibodies |
| HY-P991163 | Tixentamig | 2969220-04-8 | Inhibitory Antibodies |
| HY-P991164 | Torvutatug | 2975630-15-8 | Inhibitory Antibodies |
| HY-P991165 | Trovostobart | 3006784-09-1 | Inhibitory Antibodies |
| HY-P991166 | Ubletamig | 3008247-27-3 | Inhibitory Antibodies |
| HY-P991167 | Vecantoxatug | 2956766-52-0 | Inhibitory Antibodies |
| HY-P991168 | Velaprumig | 2988741-17-7 | Inhibitory Antibodies |
| HY-P991169 | Zemocimig | 2955620-21-8 | Inhibitory Antibodies |
| HY-P99117 | Cadonilimab | 2394841-59-7 | Inhibitory Antibodies |
| HY-P991170 | Ibramvibart | 3031270-42-2 | Inhibitory Antibodies |
| HY-P991171 | Anti-CD4 Antibody (Hu5A8) | Inhibitory Antibodies | |
| HY-P991172 | JNJ-70218902 | Inhibitory Antibodies | |
| HY-P991173 | AMG-119 | Inhibitory Antibodies | |
| HY-P991174 | Anti-TREM2 Antibody (AL2p-58) | Inhibitory Antibodies | |
| HY-P991175 | Anti-Dectin-1 Antibody (2M24) | Inhibitory Antibodies | |
| HY-P991176 | RG-6333 | Inhibitory Antibodies | |
| HY-P991177 | Anti-c-Met/HGFR Antibody | Inhibitory Antibodies | |
| HY-P991178 | BMS-986156 | Inhibitory Antibodies | |
| HY-P991179 | MK-4166 | Inhibitory Antibodies | |
| HY-P99118 | Serplulimab | 2231029-82-4 | Inhibitory Antibodies |
| HY-P991180 | TRX-518 | Inhibitory Antibodies | |
| HY-P991181 | VTX-1218 | Inhibitory Antibodies | |
| HY-P991182 | Anti-CCR8 Antibody (10A11) | Inhibitory Antibodies | |
| HY-P991183 | SAR-442257 | Inhibitory Antibodies | |
| HY-P991184 | Anti-LY6G6D Antibody (1G4) | Inhibitory Antibodies | |
| HY-P991185 | Anti-MST1R Antibody (MOR07692) | Inhibitory Antibodies | |
| HY-P991186 | IMM-20059 | Inhibitory Antibodies | |
| HY-P991187 | Anti-TM4SF1 Antibody (AGX-A07) | Inhibitory Antibodies | |
| HY-P991188 | MGD007 | Inhibitory Antibodies | |
| HY-P991189 | AMG-305 | Inhibitory Antibodies | |
| HY-P99119 | Anti-Mouse 4-1BB/CD137 Antibody (3H3) | Inhibitory Antibodies | |
| HY-P991190 | AV-380 | Inhibitory Antibodies | |
| HY-P991191 | REGN-5054 | Inhibitory Antibodies | |
| HY-P991192 | BI-1808 | Inhibitory Antibodies | |
| HY-P991193 | NGM-438 | Inhibitory Antibodies | |
| HY-P991194 | HFB-200301 | Inhibitory Antibodies | |
| HY-P991195 | SIM-0235 | Inhibitory Antibodies | |
| HY-P991196 | Anti-CD24 Antibody (SWA11) | Inhibitory Antibodies | |
| HY-P991197 | Anti-GPRC5D Antibody | Inhibitory Antibodies | |
| HY-P991198 | M6903 | Inhibitory Antibodies | |
| HY-P99119A | Anti-Mouse 4-1BB/CD137 (LALA-PG) Antibody (LOB12.3) | Inhibitory Antibodies | |
| HY-P9911A | Vedolizumab (anti-α4β7-integrin) | 943609-66-3 | Inhibitory Antibodies |
| HY-P9912 | Pertuzumab | 380610-27-5 | Inhibitory Antibodies |
| HY-P99120 | Anti-Mouse CD11a Antibody (FD441.8) | Inhibitory Antibodies | |
| HY-P991200 | OM-7D3-B3 | Inhibitory Antibodies | |
| HY-P991201 | REGN-7257 | Inhibitory Antibodies | |
| HY-P991202 | Anti-TSHR Antibody (M22) | Inhibitory Antibodies | |
| HY-P991203 | PF-07062119 | Inhibitory Antibodies | |
| HY-P991204 | Anti-PSMA Antibody | Inhibitory Antibodies | |
| HY-P991206 | Human IgG2 lambda, Isotype Control | Inhibitory Antibodies | |
| HY-P991207 | Human IgG1 (L234A/L235A) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99121 | Anti-Mouse CD11b Antibody (M1/70) | Inhibitory Antibodies | |
| HY-P99122 | Anti-Mouse CD209b Antibody (22D1) | Inhibitory Antibodies | |
| HY-P99123 | Anti-Mouse CD28 Antibody (37.51) | Inhibitory Antibodies | |
| HY-P99123A | Anti-Mouse CD28 (LALA-PG) Antibody (D665) | Inhibitory Antibodies | |
| HY-P99124 | Anti-Mouse CD3 Antibody (17A2) | Inhibitory Antibodies | |
| HY-P99125 | Anti-Mouse CD16/CD32 Antibody (2.4G2) | Inhibitory Antibodies | |
| HY-P99126 | Anti-Mouse CD44 Antibody (IM7) | Inhibitory Antibodies | |
| HY-P99127 | Anti-Mouse CD54 Antibody (YN1/1.7.4) | Inhibitory Antibodies | |
| HY-P99128 | Anti-Mouse CD8 beta Antibody (53-5.8) | Inhibitory Antibodies | |
| HY-P99129 | Anti-Mouse CD8a Antibody (53-6.7) | Inhibitory Antibodies | |
| HY-P9912A | Pertuzumab (anti-HER2) | 380610-27-5 | Inhibitory Antibodies |
| HY-P9913 | Rituximab | 174722-31-7 | Inhibitory Antibodies |
| HY-P99130 | Anti-Mouse CD90 Antibody (T24/31) | Inhibitory Antibodies | |
| HY-P99131 | Anti-Mouse CD90.2 Antibody (30H12) | Inhibitory Antibodies | |
| HY-P99132 | Anti-Mouse CTLA-4 Antibody (9D9) | Inhibitory Antibodies | |
| HY-P99133 | Anti-Mouse Fas Ligand Antibody (MFL3) | Inhibitory Antibodies | |
| HY-P99134 | Anti-Mouse GM-CSF Antibody (MP1-22E9) | Inhibitory Antibodies | |
| HY-P99135 | Anti-Mouse H-2K Antibody (Y-3) | Inhibitory Antibodies | |
| HY-P99136 | Anti-Mouse IFN gamma Antibody (H22) | Inhibitory Antibodies | |
| HY-P99137 | Anti-Mouse IFNAR1 Antibody (MAR1-5A3) | Inhibitory Antibodies | |
| HY-P99138 | Anti-Mouse IL-1a Antibody (ALF-161) | Inhibitory Antibodies | |
| HY-P99139 | Anti-Mouse IL-1b Antibody (B122) | Inhibitory Antibodies | |
| HY-P9913A | Rituximab (anti-CD20) | 174722-31-7 | Inhibitory Antibodies |
| HY-P9914 | Eculizumab | 219685-50-4 | Inhibitory Antibodies |
| HY-P99140 | Anti-Mouse IL-1R Antibody (JAMA-147) | Inhibitory Antibodies | |
| HY-P99141 | Anti-Mouse LAG-3 Antibody (C9B7W) | Inhibitory Antibodies | |
| HY-P99142 | Anti-Mouse Ly-6G/Ly-6C Antibody (RB6-8C5) | Inhibitory Antibodies | |
| HY-P99143 | Anti-Mouse NK1.1 Antibody (PK136) | Inhibitory Antibodies | |
| HY-P99144 | Anti-Mouse PD-1 Antibody (RMP1-14) | Inhibitory Antibodies | |
| HY-P99144A | Anti-Mouse PD-1 Antibody (S-5001) | Inhibitory Antibodies | |
| HY-P99145 | Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) | Inhibitory Antibodies | |
| HY-P99145A | Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2-Mouse IgG1) | Inhibitory Antibodies | |
| HY-P99146 | Anti-Mouse TCR gamma/delta Antibody (UC7-13D5) | Inhibitory Antibodies | |
| HY-P99147 | Anti-Mouse TCR V gamma 2 Antibody (UC3-10A6) | Inhibitory Antibodies | |
| HY-P99148 | Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) | Inhibitory Antibodies | |
| HY-P99149 | Anti-Mouse TNFR2 Antibody (TR75-54.7) | Inhibitory Antibodies | |
| HY-P9915 | Daratumumab | 945721-28-8 | Inhibitory Antibodies |
| HY-P991502 | Armenian hamster IgG1 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99151 | Brentuximab | 2088770-90-3 | Inhibitory Antibodies |
| HY-P99152 | Muromonab | 140608-64-6 | Inhibitory Antibodies |
| HY-P99153 | Farletuzumab | 896723-44-7 | Inhibitory Antibodies |
| HY-P99155 | Zalutumumab | 667901-13-5 | Inhibitory Antibodies |
| HY-P99156 | Relatlimab | 1673516-98-7 | Inhibitory Antibodies |
| HY-P99157 | Omburtamab | 1895083-75-6 | Inhibitory Antibodies |
| HY-P99159 | Ivuxolimab | 2128729-41-7 | Inhibitory Antibodies |
| HY-P9915A | Daratumumab (PBS) | 945721-28-8 | Inhibitory Antibodies |
| HY-P9916 | Sarilumab | 1189541-98-7 | Inhibitory Antibodies |
| HY-P99160 | Labetuzumab | 219649-07-7 | Inhibitory Antibodies |
| HY-P99161 | Tilvestamab | 2226775-26-2 | Inhibitory Antibodies |
| HY-P99162 | Nemolizumab | 1476039-58-3 | Inhibitory Antibodies |
| HY-P99163 | Tilavonemab | 2096513-89-0 | Inhibitory Antibodies |
| HY-P99164 | Zagotenemab | 2019133-28-7 | Inhibitory Antibodies |
| HY-P99165 | Teprotumumab | 1036734-93-6 | Inhibitory Antibodies |
| HY-P99166 | Vudalimab | 2329669-72-7 | Inhibitory Antibodies |
| HY-P99167 | Lucatumumab | 903512-50-5 | Inhibitory Antibodies |
| HY-P99168 | Anifrolumab | 1326232-46-5 | Inhibitory Antibodies |
| HY-P99169 | Uliledlimab | 2378407-27-1 | Inhibitory Antibodies |
| HY-P9917 | Tocilizumab | 375823-41-9 | Inhibitory Antibodies |
| HY-P99171 | Gevokizumab | 1129435-60-4 | Inhibitory Antibodies |
| HY-P99172 | CC-90002 | 2085844-54-6 | Inhibitory Antibodies |
| HY-P99175 | KWAR 23 | 2243227-60-1 | Inhibitory Antibodies |
| HY-P99176 | ATG-031 | Inhibitory Antibodies | |
| HY-P99177 | Enibarcimab | 2305638-98-4 | Inhibitory Antibodies |
| HY-P99178 | CTX-471 | 2377152-49-1 | Inhibitory Antibodies |
| HY-P99179 | CTX-2026 | Inhibitory Antibodies | |
| HY-P9918 | Tremelimumab | 745013-59-6 | Inhibitory Antibodies |
| HY-P99181 | Mupadolimab | 2451856-97-4 | Inhibitory Antibodies |
| HY-P99183 | Abituzumab | 1105038-73-0 | Inhibitory Antibodies |
| HY-P99184 | Abrilumab | 1342290-43-0 | Inhibitory Antibodies |
| HY-P99185 | Bapineuzumab | 648895-38-9 | Inhibitory Antibodies |
| HY-P99186 | Blosozumab | 1132758-87-2 | Inhibitory Antibodies |
| HY-P99187 | Bococizumab | 1407495-02-6 | Inhibitory Antibodies |
| HY-P99188 | Carlumab | 915404-94-3 | Inhibitory Antibodies |
| HY-P99189 | Cixutumumab | 947687-12-9 | Inhibitory Antibodies |
| HY-P9919 | Durvalumab | 1428935-60-7 | Inhibitory Antibodies |
| HY-P99190 | Eldelumab | 946414-98-8 | Inhibitory Antibodies |
| HY-P99191 | Emapalumab | 1709815-23-5 | Inhibitory Antibodies |
| HY-P99192 | Emibetuzumab | 1365287-97-3 | Inhibitory Antibodies |
| HY-P99193 | Enokizumab | 909875-08-7 | Inhibitory Antibodies |
| HY-P99194 | Evinacumab | 1446419-85-7 | Inhibitory Antibodies |
| HY-P99195 | Fasinumab | 1190239-42-9 | Inhibitory Antibodies |
| HY-P99196 | Ficlatuzumab | 1174900-84-5 | Inhibitory Antibodies |
| HY-P99197 | Figitumumab | 943453-46-1 | Inhibitory Antibodies |
| HY-P99198 | Fletikumab | 1357158-22-5 | Inhibitory Antibodies |
| HY-P99199 | Foralumab | 946415-64-1 | Inhibitory Antibodies |
| HY-P9919A | Durvalumab (anti-PD-L1) | 1428935-60-7 | Inhibitory Antibodies |
| HY-P99200 | Fulranumab | 902141-80-4 | Inhibitory Antibodies |
| HY-P99201 | Zilovertamab | 2485779-13-1 | Inhibitory Antibodies |
| HY-P99202 | Vibostolimab | 2231305-30-7 | Inhibitory Antibodies |
| HY-P99203 | Cemiplimab | 1801342-60-8 | Inhibitory Antibodies |
| HY-P99205 | Glembatumumab | 1020264-78-1 | Inhibitory Antibodies |
| HY-P99206 | Naxitamab | 1879925-92-4 | Inhibitory Antibodies |
| HY-P99207 | Lenzilumab | 1229575-09-0 | Inhibitory Antibodies |
| HY-P99208 | Lirilumab | 1000676-41-4 | Inhibitory Antibodies |
| HY-P99209 | Motavizumab | 677010-34-3 | Inhibitory Antibodies |
| HY-P9920A | Ramucirumab (anti-VEGFR) | 947687-13-0 | Inhibitory Antibodies |
| HY-P9921 | Trastuzumab emtansine | 1018448-65-1 | ADC Related |
| HY-P99210 | Olokizumab | 1007223-17-7 | Inhibitory Antibodies |
| HY-P99211 | Otelixizumab | 881191-44-2 | Inhibitory Antibodies |
| HY-P99212 | Otlertuzumab | 1372645-37-8 | Inhibitory Antibodies |
| HY-P99213 | Ozanezumab | 1310680-64-8 | Inhibitory Antibodies |
| HY-P99214 | Panobacumab | 885053-97-4 | Inhibitory Antibodies |
| HY-P99215 | Parsatuzumab | 1312797-14-0 | Inhibitory Antibodies |
| HY-P99216 | Ponezumab | 1178862-65-1 | Inhibitory Antibodies |
| HY-P99217 | Rilotumumab | 872514-65-3 | Inhibitory Antibodies |
| HY-P99218 | Robatumumab | 934235-44-6 | Inhibitory Antibodies |
| HY-P99219 | Sifalimumab | 1006877-41-3 | Inhibitory Antibodies |
| HY-P9921A | Trastuzumab emtansine (solution) | 1018448-65-1 | ADC Related |
| HY-P9922 | Olaratumab | 1024603-93-7 | Inhibitory Antibodies |
| HY-P99220 | Tabalumab | 1143503-67-6 | Inhibitory Antibodies |
| HY-P99221 | Tanezumab | 880266-57-9 | Inhibitory Antibodies |
| HY-P99222 | Teplizumab | 876387-05-2 | Inhibitory Antibodies |
| HY-P99223 | Tovetumab | 1243266-04-7 | Inhibitory Antibodies |
| HY-P99224 | Veltuzumab | 728917-18-8 | Inhibitory Antibodies |
| HY-P99225 | Mirvetuximab | 1453084-36-0 | Inhibitory Antibodies |
| HY-P99226 | Daxdilimab | 2245966-28-1 | Inhibitory Antibodies |
| HY-P99227 | Caplacizumab | 915810-67-2 | Inhibitory Antibodies |
| HY-P99229 | Upifitamab | 2254118-43-7 | Inhibitory Antibodies |
| HY-P9923 | Benralizumab | 1044511-01-4 | Inhibitory Antibodies |
| HY-P99230 | Pinatuzumab | 1639820-81-7 | Inhibitory Antibodies |
| HY-P99231 | Edrecolomab | 156586-89-9 | Inhibitory Antibodies |
| HY-P99232 | Indusatumab | 1497400-26-6 | Inhibitory Antibodies |
| HY-P99233 | Camidanlumab | 921618-45-3 | Inhibitory Antibodies |
| HY-P99234 | Pivekimab | 2234335-84-1 | Inhibitory Antibodies |
| HY-P99236 | Bexmarilimab | 2259301-27-2 | Inhibitory Antibodies |
| HY-P99237 | Sofituzumab | 1615692-28-8 | Inhibitory Antibodies |
| HY-P99238 | Rolinsatamab | 2095467-30-2 | Inhibitory Antibodies |
| HY-P99239 | Rosopatamab | 2260767-49-3 | Inhibitory Antibodies |
| HY-P9923A | Benralizumab (anti-IL5RA ) | 1044511-01-4 | Inhibitory Antibodies |
| HY-P9924 | Ixekizumab | 1143503-69-8 | Inhibitory Antibodies |
| HY-P99241 | Ponsegromab | 2368950-15-4 | Inhibitory Antibodies |
| HY-P99242 | Alsevalimab | 2254029-91-7 | Inhibitory Antibodies |
| HY-P99244 | Fezakinumab | 1007106-86-6 | Inhibitory Antibodies |
| HY-P99245 | Emactuzumab | 1448221-67-7 | Inhibitory Antibodies |
| HY-P99246 | Bermekimab | 1401965-15-8 | Inhibitory Antibodies |
| HY-P99248 | Risankizumab | 1612838-76-2 | Inhibitory Antibodies |
| HY-P99249 | Vonlerolizumab | 1638935-72-4 | Inhibitory Antibodies |
| HY-P9925 | Brodalumab | 1174395-19-7 | Inhibitory Antibodies |
| HY-P99250 | Onartuzumab | 1133766-06-9 | Inhibitory Antibodies |
| HY-P99251 | Lodelcizumab | 1355338-54-3 | Inhibitory Antibodies |
| HY-P99252 | Itolizumab | 1116433-11-4 | Inhibitory Antibodies |
| HY-P99253 | Mogamulizumab | 1159266-37-1 | Inhibitory Antibodies |
| HY-P99254 | Racotumomab | 946832-34-4 | Inhibitory Antibodies |
| HY-P99256 | Tildrakizumab | 1326244-10-3 | Inhibitory Antibodies |
| HY-P99257 | Bleselumab | 1453067-91-8 | Inhibitory Antibodies |
| HY-P99258 | Brontictuzumab | 1447814-75-6 | Inhibitory Antibodies |
| HY-P99259 | Cabiralizumab | 1613144-80-1 | Inhibitory Antibodies |
| HY-P9926 | Dupilumab | 1190264-60-8 | Inhibitory Antibodies |
| HY-P99260 | Conatumumab | 896731-82-1 | Inhibitory Antibodies |
| HY-P99261 | Demcizumab | 1243262-17-0 | Inhibitory Antibodies |
| HY-P99262 | Imalumab | 1430205-07-4 | Inhibitory Antibodies |
| HY-P99263 | Inclacumab | 1256258-86-2 | Inhibitory Antibodies |
| HY-P99264 | Inotuzumab | 1660159-36-3 | Inhibitory Antibodies |
| HY-P99265 | Mapatumumab | 658052-09-6 | Inhibitory Antibodies |
| HY-P99266 | Zanolimumab | 652153-01-0 | Inhibitory Antibodies |
| HY-P99267 | Rontalizumab | 948570-30-7 | Inhibitory Antibodies |
| HY-P99268 | Seribantumab | 1334296-12-6 | Inhibitory Antibodies |
| HY-P99269 | Sibrotuzumab | 216669-97-5 | Inhibitory Antibodies |
| HY-P9927 | Secukinumab | 1229022-83-6 | Inhibitory Antibodies |
| HY-P99270 | Tigatuzumab | 918127-53-4 | Inhibitory Antibodies |
| HY-P99271 | Tisotumab | 1418628-81-5 | Inhibitory Antibodies |
| HY-P99272 | Ulocuplumab | 1375830-34-4 | Inhibitory Antibodies |
| HY-P99273 | Vorsetuzumab | 1165740-62-4 | Inhibitory Antibodies |
| HY-P99274 | Xentuzumab | 1417158-65-6 | Inhibitory Antibodies |
| HY-P99275 | Patritumab | 1262787-83-6 | Inhibitory Antibodies |
| HY-P99276 | Abagovomab | 792921-10-9 | Inhibitory Antibodies |
| HY-P99277 | Actoxumab | 1245634-25-6 | Inhibitory Antibodies |
| HY-P99278 | Adecatumumab | 503605-66-1 | Inhibitory Antibodies |
| HY-P99279 | Bavituximab | 648904-28-3 | Inhibitory Antibodies |
| HY-P9927A | Secukinumab (Anti-Human IL-17A) | 1229022-83-6 | Inhibitory Antibodies |
| HY-P9928 | Alirocumab | 1245916-14-6 | Inhibitory Antibodies |
| HY-P99280 | Bimekizumab | 1418205-77-2 | Inhibitory Antibodies |
| HY-P99281 | Bivatuzumab | 214559-60-1 | Inhibitory Antibodies |
| HY-P99282 | Citatuzumab bogatox | 945228-49-9 | Inhibitory Antibodies |
| HY-P99283 | Concizumab | 1312299-39-0 | Inhibitory Antibodies |
| HY-P99284 | Dalotuzumab | 1005389-60-5 | Inhibitory Antibodies |
| HY-P99285 | Denintuzumab | 1630074-14-4 | Inhibitory Antibodies |
| HY-P99286 | Drozitumab | 912628-39-8 | Inhibitory Antibodies |
| HY-P99287 | Elsilimomab | 468715-71-1 | Inhibitory Antibodies |
| HY-P99288 | FG-3019 | 946415-13-0 | Inhibitory Antibodies |
| HY-P99289 | Epratuzumab | 205923-57-5 | Inhibitory Antibodies |
| HY-P9928A | Alirocumab (anti-PCSK9) | 1245916-14-6 | Inhibitory Antibodies |
| HY-P9929 | Bezlotoxumab | 1246264-45-8 | Inhibitory Antibodies |
| HY-P99291 | Etaracizumab | 892553-42-3 | Inhibitory Antibodies |
| HY-P99292 | Fontolizumab | 326859-36-3 | Inhibitory Antibodies |
| HY-P99293 | Galiximab | 357613-77-5 | Inhibitory Antibodies |
| HY-P99294 | Ganitumab | 905703-97-1 | Inhibitory Antibodies |
| HY-P99295 | Imgatuzumab | 959963-46-3 | Inhibitory Antibodies |
| HY-P99296 | Intetumumab | 725735-28-4 | Inhibitory Antibodies |
| HY-P99297 | Bedinvetmab | 2171034-69-6 | Inhibitory Antibodies |
| HY-P99298 | Lampalizumab | 1278466-20-8 | Inhibitory Antibodies |
| HY-P99299 | Lexatumumab | 845816-02-6 | Inhibitory Antibodies |
| HY-P9930 | Evolocumab | 1256937-27-5 | Inhibitory Antibodies |
| HY-P99300 | Ligelizumab | 1322627-61-1 | Inhibitory Antibodies |
| HY-P99301 | Lokivetmab | 1533403-95-0 | Inhibitory Antibodies |
| HY-P99302 | Lulizumab | 2235419-62-0 | Inhibitory Antibodies |
| HY-P99303 | Lumiliximab | 357613-86-6 | Inhibitory Antibodies |
| HY-P99304 | Lumretuzumab | 1448327-63-6 | Inhibitory Antibodies |
| HY-P99305 | Metelimumab | 272780-74-2 | Inhibitory Antibodies |
| HY-P99306 | Modotuximab | 1310460-86-6 | Inhibitory Antibodies |
| HY-P99307 | Namilumab | 1206681-39-1 | Inhibitory Antibodies |
| HY-P99308 | Ocaratuzumab | 1169956-08-4 | Inhibitory Antibodies |
| HY-P99309 | Pagibaximab | 595566-61-3 | Inhibitory Antibodies |
| HY-P9931 | Guselkumab | 1350289-85-8 | Inhibitory Antibodies |
| HY-P99310 | Perakizumab | 89957-37-9 | Inhibitory Antibodies |
| HY-P99313 | Quilizumab | 1228538-47-3 | Inhibitory Antibodies |
| HY-P99315 | Ruplizumab | 220651-94-5 | Inhibitory Antibodies |
| HY-P99316 | Sirukumab | 1194585-53-9 | Inhibitory Antibodies |
| HY-P99317 | Solanezumab | 955085-14-0 | Inhibitory Antibodies |
| HY-P99318 | Sonepcizumab | 1031360-18-5 | Inhibitory Antibodies |
| HY-P99319 | Talizumab | 380610-22-0 | Inhibitory Antibodies |
| HY-P9932 | Obiltoxaximab | 1351337-07-9 | Inhibitory Antibodies |
| HY-P99320 | Tarextumab | 1359940-55-8 | Inhibitory Antibodies |
| HY-P99321 | Teneliximab | 299423-37-3 | Inhibitory Antibodies |
| HY-P99322 | Tesidolumab | 1531594-08-7 | Inhibitory Antibodies |
| HY-P99323 | Timolumab | 1073538-99-4 | Inhibitory Antibodies |
| HY-P99324 | Tomuzotuximab | 1646321-00-7 | Inhibitory Antibodies |
| HY-P99325 | Toralizumab | 252662-47-8 | Inhibitory Antibodies |
| HY-P99326 | Tositumomab | 192391-48-3 | Inhibitory Antibodies |
| HY-P99327 | Tregalizumab | 1207446-68-1 | Inhibitory Antibodies |
| HY-P99328 | Tucotuzumab | Inhibitory Antibodies | |
| HY-P99329 | Vadastuximab | 1436390-64-5 | Inhibitory Antibodies |
| HY-P9933 | Dinutuximab | 1363687-32-4 | Inhibitory Antibodies |
| HY-P99330 | Vanucizumab | 1448221-05-3 | Inhibitory Antibodies |
| HY-P99332 | Visilizumab | 219716-33-3 | Inhibitory Antibodies |
| HY-P99333 | Volociximab | 558480-40-3 | Inhibitory Antibodies |
| HY-P99334 | Vorsetuzumab mafodotin | 1165741-01-4 | ADC Related |
| HY-P99335 | Vunakizumab | 1792181-33-9 | Inhibitory Antibodies |
| HY-P99336 | Enlimomab | 142864-19-5 | Inhibitory Antibodies |
| HY-P99337 | Ansuvimab | 2375952-29-5 | Inhibitory Antibodies |
| HY-P99338 | Tisagenlecleucel | 1823078-37-0 | Inhibitory Antibodies |
| HY-P99339 | Tebentafusp | 1874157-95-5 | Inhibitory Antibodies |
| HY-P9934 | Abciximab | 143653-53-6 | Inhibitory Antibodies |
| HY-P99340 | Sotrovimab | 2423014-07-5 | Inhibitory Antibodies |
| HY-P99341 | Casirivimab | 2415933-42-3 | Inhibitory Antibodies |
| HY-P99342 | Imdevimab | 2415933-40-1 | Inhibitory Antibodies |
| HY-P99343 | Atoltivimab | 2135632-29-8 | Inhibitory Antibodies |
| HY-P99344 | Bamlanivimab | 2423943-37-5 | Inhibitory Antibodies |
| HY-P99345 | Dostarlimab | 2022215-59-2 | Inhibitory Antibodies |
| HY-P99346 | Regdanvimab | 2444308-95-4 | Inhibitory Antibodies |
| HY-P99347 | Etesevimab | 2423948-94-9 | Inhibitory Antibodies |
| HY-P99348 | Ropeginterferon alfa-2b | 1335098-50-4 | Inhibitory Antibodies |
| HY-P99349 | Loncastuximab tesirine | 1879918-31-6 | ADC Related |
| HY-P99350 | Gresonitamab | 2413817-97-5 | Inhibitory Antibodies |
| HY-P99351 | Andecaliximab | 1518996-49-0 | Inhibitory Antibodies |
| HY-P99352 | Anetumab | 1954758-84-9 | Inhibitory Antibodies |
| HY-P99353 | Ascrinvacumab | 1463459-96-2 | Inhibitory Antibodies |
| HY-P99354 | Bavunalimab | 2329669-78-3 | Inhibitory Antibodies |
| HY-P99355 | Bimagrumab | 1356922-05-8 | Inhibitory Antibodies |
| HY-P99356 | Cinpanemab | 2094516-02-4 | Inhibitory Antibodies |
| HY-P99357 | Crotedumab | 1452387-69-7 | Inhibitory Antibodies |
| HY-P99358 | Dezamizumab | 1662664-56-3 | Inhibitory Antibodies |
| HY-P99359 | Elezanumab | 1791416-49-3 | Inhibitory Antibodies |
| HY-P99360 | Enapotamab | 1912423-61-0 | Inhibitory Antibodies |
| HY-P99361 | Enavatuzumab | 1062149-33-0 | Inhibitory Antibodies |
| HY-P99362 | Ensituximab | 1092658-06-4 | Inhibitory Antibodies |
| HY-P99363 | Feladilimab | 2252518-85-5 | Inhibitory Antibodies |
| HY-P99364 | Icrucumab | 1024603-92-6 | Inhibitory Antibodies |
| HY-P99365 | Ravulizumab | 1803171-55-2 | Inhibitory Antibodies |
| HY-P99366A | Tezepelumab (anti-TSLP) | 1572943-04-4 | Inhibitory Antibodies |
| HY-P99367 | Ifinatamab | 2484870-90-6 | Inhibitory Antibodies |
| HY-P99368 | Lacnotuzumab | 1831128-32-5 | Inhibitory Antibodies |
| HY-P99369 | Lacutamab | 2187368-16-5 | Inhibitory Antibodies |
| HY-P9937 | Arcitumomab | 154361-48-5 | Inhibitory Antibodies |
| HY-P99370 | Landogrozumab | 1391726-30-9 | Inhibitory Antibodies |
| HY-P99371 | Lirentelimab | 2283348-97-8 | Inhibitory Antibodies |
| HY-P99372 | Lorvotuzumab | 339306-30-8 | Inhibitory Antibodies |
| HY-P99374 | Naratuximab | 1622327-39-2 | Inhibitory Antibodies |
| HY-P99375 | Narnatumab | 1188275-92-4 | Inhibitory Antibodies |
| HY-P99376 | Narsoplimab | 2108782-45-0 | Inhibitory Antibodies |
| HY-P99377 | Navicixizumab | 1638338-43-8 | Inhibitory Antibodies |
| HY-P99378 | Neihulizumab | 2158362-38-8 | Inhibitory Antibodies |
| HY-P99379 | Nidanilimab (Nadunolimab) | 2171061-85-9 | Inhibitory Antibodies |
| HY-P9938 | Erenumab | 1582205-90-0 | Inhibitory Antibodies |
| HY-P99380 | Zanidatamab | 2169946-15-8 | Inhibitory Antibodies |
| HY-P99381 | XmAb 5592 | 1221901-33-2 | Inhibitory Antibodies |
| HY-P99382 | Vopratelimab | 2039148-04-2 | Inhibitory Antibodies |
| HY-P99383 | Volagidemab | 1233956-13-2 | Inhibitory Antibodies |
| HY-P99384 | Vofatamab | 1312305-12-6 | Inhibitory Antibodies |
| HY-P99385 | Vobarilizumab | 1628814-88-9 | Inhibitory Antibodies |
| HY-P99386 | Vesencumab | 1205533-60-3 | Inhibitory Antibodies |
| HY-P99388 | Trevogrumab | 1429201-24-0 | Inhibitory Antibodies |
| HY-P99389 | Tesnatilimab | 2242758-08-1 | Inhibitory Antibodies |
| HY-P9939 | Burosumab | 1610833-03-8 | Inhibitory Antibodies |
| HY-P99390 | Tepoditamab | 2044679-53-8 | Inhibitory Antibodies |
| HY-P99391 | Telisotuzumab | 1781223-80-0 | Inhibitory Antibodies |
| HY-P99392 | Teclistamab | 2119595-80-9 | Inhibitory Antibodies |
| HY-P99393 | Tavolixizumab | 1635395-25-3 | Inhibitory Antibodies |
| HY-P99394 | Talquetamab | 2226212-40-2 | Inhibitory Antibodies |
| HY-P99395 | Talacotuzumab | 1826831-79-1 | Inhibitory Antibodies |
| HY-P99396 | Spesolimab | 2097104-58-8 | Inhibitory Antibodies |
| HY-P99397 | Sonelokimab | 1414386-05-2 | Inhibitory Antibodies |
| HY-P99398 | Setrusumab | 1847394-95-9 | Inhibitory Antibodies |
| HY-P99399 | Semorinemab | 2159141-27-0 | Inhibitory Antibodies |
| HY-P9940 | Emicizumab | 1610943-06-0 | Inhibitory Antibodies |
| HY-P99400 | Samalizumab | 1073059-33-2 | Inhibitory Antibodies |
| HY-P99401 | Rosmantuzumab | 1684393-04-1 | Inhibitory Antibodies |
| HY-P99402 | Rinucumab | 1569263-06-4 | Inhibitory Antibodies |
| HY-P99403 | Refanezumab | 1233953-61-1 | Inhibitory Antibodies |
| HY-P99404 | Quetmolimab | 2084037-83-0 | Inhibitory Antibodies |
| HY-P99405 | Prasinezumab | 1960462-19-4 | Inhibitory Antibodies |
| HY-P99406 | Petosemtamab | 2213450-26-9 | Inhibitory Antibodies |
| HY-P99406A | Petosemtamab (FUT8-KO) | Inhibitory Antibodies | |
| HY-P99407 | Pepinemab | 2097151-87-4 | Inhibitory Antibodies |
| HY-P99408 | Oxelumab | 1186098-83-8 | Inhibitory Antibodies |
| HY-P99409 | Oregovomab | 213327-37-8 | Inhibitory Antibodies |
| HY-P99410 | Ordesekimab | 879293-15-9 | Inhibitory Antibodies |
| HY-P99411 | Ontamalimab | 2098790-40-8 | Inhibitory Antibodies |
| HY-P99412 | Lusvertikimab | 2375835-91-7 | Inhibitory Antibodies |
| HY-P99413 | IMAB027 | 1650599-68-0 | Inhibitory Antibodies |
| HY-P99414 | Prezalumab | 1523164-68-2 | Inhibitory Antibodies |
| HY-P99415 | Abelacimab | 2098724-83-3 | Inhibitory Antibodies |
| HY-P99417 | Abrezekimab | 2043952-59-4 | Inhibitory Antibodies |
| HY-P99418 | Acapatamab | 2314491-93-3 | Inhibitory Antibodies |
| HY-P99419 | Acasunlimab | 2253937-12-9 | Inhibitory Antibodies |
| HY-P9942 | Sulesomab | 167747-19-5 | Inhibitory Antibodies |
| HY-P99420 | Acazicolcept | 2797026-97-0 | Inhibitory Antibodies |
| HY-P99422 | Adebrelimab | 2247114-85-6 | Inhibitory Antibodies |
| HY-P99423 | Adintrevimab | 2516243-54-0 | Inhibitory Antibodies |
| HY-P99424 | Afasevikumab | 1589503-30-9 | Inhibitory Antibodies |
| HY-P99425 | Afelimomab | 156227-98-4 | Inhibitory Antibodies |
| HY-P99427 | Albinterferon alfa-2B | 472960-22-8 | Inhibitory Antibodies |
| HY-P99428 | Aldafermin | 1616639-03-2 | Inhibitory Antibodies |
| HY-P99429 | Alefacept | 222535-22-0 | Inhibitory Antibodies |
| HY-P9943 | Igovomab | 171656-50-1 | Inhibitory Antibodies |
| HY-P99430 | Alnuctamab | 2296827-07-9 | Inhibitory Antibodies |
| HY-P99431 | KY-1044 | 2489390-15-8 | Inhibitory Antibodies |
| HY-P99433 | Alvircept sudotox | 137487-62-8 | Inhibitory Antibodies |
| HY-P99434 | Amlitelimab | 2378692-15-8 | Inhibitory Antibodies |
| HY-P99435 | Amubarvimab | 2509447-07-6 | Inhibitory Antibodies |
| HY-P99436 | Anatumomab mafenatox | 1370261-50-9 | Inhibitory Antibodies |
| HY-P99437 | Anbenitamab | 2367012-88-0 | Inhibitory Antibodies |
| HY-P99438 | Anivovetmab | 2370896-63-0 | Inhibitory Antibodies |
| HY-P99439 | Anrukinzumab | 910649-32-0 | Inhibitory Antibodies |
| HY-P9944 | Palivizumab | 188039-54-5 | Inhibitory Antibodies |
| HY-P99440 | Anumigilimab | 2416593-08-1 | Inhibitory Antibodies |
| HY-P99441 | Apitegromab | 2278276-46-1 | Inhibitory Antibodies |
| HY-P99442 | Apolizumab | 267227-08-7 | Inhibitory Antibodies |
| HY-P99443 | Aselizumab | 395639-53-9 | Inhibitory Antibodies |
| HY-P99444 | Astegolimab | 2173054-79-8 | Inhibitory Antibodies |
| HY-P99445 | Asunercept | 1450882-18-4 | Inhibitory Antibodies |
| HY-P99446 | Atacicept | 845264-92-8 | Inhibitory Antibodies |
| HY-P99447 | Atidortoxumab | 1939108-95-8 | Inhibitory Antibodies |
| HY-P99448 | Atinumab | 1226761-65-4 | Inhibitory Antibodies |
| HY-P9945 | Mepolizumab | 196078-29-2 | Inhibitory Antibodies |
| HY-P99450 | Avdoralimab | 2226393-85-5 | Inhibitory Antibodies |
| HY-P99451 | Avizakimab | 2229685-51-0 | Inhibitory Antibodies |
| HY-P99452 | Axatilimab | 2155851-88-8 | Inhibitory Antibodies |
| HY-P99453 | Azintuxizumab | 1826819-57-1 | Inhibitory Antibodies |
| HY-P99454 | Azintuxizumab vedotin | 1826819-58-2 | ADC Related |
| HY-P99455 | Bafisontamab | 2437210-79-0 | Inhibitory Antibodies |
| HY-P99456 | Baloramotide | 2207581-19-7 | Inhibitory Antibodies |
| HY-P99457 | Balstilimab | 2148321-77-9 | Inhibitory Antibodies |
| HY-P99458 | Balugrastim | 527698-09-5 | Inhibitory Antibodies |
| HY-P99459 | Baminercept | 909110-25-4 | Inhibitory Antibodies |
| HY-P9945A | Mepolizumab (anti-IL5) | 196078-29-2 | Inhibitory Antibodies |
| HY-P99460 | Bapotulimab | 2359413-58-2 | Inhibitory Antibodies |
| HY-P99461 | Barecetamab | 2275727-74-5 | Inhibitory Antibodies |
| HY-P99462 | Barzolvolimab | 2438203-51-9 | Inhibitory Antibodies |
| HY-P99463 | Batiraxcept | 2268717-61-7 | Inhibitory Antibodies |
| HY-P99464 | Bectumomab | 158318-63-9 | Inhibitory Antibodies |
| HY-P99465 | Befovacimab | 2156634-62-5 | Inhibitory Antibodies |
| HY-P99466 | Begelomab | 1403744-56-8 | Inhibitory Antibodies |
| HY-P99467 | Beludavimab | 2423016-74-2 | Inhibitory Antibodies |
| HY-P99469 | Bentracimab | 2260568-31-6 | Inhibitory Antibodies |
| HY-P9947 | Efalizumab | 214745-43-4 | Inhibitory Antibodies |
| HY-P99470 | Benufutamab | 2109730-69-8 | Inhibitory Antibodies |
| HY-P99471 | Bepranemab | 2244960-75-4 | Inhibitory Antibodies |
| HY-P99472 | Berlimatoxumab | 1939109-24-6 | Inhibitory Antibodies |
| HY-P99473 | Bersanlimab | 1987854-08-9 | Inhibitory Antibodies |
| HY-P99474 | Bertilimumab | 375348-49-5 | Inhibitory Antibodies |
| HY-P99475 | Betifisolimab | 2460539-60-8 | Inhibitory Antibodies |
| HY-P99476 | ABP 215 | 1438851-35-4 | Inhibitory Antibodies |
| HY-P99477 | Bevifimod | 2223113-32-2 | Inhibitory Antibodies |
| HY-P99478 | Bifarcept | 163796-60-9 | Inhibitory Antibodies |
| HY-P99479 | Bifikafusp alfa | 1957239-90-5 | Inhibitory Antibodies |
| HY-P9948 | Alemtuzumab | 216503-57-0 | Inhibitory Antibodies |
| HY-P99480 | Bintrafusp alfa | 1918149-01-5 | Inhibitory Antibodies |
| HY-P99481 | Birtamimab | 1608108-91-3 | Inhibitory Antibodies |
| HY-P99483 | Blontuvetmab | 1608112-78-2 | Inhibitory Antibodies |
| HY-P99484 | Botensilimab | 2408310-37-0 | Inhibitory Antibodies |
| HY-P99485 | Brazikumab | 1610353-18-8 | Inhibitory Antibodies |
| HY-P99486 | Briakinumab | 339308-60-0 | Inhibitory Antibodies |
| HY-P99487 | Briobacept | 869881-54-9 | Inhibitory Antibodies |
| HY-P99488 | Briquilimab | 2574591-89-0 | Inhibitory Antibodies |
| HY-P99489 | Budigalimab | 2098225-93-3 | Inhibitory Antibodies |
| HY-P9949 | Reslizumab | 241473-69-8 | Inhibitory Antibodies |
| HY-P99490 | Burfiralimab | 2460809-80-5 | Inhibitory Antibodies |
| HY-P99491 | Camoteskimab | 2492472-82-7 | Inhibitory Antibodies |
| HY-P99492 | Cantuzumab mertansine | 400010-39-1 | ADC Related |
| HY-P99493 | Cantuzumab ravtansine | 868747-45-9 | ADC Related |
| HY-P99494 | Carotuximab | 1268714-50-6 | Inhibitory Antibodies |
| HY-P99495 | Cedelizumab | 156586-90-2 | Inhibitory Antibodies |
| HY-P99496 | Cendakimab | 2151032-62-9 | Inhibitory Antibodies |
| HY-P99498 | Cergutuzumab amunaleukin | 1509916-03-3 | Inhibitory Antibodies |
| HY-P99499 | Cetrelimab | 2050478-92-5 | Inhibitory Antibodies |
| HY-P9950 | Omalizumab | 242138-07-4 | Inhibitory Antibodies |
| HY-P99500 | Cetuximab sarotalocan | 2166339-33-7 | Inhibitory Antibodies |
| HY-P99501 | Zuberitamab | 2251143-19-6 | Inhibitory Antibodies |
| HY-P99505 | Ziltivekimab | 2226654-05-1 | Inhibitory Antibodies |
| HY-P99506 | Tamrintamab | 2148325-59-9 | Inhibitory Antibodies |
| HY-P99507 | Zenocutuzumab | 1969309-56-5 | Inhibitory Antibodies |
| HY-P99508 | Tamgiblimab | 2411914-36-6 | Inhibitory Antibodies |
| HY-P99509 | Zelminemab | 2225850-33-7 | Inhibitory Antibodies |
| HY-P99510 | Zansecimab | 2415205-37-5 | Inhibitory Antibodies |
| HY-P99512 | Zampilimab | 2098280-42-1 | Inhibitory Antibodies |
| HY-P99513 | Zamerovimab | 2419087-87-7 | Inhibitory Antibodies |
| HY-P99514 | Zalifrelimab | 2148321-69-9 | Inhibitory Antibodies |
| HY-P99515 | Xeligekimab | 2382921-73-3 | Inhibitory Antibodies |
| HY-P99516 | Vulinacimab | 2250342-36-8 | Inhibitory Antibodies |
| HY-P99517 | Voxalatamab | 2411871-58-2 | Inhibitory Antibodies |
| HY-P99518 | Taldefgrobep alfa | 1580555-26-5 | Inhibitory Antibodies |
| HY-P99519 | Vixarelimab | 2243320-83-2 | Inhibitory Antibodies |
| HY-P9951A | Ranibizumab (anti-VEGF) | 347396-82-1 | Inhibitory Antibodies |
| HY-P9952 | Belimumab | 356547-88-1 | Inhibitory Antibodies |
| HY-P99520 | Vilobelimab | 2250440-41-4 | Inhibitory Antibodies |
| HY-P99521 | Vibecotamab | 2138442-13-2 | Inhibitory Antibodies |
| HY-P99523 | Vepsitamab | 2413453-53-7 | Inhibitory Antibodies |
| HY-P99524 | Vatelizumab | 1238217-55-4 | Inhibitory Antibodies |
| HY-P99525 | Varisacumab | 1610010-60-0 | Inhibitory Antibodies |
| HY-P99526 | Vapaliximab | 336801-86-6 | Inhibitory Antibodies |
| HY-P99527 | Vanutide cridificar | 886584-10-7 | Inhibitory Antibodies |
| HY-P99529 | Valziflocept | 1804910-11-9 | Inhibitory Antibodies |
| HY-P9953 | Certolizumab pegol | 428863-50-7 | Inhibitory Antibodies |
| HY-P99530 | Valanafusp alfa | 1815583-32-4 | Inhibitory Antibodies |
| HY-P99532 | Urtoxazumab | 502496-16-4 | Inhibitory Antibodies |
| HY-P99533 | Urabrelimab | 2249722-58-3 | Inhibitory Antibodies |
| HY-P99535 | Upanovimab | 2500633-46-3 | Inhibitory Antibodies |
| HY-P99536 | Tagraxofusp | 2055491-00-2 | Inhibitory Antibodies |
| HY-P99537 | Ulenistamab | 2415259-90-2 | Inhibitory Antibodies |
| HY-P99538 | Ublituximab | 1174014-05-1 | Inhibitory Antibodies |
| HY-P99539 | Ubamatamab | 2305629-50-7 | Inhibitory Antibodies |
| HY-P9954 | Catumaxomab | 509077-98-9 | Inhibitory Antibodies |
| HY-P99540 | Tuvonralimab | 2417649-44-4 | Inhibitory Antibodies |
| HY-P99541 | Tuvirumab | 138660-97-6 | Inhibitory Antibodies |
| HY-P99542 | Tusamitamab ravtansine | 2254086-60-5 | ADC Related |
| HY-P99543 | Tulinercept | 1623177-41-2 | Inhibitory Antibodies |
| HY-P99544 | Tagitanlimab | 2417649-97-7 | Inhibitory Antibodies |
| HY-P99545 | Trinbelimab | 2415078-44-1 | Inhibitory Antibodies |
| HY-P99546 | Trebananib | 894356-79-7 | Inhibitory Antibodies |
| HY-P99547 | Trastuzumab duocarmazine | 1642152-40-6 | ADC Related |
| HY-P99550 | Tozorakimab | 2376858-66-9 | Inhibitory Antibodies |
| HY-P99551 | Tosatoxumab | 1374419-41-6 | Inhibitory Antibodies |
| HY-P99552 | Tafolecimab | 2225109-03-3 | Inhibitory Antibodies |
| HY-P99553 | Torapsel | 204658-47-9 | Inhibitory Antibodies |
| HY-P99554 | Topsalysin | 917121-25-6 | Inhibitory Antibodies |
| HY-P99555 | Tomaralimab | 1449294-76-1 | Inhibitory Antibodies |
| HY-P99556 | Tixagevimab | 2420564-02-7 | Inhibitory Antibodies |
| HY-P99557 | Tirnovetmab | 2364504-80-1 | Inhibitory Antibodies |
| HY-P99558 | Timigutuzumab | 1665274-14-5 | Inhibitory Antibodies |
| HY-P99559 | Tilogotamab | 2109731-10-2 | Inhibitory Antibodies |
| HY-P9956 | Siltuximab | 541502-14-1 | Inhibitory Antibodies |
| HY-P99560 | Tadocizumab | 339086-80-5 | Inhibitory Antibodies |
| HY-P99562 | Tidutamab | 2148354-90-7 | Inhibitory Antibodies |
| HY-P99563 | Tibulizumab | 1849636-24-3 | Inhibitory Antibodies |
| HY-P99564 | Teropavimab | 2417213-72-8 | Inhibitory Antibodies |
| HY-P99565 | Tengonermin | 1960461-99-7 | Inhibitory Antibodies |
| HY-P99566 | Tenatumomab | 1412891-40-7 | Inhibitory Antibodies |
| HY-P99568 | Telitacicept | 2136630-26-5 | Inhibitory Antibodies |
| HY-P9957 | Raxibacumab | 565451-13-0 | Inhibitory Antibodies |
| HY-P99570 | Telazorlimab | 2126777-87-3 | Inhibitory Antibodies |
| HY-P99571 | Tefibazumab | 521079-87-8 | Inhibitory Antibodies |
| HY-P99572 | Tecaginlimab | 2253891-70-0 | Inhibitory Antibodies |
| HY-P99573 | Tebotelimab | 2245725-04-4 | Inhibitory Antibodies |
| HY-P99575 | Tarlatamab | 2307488-83-9 | Inhibitory Antibodies |
| HY-P99576 | Tarcocimab | 2408661-40-3 | Inhibitory Antibodies |
| HY-P99577 | Taplitumomab | 235428-87-2 | Inhibitory Antibodies |
| HY-P99578 | Tanfanercept | 2119738-70-2 | Inhibitory Antibodies |
| HY-P99579 | Tamtuvetmab | 1608122-71-9 | Inhibitory Antibodies |
| HY-P9958 | Denosumab | 615258-40-7 | Inhibitory Antibodies |
| HY-P99581 | Tabituximab barzuxetan (exclude Y90) | 1612758-88-9 | ADC Related |
| HY-P99582 | Tabituximab | 1644134-10-0 | Inhibitory Antibodies |
| HY-P99583 | Suvratoxumab | 1629620-18-3 | Inhibitory Antibodies |
| HY-P99584 | Suvizumab | 914257-21-9 | Inhibitory Antibodies |
| HY-P99586 | Suptavumab | 1629615-23-1 | Inhibitory Antibodies |
| HY-P99588 | Stamulumab | 705287-60-1 | Inhibitory Antibodies |
| HY-P99589 | Sotevtamab | 2411526-47-9 | Inhibitory Antibodies |
| HY-P9958A | Denosumab (anti-TNFSF11) | 615258-40-7 | Inhibitory Antibodies |
| HY-P99590 | Sotatercept | 1001080-50-7 | Inhibitory Antibodies |
| HY-P99590A | Sotatercept (mIgG2a) | Inhibitory Antibodies | |
| HY-P99591 | Sontuzumab | 372075-37-1 | Inhibitory Antibodies |
| HY-P99592 | Solitomab | 1005198-65-1 | Inhibitory Antibodies |
| HY-P99593 | Sofituzumab vedotin | 1418200-58-4 | ADC Related |
| HY-P99594 | Socazolimab | 2305043-30-3 | Inhibitory Antibodies |
| HY-P99595 | Sirtratumab vedotin | 1824663-83-3 | ADC Related |
| HY-P9960 | Ocrelizumab | 637334-45-3 | Inhibitory Antibodies |
| HY-P99601 | Cevostamab | 2249888-53-5 | Inhibitory Antibodies |
| HY-P99603 | Cifurtilimab | 1629760-27-5 | Inhibitory Antibodies |
| HY-P99604 | Cilgavimab | 2420563-99-9 | Inhibitory Antibodies |
| HY-P99605 | Cinrebafusp alfa | 2218515-90-1 | Inhibitory Antibodies |
| HY-P99606 | Cirevetmab | 2473240-98-9 | Inhibitory Antibodies |
| HY-P99607 | Clenoliximab | 182912-58-9 | Inhibitory Antibodies |
| HY-P99608 | Exbivirumab | 569658-80-6 | Inhibitory Antibodies |
| HY-P9961 | Ofatumumab | 679818-59-8 | Inhibitory Antibodies |
| HY-P99610 | Ezabenlimab | 2249882-54-8 | Inhibitory Antibodies |
| HY-P99611 | Faralimomab | 167816-91-3 | Inhibitory Antibodies |
| HY-P99612 | Farletuzumab ecteribulin | 2407465-18-1 | ADC Related |
| HY-P99613 | Favezelimab | 2231068-83-8 | Inhibitory Antibodies |
| HY-P99614 | Fazpilodemab | 2517935-02-1 | Inhibitory Antibodies |
| HY-P99616 | Felzartamab | 2197112-39-1 | Inhibitory Antibodies |
| HY-P99617 | Fianlimab | 2126132-98-5 | Inhibitory Antibodies |
| HY-P99618 | Fidasimtamab | 2377419-89-9 | Inhibitory Antibodies |
| HY-P99619 | Finotonlimab | 2350298-85-8 | Inhibitory Antibodies |
| HY-P9962 | Efungumab | 762260-74-2 | Inhibitory Antibodies |
| HY-P99620 | Firivumab | 1443004-15-6 | Inhibitory Antibodies |
| HY-P99621 | Fiztasovimab | 2467411-25-0 | Inhibitory Antibodies |
| HY-P99622 | Flanvotumab | 1188277-05-5 | Inhibitory Antibodies |
| HY-P99623 | Flotetuzumab | 1664355-28-5 | Inhibitory Antibodies |
| HY-P99624 | Foravirumab | 944548-38-3 | Inhibitory Antibodies |
| HY-P99625 | Frexalimab | 2515463-86-0 | Inhibitory Antibodies |
| HY-P99626 | Frovocimab | 1643672-70-1 | Inhibitory Antibodies |
| HY-P99627 | Frunevetmab | 1708936-80-4 | Inhibitory Antibodies |
| HY-P99628 | Futuximab | 1310460-85-5 | Inhibitory Antibodies |
| HY-P99629 | Galegenimab | 2403683-24-7 | Inhibitory Antibodies |
| HY-P9963 | Blinatumomab | 853426-35-4 | Inhibitory Antibodies |
| HY-P99630 | Gancotamab | 1509928-00-0 | Inhibitory Antibodies |
| HY-P99631 | Garadacimab | 2162134-62-3 | Inhibitory Antibodies |
| HY-P99632 | Garetosmab | 2097125-54-5 | Inhibitory Antibodies |
| HY-P99633 | Garivulimab | 2342597-81-1 | Inhibitory Antibodies |
| HY-P99634 | Gatipotuzumab | 1264737-26-9 | Inhibitory Antibodies |
| HY-P99635 | Gatralimab | 1826020-80-7 | Inhibitory Antibodies |
| HY-P99636 | Gavilimomab | 244096-20-6 | Inhibitory Antibodies |
| HY-P99637 | Gedivumab | 1807954-17-1 | Inhibitory Antibodies |
| HY-P99638 | Gefurulimab | 2456407-94-4 | Inhibitory Antibodies |
| HY-P99639 | Geptanolimab | 2348469-43-0 | Inhibitory Antibodies |
| HY-P9964 | Necitumumab | 906805-06-9 | Inhibitory Antibodies |
| HY-P99640 | Giloralimab | 2226292-20-0 | Inhibitory Antibodies |
| HY-P99641 | Gilvetmab | 1808081-43-7 | Inhibitory Antibodies |
| HY-P99642 | Gimsilumab | 1648796-29-5 | Inhibitory Antibodies |
| HY-P99643 | Ginisortamab | 2390147-17-6 | Inhibitory Antibodies |
| HY-P99643A | Ginisortamab (Mouse IgG1) | Inhibitory Antibodies | |
| HY-P99644 | ACT017 | 2101829-58-5 | Inhibitory Antibodies |
| HY-P99645 | Goflikicept | 2416984-26-2 | Inhibitory Antibodies |
| HY-P99646 | Golocdacimab | 2418540-63-1 | Inhibitory Antibodies |
| HY-P99647 | Gontivimab | 1257358-38-5 | Inhibitory Antibodies |
| HY-P99648 | Gosuranemab | 1788032-39-2 | Inhibitory Antibodies |
| HY-P99649 | Gremubamab | 1800381-36-5 | Inhibitory Antibodies |
| HY-P9965 | Elotuzumab | 915296-00-3 | Inhibitory Antibodies |
| HY-P99650 | Grisnilimab | 2367001-70-3 | Inhibitory Antibodies |
| HY-P99652 | Gumokimab | 2428381-52-4 | Inhibitory Antibodies |
| HY-P99653 | Ianalumab | 1929549-92-7 | Inhibitory Antibodies |
| HY-P99653A | Ianalumab (FUT8-KO) | Inhibitory Antibodies | |
| HY-P99654 | Idactamab | 2245205-37-0 | Inhibitory Antibodies |
| HY-P99656 | Iladatuzumab | 1906205-76-2 | Inhibitory Antibodies |
| HY-P99658 | Imaprelimab | 2014343-04-3 | Inhibitory Antibodies |
| HY-P99659 | Imsidolimab | 2102543-86-0 | Inhibitory Antibodies |
| HY-P9966 | Enoblituzumab | 1353485-38-7 | Inhibitory Antibodies |
| HY-P99661 | Inbakicept | 2135939-52-3 | Inhibitory Antibodies |
| HY-P99662 | Indusatumab vedotin | 1514889-12-3 | ADC Related |
| HY-P99663 | Inezetamab | 2568264-76-4 | Inhibitory Antibodies |
| HY-P99664 | Inolimomab | 152981-31-2 | Inhibitory Antibodies |
| HY-P99665 | Insulin efsitora alfa | 2131038-11-2 | Inhibitory Antibodies |
| HY-P99666 | Interferon alfa | Inhibitory Antibodies | |
| HY-P99667 | Ipafricept | 1391727-24-4 | Inhibitory Antibodies |
| HY-P99668 | Iparomlimab | 2417649-33-1 | Inhibitory Antibodies |
| HY-P99669 | Iratumumab | 640735-09-7 | Inhibitory Antibodies |
| HY-P9967 | Aducanumab | 1384260-65-4 | Inhibitory Antibodies |
| HY-P99670 | Iscalimab | 2031153-61-2 | Inhibitory Antibodies |
| HY-P99671 | Isecarosmab | 2254082-79-4 | Inhibitory Antibodies |
| HY-P99672 | Istiratumab | 1509928-04-4 | Inhibitory Antibodies |
| HY-P99673 | Itepekimab | 2226742-52-3 | Inhibitory Antibodies |
| HY-P99674 | Ivicentamab | 2364496-42-2 | Inhibitory Antibodies |
| HY-P99675 | Ivonescimab | 2428381-53-5 | Inhibitory Antibodies |
| HY-P99676 | Izalontamab | 2559704-24-2 | Inhibitory Antibodies |
| HY-P99677 | Izenivetmab | 2447755-72-6 | Inhibitory Antibodies |
| HY-P99679 | Izuralimab | 2329669-80-7 | Inhibitory Antibodies |
| HY-P9968 | Nimotuzumab | 780758-10-3 | Inhibitory Antibodies |
| HY-P99680 | Keliximab | 174722-30-6 | Inhibitory Antibodies |
| HY-P99681 | Labetuzumab govitecan | 1469876-18-3 | ADC Related |
| HY-P99682 | Ladiratuzumab | 1629760-28-6 | Inhibitory Antibodies |
| HY-P99683 | Ladiratuzumab vedotin | 1629760-29-7 | ADC Related |
| HY-P99684 | Laprituximab | 1622327-38-1 | Inhibitory Antibodies |
| HY-P99685 | Laprituximab emtansine | 1622327-37-0 | ADC Related |
| HY-P99686 | Larcaviximab | 1792982-56-9 | Inhibitory Antibodies |
| HY-P99687 | Latikafusp | 2552814-07-8 | Inhibitory Antibodies |
| HY-P99688 | Latozinemab | 2376132-27-1 | Inhibitory Antibodies |
| HY-P9969 | Matuzumab | 339186-68-4 | Inhibitory Antibodies |
| HY-P99690 | Ledelabricin alfa | 2252176-75-1 | Inhibitory Antibodies |
| HY-P99691 | Lemalesomab | 250242-54-7 | Inhibitory Antibodies |
| HY-P99692 | Lenercept | 156679-34-4 | Inhibitory Antibodies |
| HY-P99693 | Lenvervimab | 2055006-79-4 | Inhibitory Antibodies |
| HY-P99694 | Lepunafusp alfa | 2396411-71-3 | Inhibitory Antibodies |
| HY-P99695 | Lerdelimumab | 285985-06-0 | Inhibitory Antibodies |
| HY-P99696 | Lerodalcibep | 2250073-78-8 | Inhibitory Antibodies |
| HY-P99697 | Leronlimab | 674782-26-4 | Inhibitory Antibodies |
| HY-P99698 | Lesabelimab | 2475402-56-1 | Inhibitory Antibodies |
| HY-P99699 | Lesofavumab | 1807960-57-1 | Inhibitory Antibodies |
| HY-P9970 | Infliximab | 170277-31-3 | Inhibitory Antibodies |
| HY-P99700 | Letaplimab | 2283356-07-8 | Inhibitory Antibodies |
| HY-P99701 | Letolizumab | 1450981-87-9 | Inhibitory Antibodies |
| HY-P99702 | Levilimab | 2035008-70-7 | Inhibitory Antibodies |
| HY-P99703 | Libivirumab | 569658-79-3 | Inhibitory Antibodies |
| HY-P99704 | Licaminlimab | 1688648-13-6 | Inhibitory Antibodies |
| HY-P99705 | Lifastuzumab vedotin | 1401812-88-1 | ADC Related |
| HY-P99706 | Ligufalimab | 2428381-55-7 | Inhibitory Antibodies |
| HY-P99707 | Lilotomab | 1453362-55-4 | Inhibitory Antibodies |
| HY-P99708 | Livmoniplimab | 2412004-88-5 | Inhibitory Antibodies |
| HY-P99709 | Lodapolimab | 2118349-31-6 | Inhibitory Antibodies |
| HY-P9970A | Infliximab (Anti-TNF-α) | Inhibitory Antibodies | |
| HY-P9971 | Camrelizumab | 1798286-48-2 | Inhibitory Antibodies |
| HY-P99710 | Lomtegovimab | 2550869-33-3 | Inhibitory Antibodies |
| HY-P99711 | Loncastuximab | 1875032-68-0 | Inhibitory Antibodies |
| HY-P99712 | Lonigutamab | 2362015-67-4 | Inhibitory Antibodies |
| HY-P99714 | Lorigerlimab | 2416595-46-3 | Inhibitory Antibodies |
| HY-P99715 | Losatuxizumab | 1801544-27-3 | Inhibitory Antibodies |
| HY-P99718 | Lupartumab | 1640971-88-5 | Inhibitory Antibodies |
| HY-P9972 | Spartalizumab | 1935694-88-4 | Inhibitory Antibodies |
| HY-P99720 | Luspatercept | 1373715-00-4 | Inhibitory Antibodies |
| HY-P99721 | Lutikizumab | 1791411-57-8 | Inhibitory Antibodies |
| HY-P99722 | Maftivimab | 2135632-36-7 | Inhibitory Antibodies |
| HY-P99723 | Manelimab | 2168561-26-8 | Inhibitory Antibodies |
| HY-P99724 | Manfidokimab | 2428381-56-8 | Inhibitory Antibodies |
| HY-P99725 | Marstacimab | 1985638-39-8 | Inhibitory Antibodies |
| HY-P99726 | Maslimomab | 127757-92-0 | Inhibitory Antibodies |
| HY-P99727 | Mazorelvimab | 2419087-89-9 | Inhibitory Antibodies |
| HY-P99728 | Melredableukin alfa | 2056881-92-4 | Inhibitory Antibodies |
| HY-P99729 | Melrilimab | 2222865-46-3 | Inhibitory Antibodies |
| HY-P9973 | Brolucizumab | 1531589-13-5 | Inhibitory Antibodies |
| HY-P99730 | Mezagitamab | 2227490-52-8 | Inhibitory Antibodies |
| HY-P99731 | Milatuzumab | 899796-83-9 | Inhibitory Antibodies |
| HY-P99732 | Minretumomab | 195189-17-4 | Inhibitory Antibodies |
| HY-P99733 | Mipasetamab | 2361055-48-1 | Inhibitory Antibodies |
| HY-P99735 | Mipeginterferon alfa-2b | 1619970-39-6 | Inhibitory Antibodies |
| HY-P99736 | Miptenalimab | 2249882-55-9 | Inhibitory Antibodies |
| HY-P99737 | Mirikizumab | 1884201-71-1 | Inhibitory Antibodies |
| HY-P99739 | Miromavimab | 2247163-73-9 | Inhibitory Antibodies |
| HY-P9974 | Vantictumab | 1345009-45-1 | Inhibitory Antibodies |
| HY-P99740 | Mirzotamab | 2229859-11-2 | Inhibitory Antibodies |
| HY-P99742 | Mitazalimab | 2055640-86-1 | Inhibitory Antibodies |
| HY-P99743 | Mitumomab | 216503-58-1 | Inhibitory Antibodies |
| HY-P99744 | Modakafusp alfa | 2254522-19-3 | Inhibitory Antibodies |
| HY-P99745 | Morolimumab | 202833-07-6 | Inhibitory Antibodies |
| HY-P99746 | Murlentamab | 2058047-65-5 | Inhibitory Antibodies |
| HY-P99748 | Nadecnemab | 2377679-19-9 | Inhibitory Antibodies |
| HY-P9975 | Theralizumab | 906068-56-2 | Inhibitory Antibodies |
| HY-P99750 | Navivumab | 1443004-16-7 | Inhibitory Antibodies |
| HY-P99752 | Nemvaleukin alfa | 2315268-27-8 | Inhibitory Antibodies |
| HY-P99753 | Nerelimomab | 162774-06-3 | Inhibitory Antibodies |
| HY-P99754 | Netakimab | 1796570-08-5 | Inhibitory Antibodies |
| HY-P99756 | Nirsevimab | 1989556-22-0 | Inhibitory Antibodies |
| HY-P99757 | Nivatrotamab | 2278244-14-5 | Inhibitory Antibodies |
| HY-P99758 | Nofazinlimab | 2377845-98-0 | Inhibitory Antibodies |
| HY-P99759 | Nogapendekin alfa (his tag) | 1622189-43-8 | Inhibitory Antibodies |
| HY-P9976 | Isatuximab | 1461640-62-9 | Inhibitory Antibodies |
| HY-P99760 | Nurulimab | 2168561-20-2 | Inhibitory Antibodies |
| HY-P99761 | Obexelimab | 1690307-05-1 | Inhibitory Antibodies |
| HY-P99762 | Obrindatamab | 2069959-72-2 | Inhibitory Antibodies |
| HY-P99763 | Ociperlimab | 2342597-93-5 | Inhibitory Antibodies |
| HY-P99764 | Odesivimab | 2135632-30-1 | Inhibitory Antibodies |
| HY-P99767 | Olendalizumab | 2210314-30-8 | Inhibitory Antibodies |
| HY-P99768 | Olinvacimab | 2095504-49-5 | Inhibitory Antibodies |
| HY-P99769 | Omfiloctocog alfa | 2249927-58-8 | Inhibitory Antibodies |
| HY-P9976A | Isatuximab (anti-CD38) | 1461640-62-9 | Inhibitory Antibodies |
| HY-P9977 | Amivantamab | 2171511-58-1 | Inhibitory Antibodies |
| HY-P99770 | Omodenbamab | 2241724-48-9 | Inhibitory Antibodies |
| HY-P99771 | Onercept | 199685-57-9 | Inhibitory Antibodies |
| HY-P99772 | Onfekafusp alfa | 1957239-88-1 | Inhibitory Antibodies |
| HY-P99773 | Ongericimab | 2145096-91-7 | Inhibitory Antibodies |
| HY-P99775 | Placulumab | 945781-29-3 | Inhibitory Antibodies |
| HY-P99776 | Plamotamab | 2138442-31-4 | Inhibitory Antibodies |
| HY-P99777 | Ontorpacept | 2131089-46-6 | Inhibitory Antibodies |
| HY-P99778 | Ontuxizumab | 946415-62-9 | Inhibitory Antibodies |
| HY-P99779 | Plonmarlimab | 2377482-36-3 | Inhibitory Antibodies |
| HY-P9977A | Amivantamab (FUT8-KO) | Inhibitory Antibodies | |
| HY-P9978 | Toripalimab | 1924598-82-2 | Inhibitory Antibodies |
| HY-P99780 | Opicinumab | 1422268-07-2 | Inhibitory Antibodies |
| HY-P99781 | Plozalizumab | 1610761-46-0 | Inhibitory Antibodies |
| HY-P99782 | Opinercept | 2055118-96-0 | Inhibitory Antibodies |
| HY-P99784 | Porgaviximab | 1792982-55-8 | Inhibitory Antibodies |
| HY-P99785 | Opucolimab | 2251771-79-4 | Inhibitory Antibodies |
| HY-P99786 | Pozelimab | 2096328-94-6 | Inhibitory Antibodies |
| HY-P99788 | Praluzatamab | 2145109-70-0 | Inhibitory Antibodies |
| HY-P9979 | Rozanolixizumab | 1584645-37-3 | Inhibitory Antibodies |
| HY-P99790 | Priliximab | 147191-91-1 | Inhibitory Antibodies |
| HY-P99791 | Orilanolimab | 2066544-85-0 | Inhibitory Antibodies |
| HY-P99792 | Ormutivimab | 2449086-91-1 | Inhibitory Antibodies |
| HY-P99793 | Orticumab | 1314241-10-5 | Inhibitory Antibodies |
| HY-P99794 | Osocimab | 2056878-75-0 | Inhibitory Antibodies |
| HY-P99795 | Otilimab | 1638332-55-4 | Inhibitory Antibodies |
| HY-P99796 | Ozoralizumab | 1167985-17-2 | Inhibitory Antibodies |
| HY-P99797 | Pabinafusp alfa | 2140211-48-7 | Inhibitory Antibodies |
| HY-P99798 | Pacanalotamab | 2251756-52-0 | Inhibitory Antibodies |
| HY-P99799 | Pacmilimab | 2145091-51-4 | Inhibitory Antibodies |
| HY-P9980 | Belantamab | 2061894-48-0 | Inhibitory Antibodies |
| HY-P99800 | Pritoxaximab | 1351470-16-0 | Inhibitory Antibodies |
| HY-P99801 | Pascolizumab | 331243-22-2 | Inhibitory Antibodies |
| HY-P99802 | Pasotuxizumab | 1442657-12-6 | Inhibitory Antibodies |
| HY-P99803 | Clervonafusp alfa | 2145123-44-8 | Inhibitory Antibodies |
| HY-P99804 | Clesrovimab | 2429913-18-6 | Inhibitory Antibodies |
| HY-P99806 | Pritumumab | 499212-74-7 | Inhibitory Antibodies |
| HY-P99807 | Prolgolimab | 2093956-19-3 | Inhibitory Antibodies |
| HY-P99808 | Pulocimab | 2428381-49-9 | Inhibitory Antibodies |
| HY-P99809 | Quavonlimab | 2254059-25-9 | Inhibitory Antibodies |
| HY-P9980A | Belantamab (FUT-8 KO) | Inhibitory Antibodies | |
| HY-P9981 | Tafasitamab | 1422527-84-1 | Inhibitory Antibodies |
| HY-P99810 | Quisovalimab | 2427667-03-4 | Inhibitory Antibodies |
| HY-P99811 | Rafivirumab | 944548-37-2 | Inhibitory Antibodies |
| HY-P99812 | Ragifilimab | 2207590-51-8 | Inhibitory Antibodies |
| HY-P99813 | Patritumab deruxtecan | 2227102-46-5 | ADC Related |
| HY-P99814 | Pavurutamab | 2250292-39-6 | Inhibitory Antibodies |
| HY-P99815 | Pegacaristim | 187139-68-0 | Inhibitory Antibodies |
| HY-P99816 | Ralpancizumab | 1407495-04-8 | Inhibitory Antibodies |
| HY-P99818 | Ramatercept | 1169766-01-1 | Inhibitory Antibodies |
| HY-P9982 | Romosozumab | 909395-70-6 | Inhibitory Antibodies |
| HY-P99820 | Ranevetmab | 1632282-27-9 | Inhibitory Antibodies |
| HY-P99821 | Ravagalimab | 2050816-56-1 | Inhibitory Antibodies |
| HY-P99822 | Recaticimab | 2361290-85-7 | Inhibitory Antibodies |
| HY-P99823 | Recifercept | 2226238-09-9 | Inhibitory Antibodies |
| HY-P99825 | Relfovetmab | 2171034-70-9 | Inhibitory Antibodies |
| HY-P99827 | Cobolimab | 2022215-65-0 | Inhibitory Antibodies |
| HY-P99828 | Cofetuzumab | 1869928-62-0 | Inhibitory Antibodies |
| HY-P99829 | Cofetuzumab pelidotin | 1869937-48-3 | ADC Related |
| HY-P9983 | Lintuzumab | 166089-32-3 | Inhibitory Antibodies |
| HY-P99830 | Conbercept | 1227158-72-6 | Inhibitory Antibodies |
| HY-P99831 | Coprelotamab | 2348469-84-9 | Inhibitory Antibodies |
| HY-P99832 | Cosfroviximab | 1792982-57-0 | Inhibitory Antibodies |
| HY-P99833 | Cosibelimab | 2216751-26-5 | Inhibitory Antibodies |
| HY-P99834 | Crefmirlimab | 2611099-93-3 | Inhibitory Antibodies |
| HY-P99835 | Crenezumab | 1095207-05-8 | Inhibitory Antibodies |
| HY-P99836 | Cudarolimab | 2244739-29-3 | Inhibitory Antibodies |
| HY-P99837 | Dafsolimab | 2367001-71-4 | Inhibitory Antibodies |
| HY-P9984 | Etrolizumab | 1044758-60-2 | Inhibitory Antibodies |
| HY-P99840 | Dalcinonacog alfa | 2055206-13-6 | Inhibitory Antibodies |
| HY-P99841 | Dalutrafusp alfa | 2419918-89-9 | Inhibitory Antibodies |
| HY-P99842A | Dapirolizumab | 1416147-64-2 | Inhibitory Antibodies |
| HY-P99843 | Datopotamab | 2267989-53-5 | Inhibitory Antibodies |
| HY-P99844 | Davoceticept | 2307144-64-3 | Inhibitory Antibodies |
| HY-P99845 | Dazodalibep | 2245953-10-8 | Inhibitory Antibodies |
| HY-P99846 | Dectrekumab | 1528523-94-5 | Inhibitory Antibodies |
| HY-P99849 | Depatuxizumab | 1471999-69-5 | Inhibitory Antibodies |
| HY-P9985 | Disitamab vedotin | 2136633-23-1 | ADC Related |
| HY-P99850 | Depemokimab | 2243274-14-6 | Inhibitory Antibodies |
| HY-P99851 | Detumomab | 145832-33-3 | Inhibitory Antibodies |
| HY-P99852 | Dilpacimab | 1791420-09-1 | Inhibitory Antibodies |
| HY-P99853 | Diridavumab | 1393659-46-5 | Inhibitory Antibodies |
| HY-P99854 | Disitamab | 2185868-98-6 | Inhibitory Antibodies |
| HY-P99855 | Divozilimab | 2254061-60-2 | Inhibitory Antibodies |
| HY-P99856 | Docaravimab | 2247196-23-0 | Inhibitory Antibodies |
| HY-P99857 | Domagrozumab | 1629605-31-7 | Inhibitory Antibodies |
| HY-P99858 | Domvanalimab | 2368219-35-4 | Inhibitory Antibodies |
| HY-P99859 | Donanemab | 1931944-80-7 | Inhibitory Antibodies |
| HY-P9986 | Tiragolumab | 1918185-84-8 | Inhibitory Antibodies |
| HY-P99860 | Peginterferon alfacon-2 | 1848968-91-1 | Inhibitory Antibodies |
| HY-P99863 | Dorlimomab aritox | 122722-03-6 | Inhibitory Antibodies |
| HY-P99864 | Dovanvetmab | 2171034-71-0 | Inhibitory Antibodies |
| HY-P99865 | Dresbuxelimab | 2550560-20-6 | Inhibitory Antibodies |
| HY-P99866 | Duligotuzumab | 1314238-96-4 | Inhibitory Antibodies |
| HY-P99867 | Dusigitumab | 1204390-13-5 | Inhibitory Antibodies |
| HY-P99868 | Duvortuxizumab | 1831098-91-9 | Inhibitory Antibodies |
| HY-P99869 | Ebdarokimab | 2393651-11-9 | Inhibitory Antibodies |
| HY-P9987 | Crizanlizumab | 1690318-25-2 | Inhibitory Antibodies |
| HY-P99870 | Eblasakimab | 2445460-16-0 | Inhibitory Antibodies |
| HY-P99871 | Ebronucimab | 2304800-90-4 | Inhibitory Antibodies |
| HY-P99872 | Ecleralimab | 2415207-91-7 | Inhibitory Antibodies |
| HY-P99873 | Ecromeximab | 292819-64-8 | Inhibitory Antibodies |
| HY-P99875 | Efanesoctocog alfa | 2252477-42-0 | Inhibitory Antibodies |
| HY-P99876 | Efaprinermin alfa | 2102200-64-4 | Inhibitory Antibodies |
| HY-P99877 | Efavaleukin alfa | 2049067-94-7 | Inhibitory Antibodies |
| HY-P99879 | Efbemalenograstim alfa | 2200269-79-8 | Inhibitory Antibodies |
| HY-P9988 | Mecbotamab | 2460400-28-4 | Inhibitory Antibodies |
| HY-P99880 | Roledumab | 1174008-79-7 | Inhibitory Antibodies |
| HY-P99881 | Rolinsatamab talirine | 2095467-44-8 | ADC Related |
| HY-P99883 | Romilkimab | 1399584-78-1 | Inhibitory Antibodies |
| HY-P99884 | Sasanlimab | 2206792-50-7 | Inhibitory Antibodies |
| HY-P99886 | Pexelizumab | 219685-93-5 | Inhibitory Antibodies |
| HY-P99887 | Pimivalimab | 2293951-22-9 | Inhibitory Antibodies |
| HY-P99888 | Pimurutamab | 2251771-76-1 | Inhibitory Antibodies |
| HY-P99889 | Romlusevimab | 2509447-08-7 | Inhibitory Antibodies |
| HY-P9989 | Linvoseltamab | 2408319-25-3 | Inhibitory Antibodies |
| HY-P99891 | Rovelizumab | 339086-79-2 | Inhibitory Antibodies |
| HY-P99892 | Serclutamab | 2140172-41-2 | Inhibitory Antibodies |
| HY-P99893 | Rozibafusp alfa | 2143449-47-0 | Inhibitory Antibodies |
| HY-P99895 | Rulonilimab | 2417124-95-7 | Inhibitory Antibodies |
| HY-P99896 | Runimotamab | 2361325-98-4 | Inhibitory Antibodies |
| HY-P99898 | Setoxaximab | 1351470-17-1 | Inhibitory Antibodies |
| HY-P99899 | Samrotamab | 2052591-32-7 | Inhibitory Antibodies |
| HY-P9990 | Litifilimab | 2407378-48-5 | Inhibitory Antibodies |
| HY-P99900 | Sevirumab | 138660-96-5 | Inhibitory Antibodies |
| HY-P99901 | Sibeprenlimab | 2382896-07-1 | Inhibitory Antibodies |
| HY-P99902 | Simlukafusp alfa | 1776942-10-9 | Inhibitory Antibodies |
| HY-P99903 | Simridarlimab | 2378862-90-7 | Inhibitory Antibodies |
| HY-P99904 | Siplizumab | 288392-69-8 | Inhibitory Antibodies |
| HY-P99905 | Efdamrofusp alfa | 2375661-82-6 | Inhibitory Antibodies |
| HY-P99906 | Sirexatamab | 2414962-49-3 | Inhibitory Antibodies |
| HY-P99907 | Efgivanermin alfa | 1807864-13-6 | Inhibitory Antibodies |
| HY-P99908 | Efineptakin alfa | 2026634-47-7 | Inhibitory Antibodies |
| HY-P99909 | Elranatamab | 2408850-14-4 | Inhibitory Antibodies |
| HY-P9991 | Osemitamab | 2460539-61-9 | Inhibitory Antibodies |
| HY-P99910 | Eluvixtamab | 1679391-73-1 | Inhibitory Antibodies |
| HY-P99911 | Efizonerimod alfa | 1635395-27-5 | Inhibitory Antibodies |
| HY-P99912 | Emerfetamab | 2250261-27-7 | Inhibitory Antibodies |
| HY-P99913 | Eflapegrastim | 1384099-30-2 | Inhibitory Antibodies |
| HY-P99914 | Emfizatamab | 2559704-23-1 | Inhibitory Antibodies |
| HY-P99916 | Emirodatamab | 2449199-61-3 | Inhibitory Antibodies |
| HY-P99917 | Eflepedocokin alfa | 2200269-84-5 | Inhibitory Antibodies |
| HY-P99919 | Efmarodocokin alfa | 2247840-74-8 | Inhibitory Antibodies |
| HY-P9991A | Osemitamab (FUT8-KO) | Inhibitory Antibodies | |
| HY-P9992 | Pelgifatamab | 2414550-93-7 | Inhibitory Antibodies |
| HY-P99921 | Enapotamab vedotin | 1912424-97-5 | ADC Related |
| HY-P99922 | Encelimab | 2173096-82-5 | Inhibitory Antibodies |
| HY-P99924 | Efpegsomatropin | 1314472-89-3 | Inhibitory Antibodies |
| HY-P99925 | Enoticumab | 1192578-27-0 | Inhibitory Antibodies |
| HY-P99928 | Efprezimod alfa | 2574508-57-7 | Inhibitory Antibodies |
| HY-P99929 | Enuzovimab | 2531098-91-4 | Inhibitory Antibodies |
| HY-P9993 | Peresolimab | 2411580-63-5 | Inhibitory Antibodies |
| HY-P99930 | Efruxifermin | 2375240-92-7 | Inhibitory Antibodies |
| HY-P99931 | Epcoritamab | 2134641-34-0 | Inhibitory Antibodies |
| HY-P99932 | Eftansomatropin alfa | 1905448-17-0 | Inhibitory Antibodies |
| HY-P99933 | Eftilagimod alfa | 1800476-36-1 | Inhibitory Antibodies |
| HY-P99934 | Eftozanermin alfa | 1820660-69-2 | Inhibitory Antibodies |
| HY-P99935 | Elarekibep | 2485020-60-6 | Inhibitory Antibodies |
| HY-P99936 | Elgemtumab | 1512559-37-3 | Inhibitory Antibodies |
| HY-P99937 | Elipovimab | 2101210-43-7 | Inhibitory Antibodies |
| HY-P99938 | Pucotenlimab | 2403647-03-8 | Inhibitory Antibodies |
| HY-P99940 | Remtolumab | 1791410-27-9 | Inhibitory Antibodies |
| HY-P99941 | Retifanlimab | 2079108-44-2 | Inhibitory Antibodies |
| HY-P99943 | Erfonrilimab | 2367013-69-0 | Inhibitory Antibodies |
| HY-P99944 | SHR-1701 | 2891860-17-4 | Inhibitory Antibodies |
| HY-P99945 | Revdofilimab | 2230138-89-1 | Inhibitory Antibodies |
| HY-P99946 | Erlizumab | 211323-03-4 | Inhibitory Antibodies |
| HY-P99947 | Rimteravimab | 2540797-21-3 | Inhibitory Antibodies |
| HY-P99948 | Etevritamab | 2329692-74-0 | Inhibitory Antibodies |
| HY-P99949 | Etigilimab | 2044984-83-8 | Inhibitory Antibodies |
| HY-P9995 | Posdinemab | 2517973-04-3 | Inhibitory Antibodies |
| HY-P99950 | Evorpacept | 2484949-51-9 | Inhibitory Antibodies |
| HY-P99951 | Ripafollitropin alfa (bovine) | 2376991-13-6 | Inhibitory Antibodies |
| HY-P99952 | Ripertamab | 2249927-04-4 | Inhibitory Antibodies |
| HY-P99953 | Rivabazumab | 1627519-84-9 | Inhibitory Antibodies |
| HY-P99954 | Rivabazumab pegol | 1613506-32-3 | Inhibitory Antibodies |
| HY-P99955 | Rocatinlimab | 2431972-52-8 | Inhibitory Antibodies |
| HY-P99956 | Zilovertamab vedotin | ADC Related | |
| HY-P99957 | Zeluvalimab | 2315361-37-4 | Inhibitory Antibodies |
| HY-P99958 | Vixtimotamab | 2243775-32-6 | Inhibitory Antibodies |
| HY-P99959 | Unasnemab | 2379805-59-9 | Inhibitory Antibodies |
| HY-P9996 | Reozalimab | 2445259-99-2 | Inhibitory Antibodies |
| HY-P99961 | Tifcemalimab | 2236068-83-8 | Inhibitory Antibodies |
| HY-P99962 | Surzebiclimab | 2342597-90-2 | Inhibitory Antibodies |
| HY-P99963 | Sudubrilimab | 2387417-06-1 | Inhibitory Antibodies |
| HY-P99964 | Sirtratumab | 1824663-82-2 | Inhibitory Antibodies |
| HY-P99965 | Crovalimab | 1917321-26-6 | Inhibitory Antibodies |
| HY-P99966 | Narlumosbart | 2646587-68-8 | Inhibitory Antibodies |
| HY-P99967 | Cantuzumab | 1204740-23-7 | Inhibitory Antibodies |
| HY-P99968 | Clivatuzumab | 1622075-09-5 | Inhibitory Antibodies |
| HY-P99969 | Inetetamab | Inhibitory Antibodies | |
| HY-P9997 | Rosnilimab | 2412764-40-8 | Inhibitory Antibodies |
| HY-P99970 | Lifastuzumab | 1615697-16-9 | Inhibitory Antibodies |
| HY-P99971 | Gemtuzumab | 220578-59-6 | Inhibitory Antibodies |
| HY-P99974 | Nab-Paclitaxel | Inhibitory Antibodies | |
| HY-P99976 | Anti-Mouse CD19 Antibody (1D3) | Inhibitory Antibodies | |
| HY-P99977 | Mouse IgG1 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99978 | Mouse IgG2a kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99978A | Mouse IgG2a (LALA-PG), Isotype Control | Inhibitory Antibodies | |
| HY-P99979 | Rat IgG1 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P9998 | Semzuvolimab | 2409099-32-5 | Inhibitory Antibodies |
| HY-P99980 | Rabbit IgG1 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99981 | Mouse IgG2c kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99982 | Mouse IgG2b kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99983 | Mouse IgG1 (D265A) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99984 | Mouse IgG1 (N297A) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99985 | Mouse IgG3 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99986 | Mouse lgG2a (D265A) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99987 | Human IgG4 (S228P) lambda1, Isotype Control | Inhibitory Antibodies | |
| HY-P9999 | Trontinemab | 2568868-35-7 | Inhibitory Antibodies |
| HY-P99990 | Human IgG3 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99992 | Human IgG1 lambda1, Isotype Control | Inhibitory Antibodies | |
| HY-P99993 | Human IgG1 (S239D/I332E) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99994 | Human IgG1 (N297A) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99995 | Human IgG1 (K214R) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99996 | Human IgG1 (D265A) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99997 | Human IgG1 (D270N) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99998 | Human IgG1 (F405L) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P99999 | Anti-Mouse CD4 Antibody (YTS 191) | Inhibitory Antibodies | |
| HY-P9S0008 | Cetuximab (PBS) | Inhibitory Antibodies | |
| HY-P9S0009 | Adalimumab (Powder) | 331731-18-1 | Inhibitory Antibodies |
| HY-PS0002 | Fmoc-Ala-Wang resin | Peptides | |
| HY-PS0005 | Fmoc-Arg(Pbf)-Wang resin | Peptides | |
| HY-PS0011 | Fmoc-Gly-Wang resin | Peptides | |
| HY-PS0015 | Fmoc-Lys(Boc)-Wang resin | Peptides | |
| HY-Q04764 | TI17 | 1005178-02-8 | Reference compound |
| HY-Q22471 | ROCK1-IN-1 | 692869-38-8 | Reference compound |
| HY-Q25865 | MG-V-53 | 920157-23-9 | Reference compound |
| HY-Q36392 | JNJ-9350 | 326923-09-5 | Reference compound |
| HY-Q36691 | PRMT5-IN-30 | 330951-01-4 | Reference compound |
| HY-Q40175 | Antitrypanosomal agent 9 | 438474-67-0 | Reference compound |
| HY-Q40876 | BBT | 445000-45-3 | Reference compound |
| HY-Q43097 | Hsp110-STAT3 interaction-IN-1 | 882582-26-5 | Reference compound |
| HY-Q45780 | ZINC00640089 | 667880-11-7 | Reference compound |
| HY-Q48328 | GSK3-IN-1 | 478482-74-5 | Reference compound |
| HY-Q49697 | Sirtuin modulator 3 | 708995-11-3 | Reference compound |
| HY-Q50147 | Antimicrobial agent-21 | 724746-07-0 | Reference compound |
| HY-Q51221 | 3-Benzyl-8,9-dimethoxy-5-[(2-methylbenzyl)thio]imidazo[1,2-c]quinazolin-2(3H)-one | 477768-54-0 | Reference compound |
| HY-Q51222 | 6-(3-Nitrophenyl)-5H-dibenzo[c,e]azepine-5,7(6H)-dione | 100264-64-0 | Reference compound |
| HY-R00001 | hsa-let-7a-2-3p mimic | Oligonucleotides | |
| HY-R00001A | hsa-let-7a-2-3p agomir | Oligonucleotides | |
| HY-R00002 | hsa-let-7a-3p mimic | Oligonucleotides | |
| HY-R00002A | hsa-let-7a-3p agomir | Oligonucleotides | |
| HY-R00003 | hsa-let-7a-5p mimic | Oligonucleotides | |
| HY-R00003A | hsa-let-7a-5p agomir | Oligonucleotides | |
| HY-R00004 | hsa-let-7b-3p mimic | Oligonucleotides | |
| HY-R00004A | hsa-let-7b-3p agomir | Oligonucleotides | |
| HY-R00005 | hsa-let-7b-5p mimic | Oligonucleotides | |
| HY-R00005A | hsa-let-7b-5p agomir | Oligonucleotides | |
| HY-R00006 | hsa-let-7c-3p mimic | Oligonucleotides | |
| HY-R00006A | hsa-let-7c-3p agomir | Oligonucleotides | |
| HY-R00007 | hsa-let-7c-5p mimic | Oligonucleotides | |
| HY-R00007A | hsa-let-7c-5p agomir | Oligonucleotides | |
| HY-R00008 | hsa-let-7d-3p mimic | Oligonucleotides | |
| HY-R00008A | hsa-let-7d-3p agomir | Oligonucleotides | |
| HY-R00009 | hsa-let-7e-3p mimic | Oligonucleotides | |
| HY-R00009A | hsa-let-7e-3p agomir | Oligonucleotides | |
| HY-R00010 | hsa-let-7f-1-3p mimic | Oligonucleotides | |
| HY-R00010A | hsa-let-7f-1-3p agomir | Oligonucleotides | |
| HY-R00011 | hsa-let-7f-2-3p mimic | Oligonucleotides | |
| HY-R00011A | hsa-let-7f-2-3p agomir | Oligonucleotides | |
| HY-R00012 | hsa-let-7g-5p mimic | Oligonucleotides | |
| HY-R00012A | hsa-let-7g-5p agomir | Oligonucleotides | |
| HY-R00013 | hsa-let-7i-3p mimic | Oligonucleotides | |
| HY-R00013A | hsa-let-7i-3p agomir | Oligonucleotides | |
| HY-R00014 | hsa-let-7i-5p mimic | Oligonucleotides | |
| HY-R00014A | hsa-let-7i-5p agomir | Oligonucleotides | |
| HY-R00015 | hsa-miR-100-5p mimic | Oligonucleotides | |
| HY-R00015A | hsa-miR-100-5p agomir | Oligonucleotides | |
| HY-R00016 | hsa-miR-101-2-5p mimic | Oligonucleotides | |
| HY-R00016A | hsa-miR-101-2-5p agomir | Oligonucleotides | |
| HY-R00017 | hsa-miR-101-3p mimic | Oligonucleotides | |
| HY-R00017A | hsa-miR-101-3p agomir | Oligonucleotides | |
| HY-R00018 | hsa-miR-101-5p mimic | Oligonucleotides | |
| HY-R00018A | hsa-miR-101-5p agomir | Oligonucleotides | |
| HY-R00019 | hsa-miR-10226 mimic | Oligonucleotides | |
| HY-R00019A | hsa-miR-10226 agomir | Oligonucleotides | |
| HY-R00020 | hsa-miR-10392-3p mimic | Oligonucleotides | |
| HY-R00020A | hsa-miR-10392-3p agomir | Oligonucleotides | |
| HY-R00021 | hsa-miR-10392-5p mimic | Oligonucleotides | |
| HY-R00021A | hsa-miR-10392-5p agomir | Oligonucleotides | |
| HY-R00022 | hsa-miR-10393-3p mimic | Oligonucleotides | |
| HY-R00022A | hsa-miR-10393-3p agomir | Oligonucleotides | |
| HY-R00023 | hsa-miR-10393-5p mimic | Oligonucleotides | |
| HY-R00023A | hsa-miR-10393-5p agomir | Oligonucleotides | |
| HY-R00024 | hsa-miR-10394-3p mimic | Oligonucleotides | |
| HY-R00024A | hsa-miR-10394-3p agomir | Oligonucleotides | |
| HY-R00025 | hsa-miR-10394-5p mimic | Oligonucleotides | |
| HY-R00025A | hsa-miR-10394-5p agomir | Oligonucleotides | |
| HY-R00026 | hsa-miR-10395-3p mimic | Oligonucleotides | |
| HY-R00026A | hsa-miR-10395-3p agomir | Oligonucleotides | |
| HY-R00027 | hsa-miR-10395-5p mimic | Oligonucleotides | |
| HY-R00027A | hsa-miR-10395-5p agomir | Oligonucleotides | |
| HY-R00028 | hsa-miR-10396a-3p mimic | Oligonucleotides | |
| HY-R00028A | hsa-miR-10396a-3p agomir | Oligonucleotides | |
| HY-R00029 | hsa-miR-10396a-5p mimic | Oligonucleotides | |
| HY-R00029A | hsa-miR-10396a-5p agomir | Oligonucleotides | |
| HY-R00030 | hsa-miR-10396b-3p mimic | Oligonucleotides | |
| HY-R00030A | hsa-miR-10396b-3p agomir | Oligonucleotides | |
| HY-R00031 | hsa-miR-10396b-5p mimic | Oligonucleotides | |
| HY-R00031A | hsa-miR-10396b-5p agomir | Oligonucleotides | |
| HY-R00032 | hsa-miR-10397-3p mimic | Oligonucleotides | |
| HY-R00032A | hsa-miR-10397-3p agomir | Oligonucleotides | |
| HY-R00033 | hsa-miR-10397-5p mimic | Oligonucleotides | |
| HY-R00033A | hsa-miR-10397-5p agomir | Oligonucleotides | |
| HY-R00034 | hsa-miR-10398-3p mimic | Oligonucleotides | |
| HY-R00034A | hsa-miR-10398-3p agomir | Oligonucleotides | |
| HY-R00035 | hsa-miR-10398-5p mimic | Oligonucleotides | |
| HY-R00035A | hsa-miR-10398-5p agomir | Oligonucleotides | |
| HY-R00036 | hsa-miR-10399-3p mimic | Oligonucleotides | |
| HY-R00036A | hsa-miR-10399-3p agomir | Oligonucleotides | |
| HY-R00037 | hsa-miR-10399-5p mimic | Oligonucleotides | |
| HY-R00037A | hsa-miR-10399-5p agomir | Oligonucleotides | |
| HY-R00038 | hsa-miR-103a-1-5p mimic | Oligonucleotides | |
| HY-R00038A | hsa-miR-103a-1-5p agomir | Oligonucleotides | |
| HY-R00039 | hsa-miR-103a-2-5p mimic | Oligonucleotides | |
| HY-R00039A | hsa-miR-103a-2-5p agomir | Oligonucleotides | |
| HY-R00040 | hsa-miR-103a-3p mimic | Oligonucleotides | |
| HY-R00040A | hsa-miR-103a-3p agomir | Oligonucleotides | |
| HY-R00041 | hsa-miR-10400-3p mimic | Oligonucleotides | |
| HY-R00041A | hsa-miR-10400-3p agomir | Oligonucleotides | |
| HY-R00042 | hsa-miR-10400-5p mimic | Oligonucleotides | |
| HY-R00042A | hsa-miR-10400-5p agomir | Oligonucleotides | |
| HY-R00043 | hsa-miR-10401-3p mimic | Oligonucleotides | |
| HY-R00043A | hsa-miR-10401-3p agomir | Oligonucleotides | |
| HY-R00044 | hsa-miR-10401-5p mimic | Oligonucleotides | |
| HY-R00044A | hsa-miR-10401-5p agomir | Oligonucleotides | |
| HY-R00045 | hsa-miR-10522-5p mimic | Oligonucleotides | |
| HY-R00045A | hsa-miR-10522-5p agomir | Oligonucleotides | |
| HY-R00046 | hsa-miR-10523-5p mimic | Oligonucleotides | |
| HY-R00046A | hsa-miR-10523-5p agomir | Oligonucleotides | |
| HY-R00047 | hsa-miR-10524-5p mimic | Oligonucleotides | |
| HY-R00047A | hsa-miR-10524-5p agomir | Oligonucleotides | |
| HY-R00048 | hsa-miR-10525-3p mimic | Oligonucleotides | |
| HY-R00048A | hsa-miR-10525-3p agomir | Oligonucleotides | |
| HY-R00049 | hsa-miR-10526-3p mimic | Oligonucleotides | |
| HY-R00049A | hsa-miR-10526-3p agomir | Oligonucleotides | |
| HY-R00050 | hsa-miR-10527-5p mimic | Oligonucleotides | |
| HY-R00050A | hsa-miR-10527-5p agomir | Oligonucleotides | |
| HY-R00051 | hsa-miR-105-3p mimic | Oligonucleotides | |
| HY-R00051A | hsa-miR-105-3p agomir | Oligonucleotides | |
| HY-R00052 | hsa-miR-105-5p mimic | Oligonucleotides | |
| HY-R00052A | hsa-miR-105-5p agomir | Oligonucleotides | |
| HY-R00053 | hsa-miR-106a-3p mimic | Oligonucleotides | |
| HY-R00053A | hsa-miR-106a-3p agomir | Oligonucleotides | |
| HY-R00054 | hsa-miR-106a-5p mimic | Oligonucleotides | |
| HY-R00054A | hsa-miR-106a-5p agomir | Oligonucleotides | |
| HY-R00055 | hsa-miR-106b-3p mimic | Oligonucleotides | |
| HY-R00055A | hsa-miR-106b-3p agomir | Oligonucleotides | |
| HY-R00056 | hsa-miR-106b-5p mimic | Oligonucleotides | |
| HY-R00056A | hsa-miR-106b-5p agomir | Oligonucleotides | |
| HY-R00057 | hsa-miR-107 mimic | Oligonucleotides | |
| HY-R00057A | hsa-miR-107 agomir | Oligonucleotides | |
| HY-R00058 | hsa-miR-10a-3p mimic | Oligonucleotides | |
| HY-R00058A | hsa-miR-10a-3p agomir | Oligonucleotides | |
| HY-R00059 | hsa-miR-10a-5p mimic | Oligonucleotides | |
| HY-R00059A | hsa-miR-10a-5p agomir | Oligonucleotides | |
| HY-R00060 | hsa-miR-10b-3p mimic | Oligonucleotides | |
| HY-R00060A | hsa-miR-10b-3p agomir | Oligonucleotides | |
| HY-R00061 | hsa-miR-10b-5p mimic | Oligonucleotides | |
| HY-R00061A | hsa-miR-10b-5p agomir | Oligonucleotides | |
| HY-R00062 | hsa-miR-11181-3p mimic | Oligonucleotides | |
| HY-R00062A | hsa-miR-11181-3p agomir | Oligonucleotides | |
| HY-R00063 | hsa-miR-11181-5p mimic | Oligonucleotides | |
| HY-R00063A | hsa-miR-11181-5p agomir | Oligonucleotides | |
| HY-R00064 | hsa-miR-11399 mimic | Oligonucleotides | |
| HY-R00064A | hsa-miR-11399 agomir | Oligonucleotides | |
| HY-R00065 | hsa-miR-11400 mimic | Oligonucleotides | |
| HY-R00065A | hsa-miR-11400 agomir | Oligonucleotides | |
| HY-R00066 | hsa-miR-11401 mimic | Oligonucleotides | |
| HY-R00066A | hsa-miR-11401 agomir | Oligonucleotides | |
| HY-R00067 | hsa-miR-1178-3p mimic | Oligonucleotides | |
| HY-R00067A | hsa-miR-1178-3p agomir | Oligonucleotides | |
| HY-R00068 | hsa-miR-1178-5p mimic | Oligonucleotides | |
| HY-R00068A | hsa-miR-1178-5p agomir | Oligonucleotides | |
| HY-R00069 | hsa-miR-1179 mimic | Oligonucleotides | |
| HY-R00069A | hsa-miR-1179 agomir | Oligonucleotides | |
| HY-R00070 | hsa-miR-1180-3p mimic | Oligonucleotides | |
| HY-R00070A | hsa-miR-1180-3p agomir | Oligonucleotides | |
| HY-R00071 | hsa-miR-1180-5p mimic | Oligonucleotides | |
| HY-R00071A | hsa-miR-1180-5p agomir | Oligonucleotides | |
| HY-R00072 | hsa-miR-1182 mimic | Oligonucleotides | |
| HY-R00072A | hsa-miR-1182 agomir | Oligonucleotides | |
| HY-R00073 | hsa-miR-1183 mimic | Oligonucleotides | |
| HY-R00073A | hsa-miR-1183 agomir | Oligonucleotides | |
| HY-R00074 | hsa-miR-1184 mimic | Oligonucleotides | |
| HY-R00074A | hsa-miR-1184 agomir | Oligonucleotides | |
| HY-R00075 | hsa-miR-1185-1-3p mimic | Oligonucleotides | |
| HY-R00075A | hsa-miR-1185-1-3p agomir | Oligonucleotides | |
| HY-R00076 | hsa-miR-1185-2-3p mimic | Oligonucleotides | |
| HY-R00076A | hsa-miR-1185-2-3p agomir | Oligonucleotides | |
| HY-R00077 | hsa-miR-1185-5p mimic | Oligonucleotides | |
| HY-R00077A | hsa-miR-1185-5p agomir | Oligonucleotides | |
| HY-R00078 | hsa-miR-1193 mimic | Oligonucleotides | |
| HY-R00078A | hsa-miR-1193 agomir | Oligonucleotides | |
| HY-R00079 | hsa-miR-1197 mimic | Oligonucleotides | |
| HY-R00079A | hsa-miR-1197 agomir | Oligonucleotides | |
| HY-R00080 | hsa-miR-1199-3p mimic | Oligonucleotides | |
| HY-R00080A | hsa-miR-1199-3p agomir | Oligonucleotides | |
| HY-R00081 | hsa-miR-1199-5p mimic | Oligonucleotides | |
| HY-R00081A | hsa-miR-1199-5p agomir | Oligonucleotides | |
| HY-R00082 | hsa-miR-1202 mimic | Oligonucleotides | |
| HY-R00082A | hsa-miR-1202 agomir | Oligonucleotides | |
| HY-R00083 | hsa-miR-1203 mimic | Oligonucleotides | |
| HY-R00083A | hsa-miR-1203 agomir | Oligonucleotides | |
| HY-R00084 | hsa-miR-1204 mimic | Oligonucleotides | |
| HY-R00084A | hsa-miR-1204 agomir | Oligonucleotides | |
| HY-R00085 | hsa-miR-1205 mimic | Oligonucleotides | |
| HY-R00085A | hsa-miR-1205 agomir | Oligonucleotides | |
| HY-R00086 | hsa-miR-1207-3p mimic | Oligonucleotides | |
| HY-R00086A | hsa-miR-1207-3p agomir | Oligonucleotides | |
| HY-R00087 | hsa-miR-1207-5p mimic | Oligonucleotides | |
| HY-R00087A | hsa-miR-1207-5p agomir | Oligonucleotides | |
| HY-R00088 | hsa-miR-1208 mimic | Oligonucleotides | |
| HY-R00088A | hsa-miR-1208 agomir | Oligonucleotides | |
| HY-R00089 | hsa-miR-12113 mimic | Oligonucleotides | |
| HY-R00089A | hsa-miR-12113 agomir | Oligonucleotides | |
| HY-R00090 | hsa-miR-12114 mimic | Oligonucleotides | |
| HY-R00090A | hsa-miR-12114 agomir | Oligonucleotides | |
| HY-R00091 | hsa-miR-12115 mimic | Oligonucleotides | |
| HY-R00091A | hsa-miR-12115 agomir | Oligonucleotides | |
| HY-R00092 | hsa-miR-12116 mimic | Oligonucleotides | |
| HY-R00092A | hsa-miR-12116 agomir | Oligonucleotides | |
| HY-R00093 | hsa-miR-12117 mimic | Oligonucleotides | |
| HY-R00093A | hsa-miR-12117 agomir | Oligonucleotides | |
| HY-R00094 | hsa-miR-12118 mimic | Oligonucleotides | |
| HY-R00094A | hsa-miR-12118 agomir | Oligonucleotides | |
| HY-R00095 | hsa-miR-12119 mimic | Oligonucleotides | |
| HY-R00095A | hsa-miR-12119 agomir | Oligonucleotides | |
| HY-R00096 | hsa-miR-12120 mimic | Oligonucleotides | |
| HY-R00096A | hsa-miR-12120 agomir | Oligonucleotides | |
| HY-R00097 | hsa-miR-12121 mimic | Oligonucleotides | |
| HY-R00097A | hsa-miR-12121 agomir | Oligonucleotides | |
| HY-R00098 | hsa-miR-12122 mimic | Oligonucleotides | |
| HY-R00098A | hsa-miR-12122 agomir | Oligonucleotides | |
| HY-R00099 | hsa-miR-12123 mimic | Oligonucleotides | |
| HY-R00099A | hsa-miR-12123 agomir | Oligonucleotides | |
| HY-R00100 | hsa-miR-12124 mimic | Oligonucleotides | |
| HY-R00100A | hsa-miR-12124 agomir | Oligonucleotides | |
| HY-R00101 | hsa-miR-12125 mimic | Oligonucleotides | |
| HY-R00101A | hsa-miR-12125 agomir | Oligonucleotides | |
| HY-R00102 | hsa-miR-12126 mimic | Oligonucleotides | |
| HY-R00102A | hsa-miR-12126 agomir | Oligonucleotides | |
| HY-R00103 | hsa-miR-12127 mimic | Oligonucleotides | |
| HY-R00103A | hsa-miR-12127 agomir | Oligonucleotides | |
| HY-R00104 | hsa-miR-12128 mimic | Oligonucleotides | |
| HY-R00104A | hsa-miR-12128 agomir | Oligonucleotides | |
| HY-R00105 | hsa-miR-12129 mimic | Oligonucleotides | |
| HY-R00105A | hsa-miR-12129 agomir | Oligonucleotides | |
| HY-R00106 | hsa-miR-12130 mimic | Oligonucleotides | |
| HY-R00106A | hsa-miR-12130 agomir | Oligonucleotides | |
| HY-R00107 | hsa-miR-12131 mimic | Oligonucleotides | |
| HY-R00107A | hsa-miR-12131 agomir | Oligonucleotides | |
| HY-R00108 | hsa-miR-12132 mimic | Oligonucleotides | |
| HY-R00108A | hsa-miR-12132 agomir | Oligonucleotides | |
| HY-R00109 | hsa-miR-12133 mimic | Oligonucleotides | |
| HY-R00109A | hsa-miR-12133 agomir | Oligonucleotides | |
| HY-R00110 | hsa-miR-12135 mimic | Oligonucleotides | |
| HY-R00110A | hsa-miR-12135 agomir | Oligonucleotides | |
| HY-R00111 | hsa-miR-12136 mimic | Oligonucleotides | |
| HY-R00111A | hsa-miR-12136 agomir | Oligonucleotides | |
| HY-R00112 | hsa-miR-122-3p mimic | Oligonucleotides | |
| HY-R00112A | hsa-miR-122-3p agomir | Oligonucleotides | |
| HY-R00113 | hsa-miR-1224-3p mimic | Oligonucleotides | |
| HY-R00113A | hsa-miR-1224-3p agomir | Oligonucleotides | |
| HY-R00114 | hsa-miR-1224-5p mimic | Oligonucleotides | |
| HY-R00114A | hsa-miR-1224-5p agomir | Oligonucleotides | |
| HY-R00115 | hsa-miR-1225-5p mimic | Oligonucleotides | |
| HY-R00115A | hsa-miR-1225-5p agomir | Oligonucleotides | |
| HY-R00116 | hsa-miR-122-5p mimic | Oligonucleotides | |
| HY-R00116A | hsa-miR-122-5p agomir | Oligonucleotides | |
| HY-R00117 | hsa-miR-1226-3p mimic | Oligonucleotides | |
| HY-R00117A | hsa-miR-1226-3p agomir | Oligonucleotides | |
| HY-R00118 | hsa-miR-1226-5p mimic | Oligonucleotides | |
| HY-R00118A | hsa-miR-1226-5p agomir | Oligonucleotides | |
| HY-R00119 | hsa-miR-1227-3p mimic | Oligonucleotides | |
| HY-R00119A | hsa-miR-1227-3p agomir | Oligonucleotides | |
| HY-R00120 | hsa-miR-1227-5p mimic | Oligonucleotides | |
| HY-R00120A | hsa-miR-1227-5p agomir | Oligonucleotides | |
| HY-R00121 | hsa-miR-1228-3p mimic | Oligonucleotides | |
| HY-R00121A | hsa-miR-1228-3p agomir | Oligonucleotides | |
| HY-R00122 | hsa-miR-1228-5p mimic | Oligonucleotides | |
| HY-R00122A | hsa-miR-1228-5p agomir | Oligonucleotides | |
| HY-R00123 | hsa-miR-1229-3p mimic | Oligonucleotides | |
| HY-R00123A | hsa-miR-1229-3p agomir | Oligonucleotides | |
| HY-R00124 | hsa-miR-1229-5p mimic | Oligonucleotides | |
| HY-R00124A | hsa-miR-1229-5p agomir | Oligonucleotides | |
| HY-R00125 | hsa-miR-122b-3p mimic | Oligonucleotides | |
| HY-R00125A | hsa-miR-122b-3p agomir | Oligonucleotides | |
| HY-R00126 | hsa-miR-122b-5p mimic | Oligonucleotides | |
| HY-R00126A | hsa-miR-122b-5p agomir | Oligonucleotides | |
| HY-R00127 | hsa-miR-1231 mimic | Oligonucleotides | |
| HY-R00127A | hsa-miR-1231 agomir | Oligonucleotides | |
| HY-R00128 | hsa-miR-1233-3p mimic | Oligonucleotides | |
| HY-R00128A | hsa-miR-1233-3p agomir | Oligonucleotides | |
| HY-R00129 | hsa-miR-1233-5p mimic | Oligonucleotides | |
| HY-R00129A | hsa-miR-1233-5p agomir | Oligonucleotides | |
| HY-R00130 | hsa-miR-1234-3p mimic | Oligonucleotides | |
| HY-R00130A | hsa-miR-1234-3p agomir | Oligonucleotides | |
| HY-R00131 | hsa-miR-1236-3p mimic | Oligonucleotides | |
| HY-R00131A | hsa-miR-1236-3p agomir | Oligonucleotides | |
| HY-R00132 | hsa-miR-1236-5p mimic | Oligonucleotides | |
| HY-R00132A | hsa-miR-1236-5p agomir | Oligonucleotides | |
| HY-R00133 | hsa-miR-1237-3p mimic | Oligonucleotides | |
| HY-R00133A | hsa-miR-1237-3p agomir | Oligonucleotides | |
| HY-R00134 | hsa-miR-1237-5p mimic | Oligonucleotides | |
| HY-R00134A | hsa-miR-1237-5p agomir | Oligonucleotides | |
| HY-R00135 | hsa-miR-1238-3p mimic | Oligonucleotides | |
| HY-R00135A | hsa-miR-1238-3p agomir | Oligonucleotides | |
| HY-R00136 | hsa-miR-1238-5p mimic | Oligonucleotides | |
| HY-R00136A | hsa-miR-1238-5p agomir | Oligonucleotides | |
| HY-R00137 | hsa-miR-1243 mimic | Oligonucleotides | |
| HY-R00137A | hsa-miR-1243 agomir | Oligonucleotides | |
| HY-R00138 | hsa-miR-124-3p mimic | Oligonucleotides | |
| HY-R00138A | hsa-miR-124-3p agomir | Oligonucleotides | |
| HY-R00139 | hsa-miR-1244 mimic | Oligonucleotides | |
| HY-R00139A | hsa-miR-1244 agomir | Oligonucleotides | |
| HY-R00140 | hsa-miR-1245a mimic | Oligonucleotides | |
| HY-R00140A | hsa-miR-1245a agomir | Oligonucleotides | |
| HY-R00141 | hsa-miR-1245b-3p mimic | Oligonucleotides | |
| HY-R00141A | hsa-miR-1245b-3p agomir | Oligonucleotides | |
| HY-R00142 | hsa-miR-1245b-5p mimic | Oligonucleotides | |
| HY-R00142A | hsa-miR-1245b-5p agomir | Oligonucleotides | |
| HY-R00143 | hsa-miR-124-5p mimic | Oligonucleotides | |
| HY-R00143A | hsa-miR-124-5p agomir | Oligonucleotides | |
| HY-R00144 | hsa-miR-1246 mimic | Oligonucleotides | |
| HY-R00144A | hsa-miR-1246 agomir | Oligonucleotides | |
| HY-R00145 | hsa-miR-1247-3p mimic | Oligonucleotides | |
| HY-R00145A | hsa-miR-1247-3p agomir | Oligonucleotides | |
| HY-R00146 | hsa-miR-1247-5p mimic | Oligonucleotides | |
| HY-R00146A | hsa-miR-1247-5p agomir | Oligonucleotides | |
| HY-R00147 | hsa-miR-1248 mimic | Oligonucleotides | |
| HY-R00147A | hsa-miR-1248 agomir | Oligonucleotides | |
| HY-R00148 | hsa-miR-1249-3p mimic | Oligonucleotides | |
| HY-R00148A | hsa-miR-1249-3p agomir | Oligonucleotides | |
| HY-R00149 | hsa-miR-1249-5p mimic | Oligonucleotides | |
| HY-R00149A | hsa-miR-1249-5p agomir | Oligonucleotides | |
| HY-R00150 | hsa-miR-1250-3p mimic | Oligonucleotides | |
| HY-R00150A | hsa-miR-1250-3p agomir | Oligonucleotides | |
| HY-R00151 | hsa-miR-1250-5p mimic | Oligonucleotides | |
| HY-R00151A | hsa-miR-1250-5p agomir | Oligonucleotides | |
| HY-R00152 | hsa-miR-1251-3p mimic | Oligonucleotides | |
| HY-R00152A | hsa-miR-1251-3p agomir | Oligonucleotides | |
| HY-R00153 | hsa-miR-1251-5p mimic | Oligonucleotides | |
| HY-R00153A | hsa-miR-1251-5p agomir | Oligonucleotides | |
| HY-R00154 | hsa-miR-1252-3p mimic | Oligonucleotides | |
| HY-R00154A | hsa-miR-1252-3p agomir | Oligonucleotides | |
| HY-R00155 | hsa-miR-1252-5p mimic | Oligonucleotides | |
| HY-R00155A | hsa-miR-1252-5p agomir | Oligonucleotides | |
| HY-R00156 | hsa-miR-1253 mimic | Oligonucleotides | |
| HY-R00156A | hsa-miR-1253 agomir | Oligonucleotides | |
| HY-R00157 | hsa-miR-1255a mimic | Oligonucleotides | |
| HY-R00157A | hsa-miR-1255a agomir | Oligonucleotides | |
| HY-R00158 | hsa-miR-1255b-2-3p mimic | Oligonucleotides | |
| HY-R00158A | hsa-miR-1255b-2-3p agomir | Oligonucleotides | |
| HY-R00159 | hsa-miR-1255b-5p mimic | Oligonucleotides | |
| HY-R00159A | hsa-miR-1255b-5p agomir | Oligonucleotides | |
| HY-R00160 | hsa-miR-1256 mimic | Oligonucleotides | |
| HY-R00160A | hsa-miR-1256 agomir | Oligonucleotides | |
| HY-R00161 | hsa-miR-1257 mimic | Oligonucleotides | |
| HY-R00161A | hsa-miR-1257 agomir | Oligonucleotides | |
| HY-R00162 | hsa-miR-1258 mimic | Oligonucleotides | |
| HY-R00162A | hsa-miR-1258 agomir | Oligonucleotides | |
| HY-R00163 | hsa-miR-125a-3p mimic | Oligonucleotides | |
| HY-R00163A | hsa-miR-125a-3p agomir | Oligonucleotides | |
| HY-R00164 | hsa-miR-125a-5p mimic | Oligonucleotides | |
| HY-R00164A | hsa-miR-125a-5p agomir | Oligonucleotides | |
| HY-R00165 | hsa-miR-125b-1-3p mimic | Oligonucleotides | |
| HY-R00165A | hsa-miR-125b-1-3p agomir | Oligonucleotides | |
| HY-R00166 | hsa-miR-125b-2-3p mimic | Oligonucleotides | |
| HY-R00166A | hsa-miR-125b-2-3p agomir | Oligonucleotides | |
| HY-R00167 | hsa-miR-125b-5p mimic | Oligonucleotides | |
| HY-R00167A | hsa-miR-125b-5p agomir | Oligonucleotides | |
| HY-R00168 | hsa-miR-1260b mimic | Oligonucleotides | |
| HY-R00168A | hsa-miR-1260b agomir | Oligonucleotides | |
| HY-R00169 | hsa-miR-1261 mimic | Oligonucleotides | |
| HY-R00169A | hsa-miR-1261 agomir | Oligonucleotides | |
| HY-R00170 | hsa-miR-1262 mimic | Oligonucleotides | |
| HY-R00170A | hsa-miR-1262 agomir | Oligonucleotides | |
| HY-R00171 | hsa-miR-1263 mimic | Oligonucleotides | |
| HY-R00171A | hsa-miR-1263 agomir | Oligonucleotides | |
| HY-R00172 | hsa-miR-126-3p mimic | Oligonucleotides | |
| HY-R00172A | hsa-miR-126-3p agomir | Oligonucleotides | |
| HY-R00173 | hsa-miR-1264 mimic | Oligonucleotides | |
| HY-R00173A | hsa-miR-1264 agomir | Oligonucleotides | |
| HY-R00174 | hsa-miR-1265 mimic | Oligonucleotides | |
| HY-R00174A | hsa-miR-1265 agomir | Oligonucleotides | |
| HY-R00175 | hsa-miR-126-5p mimic | Oligonucleotides | |
| HY-R00175A | hsa-miR-126-5p agomir | Oligonucleotides | |
| HY-R00176 | hsa-miR-1266-3p mimic | Oligonucleotides | |
| HY-R00176A | hsa-miR-1266-3p agomir | Oligonucleotides | |
| HY-R00177 | hsa-miR-1266-5p mimic | Oligonucleotides | |
| HY-R00177A | hsa-miR-1266-5p agomir | Oligonucleotides | |
| HY-R00178 | hsa-miR-1267 mimic | Oligonucleotides | |
| HY-R00178A | hsa-miR-1267 agomir | Oligonucleotides | |
| HY-R00179 | hsa-miR-1268a mimic | Oligonucleotides | |
| HY-R00179A | hsa-miR-1268a agomir | Oligonucleotides | |
| HY-R00180 | hsa-miR-1268b mimic | Oligonucleotides | |
| HY-R00180A | hsa-miR-1268b agomir | Oligonucleotides | |
| HY-R00181 | hsa-miR-1269a mimic | Oligonucleotides | |
| HY-R00181A | hsa-miR-1269a agomir | Oligonucleotides | |
| HY-R00182 | hsa-miR-1269b mimic | Oligonucleotides | |
| HY-R00182A | hsa-miR-1269b agomir | Oligonucleotides | |
| HY-R00183 | hsa-miR-1270 mimic | Oligonucleotides | |
| HY-R00183A | hsa-miR-1270 agomir | Oligonucleotides | |
| HY-R00184 | hsa-miR-1271-3p mimic | Oligonucleotides | |
| HY-R00184A | hsa-miR-1271-3p agomir | Oligonucleotides | |
| HY-R00185 | hsa-miR-1271-5p mimic | Oligonucleotides | |
| HY-R00185A | hsa-miR-1271-5p agomir | Oligonucleotides | |
| HY-R00186 | hsa-miR-1272 mimic | Oligonucleotides | |
| HY-R00186A | hsa-miR-1272 agomir | Oligonucleotides | |
| HY-R00187 | hsa-miR-1273c mimic | Oligonucleotides | |
| HY-R00187A | hsa-miR-1273c agomir | Oligonucleotides | |
| HY-R00188 | hsa-miR-1273h-3p mimic | Oligonucleotides | |
| HY-R00188A | hsa-miR-1273h-3p agomir | Oligonucleotides | |
| HY-R00189 | hsa-miR-1273h-5p mimic | Oligonucleotides | |
| HY-R00189A | hsa-miR-1273h-5p agomir | Oligonucleotides | |
| HY-R00190 | hsa-miR-127-3p mimic | Oligonucleotides | |
| HY-R00190A | hsa-miR-127-3p agomir | Oligonucleotides | |
| HY-R00191 | hsa-miR-127-5p mimic | Oligonucleotides | |
| HY-R00191A | hsa-miR-127-5p agomir | Oligonucleotides | |
| HY-R00192 | hsa-miR-1276 mimic | Oligonucleotides | |
| HY-R00192A | hsa-miR-1276 agomir | Oligonucleotides | |
| HY-R00193 | hsa-miR-1277-3p mimic | Oligonucleotides | |
| HY-R00193A | hsa-miR-1277-3p agomir | Oligonucleotides | |
| HY-R00194 | hsa-miR-1277-5p mimic | Oligonucleotides | |
| HY-R00194A | hsa-miR-1277-5p agomir | Oligonucleotides | |
| HY-R00195 | hsa-miR-1278 mimic | Oligonucleotides | |
| HY-R00195A | hsa-miR-1278 agomir | Oligonucleotides | |
| HY-R00196 | hsa-miR-1279 mimic | Oligonucleotides | |
| HY-R00196A | hsa-miR-1279 agomir | Oligonucleotides | |
| HY-R00197 | hsa-miR-1281 mimic | Oligonucleotides | |
| HY-R00197A | hsa-miR-1281 agomir | Oligonucleotides | |
| HY-R00198 | hsa-miR-128-1-5p mimic | Oligonucleotides | |
| HY-R00198A | hsa-miR-128-1-5p agomir | Oligonucleotides | |
| HY-R00199 | hsa-miR-1282 mimic | Oligonucleotides | |
| HY-R00199A | hsa-miR-1282 agomir | Oligonucleotides | |
| HY-R00200 | hsa-miR-128-2-5p mimic | Oligonucleotides | |
| HY-R00200A | hsa-miR-128-2-5p agomir | Oligonucleotides | |
| HY-R00201 | hsa-miR-1283 mimic | Oligonucleotides | |
| HY-R00201A | hsa-miR-1283 agomir | Oligonucleotides | |
| HY-R00202 | hsa-miR-128-3p mimic | Oligonucleotides | |
| HY-R00202A | hsa-miR-128-3p agomir | Oligonucleotides | |
| HY-R00203 | hsa-miR-1284 mimic | Oligonucleotides | |
| HY-R00203A | hsa-miR-1284 agomir | Oligonucleotides | |
| HY-R00204 | hsa-miR-1285-3p mimic | Oligonucleotides | |
| HY-R00204A | hsa-miR-1285-3p agomir | Oligonucleotides | |
| HY-R00205 | hsa-miR-1285-5p mimic | Oligonucleotides | |
| HY-R00205A | hsa-miR-1285-5p agomir | Oligonucleotides | |
| HY-R00206 | hsa-miR-1286 mimic | Oligonucleotides | |
| HY-R00206A | hsa-miR-1286 agomir | Oligonucleotides | |
| HY-R00207 | hsa-miR-1287-3p mimic | Oligonucleotides | |
| HY-R00207A | hsa-miR-1287-3p agomir | Oligonucleotides | |
| HY-R00208 | hsa-miR-1287-5p mimic | Oligonucleotides | |
| HY-R00208A | hsa-miR-1287-5p agomir | Oligonucleotides | |
| HY-R00209 | hsa-miR-1288-3p mimic | Oligonucleotides | |
| HY-R00209A | hsa-miR-1288-3p agomir | Oligonucleotides | |
| HY-R00210 | hsa-miR-1288-5p mimic | Oligonucleotides | |
| HY-R00210A | hsa-miR-1288-5p agomir | Oligonucleotides | |
| HY-R00211 | hsa-miR-1289 mimic | Oligonucleotides | |
| HY-R00211A | hsa-miR-1289 agomir | Oligonucleotides | |
| HY-R00212 | hsa-miR-1290 mimic | Oligonucleotides | |
| HY-R00212A | hsa-miR-1290 agomir | Oligonucleotides | |
| HY-R00213 | hsa-miR-1291 mimic | Oligonucleotides | |
| HY-R00213A | hsa-miR-1291 agomir | Oligonucleotides | |
| HY-R00214 | hsa-miR-129-1-3p mimic | Oligonucleotides | |
| HY-R00214A | hsa-miR-129-1-3p agomir | Oligonucleotides | |
| HY-R00215 | hsa-miR-1292-3p mimic | Oligonucleotides | |
| HY-R00215A | hsa-miR-1292-3p agomir | Oligonucleotides | |
| HY-R00216 | hsa-miR-129-2-3p mimic | Oligonucleotides | |
| HY-R00216A | hsa-miR-129-2-3p agomir | Oligonucleotides | |
| HY-R00217 | hsa-miR-1292-5p mimic | Oligonucleotides | |
| HY-R00217A | hsa-miR-1292-5p agomir | Oligonucleotides | |
| HY-R00218 | hsa-miR-1293 mimic | Oligonucleotides | |
| HY-R00218A | hsa-miR-1293 agomir | Oligonucleotides | |
| HY-R00219 | hsa-miR-1294 mimic | Oligonucleotides | |
| HY-R00219A | hsa-miR-1294 agomir | Oligonucleotides | |
| HY-R00220 | hsa-miR-1295a mimic | Oligonucleotides | |
| HY-R00220A | hsa-miR-1295a agomir | Oligonucleotides | |
| HY-R00221 | hsa-miR-1295b-3p mimic | Oligonucleotides | |
| HY-R00221A | hsa-miR-1295b-3p agomir | Oligonucleotides | |
| HY-R00222 | hsa-miR-1295b-5p mimic | Oligonucleotides | |
| HY-R00222A | hsa-miR-1295b-5p agomir | Oligonucleotides | |
| HY-R00223 | hsa-miR-129-5p mimic | Oligonucleotides | |
| HY-R00223A | hsa-miR-129-5p agomir | Oligonucleotides | |
| HY-R00224 | hsa-miR-1296-3p mimic | Oligonucleotides | |
| HY-R00224A | hsa-miR-1296-3p agomir | Oligonucleotides | |
| HY-R00225 | hsa-miR-1296-5p mimic | Oligonucleotides | |
| HY-R00225A | hsa-miR-1296-5p agomir | Oligonucleotides | |
| HY-R00226 | hsa-miR-1297 mimic | Oligonucleotides | |
| HY-R00226A | hsa-miR-1297 agomir | Oligonucleotides | |
| HY-R00227 | hsa-miR-1298-3p mimic | Oligonucleotides | |
| HY-R00227A | hsa-miR-1298-3p agomir | Oligonucleotides | |
| HY-R00228 | hsa-miR-1298-5p mimic | Oligonucleotides | |
| HY-R00228A | hsa-miR-1298-5p agomir | Oligonucleotides | |
| HY-R00229 | hsa-miR-1299 mimic | Oligonucleotides | |
| HY-R00229A | hsa-miR-1299 agomir | Oligonucleotides | |
| HY-R00230 | hsa-miR-1301-3p mimic | Oligonucleotides | |
| HY-R00230A | hsa-miR-1301-3p agomir | Oligonucleotides | |
| HY-R00231 | hsa-miR-1301-5p mimic | Oligonucleotides | |
| HY-R00231A | hsa-miR-1301-5p agomir | Oligonucleotides | |
| HY-R00232 | hsa-miR-1302 mimic | Oligonucleotides | |
| HY-R00232A | hsa-miR-1302 agomir | Oligonucleotides | |
| HY-R00233 | hsa-miR-1303 mimic | Oligonucleotides | |
| HY-R00233A | hsa-miR-1303 agomir | Oligonucleotides | |
| HY-R00234 | hsa-miR-1304-3p mimic | Oligonucleotides | |
| HY-R00234A | hsa-miR-1304-3p agomir | Oligonucleotides | |
| HY-R00235 | hsa-miR-1304-5p mimic | Oligonucleotides | |
| HY-R00235A | hsa-miR-1304-5p agomir | Oligonucleotides | |
| HY-R00236 | hsa-miR-1305 mimic | Oligonucleotides | |
| HY-R00236A | hsa-miR-1305 agomir | Oligonucleotides | |
| HY-R00237 | hsa-miR-1306-3p mimic | Oligonucleotides | |
| HY-R00237A | hsa-miR-1306-3p agomir | Oligonucleotides | |
| HY-R00238 | hsa-miR-1306-5p mimic | Oligonucleotides | |
| HY-R00238A | hsa-miR-1306-5p agomir | Oligonucleotides | |
| HY-R00239 | hsa-miR-1307-3p mimic | Oligonucleotides | |
| HY-R00239A | hsa-miR-1307-3p agomir | Oligonucleotides | |
| HY-R00240 | hsa-miR-1307-5p mimic | Oligonucleotides | |
| HY-R00240A | hsa-miR-1307-5p agomir | Oligonucleotides | |
| HY-R00241 | hsa-miR-130a-3p mimic | Oligonucleotides | |
| HY-R00241A | hsa-miR-130a-3p agomir | Oligonucleotides | |
| HY-R00242 | hsa-miR-130a-5p mimic | Oligonucleotides | |
| HY-R00242A | hsa-miR-130a-5p agomir | Oligonucleotides | |
| HY-R00243 | hsa-miR-130b-3p mimic | Oligonucleotides | |
| HY-R00243A | hsa-miR-130b-3p agomir | Oligonucleotides | |
| HY-R00244 | hsa-miR-130b-5p mimic | Oligonucleotides | |
| HY-R00244A | hsa-miR-130b-5p agomir | Oligonucleotides | |
| HY-R00245 | hsa-miR-1321 mimic | Oligonucleotides | |
| HY-R00245A | hsa-miR-1321 agomir | Oligonucleotides | |
| HY-R00246 | hsa-miR-1322 mimic | Oligonucleotides | |
| HY-R00246A | hsa-miR-1322 agomir | Oligonucleotides | |
| HY-R00247 | hsa-miR-1323 mimic | Oligonucleotides | |
| HY-R00247A | hsa-miR-1323 agomir | Oligonucleotides | |
| HY-R00248 | hsa-miR-132-3p mimic | Oligonucleotides | |
| HY-R00248A | hsa-miR-132-3p agomir | Oligonucleotides | |
| HY-R00249 | hsa-miR-1324 mimic | Oligonucleotides | |
| HY-R00249A | hsa-miR-1324 agomir | Oligonucleotides | |
| HY-R00250 | hsa-miR-132-5p mimic | Oligonucleotides | |
| HY-R00250A | hsa-miR-132-5p agomir | Oligonucleotides | |
| HY-R00251 | hsa-miR-133a-3p mimic | Oligonucleotides | |
| HY-R00251A | hsa-miR-133a-3p agomir | Oligonucleotides | |
| HY-R00252 | hsa-miR-133a-5p mimic | Oligonucleotides | |
| HY-R00252A | hsa-miR-133a-5p agomir | Oligonucleotides | |
| HY-R00253 | hsa-miR-133b mimic | Oligonucleotides | |
| HY-R00253A | hsa-miR-133b agomir | Oligonucleotides | |
| HY-R00254 | hsa-miR-1343-3p mimic | Oligonucleotides | |
| HY-R00254A | hsa-miR-1343-3p agomir | Oligonucleotides | |
| HY-R00255 | hsa-miR-1343-5p mimic | Oligonucleotides | |
| HY-R00255A | hsa-miR-1343-5p agomir | Oligonucleotides | |
| HY-R00256 | hsa-miR-134-5p mimic | Oligonucleotides | |
| HY-R00256A | hsa-miR-134-5p agomir | Oligonucleotides | |
| HY-R00257 | hsa-miR-135a-2-3p mimic | Oligonucleotides | |
| HY-R00257A | hsa-miR-135a-2-3p agomir | Oligonucleotides | |
| HY-R00258 | hsa-miR-135a-3p mimic | Oligonucleotides | |
| HY-R00258A | hsa-miR-135a-3p agomir | Oligonucleotides | |
| HY-R00259 | hsa-miR-135a-5p mimic | Oligonucleotides | |
| HY-R00259A | hsa-miR-135a-5p agomir | Oligonucleotides | |
| HY-R00260 | hsa-miR-135b-3p mimic | Oligonucleotides | |
| HY-R00260A | hsa-miR-135b-3p agomir | Oligonucleotides | |
| HY-R00261 | hsa-miR-135b-5p mimic | Oligonucleotides | |
| HY-R00261A | hsa-miR-135b-5p agomir | Oligonucleotides | |
| HY-R00262 | hsa-miR-136-3p mimic | Oligonucleotides | |
| HY-R00262A | hsa-miR-136-3p agomir | Oligonucleotides | |
| HY-R00263 | hsa-miR-136-5p mimic | Oligonucleotides | |
| HY-R00263A | hsa-miR-136-5p agomir | Oligonucleotides | |
| HY-R00264 | hsa-miR-137-3p mimic | Oligonucleotides | |
| HY-R00264A | hsa-miR-137-3p agomir | Oligonucleotides | |
| HY-R00265 | hsa-miR-137-5p mimic | Oligonucleotides | |
| HY-R00265A | hsa-miR-137-5p agomir | Oligonucleotides | |
| HY-R00266 | hsa-miR-138-1-3p mimic | Oligonucleotides | |
| HY-R00266A | hsa-miR-138-1-3p agomir | Oligonucleotides | |
| HY-R00267 | hsa-miR-138-2-3p mimic | Oligonucleotides | |
| HY-R00267A | hsa-miR-138-2-3p agomir | Oligonucleotides | |
| HY-R00268 | hsa-miR-138-5p mimic | Oligonucleotides | |
| HY-R00268A | hsa-miR-138-5p agomir | Oligonucleotides | |
| HY-R00269 | hsa-miR-139-3p mimic | Oligonucleotides | |
| HY-R00269A | hsa-miR-139-3p agomir | Oligonucleotides | |
| HY-R00270 | hsa-miR-139-5p mimic | Oligonucleotides | |
| HY-R00270A | hsa-miR-139-5p agomir | Oligonucleotides | |
| HY-R00271 | hsa-miR-1-3p mimic | Oligonucleotides | |
| HY-R00271A | hsa-miR-1-3p agomir | Oligonucleotides | |
| HY-R00272 | hsa-miR-140-3p mimic | Oligonucleotides | |
| HY-R00272A | hsa-miR-140-3p agomir | Oligonucleotides | |
| HY-R00273 | hsa-miR-140-5p mimic | Oligonucleotides | |
| HY-R00273A | hsa-miR-140-5p agomir | Oligonucleotides | |
| HY-R00274 | hsa-miR-141-3p mimic | Oligonucleotides | |
| HY-R00274A | hsa-miR-141-3p agomir | Oligonucleotides | |
| HY-R00275 | hsa-miR-141-5p mimic | Oligonucleotides | |
| HY-R00275A | hsa-miR-141-5p agomir | Oligonucleotides | |
| HY-R00276 | hsa-miR-142-3p mimic | Oligonucleotides | |
| HY-R00276A | hsa-miR-142-3p agomir | Oligonucleotides | |
| HY-R00277 | hsa-miR-142-5p mimic | Oligonucleotides | |
| HY-R00277A | hsa-miR-142-5p agomir | Oligonucleotides | |
| HY-R00278 | hsa-miR-143-3p mimic | Oligonucleotides | |
| HY-R00278A | hsa-miR-143-3p agomir | Oligonucleotides | |
| HY-R00279 | hsa-miR-144-3p mimic | Oligonucleotides | |
| HY-R00279A | hsa-miR-144-3p agomir | Oligonucleotides | |
| HY-R00280 | hsa-miR-144-5p mimic | Oligonucleotides | |
| HY-R00280A | hsa-miR-144-5p agomir | Oligonucleotides | |
| HY-R00281 | hsa-miR-145-3p mimic | Oligonucleotides | |
| HY-R00281A | hsa-miR-145-3p agomir | Oligonucleotides | |
| HY-R00282 | hsa-miR-145-5p mimic | Oligonucleotides | |
| HY-R00282A | hsa-miR-145-5p agomir | Oligonucleotides | |
| HY-R00283 | hsa-miR-1468-3p mimic | Oligonucleotides | |
| HY-R00283A | hsa-miR-1468-3p agomir | Oligonucleotides | |
| HY-R00284 | hsa-miR-1468-5p mimic | Oligonucleotides | |
| HY-R00284A | hsa-miR-1468-5p agomir | Oligonucleotides | |
| HY-R00285 | hsa-miR-1469 mimic | Oligonucleotides | |
| HY-R00285A | hsa-miR-1469 agomir | Oligonucleotides | |
| HY-R00286 | hsa-miR-146a-3p mimic | Oligonucleotides | |
| HY-R00286A | hsa-miR-146a-3p agomir | Oligonucleotides | |
| HY-R00287 | hsa-miR-146a-5p mimic | Oligonucleotides | |
| HY-R00287A | hsa-miR-146a-5p agomir | Oligonucleotides | |
| HY-R00288 | hsa-miR-146b-3p mimic | Oligonucleotides | |
| HY-R00288A | hsa-miR-146b-3p agomir | Oligonucleotides | |
| HY-R00289 | hsa-miR-146b-5p mimic | Oligonucleotides | |
| HY-R00289A | hsa-miR-146b-5p agomir | Oligonucleotides | |
| HY-R00290 | hsa-miR-1470 mimic | Oligonucleotides | |
| HY-R00290A | hsa-miR-1470 agomir | Oligonucleotides | |
| HY-R00291 | hsa-miR-1471 mimic | Oligonucleotides | |
| HY-R00291A | hsa-miR-1471 agomir | Oligonucleotides | |
| HY-R00292 | hsa-miR-147a mimic | Oligonucleotides | |
| HY-R00292A | hsa-miR-147a agomir | Oligonucleotides | |
| HY-R00293 | hsa-miR-147b-5p mimic | Oligonucleotides | |
| HY-R00293A | hsa-miR-147b-5p agomir | Oligonucleotides | |
| HY-R00294 | hsa-miR-148a-3p mimic | Oligonucleotides | |
| HY-R00294A | hsa-miR-148a-3p agomir | Oligonucleotides | |
| HY-R00295 | hsa-miR-148a-5p mimic | Oligonucleotides | |
| HY-R00295A | hsa-miR-148a-5p agomir | Oligonucleotides | |
| HY-R00296 | hsa-miR-148b-3p mimic | Oligonucleotides | |
| HY-R00296A | hsa-miR-148b-3p agomir | Oligonucleotides | |
| HY-R00297 | hsa-miR-148b-5p mimic | Oligonucleotides | |
| HY-R00297A | hsa-miR-148b-5p agomir | Oligonucleotides | |
| HY-R00298 | hsa-miR-149-3p mimic | Oligonucleotides | |
| HY-R00298A | hsa-miR-149-3p agomir | Oligonucleotides | |
| HY-R00299 | hsa-miR-149-5p mimic | Oligonucleotides | |
| HY-R00299A | hsa-miR-149-5p agomir | Oligonucleotides | |
| HY-R00300 | hsa-miR-150-3p mimic | Oligonucleotides | |
| HY-R00300A | hsa-miR-150-3p agomir | Oligonucleotides | |
| HY-R00301 | hsa-miR-150-5p mimic | Oligonucleotides | |
| HY-R00301A | hsa-miR-150-5p agomir | Oligonucleotides | |
| HY-R00302 | hsa-miR-151a-3p mimic | Oligonucleotides | |
| HY-R00302A | hsa-miR-151a-3p agomir | Oligonucleotides | |
| HY-R00303 | hsa-miR-151a-5p mimic | Oligonucleotides | |
| HY-R00303A | hsa-miR-151a-5p agomir | Oligonucleotides | |
| HY-R00304 | hsa-miR-151b mimic | Oligonucleotides | |
| HY-R00304A | hsa-miR-151b agomir | Oligonucleotides | |
| HY-R00305 | hsa-miR-152-3p mimic | Oligonucleotides | |
| HY-R00305A | hsa-miR-152-3p agomir | Oligonucleotides | |
| HY-R00306 | hsa-miR-152-5p mimic | Oligonucleotides | |
| HY-R00306A | hsa-miR-152-5p agomir | Oligonucleotides | |
| HY-R00307 | hsa-miR-153-3p mimic | Oligonucleotides | |
| HY-R00307A | hsa-miR-153-3p agomir | Oligonucleotides | |
| HY-R00308 | hsa-miR-153-5p mimic | Oligonucleotides | |
| HY-R00308A | hsa-miR-153-5p agomir | Oligonucleotides | |
| HY-R00309 | hsa-miR-1537-3p mimic | Oligonucleotides | |
| HY-R00309A | hsa-miR-1537-3p agomir | Oligonucleotides | |
| HY-R00310 | hsa-miR-1537-5p mimic | Oligonucleotides | |
| HY-R00310A | hsa-miR-1537-5p agomir | Oligonucleotides | |
| HY-R00311 | hsa-miR-1538 mimic | Oligonucleotides | |
| HY-R00311A | hsa-miR-1538 agomir | Oligonucleotides | |
| HY-R00312 | hsa-miR-1539 mimic | Oligonucleotides | |
| HY-R00312A | hsa-miR-1539 agomir | Oligonucleotides | |
| HY-R00313 | hsa-miR-154-3p mimic | Oligonucleotides | |
| HY-R00313A | hsa-miR-154-3p agomir | Oligonucleotides | |
| HY-R00314 | hsa-miR-154-5p mimic | Oligonucleotides | |
| HY-R00314A | hsa-miR-154-5p agomir | Oligonucleotides | |
| HY-R00315 | hsa-miR-155-3p mimic | Oligonucleotides | |
| HY-R00315A | hsa-miR-155-3p agomir | Oligonucleotides | |
| HY-R00316 | hsa-miR-155-5p mimic | Oligonucleotides | |
| HY-R00316A | hsa-miR-155-5p agomir | Oligonucleotides | |
| HY-R00317 | hsa-miR-1587 mimic | Oligonucleotides | |
| HY-R00317A | hsa-miR-1587 agomir | Oligonucleotides | |
| HY-R00318 | hsa-miR-15a-3p mimic | Oligonucleotides | |
| HY-R00318A | hsa-miR-15a-3p agomir | Oligonucleotides | |
| HY-R00319 | hsa-miR-15a-5p mimic | Oligonucleotides | |
| HY-R00319A | hsa-miR-15a-5p agomir | Oligonucleotides | |
| HY-R00320 | hsa-miR-15b-3p mimic | Oligonucleotides | |
| HY-R00320A | hsa-miR-15b-3p agomir | Oligonucleotides | |
| HY-R00321 | hsa-miR-15b-5p mimic | Oligonucleotides | |
| HY-R00321A | hsa-miR-15b-5p agomir | Oligonucleotides | |
| HY-R00322 | hsa-miR-16-1-3p mimic | Oligonucleotides | |
| HY-R00322A | hsa-miR-16-1-3p agomir | Oligonucleotides | |
| HY-R00323 | hsa-miR-16-2-3p mimic | Oligonucleotides | |
| HY-R00323A | hsa-miR-16-2-3p agomir | Oligonucleotides | |
| HY-R00324 | hsa-miR-16-5p mimic | Oligonucleotides | |
| HY-R00324A | hsa-miR-16-5p agomir | Oligonucleotides | |
| HY-R00325 | hsa-miR-17-3p mimic | Oligonucleotides | |
| HY-R00325A | hsa-miR-17-3p agomir | Oligonucleotides | |
| HY-R00326 | hsa-miR-17-5p mimic | Oligonucleotides | |
| HY-R00326A | hsa-miR-17-5p agomir | Oligonucleotides | |
| HY-R00327 | hsa-miR-181a-2-3p mimic | Oligonucleotides | |
| HY-R00327A | hsa-miR-181a-2-3p agomir | Oligonucleotides | |
| HY-R00328 | hsa-miR-181a-3p mimic | Oligonucleotides | |
| HY-R00328A | hsa-miR-181a-3p agomir | Oligonucleotides | |
| HY-R00329 | hsa-miR-181a-5p mimic | Oligonucleotides | |
| HY-R00329A | hsa-miR-181a-5p agomir | Oligonucleotides | |
| HY-R00330 | hsa-miR-181b-2-3p mimic | Oligonucleotides | |
| HY-R00330A | hsa-miR-181b-2-3p agomir | Oligonucleotides | |
| HY-R00331 | hsa-miR-181b-3p mimic | Oligonucleotides | |
| HY-R00331A | hsa-miR-181b-3p agomir | Oligonucleotides | |
| HY-R00332 | hsa-miR-181b-5p mimic | Oligonucleotides | |
| HY-R00332A | hsa-miR-181b-5p agomir | Oligonucleotides | |
| HY-R00333 | hsa-miR-181c-3p mimic | Oligonucleotides | |
| HY-R00333A | hsa-miR-181c-3p agomir | Oligonucleotides | |
| HY-R00334 | hsa-miR-181c-5p mimic | Oligonucleotides | |
| HY-R00334A | hsa-miR-181c-5p agomir | Oligonucleotides | |
| HY-R00335 | hsa-miR-181d-3p mimic | Oligonucleotides | |
| HY-R00335A | hsa-miR-181d-3p agomir | Oligonucleotides | |
| HY-R00336 | hsa-miR-181d-5p mimic | Oligonucleotides | |
| HY-R00336A | hsa-miR-181d-5p agomir | Oligonucleotides | |
| HY-R00337 | hsa-miR-182-3p mimic | Oligonucleotides | |
| HY-R00337A | hsa-miR-182-3p agomir | Oligonucleotides | |
| HY-R00338 | hsa-miR-1825 mimic | Oligonucleotides | |
| HY-R00338A | hsa-miR-1825 agomir | Oligonucleotides | |
| HY-R00339 | hsa-miR-182-5p mimic | Oligonucleotides | |
| HY-R00339A | hsa-miR-182-5p agomir | Oligonucleotides | |
| HY-R00340 | hsa-miR-1827 mimic | Oligonucleotides | |
| HY-R00340A | hsa-miR-1827 agomir | Oligonucleotides | |
| HY-R00341 | hsa-miR-183-3p mimic | Oligonucleotides | |
| HY-R00341A | hsa-miR-183-3p agomir | Oligonucleotides | |
| HY-R00342 | hsa-miR-183-5p mimic | Oligonucleotides | |
| HY-R00342A | hsa-miR-183-5p agomir | Oligonucleotides | |
| HY-R00343 | hsa-miR-184 mimic | Oligonucleotides | |
| HY-R00343A | hsa-miR-184 agomir | Oligonucleotides | |
| HY-R00344 | hsa-miR-1843 mimic | Oligonucleotides | |
| HY-R00344A | hsa-miR-1843 agomir | Oligonucleotides | |
| HY-R00345 | hsa-miR-185-3p mimic | Oligonucleotides | |
| HY-R00345A | hsa-miR-185-3p agomir | Oligonucleotides | |
| HY-R00346 | hsa-miR-185-5p mimic | Oligonucleotides | |
| HY-R00346A | hsa-miR-185-5p agomir | Oligonucleotides | |
| HY-R00347 | hsa-miR-186-3p mimic | Oligonucleotides | |
| HY-R00347A | hsa-miR-186-3p agomir | Oligonucleotides | |
| HY-R00348 | hsa-miR-186-5p mimic | Oligonucleotides | |
| HY-R00348A | hsa-miR-186-5p agomir | Oligonucleotides | |
| HY-R00349 | hsa-miR-187-3p mimic | Oligonucleotides | |
| HY-R00349A | hsa-miR-187-3p agomir | Oligonucleotides | |
| HY-R00350 | hsa-miR-187-5p mimic | Oligonucleotides | |
| HY-R00350A | hsa-miR-187-5p agomir | Oligonucleotides | |
| HY-R00351 | hsa-miR-188-5p mimic | Oligonucleotides | |
| HY-R00351A | hsa-miR-188-5p agomir | Oligonucleotides | |
| HY-R00352 | hsa-miR-18a-3p mimic | Oligonucleotides | |
| HY-R00352A | hsa-miR-18a-3p agomir | Oligonucleotides | |
| HY-R00353 | hsa-miR-18a-5p mimic | Oligonucleotides | |
| HY-R00353A | hsa-miR-18a-5p agomir | Oligonucleotides | |
| HY-R00354 | hsa-miR-18b-3p mimic | Oligonucleotides | |
| HY-R00354A | hsa-miR-18b-3p agomir | Oligonucleotides | |
| HY-R00355 | hsa-miR-18b-5p mimic | Oligonucleotides | |
| HY-R00355A | hsa-miR-18b-5p agomir | Oligonucleotides | |
| HY-R00356 | hsa-miR-1908-3p mimic | Oligonucleotides | |
| HY-R00356A | hsa-miR-1908-3p agomir | Oligonucleotides | |
| HY-R00357 | hsa-miR-1908-5p mimic | Oligonucleotides | |
| HY-R00357A | hsa-miR-1908-5p agomir | Oligonucleotides | |
| HY-R00358 | hsa-miR-1909-3p mimic | Oligonucleotides | |
| HY-R00358A | hsa-miR-1909-3p agomir | Oligonucleotides | |
| HY-R00359 | hsa-miR-1909-5p mimic | Oligonucleotides | |
| HY-R00359A | hsa-miR-1909-5p agomir | Oligonucleotides | |
| HY-R00360 | hsa-miR-190a-3p mimic | Oligonucleotides | |
| HY-R00360A | hsa-miR-190a-3p agomir | Oligonucleotides | |
| HY-R00361 | hsa-miR-190a-5p mimic | Oligonucleotides | |
| HY-R00361A | hsa-miR-190a-5p agomir | Oligonucleotides | |
| HY-R00362 | hsa-miR-190b-3p mimic | Oligonucleotides | |
| HY-R00362A | hsa-miR-190b-3p agomir | Oligonucleotides | |
| HY-R00363 | hsa-miR-190b-5p mimic | Oligonucleotides | |
| HY-R00363A | hsa-miR-190b-5p agomir | Oligonucleotides | |
| HY-R00364 | hsa-miR-1910-3p mimic | Oligonucleotides | |
| HY-R00364A | hsa-miR-1910-3p agomir | Oligonucleotides | |
| HY-R00365 | hsa-miR-1910-5p mimic | Oligonucleotides | |
| HY-R00365A | hsa-miR-1910-5p agomir | Oligonucleotides | |
| HY-R00366 | hsa-miR-1911-3p mimic | Oligonucleotides | |
| HY-R00366A | hsa-miR-1911-3p agomir | Oligonucleotides | |
| HY-R00367 | hsa-miR-1911-5p mimic | Oligonucleotides | |
| HY-R00367A | hsa-miR-1911-5p agomir | Oligonucleotides | |
| HY-R00368 | hsa-miR-1912-3p mimic | Oligonucleotides | |
| HY-R00368A | hsa-miR-1912-3p agomir | Oligonucleotides | |
| HY-R00369 | hsa-miR-1912-5p mimic | Oligonucleotides | |
| HY-R00369A | hsa-miR-1912-5p agomir | Oligonucleotides | |
| HY-R00370 | hsa-miR-1913 mimic | Oligonucleotides | |
| HY-R00370A | hsa-miR-1913 agomir | Oligonucleotides | |
| HY-R00371 | hsa-miR-191-3p mimic | Oligonucleotides | |
| HY-R00371A | hsa-miR-191-3p agomir | Oligonucleotides | |
| HY-R00372 | hsa-miR-1914-3p mimic | Oligonucleotides | |
| HY-R00372A | hsa-miR-1914-3p agomir | Oligonucleotides | |
| HY-R00373 | hsa-miR-1914-5p mimic | Oligonucleotides | |
| HY-R00373A | hsa-miR-1914-5p agomir | Oligonucleotides | |
| HY-R00374 | hsa-miR-1915-3p mimic | Oligonucleotides | |
| HY-R00374A | hsa-miR-1915-3p agomir | Oligonucleotides | |
| HY-R00375 | hsa-miR-1915-5p mimic | Oligonucleotides | |
| HY-R00375A | hsa-miR-1915-5p agomir | Oligonucleotides | |
| HY-R00376 | hsa-miR-191-5p mimic | Oligonucleotides | |
| HY-R00376A | hsa-miR-191-5p agomir | Oligonucleotides | |
| HY-R00377 | hsa-miR-192-3p mimic | Oligonucleotides | |
| HY-R00377A | hsa-miR-192-3p agomir | Oligonucleotides | |
| HY-R00378 | hsa-miR-192-5p mimic | Oligonucleotides | |
| HY-R00378A | hsa-miR-192-5p agomir | Oligonucleotides | |
| HY-R00379 | hsa-miR-193a-3p mimic | Oligonucleotides | |
| HY-R00379A | hsa-miR-193a-3p agomir | Oligonucleotides | |
| HY-R00380 | hsa-miR-193a-5p mimic | Oligonucleotides | |
| HY-R00380A | hsa-miR-193a-5p agomir | Oligonucleotides | |
| HY-R00381 | hsa-miR-193b-3p mimic | Oligonucleotides | |
| HY-R00381A | hsa-miR-193b-3p agomir | Oligonucleotides | |
| HY-R00382 | hsa-miR-193b-5p mimic | Oligonucleotides | |
| HY-R00382A | hsa-miR-193b-5p agomir | Oligonucleotides | |
| HY-R00383 | hsa-miR-194-3p mimic | Oligonucleotides | |
| HY-R00383A | hsa-miR-194-3p agomir | Oligonucleotides | |
| HY-R00384 | hsa-miR-194-5p mimic | Oligonucleotides | |
| HY-R00384A | hsa-miR-194-5p agomir | Oligonucleotides | |
| HY-R00385 | hsa-miR-195-3p mimic | Oligonucleotides | |
| HY-R00385A | hsa-miR-195-3p agomir | Oligonucleotides | |
| HY-R00386 | hsa-miR-195-5p mimic | Oligonucleotides | |
| HY-R00386A | hsa-miR-195-5p agomir | Oligonucleotides | |
| HY-R00387 | hsa-miR-196a-1-3p mimic | Oligonucleotides | |
| HY-R00387A | hsa-miR-196a-1-3p agomir | Oligonucleotides | |
| HY-R00388 | hsa-miR-196a-3p mimic | Oligonucleotides | |
| HY-R00388A | hsa-miR-196a-3p agomir | Oligonucleotides | |
| HY-R00389 | hsa-miR-196a-5p mimic | Oligonucleotides | |
| HY-R00389A | hsa-miR-196a-5p agomir | Oligonucleotides | |
| HY-R00390 | hsa-miR-196b-3p mimic | Oligonucleotides | |
| HY-R00390A | hsa-miR-196b-3p agomir | Oligonucleotides | |
| HY-R00391 | hsa-miR-196b-5p mimic | Oligonucleotides | |
| HY-R00391A | hsa-miR-196b-5p agomir | Oligonucleotides | |
| HY-R00392 | hsa-miR-1972 mimic | Oligonucleotides | |
| HY-R00392A | hsa-miR-1972 agomir | Oligonucleotides | |
| HY-R00393 | hsa-miR-1973 mimic | Oligonucleotides | |
| HY-R00393A | hsa-miR-1973 agomir | Oligonucleotides | |
| HY-R00394 | hsa-miR-197-3p mimic | Oligonucleotides | |
| HY-R00394A | hsa-miR-197-3p agomir | Oligonucleotides | |
| HY-R00395 | hsa-miR-197-5p mimic | Oligonucleotides | |
| HY-R00395A | hsa-miR-197-5p agomir | Oligonucleotides | |
| HY-R00396 | hsa-miR-1976 mimic | Oligonucleotides | |
| HY-R00396A | hsa-miR-1976 agomir | Oligonucleotides | |
| HY-R00397 | hsa-miR-198 mimic | Oligonucleotides | |
| HY-R00397A | hsa-miR-198 agomir | Oligonucleotides | |
| HY-R00398 | hsa-miR-199a-3p mimic | Oligonucleotides | |
| HY-R00398A | hsa-miR-199a-3p agomir | Oligonucleotides | |
| HY-R00399 | hsa-miR-199a-5p mimic | Oligonucleotides | |
| HY-R00399A | hsa-miR-199a-5p agomir | Oligonucleotides | |
| HY-R00400 | hsa-miR-199b-5p mimic | Oligonucleotides | |
| HY-R00400A | hsa-miR-199b-5p agomir | Oligonucleotides | |
| HY-R00401 | hsa-miR-19a-3p mimic | Oligonucleotides | |
| HY-R00401A | hsa-miR-19a-3p agomir | Oligonucleotides | |
| HY-R00402 | hsa-miR-19a-5p mimic | Oligonucleotides | |
| HY-R00402A | hsa-miR-19a-5p agomir | Oligonucleotides | |
| HY-R00403 | hsa-miR-19b-2-5p mimic | Oligonucleotides | |
| HY-R00403A | hsa-miR-19b-2-5p agomir | Oligonucleotides | |
| HY-R00404 | hsa-miR-19b-3p mimic | Oligonucleotides | |
| HY-R00404A | hsa-miR-19b-3p agomir | Oligonucleotides | |
| HY-R00405 | hsa-miR-200a-3p mimic | Oligonucleotides | |
| HY-R00405A | hsa-miR-200a-3p agomir | Oligonucleotides | |
| HY-R00406 | hsa-miR-200b-3p mimic | Oligonucleotides | |
| HY-R00406A | hsa-miR-200b-3p agomir | Oligonucleotides | |
| HY-R00407 | hsa-miR-200c-3p mimic | Oligonucleotides | |
| HY-R00407A | hsa-miR-200c-3p agomir | Oligonucleotides | |
| HY-R00408 | hsa-miR-200c-5p mimic | Oligonucleotides | |
| HY-R00408A | hsa-miR-200c-5p agomir | Oligonucleotides | |
| HY-R00409 | hsa-miR-202-3p mimic | Oligonucleotides | |
| HY-R00409A | hsa-miR-202-3p agomir | Oligonucleotides | |
| HY-R00410 | hsa-miR-202-5p mimic | Oligonucleotides | |
| HY-R00410A | hsa-miR-202-5p agomir | Oligonucleotides | |
| HY-R00411 | hsa-miR-203a-3p mimic | Oligonucleotides | |
| HY-R00411A | hsa-miR-203a-3p agomir | Oligonucleotides | |
| HY-R00412 | hsa-miR-203a-5p mimic | Oligonucleotides | |
| HY-R00412A | hsa-miR-203a-5p agomir | Oligonucleotides | |
| HY-R00413 | hsa-miR-203b-3p mimic | Oligonucleotides | |
| HY-R00413A | hsa-miR-203b-3p agomir | Oligonucleotides | |
| HY-R00414 | hsa-miR-203b-5p mimic | Oligonucleotides | |
| HY-R00414A | hsa-miR-203b-5p agomir | Oligonucleotides | |
| HY-R00415 | hsa-miR-204-3p mimic | Oligonucleotides | |
| HY-R00415A | hsa-miR-204-3p agomir | Oligonucleotides | |
| HY-R00416 | hsa-miR-204-5p mimic | Oligonucleotides | |
| HY-R00416A | hsa-miR-204-5p agomir | Oligonucleotides | |
| HY-R00417 | hsa-miR-2052 mimic | Oligonucleotides | |
| HY-R00417A | hsa-miR-2052 agomir | Oligonucleotides | |
| HY-R00418 | hsa-miR-2053 mimic | Oligonucleotides | |
| HY-R00418A | hsa-miR-2053 agomir | Oligonucleotides | |
| HY-R00419 | hsa-miR-205-3p mimic | Oligonucleotides | |
| HY-R00419A | hsa-miR-205-3p agomir | Oligonucleotides | |
| HY-R00420 | hsa-miR-2054 mimic | Oligonucleotides | |
| HY-R00420A | hsa-miR-2054 agomir | Oligonucleotides | |
| HY-R00421 | hsa-miR-205-5p mimic | Oligonucleotides | |
| HY-R00421A | hsa-miR-205-5p agomir | Oligonucleotides | |
| HY-R00422 | hsa-miR-208a-3p mimic | Oligonucleotides | |
| HY-R00422A | hsa-miR-208a-3p agomir | Oligonucleotides | |
| HY-R00423 | hsa-miR-208b-3p mimic | Oligonucleotides | |
| HY-R00423A | hsa-miR-208b-3p agomir | Oligonucleotides | |
| HY-R00424 | hsa-miR-208b-5p mimic | Oligonucleotides | |
| HY-R00424A | hsa-miR-208b-5p agomir | Oligonucleotides | |
| HY-R00425 | hsa-miR-20a-3p mimic | Oligonucleotides | |
| HY-R00425A | hsa-miR-20a-3p agomir | Oligonucleotides | |
| HY-R00426 | hsa-miR-20a-5p mimic | Oligonucleotides | |
| HY-R00426A | hsa-miR-20a-5p agomir | Oligonucleotides | |
| HY-R00427 | hsa-miR-20b-3p mimic | Oligonucleotides | |
| HY-R00427A | hsa-miR-20b-3p agomir | Oligonucleotides | |
| HY-R00428 | hsa-miR-20b-5p mimic | Oligonucleotides | |
| HY-R00428A | hsa-miR-20b-5p agomir | Oligonucleotides | |
| HY-R00429 | hsa-miR-210-3p mimic | Oligonucleotides | |
| HY-R00429A | hsa-miR-210-3p agomir | Oligonucleotides | |
| HY-R00430 | hsa-miR-210-5p mimic | Oligonucleotides | |
| HY-R00430A | hsa-miR-210-5p agomir | Oligonucleotides | |
| HY-R00431 | hsa-miR-2110 mimic | Oligonucleotides | |
| HY-R00431A | hsa-miR-2110 agomir | Oligonucleotides | |
| HY-R00432 | hsa-miR-2113 mimic | Oligonucleotides | |
| HY-R00432A | hsa-miR-2113 agomir | Oligonucleotides | |
| HY-R00433 | hsa-miR-211-3p mimic | Oligonucleotides | |
| HY-R00433A | hsa-miR-211-3p agomir | Oligonucleotides | |
| HY-R00434 | hsa-miR-2114-3p mimic | Oligonucleotides | |
| HY-R00434A | hsa-miR-2114-3p agomir | Oligonucleotides | |
| HY-R00435 | hsa-miR-2114-5p mimic | Oligonucleotides | |
| HY-R00435A | hsa-miR-2114-5p agomir | Oligonucleotides | |
| HY-R00436 | hsa-miR-2115-3p mimic | Oligonucleotides | |
| HY-R00436A | hsa-miR-2115-3p agomir | Oligonucleotides | |
| HY-R00437 | hsa-miR-2115-5p mimic | Oligonucleotides | |
| HY-R00437A | hsa-miR-2115-5p agomir | Oligonucleotides | |
| HY-R00438 | hsa-miR-211-5p mimic | Oligonucleotides | |
| HY-R00438A | hsa-miR-211-5p agomir | Oligonucleotides | |
| HY-R00439 | hsa-miR-2116-3p mimic | Oligonucleotides | |
| HY-R00439A | hsa-miR-2116-3p agomir | Oligonucleotides | |
| HY-R00440 | hsa-miR-2116-5p mimic | Oligonucleotides | |
| HY-R00440A | hsa-miR-2116-5p agomir | Oligonucleotides | |
| HY-R00441 | hsa-miR-2117 mimic | Oligonucleotides | |
| HY-R00441A | hsa-miR-2117 agomir | Oligonucleotides | |
| HY-R00442 | hsa-miR-212-3p mimic | Oligonucleotides | |
| HY-R00442A | hsa-miR-212-3p agomir | Oligonucleotides | |
| HY-R00443 | hsa-miR-212-5p mimic | Oligonucleotides | |
| HY-R00443A | hsa-miR-212-5p agomir | Oligonucleotides | |
| HY-R00444 | hsa-miR-21-3p mimic | Oligonucleotides | |
| HY-R00444A | hsa-miR-21-3p agomir | Oligonucleotides | |
| HY-R00445 | hsa-miR-214-3p mimic | Oligonucleotides | |
| HY-R00445A | hsa-miR-214-3p agomir | Oligonucleotides | |
| HY-R00446 | hsa-miR-214-5p mimic | Oligonucleotides | |
| HY-R00446A | hsa-miR-214-5p agomir | Oligonucleotides | |
| HY-R00447 | hsa-miR-215-3p mimic | Oligonucleotides | |
| HY-R00447A | hsa-miR-215-3p agomir | Oligonucleotides | |
| HY-R00448 | hsa-miR-215-5p mimic | Oligonucleotides | |
| HY-R00448A | hsa-miR-215-5p agomir | Oligonucleotides | |
| HY-R00449 | hsa-miR-21-5p mimic | Oligonucleotides | |
| HY-R00449A | hsa-miR-21-5p agomir | Oligonucleotides | |
| HY-R00450 | hsa-miR-216a-3p mimic | Oligonucleotides | |
| HY-R00450A | hsa-miR-216a-3p agomir | Oligonucleotides | |
| HY-R00451 | hsa-miR-216a-5p mimic | Oligonucleotides | |
| HY-R00451A | hsa-miR-216a-5p agomir | Oligonucleotides | |
| HY-R00452 | hsa-miR-216b-3p mimic | Oligonucleotides | |
| HY-R00452A | hsa-miR-216b-3p agomir | Oligonucleotides | |
| HY-R00453 | hsa-miR-216b-5p mimic | Oligonucleotides | |
| HY-R00453A | hsa-miR-216b-5p agomir | Oligonucleotides | |
| HY-R00454 | hsa-miR-217-3p mimic | Oligonucleotides | |
| HY-R00454A | hsa-miR-217-3p agomir | Oligonucleotides | |
| HY-R00455 | hsa-miR-217-5p mimic | Oligonucleotides | |
| HY-R00455A | hsa-miR-217-5p agomir | Oligonucleotides | |
| HY-R00456 | hsa-miR-218-1-3p mimic | Oligonucleotides | |
| HY-R00456A | hsa-miR-218-1-3p agomir | Oligonucleotides | |
| HY-R00457 | hsa-miR-218-2-3p mimic | Oligonucleotides | |
| HY-R00457A | hsa-miR-218-2-3p agomir | Oligonucleotides | |
| HY-R00458 | hsa-miR-218-5p mimic | Oligonucleotides | |
| HY-R00458A | hsa-miR-218-5p agomir | Oligonucleotides | |
| HY-R00459 | hsa-miR-219a-1-3p mimic | Oligonucleotides | |
| HY-R00459A | hsa-miR-219a-1-3p agomir | Oligonucleotides | |
| HY-R00460 | hsa-miR-219a-2-3p mimic | Oligonucleotides | |
| HY-R00460A | hsa-miR-219a-2-3p agomir | Oligonucleotides | |
| HY-R00461 | hsa-miR-219a-5p mimic | Oligonucleotides | |
| HY-R00461A | hsa-miR-219a-5p agomir | Oligonucleotides | |
| HY-R00462 | hsa-miR-219b-3p mimic | Oligonucleotides | |
| HY-R00462A | hsa-miR-219b-3p agomir | Oligonucleotides | |
| HY-R00463 | hsa-miR-219b-5p mimic | Oligonucleotides | |
| HY-R00463A | hsa-miR-219b-5p agomir | Oligonucleotides | |
| HY-R00464 | hsa-miR-221-3p mimic | Oligonucleotides | |
| HY-R00464A | hsa-miR-221-3p agomir | Oligonucleotides | |
| HY-R00465 | hsa-miR-221-5p mimic | Oligonucleotides | |
| HY-R00465A | hsa-miR-221-5p agomir | Oligonucleotides | |
| HY-R00466 | hsa-miR-222-5p mimic | Oligonucleotides | |
| HY-R00466A | hsa-miR-222-5p agomir | Oligonucleotides | |
| HY-R00467 | hsa-miR-223-3p mimic | Oligonucleotides | |
| HY-R00467A | hsa-miR-223-3p agomir | Oligonucleotides | |
| HY-R00468 | hsa-miR-223-5p mimic | Oligonucleotides | |
| HY-R00468A | hsa-miR-223-5p agomir | Oligonucleotides | |
| HY-R00469 | hsa-miR-224-3p mimic | Oligonucleotides | |
| HY-R00469A | hsa-miR-224-3p agomir | Oligonucleotides | |
| HY-R00470 | hsa-miR-224-5p mimic | Oligonucleotides | |
| HY-R00470A | hsa-miR-224-5p agomir | Oligonucleotides | |
| HY-R00471 | hsa-miR-22-5p mimic | Oligonucleotides | |
| HY-R00471A | hsa-miR-22-5p agomir | Oligonucleotides | |
| HY-R00472 | hsa-miR-2276-3p mimic | Oligonucleotides | |
| HY-R00472A | hsa-miR-2276-3p agomir | Oligonucleotides | |
| HY-R00473 | hsa-miR-2276-5p mimic | Oligonucleotides | |
| HY-R00473A | hsa-miR-2276-5p agomir | Oligonucleotides | |
| HY-R00474 | hsa-miR-2277-3p mimic | Oligonucleotides | |
| HY-R00474A | hsa-miR-2277-3p agomir | Oligonucleotides | |
| HY-R00475 | hsa-miR-2277-5p mimic | Oligonucleotides | |
| HY-R00475A | hsa-miR-2277-5p agomir | Oligonucleotides | |
| HY-R00476 | hsa-miR-2278 mimic | Oligonucleotides | |
| HY-R00476A | hsa-miR-2278 agomir | Oligonucleotides | |
| HY-R00477 | hsa-miR-2355-3p mimic | Oligonucleotides | |
| HY-R00477A | hsa-miR-2355-3p agomir | Oligonucleotides | |
| HY-R00478 | hsa-miR-2355-5p mimic | Oligonucleotides | |
| HY-R00478A | hsa-miR-2355-5p agomir | Oligonucleotides | |
| HY-R00479 | hsa-miR-2392 mimic | Oligonucleotides | |
| HY-R00479A | hsa-miR-2392 agomir | Oligonucleotides | |
| HY-R00480 | hsa-miR-23a-3p mimic | Oligonucleotides | |
| HY-R00480A | hsa-miR-23a-3p agomir | Oligonucleotides | |
| HY-R00481 | hsa-miR-23a-5p mimic | Oligonucleotides | |
| HY-R00481A | hsa-miR-23a-5p agomir | Oligonucleotides | |
| HY-R00482 | hsa-miR-23b-5p mimic | Oligonucleotides | |
| HY-R00482A | hsa-miR-23b-5p agomir | Oligonucleotides | |
| HY-R00483 | hsa-miR-23c mimic | Oligonucleotides | |
| HY-R00483A | hsa-miR-23c agomir | Oligonucleotides | |
| HY-R00484 | hsa-miR-24-1-5p mimic | Oligonucleotides | |
| HY-R00484A | hsa-miR-24-1-5p agomir | Oligonucleotides | |
| HY-R00485 | hsa-miR-24-2-5p mimic | Oligonucleotides | |
| HY-R00485A | hsa-miR-24-2-5p agomir | Oligonucleotides | |
| HY-R00486 | hsa-miR-2467-3p mimic | Oligonucleotides | |
| HY-R00486A | hsa-miR-2467-3p agomir | Oligonucleotides | |
| HY-R00487 | hsa-miR-2467-5p mimic | Oligonucleotides | |
| HY-R00487A | hsa-miR-2467-5p agomir | Oligonucleotides | |
| HY-R00488 | hsa-miR-25-5p mimic | Oligonucleotides | |
| HY-R00488A | hsa-miR-25-5p agomir | Oligonucleotides | |
| HY-R00489 | hsa-miR-2681-3p mimic | Oligonucleotides | |
| HY-R00489A | hsa-miR-2681-3p agomir | Oligonucleotides | |
| HY-R00490 | hsa-miR-2681-5p mimic | Oligonucleotides | |
| HY-R00490A | hsa-miR-2681-5p agomir | Oligonucleotides | |
| HY-R00491 | hsa-miR-2682-3p mimic | Oligonucleotides | |
| HY-R00491A | hsa-miR-2682-3p agomir | Oligonucleotides | |
| HY-R00492 | hsa-miR-2682-5p mimic | Oligonucleotides | |
| HY-R00492A | hsa-miR-2682-5p agomir | Oligonucleotides | |
| HY-R00493 | hsa-miR-26a-1-3p mimic | Oligonucleotides | |
| HY-R00493A | hsa-miR-26a-1-3p agomir | Oligonucleotides | |
| HY-R00494 | hsa-miR-26a-2-3p mimic | Oligonucleotides | |
| HY-R00494A | hsa-miR-26a-2-3p agomir | Oligonucleotides | |
| HY-R00495 | hsa-miR-26a-5p mimic | Oligonucleotides | |
| HY-R00495A | hsa-miR-26a-5p agomir | Oligonucleotides | |
| HY-R00496 | hsa-miR-26b-3p mimic | Oligonucleotides | |
| HY-R00496A | hsa-miR-26b-3p agomir | Oligonucleotides | |
| HY-R00497 | hsa-miR-26b-5p mimic | Oligonucleotides | |
| HY-R00497A | hsa-miR-26b-5p agomir | Oligonucleotides | |
| HY-R00498 | hsa-miR-27a-3p mimic | Oligonucleotides | |
| HY-R00498A | hsa-miR-27a-3p agomir | Oligonucleotides | |
| HY-R00499 | hsa-miR-27a-5p mimic | Oligonucleotides | |
| HY-R00499A | hsa-miR-27a-5p agomir | Oligonucleotides | |
| HY-R00500 | hsa-miR-27b-3p mimic | Oligonucleotides | |
| HY-R00500A | hsa-miR-27b-3p agomir | Oligonucleotides | |
| HY-R00501 | hsa-miR-28-3p mimic | Oligonucleotides | |
| HY-R00501A | hsa-miR-28-3p agomir | Oligonucleotides | |
| HY-R00502 | hsa-miR-28-5p mimic | Oligonucleotides | |
| HY-R00502A | hsa-miR-28-5p agomir | Oligonucleotides | |
| HY-R00503 | hsa-miR-2861 mimic | Oligonucleotides | |
| HY-R00503A | hsa-miR-2861 agomir | Oligonucleotides | |
| HY-R00504 | hsa-miR-2909 mimic | Oligonucleotides | |
| HY-R00504A | hsa-miR-2909 agomir | Oligonucleotides | |
| HY-R00505 | hsa-miR-296-3p mimic | Oligonucleotides | |
| HY-R00505A | hsa-miR-296-3p agomir | Oligonucleotides | |
| HY-R00506 | hsa-miR-297 mimic | Oligonucleotides | |
| HY-R00506A | hsa-miR-297 agomir | Oligonucleotides | |
| HY-R00507 | hsa-miR-298 mimic | Oligonucleotides | |
| HY-R00507A | hsa-miR-298 agomir | Oligonucleotides | |
| HY-R00508 | hsa-miR-299-3p mimic | Oligonucleotides | |
| HY-R00508A | hsa-miR-299-3p agomir | Oligonucleotides | |
| HY-R00509 | hsa-miR-299-5p mimic | Oligonucleotides | |
| HY-R00509A | hsa-miR-299-5p agomir | Oligonucleotides | |
| HY-R00510 | hsa-miR-29a-3p mimic | Oligonucleotides | |
| HY-R00510A | hsa-miR-29a-3p agomir | Oligonucleotides | |
| HY-R00511 | hsa-miR-29a-5p mimic | Oligonucleotides | |
| HY-R00511A | hsa-miR-29a-5p agomir | Oligonucleotides | |
| HY-R00512 | hsa-miR-29b-1-5p mimic | Oligonucleotides | |
| HY-R00512A | hsa-miR-29b-1-5p agomir | Oligonucleotides | |
| HY-R00513 | hsa-miR-29b-2-5p mimic | Oligonucleotides | |
| HY-R00513A | hsa-miR-29b-2-5p agomir | Oligonucleotides | |
| HY-R00514 | hsa-miR-29c-5p mimic | Oligonucleotides | |
| HY-R00514A | hsa-miR-29c-5p agomir | Oligonucleotides | |
| HY-R00515 | hsa-miR-300 mimic | Oligonucleotides | |
| HY-R00515A | hsa-miR-300 agomir | Oligonucleotides | |
| HY-R00516 | hsa-miR-301a-3p mimic | Oligonucleotides | |
| HY-R00516A | hsa-miR-301a-3p agomir | Oligonucleotides | |
| HY-R00517 | hsa-miR-301a-5p mimic | Oligonucleotides | |
| HY-R00517A | hsa-miR-301a-5p agomir | Oligonucleotides | |
| HY-R00518 | hsa-miR-302a-3p mimic | Oligonucleotides | |
| HY-R00518A | hsa-miR-302a-3p agomir | Oligonucleotides | |
| HY-R00519 | hsa-miR-302a-5p mimic | Oligonucleotides | |
| HY-R00519A | hsa-miR-302a-5p agomir | Oligonucleotides | |
| HY-R00520 | hsa-miR-302b-5p mimic | Oligonucleotides | |
| HY-R00520A | hsa-miR-302b-5p agomir | Oligonucleotides | |
| HY-R00521 | hsa-miR-302d-3p mimic | Oligonucleotides | |
| HY-R00521A | hsa-miR-302d-3p agomir | Oligonucleotides | |
| HY-R00522 | hsa-miR-302d-5p mimic | Oligonucleotides | |
| HY-R00522A | hsa-miR-302d-5p agomir | Oligonucleotides | |
| HY-R00523 | hsa-miR-302e mimic | Oligonucleotides | |
| HY-R00523A | hsa-miR-302e agomir | Oligonucleotides | |
| HY-R00524 | hsa-miR-302f mimic | Oligonucleotides | |
| HY-R00524A | hsa-miR-302f agomir | Oligonucleotides | |
| HY-R00525 | hsa-miR-3059-3p mimic | Oligonucleotides | |
| HY-R00525A | hsa-miR-3059-3p agomir | Oligonucleotides | |
| HY-R00526 | hsa-miR-3059-5p mimic | Oligonucleotides | |
| HY-R00526A | hsa-miR-3059-5p agomir | Oligonucleotides | |
| HY-R00527 | hsa-miR-3064-3p mimic | Oligonucleotides | |
| HY-R00527A | hsa-miR-3064-3p agomir | Oligonucleotides | |
| HY-R00528 | hsa-miR-3065-3p mimic | Oligonucleotides | |
| HY-R00528A | hsa-miR-3065-3p agomir | Oligonucleotides | |
| HY-R00529 | hsa-miR-3065-5p mimic | Oligonucleotides | |
| HY-R00529A | hsa-miR-3065-5p agomir | Oligonucleotides | |
| HY-R00530 | hsa-miR-3074-3p mimic | Oligonucleotides | |
| HY-R00530A | hsa-miR-3074-3p agomir | Oligonucleotides | |
| HY-R00531 | hsa-miR-3074-5p mimic | Oligonucleotides | |
| HY-R00531A | hsa-miR-3074-5p agomir | Oligonucleotides | |
| HY-R00532 | hsa-miR-3085-3p mimic | Oligonucleotides | |
| HY-R00532A | hsa-miR-3085-3p agomir | Oligonucleotides | |
| HY-R00533 | hsa-miR-3085-5p mimic | Oligonucleotides | |
| HY-R00533A | hsa-miR-3085-5p agomir | Oligonucleotides | |
| HY-R00534 | hsa-miR-30a-3p mimic | Oligonucleotides | |
| HY-R00534A | hsa-miR-30a-3p agomir | Oligonucleotides | |
| HY-R00535 | hsa-miR-30a-5p mimic | Oligonucleotides | |
| HY-R00535A | hsa-miR-30a-5p agomir | Oligonucleotides | |
| HY-R00536 | hsa-miR-30b-3p mimic | Oligonucleotides | |
| HY-R00536A | hsa-miR-30b-3p agomir | Oligonucleotides | |
| HY-R00537 | hsa-miR-30b-5p mimic | Oligonucleotides | |
| HY-R00537A | hsa-miR-30b-5p agomir | Oligonucleotides | |
| HY-R00538 | hsa-miR-30c-1-3p mimic | Oligonucleotides | |
| HY-R00538A | hsa-miR-30c-1-3p agomir | Oligonucleotides | |
| HY-R00539 | hsa-miR-30c-2-3p mimic | Oligonucleotides | |
| HY-R00539A | hsa-miR-30c-2-3p agomir | Oligonucleotides | |
| HY-R00540 | hsa-miR-30c-5p mimic | Oligonucleotides | |
| HY-R00540A | hsa-miR-30c-5p agomir | Oligonucleotides | |
| HY-R00541 | hsa-miR-30d-3p mimic | Oligonucleotides | |
| HY-R00541A | hsa-miR-30d-3p agomir | Oligonucleotides | |
| HY-R00542 | hsa-miR-30d-5p mimic | Oligonucleotides | |
| HY-R00542A | hsa-miR-30d-5p agomir | Oligonucleotides | |
| HY-R00543 | hsa-miR-30e-3p mimic | Oligonucleotides | |
| HY-R00543A | hsa-miR-30e-3p agomir | Oligonucleotides | |
| HY-R00544 | hsa-miR-30e-5p mimic | Oligonucleotides | |
| HY-R00544A | hsa-miR-30e-5p agomir | Oligonucleotides | |
| HY-R00545 | hsa-miR-3115 mimic | Oligonucleotides | |
| HY-R00545A | hsa-miR-3115 agomir | Oligonucleotides | |
| HY-R00546 | hsa-miR-3116 mimic | Oligonucleotides | |
| HY-R00546A | hsa-miR-3116 agomir | Oligonucleotides | |
| HY-R00547 | hsa-miR-3117-3p mimic | Oligonucleotides | |
| HY-R00547A | hsa-miR-3117-3p agomir | Oligonucleotides | |
| HY-R00548 | hsa-miR-3117-5p mimic | Oligonucleotides | |
| HY-R00548A | hsa-miR-3117-5p agomir | Oligonucleotides | |
| HY-R00549 | hsa-miR-3118 mimic | Oligonucleotides | |
| HY-R00549A | hsa-miR-3118 agomir | Oligonucleotides | |
| HY-R00550 | hsa-miR-3119 mimic | Oligonucleotides | |
| HY-R00550A | hsa-miR-3119 agomir | Oligonucleotides | |
| HY-R00551 | hsa-miR-3120-3p mimic | Oligonucleotides | |
| HY-R00551A | hsa-miR-3120-3p agomir | Oligonucleotides | |
| HY-R00552 | hsa-miR-3120-5p mimic | Oligonucleotides | |
| HY-R00552A | hsa-miR-3120-5p agomir | Oligonucleotides | |
| HY-R00553 | hsa-miR-3121-3p mimic | Oligonucleotides | |
| HY-R00553A | hsa-miR-3121-3p agomir | Oligonucleotides | |
| HY-R00554 | hsa-miR-3121-5p mimic | Oligonucleotides | |
| HY-R00554A | hsa-miR-3121-5p agomir | Oligonucleotides | |
| HY-R00555 | hsa-miR-3122 mimic | Oligonucleotides | |
| HY-R00555A | hsa-miR-3122 agomir | Oligonucleotides | |
| HY-R00556 | hsa-miR-3123 mimic | Oligonucleotides | |
| HY-R00556A | hsa-miR-3123 agomir | Oligonucleotides | |
| HY-R00557 | hsa-miR-3124-3p mimic | Oligonucleotides | |
| HY-R00557A | hsa-miR-3124-3p agomir | Oligonucleotides | |
| HY-R00558 | hsa-miR-3124-5p mimic | Oligonucleotides | |
| HY-R00558A | hsa-miR-3124-5p agomir | Oligonucleotides | |
| HY-R00559 | hsa-miR-3125 mimic | Oligonucleotides | |
| HY-R00559A | hsa-miR-3125 agomir | Oligonucleotides | |
| HY-R00560 | hsa-miR-3126-3p mimic | Oligonucleotides | |
| HY-R00560A | hsa-miR-3126-3p agomir | Oligonucleotides | |
| HY-R00561 | hsa-miR-3126-5p mimic | Oligonucleotides | |
| HY-R00561A | hsa-miR-3126-5p agomir | Oligonucleotides | |
| HY-R00562 | hsa-miR-3127-3p mimic | Oligonucleotides | |
| HY-R00562A | hsa-miR-3127-3p agomir | Oligonucleotides | |
| HY-R00563 | hsa-miR-3127-5p mimic | Oligonucleotides | |
| HY-R00563A | hsa-miR-3127-5p agomir | Oligonucleotides | |
| HY-R00564 | hsa-miR-3128 mimic | Oligonucleotides | |
| HY-R00564A | hsa-miR-3128 agomir | Oligonucleotides | |
| HY-R00565 | hsa-miR-3129-3p mimic | Oligonucleotides | |
| HY-R00565A | hsa-miR-3129-3p agomir | Oligonucleotides | |
| HY-R00566 | hsa-miR-3129-5p mimic | Oligonucleotides | |
| HY-R00566A | hsa-miR-3129-5p agomir | Oligonucleotides | |
| HY-R00567 | hsa-miR-3130-3p mimic | Oligonucleotides | |
| HY-R00567A | hsa-miR-3130-3p agomir | Oligonucleotides | |
| HY-R00568 | hsa-miR-3130-5p mimic | Oligonucleotides | |
| HY-R00568A | hsa-miR-3130-5p agomir | Oligonucleotides | |
| HY-R00569 | hsa-miR-3131 mimic | Oligonucleotides | |
| HY-R00569A | hsa-miR-3131 agomir | Oligonucleotides | |
| HY-R00570 | hsa-miR-3132 mimic | Oligonucleotides | |
| HY-R00570A | hsa-miR-3132 agomir | Oligonucleotides | |
| HY-R00571 | hsa-miR-3133 mimic | Oligonucleotides | |
| HY-R00571A | hsa-miR-3133 agomir | Oligonucleotides | |
| HY-R00572 | hsa-miR-3134 mimic | Oligonucleotides | |
| HY-R00572A | hsa-miR-3134 agomir | Oligonucleotides | |
| HY-R00573 | hsa-miR-3135a mimic | Oligonucleotides | |
| HY-R00573A | hsa-miR-3135a agomir | Oligonucleotides | |
| HY-R00574 | hsa-miR-3135b mimic | Oligonucleotides | |
| HY-R00574A | hsa-miR-3135b agomir | Oligonucleotides | |
| HY-R00575 | hsa-miR-3136-3p mimic | Oligonucleotides | |
| HY-R00575A | hsa-miR-3136-3p agomir | Oligonucleotides | |
| HY-R00576 | hsa-miR-3136-5p mimic | Oligonucleotides | |
| HY-R00576A | hsa-miR-3136-5p agomir | Oligonucleotides | |
| HY-R00577 | hsa-miR-3137 mimic | Oligonucleotides | |
| HY-R00577A | hsa-miR-3137 agomir | Oligonucleotides | |
| HY-R00578 | hsa-miR-3138 mimic | Oligonucleotides | |
| HY-R00578A | hsa-miR-3138 agomir | Oligonucleotides | |
| HY-R00579 | hsa-miR-3139 mimic | Oligonucleotides | |
| HY-R00579A | hsa-miR-3139 agomir | Oligonucleotides | |
| HY-R00580 | hsa-miR-31-3p mimic | Oligonucleotides | |
| HY-R00580A | hsa-miR-31-3p agomir | Oligonucleotides | |
| HY-R00581 | hsa-miR-3140-3p mimic | Oligonucleotides | |
| HY-R00581A | hsa-miR-3140-3p agomir | Oligonucleotides | |
| HY-R00582 | hsa-miR-3140-5p mimic | Oligonucleotides | |
| HY-R00582A | hsa-miR-3140-5p agomir | Oligonucleotides | |
| HY-R00583 | hsa-miR-3141 mimic | Oligonucleotides | |
| HY-R00583A | hsa-miR-3141 agomir | Oligonucleotides | |
| HY-R00584 | hsa-miR-3142 mimic | Oligonucleotides | |
| HY-R00584A | hsa-miR-3142 agomir | Oligonucleotides | |
| HY-R00585 | hsa-miR-3143 mimic | Oligonucleotides | |
| HY-R00585A | hsa-miR-3143 agomir | Oligonucleotides | |
| HY-R00586 | hsa-miR-3144-3p mimic | Oligonucleotides | |
| HY-R00586A | hsa-miR-3144-3p agomir | Oligonucleotides | |
| HY-R00587 | hsa-miR-3144-5p mimic | Oligonucleotides | |
| HY-R00587A | hsa-miR-3144-5p agomir | Oligonucleotides | |
| HY-R00588 | hsa-miR-3145-3p mimic | Oligonucleotides | |
| HY-R00588A | hsa-miR-3145-3p agomir | Oligonucleotides | |
| HY-R00589 | hsa-miR-3145-5p mimic | Oligonucleotides | |
| HY-R00589A | hsa-miR-3145-5p agomir | Oligonucleotides | |
| HY-R00590 | hsa-miR-3146 mimic | Oligonucleotides | |
| HY-R00590A | hsa-miR-3146 agomir | Oligonucleotides | |
| HY-R00591 | hsa-miR-3147 mimic | Oligonucleotides | |
| HY-R00591A | hsa-miR-3147 agomir | Oligonucleotides | |
| HY-R00592 | hsa-miR-3148 mimic | Oligonucleotides | |
| HY-R00592A | hsa-miR-3148 agomir | Oligonucleotides | |
| HY-R00593 | hsa-miR-3149 mimic | Oligonucleotides | |
| HY-R00593A | hsa-miR-3149 agomir | Oligonucleotides | |
| HY-R00594 | hsa-miR-3150a-3p mimic | Oligonucleotides | |
| HY-R00594A | hsa-miR-3150a-3p agomir | Oligonucleotides | |
| HY-R00595 | hsa-miR-3150a-5p mimic | Oligonucleotides | |
| HY-R00595A | hsa-miR-3150a-5p agomir | Oligonucleotides | |
| HY-R00596 | hsa-miR-3150b-3p mimic | Oligonucleotides | |
| HY-R00596A | hsa-miR-3150b-3p agomir | Oligonucleotides | |
| HY-R00597 | hsa-miR-3150b-5p mimic | Oligonucleotides | |
| HY-R00597A | hsa-miR-3150b-5p agomir | Oligonucleotides | |
| HY-R00598 | hsa-miR-3151-3p mimic | Oligonucleotides | |
| HY-R00598A | hsa-miR-3151-3p agomir | Oligonucleotides | |
| HY-R00599 | hsa-miR-3151-5p mimic | Oligonucleotides | |
| HY-R00599A | hsa-miR-3151-5p agomir | Oligonucleotides | |
| HY-R00600 | hsa-miR-3152-3p mimic | Oligonucleotides | |
| HY-R00600A | hsa-miR-3152-3p agomir | Oligonucleotides | |
| HY-R00601 | hsa-miR-3152-5p mimic | Oligonucleotides | |
| HY-R00601A | hsa-miR-3152-5p agomir | Oligonucleotides | |
| HY-R00602 | hsa-miR-3153 mimic | Oligonucleotides | |
| HY-R00602A | hsa-miR-3153 agomir | Oligonucleotides | |
| HY-R00603 | hsa-miR-3154 mimic | Oligonucleotides | |
| HY-R00603A | hsa-miR-3154 agomir | Oligonucleotides | |
| HY-R00604 | hsa-miR-3155a mimic | Oligonucleotides | |
| HY-R00604A | hsa-miR-3155a agomir | Oligonucleotides | |
| HY-R00605 | hsa-miR-3155b mimic | Oligonucleotides | |
| HY-R00605A | hsa-miR-3155b agomir | Oligonucleotides | |
| HY-R00606 | hsa-miR-3156-3p mimic | Oligonucleotides | |
| HY-R00606A | hsa-miR-3156-3p agomir | Oligonucleotides | |
| HY-R00607 | hsa-miR-3156-5p mimic | Oligonucleotides | |
| HY-R00607A | hsa-miR-3156-5p agomir | Oligonucleotides | |
| HY-R00608 | hsa-miR-3157-3p mimic | Oligonucleotides | |
| HY-R00608A | hsa-miR-3157-3p agomir | Oligonucleotides | |
| HY-R00609 | hsa-miR-3157-5p mimic | Oligonucleotides | |
| HY-R00609A | hsa-miR-3157-5p agomir | Oligonucleotides | |
| HY-R00610 | hsa-miR-3158-3p mimic | Oligonucleotides | |
| HY-R00610A | hsa-miR-3158-3p agomir | Oligonucleotides | |
| HY-R00611 | hsa-miR-3158-5p mimic | Oligonucleotides | |
| HY-R00611A | hsa-miR-3158-5p agomir | Oligonucleotides | |
| HY-R00612 | hsa-miR-3159 mimic | Oligonucleotides | |
| HY-R00612A | hsa-miR-3159 agomir | Oligonucleotides | |
| HY-R00613 | hsa-miR-31-5p mimic | Oligonucleotides | |
| HY-R00613A | hsa-miR-31-5p agomir | Oligonucleotides | |
| HY-R00614 | hsa-miR-3160-3p mimic | Oligonucleotides | |
| HY-R00614A | hsa-miR-3160-3p agomir | Oligonucleotides | |
| HY-R00615 | hsa-miR-3160-5p mimic | Oligonucleotides | |
| HY-R00615A | hsa-miR-3160-5p agomir | Oligonucleotides | |
| HY-R00616 | hsa-miR-3161 mimic | Oligonucleotides | |
| HY-R00616A | hsa-miR-3161 agomir | Oligonucleotides | |
| HY-R00617 | hsa-miR-3162-3p mimic | Oligonucleotides | |
| HY-R00617A | hsa-miR-3162-3p agomir | Oligonucleotides | |
| HY-R00618 | hsa-miR-3162-5p mimic | Oligonucleotides | |
| HY-R00618A | hsa-miR-3162-5p agomir | Oligonucleotides | |
| HY-R00619 | hsa-miR-3163 mimic | Oligonucleotides | |
| HY-R00619A | hsa-miR-3163 agomir | Oligonucleotides | |
| HY-R00620 | hsa-miR-3164 mimic | Oligonucleotides | |
| HY-R00620A | hsa-miR-3164 agomir | Oligonucleotides | |
| HY-R00621 | hsa-miR-3165 mimic | Oligonucleotides | |
| HY-R00621A | hsa-miR-3165 agomir | Oligonucleotides | |
| HY-R00622 | hsa-miR-3166 mimic | Oligonucleotides | |
| HY-R00622A | hsa-miR-3166 agomir | Oligonucleotides | |
| HY-R00623 | hsa-miR-3167 mimic | Oligonucleotides | |
| HY-R00623A | hsa-miR-3167 agomir | Oligonucleotides | |
| HY-R00624 | hsa-miR-3168 mimic | Oligonucleotides | |
| HY-R00624A | hsa-miR-3168 agomir | Oligonucleotides | |
| HY-R00625 | hsa-miR-3169 mimic | Oligonucleotides | |
| HY-R00625A | hsa-miR-3169 agomir | Oligonucleotides | |
| HY-R00626 | hsa-miR-3170 mimic | Oligonucleotides | |
| HY-R00626A | hsa-miR-3170 agomir | Oligonucleotides | |
| HY-R00627 | hsa-miR-3171 mimic | Oligonucleotides | |
| HY-R00627A | hsa-miR-3171 agomir | Oligonucleotides | |
| HY-R00628 | hsa-miR-3173-3p mimic | Oligonucleotides | |
| HY-R00628A | hsa-miR-3173-3p agomir | Oligonucleotides | |
| HY-R00629 | hsa-miR-3173-5p mimic | Oligonucleotides | |
| HY-R00629A | hsa-miR-3173-5p agomir | Oligonucleotides | |
| HY-R00630 | hsa-miR-3174 mimic | Oligonucleotides | |
| HY-R00630A | hsa-miR-3174 agomir | Oligonucleotides | |
| HY-R00631 | hsa-miR-3175 mimic | Oligonucleotides | |
| HY-R00631A | hsa-miR-3175 agomir | Oligonucleotides | |
| HY-R00632 | hsa-miR-3176 mimic | Oligonucleotides | |
| HY-R00632A | hsa-miR-3176 agomir | Oligonucleotides | |
| HY-R00633 | hsa-miR-3177-3p mimic | Oligonucleotides | |
| HY-R00633A | hsa-miR-3177-3p agomir | Oligonucleotides | |
| HY-R00634 | hsa-miR-3177-5p mimic | Oligonucleotides | |
| HY-R00634A | hsa-miR-3177-5p agomir | Oligonucleotides | |
| HY-R00635 | hsa-miR-3178 mimic | Oligonucleotides | |
| HY-R00635A | hsa-miR-3178 agomir | Oligonucleotides | |
| HY-R00636 | hsa-miR-3179 mimic | Oligonucleotides | |
| HY-R00636A | hsa-miR-3179 agomir | Oligonucleotides | |
| HY-R00637 | hsa-miR-3180 mimic | Oligonucleotides | |
| HY-R00637A | hsa-miR-3180 agomir | Oligonucleotides | |
| HY-R00638 | hsa-miR-3180-3p mimic | Oligonucleotides | |
| HY-R00638A | hsa-miR-3180-3p agomir | Oligonucleotides | |
| HY-R00639 | hsa-miR-3180-5p mimic | Oligonucleotides | |
| HY-R00639A | hsa-miR-3180-5p agomir | Oligonucleotides | |
| HY-R00640 | hsa-miR-3181 mimic | Oligonucleotides | |
| HY-R00640A | hsa-miR-3181 agomir | Oligonucleotides | |
| HY-R00641 | hsa-miR-3182 mimic | Oligonucleotides | |
| HY-R00641A | hsa-miR-3182 agomir | Oligonucleotides | |
| HY-R00642 | hsa-miR-3183 mimic | Oligonucleotides | |
| HY-R00642A | hsa-miR-3183 agomir | Oligonucleotides | |
| HY-R00643 | hsa-miR-3184-3p mimic | Oligonucleotides | |
| HY-R00643A | hsa-miR-3184-3p agomir | Oligonucleotides | |
| HY-R00644 | hsa-miR-3184-5p mimic | Oligonucleotides | |
| HY-R00644A | hsa-miR-3184-5p agomir | Oligonucleotides | |
| HY-R00645 | hsa-miR-3185 mimic | Oligonucleotides | |
| HY-R00645A | hsa-miR-3185 agomir | Oligonucleotides | |
| HY-R00646 | hsa-miR-3186-3p mimic | Oligonucleotides | |
| HY-R00646A | hsa-miR-3186-3p agomir | Oligonucleotides | |
| HY-R00647 | hsa-miR-3186-5p mimic | Oligonucleotides | |
| HY-R00647A | hsa-miR-3186-5p agomir | Oligonucleotides | |
| HY-R00648 | hsa-miR-3187-3p mimic | Oligonucleotides | |
| HY-R00648A | hsa-miR-3187-3p agomir | Oligonucleotides | |
| HY-R00649 | hsa-miR-3187-5p mimic | Oligonucleotides | |
| HY-R00649A | hsa-miR-3187-5p agomir | Oligonucleotides | |
| HY-R00650 | hsa-miR-3188 mimic | Oligonucleotides | |
| HY-R00650A | hsa-miR-3188 agomir | Oligonucleotides | |
| HY-R00651 | hsa-miR-3189-3p mimic | Oligonucleotides | |
| HY-R00651A | hsa-miR-3189-3p agomir | Oligonucleotides | |
| HY-R00652 | hsa-miR-3189-5p mimic | Oligonucleotides | |
| HY-R00652A | hsa-miR-3189-5p agomir | Oligonucleotides | |
| HY-R00653 | hsa-miR-3190-3p mimic | Oligonucleotides | |
| HY-R00653A | hsa-miR-3190-3p agomir | Oligonucleotides | |
| HY-R00654 | hsa-miR-3190-5p mimic | Oligonucleotides | |
| HY-R00654A | hsa-miR-3190-5p agomir | Oligonucleotides | |
| HY-R00655 | hsa-miR-3191-3p mimic | Oligonucleotides | |
| HY-R00655A | hsa-miR-3191-3p agomir | Oligonucleotides | |
| HY-R00656 | hsa-miR-3191-5p mimic | Oligonucleotides | |
| HY-R00656A | hsa-miR-3191-5p agomir | Oligonucleotides | |
| HY-R00657 | hsa-miR-3192-3p mimic | Oligonucleotides | |
| HY-R00657A | hsa-miR-3192-3p agomir | Oligonucleotides | |
| HY-R00658 | hsa-miR-3192-5p mimic | Oligonucleotides | |
| HY-R00658A | hsa-miR-3192-5p agomir | Oligonucleotides | |
| HY-R00659 | hsa-miR-3193 mimic | Oligonucleotides | |
| HY-R00659A | hsa-miR-3193 agomir | Oligonucleotides | |
| HY-R00660 | hsa-miR-3194-3p mimic | Oligonucleotides | |
| HY-R00660A | hsa-miR-3194-3p agomir | Oligonucleotides | |
| HY-R00661 | hsa-miR-3194-5p mimic | Oligonucleotides | |
| HY-R00661A | hsa-miR-3194-5p agomir | Oligonucleotides | |
| HY-R00662 | hsa-miR-3195 mimic | Oligonucleotides | |
| HY-R00662A | hsa-miR-3195 agomir | Oligonucleotides | |
| HY-R00663 | hsa-miR-3196 mimic | Oligonucleotides | |
| HY-R00663A | hsa-miR-3196 agomir | Oligonucleotides | |
| HY-R00664 | hsa-miR-3197 mimic | Oligonucleotides | |
| HY-R00664A | hsa-miR-3197 agomir | Oligonucleotides | |
| HY-R00665 | hsa-miR-3198 mimic | Oligonucleotides | |
| HY-R00665A | hsa-miR-3198 agomir | Oligonucleotides | |
| HY-R00666 | hsa-miR-3199 mimic | Oligonucleotides | |
| HY-R00666A | hsa-miR-3199 agomir | Oligonucleotides | |
| HY-R00667 | hsa-miR-3200-3p mimic | Oligonucleotides | |
| HY-R00667A | hsa-miR-3200-3p agomir | Oligonucleotides | |
| HY-R00668 | hsa-miR-3200-5p mimic | Oligonucleotides | |
| HY-R00668A | hsa-miR-3200-5p agomir | Oligonucleotides | |
| HY-R00669 | hsa-miR-3201 mimic | Oligonucleotides | |
| HY-R00669A | hsa-miR-3201 agomir | Oligonucleotides | |
| HY-R00670 | hsa-miR-3202 mimic | Oligonucleotides | |
| HY-R00670A | hsa-miR-3202 agomir | Oligonucleotides | |
| HY-R00671 | hsa-miR-320a-3p mimic | Oligonucleotides | |
| HY-R00671A | hsa-miR-320a-3p agomir | Oligonucleotides | |
| HY-R00672 | hsa-miR-320a-5p mimic | Oligonucleotides | |
| HY-R00672A | hsa-miR-320a-5p agomir | Oligonucleotides | |
| HY-R00673 | hsa-miR-320b mimic | Oligonucleotides | |
| HY-R00673A | hsa-miR-320b agomir | Oligonucleotides | |
| HY-R00674 | hsa-miR-320c mimic | Oligonucleotides | |
| HY-R00674A | hsa-miR-320c agomir | Oligonucleotides | |
| HY-R00675 | hsa-miR-320e mimic | Oligonucleotides | |
| HY-R00675A | hsa-miR-320e agomir | Oligonucleotides | |
| HY-R00676 | hsa-miR-323a-3p mimic | Oligonucleotides | |
| HY-R00676A | hsa-miR-323a-3p agomir | Oligonucleotides | |
| HY-R00677 | hsa-miR-323a-5p mimic | Oligonucleotides | |
| HY-R00677A | hsa-miR-323a-5p agomir | Oligonucleotides | |
| HY-R00678 | hsa-miR-323b-3p mimic | Oligonucleotides | |
| HY-R00678A | hsa-miR-323b-3p agomir | Oligonucleotides | |
| HY-R00679 | hsa-miR-323b-5p mimic | Oligonucleotides | |
| HY-R00679A | hsa-miR-323b-5p agomir | Oligonucleotides | |
| HY-R00680 | hsa-miR-32-3p mimic | Oligonucleotides | |
| HY-R00680A | hsa-miR-32-3p agomir | Oligonucleotides | |
| HY-R00681 | hsa-miR-324-3p mimic | Oligonucleotides | |
| HY-R00681A | hsa-miR-324-3p agomir | Oligonucleotides | |
| HY-R00682 | hsa-miR-324-5p mimic | Oligonucleotides | |
| HY-R00682A | hsa-miR-324-5p agomir | Oligonucleotides | |
| HY-R00683 | hsa-miR-325 mimic | Oligonucleotides | |
| HY-R00683A | hsa-miR-325 agomir | Oligonucleotides | |
| HY-R00684 | hsa-miR-32-5p mimic | Oligonucleotides | |
| HY-R00684A | hsa-miR-32-5p agomir | Oligonucleotides | |
| HY-R00685 | hsa-miR-326 mimic | Oligonucleotides | |
| HY-R00685A | hsa-miR-326 agomir | Oligonucleotides | |
| HY-R00686 | hsa-miR-328-3p mimic | Oligonucleotides | |
| HY-R00686A | hsa-miR-328-3p agomir | Oligonucleotides | |
| HY-R00687 | hsa-miR-328-5p mimic | Oligonucleotides | |
| HY-R00687A | hsa-miR-328-5p agomir | Oligonucleotides | |
| HY-R00688 | hsa-miR-329-3p mimic | Oligonucleotides | |
| HY-R00688A | hsa-miR-329-3p agomir | Oligonucleotides | |
| HY-R00689 | hsa-miR-329-5p mimic | Oligonucleotides | |
| HY-R00689A | hsa-miR-329-5p agomir | Oligonucleotides | |
| HY-R00690 | hsa-miR-330-3p mimic | Oligonucleotides | |
| HY-R00690A | hsa-miR-330-3p agomir | Oligonucleotides | |
| HY-R00691 | hsa-miR-330-5p mimic | Oligonucleotides | |
| HY-R00691A | hsa-miR-330-5p agomir | Oligonucleotides | |
| HY-R00692 | hsa-miR-331-3p mimic | Oligonucleotides | |
| HY-R00692A | hsa-miR-331-3p agomir | Oligonucleotides | |
| HY-R00693 | hsa-miR-331-5p mimic | Oligonucleotides | |
| HY-R00693A | hsa-miR-331-5p agomir | Oligonucleotides | |
| HY-R00694 | hsa-miR-335-3p mimic | Oligonucleotides | |
| HY-R00694A | hsa-miR-335-3p agomir | Oligonucleotides | |
| HY-R00695 | hsa-miR-335-5p mimic | Oligonucleotides | |
| HY-R00695A | hsa-miR-335-5p agomir | Oligonucleotides | |
| HY-R00696 | hsa-miR-337-3p mimic | Oligonucleotides | |
| HY-R00696A | hsa-miR-337-3p agomir | Oligonucleotides | |
| HY-R00697 | hsa-miR-337-5p mimic | Oligonucleotides | |
| HY-R00697A | hsa-miR-337-5p agomir | Oligonucleotides | |
| HY-R00698 | hsa-miR-338-3p mimic | Oligonucleotides | |
| HY-R00698A | hsa-miR-338-3p agomir | Oligonucleotides | |
| HY-R00699 | hsa-miR-338-5p mimic | Oligonucleotides | |
| HY-R00699A | hsa-miR-338-5p agomir | Oligonucleotides | |
| HY-R00700 | hsa-miR-339-3p mimic | Oligonucleotides | |
| HY-R00700A | hsa-miR-339-3p agomir | Oligonucleotides | |
| HY-R00701 | hsa-miR-339-5p mimic | Oligonucleotides | |
| HY-R00701A | hsa-miR-339-5p agomir | Oligonucleotides | |
| HY-R00702 | hsa-miR-33a-3p mimic | Oligonucleotides | |
| HY-R00702A | hsa-miR-33a-3p agomir | Oligonucleotides | |
| HY-R00703 | hsa-miR-33a-5p mimic | Oligonucleotides | |
| HY-R00703A | hsa-miR-33a-5p agomir | Oligonucleotides | |
| HY-R00704 | hsa-miR-33b-3p mimic | Oligonucleotides | |
| HY-R00704A | hsa-miR-33b-3p agomir | Oligonucleotides | |
| HY-R00705 | hsa-miR-33b-5p mimic | Oligonucleotides | |
| HY-R00705A | hsa-miR-33b-5p agomir | Oligonucleotides | |
| HY-R00706 | hsa-miR-340-3p mimic | Oligonucleotides | |
| HY-R00706A | hsa-miR-340-3p agomir | Oligonucleotides | |
| HY-R00707 | hsa-miR-340-5p mimic | Oligonucleotides | |
| HY-R00707A | hsa-miR-340-5p agomir | Oligonucleotides | |
| HY-R00708 | hsa-miR-342-3p mimic | Oligonucleotides | |
| HY-R00708A | hsa-miR-342-3p agomir | Oligonucleotides | |
| HY-R00709 | hsa-miR-342-5p mimic | Oligonucleotides | |
| HY-R00709A | hsa-miR-342-5p agomir | Oligonucleotides | |
| HY-R00710 | hsa-miR-345-3p mimic | Oligonucleotides | |
| HY-R00710A | hsa-miR-345-3p agomir | Oligonucleotides | |
| HY-R00711 | hsa-miR-345-5p mimic | Oligonucleotides | |
| HY-R00711A | hsa-miR-345-5p agomir | Oligonucleotides | |
| HY-R00712 | hsa-miR-346 mimic | Oligonucleotides | |
| HY-R00712A | hsa-miR-346 agomir | Oligonucleotides | |
| HY-R00713 | hsa-miR-34a-3p mimic | Oligonucleotides | |
| HY-R00713A | hsa-miR-34a-3p agomir | Oligonucleotides | |
| HY-R00714 | hsa-miR-34a-5p mimic | Oligonucleotides | |
| HY-R00714A | hsa-miR-34a-5p agomir | Oligonucleotides | |
| HY-R00715 | hsa-miR-34b-3p mimic | Oligonucleotides | |
| HY-R00715A | hsa-miR-34b-3p agomir | Oligonucleotides | |
| HY-R00716 | hsa-miR-34b-5p mimic | Oligonucleotides | |
| HY-R00716A | hsa-miR-34b-5p agomir | Oligonucleotides | |
| HY-R00717 | hsa-miR-34c-3p mimic | Oligonucleotides | |
| HY-R00717A | hsa-miR-34c-3p agomir | Oligonucleotides | |
| HY-R00718 | hsa-miR-34c-5p mimic | Oligonucleotides | |
| HY-R00718A | hsa-miR-34c-5p agomir | Oligonucleotides | |
| HY-R00719 | hsa-miR-3529-3p mimic | Oligonucleotides | |
| HY-R00719A | hsa-miR-3529-3p agomir | Oligonucleotides | |
| HY-R00720 | hsa-miR-3529-5p mimic | Oligonucleotides | |
| HY-R00720A | hsa-miR-3529-5p agomir | Oligonucleotides | |
| HY-R00721 | hsa-miR-3605-3p mimic | Oligonucleotides | |
| HY-R00721A | hsa-miR-3605-3p agomir | Oligonucleotides | |
| HY-R00722 | hsa-miR-3605-5p mimic | Oligonucleotides | |
| HY-R00722A | hsa-miR-3605-5p agomir | Oligonucleotides | |
| HY-R00723 | hsa-miR-3606-3p mimic | Oligonucleotides | |
| HY-R00723A | hsa-miR-3606-3p agomir | Oligonucleotides | |
| HY-R00724 | hsa-miR-3606-5p mimic | Oligonucleotides | |
| HY-R00724A | hsa-miR-3606-5p agomir | Oligonucleotides | |
| HY-R00725 | hsa-miR-3609 mimic | Oligonucleotides | |
| HY-R00725A | hsa-miR-3609 agomir | Oligonucleotides | |
| HY-R00726 | hsa-miR-3610 mimic | Oligonucleotides | |
| HY-R00726A | hsa-miR-3610 agomir | Oligonucleotides | |
| HY-R00727 | hsa-miR-3611 mimic | Oligonucleotides | |
| HY-R00727A | hsa-miR-3611 agomir | Oligonucleotides | |
| HY-R00728 | hsa-miR-3612 mimic | Oligonucleotides | |
| HY-R00728A | hsa-miR-3612 agomir | Oligonucleotides | |
| HY-R00729 | hsa-miR-3613-3p mimic | Oligonucleotides | |
| HY-R00729A | hsa-miR-3613-3p agomir | Oligonucleotides | |
| HY-R00730 | hsa-miR-3613-5p mimic | Oligonucleotides | |
| HY-R00730A | hsa-miR-3613-5p agomir | Oligonucleotides | |
| HY-R00731 | hsa-miR-3614-3p mimic | Oligonucleotides | |
| HY-R00731A | hsa-miR-3614-3p agomir | Oligonucleotides | |
| HY-R00732 | hsa-miR-3614-5p mimic | Oligonucleotides | |
| HY-R00732A | hsa-miR-3614-5p agomir | Oligonucleotides | |
| HY-R00733 | hsa-miR-3615 mimic | Oligonucleotides | |
| HY-R00733A | hsa-miR-3615 agomir | Oligonucleotides | |
| HY-R00734 | hsa-miR-361-5p mimic | Oligonucleotides | |
| HY-R00734A | hsa-miR-361-5p agomir | Oligonucleotides | |
| HY-R00735 | hsa-miR-3616-3p mimic | Oligonucleotides | |
| HY-R00735A | hsa-miR-3616-3p agomir | Oligonucleotides | |
| HY-R00736 | hsa-miR-3616-5p mimic | Oligonucleotides | |
| HY-R00736A | hsa-miR-3616-5p agomir | Oligonucleotides | |
| HY-R00737 | hsa-miR-3617-3p mimic | Oligonucleotides | |
| HY-R00737A | hsa-miR-3617-3p agomir | Oligonucleotides | |
| HY-R00738 | hsa-miR-3617-5p mimic | Oligonucleotides | |
| HY-R00738A | hsa-miR-3617-5p agomir | Oligonucleotides | |
| HY-R00739 | hsa-miR-3618 mimic | Oligonucleotides | |
| HY-R00739A | hsa-miR-3618 agomir | Oligonucleotides | |
| HY-R00740 | hsa-miR-3619-3p mimic | Oligonucleotides | |
| HY-R00740A | hsa-miR-3619-3p agomir | Oligonucleotides | |
| HY-R00741 | hsa-miR-3619-5p mimic | Oligonucleotides | |
| HY-R00741A | hsa-miR-3619-5p agomir | Oligonucleotides | |
| HY-R00742 | hsa-miR-3620-3p mimic | Oligonucleotides | |
| HY-R00742A | hsa-miR-3620-3p agomir | Oligonucleotides | |
| HY-R00743 | hsa-miR-3620-5p mimic | Oligonucleotides | |
| HY-R00743A | hsa-miR-3620-5p agomir | Oligonucleotides | |
| HY-R00744 | hsa-miR-3621 mimic | Oligonucleotides | |
| HY-R00744A | hsa-miR-3621 agomir | Oligonucleotides | |
| HY-R00745 | hsa-miR-3622a-3p mimic | Oligonucleotides | |
| HY-R00745A | hsa-miR-3622a-3p agomir | Oligonucleotides | |
| HY-R00746 | hsa-miR-3622a-5p mimic | Oligonucleotides | |
| HY-R00746A | hsa-miR-3622a-5p agomir | Oligonucleotides | |
| HY-R00747 | hsa-miR-3622b-3p mimic | Oligonucleotides | |
| HY-R00747A | hsa-miR-3622b-3p agomir | Oligonucleotides | |
| HY-R00748 | hsa-miR-3622b-5p mimic | Oligonucleotides | |
| HY-R00748A | hsa-miR-3622b-5p agomir | Oligonucleotides | |
| HY-R00749 | hsa-miR-362-3p mimic | Oligonucleotides | |
| HY-R00749A | hsa-miR-362-3p agomir | Oligonucleotides | |
| HY-R00750 | hsa-miR-362-5p mimic | Oligonucleotides | |
| HY-R00750A | hsa-miR-362-5p agomir | Oligonucleotides | |
| HY-R00751 | hsa-miR-363-3p mimic | Oligonucleotides | |
| HY-R00751A | hsa-miR-363-3p agomir | Oligonucleotides | |
| HY-R00752 | hsa-miR-363-5p mimic | Oligonucleotides | |
| HY-R00752A | hsa-miR-363-5p agomir | Oligonucleotides | |
| HY-R00753 | hsa-miR-3646 mimic | Oligonucleotides | |
| HY-R00753A | hsa-miR-3646 agomir | Oligonucleotides | |
| HY-R00754 | hsa-miR-3648 mimic | Oligonucleotides | |
| HY-R00754A | hsa-miR-3648 agomir | Oligonucleotides | |
| HY-R00755 | hsa-miR-3649 mimic | Oligonucleotides | |
| HY-R00755A | hsa-miR-3649 agomir | Oligonucleotides | |
| HY-R00756 | hsa-miR-3650 mimic | Oligonucleotides | |
| HY-R00756A | hsa-miR-3650 agomir | Oligonucleotides | |
| HY-R00757 | hsa-miR-3651 mimic | Oligonucleotides | |
| HY-R00757A | hsa-miR-3651 agomir | Oligonucleotides | |
| HY-R00758 | hsa-miR-3652 mimic | Oligonucleotides | |
| HY-R00758A | hsa-miR-3652 agomir | Oligonucleotides | |
| HY-R00759 | hsa-miR-3654 mimic | Oligonucleotides | |
| HY-R00759A | hsa-miR-3654 agomir | Oligonucleotides | |
| HY-R00760 | hsa-miR-3655 mimic | Oligonucleotides | |
| HY-R00760A | hsa-miR-3655 agomir | Oligonucleotides | |
| HY-R00761 | hsa-miR-3657 mimic | Oligonucleotides | |
| HY-R00761A | hsa-miR-3657 agomir | Oligonucleotides | |
| HY-R00762 | hsa-miR-3658 mimic | Oligonucleotides | |
| HY-R00762A | hsa-miR-3658 agomir | Oligonucleotides | |
| HY-R00763 | hsa-miR-3659 mimic | Oligonucleotides | |
| HY-R00763A | hsa-miR-3659 agomir | Oligonucleotides | |
| HY-R00764 | hsa-miR-365a-3p mimic | Oligonucleotides | |
| HY-R00764A | hsa-miR-365a-3p agomir | Oligonucleotides | |
| HY-R00765 | hsa-miR-365a-5p mimic | Oligonucleotides | |
| HY-R00765A | hsa-miR-365a-5p agomir | Oligonucleotides | |
| HY-R00766 | hsa-miR-365b-5p mimic | Oligonucleotides | |
| HY-R00766A | hsa-miR-365b-5p agomir | Oligonucleotides | |
| HY-R00767 | hsa-miR-3660 mimic | Oligonucleotides | |
| HY-R00767A | hsa-miR-3660 agomir | Oligonucleotides | |
| HY-R00768 | hsa-miR-3661 mimic | Oligonucleotides | |
| HY-R00768A | hsa-miR-3661 agomir | Oligonucleotides | |
| HY-R00769 | hsa-miR-3662 mimic | Oligonucleotides | |
| HY-R00769A | hsa-miR-3662 agomir | Oligonucleotides | |
| HY-R00770 | hsa-miR-3663-3p mimic | Oligonucleotides | |
| HY-R00770A | hsa-miR-3663-3p agomir | Oligonucleotides | |
| HY-R00771 | hsa-miR-3663-5p mimic | Oligonucleotides | |
| HY-R00771A | hsa-miR-3663-5p agomir | Oligonucleotides | |
| HY-R00772 | hsa-miR-3664-3p mimic | Oligonucleotides | |
| HY-R00772A | hsa-miR-3664-3p agomir | Oligonucleotides | |
| HY-R00773 | hsa-miR-3664-5p mimic | Oligonucleotides | |
| HY-R00773A | hsa-miR-3664-5p agomir | Oligonucleotides | |
| HY-R00774 | hsa-miR-3665 mimic | Oligonucleotides | |
| HY-R00774A | hsa-miR-3665 agomir | Oligonucleotides | |
| HY-R00775 | hsa-miR-3666 mimic | Oligonucleotides | |
| HY-R00775A | hsa-miR-3666 agomir | Oligonucleotides | |
| HY-R00776 | hsa-miR-3667-3p mimic | Oligonucleotides | |
| HY-R00776A | hsa-miR-3667-3p agomir | Oligonucleotides | |
| HY-R00777 | hsa-miR-3667-5p mimic | Oligonucleotides | |
| HY-R00777A | hsa-miR-3667-5p agomir | Oligonucleotides | |
| HY-R00778 | hsa-miR-3668 mimic | Oligonucleotides | |
| HY-R00778A | hsa-miR-3668 agomir | Oligonucleotides | |
| HY-R00779 | hsa-miR-3670 mimic | Oligonucleotides | |
| HY-R00779A | hsa-miR-3670 agomir | Oligonucleotides | |
| HY-R00780 | hsa-miR-3671 mimic | Oligonucleotides | |
| HY-R00780A | hsa-miR-3671 agomir | Oligonucleotides | |
| HY-R00781 | hsa-miR-3672 mimic | Oligonucleotides | |
| HY-R00781A | hsa-miR-3672 agomir | Oligonucleotides | |
| HY-R00782 | hsa-miR-367-3p mimic | Oligonucleotides | |
| HY-R00782A | hsa-miR-367-3p agomir | Oligonucleotides | |
| HY-R00783 | hsa-miR-3674 mimic | Oligonucleotides | |
| HY-R00783A | hsa-miR-3674 agomir | Oligonucleotides | |
| HY-R00784 | hsa-miR-3675-3p mimic | Oligonucleotides | |
| HY-R00784A | hsa-miR-3675-3p agomir | Oligonucleotides | |
| HY-R00785 | hsa-miR-3675-5p mimic | Oligonucleotides | |
| HY-R00785A | hsa-miR-3675-5p agomir | Oligonucleotides | |
| HY-R00786 | hsa-miR-367-5p mimic | Oligonucleotides | |
| HY-R00786A | hsa-miR-367-5p agomir | Oligonucleotides | |
| HY-R00787 | hsa-miR-3677-3p mimic | Oligonucleotides | |
| HY-R00787A | hsa-miR-3677-3p agomir | Oligonucleotides | |
| HY-R00788 | hsa-miR-3677-5p mimic | Oligonucleotides | |
| HY-R00788A | hsa-miR-3677-5p agomir | Oligonucleotides | |
| HY-R00789 | hsa-miR-3678-3p mimic | Oligonucleotides | |
| HY-R00789A | hsa-miR-3678-3p agomir | Oligonucleotides | |
| HY-R00790 | hsa-miR-3678-5p mimic | Oligonucleotides | |
| HY-R00790A | hsa-miR-3678-5p agomir | Oligonucleotides | |
| HY-R00791 | hsa-miR-3679-3p mimic | Oligonucleotides | |
| HY-R00791A | hsa-miR-3679-3p agomir | Oligonucleotides | |
| HY-R00792 | hsa-miR-3679-5p mimic | Oligonucleotides | |
| HY-R00792A | hsa-miR-3679-5p agomir | Oligonucleotides | |
| HY-R00793 | hsa-miR-3680-3p mimic | Oligonucleotides | |
| HY-R00793A | hsa-miR-3680-3p agomir | Oligonucleotides | |
| HY-R00794 | hsa-miR-3680-5p mimic | Oligonucleotides | |
| HY-R00794A | hsa-miR-3680-5p agomir | Oligonucleotides | |
| HY-R00795 | hsa-miR-3681-3p mimic | Oligonucleotides | |
| HY-R00795A | hsa-miR-3681-3p agomir | Oligonucleotides | |
| HY-R00796 | hsa-miR-3681-5p mimic | Oligonucleotides | |
| HY-R00796A | hsa-miR-3681-5p agomir | Oligonucleotides | |
| HY-R00797 | hsa-miR-3682-3p mimic | Oligonucleotides | |
| HY-R00797A | hsa-miR-3682-3p agomir | Oligonucleotides | |
| HY-R00798 | hsa-miR-3682-5p mimic | Oligonucleotides | |
| HY-R00798A | hsa-miR-3682-5p agomir | Oligonucleotides | |
| HY-R00799 | hsa-miR-3683 mimic | Oligonucleotides | |
| HY-R00799A | hsa-miR-3683 agomir | Oligonucleotides | |
| HY-R00800 | hsa-miR-3684 mimic | Oligonucleotides | |
| HY-R00800A | hsa-miR-3684 agomir | Oligonucleotides | |
| HY-R00801 | hsa-miR-3685 mimic | Oligonucleotides | |
| HY-R00801A | hsa-miR-3685 agomir | Oligonucleotides | |
| HY-R00802 | hsa-miR-3686 mimic | Oligonucleotides | |
| HY-R00802A | hsa-miR-3686 agomir | Oligonucleotides | |
| HY-R00803 | hsa-miR-3688-3p mimic | Oligonucleotides | |
| HY-R00803A | hsa-miR-3688-3p agomir | Oligonucleotides | |
| HY-R00804 | hsa-miR-3688-5p mimic | Oligonucleotides | |
| HY-R00804A | hsa-miR-3688-5p agomir | Oligonucleotides | |
| HY-R00805 | hsa-miR-3689a-3p mimic | Oligonucleotides | |
| HY-R00805A | hsa-miR-3689a-3p agomir | Oligonucleotides | |
| HY-R00806 | hsa-miR-3689a-5p mimic | Oligonucleotides | |
| HY-R00806A | hsa-miR-3689a-5p agomir | Oligonucleotides | |
| HY-R00807 | hsa-miR-3689b-3p mimic | Oligonucleotides | |
| HY-R00807A | hsa-miR-3689b-3p agomir | Oligonucleotides | |
| HY-R00808 | hsa-miR-3689d mimic | Oligonucleotides | |
| HY-R00808A | hsa-miR-3689d agomir | Oligonucleotides | |
| HY-R00809 | hsa-miR-3689f mimic | Oligonucleotides | |
| HY-R00809A | hsa-miR-3689f agomir | Oligonucleotides | |
| HY-R00810 | hsa-miR-3690 mimic | Oligonucleotides | |
| HY-R00810A | hsa-miR-3690 agomir | Oligonucleotides | |
| HY-R00811 | hsa-miR-3691-3p mimic | Oligonucleotides | |
| HY-R00811A | hsa-miR-3691-3p agomir | Oligonucleotides | |
| HY-R00812 | hsa-miR-3691-5p mimic | Oligonucleotides | |
| HY-R00812A | hsa-miR-3691-5p agomir | Oligonucleotides | |
| HY-R00813 | hsa-miR-3692-3p mimic | Oligonucleotides | |
| HY-R00813A | hsa-miR-3692-3p agomir | Oligonucleotides | |
| HY-R00814 | hsa-miR-3692-5p mimic | Oligonucleotides | |
| HY-R00814A | hsa-miR-3692-5p agomir | Oligonucleotides | |
| HY-R00815 | hsa-miR-369-3p mimic | Oligonucleotides | |
| HY-R00815A | hsa-miR-369-3p agomir | Oligonucleotides | |
| HY-R00816 | hsa-miR-370-3p mimic | Oligonucleotides | |
| HY-R00816A | hsa-miR-370-3p agomir | Oligonucleotides | |
| HY-R00817 | hsa-miR-370-5p mimic | Oligonucleotides | |
| HY-R00817A | hsa-miR-370-5p agomir | Oligonucleotides | |
| HY-R00818 | hsa-miR-3713 mimic | Oligonucleotides | |
| HY-R00818A | hsa-miR-3713 agomir | Oligonucleotides | |
| HY-R00819 | hsa-miR-3714 mimic | Oligonucleotides | |
| HY-R00819A | hsa-miR-3714 agomir | Oligonucleotides | |
| HY-R00820 | hsa-miR-371a-3p mimic | Oligonucleotides | |
| HY-R00820A | hsa-miR-371a-3p agomir | Oligonucleotides | |
| HY-R00821 | hsa-miR-371a-5p mimic | Oligonucleotides | |
| HY-R00821A | hsa-miR-371a-5p agomir | Oligonucleotides | |
| HY-R00822 | hsa-miR-371b-3p mimic | Oligonucleotides | |
| HY-R00822A | hsa-miR-371b-3p agomir | Oligonucleotides | |
| HY-R00823 | hsa-miR-371b-5p mimic | Oligonucleotides | |
| HY-R00823A | hsa-miR-371b-5p agomir | Oligonucleotides | |
| HY-R00824 | hsa-miR-372-3p mimic | Oligonucleotides | |
| HY-R00824A | hsa-miR-372-3p agomir | Oligonucleotides | |
| HY-R00825 | hsa-miR-372-5p mimic | Oligonucleotides | |
| HY-R00825A | hsa-miR-372-5p agomir | Oligonucleotides | |
| HY-R00826 | hsa-miR-373-3p mimic | Oligonucleotides | |
| HY-R00826A | hsa-miR-373-3p agomir | Oligonucleotides | |
| HY-R00827 | hsa-miR-373-5p mimic | Oligonucleotides | |
| HY-R00827A | hsa-miR-373-5p agomir | Oligonucleotides | |
| HY-R00828 | hsa-miR-374a-3p mimic | Oligonucleotides | |
| HY-R00828A | hsa-miR-374a-3p agomir | Oligonucleotides | |
| HY-R00829 | hsa-miR-374a-5p mimic | Oligonucleotides | |
| HY-R00829A | hsa-miR-374a-5p agomir | Oligonucleotides | |
| HY-R00830 | hsa-miR-374b-3p mimic | Oligonucleotides | |
| HY-R00830A | hsa-miR-374b-3p agomir | Oligonucleotides | |
| HY-R00831 | hsa-miR-374b-5p mimic | Oligonucleotides | |
| HY-R00831A | hsa-miR-374b-5p agomir | Oligonucleotides | |
| HY-R00832 | hsa-miR-374c-3p mimic | Oligonucleotides | |
| HY-R00832A | hsa-miR-374c-3p agomir | Oligonucleotides | |
| HY-R00833 | hsa-miR-374c-5p mimic | Oligonucleotides | |
| HY-R00833A | hsa-miR-374c-5p agomir | Oligonucleotides | |
| HY-R00834 | hsa-miR-375-3p mimic | Oligonucleotides | |
| HY-R00834A | hsa-miR-375-3p agomir | Oligonucleotides | |
| HY-R00835 | hsa-miR-375-5p mimic | Oligonucleotides | |
| HY-R00835A | hsa-miR-375-5p agomir | Oligonucleotides | |
| HY-R00836 | hsa-miR-376a-2-5p mimic | Oligonucleotides | |
| HY-R00836A | hsa-miR-376a-2-5p agomir | Oligonucleotides | |
| HY-R00837 | hsa-miR-376a-5p mimic | Oligonucleotides | |
| HY-R00837A | hsa-miR-376a-5p agomir | Oligonucleotides | |
| HY-R00838 | hsa-miR-376b-3p mimic | Oligonucleotides | |
| HY-R00838A | hsa-miR-376b-3p agomir | Oligonucleotides | |
| HY-R00839 | hsa-miR-376b-5p mimic | Oligonucleotides | |
| HY-R00839A | hsa-miR-376b-5p agomir | Oligonucleotides | |
| HY-R00840 | hsa-miR-376c-3p mimic | Oligonucleotides | |
| HY-R00840A | hsa-miR-376c-3p agomir | Oligonucleotides | |
| HY-R00841 | hsa-miR-376c-5p mimic | Oligonucleotides | |
| HY-R00841A | hsa-miR-376c-5p agomir | Oligonucleotides | |
| HY-R00842 | hsa-miR-377-3p mimic | Oligonucleotides | |
| HY-R00842A | hsa-miR-377-3p agomir | Oligonucleotides | |
| HY-R00843 | hsa-miR-378a-3p mimic | Oligonucleotides | |
| HY-R00843A | hsa-miR-378a-3p agomir | Oligonucleotides | |
| HY-R00844 | hsa-miR-378a-5p mimic | Oligonucleotides | |
| HY-R00844A | hsa-miR-378a-5p agomir | Oligonucleotides | |
| HY-R00845 | hsa-miR-378b mimic | Oligonucleotides | |
| HY-R00845A | hsa-miR-378b agomir | Oligonucleotides | |
| HY-R00846 | hsa-miR-378c mimic | Oligonucleotides | |
| HY-R00846A | hsa-miR-378c agomir | Oligonucleotides | |
| HY-R00847 | hsa-miR-378d mimic | Oligonucleotides | |
| HY-R00847A | hsa-miR-378d agomir | Oligonucleotides | |
| HY-R00848 | hsa-miR-378e mimic | Oligonucleotides | |
| HY-R00848A | hsa-miR-378e agomir | Oligonucleotides | |
| HY-R00849 | hsa-miR-378f mimic | Oligonucleotides | |
| HY-R00849A | hsa-miR-378f agomir | Oligonucleotides | |
| HY-R00850 | hsa-miR-378g mimic | Oligonucleotides | |
| HY-R00850A | hsa-miR-378g agomir | Oligonucleotides | |
| HY-R00851 | hsa-miR-378h mimic | Oligonucleotides | |
| HY-R00851A | hsa-miR-378h agomir | Oligonucleotides | |
| HY-R00852 | hsa-miR-378i mimic | Oligonucleotides | |
| HY-R00852A | hsa-miR-378i agomir | Oligonucleotides | |
| HY-R00853 | hsa-miR-378j mimic | Oligonucleotides | |
| HY-R00853A | hsa-miR-378j agomir | Oligonucleotides | |
| HY-R00854 | hsa-miR-379-3p mimic | Oligonucleotides | |
| HY-R00854A | hsa-miR-379-3p agomir | Oligonucleotides | |
| HY-R00855 | hsa-miR-379-5p mimic | Oligonucleotides | |
| HY-R00855A | hsa-miR-379-5p agomir | Oligonucleotides | |
| HY-R00856 | hsa-miR-380-3p mimic | Oligonucleotides | |
| HY-R00856A | hsa-miR-380-3p agomir | Oligonucleotides | |
| HY-R00857 | hsa-miR-380-5p mimic | Oligonucleotides | |
| HY-R00857A | hsa-miR-380-5p agomir | Oligonucleotides | |
| HY-R00858 | hsa-miR-381-3p mimic | Oligonucleotides | |
| HY-R00858A | hsa-miR-381-3p agomir | Oligonucleotides | |
| HY-R00859 | hsa-miR-381-5p mimic | Oligonucleotides | |
| HY-R00859A | hsa-miR-381-5p agomir | Oligonucleotides | |
| HY-R00860 | hsa-miR-382-3p mimic | Oligonucleotides | |
| HY-R00860A | hsa-miR-382-3p agomir | Oligonucleotides | |
| HY-R00861 | hsa-miR-382-5p mimic | Oligonucleotides | |
| HY-R00861A | hsa-miR-382-5p agomir | Oligonucleotides | |
| HY-R00862 | hsa-miR-383-3p mimic | Oligonucleotides | |
| HY-R00862A | hsa-miR-383-3p agomir | Oligonucleotides | |
| HY-R00863 | hsa-miR-384 mimic | Oligonucleotides | |
| HY-R00863A | hsa-miR-384 agomir | Oligonucleotides | |
| HY-R00864 | hsa-miR-3907 mimic | Oligonucleotides | |
| HY-R00864A | hsa-miR-3907 agomir | Oligonucleotides | |
| HY-R00865 | hsa-miR-3908 mimic | Oligonucleotides | |
| HY-R00865A | hsa-miR-3908 agomir | Oligonucleotides | |
| HY-R00866 | hsa-miR-3909 mimic | Oligonucleotides | |
| HY-R00866A | hsa-miR-3909 agomir | Oligonucleotides | |
| HY-R00867 | hsa-miR-3910 mimic | Oligonucleotides | |
| HY-R00867A | hsa-miR-3910 agomir | Oligonucleotides | |
| HY-R00868 | hsa-miR-3911 mimic | Oligonucleotides | |
| HY-R00868A | hsa-miR-3911 agomir | Oligonucleotides | |
| HY-R00869 | hsa-miR-3912-3p mimic | Oligonucleotides | |
| HY-R00869A | hsa-miR-3912-3p agomir | Oligonucleotides | |
| HY-R00870 | hsa-miR-3912-5p mimic | Oligonucleotides | |
| HY-R00870A | hsa-miR-3912-5p agomir | Oligonucleotides | |
| HY-R00871 | hsa-miR-3913-3p mimic | Oligonucleotides | |
| HY-R00871A | hsa-miR-3913-3p agomir | Oligonucleotides | |
| HY-R00872 | hsa-miR-3913-5p mimic | Oligonucleotides | |
| HY-R00872A | hsa-miR-3913-5p agomir | Oligonucleotides | |
| HY-R00873 | hsa-miR-3914 mimic | Oligonucleotides | |
| HY-R00873A | hsa-miR-3914 agomir | Oligonucleotides | |
| HY-R00874 | hsa-miR-3915 mimic | Oligonucleotides | |
| HY-R00874A | hsa-miR-3915 agomir | Oligonucleotides | |
| HY-R00875 | hsa-miR-3916 mimic | Oligonucleotides | |
| HY-R00875A | hsa-miR-3916 agomir | Oligonucleotides | |
| HY-R00876 | hsa-miR-3917 mimic | Oligonucleotides | |
| HY-R00876A | hsa-miR-3917 agomir | Oligonucleotides | |
| HY-R00877 | hsa-miR-3918 mimic | Oligonucleotides | |
| HY-R00877A | hsa-miR-3918 agomir | Oligonucleotides | |
| HY-R00878 | hsa-miR-3919 mimic | Oligonucleotides | |
| HY-R00878A | hsa-miR-3919 agomir | Oligonucleotides | |
| HY-R00879 | hsa-miR-3920 mimic | Oligonucleotides | |
| HY-R00879A | hsa-miR-3920 agomir | Oligonucleotides | |
| HY-R00880 | hsa-miR-3921 mimic | Oligonucleotides | |
| HY-R00880A | hsa-miR-3921 agomir | Oligonucleotides | |
| HY-R00881 | hsa-miR-3922-3p mimic | Oligonucleotides | |
| HY-R00881A | hsa-miR-3922-3p agomir | Oligonucleotides | |
| HY-R00882 | hsa-miR-3922-5p mimic | Oligonucleotides | |
| HY-R00882A | hsa-miR-3922-5p agomir | Oligonucleotides | |
| HY-R00883 | hsa-miR-3923 mimic | Oligonucleotides | |
| HY-R00883A | hsa-miR-3923 agomir | Oligonucleotides | |
| HY-R00884 | hsa-miR-3924 mimic | Oligonucleotides | |
| HY-R00884A | hsa-miR-3924 agomir | Oligonucleotides | |
| HY-R00885 | hsa-miR-3925-3p mimic | Oligonucleotides | |
| HY-R00885A | hsa-miR-3925-3p agomir | Oligonucleotides | |
| HY-R00886 | hsa-miR-3925-5p mimic | Oligonucleotides | |
| HY-R00886A | hsa-miR-3925-5p agomir | Oligonucleotides | |
| HY-R00887 | hsa-miR-3926 mimic | Oligonucleotides | |
| HY-R00887A | hsa-miR-3926 agomir | Oligonucleotides | |
| HY-R00888 | hsa-miR-3927-3p mimic | Oligonucleotides | |
| HY-R00888A | hsa-miR-3927-3p agomir | Oligonucleotides | |
| HY-R00889 | hsa-miR-3927-5p mimic | Oligonucleotides | |
| HY-R00889A | hsa-miR-3927-5p agomir | Oligonucleotides | |
| HY-R00890 | hsa-miR-3928-3p mimic | Oligonucleotides | |
| HY-R00890A | hsa-miR-3928-3p agomir | Oligonucleotides | |
| HY-R00891 | hsa-miR-3928-5p mimic | Oligonucleotides | |
| HY-R00891A | hsa-miR-3928-5p agomir | Oligonucleotides | |
| HY-R00892 | hsa-miR-3929 mimic | Oligonucleotides | |
| HY-R00892A | hsa-miR-3929 agomir | Oligonucleotides | |
| HY-R00893 | hsa-miR-3934-3p mimic | Oligonucleotides | |
| HY-R00893A | hsa-miR-3934-3p agomir | Oligonucleotides | |
| HY-R00894 | hsa-miR-3934-5p mimic | Oligonucleotides | |
| HY-R00894A | hsa-miR-3934-5p agomir | Oligonucleotides | |
| HY-R00895 | hsa-miR-3935 mimic | Oligonucleotides | |
| HY-R00895A | hsa-miR-3935 agomir | Oligonucleotides | |
| HY-R00896 | hsa-miR-3936 mimic | Oligonucleotides | |
| HY-R00896A | hsa-miR-3936 agomir | Oligonucleotides | |
| HY-R00897 | hsa-miR-3937 mimic | Oligonucleotides | |
| HY-R00897A | hsa-miR-3937 agomir | Oligonucleotides | |
| HY-R00898 | hsa-miR-3938 mimic | Oligonucleotides | |
| HY-R00898A | hsa-miR-3938 agomir | Oligonucleotides | |
| HY-R00899 | hsa-miR-3939 mimic | Oligonucleotides | |
| HY-R00899A | hsa-miR-3939 agomir | Oligonucleotides | |
| HY-R00900 | hsa-miR-3940-3p mimic | Oligonucleotides | |
| HY-R00900A | hsa-miR-3940-3p agomir | Oligonucleotides | |
| HY-R00901 | hsa-miR-3940-5p mimic | Oligonucleotides | |
| HY-R00901A | hsa-miR-3940-5p agomir | Oligonucleotides | |
| HY-R00902 | hsa-miR-3941 mimic | Oligonucleotides | |
| HY-R00902A | hsa-miR-3941 agomir | Oligonucleotides | |
| HY-R00903 | hsa-miR-3942-3p mimic | Oligonucleotides | |
| HY-R00903A | hsa-miR-3942-3p agomir | Oligonucleotides | |
| HY-R00904 | hsa-miR-3942-5p mimic | Oligonucleotides | |
| HY-R00904A | hsa-miR-3942-5p agomir | Oligonucleotides | |
| HY-R00905 | hsa-miR-3943 mimic | Oligonucleotides | |
| HY-R00905A | hsa-miR-3943 agomir | Oligonucleotides | |
| HY-R00906 | hsa-miR-3944-3p mimic | Oligonucleotides | |
| HY-R00906A | hsa-miR-3944-3p agomir | Oligonucleotides | |
| HY-R00907 | hsa-miR-3944-5p mimic | Oligonucleotides | |
| HY-R00907A | hsa-miR-3944-5p agomir | Oligonucleotides | |
| HY-R00908 | hsa-miR-3945 mimic | Oligonucleotides | |
| HY-R00908A | hsa-miR-3945 agomir | Oligonucleotides | |
| HY-R00909 | hsa-miR-3960 mimic | Oligonucleotides | |
| HY-R00909A | hsa-miR-3960 agomir | Oligonucleotides | |
| HY-R00910 | hsa-miR-3972 mimic | Oligonucleotides | |
| HY-R00910A | hsa-miR-3972 agomir | Oligonucleotides | |
| HY-R00911 | hsa-miR-3973 mimic | Oligonucleotides | |
| HY-R00911A | hsa-miR-3973 agomir | Oligonucleotides | |
| HY-R00912 | hsa-miR-3974 mimic | Oligonucleotides | |
| HY-R00912A | hsa-miR-3974 agomir | Oligonucleotides | |
| HY-R00913 | hsa-miR-3975 mimic | Oligonucleotides | |
| HY-R00913A | hsa-miR-3975 agomir | Oligonucleotides | |
| HY-R00914 | hsa-miR-3976 mimic | Oligonucleotides | |
| HY-R00914A | hsa-miR-3976 agomir | Oligonucleotides | |
| HY-R00915 | hsa-miR-3977 mimic | Oligonucleotides | |
| HY-R00915A | hsa-miR-3977 agomir | Oligonucleotides | |
| HY-R00916 | hsa-miR-3978 mimic | Oligonucleotides | |
| HY-R00916A | hsa-miR-3978 agomir | Oligonucleotides | |
| HY-R00917 | hsa-miR-409-3p mimic | Oligonucleotides | |
| HY-R00917A | hsa-miR-409-3p agomir | Oligonucleotides | |
| HY-R00918 | hsa-miR-409-5p mimic | Oligonucleotides | |
| HY-R00918A | hsa-miR-409-5p agomir | Oligonucleotides | |
| HY-R00919 | hsa-miR-410-3p mimic | Oligonucleotides | |
| HY-R00919A | hsa-miR-410-3p agomir | Oligonucleotides | |
| HY-R00920 | hsa-miR-410-5p mimic | Oligonucleotides | |
| HY-R00920A | hsa-miR-410-5p agomir | Oligonucleotides | |
| HY-R00921 | hsa-miR-411-3p mimic | Oligonucleotides | |
| HY-R00921A | hsa-miR-411-3p agomir | Oligonucleotides | |
| HY-R00922 | hsa-miR-412-3p mimic | Oligonucleotides | |
| HY-R00922A | hsa-miR-412-3p agomir | Oligonucleotides | |
| HY-R00923 | hsa-miR-412-5p mimic | Oligonucleotides | |
| HY-R00923A | hsa-miR-412-5p agomir | Oligonucleotides | |
| HY-R00924 | hsa-miR-422a mimic | Oligonucleotides | |
| HY-R00924A | hsa-miR-422a agomir | Oligonucleotides | |
| HY-R00925 | hsa-miR-423-3p mimic | Oligonucleotides | |
| HY-R00925A | hsa-miR-423-3p agomir | Oligonucleotides | |
| HY-R00926 | hsa-miR-423-5p mimic | Oligonucleotides | |
| HY-R00926A | hsa-miR-423-5p agomir | Oligonucleotides | |
| HY-R00927 | hsa-miR-424-3p mimic | Oligonucleotides | |
| HY-R00927A | hsa-miR-424-3p agomir | Oligonucleotides | |
| HY-R00928 | hsa-miR-424-5p mimic | Oligonucleotides | |
| HY-R00928A | hsa-miR-424-5p agomir | Oligonucleotides | |
| HY-R00929 | hsa-miR-4251 mimic | Oligonucleotides | |
| HY-R00929A | hsa-miR-4251 agomir | Oligonucleotides | |
| HY-R00930 | hsa-miR-4252 mimic | Oligonucleotides | |
| HY-R00930A | hsa-miR-4252 agomir | Oligonucleotides | |
| HY-R00931 | hsa-miR-4253 mimic | Oligonucleotides | |
| HY-R00931A | hsa-miR-4253 agomir | Oligonucleotides | |
| HY-R00932 | hsa-miR-425-3p mimic | Oligonucleotides | |
| HY-R00932A | hsa-miR-425-3p agomir | Oligonucleotides | |
| HY-R00933 | hsa-miR-4254 mimic | Oligonucleotides | |
| HY-R00933A | hsa-miR-4254 agomir | Oligonucleotides | |
| HY-R00934 | hsa-miR-4255 mimic | Oligonucleotides | |
| HY-R00934A | hsa-miR-4255 agomir | Oligonucleotides | |
| HY-R00935 | hsa-miR-4256 mimic | Oligonucleotides | |
| HY-R00935A | hsa-miR-4256 agomir | Oligonucleotides | |
| HY-R00936 | hsa-miR-4257 mimic | Oligonucleotides | |
| HY-R00936A | hsa-miR-4257 agomir | Oligonucleotides | |
| HY-R00937 | hsa-miR-4258 mimic | Oligonucleotides | |
| HY-R00937A | hsa-miR-4258 agomir | Oligonucleotides | |
| HY-R00938 | hsa-miR-4259 mimic | Oligonucleotides | |
| HY-R00938A | hsa-miR-4259 agomir | Oligonucleotides | |
| HY-R00939 | hsa-miR-4260 mimic | Oligonucleotides | |
| HY-R00939A | hsa-miR-4260 agomir | Oligonucleotides | |
| HY-R00940 | hsa-miR-4261 mimic | Oligonucleotides | |
| HY-R00940A | hsa-miR-4261 agomir | Oligonucleotides | |
| HY-R00941 | hsa-miR-4262 mimic | Oligonucleotides | |
| HY-R00941A | hsa-miR-4262 agomir | Oligonucleotides | |
| HY-R00942 | hsa-miR-4263 mimic | Oligonucleotides | |
| HY-R00942A | hsa-miR-4263 agomir | Oligonucleotides | |
| HY-R00943 | hsa-miR-4264 mimic | Oligonucleotides | |
| HY-R00943A | hsa-miR-4264 agomir | Oligonucleotides | |
| HY-R00944 | hsa-miR-4265 mimic | Oligonucleotides | |
| HY-R00944A | hsa-miR-4265 agomir | Oligonucleotides | |
| HY-R00945 | hsa-miR-4266 mimic | Oligonucleotides | |
| HY-R00945A | hsa-miR-4266 agomir | Oligonucleotides | |
| HY-R00946 | hsa-miR-4267 mimic | Oligonucleotides | |
| HY-R00946A | hsa-miR-4267 agomir | Oligonucleotides | |
| HY-R00947 | hsa-miR-4268 mimic | Oligonucleotides | |
| HY-R00947A | hsa-miR-4268 agomir | Oligonucleotides | |
| HY-R00948 | hsa-miR-4269 mimic | Oligonucleotides | |
| HY-R00948A | hsa-miR-4269 agomir | Oligonucleotides | |
| HY-R00949 | hsa-miR-4270 mimic | Oligonucleotides | |
| HY-R00949A | hsa-miR-4270 agomir | Oligonucleotides | |
| HY-R00950 | hsa-miR-4271 mimic | Oligonucleotides | |
| HY-R00950A | hsa-miR-4271 agomir | Oligonucleotides | |
| HY-R00951 | hsa-miR-4272 mimic | Oligonucleotides | |
| HY-R00951A | hsa-miR-4272 agomir | Oligonucleotides | |
| HY-R00952 | hsa-miR-4273 mimic | Oligonucleotides | |
| HY-R00952A | hsa-miR-4273 agomir | Oligonucleotides | |
| HY-R00953 | hsa-miR-4274 mimic | Oligonucleotides | |
| HY-R00953A | hsa-miR-4274 agomir | Oligonucleotides | |
| HY-R00954 | hsa-miR-4275 mimic | Oligonucleotides | |
| HY-R00954A | hsa-miR-4275 agomir | Oligonucleotides | |
| HY-R00955 | hsa-miR-4276 mimic | Oligonucleotides | |
| HY-R00955A | hsa-miR-4276 agomir | Oligonucleotides | |
| HY-R00956 | hsa-miR-4277 mimic | Oligonucleotides | |
| HY-R00956A | hsa-miR-4277 agomir | Oligonucleotides | |
| HY-R00957 | hsa-miR-4278 mimic | Oligonucleotides | |
| HY-R00957A | hsa-miR-4278 agomir | Oligonucleotides | |
| HY-R00958 | hsa-miR-4279 mimic | Oligonucleotides | |
| HY-R00958A | hsa-miR-4279 agomir | Oligonucleotides | |
| HY-R00959 | hsa-miR-4280 mimic | Oligonucleotides | |
| HY-R00959A | hsa-miR-4280 agomir | Oligonucleotides | |
| HY-R00960 | hsa-miR-4281 mimic | Oligonucleotides | |
| HY-R00960A | hsa-miR-4281 agomir | Oligonucleotides | |
| HY-R00961 | hsa-miR-4282 mimic | Oligonucleotides | |
| HY-R00961A | hsa-miR-4282 agomir | Oligonucleotides | |
| HY-R00962 | hsa-miR-4283 mimic | Oligonucleotides | |
| HY-R00962A | hsa-miR-4283 agomir | Oligonucleotides | |
| HY-R00963 | hsa-miR-4284 mimic | Oligonucleotides | |
| HY-R00963A | hsa-miR-4284 agomir | Oligonucleotides | |
| HY-R00964 | hsa-miR-4285 mimic | Oligonucleotides | |
| HY-R00964A | hsa-miR-4285 agomir | Oligonucleotides | |
| HY-R00965 | hsa-miR-4286 mimic | Oligonucleotides | |
| HY-R00965A | hsa-miR-4286 agomir | Oligonucleotides | |
| HY-R00966 | hsa-miR-4287 mimic | Oligonucleotides | |
| HY-R00966A | hsa-miR-4287 agomir | Oligonucleotides | |
| HY-R00967 | hsa-miR-4288 mimic | Oligonucleotides | |
| HY-R00967A | hsa-miR-4288 agomir | Oligonucleotides | |
| HY-R00968 | hsa-miR-4289 mimic | Oligonucleotides | |
| HY-R00968A | hsa-miR-4289 agomir | Oligonucleotides | |
| HY-R00969 | hsa-miR-429 mimic | Oligonucleotides | |
| HY-R00969A | hsa-miR-429 agomir | Oligonucleotides | |
| HY-R00970 | hsa-miR-4290 mimic | Oligonucleotides | |
| HY-R00970A | hsa-miR-4290 agomir | Oligonucleotides | |
| HY-R00971 | hsa-miR-4291 mimic | Oligonucleotides | |
| HY-R00971A | hsa-miR-4291 agomir | Oligonucleotides | |
| HY-R00972 | hsa-miR-4292 mimic | Oligonucleotides | |
| HY-R00972A | hsa-miR-4292 agomir | Oligonucleotides | |
| HY-R00973 | hsa-miR-4293 mimic | Oligonucleotides | |
| HY-R00973A | hsa-miR-4293 agomir | Oligonucleotides | |
| HY-R00974 | hsa-miR-4294 mimic | Oligonucleotides | |
| HY-R00974A | hsa-miR-4294 agomir | Oligonucleotides | |
| HY-R00975 | hsa-miR-4295 mimic | Oligonucleotides | |
| HY-R00975A | hsa-miR-4295 agomir | Oligonucleotides | |
| HY-R00976 | hsa-miR-4296 mimic | Oligonucleotides | |
| HY-R00976A | hsa-miR-4296 agomir | Oligonucleotides | |
| HY-R00977 | hsa-miR-4297 mimic | Oligonucleotides | |
| HY-R00977A | hsa-miR-4297 agomir | Oligonucleotides | |
| HY-R00978 | hsa-miR-4298 mimic | Oligonucleotides | |
| HY-R00978A | hsa-miR-4298 agomir | Oligonucleotides | |
| HY-R00979 | hsa-miR-4299 mimic | Oligonucleotides | |
| HY-R00979A | hsa-miR-4299 agomir | Oligonucleotides | |
| HY-R00980 | hsa-miR-4300 mimic | Oligonucleotides | |
| HY-R00980A | hsa-miR-4300 agomir | Oligonucleotides | |
| HY-R00981 | hsa-miR-4301 mimic | Oligonucleotides | |
| HY-R00981A | hsa-miR-4301 agomir | Oligonucleotides | |
| HY-R00982 | hsa-miR-4302 mimic | Oligonucleotides | |
| HY-R00982A | hsa-miR-4302 agomir | Oligonucleotides | |
| HY-R00983 | hsa-miR-4303 mimic | Oligonucleotides | |
| HY-R00983A | hsa-miR-4303 agomir | Oligonucleotides | |
| HY-R00984 | hsa-miR-4304 mimic | Oligonucleotides | |
| HY-R00984A | hsa-miR-4304 agomir | Oligonucleotides | |
| HY-R00985 | hsa-miR-4305 mimic | Oligonucleotides | |
| HY-R00985A | hsa-miR-4305 agomir | Oligonucleotides | |
| HY-R00986 | hsa-miR-4306 mimic | Oligonucleotides | |
| HY-R00986A | hsa-miR-4306 agomir | Oligonucleotides | |
| HY-R00987 | hsa-miR-4307 mimic | Oligonucleotides | |
| HY-R00987A | hsa-miR-4307 agomir | Oligonucleotides | |
| HY-R00988 | hsa-miR-4308 mimic | Oligonucleotides | |
| HY-R00988A | hsa-miR-4308 agomir | Oligonucleotides | |
| HY-R00989 | hsa-miR-4309 mimic | Oligonucleotides | |
| HY-R00989A | hsa-miR-4309 agomir | Oligonucleotides | |
| HY-R00990 | hsa-miR-4310 mimic | Oligonucleotides | |
| HY-R00990A | hsa-miR-4310 agomir | Oligonucleotides | |
| HY-R00991 | hsa-miR-4311 mimic | Oligonucleotides | |
| HY-R00991A | hsa-miR-4311 agomir | Oligonucleotides | |
| HY-R00992 | hsa-miR-4312 mimic | Oligonucleotides | |
| HY-R00992A | hsa-miR-4312 agomir | Oligonucleotides | |
| HY-R00993 | hsa-miR-4313 mimic | Oligonucleotides | |
| HY-R00993A | hsa-miR-4313 agomir | Oligonucleotides | |
| HY-R00994 | hsa-miR-431-3p mimic | Oligonucleotides | |
| HY-R00994A | hsa-miR-431-3p agomir | Oligonucleotides | |
| HY-R00995 | hsa-miR-4314 mimic | Oligonucleotides | |
| HY-R00995A | hsa-miR-4314 agomir | Oligonucleotides | |
| HY-R00996 | hsa-miR-4315 mimic | Oligonucleotides | |
| HY-R00996A | hsa-miR-4315 agomir | Oligonucleotides | |
| HY-R00997 | hsa-miR-431-5p mimic | Oligonucleotides | |
| HY-R00997A | hsa-miR-431-5p agomir | Oligonucleotides | |
| HY-R00998 | hsa-miR-4316 mimic | Oligonucleotides | |
| HY-R00998A | hsa-miR-4316 agomir | Oligonucleotides | |
| HY-R00999 | hsa-miR-4317 mimic | Oligonucleotides | |
| HY-R00999A | hsa-miR-4317 agomir | Oligonucleotides | |
| HY-R01000 | hsa-miR-4318 mimic | Oligonucleotides | |
| HY-R01000A | hsa-miR-4318 agomir | Oligonucleotides | |
| HY-R01001 | hsa-miR-4319 mimic | Oligonucleotides | |
| HY-R01001A | hsa-miR-4319 agomir | Oligonucleotides | |
| HY-R01002 | hsa-miR-4320 mimic | Oligonucleotides | |
| HY-R01002A | hsa-miR-4320 agomir | Oligonucleotides | |
| HY-R01003 | hsa-miR-4321 mimic | Oligonucleotides | |
| HY-R01003A | hsa-miR-4321 agomir | Oligonucleotides | |
| HY-R01004 | hsa-miR-4322 mimic | Oligonucleotides | |
| HY-R01004A | hsa-miR-4322 agomir | Oligonucleotides | |
| HY-R01005 | hsa-miR-4323 mimic | Oligonucleotides | |
| HY-R01005A | hsa-miR-4323 agomir | Oligonucleotides | |
| HY-R01006 | hsa-miR-432-3p mimic | Oligonucleotides | |
| HY-R01006A | hsa-miR-432-3p agomir | Oligonucleotides | |
| HY-R01007 | hsa-miR-4324 mimic | Oligonucleotides | |
| HY-R01007A | hsa-miR-4324 agomir | Oligonucleotides | |
| HY-R01008 | hsa-miR-4325 mimic | Oligonucleotides | |
| HY-R01008A | hsa-miR-4325 agomir | Oligonucleotides | |
| HY-R01009 | hsa-miR-432-5p mimic | Oligonucleotides | |
| HY-R01009A | hsa-miR-432-5p agomir | Oligonucleotides | |
| HY-R01010 | hsa-miR-4326 mimic | Oligonucleotides | |
| HY-R01010A | hsa-miR-4326 agomir | Oligonucleotides | |
| HY-R01011 | hsa-miR-4327 mimic | Oligonucleotides | |
| HY-R01011A | hsa-miR-4327 agomir | Oligonucleotides | |
| HY-R01012 | hsa-miR-4328 mimic | Oligonucleotides | |
| HY-R01012A | hsa-miR-4328 agomir | Oligonucleotides | |
| HY-R01013 | hsa-miR-4329 mimic | Oligonucleotides | |
| HY-R01013A | hsa-miR-4329 agomir | Oligonucleotides | |
| HY-R01014 | hsa-miR-4330 mimic | Oligonucleotides | |
| HY-R01014A | hsa-miR-4330 agomir | Oligonucleotides | |
| HY-R01015 | hsa-miR-433-3p mimic | Oligonucleotides | |
| HY-R01015A | hsa-miR-433-3p agomir | Oligonucleotides | |
| HY-R01016 | hsa-miR-433-5p mimic | Oligonucleotides | |
| HY-R01016A | hsa-miR-433-5p agomir | Oligonucleotides | |
| HY-R01017 | hsa-miR-4418 mimic | Oligonucleotides | |
| HY-R01017A | hsa-miR-4418 agomir | Oligonucleotides | |
| HY-R01018 | hsa-miR-4420 mimic | Oligonucleotides | |
| HY-R01018A | hsa-miR-4420 agomir | Oligonucleotides | |
| HY-R01019 | hsa-miR-4421 mimic | Oligonucleotides | |
| HY-R01019A | hsa-miR-4421 agomir | Oligonucleotides | |
| HY-R01020 | hsa-miR-4422 mimic | Oligonucleotides | |
| HY-R01020A | hsa-miR-4422 agomir | Oligonucleotides | |
| HY-R01021 | hsa-miR-4423-3p mimic | Oligonucleotides | |
| HY-R01021A | hsa-miR-4423-3p agomir | Oligonucleotides | |
| HY-R01022 | hsa-miR-4423-5p mimic | Oligonucleotides | |
| HY-R01022A | hsa-miR-4423-5p agomir | Oligonucleotides | |
| HY-R01023 | hsa-miR-4424 mimic | Oligonucleotides | |
| HY-R01023A | hsa-miR-4424 agomir | Oligonucleotides | |
| HY-R01024 | hsa-miR-4425 mimic | Oligonucleotides | |
| HY-R01024A | hsa-miR-4425 agomir | Oligonucleotides | |
| HY-R01025 | hsa-miR-4426 mimic | Oligonucleotides | |
| HY-R01025A | hsa-miR-4426 agomir | Oligonucleotides | |
| HY-R01026 | hsa-miR-4427 mimic | Oligonucleotides | |
| HY-R01026A | hsa-miR-4427 agomir | Oligonucleotides | |
| HY-R01027 | hsa-miR-4428 mimic | Oligonucleotides | |
| HY-R01027A | hsa-miR-4428 agomir | Oligonucleotides | |
| HY-R01028 | hsa-miR-4429 mimic | Oligonucleotides | |
| HY-R01028A | hsa-miR-4429 agomir | Oligonucleotides | |
| HY-R01029 | hsa-miR-4430 mimic | Oligonucleotides | |
| HY-R01029A | hsa-miR-4430 agomir | Oligonucleotides | |
| HY-R01030 | hsa-miR-4431 mimic | Oligonucleotides | |
| HY-R01030A | hsa-miR-4431 agomir | Oligonucleotides | |
| HY-R01031 | hsa-miR-4432 mimic | Oligonucleotides | |
| HY-R01031A | hsa-miR-4432 agomir | Oligonucleotides | |
| HY-R01032 | hsa-miR-4433a-3p mimic | Oligonucleotides | |
| HY-R01032A | hsa-miR-4433a-3p agomir | Oligonucleotides | |
| HY-R01033 | hsa-miR-4433a-5p mimic | Oligonucleotides | |
| HY-R01033A | hsa-miR-4433a-5p agomir | Oligonucleotides | |
| HY-R01034 | hsa-miR-4433b-3p mimic | Oligonucleotides | |
| HY-R01034A | hsa-miR-4433b-3p agomir | Oligonucleotides | |
| HY-R01035 | hsa-miR-4433b-5p mimic | Oligonucleotides | |
| HY-R01035A | hsa-miR-4433b-5p agomir | Oligonucleotides | |
| HY-R01036 | hsa-miR-4434 mimic | Oligonucleotides | |
| HY-R01036A | hsa-miR-4434 agomir | Oligonucleotides | |
| HY-R01037 | hsa-miR-4435 mimic | Oligonucleotides | |
| HY-R01037A | hsa-miR-4435 agomir | Oligonucleotides | |
| HY-R01038 | hsa-miR-4436a mimic | Oligonucleotides | |
| HY-R01038A | hsa-miR-4436a agomir | Oligonucleotides | |
| HY-R01039 | hsa-miR-4436b-3p mimic | Oligonucleotides | |
| HY-R01039A | hsa-miR-4436b-3p agomir | Oligonucleotides | |
| HY-R01040 | hsa-miR-4436b-5p mimic | Oligonucleotides | |
| HY-R01040A | hsa-miR-4436b-5p agomir | Oligonucleotides | |
| HY-R01041 | hsa-miR-4437 mimic | Oligonucleotides | |
| HY-R01041A | hsa-miR-4437 agomir | Oligonucleotides | |
| HY-R01042 | hsa-miR-4438 mimic | Oligonucleotides | |
| HY-R01042A | hsa-miR-4438 agomir | Oligonucleotides | |
| HY-R01043 | hsa-miR-4439 mimic | Oligonucleotides | |
| HY-R01043A | hsa-miR-4439 agomir | Oligonucleotides | |
| HY-R01044 | hsa-miR-4440 mimic | Oligonucleotides | |
| HY-R01044A | hsa-miR-4440 agomir | Oligonucleotides | |
| HY-R01045 | hsa-miR-4441 mimic | Oligonucleotides | |
| HY-R01045A | hsa-miR-4441 agomir | Oligonucleotides | |
| HY-R01046 | hsa-miR-4442 mimic | Oligonucleotides | |
| HY-R01046A | hsa-miR-4442 agomir | Oligonucleotides | |
| HY-R01047 | hsa-miR-4443 mimic | Oligonucleotides | |
| HY-R01047A | hsa-miR-4443 agomir | Oligonucleotides | |
| HY-R01048 | hsa-miR-4444 mimic | Oligonucleotides | |
| HY-R01048A | hsa-miR-4444 agomir | Oligonucleotides | |
| HY-R01049 | hsa-miR-4445-3p mimic | Oligonucleotides | |
| HY-R01049A | hsa-miR-4445-3p agomir | Oligonucleotides | |
| HY-R01050 | hsa-miR-4445-5p mimic | Oligonucleotides | |
| HY-R01050A | hsa-miR-4445-5p agomir | Oligonucleotides | |
| HY-R01051 | hsa-miR-4446-3p mimic | Oligonucleotides | |
| HY-R01051A | hsa-miR-4446-3p agomir | Oligonucleotides | |
| HY-R01052 | hsa-miR-4446-5p mimic | Oligonucleotides | |
| HY-R01052A | hsa-miR-4446-5p agomir | Oligonucleotides | |
| HY-R01053 | hsa-miR-4447 mimic | Oligonucleotides | |
| HY-R01053A | hsa-miR-4447 agomir | Oligonucleotides | |
| HY-R01054 | hsa-miR-4448 mimic | Oligonucleotides | |
| HY-R01054A | hsa-miR-4448 agomir | Oligonucleotides | |
| HY-R01055 | hsa-miR-4449 mimic | Oligonucleotides | |
| HY-R01055A | hsa-miR-4449 agomir | Oligonucleotides | |
| HY-R01056 | hsa-miR-4450 mimic | Oligonucleotides | |
| HY-R01056A | hsa-miR-4450 agomir | Oligonucleotides | |
| HY-R01057 | hsa-miR-4451 mimic | Oligonucleotides | |
| HY-R01057A | hsa-miR-4451 agomir | Oligonucleotides | |
| HY-R01058 | hsa-miR-4452 mimic | Oligonucleotides | |
| HY-R01058A | hsa-miR-4452 agomir | Oligonucleotides | |
| HY-R01059 | hsa-miR-4453 mimic | Oligonucleotides | |
| HY-R01059A | hsa-miR-4453 agomir | Oligonucleotides | |
| HY-R01060 | hsa-miR-4454 mimic | Oligonucleotides | |
| HY-R01060A | hsa-miR-4454 agomir | Oligonucleotides | |
| HY-R01061 | hsa-miR-4455 mimic | Oligonucleotides | |
| HY-R01061A | hsa-miR-4455 agomir | Oligonucleotides | |
| HY-R01062 | hsa-miR-4456 mimic | Oligonucleotides | |
| HY-R01062A | hsa-miR-4456 agomir | Oligonucleotides | |
| HY-R01063 | hsa-miR-4457 mimic | Oligonucleotides | |
| HY-R01063A | hsa-miR-4457 agomir | Oligonucleotides | |
| HY-R01064 | hsa-miR-4458 mimic | Oligonucleotides | |
| HY-R01064A | hsa-miR-4458 agomir | Oligonucleotides | |
| HY-R01065 | hsa-miR-4460 mimic | Oligonucleotides | |
| HY-R01065A | hsa-miR-4460 agomir | Oligonucleotides | |
| HY-R01066 | hsa-miR-4462 mimic | Oligonucleotides | |
| HY-R01066A | hsa-miR-4462 agomir | Oligonucleotides | |
| HY-R01067 | hsa-miR-4463 mimic | Oligonucleotides | |
| HY-R01067A | hsa-miR-4463 agomir | Oligonucleotides | |
| HY-R01068 | hsa-miR-4464 mimic | Oligonucleotides | |
| HY-R01068A | hsa-miR-4464 agomir | Oligonucleotides | |
| HY-R01069 | hsa-miR-4465 mimic | Oligonucleotides | |
| HY-R01069A | hsa-miR-4465 agomir | Oligonucleotides | |
| HY-R01070 | hsa-miR-4466 mimic | Oligonucleotides | |
| HY-R01070A | hsa-miR-4466 agomir | Oligonucleotides | |
| HY-R01071 | hsa-miR-4467 mimic | Oligonucleotides | |
| HY-R01071A | hsa-miR-4467 agomir | Oligonucleotides | |
| HY-R01072 | hsa-miR-4468 mimic | Oligonucleotides | |
| HY-R01072A | hsa-miR-4468 agomir | Oligonucleotides | |
| HY-R01073 | hsa-miR-4469 mimic | Oligonucleotides | |
| HY-R01073A | hsa-miR-4469 agomir | Oligonucleotides | |
| HY-R01074 | hsa-miR-4470 mimic | Oligonucleotides | |
| HY-R01074A | hsa-miR-4470 agomir | Oligonucleotides | |
| HY-R01075 | hsa-miR-4471 mimic | Oligonucleotides | |
| HY-R01075A | hsa-miR-4471 agomir | Oligonucleotides | |
| HY-R01076 | hsa-miR-4472 mimic | Oligonucleotides | |
| HY-R01076A | hsa-miR-4472 agomir | Oligonucleotides | |
| HY-R01077 | hsa-miR-4473 mimic | Oligonucleotides | |
| HY-R01077A | hsa-miR-4473 agomir | Oligonucleotides | |
| HY-R01078 | hsa-miR-4474-3p mimic | Oligonucleotides | |
| HY-R01078A | hsa-miR-4474-3p agomir | Oligonucleotides | |
| HY-R01079 | hsa-miR-4474-5p mimic | Oligonucleotides | |
| HY-R01079A | hsa-miR-4474-5p agomir | Oligonucleotides | |
| HY-R01080 | hsa-miR-4475 mimic | Oligonucleotides | |
| HY-R01080A | hsa-miR-4475 agomir | Oligonucleotides | |
| HY-R01081 | hsa-miR-4476 mimic | Oligonucleotides | |
| HY-R01081A | hsa-miR-4476 agomir | Oligonucleotides | |
| HY-R01082 | hsa-miR-4477a mimic | Oligonucleotides | |
| HY-R01082A | hsa-miR-4477a agomir | Oligonucleotides | |
| HY-R01083 | hsa-miR-4477b mimic | Oligonucleotides | |
| HY-R01083A | hsa-miR-4477b agomir | Oligonucleotides | |
| HY-R01084 | hsa-miR-4478 mimic | Oligonucleotides | |
| HY-R01084A | hsa-miR-4478 agomir | Oligonucleotides | |
| HY-R01085 | hsa-miR-4479 mimic | Oligonucleotides | |
| HY-R01085A | hsa-miR-4479 agomir | Oligonucleotides | |
| HY-R01086 | hsa-miR-448 mimic | Oligonucleotides | |
| HY-R01086A | hsa-miR-448 agomir | Oligonucleotides | |
| HY-R01087 | hsa-miR-4480 mimic | Oligonucleotides | |
| HY-R01087A | hsa-miR-4480 agomir | Oligonucleotides | |
| HY-R01088 | hsa-miR-4481 mimic | Oligonucleotides | |
| HY-R01088A | hsa-miR-4481 agomir | Oligonucleotides | |
| HY-R01089 | hsa-miR-4482-3p mimic | Oligonucleotides | |
| HY-R01089A | hsa-miR-4482-3p agomir | Oligonucleotides | |
| HY-R01090 | hsa-miR-4482-5p mimic | Oligonucleotides | |
| HY-R01090A | hsa-miR-4482-5p agomir | Oligonucleotides | |
| HY-R01091 | hsa-miR-4483 mimic | Oligonucleotides | |
| HY-R01091A | hsa-miR-4483 agomir | Oligonucleotides | |
| HY-R01092 | hsa-miR-4484 mimic | Oligonucleotides | |
| HY-R01092A | hsa-miR-4484 agomir | Oligonucleotides | |
| HY-R01093 | hsa-miR-4485-3p mimic | Oligonucleotides | |
| HY-R01093A | hsa-miR-4485-3p agomir | Oligonucleotides | |
| HY-R01094 | hsa-miR-4485-5p mimic | Oligonucleotides | |
| HY-R01094A | hsa-miR-4485-5p agomir | Oligonucleotides | |
| HY-R01095 | hsa-miR-4486 mimic | Oligonucleotides | |
| HY-R01095A | hsa-miR-4486 agomir | Oligonucleotides | |
| HY-R01096 | hsa-miR-4487 mimic | Oligonucleotides | |
| HY-R01096A | hsa-miR-4487 agomir | Oligonucleotides | |
| HY-R01097 | hsa-miR-4488 mimic | Oligonucleotides | |
| HY-R01097A | hsa-miR-4488 agomir | Oligonucleotides | |
| HY-R01098 | hsa-miR-4489 mimic | Oligonucleotides | |
| HY-R01098A | hsa-miR-4489 agomir | Oligonucleotides | |
| HY-R01099 | hsa-miR-4490 mimic | Oligonucleotides | |
| HY-R01099A | hsa-miR-4490 agomir | Oligonucleotides | |
| HY-R01100 | hsa-miR-4491 mimic | Oligonucleotides | |
| HY-R01100A | hsa-miR-4491 agomir | Oligonucleotides | |
| HY-R01101 | hsa-miR-4492 mimic | Oligonucleotides | |
| HY-R01101A | hsa-miR-4492 agomir | Oligonucleotides | |
| HY-R01102 | hsa-miR-4493 mimic | Oligonucleotides | |
| HY-R01102A | hsa-miR-4493 agomir | Oligonucleotides | |
| HY-R01103 | hsa-miR-4494 mimic | Oligonucleotides | |
| HY-R01103A | hsa-miR-4494 agomir | Oligonucleotides | |
| HY-R01104 | hsa-miR-4495 mimic | Oligonucleotides | |
| HY-R01104A | hsa-miR-4495 agomir | Oligonucleotides | |
| HY-R01105 | hsa-miR-4496 mimic | Oligonucleotides | |
| HY-R01105A | hsa-miR-4496 agomir | Oligonucleotides | |
| HY-R01106 | hsa-miR-4497 mimic | Oligonucleotides | |
| HY-R01106A | hsa-miR-4497 agomir | Oligonucleotides | |
| HY-R01107 | hsa-miR-4498 mimic | Oligonucleotides | |
| HY-R01107A | hsa-miR-4498 agomir | Oligonucleotides | |
| HY-R01108 | hsa-miR-4499 mimic | Oligonucleotides | |
| HY-R01108A | hsa-miR-4499 agomir | Oligonucleotides | |
| HY-R01109 | hsa-miR-449a mimic | Oligonucleotides | |
| HY-R01109A | hsa-miR-449a agomir | Oligonucleotides | |
| HY-R01110 | hsa-miR-449b-3p mimic | Oligonucleotides | |
| HY-R01110A | hsa-miR-449b-3p agomir | Oligonucleotides | |
| HY-R01111 | hsa-miR-449b-5p mimic | Oligonucleotides | |
| HY-R01111A | hsa-miR-449b-5p agomir | Oligonucleotides | |
| HY-R01112 | hsa-miR-449c-3p mimic | Oligonucleotides | |
| HY-R01112A | hsa-miR-449c-3p agomir | Oligonucleotides | |
| HY-R01113 | hsa-miR-449c-5p mimic | Oligonucleotides | |
| HY-R01113A | hsa-miR-449c-5p agomir | Oligonucleotides | |
| HY-R01114 | hsa-miR-4500 mimic | Oligonucleotides | |
| HY-R01114A | hsa-miR-4500 agomir | Oligonucleotides | |
| HY-R01115 | hsa-miR-4501 mimic | Oligonucleotides | |
| HY-R01115A | hsa-miR-4501 agomir | Oligonucleotides | |
| HY-R01116 | hsa-miR-4502 mimic | Oligonucleotides | |
| HY-R01116A | hsa-miR-4502 agomir | Oligonucleotides | |
| HY-R01117 | hsa-miR-4503 mimic | Oligonucleotides | |
| HY-R01117A | hsa-miR-4503 agomir | Oligonucleotides | |
| HY-R01118 | hsa-miR-4504 mimic | Oligonucleotides | |
| HY-R01118A | hsa-miR-4504 agomir | Oligonucleotides | |
| HY-R01119 | hsa-miR-4505 mimic | Oligonucleotides | |
| HY-R01119A | hsa-miR-4505 agomir | Oligonucleotides | |
| HY-R01120 | hsa-miR-4506 mimic | Oligonucleotides | |
| HY-R01120A | hsa-miR-4506 agomir | Oligonucleotides | |
| HY-R01121 | hsa-miR-4507 mimic | Oligonucleotides | |
| HY-R01121A | hsa-miR-4507 agomir | Oligonucleotides | |
| HY-R01122 | hsa-miR-4508 mimic | Oligonucleotides | |
| HY-R01122A | hsa-miR-4508 agomir | Oligonucleotides | |
| HY-R01123 | hsa-miR-4509 mimic | Oligonucleotides | |
| HY-R01123A | hsa-miR-4509 agomir | Oligonucleotides | |
| HY-R01124 | hsa-miR-450a-1-3p mimic | Oligonucleotides | |
| HY-R01124A | hsa-miR-450a-1-3p agomir | Oligonucleotides | |
| HY-R01125 | hsa-miR-450a-2-3p mimic | Oligonucleotides | |
| HY-R01125A | hsa-miR-450a-2-3p agomir | Oligonucleotides | |
| HY-R01126 | hsa-miR-450a-5p mimic | Oligonucleotides | |
| HY-R01126A | hsa-miR-450a-5p agomir | Oligonucleotides | |
| HY-R01127 | hsa-miR-450b-3p mimic | Oligonucleotides | |
| HY-R01127A | hsa-miR-450b-3p agomir | Oligonucleotides | |
| HY-R01128 | hsa-miR-450b-5p mimic | Oligonucleotides | |
| HY-R01128A | hsa-miR-450b-5p agomir | Oligonucleotides | |
| HY-R01129 | hsa-miR-4510 mimic | Oligonucleotides | |
| HY-R01129A | hsa-miR-4510 agomir | Oligonucleotides | |
| HY-R01130 | hsa-miR-4511 mimic | Oligonucleotides | |
| HY-R01130A | hsa-miR-4511 agomir | Oligonucleotides | |
| HY-R01131 | hsa-miR-4512 mimic | Oligonucleotides | |
| HY-R01131A | hsa-miR-4512 agomir | Oligonucleotides | |
| HY-R01132 | hsa-miR-4513 mimic | Oligonucleotides | |
| HY-R01132A | hsa-miR-4513 agomir | Oligonucleotides | |
| HY-R01133 | hsa-miR-4514 mimic | Oligonucleotides | |
| HY-R01133A | hsa-miR-4514 agomir | Oligonucleotides | |
| HY-R01134 | hsa-miR-4515 mimic | Oligonucleotides | |
| HY-R01134A | hsa-miR-4515 agomir | Oligonucleotides | |
| HY-R01135 | hsa-miR-4516 mimic | Oligonucleotides | |
| HY-R01135A | hsa-miR-4516 agomir | Oligonucleotides | |
| HY-R01136 | hsa-miR-4517 mimic | Oligonucleotides | |
| HY-R01136A | hsa-miR-4517 agomir | Oligonucleotides | |
| HY-R01137 | hsa-miR-4518 mimic | Oligonucleotides | |
| HY-R01137A | hsa-miR-4518 agomir | Oligonucleotides | |
| HY-R01138 | hsa-miR-4519 mimic | Oligonucleotides | |
| HY-R01138A | hsa-miR-4519 agomir | Oligonucleotides | |
| HY-R01139 | hsa-miR-451a mimic | Oligonucleotides | |
| HY-R01139A | hsa-miR-451a agomir | Oligonucleotides | |
| HY-R01140 | hsa-miR-451b mimic | Oligonucleotides | |
| HY-R01140A | hsa-miR-451b agomir | Oligonucleotides | |
| HY-R01141 | hsa-miR-4520-2-3p mimic | Oligonucleotides | |
| HY-R01141A | hsa-miR-4520-2-3p agomir | Oligonucleotides | |
| HY-R01142 | hsa-miR-4520-3p mimic | Oligonucleotides | |
| HY-R01142A | hsa-miR-4520-3p agomir | Oligonucleotides | |
| HY-R01143 | hsa-miR-4520-5p mimic | Oligonucleotides | |
| HY-R01143A | hsa-miR-4520-5p agomir | Oligonucleotides | |
| HY-R01144 | hsa-miR-4521 mimic | Oligonucleotides | |
| HY-R01144A | hsa-miR-4521 agomir | Oligonucleotides | |
| HY-R01145 | hsa-miR-4522 mimic | Oligonucleotides | |
| HY-R01145A | hsa-miR-4522 agomir | Oligonucleotides | |
| HY-R01146 | hsa-miR-4523 mimic | Oligonucleotides | |
| HY-R01146A | hsa-miR-4523 agomir | Oligonucleotides | |
| HY-R01147 | hsa-miR-452-3p mimic | Oligonucleotides | |
| HY-R01147A | hsa-miR-452-3p agomir | Oligonucleotides | |
| HY-R01148 | hsa-miR-4524a-3p mimic | Oligonucleotides | |
| HY-R01148A | hsa-miR-4524a-3p agomir | Oligonucleotides | |
| HY-R01149 | hsa-miR-4524a-5p mimic | Oligonucleotides | |
| HY-R01149A | hsa-miR-4524a-5p agomir | Oligonucleotides | |
| HY-R01150 | hsa-miR-4524b-3p mimic | Oligonucleotides | |
| HY-R01150A | hsa-miR-4524b-3p agomir | Oligonucleotides | |
| HY-R01151 | hsa-miR-4524b-5p mimic | Oligonucleotides | |
| HY-R01151A | hsa-miR-4524b-5p agomir | Oligonucleotides | |
| HY-R01152 | hsa-miR-4525 mimic | Oligonucleotides | |
| HY-R01152A | hsa-miR-4525 agomir | Oligonucleotides | |
| HY-R01153 | hsa-miR-4526 mimic | Oligonucleotides | |
| HY-R01153A | hsa-miR-4526 agomir | Oligonucleotides | |
| HY-R01154 | hsa-miR-4527 mimic | Oligonucleotides | |
| HY-R01154A | hsa-miR-4527 agomir | Oligonucleotides | |
| HY-R01155 | hsa-miR-4528 mimic | Oligonucleotides | |
| HY-R01155A | hsa-miR-4528 agomir | Oligonucleotides | |
| HY-R01156 | hsa-miR-4529-3p mimic | Oligonucleotides | |
| HY-R01156A | hsa-miR-4529-3p agomir | Oligonucleotides | |
| HY-R01157 | hsa-miR-4529-5p mimic | Oligonucleotides | |
| HY-R01157A | hsa-miR-4529-5p agomir | Oligonucleotides | |
| HY-R01158 | hsa-miR-4530 mimic | Oligonucleotides | |
| HY-R01158A | hsa-miR-4530 agomir | Oligonucleotides | |
| HY-R01159 | hsa-miR-4531 mimic | Oligonucleotides | |
| HY-R01159A | hsa-miR-4531 agomir | Oligonucleotides | |
| HY-R01160 | hsa-miR-4533 mimic | Oligonucleotides | |
| HY-R01160A | hsa-miR-4533 agomir | Oligonucleotides | |
| HY-R01161 | hsa-miR-4534 mimic | Oligonucleotides | |
| HY-R01161A | hsa-miR-4534 agomir | Oligonucleotides | |
| HY-R01162 | hsa-miR-4535 mimic | Oligonucleotides | |
| HY-R01162A | hsa-miR-4535 agomir | Oligonucleotides | |
| HY-R01163 | hsa-miR-4536-3p mimic | Oligonucleotides | |
| HY-R01163A | hsa-miR-4536-3p agomir | Oligonucleotides | |
| HY-R01164 | hsa-miR-4536-5p mimic | Oligonucleotides | |
| HY-R01164A | hsa-miR-4536-5p agomir | Oligonucleotides | |
| HY-R01165 | hsa-miR-4537 mimic | Oligonucleotides | |
| HY-R01165A | hsa-miR-4537 agomir | Oligonucleotides | |
| HY-R01166 | hsa-miR-4538 mimic | Oligonucleotides | |
| HY-R01166A | hsa-miR-4538 agomir | Oligonucleotides | |
| HY-R01167 | hsa-miR-4539 mimic | Oligonucleotides | |
| HY-R01167A | hsa-miR-4539 agomir | Oligonucleotides | |
| HY-R01168 | hsa-miR-4540 mimic | Oligonucleotides | |
| HY-R01168A | hsa-miR-4540 agomir | Oligonucleotides | |
| HY-R01169 | hsa-miR-454-3p mimic | Oligonucleotides | |
| HY-R01169A | hsa-miR-454-3p agomir | Oligonucleotides | |
| HY-R01170 | hsa-miR-454-5p mimic | Oligonucleotides | |
| HY-R01170A | hsa-miR-454-5p agomir | Oligonucleotides | |
| HY-R01171 | hsa-miR-455-5p mimic | Oligonucleotides | |
| HY-R01171A | hsa-miR-455-5p agomir | Oligonucleotides | |
| HY-R01172 | hsa-miR-4632-3p mimic | Oligonucleotides | |
| HY-R01172A | hsa-miR-4632-3p agomir | Oligonucleotides | |
| HY-R01173 | hsa-miR-4632-5p mimic | Oligonucleotides | |
| HY-R01173A | hsa-miR-4632-5p agomir | Oligonucleotides | |
| HY-R01174 | hsa-miR-4633-3p mimic | Oligonucleotides | |
| HY-R01174A | hsa-miR-4633-3p agomir | Oligonucleotides | |
| HY-R01175 | hsa-miR-4633-5p mimic | Oligonucleotides | |
| HY-R01175A | hsa-miR-4633-5p agomir | Oligonucleotides | |
| HY-R01176 | hsa-miR-4634 mimic | Oligonucleotides | |
| HY-R01176A | hsa-miR-4634 agomir | Oligonucleotides | |
| HY-R01177 | hsa-miR-4635 mimic | Oligonucleotides | |
| HY-R01177A | hsa-miR-4635 agomir | Oligonucleotides | |
| HY-R01178 | hsa-miR-4636 mimic | Oligonucleotides | |
| HY-R01178A | hsa-miR-4636 agomir | Oligonucleotides | |
| HY-R01179 | hsa-miR-4637 mimic | Oligonucleotides | |
| HY-R01179A | hsa-miR-4637 agomir | Oligonucleotides | |
| HY-R01180 | hsa-miR-4638-3p mimic | Oligonucleotides | |
| HY-R01180A | hsa-miR-4638-3p agomir | Oligonucleotides | |
| HY-R01181 | hsa-miR-4638-5p mimic | Oligonucleotides | |
| HY-R01181A | hsa-miR-4638-5p agomir | Oligonucleotides | |
| HY-R01182 | hsa-miR-4639-3p mimic | Oligonucleotides | |
| HY-R01182A | hsa-miR-4639-3p agomir | Oligonucleotides | |
| HY-R01183 | hsa-miR-4639-5p mimic | Oligonucleotides | |
| HY-R01183A | hsa-miR-4639-5p agomir | Oligonucleotides | |
| HY-R01184 | hsa-miR-4640-3p mimic | Oligonucleotides | |
| HY-R01184A | hsa-miR-4640-3p agomir | Oligonucleotides | |
| HY-R01185 | hsa-miR-4640-5p mimic | Oligonucleotides | |
| HY-R01185A | hsa-miR-4640-5p agomir | Oligonucleotides | |
| HY-R01186 | hsa-miR-4641 mimic | Oligonucleotides | |
| HY-R01186A | hsa-miR-4641 agomir | Oligonucleotides | |
| HY-R01187 | hsa-miR-4642 mimic | Oligonucleotides | |
| HY-R01187A | hsa-miR-4642 agomir | Oligonucleotides | |
| HY-R01188 | hsa-miR-4643 mimic | Oligonucleotides | |
| HY-R01188A | hsa-miR-4643 agomir | Oligonucleotides | |
| HY-R01189 | hsa-miR-4644 mimic | Oligonucleotides | |
| HY-R01189A | hsa-miR-4644 agomir | Oligonucleotides | |
| HY-R01190 | hsa-miR-4645-3p mimic | Oligonucleotides | |
| HY-R01190A | hsa-miR-4645-3p agomir | Oligonucleotides | |
| HY-R01191 | hsa-miR-4645-5p mimic | Oligonucleotides | |
| HY-R01191A | hsa-miR-4645-5p agomir | Oligonucleotides | |
| HY-R01192 | hsa-miR-4646-3p mimic | Oligonucleotides | |
| HY-R01192A | hsa-miR-4646-3p agomir | Oligonucleotides | |
| HY-R01193 | hsa-miR-4646-5p mimic | Oligonucleotides | |
| HY-R01193A | hsa-miR-4646-5p agomir | Oligonucleotides | |
| HY-R01194 | hsa-miR-4647 mimic | Oligonucleotides | |
| HY-R01194A | hsa-miR-4647 agomir | Oligonucleotides | |
| HY-R01195 | hsa-miR-4648 mimic | Oligonucleotides | |
| HY-R01195A | hsa-miR-4648 agomir | Oligonucleotides | |
| HY-R01196 | hsa-miR-4649-3p mimic | Oligonucleotides | |
| HY-R01196A | hsa-miR-4649-3p agomir | Oligonucleotides | |
| HY-R01197 | hsa-miR-4649-5p mimic | Oligonucleotides | |
| HY-R01197A | hsa-miR-4649-5p agomir | Oligonucleotides | |
| HY-R01198 | hsa-miR-4650-3p mimic | Oligonucleotides | |
| HY-R01198A | hsa-miR-4650-3p agomir | Oligonucleotides | |
| HY-R01199 | hsa-miR-4650-5p mimic | Oligonucleotides | |
| HY-R01199A | hsa-miR-4650-5p agomir | Oligonucleotides | |
| HY-R01200 | hsa-miR-4651 mimic | Oligonucleotides | |
| HY-R01200A | hsa-miR-4651 agomir | Oligonucleotides | |
| HY-R01201 | hsa-miR-4652-3p mimic | Oligonucleotides | |
| HY-R01201A | hsa-miR-4652-3p agomir | Oligonucleotides | |
| HY-R01202 | hsa-miR-4652-5p mimic | Oligonucleotides | |
| HY-R01202A | hsa-miR-4652-5p agomir | Oligonucleotides | |
| HY-R01203 | hsa-miR-4653-3p mimic | Oligonucleotides | |
| HY-R01203A | hsa-miR-4653-3p agomir | Oligonucleotides | |
| HY-R01204 | hsa-miR-4653-5p mimic | Oligonucleotides | |
| HY-R01204A | hsa-miR-4653-5p agomir | Oligonucleotides | |
| HY-R01205 | hsa-miR-4654 mimic | Oligonucleotides | |
| HY-R01205A | hsa-miR-4654 agomir | Oligonucleotides | |
| HY-R01206 | hsa-miR-4655-3p mimic | Oligonucleotides | |
| HY-R01206A | hsa-miR-4655-3p agomir | Oligonucleotides | |
| HY-R01207 | hsa-miR-4655-5p mimic | Oligonucleotides | |
| HY-R01207A | hsa-miR-4655-5p agomir | Oligonucleotides | |
| HY-R01208 | hsa-miR-4656 mimic | Oligonucleotides | |
| HY-R01208A | hsa-miR-4656 agomir | Oligonucleotides | |
| HY-R01209 | hsa-miR-4657 mimic | Oligonucleotides | |
| HY-R01209A | hsa-miR-4657 agomir | Oligonucleotides | |
| HY-R01210 | hsa-miR-4658 mimic | Oligonucleotides | |
| HY-R01210A | hsa-miR-4658 agomir | Oligonucleotides | |
| HY-R01211 | hsa-miR-4659a-3p mimic | Oligonucleotides | |
| HY-R01211A | hsa-miR-4659a-3p agomir | Oligonucleotides | |
| HY-R01212 | hsa-miR-4659a-5p mimic | Oligonucleotides | |
| HY-R01212A | hsa-miR-4659a-5p agomir | Oligonucleotides | |
| HY-R01213 | hsa-miR-4659b-3p mimic | Oligonucleotides | |
| HY-R01213A | hsa-miR-4659b-3p agomir | Oligonucleotides | |
| HY-R01214 | hsa-miR-4659b-5p mimic | Oligonucleotides | |
| HY-R01214A | hsa-miR-4659b-5p agomir | Oligonucleotides | |
| HY-R01215 | hsa-miR-466 mimic | Oligonucleotides | |
| HY-R01215A | hsa-miR-466 agomir | Oligonucleotides | |
| HY-R01216 | hsa-miR-4660 mimic | Oligonucleotides | |
| HY-R01216A | hsa-miR-4660 agomir | Oligonucleotides | |
| HY-R01217 | hsa-miR-4661-3p mimic | Oligonucleotides | |
| HY-R01217A | hsa-miR-4661-3p agomir | Oligonucleotides | |
| HY-R01218 | hsa-miR-4661-5p mimic | Oligonucleotides | |
| HY-R01218A | hsa-miR-4661-5p agomir | Oligonucleotides | |
| HY-R01219 | hsa-miR-4662a-3p mimic | Oligonucleotides | |
| HY-R01219A | hsa-miR-4662a-3p agomir | Oligonucleotides | |
| HY-R01220 | hsa-miR-4662a-5p mimic | Oligonucleotides | |
| HY-R01220A | hsa-miR-4662a-5p agomir | Oligonucleotides | |
| HY-R01221 | hsa-miR-4662b mimic | Oligonucleotides | |
| HY-R01221A | hsa-miR-4662b agomir | Oligonucleotides | |
| HY-R01222 | hsa-miR-4663 mimic | Oligonucleotides | |
| HY-R01222A | hsa-miR-4663 agomir | Oligonucleotides | |
| HY-R01223 | hsa-miR-4664-3p mimic | Oligonucleotides | |
| HY-R01223A | hsa-miR-4664-3p agomir | Oligonucleotides | |
| HY-R01224 | hsa-miR-4664-5p mimic | Oligonucleotides | |
| HY-R01224A | hsa-miR-4664-5p agomir | Oligonucleotides | |
| HY-R01225 | hsa-miR-4665-3p mimic | Oligonucleotides | |
| HY-R01225A | hsa-miR-4665-3p agomir | Oligonucleotides | |
| HY-R01226 | hsa-miR-4665-5p mimic | Oligonucleotides | |
| HY-R01226A | hsa-miR-4665-5p agomir | Oligonucleotides | |
| HY-R01227 | hsa-miR-4666a-3p mimic | Oligonucleotides | |
| HY-R01227A | hsa-miR-4666a-3p agomir | Oligonucleotides | |
| HY-R01228 | hsa-miR-4666a-5p mimic | Oligonucleotides | |
| HY-R01228A | hsa-miR-4666a-5p agomir | Oligonucleotides | |
| HY-R01229 | hsa-miR-4666b mimic | Oligonucleotides | |
| HY-R01229A | hsa-miR-4666b agomir | Oligonucleotides | |
| HY-R01230 | hsa-miR-4667-3p mimic | Oligonucleotides | |
| HY-R01230A | hsa-miR-4667-3p agomir | Oligonucleotides | |
| HY-R01231 | hsa-miR-4667-5p mimic | Oligonucleotides | |
| HY-R01231A | hsa-miR-4667-5p agomir | Oligonucleotides | |
| HY-R01232 | hsa-miR-4668-3p mimic | Oligonucleotides | |
| HY-R01232A | hsa-miR-4668-3p agomir | Oligonucleotides | |
| HY-R01233 | hsa-miR-4668-5p mimic | Oligonucleotides | |
| HY-R01233A | hsa-miR-4668-5p agomir | Oligonucleotides | |
| HY-R01234 | hsa-miR-4669 mimic | Oligonucleotides | |
| HY-R01234A | hsa-miR-4669 agomir | Oligonucleotides | |
| HY-R01235 | hsa-miR-4670-3p mimic | Oligonucleotides | |
| HY-R01235A | hsa-miR-4670-3p agomir | Oligonucleotides | |
| HY-R01236 | hsa-miR-4670-5p mimic | Oligonucleotides | |
| HY-R01236A | hsa-miR-4670-5p agomir | Oligonucleotides | |
| HY-R01237 | hsa-miR-4671-3p mimic | Oligonucleotides | |
| HY-R01237A | hsa-miR-4671-3p agomir | Oligonucleotides | |
| HY-R01238 | hsa-miR-4671-5p mimic | Oligonucleotides | |
| HY-R01238A | hsa-miR-4671-5p agomir | Oligonucleotides | |
| HY-R01239 | hsa-miR-4672 mimic | Oligonucleotides | |
| HY-R01239A | hsa-miR-4672 agomir | Oligonucleotides | |
| HY-R01240 | hsa-miR-4673 mimic | Oligonucleotides | |
| HY-R01240A | hsa-miR-4673 agomir | Oligonucleotides | |
| HY-R01241 | hsa-miR-4674 mimic | Oligonucleotides | |
| HY-R01241A | hsa-miR-4674 agomir | Oligonucleotides | |
| HY-R01242 | hsa-miR-4675 mimic | Oligonucleotides | |
| HY-R01242A | hsa-miR-4675 agomir | Oligonucleotides | |
| HY-R01243 | hsa-miR-4676-3p mimic | Oligonucleotides | |
| HY-R01243A | hsa-miR-4676-3p agomir | Oligonucleotides | |
| HY-R01244 | hsa-miR-4676-5p mimic | Oligonucleotides | |
| HY-R01244A | hsa-miR-4676-5p agomir | Oligonucleotides | |
| HY-R01245 | hsa-miR-4677-3p mimic | Oligonucleotides | |
| HY-R01245A | hsa-miR-4677-3p agomir | Oligonucleotides | |
| HY-R01246 | hsa-miR-4677-5p mimic | Oligonucleotides | |
| HY-R01246A | hsa-miR-4677-5p agomir | Oligonucleotides | |
| HY-R01247 | hsa-miR-4678 mimic | Oligonucleotides | |
| HY-R01247A | hsa-miR-4678 agomir | Oligonucleotides | |
| HY-R01248 | hsa-miR-4679 mimic | Oligonucleotides | |
| HY-R01248A | hsa-miR-4679 agomir | Oligonucleotides | |
| HY-R01249 | hsa-miR-4680-3p mimic | Oligonucleotides | |
| HY-R01249A | hsa-miR-4680-3p agomir | Oligonucleotides | |
| HY-R01250 | hsa-miR-4680-5p mimic | Oligonucleotides | |
| HY-R01250A | hsa-miR-4680-5p agomir | Oligonucleotides | |
| HY-R01251 | hsa-miR-4681 mimic | Oligonucleotides | |
| HY-R01251A | hsa-miR-4681 agomir | Oligonucleotides | |
| HY-R01252 | hsa-miR-4682 mimic | Oligonucleotides | |
| HY-R01252A | hsa-miR-4682 agomir | Oligonucleotides | |
| HY-R01253 | hsa-miR-4683 mimic | Oligonucleotides | |
| HY-R01253A | hsa-miR-4683 agomir | Oligonucleotides | |
| HY-R01254 | hsa-miR-4684-3p mimic | Oligonucleotides | |
| HY-R01254A | hsa-miR-4684-3p agomir | Oligonucleotides | |
| HY-R01255 | hsa-miR-4684-5p mimic | Oligonucleotides | |
| HY-R01255A | hsa-miR-4684-5p agomir | Oligonucleotides | |
| HY-R01256 | hsa-miR-4685-3p mimic | Oligonucleotides | |
| HY-R01256A | hsa-miR-4685-3p agomir | Oligonucleotides | |
| HY-R01257 | hsa-miR-4685-5p mimic | Oligonucleotides | |
| HY-R01257A | hsa-miR-4685-5p agomir | Oligonucleotides | |
| HY-R01258 | hsa-miR-4686 mimic | Oligonucleotides | |
| HY-R01258A | hsa-miR-4686 agomir | Oligonucleotides | |
| HY-R01259 | hsa-miR-4687-3p mimic | Oligonucleotides | |
| HY-R01259A | hsa-miR-4687-3p agomir | Oligonucleotides | |
| HY-R01260 | hsa-miR-4687-5p mimic | Oligonucleotides | |
| HY-R01260A | hsa-miR-4687-5p agomir | Oligonucleotides | |
| HY-R01261 | hsa-miR-4688 mimic | Oligonucleotides | |
| HY-R01261A | hsa-miR-4688 agomir | Oligonucleotides | |
| HY-R01262 | hsa-miR-4689 mimic | Oligonucleotides | |
| HY-R01262A | hsa-miR-4689 agomir | Oligonucleotides | |
| HY-R01263 | hsa-miR-4690-3p mimic | Oligonucleotides | |
| HY-R01263A | hsa-miR-4690-3p agomir | Oligonucleotides | |
| HY-R01264 | hsa-miR-4690-5p mimic | Oligonucleotides | |
| HY-R01264A | hsa-miR-4690-5p agomir | Oligonucleotides | |
| HY-R01265 | hsa-miR-4691-3p mimic | Oligonucleotides | |
| HY-R01265A | hsa-miR-4691-3p agomir | Oligonucleotides | |
| HY-R01266 | hsa-miR-4691-5p mimic | Oligonucleotides | |
| HY-R01266A | hsa-miR-4691-5p agomir | Oligonucleotides | |
| HY-R01267 | hsa-miR-4692 mimic | Oligonucleotides | |
| HY-R01267A | hsa-miR-4692 agomir | Oligonucleotides | |
| HY-R01268 | hsa-miR-4693-3p mimic | Oligonucleotides | |
| HY-R01268A | hsa-miR-4693-3p agomir | Oligonucleotides | |
| HY-R01269 | hsa-miR-4693-5p mimic | Oligonucleotides | |
| HY-R01269A | hsa-miR-4693-5p agomir | Oligonucleotides | |
| HY-R01270 | hsa-miR-4694-3p mimic | Oligonucleotides | |
| HY-R01270A | hsa-miR-4694-3p agomir | Oligonucleotides | |
| HY-R01271 | hsa-miR-4694-5p mimic | Oligonucleotides | |
| HY-R01271A | hsa-miR-4694-5p agomir | Oligonucleotides | |
| HY-R01272 | hsa-miR-4695-3p mimic | Oligonucleotides | |
| HY-R01272A | hsa-miR-4695-3p agomir | Oligonucleotides | |
| HY-R01273 | hsa-miR-4695-5p mimic | Oligonucleotides | |
| HY-R01273A | hsa-miR-4695-5p agomir | Oligonucleotides | |
| HY-R01274 | hsa-miR-4696 mimic | Oligonucleotides | |
| HY-R01274A | hsa-miR-4696 agomir | Oligonucleotides | |
| HY-R01275 | hsa-miR-4697-3p mimic | Oligonucleotides | |
| HY-R01275A | hsa-miR-4697-3p agomir | Oligonucleotides | |
| HY-R01276 | hsa-miR-4697-5p mimic | Oligonucleotides | |
| HY-R01276A | hsa-miR-4697-5p agomir | Oligonucleotides | |
| HY-R01277 | hsa-miR-4698 mimic | Oligonucleotides | |
| HY-R01277A | hsa-miR-4698 agomir | Oligonucleotides | |
| HY-R01278 | hsa-miR-4699-3p mimic | Oligonucleotides | |
| HY-R01278A | hsa-miR-4699-3p agomir | Oligonucleotides | |
| HY-R01279 | hsa-miR-4699-5p mimic | Oligonucleotides | |
| HY-R01279A | hsa-miR-4699-5p agomir | Oligonucleotides | |
| HY-R01280 | hsa-miR-4700-3p mimic | Oligonucleotides | |
| HY-R01280A | hsa-miR-4700-3p agomir | Oligonucleotides | |
| HY-R01281 | hsa-miR-4700-5p mimic | Oligonucleotides | |
| HY-R01281A | hsa-miR-4700-5p agomir | Oligonucleotides | |
| HY-R01282 | hsa-miR-4701-3p mimic | Oligonucleotides | |
| HY-R01282A | hsa-miR-4701-3p agomir | Oligonucleotides | |
| HY-R01283 | hsa-miR-4701-5p mimic | Oligonucleotides | |
| HY-R01283A | hsa-miR-4701-5p agomir | Oligonucleotides | |
| HY-R01284 | hsa-miR-4703-3p mimic | Oligonucleotides | |
| HY-R01284A | hsa-miR-4703-3p agomir | Oligonucleotides | |
| HY-R01285 | hsa-miR-4703-5p mimic | Oligonucleotides | |
| HY-R01285A | hsa-miR-4703-5p agomir | Oligonucleotides | |
| HY-R01286 | hsa-miR-4704-3p mimic | Oligonucleotides | |
| HY-R01286A | hsa-miR-4704-3p agomir | Oligonucleotides | |
| HY-R01287 | hsa-miR-4704-5p mimic | Oligonucleotides | |
| HY-R01287A | hsa-miR-4704-5p agomir | Oligonucleotides | |
| HY-R01288 | hsa-miR-4705 mimic | Oligonucleotides | |
| HY-R01288A | hsa-miR-4705 agomir | Oligonucleotides | |
| HY-R01289 | hsa-miR-4706 mimic | Oligonucleotides | |
| HY-R01289A | hsa-miR-4706 agomir | Oligonucleotides | |
| HY-R01290 | hsa-miR-4707-3p mimic | Oligonucleotides | |
| HY-R01290A | hsa-miR-4707-3p agomir | Oligonucleotides | |
| HY-R01291 | hsa-miR-4707-5p mimic | Oligonucleotides | |
| HY-R01291A | hsa-miR-4707-5p agomir | Oligonucleotides | |
| HY-R01292 | hsa-miR-4708-3p mimic | Oligonucleotides | |
| HY-R01292A | hsa-miR-4708-3p agomir | Oligonucleotides | |
| HY-R01293 | hsa-miR-4708-5p mimic | Oligonucleotides | |
| HY-R01293A | hsa-miR-4708-5p agomir | Oligonucleotides | |
| HY-R01294 | hsa-miR-4709-3p mimic | Oligonucleotides | |
| HY-R01294A | hsa-miR-4709-3p agomir | Oligonucleotides | |
| HY-R01295 | hsa-miR-4709-5p mimic | Oligonucleotides | |
| HY-R01295A | hsa-miR-4709-5p agomir | Oligonucleotides | |
| HY-R01296 | hsa-miR-4710 mimic | Oligonucleotides | |
| HY-R01296A | hsa-miR-4710 agomir | Oligonucleotides | |
| HY-R01297 | hsa-miR-4711-3p mimic | Oligonucleotides | |
| HY-R01297A | hsa-miR-4711-3p agomir | Oligonucleotides | |
| HY-R01298 | hsa-miR-4711-5p mimic | Oligonucleotides | |
| HY-R01298A | hsa-miR-4711-5p agomir | Oligonucleotides | |
| HY-R01299 | hsa-miR-4712-3p mimic | Oligonucleotides | |
| HY-R01299A | hsa-miR-4712-3p agomir | Oligonucleotides | |
| HY-R01300 | hsa-miR-4712-5p mimic | Oligonucleotides | |
| HY-R01300A | hsa-miR-4712-5p agomir | Oligonucleotides | |
| HY-R01301 | hsa-miR-4713-3p mimic | Oligonucleotides | |
| HY-R01301A | hsa-miR-4713-3p agomir | Oligonucleotides | |
| HY-R01302 | hsa-miR-4713-5p mimic | Oligonucleotides | |
| HY-R01302A | hsa-miR-4713-5p agomir | Oligonucleotides | |
| HY-R01303 | hsa-miR-4714-3p mimic | Oligonucleotides | |
| HY-R01303A | hsa-miR-4714-3p agomir | Oligonucleotides | |
| HY-R01304 | hsa-miR-4715-3p mimic | Oligonucleotides | |
| HY-R01304A | hsa-miR-4715-3p agomir | Oligonucleotides | |
| HY-R01305 | hsa-miR-4715-5p mimic | Oligonucleotides | |
| HY-R01305A | hsa-miR-4715-5p agomir | Oligonucleotides | |
| HY-R01306 | hsa-miR-4716-3p mimic | Oligonucleotides | |
| HY-R01306A | hsa-miR-4716-3p agomir | Oligonucleotides | |
| HY-R01307 | hsa-miR-4716-5p mimic | Oligonucleotides | |
| HY-R01307A | hsa-miR-4716-5p agomir | Oligonucleotides | |
| HY-R01308 | hsa-miR-4717-3p mimic | Oligonucleotides | |
| HY-R01308A | hsa-miR-4717-3p agomir | Oligonucleotides | |
| HY-R01309 | hsa-miR-4717-5p mimic | Oligonucleotides | |
| HY-R01309A | hsa-miR-4717-5p agomir | Oligonucleotides | |
| HY-R01310 | hsa-miR-4718 mimic | Oligonucleotides | |
| HY-R01310A | hsa-miR-4718 agomir | Oligonucleotides | |
| HY-R01311 | hsa-miR-4719 mimic | Oligonucleotides | |
| HY-R01311A | hsa-miR-4719 agomir | Oligonucleotides | |
| HY-R01312 | hsa-miR-4720-3p mimic | Oligonucleotides | |
| HY-R01312A | hsa-miR-4720-3p agomir | Oligonucleotides | |
| HY-R01313 | hsa-miR-4720-5p mimic | Oligonucleotides | |
| HY-R01313A | hsa-miR-4720-5p agomir | Oligonucleotides | |
| HY-R01314 | hsa-miR-4721 mimic | Oligonucleotides | |
| HY-R01314A | hsa-miR-4721 agomir | Oligonucleotides | |
| HY-R01315 | hsa-miR-4722-3p mimic | Oligonucleotides | |
| HY-R01315A | hsa-miR-4722-3p agomir | Oligonucleotides | |
| HY-R01316 | hsa-miR-4722-5p mimic | Oligonucleotides | |
| HY-R01316A | hsa-miR-4722-5p agomir | Oligonucleotides | |
| HY-R01317 | hsa-miR-4723-3p mimic | Oligonucleotides | |
| HY-R01317A | hsa-miR-4723-3p agomir | Oligonucleotides | |
| HY-R01318 | hsa-miR-4723-5p mimic | Oligonucleotides | |
| HY-R01318A | hsa-miR-4723-5p agomir | Oligonucleotides | |
| HY-R01319 | hsa-miR-4724-3p mimic | Oligonucleotides | |
| HY-R01319A | hsa-miR-4724-3p agomir | Oligonucleotides | |
| HY-R01320 | hsa-miR-4724-5p mimic | Oligonucleotides | |
| HY-R01320A | hsa-miR-4724-5p agomir | Oligonucleotides | |
| HY-R01321 | hsa-miR-4725-3p mimic | Oligonucleotides | |
| HY-R01321A | hsa-miR-4725-3p agomir | Oligonucleotides | |
| HY-R01322 | hsa-miR-4725-5p mimic | Oligonucleotides | |
| HY-R01322A | hsa-miR-4725-5p agomir | Oligonucleotides | |
| HY-R01323 | hsa-miR-4726-3p mimic | Oligonucleotides | |
| HY-R01323A | hsa-miR-4726-3p agomir | Oligonucleotides | |
| HY-R01324 | hsa-miR-4726-5p mimic | Oligonucleotides | |
| HY-R01324A | hsa-miR-4726-5p agomir | Oligonucleotides | |
| HY-R01325 | hsa-miR-4727-3p mimic | Oligonucleotides | |
| HY-R01325A | hsa-miR-4727-3p agomir | Oligonucleotides | |
| HY-R01326 | hsa-miR-4727-5p mimic | Oligonucleotides | |
| HY-R01326A | hsa-miR-4727-5p agomir | Oligonucleotides | |
| HY-R01327 | hsa-miR-4728-3p mimic | Oligonucleotides | |
| HY-R01327A | hsa-miR-4728-3p agomir | Oligonucleotides | |
| HY-R01328 | hsa-miR-4728-5p mimic | Oligonucleotides | |
| HY-R01328A | hsa-miR-4728-5p agomir | Oligonucleotides | |
| HY-R01329 | hsa-miR-4729 mimic | Oligonucleotides | |
| HY-R01329A | hsa-miR-4729 agomir | Oligonucleotides | |
| HY-R01330 | hsa-miR-4730 mimic | Oligonucleotides | |
| HY-R01330A | hsa-miR-4730 agomir | Oligonucleotides | |
| HY-R01331 | hsa-miR-4731-3p mimic | Oligonucleotides | |
| HY-R01331A | hsa-miR-4731-3p agomir | Oligonucleotides | |
| HY-R01332 | hsa-miR-4731-5p mimic | Oligonucleotides | |
| HY-R01332A | hsa-miR-4731-5p agomir | Oligonucleotides | |
| HY-R01333 | hsa-miR-4732-3p mimic | Oligonucleotides | |
| HY-R01333A | hsa-miR-4732-3p agomir | Oligonucleotides | |
| HY-R01334 | hsa-miR-4732-5p mimic | Oligonucleotides | |
| HY-R01334A | hsa-miR-4732-5p agomir | Oligonucleotides | |
| HY-R01335 | hsa-miR-4733-3p mimic | Oligonucleotides | |
| HY-R01335A | hsa-miR-4733-3p agomir | Oligonucleotides | |
| HY-R01336 | hsa-miR-4733-5p mimic | Oligonucleotides | |
| HY-R01336A | hsa-miR-4733-5p agomir | Oligonucleotides | |
| HY-R01337 | hsa-miR-4734 mimic | Oligonucleotides | |
| HY-R01337A | hsa-miR-4734 agomir | Oligonucleotides | |
| HY-R01338 | hsa-miR-4735-3p mimic | Oligonucleotides | |
| HY-R01338A | hsa-miR-4735-3p agomir | Oligonucleotides | |
| HY-R01339 | hsa-miR-4735-5p mimic | Oligonucleotides | |
| HY-R01339A | hsa-miR-4735-5p agomir | Oligonucleotides | |
| HY-R01340 | hsa-miR-4736 mimic | Oligonucleotides | |
| HY-R01340A | hsa-miR-4736 agomir | Oligonucleotides | |
| HY-R01341 | hsa-miR-4737 mimic | Oligonucleotides | |
| HY-R01341A | hsa-miR-4737 agomir | Oligonucleotides | |
| HY-R01342 | hsa-miR-4738-3p mimic | Oligonucleotides | |
| HY-R01342A | hsa-miR-4738-3p agomir | Oligonucleotides | |
| HY-R01343 | hsa-miR-4738-5p mimic | Oligonucleotides | |
| HY-R01343A | hsa-miR-4738-5p agomir | Oligonucleotides | |
| HY-R01344 | hsa-miR-4739 mimic | Oligonucleotides | |
| HY-R01344A | hsa-miR-4739 agomir | Oligonucleotides | |
| HY-R01345 | hsa-miR-4740-3p mimic | Oligonucleotides | |
| HY-R01345A | hsa-miR-4740-3p agomir | Oligonucleotides | |
| HY-R01346 | hsa-miR-4740-5p mimic | Oligonucleotides | |
| HY-R01346A | hsa-miR-4740-5p agomir | Oligonucleotides | |
| HY-R01347 | hsa-miR-4741 mimic | Oligonucleotides | |
| HY-R01347A | hsa-miR-4741 agomir | Oligonucleotides | |
| HY-R01348 | hsa-miR-4742-3p mimic | Oligonucleotides | |
| HY-R01348A | hsa-miR-4742-3p agomir | Oligonucleotides | |
| HY-R01349 | hsa-miR-4742-5p mimic | Oligonucleotides | |
| HY-R01349A | hsa-miR-4742-5p agomir | Oligonucleotides | |
| HY-R01350 | hsa-miR-4743-3p mimic | Oligonucleotides | |
| HY-R01350A | hsa-miR-4743-3p agomir | Oligonucleotides | |
| HY-R01351 | hsa-miR-4743-5p mimic | Oligonucleotides | |
| HY-R01351A | hsa-miR-4743-5p agomir | Oligonucleotides | |
| HY-R01352 | hsa-miR-4744 mimic | Oligonucleotides | |
| HY-R01352A | hsa-miR-4744 agomir | Oligonucleotides | |
| HY-R01353 | hsa-miR-4745-3p mimic | Oligonucleotides | |
| HY-R01353A | hsa-miR-4745-3p agomir | Oligonucleotides | |
| HY-R01354 | hsa-miR-4745-5p mimic | Oligonucleotides | |
| HY-R01354A | hsa-miR-4745-5p agomir | Oligonucleotides | |
| HY-R01355 | hsa-miR-4746-3p mimic | Oligonucleotides | |
| HY-R01355A | hsa-miR-4746-3p agomir | Oligonucleotides | |
| HY-R01356 | hsa-miR-4746-5p mimic | Oligonucleotides | |
| HY-R01356A | hsa-miR-4746-5p agomir | Oligonucleotides | |
| HY-R01357 | hsa-miR-4747-3p mimic | Oligonucleotides | |
| HY-R01357A | hsa-miR-4747-3p agomir | Oligonucleotides | |
| HY-R01358 | hsa-miR-4747-5p mimic | Oligonucleotides | |
| HY-R01358A | hsa-miR-4747-5p agomir | Oligonucleotides | |
| HY-R01359 | hsa-miR-4748 mimic | Oligonucleotides | |
| HY-R01359A | hsa-miR-4748 agomir | Oligonucleotides | |
| HY-R01360 | hsa-miR-4749-3p mimic | Oligonucleotides | |
| HY-R01360A | hsa-miR-4749-3p agomir | Oligonucleotides | |
| HY-R01361 | hsa-miR-4749-5p mimic | Oligonucleotides | |
| HY-R01361A | hsa-miR-4749-5p agomir | Oligonucleotides | |
| HY-R01362 | hsa-miR-4750-3p mimic | Oligonucleotides | |
| HY-R01362A | hsa-miR-4750-3p agomir | Oligonucleotides | |
| HY-R01363 | hsa-miR-4750-5p mimic | Oligonucleotides | |
| HY-R01363A | hsa-miR-4750-5p agomir | Oligonucleotides | |
| HY-R01364 | hsa-miR-4751 mimic | Oligonucleotides | |
| HY-R01364A | hsa-miR-4751 agomir | Oligonucleotides | |
| HY-R01365 | hsa-miR-4752 mimic | Oligonucleotides | |
| HY-R01365A | hsa-miR-4752 agomir | Oligonucleotides | |
| HY-R01366 | hsa-miR-4753-3p mimic | Oligonucleotides | |
| HY-R01366A | hsa-miR-4753-3p agomir | Oligonucleotides | |
| HY-R01367 | hsa-miR-4753-5p mimic | Oligonucleotides | |
| HY-R01367A | hsa-miR-4753-5p agomir | Oligonucleotides | |
| HY-R01368 | hsa-miR-4754 mimic | Oligonucleotides | |
| HY-R01368A | hsa-miR-4754 agomir | Oligonucleotides | |
| HY-R01369 | hsa-miR-4755-3p mimic | Oligonucleotides | |
| HY-R01369A | hsa-miR-4755-3p agomir | Oligonucleotides | |
| HY-R01370 | hsa-miR-4755-5p mimic | Oligonucleotides | |
| HY-R01370A | hsa-miR-4755-5p agomir | Oligonucleotides | |
| HY-R01371 | hsa-miR-4756-3p mimic | Oligonucleotides | |
| HY-R01371A | hsa-miR-4756-3p agomir | Oligonucleotides | |
| HY-R01372 | hsa-miR-4756-5p mimic | Oligonucleotides | |
| HY-R01372A | hsa-miR-4756-5p agomir | Oligonucleotides | |
| HY-R01373 | hsa-miR-4757-3p mimic | Oligonucleotides | |
| HY-R01373A | hsa-miR-4757-3p agomir | Oligonucleotides | |
| HY-R01374 | hsa-miR-4757-5p mimic | Oligonucleotides | |
| HY-R01374A | hsa-miR-4757-5p agomir | Oligonucleotides | |
| HY-R01375 | hsa-miR-4758-3p mimic | Oligonucleotides | |
| HY-R01375A | hsa-miR-4758-3p agomir | Oligonucleotides | |
| HY-R01376 | hsa-miR-4758-5p mimic | Oligonucleotides | |
| HY-R01376A | hsa-miR-4758-5p agomir | Oligonucleotides | |
| HY-R01377 | hsa-miR-4759 mimic | Oligonucleotides | |
| HY-R01377A | hsa-miR-4759 agomir | Oligonucleotides | |
| HY-R01378 | hsa-miR-4760-3p mimic | Oligonucleotides | |
| HY-R01378A | hsa-miR-4760-3p agomir | Oligonucleotides | |
| HY-R01379 | hsa-miR-4760-5p mimic | Oligonucleotides | |
| HY-R01379A | hsa-miR-4760-5p agomir | Oligonucleotides | |
| HY-R01380 | hsa-miR-4761-3p mimic | Oligonucleotides | |
| HY-R01380A | hsa-miR-4761-3p agomir | Oligonucleotides | |
| HY-R01381 | hsa-miR-4761-5p mimic | Oligonucleotides | |
| HY-R01381A | hsa-miR-4761-5p agomir | Oligonucleotides | |
| HY-R01382 | hsa-miR-4762-3p mimic | Oligonucleotides | |
| HY-R01382A | hsa-miR-4762-3p agomir | Oligonucleotides | |
| HY-R01383 | hsa-miR-4762-5p mimic | Oligonucleotides | |
| HY-R01383A | hsa-miR-4762-5p agomir | Oligonucleotides | |
| HY-R01384 | hsa-miR-4763-3p mimic | Oligonucleotides | |
| HY-R01384A | hsa-miR-4763-3p agomir | Oligonucleotides | |
| HY-R01385 | hsa-miR-4763-5p mimic | Oligonucleotides | |
| HY-R01385A | hsa-miR-4763-5p agomir | Oligonucleotides | |
| HY-R01386 | hsa-miR-4764-3p mimic | Oligonucleotides | |
| HY-R01386A | hsa-miR-4764-3p agomir | Oligonucleotides | |
| HY-R01387 | hsa-miR-4764-5p mimic | Oligonucleotides | |
| HY-R01387A | hsa-miR-4764-5p agomir | Oligonucleotides | |
| HY-R01388 | hsa-miR-4765 mimic | Oligonucleotides | |
| HY-R01388A | hsa-miR-4765 agomir | Oligonucleotides | |
| HY-R01389 | hsa-miR-4766-3p mimic | Oligonucleotides | |
| HY-R01389A | hsa-miR-4766-3p agomir | Oligonucleotides | |
| HY-R01390 | hsa-miR-4766-5p mimic | Oligonucleotides | |
| HY-R01390A | hsa-miR-4766-5p agomir | Oligonucleotides | |
| HY-R01391 | hsa-miR-4767 mimic | Oligonucleotides | |
| HY-R01391A | hsa-miR-4767 agomir | Oligonucleotides | |
| HY-R01392 | hsa-miR-4768-3p mimic | Oligonucleotides | |
| HY-R01392A | hsa-miR-4768-3p agomir | Oligonucleotides | |
| HY-R01393 | hsa-miR-4768-5p mimic | Oligonucleotides | |
| HY-R01393A | hsa-miR-4768-5p agomir | Oligonucleotides | |
| HY-R01394 | hsa-miR-4769-3p mimic | Oligonucleotides | |
| HY-R01394A | hsa-miR-4769-3p agomir | Oligonucleotides | |
| HY-R01395 | hsa-miR-4769-5p mimic | Oligonucleotides | |
| HY-R01395A | hsa-miR-4769-5p agomir | Oligonucleotides | |
| HY-R01396 | hsa-miR-4770 mimic | Oligonucleotides | |
| HY-R01396A | hsa-miR-4770 agomir | Oligonucleotides | |
| HY-R01397 | hsa-miR-4771 mimic | Oligonucleotides | |
| HY-R01397A | hsa-miR-4771 agomir | Oligonucleotides | |
| HY-R01398 | hsa-miR-4772-3p mimic | Oligonucleotides | |
| HY-R01398A | hsa-miR-4772-3p agomir | Oligonucleotides | |
| HY-R01399 | hsa-miR-4772-5p mimic | Oligonucleotides | |
| HY-R01399A | hsa-miR-4772-5p agomir | Oligonucleotides | |
| HY-R01400 | hsa-miR-4773 mimic | Oligonucleotides | |
| HY-R01400A | hsa-miR-4773 agomir | Oligonucleotides | |
| HY-R01401 | hsa-miR-4774-3p mimic | Oligonucleotides | |
| HY-R01401A | hsa-miR-4774-3p agomir | Oligonucleotides | |
| HY-R01402 | hsa-miR-4774-5p mimic | Oligonucleotides | |
| HY-R01402A | hsa-miR-4774-5p agomir | Oligonucleotides | |
| HY-R01403 | hsa-miR-4775 mimic | Oligonucleotides | |
| HY-R01403A | hsa-miR-4775 agomir | Oligonucleotides | |
| HY-R01404 | hsa-miR-4776-3p mimic | Oligonucleotides | |
| HY-R01404A | hsa-miR-4776-3p agomir | Oligonucleotides | |
| HY-R01405 | hsa-miR-4776-5p mimic | Oligonucleotides | |
| HY-R01405A | hsa-miR-4776-5p agomir | Oligonucleotides | |
| HY-R01406 | hsa-miR-4777-3p mimic | Oligonucleotides | |
| HY-R01406A | hsa-miR-4777-3p agomir | Oligonucleotides | |
| HY-R01407 | hsa-miR-4777-5p mimic | Oligonucleotides | |
| HY-R01407A | hsa-miR-4777-5p agomir | Oligonucleotides | |
| HY-R01408 | hsa-miR-4778-3p mimic | Oligonucleotides | |
| HY-R01408A | hsa-miR-4778-3p agomir | Oligonucleotides | |
| HY-R01409 | hsa-miR-4778-5p mimic | Oligonucleotides | |
| HY-R01409A | hsa-miR-4778-5p agomir | Oligonucleotides | |
| HY-R01410 | hsa-miR-4779 mimic | Oligonucleotides | |
| HY-R01410A | hsa-miR-4779 agomir | Oligonucleotides | |
| HY-R01411 | hsa-miR-4780 mimic | Oligonucleotides | |
| HY-R01411A | hsa-miR-4780 agomir | Oligonucleotides | |
| HY-R01412 | hsa-miR-4781-3p mimic | Oligonucleotides | |
| HY-R01412A | hsa-miR-4781-3p agomir | Oligonucleotides | |
| HY-R01413 | hsa-miR-4781-5p mimic | Oligonucleotides | |
| HY-R01413A | hsa-miR-4781-5p agomir | Oligonucleotides | |
| HY-R01414 | hsa-miR-4782-3p mimic | Oligonucleotides | |
| HY-R01414A | hsa-miR-4782-3p agomir | Oligonucleotides | |
| HY-R01415 | hsa-miR-4782-5p mimic | Oligonucleotides | |
| HY-R01415A | hsa-miR-4782-5p agomir | Oligonucleotides | |
| HY-R01416 | hsa-miR-4783-3p mimic | Oligonucleotides | |
| HY-R01416A | hsa-miR-4783-3p agomir | Oligonucleotides | |
| HY-R01417 | hsa-miR-4783-5p mimic | Oligonucleotides | |
| HY-R01417A | hsa-miR-4783-5p agomir | Oligonucleotides | |
| HY-R01418 | hsa-miR-4784 mimic | Oligonucleotides | |
| HY-R01418A | hsa-miR-4784 agomir | Oligonucleotides | |
| HY-R01419 | hsa-miR-4785 mimic | Oligonucleotides | |
| HY-R01419A | hsa-miR-4785 agomir | Oligonucleotides | |
| HY-R01420 | hsa-miR-4786-3p mimic | Oligonucleotides | |
| HY-R01420A | hsa-miR-4786-3p agomir | Oligonucleotides | |
| HY-R01421 | hsa-miR-4786-5p mimic | Oligonucleotides | |
| HY-R01421A | hsa-miR-4786-5p agomir | Oligonucleotides | |
| HY-R01422 | hsa-miR-4787-3p mimic | Oligonucleotides | |
| HY-R01422A | hsa-miR-4787-3p agomir | Oligonucleotides | |
| HY-R01423 | hsa-miR-4787-5p mimic | Oligonucleotides | |
| HY-R01423A | hsa-miR-4787-5p agomir | Oligonucleotides | |
| HY-R01424 | hsa-miR-4788 mimic | Oligonucleotides | |
| HY-R01424A | hsa-miR-4788 agomir | Oligonucleotides | |
| HY-R01425 | hsa-miR-4789-3p mimic | Oligonucleotides | |
| HY-R01425A | hsa-miR-4789-3p agomir | Oligonucleotides | |
| HY-R01426 | hsa-miR-4789-5p mimic | Oligonucleotides | |
| HY-R01426A | hsa-miR-4789-5p agomir | Oligonucleotides | |
| HY-R01427 | hsa-miR-4790-3p mimic | Oligonucleotides | |
| HY-R01427A | hsa-miR-4790-3p agomir | Oligonucleotides | |
| HY-R01428 | hsa-miR-4790-5p mimic | Oligonucleotides | |
| HY-R01428A | hsa-miR-4790-5p agomir | Oligonucleotides | |
| HY-R01429 | hsa-miR-4791 mimic | Oligonucleotides | |
| HY-R01429A | hsa-miR-4791 agomir | Oligonucleotides | |
| HY-R01430 | hsa-miR-4793-3p mimic | Oligonucleotides | |
| HY-R01430A | hsa-miR-4793-3p agomir | Oligonucleotides | |
| HY-R01431 | hsa-miR-4793-5p mimic | Oligonucleotides | |
| HY-R01431A | hsa-miR-4793-5p agomir | Oligonucleotides | |
| HY-R01432 | hsa-miR-4794 mimic | Oligonucleotides | |
| HY-R01432A | hsa-miR-4794 agomir | Oligonucleotides | |
| HY-R01433 | hsa-miR-4795-3p mimic | Oligonucleotides | |
| HY-R01433A | hsa-miR-4795-3p agomir | Oligonucleotides | |
| HY-R01434 | hsa-miR-4795-5p mimic | Oligonucleotides | |
| HY-R01434A | hsa-miR-4795-5p agomir | Oligonucleotides | |
| HY-R01435 | hsa-miR-4796-3p mimic | Oligonucleotides | |
| HY-R01435A | hsa-miR-4796-3p agomir | Oligonucleotides | |
| HY-R01436 | hsa-miR-4796-5p mimic | Oligonucleotides | |
| HY-R01436A | hsa-miR-4796-5p agomir | Oligonucleotides | |
| HY-R01437 | hsa-miR-4797-3p mimic | Oligonucleotides | |
| HY-R01437A | hsa-miR-4797-3p agomir | Oligonucleotides | |
| HY-R01438 | hsa-miR-4797-5p mimic | Oligonucleotides | |
| HY-R01438A | hsa-miR-4797-5p agomir | Oligonucleotides | |
| HY-R01439 | hsa-miR-4798-3p mimic | Oligonucleotides | |
| HY-R01439A | hsa-miR-4798-3p agomir | Oligonucleotides | |
| HY-R01440 | hsa-miR-4798-5p mimic | Oligonucleotides | |
| HY-R01440A | hsa-miR-4798-5p agomir | Oligonucleotides | |
| HY-R01441 | hsa-miR-4799-3p mimic | Oligonucleotides | |
| HY-R01441A | hsa-miR-4799-3p agomir | Oligonucleotides | |
| HY-R01442 | hsa-miR-4799-5p mimic | Oligonucleotides | |
| HY-R01442A | hsa-miR-4799-5p agomir | Oligonucleotides | |
| HY-R01443 | hsa-miR-4800-3p mimic | Oligonucleotides | |
| HY-R01443A | hsa-miR-4800-3p agomir | Oligonucleotides | |
| HY-R01444 | hsa-miR-4800-5p mimic | Oligonucleotides | |
| HY-R01444A | hsa-miR-4800-5p agomir | Oligonucleotides | |
| HY-R01445 | hsa-miR-4801 mimic | Oligonucleotides | |
| HY-R01445A | hsa-miR-4801 agomir | Oligonucleotides | |
| HY-R01446 | hsa-miR-4802-3p mimic | Oligonucleotides | |
| HY-R01446A | hsa-miR-4802-3p agomir | Oligonucleotides | |
| HY-R01447 | hsa-miR-4802-5p mimic | Oligonucleotides | |
| HY-R01447A | hsa-miR-4802-5p agomir | Oligonucleotides | |
| HY-R01448 | hsa-miR-4803 mimic | Oligonucleotides | |
| HY-R01448A | hsa-miR-4803 agomir | Oligonucleotides | |
| HY-R01449 | hsa-miR-4804-3p mimic | Oligonucleotides | |
| HY-R01449A | hsa-miR-4804-3p agomir | Oligonucleotides | |
| HY-R01450 | hsa-miR-4804-5p mimic | Oligonucleotides | |
| HY-R01450A | hsa-miR-4804-5p agomir | Oligonucleotides | |
| HY-R01451 | hsa-miR-483-3p mimic | Oligonucleotides | |
| HY-R01451A | hsa-miR-483-3p agomir | Oligonucleotides | |
| HY-R01452 | hsa-miR-483-5p mimic | Oligonucleotides | |
| HY-R01452A | hsa-miR-483-5p agomir | Oligonucleotides | |
| HY-R01453 | hsa-miR-484 mimic | Oligonucleotides | |
| HY-R01453A | hsa-miR-484 agomir | Oligonucleotides | |
| HY-R01454 | hsa-miR-485-3p mimic | Oligonucleotides | |
| HY-R01454A | hsa-miR-485-3p agomir | Oligonucleotides | |
| HY-R01455 | hsa-miR-485-5p mimic | Oligonucleotides | |
| HY-R01455A | hsa-miR-485-5p agomir | Oligonucleotides | |
| HY-R01456 | hsa-miR-486-3p mimic | Oligonucleotides | |
| HY-R01456A | hsa-miR-486-3p agomir | Oligonucleotides | |
| HY-R01457 | hsa-miR-486-5p mimic | Oligonucleotides | |
| HY-R01457A | hsa-miR-486-5p agomir | Oligonucleotides | |
| HY-R01458 | hsa-miR-487a-3p mimic | Oligonucleotides | |
| HY-R01458A | hsa-miR-487a-3p agomir | Oligonucleotides | |
| HY-R01459 | hsa-miR-487a-5p mimic | Oligonucleotides | |
| HY-R01459A | hsa-miR-487a-5p agomir | Oligonucleotides | |
| HY-R01460 | hsa-miR-487b-3p mimic | Oligonucleotides | |
| HY-R01460A | hsa-miR-487b-3p agomir | Oligonucleotides | |
| HY-R01461 | hsa-miR-487b-5p mimic | Oligonucleotides | |
| HY-R01461A | hsa-miR-487b-5p agomir | Oligonucleotides | |
| HY-R01462 | hsa-miR-488-3p mimic | Oligonucleotides | |
| HY-R01462A | hsa-miR-488-3p agomir | Oligonucleotides | |
| HY-R01463 | hsa-miR-488-5p mimic | Oligonucleotides | |
| HY-R01463A | hsa-miR-488-5p agomir | Oligonucleotides | |
| HY-R01464 | hsa-miR-489-5p mimic | Oligonucleotides | |
| HY-R01464A | hsa-miR-489-5p agomir | Oligonucleotides | |
| HY-R01465 | hsa-miR-490-5p mimic | Oligonucleotides | |
| HY-R01465A | hsa-miR-490-5p agomir | Oligonucleotides | |
| HY-R01466 | hsa-miR-491-5p mimic | Oligonucleotides | |
| HY-R01466A | hsa-miR-491-5p agomir | Oligonucleotides | |
| HY-R01467 | hsa-miR-492 mimic | Oligonucleotides | |
| HY-R01467A | hsa-miR-492 agomir | Oligonucleotides | |
| HY-R01468 | hsa-miR-493-3p mimic | Oligonucleotides | |
| HY-R01468A | hsa-miR-493-3p agomir | Oligonucleotides | |
| HY-R01469 | hsa-miR-493-5p mimic | Oligonucleotides | |
| HY-R01469A | hsa-miR-493-5p agomir | Oligonucleotides | |
| HY-R01470 | hsa-miR-494-3p mimic | Oligonucleotides | |
| HY-R01470A | hsa-miR-494-3p agomir | Oligonucleotides | |
| HY-R01471 | hsa-miR-494-5p mimic | Oligonucleotides | |
| HY-R01471A | hsa-miR-494-5p agomir | Oligonucleotides | |
| HY-R01472 | hsa-miR-495-3p mimic | Oligonucleotides | |
| HY-R01472A | hsa-miR-495-3p agomir | Oligonucleotides | |
| HY-R01473 | hsa-miR-495-5p mimic | Oligonucleotides | |
| HY-R01473A | hsa-miR-495-5p agomir | Oligonucleotides | |
| HY-R01474 | hsa-miR-496 mimic | Oligonucleotides | |
| HY-R01474A | hsa-miR-496 agomir | Oligonucleotides | |
| HY-R01475 | hsa-miR-497-3p mimic | Oligonucleotides | |
| HY-R01475A | hsa-miR-497-3p agomir | Oligonucleotides | |
| HY-R01476 | hsa-miR-497-5p mimic | Oligonucleotides | |
| HY-R01476A | hsa-miR-497-5p agomir | Oligonucleotides | |
| HY-R01477 | hsa-miR-498-3p mimic | Oligonucleotides | |
| HY-R01477A | hsa-miR-498-3p agomir | Oligonucleotides | |
| HY-R01478 | hsa-miR-498-5p mimic | Oligonucleotides | |
| HY-R01478A | hsa-miR-498-5p agomir | Oligonucleotides | |
| HY-R01479 | hsa-miR-4999-3p mimic | Oligonucleotides | |
| HY-R01479A | hsa-miR-4999-3p agomir | Oligonucleotides | |
| HY-R01480 | hsa-miR-4999-5p mimic | Oligonucleotides | |
| HY-R01480A | hsa-miR-4999-5p agomir | Oligonucleotides | |
| HY-R01481 | hsa-miR-499a-3p mimic | Oligonucleotides | |
| HY-R01481A | hsa-miR-499a-3p agomir | Oligonucleotides | |
| HY-R01482 | hsa-miR-499a-5p mimic | Oligonucleotides | |
| HY-R01482A | hsa-miR-499a-5p agomir | Oligonucleotides | |
| HY-R01483 | hsa-miR-499b-3p mimic | Oligonucleotides | |
| HY-R01483A | hsa-miR-499b-3p agomir | Oligonucleotides | |
| HY-R01484 | hsa-miR-499b-5p mimic | Oligonucleotides | |
| HY-R01484A | hsa-miR-499b-5p agomir | Oligonucleotides | |
| HY-R01485 | hsa-miR-5000-3p mimic | Oligonucleotides | |
| HY-R01485A | hsa-miR-5000-3p agomir | Oligonucleotides | |
| HY-R01486 | hsa-miR-5000-5p mimic | Oligonucleotides | |
| HY-R01486A | hsa-miR-5000-5p agomir | Oligonucleotides | |
| HY-R01487 | hsa-miR-5001-3p mimic | Oligonucleotides | |
| HY-R01487A | hsa-miR-5001-3p agomir | Oligonucleotides | |
| HY-R01488 | hsa-miR-5001-5p mimic | Oligonucleotides | |
| HY-R01488A | hsa-miR-5001-5p agomir | Oligonucleotides | |
| HY-R01489 | hsa-miR-5002-3p mimic | Oligonucleotides | |
| HY-R01489A | hsa-miR-5002-3p agomir | Oligonucleotides | |
| HY-R01490 | hsa-miR-5002-5p mimic | Oligonucleotides | |
| HY-R01490A | hsa-miR-5002-5p agomir | Oligonucleotides | |
| HY-R01491 | hsa-miR-5003-3p mimic | Oligonucleotides | |
| HY-R01491A | hsa-miR-5003-3p agomir | Oligonucleotides | |
| HY-R01492 | hsa-miR-5003-5p mimic | Oligonucleotides | |
| HY-R01492A | hsa-miR-5003-5p agomir | Oligonucleotides | |
| HY-R01493 | hsa-miR-5004-3p mimic | Oligonucleotides | |
| HY-R01493A | hsa-miR-5004-3p agomir | Oligonucleotides | |
| HY-R01494 | hsa-miR-5004-5p mimic | Oligonucleotides | |
| HY-R01494A | hsa-miR-5004-5p agomir | Oligonucleotides | |
| HY-R01495 | hsa-miR-5006-3p mimic | Oligonucleotides | |
| HY-R01495A | hsa-miR-5006-3p agomir | Oligonucleotides | |
| HY-R01496 | hsa-miR-5006-5p mimic | Oligonucleotides | |
| HY-R01496A | hsa-miR-5006-5p agomir | Oligonucleotides | |
| HY-R01497 | hsa-miR-5007-3p mimic | Oligonucleotides | |
| HY-R01497A | hsa-miR-5007-3p agomir | Oligonucleotides | |
| HY-R01498 | hsa-miR-5007-5p mimic | Oligonucleotides | |
| HY-R01498A | hsa-miR-5007-5p agomir | Oligonucleotides | |
| HY-R01499 | hsa-miR-5008-3p mimic | Oligonucleotides | |
| HY-R01499A | hsa-miR-5008-3p agomir | Oligonucleotides | |
| HY-R01500 | hsa-miR-5008-5p mimic | Oligonucleotides | |
| HY-R01500A | hsa-miR-5008-5p agomir | Oligonucleotides | |
| HY-R01501 | hsa-miR-5009-3p mimic | Oligonucleotides | |
| HY-R01501A | hsa-miR-5009-3p agomir | Oligonucleotides | |
| HY-R01502 | hsa-miR-5009-5p mimic | Oligonucleotides | |
| HY-R01502A | hsa-miR-5009-5p agomir | Oligonucleotides | |
| HY-R01503 | hsa-miR-500a-3p mimic | Oligonucleotides | |
| HY-R01503A | hsa-miR-500a-3p agomir | Oligonucleotides | |
| HY-R01504 | hsa-miR-500b-3p mimic | Oligonucleotides | |
| HY-R01504A | hsa-miR-500b-3p agomir | Oligonucleotides | |
| HY-R01505 | hsa-miR-500b-5p mimic | Oligonucleotides | |
| HY-R01505A | hsa-miR-500b-5p agomir | Oligonucleotides | |
| HY-R01506 | hsa-miR-5010-3p mimic | Oligonucleotides | |
| HY-R01506A | hsa-miR-5010-3p agomir | Oligonucleotides | |
| HY-R01507 | hsa-miR-5010-5p mimic | Oligonucleotides | |
| HY-R01507A | hsa-miR-5010-5p agomir | Oligonucleotides | |
| HY-R01508 | hsa-miR-5011-3p mimic | Oligonucleotides | |
| HY-R01508A | hsa-miR-5011-3p agomir | Oligonucleotides | |
| HY-R01509 | hsa-miR-5011-5p mimic | Oligonucleotides | |
| HY-R01509A | hsa-miR-5011-5p agomir | Oligonucleotides | |
| HY-R01510 | hsa-miR-501-3p mimic | Oligonucleotides | |
| HY-R01510A | hsa-miR-501-3p agomir | Oligonucleotides | |
| HY-R01511 | hsa-miR-501-5p mimic | Oligonucleotides | |
| HY-R01511A | hsa-miR-501-5p agomir | Oligonucleotides | |
| HY-R01512 | hsa-miR-502-5p mimic | Oligonucleotides | |
| HY-R01512A | hsa-miR-502-5p agomir | Oligonucleotides | |
| HY-R01513 | hsa-miR-503-3p mimic | Oligonucleotides | |
| HY-R01513A | hsa-miR-503-3p agomir | Oligonucleotides | |
| HY-R01514 | hsa-miR-503-5p mimic | Oligonucleotides | |
| HY-R01514A | hsa-miR-503-5p agomir | Oligonucleotides | |
| HY-R01515 | hsa-miR-5047 mimic | Oligonucleotides | |
| HY-R01515A | hsa-miR-5047 agomir | Oligonucleotides | |
| HY-R01516 | hsa-miR-505-3p mimic | Oligonucleotides | |
| HY-R01516A | hsa-miR-505-3p agomir | Oligonucleotides | |
| HY-R01517 | hsa-miR-505-5p mimic | Oligonucleotides | |
| HY-R01517A | hsa-miR-505-5p agomir | Oligonucleotides | |
| HY-R01518 | hsa-miR-506-3p mimic | Oligonucleotides | |
| HY-R01518A | hsa-miR-506-3p agomir | Oligonucleotides | |
| HY-R01519 | hsa-miR-506-5p mimic | Oligonucleotides | |
| HY-R01519A | hsa-miR-506-5p agomir | Oligonucleotides | |
| HY-R01520 | hsa-miR-508-3p mimic | Oligonucleotides | |
| HY-R01520A | hsa-miR-508-3p agomir | Oligonucleotides | |
| HY-R01521 | hsa-miR-508-5p mimic | Oligonucleotides | |
| HY-R01521A | hsa-miR-508-5p agomir | Oligonucleotides | |
| HY-R01522 | hsa-miR-5087 mimic | Oligonucleotides | |
| HY-R01522A | hsa-miR-5087 agomir | Oligonucleotides | |
| HY-R01523 | hsa-miR-5088-3p mimic | Oligonucleotides | |
| HY-R01523A | hsa-miR-5088-3p agomir | Oligonucleotides | |
| HY-R01524 | hsa-miR-5088-5p mimic | Oligonucleotides | |
| HY-R01524A | hsa-miR-5088-5p agomir | Oligonucleotides | |
| HY-R01525 | hsa-miR-5089-3p mimic | Oligonucleotides | |
| HY-R01525A | hsa-miR-5089-3p agomir | Oligonucleotides | |
| HY-R01526 | hsa-miR-5089-5p mimic | Oligonucleotides | |
| HY-R01526A | hsa-miR-5089-5p agomir | Oligonucleotides | |
| HY-R01527 | hsa-miR-5090 mimic | Oligonucleotides | |
| HY-R01527A | hsa-miR-5090 agomir | Oligonucleotides | |
| HY-R01528 | hsa-miR-5091 mimic | Oligonucleotides | |
| HY-R01528A | hsa-miR-5091 agomir | Oligonucleotides | |
| HY-R01529 | hsa-miR-5092 mimic | Oligonucleotides | |
| HY-R01529A | hsa-miR-5092 agomir | Oligonucleotides | |
| HY-R01530 | hsa-miR-5093 mimic | Oligonucleotides | |
| HY-R01530A | hsa-miR-5093 agomir | Oligonucleotides | |
| HY-R01531 | hsa-miR-509-3-5p mimic | Oligonucleotides | |
| HY-R01531A | hsa-miR-509-3-5p agomir | Oligonucleotides | |
| HY-R01532 | hsa-miR-509-3p mimic | Oligonucleotides | |
| HY-R01532A | hsa-miR-509-3p agomir | Oligonucleotides | |
| HY-R01533 | hsa-miR-5094 mimic | Oligonucleotides | |
| HY-R01533A | hsa-miR-5094 agomir | Oligonucleotides | |
| HY-R01534 | hsa-miR-509-5p mimic | Oligonucleotides | |
| HY-R01534A | hsa-miR-509-5p agomir | Oligonucleotides | |
| HY-R01535 | hsa-miR-5100 mimic | Oligonucleotides | |
| HY-R01535A | hsa-miR-5100 agomir | Oligonucleotides | |
| HY-R01536 | hsa-miR-510-3p mimic | Oligonucleotides | |
| HY-R01536A | hsa-miR-510-3p agomir | Oligonucleotides | |
| HY-R01537 | hsa-miR-510-5p mimic | Oligonucleotides | |
| HY-R01537A | hsa-miR-510-5p agomir | Oligonucleotides | |
| HY-R01538 | hsa-miR-511-3p mimic | Oligonucleotides | |
| HY-R01538A | hsa-miR-511-3p agomir | Oligonucleotides | |
| HY-R01539 | hsa-miR-511-5p mimic | Oligonucleotides | |
| HY-R01539A | hsa-miR-511-5p agomir | Oligonucleotides | |
| HY-R01540 | hsa-miR-512-3p mimic | Oligonucleotides | |
| HY-R01540A | hsa-miR-512-3p agomir | Oligonucleotides | |
| HY-R01541 | hsa-miR-512-5p mimic | Oligonucleotides | |
| HY-R01541A | hsa-miR-512-5p agomir | Oligonucleotides | |
| HY-R01542 | hsa-miR-513a-3p mimic | Oligonucleotides | |
| HY-R01542A | hsa-miR-513a-3p agomir | Oligonucleotides | |
| HY-R01543 | hsa-miR-513a-5p mimic | Oligonucleotides | |
| HY-R01543A | hsa-miR-513a-5p agomir | Oligonucleotides | |
| HY-R01544 | hsa-miR-513b-3p mimic | Oligonucleotides | |
| HY-R01544A | hsa-miR-513b-3p agomir | Oligonucleotides | |
| HY-R01545 | hsa-miR-513b-5p mimic | Oligonucleotides | |
| HY-R01545A | hsa-miR-513b-5p agomir | Oligonucleotides | |
| HY-R01546 | hsa-miR-513c-3p mimic | Oligonucleotides | |
| HY-R01546A | hsa-miR-513c-3p agomir | Oligonucleotides | |
| HY-R01547 | hsa-miR-513c-5p mimic | Oligonucleotides | |
| HY-R01547A | hsa-miR-513c-5p agomir | Oligonucleotides | |
| HY-R01548 | hsa-miR-514a-3p mimic | Oligonucleotides | |
| HY-R01548A | hsa-miR-514a-3p agomir | Oligonucleotides | |
| HY-R01549 | hsa-miR-514a-5p mimic | Oligonucleotides | |
| HY-R01549A | hsa-miR-514a-5p agomir | Oligonucleotides | |
| HY-R01550 | hsa-miR-514b-3p mimic | Oligonucleotides | |
| HY-R01550A | hsa-miR-514b-3p agomir | Oligonucleotides | |
| HY-R01551 | hsa-miR-514b-5p mimic | Oligonucleotides | |
| HY-R01551A | hsa-miR-514b-5p agomir | Oligonucleotides | |
| HY-R01552 | hsa-miR-515-3p mimic | Oligonucleotides | |
| HY-R01552A | hsa-miR-515-3p agomir | Oligonucleotides | |
| HY-R01553 | hsa-miR-515-5p mimic | Oligonucleotides | |
| HY-R01553A | hsa-miR-515-5p agomir | Oligonucleotides | |
| HY-R01554 | hsa-miR-516a-3p mimic | Oligonucleotides | |
| HY-R01554A | hsa-miR-516a-3p agomir | Oligonucleotides | |
| HY-R01555 | hsa-miR-516a-5p mimic | Oligonucleotides | |
| HY-R01555A | hsa-miR-516a-5p agomir | Oligonucleotides | |
| HY-R01556 | hsa-miR-516b-5p mimic | Oligonucleotides | |
| HY-R01556A | hsa-miR-516b-5p agomir | Oligonucleotides | |
| HY-R01557 | hsa-miR-517-5p mimic | Oligonucleotides | |
| HY-R01557A | hsa-miR-517-5p agomir | Oligonucleotides | |
| HY-R01558 | hsa-miR-517a-3p mimic | Oligonucleotides | |
| HY-R01558A | hsa-miR-517a-3p agomir | Oligonucleotides | |
| HY-R01559 | hsa-miR-5186 mimic | Oligonucleotides | |
| HY-R01559A | hsa-miR-5186 agomir | Oligonucleotides | |
| HY-R01560 | hsa-miR-5187-3p mimic | Oligonucleotides | |
| HY-R01560A | hsa-miR-5187-3p agomir | Oligonucleotides | |
| HY-R01561 | hsa-miR-5187-5p mimic | Oligonucleotides | |
| HY-R01561A | hsa-miR-5187-5p agomir | Oligonucleotides | |
| HY-R01562 | hsa-miR-5188 mimic | Oligonucleotides | |
| HY-R01562A | hsa-miR-5188 agomir | Oligonucleotides | |
| HY-R01563 | hsa-miR-5189-3p mimic | Oligonucleotides | |
| HY-R01563A | hsa-miR-5189-3p agomir | Oligonucleotides | |
| HY-R01564 | hsa-miR-5189-5p mimic | Oligonucleotides | |
| HY-R01564A | hsa-miR-5189-5p agomir | Oligonucleotides | |
| HY-R01565 | hsa-miR-518a-3p mimic | Oligonucleotides | |
| HY-R01565A | hsa-miR-518a-3p agomir | Oligonucleotides | |
| HY-R01566 | hsa-miR-518a-5p mimic | Oligonucleotides | |
| HY-R01566A | hsa-miR-518a-5p agomir | Oligonucleotides | |
| HY-R01567 | hsa-miR-518b mimic | Oligonucleotides | |
| HY-R01567A | hsa-miR-518b agomir | Oligonucleotides | |
| HY-R01568 | hsa-miR-518c-3p mimic | Oligonucleotides | |
| HY-R01568A | hsa-miR-518c-3p agomir | Oligonucleotides | |
| HY-R01569 | hsa-miR-518c-5p mimic | Oligonucleotides | |
| HY-R01569A | hsa-miR-518c-5p agomir | Oligonucleotides | |
| HY-R01570 | hsa-miR-518d-3p mimic | Oligonucleotides | |
| HY-R01570A | hsa-miR-518d-3p agomir | Oligonucleotides | |
| HY-R01571 | hsa-miR-518d-5p mimic | Oligonucleotides | |
| HY-R01571A | hsa-miR-518d-5p agomir | Oligonucleotides | |
| HY-R01572 | hsa-miR-518e-3p mimic | Oligonucleotides | |
| HY-R01572A | hsa-miR-518e-3p agomir | Oligonucleotides | |
| HY-R01573 | hsa-miR-518e-5p mimic | Oligonucleotides | |
| HY-R01573A | hsa-miR-518e-5p agomir | Oligonucleotides | |
| HY-R01574 | hsa-miR-518f-3p mimic | Oligonucleotides | |
| HY-R01574A | hsa-miR-518f-3p agomir | Oligonucleotides | |
| HY-R01575 | hsa-miR-518f-5p mimic | Oligonucleotides | |
| HY-R01575A | hsa-miR-518f-5p agomir | Oligonucleotides | |
| HY-R01576 | hsa-miR-5190 mimic | Oligonucleotides | |
| HY-R01576A | hsa-miR-5190 agomir | Oligonucleotides | |
| HY-R01577 | hsa-miR-5191 mimic | Oligonucleotides | |
| HY-R01577A | hsa-miR-5191 agomir | Oligonucleotides | |
| HY-R01578 | hsa-miR-5192 mimic | Oligonucleotides | |
| HY-R01578A | hsa-miR-5192 agomir | Oligonucleotides | |
| HY-R01579 | hsa-miR-5193 mimic | Oligonucleotides | |
| HY-R01579A | hsa-miR-5193 agomir | Oligonucleotides | |
| HY-R01580 | hsa-miR-5194 mimic | Oligonucleotides | |
| HY-R01580A | hsa-miR-5194 agomir | Oligonucleotides | |
| HY-R01581 | hsa-miR-5195-3p mimic | Oligonucleotides | |
| HY-R01581A | hsa-miR-5195-3p agomir | Oligonucleotides | |
| HY-R01582 | hsa-miR-5195-5p mimic | Oligonucleotides | |
| HY-R01582A | hsa-miR-5195-5p agomir | Oligonucleotides | |
| HY-R01583 | hsa-miR-5196-3p mimic | Oligonucleotides | |
| HY-R01583A | hsa-miR-5196-3p agomir | Oligonucleotides | |
| HY-R01584 | hsa-miR-5196-5p mimic | Oligonucleotides | |
| HY-R01584A | hsa-miR-5196-5p agomir | Oligonucleotides | |
| HY-R01585 | hsa-miR-5197-3p mimic | Oligonucleotides | |
| HY-R01585A | hsa-miR-5197-3p agomir | Oligonucleotides | |
| HY-R01586 | hsa-miR-5197-5p mimic | Oligonucleotides | |
| HY-R01586A | hsa-miR-5197-5p agomir | Oligonucleotides | |
| HY-R01587 | hsa-miR-519a-2-5p mimic | Oligonucleotides | |
| HY-R01587A | hsa-miR-519a-2-5p agomir | Oligonucleotides | |
| HY-R01588 | hsa-miR-519a-3p mimic | Oligonucleotides | |
| HY-R01588A | hsa-miR-519a-3p agomir | Oligonucleotides | |
| HY-R01589 | hsa-miR-519b-3p mimic | Oligonucleotides | |
| HY-R01589A | hsa-miR-519b-3p agomir | Oligonucleotides | |
| HY-R01590 | hsa-miR-519c-3p mimic | Oligonucleotides | |
| HY-R01590A | hsa-miR-519c-3p agomir | Oligonucleotides | |
| HY-R01591 | hsa-miR-519d-3p mimic | Oligonucleotides | |
| HY-R01591A | hsa-miR-519d-3p agomir | Oligonucleotides | |
| HY-R01592 | hsa-miR-519d-5p mimic | Oligonucleotides | |
| HY-R01592A | hsa-miR-519d-5p agomir | Oligonucleotides | |
| HY-R01593 | hsa-miR-519e-3p mimic | Oligonucleotides | |
| HY-R01593A | hsa-miR-519e-3p agomir | Oligonucleotides | |
| HY-R01594 | hsa-miR-519e-5p mimic | Oligonucleotides | |
| HY-R01594A | hsa-miR-519e-5p agomir | Oligonucleotides | |
| HY-R01595 | hsa-miR-520a-3p mimic | Oligonucleotides | |
| HY-R01595A | hsa-miR-520a-3p agomir | Oligonucleotides | |
| HY-R01596 | hsa-miR-520a-5p mimic | Oligonucleotides | |
| HY-R01596A | hsa-miR-520a-5p agomir | Oligonucleotides | |
| HY-R01597 | hsa-miR-520b-3p mimic | Oligonucleotides | |
| HY-R01597A | hsa-miR-520b-3p agomir | Oligonucleotides | |
| HY-R01598 | hsa-miR-520c-3p mimic | Oligonucleotides | |
| HY-R01598A | hsa-miR-520c-3p agomir | Oligonucleotides | |
| HY-R01599 | hsa-miR-520d-3p mimic | Oligonucleotides | |
| HY-R01599A | hsa-miR-520d-3p agomir | Oligonucleotides | |
| HY-R01600 | hsa-miR-520d-5p mimic | Oligonucleotides | |
| HY-R01600A | hsa-miR-520d-5p agomir | Oligonucleotides | |
| HY-R01601 | hsa-miR-520e-3p mimic | Oligonucleotides | |
| HY-R01601A | hsa-miR-520e-3p agomir | Oligonucleotides | |
| HY-R01602 | hsa-miR-520e-5p mimic | Oligonucleotides | |
| HY-R01602A | hsa-miR-520e-5p agomir | Oligonucleotides | |
| HY-R01603 | hsa-miR-520f-3p mimic | Oligonucleotides | |
| HY-R01603A | hsa-miR-520f-3p agomir | Oligonucleotides | |
| HY-R01604 | hsa-miR-520f-5p mimic | Oligonucleotides | |
| HY-R01604A | hsa-miR-520f-5p agomir | Oligonucleotides | |
| HY-R01605 | hsa-miR-520g-3p mimic | Oligonucleotides | |
| HY-R01605A | hsa-miR-520g-3p agomir | Oligonucleotides | |
| HY-R01606 | hsa-miR-520g-5p mimic | Oligonucleotides | |
| HY-R01606A | hsa-miR-520g-5p agomir | Oligonucleotides | |
| HY-R01607 | hsa-miR-520h mimic | Oligonucleotides | |
| HY-R01607A | hsa-miR-520h agomir | Oligonucleotides | |
| HY-R01608 | hsa-miR-521 mimic | Oligonucleotides | |
| HY-R01608A | hsa-miR-521 agomir | Oligonucleotides | |
| HY-R01609 | hsa-miR-522-3p mimic | Oligonucleotides | |
| HY-R01609A | hsa-miR-522-3p agomir | Oligonucleotides | |
| HY-R01610 | hsa-miR-523-3p mimic | Oligonucleotides | |
| HY-R01610A | hsa-miR-523-3p agomir | Oligonucleotides | |
| HY-R01611 | hsa-miR-524-3p mimic | Oligonucleotides | |
| HY-R01611A | hsa-miR-524-3p agomir | Oligonucleotides | |
| HY-R01612 | hsa-miR-524-5p mimic | Oligonucleotides | |
| HY-R01612A | hsa-miR-524-5p agomir | Oligonucleotides | |
| HY-R01613 | hsa-miR-525-3p mimic | Oligonucleotides | |
| HY-R01613A | hsa-miR-525-3p agomir | Oligonucleotides | |
| HY-R01614 | hsa-miR-525-5p mimic | Oligonucleotides | |
| HY-R01614A | hsa-miR-525-5p agomir | Oligonucleotides | |
| HY-R01615 | hsa-miR-526a-3p mimic | Oligonucleotides | |
| HY-R01615A | hsa-miR-526a-3p agomir | Oligonucleotides | |
| HY-R01616 | hsa-miR-526b-3p mimic | Oligonucleotides | |
| HY-R01616A | hsa-miR-526b-3p agomir | Oligonucleotides | |
| HY-R01617 | hsa-miR-526b-5p mimic | Oligonucleotides | |
| HY-R01617A | hsa-miR-526b-5p agomir | Oligonucleotides | |
| HY-R01618 | hsa-miR-532-3p mimic | Oligonucleotides | |
| HY-R01618A | hsa-miR-532-3p agomir | Oligonucleotides | |
| HY-R01619 | hsa-miR-532-5p mimic | Oligonucleotides | |
| HY-R01619A | hsa-miR-532-5p agomir | Oligonucleotides | |
| HY-R01620 | hsa-miR-539-3p mimic | Oligonucleotides | |
| HY-R01620A | hsa-miR-539-3p agomir | Oligonucleotides | |
| HY-R01621 | hsa-miR-539-5p mimic | Oligonucleotides | |
| HY-R01621A | hsa-miR-539-5p agomir | Oligonucleotides | |
| HY-R01622 | hsa-miR-541-3p mimic | Oligonucleotides | |
| HY-R01622A | hsa-miR-541-3p agomir | Oligonucleotides | |
| HY-R01623 | hsa-miR-541-5p mimic | Oligonucleotides | |
| HY-R01623A | hsa-miR-541-5p agomir | Oligonucleotides | |
| HY-R01624 | hsa-miR-542-3p mimic | Oligonucleotides | |
| HY-R01624A | hsa-miR-542-3p agomir | Oligonucleotides | |
| HY-R01625 | hsa-miR-542-5p mimic | Oligonucleotides | |
| HY-R01625A | hsa-miR-542-5p agomir | Oligonucleotides | |
| HY-R01626 | hsa-miR-543 mimic | Oligonucleotides | |
| HY-R01626A | hsa-miR-543 agomir | Oligonucleotides | |
| HY-R01627 | hsa-miR-544a mimic | Oligonucleotides | |
| HY-R01627A | hsa-miR-544a agomir | Oligonucleotides | |
| HY-R01628 | hsa-miR-544b mimic | Oligonucleotides | |
| HY-R01628A | hsa-miR-544b agomir | Oligonucleotides | |
| HY-R01629 | hsa-miR-545-3p mimic | Oligonucleotides | |
| HY-R01629A | hsa-miR-545-3p agomir | Oligonucleotides | |
| HY-R01630 | hsa-miR-545-5p mimic | Oligonucleotides | |
| HY-R01630A | hsa-miR-545-5p agomir | Oligonucleotides | |
| HY-R01631 | hsa-miR-548a-3p mimic | Oligonucleotides | |
| HY-R01631A | hsa-miR-548a-3p agomir | Oligonucleotides | |
| HY-R01632 | hsa-miR-548a-5p mimic | Oligonucleotides | |
| HY-R01632A | hsa-miR-548a-5p agomir | Oligonucleotides | |
| HY-R01633 | hsa-miR-548aa mimic | Oligonucleotides | |
| HY-R01633A | hsa-miR-548aa agomir | Oligonucleotides | |
| HY-R01634 | hsa-miR-548ab mimic | Oligonucleotides | |
| HY-R01634A | hsa-miR-548ab agomir | Oligonucleotides | |
| HY-R01635 | hsa-miR-548ac mimic | Oligonucleotides | |
| HY-R01635A | hsa-miR-548ac agomir | Oligonucleotides | |
| HY-R01636 | hsa-miR-548ad-3p mimic | Oligonucleotides | |
| HY-R01636A | hsa-miR-548ad-3p agomir | Oligonucleotides | |
| HY-R01637 | hsa-miR-548ad-5p mimic | Oligonucleotides | |
| HY-R01637A | hsa-miR-548ad-5p agomir | Oligonucleotides | |
| HY-R01638 | hsa-miR-548ae-3p mimic | Oligonucleotides | |
| HY-R01638A | hsa-miR-548ae-3p agomir | Oligonucleotides | |
| HY-R01639 | hsa-miR-548ag mimic | Oligonucleotides | |
| HY-R01639A | hsa-miR-548ag agomir | Oligonucleotides | |
| HY-R01640 | hsa-miR-548ah-3p mimic | Oligonucleotides | |
| HY-R01640A | hsa-miR-548ah-3p agomir | Oligonucleotides | |
| HY-R01641 | hsa-miR-548ah-5p mimic | Oligonucleotides | |
| HY-R01641A | hsa-miR-548ah-5p agomir | Oligonucleotides | |
| HY-R01642 | hsa-miR-548ai mimic | Oligonucleotides | |
| HY-R01642A | hsa-miR-548ai agomir | Oligonucleotides | |
| HY-R01643 | hsa-miR-548aj-3p mimic | Oligonucleotides | |
| HY-R01643A | hsa-miR-548aj-3p agomir | Oligonucleotides | |
| HY-R01644 | hsa-miR-548aj-5p mimic | Oligonucleotides | |
| HY-R01644A | hsa-miR-548aj-5p agomir | Oligonucleotides | |
| HY-R01645 | hsa-miR-548ak mimic | Oligonucleotides | |
| HY-R01645A | hsa-miR-548ak agomir | Oligonucleotides | |
| HY-R01646 | hsa-miR-548al mimic | Oligonucleotides | |
| HY-R01646A | hsa-miR-548al agomir | Oligonucleotides | |
| HY-R01647 | hsa-miR-548am-3p mimic | Oligonucleotides | |
| HY-R01647A | hsa-miR-548am-3p agomir | Oligonucleotides | |
| HY-R01648 | hsa-miR-548am-5p mimic | Oligonucleotides | |
| HY-R01648A | hsa-miR-548am-5p agomir | Oligonucleotides | |
| HY-R01649 | hsa-miR-548an mimic | Oligonucleotides | |
| HY-R01649A | hsa-miR-548an agomir | Oligonucleotides | |
| HY-R01650 | hsa-miR-548ao-3p mimic | Oligonucleotides | |
| HY-R01650A | hsa-miR-548ao-3p agomir | Oligonucleotides | |
| HY-R01651 | hsa-miR-548ao-5p mimic | Oligonucleotides | |
| HY-R01651A | hsa-miR-548ao-5p agomir | Oligonucleotides | |
| HY-R01652 | hsa-miR-548ap-3p mimic | Oligonucleotides | |
| HY-R01652A | hsa-miR-548ap-3p agomir | Oligonucleotides | |
| HY-R01653 | hsa-miR-548ap-5p mimic | Oligonucleotides | |
| HY-R01653A | hsa-miR-548ap-5p agomir | Oligonucleotides | |
| HY-R01654 | hsa-miR-548aq-3p mimic | Oligonucleotides | |
| HY-R01654A | hsa-miR-548aq-3p agomir | Oligonucleotides | |
| HY-R01655 | hsa-miR-548aq-5p mimic | Oligonucleotides | |
| HY-R01655A | hsa-miR-548aq-5p agomir | Oligonucleotides | |
| HY-R01656 | hsa-miR-548ar-3p mimic | Oligonucleotides | |
| HY-R01656A | hsa-miR-548ar-3p agomir | Oligonucleotides | |
| HY-R01657 | hsa-miR-548ar-5p mimic | Oligonucleotides | |
| HY-R01657A | hsa-miR-548ar-5p agomir | Oligonucleotides | |
| HY-R01658 | hsa-miR-548as-3p mimic | Oligonucleotides | |
| HY-R01658A | hsa-miR-548as-3p agomir | Oligonucleotides | |
| HY-R01659 | hsa-miR-548as-5p mimic | Oligonucleotides | |
| HY-R01659A | hsa-miR-548as-5p agomir | Oligonucleotides | |
| HY-R01660 | hsa-miR-548at-3p mimic | Oligonucleotides | |
| HY-R01660A | hsa-miR-548at-3p agomir | Oligonucleotides | |
| HY-R01661 | hsa-miR-548at-5p mimic | Oligonucleotides | |
| HY-R01661A | hsa-miR-548at-5p agomir | Oligonucleotides | |
| HY-R01662 | hsa-miR-548au-3p mimic | Oligonucleotides | |
| HY-R01662A | hsa-miR-548au-3p agomir | Oligonucleotides | |
| HY-R01663 | hsa-miR-548au-5p mimic | Oligonucleotides | |
| HY-R01663A | hsa-miR-548au-5p agomir | Oligonucleotides | |
| HY-R01664 | hsa-miR-548av-3p mimic | Oligonucleotides | |
| HY-R01664A | hsa-miR-548av-3p agomir | Oligonucleotides | |
| HY-R01665 | hsa-miR-548av-5p mimic | Oligonucleotides | |
| HY-R01665A | hsa-miR-548av-5p agomir | Oligonucleotides | |
| HY-R01666 | hsa-miR-548aw mimic | Oligonucleotides | |
| HY-R01666A | hsa-miR-548aw agomir | Oligonucleotides | |
| HY-R01667 | hsa-miR-548ax mimic | Oligonucleotides | |
| HY-R01667A | hsa-miR-548ax agomir | Oligonucleotides | |
| HY-R01668 | hsa-miR-548ay-3p mimic | Oligonucleotides | |
| HY-R01668A | hsa-miR-548ay-3p agomir | Oligonucleotides | |
| HY-R01669 | hsa-miR-548ay-5p mimic | Oligonucleotides | |
| HY-R01669A | hsa-miR-548ay-5p agomir | Oligonucleotides | |
| HY-R01670 | hsa-miR-548az-3p mimic | Oligonucleotides | |
| HY-R01670A | hsa-miR-548az-3p agomir | Oligonucleotides | |
| HY-R01671 | hsa-miR-548az-5p mimic | Oligonucleotides | |
| HY-R01671A | hsa-miR-548az-5p agomir | Oligonucleotides | |
| HY-R01672 | hsa-miR-548b-3p mimic | Oligonucleotides | |
| HY-R01672A | hsa-miR-548b-3p agomir | Oligonucleotides | |
| HY-R01673 | hsa-miR-548b-5p mimic | Oligonucleotides | |
| HY-R01673A | hsa-miR-548b-5p agomir | Oligonucleotides | |
| HY-R01674 | hsa-miR-548ba mimic | Oligonucleotides | |
| HY-R01674A | hsa-miR-548ba agomir | Oligonucleotides | |
| HY-R01675 | hsa-miR-548bb-3p mimic | Oligonucleotides | |
| HY-R01675A | hsa-miR-548bb-3p agomir | Oligonucleotides | |
| HY-R01676 | hsa-miR-548bb-5p mimic | Oligonucleotides | |
| HY-R01676A | hsa-miR-548bb-5p agomir | Oligonucleotides | |
| HY-R01677 | hsa-miR-548bc mimic | Oligonucleotides | |
| HY-R01677A | hsa-miR-548bc agomir | Oligonucleotides | |
| HY-R01678 | hsa-miR-548c-3p mimic | Oligonucleotides | |
| HY-R01678A | hsa-miR-548c-3p agomir | Oligonucleotides | |
| HY-R01679 | hsa-miR-548d-3p mimic | Oligonucleotides | |
| HY-R01679A | hsa-miR-548d-3p agomir | Oligonucleotides | |
| HY-R01680 | hsa-miR-548d-5p mimic | Oligonucleotides | |
| HY-R01680A | hsa-miR-548d-5p agomir | Oligonucleotides | |
| HY-R01681 | hsa-miR-548e-3p mimic | Oligonucleotides | |
| HY-R01681A | hsa-miR-548e-3p agomir | Oligonucleotides | |
| HY-R01682 | hsa-miR-548e-5p mimic | Oligonucleotides | |
| HY-R01682A | hsa-miR-548e-5p agomir | Oligonucleotides | |
| HY-R01683 | hsa-miR-548f-3p mimic | Oligonucleotides | |
| HY-R01683A | hsa-miR-548f-3p agomir | Oligonucleotides | |
| HY-R01684 | hsa-miR-548f-5p mimic | Oligonucleotides | |
| HY-R01684A | hsa-miR-548f-5p agomir | Oligonucleotides | |
| HY-R01685 | hsa-miR-548h-3p mimic | Oligonucleotides | |
| HY-R01685A | hsa-miR-548h-3p agomir | Oligonucleotides | |
| HY-R01686 | hsa-miR-548h-5p mimic | Oligonucleotides | |
| HY-R01686A | hsa-miR-548h-5p agomir | Oligonucleotides | |
| HY-R01687 | hsa-miR-548i mimic | Oligonucleotides | |
| HY-R01687A | hsa-miR-548i agomir | Oligonucleotides | |
| HY-R01688 | hsa-miR-548j-3p mimic | Oligonucleotides | |
| HY-R01688A | hsa-miR-548j-3p agomir | Oligonucleotides | |
| HY-R01689 | hsa-miR-548j-5p mimic | Oligonucleotides | |
| HY-R01689A | hsa-miR-548j-5p agomir | Oligonucleotides | |
| HY-R01690 | hsa-miR-548k mimic | Oligonucleotides | |
| HY-R01690A | hsa-miR-548k agomir | Oligonucleotides | |
| HY-R01691 | hsa-miR-548l mimic | Oligonucleotides | |
| HY-R01691A | hsa-miR-548l agomir | Oligonucleotides | |
| HY-R01692 | hsa-miR-548m mimic | Oligonucleotides | |
| HY-R01692A | hsa-miR-548m agomir | Oligonucleotides | |
| HY-R01693 | hsa-miR-548n mimic | Oligonucleotides | |
| HY-R01693A | hsa-miR-548n agomir | Oligonucleotides | |
| HY-R01694 | hsa-miR-548o-3p mimic | Oligonucleotides | |
| HY-R01694A | hsa-miR-548o-3p agomir | Oligonucleotides | |
| HY-R01695 | hsa-miR-548p mimic | Oligonucleotides | |
| HY-R01695A | hsa-miR-548p agomir | Oligonucleotides | |
| HY-R01696 | hsa-miR-548q mimic | Oligonucleotides | |
| HY-R01696A | hsa-miR-548q agomir | Oligonucleotides | |
| HY-R01697 | hsa-miR-548s mimic | Oligonucleotides | |
| HY-R01697A | hsa-miR-548s agomir | Oligonucleotides | |
| HY-R01698 | hsa-miR-548t-5p mimic | Oligonucleotides | |
| HY-R01698A | hsa-miR-548t-5p agomir | Oligonucleotides | |
| HY-R01699 | hsa-miR-548u mimic | Oligonucleotides | |
| HY-R01699A | hsa-miR-548u agomir | Oligonucleotides | |
| HY-R01700 | hsa-miR-548v mimic | Oligonucleotides | |
| HY-R01700A | hsa-miR-548v agomir | Oligonucleotides | |
| HY-R01701 | hsa-miR-548w mimic | Oligonucleotides | |
| HY-R01701A | hsa-miR-548w agomir | Oligonucleotides | |
| HY-R01702 | hsa-miR-548x-3p mimic | Oligonucleotides | |
| HY-R01702A | hsa-miR-548x-3p agomir | Oligonucleotides | |
| HY-R01703 | hsa-miR-548y mimic | Oligonucleotides | |
| HY-R01703A | hsa-miR-548y agomir | Oligonucleotides | |
| HY-R01704 | hsa-miR-549a-3p mimic | Oligonucleotides | |
| HY-R01704A | hsa-miR-549a-3p agomir | Oligonucleotides | |
| HY-R01705 | hsa-miR-549a-5p mimic | Oligonucleotides | |
| HY-R01705A | hsa-miR-549a-5p agomir | Oligonucleotides | |
| HY-R01706 | hsa-miR-550a-3-5p mimic | Oligonucleotides | |
| HY-R01706A | hsa-miR-550a-3-5p agomir | Oligonucleotides | |
| HY-R01707 | hsa-miR-550a-3p mimic | Oligonucleotides | |
| HY-R01707A | hsa-miR-550a-3p agomir | Oligonucleotides | |
| HY-R01708 | hsa-miR-550a-5p mimic | Oligonucleotides | |
| HY-R01708A | hsa-miR-550a-5p agomir | Oligonucleotides | |
| HY-R01709 | hsa-miR-550b-2-5p mimic | Oligonucleotides | |
| HY-R01709A | hsa-miR-550b-2-5p agomir | Oligonucleotides | |
| HY-R01710 | hsa-miR-550b-3p mimic | Oligonucleotides | |
| HY-R01710A | hsa-miR-550b-3p agomir | Oligonucleotides | |
| HY-R01711 | hsa-miR-551a mimic | Oligonucleotides | |
| HY-R01711A | hsa-miR-551a agomir | Oligonucleotides | |
| HY-R01712 | hsa-miR-551b-3p mimic | Oligonucleotides | |
| HY-R01712A | hsa-miR-551b-3p agomir | Oligonucleotides | |
| HY-R01713 | hsa-miR-551b-5p mimic | Oligonucleotides | |
| HY-R01713A | hsa-miR-551b-5p agomir | Oligonucleotides | |
| HY-R01714 | hsa-miR-552-3p mimic | Oligonucleotides | |
| HY-R01714A | hsa-miR-552-3p agomir | Oligonucleotides | |
| HY-R01715 | hsa-miR-552-5p mimic | Oligonucleotides | |
| HY-R01715A | hsa-miR-552-5p agomir | Oligonucleotides | |
| HY-R01716 | hsa-miR-553 mimic | Oligonucleotides | |
| HY-R01716A | hsa-miR-553 agomir | Oligonucleotides | |
| HY-R01717 | hsa-miR-554 mimic | Oligonucleotides | |
| HY-R01717A | hsa-miR-554 agomir | Oligonucleotides | |
| HY-R01718 | hsa-miR-555 mimic | Oligonucleotides | |
| HY-R01718A | hsa-miR-555 agomir | Oligonucleotides | |
| HY-R01719 | hsa-miR-556-3p mimic | Oligonucleotides | |
| HY-R01719A | hsa-miR-556-3p agomir | Oligonucleotides | |
| HY-R01720 | hsa-miR-556-5p mimic | Oligonucleotides | |
| HY-R01720A | hsa-miR-556-5p agomir | Oligonucleotides | |
| HY-R01721 | hsa-miR-5571-3p mimic | Oligonucleotides | |
| HY-R01721A | hsa-miR-5571-3p agomir | Oligonucleotides | |
| HY-R01722 | hsa-miR-5571-5p mimic | Oligonucleotides | |
| HY-R01722A | hsa-miR-5571-5p agomir | Oligonucleotides | |
| HY-R01723 | hsa-miR-5572 mimic | Oligonucleotides | |
| HY-R01723A | hsa-miR-5572 agomir | Oligonucleotides | |
| HY-R01724 | hsa-miR-5579-3p mimic | Oligonucleotides | |
| HY-R01724A | hsa-miR-5579-3p agomir | Oligonucleotides | |
| HY-R01725 | hsa-miR-5579-5p mimic | Oligonucleotides | |
| HY-R01725A | hsa-miR-5579-5p agomir | Oligonucleotides | |
| HY-R01726 | hsa-miR-5580-3p mimic | Oligonucleotides | |
| HY-R01726A | hsa-miR-5580-3p agomir | Oligonucleotides | |
| HY-R01727 | hsa-miR-5580-5p mimic | Oligonucleotides | |
| HY-R01727A | hsa-miR-5580-5p agomir | Oligonucleotides | |
| HY-R01728 | hsa-miR-5581-3p mimic | Oligonucleotides | |
| HY-R01728A | hsa-miR-5581-3p agomir | Oligonucleotides | |
| HY-R01729 | hsa-miR-5581-5p mimic | Oligonucleotides | |
| HY-R01729A | hsa-miR-5581-5p agomir | Oligonucleotides | |
| HY-R01730 | hsa-miR-5582-3p mimic | Oligonucleotides | |
| HY-R01730A | hsa-miR-5582-3p agomir | Oligonucleotides | |
| HY-R01731 | hsa-miR-5582-5p mimic | Oligonucleotides | |
| HY-R01731A | hsa-miR-5582-5p agomir | Oligonucleotides | |
| HY-R01732 | hsa-miR-5583-3p mimic | Oligonucleotides | |
| HY-R01732A | hsa-miR-5583-3p agomir | Oligonucleotides | |
| HY-R01733 | hsa-miR-5583-5p mimic | Oligonucleotides | |
| HY-R01733A | hsa-miR-5583-5p agomir | Oligonucleotides | |
| HY-R01734 | hsa-miR-5584-3p mimic | Oligonucleotides | |
| HY-R01734A | hsa-miR-5584-3p agomir | Oligonucleotides | |
| HY-R01735 | hsa-miR-5584-5p mimic | Oligonucleotides | |
| HY-R01735A | hsa-miR-5584-5p agomir | Oligonucleotides | |
| HY-R01736 | hsa-miR-5585-3p mimic | Oligonucleotides | |
| HY-R01736A | hsa-miR-5585-3p agomir | Oligonucleotides | |
| HY-R01737 | hsa-miR-5585-5p mimic | Oligonucleotides | |
| HY-R01737A | hsa-miR-5585-5p agomir | Oligonucleotides | |
| HY-R01738 | hsa-miR-5586-3p mimic | Oligonucleotides | |
| HY-R01738A | hsa-miR-5586-3p agomir | Oligonucleotides | |
| HY-R01739 | hsa-miR-5586-5p mimic | Oligonucleotides | |
| HY-R01739A | hsa-miR-5586-5p agomir | Oligonucleotides | |
| HY-R01740 | hsa-miR-5587-3p mimic | Oligonucleotides | |
| HY-R01740A | hsa-miR-5587-3p agomir | Oligonucleotides | |
| HY-R01741 | hsa-miR-5587-5p mimic | Oligonucleotides | |
| HY-R01741A | hsa-miR-5587-5p agomir | Oligonucleotides | |
| HY-R01742 | hsa-miR-5588-3p mimic | Oligonucleotides | |
| HY-R01742A | hsa-miR-5588-3p agomir | Oligonucleotides | |
| HY-R01743 | hsa-miR-5588-5p mimic | Oligonucleotides | |
| HY-R01743A | hsa-miR-5588-5p agomir | Oligonucleotides | |
| HY-R01744 | hsa-miR-5589-3p mimic | Oligonucleotides | |
| HY-R01744A | hsa-miR-5589-3p agomir | Oligonucleotides | |
| HY-R01745 | hsa-miR-5589-5p mimic | Oligonucleotides | |
| HY-R01745A | hsa-miR-5589-5p agomir | Oligonucleotides | |
| HY-R01746 | hsa-miR-559 mimic | Oligonucleotides | |
| HY-R01746A | hsa-miR-559 agomir | Oligonucleotides | |
| HY-R01747 | hsa-miR-5590-3p mimic | Oligonucleotides | |
| HY-R01747A | hsa-miR-5590-3p agomir | Oligonucleotides | |
| HY-R01748 | hsa-miR-5590-5p mimic | Oligonucleotides | |
| HY-R01748A | hsa-miR-5590-5p agomir | Oligonucleotides | |
| HY-R01749 | hsa-miR-5591-3p mimic | Oligonucleotides | |
| HY-R01749A | hsa-miR-5591-3p agomir | Oligonucleotides | |
| HY-R01750 | hsa-miR-5591-5p mimic | Oligonucleotides | |
| HY-R01750A | hsa-miR-5591-5p agomir | Oligonucleotides | |
| HY-R01751 | hsa-miR-561-3p mimic | Oligonucleotides | |
| HY-R01751A | hsa-miR-561-3p agomir | Oligonucleotides | |
| HY-R01752 | hsa-miR-561-5p mimic | Oligonucleotides | |
| HY-R01752A | hsa-miR-561-5p agomir | Oligonucleotides | |
| HY-R01753 | hsa-miR-562 mimic | Oligonucleotides | |
| HY-R01753A | hsa-miR-562 agomir | Oligonucleotides | |
| HY-R01754 | hsa-miR-563 mimic | Oligonucleotides | |
| HY-R01754A | hsa-miR-563 agomir | Oligonucleotides | |
| HY-R01755 | hsa-miR-564 mimic | Oligonucleotides | |
| HY-R01755A | hsa-miR-564 agomir | Oligonucleotides | |
| HY-R01756 | hsa-miR-567 mimic | Oligonucleotides | |
| HY-R01756A | hsa-miR-567 agomir | Oligonucleotides | |
| HY-R01757 | hsa-miR-568 mimic | Oligonucleotides | |
| HY-R01757A | hsa-miR-568 agomir | Oligonucleotides | |
| HY-R01758 | hsa-miR-5680 mimic | Oligonucleotides | |
| HY-R01758A | hsa-miR-5680 agomir | Oligonucleotides | |
| HY-R01759 | hsa-miR-5681a mimic | Oligonucleotides | |
| HY-R01759A | hsa-miR-5681a agomir | Oligonucleotides | |
| HY-R01760 | hsa-miR-5681b mimic | Oligonucleotides | |
| HY-R01760A | hsa-miR-5681b agomir | Oligonucleotides | |
| HY-R01761 | hsa-miR-5682 mimic | Oligonucleotides | |
| HY-R01761A | hsa-miR-5682 agomir | Oligonucleotides | |
| HY-R01762 | hsa-miR-5683 mimic | Oligonucleotides | |
| HY-R01762A | hsa-miR-5683 agomir | Oligonucleotides | |
| HY-R01763 | hsa-miR-5684 mimic | Oligonucleotides | |
| HY-R01763A | hsa-miR-5684 agomir | Oligonucleotides | |
| HY-R01764 | hsa-miR-5685 mimic | Oligonucleotides | |
| HY-R01764A | hsa-miR-5685 agomir | Oligonucleotides | |
| HY-R01765 | hsa-miR-5687 mimic | Oligonucleotides | |
| HY-R01765A | hsa-miR-5687 agomir | Oligonucleotides | |
| HY-R01766 | hsa-miR-5688 mimic | Oligonucleotides | |
| HY-R01766A | hsa-miR-5688 agomir | Oligonucleotides | |
| HY-R01767 | hsa-miR-5689 mimic | Oligonucleotides | |
| HY-R01767A | hsa-miR-5689 agomir | Oligonucleotides | |
| HY-R01768 | hsa-miR-569 mimic | Oligonucleotides | |
| HY-R01768A | hsa-miR-569 agomir | Oligonucleotides | |
| HY-R01769 | hsa-miR-5690 mimic | Oligonucleotides | |
| HY-R01769A | hsa-miR-5690 agomir | Oligonucleotides | |
| HY-R01770 | hsa-miR-5691 mimic | Oligonucleotides | |
| HY-R01770A | hsa-miR-5691 agomir | Oligonucleotides | |
| HY-R01771 | hsa-miR-5692a mimic | Oligonucleotides | |
| HY-R01771A | hsa-miR-5692a agomir | Oligonucleotides | |
| HY-R01772 | hsa-miR-5692b mimic | Oligonucleotides | |
| HY-R01772A | hsa-miR-5692b agomir | Oligonucleotides | |
| HY-R01773 | hsa-miR-5692c mimic | Oligonucleotides | |
| HY-R01773A | hsa-miR-5692c agomir | Oligonucleotides | |
| HY-R01774 | hsa-miR-5693 mimic | Oligonucleotides | |
| HY-R01774A | hsa-miR-5693 agomir | Oligonucleotides | |
| HY-R01775 | hsa-miR-5694 mimic | Oligonucleotides | |
| HY-R01775A | hsa-miR-5694 agomir | Oligonucleotides | |
| HY-R01776 | hsa-miR-5695 mimic | Oligonucleotides | |
| HY-R01776A | hsa-miR-5695 agomir | Oligonucleotides | |
| HY-R01777 | hsa-miR-5696 mimic | Oligonucleotides | |
| HY-R01777A | hsa-miR-5696 agomir | Oligonucleotides | |
| HY-R01778 | hsa-miR-5697 mimic | Oligonucleotides | |
| HY-R01778A | hsa-miR-5697 agomir | Oligonucleotides | |
| HY-R01779 | hsa-miR-5698 mimic | Oligonucleotides | |
| HY-R01779A | hsa-miR-5698 agomir | Oligonucleotides | |
| HY-R01780 | hsa-miR-5699-3p mimic | Oligonucleotides | |
| HY-R01780A | hsa-miR-5699-3p agomir | Oligonucleotides | |
| HY-R01781 | hsa-miR-5699-5p mimic | Oligonucleotides | |
| HY-R01781A | hsa-miR-5699-5p agomir | Oligonucleotides | |
| HY-R01782 | hsa-miR-5700 mimic | Oligonucleotides | |
| HY-R01782A | hsa-miR-5700 agomir | Oligonucleotides | |
| HY-R01783 | hsa-miR-5701 mimic | Oligonucleotides | |
| HY-R01783A | hsa-miR-5701 agomir | Oligonucleotides | |
| HY-R01784 | hsa-miR-5702 mimic | Oligonucleotides | |
| HY-R01784A | hsa-miR-5702 agomir | Oligonucleotides | |
| HY-R01785 | hsa-miR-5703 mimic | Oligonucleotides | |
| HY-R01785A | hsa-miR-5703 agomir | Oligonucleotides | |
| HY-R01786 | hsa-miR-570-3p mimic | Oligonucleotides | |
| HY-R01786A | hsa-miR-570-3p agomir | Oligonucleotides | |
| HY-R01787 | hsa-miR-5704 mimic | Oligonucleotides | |
| HY-R01787A | hsa-miR-5704 agomir | Oligonucleotides | |
| HY-R01788 | hsa-miR-5705 mimic | Oligonucleotides | |
| HY-R01788A | hsa-miR-5705 agomir | Oligonucleotides | |
| HY-R01789 | hsa-miR-5706 mimic | Oligonucleotides | |
| HY-R01789A | hsa-miR-5706 agomir | Oligonucleotides | |
| HY-R01790 | hsa-miR-5707 mimic | Oligonucleotides | |
| HY-R01790A | hsa-miR-5707 agomir | Oligonucleotides | |
| HY-R01791 | hsa-miR-5708 mimic | Oligonucleotides | |
| HY-R01791A | hsa-miR-5708 agomir | Oligonucleotides | |
| HY-R01792 | hsa-miR-571 mimic | Oligonucleotides | |
| HY-R01792A | hsa-miR-571 agomir | Oligonucleotides | |
| HY-R01793 | hsa-miR-572 mimic | Oligonucleotides | |
| HY-R01793A | hsa-miR-572 agomir | Oligonucleotides | |
| HY-R01794 | hsa-miR-573 mimic | Oligonucleotides | |
| HY-R01794A | hsa-miR-573 agomir | Oligonucleotides | |
| HY-R01795 | hsa-miR-5739 mimic | Oligonucleotides | |
| HY-R01795A | hsa-miR-5739 agomir | Oligonucleotides | |
| HY-R01796 | hsa-miR-574-3p mimic | Oligonucleotides | |
| HY-R01796A | hsa-miR-574-3p agomir | Oligonucleotides | |
| HY-R01797 | hsa-miR-574-5p mimic | Oligonucleotides | |
| HY-R01797A | hsa-miR-574-5p agomir | Oligonucleotides | |
| HY-R01798 | hsa-miR-575 mimic | Oligonucleotides | |
| HY-R01798A | hsa-miR-575 agomir | Oligonucleotides | |
| HY-R01799 | hsa-miR-576-3p mimic | Oligonucleotides | |
| HY-R01799A | hsa-miR-576-3p agomir | Oligonucleotides | |
| HY-R01800 | hsa-miR-576-5p mimic | Oligonucleotides | |
| HY-R01800A | hsa-miR-576-5p agomir | Oligonucleotides | |
| HY-R01801 | hsa-miR-577 mimic | Oligonucleotides | |
| HY-R01801A | hsa-miR-577 agomir | Oligonucleotides | |
| HY-R01802 | hsa-miR-578 mimic | Oligonucleotides | |
| HY-R01802A | hsa-miR-578 agomir | Oligonucleotides | |
| HY-R01803 | hsa-miR-5787 mimic | Oligonucleotides | |
| HY-R01803A | hsa-miR-5787 agomir | Oligonucleotides | |
| HY-R01804 | hsa-miR-579-3p mimic | Oligonucleotides | |
| HY-R01804A | hsa-miR-579-3p agomir | Oligonucleotides | |
| HY-R01805 | hsa-miR-579-5p mimic | Oligonucleotides | |
| HY-R01805A | hsa-miR-579-5p agomir | Oligonucleotides | |
| HY-R01806 | hsa-miR-580-3p mimic | Oligonucleotides | |
| HY-R01806A | hsa-miR-580-3p agomir | Oligonucleotides | |
| HY-R01807 | hsa-miR-580-5p mimic | Oligonucleotides | |
| HY-R01807A | hsa-miR-580-5p agomir | Oligonucleotides | |
| HY-R01808 | hsa-miR-581 mimic | Oligonucleotides | |
| HY-R01808A | hsa-miR-581 agomir | Oligonucleotides | |
| HY-R01809 | hsa-miR-582-3p mimic | Oligonucleotides | |
| HY-R01809A | hsa-miR-582-3p agomir | Oligonucleotides | |
| HY-R01810 | hsa-miR-582-5p mimic | Oligonucleotides | |
| HY-R01810A | hsa-miR-582-5p agomir | Oligonucleotides | |
| HY-R01811 | hsa-miR-583 mimic | Oligonucleotides | |
| HY-R01811A | hsa-miR-583 agomir | Oligonucleotides | |
| HY-R01812 | hsa-miR-584-3p mimic | Oligonucleotides | |
| HY-R01812A | hsa-miR-584-3p agomir | Oligonucleotides | |
| HY-R01813 | hsa-miR-584-5p mimic | Oligonucleotides | |
| HY-R01813A | hsa-miR-584-5p agomir | Oligonucleotides | |
| HY-R01814 | hsa-miR-585-3p mimic | Oligonucleotides | |
| HY-R01814A | hsa-miR-585-3p agomir | Oligonucleotides | |
| HY-R01815 | hsa-miR-585-5p mimic | Oligonucleotides | |
| HY-R01815A | hsa-miR-585-5p agomir | Oligonucleotides | |
| HY-R01816 | hsa-miR-586 mimic | Oligonucleotides | |
| HY-R01816A | hsa-miR-586 agomir | Oligonucleotides | |
| HY-R01817 | hsa-miR-587 mimic | Oligonucleotides | |
| HY-R01817A | hsa-miR-587 agomir | Oligonucleotides | |
| HY-R01818 | hsa-miR-588 mimic | Oligonucleotides | |
| HY-R01818A | hsa-miR-588 agomir | Oligonucleotides | |
| HY-R01819 | hsa-miR-589-3p mimic | Oligonucleotides | |
| HY-R01819A | hsa-miR-589-3p agomir | Oligonucleotides | |
| HY-R01820 | hsa-miR-589-5p mimic | Oligonucleotides | |
| HY-R01820A | hsa-miR-589-5p agomir | Oligonucleotides | |
| HY-R01821 | hsa-miR-590-3p mimic | Oligonucleotides | |
| HY-R01821A | hsa-miR-590-3p agomir | Oligonucleotides | |
| HY-R01822 | hsa-miR-590-5p mimic | Oligonucleotides | |
| HY-R01822A | hsa-miR-590-5p agomir | Oligonucleotides | |
| HY-R01823 | hsa-miR-591 mimic | Oligonucleotides | |
| HY-R01823A | hsa-miR-591 agomir | Oligonucleotides | |
| HY-R01824 | hsa-miR-592 mimic | Oligonucleotides | |
| HY-R01824A | hsa-miR-592 agomir | Oligonucleotides | |
| HY-R01825 | hsa-miR-593-3p mimic | Oligonucleotides | |
| HY-R01825A | hsa-miR-593-3p agomir | Oligonucleotides | |
| HY-R01826 | hsa-miR-593-5p mimic | Oligonucleotides | |
| HY-R01826A | hsa-miR-593-5p agomir | Oligonucleotides | |
| HY-R01827 | hsa-miR-595 mimic | Oligonucleotides | |
| HY-R01827A | hsa-miR-595 agomir | Oligonucleotides | |
| HY-R01828 | hsa-miR-596 mimic | Oligonucleotides | |
| HY-R01828A | hsa-miR-596 agomir | Oligonucleotides | |
| HY-R01829 | hsa-miR-597-3p mimic | Oligonucleotides | |
| HY-R01829A | hsa-miR-597-3p agomir | Oligonucleotides | |
| HY-R01830 | hsa-miR-597-5p mimic | Oligonucleotides | |
| HY-R01830A | hsa-miR-597-5p agomir | Oligonucleotides | |
| HY-R01831 | hsa-miR-598-5p mimic | Oligonucleotides | |
| HY-R01831A | hsa-miR-598-5p agomir | Oligonucleotides | |
| HY-R01832 | hsa-miR-599 mimic | Oligonucleotides | |
| HY-R01832A | hsa-miR-599 agomir | Oligonucleotides | |
| HY-R01833 | hsa-miR-600 mimic | Oligonucleotides | |
| HY-R01833A | hsa-miR-600 agomir | Oligonucleotides | |
| HY-R01834 | hsa-miR-601 mimic | Oligonucleotides | |
| HY-R01834A | hsa-miR-601 agomir | Oligonucleotides | |
| HY-R01835 | hsa-miR-602 mimic | Oligonucleotides | |
| HY-R01835A | hsa-miR-602 agomir | Oligonucleotides | |
| HY-R01836 | hsa-miR-603 mimic | Oligonucleotides | |
| HY-R01836A | hsa-miR-603 agomir | Oligonucleotides | |
| HY-R01837 | hsa-miR-604 mimic | Oligonucleotides | |
| HY-R01837A | hsa-miR-604 agomir | Oligonucleotides | |
| HY-R01838 | hsa-miR-605-3p mimic | Oligonucleotides | |
| HY-R01838A | hsa-miR-605-3p agomir | Oligonucleotides | |
| HY-R01839 | hsa-miR-605-5p mimic | Oligonucleotides | |
| HY-R01839A | hsa-miR-605-5p agomir | Oligonucleotides | |
| HY-R01840 | hsa-miR-606 mimic | Oligonucleotides | |
| HY-R01840A | hsa-miR-606 agomir | Oligonucleotides | |
| HY-R01841 | hsa-miR-6068 mimic | Oligonucleotides | |
| HY-R01841A | hsa-miR-6068 agomir | Oligonucleotides | |
| HY-R01842 | hsa-miR-6069 mimic | Oligonucleotides | |
| HY-R01842A | hsa-miR-6069 agomir | Oligonucleotides | |
| HY-R01843 | hsa-miR-607 mimic | Oligonucleotides | |
| HY-R01843A | hsa-miR-607 agomir | Oligonucleotides | |
| HY-R01844 | hsa-miR-6070 mimic | Oligonucleotides | |
| HY-R01844A | hsa-miR-6070 agomir | Oligonucleotides | |
| HY-R01845 | hsa-miR-6071 mimic | Oligonucleotides | |
| HY-R01845A | hsa-miR-6071 agomir | Oligonucleotides | |
| HY-R01846 | hsa-miR-6072 mimic | Oligonucleotides | |
| HY-R01846A | hsa-miR-6072 agomir | Oligonucleotides | |
| HY-R01847 | hsa-miR-6073 mimic | Oligonucleotides | |
| HY-R01847A | hsa-miR-6073 agomir | Oligonucleotides | |
| HY-R01848 | hsa-miR-6074 mimic | Oligonucleotides | |
| HY-R01848A | hsa-miR-6074 agomir | Oligonucleotides | |
| HY-R01849 | hsa-miR-6075 mimic | Oligonucleotides | |
| HY-R01849A | hsa-miR-6075 agomir | Oligonucleotides | |
| HY-R01850 | hsa-miR-6076 mimic | Oligonucleotides | |
| HY-R01850A | hsa-miR-6076 agomir | Oligonucleotides | |
| HY-R01851 | hsa-miR-6077 mimic | Oligonucleotides | |
| HY-R01851A | hsa-miR-6077 agomir | Oligonucleotides | |
| HY-R01852 | hsa-miR-6078 mimic | Oligonucleotides | |
| HY-R01852A | hsa-miR-6078 agomir | Oligonucleotides | |
| HY-R01853 | hsa-miR-6079 mimic | Oligonucleotides | |
| HY-R01853A | hsa-miR-6079 agomir | Oligonucleotides | |
| HY-R01854 | hsa-miR-608 mimic | Oligonucleotides | |
| HY-R01854A | hsa-miR-608 agomir | Oligonucleotides | |
| HY-R01855 | hsa-miR-6080 mimic | Oligonucleotides | |
| HY-R01855A | hsa-miR-6080 agomir | Oligonucleotides | |
| HY-R01856 | hsa-miR-6081 mimic | Oligonucleotides | |
| HY-R01856A | hsa-miR-6081 agomir | Oligonucleotides | |
| HY-R01857 | hsa-miR-6082 mimic | Oligonucleotides | |
| HY-R01857A | hsa-miR-6082 agomir | Oligonucleotides | |
| HY-R01858 | hsa-miR-6083 mimic | Oligonucleotides | |
| HY-R01858A | hsa-miR-6083 agomir | Oligonucleotides | |
| HY-R01859 | hsa-miR-6084 mimic | Oligonucleotides | |
| HY-R01859A | hsa-miR-6084 agomir | Oligonucleotides | |
| HY-R01860 | hsa-miR-6085 mimic | Oligonucleotides | |
| HY-R01860A | hsa-miR-6085 agomir | Oligonucleotides | |
| HY-R01861 | hsa-miR-6086 mimic | Oligonucleotides | |
| HY-R01861A | hsa-miR-6086 agomir | Oligonucleotides | |
| HY-R01862 | hsa-miR-6088 mimic | Oligonucleotides | |
| HY-R01862A | hsa-miR-6088 agomir | Oligonucleotides | |
| HY-R01863 | hsa-miR-6089 mimic | Oligonucleotides | |
| HY-R01863A | hsa-miR-6089 agomir | Oligonucleotides | |
| HY-R01864 | hsa-miR-609 mimic | Oligonucleotides | |
| HY-R01864A | hsa-miR-609 agomir | Oligonucleotides | |
| HY-R01865 | hsa-miR-6090 mimic | Oligonucleotides | |
| HY-R01865A | hsa-miR-6090 agomir | Oligonucleotides | |
| HY-R01866 | hsa-miR-610 mimic | Oligonucleotides | |
| HY-R01866A | hsa-miR-610 agomir | Oligonucleotides | |
| HY-R01867 | hsa-miR-612 mimic | Oligonucleotides | |
| HY-R01867A | hsa-miR-612 agomir | Oligonucleotides | |
| HY-R01868 | hsa-miR-6124 mimic | Oligonucleotides | |
| HY-R01868A | hsa-miR-6124 agomir | Oligonucleotides | |
| HY-R01869 | hsa-miR-6125 mimic | Oligonucleotides | |
| HY-R01869A | hsa-miR-6125 agomir | Oligonucleotides | |
| HY-R01870 | hsa-miR-6126 mimic | Oligonucleotides | |
| HY-R01870A | hsa-miR-6126 agomir | Oligonucleotides | |
| HY-R01871 | hsa-miR-6127 mimic | Oligonucleotides | |
| HY-R01871A | hsa-miR-6127 agomir | Oligonucleotides | |
| HY-R01872 | hsa-miR-6128 mimic | Oligonucleotides | |
| HY-R01872A | hsa-miR-6128 agomir | Oligonucleotides | |
| HY-R01873 | hsa-miR-6129 mimic | Oligonucleotides | |
| HY-R01873A | hsa-miR-6129 agomir | Oligonucleotides | |
| HY-R01874 | hsa-miR-613 mimic | Oligonucleotides | |
| HY-R01874A | hsa-miR-613 agomir | Oligonucleotides | |
| HY-R01875 | hsa-miR-6130 mimic | Oligonucleotides | |
| HY-R01875A | hsa-miR-6130 agomir | Oligonucleotides | |
| HY-R01876 | hsa-miR-6131 mimic | Oligonucleotides | |
| HY-R01876A | hsa-miR-6131 agomir | Oligonucleotides | |
| HY-R01877 | hsa-miR-6132 mimic | Oligonucleotides | |
| HY-R01877A | hsa-miR-6132 agomir | Oligonucleotides | |
| HY-R01878 | hsa-miR-6133 mimic | Oligonucleotides | |
| HY-R01878A | hsa-miR-6133 agomir | Oligonucleotides | |
| HY-R01879 | hsa-miR-6134 mimic | Oligonucleotides | |
| HY-R01879A | hsa-miR-6134 agomir | Oligonucleotides | |
| HY-R01880 | hsa-miR-614 mimic | Oligonucleotides | |
| HY-R01880A | hsa-miR-614 agomir | Oligonucleotides | |
| HY-R01881 | hsa-miR-615-3p mimic | Oligonucleotides | |
| HY-R01881A | hsa-miR-615-3p agomir | Oligonucleotides | |
| HY-R01882 | hsa-miR-615-5p mimic | Oligonucleotides | |
| HY-R01882A | hsa-miR-615-5p agomir | Oligonucleotides | |
| HY-R01883 | hsa-miR-616-3p mimic | Oligonucleotides | |
| HY-R01883A | hsa-miR-616-3p agomir | Oligonucleotides | |
| HY-R01884 | hsa-miR-6165 mimic | Oligonucleotides | |
| HY-R01884A | hsa-miR-6165 agomir | Oligonucleotides | |
| HY-R01885 | hsa-miR-616-5p mimic | Oligonucleotides | |
| HY-R01885A | hsa-miR-616-5p agomir | Oligonucleotides | |
| HY-R01886 | hsa-miR-617 mimic | Oligonucleotides | |
| HY-R01886A | hsa-miR-617 agomir | Oligonucleotides | |
| HY-R01887 | hsa-miR-618 mimic | Oligonucleotides | |
| HY-R01887A | hsa-miR-618 agomir | Oligonucleotides | |
| HY-R01888 | hsa-miR-619-3p mimic | Oligonucleotides | |
| HY-R01888A | hsa-miR-619-3p agomir | Oligonucleotides | |
| HY-R01889 | hsa-miR-619-5p mimic | Oligonucleotides | |
| HY-R01889A | hsa-miR-619-5p agomir | Oligonucleotides | |
| HY-R01890 | hsa-miR-620 mimic | Oligonucleotides | |
| HY-R01890A | hsa-miR-620 agomir | Oligonucleotides | |
| HY-R01891 | hsa-miR-621 mimic | Oligonucleotides | |
| HY-R01891A | hsa-miR-621 agomir | Oligonucleotides | |
| HY-R01892 | hsa-miR-623 mimic | Oligonucleotides | |
| HY-R01892A | hsa-miR-623 agomir | Oligonucleotides | |
| HY-R01893 | hsa-miR-624-3p mimic | Oligonucleotides | |
| HY-R01893A | hsa-miR-624-3p agomir | Oligonucleotides | |
| HY-R01894 | hsa-miR-624-5p mimic | Oligonucleotides | |
| HY-R01894A | hsa-miR-624-5p agomir | Oligonucleotides | |
| HY-R01895 | hsa-miR-625-3p mimic | Oligonucleotides | |
| HY-R01895A | hsa-miR-625-3p agomir | Oligonucleotides | |
| HY-R01896 | hsa-miR-625-5p mimic | Oligonucleotides | |
| HY-R01896A | hsa-miR-625-5p agomir | Oligonucleotides | |
| HY-R01897 | hsa-miR-626 mimic | Oligonucleotides | |
| HY-R01897A | hsa-miR-626 agomir | Oligonucleotides | |
| HY-R01898 | hsa-miR-627-3p mimic | Oligonucleotides | |
| HY-R01898A | hsa-miR-627-3p agomir | Oligonucleotides | |
| HY-R01899 | hsa-miR-627-5p mimic | Oligonucleotides | |
| HY-R01899A | hsa-miR-627-5p agomir | Oligonucleotides | |
| HY-R01900 | hsa-miR-628-3p mimic | Oligonucleotides | |
| HY-R01900A | hsa-miR-628-3p agomir | Oligonucleotides | |
| HY-R01901 | hsa-miR-628-5p mimic | Oligonucleotides | |
| HY-R01901A | hsa-miR-628-5p agomir | Oligonucleotides | |
| HY-R01902 | hsa-miR-629-3p mimic | Oligonucleotides | |
| HY-R01902A | hsa-miR-629-3p agomir | Oligonucleotides | |
| HY-R01903 | hsa-miR-629-5p mimic | Oligonucleotides | |
| HY-R01903A | hsa-miR-629-5p agomir | Oligonucleotides | |
| HY-R01904 | hsa-miR-630 mimic | Oligonucleotides | |
| HY-R01904A | hsa-miR-630 agomir | Oligonucleotides | |
| HY-R01905 | hsa-miR-631 mimic | Oligonucleotides | |
| HY-R01905A | hsa-miR-631 agomir | Oligonucleotides | |
| HY-R01906 | hsa-miR-632 mimic | Oligonucleotides | |
| HY-R01906A | hsa-miR-632 agomir | Oligonucleotides | |
| HY-R01907 | hsa-miR-633 mimic | Oligonucleotides | |
| HY-R01907A | hsa-miR-633 agomir | Oligonucleotides | |
| HY-R01908 | hsa-miR-634 mimic | Oligonucleotides | |
| HY-R01908A | hsa-miR-634 agomir | Oligonucleotides | |
| HY-R01909 | hsa-miR-635 mimic | Oligonucleotides | |
| HY-R01909A | hsa-miR-635 agomir | Oligonucleotides | |
| HY-R01910 | hsa-miR-636 mimic | Oligonucleotides | |
| HY-R01910A | hsa-miR-636 agomir | Oligonucleotides | |
| HY-R01911 | hsa-miR-637 mimic | Oligonucleotides | |
| HY-R01911A | hsa-miR-637 agomir | Oligonucleotides | |
| HY-R01912 | hsa-miR-638 mimic | Oligonucleotides | |
| HY-R01912A | hsa-miR-638 agomir | Oligonucleotides | |
| HY-R01913 | hsa-miR-639 mimic | Oligonucleotides | |
| HY-R01913A | hsa-miR-639 agomir | Oligonucleotides | |
| HY-R01914 | hsa-miR-640 mimic | Oligonucleotides | |
| HY-R01914A | hsa-miR-640 agomir | Oligonucleotides | |
| HY-R01915 | hsa-miR-641 mimic | Oligonucleotides | |
| HY-R01915A | hsa-miR-641 agomir | Oligonucleotides | |
| HY-R01916 | hsa-miR-642a-3p mimic | Oligonucleotides | |
| HY-R01916A | hsa-miR-642a-3p agomir | Oligonucleotides | |
| HY-R01917 | hsa-miR-642a-5p mimic | Oligonucleotides | |
| HY-R01917A | hsa-miR-642a-5p agomir | Oligonucleotides | |
| HY-R01918 | hsa-miR-642b-3p mimic | Oligonucleotides | |
| HY-R01918A | hsa-miR-642b-3p agomir | Oligonucleotides | |
| HY-R01919 | hsa-miR-642b-5p mimic | Oligonucleotides | |
| HY-R01919A | hsa-miR-642b-5p agomir | Oligonucleotides | |
| HY-R01920 | hsa-miR-644a mimic | Oligonucleotides | |
| HY-R01920A | hsa-miR-644a agomir | Oligonucleotides | |
| HY-R01921 | hsa-miR-645 mimic | Oligonucleotides | |
| HY-R01921A | hsa-miR-645 agomir | Oligonucleotides | |
| HY-R01922 | hsa-miR-647 mimic | Oligonucleotides | |
| HY-R01922A | hsa-miR-647 agomir | Oligonucleotides | |
| HY-R01923 | hsa-miR-648 mimic | Oligonucleotides | |
| HY-R01923A | hsa-miR-648 agomir | Oligonucleotides | |
| HY-R01924 | hsa-miR-6499-3p mimic | Oligonucleotides | |
| HY-R01924A | hsa-miR-6499-3p agomir | Oligonucleotides | |
| HY-R01925 | hsa-miR-6499-5p mimic | Oligonucleotides | |
| HY-R01925A | hsa-miR-6499-5p agomir | Oligonucleotides | |
| HY-R01926 | hsa-miR-650 mimic | Oligonucleotides | |
| HY-R01926A | hsa-miR-650 agomir | Oligonucleotides | |
| HY-R01927 | hsa-miR-6500-3p mimic | Oligonucleotides | |
| HY-R01927A | hsa-miR-6500-3p agomir | Oligonucleotides | |
| HY-R01928 | hsa-miR-6500-5p mimic | Oligonucleotides | |
| HY-R01928A | hsa-miR-6500-5p agomir | Oligonucleotides | |
| HY-R01929 | hsa-miR-6501-3p mimic | Oligonucleotides | |
| HY-R01929A | hsa-miR-6501-3p agomir | Oligonucleotides | |
| HY-R01930 | hsa-miR-6501-5p mimic | Oligonucleotides | |
| HY-R01930A | hsa-miR-6501-5p agomir | Oligonucleotides | |
| HY-R01931 | hsa-miR-6502-3p mimic | Oligonucleotides | |
| HY-R01931A | hsa-miR-6502-3p agomir | Oligonucleotides | |
| HY-R01932 | hsa-miR-6502-5p mimic | Oligonucleotides | |
| HY-R01932A | hsa-miR-6502-5p agomir | Oligonucleotides | |
| HY-R01933 | hsa-miR-6503-3p mimic | Oligonucleotides | |
| HY-R01933A | hsa-miR-6503-3p agomir | Oligonucleotides | |
| HY-R01934 | hsa-miR-6503-5p mimic | Oligonucleotides | |
| HY-R01934A | hsa-miR-6503-5p agomir | Oligonucleotides | |
| HY-R01935 | hsa-miR-6504-3p mimic | Oligonucleotides | |
| HY-R01935A | hsa-miR-6504-3p agomir | Oligonucleotides | |
| HY-R01936 | hsa-miR-6504-5p mimic | Oligonucleotides | |
| HY-R01936A | hsa-miR-6504-5p agomir | Oligonucleotides | |
| HY-R01937 | hsa-miR-6505-3p mimic | Oligonucleotides | |
| HY-R01937A | hsa-miR-6505-3p agomir | Oligonucleotides | |
| HY-R01938 | hsa-miR-6505-5p mimic | Oligonucleotides | |
| HY-R01938A | hsa-miR-6505-5p agomir | Oligonucleotides | |
| HY-R01939 | hsa-miR-6506-3p mimic | Oligonucleotides | |
| HY-R01939A | hsa-miR-6506-3p agomir | Oligonucleotides | |
| HY-R01940 | hsa-miR-6506-5p mimic | Oligonucleotides | |
| HY-R01940A | hsa-miR-6506-5p agomir | Oligonucleotides | |
| HY-R01941 | hsa-miR-6507-3p mimic | Oligonucleotides | |
| HY-R01941A | hsa-miR-6507-3p agomir | Oligonucleotides | |
| HY-R01942 | hsa-miR-6507-5p mimic | Oligonucleotides | |
| HY-R01942A | hsa-miR-6507-5p agomir | Oligonucleotides | |
| HY-R01943 | hsa-miR-6508-3p mimic | Oligonucleotides | |
| HY-R01943A | hsa-miR-6508-3p agomir | Oligonucleotides | |
| HY-R01944 | hsa-miR-6508-5p mimic | Oligonucleotides | |
| HY-R01944A | hsa-miR-6508-5p agomir | Oligonucleotides | |
| HY-R01945 | hsa-miR-6509-3p mimic | Oligonucleotides | |
| HY-R01945A | hsa-miR-6509-3p agomir | Oligonucleotides | |
| HY-R01946 | hsa-miR-6509-5p mimic | Oligonucleotides | |
| HY-R01946A | hsa-miR-6509-5p agomir | Oligonucleotides | |
| HY-R01947 | hsa-miR-6510-3p mimic | Oligonucleotides | |
| HY-R01947A | hsa-miR-6510-3p agomir | Oligonucleotides | |
| HY-R01948 | hsa-miR-6510-5p mimic | Oligonucleotides | |
| HY-R01948A | hsa-miR-6510-5p agomir | Oligonucleotides | |
| HY-R01949 | hsa-miR-6511a-3p mimic | Oligonucleotides | |
| HY-R01949A | hsa-miR-6511a-3p agomir | Oligonucleotides | |
| HY-R01950 | hsa-miR-6511a-5p mimic | Oligonucleotides | |
| HY-R01950A | hsa-miR-6511a-5p agomir | Oligonucleotides | |
| HY-R01951 | hsa-miR-6511b-3p mimic | Oligonucleotides | |
| HY-R01951A | hsa-miR-6511b-3p agomir | Oligonucleotides | |
| HY-R01952 | hsa-miR-6511b-5p mimic | Oligonucleotides | |
| HY-R01952A | hsa-miR-6511b-5p agomir | Oligonucleotides | |
| HY-R01953 | hsa-miR-6512-3p mimic | Oligonucleotides | |
| HY-R01953A | hsa-miR-6512-3p agomir | Oligonucleotides | |
| HY-R01954 | hsa-miR-6512-5p mimic | Oligonucleotides | |
| HY-R01954A | hsa-miR-6512-5p agomir | Oligonucleotides | |
| HY-R01955 | hsa-miR-6513-3p mimic | Oligonucleotides | |
| HY-R01955A | hsa-miR-6513-3p agomir | Oligonucleotides | |
| HY-R01956 | hsa-miR-6513-5p mimic | Oligonucleotides | |
| HY-R01956A | hsa-miR-6513-5p agomir | Oligonucleotides | |
| HY-R01957 | hsa-miR-651-3p mimic | Oligonucleotides | |
| HY-R01957A | hsa-miR-651-3p agomir | Oligonucleotides | |
| HY-R01958 | hsa-miR-6514-3p mimic | Oligonucleotides | |
| HY-R01958A | hsa-miR-6514-3p agomir | Oligonucleotides | |
| HY-R01959 | hsa-miR-6514-5p mimic | Oligonucleotides | |
| HY-R01959A | hsa-miR-6514-5p agomir | Oligonucleotides | |
| HY-R01960 | hsa-miR-6515-3p mimic | Oligonucleotides | |
| HY-R01960A | hsa-miR-6515-3p agomir | Oligonucleotides | |
| HY-R01961 | hsa-miR-6515-5p mimic | Oligonucleotides | |
| HY-R01961A | hsa-miR-6515-5p agomir | Oligonucleotides | |
| HY-R01962 | hsa-miR-651-5p mimic | Oligonucleotides | |
| HY-R01962A | hsa-miR-651-5p agomir | Oligonucleotides | |
| HY-R01963 | hsa-miR-6516-3p mimic | Oligonucleotides | |
| HY-R01963A | hsa-miR-6516-3p agomir | Oligonucleotides | |
| HY-R01964 | hsa-miR-6516-5p mimic | Oligonucleotides | |
| HY-R01964A | hsa-miR-6516-5p agomir | Oligonucleotides | |
| HY-R01965 | hsa-miR-652-3p mimic | Oligonucleotides | |
| HY-R01965A | hsa-miR-652-3p agomir | Oligonucleotides | |
| HY-R01966 | hsa-miR-652-5p mimic | Oligonucleotides | |
| HY-R01966A | hsa-miR-652-5p agomir | Oligonucleotides | |
| HY-R01967 | hsa-miR-6529-3p mimic | Oligonucleotides | |
| HY-R01967A | hsa-miR-6529-3p agomir | Oligonucleotides | |
| HY-R01968 | hsa-miR-6529-5p mimic | Oligonucleotides | |
| HY-R01968A | hsa-miR-6529-5p agomir | Oligonucleotides | |
| HY-R01969 | hsa-miR-653-3p mimic | Oligonucleotides | |
| HY-R01969A | hsa-miR-653-3p agomir | Oligonucleotides | |
| HY-R01970 | hsa-miR-653-5p mimic | Oligonucleotides | |
| HY-R01970A | hsa-miR-653-5p agomir | Oligonucleotides | |
| HY-R01971 | hsa-miR-654-3p mimic | Oligonucleotides | |
| HY-R01971A | hsa-miR-654-3p agomir | Oligonucleotides | |
| HY-R01972 | hsa-miR-654-5p mimic | Oligonucleotides | |
| HY-R01972A | hsa-miR-654-5p agomir | Oligonucleotides | |
| HY-R01973 | hsa-miR-655-3p mimic | Oligonucleotides | |
| HY-R01973A | hsa-miR-655-3p agomir | Oligonucleotides | |
| HY-R01974 | hsa-miR-655-5p mimic | Oligonucleotides | |
| HY-R01974A | hsa-miR-655-5p agomir | Oligonucleotides | |
| HY-R01975 | hsa-miR-656-3p mimic | Oligonucleotides | |
| HY-R01975A | hsa-miR-656-3p agomir | Oligonucleotides | |
| HY-R01976 | hsa-miR-656-5p mimic | Oligonucleotides | |
| HY-R01976A | hsa-miR-656-5p agomir | Oligonucleotides | |
| HY-R01977 | hsa-miR-657 mimic | Oligonucleotides | |
| HY-R01977A | hsa-miR-657 agomir | Oligonucleotides | |
| HY-R01978 | hsa-miR-658 mimic | Oligonucleotides | |
| HY-R01978A | hsa-miR-658 agomir | Oligonucleotides | |
| HY-R01979 | hsa-miR-659-3p mimic | Oligonucleotides | |
| HY-R01979A | hsa-miR-659-3p agomir | Oligonucleotides | |
| HY-R01980 | hsa-miR-659-5p mimic | Oligonucleotides | |
| HY-R01980A | hsa-miR-659-5p agomir | Oligonucleotides | |
| HY-R01981 | hsa-miR-660-3p mimic | Oligonucleotides | |
| HY-R01981A | hsa-miR-660-3p agomir | Oligonucleotides | |
| HY-R01982 | hsa-miR-660-5p mimic | Oligonucleotides | |
| HY-R01982A | hsa-miR-660-5p agomir | Oligonucleotides | |
| HY-R01983 | hsa-miR-661 mimic | Oligonucleotides | |
| HY-R01983A | hsa-miR-661 agomir | Oligonucleotides | |
| HY-R01984 | hsa-miR-662 mimic | Oligonucleotides | |
| HY-R01984A | hsa-miR-662 agomir | Oligonucleotides | |
| HY-R01985 | hsa-miR-663b mimic | Oligonucleotides | |
| HY-R01985A | hsa-miR-663b agomir | Oligonucleotides | |
| HY-R01986 | hsa-miR-664a-5p mimic | Oligonucleotides | |
| HY-R01986A | hsa-miR-664a-5p agomir | Oligonucleotides | |
| HY-R01987 | hsa-miR-664b-3p mimic | Oligonucleotides | |
| HY-R01987A | hsa-miR-664b-3p agomir | Oligonucleotides | |
| HY-R01988 | hsa-miR-664b-5p mimic | Oligonucleotides | |
| HY-R01988A | hsa-miR-664b-5p agomir | Oligonucleotides | |
| HY-R01989 | hsa-miR-665 mimic | Oligonucleotides | |
| HY-R01989A | hsa-miR-665 agomir | Oligonucleotides | |
| HY-R01990 | hsa-miR-668-5p mimic | Oligonucleotides | |
| HY-R01990A | hsa-miR-668-5p agomir | Oligonucleotides | |
| HY-R01991 | hsa-miR-670-3p mimic | Oligonucleotides | |
| HY-R01991A | hsa-miR-670-3p agomir | Oligonucleotides | |
| HY-R01992 | hsa-miR-670-5p mimic | Oligonucleotides | |
| HY-R01992A | hsa-miR-670-5p agomir | Oligonucleotides | |
| HY-R01993 | hsa-miR-671-3p mimic | Oligonucleotides | |
| HY-R01993A | hsa-miR-671-3p agomir | Oligonucleotides | |
| HY-R01994 | hsa-miR-6715a-3p mimic | Oligonucleotides | |
| HY-R01994A | hsa-miR-6715a-3p agomir | Oligonucleotides | |
| HY-R01995 | hsa-miR-6715b-3p mimic | Oligonucleotides | |
| HY-R01995A | hsa-miR-6715b-3p agomir | Oligonucleotides | |
| HY-R01996 | hsa-miR-6715b-5p mimic | Oligonucleotides | |
| HY-R01996A | hsa-miR-6715b-5p agomir | Oligonucleotides | |
| HY-R01997 | hsa-miR-671-5p mimic | Oligonucleotides | |
| HY-R01997A | hsa-miR-671-5p agomir | Oligonucleotides | |
| HY-R01998 | hsa-miR-6716-3p mimic | Oligonucleotides | |
| HY-R01998A | hsa-miR-6716-3p agomir | Oligonucleotides | |
| HY-R01999 | hsa-miR-6716-5p mimic | Oligonucleotides | |
| HY-R01999A | hsa-miR-6716-5p agomir | Oligonucleotides | |
| HY-R02000 | hsa-miR-6717-5p mimic | Oligonucleotides | |
| HY-R02000A | hsa-miR-6717-5p agomir | Oligonucleotides | |
| HY-R02001 | hsa-miR-6718-5p mimic | Oligonucleotides | |
| HY-R02001A | hsa-miR-6718-5p agomir | Oligonucleotides | |
| HY-R02002 | hsa-miR-6719-3p mimic | Oligonucleotides | |
| HY-R02002A | hsa-miR-6719-3p agomir | Oligonucleotides | |
| HY-R02003 | hsa-miR-6720-3p mimic | Oligonucleotides | |
| HY-R02003A | hsa-miR-6720-3p agomir | Oligonucleotides | |
| HY-R02004 | hsa-miR-6720-5p mimic | Oligonucleotides | |
| HY-R02004A | hsa-miR-6720-5p agomir | Oligonucleotides | |
| HY-R02005 | hsa-miR-6721-5p mimic | Oligonucleotides | |
| HY-R02005A | hsa-miR-6721-5p agomir | Oligonucleotides | |
| HY-R02006 | hsa-miR-6722-3p mimic | Oligonucleotides | |
| HY-R02006A | hsa-miR-6722-3p agomir | Oligonucleotides | |
| HY-R02007 | hsa-miR-6722-5p mimic | Oligonucleotides | |
| HY-R02007A | hsa-miR-6722-5p agomir | Oligonucleotides | |
| HY-R02008 | hsa-miR-6724-5p mimic | Oligonucleotides | |
| HY-R02008A | hsa-miR-6724-5p agomir | Oligonucleotides | |
| HY-R02009 | hsa-miR-6726-3p mimic | Oligonucleotides | |
| HY-R02009A | hsa-miR-6726-3p agomir | Oligonucleotides | |
| HY-R02010 | hsa-miR-6726-5p mimic | Oligonucleotides | |
| HY-R02010A | hsa-miR-6726-5p agomir | Oligonucleotides | |
| HY-R02011 | hsa-miR-6727-3p mimic | Oligonucleotides | |
| HY-R02011A | hsa-miR-6727-3p agomir | Oligonucleotides | |
| HY-R02012 | hsa-miR-6727-5p mimic | Oligonucleotides | |
| HY-R02012A | hsa-miR-6727-5p agomir | Oligonucleotides | |
| HY-R02013 | hsa-miR-6728-3p mimic | Oligonucleotides | |
| HY-R02013A | hsa-miR-6728-3p agomir | Oligonucleotides | |
| HY-R02014 | hsa-miR-6728-5p mimic | Oligonucleotides | |
| HY-R02014A | hsa-miR-6728-5p agomir | Oligonucleotides | |
| HY-R02015 | hsa-miR-6729-3p mimic | Oligonucleotides | |
| HY-R02015A | hsa-miR-6729-3p agomir | Oligonucleotides | |
| HY-R02016 | hsa-miR-6729-5p mimic | Oligonucleotides | |
| HY-R02016A | hsa-miR-6729-5p agomir | Oligonucleotides | |
| HY-R02017 | hsa-miR-6730-3p mimic | Oligonucleotides | |
| HY-R02017A | hsa-miR-6730-3p agomir | Oligonucleotides | |
| HY-R02018 | hsa-miR-6730-5p mimic | Oligonucleotides | |
| HY-R02018A | hsa-miR-6730-5p agomir | Oligonucleotides | |
| HY-R02019 | hsa-miR-6731-3p mimic | Oligonucleotides | |
| HY-R02019A | hsa-miR-6731-3p agomir | Oligonucleotides | |
| HY-R02020 | hsa-miR-6731-5p mimic | Oligonucleotides | |
| HY-R02020A | hsa-miR-6731-5p agomir | Oligonucleotides | |
| HY-R02021 | hsa-miR-6732-3p mimic | Oligonucleotides | |
| HY-R02021A | hsa-miR-6732-3p agomir | Oligonucleotides | |
| HY-R02022 | hsa-miR-6732-5p mimic | Oligonucleotides | |
| HY-R02022A | hsa-miR-6732-5p agomir | Oligonucleotides | |
| HY-R02023 | hsa-miR-6733-3p mimic | Oligonucleotides | |
| HY-R02023A | hsa-miR-6733-3p agomir | Oligonucleotides | |
| HY-R02024 | hsa-miR-6733-5p mimic | Oligonucleotides | |
| HY-R02024A | hsa-miR-6733-5p agomir | Oligonucleotides | |
| HY-R02025 | hsa-miR-6734-3p mimic | Oligonucleotides | |
| HY-R02025A | hsa-miR-6734-3p agomir | Oligonucleotides | |
| HY-R02026 | hsa-miR-6734-5p mimic | Oligonucleotides | |
| HY-R02026A | hsa-miR-6734-5p agomir | Oligonucleotides | |
| HY-R02027 | hsa-miR-6735-3p mimic | Oligonucleotides | |
| HY-R02027A | hsa-miR-6735-3p agomir | Oligonucleotides | |
| HY-R02028 | hsa-miR-6735-5p mimic | Oligonucleotides | |
| HY-R02028A | hsa-miR-6735-5p agomir | Oligonucleotides | |
| HY-R02029 | hsa-miR-6736-3p mimic | Oligonucleotides | |
| HY-R02029A | hsa-miR-6736-3p agomir | Oligonucleotides | |
| HY-R02030 | hsa-miR-6736-5p mimic | Oligonucleotides | |
| HY-R02030A | hsa-miR-6736-5p agomir | Oligonucleotides | |
| HY-R02031 | hsa-miR-6737-3p mimic | Oligonucleotides | |
| HY-R02031A | hsa-miR-6737-3p agomir | Oligonucleotides | |
| HY-R02032 | hsa-miR-6737-5p mimic | Oligonucleotides | |
| HY-R02032A | hsa-miR-6737-5p agomir | Oligonucleotides | |
| HY-R02033 | hsa-miR-6738-3p mimic | Oligonucleotides | |
| HY-R02033A | hsa-miR-6738-3p agomir | Oligonucleotides | |
| HY-R02034 | hsa-miR-6738-5p mimic | Oligonucleotides | |
| HY-R02034A | hsa-miR-6738-5p agomir | Oligonucleotides | |
| HY-R02035 | hsa-miR-6739-3p mimic | Oligonucleotides | |
| HY-R02035A | hsa-miR-6739-3p agomir | Oligonucleotides | |
| HY-R02036 | hsa-miR-6739-5p mimic | Oligonucleotides | |
| HY-R02036A | hsa-miR-6739-5p agomir | Oligonucleotides | |
| HY-R02037 | hsa-miR-6740-3p mimic | Oligonucleotides | |
| HY-R02037A | hsa-miR-6740-3p agomir | Oligonucleotides | |
| HY-R02038 | hsa-miR-6740-5p mimic | Oligonucleotides | |
| HY-R02038A | hsa-miR-6740-5p agomir | Oligonucleotides | |
| HY-R02039 | hsa-miR-6741-3p mimic | Oligonucleotides | |
| HY-R02039A | hsa-miR-6741-3p agomir | Oligonucleotides | |
| HY-R02040 | hsa-miR-6741-5p mimic | Oligonucleotides | |
| HY-R02040A | hsa-miR-6741-5p agomir | Oligonucleotides | |
| HY-R02041 | hsa-miR-6742-3p mimic | Oligonucleotides | |
| HY-R02041A | hsa-miR-6742-3p agomir | Oligonucleotides | |
| HY-R02042 | hsa-miR-6742-5p mimic | Oligonucleotides | |
| HY-R02042A | hsa-miR-6742-5p agomir | Oligonucleotides | |
| HY-R02043 | hsa-miR-6743-3p mimic | Oligonucleotides | |
| HY-R02043A | hsa-miR-6743-3p agomir | Oligonucleotides | |
| HY-R02044 | hsa-miR-6743-5p mimic | Oligonucleotides | |
| HY-R02044A | hsa-miR-6743-5p agomir | Oligonucleotides | |
| HY-R02045 | hsa-miR-6744-3p mimic | Oligonucleotides | |
| HY-R02045A | hsa-miR-6744-3p agomir | Oligonucleotides | |
| HY-R02046 | hsa-miR-6744-5p mimic | Oligonucleotides | |
| HY-R02046A | hsa-miR-6744-5p agomir | Oligonucleotides | |
| HY-R02047 | hsa-miR-6745 mimic | Oligonucleotides | |
| HY-R02047A | hsa-miR-6745 agomir | Oligonucleotides | |
| HY-R02048 | hsa-miR-6746-3p mimic | Oligonucleotides | |
| HY-R02048A | hsa-miR-6746-3p agomir | Oligonucleotides | |
| HY-R02049 | hsa-miR-6746-5p mimic | Oligonucleotides | |
| HY-R02049A | hsa-miR-6746-5p agomir | Oligonucleotides | |
| HY-R02050 | hsa-miR-6747-3p mimic | Oligonucleotides | |
| HY-R02050A | hsa-miR-6747-3p agomir | Oligonucleotides | |
| HY-R02051 | hsa-miR-6747-5p mimic | Oligonucleotides | |
| HY-R02051A | hsa-miR-6747-5p agomir | Oligonucleotides | |
| HY-R02052 | hsa-miR-6748-3p mimic | Oligonucleotides | |
| HY-R02052A | hsa-miR-6748-3p agomir | Oligonucleotides | |
| HY-R02053 | hsa-miR-6748-5p mimic | Oligonucleotides | |
| HY-R02053A | hsa-miR-6748-5p agomir | Oligonucleotides | |
| HY-R02054 | hsa-miR-6749-3p mimic | Oligonucleotides | |
| HY-R02054A | hsa-miR-6749-3p agomir | Oligonucleotides | |
| HY-R02055 | hsa-miR-6749-5p mimic | Oligonucleotides | |
| HY-R02055A | hsa-miR-6749-5p agomir | Oligonucleotides | |
| HY-R02056 | hsa-miR-6750-3p mimic | Oligonucleotides | |
| HY-R02056A | hsa-miR-6750-3p agomir | Oligonucleotides | |
| HY-R02057 | hsa-miR-6750-5p mimic | Oligonucleotides | |
| HY-R02057A | hsa-miR-6750-5p agomir | Oligonucleotides | |
| HY-R02058 | hsa-miR-6751-3p mimic | Oligonucleotides | |
| HY-R02058A | hsa-miR-6751-3p agomir | Oligonucleotides | |
| HY-R02059 | hsa-miR-6751-5p mimic | Oligonucleotides | |
| HY-R02059A | hsa-miR-6751-5p agomir | Oligonucleotides | |
| HY-R02060 | hsa-miR-6752-3p mimic | Oligonucleotides | |
| HY-R02060A | hsa-miR-6752-3p agomir | Oligonucleotides | |
| HY-R02061 | hsa-miR-6752-5p mimic | Oligonucleotides | |
| HY-R02061A | hsa-miR-6752-5p agomir | Oligonucleotides | |
| HY-R02062 | hsa-miR-6753-3p mimic | Oligonucleotides | |
| HY-R02062A | hsa-miR-6753-3p agomir | Oligonucleotides | |
| HY-R02063 | hsa-miR-6753-5p mimic | Oligonucleotides | |
| HY-R02063A | hsa-miR-6753-5p agomir | Oligonucleotides | |
| HY-R02064 | hsa-miR-675-3p mimic | Oligonucleotides | |
| HY-R02064A | hsa-miR-675-3p agomir | Oligonucleotides | |
| HY-R02065 | hsa-miR-6754-3p mimic | Oligonucleotides | |
| HY-R02065A | hsa-miR-6754-3p agomir | Oligonucleotides | |
| HY-R02066 | hsa-miR-6754-5p mimic | Oligonucleotides | |
| HY-R02066A | hsa-miR-6754-5p agomir | Oligonucleotides | |
| HY-R02067 | hsa-miR-6755-3p mimic | Oligonucleotides | |
| HY-R02067A | hsa-miR-6755-3p agomir | Oligonucleotides | |
| HY-R02068 | hsa-miR-6755-5p mimic | Oligonucleotides | |
| HY-R02068A | hsa-miR-6755-5p agomir | Oligonucleotides | |
| HY-R02069 | hsa-miR-675-5p mimic | Oligonucleotides | |
| HY-R02069A | hsa-miR-675-5p agomir | Oligonucleotides | |
| HY-R02070 | hsa-miR-6756-3p mimic | Oligonucleotides | |
| HY-R02070A | hsa-miR-6756-3p agomir | Oligonucleotides | |
| HY-R02071 | hsa-miR-6756-5p mimic | Oligonucleotides | |
| HY-R02071A | hsa-miR-6756-5p agomir | Oligonucleotides | |
| HY-R02072 | hsa-miR-6757-3p mimic | Oligonucleotides | |
| HY-R02072A | hsa-miR-6757-3p agomir | Oligonucleotides | |
| HY-R02073 | hsa-miR-6757-5p mimic | Oligonucleotides | |
| HY-R02073A | hsa-miR-6757-5p agomir | Oligonucleotides | |
| HY-R02074 | hsa-miR-6758-3p mimic | Oligonucleotides | |
| HY-R02074A | hsa-miR-6758-3p agomir | Oligonucleotides | |
| HY-R02075 | hsa-miR-6758-5p mimic | Oligonucleotides | |
| HY-R02075A | hsa-miR-6758-5p agomir | Oligonucleotides | |
| HY-R02076 | hsa-miR-6759-3p mimic | Oligonucleotides | |
| HY-R02076A | hsa-miR-6759-3p agomir | Oligonucleotides | |
| HY-R02077 | hsa-miR-6759-5p mimic | Oligonucleotides | |
| HY-R02077A | hsa-miR-6759-5p agomir | Oligonucleotides | |
| HY-R02078 | hsa-miR-6760-3p mimic | Oligonucleotides | |
| HY-R02078A | hsa-miR-6760-3p agomir | Oligonucleotides | |
| HY-R02079 | hsa-miR-6760-5p mimic | Oligonucleotides | |
| HY-R02079A | hsa-miR-6760-5p agomir | Oligonucleotides | |
| HY-R02080 | hsa-miR-6761-3p mimic | Oligonucleotides | |
| HY-R02080A | hsa-miR-6761-3p agomir | Oligonucleotides | |
| HY-R02081 | hsa-miR-6761-5p mimic | Oligonucleotides | |
| HY-R02081A | hsa-miR-6761-5p agomir | Oligonucleotides | |
| HY-R02082 | hsa-miR-6762-3p mimic | Oligonucleotides | |
| HY-R02082A | hsa-miR-6762-3p agomir | Oligonucleotides | |
| HY-R02083 | hsa-miR-6762-5p mimic | Oligonucleotides | |
| HY-R02083A | hsa-miR-6762-5p agomir | Oligonucleotides | |
| HY-R02084 | hsa-miR-6763-3p mimic | Oligonucleotides | |
| HY-R02084A | hsa-miR-6763-3p agomir | Oligonucleotides | |
| HY-R02085 | hsa-miR-6763-5p mimic | Oligonucleotides | |
| HY-R02085A | hsa-miR-6763-5p agomir | Oligonucleotides | |
| HY-R02086 | hsa-miR-676-3p mimic | Oligonucleotides | |
| HY-R02086A | hsa-miR-676-3p agomir | Oligonucleotides | |
| HY-R02087 | hsa-miR-6764-3p mimic | Oligonucleotides | |
| HY-R02087A | hsa-miR-6764-3p agomir | Oligonucleotides | |
| HY-R02088 | hsa-miR-6764-5p mimic | Oligonucleotides | |
| HY-R02088A | hsa-miR-6764-5p agomir | Oligonucleotides | |
| HY-R02089 | hsa-miR-6765-3p mimic | Oligonucleotides | |
| HY-R02089A | hsa-miR-6765-3p agomir | Oligonucleotides | |
| HY-R02090 | hsa-miR-6765-5p mimic | Oligonucleotides | |
| HY-R02090A | hsa-miR-6765-5p agomir | Oligonucleotides | |
| HY-R02091 | hsa-miR-676-5p mimic | Oligonucleotides | |
| HY-R02091A | hsa-miR-676-5p agomir | Oligonucleotides | |
| HY-R02092 | hsa-miR-6766-3p mimic | Oligonucleotides | |
| HY-R02092A | hsa-miR-6766-3p agomir | Oligonucleotides | |
| HY-R02093 | hsa-miR-6766-5p mimic | Oligonucleotides | |
| HY-R02093A | hsa-miR-6766-5p agomir | Oligonucleotides | |
| HY-R02094 | hsa-miR-6767-3p mimic | Oligonucleotides | |
| HY-R02094A | hsa-miR-6767-3p agomir | Oligonucleotides | |
| HY-R02095 | hsa-miR-6767-5p mimic | Oligonucleotides | |
| HY-R02095A | hsa-miR-6767-5p agomir | Oligonucleotides | |
| HY-R02096 | hsa-miR-6768-3p mimic | Oligonucleotides | |
| HY-R02096A | hsa-miR-6768-3p agomir | Oligonucleotides | |
| HY-R02097 | hsa-miR-6768-5p mimic | Oligonucleotides | |
| HY-R02097A | hsa-miR-6768-5p agomir | Oligonucleotides | |
| HY-R02098 | hsa-miR-6769a-3p mimic | Oligonucleotides | |
| HY-R02098A | hsa-miR-6769a-3p agomir | Oligonucleotides | |
| HY-R02099 | hsa-miR-6769a-5p mimic | Oligonucleotides | |
| HY-R02099A | hsa-miR-6769a-5p agomir | Oligonucleotides | |
| HY-R02100 | hsa-miR-6769b-3p mimic | Oligonucleotides | |
| HY-R02100A | hsa-miR-6769b-3p agomir | Oligonucleotides | |
| HY-R02101 | hsa-miR-6769b-5p mimic | Oligonucleotides | |
| HY-R02101A | hsa-miR-6769b-5p agomir | Oligonucleotides | |
| HY-R02102 | hsa-miR-6770-3p mimic | Oligonucleotides | |
| HY-R02102A | hsa-miR-6770-3p agomir | Oligonucleotides | |
| HY-R02103 | hsa-miR-6770-5p mimic | Oligonucleotides | |
| HY-R02103A | hsa-miR-6770-5p agomir | Oligonucleotides | |
| HY-R02104 | hsa-miR-6771-3p mimic | Oligonucleotides | |
| HY-R02104A | hsa-miR-6771-3p agomir | Oligonucleotides | |
| HY-R02105 | hsa-miR-6771-5p mimic | Oligonucleotides | |
| HY-R02105A | hsa-miR-6771-5p agomir | Oligonucleotides | |
| HY-R02106 | hsa-miR-6772-3p mimic | Oligonucleotides | |
| HY-R02106A | hsa-miR-6772-3p agomir | Oligonucleotides | |
| HY-R02107 | hsa-miR-6772-5p mimic | Oligonucleotides | |
| HY-R02107A | hsa-miR-6772-5p agomir | Oligonucleotides | |
| HY-R02108 | hsa-miR-6773-3p mimic | Oligonucleotides | |
| HY-R02108A | hsa-miR-6773-3p agomir | Oligonucleotides | |
| HY-R02109 | hsa-miR-6773-5p mimic | Oligonucleotides | |
| HY-R02109A | hsa-miR-6773-5p agomir | Oligonucleotides | |
| HY-R02110 | hsa-miR-6774-3p mimic | Oligonucleotides | |
| HY-R02110A | hsa-miR-6774-3p agomir | Oligonucleotides | |
| HY-R02111 | hsa-miR-6774-5p mimic | Oligonucleotides | |
| HY-R02111A | hsa-miR-6774-5p agomir | Oligonucleotides | |
| HY-R02112 | hsa-miR-6775-3p mimic | Oligonucleotides | |
| HY-R02112A | hsa-miR-6775-3p agomir | Oligonucleotides | |
| HY-R02113 | hsa-miR-6775-5p mimic | Oligonucleotides | |
| HY-R02113A | hsa-miR-6775-5p agomir | Oligonucleotides | |
| HY-R02114 | hsa-miR-6776-3p mimic | Oligonucleotides | |
| HY-R02114A | hsa-miR-6776-3p agomir | Oligonucleotides | |
| HY-R02115 | hsa-miR-6776-5p mimic | Oligonucleotides | |
| HY-R02115A | hsa-miR-6776-5p agomir | Oligonucleotides | |
| HY-R02116 | hsa-miR-6777-3p mimic | Oligonucleotides | |
| HY-R02116A | hsa-miR-6777-3p agomir | Oligonucleotides | |
| HY-R02117 | hsa-miR-6777-5p mimic | Oligonucleotides | |
| HY-R02117A | hsa-miR-6777-5p agomir | Oligonucleotides | |
| HY-R02118 | hsa-miR-6778-3p mimic | Oligonucleotides | |
| HY-R02118A | hsa-miR-6778-3p agomir | Oligonucleotides | |
| HY-R02119 | hsa-miR-6778-5p mimic | Oligonucleotides | |
| HY-R02119A | hsa-miR-6778-5p agomir | Oligonucleotides | |
| HY-R02120 | hsa-miR-6779-3p mimic | Oligonucleotides | |
| HY-R02120A | hsa-miR-6779-3p agomir | Oligonucleotides | |
| HY-R02121 | hsa-miR-6779-5p mimic | Oligonucleotides | |
| HY-R02121A | hsa-miR-6779-5p agomir | Oligonucleotides | |
| HY-R02122 | hsa-miR-6780a-3p mimic | Oligonucleotides | |
| HY-R02122A | hsa-miR-6780a-3p agomir | Oligonucleotides | |
| HY-R02123 | hsa-miR-6780a-5p mimic | Oligonucleotides | |
| HY-R02123A | hsa-miR-6780a-5p agomir | Oligonucleotides | |
| HY-R02124 | hsa-miR-6780b-3p mimic | Oligonucleotides | |
| HY-R02124A | hsa-miR-6780b-3p agomir | Oligonucleotides | |
| HY-R02125 | hsa-miR-6780b-5p mimic | Oligonucleotides | |
| HY-R02125A | hsa-miR-6780b-5p agomir | Oligonucleotides | |
| HY-R02126 | hsa-miR-6781-3p mimic | Oligonucleotides | |
| HY-R02126A | hsa-miR-6781-3p agomir | Oligonucleotides | |
| HY-R02127 | hsa-miR-6781-5p mimic | Oligonucleotides | |
| HY-R02127A | hsa-miR-6781-5p agomir | Oligonucleotides | |
| HY-R02128 | hsa-miR-6782-3p mimic | Oligonucleotides | |
| HY-R02128A | hsa-miR-6782-3p agomir | Oligonucleotides | |
| HY-R02129 | hsa-miR-6782-5p mimic | Oligonucleotides | |
| HY-R02129A | hsa-miR-6782-5p agomir | Oligonucleotides | |
| HY-R02130 | hsa-miR-6783-3p mimic | Oligonucleotides | |
| HY-R02130A | hsa-miR-6783-3p agomir | Oligonucleotides | |
| HY-R02131 | hsa-miR-6783-5p mimic | Oligonucleotides | |
| HY-R02131A | hsa-miR-6783-5p agomir | Oligonucleotides | |
| HY-R02132 | hsa-miR-6784-3p mimic | Oligonucleotides | |
| HY-R02132A | hsa-miR-6784-3p agomir | Oligonucleotides | |
| HY-R02133 | hsa-miR-6784-5p mimic | Oligonucleotides | |
| HY-R02133A | hsa-miR-6784-5p agomir | Oligonucleotides | |
| HY-R02134 | hsa-miR-6785-3p mimic | Oligonucleotides | |
| HY-R02134A | hsa-miR-6785-3p agomir | Oligonucleotides | |
| HY-R02135 | hsa-miR-6785-5p mimic | Oligonucleotides | |
| HY-R02135A | hsa-miR-6785-5p agomir | Oligonucleotides | |
| HY-R02136 | hsa-miR-6786-3p mimic | Oligonucleotides | |
| HY-R02136A | hsa-miR-6786-3p agomir | Oligonucleotides | |
| HY-R02137 | hsa-miR-6786-5p mimic | Oligonucleotides | |
| HY-R02137A | hsa-miR-6786-5p agomir | Oligonucleotides | |
| HY-R02138 | hsa-miR-6787-3p mimic | Oligonucleotides | |
| HY-R02138A | hsa-miR-6787-3p agomir | Oligonucleotides | |
| HY-R02139 | hsa-miR-6787-5p mimic | Oligonucleotides | |
| HY-R02139A | hsa-miR-6787-5p agomir | Oligonucleotides | |
| HY-R02140 | hsa-miR-6788-3p mimic | Oligonucleotides | |
| HY-R02140A | hsa-miR-6788-3p agomir | Oligonucleotides | |
| HY-R02141 | hsa-miR-6788-5p mimic | Oligonucleotides | |
| HY-R02141A | hsa-miR-6788-5p agomir | Oligonucleotides | |
| HY-R02142 | hsa-miR-6789-3p mimic | Oligonucleotides | |
| HY-R02142A | hsa-miR-6789-3p agomir | Oligonucleotides | |
| HY-R02143 | hsa-miR-6789-5p mimic | Oligonucleotides | |
| HY-R02143A | hsa-miR-6789-5p agomir | Oligonucleotides | |
| HY-R02144 | hsa-miR-6790-3p mimic | Oligonucleotides | |
| HY-R02144A | hsa-miR-6790-3p agomir | Oligonucleotides | |
| HY-R02145 | hsa-miR-6790-5p mimic | Oligonucleotides | |
| HY-R02145A | hsa-miR-6790-5p agomir | Oligonucleotides | |
| HY-R02146 | hsa-miR-6791-3p mimic | Oligonucleotides | |
| HY-R02146A | hsa-miR-6791-3p agomir | Oligonucleotides | |
| HY-R02147 | hsa-miR-6791-5p mimic | Oligonucleotides | |
| HY-R02147A | hsa-miR-6791-5p agomir | Oligonucleotides | |
| HY-R02148 | hsa-miR-6792-3p mimic | Oligonucleotides | |
| HY-R02148A | hsa-miR-6792-3p agomir | Oligonucleotides | |
| HY-R02149 | hsa-miR-6792-5p mimic | Oligonucleotides | |
| HY-R02149A | hsa-miR-6792-5p agomir | Oligonucleotides | |
| HY-R02150 | hsa-miR-6793-3p mimic | Oligonucleotides | |
| HY-R02150A | hsa-miR-6793-3p agomir | Oligonucleotides | |
| HY-R02151 | hsa-miR-6793-5p mimic | Oligonucleotides | |
| HY-R02151A | hsa-miR-6793-5p agomir | Oligonucleotides | |
| HY-R02152 | hsa-miR-6794-3p mimic | Oligonucleotides | |
| HY-R02152A | hsa-miR-6794-3p agomir | Oligonucleotides | |
| HY-R02153 | hsa-miR-6794-5p mimic | Oligonucleotides | |
| HY-R02153A | hsa-miR-6794-5p agomir | Oligonucleotides | |
| HY-R02154 | hsa-miR-6795-3p mimic | Oligonucleotides | |
| HY-R02154A | hsa-miR-6795-3p agomir | Oligonucleotides | |
| HY-R02155 | hsa-miR-6795-5p mimic | Oligonucleotides | |
| HY-R02155A | hsa-miR-6795-5p agomir | Oligonucleotides | |
| HY-R02156 | hsa-miR-6796-3p mimic | Oligonucleotides | |
| HY-R02156A | hsa-miR-6796-3p agomir | Oligonucleotides | |
| HY-R02157 | hsa-miR-6796-5p mimic | Oligonucleotides | |
| HY-R02157A | hsa-miR-6796-5p agomir | Oligonucleotides | |
| HY-R02158 | hsa-miR-6797-3p mimic | Oligonucleotides | |
| HY-R02158A | hsa-miR-6797-3p agomir | Oligonucleotides | |
| HY-R02159 | hsa-miR-6797-5p mimic | Oligonucleotides | |
| HY-R02159A | hsa-miR-6797-5p agomir | Oligonucleotides | |
| HY-R02160 | hsa-miR-6798-3p mimic | Oligonucleotides | |
| HY-R02160A | hsa-miR-6798-3p agomir | Oligonucleotides | |
| HY-R02161 | hsa-miR-6798-5p mimic | Oligonucleotides | |
| HY-R02161A | hsa-miR-6798-5p agomir | Oligonucleotides | |
| HY-R02162 | hsa-miR-6799-3p mimic | Oligonucleotides | |
| HY-R02162A | hsa-miR-6799-3p agomir | Oligonucleotides | |
| HY-R02163 | hsa-miR-6799-5p mimic | Oligonucleotides | |
| HY-R02163A | hsa-miR-6799-5p agomir | Oligonucleotides | |
| HY-R02164 | hsa-miR-6800-3p mimic | Oligonucleotides | |
| HY-R02164A | hsa-miR-6800-3p agomir | Oligonucleotides | |
| HY-R02165 | hsa-miR-6800-5p mimic | Oligonucleotides | |
| HY-R02165A | hsa-miR-6800-5p agomir | Oligonucleotides | |
| HY-R02166 | hsa-miR-6801-3p mimic | Oligonucleotides | |
| HY-R02166A | hsa-miR-6801-3p agomir | Oligonucleotides | |
| HY-R02167 | hsa-miR-6801-5p mimic | Oligonucleotides | |
| HY-R02167A | hsa-miR-6801-5p agomir | Oligonucleotides | |
| HY-R02168 | hsa-miR-6802-3p mimic | Oligonucleotides | |
| HY-R02168A | hsa-miR-6802-3p agomir | Oligonucleotides | |
| HY-R02169 | hsa-miR-6802-5p mimic | Oligonucleotides | |
| HY-R02169A | hsa-miR-6802-5p agomir | Oligonucleotides | |
| HY-R02170 | hsa-miR-6803-3p mimic | Oligonucleotides | |
| HY-R02170A | hsa-miR-6803-3p agomir | Oligonucleotides | |
| HY-R02171 | hsa-miR-6803-5p mimic | Oligonucleotides | |
| HY-R02171A | hsa-miR-6803-5p agomir | Oligonucleotides | |
| HY-R02172 | hsa-miR-6804-3p mimic | Oligonucleotides | |
| HY-R02172A | hsa-miR-6804-3p agomir | Oligonucleotides | |
| HY-R02173 | hsa-miR-6804-5p mimic | Oligonucleotides | |
| HY-R02173A | hsa-miR-6804-5p agomir | Oligonucleotides | |
| HY-R02174 | hsa-miR-6805-3p mimic | Oligonucleotides | |
| HY-R02174A | hsa-miR-6805-3p agomir | Oligonucleotides | |
| HY-R02175 | hsa-miR-6805-5p mimic | Oligonucleotides | |
| HY-R02175A | hsa-miR-6805-5p agomir | Oligonucleotides | |
| HY-R02176 | hsa-miR-6806-3p mimic | Oligonucleotides | |
| HY-R02176A | hsa-miR-6806-3p agomir | Oligonucleotides | |
| HY-R02177 | hsa-miR-6806-5p mimic | Oligonucleotides | |
| HY-R02177A | hsa-miR-6806-5p agomir | Oligonucleotides | |
| HY-R02178 | hsa-miR-6807-3p mimic | Oligonucleotides | |
| HY-R02178A | hsa-miR-6807-3p agomir | Oligonucleotides | |
| HY-R02179 | hsa-miR-6807-5p mimic | Oligonucleotides | |
| HY-R02179A | hsa-miR-6807-5p agomir | Oligonucleotides | |
| HY-R02180 | hsa-miR-6808-3p mimic | Oligonucleotides | |
| HY-R02180A | hsa-miR-6808-3p agomir | Oligonucleotides | |
| HY-R02181 | hsa-miR-6808-5p mimic | Oligonucleotides | |
| HY-R02181A | hsa-miR-6808-5p agomir | Oligonucleotides | |
| HY-R02182 | hsa-miR-6809-3p mimic | Oligonucleotides | |
| HY-R02182A | hsa-miR-6809-3p agomir | Oligonucleotides | |
| HY-R02183 | hsa-miR-6809-5p mimic | Oligonucleotides | |
| HY-R02183A | hsa-miR-6809-5p agomir | Oligonucleotides | |
| HY-R02184 | hsa-miR-6810-3p mimic | Oligonucleotides | |
| HY-R02184A | hsa-miR-6810-3p agomir | Oligonucleotides | |
| HY-R02185 | hsa-miR-6810-5p mimic | Oligonucleotides | |
| HY-R02185A | hsa-miR-6810-5p agomir | Oligonucleotides | |
| HY-R02186 | hsa-miR-6811-3p mimic | Oligonucleotides | |
| HY-R02186A | hsa-miR-6811-3p agomir | Oligonucleotides | |
| HY-R02187 | hsa-miR-6811-5p mimic | Oligonucleotides | |
| HY-R02187A | hsa-miR-6811-5p agomir | Oligonucleotides | |
| HY-R02188 | hsa-miR-6812-3p mimic | Oligonucleotides | |
| HY-R02188A | hsa-miR-6812-3p agomir | Oligonucleotides | |
| HY-R02189 | hsa-miR-6812-5p mimic | Oligonucleotides | |
| HY-R02189A | hsa-miR-6812-5p agomir | Oligonucleotides | |
| HY-R02190 | hsa-miR-6813-3p mimic | Oligonucleotides | |
| HY-R02190A | hsa-miR-6813-3p agomir | Oligonucleotides | |
| HY-R02191 | hsa-miR-6813-5p mimic | Oligonucleotides | |
| HY-R02191A | hsa-miR-6813-5p agomir | Oligonucleotides | |
| HY-R02192 | hsa-miR-6814-3p mimic | Oligonucleotides | |
| HY-R02192A | hsa-miR-6814-3p agomir | Oligonucleotides | |
| HY-R02193 | hsa-miR-6814-5p mimic | Oligonucleotides | |
| HY-R02193A | hsa-miR-6814-5p agomir | Oligonucleotides | |
| HY-R02194 | hsa-miR-6815-3p mimic | Oligonucleotides | |
| HY-R02194A | hsa-miR-6815-3p agomir | Oligonucleotides | |
| HY-R02195 | hsa-miR-6815-5p mimic | Oligonucleotides | |
| HY-R02195A | hsa-miR-6815-5p agomir | Oligonucleotides | |
| HY-R02196 | hsa-miR-6816-3p mimic | Oligonucleotides | |
| HY-R02196A | hsa-miR-6816-3p agomir | Oligonucleotides | |
| HY-R02197 | hsa-miR-6816-5p mimic | Oligonucleotides | |
| HY-R02197A | hsa-miR-6816-5p agomir | Oligonucleotides | |
| HY-R02198 | hsa-miR-6817-3p mimic | Oligonucleotides | |
| HY-R02198A | hsa-miR-6817-3p agomir | Oligonucleotides | |
| HY-R02199 | hsa-miR-6817-5p mimic | Oligonucleotides | |
| HY-R02199A | hsa-miR-6817-5p agomir | Oligonucleotides | |
| HY-R02200 | hsa-miR-6818-3p mimic | Oligonucleotides | |
| HY-R02200A | hsa-miR-6818-3p agomir | Oligonucleotides | |
| HY-R02201 | hsa-miR-6818-5p mimic | Oligonucleotides | |
| HY-R02201A | hsa-miR-6818-5p agomir | Oligonucleotides | |
| HY-R02202 | hsa-miR-6819-3p mimic | Oligonucleotides | |
| HY-R02202A | hsa-miR-6819-3p agomir | Oligonucleotides | |
| HY-R02203 | hsa-miR-6819-5p mimic | Oligonucleotides | |
| HY-R02203A | hsa-miR-6819-5p agomir | Oligonucleotides | |
| HY-R02204 | hsa-miR-6820-3p mimic | Oligonucleotides | |
| HY-R02204A | hsa-miR-6820-3p agomir | Oligonucleotides | |
| HY-R02205 | hsa-miR-6820-5p mimic | Oligonucleotides | |
| HY-R02205A | hsa-miR-6820-5p agomir | Oligonucleotides | |
| HY-R02206 | hsa-miR-6821-3p mimic | Oligonucleotides | |
| HY-R02206A | hsa-miR-6821-3p agomir | Oligonucleotides | |
| HY-R02207 | hsa-miR-6821-5p mimic | Oligonucleotides | |
| HY-R02207A | hsa-miR-6821-5p agomir | Oligonucleotides | |
| HY-R02208 | hsa-miR-6822-3p mimic | Oligonucleotides | |
| HY-R02208A | hsa-miR-6822-3p agomir | Oligonucleotides | |
| HY-R02209 | hsa-miR-6822-5p mimic | Oligonucleotides | |
| HY-R02209A | hsa-miR-6822-5p agomir | Oligonucleotides | |
| HY-R02210 | hsa-miR-6823-3p mimic | Oligonucleotides | |
| HY-R02210A | hsa-miR-6823-3p agomir | Oligonucleotides | |
| HY-R02211 | hsa-miR-6823-5p mimic | Oligonucleotides | |
| HY-R02211A | hsa-miR-6823-5p agomir | Oligonucleotides | |
| HY-R02212 | hsa-miR-6824-3p mimic | Oligonucleotides | |
| HY-R02212A | hsa-miR-6824-3p agomir | Oligonucleotides | |
| HY-R02213 | hsa-miR-6824-5p mimic | Oligonucleotides | |
| HY-R02213A | hsa-miR-6824-5p agomir | Oligonucleotides | |
| HY-R02214 | hsa-miR-6825-3p mimic | Oligonucleotides | |
| HY-R02214A | hsa-miR-6825-3p agomir | Oligonucleotides | |
| HY-R02215 | hsa-miR-6825-5p mimic | Oligonucleotides | |
| HY-R02215A | hsa-miR-6825-5p agomir | Oligonucleotides | |
| HY-R02216 | hsa-miR-6826-3p mimic | Oligonucleotides | |
| HY-R02216A | hsa-miR-6826-3p agomir | Oligonucleotides | |
| HY-R02217 | hsa-miR-6826-5p mimic | Oligonucleotides | |
| HY-R02217A | hsa-miR-6826-5p agomir | Oligonucleotides | |
| HY-R02218 | hsa-miR-6827-3p mimic | Oligonucleotides | |
| HY-R02218A | hsa-miR-6827-3p agomir | Oligonucleotides | |
| HY-R02219 | hsa-miR-6827-5p mimic | Oligonucleotides | |
| HY-R02219A | hsa-miR-6827-5p agomir | Oligonucleotides | |
| HY-R02220 | hsa-miR-6828-3p mimic | Oligonucleotides | |
| HY-R02220A | hsa-miR-6828-3p agomir | Oligonucleotides | |
| HY-R02221 | hsa-miR-6828-5p mimic | Oligonucleotides | |
| HY-R02221A | hsa-miR-6828-5p agomir | Oligonucleotides | |
| HY-R02222 | hsa-miR-6829-3p mimic | Oligonucleotides | |
| HY-R02222A | hsa-miR-6829-3p agomir | Oligonucleotides | |
| HY-R02223 | hsa-miR-6829-5p mimic | Oligonucleotides | |
| HY-R02223A | hsa-miR-6829-5p agomir | Oligonucleotides | |
| HY-R02224 | hsa-miR-6830-3p mimic | Oligonucleotides | |
| HY-R02224A | hsa-miR-6830-3p agomir | Oligonucleotides | |
| HY-R02225 | hsa-miR-6830-5p mimic | Oligonucleotides | |
| HY-R02225A | hsa-miR-6830-5p agomir | Oligonucleotides | |
| HY-R02226 | hsa-miR-6831-3p mimic | Oligonucleotides | |
| HY-R02226A | hsa-miR-6831-3p agomir | Oligonucleotides | |
| HY-R02227 | hsa-miR-6831-5p mimic | Oligonucleotides | |
| HY-R02227A | hsa-miR-6831-5p agomir | Oligonucleotides | |
| HY-R02228 | hsa-miR-6832-3p mimic | Oligonucleotides | |
| HY-R02228A | hsa-miR-6832-3p agomir | Oligonucleotides | |
| HY-R02229 | hsa-miR-6832-5p mimic | Oligonucleotides | |
| HY-R02229A | hsa-miR-6832-5p agomir | Oligonucleotides | |
| HY-R02230 | hsa-miR-6833-3p mimic | Oligonucleotides | |
| HY-R02230A | hsa-miR-6833-3p agomir | Oligonucleotides | |
| HY-R02231 | hsa-miR-6833-5p mimic | Oligonucleotides | |
| HY-R02231A | hsa-miR-6833-5p agomir | Oligonucleotides | |
| HY-R02232 | hsa-miR-6834-3p mimic | Oligonucleotides | |
| HY-R02232A | hsa-miR-6834-3p agomir | Oligonucleotides | |
| HY-R02233 | hsa-miR-6834-5p mimic | Oligonucleotides | |
| HY-R02233A | hsa-miR-6834-5p agomir | Oligonucleotides | |
| HY-R02234 | hsa-miR-6835-3p mimic | Oligonucleotides | |
| HY-R02234A | hsa-miR-6835-3p agomir | Oligonucleotides | |
| HY-R02235 | hsa-miR-6835-5p mimic | Oligonucleotides | |
| HY-R02235A | hsa-miR-6835-5p agomir | Oligonucleotides | |
| HY-R02236 | hsa-miR-6836-3p mimic | Oligonucleotides | |
| HY-R02236A | hsa-miR-6836-3p agomir | Oligonucleotides | |
| HY-R02237 | hsa-miR-6836-5p mimic | Oligonucleotides | |
| HY-R02237A | hsa-miR-6836-5p agomir | Oligonucleotides | |
| HY-R02238 | hsa-miR-6837-3p mimic | Oligonucleotides | |
| HY-R02238A | hsa-miR-6837-3p agomir | Oligonucleotides | |
| HY-R02239 | hsa-miR-6837-5p mimic | Oligonucleotides | |
| HY-R02239A | hsa-miR-6837-5p agomir | Oligonucleotides | |
| HY-R02240 | hsa-miR-6838-3p mimic | Oligonucleotides | |
| HY-R02240A | hsa-miR-6838-3p agomir | Oligonucleotides | |
| HY-R02241 | hsa-miR-6838-5p mimic | Oligonucleotides | |
| HY-R02241A | hsa-miR-6838-5p agomir | Oligonucleotides | |
| HY-R02242 | hsa-miR-6839-3p mimic | Oligonucleotides | |
| HY-R02242A | hsa-miR-6839-3p agomir | Oligonucleotides | |
| HY-R02243 | hsa-miR-6839-5p mimic | Oligonucleotides | |
| HY-R02243A | hsa-miR-6839-5p agomir | Oligonucleotides | |
| HY-R02244 | hsa-miR-6840-3p mimic | Oligonucleotides | |
| HY-R02244A | hsa-miR-6840-3p agomir | Oligonucleotides | |
| HY-R02245 | hsa-miR-6840-5p mimic | Oligonucleotides | |
| HY-R02245A | hsa-miR-6840-5p agomir | Oligonucleotides | |
| HY-R02246 | hsa-miR-6841-3p mimic | Oligonucleotides | |
| HY-R02246A | hsa-miR-6841-3p agomir | Oligonucleotides | |
| HY-R02247 | hsa-miR-6841-5p mimic | Oligonucleotides | |
| HY-R02247A | hsa-miR-6841-5p agomir | Oligonucleotides | |
| HY-R02248 | hsa-miR-6842-3p mimic | Oligonucleotides | |
| HY-R02248A | hsa-miR-6842-3p agomir | Oligonucleotides | |
| HY-R02249 | hsa-miR-6842-5p mimic | Oligonucleotides | |
| HY-R02249A | hsa-miR-6842-5p agomir | Oligonucleotides | |
| HY-R02250 | hsa-miR-6843-3p mimic | Oligonucleotides | |
| HY-R02250A | hsa-miR-6843-3p agomir | Oligonucleotides | |
| HY-R02251 | hsa-miR-6844 mimic | Oligonucleotides | |
| HY-R02251A | hsa-miR-6844 agomir | Oligonucleotides | |
| HY-R02252 | hsa-miR-6845-3p mimic | Oligonucleotides | |
| HY-R02252A | hsa-miR-6845-3p agomir | Oligonucleotides | |
| HY-R02253 | hsa-miR-6845-5p mimic | Oligonucleotides | |
| HY-R02253A | hsa-miR-6845-5p agomir | Oligonucleotides | |
| HY-R02254 | hsa-miR-6846-3p mimic | Oligonucleotides | |
| HY-R02254A | hsa-miR-6846-3p agomir | Oligonucleotides | |
| HY-R02255 | hsa-miR-6846-5p mimic | Oligonucleotides | |
| HY-R02255A | hsa-miR-6846-5p agomir | Oligonucleotides | |
| HY-R02256 | hsa-miR-6847-3p mimic | Oligonucleotides | |
| HY-R02256A | hsa-miR-6847-3p agomir | Oligonucleotides | |
| HY-R02257 | hsa-miR-6847-5p mimic | Oligonucleotides | |
| HY-R02257A | hsa-miR-6847-5p agomir | Oligonucleotides | |
| HY-R02258 | hsa-miR-6848-3p mimic | Oligonucleotides | |
| HY-R02258A | hsa-miR-6848-3p agomir | Oligonucleotides | |
| HY-R02259 | hsa-miR-6848-5p mimic | Oligonucleotides | |
| HY-R02259A | hsa-miR-6848-5p agomir | Oligonucleotides | |
| HY-R02260 | hsa-miR-6849-3p mimic | Oligonucleotides | |
| HY-R02260A | hsa-miR-6849-3p agomir | Oligonucleotides | |
| HY-R02261 | hsa-miR-6849-5p mimic | Oligonucleotides | |
| HY-R02261A | hsa-miR-6849-5p agomir | Oligonucleotides | |
| HY-R02262 | hsa-miR-6850-3p mimic | Oligonucleotides | |
| HY-R02262A | hsa-miR-6850-3p agomir | Oligonucleotides | |
| HY-R02263 | hsa-miR-6850-5p mimic | Oligonucleotides | |
| HY-R02263A | hsa-miR-6850-5p agomir | Oligonucleotides | |
| HY-R02264 | hsa-miR-6851-3p mimic | Oligonucleotides | |
| HY-R02264A | hsa-miR-6851-3p agomir | Oligonucleotides | |
| HY-R02265 | hsa-miR-6851-5p mimic | Oligonucleotides | |
| HY-R02265A | hsa-miR-6851-5p agomir | Oligonucleotides | |
| HY-R02266 | hsa-miR-6852-3p mimic | Oligonucleotides | |
| HY-R02266A | hsa-miR-6852-3p agomir | Oligonucleotides | |
| HY-R02267 | hsa-miR-6852-5p mimic | Oligonucleotides | |
| HY-R02267A | hsa-miR-6852-5p agomir | Oligonucleotides | |
| HY-R02268 | hsa-miR-6853-3p mimic | Oligonucleotides | |
| HY-R02268A | hsa-miR-6853-3p agomir | Oligonucleotides | |
| HY-R02269 | hsa-miR-6853-5p mimic | Oligonucleotides | |
| HY-R02269A | hsa-miR-6853-5p agomir | Oligonucleotides | |
| HY-R02270 | hsa-miR-6854-3p mimic | Oligonucleotides | |
| HY-R02270A | hsa-miR-6854-3p agomir | Oligonucleotides | |
| HY-R02271 | hsa-miR-6854-5p mimic | Oligonucleotides | |
| HY-R02271A | hsa-miR-6854-5p agomir | Oligonucleotides | |
| HY-R02272 | hsa-miR-6855-3p mimic | Oligonucleotides | |
| HY-R02272A | hsa-miR-6855-3p agomir | Oligonucleotides | |
| HY-R02273 | hsa-miR-6855-5p mimic | Oligonucleotides | |
| HY-R02273A | hsa-miR-6855-5p agomir | Oligonucleotides | |
| HY-R02274 | hsa-miR-6856-3p mimic | Oligonucleotides | |
| HY-R02274A | hsa-miR-6856-3p agomir | Oligonucleotides | |
| HY-R02275 | hsa-miR-6856-5p mimic | Oligonucleotides | |
| HY-R02275A | hsa-miR-6856-5p agomir | Oligonucleotides | |
| HY-R02276 | hsa-miR-6857-3p mimic | Oligonucleotides | |
| HY-R02276A | hsa-miR-6857-3p agomir | Oligonucleotides | |
| HY-R02277 | hsa-miR-6857-5p mimic | Oligonucleotides | |
| HY-R02277A | hsa-miR-6857-5p agomir | Oligonucleotides | |
| HY-R02278 | hsa-miR-6858-3p mimic | Oligonucleotides | |
| HY-R02278A | hsa-miR-6858-3p agomir | Oligonucleotides | |
| HY-R02279 | hsa-miR-6858-5p mimic | Oligonucleotides | |
| HY-R02279A | hsa-miR-6858-5p agomir | Oligonucleotides | |
| HY-R02280 | hsa-miR-6859-3p mimic | Oligonucleotides | |
| HY-R02280A | hsa-miR-6859-3p agomir | Oligonucleotides | |
| HY-R02281 | hsa-miR-6859-5p mimic | Oligonucleotides | |
| HY-R02281A | hsa-miR-6859-5p agomir | Oligonucleotides | |
| HY-R02282 | hsa-miR-6860 mimic | Oligonucleotides | |
| HY-R02282A | hsa-miR-6860 agomir | Oligonucleotides | |
| HY-R02283 | hsa-miR-6861-3p mimic | Oligonucleotides | |
| HY-R02283A | hsa-miR-6861-3p agomir | Oligonucleotides | |
| HY-R02284 | hsa-miR-6861-5p mimic | Oligonucleotides | |
| HY-R02284A | hsa-miR-6861-5p agomir | Oligonucleotides | |
| HY-R02285 | hsa-miR-6862-3p mimic | Oligonucleotides | |
| HY-R02285A | hsa-miR-6862-3p agomir | Oligonucleotides | |
| HY-R02286 | hsa-miR-6862-5p mimic | Oligonucleotides | |
| HY-R02286A | hsa-miR-6862-5p agomir | Oligonucleotides | |
| HY-R02287 | hsa-miR-6863 mimic | Oligonucleotides | |
| HY-R02287A | hsa-miR-6863 agomir | Oligonucleotides | |
| HY-R02288 | hsa-miR-6864-3p mimic | Oligonucleotides | |
| HY-R02288A | hsa-miR-6864-3p agomir | Oligonucleotides | |
| HY-R02289 | hsa-miR-6864-5p mimic | Oligonucleotides | |
| HY-R02289A | hsa-miR-6864-5p agomir | Oligonucleotides | |
| HY-R02290 | hsa-miR-6865-3p mimic | Oligonucleotides | |
| HY-R02290A | hsa-miR-6865-3p agomir | Oligonucleotides | |
| HY-R02291 | hsa-miR-6865-5p mimic | Oligonucleotides | |
| HY-R02291A | hsa-miR-6865-5p agomir | Oligonucleotides | |
| HY-R02292 | hsa-miR-6866-3p mimic | Oligonucleotides | |
| HY-R02292A | hsa-miR-6866-3p agomir | Oligonucleotides | |
| HY-R02293 | hsa-miR-6866-5p mimic | Oligonucleotides | |
| HY-R02293A | hsa-miR-6866-5p agomir | Oligonucleotides | |
| HY-R02294 | hsa-miR-6867-3p mimic | Oligonucleotides | |
| HY-R02294A | hsa-miR-6867-3p agomir | Oligonucleotides | |
| HY-R02295 | hsa-miR-6867-5p mimic | Oligonucleotides | |
| HY-R02295A | hsa-miR-6867-5p agomir | Oligonucleotides | |
| HY-R02296 | hsa-miR-6868-3p mimic | Oligonucleotides | |
| HY-R02296A | hsa-miR-6868-3p agomir | Oligonucleotides | |
| HY-R02297 | hsa-miR-6868-5p mimic | Oligonucleotides | |
| HY-R02297A | hsa-miR-6868-5p agomir | Oligonucleotides | |
| HY-R02298 | hsa-miR-6869-3p mimic | Oligonucleotides | |
| HY-R02298A | hsa-miR-6869-3p agomir | Oligonucleotides | |
| HY-R02299 | hsa-miR-6869-5p mimic | Oligonucleotides | |
| HY-R02299A | hsa-miR-6869-5p agomir | Oligonucleotides | |
| HY-R02300 | hsa-miR-6870-3p mimic | Oligonucleotides | |
| HY-R02300A | hsa-miR-6870-3p agomir | Oligonucleotides | |
| HY-R02301 | hsa-miR-6870-5p mimic | Oligonucleotides | |
| HY-R02301A | hsa-miR-6870-5p agomir | Oligonucleotides | |
| HY-R02302 | hsa-miR-6871-3p mimic | Oligonucleotides | |
| HY-R02302A | hsa-miR-6871-3p agomir | Oligonucleotides | |
| HY-R02303 | hsa-miR-6871-5p mimic | Oligonucleotides | |
| HY-R02303A | hsa-miR-6871-5p agomir | Oligonucleotides | |
| HY-R02304 | hsa-miR-6872-3p mimic | Oligonucleotides | |
| HY-R02304A | hsa-miR-6872-3p agomir | Oligonucleotides | |
| HY-R02305 | hsa-miR-6872-5p mimic | Oligonucleotides | |
| HY-R02305A | hsa-miR-6872-5p agomir | Oligonucleotides | |
| HY-R02306 | hsa-miR-6873-3p mimic | Oligonucleotides | |
| HY-R02306A | hsa-miR-6873-3p agomir | Oligonucleotides | |
| HY-R02307 | hsa-miR-6873-5p mimic | Oligonucleotides | |
| HY-R02307A | hsa-miR-6873-5p agomir | Oligonucleotides | |
| HY-R02308 | hsa-miR-6874-3p mimic | Oligonucleotides | |
| HY-R02308A | hsa-miR-6874-3p agomir | Oligonucleotides | |
| HY-R02309 | hsa-miR-6874-5p mimic | Oligonucleotides | |
| HY-R02309A | hsa-miR-6874-5p agomir | Oligonucleotides | |
| HY-R02310 | hsa-miR-6875-3p mimic | Oligonucleotides | |
| HY-R02310A | hsa-miR-6875-3p agomir | Oligonucleotides | |
| HY-R02311 | hsa-miR-6875-5p mimic | Oligonucleotides | |
| HY-R02311A | hsa-miR-6875-5p agomir | Oligonucleotides | |
| HY-R02312 | hsa-miR-6876-3p mimic | Oligonucleotides | |
| HY-R02312A | hsa-miR-6876-3p agomir | Oligonucleotides | |
| HY-R02313 | hsa-miR-6876-5p mimic | Oligonucleotides | |
| HY-R02313A | hsa-miR-6876-5p agomir | Oligonucleotides | |
| HY-R02314 | hsa-miR-6877-3p mimic | Oligonucleotides | |
| HY-R02314A | hsa-miR-6877-3p agomir | Oligonucleotides | |
| HY-R02315 | hsa-miR-6877-5p mimic | Oligonucleotides | |
| HY-R02315A | hsa-miR-6877-5p agomir | Oligonucleotides | |
| HY-R02316 | hsa-miR-6878-3p mimic | Oligonucleotides | |
| HY-R02316A | hsa-miR-6878-3p agomir | Oligonucleotides | |
| HY-R02317 | hsa-miR-6878-5p mimic | Oligonucleotides | |
| HY-R02317A | hsa-miR-6878-5p agomir | Oligonucleotides | |
| HY-R02318 | hsa-miR-6879-3p mimic | Oligonucleotides | |
| HY-R02318A | hsa-miR-6879-3p agomir | Oligonucleotides | |
| HY-R02319 | hsa-miR-6879-5p mimic | Oligonucleotides | |
| HY-R02319A | hsa-miR-6879-5p agomir | Oligonucleotides | |
| HY-R02320 | hsa-miR-6880-3p mimic | Oligonucleotides | |
| HY-R02320A | hsa-miR-6880-3p agomir | Oligonucleotides | |
| HY-R02321 | hsa-miR-6880-5p mimic | Oligonucleotides | |
| HY-R02321A | hsa-miR-6880-5p agomir | Oligonucleotides | |
| HY-R02322 | hsa-miR-6881-3p mimic | Oligonucleotides | |
| HY-R02322A | hsa-miR-6881-3p agomir | Oligonucleotides | |
| HY-R02323 | hsa-miR-6881-5p mimic | Oligonucleotides | |
| HY-R02323A | hsa-miR-6881-5p agomir | Oligonucleotides | |
| HY-R02324 | hsa-miR-6882-3p mimic | Oligonucleotides | |
| HY-R02324A | hsa-miR-6882-3p agomir | Oligonucleotides | |
| HY-R02325 | hsa-miR-6882-5p mimic | Oligonucleotides | |
| HY-R02325A | hsa-miR-6882-5p agomir | Oligonucleotides | |
| HY-R02326 | hsa-miR-6883-3p mimic | Oligonucleotides | |
| HY-R02326A | hsa-miR-6883-3p agomir | Oligonucleotides | |
| HY-R02327 | hsa-miR-6883-5p mimic | Oligonucleotides | |
| HY-R02327A | hsa-miR-6883-5p agomir | Oligonucleotides | |
| HY-R02328 | hsa-miR-6884-3p mimic | Oligonucleotides | |
| HY-R02328A | hsa-miR-6884-3p agomir | Oligonucleotides | |
| HY-R02329 | hsa-miR-6884-5p mimic | Oligonucleotides | |
| HY-R02329A | hsa-miR-6884-5p agomir | Oligonucleotides | |
| HY-R02330 | hsa-miR-6885-3p mimic | Oligonucleotides | |
| HY-R02330A | hsa-miR-6885-3p agomir | Oligonucleotides | |
| HY-R02331 | hsa-miR-6885-5p mimic | Oligonucleotides | |
| HY-R02331A | hsa-miR-6885-5p agomir | Oligonucleotides | |
| HY-R02332 | hsa-miR-6886-3p mimic | Oligonucleotides | |
| HY-R02332A | hsa-miR-6886-3p agomir | Oligonucleotides | |
| HY-R02333 | hsa-miR-6886-5p mimic | Oligonucleotides | |
| HY-R02333A | hsa-miR-6886-5p agomir | Oligonucleotides | |
| HY-R02334 | hsa-miR-6887-3p mimic | Oligonucleotides | |
| HY-R02334A | hsa-miR-6887-3p agomir | Oligonucleotides | |
| HY-R02335 | hsa-miR-6887-5p mimic | Oligonucleotides | |
| HY-R02335A | hsa-miR-6887-5p agomir | Oligonucleotides | |
| HY-R02336 | hsa-miR-6888-3p mimic | Oligonucleotides | |
| HY-R02336A | hsa-miR-6888-3p agomir | Oligonucleotides | |
| HY-R02337 | hsa-miR-6888-5p mimic | Oligonucleotides | |
| HY-R02337A | hsa-miR-6888-5p agomir | Oligonucleotides | |
| HY-R02338 | hsa-miR-6889-3p mimic | Oligonucleotides | |
| HY-R02338A | hsa-miR-6889-3p agomir | Oligonucleotides | |
| HY-R02339 | hsa-miR-6889-5p mimic | Oligonucleotides | |
| HY-R02339A | hsa-miR-6889-5p agomir | Oligonucleotides | |
| HY-R02340 | hsa-miR-6890-3p mimic | Oligonucleotides | |
| HY-R02340A | hsa-miR-6890-3p agomir | Oligonucleotides | |
| HY-R02341 | hsa-miR-6890-5p mimic | Oligonucleotides | |
| HY-R02341A | hsa-miR-6890-5p agomir | Oligonucleotides | |
| HY-R02342 | hsa-miR-6891-3p mimic | Oligonucleotides | |
| HY-R02342A | hsa-miR-6891-3p agomir | Oligonucleotides | |
| HY-R02343 | hsa-miR-6891-5p mimic | Oligonucleotides | |
| HY-R02343A | hsa-miR-6891-5p agomir | Oligonucleotides | |
| HY-R02344 | hsa-miR-6892-3p mimic | Oligonucleotides | |
| HY-R02344A | hsa-miR-6892-3p agomir | Oligonucleotides | |
| HY-R02345 | hsa-miR-6892-5p mimic | Oligonucleotides | |
| HY-R02345A | hsa-miR-6892-5p agomir | Oligonucleotides | |
| HY-R02346 | hsa-miR-6893-3p mimic | Oligonucleotides | |
| HY-R02346A | hsa-miR-6893-3p agomir | Oligonucleotides | |
| HY-R02347 | hsa-miR-6893-5p mimic | Oligonucleotides | |
| HY-R02347A | hsa-miR-6893-5p agomir | Oligonucleotides | |
| HY-R02348 | hsa-miR-6894-3p mimic | Oligonucleotides | |
| HY-R02348A | hsa-miR-6894-3p agomir | Oligonucleotides | |
| HY-R02349 | hsa-miR-6894-5p mimic | Oligonucleotides | |
| HY-R02349A | hsa-miR-6894-5p agomir | Oligonucleotides | |
| HY-R02350 | hsa-miR-6895-3p mimic | Oligonucleotides | |
| HY-R02350A | hsa-miR-6895-3p agomir | Oligonucleotides | |
| HY-R02351 | hsa-miR-6895-5p mimic | Oligonucleotides | |
| HY-R02351A | hsa-miR-6895-5p agomir | Oligonucleotides | |
| HY-R02352 | hsa-miR-708-3p mimic | Oligonucleotides | |
| HY-R02352A | hsa-miR-708-3p agomir | Oligonucleotides | |
| HY-R02353 | hsa-miR-708-5p mimic | Oligonucleotides | |
| HY-R02353A | hsa-miR-708-5p agomir | Oligonucleotides | |
| HY-R02354 | hsa-miR-7106-3p mimic | Oligonucleotides | |
| HY-R02354A | hsa-miR-7106-3p agomir | Oligonucleotides | |
| HY-R02355 | hsa-miR-7106-5p mimic | Oligonucleotides | |
| HY-R02355A | hsa-miR-7106-5p agomir | Oligonucleotides | |
| HY-R02356 | hsa-miR-7107-3p mimic | Oligonucleotides | |
| HY-R02356A | hsa-miR-7107-3p agomir | Oligonucleotides | |
| HY-R02357 | hsa-miR-7107-5p mimic | Oligonucleotides | |
| HY-R02357A | hsa-miR-7107-5p agomir | Oligonucleotides | |
| HY-R02358 | hsa-miR-7108-3p mimic | Oligonucleotides | |
| HY-R02358A | hsa-miR-7108-3p agomir | Oligonucleotides | |
| HY-R02359 | hsa-miR-7108-5p mimic | Oligonucleotides | |
| HY-R02359A | hsa-miR-7108-5p agomir | Oligonucleotides | |
| HY-R02360 | hsa-miR-7109-3p mimic | Oligonucleotides | |
| HY-R02360A | hsa-miR-7109-3p agomir | Oligonucleotides | |
| HY-R02361 | hsa-miR-7109-5p mimic | Oligonucleotides | |
| HY-R02361A | hsa-miR-7109-5p agomir | Oligonucleotides | |
| HY-R02362 | hsa-miR-711 mimic | Oligonucleotides | |
| HY-R02362A | hsa-miR-711 agomir | Oligonucleotides | |
| HY-R02363 | hsa-miR-7110-3p mimic | Oligonucleotides | |
| HY-R02363A | hsa-miR-7110-3p agomir | Oligonucleotides | |
| HY-R02364 | hsa-miR-7110-5p mimic | Oligonucleotides | |
| HY-R02364A | hsa-miR-7110-5p agomir | Oligonucleotides | |
| HY-R02365 | hsa-miR-7111-3p mimic | Oligonucleotides | |
| HY-R02365A | hsa-miR-7111-3p agomir | Oligonucleotides | |
| HY-R02366 | hsa-miR-7111-5p mimic | Oligonucleotides | |
| HY-R02366A | hsa-miR-7111-5p agomir | Oligonucleotides | |
| HY-R02367 | hsa-miR-7112-3p mimic | Oligonucleotides | |
| HY-R02367A | hsa-miR-7112-3p agomir | Oligonucleotides | |
| HY-R02368 | hsa-miR-7112-5p mimic | Oligonucleotides | |
| HY-R02368A | hsa-miR-7112-5p agomir | Oligonucleotides | |
| HY-R02369 | hsa-miR-7113-3p mimic | Oligonucleotides | |
| HY-R02369A | hsa-miR-7113-3p agomir | Oligonucleotides | |
| HY-R02370 | hsa-miR-7113-5p mimic | Oligonucleotides | |
| HY-R02370A | hsa-miR-7113-5p agomir | Oligonucleotides | |
| HY-R02371 | hsa-miR-7114-3p mimic | Oligonucleotides | |
| HY-R02371A | hsa-miR-7114-3p agomir | Oligonucleotides | |
| HY-R02372 | hsa-miR-7114-5p mimic | Oligonucleotides | |
| HY-R02372A | hsa-miR-7114-5p agomir | Oligonucleotides | |
| HY-R02373 | hsa-miR-7-1-3p mimic | Oligonucleotides | |
| HY-R02373A | hsa-miR-7-1-3p agomir | Oligonucleotides | |
| HY-R02374 | hsa-miR-7150 mimic | Oligonucleotides | |
| HY-R02374A | hsa-miR-7150 agomir | Oligonucleotides | |
| HY-R02375 | hsa-miR-7151-3p mimic | Oligonucleotides | |
| HY-R02375A | hsa-miR-7151-3p agomir | Oligonucleotides | |
| HY-R02376 | hsa-miR-7151-5p mimic | Oligonucleotides | |
| HY-R02376A | hsa-miR-7151-5p agomir | Oligonucleotides | |
| HY-R02377 | hsa-miR-7152-3p mimic | Oligonucleotides | |
| HY-R02377A | hsa-miR-7152-3p agomir | Oligonucleotides | |
| HY-R02378 | hsa-miR-7152-5p mimic | Oligonucleotides | |
| HY-R02378A | hsa-miR-7152-5p agomir | Oligonucleotides | |
| HY-R02379 | hsa-miR-7153-3p mimic | Oligonucleotides | |
| HY-R02379A | hsa-miR-7153-3p agomir | Oligonucleotides | |
| HY-R02380 | hsa-miR-7153-5p mimic | Oligonucleotides | |
| HY-R02380A | hsa-miR-7153-5p agomir | Oligonucleotides | |
| HY-R02381 | hsa-miR-7154-3p mimic | Oligonucleotides | |
| HY-R02381A | hsa-miR-7154-3p agomir | Oligonucleotides | |
| HY-R02382 | hsa-miR-7154-5p mimic | Oligonucleotides | |
| HY-R02382A | hsa-miR-7154-5p agomir | Oligonucleotides | |
| HY-R02383 | hsa-miR-7155-3p mimic | Oligonucleotides | |
| HY-R02383A | hsa-miR-7155-3p agomir | Oligonucleotides | |
| HY-R02384 | hsa-miR-7155-5p mimic | Oligonucleotides | |
| HY-R02384A | hsa-miR-7155-5p agomir | Oligonucleotides | |
| HY-R02385 | hsa-miR-7156-3p mimic | Oligonucleotides | |
| HY-R02385A | hsa-miR-7156-3p agomir | Oligonucleotides | |
| HY-R02386 | hsa-miR-7156-5p mimic | Oligonucleotides | |
| HY-R02386A | hsa-miR-7156-5p agomir | Oligonucleotides | |
| HY-R02387 | hsa-miR-7157-3p mimic | Oligonucleotides | |
| HY-R02387A | hsa-miR-7157-3p agomir | Oligonucleotides | |
| HY-R02388 | hsa-miR-7157-5p mimic | Oligonucleotides | |
| HY-R02388A | hsa-miR-7157-5p agomir | Oligonucleotides | |
| HY-R02389 | hsa-miR-7158-3p mimic | Oligonucleotides | |
| HY-R02389A | hsa-miR-7158-3p agomir | Oligonucleotides | |
| HY-R02390 | hsa-miR-7158-5p mimic | Oligonucleotides | |
| HY-R02390A | hsa-miR-7158-5p agomir | Oligonucleotides | |
| HY-R02391 | hsa-miR-7159-3p mimic | Oligonucleotides | |
| HY-R02391A | hsa-miR-7159-3p agomir | Oligonucleotides | |
| HY-R02392 | hsa-miR-7159-5p mimic | Oligonucleotides | |
| HY-R02392A | hsa-miR-7159-5p agomir | Oligonucleotides | |
| HY-R02393 | hsa-miR-7160-3p mimic | Oligonucleotides | |
| HY-R02393A | hsa-miR-7160-3p agomir | Oligonucleotides | |
| HY-R02394 | hsa-miR-7160-5p mimic | Oligonucleotides | |
| HY-R02394A | hsa-miR-7160-5p agomir | Oligonucleotides | |
| HY-R02395 | hsa-miR-7161-3p mimic | Oligonucleotides | |
| HY-R02395A | hsa-miR-7161-3p agomir | Oligonucleotides | |
| HY-R02396 | hsa-miR-7161-5p mimic | Oligonucleotides | |
| HY-R02396A | hsa-miR-7161-5p agomir | Oligonucleotides | |
| HY-R02397 | hsa-miR-7162-3p mimic | Oligonucleotides | |
| HY-R02397A | hsa-miR-7162-3p agomir | Oligonucleotides | |
| HY-R02398 | hsa-miR-7162-5p mimic | Oligonucleotides | |
| HY-R02398A | hsa-miR-7162-5p agomir | Oligonucleotides | |
| HY-R02399 | hsa-miR-718 mimic | Oligonucleotides | |
| HY-R02399A | hsa-miR-718 agomir | Oligonucleotides | |
| HY-R02400 | hsa-miR-7-2-3p mimic | Oligonucleotides | |
| HY-R02400A | hsa-miR-7-2-3p agomir | Oligonucleotides | |
| HY-R02401 | hsa-miR-744-3p mimic | Oligonucleotides | |
| HY-R02401A | hsa-miR-744-3p agomir | Oligonucleotides | |
| HY-R02402 | hsa-miR-744-5p mimic | Oligonucleotides | |
| HY-R02402A | hsa-miR-744-5p agomir | Oligonucleotides | |
| HY-R02403 | hsa-miR-7515 mimic | Oligonucleotides | |
| HY-R02403A | hsa-miR-7515 agomir | Oligonucleotides | |
| HY-R02404 | hsa-miR-758-3p mimic | Oligonucleotides | |
| HY-R02404A | hsa-miR-758-3p agomir | Oligonucleotides | |
| HY-R02405 | hsa-miR-758-5p mimic | Oligonucleotides | |
| HY-R02405A | hsa-miR-758-5p agomir | Oligonucleotides | |
| HY-R02406 | hsa-miR-7-5p mimic | Oligonucleotides | |
| HY-R02406A | hsa-miR-7-5p agomir | Oligonucleotides | |
| HY-R02407 | hsa-miR-760 mimic | Oligonucleotides | |
| HY-R02407A | hsa-miR-760 agomir | Oligonucleotides | |
| HY-R02408 | hsa-miR-761 mimic | Oligonucleotides | |
| HY-R02408A | hsa-miR-761 agomir | Oligonucleotides | |
| HY-R02409 | hsa-miR-762 mimic | Oligonucleotides | |
| HY-R02409A | hsa-miR-762 agomir | Oligonucleotides | |
| HY-R02410 | hsa-miR-764 mimic | Oligonucleotides | |
| HY-R02410A | hsa-miR-764 agomir | Oligonucleotides | |
| HY-R02411 | hsa-miR-765 mimic | Oligonucleotides | |
| HY-R02411A | hsa-miR-765 agomir | Oligonucleotides | |
| HY-R02412 | hsa-miR-766-3p mimic | Oligonucleotides | |
| HY-R02412A | hsa-miR-766-3p agomir | Oligonucleotides | |
| HY-R02413 | hsa-miR-766-5p mimic | Oligonucleotides | |
| HY-R02413A | hsa-miR-766-5p agomir | Oligonucleotides | |
| HY-R02414 | hsa-miR-767-3p mimic | Oligonucleotides | |
| HY-R02414A | hsa-miR-767-3p agomir | Oligonucleotides | |
| HY-R02415 | hsa-miR-769-3p mimic | Oligonucleotides | |
| HY-R02415A | hsa-miR-769-3p agomir | Oligonucleotides | |
| HY-R02416 | hsa-miR-769-5p mimic | Oligonucleotides | |
| HY-R02416A | hsa-miR-769-5p agomir | Oligonucleotides | |
| HY-R02417 | hsa-miR-7702 mimic | Oligonucleotides | |
| HY-R02417A | hsa-miR-7702 agomir | Oligonucleotides | |
| HY-R02418 | hsa-miR-7703 mimic | Oligonucleotides | |
| HY-R02418A | hsa-miR-7703 agomir | Oligonucleotides | |
| HY-R02419 | hsa-miR-7704 mimic | Oligonucleotides | |
| HY-R02419A | hsa-miR-7704 agomir | Oligonucleotides | |
| HY-R02420 | hsa-miR-7705 mimic | Oligonucleotides | |
| HY-R02420A | hsa-miR-7705 agomir | Oligonucleotides | |
| HY-R02421 | hsa-miR-7706 mimic | Oligonucleotides | |
| HY-R02421A | hsa-miR-7706 agomir | Oligonucleotides | |
| HY-R02422 | hsa-miR-7843-3p mimic | Oligonucleotides | |
| HY-R02422A | hsa-miR-7843-3p agomir | Oligonucleotides | |
| HY-R02423 | hsa-miR-7843-5p mimic | Oligonucleotides | |
| HY-R02423A | hsa-miR-7843-5p agomir | Oligonucleotides | |
| HY-R02424 | hsa-miR-7844-5p mimic | Oligonucleotides | |
| HY-R02424A | hsa-miR-7844-5p agomir | Oligonucleotides | |
| HY-R02425 | hsa-miR-7845-5p mimic | Oligonucleotides | |
| HY-R02425A | hsa-miR-7845-5p agomir | Oligonucleotides | |
| HY-R02426 | hsa-miR-7846-3p mimic | Oligonucleotides | |
| HY-R02426A | hsa-miR-7846-3p agomir | Oligonucleotides | |
| HY-R02427 | hsa-miR-7847-3p mimic | Oligonucleotides | |
| HY-R02427A | hsa-miR-7847-3p agomir | Oligonucleotides | |
| HY-R02428 | hsa-miR-7848-3p mimic | Oligonucleotides | |
| HY-R02428A | hsa-miR-7848-3p agomir | Oligonucleotides | |
| HY-R02429 | hsa-miR-7849-3p mimic | Oligonucleotides | |
| HY-R02429A | hsa-miR-7849-3p agomir | Oligonucleotides | |
| HY-R02430 | hsa-miR-7850-5p mimic | Oligonucleotides | |
| HY-R02430A | hsa-miR-7850-5p agomir | Oligonucleotides | |
| HY-R02431 | hsa-miR-7851-3p mimic | Oligonucleotides | |
| HY-R02431A | hsa-miR-7851-3p agomir | Oligonucleotides | |
| HY-R02432 | hsa-miR-7852-3p mimic | Oligonucleotides | |
| HY-R02432A | hsa-miR-7852-3p agomir | Oligonucleotides | |
| HY-R02433 | hsa-miR-7853-5p mimic | Oligonucleotides | |
| HY-R02433A | hsa-miR-7853-5p agomir | Oligonucleotides | |
| HY-R02434 | hsa-miR-7854-3p mimic | Oligonucleotides | |
| HY-R02434A | hsa-miR-7854-3p agomir | Oligonucleotides | |
| HY-R02435 | hsa-miR-7855-5p mimic | Oligonucleotides | |
| HY-R02435A | hsa-miR-7855-5p agomir | Oligonucleotides | |
| HY-R02436 | hsa-miR-7856-5p mimic | Oligonucleotides | |
| HY-R02436A | hsa-miR-7856-5p agomir | Oligonucleotides | |
| HY-R02437 | hsa-miR-7973 mimic | Oligonucleotides | |
| HY-R02437A | hsa-miR-7973 agomir | Oligonucleotides | |
| HY-R02438 | hsa-miR-7974 mimic | Oligonucleotides | |
| HY-R02438A | hsa-miR-7974 agomir | Oligonucleotides | |
| HY-R02439 | hsa-miR-7975 mimic | Oligonucleotides | |
| HY-R02439A | hsa-miR-7975 agomir | Oligonucleotides | |
| HY-R02440 | hsa-miR-7976 mimic | Oligonucleotides | |
| HY-R02440A | hsa-miR-7976 agomir | Oligonucleotides | |
| HY-R02441 | hsa-miR-7977 mimic | Oligonucleotides | |
| HY-R02441A | hsa-miR-7977 agomir | Oligonucleotides | |
| HY-R02442 | hsa-miR-7978 mimic | Oligonucleotides | |
| HY-R02442A | hsa-miR-7978 agomir | Oligonucleotides | |
| HY-R02443 | hsa-miR-802 mimic | Oligonucleotides | |
| HY-R02443A | hsa-miR-802 agomir | Oligonucleotides | |
| HY-R02444 | hsa-miR-8052 mimic | Oligonucleotides | |
| HY-R02444A | hsa-miR-8052 agomir | Oligonucleotides | |
| HY-R02445 | hsa-miR-8053 mimic | Oligonucleotides | |
| HY-R02445A | hsa-miR-8053 agomir | Oligonucleotides | |
| HY-R02446 | hsa-miR-8054 mimic | Oligonucleotides | |
| HY-R02446A | hsa-miR-8054 agomir | Oligonucleotides | |
| HY-R02447 | hsa-miR-8055 mimic | Oligonucleotides | |
| HY-R02447A | hsa-miR-8055 agomir | Oligonucleotides | |
| HY-R02448 | hsa-miR-8056 mimic | Oligonucleotides | |
| HY-R02448A | hsa-miR-8056 agomir | Oligonucleotides | |
| HY-R02449 | hsa-miR-8057 mimic | Oligonucleotides | |
| HY-R02449A | hsa-miR-8057 agomir | Oligonucleotides | |
| HY-R02450 | hsa-miR-8058 mimic | Oligonucleotides | |
| HY-R02450A | hsa-miR-8058 agomir | Oligonucleotides | |
| HY-R02451 | hsa-miR-8059 mimic | Oligonucleotides | |
| HY-R02451A | hsa-miR-8059 agomir | Oligonucleotides | |
| HY-R02452 | hsa-miR-8060 mimic | Oligonucleotides | |
| HY-R02452A | hsa-miR-8060 agomir | Oligonucleotides | |
| HY-R02453 | hsa-miR-8061 mimic | Oligonucleotides | |
| HY-R02453A | hsa-miR-8061 agomir | Oligonucleotides | |
| HY-R02454 | hsa-miR-8062 mimic | Oligonucleotides | |
| HY-R02454A | hsa-miR-8062 agomir | Oligonucleotides | |
| HY-R02455 | hsa-miR-8063 mimic | Oligonucleotides | |
| HY-R02455A | hsa-miR-8063 agomir | Oligonucleotides | |
| HY-R02456 | hsa-miR-8064 mimic | Oligonucleotides | |
| HY-R02456A | hsa-miR-8064 agomir | Oligonucleotides | |
| HY-R02457 | hsa-miR-8065 mimic | Oligonucleotides | |
| HY-R02457A | hsa-miR-8065 agomir | Oligonucleotides | |
| HY-R02458 | hsa-miR-8066 mimic | Oligonucleotides | |
| HY-R02458A | hsa-miR-8066 agomir | Oligonucleotides | |
| HY-R02459 | hsa-miR-8067 mimic | Oligonucleotides | |
| HY-R02459A | hsa-miR-8067 agomir | Oligonucleotides | |
| HY-R02460 | hsa-miR-8068 mimic | Oligonucleotides | |
| HY-R02460A | hsa-miR-8068 agomir | Oligonucleotides | |
| HY-R02461 | hsa-miR-8069 mimic | Oligonucleotides | |
| HY-R02461A | hsa-miR-8069 agomir | Oligonucleotides | |
| HY-R02462 | hsa-miR-8070 mimic | Oligonucleotides | |
| HY-R02462A | hsa-miR-8070 agomir | Oligonucleotides | |
| HY-R02463 | hsa-miR-8071 mimic | Oligonucleotides | |
| HY-R02463A | hsa-miR-8071 agomir | Oligonucleotides | |
| HY-R02464 | hsa-miR-8072 mimic | Oligonucleotides | |
| HY-R02464A | hsa-miR-8072 agomir | Oligonucleotides | |
| HY-R02465 | hsa-miR-8073 mimic | Oligonucleotides | |
| HY-R02465A | hsa-miR-8073 agomir | Oligonucleotides | |
| HY-R02466 | hsa-miR-8074 mimic | Oligonucleotides | |
| HY-R02466A | hsa-miR-8074 agomir | Oligonucleotides | |
| HY-R02467 | hsa-miR-8075 mimic | Oligonucleotides | |
| HY-R02467A | hsa-miR-8075 agomir | Oligonucleotides | |
| HY-R02468 | hsa-miR-8076 mimic | Oligonucleotides | |
| HY-R02468A | hsa-miR-8076 agomir | Oligonucleotides | |
| HY-R02469 | hsa-miR-8077 mimic | Oligonucleotides | |
| HY-R02469A | hsa-miR-8077 agomir | Oligonucleotides | |
| HY-R02470 | hsa-miR-8078 mimic | Oligonucleotides | |
| HY-R02470A | hsa-miR-8078 agomir | Oligonucleotides | |
| HY-R02471 | hsa-miR-8079 mimic | Oligonucleotides | |
| HY-R02471A | hsa-miR-8079 agomir | Oligonucleotides | |
| HY-R02472 | hsa-miR-8080 mimic | Oligonucleotides | |
| HY-R02472A | hsa-miR-8080 agomir | Oligonucleotides | |
| HY-R02473 | hsa-miR-8081 mimic | Oligonucleotides | |
| HY-R02473A | hsa-miR-8081 agomir | Oligonucleotides | |
| HY-R02474 | hsa-miR-8082 mimic | Oligonucleotides | |
| HY-R02474A | hsa-miR-8082 agomir | Oligonucleotides | |
| HY-R02475 | hsa-miR-8083 mimic | Oligonucleotides | |
| HY-R02475A | hsa-miR-8083 agomir | Oligonucleotides | |
| HY-R02476 | hsa-miR-8084 mimic | Oligonucleotides | |
| HY-R02476A | hsa-miR-8084 agomir | Oligonucleotides | |
| HY-R02477 | hsa-miR-8085 mimic | Oligonucleotides | |
| HY-R02477A | hsa-miR-8085 agomir | Oligonucleotides | |
| HY-R02478 | hsa-miR-8086 mimic | Oligonucleotides | |
| HY-R02478A | hsa-miR-8086 agomir | Oligonucleotides | |
| HY-R02479 | hsa-miR-8087 mimic | Oligonucleotides | |
| HY-R02479A | hsa-miR-8087 agomir | Oligonucleotides | |
| HY-R02480 | hsa-miR-8088 mimic | Oligonucleotides | |
| HY-R02480A | hsa-miR-8088 agomir | Oligonucleotides | |
| HY-R02481 | hsa-miR-8089 mimic | Oligonucleotides | |
| HY-R02481A | hsa-miR-8089 agomir | Oligonucleotides | |
| HY-R02482 | hsa-miR-8485 mimic | Oligonucleotides | |
| HY-R02482A | hsa-miR-8485 agomir | Oligonucleotides | |
| HY-R02483 | hsa-miR-873-3p mimic | Oligonucleotides | |
| HY-R02483A | hsa-miR-873-3p agomir | Oligonucleotides | |
| HY-R02484 | hsa-miR-873-5p mimic | Oligonucleotides | |
| HY-R02484A | hsa-miR-873-5p agomir | Oligonucleotides | |
| HY-R02485 | hsa-miR-874-3p mimic | Oligonucleotides | |
| HY-R02485A | hsa-miR-874-3p agomir | Oligonucleotides | |
| HY-R02486 | hsa-miR-874-5p mimic | Oligonucleotides | |
| HY-R02486A | hsa-miR-874-5p agomir | Oligonucleotides | |
| HY-R02487 | hsa-miR-875-3p mimic | Oligonucleotides | |
| HY-R02487A | hsa-miR-875-3p agomir | Oligonucleotides | |
| HY-R02488 | hsa-miR-875-5p mimic | Oligonucleotides | |
| HY-R02488A | hsa-miR-875-5p agomir | Oligonucleotides | |
| HY-R02489 | hsa-miR-876-3p mimic | Oligonucleotides | |
| HY-R02489A | hsa-miR-876-3p agomir | Oligonucleotides | |
| HY-R02490 | hsa-miR-876-5p mimic | Oligonucleotides | |
| HY-R02490A | hsa-miR-876-5p agomir | Oligonucleotides | |
| HY-R02491 | hsa-miR-877-3p mimic | Oligonucleotides | |
| HY-R02491A | hsa-miR-877-3p agomir | Oligonucleotides | |
| HY-R02492 | hsa-miR-877-5p mimic | Oligonucleotides | |
| HY-R02492A | hsa-miR-877-5p agomir | Oligonucleotides | |
| HY-R02493 | hsa-miR-885-3p mimic | Oligonucleotides | |
| HY-R02493A | hsa-miR-885-3p agomir | Oligonucleotides | |
| HY-R02494 | hsa-miR-885-5p mimic | Oligonucleotides | |
| HY-R02494A | hsa-miR-885-5p agomir | Oligonucleotides | |
| HY-R02495 | hsa-miR-887-3p mimic | Oligonucleotides | |
| HY-R02495A | hsa-miR-887-3p agomir | Oligonucleotides | |
| HY-R02496 | hsa-miR-887-5p mimic | Oligonucleotides | |
| HY-R02496A | hsa-miR-887-5p agomir | Oligonucleotides | |
| HY-R02497 | hsa-miR-888-3p mimic | Oligonucleotides | |
| HY-R02497A | hsa-miR-888-3p agomir | Oligonucleotides | |
| HY-R02498 | hsa-miR-889-3p mimic | Oligonucleotides | |
| HY-R02498A | hsa-miR-889-3p agomir | Oligonucleotides | |
| HY-R02499 | hsa-miR-889-5p mimic | Oligonucleotides | |
| HY-R02499A | hsa-miR-889-5p agomir | Oligonucleotides | |
| HY-R02500 | hsa-miR-890 mimic | Oligonucleotides | |
| HY-R02500A | hsa-miR-890 agomir | Oligonucleotides | |
| HY-R02501 | hsa-miR-891a-3p mimic | Oligonucleotides | |
| HY-R02501A | hsa-miR-891a-3p agomir | Oligonucleotides | |
| HY-R02502 | hsa-miR-891a-5p mimic | Oligonucleotides | |
| HY-R02502A | hsa-miR-891a-5p agomir | Oligonucleotides | |
| HY-R02503 | hsa-miR-891b mimic | Oligonucleotides | |
| HY-R02503A | hsa-miR-891b agomir | Oligonucleotides | |
| HY-R02504 | hsa-miR-892a mimic | Oligonucleotides | |
| HY-R02504A | hsa-miR-892a agomir | Oligonucleotides | |
| HY-R02505 | hsa-miR-892b mimic | Oligonucleotides | |
| HY-R02505A | hsa-miR-892b agomir | Oligonucleotides | |
| HY-R02506 | hsa-miR-892c-3p mimic | Oligonucleotides | |
| HY-R02506A | hsa-miR-892c-3p agomir | Oligonucleotides | |
| HY-R02507 | hsa-miR-892c-5p mimic | Oligonucleotides | |
| HY-R02507A | hsa-miR-892c-5p agomir | Oligonucleotides | |
| HY-R02508 | hsa-miR-921 mimic | Oligonucleotides | |
| HY-R02508A | hsa-miR-921 agomir | Oligonucleotides | |
| HY-R02509 | hsa-miR-922 mimic | Oligonucleotides | |
| HY-R02509A | hsa-miR-922 agomir | Oligonucleotides | |
| HY-R02510 | hsa-miR-924 mimic | Oligonucleotides | |
| HY-R02510A | hsa-miR-924 agomir | Oligonucleotides | |
| HY-R02511 | hsa-miR-92a-1-5p mimic | Oligonucleotides | |
| HY-R02511A | hsa-miR-92a-1-5p agomir | Oligonucleotides | |
| HY-R02512 | hsa-miR-92a-2-5p mimic | Oligonucleotides | |
| HY-R02512A | hsa-miR-92a-2-5p agomir | Oligonucleotides | |
| HY-R02513 | hsa-miR-92a-3p mimic | Oligonucleotides | |
| HY-R02513A | hsa-miR-92a-3p agomir | Oligonucleotides | |
| HY-R02514 | hsa-miR-92b-3p mimic | Oligonucleotides | |
| HY-R02514A | hsa-miR-92b-3p agomir | Oligonucleotides | |
| HY-R02515 | hsa-miR-92b-5p mimic | Oligonucleotides | |
| HY-R02515A | hsa-miR-92b-5p agomir | Oligonucleotides | |
| HY-R02516 | hsa-miR-933 mimic | Oligonucleotides | |
| HY-R02516A | hsa-miR-933 agomir | Oligonucleotides | |
| HY-R02517 | hsa-miR-93-3p mimic | Oligonucleotides | |
| HY-R02517A | hsa-miR-93-3p agomir | Oligonucleotides | |
| HY-R02518 | hsa-miR-934 mimic | Oligonucleotides | |
| HY-R02518A | hsa-miR-934 agomir | Oligonucleotides | |
| HY-R02519 | hsa-miR-935 mimic | Oligonucleotides | |
| HY-R02519A | hsa-miR-935 agomir | Oligonucleotides | |
| HY-R02520 | hsa-miR-93-5p mimic | Oligonucleotides | |
| HY-R02520A | hsa-miR-93-5p agomir | Oligonucleotides | |
| HY-R02521 | hsa-miR-936 mimic | Oligonucleotides | |
| HY-R02521A | hsa-miR-936 agomir | Oligonucleotides | |
| HY-R02522 | hsa-miR-937-3p mimic | Oligonucleotides | |
| HY-R02522A | hsa-miR-937-3p agomir | Oligonucleotides | |
| HY-R02523 | hsa-miR-937-5p mimic | Oligonucleotides | |
| HY-R02523A | hsa-miR-937-5p agomir | Oligonucleotides | |
| HY-R02524 | hsa-miR-938 mimic | Oligonucleotides | |
| HY-R02524A | hsa-miR-938 agomir | Oligonucleotides | |
| HY-R02525 | hsa-miR-939-3p mimic | Oligonucleotides | |
| HY-R02525A | hsa-miR-939-3p agomir | Oligonucleotides | |
| HY-R02526 | hsa-miR-939-5p mimic | Oligonucleotides | |
| HY-R02526A | hsa-miR-939-5p agomir | Oligonucleotides | |
| HY-R02527 | hsa-miR-9-3p mimic | Oligonucleotides | |
| HY-R02527A | hsa-miR-9-3p agomir | Oligonucleotides | |
| HY-R02528 | hsa-miR-940 mimic | Oligonucleotides | |
| HY-R02528A | hsa-miR-940 agomir | Oligonucleotides | |
| HY-R02529 | hsa-miR-941 mimic | Oligonucleotides | |
| HY-R02529A | hsa-miR-941 agomir | Oligonucleotides | |
| HY-R02530 | hsa-miR-942-3p mimic | Oligonucleotides | |
| HY-R02530A | hsa-miR-942-3p agomir | Oligonucleotides | |
| HY-R02531 | hsa-miR-942-5p mimic | Oligonucleotides | |
| HY-R02531A | hsa-miR-942-5p agomir | Oligonucleotides | |
| HY-R02532 | hsa-miR-943 mimic | Oligonucleotides | |
| HY-R02532A | hsa-miR-943 agomir | Oligonucleotides | |
| HY-R02533 | hsa-miR-944 mimic | Oligonucleotides | |
| HY-R02533A | hsa-miR-944 agomir | Oligonucleotides | |
| HY-R02534 | hsa-miR-9500 mimic | Oligonucleotides | |
| HY-R02534A | hsa-miR-9500 agomir | Oligonucleotides | |
| HY-R02535 | hsa-miR-95-3p mimic | Oligonucleotides | |
| HY-R02535A | hsa-miR-95-3p agomir | Oligonucleotides | |
| HY-R02536 | hsa-miR-9-5p mimic | Oligonucleotides | |
| HY-R02536A | hsa-miR-9-5p agomir | Oligonucleotides | |
| HY-R02537 | hsa-miR-96-3p mimic | Oligonucleotides | |
| HY-R02537A | hsa-miR-96-3p agomir | Oligonucleotides | |
| HY-R02538 | hsa-miR-96-5p mimic | Oligonucleotides | |
| HY-R02538A | hsa-miR-96-5p agomir | Oligonucleotides | |
| HY-R02539 | hsa-miR-9718 mimic | Oligonucleotides | |
| HY-R02539A | hsa-miR-9718 agomir | Oligonucleotides | |
| HY-R02540 | hsa-miR-98-3p mimic | Oligonucleotides | |
| HY-R02540A | hsa-miR-98-3p agomir | Oligonucleotides | |
| HY-R02541 | hsa-miR-9851-3p mimic | Oligonucleotides | |
| HY-R02541A | hsa-miR-9851-3p agomir | Oligonucleotides | |
| HY-R02542 | hsa-miR-9851-5p mimic | Oligonucleotides | |
| HY-R02542A | hsa-miR-9851-5p agomir | Oligonucleotides | |
| HY-R02543 | hsa-miR-98-5p mimic | Oligonucleotides | |
| HY-R02543A | hsa-miR-98-5p agomir | Oligonucleotides | |
| HY-R02544 | hsa-miR-9898 mimic | Oligonucleotides | |
| HY-R02544A | hsa-miR-9898 agomir | Oligonucleotides | |
| HY-R02545 | hsa-miR-9899 mimic | Oligonucleotides | |
| HY-R02545A | hsa-miR-9899 agomir | Oligonucleotides | |
| HY-R02546 | hsa-miR-9900 mimic | Oligonucleotides | |
| HY-R02546A | hsa-miR-9900 agomir | Oligonucleotides | |
| HY-R02547 | hsa-miR-9901 mimic | Oligonucleotides | |
| HY-R02547A | hsa-miR-9901 agomir | Oligonucleotides | |
| HY-R02548 | hsa-miR-9902 mimic | Oligonucleotides | |
| HY-R02548A | hsa-miR-9902 agomir | Oligonucleotides | |
| HY-R02549 | hsa-miR-9903 mimic | Oligonucleotides | |
| HY-R02549A | hsa-miR-9903 agomir | Oligonucleotides | |
| HY-R02550 | hsa-miR-9983-3p mimic | Oligonucleotides | |
| HY-R02550A | hsa-miR-9983-3p agomir | Oligonucleotides | |
| HY-R02551 | hsa-miR-9985 mimic | Oligonucleotides | |
| HY-R02551A | hsa-miR-9985 agomir | Oligonucleotides | |
| HY-R02552 | hsa-miR-9986 mimic | Oligonucleotides | |
| HY-R02552A | hsa-miR-9986 agomir | Oligonucleotides | |
| HY-R02553 | hsa-miR-99a-3p mimic | Oligonucleotides | |
| HY-R02553A | hsa-miR-99a-3p agomir | Oligonucleotides | |
| HY-R02554 | hsa-miR-99a-5p mimic | Oligonucleotides | |
| HY-R02554A | hsa-miR-99a-5p agomir | Oligonucleotides | |
| HY-R02555 | hsa-miR-99b-3p mimic | Oligonucleotides | |
| HY-R02555A | hsa-miR-99b-3p agomir | Oligonucleotides | |
| HY-R02556 | hsa-miR-99b-5p mimic | Oligonucleotides | |
| HY-R02556A | hsa-miR-99b-5p agomir | Oligonucleotides | |
| HY-R02557 | mmu-let-7a-1-3p mimic | Oligonucleotides | |
| HY-R02557A | mmu-let-7a-1-3p agomir | Oligonucleotides | |
| HY-R02558 | mmu-let-7a-2-3p mimic | Oligonucleotides | |
| HY-R02558A | mmu-let-7a-2-3p agomir | Oligonucleotides | |
| HY-R02559 | mmu-let-7f-2-3p mimic | Oligonucleotides | |
| HY-R02559A | mmu-let-7f-2-3p agomir | Oligonucleotides | |
| HY-R02560 | mmu-let-7j mimic | Oligonucleotides | |
| HY-R02560A | mmu-let-7j agomir | Oligonucleotides | |
| HY-R02561 | mmu-let-7k mimic | Oligonucleotides | |
| HY-R02561A | mmu-let-7k agomir | Oligonucleotides | |
| HY-R02562 | mmu-miR-100-3p mimic | Oligonucleotides | |
| HY-R02562A | mmu-miR-100-3p agomir | Oligonucleotides | |
| HY-R02563 | mmu-miR-101a-5p mimic | Oligonucleotides | |
| HY-R02563A | mmu-miR-101a-5p agomir | Oligonucleotides | |
| HY-R02564 | mmu-miR-101b-3p mimic | Oligonucleotides | |
| HY-R02564A | mmu-miR-101b-3p agomir | Oligonucleotides | |
| HY-R02565 | mmu-miR-101b-5p mimic | Oligonucleotides | |
| HY-R02565A | mmu-miR-101b-5p agomir | Oligonucleotides | |
| HY-R02566 | mmu-miR-101c mimic | Oligonucleotides | |
| HY-R02566A | mmu-miR-101c agomir | Oligonucleotides | |
| HY-R02567 | mmu-miR-105 mimic | Oligonucleotides | |
| HY-R02567A | mmu-miR-105 agomir | Oligonucleotides | |
| HY-R02568 | mmu-miR-106a-3p mimic | Oligonucleotides | |
| HY-R02568A | mmu-miR-106a-3p agomir | Oligonucleotides | |
| HY-R02569 | mmu-miR-106a-5p mimic | Oligonucleotides | |
| HY-R02569A | mmu-miR-106a-5p agomir | Oligonucleotides | |
| HY-R02570 | mmu-miR-107-5p mimic | Oligonucleotides | |
| HY-R02570A | mmu-miR-107-5p agomir | Oligonucleotides | |
| HY-R02571 | mmu-miR-10b-3p mimic | Oligonucleotides | |
| HY-R02571A | mmu-miR-10b-3p agomir | Oligonucleotides | |
| HY-R02572 | mmu-miR-1187 mimic | Oligonucleotides | |
| HY-R02572A | mmu-miR-1187 agomir | Oligonucleotides | |
| HY-R02573 | mmu-miR-1188-3p mimic | Oligonucleotides | |
| HY-R02573A | mmu-miR-1188-3p agomir | Oligonucleotides | |
| HY-R02574 | mmu-miR-1188-5p mimic | Oligonucleotides | |
| HY-R02574A | mmu-miR-1188-5p agomir | Oligonucleotides | |
| HY-R02575 | mmu-miR-1190 mimic | Oligonucleotides | |
| HY-R02575A | mmu-miR-1190 agomir | Oligonucleotides | |
| HY-R02576 | mmu-miR-1191a mimic | Oligonucleotides | |
| HY-R02576A | mmu-miR-1191a agomir | Oligonucleotides | |
| HY-R02577 | mmu-miR-1191b-3p mimic | Oligonucleotides | |
| HY-R02577A | mmu-miR-1191b-3p agomir | Oligonucleotides | |
| HY-R02578 | mmu-miR-1191b-5p mimic | Oligonucleotides | |
| HY-R02578A | mmu-miR-1191b-5p agomir | Oligonucleotides | |
| HY-R02579 | mmu-miR-1192 mimic | Oligonucleotides | |
| HY-R02579A | mmu-miR-1192 agomir | Oligonucleotides | |
| HY-R02580 | mmu-miR-1193-3p mimic | Oligonucleotides | |
| HY-R02580A | mmu-miR-1193-3p agomir | Oligonucleotides | |
| HY-R02581 | mmu-miR-1193-5p mimic | Oligonucleotides | |
| HY-R02581A | mmu-miR-1193-5p agomir | Oligonucleotides | |
| HY-R02582 | mmu-miR-1194 mimic | Oligonucleotides | |
| HY-R02582A | mmu-miR-1194 agomir | Oligonucleotides | |
| HY-R02583 | mmu-miR-1195 mimic | Oligonucleotides | |
| HY-R02583A | mmu-miR-1195 agomir | Oligonucleotides | |
| HY-R02584 | mmu-miR-1197-5p mimic | Oligonucleotides | |
| HY-R02584A | mmu-miR-1197-5p agomir | Oligonucleotides | |
| HY-R02585 | mmu-miR-1198-3p mimic | Oligonucleotides | |
| HY-R02585A | mmu-miR-1198-3p agomir | Oligonucleotides | |
| HY-R02586 | mmu-miR-1198-5p mimic | Oligonucleotides | |
| HY-R02586A | mmu-miR-1198-5p agomir | Oligonucleotides | |
| HY-R02587 | mmu-miR-1199-3p mimic | Oligonucleotides | |
| HY-R02587A | mmu-miR-1199-3p agomir | Oligonucleotides | |
| HY-R02588 | mmu-miR-1199-5p mimic | Oligonucleotides | |
| HY-R02588A | mmu-miR-1199-5p agomir | Oligonucleotides | |
| HY-R02589 | mmu-miR-12178-3p mimic | Oligonucleotides | |
| HY-R02589A | mmu-miR-12178-3p agomir | Oligonucleotides | |
| HY-R02590 | mmu-miR-12178-5p mimic | Oligonucleotides | |
| HY-R02590A | mmu-miR-12178-5p agomir | Oligonucleotides | |
| HY-R02591 | mmu-miR-12179-5p mimic | Oligonucleotides | |
| HY-R02591A | mmu-miR-12179-5p agomir | Oligonucleotides | |
| HY-R02592 | mmu-miR-12180-3p mimic | Oligonucleotides | |
| HY-R02592A | mmu-miR-12180-3p agomir | Oligonucleotides | |
| HY-R02593 | mmu-miR-12181-3p mimic | Oligonucleotides | |
| HY-R02593A | mmu-miR-12181-3p agomir | Oligonucleotides | |
| HY-R02594 | mmu-miR-12181-5p mimic | Oligonucleotides | |
| HY-R02594A | mmu-miR-12181-5p agomir | Oligonucleotides | |
| HY-R02595 | mmu-miR-12182-3p mimic | Oligonucleotides | |
| HY-R02595A | mmu-miR-12182-3p agomir | Oligonucleotides | |
| HY-R02596 | mmu-miR-12182-5p mimic | Oligonucleotides | |
| HY-R02596A | mmu-miR-12182-5p agomir | Oligonucleotides | |
| HY-R02597 | mmu-miR-12183-5p mimic | Oligonucleotides | |
| HY-R02597A | mmu-miR-12183-5p agomir | Oligonucleotides | |
| HY-R02598 | mmu-miR-12184-3p mimic | Oligonucleotides | |
| HY-R02598A | mmu-miR-12184-3p agomir | Oligonucleotides | |
| HY-R02599 | mmu-miR-12184-5p mimic | Oligonucleotides | |
| HY-R02599A | mmu-miR-12184-5p agomir | Oligonucleotides | |
| HY-R02600 | mmu-miR-12185-3p mimic | Oligonucleotides | |
| HY-R02600A | mmu-miR-12185-3p agomir | Oligonucleotides | |
| HY-R02601 | mmu-miR-12185-5p mimic | Oligonucleotides | |
| HY-R02601A | mmu-miR-12185-5p agomir | Oligonucleotides | |
| HY-R02602 | mmu-miR-12186-3p mimic | Oligonucleotides | |
| HY-R02602A | mmu-miR-12186-3p agomir | Oligonucleotides | |
| HY-R02603 | mmu-miR-12186-5p mimic | Oligonucleotides | |
| HY-R02603A | mmu-miR-12186-5p agomir | Oligonucleotides | |
| HY-R02604 | mmu-miR-12187-3p mimic | Oligonucleotides | |
| HY-R02604A | mmu-miR-12187-3p agomir | Oligonucleotides | |
| HY-R02605 | mmu-miR-12187-5p mimic | Oligonucleotides | |
| HY-R02605A | mmu-miR-12187-5p agomir | Oligonucleotides | |
| HY-R02606 | mmu-miR-12188-3p mimic | Oligonucleotides | |
| HY-R02606A | mmu-miR-12188-3p agomir | Oligonucleotides | |
| HY-R02607 | mmu-miR-12188-5p mimic | Oligonucleotides | |
| HY-R02607A | mmu-miR-12188-5p agomir | Oligonucleotides | |
| HY-R02608 | mmu-miR-12189-3p mimic | Oligonucleotides | |
| HY-R02608A | mmu-miR-12189-3p agomir | Oligonucleotides | |
| HY-R02609 | mmu-miR-12190-3p mimic | Oligonucleotides | |
| HY-R02609A | mmu-miR-12190-3p agomir | Oligonucleotides | |
| HY-R02610 | mmu-miR-12191-3p mimic | Oligonucleotides | |
| HY-R02610A | mmu-miR-12191-3p agomir | Oligonucleotides | |
| HY-R02611 | mmu-miR-12191-5p mimic | Oligonucleotides | |
| HY-R02611A | mmu-miR-12191-5p agomir | Oligonucleotides | |
| HY-R02612 | mmu-miR-12192-5p mimic | Oligonucleotides | |
| HY-R02612A | mmu-miR-12192-5p agomir | Oligonucleotides | |
| HY-R02613 | mmu-miR-12193-3p mimic | Oligonucleotides | |
| HY-R02613A | mmu-miR-12193-3p agomir | Oligonucleotides | |
| HY-R02614 | mmu-miR-12193-5p mimic | Oligonucleotides | |
| HY-R02614A | mmu-miR-12193-5p agomir | Oligonucleotides | |
| HY-R02615 | mmu-miR-12194-3p mimic | Oligonucleotides | |
| HY-R02615A | mmu-miR-12194-3p agomir | Oligonucleotides | |
| HY-R02616 | mmu-miR-12195-3p mimic | Oligonucleotides | |
| HY-R02616A | mmu-miR-12195-3p agomir | Oligonucleotides | |
| HY-R02617 | mmu-miR-12195-5p mimic | Oligonucleotides | |
| HY-R02617A | mmu-miR-12195-5p agomir | Oligonucleotides | |
| HY-R02618 | mmu-miR-12196-3p mimic | Oligonucleotides | |
| HY-R02618A | mmu-miR-12196-3p agomir | Oligonucleotides | |
| HY-R02619 | mmu-miR-12196-5p mimic | Oligonucleotides | |
| HY-R02619A | mmu-miR-12196-5p agomir | Oligonucleotides | |
| HY-R02620 | mmu-miR-12197-3p mimic | Oligonucleotides | |
| HY-R02620A | mmu-miR-12197-3p agomir | Oligonucleotides | |
| HY-R02621 | mmu-miR-12198-3p mimic | Oligonucleotides | |
| HY-R02621A | mmu-miR-12198-3p agomir | Oligonucleotides | |
| HY-R02622 | mmu-miR-12199-3p mimic | Oligonucleotides | |
| HY-R02622A | mmu-miR-12199-3p agomir | Oligonucleotides | |
| HY-R02623 | mmu-miR-12200-3p mimic | Oligonucleotides | |
| HY-R02623A | mmu-miR-12200-3p agomir | Oligonucleotides | |
| HY-R02624 | mmu-miR-12200-5p mimic | Oligonucleotides | |
| HY-R02624A | mmu-miR-12200-5p agomir | Oligonucleotides | |
| HY-R02625 | mmu-miR-12201-3p mimic | Oligonucleotides | |
| HY-R02625A | mmu-miR-12201-3p agomir | Oligonucleotides | |
| HY-R02626 | mmu-miR-12201-5p mimic | Oligonucleotides | |
| HY-R02626A | mmu-miR-12201-5p agomir | Oligonucleotides | |
| HY-R02627 | mmu-miR-12202-3p mimic | Oligonucleotides | |
| HY-R02627A | mmu-miR-12202-3p agomir | Oligonucleotides | |
| HY-R02628 | mmu-miR-12202-5p mimic | Oligonucleotides | |
| HY-R02628A | mmu-miR-12202-5p agomir | Oligonucleotides | |
| HY-R02629 | mmu-miR-12203-3p mimic | Oligonucleotides | |
| HY-R02629A | mmu-miR-12203-3p agomir | Oligonucleotides | |
| HY-R02630 | mmu-miR-12203-5p mimic | Oligonucleotides | |
| HY-R02630A | mmu-miR-12203-5p agomir | Oligonucleotides | |
| HY-R02631 | mmu-miR-12204-5p mimic | Oligonucleotides | |
| HY-R02631A | mmu-miR-12204-5p agomir | Oligonucleotides | |
| HY-R02632 | mmu-miR-12205-3p mimic | Oligonucleotides | |
| HY-R02632A | mmu-miR-12205-3p agomir | Oligonucleotides | |
| HY-R02633 | mmu-miR-12205-5p mimic | Oligonucleotides | |
| HY-R02633A | mmu-miR-12205-5p agomir | Oligonucleotides | |
| HY-R02634 | mmu-miR-12206-5p mimic | Oligonucleotides | |
| HY-R02634A | mmu-miR-12206-5p agomir | Oligonucleotides | |
| HY-R02635 | mmu-miR-122-3p mimic | Oligonucleotides | |
| HY-R02635A | mmu-miR-122-3p agomir | Oligonucleotides | |
| HY-R02636 | mmu-miR-1224-3p mimic | Oligonucleotides | |
| HY-R02636A | mmu-miR-1224-3p agomir | Oligonucleotides | |
| HY-R02637 | mmu-miR-1224-5p mimic | Oligonucleotides | |
| HY-R02637A | mmu-miR-1224-5p agomir | Oligonucleotides | |
| HY-R02638 | mmu-miR-122b-5p mimic | Oligonucleotides | |
| HY-R02638A | mmu-miR-122b-5p agomir | Oligonucleotides | |
| HY-R02639 | mmu-miR-1231-3p mimic | Oligonucleotides | |
| HY-R02639A | mmu-miR-1231-3p agomir | Oligonucleotides | |
| HY-R02640 | mmu-miR-1231-5p mimic | Oligonucleotides | |
| HY-R02640A | mmu-miR-1231-5p agomir | Oligonucleotides | |
| HY-R02641 | mmu-miR-124-3p mimic | Oligonucleotides | |
| HY-R02641A | mmu-miR-124-3p agomir | Oligonucleotides | |
| HY-R02642 | mmu-miR-1247-3p mimic | Oligonucleotides | |
| HY-R02642A | mmu-miR-1247-3p agomir | Oligonucleotides | |
| HY-R02643 | mmu-miR-1249-5p mimic | Oligonucleotides | |
| HY-R02643A | mmu-miR-1249-5p agomir | Oligonucleotides | |
| HY-R02644 | mmu-miR-124b-3p mimic | Oligonucleotides | |
| HY-R02644A | mmu-miR-124b-3p agomir | Oligonucleotides | |
| HY-R02645 | mmu-miR-1258-3p mimic | Oligonucleotides | |
| HY-R02645A | mmu-miR-1258-3p agomir | Oligonucleotides | |
| HY-R02646 | mmu-miR-1258-5p mimic | Oligonucleotides | |
| HY-R02646A | mmu-miR-1258-5p agomir | Oligonucleotides | |
| HY-R02647 | mmu-miR-125b-2-3p mimic | Oligonucleotides | |
| HY-R02647A | mmu-miR-125b-2-3p agomir | Oligonucleotides | |
| HY-R02648 | mmu-miR-1264-3p mimic | Oligonucleotides | |
| HY-R02648A | mmu-miR-1264-3p agomir | Oligonucleotides | |
| HY-R02649 | mmu-miR-1264-5p mimic | Oligonucleotides | |
| HY-R02649A | mmu-miR-1264-5p agomir | Oligonucleotides | |
| HY-R02650 | mmu-miR-126b-3p mimic | Oligonucleotides | |
| HY-R02650A | mmu-miR-126b-3p agomir | Oligonucleotides | |
| HY-R02651 | mmu-miR-126b-5p mimic | Oligonucleotides | |
| HY-R02651A | mmu-miR-126b-5p agomir | Oligonucleotides | |
| HY-R02652 | mmu-miR-1271-3p mimic | Oligonucleotides | |
| HY-R02652A | mmu-miR-1271-3p agomir | Oligonucleotides | |
| HY-R02653 | mmu-miR-1271-5p mimic | Oligonucleotides | |
| HY-R02653A | mmu-miR-1271-5p agomir | Oligonucleotides | |
| HY-R02654 | mmu-miR-128-1-5p mimic | Oligonucleotides | |
| HY-R02654A | mmu-miR-128-1-5p agomir | Oligonucleotides | |
| HY-R02655 | mmu-miR-128-2-5p mimic | Oligonucleotides | |
| HY-R02655A | mmu-miR-128-2-5p agomir | Oligonucleotides | |
| HY-R02656 | mmu-miR-1291 mimic | Oligonucleotides | |
| HY-R02656A | mmu-miR-1291 agomir | Oligonucleotides | |
| HY-R02657 | mmu-miR-1298-3p mimic | Oligonucleotides | |
| HY-R02657A | mmu-miR-1298-3p agomir | Oligonucleotides | |
| HY-R02658 | mmu-miR-129b-3p mimic | Oligonucleotides | |
| HY-R02658A | mmu-miR-129b-3p agomir | Oligonucleotides | |
| HY-R02659 | mmu-miR-129b-5p mimic | Oligonucleotides | |
| HY-R02659A | mmu-miR-129b-5p agomir | Oligonucleotides | |
| HY-R02660 | mmu-miR-1306-3p mimic | Oligonucleotides | |
| HY-R02660A | mmu-miR-1306-3p agomir | Oligonucleotides | |
| HY-R02661 | mmu-miR-1306-5p mimic | Oligonucleotides | |
| HY-R02661A | mmu-miR-1306-5p agomir | Oligonucleotides | |
| HY-R02662 | mmu-miR-130b-5p mimic | Oligonucleotides | |
| HY-R02662A | mmu-miR-130b-5p agomir | Oligonucleotides | |
| HY-R02663 | mmu-miR-130c mimic | Oligonucleotides | |
| HY-R02663A | mmu-miR-130c agomir | Oligonucleotides | |
| HY-R02664 | mmu-miR-132-5p mimic | Oligonucleotides | |
| HY-R02664A | mmu-miR-132-5p agomir | Oligonucleotides | |
| HY-R02665 | mmu-miR-133a-5p mimic | Oligonucleotides | |
| HY-R02665A | mmu-miR-133a-5p agomir | Oligonucleotides | |
| HY-R02666 | mmu-miR-133b-5p mimic | Oligonucleotides | |
| HY-R02666A | mmu-miR-133b-5p agomir | Oligonucleotides | |
| HY-R02667 | mmu-miR-133c mimic | Oligonucleotides | |
| HY-R02667A | mmu-miR-133c agomir | Oligonucleotides | |
| HY-R02668 | mmu-miR-134-3p mimic | Oligonucleotides | |
| HY-R02668A | mmu-miR-134-3p agomir | Oligonucleotides | |
| HY-R02669 | mmu-miR-135a-2-3p mimic | Oligonucleotides | |
| HY-R02669A | mmu-miR-135a-2-3p agomir | Oligonucleotides | |
| HY-R02670 | mmu-miR-136-3p mimic | Oligonucleotides | |
| HY-R02670A | mmu-miR-136-3p agomir | Oligonucleotides | |
| HY-R02671 | mmu-miR-136-5p mimic | Oligonucleotides | |
| HY-R02671A | mmu-miR-136-5p agomir | Oligonucleotides | |
| HY-R02672 | mmu-miR-138-1-3p mimic | Oligonucleotides | |
| HY-R02672A | mmu-miR-138-1-3p agomir | Oligonucleotides | |
| HY-R02673 | mmu-miR-138-2-3p mimic | Oligonucleotides | |
| HY-R02673A | mmu-miR-138-2-3p agomir | Oligonucleotides | |
| HY-R02674 | mmu-miR-139-5p mimic | Oligonucleotides | |
| HY-R02674A | mmu-miR-139-5p agomir | Oligonucleotides | |
| HY-R02675 | mmu-miR-141-5p mimic | Oligonucleotides | |
| HY-R02675A | mmu-miR-141-5p agomir | Oligonucleotides | |
| HY-R02676 | mmu-miR-142b mimic | Oligonucleotides | |
| HY-R02676A | mmu-miR-142b agomir | Oligonucleotides | |
| HY-R02677 | mmu-miR-143-5p mimic | Oligonucleotides | |
| HY-R02677A | mmu-miR-143-5p agomir | Oligonucleotides | |
| HY-R02678 | mmu-miR-144-5p mimic | Oligonucleotides | |
| HY-R02678A | mmu-miR-144-5p agomir | Oligonucleotides | |
| HY-R02679 | mmu-miR-145a-3p mimic | Oligonucleotides | |
| HY-R02679A | mmu-miR-145a-3p agomir | Oligonucleotides | |
| HY-R02680 | mmu-miR-145b mimic | Oligonucleotides | |
| HY-R02680A | mmu-miR-145b agomir | Oligonucleotides | |
| HY-R02681 | mmu-miR-146a-3p mimic | Oligonucleotides | |
| HY-R02681A | mmu-miR-146a-3p agomir | Oligonucleotides | |
| HY-R02682 | mmu-miR-146b-3p mimic | Oligonucleotides | |
| HY-R02682A | mmu-miR-146b-3p agomir | Oligonucleotides | |
| HY-R02683 | mmu-miR-147-3p mimic | Oligonucleotides | |
| HY-R02683A | mmu-miR-147-3p agomir | Oligonucleotides | |
| HY-R02684 | mmu-miR-147-5p mimic | Oligonucleotides | |
| HY-R02684A | mmu-miR-147-5p agomir | Oligonucleotides | |
| HY-R02685 | mmu-miR-148b-5p mimic | Oligonucleotides | |
| HY-R02685A | mmu-miR-148b-5p agomir | Oligonucleotides | |
| HY-R02686 | mmu-miR-149-3p mimic | Oligonucleotides | |
| HY-R02686A | mmu-miR-149-3p agomir | Oligonucleotides | |
| HY-R02687 | mmu-miR-150-3p mimic | Oligonucleotides | |
| HY-R02687A | mmu-miR-150-3p agomir | Oligonucleotides | |
| HY-R02688 | mmu-miR-151-3p mimic | Oligonucleotides | |
| HY-R02688A | mmu-miR-151-3p agomir | Oligonucleotides | |
| HY-R02689 | mmu-miR-152-5p mimic | Oligonucleotides | |
| HY-R02689A | mmu-miR-152-5p agomir | Oligonucleotides | |
| HY-R02690 | mmu-miR-153-5p mimic | Oligonucleotides | |
| HY-R02690A | mmu-miR-153-5p agomir | Oligonucleotides | |
| HY-R02691 | mmu-miR-155-5p mimic | Oligonucleotides | |
| HY-R02691A | mmu-miR-155-5p agomir | Oligonucleotides | |
| HY-R02692 | mmu-miR-15a-3p mimic | Oligonucleotides | |
| HY-R02692A | mmu-miR-15a-3p agomir | Oligonucleotides | |
| HY-R02693 | mmu-miR-16-1-3p mimic | Oligonucleotides | |
| HY-R02693A | mmu-miR-16-1-3p agomir | Oligonucleotides | |
| HY-R02694 | mmu-miR-1668 mimic | Oligonucleotides | |
| HY-R02694A | mmu-miR-1668 agomir | Oligonucleotides | |
| HY-R02695 | mmu-miR-17-3p mimic | Oligonucleotides | |
| HY-R02695A | mmu-miR-17-3p agomir | Oligonucleotides | |
| HY-R02696 | mmu-miR-181b-2-3p mimic | Oligonucleotides | |
| HY-R02696A | mmu-miR-181b-2-3p agomir | Oligonucleotides | |
| HY-R02697 | mmu-miR-181b-5p mimic | Oligonucleotides | |
| HY-R02697A | mmu-miR-181b-5p agomir | Oligonucleotides | |
| HY-R02698 | mmu-miR-181c-3p mimic | Oligonucleotides | |
| HY-R02698A | mmu-miR-181c-3p agomir | Oligonucleotides | |
| HY-R02699 | mmu-miR-181d-3p mimic | Oligonucleotides | |
| HY-R02699A | mmu-miR-181d-3p agomir | Oligonucleotides | |
| HY-R02700 | mmu-miR-182-3p mimic | Oligonucleotides | |
| HY-R02700A | mmu-miR-182-3p agomir | Oligonucleotides | |
| HY-R02701 | mmu-miR-182-5p mimic | Oligonucleotides | |
| HY-R02701A | mmu-miR-182-5p agomir | Oligonucleotides | |
| HY-R02702 | mmu-miR-1839-3p mimic | Oligonucleotides | |
| HY-R02702A | mmu-miR-1839-3p agomir | Oligonucleotides | |
| HY-R02703 | mmu-miR-1839-5p mimic | Oligonucleotides | |
| HY-R02703A | mmu-miR-1839-5p agomir | Oligonucleotides | |
| HY-R02704 | mmu-miR-1843a-3p mimic | Oligonucleotides | |
| HY-R02704A | mmu-miR-1843a-3p agomir | Oligonucleotides | |
| HY-R02705 | mmu-miR-1843a-5p mimic | Oligonucleotides | |
| HY-R02705A | mmu-miR-1843a-5p agomir | Oligonucleotides | |
| HY-R02706 | mmu-miR-1843b-3p mimic | Oligonucleotides | |
| HY-R02706A | mmu-miR-1843b-3p agomir | Oligonucleotides | |
| HY-R02707 | mmu-miR-1843b-5p mimic | Oligonucleotides | |
| HY-R02707A | mmu-miR-1843b-5p agomir | Oligonucleotides | |
| HY-R02708 | mmu-miR-184-5p mimic | Oligonucleotides | |
| HY-R02708A | mmu-miR-184-5p agomir | Oligonucleotides | |
| HY-R02709 | mmu-miR-185-3p mimic | Oligonucleotides | |
| HY-R02709A | mmu-miR-185-3p agomir | Oligonucleotides | |
| HY-R02710 | mmu-miR-186-3p mimic | Oligonucleotides | |
| HY-R02710A | mmu-miR-186-3p agomir | Oligonucleotides | |
| HY-R02711 | mmu-miR-187-5p mimic | Oligonucleotides | |
| HY-R02711A | mmu-miR-187-5p agomir | Oligonucleotides | |
| HY-R02712 | mmu-miR-1892 mimic | Oligonucleotides | |
| HY-R02712A | mmu-miR-1892 agomir | Oligonucleotides | |
| HY-R02713 | mmu-miR-1893 mimic | Oligonucleotides | |
| HY-R02713A | mmu-miR-1893 agomir | Oligonucleotides | |
| HY-R02714 | mmu-miR-1894-3p mimic | Oligonucleotides | |
| HY-R02714A | mmu-miR-1894-3p agomir | Oligonucleotides | |
| HY-R02715 | mmu-miR-1894-5p mimic | Oligonucleotides | |
| HY-R02715A | mmu-miR-1894-5p agomir | Oligonucleotides | |
| HY-R02716 | mmu-miR-1895 mimic | Oligonucleotides | |
| HY-R02716A | mmu-miR-1895 agomir | Oligonucleotides | |
| HY-R02717 | mmu-miR-1896 mimic | Oligonucleotides | |
| HY-R02717A | mmu-miR-1896 agomir | Oligonucleotides | |
| HY-R02718 | mmu-miR-1897-3p mimic | Oligonucleotides | |
| HY-R02718A | mmu-miR-1897-3p agomir | Oligonucleotides | |
| HY-R02719 | mmu-miR-1897-5p mimic | Oligonucleotides | |
| HY-R02719A | mmu-miR-1897-5p agomir | Oligonucleotides | |
| HY-R02720 | mmu-miR-1898 mimic | Oligonucleotides | |
| HY-R02720A | mmu-miR-1898 agomir | Oligonucleotides | |
| HY-R02721 | mmu-miR-1899 mimic | Oligonucleotides | |
| HY-R02721A | mmu-miR-1899 agomir | Oligonucleotides | |
| HY-R02722 | mmu-miR-18a-3p mimic | Oligonucleotides | |
| HY-R02722A | mmu-miR-18a-3p agomir | Oligonucleotides | |
| HY-R02723 | mmu-miR-18b-3p mimic | Oligonucleotides | |
| HY-R02723A | mmu-miR-18b-3p agomir | Oligonucleotides | |
| HY-R02724 | mmu-miR-18b-5p mimic | Oligonucleotides | |
| HY-R02724A | mmu-miR-18b-5p agomir | Oligonucleotides | |
| HY-R02725 | mmu-miR-1900 mimic | Oligonucleotides | |
| HY-R02725A | mmu-miR-1900 agomir | Oligonucleotides | |
| HY-R02726 | mmu-miR-1901 mimic | Oligonucleotides | |
| HY-R02726A | mmu-miR-1901 agomir | Oligonucleotides | |
| HY-R02727 | mmu-miR-1902 mimic | Oligonucleotides | |
| HY-R02727A | mmu-miR-1902 agomir | Oligonucleotides | |
| HY-R02728 | mmu-miR-1903 mimic | Oligonucleotides | |
| HY-R02728A | mmu-miR-1903 agomir | Oligonucleotides | |
| HY-R02729 | mmu-miR-1904 mimic | Oligonucleotides | |
| HY-R02729A | mmu-miR-1904 agomir | Oligonucleotides | |
| HY-R02730 | mmu-miR-1905 mimic | Oligonucleotides | |
| HY-R02730A | mmu-miR-1905 agomir | Oligonucleotides | |
| HY-R02731 | mmu-miR-1906 mimic | Oligonucleotides | |
| HY-R02731A | mmu-miR-1906 agomir | Oligonucleotides | |
| HY-R02732 | mmu-miR-1907 mimic | Oligonucleotides | |
| HY-R02732A | mmu-miR-1907 agomir | Oligonucleotides | |
| HY-R02733 | mmu-miR-190b-3p mimic | Oligonucleotides | |
| HY-R02733A | mmu-miR-190b-3p agomir | Oligonucleotides | |
| HY-R02734 | mmu-miR-1911-3p mimic | Oligonucleotides | |
| HY-R02734A | mmu-miR-1911-3p agomir | Oligonucleotides | |
| HY-R02735 | mmu-miR-1911-5p mimic | Oligonucleotides | |
| HY-R02735A | mmu-miR-1911-5p agomir | Oligonucleotides | |
| HY-R02736 | mmu-miR-1912-3p mimic | Oligonucleotides | |
| HY-R02736A | mmu-miR-1912-3p agomir | Oligonucleotides | |
| HY-R02737 | mmu-miR-1912-5p mimic | Oligonucleotides | |
| HY-R02737A | mmu-miR-1912-5p agomir | Oligonucleotides | |
| HY-R02738 | mmu-miR-191-3p mimic | Oligonucleotides | |
| HY-R02738A | mmu-miR-191-3p agomir | Oligonucleotides | |
| HY-R02739 | mmu-miR-1927 mimic | Oligonucleotides | |
| HY-R02739A | mmu-miR-1927 agomir | Oligonucleotides | |
| HY-R02740 | mmu-miR-1928 mimic | Oligonucleotides | |
| HY-R02740A | mmu-miR-1928 agomir | Oligonucleotides | |
| HY-R02741 | mmu-miR-1929-3p mimic | Oligonucleotides | |
| HY-R02741A | mmu-miR-1929-3p agomir | Oligonucleotides | |
| HY-R02742 | mmu-miR-1929-5p mimic | Oligonucleotides | |
| HY-R02742A | mmu-miR-1929-5p agomir | Oligonucleotides | |
| HY-R02743 | mmu-miR-1930-3p mimic | Oligonucleotides | |
| HY-R02743A | mmu-miR-1930-3p agomir | Oligonucleotides | |
| HY-R02744 | mmu-miR-1930-5p mimic | Oligonucleotides | |
| HY-R02744A | mmu-miR-1930-5p agomir | Oligonucleotides | |
| HY-R02745 | mmu-miR-1931 mimic | Oligonucleotides | |
| HY-R02745A | mmu-miR-1931 agomir | Oligonucleotides | |
| HY-R02746 | mmu-miR-1932 mimic | Oligonucleotides | |
| HY-R02746A | mmu-miR-1932 agomir | Oligonucleotides | |
| HY-R02747 | mmu-miR-1933-3p mimic | Oligonucleotides | |
| HY-R02747A | mmu-miR-1933-3p agomir | Oligonucleotides | |
| HY-R02748 | mmu-miR-1933-5p mimic | Oligonucleotides | |
| HY-R02748A | mmu-miR-1933-5p agomir | Oligonucleotides | |
| HY-R02749 | mmu-miR-1934-3p mimic | Oligonucleotides | |
| HY-R02749A | mmu-miR-1934-3p agomir | Oligonucleotides | |
| HY-R02750 | mmu-miR-1934-5p mimic | Oligonucleotides | |
| HY-R02750A | mmu-miR-1934-5p agomir | Oligonucleotides | |
| HY-R02751 | mmu-miR-1936 mimic | Oligonucleotides | |
| HY-R02751A | mmu-miR-1936 agomir | Oligonucleotides | |
| HY-R02752 | mmu-miR-1938 mimic | Oligonucleotides | |
| HY-R02752A | mmu-miR-1938 agomir | Oligonucleotides | |
| HY-R02753 | mmu-miR-193a-5p mimic | Oligonucleotides | |
| HY-R02753A | mmu-miR-193a-5p agomir | Oligonucleotides | |
| HY-R02754 | mmu-miR-193b-3p mimic | Oligonucleotides | |
| HY-R02754A | mmu-miR-193b-3p agomir | Oligonucleotides | |
| HY-R02755 | mmu-miR-1941-3p mimic | Oligonucleotides | |
| HY-R02755A | mmu-miR-1941-3p agomir | Oligonucleotides | |
| HY-R02756 | mmu-miR-194-1-3p mimic | Oligonucleotides | |
| HY-R02756A | mmu-miR-194-1-3p agomir | Oligonucleotides | |
| HY-R02757 | mmu-miR-1941-5p mimic | Oligonucleotides | |
| HY-R02757A | mmu-miR-1941-5p agomir | Oligonucleotides | |
| HY-R02758 | mmu-miR-1942 mimic | Oligonucleotides | |
| HY-R02758A | mmu-miR-1942 agomir | Oligonucleotides | |
| HY-R02759 | mmu-miR-1943-3p mimic | Oligonucleotides | |
| HY-R02759A | mmu-miR-1943-3p agomir | Oligonucleotides | |
| HY-R02760 | mmu-miR-1943-5p mimic | Oligonucleotides | |
| HY-R02760A | mmu-miR-1943-5p agomir | Oligonucleotides | |
| HY-R02761 | mmu-miR-1945 mimic | Oligonucleotides | |
| HY-R02761A | mmu-miR-1945 agomir | Oligonucleotides | |
| HY-R02762 | mmu-miR-1946a mimic | Oligonucleotides | |
| HY-R02762A | mmu-miR-1946a agomir | Oligonucleotides | |
| HY-R02763 | mmu-miR-1946b mimic | Oligonucleotides | |
| HY-R02763A | mmu-miR-1946b agomir | Oligonucleotides | |
| HY-R02764 | mmu-miR-1947-3p mimic | Oligonucleotides | |
| HY-R02764A | mmu-miR-1947-3p agomir | Oligonucleotides | |
| HY-R02765 | mmu-miR-1947-5p mimic | Oligonucleotides | |
| HY-R02765A | mmu-miR-1947-5p agomir | Oligonucleotides | |
| HY-R02766 | mmu-miR-1948-3p mimic | Oligonucleotides | |
| HY-R02766A | mmu-miR-1948-3p agomir | Oligonucleotides | |
| HY-R02767 | mmu-miR-1948-5p mimic | Oligonucleotides | |
| HY-R02767A | mmu-miR-1948-5p agomir | Oligonucleotides | |
| HY-R02768 | mmu-miR-1949 mimic | Oligonucleotides | |
| HY-R02768A | mmu-miR-1949 agomir | Oligonucleotides | |
| HY-R02769 | mmu-miR-1950 mimic | Oligonucleotides | |
| HY-R02769A | mmu-miR-1950 agomir | Oligonucleotides | |
| HY-R02770 | mmu-miR-1951 mimic | Oligonucleotides | |
| HY-R02770A | mmu-miR-1951 agomir | Oligonucleotides | |
| HY-R02771 | mmu-miR-1952 mimic | Oligonucleotides | |
| HY-R02771A | mmu-miR-1952 agomir | Oligonucleotides | |
| HY-R02772 | mmu-miR-1953 mimic | Oligonucleotides | |
| HY-R02772A | mmu-miR-1953 agomir | Oligonucleotides | |
| HY-R02773 | mmu-miR-1954 mimic | Oligonucleotides | |
| HY-R02773A | mmu-miR-1954 agomir | Oligonucleotides | |
| HY-R02774 | mmu-miR-1955-3p mimic | Oligonucleotides | |
| HY-R02774A | mmu-miR-1955-3p agomir | Oligonucleotides | |
| HY-R02775 | mmu-miR-1955-5p mimic | Oligonucleotides | |
| HY-R02775A | mmu-miR-1955-5p agomir | Oligonucleotides | |
| HY-R02776 | mmu-miR-1956 mimic | Oligonucleotides | |
| HY-R02776A | mmu-miR-1956 agomir | Oligonucleotides | |
| HY-R02777 | mmu-miR-1958 mimic | Oligonucleotides | |
| HY-R02777A | mmu-miR-1958 agomir | Oligonucleotides | |
| HY-R02778 | mmu-miR-195b mimic | Oligonucleotides | |
| HY-R02778A | mmu-miR-195b agomir | Oligonucleotides | |
| HY-R02779 | mmu-miR-1960 mimic | Oligonucleotides | |
| HY-R02779A | mmu-miR-1960 agomir | Oligonucleotides | |
| HY-R02780 | mmu-miR-1961 mimic | Oligonucleotides | |
| HY-R02780A | mmu-miR-1961 agomir | Oligonucleotides | |
| HY-R02781 | mmu-miR-1962 mimic | Oligonucleotides | |
| HY-R02781A | mmu-miR-1962 agomir | Oligonucleotides | |
| HY-R02782 | mmu-miR-1963 mimic | Oligonucleotides | |
| HY-R02782A | mmu-miR-1963 agomir | Oligonucleotides | |
| HY-R02783 | mmu-miR-1964-3p mimic | Oligonucleotides | |
| HY-R02783A | mmu-miR-1964-3p agomir | Oligonucleotides | |
| HY-R02784 | mmu-miR-1964-5p mimic | Oligonucleotides | |
| HY-R02784A | mmu-miR-1964-5p agomir | Oligonucleotides | |
| HY-R02785 | mmu-miR-1966-3p mimic | Oligonucleotides | |
| HY-R02785A | mmu-miR-1966-3p agomir | Oligonucleotides | |
| HY-R02786 | mmu-miR-1966-5p mimic | Oligonucleotides | |
| HY-R02786A | mmu-miR-1966-5p agomir | Oligonucleotides | |
| HY-R02787 | mmu-miR-1967 mimic | Oligonucleotides | |
| HY-R02787A | mmu-miR-1967 agomir | Oligonucleotides | |
| HY-R02788 | mmu-miR-1968-3p mimic | Oligonucleotides | |
| HY-R02788A | mmu-miR-1968-3p agomir | Oligonucleotides | |
| HY-R02789 | mmu-miR-1968-5p mimic | Oligonucleotides | |
| HY-R02789A | mmu-miR-1968-5p agomir | Oligonucleotides | |
| HY-R02790 | mmu-miR-1969 mimic | Oligonucleotides | |
| HY-R02790A | mmu-miR-1969 agomir | Oligonucleotides | |
| HY-R02791 | mmu-miR-196a-1-3p mimic | Oligonucleotides | |
| HY-R02791A | mmu-miR-196a-1-3p agomir | Oligonucleotides | |
| HY-R02792 | mmu-miR-196a-2-3p mimic | Oligonucleotides | |
| HY-R02792A | mmu-miR-196a-2-3p agomir | Oligonucleotides | |
| HY-R02793 | mmu-miR-1970 mimic | Oligonucleotides | |
| HY-R02793A | mmu-miR-1970 agomir | Oligonucleotides | |
| HY-R02794 | mmu-miR-1970b-5p mimic | Oligonucleotides | |
| HY-R02794A | mmu-miR-1970b-5p agomir | Oligonucleotides | |
| HY-R02795 | mmu-miR-1970c-3p mimic | Oligonucleotides | |
| HY-R02795A | mmu-miR-1970c-3p agomir | Oligonucleotides | |
| HY-R02796 | mmu-miR-1970c-5p mimic | Oligonucleotides | |
| HY-R02796A | mmu-miR-1970c-5p agomir | Oligonucleotides | |
| HY-R02797 | mmu-miR-1971 mimic | Oligonucleotides | |
| HY-R02797A | mmu-miR-1971 agomir | Oligonucleotides | |
| HY-R02798 | mmu-miR-1981-3p mimic | Oligonucleotides | |
| HY-R02798A | mmu-miR-1981-3p agomir | Oligonucleotides | |
| HY-R02799 | mmu-miR-1981-5p mimic | Oligonucleotides | |
| HY-R02799A | mmu-miR-1981-5p agomir | Oligonucleotides | |
| HY-R02800 | mmu-miR-1982-3p mimic | Oligonucleotides | |
| HY-R02800A | mmu-miR-1982-3p agomir | Oligonucleotides | |
| HY-R02801 | mmu-miR-1982-5p mimic | Oligonucleotides | |
| HY-R02801A | mmu-miR-1982-5p agomir | Oligonucleotides | |
| HY-R02802 | mmu-miR-1983 mimic | Oligonucleotides | |
| HY-R02802A | mmu-miR-1983 agomir | Oligonucleotides | |
| HY-R02803 | mmu-miR-199b-5p mimic | Oligonucleotides | |
| HY-R02803A | mmu-miR-199b-5p agomir | Oligonucleotides | |
| HY-R02804 | mmu-miR-19a-5p mimic | Oligonucleotides | |
| HY-R02804A | mmu-miR-19a-5p agomir | Oligonucleotides | |
| HY-R02805 | mmu-miR-19b-2-5p mimic | Oligonucleotides | |
| HY-R02805A | mmu-miR-19b-2-5p agomir | Oligonucleotides | |
| HY-R02806 | mmu-miR-1a-1-5p mimic | Oligonucleotides | |
| HY-R02806A | mmu-miR-1a-1-5p agomir | Oligonucleotides | |
| HY-R02807 | mmu-miR-1a-2-5p mimic | Oligonucleotides | |
| HY-R02807A | mmu-miR-1a-2-5p agomir | Oligonucleotides | |
| HY-R02808 | mmu-miR-1b-3p mimic | Oligonucleotides | |
| HY-R02808A | mmu-miR-1b-3p agomir | Oligonucleotides | |
| HY-R02809 | mmu-miR-1b-5p mimic | Oligonucleotides | |
| HY-R02809A | mmu-miR-1b-5p agomir | Oligonucleotides | |
| HY-R02810 | mmu-miR-201-3p mimic | Oligonucleotides | |
| HY-R02810A | mmu-miR-201-3p agomir | Oligonucleotides | |
| HY-R02811 | mmu-miR-201-5p mimic | Oligonucleotides | |
| HY-R02811A | mmu-miR-201-5p agomir | Oligonucleotides | |
| HY-R02812 | mmu-miR-202-3p mimic | Oligonucleotides | |
| HY-R02812A | mmu-miR-202-3p agomir | Oligonucleotides | |
| HY-R02813 | mmu-miR-202-5p mimic | Oligonucleotides | |
| HY-R02813A | mmu-miR-202-5p agomir | Oligonucleotides | |
| HY-R02814 | mmu-miR-203-5p mimic | Oligonucleotides | |
| HY-R02814A | mmu-miR-203-5p agomir | Oligonucleotides | |
| HY-R02815 | mmu-miR-203b-3p mimic | Oligonucleotides | |
| HY-R02815A | mmu-miR-203b-3p agomir | Oligonucleotides | |
| HY-R02816 | mmu-miR-203b-5p mimic | Oligonucleotides | |
| HY-R02816A | mmu-miR-203b-5p agomir | Oligonucleotides | |
| HY-R02817 | mmu-miR-205-3p mimic | Oligonucleotides | |
| HY-R02817A | mmu-miR-205-3p agomir | Oligonucleotides | |
| HY-R02818 | mmu-miR-206-5p mimic | Oligonucleotides | |
| HY-R02818A | mmu-miR-206-5p agomir | Oligonucleotides | |
| HY-R02819 | mmu-miR-207 mimic | Oligonucleotides | |
| HY-R02819A | mmu-miR-207 agomir | Oligonucleotides | |
| HY-R02820 | mmu-miR-20a-3p mimic | Oligonucleotides | |
| HY-R02820A | mmu-miR-20a-3p agomir | Oligonucleotides | |
| HY-R02821 | mmu-miR-20b-3p mimic | Oligonucleotides | |
| HY-R02821A | mmu-miR-20b-3p agomir | Oligonucleotides | |
| HY-R02822 | mmu-miR-210-5p mimic | Oligonucleotides | |
| HY-R02822A | mmu-miR-210-5p agomir | Oligonucleotides | |
| HY-R02823 | mmu-miR-211-3p mimic | Oligonucleotides | |
| HY-R02823A | mmu-miR-211-3p agomir | Oligonucleotides | |
| HY-R02824 | mmu-miR-211-5p mimic | Oligonucleotides | |
| HY-R02824A | mmu-miR-211-5p agomir | Oligonucleotides | |
| HY-R02825 | mmu-miR-212-3p mimic | Oligonucleotides | |
| HY-R02825A | mmu-miR-212-3p agomir | Oligonucleotides | |
| HY-R02826 | mmu-miR-2136 mimic | Oligonucleotides | |
| HY-R02826A | mmu-miR-2136 agomir | Oligonucleotides | |
| HY-R02827 | mmu-miR-2137 mimic | Oligonucleotides | |
| HY-R02827A | mmu-miR-2137 agomir | Oligonucleotides | |
| HY-R02828 | mmu-miR-2139 mimic | Oligonucleotides | |
| HY-R02828A | mmu-miR-2139 agomir | Oligonucleotides | |
| HY-R02829 | mmu-miR-215-3p mimic | Oligonucleotides | |
| HY-R02829A | mmu-miR-215-3p agomir | Oligonucleotides | |
| HY-R02830 | mmu-miR-215-5p mimic | Oligonucleotides | |
| HY-R02830A | mmu-miR-215-5p agomir | Oligonucleotides | |
| HY-R02831 | mmu-miR-216a-3p mimic | Oligonucleotides | |
| HY-R02831A | mmu-miR-216a-3p agomir | Oligonucleotides | |
| HY-R02832 | mmu-miR-216b-3p mimic | Oligonucleotides | |
| HY-R02832A | mmu-miR-216b-3p agomir | Oligonucleotides | |
| HY-R02833 | mmu-miR-216c-3p mimic | Oligonucleotides | |
| HY-R02833A | mmu-miR-216c-3p agomir | Oligonucleotides | |
| HY-R02834 | mmu-miR-216c-5p mimic | Oligonucleotides | |
| HY-R02834A | mmu-miR-216c-5p agomir | Oligonucleotides | |
| HY-R02835 | mmu-miR-217-3p mimic | Oligonucleotides | |
| HY-R02835A | mmu-miR-217-3p agomir | Oligonucleotides | |
| HY-R02836 | mmu-miR-217-5p mimic | Oligonucleotides | |
| HY-R02836A | mmu-miR-217-5p agomir | Oligonucleotides | |
| HY-R02837 | mmu-miR-218-1-3p mimic | Oligonucleotides | |
| HY-R02837A | mmu-miR-218-1-3p agomir | Oligonucleotides | |
| HY-R02838 | mmu-miR-2183 mimic | Oligonucleotides | |
| HY-R02838A | mmu-miR-2183 agomir | Oligonucleotides | |
| HY-R02839 | mmu-miR-219a-1-3p mimic | Oligonucleotides | |
| HY-R02839A | mmu-miR-219a-1-3p agomir | Oligonucleotides | |
| HY-R02840 | mmu-miR-219c-3p mimic | Oligonucleotides | |
| HY-R02840A | mmu-miR-219c-3p agomir | Oligonucleotides | |
| HY-R02841 | mmu-miR-219c-5p mimic | Oligonucleotides | |
| HY-R02841A | mmu-miR-219c-5p agomir | Oligonucleotides | |
| HY-R02842 | mmu-miR-21a-3p mimic | Oligonucleotides | |
| HY-R02842A | mmu-miR-21a-3p agomir | Oligonucleotides | |
| HY-R02843 | mmu-miR-21b mimic | Oligonucleotides | |
| HY-R02843A | mmu-miR-21b agomir | Oligonucleotides | |
| HY-R02844 | mmu-miR-21c mimic | Oligonucleotides | |
| HY-R02844A | mmu-miR-21c agomir | Oligonucleotides | |
| HY-R02845 | mmu-miR-221-5p mimic | Oligonucleotides | |
| HY-R02845A | mmu-miR-221-5p agomir | Oligonucleotides | |
| HY-R02846 | mmu-miR-222-3p mimic | Oligonucleotides | |
| HY-R02846A | mmu-miR-222-3p agomir | Oligonucleotides | |
| HY-R02847 | mmu-miR-222-5p mimic | Oligonucleotides | |
| HY-R02847A | mmu-miR-222-5p agomir | Oligonucleotides | |
| HY-R02848 | mmu-miR-223-5p mimic | Oligonucleotides | |
| HY-R02848A | mmu-miR-223-5p agomir | Oligonucleotides | |
| HY-R02849 | mmu-miR-224-3p mimic | Oligonucleotides | |
| HY-R02849A | mmu-miR-224-3p agomir | Oligonucleotides | |
| HY-R02850 | mmu-miR-224-5p mimic | Oligonucleotides | |
| HY-R02850A | mmu-miR-224-5p agomir | Oligonucleotides | |
| HY-R02851 | mmu-miR-23b-3p mimic | Oligonucleotides | |
| HY-R02851A | mmu-miR-23b-3p agomir | Oligonucleotides | |
| HY-R02852 | mmu-miR-23b-5p mimic | Oligonucleotides | |
| HY-R02852A | mmu-miR-23b-5p agomir | Oligonucleotides | |
| HY-R02853 | mmu-miR-24-1-5p mimic | Oligonucleotides | |
| HY-R02853A | mmu-miR-24-1-5p agomir | Oligonucleotides | |
| HY-R02854 | mmu-miR-24-2-5p mimic | Oligonucleotides | |
| HY-R02854A | mmu-miR-24-2-5p agomir | Oligonucleotides | |
| HY-R02855 | mmu-miR-25-5p mimic | Oligonucleotides | |
| HY-R02855A | mmu-miR-25-5p agomir | Oligonucleotides | |
| HY-R02856 | mmu-miR-26a-2-3p mimic | Oligonucleotides | |
| HY-R02856A | mmu-miR-26a-2-3p agomir | Oligonucleotides | |
| HY-R02857 | mmu-miR-26b-3p mimic | Oligonucleotides | |
| HY-R02857A | mmu-miR-26b-3p agomir | Oligonucleotides | |
| HY-R02858 | mmu-miR-2861 mimic | Oligonucleotides | |
| HY-R02858A | mmu-miR-2861 agomir | Oligonucleotides | |
| HY-R02859 | mmu-miR-28a-3p mimic | Oligonucleotides | |
| HY-R02859A | mmu-miR-28a-3p agomir | Oligonucleotides | |
| HY-R02860 | mmu-miR-28b mimic | Oligonucleotides | |
| HY-R02860A | mmu-miR-28b agomir | Oligonucleotides | |
| HY-R02861 | mmu-miR-28c mimic | Oligonucleotides | |
| HY-R02861A | mmu-miR-28c agomir | Oligonucleotides | |
| HY-R02862 | mmu-miR-290a-3p mimic | Oligonucleotides | |
| HY-R02862A | mmu-miR-290a-3p agomir | Oligonucleotides | |
| HY-R02863 | mmu-miR-290a-5p mimic | Oligonucleotides | |
| HY-R02863A | mmu-miR-290a-5p agomir | Oligonucleotides | |
| HY-R02864 | mmu-miR-290b-3p mimic | Oligonucleotides | |
| HY-R02864A | mmu-miR-290b-3p agomir | Oligonucleotides | |
| HY-R02865 | mmu-miR-290b-5p mimic | Oligonucleotides | |
| HY-R02865A | mmu-miR-290b-5p agomir | Oligonucleotides | |
| HY-R02866 | mmu-miR-291a-3p mimic | Oligonucleotides | |
| HY-R02866A | mmu-miR-291a-3p agomir | Oligonucleotides | |
| HY-R02867 | mmu-miR-291a-5p mimic | Oligonucleotides | |
| HY-R02867A | mmu-miR-291a-5p agomir | Oligonucleotides | |
| HY-R02868 | mmu-miR-291b-3p mimic | Oligonucleotides | |
| HY-R02868A | mmu-miR-291b-3p agomir | Oligonucleotides | |
| HY-R02869 | mmu-miR-291b-5p mimic | Oligonucleotides | |
| HY-R02869A | mmu-miR-291b-5p agomir | Oligonucleotides | |
| HY-R02870 | mmu-miR-292a-3p mimic | Oligonucleotides | |
| HY-R02870A | mmu-miR-292a-3p agomir | Oligonucleotides | |
| HY-R02871 | mmu-miR-292a-5p mimic | Oligonucleotides | |
| HY-R02871A | mmu-miR-292a-5p agomir | Oligonucleotides | |
| HY-R02872 | mmu-miR-292b-3p mimic | Oligonucleotides | |
| HY-R02872A | mmu-miR-292b-3p agomir | Oligonucleotides | |
| HY-R02873 | mmu-miR-292b-5p mimic | Oligonucleotides | |
| HY-R02873A | mmu-miR-292b-5p agomir | Oligonucleotides | |
| HY-R02874 | mmu-miR-293-3p mimic | Oligonucleotides | |
| HY-R02874A | mmu-miR-293-3p agomir | Oligonucleotides | |
| HY-R02875 | mmu-miR-293-5p mimic | Oligonucleotides | |
| HY-R02875A | mmu-miR-293-5p agomir | Oligonucleotides | |
| HY-R02876 | mmu-miR-294-3p mimic | Oligonucleotides | |
| HY-R02876A | mmu-miR-294-3p agomir | Oligonucleotides | |
| HY-R02877 | mmu-miR-294-5p mimic | Oligonucleotides | |
| HY-R02877A | mmu-miR-294-5p agomir | Oligonucleotides | |
| HY-R02878 | mmu-miR-295-3p mimic | Oligonucleotides | |
| HY-R02878A | mmu-miR-295-3p agomir | Oligonucleotides | |
| HY-R02879 | mmu-miR-295-5p mimic | Oligonucleotides | |
| HY-R02879A | mmu-miR-295-5p agomir | Oligonucleotides | |
| HY-R02880 | mmu-miR-297a-3p mimic | Oligonucleotides | |
| HY-R02880A | mmu-miR-297a-3p agomir | Oligonucleotides | |
| HY-R02881 | mmu-miR-297a-5p mimic | Oligonucleotides | |
| HY-R02881A | mmu-miR-297a-5p agomir | Oligonucleotides | |
| HY-R02882 | mmu-miR-297b-5p mimic | Oligonucleotides | |
| HY-R02882A | mmu-miR-297b-5p agomir | Oligonucleotides | |
| HY-R02883 | mmu-miR-297c-5p mimic | Oligonucleotides | |
| HY-R02883A | mmu-miR-297c-5p agomir | Oligonucleotides | |
| HY-R02884 | mmu-miR-298-3p mimic | Oligonucleotides | |
| HY-R02884A | mmu-miR-298-3p agomir | Oligonucleotides | |
| HY-R02885 | mmu-miR-298-5p mimic | Oligonucleotides | |
| HY-R02885A | mmu-miR-298-5p agomir | Oligonucleotides | |
| HY-R02886 | mmu-miR-299a-3p mimic | Oligonucleotides | |
| HY-R02886A | mmu-miR-299a-3p agomir | Oligonucleotides | |
| HY-R02887 | mmu-miR-299b-3p mimic | Oligonucleotides | |
| HY-R02887A | mmu-miR-299b-3p agomir | Oligonucleotides | |
| HY-R02888 | mmu-miR-299b-5p mimic | Oligonucleotides | |
| HY-R02888A | mmu-miR-299b-5p agomir | Oligonucleotides | |
| HY-R02889 | mmu-miR-29b-1-5p mimic | Oligonucleotides | |
| HY-R02889A | mmu-miR-29b-1-5p agomir | Oligonucleotides | |
| HY-R02890 | mmu-miR-29b-2-5p mimic | Oligonucleotides | |
| HY-R02890A | mmu-miR-29b-2-5p agomir | Oligonucleotides | |
| HY-R02891 | mmu-miR-300-3p mimic | Oligonucleotides | |
| HY-R02891A | mmu-miR-300-3p agomir | Oligonucleotides | |
| HY-R02892 | mmu-miR-300-5p mimic | Oligonucleotides | |
| HY-R02892A | mmu-miR-300-5p agomir | Oligonucleotides | |
| HY-R02893 | mmu-miR-301b-3p mimic | Oligonucleotides | |
| HY-R02893A | mmu-miR-301b-3p agomir | Oligonucleotides | |
| HY-R02894 | mmu-miR-301b-5p mimic | Oligonucleotides | |
| HY-R02894A | mmu-miR-301b-5p agomir | Oligonucleotides | |
| HY-R02895 | mmu-miR-302a-5p mimic | Oligonucleotides | |
| HY-R02895A | mmu-miR-302a-5p agomir | Oligonucleotides | |
| HY-R02896 | mmu-miR-302b-5p mimic | Oligonucleotides | |
| HY-R02896A | mmu-miR-302b-5p agomir | Oligonucleotides | |
| HY-R02897 | mmu-miR-302c-3p mimic | Oligonucleotides | |
| HY-R02897A | mmu-miR-302c-3p agomir | Oligonucleotides | |
| HY-R02898 | mmu-miR-302c-5p mimic | Oligonucleotides | |
| HY-R02898A | mmu-miR-302c-5p agomir | Oligonucleotides | |
| HY-R02899 | mmu-miR-302d-5p mimic | Oligonucleotides | |
| HY-R02899A | mmu-miR-302d-5p agomir | Oligonucleotides | |
| HY-R02900 | mmu-miR-3057-3p mimic | Oligonucleotides | |
| HY-R02900A | mmu-miR-3057-3p agomir | Oligonucleotides | |
| HY-R02901 | mmu-miR-3057-5p mimic | Oligonucleotides | |
| HY-R02901A | mmu-miR-3057-5p agomir | Oligonucleotides | |
| HY-R02902 | mmu-miR-3058-3p mimic | Oligonucleotides | |
| HY-R02902A | mmu-miR-3058-3p agomir | Oligonucleotides | |
| HY-R02903 | mmu-miR-3058-5p mimic | Oligonucleotides | |
| HY-R02903A | mmu-miR-3058-5p agomir | Oligonucleotides | |
| HY-R02904 | mmu-miR-3059-5p mimic | Oligonucleotides | |
| HY-R02904A | mmu-miR-3059-5p agomir | Oligonucleotides | |
| HY-R02905 | mmu-miR-3060-3p mimic | Oligonucleotides | |
| HY-R02905A | mmu-miR-3060-3p agomir | Oligonucleotides | |
| HY-R02906 | mmu-miR-3060-5p mimic | Oligonucleotides | |
| HY-R02906A | mmu-miR-3060-5p agomir | Oligonucleotides | |
| HY-R02907 | mmu-miR-3061-3p mimic | Oligonucleotides | |
| HY-R02907A | mmu-miR-3061-3p agomir | Oligonucleotides | |
| HY-R02908 | mmu-miR-3061-5p mimic | Oligonucleotides | |
| HY-R02908A | mmu-miR-3061-5p agomir | Oligonucleotides | |
| HY-R02909 | mmu-miR-3062-3p mimic | Oligonucleotides | |
| HY-R02909A | mmu-miR-3062-3p agomir | Oligonucleotides | |
| HY-R02910 | mmu-miR-3062-5p mimic | Oligonucleotides | |
| HY-R02910A | mmu-miR-3062-5p agomir | Oligonucleotides | |
| HY-R02911 | mmu-miR-3063-3p mimic | Oligonucleotides | |
| HY-R02911A | mmu-miR-3063-3p agomir | Oligonucleotides | |
| HY-R02912 | mmu-miR-3063-5p mimic | Oligonucleotides | |
| HY-R02912A | mmu-miR-3063-5p agomir | Oligonucleotides | |
| HY-R02913 | mmu-miR-3064-3p mimic | Oligonucleotides | |
| HY-R02913A | mmu-miR-3064-3p agomir | Oligonucleotides | |
| HY-R02914 | mmu-miR-3064-5p mimic | Oligonucleotides | |
| HY-R02914A | mmu-miR-3064-5p agomir | Oligonucleotides | |
| HY-R02915 | mmu-miR-3065-3p mimic | Oligonucleotides | |
| HY-R02915A | mmu-miR-3065-3p agomir | Oligonucleotides | |
| HY-R02916 | mmu-miR-3065-5p mimic | Oligonucleotides | |
| HY-R02916A | mmu-miR-3065-5p agomir | Oligonucleotides | |
| HY-R02917 | mmu-miR-3066-3p mimic | Oligonucleotides | |
| HY-R02917A | mmu-miR-3066-3p agomir | Oligonucleotides | |
| HY-R02918 | mmu-miR-3066-5p mimic | Oligonucleotides | |
| HY-R02918A | mmu-miR-3066-5p agomir | Oligonucleotides | |
| HY-R02919 | mmu-miR-3067-3p mimic | Oligonucleotides | |
| HY-R02919A | mmu-miR-3067-3p agomir | Oligonucleotides | |
| HY-R02920 | mmu-miR-3067-5p mimic | Oligonucleotides | |
| HY-R02920A | mmu-miR-3067-5p agomir | Oligonucleotides | |
| HY-R02921 | mmu-miR-3068-3p mimic | Oligonucleotides | |
| HY-R02921A | mmu-miR-3068-3p agomir | Oligonucleotides | |
| HY-R02922 | mmu-miR-3068-5p mimic | Oligonucleotides | |
| HY-R02922A | mmu-miR-3068-5p agomir | Oligonucleotides | |
| HY-R02923 | mmu-miR-3069-3p mimic | Oligonucleotides | |
| HY-R02923A | mmu-miR-3069-3p agomir | Oligonucleotides | |
| HY-R02924 | mmu-miR-3069-5p mimic | Oligonucleotides | |
| HY-R02924A | mmu-miR-3069-5p agomir | Oligonucleotides | |
| HY-R02925 | mmu-miR-3070-2-3p mimic | Oligonucleotides | |
| HY-R02925A | mmu-miR-3070-2-3p agomir | Oligonucleotides | |
| HY-R02926 | mmu-miR-3070-3p mimic | Oligonucleotides | |
| HY-R02926A | mmu-miR-3070-3p agomir | Oligonucleotides | |
| HY-R02927 | mmu-miR-3070-5p mimic | Oligonucleotides | |
| HY-R02927A | mmu-miR-3070-5p agomir | Oligonucleotides | |
| HY-R02928 | mmu-miR-3071-3p mimic | Oligonucleotides | |
| HY-R02928A | mmu-miR-3071-3p agomir | Oligonucleotides | |
| HY-R02929 | mmu-miR-3071-5p mimic | Oligonucleotides | |
| HY-R02929A | mmu-miR-3071-5p agomir | Oligonucleotides | |
| HY-R02930 | mmu-miR-3072-3p mimic | Oligonucleotides | |
| HY-R02930A | mmu-miR-3072-3p agomir | Oligonucleotides | |
| HY-R02931 | mmu-miR-3072-5p mimic | Oligonucleotides | |
| HY-R02931A | mmu-miR-3072-5p agomir | Oligonucleotides | |
| HY-R02932 | mmu-miR-3073a-3p mimic | Oligonucleotides | |
| HY-R02932A | mmu-miR-3073a-3p agomir | Oligonucleotides | |
| HY-R02933 | mmu-miR-3073a-5p mimic | Oligonucleotides | |
| HY-R02933A | mmu-miR-3073a-5p agomir | Oligonucleotides | |
| HY-R02934 | mmu-miR-3073b-3p mimic | Oligonucleotides | |
| HY-R02934A | mmu-miR-3073b-3p agomir | Oligonucleotides | |
| HY-R02935 | mmu-miR-3073b-5p mimic | Oligonucleotides | |
| HY-R02935A | mmu-miR-3073b-5p agomir | Oligonucleotides | |
| HY-R02936 | mmu-miR-3074-2-3p mimic | Oligonucleotides | |
| HY-R02936A | mmu-miR-3074-2-3p agomir | Oligonucleotides | |
| HY-R02937 | mmu-miR-3074-5p mimic | Oligonucleotides | |
| HY-R02937A | mmu-miR-3074-5p agomir | Oligonucleotides | |
| HY-R02938 | mmu-miR-3075-3p mimic | Oligonucleotides | |
| HY-R02938A | mmu-miR-3075-3p agomir | Oligonucleotides | |
| HY-R02939 | mmu-miR-3075-5p mimic | Oligonucleotides | |
| HY-R02939A | mmu-miR-3075-5p agomir | Oligonucleotides | |
| HY-R02940 | mmu-miR-3076-3p mimic | Oligonucleotides | |
| HY-R02940A | mmu-miR-3076-3p agomir | Oligonucleotides | |
| HY-R02941 | mmu-miR-3076-5p mimic | Oligonucleotides | |
| HY-R02941A | mmu-miR-3076-5p agomir | Oligonucleotides | |
| HY-R02942 | mmu-miR-3077-3p mimic | Oligonucleotides | |
| HY-R02942A | mmu-miR-3077-3p agomir | Oligonucleotides | |
| HY-R02943 | mmu-miR-3077-5p mimic | Oligonucleotides | |
| HY-R02943A | mmu-miR-3077-5p agomir | Oligonucleotides | |
| HY-R02944 | mmu-miR-3078-3p mimic | Oligonucleotides | |
| HY-R02944A | mmu-miR-3078-3p agomir | Oligonucleotides | |
| HY-R02945 | mmu-miR-3078-5p mimic | Oligonucleotides | |
| HY-R02945A | mmu-miR-3078-5p agomir | Oligonucleotides | |
| HY-R02946 | mmu-miR-3079-3p mimic | Oligonucleotides | |
| HY-R02946A | mmu-miR-3079-3p agomir | Oligonucleotides | |
| HY-R02947 | mmu-miR-3079-5p mimic | Oligonucleotides | |
| HY-R02947A | mmu-miR-3079-5p agomir | Oligonucleotides | |
| HY-R02948 | mmu-miR-3080-3p mimic | Oligonucleotides | |
| HY-R02948A | mmu-miR-3080-3p agomir | Oligonucleotides | |
| HY-R02949 | mmu-miR-3080-5p mimic | Oligonucleotides | |
| HY-R02949A | mmu-miR-3080-5p agomir | Oligonucleotides | |
| HY-R02950 | mmu-miR-3081-3p mimic | Oligonucleotides | |
| HY-R02950A | mmu-miR-3081-3p agomir | Oligonucleotides | |
| HY-R02951 | mmu-miR-3081-5p mimic | Oligonucleotides | |
| HY-R02951A | mmu-miR-3081-5p agomir | Oligonucleotides | |
| HY-R02952 | mmu-miR-3082-3p mimic | Oligonucleotides | |
| HY-R02952A | mmu-miR-3082-3p agomir | Oligonucleotides | |
| HY-R02953 | mmu-miR-3082-5p mimic | Oligonucleotides | |
| HY-R02953A | mmu-miR-3082-5p agomir | Oligonucleotides | |
| HY-R02954 | mmu-miR-3083-3p mimic | Oligonucleotides | |
| HY-R02954A | mmu-miR-3083-3p agomir | Oligonucleotides | |
| HY-R02955 | mmu-miR-3083-5p mimic | Oligonucleotides | |
| HY-R02955A | mmu-miR-3083-5p agomir | Oligonucleotides | |
| HY-R02956 | mmu-miR-3083b-3p mimic | Oligonucleotides | |
| HY-R02956A | mmu-miR-3083b-3p agomir | Oligonucleotides | |
| HY-R02957 | mmu-miR-3083b-5p mimic | Oligonucleotides | |
| HY-R02957A | mmu-miR-3083b-5p agomir | Oligonucleotides | |
| HY-R02958 | mmu-miR-3084-3p mimic | Oligonucleotides | |
| HY-R02958A | mmu-miR-3084-3p agomir | Oligonucleotides | |
| HY-R02959 | mmu-miR-3084-5p mimic | Oligonucleotides | |
| HY-R02959A | mmu-miR-3084-5p agomir | Oligonucleotides | |
| HY-R02960 | mmu-miR-3085-5p mimic | Oligonucleotides | |
| HY-R02960A | mmu-miR-3085-5p agomir | Oligonucleotides | |
| HY-R02961 | mmu-miR-3086-3p mimic | Oligonucleotides | |
| HY-R02961A | mmu-miR-3086-3p agomir | Oligonucleotides | |
| HY-R02962 | mmu-miR-3086-5p mimic | Oligonucleotides | |
| HY-R02962A | mmu-miR-3086-5p agomir | Oligonucleotides | |
| HY-R02963 | mmu-miR-3087-3p mimic | Oligonucleotides | |
| HY-R02963A | mmu-miR-3087-3p agomir | Oligonucleotides | |
| HY-R02964 | mmu-miR-3087-5p mimic | Oligonucleotides | |
| HY-R02964A | mmu-miR-3087-5p agomir | Oligonucleotides | |
| HY-R02965 | mmu-miR-3088-3p mimic | Oligonucleotides | |
| HY-R02965A | mmu-miR-3088-3p agomir | Oligonucleotides | |
| HY-R02966 | mmu-miR-3088-5p mimic | Oligonucleotides | |
| HY-R02966A | mmu-miR-3088-5p agomir | Oligonucleotides | |
| HY-R02967 | mmu-miR-3089-3p mimic | Oligonucleotides | |
| HY-R02967A | mmu-miR-3089-3p agomir | Oligonucleotides | |
| HY-R02968 | mmu-miR-3089-5p mimic | Oligonucleotides | |
| HY-R02968A | mmu-miR-3089-5p agomir | Oligonucleotides | |
| HY-R02969 | mmu-miR-3090-3p mimic | Oligonucleotides | |
| HY-R02969A | mmu-miR-3090-3p agomir | Oligonucleotides | |
| HY-R02970 | mmu-miR-3090-5p mimic | Oligonucleotides | |
| HY-R02970A | mmu-miR-3090-5p agomir | Oligonucleotides | |
| HY-R02971 | mmu-miR-3091-3p mimic | Oligonucleotides | |
| HY-R02971A | mmu-miR-3091-3p agomir | Oligonucleotides | |
| HY-R02972 | mmu-miR-3091-5p mimic | Oligonucleotides | |
| HY-R02972A | mmu-miR-3091-5p agomir | Oligonucleotides | |
| HY-R02973 | mmu-miR-3092-3p mimic | Oligonucleotides | |
| HY-R02973A | mmu-miR-3092-3p agomir | Oligonucleotides | |
| HY-R02974 | mmu-miR-3092-5p mimic | Oligonucleotides | |
| HY-R02974A | mmu-miR-3092-5p agomir | Oligonucleotides | |
| HY-R02975 | mmu-miR-3093-3p mimic | Oligonucleotides | |
| HY-R02975A | mmu-miR-3093-3p agomir | Oligonucleotides | |
| HY-R02976 | mmu-miR-3093-5p mimic | Oligonucleotides | |
| HY-R02976A | mmu-miR-3093-5p agomir | Oligonucleotides | |
| HY-R02977 | mmu-miR-3094-3p mimic | Oligonucleotides | |
| HY-R02977A | mmu-miR-3094-3p agomir | Oligonucleotides | |
| HY-R02978 | mmu-miR-3094-5p mimic | Oligonucleotides | |
| HY-R02978A | mmu-miR-3094-5p agomir | Oligonucleotides | |
| HY-R02979 | mmu-miR-3095-3p mimic | Oligonucleotides | |
| HY-R02979A | mmu-miR-3095-3p agomir | Oligonucleotides | |
| HY-R02980 | mmu-miR-3095-5p mimic | Oligonucleotides | |
| HY-R02980A | mmu-miR-3095-5p agomir | Oligonucleotides | |
| HY-R02981 | mmu-miR-3097-3p mimic | Oligonucleotides | |
| HY-R02981A | mmu-miR-3097-3p agomir | Oligonucleotides | |
| HY-R02982 | mmu-miR-3097-5p mimic | Oligonucleotides | |
| HY-R02982A | mmu-miR-3097-5p agomir | Oligonucleotides | |
| HY-R02983 | mmu-miR-3098-3p mimic | Oligonucleotides | |
| HY-R02983A | mmu-miR-3098-3p agomir | Oligonucleotides | |
| HY-R02984 | mmu-miR-3098-5p mimic | Oligonucleotides | |
| HY-R02984A | mmu-miR-3098-5p agomir | Oligonucleotides | |
| HY-R02985 | mmu-miR-3099-3p mimic | Oligonucleotides | |
| HY-R02985A | mmu-miR-3099-3p agomir | Oligonucleotides | |
| HY-R02986 | mmu-miR-3099-5p mimic | Oligonucleotides | |
| HY-R02986A | mmu-miR-3099-5p agomir | Oligonucleotides | |
| HY-R02987 | mmu-miR-30b-3p mimic | Oligonucleotides | |
| HY-R02987A | mmu-miR-30b-3p agomir | Oligonucleotides | |
| HY-R02988 | mmu-miR-30f mimic | Oligonucleotides | |
| HY-R02988A | mmu-miR-30f agomir | Oligonucleotides | |
| HY-R02989 | mmu-miR-3100-3p mimic | Oligonucleotides | |
| HY-R02989A | mmu-miR-3100-3p agomir | Oligonucleotides | |
| HY-R02990 | mmu-miR-3100-5p mimic | Oligonucleotides | |
| HY-R02990A | mmu-miR-3100-5p agomir | Oligonucleotides | |
| HY-R02991 | mmu-miR-3101-3p mimic | Oligonucleotides | |
| HY-R02991A | mmu-miR-3101-3p agomir | Oligonucleotides | |
| HY-R02992 | mmu-miR-3101-5p mimic | Oligonucleotides | |
| HY-R02992A | mmu-miR-3101-5p agomir | Oligonucleotides | |
| HY-R02993 | mmu-miR-3102-3p mimic | Oligonucleotides | |
| HY-R02993A | mmu-miR-3102-3p agomir | Oligonucleotides | |
| HY-R02994 | mmu-miR-3102-3p.2-3p mimic | Oligonucleotides | |
| HY-R02994A | mmu-miR-3102-3p.2-3p agomir | Oligonucleotides | |
| HY-R02995 | mmu-miR-3102-5p mimic | Oligonucleotides | |
| HY-R02995A | mmu-miR-3102-5p agomir | Oligonucleotides | |
| HY-R02996 | mmu-miR-3102-5p.2-5p mimic | Oligonucleotides | |
| HY-R02996A | mmu-miR-3102-5p.2-5p agomir | Oligonucleotides | |
| HY-R02997 | mmu-miR-3103-3p mimic | Oligonucleotides | |
| HY-R02997A | mmu-miR-3103-3p agomir | Oligonucleotides | |
| HY-R02998 | mmu-miR-3103-5p mimic | Oligonucleotides | |
| HY-R02998A | mmu-miR-3103-5p agomir | Oligonucleotides | |
| HY-R02999 | mmu-miR-3104-3p mimic | Oligonucleotides | |
| HY-R02999A | mmu-miR-3104-3p agomir | Oligonucleotides | |
| HY-R03000 | mmu-miR-3104-5p mimic | Oligonucleotides | |
| HY-R03000A | mmu-miR-3104-5p agomir | Oligonucleotides | |
| HY-R03001 | mmu-miR-3105-3p mimic | Oligonucleotides | |
| HY-R03001A | mmu-miR-3105-3p agomir | Oligonucleotides | |
| HY-R03002 | mmu-miR-3105-5p mimic | Oligonucleotides | |
| HY-R03002A | mmu-miR-3105-5p agomir | Oligonucleotides | |
| HY-R03003 | mmu-miR-3106-3p mimic | Oligonucleotides | |
| HY-R03003A | mmu-miR-3106-3p agomir | Oligonucleotides | |
| HY-R03004 | mmu-miR-3106-5p mimic | Oligonucleotides | |
| HY-R03004A | mmu-miR-3106-5p agomir | Oligonucleotides | |
| HY-R03005 | mmu-miR-3108-3p mimic | Oligonucleotides | |
| HY-R03005A | mmu-miR-3108-3p agomir | Oligonucleotides | |
| HY-R03006 | mmu-miR-3108-5p mimic | Oligonucleotides | |
| HY-R03006A | mmu-miR-3108-5p agomir | Oligonucleotides | |
| HY-R03007 | mmu-miR-3109-3p mimic | Oligonucleotides | |
| HY-R03007A | mmu-miR-3109-3p agomir | Oligonucleotides | |
| HY-R03008 | mmu-miR-3109-5p mimic | Oligonucleotides | |
| HY-R03008A | mmu-miR-3109-5p agomir | Oligonucleotides | |
| HY-R03009 | mmu-miR-3110-3p mimic | Oligonucleotides | |
| HY-R03009A | mmu-miR-3110-3p agomir | Oligonucleotides | |
| HY-R03010 | mmu-miR-3110-5p mimic | Oligonucleotides | |
| HY-R03010A | mmu-miR-3110-5p agomir | Oligonucleotides | |
| HY-R03011 | mmu-miR-3112-3p mimic | Oligonucleotides | |
| HY-R03011A | mmu-miR-3112-3p agomir | Oligonucleotides | |
| HY-R03012 | mmu-miR-3112-5p mimic | Oligonucleotides | |
| HY-R03012A | mmu-miR-3112-5p agomir | Oligonucleotides | |
| HY-R03013 | mmu-miR-3113-3p mimic | Oligonucleotides | |
| HY-R03013A | mmu-miR-3113-3p agomir | Oligonucleotides | |
| HY-R03014 | mmu-miR-3113-5p mimic | Oligonucleotides | |
| HY-R03014A | mmu-miR-3113-5p agomir | Oligonucleotides | |
| HY-R03015 | mmu-miR-31-3p mimic | Oligonucleotides | |
| HY-R03015A | mmu-miR-31-3p agomir | Oligonucleotides | |
| HY-R03016 | mmu-miR-3154 mimic | Oligonucleotides | |
| HY-R03016A | mmu-miR-3154 agomir | Oligonucleotides | |
| HY-R03017 | mmu-miR-31-5p mimic | Oligonucleotides | |
| HY-R03017A | mmu-miR-31-5p agomir | Oligonucleotides | |
| HY-R03018 | mmu-miR-322-3p mimic | Oligonucleotides | |
| HY-R03018A | mmu-miR-322-3p agomir | Oligonucleotides | |
| HY-R03019 | mmu-miR-322-5p mimic | Oligonucleotides | |
| HY-R03019A | mmu-miR-322-5p agomir | Oligonucleotides | |
| HY-R03020 | mmu-miR-32-3p mimic | Oligonucleotides | |
| HY-R03020A | mmu-miR-32-3p agomir | Oligonucleotides | |
| HY-R03021 | mmu-miR-324-3p mimic | Oligonucleotides | |
| HY-R03021A | mmu-miR-324-3p agomir | Oligonucleotides | |
| HY-R03022 | mmu-miR-324-5p mimic | Oligonucleotides | |
| HY-R03022A | mmu-miR-324-5p agomir | Oligonucleotides | |
| HY-R03023 | mmu-miR-325-3p mimic | Oligonucleotides | |
| HY-R03023A | mmu-miR-325-3p agomir | Oligonucleotides | |
| HY-R03024 | mmu-miR-325-5p mimic | Oligonucleotides | |
| HY-R03024A | mmu-miR-325-5p agomir | Oligonucleotides | |
| HY-R03025 | mmu-miR-326-3p mimic | Oligonucleotides | |
| HY-R03025A | mmu-miR-326-3p agomir | Oligonucleotides | |
| HY-R03026 | mmu-miR-326-5p mimic | Oligonucleotides | |
| HY-R03026A | mmu-miR-326-5p agomir | Oligonucleotides | |
| HY-R03027 | mmu-miR-327 mimic | Oligonucleotides | |
| HY-R03027A | mmu-miR-327 agomir | Oligonucleotides | |
| HY-R03028 | mmu-miR-328-5p mimic | Oligonucleotides | |
| HY-R03028A | mmu-miR-328-5p agomir | Oligonucleotides | |
| HY-R03029 | mmu-miR-329-3p mimic | Oligonucleotides | |
| HY-R03029A | mmu-miR-329-3p agomir | Oligonucleotides | |
| HY-R03030 | mmu-miR-329-5p mimic | Oligonucleotides | |
| HY-R03030A | mmu-miR-329-5p agomir | Oligonucleotides | |
| HY-R03031 | mmu-miR-330-3p mimic | Oligonucleotides | |
| HY-R03031A | mmu-miR-330-3p agomir | Oligonucleotides | |
| HY-R03032 | mmu-miR-337-3p mimic | Oligonucleotides | |
| HY-R03032A | mmu-miR-337-3p agomir | Oligonucleotides | |
| HY-R03033 | mmu-miR-337-5p mimic | Oligonucleotides | |
| HY-R03033A | mmu-miR-337-5p agomir | Oligonucleotides | |
| HY-R03034 | mmu-miR-339-3p mimic | Oligonucleotides | |
| HY-R03034A | mmu-miR-339-3p agomir | Oligonucleotides | |
| HY-R03035 | mmu-miR-341-3p mimic | Oligonucleotides | |
| HY-R03035A | mmu-miR-341-3p agomir | Oligonucleotides | |
| HY-R03036 | mmu-miR-341-5p mimic | Oligonucleotides | |
| HY-R03036A | mmu-miR-341-5p agomir | Oligonucleotides | |
| HY-R03037 | mmu-miR-342-5p mimic | Oligonucleotides | |
| HY-R03037A | mmu-miR-342-5p agomir | Oligonucleotides | |
| HY-R03038 | mmu-miR-343 mimic | Oligonucleotides | |
| HY-R03038A | mmu-miR-343 agomir | Oligonucleotides | |
| HY-R03039 | mmu-miR-344-3p mimic | Oligonucleotides | |
| HY-R03039A | mmu-miR-344-3p agomir | Oligonucleotides | |
| HY-R03040 | mmu-miR-344-5p mimic | Oligonucleotides | |
| HY-R03040A | mmu-miR-344-5p agomir | Oligonucleotides | |
| HY-R03041 | mmu-miR-344b-3p mimic | Oligonucleotides | |
| HY-R03041A | mmu-miR-344b-3p agomir | Oligonucleotides | |
| HY-R03042 | mmu-miR-344b-5p mimic | Oligonucleotides | |
| HY-R03042A | mmu-miR-344b-5p agomir | Oligonucleotides | |
| HY-R03043 | mmu-miR-344c-3p mimic | Oligonucleotides | |
| HY-R03043A | mmu-miR-344c-3p agomir | Oligonucleotides | |
| HY-R03044 | mmu-miR-344c-5p mimic | Oligonucleotides | |
| HY-R03044A | mmu-miR-344c-5p agomir | Oligonucleotides | |
| HY-R03045 | mmu-miR-344d-1-5p mimic | Oligonucleotides | |
| HY-R03045A | mmu-miR-344d-1-5p agomir | Oligonucleotides | |
| HY-R03046 | mmu-miR-344d-2-5p mimic | Oligonucleotides | |
| HY-R03046A | mmu-miR-344d-2-5p agomir | Oligonucleotides | |
| HY-R03047 | mmu-miR-344d-3-5p mimic | Oligonucleotides | |
| HY-R03047A | mmu-miR-344d-3-5p agomir | Oligonucleotides | |
| HY-R03048 | mmu-miR-344d-3p mimic | Oligonucleotides | |
| HY-R03048A | mmu-miR-344d-3p agomir | Oligonucleotides | |
| HY-R03049 | mmu-miR-344e-3p mimic | Oligonucleotides | |
| HY-R03049A | mmu-miR-344e-3p agomir | Oligonucleotides | |
| HY-R03050 | mmu-miR-344e-5p mimic | Oligonucleotides | |
| HY-R03050A | mmu-miR-344e-5p agomir | Oligonucleotides | |
| HY-R03051 | mmu-miR-344f-3p mimic | Oligonucleotides | |
| HY-R03051A | mmu-miR-344f-3p agomir | Oligonucleotides | |
| HY-R03052 | mmu-miR-344f-5p mimic | Oligonucleotides | |
| HY-R03052A | mmu-miR-344f-5p agomir | Oligonucleotides | |
| HY-R03053 | mmu-miR-344g-3p mimic | Oligonucleotides | |
| HY-R03053A | mmu-miR-344g-3p agomir | Oligonucleotides | |
| HY-R03054 | mmu-miR-344g-5p mimic | Oligonucleotides | |
| HY-R03054A | mmu-miR-344g-5p agomir | Oligonucleotides | |
| HY-R03055 | mmu-miR-344h-3p mimic | Oligonucleotides | |
| HY-R03055A | mmu-miR-344h-3p agomir | Oligonucleotides | |
| HY-R03056 | mmu-miR-344i mimic | Oligonucleotides | |
| HY-R03056A | mmu-miR-344i agomir | Oligonucleotides | |
| HY-R03057 | mmu-miR-345-3p mimic | Oligonucleotides | |
| HY-R03057A | mmu-miR-345-3p agomir | Oligonucleotides | |
| HY-R03058 | mmu-miR-345-5p mimic | Oligonucleotides | |
| HY-R03058A | mmu-miR-345-5p agomir | Oligonucleotides | |
| HY-R03059 | mmu-miR-346-3p mimic | Oligonucleotides | |
| HY-R03059A | mmu-miR-346-3p agomir | Oligonucleotides | |
| HY-R03060 | mmu-miR-346-5p mimic | Oligonucleotides | |
| HY-R03060A | mmu-miR-346-5p agomir | Oligonucleotides | |
| HY-R03061 | mmu-miR-3470a mimic | Oligonucleotides | |
| HY-R03061A | mmu-miR-3470a agomir | Oligonucleotides | |
| HY-R03062 | mmu-miR-3470b mimic | Oligonucleotides | |
| HY-R03062A | mmu-miR-3470b agomir | Oligonucleotides | |
| HY-R03063 | mmu-miR-3471 mimic | Oligonucleotides | |
| HY-R03063A | mmu-miR-3471 agomir | Oligonucleotides | |
| HY-R03064 | mmu-miR-3472 mimic | Oligonucleotides | |
| HY-R03064A | mmu-miR-3472 agomir | Oligonucleotides | |
| HY-R03065 | mmu-miR-3473a mimic | Oligonucleotides | |
| HY-R03065A | mmu-miR-3473a agomir | Oligonucleotides | |
| HY-R03066 | mmu-miR-3473b mimic | Oligonucleotides | |
| HY-R03066A | mmu-miR-3473b agomir | Oligonucleotides | |
| HY-R03067 | mmu-miR-3473c mimic | Oligonucleotides | |
| HY-R03067A | mmu-miR-3473c agomir | Oligonucleotides | |
| HY-R03068 | mmu-miR-3473d mimic | Oligonucleotides | |
| HY-R03068A | mmu-miR-3473d agomir | Oligonucleotides | |
| HY-R03069 | mmu-miR-3473e mimic | Oligonucleotides | |
| HY-R03069A | mmu-miR-3473e agomir | Oligonucleotides | |
| HY-R03070 | mmu-miR-3473f mimic | Oligonucleotides | |
| HY-R03070A | mmu-miR-3473f agomir | Oligonucleotides | |
| HY-R03071 | mmu-miR-3473g mimic | Oligonucleotides | |
| HY-R03071A | mmu-miR-3473g agomir | Oligonucleotides | |
| HY-R03072 | mmu-miR-3473h-5p mimic | Oligonucleotides | |
| HY-R03072A | mmu-miR-3473h-5p agomir | Oligonucleotides | |
| HY-R03073 | mmu-miR-3474 mimic | Oligonucleotides | |
| HY-R03073A | mmu-miR-3474 agomir | Oligonucleotides | |
| HY-R03074 | mmu-miR-3475-3p mimic | Oligonucleotides | |
| HY-R03074A | mmu-miR-3475-3p agomir | Oligonucleotides | |
| HY-R03075 | mmu-miR-3475-5p mimic | Oligonucleotides | |
| HY-R03075A | mmu-miR-3475-5p agomir | Oligonucleotides | |
| HY-R03076 | mmu-miR-34a-3p mimic | Oligonucleotides | |
| HY-R03076A | mmu-miR-34a-3p agomir | Oligonucleotides | |
| HY-R03077 | mmu-miR-34c-3p mimic | Oligonucleotides | |
| HY-R03077A | mmu-miR-34c-3p agomir | Oligonucleotides | |
| HY-R03078 | mmu-miR-350-3p mimic | Oligonucleotides | |
| HY-R03078A | mmu-miR-350-3p agomir | Oligonucleotides | |
| HY-R03079 | mmu-miR-350-5p mimic | Oligonucleotides | |
| HY-R03079A | mmu-miR-350-5p agomir | Oligonucleotides | |
| HY-R03080 | mmu-miR-351-3p mimic | Oligonucleotides | |
| HY-R03080A | mmu-miR-351-3p agomir | Oligonucleotides | |
| HY-R03081 | mmu-miR-351-5p mimic | Oligonucleotides | |
| HY-R03081A | mmu-miR-351-5p agomir | Oligonucleotides | |
| HY-R03082 | mmu-miR-3535 mimic | Oligonucleotides | |
| HY-R03082A | mmu-miR-3535 agomir | Oligonucleotides | |
| HY-R03083 | mmu-miR-3544-3p mimic | Oligonucleotides | |
| HY-R03083A | mmu-miR-3544-3p agomir | Oligonucleotides | |
| HY-R03084 | mmu-miR-3544-5p mimic | Oligonucleotides | |
| HY-R03084A | mmu-miR-3544-5p agomir | Oligonucleotides | |
| HY-R03085 | mmu-miR-3547-3p mimic | Oligonucleotides | |
| HY-R03085A | mmu-miR-3547-3p agomir | Oligonucleotides | |
| HY-R03086 | mmu-miR-3547-5p mimic | Oligonucleotides | |
| HY-R03086A | mmu-miR-3547-5p agomir | Oligonucleotides | |
| HY-R03087 | mmu-miR-3552 mimic | Oligonucleotides | |
| HY-R03087A | mmu-miR-3552 agomir | Oligonucleotides | |
| HY-R03088 | mmu-miR-3569-3p mimic | Oligonucleotides | |
| HY-R03088A | mmu-miR-3569-3p agomir | Oligonucleotides | |
| HY-R03089 | mmu-miR-3569-5p mimic | Oligonucleotides | |
| HY-R03089A | mmu-miR-3569-5p agomir | Oligonucleotides | |
| HY-R03090 | mmu-miR-3572-3p mimic | Oligonucleotides | |
| HY-R03090A | mmu-miR-3572-3p agomir | Oligonucleotides | |
| HY-R03091 | mmu-miR-3572-5p mimic | Oligonucleotides | |
| HY-R03091A | mmu-miR-3572-5p agomir | Oligonucleotides | |
| HY-R03092 | mmu-miR-361-3p mimic | Oligonucleotides | |
| HY-R03092A | mmu-miR-361-3p agomir | Oligonucleotides | |
| HY-R03093 | mmu-miR-3618-3p mimic | Oligonucleotides | |
| HY-R03093A | mmu-miR-3618-3p agomir | Oligonucleotides | |
| HY-R03094 | mmu-miR-3618-5p mimic | Oligonucleotides | |
| HY-R03094A | mmu-miR-3618-5p agomir | Oligonucleotides | |
| HY-R03095 | mmu-miR-3620-3p mimic | Oligonucleotides | |
| HY-R03095A | mmu-miR-3620-3p agomir | Oligonucleotides | |
| HY-R03096 | mmu-miR-3620-5p mimic | Oligonucleotides | |
| HY-R03096A | mmu-miR-3620-5p agomir | Oligonucleotides | |
| HY-R03097 | mmu-miR-362-3p mimic | Oligonucleotides | |
| HY-R03097A | mmu-miR-362-3p agomir | Oligonucleotides | |
| HY-R03098 | mmu-miR-362-5p mimic | Oligonucleotides | |
| HY-R03098A | mmu-miR-362-5p agomir | Oligonucleotides | |
| HY-R03099 | mmu-miR-363-5p mimic | Oligonucleotides | |
| HY-R03099A | mmu-miR-363-5p agomir | Oligonucleotides | |
| HY-R03100 | mmu-miR-365-2-5p mimic | Oligonucleotides | |
| HY-R03100A | mmu-miR-365-2-5p agomir | Oligonucleotides | |
| HY-R03101 | mmu-miR-367-5p mimic | Oligonucleotides | |
| HY-R03101A | mmu-miR-367-5p agomir | Oligonucleotides | |
| HY-R03102 | mmu-miR-370-5p mimic | Oligonucleotides | |
| HY-R03102A | mmu-miR-370-5p agomir | Oligonucleotides | |
| HY-R03103 | mmu-miR-374b-3p mimic | Oligonucleotides | |
| HY-R03103A | mmu-miR-374b-3p agomir | Oligonucleotides | |
| HY-R03104 | mmu-miR-374c-3p mimic | Oligonucleotides | |
| HY-R03104A | mmu-miR-374c-3p agomir | Oligonucleotides | |
| HY-R03105 | mmu-miR-374c-5p mimic | Oligonucleotides | |
| HY-R03105A | mmu-miR-374c-5p agomir | Oligonucleotides | |
| HY-R03106 | mmu-miR-375-5p mimic | Oligonucleotides | |
| HY-R03106A | mmu-miR-375-5p agomir | Oligonucleotides | |
| HY-R03107 | mmu-miR-376a-3p mimic | Oligonucleotides | |
| HY-R03107A | mmu-miR-376a-3p agomir | Oligonucleotides | |
| HY-R03108 | mmu-miR-376a-5p mimic | Oligonucleotides | |
| HY-R03108A | mmu-miR-376a-5p agomir | Oligonucleotides | |
| HY-R03109 | mmu-miR-376b-3p mimic | Oligonucleotides | |
| HY-R03109A | mmu-miR-376b-3p agomir | Oligonucleotides | |
| HY-R03110 | mmu-miR-376b-5p mimic | Oligonucleotides | |
| HY-R03110A | mmu-miR-376b-5p agomir | Oligonucleotides | |
| HY-R03111 | mmu-miR-376c-3p mimic | Oligonucleotides | |
| HY-R03111A | mmu-miR-376c-3p agomir | Oligonucleotides | |
| HY-R03112 | mmu-miR-376c-5p mimic | Oligonucleotides | |
| HY-R03112A | mmu-miR-376c-5p agomir | Oligonucleotides | |
| HY-R03113 | mmu-miR-378a-3p mimic | Oligonucleotides | |
| HY-R03113A | mmu-miR-378a-3p agomir | Oligonucleotides | |
| HY-R03114 | mmu-miR-378b mimic | Oligonucleotides | |
| HY-R03114A | mmu-miR-378b agomir | Oligonucleotides | |
| HY-R03115 | mmu-miR-378c mimic | Oligonucleotides | |
| HY-R03115A | mmu-miR-378c agomir | Oligonucleotides | |
| HY-R03116 | mmu-miR-378d mimic | Oligonucleotides | |
| HY-R03116A | mmu-miR-378d agomir | Oligonucleotides | |
| HY-R03117 | mmu-miR-380-3p mimic | Oligonucleotides | |
| HY-R03117A | mmu-miR-380-3p agomir | Oligonucleotides | |
| HY-R03118 | mmu-miR-380-5p mimic | Oligonucleotides | |
| HY-R03118A | mmu-miR-380-5p agomir | Oligonucleotides | |
| HY-R03119 | mmu-miR-381-5p mimic | Oligonucleotides | |
| HY-R03119A | mmu-miR-381-5p agomir | Oligonucleotides | |
| HY-R03120 | mmu-miR-382-3p mimic | Oligonucleotides | |
| HY-R03120A | mmu-miR-382-3p agomir | Oligonucleotides | |
| HY-R03121 | mmu-miR-383-3p mimic | Oligonucleotides | |
| HY-R03121A | mmu-miR-383-3p agomir | Oligonucleotides | |
| HY-R03122 | mmu-miR-383-5p mimic | Oligonucleotides | |
| HY-R03122A | mmu-miR-383-5p agomir | Oligonucleotides | |
| HY-R03123 | mmu-miR-384-3p mimic | Oligonucleotides | |
| HY-R03123A | mmu-miR-384-3p agomir | Oligonucleotides | |
| HY-R03124 | mmu-miR-384-5p mimic | Oligonucleotides | |
| HY-R03124A | mmu-miR-384-5p agomir | Oligonucleotides | |
| HY-R03125 | mmu-miR-3961 mimic | Oligonucleotides | |
| HY-R03125A | mmu-miR-3961 agomir | Oligonucleotides | |
| HY-R03126 | mmu-miR-3962 mimic | Oligonucleotides | |
| HY-R03126A | mmu-miR-3962 agomir | Oligonucleotides | |
| HY-R03127 | mmu-miR-3963 mimic | Oligonucleotides | |
| HY-R03127A | mmu-miR-3963 agomir | Oligonucleotides | |
| HY-R03128 | mmu-miR-3964 mimic | Oligonucleotides | |
| HY-R03128A | mmu-miR-3964 agomir | Oligonucleotides | |
| HY-R03129 | mmu-miR-3965 mimic | Oligonucleotides | |
| HY-R03129A | mmu-miR-3965 agomir | Oligonucleotides | |
| HY-R03130 | mmu-miR-3966 mimic | Oligonucleotides | |
| HY-R03130A | mmu-miR-3966 agomir | Oligonucleotides | |
| HY-R03131 | mmu-miR-3967 mimic | Oligonucleotides | |
| HY-R03131A | mmu-miR-3967 agomir | Oligonucleotides | |
| HY-R03132 | mmu-miR-3968 mimic | Oligonucleotides | |
| HY-R03132A | mmu-miR-3968 agomir | Oligonucleotides | |
| HY-R03133 | mmu-miR-3969 mimic | Oligonucleotides | |
| HY-R03133A | mmu-miR-3969 agomir | Oligonucleotides | |
| HY-R03134 | mmu-miR-3970 mimic | Oligonucleotides | |
| HY-R03134A | mmu-miR-3970 agomir | Oligonucleotides | |
| HY-R03135 | mmu-miR-3971 mimic | Oligonucleotides | |
| HY-R03135A | mmu-miR-3971 agomir | Oligonucleotides | |
| HY-R03136 | mmu-miR-412-3p mimic | Oligonucleotides | |
| HY-R03136A | mmu-miR-412-3p agomir | Oligonucleotides | |
| HY-R03137 | mmu-miR-412-5p mimic | Oligonucleotides | |
| HY-R03137A | mmu-miR-412-5p agomir | Oligonucleotides | |
| HY-R03138 | mmu-miR-421-5p mimic | Oligonucleotides | |
| HY-R03138A | mmu-miR-421-5p agomir | Oligonucleotides | |
| HY-R03139 | mmu-miR-425-3p mimic | Oligonucleotides | |
| HY-R03139A | mmu-miR-425-3p agomir | Oligonucleotides | |
| HY-R03140 | mmu-miR-429-3p mimic | Oligonucleotides | |
| HY-R03140A | mmu-miR-429-3p agomir | Oligonucleotides | |
| HY-R03141 | mmu-miR-429-5p mimic | Oligonucleotides | |
| HY-R03141A | mmu-miR-429-5p agomir | Oligonucleotides | |
| HY-R03142 | mmu-miR-432 mimic | Oligonucleotides | |
| HY-R03142A | mmu-miR-432 agomir | Oligonucleotides | |
| HY-R03143 | mmu-miR-434-3p mimic | Oligonucleotides | |
| HY-R03143A | mmu-miR-434-3p agomir | Oligonucleotides | |
| HY-R03144 | mmu-miR-434-5p mimic | Oligonucleotides | |
| HY-R03144A | mmu-miR-434-5p agomir | Oligonucleotides | |
| HY-R03145 | mmu-miR-448-5p mimic | Oligonucleotides | |
| HY-R03145A | mmu-miR-448-5p agomir | Oligonucleotides | |
| HY-R03146 | mmu-miR-449a-3p mimic | Oligonucleotides | |
| HY-R03146A | mmu-miR-449a-3p agomir | Oligonucleotides | |
| HY-R03147 | mmu-miR-449b mimic | Oligonucleotides | |
| HY-R03147A | mmu-miR-449b agomir | Oligonucleotides | |
| HY-R03148 | mmu-miR-449c-3p mimic | Oligonucleotides | |
| HY-R03148A | mmu-miR-449c-3p agomir | Oligonucleotides | |
| HY-R03149 | mmu-miR-449c-5p mimic | Oligonucleotides | |
| HY-R03149A | mmu-miR-449c-5p agomir | Oligonucleotides | |
| HY-R03150 | mmu-miR-450a-1-3p mimic | Oligonucleotides | |
| HY-R03150A | mmu-miR-450a-1-3p agomir | Oligonucleotides | |
| HY-R03151 | mmu-miR-450a-2-3p mimic | Oligonucleotides | |
| HY-R03151A | mmu-miR-450a-2-3p agomir | Oligonucleotides | |
| HY-R03152 | mmu-miR-450b-3p mimic | Oligonucleotides | |
| HY-R03152A | mmu-miR-450b-3p agomir | Oligonucleotides | |
| HY-R03153 | mmu-miR-450b-5p mimic | Oligonucleotides | |
| HY-R03153A | mmu-miR-450b-5p agomir | Oligonucleotides | |
| HY-R03154 | mmu-miR-451b mimic | Oligonucleotides | |
| HY-R03154A | mmu-miR-451b agomir | Oligonucleotides | |
| HY-R03155 | mmu-miR-452-3p mimic | Oligonucleotides | |
| HY-R03155A | mmu-miR-452-3p agomir | Oligonucleotides | |
| HY-R03156 | mmu-miR-452-5p mimic | Oligonucleotides | |
| HY-R03156A | mmu-miR-452-5p agomir | Oligonucleotides | |
| HY-R03157 | mmu-miR-453 mimic | Oligonucleotides | |
| HY-R03157A | mmu-miR-453 agomir | Oligonucleotides | |
| HY-R03158 | mmu-miR-455-3p mimic | Oligonucleotides | |
| HY-R03158A | mmu-miR-455-3p agomir | Oligonucleotides | |
| HY-R03159 | mmu-miR-463-3p mimic | Oligonucleotides | |
| HY-R03159A | mmu-miR-463-3p agomir | Oligonucleotides | |
| HY-R03160 | mmu-miR-463-5p mimic | Oligonucleotides | |
| HY-R03160A | mmu-miR-463-5p agomir | Oligonucleotides | |
| HY-R03161 | mmu-miR-465a-3p mimic | Oligonucleotides | |
| HY-R03161A | mmu-miR-465a-3p agomir | Oligonucleotides | |
| HY-R03162 | mmu-miR-465a-5p mimic | Oligonucleotides | |
| HY-R03162A | mmu-miR-465a-5p agomir | Oligonucleotides | |
| HY-R03163 | mmu-miR-465b-5p mimic | Oligonucleotides | |
| HY-R03163A | mmu-miR-465b-5p agomir | Oligonucleotides | |
| HY-R03164 | mmu-miR-465c-5p mimic | Oligonucleotides | |
| HY-R03164A | mmu-miR-465c-5p agomir | Oligonucleotides | |
| HY-R03165 | mmu-miR-465d-3p mimic | Oligonucleotides | |
| HY-R03165A | mmu-miR-465d-3p agomir | Oligonucleotides | |
| HY-R03166 | mmu-miR-465d-5p mimic | Oligonucleotides | |
| HY-R03166A | mmu-miR-465d-5p agomir | Oligonucleotides | |
| HY-R03167 | mmu-miR-466a-3p mimic | Oligonucleotides | |
| HY-R03167A | mmu-miR-466a-3p agomir | Oligonucleotides | |
| HY-R03168 | mmu-miR-466a-5p mimic | Oligonucleotides | |
| HY-R03168A | mmu-miR-466a-5p agomir | Oligonucleotides | |
| HY-R03169 | mmu-miR-466b-3p mimic | Oligonucleotides | |
| HY-R03169A | mmu-miR-466b-3p agomir | Oligonucleotides | |
| HY-R03170 | mmu-miR-466b-5p mimic | Oligonucleotides | |
| HY-R03170A | mmu-miR-466b-5p agomir | Oligonucleotides | |
| HY-R03171 | mmu-miR-466c-5p mimic | Oligonucleotides | |
| HY-R03171A | mmu-miR-466c-5p agomir | Oligonucleotides | |
| HY-R03172 | mmu-miR-466d-3p mimic | Oligonucleotides | |
| HY-R03172A | mmu-miR-466d-3p agomir | Oligonucleotides | |
| HY-R03173 | mmu-miR-466d-5p mimic | Oligonucleotides | |
| HY-R03173A | mmu-miR-466d-5p agomir | Oligonucleotides | |
| HY-R03174 | mmu-miR-466e-5p mimic | Oligonucleotides | |
| HY-R03174A | mmu-miR-466e-5p agomir | Oligonucleotides | |
| HY-R03175 | mmu-miR-466f mimic | Oligonucleotides | |
| HY-R03175A | mmu-miR-466f agomir | Oligonucleotides | |
| HY-R03176 | mmu-miR-466f-3p mimic | Oligonucleotides | |
| HY-R03176A | mmu-miR-466f-3p agomir | Oligonucleotides | |
| HY-R03177 | mmu-miR-466f-5p mimic | Oligonucleotides | |
| HY-R03177A | mmu-miR-466f-5p agomir | Oligonucleotides | |
| HY-R03178 | mmu-miR-466g mimic | Oligonucleotides | |
| HY-R03178A | mmu-miR-466g agomir | Oligonucleotides | |
| HY-R03179 | mmu-miR-466h-3p mimic | Oligonucleotides | |
| HY-R03179A | mmu-miR-466h-3p agomir | Oligonucleotides | |
| HY-R03180 | mmu-miR-466h-5p mimic | Oligonucleotides | |
| HY-R03180A | mmu-miR-466h-5p agomir | Oligonucleotides | |
| HY-R03181 | mmu-miR-466i-3p mimic | Oligonucleotides | |
| HY-R03181A | mmu-miR-466i-3p agomir | Oligonucleotides | |
| HY-R03182 | mmu-miR-466i-5p mimic | Oligonucleotides | |
| HY-R03182A | mmu-miR-466i-5p agomir | Oligonucleotides | |
| HY-R03183 | mmu-miR-466j mimic | Oligonucleotides | |
| HY-R03183A | mmu-miR-466j agomir | Oligonucleotides | |
| HY-R03184 | mmu-miR-466k mimic | Oligonucleotides | |
| HY-R03184A | mmu-miR-466k agomir | Oligonucleotides | |
| HY-R03185 | mmu-miR-466l-3p mimic | Oligonucleotides | |
| HY-R03185A | mmu-miR-466l-3p agomir | Oligonucleotides | |
| HY-R03186 | mmu-miR-466l-5p mimic | Oligonucleotides | |
| HY-R03186A | mmu-miR-466l-5p agomir | Oligonucleotides | |
| HY-R03187 | mmu-miR-466m-3p mimic | Oligonucleotides | |
| HY-R03187A | mmu-miR-466m-3p agomir | Oligonucleotides | |
| HY-R03188 | mmu-miR-466m-5p mimic | Oligonucleotides | |
| HY-R03188A | mmu-miR-466m-5p agomir | Oligonucleotides | |
| HY-R03189 | mmu-miR-466n-3p mimic | Oligonucleotides | |
| HY-R03189A | mmu-miR-466n-3p agomir | Oligonucleotides | |
| HY-R03190 | mmu-miR-466n-5p mimic | Oligonucleotides | |
| HY-R03190A | mmu-miR-466n-5p agomir | Oligonucleotides | |
| HY-R03191 | mmu-miR-466o-3p mimic | Oligonucleotides | |
| HY-R03191A | mmu-miR-466o-3p agomir | Oligonucleotides | |
| HY-R03192 | mmu-miR-466p-5p mimic | Oligonucleotides | |
| HY-R03192A | mmu-miR-466p-5p agomir | Oligonucleotides | |
| HY-R03193 | mmu-miR-466q mimic | Oligonucleotides | |
| HY-R03193A | mmu-miR-466q agomir | Oligonucleotides | |
| HY-R03194 | mmu-miR-467a-3p mimic | Oligonucleotides | |
| HY-R03194A | mmu-miR-467a-3p agomir | Oligonucleotides | |
| HY-R03195 | mmu-miR-467a-5p mimic | Oligonucleotides | |
| HY-R03195A | mmu-miR-467a-5p agomir | Oligonucleotides | |
| HY-R03196 | mmu-miR-467b-3p mimic | Oligonucleotides | |
| HY-R03196A | mmu-miR-467b-3p agomir | Oligonucleotides | |
| HY-R03197 | mmu-miR-467b-5p mimic | Oligonucleotides | |
| HY-R03197A | mmu-miR-467b-5p agomir | Oligonucleotides | |
| HY-R03198 | mmu-miR-467c-3p mimic | Oligonucleotides | |
| HY-R03198A | mmu-miR-467c-3p agomir | Oligonucleotides | |
| HY-R03199 | mmu-miR-467c-5p mimic | Oligonucleotides | |
| HY-R03199A | mmu-miR-467c-5p agomir | Oligonucleotides | |
| HY-R03200 | mmu-miR-467d-3p mimic | Oligonucleotides | |
| HY-R03200A | mmu-miR-467d-3p agomir | Oligonucleotides | |
| HY-R03201 | mmu-miR-467d-5p mimic | Oligonucleotides | |
| HY-R03201A | mmu-miR-467d-5p agomir | Oligonucleotides | |
| HY-R03202 | mmu-miR-467e-3p mimic | Oligonucleotides | |
| HY-R03202A | mmu-miR-467e-3p agomir | Oligonucleotides | |
| HY-R03203 | mmu-miR-467e-5p mimic | Oligonucleotides | |
| HY-R03203A | mmu-miR-467e-5p agomir | Oligonucleotides | |
| HY-R03204 | mmu-miR-467f mimic | Oligonucleotides | |
| HY-R03204A | mmu-miR-467f agomir | Oligonucleotides | |
| HY-R03205 | mmu-miR-467g mimic | Oligonucleotides | |
| HY-R03205A | mmu-miR-467g agomir | Oligonucleotides | |
| HY-R03206 | mmu-miR-467h mimic | Oligonucleotides | |
| HY-R03206A | mmu-miR-467h agomir | Oligonucleotides | |
| HY-R03207 | mmu-miR-468-3p mimic | Oligonucleotides | |
| HY-R03207A | mmu-miR-468-3p agomir | Oligonucleotides | |
| HY-R03208 | mmu-miR-468-5p mimic | Oligonucleotides | |
| HY-R03208A | mmu-miR-468-5p agomir | Oligonucleotides | |
| HY-R03209 | mmu-miR-470-3p mimic | Oligonucleotides | |
| HY-R03209A | mmu-miR-470-3p agomir | Oligonucleotides | |
| HY-R03210 | mmu-miR-470-5p mimic | Oligonucleotides | |
| HY-R03210A | mmu-miR-470-5p agomir | Oligonucleotides | |
| HY-R03211 | mmu-miR-471-3p mimic | Oligonucleotides | |
| HY-R03211A | mmu-miR-471-3p agomir | Oligonucleotides | |
| HY-R03212 | mmu-miR-471-5p mimic | Oligonucleotides | |
| HY-R03212A | mmu-miR-471-5p agomir | Oligonucleotides | |
| HY-R03213 | mmu-miR-483-3p mimic | Oligonucleotides | |
| HY-R03213A | mmu-miR-483-3p agomir | Oligonucleotides | |
| HY-R03214 | mmu-miR-483-5p mimic | Oligonucleotides | |
| HY-R03214A | mmu-miR-483-5p agomir | Oligonucleotides | |
| HY-R03215 | mmu-miR-485-3p mimic | Oligonucleotides | |
| HY-R03215A | mmu-miR-485-3p agomir | Oligonucleotides | |
| HY-R03216 | mmu-miR-486b-3p mimic | Oligonucleotides | |
| HY-R03216A | mmu-miR-486b-3p agomir | Oligonucleotides | |
| HY-R03217 | mmu-miR-487b-5p mimic | Oligonucleotides | |
| HY-R03217A | mmu-miR-487b-5p agomir | Oligonucleotides | |
| HY-R03218 | mmu-miR-488-3p mimic | Oligonucleotides | |
| HY-R03218A | mmu-miR-488-3p agomir | Oligonucleotides | |
| HY-R03219 | mmu-miR-488-5p mimic | Oligonucleotides | |
| HY-R03219A | mmu-miR-488-5p agomir | Oligonucleotides | |
| HY-R03220 | mmu-miR-489-3p mimic | Oligonucleotides | |
| HY-R03220A | mmu-miR-489-3p agomir | Oligonucleotides | |
| HY-R03221 | mmu-miR-489-5p mimic | Oligonucleotides | |
| HY-R03221A | mmu-miR-489-5p agomir | Oligonucleotides | |
| HY-R03222 | mmu-miR-493-3p mimic | Oligonucleotides | |
| HY-R03222A | mmu-miR-493-3p agomir | Oligonucleotides | |
| HY-R03223 | mmu-miR-493-5p mimic | Oligonucleotides | |
| HY-R03223A | mmu-miR-493-5p agomir | Oligonucleotides | |
| HY-R03224 | mmu-miR-494-5p mimic | Oligonucleotides | |
| HY-R03224A | mmu-miR-494-5p agomir | Oligonucleotides | |
| HY-R03225 | mmu-miR-495-5p mimic | Oligonucleotides | |
| HY-R03225A | mmu-miR-495-5p agomir | Oligonucleotides | |
| HY-R03226 | mmu-miR-496a-5p mimic | Oligonucleotides | |
| HY-R03226A | mmu-miR-496a-5p agomir | Oligonucleotides | |
| HY-R03227 | mmu-miR-496b mimic | Oligonucleotides | |
| HY-R03227A | mmu-miR-496b agomir | Oligonucleotides | |
| HY-R03228 | mmu-miR-497a-3p mimic | Oligonucleotides | |
| HY-R03228A | mmu-miR-497a-3p agomir | Oligonucleotides | |
| HY-R03229 | mmu-miR-497a-5p mimic | Oligonucleotides | |
| HY-R03229A | mmu-miR-497a-5p agomir | Oligonucleotides | |
| HY-R03230 | mmu-miR-497b mimic | Oligonucleotides | |
| HY-R03230A | mmu-miR-497b agomir | Oligonucleotides | |
| HY-R03231 | mmu-miR-499-3p mimic | Oligonucleotides | |
| HY-R03231A | mmu-miR-499-3p agomir | Oligonucleotides | |
| HY-R03232 | mmu-miR-500-3p mimic | Oligonucleotides | |
| HY-R03232A | mmu-miR-500-3p agomir | Oligonucleotides | |
| HY-R03233 | mmu-miR-500-5p mimic | Oligonucleotides | |
| HY-R03233A | mmu-miR-500-5p agomir | Oligonucleotides | |
| HY-R03234 | mmu-miR-501-3p mimic | Oligonucleotides | |
| HY-R03234A | mmu-miR-501-3p agomir | Oligonucleotides | |
| HY-R03235 | mmu-miR-501-5p mimic | Oligonucleotides | |
| HY-R03235A | mmu-miR-501-5p agomir | Oligonucleotides | |
| HY-R03236 | mmu-miR-503-3p mimic | Oligonucleotides | |
| HY-R03236A | mmu-miR-503-3p agomir | Oligonucleotides | |
| HY-R03237 | mmu-miR-503-5p mimic | Oligonucleotides | |
| HY-R03237A | mmu-miR-503-5p agomir | Oligonucleotides | |
| HY-R03238 | mmu-miR-504-3p mimic | Oligonucleotides | |
| HY-R03238A | mmu-miR-504-3p agomir | Oligonucleotides | |
| HY-R03239 | mmu-miR-5046 mimic | Oligonucleotides | |
| HY-R03239A | mmu-miR-5046 agomir | Oligonucleotides | |
| HY-R03240 | mmu-miR-505-3p mimic | Oligonucleotides | |
| HY-R03240A | mmu-miR-505-3p agomir | Oligonucleotides | |
| HY-R03241 | mmu-miR-505-5p mimic | Oligonucleotides | |
| HY-R03241A | mmu-miR-505-5p agomir | Oligonucleotides | |
| HY-R03242 | mmu-miR-509-3p mimic | Oligonucleotides | |
| HY-R03242A | mmu-miR-509-3p agomir | Oligonucleotides | |
| HY-R03243 | mmu-miR-509-5p mimic | Oligonucleotides | |
| HY-R03243A | mmu-miR-509-5p agomir | Oligonucleotides | |
| HY-R03244 | mmu-miR-5098 mimic | Oligonucleotides | |
| HY-R03244A | mmu-miR-5098 agomir | Oligonucleotides | |
| HY-R03245 | mmu-miR-5099 mimic | Oligonucleotides | |
| HY-R03245A | mmu-miR-5099 agomir | Oligonucleotides | |
| HY-R03246 | mmu-miR-5100 mimic | Oligonucleotides | |
| HY-R03246A | mmu-miR-5100 agomir | Oligonucleotides | |
| HY-R03247 | mmu-miR-5101 mimic | Oligonucleotides | |
| HY-R03247A | mmu-miR-5101 agomir | Oligonucleotides | |
| HY-R03248 | mmu-miR-5103 mimic | Oligonucleotides | |
| HY-R03248A | mmu-miR-5103 agomir | Oligonucleotides | |
| HY-R03249 | mmu-miR-5104 mimic | Oligonucleotides | |
| HY-R03249A | mmu-miR-5104 agomir | Oligonucleotides | |
| HY-R03250 | mmu-miR-5104b-5p mimic | Oligonucleotides | |
| HY-R03250A | mmu-miR-5104b-5p agomir | Oligonucleotides | |
| HY-R03251 | mmu-miR-5106 mimic | Oligonucleotides | |
| HY-R03251A | mmu-miR-5106 agomir | Oligonucleotides | |
| HY-R03252 | mmu-miR-5107-3p mimic | Oligonucleotides | |
| HY-R03252A | mmu-miR-5107-3p agomir | Oligonucleotides | |
| HY-R03253 | mmu-miR-5107-5p mimic | Oligonucleotides | |
| HY-R03253A | mmu-miR-5107-5p agomir | Oligonucleotides | |
| HY-R03254 | mmu-miR-5108 mimic | Oligonucleotides | |
| HY-R03254A | mmu-miR-5108 agomir | Oligonucleotides | |
| HY-R03255 | mmu-miR-5110 mimic | Oligonucleotides | |
| HY-R03255A | mmu-miR-5110 agomir | Oligonucleotides | |
| HY-R03256 | mmu-miR-5112 mimic | Oligonucleotides | |
| HY-R03256A | mmu-miR-5112 agomir | Oligonucleotides | |
| HY-R03257 | mmu-miR-5113 mimic | Oligonucleotides | |
| HY-R03257A | mmu-miR-5113 agomir | Oligonucleotides | |
| HY-R03258 | mmu-miR-511-3p mimic | Oligonucleotides | |
| HY-R03258A | mmu-miR-511-3p agomir | Oligonucleotides | |
| HY-R03259 | mmu-miR-5114 mimic | Oligonucleotides | |
| HY-R03259A | mmu-miR-5114 agomir | Oligonucleotides | |
| HY-R03260 | mmu-miR-511-5p mimic | Oligonucleotides | |
| HY-R03260A | mmu-miR-511-5p agomir | Oligonucleotides | |
| HY-R03261 | mmu-miR-5116 mimic | Oligonucleotides | |
| HY-R03261A | mmu-miR-5116 agomir | Oligonucleotides | |
| HY-R03262 | mmu-miR-5118 mimic | Oligonucleotides | |
| HY-R03262A | mmu-miR-5118 agomir | Oligonucleotides | |
| HY-R03263 | mmu-miR-5119 mimic | Oligonucleotides | |
| HY-R03263A | mmu-miR-5119 agomir | Oligonucleotides | |
| HY-R03264 | mmu-miR-5120 mimic | Oligonucleotides | |
| HY-R03264A | mmu-miR-5120 agomir | Oligonucleotides | |
| HY-R03265 | mmu-miR-5121 mimic | Oligonucleotides | |
| HY-R03265A | mmu-miR-5121 agomir | Oligonucleotides | |
| HY-R03266 | mmu-miR-5122 mimic | Oligonucleotides | |
| HY-R03266A | mmu-miR-5122 agomir | Oligonucleotides | |
| HY-R03267 | mmu-miR-5123 mimic | Oligonucleotides | |
| HY-R03267A | mmu-miR-5123 agomir | Oligonucleotides | |
| HY-R03268 | mmu-miR-5124a mimic | Oligonucleotides | |
| HY-R03268A | mmu-miR-5124a agomir | Oligonucleotides | |
| HY-R03269 | mmu-miR-5124b mimic | Oligonucleotides | |
| HY-R03269A | mmu-miR-5124b agomir | Oligonucleotides | |
| HY-R03270 | mmu-miR-5125 mimic | Oligonucleotides | |
| HY-R03270A | mmu-miR-5125 agomir | Oligonucleotides | |
| HY-R03271 | mmu-miR-5126 mimic | Oligonucleotides | |
| HY-R03271A | mmu-miR-5126 agomir | Oligonucleotides | |
| HY-R03272 | mmu-miR-5127 mimic | Oligonucleotides | |
| HY-R03272A | mmu-miR-5127 agomir | Oligonucleotides | |
| HY-R03273 | mmu-miR-5128 mimic | Oligonucleotides | |
| HY-R03273A | mmu-miR-5128 agomir | Oligonucleotides | |
| HY-R03274 | mmu-miR-5129-3p mimic | Oligonucleotides | |
| HY-R03274A | mmu-miR-5129-3p agomir | Oligonucleotides | |
| HY-R03275 | mmu-miR-5129-5p mimic | Oligonucleotides | |
| HY-R03275A | mmu-miR-5129-5p agomir | Oligonucleotides | |
| HY-R03276 | mmu-miR-5130 mimic | Oligonucleotides | |
| HY-R03276A | mmu-miR-5130 agomir | Oligonucleotides | |
| HY-R03277 | mmu-miR-5131 mimic | Oligonucleotides | |
| HY-R03277A | mmu-miR-5131 agomir | Oligonucleotides | |
| HY-R03278 | mmu-miR-5132-3p mimic | Oligonucleotides | |
| HY-R03278A | mmu-miR-5132-3p agomir | Oligonucleotides | |
| HY-R03279 | mmu-miR-5132-5p mimic | Oligonucleotides | |
| HY-R03279A | mmu-miR-5132-5p agomir | Oligonucleotides | |
| HY-R03280 | mmu-miR-5133 mimic | Oligonucleotides | |
| HY-R03280A | mmu-miR-5133 agomir | Oligonucleotides | |
| HY-R03281 | mmu-miR-5134-3p mimic | Oligonucleotides | |
| HY-R03281A | mmu-miR-5134-3p agomir | Oligonucleotides | |
| HY-R03282 | mmu-miR-5134-5p mimic | Oligonucleotides | |
| HY-R03282A | mmu-miR-5134-5p agomir | Oligonucleotides | |
| HY-R03283 | mmu-miR-5135 mimic | Oligonucleotides | |
| HY-R03283A | mmu-miR-5135 agomir | Oligonucleotides | |
| HY-R03284 | mmu-miR-5136 mimic | Oligonucleotides | |
| HY-R03284A | mmu-miR-5136 agomir | Oligonucleotides | |
| HY-R03285 | mmu-miR-539-3p mimic | Oligonucleotides | |
| HY-R03285A | mmu-miR-539-3p agomir | Oligonucleotides | |
| HY-R03286 | mmu-miR-540-3p mimic | Oligonucleotides | |
| HY-R03286A | mmu-miR-540-3p agomir | Oligonucleotides | |
| HY-R03287 | mmu-miR-540-5p mimic | Oligonucleotides | |
| HY-R03287A | mmu-miR-540-5p agomir | Oligonucleotides | |
| HY-R03288 | mmu-miR-541-3p mimic | Oligonucleotides | |
| HY-R03288A | mmu-miR-541-3p agomir | Oligonucleotides | |
| HY-R03289 | mmu-miR-541-5p mimic | Oligonucleotides | |
| HY-R03289A | mmu-miR-541-5p agomir | Oligonucleotides | |
| HY-R03290 | mmu-miR-542-5p mimic | Oligonucleotides | |
| HY-R03290A | mmu-miR-542-5p agomir | Oligonucleotides | |
| HY-R03291 | mmu-miR-543-5p mimic | Oligonucleotides | |
| HY-R03291A | mmu-miR-543-5p agomir | Oligonucleotides | |
| HY-R03292 | mmu-miR-544-3p mimic | Oligonucleotides | |
| HY-R03292A | mmu-miR-544-3p agomir | Oligonucleotides | |
| HY-R03293 | mmu-miR-544-5p mimic | Oligonucleotides | |
| HY-R03293A | mmu-miR-544-5p agomir | Oligonucleotides | |
| HY-R03294 | mmu-miR-546 mimic | Oligonucleotides | |
| HY-R03294A | mmu-miR-546 agomir | Oligonucleotides | |
| HY-R03295 | mmu-miR-547-3p mimic | Oligonucleotides | |
| HY-R03295A | mmu-miR-547-3p agomir | Oligonucleotides | |
| HY-R03296 | mmu-miR-547-5p mimic | Oligonucleotides | |
| HY-R03296A | mmu-miR-547-5p agomir | Oligonucleotides | |
| HY-R03297 | mmu-miR-551b-5p mimic | Oligonucleotides | |
| HY-R03297A | mmu-miR-551b-5p agomir | Oligonucleotides | |
| HY-R03298 | mmu-miR-5615-3p mimic | Oligonucleotides | |
| HY-R03298A | mmu-miR-5615-3p agomir | Oligonucleotides | |
| HY-R03299 | mmu-miR-5615-5p mimic | Oligonucleotides | |
| HY-R03299A | mmu-miR-5615-5p agomir | Oligonucleotides | |
| HY-R03300 | mmu-miR-5616-3p mimic | Oligonucleotides | |
| HY-R03300A | mmu-miR-5616-3p agomir | Oligonucleotides | |
| HY-R03301 | mmu-miR-5616-5p mimic | Oligonucleotides | |
| HY-R03301A | mmu-miR-5616-5p agomir | Oligonucleotides | |
| HY-R03302 | mmu-miR-5617-3p mimic | Oligonucleotides | |
| HY-R03302A | mmu-miR-5617-3p agomir | Oligonucleotides | |
| HY-R03303 | mmu-miR-5617-5p mimic | Oligonucleotides | |
| HY-R03303A | mmu-miR-5617-5p agomir | Oligonucleotides | |
| HY-R03304 | mmu-miR-5618-3p mimic | Oligonucleotides | |
| HY-R03304A | mmu-miR-5618-3p agomir | Oligonucleotides | |
| HY-R03305 | mmu-miR-5618-5p mimic | Oligonucleotides | |
| HY-R03305A | mmu-miR-5618-5p agomir | Oligonucleotides | |
| HY-R03306 | mmu-miR-5619-3p mimic | Oligonucleotides | |
| HY-R03306A | mmu-miR-5619-3p agomir | Oligonucleotides | |
| HY-R03307 | mmu-miR-5619-5p mimic | Oligonucleotides | |
| HY-R03307A | mmu-miR-5619-5p agomir | Oligonucleotides | |
| HY-R03308 | mmu-miR-5620-3p mimic | Oligonucleotides | |
| HY-R03308A | mmu-miR-5620-3p agomir | Oligonucleotides | |
| HY-R03309 | mmu-miR-5620-5p mimic | Oligonucleotides | |
| HY-R03309A | mmu-miR-5620-5p agomir | Oligonucleotides | |
| HY-R03310 | mmu-miR-5621-3p mimic | Oligonucleotides | |
| HY-R03310A | mmu-miR-5621-3p agomir | Oligonucleotides | |
| HY-R03311 | mmu-miR-5621-5p mimic | Oligonucleotides | |
| HY-R03311A | mmu-miR-5621-5p agomir | Oligonucleotides | |
| HY-R03312 | mmu-miR-5622-3p mimic | Oligonucleotides | |
| HY-R03312A | mmu-miR-5622-3p agomir | Oligonucleotides | |
| HY-R03313 | mmu-miR-5622-5p mimic | Oligonucleotides | |
| HY-R03313A | mmu-miR-5622-5p agomir | Oligonucleotides | |
| HY-R03314 | mmu-miR-5623-3p mimic | Oligonucleotides | |
| HY-R03314A | mmu-miR-5623-3p agomir | Oligonucleotides | |
| HY-R03315 | mmu-miR-5623-5p mimic | Oligonucleotides | |
| HY-R03315A | mmu-miR-5623-5p agomir | Oligonucleotides | |
| HY-R03316 | mmu-miR-5624-3p mimic | Oligonucleotides | |
| HY-R03316A | mmu-miR-5624-3p agomir | Oligonucleotides | |
| HY-R03317 | mmu-miR-5624-5p mimic | Oligonucleotides | |
| HY-R03317A | mmu-miR-5624-5p agomir | Oligonucleotides | |
| HY-R03318 | mmu-miR-5625-3p mimic | Oligonucleotides | |
| HY-R03318A | mmu-miR-5625-3p agomir | Oligonucleotides | |
| HY-R03319 | mmu-miR-5625-5p mimic | Oligonucleotides | |
| HY-R03319A | mmu-miR-5625-5p agomir | Oligonucleotides | |
| HY-R03320 | mmu-miR-5626-3p mimic | Oligonucleotides | |
| HY-R03320A | mmu-miR-5626-3p agomir | Oligonucleotides | |
| HY-R03321 | mmu-miR-5626-5p mimic | Oligonucleotides | |
| HY-R03321A | mmu-miR-5626-5p agomir | Oligonucleotides | |
| HY-R03322 | mmu-miR-5627-3p mimic | Oligonucleotides | |
| HY-R03322A | mmu-miR-5627-3p agomir | Oligonucleotides | |
| HY-R03323 | mmu-miR-5627-5p mimic | Oligonucleotides | |
| HY-R03323A | mmu-miR-5627-5p agomir | Oligonucleotides | |
| HY-R03324 | mmu-miR-5709-3p mimic | Oligonucleotides | |
| HY-R03324A | mmu-miR-5709-3p agomir | Oligonucleotides | |
| HY-R03325 | mmu-miR-5709-5p mimic | Oligonucleotides | |
| HY-R03325A | mmu-miR-5709-5p agomir | Oligonucleotides | |
| HY-R03326 | mmu-miR-5710 mimic | Oligonucleotides | |
| HY-R03326A | mmu-miR-5710 agomir | Oligonucleotides | |
| HY-R03327 | mmu-miR-582-3p mimic | Oligonucleotides | |
| HY-R03327A | mmu-miR-582-3p agomir | Oligonucleotides | |
| HY-R03328 | mmu-miR-582-5p mimic | Oligonucleotides | |
| HY-R03328A | mmu-miR-582-5p agomir | Oligonucleotides | |
| HY-R03329 | mmu-miR-592-3p mimic | Oligonucleotides | |
| HY-R03329A | mmu-miR-592-3p agomir | Oligonucleotides | |
| HY-R03330 | mmu-miR-592-5p mimic | Oligonucleotides | |
| HY-R03330A | mmu-miR-592-5p agomir | Oligonucleotides | |
| HY-R03331 | mmu-miR-598-3p mimic | Oligonucleotides | |
| HY-R03331A | mmu-miR-598-3p agomir | Oligonucleotides | |
| HY-R03332 | mmu-miR-598-5p mimic | Oligonucleotides | |
| HY-R03332A | mmu-miR-598-5p agomir | Oligonucleotides | |
| HY-R03333 | mmu-miR-599 mimic | Oligonucleotides | |
| HY-R03333A | mmu-miR-599 agomir | Oligonucleotides | |
| HY-R03334 | mmu-miR-6236 mimic | Oligonucleotides | |
| HY-R03334A | mmu-miR-6236 agomir | Oligonucleotides | |
| HY-R03335 | mmu-miR-6237 mimic | Oligonucleotides | |
| HY-R03335A | mmu-miR-6237 agomir | Oligonucleotides | |
| HY-R03336 | mmu-miR-6238 mimic | Oligonucleotides | |
| HY-R03336A | mmu-miR-6238 agomir | Oligonucleotides | |
| HY-R03337 | mmu-miR-6239 mimic | Oligonucleotides | |
| HY-R03337A | mmu-miR-6239 agomir | Oligonucleotides | |
| HY-R03338 | mmu-miR-6240 mimic | Oligonucleotides | |
| HY-R03338A | mmu-miR-6240 agomir | Oligonucleotides | |
| HY-R03339 | mmu-miR-6241 mimic | Oligonucleotides | |
| HY-R03339A | mmu-miR-6241 agomir | Oligonucleotides | |
| HY-R03340 | mmu-miR-6244 mimic | Oligonucleotides | |
| HY-R03340A | mmu-miR-6244 agomir | Oligonucleotides | |
| HY-R03341 | mmu-miR-6335 mimic | Oligonucleotides | |
| HY-R03341A | mmu-miR-6335 agomir | Oligonucleotides | |
| HY-R03342 | mmu-miR-6336 mimic | Oligonucleotides | |
| HY-R03342A | mmu-miR-6336 agomir | Oligonucleotides | |
| HY-R03343 | mmu-miR-6337 mimic | Oligonucleotides | |
| HY-R03343A | mmu-miR-6337 agomir | Oligonucleotides | |
| HY-R03344 | mmu-miR-6338 mimic | Oligonucleotides | |
| HY-R03344A | mmu-miR-6338 agomir | Oligonucleotides | |
| HY-R03345 | mmu-miR-6339 mimic | Oligonucleotides | |
| HY-R03345A | mmu-miR-6339 agomir | Oligonucleotides | |
| HY-R03346 | mmu-miR-6340 mimic | Oligonucleotides | |
| HY-R03346A | mmu-miR-6340 agomir | Oligonucleotides | |
| HY-R03347 | mmu-miR-6341 mimic | Oligonucleotides | |
| HY-R03347A | mmu-miR-6341 agomir | Oligonucleotides | |
| HY-R03348 | mmu-miR-6342 mimic | Oligonucleotides | |
| HY-R03348A | mmu-miR-6342 agomir | Oligonucleotides | |
| HY-R03349 | mmu-miR-6343 mimic | Oligonucleotides | |
| HY-R03349A | mmu-miR-6343 agomir | Oligonucleotides | |
| HY-R03350 | mmu-miR-6344 mimic | Oligonucleotides | |
| HY-R03350A | mmu-miR-6344 agomir | Oligonucleotides | |
| HY-R03351 | mmu-miR-6345 mimic | Oligonucleotides | |
| HY-R03351A | mmu-miR-6345 agomir | Oligonucleotides | |
| HY-R03352 | mmu-miR-6346 mimic | Oligonucleotides | |
| HY-R03352A | mmu-miR-6346 agomir | Oligonucleotides | |
| HY-R03353 | mmu-miR-6347 mimic | Oligonucleotides | |
| HY-R03353A | mmu-miR-6347 agomir | Oligonucleotides | |
| HY-R03354 | mmu-miR-6348 mimic | Oligonucleotides | |
| HY-R03354A | mmu-miR-6348 agomir | Oligonucleotides | |
| HY-R03355 | mmu-miR-6349 mimic | Oligonucleotides | |
| HY-R03355A | mmu-miR-6349 agomir | Oligonucleotides | |
| HY-R03356 | mmu-miR-6350 mimic | Oligonucleotides | |
| HY-R03356A | mmu-miR-6350 agomir | Oligonucleotides | |
| HY-R03357 | mmu-miR-6351 mimic | Oligonucleotides | |
| HY-R03357A | mmu-miR-6351 agomir | Oligonucleotides | |
| HY-R03358 | mmu-miR-6352 mimic | Oligonucleotides | |
| HY-R03358A | mmu-miR-6352 agomir | Oligonucleotides | |
| HY-R03359 | mmu-miR-6353 mimic | Oligonucleotides | |
| HY-R03359A | mmu-miR-6353 agomir | Oligonucleotides | |
| HY-R03360 | mmu-miR-6354 mimic | Oligonucleotides | |
| HY-R03360A | mmu-miR-6354 agomir | Oligonucleotides | |
| HY-R03361 | mmu-miR-6355 mimic | Oligonucleotides | |
| HY-R03361A | mmu-miR-6355 agomir | Oligonucleotides | |
| HY-R03362 | mmu-miR-6356 mimic | Oligonucleotides | |
| HY-R03362A | mmu-miR-6356 agomir | Oligonucleotides | |
| HY-R03363 | mmu-miR-6357 mimic | Oligonucleotides | |
| HY-R03363A | mmu-miR-6357 agomir | Oligonucleotides | |
| HY-R03364 | mmu-miR-6358 mimic | Oligonucleotides | |
| HY-R03364A | mmu-miR-6358 agomir | Oligonucleotides | |
| HY-R03365 | mmu-miR-6359 mimic | Oligonucleotides | |
| HY-R03365A | mmu-miR-6359 agomir | Oligonucleotides | |
| HY-R03366 | mmu-miR-6360 mimic | Oligonucleotides | |
| HY-R03366A | mmu-miR-6360 agomir | Oligonucleotides | |
| HY-R03367 | mmu-miR-6361 mimic | Oligonucleotides | |
| HY-R03367A | mmu-miR-6361 agomir | Oligonucleotides | |
| HY-R03368 | mmu-miR-6362 mimic | Oligonucleotides | |
| HY-R03368A | mmu-miR-6362 agomir | Oligonucleotides | |
| HY-R03369 | mmu-miR-6363 mimic | Oligonucleotides | |
| HY-R03369A | mmu-miR-6363 agomir | Oligonucleotides | |
| HY-R03370 | mmu-miR-6364 mimic | Oligonucleotides | |
| HY-R03370A | mmu-miR-6364 agomir | Oligonucleotides | |
| HY-R03371 | mmu-miR-6365 mimic | Oligonucleotides | |
| HY-R03371A | mmu-miR-6365 agomir | Oligonucleotides | |
| HY-R03372 | mmu-miR-6366 mimic | Oligonucleotides | |
| HY-R03372A | mmu-miR-6366 agomir | Oligonucleotides | |
| HY-R03373 | mmu-miR-6367 mimic | Oligonucleotides | |
| HY-R03373A | mmu-miR-6367 agomir | Oligonucleotides | |
| HY-R03374 | mmu-miR-6368 mimic | Oligonucleotides | |
| HY-R03374A | mmu-miR-6368 agomir | Oligonucleotides | |
| HY-R03375 | mmu-miR-6369 mimic | Oligonucleotides | |
| HY-R03375A | mmu-miR-6369 agomir | Oligonucleotides | |
| HY-R03376 | mmu-miR-6370 mimic | Oligonucleotides | |
| HY-R03376A | mmu-miR-6370 agomir | Oligonucleotides | |
| HY-R03377 | mmu-miR-6371 mimic | Oligonucleotides | |
| HY-R03377A | mmu-miR-6371 agomir | Oligonucleotides | |
| HY-R03378 | mmu-miR-6372 mimic | Oligonucleotides | |
| HY-R03378A | mmu-miR-6372 agomir | Oligonucleotides | |
| HY-R03379 | mmu-miR-6373 mimic | Oligonucleotides | |
| HY-R03379A | mmu-miR-6373 agomir | Oligonucleotides | |
| HY-R03380 | mmu-miR-6374 mimic | Oligonucleotides | |
| HY-R03380A | mmu-miR-6374 agomir | Oligonucleotides | |
| HY-R03381 | mmu-miR-6375 mimic | Oligonucleotides | |
| HY-R03381A | mmu-miR-6375 agomir | Oligonucleotides | |
| HY-R03382 | mmu-miR-6376 mimic | Oligonucleotides | |
| HY-R03382A | mmu-miR-6376 agomir | Oligonucleotides | |
| HY-R03383 | mmu-miR-6377 mimic | Oligonucleotides | |
| HY-R03383A | mmu-miR-6377 agomir | Oligonucleotides | |
| HY-R03384 | mmu-miR-6378 mimic | Oligonucleotides | |
| HY-R03384A | mmu-miR-6378 agomir | Oligonucleotides | |
| HY-R03385 | mmu-miR-6379 mimic | Oligonucleotides | |
| HY-R03385A | mmu-miR-6379 agomir | Oligonucleotides | |
| HY-R03386 | mmu-miR-6380 mimic | Oligonucleotides | |
| HY-R03386A | mmu-miR-6380 agomir | Oligonucleotides | |
| HY-R03387 | mmu-miR-6381 mimic | Oligonucleotides | |
| HY-R03387A | mmu-miR-6381 agomir | Oligonucleotides | |
| HY-R03388 | mmu-miR-6382 mimic | Oligonucleotides | |
| HY-R03388A | mmu-miR-6382 agomir | Oligonucleotides | |
| HY-R03389 | mmu-miR-6383 mimic | Oligonucleotides | |
| HY-R03389A | mmu-miR-6383 agomir | Oligonucleotides | |
| HY-R03390 | mmu-miR-6384 mimic | Oligonucleotides | |
| HY-R03390A | mmu-miR-6384 agomir | Oligonucleotides | |
| HY-R03391 | mmu-miR-6385 mimic | Oligonucleotides | |
| HY-R03391A | mmu-miR-6385 agomir | Oligonucleotides | |
| HY-R03392 | mmu-miR-6386 mimic | Oligonucleotides | |
| HY-R03392A | mmu-miR-6386 agomir | Oligonucleotides | |
| HY-R03393 | mmu-miR-6387 mimic | Oligonucleotides | |
| HY-R03393A | mmu-miR-6387 agomir | Oligonucleotides | |
| HY-R03394 | mmu-miR-6388 mimic | Oligonucleotides | |
| HY-R03394A | mmu-miR-6388 agomir | Oligonucleotides | |
| HY-R03395 | mmu-miR-6389 mimic | Oligonucleotides | |
| HY-R03395A | mmu-miR-6389 agomir | Oligonucleotides | |
| HY-R03396 | mmu-miR-6390 mimic | Oligonucleotides | |
| HY-R03396A | mmu-miR-6390 agomir | Oligonucleotides | |
| HY-R03397 | mmu-miR-6391 mimic | Oligonucleotides | |
| HY-R03397A | mmu-miR-6391 agomir | Oligonucleotides | |
| HY-R03398 | mmu-miR-6392-3p mimic | Oligonucleotides | |
| HY-R03398A | mmu-miR-6392-3p agomir | Oligonucleotides | |
| HY-R03399 | mmu-miR-6392-5p mimic | Oligonucleotides | |
| HY-R03399A | mmu-miR-6392-5p agomir | Oligonucleotides | |
| HY-R03400 | mmu-miR-6393 mimic | Oligonucleotides | |
| HY-R03400A | mmu-miR-6393 agomir | Oligonucleotides | |
| HY-R03401 | mmu-miR-6394 mimic | Oligonucleotides | |
| HY-R03401A | mmu-miR-6394 agomir | Oligonucleotides | |
| HY-R03402 | mmu-miR-6395 mimic | Oligonucleotides | |
| HY-R03402A | mmu-miR-6395 agomir | Oligonucleotides | |
| HY-R03403 | mmu-miR-6396 mimic | Oligonucleotides | |
| HY-R03403A | mmu-miR-6396 agomir | Oligonucleotides | |
| HY-R03404 | mmu-miR-6397 mimic | Oligonucleotides | |
| HY-R03404A | mmu-miR-6397 agomir | Oligonucleotides | |
| HY-R03405 | mmu-miR-6398 mimic | Oligonucleotides | |
| HY-R03405A | mmu-miR-6398 agomir | Oligonucleotides | |
| HY-R03406 | mmu-miR-6399 mimic | Oligonucleotides | |
| HY-R03406A | mmu-miR-6399 agomir | Oligonucleotides | |
| HY-R03407 | mmu-miR-6400 mimic | Oligonucleotides | |
| HY-R03407A | mmu-miR-6400 agomir | Oligonucleotides | |
| HY-R03408 | mmu-miR-6401 mimic | Oligonucleotides | |
| HY-R03408A | mmu-miR-6401 agomir | Oligonucleotides | |
| HY-R03409 | mmu-miR-6402 mimic | Oligonucleotides | |
| HY-R03409A | mmu-miR-6402 agomir | Oligonucleotides | |
| HY-R03410 | mmu-miR-6403 mimic | Oligonucleotides | |
| HY-R03410A | mmu-miR-6403 agomir | Oligonucleotides | |
| HY-R03411 | mmu-miR-6404 mimic | Oligonucleotides | |
| HY-R03411A | mmu-miR-6404 agomir | Oligonucleotides | |
| HY-R03412 | mmu-miR-6405 mimic | Oligonucleotides | |
| HY-R03412A | mmu-miR-6405 agomir | Oligonucleotides | |
| HY-R03413 | mmu-miR-6406 mimic | Oligonucleotides | |
| HY-R03413A | mmu-miR-6406 agomir | Oligonucleotides | |
| HY-R03414 | mmu-miR-6407 mimic | Oligonucleotides | |
| HY-R03414A | mmu-miR-6407 agomir | Oligonucleotides | |
| HY-R03415 | mmu-miR-6408 mimic | Oligonucleotides | |
| HY-R03415A | mmu-miR-6408 agomir | Oligonucleotides | |
| HY-R03416 | mmu-miR-6409 mimic | Oligonucleotides | |
| HY-R03416A | mmu-miR-6409 agomir | Oligonucleotides | |
| HY-R03417 | mmu-miR-6410 mimic | Oligonucleotides | |
| HY-R03417A | mmu-miR-6410 agomir | Oligonucleotides | |
| HY-R03418 | mmu-miR-6411 mimic | Oligonucleotides | |
| HY-R03418A | mmu-miR-6411 agomir | Oligonucleotides | |
| HY-R03419 | mmu-miR-6412 mimic | Oligonucleotides | |
| HY-R03419A | mmu-miR-6412 agomir | Oligonucleotides | |
| HY-R03420 | mmu-miR-6413 mimic | Oligonucleotides | |
| HY-R03420A | mmu-miR-6413 agomir | Oligonucleotides | |
| HY-R03421 | mmu-miR-6414 mimic | Oligonucleotides | |
| HY-R03421A | mmu-miR-6414 agomir | Oligonucleotides | |
| HY-R03422 | mmu-miR-6415 mimic | Oligonucleotides | |
| HY-R03422A | mmu-miR-6415 agomir | Oligonucleotides | |
| HY-R03423 | mmu-miR-6416-3p mimic | Oligonucleotides | |
| HY-R03423A | mmu-miR-6416-3p agomir | Oligonucleotides | |
| HY-R03424 | mmu-miR-6416-5p mimic | Oligonucleotides | |
| HY-R03424A | mmu-miR-6416-5p agomir | Oligonucleotides | |
| HY-R03425 | mmu-miR-6417 mimic | Oligonucleotides | |
| HY-R03425A | mmu-miR-6417 agomir | Oligonucleotides | |
| HY-R03426 | mmu-miR-6418-3p mimic | Oligonucleotides | |
| HY-R03426A | mmu-miR-6418-3p agomir | Oligonucleotides | |
| HY-R03427 | mmu-miR-6418-5p mimic | Oligonucleotides | |
| HY-R03427A | mmu-miR-6418-5p agomir | Oligonucleotides | |
| HY-R03428 | mmu-miR-6419 mimic | Oligonucleotides | |
| HY-R03428A | mmu-miR-6419 agomir | Oligonucleotides | |
| HY-R03429 | mmu-miR-6420 mimic | Oligonucleotides | |
| HY-R03429A | mmu-miR-6420 agomir | Oligonucleotides | |
| HY-R03430 | mmu-miR-6481 mimic | Oligonucleotides | |
| HY-R03430A | mmu-miR-6481 agomir | Oligonucleotides | |
| HY-R03431 | mmu-miR-6516-3p mimic | Oligonucleotides | |
| HY-R03431A | mmu-miR-6516-3p agomir | Oligonucleotides | |
| HY-R03432 | mmu-miR-6516-5p mimic | Oligonucleotides | |
| HY-R03432A | mmu-miR-6516-5p agomir | Oligonucleotides | |
| HY-R03433 | mmu-miR-652-5p mimic | Oligonucleotides | |
| HY-R03433A | mmu-miR-652-5p agomir | Oligonucleotides | |
| HY-R03434 | mmu-miR-653-3p mimic | Oligonucleotides | |
| HY-R03434A | mmu-miR-653-3p agomir | Oligonucleotides | |
| HY-R03435 | mmu-miR-6537-3p mimic | Oligonucleotides | |
| HY-R03435A | mmu-miR-6537-3p agomir | Oligonucleotides | |
| HY-R03436 | mmu-miR-6537-5p mimic | Oligonucleotides | |
| HY-R03436A | mmu-miR-6537-5p agomir | Oligonucleotides | |
| HY-R03437 | mmu-miR-6538 mimic | Oligonucleotides | |
| HY-R03437A | mmu-miR-6538 agomir | Oligonucleotides | |
| HY-R03438 | mmu-miR-6539 mimic | Oligonucleotides | |
| HY-R03438A | mmu-miR-6539 agomir | Oligonucleotides | |
| HY-R03439 | mmu-miR-6540-3p mimic | Oligonucleotides | |
| HY-R03439A | mmu-miR-6540-3p agomir | Oligonucleotides | |
| HY-R03440 | mmu-miR-6540-5p mimic | Oligonucleotides | |
| HY-R03440A | mmu-miR-6540-5p agomir | Oligonucleotides | |
| HY-R03441 | mmu-miR-6541 mimic | Oligonucleotides | |
| HY-R03441A | mmu-miR-6541 agomir | Oligonucleotides | |
| HY-R03442 | mmu-miR-654-5p mimic | Oligonucleotides | |
| HY-R03442A | mmu-miR-654-5p agomir | Oligonucleotides | |
| HY-R03443 | mmu-miR-6546-3p mimic | Oligonucleotides | |
| HY-R03443A | mmu-miR-6546-3p agomir | Oligonucleotides | |
| HY-R03444 | mmu-miR-6546-5p mimic | Oligonucleotides | |
| HY-R03444A | mmu-miR-6546-5p agomir | Oligonucleotides | |
| HY-R03445 | mmu-miR-664-3p mimic | Oligonucleotides | |
| HY-R03445A | mmu-miR-664-3p agomir | Oligonucleotides | |
| HY-R03446 | mmu-miR-664-5p mimic | Oligonucleotides | |
| HY-R03446A | mmu-miR-664-5p agomir | Oligonucleotides | |
| HY-R03447 | mmu-miR-665-3p mimic | Oligonucleotides | |
| HY-R03447A | mmu-miR-665-3p agomir | Oligonucleotides | |
| HY-R03448 | mmu-miR-665-5p mimic | Oligonucleotides | |
| HY-R03448A | mmu-miR-665-5p agomir | Oligonucleotides | |
| HY-R03449 | mmu-miR-666-3p mimic | Oligonucleotides | |
| HY-R03449A | mmu-miR-666-3p agomir | Oligonucleotides | |
| HY-R03450 | mmu-miR-666-5p mimic | Oligonucleotides | |
| HY-R03450A | mmu-miR-666-5p agomir | Oligonucleotides | |
| HY-R03451 | mmu-miR-667-3p mimic | Oligonucleotides | |
| HY-R03451A | mmu-miR-667-3p agomir | Oligonucleotides | |
| HY-R03452 | mmu-miR-667-5p mimic | Oligonucleotides | |
| HY-R03452A | mmu-miR-667-5p agomir | Oligonucleotides | |
| HY-R03453 | mmu-miR-668-3p mimic | Oligonucleotides | |
| HY-R03453A | mmu-miR-668-3p agomir | Oligonucleotides | |
| HY-R03454 | mmu-miR-668-5p mimic | Oligonucleotides | |
| HY-R03454A | mmu-miR-668-5p agomir | Oligonucleotides | |
| HY-R03455 | mmu-miR-669a-3-3p mimic | Oligonucleotides | |
| HY-R03455A | mmu-miR-669a-3-3p agomir | Oligonucleotides | |
| HY-R03456 | mmu-miR-669a-3p mimic | Oligonucleotides | |
| HY-R03456A | mmu-miR-669a-3p agomir | Oligonucleotides | |
| HY-R03457 | mmu-miR-669a-5p mimic | Oligonucleotides | |
| HY-R03457A | mmu-miR-669a-5p agomir | Oligonucleotides | |
| HY-R03458 | mmu-miR-669b-3p mimic | Oligonucleotides | |
| HY-R03458A | mmu-miR-669b-3p agomir | Oligonucleotides | |
| HY-R03459 | mmu-miR-669b-5p mimic | Oligonucleotides | |
| HY-R03459A | mmu-miR-669b-5p agomir | Oligonucleotides | |
| HY-R03460 | mmu-miR-669c-3p mimic | Oligonucleotides | |
| HY-R03460A | mmu-miR-669c-3p agomir | Oligonucleotides | |
| HY-R03461 | mmu-miR-669c-5p mimic | Oligonucleotides | |
| HY-R03461A | mmu-miR-669c-5p agomir | Oligonucleotides | |
| HY-R03462 | mmu-miR-669d-2-3p mimic | Oligonucleotides | |
| HY-R03462A | mmu-miR-669d-2-3p agomir | Oligonucleotides | |
| HY-R03463 | mmu-miR-669d-3p mimic | Oligonucleotides | |
| HY-R03463A | mmu-miR-669d-3p agomir | Oligonucleotides | |
| HY-R03464 | mmu-miR-669d-5p mimic | Oligonucleotides | |
| HY-R03464A | mmu-miR-669d-5p agomir | Oligonucleotides | |
| HY-R03465 | mmu-miR-669e-3p mimic | Oligonucleotides | |
| HY-R03465A | mmu-miR-669e-3p agomir | Oligonucleotides | |
| HY-R03466 | mmu-miR-669e-5p mimic | Oligonucleotides | |
| HY-R03466A | mmu-miR-669e-5p agomir | Oligonucleotides | |
| HY-R03467 | mmu-miR-669f-3p mimic | Oligonucleotides | |
| HY-R03467A | mmu-miR-669f-3p agomir | Oligonucleotides | |
| HY-R03468 | mmu-miR-669f-5p mimic | Oligonucleotides | |
| HY-R03468A | mmu-miR-669f-5p agomir | Oligonucleotides | |
| HY-R03469 | mmu-miR-669g mimic | Oligonucleotides | |
| HY-R03469A | mmu-miR-669g agomir | Oligonucleotides | |
| HY-R03470 | mmu-miR-669h-3p mimic | Oligonucleotides | |
| HY-R03470A | mmu-miR-669h-3p agomir | Oligonucleotides | |
| HY-R03471 | mmu-miR-669h-5p mimic | Oligonucleotides | |
| HY-R03471A | mmu-miR-669h-5p agomir | Oligonucleotides | |
| HY-R03472 | mmu-miR-669i mimic | Oligonucleotides | |
| HY-R03472A | mmu-miR-669i agomir | Oligonucleotides | |
| HY-R03473 | mmu-miR-669j mimic | Oligonucleotides | |
| HY-R03473A | mmu-miR-669j agomir | Oligonucleotides | |
| HY-R03474 | mmu-miR-669k-3p mimic | Oligonucleotides | |
| HY-R03474A | mmu-miR-669k-3p agomir | Oligonucleotides | |
| HY-R03475 | mmu-miR-669k-5p mimic | Oligonucleotides | |
| HY-R03475A | mmu-miR-669k-5p agomir | Oligonucleotides | |
| HY-R03476 | mmu-miR-669l-3p mimic | Oligonucleotides | |
| HY-R03476A | mmu-miR-669l-3p agomir | Oligonucleotides | |
| HY-R03477 | mmu-miR-669l-5p mimic | Oligonucleotides | |
| HY-R03477A | mmu-miR-669l-5p agomir | Oligonucleotides | |
| HY-R03478 | mmu-miR-669m-3p mimic | Oligonucleotides | |
| HY-R03478A | mmu-miR-669m-3p agomir | Oligonucleotides | |
| HY-R03479 | mmu-miR-669n mimic | Oligonucleotides | |
| HY-R03479A | mmu-miR-669n agomir | Oligonucleotides | |
| HY-R03480 | mmu-miR-669o-5p mimic | Oligonucleotides | |
| HY-R03480A | mmu-miR-669o-5p agomir | Oligonucleotides | |
| HY-R03481 | mmu-miR-669p-3p mimic | Oligonucleotides | |
| HY-R03481A | mmu-miR-669p-3p agomir | Oligonucleotides | |
| HY-R03482 | mmu-miR-670-3p mimic | Oligonucleotides | |
| HY-R03482A | mmu-miR-670-3p agomir | Oligonucleotides | |
| HY-R03483 | mmu-miR-670-5p mimic | Oligonucleotides | |
| HY-R03483A | mmu-miR-670-5p agomir | Oligonucleotides | |
| HY-R03484 | mmu-miR-6715-3p mimic | Oligonucleotides | |
| HY-R03484A | mmu-miR-6715-3p agomir | Oligonucleotides | |
| HY-R03485 | mmu-miR-6715-5p mimic | Oligonucleotides | |
| HY-R03485A | mmu-miR-6715-5p agomir | Oligonucleotides | |
| HY-R03486 | mmu-miR-672-3p mimic | Oligonucleotides | |
| HY-R03486A | mmu-miR-672-3p agomir | Oligonucleotides | |
| HY-R03487 | mmu-miR-672-5p mimic | Oligonucleotides | |
| HY-R03487A | mmu-miR-672-5p agomir | Oligonucleotides | |
| HY-R03488 | mmu-miR-673-3p mimic | Oligonucleotides | |
| HY-R03488A | mmu-miR-673-3p agomir | Oligonucleotides | |
| HY-R03489 | mmu-miR-673-5p mimic | Oligonucleotides | |
| HY-R03489A | mmu-miR-673-5p agomir | Oligonucleotides | |
| HY-R03490 | mmu-miR-674-3p mimic | Oligonucleotides | |
| HY-R03490A | mmu-miR-674-3p agomir | Oligonucleotides | |
| HY-R03491 | mmu-miR-674-5p mimic | Oligonucleotides | |
| HY-R03491A | mmu-miR-674-5p agomir | Oligonucleotides | |
| HY-R03492 | mmu-miR-675-3p mimic | Oligonucleotides | |
| HY-R03492A | mmu-miR-675-3p agomir | Oligonucleotides | |
| HY-R03493 | mmu-miR-675-5p mimic | Oligonucleotides | |
| HY-R03493A | mmu-miR-675-5p agomir | Oligonucleotides | |
| HY-R03494 | mmu-miR-676-3p mimic | Oligonucleotides | |
| HY-R03494A | mmu-miR-676-3p agomir | Oligonucleotides | |
| HY-R03495 | mmu-miR-676-5p mimic | Oligonucleotides | |
| HY-R03495A | mmu-miR-676-5p agomir | Oligonucleotides | |
| HY-R03496 | mmu-miR-6769b-3p mimic | Oligonucleotides | |
| HY-R03496A | mmu-miR-6769b-3p agomir | Oligonucleotides | |
| HY-R03497 | mmu-miR-6769b-5p mimic | Oligonucleotides | |
| HY-R03497A | mmu-miR-6769b-5p agomir | Oligonucleotides | |
| HY-R03498 | mmu-miR-677-3p mimic | Oligonucleotides | |
| HY-R03498A | mmu-miR-677-3p agomir | Oligonucleotides | |
| HY-R03499 | mmu-miR-677-5p mimic | Oligonucleotides | |
| HY-R03499A | mmu-miR-677-5p agomir | Oligonucleotides | |
| HY-R03500 | mmu-miR-678 mimic | Oligonucleotides | |
| HY-R03500A | mmu-miR-678 agomir | Oligonucleotides | |
| HY-R03501 | mmu-miR-679-3p mimic | Oligonucleotides | |
| HY-R03501A | mmu-miR-679-3p agomir | Oligonucleotides | |
| HY-R03502 | mmu-miR-679-5p mimic | Oligonucleotides | |
| HY-R03502A | mmu-miR-679-5p agomir | Oligonucleotides | |
| HY-R03503 | mmu-miR-680 mimic | Oligonucleotides | |
| HY-R03503A | mmu-miR-680 agomir | Oligonucleotides | |
| HY-R03504 | mmu-miR-681 mimic | Oligonucleotides | |
| HY-R03504A | mmu-miR-681 agomir | Oligonucleotides | |
| HY-R03505 | mmu-miR-682 mimic | Oligonucleotides | |
| HY-R03505A | mmu-miR-682 agomir | Oligonucleotides | |
| HY-R03506 | mmu-miR-683 mimic | Oligonucleotides | |
| HY-R03506A | mmu-miR-683 agomir | Oligonucleotides | |
| HY-R03507 | mmu-miR-684 mimic | Oligonucleotides | |
| HY-R03507A | mmu-miR-684 agomir | Oligonucleotides | |
| HY-R03508 | mmu-miR-686 mimic | Oligonucleotides | |
| HY-R03508A | mmu-miR-686 agomir | Oligonucleotides | |
| HY-R03509 | mmu-miR-687 mimic | Oligonucleotides | |
| HY-R03509A | mmu-miR-687 agomir | Oligonucleotides | |
| HY-R03510 | mmu-miR-688 mimic | Oligonucleotides | |
| HY-R03510A | mmu-miR-688 agomir | Oligonucleotides | |
| HY-R03511 | mmu-miR-6896-3p mimic | Oligonucleotides | |
| HY-R03511A | mmu-miR-6896-3p agomir | Oligonucleotides | |
| HY-R03512 | mmu-miR-6896-5p mimic | Oligonucleotides | |
| HY-R03512A | mmu-miR-6896-5p agomir | Oligonucleotides | |
| HY-R03513 | mmu-miR-6897-3p mimic | Oligonucleotides | |
| HY-R03513A | mmu-miR-6897-3p agomir | Oligonucleotides | |
| HY-R03514 | mmu-miR-6897-5p mimic | Oligonucleotides | |
| HY-R03514A | mmu-miR-6897-5p agomir | Oligonucleotides | |
| HY-R03515 | mmu-miR-6898-3p mimic | Oligonucleotides | |
| HY-R03515A | mmu-miR-6898-3p agomir | Oligonucleotides | |
| HY-R03516 | mmu-miR-6898-5p mimic | Oligonucleotides | |
| HY-R03516A | mmu-miR-6898-5p agomir | Oligonucleotides | |
| HY-R03517 | mmu-miR-6899-3p mimic | Oligonucleotides | |
| HY-R03517A | mmu-miR-6899-3p agomir | Oligonucleotides | |
| HY-R03518 | mmu-miR-6899-5p mimic | Oligonucleotides | |
| HY-R03518A | mmu-miR-6899-5p agomir | Oligonucleotides | |
| HY-R03519 | mmu-miR-690 mimic | Oligonucleotides | |
| HY-R03519A | mmu-miR-690 agomir | Oligonucleotides | |
| HY-R03520 | mmu-miR-6900-3p mimic | Oligonucleotides | |
| HY-R03520A | mmu-miR-6900-3p agomir | Oligonucleotides | |
| HY-R03521 | mmu-miR-6900-5p mimic | Oligonucleotides | |
| HY-R03521A | mmu-miR-6900-5p agomir | Oligonucleotides | |
| HY-R03522 | mmu-miR-6901-3p mimic | Oligonucleotides | |
| HY-R03522A | mmu-miR-6901-3p agomir | Oligonucleotides | |
| HY-R03523 | mmu-miR-6901-5p mimic | Oligonucleotides | |
| HY-R03523A | mmu-miR-6901-5p agomir | Oligonucleotides | |
| HY-R03524 | mmu-miR-6902-3p mimic | Oligonucleotides | |
| HY-R03524A | mmu-miR-6902-3p agomir | Oligonucleotides | |
| HY-R03525 | mmu-miR-6902-5p mimic | Oligonucleotides | |
| HY-R03525A | mmu-miR-6902-5p agomir | Oligonucleotides | |
| HY-R03526 | mmu-miR-6903-3p mimic | Oligonucleotides | |
| HY-R03526A | mmu-miR-6903-3p agomir | Oligonucleotides | |
| HY-R03527 | mmu-miR-6903-5p mimic | Oligonucleotides | |
| HY-R03527A | mmu-miR-6903-5p agomir | Oligonucleotides | |
| HY-R03528 | mmu-miR-6904-3p mimic | Oligonucleotides | |
| HY-R03528A | mmu-miR-6904-3p agomir | Oligonucleotides | |
| HY-R03529 | mmu-miR-6904-5p mimic | Oligonucleotides | |
| HY-R03529A | mmu-miR-6904-5p agomir | Oligonucleotides | |
| HY-R03530 | mmu-miR-6905-3p mimic | Oligonucleotides | |
| HY-R03530A | mmu-miR-6905-3p agomir | Oligonucleotides | |
| HY-R03531 | mmu-miR-6905-5p mimic | Oligonucleotides | |
| HY-R03531A | mmu-miR-6905-5p agomir | Oligonucleotides | |
| HY-R03532 | mmu-miR-6906-3p mimic | Oligonucleotides | |
| HY-R03532A | mmu-miR-6906-3p agomir | Oligonucleotides | |
| HY-R03533 | mmu-miR-6906-5p mimic | Oligonucleotides | |
| HY-R03533A | mmu-miR-6906-5p agomir | Oligonucleotides | |
| HY-R03534 | mmu-miR-6907-3p mimic | Oligonucleotides | |
| HY-R03534A | mmu-miR-6907-3p agomir | Oligonucleotides | |
| HY-R03535 | mmu-miR-6907-5p mimic | Oligonucleotides | |
| HY-R03535A | mmu-miR-6907-5p agomir | Oligonucleotides | |
| HY-R03536 | mmu-miR-6908-3p mimic | Oligonucleotides | |
| HY-R03536A | mmu-miR-6908-3p agomir | Oligonucleotides | |
| HY-R03537 | mmu-miR-6908-5p mimic | Oligonucleotides | |
| HY-R03537A | mmu-miR-6908-5p agomir | Oligonucleotides | |
| HY-R03538 | mmu-miR-6909-3p mimic | Oligonucleotides | |
| HY-R03538A | mmu-miR-6909-3p agomir | Oligonucleotides | |
| HY-R03539 | mmu-miR-6909-5p mimic | Oligonucleotides | |
| HY-R03539A | mmu-miR-6909-5p agomir | Oligonucleotides | |
| HY-R03540 | mmu-miR-691 mimic | Oligonucleotides | |
| HY-R03540A | mmu-miR-691 agomir | Oligonucleotides | |
| HY-R03541 | mmu-miR-6910-3p mimic | Oligonucleotides | |
| HY-R03541A | mmu-miR-6910-3p agomir | Oligonucleotides | |
| HY-R03542 | mmu-miR-6910-5p mimic | Oligonucleotides | |
| HY-R03542A | mmu-miR-6910-5p agomir | Oligonucleotides | |
| HY-R03543 | mmu-miR-6911-3p mimic | Oligonucleotides | |
| HY-R03543A | mmu-miR-6911-3p agomir | Oligonucleotides | |
| HY-R03544 | mmu-miR-6911-5p mimic | Oligonucleotides | |
| HY-R03544A | mmu-miR-6911-5p agomir | Oligonucleotides | |
| HY-R03545 | mmu-miR-6912-3p mimic | Oligonucleotides | |
| HY-R03545A | mmu-miR-6912-3p agomir | Oligonucleotides | |
| HY-R03546 | mmu-miR-6912-5p mimic | Oligonucleotides | |
| HY-R03546A | mmu-miR-6912-5p agomir | Oligonucleotides | |
| HY-R03547 | mmu-miR-6913-3p mimic | Oligonucleotides | |
| HY-R03547A | mmu-miR-6913-3p agomir | Oligonucleotides | |
| HY-R03548 | mmu-miR-6913-5p mimic | Oligonucleotides | |
| HY-R03548A | mmu-miR-6913-5p agomir | Oligonucleotides | |
| HY-R03549 | mmu-miR-6914-3p mimic | Oligonucleotides | |
| HY-R03549A | mmu-miR-6914-3p agomir | Oligonucleotides | |
| HY-R03550 | mmu-miR-6914-5p mimic | Oligonucleotides | |
| HY-R03550A | mmu-miR-6914-5p agomir | Oligonucleotides | |
| HY-R03551 | mmu-miR-6915-3p mimic | Oligonucleotides | |
| HY-R03551A | mmu-miR-6915-3p agomir | Oligonucleotides | |
| HY-R03552 | mmu-miR-6915-5p mimic | Oligonucleotides | |
| HY-R03552A | mmu-miR-6915-5p agomir | Oligonucleotides | |
| HY-R03553 | mmu-miR-6916-3p mimic | Oligonucleotides | |
| HY-R03553A | mmu-miR-6916-3p agomir | Oligonucleotides | |
| HY-R03554 | mmu-miR-6916-5p mimic | Oligonucleotides | |
| HY-R03554A | mmu-miR-6916-5p agomir | Oligonucleotides | |
| HY-R03555 | mmu-miR-6917-3p mimic | Oligonucleotides | |
| HY-R03555A | mmu-miR-6917-3p agomir | Oligonucleotides | |
| HY-R03556 | mmu-miR-6917-5p mimic | Oligonucleotides | |
| HY-R03556A | mmu-miR-6917-5p agomir | Oligonucleotides | |
| HY-R03557 | mmu-miR-6918-3p mimic | Oligonucleotides | |
| HY-R03557A | mmu-miR-6918-3p agomir | Oligonucleotides | |
| HY-R03558 | mmu-miR-6918-5p mimic | Oligonucleotides | |
| HY-R03558A | mmu-miR-6918-5p agomir | Oligonucleotides | |
| HY-R03559 | mmu-miR-6919-3p mimic | Oligonucleotides | |
| HY-R03559A | mmu-miR-6919-3p agomir | Oligonucleotides | |
| HY-R03560 | mmu-miR-6919-5p mimic | Oligonucleotides | |
| HY-R03560A | mmu-miR-6919-5p agomir | Oligonucleotides | |
| HY-R03561 | mmu-miR-692 mimic | Oligonucleotides | |
| HY-R03561A | mmu-miR-692 agomir | Oligonucleotides | |
| HY-R03562 | mmu-miR-6920-3p mimic | Oligonucleotides | |
| HY-R03562A | mmu-miR-6920-3p agomir | Oligonucleotides | |
| HY-R03563 | mmu-miR-6920-5p mimic | Oligonucleotides | |
| HY-R03563A | mmu-miR-6920-5p agomir | Oligonucleotides | |
| HY-R03564 | mmu-miR-6921-3p mimic | Oligonucleotides | |
| HY-R03564A | mmu-miR-6921-3p agomir | Oligonucleotides | |
| HY-R03565 | mmu-miR-6921-5p mimic | Oligonucleotides | |
| HY-R03565A | mmu-miR-6921-5p agomir | Oligonucleotides | |
| HY-R03566 | mmu-miR-6922-3p mimic | Oligonucleotides | |
| HY-R03566A | mmu-miR-6922-3p agomir | Oligonucleotides | |
| HY-R03567 | mmu-miR-6922-5p mimic | Oligonucleotides | |
| HY-R03567A | mmu-miR-6922-5p agomir | Oligonucleotides | |
| HY-R03568 | mmu-miR-6923-3p mimic | Oligonucleotides | |
| HY-R03568A | mmu-miR-6923-3p agomir | Oligonucleotides | |
| HY-R03569 | mmu-miR-6923-5p mimic | Oligonucleotides | |
| HY-R03569A | mmu-miR-6923-5p agomir | Oligonucleotides | |
| HY-R03570 | mmu-miR-6924-3p mimic | Oligonucleotides | |
| HY-R03570A | mmu-miR-6924-3p agomir | Oligonucleotides | |
| HY-R03571 | mmu-miR-6924-5p mimic | Oligonucleotides | |
| HY-R03571A | mmu-miR-6924-5p agomir | Oligonucleotides | |
| HY-R03572 | mmu-miR-6925-3p mimic | Oligonucleotides | |
| HY-R03572A | mmu-miR-6925-3p agomir | Oligonucleotides | |
| HY-R03573 | mmu-miR-6925-5p mimic | Oligonucleotides | |
| HY-R03573A | mmu-miR-6925-5p agomir | Oligonucleotides | |
| HY-R03574 | mmu-miR-6926-3p mimic | Oligonucleotides | |
| HY-R03574A | mmu-miR-6926-3p agomir | Oligonucleotides | |
| HY-R03575 | mmu-miR-6926-5p mimic | Oligonucleotides | |
| HY-R03575A | mmu-miR-6926-5p agomir | Oligonucleotides | |
| HY-R03576 | mmu-miR-6927-3p mimic | Oligonucleotides | |
| HY-R03576A | mmu-miR-6927-3p agomir | Oligonucleotides | |
| HY-R03577 | mmu-miR-6927-5p mimic | Oligonucleotides | |
| HY-R03577A | mmu-miR-6927-5p agomir | Oligonucleotides | |
| HY-R03578 | mmu-miR-6928-3p mimic | Oligonucleotides | |
| HY-R03578A | mmu-miR-6928-3p agomir | Oligonucleotides | |
| HY-R03579 | mmu-miR-6928-5p mimic | Oligonucleotides | |
| HY-R03579A | mmu-miR-6928-5p agomir | Oligonucleotides | |
| HY-R03580 | mmu-miR-6929-3p mimic | Oligonucleotides | |
| HY-R03580A | mmu-miR-6929-3p agomir | Oligonucleotides | |
| HY-R03581 | mmu-miR-6929-5p mimic | Oligonucleotides | |
| HY-R03581A | mmu-miR-6929-5p agomir | Oligonucleotides | |
| HY-R03582 | mmu-miR-6930-3p mimic | Oligonucleotides | |
| HY-R03582A | mmu-miR-6930-3p agomir | Oligonucleotides | |
| HY-R03583 | mmu-miR-6930-5p mimic | Oligonucleotides | |
| HY-R03583A | mmu-miR-6930-5p agomir | Oligonucleotides | |
| HY-R03584 | mmu-miR-6931-3p mimic | Oligonucleotides | |
| HY-R03584A | mmu-miR-6931-3p agomir | Oligonucleotides | |
| HY-R03585 | mmu-miR-6931-5p mimic | Oligonucleotides | |
| HY-R03585A | mmu-miR-6931-5p agomir | Oligonucleotides | |
| HY-R03586 | mmu-miR-6932-3p mimic | Oligonucleotides | |
| HY-R03586A | mmu-miR-6932-3p agomir | Oligonucleotides | |
| HY-R03587 | mmu-miR-6932-5p mimic | Oligonucleotides | |
| HY-R03587A | mmu-miR-6932-5p agomir | Oligonucleotides | |
| HY-R03588 | mmu-miR-6933-3p mimic | Oligonucleotides | |
| HY-R03588A | mmu-miR-6933-3p agomir | Oligonucleotides | |
| HY-R03589 | mmu-miR-6933-5p mimic | Oligonucleotides | |
| HY-R03589A | mmu-miR-6933-5p agomir | Oligonucleotides | |
| HY-R03590 | mmu-miR-693-3p mimic | Oligonucleotides | |
| HY-R03590A | mmu-miR-693-3p agomir | Oligonucleotides | |
| HY-R03591 | mmu-miR-6934-3p mimic | Oligonucleotides | |
| HY-R03591A | mmu-miR-6934-3p agomir | Oligonucleotides | |
| HY-R03592 | mmu-miR-6934-5p mimic | Oligonucleotides | |
| HY-R03592A | mmu-miR-6934-5p agomir | Oligonucleotides | |
| HY-R03593 | mmu-miR-6935-3p mimic | Oligonucleotides | |
| HY-R03593A | mmu-miR-6935-3p agomir | Oligonucleotides | |
| HY-R03594 | mmu-miR-6935-5p mimic | Oligonucleotides | |
| HY-R03594A | mmu-miR-6935-5p agomir | Oligonucleotides | |
| HY-R03595 | mmu-miR-693-5p mimic | Oligonucleotides | |
| HY-R03595A | mmu-miR-693-5p agomir | Oligonucleotides | |
| HY-R03596 | mmu-miR-6936-3p mimic | Oligonucleotides | |
| HY-R03596A | mmu-miR-6936-3p agomir | Oligonucleotides | |
| HY-R03597 | mmu-miR-6936-5p mimic | Oligonucleotides | |
| HY-R03597A | mmu-miR-6936-5p agomir | Oligonucleotides | |
| HY-R03598 | mmu-miR-6937-3p mimic | Oligonucleotides | |
| HY-R03598A | mmu-miR-6937-3p agomir | Oligonucleotides | |
| HY-R03599 | mmu-miR-6937-5p mimic | Oligonucleotides | |
| HY-R03599A | mmu-miR-6937-5p agomir | Oligonucleotides | |
| HY-R03600 | mmu-miR-6938-3p mimic | Oligonucleotides | |
| HY-R03600A | mmu-miR-6938-3p agomir | Oligonucleotides | |
| HY-R03601 | mmu-miR-6938-5p mimic | Oligonucleotides | |
| HY-R03601A | mmu-miR-6938-5p agomir | Oligonucleotides | |
| HY-R03602 | mmu-miR-6939-3p mimic | Oligonucleotides | |
| HY-R03602A | mmu-miR-6939-3p agomir | Oligonucleotides | |
| HY-R03603 | mmu-miR-6939-5p mimic | Oligonucleotides | |
| HY-R03603A | mmu-miR-6939-5p agomir | Oligonucleotides | |
| HY-R03604 | mmu-miR-694 mimic | Oligonucleotides | |
| HY-R03604A | mmu-miR-694 agomir | Oligonucleotides | |
| HY-R03605 | mmu-miR-6940-3p mimic | Oligonucleotides | |
| HY-R03605A | mmu-miR-6940-3p agomir | Oligonucleotides | |
| HY-R03606 | mmu-miR-6940-5p mimic | Oligonucleotides | |
| HY-R03606A | mmu-miR-6940-5p agomir | Oligonucleotides | |
| HY-R03607 | mmu-miR-6941-3p mimic | Oligonucleotides | |
| HY-R03607A | mmu-miR-6941-3p agomir | Oligonucleotides | |
| HY-R03608 | mmu-miR-6941-5p mimic | Oligonucleotides | |
| HY-R03608A | mmu-miR-6941-5p agomir | Oligonucleotides | |
| HY-R03609 | mmu-miR-6942-3p mimic | Oligonucleotides | |
| HY-R03609A | mmu-miR-6942-3p agomir | Oligonucleotides | |
| HY-R03610 | mmu-miR-6942-5p mimic | Oligonucleotides | |
| HY-R03610A | mmu-miR-6942-5p agomir | Oligonucleotides | |
| HY-R03611 | mmu-miR-6943-3p mimic | Oligonucleotides | |
| HY-R03611A | mmu-miR-6943-3p agomir | Oligonucleotides | |
| HY-R03612 | mmu-miR-6943-5p mimic | Oligonucleotides | |
| HY-R03612A | mmu-miR-6943-5p agomir | Oligonucleotides | |
| HY-R03613 | mmu-miR-6944-3p mimic | Oligonucleotides | |
| HY-R03613A | mmu-miR-6944-3p agomir | Oligonucleotides | |
| HY-R03614 | mmu-miR-6944-5p mimic | Oligonucleotides | |
| HY-R03614A | mmu-miR-6944-5p agomir | Oligonucleotides | |
| HY-R03615 | mmu-miR-6945-3p mimic | Oligonucleotides | |
| HY-R03615A | mmu-miR-6945-3p agomir | Oligonucleotides | |
| HY-R03616 | mmu-miR-6945-5p mimic | Oligonucleotides | |
| HY-R03616A | mmu-miR-6945-5p agomir | Oligonucleotides | |
| HY-R03617 | mmu-miR-6946-3p mimic | Oligonucleotides | |
| HY-R03617A | mmu-miR-6946-3p agomir | Oligonucleotides | |
| HY-R03618 | mmu-miR-6946-5p mimic | Oligonucleotides | |
| HY-R03618A | mmu-miR-6946-5p agomir | Oligonucleotides | |
| HY-R03619 | mmu-miR-6947-3p mimic | Oligonucleotides | |
| HY-R03619A | mmu-miR-6947-3p agomir | Oligonucleotides | |
| HY-R03620 | mmu-miR-6947-5p mimic | Oligonucleotides | |
| HY-R03620A | mmu-miR-6947-5p agomir | Oligonucleotides | |
| HY-R03621 | mmu-miR-6948-3p mimic | Oligonucleotides | |
| HY-R03621A | mmu-miR-6948-3p agomir | Oligonucleotides | |
| HY-R03622 | mmu-miR-6948-5p mimic | Oligonucleotides | |
| HY-R03622A | mmu-miR-6948-5p agomir | Oligonucleotides | |
| HY-R03623 | mmu-miR-6949-3p mimic | Oligonucleotides | |
| HY-R03623A | mmu-miR-6949-3p agomir | Oligonucleotides | |
| HY-R03624 | mmu-miR-6949-5p mimic | Oligonucleotides | |
| HY-R03624A | mmu-miR-6949-5p agomir | Oligonucleotides | |
| HY-R03625 | mmu-miR-695 mimic | Oligonucleotides | |
| HY-R03625A | mmu-miR-695 agomir | Oligonucleotides | |
| HY-R03626 | mmu-miR-6950-3p mimic | Oligonucleotides | |
| HY-R03626A | mmu-miR-6950-3p agomir | Oligonucleotides | |
| HY-R03627 | mmu-miR-6950-5p mimic | Oligonucleotides | |
| HY-R03627A | mmu-miR-6950-5p agomir | Oligonucleotides | |
| HY-R03628 | mmu-miR-6951-3p mimic | Oligonucleotides | |
| HY-R03628A | mmu-miR-6951-3p agomir | Oligonucleotides | |
| HY-R03629 | mmu-miR-6951-5p mimic | Oligonucleotides | |
| HY-R03629A | mmu-miR-6951-5p agomir | Oligonucleotides | |
| HY-R03630 | mmu-miR-6952-3p mimic | Oligonucleotides | |
| HY-R03630A | mmu-miR-6952-3p agomir | Oligonucleotides | |
| HY-R03631 | mmu-miR-6952-5p mimic | Oligonucleotides | |
| HY-R03631A | mmu-miR-6952-5p agomir | Oligonucleotides | |
| HY-R03632 | mmu-miR-6953-3p mimic | Oligonucleotides | |
| HY-R03632A | mmu-miR-6953-3p agomir | Oligonucleotides | |
| HY-R03633 | mmu-miR-6953-5p mimic | Oligonucleotides | |
| HY-R03633A | mmu-miR-6953-5p agomir | Oligonucleotides | |
| HY-R03634 | mmu-miR-6954-3p mimic | Oligonucleotides | |
| HY-R03634A | mmu-miR-6954-3p agomir | Oligonucleotides | |
| HY-R03635 | mmu-miR-6954-5p mimic | Oligonucleotides | |
| HY-R03635A | mmu-miR-6954-5p agomir | Oligonucleotides | |
| HY-R03636 | mmu-miR-6955-3p mimic | Oligonucleotides | |
| HY-R03636A | mmu-miR-6955-3p agomir | Oligonucleotides | |
| HY-R03637 | mmu-miR-6955-5p mimic | Oligonucleotides | |
| HY-R03637A | mmu-miR-6955-5p agomir | Oligonucleotides | |
| HY-R03638 | mmu-miR-6956-3p mimic | Oligonucleotides | |
| HY-R03638A | mmu-miR-6956-3p agomir | Oligonucleotides | |
| HY-R03639 | mmu-miR-6956-5p mimic | Oligonucleotides | |
| HY-R03639A | mmu-miR-6956-5p agomir | Oligonucleotides | |
| HY-R03640 | mmu-miR-6957-3p mimic | Oligonucleotides | |
| HY-R03640A | mmu-miR-6957-3p agomir | Oligonucleotides | |
| HY-R03641 | mmu-miR-6957-5p mimic | Oligonucleotides | |
| HY-R03641A | mmu-miR-6957-5p agomir | Oligonucleotides | |
| HY-R03642 | mmu-miR-6958-3p mimic | Oligonucleotides | |
| HY-R03642A | mmu-miR-6958-3p agomir | Oligonucleotides | |
| HY-R03643 | mmu-miR-6958-5p mimic | Oligonucleotides | |
| HY-R03643A | mmu-miR-6958-5p agomir | Oligonucleotides | |
| HY-R03644 | mmu-miR-6959-3p mimic | Oligonucleotides | |
| HY-R03644A | mmu-miR-6959-3p agomir | Oligonucleotides | |
| HY-R03645 | mmu-miR-6959-5p mimic | Oligonucleotides | |
| HY-R03645A | mmu-miR-6959-5p agomir | Oligonucleotides | |
| HY-R03646 | mmu-miR-696 mimic | Oligonucleotides | |
| HY-R03646A | mmu-miR-696 agomir | Oligonucleotides | |
| HY-R03647 | mmu-miR-6960-3p mimic | Oligonucleotides | |
| HY-R03647A | mmu-miR-6960-3p agomir | Oligonucleotides | |
| HY-R03648 | mmu-miR-6960-5p mimic | Oligonucleotides | |
| HY-R03648A | mmu-miR-6960-5p agomir | Oligonucleotides | |
| HY-R03649 | mmu-miR-6961-3p mimic | Oligonucleotides | |
| HY-R03649A | mmu-miR-6961-3p agomir | Oligonucleotides | |
| HY-R03650 | mmu-miR-6961-5p mimic | Oligonucleotides | |
| HY-R03650A | mmu-miR-6961-5p agomir | Oligonucleotides | |
| HY-R03651 | mmu-miR-6962-3p mimic | Oligonucleotides | |
| HY-R03651A | mmu-miR-6962-3p agomir | Oligonucleotides | |
| HY-R03652 | mmu-miR-6962-5p mimic | Oligonucleotides | |
| HY-R03652A | mmu-miR-6962-5p agomir | Oligonucleotides | |
| HY-R03653 | mmu-miR-6963-3p mimic | Oligonucleotides | |
| HY-R03653A | mmu-miR-6963-3p agomir | Oligonucleotides | |
| HY-R03654 | mmu-miR-6963-5p mimic | Oligonucleotides | |
| HY-R03654A | mmu-miR-6963-5p agomir | Oligonucleotides | |
| HY-R03655 | mmu-miR-6964-3p mimic | Oligonucleotides | |
| HY-R03655A | mmu-miR-6964-3p agomir | Oligonucleotides | |
| HY-R03656 | mmu-miR-6964-5p mimic | Oligonucleotides | |
| HY-R03656A | mmu-miR-6964-5p agomir | Oligonucleotides | |
| HY-R03657 | mmu-miR-6965-3p mimic | Oligonucleotides | |
| HY-R03657A | mmu-miR-6965-3p agomir | Oligonucleotides | |
| HY-R03658 | mmu-miR-6965-5p mimic | Oligonucleotides | |
| HY-R03658A | mmu-miR-6965-5p agomir | Oligonucleotides | |
| HY-R03659 | mmu-miR-6966-3p mimic | Oligonucleotides | |
| HY-R03659A | mmu-miR-6966-3p agomir | Oligonucleotides | |
| HY-R03660 | mmu-miR-6966-5p mimic | Oligonucleotides | |
| HY-R03660A | mmu-miR-6966-5p agomir | Oligonucleotides | |
| HY-R03661 | mmu-miR-6967-3p mimic | Oligonucleotides | |
| HY-R03661A | mmu-miR-6967-3p agomir | Oligonucleotides | |
| HY-R03662 | mmu-miR-6967-5p mimic | Oligonucleotides | |
| HY-R03662A | mmu-miR-6967-5p agomir | Oligonucleotides | |
| HY-R03663 | mmu-miR-6968-3p mimic | Oligonucleotides | |
| HY-R03663A | mmu-miR-6968-3p agomir | Oligonucleotides | |
| HY-R03664 | mmu-miR-6968-5p mimic | Oligonucleotides | |
| HY-R03664A | mmu-miR-6968-5p agomir | Oligonucleotides | |
| HY-R03665 | mmu-miR-6969-3p mimic | Oligonucleotides | |
| HY-R03665A | mmu-miR-6969-3p agomir | Oligonucleotides | |
| HY-R03666 | mmu-miR-6969-5p mimic | Oligonucleotides | |
| HY-R03666A | mmu-miR-6969-5p agomir | Oligonucleotides | |
| HY-R03667 | mmu-miR-697 mimic | Oligonucleotides | |
| HY-R03667A | mmu-miR-697 agomir | Oligonucleotides | |
| HY-R03668 | mmu-miR-6970-3p mimic | Oligonucleotides | |
| HY-R03668A | mmu-miR-6970-3p agomir | Oligonucleotides | |
| HY-R03669 | mmu-miR-6970-5p mimic | Oligonucleotides | |
| HY-R03669A | mmu-miR-6970-5p agomir | Oligonucleotides | |
| HY-R03670 | mmu-miR-6971-3p mimic | Oligonucleotides | |
| HY-R03670A | mmu-miR-6971-3p agomir | Oligonucleotides | |
| HY-R03671 | mmu-miR-6971-5p mimic | Oligonucleotides | |
| HY-R03671A | mmu-miR-6971-5p agomir | Oligonucleotides | |
| HY-R03672 | mmu-miR-6972-3p mimic | Oligonucleotides | |
| HY-R03672A | mmu-miR-6972-3p agomir | Oligonucleotides | |
| HY-R03673 | mmu-miR-6972-5p mimic | Oligonucleotides | |
| HY-R03673A | mmu-miR-6972-5p agomir | Oligonucleotides | |
| HY-R03674 | mmu-miR-6973a-3p mimic | Oligonucleotides | |
| HY-R03674A | mmu-miR-6973a-3p agomir | Oligonucleotides | |
| HY-R03675 | mmu-miR-6973a-5p mimic | Oligonucleotides | |
| HY-R03675A | mmu-miR-6973a-5p agomir | Oligonucleotides | |
| HY-R03676 | mmu-miR-6973b-3p mimic | Oligonucleotides | |
| HY-R03676A | mmu-miR-6973b-3p agomir | Oligonucleotides | |
| HY-R03677 | mmu-miR-6973b-5p mimic | Oligonucleotides | |
| HY-R03677A | mmu-miR-6973b-5p agomir | Oligonucleotides | |
| HY-R03678 | mmu-miR-6974-3p mimic | Oligonucleotides | |
| HY-R03678A | mmu-miR-6974-3p agomir | Oligonucleotides | |
| HY-R03679 | mmu-miR-6974-5p mimic | Oligonucleotides | |
| HY-R03679A | mmu-miR-6974-5p agomir | Oligonucleotides | |
| HY-R03680 | mmu-miR-6975-3p mimic | Oligonucleotides | |
| HY-R03680A | mmu-miR-6975-3p agomir | Oligonucleotides | |
| HY-R03681 | mmu-miR-6975-5p mimic | Oligonucleotides | |
| HY-R03681A | mmu-miR-6975-5p agomir | Oligonucleotides | |
| HY-R03682 | mmu-miR-6976-3p mimic | Oligonucleotides | |
| HY-R03682A | mmu-miR-6976-3p agomir | Oligonucleotides | |
| HY-R03683 | mmu-miR-6976-5p mimic | Oligonucleotides | |
| HY-R03683A | mmu-miR-6976-5p agomir | Oligonucleotides | |
| HY-R03684 | mmu-miR-6977-3p mimic | Oligonucleotides | |
| HY-R03684A | mmu-miR-6977-3p agomir | Oligonucleotides | |
| HY-R03685 | mmu-miR-6977-5p mimic | Oligonucleotides | |
| HY-R03685A | mmu-miR-6977-5p agomir | Oligonucleotides | |
| HY-R03686 | mmu-miR-6978-3p mimic | Oligonucleotides | |
| HY-R03686A | mmu-miR-6978-3p agomir | Oligonucleotides | |
| HY-R03687 | mmu-miR-6978-5p mimic | Oligonucleotides | |
| HY-R03687A | mmu-miR-6978-5p agomir | Oligonucleotides | |
| HY-R03688 | mmu-miR-6979-3p mimic | Oligonucleotides | |
| HY-R03688A | mmu-miR-6979-3p agomir | Oligonucleotides | |
| HY-R03689 | mmu-miR-6979-5p mimic | Oligonucleotides | |
| HY-R03689A | mmu-miR-6979-5p agomir | Oligonucleotides | |
| HY-R03690 | mmu-miR-6980-3p mimic | Oligonucleotides | |
| HY-R03690A | mmu-miR-6980-3p agomir | Oligonucleotides | |
| HY-R03691 | mmu-miR-6980-5p mimic | Oligonucleotides | |
| HY-R03691A | mmu-miR-6980-5p agomir | Oligonucleotides | |
| HY-R03692 | mmu-miR-6981-3p mimic | Oligonucleotides | |
| HY-R03692A | mmu-miR-6981-3p agomir | Oligonucleotides | |
| HY-R03693 | mmu-miR-6981-5p mimic | Oligonucleotides | |
| HY-R03693A | mmu-miR-6981-5p agomir | Oligonucleotides | |
| HY-R03694 | mmu-miR-6982-3p mimic | Oligonucleotides | |
| HY-R03694A | mmu-miR-6982-3p agomir | Oligonucleotides | |
| HY-R03695 | mmu-miR-6982-5p mimic | Oligonucleotides | |
| HY-R03695A | mmu-miR-6982-5p agomir | Oligonucleotides | |
| HY-R03696 | mmu-miR-6983-3p mimic | Oligonucleotides | |
| HY-R03696A | mmu-miR-6983-3p agomir | Oligonucleotides | |
| HY-R03697 | mmu-miR-6983-5p mimic | Oligonucleotides | |
| HY-R03697A | mmu-miR-6983-5p agomir | Oligonucleotides | |
| HY-R03698 | mmu-miR-698-3p mimic | Oligonucleotides | |
| HY-R03698A | mmu-miR-698-3p agomir | Oligonucleotides | |
| HY-R03699 | mmu-miR-6984-3p mimic | Oligonucleotides | |
| HY-R03699A | mmu-miR-6984-3p agomir | Oligonucleotides | |
| HY-R03700 | mmu-miR-6984-5p mimic | Oligonucleotides | |
| HY-R03700A | mmu-miR-6984-5p agomir | Oligonucleotides | |
| HY-R03701 | mmu-miR-6985-3p mimic | Oligonucleotides | |
| HY-R03701A | mmu-miR-6985-3p agomir | Oligonucleotides | |
| HY-R03702 | mmu-miR-6985-5p mimic | Oligonucleotides | |
| HY-R03702A | mmu-miR-6985-5p agomir | Oligonucleotides | |
| HY-R03703 | mmu-miR-698-5p mimic | Oligonucleotides | |
| HY-R03703A | mmu-miR-698-5p agomir | Oligonucleotides | |
| HY-R03704 | mmu-miR-6986-3p mimic | Oligonucleotides | |
| HY-R03704A | mmu-miR-6986-3p agomir | Oligonucleotides | |
| HY-R03705 | mmu-miR-6986-5p mimic | Oligonucleotides | |
| HY-R03705A | mmu-miR-6986-5p agomir | Oligonucleotides | |
| HY-R03706 | mmu-miR-6987-3p mimic | Oligonucleotides | |
| HY-R03706A | mmu-miR-6987-3p agomir | Oligonucleotides | |
| HY-R03707 | mmu-miR-6987-5p mimic | Oligonucleotides | |
| HY-R03707A | mmu-miR-6987-5p agomir | Oligonucleotides | |
| HY-R03708 | mmu-miR-6988-3p mimic | Oligonucleotides | |
| HY-R03708A | mmu-miR-6988-3p agomir | Oligonucleotides | |
| HY-R03709 | mmu-miR-6988-5p mimic | Oligonucleotides | |
| HY-R03709A | mmu-miR-6988-5p agomir | Oligonucleotides | |
| HY-R03710 | mmu-miR-6989-3p mimic | Oligonucleotides | |
| HY-R03710A | mmu-miR-6989-3p agomir | Oligonucleotides | |
| HY-R03711 | mmu-miR-6989-5p mimic | Oligonucleotides | |
| HY-R03711A | mmu-miR-6989-5p agomir | Oligonucleotides | |
| HY-R03712 | mmu-miR-6990-3p mimic | Oligonucleotides | |
| HY-R03712A | mmu-miR-6990-3p agomir | Oligonucleotides | |
| HY-R03713 | mmu-miR-6990-5p mimic | Oligonucleotides | |
| HY-R03713A | mmu-miR-6990-5p agomir | Oligonucleotides | |
| HY-R03714 | mmu-miR-6991-3p mimic | Oligonucleotides | |
| HY-R03714A | mmu-miR-6991-3p agomir | Oligonucleotides | |
| HY-R03715 | mmu-miR-6991-5p mimic | Oligonucleotides | |
| HY-R03715A | mmu-miR-6991-5p agomir | Oligonucleotides | |
| HY-R03716 | mmu-miR-6992-3p mimic | Oligonucleotides | |
| HY-R03716A | mmu-miR-6992-3p agomir | Oligonucleotides | |
| HY-R03717 | mmu-miR-6992-5p mimic | Oligonucleotides | |
| HY-R03717A | mmu-miR-6992-5p agomir | Oligonucleotides | |
| HY-R03718 | mmu-miR-6993-3p mimic | Oligonucleotides | |
| HY-R03718A | mmu-miR-6993-3p agomir | Oligonucleotides | |
| HY-R03719 | mmu-miR-6993-5p mimic | Oligonucleotides | |
| HY-R03719A | mmu-miR-6993-5p agomir | Oligonucleotides | |
| HY-R03720 | mmu-miR-6994-3p mimic | Oligonucleotides | |
| HY-R03720A | mmu-miR-6994-3p agomir | Oligonucleotides | |
| HY-R03721 | mmu-miR-6994-5p mimic | Oligonucleotides | |
| HY-R03721A | mmu-miR-6994-5p agomir | Oligonucleotides | |
| HY-R03722 | mmu-miR-6995-3p mimic | Oligonucleotides | |
| HY-R03722A | mmu-miR-6995-3p agomir | Oligonucleotides | |
| HY-R03723 | mmu-miR-6995-5p mimic | Oligonucleotides | |
| HY-R03723A | mmu-miR-6995-5p agomir | Oligonucleotides | |
| HY-R03724 | mmu-miR-6996-3p mimic | Oligonucleotides | |
| HY-R03724A | mmu-miR-6996-3p agomir | Oligonucleotides | |
| HY-R03725 | mmu-miR-6996-5p mimic | Oligonucleotides | |
| HY-R03725A | mmu-miR-6996-5p agomir | Oligonucleotides | |
| HY-R03726 | mmu-miR-6997-3p mimic | Oligonucleotides | |
| HY-R03726A | mmu-miR-6997-3p agomir | Oligonucleotides | |
| HY-R03727 | mmu-miR-6997-5p mimic | Oligonucleotides | |
| HY-R03727A | mmu-miR-6997-5p agomir | Oligonucleotides | |
| HY-R03728 | mmu-miR-6998-3p mimic | Oligonucleotides | |
| HY-R03728A | mmu-miR-6998-3p agomir | Oligonucleotides | |
| HY-R03729 | mmu-miR-6998-5p mimic | Oligonucleotides | |
| HY-R03729A | mmu-miR-6998-5p agomir | Oligonucleotides | |
| HY-R03730 | mmu-miR-6999-3p mimic | Oligonucleotides | |
| HY-R03730A | mmu-miR-6999-3p agomir | Oligonucleotides | |
| HY-R03731 | mmu-miR-6999-5p mimic | Oligonucleotides | |
| HY-R03731A | mmu-miR-6999-5p agomir | Oligonucleotides | |
| HY-R03732 | mmu-miR-7000-3p mimic | Oligonucleotides | |
| HY-R03732A | mmu-miR-7000-3p agomir | Oligonucleotides | |
| HY-R03733 | mmu-miR-7000-5p mimic | Oligonucleotides | |
| HY-R03733A | mmu-miR-7000-5p agomir | Oligonucleotides | |
| HY-R03734 | mmu-miR-7001-3p mimic | Oligonucleotides | |
| HY-R03734A | mmu-miR-7001-3p agomir | Oligonucleotides | |
| HY-R03735 | mmu-miR-7001-5p mimic | Oligonucleotides | |
| HY-R03735A | mmu-miR-7001-5p agomir | Oligonucleotides | |
| HY-R03736 | mmu-miR-7002-3p mimic | Oligonucleotides | |
| HY-R03736A | mmu-miR-7002-3p agomir | Oligonucleotides | |
| HY-R03737 | mmu-miR-7002-5p mimic | Oligonucleotides | |
| HY-R03737A | mmu-miR-7002-5p agomir | Oligonucleotides | |
| HY-R03738 | mmu-miR-7003-3p mimic | Oligonucleotides | |
| HY-R03738A | mmu-miR-7003-3p agomir | Oligonucleotides | |
| HY-R03739 | mmu-miR-7003-5p mimic | Oligonucleotides | |
| HY-R03739A | mmu-miR-7003-5p agomir | Oligonucleotides | |
| HY-R03740 | mmu-miR-700-3p mimic | Oligonucleotides | |
| HY-R03740A | mmu-miR-700-3p agomir | Oligonucleotides | |
| HY-R03741 | mmu-miR-7004-3p mimic | Oligonucleotides | |
| HY-R03741A | mmu-miR-7004-3p agomir | Oligonucleotides | |
| HY-R03742 | mmu-miR-7004-5p mimic | Oligonucleotides | |
| HY-R03742A | mmu-miR-7004-5p agomir | Oligonucleotides | |
| HY-R03743 | mmu-miR-7005-3p mimic | Oligonucleotides | |
| HY-R03743A | mmu-miR-7005-3p agomir | Oligonucleotides | |
| HY-R03744 | mmu-miR-7005-5p mimic | Oligonucleotides | |
| HY-R03744A | mmu-miR-7005-5p agomir | Oligonucleotides | |
| HY-R03745 | mmu-miR-700-5p mimic | Oligonucleotides | |
| HY-R03745A | mmu-miR-700-5p agomir | Oligonucleotides | |
| HY-R03746 | mmu-miR-7006-3p mimic | Oligonucleotides | |
| HY-R03746A | mmu-miR-7006-3p agomir | Oligonucleotides | |
| HY-R03747 | mmu-miR-7006-5p mimic | Oligonucleotides | |
| HY-R03747A | mmu-miR-7006-5p agomir | Oligonucleotides | |
| HY-R03748 | mmu-miR-7007-3p mimic | Oligonucleotides | |
| HY-R03748A | mmu-miR-7007-3p agomir | Oligonucleotides | |
| HY-R03749 | mmu-miR-7007-5p mimic | Oligonucleotides | |
| HY-R03749A | mmu-miR-7007-5p agomir | Oligonucleotides | |
| HY-R03750 | mmu-miR-7008-3p mimic | Oligonucleotides | |
| HY-R03750A | mmu-miR-7008-3p agomir | Oligonucleotides | |
| HY-R03751 | mmu-miR-7008-5p mimic | Oligonucleotides | |
| HY-R03751A | mmu-miR-7008-5p agomir | Oligonucleotides | |
| HY-R03752 | mmu-miR-7009-3p mimic | Oligonucleotides | |
| HY-R03752A | mmu-miR-7009-3p agomir | Oligonucleotides | |
| HY-R03753 | mmu-miR-7009-5p mimic | Oligonucleotides | |
| HY-R03753A | mmu-miR-7009-5p agomir | Oligonucleotides | |
| HY-R03754 | mmu-miR-7010-3p mimic | Oligonucleotides | |
| HY-R03754A | mmu-miR-7010-3p agomir | Oligonucleotides | |
| HY-R03755 | mmu-miR-7010-5p mimic | Oligonucleotides | |
| HY-R03755A | mmu-miR-7010-5p agomir | Oligonucleotides | |
| HY-R03756 | mmu-miR-7011-3p mimic | Oligonucleotides | |
| HY-R03756A | mmu-miR-7011-3p agomir | Oligonucleotides | |
| HY-R03757 | mmu-miR-7011-5p mimic | Oligonucleotides | |
| HY-R03757A | mmu-miR-7011-5p agomir | Oligonucleotides | |
| HY-R03758 | mmu-miR-7012-3p mimic | Oligonucleotides | |
| HY-R03758A | mmu-miR-7012-3p agomir | Oligonucleotides | |
| HY-R03759 | mmu-miR-7012-5p mimic | Oligonucleotides | |
| HY-R03759A | mmu-miR-7012-5p agomir | Oligonucleotides | |
| HY-R03760 | mmu-miR-7013-3p mimic | Oligonucleotides | |
| HY-R03760A | mmu-miR-7013-3p agomir | Oligonucleotides | |
| HY-R03761 | mmu-miR-7013-5p mimic | Oligonucleotides | |
| HY-R03761A | mmu-miR-7013-5p agomir | Oligonucleotides | |
| HY-R03762 | mmu-miR-701-3p mimic | Oligonucleotides | |
| HY-R03762A | mmu-miR-701-3p agomir | Oligonucleotides | |
| HY-R03763 | mmu-miR-7014-3p mimic | Oligonucleotides | |
| HY-R03763A | mmu-miR-7014-3p agomir | Oligonucleotides | |
| HY-R03764 | mmu-miR-7014-5p mimic | Oligonucleotides | |
| HY-R03764A | mmu-miR-7014-5p agomir | Oligonucleotides | |
| HY-R03765 | mmu-miR-7015-3p mimic | Oligonucleotides | |
| HY-R03765A | mmu-miR-7015-3p agomir | Oligonucleotides | |
| HY-R03766 | mmu-miR-7015-5p mimic | Oligonucleotides | |
| HY-R03766A | mmu-miR-7015-5p agomir | Oligonucleotides | |
| HY-R03767 | mmu-miR-701-5p mimic | Oligonucleotides | |
| HY-R03767A | mmu-miR-701-5p agomir | Oligonucleotides | |
| HY-R03768 | mmu-miR-7016-3p mimic | Oligonucleotides | |
| HY-R03768A | mmu-miR-7016-3p agomir | Oligonucleotides | |
| HY-R03769 | mmu-miR-7016-5p mimic | Oligonucleotides | |
| HY-R03769A | mmu-miR-7016-5p agomir | Oligonucleotides | |
| HY-R03770 | mmu-miR-7017-3p mimic | Oligonucleotides | |
| HY-R03770A | mmu-miR-7017-3p agomir | Oligonucleotides | |
| HY-R03771 | mmu-miR-7017-5p mimic | Oligonucleotides | |
| HY-R03771A | mmu-miR-7017-5p agomir | Oligonucleotides | |
| HY-R03772 | mmu-miR-7018-3p mimic | Oligonucleotides | |
| HY-R03772A | mmu-miR-7018-3p agomir | Oligonucleotides | |
| HY-R03773 | mmu-miR-7018-5p mimic | Oligonucleotides | |
| HY-R03773A | mmu-miR-7018-5p agomir | Oligonucleotides | |
| HY-R03774 | mmu-miR-7019-3p mimic | Oligonucleotides | |
| HY-R03774A | mmu-miR-7019-3p agomir | Oligonucleotides | |
| HY-R03775 | mmu-miR-7019-5p mimic | Oligonucleotides | |
| HY-R03775A | mmu-miR-7019-5p agomir | Oligonucleotides | |
| HY-R03776 | mmu-miR-7020-3p mimic | Oligonucleotides | |
| HY-R03776A | mmu-miR-7020-3p agomir | Oligonucleotides | |
| HY-R03777 | mmu-miR-7020-5p mimic | Oligonucleotides | |
| HY-R03777A | mmu-miR-7020-5p agomir | Oligonucleotides | |
| HY-R03778 | mmu-miR-7021-3p mimic | Oligonucleotides | |
| HY-R03778A | mmu-miR-7021-3p agomir | Oligonucleotides | |
| HY-R03779 | mmu-miR-7021-5p mimic | Oligonucleotides | |
| HY-R03779A | mmu-miR-7021-5p agomir | Oligonucleotides | |
| HY-R03780 | mmu-miR-7022-3p mimic | Oligonucleotides | |
| HY-R03780A | mmu-miR-7022-3p agomir | Oligonucleotides | |
| HY-R03781 | mmu-miR-7022-5p mimic | Oligonucleotides | |
| HY-R03781A | mmu-miR-7022-5p agomir | Oligonucleotides | |
| HY-R03782 | mmu-miR-7023-3p mimic | Oligonucleotides | |
| HY-R03782A | mmu-miR-7023-3p agomir | Oligonucleotides | |
| HY-R03783 | mmu-miR-7023-5p mimic | Oligonucleotides | |
| HY-R03783A | mmu-miR-7023-5p agomir | Oligonucleotides | |
| HY-R03784 | mmu-miR-702-3p mimic | Oligonucleotides | |
| HY-R03784A | mmu-miR-702-3p agomir | Oligonucleotides | |
| HY-R03785 | mmu-miR-7024-3p mimic | Oligonucleotides | |
| HY-R03785A | mmu-miR-7024-3p agomir | Oligonucleotides | |
| HY-R03786 | mmu-miR-7024-5p mimic | Oligonucleotides | |
| HY-R03786A | mmu-miR-7024-5p agomir | Oligonucleotides | |
| HY-R03787 | mmu-miR-7025-3p mimic | Oligonucleotides | |
| HY-R03787A | mmu-miR-7025-3p agomir | Oligonucleotides | |
| HY-R03788 | mmu-miR-7025-5p mimic | Oligonucleotides | |
| HY-R03788A | mmu-miR-7025-5p agomir | Oligonucleotides | |
| HY-R03789 | mmu-miR-702-5p mimic | Oligonucleotides | |
| HY-R03789A | mmu-miR-702-5p agomir | Oligonucleotides | |
| HY-R03790 | mmu-miR-7026-3p mimic | Oligonucleotides | |
| HY-R03790A | mmu-miR-7026-3p agomir | Oligonucleotides | |
| HY-R03791 | mmu-miR-7026-5p mimic | Oligonucleotides | |
| HY-R03791A | mmu-miR-7026-5p agomir | Oligonucleotides | |
| HY-R03792 | mmu-miR-7027-3p mimic | Oligonucleotides | |
| HY-R03792A | mmu-miR-7027-3p agomir | Oligonucleotides | |
| HY-R03793 | mmu-miR-7027-5p mimic | Oligonucleotides | |
| HY-R03793A | mmu-miR-7027-5p agomir | Oligonucleotides | |
| HY-R03794 | mmu-miR-7028-3p mimic | Oligonucleotides | |
| HY-R03794A | mmu-miR-7028-3p agomir | Oligonucleotides | |
| HY-R03795 | mmu-miR-7028-5p mimic | Oligonucleotides | |
| HY-R03795A | mmu-miR-7028-5p agomir | Oligonucleotides | |
| HY-R03796 | mmu-miR-7029-3p mimic | Oligonucleotides | |
| HY-R03796A | mmu-miR-7029-3p agomir | Oligonucleotides | |
| HY-R03797 | mmu-miR-7029-5p mimic | Oligonucleotides | |
| HY-R03797A | mmu-miR-7029-5p agomir | Oligonucleotides | |
| HY-R03798 | mmu-miR-703 mimic | Oligonucleotides | |
| HY-R03798A | mmu-miR-703 agomir | Oligonucleotides | |
| HY-R03799 | mmu-miR-7030-3p mimic | Oligonucleotides | |
| HY-R03799A | mmu-miR-7030-3p agomir | Oligonucleotides | |
| HY-R03800 | mmu-miR-7030-5p mimic | Oligonucleotides | |
| HY-R03800A | mmu-miR-7030-5p agomir | Oligonucleotides | |
| HY-R03801 | mmu-miR-7031-3p mimic | Oligonucleotides | |
| HY-R03801A | mmu-miR-7031-3p agomir | Oligonucleotides | |
| HY-R03802 | mmu-miR-7031-5p mimic | Oligonucleotides | |
| HY-R03802A | mmu-miR-7031-5p agomir | Oligonucleotides | |
| HY-R03803 | mmu-miR-7032-3p mimic | Oligonucleotides | |
| HY-R03803A | mmu-miR-7032-3p agomir | Oligonucleotides | |
| HY-R03804 | mmu-miR-7032-5p mimic | Oligonucleotides | |
| HY-R03804A | mmu-miR-7032-5p agomir | Oligonucleotides | |
| HY-R03805 | mmu-miR-7033-3p mimic | Oligonucleotides | |
| HY-R03805A | mmu-miR-7033-3p agomir | Oligonucleotides | |
| HY-R03806 | mmu-miR-7033-5p mimic | Oligonucleotides | |
| HY-R03806A | mmu-miR-7033-5p agomir | Oligonucleotides | |
| HY-R03807 | mmu-miR-7034-3p mimic | Oligonucleotides | |
| HY-R03807A | mmu-miR-7034-3p agomir | Oligonucleotides | |
| HY-R03808 | mmu-miR-7034-5p mimic | Oligonucleotides | |
| HY-R03808A | mmu-miR-7034-5p agomir | Oligonucleotides | |
| HY-R03809 | mmu-miR-7035-3p mimic | Oligonucleotides | |
| HY-R03809A | mmu-miR-7035-3p agomir | Oligonucleotides | |
| HY-R03810 | mmu-miR-7035-5p mimic | Oligonucleotides | |
| HY-R03810A | mmu-miR-7035-5p agomir | Oligonucleotides | |
| HY-R03811 | mmu-miR-7036a-3p mimic | Oligonucleotides | |
| HY-R03811A | mmu-miR-7036a-3p agomir | Oligonucleotides | |
| HY-R03812 | mmu-miR-7036a-5p mimic | Oligonucleotides | |
| HY-R03812A | mmu-miR-7036a-5p agomir | Oligonucleotides | |
| HY-R03813 | mmu-miR-7036b-3p mimic | Oligonucleotides | |
| HY-R03813A | mmu-miR-7036b-3p agomir | Oligonucleotides | |
| HY-R03814 | mmu-miR-7036b-5p mimic | Oligonucleotides | |
| HY-R03814A | mmu-miR-7036b-5p agomir | Oligonucleotides | |
| HY-R03815 | mmu-miR-7037-3p mimic | Oligonucleotides | |
| HY-R03815A | mmu-miR-7037-3p agomir | Oligonucleotides | |
| HY-R03816 | mmu-miR-7037-5p mimic | Oligonucleotides | |
| HY-R03816A | mmu-miR-7037-5p agomir | Oligonucleotides | |
| HY-R03817 | mmu-miR-7038-3p mimic | Oligonucleotides | |
| HY-R03817A | mmu-miR-7038-3p agomir | Oligonucleotides | |
| HY-R03818 | mmu-miR-7038-5p mimic | Oligonucleotides | |
| HY-R03818A | mmu-miR-7038-5p agomir | Oligonucleotides | |
| HY-R03819 | mmu-miR-7039-3p mimic | Oligonucleotides | |
| HY-R03819A | mmu-miR-7039-3p agomir | Oligonucleotides | |
| HY-R03820 | mmu-miR-7039-5p mimic | Oligonucleotides | |
| HY-R03820A | mmu-miR-7039-5p agomir | Oligonucleotides | |
| HY-R03821 | mmu-miR-704 mimic | Oligonucleotides | |
| HY-R03821A | mmu-miR-704 agomir | Oligonucleotides | |
| HY-R03822 | mmu-miR-7040-3p mimic | Oligonucleotides | |
| HY-R03822A | mmu-miR-7040-3p agomir | Oligonucleotides | |
| HY-R03823 | mmu-miR-7040-5p mimic | Oligonucleotides | |
| HY-R03823A | mmu-miR-7040-5p agomir | Oligonucleotides | |
| HY-R03824 | mmu-miR-7041-3p mimic | Oligonucleotides | |
| HY-R03824A | mmu-miR-7041-3p agomir | Oligonucleotides | |
| HY-R03825 | mmu-miR-7041-5p mimic | Oligonucleotides | |
| HY-R03825A | mmu-miR-7041-5p agomir | Oligonucleotides | |
| HY-R03826 | mmu-miR-7042-3p mimic | Oligonucleotides | |
| HY-R03826A | mmu-miR-7042-3p agomir | Oligonucleotides | |
| HY-R03827 | mmu-miR-7042-5p mimic | Oligonucleotides | |
| HY-R03827A | mmu-miR-7042-5p agomir | Oligonucleotides | |
| HY-R03828 | mmu-miR-7043-3p mimic | Oligonucleotides | |
| HY-R03828A | mmu-miR-7043-3p agomir | Oligonucleotides | |
| HY-R03829 | mmu-miR-7043-5p mimic | Oligonucleotides | |
| HY-R03829A | mmu-miR-7043-5p agomir | Oligonucleotides | |
| HY-R03830 | mmu-miR-7044-3p mimic | Oligonucleotides | |
| HY-R03830A | mmu-miR-7044-3p agomir | Oligonucleotides | |
| HY-R03831 | mmu-miR-7044-5p mimic | Oligonucleotides | |
| HY-R03831A | mmu-miR-7044-5p agomir | Oligonucleotides | |
| HY-R03832 | mmu-miR-7045-3p mimic | Oligonucleotides | |
| HY-R03832A | mmu-miR-7045-3p agomir | Oligonucleotides | |
| HY-R03833 | mmu-miR-7045-5p mimic | Oligonucleotides | |
| HY-R03833A | mmu-miR-7045-5p agomir | Oligonucleotides | |
| HY-R03834 | mmu-miR-7046-3p mimic | Oligonucleotides | |
| HY-R03834A | mmu-miR-7046-3p agomir | Oligonucleotides | |
| HY-R03835 | mmu-miR-7046-5p mimic | Oligonucleotides | |
| HY-R03835A | mmu-miR-7046-5p agomir | Oligonucleotides | |
| HY-R03836 | mmu-miR-7047-3p mimic | Oligonucleotides | |
| HY-R03836A | mmu-miR-7047-3p agomir | Oligonucleotides | |
| HY-R03837 | mmu-miR-7047-5p mimic | Oligonucleotides | |
| HY-R03837A | mmu-miR-7047-5p agomir | Oligonucleotides | |
| HY-R03838 | mmu-miR-7048-3p mimic | Oligonucleotides | |
| HY-R03838A | mmu-miR-7048-3p agomir | Oligonucleotides | |
| HY-R03839 | mmu-miR-7048-5p mimic | Oligonucleotides | |
| HY-R03839A | mmu-miR-7048-5p agomir | Oligonucleotides | |
| HY-R03840 | mmu-miR-7049-3p mimic | Oligonucleotides | |
| HY-R03840A | mmu-miR-7049-3p agomir | Oligonucleotides | |
| HY-R03841 | mmu-miR-7049-5p mimic | Oligonucleotides | |
| HY-R03841A | mmu-miR-7049-5p agomir | Oligonucleotides | |
| HY-R03842 | mmu-miR-705 mimic | Oligonucleotides | |
| HY-R03842A | mmu-miR-705 agomir | Oligonucleotides | |
| HY-R03843 | mmu-miR-7050-3p mimic | Oligonucleotides | |
| HY-R03843A | mmu-miR-7050-3p agomir | Oligonucleotides | |
| HY-R03844 | mmu-miR-7050-5p mimic | Oligonucleotides | |
| HY-R03844A | mmu-miR-7050-5p agomir | Oligonucleotides | |
| HY-R03845 | mmu-miR-7051-3p mimic | Oligonucleotides | |
| HY-R03845A | mmu-miR-7051-3p agomir | Oligonucleotides | |
| HY-R03846 | mmu-miR-7051-5p mimic | Oligonucleotides | |
| HY-R03846A | mmu-miR-7051-5p agomir | Oligonucleotides | |
| HY-R03847 | mmu-miR-7052-3p mimic | Oligonucleotides | |
| HY-R03847A | mmu-miR-7052-3p agomir | Oligonucleotides | |
| HY-R03848 | mmu-miR-7052-5p mimic | Oligonucleotides | |
| HY-R03848A | mmu-miR-7052-5p agomir | Oligonucleotides | |
| HY-R03849 | mmu-miR-7053-3p mimic | Oligonucleotides | |
| HY-R03849A | mmu-miR-7053-3p agomir | Oligonucleotides | |
| HY-R03850 | mmu-miR-7053-5p mimic | Oligonucleotides | |
| HY-R03850A | mmu-miR-7053-5p agomir | Oligonucleotides | |
| HY-R03851 | mmu-miR-7054-3p mimic | Oligonucleotides | |
| HY-R03851A | mmu-miR-7054-3p agomir | Oligonucleotides | |
| HY-R03852 | mmu-miR-7054-5p mimic | Oligonucleotides | |
| HY-R03852A | mmu-miR-7054-5p agomir | Oligonucleotides | |
| HY-R03853 | mmu-miR-7055-3p mimic | Oligonucleotides | |
| HY-R03853A | mmu-miR-7055-3p agomir | Oligonucleotides | |
| HY-R03854 | mmu-miR-7055-5p mimic | Oligonucleotides | |
| HY-R03854A | mmu-miR-7055-5p agomir | Oligonucleotides | |
| HY-R03855 | mmu-miR-7056-3p mimic | Oligonucleotides | |
| HY-R03855A | mmu-miR-7056-3p agomir | Oligonucleotides | |
| HY-R03856 | mmu-miR-7056-5p mimic | Oligonucleotides | |
| HY-R03856A | mmu-miR-7056-5p agomir | Oligonucleotides | |
| HY-R03857 | mmu-miR-7057-3p mimic | Oligonucleotides | |
| HY-R03857A | mmu-miR-7057-3p agomir | Oligonucleotides | |
| HY-R03858 | mmu-miR-7057-5p mimic | Oligonucleotides | |
| HY-R03858A | mmu-miR-7057-5p agomir | Oligonucleotides | |
| HY-R03859 | mmu-miR-7058-3p mimic | Oligonucleotides | |
| HY-R03859A | mmu-miR-7058-3p agomir | Oligonucleotides | |
| HY-R03860 | mmu-miR-7058-5p mimic | Oligonucleotides | |
| HY-R03860A | mmu-miR-7058-5p agomir | Oligonucleotides | |
| HY-R03861 | mmu-miR-7059-3p mimic | Oligonucleotides | |
| HY-R03861A | mmu-miR-7059-3p agomir | Oligonucleotides | |
| HY-R03862 | mmu-miR-7059-5p mimic | Oligonucleotides | |
| HY-R03862A | mmu-miR-7059-5p agomir | Oligonucleotides | |
| HY-R03863 | mmu-miR-706 mimic | Oligonucleotides | |
| HY-R03863A | mmu-miR-706 agomir | Oligonucleotides | |
| HY-R03864 | mmu-miR-7060-3p mimic | Oligonucleotides | |
| HY-R03864A | mmu-miR-7060-3p agomir | Oligonucleotides | |
| HY-R03865 | mmu-miR-7060-5p mimic | Oligonucleotides | |
| HY-R03865A | mmu-miR-7060-5p agomir | Oligonucleotides | |
| HY-R03866 | mmu-miR-7061-3p mimic | Oligonucleotides | |
| HY-R03866A | mmu-miR-7061-3p agomir | Oligonucleotides | |
| HY-R03867 | mmu-miR-7061-5p mimic | Oligonucleotides | |
| HY-R03867A | mmu-miR-7061-5p agomir | Oligonucleotides | |
| HY-R03868 | mmu-miR-7062-3p mimic | Oligonucleotides | |
| HY-R03868A | mmu-miR-7062-3p agomir | Oligonucleotides | |
| HY-R03869 | mmu-miR-7062-5p mimic | Oligonucleotides | |
| HY-R03869A | mmu-miR-7062-5p agomir | Oligonucleotides | |
| HY-R03870 | mmu-miR-7063-3p mimic | Oligonucleotides | |
| HY-R03870A | mmu-miR-7063-3p agomir | Oligonucleotides | |
| HY-R03871 | mmu-miR-7063-5p mimic | Oligonucleotides | |
| HY-R03871A | mmu-miR-7063-5p agomir | Oligonucleotides | |
| HY-R03872 | mmu-miR-7064-3p mimic | Oligonucleotides | |
| HY-R03872A | mmu-miR-7064-3p agomir | Oligonucleotides | |
| HY-R03873 | mmu-miR-7064-5p mimic | Oligonucleotides | |
| HY-R03873A | mmu-miR-7064-5p agomir | Oligonucleotides | |
| HY-R03874 | mmu-miR-7065-3p mimic | Oligonucleotides | |
| HY-R03874A | mmu-miR-7065-3p agomir | Oligonucleotides | |
| HY-R03875 | mmu-miR-7065-5p mimic | Oligonucleotides | |
| HY-R03875A | mmu-miR-7065-5p agomir | Oligonucleotides | |
| HY-R03876 | mmu-miR-7066-3p mimic | Oligonucleotides | |
| HY-R03876A | mmu-miR-7066-3p agomir | Oligonucleotides | |
| HY-R03877 | mmu-miR-7066-5p mimic | Oligonucleotides | |
| HY-R03877A | mmu-miR-7066-5p agomir | Oligonucleotides | |
| HY-R03878 | mmu-miR-7067-3p mimic | Oligonucleotides | |
| HY-R03878A | mmu-miR-7067-3p agomir | Oligonucleotides | |
| HY-R03879 | mmu-miR-7067-5p mimic | Oligonucleotides | |
| HY-R03879A | mmu-miR-7067-5p agomir | Oligonucleotides | |
| HY-R03880 | mmu-miR-7068-3p mimic | Oligonucleotides | |
| HY-R03880A | mmu-miR-7068-3p agomir | Oligonucleotides | |
| HY-R03881 | mmu-miR-7068-5p mimic | Oligonucleotides | |
| HY-R03881A | mmu-miR-7068-5p agomir | Oligonucleotides | |
| HY-R03882 | mmu-miR-7069-3p mimic | Oligonucleotides | |
| HY-R03882A | mmu-miR-7069-3p agomir | Oligonucleotides | |
| HY-R03883 | mmu-miR-7069-5p mimic | Oligonucleotides | |
| HY-R03883A | mmu-miR-7069-5p agomir | Oligonucleotides | |
| HY-R03884 | mmu-miR-707 mimic | Oligonucleotides | |
| HY-R03884A | mmu-miR-707 agomir | Oligonucleotides | |
| HY-R03885 | mmu-miR-7070-3p mimic | Oligonucleotides | |
| HY-R03885A | mmu-miR-7070-3p agomir | Oligonucleotides | |
| HY-R03886 | mmu-miR-7070-5p mimic | Oligonucleotides | |
| HY-R03886A | mmu-miR-7070-5p agomir | Oligonucleotides | |
| HY-R03887 | mmu-miR-7071-3p mimic | Oligonucleotides | |
| HY-R03887A | mmu-miR-7071-3p agomir | Oligonucleotides | |
| HY-R03888 | mmu-miR-7071-5p mimic | Oligonucleotides | |
| HY-R03888A | mmu-miR-7071-5p agomir | Oligonucleotides | |
| HY-R03889 | mmu-miR-7072-3p mimic | Oligonucleotides | |
| HY-R03889A | mmu-miR-7072-3p agomir | Oligonucleotides | |
| HY-R03890 | mmu-miR-7072-5p mimic | Oligonucleotides | |
| HY-R03890A | mmu-miR-7072-5p agomir | Oligonucleotides | |
| HY-R03891 | mmu-miR-7073-3p mimic | Oligonucleotides | |
| HY-R03891A | mmu-miR-7073-3p agomir | Oligonucleotides | |
| HY-R03892 | mmu-miR-7073-5p mimic | Oligonucleotides | |
| HY-R03892A | mmu-miR-7073-5p agomir | Oligonucleotides | |
| HY-R03893 | mmu-miR-7074-3p mimic | Oligonucleotides | |
| HY-R03893A | mmu-miR-7074-3p agomir | Oligonucleotides | |
| HY-R03894 | mmu-miR-7074-5p mimic | Oligonucleotides | |
| HY-R03894A | mmu-miR-7074-5p agomir | Oligonucleotides | |
| HY-R03895 | mmu-miR-7075-3p mimic | Oligonucleotides | |
| HY-R03895A | mmu-miR-7075-3p agomir | Oligonucleotides | |
| HY-R03896 | mmu-miR-7075-5p mimic | Oligonucleotides | |
| HY-R03896A | mmu-miR-7075-5p agomir | Oligonucleotides | |
| HY-R03897 | mmu-miR-7076-3p mimic | Oligonucleotides | |
| HY-R03897A | mmu-miR-7076-3p agomir | Oligonucleotides | |
| HY-R03898 | mmu-miR-7076-5p mimic | Oligonucleotides | |
| HY-R03898A | mmu-miR-7076-5p agomir | Oligonucleotides | |
| HY-R03899 | mmu-miR-7077-3p mimic | Oligonucleotides | |
| HY-R03899A | mmu-miR-7077-3p agomir | Oligonucleotides | |
| HY-R03900 | mmu-miR-7077-5p mimic | Oligonucleotides | |
| HY-R03900A | mmu-miR-7077-5p agomir | Oligonucleotides | |
| HY-R03901 | mmu-miR-7078-3p mimic | Oligonucleotides | |
| HY-R03901A | mmu-miR-7078-3p agomir | Oligonucleotides | |
| HY-R03902 | mmu-miR-7078-5p mimic | Oligonucleotides | |
| HY-R03902A | mmu-miR-7078-5p agomir | Oligonucleotides | |
| HY-R03903 | mmu-miR-7079-3p mimic | Oligonucleotides | |
| HY-R03903A | mmu-miR-7079-3p agomir | Oligonucleotides | |
| HY-R03904 | mmu-miR-7079-5p mimic | Oligonucleotides | |
| HY-R03904A | mmu-miR-7079-5p agomir | Oligonucleotides | |
| HY-R03905 | mmu-miR-7080-3p mimic | Oligonucleotides | |
| HY-R03905A | mmu-miR-7080-3p agomir | Oligonucleotides | |
| HY-R03906 | mmu-miR-7080-5p mimic | Oligonucleotides | |
| HY-R03906A | mmu-miR-7080-5p agomir | Oligonucleotides | |
| HY-R03907 | mmu-miR-7081-3p mimic | Oligonucleotides | |
| HY-R03907A | mmu-miR-7081-3p agomir | Oligonucleotides | |
| HY-R03908 | mmu-miR-7081-5p mimic | Oligonucleotides | |
| HY-R03908A | mmu-miR-7081-5p agomir | Oligonucleotides | |
| HY-R03909 | mmu-miR-7082-3p mimic | Oligonucleotides | |
| HY-R03909A | mmu-miR-7082-3p agomir | Oligonucleotides | |
| HY-R03910 | mmu-miR-7082-5p mimic | Oligonucleotides | |
| HY-R03910A | mmu-miR-7082-5p agomir | Oligonucleotides | |
| HY-R03911 | mmu-miR-7083-3p mimic | Oligonucleotides | |
| HY-R03911A | mmu-miR-7083-3p agomir | Oligonucleotides | |
| HY-R03912 | mmu-miR-7083-5p mimic | Oligonucleotides | |
| HY-R03912A | mmu-miR-7083-5p agomir | Oligonucleotides | |
| HY-R03913 | mmu-miR-7084-3p mimic | Oligonucleotides | |
| HY-R03913A | mmu-miR-7084-3p agomir | Oligonucleotides | |
| HY-R03914 | mmu-miR-7084-5p mimic | Oligonucleotides | |
| HY-R03914A | mmu-miR-7084-5p agomir | Oligonucleotides | |
| HY-R03915 | mmu-miR-7085-3p mimic | Oligonucleotides | |
| HY-R03915A | mmu-miR-7085-3p agomir | Oligonucleotides | |
| HY-R03916 | mmu-miR-7085-5p mimic | Oligonucleotides | |
| HY-R03916A | mmu-miR-7085-5p agomir | Oligonucleotides | |
| HY-R03917 | mmu-miR-7086-3p mimic | Oligonucleotides | |
| HY-R03917A | mmu-miR-7086-3p agomir | Oligonucleotides | |
| HY-R03918 | mmu-miR-7086-5p mimic | Oligonucleotides | |
| HY-R03918A | mmu-miR-7086-5p agomir | Oligonucleotides | |
| HY-R03919 | mmu-miR-7087-3p mimic | Oligonucleotides | |
| HY-R03919A | mmu-miR-7087-3p agomir | Oligonucleotides | |
| HY-R03920 | mmu-miR-7087-5p mimic | Oligonucleotides | |
| HY-R03920A | mmu-miR-7087-5p agomir | Oligonucleotides | |
| HY-R03921 | mmu-miR-7088-3p mimic | Oligonucleotides | |
| HY-R03921A | mmu-miR-7088-3p agomir | Oligonucleotides | |
| HY-R03922 | mmu-miR-7088-5p mimic | Oligonucleotides | |
| HY-R03922A | mmu-miR-7088-5p agomir | Oligonucleotides | |
| HY-R03923 | mmu-miR-7089-3p mimic | Oligonucleotides | |
| HY-R03923A | mmu-miR-7089-3p agomir | Oligonucleotides | |
| HY-R03924 | mmu-miR-7089-5p mimic | Oligonucleotides | |
| HY-R03924A | mmu-miR-7089-5p agomir | Oligonucleotides | |
| HY-R03925 | mmu-miR-709 mimic | Oligonucleotides | |
| HY-R03925A | mmu-miR-709 agomir | Oligonucleotides | |
| HY-R03926 | mmu-miR-7090-3p mimic | Oligonucleotides | |
| HY-R03926A | mmu-miR-7090-3p agomir | Oligonucleotides | |
| HY-R03927 | mmu-miR-7090-5p mimic | Oligonucleotides | |
| HY-R03927A | mmu-miR-7090-5p agomir | Oligonucleotides | |
| HY-R03928 | mmu-miR-7091-3p mimic | Oligonucleotides | |
| HY-R03928A | mmu-miR-7091-3p agomir | Oligonucleotides | |
| HY-R03929 | mmu-miR-7091-5p mimic | Oligonucleotides | |
| HY-R03929A | mmu-miR-7091-5p agomir | Oligonucleotides | |
| HY-R03930 | mmu-miR-7092-3p mimic | Oligonucleotides | |
| HY-R03930A | mmu-miR-7092-3p agomir | Oligonucleotides | |
| HY-R03931 | mmu-miR-7092-5p mimic | Oligonucleotides | |
| HY-R03931A | mmu-miR-7092-5p agomir | Oligonucleotides | |
| HY-R03932 | mmu-miR-7093-3p mimic | Oligonucleotides | |
| HY-R03932A | mmu-miR-7093-3p agomir | Oligonucleotides | |
| HY-R03933 | mmu-miR-7093-5p mimic | Oligonucleotides | |
| HY-R03933A | mmu-miR-7093-5p agomir | Oligonucleotides | |
| HY-R03934 | mmu-miR-7094-1-5p mimic | Oligonucleotides | |
| HY-R03934A | mmu-miR-7094-1-5p agomir | Oligonucleotides | |
| HY-R03935 | mmu-miR-7094-3p mimic | Oligonucleotides | |
| HY-R03935A | mmu-miR-7094-3p agomir | Oligonucleotides | |
| HY-R03936 | mmu-miR-7094b-2-5p mimic | Oligonucleotides | |
| HY-R03936A | mmu-miR-7094b-2-5p agomir | Oligonucleotides | |
| HY-R03937 | mmu-miR-710 mimic | Oligonucleotides | |
| HY-R03937A | mmu-miR-710 agomir | Oligonucleotides | |
| HY-R03938 | mmu-miR-711 mimic | Oligonucleotides | |
| HY-R03938A | mmu-miR-711 agomir | Oligonucleotides | |
| HY-R03939 | mmu-miR-7115-3p mimic | Oligonucleotides | |
| HY-R03939A | mmu-miR-7115-3p agomir | Oligonucleotides | |
| HY-R03940 | mmu-miR-7115-5p mimic | Oligonucleotides | |
| HY-R03940A | mmu-miR-7115-5p agomir | Oligonucleotides | |
| HY-R03941 | mmu-miR-7116-3p mimic | Oligonucleotides | |
| HY-R03941A | mmu-miR-7116-3p agomir | Oligonucleotides | |
| HY-R03942 | mmu-miR-7116-5p mimic | Oligonucleotides | |
| HY-R03942A | mmu-miR-7116-5p agomir | Oligonucleotides | |
| HY-R03943 | mmu-miR-7117-3p mimic | Oligonucleotides | |
| HY-R03943A | mmu-miR-7117-3p agomir | Oligonucleotides | |
| HY-R03944 | mmu-miR-7117-5p mimic | Oligonucleotides | |
| HY-R03944A | mmu-miR-7117-5p agomir | Oligonucleotides | |
| HY-R03945 | mmu-miR-7118-3p mimic | Oligonucleotides | |
| HY-R03945A | mmu-miR-7118-3p agomir | Oligonucleotides | |
| HY-R03946 | mmu-miR-7118-5p mimic | Oligonucleotides | |
| HY-R03946A | mmu-miR-7118-5p agomir | Oligonucleotides | |
| HY-R03947 | mmu-miR-7119-3p mimic | Oligonucleotides | |
| HY-R03947A | mmu-miR-7119-3p agomir | Oligonucleotides | |
| HY-R03948 | mmu-miR-7119-5p mimic | Oligonucleotides | |
| HY-R03948A | mmu-miR-7119-5p agomir | Oligonucleotides | |
| HY-R03949 | mmu-miR-712-3p mimic | Oligonucleotides | |
| HY-R03949A | mmu-miR-712-3p agomir | Oligonucleotides | |
| HY-R03950 | mmu-miR-712-5p mimic | Oligonucleotides | |
| HY-R03950A | mmu-miR-712-5p agomir | Oligonucleotides | |
| HY-R03951 | mmu-miR-713 mimic | Oligonucleotides | |
| HY-R03951A | mmu-miR-713 agomir | Oligonucleotides | |
| HY-R03952 | mmu-miR-714 mimic | Oligonucleotides | |
| HY-R03952A | mmu-miR-714 agomir | Oligonucleotides | |
| HY-R03953 | mmu-miR-717 mimic | Oligonucleotides | |
| HY-R03953A | mmu-miR-717 agomir | Oligonucleotides | |
| HY-R03954 | mmu-miR-718 mimic | Oligonucleotides | |
| HY-R03954A | mmu-miR-718 agomir | Oligonucleotides | |
| HY-R03955 | mmu-miR-719 mimic | Oligonucleotides | |
| HY-R03955A | mmu-miR-719 agomir | Oligonucleotides | |
| HY-R03956 | mmu-miR-721 mimic | Oligonucleotides | |
| HY-R03956A | mmu-miR-721 agomir | Oligonucleotides | |
| HY-R03957 | mmu-miR-7210-3p mimic | Oligonucleotides | |
| HY-R03957A | mmu-miR-7210-3p agomir | Oligonucleotides | |
| HY-R03958 | mmu-miR-7210-5p mimic | Oligonucleotides | |
| HY-R03958A | mmu-miR-7210-5p agomir | Oligonucleotides | |
| HY-R03959 | mmu-miR-7211-3p mimic | Oligonucleotides | |
| HY-R03959A | mmu-miR-7211-3p agomir | Oligonucleotides | |
| HY-R03960 | mmu-miR-7211-5p mimic | Oligonucleotides | |
| HY-R03960A | mmu-miR-7211-5p agomir | Oligonucleotides | |
| HY-R03961 | mmu-miR-7212-3p mimic | Oligonucleotides | |
| HY-R03961A | mmu-miR-7212-3p agomir | Oligonucleotides | |
| HY-R03962 | mmu-miR-7212-5p mimic | Oligonucleotides | |
| HY-R03962A | mmu-miR-7212-5p agomir | Oligonucleotides | |
| HY-R03963 | mmu-miR-7213-3p mimic | Oligonucleotides | |
| HY-R03963A | mmu-miR-7213-3p agomir | Oligonucleotides | |
| HY-R03964 | mmu-miR-7213-5p mimic | Oligonucleotides | |
| HY-R03964A | mmu-miR-7213-5p agomir | Oligonucleotides | |
| HY-R03965 | mmu-miR-7214-3p mimic | Oligonucleotides | |
| HY-R03965A | mmu-miR-7214-3p agomir | Oligonucleotides | |
| HY-R03966 | mmu-miR-7214-5p mimic | Oligonucleotides | |
| HY-R03966A | mmu-miR-7214-5p agomir | Oligonucleotides | |
| HY-R03967 | mmu-miR-7215-3p mimic | Oligonucleotides | |
| HY-R03967A | mmu-miR-7215-3p agomir | Oligonucleotides | |
| HY-R03968 | mmu-miR-7215-5p mimic | Oligonucleotides | |
| HY-R03968A | mmu-miR-7215-5p agomir | Oligonucleotides | |
| HY-R03969 | mmu-miR-7216-3p mimic | Oligonucleotides | |
| HY-R03969A | mmu-miR-7216-3p agomir | Oligonucleotides | |
| HY-R03970 | mmu-miR-7216-5p mimic | Oligonucleotides | |
| HY-R03970A | mmu-miR-7216-5p agomir | Oligonucleotides | |
| HY-R03971 | mmu-miR-7217-3p mimic | Oligonucleotides | |
| HY-R03971A | mmu-miR-7217-3p agomir | Oligonucleotides | |
| HY-R03972 | mmu-miR-7217-5p mimic | Oligonucleotides | |
| HY-R03972A | mmu-miR-7217-5p agomir | Oligonucleotides | |
| HY-R03973 | mmu-miR-7218-3p mimic | Oligonucleotides | |
| HY-R03973A | mmu-miR-7218-3p agomir | Oligonucleotides | |
| HY-R03974 | mmu-miR-7218-5p mimic | Oligonucleotides | |
| HY-R03974A | mmu-miR-7218-5p agomir | Oligonucleotides | |
| HY-R03975 | mmu-miR-7219-3p mimic | Oligonucleotides | |
| HY-R03975A | mmu-miR-7219-3p agomir | Oligonucleotides | |
| HY-R03976 | mmu-miR-7219-5p mimic | Oligonucleotides | |
| HY-R03976A | mmu-miR-7219-5p agomir | Oligonucleotides | |
| HY-R03977 | mmu-miR-7220-3p mimic | Oligonucleotides | |
| HY-R03977A | mmu-miR-7220-3p agomir | Oligonucleotides | |
| HY-R03978 | mmu-miR-7220-5p mimic | Oligonucleotides | |
| HY-R03978A | mmu-miR-7220-5p agomir | Oligonucleotides | |
| HY-R03979 | mmu-miR-7221-3p mimic | Oligonucleotides | |
| HY-R03979A | mmu-miR-7221-3p agomir | Oligonucleotides | |
| HY-R03980 | mmu-miR-7221-5p mimic | Oligonucleotides | |
| HY-R03980A | mmu-miR-7221-5p agomir | Oligonucleotides | |
| HY-R03981 | mmu-miR-7222-3p mimic | Oligonucleotides | |
| HY-R03981A | mmu-miR-7222-3p agomir | Oligonucleotides | |
| HY-R03982 | mmu-miR-7222-5p mimic | Oligonucleotides | |
| HY-R03982A | mmu-miR-7222-5p agomir | Oligonucleotides | |
| HY-R03983 | mmu-miR-7223-3p mimic | Oligonucleotides | |
| HY-R03983A | mmu-miR-7223-3p agomir | Oligonucleotides | |
| HY-R03984 | mmu-miR-7223-5p mimic | Oligonucleotides | |
| HY-R03984A | mmu-miR-7223-5p agomir | Oligonucleotides | |
| HY-R03985 | mmu-miR-7224-3p mimic | Oligonucleotides | |
| HY-R03985A | mmu-miR-7224-3p agomir | Oligonucleotides | |
| HY-R03986 | mmu-miR-7224-5p mimic | Oligonucleotides | |
| HY-R03986A | mmu-miR-7224-5p agomir | Oligonucleotides | |
| HY-R03987 | mmu-miR-7225-3p mimic | Oligonucleotides | |
| HY-R03987A | mmu-miR-7225-3p agomir | Oligonucleotides | |
| HY-R03988 | mmu-miR-7225-5p mimic | Oligonucleotides | |
| HY-R03988A | mmu-miR-7225-5p agomir | Oligonucleotides | |
| HY-R03989 | mmu-miR-7226-3p mimic | Oligonucleotides | |
| HY-R03989A | mmu-miR-7226-3p agomir | Oligonucleotides | |
| HY-R03990 | mmu-miR-7226-5p mimic | Oligonucleotides | |
| HY-R03990A | mmu-miR-7226-5p agomir | Oligonucleotides | |
| HY-R03991 | mmu-miR-7227-3p mimic | Oligonucleotides | |
| HY-R03991A | mmu-miR-7227-3p agomir | Oligonucleotides | |
| HY-R03992 | mmu-miR-7227-5p mimic | Oligonucleotides | |
| HY-R03992A | mmu-miR-7227-5p agomir | Oligonucleotides | |
| HY-R03993 | mmu-miR-7228-3p mimic | Oligonucleotides | |
| HY-R03993A | mmu-miR-7228-3p agomir | Oligonucleotides | |
| HY-R03994 | mmu-miR-7228-5p mimic | Oligonucleotides | |
| HY-R03994A | mmu-miR-7228-5p agomir | Oligonucleotides | |
| HY-R03995 | mmu-miR-7229-3p mimic | Oligonucleotides | |
| HY-R03995A | mmu-miR-7229-3p agomir | Oligonucleotides | |
| HY-R03996 | mmu-miR-7229-5p mimic | Oligonucleotides | |
| HY-R03996A | mmu-miR-7229-5p agomir | Oligonucleotides | |
| HY-R03997 | mmu-miR-7230-3p mimic | Oligonucleotides | |
| HY-R03997A | mmu-miR-7230-3p agomir | Oligonucleotides | |
| HY-R03998 | mmu-miR-7230-5p mimic | Oligonucleotides | |
| HY-R03998A | mmu-miR-7230-5p agomir | Oligonucleotides | |
| HY-R03999 | mmu-miR-7231-3p mimic | Oligonucleotides | |
| HY-R03999A | mmu-miR-7231-3p agomir | Oligonucleotides | |
| HY-R04000 | mmu-miR-7231-5p mimic | Oligonucleotides | |
| HY-R04000A | mmu-miR-7231-5p agomir | Oligonucleotides | |
| HY-R04001 | mmu-miR-7232-3p mimic | Oligonucleotides | |
| HY-R04001A | mmu-miR-7232-3p agomir | Oligonucleotides | |
| HY-R04002 | mmu-miR-7232-5p mimic | Oligonucleotides | |
| HY-R04002A | mmu-miR-7232-5p agomir | Oligonucleotides | |
| HY-R04003 | mmu-miR-7233-3p mimic | Oligonucleotides | |
| HY-R04003A | mmu-miR-7233-3p agomir | Oligonucleotides | |
| HY-R04004 | mmu-miR-7233-5p mimic | Oligonucleotides | |
| HY-R04004A | mmu-miR-7233-5p agomir | Oligonucleotides | |
| HY-R04005 | mmu-miR-7234-3p mimic | Oligonucleotides | |
| HY-R04005A | mmu-miR-7234-3p agomir | Oligonucleotides | |
| HY-R04006 | mmu-miR-7234-5p mimic | Oligonucleotides | |
| HY-R04006A | mmu-miR-7234-5p agomir | Oligonucleotides | |
| HY-R04007 | mmu-miR-7235-3p mimic | Oligonucleotides | |
| HY-R04007A | mmu-miR-7235-3p agomir | Oligonucleotides | |
| HY-R04008 | mmu-miR-7235-5p mimic | Oligonucleotides | |
| HY-R04008A | mmu-miR-7235-5p agomir | Oligonucleotides | |
| HY-R04009 | mmu-miR-7236-3p mimic | Oligonucleotides | |
| HY-R04009A | mmu-miR-7236-3p agomir | Oligonucleotides | |
| HY-R04010 | mmu-miR-7236-5p mimic | Oligonucleotides | |
| HY-R04010A | mmu-miR-7236-5p agomir | Oligonucleotides | |
| HY-R04011 | mmu-miR-7237-3p mimic | Oligonucleotides | |
| HY-R04011A | mmu-miR-7237-3p agomir | Oligonucleotides | |
| HY-R04012 | mmu-miR-7237-5p mimic | Oligonucleotides | |
| HY-R04012A | mmu-miR-7237-5p agomir | Oligonucleotides | |
| HY-R04013 | mmu-miR-7238-3p mimic | Oligonucleotides | |
| HY-R04013A | mmu-miR-7238-3p agomir | Oligonucleotides | |
| HY-R04014 | mmu-miR-7238-5p mimic | Oligonucleotides | |
| HY-R04014A | mmu-miR-7238-5p agomir | Oligonucleotides | |
| HY-R04015 | mmu-miR-7239-3p mimic | Oligonucleotides | |
| HY-R04015A | mmu-miR-7239-3p agomir | Oligonucleotides | |
| HY-R04016 | mmu-miR-7239-5p mimic | Oligonucleotides | |
| HY-R04016A | mmu-miR-7239-5p agomir | Oligonucleotides | |
| HY-R04017 | mmu-miR-7240-3p mimic | Oligonucleotides | |
| HY-R04017A | mmu-miR-7240-3p agomir | Oligonucleotides | |
| HY-R04018 | mmu-miR-7240-5p mimic | Oligonucleotides | |
| HY-R04018A | mmu-miR-7240-5p agomir | Oligonucleotides | |
| HY-R04019 | mmu-miR-7241-3p mimic | Oligonucleotides | |
| HY-R04019A | mmu-miR-7241-3p agomir | Oligonucleotides | |
| HY-R04020 | mmu-miR-7241-5p mimic | Oligonucleotides | |
| HY-R04020A | mmu-miR-7241-5p agomir | Oligonucleotides | |
| HY-R04021 | mmu-miR-7242-3p mimic | Oligonucleotides | |
| HY-R04021A | mmu-miR-7242-3p agomir | Oligonucleotides | |
| HY-R04022 | mmu-miR-7242-5p mimic | Oligonucleotides | |
| HY-R04022A | mmu-miR-7242-5p agomir | Oligonucleotides | |
| HY-R04023 | mmu-miR-7243-3p mimic | Oligonucleotides | |
| HY-R04023A | mmu-miR-7243-3p agomir | Oligonucleotides | |
| HY-R04024 | mmu-miR-7243-5p mimic | Oligonucleotides | |
| HY-R04024A | mmu-miR-7243-5p agomir | Oligonucleotides | |
| HY-R04025 | mmu-miR-741-3p mimic | Oligonucleotides | |
| HY-R04025A | mmu-miR-741-3p agomir | Oligonucleotides | |
| HY-R04026 | mmu-miR-741-5p mimic | Oligonucleotides | |
| HY-R04026A | mmu-miR-741-5p agomir | Oligonucleotides | |
| HY-R04027 | mmu-miR-742-3p mimic | Oligonucleotides | |
| HY-R04027A | mmu-miR-742-3p agomir | Oligonucleotides | |
| HY-R04028 | mmu-miR-742-5p mimic | Oligonucleotides | |
| HY-R04028A | mmu-miR-742-5p agomir | Oligonucleotides | |
| HY-R04029 | mmu-miR-743a-3p mimic | Oligonucleotides | |
| HY-R04029A | mmu-miR-743a-3p agomir | Oligonucleotides | |
| HY-R04030 | mmu-miR-743a-5p mimic | Oligonucleotides | |
| HY-R04030A | mmu-miR-743a-5p agomir | Oligonucleotides | |
| HY-R04031 | mmu-miR-743b-3p mimic | Oligonucleotides | |
| HY-R04031A | mmu-miR-743b-3p agomir | Oligonucleotides | |
| HY-R04032 | mmu-miR-743b-5p mimic | Oligonucleotides | |
| HY-R04032A | mmu-miR-743b-5p agomir | Oligonucleotides | |
| HY-R04033 | mmu-miR-7578 mimic | Oligonucleotides | |
| HY-R04033A | mmu-miR-7578 agomir | Oligonucleotides | |
| HY-R04034 | mmu-miR-758-3p mimic | Oligonucleotides | |
| HY-R04034A | mmu-miR-758-3p agomir | Oligonucleotides | |
| HY-R04035 | mmu-miR-758-5p mimic | Oligonucleotides | |
| HY-R04035A | mmu-miR-758-5p agomir | Oligonucleotides | |
| HY-R04036 | mmu-miR-760-5p mimic | Oligonucleotides | |
| HY-R04036A | mmu-miR-760-5p agomir | Oligonucleotides | |
| HY-R04037 | mmu-miR-762 mimic | Oligonucleotides | |
| HY-R04037A | mmu-miR-762 agomir | Oligonucleotides | |
| HY-R04038 | mmu-miR-763 mimic | Oligonucleotides | |
| HY-R04038A | mmu-miR-763 agomir | Oligonucleotides | |
| HY-R04039 | mmu-miR-764-3p mimic | Oligonucleotides | |
| HY-R04039A | mmu-miR-764-3p agomir | Oligonucleotides | |
| HY-R04040 | mmu-miR-764-5p mimic | Oligonucleotides | |
| HY-R04040A | mmu-miR-764-5p agomir | Oligonucleotides | |
| HY-R04041 | mmu-miR-7646-3p mimic | Oligonucleotides | |
| HY-R04041A | mmu-miR-7646-3p agomir | Oligonucleotides | |
| HY-R04042 | mmu-miR-7646-5p mimic | Oligonucleotides | |
| HY-R04042A | mmu-miR-7646-5p agomir | Oligonucleotides | |
| HY-R04043 | mmu-miR-7647-3p mimic | Oligonucleotides | |
| HY-R04043A | mmu-miR-7647-3p agomir | Oligonucleotides | |
| HY-R04044 | mmu-miR-7647-5p mimic | Oligonucleotides | |
| HY-R04044A | mmu-miR-7647-5p agomir | Oligonucleotides | |
| HY-R04045 | mmu-miR-7648-3p mimic | Oligonucleotides | |
| HY-R04045A | mmu-miR-7648-3p agomir | Oligonucleotides | |
| HY-R04046 | mmu-miR-7648-5p mimic | Oligonucleotides | |
| HY-R04046A | mmu-miR-7648-5p agomir | Oligonucleotides | |
| HY-R04047 | mmu-miR-7649-3p mimic | Oligonucleotides | |
| HY-R04047A | mmu-miR-7649-3p agomir | Oligonucleotides | |
| HY-R04048 | mmu-miR-7649-5p mimic | Oligonucleotides | |
| HY-R04048A | mmu-miR-7649-5p agomir | Oligonucleotides | |
| HY-R04049 | mmu-miR-7650-3p mimic | Oligonucleotides | |
| HY-R04049A | mmu-miR-7650-3p agomir | Oligonucleotides | |
| HY-R04050 | mmu-miR-7650-5p mimic | Oligonucleotides | |
| HY-R04050A | mmu-miR-7650-5p agomir | Oligonucleotides | |
| HY-R04051 | mmu-miR-7651-3p mimic | Oligonucleotides | |
| HY-R04051A | mmu-miR-7651-3p agomir | Oligonucleotides | |
| HY-R04052 | mmu-miR-7651-5p mimic | Oligonucleotides | |
| HY-R04052A | mmu-miR-7651-5p agomir | Oligonucleotides | |
| HY-R04053 | mmu-miR-7652-3p mimic | Oligonucleotides | |
| HY-R04053A | mmu-miR-7652-3p agomir | Oligonucleotides | |
| HY-R04054 | mmu-miR-7652-5p mimic | Oligonucleotides | |
| HY-R04054A | mmu-miR-7652-5p agomir | Oligonucleotides | |
| HY-R04055 | mmu-miR-7653-3p mimic | Oligonucleotides | |
| HY-R04055A | mmu-miR-7653-3p agomir | Oligonucleotides | |
| HY-R04056 | mmu-miR-7653-5p mimic | Oligonucleotides | |
| HY-R04056A | mmu-miR-7653-5p agomir | Oligonucleotides | |
| HY-R04057 | mmu-miR-7654-3p mimic | Oligonucleotides | |
| HY-R04057A | mmu-miR-7654-3p agomir | Oligonucleotides | |
| HY-R04058 | mmu-miR-7654-5p mimic | Oligonucleotides | |
| HY-R04058A | mmu-miR-7654-5p agomir | Oligonucleotides | |
| HY-R04059 | mmu-miR-7655-3p mimic | Oligonucleotides | |
| HY-R04059A | mmu-miR-7655-3p agomir | Oligonucleotides | |
| HY-R04060 | mmu-miR-7655-5p mimic | Oligonucleotides | |
| HY-R04060A | mmu-miR-7655-5p agomir | Oligonucleotides | |
| HY-R04061 | mmu-miR-7656-3p mimic | Oligonucleotides | |
| HY-R04061A | mmu-miR-7656-3p agomir | Oligonucleotides | |
| HY-R04062 | mmu-miR-7656-5p mimic | Oligonucleotides | |
| HY-R04062A | mmu-miR-7656-5p agomir | Oligonucleotides | |
| HY-R04063 | mmu-miR-7657-3p mimic | Oligonucleotides | |
| HY-R04063A | mmu-miR-7657-3p agomir | Oligonucleotides | |
| HY-R04064 | mmu-miR-7657-5p mimic | Oligonucleotides | |
| HY-R04064A | mmu-miR-7657-5p agomir | Oligonucleotides | |
| HY-R04065 | mmu-miR-7658-3p mimic | Oligonucleotides | |
| HY-R04065A | mmu-miR-7658-3p agomir | Oligonucleotides | |
| HY-R04066 | mmu-miR-7658-5p mimic | Oligonucleotides | |
| HY-R04066A | mmu-miR-7658-5p agomir | Oligonucleotides | |
| HY-R04067 | mmu-miR-7659-3p mimic | Oligonucleotides | |
| HY-R04067A | mmu-miR-7659-3p agomir | Oligonucleotides | |
| HY-R04068 | mmu-miR-7659-5p mimic | Oligonucleotides | |
| HY-R04068A | mmu-miR-7659-5p agomir | Oligonucleotides | |
| HY-R04069 | mmu-miR-7660-3p mimic | Oligonucleotides | |
| HY-R04069A | mmu-miR-7660-3p agomir | Oligonucleotides | |
| HY-R04070 | mmu-miR-7660-5p mimic | Oligonucleotides | |
| HY-R04070A | mmu-miR-7660-5p agomir | Oligonucleotides | |
| HY-R04071 | mmu-miR-7661-3p mimic | Oligonucleotides | |
| HY-R04071A | mmu-miR-7661-3p agomir | Oligonucleotides | |
| HY-R04072 | mmu-miR-7661-5p mimic | Oligonucleotides | |
| HY-R04072A | mmu-miR-7661-5p agomir | Oligonucleotides | |
| HY-R04073 | mmu-miR-7662-3p mimic | Oligonucleotides | |
| HY-R04073A | mmu-miR-7662-3p agomir | Oligonucleotides | |
| HY-R04074 | mmu-miR-7662-5p mimic | Oligonucleotides | |
| HY-R04074A | mmu-miR-7662-5p agomir | Oligonucleotides | |
| HY-R04075 | mmu-miR-7663-3p mimic | Oligonucleotides | |
| HY-R04075A | mmu-miR-7663-3p agomir | Oligonucleotides | |
| HY-R04076 | mmu-miR-7663-5p mimic | Oligonucleotides | |
| HY-R04076A | mmu-miR-7663-5p agomir | Oligonucleotides | |
| HY-R04077 | mmu-miR-7664-3p mimic | Oligonucleotides | |
| HY-R04077A | mmu-miR-7664-3p agomir | Oligonucleotides | |
| HY-R04078 | mmu-miR-7664-5p mimic | Oligonucleotides | |
| HY-R04078A | mmu-miR-7664-5p agomir | Oligonucleotides | |
| HY-R04079 | mmu-miR-7665-3p mimic | Oligonucleotides | |
| HY-R04079A | mmu-miR-7665-3p agomir | Oligonucleotides | |
| HY-R04080 | mmu-miR-7665-5p mimic | Oligonucleotides | |
| HY-R04080A | mmu-miR-7665-5p agomir | Oligonucleotides | |
| HY-R04081 | mmu-miR-7666-3p mimic | Oligonucleotides | |
| HY-R04081A | mmu-miR-7666-3p agomir | Oligonucleotides | |
| HY-R04082 | mmu-miR-7666-5p mimic | Oligonucleotides | |
| HY-R04082A | mmu-miR-7666-5p agomir | Oligonucleotides | |
| HY-R04083 | mmu-miR-7667-3p mimic | Oligonucleotides | |
| HY-R04083A | mmu-miR-7667-3p agomir | Oligonucleotides | |
| HY-R04084 | mmu-miR-7667-5p mimic | Oligonucleotides | |
| HY-R04084A | mmu-miR-7667-5p agomir | Oligonucleotides | |
| HY-R04085 | mmu-miR-7668-3p mimic | Oligonucleotides | |
| HY-R04085A | mmu-miR-7668-3p agomir | Oligonucleotides | |
| HY-R04086 | mmu-miR-7668-5p mimic | Oligonucleotides | |
| HY-R04086A | mmu-miR-7668-5p agomir | Oligonucleotides | |
| HY-R04087 | mmu-miR-7669-3p mimic | Oligonucleotides | |
| HY-R04087A | mmu-miR-7669-3p agomir | Oligonucleotides | |
| HY-R04088 | mmu-miR-7669-5p mimic | Oligonucleotides | |
| HY-R04088A | mmu-miR-7669-5p agomir | Oligonucleotides | |
| HY-R04089 | mmu-miR-767 mimic | Oligonucleotides | |
| HY-R04089A | mmu-miR-767 agomir | Oligonucleotides | |
| HY-R04090 | mmu-miR-7670-3p mimic | Oligonucleotides | |
| HY-R04090A | mmu-miR-7670-3p agomir | Oligonucleotides | |
| HY-R04091 | mmu-miR-7670-5p mimic | Oligonucleotides | |
| HY-R04091A | mmu-miR-7670-5p agomir | Oligonucleotides | |
| HY-R04092 | mmu-miR-7671-3p mimic | Oligonucleotides | |
| HY-R04092A | mmu-miR-7671-3p agomir | Oligonucleotides | |
| HY-R04093 | mmu-miR-7671-5p mimic | Oligonucleotides | |
| HY-R04093A | mmu-miR-7671-5p agomir | Oligonucleotides | |
| HY-R04094 | mmu-miR-7672-3p mimic | Oligonucleotides | |
| HY-R04094A | mmu-miR-7672-3p agomir | Oligonucleotides | |
| HY-R04095 | mmu-miR-7672-5p mimic | Oligonucleotides | |
| HY-R04095A | mmu-miR-7672-5p agomir | Oligonucleotides | |
| HY-R04096 | mmu-miR-7673-3p mimic | Oligonucleotides | |
| HY-R04096A | mmu-miR-7673-3p agomir | Oligonucleotides | |
| HY-R04097 | mmu-miR-7673-5p mimic | Oligonucleotides | |
| HY-R04097A | mmu-miR-7673-5p agomir | Oligonucleotides | |
| HY-R04098 | mmu-miR-7674-3p mimic | Oligonucleotides | |
| HY-R04098A | mmu-miR-7674-3p agomir | Oligonucleotides | |
| HY-R04099 | mmu-miR-7674-5p mimic | Oligonucleotides | |
| HY-R04099A | mmu-miR-7674-5p agomir | Oligonucleotides | |
| HY-R04100 | mmu-miR-7675-3p mimic | Oligonucleotides | |
| HY-R04100A | mmu-miR-7675-3p agomir | Oligonucleotides | |
| HY-R04101 | mmu-miR-7675-5p mimic | Oligonucleotides | |
| HY-R04101A | mmu-miR-7675-5p agomir | Oligonucleotides | |
| HY-R04102 | mmu-miR-7676-3p mimic | Oligonucleotides | |
| HY-R04102A | mmu-miR-7676-3p agomir | Oligonucleotides | |
| HY-R04103 | mmu-miR-7676-5p mimic | Oligonucleotides | |
| HY-R04103A | mmu-miR-7676-5p agomir | Oligonucleotides | |
| HY-R04104 | mmu-miR-7677-3p mimic | Oligonucleotides | |
| HY-R04104A | mmu-miR-7677-3p agomir | Oligonucleotides | |
| HY-R04105 | mmu-miR-7677-5p mimic | Oligonucleotides | |
| HY-R04105A | mmu-miR-7677-5p agomir | Oligonucleotides | |
| HY-R04106 | mmu-miR-7678-3p mimic | Oligonucleotides | |
| HY-R04106A | mmu-miR-7678-3p agomir | Oligonucleotides | |
| HY-R04107 | mmu-miR-7678-5p mimic | Oligonucleotides | |
| HY-R04107A | mmu-miR-7678-5p agomir | Oligonucleotides | |
| HY-R04108 | mmu-miR-7679-3p mimic | Oligonucleotides | |
| HY-R04108A | mmu-miR-7679-3p agomir | Oligonucleotides | |
| HY-R04109 | mmu-miR-7679-5p mimic | Oligonucleotides | |
| HY-R04109A | mmu-miR-7679-5p agomir | Oligonucleotides | |
| HY-R04110 | mmu-miR-7680-3p mimic | Oligonucleotides | |
| HY-R04110A | mmu-miR-7680-3p agomir | Oligonucleotides | |
| HY-R04111 | mmu-miR-7680-5p mimic | Oligonucleotides | |
| HY-R04111A | mmu-miR-7680-5p agomir | Oligonucleotides | |
| HY-R04112 | mmu-miR-7681-3p mimic | Oligonucleotides | |
| HY-R04112A | mmu-miR-7681-3p agomir | Oligonucleotides | |
| HY-R04113 | mmu-miR-7681-5p mimic | Oligonucleotides | |
| HY-R04113A | mmu-miR-7681-5p agomir | Oligonucleotides | |
| HY-R04114 | mmu-miR-7682-3p mimic | Oligonucleotides | |
| HY-R04114A | mmu-miR-7682-3p agomir | Oligonucleotides | |
| HY-R04115 | mmu-miR-7682-5p mimic | Oligonucleotides | |
| HY-R04115A | mmu-miR-7682-5p agomir | Oligonucleotides | |
| HY-R04116 | mmu-miR-7683-3p mimic | Oligonucleotides | |
| HY-R04116A | mmu-miR-7683-3p agomir | Oligonucleotides | |
| HY-R04117 | mmu-miR-7683-5p mimic | Oligonucleotides | |
| HY-R04117A | mmu-miR-7683-5p agomir | Oligonucleotides | |
| HY-R04118 | mmu-miR-7684-3p mimic | Oligonucleotides | |
| HY-R04118A | mmu-miR-7684-3p agomir | Oligonucleotides | |
| HY-R04119 | mmu-miR-7684-5p mimic | Oligonucleotides | |
| HY-R04119A | mmu-miR-7684-5p agomir | Oligonucleotides | |
| HY-R04120 | mmu-miR-7685-3p mimic | Oligonucleotides | |
| HY-R04120A | mmu-miR-7685-3p agomir | Oligonucleotides | |
| HY-R04121 | mmu-miR-7685-5p mimic | Oligonucleotides | |
| HY-R04121A | mmu-miR-7685-5p agomir | Oligonucleotides | |
| HY-R04122 | mmu-miR-7686-3p mimic | Oligonucleotides | |
| HY-R04122A | mmu-miR-7686-3p agomir | Oligonucleotides | |
| HY-R04123 | mmu-miR-7686-5p mimic | Oligonucleotides | |
| HY-R04123A | mmu-miR-7686-5p agomir | Oligonucleotides | |
| HY-R04124 | mmu-miR-7687-3p mimic | Oligonucleotides | |
| HY-R04124A | mmu-miR-7687-3p agomir | Oligonucleotides | |
| HY-R04125 | mmu-miR-7687-5p mimic | Oligonucleotides | |
| HY-R04125A | mmu-miR-7687-5p agomir | Oligonucleotides | |
| HY-R04126 | mmu-miR-7688-3p mimic | Oligonucleotides | |
| HY-R04126A | mmu-miR-7688-3p agomir | Oligonucleotides | |
| HY-R04127 | mmu-miR-7688-5p mimic | Oligonucleotides | |
| HY-R04127A | mmu-miR-7688-5p agomir | Oligonucleotides | |
| HY-R04128 | mmu-miR-7689-3p mimic | Oligonucleotides | |
| HY-R04128A | mmu-miR-7689-3p agomir | Oligonucleotides | |
| HY-R04129 | mmu-miR-7689-5p mimic | Oligonucleotides | |
| HY-R04129A | mmu-miR-7689-5p agomir | Oligonucleotides | |
| HY-R04130 | mmu-miR-770-3p mimic | Oligonucleotides | |
| HY-R04130A | mmu-miR-770-3p agomir | Oligonucleotides | |
| HY-R04131 | mmu-miR-770-5p mimic | Oligonucleotides | |
| HY-R04131A | mmu-miR-770-5p agomir | Oligonucleotides | |
| HY-R04132 | mmu-miR-7a-2-3p mimic | Oligonucleotides | |
| HY-R04132A | mmu-miR-7a-2-3p agomir | Oligonucleotides | |
| HY-R04133 | mmu-miR-7a-5p mimic | Oligonucleotides | |
| HY-R04133A | mmu-miR-7a-5p agomir | Oligonucleotides | |
| HY-R04134 | mmu-miR-7b-3p mimic | Oligonucleotides | |
| HY-R04134A | mmu-miR-7b-3p agomir | Oligonucleotides | |
| HY-R04135 | mmu-miR-802-3p mimic | Oligonucleotides | |
| HY-R04135A | mmu-miR-802-3p agomir | Oligonucleotides | |
| HY-R04136 | mmu-miR-802-5p mimic | Oligonucleotides | |
| HY-R04136A | mmu-miR-802-5p agomir | Oligonucleotides | |
| HY-R04137 | mmu-miR-804 mimic | Oligonucleotides | |
| HY-R04137A | mmu-miR-804 agomir | Oligonucleotides | |
| HY-R04138 | mmu-miR-8090 mimic | Oligonucleotides | |
| HY-R04138A | mmu-miR-8090 agomir | Oligonucleotides | |
| HY-R04139 | mmu-miR-8091 mimic | Oligonucleotides | |
| HY-R04139A | mmu-miR-8091 agomir | Oligonucleotides | |
| HY-R04140 | mmu-miR-8092 mimic | Oligonucleotides | |
| HY-R04140A | mmu-miR-8092 agomir | Oligonucleotides | |
| HY-R04141 | mmu-miR-8093 mimic | Oligonucleotides | |
| HY-R04141A | mmu-miR-8093 agomir | Oligonucleotides | |
| HY-R04142 | mmu-miR-8094 mimic | Oligonucleotides | |
| HY-R04142A | mmu-miR-8094 agomir | Oligonucleotides | |
| HY-R04143 | mmu-miR-8095 mimic | Oligonucleotides | |
| HY-R04143A | mmu-miR-8095 agomir | Oligonucleotides | |
| HY-R04144 | mmu-miR-8096 mimic | Oligonucleotides | |
| HY-R04144A | mmu-miR-8096 agomir | Oligonucleotides | |
| HY-R04145 | mmu-miR-8097 mimic | Oligonucleotides | |
| HY-R04145A | mmu-miR-8097 agomir | Oligonucleotides | |
| HY-R04146 | mmu-miR-8098 mimic | Oligonucleotides | |
| HY-R04146A | mmu-miR-8098 agomir | Oligonucleotides | |
| HY-R04147 | mmu-miR-8099 mimic | Oligonucleotides | |
| HY-R04147A | mmu-miR-8099 agomir | Oligonucleotides | |
| HY-R04148 | mmu-miR-8100 mimic | Oligonucleotides | |
| HY-R04148A | mmu-miR-8100 agomir | Oligonucleotides | |
| HY-R04149 | mmu-miR-8101 mimic | Oligonucleotides | |
| HY-R04149A | mmu-miR-8101 agomir | Oligonucleotides | |
| HY-R04150 | mmu-miR-8102 mimic | Oligonucleotides | |
| HY-R04150A | mmu-miR-8102 agomir | Oligonucleotides | |
| HY-R04151 | mmu-miR-8103 mimic | Oligonucleotides | |
| HY-R04151A | mmu-miR-8103 agomir | Oligonucleotides | |
| HY-R04152 | mmu-miR-8104 mimic | Oligonucleotides | |
| HY-R04152A | mmu-miR-8104 agomir | Oligonucleotides | |
| HY-R04153 | mmu-miR-8105 mimic | Oligonucleotides | |
| HY-R04153A | mmu-miR-8105 agomir | Oligonucleotides | |
| HY-R04154 | mmu-miR-8106 mimic | Oligonucleotides | |
| HY-R04154A | mmu-miR-8106 agomir | Oligonucleotides | |
| HY-R04155 | mmu-miR-8107 mimic | Oligonucleotides | |
| HY-R04155A | mmu-miR-8107 agomir | Oligonucleotides | |
| HY-R04156 | mmu-miR-8108 mimic | Oligonucleotides | |
| HY-R04156A | mmu-miR-8108 agomir | Oligonucleotides | |
| HY-R04157 | mmu-miR-8109 mimic | Oligonucleotides | |
| HY-R04157A | mmu-miR-8109 agomir | Oligonucleotides | |
| HY-R04158 | mmu-miR-8110 mimic | Oligonucleotides | |
| HY-R04158A | mmu-miR-8110 agomir | Oligonucleotides | |
| HY-R04159 | mmu-miR-8111 mimic | Oligonucleotides | |
| HY-R04159A | mmu-miR-8111 agomir | Oligonucleotides | |
| HY-R04160 | mmu-miR-8112 mimic | Oligonucleotides | |
| HY-R04160A | mmu-miR-8112 agomir | Oligonucleotides | |
| HY-R04161 | mmu-miR-8113 mimic | Oligonucleotides | |
| HY-R04161A | mmu-miR-8113 agomir | Oligonucleotides | |
| HY-R04162 | mmu-miR-8114 mimic | Oligonucleotides | |
| HY-R04162A | mmu-miR-8114 agomir | Oligonucleotides | |
| HY-R04163 | mmu-miR-8115 mimic | Oligonucleotides | |
| HY-R04163A | mmu-miR-8115 agomir | Oligonucleotides | |
| HY-R04164 | mmu-miR-8116 mimic | Oligonucleotides | |
| HY-R04164A | mmu-miR-8116 agomir | Oligonucleotides | |
| HY-R04165 | mmu-miR-8117 mimic | Oligonucleotides | |
| HY-R04165A | mmu-miR-8117 agomir | Oligonucleotides | |
| HY-R04166 | mmu-miR-8118 mimic | Oligonucleotides | |
| HY-R04166A | mmu-miR-8118 agomir | Oligonucleotides | |
| HY-R04167 | mmu-miR-8119 mimic | Oligonucleotides | |
| HY-R04167A | mmu-miR-8119 agomir | Oligonucleotides | |
| HY-R04168 | mmu-miR-8120 mimic | Oligonucleotides | |
| HY-R04168A | mmu-miR-8120 agomir | Oligonucleotides | |
| HY-R04169 | mmu-miR-871-3p mimic | Oligonucleotides | |
| HY-R04169A | mmu-miR-871-3p agomir | Oligonucleotides | |
| HY-R04170 | mmu-miR-871-5p mimic | Oligonucleotides | |
| HY-R04170A | mmu-miR-871-5p agomir | Oligonucleotides | |
| HY-R04171 | mmu-miR-872-3p mimic | Oligonucleotides | |
| HY-R04171A | mmu-miR-872-3p agomir | Oligonucleotides | |
| HY-R04172 | mmu-miR-873a-3p mimic | Oligonucleotides | |
| HY-R04172A | mmu-miR-873a-3p agomir | Oligonucleotides | |
| HY-R04173 | mmu-miR-873b mimic | Oligonucleotides | |
| HY-R04173A | mmu-miR-873b agomir | Oligonucleotides | |
| HY-R04174 | mmu-miR-874-5p mimic | Oligonucleotides | |
| HY-R04174A | mmu-miR-874-5p agomir | Oligonucleotides | |
| HY-R04175 | mmu-miR-875-3p mimic | Oligonucleotides | |
| HY-R04175A | mmu-miR-875-3p agomir | Oligonucleotides | |
| HY-R04176 | mmu-miR-876-3p mimic | Oligonucleotides | |
| HY-R04176A | mmu-miR-876-3p agomir | Oligonucleotides | |
| HY-R04177 | mmu-miR-876-5p mimic | Oligonucleotides | |
| HY-R04177A | mmu-miR-876-5p agomir | Oligonucleotides | |
| HY-R04178 | mmu-miR-877-3p mimic | Oligonucleotides | |
| HY-R04178A | mmu-miR-877-3p agomir | Oligonucleotides | |
| HY-R04179 | mmu-miR-878-3p mimic | Oligonucleotides | |
| HY-R04179A | mmu-miR-878-3p agomir | Oligonucleotides | |
| HY-R04180 | mmu-miR-878-5p mimic | Oligonucleotides | |
| HY-R04180A | mmu-miR-878-5p agomir | Oligonucleotides | |
| HY-R04181 | mmu-miR-879-3p mimic | Oligonucleotides | |
| HY-R04181A | mmu-miR-879-3p agomir | Oligonucleotides | |
| HY-R04182 | mmu-miR-879-5p mimic | Oligonucleotides | |
| HY-R04182A | mmu-miR-879-5p agomir | Oligonucleotides | |
| HY-R04183 | mmu-miR-880-3p mimic | Oligonucleotides | |
| HY-R04183A | mmu-miR-880-3p agomir | Oligonucleotides | |
| HY-R04184 | mmu-miR-880-5p mimic | Oligonucleotides | |
| HY-R04184A | mmu-miR-880-5p agomir | Oligonucleotides | |
| HY-R04185 | mmu-miR-881-3p mimic | Oligonucleotides | |
| HY-R04185A | mmu-miR-881-3p agomir | Oligonucleotides | |
| HY-R04186 | mmu-miR-881-5p mimic | Oligonucleotides | |
| HY-R04186A | mmu-miR-881-5p agomir | Oligonucleotides | |
| HY-R04187 | mmu-miR-882 mimic | Oligonucleotides | |
| HY-R04187A | mmu-miR-882 agomir | Oligonucleotides | |
| HY-R04188 | mmu-miR-883a-3p mimic | Oligonucleotides | |
| HY-R04188A | mmu-miR-883a-3p agomir | Oligonucleotides | |
| HY-R04189 | mmu-miR-883a-5p mimic | Oligonucleotides | |
| HY-R04189A | mmu-miR-883a-5p agomir | Oligonucleotides | |
| HY-R04190 | mmu-miR-883b-3p mimic | Oligonucleotides | |
| HY-R04190A | mmu-miR-883b-3p agomir | Oligonucleotides | |
| HY-R04191 | mmu-miR-883b-5p mimic | Oligonucleotides | |
| HY-R04191A | mmu-miR-883b-5p agomir | Oligonucleotides | |
| HY-R04192 | mmu-miR-92a-1-5p mimic | Oligonucleotides | |
| HY-R04192A | mmu-miR-92a-1-5p agomir | Oligonucleotides | |
| HY-R04193 | mmu-miR-92a-2-5p mimic | Oligonucleotides | |
| HY-R04193A | mmu-miR-92a-2-5p agomir | Oligonucleotides | |
| HY-R04194 | mmu-miR-92a-3p mimic | Oligonucleotides | |
| HY-R04194A | mmu-miR-92a-3p agomir | Oligonucleotides | |
| HY-R04195 | mmu-miR-92b-5p mimic | Oligonucleotides | |
| HY-R04195A | mmu-miR-92b-5p agomir | Oligonucleotides | |
| HY-R04196 | mmu-miR-935 mimic | Oligonucleotides | |
| HY-R04196A | mmu-miR-935 agomir | Oligonucleotides | |
| HY-R04197 | mmu-miR-9768-3p mimic | Oligonucleotides | |
| HY-R04197A | mmu-miR-9768-3p agomir | Oligonucleotides | |
| HY-R04198 | mmu-miR-9768-5p mimic | Oligonucleotides | |
| HY-R04198A | mmu-miR-9768-5p agomir | Oligonucleotides | |
| HY-R04199 | mmu-miR-9769-3p mimic | Oligonucleotides | |
| HY-R04199A | mmu-miR-9769-3p agomir | Oligonucleotides | |
| HY-R04200 | mmu-miR-9769-5p mimic | Oligonucleotides | |
| HY-R04200A | mmu-miR-9769-5p agomir | Oligonucleotides | |
| HY-R04201 | mmu-miR-98-3p mimic | Oligonucleotides | |
| HY-R04201A | mmu-miR-98-3p agomir | Oligonucleotides | |
| HY-R04202 | mmu-miR-99a-3p mimic | Oligonucleotides | |
| HY-R04202A | mmu-miR-99a-3p agomir | Oligonucleotides | |
| HY-R04203 | mmu-miR-9b-3p mimic | Oligonucleotides | |
| HY-R04203A | mmu-miR-9b-3p agomir | Oligonucleotides | |
| HY-R04204 | mmu-miR-9b-5p mimic | Oligonucleotides | |
| HY-R04204A | mmu-miR-9b-5p agomir | Oligonucleotides | |
| HY-R04205 | rno-let-7f-1-3p mimic | Oligonucleotides | |
| HY-R04205A | rno-let-7f-1-3p agomir | Oligonucleotides | |
| HY-R04206 | rno-miR-100-3p mimic | Oligonucleotides | |
| HY-R04206A | rno-miR-100-3p agomir | Oligonucleotides | |
| HY-R04207 | rno-miR-101b-3p mimic | Oligonucleotides | |
| HY-R04207A | rno-miR-101b-3p agomir | Oligonucleotides | |
| HY-R04208 | rno-miR-103-2-5p mimic | Oligonucleotides | |
| HY-R04208A | rno-miR-103-2-5p agomir | Oligonucleotides | |
| HY-R04209 | rno-miR-105 mimic | Oligonucleotides | |
| HY-R04209A | rno-miR-105 agomir | Oligonucleotides | |
| HY-R04210 | rno-miR-107-5p mimic | Oligonucleotides | |
| HY-R04210A | rno-miR-107-5p agomir | Oligonucleotides | |
| HY-R04211 | rno-miR-10b-3p mimic | Oligonucleotides | |
| HY-R04211A | rno-miR-10b-3p agomir | Oligonucleotides | |
| HY-R04212 | rno-miR-10b-5p mimic | Oligonucleotides | |
| HY-R04212A | rno-miR-10b-5p agomir | Oligonucleotides | |
| HY-R04213 | rno-miR-1188-3p mimic | Oligonucleotides | |
| HY-R04213A | rno-miR-1188-3p agomir | Oligonucleotides | |
| HY-R04214 | rno-miR-1193-3p mimic | Oligonucleotides | |
| HY-R04214A | rno-miR-1193-3p agomir | Oligonucleotides | |
| HY-R04215 | rno-miR-1193-5p mimic | Oligonucleotides | |
| HY-R04215A | rno-miR-1193-5p agomir | Oligonucleotides | |
| HY-R04216 | rno-miR-1199-3p mimic | Oligonucleotides | |
| HY-R04216A | rno-miR-1199-3p agomir | Oligonucleotides | |
| HY-R04217 | rno-miR-1199-5p mimic | Oligonucleotides | |
| HY-R04217A | rno-miR-1199-5p agomir | Oligonucleotides | |
| HY-R04218 | rno-miR-122-3p mimic | Oligonucleotides | |
| HY-R04218A | rno-miR-122-3p agomir | Oligonucleotides | |
| HY-R04219 | rno-miR-122b mimic | Oligonucleotides | |
| HY-R04219A | rno-miR-122b agomir | Oligonucleotides | |
| HY-R04220 | rno-miR-125b-2-3p mimic | Oligonucleotides | |
| HY-R04220A | rno-miR-125b-2-3p agomir | Oligonucleotides | |
| HY-R04221 | rno-miR-126b mimic | Oligonucleotides | |
| HY-R04221A | rno-miR-126b agomir | Oligonucleotides | |
| HY-R04222 | rno-miR-127-5p mimic | Oligonucleotides | |
| HY-R04222A | rno-miR-127-5p agomir | Oligonucleotides | |
| HY-R04223 | rno-miR-128-2-5p mimic | Oligonucleotides | |
| HY-R04223A | rno-miR-128-2-5p agomir | Oligonucleotides | |
| HY-R04224 | rno-miR-129-1-3p mimic | Oligonucleotides | |
| HY-R04224A | rno-miR-129-1-3p agomir | Oligonucleotides | |
| HY-R04225 | rno-miR-1297 mimic | Oligonucleotides | |
| HY-R04225A | rno-miR-1297 agomir | Oligonucleotides | |
| HY-R04226 | rno-miR-1306-3p mimic | Oligonucleotides | |
| HY-R04226A | rno-miR-1306-3p agomir | Oligonucleotides | |
| HY-R04227 | rno-miR-133b-5p mimic | Oligonucleotides | |
| HY-R04227A | rno-miR-133b-5p agomir | Oligonucleotides | |
| HY-R04228 | rno-miR-133c mimic | Oligonucleotides | |
| HY-R04228A | rno-miR-133c agomir | Oligonucleotides | |
| HY-R04229 | rno-miR-134-3p mimic | Oligonucleotides | |
| HY-R04229A | rno-miR-134-3p agomir | Oligonucleotides | |
| HY-R04230 | rno-miR-135a-3p mimic | Oligonucleotides | |
| HY-R04230A | rno-miR-135a-3p agomir | Oligonucleotides | |
| HY-R04231 | rno-miR-137-5p mimic | Oligonucleotides | |
| HY-R04231A | rno-miR-137-5p agomir | Oligonucleotides | |
| HY-R04232 | rno-miR-1-3p mimic | Oligonucleotides | |
| HY-R04232A | rno-miR-1-3p agomir | Oligonucleotides | |
| HY-R04233 | rno-miR-141-5p mimic | Oligonucleotides | |
| HY-R04233A | rno-miR-141-5p agomir | Oligonucleotides | |
| HY-R04234 | rno-miR-143-3p mimic | Oligonucleotides | |
| HY-R04234A | rno-miR-143-3p agomir | Oligonucleotides | |
| HY-R04235 | rno-miR-145-3p mimic | Oligonucleotides | |
| HY-R04235A | rno-miR-145-3p agomir | Oligonucleotides | |
| HY-R04236 | rno-miR-146a-3p mimic | Oligonucleotides | |
| HY-R04236A | rno-miR-146a-3p agomir | Oligonucleotides | |
| HY-R04237 | rno-miR-146b-3p mimic | Oligonucleotides | |
| HY-R04237A | rno-miR-146b-3p agomir | Oligonucleotides | |
| HY-R04238 | rno-miR-146b-5p mimic | Oligonucleotides | |
| HY-R04238A | rno-miR-146b-5p agomir | Oligonucleotides | |
| HY-R04239 | rno-miR-148a-3p mimic | Oligonucleotides | |
| HY-R04239A | rno-miR-148a-3p agomir | Oligonucleotides | |
| HY-R04240 | rno-miR-148a-5p mimic | Oligonucleotides | |
| HY-R04240A | rno-miR-148a-5p agomir | Oligonucleotides | |
| HY-R04241 | rno-miR-148b-5p mimic | Oligonucleotides | |
| HY-R04241A | rno-miR-148b-5p agomir | Oligonucleotides | |
| HY-R04242 | rno-miR-149-3p mimic | Oligonucleotides | |
| HY-R04242A | rno-miR-149-3p agomir | Oligonucleotides | |
| HY-R04243 | rno-miR-150-3p mimic | Oligonucleotides | |
| HY-R04243A | rno-miR-150-3p agomir | Oligonucleotides | |
| HY-R04244 | rno-miR-153-5p mimic | Oligonucleotides | |
| HY-R04244A | rno-miR-153-5p agomir | Oligonucleotides | |
| HY-R04245 | rno-miR-15a-3p mimic | Oligonucleotides | |
| HY-R04245A | rno-miR-15a-3p agomir | Oligonucleotides | |
| HY-R04246 | rno-miR-15a-5p mimic | Oligonucleotides | |
| HY-R04246A | rno-miR-15a-5p agomir | Oligonucleotides | |
| HY-R04247 | rno-miR-1-5p mimic | Oligonucleotides | |
| HY-R04247A | rno-miR-1-5p agomir | Oligonucleotides | |
| HY-R04248 | rno-miR-16-3p mimic | Oligonucleotides | |
| HY-R04248A | rno-miR-16-3p agomir | Oligonucleotides | |
| HY-R04249 | rno-miR-17-1-3p mimic | Oligonucleotides | |
| HY-R04249A | rno-miR-17-1-3p agomir | Oligonucleotides | |
| HY-R04250 | rno-miR-17-2-3p mimic | Oligonucleotides | |
| HY-R04250A | rno-miR-17-2-3p agomir | Oligonucleotides | |
| HY-R04251 | rno-miR-181a-2-3p mimic | Oligonucleotides | |
| HY-R04251A | rno-miR-181a-2-3p agomir | Oligonucleotides | |
| HY-R04252 | rno-miR-181b-2-3p mimic | Oligonucleotides | |
| HY-R04252A | rno-miR-181b-2-3p agomir | Oligonucleotides | |
| HY-R04253 | rno-miR-181d-3p mimic | Oligonucleotides | |
| HY-R04253A | rno-miR-181d-3p agomir | Oligonucleotides | |
| HY-R04254 | rno-miR-183-3p mimic | Oligonucleotides | |
| HY-R04254A | rno-miR-183-3p agomir | Oligonucleotides | |
| HY-R04255 | rno-miR-1839-3p mimic | Oligonucleotides | |
| HY-R04255A | rno-miR-1839-3p agomir | Oligonucleotides | |
| HY-R04256 | rno-miR-1843b-3p mimic | Oligonucleotides | |
| HY-R04256A | rno-miR-1843b-3p agomir | Oligonucleotides | |
| HY-R04257 | rno-miR-1843b-5p mimic | Oligonucleotides | |
| HY-R04257A | rno-miR-1843b-5p agomir | Oligonucleotides | |
| HY-R04258 | rno-miR-185-3p mimic | Oligonucleotides | |
| HY-R04258A | rno-miR-185-3p agomir | Oligonucleotides | |
| HY-R04259 | rno-miR-186-3p mimic | Oligonucleotides | |
| HY-R04259A | rno-miR-186-3p agomir | Oligonucleotides | |
| HY-R04260 | rno-miR-187-5p mimic | Oligonucleotides | |
| HY-R04260A | rno-miR-187-5p agomir | Oligonucleotides | |
| HY-R04261 | rno-miR-188-3p mimic | Oligonucleotides | |
| HY-R04261A | rno-miR-188-3p agomir | Oligonucleotides | |
| HY-R04262 | rno-miR-1896 mimic | Oligonucleotides | |
| HY-R04262A | rno-miR-1896 agomir | Oligonucleotides | |
| HY-R04263 | rno-miR-18a-3p mimic | Oligonucleotides | |
| HY-R04263A | rno-miR-18a-3p agomir | Oligonucleotides | |
| HY-R04264 | rno-miR-190b-3p mimic | Oligonucleotides | |
| HY-R04264A | rno-miR-190b-3p agomir | Oligonucleotides | |
| HY-R04265 | rno-miR-190b-5p mimic | Oligonucleotides | |
| HY-R04265A | rno-miR-190b-5p agomir | Oligonucleotides | |
| HY-R04266 | rno-miR-1912-3p mimic | Oligonucleotides | |
| HY-R04266A | rno-miR-1912-3p agomir | Oligonucleotides | |
| HY-R04267 | rno-miR-1912-5p mimic | Oligonucleotides | |
| HY-R04267A | rno-miR-1912-5p agomir | Oligonucleotides | |
| HY-R04268 | rno-miR-191b mimic | Oligonucleotides | |
| HY-R04268A | rno-miR-191b agomir | Oligonucleotides | |
| HY-R04269 | rno-miR-192-3p mimic | Oligonucleotides | |
| HY-R04269A | rno-miR-192-3p agomir | Oligonucleotides | |
| HY-R04270 | rno-miR-193b-3p mimic | Oligonucleotides | |
| HY-R04270A | rno-miR-193b-3p agomir | Oligonucleotides | |
| HY-R04271 | rno-miR-193b-5p mimic | Oligonucleotides | |
| HY-R04271A | rno-miR-193b-5p agomir | Oligonucleotides | |
| HY-R04272 | rno-miR-194-3p mimic | Oligonucleotides | |
| HY-R04272A | rno-miR-194-3p agomir | Oligonucleotides | |
| HY-R04273 | rno-miR-1949 mimic | Oligonucleotides | |
| HY-R04273A | rno-miR-1949 agomir | Oligonucleotides | |
| HY-R04274 | rno-miR-195-3p mimic | Oligonucleotides | |
| HY-R04274A | rno-miR-195-3p agomir | Oligonucleotides | |
| HY-R04275 | rno-miR-1956-3p mimic | Oligonucleotides | |
| HY-R04275A | rno-miR-1956-3p agomir | Oligonucleotides | |
| HY-R04276 | rno-miR-196b-3p mimic | Oligonucleotides | |
| HY-R04276A | rno-miR-196b-3p agomir | Oligonucleotides | |
| HY-R04277 | rno-miR-196c-3p mimic | Oligonucleotides | |
| HY-R04277A | rno-miR-196c-3p agomir | Oligonucleotides | |
| HY-R04278 | rno-miR-196c-5p mimic | Oligonucleotides | |
| HY-R04278A | rno-miR-196c-5p agomir | Oligonucleotides | |
| HY-R04279 | rno-miR-19a-5p mimic | Oligonucleotides | |
| HY-R04279A | rno-miR-19a-5p agomir | Oligonucleotides | |
| HY-R04280 | rno-miR-19b-1-5p mimic | Oligonucleotides | |
| HY-R04280A | rno-miR-19b-1-5p agomir | Oligonucleotides | |
| HY-R04281 | rno-miR-19b-2-5p mimic | Oligonucleotides | |
| HY-R04281A | rno-miR-19b-2-5p agomir | Oligonucleotides | |
| HY-R04282 | rno-miR-200a-5p mimic | Oligonucleotides | |
| HY-R04282A | rno-miR-200a-5p agomir | Oligonucleotides | |
| HY-R04283 | rno-miR-200b-3p mimic | Oligonucleotides | |
| HY-R04283A | rno-miR-200b-3p agomir | Oligonucleotides | |
| HY-R04284 | rno-miR-200c-3p mimic | Oligonucleotides | |
| HY-R04284A | rno-miR-200c-3p agomir | Oligonucleotides | |
| HY-R04285 | rno-miR-200c-5p mimic | Oligonucleotides | |
| HY-R04285A | rno-miR-200c-5p agomir | Oligonucleotides | |
| HY-R04286 | rno-miR-201-3p mimic | Oligonucleotides | |
| HY-R04286A | rno-miR-201-3p agomir | Oligonucleotides | |
| HY-R04287 | rno-miR-201-5p mimic | Oligonucleotides | |
| HY-R04287A | rno-miR-201-5p agomir | Oligonucleotides | |
| HY-R04288 | rno-miR-202-3p mimic | Oligonucleotides | |
| HY-R04288A | rno-miR-202-3p agomir | Oligonucleotides | |
| HY-R04289 | rno-miR-202-5p mimic | Oligonucleotides | |
| HY-R04289A | rno-miR-202-5p agomir | Oligonucleotides | |
| HY-R04290 | rno-miR-203a-5p mimic | Oligonucleotides | |
| HY-R04290A | rno-miR-203a-5p agomir | Oligonucleotides | |
| HY-R04291 | rno-miR-204-3p mimic | Oligonucleotides | |
| HY-R04291A | rno-miR-204-3p agomir | Oligonucleotides | |
| HY-R04292 | rno-miR-205 mimic | Oligonucleotides | |
| HY-R04292A | rno-miR-205 agomir | Oligonucleotides | |
| HY-R04293 | rno-miR-206-5p mimic | Oligonucleotides | |
| HY-R04293A | rno-miR-206-5p agomir | Oligonucleotides | |
| HY-R04294 | rno-miR-207 mimic | Oligonucleotides | |
| HY-R04294A | rno-miR-207 agomir | Oligonucleotides | |
| HY-R04295 | rno-miR-208a-3p mimic | Oligonucleotides | |
| HY-R04295A | rno-miR-208a-3p agomir | Oligonucleotides | |
| HY-R04296 | rno-miR-208b-3p mimic | Oligonucleotides | |
| HY-R04296A | rno-miR-208b-3p agomir | Oligonucleotides | |
| HY-R04297 | rno-miR-208b-5p mimic | Oligonucleotides | |
| HY-R04297A | rno-miR-208b-5p agomir | Oligonucleotides | |
| HY-R04298 | rno-miR-20a-3p mimic | Oligonucleotides | |
| HY-R04298A | rno-miR-20a-3p agomir | Oligonucleotides | |
| HY-R04299 | rno-miR-20b-3p mimic | Oligonucleotides | |
| HY-R04299A | rno-miR-20b-3p agomir | Oligonucleotides | |
| HY-R04300 | rno-miR-210-5p mimic | Oligonucleotides | |
| HY-R04300A | rno-miR-210-5p agomir | Oligonucleotides | |
| HY-R04301 | rno-miR-211-3p mimic | Oligonucleotides | |
| HY-R04301A | rno-miR-211-3p agomir | Oligonucleotides | |
| HY-R04302 | rno-miR-212-5p mimic | Oligonucleotides | |
| HY-R04302A | rno-miR-212-5p agomir | Oligonucleotides | |
| HY-R04303 | rno-miR-214-3p mimic | Oligonucleotides | |
| HY-R04303A | rno-miR-214-3p agomir | Oligonucleotides | |
| HY-R04304 | rno-miR-214-5p mimic | Oligonucleotides | |
| HY-R04304A | rno-miR-214-5p agomir | Oligonucleotides | |
| HY-R04305 | rno-miR-215 mimic | Oligonucleotides | |
| HY-R04305A | rno-miR-215 agomir | Oligonucleotides | |
| HY-R04306 | rno-miR-216b-3p mimic | Oligonucleotides | |
| HY-R04306A | rno-miR-216b-3p agomir | Oligonucleotides | |
| HY-R04307 | rno-miR-217-3p mimic | Oligonucleotides | |
| HY-R04307A | rno-miR-217-3p agomir | Oligonucleotides | |
| HY-R04308 | rno-miR-217-5p mimic | Oligonucleotides | |
| HY-R04308A | rno-miR-217-5p agomir | Oligonucleotides | |
| HY-R04309 | rno-miR-218a-1-3p mimic | Oligonucleotides | |
| HY-R04309A | rno-miR-218a-1-3p agomir | Oligonucleotides | |
| HY-R04310 | rno-miR-218b mimic | Oligonucleotides | |
| HY-R04310A | rno-miR-218b agomir | Oligonucleotides | |
| HY-R04311 | rno-miR-221-5p mimic | Oligonucleotides | |
| HY-R04311A | rno-miR-221-5p agomir | Oligonucleotides | |
| HY-R04312 | rno-miR-222-5p mimic | Oligonucleotides | |
| HY-R04312A | rno-miR-222-5p agomir | Oligonucleotides | |
| HY-R04313 | rno-miR-223-3p mimic | Oligonucleotides | |
| HY-R04313A | rno-miR-223-3p agomir | Oligonucleotides | |
| HY-R04314 | rno-miR-24-1-5p mimic | Oligonucleotides | |
| HY-R04314A | rno-miR-24-1-5p agomir | Oligonucleotides | |
| HY-R04315 | rno-miR-25-5p mimic | Oligonucleotides | |
| HY-R04315A | rno-miR-25-5p agomir | Oligonucleotides | |
| HY-R04316 | rno-miR-26a-3p mimic | Oligonucleotides | |
| HY-R04316A | rno-miR-26a-3p agomir | Oligonucleotides | |
| HY-R04317 | rno-miR-27b-5p mimic | Oligonucleotides | |
| HY-R04317A | rno-miR-27b-5p agomir | Oligonucleotides | |
| HY-R04318 | rno-miR-290 mimic | Oligonucleotides | |
| HY-R04318A | rno-miR-290 agomir | Oligonucleotides | |
| HY-R04319 | rno-miR-291a-3p mimic | Oligonucleotides | |
| HY-R04319A | rno-miR-291a-3p agomir | Oligonucleotides | |
| HY-R04320 | rno-miR-291b mimic | Oligonucleotides | |
| HY-R04320A | rno-miR-291b agomir | Oligonucleotides | |
| HY-R04321 | rno-miR-292-3p mimic | Oligonucleotides | |
| HY-R04321A | rno-miR-292-3p agomir | Oligonucleotides | |
| HY-R04322 | rno-miR-293-3p mimic | Oligonucleotides | |
| HY-R04322A | rno-miR-293-3p agomir | Oligonucleotides | |
| HY-R04323 | rno-miR-293-5p mimic | Oligonucleotides | |
| HY-R04323A | rno-miR-293-5p agomir | Oligonucleotides | |
| HY-R04324 | rno-miR-294 mimic | Oligonucleotides | |
| HY-R04324A | rno-miR-294 agomir | Oligonucleotides | |
| HY-R04325 | rno-miR-295-3p mimic | Oligonucleotides | |
| HY-R04325A | rno-miR-295-3p agomir | Oligonucleotides | |
| HY-R04326 | rno-miR-295-5p mimic | Oligonucleotides | |
| HY-R04326A | rno-miR-295-5p agomir | Oligonucleotides | |
| HY-R04327 | rno-miR-297 mimic | Oligonucleotides | |
| HY-R04327A | rno-miR-297 agomir | Oligonucleotides | |
| HY-R04328 | rno-miR-298-3p mimic | Oligonucleotides | |
| HY-R04328A | rno-miR-298-3p agomir | Oligonucleotides | |
| HY-R04329 | rno-miR-2985 mimic | Oligonucleotides | |
| HY-R04329A | rno-miR-2985 agomir | Oligonucleotides | |
| HY-R04330 | rno-miR-299b-3p mimic | Oligonucleotides | |
| HY-R04330A | rno-miR-299b-3p agomir | Oligonucleotides | |
| HY-R04331 | rno-miR-299b-5p mimic | Oligonucleotides | |
| HY-R04331A | rno-miR-299b-5p agomir | Oligonucleotides | |
| HY-R04332 | rno-miR-29b-1-5p mimic | Oligonucleotides | |
| HY-R04332A | rno-miR-29b-1-5p agomir | Oligonucleotides | |
| HY-R04333 | rno-miR-301a-5p mimic | Oligonucleotides | |
| HY-R04333A | rno-miR-301a-5p agomir | Oligonucleotides | |
| HY-R04334 | rno-miR-3064-3p mimic | Oligonucleotides | |
| HY-R04334A | rno-miR-3064-3p agomir | Oligonucleotides | |
| HY-R04335 | rno-miR-3064-5p mimic | Oligonucleotides | |
| HY-R04335A | rno-miR-3064-5p agomir | Oligonucleotides | |
| HY-R04336 | rno-miR-3065-3p mimic | Oligonucleotides | |
| HY-R04336A | rno-miR-3065-3p agomir | Oligonucleotides | |
| HY-R04337 | rno-miR-3065-5p mimic | Oligonucleotides | |
| HY-R04337A | rno-miR-3065-5p agomir | Oligonucleotides | |
| HY-R04338 | rno-miR-3068-5p mimic | Oligonucleotides | |
| HY-R04338A | rno-miR-3068-5p agomir | Oligonucleotides | |
| HY-R04339 | rno-miR-3072 mimic | Oligonucleotides | |
| HY-R04339A | rno-miR-3072 agomir | Oligonucleotides | |
| HY-R04340 | rno-miR-3075 mimic | Oligonucleotides | |
| HY-R04340A | rno-miR-3075 agomir | Oligonucleotides | |
| HY-R04341 | rno-miR-3084a-1-5p mimic | Oligonucleotides | |
| HY-R04341A | rno-miR-3084a-1-5p agomir | Oligonucleotides | |
| HY-R04342 | rno-miR-3084a-3p mimic | Oligonucleotides | |
| HY-R04342A | rno-miR-3084a-3p agomir | Oligonucleotides | |
| HY-R04343 | rno-miR-3084b-3p mimic | Oligonucleotides | |
| HY-R04343A | rno-miR-3084b-3p agomir | Oligonucleotides | |
| HY-R04344 | rno-miR-3084b-5p mimic | Oligonucleotides | |
| HY-R04344A | rno-miR-3084b-5p agomir | Oligonucleotides | |
| HY-R04345 | rno-miR-3099 mimic | Oligonucleotides | |
| HY-R04345A | rno-miR-3099 agomir | Oligonucleotides | |
| HY-R04346 | rno-miR-31b mimic | Oligonucleotides | |
| HY-R04346A | rno-miR-31b agomir | Oligonucleotides | |
| HY-R04347 | rno-miR-322-3p mimic | Oligonucleotides | |
| HY-R04347A | rno-miR-322-3p agomir | Oligonucleotides | |
| HY-R04348 | rno-miR-32-3p mimic | Oligonucleotides | |
| HY-R04348A | rno-miR-32-3p agomir | Oligonucleotides | |
| HY-R04349 | rno-miR-324-3p mimic | Oligonucleotides | |
| HY-R04349A | rno-miR-324-3p agomir | Oligonucleotides | |
| HY-R04350 | rno-miR-326-5p mimic | Oligonucleotides | |
| HY-R04350A | rno-miR-326-5p agomir | Oligonucleotides | |
| HY-R04351 | rno-miR-327 mimic | Oligonucleotides | |
| HY-R04351A | rno-miR-327 agomir | Oligonucleotides | |
| HY-R04352 | rno-miR-328a-5p mimic | Oligonucleotides | |
| HY-R04352A | rno-miR-328a-5p agomir | Oligonucleotides | |
| HY-R04353 | rno-miR-328b-3p mimic | Oligonucleotides | |
| HY-R04353A | rno-miR-328b-3p agomir | Oligonucleotides | |
| HY-R04354 | rno-miR-329-5p mimic | Oligonucleotides | |
| HY-R04354A | rno-miR-329-5p agomir | Oligonucleotides | |
| HY-R04355 | rno-miR-331-5p mimic | Oligonucleotides | |
| HY-R04355A | rno-miR-331-5p agomir | Oligonucleotides | |
| HY-R04356 | rno-miR-33-3p mimic | Oligonucleotides | |
| HY-R04356A | rno-miR-33-3p agomir | Oligonucleotides | |
| HY-R04357 | rno-miR-336-3p mimic | Oligonucleotides | |
| HY-R04357A | rno-miR-336-3p agomir | Oligonucleotides | |
| HY-R04358 | rno-miR-336-5p mimic | Oligonucleotides | |
| HY-R04358A | rno-miR-336-5p agomir | Oligonucleotides | |
| HY-R04359 | rno-miR-337-3p mimic | Oligonucleotides | |
| HY-R04359A | rno-miR-337-3p agomir | Oligonucleotides | |
| HY-R04360 | rno-miR-337-5p mimic | Oligonucleotides | |
| HY-R04360A | rno-miR-337-5p agomir | Oligonucleotides | |
| HY-R04361 | rno-miR-339-3p mimic | Oligonucleotides | |
| HY-R04361A | rno-miR-339-3p agomir | Oligonucleotides | |
| HY-R04362 | rno-miR-343 mimic | Oligonucleotides | |
| HY-R04362A | rno-miR-343 agomir | Oligonucleotides | |
| HY-R04363 | rno-miR-344a-5p mimic | Oligonucleotides | |
| HY-R04363A | rno-miR-344a-5p agomir | Oligonucleotides | |
| HY-R04364 | rno-miR-344b-1-3p mimic | Oligonucleotides | |
| HY-R04364A | rno-miR-344b-1-3p agomir | Oligonucleotides | |
| HY-R04365 | rno-miR-344b-5p mimic | Oligonucleotides | |
| HY-R04365A | rno-miR-344b-5p agomir | Oligonucleotides | |
| HY-R04366 | rno-miR-344g mimic | Oligonucleotides | |
| HY-R04366A | rno-miR-344g agomir | Oligonucleotides | |
| HY-R04367 | rno-miR-344i mimic | Oligonucleotides | |
| HY-R04367A | rno-miR-344i agomir | Oligonucleotides | |
| HY-R04368 | rno-miR-345-3p mimic | Oligonucleotides | |
| HY-R04368A | rno-miR-345-3p agomir | Oligonucleotides | |
| HY-R04369 | rno-miR-345-5p mimic | Oligonucleotides | |
| HY-R04369A | rno-miR-345-5p agomir | Oligonucleotides | |
| HY-R04370 | rno-miR-346 mimic | Oligonucleotides | |
| HY-R04370A | rno-miR-346 agomir | Oligonucleotides | |
| HY-R04371 | rno-miR-347 mimic | Oligonucleotides | |
| HY-R04371A | rno-miR-347 agomir | Oligonucleotides | |
| HY-R04372 | rno-miR-3473 mimic | Oligonucleotides | |
| HY-R04372A | rno-miR-3473 agomir | Oligonucleotides | |
| HY-R04373 | rno-miR-349 mimic | Oligonucleotides | |
| HY-R04373A | rno-miR-349 agomir | Oligonucleotides | |
| HY-R04374 | rno-miR-34a-3p mimic | Oligonucleotides | |
| HY-R04374A | rno-miR-34a-3p agomir | Oligonucleotides | |
| HY-R04375 | rno-miR-350 mimic | Oligonucleotides | |
| HY-R04375A | rno-miR-350 agomir | Oligonucleotides | |
| HY-R04376 | rno-miR-351-5p mimic | Oligonucleotides | |
| HY-R04376A | rno-miR-351-5p agomir | Oligonucleotides | |
| HY-R04377 | rno-miR-352 mimic | Oligonucleotides | |
| HY-R04377A | rno-miR-352 agomir | Oligonucleotides | |
| HY-R04378 | rno-miR-3541 mimic | Oligonucleotides | |
| HY-R04378A | rno-miR-3541 agomir | Oligonucleotides | |
| HY-R04379 | rno-miR-3542 mimic | Oligonucleotides | |
| HY-R04379A | rno-miR-3542 agomir | Oligonucleotides | |
| HY-R04380 | rno-miR-3543 mimic | Oligonucleotides | |
| HY-R04380A | rno-miR-3543 agomir | Oligonucleotides | |
| HY-R04381 | rno-miR-3544 mimic | Oligonucleotides | |
| HY-R04381A | rno-miR-3544 agomir | Oligonucleotides | |
| HY-R04382 | rno-miR-3546 mimic | Oligonucleotides | |
| HY-R04382A | rno-miR-3546 agomir | Oligonucleotides | |
| HY-R04383 | rno-miR-3547 mimic | Oligonucleotides | |
| HY-R04383A | rno-miR-3547 agomir | Oligonucleotides | |
| HY-R04384 | rno-miR-3548 mimic | Oligonucleotides | |
| HY-R04384A | rno-miR-3548 agomir | Oligonucleotides | |
| HY-R04385 | rno-miR-3549 mimic | Oligonucleotides | |
| HY-R04385A | rno-miR-3549 agomir | Oligonucleotides | |
| HY-R04386 | rno-miR-3550 mimic | Oligonucleotides | |
| HY-R04386A | rno-miR-3550 agomir | Oligonucleotides | |
| HY-R04387 | rno-miR-3551-3p mimic | Oligonucleotides | |
| HY-R04387A | rno-miR-3551-3p agomir | Oligonucleotides | |
| HY-R04388 | rno-miR-3551-5p mimic | Oligonucleotides | |
| HY-R04388A | rno-miR-3551-5p agomir | Oligonucleotides | |
| HY-R04389 | rno-miR-3553 mimic | Oligonucleotides | |
| HY-R04389A | rno-miR-3553 agomir | Oligonucleotides | |
| HY-R04390 | rno-miR-3556a mimic | Oligonucleotides | |
| HY-R04390A | rno-miR-3556a agomir | Oligonucleotides | |
| HY-R04391 | rno-miR-3556b mimic | Oligonucleotides | |
| HY-R04391A | rno-miR-3556b agomir | Oligonucleotides | |
| HY-R04392 | rno-miR-3557-3p mimic | Oligonucleotides | |
| HY-R04392A | rno-miR-3557-3p agomir | Oligonucleotides | |
| HY-R04393 | rno-miR-3557-5p mimic | Oligonucleotides | |
| HY-R04393A | rno-miR-3557-5p agomir | Oligonucleotides | |
| HY-R04394 | rno-miR-3558-3p mimic | Oligonucleotides | |
| HY-R04394A | rno-miR-3558-3p agomir | Oligonucleotides | |
| HY-R04395 | rno-miR-3558-5p mimic | Oligonucleotides | |
| HY-R04395A | rno-miR-3558-5p agomir | Oligonucleotides | |
| HY-R04396 | rno-miR-3559-3p mimic | Oligonucleotides | |
| HY-R04396A | rno-miR-3559-3p agomir | Oligonucleotides | |
| HY-R04397 | rno-miR-3559-5p mimic | Oligonucleotides | |
| HY-R04397A | rno-miR-3559-5p agomir | Oligonucleotides | |
| HY-R04398 | rno-miR-3560 mimic | Oligonucleotides | |
| HY-R04398A | rno-miR-3560 agomir | Oligonucleotides | |
| HY-R04399 | rno-miR-3561-3p mimic | Oligonucleotides | |
| HY-R04399A | rno-miR-3561-3p agomir | Oligonucleotides | |
| HY-R04400 | rno-miR-3561-5p mimic | Oligonucleotides | |
| HY-R04400A | rno-miR-3561-5p agomir | Oligonucleotides | |
| HY-R04401 | rno-miR-3562 mimic | Oligonucleotides | |
| HY-R04401A | rno-miR-3562 agomir | Oligonucleotides | |
| HY-R04402 | rno-miR-3564 mimic | Oligonucleotides | |
| HY-R04402A | rno-miR-3564 agomir | Oligonucleotides | |
| HY-R04403 | rno-miR-3566 mimic | Oligonucleotides | |
| HY-R04403A | rno-miR-3566 agomir | Oligonucleotides | |
| HY-R04404 | rno-miR-3568 mimic | Oligonucleotides | |
| HY-R04404A | rno-miR-3568 agomir | Oligonucleotides | |
| HY-R04405 | rno-miR-3569 mimic | Oligonucleotides | |
| HY-R04405A | rno-miR-3569 agomir | Oligonucleotides | |
| HY-R04406 | rno-miR-3570 mimic | Oligonucleotides | |
| HY-R04406A | rno-miR-3570 agomir | Oligonucleotides | |
| HY-R04407 | rno-miR-3571 mimic | Oligonucleotides | |
| HY-R04407A | rno-miR-3571 agomir | Oligonucleotides | |
| HY-R04408 | rno-miR-3572 mimic | Oligonucleotides | |
| HY-R04408A | rno-miR-3572 agomir | Oligonucleotides | |
| HY-R04409 | rno-miR-3573-3p mimic | Oligonucleotides | |
| HY-R04409A | rno-miR-3573-3p agomir | Oligonucleotides | |
| HY-R04410 | rno-miR-3573-5p mimic | Oligonucleotides | |
| HY-R04410A | rno-miR-3573-5p agomir | Oligonucleotides | |
| HY-R04411 | rno-miR-3574 mimic | Oligonucleotides | |
| HY-R04411A | rno-miR-3574 agomir | Oligonucleotides | |
| HY-R04412 | rno-miR-3575 mimic | Oligonucleotides | |
| HY-R04412A | rno-miR-3575 agomir | Oligonucleotides | |
| HY-R04413 | rno-miR-3576 mimic | Oligonucleotides | |
| HY-R04413A | rno-miR-3576 agomir | Oligonucleotides | |
| HY-R04414 | rno-miR-3577 mimic | Oligonucleotides | |
| HY-R04414A | rno-miR-3577 agomir | Oligonucleotides | |
| HY-R04415 | rno-miR-3578 mimic | Oligonucleotides | |
| HY-R04415A | rno-miR-3578 agomir | Oligonucleotides | |
| HY-R04416 | rno-miR-3579 mimic | Oligonucleotides | |
| HY-R04416A | rno-miR-3579 agomir | Oligonucleotides | |
| HY-R04417 | rno-miR-3580-3p mimic | Oligonucleotides | |
| HY-R04417A | rno-miR-3580-3p agomir | Oligonucleotides | |
| HY-R04418 | rno-miR-3580-5p mimic | Oligonucleotides | |
| HY-R04418A | rno-miR-3580-5p agomir | Oligonucleotides | |
| HY-R04419 | rno-miR-3583-3p mimic | Oligonucleotides | |
| HY-R04419A | rno-miR-3583-3p agomir | Oligonucleotides | |
| HY-R04420 | rno-miR-3583-5p mimic | Oligonucleotides | |
| HY-R04420A | rno-miR-3583-5p agomir | Oligonucleotides | |
| HY-R04421 | rno-miR-3584-3p mimic | Oligonucleotides | |
| HY-R04421A | rno-miR-3584-3p agomir | Oligonucleotides | |
| HY-R04422 | rno-miR-3584-5p mimic | Oligonucleotides | |
| HY-R04422A | rno-miR-3584-5p agomir | Oligonucleotides | |
| HY-R04423 | rno-miR-3585-3p mimic | Oligonucleotides | |
| HY-R04423A | rno-miR-3585-3p agomir | Oligonucleotides | |
| HY-R04424 | rno-miR-3585-5p mimic | Oligonucleotides | |
| HY-R04424A | rno-miR-3585-5p agomir | Oligonucleotides | |
| HY-R04425 | rno-miR-3586-3p mimic | Oligonucleotides | |
| HY-R04425A | rno-miR-3586-3p agomir | Oligonucleotides | |
| HY-R04426 | rno-miR-3586-5p mimic | Oligonucleotides | |
| HY-R04426A | rno-miR-3586-5p agomir | Oligonucleotides | |
| HY-R04427 | rno-miR-3587 mimic | Oligonucleotides | |
| HY-R04427A | rno-miR-3587 agomir | Oligonucleotides | |
| HY-R04428 | rno-miR-3588 mimic | Oligonucleotides | |
| HY-R04428A | rno-miR-3588 agomir | Oligonucleotides | |
| HY-R04429 | rno-miR-3589 mimic | Oligonucleotides | |
| HY-R04429A | rno-miR-3589 agomir | Oligonucleotides | |
| HY-R04430 | rno-miR-3590-3p mimic | Oligonucleotides | |
| HY-R04430A | rno-miR-3590-3p agomir | Oligonucleotides | |
| HY-R04431 | rno-miR-3590-5p mimic | Oligonucleotides | |
| HY-R04431A | rno-miR-3590-5p agomir | Oligonucleotides | |
| HY-R04432 | rno-miR-3592 mimic | Oligonucleotides | |
| HY-R04432A | rno-miR-3592 agomir | Oligonucleotides | |
| HY-R04433 | rno-miR-3593-3p mimic | Oligonucleotides | |
| HY-R04433A | rno-miR-3593-3p agomir | Oligonucleotides | |
| HY-R04434 | rno-miR-3593-5p mimic | Oligonucleotides | |
| HY-R04434A | rno-miR-3593-5p agomir | Oligonucleotides | |
| HY-R04435 | rno-miR-3594-3p mimic | Oligonucleotides | |
| HY-R04435A | rno-miR-3594-3p agomir | Oligonucleotides | |
| HY-R04436 | rno-miR-3594-5p mimic | Oligonucleotides | |
| HY-R04436A | rno-miR-3594-5p agomir | Oligonucleotides | |
| HY-R04437 | rno-miR-3595 mimic | Oligonucleotides | |
| HY-R04437A | rno-miR-3595 agomir | Oligonucleotides | |
| HY-R04438 | rno-miR-3596a mimic | Oligonucleotides | |
| HY-R04438A | rno-miR-3596a agomir | Oligonucleotides | |
| HY-R04439 | rno-miR-3596b mimic | Oligonucleotides | |
| HY-R04439A | rno-miR-3596b agomir | Oligonucleotides | |
| HY-R04440 | rno-miR-3596c mimic | Oligonucleotides | |
| HY-R04440A | rno-miR-3596c agomir | Oligonucleotides | |
| HY-R04441 | rno-miR-3596d mimic | Oligonucleotides | |
| HY-R04441A | rno-miR-3596d agomir | Oligonucleotides | |
| HY-R04442 | rno-miR-361-3p mimic | Oligonucleotides | |
| HY-R04442A | rno-miR-361-3p agomir | Oligonucleotides | |
| HY-R04443 | rno-miR-363-3p mimic | Oligonucleotides | |
| HY-R04443A | rno-miR-363-3p agomir | Oligonucleotides | |
| HY-R04444 | rno-miR-365-5p mimic | Oligonucleotides | |
| HY-R04444A | rno-miR-365-5p agomir | Oligonucleotides | |
| HY-R04445 | rno-miR-370-5p mimic | Oligonucleotides | |
| HY-R04445A | rno-miR-370-5p agomir | Oligonucleotides | |
| HY-R04446 | rno-miR-374-3p mimic | Oligonucleotides | |
| HY-R04446A | rno-miR-374-3p agomir | Oligonucleotides | |
| HY-R04447 | rno-miR-376a-5p mimic | Oligonucleotides | |
| HY-R04447A | rno-miR-376a-5p agomir | Oligonucleotides | |
| HY-R04448 | rno-miR-376c-5p mimic | Oligonucleotides | |
| HY-R04448A | rno-miR-376c-5p agomir | Oligonucleotides | |
| HY-R04449 | rno-miR-377-3p mimic | Oligonucleotides | |
| HY-R04449A | rno-miR-377-3p agomir | Oligonucleotides | |
| HY-R04450 | rno-miR-378b mimic | Oligonucleotides | |
| HY-R04450A | rno-miR-378b agomir | Oligonucleotides | |
| HY-R04451 | rno-miR-379-3p mimic | Oligonucleotides | |
| HY-R04451A | rno-miR-379-3p agomir | Oligonucleotides | |
| HY-R04452 | rno-miR-380-3p mimic | Oligonucleotides | |
| HY-R04452A | rno-miR-380-3p agomir | Oligonucleotides | |
| HY-R04453 | rno-miR-381-3p mimic | Oligonucleotides | |
| HY-R04453A | rno-miR-381-3p agomir | Oligonucleotides | |
| HY-R04454 | rno-miR-383-5p mimic | Oligonucleotides | |
| HY-R04454A | rno-miR-383-5p agomir | Oligonucleotides | |
| HY-R04455 | rno-miR-409a-3p mimic | Oligonucleotides | |
| HY-R04455A | rno-miR-409a-3p agomir | Oligonucleotides | |
| HY-R04456 | rno-miR-409b mimic | Oligonucleotides | |
| HY-R04456A | rno-miR-409b agomir | Oligonucleotides | |
| HY-R04457 | rno-miR-411-3p mimic | Oligonucleotides | |
| HY-R04457A | rno-miR-411-3p agomir | Oligonucleotides | |
| HY-R04458 | rno-miR-412-3p mimic | Oligonucleotides | |
| HY-R04458A | rno-miR-412-3p agomir | Oligonucleotides | |
| HY-R04459 | rno-miR-412-5p mimic | Oligonucleotides | |
| HY-R04459A | rno-miR-412-5p agomir | Oligonucleotides | |
| HY-R04460 | rno-miR-421-3p mimic | Oligonucleotides | |
| HY-R04460A | rno-miR-421-3p agomir | Oligonucleotides | |
| HY-R04461 | rno-miR-421-5p mimic | Oligonucleotides | |
| HY-R04461A | rno-miR-421-5p agomir | Oligonucleotides | |
| HY-R04462 | rno-miR-423-5p mimic | Oligonucleotides | |
| HY-R04462A | rno-miR-423-5p agomir | Oligonucleotides | |
| HY-R04463 | rno-miR-425-3p mimic | Oligonucleotides | |
| HY-R04463A | rno-miR-425-3p agomir | Oligonucleotides | |
| HY-R04464 | rno-miR-434-5p mimic | Oligonucleotides | |
| HY-R04464A | rno-miR-434-5p agomir | Oligonucleotides | |
| HY-R04465 | rno-miR-448-3p mimic | Oligonucleotides | |
| HY-R04465A | rno-miR-448-3p agomir | Oligonucleotides | |
| HY-R04466 | rno-miR-448-5p mimic | Oligonucleotides | |
| HY-R04466A | rno-miR-448-5p agomir | Oligonucleotides | |
| HY-R04467 | rno-miR-449a-3p mimic | Oligonucleotides | |
| HY-R04467A | rno-miR-449a-3p agomir | Oligonucleotides | |
| HY-R04468 | rno-miR-449c-3p mimic | Oligonucleotides | |
| HY-R04468A | rno-miR-449c-3p agomir | Oligonucleotides | |
| HY-R04469 | rno-miR-450a-3p mimic | Oligonucleotides | |
| HY-R04469A | rno-miR-450a-3p agomir | Oligonucleotides | |
| HY-R04470 | rno-miR-450a-5p mimic | Oligonucleotides | |
| HY-R04470A | rno-miR-450a-5p agomir | Oligonucleotides | |
| HY-R04471 | rno-miR-450b-3p mimic | Oligonucleotides | |
| HY-R04471A | rno-miR-450b-3p agomir | Oligonucleotides | |
| HY-R04472 | rno-miR-450b-5p mimic | Oligonucleotides | |
| HY-R04472A | rno-miR-450b-5p agomir | Oligonucleotides | |
| HY-R04473 | rno-miR-451-3p mimic | Oligonucleotides | |
| HY-R04473A | rno-miR-451-3p agomir | Oligonucleotides | |
| HY-R04474 | rno-miR-452-3p mimic | Oligonucleotides | |
| HY-R04474A | rno-miR-452-3p agomir | Oligonucleotides | |
| HY-R04475 | rno-miR-452-5p mimic | Oligonucleotides | |
| HY-R04475A | rno-miR-452-5p agomir | Oligonucleotides | |
| HY-R04476 | rno-miR-455-3p mimic | Oligonucleotides | |
| HY-R04476A | rno-miR-455-3p agomir | Oligonucleotides | |
| HY-R04477 | rno-miR-463-3p mimic | Oligonucleotides | |
| HY-R04477A | rno-miR-463-3p agomir | Oligonucleotides | |
| HY-R04478 | rno-miR-463-5p mimic | Oligonucleotides | |
| HY-R04478A | rno-miR-463-5p agomir | Oligonucleotides | |
| HY-R04479 | rno-miR-465-3p mimic | Oligonucleotides | |
| HY-R04479A | rno-miR-465-3p agomir | Oligonucleotides | |
| HY-R04480 | rno-miR-465-5p mimic | Oligonucleotides | |
| HY-R04480A | rno-miR-465-5p agomir | Oligonucleotides | |
| HY-R04481 | rno-miR-466b-2-3p mimic | Oligonucleotides | |
| HY-R04481A | rno-miR-466b-2-3p agomir | Oligonucleotides | |
| HY-R04482 | rno-miR-466b-3p mimic | Oligonucleotides | |
| HY-R04482A | rno-miR-466b-3p agomir | Oligonucleotides | |
| HY-R04483 | rno-miR-466b-5p mimic | Oligonucleotides | |
| HY-R04483A | rno-miR-466b-5p agomir | Oligonucleotides | |
| HY-R04484 | rno-miR-466c-3p mimic | Oligonucleotides | |
| HY-R04484A | rno-miR-466c-3p agomir | Oligonucleotides | |
| HY-R04485 | rno-miR-466c-5p mimic | Oligonucleotides | |
| HY-R04485A | rno-miR-466c-5p agomir | Oligonucleotides | |
| HY-R04486 | rno-miR-466d mimic | Oligonucleotides | |
| HY-R04486A | rno-miR-466d agomir | Oligonucleotides | |
| HY-R04487 | rno-miR-471-3p mimic | Oligonucleotides | |
| HY-R04487A | rno-miR-471-3p agomir | Oligonucleotides | |
| HY-R04488 | rno-miR-483-3p mimic | Oligonucleotides | |
| HY-R04488A | rno-miR-483-3p agomir | Oligonucleotides | |
| HY-R04489 | rno-miR-485-3p mimic | Oligonucleotides | |
| HY-R04489A | rno-miR-485-3p agomir | Oligonucleotides | |
| HY-R04490 | rno-miR-487b-5p mimic | Oligonucleotides | |
| HY-R04490A | rno-miR-487b-5p agomir | Oligonucleotides | |
| HY-R04491 | rno-miR-489-3p mimic | Oligonucleotides | |
| HY-R04491A | rno-miR-489-3p agomir | Oligonucleotides | |
| HY-R04492 | rno-miR-489-5p mimic | Oligonucleotides | |
| HY-R04492A | rno-miR-489-5p agomir | Oligonucleotides | |
| HY-R04493 | rno-miR-493-3p mimic | Oligonucleotides | |
| HY-R04493A | rno-miR-493-3p agomir | Oligonucleotides | |
| HY-R04494 | rno-miR-494-3p mimic | Oligonucleotides | |
| HY-R04494A | rno-miR-494-3p agomir | Oligonucleotides | |
| HY-R04495 | rno-miR-496-3p mimic | Oligonucleotides | |
| HY-R04495A | rno-miR-496-3p agomir | Oligonucleotides | |
| HY-R04496 | rno-miR-496-5p mimic | Oligonucleotides | |
| HY-R04496A | rno-miR-496-5p agomir | Oligonucleotides | |
| HY-R04497 | rno-miR-497-3p mimic | Oligonucleotides | |
| HY-R04497A | rno-miR-497-3p agomir | Oligonucleotides | |
| HY-R04498 | rno-miR-500-5p mimic | Oligonucleotides | |
| HY-R04498A | rno-miR-500-5p agomir | Oligonucleotides | |
| HY-R04499 | rno-miR-501-3p mimic | Oligonucleotides | |
| HY-R04499A | rno-miR-501-3p agomir | Oligonucleotides | |
| HY-R04500 | rno-miR-501-5p mimic | Oligonucleotides | |
| HY-R04500A | rno-miR-501-5p agomir | Oligonucleotides | |
| HY-R04501 | rno-miR-503-3p mimic | Oligonucleotides | |
| HY-R04501A | rno-miR-503-3p agomir | Oligonucleotides | |
| HY-R04502 | rno-miR-504 mimic | Oligonucleotides | |
| HY-R04502A | rno-miR-504 agomir | Oligonucleotides | |
| HY-R04503 | rno-miR-505-3p mimic | Oligonucleotides | |
| HY-R04503A | rno-miR-505-3p agomir | Oligonucleotides | |
| HY-R04504 | rno-miR-509-3p mimic | Oligonucleotides | |
| HY-R04504A | rno-miR-509-3p agomir | Oligonucleotides | |
| HY-R04505 | rno-miR-509-5p mimic | Oligonucleotides | |
| HY-R04505A | rno-miR-509-5p agomir | Oligonucleotides | |
| HY-R04506 | rno-miR-511-3p mimic | Oligonucleotides | |
| HY-R04506A | rno-miR-511-3p agomir | Oligonucleotides | |
| HY-R04507 | rno-miR-511-5p mimic | Oligonucleotides | |
| HY-R04507A | rno-miR-511-5p agomir | Oligonucleotides | |
| HY-R04508 | rno-miR-5132-3p mimic | Oligonucleotides | |
| HY-R04508A | rno-miR-5132-3p agomir | Oligonucleotides | |
| HY-R04509 | rno-miR-5132-5p mimic | Oligonucleotides | |
| HY-R04509A | rno-miR-5132-5p agomir | Oligonucleotides | |
| HY-R04510 | rno-miR-532-5p mimic | Oligonucleotides | |
| HY-R04510A | rno-miR-532-5p agomir | Oligonucleotides | |
| HY-R04511 | rno-miR-539-3p mimic | Oligonucleotides | |
| HY-R04511A | rno-miR-539-3p agomir | Oligonucleotides | |
| HY-R04512 | rno-miR-540-3p mimic | Oligonucleotides | |
| HY-R04512A | rno-miR-540-3p agomir | Oligonucleotides | |
| HY-R04513 | rno-miR-541-3p mimic | Oligonucleotides | |
| HY-R04513A | rno-miR-541-3p agomir | Oligonucleotides | |
| HY-R04514 | rno-miR-543-3p mimic | Oligonucleotides | |
| HY-R04514A | rno-miR-543-3p agomir | Oligonucleotides | |
| HY-R04515 | rno-miR-544-3p mimic | Oligonucleotides | |
| HY-R04515A | rno-miR-544-3p agomir | Oligonucleotides | |
| HY-R04516 | rno-miR-544-5p mimic | Oligonucleotides | |
| HY-R04516A | rno-miR-544-5p agomir | Oligonucleotides | |
| HY-R04517 | rno-miR-547-3p mimic | Oligonucleotides | |
| HY-R04517A | rno-miR-547-3p agomir | Oligonucleotides | |
| HY-R04518 | rno-miR-547-5p mimic | Oligonucleotides | |
| HY-R04518A | rno-miR-547-5p agomir | Oligonucleotides | |
| HY-R04519 | rno-miR-551b-3p mimic | Oligonucleotides | |
| HY-R04519A | rno-miR-551b-3p agomir | Oligonucleotides | |
| HY-R04520 | rno-miR-582-3p mimic | Oligonucleotides | |
| HY-R04520A | rno-miR-582-3p agomir | Oligonucleotides | |
| HY-R04521 | rno-miR-598-5p mimic | Oligonucleotides | |
| HY-R04521A | rno-miR-598-5p agomir | Oligonucleotides | |
| HY-R04522 | rno-miR-6215 mimic | Oligonucleotides | |
| HY-R04522A | rno-miR-6215 agomir | Oligonucleotides | |
| HY-R04523 | rno-miR-6216 mimic | Oligonucleotides | |
| HY-R04523A | rno-miR-6216 agomir | Oligonucleotides | |
| HY-R04524 | rno-miR-628 mimic | Oligonucleotides | |
| HY-R04524A | rno-miR-628 agomir | Oligonucleotides | |
| HY-R04525 | rno-miR-6314 mimic | Oligonucleotides | |
| HY-R04525A | rno-miR-6314 agomir | Oligonucleotides | |
| HY-R04526 | rno-miR-6315 mimic | Oligonucleotides | |
| HY-R04526A | rno-miR-6315 agomir | Oligonucleotides | |
| HY-R04527 | rno-miR-6316 mimic | Oligonucleotides | |
| HY-R04527A | rno-miR-6316 agomir | Oligonucleotides | |
| HY-R04528 | rno-miR-6317 mimic | Oligonucleotides | |
| HY-R04528A | rno-miR-6317 agomir | Oligonucleotides | |
| HY-R04529 | rno-miR-6318 mimic | Oligonucleotides | |
| HY-R04529A | rno-miR-6318 agomir | Oligonucleotides | |
| HY-R04530 | rno-miR-6319 mimic | Oligonucleotides | |
| HY-R04530A | rno-miR-6319 agomir | Oligonucleotides | |
| HY-R04531 | rno-miR-632 mimic | Oligonucleotides | |
| HY-R04531A | rno-miR-632 agomir | Oligonucleotides | |
| HY-R04532 | rno-miR-6320 mimic | Oligonucleotides | |
| HY-R04532A | rno-miR-6320 agomir | Oligonucleotides | |
| HY-R04533 | rno-miR-6321 mimic | Oligonucleotides | |
| HY-R04533A | rno-miR-6321 agomir | Oligonucleotides | |
| HY-R04534 | rno-miR-6322 mimic | Oligonucleotides | |
| HY-R04534A | rno-miR-6322 agomir | Oligonucleotides | |
| HY-R04535 | rno-miR-6323 mimic | Oligonucleotides | |
| HY-R04535A | rno-miR-6323 agomir | Oligonucleotides | |
| HY-R04536 | rno-miR-6324 mimic | Oligonucleotides | |
| HY-R04536A | rno-miR-6324 agomir | Oligonucleotides | |
| HY-R04537 | rno-miR-6325 mimic | Oligonucleotides | |
| HY-R04537A | rno-miR-6325 agomir | Oligonucleotides | |
| HY-R04538 | rno-miR-6326 mimic | Oligonucleotides | |
| HY-R04538A | rno-miR-6326 agomir | Oligonucleotides | |
| HY-R04539 | rno-miR-6327 mimic | Oligonucleotides | |
| HY-R04539A | rno-miR-6327 agomir | Oligonucleotides | |
| HY-R04540 | rno-miR-6328 mimic | Oligonucleotides | |
| HY-R04540A | rno-miR-6328 agomir | Oligonucleotides | |
| HY-R04541 | rno-miR-6329 mimic | Oligonucleotides | |
| HY-R04541A | rno-miR-6329 agomir | Oligonucleotides | |
| HY-R04542 | rno-miR-6330 mimic | Oligonucleotides | |
| HY-R04542A | rno-miR-6330 agomir | Oligonucleotides | |
| HY-R04543 | rno-miR-6331 mimic | Oligonucleotides | |
| HY-R04543A | rno-miR-6331 agomir | Oligonucleotides | |
| HY-R04544 | rno-miR-6332 mimic | Oligonucleotides | |
| HY-R04544A | rno-miR-6332 agomir | Oligonucleotides | |
| HY-R04545 | rno-miR-6333 mimic | Oligonucleotides | |
| HY-R04545A | rno-miR-6333 agomir | Oligonucleotides | |
| HY-R04546 | rno-miR-6334 mimic | Oligonucleotides | |
| HY-R04546A | rno-miR-6334 agomir | Oligonucleotides | |
| HY-R04547 | rno-miR-652-5p mimic | Oligonucleotides | |
| HY-R04547A | rno-miR-652-5p agomir | Oligonucleotides | |
| HY-R04548 | rno-miR-653-3p mimic | Oligonucleotides | |
| HY-R04548A | rno-miR-653-3p agomir | Oligonucleotides | |
| HY-R04549 | rno-miR-653-5p mimic | Oligonucleotides | |
| HY-R04549A | rno-miR-653-5p agomir | Oligonucleotides | |
| HY-R04550 | rno-miR-664-1-5p mimic | Oligonucleotides | |
| HY-R04550A | rno-miR-664-1-5p agomir | Oligonucleotides | |
| HY-R04551 | rno-miR-664-2-5p mimic | Oligonucleotides | |
| HY-R04551A | rno-miR-664-2-5p agomir | Oligonucleotides | |
| HY-R04552 | rno-miR-665 mimic | Oligonucleotides | |
| HY-R04552A | rno-miR-665 agomir | Oligonucleotides | |
| HY-R04553 | rno-miR-666-3p mimic | Oligonucleotides | |
| HY-R04553A | rno-miR-666-3p agomir | Oligonucleotides | |
| HY-R04554 | rno-miR-666-5p mimic | Oligonucleotides | |
| HY-R04554A | rno-miR-666-5p agomir | Oligonucleotides | |
| HY-R04555 | rno-miR-667-3p mimic | Oligonucleotides | |
| HY-R04555A | rno-miR-667-3p agomir | Oligonucleotides | |
| HY-R04556 | rno-miR-667-5p mimic | Oligonucleotides | |
| HY-R04556A | rno-miR-667-5p agomir | Oligonucleotides | |
| HY-R04557 | rno-miR-672-3p mimic | Oligonucleotides | |
| HY-R04557A | rno-miR-672-3p agomir | Oligonucleotides | |
| HY-R04558 | rno-miR-673-3p mimic | Oligonucleotides | |
| HY-R04558A | rno-miR-673-3p agomir | Oligonucleotides | |
| HY-R04559 | rno-miR-673-5p mimic | Oligonucleotides | |
| HY-R04559A | rno-miR-673-5p agomir | Oligonucleotides | |
| HY-R04560 | rno-miR-675-3p mimic | Oligonucleotides | |
| HY-R04560A | rno-miR-675-3p agomir | Oligonucleotides | |
| HY-R04561 | rno-miR-676 mimic | Oligonucleotides | |
| HY-R04561A | rno-miR-676 agomir | Oligonucleotides | |
| HY-R04562 | rno-miR-678 mimic | Oligonucleotides | |
| HY-R04562A | rno-miR-678 agomir | Oligonucleotides | |
| HY-R04563 | rno-miR-679 mimic | Oligonucleotides | |
| HY-R04563A | rno-miR-679 agomir | Oligonucleotides | |
| HY-R04564 | rno-miR-702-3p mimic | Oligonucleotides | |
| HY-R04564A | rno-miR-702-3p agomir | Oligonucleotides | |
| HY-R04565 | rno-miR-709 mimic | Oligonucleotides | |
| HY-R04565A | rno-miR-709 agomir | Oligonucleotides | |
| HY-R04566 | rno-miR-711 mimic | Oligonucleotides | |
| HY-R04566A | rno-miR-711 agomir | Oligonucleotides | |
| HY-R04567 | rno-miR-741-3p mimic | Oligonucleotides | |
| HY-R04567A | rno-miR-741-3p agomir | Oligonucleotides | |
| HY-R04568 | rno-miR-741-5p mimic | Oligonucleotides | |
| HY-R04568A | rno-miR-741-5p agomir | Oligonucleotides | |
| HY-R04569 | rno-miR-742-3p mimic | Oligonucleotides | |
| HY-R04569A | rno-miR-742-3p agomir | Oligonucleotides | |
| HY-R04570 | rno-miR-743a-3p mimic | Oligonucleotides | |
| HY-R04570A | rno-miR-743a-3p agomir | Oligonucleotides | |
| HY-R04571 | rno-miR-743b-3p mimic | Oligonucleotides | |
| HY-R04571A | rno-miR-743b-3p agomir | Oligonucleotides | |
| HY-R04572 | rno-miR-743b-5p mimic | Oligonucleotides | |
| HY-R04572A | rno-miR-743b-5p agomir | Oligonucleotides | |
| HY-R04573 | rno-miR-7578 mimic | Oligonucleotides | |
| HY-R04573A | rno-miR-7578 agomir | Oligonucleotides | |
| HY-R04574 | rno-miR-760-5p mimic | Oligonucleotides | |
| HY-R04574A | rno-miR-760-5p agomir | Oligonucleotides | |
| HY-R04575 | rno-miR-762 mimic | Oligonucleotides | |
| HY-R04575A | rno-miR-762 agomir | Oligonucleotides | |
| HY-R04576 | rno-miR-764-3p mimic | Oligonucleotides | |
| HY-R04576A | rno-miR-764-3p agomir | Oligonucleotides | |
| HY-R04577 | rno-miR-764-5p mimic | Oligonucleotides | |
| HY-R04577A | rno-miR-764-5p agomir | Oligonucleotides | |
| HY-R04578 | rno-miR-770-3p mimic | Oligonucleotides | |
| HY-R04578A | rno-miR-770-3p agomir | Oligonucleotides | |
| HY-R04579 | rno-miR-7a-1-3p mimic | Oligonucleotides | |
| HY-R04579A | rno-miR-7a-1-3p agomir | Oligonucleotides | |
| HY-R04580 | rno-miR-7b mimic | Oligonucleotides | |
| HY-R04580A | rno-miR-7b agomir | Oligonucleotides | |
| HY-R04581 | rno-miR-802-3p mimic | Oligonucleotides | |
| HY-R04581A | rno-miR-802-3p agomir | Oligonucleotides | |
| HY-R04582 | rno-miR-802-5p mimic | Oligonucleotides | |
| HY-R04582A | rno-miR-802-5p agomir | Oligonucleotides | |
| HY-R04583 | rno-miR-871-3p mimic | Oligonucleotides | |
| HY-R04583A | rno-miR-871-3p agomir | Oligonucleotides | |
| HY-R04584 | rno-miR-871-5p mimic | Oligonucleotides | |
| HY-R04584A | rno-miR-871-5p agomir | Oligonucleotides | |
| HY-R04585 | rno-miR-874-5p mimic | Oligonucleotides | |
| HY-R04585A | rno-miR-874-5p agomir | Oligonucleotides | |
| HY-R04586 | rno-miR-876 mimic | Oligonucleotides | |
| HY-R04586A | rno-miR-876 agomir | Oligonucleotides | |
| HY-R04587 | rno-miR-878 mimic | Oligonucleotides | |
| HY-R04587A | rno-miR-878 agomir | Oligonucleotides | |
| HY-R04588 | rno-miR-879-3p mimic | Oligonucleotides | |
| HY-R04588A | rno-miR-879-3p agomir | Oligonucleotides | |
| HY-R04589 | rno-miR-880-3p mimic | Oligonucleotides | |
| HY-R04589A | rno-miR-880-3p agomir | Oligonucleotides | |
| HY-R04590 | rno-miR-880-5p mimic | Oligonucleotides | |
| HY-R04590A | rno-miR-880-5p agomir | Oligonucleotides | |
| HY-R04591 | rno-miR-881-3p mimic | Oligonucleotides | |
| HY-R04591A | rno-miR-881-3p agomir | Oligonucleotides | |
| HY-R04592 | rno-miR-881-5p mimic | Oligonucleotides | |
| HY-R04592A | rno-miR-881-5p agomir | Oligonucleotides | |
| HY-R04593 | rno-miR-883-5p mimic | Oligonucleotides | |
| HY-R04593A | rno-miR-883-5p agomir | Oligonucleotides | |
| HY-R04594 | rno-miR-92a-2-5p mimic | Oligonucleotides | |
| HY-R04594A | rno-miR-92a-2-5p agomir | Oligonucleotides | |
| HY-R04595 | rno-miR-92b-5p mimic | Oligonucleotides | |
| HY-R04595A | rno-miR-92b-5p agomir | Oligonucleotides | |
| HY-R04596 | rno-miR-93-3p mimic | Oligonucleotides | |
| HY-R04596A | rno-miR-93-3p agomir | Oligonucleotides | |
| HY-R04597 | rno-miR-96-3p mimic | Oligonucleotides | |
| HY-R04597A | rno-miR-96-3p agomir | Oligonucleotides | |
| HY-R04598 | rno-miR-98-3p mimic | Oligonucleotides | |
| HY-R04598A | rno-miR-98-3p agomir | Oligonucleotides | |
| HY-R04599 | rno-miR-99a-3p mimic | Oligonucleotides | |
| HY-R04599A | rno-miR-99a-3p agomir | Oligonucleotides | |
| HY-R04600 | rno-miR-9b-3p mimic | Oligonucleotides | |
| HY-R04600A | rno-miR-9b-3p agomir | Oligonucleotides | |
| HY-R04601 | rno-miR-9b-5p mimic | Oligonucleotides | |
| HY-R04601A | rno-miR-9b-5p agomir | Oligonucleotides | |
| HY-R04602 | MicroRNA Mimic Negative Control | Oligonucleotides | |
| HY-R04602A | MicroRNA Agomir Negative Control | Oligonucleotides | |
| HY-R04604 | mmu-miR-186-5p mimic | Oligonucleotides | |
| HY-R04604A | mmu-miR-186-5p agomir | Oligonucleotides | |
| HY-R04605 | mmu-miR-378a-5p mimic | Oligonucleotides | |
| HY-R04605A | mmu-miR-378a-5p agomir | Oligonucleotides | |
| HY-R04606 | hsa-miR-24-3p mimic | Oligonucleotides | |
| HY-R04606A | hsa-miR-24-3p agomir | Oligonucleotides | |
| HY-R04607 | hsa-miR-134-3p mimic | Oligonucleotides | |
| HY-R04607A | hsa-miR-134-3p agomir | Oligonucleotides | |
| HY-R04608 | RAD51 SSDNA-1 | Oligonucleotides | |
| HY-R04609A | In Vivo Rgma Rat Pre-designed siRNA Set A-1 | Oligonucleotides | |
| HY-R04609B | In Vivo Rgma Rat Pre-designed siRNA Set A-2 | Oligonucleotides | |
| HY-R04609C | In Vivo Rgma Rat Pre-designed siRNA Set A-3 | Oligonucleotides | |
| HY-R04611 | hsa-miR-302b-3p mimic | Oligonucleotides | |
| HY-R04612 | 4o8G-miR-592 | Oligonucleotides | |
| HY-RI00001 | hsa-let-7a-2-3p inhibitor | Oligonucleotides | |
| HY-RI00001A | hsa-let-7a-2-3p antagomir | Oligonucleotides | |
| HY-RI00002 | hsa-let-7a-3p inhibitor | Oligonucleotides | |
| HY-RI00002A | hsa-let-7a-3p antagomir | Oligonucleotides | |
| HY-RI00003 | hsa-let-7a-5p inhibitor | Oligonucleotides | |
| HY-RI00003A | hsa-let-7a-5p antagomir | Oligonucleotides | |
| HY-RI00004 | hsa-let-7b-3p inhibitor | Oligonucleotides | |
| HY-RI00004A | hsa-let-7b-3p antagomir | Oligonucleotides | |
| HY-RI00005 | hsa-let-7b-5p inhibitor | Oligonucleotides | |
| HY-RI00005A | hsa-let-7b-5p antagomir | Oligonucleotides | |
| HY-RI00006 | hsa-let-7c-3p inhibitor | Oligonucleotides | |
| HY-RI00006A | hsa-let-7c-3p antagomir | Oligonucleotides | |
| HY-RI00007 | hsa-let-7c-5p inhibitor | Oligonucleotides | |
| HY-RI00007A | hsa-let-7c-5p antagomir | Oligonucleotides | |
| HY-RI00008 | hsa-let-7d-3p inhibitor | Oligonucleotides | |
| HY-RI00008A | hsa-let-7d-3p antagomir | Oligonucleotides | |
| HY-RI00009 | hsa-let-7e-3p inhibitor | Oligonucleotides | |
| HY-RI00009A | hsa-let-7e-3p antagomir | Oligonucleotides | |
| HY-RI00010 | hsa-let-7f-1-3p inhibitor | Oligonucleotides | |
| HY-RI00010A | hsa-let-7f-1-3p antagomir | Oligonucleotides | |
| HY-RI00011 | hsa-let-7f-2-3p inhibitor | Oligonucleotides | |
| HY-RI00011A | hsa-let-7f-2-3p antagomir | Oligonucleotides | |
| HY-RI00012 | hsa-let-7g-5p inhibitor | Oligonucleotides | |
| HY-RI00012A | hsa-let-7g-5p antagomir | Oligonucleotides | |
| HY-RI00013 | hsa-let-7i-3p inhibitor | Oligonucleotides | |
| HY-RI00013A | hsa-let-7i-3p antagomir | Oligonucleotides | |
| HY-RI00014 | hsa-let-7i-5p inhibitor | Oligonucleotides | |
| HY-RI00014A | hsa-let-7i-5p antagomir | Oligonucleotides | |
| HY-RI00015 | hsa-miR-100-5p inhibitor | Oligonucleotides | |
| HY-RI00015A | hsa-miR-100-5p antagomir | Oligonucleotides | |
| HY-RI00016 | hsa-miR-101-2-5p inhibitor | Oligonucleotides | |
| HY-RI00016A | hsa-miR-101-2-5p antagomir | Oligonucleotides | |
| HY-RI00017 | hsa-miR-101-3p inhibitor | Oligonucleotides | |
| HY-RI00017A | hsa-miR-101-3p antagomir | Oligonucleotides | |
| HY-RI00018 | hsa-miR-101-5p inhibitor | Oligonucleotides | |
| HY-RI00018A | hsa-miR-101-5p antagomir | Oligonucleotides | |
| HY-RI00019 | hsa-miR-10226 inhibitor | Oligonucleotides | |
| HY-RI00019A | hsa-miR-10226 antagomir | Oligonucleotides | |
| HY-RI00020 | hsa-miR-10392-3p inhibitor | Oligonucleotides | |
| HY-RI00020A | hsa-miR-10392-3p antagomir | Oligonucleotides | |
| HY-RI00021 | hsa-miR-10392-5p inhibitor | Oligonucleotides | |
| HY-RI00021A | hsa-miR-10392-5p antagomir | Oligonucleotides | |
| HY-RI00022 | hsa-miR-10393-3p inhibitor | Oligonucleotides | |
| HY-RI00022A | hsa-miR-10393-3p antagomir | Oligonucleotides | |
| HY-RI00023 | hsa-miR-10393-5p inhibitor | Oligonucleotides | |
| HY-RI00023A | hsa-miR-10393-5p antagomir | Oligonucleotides | |
| HY-RI00024 | hsa-miR-10394-3p inhibitor | Oligonucleotides | |
| HY-RI00024A | hsa-miR-10394-3p antagomir | Oligonucleotides | |
| HY-RI00025 | hsa-miR-10394-5p inhibitor | Oligonucleotides | |
| HY-RI00025A | hsa-miR-10394-5p antagomir | Oligonucleotides | |
| HY-RI00026 | hsa-miR-10395-3p inhibitor | Oligonucleotides | |
| HY-RI00026A | hsa-miR-10395-3p antagomir | Oligonucleotides | |
| HY-RI00027 | hsa-miR-10395-5p inhibitor | Oligonucleotides | |
| HY-RI00027A | hsa-miR-10395-5p antagomir | Oligonucleotides | |
| HY-RI00028 | hsa-miR-10396a-3p inhibitor | Oligonucleotides | |
| HY-RI00028A | hsa-miR-10396a-3p antagomir | Oligonucleotides | |
| HY-RI00029 | hsa-miR-10396a-5p inhibitor | Oligonucleotides | |
| HY-RI00029A | hsa-miR-10396a-5p antagomir | Oligonucleotides | |
| HY-RI00030 | hsa-miR-10396b-3p inhibitor | Oligonucleotides | |
| HY-RI00030A | hsa-miR-10396b-3p antagomir | Oligonucleotides | |
| HY-RI00031 | hsa-miR-10396b-5p inhibitor | Oligonucleotides | |
| HY-RI00031A | hsa-miR-10396b-5p antagomir | Oligonucleotides | |
| HY-RI00032 | hsa-miR-10397-3p inhibitor | Oligonucleotides | |
| HY-RI00032A | hsa-miR-10397-3p antagomir | Oligonucleotides | |
| HY-RI00033 | hsa-miR-10397-5p inhibitor | Oligonucleotides | |
| HY-RI00033A | hsa-miR-10397-5p antagomir | Oligonucleotides | |
| HY-RI00034 | hsa-miR-10398-3p inhibitor | Oligonucleotides | |
| HY-RI00034A | hsa-miR-10398-3p antagomir | Oligonucleotides | |
| HY-RI00035 | hsa-miR-10398-5p inhibitor | Oligonucleotides | |
| HY-RI00035A | hsa-miR-10398-5p antagomir | Oligonucleotides | |
| HY-RI00036 | hsa-miR-10399-3p inhibitor | Oligonucleotides | |
| HY-RI00036A | hsa-miR-10399-3p antagomir | Oligonucleotides | |
| HY-RI00037 | hsa-miR-10399-5p inhibitor | Oligonucleotides | |
| HY-RI00037A | hsa-miR-10399-5p antagomir | Oligonucleotides | |
| HY-RI00038 | hsa-miR-103a-1-5p inhibitor | Oligonucleotides | |
| HY-RI00038A | hsa-miR-103a-1-5p antagomir | Oligonucleotides | |
| HY-RI00039 | hsa-miR-103a-2-5p inhibitor | Oligonucleotides | |
| HY-RI00039A | hsa-miR-103a-2-5p antagomir | Oligonucleotides | |
| HY-RI00040 | hsa-miR-103a-3p inhibitor | Oligonucleotides | |
| HY-RI00040A | hsa-miR-103a-3p antagomir | Oligonucleotides | |
| HY-RI00041 | hsa-miR-10400-3p inhibitor | Oligonucleotides | |
| HY-RI00041A | hsa-miR-10400-3p antagomir | Oligonucleotides | |
| HY-RI00042 | hsa-miR-10400-5p inhibitor | Oligonucleotides | |
| HY-RI00042A | hsa-miR-10400-5p antagomir | Oligonucleotides | |
| HY-RI00043 | hsa-miR-10401-3p inhibitor | Oligonucleotides | |
| HY-RI00043A | hsa-miR-10401-3p antagomir | Oligonucleotides | |
| HY-RI00044 | hsa-miR-10401-5p inhibitor | Oligonucleotides | |
| HY-RI00044A | hsa-miR-10401-5p antagomir | Oligonucleotides | |
| HY-RI00045 | hsa-miR-10522-5p inhibitor | Oligonucleotides | |
| HY-RI00045A | hsa-miR-10522-5p antagomir | Oligonucleotides | |
| HY-RI00046 | hsa-miR-10523-5p inhibitor | Oligonucleotides | |
| HY-RI00046A | hsa-miR-10523-5p antagomir | Oligonucleotides | |
| HY-RI00047 | hsa-miR-10524-5p inhibitor | Oligonucleotides | |
| HY-RI00047A | hsa-miR-10524-5p antagomir | Oligonucleotides | |
| HY-RI00048 | hsa-miR-10525-3p inhibitor | Oligonucleotides | |
| HY-RI00048A | hsa-miR-10525-3p antagomir | Oligonucleotides | |
| HY-RI00049 | hsa-miR-10526-3p inhibitor | Oligonucleotides | |
| HY-RI00049A | hsa-miR-10526-3p antagomir | Oligonucleotides | |
| HY-RI00050 | hsa-miR-10527-5p inhibitor | Oligonucleotides | |
| HY-RI00050A | hsa-miR-10527-5p antagomir | Oligonucleotides | |
| HY-RI00051 | hsa-miR-105-3p inhibitor | Oligonucleotides | |
| HY-RI00051A | hsa-miR-105-3p antagomir | Oligonucleotides | |
| HY-RI00052 | hsa-miR-105-5p inhibitor | Oligonucleotides | |
| HY-RI00052A | hsa-miR-105-5p antagomir | Oligonucleotides | |
| HY-RI00053 | hsa-miR-106a-3p inhibitor | Oligonucleotides | |
| HY-RI00053A | hsa-miR-106a-3p antagomir | Oligonucleotides | |
| HY-RI00054 | hsa-miR-106a-5p inhibitor | Oligonucleotides | |
| HY-RI00054A | hsa-miR-106a-5p antagomir | Oligonucleotides | |
| HY-RI00055 | hsa-miR-106b-3p inhibitor | Oligonucleotides | |
| HY-RI00055A | hsa-miR-106b-3p antagomir | Oligonucleotides | |
| HY-RI00056 | hsa-miR-106b-5p inhibitor | Oligonucleotides | |
| HY-RI00056A | hsa-miR-106b-5p antagomir | Oligonucleotides | |
| HY-RI00057 | hsa-miR-107 inhibitor | Oligonucleotides | |
| HY-RI00057A | hsa-miR-107 antagomir | Oligonucleotides | |
| HY-RI00058 | hsa-miR-10a-3p inhibitor | Oligonucleotides | |
| HY-RI00058A | hsa-miR-10a-3p antagomir | Oligonucleotides | |
| HY-RI00059 | hsa-miR-10a-5p inhibitor | Oligonucleotides | |
| HY-RI00059A | hsa-miR-10a-5p antagomir | Oligonucleotides | |
| HY-RI00060 | hsa-miR-10b-3p inhibitor | Oligonucleotides | |
| HY-RI00060A | hsa-miR-10b-3p antagomir | Oligonucleotides | |
| HY-RI00061 | hsa-miR-10b-5p inhibitor | Oligonucleotides | |
| HY-RI00061A | hsa-miR-10b-5p antagomir | Oligonucleotides | |
| HY-RI00062 | hsa-miR-11181-3p inhibitor | Oligonucleotides | |
| HY-RI00062A | hsa-miR-11181-3p antagomir | Oligonucleotides | |
| HY-RI00063 | hsa-miR-11181-5p inhibitor | Oligonucleotides | |
| HY-RI00063A | hsa-miR-11181-5p antagomir | Oligonucleotides | |
| HY-RI00064 | hsa-miR-11399 inhibitor | Oligonucleotides | |
| HY-RI00064A | hsa-miR-11399 antagomir | Oligonucleotides | |
| HY-RI00065 | hsa-miR-11400 inhibitor | Oligonucleotides | |
| HY-RI00065A | hsa-miR-11400 antagomir | Oligonucleotides | |
| HY-RI00066 | hsa-miR-11401 inhibitor | Oligonucleotides | |
| HY-RI00066A | hsa-miR-11401 antagomir | Oligonucleotides | |
| HY-RI00067 | hsa-miR-1178-3p inhibitor | Oligonucleotides | |
| HY-RI00067A | hsa-miR-1178-3p antagomir | Oligonucleotides | |
| HY-RI00068 | hsa-miR-1178-5p inhibitor | Oligonucleotides | |
| HY-RI00068A | hsa-miR-1178-5p antagomir | Oligonucleotides | |
| HY-RI00069 | hsa-miR-1179 inhibitor | Oligonucleotides | |
| HY-RI00069A | hsa-miR-1179 antagomir | Oligonucleotides | |
| HY-RI00070 | hsa-miR-1180-3p inhibitor | Oligonucleotides | |
| HY-RI00070A | hsa-miR-1180-3p antagomir | Oligonucleotides | |
| HY-RI00071 | hsa-miR-1180-5p inhibitor | Oligonucleotides | |
| HY-RI00071A | hsa-miR-1180-5p antagomir | Oligonucleotides | |
| HY-RI00072 | hsa-miR-1182 inhibitor | Oligonucleotides | |
| HY-RI00072A | hsa-miR-1182 antagomir | Oligonucleotides | |
| HY-RI00073 | hsa-miR-1183 inhibitor | Oligonucleotides | |
| HY-RI00073A | hsa-miR-1183 antagomir | Oligonucleotides | |
| HY-RI00074 | hsa-miR-1184 inhibitor | Oligonucleotides | |
| HY-RI00074A | hsa-miR-1184 antagomir | Oligonucleotides | |
| HY-RI00075 | hsa-miR-1185-1-3p inhibitor | Oligonucleotides | |
| HY-RI00075A | hsa-miR-1185-1-3p antagomir | Oligonucleotides | |
| HY-RI00076 | hsa-miR-1185-2-3p inhibitor | Oligonucleotides | |
| HY-RI00076A | hsa-miR-1185-2-3p antagomir | Oligonucleotides | |
| HY-RI00077 | hsa-miR-1185-5p inhibitor | Oligonucleotides | |
| HY-RI00077A | hsa-miR-1185-5p antagomir | Oligonucleotides | |
| HY-RI00078 | hsa-miR-1193 inhibitor | Oligonucleotides | |
| HY-RI00078A | hsa-miR-1193 antagomir | Oligonucleotides | |
| HY-RI00079 | hsa-miR-1197 inhibitor | Oligonucleotides | |
| HY-RI00079A | hsa-miR-1197 antagomir | Oligonucleotides | |
| HY-RI00080 | hsa-miR-1199-3p inhibitor | Oligonucleotides | |
| HY-RI00080A | hsa-miR-1199-3p antagomir | Oligonucleotides | |
| HY-RI00081 | hsa-miR-1199-5p inhibitor | Oligonucleotides | |
| HY-RI00081A | hsa-miR-1199-5p antagomir | Oligonucleotides | |
| HY-RI00082 | hsa-miR-1202 inhibitor | Oligonucleotides | |
| HY-RI00082A | hsa-miR-1202 antagomir | Oligonucleotides | |
| HY-RI00083 | hsa-miR-1203 inhibitor | Oligonucleotides | |
| HY-RI00083A | hsa-miR-1203 antagomir | Oligonucleotides | |
| HY-RI00084 | hsa-miR-1204 inhibitor | Oligonucleotides | |
| HY-RI00084A | hsa-miR-1204 antagomir | Oligonucleotides | |
| HY-RI00085 | hsa-miR-1205 inhibitor | Oligonucleotides | |
| HY-RI00085A | hsa-miR-1205 antagomir | Oligonucleotides | |
| HY-RI00086 | hsa-miR-1207-3p inhibitor | Oligonucleotides | |
| HY-RI00086A | hsa-miR-1207-3p antagomir | Oligonucleotides | |
| HY-RI00087 | hsa-miR-1207-5p inhibitor | Oligonucleotides | |
| HY-RI00087A | hsa-miR-1207-5p antagomir | Oligonucleotides | |
| HY-RI00088 | hsa-miR-1208 inhibitor | Oligonucleotides | |
| HY-RI00088A | hsa-miR-1208 antagomir | Oligonucleotides | |
| HY-RI00089 | hsa-miR-12113 inhibitor | Oligonucleotides | |
| HY-RI00089A | hsa-miR-12113 antagomir | Oligonucleotides | |
| HY-RI00090 | hsa-miR-12114 inhibitor | Oligonucleotides | |
| HY-RI00090A | hsa-miR-12114 antagomir | Oligonucleotides | |
| HY-RI00091 | hsa-miR-12115 inhibitor | Oligonucleotides | |
| HY-RI00091A | hsa-miR-12115 antagomir | Oligonucleotides | |
| HY-RI00092 | hsa-miR-12116 inhibitor | Oligonucleotides | |
| HY-RI00092A | hsa-miR-12116 antagomir | Oligonucleotides | |
| HY-RI00093 | hsa-miR-12117 inhibitor | Oligonucleotides | |
| HY-RI00093A | hsa-miR-12117 antagomir | Oligonucleotides | |
| HY-RI00094 | hsa-miR-12118 inhibitor | Oligonucleotides | |
| HY-RI00094A | hsa-miR-12118 antagomir | Oligonucleotides | |
| HY-RI00095 | hsa-miR-12119 inhibitor | Oligonucleotides | |
| HY-RI00095A | hsa-miR-12119 antagomir | Oligonucleotides | |
| HY-RI00096 | hsa-miR-12120 inhibitor | Oligonucleotides | |
| HY-RI00096A | hsa-miR-12120 antagomir | Oligonucleotides | |
| HY-RI00097 | hsa-miR-12121 inhibitor | Oligonucleotides | |
| HY-RI00097A | hsa-miR-12121 antagomir | Oligonucleotides | |
| HY-RI00098 | hsa-miR-12122 inhibitor | Oligonucleotides | |
| HY-RI00098A | hsa-miR-12122 antagomir | Oligonucleotides | |
| HY-RI00099 | hsa-miR-12123 inhibitor | Oligonucleotides | |
| HY-RI00099A | hsa-miR-12123 antagomir | Oligonucleotides | |
| HY-RI00100 | hsa-miR-12124 inhibitor | Oligonucleotides | |
| HY-RI00100A | hsa-miR-12124 antagomir | Oligonucleotides | |
| HY-RI00101 | hsa-miR-12125 inhibitor | Oligonucleotides | |
| HY-RI00101A | hsa-miR-12125 antagomir | Oligonucleotides | |
| HY-RI00102 | hsa-miR-12126 inhibitor | Oligonucleotides | |
| HY-RI00102A | hsa-miR-12126 antagomir | Oligonucleotides | |
| HY-RI00103 | hsa-miR-12127 inhibitor | Oligonucleotides | |
| HY-RI00103A | hsa-miR-12127 antagomir | Oligonucleotides | |
| HY-RI00104 | hsa-miR-12128 inhibitor | Oligonucleotides | |
| HY-RI00104A | hsa-miR-12128 antagomir | Oligonucleotides | |
| HY-RI00105 | hsa-miR-12129 inhibitor | Oligonucleotides | |
| HY-RI00105A | hsa-miR-12129 antagomir | Oligonucleotides | |
| HY-RI00106 | hsa-miR-12130 inhibitor | Oligonucleotides | |
| HY-RI00106A | hsa-miR-12130 antagomir | Oligonucleotides | |
| HY-RI00107 | hsa-miR-12131 inhibitor | Oligonucleotides | |
| HY-RI00107A | hsa-miR-12131 antagomir | Oligonucleotides | |
| HY-RI00108 | hsa-miR-12132 inhibitor | Oligonucleotides | |
| HY-RI00108A | hsa-miR-12132 antagomir | Oligonucleotides | |
| HY-RI00109 | hsa-miR-12133 inhibitor | Oligonucleotides | |
| HY-RI00109A | hsa-miR-12133 antagomir | Oligonucleotides | |
| HY-RI00110 | hsa-miR-12135 inhibitor | Oligonucleotides | |
| HY-RI00110A | hsa-miR-12135 antagomir | Oligonucleotides | |
| HY-RI00111 | hsa-miR-12136 inhibitor | Oligonucleotides | |
| HY-RI00111A | hsa-miR-12136 antagomir | Oligonucleotides | |
| HY-RI00112 | hsa-miR-122-3p inhibitor | Oligonucleotides | |
| HY-RI00112A | hsa-miR-122-3p antagomir | Oligonucleotides | |
| HY-RI00113 | hsa-miR-1224-3p inhibitor | Oligonucleotides | |
| HY-RI00113A | hsa-miR-1224-3p antagomir | Oligonucleotides | |
| HY-RI00114 | hsa-miR-1224-5p inhibitor | Oligonucleotides | |
| HY-RI00114A | hsa-miR-1224-5p antagomir | Oligonucleotides | |
| HY-RI00115 | hsa-miR-1225-5p inhibitor | Oligonucleotides | |
| HY-RI00115A | hsa-miR-1225-5p antagomir | Oligonucleotides | |
| HY-RI00116 | hsa-miR-122-5p inhibitor | Oligonucleotides | |
| HY-RI00116A | hsa-miR-122-5p antagomir | Oligonucleotides | |
| HY-RI00117 | hsa-miR-1226-3p inhibitor | Oligonucleotides | |
| HY-RI00117A | hsa-miR-1226-3p antagomir | Oligonucleotides | |
| HY-RI00118 | hsa-miR-1226-5p inhibitor | Oligonucleotides | |
| HY-RI00118A | hsa-miR-1226-5p antagomir | Oligonucleotides | |
| HY-RI00119 | hsa-miR-1227-3p inhibitor | Oligonucleotides | |
| HY-RI00119A | hsa-miR-1227-3p antagomir | Oligonucleotides | |
| HY-RI00120 | hsa-miR-1227-5p inhibitor | Oligonucleotides | |
| HY-RI00120A | hsa-miR-1227-5p antagomir | Oligonucleotides | |
| HY-RI00121 | hsa-miR-1228-3p inhibitor | Oligonucleotides | |
| HY-RI00121A | hsa-miR-1228-3p antagomir | Oligonucleotides | |
| HY-RI00122 | hsa-miR-1228-5p inhibitor | Oligonucleotides | |
| HY-RI00122A | hsa-miR-1228-5p antagomir | Oligonucleotides | |
| HY-RI00123 | hsa-miR-1229-3p inhibitor | Oligonucleotides | |
| HY-RI00123A | hsa-miR-1229-3p antagomir | Oligonucleotides | |
| HY-RI00124 | hsa-miR-1229-5p inhibitor | Oligonucleotides | |
| HY-RI00124A | hsa-miR-1229-5p antagomir | Oligonucleotides | |
| HY-RI00125 | hsa-miR-122b-3p inhibitor | Oligonucleotides | |
| HY-RI00125A | hsa-miR-122b-3p antagomir | Oligonucleotides | |
| HY-RI00126 | hsa-miR-122b-5p inhibitor | Oligonucleotides | |
| HY-RI00126A | hsa-miR-122b-5p antagomir | Oligonucleotides | |
| HY-RI00127 | hsa-miR-1231 inhibitor | Oligonucleotides | |
| HY-RI00127A | hsa-miR-1231 antagomir | Oligonucleotides | |
| HY-RI00128 | hsa-miR-1233-3p inhibitor | Oligonucleotides | |
| HY-RI00128A | hsa-miR-1233-3p antagomir | Oligonucleotides | |
| HY-RI00129 | hsa-miR-1233-5p inhibitor | Oligonucleotides | |
| HY-RI00129A | hsa-miR-1233-5p antagomir | Oligonucleotides | |
| HY-RI00130 | hsa-miR-1234-3p inhibitor | Oligonucleotides | |
| HY-RI00130A | hsa-miR-1234-3p antagomir | Oligonucleotides | |
| HY-RI00131 | hsa-miR-1236-3p inhibitor | Oligonucleotides | |
| HY-RI00131A | hsa-miR-1236-3p antagomir | Oligonucleotides | |
| HY-RI00132 | hsa-miR-1236-5p inhibitor | Oligonucleotides | |
| HY-RI00132A | hsa-miR-1236-5p antagomir | Oligonucleotides | |
| HY-RI00133 | hsa-miR-1237-3p inhibitor | Oligonucleotides | |
| HY-RI00133A | hsa-miR-1237-3p antagomir | Oligonucleotides | |
| HY-RI00134 | hsa-miR-1237-5p inhibitor | Oligonucleotides | |
| HY-RI00134A | hsa-miR-1237-5p antagomir | Oligonucleotides | |
| HY-RI00135 | hsa-miR-1238-3p inhibitor | Oligonucleotides | |
| HY-RI00135A | hsa-miR-1238-3p antagomir | Oligonucleotides | |
| HY-RI00136 | hsa-miR-1238-5p inhibitor | Oligonucleotides | |
| HY-RI00136A | hsa-miR-1238-5p antagomir | Oligonucleotides | |
| HY-RI00137 | hsa-miR-1243 inhibitor | Oligonucleotides | |
| HY-RI00137A | hsa-miR-1243 antagomir | Oligonucleotides | |
| HY-RI00138 | hsa-miR-124-3p inhibitor | Oligonucleotides | |
| HY-RI00138A | hsa-miR-124-3p antagomir | Oligonucleotides | |
| HY-RI00139 | hsa-miR-1244 inhibitor | Oligonucleotides | |
| HY-RI00139A | hsa-miR-1244 antagomir | Oligonucleotides | |
| HY-RI00140 | hsa-miR-1245a inhibitor | Oligonucleotides | |
| HY-RI00140A | hsa-miR-1245a antagomir | Oligonucleotides | |
| HY-RI00141 | hsa-miR-1245b-3p inhibitor | Oligonucleotides | |
| HY-RI00141A | hsa-miR-1245b-3p antagomir | Oligonucleotides | |
| HY-RI00142 | hsa-miR-1245b-5p inhibitor | Oligonucleotides | |
| HY-RI00142A | hsa-miR-1245b-5p antagomir | Oligonucleotides | |
| HY-RI00143 | hsa-miR-124-5p inhibitor | Oligonucleotides | |
| HY-RI00143A | hsa-miR-124-5p antagomir | Oligonucleotides | |
| HY-RI00144 | hsa-miR-1246 inhibitor | Oligonucleotides | |
| HY-RI00144A | hsa-miR-1246 antagomir | Oligonucleotides | |
| HY-RI00145 | hsa-miR-1247-3p inhibitor | Oligonucleotides | |
| HY-RI00145A | hsa-miR-1247-3p antagomir | Oligonucleotides | |
| HY-RI00146 | hsa-miR-1247-5p inhibitor | Oligonucleotides | |
| HY-RI00146A | hsa-miR-1247-5p antagomir | Oligonucleotides | |
| HY-RI00147 | hsa-miR-1248 inhibitor | Oligonucleotides | |
| HY-RI00147A | hsa-miR-1248 antagomir | Oligonucleotides | |
| HY-RI00148 | hsa-miR-1249-3p inhibitor | Oligonucleotides | |
| HY-RI00148A | hsa-miR-1249-3p antagomir | Oligonucleotides | |
| HY-RI00149 | hsa-miR-1249-5p inhibitor | Oligonucleotides | |
| HY-RI00149A | hsa-miR-1249-5p antagomir | Oligonucleotides | |
| HY-RI00150 | hsa-miR-1250-3p inhibitor | Oligonucleotides | |
| HY-RI00150A | hsa-miR-1250-3p antagomir | Oligonucleotides | |
| HY-RI00151 | hsa-miR-1250-5p inhibitor | Oligonucleotides | |
| HY-RI00151A | hsa-miR-1250-5p antagomir | Oligonucleotides | |
| HY-RI00152 | hsa-miR-1251-3p inhibitor | Oligonucleotides | |
| HY-RI00152A | hsa-miR-1251-3p antagomir | Oligonucleotides | |
| HY-RI00153 | hsa-miR-1251-5p inhibitor | Oligonucleotides | |
| HY-RI00153A | hsa-miR-1251-5p antagomir | Oligonucleotides | |
| HY-RI00154 | hsa-miR-1252-3p inhibitor | Oligonucleotides | |
| HY-RI00154A | hsa-miR-1252-3p antagomir | Oligonucleotides | |
| HY-RI00155 | hsa-miR-1252-5p inhibitor | Oligonucleotides | |
| HY-RI00155A | hsa-miR-1252-5p antagomir | Oligonucleotides | |
| HY-RI00156 | hsa-miR-1253 inhibitor | Oligonucleotides | |
| HY-RI00156A | hsa-miR-1253 antagomir | Oligonucleotides | |
| HY-RI00157 | hsa-miR-1255a inhibitor | Oligonucleotides | |
| HY-RI00157A | hsa-miR-1255a antagomir | Oligonucleotides | |
| HY-RI00158 | hsa-miR-1255b-2-3p inhibitor | Oligonucleotides | |
| HY-RI00158A | hsa-miR-1255b-2-3p antagomir | Oligonucleotides | |
| HY-RI00159 | hsa-miR-1255b-5p inhibitor | Oligonucleotides | |
| HY-RI00159A | hsa-miR-1255b-5p antagomir | Oligonucleotides | |
| HY-RI00160 | hsa-miR-1256 inhibitor | Oligonucleotides | |
| HY-RI00160A | hsa-miR-1256 antagomir | Oligonucleotides | |
| HY-RI00161 | hsa-miR-1257 inhibitor | Oligonucleotides | |
| HY-RI00161A | hsa-miR-1257 antagomir | Oligonucleotides | |
| HY-RI00162 | hsa-miR-1258 inhibitor | Oligonucleotides | |
| HY-RI00162A | hsa-miR-1258 antagomir | Oligonucleotides | |
| HY-RI00163 | hsa-miR-125a-3p inhibitor | Oligonucleotides | |
| HY-RI00163A | hsa-miR-125a-3p antagomir | Oligonucleotides | |
| HY-RI00164 | hsa-miR-125a-5p inhibitor | Oligonucleotides | |
| HY-RI00164A | hsa-miR-125a-5p antagomir | Oligonucleotides | |
| HY-RI00165 | hsa-miR-125b-1-3p inhibitor | Oligonucleotides | |
| HY-RI00165A | hsa-miR-125b-1-3p antagomir | Oligonucleotides | |
| HY-RI00166 | hsa-miR-125b-2-3p inhibitor | Oligonucleotides | |
| HY-RI00166A | hsa-miR-125b-2-3p antagomir | Oligonucleotides | |
| HY-RI00167 | hsa-miR-125b-5p inhibitor | Oligonucleotides | |
| HY-RI00167A | hsa-miR-125b-5p antagomir | Oligonucleotides | |
| HY-RI00168 | hsa-miR-1260b inhibitor | Oligonucleotides | |
| HY-RI00168A | hsa-miR-1260b antagomir | Oligonucleotides | |
| HY-RI00169 | hsa-miR-1261 inhibitor | Oligonucleotides | |
| HY-RI00169A | hsa-miR-1261 antagomir | Oligonucleotides | |
| HY-RI00170 | hsa-miR-1262 inhibitor | Oligonucleotides | |
| HY-RI00170A | hsa-miR-1262 antagomir | Oligonucleotides | |
| HY-RI00171 | hsa-miR-1263 inhibitor | Oligonucleotides | |
| HY-RI00171A | hsa-miR-1263 antagomir | Oligonucleotides | |
| HY-RI00172 | hsa-miR-126-3p inhibitor | Oligonucleotides | |
| HY-RI00172A | hsa-miR-126-3p antagomir | Oligonucleotides | |
| HY-RI00173 | hsa-miR-1264 inhibitor | Oligonucleotides | |
| HY-RI00173A | hsa-miR-1264 antagomir | Oligonucleotides | |
| HY-RI00174 | hsa-miR-1265 inhibitor | Oligonucleotides | |
| HY-RI00174A | hsa-miR-1265 antagomir | Oligonucleotides | |
| HY-RI00175 | hsa-miR-126-5p inhibitor | Oligonucleotides | |
| HY-RI00175A | hsa-miR-126-5p antagomir | Oligonucleotides | |
| HY-RI00176 | hsa-miR-1266-3p inhibitor | Oligonucleotides | |
| HY-RI00176A | hsa-miR-1266-3p antagomir | Oligonucleotides | |
| HY-RI00177 | hsa-miR-1266-5p inhibitor | Oligonucleotides | |
| HY-RI00177A | hsa-miR-1266-5p antagomir | Oligonucleotides | |
| HY-RI00178 | hsa-miR-1267 inhibitor | Oligonucleotides | |
| HY-RI00178A | hsa-miR-1267 antagomir | Oligonucleotides | |
| HY-RI00179 | hsa-miR-1268a inhibitor | Oligonucleotides | |
| HY-RI00179A | hsa-miR-1268a antagomir | Oligonucleotides | |
| HY-RI00180 | hsa-miR-1268b inhibitor | Oligonucleotides | |
| HY-RI00180A | hsa-miR-1268b antagomir | Oligonucleotides | |
| HY-RI00181 | hsa-miR-1269a inhibitor | Oligonucleotides | |
| HY-RI00181A | hsa-miR-1269a antagomir | Oligonucleotides | |
| HY-RI00182 | hsa-miR-1269b inhibitor | Oligonucleotides | |
| HY-RI00182A | hsa-miR-1269b antagomir | Oligonucleotides | |
| HY-RI00183 | hsa-miR-1270 inhibitor | Oligonucleotides | |
| HY-RI00183A | hsa-miR-1270 antagomir | Oligonucleotides | |
| HY-RI00184 | hsa-miR-1271-3p inhibitor | Oligonucleotides | |
| HY-RI00184A | hsa-miR-1271-3p antagomir | Oligonucleotides | |
| HY-RI00185 | hsa-miR-1271-5p inhibitor | Oligonucleotides | |
| HY-RI00185A | hsa-miR-1271-5p antagomir | Oligonucleotides | |
| HY-RI00186 | hsa-miR-1272 inhibitor | Oligonucleotides | |
| HY-RI00186A | hsa-miR-1272 antagomir | Oligonucleotides | |
| HY-RI00187 | hsa-miR-1273c inhibitor | Oligonucleotides | |
| HY-RI00187A | hsa-miR-1273c antagomir | Oligonucleotides | |
| HY-RI00188 | hsa-miR-1273h-3p inhibitor | Oligonucleotides | |
| HY-RI00188A | hsa-miR-1273h-3p antagomir | Oligonucleotides | |
| HY-RI00189 | hsa-miR-1273h-5p inhibitor | Oligonucleotides | |
| HY-RI00189A | hsa-miR-1273h-5p antagomir | Oligonucleotides | |
| HY-RI00190 | hsa-miR-127-3p inhibitor | Oligonucleotides | |
| HY-RI00190A | hsa-miR-127-3p antagomir | Oligonucleotides | |
| HY-RI00191 | hsa-miR-127-5p inhibitor | Oligonucleotides | |
| HY-RI00191A | hsa-miR-127-5p antagomir | Oligonucleotides | |
| HY-RI00192 | hsa-miR-1276 inhibitor | Oligonucleotides | |
| HY-RI00192A | hsa-miR-1276 antagomir | Oligonucleotides | |
| HY-RI00193 | hsa-miR-1277-3p inhibitor | Oligonucleotides | |
| HY-RI00193A | hsa-miR-1277-3p antagomir | Oligonucleotides | |
| HY-RI00194 | hsa-miR-1277-5p inhibitor | Oligonucleotides | |
| HY-RI00194A | hsa-miR-1277-5p antagomir | Oligonucleotides | |
| HY-RI00195 | hsa-miR-1278 inhibitor | Oligonucleotides | |
| HY-RI00195A | hsa-miR-1278 antagomir | Oligonucleotides | |
| HY-RI00196 | hsa-miR-1279 inhibitor | Oligonucleotides | |
| HY-RI00196A | hsa-miR-1279 antagomir | Oligonucleotides | |
| HY-RI00197 | hsa-miR-1281 inhibitor | Oligonucleotides | |
| HY-RI00197A | hsa-miR-1281 antagomir | Oligonucleotides | |
| HY-RI00198 | hsa-miR-128-1-5p inhibitor | Oligonucleotides | |
| HY-RI00198A | hsa-miR-128-1-5p antagomir | Oligonucleotides | |
| HY-RI00199 | hsa-miR-1282 inhibitor | Oligonucleotides | |
| HY-RI00199A | hsa-miR-1282 antagomir | Oligonucleotides | |
| HY-RI00200 | hsa-miR-128-2-5p inhibitor | Oligonucleotides | |
| HY-RI00200A | hsa-miR-128-2-5p antagomir | Oligonucleotides | |
| HY-RI00201 | hsa-miR-1283 inhibitor | Oligonucleotides | |
| HY-RI00201A | hsa-miR-1283 antagomir | Oligonucleotides | |
| HY-RI00202 | hsa-miR-128-3p inhibitor | Oligonucleotides | |
| HY-RI00202A | hsa-miR-128-3p antagomir | Oligonucleotides | |
| HY-RI00203 | hsa-miR-1284 inhibitor | Oligonucleotides | |
| HY-RI00203A | hsa-miR-1284 antagomir | Oligonucleotides | |
| HY-RI00204 | hsa-miR-1285-3p inhibitor | Oligonucleotides | |
| HY-RI00204A | hsa-miR-1285-3p antagomir | Oligonucleotides | |
| HY-RI00205 | hsa-miR-1285-5p inhibitor | Oligonucleotides | |
| HY-RI00205A | hsa-miR-1285-5p antagomir | Oligonucleotides | |
| HY-RI00206 | hsa-miR-1286 inhibitor | Oligonucleotides | |
| HY-RI00206A | hsa-miR-1286 antagomir | Oligonucleotides | |
| HY-RI00207 | hsa-miR-1287-3p inhibitor | Oligonucleotides | |
| HY-RI00207A | hsa-miR-1287-3p antagomir | Oligonucleotides | |
| HY-RI00208 | hsa-miR-1287-5p inhibitor | Oligonucleotides | |
| HY-RI00208A | hsa-miR-1287-5p antagomir | Oligonucleotides | |
| HY-RI00209 | hsa-miR-1288-3p inhibitor | Oligonucleotides | |
| HY-RI00209A | hsa-miR-1288-3p antagomir | Oligonucleotides | |
| HY-RI00210 | hsa-miR-1288-5p inhibitor | Oligonucleotides | |
| HY-RI00210A | hsa-miR-1288-5p antagomir | Oligonucleotides | |
| HY-RI00211 | hsa-miR-1289 inhibitor | Oligonucleotides | |
| HY-RI00211A | hsa-miR-1289 antagomir | Oligonucleotides | |
| HY-RI00212 | hsa-miR-1290 inhibitor | Oligonucleotides | |
| HY-RI00212A | hsa-miR-1290 antagomir | Oligonucleotides | |
| HY-RI00213 | hsa-miR-1291 inhibitor | Oligonucleotides | |
| HY-RI00213A | hsa-miR-1291 antagomir | Oligonucleotides | |
| HY-RI00214 | hsa-miR-129-1-3p inhibitor | Oligonucleotides | |
| HY-RI00214A | hsa-miR-129-1-3p antagomir | Oligonucleotides | |
| HY-RI00215 | hsa-miR-1292-3p inhibitor | Oligonucleotides | |
| HY-RI00215A | hsa-miR-1292-3p antagomir | Oligonucleotides | |
| HY-RI00216 | hsa-miR-129-2-3p inhibitor | Oligonucleotides | |
| HY-RI00216A | hsa-miR-129-2-3p antagomir | Oligonucleotides | |
| HY-RI00217 | hsa-miR-1292-5p inhibitor | Oligonucleotides | |
| HY-RI00217A | hsa-miR-1292-5p antagomir | Oligonucleotides | |
| HY-RI00218 | hsa-miR-1293 inhibitor | Oligonucleotides | |
| HY-RI00218A | hsa-miR-1293 antagomir | Oligonucleotides | |
| HY-RI00219 | hsa-miR-1294 inhibitor | Oligonucleotides | |
| HY-RI00219A | hsa-miR-1294 antagomir | Oligonucleotides | |
| HY-RI00220 | hsa-miR-1295a inhibitor | Oligonucleotides | |
| HY-RI00220A | hsa-miR-1295a antagomir | Oligonucleotides | |
| HY-RI00221 | hsa-miR-1295b-3p inhibitor | Oligonucleotides | |
| HY-RI00221A | hsa-miR-1295b-3p antagomir | Oligonucleotides | |
| HY-RI00222 | hsa-miR-1295b-5p inhibitor | Oligonucleotides | |
| HY-RI00222A | hsa-miR-1295b-5p antagomir | Oligonucleotides | |
| HY-RI00223 | hsa-miR-129-5p inhibitor | Oligonucleotides | |
| HY-RI00223A | hsa-miR-129-5p antagomir | Oligonucleotides | |
| HY-RI00224 | hsa-miR-1296-3p inhibitor | Oligonucleotides | |
| HY-RI00224A | hsa-miR-1296-3p antagomir | Oligonucleotides | |
| HY-RI00225 | hsa-miR-1296-5p inhibitor | Oligonucleotides | |
| HY-RI00225A | hsa-miR-1296-5p antagomir | Oligonucleotides | |
| HY-RI00226 | hsa-miR-1297 inhibitor | Oligonucleotides | |
| HY-RI00226A | hsa-miR-1297 antagomir | Oligonucleotides | |
| HY-RI00227 | hsa-miR-1298-3p inhibitor | Oligonucleotides | |
| HY-RI00227A | hsa-miR-1298-3p antagomir | Oligonucleotides | |
| HY-RI00228 | hsa-miR-1298-5p inhibitor | Oligonucleotides | |
| HY-RI00228A | hsa-miR-1298-5p antagomir | Oligonucleotides | |
| HY-RI00229 | hsa-miR-1299 inhibitor | Oligonucleotides | |
| HY-RI00229A | hsa-miR-1299 antagomir | Oligonucleotides | |
| HY-RI00230 | hsa-miR-1301-3p inhibitor | Oligonucleotides | |
| HY-RI00230A | hsa-miR-1301-3p antagomir | Oligonucleotides | |
| HY-RI00231 | hsa-miR-1301-5p inhibitor | Oligonucleotides | |
| HY-RI00231A | hsa-miR-1301-5p antagomir | Oligonucleotides | |
| HY-RI00232 | hsa-miR-1302 inhibitor | Oligonucleotides | |
| HY-RI00232A | hsa-miR-1302 antagomir | Oligonucleotides | |
| HY-RI00233 | hsa-miR-1303 inhibitor | Oligonucleotides | |
| HY-RI00233A | hsa-miR-1303 antagomir | Oligonucleotides | |
| HY-RI00234 | hsa-miR-1304-3p inhibitor | Oligonucleotides | |
| HY-RI00234A | hsa-miR-1304-3p antagomir | Oligonucleotides | |
| HY-RI00235 | hsa-miR-1304-5p inhibitor | Oligonucleotides | |
| HY-RI00235A | hsa-miR-1304-5p antagomir | Oligonucleotides | |
| HY-RI00236 | hsa-miR-1305 inhibitor | Oligonucleotides | |
| HY-RI00236A | hsa-miR-1305 antagomir | Oligonucleotides | |
| HY-RI00237 | hsa-miR-1306-3p inhibitor | Oligonucleotides | |
| HY-RI00237A | hsa-miR-1306-3p antagomir | Oligonucleotides | |
| HY-RI00238 | hsa-miR-1306-5p inhibitor | Oligonucleotides | |
| HY-RI00238A | hsa-miR-1306-5p antagomir | Oligonucleotides | |
| HY-RI00239 | hsa-miR-1307-3p inhibitor | Oligonucleotides | |
| HY-RI00239A | hsa-miR-1307-3p antagomir | Oligonucleotides | |
| HY-RI00240 | hsa-miR-1307-5p inhibitor | Oligonucleotides | |
| HY-RI00240A | hsa-miR-1307-5p antagomir | Oligonucleotides | |
| HY-RI00241 | hsa-miR-130a-3p inhibitor | Oligonucleotides | |
| HY-RI00241A | hsa-miR-130a-3p antagomir | Oligonucleotides | |
| HY-RI00242 | hsa-miR-130a-5p inhibitor | Oligonucleotides | |
| HY-RI00242A | hsa-miR-130a-5p antagomir | Oligonucleotides | |
| HY-RI00243 | hsa-miR-130b-3p inhibitor | Oligonucleotides | |
| HY-RI00243A | hsa-miR-130b-3p antagomir | Oligonucleotides | |
| HY-RI00244 | hsa-miR-130b-5p inhibitor | Oligonucleotides | |
| HY-RI00244A | hsa-miR-130b-5p antagomir | Oligonucleotides | |
| HY-RI00245 | hsa-miR-1321 inhibitor | Oligonucleotides | |
| HY-RI00245A | hsa-miR-1321 antagomir | Oligonucleotides | |
| HY-RI00246 | hsa-miR-1322 inhibitor | Oligonucleotides | |
| HY-RI00246A | hsa-miR-1322 antagomir | Oligonucleotides | |
| HY-RI00247 | hsa-miR-1323 inhibitor | Oligonucleotides | |
| HY-RI00247A | hsa-miR-1323 antagomir | Oligonucleotides | |
| HY-RI00248 | hsa-miR-132-3p inhibitor | Oligonucleotides | |
| HY-RI00248A | hsa-miR-132-3p antagomir | Oligonucleotides | |
| HY-RI00249 | hsa-miR-1324 inhibitor | Oligonucleotides | |
| HY-RI00249A | hsa-miR-1324 antagomir | Oligonucleotides | |
| HY-RI00250 | hsa-miR-132-5p inhibitor | Oligonucleotides | |
| HY-RI00250A | hsa-miR-132-5p antagomir | Oligonucleotides | |
| HY-RI00251 | hsa-miR-133a-3p inhibitor | Oligonucleotides | |
| HY-RI00251A | hsa-miR-133a-3p antagomir | Oligonucleotides | |
| HY-RI00252 | hsa-miR-133a-5p inhibitor | Oligonucleotides | |
| HY-RI00252A | hsa-miR-133a-5p antagomir | Oligonucleotides | |
| HY-RI00253 | hsa-miR-133b inhibitor | Oligonucleotides | |
| HY-RI00253A | hsa-miR-133b antagomir | Oligonucleotides | |
| HY-RI00254 | hsa-miR-1343-3p inhibitor | Oligonucleotides | |
| HY-RI00254A | hsa-miR-1343-3p antagomir | Oligonucleotides | |
| HY-RI00255 | hsa-miR-1343-5p inhibitor | Oligonucleotides | |
| HY-RI00255A | hsa-miR-1343-5p antagomir | Oligonucleotides | |
| HY-RI00256 | hsa-miR-134-5p inhibitor | Oligonucleotides | |
| HY-RI00256A | hsa-miR-134-5p antagomir | Oligonucleotides | |
| HY-RI00257 | hsa-miR-135a-2-3p inhibitor | Oligonucleotides | |
| HY-RI00257A | hsa-miR-135a-2-3p antagomir | Oligonucleotides | |
| HY-RI00258 | hsa-miR-135a-3p inhibitor | Oligonucleotides | |
| HY-RI00258A | hsa-miR-135a-3p antagomir | Oligonucleotides | |
| HY-RI00259 | hsa-miR-135a-5p inhibitor | Oligonucleotides | |
| HY-RI00259A | hsa-miR-135a-5p antagomir | Oligonucleotides | |
| HY-RI00260 | hsa-miR-135b-3p inhibitor | Oligonucleotides | |
| HY-RI00260A | hsa-miR-135b-3p antagomir | Oligonucleotides | |
| HY-RI00261 | hsa-miR-135b-5p inhibitor | Oligonucleotides | |
| HY-RI00261A | hsa-miR-135b-5p antagomir | Oligonucleotides | |
| HY-RI00262 | hsa-miR-136-3p inhibitor | Oligonucleotides | |
| HY-RI00262A | hsa-miR-136-3p antagomir | Oligonucleotides | |
| HY-RI00263 | hsa-miR-136-5p inhibitor | Oligonucleotides | |
| HY-RI00263A | hsa-miR-136-5p antagomir | Oligonucleotides | |
| HY-RI00264 | hsa-miR-137-3p inhibitor | Oligonucleotides | |
| HY-RI00264A | hsa-miR-137-3p antagomir | Oligonucleotides | |
| HY-RI00265 | hsa-miR-137-5p inhibitor | Oligonucleotides | |
| HY-RI00265A | hsa-miR-137-5p antagomir | Oligonucleotides | |
| HY-RI00266 | hsa-miR-138-1-3p inhibitor | Oligonucleotides | |
| HY-RI00266A | hsa-miR-138-1-3p antagomir | Oligonucleotides | |
| HY-RI00267 | hsa-miR-138-2-3p inhibitor | Oligonucleotides | |
| HY-RI00267A | hsa-miR-138-2-3p antagomir | Oligonucleotides | |
| HY-RI00268 | hsa-miR-138-5p inhibitor | Oligonucleotides | |
| HY-RI00268A | hsa-miR-138-5p antagomir | Oligonucleotides | |
| HY-RI00269 | hsa-miR-139-3p inhibitor | Oligonucleotides | |
| HY-RI00269A | hsa-miR-139-3p antagomir | Oligonucleotides | |
| HY-RI00270 | hsa-miR-139-5p inhibitor | Oligonucleotides | |
| HY-RI00270A | hsa-miR-139-5p antagomir | Oligonucleotides | |
| HY-RI00271 | hsa-miR-1-3p inhibitor | Oligonucleotides | |
| HY-RI00271A | hsa-miR-1-3p antagomir | Oligonucleotides | |
| HY-RI00272 | hsa-miR-140-3p inhibitor | Oligonucleotides | |
| HY-RI00272A | hsa-miR-140-3p antagomir | Oligonucleotides | |
| HY-RI00273 | hsa-miR-140-5p inhibitor | Oligonucleotides | |
| HY-RI00273A | hsa-miR-140-5p antagomir | Oligonucleotides | |
| HY-RI00274 | hsa-miR-141-3p inhibitor | Oligonucleotides | |
| HY-RI00274A | hsa-miR-141-3p antagomir | Oligonucleotides | |
| HY-RI00275 | hsa-miR-141-5p inhibitor | Oligonucleotides | |
| HY-RI00275A | hsa-miR-141-5p antagomir | Oligonucleotides | |
| HY-RI00276 | hsa-miR-142-3p inhibitor | Oligonucleotides | |
| HY-RI00276A | hsa-miR-142-3p antagomir | Oligonucleotides | |
| HY-RI00277 | hsa-miR-142-5p inhibitor | Oligonucleotides | |
| HY-RI00277A | hsa-miR-142-5p antagomir | Oligonucleotides | |
| HY-RI00278 | hsa-miR-143-3p inhibitor | Oligonucleotides | |
| HY-RI00278A | hsa-miR-143-3p antagomir | Oligonucleotides | |
| HY-RI00279 | hsa-miR-144-3p inhibitor | Oligonucleotides | |
| HY-RI00279A | hsa-miR-144-3p antagomir | Oligonucleotides | |
| HY-RI00280 | hsa-miR-144-5p inhibitor | Oligonucleotides | |
| HY-RI00280A | hsa-miR-144-5p antagomir | Oligonucleotides | |
| HY-RI00281 | hsa-miR-145-3p inhibitor | Oligonucleotides | |
| HY-RI00281A | hsa-miR-145-3p antagomir | Oligonucleotides | |
| HY-RI00282 | hsa-miR-145-5p inhibitor | Oligonucleotides | |
| HY-RI00282A | hsa-miR-145-5p antagomir | Oligonucleotides | |
| HY-RI00283 | hsa-miR-1468-3p inhibitor | Oligonucleotides | |
| HY-RI00283A | hsa-miR-1468-3p antagomir | Oligonucleotides | |
| HY-RI00284 | hsa-miR-1468-5p inhibitor | Oligonucleotides | |
| HY-RI00284A | hsa-miR-1468-5p antagomir | Oligonucleotides | |
| HY-RI00285 | hsa-miR-1469 inhibitor | Oligonucleotides | |
| HY-RI00285A | hsa-miR-1469 antagomir | Oligonucleotides | |
| HY-RI00286 | hsa-miR-146a-3p inhibitor | Oligonucleotides | |
| HY-RI00286A | hsa-miR-146a-3p antagomir | Oligonucleotides | |
| HY-RI00287 | hsa-miR-146a-5p inhibitor | Oligonucleotides | |
| HY-RI00287A | hsa-miR-146a-5p antagomir | Oligonucleotides | |
| HY-RI00288 | hsa-miR-146b-3p inhibitor | Oligonucleotides | |
| HY-RI00288A | hsa-miR-146b-3p antagomir | Oligonucleotides | |
| HY-RI00289 | hsa-miR-146b-5p inhibitor | Oligonucleotides | |
| HY-RI00289A | hsa-miR-146b-5p antagomir | Oligonucleotides | |
| HY-RI00290 | hsa-miR-1470 inhibitor | Oligonucleotides | |
| HY-RI00290A | hsa-miR-1470 antagomir | Oligonucleotides | |
| HY-RI00291 | hsa-miR-1471 inhibitor | Oligonucleotides | |
| HY-RI00291A | hsa-miR-1471 antagomir | Oligonucleotides | |
| HY-RI00292 | hsa-miR-147a inhibitor | Oligonucleotides | |
| HY-RI00292A | hsa-miR-147a antagomir | Oligonucleotides | |
| HY-RI00293 | hsa-miR-147b-5p inhibitor | Oligonucleotides | |
| HY-RI00293A | hsa-miR-147b-5p antagomir | Oligonucleotides | |
| HY-RI00294 | hsa-miR-148a-3p inhibitor | Oligonucleotides | |
| HY-RI00294A | hsa-miR-148a-3p antagomir | Oligonucleotides | |
| HY-RI00295 | hsa-miR-148a-5p inhibitor | Oligonucleotides | |
| HY-RI00295A | hsa-miR-148a-5p antagomir | Oligonucleotides | |
| HY-RI00296 | hsa-miR-148b-3p inhibitor | Oligonucleotides | |
| HY-RI00296A | hsa-miR-148b-3p antagomir | Oligonucleotides | |
| HY-RI00297 | hsa-miR-148b-5p inhibitor | Oligonucleotides | |
| HY-RI00297A | hsa-miR-148b-5p antagomir | Oligonucleotides | |
| HY-RI00298 | hsa-miR-149-3p inhibitor | Oligonucleotides | |
| HY-RI00298A | hsa-miR-149-3p antagomir | Oligonucleotides | |
| HY-RI00299 | hsa-miR-149-5p inhibitor | Oligonucleotides | |
| HY-RI00299A | hsa-miR-149-5p antagomir | Oligonucleotides | |
| HY-RI00300 | hsa-miR-150-3p inhibitor | Oligonucleotides | |
| HY-RI00300A | hsa-miR-150-3p antagomir | Oligonucleotides | |
| HY-RI00301 | hsa-miR-150-5p inhibitor | Oligonucleotides | |
| HY-RI00301A | hsa-miR-150-5p antagomir | Oligonucleotides | |
| HY-RI00302 | hsa-miR-151a-3p inhibitor | Oligonucleotides | |
| HY-RI00302A | hsa-miR-151a-3p antagomir | Oligonucleotides | |
| HY-RI00303 | hsa-miR-151a-5p inhibitor | Oligonucleotides | |
| HY-RI00303A | hsa-miR-151a-5p antagomir | Oligonucleotides | |
| HY-RI00304 | hsa-miR-151b inhibitor | Oligonucleotides | |
| HY-RI00304A | hsa-miR-151b antagomir | Oligonucleotides | |
| HY-RI00305 | hsa-miR-152-3p inhibitor | Oligonucleotides | |
| HY-RI00305A | hsa-miR-152-3p antagomir | Oligonucleotides | |
| HY-RI00306 | hsa-miR-152-5p inhibitor | Oligonucleotides | |
| HY-RI00306A | hsa-miR-152-5p antagomir | Oligonucleotides | |
| HY-RI00307 | hsa-miR-153-3p inhibitor | Oligonucleotides | |
| HY-RI00307A | hsa-miR-153-3p antagomir | Oligonucleotides | |
| HY-RI00308 | hsa-miR-153-5p inhibitor | Oligonucleotides | |
| HY-RI00308A | hsa-miR-153-5p antagomir | Oligonucleotides | |
| HY-RI00309 | hsa-miR-1537-3p inhibitor | Oligonucleotides | |
| HY-RI00309A | hsa-miR-1537-3p antagomir | Oligonucleotides | |
| HY-RI00310 | hsa-miR-1537-5p inhibitor | Oligonucleotides | |
| HY-RI00310A | hsa-miR-1537-5p antagomir | Oligonucleotides | |
| HY-RI00311 | hsa-miR-1538 inhibitor | Oligonucleotides | |
| HY-RI00311A | hsa-miR-1538 antagomir | Oligonucleotides | |
| HY-RI00312 | hsa-miR-1539 inhibitor | Oligonucleotides | |
| HY-RI00312A | hsa-miR-1539 antagomir | Oligonucleotides | |
| HY-RI00313 | hsa-miR-154-3p inhibitor | Oligonucleotides | |
| HY-RI00313A | hsa-miR-154-3p antagomir | Oligonucleotides | |
| HY-RI00314 | hsa-miR-154-5p inhibitor | Oligonucleotides | |
| HY-RI00314A | hsa-miR-154-5p antagomir | Oligonucleotides | |
| HY-RI00315 | hsa-miR-155-3p inhibitor | Oligonucleotides | |
| HY-RI00315A | hsa-miR-155-3p antagomir | Oligonucleotides | |
| HY-RI00316 | hsa-miR-155-5p inhibitor | Oligonucleotides | |
| HY-RI00316A | hsa-miR-155-5p antagomir | Oligonucleotides | |
| HY-RI00317 | hsa-miR-1587 inhibitor | Oligonucleotides | |
| HY-RI00317A | hsa-miR-1587 antagomir | Oligonucleotides | |
| HY-RI00318 | hsa-miR-15a-3p inhibitor | Oligonucleotides | |
| HY-RI00318A | hsa-miR-15a-3p antagomir | Oligonucleotides | |
| HY-RI00319 | hsa-miR-15a-5p inhibitor | Oligonucleotides | |
| HY-RI00319A | hsa-miR-15a-5p antagomir | Oligonucleotides | |
| HY-RI00320 | hsa-miR-15b-3p inhibitor | Oligonucleotides | |
| HY-RI00320A | hsa-miR-15b-3p antagomir | Oligonucleotides | |
| HY-RI00321 | hsa-miR-15b-5p inhibitor | Oligonucleotides | |
| HY-RI00321A | hsa-miR-15b-5p antagomir | Oligonucleotides | |
| HY-RI00322 | hsa-miR-16-1-3p inhibitor | Oligonucleotides | |
| HY-RI00322A | hsa-miR-16-1-3p antagomir | Oligonucleotides | |
| HY-RI00323 | hsa-miR-16-2-3p inhibitor | Oligonucleotides | |
| HY-RI00323A | hsa-miR-16-2-3p antagomir | Oligonucleotides | |
| HY-RI00324 | hsa-miR-16-5p inhibitor | Oligonucleotides | |
| HY-RI00324A | hsa-miR-16-5p antagomir | Oligonucleotides | |
| HY-RI00325 | hsa-miR-17-3p inhibitor | Oligonucleotides | |
| HY-RI00325A | hsa-miR-17-3p antagomir | Oligonucleotides | |
| HY-RI00326 | hsa-miR-17-5p inhibitor | Oligonucleotides | |
| HY-RI00326A | hsa-miR-17-5p antagomir | Oligonucleotides | |
| HY-RI00327 | hsa-miR-181a-2-3p inhibitor | Oligonucleotides | |
| HY-RI00327A | hsa-miR-181a-2-3p antagomir | Oligonucleotides | |
| HY-RI00328 | hsa-miR-181a-3p inhibitor | Oligonucleotides | |
| HY-RI00328A | hsa-miR-181a-3p antagomir | Oligonucleotides | |
| HY-RI00329 | hsa-miR-181a-5p inhibitor | Oligonucleotides | |
| HY-RI00329A | hsa-miR-181a-5p antagomir | Oligonucleotides | |
| HY-RI00330 | hsa-miR-181b-2-3p inhibitor | Oligonucleotides | |
| HY-RI00330A | hsa-miR-181b-2-3p antagomir | Oligonucleotides | |
| HY-RI00331 | hsa-miR-181b-3p inhibitor | Oligonucleotides | |
| HY-RI00331A | hsa-miR-181b-3p antagomir | Oligonucleotides | |
| HY-RI00332 | hsa-miR-181b-5p inhibitor | Oligonucleotides | |
| HY-RI00332A | hsa-miR-181b-5p antagomir | Oligonucleotides | |
| HY-RI00333 | hsa-miR-181c-3p inhibitor | Oligonucleotides | |
| HY-RI00333A | hsa-miR-181c-3p antagomir | Oligonucleotides | |
| HY-RI00334 | hsa-miR-181c-5p inhibitor | Oligonucleotides | |
| HY-RI00334A | hsa-miR-181c-5p antagomir | Oligonucleotides | |
| HY-RI00335 | hsa-miR-181d-3p inhibitor | Oligonucleotides | |
| HY-RI00335A | hsa-miR-181d-3p antagomir | Oligonucleotides | |
| HY-RI00336 | hsa-miR-181d-5p inhibitor | Oligonucleotides | |
| HY-RI00336A | hsa-miR-181d-5p antagomir | Oligonucleotides | |
| HY-RI00337 | hsa-miR-182-3p inhibitor | Oligonucleotides | |
| HY-RI00337A | hsa-miR-182-3p antagomir | Oligonucleotides | |
| HY-RI00338 | hsa-miR-1825 inhibitor | Oligonucleotides | |
| HY-RI00338A | hsa-miR-1825 antagomir | Oligonucleotides | |
| HY-RI00339 | hsa-miR-182-5p inhibitor | Oligonucleotides | |
| HY-RI00339A | hsa-miR-182-5p antagomir | Oligonucleotides | |
| HY-RI00340 | hsa-miR-1827 inhibitor | Oligonucleotides | |
| HY-RI00340A | hsa-miR-1827 antagomir | Oligonucleotides | |
| HY-RI00341 | hsa-miR-183-3p inhibitor | Oligonucleotides | |
| HY-RI00341A | hsa-miR-183-3p antagomir | Oligonucleotides | |
| HY-RI00342 | hsa-miR-183-5p inhibitor | Oligonucleotides | |
| HY-RI00342A | hsa-miR-183-5p antagomir | Oligonucleotides | |
| HY-RI00343 | hsa-miR-184 inhibitor | Oligonucleotides | |
| HY-RI00343A | hsa-miR-184 antagomir | Oligonucleotides | |
| HY-RI00344 | hsa-miR-1843 inhibitor | Oligonucleotides | |
| HY-RI00344A | hsa-miR-1843 antagomir | Oligonucleotides | |
| HY-RI00345 | hsa-miR-185-3p inhibitor | Oligonucleotides | |
| HY-RI00345A | hsa-miR-185-3p antagomir | Oligonucleotides | |
| HY-RI00346 | hsa-miR-185-5p inhibitor | Oligonucleotides | |
| HY-RI00346A | hsa-miR-185-5p antagomir | Oligonucleotides | |
| HY-RI00347 | hsa-miR-186-3p inhibitor | Oligonucleotides | |
| HY-RI00347A | hsa-miR-186-3p antagomir | Oligonucleotides | |
| HY-RI00348 | hsa-miR-186-5p inhibitor | Oligonucleotides | |
| HY-RI00348A | hsa-miR-186-5p antagomir | Oligonucleotides | |
| HY-RI00349 | hsa-miR-187-3p inhibitor | Oligonucleotides | |
| HY-RI00349A | hsa-miR-187-3p antagomir | Oligonucleotides | |
| HY-RI00350 | hsa-miR-187-5p inhibitor | Oligonucleotides | |
| HY-RI00350A | hsa-miR-187-5p antagomir | Oligonucleotides | |
| HY-RI00351 | hsa-miR-188-5p inhibitor | Oligonucleotides | |
| HY-RI00351A | hsa-miR-188-5p antagomir | Oligonucleotides | |
| HY-RI00352 | hsa-miR-18a-3p inhibitor | Oligonucleotides | |
| HY-RI00352A | hsa-miR-18a-3p antagomir | Oligonucleotides | |
| HY-RI00353 | hsa-miR-18a-5p inhibitor | Oligonucleotides | |
| HY-RI00353A | hsa-miR-18a-5p antagomir | Oligonucleotides | |
| HY-RI00354 | hsa-miR-18b-3p inhibitor | Oligonucleotides | |
| HY-RI00354A | hsa-miR-18b-3p antagomir | Oligonucleotides | |
| HY-RI00355 | hsa-miR-18b-5p inhibitor | Oligonucleotides | |
| HY-RI00355A | hsa-miR-18b-5p antagomir | Oligonucleotides | |
| HY-RI00356 | hsa-miR-1908-3p inhibitor | Oligonucleotides | |
| HY-RI00356A | hsa-miR-1908-3p antagomir | Oligonucleotides | |
| HY-RI00357 | hsa-miR-1908-5p inhibitor | Oligonucleotides | |
| HY-RI00357A | hsa-miR-1908-5p antagomir | Oligonucleotides | |
| HY-RI00358 | hsa-miR-1909-3p inhibitor | Oligonucleotides | |
| HY-RI00358A | hsa-miR-1909-3p antagomir | Oligonucleotides | |
| HY-RI00359 | hsa-miR-1909-5p inhibitor | Oligonucleotides | |
| HY-RI00359A | hsa-miR-1909-5p antagomir | Oligonucleotides | |
| HY-RI00360 | hsa-miR-190a-3p inhibitor | Oligonucleotides | |
| HY-RI00360A | hsa-miR-190a-3p antagomir | Oligonucleotides | |
| HY-RI00361 | hsa-miR-190a-5p inhibitor | Oligonucleotides | |
| HY-RI00361A | hsa-miR-190a-5p antagomir | Oligonucleotides | |
| HY-RI00362 | hsa-miR-190b-3p inhibitor | Oligonucleotides | |
| HY-RI00362A | hsa-miR-190b-3p antagomir | Oligonucleotides | |
| HY-RI00363 | hsa-miR-190b-5p inhibitor | Oligonucleotides | |
| HY-RI00363A | hsa-miR-190b-5p antagomir | Oligonucleotides | |
| HY-RI00364 | hsa-miR-1910-3p inhibitor | Oligonucleotides | |
| HY-RI00364A | hsa-miR-1910-3p antagomir | Oligonucleotides | |
| HY-RI00365 | hsa-miR-1910-5p inhibitor | Oligonucleotides | |
| HY-RI00365A | hsa-miR-1910-5p antagomir | Oligonucleotides | |
| HY-RI00366 | hsa-miR-1911-3p inhibitor | Oligonucleotides | |
| HY-RI00366A | hsa-miR-1911-3p antagomir | Oligonucleotides | |
| HY-RI00367 | hsa-miR-1911-5p inhibitor | Oligonucleotides | |
| HY-RI00367A | hsa-miR-1911-5p antagomir | Oligonucleotides | |
| HY-RI00368 | hsa-miR-1912-3p inhibitor | Oligonucleotides | |
| HY-RI00368A | hsa-miR-1912-3p antagomir | Oligonucleotides | |
| HY-RI00369 | hsa-miR-1912-5p inhibitor | Oligonucleotides | |
| HY-RI00369A | hsa-miR-1912-5p antagomir | Oligonucleotides | |
| HY-RI00370 | hsa-miR-1913 inhibitor | Oligonucleotides | |
| HY-RI00370A | hsa-miR-1913 antagomir | Oligonucleotides | |
| HY-RI00371 | hsa-miR-191-3p inhibitor | Oligonucleotides | |
| HY-RI00371A | hsa-miR-191-3p antagomir | Oligonucleotides | |
| HY-RI00372 | hsa-miR-1914-3p inhibitor | Oligonucleotides | |
| HY-RI00372A | hsa-miR-1914-3p antagomir | Oligonucleotides | |
| HY-RI00373 | hsa-miR-1914-5p inhibitor | Oligonucleotides | |
| HY-RI00373A | hsa-miR-1914-5p antagomir | Oligonucleotides | |
| HY-RI00374 | hsa-miR-1915-3p inhibitor | Oligonucleotides | |
| HY-RI00374A | hsa-miR-1915-3p antagomir | Oligonucleotides | |
| HY-RI00375 | hsa-miR-1915-5p inhibitor | Oligonucleotides | |
| HY-RI00375A | hsa-miR-1915-5p antagomir | Oligonucleotides | |
| HY-RI00376 | hsa-miR-191-5p inhibitor | Oligonucleotides | |
| HY-RI00376A | hsa-miR-191-5p antagomir | Oligonucleotides | |
| HY-RI00377 | hsa-miR-192-3p inhibitor | Oligonucleotides | |
| HY-RI00377A | hsa-miR-192-3p antagomir | Oligonucleotides | |
| HY-RI00378 | hsa-miR-192-5p inhibitor | Oligonucleotides | |
| HY-RI00378A | hsa-miR-192-5p antagomir | Oligonucleotides | |
| HY-RI00379 | hsa-miR-193a-3p inhibitor | Oligonucleotides | |
| HY-RI00379A | hsa-miR-193a-3p antagomir | Oligonucleotides | |
| HY-RI00380 | hsa-miR-193a-5p inhibitor | Oligonucleotides | |
| HY-RI00380A | hsa-miR-193a-5p antagomir | Oligonucleotides | |
| HY-RI00381 | hsa-miR-193b-3p inhibitor | Oligonucleotides | |
| HY-RI00381A | hsa-miR-193b-3p antagomir | Oligonucleotides | |
| HY-RI00382 | hsa-miR-193b-5p inhibitor | Oligonucleotides | |
| HY-RI00382A | hsa-miR-193b-5p antagomir | Oligonucleotides | |
| HY-RI00383 | hsa-miR-194-3p inhibitor | Oligonucleotides | |
| HY-RI00383A | hsa-miR-194-3p antagomir | Oligonucleotides | |
| HY-RI00384 | hsa-miR-194-5p inhibitor | Oligonucleotides | |
| HY-RI00384A | hsa-miR-194-5p antagomir | Oligonucleotides | |
| HY-RI00385 | hsa-miR-195-3p inhibitor | Oligonucleotides | |
| HY-RI00385A | hsa-miR-195-3p antagomir | Oligonucleotides | |
| HY-RI00386 | hsa-miR-195-5p inhibitor | Oligonucleotides | |
| HY-RI00386A | hsa-miR-195-5p antagomir | Oligonucleotides | |
| HY-RI00387 | hsa-miR-196a-1-3p inhibitor | Oligonucleotides | |
| HY-RI00387A | hsa-miR-196a-1-3p antagomir | Oligonucleotides | |
| HY-RI00388 | hsa-miR-196a-3p inhibitor | Oligonucleotides | |
| HY-RI00388A | hsa-miR-196a-3p antagomir | Oligonucleotides | |
| HY-RI00389 | hsa-miR-196a-5p inhibitor | Oligonucleotides | |
| HY-RI00389A | hsa-miR-196a-5p antagomir | Oligonucleotides | |
| HY-RI00390 | hsa-miR-196b-3p inhibitor | Oligonucleotides | |
| HY-RI00390A | hsa-miR-196b-3p antagomir | Oligonucleotides | |
| HY-RI00391 | hsa-miR-196b-5p inhibitor | Oligonucleotides | |
| HY-RI00391A | hsa-miR-196b-5p antagomir | Oligonucleotides | |
| HY-RI00392 | hsa-miR-1972 inhibitor | Oligonucleotides | |
| HY-RI00392A | hsa-miR-1972 antagomir | Oligonucleotides | |
| HY-RI00393 | hsa-miR-1973 inhibitor | Oligonucleotides | |
| HY-RI00393A | hsa-miR-1973 antagomir | Oligonucleotides | |
| HY-RI00394 | hsa-miR-197-3p inhibitor | Oligonucleotides | |
| HY-RI00394A | hsa-miR-197-3p antagomir | Oligonucleotides | |
| HY-RI00395 | hsa-miR-197-5p inhibitor | Oligonucleotides | |
| HY-RI00395A | hsa-miR-197-5p antagomir | Oligonucleotides | |
| HY-RI00396 | hsa-miR-1976 inhibitor | Oligonucleotides | |
| HY-RI00396A | hsa-miR-1976 antagomir | Oligonucleotides | |
| HY-RI00397 | hsa-miR-198 inhibitor | Oligonucleotides | |
| HY-RI00397A | hsa-miR-198 antagomir | Oligonucleotides | |
| HY-RI00398 | hsa-miR-199a-3p inhibitor | Oligonucleotides | |
| HY-RI00398A | hsa-miR-199a-3p antagomir | Oligonucleotides | |
| HY-RI00399 | hsa-miR-199a-5p inhibitor | Oligonucleotides | |
| HY-RI00399A | hsa-miR-199a-5p antagomir | Oligonucleotides | |
| HY-RI00400 | hsa-miR-199b-5p inhibitor | Oligonucleotides | |
| HY-RI00400A | hsa-miR-199b-5p antagomir | Oligonucleotides | |
| HY-RI00401 | hsa-miR-19a-3p inhibitor | Oligonucleotides | |
| HY-RI00401A | hsa-miR-19a-3p antagomir | Oligonucleotides | |
| HY-RI00402 | hsa-miR-19a-5p inhibitor | Oligonucleotides | |
| HY-RI00402A | hsa-miR-19a-5p antagomir | Oligonucleotides | |
| HY-RI00403 | hsa-miR-19b-2-5p inhibitor | Oligonucleotides | |
| HY-RI00403A | hsa-miR-19b-2-5p antagomir | Oligonucleotides | |
| HY-RI00404 | hsa-miR-19b-3p inhibitor | Oligonucleotides | |
| HY-RI00404A | hsa-miR-19b-3p antagomir | Oligonucleotides | |
| HY-RI00405 | hsa-miR-200a-3p inhibitor | Oligonucleotides | |
| HY-RI00405A | hsa-miR-200a-3p antagomir | Oligonucleotides | |
| HY-RI00406 | hsa-miR-200b-3p inhibitor | Oligonucleotides | |
| HY-RI00406A | hsa-miR-200b-3p antagomir | Oligonucleotides | |
| HY-RI00407 | hsa-miR-200c-3p inhibitor | Oligonucleotides | |
| HY-RI00407A | hsa-miR-200c-3p antagomir | Oligonucleotides | |
| HY-RI00408 | hsa-miR-200c-5p inhibitor | Oligonucleotides | |
| HY-RI00408A | hsa-miR-200c-5p antagomir | Oligonucleotides | |
| HY-RI00409 | hsa-miR-202-3p inhibitor | Oligonucleotides | |
| HY-RI00409A | hsa-miR-202-3p antagomir | Oligonucleotides | |
| HY-RI00410 | hsa-miR-202-5p inhibitor | Oligonucleotides | |
| HY-RI00410A | hsa-miR-202-5p antagomir | Oligonucleotides | |
| HY-RI00411 | hsa-miR-203a-3p inhibitor | Oligonucleotides | |
| HY-RI00411A | hsa-miR-203a-3p antagomir | Oligonucleotides | |
| HY-RI00412 | hsa-miR-203a-5p inhibitor | Oligonucleotides | |
| HY-RI00412A | hsa-miR-203a-5p antagomir | Oligonucleotides | |
| HY-RI00413 | hsa-miR-203b-3p inhibitor | Oligonucleotides | |
| HY-RI00413A | hsa-miR-203b-3p antagomir | Oligonucleotides | |
| HY-RI00414 | hsa-miR-203b-5p inhibitor | Oligonucleotides | |
| HY-RI00414A | hsa-miR-203b-5p antagomir | Oligonucleotides | |
| HY-RI00415 | hsa-miR-204-3p inhibitor | Oligonucleotides | |
| HY-RI00415A | hsa-miR-204-3p antagomir | Oligonucleotides | |
| HY-RI00416 | hsa-miR-204-5p inhibitor | Oligonucleotides | |
| HY-RI00416A | hsa-miR-204-5p antagomir | Oligonucleotides | |
| HY-RI00417 | hsa-miR-2052 inhibitor | Oligonucleotides | |
| HY-RI00417A | hsa-miR-2052 antagomir | Oligonucleotides | |
| HY-RI00418 | hsa-miR-2053 inhibitor | Oligonucleotides | |
| HY-RI00418A | hsa-miR-2053 antagomir | Oligonucleotides | |
| HY-RI00419 | hsa-miR-205-3p inhibitor | Oligonucleotides | |
| HY-RI00419A | hsa-miR-205-3p antagomir | Oligonucleotides | |
| HY-RI00420 | hsa-miR-2054 inhibitor | Oligonucleotides | |
| HY-RI00420A | hsa-miR-2054 antagomir | Oligonucleotides | |
| HY-RI00421 | hsa-miR-205-5p inhibitor | Oligonucleotides | |
| HY-RI00421A | hsa-miR-205-5p antagomir | Oligonucleotides | |
| HY-RI00422 | hsa-miR-208a-3p inhibitor | Oligonucleotides | |
| HY-RI00422A | hsa-miR-208a-3p antagomir | Oligonucleotides | |
| HY-RI00423 | hsa-miR-208b-3p inhibitor | Oligonucleotides | |
| HY-RI00423A | hsa-miR-208b-3p antagomir | Oligonucleotides | |
| HY-RI00424 | hsa-miR-208b-5p inhibitor | Oligonucleotides | |
| HY-RI00424A | hsa-miR-208b-5p antagomir | Oligonucleotides | |
| HY-RI00425 | hsa-miR-20a-3p inhibitor | Oligonucleotides | |
| HY-RI00425A | hsa-miR-20a-3p antagomir | Oligonucleotides | |
| HY-RI00426 | hsa-miR-20a-5p inhibitor | Oligonucleotides | |
| HY-RI00426A | hsa-miR-20a-5p antagomir | Oligonucleotides | |
| HY-RI00427 | hsa-miR-20b-3p inhibitor | Oligonucleotides | |
| HY-RI00427A | hsa-miR-20b-3p antagomir | Oligonucleotides | |
| HY-RI00428 | hsa-miR-20b-5p inhibitor | Oligonucleotides | |
| HY-RI00428A | hsa-miR-20b-5p antagomir | Oligonucleotides | |
| HY-RI00429 | hsa-miR-210-3p inhibitor | Oligonucleotides | |
| HY-RI00429A | hsa-miR-210-3p antagomir | Oligonucleotides | |
| HY-RI00430 | hsa-miR-210-5p inhibitor | Oligonucleotides | |
| HY-RI00430A | hsa-miR-210-5p antagomir | Oligonucleotides | |
| HY-RI00431 | hsa-miR-2110 inhibitor | Oligonucleotides | |
| HY-RI00431A | hsa-miR-2110 antagomir | Oligonucleotides | |
| HY-RI00432 | hsa-miR-2113 inhibitor | Oligonucleotides | |
| HY-RI00432A | hsa-miR-2113 antagomir | Oligonucleotides | |
| HY-RI00433 | hsa-miR-211-3p inhibitor | Oligonucleotides | |
| HY-RI00433A | hsa-miR-211-3p antagomir | Oligonucleotides | |
| HY-RI00434 | hsa-miR-2114-3p inhibitor | Oligonucleotides | |
| HY-RI00434A | hsa-miR-2114-3p antagomir | Oligonucleotides | |
| HY-RI00435 | hsa-miR-2114-5p inhibitor | Oligonucleotides | |
| HY-RI00435A | hsa-miR-2114-5p antagomir | Oligonucleotides | |
| HY-RI00436 | hsa-miR-2115-3p inhibitor | Oligonucleotides | |
| HY-RI00436A | hsa-miR-2115-3p antagomir | Oligonucleotides | |
| HY-RI00437 | hsa-miR-2115-5p inhibitor | Oligonucleotides | |
| HY-RI00437A | hsa-miR-2115-5p antagomir | Oligonucleotides | |
| HY-RI00438 | hsa-miR-211-5p inhibitor | Oligonucleotides | |
| HY-RI00438A | hsa-miR-211-5p antagomir | Oligonucleotides | |
| HY-RI00439 | hsa-miR-2116-3p inhibitor | Oligonucleotides | |
| HY-RI00439A | hsa-miR-2116-3p antagomir | Oligonucleotides | |
| HY-RI00440 | hsa-miR-2116-5p inhibitor | Oligonucleotides | |
| HY-RI00440A | hsa-miR-2116-5p antagomir | Oligonucleotides | |
| HY-RI00441 | hsa-miR-2117 inhibitor | Oligonucleotides | |
| HY-RI00441A | hsa-miR-2117 antagomir | Oligonucleotides | |
| HY-RI00442 | hsa-miR-212-3p inhibitor | Oligonucleotides | |
| HY-RI00442A | hsa-miR-212-3p antagomir | Oligonucleotides | |
| HY-RI00443 | hsa-miR-212-5p inhibitor | Oligonucleotides | |
| HY-RI00443A | hsa-miR-212-5p antagomir | Oligonucleotides | |
| HY-RI00444 | hsa-miR-21-3p inhibitor | Oligonucleotides | |
| HY-RI00444A | hsa-miR-21-3p antagomir | Oligonucleotides | |
| HY-RI00445 | hsa-miR-214-3p inhibitor | Oligonucleotides | |
| HY-RI00445A | hsa-miR-214-3p antagomir | Oligonucleotides | |
| HY-RI00446 | hsa-miR-214-5p inhibitor | Oligonucleotides | |
| HY-RI00446A | hsa-miR-214-5p antagomir | Oligonucleotides | |
| HY-RI00447 | hsa-miR-215-3p inhibitor | Oligonucleotides | |
| HY-RI00447A | hsa-miR-215-3p antagomir | Oligonucleotides | |
| HY-RI00448 | hsa-miR-215-5p inhibitor | Oligonucleotides | |
| HY-RI00448A | hsa-miR-215-5p antagomir | Oligonucleotides | |
| HY-RI00449 | hsa-miR-21-5p inhibitor | Oligonucleotides | |
| HY-RI00449A | hsa-miR-21-5p antagomir | Oligonucleotides | |
| HY-RI00450 | hsa-miR-216a-3p inhibitor | Oligonucleotides | |
| HY-RI00450A | hsa-miR-216a-3p antagomir | Oligonucleotides | |
| HY-RI00451 | hsa-miR-216a-5p inhibitor | Oligonucleotides | |
| HY-RI00451A | hsa-miR-216a-5p antagomir | Oligonucleotides | |
| HY-RI00452 | hsa-miR-216b-3p inhibitor | Oligonucleotides | |
| HY-RI00452A | hsa-miR-216b-3p antagomir | Oligonucleotides | |
| HY-RI00453 | hsa-miR-216b-5p inhibitor | Oligonucleotides | |
| HY-RI00453A | hsa-miR-216b-5p antagomir | Oligonucleotides | |
| HY-RI00454 | hsa-miR-217-3p inhibitor | Oligonucleotides | |
| HY-RI00454A | hsa-miR-217-3p antagomir | Oligonucleotides | |
| HY-RI00455 | hsa-miR-217-5p inhibitor | Oligonucleotides | |
| HY-RI00455A | hsa-miR-217-5p antagomir | Oligonucleotides | |
| HY-RI00456 | hsa-miR-218-1-3p inhibitor | Oligonucleotides | |
| HY-RI00456A | hsa-miR-218-1-3p antagomir | Oligonucleotides | |
| HY-RI00457 | hsa-miR-218-2-3p inhibitor | Oligonucleotides | |
| HY-RI00457A | hsa-miR-218-2-3p antagomir | Oligonucleotides | |
| HY-RI00458 | hsa-miR-218-5p inhibitor | Oligonucleotides | |
| HY-RI00458A | hsa-miR-218-5p antagomir | Oligonucleotides | |
| HY-RI00459 | hsa-miR-219a-1-3p inhibitor | Oligonucleotides | |
| HY-RI00459A | hsa-miR-219a-1-3p antagomir | Oligonucleotides | |
| HY-RI00460 | hsa-miR-219a-2-3p inhibitor | Oligonucleotides | |
| HY-RI00460A | hsa-miR-219a-2-3p antagomir | Oligonucleotides | |
| HY-RI00461 | hsa-miR-219a-5p inhibitor | Oligonucleotides | |
| HY-RI00461A | hsa-miR-219a-5p antagomir | Oligonucleotides | |
| HY-RI00462 | hsa-miR-219b-3p inhibitor | Oligonucleotides | |
| HY-RI00462A | hsa-miR-219b-3p antagomir | Oligonucleotides | |
| HY-RI00463 | hsa-miR-219b-5p inhibitor | Oligonucleotides | |
| HY-RI00463A | hsa-miR-219b-5p antagomir | Oligonucleotides | |
| HY-RI00464 | hsa-miR-221-3p inhibitor | Oligonucleotides | |
| HY-RI00464A | hsa-miR-221-3p antagomir | Oligonucleotides | |
| HY-RI00465 | hsa-miR-221-5p inhibitor | Oligonucleotides | |
| HY-RI00465A | hsa-miR-221-5p antagomir | Oligonucleotides | |
| HY-RI00466 | hsa-miR-222-5p inhibitor | Oligonucleotides | |
| HY-RI00466A | hsa-miR-222-5p antagomir | Oligonucleotides | |
| HY-RI00467 | hsa-miR-223-3p inhibitor | Oligonucleotides | |
| HY-RI00467A | hsa-miR-223-3p antagomir | Oligonucleotides | |
| HY-RI00468 | hsa-miR-223-5p inhibitor | Oligonucleotides | |
| HY-RI00468A | hsa-miR-223-5p antagomir | Oligonucleotides | |
| HY-RI00469 | hsa-miR-224-3p inhibitor | Oligonucleotides | |
| HY-RI00469A | hsa-miR-224-3p antagomir | Oligonucleotides | |
| HY-RI00470 | hsa-miR-224-5p inhibitor | Oligonucleotides | |
| HY-RI00470A | hsa-miR-224-5p antagomir | Oligonucleotides | |
| HY-RI00471 | hsa-miR-22-5p inhibitor | Oligonucleotides | |
| HY-RI00471A | hsa-miR-22-5p antagomir | Oligonucleotides | |
| HY-RI00472 | hsa-miR-2276-3p inhibitor | Oligonucleotides | |
| HY-RI00472A | hsa-miR-2276-3p antagomir | Oligonucleotides | |
| HY-RI00473 | hsa-miR-2276-5p inhibitor | Oligonucleotides | |
| HY-RI00473A | hsa-miR-2276-5p antagomir | Oligonucleotides | |
| HY-RI00474 | hsa-miR-2277-3p inhibitor | Oligonucleotides | |
| HY-RI00474A | hsa-miR-2277-3p antagomir | Oligonucleotides | |
| HY-RI00475 | hsa-miR-2277-5p inhibitor | Oligonucleotides | |
| HY-RI00475A | hsa-miR-2277-5p antagomir | Oligonucleotides | |
| HY-RI00476 | hsa-miR-2278 inhibitor | Oligonucleotides | |
| HY-RI00476A | hsa-miR-2278 antagomir | Oligonucleotides | |
| HY-RI00477 | hsa-miR-2355-3p inhibitor | Oligonucleotides | |
| HY-RI00477A | hsa-miR-2355-3p antagomir | Oligonucleotides | |
| HY-RI00478 | hsa-miR-2355-5p inhibitor | Oligonucleotides | |
| HY-RI00478A | hsa-miR-2355-5p antagomir | Oligonucleotides | |
| HY-RI00479 | hsa-miR-2392 inhibitor | Oligonucleotides | |
| HY-RI00479A | hsa-miR-2392 antagomir | Oligonucleotides | |
| HY-RI00480 | hsa-miR-23a-3p inhibitor | Oligonucleotides | |
| HY-RI00480A | hsa-miR-23a-3p antagomir | Oligonucleotides | |
| HY-RI00481 | hsa-miR-23a-5p inhibitor | Oligonucleotides | |
| HY-RI00481A | hsa-miR-23a-5p antagomir | Oligonucleotides | |
| HY-RI00482 | hsa-miR-23b-5p inhibitor | Oligonucleotides | |
| HY-RI00482A | hsa-miR-23b-5p antagomir | Oligonucleotides | |
| HY-RI00483 | hsa-miR-23c inhibitor | Oligonucleotides | |
| HY-RI00483A | hsa-miR-23c antagomir | Oligonucleotides | |
| HY-RI00484 | hsa-miR-24-1-5p inhibitor | Oligonucleotides | |
| HY-RI00484A | hsa-miR-24-1-5p antagomir | Oligonucleotides | |
| HY-RI00485 | hsa-miR-24-2-5p inhibitor | Oligonucleotides | |
| HY-RI00485A | hsa-miR-24-2-5p antagomir | Oligonucleotides | |
| HY-RI00486 | hsa-miR-2467-3p inhibitor | Oligonucleotides | |
| HY-RI00486A | hsa-miR-2467-3p antagomir | Oligonucleotides | |
| HY-RI00487 | hsa-miR-2467-5p inhibitor | Oligonucleotides | |
| HY-RI00487A | hsa-miR-2467-5p antagomir | Oligonucleotides | |
| HY-RI00488 | hsa-miR-25-5p inhibitor | Oligonucleotides | |
| HY-RI00488A | hsa-miR-25-5p antagomir | Oligonucleotides | |
| HY-RI00489 | hsa-miR-2681-3p inhibitor | Oligonucleotides | |
| HY-RI00489A | hsa-miR-2681-3p antagomir | Oligonucleotides | |
| HY-RI00490 | hsa-miR-2681-5p inhibitor | Oligonucleotides | |
| HY-RI00490A | hsa-miR-2681-5p antagomir | Oligonucleotides | |
| HY-RI00491 | hsa-miR-2682-3p inhibitor | Oligonucleotides | |
| HY-RI00491A | hsa-miR-2682-3p antagomir | Oligonucleotides | |
| HY-RI00492 | hsa-miR-2682-5p inhibitor | Oligonucleotides | |
| HY-RI00492A | hsa-miR-2682-5p antagomir | Oligonucleotides | |
| HY-RI00493 | hsa-miR-26a-1-3p inhibitor | Oligonucleotides | |
| HY-RI00493A | hsa-miR-26a-1-3p antagomir | Oligonucleotides | |
| HY-RI00494 | hsa-miR-26a-2-3p inhibitor | Oligonucleotides | |
| HY-RI00494A | hsa-miR-26a-2-3p antagomir | Oligonucleotides | |
| HY-RI00495 | hsa-miR-26a-5p inhibitor | Oligonucleotides | |
| HY-RI00495A | hsa-miR-26a-5p antagomir | Oligonucleotides | |
| HY-RI00496 | hsa-miR-26b-3p inhibitor | Oligonucleotides | |
| HY-RI00496A | hsa-miR-26b-3p antagomir | Oligonucleotides | |
| HY-RI00497 | hsa-miR-26b-5p inhibitor | Oligonucleotides | |
| HY-RI00497A | hsa-miR-26b-5p antagomir | Oligonucleotides | |
| HY-RI00498 | hsa-miR-27a-3p inhibitor | Oligonucleotides | |
| HY-RI00498A | hsa-miR-27a-3p antagomir | Oligonucleotides | |
| HY-RI00499 | hsa-miR-27a-5p inhibitor | Oligonucleotides | |
| HY-RI00499A | hsa-miR-27a-5p antagomir | Oligonucleotides | |
| HY-RI00500 | hsa-miR-27b-3p inhibitor | Oligonucleotides | |
| HY-RI00500A | hsa-miR-27b-3p antagomir | Oligonucleotides | |
| HY-RI00501 | hsa-miR-28-3p inhibitor | Oligonucleotides | |
| HY-RI00501A | hsa-miR-28-3p antagomir | Oligonucleotides | |
| HY-RI00502 | hsa-miR-28-5p inhibitor | Oligonucleotides | |
| HY-RI00502A | hsa-miR-28-5p antagomir | Oligonucleotides | |
| HY-RI00503 | hsa-miR-2861 inhibitor | Oligonucleotides | |
| HY-RI00503A | hsa-miR-2861 antagomir | Oligonucleotides | |
| HY-RI00504 | hsa-miR-2909 inhibitor | Oligonucleotides | |
| HY-RI00504A | hsa-miR-2909 antagomir | Oligonucleotides | |
| HY-RI00505 | hsa-miR-296-3p inhibitor | Oligonucleotides | |
| HY-RI00505A | hsa-miR-296-3p antagomir | Oligonucleotides | |
| HY-RI00506 | hsa-miR-297 inhibitor | Oligonucleotides | |
| HY-RI00506A | hsa-miR-297 antagomir | Oligonucleotides | |
| HY-RI00507 | hsa-miR-298 inhibitor | Oligonucleotides | |
| HY-RI00507A | hsa-miR-298 antagomir | Oligonucleotides | |
| HY-RI00508 | hsa-miR-299-3p inhibitor | Oligonucleotides | |
| HY-RI00508A | hsa-miR-299-3p antagomir | Oligonucleotides | |
| HY-RI00509 | hsa-miR-299-5p inhibitor | Oligonucleotides | |
| HY-RI00509A | hsa-miR-299-5p antagomir | Oligonucleotides | |
| HY-RI00510 | hsa-miR-29a-3p inhibitor | Oligonucleotides | |
| HY-RI00510A | hsa-miR-29a-3p antagomir | Oligonucleotides | |
| HY-RI00511 | hsa-miR-29a-5p inhibitor | Oligonucleotides | |
| HY-RI00511A | hsa-miR-29a-5p antagomir | Oligonucleotides | |
| HY-RI00512 | hsa-miR-29b-1-5p inhibitor | Oligonucleotides | |
| HY-RI00512A | hsa-miR-29b-1-5p antagomir | Oligonucleotides | |
| HY-RI00513 | hsa-miR-29b-2-5p inhibitor | Oligonucleotides | |
| HY-RI00513A | hsa-miR-29b-2-5p antagomir | Oligonucleotides | |
| HY-RI00514 | hsa-miR-29c-5p inhibitor | Oligonucleotides | |
| HY-RI00514A | hsa-miR-29c-5p antagomir | Oligonucleotides | |
| HY-RI00515 | hsa-miR-300 inhibitor | Oligonucleotides | |
| HY-RI00515A | hsa-miR-300 antagomir | Oligonucleotides | |
| HY-RI00516 | hsa-miR-301a-3p inhibitor | Oligonucleotides | |
| HY-RI00516A | hsa-miR-301a-3p antagomir | Oligonucleotides | |
| HY-RI00517 | hsa-miR-301a-5p inhibitor | Oligonucleotides | |
| HY-RI00517A | hsa-miR-301a-5p antagomir | Oligonucleotides | |
| HY-RI00518 | hsa-miR-302a-3p inhibitor | Oligonucleotides | |
| HY-RI00518A | hsa-miR-302a-3p antagomir | Oligonucleotides | |
| HY-RI00519 | hsa-miR-302a-5p inhibitor | Oligonucleotides | |
| HY-RI00519A | hsa-miR-302a-5p antagomir | Oligonucleotides | |
| HY-RI00520 | hsa-miR-302b-5p inhibitor | Oligonucleotides | |
| HY-RI00520A | hsa-miR-302b-5p antagomir | Oligonucleotides | |
| HY-RI00521 | hsa-miR-302d-3p inhibitor | Oligonucleotides | |
| HY-RI00521A | hsa-miR-302d-3p antagomir | Oligonucleotides | |
| HY-RI00522 | hsa-miR-302d-5p inhibitor | Oligonucleotides | |
| HY-RI00522A | hsa-miR-302d-5p antagomir | Oligonucleotides | |
| HY-RI00523 | hsa-miR-302e inhibitor | Oligonucleotides | |
| HY-RI00523A | hsa-miR-302e antagomir | Oligonucleotides | |
| HY-RI00524 | hsa-miR-302f inhibitor | Oligonucleotides | |
| HY-RI00524A | hsa-miR-302f antagomir | Oligonucleotides | |
| HY-RI00525 | hsa-miR-3059-3p inhibitor | Oligonucleotides | |
| HY-RI00525A | hsa-miR-3059-3p antagomir | Oligonucleotides | |
| HY-RI00526 | hsa-miR-3059-5p inhibitor | Oligonucleotides | |
| HY-RI00526A | hsa-miR-3059-5p antagomir | Oligonucleotides | |
| HY-RI00527 | hsa-miR-3064-3p inhibitor | Oligonucleotides | |
| HY-RI00527A | hsa-miR-3064-3p antagomir | Oligonucleotides | |
| HY-RI00528 | hsa-miR-3065-3p inhibitor | Oligonucleotides | |
| HY-RI00528A | hsa-miR-3065-3p antagomir | Oligonucleotides | |
| HY-RI00529 | hsa-miR-3065-5p inhibitor | Oligonucleotides | |
| HY-RI00529A | hsa-miR-3065-5p antagomir | Oligonucleotides | |
| HY-RI00530 | hsa-miR-3074-3p inhibitor | Oligonucleotides | |
| HY-RI00530A | hsa-miR-3074-3p antagomir | Oligonucleotides | |
| HY-RI00531 | hsa-miR-3074-5p inhibitor | Oligonucleotides | |
| HY-RI00531A | hsa-miR-3074-5p antagomir | Oligonucleotides | |
| HY-RI00532 | hsa-miR-3085-3p inhibitor | Oligonucleotides | |
| HY-RI00532A | hsa-miR-3085-3p antagomir | Oligonucleotides | |
| HY-RI00533 | hsa-miR-3085-5p inhibitor | Oligonucleotides | |
| HY-RI00533A | hsa-miR-3085-5p antagomir | Oligonucleotides | |
| HY-RI00534 | hsa-miR-30a-3p inhibitor | Oligonucleotides | |
| HY-RI00534A | hsa-miR-30a-3p antagomir | Oligonucleotides | |
| HY-RI00535 | hsa-miR-30a-5p inhibitor | Oligonucleotides | |
| HY-RI00535A | hsa-miR-30a-5p antagomir | Oligonucleotides | |
| HY-RI00536 | hsa-miR-30b-3p inhibitor | Oligonucleotides | |
| HY-RI00536A | hsa-miR-30b-3p antagomir | Oligonucleotides | |
| HY-RI00537 | hsa-miR-30b-5p inhibitor | Oligonucleotides | |
| HY-RI00537A | hsa-miR-30b-5p antagomir | Oligonucleotides | |
| HY-RI00538 | hsa-miR-30c-1-3p inhibitor | Oligonucleotides | |
| HY-RI00538A | hsa-miR-30c-1-3p antagomir | Oligonucleotides | |
| HY-RI00539 | hsa-miR-30c-2-3p inhibitor | Oligonucleotides | |
| HY-RI00539A | hsa-miR-30c-2-3p antagomir | Oligonucleotides | |
| HY-RI00540 | hsa-miR-30c-5p inhibitor | Oligonucleotides | |
| HY-RI00540A | hsa-miR-30c-5p antagomir | Oligonucleotides | |
| HY-RI00541 | hsa-miR-30d-3p inhibitor | Oligonucleotides | |
| HY-RI00541A | hsa-miR-30d-3p antagomir | Oligonucleotides | |
| HY-RI00542 | hsa-miR-30d-5p inhibitor | Oligonucleotides | |
| HY-RI00542A | hsa-miR-30d-5p antagomir | Oligonucleotides | |
| HY-RI00543 | hsa-miR-30e-3p inhibitor | Oligonucleotides | |
| HY-RI00543A | hsa-miR-30e-3p antagomir | Oligonucleotides | |
| HY-RI00544 | hsa-miR-30e-5p inhibitor | Oligonucleotides | |
| HY-RI00544A | hsa-miR-30e-5p antagomir | Oligonucleotides | |
| HY-RI00545 | hsa-miR-3115 inhibitor | Oligonucleotides | |
| HY-RI00545A | hsa-miR-3115 antagomir | Oligonucleotides | |
| HY-RI00546 | hsa-miR-3116 inhibitor | Oligonucleotides | |
| HY-RI00546A | hsa-miR-3116 antagomir | Oligonucleotides | |
| HY-RI00547 | hsa-miR-3117-3p inhibitor | Oligonucleotides | |
| HY-RI00547A | hsa-miR-3117-3p antagomir | Oligonucleotides | |
| HY-RI00548 | hsa-miR-3117-5p inhibitor | Oligonucleotides | |
| HY-RI00548A | hsa-miR-3117-5p antagomir | Oligonucleotides | |
| HY-RI00549 | hsa-miR-3118 inhibitor | Oligonucleotides | |
| HY-RI00549A | hsa-miR-3118 antagomir | Oligonucleotides | |
| HY-RI00550 | hsa-miR-3119 inhibitor | Oligonucleotides | |
| HY-RI00550A | hsa-miR-3119 antagomir | Oligonucleotides | |
| HY-RI00551 | hsa-miR-3120-3p inhibitor | Oligonucleotides | |
| HY-RI00551A | hsa-miR-3120-3p antagomir | Oligonucleotides | |
| HY-RI00552 | hsa-miR-3120-5p inhibitor | Oligonucleotides | |
| HY-RI00552A | hsa-miR-3120-5p antagomir | Oligonucleotides | |
| HY-RI00553 | hsa-miR-3121-3p inhibitor | Oligonucleotides | |
| HY-RI00553A | hsa-miR-3121-3p antagomir | Oligonucleotides | |
| HY-RI00554 | hsa-miR-3121-5p inhibitor | Oligonucleotides | |
| HY-RI00554A | hsa-miR-3121-5p antagomir | Oligonucleotides | |
| HY-RI00555 | hsa-miR-3122 inhibitor | Oligonucleotides | |
| HY-RI00555A | hsa-miR-3122 antagomir | Oligonucleotides | |
| HY-RI00556 | hsa-miR-3123 inhibitor | Oligonucleotides | |
| HY-RI00556A | hsa-miR-3123 antagomir | Oligonucleotides | |
| HY-RI00557 | hsa-miR-3124-3p inhibitor | Oligonucleotides | |
| HY-RI00557A | hsa-miR-3124-3p antagomir | Oligonucleotides | |
| HY-RI00558 | hsa-miR-3124-5p inhibitor | Oligonucleotides | |
| HY-RI00558A | hsa-miR-3124-5p antagomir | Oligonucleotides | |
| HY-RI00559 | hsa-miR-3125 inhibitor | Oligonucleotides | |
| HY-RI00559A | hsa-miR-3125 antagomir | Oligonucleotides | |
| HY-RI00560 | hsa-miR-3126-3p inhibitor | Oligonucleotides | |
| HY-RI00560A | hsa-miR-3126-3p antagomir | Oligonucleotides | |
| HY-RI00561 | hsa-miR-3126-5p inhibitor | Oligonucleotides | |
| HY-RI00561A | hsa-miR-3126-5p antagomir | Oligonucleotides | |
| HY-RI00562 | hsa-miR-3127-3p inhibitor | Oligonucleotides | |
| HY-RI00562A | hsa-miR-3127-3p antagomir | Oligonucleotides | |
| HY-RI00563 | hsa-miR-3127-5p inhibitor | Oligonucleotides | |
| HY-RI00563A | hsa-miR-3127-5p antagomir | Oligonucleotides | |
| HY-RI00564 | hsa-miR-3128 inhibitor | Oligonucleotides | |
| HY-RI00564A | hsa-miR-3128 antagomir | Oligonucleotides | |
| HY-RI00565 | hsa-miR-3129-3p inhibitor | Oligonucleotides | |
| HY-RI00565A | hsa-miR-3129-3p antagomir | Oligonucleotides | |
| HY-RI00566 | hsa-miR-3129-5p inhibitor | Oligonucleotides | |
| HY-RI00566A | hsa-miR-3129-5p antagomir | Oligonucleotides | |
| HY-RI00567 | hsa-miR-3130-3p inhibitor | Oligonucleotides | |
| HY-RI00567A | hsa-miR-3130-3p antagomir | Oligonucleotides | |
| HY-RI00568 | hsa-miR-3130-5p inhibitor | Oligonucleotides | |
| HY-RI00568A | hsa-miR-3130-5p antagomir | Oligonucleotides | |
| HY-RI00569 | hsa-miR-3131 inhibitor | Oligonucleotides | |
| HY-RI00569A | hsa-miR-3131 antagomir | Oligonucleotides | |
| HY-RI00570 | hsa-miR-3132 inhibitor | Oligonucleotides | |
| HY-RI00570A | hsa-miR-3132 antagomir | Oligonucleotides | |
| HY-RI00571 | hsa-miR-3133 inhibitor | Oligonucleotides | |
| HY-RI00571A | hsa-miR-3133 antagomir | Oligonucleotides | |
| HY-RI00572 | hsa-miR-3134 inhibitor | Oligonucleotides | |
| HY-RI00572A | hsa-miR-3134 antagomir | Oligonucleotides | |
| HY-RI00573 | hsa-miR-3135a inhibitor | Oligonucleotides | |
| HY-RI00573A | hsa-miR-3135a antagomir | Oligonucleotides | |
| HY-RI00574 | hsa-miR-3135b inhibitor | Oligonucleotides | |
| HY-RI00574A | hsa-miR-3135b antagomir | Oligonucleotides | |
| HY-RI00575 | hsa-miR-3136-3p inhibitor | Oligonucleotides | |
| HY-RI00575A | hsa-miR-3136-3p antagomir | Oligonucleotides | |
| HY-RI00576 | hsa-miR-3136-5p inhibitor | Oligonucleotides | |
| HY-RI00576A | hsa-miR-3136-5p antagomir | Oligonucleotides | |
| HY-RI00577 | hsa-miR-3137 inhibitor | Oligonucleotides | |
| HY-RI00577A | hsa-miR-3137 antagomir | Oligonucleotides | |
| HY-RI00578 | hsa-miR-3138 inhibitor | Oligonucleotides | |
| HY-RI00578A | hsa-miR-3138 antagomir | Oligonucleotides | |
| HY-RI00579 | hsa-miR-3139 inhibitor | Oligonucleotides | |
| HY-RI00579A | hsa-miR-3139 antagomir | Oligonucleotides | |
| HY-RI00580 | hsa-miR-31-3p inhibitor | Oligonucleotides | |
| HY-RI00580A | hsa-miR-31-3p antagomir | Oligonucleotides | |
| HY-RI00581 | hsa-miR-3140-3p inhibitor | Oligonucleotides | |
| HY-RI00581A | hsa-miR-3140-3p antagomir | Oligonucleotides | |
| HY-RI00582 | hsa-miR-3140-5p inhibitor | Oligonucleotides | |
| HY-RI00582A | hsa-miR-3140-5p antagomir | Oligonucleotides | |
| HY-RI00583 | hsa-miR-3141 inhibitor | Oligonucleotides | |
| HY-RI00583A | hsa-miR-3141 antagomir | Oligonucleotides | |
| HY-RI00584 | hsa-miR-3142 inhibitor | Oligonucleotides | |
| HY-RI00584A | hsa-miR-3142 antagomir | Oligonucleotides | |
| HY-RI00585 | hsa-miR-3143 inhibitor | Oligonucleotides | |
| HY-RI00585A | hsa-miR-3143 antagomir | Oligonucleotides | |
| HY-RI00586 | hsa-miR-3144-3p inhibitor | Oligonucleotides | |
| HY-RI00586A | hsa-miR-3144-3p antagomir | Oligonucleotides | |
| HY-RI00587 | hsa-miR-3144-5p inhibitor | Oligonucleotides | |
| HY-RI00587A | hsa-miR-3144-5p antagomir | Oligonucleotides | |
| HY-RI00588 | hsa-miR-3145-3p inhibitor | Oligonucleotides | |
| HY-RI00588A | hsa-miR-3145-3p antagomir | Oligonucleotides | |
| HY-RI00589 | hsa-miR-3145-5p inhibitor | Oligonucleotides | |
| HY-RI00589A | hsa-miR-3145-5p antagomir | Oligonucleotides | |
| HY-RI00590 | hsa-miR-3146 inhibitor | Oligonucleotides | |
| HY-RI00590A | hsa-miR-3146 antagomir | Oligonucleotides | |
| HY-RI00591 | hsa-miR-3147 inhibitor | Oligonucleotides | |
| HY-RI00591A | hsa-miR-3147 antagomir | Oligonucleotides | |
| HY-RI00592 | hsa-miR-3148 inhibitor | Oligonucleotides | |
| HY-RI00592A | hsa-miR-3148 antagomir | Oligonucleotides | |
| HY-RI00593 | hsa-miR-3149 inhibitor | Oligonucleotides | |
| HY-RI00593A | hsa-miR-3149 antagomir | Oligonucleotides | |
| HY-RI00594 | hsa-miR-3150a-3p inhibitor | Oligonucleotides | |
| HY-RI00594A | hsa-miR-3150a-3p antagomir | Oligonucleotides | |
| HY-RI00595 | hsa-miR-3150a-5p inhibitor | Oligonucleotides | |
| HY-RI00595A | hsa-miR-3150a-5p antagomir | Oligonucleotides | |
| HY-RI00596 | hsa-miR-3150b-3p inhibitor | Oligonucleotides | |
| HY-RI00596A | hsa-miR-3150b-3p antagomir | Oligonucleotides | |
| HY-RI00597 | hsa-miR-3150b-5p inhibitor | Oligonucleotides | |
| HY-RI00597A | hsa-miR-3150b-5p antagomir | Oligonucleotides | |
| HY-RI00598 | hsa-miR-3151-3p inhibitor | Oligonucleotides | |
| HY-RI00598A | hsa-miR-3151-3p antagomir | Oligonucleotides | |
| HY-RI00599 | hsa-miR-3151-5p inhibitor | Oligonucleotides | |
| HY-RI00599A | hsa-miR-3151-5p antagomir | Oligonucleotides | |
| HY-RI00600 | hsa-miR-3152-3p inhibitor | Oligonucleotides | |
| HY-RI00600A | hsa-miR-3152-3p antagomir | Oligonucleotides | |
| HY-RI00601 | hsa-miR-3152-5p inhibitor | Oligonucleotides | |
| HY-RI00601A | hsa-miR-3152-5p antagomir | Oligonucleotides | |
| HY-RI00602 | hsa-miR-3153 inhibitor | Oligonucleotides | |
| HY-RI00602A | hsa-miR-3153 antagomir | Oligonucleotides | |
| HY-RI00603 | hsa-miR-3154 inhibitor | Oligonucleotides | |
| HY-RI00603A | hsa-miR-3154 antagomir | Oligonucleotides | |
| HY-RI00604 | hsa-miR-3155a inhibitor | Oligonucleotides | |
| HY-RI00604A | hsa-miR-3155a antagomir | Oligonucleotides | |
| HY-RI00605 | hsa-miR-3155b inhibitor | Oligonucleotides | |
| HY-RI00605A | hsa-miR-3155b antagomir | Oligonucleotides | |
| HY-RI00606 | hsa-miR-3156-3p inhibitor | Oligonucleotides | |
| HY-RI00606A | hsa-miR-3156-3p antagomir | Oligonucleotides | |
| HY-RI00607 | hsa-miR-3156-5p inhibitor | Oligonucleotides | |
| HY-RI00607A | hsa-miR-3156-5p antagomir | Oligonucleotides | |
| HY-RI00608 | hsa-miR-3157-3p inhibitor | Oligonucleotides | |
| HY-RI00608A | hsa-miR-3157-3p antagomir | Oligonucleotides | |
| HY-RI00609 | hsa-miR-3157-5p inhibitor | Oligonucleotides | |
| HY-RI00609A | hsa-miR-3157-5p antagomir | Oligonucleotides | |
| HY-RI00610 | hsa-miR-3158-3p inhibitor | Oligonucleotides | |
| HY-RI00610A | hsa-miR-3158-3p antagomir | Oligonucleotides | |
| HY-RI00611 | hsa-miR-3158-5p inhibitor | Oligonucleotides | |
| HY-RI00611A | hsa-miR-3158-5p antagomir | Oligonucleotides | |
| HY-RI00612 | hsa-miR-3159 inhibitor | Oligonucleotides | |
| HY-RI00612A | hsa-miR-3159 antagomir | Oligonucleotides | |
| HY-RI00613 | hsa-miR-31-5p inhibitor | Oligonucleotides | |
| HY-RI00613A | hsa-miR-31-5p antagomir | Oligonucleotides | |
| HY-RI00614 | hsa-miR-3160-3p inhibitor | Oligonucleotides | |
| HY-RI00614A | hsa-miR-3160-3p antagomir | Oligonucleotides | |
| HY-RI00615 | hsa-miR-3160-5p inhibitor | Oligonucleotides | |
| HY-RI00615A | hsa-miR-3160-5p antagomir | Oligonucleotides | |
| HY-RI00616 | hsa-miR-3161 inhibitor | Oligonucleotides | |
| HY-RI00616A | hsa-miR-3161 antagomir | Oligonucleotides | |
| HY-RI00617 | hsa-miR-3162-3p inhibitor | Oligonucleotides | |
| HY-RI00617A | hsa-miR-3162-3p antagomir | Oligonucleotides | |
| HY-RI00618 | hsa-miR-3162-5p inhibitor | Oligonucleotides | |
| HY-RI00618A | hsa-miR-3162-5p antagomir | Oligonucleotides | |
| HY-RI00619 | hsa-miR-3163 inhibitor | Oligonucleotides | |
| HY-RI00619A | hsa-miR-3163 antagomir | Oligonucleotides | |
| HY-RI00620 | hsa-miR-3164 inhibitor | Oligonucleotides | |
| HY-RI00620A | hsa-miR-3164 antagomir | Oligonucleotides | |
| HY-RI00621 | hsa-miR-3165 inhibitor | Oligonucleotides | |
| HY-RI00621A | hsa-miR-3165 antagomir | Oligonucleotides | |
| HY-RI00622 | hsa-miR-3166 inhibitor | Oligonucleotides | |
| HY-RI00622A | hsa-miR-3166 antagomir | Oligonucleotides | |
| HY-RI00623 | hsa-miR-3167 inhibitor | Oligonucleotides | |
| HY-RI00623A | hsa-miR-3167 antagomir | Oligonucleotides | |
| HY-RI00624 | hsa-miR-3168 inhibitor | Oligonucleotides | |
| HY-RI00624A | hsa-miR-3168 antagomir | Oligonucleotides | |
| HY-RI00625 | hsa-miR-3169 inhibitor | Oligonucleotides | |
| HY-RI00625A | hsa-miR-3169 antagomir | Oligonucleotides | |
| HY-RI00626 | hsa-miR-3170 inhibitor | Oligonucleotides | |
| HY-RI00626A | hsa-miR-3170 antagomir | Oligonucleotides | |
| HY-RI00627 | hsa-miR-3171 inhibitor | Oligonucleotides | |
| HY-RI00627A | hsa-miR-3171 antagomir | Oligonucleotides | |
| HY-RI00628 | hsa-miR-3173-3p inhibitor | Oligonucleotides | |
| HY-RI00628A | hsa-miR-3173-3p antagomir | Oligonucleotides | |
| HY-RI00629 | hsa-miR-3173-5p inhibitor | Oligonucleotides | |
| HY-RI00629A | hsa-miR-3173-5p antagomir | Oligonucleotides | |
| HY-RI00630 | hsa-miR-3174 inhibitor | Oligonucleotides | |
| HY-RI00630A | hsa-miR-3174 antagomir | Oligonucleotides | |
| HY-RI00631 | hsa-miR-3175 inhibitor | Oligonucleotides | |
| HY-RI00631A | hsa-miR-3175 antagomir | Oligonucleotides | |
| HY-RI00632 | hsa-miR-3176 inhibitor | Oligonucleotides | |
| HY-RI00632A | hsa-miR-3176 antagomir | Oligonucleotides | |
| HY-RI00633 | hsa-miR-3177-3p inhibitor | Oligonucleotides | |
| HY-RI00633A | hsa-miR-3177-3p antagomir | Oligonucleotides | |
| HY-RI00634 | hsa-miR-3177-5p inhibitor | Oligonucleotides | |
| HY-RI00634A | hsa-miR-3177-5p antagomir | Oligonucleotides | |
| HY-RI00635 | hsa-miR-3178 inhibitor | Oligonucleotides | |
| HY-RI00635A | hsa-miR-3178 antagomir | Oligonucleotides | |
| HY-RI00636 | hsa-miR-3179 inhibitor | Oligonucleotides | |
| HY-RI00636A | hsa-miR-3179 antagomir | Oligonucleotides | |
| HY-RI00637 | hsa-miR-3180 inhibitor | Oligonucleotides | |
| HY-RI00637A | hsa-miR-3180 antagomir | Oligonucleotides | |
| HY-RI00638 | hsa-miR-3180-3p inhibitor | Oligonucleotides | |
| HY-RI00638A | hsa-miR-3180-3p antagomir | Oligonucleotides | |
| HY-RI00639 | hsa-miR-3180-5p inhibitor | Oligonucleotides | |
| HY-RI00639A | hsa-miR-3180-5p antagomir | Oligonucleotides | |
| HY-RI00640 | hsa-miR-3181 inhibitor | Oligonucleotides | |
| HY-RI00640A | hsa-miR-3181 antagomir | Oligonucleotides | |
| HY-RI00641 | hsa-miR-3182 inhibitor | Oligonucleotides | |
| HY-RI00641A | hsa-miR-3182 antagomir | Oligonucleotides | |
| HY-RI00642 | hsa-miR-3183 inhibitor | Oligonucleotides | |
| HY-RI00642A | hsa-miR-3183 antagomir | Oligonucleotides | |
| HY-RI00643 | hsa-miR-3184-3p inhibitor | Oligonucleotides | |
| HY-RI00643A | hsa-miR-3184-3p antagomir | Oligonucleotides | |
| HY-RI00644 | hsa-miR-3184-5p inhibitor | Oligonucleotides | |
| HY-RI00644A | hsa-miR-3184-5p antagomir | Oligonucleotides | |
| HY-RI00645 | hsa-miR-3185 inhibitor | Oligonucleotides | |
| HY-RI00645A | hsa-miR-3185 antagomir | Oligonucleotides | |
| HY-RI00646 | hsa-miR-3186-3p inhibitor | Oligonucleotides | |
| HY-RI00646A | hsa-miR-3186-3p antagomir | Oligonucleotides | |
| HY-RI00647 | hsa-miR-3186-5p inhibitor | Oligonucleotides | |
| HY-RI00647A | hsa-miR-3186-5p antagomir | Oligonucleotides | |
| HY-RI00648 | hsa-miR-3187-3p inhibitor | Oligonucleotides | |
| HY-RI00648A | hsa-miR-3187-3p antagomir | Oligonucleotides | |
| HY-RI00649 | hsa-miR-3187-5p inhibitor | Oligonucleotides | |
| HY-RI00649A | hsa-miR-3187-5p antagomir | Oligonucleotides | |
| HY-RI00650 | hsa-miR-3188 inhibitor | Oligonucleotides | |
| HY-RI00650A | hsa-miR-3188 antagomir | Oligonucleotides | |
| HY-RI00651 | hsa-miR-3189-3p inhibitor | Oligonucleotides | |
| HY-RI00651A | hsa-miR-3189-3p antagomir | Oligonucleotides | |
| HY-RI00652 | hsa-miR-3189-5p inhibitor | Oligonucleotides | |
| HY-RI00652A | hsa-miR-3189-5p antagomir | Oligonucleotides | |
| HY-RI00653 | hsa-miR-3190-3p inhibitor | Oligonucleotides | |
| HY-RI00653A | hsa-miR-3190-3p antagomir | Oligonucleotides | |
| HY-RI00654 | hsa-miR-3190-5p inhibitor | Oligonucleotides | |
| HY-RI00654A | hsa-miR-3190-5p antagomir | Oligonucleotides | |
| HY-RI00655 | hsa-miR-3191-3p inhibitor | Oligonucleotides | |
| HY-RI00655A | hsa-miR-3191-3p antagomir | Oligonucleotides | |
| HY-RI00656 | hsa-miR-3191-5p inhibitor | Oligonucleotides | |
| HY-RI00656A | hsa-miR-3191-5p antagomir | Oligonucleotides | |
| HY-RI00657 | hsa-miR-3192-3p inhibitor | Oligonucleotides | |
| HY-RI00657A | hsa-miR-3192-3p antagomir | Oligonucleotides | |
| HY-RI00658 | hsa-miR-3192-5p inhibitor | Oligonucleotides | |
| HY-RI00658A | hsa-miR-3192-5p antagomir | Oligonucleotides | |
| HY-RI00659 | hsa-miR-3193 inhibitor | Oligonucleotides | |
| HY-RI00659A | hsa-miR-3193 antagomir | Oligonucleotides | |
| HY-RI00660 | hsa-miR-3194-3p inhibitor | Oligonucleotides | |
| HY-RI00660A | hsa-miR-3194-3p antagomir | Oligonucleotides | |
| HY-RI00661 | hsa-miR-3194-5p inhibitor | Oligonucleotides | |
| HY-RI00661A | hsa-miR-3194-5p antagomir | Oligonucleotides | |
| HY-RI00662 | hsa-miR-3195 inhibitor | Oligonucleotides | |
| HY-RI00662A | hsa-miR-3195 antagomir | Oligonucleotides | |
| HY-RI00663 | hsa-miR-3196 inhibitor | Oligonucleotides | |
| HY-RI00663A | hsa-miR-3196 antagomir | Oligonucleotides | |
| HY-RI00664 | hsa-miR-3197 inhibitor | Oligonucleotides | |
| HY-RI00664A | hsa-miR-3197 antagomir | Oligonucleotides | |
| HY-RI00665 | hsa-miR-3198 inhibitor | Oligonucleotides | |
| HY-RI00665A | hsa-miR-3198 antagomir | Oligonucleotides | |
| HY-RI00666 | hsa-miR-3199 inhibitor | Oligonucleotides | |
| HY-RI00666A | hsa-miR-3199 antagomir | Oligonucleotides | |
| HY-RI00667 | hsa-miR-3200-3p inhibitor | Oligonucleotides | |
| HY-RI00667A | hsa-miR-3200-3p antagomir | Oligonucleotides | |
| HY-RI00668 | hsa-miR-3200-5p inhibitor | Oligonucleotides | |
| HY-RI00668A | hsa-miR-3200-5p antagomir | Oligonucleotides | |
| HY-RI00669 | hsa-miR-3201 inhibitor | Oligonucleotides | |
| HY-RI00669A | hsa-miR-3201 antagomir | Oligonucleotides | |
| HY-RI00670 | hsa-miR-3202 inhibitor | Oligonucleotides | |
| HY-RI00670A | hsa-miR-3202 antagomir | Oligonucleotides | |
| HY-RI00671 | hsa-miR-320a-3p inhibitor | Oligonucleotides | |
| HY-RI00671A | hsa-miR-320a-3p antagomir | Oligonucleotides | |
| HY-RI00672 | hsa-miR-320a-5p inhibitor | Oligonucleotides | |
| HY-RI00672A | hsa-miR-320a-5p antagomir | Oligonucleotides | |
| HY-RI00673 | hsa-miR-320b inhibitor | Oligonucleotides | |
| HY-RI00673A | hsa-miR-320b antagomir | Oligonucleotides | |
| HY-RI00674 | hsa-miR-320c inhibitor | Oligonucleotides | |
| HY-RI00674A | hsa-miR-320c antagomir | Oligonucleotides | |
| HY-RI00675 | hsa-miR-320e inhibitor | Oligonucleotides | |
| HY-RI00675A | hsa-miR-320e antagomir | Oligonucleotides | |
| HY-RI00676 | hsa-miR-323a-3p inhibitor | Oligonucleotides | |
| HY-RI00676A | hsa-miR-323a-3p antagomir | Oligonucleotides | |
| HY-RI00677 | hsa-miR-323a-5p inhibitor | Oligonucleotides | |
| HY-RI00677A | hsa-miR-323a-5p antagomir | Oligonucleotides | |
| HY-RI00678 | hsa-miR-323b-3p inhibitor | Oligonucleotides | |
| HY-RI00678A | hsa-miR-323b-3p antagomir | Oligonucleotides | |
| HY-RI00679 | hsa-miR-323b-5p inhibitor | Oligonucleotides | |
| HY-RI00679A | hsa-miR-323b-5p antagomir | Oligonucleotides | |
| HY-RI00680 | hsa-miR-32-3p inhibitor | Oligonucleotides | |
| HY-RI00680A | hsa-miR-32-3p antagomir | Oligonucleotides | |
| HY-RI00681 | hsa-miR-324-3p inhibitor | Oligonucleotides | |
| HY-RI00681A | hsa-miR-324-3p antagomir | Oligonucleotides | |
| HY-RI00682 | hsa-miR-324-5p inhibitor | Oligonucleotides | |
| HY-RI00682A | hsa-miR-324-5p antagomir | Oligonucleotides | |
| HY-RI00683 | hsa-miR-325 inhibitor | Oligonucleotides | |
| HY-RI00683A | hsa-miR-325 antagomir | Oligonucleotides | |
| HY-RI00684 | hsa-miR-32-5p inhibitor | Oligonucleotides | |
| HY-RI00684A | hsa-miR-32-5p antagomir | Oligonucleotides | |
| HY-RI00685 | hsa-miR-326 inhibitor | Oligonucleotides | |
| HY-RI00685A | hsa-miR-326 antagomir | Oligonucleotides | |
| HY-RI00686 | hsa-miR-328-3p inhibitor | Oligonucleotides | |
| HY-RI00686A | hsa-miR-328-3p antagomir | Oligonucleotides | |
| HY-RI00687 | hsa-miR-328-5p inhibitor | Oligonucleotides | |
| HY-RI00687A | hsa-miR-328-5p antagomir | Oligonucleotides | |
| HY-RI00688 | hsa-miR-329-3p inhibitor | Oligonucleotides | |
| HY-RI00688A | hsa-miR-329-3p antagomir | Oligonucleotides | |
| HY-RI00689 | hsa-miR-329-5p inhibitor | Oligonucleotides | |
| HY-RI00689A | hsa-miR-329-5p antagomir | Oligonucleotides | |
| HY-RI00690 | hsa-miR-330-3p inhibitor | Oligonucleotides | |
| HY-RI00690A | hsa-miR-330-3p antagomir | Oligonucleotides | |
| HY-RI00691 | hsa-miR-330-5p inhibitor | Oligonucleotides | |
| HY-RI00691A | hsa-miR-330-5p antagomir | Oligonucleotides | |
| HY-RI00692 | hsa-miR-331-3p inhibitor | Oligonucleotides | |
| HY-RI00692A | hsa-miR-331-3p antagomir | Oligonucleotides | |
| HY-RI00693 | hsa-miR-331-5p inhibitor | Oligonucleotides | |
| HY-RI00693A | hsa-miR-331-5p antagomir | Oligonucleotides | |
| HY-RI00694 | hsa-miR-335-3p inhibitor | Oligonucleotides | |
| HY-RI00694A | hsa-miR-335-3p antagomir | Oligonucleotides | |
| HY-RI00695 | hsa-miR-335-5p inhibitor | Oligonucleotides | |
| HY-RI00695A | hsa-miR-335-5p antagomir | Oligonucleotides | |
| HY-RI00696 | hsa-miR-337-3p inhibitor | Oligonucleotides | |
| HY-RI00696A | hsa-miR-337-3p antagomir | Oligonucleotides | |
| HY-RI00697 | hsa-miR-337-5p inhibitor | Oligonucleotides | |
| HY-RI00697A | hsa-miR-337-5p antagomir | Oligonucleotides | |
| HY-RI00698 | hsa-miR-338-3p inhibitor | Oligonucleotides | |
| HY-RI00698A | hsa-miR-338-3p antagomir | Oligonucleotides | |
| HY-RI00699 | hsa-miR-338-5p inhibitor | Oligonucleotides | |
| HY-RI00699A | hsa-miR-338-5p antagomir | Oligonucleotides | |
| HY-RI00700 | hsa-miR-339-3p inhibitor | Oligonucleotides | |
| HY-RI00700A | hsa-miR-339-3p antagomir | Oligonucleotides | |
| HY-RI00701 | hsa-miR-339-5p inhibitor | Oligonucleotides | |
| HY-RI00701A | hsa-miR-339-5p antagomir | Oligonucleotides | |
| HY-RI00702 | hsa-miR-33a-3p inhibitor | Oligonucleotides | |
| HY-RI00702A | hsa-miR-33a-3p antagomir | Oligonucleotides | |
| HY-RI00703 | hsa-miR-33a-5p inhibitor | Oligonucleotides | |
| HY-RI00703A | hsa-miR-33a-5p antagomir | Oligonucleotides | |
| HY-RI00704 | hsa-miR-33b-3p inhibitor | Oligonucleotides | |
| HY-RI00704A | hsa-miR-33b-3p antagomir | Oligonucleotides | |
| HY-RI00705 | hsa-miR-33b-5p inhibitor | Oligonucleotides | |
| HY-RI00705A | hsa-miR-33b-5p antagomir | Oligonucleotides | |
| HY-RI00706 | hsa-miR-340-3p inhibitor | Oligonucleotides | |
| HY-RI00706A | hsa-miR-340-3p antagomir | Oligonucleotides | |
| HY-RI00707 | hsa-miR-340-5p inhibitor | Oligonucleotides | |
| HY-RI00707A | hsa-miR-340-5p antagomir | Oligonucleotides | |
| HY-RI00708 | hsa-miR-342-3p inhibitor | Oligonucleotides | |
| HY-RI00708A | hsa-miR-342-3p antagomir | Oligonucleotides | |
| HY-RI00709 | hsa-miR-342-5p inhibitor | Oligonucleotides | |
| HY-RI00709A | hsa-miR-342-5p antagomir | Oligonucleotides | |
| HY-RI00710 | hsa-miR-345-3p inhibitor | Oligonucleotides | |
| HY-RI00710A | hsa-miR-345-3p antagomir | Oligonucleotides | |
| HY-RI00711 | hsa-miR-345-5p inhibitor | Oligonucleotides | |
| HY-RI00711A | hsa-miR-345-5p antagomir | Oligonucleotides | |
| HY-RI00712 | hsa-miR-346 inhibitor | Oligonucleotides | |
| HY-RI00712A | hsa-miR-346 antagomir | Oligonucleotides | |
| HY-RI00713 | hsa-miR-34a-3p inhibitor | Oligonucleotides | |
| HY-RI00713A | hsa-miR-34a-3p antagomir | Oligonucleotides | |
| HY-RI00714 | hsa-miR-34a-5p inhibitor | Oligonucleotides | |
| HY-RI00714A | hsa-miR-34a-5p antagomir | Oligonucleotides | |
| HY-RI00715 | hsa-miR-34b-3p inhibitor | Oligonucleotides | |
| HY-RI00715A | hsa-miR-34b-3p antagomir | Oligonucleotides | |
| HY-RI00716 | hsa-miR-34b-5p inhibitor | Oligonucleotides | |
| HY-RI00716A | hsa-miR-34b-5p antagomir | Oligonucleotides | |
| HY-RI00717 | hsa-miR-34c-3p inhibitor | Oligonucleotides | |
| HY-RI00717A | hsa-miR-34c-3p antagomir | Oligonucleotides | |
| HY-RI00718 | hsa-miR-34c-5p inhibitor | Oligonucleotides | |
| HY-RI00718A | hsa-miR-34c-5p antagomir | Oligonucleotides | |
| HY-RI00719 | hsa-miR-3529-3p inhibitor | Oligonucleotides | |
| HY-RI00719A | hsa-miR-3529-3p antagomir | Oligonucleotides | |
| HY-RI00720 | hsa-miR-3529-5p inhibitor | Oligonucleotides | |
| HY-RI00720A | hsa-miR-3529-5p antagomir | Oligonucleotides | |
| HY-RI00721 | hsa-miR-3605-3p inhibitor | Oligonucleotides | |
| HY-RI00721A | hsa-miR-3605-3p antagomir | Oligonucleotides | |
| HY-RI00722 | hsa-miR-3605-5p inhibitor | Oligonucleotides | |
| HY-RI00722A | hsa-miR-3605-5p antagomir | Oligonucleotides | |
| HY-RI00723 | hsa-miR-3606-3p inhibitor | Oligonucleotides | |
| HY-RI00723A | hsa-miR-3606-3p antagomir | Oligonucleotides | |
| HY-RI00724 | hsa-miR-3606-5p inhibitor | Oligonucleotides | |
| HY-RI00724A | hsa-miR-3606-5p antagomir | Oligonucleotides | |
| HY-RI00725 | hsa-miR-3609 inhibitor | Oligonucleotides | |
| HY-RI00725A | hsa-miR-3609 antagomir | Oligonucleotides | |
| HY-RI00726 | hsa-miR-3610 inhibitor | Oligonucleotides | |
| HY-RI00726A | hsa-miR-3610 antagomir | Oligonucleotides | |
| HY-RI00727 | hsa-miR-3611 inhibitor | Oligonucleotides | |
| HY-RI00727A | hsa-miR-3611 antagomir | Oligonucleotides | |
| HY-RI00728 | hsa-miR-3612 inhibitor | Oligonucleotides | |
| HY-RI00728A | hsa-miR-3612 antagomir | Oligonucleotides | |
| HY-RI00729 | hsa-miR-3613-3p inhibitor | Oligonucleotides | |
| HY-RI00729A | hsa-miR-3613-3p antagomir | Oligonucleotides | |
| HY-RI00730 | hsa-miR-3613-5p inhibitor | Oligonucleotides | |
| HY-RI00730A | hsa-miR-3613-5p antagomir | Oligonucleotides | |
| HY-RI00731 | hsa-miR-3614-3p inhibitor | Oligonucleotides | |
| HY-RI00731A | hsa-miR-3614-3p antagomir | Oligonucleotides | |
| HY-RI00732 | hsa-miR-3614-5p inhibitor | Oligonucleotides | |
| HY-RI00732A | hsa-miR-3614-5p antagomir | Oligonucleotides | |
| HY-RI00733 | hsa-miR-3615 inhibitor | Oligonucleotides | |
| HY-RI00733A | hsa-miR-3615 antagomir | Oligonucleotides | |
| HY-RI00734 | hsa-miR-361-5p inhibitor | Oligonucleotides | |
| HY-RI00734A | hsa-miR-361-5p antagomir | Oligonucleotides | |
| HY-RI00735 | hsa-miR-3616-3p inhibitor | Oligonucleotides | |
| HY-RI00735A | hsa-miR-3616-3p antagomir | Oligonucleotides | |
| HY-RI00736 | hsa-miR-3616-5p inhibitor | Oligonucleotides | |
| HY-RI00736A | hsa-miR-3616-5p antagomir | Oligonucleotides | |
| HY-RI00737 | hsa-miR-3617-3p inhibitor | Oligonucleotides | |
| HY-RI00737A | hsa-miR-3617-3p antagomir | Oligonucleotides | |
| HY-RI00738 | hsa-miR-3617-5p inhibitor | Oligonucleotides | |
| HY-RI00738A | hsa-miR-3617-5p antagomir | Oligonucleotides | |
| HY-RI00739 | hsa-miR-3618 inhibitor | Oligonucleotides | |
| HY-RI00739A | hsa-miR-3618 antagomir | Oligonucleotides | |
| HY-RI00740 | hsa-miR-3619-3p inhibitor | Oligonucleotides | |
| HY-RI00740A | hsa-miR-3619-3p antagomir | Oligonucleotides | |
| HY-RI00741 | hsa-miR-3619-5p inhibitor | Oligonucleotides | |
| HY-RI00741A | hsa-miR-3619-5p antagomir | Oligonucleotides | |
| HY-RI00742 | hsa-miR-3620-3p inhibitor | Oligonucleotides | |
| HY-RI00742A | hsa-miR-3620-3p antagomir | Oligonucleotides | |
| HY-RI00743 | hsa-miR-3620-5p inhibitor | Oligonucleotides | |
| HY-RI00743A | hsa-miR-3620-5p antagomir | Oligonucleotides | |
| HY-RI00744 | hsa-miR-3621 inhibitor | Oligonucleotides | |
| HY-RI00744A | hsa-miR-3621 antagomir | Oligonucleotides | |
| HY-RI00745 | hsa-miR-3622a-3p inhibitor | Oligonucleotides | |
| HY-RI00745A | hsa-miR-3622a-3p antagomir | Oligonucleotides | |
| HY-RI00746 | hsa-miR-3622a-5p inhibitor | Oligonucleotides | |
| HY-RI00746A | hsa-miR-3622a-5p antagomir | Oligonucleotides | |
| HY-RI00747 | hsa-miR-3622b-3p inhibitor | Oligonucleotides | |
| HY-RI00747A | hsa-miR-3622b-3p antagomir | Oligonucleotides | |
| HY-RI00748 | hsa-miR-3622b-5p inhibitor | Oligonucleotides | |
| HY-RI00748A | hsa-miR-3622b-5p antagomir | Oligonucleotides | |
| HY-RI00749 | hsa-miR-362-3p inhibitor | Oligonucleotides | |
| HY-RI00749A | hsa-miR-362-3p antagomir | Oligonucleotides | |
| HY-RI00750 | hsa-miR-362-5p inhibitor | Oligonucleotides | |
| HY-RI00750A | hsa-miR-362-5p antagomir | Oligonucleotides | |
| HY-RI00751 | hsa-miR-363-3p inhibitor | Oligonucleotides | |
| HY-RI00751A | hsa-miR-363-3p antagomir | Oligonucleotides | |
| HY-RI00752 | hsa-miR-363-5p inhibitor | Oligonucleotides | |
| HY-RI00752A | hsa-miR-363-5p antagomir | Oligonucleotides | |
| HY-RI00753 | hsa-miR-3646 inhibitor | Oligonucleotides | |
| HY-RI00753A | hsa-miR-3646 antagomir | Oligonucleotides | |
| HY-RI00754 | hsa-miR-3648 inhibitor | Oligonucleotides | |
| HY-RI00754A | hsa-miR-3648 antagomir | Oligonucleotides | |
| HY-RI00755 | hsa-miR-3649 inhibitor | Oligonucleotides | |
| HY-RI00755A | hsa-miR-3649 antagomir | Oligonucleotides | |
| HY-RI00756 | hsa-miR-3650 inhibitor | Oligonucleotides | |
| HY-RI00756A | hsa-miR-3650 antagomir | Oligonucleotides | |
| HY-RI00757 | hsa-miR-3651 inhibitor | Oligonucleotides | |
| HY-RI00757A | hsa-miR-3651 antagomir | Oligonucleotides | |
| HY-RI00758 | hsa-miR-3652 inhibitor | Oligonucleotides | |
| HY-RI00758A | hsa-miR-3652 antagomir | Oligonucleotides | |
| HY-RI00759 | hsa-miR-3654 inhibitor | Oligonucleotides | |
| HY-RI00759A | hsa-miR-3654 antagomir | Oligonucleotides | |
| HY-RI00760 | hsa-miR-3655 inhibitor | Oligonucleotides | |
| HY-RI00760A | hsa-miR-3655 antagomir | Oligonucleotides | |
| HY-RI00761 | hsa-miR-3657 inhibitor | Oligonucleotides | |
| HY-RI00761A | hsa-miR-3657 antagomir | Oligonucleotides | |
| HY-RI00762 | hsa-miR-3658 inhibitor | Oligonucleotides | |
| HY-RI00762A | hsa-miR-3658 antagomir | Oligonucleotides | |
| HY-RI00763 | hsa-miR-3659 inhibitor | Oligonucleotides | |
| HY-RI00763A | hsa-miR-3659 antagomir | Oligonucleotides | |
| HY-RI00764 | hsa-miR-365a-3p inhibitor | Oligonucleotides | |
| HY-RI00764A | hsa-miR-365a-3p antagomir | Oligonucleotides | |
| HY-RI00765 | hsa-miR-365a-5p inhibitor | Oligonucleotides | |
| HY-RI00765A | hsa-miR-365a-5p antagomir | Oligonucleotides | |
| HY-RI00766 | hsa-miR-365b-5p inhibitor | Oligonucleotides | |
| HY-RI00766A | hsa-miR-365b-5p antagomir | Oligonucleotides | |
| HY-RI00767 | hsa-miR-3660 inhibitor | Oligonucleotides | |
| HY-RI00767A | hsa-miR-3660 antagomir | Oligonucleotides | |
| HY-RI00768 | hsa-miR-3661 inhibitor | Oligonucleotides | |
| HY-RI00768A | hsa-miR-3661 antagomir | Oligonucleotides | |
| HY-RI00769 | hsa-miR-3662 inhibitor | Oligonucleotides | |
| HY-RI00769A | hsa-miR-3662 antagomir | Oligonucleotides | |
| HY-RI00770 | hsa-miR-3663-3p inhibitor | Oligonucleotides | |
| HY-RI00770A | hsa-miR-3663-3p antagomir | Oligonucleotides | |
| HY-RI00771 | hsa-miR-3663-5p inhibitor | Oligonucleotides | |
| HY-RI00771A | hsa-miR-3663-5p antagomir | Oligonucleotides | |
| HY-RI00772 | hsa-miR-3664-3p inhibitor | Oligonucleotides | |
| HY-RI00772A | hsa-miR-3664-3p antagomir | Oligonucleotides | |
| HY-RI00773 | hsa-miR-3664-5p inhibitor | Oligonucleotides | |
| HY-RI00773A | hsa-miR-3664-5p antagomir | Oligonucleotides | |
| HY-RI00774 | hsa-miR-3665 inhibitor | Oligonucleotides | |
| HY-RI00774A | hsa-miR-3665 antagomir | Oligonucleotides | |
| HY-RI00775 | hsa-miR-3666 inhibitor | Oligonucleotides | |
| HY-RI00775A | hsa-miR-3666 antagomir | Oligonucleotides | |
| HY-RI00776 | hsa-miR-3667-3p inhibitor | Oligonucleotides | |
| HY-RI00776A | hsa-miR-3667-3p antagomir | Oligonucleotides | |
| HY-RI00777 | hsa-miR-3667-5p inhibitor | Oligonucleotides | |
| HY-RI00777A | hsa-miR-3667-5p antagomir | Oligonucleotides | |
| HY-RI00778 | hsa-miR-3668 inhibitor | Oligonucleotides | |
| HY-RI00778A | hsa-miR-3668 antagomir | Oligonucleotides | |
| HY-RI00779 | hsa-miR-3670 inhibitor | Oligonucleotides | |
| HY-RI00779A | hsa-miR-3670 antagomir | Oligonucleotides | |
| HY-RI00780 | hsa-miR-3671 inhibitor | Oligonucleotides | |
| HY-RI00780A | hsa-miR-3671 antagomir | Oligonucleotides | |
| HY-RI00781 | hsa-miR-3672 inhibitor | Oligonucleotides | |
| HY-RI00781A | hsa-miR-3672 antagomir | Oligonucleotides | |
| HY-RI00782 | hsa-miR-367-3p inhibitor | Oligonucleotides | |
| HY-RI00782A | hsa-miR-367-3p antagomir | Oligonucleotides | |
| HY-RI00783 | hsa-miR-3674 inhibitor | Oligonucleotides | |
| HY-RI00783A | hsa-miR-3674 antagomir | Oligonucleotides | |
| HY-RI00784 | hsa-miR-3675-3p inhibitor | Oligonucleotides | |
| HY-RI00784A | hsa-miR-3675-3p antagomir | Oligonucleotides | |
| HY-RI00785 | hsa-miR-3675-5p inhibitor | Oligonucleotides | |
| HY-RI00785A | hsa-miR-3675-5p antagomir | Oligonucleotides | |
| HY-RI00786 | hsa-miR-367-5p inhibitor | Oligonucleotides | |
| HY-RI00786A | hsa-miR-367-5p antagomir | Oligonucleotides | |
| HY-RI00787 | hsa-miR-3677-3p inhibitor | Oligonucleotides | |
| HY-RI00787A | hsa-miR-3677-3p antagomir | Oligonucleotides | |
| HY-RI00788 | hsa-miR-3677-5p inhibitor | Oligonucleotides | |
| HY-RI00788A | hsa-miR-3677-5p antagomir | Oligonucleotides | |
| HY-RI00789 | hsa-miR-3678-3p inhibitor | Oligonucleotides | |
| HY-RI00789A | hsa-miR-3678-3p antagomir | Oligonucleotides | |
| HY-RI00790 | hsa-miR-3678-5p inhibitor | Oligonucleotides | |
| HY-RI00790A | hsa-miR-3678-5p antagomir | Oligonucleotides | |
| HY-RI00791 | hsa-miR-3679-3p inhibitor | Oligonucleotides | |
| HY-RI00791A | hsa-miR-3679-3p antagomir | Oligonucleotides | |
| HY-RI00792 | hsa-miR-3679-5p inhibitor | Oligonucleotides | |
| HY-RI00792A | hsa-miR-3679-5p antagomir | Oligonucleotides | |
| HY-RI00793 | hsa-miR-3680-3p inhibitor | Oligonucleotides | |
| HY-RI00793A | hsa-miR-3680-3p antagomir | Oligonucleotides | |
| HY-RI00794 | hsa-miR-3680-5p inhibitor | Oligonucleotides | |
| HY-RI00794A | hsa-miR-3680-5p antagomir | Oligonucleotides | |
| HY-RI00795 | hsa-miR-3681-3p inhibitor | Oligonucleotides | |
| HY-RI00795A | hsa-miR-3681-3p antagomir | Oligonucleotides | |
| HY-RI00796 | hsa-miR-3681-5p inhibitor | Oligonucleotides | |
| HY-RI00796A | hsa-miR-3681-5p antagomir | Oligonucleotides | |
| HY-RI00797 | hsa-miR-3682-3p inhibitor | Oligonucleotides | |
| HY-RI00797A | hsa-miR-3682-3p antagomir | Oligonucleotides | |
| HY-RI00798 | hsa-miR-3682-5p inhibitor | Oligonucleotides | |
| HY-RI00798A | hsa-miR-3682-5p antagomir | Oligonucleotides | |
| HY-RI00799 | hsa-miR-3683 inhibitor | Oligonucleotides | |
| HY-RI00799A | hsa-miR-3683 antagomir | Oligonucleotides | |
| HY-RI00800 | hsa-miR-3684 inhibitor | Oligonucleotides | |
| HY-RI00800A | hsa-miR-3684 antagomir | Oligonucleotides | |
| HY-RI00801 | hsa-miR-3685 inhibitor | Oligonucleotides | |
| HY-RI00801A | hsa-miR-3685 antagomir | Oligonucleotides | |
| HY-RI00802 | hsa-miR-3686 inhibitor | Oligonucleotides | |
| HY-RI00802A | hsa-miR-3686 antagomir | Oligonucleotides | |
| HY-RI00803 | hsa-miR-3688-3p inhibitor | Oligonucleotides | |
| HY-RI00803A | hsa-miR-3688-3p antagomir | Oligonucleotides | |
| HY-RI00804 | hsa-miR-3688-5p inhibitor | Oligonucleotides | |
| HY-RI00804A | hsa-miR-3688-5p antagomir | Oligonucleotides | |
| HY-RI00805 | hsa-miR-3689a-3p inhibitor | Oligonucleotides | |
| HY-RI00805A | hsa-miR-3689a-3p antagomir | Oligonucleotides | |
| HY-RI00806 | hsa-miR-3689a-5p inhibitor | Oligonucleotides | |
| HY-RI00806A | hsa-miR-3689a-5p antagomir | Oligonucleotides | |
| HY-RI00807 | hsa-miR-3689b-3p inhibitor | Oligonucleotides | |
| HY-RI00807A | hsa-miR-3689b-3p antagomir | Oligonucleotides | |
| HY-RI00808 | hsa-miR-3689d inhibitor | Oligonucleotides | |
| HY-RI00808A | hsa-miR-3689d antagomir | Oligonucleotides | |
| HY-RI00809 | hsa-miR-3689f inhibitor | Oligonucleotides | |
| HY-RI00809A | hsa-miR-3689f antagomir | Oligonucleotides | |
| HY-RI00810 | hsa-miR-3690 inhibitor | Oligonucleotides | |
| HY-RI00810A | hsa-miR-3690 antagomir | Oligonucleotides | |
| HY-RI00811 | hsa-miR-3691-3p inhibitor | Oligonucleotides | |
| HY-RI00811A | hsa-miR-3691-3p antagomir | Oligonucleotides | |
| HY-RI00812 | hsa-miR-3691-5p inhibitor | Oligonucleotides | |
| HY-RI00812A | hsa-miR-3691-5p antagomir | Oligonucleotides | |
| HY-RI00813 | hsa-miR-3692-3p inhibitor | Oligonucleotides | |
| HY-RI00813A | hsa-miR-3692-3p antagomir | Oligonucleotides | |
| HY-RI00814 | hsa-miR-3692-5p inhibitor | Oligonucleotides | |
| HY-RI00814A | hsa-miR-3692-5p antagomir | Oligonucleotides | |
| HY-RI00815 | hsa-miR-369-3p inhibitor | Oligonucleotides | |
| HY-RI00815A | hsa-miR-369-3p antagomir | Oligonucleotides | |
| HY-RI00816 | hsa-miR-370-3p inhibitor | Oligonucleotides | |
| HY-RI00816A | hsa-miR-370-3p antagomir | Oligonucleotides | |
| HY-RI00817 | hsa-miR-370-5p inhibitor | Oligonucleotides | |
| HY-RI00817A | hsa-miR-370-5p antagomir | Oligonucleotides | |
| HY-RI00818 | hsa-miR-3713 inhibitor | Oligonucleotides | |
| HY-RI00818A | hsa-miR-3713 antagomir | Oligonucleotides | |
| HY-RI00819 | hsa-miR-3714 inhibitor | Oligonucleotides | |
| HY-RI00819A | hsa-miR-3714 antagomir | Oligonucleotides | |
| HY-RI00820 | hsa-miR-371a-3p inhibitor | Oligonucleotides | |
| HY-RI00820A | hsa-miR-371a-3p antagomir | Oligonucleotides | |
| HY-RI00821 | hsa-miR-371a-5p inhibitor | Oligonucleotides | |
| HY-RI00821A | hsa-miR-371a-5p antagomir | Oligonucleotides | |
| HY-RI00822 | hsa-miR-371b-3p inhibitor | Oligonucleotides | |
| HY-RI00822A | hsa-miR-371b-3p antagomir | Oligonucleotides | |
| HY-RI00823 | hsa-miR-371b-5p inhibitor | Oligonucleotides | |
| HY-RI00823A | hsa-miR-371b-5p antagomir | Oligonucleotides | |
| HY-RI00824 | hsa-miR-372-3p inhibitor | Oligonucleotides | |
| HY-RI00824A | hsa-miR-372-3p antagomir | Oligonucleotides | |
| HY-RI00825 | hsa-miR-372-5p inhibitor | Oligonucleotides | |
| HY-RI00825A | hsa-miR-372-5p antagomir | Oligonucleotides | |
| HY-RI00826 | hsa-miR-373-3p inhibitor | Oligonucleotides | |
| HY-RI00826A | hsa-miR-373-3p antagomir | Oligonucleotides | |
| HY-RI00827 | hsa-miR-373-5p inhibitor | Oligonucleotides | |
| HY-RI00827A | hsa-miR-373-5p antagomir | Oligonucleotides | |
| HY-RI00828 | hsa-miR-374a-3p inhibitor | Oligonucleotides | |
| HY-RI00828A | hsa-miR-374a-3p antagomir | Oligonucleotides | |
| HY-RI00829 | hsa-miR-374a-5p inhibitor | Oligonucleotides | |
| HY-RI00829A | hsa-miR-374a-5p antagomir | Oligonucleotides | |
| HY-RI00830 | hsa-miR-374b-3p inhibitor | Oligonucleotides | |
| HY-RI00830A | hsa-miR-374b-3p antagomir | Oligonucleotides | |
| HY-RI00831 | hsa-miR-374b-5p inhibitor | Oligonucleotides | |
| HY-RI00831A | hsa-miR-374b-5p antagomir | Oligonucleotides | |
| HY-RI00832 | hsa-miR-374c-3p inhibitor | Oligonucleotides | |
| HY-RI00832A | hsa-miR-374c-3p antagomir | Oligonucleotides | |
| HY-RI00833 | hsa-miR-374c-5p inhibitor | Oligonucleotides | |
| HY-RI00833A | hsa-miR-374c-5p antagomir | Oligonucleotides | |
| HY-RI00834 | hsa-miR-375-3p inhibitor | Oligonucleotides | |
| HY-RI00834A | hsa-miR-375-3p antagomir | Oligonucleotides | |
| HY-RI00835 | hsa-miR-375-5p inhibitor | Oligonucleotides | |
| HY-RI00835A | hsa-miR-375-5p antagomir | Oligonucleotides | |
| HY-RI00836 | hsa-miR-376a-2-5p inhibitor | Oligonucleotides | |
| HY-RI00836A | hsa-miR-376a-2-5p antagomir | Oligonucleotides | |
| HY-RI00837 | hsa-miR-376a-5p inhibitor | Oligonucleotides | |
| HY-RI00837A | hsa-miR-376a-5p antagomir | Oligonucleotides | |
| HY-RI00838 | hsa-miR-376b-3p inhibitor | Oligonucleotides | |
| HY-RI00838A | hsa-miR-376b-3p antagomir | Oligonucleotides | |
| HY-RI00839 | hsa-miR-376b-5p inhibitor | Oligonucleotides | |
| HY-RI00839A | hsa-miR-376b-5p antagomir | Oligonucleotides | |
| HY-RI00840 | hsa-miR-376c-3p inhibitor | Oligonucleotides | |
| HY-RI00840A | hsa-miR-376c-3p antagomir | Oligonucleotides | |
| HY-RI00841 | hsa-miR-376c-5p inhibitor | Oligonucleotides | |
| HY-RI00841A | hsa-miR-376c-5p antagomir | Oligonucleotides | |
| HY-RI00842 | hsa-miR-377-3p inhibitor | Oligonucleotides | |
| HY-RI00842A | hsa-miR-377-3p antagomir | Oligonucleotides | |
| HY-RI00843 | hsa-miR-378a-3p inhibitor | Oligonucleotides | |
| HY-RI00843A | hsa-miR-378a-3p antagomir | Oligonucleotides | |
| HY-RI00844 | hsa-miR-378a-5p inhibitor | Oligonucleotides | |
| HY-RI00844A | hsa-miR-378a-5p antagomir | Oligonucleotides | |
| HY-RI00845 | hsa-miR-378b inhibitor | Oligonucleotides | |
| HY-RI00845A | hsa-miR-378b antagomir | Oligonucleotides | |
| HY-RI00846 | hsa-miR-378c inhibitor | Oligonucleotides | |
| HY-RI00846A | hsa-miR-378c antagomir | Oligonucleotides | |
| HY-RI00847 | hsa-miR-378d inhibitor | Oligonucleotides | |
| HY-RI00847A | hsa-miR-378d antagomir | Oligonucleotides | |
| HY-RI00848 | hsa-miR-378e inhibitor | Oligonucleotides | |
| HY-RI00848A | hsa-miR-378e antagomir | Oligonucleotides | |
| HY-RI00849 | hsa-miR-378f inhibitor | Oligonucleotides | |
| HY-RI00849A | hsa-miR-378f antagomir | Oligonucleotides | |
| HY-RI00850 | hsa-miR-378g inhibitor | Oligonucleotides | |
| HY-RI00850A | hsa-miR-378g antagomir | Oligonucleotides | |
| HY-RI00851 | hsa-miR-378h inhibitor | Oligonucleotides | |
| HY-RI00851A | hsa-miR-378h antagomir | Oligonucleotides | |
| HY-RI00852 | hsa-miR-378i inhibitor | Oligonucleotides | |
| HY-RI00852A | hsa-miR-378i antagomir | Oligonucleotides | |
| HY-RI00853 | hsa-miR-378j inhibitor | Oligonucleotides | |
| HY-RI00853A | hsa-miR-378j antagomir | Oligonucleotides | |
| HY-RI00854 | hsa-miR-379-3p inhibitor | Oligonucleotides | |
| HY-RI00854A | hsa-miR-379-3p antagomir | Oligonucleotides | |
| HY-RI00855 | hsa-miR-379-5p inhibitor | Oligonucleotides | |
| HY-RI00855A | hsa-miR-379-5p antagomir | Oligonucleotides | |
| HY-RI00856 | hsa-miR-380-3p inhibitor | Oligonucleotides | |
| HY-RI00856A | hsa-miR-380-3p antagomir | Oligonucleotides | |
| HY-RI00857 | hsa-miR-380-5p inhibitor | Oligonucleotides | |
| HY-RI00857A | hsa-miR-380-5p antagomir | Oligonucleotides | |
| HY-RI00858 | hsa-miR-381-3p inhibitor | Oligonucleotides | |
| HY-RI00858A | hsa-miR-381-3p antagomir | Oligonucleotides | |
| HY-RI00859 | hsa-miR-381-5p inhibitor | Oligonucleotides | |
| HY-RI00859A | hsa-miR-381-5p antagomir | Oligonucleotides | |
| HY-RI00860 | hsa-miR-382-3p inhibitor | Oligonucleotides | |
| HY-RI00860A | hsa-miR-382-3p antagomir | Oligonucleotides | |
| HY-RI00861 | hsa-miR-382-5p inhibitor | Oligonucleotides | |
| HY-RI00861A | hsa-miR-382-5p antagomir | Oligonucleotides | |
| HY-RI00862 | hsa-miR-383-3p inhibitor | Oligonucleotides | |
| HY-RI00862A | hsa-miR-383-3p antagomir | Oligonucleotides | |
| HY-RI00863 | hsa-miR-384 inhibitor | Oligonucleotides | |
| HY-RI00863A | hsa-miR-384 antagomir | Oligonucleotides | |
| HY-RI00864 | hsa-miR-3907 inhibitor | Oligonucleotides | |
| HY-RI00864A | hsa-miR-3907 antagomir | Oligonucleotides | |
| HY-RI00865 | hsa-miR-3908 inhibitor | Oligonucleotides | |
| HY-RI00865A | hsa-miR-3908 antagomir | Oligonucleotides | |
| HY-RI00866 | hsa-miR-3909 inhibitor | Oligonucleotides | |
| HY-RI00866A | hsa-miR-3909 antagomir | Oligonucleotides | |
| HY-RI00867 | hsa-miR-3910 inhibitor | Oligonucleotides | |
| HY-RI00867A | hsa-miR-3910 antagomir | Oligonucleotides | |
| HY-RI00868 | hsa-miR-3911 inhibitor | Oligonucleotides | |
| HY-RI00868A | hsa-miR-3911 antagomir | Oligonucleotides | |
| HY-RI00869 | hsa-miR-3912-3p inhibitor | Oligonucleotides | |
| HY-RI00869A | hsa-miR-3912-3p antagomir | Oligonucleotides | |
| HY-RI00870 | hsa-miR-3912-5p inhibitor | Oligonucleotides | |
| HY-RI00870A | hsa-miR-3912-5p antagomir | Oligonucleotides | |
| HY-RI00871 | hsa-miR-3913-3p inhibitor | Oligonucleotides | |
| HY-RI00871A | hsa-miR-3913-3p antagomir | Oligonucleotides | |
| HY-RI00872 | hsa-miR-3913-5p inhibitor | Oligonucleotides | |
| HY-RI00872A | hsa-miR-3913-5p antagomir | Oligonucleotides | |
| HY-RI00873 | hsa-miR-3914 inhibitor | Oligonucleotides | |
| HY-RI00873A | hsa-miR-3914 antagomir | Oligonucleotides | |
| HY-RI00874 | hsa-miR-3915 inhibitor | Oligonucleotides | |
| HY-RI00874A | hsa-miR-3915 antagomir | Oligonucleotides | |
| HY-RI00875 | hsa-miR-3916 inhibitor | Oligonucleotides | |
| HY-RI00875A | hsa-miR-3916 antagomir | Oligonucleotides | |
| HY-RI00876 | hsa-miR-3917 inhibitor | Oligonucleotides | |
| HY-RI00876A | hsa-miR-3917 antagomir | Oligonucleotides | |
| HY-RI00877 | hsa-miR-3918 inhibitor | Oligonucleotides | |
| HY-RI00877A | hsa-miR-3918 antagomir | Oligonucleotides | |
| HY-RI00878 | hsa-miR-3919 inhibitor | Oligonucleotides | |
| HY-RI00878A | hsa-miR-3919 antagomir | Oligonucleotides | |
| HY-RI00879 | hsa-miR-3920 inhibitor | Oligonucleotides | |
| HY-RI00879A | hsa-miR-3920 antagomir | Oligonucleotides | |
| HY-RI00880 | hsa-miR-3921 inhibitor | Oligonucleotides | |
| HY-RI00880A | hsa-miR-3921 antagomir | Oligonucleotides | |
| HY-RI00881 | hsa-miR-3922-3p inhibitor | Oligonucleotides | |
| HY-RI00881A | hsa-miR-3922-3p antagomir | Oligonucleotides | |
| HY-RI00882 | hsa-miR-3922-5p inhibitor | Oligonucleotides | |
| HY-RI00882A | hsa-miR-3922-5p antagomir | Oligonucleotides | |
| HY-RI00883 | hsa-miR-3923 inhibitor | Oligonucleotides | |
| HY-RI00883A | hsa-miR-3923 antagomir | Oligonucleotides | |
| HY-RI00884 | hsa-miR-3924 inhibitor | Oligonucleotides | |
| HY-RI00884A | hsa-miR-3924 antagomir | Oligonucleotides | |
| HY-RI00885 | hsa-miR-3925-3p inhibitor | Oligonucleotides | |
| HY-RI00885A | hsa-miR-3925-3p antagomir | Oligonucleotides | |
| HY-RI00886 | hsa-miR-3925-5p inhibitor | Oligonucleotides | |
| HY-RI00886A | hsa-miR-3925-5p antagomir | Oligonucleotides | |
| HY-RI00887 | hsa-miR-3926 inhibitor | Oligonucleotides | |
| HY-RI00887A | hsa-miR-3926 antagomir | Oligonucleotides | |
| HY-RI00888 | hsa-miR-3927-3p inhibitor | Oligonucleotides | |
| HY-RI00888A | hsa-miR-3927-3p antagomir | Oligonucleotides | |
| HY-RI00889 | hsa-miR-3927-5p inhibitor | Oligonucleotides | |
| HY-RI00889A | hsa-miR-3927-5p antagomir | Oligonucleotides | |
| HY-RI00890 | hsa-miR-3928-3p inhibitor | Oligonucleotides | |
| HY-RI00890A | hsa-miR-3928-3p antagomir | Oligonucleotides | |
| HY-RI00891 | hsa-miR-3928-5p inhibitor | Oligonucleotides | |
| HY-RI00891A | hsa-miR-3928-5p antagomir | Oligonucleotides | |
| HY-RI00892 | hsa-miR-3929 inhibitor | Oligonucleotides | |
| HY-RI00892A | hsa-miR-3929 antagomir | Oligonucleotides | |
| HY-RI00893 | hsa-miR-3934-3p inhibitor | Oligonucleotides | |
| HY-RI00893A | hsa-miR-3934-3p antagomir | Oligonucleotides | |
| HY-RI00894 | hsa-miR-3934-5p inhibitor | Oligonucleotides | |
| HY-RI00894A | hsa-miR-3934-5p antagomir | Oligonucleotides | |
| HY-RI00895 | hsa-miR-3935 inhibitor | Oligonucleotides | |
| HY-RI00895A | hsa-miR-3935 antagomir | Oligonucleotides | |
| HY-RI00896 | hsa-miR-3936 inhibitor | Oligonucleotides | |
| HY-RI00896A | hsa-miR-3936 antagomir | Oligonucleotides | |
| HY-RI00897 | hsa-miR-3937 inhibitor | Oligonucleotides | |
| HY-RI00897A | hsa-miR-3937 antagomir | Oligonucleotides | |
| HY-RI00898 | hsa-miR-3938 inhibitor | Oligonucleotides | |
| HY-RI00898A | hsa-miR-3938 antagomir | Oligonucleotides | |
| HY-RI00899 | hsa-miR-3939 inhibitor | Oligonucleotides | |
| HY-RI00899A | hsa-miR-3939 antagomir | Oligonucleotides | |
| HY-RI00900 | hsa-miR-3940-3p inhibitor | Oligonucleotides | |
| HY-RI00900A | hsa-miR-3940-3p antagomir | Oligonucleotides | |
| HY-RI00901 | hsa-miR-3940-5p inhibitor | Oligonucleotides | |
| HY-RI00901A | hsa-miR-3940-5p antagomir | Oligonucleotides | |
| HY-RI00902 | hsa-miR-3941 inhibitor | Oligonucleotides | |
| HY-RI00902A | hsa-miR-3941 antagomir | Oligonucleotides | |
| HY-RI00903 | hsa-miR-3942-3p inhibitor | Oligonucleotides | |
| HY-RI00903A | hsa-miR-3942-3p antagomir | Oligonucleotides | |
| HY-RI00904 | hsa-miR-3942-5p inhibitor | Oligonucleotides | |
| HY-RI00904A | hsa-miR-3942-5p antagomir | Oligonucleotides | |
| HY-RI00905 | hsa-miR-3943 inhibitor | Oligonucleotides | |
| HY-RI00905A | hsa-miR-3943 antagomir | Oligonucleotides | |
| HY-RI00906 | hsa-miR-3944-3p inhibitor | Oligonucleotides | |
| HY-RI00906A | hsa-miR-3944-3p antagomir | Oligonucleotides | |
| HY-RI00907 | hsa-miR-3944-5p inhibitor | Oligonucleotides | |
| HY-RI00907A | hsa-miR-3944-5p antagomir | Oligonucleotides | |
| HY-RI00908 | hsa-miR-3945 inhibitor | Oligonucleotides | |
| HY-RI00908A | hsa-miR-3945 antagomir | Oligonucleotides | |
| HY-RI00909 | hsa-miR-3960 inhibitor | Oligonucleotides | |
| HY-RI00909A | hsa-miR-3960 antagomir | Oligonucleotides | |
| HY-RI00910 | hsa-miR-3972 inhibitor | Oligonucleotides | |
| HY-RI00910A | hsa-miR-3972 antagomir | Oligonucleotides | |
| HY-RI00911 | hsa-miR-3973 inhibitor | Oligonucleotides | |
| HY-RI00911A | hsa-miR-3973 antagomir | Oligonucleotides | |
| HY-RI00912 | hsa-miR-3974 inhibitor | Oligonucleotides | |
| HY-RI00912A | hsa-miR-3974 antagomir | Oligonucleotides | |
| HY-RI00913 | hsa-miR-3975 inhibitor | Oligonucleotides | |
| HY-RI00913A | hsa-miR-3975 antagomir | Oligonucleotides | |
| HY-RI00914 | hsa-miR-3976 inhibitor | Oligonucleotides | |
| HY-RI00914A | hsa-miR-3976 antagomir | Oligonucleotides | |
| HY-RI00915 | hsa-miR-3977 inhibitor | Oligonucleotides | |
| HY-RI00915A | hsa-miR-3977 antagomir | Oligonucleotides | |
| HY-RI00916 | hsa-miR-3978 inhibitor | Oligonucleotides | |
| HY-RI00916A | hsa-miR-3978 antagomir | Oligonucleotides | |
| HY-RI00917 | hsa-miR-409-3p inhibitor | Oligonucleotides | |
| HY-RI00917A | hsa-miR-409-3p antagomir | Oligonucleotides | |
| HY-RI00918 | hsa-miR-409-5p inhibitor | Oligonucleotides | |
| HY-RI00918A | hsa-miR-409-5p antagomir | Oligonucleotides | |
| HY-RI00919 | hsa-miR-410-3p inhibitor | Oligonucleotides | |
| HY-RI00919A | hsa-miR-410-3p antagomir | Oligonucleotides | |
| HY-RI00920 | hsa-miR-410-5p inhibitor | Oligonucleotides | |
| HY-RI00920A | hsa-miR-410-5p antagomir | Oligonucleotides | |
| HY-RI00921 | hsa-miR-411-3p inhibitor | Oligonucleotides | |
| HY-RI00921A | hsa-miR-411-3p antagomir | Oligonucleotides | |
| HY-RI00922 | hsa-miR-412-3p inhibitor | Oligonucleotides | |
| HY-RI00922A | hsa-miR-412-3p antagomir | Oligonucleotides | |
| HY-RI00923 | hsa-miR-412-5p inhibitor | Oligonucleotides | |
| HY-RI00923A | hsa-miR-412-5p antagomir | Oligonucleotides | |
| HY-RI00924 | hsa-miR-422a inhibitor | Oligonucleotides | |
| HY-RI00924A | hsa-miR-422a antagomir | Oligonucleotides | |
| HY-RI00925 | hsa-miR-423-3p inhibitor | Oligonucleotides | |
| HY-RI00925A | hsa-miR-423-3p antagomir | Oligonucleotides | |
| HY-RI00926 | hsa-miR-423-5p inhibitor | Oligonucleotides | |
| HY-RI00926A | hsa-miR-423-5p antagomir | Oligonucleotides | |
| HY-RI00927 | hsa-miR-424-3p inhibitor | Oligonucleotides | |
| HY-RI00927A | hsa-miR-424-3p antagomir | Oligonucleotides | |
| HY-RI00928 | hsa-miR-424-5p inhibitor | Oligonucleotides | |
| HY-RI00928A | hsa-miR-424-5p antagomir | Oligonucleotides | |
| HY-RI00929 | hsa-miR-4251 inhibitor | Oligonucleotides | |
| HY-RI00929A | hsa-miR-4251 antagomir | Oligonucleotides | |
| HY-RI00930 | hsa-miR-4252 inhibitor | Oligonucleotides | |
| HY-RI00930A | hsa-miR-4252 antagomir | Oligonucleotides | |
| HY-RI00931 | hsa-miR-4253 inhibitor | Oligonucleotides | |
| HY-RI00931A | hsa-miR-4253 antagomir | Oligonucleotides | |
| HY-RI00932 | hsa-miR-425-3p inhibitor | Oligonucleotides | |
| HY-RI00932A | hsa-miR-425-3p antagomir | Oligonucleotides | |
| HY-RI00933 | hsa-miR-4254 inhibitor | Oligonucleotides | |
| HY-RI00933A | hsa-miR-4254 antagomir | Oligonucleotides | |
| HY-RI00934 | hsa-miR-4255 inhibitor | Oligonucleotides | |
| HY-RI00934A | hsa-miR-4255 antagomir | Oligonucleotides | |
| HY-RI00935 | hsa-miR-4256 inhibitor | Oligonucleotides | |
| HY-RI00935A | hsa-miR-4256 antagomir | Oligonucleotides | |
| HY-RI00936 | hsa-miR-4257 inhibitor | Oligonucleotides | |
| HY-RI00936A | hsa-miR-4257 antagomir | Oligonucleotides | |
| HY-RI00937 | hsa-miR-4258 inhibitor | Oligonucleotides | |
| HY-RI00937A | hsa-miR-4258 antagomir | Oligonucleotides | |
| HY-RI00938 | hsa-miR-4259 inhibitor | Oligonucleotides | |
| HY-RI00938A | hsa-miR-4259 antagomir | Oligonucleotides | |
| HY-RI00939 | hsa-miR-4260 inhibitor | Oligonucleotides | |
| HY-RI00939A | hsa-miR-4260 antagomir | Oligonucleotides | |
| HY-RI00940 | hsa-miR-4261 inhibitor | Oligonucleotides | |
| HY-RI00940A | hsa-miR-4261 antagomir | Oligonucleotides | |
| HY-RI00941 | hsa-miR-4262 inhibitor | Oligonucleotides | |
| HY-RI00941A | hsa-miR-4262 antagomir | Oligonucleotides | |
| HY-RI00942 | hsa-miR-4263 inhibitor | Oligonucleotides | |
| HY-RI00942A | hsa-miR-4263 antagomir | Oligonucleotides | |
| HY-RI00943 | hsa-miR-4264 inhibitor | Oligonucleotides | |
| HY-RI00943A | hsa-miR-4264 antagomir | Oligonucleotides | |
| HY-RI00944 | hsa-miR-4265 inhibitor | Oligonucleotides | |
| HY-RI00944A | hsa-miR-4265 antagomir | Oligonucleotides | |
| HY-RI00945 | hsa-miR-4266 inhibitor | Oligonucleotides | |
| HY-RI00945A | hsa-miR-4266 antagomir | Oligonucleotides | |
| HY-RI00946 | hsa-miR-4267 inhibitor | Oligonucleotides | |
| HY-RI00946A | hsa-miR-4267 antagomir | Oligonucleotides | |
| HY-RI00947 | hsa-miR-4268 inhibitor | Oligonucleotides | |
| HY-RI00947A | hsa-miR-4268 antagomir | Oligonucleotides | |
| HY-RI00948 | hsa-miR-4269 inhibitor | Oligonucleotides | |
| HY-RI00948A | hsa-miR-4269 antagomir | Oligonucleotides | |
| HY-RI00949 | hsa-miR-4270 inhibitor | Oligonucleotides | |
| HY-RI00949A | hsa-miR-4270 antagomir | Oligonucleotides | |
| HY-RI00950 | hsa-miR-4271 inhibitor | Oligonucleotides | |
| HY-RI00950A | hsa-miR-4271 antagomir | Oligonucleotides | |
| HY-RI00951 | hsa-miR-4272 inhibitor | Oligonucleotides | |
| HY-RI00951A | hsa-miR-4272 antagomir | Oligonucleotides | |
| HY-RI00952 | hsa-miR-4273 inhibitor | Oligonucleotides | |
| HY-RI00952A | hsa-miR-4273 antagomir | Oligonucleotides | |
| HY-RI00953 | hsa-miR-4274 inhibitor | Oligonucleotides | |
| HY-RI00953A | hsa-miR-4274 antagomir | Oligonucleotides | |
| HY-RI00954 | hsa-miR-4275 inhibitor | Oligonucleotides | |
| HY-RI00954A | hsa-miR-4275 antagomir | Oligonucleotides | |
| HY-RI00955 | hsa-miR-4276 inhibitor | Oligonucleotides | |
| HY-RI00955A | hsa-miR-4276 antagomir | Oligonucleotides | |
| HY-RI00956 | hsa-miR-4277 inhibitor | Oligonucleotides | |
| HY-RI00956A | hsa-miR-4277 antagomir | Oligonucleotides | |
| HY-RI00957 | hsa-miR-4278 inhibitor | Oligonucleotides | |
| HY-RI00957A | hsa-miR-4278 antagomir | Oligonucleotides | |
| HY-RI00958 | hsa-miR-4279 inhibitor | Oligonucleotides | |
| HY-RI00958A | hsa-miR-4279 antagomir | Oligonucleotides | |
| HY-RI00959 | hsa-miR-4280 inhibitor | Oligonucleotides | |
| HY-RI00959A | hsa-miR-4280 antagomir | Oligonucleotides | |
| HY-RI00960 | hsa-miR-4281 inhibitor | Oligonucleotides | |
| HY-RI00960A | hsa-miR-4281 antagomir | Oligonucleotides | |
| HY-RI00961 | hsa-miR-4282 inhibitor | Oligonucleotides | |
| HY-RI00961A | hsa-miR-4282 antagomir | Oligonucleotides | |
| HY-RI00962 | hsa-miR-4283 inhibitor | Oligonucleotides | |
| HY-RI00962A | hsa-miR-4283 antagomir | Oligonucleotides | |
| HY-RI00963 | hsa-miR-4284 inhibitor | Oligonucleotides | |
| HY-RI00963A | hsa-miR-4284 antagomir | Oligonucleotides | |
| HY-RI00964 | hsa-miR-4285 inhibitor | Oligonucleotides | |
| HY-RI00964A | hsa-miR-4285 antagomir | Oligonucleotides | |
| HY-RI00965 | hsa-miR-4286 inhibitor | Oligonucleotides | |
| HY-RI00965A | hsa-miR-4286 antagomir | Oligonucleotides | |
| HY-RI00966 | hsa-miR-4287 inhibitor | Oligonucleotides | |
| HY-RI00966A | hsa-miR-4287 antagomir | Oligonucleotides | |
| HY-RI00967 | hsa-miR-4288 inhibitor | Oligonucleotides | |
| HY-RI00967A | hsa-miR-4288 antagomir | Oligonucleotides | |
| HY-RI00968 | hsa-miR-4289 inhibitor | Oligonucleotides | |
| HY-RI00968A | hsa-miR-4289 antagomir | Oligonucleotides | |
| HY-RI00969 | hsa-miR-429 inhibitor | Oligonucleotides | |
| HY-RI00969A | hsa-miR-429 antagomir | Oligonucleotides | |
| HY-RI00970 | hsa-miR-4290 inhibitor | Oligonucleotides | |
| HY-RI00970A | hsa-miR-4290 antagomir | Oligonucleotides | |
| HY-RI00971 | hsa-miR-4291 inhibitor | Oligonucleotides | |
| HY-RI00971A | hsa-miR-4291 antagomir | Oligonucleotides | |
| HY-RI00972 | hsa-miR-4292 inhibitor | Oligonucleotides | |
| HY-RI00972A | hsa-miR-4292 antagomir | Oligonucleotides | |
| HY-RI00973 | hsa-miR-4293 inhibitor | Oligonucleotides | |
| HY-RI00973A | hsa-miR-4293 antagomir | Oligonucleotides | |
| HY-RI00974 | hsa-miR-4294 inhibitor | Oligonucleotides | |
| HY-RI00974A | hsa-miR-4294 antagomir | Oligonucleotides | |
| HY-RI00975 | hsa-miR-4295 inhibitor | Oligonucleotides | |
| HY-RI00975A | hsa-miR-4295 antagomir | Oligonucleotides | |
| HY-RI00976 | hsa-miR-4296 inhibitor | Oligonucleotides | |
| HY-RI00976A | hsa-miR-4296 antagomir | Oligonucleotides | |
| HY-RI00977 | hsa-miR-4297 inhibitor | Oligonucleotides | |
| HY-RI00977A | hsa-miR-4297 antagomir | Oligonucleotides | |
| HY-RI00978 | hsa-miR-4298 inhibitor | Oligonucleotides | |
| HY-RI00978A | hsa-miR-4298 antagomir | Oligonucleotides | |
| HY-RI00979 | hsa-miR-4299 inhibitor | Oligonucleotides | |
| HY-RI00979A | hsa-miR-4299 antagomir | Oligonucleotides | |
| HY-RI00980 | hsa-miR-4300 inhibitor | Oligonucleotides | |
| HY-RI00980A | hsa-miR-4300 antagomir | Oligonucleotides | |
| HY-RI00981 | hsa-miR-4301 inhibitor | Oligonucleotides | |
| HY-RI00981A | hsa-miR-4301 antagomir | Oligonucleotides | |
| HY-RI00982 | hsa-miR-4302 inhibitor | Oligonucleotides | |
| HY-RI00982A | hsa-miR-4302 antagomir | Oligonucleotides | |
| HY-RI00983 | hsa-miR-4303 inhibitor | Oligonucleotides | |
| HY-RI00983A | hsa-miR-4303 antagomir | Oligonucleotides | |
| HY-RI00984 | hsa-miR-4304 inhibitor | Oligonucleotides | |
| HY-RI00984A | hsa-miR-4304 antagomir | Oligonucleotides | |
| HY-RI00985 | hsa-miR-4305 inhibitor | Oligonucleotides | |
| HY-RI00985A | hsa-miR-4305 antagomir | Oligonucleotides | |
| HY-RI00986 | hsa-miR-4306 inhibitor | Oligonucleotides | |
| HY-RI00986A | hsa-miR-4306 antagomir | Oligonucleotides | |
| HY-RI00987 | hsa-miR-4307 inhibitor | Oligonucleotides | |
| HY-RI00987A | hsa-miR-4307 antagomir | Oligonucleotides | |
| HY-RI00988 | hsa-miR-4308 inhibitor | Oligonucleotides | |
| HY-RI00988A | hsa-miR-4308 antagomir | Oligonucleotides | |
| HY-RI00989 | hsa-miR-4309 inhibitor | Oligonucleotides | |
| HY-RI00989A | hsa-miR-4309 antagomir | Oligonucleotides | |
| HY-RI00990 | hsa-miR-4310 inhibitor | Oligonucleotides | |
| HY-RI00990A | hsa-miR-4310 antagomir | Oligonucleotides | |
| HY-RI00991 | hsa-miR-4311 inhibitor | Oligonucleotides | |
| HY-RI00991A | hsa-miR-4311 antagomir | Oligonucleotides | |
| HY-RI00992 | hsa-miR-4312 inhibitor | Oligonucleotides | |
| HY-RI00992A | hsa-miR-4312 antagomir | Oligonucleotides | |
| HY-RI00993 | hsa-miR-4313 inhibitor | Oligonucleotides | |
| HY-RI00993A | hsa-miR-4313 antagomir | Oligonucleotides | |
| HY-RI00994 | hsa-miR-431-3p inhibitor | Oligonucleotides | |
| HY-RI00994A | hsa-miR-431-3p antagomir | Oligonucleotides | |
| HY-RI00995 | hsa-miR-4314 inhibitor | Oligonucleotides | |
| HY-RI00995A | hsa-miR-4314 antagomir | Oligonucleotides | |
| HY-RI00996 | hsa-miR-4315 inhibitor | Oligonucleotides | |
| HY-RI00996A | hsa-miR-4315 antagomir | Oligonucleotides | |
| HY-RI00997 | hsa-miR-431-5p inhibitor | Oligonucleotides | |
| HY-RI00997A | hsa-miR-431-5p antagomir | Oligonucleotides | |
| HY-RI00998 | hsa-miR-4316 inhibitor | Oligonucleotides | |
| HY-RI00998A | hsa-miR-4316 antagomir | Oligonucleotides | |
| HY-RI00999 | hsa-miR-4317 inhibitor | Oligonucleotides | |
| HY-RI00999A | hsa-miR-4317 antagomir | Oligonucleotides | |
| HY-RI01000 | hsa-miR-4318 inhibitor | Oligonucleotides | |
| HY-RI01000A | hsa-miR-4318 antagomir | Oligonucleotides | |
| HY-RI01001 | hsa-miR-4319 inhibitor | Oligonucleotides | |
| HY-RI01001A | hsa-miR-4319 antagomir | Oligonucleotides | |
| HY-RI01002 | hsa-miR-4320 inhibitor | Oligonucleotides | |
| HY-RI01002A | hsa-miR-4320 antagomir | Oligonucleotides | |
| HY-RI01003 | hsa-miR-4321 inhibitor | Oligonucleotides | |
| HY-RI01003A | hsa-miR-4321 antagomir | Oligonucleotides | |
| HY-RI01004 | hsa-miR-4322 inhibitor | Oligonucleotides | |
| HY-RI01004A | hsa-miR-4322 antagomir | Oligonucleotides | |
| HY-RI01005 | hsa-miR-4323 inhibitor | Oligonucleotides | |
| HY-RI01005A | hsa-miR-4323 antagomir | Oligonucleotides | |
| HY-RI01006 | hsa-miR-432-3p inhibitor | Oligonucleotides | |
| HY-RI01006A | hsa-miR-432-3p antagomir | Oligonucleotides | |
| HY-RI01007 | hsa-miR-4324 inhibitor | Oligonucleotides | |
| HY-RI01007A | hsa-miR-4324 antagomir | Oligonucleotides | |
| HY-RI01008 | hsa-miR-4325 inhibitor | Oligonucleotides | |
| HY-RI01008A | hsa-miR-4325 antagomir | Oligonucleotides | |
| HY-RI01009 | hsa-miR-432-5p inhibitor | Oligonucleotides | |
| HY-RI01009A | hsa-miR-432-5p antagomir | Oligonucleotides | |
| HY-RI01010 | hsa-miR-4326 inhibitor | Oligonucleotides | |
| HY-RI01010A | hsa-miR-4326 antagomir | Oligonucleotides | |
| HY-RI01011 | hsa-miR-4327 inhibitor | Oligonucleotides | |
| HY-RI01011A | hsa-miR-4327 antagomir | Oligonucleotides | |
| HY-RI01012 | hsa-miR-4328 inhibitor | Oligonucleotides | |
| HY-RI01012A | hsa-miR-4328 antagomir | Oligonucleotides | |
| HY-RI01013 | hsa-miR-4329 inhibitor | Oligonucleotides | |
| HY-RI01013A | hsa-miR-4329 antagomir | Oligonucleotides | |
| HY-RI01014 | hsa-miR-4330 inhibitor | Oligonucleotides | |
| HY-RI01014A | hsa-miR-4330 antagomir | Oligonucleotides | |
| HY-RI01015 | hsa-miR-433-3p inhibitor | Oligonucleotides | |
| HY-RI01015A | hsa-miR-433-3p antagomir | Oligonucleotides | |
| HY-RI01016 | hsa-miR-433-5p inhibitor | Oligonucleotides | |
| HY-RI01016A | hsa-miR-433-5p antagomir | Oligonucleotides | |
| HY-RI01017 | hsa-miR-4418 inhibitor | Oligonucleotides | |
| HY-RI01017A | hsa-miR-4418 antagomir | Oligonucleotides | |
| HY-RI01018 | hsa-miR-4420 inhibitor | Oligonucleotides | |
| HY-RI01018A | hsa-miR-4420 antagomir | Oligonucleotides | |
| HY-RI01019 | hsa-miR-4421 inhibitor | Oligonucleotides | |
| HY-RI01019A | hsa-miR-4421 antagomir | Oligonucleotides | |
| HY-RI01020 | hsa-miR-4422 inhibitor | Oligonucleotides | |
| HY-RI01020A | hsa-miR-4422 antagomir | Oligonucleotides | |
| HY-RI01021 | hsa-miR-4423-3p inhibitor | Oligonucleotides | |
| HY-RI01021A | hsa-miR-4423-3p antagomir | Oligonucleotides | |
| HY-RI01022 | hsa-miR-4423-5p inhibitor | Oligonucleotides | |
| HY-RI01022A | hsa-miR-4423-5p antagomir | Oligonucleotides | |
| HY-RI01023 | hsa-miR-4424 inhibitor | Oligonucleotides | |
| HY-RI01023A | hsa-miR-4424 antagomir | Oligonucleotides | |
| HY-RI01024 | hsa-miR-4425 inhibitor | Oligonucleotides | |
| HY-RI01024A | hsa-miR-4425 antagomir | Oligonucleotides | |
| HY-RI01025 | hsa-miR-4426 inhibitor | Oligonucleotides | |
| HY-RI01025A | hsa-miR-4426 antagomir | Oligonucleotides | |
| HY-RI01026 | hsa-miR-4427 inhibitor | Oligonucleotides | |
| HY-RI01026A | hsa-miR-4427 antagomir | Oligonucleotides | |
| HY-RI01027 | hsa-miR-4428 inhibitor | Oligonucleotides | |
| HY-RI01027A | hsa-miR-4428 antagomir | Oligonucleotides | |
| HY-RI01028 | hsa-miR-4429 inhibitor | Oligonucleotides | |
| HY-RI01028A | hsa-miR-4429 antagomir | Oligonucleotides | |
| HY-RI01029 | hsa-miR-4430 inhibitor | Oligonucleotides | |
| HY-RI01029A | hsa-miR-4430 antagomir | Oligonucleotides | |
| HY-RI01030 | hsa-miR-4431 inhibitor | Oligonucleotides | |
| HY-RI01030A | hsa-miR-4431 antagomir | Oligonucleotides | |
| HY-RI01031 | hsa-miR-4432 inhibitor | Oligonucleotides | |
| HY-RI01031A | hsa-miR-4432 antagomir | Oligonucleotides | |
| HY-RI01032 | hsa-miR-4433a-3p inhibitor | Oligonucleotides | |
| HY-RI01032A | hsa-miR-4433a-3p antagomir | Oligonucleotides | |
| HY-RI01033 | hsa-miR-4433a-5p inhibitor | Oligonucleotides | |
| HY-RI01033A | hsa-miR-4433a-5p antagomir | Oligonucleotides | |
| HY-RI01034 | hsa-miR-4433b-3p inhibitor | Oligonucleotides | |
| HY-RI01034A | hsa-miR-4433b-3p antagomir | Oligonucleotides | |
| HY-RI01035 | hsa-miR-4433b-5p inhibitor | Oligonucleotides | |
| HY-RI01035A | hsa-miR-4433b-5p antagomir | Oligonucleotides | |
| HY-RI01036 | hsa-miR-4434 inhibitor | Oligonucleotides | |
| HY-RI01036A | hsa-miR-4434 antagomir | Oligonucleotides | |
| HY-RI01037 | hsa-miR-4435 inhibitor | Oligonucleotides | |
| HY-RI01037A | hsa-miR-4435 antagomir | Oligonucleotides | |
| HY-RI01038 | hsa-miR-4436a inhibitor | Oligonucleotides | |
| HY-RI01038A | hsa-miR-4436a antagomir | Oligonucleotides | |
| HY-RI01039 | hsa-miR-4436b-3p inhibitor | Oligonucleotides | |
| HY-RI01039A | hsa-miR-4436b-3p antagomir | Oligonucleotides | |
| HY-RI01040 | hsa-miR-4436b-5p inhibitor | Oligonucleotides | |
| HY-RI01040A | hsa-miR-4436b-5p antagomir | Oligonucleotides | |
| HY-RI01041 | hsa-miR-4437 inhibitor | Oligonucleotides | |
| HY-RI01041A | hsa-miR-4437 antagomir | Oligonucleotides | |
| HY-RI01042 | hsa-miR-4438 inhibitor | Oligonucleotides | |
| HY-RI01042A | hsa-miR-4438 antagomir | Oligonucleotides | |
| HY-RI01043 | hsa-miR-4439 inhibitor | Oligonucleotides | |
| HY-RI01043A | hsa-miR-4439 antagomir | Oligonucleotides | |
| HY-RI01044 | hsa-miR-4440 inhibitor | Oligonucleotides | |
| HY-RI01044A | hsa-miR-4440 antagomir | Oligonucleotides | |
| HY-RI01045 | hsa-miR-4441 inhibitor | Oligonucleotides | |
| HY-RI01045A | hsa-miR-4441 antagomir | Oligonucleotides | |
| HY-RI01046 | hsa-miR-4442 inhibitor | Oligonucleotides | |
| HY-RI01046A | hsa-miR-4442 antagomir | Oligonucleotides | |
| HY-RI01047 | hsa-miR-4443 inhibitor | Oligonucleotides | |
| HY-RI01047A | hsa-miR-4443 antagomir | Oligonucleotides | |
| HY-RI01048 | hsa-miR-4444 inhibitor | Oligonucleotides | |
| HY-RI01048A | hsa-miR-4444 antagomir | Oligonucleotides | |
| HY-RI01049 | hsa-miR-4445-3p inhibitor | Oligonucleotides | |
| HY-RI01049A | hsa-miR-4445-3p antagomir | Oligonucleotides | |
| HY-RI01050 | hsa-miR-4445-5p inhibitor | Oligonucleotides | |
| HY-RI01050A | hsa-miR-4445-5p antagomir | Oligonucleotides | |
| HY-RI01051 | hsa-miR-4446-3p inhibitor | Oligonucleotides | |
| HY-RI01051A | hsa-miR-4446-3p antagomir | Oligonucleotides | |
| HY-RI01052 | hsa-miR-4446-5p inhibitor | Oligonucleotides | |
| HY-RI01052A | hsa-miR-4446-5p antagomir | Oligonucleotides | |
| HY-RI01053 | hsa-miR-4447 inhibitor | Oligonucleotides | |
| HY-RI01053A | hsa-miR-4447 antagomir | Oligonucleotides | |
| HY-RI01054 | hsa-miR-4448 inhibitor | Oligonucleotides | |
| HY-RI01054A | hsa-miR-4448 antagomir | Oligonucleotides | |
| HY-RI01055 | hsa-miR-4449 inhibitor | Oligonucleotides | |
| HY-RI01055A | hsa-miR-4449 antagomir | Oligonucleotides | |
| HY-RI01056 | hsa-miR-4450 inhibitor | Oligonucleotides | |
| HY-RI01056A | hsa-miR-4450 antagomir | Oligonucleotides | |
| HY-RI01057 | hsa-miR-4451 inhibitor | Oligonucleotides | |
| HY-RI01057A | hsa-miR-4451 antagomir | Oligonucleotides | |
| HY-RI01058 | hsa-miR-4452 inhibitor | Oligonucleotides | |
| HY-RI01058A | hsa-miR-4452 antagomir | Oligonucleotides | |
| HY-RI01059 | hsa-miR-4453 inhibitor | Oligonucleotides | |
| HY-RI01059A | hsa-miR-4453 antagomir | Oligonucleotides | |
| HY-RI01060 | hsa-miR-4454 inhibitor | Oligonucleotides | |
| HY-RI01060A | hsa-miR-4454 antagomir | Oligonucleotides | |
| HY-RI01061 | hsa-miR-4455 inhibitor | Oligonucleotides | |
| HY-RI01061A | hsa-miR-4455 antagomir | Oligonucleotides | |
| HY-RI01062 | hsa-miR-4456 inhibitor | Oligonucleotides | |
| HY-RI01062A | hsa-miR-4456 antagomir | Oligonucleotides | |
| HY-RI01063 | hsa-miR-4457 inhibitor | Oligonucleotides | |
| HY-RI01063A | hsa-miR-4457 antagomir | Oligonucleotides | |
| HY-RI01064 | hsa-miR-4458 inhibitor | Oligonucleotides | |
| HY-RI01064A | hsa-miR-4458 antagomir | Oligonucleotides | |
| HY-RI01065 | hsa-miR-4460 inhibitor | Oligonucleotides | |
| HY-RI01065A | hsa-miR-4460 antagomir | Oligonucleotides | |
| HY-RI01066 | hsa-miR-4462 inhibitor | Oligonucleotides | |
| HY-RI01066A | hsa-miR-4462 antagomir | Oligonucleotides | |
| HY-RI01067 | hsa-miR-4463 inhibitor | Oligonucleotides | |
| HY-RI01067A | hsa-miR-4463 antagomir | Oligonucleotides | |
| HY-RI01068 | hsa-miR-4464 inhibitor | Oligonucleotides | |
| HY-RI01068A | hsa-miR-4464 antagomir | Oligonucleotides | |
| HY-RI01069 | hsa-miR-4465 inhibitor | Oligonucleotides | |
| HY-RI01069A | hsa-miR-4465 antagomir | Oligonucleotides | |
| HY-RI01070 | hsa-miR-4466 inhibitor | Oligonucleotides | |
| HY-RI01070A | hsa-miR-4466 antagomir | Oligonucleotides | |
| HY-RI01071 | hsa-miR-4467 inhibitor | Oligonucleotides | |
| HY-RI01071A | hsa-miR-4467 antagomir | Oligonucleotides | |
| HY-RI01072 | hsa-miR-4468 inhibitor | Oligonucleotides | |
| HY-RI01072A | hsa-miR-4468 antagomir | Oligonucleotides | |
| HY-RI01073 | hsa-miR-4469 inhibitor | Oligonucleotides | |
| HY-RI01073A | hsa-miR-4469 antagomir | Oligonucleotides | |
| HY-RI01074 | hsa-miR-4470 inhibitor | Oligonucleotides | |
| HY-RI01074A | hsa-miR-4470 antagomir | Oligonucleotides | |
| HY-RI01075 | hsa-miR-4471 inhibitor | Oligonucleotides | |
| HY-RI01075A | hsa-miR-4471 antagomir | Oligonucleotides | |
| HY-RI01076 | hsa-miR-4472 inhibitor | Oligonucleotides | |
| HY-RI01076A | hsa-miR-4472 antagomir | Oligonucleotides | |
| HY-RI01077 | hsa-miR-4473 inhibitor | Oligonucleotides | |
| HY-RI01077A | hsa-miR-4473 antagomir | Oligonucleotides | |
| HY-RI01078 | hsa-miR-4474-3p inhibitor | Oligonucleotides | |
| HY-RI01078A | hsa-miR-4474-3p antagomir | Oligonucleotides | |
| HY-RI01079 | hsa-miR-4474-5p inhibitor | Oligonucleotides | |
| HY-RI01079A | hsa-miR-4474-5p antagomir | Oligonucleotides | |
| HY-RI01080 | hsa-miR-4475 inhibitor | Oligonucleotides | |
| HY-RI01080A | hsa-miR-4475 antagomir | Oligonucleotides | |
| HY-RI01081 | hsa-miR-4476 inhibitor | Oligonucleotides | |
| HY-RI01081A | hsa-miR-4476 antagomir | Oligonucleotides | |
| HY-RI01082 | hsa-miR-4477a inhibitor | Oligonucleotides | |
| HY-RI01082A | hsa-miR-4477a antagomir | Oligonucleotides | |
| HY-RI01083 | hsa-miR-4477b inhibitor | Oligonucleotides | |
| HY-RI01083A | hsa-miR-4477b antagomir | Oligonucleotides | |
| HY-RI01084 | hsa-miR-4478 inhibitor | Oligonucleotides | |
| HY-RI01084A | hsa-miR-4478 antagomir | Oligonucleotides | |
| HY-RI01085 | hsa-miR-4479 inhibitor | Oligonucleotides | |
| HY-RI01085A | hsa-miR-4479 antagomir | Oligonucleotides | |
| HY-RI01086 | hsa-miR-448 inhibitor | Oligonucleotides | |
| HY-RI01086A | hsa-miR-448 antagomir | Oligonucleotides | |
| HY-RI01087 | hsa-miR-4480 inhibitor | Oligonucleotides | |
| HY-RI01087A | hsa-miR-4480 antagomir | Oligonucleotides | |
| HY-RI01088 | hsa-miR-4481 inhibitor | Oligonucleotides | |
| HY-RI01088A | hsa-miR-4481 antagomir | Oligonucleotides | |
| HY-RI01089 | hsa-miR-4482-3p inhibitor | Oligonucleotides | |
| HY-RI01089A | hsa-miR-4482-3p antagomir | Oligonucleotides | |
| HY-RI01090 | hsa-miR-4482-5p inhibitor | Oligonucleotides | |
| HY-RI01090A | hsa-miR-4482-5p antagomir | Oligonucleotides | |
| HY-RI01091 | hsa-miR-4483 inhibitor | Oligonucleotides | |
| HY-RI01091A | hsa-miR-4483 antagomir | Oligonucleotides | |
| HY-RI01092 | hsa-miR-4484 inhibitor | Oligonucleotides | |
| HY-RI01092A | hsa-miR-4484 antagomir | Oligonucleotides | |
| HY-RI01093 | hsa-miR-4485-3p inhibitor | Oligonucleotides | |
| HY-RI01093A | hsa-miR-4485-3p antagomir | Oligonucleotides | |
| HY-RI01094 | hsa-miR-4485-5p inhibitor | Oligonucleotides | |
| HY-RI01094A | hsa-miR-4485-5p antagomir | Oligonucleotides | |
| HY-RI01095 | hsa-miR-4486 inhibitor | Oligonucleotides | |
| HY-RI01095A | hsa-miR-4486 antagomir | Oligonucleotides | |
| HY-RI01096 | hsa-miR-4487 inhibitor | Oligonucleotides | |
| HY-RI01096A | hsa-miR-4487 antagomir | Oligonucleotides | |
| HY-RI01097 | hsa-miR-4488 inhibitor | Oligonucleotides | |
| HY-RI01097A | hsa-miR-4488 antagomir | Oligonucleotides | |
| HY-RI01098 | hsa-miR-4489 inhibitor | Oligonucleotides | |
| HY-RI01098A | hsa-miR-4489 antagomir | Oligonucleotides | |
| HY-RI01099 | hsa-miR-4490 inhibitor | Oligonucleotides | |
| HY-RI01099A | hsa-miR-4490 antagomir | Oligonucleotides | |
| HY-RI01100 | hsa-miR-4491 inhibitor | Oligonucleotides | |
| HY-RI01100A | hsa-miR-4491 antagomir | Oligonucleotides | |
| HY-RI01101 | hsa-miR-4492 inhibitor | Oligonucleotides | |
| HY-RI01101A | hsa-miR-4492 antagomir | Oligonucleotides | |
| HY-RI01102 | hsa-miR-4493 inhibitor | Oligonucleotides | |
| HY-RI01102A | hsa-miR-4493 antagomir | Oligonucleotides | |
| HY-RI01103 | hsa-miR-4494 inhibitor | Oligonucleotides | |
| HY-RI01103A | hsa-miR-4494 antagomir | Oligonucleotides | |
| HY-RI01104 | hsa-miR-4495 inhibitor | Oligonucleotides | |
| HY-RI01104A | hsa-miR-4495 antagomir | Oligonucleotides | |
| HY-RI01105 | hsa-miR-4496 inhibitor | Oligonucleotides | |
| HY-RI01105A | hsa-miR-4496 antagomir | Oligonucleotides | |
| HY-RI01106 | hsa-miR-4497 inhibitor | Oligonucleotides | |
| HY-RI01106A | hsa-miR-4497 antagomir | Oligonucleotides | |
| HY-RI01107 | hsa-miR-4498 inhibitor | Oligonucleotides | |
| HY-RI01107A | hsa-miR-4498 antagomir | Oligonucleotides | |
| HY-RI01108 | hsa-miR-4499 inhibitor | Oligonucleotides | |
| HY-RI01108A | hsa-miR-4499 antagomir | Oligonucleotides | |
| HY-RI01109 | hsa-miR-449a inhibitor | Oligonucleotides | |
| HY-RI01109A | hsa-miR-449a antagomir | Oligonucleotides | |
| HY-RI01110 | hsa-miR-449b-3p inhibitor | Oligonucleotides | |
| HY-RI01110A | hsa-miR-449b-3p antagomir | Oligonucleotides | |
| HY-RI01111 | hsa-miR-449b-5p inhibitor | Oligonucleotides | |
| HY-RI01111A | hsa-miR-449b-5p antagomir | Oligonucleotides | |
| HY-RI01112 | hsa-miR-449c-3p inhibitor | Oligonucleotides | |
| HY-RI01112A | hsa-miR-449c-3p antagomir | Oligonucleotides | |
| HY-RI01113 | hsa-miR-449c-5p inhibitor | Oligonucleotides | |
| HY-RI01113A | hsa-miR-449c-5p antagomir | Oligonucleotides | |
| HY-RI01114 | hsa-miR-4500 inhibitor | Oligonucleotides | |
| HY-RI01114A | hsa-miR-4500 antagomir | Oligonucleotides | |
| HY-RI01115 | hsa-miR-4501 inhibitor | Oligonucleotides | |
| HY-RI01115A | hsa-miR-4501 antagomir | Oligonucleotides | |
| HY-RI01116 | hsa-miR-4502 inhibitor | Oligonucleotides | |
| HY-RI01116A | hsa-miR-4502 antagomir | Oligonucleotides | |
| HY-RI01117 | hsa-miR-4503 inhibitor | Oligonucleotides | |
| HY-RI01117A | hsa-miR-4503 antagomir | Oligonucleotides | |
| HY-RI01118 | hsa-miR-4504 inhibitor | Oligonucleotides | |
| HY-RI01118A | hsa-miR-4504 antagomir | Oligonucleotides | |
| HY-RI01119 | hsa-miR-4505 inhibitor | Oligonucleotides | |
| HY-RI01119A | hsa-miR-4505 antagomir | Oligonucleotides | |
| HY-RI01120 | hsa-miR-4506 inhibitor | Oligonucleotides | |
| HY-RI01120A | hsa-miR-4506 antagomir | Oligonucleotides | |
| HY-RI01121 | hsa-miR-4507 inhibitor | Oligonucleotides | |
| HY-RI01121A | hsa-miR-4507 antagomir | Oligonucleotides | |
| HY-RI01122 | hsa-miR-4508 inhibitor | Oligonucleotides | |
| HY-RI01122A | hsa-miR-4508 antagomir | Oligonucleotides | |
| HY-RI01123 | hsa-miR-4509 inhibitor | Oligonucleotides | |
| HY-RI01123A | hsa-miR-4509 antagomir | Oligonucleotides | |
| HY-RI01124 | hsa-miR-450a-1-3p inhibitor | Oligonucleotides | |
| HY-RI01124A | hsa-miR-450a-1-3p antagomir | Oligonucleotides | |
| HY-RI01125 | hsa-miR-450a-2-3p inhibitor | Oligonucleotides | |
| HY-RI01125A | hsa-miR-450a-2-3p antagomir | Oligonucleotides | |
| HY-RI01126 | hsa-miR-450a-5p inhibitor | Oligonucleotides | |
| HY-RI01126A | hsa-miR-450a-5p antagomir | Oligonucleotides | |
| HY-RI01127 | hsa-miR-450b-3p inhibitor | Oligonucleotides | |
| HY-RI01127A | hsa-miR-450b-3p antagomir | Oligonucleotides | |
| HY-RI01128 | hsa-miR-450b-5p inhibitor | Oligonucleotides | |
| HY-RI01128A | hsa-miR-450b-5p antagomir | Oligonucleotides | |
| HY-RI01129 | hsa-miR-4510 inhibitor | Oligonucleotides | |
| HY-RI01129A | hsa-miR-4510 antagomir | Oligonucleotides | |
| HY-RI01130 | hsa-miR-4511 inhibitor | Oligonucleotides | |
| HY-RI01130A | hsa-miR-4511 antagomir | Oligonucleotides | |
| HY-RI01131 | hsa-miR-4512 inhibitor | Oligonucleotides | |
| HY-RI01131A | hsa-miR-4512 antagomir | Oligonucleotides | |
| HY-RI01132 | hsa-miR-4513 inhibitor | Oligonucleotides | |
| HY-RI01132A | hsa-miR-4513 antagomir | Oligonucleotides | |
| HY-RI01133 | hsa-miR-4514 inhibitor | Oligonucleotides | |
| HY-RI01133A | hsa-miR-4514 antagomir | Oligonucleotides | |
| HY-RI01134 | hsa-miR-4515 inhibitor | Oligonucleotides | |
| HY-RI01134A | hsa-miR-4515 antagomir | Oligonucleotides | |
| HY-RI01135 | hsa-miR-4516 inhibitor | Oligonucleotides | |
| HY-RI01135A | hsa-miR-4516 antagomir | Oligonucleotides | |
| HY-RI01136 | hsa-miR-4517 inhibitor | Oligonucleotides | |
| HY-RI01136A | hsa-miR-4517 antagomir | Oligonucleotides | |
| HY-RI01137 | hsa-miR-4518 inhibitor | Oligonucleotides | |
| HY-RI01137A | hsa-miR-4518 antagomir | Oligonucleotides | |
| HY-RI01138 | hsa-miR-4519 inhibitor | Oligonucleotides | |
| HY-RI01138A | hsa-miR-4519 antagomir | Oligonucleotides | |
| HY-RI01139 | hsa-miR-451a inhibitor | Oligonucleotides | |
| HY-RI01139A | hsa-miR-451a antagomir | Oligonucleotides | |
| HY-RI01140 | hsa-miR-451b inhibitor | Oligonucleotides | |
| HY-RI01140A | hsa-miR-451b antagomir | Oligonucleotides | |
| HY-RI01141 | hsa-miR-4520-2-3p inhibitor | Oligonucleotides | |
| HY-RI01141A | hsa-miR-4520-2-3p antagomir | Oligonucleotides | |
| HY-RI01142 | hsa-miR-4520-3p inhibitor | Oligonucleotides | |
| HY-RI01142A | hsa-miR-4520-3p antagomir | Oligonucleotides | |
| HY-RI01143 | hsa-miR-4520-5p inhibitor | Oligonucleotides | |
| HY-RI01143A | hsa-miR-4520-5p antagomir | Oligonucleotides | |
| HY-RI01144 | hsa-miR-4521 inhibitor | Oligonucleotides | |
| HY-RI01144A | hsa-miR-4521 antagomir | Oligonucleotides | |
| HY-RI01145 | hsa-miR-4522 inhibitor | Oligonucleotides | |
| HY-RI01145A | hsa-miR-4522 antagomir | Oligonucleotides | |
| HY-RI01146 | hsa-miR-4523 inhibitor | Oligonucleotides | |
| HY-RI01146A | hsa-miR-4523 antagomir | Oligonucleotides | |
| HY-RI01147 | hsa-miR-452-3p inhibitor | Oligonucleotides | |
| HY-RI01147A | hsa-miR-452-3p antagomir | Oligonucleotides | |
| HY-RI01148 | hsa-miR-4524a-3p inhibitor | Oligonucleotides | |
| HY-RI01148A | hsa-miR-4524a-3p antagomir | Oligonucleotides | |
| HY-RI01149 | hsa-miR-4524a-5p inhibitor | Oligonucleotides | |
| HY-RI01149A | hsa-miR-4524a-5p antagomir | Oligonucleotides | |
| HY-RI01150 | hsa-miR-4524b-3p inhibitor | Oligonucleotides | |
| HY-RI01150A | hsa-miR-4524b-3p antagomir | Oligonucleotides | |
| HY-RI01151 | hsa-miR-4524b-5p inhibitor | Oligonucleotides | |
| HY-RI01151A | hsa-miR-4524b-5p antagomir | Oligonucleotides | |
| HY-RI01152 | hsa-miR-4525 inhibitor | Oligonucleotides | |
| HY-RI01152A | hsa-miR-4525 antagomir | Oligonucleotides | |
| HY-RI01153 | hsa-miR-4526 inhibitor | Oligonucleotides | |
| HY-RI01153A | hsa-miR-4526 antagomir | Oligonucleotides | |
| HY-RI01154 | hsa-miR-4527 inhibitor | Oligonucleotides | |
| HY-RI01154A | hsa-miR-4527 antagomir | Oligonucleotides | |
| HY-RI01155 | hsa-miR-4528 inhibitor | Oligonucleotides | |
| HY-RI01155A | hsa-miR-4528 antagomir | Oligonucleotides | |
| HY-RI01156 | hsa-miR-4529-3p inhibitor | Oligonucleotides | |
| HY-RI01156A | hsa-miR-4529-3p antagomir | Oligonucleotides | |
| HY-RI01157 | hsa-miR-4529-5p inhibitor | Oligonucleotides | |
| HY-RI01157A | hsa-miR-4529-5p antagomir | Oligonucleotides | |
| HY-RI01158 | hsa-miR-4530 inhibitor | Oligonucleotides | |
| HY-RI01158A | hsa-miR-4530 antagomir | Oligonucleotides | |
| HY-RI01159 | hsa-miR-4531 inhibitor | Oligonucleotides | |
| HY-RI01159A | hsa-miR-4531 antagomir | Oligonucleotides | |
| HY-RI01160 | hsa-miR-4533 inhibitor | Oligonucleotides | |
| HY-RI01160A | hsa-miR-4533 antagomir | Oligonucleotides | |
| HY-RI01161 | hsa-miR-4534 inhibitor | Oligonucleotides | |
| HY-RI01161A | hsa-miR-4534 antagomir | Oligonucleotides | |
| HY-RI01162 | hsa-miR-4535 inhibitor | Oligonucleotides | |
| HY-RI01162A | hsa-miR-4535 antagomir | Oligonucleotides | |
| HY-RI01163 | hsa-miR-4536-3p inhibitor | Oligonucleotides | |
| HY-RI01163A | hsa-miR-4536-3p antagomir | Oligonucleotides | |
| HY-RI01164 | hsa-miR-4536-5p inhibitor | Oligonucleotides | |
| HY-RI01164A | hsa-miR-4536-5p antagomir | Oligonucleotides | |
| HY-RI01165 | hsa-miR-4537 inhibitor | Oligonucleotides | |
| HY-RI01165A | hsa-miR-4537 antagomir | Oligonucleotides | |
| HY-RI01166 | hsa-miR-4538 inhibitor | Oligonucleotides | |
| HY-RI01166A | hsa-miR-4538 antagomir | Oligonucleotides | |
| HY-RI01167 | hsa-miR-4539 inhibitor | Oligonucleotides | |
| HY-RI01167A | hsa-miR-4539 antagomir | Oligonucleotides | |
| HY-RI01168 | hsa-miR-4540 inhibitor | Oligonucleotides | |
| HY-RI01168A | hsa-miR-4540 antagomir | Oligonucleotides | |
| HY-RI01169 | hsa-miR-454-3p inhibitor | Oligonucleotides | |
| HY-RI01169A | hsa-miR-454-3p antagomir | Oligonucleotides | |
| HY-RI01170 | hsa-miR-454-5p inhibitor | Oligonucleotides | |
| HY-RI01170A | hsa-miR-454-5p antagomir | Oligonucleotides | |
| HY-RI01171 | hsa-miR-455-5p inhibitor | Oligonucleotides | |
| HY-RI01171A | hsa-miR-455-5p antagomir | Oligonucleotides | |
| HY-RI01172 | hsa-miR-4632-3p inhibitor | Oligonucleotides | |
| HY-RI01172A | hsa-miR-4632-3p antagomir | Oligonucleotides | |
| HY-RI01173 | hsa-miR-4632-5p inhibitor | Oligonucleotides | |
| HY-RI01173A | hsa-miR-4632-5p antagomir | Oligonucleotides | |
| HY-RI01174 | hsa-miR-4633-3p inhibitor | Oligonucleotides | |
| HY-RI01174A | hsa-miR-4633-3p antagomir | Oligonucleotides | |
| HY-RI01175 | hsa-miR-4633-5p inhibitor | Oligonucleotides | |
| HY-RI01175A | hsa-miR-4633-5p antagomir | Oligonucleotides | |
| HY-RI01176 | hsa-miR-4634 inhibitor | Oligonucleotides | |
| HY-RI01176A | hsa-miR-4634 antagomir | Oligonucleotides | |
| HY-RI01177 | hsa-miR-4635 inhibitor | Oligonucleotides | |
| HY-RI01177A | hsa-miR-4635 antagomir | Oligonucleotides | |
| HY-RI01178 | hsa-miR-4636 inhibitor | Oligonucleotides | |
| HY-RI01178A | hsa-miR-4636 antagomir | Oligonucleotides | |
| HY-RI01179 | hsa-miR-4637 inhibitor | Oligonucleotides | |
| HY-RI01179A | hsa-miR-4637 antagomir | Oligonucleotides | |
| HY-RI01180 | hsa-miR-4638-3p inhibitor | Oligonucleotides | |
| HY-RI01180A | hsa-miR-4638-3p antagomir | Oligonucleotides | |
| HY-RI01181 | hsa-miR-4638-5p inhibitor | Oligonucleotides | |
| HY-RI01181A | hsa-miR-4638-5p antagomir | Oligonucleotides | |
| HY-RI01182 | hsa-miR-4639-3p inhibitor | Oligonucleotides | |
| HY-RI01182A | hsa-miR-4639-3p antagomir | Oligonucleotides | |
| HY-RI01183 | hsa-miR-4639-5p inhibitor | Oligonucleotides | |
| HY-RI01183A | hsa-miR-4639-5p antagomir | Oligonucleotides | |
| HY-RI01184 | hsa-miR-4640-3p inhibitor | Oligonucleotides | |
| HY-RI01184A | hsa-miR-4640-3p antagomir | Oligonucleotides | |
| HY-RI01185 | hsa-miR-4640-5p inhibitor | Oligonucleotides | |
| HY-RI01185A | hsa-miR-4640-5p antagomir | Oligonucleotides | |
| HY-RI01186 | hsa-miR-4641 inhibitor | Oligonucleotides | |
| HY-RI01186A | hsa-miR-4641 antagomir | Oligonucleotides | |
| HY-RI01187 | hsa-miR-4642 inhibitor | Oligonucleotides | |
| HY-RI01187A | hsa-miR-4642 antagomir | Oligonucleotides | |
| HY-RI01188 | hsa-miR-4643 inhibitor | Oligonucleotides | |
| HY-RI01188A | hsa-miR-4643 antagomir | Oligonucleotides | |
| HY-RI01189 | hsa-miR-4644 inhibitor | Oligonucleotides | |
| HY-RI01189A | hsa-miR-4644 antagomir | Oligonucleotides | |
| HY-RI01190 | hsa-miR-4645-3p inhibitor | Oligonucleotides | |
| HY-RI01190A | hsa-miR-4645-3p antagomir | Oligonucleotides | |
| HY-RI01191 | hsa-miR-4645-5p inhibitor | Oligonucleotides | |
| HY-RI01191A | hsa-miR-4645-5p antagomir | Oligonucleotides | |
| HY-RI01192 | hsa-miR-4646-3p inhibitor | Oligonucleotides | |
| HY-RI01192A | hsa-miR-4646-3p antagomir | Oligonucleotides | |
| HY-RI01193 | hsa-miR-4646-5p inhibitor | Oligonucleotides | |
| HY-RI01193A | hsa-miR-4646-5p antagomir | Oligonucleotides | |
| HY-RI01194 | hsa-miR-4647 inhibitor | Oligonucleotides | |
| HY-RI01194A | hsa-miR-4647 antagomir | Oligonucleotides | |
| HY-RI01195 | hsa-miR-4648 inhibitor | Oligonucleotides | |
| HY-RI01195A | hsa-miR-4648 antagomir | Oligonucleotides | |
| HY-RI01196 | hsa-miR-4649-3p inhibitor | Oligonucleotides | |
| HY-RI01196A | hsa-miR-4649-3p antagomir | Oligonucleotides | |
| HY-RI01197 | hsa-miR-4649-5p inhibitor | Oligonucleotides | |
| HY-RI01197A | hsa-miR-4649-5p antagomir | Oligonucleotides | |
| HY-RI01198 | hsa-miR-4650-3p inhibitor | Oligonucleotides | |
| HY-RI01198A | hsa-miR-4650-3p antagomir | Oligonucleotides | |
| HY-RI01199 | hsa-miR-4650-5p inhibitor | Oligonucleotides | |
| HY-RI01199A | hsa-miR-4650-5p antagomir | Oligonucleotides | |
| HY-RI01200 | hsa-miR-4651 inhibitor | Oligonucleotides | |
| HY-RI01200A | hsa-miR-4651 antagomir | Oligonucleotides | |
| HY-RI01201 | hsa-miR-4652-3p inhibitor | Oligonucleotides | |
| HY-RI01201A | hsa-miR-4652-3p antagomir | Oligonucleotides | |
| HY-RI01202 | hsa-miR-4652-5p inhibitor | Oligonucleotides | |
| HY-RI01202A | hsa-miR-4652-5p antagomir | Oligonucleotides | |
| HY-RI01203 | hsa-miR-4653-3p inhibitor | Oligonucleotides | |
| HY-RI01203A | hsa-miR-4653-3p antagomir | Oligonucleotides | |
| HY-RI01204 | hsa-miR-4653-5p inhibitor | Oligonucleotides | |
| HY-RI01204A | hsa-miR-4653-5p antagomir | Oligonucleotides | |
| HY-RI01205 | hsa-miR-4654 inhibitor | Oligonucleotides | |
| HY-RI01205A | hsa-miR-4654 antagomir | Oligonucleotides | |
| HY-RI01206 | hsa-miR-4655-3p inhibitor | Oligonucleotides | |
| HY-RI01206A | hsa-miR-4655-3p antagomir | Oligonucleotides | |
| HY-RI01207 | hsa-miR-4655-5p inhibitor | Oligonucleotides | |
| HY-RI01207A | hsa-miR-4655-5p antagomir | Oligonucleotides | |
| HY-RI01208 | hsa-miR-4656 inhibitor | Oligonucleotides | |
| HY-RI01208A | hsa-miR-4656 antagomir | Oligonucleotides | |
| HY-RI01209 | hsa-miR-4657 inhibitor | Oligonucleotides | |
| HY-RI01209A | hsa-miR-4657 antagomir | Oligonucleotides | |
| HY-RI01210 | hsa-miR-4658 inhibitor | Oligonucleotides | |
| HY-RI01210A | hsa-miR-4658 antagomir | Oligonucleotides | |
| HY-RI01211 | hsa-miR-4659a-3p inhibitor | Oligonucleotides | |
| HY-RI01211A | hsa-miR-4659a-3p antagomir | Oligonucleotides | |
| HY-RI01212 | hsa-miR-4659a-5p inhibitor | Oligonucleotides | |
| HY-RI01212A | hsa-miR-4659a-5p antagomir | Oligonucleotides | |
| HY-RI01213 | hsa-miR-4659b-3p inhibitor | Oligonucleotides | |
| HY-RI01213A | hsa-miR-4659b-3p antagomir | Oligonucleotides | |
| HY-RI01214 | hsa-miR-4659b-5p inhibitor | Oligonucleotides | |
| HY-RI01214A | hsa-miR-4659b-5p antagomir | Oligonucleotides | |
| HY-RI01215 | hsa-miR-466 inhibitor | Oligonucleotides | |
| HY-RI01215A | hsa-miR-466 antagomir | Oligonucleotides | |
| HY-RI01216 | hsa-miR-4660 inhibitor | Oligonucleotides | |
| HY-RI01216A | hsa-miR-4660 antagomir | Oligonucleotides | |
| HY-RI01217 | hsa-miR-4661-3p inhibitor | Oligonucleotides | |
| HY-RI01217A | hsa-miR-4661-3p antagomir | Oligonucleotides | |
| HY-RI01218 | hsa-miR-4661-5p inhibitor | Oligonucleotides | |
| HY-RI01218A | hsa-miR-4661-5p antagomir | Oligonucleotides | |
| HY-RI01219 | hsa-miR-4662a-3p inhibitor | Oligonucleotides | |
| HY-RI01219A | hsa-miR-4662a-3p antagomir | Oligonucleotides | |
| HY-RI01220 | hsa-miR-4662a-5p inhibitor | Oligonucleotides | |
| HY-RI01220A | hsa-miR-4662a-5p antagomir | Oligonucleotides | |
| HY-RI01221 | hsa-miR-4662b inhibitor | Oligonucleotides | |
| HY-RI01221A | hsa-miR-4662b antagomir | Oligonucleotides | |
| HY-RI01222 | hsa-miR-4663 inhibitor | Oligonucleotides | |
| HY-RI01222A | hsa-miR-4663 antagomir | Oligonucleotides | |
| HY-RI01223 | hsa-miR-4664-3p inhibitor | Oligonucleotides | |
| HY-RI01223A | hsa-miR-4664-3p antagomir | Oligonucleotides | |
| HY-RI01224 | hsa-miR-4664-5p inhibitor | Oligonucleotides | |
| HY-RI01224A | hsa-miR-4664-5p antagomir | Oligonucleotides | |
| HY-RI01225 | hsa-miR-4665-3p inhibitor | Oligonucleotides | |
| HY-RI01225A | hsa-miR-4665-3p antagomir | Oligonucleotides | |
| HY-RI01226 | hsa-miR-4665-5p inhibitor | Oligonucleotides | |
| HY-RI01226A | hsa-miR-4665-5p antagomir | Oligonucleotides | |
| HY-RI01227 | hsa-miR-4666a-3p inhibitor | Oligonucleotides | |
| HY-RI01227A | hsa-miR-4666a-3p antagomir | Oligonucleotides | |
| HY-RI01228 | hsa-miR-4666a-5p inhibitor | Oligonucleotides | |
| HY-RI01228A | hsa-miR-4666a-5p antagomir | Oligonucleotides | |
| HY-RI01229 | hsa-miR-4666b inhibitor | Oligonucleotides | |
| HY-RI01229A | hsa-miR-4666b antagomir | Oligonucleotides | |
| HY-RI01230 | hsa-miR-4667-3p inhibitor | Oligonucleotides | |
| HY-RI01230A | hsa-miR-4667-3p antagomir | Oligonucleotides | |
| HY-RI01231 | hsa-miR-4667-5p inhibitor | Oligonucleotides | |
| HY-RI01231A | hsa-miR-4667-5p antagomir | Oligonucleotides | |
| HY-RI01232 | hsa-miR-4668-3p inhibitor | Oligonucleotides | |
| HY-RI01232A | hsa-miR-4668-3p antagomir | Oligonucleotides | |
| HY-RI01233 | hsa-miR-4668-5p inhibitor | Oligonucleotides | |
| HY-RI01233A | hsa-miR-4668-5p antagomir | Oligonucleotides | |
| HY-RI01234 | hsa-miR-4669 inhibitor | Oligonucleotides | |
| HY-RI01234A | hsa-miR-4669 antagomir | Oligonucleotides | |
| HY-RI01235 | hsa-miR-4670-3p inhibitor | Oligonucleotides | |
| HY-RI01235A | hsa-miR-4670-3p antagomir | Oligonucleotides | |
| HY-RI01236 | hsa-miR-4670-5p inhibitor | Oligonucleotides | |
| HY-RI01236A | hsa-miR-4670-5p antagomir | Oligonucleotides | |
| HY-RI01237 | hsa-miR-4671-3p inhibitor | Oligonucleotides | |
| HY-RI01237A | hsa-miR-4671-3p antagomir | Oligonucleotides | |
| HY-RI01238 | hsa-miR-4671-5p inhibitor | Oligonucleotides | |
| HY-RI01238A | hsa-miR-4671-5p antagomir | Oligonucleotides | |
| HY-RI01239 | hsa-miR-4672 inhibitor | Oligonucleotides | |
| HY-RI01239A | hsa-miR-4672 antagomir | Oligonucleotides | |
| HY-RI01240 | hsa-miR-4673 inhibitor | Oligonucleotides | |
| HY-RI01240A | hsa-miR-4673 antagomir | Oligonucleotides | |
| HY-RI01241 | hsa-miR-4674 inhibitor | Oligonucleotides | |
| HY-RI01241A | hsa-miR-4674 antagomir | Oligonucleotides | |
| HY-RI01242 | hsa-miR-4675 inhibitor | Oligonucleotides | |
| HY-RI01242A | hsa-miR-4675 antagomir | Oligonucleotides | |
| HY-RI01243 | hsa-miR-4676-3p inhibitor | Oligonucleotides | |
| HY-RI01243A | hsa-miR-4676-3p antagomir | Oligonucleotides | |
| HY-RI01244 | hsa-miR-4676-5p inhibitor | Oligonucleotides | |
| HY-RI01244A | hsa-miR-4676-5p antagomir | Oligonucleotides | |
| HY-RI01245 | hsa-miR-4677-3p inhibitor | Oligonucleotides | |
| HY-RI01245A | hsa-miR-4677-3p antagomir | Oligonucleotides | |
| HY-RI01246 | hsa-miR-4677-5p inhibitor | Oligonucleotides | |
| HY-RI01246A | hsa-miR-4677-5p antagomir | Oligonucleotides | |
| HY-RI01247 | hsa-miR-4678 inhibitor | Oligonucleotides | |
| HY-RI01247A | hsa-miR-4678 antagomir | Oligonucleotides | |
| HY-RI01248 | hsa-miR-4679 inhibitor | Oligonucleotides | |
| HY-RI01248A | hsa-miR-4679 antagomir | Oligonucleotides | |
| HY-RI01249 | hsa-miR-4680-3p inhibitor | Oligonucleotides | |
| HY-RI01249A | hsa-miR-4680-3p antagomir | Oligonucleotides | |
| HY-RI01250 | hsa-miR-4680-5p inhibitor | Oligonucleotides | |
| HY-RI01250A | hsa-miR-4680-5p antagomir | Oligonucleotides | |
| HY-RI01251 | hsa-miR-4681 inhibitor | Oligonucleotides | |
| HY-RI01251A | hsa-miR-4681 antagomir | Oligonucleotides | |
| HY-RI01252 | hsa-miR-4682 inhibitor | Oligonucleotides | |
| HY-RI01252A | hsa-miR-4682 antagomir | Oligonucleotides | |
| HY-RI01253 | hsa-miR-4683 inhibitor | Oligonucleotides | |
| HY-RI01253A | hsa-miR-4683 antagomir | Oligonucleotides | |
| HY-RI01254 | hsa-miR-4684-3p inhibitor | Oligonucleotides | |
| HY-RI01254A | hsa-miR-4684-3p antagomir | Oligonucleotides | |
| HY-RI01255 | hsa-miR-4684-5p inhibitor | Oligonucleotides | |
| HY-RI01255A | hsa-miR-4684-5p antagomir | Oligonucleotides | |
| HY-RI01256 | hsa-miR-4685-3p inhibitor | Oligonucleotides | |
| HY-RI01256A | hsa-miR-4685-3p antagomir | Oligonucleotides | |
| HY-RI01257 | hsa-miR-4685-5p inhibitor | Oligonucleotides | |
| HY-RI01257A | hsa-miR-4685-5p antagomir | Oligonucleotides | |
| HY-RI01258 | hsa-miR-4686 inhibitor | Oligonucleotides | |
| HY-RI01258A | hsa-miR-4686 antagomir | Oligonucleotides | |
| HY-RI01259 | hsa-miR-4687-3p inhibitor | Oligonucleotides | |
| HY-RI01259A | hsa-miR-4687-3p antagomir | Oligonucleotides | |
| HY-RI01260 | hsa-miR-4687-5p inhibitor | Oligonucleotides | |
| HY-RI01260A | hsa-miR-4687-5p antagomir | Oligonucleotides | |
| HY-RI01261 | hsa-miR-4688 inhibitor | Oligonucleotides | |
| HY-RI01261A | hsa-miR-4688 antagomir | Oligonucleotides | |
| HY-RI01262 | hsa-miR-4689 inhibitor | Oligonucleotides | |
| HY-RI01262A | hsa-miR-4689 antagomir | Oligonucleotides | |
| HY-RI01263 | hsa-miR-4690-3p inhibitor | Oligonucleotides | |
| HY-RI01263A | hsa-miR-4690-3p antagomir | Oligonucleotides | |
| HY-RI01264 | hsa-miR-4690-5p inhibitor | Oligonucleotides | |
| HY-RI01264A | hsa-miR-4690-5p antagomir | Oligonucleotides | |
| HY-RI01265 | hsa-miR-4691-3p inhibitor | Oligonucleotides | |
| HY-RI01265A | hsa-miR-4691-3p antagomir | Oligonucleotides | |
| HY-RI01266 | hsa-miR-4691-5p inhibitor | Oligonucleotides | |
| HY-RI01266A | hsa-miR-4691-5p antagomir | Oligonucleotides | |
| HY-RI01267 | hsa-miR-4692 inhibitor | Oligonucleotides | |
| HY-RI01267A | hsa-miR-4692 antagomir | Oligonucleotides | |
| HY-RI01268 | hsa-miR-4693-3p inhibitor | Oligonucleotides | |
| HY-RI01268A | hsa-miR-4693-3p antagomir | Oligonucleotides | |
| HY-RI01269 | hsa-miR-4693-5p inhibitor | Oligonucleotides | |
| HY-RI01269A | hsa-miR-4693-5p antagomir | Oligonucleotides | |
| HY-RI01270 | hsa-miR-4694-3p inhibitor | Oligonucleotides | |
| HY-RI01270A | hsa-miR-4694-3p antagomir | Oligonucleotides | |
| HY-RI01271 | hsa-miR-4694-5p inhibitor | Oligonucleotides | |
| HY-RI01271A | hsa-miR-4694-5p antagomir | Oligonucleotides | |
| HY-RI01272 | hsa-miR-4695-3p inhibitor | Oligonucleotides | |
| HY-RI01272A | hsa-miR-4695-3p antagomir | Oligonucleotides | |
| HY-RI01273 | hsa-miR-4695-5p inhibitor | Oligonucleotides | |
| HY-RI01273A | hsa-miR-4695-5p antagomir | Oligonucleotides | |
| HY-RI01274 | hsa-miR-4696 inhibitor | Oligonucleotides | |
| HY-RI01274A | hsa-miR-4696 antagomir | Oligonucleotides | |
| HY-RI01275 | hsa-miR-4697-3p inhibitor | Oligonucleotides | |
| HY-RI01275A | hsa-miR-4697-3p antagomir | Oligonucleotides | |
| HY-RI01276 | hsa-miR-4697-5p inhibitor | Oligonucleotides | |
| HY-RI01276A | hsa-miR-4697-5p antagomir | Oligonucleotides | |
| HY-RI01277 | hsa-miR-4698 inhibitor | Oligonucleotides | |
| HY-RI01277A | hsa-miR-4698 antagomir | Oligonucleotides | |
| HY-RI01278 | hsa-miR-4699-3p inhibitor | Oligonucleotides | |
| HY-RI01278A | hsa-miR-4699-3p antagomir | Oligonucleotides | |
| HY-RI01279 | hsa-miR-4699-5p inhibitor | Oligonucleotides | |
| HY-RI01279A | hsa-miR-4699-5p antagomir | Oligonucleotides | |
| HY-RI01280 | hsa-miR-4700-3p inhibitor | Oligonucleotides | |
| HY-RI01280A | hsa-miR-4700-3p antagomir | Oligonucleotides | |
| HY-RI01281 | hsa-miR-4700-5p inhibitor | Oligonucleotides | |
| HY-RI01281A | hsa-miR-4700-5p antagomir | Oligonucleotides | |
| HY-RI01282 | hsa-miR-4701-3p inhibitor | Oligonucleotides | |
| HY-RI01282A | hsa-miR-4701-3p antagomir | Oligonucleotides | |
| HY-RI01283 | hsa-miR-4701-5p inhibitor | Oligonucleotides | |
| HY-RI01283A | hsa-miR-4701-5p antagomir | Oligonucleotides | |
| HY-RI01284 | hsa-miR-4703-3p inhibitor | Oligonucleotides | |
| HY-RI01284A | hsa-miR-4703-3p antagomir | Oligonucleotides | |
| HY-RI01285 | hsa-miR-4703-5p inhibitor | Oligonucleotides | |
| HY-RI01285A | hsa-miR-4703-5p antagomir | Oligonucleotides | |
| HY-RI01286 | hsa-miR-4704-3p inhibitor | Oligonucleotides | |
| HY-RI01286A | hsa-miR-4704-3p antagomir | Oligonucleotides | |
| HY-RI01287 | hsa-miR-4704-5p inhibitor | Oligonucleotides | |
| HY-RI01287A | hsa-miR-4704-5p antagomir | Oligonucleotides | |
| HY-RI01288 | hsa-miR-4705 inhibitor | Oligonucleotides | |
| HY-RI01288A | hsa-miR-4705 antagomir | Oligonucleotides | |
| HY-RI01289 | hsa-miR-4706 inhibitor | Oligonucleotides | |
| HY-RI01289A | hsa-miR-4706 antagomir | Oligonucleotides | |
| HY-RI01290 | hsa-miR-4707-3p inhibitor | Oligonucleotides | |
| HY-RI01290A | hsa-miR-4707-3p antagomir | Oligonucleotides | |
| HY-RI01291 | hsa-miR-4707-5p inhibitor | Oligonucleotides | |
| HY-RI01291A | hsa-miR-4707-5p antagomir | Oligonucleotides | |
| HY-RI01292 | hsa-miR-4708-3p inhibitor | Oligonucleotides | |
| HY-RI01292A | hsa-miR-4708-3p antagomir | Oligonucleotides | |
| HY-RI01293 | hsa-miR-4708-5p inhibitor | Oligonucleotides | |
| HY-RI01293A | hsa-miR-4708-5p antagomir | Oligonucleotides | |
| HY-RI01294 | hsa-miR-4709-3p inhibitor | Oligonucleotides | |
| HY-RI01294A | hsa-miR-4709-3p antagomir | Oligonucleotides | |
| HY-RI01295 | hsa-miR-4709-5p inhibitor | Oligonucleotides | |
| HY-RI01295A | hsa-miR-4709-5p antagomir | Oligonucleotides | |
| HY-RI01296 | hsa-miR-4710 inhibitor | Oligonucleotides | |
| HY-RI01296A | hsa-miR-4710 antagomir | Oligonucleotides | |
| HY-RI01297 | hsa-miR-4711-3p inhibitor | Oligonucleotides | |
| HY-RI01297A | hsa-miR-4711-3p antagomir | Oligonucleotides | |
| HY-RI01298 | hsa-miR-4711-5p inhibitor | Oligonucleotides | |
| HY-RI01298A | hsa-miR-4711-5p antagomir | Oligonucleotides | |
| HY-RI01299 | hsa-miR-4712-3p inhibitor | Oligonucleotides | |
| HY-RI01299A | hsa-miR-4712-3p antagomir | Oligonucleotides | |
| HY-RI01300 | hsa-miR-4712-5p inhibitor | Oligonucleotides | |
| HY-RI01300A | hsa-miR-4712-5p antagomir | Oligonucleotides | |
| HY-RI01301 | hsa-miR-4713-3p inhibitor | Oligonucleotides | |
| HY-RI01301A | hsa-miR-4713-3p antagomir | Oligonucleotides | |
| HY-RI01302 | hsa-miR-4713-5p inhibitor | Oligonucleotides | |
| HY-RI01302A | hsa-miR-4713-5p antagomir | Oligonucleotides | |
| HY-RI01303 | hsa-miR-4714-3p inhibitor | Oligonucleotides | |
| HY-RI01303A | hsa-miR-4714-3p antagomir | Oligonucleotides | |
| HY-RI01304 | hsa-miR-4715-3p inhibitor | Oligonucleotides | |
| HY-RI01304A | hsa-miR-4715-3p antagomir | Oligonucleotides | |
| HY-RI01305 | hsa-miR-4715-5p inhibitor | Oligonucleotides | |
| HY-RI01305A | hsa-miR-4715-5p antagomir | Oligonucleotides | |
| HY-RI01306 | hsa-miR-4716-3p inhibitor | Oligonucleotides | |
| HY-RI01306A | hsa-miR-4716-3p antagomir | Oligonucleotides | |
| HY-RI01307 | hsa-miR-4716-5p inhibitor | Oligonucleotides | |
| HY-RI01307A | hsa-miR-4716-5p antagomir | Oligonucleotides | |
| HY-RI01308 | hsa-miR-4717-3p inhibitor | Oligonucleotides | |
| HY-RI01308A | hsa-miR-4717-3p antagomir | Oligonucleotides | |
| HY-RI01309 | hsa-miR-4717-5p inhibitor | Oligonucleotides | |
| HY-RI01309A | hsa-miR-4717-5p antagomir | Oligonucleotides | |
| HY-RI01310 | hsa-miR-4718 inhibitor | Oligonucleotides | |
| HY-RI01310A | hsa-miR-4718 antagomir | Oligonucleotides | |
| HY-RI01311 | hsa-miR-4719 inhibitor | Oligonucleotides | |
| HY-RI01311A | hsa-miR-4719 antagomir | Oligonucleotides | |
| HY-RI01312 | hsa-miR-4720-3p inhibitor | Oligonucleotides | |
| HY-RI01312A | hsa-miR-4720-3p antagomir | Oligonucleotides | |
| HY-RI01313 | hsa-miR-4720-5p inhibitor | Oligonucleotides | |
| HY-RI01313A | hsa-miR-4720-5p antagomir | Oligonucleotides | |
| HY-RI01314 | hsa-miR-4721 inhibitor | Oligonucleotides | |
| HY-RI01314A | hsa-miR-4721 antagomir | Oligonucleotides | |
| HY-RI01315 | hsa-miR-4722-3p inhibitor | Oligonucleotides | |
| HY-RI01315A | hsa-miR-4722-3p antagomir | Oligonucleotides | |
| HY-RI01316 | hsa-miR-4722-5p inhibitor | Oligonucleotides | |
| HY-RI01316A | hsa-miR-4722-5p antagomir | Oligonucleotides | |
| HY-RI01317 | hsa-miR-4723-3p inhibitor | Oligonucleotides | |
| HY-RI01317A | hsa-miR-4723-3p antagomir | Oligonucleotides | |
| HY-RI01318 | hsa-miR-4723-5p inhibitor | Oligonucleotides | |
| HY-RI01318A | hsa-miR-4723-5p antagomir | Oligonucleotides | |
| HY-RI01319 | hsa-miR-4724-3p inhibitor | Oligonucleotides | |
| HY-RI01319A | hsa-miR-4724-3p antagomir | Oligonucleotides | |
| HY-RI01320 | hsa-miR-4724-5p inhibitor | Oligonucleotides | |
| HY-RI01320A | hsa-miR-4724-5p antagomir | Oligonucleotides | |
| HY-RI01321 | hsa-miR-4725-3p inhibitor | Oligonucleotides | |
| HY-RI01321A | hsa-miR-4725-3p antagomir | Oligonucleotides | |
| HY-RI01322 | hsa-miR-4725-5p inhibitor | Oligonucleotides | |
| HY-RI01322A | hsa-miR-4725-5p antagomir | Oligonucleotides | |
| HY-RI01323 | hsa-miR-4726-3p inhibitor | Oligonucleotides | |
| HY-RI01323A | hsa-miR-4726-3p antagomir | Oligonucleotides | |
| HY-RI01324 | hsa-miR-4726-5p inhibitor | Oligonucleotides | |
| HY-RI01324A | hsa-miR-4726-5p antagomir | Oligonucleotides | |
| HY-RI01325 | hsa-miR-4727-3p inhibitor | Oligonucleotides | |
| HY-RI01325A | hsa-miR-4727-3p antagomir | Oligonucleotides | |
| HY-RI01326 | hsa-miR-4727-5p inhibitor | Oligonucleotides | |
| HY-RI01326A | hsa-miR-4727-5p antagomir | Oligonucleotides | |
| HY-RI01327 | hsa-miR-4728-3p inhibitor | Oligonucleotides | |
| HY-RI01327A | hsa-miR-4728-3p antagomir | Oligonucleotides | |
| HY-RI01328 | hsa-miR-4728-5p inhibitor | Oligonucleotides | |
| HY-RI01328A | hsa-miR-4728-5p antagomir | Oligonucleotides | |
| HY-RI01329 | hsa-miR-4729 inhibitor | Oligonucleotides | |
| HY-RI01329A | hsa-miR-4729 antagomir | Oligonucleotides | |
| HY-RI01330 | hsa-miR-4730 inhibitor | Oligonucleotides | |
| HY-RI01330A | hsa-miR-4730 antagomir | Oligonucleotides | |
| HY-RI01331 | hsa-miR-4731-3p inhibitor | Oligonucleotides | |
| HY-RI01331A | hsa-miR-4731-3p antagomir | Oligonucleotides | |
| HY-RI01332 | hsa-miR-4731-5p inhibitor | Oligonucleotides | |
| HY-RI01332A | hsa-miR-4731-5p antagomir | Oligonucleotides | |
| HY-RI01333 | hsa-miR-4732-3p inhibitor | Oligonucleotides | |
| HY-RI01333A | hsa-miR-4732-3p antagomir | Oligonucleotides | |
| HY-RI01334 | hsa-miR-4732-5p inhibitor | Oligonucleotides | |
| HY-RI01334A | hsa-miR-4732-5p antagomir | Oligonucleotides | |
| HY-RI01335 | hsa-miR-4733-3p inhibitor | Oligonucleotides | |
| HY-RI01335A | hsa-miR-4733-3p antagomir | Oligonucleotides | |
| HY-RI01336 | hsa-miR-4733-5p inhibitor | Oligonucleotides | |
| HY-RI01336A | hsa-miR-4733-5p antagomir | Oligonucleotides | |
| HY-RI01337 | hsa-miR-4734 inhibitor | Oligonucleotides | |
| HY-RI01337A | hsa-miR-4734 antagomir | Oligonucleotides | |
| HY-RI01338 | hsa-miR-4735-3p inhibitor | Oligonucleotides | |
| HY-RI01338A | hsa-miR-4735-3p antagomir | Oligonucleotides | |
| HY-RI01339 | hsa-miR-4735-5p inhibitor | Oligonucleotides | |
| HY-RI01339A | hsa-miR-4735-5p antagomir | Oligonucleotides | |
| HY-RI01340 | hsa-miR-4736 inhibitor | Oligonucleotides | |
| HY-RI01340A | hsa-miR-4736 antagomir | Oligonucleotides | |
| HY-RI01341 | hsa-miR-4737 inhibitor | Oligonucleotides | |
| HY-RI01341A | hsa-miR-4737 antagomir | Oligonucleotides | |
| HY-RI01342 | hsa-miR-4738-3p inhibitor | Oligonucleotides | |
| HY-RI01342A | hsa-miR-4738-3p antagomir | Oligonucleotides | |
| HY-RI01343 | hsa-miR-4738-5p inhibitor | Oligonucleotides | |
| HY-RI01343A | hsa-miR-4738-5p antagomir | Oligonucleotides | |
| HY-RI01344 | hsa-miR-4739 inhibitor | Oligonucleotides | |
| HY-RI01344A | hsa-miR-4739 antagomir | Oligonucleotides | |
| HY-RI01345 | hsa-miR-4740-3p inhibitor | Oligonucleotides | |
| HY-RI01345A | hsa-miR-4740-3p antagomir | Oligonucleotides | |
| HY-RI01346 | hsa-miR-4740-5p inhibitor | Oligonucleotides | |
| HY-RI01346A | hsa-miR-4740-5p antagomir | Oligonucleotides | |
| HY-RI01347 | hsa-miR-4741 inhibitor | Oligonucleotides | |
| HY-RI01347A | hsa-miR-4741 antagomir | Oligonucleotides | |
| HY-RI01348 | hsa-miR-4742-3p inhibitor | Oligonucleotides | |
| HY-RI01348A | hsa-miR-4742-3p antagomir | Oligonucleotides | |
| HY-RI01349 | hsa-miR-4742-5p inhibitor | Oligonucleotides | |
| HY-RI01349A | hsa-miR-4742-5p antagomir | Oligonucleotides | |
| HY-RI01350 | hsa-miR-4743-3p inhibitor | Oligonucleotides | |
| HY-RI01350A | hsa-miR-4743-3p antagomir | Oligonucleotides | |
| HY-RI01351 | hsa-miR-4743-5p inhibitor | Oligonucleotides | |
| HY-RI01351A | hsa-miR-4743-5p antagomir | Oligonucleotides | |
| HY-RI01352 | hsa-miR-4744 inhibitor | Oligonucleotides | |
| HY-RI01352A | hsa-miR-4744 antagomir | Oligonucleotides | |
| HY-RI01353 | hsa-miR-4745-3p inhibitor | Oligonucleotides | |
| HY-RI01353A | hsa-miR-4745-3p antagomir | Oligonucleotides | |
| HY-RI01354 | hsa-miR-4745-5p inhibitor | Oligonucleotides | |
| HY-RI01354A | hsa-miR-4745-5p antagomir | Oligonucleotides | |
| HY-RI01355 | hsa-miR-4746-3p inhibitor | Oligonucleotides | |
| HY-RI01355A | hsa-miR-4746-3p antagomir | Oligonucleotides | |
| HY-RI01356 | hsa-miR-4746-5p inhibitor | Oligonucleotides | |
| HY-RI01356A | hsa-miR-4746-5p antagomir | Oligonucleotides | |
| HY-RI01357 | hsa-miR-4747-3p inhibitor | Oligonucleotides | |
| HY-RI01357A | hsa-miR-4747-3p antagomir | Oligonucleotides | |
| HY-RI01358 | hsa-miR-4747-5p inhibitor | Oligonucleotides | |
| HY-RI01358A | hsa-miR-4747-5p antagomir | Oligonucleotides | |
| HY-RI01359 | hsa-miR-4748 inhibitor | Oligonucleotides | |
| HY-RI01359A | hsa-miR-4748 antagomir | Oligonucleotides | |
| HY-RI01360 | hsa-miR-4749-3p inhibitor | Oligonucleotides | |
| HY-RI01360A | hsa-miR-4749-3p antagomir | Oligonucleotides | |
| HY-RI01361 | hsa-miR-4749-5p inhibitor | Oligonucleotides | |
| HY-RI01361A | hsa-miR-4749-5p antagomir | Oligonucleotides | |
| HY-RI01362 | hsa-miR-4750-3p inhibitor | Oligonucleotides | |
| HY-RI01362A | hsa-miR-4750-3p antagomir | Oligonucleotides | |
| HY-RI01363 | hsa-miR-4750-5p inhibitor | Oligonucleotides | |
| HY-RI01363A | hsa-miR-4750-5p antagomir | Oligonucleotides | |
| HY-RI01364 | hsa-miR-4751 inhibitor | Oligonucleotides | |
| HY-RI01364A | hsa-miR-4751 antagomir | Oligonucleotides | |
| HY-RI01365 | hsa-miR-4752 inhibitor | Oligonucleotides | |
| HY-RI01365A | hsa-miR-4752 antagomir | Oligonucleotides | |
| HY-RI01366 | hsa-miR-4753-3p inhibitor | Oligonucleotides | |
| HY-RI01366A | hsa-miR-4753-3p antagomir | Oligonucleotides | |
| HY-RI01367 | hsa-miR-4753-5p inhibitor | Oligonucleotides | |
| HY-RI01367A | hsa-miR-4753-5p antagomir | Oligonucleotides | |
| HY-RI01368 | hsa-miR-4754 inhibitor | Oligonucleotides | |
| HY-RI01368A | hsa-miR-4754 antagomir | Oligonucleotides | |
| HY-RI01369 | hsa-miR-4755-3p inhibitor | Oligonucleotides | |
| HY-RI01369A | hsa-miR-4755-3p antagomir | Oligonucleotides | |
| HY-RI01370 | hsa-miR-4755-5p inhibitor | Oligonucleotides | |
| HY-RI01370A | hsa-miR-4755-5p antagomir | Oligonucleotides | |
| HY-RI01371 | hsa-miR-4756-3p inhibitor | Oligonucleotides | |
| HY-RI01371A | hsa-miR-4756-3p antagomir | Oligonucleotides | |
| HY-RI01372 | hsa-miR-4756-5p inhibitor | Oligonucleotides | |
| HY-RI01372A | hsa-miR-4756-5p antagomir | Oligonucleotides | |
| HY-RI01373 | hsa-miR-4757-3p inhibitor | Oligonucleotides | |
| HY-RI01373A | hsa-miR-4757-3p antagomir | Oligonucleotides | |
| HY-RI01374 | hsa-miR-4757-5p inhibitor | Oligonucleotides | |
| HY-RI01374A | hsa-miR-4757-5p antagomir | Oligonucleotides | |
| HY-RI01375 | hsa-miR-4758-3p inhibitor | Oligonucleotides | |
| HY-RI01375A | hsa-miR-4758-3p antagomir | Oligonucleotides | |
| HY-RI01376 | hsa-miR-4758-5p inhibitor | Oligonucleotides | |
| HY-RI01376A | hsa-miR-4758-5p antagomir | Oligonucleotides | |
| HY-RI01377 | hsa-miR-4759 inhibitor | Oligonucleotides | |
| HY-RI01377A | hsa-miR-4759 antagomir | Oligonucleotides | |
| HY-RI01378 | hsa-miR-4760-3p inhibitor | Oligonucleotides | |
| HY-RI01378A | hsa-miR-4760-3p antagomir | Oligonucleotides | |
| HY-RI01379 | hsa-miR-4760-5p inhibitor | Oligonucleotides | |
| HY-RI01379A | hsa-miR-4760-5p antagomir | Oligonucleotides | |
| HY-RI01380 | hsa-miR-4761-3p inhibitor | Oligonucleotides | |
| HY-RI01380A | hsa-miR-4761-3p antagomir | Oligonucleotides | |
| HY-RI01381 | hsa-miR-4761-5p inhibitor | Oligonucleotides | |
| HY-RI01381A | hsa-miR-4761-5p antagomir | Oligonucleotides | |
| HY-RI01382 | hsa-miR-4762-3p inhibitor | Oligonucleotides | |
| HY-RI01382A | hsa-miR-4762-3p antagomir | Oligonucleotides | |
| HY-RI01383 | hsa-miR-4762-5p inhibitor | Oligonucleotides | |
| HY-RI01383A | hsa-miR-4762-5p antagomir | Oligonucleotides | |
| HY-RI01384 | hsa-miR-4763-3p inhibitor | Oligonucleotides | |
| HY-RI01384A | hsa-miR-4763-3p antagomir | Oligonucleotides | |
| HY-RI01385 | hsa-miR-4763-5p inhibitor | Oligonucleotides | |
| HY-RI01385A | hsa-miR-4763-5p antagomir | Oligonucleotides | |
| HY-RI01386 | hsa-miR-4764-3p inhibitor | Oligonucleotides | |
| HY-RI01386A | hsa-miR-4764-3p antagomir | Oligonucleotides | |
| HY-RI01387 | hsa-miR-4764-5p inhibitor | Oligonucleotides | |
| HY-RI01387A | hsa-miR-4764-5p antagomir | Oligonucleotides | |
| HY-RI01388 | hsa-miR-4765 inhibitor | Oligonucleotides | |
| HY-RI01388A | hsa-miR-4765 antagomir | Oligonucleotides | |
| HY-RI01389 | hsa-miR-4766-3p inhibitor | Oligonucleotides | |
| HY-RI01389A | hsa-miR-4766-3p antagomir | Oligonucleotides | |
| HY-RI01390 | hsa-miR-4766-5p inhibitor | Oligonucleotides | |
| HY-RI01390A | hsa-miR-4766-5p antagomir | Oligonucleotides | |
| HY-RI01391 | hsa-miR-4767 inhibitor | Oligonucleotides | |
| HY-RI01391A | hsa-miR-4767 antagomir | Oligonucleotides | |
| HY-RI01392 | hsa-miR-4768-3p inhibitor | Oligonucleotides | |
| HY-RI01392A | hsa-miR-4768-3p antagomir | Oligonucleotides | |
| HY-RI01393 | hsa-miR-4768-5p inhibitor | Oligonucleotides | |
| HY-RI01393A | hsa-miR-4768-5p antagomir | Oligonucleotides | |
| HY-RI01394 | hsa-miR-4769-3p inhibitor | Oligonucleotides | |
| HY-RI01394A | hsa-miR-4769-3p antagomir | Oligonucleotides | |
| HY-RI01395 | hsa-miR-4769-5p inhibitor | Oligonucleotides | |
| HY-RI01395A | hsa-miR-4769-5p antagomir | Oligonucleotides | |
| HY-RI01396 | hsa-miR-4770 inhibitor | Oligonucleotides | |
| HY-RI01396A | hsa-miR-4770 antagomir | Oligonucleotides | |
| HY-RI01397 | hsa-miR-4771 inhibitor | Oligonucleotides | |
| HY-RI01397A | hsa-miR-4771 antagomir | Oligonucleotides | |
| HY-RI01398 | hsa-miR-4772-3p inhibitor | Oligonucleotides | |
| HY-RI01398A | hsa-miR-4772-3p antagomir | Oligonucleotides | |
| HY-RI01399 | hsa-miR-4772-5p inhibitor | Oligonucleotides | |
| HY-RI01399A | hsa-miR-4772-5p antagomir | Oligonucleotides | |
| HY-RI01400 | hsa-miR-4773 inhibitor | Oligonucleotides | |
| HY-RI01400A | hsa-miR-4773 antagomir | Oligonucleotides | |
| HY-RI01401 | hsa-miR-4774-3p inhibitor | Oligonucleotides | |
| HY-RI01401A | hsa-miR-4774-3p antagomir | Oligonucleotides | |
| HY-RI01402 | hsa-miR-4774-5p inhibitor | Oligonucleotides | |
| HY-RI01402A | hsa-miR-4774-5p antagomir | Oligonucleotides | |
| HY-RI01403 | hsa-miR-4775 inhibitor | Oligonucleotides | |
| HY-RI01403A | hsa-miR-4775 antagomir | Oligonucleotides | |
| HY-RI01404 | hsa-miR-4776-3p inhibitor | Oligonucleotides | |
| HY-RI01404A | hsa-miR-4776-3p antagomir | Oligonucleotides | |
| HY-RI01405 | hsa-miR-4776-5p inhibitor | Oligonucleotides | |
| HY-RI01405A | hsa-miR-4776-5p antagomir | Oligonucleotides | |
| HY-RI01406 | hsa-miR-4777-3p inhibitor | Oligonucleotides | |
| HY-RI01406A | hsa-miR-4777-3p antagomir | Oligonucleotides | |
| HY-RI01407 | hsa-miR-4777-5p inhibitor | Oligonucleotides | |
| HY-RI01407A | hsa-miR-4777-5p antagomir | Oligonucleotides | |
| HY-RI01408 | hsa-miR-4778-3p inhibitor | Oligonucleotides | |
| HY-RI01408A | hsa-miR-4778-3p antagomir | Oligonucleotides | |
| HY-RI01409 | hsa-miR-4778-5p inhibitor | Oligonucleotides | |
| HY-RI01409A | hsa-miR-4778-5p antagomir | Oligonucleotides | |
| HY-RI01410 | hsa-miR-4779 inhibitor | Oligonucleotides | |
| HY-RI01410A | hsa-miR-4779 antagomir | Oligonucleotides | |
| HY-RI01411 | hsa-miR-4780 inhibitor | Oligonucleotides | |
| HY-RI01411A | hsa-miR-4780 antagomir | Oligonucleotides | |
| HY-RI01412 | hsa-miR-4781-3p inhibitor | Oligonucleotides | |
| HY-RI01412A | hsa-miR-4781-3p antagomir | Oligonucleotides | |
| HY-RI01413 | hsa-miR-4781-5p inhibitor | Oligonucleotides | |
| HY-RI01413A | hsa-miR-4781-5p antagomir | Oligonucleotides | |
| HY-RI01414 | hsa-miR-4782-3p inhibitor | Oligonucleotides | |
| HY-RI01414A | hsa-miR-4782-3p antagomir | Oligonucleotides | |
| HY-RI01415 | hsa-miR-4782-5p inhibitor | Oligonucleotides | |
| HY-RI01415A | hsa-miR-4782-5p antagomir | Oligonucleotides | |
| HY-RI01416 | hsa-miR-4783-3p inhibitor | Oligonucleotides | |
| HY-RI01416A | hsa-miR-4783-3p antagomir | Oligonucleotides | |
| HY-RI01417 | hsa-miR-4783-5p inhibitor | Oligonucleotides | |
| HY-RI01417A | hsa-miR-4783-5p antagomir | Oligonucleotides | |
| HY-RI01418 | hsa-miR-4784 inhibitor | Oligonucleotides | |
| HY-RI01418A | hsa-miR-4784 antagomir | Oligonucleotides | |
| HY-RI01419 | hsa-miR-4785 inhibitor | Oligonucleotides | |
| HY-RI01419A | hsa-miR-4785 antagomir | Oligonucleotides | |
| HY-RI01420 | hsa-miR-4786-3p inhibitor | Oligonucleotides | |
| HY-RI01420A | hsa-miR-4786-3p antagomir | Oligonucleotides | |
| HY-RI01421 | hsa-miR-4786-5p inhibitor | Oligonucleotides | |
| HY-RI01421A | hsa-miR-4786-5p antagomir | Oligonucleotides | |
| HY-RI01422 | hsa-miR-4787-3p inhibitor | Oligonucleotides | |
| HY-RI01422A | hsa-miR-4787-3p antagomir | Oligonucleotides | |
| HY-RI01423 | hsa-miR-4787-5p inhibitor | Oligonucleotides | |
| HY-RI01423A | hsa-miR-4787-5p antagomir | Oligonucleotides | |
| HY-RI01424 | hsa-miR-4788 inhibitor | Oligonucleotides | |
| HY-RI01424A | hsa-miR-4788 antagomir | Oligonucleotides | |
| HY-RI01425 | hsa-miR-4789-3p inhibitor | Oligonucleotides | |
| HY-RI01425A | hsa-miR-4789-3p antagomir | Oligonucleotides | |
| HY-RI01426 | hsa-miR-4789-5p inhibitor | Oligonucleotides | |
| HY-RI01426A | hsa-miR-4789-5p antagomir | Oligonucleotides | |
| HY-RI01427 | hsa-miR-4790-3p inhibitor | Oligonucleotides | |
| HY-RI01427A | hsa-miR-4790-3p antagomir | Oligonucleotides | |
| HY-RI01428 | hsa-miR-4790-5p inhibitor | Oligonucleotides | |
| HY-RI01428A | hsa-miR-4790-5p antagomir | Oligonucleotides | |
| HY-RI01429 | hsa-miR-4791 inhibitor | Oligonucleotides | |
| HY-RI01429A | hsa-miR-4791 antagomir | Oligonucleotides | |
| HY-RI01430 | hsa-miR-4793-3p inhibitor | Oligonucleotides | |
| HY-RI01430A | hsa-miR-4793-3p antagomir | Oligonucleotides | |
| HY-RI01431 | hsa-miR-4793-5p inhibitor | Oligonucleotides | |
| HY-RI01431A | hsa-miR-4793-5p antagomir | Oligonucleotides | |
| HY-RI01432 | hsa-miR-4794 inhibitor | Oligonucleotides | |
| HY-RI01432A | hsa-miR-4794 antagomir | Oligonucleotides | |
| HY-RI01433 | hsa-miR-4795-3p inhibitor | Oligonucleotides | |
| HY-RI01433A | hsa-miR-4795-3p antagomir | Oligonucleotides | |
| HY-RI01434 | hsa-miR-4795-5p inhibitor | Oligonucleotides | |
| HY-RI01434A | hsa-miR-4795-5p antagomir | Oligonucleotides | |
| HY-RI01435 | hsa-miR-4796-3p inhibitor | Oligonucleotides | |
| HY-RI01435A | hsa-miR-4796-3p antagomir | Oligonucleotides | |
| HY-RI01436 | hsa-miR-4796-5p inhibitor | Oligonucleotides | |
| HY-RI01436A | hsa-miR-4796-5p antagomir | Oligonucleotides | |
| HY-RI01437 | hsa-miR-4797-3p inhibitor | Oligonucleotides | |
| HY-RI01437A | hsa-miR-4797-3p antagomir | Oligonucleotides | |
| HY-RI01438 | hsa-miR-4797-5p inhibitor | Oligonucleotides | |
| HY-RI01438A | hsa-miR-4797-5p antagomir | Oligonucleotides | |
| HY-RI01439 | hsa-miR-4798-3p inhibitor | Oligonucleotides | |
| HY-RI01439A | hsa-miR-4798-3p antagomir | Oligonucleotides | |
| HY-RI01440 | hsa-miR-4798-5p inhibitor | Oligonucleotides | |
| HY-RI01440A | hsa-miR-4798-5p antagomir | Oligonucleotides | |
| HY-RI01441 | hsa-miR-4799-3p inhibitor | Oligonucleotides | |
| HY-RI01441A | hsa-miR-4799-3p antagomir | Oligonucleotides | |
| HY-RI01442 | hsa-miR-4799-5p inhibitor | Oligonucleotides | |
| HY-RI01442A | hsa-miR-4799-5p antagomir | Oligonucleotides | |
| HY-RI01443 | hsa-miR-4800-3p inhibitor | Oligonucleotides | |
| HY-RI01443A | hsa-miR-4800-3p antagomir | Oligonucleotides | |
| HY-RI01444 | hsa-miR-4800-5p inhibitor | Oligonucleotides | |
| HY-RI01444A | hsa-miR-4800-5p antagomir | Oligonucleotides | |
| HY-RI01445 | hsa-miR-4801 inhibitor | Oligonucleotides | |
| HY-RI01445A | hsa-miR-4801 antagomir | Oligonucleotides | |
| HY-RI01446 | hsa-miR-4802-3p inhibitor | Oligonucleotides | |
| HY-RI01446A | hsa-miR-4802-3p antagomir | Oligonucleotides | |
| HY-RI01447 | hsa-miR-4802-5p inhibitor | Oligonucleotides | |
| HY-RI01447A | hsa-miR-4802-5p antagomir | Oligonucleotides | |
| HY-RI01448 | hsa-miR-4803 inhibitor | Oligonucleotides | |
| HY-RI01448A | hsa-miR-4803 antagomir | Oligonucleotides | |
| HY-RI01449 | hsa-miR-4804-3p inhibitor | Oligonucleotides | |
| HY-RI01449A | hsa-miR-4804-3p antagomir | Oligonucleotides | |
| HY-RI01450 | hsa-miR-4804-5p inhibitor | Oligonucleotides | |
| HY-RI01450A | hsa-miR-4804-5p antagomir | Oligonucleotides | |
| HY-RI01451 | hsa-miR-483-3p inhibitor | Oligonucleotides | |
| HY-RI01451A | hsa-miR-483-3p antagomir | Oligonucleotides | |
| HY-RI01452 | hsa-miR-483-5p inhibitor | Oligonucleotides | |
| HY-RI01452A | hsa-miR-483-5p antagomir | Oligonucleotides | |
| HY-RI01453 | hsa-miR-484 inhibitor | Oligonucleotides | |
| HY-RI01453A | hsa-miR-484 antagomir | Oligonucleotides | |
| HY-RI01454 | hsa-miR-485-3p inhibitor | Oligonucleotides | |
| HY-RI01454A | hsa-miR-485-3p antagomir | Oligonucleotides | |
| HY-RI01455 | hsa-miR-485-5p inhibitor | Oligonucleotides | |
| HY-RI01455A | hsa-miR-485-5p antagomir | Oligonucleotides | |
| HY-RI01456 | hsa-miR-486-3p inhibitor | Oligonucleotides | |
| HY-RI01456A | hsa-miR-486-3p antagomir | Oligonucleotides | |
| HY-RI01457 | hsa-miR-486-5p inhibitor | Oligonucleotides | |
| HY-RI01457A | hsa-miR-486-5p antagomir | Oligonucleotides | |
| HY-RI01458 | hsa-miR-487a-3p inhibitor | Oligonucleotides | |
| HY-RI01458A | hsa-miR-487a-3p antagomir | Oligonucleotides | |
| HY-RI01459 | hsa-miR-487a-5p inhibitor | Oligonucleotides | |
| HY-RI01459A | hsa-miR-487a-5p antagomir | Oligonucleotides | |
| HY-RI01460 | hsa-miR-487b-3p inhibitor | Oligonucleotides | |
| HY-RI01460A | hsa-miR-487b-3p antagomir | Oligonucleotides | |
| HY-RI01461 | hsa-miR-487b-5p inhibitor | Oligonucleotides | |
| HY-RI01461A | hsa-miR-487b-5p antagomir | Oligonucleotides | |
| HY-RI01462 | hsa-miR-488-3p inhibitor | Oligonucleotides | |
| HY-RI01462A | hsa-miR-488-3p antagomir | Oligonucleotides | |
| HY-RI01463 | hsa-miR-488-5p inhibitor | Oligonucleotides | |
| HY-RI01463A | hsa-miR-488-5p antagomir | Oligonucleotides | |
| HY-RI01464 | hsa-miR-489-5p inhibitor | Oligonucleotides | |
| HY-RI01464A | hsa-miR-489-5p antagomir | Oligonucleotides | |
| HY-RI01465 | hsa-miR-490-5p inhibitor | Oligonucleotides | |
| HY-RI01465A | hsa-miR-490-5p antagomir | Oligonucleotides | |
| HY-RI01466 | hsa-miR-491-5p inhibitor | Oligonucleotides | |
| HY-RI01466A | hsa-miR-491-5p antagomir | Oligonucleotides | |
| HY-RI01467 | hsa-miR-492 inhibitor | Oligonucleotides | |
| HY-RI01467A | hsa-miR-492 antagomir | Oligonucleotides | |
| HY-RI01468 | hsa-miR-493-3p inhibitor | Oligonucleotides | |
| HY-RI01468A | hsa-miR-493-3p antagomir | Oligonucleotides | |
| HY-RI01469 | hsa-miR-493-5p inhibitor | Oligonucleotides | |
| HY-RI01469A | hsa-miR-493-5p antagomir | Oligonucleotides | |
| HY-RI01470 | hsa-miR-494-3p inhibitor | Oligonucleotides | |
| HY-RI01470A | hsa-miR-494-3p antagomir | Oligonucleotides | |
| HY-RI01471 | hsa-miR-494-5p inhibitor | Oligonucleotides | |
| HY-RI01471A | hsa-miR-494-5p antagomir | Oligonucleotides | |
| HY-RI01472 | hsa-miR-495-3p inhibitor | Oligonucleotides | |
| HY-RI01472A | hsa-miR-495-3p antagomir | Oligonucleotides | |
| HY-RI01473 | hsa-miR-495-5p inhibitor | Oligonucleotides | |
| HY-RI01473A | hsa-miR-495-5p antagomir | Oligonucleotides | |
| HY-RI01474 | hsa-miR-496 inhibitor | Oligonucleotides | |
| HY-RI01474A | hsa-miR-496 antagomir | Oligonucleotides | |
| HY-RI01475 | hsa-miR-497-3p inhibitor | Oligonucleotides | |
| HY-RI01475A | hsa-miR-497-3p antagomir | Oligonucleotides | |
| HY-RI01476 | hsa-miR-497-5p inhibitor | Oligonucleotides | |
| HY-RI01476A | hsa-miR-497-5p antagomir | Oligonucleotides | |
| HY-RI01477 | hsa-miR-498-3p inhibitor | Oligonucleotides | |
| HY-RI01477A | hsa-miR-498-3p antagomir | Oligonucleotides | |
| HY-RI01478 | hsa-miR-498-5p inhibitor | Oligonucleotides | |
| HY-RI01478A | hsa-miR-498-5p antagomir | Oligonucleotides | |
| HY-RI01479 | hsa-miR-4999-3p inhibitor | Oligonucleotides | |
| HY-RI01479A | hsa-miR-4999-3p antagomir | Oligonucleotides | |
| HY-RI01480 | hsa-miR-4999-5p inhibitor | Oligonucleotides | |
| HY-RI01480A | hsa-miR-4999-5p antagomir | Oligonucleotides | |
| HY-RI01481 | hsa-miR-499a-3p inhibitor | Oligonucleotides | |
| HY-RI01481A | hsa-miR-499a-3p antagomir | Oligonucleotides | |
| HY-RI01482 | hsa-miR-499a-5p inhibitor | Oligonucleotides | |
| HY-RI01482A | hsa-miR-499a-5p antagomir | Oligonucleotides | |
| HY-RI01483 | hsa-miR-499b-3p inhibitor | Oligonucleotides | |
| HY-RI01483A | hsa-miR-499b-3p antagomir | Oligonucleotides | |
| HY-RI01484 | hsa-miR-499b-5p inhibitor | Oligonucleotides | |
| HY-RI01484A | hsa-miR-499b-5p antagomir | Oligonucleotides | |
| HY-RI01485 | hsa-miR-5000-3p inhibitor | Oligonucleotides | |
| HY-RI01485A | hsa-miR-5000-3p antagomir | Oligonucleotides | |
| HY-RI01486 | hsa-miR-5000-5p inhibitor | Oligonucleotides | |
| HY-RI01486A | hsa-miR-5000-5p antagomir | Oligonucleotides | |
| HY-RI01487 | hsa-miR-5001-3p inhibitor | Oligonucleotides | |
| HY-RI01487A | hsa-miR-5001-3p antagomir | Oligonucleotides | |
| HY-RI01488 | hsa-miR-5001-5p inhibitor | Oligonucleotides | |
| HY-RI01488A | hsa-miR-5001-5p antagomir | Oligonucleotides | |
| HY-RI01489 | hsa-miR-5002-3p inhibitor | Oligonucleotides | |
| HY-RI01489A | hsa-miR-5002-3p antagomir | Oligonucleotides | |
| HY-RI01490 | hsa-miR-5002-5p inhibitor | Oligonucleotides | |
| HY-RI01490A | hsa-miR-5002-5p antagomir | Oligonucleotides | |
| HY-RI01491 | hsa-miR-5003-3p inhibitor | Oligonucleotides | |
| HY-RI01491A | hsa-miR-5003-3p antagomir | Oligonucleotides | |
| HY-RI01492 | hsa-miR-5003-5p inhibitor | Oligonucleotides | |
| HY-RI01492A | hsa-miR-5003-5p antagomir | Oligonucleotides | |
| HY-RI01493 | hsa-miR-5004-3p inhibitor | Oligonucleotides | |
| HY-RI01493A | hsa-miR-5004-3p antagomir | Oligonucleotides | |
| HY-RI01494 | hsa-miR-5004-5p inhibitor | Oligonucleotides | |
| HY-RI01494A | hsa-miR-5004-5p antagomir | Oligonucleotides | |
| HY-RI01495 | hsa-miR-5006-3p inhibitor | Oligonucleotides | |
| HY-RI01495A | hsa-miR-5006-3p antagomir | Oligonucleotides | |
| HY-RI01496 | hsa-miR-5006-5p inhibitor | Oligonucleotides | |
| HY-RI01496A | hsa-miR-5006-5p antagomir | Oligonucleotides | |
| HY-RI01497 | hsa-miR-5007-3p inhibitor | Oligonucleotides | |
| HY-RI01497A | hsa-miR-5007-3p antagomir | Oligonucleotides | |
| HY-RI01498 | hsa-miR-5007-5p inhibitor | Oligonucleotides | |
| HY-RI01498A | hsa-miR-5007-5p antagomir | Oligonucleotides | |
| HY-RI01499 | hsa-miR-5008-3p inhibitor | Oligonucleotides | |
| HY-RI01499A | hsa-miR-5008-3p antagomir | Oligonucleotides | |
| HY-RI01500 | hsa-miR-5008-5p inhibitor | Oligonucleotides | |
| HY-RI01500A | hsa-miR-5008-5p antagomir | Oligonucleotides | |
| HY-RI01501 | hsa-miR-5009-3p inhibitor | Oligonucleotides | |
| HY-RI01501A | hsa-miR-5009-3p antagomir | Oligonucleotides | |
| HY-RI01502 | hsa-miR-5009-5p inhibitor | Oligonucleotides | |
| HY-RI01502A | hsa-miR-5009-5p antagomir | Oligonucleotides | |
| HY-RI01503 | hsa-miR-500a-3p inhibitor | Oligonucleotides | |
| HY-RI01503A | hsa-miR-500a-3p antagomir | Oligonucleotides | |
| HY-RI01504 | hsa-miR-500b-3p inhibitor | Oligonucleotides | |
| HY-RI01504A | hsa-miR-500b-3p antagomir | Oligonucleotides | |
| HY-RI01505 | hsa-miR-500b-5p inhibitor | Oligonucleotides | |
| HY-RI01505A | hsa-miR-500b-5p antagomir | Oligonucleotides | |
| HY-RI01506 | hsa-miR-5010-3p inhibitor | Oligonucleotides | |
| HY-RI01506A | hsa-miR-5010-3p antagomir | Oligonucleotides | |
| HY-RI01507 | hsa-miR-5010-5p inhibitor | Oligonucleotides | |
| HY-RI01507A | hsa-miR-5010-5p antagomir | Oligonucleotides | |
| HY-RI01508 | hsa-miR-5011-3p inhibitor | Oligonucleotides | |
| HY-RI01508A | hsa-miR-5011-3p antagomir | Oligonucleotides | |
| HY-RI01509 | hsa-miR-5011-5p inhibitor | Oligonucleotides | |
| HY-RI01509A | hsa-miR-5011-5p antagomir | Oligonucleotides | |
| HY-RI01510 | hsa-miR-501-3p inhibitor | Oligonucleotides | |
| HY-RI01510A | hsa-miR-501-3p antagomir | Oligonucleotides | |
| HY-RI01511 | hsa-miR-501-5p inhibitor | Oligonucleotides | |
| HY-RI01511A | hsa-miR-501-5p antagomir | Oligonucleotides | |
| HY-RI01512 | hsa-miR-502-5p inhibitor | Oligonucleotides | |
| HY-RI01512A | hsa-miR-502-5p antagomir | Oligonucleotides | |
| HY-RI01513 | hsa-miR-503-3p inhibitor | Oligonucleotides | |
| HY-RI01513A | hsa-miR-503-3p antagomir | Oligonucleotides | |
| HY-RI01514 | hsa-miR-503-5p inhibitor | Oligonucleotides | |
| HY-RI01514A | hsa-miR-503-5p antagomir | Oligonucleotides | |
| HY-RI01515 | hsa-miR-5047 inhibitor | Oligonucleotides | |
| HY-RI01515A | hsa-miR-5047 antagomir | Oligonucleotides | |
| HY-RI01516 | hsa-miR-505-3p inhibitor | Oligonucleotides | |
| HY-RI01516A | hsa-miR-505-3p antagomir | Oligonucleotides | |
| HY-RI01517 | hsa-miR-505-5p inhibitor | Oligonucleotides | |
| HY-RI01517A | hsa-miR-505-5p antagomir | Oligonucleotides | |
| HY-RI01518 | hsa-miR-506-3p inhibitor | Oligonucleotides | |
| HY-RI01518A | hsa-miR-506-3p antagomir | Oligonucleotides | |
| HY-RI01519 | hsa-miR-506-5p inhibitor | Oligonucleotides | |
| HY-RI01519A | hsa-miR-506-5p antagomir | Oligonucleotides | |
| HY-RI01520 | hsa-miR-508-3p inhibitor | Oligonucleotides | |
| HY-RI01520A | hsa-miR-508-3p antagomir | Oligonucleotides | |
| HY-RI01521 | hsa-miR-508-5p inhibitor | Oligonucleotides | |
| HY-RI01521A | hsa-miR-508-5p antagomir | Oligonucleotides | |
| HY-RI01522 | hsa-miR-5087 inhibitor | Oligonucleotides | |
| HY-RI01522A | hsa-miR-5087 antagomir | Oligonucleotides | |
| HY-RI01523 | hsa-miR-5088-3p inhibitor | Oligonucleotides | |
| HY-RI01523A | hsa-miR-5088-3p antagomir | Oligonucleotides | |
| HY-RI01524 | hsa-miR-5088-5p inhibitor | Oligonucleotides | |
| HY-RI01524A | hsa-miR-5088-5p antagomir | Oligonucleotides | |
| HY-RI01525 | hsa-miR-5089-3p inhibitor | Oligonucleotides | |
| HY-RI01525A | hsa-miR-5089-3p antagomir | Oligonucleotides | |
| HY-RI01526 | hsa-miR-5089-5p inhibitor | Oligonucleotides | |
| HY-RI01526A | hsa-miR-5089-5p antagomir | Oligonucleotides | |
| HY-RI01527 | hsa-miR-5090 inhibitor | Oligonucleotides | |
| HY-RI01527A | hsa-miR-5090 antagomir | Oligonucleotides | |
| HY-RI01528 | hsa-miR-5091 inhibitor | Oligonucleotides | |
| HY-RI01528A | hsa-miR-5091 antagomir | Oligonucleotides | |
| HY-RI01529 | hsa-miR-5092 inhibitor | Oligonucleotides | |
| HY-RI01529A | hsa-miR-5092 antagomir | Oligonucleotides | |
| HY-RI01530 | hsa-miR-5093 inhibitor | Oligonucleotides | |
| HY-RI01530A | hsa-miR-5093 antagomir | Oligonucleotides | |
| HY-RI01531 | hsa-miR-509-3-5p inhibitor | Oligonucleotides | |
| HY-RI01531A | hsa-miR-509-3-5p antagomir | Oligonucleotides | |
| HY-RI01532 | hsa-miR-509-3p inhibitor | Oligonucleotides | |
| HY-RI01532A | hsa-miR-509-3p antagomir | Oligonucleotides | |
| HY-RI01533 | hsa-miR-5094 inhibitor | Oligonucleotides | |
| HY-RI01533A | hsa-miR-5094 antagomir | Oligonucleotides | |
| HY-RI01534 | hsa-miR-509-5p inhibitor | Oligonucleotides | |
| HY-RI01534A | hsa-miR-509-5p antagomir | Oligonucleotides | |
| HY-RI01535 | hsa-miR-5100 inhibitor | Oligonucleotides | |
| HY-RI01535A | hsa-miR-5100 antagomir | Oligonucleotides | |
| HY-RI01536 | hsa-miR-510-3p inhibitor | Oligonucleotides | |
| HY-RI01536A | hsa-miR-510-3p antagomir | Oligonucleotides | |
| HY-RI01537 | hsa-miR-510-5p inhibitor | Oligonucleotides | |
| HY-RI01537A | hsa-miR-510-5p antagomir | Oligonucleotides | |
| HY-RI01538 | hsa-miR-511-3p inhibitor | Oligonucleotides | |
| HY-RI01538A | hsa-miR-511-3p antagomir | Oligonucleotides | |
| HY-RI01539 | hsa-miR-511-5p inhibitor | Oligonucleotides | |
| HY-RI01539A | hsa-miR-511-5p antagomir | Oligonucleotides | |
| HY-RI01540 | hsa-miR-512-3p inhibitor | Oligonucleotides | |
| HY-RI01540A | hsa-miR-512-3p antagomir | Oligonucleotides | |
| HY-RI01541 | hsa-miR-512-5p inhibitor | Oligonucleotides | |
| HY-RI01541A | hsa-miR-512-5p antagomir | Oligonucleotides | |
| HY-RI01542 | hsa-miR-513a-3p inhibitor | Oligonucleotides | |
| HY-RI01542A | hsa-miR-513a-3p antagomir | Oligonucleotides | |
| HY-RI01543 | hsa-miR-513a-5p inhibitor | Oligonucleotides | |
| HY-RI01543A | hsa-miR-513a-5p antagomir | Oligonucleotides | |
| HY-RI01544 | hsa-miR-513b-3p inhibitor | Oligonucleotides | |
| HY-RI01544A | hsa-miR-513b-3p antagomir | Oligonucleotides | |
| HY-RI01545 | hsa-miR-513b-5p inhibitor | Oligonucleotides | |
| HY-RI01545A | hsa-miR-513b-5p antagomir | Oligonucleotides | |
| HY-RI01546 | hsa-miR-513c-3p inhibitor | Oligonucleotides | |
| HY-RI01546A | hsa-miR-513c-3p antagomir | Oligonucleotides | |
| HY-RI01547 | hsa-miR-513c-5p inhibitor | Oligonucleotides | |
| HY-RI01547A | hsa-miR-513c-5p antagomir | Oligonucleotides | |
| HY-RI01548 | hsa-miR-514a-3p inhibitor | Oligonucleotides | |
| HY-RI01548A | hsa-miR-514a-3p antagomir | Oligonucleotides | |
| HY-RI01549 | hsa-miR-514a-5p inhibitor | Oligonucleotides | |
| HY-RI01549A | hsa-miR-514a-5p antagomir | Oligonucleotides | |
| HY-RI01550 | hsa-miR-514b-3p inhibitor | Oligonucleotides | |
| HY-RI01550A | hsa-miR-514b-3p antagomir | Oligonucleotides | |
| HY-RI01551 | hsa-miR-514b-5p inhibitor | Oligonucleotides | |
| HY-RI01551A | hsa-miR-514b-5p antagomir | Oligonucleotides | |
| HY-RI01552 | hsa-miR-515-3p inhibitor | Oligonucleotides | |
| HY-RI01552A | hsa-miR-515-3p antagomir | Oligonucleotides | |
| HY-RI01553 | hsa-miR-515-5p inhibitor | Oligonucleotides | |
| HY-RI01553A | hsa-miR-515-5p antagomir | Oligonucleotides | |
| HY-RI01554 | hsa-miR-516a-3p inhibitor | Oligonucleotides | |
| HY-RI01554A | hsa-miR-516a-3p antagomir | Oligonucleotides | |
| HY-RI01555 | hsa-miR-516a-5p inhibitor | Oligonucleotides | |
| HY-RI01555A | hsa-miR-516a-5p antagomir | Oligonucleotides | |
| HY-RI01556 | hsa-miR-516b-5p inhibitor | Oligonucleotides | |
| HY-RI01556A | hsa-miR-516b-5p antagomir | Oligonucleotides | |
| HY-RI01557 | hsa-miR-517-5p inhibitor | Oligonucleotides | |
| HY-RI01557A | hsa-miR-517-5p antagomir | Oligonucleotides | |
| HY-RI01558 | hsa-miR-517a-3p inhibitor | Oligonucleotides | |
| HY-RI01558A | hsa-miR-517a-3p antagomir | Oligonucleotides | |
| HY-RI01559 | hsa-miR-5186 inhibitor | Oligonucleotides | |
| HY-RI01559A | hsa-miR-5186 antagomir | Oligonucleotides | |
| HY-RI01560 | hsa-miR-5187-3p inhibitor | Oligonucleotides | |
| HY-RI01560A | hsa-miR-5187-3p antagomir | Oligonucleotides | |
| HY-RI01561 | hsa-miR-5187-5p inhibitor | Oligonucleotides | |
| HY-RI01561A | hsa-miR-5187-5p antagomir | Oligonucleotides | |
| HY-RI01562 | hsa-miR-5188 inhibitor | Oligonucleotides | |
| HY-RI01562A | hsa-miR-5188 antagomir | Oligonucleotides | |
| HY-RI01563 | hsa-miR-5189-3p inhibitor | Oligonucleotides | |
| HY-RI01563A | hsa-miR-5189-3p antagomir | Oligonucleotides | |
| HY-RI01564 | hsa-miR-5189-5p inhibitor | Oligonucleotides | |
| HY-RI01564A | hsa-miR-5189-5p antagomir | Oligonucleotides | |
| HY-RI01565 | hsa-miR-518a-3p inhibitor | Oligonucleotides | |
| HY-RI01565A | hsa-miR-518a-3p antagomir | Oligonucleotides | |
| HY-RI01566 | hsa-miR-518a-5p inhibitor | Oligonucleotides | |
| HY-RI01566A | hsa-miR-518a-5p antagomir | Oligonucleotides | |
| HY-RI01567 | hsa-miR-518b inhibitor | Oligonucleotides | |
| HY-RI01567A | hsa-miR-518b antagomir | Oligonucleotides | |
| HY-RI01568 | hsa-miR-518c-3p inhibitor | Oligonucleotides | |
| HY-RI01568A | hsa-miR-518c-3p antagomir | Oligonucleotides | |
| HY-RI01569 | hsa-miR-518c-5p inhibitor | Oligonucleotides | |
| HY-RI01569A | hsa-miR-518c-5p antagomir | Oligonucleotides | |
| HY-RI01570 | hsa-miR-518d-3p inhibitor | Oligonucleotides | |
| HY-RI01570A | hsa-miR-518d-3p antagomir | Oligonucleotides | |
| HY-RI01571 | hsa-miR-518d-5p inhibitor | Oligonucleotides | |
| HY-RI01571A | hsa-miR-518d-5p antagomir | Oligonucleotides | |
| HY-RI01572 | hsa-miR-518e-3p inhibitor | Oligonucleotides | |
| HY-RI01572A | hsa-miR-518e-3p antagomir | Oligonucleotides | |
| HY-RI01573 | hsa-miR-518e-5p inhibitor | Oligonucleotides | |
| HY-RI01573A | hsa-miR-518e-5p antagomir | Oligonucleotides | |
| HY-RI01574 | hsa-miR-518f-3p inhibitor | Oligonucleotides | |
| HY-RI01574A | hsa-miR-518f-3p antagomir | Oligonucleotides | |
| HY-RI01575 | hsa-miR-518f-5p inhibitor | Oligonucleotides | |
| HY-RI01575A | hsa-miR-518f-5p antagomir | Oligonucleotides | |
| HY-RI01576 | hsa-miR-5190 inhibitor | Oligonucleotides | |
| HY-RI01576A | hsa-miR-5190 antagomir | Oligonucleotides | |
| HY-RI01577 | hsa-miR-5191 inhibitor | Oligonucleotides | |
| HY-RI01577A | hsa-miR-5191 antagomir | Oligonucleotides | |
| HY-RI01578 | hsa-miR-5192 inhibitor | Oligonucleotides | |
| HY-RI01578A | hsa-miR-5192 antagomir | Oligonucleotides | |
| HY-RI01579 | hsa-miR-5193 inhibitor | Oligonucleotides | |
| HY-RI01579A | hsa-miR-5193 antagomir | Oligonucleotides | |
| HY-RI01580 | hsa-miR-5194 inhibitor | Oligonucleotides | |
| HY-RI01580A | hsa-miR-5194 antagomir | Oligonucleotides | |
| HY-RI01581 | hsa-miR-5195-3p inhibitor | Oligonucleotides | |
| HY-RI01581A | hsa-miR-5195-3p antagomir | Oligonucleotides | |
| HY-RI01582 | hsa-miR-5195-5p inhibitor | Oligonucleotides | |
| HY-RI01582A | hsa-miR-5195-5p antagomir | Oligonucleotides | |
| HY-RI01583 | hsa-miR-5196-3p inhibitor | Oligonucleotides | |
| HY-RI01583A | hsa-miR-5196-3p antagomir | Oligonucleotides | |
| HY-RI01584 | hsa-miR-5196-5p inhibitor | Oligonucleotides | |
| HY-RI01584A | hsa-miR-5196-5p antagomir | Oligonucleotides | |
| HY-RI01585 | hsa-miR-5197-3p inhibitor | Oligonucleotides | |
| HY-RI01585A | hsa-miR-5197-3p antagomir | Oligonucleotides | |
| HY-RI01586 | hsa-miR-5197-5p inhibitor | Oligonucleotides | |
| HY-RI01586A | hsa-miR-5197-5p antagomir | Oligonucleotides | |
| HY-RI01587 | hsa-miR-519a-2-5p inhibitor | Oligonucleotides | |
| HY-RI01587A | hsa-miR-519a-2-5p antagomir | Oligonucleotides | |
| HY-RI01588 | hsa-miR-519a-3p inhibitor | Oligonucleotides | |
| HY-RI01588A | hsa-miR-519a-3p antagomir | Oligonucleotides | |
| HY-RI01589 | hsa-miR-519b-3p inhibitor | Oligonucleotides | |
| HY-RI01589A | hsa-miR-519b-3p antagomir | Oligonucleotides | |
| HY-RI01590 | hsa-miR-519c-3p inhibitor | Oligonucleotides | |
| HY-RI01590A | hsa-miR-519c-3p antagomir | Oligonucleotides | |
| HY-RI01591 | hsa-miR-519d-3p inhibitor | Oligonucleotides | |
| HY-RI01591A | hsa-miR-519d-3p antagomir | Oligonucleotides | |
| HY-RI01592 | hsa-miR-519d-5p inhibitor | Oligonucleotides | |
| HY-RI01592A | hsa-miR-519d-5p antagomir | Oligonucleotides | |
| HY-RI01593 | hsa-miR-519e-3p inhibitor | Oligonucleotides | |
| HY-RI01593A | hsa-miR-519e-3p antagomir | Oligonucleotides | |
| HY-RI01594 | hsa-miR-519e-5p inhibitor | Oligonucleotides | |
| HY-RI01594A | hsa-miR-519e-5p antagomir | Oligonucleotides | |
| HY-RI01595 | hsa-miR-520a-3p inhibitor | Oligonucleotides | |
| HY-RI01595A | hsa-miR-520a-3p antagomir | Oligonucleotides | |
| HY-RI01596 | hsa-miR-520a-5p inhibitor | Oligonucleotides | |
| HY-RI01596A | hsa-miR-520a-5p antagomir | Oligonucleotides | |
| HY-RI01597 | hsa-miR-520b-3p inhibitor | Oligonucleotides | |
| HY-RI01597A | hsa-miR-520b-3p antagomir | Oligonucleotides | |
| HY-RI01598 | hsa-miR-520c-3p inhibitor | Oligonucleotides | |
| HY-RI01598A | hsa-miR-520c-3p antagomir | Oligonucleotides | |
| HY-RI01599 | hsa-miR-520d-3p inhibitor | Oligonucleotides | |
| HY-RI01599A | hsa-miR-520d-3p antagomir | Oligonucleotides | |
| HY-RI01600 | hsa-miR-520d-5p inhibitor | Oligonucleotides | |
| HY-RI01600A | hsa-miR-520d-5p antagomir | Oligonucleotides | |
| HY-RI01601 | hsa-miR-520e-3p inhibitor | Oligonucleotides | |
| HY-RI01601A | hsa-miR-520e-3p antagomir | Oligonucleotides | |
| HY-RI01602 | hsa-miR-520e-5p inhibitor | Oligonucleotides | |
| HY-RI01602A | hsa-miR-520e-5p antagomir | Oligonucleotides | |
| HY-RI01603 | hsa-miR-520f-3p inhibitor | Oligonucleotides | |
| HY-RI01603A | hsa-miR-520f-3p antagomir | Oligonucleotides | |
| HY-RI01604 | hsa-miR-520f-5p inhibitor | Oligonucleotides | |
| HY-RI01604A | hsa-miR-520f-5p antagomir | Oligonucleotides | |
| HY-RI01605 | hsa-miR-520g-3p inhibitor | Oligonucleotides | |
| HY-RI01605A | hsa-miR-520g-3p antagomir | Oligonucleotides | |
| HY-RI01606 | hsa-miR-520g-5p inhibitor | Oligonucleotides | |
| HY-RI01606A | hsa-miR-520g-5p antagomir | Oligonucleotides | |
| HY-RI01607 | hsa-miR-520h inhibitor | Oligonucleotides | |
| HY-RI01607A | hsa-miR-520h antagomir | Oligonucleotides | |
| HY-RI01608 | hsa-miR-521 inhibitor | Oligonucleotides | |
| HY-RI01608A | hsa-miR-521 antagomir | Oligonucleotides | |
| HY-RI01609 | hsa-miR-522-3p inhibitor | Oligonucleotides | |
| HY-RI01609A | hsa-miR-522-3p antagomir | Oligonucleotides | |
| HY-RI01610 | hsa-miR-523-3p inhibitor | Oligonucleotides | |
| HY-RI01610A | hsa-miR-523-3p antagomir | Oligonucleotides | |
| HY-RI01611 | hsa-miR-524-3p inhibitor | Oligonucleotides | |
| HY-RI01611A | hsa-miR-524-3p antagomir | Oligonucleotides | |
| HY-RI01612 | hsa-miR-524-5p inhibitor | Oligonucleotides | |
| HY-RI01612A | hsa-miR-524-5p antagomir | Oligonucleotides | |
| HY-RI01613 | hsa-miR-525-3p inhibitor | Oligonucleotides | |
| HY-RI01613A | hsa-miR-525-3p antagomir | Oligonucleotides | |
| HY-RI01614 | hsa-miR-525-5p inhibitor | Oligonucleotides | |
| HY-RI01614A | hsa-miR-525-5p antagomir | Oligonucleotides | |
| HY-RI01615 | hsa-miR-526a-3p inhibitor | Oligonucleotides | |
| HY-RI01615A | hsa-miR-526a-3p antagomir | Oligonucleotides | |
| HY-RI01616 | hsa-miR-526b-3p inhibitor | Oligonucleotides | |
| HY-RI01616A | hsa-miR-526b-3p antagomir | Oligonucleotides | |
| HY-RI01617 | hsa-miR-526b-5p inhibitor | Oligonucleotides | |
| HY-RI01617A | hsa-miR-526b-5p antagomir | Oligonucleotides | |
| HY-RI01618 | hsa-miR-532-3p inhibitor | Oligonucleotides | |
| HY-RI01618A | hsa-miR-532-3p antagomir | Oligonucleotides | |
| HY-RI01619 | hsa-miR-532-5p inhibitor | Oligonucleotides | |
| HY-RI01619A | hsa-miR-532-5p antagomir | Oligonucleotides | |
| HY-RI01620 | hsa-miR-539-3p inhibitor | Oligonucleotides | |
| HY-RI01620A | hsa-miR-539-3p antagomir | Oligonucleotides | |
| HY-RI01621 | hsa-miR-539-5p inhibitor | Oligonucleotides | |
| HY-RI01621A | hsa-miR-539-5p antagomir | Oligonucleotides | |
| HY-RI01622 | hsa-miR-541-3p inhibitor | Oligonucleotides | |
| HY-RI01622A | hsa-miR-541-3p antagomir | Oligonucleotides | |
| HY-RI01623 | hsa-miR-541-5p inhibitor | Oligonucleotides | |
| HY-RI01623A | hsa-miR-541-5p antagomir | Oligonucleotides | |
| HY-RI01624 | hsa-miR-542-3p inhibitor | Oligonucleotides | |
| HY-RI01624A | hsa-miR-542-3p antagomir | Oligonucleotides | |
| HY-RI01625 | hsa-miR-542-5p inhibitor | Oligonucleotides | |
| HY-RI01625A | hsa-miR-542-5p antagomir | Oligonucleotides | |
| HY-RI01626 | hsa-miR-543 inhibitor | Oligonucleotides | |
| HY-RI01626A | hsa-miR-543 antagomir | Oligonucleotides | |
| HY-RI01627 | hsa-miR-544a inhibitor | Oligonucleotides | |
| HY-RI01627A | hsa-miR-544a antagomir | Oligonucleotides | |
| HY-RI01628 | hsa-miR-544b inhibitor | Oligonucleotides | |
| HY-RI01628A | hsa-miR-544b antagomir | Oligonucleotides | |
| HY-RI01629 | hsa-miR-545-3p inhibitor | Oligonucleotides | |
| HY-RI01629A | hsa-miR-545-3p antagomir | Oligonucleotides | |
| HY-RI01630 | hsa-miR-545-5p inhibitor | Oligonucleotides | |
| HY-RI01630A | hsa-miR-545-5p antagomir | Oligonucleotides | |
| HY-RI01631 | hsa-miR-548a-3p inhibitor | Oligonucleotides | |
| HY-RI01631A | hsa-miR-548a-3p antagomir | Oligonucleotides | |
| HY-RI01632 | hsa-miR-548a-5p inhibitor | Oligonucleotides | |
| HY-RI01632A | hsa-miR-548a-5p antagomir | Oligonucleotides | |
| HY-RI01633 | hsa-miR-548aa inhibitor | Oligonucleotides | |
| HY-RI01633A | hsa-miR-548aa antagomir | Oligonucleotides | |
| HY-RI01634 | hsa-miR-548ab inhibitor | Oligonucleotides | |
| HY-RI01634A | hsa-miR-548ab antagomir | Oligonucleotides | |
| HY-RI01635 | hsa-miR-548ac inhibitor | Oligonucleotides | |
| HY-RI01635A | hsa-miR-548ac antagomir | Oligonucleotides | |
| HY-RI01636 | hsa-miR-548ad-3p inhibitor | Oligonucleotides | |
| HY-RI01636A | hsa-miR-548ad-3p antagomir | Oligonucleotides | |
| HY-RI01637 | hsa-miR-548ad-5p inhibitor | Oligonucleotides | |
| HY-RI01637A | hsa-miR-548ad-5p antagomir | Oligonucleotides | |
| HY-RI01638 | hsa-miR-548ae-3p inhibitor | Oligonucleotides | |
| HY-RI01638A | hsa-miR-548ae-3p antagomir | Oligonucleotides | |
| HY-RI01639 | hsa-miR-548ag inhibitor | Oligonucleotides | |
| HY-RI01639A | hsa-miR-548ag antagomir | Oligonucleotides | |
| HY-RI01640 | hsa-miR-548ah-3p inhibitor | Oligonucleotides | |
| HY-RI01640A | hsa-miR-548ah-3p antagomir | Oligonucleotides | |
| HY-RI01641 | hsa-miR-548ah-5p inhibitor | Oligonucleotides | |
| HY-RI01641A | hsa-miR-548ah-5p antagomir | Oligonucleotides | |
| HY-RI01642 | hsa-miR-548ai inhibitor | Oligonucleotides | |
| HY-RI01642A | hsa-miR-548ai antagomir | Oligonucleotides | |
| HY-RI01643 | hsa-miR-548aj-3p inhibitor | Oligonucleotides | |
| HY-RI01643A | hsa-miR-548aj-3p antagomir | Oligonucleotides | |
| HY-RI01644 | hsa-miR-548aj-5p inhibitor | Oligonucleotides | |
| HY-RI01644A | hsa-miR-548aj-5p antagomir | Oligonucleotides | |
| HY-RI01645 | hsa-miR-548ak inhibitor | Oligonucleotides | |
| HY-RI01645A | hsa-miR-548ak antagomir | Oligonucleotides | |
| HY-RI01646 | hsa-miR-548al inhibitor | Oligonucleotides | |
| HY-RI01646A | hsa-miR-548al antagomir | Oligonucleotides | |
| HY-RI01647 | hsa-miR-548am-3p inhibitor | Oligonucleotides | |
| HY-RI01647A | hsa-miR-548am-3p antagomir | Oligonucleotides | |
| HY-RI01648 | hsa-miR-548am-5p inhibitor | Oligonucleotides | |
| HY-RI01648A | hsa-miR-548am-5p antagomir | Oligonucleotides | |
| HY-RI01649 | hsa-miR-548an inhibitor | Oligonucleotides | |
| HY-RI01649A | hsa-miR-548an antagomir | Oligonucleotides | |
| HY-RI01650 | hsa-miR-548ao-3p inhibitor | Oligonucleotides | |
| HY-RI01650A | hsa-miR-548ao-3p antagomir | Oligonucleotides | |
| HY-RI01651 | hsa-miR-548ao-5p inhibitor | Oligonucleotides | |
| HY-RI01651A | hsa-miR-548ao-5p antagomir | Oligonucleotides | |
| HY-RI01652 | hsa-miR-548ap-3p inhibitor | Oligonucleotides | |
| HY-RI01652A | hsa-miR-548ap-3p antagomir | Oligonucleotides | |
| HY-RI01653 | hsa-miR-548ap-5p inhibitor | Oligonucleotides | |
| HY-RI01653A | hsa-miR-548ap-5p antagomir | Oligonucleotides | |
| HY-RI01654 | hsa-miR-548aq-3p inhibitor | Oligonucleotides | |
| HY-RI01654A | hsa-miR-548aq-3p antagomir | Oligonucleotides | |
| HY-RI01655 | hsa-miR-548aq-5p inhibitor | Oligonucleotides | |
| HY-RI01655A | hsa-miR-548aq-5p antagomir | Oligonucleotides | |
| HY-RI01656 | hsa-miR-548ar-3p inhibitor | Oligonucleotides | |
| HY-RI01656A | hsa-miR-548ar-3p antagomir | Oligonucleotides | |
| HY-RI01657 | hsa-miR-548ar-5p inhibitor | Oligonucleotides | |
| HY-RI01657A | hsa-miR-548ar-5p antagomir | Oligonucleotides | |
| HY-RI01658 | hsa-miR-548as-3p inhibitor | Oligonucleotides | |
| HY-RI01658A | hsa-miR-548as-3p antagomir | Oligonucleotides | |
| HY-RI01659 | hsa-miR-548as-5p inhibitor | Oligonucleotides | |
| HY-RI01659A | hsa-miR-548as-5p antagomir | Oligonucleotides | |
| HY-RI01660 | hsa-miR-548at-3p inhibitor | Oligonucleotides | |
| HY-RI01660A | hsa-miR-548at-3p antagomir | Oligonucleotides | |
| HY-RI01661 | hsa-miR-548at-5p inhibitor | Oligonucleotides | |
| HY-RI01661A | hsa-miR-548at-5p antagomir | Oligonucleotides | |
| HY-RI01662 | hsa-miR-548au-3p inhibitor | Oligonucleotides | |
| HY-RI01662A | hsa-miR-548au-3p antagomir | Oligonucleotides | |
| HY-RI01663 | hsa-miR-548au-5p inhibitor | Oligonucleotides | |
| HY-RI01663A | hsa-miR-548au-5p antagomir | Oligonucleotides | |
| HY-RI01664 | hsa-miR-548av-3p inhibitor | Oligonucleotides | |
| HY-RI01664A | hsa-miR-548av-3p antagomir | Oligonucleotides | |
| HY-RI01665 | hsa-miR-548av-5p inhibitor | Oligonucleotides | |
| HY-RI01665A | hsa-miR-548av-5p antagomir | Oligonucleotides | |
| HY-RI01666 | hsa-miR-548aw inhibitor | Oligonucleotides | |
| HY-RI01666A | hsa-miR-548aw antagomir | Oligonucleotides | |
| HY-RI01667 | hsa-miR-548ax inhibitor | Oligonucleotides | |
| HY-RI01667A | hsa-miR-548ax antagomir | Oligonucleotides | |
| HY-RI01668 | hsa-miR-548ay-3p inhibitor | Oligonucleotides | |
| HY-RI01668A | hsa-miR-548ay-3p antagomir | Oligonucleotides | |
| HY-RI01669 | hsa-miR-548ay-5p inhibitor | Oligonucleotides | |
| HY-RI01669A | hsa-miR-548ay-5p antagomir | Oligonucleotides | |
| HY-RI01670 | hsa-miR-548az-3p inhibitor | Oligonucleotides | |
| HY-RI01670A | hsa-miR-548az-3p antagomir | Oligonucleotides | |
| HY-RI01671 | hsa-miR-548az-5p inhibitor | Oligonucleotides | |
| HY-RI01671A | hsa-miR-548az-5p antagomir | Oligonucleotides | |
| HY-RI01672 | hsa-miR-548b-3p inhibitor | Oligonucleotides | |
| HY-RI01672A | hsa-miR-548b-3p antagomir | Oligonucleotides | |
| HY-RI01673 | hsa-miR-548b-5p inhibitor | Oligonucleotides | |
| HY-RI01673A | hsa-miR-548b-5p antagomir | Oligonucleotides | |
| HY-RI01674 | hsa-miR-548ba inhibitor | Oligonucleotides | |
| HY-RI01674A | hsa-miR-548ba antagomir | Oligonucleotides | |
| HY-RI01675 | hsa-miR-548bb-3p inhibitor | Oligonucleotides | |
| HY-RI01675A | hsa-miR-548bb-3p antagomir | Oligonucleotides | |
| HY-RI01676 | hsa-miR-548bb-5p inhibitor | Oligonucleotides | |
| HY-RI01676A | hsa-miR-548bb-5p antagomir | Oligonucleotides | |
| HY-RI01677 | hsa-miR-548bc inhibitor | Oligonucleotides | |
| HY-RI01677A | hsa-miR-548bc antagomir | Oligonucleotides | |
| HY-RI01678 | hsa-miR-548c-3p inhibitor | Oligonucleotides | |
| HY-RI01678A | hsa-miR-548c-3p antagomir | Oligonucleotides | |
| HY-RI01679 | hsa-miR-548d-3p inhibitor | Oligonucleotides | |
| HY-RI01679A | hsa-miR-548d-3p antagomir | Oligonucleotides | |
| HY-RI01680 | hsa-miR-548d-5p inhibitor | Oligonucleotides | |
| HY-RI01680A | hsa-miR-548d-5p antagomir | Oligonucleotides | |
| HY-RI01681 | hsa-miR-548e-3p inhibitor | Oligonucleotides | |
| HY-RI01681A | hsa-miR-548e-3p antagomir | Oligonucleotides | |
| HY-RI01682 | hsa-miR-548e-5p inhibitor | Oligonucleotides | |
| HY-RI01682A | hsa-miR-548e-5p antagomir | Oligonucleotides | |
| HY-RI01683 | hsa-miR-548f-3p inhibitor | Oligonucleotides | |
| HY-RI01683A | hsa-miR-548f-3p antagomir | Oligonucleotides | |
| HY-RI01684 | hsa-miR-548f-5p inhibitor | Oligonucleotides | |
| HY-RI01684A | hsa-miR-548f-5p antagomir | Oligonucleotides | |
| HY-RI01685 | hsa-miR-548h-3p inhibitor | Oligonucleotides | |
| HY-RI01685A | hsa-miR-548h-3p antagomir | Oligonucleotides | |
| HY-RI01686 | hsa-miR-548h-5p inhibitor | Oligonucleotides | |
| HY-RI01686A | hsa-miR-548h-5p antagomir | Oligonucleotides | |
| HY-RI01687 | hsa-miR-548i inhibitor | Oligonucleotides | |
| HY-RI01687A | hsa-miR-548i antagomir | Oligonucleotides | |
| HY-RI01688 | hsa-miR-548j-3p inhibitor | Oligonucleotides | |
| HY-RI01688A | hsa-miR-548j-3p antagomir | Oligonucleotides | |
| HY-RI01689 | hsa-miR-548j-5p inhibitor | Oligonucleotides | |
| HY-RI01689A | hsa-miR-548j-5p antagomir | Oligonucleotides | |
| HY-RI01690 | hsa-miR-548k inhibitor | Oligonucleotides | |
| HY-RI01690A | hsa-miR-548k antagomir | Oligonucleotides | |
| HY-RI01691 | hsa-miR-548l inhibitor | Oligonucleotides | |
| HY-RI01691A | hsa-miR-548l antagomir | Oligonucleotides | |
| HY-RI01692 | hsa-miR-548m inhibitor | Oligonucleotides | |
| HY-RI01692A | hsa-miR-548m antagomir | Oligonucleotides | |
| HY-RI01693 | hsa-miR-548n inhibitor | Oligonucleotides | |
| HY-RI01693A | hsa-miR-548n antagomir | Oligonucleotides | |
| HY-RI01694 | hsa-miR-548o-3p inhibitor | Oligonucleotides | |
| HY-RI01694A | hsa-miR-548o-3p antagomir | Oligonucleotides | |
| HY-RI01695 | hsa-miR-548p inhibitor | Oligonucleotides | |
| HY-RI01695A | hsa-miR-548p antagomir | Oligonucleotides | |
| HY-RI01696 | hsa-miR-548q inhibitor | Oligonucleotides | |
| HY-RI01696A | hsa-miR-548q antagomir | Oligonucleotides | |
| HY-RI01697 | hsa-miR-548s inhibitor | Oligonucleotides | |
| HY-RI01697A | hsa-miR-548s antagomir | Oligonucleotides | |
| HY-RI01698 | hsa-miR-548t-5p inhibitor | Oligonucleotides | |
| HY-RI01698A | hsa-miR-548t-5p antagomir | Oligonucleotides | |
| HY-RI01699 | hsa-miR-548u inhibitor | Oligonucleotides | |
| HY-RI01699A | hsa-miR-548u antagomir | Oligonucleotides | |
| HY-RI01700 | hsa-miR-548v inhibitor | Oligonucleotides | |
| HY-RI01700A | hsa-miR-548v antagomir | Oligonucleotides | |
| HY-RI01701 | hsa-miR-548w inhibitor | Oligonucleotides | |
| HY-RI01701A | hsa-miR-548w antagomir | Oligonucleotides | |
| HY-RI01702 | hsa-miR-548x-3p inhibitor | Oligonucleotides | |
| HY-RI01702A | hsa-miR-548x-3p antagomir | Oligonucleotides | |
| HY-RI01703 | hsa-miR-548y inhibitor | Oligonucleotides | |
| HY-RI01703A | hsa-miR-548y antagomir | Oligonucleotides | |
| HY-RI01704 | hsa-miR-549a-3p inhibitor | Oligonucleotides | |
| HY-RI01704A | hsa-miR-549a-3p antagomir | Oligonucleotides | |
| HY-RI01705 | hsa-miR-549a-5p inhibitor | Oligonucleotides | |
| HY-RI01705A | hsa-miR-549a-5p antagomir | Oligonucleotides | |
| HY-RI01706 | hsa-miR-550a-3-5p inhibitor | Oligonucleotides | |
| HY-RI01706A | hsa-miR-550a-3-5p antagomir | Oligonucleotides | |
| HY-RI01707 | hsa-miR-550a-3p inhibitor | Oligonucleotides | |
| HY-RI01707A | hsa-miR-550a-3p antagomir | Oligonucleotides | |
| HY-RI01708 | hsa-miR-550a-5p inhibitor | Oligonucleotides | |
| HY-RI01708A | hsa-miR-550a-5p antagomir | Oligonucleotides | |
| HY-RI01709 | hsa-miR-550b-2-5p inhibitor | Oligonucleotides | |
| HY-RI01709A | hsa-miR-550b-2-5p antagomir | Oligonucleotides | |
| HY-RI01710 | hsa-miR-550b-3p inhibitor | Oligonucleotides | |
| HY-RI01710A | hsa-miR-550b-3p antagomir | Oligonucleotides | |
| HY-RI01711 | hsa-miR-551a inhibitor | Oligonucleotides | |
| HY-RI01711A | hsa-miR-551a antagomir | Oligonucleotides | |
| HY-RI01712 | hsa-miR-551b-3p inhibitor | Oligonucleotides | |
| HY-RI01712A | hsa-miR-551b-3p antagomir | Oligonucleotides | |
| HY-RI01713 | hsa-miR-551b-5p inhibitor | Oligonucleotides | |
| HY-RI01713A | hsa-miR-551b-5p antagomir | Oligonucleotides | |
| HY-RI01714 | hsa-miR-552-3p inhibitor | Oligonucleotides | |
| HY-RI01714A | hsa-miR-552-3p antagomir | Oligonucleotides | |
| HY-RI01715 | hsa-miR-552-5p inhibitor | Oligonucleotides | |
| HY-RI01715A | hsa-miR-552-5p antagomir | Oligonucleotides | |
| HY-RI01716 | hsa-miR-553 inhibitor | Oligonucleotides | |
| HY-RI01716A | hsa-miR-553 antagomir | Oligonucleotides | |
| HY-RI01717 | hsa-miR-554 inhibitor | Oligonucleotides | |
| HY-RI01717A | hsa-miR-554 antagomir | Oligonucleotides | |
| HY-RI01718 | hsa-miR-555 inhibitor | Oligonucleotides | |
| HY-RI01718A | hsa-miR-555 antagomir | Oligonucleotides | |
| HY-RI01719 | hsa-miR-556-3p inhibitor | Oligonucleotides | |
| HY-RI01719A | hsa-miR-556-3p antagomir | Oligonucleotides | |
| HY-RI01720 | hsa-miR-556-5p inhibitor | Oligonucleotides | |
| HY-RI01720A | hsa-miR-556-5p antagomir | Oligonucleotides | |
| HY-RI01721 | hsa-miR-5571-3p inhibitor | Oligonucleotides | |
| HY-RI01721A | hsa-miR-5571-3p antagomir | Oligonucleotides | |
| HY-RI01722 | hsa-miR-5571-5p inhibitor | Oligonucleotides | |
| HY-RI01722A | hsa-miR-5571-5p antagomir | Oligonucleotides | |
| HY-RI01723 | hsa-miR-5572 inhibitor | Oligonucleotides | |
| HY-RI01723A | hsa-miR-5572 antagomir | Oligonucleotides | |
| HY-RI01724 | hsa-miR-5579-3p inhibitor | Oligonucleotides | |
| HY-RI01724A | hsa-miR-5579-3p antagomir | Oligonucleotides | |
| HY-RI01725 | hsa-miR-5579-5p inhibitor | Oligonucleotides | |
| HY-RI01725A | hsa-miR-5579-5p antagomir | Oligonucleotides | |
| HY-RI01726 | hsa-miR-5580-3p inhibitor | Oligonucleotides | |
| HY-RI01726A | hsa-miR-5580-3p antagomir | Oligonucleotides | |
| HY-RI01727 | hsa-miR-5580-5p inhibitor | Oligonucleotides | |
| HY-RI01727A | hsa-miR-5580-5p antagomir | Oligonucleotides | |
| HY-RI01728 | hsa-miR-5581-3p inhibitor | Oligonucleotides | |
| HY-RI01728A | hsa-miR-5581-3p antagomir | Oligonucleotides | |
| HY-RI01729 | hsa-miR-5581-5p inhibitor | Oligonucleotides | |
| HY-RI01729A | hsa-miR-5581-5p antagomir | Oligonucleotides | |
| HY-RI01730 | hsa-miR-5582-3p inhibitor | Oligonucleotides | |
| HY-RI01730A | hsa-miR-5582-3p antagomir | Oligonucleotides | |
| HY-RI01731 | hsa-miR-5582-5p inhibitor | Oligonucleotides | |
| HY-RI01731A | hsa-miR-5582-5p antagomir | Oligonucleotides | |
| HY-RI01732 | hsa-miR-5583-3p inhibitor | Oligonucleotides | |
| HY-RI01732A | hsa-miR-5583-3p antagomir | Oligonucleotides | |
| HY-RI01733 | hsa-miR-5583-5p inhibitor | Oligonucleotides | |
| HY-RI01733A | hsa-miR-5583-5p antagomir | Oligonucleotides | |
| HY-RI01734 | hsa-miR-5584-3p inhibitor | Oligonucleotides | |
| HY-RI01734A | hsa-miR-5584-3p antagomir | Oligonucleotides | |
| HY-RI01735 | hsa-miR-5584-5p inhibitor | Oligonucleotides | |
| HY-RI01735A | hsa-miR-5584-5p antagomir | Oligonucleotides | |
| HY-RI01736 | hsa-miR-5585-3p inhibitor | Oligonucleotides | |
| HY-RI01736A | hsa-miR-5585-3p antagomir | Oligonucleotides | |
| HY-RI01737 | hsa-miR-5585-5p inhibitor | Oligonucleotides | |
| HY-RI01737A | hsa-miR-5585-5p antagomir | Oligonucleotides | |
| HY-RI01738 | hsa-miR-5586-3p inhibitor | Oligonucleotides | |
| HY-RI01738A | hsa-miR-5586-3p antagomir | Oligonucleotides | |
| HY-RI01739 | hsa-miR-5586-5p inhibitor | Oligonucleotides | |
| HY-RI01739A | hsa-miR-5586-5p antagomir | Oligonucleotides | |
| HY-RI01740 | hsa-miR-5587-3p inhibitor | Oligonucleotides | |
| HY-RI01740A | hsa-miR-5587-3p antagomir | Oligonucleotides | |
| HY-RI01741 | hsa-miR-5587-5p inhibitor | Oligonucleotides | |
| HY-RI01741A | hsa-miR-5587-5p antagomir | Oligonucleotides | |
| HY-RI01742 | hsa-miR-5588-3p inhibitor | Oligonucleotides | |
| HY-RI01742A | hsa-miR-5588-3p antagomir | Oligonucleotides | |
| HY-RI01743 | hsa-miR-5588-5p inhibitor | Oligonucleotides | |
| HY-RI01743A | hsa-miR-5588-5p antagomir | Oligonucleotides | |
| HY-RI01744 | hsa-miR-5589-3p inhibitor | Oligonucleotides | |
| HY-RI01744A | hsa-miR-5589-3p antagomir | Oligonucleotides | |
| HY-RI01745 | hsa-miR-5589-5p inhibitor | Oligonucleotides | |
| HY-RI01745A | hsa-miR-5589-5p antagomir | Oligonucleotides | |
| HY-RI01746 | hsa-miR-559 inhibitor | Oligonucleotides | |
| HY-RI01746A | hsa-miR-559 antagomir | Oligonucleotides | |
| HY-RI01747 | hsa-miR-5590-3p inhibitor | Oligonucleotides | |
| HY-RI01747A | hsa-miR-5590-3p antagomir | Oligonucleotides | |
| HY-RI01748 | hsa-miR-5590-5p inhibitor | Oligonucleotides | |
| HY-RI01748A | hsa-miR-5590-5p antagomir | Oligonucleotides | |
| HY-RI01749 | hsa-miR-5591-3p inhibitor | Oligonucleotides | |
| HY-RI01749A | hsa-miR-5591-3p antagomir | Oligonucleotides | |
| HY-RI01750 | hsa-miR-5591-5p inhibitor | Oligonucleotides | |
| HY-RI01750A | hsa-miR-5591-5p antagomir | Oligonucleotides | |
| HY-RI01751 | hsa-miR-561-3p inhibitor | Oligonucleotides | |
| HY-RI01751A | hsa-miR-561-3p antagomir | Oligonucleotides | |
| HY-RI01752 | hsa-miR-561-5p inhibitor | Oligonucleotides | |
| HY-RI01752A | hsa-miR-561-5p antagomir | Oligonucleotides | |
| HY-RI01753 | hsa-miR-562 inhibitor | Oligonucleotides | |
| HY-RI01753A | hsa-miR-562 antagomir | Oligonucleotides | |
| HY-RI01754 | hsa-miR-563 inhibitor | Oligonucleotides | |
| HY-RI01754A | hsa-miR-563 antagomir | Oligonucleotides | |
| HY-RI01755 | hsa-miR-564 inhibitor | Oligonucleotides | |
| HY-RI01755A | hsa-miR-564 antagomir | Oligonucleotides | |
| HY-RI01756 | hsa-miR-567 inhibitor | Oligonucleotides | |
| HY-RI01756A | hsa-miR-567 antagomir | Oligonucleotides | |
| HY-RI01757 | hsa-miR-568 inhibitor | Oligonucleotides | |
| HY-RI01757A | hsa-miR-568 antagomir | Oligonucleotides | |
| HY-RI01758 | hsa-miR-5680 inhibitor | Oligonucleotides | |
| HY-RI01758A | hsa-miR-5680 antagomir | Oligonucleotides | |
| HY-RI01759 | hsa-miR-5681a inhibitor | Oligonucleotides | |
| HY-RI01759A | hsa-miR-5681a antagomir | Oligonucleotides | |
| HY-RI01760 | hsa-miR-5681b inhibitor | Oligonucleotides | |
| HY-RI01760A | hsa-miR-5681b antagomir | Oligonucleotides | |
| HY-RI01761 | hsa-miR-5682 inhibitor | Oligonucleotides | |
| HY-RI01761A | hsa-miR-5682 antagomir | Oligonucleotides | |
| HY-RI01762 | hsa-miR-5683 inhibitor | Oligonucleotides | |
| HY-RI01762A | hsa-miR-5683 antagomir | Oligonucleotides | |
| HY-RI01763 | hsa-miR-5684 inhibitor | Oligonucleotides | |
| HY-RI01763A | hsa-miR-5684 antagomir | Oligonucleotides | |
| HY-RI01764 | hsa-miR-5685 inhibitor | Oligonucleotides | |
| HY-RI01764A | hsa-miR-5685 antagomir | Oligonucleotides | |
| HY-RI01765 | hsa-miR-5687 inhibitor | Oligonucleotides | |
| HY-RI01765A | hsa-miR-5687 antagomir | Oligonucleotides | |
| HY-RI01766 | hsa-miR-5688 inhibitor | Oligonucleotides | |
| HY-RI01766A | hsa-miR-5688 antagomir | Oligonucleotides | |
| HY-RI01767 | hsa-miR-5689 inhibitor | Oligonucleotides | |
| HY-RI01767A | hsa-miR-5689 antagomir | Oligonucleotides | |
| HY-RI01768 | hsa-miR-569 inhibitor | Oligonucleotides | |
| HY-RI01768A | hsa-miR-569 antagomir | Oligonucleotides | |
| HY-RI01769 | hsa-miR-5690 inhibitor | Oligonucleotides | |
| HY-RI01769A | hsa-miR-5690 antagomir | Oligonucleotides | |
| HY-RI01770 | hsa-miR-5691 inhibitor | Oligonucleotides | |
| HY-RI01770A | hsa-miR-5691 antagomir | Oligonucleotides | |
| HY-RI01771 | hsa-miR-5692a inhibitor | Oligonucleotides | |
| HY-RI01771A | hsa-miR-5692a antagomir | Oligonucleotides | |
| HY-RI01772 | hsa-miR-5692b inhibitor | Oligonucleotides | |
| HY-RI01772A | hsa-miR-5692b antagomir | Oligonucleotides | |
| HY-RI01773 | hsa-miR-5692c inhibitor | Oligonucleotides | |
| HY-RI01773A | hsa-miR-5692c antagomir | Oligonucleotides | |
| HY-RI01774 | hsa-miR-5693 inhibitor | Oligonucleotides | |
| HY-RI01774A | hsa-miR-5693 antagomir | Oligonucleotides | |
| HY-RI01775 | hsa-miR-5694 inhibitor | Oligonucleotides | |
| HY-RI01775A | hsa-miR-5694 antagomir | Oligonucleotides | |
| HY-RI01776 | hsa-miR-5695 inhibitor | Oligonucleotides | |
| HY-RI01776A | hsa-miR-5695 antagomir | Oligonucleotides | |
| HY-RI01777 | hsa-miR-5696 inhibitor | Oligonucleotides | |
| HY-RI01777A | hsa-miR-5696 antagomir | Oligonucleotides | |
| HY-RI01778 | hsa-miR-5697 inhibitor | Oligonucleotides | |
| HY-RI01778A | hsa-miR-5697 antagomir | Oligonucleotides | |
| HY-RI01779 | hsa-miR-5698 inhibitor | Oligonucleotides | |
| HY-RI01779A | hsa-miR-5698 antagomir | Oligonucleotides | |
| HY-RI01780 | hsa-miR-5699-3p inhibitor | Oligonucleotides | |
| HY-RI01780A | hsa-miR-5699-3p antagomir | Oligonucleotides | |
| HY-RI01781 | hsa-miR-5699-5p inhibitor | Oligonucleotides | |
| HY-RI01781A | hsa-miR-5699-5p antagomir | Oligonucleotides | |
| HY-RI01782 | hsa-miR-5700 inhibitor | Oligonucleotides | |
| HY-RI01782A | hsa-miR-5700 antagomir | Oligonucleotides | |
| HY-RI01783 | hsa-miR-5701 inhibitor | Oligonucleotides | |
| HY-RI01783A | hsa-miR-5701 antagomir | Oligonucleotides | |
| HY-RI01784 | hsa-miR-5702 inhibitor | Oligonucleotides | |
| HY-RI01784A | hsa-miR-5702 antagomir | Oligonucleotides | |
| HY-RI01785 | hsa-miR-5703 inhibitor | Oligonucleotides | |
| HY-RI01785A | hsa-miR-5703 antagomir | Oligonucleotides | |
| HY-RI01786 | hsa-miR-570-3p inhibitor | Oligonucleotides | |
| HY-RI01786A | hsa-miR-570-3p antagomir | Oligonucleotides | |
| HY-RI01787 | hsa-miR-5704 inhibitor | Oligonucleotides | |
| HY-RI01787A | hsa-miR-5704 antagomir | Oligonucleotides | |
| HY-RI01788 | hsa-miR-5705 inhibitor | Oligonucleotides | |
| HY-RI01788A | hsa-miR-5705 antagomir | Oligonucleotides | |
| HY-RI01789 | hsa-miR-5706 inhibitor | Oligonucleotides | |
| HY-RI01789A | hsa-miR-5706 antagomir | Oligonucleotides | |
| HY-RI01790 | hsa-miR-5707 inhibitor | Oligonucleotides | |
| HY-RI01790A | hsa-miR-5707 antagomir | Oligonucleotides | |
| HY-RI01791 | hsa-miR-5708 inhibitor | Oligonucleotides | |
| HY-RI01791A | hsa-miR-5708 antagomir | Oligonucleotides | |
| HY-RI01792 | hsa-miR-571 inhibitor | Oligonucleotides | |
| HY-RI01792A | hsa-miR-571 antagomir | Oligonucleotides | |
| HY-RI01793 | hsa-miR-572 inhibitor | Oligonucleotides | |
| HY-RI01793A | hsa-miR-572 antagomir | Oligonucleotides | |
| HY-RI01794 | hsa-miR-573 inhibitor | Oligonucleotides | |
| HY-RI01794A | hsa-miR-573 antagomir | Oligonucleotides | |
| HY-RI01795 | hsa-miR-5739 inhibitor | Oligonucleotides | |
| HY-RI01795A | hsa-miR-5739 antagomir | Oligonucleotides | |
| HY-RI01796 | hsa-miR-574-3p inhibitor | Oligonucleotides | |
| HY-RI01796A | hsa-miR-574-3p antagomir | Oligonucleotides | |
| HY-RI01797 | hsa-miR-574-5p inhibitor | Oligonucleotides | |
| HY-RI01797A | hsa-miR-574-5p antagomir | Oligonucleotides | |
| HY-RI01798 | hsa-miR-575 inhibitor | Oligonucleotides | |
| HY-RI01798A | hsa-miR-575 antagomir | Oligonucleotides | |
| HY-RI01799 | hsa-miR-576-3p inhibitor | Oligonucleotides | |
| HY-RI01799A | hsa-miR-576-3p antagomir | Oligonucleotides | |
| HY-RI01800 | hsa-miR-576-5p inhibitor | Oligonucleotides | |
| HY-RI01800A | hsa-miR-576-5p antagomir | Oligonucleotides | |
| HY-RI01801 | hsa-miR-577 inhibitor | Oligonucleotides | |
| HY-RI01801A | hsa-miR-577 antagomir | Oligonucleotides | |
| HY-RI01802 | hsa-miR-578 inhibitor | Oligonucleotides | |
| HY-RI01802A | hsa-miR-578 antagomir | Oligonucleotides | |
| HY-RI01803 | hsa-miR-5787 inhibitor | Oligonucleotides | |
| HY-RI01803A | hsa-miR-5787 antagomir | Oligonucleotides | |
| HY-RI01804 | hsa-miR-579-3p inhibitor | Oligonucleotides | |
| HY-RI01804A | hsa-miR-579-3p antagomir | Oligonucleotides | |
| HY-RI01805 | hsa-miR-579-5p inhibitor | Oligonucleotides | |
| HY-RI01805A | hsa-miR-579-5p antagomir | Oligonucleotides | |
| HY-RI01806 | hsa-miR-580-3p inhibitor | Oligonucleotides | |
| HY-RI01806A | hsa-miR-580-3p antagomir | Oligonucleotides | |
| HY-RI01807 | hsa-miR-580-5p inhibitor | Oligonucleotides | |
| HY-RI01807A | hsa-miR-580-5p antagomir | Oligonucleotides | |
| HY-RI01808 | hsa-miR-581 inhibitor | Oligonucleotides | |
| HY-RI01808A | hsa-miR-581 antagomir | Oligonucleotides | |
| HY-RI01809 | hsa-miR-582-3p inhibitor | Oligonucleotides | |
| HY-RI01809A | hsa-miR-582-3p antagomir | Oligonucleotides | |
| HY-RI01810 | hsa-miR-582-5p inhibitor | Oligonucleotides | |
| HY-RI01810A | hsa-miR-582-5p antagomir | Oligonucleotides | |
| HY-RI01811 | hsa-miR-583 inhibitor | Oligonucleotides | |
| HY-RI01811A | hsa-miR-583 antagomir | Oligonucleotides | |
| HY-RI01812 | hsa-miR-584-3p inhibitor | Oligonucleotides | |
| HY-RI01812A | hsa-miR-584-3p antagomir | Oligonucleotides | |
| HY-RI01813 | hsa-miR-584-5p inhibitor | Oligonucleotides | |
| HY-RI01813A | hsa-miR-584-5p antagomir | Oligonucleotides | |
| HY-RI01814 | hsa-miR-585-3p inhibitor | Oligonucleotides | |
| HY-RI01814A | hsa-miR-585-3p antagomir | Oligonucleotides | |
| HY-RI01815 | hsa-miR-585-5p inhibitor | Oligonucleotides | |
| HY-RI01815A | hsa-miR-585-5p antagomir | Oligonucleotides | |
| HY-RI01816 | hsa-miR-586 inhibitor | Oligonucleotides | |
| HY-RI01816A | hsa-miR-586 antagomir | Oligonucleotides | |
| HY-RI01817 | hsa-miR-587 inhibitor | Oligonucleotides | |
| HY-RI01817A | hsa-miR-587 antagomir | Oligonucleotides | |
| HY-RI01818 | hsa-miR-588 inhibitor | Oligonucleotides | |
| HY-RI01818A | hsa-miR-588 antagomir | Oligonucleotides | |
| HY-RI01819 | hsa-miR-589-3p inhibitor | Oligonucleotides | |
| HY-RI01819A | hsa-miR-589-3p antagomir | Oligonucleotides | |
| HY-RI01820 | hsa-miR-589-5p inhibitor | Oligonucleotides | |
| HY-RI01820A | hsa-miR-589-5p antagomir | Oligonucleotides | |
| HY-RI01821 | hsa-miR-590-3p inhibitor | Oligonucleotides | |
| HY-RI01821A | hsa-miR-590-3p antagomir | Oligonucleotides | |
| HY-RI01822 | hsa-miR-590-5p inhibitor | Oligonucleotides | |
| HY-RI01822A | hsa-miR-590-5p antagomir | Oligonucleotides | |
| HY-RI01823 | hsa-miR-591 inhibitor | Oligonucleotides | |
| HY-RI01823A | hsa-miR-591 antagomir | Oligonucleotides | |
| HY-RI01824 | hsa-miR-592 inhibitor | Oligonucleotides | |
| HY-RI01824A | hsa-miR-592 antagomir | Oligonucleotides | |
| HY-RI01825 | hsa-miR-593-3p inhibitor | Oligonucleotides | |
| HY-RI01825A | hsa-miR-593-3p antagomir | Oligonucleotides | |
| HY-RI01826 | hsa-miR-593-5p inhibitor | Oligonucleotides | |
| HY-RI01826A | hsa-miR-593-5p antagomir | Oligonucleotides | |
| HY-RI01827 | hsa-miR-595 inhibitor | Oligonucleotides | |
| HY-RI01827A | hsa-miR-595 antagomir | Oligonucleotides | |
| HY-RI01828 | hsa-miR-596 inhibitor | Oligonucleotides | |
| HY-RI01828A | hsa-miR-596 antagomir | Oligonucleotides | |
| HY-RI01829 | hsa-miR-597-3p inhibitor | Oligonucleotides | |
| HY-RI01829A | hsa-miR-597-3p antagomir | Oligonucleotides | |
| HY-RI01830 | hsa-miR-597-5p inhibitor | Oligonucleotides | |
| HY-RI01830A | hsa-miR-597-5p antagomir | Oligonucleotides | |
| HY-RI01831 | hsa-miR-598-5p inhibitor | Oligonucleotides | |
| HY-RI01831A | hsa-miR-598-5p antagomir | Oligonucleotides | |
| HY-RI01832 | hsa-miR-599 inhibitor | Oligonucleotides | |
| HY-RI01832A | hsa-miR-599 antagomir | Oligonucleotides | |
| HY-RI01833 | hsa-miR-600 inhibitor | Oligonucleotides | |
| HY-RI01833A | hsa-miR-600 antagomir | Oligonucleotides | |
| HY-RI01834 | hsa-miR-601 inhibitor | Oligonucleotides | |
| HY-RI01834A | hsa-miR-601 antagomir | Oligonucleotides | |
| HY-RI01835 | hsa-miR-602 inhibitor | Oligonucleotides | |
| HY-RI01835A | hsa-miR-602 antagomir | Oligonucleotides | |
| HY-RI01836 | hsa-miR-603 inhibitor | Oligonucleotides | |
| HY-RI01836A | hsa-miR-603 antagomir | Oligonucleotides | |
| HY-RI01837 | hsa-miR-604 inhibitor | Oligonucleotides | |
| HY-RI01837A | hsa-miR-604 antagomir | Oligonucleotides | |
| HY-RI01838 | hsa-miR-605-3p inhibitor | Oligonucleotides | |
| HY-RI01838A | hsa-miR-605-3p antagomir | Oligonucleotides | |
| HY-RI01839 | hsa-miR-605-5p inhibitor | Oligonucleotides | |
| HY-RI01839A | hsa-miR-605-5p antagomir | Oligonucleotides | |
| HY-RI01840 | hsa-miR-606 inhibitor | Oligonucleotides | |
| HY-RI01840A | hsa-miR-606 antagomir | Oligonucleotides | |
| HY-RI01841 | hsa-miR-6068 inhibitor | Oligonucleotides | |
| HY-RI01841A | hsa-miR-6068 antagomir | Oligonucleotides | |
| HY-RI01842 | hsa-miR-6069 inhibitor | Oligonucleotides | |
| HY-RI01842A | hsa-miR-6069 antagomir | Oligonucleotides | |
| HY-RI01843 | hsa-miR-607 inhibitor | Oligonucleotides | |
| HY-RI01843A | hsa-miR-607 antagomir | Oligonucleotides | |
| HY-RI01844 | hsa-miR-6070 inhibitor | Oligonucleotides | |
| HY-RI01844A | hsa-miR-6070 antagomir | Oligonucleotides | |
| HY-RI01845 | hsa-miR-6071 inhibitor | Oligonucleotides | |
| HY-RI01845A | hsa-miR-6071 antagomir | Oligonucleotides | |
| HY-RI01846 | hsa-miR-6072 inhibitor | Oligonucleotides | |
| HY-RI01846A | hsa-miR-6072 antagomir | Oligonucleotides | |
| HY-RI01847 | hsa-miR-6073 inhibitor | Oligonucleotides | |
| HY-RI01847A | hsa-miR-6073 antagomir | Oligonucleotides | |
| HY-RI01848 | hsa-miR-6074 inhibitor | Oligonucleotides | |
| HY-RI01848A | hsa-miR-6074 antagomir | Oligonucleotides | |
| HY-RI01849 | hsa-miR-6075 inhibitor | Oligonucleotides | |
| HY-RI01849A | hsa-miR-6075 antagomir | Oligonucleotides | |
| HY-RI01850 | hsa-miR-6076 inhibitor | Oligonucleotides | |
| HY-RI01850A | hsa-miR-6076 antagomir | Oligonucleotides | |
| HY-RI01851 | hsa-miR-6077 inhibitor | Oligonucleotides | |
| HY-RI01851A | hsa-miR-6077 antagomir | Oligonucleotides | |
| HY-RI01852 | hsa-miR-6078 inhibitor | Oligonucleotides | |
| HY-RI01852A | hsa-miR-6078 antagomir | Oligonucleotides | |
| HY-RI01853 | hsa-miR-6079 inhibitor | Oligonucleotides | |
| HY-RI01853A | hsa-miR-6079 antagomir | Oligonucleotides | |
| HY-RI01854 | hsa-miR-608 inhibitor | Oligonucleotides | |
| HY-RI01854A | hsa-miR-608 antagomir | Oligonucleotides | |
| HY-RI01855 | hsa-miR-6080 inhibitor | Oligonucleotides | |
| HY-RI01855A | hsa-miR-6080 antagomir | Oligonucleotides | |
| HY-RI01856 | hsa-miR-6081 inhibitor | Oligonucleotides | |
| HY-RI01856A | hsa-miR-6081 antagomir | Oligonucleotides | |
| HY-RI01857 | hsa-miR-6082 inhibitor | Oligonucleotides | |
| HY-RI01857A | hsa-miR-6082 antagomir | Oligonucleotides | |
| HY-RI01858 | hsa-miR-6083 inhibitor | Oligonucleotides | |
| HY-RI01858A | hsa-miR-6083 antagomir | Oligonucleotides | |
| HY-RI01859 | hsa-miR-6084 inhibitor | Oligonucleotides | |
| HY-RI01859A | hsa-miR-6084 antagomir | Oligonucleotides | |
| HY-RI01860 | hsa-miR-6085 inhibitor | Oligonucleotides | |
| HY-RI01860A | hsa-miR-6085 antagomir | Oligonucleotides | |
| HY-RI01861 | hsa-miR-6086 inhibitor | Oligonucleotides | |
| HY-RI01861A | hsa-miR-6086 antagomir | Oligonucleotides | |
| HY-RI01862 | hsa-miR-6088 inhibitor | Oligonucleotides | |
| HY-RI01862A | hsa-miR-6088 antagomir | Oligonucleotides | |
| HY-RI01863 | hsa-miR-6089 inhibitor | Oligonucleotides | |
| HY-RI01863A | hsa-miR-6089 antagomir | Oligonucleotides | |
| HY-RI01864 | hsa-miR-609 inhibitor | Oligonucleotides | |
| HY-RI01864A | hsa-miR-609 antagomir | Oligonucleotides | |
| HY-RI01865 | hsa-miR-6090 inhibitor | Oligonucleotides | |
| HY-RI01865A | hsa-miR-6090 antagomir | Oligonucleotides | |
| HY-RI01866 | hsa-miR-610 inhibitor | Oligonucleotides | |
| HY-RI01866A | hsa-miR-610 antagomir | Oligonucleotides | |
| HY-RI01867 | hsa-miR-612 inhibitor | Oligonucleotides | |
| HY-RI01867A | hsa-miR-612 antagomir | Oligonucleotides | |
| HY-RI01868 | hsa-miR-6124 inhibitor | Oligonucleotides | |
| HY-RI01868A | hsa-miR-6124 antagomir | Oligonucleotides | |
| HY-RI01869 | hsa-miR-6125 inhibitor | Oligonucleotides | |
| HY-RI01869A | hsa-miR-6125 antagomir | Oligonucleotides | |
| HY-RI01870 | hsa-miR-6126 inhibitor | Oligonucleotides | |
| HY-RI01870A | hsa-miR-6126 antagomir | Oligonucleotides | |
| HY-RI01871 | hsa-miR-6127 inhibitor | Oligonucleotides | |
| HY-RI01871A | hsa-miR-6127 antagomir | Oligonucleotides | |
| HY-RI01872 | hsa-miR-6128 inhibitor | Oligonucleotides | |
| HY-RI01872A | hsa-miR-6128 antagomir | Oligonucleotides | |
| HY-RI01873 | hsa-miR-6129 inhibitor | Oligonucleotides | |
| HY-RI01873A | hsa-miR-6129 antagomir | Oligonucleotides | |
| HY-RI01874 | hsa-miR-613 inhibitor | Oligonucleotides | |
| HY-RI01874A | hsa-miR-613 antagomir | Oligonucleotides | |
| HY-RI01875 | hsa-miR-6130 inhibitor | Oligonucleotides | |
| HY-RI01875A | hsa-miR-6130 antagomir | Oligonucleotides | |
| HY-RI01876 | hsa-miR-6131 inhibitor | Oligonucleotides | |
| HY-RI01876A | hsa-miR-6131 antagomir | Oligonucleotides | |
| HY-RI01877 | hsa-miR-6132 inhibitor | Oligonucleotides | |
| HY-RI01877A | hsa-miR-6132 antagomir | Oligonucleotides | |
| HY-RI01878 | hsa-miR-6133 inhibitor | Oligonucleotides | |
| HY-RI01878A | hsa-miR-6133 antagomir | Oligonucleotides | |
| HY-RI01879 | hsa-miR-6134 inhibitor | Oligonucleotides | |
| HY-RI01879A | hsa-miR-6134 antagomir | Oligonucleotides | |
| HY-RI01880 | hsa-miR-614 inhibitor | Oligonucleotides | |
| HY-RI01880A | hsa-miR-614 antagomir | Oligonucleotides | |
| HY-RI01881 | hsa-miR-615-3p inhibitor | Oligonucleotides | |
| HY-RI01881A | hsa-miR-615-3p antagomir | Oligonucleotides | |
| HY-RI01882 | hsa-miR-615-5p inhibitor | Oligonucleotides | |
| HY-RI01882A | hsa-miR-615-5p antagomir | Oligonucleotides | |
| HY-RI01883 | hsa-miR-616-3p inhibitor | Oligonucleotides | |
| HY-RI01883A | hsa-miR-616-3p antagomir | Oligonucleotides | |
| HY-RI01884 | hsa-miR-6165 inhibitor | Oligonucleotides | |
| HY-RI01884A | hsa-miR-6165 antagomir | Oligonucleotides | |
| HY-RI01885 | hsa-miR-616-5p inhibitor | Oligonucleotides | |
| HY-RI01885A | hsa-miR-616-5p antagomir | Oligonucleotides | |
| HY-RI01886 | hsa-miR-617 inhibitor | Oligonucleotides | |
| HY-RI01886A | hsa-miR-617 antagomir | Oligonucleotides | |
| HY-RI01887 | hsa-miR-618 inhibitor | Oligonucleotides | |
| HY-RI01887A | hsa-miR-618 antagomir | Oligonucleotides | |
| HY-RI01888 | hsa-miR-619-3p inhibitor | Oligonucleotides | |
| HY-RI01888A | hsa-miR-619-3p antagomir | Oligonucleotides | |
| HY-RI01889 | hsa-miR-619-5p inhibitor | Oligonucleotides | |
| HY-RI01889A | hsa-miR-619-5p antagomir | Oligonucleotides | |
| HY-RI01890 | hsa-miR-620 inhibitor | Oligonucleotides | |
| HY-RI01890A | hsa-miR-620 antagomir | Oligonucleotides | |
| HY-RI01891 | hsa-miR-621 inhibitor | Oligonucleotides | |
| HY-RI01891A | hsa-miR-621 antagomir | Oligonucleotides | |
| HY-RI01892 | hsa-miR-623 inhibitor | Oligonucleotides | |
| HY-RI01892A | hsa-miR-623 antagomir | Oligonucleotides | |
| HY-RI01893 | hsa-miR-624-3p inhibitor | Oligonucleotides | |
| HY-RI01893A | hsa-miR-624-3p antagomir | Oligonucleotides | |
| HY-RI01894 | hsa-miR-624-5p inhibitor | Oligonucleotides | |
| HY-RI01894A | hsa-miR-624-5p antagomir | Oligonucleotides | |
| HY-RI01895 | hsa-miR-625-3p inhibitor | Oligonucleotides | |
| HY-RI01895A | hsa-miR-625-3p antagomir | Oligonucleotides | |
| HY-RI01896 | hsa-miR-625-5p inhibitor | Oligonucleotides | |
| HY-RI01896A | hsa-miR-625-5p antagomir | Oligonucleotides | |
| HY-RI01897 | hsa-miR-626 inhibitor | Oligonucleotides | |
| HY-RI01897A | hsa-miR-626 antagomir | Oligonucleotides | |
| HY-RI01898 | hsa-miR-627-3p inhibitor | Oligonucleotides | |
| HY-RI01898A | hsa-miR-627-3p antagomir | Oligonucleotides | |
| HY-RI01899 | hsa-miR-627-5p inhibitor | Oligonucleotides | |
| HY-RI01899A | hsa-miR-627-5p antagomir | Oligonucleotides | |
| HY-RI01900 | hsa-miR-628-3p inhibitor | Oligonucleotides | |
| HY-RI01900A | hsa-miR-628-3p antagomir | Oligonucleotides | |
| HY-RI01901 | hsa-miR-628-5p inhibitor | Oligonucleotides | |
| HY-RI01901A | hsa-miR-628-5p antagomir | Oligonucleotides | |
| HY-RI01902 | hsa-miR-629-3p inhibitor | Oligonucleotides | |
| HY-RI01902A | hsa-miR-629-3p antagomir | Oligonucleotides | |
| HY-RI01903 | hsa-miR-629-5p inhibitor | Oligonucleotides | |
| HY-RI01903A | hsa-miR-629-5p antagomir | Oligonucleotides | |
| HY-RI01904 | hsa-miR-630 inhibitor | Oligonucleotides | |
| HY-RI01904A | hsa-miR-630 antagomir | Oligonucleotides | |
| HY-RI01905 | hsa-miR-631 inhibitor | Oligonucleotides | |
| HY-RI01905A | hsa-miR-631 antagomir | Oligonucleotides | |
| HY-RI01906 | hsa-miR-632 inhibitor | Oligonucleotides | |
| HY-RI01906A | hsa-miR-632 antagomir | Oligonucleotides | |
| HY-RI01907 | hsa-miR-633 inhibitor | Oligonucleotides | |
| HY-RI01907A | hsa-miR-633 antagomir | Oligonucleotides | |
| HY-RI01908 | hsa-miR-634 inhibitor | Oligonucleotides | |
| HY-RI01908A | hsa-miR-634 antagomir | Oligonucleotides | |
| HY-RI01909 | hsa-miR-635 inhibitor | Oligonucleotides | |
| HY-RI01909A | hsa-miR-635 antagomir | Oligonucleotides | |
| HY-RI01910 | hsa-miR-636 inhibitor | Oligonucleotides | |
| HY-RI01910A | hsa-miR-636 antagomir | Oligonucleotides | |
| HY-RI01911 | hsa-miR-637 inhibitor | Oligonucleotides | |
| HY-RI01911A | hsa-miR-637 antagomir | Oligonucleotides | |
| HY-RI01912 | hsa-miR-638 inhibitor | Oligonucleotides | |
| HY-RI01912A | hsa-miR-638 antagomir | Oligonucleotides | |
| HY-RI01913 | hsa-miR-639 inhibitor | Oligonucleotides | |
| HY-RI01913A | hsa-miR-639 antagomir | Oligonucleotides | |
| HY-RI01914 | hsa-miR-640 inhibitor | Oligonucleotides | |
| HY-RI01914A | hsa-miR-640 antagomir | Oligonucleotides | |
| HY-RI01915 | hsa-miR-641 inhibitor | Oligonucleotides | |
| HY-RI01915A | hsa-miR-641 antagomir | Oligonucleotides | |
| HY-RI01916 | hsa-miR-642a-3p inhibitor | Oligonucleotides | |
| HY-RI01916A | hsa-miR-642a-3p antagomir | Oligonucleotides | |
| HY-RI01917 | hsa-miR-642a-5p inhibitor | Oligonucleotides | |
| HY-RI01917A | hsa-miR-642a-5p antagomir | Oligonucleotides | |
| HY-RI01918 | hsa-miR-642b-3p inhibitor | Oligonucleotides | |
| HY-RI01918A | hsa-miR-642b-3p antagomir | Oligonucleotides | |
| HY-RI01919 | hsa-miR-642b-5p inhibitor | Oligonucleotides | |
| HY-RI01919A | hsa-miR-642b-5p antagomir | Oligonucleotides | |
| HY-RI01920 | hsa-miR-644a inhibitor | Oligonucleotides | |
| HY-RI01920A | hsa-miR-644a antagomir | Oligonucleotides | |
| HY-RI01921 | hsa-miR-645 inhibitor | Oligonucleotides | |
| HY-RI01921A | hsa-miR-645 antagomir | Oligonucleotides | |
| HY-RI01922 | hsa-miR-647 inhibitor | Oligonucleotides | |
| HY-RI01922A | hsa-miR-647 antagomir | Oligonucleotides | |
| HY-RI01923 | hsa-miR-648 inhibitor | Oligonucleotides | |
| HY-RI01923A | hsa-miR-648 antagomir | Oligonucleotides | |
| HY-RI01924 | hsa-miR-6499-3p inhibitor | Oligonucleotides | |
| HY-RI01924A | hsa-miR-6499-3p antagomir | Oligonucleotides | |
| HY-RI01925 | hsa-miR-6499-5p inhibitor | Oligonucleotides | |
| HY-RI01925A | hsa-miR-6499-5p antagomir | Oligonucleotides | |
| HY-RI01926 | hsa-miR-650 inhibitor | Oligonucleotides | |
| HY-RI01926A | hsa-miR-650 antagomir | Oligonucleotides | |
| HY-RI01927 | hsa-miR-6500-3p inhibitor | Oligonucleotides | |
| HY-RI01927A | hsa-miR-6500-3p antagomir | Oligonucleotides | |
| HY-RI01928 | hsa-miR-6500-5p inhibitor | Oligonucleotides | |
| HY-RI01928A | hsa-miR-6500-5p antagomir | Oligonucleotides | |
| HY-RI01929 | hsa-miR-6501-3p inhibitor | Oligonucleotides | |
| HY-RI01929A | hsa-miR-6501-3p antagomir | Oligonucleotides | |
| HY-RI01930 | hsa-miR-6501-5p inhibitor | Oligonucleotides | |
| HY-RI01930A | hsa-miR-6501-5p antagomir | Oligonucleotides | |
| HY-RI01931 | hsa-miR-6502-3p inhibitor | Oligonucleotides | |
| HY-RI01931A | hsa-miR-6502-3p antagomir | Oligonucleotides | |
| HY-RI01932 | hsa-miR-6502-5p inhibitor | Oligonucleotides | |
| HY-RI01932A | hsa-miR-6502-5p antagomir | Oligonucleotides | |
| HY-RI01933 | hsa-miR-6503-3p inhibitor | Oligonucleotides | |
| HY-RI01933A | hsa-miR-6503-3p antagomir | Oligonucleotides | |
| HY-RI01934 | hsa-miR-6503-5p inhibitor | Oligonucleotides | |
| HY-RI01934A | hsa-miR-6503-5p antagomir | Oligonucleotides | |
| HY-RI01935 | hsa-miR-6504-3p inhibitor | Oligonucleotides | |
| HY-RI01935A | hsa-miR-6504-3p antagomir | Oligonucleotides | |
| HY-RI01936 | hsa-miR-6504-5p inhibitor | Oligonucleotides | |
| HY-RI01936A | hsa-miR-6504-5p antagomir | Oligonucleotides | |
| HY-RI01937 | hsa-miR-6505-3p inhibitor | Oligonucleotides | |
| HY-RI01937A | hsa-miR-6505-3p antagomir | Oligonucleotides | |
| HY-RI01938 | hsa-miR-6505-5p inhibitor | Oligonucleotides | |
| HY-RI01938A | hsa-miR-6505-5p antagomir | Oligonucleotides | |
| HY-RI01939 | hsa-miR-6506-3p inhibitor | Oligonucleotides | |
| HY-RI01939A | hsa-miR-6506-3p antagomir | Oligonucleotides | |
| HY-RI01940 | hsa-miR-6506-5p inhibitor | Oligonucleotides | |
| HY-RI01940A | hsa-miR-6506-5p antagomir | Oligonucleotides | |
| HY-RI01941 | hsa-miR-6507-3p inhibitor | Oligonucleotides | |
| HY-RI01941A | hsa-miR-6507-3p antagomir | Oligonucleotides | |
| HY-RI01942 | hsa-miR-6507-5p inhibitor | Oligonucleotides | |
| HY-RI01942A | hsa-miR-6507-5p antagomir | Oligonucleotides | |
| HY-RI01943 | hsa-miR-6508-3p inhibitor | Oligonucleotides | |
| HY-RI01943A | hsa-miR-6508-3p antagomir | Oligonucleotides | |
| HY-RI01944 | hsa-miR-6508-5p inhibitor | Oligonucleotides | |
| HY-RI01944A | hsa-miR-6508-5p antagomir | Oligonucleotides | |
| HY-RI01945 | hsa-miR-6509-3p inhibitor | Oligonucleotides | |
| HY-RI01945A | hsa-miR-6509-3p antagomir | Oligonucleotides | |
| HY-RI01946 | hsa-miR-6509-5p inhibitor | Oligonucleotides | |
| HY-RI01946A | hsa-miR-6509-5p antagomir | Oligonucleotides | |
| HY-RI01947 | hsa-miR-6510-3p inhibitor | Oligonucleotides | |
| HY-RI01947A | hsa-miR-6510-3p antagomir | Oligonucleotides | |
| HY-RI01948 | hsa-miR-6510-5p inhibitor | Oligonucleotides | |
| HY-RI01948A | hsa-miR-6510-5p antagomir | Oligonucleotides | |
| HY-RI01949 | hsa-miR-6511a-3p inhibitor | Oligonucleotides | |
| HY-RI01949A | hsa-miR-6511a-3p antagomir | Oligonucleotides | |
| HY-RI01950 | hsa-miR-6511a-5p inhibitor | Oligonucleotides | |
| HY-RI01950A | hsa-miR-6511a-5p antagomir | Oligonucleotides | |
| HY-RI01951 | hsa-miR-6511b-3p inhibitor | Oligonucleotides | |
| HY-RI01951A | hsa-miR-6511b-3p antagomir | Oligonucleotides | |
| HY-RI01952 | hsa-miR-6511b-5p inhibitor | Oligonucleotides | |
| HY-RI01952A | hsa-miR-6511b-5p antagomir | Oligonucleotides | |
| HY-RI01953 | hsa-miR-6512-3p inhibitor | Oligonucleotides | |
| HY-RI01953A | hsa-miR-6512-3p antagomir | Oligonucleotides | |
| HY-RI01954 | hsa-miR-6512-5p inhibitor | Oligonucleotides | |
| HY-RI01954A | hsa-miR-6512-5p antagomir | Oligonucleotides | |
| HY-RI01955 | hsa-miR-6513-3p inhibitor | Oligonucleotides | |
| HY-RI01955A | hsa-miR-6513-3p antagomir | Oligonucleotides | |
| HY-RI01956 | hsa-miR-6513-5p inhibitor | Oligonucleotides | |
| HY-RI01956A | hsa-miR-6513-5p antagomir | Oligonucleotides | |
| HY-RI01957 | hsa-miR-651-3p inhibitor | Oligonucleotides | |
| HY-RI01957A | hsa-miR-651-3p antagomir | Oligonucleotides | |
| HY-RI01958 | hsa-miR-6514-3p inhibitor | Oligonucleotides | |
| HY-RI01958A | hsa-miR-6514-3p antagomir | Oligonucleotides | |
| HY-RI01959 | hsa-miR-6514-5p inhibitor | Oligonucleotides | |
| HY-RI01959A | hsa-miR-6514-5p antagomir | Oligonucleotides | |
| HY-RI01960 | hsa-miR-6515-3p inhibitor | Oligonucleotides | |
| HY-RI01960A | hsa-miR-6515-3p antagomir | Oligonucleotides | |
| HY-RI01961 | hsa-miR-6515-5p inhibitor | Oligonucleotides | |
| HY-RI01961A | hsa-miR-6515-5p antagomir | Oligonucleotides | |
| HY-RI01962 | hsa-miR-651-5p inhibitor | Oligonucleotides | |
| HY-RI01962A | hsa-miR-651-5p antagomir | Oligonucleotides | |
| HY-RI01963 | hsa-miR-6516-3p inhibitor | Oligonucleotides | |
| HY-RI01963A | hsa-miR-6516-3p antagomir | Oligonucleotides | |
| HY-RI01964 | hsa-miR-6516-5p inhibitor | Oligonucleotides | |
| HY-RI01964A | hsa-miR-6516-5p antagomir | Oligonucleotides | |
| HY-RI01965 | hsa-miR-652-3p inhibitor | Oligonucleotides | |
| HY-RI01965A | hsa-miR-652-3p antagomir | Oligonucleotides | |
| HY-RI01966 | hsa-miR-652-5p inhibitor | Oligonucleotides | |
| HY-RI01966A | hsa-miR-652-5p antagomir | Oligonucleotides | |
| HY-RI01967 | hsa-miR-6529-3p inhibitor | Oligonucleotides | |
| HY-RI01967A | hsa-miR-6529-3p antagomir | Oligonucleotides | |
| HY-RI01968 | hsa-miR-6529-5p inhibitor | Oligonucleotides | |
| HY-RI01968A | hsa-miR-6529-5p antagomir | Oligonucleotides | |
| HY-RI01969 | hsa-miR-653-3p inhibitor | Oligonucleotides | |
| HY-RI01969A | hsa-miR-653-3p antagomir | Oligonucleotides | |
| HY-RI01970 | hsa-miR-653-5p inhibitor | Oligonucleotides | |
| HY-RI01970A | hsa-miR-653-5p antagomir | Oligonucleotides | |
| HY-RI01971 | hsa-miR-654-3p inhibitor | Oligonucleotides | |
| HY-RI01971A | hsa-miR-654-3p antagomir | Oligonucleotides | |
| HY-RI01972 | hsa-miR-654-5p inhibitor | Oligonucleotides | |
| HY-RI01972A | hsa-miR-654-5p antagomir | Oligonucleotides | |
| HY-RI01973 | hsa-miR-655-3p inhibitor | Oligonucleotides | |
| HY-RI01973A | hsa-miR-655-3p antagomir | Oligonucleotides | |
| HY-RI01974 | hsa-miR-655-5p inhibitor | Oligonucleotides | |
| HY-RI01974A | hsa-miR-655-5p antagomir | Oligonucleotides | |
| HY-RI01975 | hsa-miR-656-3p inhibitor | Oligonucleotides | |
| HY-RI01975A | hsa-miR-656-3p antagomir | Oligonucleotides | |
| HY-RI01976 | hsa-miR-656-5p inhibitor | Oligonucleotides | |
| HY-RI01976A | hsa-miR-656-5p antagomir | Oligonucleotides | |
| HY-RI01977 | hsa-miR-657 inhibitor | Oligonucleotides | |
| HY-RI01977A | hsa-miR-657 antagomir | Oligonucleotides | |
| HY-RI01978 | hsa-miR-658 inhibitor | Oligonucleotides | |
| HY-RI01978A | hsa-miR-658 antagomir | Oligonucleotides | |
| HY-RI01979 | hsa-miR-659-3p inhibitor | Oligonucleotides | |
| HY-RI01979A | hsa-miR-659-3p antagomir | Oligonucleotides | |
| HY-RI01980 | hsa-miR-659-5p inhibitor | Oligonucleotides | |
| HY-RI01980A | hsa-miR-659-5p antagomir | Oligonucleotides | |
| HY-RI01981 | hsa-miR-660-3p inhibitor | Oligonucleotides | |
| HY-RI01981A | hsa-miR-660-3p antagomir | Oligonucleotides | |
| HY-RI01982 | hsa-miR-660-5p inhibitor | Oligonucleotides | |
| HY-RI01982A | hsa-miR-660-5p antagomir | Oligonucleotides | |
| HY-RI01983 | hsa-miR-661 inhibitor | Oligonucleotides | |
| HY-RI01983A | hsa-miR-661 antagomir | Oligonucleotides | |
| HY-RI01984 | hsa-miR-662 inhibitor | Oligonucleotides | |
| HY-RI01984A | hsa-miR-662 antagomir | Oligonucleotides | |
| HY-RI01985 | hsa-miR-663b inhibitor | Oligonucleotides | |
| HY-RI01985A | hsa-miR-663b antagomir | Oligonucleotides | |
| HY-RI01986 | hsa-miR-664a-5p inhibitor | Oligonucleotides | |
| HY-RI01986A | hsa-miR-664a-5p antagomir | Oligonucleotides | |
| HY-RI01987 | hsa-miR-664b-3p inhibitor | Oligonucleotides | |
| HY-RI01987A | hsa-miR-664b-3p antagomir | Oligonucleotides | |
| HY-RI01988 | hsa-miR-664b-5p inhibitor | Oligonucleotides | |
| HY-RI01988A | hsa-miR-664b-5p antagomir | Oligonucleotides | |
| HY-RI01989 | hsa-miR-665 inhibitor | Oligonucleotides | |
| HY-RI01989A | hsa-miR-665 antagomir | Oligonucleotides | |
| HY-RI01990 | hsa-miR-668-5p inhibitor | Oligonucleotides | |
| HY-RI01990A | hsa-miR-668-5p antagomir | Oligonucleotides | |
| HY-RI01991 | hsa-miR-670-3p inhibitor | Oligonucleotides | |
| HY-RI01991A | hsa-miR-670-3p antagomir | Oligonucleotides | |
| HY-RI01992 | hsa-miR-670-5p inhibitor | Oligonucleotides | |
| HY-RI01992A | hsa-miR-670-5p antagomir | Oligonucleotides | |
| HY-RI01993 | hsa-miR-671-3p inhibitor | Oligonucleotides | |
| HY-RI01993A | hsa-miR-671-3p antagomir | Oligonucleotides | |
| HY-RI01994 | hsa-miR-6715a-3p inhibitor | Oligonucleotides | |
| HY-RI01994A | hsa-miR-6715a-3p antagomir | Oligonucleotides | |
| HY-RI01995 | hsa-miR-6715b-3p inhibitor | Oligonucleotides | |
| HY-RI01995A | hsa-miR-6715b-3p antagomir | Oligonucleotides | |
| HY-RI01996 | hsa-miR-6715b-5p inhibitor | Oligonucleotides | |
| HY-RI01996A | hsa-miR-6715b-5p antagomir | Oligonucleotides | |
| HY-RI01997 | hsa-miR-671-5p inhibitor | Oligonucleotides | |
| HY-RI01997A | hsa-miR-671-5p antagomir | Oligonucleotides | |
| HY-RI01998 | hsa-miR-6716-3p inhibitor | Oligonucleotides | |
| HY-RI01998A | hsa-miR-6716-3p antagomir | Oligonucleotides | |
| HY-RI01999 | hsa-miR-6716-5p inhibitor | Oligonucleotides | |
| HY-RI01999A | hsa-miR-6716-5p antagomir | Oligonucleotides | |
| HY-RI02000 | hsa-miR-6717-5p inhibitor | Oligonucleotides | |
| HY-RI02000A | hsa-miR-6717-5p antagomir | Oligonucleotides | |
| HY-RI02001 | hsa-miR-6718-5p inhibitor | Oligonucleotides | |
| HY-RI02001A | hsa-miR-6718-5p antagomir | Oligonucleotides | |
| HY-RI02002 | hsa-miR-6719-3p inhibitor | Oligonucleotides | |
| HY-RI02002A | hsa-miR-6719-3p antagomir | Oligonucleotides | |
| HY-RI02003 | hsa-miR-6720-3p inhibitor | Oligonucleotides | |
| HY-RI02003A | hsa-miR-6720-3p antagomir | Oligonucleotides | |
| HY-RI02004 | hsa-miR-6720-5p inhibitor | Oligonucleotides | |
| HY-RI02004A | hsa-miR-6720-5p antagomir | Oligonucleotides | |
| HY-RI02005 | hsa-miR-6721-5p inhibitor | Oligonucleotides | |
| HY-RI02005A | hsa-miR-6721-5p antagomir | Oligonucleotides | |
| HY-RI02006 | hsa-miR-6722-3p inhibitor | Oligonucleotides | |
| HY-RI02006A | hsa-miR-6722-3p antagomir | Oligonucleotides | |
| HY-RI02007 | hsa-miR-6722-5p inhibitor | Oligonucleotides | |
| HY-RI02007A | hsa-miR-6722-5p antagomir | Oligonucleotides | |
| HY-RI02008 | hsa-miR-6724-5p inhibitor | Oligonucleotides | |
| HY-RI02008A | hsa-miR-6724-5p antagomir | Oligonucleotides | |
| HY-RI02009 | hsa-miR-6726-3p inhibitor | Oligonucleotides | |
| HY-RI02009A | hsa-miR-6726-3p antagomir | Oligonucleotides | |
| HY-RI02010 | hsa-miR-6726-5p inhibitor | Oligonucleotides | |
| HY-RI02010A | hsa-miR-6726-5p antagomir | Oligonucleotides | |
| HY-RI02011 | hsa-miR-6727-3p inhibitor | Oligonucleotides | |
| HY-RI02011A | hsa-miR-6727-3p antagomir | Oligonucleotides | |
| HY-RI02012 | hsa-miR-6727-5p inhibitor | Oligonucleotides | |
| HY-RI02012A | hsa-miR-6727-5p antagomir | Oligonucleotides | |
| HY-RI02013 | hsa-miR-6728-3p inhibitor | Oligonucleotides | |
| HY-RI02013A | hsa-miR-6728-3p antagomir | Oligonucleotides | |
| HY-RI02014 | hsa-miR-6728-5p inhibitor | Oligonucleotides | |
| HY-RI02014A | hsa-miR-6728-5p antagomir | Oligonucleotides | |
| HY-RI02015 | hsa-miR-6729-3p inhibitor | Oligonucleotides | |
| HY-RI02015A | hsa-miR-6729-3p antagomir | Oligonucleotides | |
| HY-RI02016 | hsa-miR-6729-5p inhibitor | Oligonucleotides | |
| HY-RI02016A | hsa-miR-6729-5p antagomir | Oligonucleotides | |
| HY-RI02017 | hsa-miR-6730-3p inhibitor | Oligonucleotides | |
| HY-RI02017A | hsa-miR-6730-3p antagomir | Oligonucleotides | |
| HY-RI02018 | hsa-miR-6730-5p inhibitor | Oligonucleotides | |
| HY-RI02018A | hsa-miR-6730-5p antagomir | Oligonucleotides | |
| HY-RI02019 | hsa-miR-6731-3p inhibitor | Oligonucleotides | |
| HY-RI02019A | hsa-miR-6731-3p antagomir | Oligonucleotides | |
| HY-RI02020 | hsa-miR-6731-5p inhibitor | Oligonucleotides | |
| HY-RI02020A | hsa-miR-6731-5p antagomir | Oligonucleotides | |
| HY-RI02021 | hsa-miR-6732-3p inhibitor | Oligonucleotides | |
| HY-RI02021A | hsa-miR-6732-3p antagomir | Oligonucleotides | |
| HY-RI02022 | hsa-miR-6732-5p inhibitor | Oligonucleotides | |
| HY-RI02022A | hsa-miR-6732-5p antagomir | Oligonucleotides | |
| HY-RI02023 | hsa-miR-6733-3p inhibitor | Oligonucleotides | |
| HY-RI02023A | hsa-miR-6733-3p antagomir | Oligonucleotides | |
| HY-RI02024 | hsa-miR-6733-5p inhibitor | Oligonucleotides | |
| HY-RI02024A | hsa-miR-6733-5p antagomir | Oligonucleotides | |
| HY-RI02025 | hsa-miR-6734-3p inhibitor | Oligonucleotides | |
| HY-RI02025A | hsa-miR-6734-3p antagomir | Oligonucleotides | |
| HY-RI02026 | hsa-miR-6734-5p inhibitor | Oligonucleotides | |
| HY-RI02026A | hsa-miR-6734-5p antagomir | Oligonucleotides | |
| HY-RI02027 | hsa-miR-6735-3p inhibitor | Oligonucleotides | |
| HY-RI02027A | hsa-miR-6735-3p antagomir | Oligonucleotides | |
| HY-RI02028 | hsa-miR-6735-5p inhibitor | Oligonucleotides | |
| HY-RI02028A | hsa-miR-6735-5p antagomir | Oligonucleotides | |
| HY-RI02029 | hsa-miR-6736-3p inhibitor | Oligonucleotides | |
| HY-RI02029A | hsa-miR-6736-3p antagomir | Oligonucleotides | |
| HY-RI02030 | hsa-miR-6736-5p inhibitor | Oligonucleotides | |
| HY-RI02030A | hsa-miR-6736-5p antagomir | Oligonucleotides | |
| HY-RI02031 | hsa-miR-6737-3p inhibitor | Oligonucleotides | |
| HY-RI02031A | hsa-miR-6737-3p antagomir | Oligonucleotides | |
| HY-RI02032 | hsa-miR-6737-5p inhibitor | Oligonucleotides | |
| HY-RI02032A | hsa-miR-6737-5p antagomir | Oligonucleotides | |
| HY-RI02033 | hsa-miR-6738-3p inhibitor | Oligonucleotides | |
| HY-RI02033A | hsa-miR-6738-3p antagomir | Oligonucleotides | |
| HY-RI02034 | hsa-miR-6738-5p inhibitor | Oligonucleotides | |
| HY-RI02034A | hsa-miR-6738-5p antagomir | Oligonucleotides | |
| HY-RI02035 | hsa-miR-6739-3p inhibitor | Oligonucleotides | |
| HY-RI02035A | hsa-miR-6739-3p antagomir | Oligonucleotides | |
| HY-RI02036 | hsa-miR-6739-5p inhibitor | Oligonucleotides | |
| HY-RI02036A | hsa-miR-6739-5p antagomir | Oligonucleotides | |
| HY-RI02037 | hsa-miR-6740-3p inhibitor | Oligonucleotides | |
| HY-RI02037A | hsa-miR-6740-3p antagomir | Oligonucleotides | |
| HY-RI02038 | hsa-miR-6740-5p inhibitor | Oligonucleotides | |
| HY-RI02038A | hsa-miR-6740-5p antagomir | Oligonucleotides | |
| HY-RI02039 | hsa-miR-6741-3p inhibitor | Oligonucleotides | |
| HY-RI02039A | hsa-miR-6741-3p antagomir | Oligonucleotides | |
| HY-RI02040 | hsa-miR-6741-5p inhibitor | Oligonucleotides | |
| HY-RI02040A | hsa-miR-6741-5p antagomir | Oligonucleotides | |
| HY-RI02041 | hsa-miR-6742-3p inhibitor | Oligonucleotides | |
| HY-RI02041A | hsa-miR-6742-3p antagomir | Oligonucleotides | |
| HY-RI02042 | hsa-miR-6742-5p inhibitor | Oligonucleotides | |
| HY-RI02042A | hsa-miR-6742-5p antagomir | Oligonucleotides | |
| HY-RI02043 | hsa-miR-6743-3p inhibitor | Oligonucleotides | |
| HY-RI02043A | hsa-miR-6743-3p antagomir | Oligonucleotides | |
| HY-RI02044 | hsa-miR-6743-5p inhibitor | Oligonucleotides | |
| HY-RI02044A | hsa-miR-6743-5p antagomir | Oligonucleotides | |
| HY-RI02045 | hsa-miR-6744-3p inhibitor | Oligonucleotides | |
| HY-RI02045A | hsa-miR-6744-3p antagomir | Oligonucleotides | |
| HY-RI02046 | hsa-miR-6744-5p inhibitor | Oligonucleotides | |
| HY-RI02046A | hsa-miR-6744-5p antagomir | Oligonucleotides | |
| HY-RI02047 | hsa-miR-6745 inhibitor | Oligonucleotides | |
| HY-RI02047A | hsa-miR-6745 antagomir | Oligonucleotides | |
| HY-RI02048 | hsa-miR-6746-3p inhibitor | Oligonucleotides | |
| HY-RI02048A | hsa-miR-6746-3p antagomir | Oligonucleotides | |
| HY-RI02049 | hsa-miR-6746-5p inhibitor | Oligonucleotides | |
| HY-RI02049A | hsa-miR-6746-5p antagomir | Oligonucleotides | |
| HY-RI02050 | hsa-miR-6747-3p inhibitor | Oligonucleotides | |
| HY-RI02050A | hsa-miR-6747-3p antagomir | Oligonucleotides | |
| HY-RI02051 | hsa-miR-6747-5p inhibitor | Oligonucleotides | |
| HY-RI02051A | hsa-miR-6747-5p antagomir | Oligonucleotides | |
| HY-RI02052 | hsa-miR-6748-3p inhibitor | Oligonucleotides | |
| HY-RI02052A | hsa-miR-6748-3p antagomir | Oligonucleotides | |
| HY-RI02053 | hsa-miR-6748-5p inhibitor | Oligonucleotides | |
| HY-RI02053A | hsa-miR-6748-5p antagomir | Oligonucleotides | |
| HY-RI02054 | hsa-miR-6749-3p inhibitor | Oligonucleotides | |
| HY-RI02054A | hsa-miR-6749-3p antagomir | Oligonucleotides | |
| HY-RI02055 | hsa-miR-6749-5p inhibitor | Oligonucleotides | |
| HY-RI02055A | hsa-miR-6749-5p antagomir | Oligonucleotides | |
| HY-RI02056 | hsa-miR-6750-3p inhibitor | Oligonucleotides | |
| HY-RI02056A | hsa-miR-6750-3p antagomir | Oligonucleotides | |
| HY-RI02057 | hsa-miR-6750-5p inhibitor | Oligonucleotides | |
| HY-RI02057A | hsa-miR-6750-5p antagomir | Oligonucleotides | |
| HY-RI02058 | hsa-miR-6751-3p inhibitor | Oligonucleotides | |
| HY-RI02058A | hsa-miR-6751-3p antagomir | Oligonucleotides | |
| HY-RI02059 | hsa-miR-6751-5p inhibitor | Oligonucleotides | |
| HY-RI02059A | hsa-miR-6751-5p antagomir | Oligonucleotides | |
| HY-RI02060 | hsa-miR-6752-3p inhibitor | Oligonucleotides | |
| HY-RI02060A | hsa-miR-6752-3p antagomir | Oligonucleotides | |
| HY-RI02061 | hsa-miR-6752-5p inhibitor | Oligonucleotides | |
| HY-RI02061A | hsa-miR-6752-5p antagomir | Oligonucleotides | |
| HY-RI02062 | hsa-miR-6753-3p inhibitor | Oligonucleotides | |
| HY-RI02062A | hsa-miR-6753-3p antagomir | Oligonucleotides | |
| HY-RI02063 | hsa-miR-6753-5p inhibitor | Oligonucleotides | |
| HY-RI02063A | hsa-miR-6753-5p antagomir | Oligonucleotides | |
| HY-RI02064 | hsa-miR-675-3p inhibitor | Oligonucleotides | |
| HY-RI02064A | hsa-miR-675-3p antagomir | Oligonucleotides | |
| HY-RI02065 | hsa-miR-6754-3p inhibitor | Oligonucleotides | |
| HY-RI02065A | hsa-miR-6754-3p antagomir | Oligonucleotides | |
| HY-RI02066 | hsa-miR-6754-5p inhibitor | Oligonucleotides | |
| HY-RI02066A | hsa-miR-6754-5p antagomir | Oligonucleotides | |
| HY-RI02067 | hsa-miR-6755-3p inhibitor | Oligonucleotides | |
| HY-RI02067A | hsa-miR-6755-3p antagomir | Oligonucleotides | |
| HY-RI02068 | hsa-miR-6755-5p inhibitor | Oligonucleotides | |
| HY-RI02068A | hsa-miR-6755-5p antagomir | Oligonucleotides | |
| HY-RI02069 | hsa-miR-675-5p inhibitor | Oligonucleotides | |
| HY-RI02069A | hsa-miR-675-5p antagomir | Oligonucleotides | |
| HY-RI02070 | hsa-miR-6756-3p inhibitor | Oligonucleotides | |
| HY-RI02070A | hsa-miR-6756-3p antagomir | Oligonucleotides | |
| HY-RI02071 | hsa-miR-6756-5p inhibitor | Oligonucleotides | |
| HY-RI02071A | hsa-miR-6756-5p antagomir | Oligonucleotides | |
| HY-RI02072 | hsa-miR-6757-3p inhibitor | Oligonucleotides | |
| HY-RI02072A | hsa-miR-6757-3p antagomir | Oligonucleotides | |
| HY-RI02073 | hsa-miR-6757-5p inhibitor | Oligonucleotides | |
| HY-RI02073A | hsa-miR-6757-5p antagomir | Oligonucleotides | |
| HY-RI02074 | hsa-miR-6758-3p inhibitor | Oligonucleotides | |
| HY-RI02074A | hsa-miR-6758-3p antagomir | Oligonucleotides | |
| HY-RI02075 | hsa-miR-6758-5p inhibitor | Oligonucleotides | |
| HY-RI02075A | hsa-miR-6758-5p antagomir | Oligonucleotides | |
| HY-RI02076 | hsa-miR-6759-3p inhibitor | Oligonucleotides | |
| HY-RI02076A | hsa-miR-6759-3p antagomir | Oligonucleotides | |
| HY-RI02077 | hsa-miR-6759-5p inhibitor | Oligonucleotides | |
| HY-RI02077A | hsa-miR-6759-5p antagomir | Oligonucleotides | |
| HY-RI02078 | hsa-miR-6760-3p inhibitor | Oligonucleotides | |
| HY-RI02078A | hsa-miR-6760-3p antagomir | Oligonucleotides | |
| HY-RI02079 | hsa-miR-6760-5p inhibitor | Oligonucleotides | |
| HY-RI02079A | hsa-miR-6760-5p antagomir | Oligonucleotides | |
| HY-RI02080 | hsa-miR-6761-3p inhibitor | Oligonucleotides | |
| HY-RI02080A | hsa-miR-6761-3p antagomir | Oligonucleotides | |
| HY-RI02081 | hsa-miR-6761-5p inhibitor | Oligonucleotides | |
| HY-RI02081A | hsa-miR-6761-5p antagomir | Oligonucleotides | |
| HY-RI02082 | hsa-miR-6762-3p inhibitor | Oligonucleotides | |
| HY-RI02082A | hsa-miR-6762-3p antagomir | Oligonucleotides | |
| HY-RI02083 | hsa-miR-6762-5p inhibitor | Oligonucleotides | |
| HY-RI02083A | hsa-miR-6762-5p antagomir | Oligonucleotides | |
| HY-RI02084 | hsa-miR-6763-3p inhibitor | Oligonucleotides | |
| HY-RI02084A | hsa-miR-6763-3p antagomir | Oligonucleotides | |
| HY-RI02085 | hsa-miR-6763-5p inhibitor | Oligonucleotides | |
| HY-RI02085A | hsa-miR-6763-5p antagomir | Oligonucleotides | |
| HY-RI02086 | hsa-miR-676-3p inhibitor | Oligonucleotides | |
| HY-RI02086A | hsa-miR-676-3p antagomir | Oligonucleotides | |
| HY-RI02087 | hsa-miR-6764-3p inhibitor | Oligonucleotides | |
| HY-RI02087A | hsa-miR-6764-3p antagomir | Oligonucleotides | |
| HY-RI02088 | hsa-miR-6764-5p inhibitor | Oligonucleotides | |
| HY-RI02088A | hsa-miR-6764-5p antagomir | Oligonucleotides | |
| HY-RI02089 | hsa-miR-6765-3p inhibitor | Oligonucleotides | |
| HY-RI02089A | hsa-miR-6765-3p antagomir | Oligonucleotides | |
| HY-RI02090 | hsa-miR-6765-5p inhibitor | Oligonucleotides | |
| HY-RI02090A | hsa-miR-6765-5p antagomir | Oligonucleotides | |
| HY-RI02091 | hsa-miR-676-5p inhibitor | Oligonucleotides | |
| HY-RI02091A | hsa-miR-676-5p antagomir | Oligonucleotides | |
| HY-RI02092 | hsa-miR-6766-3p inhibitor | Oligonucleotides | |
| HY-RI02092A | hsa-miR-6766-3p antagomir | Oligonucleotides | |
| HY-RI02093 | hsa-miR-6766-5p inhibitor | Oligonucleotides | |
| HY-RI02093A | hsa-miR-6766-5p antagomir | Oligonucleotides | |
| HY-RI02094 | hsa-miR-6767-3p inhibitor | Oligonucleotides | |
| HY-RI02094A | hsa-miR-6767-3p antagomir | Oligonucleotides | |
| HY-RI02095 | hsa-miR-6767-5p inhibitor | Oligonucleotides | |
| HY-RI02095A | hsa-miR-6767-5p antagomir | Oligonucleotides | |
| HY-RI02096 | hsa-miR-6768-3p inhibitor | Oligonucleotides | |
| HY-RI02096A | hsa-miR-6768-3p antagomir | Oligonucleotides | |
| HY-RI02097 | hsa-miR-6768-5p inhibitor | Oligonucleotides | |
| HY-RI02097A | hsa-miR-6768-5p antagomir | Oligonucleotides | |
| HY-RI02098 | hsa-miR-6769a-3p inhibitor | Oligonucleotides | |
| HY-RI02098A | hsa-miR-6769a-3p antagomir | Oligonucleotides | |
| HY-RI02099 | hsa-miR-6769a-5p inhibitor | Oligonucleotides | |
| HY-RI02099A | hsa-miR-6769a-5p antagomir | Oligonucleotides | |
| HY-RI02100 | hsa-miR-6769b-3p inhibitor | Oligonucleotides | |
| HY-RI02100A | hsa-miR-6769b-3p antagomir | Oligonucleotides | |
| HY-RI02101 | hsa-miR-6769b-5p inhibitor | Oligonucleotides | |
| HY-RI02101A | hsa-miR-6769b-5p antagomir | Oligonucleotides | |
| HY-RI02102 | hsa-miR-6770-3p inhibitor | Oligonucleotides | |
| HY-RI02102A | hsa-miR-6770-3p antagomir | Oligonucleotides | |
| HY-RI02103 | hsa-miR-6770-5p inhibitor | Oligonucleotides | |
| HY-RI02103A | hsa-miR-6770-5p antagomir | Oligonucleotides | |
| HY-RI02104 | hsa-miR-6771-3p inhibitor | Oligonucleotides | |
| HY-RI02104A | hsa-miR-6771-3p antagomir | Oligonucleotides | |
| HY-RI02105 | hsa-miR-6771-5p inhibitor | Oligonucleotides | |
| HY-RI02105A | hsa-miR-6771-5p antagomir | Oligonucleotides | |
| HY-RI02106 | hsa-miR-6772-3p inhibitor | Oligonucleotides | |
| HY-RI02106A | hsa-miR-6772-3p antagomir | Oligonucleotides | |
| HY-RI02107 | hsa-miR-6772-5p inhibitor | Oligonucleotides | |
| HY-RI02107A | hsa-miR-6772-5p antagomir | Oligonucleotides | |
| HY-RI02108 | hsa-miR-6773-3p inhibitor | Oligonucleotides | |
| HY-RI02108A | hsa-miR-6773-3p antagomir | Oligonucleotides | |
| HY-RI02109 | hsa-miR-6773-5p inhibitor | Oligonucleotides | |
| HY-RI02109A | hsa-miR-6773-5p antagomir | Oligonucleotides | |
| HY-RI02110 | hsa-miR-6774-3p inhibitor | Oligonucleotides | |
| HY-RI02110A | hsa-miR-6774-3p antagomir | Oligonucleotides | |
| HY-RI02111 | hsa-miR-6774-5p inhibitor | Oligonucleotides | |
| HY-RI02111A | hsa-miR-6774-5p antagomir | Oligonucleotides | |
| HY-RI02112 | hsa-miR-6775-3p inhibitor | Oligonucleotides | |
| HY-RI02112A | hsa-miR-6775-3p antagomir | Oligonucleotides | |
| HY-RI02113 | hsa-miR-6775-5p inhibitor | Oligonucleotides | |
| HY-RI02113A | hsa-miR-6775-5p antagomir | Oligonucleotides | |
| HY-RI02114 | hsa-miR-6776-3p inhibitor | Oligonucleotides | |
| HY-RI02114A | hsa-miR-6776-3p antagomir | Oligonucleotides | |
| HY-RI02115 | hsa-miR-6776-5p inhibitor | Oligonucleotides | |
| HY-RI02115A | hsa-miR-6776-5p antagomir | Oligonucleotides | |
| HY-RI02116 | hsa-miR-6777-3p inhibitor | Oligonucleotides | |
| HY-RI02116A | hsa-miR-6777-3p antagomir | Oligonucleotides | |
| HY-RI02117 | hsa-miR-6777-5p inhibitor | Oligonucleotides | |
| HY-RI02117A | hsa-miR-6777-5p antagomir | Oligonucleotides | |
| HY-RI02118 | hsa-miR-6778-3p inhibitor | Oligonucleotides | |
| HY-RI02118A | hsa-miR-6778-3p antagomir | Oligonucleotides | |
| HY-RI02119 | hsa-miR-6778-5p inhibitor | Oligonucleotides | |
| HY-RI02119A | hsa-miR-6778-5p antagomir | Oligonucleotides | |
| HY-RI02120 | hsa-miR-6779-3p inhibitor | Oligonucleotides | |
| HY-RI02120A | hsa-miR-6779-3p antagomir | Oligonucleotides | |
| HY-RI02121 | hsa-miR-6779-5p inhibitor | Oligonucleotides | |
| HY-RI02121A | hsa-miR-6779-5p antagomir | Oligonucleotides | |
| HY-RI02122 | hsa-miR-6780a-3p inhibitor | Oligonucleotides | |
| HY-RI02122A | hsa-miR-6780a-3p antagomir | Oligonucleotides | |
| HY-RI02123 | hsa-miR-6780a-5p inhibitor | Oligonucleotides | |
| HY-RI02123A | hsa-miR-6780a-5p antagomir | Oligonucleotides | |
| HY-RI02124 | hsa-miR-6780b-3p inhibitor | Oligonucleotides | |
| HY-RI02124A | hsa-miR-6780b-3p antagomir | Oligonucleotides | |
| HY-RI02125 | hsa-miR-6780b-5p inhibitor | Oligonucleotides | |
| HY-RI02125A | hsa-miR-6780b-5p antagomir | Oligonucleotides | |
| HY-RI02126 | hsa-miR-6781-3p inhibitor | Oligonucleotides | |
| HY-RI02126A | hsa-miR-6781-3p antagomir | Oligonucleotides | |
| HY-RI02127 | hsa-miR-6781-5p inhibitor | Oligonucleotides | |
| HY-RI02127A | hsa-miR-6781-5p antagomir | Oligonucleotides | |
| HY-RI02128 | hsa-miR-6782-3p inhibitor | Oligonucleotides | |
| HY-RI02128A | hsa-miR-6782-3p antagomir | Oligonucleotides | |
| HY-RI02129 | hsa-miR-6782-5p inhibitor | Oligonucleotides | |
| HY-RI02129A | hsa-miR-6782-5p antagomir | Oligonucleotides | |
| HY-RI02130 | hsa-miR-6783-3p inhibitor | Oligonucleotides | |
| HY-RI02130A | hsa-miR-6783-3p antagomir | Oligonucleotides | |
| HY-RI02131 | hsa-miR-6783-5p inhibitor | Oligonucleotides | |
| HY-RI02131A | hsa-miR-6783-5p antagomir | Oligonucleotides | |
| HY-RI02132 | hsa-miR-6784-3p inhibitor | Oligonucleotides | |
| HY-RI02132A | hsa-miR-6784-3p antagomir | Oligonucleotides | |
| HY-RI02133 | hsa-miR-6784-5p inhibitor | Oligonucleotides | |
| HY-RI02133A | hsa-miR-6784-5p antagomir | Oligonucleotides | |
| HY-RI02134 | hsa-miR-6785-3p inhibitor | Oligonucleotides | |
| HY-RI02134A | hsa-miR-6785-3p antagomir | Oligonucleotides | |
| HY-RI02135 | hsa-miR-6785-5p inhibitor | Oligonucleotides | |
| HY-RI02135A | hsa-miR-6785-5p antagomir | Oligonucleotides | |
| HY-RI02136 | hsa-miR-6786-3p inhibitor | Oligonucleotides | |
| HY-RI02136A | hsa-miR-6786-3p antagomir | Oligonucleotides | |
| HY-RI02137 | hsa-miR-6786-5p inhibitor | Oligonucleotides | |
| HY-RI02137A | hsa-miR-6786-5p antagomir | Oligonucleotides | |
| HY-RI02138 | hsa-miR-6787-3p inhibitor | Oligonucleotides | |
| HY-RI02138A | hsa-miR-6787-3p antagomir | Oligonucleotides | |
| HY-RI02139 | hsa-miR-6787-5p inhibitor | Oligonucleotides | |
| HY-RI02139A | hsa-miR-6787-5p antagomir | Oligonucleotides | |
| HY-RI02140 | hsa-miR-6788-3p inhibitor | Oligonucleotides | |
| HY-RI02140A | hsa-miR-6788-3p antagomir | Oligonucleotides | |
| HY-RI02141 | hsa-miR-6788-5p inhibitor | Oligonucleotides | |
| HY-RI02141A | hsa-miR-6788-5p antagomir | Oligonucleotides | |
| HY-RI02142 | hsa-miR-6789-3p inhibitor | Oligonucleotides | |
| HY-RI02142A | hsa-miR-6789-3p antagomir | Oligonucleotides | |
| HY-RI02143 | hsa-miR-6789-5p inhibitor | Oligonucleotides | |
| HY-RI02143A | hsa-miR-6789-5p antagomir | Oligonucleotides | |
| HY-RI02144 | hsa-miR-6790-3p inhibitor | Oligonucleotides | |
| HY-RI02144A | hsa-miR-6790-3p antagomir | Oligonucleotides | |
| HY-RI02145 | hsa-miR-6790-5p inhibitor | Oligonucleotides | |
| HY-RI02145A | hsa-miR-6790-5p antagomir | Oligonucleotides | |
| HY-RI02146 | hsa-miR-6791-3p inhibitor | Oligonucleotides | |
| HY-RI02146A | hsa-miR-6791-3p antagomir | Oligonucleotides | |
| HY-RI02147 | hsa-miR-6791-5p inhibitor | Oligonucleotides | |
| HY-RI02147A | hsa-miR-6791-5p antagomir | Oligonucleotides | |
| HY-RI02148 | hsa-miR-6792-3p inhibitor | Oligonucleotides | |
| HY-RI02148A | hsa-miR-6792-3p antagomir | Oligonucleotides | |
| HY-RI02149 | hsa-miR-6792-5p inhibitor | Oligonucleotides | |
| HY-RI02149A | hsa-miR-6792-5p antagomir | Oligonucleotides | |
| HY-RI02150 | hsa-miR-6793-3p inhibitor | Oligonucleotides | |
| HY-RI02150A | hsa-miR-6793-3p antagomir | Oligonucleotides | |
| HY-RI02151 | hsa-miR-6793-5p inhibitor | Oligonucleotides | |
| HY-RI02151A | hsa-miR-6793-5p antagomir | Oligonucleotides | |
| HY-RI02152 | hsa-miR-6794-3p inhibitor | Oligonucleotides | |
| HY-RI02152A | hsa-miR-6794-3p antagomir | Oligonucleotides | |
| HY-RI02153 | hsa-miR-6794-5p inhibitor | Oligonucleotides | |
| HY-RI02153A | hsa-miR-6794-5p antagomir | Oligonucleotides | |
| HY-RI02154 | hsa-miR-6795-3p inhibitor | Oligonucleotides | |
| HY-RI02154A | hsa-miR-6795-3p antagomir | Oligonucleotides | |
| HY-RI02155 | hsa-miR-6795-5p inhibitor | Oligonucleotides | |
| HY-RI02155A | hsa-miR-6795-5p antagomir | Oligonucleotides | |
| HY-RI02156 | hsa-miR-6796-3p inhibitor | Oligonucleotides | |
| HY-RI02156A | hsa-miR-6796-3p antagomir | Oligonucleotides | |
| HY-RI02157 | hsa-miR-6796-5p inhibitor | Oligonucleotides | |
| HY-RI02157A | hsa-miR-6796-5p antagomir | Oligonucleotides | |
| HY-RI02158 | hsa-miR-6797-3p inhibitor | Oligonucleotides | |
| HY-RI02158A | hsa-miR-6797-3p antagomir | Oligonucleotides | |
| HY-RI02159 | hsa-miR-6797-5p inhibitor | Oligonucleotides | |
| HY-RI02159A | hsa-miR-6797-5p antagomir | Oligonucleotides | |
| HY-RI02160 | hsa-miR-6798-3p inhibitor | Oligonucleotides | |
| HY-RI02160A | hsa-miR-6798-3p antagomir | Oligonucleotides | |
| HY-RI02161 | hsa-miR-6798-5p inhibitor | Oligonucleotides | |
| HY-RI02161A | hsa-miR-6798-5p antagomir | Oligonucleotides | |
| HY-RI02162 | hsa-miR-6799-3p inhibitor | Oligonucleotides | |
| HY-RI02162A | hsa-miR-6799-3p antagomir | Oligonucleotides | |
| HY-RI02163 | hsa-miR-6799-5p inhibitor | Oligonucleotides | |
| HY-RI02163A | hsa-miR-6799-5p antagomir | Oligonucleotides | |
| HY-RI02164 | hsa-miR-6800-3p inhibitor | Oligonucleotides | |
| HY-RI02164A | hsa-miR-6800-3p antagomir | Oligonucleotides | |
| HY-RI02165 | hsa-miR-6800-5p inhibitor | Oligonucleotides | |
| HY-RI02165A | hsa-miR-6800-5p antagomir | Oligonucleotides | |
| HY-RI02166 | hsa-miR-6801-3p inhibitor | Oligonucleotides | |
| HY-RI02166A | hsa-miR-6801-3p antagomir | Oligonucleotides | |
| HY-RI02167 | hsa-miR-6801-5p inhibitor | Oligonucleotides | |
| HY-RI02167A | hsa-miR-6801-5p antagomir | Oligonucleotides | |
| HY-RI02168 | hsa-miR-6802-3p inhibitor | Oligonucleotides | |
| HY-RI02168A | hsa-miR-6802-3p antagomir | Oligonucleotides | |
| HY-RI02169 | hsa-miR-6802-5p inhibitor | Oligonucleotides | |
| HY-RI02169A | hsa-miR-6802-5p antagomir | Oligonucleotides | |
| HY-RI02170 | hsa-miR-6803-3p inhibitor | Oligonucleotides | |
| HY-RI02170A | hsa-miR-6803-3p antagomir | Oligonucleotides | |
| HY-RI02171 | hsa-miR-6803-5p inhibitor | Oligonucleotides | |
| HY-RI02171A | hsa-miR-6803-5p antagomir | Oligonucleotides | |
| HY-RI02172 | hsa-miR-6804-3p inhibitor | Oligonucleotides | |
| HY-RI02172A | hsa-miR-6804-3p antagomir | Oligonucleotides | |
| HY-RI02173 | hsa-miR-6804-5p inhibitor | Oligonucleotides | |
| HY-RI02173A | hsa-miR-6804-5p antagomir | Oligonucleotides | |
| HY-RI02174 | hsa-miR-6805-3p inhibitor | Oligonucleotides | |
| HY-RI02174A | hsa-miR-6805-3p antagomir | Oligonucleotides | |
| HY-RI02175 | hsa-miR-6805-5p inhibitor | Oligonucleotides | |
| HY-RI02175A | hsa-miR-6805-5p antagomir | Oligonucleotides | |
| HY-RI02176 | hsa-miR-6806-3p inhibitor | Oligonucleotides | |
| HY-RI02176A | hsa-miR-6806-3p antagomir | Oligonucleotides | |
| HY-RI02177 | hsa-miR-6806-5p inhibitor | Oligonucleotides | |
| HY-RI02177A | hsa-miR-6806-5p antagomir | Oligonucleotides | |
| HY-RI02178 | hsa-miR-6807-3p inhibitor | Oligonucleotides | |
| HY-RI02178A | hsa-miR-6807-3p antagomir | Oligonucleotides | |
| HY-RI02179 | hsa-miR-6807-5p inhibitor | Oligonucleotides | |
| HY-RI02179A | hsa-miR-6807-5p antagomir | Oligonucleotides | |
| HY-RI02180 | hsa-miR-6808-3p inhibitor | Oligonucleotides | |
| HY-RI02180A | hsa-miR-6808-3p antagomir | Oligonucleotides | |
| HY-RI02181 | hsa-miR-6808-5p inhibitor | Oligonucleotides | |
| HY-RI02181A | hsa-miR-6808-5p antagomir | Oligonucleotides | |
| HY-RI02182 | hsa-miR-6809-3p inhibitor | Oligonucleotides | |
| HY-RI02182A | hsa-miR-6809-3p antagomir | Oligonucleotides | |
| HY-RI02183 | hsa-miR-6809-5p inhibitor | Oligonucleotides | |
| HY-RI02183A | hsa-miR-6809-5p antagomir | Oligonucleotides | |
| HY-RI02184 | hsa-miR-6810-3p inhibitor | Oligonucleotides | |
| HY-RI02184A | hsa-miR-6810-3p antagomir | Oligonucleotides | |
| HY-RI02185 | hsa-miR-6810-5p inhibitor | Oligonucleotides | |
| HY-RI02185A | hsa-miR-6810-5p antagomir | Oligonucleotides | |
| HY-RI02186 | hsa-miR-6811-3p inhibitor | Oligonucleotides | |
| HY-RI02186A | hsa-miR-6811-3p antagomir | Oligonucleotides | |
| HY-RI02187 | hsa-miR-6811-5p inhibitor | Oligonucleotides | |
| HY-RI02187A | hsa-miR-6811-5p antagomir | Oligonucleotides | |
| HY-RI02188 | hsa-miR-6812-3p inhibitor | Oligonucleotides | |
| HY-RI02188A | hsa-miR-6812-3p antagomir | Oligonucleotides | |
| HY-RI02189 | hsa-miR-6812-5p inhibitor | Oligonucleotides | |
| HY-RI02189A | hsa-miR-6812-5p antagomir | Oligonucleotides | |
| HY-RI02190 | hsa-miR-6813-3p inhibitor | Oligonucleotides | |
| HY-RI02190A | hsa-miR-6813-3p antagomir | Oligonucleotides | |
| HY-RI02191 | hsa-miR-6813-5p inhibitor | Oligonucleotides | |
| HY-RI02191A | hsa-miR-6813-5p antagomir | Oligonucleotides | |
| HY-RI02192 | hsa-miR-6814-3p inhibitor | Oligonucleotides | |
| HY-RI02192A | hsa-miR-6814-3p antagomir | Oligonucleotides | |
| HY-RI02193 | hsa-miR-6814-5p inhibitor | Oligonucleotides | |
| HY-RI02193A | hsa-miR-6814-5p antagomir | Oligonucleotides | |
| HY-RI02194 | hsa-miR-6815-3p inhibitor | Oligonucleotides | |
| HY-RI02194A | hsa-miR-6815-3p antagomir | Oligonucleotides | |
| HY-RI02195 | hsa-miR-6815-5p inhibitor | Oligonucleotides | |
| HY-RI02195A | hsa-miR-6815-5p antagomir | Oligonucleotides | |
| HY-RI02196 | hsa-miR-6816-3p inhibitor | Oligonucleotides | |
| HY-RI02196A | hsa-miR-6816-3p antagomir | Oligonucleotides | |
| HY-RI02197 | hsa-miR-6816-5p inhibitor | Oligonucleotides | |
| HY-RI02197A | hsa-miR-6816-5p antagomir | Oligonucleotides | |
| HY-RI02198 | hsa-miR-6817-3p inhibitor | Oligonucleotides | |
| HY-RI02198A | hsa-miR-6817-3p antagomir | Oligonucleotides | |
| HY-RI02199 | hsa-miR-6817-5p inhibitor | Oligonucleotides | |
| HY-RI02199A | hsa-miR-6817-5p antagomir | Oligonucleotides | |
| HY-RI02200 | hsa-miR-6818-3p inhibitor | Oligonucleotides | |
| HY-RI02200A | hsa-miR-6818-3p antagomir | Oligonucleotides | |
| HY-RI02201 | hsa-miR-6818-5p inhibitor | Oligonucleotides | |
| HY-RI02201A | hsa-miR-6818-5p antagomir | Oligonucleotides | |
| HY-RI02202 | hsa-miR-6819-3p inhibitor | Oligonucleotides | |
| HY-RI02202A | hsa-miR-6819-3p antagomir | Oligonucleotides | |
| HY-RI02203 | hsa-miR-6819-5p inhibitor | Oligonucleotides | |
| HY-RI02203A | hsa-miR-6819-5p antagomir | Oligonucleotides | |
| HY-RI02204 | hsa-miR-6820-3p inhibitor | Oligonucleotides | |
| HY-RI02204A | hsa-miR-6820-3p antagomir | Oligonucleotides | |
| HY-RI02205 | hsa-miR-6820-5p inhibitor | Oligonucleotides | |
| HY-RI02205A | hsa-miR-6820-5p antagomir | Oligonucleotides | |
| HY-RI02206 | hsa-miR-6821-3p inhibitor | Oligonucleotides | |
| HY-RI02206A | hsa-miR-6821-3p antagomir | Oligonucleotides | |
| HY-RI02207 | hsa-miR-6821-5p inhibitor | Oligonucleotides | |
| HY-RI02207A | hsa-miR-6821-5p antagomir | Oligonucleotides | |
| HY-RI02208 | hsa-miR-6822-3p inhibitor | Oligonucleotides | |
| HY-RI02208A | hsa-miR-6822-3p antagomir | Oligonucleotides | |
| HY-RI02209 | hsa-miR-6822-5p inhibitor | Oligonucleotides | |
| HY-RI02209A | hsa-miR-6822-5p antagomir | Oligonucleotides | |
| HY-RI02210 | hsa-miR-6823-3p inhibitor | Oligonucleotides | |
| HY-RI02210A | hsa-miR-6823-3p antagomir | Oligonucleotides | |
| HY-RI02211 | hsa-miR-6823-5p inhibitor | Oligonucleotides | |
| HY-RI02211A | hsa-miR-6823-5p antagomir | Oligonucleotides | |
| HY-RI02212 | hsa-miR-6824-3p inhibitor | Oligonucleotides | |
| HY-RI02212A | hsa-miR-6824-3p antagomir | Oligonucleotides | |
| HY-RI02213 | hsa-miR-6824-5p inhibitor | Oligonucleotides | |
| HY-RI02213A | hsa-miR-6824-5p antagomir | Oligonucleotides | |
| HY-RI02214 | hsa-miR-6825-3p inhibitor | Oligonucleotides | |
| HY-RI02214A | hsa-miR-6825-3p antagomir | Oligonucleotides | |
| HY-RI02215 | hsa-miR-6825-5p inhibitor | Oligonucleotides | |
| HY-RI02215A | hsa-miR-6825-5p antagomir | Oligonucleotides | |
| HY-RI02216 | hsa-miR-6826-3p inhibitor | Oligonucleotides | |
| HY-RI02216A | hsa-miR-6826-3p antagomir | Oligonucleotides | |
| HY-RI02217 | hsa-miR-6826-5p inhibitor | Oligonucleotides | |
| HY-RI02217A | hsa-miR-6826-5p antagomir | Oligonucleotides | |
| HY-RI02218 | hsa-miR-6827-3p inhibitor | Oligonucleotides | |
| HY-RI02218A | hsa-miR-6827-3p antagomir | Oligonucleotides | |
| HY-RI02219 | hsa-miR-6827-5p inhibitor | Oligonucleotides | |
| HY-RI02219A | hsa-miR-6827-5p antagomir | Oligonucleotides | |
| HY-RI02220 | hsa-miR-6828-3p inhibitor | Oligonucleotides | |
| HY-RI02220A | hsa-miR-6828-3p antagomir | Oligonucleotides | |
| HY-RI02221 | hsa-miR-6828-5p inhibitor | Oligonucleotides | |
| HY-RI02221A | hsa-miR-6828-5p antagomir | Oligonucleotides | |
| HY-RI02222 | hsa-miR-6829-3p inhibitor | Oligonucleotides | |
| HY-RI02222A | hsa-miR-6829-3p antagomir | Oligonucleotides | |
| HY-RI02223 | hsa-miR-6829-5p inhibitor | Oligonucleotides | |
| HY-RI02223A | hsa-miR-6829-5p antagomir | Oligonucleotides | |
| HY-RI02224 | hsa-miR-6830-3p inhibitor | Oligonucleotides | |
| HY-RI02224A | hsa-miR-6830-3p antagomir | Oligonucleotides | |
| HY-RI02225 | hsa-miR-6830-5p inhibitor | Oligonucleotides | |
| HY-RI02225A | hsa-miR-6830-5p antagomir | Oligonucleotides | |
| HY-RI02226 | hsa-miR-6831-3p inhibitor | Oligonucleotides | |
| HY-RI02226A | hsa-miR-6831-3p antagomir | Oligonucleotides | |
| HY-RI02227 | hsa-miR-6831-5p inhibitor | Oligonucleotides | |
| HY-RI02227A | hsa-miR-6831-5p antagomir | Oligonucleotides | |
| HY-RI02228 | hsa-miR-6832-3p inhibitor | Oligonucleotides | |
| HY-RI02228A | hsa-miR-6832-3p antagomir | Oligonucleotides | |
| HY-RI02229 | hsa-miR-6832-5p inhibitor | Oligonucleotides | |
| HY-RI02229A | hsa-miR-6832-5p antagomir | Oligonucleotides | |
| HY-RI02230 | hsa-miR-6833-3p inhibitor | Oligonucleotides | |
| HY-RI02230A | hsa-miR-6833-3p antagomir | Oligonucleotides | |
| HY-RI02231 | hsa-miR-6833-5p inhibitor | Oligonucleotides | |
| HY-RI02231A | hsa-miR-6833-5p antagomir | Oligonucleotides | |
| HY-RI02232 | hsa-miR-6834-3p inhibitor | Oligonucleotides | |
| HY-RI02232A | hsa-miR-6834-3p antagomir | Oligonucleotides | |
| HY-RI02233 | hsa-miR-6834-5p inhibitor | Oligonucleotides | |
| HY-RI02233A | hsa-miR-6834-5p antagomir | Oligonucleotides | |
| HY-RI02234 | hsa-miR-6835-3p inhibitor | Oligonucleotides | |
| HY-RI02234A | hsa-miR-6835-3p antagomir | Oligonucleotides | |
| HY-RI02235 | hsa-miR-6835-5p inhibitor | Oligonucleotides | |
| HY-RI02235A | hsa-miR-6835-5p antagomir | Oligonucleotides | |
| HY-RI02236 | hsa-miR-6836-3p inhibitor | Oligonucleotides | |
| HY-RI02236A | hsa-miR-6836-3p antagomir | Oligonucleotides | |
| HY-RI02237 | hsa-miR-6836-5p inhibitor | Oligonucleotides | |
| HY-RI02237A | hsa-miR-6836-5p antagomir | Oligonucleotides | |
| HY-RI02238 | hsa-miR-6837-3p inhibitor | Oligonucleotides | |
| HY-RI02238A | hsa-miR-6837-3p antagomir | Oligonucleotides | |
| HY-RI02239 | hsa-miR-6837-5p inhibitor | Oligonucleotides | |
| HY-RI02239A | hsa-miR-6837-5p antagomir | Oligonucleotides | |
| HY-RI02240 | hsa-miR-6838-3p inhibitor | Oligonucleotides | |
| HY-RI02240A | hsa-miR-6838-3p antagomir | Oligonucleotides | |
| HY-RI02241 | hsa-miR-6838-5p inhibitor | Oligonucleotides | |
| HY-RI02241A | hsa-miR-6838-5p antagomir | Oligonucleotides | |
| HY-RI02242 | hsa-miR-6839-3p inhibitor | Oligonucleotides | |
| HY-RI02242A | hsa-miR-6839-3p antagomir | Oligonucleotides | |
| HY-RI02243 | hsa-miR-6839-5p inhibitor | Oligonucleotides | |
| HY-RI02243A | hsa-miR-6839-5p antagomir | Oligonucleotides | |
| HY-RI02244 | hsa-miR-6840-3p inhibitor | Oligonucleotides | |
| HY-RI02244A | hsa-miR-6840-3p antagomir | Oligonucleotides | |
| HY-RI02245 | hsa-miR-6840-5p inhibitor | Oligonucleotides | |
| HY-RI02245A | hsa-miR-6840-5p antagomir | Oligonucleotides | |
| HY-RI02246 | hsa-miR-6841-3p inhibitor | Oligonucleotides | |
| HY-RI02246A | hsa-miR-6841-3p antagomir | Oligonucleotides | |
| HY-RI02247 | hsa-miR-6841-5p inhibitor | Oligonucleotides | |
| HY-RI02247A | hsa-miR-6841-5p antagomir | Oligonucleotides | |
| HY-RI02248 | hsa-miR-6842-3p inhibitor | Oligonucleotides | |
| HY-RI02248A | hsa-miR-6842-3p antagomir | Oligonucleotides | |
| HY-RI02249 | hsa-miR-6842-5p inhibitor | Oligonucleotides | |
| HY-RI02249A | hsa-miR-6842-5p antagomir | Oligonucleotides | |
| HY-RI02250 | hsa-miR-6843-3p inhibitor | Oligonucleotides | |
| HY-RI02250A | hsa-miR-6843-3p antagomir | Oligonucleotides | |
| HY-RI02251 | hsa-miR-6844 inhibitor | Oligonucleotides | |
| HY-RI02251A | hsa-miR-6844 antagomir | Oligonucleotides | |
| HY-RI02252 | hsa-miR-6845-3p inhibitor | Oligonucleotides | |
| HY-RI02252A | hsa-miR-6845-3p antagomir | Oligonucleotides | |
| HY-RI02253 | hsa-miR-6845-5p inhibitor | Oligonucleotides | |
| HY-RI02253A | hsa-miR-6845-5p antagomir | Oligonucleotides | |
| HY-RI02254 | hsa-miR-6846-3p inhibitor | Oligonucleotides | |
| HY-RI02254A | hsa-miR-6846-3p antagomir | Oligonucleotides | |
| HY-RI02255 | hsa-miR-6846-5p inhibitor | Oligonucleotides | |
| HY-RI02255A | hsa-miR-6846-5p antagomir | Oligonucleotides | |
| HY-RI02256 | hsa-miR-6847-3p inhibitor | Oligonucleotides | |
| HY-RI02256A | hsa-miR-6847-3p antagomir | Oligonucleotides | |
| HY-RI02257 | hsa-miR-6847-5p inhibitor | Oligonucleotides | |
| HY-RI02257A | hsa-miR-6847-5p antagomir | Oligonucleotides | |
| HY-RI02258 | hsa-miR-6848-3p inhibitor | Oligonucleotides | |
| HY-RI02258A | hsa-miR-6848-3p antagomir | Oligonucleotides | |
| HY-RI02259 | hsa-miR-6848-5p inhibitor | Oligonucleotides | |
| HY-RI02259A | hsa-miR-6848-5p antagomir | Oligonucleotides | |
| HY-RI02260 | hsa-miR-6849-3p inhibitor | Oligonucleotides | |
| HY-RI02260A | hsa-miR-6849-3p antagomir | Oligonucleotides | |
| HY-RI02261 | hsa-miR-6849-5p inhibitor | Oligonucleotides | |
| HY-RI02261A | hsa-miR-6849-5p antagomir | Oligonucleotides | |
| HY-RI02262 | hsa-miR-6850-3p inhibitor | Oligonucleotides | |
| HY-RI02262A | hsa-miR-6850-3p antagomir | Oligonucleotides | |
| HY-RI02263 | hsa-miR-6850-5p inhibitor | Oligonucleotides | |
| HY-RI02263A | hsa-miR-6850-5p antagomir | Oligonucleotides | |
| HY-RI02264 | hsa-miR-6851-3p inhibitor | Oligonucleotides | |
| HY-RI02264A | hsa-miR-6851-3p antagomir | Oligonucleotides | |
| HY-RI02265 | hsa-miR-6851-5p inhibitor | Oligonucleotides | |
| HY-RI02265A | hsa-miR-6851-5p antagomir | Oligonucleotides | |
| HY-RI02266 | hsa-miR-6852-3p inhibitor | Oligonucleotides | |
| HY-RI02266A | hsa-miR-6852-3p antagomir | Oligonucleotides | |
| HY-RI02267 | hsa-miR-6852-5p inhibitor | Oligonucleotides | |
| HY-RI02267A | hsa-miR-6852-5p antagomir | Oligonucleotides | |
| HY-RI02268 | hsa-miR-6853-3p inhibitor | Oligonucleotides | |
| HY-RI02268A | hsa-miR-6853-3p antagomir | Oligonucleotides | |
| HY-RI02269 | hsa-miR-6853-5p inhibitor | Oligonucleotides | |
| HY-RI02269A | hsa-miR-6853-5p antagomir | Oligonucleotides | |
| HY-RI02270 | hsa-miR-6854-3p inhibitor | Oligonucleotides | |
| HY-RI02270A | hsa-miR-6854-3p antagomir | Oligonucleotides | |
| HY-RI02271 | hsa-miR-6854-5p inhibitor | Oligonucleotides | |
| HY-RI02271A | hsa-miR-6854-5p antagomir | Oligonucleotides | |
| HY-RI02272 | hsa-miR-6855-3p inhibitor | Oligonucleotides | |
| HY-RI02272A | hsa-miR-6855-3p antagomir | Oligonucleotides | |
| HY-RI02273 | hsa-miR-6855-5p inhibitor | Oligonucleotides | |
| HY-RI02273A | hsa-miR-6855-5p antagomir | Oligonucleotides | |
| HY-RI02274 | hsa-miR-6856-3p inhibitor | Oligonucleotides | |
| HY-RI02274A | hsa-miR-6856-3p antagomir | Oligonucleotides | |
| HY-RI02275 | hsa-miR-6856-5p inhibitor | Oligonucleotides | |
| HY-RI02275A | hsa-miR-6856-5p antagomir | Oligonucleotides | |
| HY-RI02276 | hsa-miR-6857-3p inhibitor | Oligonucleotides | |
| HY-RI02276A | hsa-miR-6857-3p antagomir | Oligonucleotides | |
| HY-RI02277 | hsa-miR-6857-5p inhibitor | Oligonucleotides | |
| HY-RI02277A | hsa-miR-6857-5p antagomir | Oligonucleotides | |
| HY-RI02278 | hsa-miR-6858-3p inhibitor | Oligonucleotides | |
| HY-RI02278A | hsa-miR-6858-3p antagomir | Oligonucleotides | |
| HY-RI02279 | hsa-miR-6858-5p inhibitor | Oligonucleotides | |
| HY-RI02279A | hsa-miR-6858-5p antagomir | Oligonucleotides | |
| HY-RI02280 | hsa-miR-6859-3p inhibitor | Oligonucleotides | |
| HY-RI02280A | hsa-miR-6859-3p antagomir | Oligonucleotides | |
| HY-RI02281 | hsa-miR-6859-5p inhibitor | Oligonucleotides | |
| HY-RI02281A | hsa-miR-6859-5p antagomir | Oligonucleotides | |
| HY-RI02282 | hsa-miR-6860 inhibitor | Oligonucleotides | |
| HY-RI02282A | hsa-miR-6860 antagomir | Oligonucleotides | |
| HY-RI02283 | hsa-miR-6861-3p inhibitor | Oligonucleotides | |
| HY-RI02283A | hsa-miR-6861-3p antagomir | Oligonucleotides | |
| HY-RI02284 | hsa-miR-6861-5p inhibitor | Oligonucleotides | |
| HY-RI02284A | hsa-miR-6861-5p antagomir | Oligonucleotides | |
| HY-RI02285 | hsa-miR-6862-3p inhibitor | Oligonucleotides | |
| HY-RI02285A | hsa-miR-6862-3p antagomir | Oligonucleotides | |
| HY-RI02286 | hsa-miR-6862-5p inhibitor | Oligonucleotides | |
| HY-RI02286A | hsa-miR-6862-5p antagomir | Oligonucleotides | |
| HY-RI02287 | hsa-miR-6863 inhibitor | Oligonucleotides | |
| HY-RI02287A | hsa-miR-6863 antagomir | Oligonucleotides | |
| HY-RI02288 | hsa-miR-6864-3p inhibitor | Oligonucleotides | |
| HY-RI02288A | hsa-miR-6864-3p antagomir | Oligonucleotides | |
| HY-RI02289 | hsa-miR-6864-5p inhibitor | Oligonucleotides | |
| HY-RI02289A | hsa-miR-6864-5p antagomir | Oligonucleotides | |
| HY-RI02290 | hsa-miR-6865-3p inhibitor | Oligonucleotides | |
| HY-RI02290A | hsa-miR-6865-3p antagomir | Oligonucleotides | |
| HY-RI02291 | hsa-miR-6865-5p inhibitor | Oligonucleotides | |
| HY-RI02291A | hsa-miR-6865-5p antagomir | Oligonucleotides | |
| HY-RI02292 | hsa-miR-6866-3p inhibitor | Oligonucleotides | |
| HY-RI02292A | hsa-miR-6866-3p antagomir | Oligonucleotides | |
| HY-RI02293 | hsa-miR-6866-5p inhibitor | Oligonucleotides | |
| HY-RI02293A | hsa-miR-6866-5p antagomir | Oligonucleotides | |
| HY-RI02294 | hsa-miR-6867-3p inhibitor | Oligonucleotides | |
| HY-RI02294A | hsa-miR-6867-3p antagomir | Oligonucleotides | |
| HY-RI02295 | hsa-miR-6867-5p inhibitor | Oligonucleotides | |
| HY-RI02295A | hsa-miR-6867-5p antagomir | Oligonucleotides | |
| HY-RI02296 | hsa-miR-6868-3p inhibitor | Oligonucleotides | |
| HY-RI02296A | hsa-miR-6868-3p antagomir | Oligonucleotides | |
| HY-RI02297 | hsa-miR-6868-5p inhibitor | Oligonucleotides | |
| HY-RI02297A | hsa-miR-6868-5p antagomir | Oligonucleotides | |
| HY-RI02298 | hsa-miR-6869-3p inhibitor | Oligonucleotides | |
| HY-RI02298A | hsa-miR-6869-3p antagomir | Oligonucleotides | |
| HY-RI02299 | hsa-miR-6869-5p inhibitor | Oligonucleotides | |
| HY-RI02299A | hsa-miR-6869-5p antagomir | Oligonucleotides | |
| HY-RI02300 | hsa-miR-6870-3p inhibitor | Oligonucleotides | |
| HY-RI02300A | hsa-miR-6870-3p antagomir | Oligonucleotides | |
| HY-RI02301 | hsa-miR-6870-5p inhibitor | Oligonucleotides | |
| HY-RI02301A | hsa-miR-6870-5p antagomir | Oligonucleotides | |
| HY-RI02302 | hsa-miR-6871-3p inhibitor | Oligonucleotides | |
| HY-RI02302A | hsa-miR-6871-3p antagomir | Oligonucleotides | |
| HY-RI02303 | hsa-miR-6871-5p inhibitor | Oligonucleotides | |
| HY-RI02303A | hsa-miR-6871-5p antagomir | Oligonucleotides | |
| HY-RI02304 | hsa-miR-6872-3p inhibitor | Oligonucleotides | |
| HY-RI02304A | hsa-miR-6872-3p antagomir | Oligonucleotides | |
| HY-RI02305 | hsa-miR-6872-5p inhibitor | Oligonucleotides | |
| HY-RI02305A | hsa-miR-6872-5p antagomir | Oligonucleotides | |
| HY-RI02306 | hsa-miR-6873-3p inhibitor | Oligonucleotides | |
| HY-RI02306A | hsa-miR-6873-3p antagomir | Oligonucleotides | |
| HY-RI02307 | hsa-miR-6873-5p inhibitor | Oligonucleotides | |
| HY-RI02307A | hsa-miR-6873-5p antagomir | Oligonucleotides | |
| HY-RI02308 | hsa-miR-6874-3p inhibitor | Oligonucleotides | |
| HY-RI02308A | hsa-miR-6874-3p antagomir | Oligonucleotides | |
| HY-RI02309 | hsa-miR-6874-5p inhibitor | Oligonucleotides | |
| HY-RI02309A | hsa-miR-6874-5p antagomir | Oligonucleotides | |
| HY-RI02310 | hsa-miR-6875-3p inhibitor | Oligonucleotides | |
| HY-RI02310A | hsa-miR-6875-3p antagomir | Oligonucleotides | |
| HY-RI02311 | hsa-miR-6875-5p inhibitor | Oligonucleotides | |
| HY-RI02311A | hsa-miR-6875-5p antagomir | Oligonucleotides | |
| HY-RI02312 | hsa-miR-6876-3p inhibitor | Oligonucleotides | |
| HY-RI02312A | hsa-miR-6876-3p antagomir | Oligonucleotides | |
| HY-RI02313 | hsa-miR-6876-5p inhibitor | Oligonucleotides | |
| HY-RI02313A | hsa-miR-6876-5p antagomir | Oligonucleotides | |
| HY-RI02314 | hsa-miR-6877-3p inhibitor | Oligonucleotides | |
| HY-RI02314A | hsa-miR-6877-3p antagomir | Oligonucleotides | |
| HY-RI02315 | hsa-miR-6877-5p inhibitor | Oligonucleotides | |
| HY-RI02315A | hsa-miR-6877-5p antagomir | Oligonucleotides | |
| HY-RI02316 | hsa-miR-6878-3p inhibitor | Oligonucleotides | |
| HY-RI02316A | hsa-miR-6878-3p antagomir | Oligonucleotides | |
| HY-RI02317 | hsa-miR-6878-5p inhibitor | Oligonucleotides | |
| HY-RI02317A | hsa-miR-6878-5p antagomir | Oligonucleotides | |
| HY-RI02318 | hsa-miR-6879-3p inhibitor | Oligonucleotides | |
| HY-RI02318A | hsa-miR-6879-3p antagomir | Oligonucleotides | |
| HY-RI02319 | hsa-miR-6879-5p inhibitor | Oligonucleotides | |
| HY-RI02319A | hsa-miR-6879-5p antagomir | Oligonucleotides | |
| HY-RI02320 | hsa-miR-6880-3p inhibitor | Oligonucleotides | |
| HY-RI02320A | hsa-miR-6880-3p antagomir | Oligonucleotides | |
| HY-RI02321 | hsa-miR-6880-5p inhibitor | Oligonucleotides | |
| HY-RI02321A | hsa-miR-6880-5p antagomir | Oligonucleotides | |
| HY-RI02322 | hsa-miR-6881-3p inhibitor | Oligonucleotides | |
| HY-RI02322A | hsa-miR-6881-3p antagomir | Oligonucleotides | |
| HY-RI02323 | hsa-miR-6881-5p inhibitor | Oligonucleotides | |
| HY-RI02323A | hsa-miR-6881-5p antagomir | Oligonucleotides | |
| HY-RI02324 | hsa-miR-6882-3p inhibitor | Oligonucleotides | |
| HY-RI02324A | hsa-miR-6882-3p antagomir | Oligonucleotides | |
| HY-RI02325 | hsa-miR-6882-5p inhibitor | Oligonucleotides | |
| HY-RI02325A | hsa-miR-6882-5p antagomir | Oligonucleotides | |
| HY-RI02326 | hsa-miR-6883-3p inhibitor | Oligonucleotides | |
| HY-RI02326A | hsa-miR-6883-3p antagomir | Oligonucleotides | |
| HY-RI02327 | hsa-miR-6883-5p inhibitor | Oligonucleotides | |
| HY-RI02327A | hsa-miR-6883-5p antagomir | Oligonucleotides | |
| HY-RI02328 | hsa-miR-6884-3p inhibitor | Oligonucleotides | |
| HY-RI02328A | hsa-miR-6884-3p antagomir | Oligonucleotides | |
| HY-RI02329 | hsa-miR-6884-5p inhibitor | Oligonucleotides | |
| HY-RI02329A | hsa-miR-6884-5p antagomir | Oligonucleotides | |
| HY-RI02330 | hsa-miR-6885-3p inhibitor | Oligonucleotides | |
| HY-RI02330A | hsa-miR-6885-3p antagomir | Oligonucleotides | |
| HY-RI02331 | hsa-miR-6885-5p inhibitor | Oligonucleotides | |
| HY-RI02331A | hsa-miR-6885-5p antagomir | Oligonucleotides | |
| HY-RI02332 | hsa-miR-6886-3p inhibitor | Oligonucleotides | |
| HY-RI02332A | hsa-miR-6886-3p antagomir | Oligonucleotides | |
| HY-RI02333 | hsa-miR-6886-5p inhibitor | Oligonucleotides | |
| HY-RI02333A | hsa-miR-6886-5p antagomir | Oligonucleotides | |
| HY-RI02334 | hsa-miR-6887-3p inhibitor | Oligonucleotides | |
| HY-RI02334A | hsa-miR-6887-3p antagomir | Oligonucleotides | |
| HY-RI02335 | hsa-miR-6887-5p inhibitor | Oligonucleotides | |
| HY-RI02335A | hsa-miR-6887-5p antagomir | Oligonucleotides | |
| HY-RI02336 | hsa-miR-6888-3p inhibitor | Oligonucleotides | |
| HY-RI02336A | hsa-miR-6888-3p antagomir | Oligonucleotides | |
| HY-RI02337 | hsa-miR-6888-5p inhibitor | Oligonucleotides | |
| HY-RI02337A | hsa-miR-6888-5p antagomir | Oligonucleotides | |
| HY-RI02338 | hsa-miR-6889-3p inhibitor | Oligonucleotides | |
| HY-RI02338A | hsa-miR-6889-3p antagomir | Oligonucleotides | |
| HY-RI02339 | hsa-miR-6889-5p inhibitor | Oligonucleotides | |
| HY-RI02339A | hsa-miR-6889-5p antagomir | Oligonucleotides | |
| HY-RI02340 | hsa-miR-6890-3p inhibitor | Oligonucleotides | |
| HY-RI02340A | hsa-miR-6890-3p antagomir | Oligonucleotides | |
| HY-RI02341 | hsa-miR-6890-5p inhibitor | Oligonucleotides | |
| HY-RI02341A | hsa-miR-6890-5p antagomir | Oligonucleotides | |
| HY-RI02342 | hsa-miR-6891-3p inhibitor | Oligonucleotides | |
| HY-RI02342A | hsa-miR-6891-3p antagomir | Oligonucleotides | |
| HY-RI02343 | hsa-miR-6891-5p inhibitor | Oligonucleotides | |
| HY-RI02343A | hsa-miR-6891-5p antagomir | Oligonucleotides | |
| HY-RI02344 | hsa-miR-6892-3p inhibitor | Oligonucleotides | |
| HY-RI02344A | hsa-miR-6892-3p antagomir | Oligonucleotides | |
| HY-RI02345 | hsa-miR-6892-5p inhibitor | Oligonucleotides | |
| HY-RI02345A | hsa-miR-6892-5p antagomir | Oligonucleotides | |
| HY-RI02346 | hsa-miR-6893-3p inhibitor | Oligonucleotides | |
| HY-RI02346A | hsa-miR-6893-3p antagomir | Oligonucleotides | |
| HY-RI02347 | hsa-miR-6893-5p inhibitor | Oligonucleotides | |
| HY-RI02347A | hsa-miR-6893-5p antagomir | Oligonucleotides | |
| HY-RI02348 | hsa-miR-6894-3p inhibitor | Oligonucleotides | |
| HY-RI02348A | hsa-miR-6894-3p antagomir | Oligonucleotides | |
| HY-RI02349 | hsa-miR-6894-5p inhibitor | Oligonucleotides | |
| HY-RI02349A | hsa-miR-6894-5p antagomir | Oligonucleotides | |
| HY-RI02350 | hsa-miR-6895-3p inhibitor | Oligonucleotides | |
| HY-RI02350A | hsa-miR-6895-3p antagomir | Oligonucleotides | |
| HY-RI02351 | hsa-miR-6895-5p inhibitor | Oligonucleotides | |
| HY-RI02351A | hsa-miR-6895-5p antagomir | Oligonucleotides | |
| HY-RI02352 | hsa-miR-708-3p inhibitor | Oligonucleotides | |
| HY-RI02352A | hsa-miR-708-3p antagomir | Oligonucleotides | |
| HY-RI02353 | hsa-miR-708-5p inhibitor | Oligonucleotides | |
| HY-RI02353A | hsa-miR-708-5p antagomir | Oligonucleotides | |
| HY-RI02354 | hsa-miR-7106-3p inhibitor | Oligonucleotides | |
| HY-RI02354A | hsa-miR-7106-3p antagomir | Oligonucleotides | |
| HY-RI02355 | hsa-miR-7106-5p inhibitor | Oligonucleotides | |
| HY-RI02355A | hsa-miR-7106-5p antagomir | Oligonucleotides | |
| HY-RI02356 | hsa-miR-7107-3p inhibitor | Oligonucleotides | |
| HY-RI02356A | hsa-miR-7107-3p antagomir | Oligonucleotides | |
| HY-RI02357 | hsa-miR-7107-5p inhibitor | Oligonucleotides | |
| HY-RI02357A | hsa-miR-7107-5p antagomir | Oligonucleotides | |
| HY-RI02358 | hsa-miR-7108-3p inhibitor | Oligonucleotides | |
| HY-RI02358A | hsa-miR-7108-3p antagomir | Oligonucleotides | |
| HY-RI02359 | hsa-miR-7108-5p inhibitor | Oligonucleotides | |
| HY-RI02359A | hsa-miR-7108-5p antagomir | Oligonucleotides | |
| HY-RI02360 | hsa-miR-7109-3p inhibitor | Oligonucleotides | |
| HY-RI02360A | hsa-miR-7109-3p antagomir | Oligonucleotides | |
| HY-RI02361 | hsa-miR-7109-5p inhibitor | Oligonucleotides | |
| HY-RI02361A | hsa-miR-7109-5p antagomir | Oligonucleotides | |
| HY-RI02362 | hsa-miR-711 inhibitor | Oligonucleotides | |
| HY-RI02362A | hsa-miR-711 antagomir | Oligonucleotides | |
| HY-RI02363 | hsa-miR-7110-3p inhibitor | Oligonucleotides | |
| HY-RI02363A | hsa-miR-7110-3p antagomir | Oligonucleotides | |
| HY-RI02364 | hsa-miR-7110-5p inhibitor | Oligonucleotides | |
| HY-RI02364A | hsa-miR-7110-5p antagomir | Oligonucleotides | |
| HY-RI02365 | hsa-miR-7111-3p inhibitor | Oligonucleotides | |
| HY-RI02365A | hsa-miR-7111-3p antagomir | Oligonucleotides | |
| HY-RI02366 | hsa-miR-7111-5p inhibitor | Oligonucleotides | |
| HY-RI02366A | hsa-miR-7111-5p antagomir | Oligonucleotides | |
| HY-RI02367 | hsa-miR-7112-3p inhibitor | Oligonucleotides | |
| HY-RI02367A | hsa-miR-7112-3p antagomir | Oligonucleotides | |
| HY-RI02368 | hsa-miR-7112-5p inhibitor | Oligonucleotides | |
| HY-RI02368A | hsa-miR-7112-5p antagomir | Oligonucleotides | |
| HY-RI02369 | hsa-miR-7113-3p inhibitor | Oligonucleotides | |
| HY-RI02369A | hsa-miR-7113-3p antagomir | Oligonucleotides | |
| HY-RI02370 | hsa-miR-7113-5p inhibitor | Oligonucleotides | |
| HY-RI02370A | hsa-miR-7113-5p antagomir | Oligonucleotides | |
| HY-RI02371 | hsa-miR-7114-3p inhibitor | Oligonucleotides | |
| HY-RI02371A | hsa-miR-7114-3p antagomir | Oligonucleotides | |
| HY-RI02372 | hsa-miR-7114-5p inhibitor | Oligonucleotides | |
| HY-RI02372A | hsa-miR-7114-5p antagomir | Oligonucleotides | |
| HY-RI02373 | hsa-miR-7-1-3p inhibitor | Oligonucleotides | |
| HY-RI02373A | hsa-miR-7-1-3p antagomir | Oligonucleotides | |
| HY-RI02374 | hsa-miR-7150 inhibitor | Oligonucleotides | |
| HY-RI02374A | hsa-miR-7150 antagomir | Oligonucleotides | |
| HY-RI02375 | hsa-miR-7151-3p inhibitor | Oligonucleotides | |
| HY-RI02375A | hsa-miR-7151-3p antagomir | Oligonucleotides | |
| HY-RI02376 | hsa-miR-7151-5p inhibitor | Oligonucleotides | |
| HY-RI02376A | hsa-miR-7151-5p antagomir | Oligonucleotides | |
| HY-RI02377 | hsa-miR-7152-3p inhibitor | Oligonucleotides | |
| HY-RI02377A | hsa-miR-7152-3p antagomir | Oligonucleotides | |
| HY-RI02378 | hsa-miR-7152-5p inhibitor | Oligonucleotides | |
| HY-RI02378A | hsa-miR-7152-5p antagomir | Oligonucleotides | |
| HY-RI02379 | hsa-miR-7153-3p inhibitor | Oligonucleotides | |
| HY-RI02379A | hsa-miR-7153-3p antagomir | Oligonucleotides | |
| HY-RI02380 | hsa-miR-7153-5p inhibitor | Oligonucleotides | |
| HY-RI02380A | hsa-miR-7153-5p antagomir | Oligonucleotides | |
| HY-RI02381 | hsa-miR-7154-3p inhibitor | Oligonucleotides | |
| HY-RI02381A | hsa-miR-7154-3p antagomir | Oligonucleotides | |
| HY-RI02382 | hsa-miR-7154-5p inhibitor | Oligonucleotides | |
| HY-RI02382A | hsa-miR-7154-5p antagomir | Oligonucleotides | |
| HY-RI02383 | hsa-miR-7155-3p inhibitor | Oligonucleotides | |
| HY-RI02383A | hsa-miR-7155-3p antagomir | Oligonucleotides | |
| HY-RI02384 | hsa-miR-7155-5p inhibitor | Oligonucleotides | |
| HY-RI02384A | hsa-miR-7155-5p antagomir | Oligonucleotides | |
| HY-RI02385 | hsa-miR-7156-3p inhibitor | Oligonucleotides | |
| HY-RI02385A | hsa-miR-7156-3p antagomir | Oligonucleotides | |
| HY-RI02386 | hsa-miR-7156-5p inhibitor | Oligonucleotides | |
| HY-RI02386A | hsa-miR-7156-5p antagomir | Oligonucleotides | |
| HY-RI02387 | hsa-miR-7157-3p inhibitor | Oligonucleotides | |
| HY-RI02387A | hsa-miR-7157-3p antagomir | Oligonucleotides | |
| HY-RI02388 | hsa-miR-7157-5p inhibitor | Oligonucleotides | |
| HY-RI02388A | hsa-miR-7157-5p antagomir | Oligonucleotides | |
| HY-RI02389 | hsa-miR-7158-3p inhibitor | Oligonucleotides | |
| HY-RI02389A | hsa-miR-7158-3p antagomir | Oligonucleotides | |
| HY-RI02390 | hsa-miR-7158-5p inhibitor | Oligonucleotides | |
| HY-RI02390A | hsa-miR-7158-5p antagomir | Oligonucleotides | |
| HY-RI02391 | hsa-miR-7159-3p inhibitor | Oligonucleotides | |
| HY-RI02391A | hsa-miR-7159-3p antagomir | Oligonucleotides | |
| HY-RI02392 | hsa-miR-7159-5p inhibitor | Oligonucleotides | |
| HY-RI02392A | hsa-miR-7159-5p antagomir | Oligonucleotides | |
| HY-RI02393 | hsa-miR-7160-3p inhibitor | Oligonucleotides | |
| HY-RI02393A | hsa-miR-7160-3p antagomir | Oligonucleotides | |
| HY-RI02394 | hsa-miR-7160-5p inhibitor | Oligonucleotides | |
| HY-RI02394A | hsa-miR-7160-5p antagomir | Oligonucleotides | |
| HY-RI02395 | hsa-miR-7161-3p inhibitor | Oligonucleotides | |
| HY-RI02395A | hsa-miR-7161-3p antagomir | Oligonucleotides | |
| HY-RI02396 | hsa-miR-7161-5p inhibitor | Oligonucleotides | |
| HY-RI02396A | hsa-miR-7161-5p antagomir | Oligonucleotides | |
| HY-RI02397 | hsa-miR-7162-3p inhibitor | Oligonucleotides | |
| HY-RI02397A | hsa-miR-7162-3p antagomir | Oligonucleotides | |
| HY-RI02398 | hsa-miR-7162-5p inhibitor | Oligonucleotides | |
| HY-RI02398A | hsa-miR-7162-5p antagomir | Oligonucleotides | |
| HY-RI02399 | hsa-miR-718 inhibitor | Oligonucleotides | |
| HY-RI02399A | hsa-miR-718 antagomir | Oligonucleotides | |
| HY-RI02400 | hsa-miR-7-2-3p inhibitor | Oligonucleotides | |
| HY-RI02400A | hsa-miR-7-2-3p antagomir | Oligonucleotides | |
| HY-RI02401 | hsa-miR-744-3p inhibitor | Oligonucleotides | |
| HY-RI02401A | hsa-miR-744-3p antagomir | Oligonucleotides | |
| HY-RI02402 | hsa-miR-744-5p inhibitor | Oligonucleotides | |
| HY-RI02402A | hsa-miR-744-5p antagomir | Oligonucleotides | |
| HY-RI02403 | hsa-miR-7515 inhibitor | Oligonucleotides | |
| HY-RI02403A | hsa-miR-7515 antagomir | Oligonucleotides | |
| HY-RI02404 | hsa-miR-758-3p inhibitor | Oligonucleotides | |
| HY-RI02404A | hsa-miR-758-3p antagomir | Oligonucleotides | |
| HY-RI02405 | hsa-miR-758-5p inhibitor | Oligonucleotides | |
| HY-RI02405A | hsa-miR-758-5p antagomir | Oligonucleotides | |
| HY-RI02406 | hsa-miR-7-5p inhibitor | Oligonucleotides | |
| HY-RI02406A | hsa-miR-7-5p antagomir | Oligonucleotides | |
| HY-RI02407 | hsa-miR-760 inhibitor | Oligonucleotides | |
| HY-RI02407A | hsa-miR-760 antagomir | Oligonucleotides | |
| HY-RI02408 | hsa-miR-761 inhibitor | Oligonucleotides | |
| HY-RI02408A | hsa-miR-761 antagomir | Oligonucleotides | |
| HY-RI02409 | hsa-miR-762 inhibitor | Oligonucleotides | |
| HY-RI02409A | hsa-miR-762 antagomir | Oligonucleotides | |
| HY-RI02410 | hsa-miR-764 inhibitor | Oligonucleotides | |
| HY-RI02410A | hsa-miR-764 antagomir | Oligonucleotides | |
| HY-RI02411 | hsa-miR-765 inhibitor | Oligonucleotides | |
| HY-RI02411A | hsa-miR-765 antagomir | Oligonucleotides | |
| HY-RI02412 | hsa-miR-766-3p inhibitor | Oligonucleotides | |
| HY-RI02412A | hsa-miR-766-3p antagomir | Oligonucleotides | |
| HY-RI02413 | hsa-miR-766-5p inhibitor | Oligonucleotides | |
| HY-RI02413A | hsa-miR-766-5p antagomir | Oligonucleotides | |
| HY-RI02414 | hsa-miR-767-3p inhibitor | Oligonucleotides | |
| HY-RI02414A | hsa-miR-767-3p antagomir | Oligonucleotides | |
| HY-RI02415 | hsa-miR-769-3p inhibitor | Oligonucleotides | |
| HY-RI02415A | hsa-miR-769-3p antagomir | Oligonucleotides | |
| HY-RI02416 | hsa-miR-769-5p inhibitor | Oligonucleotides | |
| HY-RI02416A | hsa-miR-769-5p antagomir | Oligonucleotides | |
| HY-RI02417 | hsa-miR-7702 inhibitor | Oligonucleotides | |
| HY-RI02417A | hsa-miR-7702 antagomir | Oligonucleotides | |
| HY-RI02418 | hsa-miR-7703 inhibitor | Oligonucleotides | |
| HY-RI02418A | hsa-miR-7703 antagomir | Oligonucleotides | |
| HY-RI02419 | hsa-miR-7704 inhibitor | Oligonucleotides | |
| HY-RI02419A | hsa-miR-7704 antagomir | Oligonucleotides | |
| HY-RI02420 | hsa-miR-7705 inhibitor | Oligonucleotides | |
| HY-RI02420A | hsa-miR-7705 antagomir | Oligonucleotides | |
| HY-RI02421 | hsa-miR-7706 inhibitor | Oligonucleotides | |
| HY-RI02421A | hsa-miR-7706 antagomir | Oligonucleotides | |
| HY-RI02422 | hsa-miR-7843-3p inhibitor | Oligonucleotides | |
| HY-RI02422A | hsa-miR-7843-3p antagomir | Oligonucleotides | |
| HY-RI02423 | hsa-miR-7843-5p inhibitor | Oligonucleotides | |
| HY-RI02423A | hsa-miR-7843-5p antagomir | Oligonucleotides | |
| HY-RI02424 | hsa-miR-7844-5p inhibitor | Oligonucleotides | |
| HY-RI02424A | hsa-miR-7844-5p antagomir | Oligonucleotides | |
| HY-RI02425 | hsa-miR-7845-5p inhibitor | Oligonucleotides | |
| HY-RI02425A | hsa-miR-7845-5p antagomir | Oligonucleotides | |
| HY-RI02426 | hsa-miR-7846-3p inhibitor | Oligonucleotides | |
| HY-RI02426A | hsa-miR-7846-3p antagomir | Oligonucleotides | |
| HY-RI02427 | hsa-miR-7847-3p inhibitor | Oligonucleotides | |
| HY-RI02427A | hsa-miR-7847-3p antagomir | Oligonucleotides | |
| HY-RI02428 | hsa-miR-7848-3p inhibitor | Oligonucleotides | |
| HY-RI02428A | hsa-miR-7848-3p antagomir | Oligonucleotides | |
| HY-RI02429 | hsa-miR-7849-3p inhibitor | Oligonucleotides | |
| HY-RI02429A | hsa-miR-7849-3p antagomir | Oligonucleotides | |
| HY-RI02430 | hsa-miR-7850-5p inhibitor | Oligonucleotides | |
| HY-RI02430A | hsa-miR-7850-5p antagomir | Oligonucleotides | |
| HY-RI02431 | hsa-miR-7851-3p inhibitor | Oligonucleotides | |
| HY-RI02431A | hsa-miR-7851-3p antagomir | Oligonucleotides | |
| HY-RI02432 | hsa-miR-7852-3p inhibitor | Oligonucleotides | |
| HY-RI02432A | hsa-miR-7852-3p antagomir | Oligonucleotides | |
| HY-RI02433 | hsa-miR-7853-5p inhibitor | Oligonucleotides | |
| HY-RI02433A | hsa-miR-7853-5p antagomir | Oligonucleotides | |
| HY-RI02434 | hsa-miR-7854-3p inhibitor | Oligonucleotides | |
| HY-RI02434A | hsa-miR-7854-3p antagomir | Oligonucleotides | |
| HY-RI02435 | hsa-miR-7855-5p inhibitor | Oligonucleotides | |
| HY-RI02435A | hsa-miR-7855-5p antagomir | Oligonucleotides | |
| HY-RI02436 | hsa-miR-7856-5p inhibitor | Oligonucleotides | |
| HY-RI02436A | hsa-miR-7856-5p antagomir | Oligonucleotides | |
| HY-RI02437 | hsa-miR-7973 inhibitor | Oligonucleotides | |
| HY-RI02437A | hsa-miR-7973 antagomir | Oligonucleotides | |
| HY-RI02438 | hsa-miR-7974 inhibitor | Oligonucleotides | |
| HY-RI02438A | hsa-miR-7974 antagomir | Oligonucleotides | |
| HY-RI02439 | hsa-miR-7975 inhibitor | Oligonucleotides | |
| HY-RI02439A | hsa-miR-7975 antagomir | Oligonucleotides | |
| HY-RI02440 | hsa-miR-7976 inhibitor | Oligonucleotides | |
| HY-RI02440A | hsa-miR-7976 antagomir | Oligonucleotides | |
| HY-RI02441 | hsa-miR-7977 inhibitor | Oligonucleotides | |
| HY-RI02441A | hsa-miR-7977 antagomir | Oligonucleotides | |
| HY-RI02442 | hsa-miR-7978 inhibitor | Oligonucleotides | |
| HY-RI02442A | hsa-miR-7978 antagomir | Oligonucleotides | |
| HY-RI02443 | hsa-miR-802 inhibitor | Oligonucleotides | |
| HY-RI02443A | hsa-miR-802 antagomir | Oligonucleotides | |
| HY-RI02444 | hsa-miR-8052 inhibitor | Oligonucleotides | |
| HY-RI02444A | hsa-miR-8052 antagomir | Oligonucleotides | |
| HY-RI02445 | hsa-miR-8053 inhibitor | Oligonucleotides | |
| HY-RI02445A | hsa-miR-8053 antagomir | Oligonucleotides | |
| HY-RI02446 | hsa-miR-8054 inhibitor | Oligonucleotides | |
| HY-RI02446A | hsa-miR-8054 antagomir | Oligonucleotides | |
| HY-RI02447 | hsa-miR-8055 inhibitor | Oligonucleotides | |
| HY-RI02447A | hsa-miR-8055 antagomir | Oligonucleotides | |
| HY-RI02448 | hsa-miR-8056 inhibitor | Oligonucleotides | |
| HY-RI02448A | hsa-miR-8056 antagomir | Oligonucleotides | |
| HY-RI02449 | hsa-miR-8057 inhibitor | Oligonucleotides | |
| HY-RI02449A | hsa-miR-8057 antagomir | Oligonucleotides | |
| HY-RI02450 | hsa-miR-8058 inhibitor | Oligonucleotides | |
| HY-RI02450A | hsa-miR-8058 antagomir | Oligonucleotides | |
| HY-RI02451 | hsa-miR-8059 inhibitor | Oligonucleotides | |
| HY-RI02451A | hsa-miR-8059 antagomir | Oligonucleotides | |
| HY-RI02452 | hsa-miR-8060 inhibitor | Oligonucleotides | |
| HY-RI02452A | hsa-miR-8060 antagomir | Oligonucleotides | |
| HY-RI02453 | hsa-miR-8061 inhibitor | Oligonucleotides | |
| HY-RI02453A | hsa-miR-8061 antagomir | Oligonucleotides | |
| HY-RI02454 | hsa-miR-8062 inhibitor | Oligonucleotides | |
| HY-RI02454A | hsa-miR-8062 antagomir | Oligonucleotides | |
| HY-RI02455 | hsa-miR-8063 inhibitor | Oligonucleotides | |
| HY-RI02455A | hsa-miR-8063 antagomir | Oligonucleotides | |
| HY-RI02456 | hsa-miR-8064 inhibitor | Oligonucleotides | |
| HY-RI02456A | hsa-miR-8064 antagomir | Oligonucleotides | |
| HY-RI02457 | hsa-miR-8065 inhibitor | Oligonucleotides | |
| HY-RI02457A | hsa-miR-8065 antagomir | Oligonucleotides | |
| HY-RI02458 | hsa-miR-8066 inhibitor | Oligonucleotides | |
| HY-RI02458A | hsa-miR-8066 antagomir | Oligonucleotides | |
| HY-RI02459 | hsa-miR-8067 inhibitor | Oligonucleotides | |
| HY-RI02459A | hsa-miR-8067 antagomir | Oligonucleotides | |
| HY-RI02460 | hsa-miR-8068 inhibitor | Oligonucleotides | |
| HY-RI02460A | hsa-miR-8068 antagomir | Oligonucleotides | |
| HY-RI02461 | hsa-miR-8069 inhibitor | Oligonucleotides | |
| HY-RI02461A | hsa-miR-8069 antagomir | Oligonucleotides | |
| HY-RI02462 | hsa-miR-8070 inhibitor | Oligonucleotides | |
| HY-RI02462A | hsa-miR-8070 antagomir | Oligonucleotides | |
| HY-RI02463 | hsa-miR-8071 inhibitor | Oligonucleotides | |
| HY-RI02463A | hsa-miR-8071 antagomir | Oligonucleotides | |
| HY-RI02464 | hsa-miR-8072 inhibitor | Oligonucleotides | |
| HY-RI02464A | hsa-miR-8072 antagomir | Oligonucleotides | |
| HY-RI02465 | hsa-miR-8073 inhibitor | Oligonucleotides | |
| HY-RI02465A | hsa-miR-8073 antagomir | Oligonucleotides | |
| HY-RI02466 | hsa-miR-8074 inhibitor | Oligonucleotides | |
| HY-RI02466A | hsa-miR-8074 antagomir | Oligonucleotides | |
| HY-RI02467 | hsa-miR-8075 inhibitor | Oligonucleotides | |
| HY-RI02467A | hsa-miR-8075 antagomir | Oligonucleotides | |
| HY-RI02468 | hsa-miR-8076 inhibitor | Oligonucleotides | |
| HY-RI02468A | hsa-miR-8076 antagomir | Oligonucleotides | |
| HY-RI02469 | hsa-miR-8077 inhibitor | Oligonucleotides | |
| HY-RI02469A | hsa-miR-8077 antagomir | Oligonucleotides | |
| HY-RI02470 | hsa-miR-8078 inhibitor | Oligonucleotides | |
| HY-RI02470A | hsa-miR-8078 antagomir | Oligonucleotides | |
| HY-RI02471 | hsa-miR-8079 inhibitor | Oligonucleotides | |
| HY-RI02471A | hsa-miR-8079 antagomir | Oligonucleotides | |
| HY-RI02472 | hsa-miR-8080 inhibitor | Oligonucleotides | |
| HY-RI02472A | hsa-miR-8080 antagomir | Oligonucleotides | |
| HY-RI02473 | hsa-miR-8081 inhibitor | Oligonucleotides | |
| HY-RI02473A | hsa-miR-8081 antagomir | Oligonucleotides | |
| HY-RI02474 | hsa-miR-8082 inhibitor | Oligonucleotides | |
| HY-RI02474A | hsa-miR-8082 antagomir | Oligonucleotides | |
| HY-RI02475 | hsa-miR-8083 inhibitor | Oligonucleotides | |
| HY-RI02475A | hsa-miR-8083 antagomir | Oligonucleotides | |
| HY-RI02476 | hsa-miR-8084 inhibitor | Oligonucleotides | |
| HY-RI02476A | hsa-miR-8084 antagomir | Oligonucleotides | |
| HY-RI02477 | hsa-miR-8085 inhibitor | Oligonucleotides | |
| HY-RI02477A | hsa-miR-8085 antagomir | Oligonucleotides | |
| HY-RI02478 | hsa-miR-8086 inhibitor | Oligonucleotides | |
| HY-RI02478A | hsa-miR-8086 antagomir | Oligonucleotides | |
| HY-RI02479 | hsa-miR-8087 inhibitor | Oligonucleotides | |
| HY-RI02479A | hsa-miR-8087 antagomir | Oligonucleotides | |
| HY-RI02480 | hsa-miR-8088 inhibitor | Oligonucleotides | |
| HY-RI02480A | hsa-miR-8088 antagomir | Oligonucleotides | |
| HY-RI02481 | hsa-miR-8089 inhibitor | Oligonucleotides | |
| HY-RI02481A | hsa-miR-8089 antagomir | Oligonucleotides | |
| HY-RI02482 | hsa-miR-8485 inhibitor | Oligonucleotides | |
| HY-RI02482A | hsa-miR-8485 antagomir | Oligonucleotides | |
| HY-RI02483 | hsa-miR-873-3p inhibitor | Oligonucleotides | |
| HY-RI02483A | hsa-miR-873-3p antagomir | Oligonucleotides | |
| HY-RI02484 | hsa-miR-873-5p inhibitor | Oligonucleotides | |
| HY-RI02484A | hsa-miR-873-5p antagomir | Oligonucleotides | |
| HY-RI02485 | hsa-miR-874-3p inhibitor | Oligonucleotides | |
| HY-RI02485A | hsa-miR-874-3p antagomir | Oligonucleotides | |
| HY-RI02486 | hsa-miR-874-5p inhibitor | Oligonucleotides | |
| HY-RI02486A | hsa-miR-874-5p antagomir | Oligonucleotides | |
| HY-RI02487 | hsa-miR-875-3p inhibitor | Oligonucleotides | |
| HY-RI02487A | hsa-miR-875-3p antagomir | Oligonucleotides | |
| HY-RI02488 | hsa-miR-875-5p inhibitor | Oligonucleotides | |
| HY-RI02488A | hsa-miR-875-5p antagomir | Oligonucleotides | |
| HY-RI02489 | hsa-miR-876-3p inhibitor | Oligonucleotides | |
| HY-RI02489A | hsa-miR-876-3p antagomir | Oligonucleotides | |
| HY-RI02490 | hsa-miR-876-5p inhibitor | Oligonucleotides | |
| HY-RI02490A | hsa-miR-876-5p antagomir | Oligonucleotides | |
| HY-RI02491 | hsa-miR-877-3p inhibitor | Oligonucleotides | |
| HY-RI02491A | hsa-miR-877-3p antagomir | Oligonucleotides | |
| HY-RI02492 | hsa-miR-877-5p inhibitor | Oligonucleotides | |
| HY-RI02492A | hsa-miR-877-5p antagomir | Oligonucleotides | |
| HY-RI02493 | hsa-miR-885-3p inhibitor | Oligonucleotides | |
| HY-RI02493A | hsa-miR-885-3p antagomir | Oligonucleotides | |
| HY-RI02494 | hsa-miR-885-5p inhibitor | Oligonucleotides | |
| HY-RI02494A | hsa-miR-885-5p antagomir | Oligonucleotides | |
| HY-RI02495 | hsa-miR-887-3p inhibitor | Oligonucleotides | |
| HY-RI02495A | hsa-miR-887-3p antagomir | Oligonucleotides | |
| HY-RI02496 | hsa-miR-887-5p inhibitor | Oligonucleotides | |
| HY-RI02496A | hsa-miR-887-5p antagomir | Oligonucleotides | |
| HY-RI02497 | hsa-miR-888-3p inhibitor | Oligonucleotides | |
| HY-RI02497A | hsa-miR-888-3p antagomir | Oligonucleotides | |
| HY-RI02498 | hsa-miR-889-3p inhibitor | Oligonucleotides | |
| HY-RI02498A | hsa-miR-889-3p antagomir | Oligonucleotides | |
| HY-RI02499 | hsa-miR-889-5p inhibitor | Oligonucleotides | |
| HY-RI02499A | hsa-miR-889-5p antagomir | Oligonucleotides | |
| HY-RI02500 | hsa-miR-890 inhibitor | Oligonucleotides | |
| HY-RI02500A | hsa-miR-890 antagomir | Oligonucleotides | |
| HY-RI02501 | hsa-miR-891a-3p inhibitor | Oligonucleotides | |
| HY-RI02501A | hsa-miR-891a-3p antagomir | Oligonucleotides | |
| HY-RI02502 | hsa-miR-891a-5p inhibitor | Oligonucleotides | |
| HY-RI02502A | hsa-miR-891a-5p antagomir | Oligonucleotides | |
| HY-RI02503 | hsa-miR-891b inhibitor | Oligonucleotides | |
| HY-RI02503A | hsa-miR-891b antagomir | Oligonucleotides | |
| HY-RI02504 | hsa-miR-892a inhibitor | Oligonucleotides | |
| HY-RI02504A | hsa-miR-892a antagomir | Oligonucleotides | |
| HY-RI02505 | hsa-miR-892b inhibitor | Oligonucleotides | |
| HY-RI02505A | hsa-miR-892b antagomir | Oligonucleotides | |
| HY-RI02506 | hsa-miR-892c-3p inhibitor | Oligonucleotides | |
| HY-RI02506A | hsa-miR-892c-3p antagomir | Oligonucleotides | |
| HY-RI02507 | hsa-miR-892c-5p inhibitor | Oligonucleotides | |
| HY-RI02507A | hsa-miR-892c-5p antagomir | Oligonucleotides | |
| HY-RI02508 | hsa-miR-921 inhibitor | Oligonucleotides | |
| HY-RI02508A | hsa-miR-921 antagomir | Oligonucleotides | |
| HY-RI02509 | hsa-miR-922 inhibitor | Oligonucleotides | |
| HY-RI02509A | hsa-miR-922 antagomir | Oligonucleotides | |
| HY-RI02510 | hsa-miR-924 inhibitor | Oligonucleotides | |
| HY-RI02510A | hsa-miR-924 antagomir | Oligonucleotides | |
| HY-RI02511 | hsa-miR-92a-1-5p inhibitor | Oligonucleotides | |
| HY-RI02511A | hsa-miR-92a-1-5p antagomir | Oligonucleotides | |
| HY-RI02512 | hsa-miR-92a-2-5p inhibitor | Oligonucleotides | |
| HY-RI02512A | hsa-miR-92a-2-5p antagomir | Oligonucleotides | |
| HY-RI02513 | hsa-miR-92a-3p inhibitor | Oligonucleotides | |
| HY-RI02513A | hsa-miR-92a-3p antagomir | Oligonucleotides | |
| HY-RI02514 | hsa-miR-92b-3p inhibitor | Oligonucleotides | |
| HY-RI02514A | hsa-miR-92b-3p antagomir | Oligonucleotides | |
| HY-RI02515 | hsa-miR-92b-5p inhibitor | Oligonucleotides | |
| HY-RI02515A | hsa-miR-92b-5p antagomir | Oligonucleotides | |
| HY-RI02516 | hsa-miR-933 inhibitor | Oligonucleotides | |
| HY-RI02516A | hsa-miR-933 antagomir | Oligonucleotides | |
| HY-RI02517 | hsa-miR-93-3p inhibitor | Oligonucleotides | |
| HY-RI02517A | hsa-miR-93-3p antagomir | Oligonucleotides | |
| HY-RI02518 | hsa-miR-934 inhibitor | Oligonucleotides | |
| HY-RI02518A | hsa-miR-934 antagomir | Oligonucleotides | |
| HY-RI02519 | hsa-miR-935 inhibitor | Oligonucleotides | |
| HY-RI02519A | hsa-miR-935 antagomir | Oligonucleotides | |
| HY-RI02520 | hsa-miR-93-5p inhibitor | Oligonucleotides | |
| HY-RI02520A | hsa-miR-93-5p antagomir | Oligonucleotides | |
| HY-RI02521 | hsa-miR-936 inhibitor | Oligonucleotides | |
| HY-RI02521A | hsa-miR-936 antagomir | Oligonucleotides | |
| HY-RI02522 | hsa-miR-937-3p inhibitor | Oligonucleotides | |
| HY-RI02522A | hsa-miR-937-3p antagomir | Oligonucleotides | |
| HY-RI02523 | hsa-miR-937-5p inhibitor | Oligonucleotides | |
| HY-RI02523A | hsa-miR-937-5p antagomir | Oligonucleotides | |
| HY-RI02524 | hsa-miR-938 inhibitor | Oligonucleotides | |
| HY-RI02524A | hsa-miR-938 antagomir | Oligonucleotides | |
| HY-RI02525 | hsa-miR-939-3p inhibitor | Oligonucleotides | |
| HY-RI02525A | hsa-miR-939-3p antagomir | Oligonucleotides | |
| HY-RI02526 | hsa-miR-939-5p inhibitor | Oligonucleotides | |
| HY-RI02526A | hsa-miR-939-5p antagomir | Oligonucleotides | |
| HY-RI02527 | hsa-miR-9-3p inhibitor | Oligonucleotides | |
| HY-RI02527A | hsa-miR-9-3p antagomir | Oligonucleotides | |
| HY-RI02528 | hsa-miR-940 inhibitor | Oligonucleotides | |
| HY-RI02528A | hsa-miR-940 antagomir | Oligonucleotides | |
| HY-RI02529 | hsa-miR-941 inhibitor | Oligonucleotides | |
| HY-RI02529A | hsa-miR-941 antagomir | Oligonucleotides | |
| HY-RI02530 | hsa-miR-942-3p inhibitor | Oligonucleotides | |
| HY-RI02530A | hsa-miR-942-3p antagomir | Oligonucleotides | |
| HY-RI02531 | hsa-miR-942-5p inhibitor | Oligonucleotides | |
| HY-RI02531A | hsa-miR-942-5p antagomir | Oligonucleotides | |
| HY-RI02532 | hsa-miR-943 inhibitor | Oligonucleotides | |
| HY-RI02532A | hsa-miR-943 antagomir | Oligonucleotides | |
| HY-RI02533 | hsa-miR-944 inhibitor | Oligonucleotides | |
| HY-RI02533A | hsa-miR-944 antagomir | Oligonucleotides | |
| HY-RI02534 | hsa-miR-9500 inhibitor | Oligonucleotides | |
| HY-RI02534A | hsa-miR-9500 antagomir | Oligonucleotides | |
| HY-RI02535 | hsa-miR-95-3p inhibitor | Oligonucleotides | |
| HY-RI02535A | hsa-miR-95-3p antagomir | Oligonucleotides | |
| HY-RI02536 | hsa-miR-9-5p inhibitor | Oligonucleotides | |
| HY-RI02536A | hsa-miR-9-5p antagomir | Oligonucleotides | |
| HY-RI02537 | hsa-miR-96-3p inhibitor | Oligonucleotides | |
| HY-RI02537A | hsa-miR-96-3p antagomir | Oligonucleotides | |
| HY-RI02538 | hsa-miR-96-5p inhibitor | Oligonucleotides | |
| HY-RI02538A | hsa-miR-96-5p antagomir | Oligonucleotides | |
| HY-RI02539 | hsa-miR-9718 inhibitor | Oligonucleotides | |
| HY-RI02539A | hsa-miR-9718 antagomir | Oligonucleotides | |
| HY-RI02540 | hsa-miR-98-3p inhibitor | Oligonucleotides | |
| HY-RI02540A | hsa-miR-98-3p antagomir | Oligonucleotides | |
| HY-RI02541 | hsa-miR-9851-3p inhibitor | Oligonucleotides | |
| HY-RI02541A | hsa-miR-9851-3p antagomir | Oligonucleotides | |
| HY-RI02542 | hsa-miR-9851-5p inhibitor | Oligonucleotides | |
| HY-RI02542A | hsa-miR-9851-5p antagomir | Oligonucleotides | |
| HY-RI02543 | hsa-miR-98-5p inhibitor | Oligonucleotides | |
| HY-RI02543A | hsa-miR-98-5p antagomir | Oligonucleotides | |
| HY-RI02544 | hsa-miR-9898 inhibitor | Oligonucleotides | |
| HY-RI02544A | hsa-miR-9898 antagomir | Oligonucleotides | |
| HY-RI02545 | hsa-miR-9899 inhibitor | Oligonucleotides | |
| HY-RI02545A | hsa-miR-9899 antagomir | Oligonucleotides | |
| HY-RI02546 | hsa-miR-9900 inhibitor | Oligonucleotides | |
| HY-RI02546A | hsa-miR-9900 antagomir | Oligonucleotides | |
| HY-RI02547 | hsa-miR-9901 inhibitor | Oligonucleotides | |
| HY-RI02547A | hsa-miR-9901 antagomir | Oligonucleotides | |
| HY-RI02548 | hsa-miR-9902 inhibitor | Oligonucleotides | |
| HY-RI02548A | hsa-miR-9902 antagomir | Oligonucleotides | |
| HY-RI02549 | hsa-miR-9903 inhibitor | Oligonucleotides | |
| HY-RI02549A | hsa-miR-9903 antagomir | Oligonucleotides | |
| HY-RI02550 | hsa-miR-9983-3p inhibitor | Oligonucleotides | |
| HY-RI02550A | hsa-miR-9983-3p antagomir | Oligonucleotides | |
| HY-RI02551 | hsa-miR-9985 inhibitor | Oligonucleotides | |
| HY-RI02551A | hsa-miR-9985 antagomir | Oligonucleotides | |
| HY-RI02552 | hsa-miR-9986 inhibitor | Oligonucleotides | |
| HY-RI02552A | hsa-miR-9986 antagomir | Oligonucleotides | |
| HY-RI02553 | hsa-miR-99a-3p inhibitor | Oligonucleotides | |
| HY-RI02553A | hsa-miR-99a-3p antagomir | Oligonucleotides | |
| HY-RI02554 | hsa-miR-99a-5p inhibitor | Oligonucleotides | |
| HY-RI02554A | hsa-miR-99a-5p antagomir | Oligonucleotides | |
| HY-RI02555 | hsa-miR-99b-3p inhibitor | Oligonucleotides | |
| HY-RI02555A | hsa-miR-99b-3p antagomir | Oligonucleotides | |
| HY-RI02556 | hsa-miR-99b-5p inhibitor | Oligonucleotides | |
| HY-RI02556A | hsa-miR-99b-5p antagomir | Oligonucleotides | |
| HY-RI02557 | mmu-let-7a-1-3p inhibitor | Oligonucleotides | |
| HY-RI02557A | mmu-let-7a-1-3p antagomir | Oligonucleotides | |
| HY-RI02558 | mmu-let-7a-2-3p inhibitor | Oligonucleotides | |
| HY-RI02558A | mmu-let-7a-2-3p antagomir | Oligonucleotides | |
| HY-RI02559 | mmu-let-7f-2-3p inhibitor | Oligonucleotides | |
| HY-RI02559A | mmu-let-7f-2-3p antagomir | Oligonucleotides | |
| HY-RI02560 | mmu-let-7j inhibitor | Oligonucleotides | |
| HY-RI02560A | mmu-let-7j antagomir | Oligonucleotides | |
| HY-RI02561 | mmu-let-7k inhibitor | Oligonucleotides | |
| HY-RI02561A | mmu-let-7k antagomir | Oligonucleotides | |
| HY-RI02562 | mmu-miR-100-3p inhibitor | Oligonucleotides | |
| HY-RI02562A | mmu-miR-100-3p antagomir | Oligonucleotides | |
| HY-RI02563 | mmu-miR-101a-5p inhibitor | Oligonucleotides | |
| HY-RI02563A | mmu-miR-101a-5p antagomir | Oligonucleotides | |
| HY-RI02564 | mmu-miR-101b-3p inhibitor | Oligonucleotides | |
| HY-RI02564A | mmu-miR-101b-3p antagomir | Oligonucleotides | |
| HY-RI02565 | mmu-miR-101b-5p inhibitor | Oligonucleotides | |
| HY-RI02565A | mmu-miR-101b-5p antagomir | Oligonucleotides | |
| HY-RI02566 | mmu-miR-101c inhibitor | Oligonucleotides | |
| HY-RI02566A | mmu-miR-101c antagomir | Oligonucleotides | |
| HY-RI02567 | mmu-miR-105 inhibitor | Oligonucleotides | |
| HY-RI02567A | mmu-miR-105 antagomir | Oligonucleotides | |
| HY-RI02568 | mmu-miR-106a-3p inhibitor | Oligonucleotides | |
| HY-RI02568A | mmu-miR-106a-3p antagomir | Oligonucleotides | |
| HY-RI02569 | mmu-miR-106a-5p inhibitor | Oligonucleotides | |
| HY-RI02569A | mmu-miR-106a-5p antagomir | Oligonucleotides | |
| HY-RI02570 | mmu-miR-107-5p inhibitor | Oligonucleotides | |
| HY-RI02570A | mmu-miR-107-5p antagomir | Oligonucleotides | |
| HY-RI02571 | mmu-miR-10b-3p inhibitor | Oligonucleotides | |
| HY-RI02571A | mmu-miR-10b-3p antagomir | Oligonucleotides | |
| HY-RI02572 | mmu-miR-1187 inhibitor | Oligonucleotides | |
| HY-RI02572A | mmu-miR-1187 antagomir | Oligonucleotides | |
| HY-RI02573 | mmu-miR-1188-3p inhibitor | Oligonucleotides | |
| HY-RI02573A | mmu-miR-1188-3p antagomir | Oligonucleotides | |
| HY-RI02574 | mmu-miR-1188-5p inhibitor | Oligonucleotides | |
| HY-RI02574A | mmu-miR-1188-5p antagomir | Oligonucleotides | |
| HY-RI02575 | mmu-miR-1190 inhibitor | Oligonucleotides | |
| HY-RI02575A | mmu-miR-1190 antagomir | Oligonucleotides | |
| HY-RI02576 | mmu-miR-1191a inhibitor | Oligonucleotides | |
| HY-RI02576A | mmu-miR-1191a antagomir | Oligonucleotides | |
| HY-RI02577 | mmu-miR-1191b-3p inhibitor | Oligonucleotides | |
| HY-RI02577A | mmu-miR-1191b-3p antagomir | Oligonucleotides | |
| HY-RI02578 | mmu-miR-1191b-5p inhibitor | Oligonucleotides | |
| HY-RI02578A | mmu-miR-1191b-5p antagomir | Oligonucleotides | |
| HY-RI02579 | mmu-miR-1192 inhibitor | Oligonucleotides | |
| HY-RI02579A | mmu-miR-1192 antagomir | Oligonucleotides | |
| HY-RI02580 | mmu-miR-1193-3p inhibitor | Oligonucleotides | |
| HY-RI02580A | mmu-miR-1193-3p antagomir | Oligonucleotides | |
| HY-RI02581 | mmu-miR-1193-5p inhibitor | Oligonucleotides | |
| HY-RI02581A | mmu-miR-1193-5p antagomir | Oligonucleotides | |
| HY-RI02582 | mmu-miR-1194 inhibitor | Oligonucleotides | |
| HY-RI02582A | mmu-miR-1194 antagomir | Oligonucleotides | |
| HY-RI02583 | mmu-miR-1195 inhibitor | Oligonucleotides | |
| HY-RI02583A | mmu-miR-1195 antagomir | Oligonucleotides | |
| HY-RI02584 | mmu-miR-1197-5p inhibitor | Oligonucleotides | |
| HY-RI02584A | mmu-miR-1197-5p antagomir | Oligonucleotides | |
| HY-RI02585 | mmu-miR-1198-3p inhibitor | Oligonucleotides | |
| HY-RI02585A | mmu-miR-1198-3p antagomir | Oligonucleotides | |
| HY-RI02586 | mmu-miR-1198-5p inhibitor | Oligonucleotides | |
| HY-RI02586A | mmu-miR-1198-5p antagomir | Oligonucleotides | |
| HY-RI02587 | mmu-miR-1199-3p inhibitor | Oligonucleotides | |
| HY-RI02587A | mmu-miR-1199-3p antagomir | Oligonucleotides | |
| HY-RI02588 | mmu-miR-1199-5p inhibitor | Oligonucleotides | |
| HY-RI02588A | mmu-miR-1199-5p antagomir | Oligonucleotides | |
| HY-RI02589 | mmu-miR-12178-3p inhibitor | Oligonucleotides | |
| HY-RI02589A | mmu-miR-12178-3p antagomir | Oligonucleotides | |
| HY-RI02590 | mmu-miR-12178-5p inhibitor | Oligonucleotides | |
| HY-RI02590A | mmu-miR-12178-5p antagomir | Oligonucleotides | |
| HY-RI02591 | mmu-miR-12179-5p inhibitor | Oligonucleotides | |
| HY-RI02591A | mmu-miR-12179-5p antagomir | Oligonucleotides | |
| HY-RI02592 | mmu-miR-12180-3p inhibitor | Oligonucleotides | |
| HY-RI02592A | mmu-miR-12180-3p antagomir | Oligonucleotides | |
| HY-RI02593 | mmu-miR-12181-3p inhibitor | Oligonucleotides | |
| HY-RI02593A | mmu-miR-12181-3p antagomir | Oligonucleotides | |
| HY-RI02594 | mmu-miR-12181-5p inhibitor | Oligonucleotides | |
| HY-RI02594A | mmu-miR-12181-5p antagomir | Oligonucleotides | |
| HY-RI02595 | mmu-miR-12182-3p inhibitor | Oligonucleotides | |
| HY-RI02595A | mmu-miR-12182-3p antagomir | Oligonucleotides | |
| HY-RI02596 | mmu-miR-12182-5p inhibitor | Oligonucleotides | |
| HY-RI02596A | mmu-miR-12182-5p antagomir | Oligonucleotides | |
| HY-RI02597 | mmu-miR-12183-5p inhibitor | Oligonucleotides | |
| HY-RI02597A | mmu-miR-12183-5p antagomir | Oligonucleotides | |
| HY-RI02598 | mmu-miR-12184-3p inhibitor | Oligonucleotides | |
| HY-RI02598A | mmu-miR-12184-3p antagomir | Oligonucleotides | |
| HY-RI02599 | mmu-miR-12184-5p inhibitor | Oligonucleotides | |
| HY-RI02599A | mmu-miR-12184-5p antagomir | Oligonucleotides | |
| HY-RI02600 | mmu-miR-12185-3p inhibitor | Oligonucleotides | |
| HY-RI02600A | mmu-miR-12185-3p antagomir | Oligonucleotides | |
| HY-RI02601 | mmu-miR-12185-5p inhibitor | Oligonucleotides | |
| HY-RI02601A | mmu-miR-12185-5p antagomir | Oligonucleotides | |
| HY-RI02602 | mmu-miR-12186-3p inhibitor | Oligonucleotides | |
| HY-RI02602A | mmu-miR-12186-3p antagomir | Oligonucleotides | |
| HY-RI02603 | mmu-miR-12186-5p inhibitor | Oligonucleotides | |
| HY-RI02603A | mmu-miR-12186-5p antagomir | Oligonucleotides | |
| HY-RI02604 | mmu-miR-12187-3p inhibitor | Oligonucleotides | |
| HY-RI02604A | mmu-miR-12187-3p antagomir | Oligonucleotides | |
| HY-RI02605 | mmu-miR-12187-5p inhibitor | Oligonucleotides | |
| HY-RI02605A | mmu-miR-12187-5p antagomir | Oligonucleotides | |
| HY-RI02606 | mmu-miR-12188-3p inhibitor | Oligonucleotides | |
| HY-RI02606A | mmu-miR-12188-3p antagomir | Oligonucleotides | |
| HY-RI02607 | mmu-miR-12188-5p inhibitor | Oligonucleotides | |
| HY-RI02607A | mmu-miR-12188-5p antagomir | Oligonucleotides | |
| HY-RI02608 | mmu-miR-12189-3p inhibitor | Oligonucleotides | |
| HY-RI02608A | mmu-miR-12189-3p antagomir | Oligonucleotides | |
| HY-RI02609 | mmu-miR-12190-3p inhibitor | Oligonucleotides | |
| HY-RI02609A | mmu-miR-12190-3p antagomir | Oligonucleotides | |
| HY-RI02610 | mmu-miR-12191-3p inhibitor | Oligonucleotides | |
| HY-RI02610A | mmu-miR-12191-3p antagomir | Oligonucleotides | |
| HY-RI02611 | mmu-miR-12191-5p inhibitor | Oligonucleotides | |
| HY-RI02611A | mmu-miR-12191-5p antagomir | Oligonucleotides | |
| HY-RI02612 | mmu-miR-12192-5p inhibitor | Oligonucleotides | |
| HY-RI02612A | mmu-miR-12192-5p antagomir | Oligonucleotides | |
| HY-RI02613 | mmu-miR-12193-3p inhibitor | Oligonucleotides | |
| HY-RI02613A | mmu-miR-12193-3p antagomir | Oligonucleotides | |
| HY-RI02614 | mmu-miR-12193-5p inhibitor | Oligonucleotides | |
| HY-RI02614A | mmu-miR-12193-5p antagomir | Oligonucleotides | |
| HY-RI02615 | mmu-miR-12194-3p inhibitor | Oligonucleotides | |
| HY-RI02615A | mmu-miR-12194-3p antagomir | Oligonucleotides | |
| HY-RI02616 | mmu-miR-12195-3p inhibitor | Oligonucleotides | |
| HY-RI02616A | mmu-miR-12195-3p antagomir | Oligonucleotides | |
| HY-RI02617 | mmu-miR-12195-5p inhibitor | Oligonucleotides | |
| HY-RI02617A | mmu-miR-12195-5p antagomir | Oligonucleotides | |
| HY-RI02618 | mmu-miR-12196-3p inhibitor | Oligonucleotides | |
| HY-RI02618A | mmu-miR-12196-3p antagomir | Oligonucleotides | |
| HY-RI02619 | mmu-miR-12196-5p inhibitor | Oligonucleotides | |
| HY-RI02619A | mmu-miR-12196-5p antagomir | Oligonucleotides | |
| HY-RI02620 | mmu-miR-12197-3p inhibitor | Oligonucleotides | |
| HY-RI02620A | mmu-miR-12197-3p antagomir | Oligonucleotides | |
| HY-RI02621 | mmu-miR-12198-3p inhibitor | Oligonucleotides | |
| HY-RI02621A | mmu-miR-12198-3p antagomir | Oligonucleotides | |
| HY-RI02622 | mmu-miR-12199-3p inhibitor | Oligonucleotides | |
| HY-RI02622A | mmu-miR-12199-3p antagomir | Oligonucleotides | |
| HY-RI02623 | mmu-miR-12200-3p inhibitor | Oligonucleotides | |
| HY-RI02623A | mmu-miR-12200-3p antagomir | Oligonucleotides | |
| HY-RI02624 | mmu-miR-12200-5p inhibitor | Oligonucleotides | |
| HY-RI02624A | mmu-miR-12200-5p antagomir | Oligonucleotides | |
| HY-RI02625 | mmu-miR-12201-3p inhibitor | Oligonucleotides | |
| HY-RI02625A | mmu-miR-12201-3p antagomir | Oligonucleotides | |
| HY-RI02626 | mmu-miR-12201-5p inhibitor | Oligonucleotides | |
| HY-RI02626A | mmu-miR-12201-5p antagomir | Oligonucleotides | |
| HY-RI02627 | mmu-miR-12202-3p inhibitor | Oligonucleotides | |
| HY-RI02627A | mmu-miR-12202-3p antagomir | Oligonucleotides | |
| HY-RI02628 | mmu-miR-12202-5p inhibitor | Oligonucleotides | |
| HY-RI02628A | mmu-miR-12202-5p antagomir | Oligonucleotides | |
| HY-RI02629 | mmu-miR-12203-3p inhibitor | Oligonucleotides | |
| HY-RI02629A | mmu-miR-12203-3p antagomir | Oligonucleotides | |
| HY-RI02630 | mmu-miR-12203-5p inhibitor | Oligonucleotides | |
| HY-RI02630A | mmu-miR-12203-5p antagomir | Oligonucleotides | |
| HY-RI02631 | mmu-miR-12204-5p inhibitor | Oligonucleotides | |
| HY-RI02631A | mmu-miR-12204-5p antagomir | Oligonucleotides | |
| HY-RI02632 | mmu-miR-12205-3p inhibitor | Oligonucleotides | |
| HY-RI02632A | mmu-miR-12205-3p antagomir | Oligonucleotides | |
| HY-RI02633 | mmu-miR-12205-5p inhibitor | Oligonucleotides | |
| HY-RI02633A | mmu-miR-12205-5p antagomir | Oligonucleotides | |
| HY-RI02634 | mmu-miR-12206-5p inhibitor | Oligonucleotides | |
| HY-RI02634A | mmu-miR-12206-5p antagomir | Oligonucleotides | |
| HY-RI02635 | mmu-miR-122-3p inhibitor | Oligonucleotides | |
| HY-RI02635A | mmu-miR-122-3p antagomir | Oligonucleotides | |
| HY-RI02636 | mmu-miR-1224-3p inhibitor | Oligonucleotides | |
| HY-RI02636A | mmu-miR-1224-3p antagomir | Oligonucleotides | |
| HY-RI02637 | mmu-miR-1224-5p inhibitor | Oligonucleotides | |
| HY-RI02637A | mmu-miR-1224-5p antagomir | Oligonucleotides | |
| HY-RI02638 | mmu-miR-122b-5p inhibitor | Oligonucleotides | |
| HY-RI02638A | mmu-miR-122b-5p antagomir | Oligonucleotides | |
| HY-RI02639 | mmu-miR-1231-3p inhibitor | Oligonucleotides | |
| HY-RI02639A | mmu-miR-1231-3p antagomir | Oligonucleotides | |
| HY-RI02640 | mmu-miR-1231-5p inhibitor | Oligonucleotides | |
| HY-RI02640A | mmu-miR-1231-5p antagomir | Oligonucleotides | |
| HY-RI02641 | mmu-miR-124-3p inhibitor | Oligonucleotides | |
| HY-RI02641A | mmu-miR-124-3p antagomir | Oligonucleotides | |
| HY-RI02642 | mmu-miR-1247-3p inhibitor | Oligonucleotides | |
| HY-RI02642A | mmu-miR-1247-3p antagomir | Oligonucleotides | |
| HY-RI02643 | mmu-miR-1249-5p inhibitor | Oligonucleotides | |
| HY-RI02643A | mmu-miR-1249-5p antagomir | Oligonucleotides | |
| HY-RI02644 | mmu-miR-124b-3p inhibitor | Oligonucleotides | |
| HY-RI02644A | mmu-miR-124b-3p antagomir | Oligonucleotides | |
| HY-RI02645 | mmu-miR-1258-3p inhibitor | Oligonucleotides | |
| HY-RI02645A | mmu-miR-1258-3p antagomir | Oligonucleotides | |
| HY-RI02646 | mmu-miR-1258-5p inhibitor | Oligonucleotides | |
| HY-RI02646A | mmu-miR-1258-5p antagomir | Oligonucleotides | |
| HY-RI02647 | mmu-miR-125b-2-3p inhibitor | Oligonucleotides | |
| HY-RI02647A | mmu-miR-125b-2-3p antagomir | Oligonucleotides | |
| HY-RI02648 | mmu-miR-1264-3p inhibitor | Oligonucleotides | |
| HY-RI02648A | mmu-miR-1264-3p antagomir | Oligonucleotides | |
| HY-RI02649 | mmu-miR-1264-5p inhibitor | Oligonucleotides | |
| HY-RI02649A | mmu-miR-1264-5p antagomir | Oligonucleotides | |
| HY-RI02650 | mmu-miR-126b-3p inhibitor | Oligonucleotides | |
| HY-RI02650A | mmu-miR-126b-3p antagomir | Oligonucleotides | |
| HY-RI02651 | mmu-miR-126b-5p inhibitor | Oligonucleotides | |
| HY-RI02651A | mmu-miR-126b-5p antagomir | Oligonucleotides | |
| HY-RI02652 | mmu-miR-1271-3p inhibitor | Oligonucleotides | |
| HY-RI02652A | mmu-miR-1271-3p antagomir | Oligonucleotides | |
| HY-RI02653 | mmu-miR-1271-5p inhibitor | Oligonucleotides | |
| HY-RI02653A | mmu-miR-1271-5p antagomir | Oligonucleotides | |
| HY-RI02654 | mmu-miR-128-1-5p inhibitor | Oligonucleotides | |
| HY-RI02654A | mmu-miR-128-1-5p antagomir | Oligonucleotides | |
| HY-RI02655 | mmu-miR-128-2-5p inhibitor | Oligonucleotides | |
| HY-RI02655A | mmu-miR-128-2-5p antagomir | Oligonucleotides | |
| HY-RI02656 | mmu-miR-1291 inhibitor | Oligonucleotides | |
| HY-RI02656A | mmu-miR-1291 antagomir | Oligonucleotides | |
| HY-RI02657 | mmu-miR-1298-3p inhibitor | Oligonucleotides | |
| HY-RI02657A | mmu-miR-1298-3p antagomir | Oligonucleotides | |
| HY-RI02658 | mmu-miR-129b-3p inhibitor | Oligonucleotides | |
| HY-RI02658A | mmu-miR-129b-3p antagomir | Oligonucleotides | |
| HY-RI02659 | mmu-miR-129b-5p inhibitor | Oligonucleotides | |
| HY-RI02659A | mmu-miR-129b-5p antagomir | Oligonucleotides | |
| HY-RI02660 | mmu-miR-1306-3p inhibitor | Oligonucleotides | |
| HY-RI02660A | mmu-miR-1306-3p antagomir | Oligonucleotides | |
| HY-RI02661 | mmu-miR-1306-5p inhibitor | Oligonucleotides | |
| HY-RI02661A | mmu-miR-1306-5p antagomir | Oligonucleotides | |
| HY-RI02662 | mmu-miR-130b-5p inhibitor | Oligonucleotides | |
| HY-RI02662A | mmu-miR-130b-5p antagomir | Oligonucleotides | |
| HY-RI02663 | mmu-miR-130c inhibitor | Oligonucleotides | |
| HY-RI02663A | mmu-miR-130c antagomir | Oligonucleotides | |
| HY-RI02664 | mmu-miR-132-5p inhibitor | Oligonucleotides | |
| HY-RI02664A | mmu-miR-132-5p antagomir | Oligonucleotides | |
| HY-RI02665 | mmu-miR-133a-5p inhibitor | Oligonucleotides | |
| HY-RI02665A | mmu-miR-133a-5p antagomir | Oligonucleotides | |
| HY-RI02666 | mmu-miR-133b-5p inhibitor | Oligonucleotides | |
| HY-RI02666A | mmu-miR-133b-5p antagomir | Oligonucleotides | |
| HY-RI02667 | mmu-miR-133c inhibitor | Oligonucleotides | |
| HY-RI02667A | mmu-miR-133c antagomir | Oligonucleotides | |
| HY-RI02668 | mmu-miR-134-3p inhibitor | Oligonucleotides | |
| HY-RI02668A | mmu-miR-134-3p antagomir | Oligonucleotides | |
| HY-RI02669 | mmu-miR-135a-2-3p inhibitor | Oligonucleotides | |
| HY-RI02669A | mmu-miR-135a-2-3p antagomir | Oligonucleotides | |
| HY-RI02670 | mmu-miR-136-3p inhibitor | Oligonucleotides | |
| HY-RI02670A | mmu-miR-136-3p antagomir | Oligonucleotides | |
| HY-RI02671 | mmu-miR-136-5p inhibitor | Oligonucleotides | |
| HY-RI02671A | mmu-miR-136-5p antagomir | Oligonucleotides | |
| HY-RI02672 | mmu-miR-138-1-3p inhibitor | Oligonucleotides | |
| HY-RI02672A | mmu-miR-138-1-3p antagomir | Oligonucleotides | |
| HY-RI02673 | mmu-miR-138-2-3p inhibitor | Oligonucleotides | |
| HY-RI02673A | mmu-miR-138-2-3p antagomir | Oligonucleotides | |
| HY-RI02674 | mmu-miR-139-5p inhibitor | Oligonucleotides | |
| HY-RI02674A | mmu-miR-139-5p antagomir | Oligonucleotides | |
| HY-RI02675 | mmu-miR-141-5p inhibitor | Oligonucleotides | |
| HY-RI02675A | mmu-miR-141-5p antagomir | Oligonucleotides | |
| HY-RI02676 | mmu-miR-142b inhibitor | Oligonucleotides | |
| HY-RI02676A | mmu-miR-142b antagomir | Oligonucleotides | |
| HY-RI02677 | mmu-miR-143-5p inhibitor | Oligonucleotides | |
| HY-RI02677A | mmu-miR-143-5p antagomir | Oligonucleotides | |
| HY-RI02678 | mmu-miR-144-5p inhibitor | Oligonucleotides | |
| HY-RI02678A | mmu-miR-144-5p antagomir | Oligonucleotides | |
| HY-RI02679 | mmu-miR-145a-3p inhibitor | Oligonucleotides | |
| HY-RI02679A | mmu-miR-145a-3p antagomir | Oligonucleotides | |
| HY-RI02680 | mmu-miR-145b inhibitor | Oligonucleotides | |
| HY-RI02680A | mmu-miR-145b antagomir | Oligonucleotides | |
| HY-RI02681 | mmu-miR-146a-3p inhibitor | Oligonucleotides | |
| HY-RI02681A | mmu-miR-146a-3p antagomir | Oligonucleotides | |
| HY-RI02682 | mmu-miR-146b-3p inhibitor | Oligonucleotides | |
| HY-RI02682A | mmu-miR-146b-3p antagomir | Oligonucleotides | |
| HY-RI02683 | mmu-miR-147-3p inhibitor | Oligonucleotides | |
| HY-RI02683A | mmu-miR-147-3p antagomir | Oligonucleotides | |
| HY-RI02684 | mmu-miR-147-5p inhibitor | Oligonucleotides | |
| HY-RI02684A | mmu-miR-147-5p antagomir | Oligonucleotides | |
| HY-RI02685 | mmu-miR-148b-5p inhibitor | Oligonucleotides | |
| HY-RI02685A | mmu-miR-148b-5p antagomir | Oligonucleotides | |
| HY-RI02686 | mmu-miR-149-3p inhibitor | Oligonucleotides | |
| HY-RI02686A | mmu-miR-149-3p antagomir | Oligonucleotides | |
| HY-RI02687 | mmu-miR-150-3p inhibitor | Oligonucleotides | |
| HY-RI02687A | mmu-miR-150-3p antagomir | Oligonucleotides | |
| HY-RI02688 | mmu-miR-151-3p inhibitor | Oligonucleotides | |
| HY-RI02688A | mmu-miR-151-3p antagomir | Oligonucleotides | |
| HY-RI02689 | mmu-miR-152-5p inhibitor | Oligonucleotides | |
| HY-RI02689A | mmu-miR-152-5p antagomir | Oligonucleotides | |
| HY-RI02690 | mmu-miR-153-5p inhibitor | Oligonucleotides | |
| HY-RI02690A | mmu-miR-153-5p antagomir | Oligonucleotides | |
| HY-RI02691 | mmu-miR-155-5p inhibitor | Oligonucleotides | |
| HY-RI02691A | mmu-miR-155-5p antagomir | Oligonucleotides | |
| HY-RI02692 | mmu-miR-15a-3p inhibitor | Oligonucleotides | |
| HY-RI02692A | mmu-miR-15a-3p antagomir | Oligonucleotides | |
| HY-RI02693 | mmu-miR-16-1-3p inhibitor | Oligonucleotides | |
| HY-RI02693A | mmu-miR-16-1-3p antagomir | Oligonucleotides | |
| HY-RI02694 | mmu-miR-1668 inhibitor | Oligonucleotides | |
| HY-RI02694A | mmu-miR-1668 antagomir | Oligonucleotides | |
| HY-RI02695 | mmu-miR-17-3p inhibitor | Oligonucleotides | |
| HY-RI02695A | mmu-miR-17-3p antagomir | Oligonucleotides | |
| HY-RI02696 | mmu-miR-181b-2-3p inhibitor | Oligonucleotides | |
| HY-RI02696A | mmu-miR-181b-2-3p antagomir | Oligonucleotides | |
| HY-RI02697 | mmu-miR-181b-5p inhibitor | Oligonucleotides | |
| HY-RI02697A | mmu-miR-181b-5p antagomir | Oligonucleotides | |
| HY-RI02698 | mmu-miR-181c-3p inhibitor | Oligonucleotides | |
| HY-RI02698A | mmu-miR-181c-3p antagomir | Oligonucleotides | |
| HY-RI02699 | mmu-miR-181d-3p inhibitor | Oligonucleotides | |
| HY-RI02699A | mmu-miR-181d-3p antagomir | Oligonucleotides | |
| HY-RI02700 | mmu-miR-182-3p inhibitor | Oligonucleotides | |
| HY-RI02700A | mmu-miR-182-3p antagomir | Oligonucleotides | |
| HY-RI02701 | mmu-miR-182-5p inhibitor | Oligonucleotides | |
| HY-RI02701A | mmu-miR-182-5p antagomir | Oligonucleotides | |
| HY-RI02702 | mmu-miR-1839-3p inhibitor | Oligonucleotides | |
| HY-RI02702A | mmu-miR-1839-3p antagomir | Oligonucleotides | |
| HY-RI02703 | mmu-miR-1839-5p inhibitor | Oligonucleotides | |
| HY-RI02703A | mmu-miR-1839-5p antagomir | Oligonucleotides | |
| HY-RI02704 | mmu-miR-1843a-3p inhibitor | Oligonucleotides | |
| HY-RI02704A | mmu-miR-1843a-3p antagomir | Oligonucleotides | |
| HY-RI02705 | mmu-miR-1843a-5p inhibitor | Oligonucleotides | |
| HY-RI02705A | mmu-miR-1843a-5p antagomir | Oligonucleotides | |
| HY-RI02706 | mmu-miR-1843b-3p inhibitor | Oligonucleotides | |
| HY-RI02706A | mmu-miR-1843b-3p antagomir | Oligonucleotides | |
| HY-RI02707 | mmu-miR-1843b-5p inhibitor | Oligonucleotides | |
| HY-RI02707A | mmu-miR-1843b-5p antagomir | Oligonucleotides | |
| HY-RI02708 | mmu-miR-184-5p inhibitor | Oligonucleotides | |
| HY-RI02708A | mmu-miR-184-5p antagomir | Oligonucleotides | |
| HY-RI02709 | mmu-miR-185-3p inhibitor | Oligonucleotides | |
| HY-RI02709A | mmu-miR-185-3p antagomir | Oligonucleotides | |
| HY-RI02710 | mmu-miR-186-3p inhibitor | Oligonucleotides | |
| HY-RI02710A | mmu-miR-186-3p antagomir | Oligonucleotides | |
| HY-RI02711 | mmu-miR-187-5p inhibitor | Oligonucleotides | |
| HY-RI02711A | mmu-miR-187-5p antagomir | Oligonucleotides | |
| HY-RI02712 | mmu-miR-1892 inhibitor | Oligonucleotides | |
| HY-RI02712A | mmu-miR-1892 antagomir | Oligonucleotides | |
| HY-RI02713 | mmu-miR-1893 inhibitor | Oligonucleotides | |
| HY-RI02713A | mmu-miR-1893 antagomir | Oligonucleotides | |
| HY-RI02714 | mmu-miR-1894-3p inhibitor | Oligonucleotides | |
| HY-RI02714A | mmu-miR-1894-3p antagomir | Oligonucleotides | |
| HY-RI02715 | mmu-miR-1894-5p inhibitor | Oligonucleotides | |
| HY-RI02715A | mmu-miR-1894-5p antagomir | Oligonucleotides | |
| HY-RI02716 | mmu-miR-1895 inhibitor | Oligonucleotides | |
| HY-RI02716A | mmu-miR-1895 antagomir | Oligonucleotides | |
| HY-RI02717 | mmu-miR-1896 inhibitor | Oligonucleotides | |
| HY-RI02717A | mmu-miR-1896 antagomir | Oligonucleotides | |
| HY-RI02718 | mmu-miR-1897-3p inhibitor | Oligonucleotides | |
| HY-RI02718A | mmu-miR-1897-3p antagomir | Oligonucleotides | |
| HY-RI02719 | mmu-miR-1897-5p inhibitor | Oligonucleotides | |
| HY-RI02719A | mmu-miR-1897-5p antagomir | Oligonucleotides | |
| HY-RI02720 | mmu-miR-1898 inhibitor | Oligonucleotides | |
| HY-RI02720A | mmu-miR-1898 antagomir | Oligonucleotides | |
| HY-RI02721 | mmu-miR-1899 inhibitor | Oligonucleotides | |
| HY-RI02721A | mmu-miR-1899 antagomir | Oligonucleotides | |
| HY-RI02722 | mmu-miR-18a-3p inhibitor | Oligonucleotides | |
| HY-RI02722A | mmu-miR-18a-3p antagomir | Oligonucleotides | |
| HY-RI02723 | mmu-miR-18b-3p inhibitor | Oligonucleotides | |
| HY-RI02723A | mmu-miR-18b-3p antagomir | Oligonucleotides | |
| HY-RI02724 | mmu-miR-18b-5p inhibitor | Oligonucleotides | |
| HY-RI02724A | mmu-miR-18b-5p antagomir | Oligonucleotides | |
| HY-RI02725 | mmu-miR-1900 inhibitor | Oligonucleotides | |
| HY-RI02725A | mmu-miR-1900 antagomir | Oligonucleotides | |
| HY-RI02726 | mmu-miR-1901 inhibitor | Oligonucleotides | |
| HY-RI02726A | mmu-miR-1901 antagomir | Oligonucleotides | |
| HY-RI02727 | mmu-miR-1902 inhibitor | Oligonucleotides | |
| HY-RI02727A | mmu-miR-1902 antagomir | Oligonucleotides | |
| HY-RI02728 | mmu-miR-1903 inhibitor | Oligonucleotides | |
| HY-RI02728A | mmu-miR-1903 antagomir | Oligonucleotides | |
| HY-RI02729 | mmu-miR-1904 inhibitor | Oligonucleotides | |
| HY-RI02729A | mmu-miR-1904 antagomir | Oligonucleotides | |
| HY-RI02730 | mmu-miR-1905 inhibitor | Oligonucleotides | |
| HY-RI02730A | mmu-miR-1905 antagomir | Oligonucleotides | |
| HY-RI02731 | mmu-miR-1906 inhibitor | Oligonucleotides | |
| HY-RI02731A | mmu-miR-1906 antagomir | Oligonucleotides | |
| HY-RI02732 | mmu-miR-1907 inhibitor | Oligonucleotides | |
| HY-RI02732A | mmu-miR-1907 antagomir | Oligonucleotides | |
| HY-RI02733 | mmu-miR-190b-3p inhibitor | Oligonucleotides | |
| HY-RI02733A | mmu-miR-190b-3p antagomir | Oligonucleotides | |
| HY-RI02734 | mmu-miR-1911-3p inhibitor | Oligonucleotides | |
| HY-RI02734A | mmu-miR-1911-3p antagomir | Oligonucleotides | |
| HY-RI02735 | mmu-miR-1911-5p inhibitor | Oligonucleotides | |
| HY-RI02735A | mmu-miR-1911-5p antagomir | Oligonucleotides | |
| HY-RI02736 | mmu-miR-1912-3p inhibitor | Oligonucleotides | |
| HY-RI02736A | mmu-miR-1912-3p antagomir | Oligonucleotides | |
| HY-RI02737 | mmu-miR-1912-5p inhibitor | Oligonucleotides | |
| HY-RI02737A | mmu-miR-1912-5p antagomir | Oligonucleotides | |
| HY-RI02738 | mmu-miR-191-3p inhibitor | Oligonucleotides | |
| HY-RI02738A | mmu-miR-191-3p antagomir | Oligonucleotides | |
| HY-RI02739 | mmu-miR-1927 inhibitor | Oligonucleotides | |
| HY-RI02739A | mmu-miR-1927 antagomir | Oligonucleotides | |
| HY-RI02740 | mmu-miR-1928 inhibitor | Oligonucleotides | |
| HY-RI02740A | mmu-miR-1928 antagomir | Oligonucleotides | |
| HY-RI02741 | mmu-miR-1929-3p inhibitor | Oligonucleotides | |
| HY-RI02741A | mmu-miR-1929-3p antagomir | Oligonucleotides | |
| HY-RI02742 | mmu-miR-1929-5p inhibitor | Oligonucleotides | |
| HY-RI02742A | mmu-miR-1929-5p antagomir | Oligonucleotides | |
| HY-RI02743 | mmu-miR-1930-3p inhibitor | Oligonucleotides | |
| HY-RI02743A | mmu-miR-1930-3p antagomir | Oligonucleotides | |
| HY-RI02744 | mmu-miR-1930-5p inhibitor | Oligonucleotides | |
| HY-RI02744A | mmu-miR-1930-5p antagomir | Oligonucleotides | |
| HY-RI02745 | mmu-miR-1931 inhibitor | Oligonucleotides | |
| HY-RI02745A | mmu-miR-1931 antagomir | Oligonucleotides | |
| HY-RI02746 | mmu-miR-1932 inhibitor | Oligonucleotides | |
| HY-RI02746A | mmu-miR-1932 antagomir | Oligonucleotides | |
| HY-RI02747 | mmu-miR-1933-3p inhibitor | Oligonucleotides | |
| HY-RI02747A | mmu-miR-1933-3p antagomir | Oligonucleotides | |
| HY-RI02748 | mmu-miR-1933-5p inhibitor | Oligonucleotides | |
| HY-RI02748A | mmu-miR-1933-5p antagomir | Oligonucleotides | |
| HY-RI02749 | mmu-miR-1934-3p inhibitor | Oligonucleotides | |
| HY-RI02749A | mmu-miR-1934-3p antagomir | Oligonucleotides | |
| HY-RI02750 | mmu-miR-1934-5p inhibitor | Oligonucleotides | |
| HY-RI02750A | mmu-miR-1934-5p antagomir | Oligonucleotides | |
| HY-RI02751 | mmu-miR-1936 inhibitor | Oligonucleotides | |
| HY-RI02751A | mmu-miR-1936 antagomir | Oligonucleotides | |
| HY-RI02752 | mmu-miR-1938 inhibitor | Oligonucleotides | |
| HY-RI02752A | mmu-miR-1938 antagomir | Oligonucleotides | |
| HY-RI02753 | mmu-miR-193a-5p inhibitor | Oligonucleotides | |
| HY-RI02753A | mmu-miR-193a-5p antagomir | Oligonucleotides | |
| HY-RI02754 | mmu-miR-193b-3p inhibitor | Oligonucleotides | |
| HY-RI02754A | mmu-miR-193b-3p antagomir | Oligonucleotides | |
| HY-RI02755 | mmu-miR-1941-3p inhibitor | Oligonucleotides | |
| HY-RI02755A | mmu-miR-1941-3p antagomir | Oligonucleotides | |
| HY-RI02756 | mmu-miR-194-1-3p inhibitor | Oligonucleotides | |
| HY-RI02756A | mmu-miR-194-1-3p antagomirs | Oligonucleotides | |
| HY-RI02757 | mmu-miR-1941-5p inhibitor | Oligonucleotides | |
| HY-RI02757A | mmu-miR-1941-5p antagomir | Oligonucleotides | |
| HY-RI02758 | mmu-miR-1942 inhibitor | Oligonucleotides | |
| HY-RI02758A | mmu-miR-1942 antagomir | Oligonucleotides | |
| HY-RI02759 | mmu-miR-1943-3p inhibitor | Oligonucleotides | |
| HY-RI02759A | mmu-miR-1943-3p antagomir | Oligonucleotides | |
| HY-RI02760 | mmu-miR-1943-5p inhibitor | Oligonucleotides | |
| HY-RI02760A | mmu-miR-1943-5p antagomir | Oligonucleotides | |
| HY-RI02761 | mmu-miR-1945 inhibitor | Oligonucleotides | |
| HY-RI02761A | mmu-miR-1945 antagomir | Oligonucleotides | |
| HY-RI02762 | mmu-miR-1946a inhibitor | Oligonucleotides | |
| HY-RI02762A | mmu-miR-1946a antagomir | Oligonucleotides | |
| HY-RI02763 | mmu-miR-1946b inhibitor | Oligonucleotides | |
| HY-RI02763A | mmu-miR-1946b antagomir | Oligonucleotides | |
| HY-RI02764 | mmu-miR-1947-3p inhibitor | Oligonucleotides | |
| HY-RI02764A | mmu-miR-1947-3p antagomir | Oligonucleotides | |
| HY-RI02765 | mmu-miR-1947-5p inhibitor | Oligonucleotides | |
| HY-RI02765A | mmu-miR-1947-5p antagomir | Oligonucleotides | |
| HY-RI02766 | mmu-miR-1948-3p inhibitor | Oligonucleotides | |
| HY-RI02766A | mmu-miR-1948-3p antagomir | Oligonucleotides | |
| HY-RI02767 | mmu-miR-1948-5p inhibitor | Oligonucleotides | |
| HY-RI02767A | mmu-miR-1948-5p antagomir | Oligonucleotides | |
| HY-RI02768 | mmu-miR-1949 inhibitor | Oligonucleotides | |
| HY-RI02768A | mmu-miR-1949 antagomir | Oligonucleotides | |
| HY-RI02769 | mmu-miR-1950 inhibitor | Oligonucleotides | |
| HY-RI02769A | mmu-miR-1950 antagomir | Oligonucleotides | |
| HY-RI02770 | mmu-miR-1951 inhibitor | Oligonucleotides | |
| HY-RI02770A | mmu-miR-1951 antagomir | Oligonucleotides | |
| HY-RI02771 | mmu-miR-1952 inhibitor | Oligonucleotides | |
| HY-RI02771A | mmu-miR-1952 antagomir | Oligonucleotides | |
| HY-RI02772 | mmu-miR-1953 inhibitor | Oligonucleotides | |
| HY-RI02772A | mmu-miR-1953 antagomir | Oligonucleotides | |
| HY-RI02773 | mmu-miR-1954 inhibitor | Oligonucleotides | |
| HY-RI02773A | mmu-miR-1954 antagomir | Oligonucleotides | |
| HY-RI02774 | mmu-miR-1955-3p inhibitor | Oligonucleotides | |
| HY-RI02774A | mmu-miR-1955-3p antagomir | Oligonucleotides | |
| HY-RI02775 | mmu-miR-1955-5p inhibitor | Oligonucleotides | |
| HY-RI02775A | mmu-miR-1955-5p antagomir | Oligonucleotides | |
| HY-RI02776 | mmu-miR-1956 inhibitor | Oligonucleotides | |
| HY-RI02776A | mmu-miR-1956 antagomir | Oligonucleotides | |
| HY-RI02777 | mmu-miR-1958 inhibitor | Oligonucleotides | |
| HY-RI02777A | mmu-miR-1958 antagomir | Oligonucleotides | |
| HY-RI02778 | mmu-miR-195b inhibitor | Oligonucleotides | |
| HY-RI02778A | mmu-miR-195b antagomir | Oligonucleotides | |
| HY-RI02779 | mmu-miR-1960 inhibitor | Oligonucleotides | |
| HY-RI02779A | mmu-miR-1960 antagomir | Oligonucleotides | |
| HY-RI02780 | mmu-miR-1961 inhibitor | Oligonucleotides | |
| HY-RI02780A | mmu-miR-1961 antagomir | Oligonucleotides | |
| HY-RI02781 | mmu-miR-1962 inhibitor | Oligonucleotides | |
| HY-RI02781A | mmu-miR-1962 antagomir | Oligonucleotides | |
| HY-RI02782 | mmu-miR-1963 inhibitor | Oligonucleotides | |
| HY-RI02782A | mmu-miR-1963 antagomir | Oligonucleotides | |
| HY-RI02783 | mmu-miR-1964-3p inhibitor | Oligonucleotides | |
| HY-RI02783A | mmu-miR-1964-3p antagomir | Oligonucleotides | |
| HY-RI02784 | mmu-miR-1964-5p inhibitor | Oligonucleotides | |
| HY-RI02784A | mmu-miR-1964-5p antagomir | Oligonucleotides | |
| HY-RI02785 | mmu-miR-1966-3p inhibitor | Oligonucleotides | |
| HY-RI02785A | mmu-miR-1966-3p antagomir | Oligonucleotides | |
| HY-RI02786 | mmu-miR-1966-5p inhibitor | Oligonucleotides | |
| HY-RI02786A | mmu-miR-1966-5p antagomir | Oligonucleotides | |
| HY-RI02787 | mmu-miR-1967 inhibitor | Oligonucleotides | |
| HY-RI02787A | mmu-miR-1967 antagomir | Oligonucleotides | |
| HY-RI02788 | mmu-miR-1968-3p inhibitor | Oligonucleotides | |
| HY-RI02788A | mmu-miR-1968-3p antagomir | Oligonucleotides | |
| HY-RI02789 | mmu-miR-1968-5p inhibitor | Oligonucleotides | |
| HY-RI02789A | mmu-miR-1968-5p antagomir | Oligonucleotides | |
| HY-RI02790 | mmu-miR-1969 inhibitor | Oligonucleotides | |
| HY-RI02790A | mmu-miR-1969 antagomir | Oligonucleotides | |
| HY-RI02791 | mmu-miR-196a-1-3p inhibitor | Oligonucleotides | |
| HY-RI02791A | mmu-miR-196a-1-3p antagomir | Oligonucleotides | |
| HY-RI02792 | mmu-miR-196a-2-3p inhibitor | Oligonucleotides | |
| HY-RI02792A | mmu-miR-196a-2-3p antagomir | Oligonucleotides | |
| HY-RI02793 | mmu-miR-1970 inhibitor | Oligonucleotides | |
| HY-RI02793A | mmu-miR-1970 antagomir | Oligonucleotides | |
| HY-RI02794 | mmu-miR-1970b-5p inhibitor | Oligonucleotides | |
| HY-RI02794A | mmu-miR-1970b-5p antagomir | Oligonucleotides | |
| HY-RI02795 | mmu-miR-1970c-3p inhibitor | Oligonucleotides | |
| HY-RI02795A | mmu-miR-1970c-3p antagomir | Oligonucleotides | |
| HY-RI02796 | mmu-miR-1970c-5p inhibitor | Oligonucleotides | |
| HY-RI02796A | mmu-miR-1970c-5p antagomir | Oligonucleotides | |
| HY-RI02797 | mmu-miR-1971 inhibitor | Oligonucleotides | |
| HY-RI02797A | mmu-miR-1971 antagomir | Oligonucleotides | |
| HY-RI02798 | mmu-miR-1981-3p inhibitor | Oligonucleotides | |
| HY-RI02798A | mmu-miR-1981-3p antagomir | Oligonucleotides | |
| HY-RI02799 | mmu-miR-1981-5p inhibitor | Oligonucleotides | |
| HY-RI02799A | mmu-miR-1981-5p antagomir | Oligonucleotides | |
| HY-RI02800 | mmu-miR-1982-3p inhibitor | Oligonucleotides | |
| HY-RI02800A | mmu-miR-1982-3p antagomir | Oligonucleotides | |
| HY-RI02801 | mmu-miR-1982-5p inhibitor | Oligonucleotides | |
| HY-RI02801A | mmu-miR-1982-5p antagomir | Oligonucleotides | |
| HY-RI02802 | mmu-miR-1983 inhibitor | Oligonucleotides | |
| HY-RI02802A | mmu-miR-1983 antagomir | Oligonucleotides | |
| HY-RI02803 | mmu-miR-199b-5p inhibitor | Oligonucleotides | |
| HY-RI02803A | mmu-miR-199b-5p antagomir | Oligonucleotides | |
| HY-RI02804 | mmu-miR-19a-5p inhibitor | Oligonucleotides | |
| HY-RI02804A | mmu-miR-19a-5p antagomir | Oligonucleotides | |
| HY-RI02805 | mmu-miR-19b-2-5p inhibitor | Oligonucleotides | |
| HY-RI02805A | mmu-miR-19b-2-5p antagomir | Oligonucleotides | |
| HY-RI02806 | mmu-miR-1a-1-5p inhibitor | Oligonucleotides | |
| HY-RI02806A | mmu-miR-1a-1-5p antagomir | Oligonucleotides | |
| HY-RI02807 | mmu-miR-1a-2-5p inhibitor | Oligonucleotides | |
| HY-RI02807A | mmu-miR-1a-2-5p antagomir | Oligonucleotides | |
| HY-RI02808 | mmu-miR-1b-3p inhibitor | Oligonucleotides | |
| HY-RI02808A | mmu-miR-1b-3p antagomir | Oligonucleotides | |
| HY-RI02809 | mmu-miR-1b-5p inhibitor | Oligonucleotides | |
| HY-RI02809A | mmu-miR-1b-5p antagomir | Oligonucleotides | |
| HY-RI02810 | mmu-miR-201-3p inhibitor | Oligonucleotides | |
| HY-RI02810A | mmu-miR-201-3p antagomir | Oligonucleotides | |
| HY-RI02811 | mmu-miR-201-5p inhibitor | Oligonucleotides | |
| HY-RI02811A | mmu-miR-201-5p antagomir | Oligonucleotides | |
| HY-RI02812 | mmu-miR-202-3p inhibitor | Oligonucleotides | |
| HY-RI02812A | mmu-miR-202-3p antagomir | Oligonucleotides | |
| HY-RI02813 | mmu-miR-202-5p inhibitor | Oligonucleotides | |
| HY-RI02813A | mmu-miR-202-5p antagomir | Oligonucleotides | |
| HY-RI02814 | mmu-miR-203-5p inhibitor | Oligonucleotides | |
| HY-RI02814A | mmu-miR-203-5p antagomir | Oligonucleotides | |
| HY-RI02815 | mmu-miR-203b-3p inhibitor | Oligonucleotides | |
| HY-RI02815A | mmu-miR-203b-3p antagomir | Oligonucleotides | |
| HY-RI02816 | mmu-miR-203b-5p inhibitor | Oligonucleotides | |
| HY-RI02816A | mmu-miR-203b-5p antagomir | Oligonucleotides | |
| HY-RI02817 | mmu-miR-205-3p inhibitor | Oligonucleotides | |
| HY-RI02817A | mmu-miR-205-3p antagomir | Oligonucleotides | |
| HY-RI02818 | mmu-miR-206-5p inhibitor | Oligonucleotides | |
| HY-RI02818A | mmu-miR-206-5p antagomir | Oligonucleotides | |
| HY-RI02819 | mmu-miR-207 inhibitor | Oligonucleotides | |
| HY-RI02819A | mmu-miR-207 antagomir | Oligonucleotides | |
| HY-RI02820 | mmu-miR-20a-3p inhibitor | Oligonucleotides | |
| HY-RI02820A | mmu-miR-20a-3p antagomir | Oligonucleotides | |
| HY-RI02821 | mmu-miR-20b-3p inhibitor | Oligonucleotides | |
| HY-RI02821A | mmu-miR-20b-3p antagomir | Oligonucleotides | |
| HY-RI02822 | mmu-miR-210-5p inhibitor | Oligonucleotides | |
| HY-RI02822A | mmu-miR-210-5p antagomir | Oligonucleotides | |
| HY-RI02823 | mmu-miR-211-3p inhibitor | Oligonucleotides | |
| HY-RI02823A | mmu-miR-211-3p antagomir | Oligonucleotides | |
| HY-RI02824 | mmu-miR-211-5p inhibitor | Oligonucleotides | |
| HY-RI02824A | mmu-miR-211-5p antagomir | Oligonucleotides | |
| HY-RI02825 | mmu-miR-212-3p inhibitor | Oligonucleotides | |
| HY-RI02825A | mmu-miR-212-3p antagomir | Oligonucleotides | |
| HY-RI02826 | mmu-miR-2136 inhibitor | Oligonucleotides | |
| HY-RI02826A | mmu-miR-2136 antagomir | Oligonucleotides | |
| HY-RI02827 | mmu-miR-2137 inhibitor | Oligonucleotides | |
| HY-RI02827A | mmu-miR-2137 antagomir | Oligonucleotides | |
| HY-RI02828 | mmu-miR-2139 inhibitor | Oligonucleotides | |
| HY-RI02828A | mmu-miR-2139 antagomir | Oligonucleotides | |
| HY-RI02829 | mmu-miR-215-3p inhibitor | Oligonucleotides | |
| HY-RI02829A | mmu-miR-215-3p antagomir | Oligonucleotides | |
| HY-RI02830 | mmu-miR-215-5p inhibitor | Oligonucleotides | |
| HY-RI02830A | mmu-miR-215-5p antagomir | Oligonucleotides | |
| HY-RI02831 | mmu-miR-216a-3p inhibitor | Oligonucleotides | |
| HY-RI02831A | mmu-miR-216a-3p antagomir | Oligonucleotides | |
| HY-RI02832 | mmu-miR-216b-3p inhibitor | Oligonucleotides | |
| HY-RI02832A | mmu-miR-216b-3p antagomir | Oligonucleotides | |
| HY-RI02833 | mmu-miR-216c-3p inhibitor | Oligonucleotides | |
| HY-RI02833A | mmu-miR-216c-3p antagomir | Oligonucleotides | |
| HY-RI02834 | mmu-miR-216c-5p inhibitor | Oligonucleotides | |
| HY-RI02834A | mmu-miR-216c-5p antagomir | Oligonucleotides | |
| HY-RI02835 | mmu-miR-217-3p inhibitor | Oligonucleotides | |
| HY-RI02835A | mmu-miR-217-3p antagomir | Oligonucleotides | |
| HY-RI02836 | mmu-miR-217-5p inhibitor | Oligonucleotides | |
| HY-RI02836A | mmu-miR-217-5p antagomir | Oligonucleotides | |
| HY-RI02837 | mmu-miR-218-1-3p inhibitor | Oligonucleotides | |
| HY-RI02837A | mmu-miR-218-1-3p antagomir | Oligonucleotides | |
| HY-RI02838 | mmu-miR-2183 inhibitor | Oligonucleotides | |
| HY-RI02838A | mmu-miR-2183 antagomir | Oligonucleotides | |
| HY-RI02839 | mmu-miR-219a-1-3p inhibitor | Oligonucleotides | |
| HY-RI02839A | mmu-miR-219a-1-3p antagomir | Oligonucleotides | |
| HY-RI02840 | mmu-miR-219c-3p inhibitor | Oligonucleotides | |
| HY-RI02840A | mmu-miR-219c-3p antagomir | Oligonucleotides | |
| HY-RI02841 | mmu-miR-219c-5p inhibitor | Oligonucleotides | |
| HY-RI02841A | mmu-miR-219c-5p antagomir | Oligonucleotides | |
| HY-RI02842 | mmu-miR-21a-3p inhibitor | Oligonucleotides | |
| HY-RI02842A | mmu-miR-21a-3p antagomir | Oligonucleotides | |
| HY-RI02843 | mmu-miR-21b inhibitor | Oligonucleotides | |
| HY-RI02843A | mmu-miR-21b antagomir | Oligonucleotides | |
| HY-RI02844 | mmu-miR-21c inhibitor | Oligonucleotides | |
| HY-RI02844A | mmu-miR-21c antagomir | Oligonucleotides | |
| HY-RI02845 | mmu-miR-221-5p inhibitor | Oligonucleotides | |
| HY-RI02845A | mmu-miR-221-5p antagomir | Oligonucleotides | |
| HY-RI02846 | mmu-miR-222-3p inhibitor | Oligonucleotides | |
| HY-RI02846A | mmu-miR-222-3p antagomir | Oligonucleotides | |
| HY-RI02847 | mmu-miR-222-5p inhibitor | Oligonucleotides | |
| HY-RI02847A | mmu-miR-222-5p antagomir | Oligonucleotides | |
| HY-RI02848 | mmu-miR-223-5p inhibitor | Oligonucleotides | |
| HY-RI02848A | mmu-miR-223-5p antagomir | Oligonucleotides | |
| HY-RI02849 | mmu-miR-224-3p inhibitor | Oligonucleotides | |
| HY-RI02849A | mmu-miR-224-3p antagomir | Oligonucleotides | |
| HY-RI02850 | mmu-miR-224-5p inhibitor | Oligonucleotides | |
| HY-RI02850A | mmu-miR-224-5p antagomir | Oligonucleotides | |
| HY-RI02851 | mmu-miR-23b-3p inhibitor | Oligonucleotides | |
| HY-RI02851A | mmu-miR-23b-3p antagomir | Oligonucleotides | |
| HY-RI02852 | mmu-miR-23b-5p inhibitor | Oligonucleotides | |
| HY-RI02852A | mmu-miR-23b-5p antagomir | Oligonucleotides | |
| HY-RI02853 | mmu-miR-24-1-5p inhibitor | Oligonucleotides | |
| HY-RI02853A | mmu-miR-24-1-5p antagomir | Oligonucleotides | |
| HY-RI02854 | mmu-miR-24-2-5p inhibitor | Oligonucleotides | |
| HY-RI02854A | mmu-miR-24-2-5p antagomir | Oligonucleotides | |
| HY-RI02855 | mmu-miR-25-5p inhibitor | Oligonucleotides | |
| HY-RI02855A | mmu-miR-25-5p antagomir | Oligonucleotides | |
| HY-RI02856 | mmu-miR-26a-2-3p inhibitor | Oligonucleotides | |
| HY-RI02856A | mmu-miR-26a-2-3p antagomir | Oligonucleotides | |
| HY-RI02857 | mmu-miR-26b-3p inhibitor | Oligonucleotides | |
| HY-RI02857A | mmu-miR-26b-3p antagomir | Oligonucleotides | |
| HY-RI02858 | mmu-miR-2861 inhibitor | Oligonucleotides | |
| HY-RI02858A | mmu-miR-2861 antagomir | Oligonucleotides | |
| HY-RI02859 | mmu-miR-28a-3p inhibitor | Oligonucleotides | |
| HY-RI02859A | mmu-miR-28a-3p antagomir | Oligonucleotides | |
| HY-RI02860 | mmu-miR-28b inhibitor | Oligonucleotides | |
| HY-RI02860A | mmu-miR-28b antagomir | Oligonucleotides | |
| HY-RI02861 | mmu-miR-28c inhibitor | Oligonucleotides | |
| HY-RI02861A | mmu-miR-28c antagomir | Oligonucleotides | |
| HY-RI02862 | mmu-miR-290a-3p inhibitor | Oligonucleotides | |
| HY-RI02862A | mmu-miR-290a-3p antagomir | Oligonucleotides | |
| HY-RI02863 | mmu-miR-290a-5p inhibitor | Oligonucleotides | |
| HY-RI02863A | mmu-miR-290a-5p antagomir | Oligonucleotides | |
| HY-RI02864 | mmu-miR-290b-3p inhibitor | Oligonucleotides | |
| HY-RI02864A | mmu-miR-290b-3p antagomir | Oligonucleotides | |
| HY-RI02865 | mmu-miR-290b-5p inhibitor | Oligonucleotides | |
| HY-RI02865A | mmu-miR-290b-5p antagomir | Oligonucleotides | |
| HY-RI02866 | mmu-miR-291a-3p inhibitor | Oligonucleotides | |
| HY-RI02866A | mmu-miR-291a-3p antagomir | Oligonucleotides | |
| HY-RI02867 | mmu-miR-291a-5p inhibitor | Oligonucleotides | |
| HY-RI02867A | mmu-miR-291a-5p antagomir | Oligonucleotides | |
| HY-RI02868 | mmu-miR-291b-3p inhibitor | Oligonucleotides | |
| HY-RI02868A | mmu-miR-291b-3p antagomir | Oligonucleotides | |
| HY-RI02869 | mmu-miR-291b-5p inhibitor | Oligonucleotides | |
| HY-RI02869A | mmu-miR-291b-5p antagomir | Oligonucleotides | |
| HY-RI02870 | mmu-miR-292a-3p inhibitor | Oligonucleotides | |
| HY-RI02870A | mmu-miR-292a-3p antagomir | Oligonucleotides | |
| HY-RI02871 | mmu-miR-292a-5p inhibitor | Oligonucleotides | |
| HY-RI02871A | mmu-miR-292a-5p antagomir | Oligonucleotides | |
| HY-RI02872 | mmu-miR-292b-3p inhibitor | Oligonucleotides | |
| HY-RI02872A | mmu-miR-292b-3p antagomir | Oligonucleotides | |
| HY-RI02873 | mmu-miR-292b-5p inhibitor | Oligonucleotides | |
| HY-RI02873A | mmu-miR-292b-5p antagomir | Oligonucleotides | |
| HY-RI02874 | mmu-miR-293-3p inhibitor | Oligonucleotides | |
| HY-RI02874A | mmu-miR-293-3p antagomir | Oligonucleotides | |
| HY-RI02875 | mmu-miR-293-5p inhibitor | Oligonucleotides | |
| HY-RI02875A | mmu-miR-293-5p antagomir | Oligonucleotides | |
| HY-RI02876 | mmu-miR-294-3p inhibitor | Oligonucleotides | |
| HY-RI02876A | mmu-miR-294-3p antagomir | Oligonucleotides | |
| HY-RI02877 | mmu-miR-294-5p inhibitor | Oligonucleotides | |
| HY-RI02877A | mmu-miR-294-5p antagomir | Oligonucleotides | |
| HY-RI02878 | mmu-miR-295-3p inhibitor | Oligonucleotides | |
| HY-RI02878A | mmu-miR-295-3p antagomir | Oligonucleotides | |
| HY-RI02879 | mmu-miR-295-5p inhibitor | Oligonucleotides | |
| HY-RI02879A | mmu-miR-295-5p antagomir | Oligonucleotides | |
| HY-RI02880 | mmu-miR-297a-3p inhibitor | Oligonucleotides | |
| HY-RI02880A | mmu-miR-297a-3p antagomir | Oligonucleotides | |
| HY-RI02881 | mmu-miR-297a-5p inhibitor | Oligonucleotides | |
| HY-RI02881A | mmu-miR-297a-5p antagomir | Oligonucleotides | |
| HY-RI02882 | mmu-miR-297b-5p inhibitor | Oligonucleotides | |
| HY-RI02882A | mmu-miR-297b-5p antagomir | Oligonucleotides | |
| HY-RI02883 | mmu-miR-297c-5p inhibitor | Oligonucleotides | |
| HY-RI02883A | mmu-miR-297c-5p antagomir | Oligonucleotides | |
| HY-RI02884 | mmu-miR-298-3p inhibitor | Oligonucleotides | |
| HY-RI02884A | mmu-miR-298-3p antagomir | Oligonucleotides | |
| HY-RI02885 | mmu-miR-298-5p inhibitor | Oligonucleotides | |
| HY-RI02885A | mmu-miR-298-5p antagomir | Oligonucleotides | |
| HY-RI02886 | mmu-miR-299a-3p inhibitor | Oligonucleotides | |
| HY-RI02886A | mmu-miR-299a-3p antagomir | Oligonucleotides | |
| HY-RI02887 | mmu-miR-299b-3p inhibitor | Oligonucleotides | |
| HY-RI02887A | mmu-miR-299b-3p antagomir | Oligonucleotides | |
| HY-RI02888 | mmu-miR-299b-5p inhibitor | Oligonucleotides | |
| HY-RI02888A | mmu-miR-299b-5p antagomir | Oligonucleotides | |
| HY-RI02889 | mmu-miR-29b-1-5p inhibitor | Oligonucleotides | |
| HY-RI02889A | mmu-miR-29b-1-5p antagomir | Oligonucleotides | |
| HY-RI02890 | mmu-miR-29b-2-5p inhibitor | Oligonucleotides | |
| HY-RI02890A | mmu-miR-29b-2-5p antagomir | Oligonucleotides | |
| HY-RI02891 | mmu-miR-300-3p inhibitor | Oligonucleotides | |
| HY-RI02891A | mmu-miR-300-3p antagomir | Oligonucleotides | |
| HY-RI02892 | mmu-miR-300-5p inhibitor | Oligonucleotides | |
| HY-RI02892A | mmu-miR-300-5p antagomir | Oligonucleotides | |
| HY-RI02893 | mmu-miR-301b-3p inhibitor | Oligonucleotides | |
| HY-RI02893A | mmu-miR-301b-3p antagomir | Oligonucleotides | |
| HY-RI02894 | mmu-miR-301b-5p inhibitor | Oligonucleotides | |
| HY-RI02894A | mmu-miR-301b-5p antagomir | Oligonucleotides | |
| HY-RI02895 | mmu-miR-302a-5p inhibitor | Oligonucleotides | |
| HY-RI02895A | mmu-miR-302a-5p antagomir | Oligonucleotides | |
| HY-RI02896 | mmu-miR-302b-5p inhibitor | Oligonucleotides | |
| HY-RI02896A | mmu-miR-302b-5p antagomir | Oligonucleotides | |
| HY-RI02897 | mmu-miR-302c-3p inhibitor | Oligonucleotides | |
| HY-RI02897A | mmu-miR-302c-3p antagomir | Oligonucleotides | |
| HY-RI02898 | mmu-miR-302c-5p inhibitor | Oligonucleotides | |
| HY-RI02898A | mmu-miR-302c-5p antagomir | Oligonucleotides | |
| HY-RI02899 | mmu-miR-302d-5p inhibitor | Oligonucleotides | |
| HY-RI02899A | mmu-miR-302d-5p antagomir | Oligonucleotides | |
| HY-RI02900 | mmu-miR-3057-3p inhibitor | Oligonucleotides | |
| HY-RI02900A | mmu-miR-3057-3p antagomir | Oligonucleotides | |
| HY-RI02901 | mmu-miR-3057-5p inhibitor | Oligonucleotides | |
| HY-RI02901A | mmu-miR-3057-5p antagomir | Oligonucleotides | |
| HY-RI02902 | mmu-miR-3058-3p inhibitor | Oligonucleotides | |
| HY-RI02902A | mmu-miR-3058-3p antagomir | Oligonucleotides | |
| HY-RI02903 | mmu-miR-3058-5p inhibitor | Oligonucleotides | |
| HY-RI02903A | mmu-miR-3058-5p antagomir | Oligonucleotides | |
| HY-RI02904 | mmu-miR-3059-5p inhibitor | Oligonucleotides | |
| HY-RI02904A | mmu-miR-3059-5p antagomir | Oligonucleotides | |
| HY-RI02905 | mmu-miR-3060-3p inhibitor | Oligonucleotides | |
| HY-RI02905A | mmu-miR-3060-3p antagomir | Oligonucleotides | |
| HY-RI02906 | mmu-miR-3060-5p inhibitor | Oligonucleotides | |
| HY-RI02906A | mmu-miR-3060-5p antagomir | Oligonucleotides | |
| HY-RI02907 | mmu-miR-3061-3p inhibitor | Oligonucleotides | |
| HY-RI02907A | mmu-miR-3061-3p antagomir | Oligonucleotides | |
| HY-RI02908 | mmu-miR-3061-5p inhibitor | Oligonucleotides | |
| HY-RI02908A | mmu-miR-3061-5p antagomir | Oligonucleotides | |
| HY-RI02909 | mmu-miR-3062-3p inhibitor | Oligonucleotides | |
| HY-RI02909A | mmu-miR-3062-3p antagomir | Oligonucleotides | |
| HY-RI02910 | mmu-miR-3062-5p inhibitor | Oligonucleotides | |
| HY-RI02910A | mmu-miR-3062-5p antagomir | Oligonucleotides | |
| HY-RI02911 | mmu-miR-3063-3p inhibitor | Oligonucleotides | |
| HY-RI02911A | mmu-miR-3063-3p antagomir | Oligonucleotides | |
| HY-RI02912 | mmu-miR-3063-5p inhibitor | Oligonucleotides | |
| HY-RI02912A | mmu-miR-3063-5p antagomir | Oligonucleotides | |
| HY-RI02913 | mmu-miR-3064-3p inhibitor | Oligonucleotides | |
| HY-RI02913A | mmu-miR-3064-3p antagomir | Oligonucleotides | |
| HY-RI02914 | mmu-miR-3064-5p inhibitor | Oligonucleotides | |
| HY-RI02914A | mmu-miR-3064-5p antagomir | Oligonucleotides | |
| HY-RI02915 | mmu-miR-3065-3p inhibitor | Oligonucleotides | |
| HY-RI02915A | mmu-miR-3065-3p antagomir | Oligonucleotides | |
| HY-RI02916 | mmu-miR-3065-5p inhibitor | Oligonucleotides | |
| HY-RI02916A | mmu-miR-3065-5p antagomir | Oligonucleotides | |
| HY-RI02917 | mmu-miR-3066-3p inhibitor | Oligonucleotides | |
| HY-RI02917A | mmu-miR-3066-3p antagomir | Oligonucleotides | |
| HY-RI02918 | mmu-miR-3066-5p inhibitor | Oligonucleotides | |
| HY-RI02918A | mmu-miR-3066-5p antagomir | Oligonucleotides | |
| HY-RI02919 | mmu-miR-3067-3p inhibitor | Oligonucleotides | |
| HY-RI02919A | mmu-miR-3067-3p antagomir | Oligonucleotides | |
| HY-RI02920 | mmu-miR-3067-5p inhibitor | Oligonucleotides | |
| HY-RI02920A | mmu-miR-3067-5p antagomir | Oligonucleotides | |
| HY-RI02921 | mmu-miR-3068-3p inhibitor | Oligonucleotides | |
| HY-RI02921A | mmu-miR-3068-3p antagomir | Oligonucleotides | |
| HY-RI02922 | mmu-miR-3068-5p inhibitor | Oligonucleotides | |
| HY-RI02922A | mmu-miR-3068-5p antagomir | Oligonucleotides | |
| HY-RI02923 | mmu-miR-3069-3p inhibitor | Oligonucleotides | |
| HY-RI02923A | mmu-miR-3069-3p antagomir | Oligonucleotides | |
| HY-RI02924 | mmu-miR-3069-5p inhibitor | Oligonucleotides | |
| HY-RI02924A | mmu-miR-3069-5p antagomir | Oligonucleotides | |
| HY-RI02925 | mmu-miR-3070-2-3p inhibitor | Oligonucleotides | |
| HY-RI02925A | mmu-miR-3070-2-3p antagomir | Oligonucleotides | |
| HY-RI02926 | mmu-miR-3070-3p inhibitor | Oligonucleotides | |
| HY-RI02926A | mmu-miR-3070-3p antagomir | Oligonucleotides | |
| HY-RI02927 | mmu-miR-3070-5p inhibitor | Oligonucleotides | |
| HY-RI02927A | mmu-miR-3070-5p antagomir | Oligonucleotides | |
| HY-RI02928 | mmu-miR-3071-3p inhibitor | Oligonucleotides | |
| HY-RI02928A | mmu-miR-3071-3p antagomir | Oligonucleotides | |
| HY-RI02929 | mmu-miR-3071-5p inhibitor | Oligonucleotides | |
| HY-RI02929A | mmu-miR-3071-5p antagomir | Oligonucleotides | |
| HY-RI02930 | mmu-miR-3072-3p inhibitor | Oligonucleotides | |
| HY-RI02930A | mmu-miR-3072-3p antagomir | Oligonucleotides | |
| HY-RI02931 | mmu-miR-3072-5p inhibitor | Oligonucleotides | |
| HY-RI02931A | mmu-miR-3072-5p antagomir | Oligonucleotides | |
| HY-RI02932 | mmu-miR-3073a-3p inhibitor | Oligonucleotides | |
| HY-RI02932A | mmu-miR-3073a-3p antagomir | Oligonucleotides | |
| HY-RI02933 | mmu-miR-3073a-5p inhibitor | Oligonucleotides | |
| HY-RI02933A | mmu-miR-3073a-5p antagomir | Oligonucleotides | |
| HY-RI02934 | mmu-miR-3073b-3p inhibitor | Oligonucleotides | |
| HY-RI02934A | mmu-miR-3073b-3p antagomir | Oligonucleotides | |
| HY-RI02935 | mmu-miR-3073b-5p inhibitor | Oligonucleotides | |
| HY-RI02935A | mmu-miR-3073b-5p antagomir | Oligonucleotides | |
| HY-RI02936 | mmu-miR-3074-2-3p inhibitor | Oligonucleotides | |
| HY-RI02936A | mmu-miR-3074-2-3p antagomir | Oligonucleotides | |
| HY-RI02937 | mmu-miR-3074-5p inhibitor | Oligonucleotides | |
| HY-RI02937A | mmu-miR-3074-5p antagomir | Oligonucleotides | |
| HY-RI02938 | mmu-miR-3075-3p inhibitor | Oligonucleotides | |
| HY-RI02938A | mmu-miR-3075-3p antagomir | Oligonucleotides | |
| HY-RI02939 | mmu-miR-3075-5p inhibitor | Oligonucleotides | |
| HY-RI02939A | mmu-miR-3075-5p antagomir | Oligonucleotides | |
| HY-RI02940 | mmu-miR-3076-3p inhibitor | Oligonucleotides | |
| HY-RI02940A | mmu-miR-3076-3p antagomir | Oligonucleotides | |
| HY-RI02941 | mmu-miR-3076-5p inhibitor | Oligonucleotides | |
| HY-RI02941A | mmu-miR-3076-5p antagomir | Oligonucleotides | |
| HY-RI02942 | mmu-miR-3077-3p inhibitor | Oligonucleotides | |
| HY-RI02942A | mmu-miR-3077-3p antagomir | Oligonucleotides | |
| HY-RI02943 | mmu-miR-3077-5p inhibitor | Oligonucleotides | |
| HY-RI02943A | mmu-miR-3077-5p antagomir | Oligonucleotides | |
| HY-RI02944 | mmu-miR-3078-3p inhibitor | Oligonucleotides | |
| HY-RI02944A | mmu-miR-3078-3p antagomir | Oligonucleotides | |
| HY-RI02945 | mmu-miR-3078-5p inhibitor | Oligonucleotides | |
| HY-RI02945A | mmu-miR-3078-5p antagomir | Oligonucleotides | |
| HY-RI02946 | mmu-miR-3079-3p inhibitor | Oligonucleotides | |
| HY-RI02946A | mmu-miR-3079-3p antagomir | Oligonucleotides | |
| HY-RI02947 | mmu-miR-3079-5p inhibitor | Oligonucleotides | |
| HY-RI02947A | mmu-miR-3079-5p antagomir | Oligonucleotides | |
| HY-RI02948 | mmu-miR-3080-3p inhibitor | Oligonucleotides | |
| HY-RI02948A | mmu-miR-3080-3p antagomir | Oligonucleotides | |
| HY-RI02949 | mmu-miR-3080-5p inhibitor | Oligonucleotides | |
| HY-RI02949A | mmu-miR-3080-5p antagomir | Oligonucleotides | |
| HY-RI02950 | mmu-miR-3081-3p inhibitor | Oligonucleotides | |
| HY-RI02950A | mmu-miR-3081-3p antagomir | Oligonucleotides | |
| HY-RI02951 | mmu-miR-3081-5p inhibitor | Oligonucleotides | |
| HY-RI02951A | mmu-miR-3081-5p antagomir | Oligonucleotides | |
| HY-RI02952 | mmu-miR-3082-3p inhibitor | Oligonucleotides | |
| HY-RI02952A | mmu-miR-3082-3p antagomir | Oligonucleotides | |
| HY-RI02953 | mmu-miR-3082-5p inhibitor | Oligonucleotides | |
| HY-RI02953A | mmu-miR-3082-5p antagomir | Oligonucleotides | |
| HY-RI02954 | mmu-miR-3083-3p inhibitor | Oligonucleotides | |
| HY-RI02954A | mmu-miR-3083-3p antagomir | Oligonucleotides | |
| HY-RI02955 | mmu-miR-3083-5p inhibitor | Oligonucleotides | |
| HY-RI02955A | mmu-miR-3083-5p antagomir | Oligonucleotides | |
| HY-RI02956 | mmu-miR-3083b-3p inhibitor | Oligonucleotides | |
| HY-RI02956A | mmu-miR-3083b-3p antagomir | Oligonucleotides | |
| HY-RI02957 | mmu-miR-3083b-5p inhibitor | Oligonucleotides | |
| HY-RI02957A | mmu-miR-3083b-5p antagomir | Oligonucleotides | |
| HY-RI02958 | mmu-miR-3084-3p inhibitor | Oligonucleotides | |
| HY-RI02958A | mmu-miR-3084-3p antagomir | Oligonucleotides | |
| HY-RI02959 | mmu-miR-3084-5p inhibitor | Oligonucleotides | |
| HY-RI02959A | mmu-miR-3084-5p antagomir | Oligonucleotides | |
| HY-RI02960 | mmu-miR-3085-5p inhibitor | Oligonucleotides | |
| HY-RI02960A | mmu-miR-3085-5p antagomir | Oligonucleotides | |
| HY-RI02961 | mmu-miR-3086-3p inhibitor | Oligonucleotides | |
| HY-RI02961A | mmu-miR-3086-3p antagomir | Oligonucleotides | |
| HY-RI02962 | mmu-miR-3086-5p inhibitor | Oligonucleotides | |
| HY-RI02962A | mmu-miR-3086-5p antagomir | Oligonucleotides | |
| HY-RI02963 | mmu-miR-3087-3p inhibitor | Oligonucleotides | |
| HY-RI02963A | mmu-miR-3087-3p antagomir | Oligonucleotides | |
| HY-RI02964 | mmu-miR-3087-5p inhibitor | Oligonucleotides | |
| HY-RI02964A | mmu-miR-3087-5p antagomir | Oligonucleotides | |
| HY-RI02965 | mmu-miR-3088-3p inhibitor | Oligonucleotides | |
| HY-RI02965A | mmu-miR-3088-3p antagomir | Oligonucleotides | |
| HY-RI02966 | mmu-miR-3088-5p inhibitor | Oligonucleotides | |
| HY-RI02966A | mmu-miR-3088-5p antagomir | Oligonucleotides | |
| HY-RI02967 | mmu-miR-3089-3p inhibitor | Oligonucleotides | |
| HY-RI02967A | mmu-miR-3089-3p antagomir | Oligonucleotides | |
| HY-RI02968 | mmu-miR-3089-5p inhibitor | Oligonucleotides | |
| HY-RI02968A | mmu-miR-3089-5p antagomir | Oligonucleotides | |
| HY-RI02969 | mmu-miR-3090-3p inhibitor | Oligonucleotides | |
| HY-RI02969A | mmu-miR-3090-3p antagomir | Oligonucleotides | |
| HY-RI02970 | mmu-miR-3090-5p inhibitor | Oligonucleotides | |
| HY-RI02970A | mmu-miR-3090-5p antagomir | Oligonucleotides | |
| HY-RI02971 | mmu-miR-3091-3p inhibitor | Oligonucleotides | |
| HY-RI02971A | mmu-miR-3091-3p antagomir | Oligonucleotides | |
| HY-RI02972 | mmu-miR-3091-5p inhibitor | Oligonucleotides | |
| HY-RI02972A | mmu-miR-3091-5p antagomir | Oligonucleotides | |
| HY-RI02973 | mmu-miR-3092-3p inhibitor | Oligonucleotides | |
| HY-RI02973A | mmu-miR-3092-3p antagomir | Oligonucleotides | |
| HY-RI02974 | mmu-miR-3092-5p inhibitor | Oligonucleotides | |
| HY-RI02974A | mmu-miR-3092-5p antagomir | Oligonucleotides | |
| HY-RI02975 | mmu-miR-3093-3p inhibitor | Oligonucleotides | |
| HY-RI02975A | mmu-miR-3093-3p antagomir | Oligonucleotides | |
| HY-RI02976 | mmu-miR-3093-5p inhibitor | Oligonucleotides | |
| HY-RI02976A | mmu-miR-3093-5p antagomir | Oligonucleotides | |
| HY-RI02977 | mmu-miR-3094-3p inhibitor | Oligonucleotides | |
| HY-RI02977A | mmu-miR-3094-3p antagomir | Oligonucleotides | |
| HY-RI02978 | mmu-miR-3094-5p inhibitor | Oligonucleotides | |
| HY-RI02978A | mmu-miR-3094-5p antagomir | Oligonucleotides | |
| HY-RI02979 | mmu-miR-3095-3p inhibitor | Oligonucleotides | |
| HY-RI02979A | mmu-miR-3095-3p antagomir | Oligonucleotides | |
| HY-RI02980 | mmu-miR-3095-5p inhibitor | Oligonucleotides | |
| HY-RI02980A | mmu-miR-3095-5p antagomir | Oligonucleotides | |
| HY-RI02981 | mmu-miR-3097-3p inhibitor | Oligonucleotides | |
| HY-RI02981A | mmu-miR-3097-3p antagomir | Oligonucleotides | |
| HY-RI02982 | mmu-miR-3097-5p inhibitor | Oligonucleotides | |
| HY-RI02982A | mmu-miR-3097-5p antagomir | Oligonucleotides | |
| HY-RI02983 | mmu-miR-3098-3p inhibitor | Oligonucleotides | |
| HY-RI02983A | mmu-miR-3098-3p antagomir | Oligonucleotides | |
| HY-RI02984 | mmu-miR-3098-5p inhibitor | Oligonucleotides | |
| HY-RI02984A | mmu-miR-3098-5p antagomir | Oligonucleotides | |
| HY-RI02985 | mmu-miR-3099-3p inhibitor | Oligonucleotides | |
| HY-RI02985A | mmu-miR-3099-3p antagomir | Oligonucleotides | |
| HY-RI02986 | mmu-miR-3099-5p inhibitor | Oligonucleotides | |
| HY-RI02986A | mmu-miR-3099-5p antagomir | Oligonucleotides | |
| HY-RI02987 | mmu-miR-30b-3p inhibitor | Oligonucleotides | |
| HY-RI02987A | mmu-miR-30b-3p antagomir | Oligonucleotides | |
| HY-RI02988 | mmu-miR-30f inhibitor | Oligonucleotides | |
| HY-RI02988A | mmu-miR-30f antagomir | Oligonucleotides | |
| HY-RI02989 | mmu-miR-3100-3p inhibitor | Oligonucleotides | |
| HY-RI02989A | mmu-miR-3100-3p antagomir | Oligonucleotides | |
| HY-RI02990 | mmu-miR-3100-5p inhibitor | Oligonucleotides | |
| HY-RI02990A | mmu-miR-3100-5p antagomir | Oligonucleotides | |
| HY-RI02991 | mmu-miR-3101-3p inhibitor | Oligonucleotides | |
| HY-RI02991A | mmu-miR-3101-3p antagomir | Oligonucleotides | |
| HY-RI02992 | mmu-miR-3101-5p inhibitor | Oligonucleotides | |
| HY-RI02992A | mmu-miR-3101-5p antagomir | Oligonucleotides | |
| HY-RI02993 | mmu-miR-3102-3p inhibitor | Oligonucleotides | |
| HY-RI02993A | mmu-miR-3102-3p antagomir | Oligonucleotides | |
| HY-RI02994 | mmu-miR-3102-3p.2-3p inhibitor | Oligonucleotides | |
| HY-RI02994A | mmu-miR-3102-3p.2-3p antagomir | Oligonucleotides | |
| HY-RI02995 | mmu-miR-3102-5p inhibitor | Oligonucleotides | |
| HY-RI02995A | mmu-miR-3102-5p antagomir | Oligonucleotides | |
| HY-RI02996 | mmu-miR-3102-5p.2-5p inhibitor | Oligonucleotides | |
| HY-RI02996A | mmu-miR-3102-5p.2-5p antagomir | Oligonucleotides | |
| HY-RI02997 | mmu-miR-3103-3p inhibitor | Oligonucleotides | |
| HY-RI02997A | mmu-miR-3103-3p antagomir | Oligonucleotides | |
| HY-RI02998 | mmu-miR-3103-5p inhibitor | Oligonucleotides | |
| HY-RI02998A | mmu-miR-3103-5p antagomir | Oligonucleotides | |
| HY-RI02999 | mmu-miR-3104-3p inhibitor | Oligonucleotides | |
| HY-RI02999A | mmu-miR-3104-3p antagomir | Oligonucleotides | |
| HY-RI03000 | mmu-miR-3104-5p inhibitor | Oligonucleotides | |
| HY-RI03000A | mmu-miR-3104-5p antagomir | Oligonucleotides | |
| HY-RI03001 | mmu-miR-3105-3p inhibitor | Oligonucleotides | |
| HY-RI03001A | mmu-miR-3105-3p antagomir | Oligonucleotides | |
| HY-RI03002 | mmu-miR-3105-5p inhibitor | Oligonucleotides | |
| HY-RI03002A | mmu-miR-3105-5p antagomir | Oligonucleotides | |
| HY-RI03003 | mmu-miR-3106-3p inhibitor | Oligonucleotides | |
| HY-RI03003A | mmu-miR-3106-3p antagomir | Oligonucleotides | |
| HY-RI03004 | mmu-miR-3106-5p inhibitor | Oligonucleotides | |
| HY-RI03004A | mmu-miR-3106-5p antagomir | Oligonucleotides | |
| HY-RI03005 | mmu-miR-3108-3p inhibitor | Oligonucleotides | |
| HY-RI03005A | mmu-miR-3108-3p antagomir | Oligonucleotides | |
| HY-RI03006 | mmu-miR-3108-5p inhibitor | Oligonucleotides | |
| HY-RI03006A | mmu-miR-3108-5p antagomir | Oligonucleotides | |
| HY-RI03007 | mmu-miR-3109-3p inhibitor | Oligonucleotides | |
| HY-RI03007A | mmu-miR-3109-3p antagomir | Oligonucleotides | |
| HY-RI03008 | mmu-miR-3109-5p inhibitor | Oligonucleotides | |
| HY-RI03008A | mmu-miR-3109-5p antagomir | Oligonucleotides | |
| HY-RI03009 | mmu-miR-3110-3p inhibitor | Oligonucleotides | |
| HY-RI03009A | mmu-miR-3110-3p antagomir | Oligonucleotides | |
| HY-RI03010 | mmu-miR-3110-5p inhibitor | Oligonucleotides | |
| HY-RI03010A | mmu-miR-3110-5p antagomir | Oligonucleotides | |
| HY-RI03011 | mmu-miR-3112-3p inhibitor | Oligonucleotides | |
| HY-RI03011A | mmu-miR-3112-3p antagomir | Oligonucleotides | |
| HY-RI03012 | mmu-miR-3112-5p inhibitor | Oligonucleotides | |
| HY-RI03012A | mmu-miR-3112-5p antagomir | Oligonucleotides | |
| HY-RI03013 | mmu-miR-3113-3p inhibitor | Oligonucleotides | |
| HY-RI03013A | mmu-miR-3113-3p antagomir | Oligonucleotides | |
| HY-RI03014 | mmu-miR-3113-5p inhibitor | Oligonucleotides | |
| HY-RI03014A | mmu-miR-3113-5p antagomir | Oligonucleotides | |
| HY-RI03015 | mmu-miR-31-3p inhibitor | Oligonucleotides | |
| HY-RI03015A | mmu-miR-31-3p antagomir | Oligonucleotides | |
| HY-RI03016 | mmu-miR-3154 inhibitor | Oligonucleotides | |
| HY-RI03016A | mmu-miR-3154 antagomir | Oligonucleotides | |
| HY-RI03017 | mmu-miR-31-5p inhibitor | Oligonucleotides | |
| HY-RI03017A | mmu-miR-31-5p antagomir | Oligonucleotides | |
| HY-RI03018 | mmu-miR-322-3p inhibitor | Oligonucleotides | |
| HY-RI03018A | mmu-miR-322-3p antagomir | Oligonucleotides | |
| HY-RI03019 | mmu-miR-322-5p inhibitor | Oligonucleotides | |
| HY-RI03019A | mmu-miR-322-5p antagomir | Oligonucleotides | |
| HY-RI03020 | mmu-miR-32-3p inhibitor | Oligonucleotides | |
| HY-RI03020A | mmu-miR-32-3p antagomir | Oligonucleotides | |
| HY-RI03021 | mmu-miR-324-3p inhibitor | Oligonucleotides | |
| HY-RI03021A | mmu-miR-324-3p antagomir | Oligonucleotides | |
| HY-RI03022 | mmu-miR-324-5p inhibitor | Oligonucleotides | |
| HY-RI03022A | mmu-miR-324-5p antagomir | Oligonucleotides | |
| HY-RI03023 | mmu-miR-325-3p inhibitor | Oligonucleotides | |
| HY-RI03023A | mmu-miR-325-3p antagomir | Oligonucleotides | |
| HY-RI03024 | mmu-miR-325-5p inhibitor | Oligonucleotides | |
| HY-RI03024A | mmu-miR-325-5p antagomir | Oligonucleotides | |
| HY-RI03025 | mmu-miR-326-3p inhibitor | Oligonucleotides | |
| HY-RI03025A | mmu-miR-326-3p antagomir | Oligonucleotides | |
| HY-RI03026 | mmu-miR-326-5p inhibitor | Oligonucleotides | |
| HY-RI03026A | mmu-miR-326-5p antagomir | Oligonucleotides | |
| HY-RI03027 | mmu-miR-327 inhibitor | Oligonucleotides | |
| HY-RI03027A | mmu-miR-327 antagomir | Oligonucleotides | |
| HY-RI03028 | mmu-miR-328-5p inhibitor | Oligonucleotides | |
| HY-RI03028A | mmu-miR-328-5p antagomir | Oligonucleotides | |
| HY-RI03029 | mmu-miR-329-3p inhibitor | Oligonucleotides | |
| HY-RI03029A | mmu-miR-329-3p antagomir | Oligonucleotides | |
| HY-RI03030 | mmu-miR-329-5p inhibitor | Oligonucleotides | |
| HY-RI03030A | mmu-miR-329-5p antagomir | Oligonucleotides | |
| HY-RI03031 | mmu-miR-330-3p inhibitor | Oligonucleotides | |
| HY-RI03031A | mmu-miR-330-3p antagomir | Oligonucleotides | |
| HY-RI03032 | mmu-miR-337-3p inhibitor | Oligonucleotides | |
| HY-RI03032A | mmu-miR-337-3p antagomir | Oligonucleotides | |
| HY-RI03033 | mmu-miR-337-5p inhibitor | Oligonucleotides | |
| HY-RI03033A | mmu-miR-337-5p antagomir | Oligonucleotides | |
| HY-RI03034 | mmu-miR-339-3p inhibitor | Oligonucleotides | |
| HY-RI03034A | mmu-miR-339-3p antagomir | Oligonucleotides | |
| HY-RI03035 | mmu-miR-341-3p inhibitor | Oligonucleotides | |
| HY-RI03035A | mmu-miR-341-3p antagomir | Oligonucleotides | |
| HY-RI03036 | mmu-miR-341-5p inhibitor | Oligonucleotides | |
| HY-RI03036A | mmu-miR-341-5p antagomir | Oligonucleotides | |
| HY-RI03037 | mmu-miR-342-5p inhibitor | Oligonucleotides | |
| HY-RI03037A | mmu-miR-342-5p antagomir | Oligonucleotides | |
| HY-RI03038 | mmu-miR-343 inhibitor | Oligonucleotides | |
| HY-RI03038A | mmu-miR-343 antagomir | Oligonucleotides | |
| HY-RI03039 | mmu-miR-344-3p inhibitor | Oligonucleotides | |
| HY-RI03039A | mmu-miR-344-3p antagomir | Oligonucleotides | |
| HY-RI03040 | mmu-miR-344-5p inhibitor | Oligonucleotides | |
| HY-RI03040A | mmu-miR-344-5p antagomir | Oligonucleotides | |
| HY-RI03041 | mmu-miR-344b-3p inhibitor | Oligonucleotides | |
| HY-RI03041A | mmu-miR-344b-3p antagomir | Oligonucleotides | |
| HY-RI03042 | mmu-miR-344b-5p inhibitor | Oligonucleotides | |
| HY-RI03042A | mmu-miR-344b-5p antagomir | Oligonucleotides | |
| HY-RI03043 | mmu-miR-344c-3p inhibitor | Oligonucleotides | |
| HY-RI03043A | mmu-miR-344c-3p antagomir | Oligonucleotides | |
| HY-RI03044 | mmu-miR-344c-5p inhibitor | Oligonucleotides | |
| HY-RI03044A | mmu-miR-344c-5p antagomir | Oligonucleotides | |
| HY-RI03045 | mmu-miR-344d-1-5p inhibitor | Oligonucleotides | |
| HY-RI03045A | mmu-miR-344d-1-5p antagomir | Oligonucleotides | |
| HY-RI03046 | mmu-miR-344d-2-5p inhibitor | Oligonucleotides | |
| HY-RI03046A | mmu-miR-344d-2-5p antagomir | Oligonucleotides | |
| HY-RI03047 | mmu-miR-344d-3-5p inhibitor | Oligonucleotides | |
| HY-RI03047A | mmu-miR-344d-3-5p antagomir | Oligonucleotides | |
| HY-RI03048 | mmu-miR-344d-3p inhibitor | Oligonucleotides | |
| HY-RI03048A | mmu-miR-344d-3p antagomir | Oligonucleotides | |
| HY-RI03049 | mmu-miR-344e-3p inhibitor | Oligonucleotides | |
| HY-RI03049A | mmu-miR-344e-3p antagomir | Oligonucleotides | |
| HY-RI03050 | mmu-miR-344e-5p inhibitor | Oligonucleotides | |
| HY-RI03050A | mmu-miR-344e-5p antagomir | Oligonucleotides | |
| HY-RI03051 | mmu-miR-344f-3p inhibitor | Oligonucleotides | |
| HY-RI03051A | mmu-miR-344f-3p antagomir | Oligonucleotides | |
| HY-RI03052 | mmu-miR-344f-5p inhibitor | Oligonucleotides | |
| HY-RI03052A | mmu-miR-344f-5p antagomir | Oligonucleotides | |
| HY-RI03053 | mmu-miR-344g-3p inhibitor | Oligonucleotides | |
| HY-RI03053A | mmu-miR-344g-3p antagomir | Oligonucleotides | |
| HY-RI03054 | mmu-miR-344g-5p inhibitor | Oligonucleotides | |
| HY-RI03054A | mmu-miR-344g-5p antagomir | Oligonucleotides | |
| HY-RI03055 | mmu-miR-344h-3p inhibitor | Oligonucleotides | |
| HY-RI03055A | mmu-miR-344h-3p antagomir | Oligonucleotides | |
| HY-RI03056 | mmu-miR-344i inhibitor | Oligonucleotides | |
| HY-RI03056A | mmu-miR-344i antagomir | Oligonucleotides | |
| HY-RI03057 | mmu-miR-345-3p inhibitor | Oligonucleotides | |
| HY-RI03057A | mmu-miR-345-3p antagomir | Oligonucleotides | |
| HY-RI03058 | mmu-miR-345-5p inhibitor | Oligonucleotides | |
| HY-RI03058A | mmu-miR-345-5p antagomir | Oligonucleotides | |
| HY-RI03059 | mmu-miR-346-3p inhibitor | Oligonucleotides | |
| HY-RI03059A | mmu-miR-346-3p antagomir | Oligonucleotides | |
| HY-RI03060 | mmu-miR-346-5p inhibitor | Oligonucleotides | |
| HY-RI03060A | mmu-miR-346-5p antagomir | Oligonucleotides | |
| HY-RI03061 | mmu-miR-3470a inhibitor | Oligonucleotides | |
| HY-RI03061A | mmu-miR-3470a antagomir | Oligonucleotides | |
| HY-RI03062 | mmu-miR-3470b inhibitor | Oligonucleotides | |
| HY-RI03062A | mmu-miR-3470b antagomir | Oligonucleotides | |
| HY-RI03063 | mmu-miR-3471 inhibitor | Oligonucleotides | |
| HY-RI03063A | mmu-miR-3471 antagomir | Oligonucleotides | |
| HY-RI03064 | mmu-miR-3472 inhibitor | Oligonucleotides | |
| HY-RI03064A | mmu-miR-3472 antagomir | Oligonucleotides | |
| HY-RI03065 | mmu-miR-3473a inhibitor | Oligonucleotides | |
| HY-RI03065A | mmu-miR-3473a antagomir | Oligonucleotides | |
| HY-RI03066 | mmu-miR-3473b inhibitor | Oligonucleotides | |
| HY-RI03066A | mmu-miR-3473b antagomir | Oligonucleotides | |
| HY-RI03067 | mmu-miR-3473c inhibitor | Oligonucleotides | |
| HY-RI03067A | mmu-miR-3473c antagomir | Oligonucleotides | |
| HY-RI03068 | mmu-miR-3473d inhibitor | Oligonucleotides | |
| HY-RI03068A | mmu-miR-3473d antagomir | Oligonucleotides | |
| HY-RI03069 | mmu-miR-3473e inhibitor | Oligonucleotides | |
| HY-RI03069A | mmu-miR-3473e antagomir | Oligonucleotides | |
| HY-RI03070 | mmu-miR-3473f inhibitor | Oligonucleotides | |
| HY-RI03070A | mmu-miR-3473f antagomir | Oligonucleotides | |
| HY-RI03071 | mmu-miR-3473g inhibitor | Oligonucleotides | |
| HY-RI03071A | mmu-miR-3473g antagomir | Oligonucleotides | |
| HY-RI03072 | mmu-miR-3473h-5p inhibitor | Oligonucleotides | |
| HY-RI03072A | mmu-miR-3473h-5p antagomir | Oligonucleotides | |
| HY-RI03073 | mmu-miR-3474 inhibitor | Oligonucleotides | |
| HY-RI03073A | mmu-miR-3474 antagomir | Oligonucleotides | |
| HY-RI03074 | mmu-miR-3475-3p inhibitor | Oligonucleotides | |
| HY-RI03074A | mmu-miR-3475-3p antagomir | Oligonucleotides | |
| HY-RI03075 | mmu-miR-3475-5p inhibitor | Oligonucleotides | |
| HY-RI03075A | mmu-miR-3475-5p antagomir | Oligonucleotides | |
| HY-RI03076 | mmu-miR-34a-3p inhibitor | Oligonucleotides | |
| HY-RI03076A | mmu-miR-34a-3p antagomir | Oligonucleotides | |
| HY-RI03077 | mmu-miR-34c-3p inhibitor | Oligonucleotides | |
| HY-RI03077A | mmu-miR-34c-3p antagomir | Oligonucleotides | |
| HY-RI03078 | mmu-miR-350-3p inhibitor | Oligonucleotides | |
| HY-RI03078A | mmu-miR-350-3p antagomir | Oligonucleotides | |
| HY-RI03079 | mmu-miR-350-5p inhibitor | Oligonucleotides | |
| HY-RI03079A | mmu-miR-350-5p antagomir | Oligonucleotides | |
| HY-RI03080 | mmu-miR-351-3p inhibitor | Oligonucleotides | |
| HY-RI03080A | mmu-miR-351-3p antagomir | Oligonucleotides | |
| HY-RI03081 | mmu-miR-351-5p inhibitor | Oligonucleotides | |
| HY-RI03081A | mmu-miR-351-5p antagomir | Oligonucleotides | |
| HY-RI03082 | mmu-miR-3535 inhibitor | Oligonucleotides | |
| HY-RI03082A | mmu-miR-3535 antagomir | Oligonucleotides | |
| HY-RI03083 | mmu-miR-3544-3p inhibitor | Oligonucleotides | |
| HY-RI03083A | mmu-miR-3544-3p antagomir | Oligonucleotides | |
| HY-RI03084 | mmu-miR-3544-5p inhibitor | Oligonucleotides | |
| HY-RI03084A | mmu-miR-3544-5p antagomir | Oligonucleotides | |
| HY-RI03085 | mmu-miR-3547-3p inhibitor | Oligonucleotides | |
| HY-RI03085A | mmu-miR-3547-3p antagomir | Oligonucleotides | |
| HY-RI03086 | mmu-miR-3547-5p inhibitor | Oligonucleotides | |
| HY-RI03086A | mmu-miR-3547-5p antagomir | Oligonucleotides | |
| HY-RI03087 | mmu-miR-3552 inhibitor | Oligonucleotides | |
| HY-RI03087A | mmu-miR-3552 antagomir | Oligonucleotides | |
| HY-RI03088 | mmu-miR-3569-3p inhibitor | Oligonucleotides | |
| HY-RI03088A | mmu-miR-3569-3p antagomir | Oligonucleotides | |
| HY-RI03089 | mmu-miR-3569-5p inhibitor | Oligonucleotides | |
| HY-RI03089A | mmu-miR-3569-5p antagomir | Oligonucleotides | |
| HY-RI03090 | mmu-miR-3572-3p inhibitor | Oligonucleotides | |
| HY-RI03090A | mmu-miR-3572-3p antagomir | Oligonucleotides | |
| HY-RI03091 | mmu-miR-3572-5p inhibitor | Oligonucleotides | |
| HY-RI03091A | mmu-miR-3572-5p antagomir | Oligonucleotides | |
| HY-RI03092 | mmu-miR-361-3p inhibitor | Oligonucleotides | |
| HY-RI03092A | mmu-miR-361-3p antagomir | Oligonucleotides | |
| HY-RI03093 | mmu-miR-3618-3p inhibitor | Oligonucleotides | |
| HY-RI03093A | mmu-miR-3618-3p antagomir | Oligonucleotides | |
| HY-RI03094 | mmu-miR-3618-5p inhibitor | Oligonucleotides | |
| HY-RI03094A | mmu-miR-3618-5p antagomir | Oligonucleotides | |
| HY-RI03095 | mmu-miR-3620-3p inhibitor | Oligonucleotides | |
| HY-RI03095A | mmu-miR-3620-3p antagomir | Oligonucleotides | |
| HY-RI03096 | mmu-miR-3620-5p inhibitor | Oligonucleotides | |
| HY-RI03096A | mmu-miR-3620-5p antagomir | Oligonucleotides | |
| HY-RI03097 | mmu-miR-362-3p inhibitor | Oligonucleotides | |
| HY-RI03097A | mmu-miR-362-3p antagomir | Oligonucleotides | |
| HY-RI03098 | mmu-miR-362-5p inhibitor | Oligonucleotides | |
| HY-RI03098A | mmu-miR-362-5p antagomir | Oligonucleotides | |
| HY-RI03099 | mmu-miR-363-5p inhibitor | Oligonucleotides | |
| HY-RI03099A | mmu-miR-363-5p antagomir | Oligonucleotides | |
| HY-RI03100 | mmu-miR-365-2-5p inhibitor | Oligonucleotides | |
| HY-RI03100A | mmu-miR-365-2-5p antagomir | Oligonucleotides | |
| HY-RI03101 | mmu-miR-367-5p inhibitor | Oligonucleotides | |
| HY-RI03101A | mmu-miR-367-5p antagomir | Oligonucleotides | |
| HY-RI03102 | mmu-miR-370-5p inhibitor | Oligonucleotides | |
| HY-RI03102A | mmu-miR-370-5p antagomir | Oligonucleotides | |
| HY-RI03103 | mmu-miR-374b-3p inhibitor | Oligonucleotides | |
| HY-RI03103A | mmu-miR-374b-3p antagomir | Oligonucleotides | |
| HY-RI03104 | mmu-miR-374c-3p inhibitor | Oligonucleotides | |
| HY-RI03104A | mmu-miR-374c-3p antagomir | Oligonucleotides | |
| HY-RI03105 | mmu-miR-374c-5p inhibitor | Oligonucleotides | |
| HY-RI03105A | mmu-miR-374c-5p antagomir | Oligonucleotides | |
| HY-RI03106 | mmu-miR-375-5p inhibitor | Oligonucleotides | |
| HY-RI03106A | mmu-miR-375-5p antagomir | Oligonucleotides | |
| HY-RI03107 | mmu-miR-376a-3p inhibitor | Oligonucleotides | |
| HY-RI03107A | mmu-miR-376a-3p antagomir | Oligonucleotides | |
| HY-RI03108 | mmu-miR-376a-5p inhibitor | Oligonucleotides | |
| HY-RI03108A | mmu-miR-376a-5p antagomir | Oligonucleotides | |
| HY-RI03109 | mmu-miR-376b-3p inhibitor | Oligonucleotides | |
| HY-RI03109A | mmu-miR-376b-3p antagomir | Oligonucleotides | |
| HY-RI03110 | mmu-miR-376b-5p inhibitor | Oligonucleotides | |
| HY-RI03110A | mmu-miR-376b-5p antagomir | Oligonucleotides | |
| HY-RI03111 | mmu-miR-376c-3p inhibitor | Oligonucleotides | |
| HY-RI03111A | mmu-miR-376c-3p antagomir | Oligonucleotides | |
| HY-RI03112 | mmu-miR-376c-5p inhibitor | Oligonucleotides | |
| HY-RI03112A | mmu-miR-376c-5p antagomir | Oligonucleotides | |
| HY-RI03113 | mmu-miR-378a-3p inhibitor | Oligonucleotides | |
| HY-RI03113A | mmu-miR-378a-3p antagomir | Oligonucleotides | |
| HY-RI03114 | mmu-miR-378b inhibitor | Oligonucleotides | |
| HY-RI03114A | mmu-miR-378b antagomir | Oligonucleotides | |
| HY-RI03115 | mmu-miR-378c inhibitor | Oligonucleotides | |
| HY-RI03115A | mmu-miR-378c antagomir | Oligonucleotides | |
| HY-RI03116 | mmu-miR-378d inhibitor | Oligonucleotides | |
| HY-RI03116A | mmu-miR-378d antagomir | Oligonucleotides | |
| HY-RI03117 | mmu-miR-380-3p inhibitor | Oligonucleotides | |
| HY-RI03117A | mmu-miR-380-3p antagomir | Oligonucleotides | |
| HY-RI03118 | mmu-miR-380-5p inhibitor | Oligonucleotides | |
| HY-RI03118A | mmu-miR-380-5p antagomir | Oligonucleotides | |
| HY-RI03119 | mmu-miR-381-5p inhibitor | Oligonucleotides | |
| HY-RI03119A | mmu-miR-381-5p antagomir | Oligonucleotides | |
| HY-RI03120 | mmu-miR-382-3p inhibitor | Oligonucleotides | |
| HY-RI03120A | mmu-miR-382-3p antagomir | Oligonucleotides | |
| HY-RI03121 | mmu-miR-383-3p inhibitor | Oligonucleotides | |
| HY-RI03121A | mmu-miR-383-3p antagomir | Oligonucleotides | |
| HY-RI03122 | mmu-miR-383-5p inhibitor | Oligonucleotides | |
| HY-RI03122A | mmu-miR-383-5p antagomir | Oligonucleotides | |
| HY-RI03123 | mmu-miR-384-3p inhibitor | Oligonucleotides | |
| HY-RI03123A | mmu-miR-384-3p antagomir | Oligonucleotides | |
| HY-RI03124 | mmu-miR-384-5p inhibitor | Oligonucleotides | |
| HY-RI03124A | mmu-miR-384-5p antagomir | Oligonucleotides | |
| HY-RI03125 | mmu-miR-3961 inhibitor | Oligonucleotides | |
| HY-RI03125A | mmu-miR-3961 antagomir | Oligonucleotides | |
| HY-RI03126 | mmu-miR-3962 inhibitor | Oligonucleotides | |
| HY-RI03126A | mmu-miR-3962 antagomir | Oligonucleotides | |
| HY-RI03127 | mmu-miR-3963 inhibitor | Oligonucleotides | |
| HY-RI03127A | mmu-miR-3963 antagomir | Oligonucleotides | |
| HY-RI03128 | mmu-miR-3964 inhibitor | Oligonucleotides | |
| HY-RI03128A | mmu-miR-3964 antagomir | Oligonucleotides | |
| HY-RI03129 | mmu-miR-3965 inhibitor | Oligonucleotides | |
| HY-RI03129A | mmu-miR-3965 antagomir | Oligonucleotides | |
| HY-RI03130 | mmu-miR-3966 inhibitor | Oligonucleotides | |
| HY-RI03130A | mmu-miR-3966 antagomir | Oligonucleotides | |
| HY-RI03131 | mmu-miR-3967 inhibitor | Oligonucleotides | |
| HY-RI03131A | mmu-miR-3967 antagomir | Oligonucleotides | |
| HY-RI03132 | mmu-miR-3968 inhibitor | Oligonucleotides | |
| HY-RI03132A | mmu-miR-3968 antagomir | Oligonucleotides | |
| HY-RI03133 | mmu-miR-3969 inhibitor | Oligonucleotides | |
| HY-RI03133A | mmu-miR-3969 antagomir | Oligonucleotides | |
| HY-RI03134 | mmu-miR-3970 inhibitor | Oligonucleotides | |
| HY-RI03134A | mmu-miR-3970 antagomir | Oligonucleotides | |
| HY-RI03135 | mmu-miR-3971 inhibitor | Oligonucleotides | |
| HY-RI03135A | mmu-miR-3971 antagomir | Oligonucleotides | |
| HY-RI03136 | mmu-miR-412-3p inhibitor | Oligonucleotides | |
| HY-RI03136A | mmu-miR-412-3p antagomir | Oligonucleotides | |
| HY-RI03137 | mmu-miR-412-5p inhibitor | Oligonucleotides | |
| HY-RI03137A | mmu-miR-412-5p antagomir | Oligonucleotides | |
| HY-RI03138 | mmu-miR-421-5p inhibitor | Oligonucleotides | |
| HY-RI03138A | mmu-miR-421-5p antagomir | Oligonucleotides | |
| HY-RI03139 | mmu-miR-425-3p inhibitor | Oligonucleotides | |
| HY-RI03139A | mmu-miR-425-3p antagomir | Oligonucleotides | |
| HY-RI03140 | mmu-miR-429-3p inhibitor | Oligonucleotides | |
| HY-RI03140A | mmu-miR-429-3p antagomir | Oligonucleotides | |
| HY-RI03141 | mmu-miR-429-5p inhibitor | Oligonucleotides | |
| HY-RI03141A | mmu-miR-429-5p antagomir | Oligonucleotides | |
| HY-RI03142 | mmu-miR-432 inhibitor | Oligonucleotides | |
| HY-RI03142A | mmu-miR-432 antagomir | Oligonucleotides | |
| HY-RI03143 | mmu-miR-434-3p inhibitor | Oligonucleotides | |
| HY-RI03143A | mmu-miR-434-3p antagomir | Oligonucleotides | |
| HY-RI03144 | mmu-miR-434-5p inhibitor | Oligonucleotides | |
| HY-RI03144A | mmu-miR-434-5p antagomir | Oligonucleotides | |
| HY-RI03145 | mmu-miR-448-5p inhibitor | Oligonucleotides | |
| HY-RI03145A | mmu-miR-448-5p antagomir | Oligonucleotides | |
| HY-RI03146 | mmu-miR-449a-3p inhibitor | Oligonucleotides | |
| HY-RI03146A | mmu-miR-449a-3p antagomir | Oligonucleotides | |
| HY-RI03147 | mmu-miR-449b inhibitor | Oligonucleotides | |
| HY-RI03147A | mmu-miR-449b antagomir | Oligonucleotides | |
| HY-RI03148 | mmu-miR-449c-3p inhibitor | Oligonucleotides | |
| HY-RI03148A | mmu-miR-449c-3p antagomir | Oligonucleotides | |
| HY-RI03149 | mmu-miR-449c-5p inhibitor | Oligonucleotides | |
| HY-RI03149A | mmu-miR-449c-5p antagomir | Oligonucleotides | |
| HY-RI03150 | mmu-miR-450a-1-3p inhibitor | Oligonucleotides | |
| HY-RI03150A | mmu-miR-450a-1-3p antagomir | Oligonucleotides | |
| HY-RI03151 | mmu-miR-450a-2-3p inhibitor | Oligonucleotides | |
| HY-RI03151A | mmu-miR-450a-2-3p antagomir | Oligonucleotides | |
| HY-RI03152 | mmu-miR-450b-3p inhibitor | Oligonucleotides | |
| HY-RI03152A | mmu-miR-450b-3p antagomir | Oligonucleotides | |
| HY-RI03153 | mmu-miR-450b-5p inhibitor | Oligonucleotides | |
| HY-RI03153A | mmu-miR-450b-5p antagomir | Oligonucleotides | |
| HY-RI03154 | mmu-miR-451b inhibitor | Oligonucleotides | |
| HY-RI03154A | mmu-miR-451b antagomir | Oligonucleotides | |
| HY-RI03155 | mmu-miR-452-3p inhibitor | Oligonucleotides | |
| HY-RI03155A | mmu-miR-452-3p antagomir | Oligonucleotides | |
| HY-RI03156 | mmu-miR-452-5p inhibitor | Oligonucleotides | |
| HY-RI03156A | mmu-miR-452-5p antagomir | Oligonucleotides | |
| HY-RI03157 | mmu-miR-453 inhibitor | Oligonucleotides | |
| HY-RI03157A | mmu-miR-453 antagomir | Oligonucleotides | |
| HY-RI03158 | mmu-miR-455-3p inhibitor | Oligonucleotides | |
| HY-RI03158A | mmu-miR-455-3p antagomir | Oligonucleotides | |
| HY-RI03159 | mmu-miR-463-3p inhibitor | Oligonucleotides | |
| HY-RI03159A | mmu-miR-463-3p antagomir | Oligonucleotides | |
| HY-RI03160 | mmu-miR-463-5p inhibitor | Oligonucleotides | |
| HY-RI03160A | mmu-miR-463-5p antagomir | Oligonucleotides | |
| HY-RI03161 | mmu-miR-465a-3p inhibitor | Oligonucleotides | |
| HY-RI03161A | mmu-miR-465a-3p antagomir | Oligonucleotides | |
| HY-RI03162 | mmu-miR-465a-5p inhibitor | Oligonucleotides | |
| HY-RI03162A | mmu-miR-465a-5p antagomir | Oligonucleotides | |
| HY-RI03163 | mmu-miR-465b-5p inhibitor | Oligonucleotides | |
| HY-RI03163A | mmu-miR-465b-5p antagomir | Oligonucleotides | |
| HY-RI03164 | mmu-miR-465c-5p inhibitor | Oligonucleotides | |
| HY-RI03164A | mmu-miR-465c-5p antagomir | Oligonucleotides | |
| HY-RI03165 | mmu-miR-465d-3p inhibitor | Oligonucleotides | |
| HY-RI03165A | mmu-miR-465d-3p antagomir | Oligonucleotides | |
| HY-RI03166 | mmu-miR-465d-5p inhibitor | Oligonucleotides | |
| HY-RI03166A | mmu-miR-465d-5p antagomir | Oligonucleotides | |
| HY-RI03167 | mmu-miR-466a-3p inhibitor | Oligonucleotides | |
| HY-RI03167A | mmu-miR-466a-3p antagomir | Oligonucleotides | |
| HY-RI03168 | mmu-miR-466a-5p inhibitor | Oligonucleotides | |
| HY-RI03168A | mmu-miR-466a-5p antagomir | Oligonucleotides | |
| HY-RI03169 | mmu-miR-466b-3p inhibitor | Oligonucleotides | |
| HY-RI03169A | mmu-miR-466b-3p antagomir | Oligonucleotides | |
| HY-RI03170 | mmu-miR-466b-5p inhibitor | Oligonucleotides | |
| HY-RI03170A | mmu-miR-466b-5p antagomir | Oligonucleotides | |
| HY-RI03171 | mmu-miR-466c-5p inhibitor | Oligonucleotides | |
| HY-RI03171A | mmu-miR-466c-5p antagomir | Oligonucleotides | |
| HY-RI03172 | mmu-miR-466d-3p inhibitor | Oligonucleotides | |
| HY-RI03172A | mmu-miR-466d-3p antagomir | Oligonucleotides | |
| HY-RI03173 | mmu-miR-466d-5p inhibitor | Oligonucleotides | |
| HY-RI03173A | mmu-miR-466d-5p antagomir | Oligonucleotides | |
| HY-RI03174 | mmu-miR-466e-5p inhibitor | Oligonucleotides | |
| HY-RI03174A | mmu-miR-466e-5p antagomir | Oligonucleotides | |
| HY-RI03175 | mmu-miR-466f inhibitor | Oligonucleotides | |
| HY-RI03175A | mmu-miR-466f antagomir | Oligonucleotides | |
| HY-RI03176 | mmu-miR-466f-3p inhibitor | Oligonucleotides | |
| HY-RI03176A | mmu-miR-466f-3p antagomir | Oligonucleotides | |
| HY-RI03177 | mmu-miR-466f-5p inhibitor | Oligonucleotides | |
| HY-RI03177A | mmu-miR-466f-5p antagomir | Oligonucleotides | |
| HY-RI03178 | mmu-miR-466g inhibitor | Oligonucleotides | |
| HY-RI03178A | mmu-miR-466g antagomir | Oligonucleotides | |
| HY-RI03179 | mmu-miR-466h-3p inhibitor | Oligonucleotides | |
| HY-RI03179A | mmu-miR-466h-3p antagomir | Oligonucleotides | |
| HY-RI03180 | mmu-miR-466h-5p inhibitor | Oligonucleotides | |
| HY-RI03180A | mmu-miR-466h-5p antagomir | Oligonucleotides | |
| HY-RI03181 | mmu-miR-466i-3p inhibitor | Oligonucleotides | |
| HY-RI03181A | mmu-miR-466i-3p antagomir | Oligonucleotides | |
| HY-RI03182 | mmu-miR-466i-5p inhibitor | Oligonucleotides | |
| HY-RI03182A | mmu-miR-466i-5p antagomir | Oligonucleotides | |
| HY-RI03183 | mmu-miR-466j inhibitor | Oligonucleotides | |
| HY-RI03183A | mmu-miR-466j antagomir | Oligonucleotides | |
| HY-RI03184 | mmu-miR-466k inhibitor | Oligonucleotides | |
| HY-RI03184A | mmu-miR-466k antagomir | Oligonucleotides | |
| HY-RI03185 | mmu-miR-466l-3p inhibitor | Oligonucleotides | |
| HY-RI03185A | mmu-miR-466l-3p antagomir | Oligonucleotides | |
| HY-RI03186 | mmu-miR-466l-5p inhibitor | Oligonucleotides | |
| HY-RI03186A | mmu-miR-466l-5p antagomir | Oligonucleotides | |
| HY-RI03187 | mmu-miR-466m-3p inhibitor | Oligonucleotides | |
| HY-RI03187A | mmu-miR-466m-3p antagomir | Oligonucleotides | |
| HY-RI03188 | mmu-miR-466m-5p inhibitor | Oligonucleotides | |
| HY-RI03188A | mmu-miR-466m-5p antagomir | Oligonucleotides | |
| HY-RI03189 | mmu-miR-466n-3p inhibitor | Oligonucleotides | |
| HY-RI03189A | mmu-miR-466n-3p antagomir | Oligonucleotides | |
| HY-RI03190 | mmu-miR-466n-5p inhibitor | Oligonucleotides | |
| HY-RI03190A | mmu-miR-466n-5p antagomir | Oligonucleotides | |
| HY-RI03191 | mmu-miR-466o-3p inhibitor | Oligonucleotides | |
| HY-RI03191A | mmu-miR-466o-3p antagomir | Oligonucleotides | |
| HY-RI03192 | mmu-miR-466p-5p inhibitor | Oligonucleotides | |
| HY-RI03192A | mmu-miR-466p-5p antagomir | Oligonucleotides | |
| HY-RI03193 | mmu-miR-466q inhibitor | Oligonucleotides | |
| HY-RI03193A | mmu-miR-466q antagomir | Oligonucleotides | |
| HY-RI03194 | mmu-miR-467a-3p inhibitor | Oligonucleotides | |
| HY-RI03194A | mmu-miR-467a-3p antagomir | Oligonucleotides | |
| HY-RI03195 | mmu-miR-467a-5p inhibitor | Oligonucleotides | |
| HY-RI03195A | mmu-miR-467a-5p antagomir | Oligonucleotides | |
| HY-RI03196 | mmu-miR-467b-3p inhibitor | Oligonucleotides | |
| HY-RI03196A | mmu-miR-467b-3p antagomir | Oligonucleotides | |
| HY-RI03197 | mmu-miR-467b-5p inhibitor | Oligonucleotides | |
| HY-RI03197A | mmu-miR-467b-5p antagomir | Oligonucleotides | |
| HY-RI03198 | mmu-miR-467c-3p inhibitor | Oligonucleotides | |
| HY-RI03198A | mmu-miR-467c-3p antagomir | Oligonucleotides | |
| HY-RI03199 | mmu-miR-467c-5p inhibitor | Oligonucleotides | |
| HY-RI03199A | mmu-miR-467c-5p antagomir | Oligonucleotides | |
| HY-RI03200 | mmu-miR-467d-3p inhibitor | Oligonucleotides | |
| HY-RI03200A | mmu-miR-467d-3p antagomir | Oligonucleotides | |
| HY-RI03201 | mmu-miR-467d-5p inhibitor | Oligonucleotides | |
| HY-RI03201A | mmu-miR-467d-5p antagomir | Oligonucleotides | |
| HY-RI03202 | mmu-miR-467e-3p inhibitor | Oligonucleotides | |
| HY-RI03202A | mmu-miR-467e-3p antagomir | Oligonucleotides | |
| HY-RI03203 | mmu-miR-467e-5p inhibitor | Oligonucleotides | |
| HY-RI03203A | mmu-miR-467e-5p antagomir | Oligonucleotides | |
| HY-RI03204 | mmu-miR-467f inhibitor | Oligonucleotides | |
| HY-RI03204A | mmu-miR-467f antagomir | Oligonucleotides | |
| HY-RI03205 | mmu-miR-467g inhibitor | Oligonucleotides | |
| HY-RI03205A | mmu-miR-467g antagomir | Oligonucleotides | |
| HY-RI03206 | mmu-miR-467h inhibitor | Oligonucleotides | |
| HY-RI03206A | mmu-miR-467h antagomir | Oligonucleotides | |
| HY-RI03207 | mmu-miR-468-3p inhibitor | Oligonucleotides | |
| HY-RI03207A | mmu-miR-468-3p antagomir | Oligonucleotides | |
| HY-RI03208 | mmu-miR-468-5p inhibitor | Oligonucleotides | |
| HY-RI03208A | mmu-miR-468-5p antagomir | Oligonucleotides | |
| HY-RI03209 | mmu-miR-470-3p inhibitor | Oligonucleotides | |
| HY-RI03209A | mmu-miR-470-3p antagomir | Oligonucleotides | |
| HY-RI03210 | mmu-miR-470-5p inhibitor | Oligonucleotides | |
| HY-RI03210A | mmu-miR-470-5p antagomir | Oligonucleotides | |
| HY-RI03211 | mmu-miR-471-3p inhibitor | Oligonucleotides | |
| HY-RI03211A | mmu-miR-471-3p antagomir | Oligonucleotides | |
| HY-RI03212 | mmu-miR-471-5p inhibitor | Oligonucleotides | |
| HY-RI03212A | mmu-miR-471-5p antagomir | Oligonucleotides | |
| HY-RI03213 | mmu-miR-483-3p inhibitor | Oligonucleotides | |
| HY-RI03213A | mmu-miR-483-3p antagomir | Oligonucleotides | |
| HY-RI03214 | mmu-miR-483-5p inhibitor | Oligonucleotides | |
| HY-RI03214A | mmu-miR-483-5p antagomir | Oligonucleotides | |
| HY-RI03215 | mmu-miR-485-3p inhibitor | Oligonucleotides | |
| HY-RI03215A | mmu-miR-485-3p antagomir | Oligonucleotides | |
| HY-RI03216 | mmu-miR-486b-3p inhibitor | Oligonucleotides | |
| HY-RI03216A | mmu-miR-486b-3p antagomir | Oligonucleotides | |
| HY-RI03217 | mmu-miR-487b-5p inhibitor | Oligonucleotides | |
| HY-RI03217A | mmu-miR-487b-5p antagomir | Oligonucleotides | |
| HY-RI03218 | mmu-miR-488-3p inhibitor | Oligonucleotides | |
| HY-RI03218A | mmu-miR-488-3p antagomir | Oligonucleotides | |
| HY-RI03219 | mmu-miR-488-5p inhibitor | Oligonucleotides | |
| HY-RI03219A | mmu-miR-488-5p antagomir | Oligonucleotides | |
| HY-RI03220 | mmu-miR-489-3p inhibitor | Oligonucleotides | |
| HY-RI03220A | mmu-miR-489-3p antagomir | Oligonucleotides | |
| HY-RI03221 | mmu-miR-489-5p inhibitor | Oligonucleotides | |
| HY-RI03221A | mmu-miR-489-5p antagomir | Oligonucleotides | |
| HY-RI03222 | mmu-miR-493-3p inhibitor | Oligonucleotides | |
| HY-RI03222A | mmu-miR-493-3p antagomir | Oligonucleotides | |
| HY-RI03223 | mmu-miR-493-5p inhibitor | Oligonucleotides | |
| HY-RI03223A | mmu-miR-493-5p antagomir | Oligonucleotides | |
| HY-RI03224 | mmu-miR-494-5p inhibitor | Oligonucleotides | |
| HY-RI03224A | mmu-miR-494-5p antagomir | Oligonucleotides | |
| HY-RI03225 | mmu-miR-495-5p inhibitor | Oligonucleotides | |
| HY-RI03225A | mmu-miR-495-5p antagomir | Oligonucleotides | |
| HY-RI03226 | mmu-miR-496a-5p inhibitor | Oligonucleotides | |
| HY-RI03226A | mmu-miR-496a-5p antagomir | Oligonucleotides | |
| HY-RI03227 | mmu-miR-496b inhibitor | Oligonucleotides | |
| HY-RI03227A | mmu-miR-496b antagomir | Oligonucleotides | |
| HY-RI03228 | mmu-miR-497a-3p inhibitor | Oligonucleotides | |
| HY-RI03228A | mmu-miR-497a-3p antagomir | Oligonucleotides | |
| HY-RI03229 | mmu-miR-497a-5p inhibitor | Oligonucleotides | |
| HY-RI03229A | mmu-miR-497a-5p antagomir | Oligonucleotides | |
| HY-RI03230 | mmu-miR-497b inhibitor | Oligonucleotides | |
| HY-RI03230A | mmu-miR-497b antagomir | Oligonucleotides | |
| HY-RI03231 | mmu-miR-499-3p inhibitor | Oligonucleotides | |
| HY-RI03231A | mmu-miR-499-3p antagomir | Oligonucleotides | |
| HY-RI03232 | mmu-miR-500-3p inhibitor | Oligonucleotides | |
| HY-RI03232A | mmu-miR-500-3p antagomir | Oligonucleotides | |
| HY-RI03233 | mmu-miR-500-5p inhibitor | Oligonucleotides | |
| HY-RI03233A | mmu-miR-500-5p antagomir | Oligonucleotides | |
| HY-RI03234 | mmu-miR-501-3p inhibitor | Oligonucleotides | |
| HY-RI03234A | mmu-miR-501-3p antagomir | Oligonucleotides | |
| HY-RI03235 | mmu-miR-501-5p inhibitor | Oligonucleotides | |
| HY-RI03235A | mmu-miR-501-5p antagomir | Oligonucleotides | |
| HY-RI03236 | mmu-miR-503-3p inhibitor | Oligonucleotides | |
| HY-RI03236A | mmu-miR-503-3p antagomir | Oligonucleotides | |
| HY-RI03237 | mmu-miR-503-5p inhibitor | Oligonucleotides | |
| HY-RI03237A | mmu-miR-503-5p antagomir | Oligonucleotides | |
| HY-RI03238 | mmu-miR-504-3p inhibitor | Oligonucleotides | |
| HY-RI03238A | mmu-miR-504-3p antagomir | Oligonucleotides | |
| HY-RI03239 | mmu-miR-5046 inhibitor | Oligonucleotides | |
| HY-RI03239A | mmu-miR-5046 antagomir | Oligonucleotides | |
| HY-RI03240 | mmu-miR-505-3p inhibitor | Oligonucleotides | |
| HY-RI03240A | mmu-miR-505-3p antagomir | Oligonucleotides | |
| HY-RI03241 | mmu-miR-505-5p inhibitor | Oligonucleotides | |
| HY-RI03241A | mmu-miR-505-5p antagomir | Oligonucleotides | |
| HY-RI03242 | mmu-miR-509-3p inhibitor | Oligonucleotides | |
| HY-RI03242A | mmu-miR-509-3p antagomir | Oligonucleotides | |
| HY-RI03243 | mmu-miR-509-5p inhibitor | Oligonucleotides | |
| HY-RI03243A | mmu-miR-509-5p antagomir | Oligonucleotides | |
| HY-RI03244 | mmu-miR-5098 inhibitor | Oligonucleotides | |
| HY-RI03244A | mmu-miR-5098 antagomir | Oligonucleotides | |
| HY-RI03245 | mmu-miR-5099 inhibitor | Oligonucleotides | |
| HY-RI03245A | mmu-miR-5099 antagomir | Oligonucleotides | |
| HY-RI03246 | mmu-miR-5100 inhibitor | Oligonucleotides | |
| HY-RI03246A | mmu-miR-5100 antagomir | Oligonucleotides | |
| HY-RI03247 | mmu-miR-5101 inhibitor | Oligonucleotides | |
| HY-RI03247A | mmu-miR-5101 antagomir | Oligonucleotides | |
| HY-RI03248 | mmu-miR-5103 inhibitor | Oligonucleotides | |
| HY-RI03248A | mmu-miR-5103 antagomir | Oligonucleotides | |
| HY-RI03249 | mmu-miR-5104 inhibitor | Oligonucleotides | |
| HY-RI03249A | mmu-miR-5104 antagomir | Oligonucleotides | |
| HY-RI03250 | mmu-miR-5104b-5p inhibitor | Oligonucleotides | |
| HY-RI03250A | mmu-miR-5104b-5p antagomir | Oligonucleotides | |
| HY-RI03251 | mmu-miR-5106 inhibitor | Oligonucleotides | |
| HY-RI03251A | mmu-miR-5106 antagomir | Oligonucleotides | |
| HY-RI03252 | mmu-miR-5107-3p inhibitor | Oligonucleotides | |
| HY-RI03252A | mmu-miR-5107-3p antagomir | Oligonucleotides | |
| HY-RI03253 | mmu-miR-5107-5p inhibitor | Oligonucleotides | |
| HY-RI03253A | mmu-miR-5107-5p antagomir | Oligonucleotides | |
| HY-RI03254 | mmu-miR-5108 inhibitor | Oligonucleotides | |
| HY-RI03254A | mmu-miR-5108 antagomir | Oligonucleotides | |
| HY-RI03255 | mmu-miR-5110 inhibitor | Oligonucleotides | |
| HY-RI03255A | mmu-miR-5110 antagomir | Oligonucleotides | |
| HY-RI03256 | mmu-miR-5112 inhibitor | Oligonucleotides | |
| HY-RI03256A | mmu-miR-5112 antagomir | Oligonucleotides | |
| HY-RI03257 | mmu-miR-5113 inhibitor | Oligonucleotides | |
| HY-RI03257A | mmu-miR-5113 antagomir | Oligonucleotides | |
| HY-RI03258 | mmu-miR-511-3p inhibitor | Oligonucleotides | |
| HY-RI03258A | mmu-miR-511-3p antagomir | Oligonucleotides | |
| HY-RI03259 | mmu-miR-5114 inhibitor | Oligonucleotides | |
| HY-RI03259A | mmu-miR-5114 antagomir | Oligonucleotides | |
| HY-RI03260 | mmu-miR-511-5p inhibitor | Oligonucleotides | |
| HY-RI03260A | mmu-miR-511-5p antagomir | Oligonucleotides | |
| HY-RI03261 | mmu-miR-5116 inhibitor | Oligonucleotides | |
| HY-RI03261A | mmu-miR-5116 antagomir | Oligonucleotides | |
| HY-RI03262 | mmu-miR-5118 inhibitor | Oligonucleotides | |
| HY-RI03262A | mmu-miR-5118 antagomir | Oligonucleotides | |
| HY-RI03263 | mmu-miR-5119 inhibitor | Oligonucleotides | |
| HY-RI03263A | mmu-miR-5119 antagomir | Oligonucleotides | |
| HY-RI03264 | mmu-miR-5120 inhibitor | Oligonucleotides | |
| HY-RI03264A | mmu-miR-5120 antagomir | Oligonucleotides | |
| HY-RI03265 | mmu-miR-5121 inhibitor | Oligonucleotides | |
| HY-RI03265A | mmu-miR-5121 antagomir | Oligonucleotides | |
| HY-RI03266 | mmu-miR-5122 inhibitor | Oligonucleotides | |
| HY-RI03266A | mmu-miR-5122 antagomir | Oligonucleotides | |
| HY-RI03267 | mmu-miR-5123 inhibitor | Oligonucleotides | |
| HY-RI03267A | mmu-miR-5123 antagomir | Oligonucleotides | |
| HY-RI03268 | mmu-miR-5124a inhibitor | Oligonucleotides | |
| HY-RI03268A | mmu-miR-5124a antagomir | Oligonucleotides | |
| HY-RI03269 | mmu-miR-5124b inhibitor | Oligonucleotides | |
| HY-RI03269A | mmu-miR-5124b antagomir | Oligonucleotides | |
| HY-RI03270 | mmu-miR-5125 inhibitor | Oligonucleotides | |
| HY-RI03270A | mmu-miR-5125 antagomir | Oligonucleotides | |
| HY-RI03271 | mmu-miR-5126 inhibitor | Oligonucleotides | |
| HY-RI03271A | mmu-miR-5126 antagomir | Oligonucleotides | |
| HY-RI03272 | mmu-miR-5127 inhibitor | Oligonucleotides | |
| HY-RI03272A | mmu-miR-5127 antagomir | Oligonucleotides | |
| HY-RI03273 | mmu-miR-5128 inhibitor | Oligonucleotides | |
| HY-RI03273A | mmu-miR-5128 antagomir | Oligonucleotides | |
| HY-RI03274 | mmu-miR-5129-3p inhibitor | Oligonucleotides | |
| HY-RI03274A | mmu-miR-5129-3p antagomir | Oligonucleotides | |
| HY-RI03275 | mmu-miR-5129-5p inhibitor | Oligonucleotides | |
| HY-RI03275A | mmu-miR-5129-5p antagomir | Oligonucleotides | |
| HY-RI03276 | mmu-miR-5130 inhibitor | Oligonucleotides | |
| HY-RI03276A | mmu-miR-5130 antagomir | Oligonucleotides | |
| HY-RI03277 | mmu-miR-5131 inhibitor | Oligonucleotides | |
| HY-RI03277A | mmu-miR-5131 antagomir | Oligonucleotides | |
| HY-RI03278 | mmu-miR-5132-3p inhibitor | Oligonucleotides | |
| HY-RI03278A | mmu-miR-5132-3p antagomir | Oligonucleotides | |
| HY-RI03279 | mmu-miR-5132-5p inhibitor | Oligonucleotides | |
| HY-RI03279A | mmu-miR-5132-5p antagomir | Oligonucleotides | |
| HY-RI03280 | mmu-miR-5133 inhibitor | Oligonucleotides | |
| HY-RI03280A | mmu-miR-5133 antagomir | Oligonucleotides | |
| HY-RI03281 | mmu-miR-5134-3p inhibitor | Oligonucleotides | |
| HY-RI03281A | mmu-miR-5134-3p antagomir | Oligonucleotides | |
| HY-RI03282 | mmu-miR-5134-5p inhibitor | Oligonucleotides | |
| HY-RI03282A | mmu-miR-5134-5p antagomir | Oligonucleotides | |
| HY-RI03283 | mmu-miR-5135 inhibitor | Oligonucleotides | |
| HY-RI03283A | mmu-miR-5135 antagomir | Oligonucleotides | |
| HY-RI03284 | mmu-miR-5136 inhibitor | Oligonucleotides | |
| HY-RI03284A | mmu-miR-5136 antagomir | Oligonucleotides | |
| HY-RI03285 | mmu-miR-539-3p inhibitor | Oligonucleotides | |
| HY-RI03285A | mmu-miR-539-3p antagomir | Oligonucleotides | |
| HY-RI03286 | mmu-miR-540-3p inhibitor | Oligonucleotides | |
| HY-RI03286A | mmu-miR-540-3p antagomir | Oligonucleotides | |
| HY-RI03287 | mmu-miR-540-5p inhibitor | Oligonucleotides | |
| HY-RI03287A | mmu-miR-540-5p antagomir | Oligonucleotides | |
| HY-RI03288 | mmu-miR-541-3p inhibitor | Oligonucleotides | |
| HY-RI03288A | mmu-miR-541-3p antagomir | Oligonucleotides | |
| HY-RI03289 | mmu-miR-541-5p inhibitor | Oligonucleotides | |
| HY-RI03289A | mmu-miR-541-5p antagomir | Oligonucleotides | |
| HY-RI03290 | mmu-miR-542-5p inhibitor | Oligonucleotides | |
| HY-RI03290A | mmu-miR-542-5p antagomir | Oligonucleotides | |
| HY-RI03291 | mmu-miR-543-5p inhibitor | Oligonucleotides | |
| HY-RI03291A | mmu-miR-543-5p antagomir | Oligonucleotides | |
| HY-RI03292 | mmu-miR-544-3p inhibitor | Oligonucleotides | |
| HY-RI03292A | mmu-miR-544-3p antagomir | Oligonucleotides | |
| HY-RI03293 | mmu-miR-544-5p inhibitor | Oligonucleotides | |
| HY-RI03293A | mmu-miR-544-5p antagomir | Oligonucleotides | |
| HY-RI03294 | mmu-miR-546 inhibitor | Oligonucleotides | |
| HY-RI03294A | mmu-miR-546 antagomir | Oligonucleotides | |
| HY-RI03295 | mmu-miR-547-3p inhibitor | Oligonucleotides | |
| HY-RI03295A | mmu-miR-547-3p antagomir | Oligonucleotides | |
| HY-RI03296 | mmu-miR-547-5p inhibitor | Oligonucleotides | |
| HY-RI03296A | mmu-miR-547-5p antagomir | Oligonucleotides | |
| HY-RI03297 | mmu-miR-551b-5p inhibitor | Oligonucleotides | |
| HY-RI03297A | mmu-miR-551b-5p antagomir | Oligonucleotides | |
| HY-RI03298 | mmu-miR-5615-3p inhibitor | Oligonucleotides | |
| HY-RI03298A | mmu-miR-5615-3p antagomir | Oligonucleotides | |
| HY-RI03299 | mmu-miR-5615-5p inhibitor | Oligonucleotides | |
| HY-RI03299A | mmu-miR-5615-5p antagomir | Oligonucleotides | |
| HY-RI03300 | mmu-miR-5616-3p inhibitor | Oligonucleotides | |
| HY-RI03300A | mmu-miR-5616-3p antagomir | Oligonucleotides | |
| HY-RI03301 | mmu-miR-5616-5p inhibitor | Oligonucleotides | |
| HY-RI03301A | mmu-miR-5616-5p antagomir | Oligonucleotides | |
| HY-RI03302 | mmu-miR-5617-3p inhibitor | Oligonucleotides | |
| HY-RI03302A | mmu-miR-5617-3p antagomir | Oligonucleotides | |
| HY-RI03303 | mmu-miR-5617-5p inhibitor | Oligonucleotides | |
| HY-RI03303A | mmu-miR-5617-5p antagomir | Oligonucleotides | |
| HY-RI03304 | mmu-miR-5618-3p inhibitor | Oligonucleotides | |
| HY-RI03304A | mmu-miR-5618-3p antagomir | Oligonucleotides | |
| HY-RI03305 | mmu-miR-5618-5p inhibitor | Oligonucleotides | |
| HY-RI03305A | mmu-miR-5618-5p antagomir | Oligonucleotides | |
| HY-RI03306 | mmu-miR-5619-3p inhibitor | Oligonucleotides | |
| HY-RI03306A | mmu-miR-5619-3p antagomir | Oligonucleotides | |
| HY-RI03307 | mmu-miR-5619-5p inhibitor | Oligonucleotides | |
| HY-RI03307A | mmu-miR-5619-5p antagomir | Oligonucleotides | |
| HY-RI03308 | mmu-miR-5620-3p inhibitor | Oligonucleotides | |
| HY-RI03308A | mmu-miR-5620-3p antagomir | Oligonucleotides | |
| HY-RI03309 | mmu-miR-5620-5p inhibitor | Oligonucleotides | |
| HY-RI03309A | mmu-miR-5620-5p antagomir | Oligonucleotides | |
| HY-RI03310 | mmu-miR-5621-3p inhibitor | Oligonucleotides | |
| HY-RI03310A | mmu-miR-5621-3p antagomir | Oligonucleotides | |
| HY-RI03311 | mmu-miR-5621-5p inhibitor | Oligonucleotides | |
| HY-RI03311A | mmu-miR-5621-5p antagomir | Oligonucleotides | |
| HY-RI03312 | mmu-miR-5622-3p inhibitor | Oligonucleotides | |
| HY-RI03312A | mmu-miR-5622-3p antagomir | Oligonucleotides | |
| HY-RI03313 | mmu-miR-5622-5p inhibitor | Oligonucleotides | |
| HY-RI03313A | mmu-miR-5622-5p antagomir | Oligonucleotides | |
| HY-RI03314 | mmu-miR-5623-3p inhibitor | Oligonucleotides | |
| HY-RI03314A | mmu-miR-5623-3p antagomir | Oligonucleotides | |
| HY-RI03315 | mmu-miR-5623-5p inhibitor | Oligonucleotides | |
| HY-RI03315A | mmu-miR-5623-5p antagomir | Oligonucleotides | |
| HY-RI03316 | mmu-miR-5624-3p inhibitor | Oligonucleotides | |
| HY-RI03316A | mmu-miR-5624-3p antagomir | Oligonucleotides | |
| HY-RI03317 | mmu-miR-5624-5p inhibitor | Oligonucleotides | |
| HY-RI03317A | mmu-miR-5624-5p antagomir | Oligonucleotides | |
| HY-RI03318 | mmu-miR-5625-3p inhibitor | Oligonucleotides | |
| HY-RI03318A | mmu-miR-5625-3p antagomir | Oligonucleotides | |
| HY-RI03319 | mmu-miR-5625-5p inhibitor | Oligonucleotides | |
| HY-RI03319A | mmu-miR-5625-5p antagomir | Oligonucleotides | |
| HY-RI03320 | mmu-miR-5626-3p inhibitor | Oligonucleotides | |
| HY-RI03320A | mmu-miR-5626-3p antagomir | Oligonucleotides | |
| HY-RI03321 | mmu-miR-5626-5p inhibitor | Oligonucleotides | |
| HY-RI03321A | mmu-miR-5626-5p antagomir | Oligonucleotides | |
| HY-RI03322 | mmu-miR-5627-3p inhibitor | Oligonucleotides | |
| HY-RI03322A | mmu-miR-5627-3p antagomir | Oligonucleotides | |
| HY-RI03323 | mmu-miR-5627-5p inhibitor | Oligonucleotides | |
| HY-RI03323A | mmu-miR-5627-5p antagomir | Oligonucleotides | |
| HY-RI03324 | mmu-miR-5709-3p inhibitor | Oligonucleotides | |
| HY-RI03324A | mmu-miR-5709-3p antagomir | Oligonucleotides | |
| HY-RI03325 | mmu-miR-5709-5p inhibitor | Oligonucleotides | |
| HY-RI03325A | mmu-miR-5709-5p antagomir | Oligonucleotides | |
| HY-RI03326 | mmu-miR-5710 inhibitor | Oligonucleotides | |
| HY-RI03326A | mmu-miR-5710 antagomir | Oligonucleotides | |
| HY-RI03327 | mmu-miR-582-3p inhibitor | Oligonucleotides | |
| HY-RI03327A | mmu-miR-582-3p antagomir | Oligonucleotides | |
| HY-RI03328 | mmu-miR-582-5p inhibitor | Oligonucleotides | |
| HY-RI03328A | mmu-miR-582-5p antagomir | Oligonucleotides | |
| HY-RI03329 | mmu-miR-592-3p inhibitor | Oligonucleotides | |
| HY-RI03329A | mmu-miR-592-3p antagomir | Oligonucleotides | |
| HY-RI03330 | mmu-miR-592-5p inhibitor | Oligonucleotides | |
| HY-RI03330A | mmu-miR-592-5p antagomir | Oligonucleotides | |
| HY-RI03331 | mmu-miR-598-3p inhibitor | Oligonucleotides | |
| HY-RI03331A | mmu-miR-598-3p antagomir | Oligonucleotides | |
| HY-RI03332 | mmu-miR-598-5p inhibitor | Oligonucleotides | |
| HY-RI03332A | mmu-miR-598-5p antagomir | Oligonucleotides | |
| HY-RI03333 | mmu-miR-599 inhibitor | Oligonucleotides | |
| HY-RI03333A | mmu-miR-599 antagomir | Oligonucleotides | |
| HY-RI03334 | mmu-miR-6236 inhibitor | Oligonucleotides | |
| HY-RI03334A | mmu-miR-6236 antagomir | Oligonucleotides | |
| HY-RI03335 | mmu-miR-6237 inhibitor | Oligonucleotides | |
| HY-RI03335A | mmu-miR-6237 antagomir | Oligonucleotides | |
| HY-RI03336 | mmu-miR-6238 inhibitor | Oligonucleotides | |
| HY-RI03336A | mmu-miR-6238 antagomir | Oligonucleotides | |
| HY-RI03337 | mmu-miR-6239 inhibitor | Oligonucleotides | |
| HY-RI03337A | mmu-miR-6239 antagomir | Oligonucleotides | |
| HY-RI03338 | mmu-miR-6240 inhibitor | Oligonucleotides | |
| HY-RI03338A | mmu-miR-6240 antagomir | Oligonucleotides | |
| HY-RI03339 | mmu-miR-6241 inhibitor | Oligonucleotides | |
| HY-RI03339A | mmu-miR-6241 antagomir | Oligonucleotides | |
| HY-RI03340 | mmu-miR-6244 inhibitor | Oligonucleotides | |
| HY-RI03340A | mmu-miR-6244 antagomir | Oligonucleotides | |
| HY-RI03341 | mmu-miR-6335 inhibitor | Oligonucleotides | |
| HY-RI03341A | mmu-miR-6335 antagomir | Oligonucleotides | |
| HY-RI03342 | mmu-miR-6336 inhibitor | Oligonucleotides | |
| HY-RI03342A | mmu-miR-6336 antagomir | Oligonucleotides | |
| HY-RI03343 | mmu-miR-6337 inhibitor | Oligonucleotides | |
| HY-RI03343A | mmu-miR-6337 antagomir | Oligonucleotides | |
| HY-RI03344 | mmu-miR-6338 inhibitor | Oligonucleotides | |
| HY-RI03344A | mmu-miR-6338 antagomir | Oligonucleotides | |
| HY-RI03345 | mmu-miR-6339 inhibitor | Oligonucleotides | |
| HY-RI03345A | mmu-miR-6339 antagomir | Oligonucleotides | |
| HY-RI03346 | mmu-miR-6340 inhibitor | Oligonucleotides | |
| HY-RI03346A | mmu-miR-6340 antagomir | Oligonucleotides | |
| HY-RI03347 | mmu-miR-6341 inhibitor | Oligonucleotides | |
| HY-RI03347A | mmu-miR-6341 antagomir | Oligonucleotides | |
| HY-RI03348 | mmu-miR-6342 inhibitor | Oligonucleotides | |
| HY-RI03348A | mmu-miR-6342 antagomir | Oligonucleotides | |
| HY-RI03349 | mmu-miR-6343 inhibitor | Oligonucleotides | |
| HY-RI03349A | mmu-miR-6343 antagomir | Oligonucleotides | |
| HY-RI03350 | mmu-miR-6344 inhibitor | Oligonucleotides | |
| HY-RI03350A | mmu-miR-6344 antagomir | Oligonucleotides | |
| HY-RI03351 | mmu-miR-6345 inhibitor | Oligonucleotides | |
| HY-RI03351A | mmu-miR-6345 antagomir | Oligonucleotides | |
| HY-RI03352 | mmu-miR-6346 inhibitor | Oligonucleotides | |
| HY-RI03352A | mmu-miR-6346 antagomir | Oligonucleotides | |
| HY-RI03353 | mmu-miR-6347 inhibitor | Oligonucleotides | |
| HY-RI03353A | mmu-miR-6347 antagomir | Oligonucleotides | |
| HY-RI03354 | mmu-miR-6348 inhibitor | Oligonucleotides | |
| HY-RI03354A | mmu-miR-6348 antagomir | Oligonucleotides | |
| HY-RI03355 | mmu-miR-6349 inhibitor | Oligonucleotides | |
| HY-RI03355A | mmu-miR-6349 antagomir | Oligonucleotides | |
| HY-RI03356 | mmu-miR-6350 inhibitor | Oligonucleotides | |
| HY-RI03356A | mmu-miR-6350 antagomir | Oligonucleotides | |
| HY-RI03357 | mmu-miR-6351 inhibitor | Oligonucleotides | |
| HY-RI03357A | mmu-miR-6351 antagomir | Oligonucleotides | |
| HY-RI03358 | mmu-miR-6352 inhibitor | Oligonucleotides | |
| HY-RI03358A | mmu-miR-6352 antagomir | Oligonucleotides | |
| HY-RI03359 | mmu-miR-6353 inhibitor | Oligonucleotides | |
| HY-RI03359A | mmu-miR-6353 antagomir | Oligonucleotides | |
| HY-RI03360 | mmu-miR-6354 inhibitor | Oligonucleotides | |
| HY-RI03360A | mmu-miR-6354 antagomir | Oligonucleotides | |
| HY-RI03361 | mmu-miR-6355 inhibitor | Oligonucleotides | |
| HY-RI03361A | mmu-miR-6355 antagomir | Oligonucleotides | |
| HY-RI03362 | mmu-miR-6356 inhibitor | Oligonucleotides | |
| HY-RI03362A | mmu-miR-6356 antagomir | Oligonucleotides | |
| HY-RI03363 | mmu-miR-6357 inhibitor | Oligonucleotides | |
| HY-RI03363A | mmu-miR-6357 antagomir | Oligonucleotides | |
| HY-RI03364 | mmu-miR-6358 inhibitor | Oligonucleotides | |
| HY-RI03364A | mmu-miR-6358 antagomir | Oligonucleotides | |
| HY-RI03365 | mmu-miR-6359 inhibitor | Oligonucleotides | |
| HY-RI03365A | mmu-miR-6359 antagomir | Oligonucleotides | |
| HY-RI03366 | mmu-miR-6360 inhibitor | Oligonucleotides | |
| HY-RI03366A | mmu-miR-6360 antagomir | Oligonucleotides | |
| HY-RI03367 | mmu-miR-6361 inhibitor | Oligonucleotides | |
| HY-RI03367A | mmu-miR-6361 antagomir | Oligonucleotides | |
| HY-RI03368 | mmu-miR-6362 inhibitor | Oligonucleotides | |
| HY-RI03368A | mmu-miR-6362 antagomir | Oligonucleotides | |
| HY-RI03369 | mmu-miR-6363 inhibitor | Oligonucleotides | |
| HY-RI03369A | mmu-miR-6363 antagomir | Oligonucleotides | |
| HY-RI03370 | mmu-miR-6364 inhibitor | Oligonucleotides | |
| HY-RI03370A | mmu-miR-6364 antagomir | Oligonucleotides | |
| HY-RI03371 | mmu-miR-6365 inhibitor | Oligonucleotides | |
| HY-RI03371A | mmu-miR-6365 antagomir | Oligonucleotides | |
| HY-RI03372 | mmu-miR-6366 inhibitor | Oligonucleotides | |
| HY-RI03372A | mmu-miR-6366 antagomir | Oligonucleotides | |
| HY-RI03373 | mmu-miR-6367 inhibitor | Oligonucleotides | |
| HY-RI03373A | mmu-miR-6367 antagomir | Oligonucleotides | |
| HY-RI03374 | mmu-miR-6368 inhibitor | Oligonucleotides | |
| HY-RI03374A | mmu-miR-6368 antagomir | Oligonucleotides | |
| HY-RI03375 | mmu-miR-6369 inhibitor | Oligonucleotides | |
| HY-RI03375A | mmu-miR-6369 antagomir | Oligonucleotides | |
| HY-RI03376 | mmu-miR-6370 inhibitor | Oligonucleotides | |
| HY-RI03376A | mmu-miR-6370 antagomir | Oligonucleotides | |
| HY-RI03377 | mmu-miR-6371 inhibitor | Oligonucleotides | |
| HY-RI03377A | mmu-miR-6371 antagomir | Oligonucleotides | |
| HY-RI03378 | mmu-miR-6372 inhibitor | Oligonucleotides | |
| HY-RI03378A | mmu-miR-6372 antagomir | Oligonucleotides | |
| HY-RI03379 | mmu-miR-6373 inhibitor | Oligonucleotides | |
| HY-RI03379A | mmu-miR-6373 antagomir | Oligonucleotides | |
| HY-RI03380 | mmu-miR-6374 inhibitor | Oligonucleotides | |
| HY-RI03380A | mmu-miR-6374 antagomir | Oligonucleotides | |
| HY-RI03381 | mmu-miR-6375 inhibitor | Oligonucleotides | |
| HY-RI03381A | mmu-miR-6375 antagomir | Oligonucleotides | |
| HY-RI03382 | mmu-miR-6376 inhibitor | Oligonucleotides | |
| HY-RI03382A | mmu-miR-6376 antagomir | Oligonucleotides | |
| HY-RI03383 | mmu-miR-6377 inhibitor | Oligonucleotides | |
| HY-RI03383A | mmu-miR-6377 antagomir | Oligonucleotides | |
| HY-RI03384 | mmu-miR-6378 inhibitor | Oligonucleotides | |
| HY-RI03384A | mmu-miR-6378 antagomir | Oligonucleotides | |
| HY-RI03385 | mmu-miR-6379 inhibitor | Oligonucleotides | |
| HY-RI03385A | mmu-miR-6379 antagomir | Oligonucleotides | |
| HY-RI03386 | mmu-miR-6380 inhibitor | Oligonucleotides | |
| HY-RI03386A | mmu-miR-6380 antagomir | Oligonucleotides | |
| HY-RI03387 | mmu-miR-6381 inhibitor | Oligonucleotides | |
| HY-RI03387A | mmu-miR-6381 antagomir | Oligonucleotides | |
| HY-RI03388 | mmu-miR-6382 inhibitor | Oligonucleotides | |
| HY-RI03388A | mmu-miR-6382 antagomir | Oligonucleotides | |
| HY-RI03389 | mmu-miR-6383 inhibitor | Oligonucleotides | |
| HY-RI03389A | mmu-miR-6383 antagomir | Oligonucleotides | |
| HY-RI03390 | mmu-miR-6384 inhibitor | Oligonucleotides | |
| HY-RI03390A | mmu-miR-6384 antagomir | Oligonucleotides | |
| HY-RI03391 | mmu-miR-6385 inhibitor | Oligonucleotides | |
| HY-RI03391A | mmu-miR-6385 antagomir | Oligonucleotides | |
| HY-RI03392 | mmu-miR-6386 inhibitor | Oligonucleotides | |
| HY-RI03392A | mmu-miR-6386 antagomir | Oligonucleotides | |
| HY-RI03393 | mmu-miR-6387 inhibitor | Oligonucleotides | |
| HY-RI03393A | mmu-miR-6387 antagomir | Oligonucleotides | |
| HY-RI03394 | mmu-miR-6388 inhibitor | Oligonucleotides | |
| HY-RI03394A | mmu-miR-6388 antagomir | Oligonucleotides | |
| HY-RI03395 | mmu-miR-6389 inhibitor | Oligonucleotides | |
| HY-RI03395A | mmu-miR-6389 antagomir | Oligonucleotides | |
| HY-RI03396 | mmu-miR-6390 inhibitor | Oligonucleotides | |
| HY-RI03396A | mmu-miR-6390 antagomir | Oligonucleotides | |
| HY-RI03397 | mmu-miR-6391 inhibitor | Oligonucleotides | |
| HY-RI03397A | mmu-miR-6391 antagomir | Oligonucleotides | |
| HY-RI03398 | mmu-miR-6392-3p inhibitor | Oligonucleotides | |
| HY-RI03398A | mmu-miR-6392-3p antagomir | Oligonucleotides | |
| HY-RI03399 | mmu-miR-6392-5p inhibitor | Oligonucleotides | |
| HY-RI03399A | mmu-miR-6392-5p antagomir | Oligonucleotides | |
| HY-RI03400 | mmu-miR-6393 inhibitor | Oligonucleotides | |
| HY-RI03400A | mmu-miR-6393 antagomir | Oligonucleotides | |
| HY-RI03401 | mmu-miR-6394 inhibitor | Oligonucleotides | |
| HY-RI03401A | mmu-miR-6394 antagomir | Oligonucleotides | |
| HY-RI03402 | mmu-miR-6395 inhibitor | Oligonucleotides | |
| HY-RI03402A | mmu-miR-6395 antagomir | Oligonucleotides | |
| HY-RI03403 | mmu-miR-6396 inhibitor | Oligonucleotides | |
| HY-RI03403A | mmu-miR-6396 antagomir | Oligonucleotides | |
| HY-RI03404 | mmu-miR-6397 inhibitor | Oligonucleotides | |
| HY-RI03404A | mmu-miR-6397 antagomir | Oligonucleotides | |
| HY-RI03405 | mmu-miR-6398 inhibitor | Oligonucleotides | |
| HY-RI03405A | mmu-miR-6398 antagomir | Oligonucleotides | |
| HY-RI03406 | mmu-miR-6399 inhibitor | Oligonucleotides | |
| HY-RI03406A | mmu-miR-6399 antagomir | Oligonucleotides | |
| HY-RI03407 | mmu-miR-6400 inhibitor | Oligonucleotides | |
| HY-RI03407A | mmu-miR-6400 antagomir | Oligonucleotides | |
| HY-RI03408 | mmu-miR-6401 inhibitor | Oligonucleotides | |
| HY-RI03408A | mmu-miR-6401 antagomir | Oligonucleotides | |
| HY-RI03409 | mmu-miR-6402 inhibitor | Oligonucleotides | |
| HY-RI03409A | mmu-miR-6402 antagomir | Oligonucleotides | |
| HY-RI03410 | mmu-miR-6403 inhibitor | Oligonucleotides | |
| HY-RI03410A | mmu-miR-6403 antagomir | Oligonucleotides | |
| HY-RI03411 | mmu-miR-6404 inhibitor | Oligonucleotides | |
| HY-RI03411A | mmu-miR-6404 antagomir | Oligonucleotides | |
| HY-RI03412 | mmu-miR-6405 inhibitor | Oligonucleotides | |
| HY-RI03412A | mmu-miR-6405 antagomir | Oligonucleotides | |
| HY-RI03413 | mmu-miR-6406 inhibitor | Oligonucleotides | |
| HY-RI03413A | mmu-miR-6406 antagomir | Oligonucleotides | |
| HY-RI03414 | mmu-miR-6407 inhibitor | Oligonucleotides | |
| HY-RI03414A | mmu-miR-6407 antagomir | Oligonucleotides | |
| HY-RI03415 | mmu-miR-6408 inhibitor | Oligonucleotides | |
| HY-RI03415A | mmu-miR-6408 antagomir | Oligonucleotides | |
| HY-RI03416 | mmu-miR-6409 inhibitor | Oligonucleotides | |
| HY-RI03416A | mmu-miR-6409 antagomir | Oligonucleotides | |
| HY-RI03417 | mmu-miR-6410 inhibitor | Oligonucleotides | |
| HY-RI03417A | mmu-miR-6410 antagomir | Oligonucleotides | |
| HY-RI03418 | mmu-miR-6411 inhibitor | Oligonucleotides | |
| HY-RI03418A | mmu-miR-6411 antagomir | Oligonucleotides | |
| HY-RI03419 | mmu-miR-6412 inhibitor | Oligonucleotides | |
| HY-RI03419A | mmu-miR-6412 antagomir | Oligonucleotides | |
| HY-RI03420 | mmu-miR-6413 inhibitor | Oligonucleotides | |
| HY-RI03420A | mmu-miR-6413 antagomir | Oligonucleotides | |
| HY-RI03421 | mmu-miR-6414 inhibitor | Oligonucleotides | |
| HY-RI03421A | mmu-miR-6414 antagomir | Oligonucleotides | |
| HY-RI03422 | mmu-miR-6415 inhibitor | Oligonucleotides | |
| HY-RI03422A | mmu-miR-6415 antagomir | Oligonucleotides | |
| HY-RI03423 | mmu-miR-6416-3p inhibitor | Oligonucleotides | |
| HY-RI03423A | mmu-miR-6416-3p antagomir | Oligonucleotides | |
| HY-RI03424 | mmu-miR-6416-5p inhibitor | Oligonucleotides | |
| HY-RI03424A | mmu-miR-6416-5p antagomir | Oligonucleotides | |
| HY-RI03425 | mmu-miR-6417 inhibitor | Oligonucleotides | |
| HY-RI03425A | mmu-miR-6417 antagomir | Oligonucleotides | |
| HY-RI03426 | mmu-miR-6418-3p inhibitor | Oligonucleotides | |
| HY-RI03426A | mmu-miR-6418-3p antagomir | Oligonucleotides | |
| HY-RI03427 | mmu-miR-6418-5p inhibitor | Oligonucleotides | |
| HY-RI03427A | mmu-miR-6418-5p antagomir | Oligonucleotides | |
| HY-RI03428 | mmu-miR-6419 inhibitor | Oligonucleotides | |
| HY-RI03428A | mmu-miR-6419 antagomir | Oligonucleotides | |
| HY-RI03429 | mmu-miR-6420 inhibitor | Oligonucleotides | |
| HY-RI03429A | mmu-miR-6420 antagomir | Oligonucleotides | |
| HY-RI03430 | mmu-miR-6481 inhibitor | Oligonucleotides | |
| HY-RI03430A | mmu-miR-6481 antagomir | Oligonucleotides | |
| HY-RI03431 | mmu-miR-6516-3p inhibitor | Oligonucleotides | |
| HY-RI03431A | mmu-miR-6516-3p antagomir | Oligonucleotides | |
| HY-RI03432 | mmu-miR-6516-5p inhibitor | Oligonucleotides | |
| HY-RI03432A | mmu-miR-6516-5p antagomir | Oligonucleotides | |
| HY-RI03433 | mmu-miR-652-5p inhibitor | Oligonucleotides | |
| HY-RI03433A | mmu-miR-652-5p antagomir | Oligonucleotides | |
| HY-RI03434 | mmu-miR-653-3p inhibitor | Oligonucleotides | |
| HY-RI03434A | mmu-miR-653-3p antagomir | Oligonucleotides | |
| HY-RI03435 | mmu-miR-6537-3p inhibitor | Oligonucleotides | |
| HY-RI03435A | mmu-miR-6537-3p antagomir | Oligonucleotides | |
| HY-RI03436 | mmu-miR-6537-5p inhibitor | Oligonucleotides | |
| HY-RI03436A | mmu-miR-6537-5p antagomir | Oligonucleotides | |
| HY-RI03437 | mmu-miR-6538 inhibitor | Oligonucleotides | |
| HY-RI03437A | mmu-miR-6538 antagomir | Oligonucleotides | |
| HY-RI03438 | mmu-miR-6539 inhibitor | Oligonucleotides | |
| HY-RI03438A | mmu-miR-6539 antagomir | Oligonucleotides | |
| HY-RI03439 | mmu-miR-6540-3p inhibitor | Oligonucleotides | |
| HY-RI03439A | mmu-miR-6540-3p antagomir | Oligonucleotides | |
| HY-RI03440 | mmu-miR-6540-5p inhibitor | Oligonucleotides | |
| HY-RI03440A | mmu-miR-6540-5p antagomir | Oligonucleotides | |
| HY-RI03441 | mmu-miR-6541 inhibitor | Oligonucleotides | |
| HY-RI03441A | mmu-miR-6541 antagomir | Oligonucleotides | |
| HY-RI03442 | mmu-miR-654-5p inhibitor | Oligonucleotides | |
| HY-RI03442A | mmu-miR-654-5p antagomir | Oligonucleotides | |
| HY-RI03443 | mmu-miR-6546-3p inhibitor | Oligonucleotides | |
| HY-RI03443A | mmu-miR-6546-3p antagomir | Oligonucleotides | |
| HY-RI03444 | mmu-miR-6546-5p inhibitor | Oligonucleotides | |
| HY-RI03444A | mmu-miR-6546-5p antagomir | Oligonucleotides | |
| HY-RI03445 | mmu-miR-664-3p inhibitor | Oligonucleotides | |
| HY-RI03445A | mmu-miR-664-3p antagomir | Oligonucleotides | |
| HY-RI03446 | mmu-miR-664-5p inhibitor | Oligonucleotides | |
| HY-RI03446A | mmu-miR-664-5p antagomir | Oligonucleotides | |
| HY-RI03447 | mmu-miR-665-3p inhibitor | Oligonucleotides | |
| HY-RI03447A | mmu-miR-665-3p antagomir | Oligonucleotides | |
| HY-RI03448 | mmu-miR-665-5p inhibitor | Oligonucleotides | |
| HY-RI03448A | mmu-miR-665-5p antagomir | Oligonucleotides | |
| HY-RI03449 | mmu-miR-666-3p inhibitor | Oligonucleotides | |
| HY-RI03449A | mmu-miR-666-3p antagomir | Oligonucleotides | |
| HY-RI03450 | mmu-miR-666-5p inhibitor | Oligonucleotides | |
| HY-RI03450A | mmu-miR-666-5p antagomir | Oligonucleotides | |
| HY-RI03451 | mmu-miR-667-3p inhibitor | Oligonucleotides | |
| HY-RI03451A | mmu-miR-667-3p antagomir | Oligonucleotides | |
| HY-RI03452 | mmu-miR-667-5p inhibitor | Oligonucleotides | |
| HY-RI03452A | mmu-miR-667-5p antagomir | Oligonucleotides | |
| HY-RI03453 | mmu-miR-668-3p inhibitor | Oligonucleotides | |
| HY-RI03453A | mmu-miR-668-3p antagomir | Oligonucleotides | |
| HY-RI03454 | mmu-miR-668-5p inhibitor | Oligonucleotides | |
| HY-RI03454A | mmu-miR-668-5p antagomir | Oligonucleotides | |
| HY-RI03455 | mmu-miR-669a-3-3p inhibitor | Oligonucleotides | |
| HY-RI03455A | mmu-miR-669a-3-3p antagomir | Oligonucleotides | |
| HY-RI03456 | mmu-miR-669a-3p inhibitor | Oligonucleotides | |
| HY-RI03456A | mmu-miR-669a-3p antagomir | Oligonucleotides | |
| HY-RI03457 | mmu-miR-669a-5p inhibitor | Oligonucleotides | |
| HY-RI03457A | mmu-miR-669a-5p antagomir | Oligonucleotides | |
| HY-RI03458 | mmu-miR-669b-3p inhibitor | Oligonucleotides | |
| HY-RI03458A | mmu-miR-669b-3p antagomir | Oligonucleotides | |
| HY-RI03459 | mmu-miR-669b-5p inhibitor | Oligonucleotides | |
| HY-RI03459A | mmu-miR-669b-5p antagomir | Oligonucleotides | |
| HY-RI03460 | mmu-miR-669c-3p inhibitor | Oligonucleotides | |
| HY-RI03460A | mmu-miR-669c-3p antagomir | Oligonucleotides | |
| HY-RI03461 | mmu-miR-669c-5p inhibitor | Oligonucleotides | |
| HY-RI03461A | mmu-miR-669c-5p antagomir | Oligonucleotides | |
| HY-RI03462 | mmu-miR-669d-2-3p inhibitor | Oligonucleotides | |
| HY-RI03462A | mmu-miR-669d-2-3p antagomir | Oligonucleotides | |
| HY-RI03463 | mmu-miR-669d-3p inhibitor | Oligonucleotides | |
| HY-RI03463A | mmu-miR-669d-3p antagomir | Oligonucleotides | |
| HY-RI03464 | mmu-miR-669d-5p inhibitor | Oligonucleotides | |
| HY-RI03464A | mmu-miR-669d-5p antagomir | Oligonucleotides | |
| HY-RI03465 | mmu-miR-669e-3p inhibitor | Oligonucleotides | |
| HY-RI03465A | mmu-miR-669e-3p antagomir | Oligonucleotides | |
| HY-RI03466 | mmu-miR-669e-5p inhibitor | Oligonucleotides | |
| HY-RI03466A | mmu-miR-669e-5p antagomir | Oligonucleotides | |
| HY-RI03467 | mmu-miR-669f-3p inhibitor | Oligonucleotides | |
| HY-RI03467A | mmu-miR-669f-3p antagomir | Oligonucleotides | |
| HY-RI03468 | mmu-miR-669f-5p inhibitor | Oligonucleotides | |
| HY-RI03468A | mmu-miR-669f-5p antagomir | Oligonucleotides | |
| HY-RI03469 | mmu-miR-669g inhibitor | Oligonucleotides | |
| HY-RI03469A | mmu-miR-669g antagomir | Oligonucleotides | |
| HY-RI03470 | mmu-miR-669h-3p inhibitor | Oligonucleotides | |
| HY-RI03470A | mmu-miR-669h-3p antagomir | Oligonucleotides | |
| HY-RI03471 | mmu-miR-669h-5p inhibitor | Oligonucleotides | |
| HY-RI03471A | mmu-miR-669h-5p antagomir | Oligonucleotides | |
| HY-RI03472 | mmu-miR-669i inhibitor | Oligonucleotides | |
| HY-RI03472A | mmu-miR-669i antagomir | Oligonucleotides | |
| HY-RI03473 | mmu-miR-669j inhibitor | Oligonucleotides | |
| HY-RI03473A | mmu-miR-669j antagomir | Oligonucleotides | |
| HY-RI03474 | mmu-miR-669k-3p inhibitor | Oligonucleotides | |
| HY-RI03474A | mmu-miR-669k-3p antagomir | Oligonucleotides | |
| HY-RI03475 | mmu-miR-669k-5p inhibitor | Oligonucleotides | |
| HY-RI03475A | mmu-miR-669k-5p antagomir | Oligonucleotides | |
| HY-RI03476 | mmu-miR-669l-3p inhibitor | Oligonucleotides | |
| HY-RI03476A | mmu-miR-669l-3p antagomir | Oligonucleotides | |
| HY-RI03477 | mmu-miR-669l-5p inhibitor | Oligonucleotides | |
| HY-RI03477A | mmu-miR-669l-5p antagomir | Oligonucleotides | |
| HY-RI03478 | mmu-miR-669m-3p inhibitor | Oligonucleotides | |
| HY-RI03478A | mmu-miR-669m-3p antagomir | Oligonucleotides | |
| HY-RI03479 | mmu-miR-669n inhibitor | Oligonucleotides | |
| HY-RI03479A | mmu-miR-669n antagomir | Oligonucleotides | |
| HY-RI03480 | mmu-miR-669o-5p inhibitor | Oligonucleotides | |
| HY-RI03480A | mmu-miR-669o-5p antagomir | Oligonucleotides | |
| HY-RI03481 | mmu-miR-669p-3p inhibitor | Oligonucleotides | |
| HY-RI03481A | mmu-miR-669p-3p antagomir | Oligonucleotides | |
| HY-RI03482 | mmu-miR-670-3p inhibitor | Oligonucleotides | |
| HY-RI03482A | mmu-miR-670-3p antagomir | Oligonucleotides | |
| HY-RI03483 | mmu-miR-670-5p inhibitor | Oligonucleotides | |
| HY-RI03483A | mmu-miR-670-5p antagomir | Oligonucleotides | |
| HY-RI03484 | mmu-miR-6715-3p inhibitor | Oligonucleotides | |
| HY-RI03484A | mmu-miR-6715-3p antagomir | Oligonucleotides | |
| HY-RI03485 | mmu-miR-6715-5p inhibitor | Oligonucleotides | |
| HY-RI03485A | mmu-miR-6715-5p antagomir | Oligonucleotides | |
| HY-RI03486 | mmu-miR-672-3p inhibitor | Oligonucleotides | |
| HY-RI03486A | mmu-miR-672-3p antagomir | Oligonucleotides | |
| HY-RI03487 | mmu-miR-672-5p inhibitor | Oligonucleotides | |
| HY-RI03487A | mmu-miR-672-5p antagomir | Oligonucleotides | |
| HY-RI03488 | mmu-miR-673-3p inhibitor | Oligonucleotides | |
| HY-RI03488A | mmu-miR-673-3p antagomir | Oligonucleotides | |
| HY-RI03489 | mmu-miR-673-5p inhibitor | Oligonucleotides | |
| HY-RI03489A | mmu-miR-673-5p antagomir | Oligonucleotides | |
| HY-RI03490 | mmu-miR-674-3p inhibitor | Oligonucleotides | |
| HY-RI03490A | mmu-miR-674-3p antagomir | Oligonucleotides | |
| HY-RI03491 | mmu-miR-674-5p inhibitor | Oligonucleotides | |
| HY-RI03491A | mmu-miR-674-5p antagomir | Oligonucleotides | |
| HY-RI03492 | mmu-miR-675-3p inhibitor | Oligonucleotides | |
| HY-RI03492A | mmu-miR-675-3p antagomir | Oligonucleotides | |
| HY-RI03493 | mmu-miR-675-5p inhibitor | Oligonucleotides | |
| HY-RI03493A | mmu-miR-675-5p antagomir | Oligonucleotides | |
| HY-RI03494 | mmu-miR-676-3p inhibitor | Oligonucleotides | |
| HY-RI03494A | mmu-miR-676-3p antagomir | Oligonucleotides | |
| HY-RI03495 | mmu-miR-676-5p inhibitor | Oligonucleotides | |
| HY-RI03495A | mmu-miR-676-5p antagomir | Oligonucleotides | |
| HY-RI03496 | mmu-miR-6769b-3p inhibitor | Oligonucleotides | |
| HY-RI03496A | mmu-miR-6769b-3p antagomir | Oligonucleotides | |
| HY-RI03497 | mmu-miR-6769b-5p inhibitor | Oligonucleotides | |
| HY-RI03497A | mmu-miR-6769b-5p antagomir | Oligonucleotides | |
| HY-RI03498 | mmu-miR-677-3p inhibitor | Oligonucleotides | |
| HY-RI03498A | mmu-miR-677-3p antagomir | Oligonucleotides | |
| HY-RI03499 | mmu-miR-677-5p inhibitor | Oligonucleotides | |
| HY-RI03499A | mmu-miR-677-5p antagomir | Oligonucleotides | |
| HY-RI03500 | mmu-miR-678 inhibitor | Oligonucleotides | |
| HY-RI03500A | mmu-miR-678 antagomir | Oligonucleotides | |
| HY-RI03501 | mmu-miR-679-3p inhibitor | Oligonucleotides | |
| HY-RI03501A | mmu-miR-679-3p antagomir | Oligonucleotides | |
| HY-RI03502 | mmu-miR-679-5p inhibitor | Oligonucleotides | |
| HY-RI03502A | mmu-miR-679-5p antagomir | Oligonucleotides | |
| HY-RI03503 | mmu-miR-680 inhibitor | Oligonucleotides | |
| HY-RI03503A | mmu-miR-680 antagomir | Oligonucleotides | |
| HY-RI03504 | mmu-miR-681 inhibitor | Oligonucleotides | |
| HY-RI03504A | mmu-miR-681 antagomir | Oligonucleotides | |
| HY-RI03505 | mmu-miR-682 inhibitor | Oligonucleotides | |
| HY-RI03505A | mmu-miR-682 antagomir | Oligonucleotides | |
| HY-RI03506 | mmu-miR-683 inhibitor | Oligonucleotides | |
| HY-RI03506A | mmu-miR-683 antagomir | Oligonucleotides | |
| HY-RI03507 | mmu-miR-684 inhibitor | Oligonucleotides | |
| HY-RI03507A | mmu-miR-684 antagomir | Oligonucleotides | |
| HY-RI03508 | mmu-miR-686 inhibitor | Oligonucleotides | |
| HY-RI03508A | mmu-miR-686 antagomir | Oligonucleotides | |
| HY-RI03509 | mmu-miR-687 inhibitor | Oligonucleotides | |
| HY-RI03509A | mmu-miR-687 antagomir | Oligonucleotides | |
| HY-RI03510 | mmu-miR-688 inhibitor | Oligonucleotides | |
| HY-RI03510A | mmu-miR-688 antagomir | Oligonucleotides | |
| HY-RI03511 | mmu-miR-6896-3p inhibitor | Oligonucleotides | |
| HY-RI03511A | mmu-miR-6896-3p antagomir | Oligonucleotides | |
| HY-RI03512 | mmu-miR-6896-5p inhibitor | Oligonucleotides | |
| HY-RI03512A | mmu-miR-6896-5p antagomir | Oligonucleotides | |
| HY-RI03513 | mmu-miR-6897-3p inhibitor | Oligonucleotides | |
| HY-RI03513A | mmu-miR-6897-3p antagomir | Oligonucleotides | |
| HY-RI03514 | mmu-miR-6897-5p inhibitor | Oligonucleotides | |
| HY-RI03514A | mmu-miR-6897-5p antagomir | Oligonucleotides | |
| HY-RI03515 | mmu-miR-6898-3p inhibitor | Oligonucleotides | |
| HY-RI03515A | mmu-miR-6898-3p antagomir | Oligonucleotides | |
| HY-RI03516 | mmu-miR-6898-5p inhibitor | Oligonucleotides | |
| HY-RI03516A | mmu-miR-6898-5p antagomir | Oligonucleotides | |
| HY-RI03517 | mmu-miR-6899-3p inhibitor | Oligonucleotides | |
| HY-RI03517A | mmu-miR-6899-3p antagomir | Oligonucleotides | |
| HY-RI03518 | mmu-miR-6899-5p inhibitor | Oligonucleotides | |
| HY-RI03518A | mmu-miR-6899-5p antagomir | Oligonucleotides | |
| HY-RI03519 | mmu-miR-690 inhibitor | Oligonucleotides | |
| HY-RI03519A | mmu-miR-690 antagomir | Oligonucleotides | |
| HY-RI03520 | mmu-miR-6900-3p inhibitor | Oligonucleotides | |
| HY-RI03520A | mmu-miR-6900-3p antagomir | Oligonucleotides | |
| HY-RI03521 | mmu-miR-6900-5p inhibitor | Oligonucleotides | |
| HY-RI03521A | mmu-miR-6900-5p antagomir | Oligonucleotides | |
| HY-RI03522 | mmu-miR-6901-3p inhibitor | Oligonucleotides | |
| HY-RI03522A | mmu-miR-6901-3p antagomir | Oligonucleotides | |
| HY-RI03523 | mmu-miR-6901-5p inhibitor | Oligonucleotides | |
| HY-RI03523A | mmu-miR-6901-5p antagomir | Oligonucleotides | |
| HY-RI03524 | mmu-miR-6902-3p inhibitor | Oligonucleotides | |
| HY-RI03524A | mmu-miR-6902-3p antagomir | Oligonucleotides | |
| HY-RI03525 | mmu-miR-6902-5p inhibitor | Oligonucleotides | |
| HY-RI03525A | mmu-miR-6902-5p antagomir | Oligonucleotides | |
| HY-RI03526 | mmu-miR-6903-3p inhibitor | Oligonucleotides | |
| HY-RI03526A | mmu-miR-6903-3p antagomir | Oligonucleotides | |
| HY-RI03527 | mmu-miR-6903-5p inhibitor | Oligonucleotides | |
| HY-RI03527A | mmu-miR-6903-5p antagomir | Oligonucleotides | |
| HY-RI03528 | mmu-miR-6904-3p inhibitor | Oligonucleotides | |
| HY-RI03528A | mmu-miR-6904-3p antagomir | Oligonucleotides | |
| HY-RI03529 | mmu-miR-6904-5p inhibitor | Oligonucleotides | |
| HY-RI03529A | mmu-miR-6904-5p antagomir | Oligonucleotides | |
| HY-RI03530 | mmu-miR-6905-3p inhibitor | Oligonucleotides | |
| HY-RI03530A | mmu-miR-6905-3p antagomir | Oligonucleotides | |
| HY-RI03531 | mmu-miR-6905-5p inhibitor | Oligonucleotides | |
| HY-RI03531A | mmu-miR-6905-5p antagomir | Oligonucleotides | |
| HY-RI03532 | mmu-miR-6906-3p inhibitor | Oligonucleotides | |
| HY-RI03532A | mmu-miR-6906-3p antagomir | Oligonucleotides | |
| HY-RI03533 | mmu-miR-6906-5p inhibitor | Oligonucleotides | |
| HY-RI03533A | mmu-miR-6906-5p antagomir | Oligonucleotides | |
| HY-RI03534 | mmu-miR-6907-3p inhibitor | Oligonucleotides | |
| HY-RI03534A | mmu-miR-6907-3p antagomir | Oligonucleotides | |
| HY-RI03535 | mmu-miR-6907-5p inhibitor | Oligonucleotides | |
| HY-RI03535A | mmu-miR-6907-5p antagomir | Oligonucleotides | |
| HY-RI03536 | mmu-miR-6908-3p inhibitor | Oligonucleotides | |
| HY-RI03536A | mmu-miR-6908-3p antagomir | Oligonucleotides | |
| HY-RI03537 | mmu-miR-6908-5p inhibitor | Oligonucleotides | |
| HY-RI03537A | mmu-miR-6908-5p antagomir | Oligonucleotides | |
| HY-RI03538 | mmu-miR-6909-3p inhibitor | Oligonucleotides | |
| HY-RI03538A | mmu-miR-6909-3p antagomir | Oligonucleotides | |
| HY-RI03539 | mmu-miR-6909-5p inhibitor | Oligonucleotides | |
| HY-RI03539A | mmu-miR-6909-5p antagomir | Oligonucleotides | |
| HY-RI03540 | mmu-miR-691 inhibitor | Oligonucleotides | |
| HY-RI03540A | mmu-miR-691 antagomir | Oligonucleotides | |
| HY-RI03541 | mmu-miR-6910-3p inhibitor | Oligonucleotides | |
| HY-RI03541A | mmu-miR-6910-3p antagomir | Oligonucleotides | |
| HY-RI03542 | mmu-miR-6910-5p inhibitor | Oligonucleotides | |
| HY-RI03542A | mmu-miR-6910-5p antagomir | Oligonucleotides | |
| HY-RI03543 | mmu-miR-6911-3p inhibitor | Oligonucleotides | |
| HY-RI03543A | mmu-miR-6911-3p antagomir | Oligonucleotides | |
| HY-RI03544 | mmu-miR-6911-5p inhibitor | Oligonucleotides | |
| HY-RI03544A | mmu-miR-6911-5p antagomir | Oligonucleotides | |
| HY-RI03545 | mmu-miR-6912-3p inhibitor | Oligonucleotides | |
| HY-RI03545A | mmu-miR-6912-3p antagomir | Oligonucleotides | |
| HY-RI03546 | mmu-miR-6912-5p inhibitor | Oligonucleotides | |
| HY-RI03546A | mmu-miR-6912-5p antagomir | Oligonucleotides | |
| HY-RI03547 | mmu-miR-6913-3p inhibitor | Oligonucleotides | |
| HY-RI03547A | mmu-miR-6913-3p antagomir | Oligonucleotides | |
| HY-RI03548 | mmu-miR-6913-5p inhibitor | Oligonucleotides | |
| HY-RI03548A | mmu-miR-6913-5p antagomir | Oligonucleotides | |
| HY-RI03549 | mmu-miR-6914-3p inhibitor | Oligonucleotides | |
| HY-RI03549A | mmu-miR-6914-3p antagomir | Oligonucleotides | |
| HY-RI03550 | mmu-miR-6914-5p inhibitor | Oligonucleotides | |
| HY-RI03550A | mmu-miR-6914-5p antagomir | Oligonucleotides | |
| HY-RI03551 | mmu-miR-6915-3p inhibitor | Oligonucleotides | |
| HY-RI03551A | mmu-miR-6915-3p antagomir | Oligonucleotides | |
| HY-RI03552 | mmu-miR-6915-5p inhibitor | Oligonucleotides | |
| HY-RI03552A | mmu-miR-6915-5p antagomir | Oligonucleotides | |
| HY-RI03553 | mmu-miR-6916-3p inhibitor | Oligonucleotides | |
| HY-RI03553A | mmu-miR-6916-3p antagomir | Oligonucleotides | |
| HY-RI03554 | mmu-miR-6916-5p inhibitor | Oligonucleotides | |
| HY-RI03554A | mmu-miR-6916-5p antagomir | Oligonucleotides | |
| HY-RI03555 | mmu-miR-6917-3p inhibitor | Oligonucleotides | |
| HY-RI03555A | mmu-miR-6917-3p antagomir | Oligonucleotides | |
| HY-RI03556 | mmu-miR-6917-5p inhibitor | Oligonucleotides | |
| HY-RI03556A | mmu-miR-6917-5p antagomir | Oligonucleotides | |
| HY-RI03557 | mmu-miR-6918-3p inhibitor | Oligonucleotides | |
| HY-RI03557A | mmu-miR-6918-3p antagomir | Oligonucleotides | |
| HY-RI03558 | mmu-miR-6918-5p inhibitor | Oligonucleotides | |
| HY-RI03558A | mmu-miR-6918-5p antagomir | Oligonucleotides | |
| HY-RI03559 | mmu-miR-6919-3p inhibitor | Oligonucleotides | |
| HY-RI03559A | mmu-miR-6919-3p antagomir | Oligonucleotides | |
| HY-RI03560 | mmu-miR-6919-5p inhibitor | Oligonucleotides | |
| HY-RI03560A | mmu-miR-6919-5p antagomir | Oligonucleotides | |
| HY-RI03561 | mmu-miR-692 inhibitor | Oligonucleotides | |
| HY-RI03561A | mmu-miR-692 antagomir | Oligonucleotides | |
| HY-RI03562 | mmu-miR-6920-3p inhibitor | Oligonucleotides | |
| HY-RI03562A | mmu-miR-6920-3p antagomir | Oligonucleotides | |
| HY-RI03563 | mmu-miR-6920-5p inhibitor | Oligonucleotides | |
| HY-RI03563A | mmu-miR-6920-5p antagomir | Oligonucleotides | |
| HY-RI03564 | mmu-miR-6921-3p inhibitor | Oligonucleotides | |
| HY-RI03564A | mmu-miR-6921-3p antagomir | Oligonucleotides | |
| HY-RI03565 | mmu-miR-6921-5p inhibitor | Oligonucleotides | |
| HY-RI03565A | mmu-miR-6921-5p antagomir | Oligonucleotides | |
| HY-RI03566 | mmu-miR-6922-3p inhibitor | Oligonucleotides | |
| HY-RI03566A | mmu-miR-6922-3p antagomir | Oligonucleotides | |
| HY-RI03567 | mmu-miR-6922-5p inhibitor | Oligonucleotides | |
| HY-RI03567A | mmu-miR-6922-5p antagomir | Oligonucleotides | |
| HY-RI03568 | mmu-miR-6923-3p inhibitor | Oligonucleotides | |
| HY-RI03568A | mmu-miR-6923-3p antagomir | Oligonucleotides | |
| HY-RI03569 | mmu-miR-6923-5p inhibitor | Oligonucleotides | |
| HY-RI03569A | mmu-miR-6923-5p antagomir | Oligonucleotides | |
| HY-RI03570 | mmu-miR-6924-3p inhibitor | Oligonucleotides | |
| HY-RI03570A | mmu-miR-6924-3p antagomir | Oligonucleotides | |
| HY-RI03571 | mmu-miR-6924-5p inhibitor | Oligonucleotides | |
| HY-RI03571A | mmu-miR-6924-5p antagomir | Oligonucleotides | |
| HY-RI03572 | mmu-miR-6925-3p inhibitor | Oligonucleotides | |
| HY-RI03572A | mmu-miR-6925-3p antagomir | Oligonucleotides | |
| HY-RI03573 | mmu-miR-6925-5p inhibitor | Oligonucleotides | |
| HY-RI03573A | mmu-miR-6925-5p antagomir | Oligonucleotides | |
| HY-RI03574 | mmu-miR-6926-3p inhibitor | Oligonucleotides | |
| HY-RI03574A | mmu-miR-6926-3p antagomir | Oligonucleotides | |
| HY-RI03575 | mmu-miR-6926-5p inhibitor | Oligonucleotides | |
| HY-RI03575A | mmu-miR-6926-5p antagomir | Oligonucleotides | |
| HY-RI03576 | mmu-miR-6927-3p inhibitor | Oligonucleotides | |
| HY-RI03576A | mmu-miR-6927-3p antagomir | Oligonucleotides | |
| HY-RI03577 | mmu-miR-6927-5p inhibitor | Oligonucleotides | |
| HY-RI03577A | mmu-miR-6927-5p antagomir | Oligonucleotides | |
| HY-RI03578 | mmu-miR-6928-3p inhibitor | Oligonucleotides | |
| HY-RI03578A | mmu-miR-6928-3p antagomir | Oligonucleotides | |
| HY-RI03579 | mmu-miR-6928-5p inhibitor | Oligonucleotides | |
| HY-RI03579A | mmu-miR-6928-5p antagomir | Oligonucleotides | |
| HY-RI03580 | mmu-miR-6929-3p inhibitor | Oligonucleotides | |
| HY-RI03580A | mmu-miR-6929-3p antagomir | Oligonucleotides | |
| HY-RI03581 | mmu-miR-6929-5p inhibitor | Oligonucleotides | |
| HY-RI03581A | mmu-miR-6929-5p antagomir | Oligonucleotides | |
| HY-RI03582 | mmu-miR-6930-3p inhibitor | Oligonucleotides | |
| HY-RI03582A | mmu-miR-6930-3p antagomir | Oligonucleotides | |
| HY-RI03583 | mmu-miR-6930-5p inhibitor | Oligonucleotides | |
| HY-RI03583A | mmu-miR-6930-5p antagomir | Oligonucleotides | |
| HY-RI03584 | mmu-miR-6931-3p inhibitor | Oligonucleotides | |
| HY-RI03584A | mmu-miR-6931-3p antagomir | Oligonucleotides | |
| HY-RI03585 | mmu-miR-6931-5p inhibitor | Oligonucleotides | |
| HY-RI03585A | mmu-miR-6931-5p antagomir | Oligonucleotides | |
| HY-RI03586 | mmu-miR-6932-3p inhibitor | Oligonucleotides | |
| HY-RI03586A | mmu-miR-6932-3p antagomir | Oligonucleotides | |
| HY-RI03587 | mmu-miR-6932-5p inhibitor | Oligonucleotides | |
| HY-RI03587A | mmu-miR-6932-5p antagomir | Oligonucleotides | |
| HY-RI03588 | mmu-miR-6933-3p inhibitor | Oligonucleotides | |
| HY-RI03588A | mmu-miR-6933-3p antagomir | Oligonucleotides | |
| HY-RI03589 | mmu-miR-6933-5p inhibitor | Oligonucleotides | |
| HY-RI03589A | mmu-miR-6933-5p antagomir | Oligonucleotides | |
| HY-RI03590 | mmu-miR-693-3p inhibitor | Oligonucleotides | |
| HY-RI03590A | mmu-miR-693-3p antagomir | Oligonucleotides | |
| HY-RI03591 | mmu-miR-6934-3p inhibitor | Oligonucleotides | |
| HY-RI03591A | mmu-miR-6934-3p antagomir | Oligonucleotides | |
| HY-RI03592 | mmu-miR-6934-5p inhibitor | Oligonucleotides | |
| HY-RI03592A | mmu-miR-6934-5p antagomir | Oligonucleotides | |
| HY-RI03593 | mmu-miR-6935-3p inhibitor | Oligonucleotides | |
| HY-RI03593A | mmu-miR-6935-3p antagomir | Oligonucleotides | |
| HY-RI03594 | mmu-miR-6935-5p inhibitor | Oligonucleotides | |
| HY-RI03594A | mmu-miR-6935-5p antagomir | Oligonucleotides | |
| HY-RI03595 | mmu-miR-693-5p inhibitor | Oligonucleotides | |
| HY-RI03595A | mmu-miR-693-5p antagomir | Oligonucleotides | |
| HY-RI03596 | mmu-miR-6936-3p inhibitor | Oligonucleotides | |
| HY-RI03596A | mmu-miR-6936-3p antagomir | Oligonucleotides | |
| HY-RI03597 | mmu-miR-6936-5p inhibitor | Oligonucleotides | |
| HY-RI03597A | mmu-miR-6936-5p antagomir | Oligonucleotides | |
| HY-RI03598 | mmu-miR-6937-3p inhibitor | Oligonucleotides | |
| HY-RI03598A | mmu-miR-6937-3p antagomir | Oligonucleotides | |
| HY-RI03599 | mmu-miR-6937-5p inhibitor | Oligonucleotides | |
| HY-RI03599A | mmu-miR-6937-5p antagomir | Oligonucleotides | |
| HY-RI03600 | mmu-miR-6938-3p inhibitor | Oligonucleotides | |
| HY-RI03600A | mmu-miR-6938-3p antagomir | Oligonucleotides | |
| HY-RI03601 | mmu-miR-6938-5p inhibitor | Oligonucleotides | |
| HY-RI03601A | mmu-miR-6938-5p antagomir | Oligonucleotides | |
| HY-RI03602 | mmu-miR-6939-3p inhibitor | Oligonucleotides | |
| HY-RI03602A | mmu-miR-6939-3p antagomir | Oligonucleotides | |
| HY-RI03603 | mmu-miR-6939-5p inhibitor | Oligonucleotides | |
| HY-RI03603A | mmu-miR-6939-5p antagomir | Oligonucleotides | |
| HY-RI03604 | mmu-miR-694 inhibitor | Oligonucleotides | |
| HY-RI03604A | mmu-miR-694 antagomir | Oligonucleotides | |
| HY-RI03605 | mmu-miR-6940-3p inhibitor | Oligonucleotides | |
| HY-RI03605A | mmu-miR-6940-3p antagomir | Oligonucleotides | |
| HY-RI03606 | mmu-miR-6940-5p inhibitor | Oligonucleotides | |
| HY-RI03606A | mmu-miR-6940-5p antagomir | Oligonucleotides | |
| HY-RI03607 | mmu-miR-6941-3p inhibitor | Oligonucleotides | |
| HY-RI03607A | mmu-miR-6941-3p antagomir | Oligonucleotides | |
| HY-RI03608 | mmu-miR-6941-5p inhibitor | Oligonucleotides | |
| HY-RI03608A | mmu-miR-6941-5p antagomir | Oligonucleotides | |
| HY-RI03609 | mmu-miR-6942-3p inhibitor | Oligonucleotides | |
| HY-RI03609A | mmu-miR-6942-3p antagomir | Oligonucleotides | |
| HY-RI03610 | mmu-miR-6942-5p inhibitor | Oligonucleotides | |
| HY-RI03610A | mmu-miR-6942-5p antagomir | Oligonucleotides | |
| HY-RI03611 | mmu-miR-6943-3p inhibitor | Oligonucleotides | |
| HY-RI03611A | mmu-miR-6943-3p antagomir | Oligonucleotides | |
| HY-RI03612 | mmu-miR-6943-5p inhibitor | Oligonucleotides | |
| HY-RI03612A | mmu-miR-6943-5p antagomir | Oligonucleotides | |
| HY-RI03613 | mmu-miR-6944-3p inhibitor | Oligonucleotides | |
| HY-RI03613A | mmu-miR-6944-3p antagomir | Oligonucleotides | |
| HY-RI03614 | mmu-miR-6944-5p inhibitor | Oligonucleotides | |
| HY-RI03614A | mmu-miR-6944-5p antagomir | Oligonucleotides | |
| HY-RI03615 | mmu-miR-6945-3p inhibitor | Oligonucleotides | |
| HY-RI03615A | mmu-miR-6945-3p antagomir | Oligonucleotides | |
| HY-RI03616 | mmu-miR-6945-5p inhibitor | Oligonucleotides | |
| HY-RI03616A | mmu-miR-6945-5p antagomir | Oligonucleotides | |
| HY-RI03617 | mmu-miR-6946-3p inhibitor | Oligonucleotides | |
| HY-RI03617A | mmu-miR-6946-3p antagomir | Oligonucleotides | |
| HY-RI03618 | mmu-miR-6946-5p inhibitor | Oligonucleotides | |
| HY-RI03618A | mmu-miR-6946-5p antagomir | Oligonucleotides | |
| HY-RI03619 | mmu-miR-6947-3p inhibitor | Oligonucleotides | |
| HY-RI03619A | mmu-miR-6947-3p antagomir | Oligonucleotides | |
| HY-RI03620 | mmu-miR-6947-5p inhibitor | Oligonucleotides | |
| HY-RI03620A | mmu-miR-6947-5p antagomir | Oligonucleotides | |
| HY-RI03621 | mmu-miR-6948-3p inhibitor | Oligonucleotides | |
| HY-RI03621A | mmu-miR-6948-3p antagomir | Oligonucleotides | |
| HY-RI03622 | mmu-miR-6948-5p inhibitor | Oligonucleotides | |
| HY-RI03622A | mmu-miR-6948-5p antagomir | Oligonucleotides | |
| HY-RI03623 | mmu-miR-6949-3p inhibitor | Oligonucleotides | |
| HY-RI03623A | mmu-miR-6949-3p antagomir | Oligonucleotides | |
| HY-RI03624 | mmu-miR-6949-5p inhibitor | Oligonucleotides | |
| HY-RI03624A | mmu-miR-6949-5p antagomir | Oligonucleotides | |
| HY-RI03625 | mmu-miR-695 inhibitor | Oligonucleotides | |
| HY-RI03625A | mmu-miR-695 antagomir | Oligonucleotides | |
| HY-RI03626 | mmu-miR-6950-3p inhibitor | Oligonucleotides | |
| HY-RI03626A | mmu-miR-6950-3p antagomir | Oligonucleotides | |
| HY-RI03627 | mmu-miR-6950-5p inhibitor | Oligonucleotides | |
| HY-RI03627A | mmu-miR-6950-5p antagomir | Oligonucleotides | |
| HY-RI03628 | mmu-miR-6951-3p inhibitor | Oligonucleotides | |
| HY-RI03628A | mmu-miR-6951-3p antagomir | Oligonucleotides | |
| HY-RI03629 | mmu-miR-6951-5p inhibitor | Oligonucleotides | |
| HY-RI03629A | mmu-miR-6951-5p antagomir | Oligonucleotides | |
| HY-RI03630 | mmu-miR-6952-3p inhibitor | Oligonucleotides | |
| HY-RI03630A | mmu-miR-6952-3p antagomir | Oligonucleotides | |
| HY-RI03631 | mmu-miR-6952-5p inhibitor | Oligonucleotides | |
| HY-RI03631A | mmu-miR-6952-5p antagomir | Oligonucleotides | |
| HY-RI03632 | mmu-miR-6953-3p inhibitor | Oligonucleotides | |
| HY-RI03632A | mmu-miR-6953-3p antagomir | Oligonucleotides | |
| HY-RI03633 | mmu-miR-6953-5p inhibitor | Oligonucleotides | |
| HY-RI03633A | mmu-miR-6953-5p antagomir | Oligonucleotides | |
| HY-RI03634 | mmu-miR-6954-3p inhibitor | Oligonucleotides | |
| HY-RI03634A | mmu-miR-6954-3p antagomir | Oligonucleotides | |
| HY-RI03635 | mmu-miR-6954-5p inhibitor | Oligonucleotides | |
| HY-RI03635A | mmu-miR-6954-5p antagomir | Oligonucleotides | |
| HY-RI03636 | mmu-miR-6955-3p inhibitor | Oligonucleotides | |
| HY-RI03636A | mmu-miR-6955-3p antagomir | Oligonucleotides | |
| HY-RI03637 | mmu-miR-6955-5p inhibitor | Oligonucleotides | |
| HY-RI03637A | mmu-miR-6955-5p antagomir | Oligonucleotides | |
| HY-RI03638 | mmu-miR-6956-3p inhibitor | Oligonucleotides | |
| HY-RI03638A | mmu-miR-6956-3p antagomir | Oligonucleotides | |
| HY-RI03639 | mmu-miR-6956-5p inhibitor | Oligonucleotides | |
| HY-RI03639A | mmu-miR-6956-5p antagomir | Oligonucleotides | |
| HY-RI03640 | mmu-miR-6957-3p inhibitor | Oligonucleotides | |
| HY-RI03640A | mmu-miR-6957-3p antagomir | Oligonucleotides | |
| HY-RI03641 | mmu-miR-6957-5p inhibitor | Oligonucleotides | |
| HY-RI03641A | mmu-miR-6957-5p antagomir | Oligonucleotides | |
| HY-RI03642 | mmu-miR-6958-3p inhibitor | Oligonucleotides | |
| HY-RI03642A | mmu-miR-6958-3p antagomir | Oligonucleotides | |
| HY-RI03643 | mmu-miR-6958-5p inhibitor | Oligonucleotides | |
| HY-RI03643A | mmu-miR-6958-5p antagomir | Oligonucleotides | |
| HY-RI03644 | mmu-miR-6959-3p inhibitor | Oligonucleotides | |
| HY-RI03644A | mmu-miR-6959-3p antagomir | Oligonucleotides | |
| HY-RI03645 | mmu-miR-6959-5p inhibitor | Oligonucleotides | |
| HY-RI03645A | mmu-miR-6959-5p antagomir | Oligonucleotides | |
| HY-RI03646 | mmu-miR-696 inhibitor | Oligonucleotides | |
| HY-RI03646A | mmu-miR-696 antagomir | Oligonucleotides | |
| HY-RI03647 | mmu-miR-6960-3p inhibitor | Oligonucleotides | |
| HY-RI03647A | mmu-miR-6960-3p antagomir | Oligonucleotides | |
| HY-RI03648 | mmu-miR-6960-5p inhibitor | Oligonucleotides | |
| HY-RI03648A | mmu-miR-6960-5p antagomir | Oligonucleotides | |
| HY-RI03649 | mmu-miR-6961-3p inhibitor | Oligonucleotides | |
| HY-RI03649A | mmu-miR-6961-3p antagomir | Oligonucleotides | |
| HY-RI03650 | mmu-miR-6961-5p inhibitor | Oligonucleotides | |
| HY-RI03650A | mmu-miR-6961-5p antagomir | Oligonucleotides | |
| HY-RI03651 | mmu-miR-6962-3p inhibitor | Oligonucleotides | |
| HY-RI03651A | mmu-miR-6962-3p antagomir | Oligonucleotides | |
| HY-RI03652 | mmu-miR-6962-5p inhibitor | Oligonucleotides | |
| HY-RI03652A | mmu-miR-6962-5p antagomir | Oligonucleotides | |
| HY-RI03653 | mmu-miR-6963-3p inhibitor | Oligonucleotides | |
| HY-RI03653A | mmu-miR-6963-3p antagomir | Oligonucleotides | |
| HY-RI03654 | mmu-miR-6963-5p inhibitor | Oligonucleotides | |
| HY-RI03654A | mmu-miR-6963-5p antagomir | Oligonucleotides | |
| HY-RI03655 | mmu-miR-6964-3p inhibitor | Oligonucleotides | |
| HY-RI03655A | mmu-miR-6964-3p antagomir | Oligonucleotides | |
| HY-RI03656 | mmu-miR-6964-5p inhibitor | Oligonucleotides | |
| HY-RI03656A | mmu-miR-6964-5p antagomir | Oligonucleotides | |
| HY-RI03657 | mmu-miR-6965-3p inhibitor | Oligonucleotides | |
| HY-RI03657A | mmu-miR-6965-3p antagomir | Oligonucleotides | |
| HY-RI03658 | mmu-miR-6965-5p inhibitor | Oligonucleotides | |
| HY-RI03658A | mmu-miR-6965-5p antagomir | Oligonucleotides | |
| HY-RI03659 | mmu-miR-6966-3p inhibitor | Oligonucleotides | |
| HY-RI03659A | mmu-miR-6966-3p antagomir | Oligonucleotides | |
| HY-RI03660 | mmu-miR-6966-5p inhibitor | Oligonucleotides | |
| HY-RI03660A | mmu-miR-6966-5p antagomir | Oligonucleotides | |
| HY-RI03661 | mmu-miR-6967-3p inhibitor | Oligonucleotides | |
| HY-RI03661A | mmu-miR-6967-3p antagomir | Oligonucleotides | |
| HY-RI03662 | mmu-miR-6967-5p inhibitor | Oligonucleotides | |
| HY-RI03662A | mmu-miR-6967-5p antagomir | Oligonucleotides | |
| HY-RI03663 | mmu-miR-6968-3p inhibitor | Oligonucleotides | |
| HY-RI03663A | mmu-miR-6968-3p antagomir | Oligonucleotides | |
| HY-RI03664 | mmu-miR-6968-5p inhibitor | Oligonucleotides | |
| HY-RI03664A | mmu-miR-6968-5p antagomir | Oligonucleotides | |
| HY-RI03665 | mmu-miR-6969-3p inhibitor | Oligonucleotides | |
| HY-RI03665A | mmu-miR-6969-3p antagomir | Oligonucleotides | |
| HY-RI03666 | mmu-miR-6969-5p inhibitor | Oligonucleotides | |
| HY-RI03666A | mmu-miR-6969-5p antagomir | Oligonucleotides | |
| HY-RI03667 | mmu-miR-697 inhibitor | Oligonucleotides | |
| HY-RI03667A | mmu-miR-697 antagomir | Oligonucleotides | |
| HY-RI03668 | mmu-miR-6970-3p inhibitor | Oligonucleotides | |
| HY-RI03668A | mmu-miR-6970-3p antagomir | Oligonucleotides | |
| HY-RI03669 | mmu-miR-6970-5p inhibitor | Oligonucleotides | |
| HY-RI03669A | mmu-miR-6970-5p antagomir | Oligonucleotides | |
| HY-RI03670 | mmu-miR-6971-3p inhibitor | Oligonucleotides | |
| HY-RI03670A | mmu-miR-6971-3p antagomir | Oligonucleotides | |
| HY-RI03671 | mmu-miR-6971-5p inhibitor | Oligonucleotides | |
| HY-RI03671A | mmu-miR-6971-5p antagomir | Oligonucleotides | |
| HY-RI03672 | mmu-miR-6972-3p inhibitor | Oligonucleotides | |
| HY-RI03672A | mmu-miR-6972-3p antagomir | Oligonucleotides | |
| HY-RI03673 | mmu-miR-6972-5p inhibitor | Oligonucleotides | |
| HY-RI03673A | mmu-miR-6972-5p antagomir | Oligonucleotides | |
| HY-RI03674 | mmu-miR-6973a-3p inhibitor | Oligonucleotides | |
| HY-RI03674A | mmu-miR-6973a-3p antagomir | Oligonucleotides | |
| HY-RI03675 | mmu-miR-6973a-5p inhibitor | Oligonucleotides | |
| HY-RI03675A | mmu-miR-6973a-5p antagomir | Oligonucleotides | |
| HY-RI03676 | mmu-miR-6973b-3p inhibitor | Oligonucleotides | |
| HY-RI03676A | mmu-miR-6973b-3p antagomir | Oligonucleotides | |
| HY-RI03677 | mmu-miR-6973b-5p inhibitor | Oligonucleotides | |
| HY-RI03677A | mmu-miR-6973b-5p antagomir | Oligonucleotides | |
| HY-RI03678 | mmu-miR-6974-3p inhibitor | Oligonucleotides | |
| HY-RI03678A | mmu-miR-6974-3p antagomir | Oligonucleotides | |
| HY-RI03679 | mmu-miR-6974-5p inhibitor | Oligonucleotides | |
| HY-RI03679A | mmu-miR-6974-5p antagomir | Oligonucleotides | |
| HY-RI03680 | mmu-miR-6975-3p inhibitor | Oligonucleotides | |
| HY-RI03680A | mmu-miR-6975-3p antagomir | Oligonucleotides | |
| HY-RI03681 | mmu-miR-6975-5p inhibitor | Oligonucleotides | |
| HY-RI03681A | mmu-miR-6975-5p antagomir | Oligonucleotides | |
| HY-RI03682 | mmu-miR-6976-3p inhibitor | Oligonucleotides | |
| HY-RI03682A | mmu-miR-6976-3p antagomir | Oligonucleotides | |
| HY-RI03683 | mmu-miR-6976-5p inhibitor | Oligonucleotides | |
| HY-RI03683A | mmu-miR-6976-5p antagomir | Oligonucleotides | |
| HY-RI03684 | mmu-miR-6977-3p inhibitor | Oligonucleotides | |
| HY-RI03684A | mmu-miR-6977-3p antagomir | Oligonucleotides | |
| HY-RI03685 | mmu-miR-6977-5p inhibitor | Oligonucleotides | |
| HY-RI03685A | mmu-miR-6977-5p antagomir | Oligonucleotides | |
| HY-RI03686 | mmu-miR-6978-3p inhibitor | Oligonucleotides | |
| HY-RI03686A | mmu-miR-6978-3p antagomir | Oligonucleotides | |
| HY-RI03687 | mmu-miR-6978-5p inhibitor | Oligonucleotides | |
| HY-RI03687A | mmu-miR-6978-5p antagomir | Oligonucleotides | |
| HY-RI03688 | mmu-miR-6979-3p inhibitor | Oligonucleotides | |
| HY-RI03688A | mmu-miR-6979-3p antagomir | Oligonucleotides | |
| HY-RI03689 | mmu-miR-6979-5p inhibitor | Oligonucleotides | |
| HY-RI03689A | mmu-miR-6979-5p antagomir | Oligonucleotides | |
| HY-RI03690 | mmu-miR-6980-3p inhibitor | Oligonucleotides | |
| HY-RI03690A | mmu-miR-6980-3p antagomir | Oligonucleotides | |
| HY-RI03691 | mmu-miR-6980-5p inhibitor | Oligonucleotides | |
| HY-RI03691A | mmu-miR-6980-5p antagomir | Oligonucleotides | |
| HY-RI03692 | mmu-miR-6981-3p inhibitor | Oligonucleotides | |
| HY-RI03692A | mmu-miR-6981-3p antagomir | Oligonucleotides | |
| HY-RI03693 | mmu-miR-6981-5p inhibitor | Oligonucleotides | |
| HY-RI03693A | mmu-miR-6981-5p antagomir | Oligonucleotides | |
| HY-RI03694 | mmu-miR-6982-3p inhibitor | Oligonucleotides | |
| HY-RI03694A | mmu-miR-6982-3p antagomir | Oligonucleotides | |
| HY-RI03695 | mmu-miR-6982-5p inhibitor | Oligonucleotides | |
| HY-RI03695A | mmu-miR-6982-5p antagomir | Oligonucleotides | |
| HY-RI03696 | mmu-miR-6983-3p inhibitor | Oligonucleotides | |
| HY-RI03696A | mmu-miR-6983-3p antagomir | Oligonucleotides | |
| HY-RI03697 | mmu-miR-6983-5p inhibitor | Oligonucleotides | |
| HY-RI03697A | mmu-miR-6983-5p antagomir | Oligonucleotides | |
| HY-RI03698 | mmu-miR-698-3p inhibitor | Oligonucleotides | |
| HY-RI03698A | mmu-miR-698-3p antagomir | Oligonucleotides | |
| HY-RI03699 | mmu-miR-6984-3p inhibitor | Oligonucleotides | |
| HY-RI03699A | mmu-miR-6984-3p antagomir | Oligonucleotides | |
| HY-RI03700 | mmu-miR-6984-5p inhibitor | Oligonucleotides | |
| HY-RI03700A | mmu-miR-6984-5p antagomir | Oligonucleotides | |
| HY-RI03701 | mmu-miR-6985-3p inhibitor | Oligonucleotides | |
| HY-RI03701A | mmu-miR-6985-3p antagomir | Oligonucleotides | |
| HY-RI03702 | mmu-miR-6985-5p inhibitor | Oligonucleotides | |
| HY-RI03702A | mmu-miR-6985-5p antagomir | Oligonucleotides | |
| HY-RI03703 | mmu-miR-698-5p inhibitor | Oligonucleotides | |
| HY-RI03703A | mmu-miR-698-5p antagomir | Oligonucleotides | |
| HY-RI03704 | mmu-miR-6986-3p inhibitor | Oligonucleotides | |
| HY-RI03704A | mmu-miR-6986-3p antagomir | Oligonucleotides | |
| HY-RI03705 | mmu-miR-6986-5p inhibitor | Oligonucleotides | |
| HY-RI03705A | mmu-miR-6986-5p antagomir | Oligonucleotides | |
| HY-RI03706 | mmu-miR-6987-3p inhibitor | Oligonucleotides | |
| HY-RI03706A | mmu-miR-6987-3p antagomir | Oligonucleotides | |
| HY-RI03707 | mmu-miR-6987-5p inhibitor | Oligonucleotides | |
| HY-RI03707A | mmu-miR-6987-5p antagomir | Oligonucleotides | |
| HY-RI03708 | mmu-miR-6988-3p inhibitor | Oligonucleotides | |
| HY-RI03708A | mmu-miR-6988-3p antagomir | Oligonucleotides | |
| HY-RI03709 | mmu-miR-6988-5p inhibitor | Oligonucleotides | |
| HY-RI03709A | mmu-miR-6988-5p antagomir | Oligonucleotides | |
| HY-RI03710 | mmu-miR-6989-3p inhibitor | Oligonucleotides | |
| HY-RI03710A | mmu-miR-6989-3p antagomir | Oligonucleotides | |
| HY-RI03711 | mmu-miR-6989-5p inhibitor | Oligonucleotides | |
| HY-RI03711A | mmu-miR-6989-5p antagomir | Oligonucleotides | |
| HY-RI03712 | mmu-miR-6990-3p inhibitor | Oligonucleotides | |
| HY-RI03712A | mmu-miR-6990-3p antagomir | Oligonucleotides | |
| HY-RI03713 | mmu-miR-6990-5p inhibitor | Oligonucleotides | |
| HY-RI03713A | mmu-miR-6990-5p antagomir | Oligonucleotides | |
| HY-RI03714 | mmu-miR-6991-3p inhibitor | Oligonucleotides | |
| HY-RI03714A | mmu-miR-6991-3p antagomir | Oligonucleotides | |
| HY-RI03715 | mmu-miR-6991-5p inhibitor | Oligonucleotides | |
| HY-RI03715A | mmu-miR-6991-5p antagomir | Oligonucleotides | |
| HY-RI03716 | mmu-miR-6992-3p inhibitor | Oligonucleotides | |
| HY-RI03716A | mmu-miR-6992-3p antagomir | Oligonucleotides | |
| HY-RI03717 | mmu-miR-6992-5p inhibitor | Oligonucleotides | |
| HY-RI03717A | mmu-miR-6992-5p antagomir | Oligonucleotides | |
| HY-RI03718 | mmu-miR-6993-3p inhibitor | Oligonucleotides | |
| HY-RI03718A | mmu-miR-6993-3p antagomir | Oligonucleotides | |
| HY-RI03719 | mmu-miR-6993-5p inhibitor | Oligonucleotides | |
| HY-RI03719A | mmu-miR-6993-5p antagomir | Oligonucleotides | |
| HY-RI03720 | mmu-miR-6994-3p inhibitor | Oligonucleotides | |
| HY-RI03720A | mmu-miR-6994-3p antagomir | Oligonucleotides | |
| HY-RI03721 | mmu-miR-6994-5p inhibitor | Oligonucleotides | |
| HY-RI03721A | mmu-miR-6994-5p antagomir | Oligonucleotides | |
| HY-RI03722 | mmu-miR-6995-3p inhibitor | Oligonucleotides | |
| HY-RI03722A | mmu-miR-6995-3p antagomir | Oligonucleotides | |
| HY-RI03723 | mmu-miR-6995-5p inhibitor | Oligonucleotides | |
| HY-RI03723A | mmu-miR-6995-5p antagomir | Oligonucleotides | |
| HY-RI03724 | mmu-miR-6996-3p inhibitor | Oligonucleotides | |
| HY-RI03724A | mmu-miR-6996-3p antagomir | Oligonucleotides | |
| HY-RI03725 | mmu-miR-6996-5p inhibitor | Oligonucleotides | |
| HY-RI03725A | mmu-miR-6996-5p antagomir | Oligonucleotides | |
| HY-RI03726 | mmu-miR-6997-3p inhibitor | Oligonucleotides | |
| HY-RI03726A | mmu-miR-6997-3p antagomir | Oligonucleotides | |
| HY-RI03727 | mmu-miR-6997-5p inhibitor | Oligonucleotides | |
| HY-RI03727A | mmu-miR-6997-5p antagomir | Oligonucleotides | |
| HY-RI03728 | mmu-miR-6998-3p inhibitor | Oligonucleotides | |
| HY-RI03728A | mmu-miR-6998-3p antagomir | Oligonucleotides | |
| HY-RI03729 | mmu-miR-6998-5p inhibitor | Oligonucleotides | |
| HY-RI03729A | mmu-miR-6998-5p antagomir | Oligonucleotides | |
| HY-RI03730 | mmu-miR-6999-3p inhibitor | Oligonucleotides | |
| HY-RI03730A | mmu-miR-6999-3p antagomir | Oligonucleotides | |
| HY-RI03731 | mmu-miR-6999-5p inhibitor | Oligonucleotides | |
| HY-RI03731A | mmu-miR-6999-5p antagomir | Oligonucleotides | |
| HY-RI03732 | mmu-miR-7000-3p inhibitor | Oligonucleotides | |
| HY-RI03732A | mmu-miR-7000-3p antagomir | Oligonucleotides | |
| HY-RI03733 | mmu-miR-7000-5p inhibitor | Oligonucleotides | |
| HY-RI03733A | mmu-miR-7000-5p antagomir | Oligonucleotides | |
| HY-RI03734 | mmu-miR-7001-3p inhibitor | Oligonucleotides | |
| HY-RI03734A | mmu-miR-7001-3p antagomir | Oligonucleotides | |
| HY-RI03735 | mmu-miR-7001-5p inhibitor | Oligonucleotides | |
| HY-RI03735A | mmu-miR-7001-5p antagomir | Oligonucleotides | |
| HY-RI03736 | mmu-miR-7002-3p inhibitor | Oligonucleotides | |
| HY-RI03736A | mmu-miR-7002-3p antagomir | Oligonucleotides | |
| HY-RI03737 | mmu-miR-7002-5p inhibitor | Oligonucleotides | |
| HY-RI03737A | mmu-miR-7002-5p antagomir | Oligonucleotides | |
| HY-RI03738 | mmu-miR-7003-3p inhibitor | Oligonucleotides | |
| HY-RI03738A | mmu-miR-7003-3p antagomir | Oligonucleotides | |
| HY-RI03739 | mmu-miR-7003-5p inhibitor | Oligonucleotides | |
| HY-RI03739A | mmu-miR-7003-5p antagomir | Oligonucleotides | |
| HY-RI03740 | mmu-miR-700-3p inhibitor | Oligonucleotides | |
| HY-RI03740A | mmu-miR-700-3p antagomir | Oligonucleotides | |
| HY-RI03741 | mmu-miR-7004-3p inhibitor | Oligonucleotides | |
| HY-RI03741A | mmu-miR-7004-3p antagomir | Oligonucleotides | |
| HY-RI03742 | mmu-miR-7004-5p inhibitor | Oligonucleotides | |
| HY-RI03742A | mmu-miR-7004-5p antagomir | Oligonucleotides | |
| HY-RI03743 | mmu-miR-7005-3p inhibitor | Oligonucleotides | |
| HY-RI03743A | mmu-miR-7005-3p antagomir | Oligonucleotides | |
| HY-RI03744 | mmu-miR-7005-5p inhibitor | Oligonucleotides | |
| HY-RI03744A | mmu-miR-7005-5p antagomir | Oligonucleotides | |
| HY-RI03745 | mmu-miR-700-5p inhibitor | Oligonucleotides | |
| HY-RI03745A | mmu-miR-700-5p antagomir | Oligonucleotides | |
| HY-RI03746 | mmu-miR-7006-3p inhibitor | Oligonucleotides | |
| HY-RI03746A | mmu-miR-7006-3p antagomir | Oligonucleotides | |
| HY-RI03747 | mmu-miR-7006-5p inhibitor | Oligonucleotides | |
| HY-RI03747A | mmu-miR-7006-5p antagomir | Oligonucleotides | |
| HY-RI03748 | mmu-miR-7007-3p inhibitor | Oligonucleotides | |
| HY-RI03748A | mmu-miR-7007-3p antagomir | Oligonucleotides | |
| HY-RI03749 | mmu-miR-7007-5p inhibitor | Oligonucleotides | |
| HY-RI03749A | mmu-miR-7007-5p antagomir | Oligonucleotides | |
| HY-RI03750 | mmu-miR-7008-3p inhibitor | Oligonucleotides | |
| HY-RI03750A | mmu-miR-7008-3p antagomir | Oligonucleotides | |
| HY-RI03751 | mmu-miR-7008-5p inhibitor | Oligonucleotides | |
| HY-RI03751A | mmu-miR-7008-5p antagomir | Oligonucleotides | |
| HY-RI03752 | mmu-miR-7009-3p inhibitor | Oligonucleotides | |
| HY-RI03752A | mmu-miR-7009-3p antagomir | Oligonucleotides | |
| HY-RI03753 | mmu-miR-7009-5p inhibitor | Oligonucleotides | |
| HY-RI03753A | mmu-miR-7009-5p antagomir | Oligonucleotides | |
| HY-RI03754 | mmu-miR-7010-3p inhibitor | Oligonucleotides | |
| HY-RI03754A | mmu-miR-7010-3p antagomir | Oligonucleotides | |
| HY-RI03755 | mmu-miR-7010-5p inhibitor | Oligonucleotides | |
| HY-RI03755A | mmu-miR-7010-5p antagomir | Oligonucleotides | |
| HY-RI03756 | mmu-miR-7011-3p inhibitor | Oligonucleotides | |
| HY-RI03756A | mmu-miR-7011-3p antagomir | Oligonucleotides | |
| HY-RI03757 | mmu-miR-7011-5p inhibitor | Oligonucleotides | |
| HY-RI03757A | mmu-miR-7011-5p antagomir | Oligonucleotides | |
| HY-RI03758 | mmu-miR-7012-3p inhibitor | Oligonucleotides | |
| HY-RI03758A | mmu-miR-7012-3p antagomir | Oligonucleotides | |
| HY-RI03759 | mmu-miR-7012-5p inhibitor | Oligonucleotides | |
| HY-RI03759A | mmu-miR-7012-5p antagomir | Oligonucleotides | |
| HY-RI03760 | mmu-miR-7013-3p inhibitor | Oligonucleotides | |
| HY-RI03760A | mmu-miR-7013-3p antagomir | Oligonucleotides | |
| HY-RI03761 | mmu-miR-7013-5p inhibitor | Oligonucleotides | |
| HY-RI03761A | mmu-miR-7013-5p antagomir | Oligonucleotides | |
| HY-RI03762 | mmu-miR-701-3p inhibitor | Oligonucleotides | |
| HY-RI03762A | mmu-miR-701-3p antagomir | Oligonucleotides | |
| HY-RI03763 | mmu-miR-7014-3p inhibitor | Oligonucleotides | |
| HY-RI03763A | mmu-miR-7014-3p antagomir | Oligonucleotides | |
| HY-RI03764 | mmu-miR-7014-5p inhibitor | Oligonucleotides | |
| HY-RI03764A | mmu-miR-7014-5p antagomir | Oligonucleotides | |
| HY-RI03765 | mmu-miR-7015-3p inhibitor | Oligonucleotides | |
| HY-RI03765A | mmu-miR-7015-3p antagomir | Oligonucleotides | |
| HY-RI03766 | mmu-miR-7015-5p inhibitor | Oligonucleotides | |
| HY-RI03766A | mmu-miR-7015-5p antagomir | Oligonucleotides | |
| HY-RI03767 | mmu-miR-701-5p inhibitor | Oligonucleotides | |
| HY-RI03767A | mmu-miR-701-5p antagomir | Oligonucleotides | |
| HY-RI03768 | mmu-miR-7016-3p inhibitor | Oligonucleotides | |
| HY-RI03768A | mmu-miR-7016-3p antagomir | Oligonucleotides | |
| HY-RI03769 | mmu-miR-7016-5p inhibitor | Oligonucleotides | |
| HY-RI03769A | mmu-miR-7016-5p antagomir | Oligonucleotides | |
| HY-RI03770 | mmu-miR-7017-3p inhibitor | Oligonucleotides | |
| HY-RI03770A | mmu-miR-7017-3p antagomir | Oligonucleotides | |
| HY-RI03771 | mmu-miR-7017-5p inhibitor | Oligonucleotides | |
| HY-RI03771A | mmu-miR-7017-5p antagomir | Oligonucleotides | |
| HY-RI03772 | mmu-miR-7018-3p inhibitor | Oligonucleotides | |
| HY-RI03772A | mmu-miR-7018-3p antagomir | Oligonucleotides | |
| HY-RI03773 | mmu-miR-7018-5p inhibitor | Oligonucleotides | |
| HY-RI03773A | mmu-miR-7018-5p antagomir | Oligonucleotides | |
| HY-RI03774 | mmu-miR-7019-3p inhibitor | Oligonucleotides | |
| HY-RI03774A | mmu-miR-7019-3p antagomir | Oligonucleotides | |
| HY-RI03775 | mmu-miR-7019-5p inhibitor | Oligonucleotides | |
| HY-RI03775A | mmu-miR-7019-5p antagomir | Oligonucleotides | |
| HY-RI03776 | mmu-miR-7020-3p inhibitor | Oligonucleotides | |
| HY-RI03776A | mmu-miR-7020-3p antagomir | Oligonucleotides | |
| HY-RI03777 | mmu-miR-7020-5p inhibitor | Oligonucleotides | |
| HY-RI03777A | mmu-miR-7020-5p antagomir | Oligonucleotides | |
| HY-RI03778 | mmu-miR-7021-3p inhibitor | Oligonucleotides | |
| HY-RI03778A | mmu-miR-7021-3p antagomir | Oligonucleotides | |
| HY-RI03779 | mmu-miR-7021-5p inhibitor | Oligonucleotides | |
| HY-RI03779A | mmu-miR-7021-5p antagomir | Oligonucleotides | |
| HY-RI03780 | mmu-miR-7022-3p inhibitor | Oligonucleotides | |
| HY-RI03780A | mmu-miR-7022-3p antagomir | Oligonucleotides | |
| HY-RI03781 | mmu-miR-7022-5p inhibitor | Oligonucleotides | |
| HY-RI03781A | mmu-miR-7022-5p antagomir | Oligonucleotides | |
| HY-RI03782 | mmu-miR-7023-3p inhibitor | Oligonucleotides | |
| HY-RI03782A | mmu-miR-7023-3p antagomir | Oligonucleotides | |
| HY-RI03783 | mmu-miR-7023-5p inhibitor | Oligonucleotides | |
| HY-RI03783A | mmu-miR-7023-5p antagomir | Oligonucleotides | |
| HY-RI03784 | mmu-miR-702-3p inhibitor | Oligonucleotides | |
| HY-RI03784A | mmu-miR-702-3p antagomir | Oligonucleotides | |
| HY-RI03785 | mmu-miR-7024-3p inhibitor | Oligonucleotides | |
| HY-RI03785A | mmu-miR-7024-3p antagomir | Oligonucleotides | |
| HY-RI03786 | mmu-miR-7024-5p inhibitor | Oligonucleotides | |
| HY-RI03786A | mmu-miR-7024-5p antagomir | Oligonucleotides | |
| HY-RI03787 | mmu-miR-7025-3p inhibitor | Oligonucleotides | |
| HY-RI03787A | mmu-miR-7025-3p antagomir | Oligonucleotides | |
| HY-RI03788 | mmu-miR-7025-5p inhibitor | Oligonucleotides | |
| HY-RI03788A | mmu-miR-7025-5p antagomir | Oligonucleotides | |
| HY-RI03789 | mmu-miR-702-5p inhibitor | Oligonucleotides | |
| HY-RI03789A | mmu-miR-702-5p antagomir | Oligonucleotides | |
| HY-RI03790 | mmu-miR-7026-3p inhibitor | Oligonucleotides | |
| HY-RI03790A | mmu-miR-7026-3p antagomir | Oligonucleotides | |
| HY-RI03791 | mmu-miR-7026-5p inhibitor | Oligonucleotides | |
| HY-RI03791A | mmu-miR-7026-5p antagomir | Oligonucleotides | |
| HY-RI03792 | mmu-miR-7027-3p inhibitor | Oligonucleotides | |
| HY-RI03792A | mmu-miR-7027-3p antagomir | Oligonucleotides | |
| HY-RI03793 | mmu-miR-7027-5p inhibitor | Oligonucleotides | |
| HY-RI03793A | mmu-miR-7027-5p antagomir | Oligonucleotides | |
| HY-RI03794 | mmu-miR-7028-3p inhibitor | Oligonucleotides | |
| HY-RI03794A | mmu-miR-7028-3p antagomir | Oligonucleotides | |
| HY-RI03795 | mmu-miR-7028-5p inhibitor | Oligonucleotides | |
| HY-RI03795A | mmu-miR-7028-5p antagomir | Oligonucleotides | |
| HY-RI03796 | mmu-miR-7029-3p inhibitor | Oligonucleotides | |
| HY-RI03796A | mmu-miR-7029-3p antagomir | Oligonucleotides | |
| HY-RI03797 | mmu-miR-7029-5p inhibitor | Oligonucleotides | |
| HY-RI03797A | mmu-miR-7029-5p antagomir | Oligonucleotides | |
| HY-RI03798 | mmu-miR-703 inhibitor | Oligonucleotides | |
| HY-RI03798A | mmu-miR-703 antagomir | Oligonucleotides | |
| HY-RI03799 | mmu-miR-7030-3p inhibitor | Oligonucleotides | |
| HY-RI03799A | mmu-miR-7030-3p antagomir | Oligonucleotides | |
| HY-RI03800 | mmu-miR-7030-5p inhibitor | Oligonucleotides | |
| HY-RI03800A | mmu-miR-7030-5p antagomir | Oligonucleotides | |
| HY-RI03801 | mmu-miR-7031-3p inhibitor | Oligonucleotides | |
| HY-RI03801A | mmu-miR-7031-3p antagomir | Oligonucleotides | |
| HY-RI03802 | mmu-miR-7031-5p inhibitor | Oligonucleotides | |
| HY-RI03802A | mmu-miR-7031-5p antagomir | Oligonucleotides | |
| HY-RI03803 | mmu-miR-7032-3p inhibitor | Oligonucleotides | |
| HY-RI03803A | mmu-miR-7032-3p antagomir | Oligonucleotides | |
| HY-RI03804 | mmu-miR-7032-5p inhibitor | Oligonucleotides | |
| HY-RI03804A | mmu-miR-7032-5p antagomir | Oligonucleotides | |
| HY-RI03805 | mmu-miR-7033-3p inhibitor | Oligonucleotides | |
| HY-RI03805A | mmu-miR-7033-3p antagomir | Oligonucleotides | |
| HY-RI03806 | mmu-miR-7033-5p inhibitor | Oligonucleotides | |
| HY-RI03806A | mmu-miR-7033-5p antagomir | Oligonucleotides | |
| HY-RI03807 | mmu-miR-7034-3p inhibitor | Oligonucleotides | |
| HY-RI03807A | mmu-miR-7034-3p antagomir | Oligonucleotides | |
| HY-RI03808 | mmu-miR-7034-5p inhibitor | Oligonucleotides | |
| HY-RI03808A | mmu-miR-7034-5p antagomir | Oligonucleotides | |
| HY-RI03809 | mmu-miR-7035-3p inhibitor | Oligonucleotides | |
| HY-RI03809A | mmu-miR-7035-3p antagomir | Oligonucleotides | |
| HY-RI03810 | mmu-miR-7035-5p inhibitor | Oligonucleotides | |
| HY-RI03810A | mmu-miR-7035-5p antagomir | Oligonucleotides | |
| HY-RI03811 | mmu-miR-7036a-3p inhibitor | Oligonucleotides | |
| HY-RI03811A | mmu-miR-7036a-3p antagomir | Oligonucleotides | |
| HY-RI03812 | mmu-miR-7036a-5p inhibitor | Oligonucleotides | |
| HY-RI03812A | mmu-miR-7036a-5p antagomir | Oligonucleotides | |
| HY-RI03813 | mmu-miR-7036b-3p inhibitor | Oligonucleotides | |
| HY-RI03813A | mmu-miR-7036b-3p antagomir | Oligonucleotides | |
| HY-RI03814 | mmu-miR-7036b-5p inhibitor | Oligonucleotides | |
| HY-RI03814A | mmu-miR-7036b-5p antagomir | Oligonucleotides | |
| HY-RI03815 | mmu-miR-7037-3p inhibitor | Oligonucleotides | |
| HY-RI03815A | mmu-miR-7037-3p antagomir | Oligonucleotides | |
| HY-RI03816 | mmu-miR-7037-5p inhibitor | Oligonucleotides | |
| HY-RI03816A | mmu-miR-7037-5p antagomir | Oligonucleotides | |
| HY-RI03817 | mmu-miR-7038-3p inhibitor | Oligonucleotides | |
| HY-RI03817A | mmu-miR-7038-3p antagomir | Oligonucleotides | |
| HY-RI03818 | mmu-miR-7038-5p inhibitor | Oligonucleotides | |
| HY-RI03818A | mmu-miR-7038-5p antagomir | Oligonucleotides | |
| HY-RI03819 | mmu-miR-7039-3p inhibitor | Oligonucleotides | |
| HY-RI03819A | mmu-miR-7039-3p antagomir | Oligonucleotides | |
| HY-RI03820 | mmu-miR-7039-5p inhibitor | Oligonucleotides | |
| HY-RI03820A | mmu-miR-7039-5p antagomir | Oligonucleotides | |
| HY-RI03821 | mmu-miR-704 inhibitor | Oligonucleotides | |
| HY-RI03821A | mmu-miR-704 antagomir | Oligonucleotides | |
| HY-RI03822 | mmu-miR-7040-3p inhibitor | Oligonucleotides | |
| HY-RI03822A | mmu-miR-7040-3p antagomir | Oligonucleotides | |
| HY-RI03823 | mmu-miR-7040-5p inhibitor | Oligonucleotides | |
| HY-RI03823A | mmu-miR-7040-5p antagomir | Oligonucleotides | |
| HY-RI03824 | mmu-miR-7041-3p inhibitor | Oligonucleotides | |
| HY-RI03824A | mmu-miR-7041-3p antagomir | Oligonucleotides | |
| HY-RI03825 | mmu-miR-7041-5p inhibitor | Oligonucleotides | |
| HY-RI03825A | mmu-miR-7041-5p antagomir | Oligonucleotides | |
| HY-RI03826 | mmu-miR-7042-3p inhibitor | Oligonucleotides | |
| HY-RI03826A | mmu-miR-7042-3p antagomir | Oligonucleotides | |
| HY-RI03827 | mmu-miR-7042-5p inhibitor | Oligonucleotides | |
| HY-RI03827A | mmu-miR-7042-5p antagomir | Oligonucleotides | |
| HY-RI03828 | mmu-miR-7043-3p inhibitor | Oligonucleotides | |
| HY-RI03828A | mmu-miR-7043-3p antagomir | Oligonucleotides | |
| HY-RI03829 | mmu-miR-7043-5p inhibitor | Oligonucleotides | |
| HY-RI03829A | mmu-miR-7043-5p antagomir | Oligonucleotides | |
| HY-RI03830 | mmu-miR-7044-3p inhibitor | Oligonucleotides | |
| HY-RI03830A | mmu-miR-7044-3p antagomir | Oligonucleotides | |
| HY-RI03831 | mmu-miR-7044-5p inhibitor | Oligonucleotides | |
| HY-RI03831A | mmu-miR-7044-5p antagomir | Oligonucleotides | |
| HY-RI03832 | mmu-miR-7045-3p inhibitor | Oligonucleotides | |
| HY-RI03832A | mmu-miR-7045-3p antagomir | Oligonucleotides | |
| HY-RI03833 | mmu-miR-7045-5p inhibitor | Oligonucleotides | |
| HY-RI03833A | mmu-miR-7045-5p antagomir | Oligonucleotides | |
| HY-RI03834 | mmu-miR-7046-3p inhibitor | Oligonucleotides | |
| HY-RI03834A | mmu-miR-7046-3p antagomir | Oligonucleotides | |
| HY-RI03835 | mmu-miR-7046-5p inhibitor | Oligonucleotides | |
| HY-RI03835A | mmu-miR-7046-5p antagomir | Oligonucleotides | |
| HY-RI03836 | mmu-miR-7047-3p inhibitor | Oligonucleotides | |
| HY-RI03836A | mmu-miR-7047-3p antagomir | Oligonucleotides | |
| HY-RI03837 | mmu-miR-7047-5p inhibitor | Oligonucleotides | |
| HY-RI03837A | mmu-miR-7047-5p antagomir | Oligonucleotides | |
| HY-RI03838 | mmu-miR-7048-3p inhibitor | Oligonucleotides | |
| HY-RI03838A | mmu-miR-7048-3p antagomir | Oligonucleotides | |
| HY-RI03839 | mmu-miR-7048-5p inhibitor | Oligonucleotides | |
| HY-RI03839A | mmu-miR-7048-5p antagomir | Oligonucleotides | |
| HY-RI03840 | mmu-miR-7049-3p inhibitor | Oligonucleotides | |
| HY-RI03840A | mmu-miR-7049-3p antagomir | Oligonucleotides | |
| HY-RI03841 | mmu-miR-7049-5p inhibitor | Oligonucleotides | |
| HY-RI03841A | mmu-miR-7049-5p antagomir | Oligonucleotides | |
| HY-RI03842 | mmu-miR-705 inhibitor | Oligonucleotides | |
| HY-RI03842A | mmu-miR-705 antagomir | Oligonucleotides | |
| HY-RI03843 | mmu-miR-7050-3p inhibitor | Oligonucleotides | |
| HY-RI03843A | mmu-miR-7050-3p antagomir | Oligonucleotides | |
| HY-RI03844 | mmu-miR-7050-5p inhibitor | Oligonucleotides | |
| HY-RI03844A | mmu-miR-7050-5p antagomir | Oligonucleotides | |
| HY-RI03845 | mmu-miR-7051-3p inhibitor | Oligonucleotides | |
| HY-RI03845A | mmu-miR-7051-3p antagomir | Oligonucleotides | |
| HY-RI03846 | mmu-miR-7051-5p inhibitor | Oligonucleotides | |
| HY-RI03846A | mmu-miR-7051-5p antagomir | Oligonucleotides | |
| HY-RI03847 | mmu-miR-7052-3p inhibitor | Oligonucleotides | |
| HY-RI03847A | mmu-miR-7052-3p antagomir | Oligonucleotides | |
| HY-RI03848 | mmu-miR-7052-5p inhibitor | Oligonucleotides | |
| HY-RI03848A | mmu-miR-7052-5p antagomir | Oligonucleotides | |
| HY-RI03849 | mmu-miR-7053-3p inhibitor | Oligonucleotides | |
| HY-RI03849A | mmu-miR-7053-3p antagomir | Oligonucleotides | |
| HY-RI03850 | mmu-miR-7053-5p inhibitor | Oligonucleotides | |
| HY-RI03850A | mmu-miR-7053-5p antagomir | Oligonucleotides | |
| HY-RI03851 | mmu-miR-7054-3p inhibitor | Oligonucleotides | |
| HY-RI03851A | mmu-miR-7054-3p antagomir | Oligonucleotides | |
| HY-RI03852 | mmu-miR-7054-5p inhibitor | Oligonucleotides | |
| HY-RI03852A | mmu-miR-7054-5p antagomir | Oligonucleotides | |
| HY-RI03853 | mmu-miR-7055-3p inhibitor | Oligonucleotides | |
| HY-RI03853A | mmu-miR-7055-3p antagomir | Oligonucleotides | |
| HY-RI03854 | mmu-miR-7055-5p inhibitor | Oligonucleotides | |
| HY-RI03854A | mmu-miR-7055-5p antagomir | Oligonucleotides | |
| HY-RI03855 | mmu-miR-7056-3p inhibitor | Oligonucleotides | |
| HY-RI03855A | mmu-miR-7056-3p antagomir | Oligonucleotides | |
| HY-RI03856 | mmu-miR-7056-5p inhibitor | Oligonucleotides | |
| HY-RI03856A | mmu-miR-7056-5p antagomir | Oligonucleotides | |
| HY-RI03857 | mmu-miR-7057-3p inhibitor | Oligonucleotides | |
| HY-RI03857A | mmu-miR-7057-3p antagomir | Oligonucleotides | |
| HY-RI03858 | mmu-miR-7057-5p inhibitor | Oligonucleotides | |
| HY-RI03858A | mmu-miR-7057-5p antagomir | Oligonucleotides | |
| HY-RI03859 | mmu-miR-7058-3p inhibitor | Oligonucleotides | |
| HY-RI03859A | mmu-miR-7058-3p antagomir | Oligonucleotides | |
| HY-RI03860 | mmu-miR-7058-5p inhibitor | Oligonucleotides | |
| HY-RI03860A | mmu-miR-7058-5p antagomir | Oligonucleotides | |
| HY-RI03861 | mmu-miR-7059-3p inhibitor | Oligonucleotides | |
| HY-RI03861A | mmu-miR-7059-3p antagomir | Oligonucleotides | |
| HY-RI03862 | mmu-miR-7059-5p inhibitor | Oligonucleotides | |
| HY-RI03862A | mmu-miR-7059-5p antagomir | Oligonucleotides | |
| HY-RI03863 | mmu-miR-706 inhibitor | Oligonucleotides | |
| HY-RI03863A | mmu-miR-706 antagomir | Oligonucleotides | |
| HY-RI03864 | mmu-miR-7060-3p inhibitor | Oligonucleotides | |
| HY-RI03864A | mmu-miR-7060-3p antagomir | Oligonucleotides | |
| HY-RI03865 | mmu-miR-7060-5p inhibitor | Oligonucleotides | |
| HY-RI03865A | mmu-miR-7060-5p antagomir | Oligonucleotides | |
| HY-RI03866 | mmu-miR-7061-3p inhibitor | Oligonucleotides | |
| HY-RI03866A | mmu-miR-7061-3p antagomir | Oligonucleotides | |
| HY-RI03867 | mmu-miR-7061-5p inhibitor | Oligonucleotides | |
| HY-RI03867A | mmu-miR-7061-5p antagomir | Oligonucleotides | |
| HY-RI03868 | mmu-miR-7062-3p inhibitor | Oligonucleotides | |
| HY-RI03868A | mmu-miR-7062-3p antagomir | Oligonucleotides | |
| HY-RI03869 | mmu-miR-7062-5p inhibitor | Oligonucleotides | |
| HY-RI03869A | mmu-miR-7062-5p antagomir | Oligonucleotides | |
| HY-RI03870 | mmu-miR-7063-3p inhibitor | Oligonucleotides | |
| HY-RI03870A | mmu-miR-7063-3p antagomir | Oligonucleotides | |
| HY-RI03871 | mmu-miR-7063-5p inhibitor | Oligonucleotides | |
| HY-RI03871A | mmu-miR-7063-5p antagomir | Oligonucleotides | |
| HY-RI03872 | mmu-miR-7064-3p inhibitor | Oligonucleotides | |
| HY-RI03872A | mmu-miR-7064-3p antagomir | Oligonucleotides | |
| HY-RI03873 | mmu-miR-7064-5p inhibitor | Oligonucleotides | |
| HY-RI03873A | mmu-miR-7064-5p antagomir | Oligonucleotides | |
| HY-RI03874 | mmu-miR-7065-3p inhibitor | Oligonucleotides | |
| HY-RI03874A | mmu-miR-7065-3p antagomir | Oligonucleotides | |
| HY-RI03875 | mmu-miR-7065-5p inhibitor | Oligonucleotides | |
| HY-RI03875A | mmu-miR-7065-5p antagomir | Oligonucleotides | |
| HY-RI03876 | mmu-miR-7066-3p inhibitor | Oligonucleotides | |
| HY-RI03876A | mmu-miR-7066-3p antagomir | Oligonucleotides | |
| HY-RI03877 | mmu-miR-7066-5p inhibitor | Oligonucleotides | |
| HY-RI03877A | mmu-miR-7066-5p antagomir | Oligonucleotides | |
| HY-RI03878 | mmu-miR-7067-3p inhibitor | Oligonucleotides | |
| HY-RI03878A | mmu-miR-7067-3p antagomir | Oligonucleotides | |
| HY-RI03879 | mmu-miR-7067-5p inhibitor | Oligonucleotides | |
| HY-RI03879A | mmu-miR-7067-5p antagomir | Oligonucleotides | |
| HY-RI03880 | mmu-miR-7068-3p inhibitor | Oligonucleotides | |
| HY-RI03880A | mmu-miR-7068-3p antagomir | Oligonucleotides | |
| HY-RI03881 | mmu-miR-7068-5p inhibitor | Oligonucleotides | |
| HY-RI03881A | mmu-miR-7068-5p antagomir | Oligonucleotides | |
| HY-RI03882 | mmu-miR-7069-3p inhibitor | Oligonucleotides | |
| HY-RI03882A | mmu-miR-7069-3p antagomir | Oligonucleotides | |
| HY-RI03883 | mmu-miR-7069-5p inhibitor | Oligonucleotides | |
| HY-RI03883A | mmu-miR-7069-5p antagomir | Oligonucleotides | |
| HY-RI03884 | mmu-miR-707 inhibitor | Oligonucleotides | |
| HY-RI03884A | mmu-miR-707 antagomir | Oligonucleotides | |
| HY-RI03885 | mmu-miR-7070-3p inhibitor | Oligonucleotides | |
| HY-RI03885A | mmu-miR-7070-3p antagomir | Oligonucleotides | |
| HY-RI03886 | mmu-miR-7070-5p inhibitor | Oligonucleotides | |
| HY-RI03886A | mmu-miR-7070-5p antagomir | Oligonucleotides | |
| HY-RI03887 | mmu-miR-7071-3p inhibitor | Oligonucleotides | |
| HY-RI03887A | mmu-miR-7071-3p antagomir | Oligonucleotides | |
| HY-RI03888 | mmu-miR-7071-5p inhibitor | Oligonucleotides | |
| HY-RI03888A | mmu-miR-7071-5p antagomir | Oligonucleotides | |
| HY-RI03889 | mmu-miR-7072-3p inhibitor | Oligonucleotides | |
| HY-RI03889A | mmu-miR-7072-3p antagomir | Oligonucleotides | |
| HY-RI03890 | mmu-miR-7072-5p inhibitor | Oligonucleotides | |
| HY-RI03890A | mmu-miR-7072-5p antagomir | Oligonucleotides | |
| HY-RI03891 | mmu-miR-7073-3p inhibitor | Oligonucleotides | |
| HY-RI03891A | mmu-miR-7073-3p antagomir | Oligonucleotides | |
| HY-RI03892 | mmu-miR-7073-5p inhibitor | Oligonucleotides | |
| HY-RI03892A | mmu-miR-7073-5p antagomir | Oligonucleotides | |
| HY-RI03893 | mmu-miR-7074-3p inhibitor | Oligonucleotides | |
| HY-RI03893A | mmu-miR-7074-3p antagomir | Oligonucleotides | |
| HY-RI03894 | mmu-miR-7074-5p inhibitor | Oligonucleotides | |
| HY-RI03894A | mmu-miR-7074-5p antagomir | Oligonucleotides | |
| HY-RI03895 | mmu-miR-7075-3p inhibitor | Oligonucleotides | |
| HY-RI03895A | mmu-miR-7075-3p antagomir | Oligonucleotides | |
| HY-RI03896 | mmu-miR-7075-5p inhibitor | Oligonucleotides | |
| HY-RI03896A | mmu-miR-7075-5p antagomir | Oligonucleotides | |
| HY-RI03897 | mmu-miR-7076-3p inhibitor | Oligonucleotides | |
| HY-RI03897A | mmu-miR-7076-3p antagomir | Oligonucleotides | |
| HY-RI03898 | mmu-miR-7076-5p inhibitor | Oligonucleotides | |
| HY-RI03898A | mmu-miR-7076-5p antagomir | Oligonucleotides | |
| HY-RI03899 | mmu-miR-7077-3p inhibitor | Oligonucleotides | |
| HY-RI03899A | mmu-miR-7077-3p antagomir | Oligonucleotides | |
| HY-RI03900 | mmu-miR-7077-5p inhibitor | Oligonucleotides | |
| HY-RI03900A | mmu-miR-7077-5p antagomir | Oligonucleotides | |
| HY-RI03901 | mmu-miR-7078-3p inhibitor | Oligonucleotides | |
| HY-RI03901A | mmu-miR-7078-3p antagomir | Oligonucleotides | |
| HY-RI03902 | mmu-miR-7078-5p inhibitor | Oligonucleotides | |
| HY-RI03902A | mmu-miR-7078-5p antagomir | Oligonucleotides | |
| HY-RI03903 | mmu-miR-7079-3p inhibitor | Oligonucleotides | |
| HY-RI03903A | mmu-miR-7079-3p antagomir | Oligonucleotides | |
| HY-RI03904 | mmu-miR-7079-5p inhibitor | Oligonucleotides | |
| HY-RI03904A | mmu-miR-7079-5p antagomir | Oligonucleotides | |
| HY-RI03905 | mmu-miR-7080-3p inhibitor | Oligonucleotides | |
| HY-RI03905A | mmu-miR-7080-3p antagomir | Oligonucleotides | |
| HY-RI03906 | mmu-miR-7080-5p inhibitor | Oligonucleotides | |
| HY-RI03906A | mmu-miR-7080-5p antagomir | Oligonucleotides | |
| HY-RI03907 | mmu-miR-7081-3p inhibitor | Oligonucleotides | |
| HY-RI03907A | mmu-miR-7081-3p antagomir | Oligonucleotides | |
| HY-RI03908 | mmu-miR-7081-5p inhibitor | Oligonucleotides | |
| HY-RI03908A | mmu-miR-7081-5p antagomir | Oligonucleotides | |
| HY-RI03909 | mmu-miR-7082-3p inhibitor | Oligonucleotides | |
| HY-RI03909A | mmu-miR-7082-3p antagomir | Oligonucleotides | |
| HY-RI03910 | mmu-miR-7082-5p inhibitor | Oligonucleotides | |
| HY-RI03910A | mmu-miR-7082-5p antagomir | Oligonucleotides | |
| HY-RI03911 | mmu-miR-7083-3p inhibitor | Oligonucleotides | |
| HY-RI03911A | mmu-miR-7083-3p antagomir | Oligonucleotides | |
| HY-RI03912 | mmu-miR-7083-5p inhibitor | Oligonucleotides | |
| HY-RI03912A | mmu-miR-7083-5p antagomir | Oligonucleotides | |
| HY-RI03913 | mmu-miR-7084-3p inhibitor | Oligonucleotides | |
| HY-RI03913A | mmu-miR-7084-3p antagomir | Oligonucleotides | |
| HY-RI03914 | mmu-miR-7084-5p inhibitor | Oligonucleotides | |
| HY-RI03914A | mmu-miR-7084-5p antagomir | Oligonucleotides | |
| HY-RI03915 | mmu-miR-7085-3p inhibitor | Oligonucleotides | |
| HY-RI03915A | mmu-miR-7085-3p antagomir | Oligonucleotides | |
| HY-RI03916 | mmu-miR-7085-5p inhibitor | Oligonucleotides | |
| HY-RI03916A | mmu-miR-7085-5p antagomir | Oligonucleotides | |
| HY-RI03917 | mmu-miR-7086-3p inhibitor | Oligonucleotides | |
| HY-RI03917A | mmu-miR-7086-3p antagomir | Oligonucleotides | |
| HY-RI03918 | mmu-miR-7086-5p inhibitor | Oligonucleotides | |
| HY-RI03918A | mmu-miR-7086-5p antagomir | Oligonucleotides | |
| HY-RI03919 | mmu-miR-7087-3p inhibitor | Oligonucleotides | |
| HY-RI03919A | mmu-miR-7087-3p antagomir | Oligonucleotides | |
| HY-RI03920 | mmu-miR-7087-5p inhibitor | Oligonucleotides | |
| HY-RI03920A | mmu-miR-7087-5p antagomir | Oligonucleotides | |
| HY-RI03921 | mmu-miR-7088-3p inhibitor | Oligonucleotides | |
| HY-RI03921A | mmu-miR-7088-3p antagomir | Oligonucleotides | |
| HY-RI03922 | mmu-miR-7088-5p inhibitor | Oligonucleotides | |
| HY-RI03922A | mmu-miR-7088-5p antagomir | Oligonucleotides | |
| HY-RI03923 | mmu-miR-7089-3p inhibitor | Oligonucleotides | |
| HY-RI03923A | mmu-miR-7089-3p antagomir | Oligonucleotides | |
| HY-RI03924 | mmu-miR-7089-5p inhibitor | Oligonucleotides | |
| HY-RI03924A | mmu-miR-7089-5p antagomir | Oligonucleotides | |
| HY-RI03925 | mmu-miR-709 inhibitor | Oligonucleotides | |
| HY-RI03925A | mmu-miR-709 antagomir | Oligonucleotides | |
| HY-RI03926 | mmu-miR-7090-3p inhibitor | Oligonucleotides | |
| HY-RI03926A | mmu-miR-7090-3p antagomir | Oligonucleotides | |
| HY-RI03927 | mmu-miR-7090-5p inhibitor | Oligonucleotides | |
| HY-RI03927A | mmu-miR-7090-5p antagomir | Oligonucleotides | |
| HY-RI03928 | mmu-miR-7091-3p inhibitor | Oligonucleotides | |
| HY-RI03928A | mmu-miR-7091-3p antagomir | Oligonucleotides | |
| HY-RI03929 | mmu-miR-7091-5p inhibitor | Oligonucleotides | |
| HY-RI03929A | mmu-miR-7091-5p antagomir | Oligonucleotides | |
| HY-RI03930 | mmu-miR-7092-3p inhibitor | Oligonucleotides | |
| HY-RI03930A | mmu-miR-7092-3p antagomir | Oligonucleotides | |
| HY-RI03931 | mmu-miR-7092-5p inhibitor | Oligonucleotides | |
| HY-RI03931A | mmu-miR-7092-5p antagomir | Oligonucleotides | |
| HY-RI03932 | mmu-miR-7093-3p inhibitor | Oligonucleotides | |
| HY-RI03932A | mmu-miR-7093-3p antagomir | Oligonucleotides | |
| HY-RI03933 | mmu-miR-7093-5p inhibitor | Oligonucleotides | |
| HY-RI03933A | mmu-miR-7093-5p antagomir | Oligonucleotides | |
| HY-RI03934 | mmu-miR-7094-1-5p inhibitor | Oligonucleotides | |
| HY-RI03934A | mmu-miR-7094-1-5p antagomir | Oligonucleotides | |
| HY-RI03935 | mmu-miR-7094-3p inhibitor | Oligonucleotides | |
| HY-RI03935A | mmu-miR-7094-3p antagomir | Oligonucleotides | |
| HY-RI03936 | mmu-miR-7094b-2-5p inhibitor | Oligonucleotides | |
| HY-RI03936A | mmu-miR-7094b-2-5p antagomir | Oligonucleotides | |
| HY-RI03937 | mmu-miR-710 inhibitor | Oligonucleotides | |
| HY-RI03937A | mmu-miR-710 antagomir | Oligonucleotides | |
| HY-RI03938 | mmu-miR-711 inhibitor | Oligonucleotides | |
| HY-RI03938A | mmu-miR-711 antagomir | Oligonucleotides | |
| HY-RI03939 | mmu-miR-7115-3p inhibitor | Oligonucleotides | |
| HY-RI03939A | mmu-miR-7115-3p antagomir | Oligonucleotides | |
| HY-RI03940 | mmu-miR-7115-5p inhibitor | Oligonucleotides | |
| HY-RI03940A | mmu-miR-7115-5p antagomir | Oligonucleotides | |
| HY-RI03941 | mmu-miR-7116-3p inhibitor | Oligonucleotides | |
| HY-RI03941A | mmu-miR-7116-3p antagomir | Oligonucleotides | |
| HY-RI03942 | mmu-miR-7116-5p inhibitor | Oligonucleotides | |
| HY-RI03942A | mmu-miR-7116-5p antagomir | Oligonucleotides | |
| HY-RI03943 | mmu-miR-7117-3p inhibitor | Oligonucleotides | |
| HY-RI03943A | mmu-miR-7117-3p antagomir | Oligonucleotides | |
| HY-RI03944 | mmu-miR-7117-5p inhibitor | Oligonucleotides | |
| HY-RI03944A | mmu-miR-7117-5p antagomir | Oligonucleotides | |
| HY-RI03945 | mmu-miR-7118-3p inhibitor | Oligonucleotides | |
| HY-RI03945A | mmu-miR-7118-3p antagomir | Oligonucleotides | |
| HY-RI03946 | mmu-miR-7118-5p inhibitor | Oligonucleotides | |
| HY-RI03946A | mmu-miR-7118-5p antagomir | Oligonucleotides | |
| HY-RI03947 | mmu-miR-7119-3p inhibitor | Oligonucleotides | |
| HY-RI03947A | mmu-miR-7119-3p antagomir | Oligonucleotides | |
| HY-RI03948 | mmu-miR-7119-5p inhibitor | Oligonucleotides | |
| HY-RI03948A | mmu-miR-7119-5p antagomir | Oligonucleotides | |
| HY-RI03949 | mmu-miR-712-3p inhibitor | Oligonucleotides | |
| HY-RI03949A | mmu-miR-712-3p antagomir | Oligonucleotides | |
| HY-RI03950 | mmu-miR-712-5p inhibitor | Oligonucleotides | |
| HY-RI03950A | mmu-miR-712-5p antagomir | Oligonucleotides | |
| HY-RI03951 | mmu-miR-713 inhibitor | Oligonucleotides | |
| HY-RI03951A | mmu-miR-713 antagomir | Oligonucleotides | |
| HY-RI03952 | mmu-miR-714 inhibitor | Oligonucleotides | |
| HY-RI03952A | mmu-miR-714 antagomir | Oligonucleotides | |
| HY-RI03953 | mmu-miR-717 inhibitor | Oligonucleotides | |
| HY-RI03953A | mmu-miR-717 antagomir | Oligonucleotides | |
| HY-RI03954 | mmu-miR-718 inhibitor | Oligonucleotides | |
| HY-RI03954A | mmu-miR-718 antagomir | Oligonucleotides | |
| HY-RI03955 | mmu-miR-719 inhibitor | Oligonucleotides | |
| HY-RI03955A | mmu-miR-719 antagomir | Oligonucleotides | |
| HY-RI03956 | mmu-miR-721 inhibitor | Oligonucleotides | |
| HY-RI03956A | mmu-miR-721 antagomir | Oligonucleotides | |
| HY-RI03957 | mmu-miR-7210-3p inhibitor | Oligonucleotides | |
| HY-RI03957A | mmu-miR-7210-3p antagomir | Oligonucleotides | |
| HY-RI03958 | mmu-miR-7210-5p inhibitor | Oligonucleotides | |
| HY-RI03958A | mmu-miR-7210-5p antagomir | Oligonucleotides | |
| HY-RI03959 | mmu-miR-7211-3p inhibitor | Oligonucleotides | |
| HY-RI03959A | mmu-miR-7211-3p antagomir | Oligonucleotides | |
| HY-RI03960 | mmu-miR-7211-5p inhibitor | Oligonucleotides | |
| HY-RI03960A | mmu-miR-7211-5p antagomir | Oligonucleotides | |
| HY-RI03961 | mmu-miR-7212-3p inhibitor | Oligonucleotides | |
| HY-RI03961A | mmu-miR-7212-3p antagomir | Oligonucleotides | |
| HY-RI03962 | mmu-miR-7212-5p inhibitor | Oligonucleotides | |
| HY-RI03962A | mmu-miR-7212-5p antagomir | Oligonucleotides | |
| HY-RI03963 | mmu-miR-7213-3p inhibitor | Oligonucleotides | |
| HY-RI03963A | mmu-miR-7213-3p antagomir | Oligonucleotides | |
| HY-RI03964 | mmu-miR-7213-5p inhibitor | Oligonucleotides | |
| HY-RI03964A | mmu-miR-7213-5p antagomir | Oligonucleotides | |
| HY-RI03965 | mmu-miR-7214-3p inhibitor | Oligonucleotides | |
| HY-RI03965A | mmu-miR-7214-3p antagomir | Oligonucleotides | |
| HY-RI03966 | mmu-miR-7214-5p inhibitor | Oligonucleotides | |
| HY-RI03966A | mmu-miR-7214-5p antagomir | Oligonucleotides | |
| HY-RI03967 | mmu-miR-7215-3p inhibitor | Oligonucleotides | |
| HY-RI03967A | mmu-miR-7215-3p antagomir | Oligonucleotides | |
| HY-RI03968 | mmu-miR-7215-5p inhibitor | Oligonucleotides | |
| HY-RI03968A | mmu-miR-7215-5p antagomir | Oligonucleotides | |
| HY-RI03969 | mmu-miR-7216-3p inhibitor | Oligonucleotides | |
| HY-RI03969A | mmu-miR-7216-3p antagomir | Oligonucleotides | |
| HY-RI03970 | mmu-miR-7216-5p inhibitor | Oligonucleotides | |
| HY-RI03970A | mmu-miR-7216-5p antagomir | Oligonucleotides | |
| HY-RI03971 | mmu-miR-7217-3p inhibitor | Oligonucleotides | |
| HY-RI03971A | mmu-miR-7217-3p antagomir | Oligonucleotides | |
| HY-RI03972 | mmu-miR-7217-5p inhibitor | Oligonucleotides | |
| HY-RI03972A | mmu-miR-7217-5p antagomir | Oligonucleotides | |
| HY-RI03973 | mmu-miR-7218-3p inhibitor | Oligonucleotides | |
| HY-RI03973A | mmu-miR-7218-3p antagomir | Oligonucleotides | |
| HY-RI03974 | mmu-miR-7218-5p inhibitor | Oligonucleotides | |
| HY-RI03974A | mmu-miR-7218-5p antagomir | Oligonucleotides | |
| HY-RI03975 | mmu-miR-7219-3p inhibitor | Oligonucleotides | |
| HY-RI03975A | mmu-miR-7219-3p antagomir | Oligonucleotides | |
| HY-RI03976 | mmu-miR-7219-5p inhibitor | Oligonucleotides | |
| HY-RI03976A | mmu-miR-7219-5p antagomir | Oligonucleotides | |
| HY-RI03977 | mmu-miR-7220-3p inhibitor | Oligonucleotides | |
| HY-RI03977A | mmu-miR-7220-3p antagomir | Oligonucleotides | |
| HY-RI03978 | mmu-miR-7220-5p inhibitor | Oligonucleotides | |
| HY-RI03978A | mmu-miR-7220-5p antagomir | Oligonucleotides | |
| HY-RI03979 | mmu-miR-7221-3p inhibitor | Oligonucleotides | |
| HY-RI03979A | mmu-miR-7221-3p antagomir | Oligonucleotides | |
| HY-RI03980 | mmu-miR-7221-5p inhibitor | Oligonucleotides | |
| HY-RI03980A | mmu-miR-7221-5p antagomir | Oligonucleotides | |
| HY-RI03981 | mmu-miR-7222-3p inhibitor | Oligonucleotides | |
| HY-RI03981A | mmu-miR-7222-3p antagomir | Oligonucleotides | |
| HY-RI03982 | mmu-miR-7222-5p inhibitor | Oligonucleotides | |
| HY-RI03982A | mmu-miR-7222-5p antagomir | Oligonucleotides | |
| HY-RI03983 | mmu-miR-7223-3p inhibitor | Oligonucleotides | |
| HY-RI03983A | mmu-miR-7223-3p antagomir | Oligonucleotides | |
| HY-RI03984 | mmu-miR-7223-5p inhibitor | Oligonucleotides | |
| HY-RI03984A | mmu-miR-7223-5p antagomir | Oligonucleotides | |
| HY-RI03985 | mmu-miR-7224-3p inhibitor | Oligonucleotides | |
| HY-RI03985A | mmu-miR-7224-3p antagomir | Oligonucleotides | |
| HY-RI03986 | mmu-miR-7224-5p inhibitor | Oligonucleotides | |
| HY-RI03986A | mmu-miR-7224-5p antagomir | Oligonucleotides | |
| HY-RI03987 | mmu-miR-7225-3p inhibitor | Oligonucleotides | |
| HY-RI03987A | mmu-miR-7225-3p antagomir | Oligonucleotides | |
| HY-RI03988 | mmu-miR-7225-5p inhibitor | Oligonucleotides | |
| HY-RI03988A | mmu-miR-7225-5p antagomir | Oligonucleotides | |
| HY-RI03989 | mmu-miR-7226-3p inhibitor | Oligonucleotides | |
| HY-RI03989A | mmu-miR-7226-3p antagomir | Oligonucleotides | |
| HY-RI03990 | mmu-miR-7226-5p inhibitor | Oligonucleotides | |
| HY-RI03990A | mmu-miR-7226-5p antagomir | Oligonucleotides | |
| HY-RI03991 | mmu-miR-7227-3p inhibitor | Oligonucleotides | |
| HY-RI03991A | mmu-miR-7227-3p antagomir | Oligonucleotides | |
| HY-RI03992 | mmu-miR-7227-5p inhibitor | Oligonucleotides | |
| HY-RI03992A | mmu-miR-7227-5p antagomir | Oligonucleotides | |
| HY-RI03993 | mmu-miR-7228-3p inhibitor | Oligonucleotides | |
| HY-RI03993A | mmu-miR-7228-3p antagomir | Oligonucleotides | |
| HY-RI03994 | mmu-miR-7228-5p inhibitor | Oligonucleotides | |
| HY-RI03994A | mmu-miR-7228-5p antagomir | Oligonucleotides | |
| HY-RI03995 | mmu-miR-7229-3p inhibitor | Oligonucleotides | |
| HY-RI03995A | mmu-miR-7229-3p antagomir | Oligonucleotides | |
| HY-RI03996 | mmu-miR-7229-5p inhibitor | Oligonucleotides | |
| HY-RI03996A | mmu-miR-7229-5p antagomir | Oligonucleotides | |
| HY-RI03997 | mmu-miR-7230-3p inhibitor | Oligonucleotides | |
| HY-RI03997A | mmu-miR-7230-3p antagomir | Oligonucleotides | |
| HY-RI03998 | mmu-miR-7230-5p inhibitor | Oligonucleotides | |
| HY-RI03998A | mmu-miR-7230-5p antagomir | Oligonucleotides | |
| HY-RI03999 | mmu-miR-7231-3p inhibitor | Oligonucleotides | |
| HY-RI03999A | mmu-miR-7231-3p antagomir | Oligonucleotides | |
| HY-RI04000 | mmu-miR-7231-5p inhibitor | Oligonucleotides | |
| HY-RI04000A | mmu-miR-7231-5p antagomir | Oligonucleotides | |
| HY-RI04001 | mmu-miR-7232-3p inhibitor | Oligonucleotides | |
| HY-RI04001A | mmu-miR-7232-3p antagomir | Oligonucleotides | |
| HY-RI04002 | mmu-miR-7232-5p inhibitor | Oligonucleotides | |
| HY-RI04002A | mmu-miR-7232-5p antagomir | Oligonucleotides | |
| HY-RI04003 | mmu-miR-7233-3p inhibitor | Oligonucleotides | |
| HY-RI04003A | mmu-miR-7233-3p antagomir | Oligonucleotides | |
| HY-RI04004 | mmu-miR-7233-5p inhibitor | Oligonucleotides | |
| HY-RI04004A | mmu-miR-7233-5p antagomir | Oligonucleotides | |
| HY-RI04005 | mmu-miR-7234-3p inhibitor | Oligonucleotides | |
| HY-RI04005A | mmu-miR-7234-3p antagomir | Oligonucleotides | |
| HY-RI04006 | mmu-miR-7234-5p inhibitor | Oligonucleotides | |
| HY-RI04006A | mmu-miR-7234-5p antagomir | Oligonucleotides | |
| HY-RI04007 | mmu-miR-7235-3p inhibitor | Oligonucleotides | |
| HY-RI04007A | mmu-miR-7235-3p antagomir | Oligonucleotides | |
| HY-RI04008 | mmu-miR-7235-5p inhibitor | Oligonucleotides | |
| HY-RI04008A | mmu-miR-7235-5p antagomir | Oligonucleotides | |
| HY-RI04009 | mmu-miR-7236-3p inhibitor | Oligonucleotides | |
| HY-RI04009A | mmu-miR-7236-3p antagomir | Oligonucleotides | |
| HY-RI04010 | mmu-miR-7236-5p inhibitor | Oligonucleotides | |
| HY-RI04010A | mmu-miR-7236-5p antagomir | Oligonucleotides | |
| HY-RI04011 | mmu-miR-7237-3p inhibitor | Oligonucleotides | |
| HY-RI04011A | mmu-miR-7237-3p antagomir | Oligonucleotides | |
| HY-RI04012 | mmu-miR-7237-5p inhibitor | Oligonucleotides | |
| HY-RI04012A | mmu-miR-7237-5p antagomir | Oligonucleotides | |
| HY-RI04013 | mmu-miR-7238-3p inhibitor | Oligonucleotides | |
| HY-RI04013A | mmu-miR-7238-3p antagomir | Oligonucleotides | |
| HY-RI04014 | mmu-miR-7238-5p inhibitor | Oligonucleotides | |
| HY-RI04014A | mmu-miR-7238-5p antagomir | Oligonucleotides | |
| HY-RI04015 | mmu-miR-7239-3p inhibitor | Oligonucleotides | |
| HY-RI04015A | mmu-miR-7239-3p antagomir | Oligonucleotides | |
| HY-RI04016 | mmu-miR-7239-5p inhibitor | Oligonucleotides | |
| HY-RI04016A | mmu-miR-7239-5p antagomir | Oligonucleotides | |
| HY-RI04017 | mmu-miR-7240-3p inhibitor | Oligonucleotides | |
| HY-RI04017A | mmu-miR-7240-3p antagomir | Oligonucleotides | |
| HY-RI04018 | mmu-miR-7240-5p inhibitor | Oligonucleotides | |
| HY-RI04018A | mmu-miR-7240-5p antagomir | Oligonucleotides | |
| HY-RI04019 | mmu-miR-7241-3p inhibitor | Oligonucleotides | |
| HY-RI04019A | mmu-miR-7241-3p antagomir | Oligonucleotides | |
| HY-RI04020 | mmu-miR-7241-5p inhibitor | Oligonucleotides | |
| HY-RI04020A | mmu-miR-7241-5p antagomir | Oligonucleotides | |
| HY-RI04021 | mmu-miR-7242-3p inhibitor | Oligonucleotides | |
| HY-RI04021A | mmu-miR-7242-3p antagomir | Oligonucleotides | |
| HY-RI04022 | mmu-miR-7242-5p inhibitor | Oligonucleotides | |
| HY-RI04022A | mmu-miR-7242-5p antagomir | Oligonucleotides | |
| HY-RI04023 | mmu-miR-7243-3p inhibitor | Oligonucleotides | |
| HY-RI04023A | mmu-miR-7243-3p antagomir | Oligonucleotides | |
| HY-RI04024 | mmu-miR-7243-5p inhibitor | Oligonucleotides | |
| HY-RI04024A | mmu-miR-7243-5p antagomir | Oligonucleotides | |
| HY-RI04025 | mmu-miR-741-3p inhibitor | Oligonucleotides | |
| HY-RI04025A | mmu-miR-741-3p antagomir | Oligonucleotides | |
| HY-RI04026 | mmu-miR-741-5p inhibitor | Oligonucleotides | |
| HY-RI04026A | mmu-miR-741-5p antagomir | Oligonucleotides | |
| HY-RI04027 | mmu-miR-742-3p inhibitor | Oligonucleotides | |
| HY-RI04027A | mmu-miR-742-3p antagomir | Oligonucleotides | |
| HY-RI04028 | mmu-miR-742-5p inhibitor | Oligonucleotides | |
| HY-RI04028A | mmu-miR-742-5p antagomir | Oligonucleotides | |
| HY-RI04029 | mmu-miR-743a-3p inhibitor | Oligonucleotides | |
| HY-RI04029A | mmu-miR-743a-3p antagomir | Oligonucleotides | |
| HY-RI04030 | mmu-miR-743a-5p inhibitor | Oligonucleotides | |
| HY-RI04030A | mmu-miR-743a-5p antagomir | Oligonucleotides | |
| HY-RI04031 | mmu-miR-743b-3p inhibitor | Oligonucleotides | |
| HY-RI04031A | mmu-miR-743b-3p antagomir | Oligonucleotides | |
| HY-RI04032 | mmu-miR-743b-5p inhibitor | Oligonucleotides | |
| HY-RI04032A | mmu-miR-743b-5p antagomir | Oligonucleotides | |
| HY-RI04033 | mmu-miR-7578 inhibitor | Oligonucleotides | |
| HY-RI04033A | mmu-miR-7578 antagomir | Oligonucleotides | |
| HY-RI04034 | mmu-miR-758-3p inhibitor | Oligonucleotides | |
| HY-RI04034A | mmu-miR-758-3p antagomir | Oligonucleotides | |
| HY-RI04035 | mmu-miR-758-5p inhibitor | Oligonucleotides | |
| HY-RI04035A | mmu-miR-758-5p antagomir | Oligonucleotides | |
| HY-RI04036 | mmu-miR-760-5p inhibitor | Oligonucleotides | |
| HY-RI04036A | mmu-miR-760-5p antagomir | Oligonucleotides | |
| HY-RI04037 | mmu-miR-762 inhibitor | Oligonucleotides | |
| HY-RI04037A | mmu-miR-762 antagomir | Oligonucleotides | |
| HY-RI04038 | mmu-miR-763 inhibitor | Oligonucleotides | |
| HY-RI04038A | mmu-miR-763 antagomir | Oligonucleotides | |
| HY-RI04039 | mmu-miR-764-3p inhibitor | Oligonucleotides | |
| HY-RI04039A | mmu-miR-764-3p antagomir | Oligonucleotides | |
| HY-RI04040 | mmu-miR-764-5p inhibitor | Oligonucleotides | |
| HY-RI04040A | mmu-miR-764-5p antagomir | Oligonucleotides | |
| HY-RI04041 | mmu-miR-7646-3p inhibitor | Oligonucleotides | |
| HY-RI04041A | mmu-miR-7646-3p antagomir | Oligonucleotides | |
| HY-RI04042 | mmu-miR-7646-5p inhibitor | Oligonucleotides | |
| HY-RI04042A | mmu-miR-7646-5p antagomir | Oligonucleotides | |
| HY-RI04043 | mmu-miR-7647-3p inhibitor | Oligonucleotides | |
| HY-RI04043A | mmu-miR-7647-3p antagomir | Oligonucleotides | |
| HY-RI04044 | mmu-miR-7647-5p inhibitor | Oligonucleotides | |
| HY-RI04044A | mmu-miR-7647-5p antagomir | Oligonucleotides | |
| HY-RI04045 | mmu-miR-7648-3p inhibitor | Oligonucleotides | |
| HY-RI04045A | mmu-miR-7648-3p antagomir | Oligonucleotides | |
| HY-RI04046 | mmu-miR-7648-5p inhibitor | Oligonucleotides | |
| HY-RI04046A | mmu-miR-7648-5p antagomir | Oligonucleotides | |
| HY-RI04047 | mmu-miR-7649-3p inhibitor | Oligonucleotides | |
| HY-RI04047A | mmu-miR-7649-3p antagomir | Oligonucleotides | |
| HY-RI04048 | mmu-miR-7649-5p inhibitor | Oligonucleotides | |
| HY-RI04048A | mmu-miR-7649-5p antagomir | Oligonucleotides | |
| HY-RI04049 | mmu-miR-7650-3p inhibitor | Oligonucleotides | |
| HY-RI04049A | mmu-miR-7650-3p antagomir | Oligonucleotides | |
| HY-RI04050 | mmu-miR-7650-5p inhibitor | Oligonucleotides | |
| HY-RI04050A | mmu-miR-7650-5p antagomir | Oligonucleotides | |
| HY-RI04051 | mmu-miR-7651-3p inhibitor | Oligonucleotides | |
| HY-RI04051A | mmu-miR-7651-3p antagomir | Oligonucleotides | |
| HY-RI04052 | mmu-miR-7651-5p inhibitor | Oligonucleotides | |
| HY-RI04052A | mmu-miR-7651-5p antagomir | Oligonucleotides | |
| HY-RI04053 | mmu-miR-7652-3p inhibitor | Oligonucleotides | |
| HY-RI04053A | mmu-miR-7652-3p antagomir | Oligonucleotides | |
| HY-RI04054 | mmu-miR-7652-5p inhibitor | Oligonucleotides | |
| HY-RI04054A | mmu-miR-7652-5p antagomir | Oligonucleotides | |
| HY-RI04055 | mmu-miR-7653-3p inhibitor | Oligonucleotides | |
| HY-RI04055A | mmu-miR-7653-3p antagomir | Oligonucleotides | |
| HY-RI04056 | mmu-miR-7653-5p inhibitor | Oligonucleotides | |
| HY-RI04056A | mmu-miR-7653-5p antagomir | Oligonucleotides | |
| HY-RI04057 | mmu-miR-7654-3p inhibitor | Oligonucleotides | |
| HY-RI04057A | mmu-miR-7654-3p antagomir | Oligonucleotides | |
| HY-RI04058 | mmu-miR-7654-5p inhibitor | Oligonucleotides | |
| HY-RI04058A | mmu-miR-7654-5p antagomir | Oligonucleotides | |
| HY-RI04059 | mmu-miR-7655-3p inhibitor | Oligonucleotides | |
| HY-RI04059A | mmu-miR-7655-3p antagomir | Oligonucleotides | |
| HY-RI04060 | mmu-miR-7655-5p inhibitor | Oligonucleotides | |
| HY-RI04060A | mmu-miR-7655-5p antagomir | Oligonucleotides | |
| HY-RI04061 | mmu-miR-7656-3p inhibitor | Oligonucleotides | |
| HY-RI04061A | mmu-miR-7656-3p antagomir | Oligonucleotides | |
| HY-RI04062 | mmu-miR-7656-5p inhibitor | Oligonucleotides | |
| HY-RI04062A | mmu-miR-7656-5p antagomir | Oligonucleotides | |
| HY-RI04063 | mmu-miR-7657-3p inhibitor | Oligonucleotides | |
| HY-RI04063A | mmu-miR-7657-3p antagomir | Oligonucleotides | |
| HY-RI04064 | mmu-miR-7657-5p inhibitor | Oligonucleotides | |
| HY-RI04064A | mmu-miR-7657-5p antagomir | Oligonucleotides | |
| HY-RI04065 | mmu-miR-7658-3p inhibitor | Oligonucleotides | |
| HY-RI04065A | mmu-miR-7658-3p antagomir | Oligonucleotides | |
| HY-RI04066 | mmu-miR-7658-5p inhibitor | Oligonucleotides | |
| HY-RI04066A | mmu-miR-7658-5p antagomir | Oligonucleotides | |
| HY-RI04067 | mmu-miR-7659-3p inhibitor | Oligonucleotides | |
| HY-RI04067A | mmu-miR-7659-3p antagomir | Oligonucleotides | |
| HY-RI04068 | mmu-miR-7659-5p inhibitor | Oligonucleotides | |
| HY-RI04068A | mmu-miR-7659-5p antagomir | Oligonucleotides | |
| HY-RI04069 | mmu-miR-7660-3p inhibitor | Oligonucleotides | |
| HY-RI04069A | mmu-miR-7660-3p antagomir | Oligonucleotides | |
| HY-RI04070 | mmu-miR-7660-5p inhibitor | Oligonucleotides | |
| HY-RI04070A | mmu-miR-7660-5p antagomir | Oligonucleotides | |
| HY-RI04071 | mmu-miR-7661-3p inhibitor | Oligonucleotides | |
| HY-RI04071A | mmu-miR-7661-3p antagomir | Oligonucleotides | |
| HY-RI04072 | mmu-miR-7661-5p inhibitor | Oligonucleotides | |
| HY-RI04072A | mmu-miR-7661-5p antagomir | Oligonucleotides | |
| HY-RI04073 | mmu-miR-7662-3p inhibitor | Oligonucleotides | |
| HY-RI04073A | mmu-miR-7662-3p antagomir | Oligonucleotides | |
| HY-RI04074 | mmu-miR-7662-5p inhibitor | Oligonucleotides | |
| HY-RI04074A | mmu-miR-7662-5p antagomir | Oligonucleotides | |
| HY-RI04075 | mmu-miR-7663-3p inhibitor | Oligonucleotides | |
| HY-RI04075A | mmu-miR-7663-3p antagomir | Oligonucleotides | |
| HY-RI04076 | mmu-miR-7663-5p inhibitor | Oligonucleotides | |
| HY-RI04076A | mmu-miR-7663-5p antagomir | Oligonucleotides | |
| HY-RI04077 | mmu-miR-7664-3p inhibitor | Oligonucleotides | |
| HY-RI04077A | mmu-miR-7664-3p antagomir | Oligonucleotides | |
| HY-RI04078 | mmu-miR-7664-5p inhibitor | Oligonucleotides | |
| HY-RI04078A | mmu-miR-7664-5p antagomir | Oligonucleotides | |
| HY-RI04079 | mmu-miR-7665-3p inhibitor | Oligonucleotides | |
| HY-RI04079A | mmu-miR-7665-3p antagomir | Oligonucleotides | |
| HY-RI04080 | mmu-miR-7665-5p inhibitor | Oligonucleotides | |
| HY-RI04080A | mmu-miR-7665-5p antagomir | Oligonucleotides | |
| HY-RI04081 | mmu-miR-7666-3p inhibitor | Oligonucleotides | |
| HY-RI04081A | mmu-miR-7666-3p antagomir | Oligonucleotides | |
| HY-RI04082 | mmu-miR-7666-5p inhibitor | Oligonucleotides | |
| HY-RI04082A | mmu-miR-7666-5p antagomir | Oligonucleotides | |
| HY-RI04083 | mmu-miR-7667-3p inhibitor | Oligonucleotides | |
| HY-RI04083A | mmu-miR-7667-3p antagomir | Oligonucleotides | |
| HY-RI04084 | mmu-miR-7667-5p inhibitor | Oligonucleotides | |
| HY-RI04084A | mmu-miR-7667-5p antagomir | Oligonucleotides | |
| HY-RI04085 | mmu-miR-7668-3p inhibitor | Oligonucleotides | |
| HY-RI04085A | mmu-miR-7668-3p antagomir | Oligonucleotides | |
| HY-RI04086 | mmu-miR-7668-5p inhibitor | Oligonucleotides | |
| HY-RI04086A | mmu-miR-7668-5p antagomir | Oligonucleotides | |
| HY-RI04087 | mmu-miR-7669-3p inhibitor | Oligonucleotides | |
| HY-RI04087A | mmu-miR-7669-3p antagomir | Oligonucleotides | |
| HY-RI04088 | mmu-miR-7669-5p inhibitor | Oligonucleotides | |
| HY-RI04088A | mmu-miR-7669-5p antagomir | Oligonucleotides | |
| HY-RI04089 | mmu-miR-767 inhibitor | Oligonucleotides | |
| HY-RI04089A | mmu-miR-767 antagomir | Oligonucleotides | |
| HY-RI04090 | mmu-miR-7670-3p inhibitor | Oligonucleotides | |
| HY-RI04090A | mmu-miR-7670-3p antagomir | Oligonucleotides | |
| HY-RI04091 | mmu-miR-7670-5p inhibitor | Oligonucleotides | |
| HY-RI04091A | mmu-miR-7670-5p antagomir | Oligonucleotides | |
| HY-RI04092 | mmu-miR-7671-3p inhibitor | Oligonucleotides | |
| HY-RI04092A | mmu-miR-7671-3p antagomir | Oligonucleotides | |
| HY-RI04093 | mmu-miR-7671-5p inhibitor | Oligonucleotides | |
| HY-RI04093A | mmu-miR-7671-5p antagomir | Oligonucleotides | |
| HY-RI04094 | mmu-miR-7672-3p inhibitor | Oligonucleotides | |
| HY-RI04094A | mmu-miR-7672-3p antagomir | Oligonucleotides | |
| HY-RI04095 | mmu-miR-7672-5p inhibitor | Oligonucleotides | |
| HY-RI04095A | mmu-miR-7672-5p antagomir | Oligonucleotides | |
| HY-RI04096 | mmu-miR-7673-3p inhibitor | Oligonucleotides | |
| HY-RI04096A | mmu-miR-7673-3p antagomir | Oligonucleotides | |
| HY-RI04097 | mmu-miR-7673-5p inhibitor | Oligonucleotides | |
| HY-RI04097A | mmu-miR-7673-5p antagomir | Oligonucleotides | |
| HY-RI04098 | mmu-miR-7674-3p inhibitor | Oligonucleotides | |
| HY-RI04098A | mmu-miR-7674-3p antagomir | Oligonucleotides | |
| HY-RI04099 | mmu-miR-7674-5p inhibitor | Oligonucleotides | |
| HY-RI04099A | mmu-miR-7674-5p antagomir | Oligonucleotides | |
| HY-RI04100 | mmu-miR-7675-3p inhibitor | Oligonucleotides | |
| HY-RI04100A | mmu-miR-7675-3p antagomir | Oligonucleotides | |
| HY-RI04101 | mmu-miR-7675-5p inhibitor | Oligonucleotides | |
| HY-RI04101A | mmu-miR-7675-5p antagomir | Oligonucleotides | |
| HY-RI04102 | mmu-miR-7676-3p inhibitor | Oligonucleotides | |
| HY-RI04102A | mmu-miR-7676-3p antagomir | Oligonucleotides | |
| HY-RI04103 | mmu-miR-7676-5p inhibitor | Oligonucleotides | |
| HY-RI04103A | mmu-miR-7676-5p antagomir | Oligonucleotides | |
| HY-RI04104 | mmu-miR-7677-3p inhibitor | Oligonucleotides | |
| HY-RI04104A | mmu-miR-7677-3p antagomir | Oligonucleotides | |
| HY-RI04105 | mmu-miR-7677-5p inhibitor | Oligonucleotides | |
| HY-RI04105A | mmu-miR-7677-5p antagomir | Oligonucleotides | |
| HY-RI04106 | mmu-miR-7678-3p inhibitor | Oligonucleotides | |
| HY-RI04106A | mmu-miR-7678-3p antagomir | Oligonucleotides | |
| HY-RI04107 | mmu-miR-7678-5p inhibitor | Oligonucleotides | |
| HY-RI04107A | mmu-miR-7678-5p antagomir | Oligonucleotides | |
| HY-RI04108 | mmu-miR-7679-3p inhibitor | Oligonucleotides | |
| HY-RI04108A | mmu-miR-7679-3p antagomir | Oligonucleotides | |
| HY-RI04109 | mmu-miR-7679-5p inhibitor | Oligonucleotides | |
| HY-RI04109A | mmu-miR-7679-5p antagomir | Oligonucleotides | |
| HY-RI04110 | mmu-miR-7680-3p inhibitor | Oligonucleotides | |
| HY-RI04110A | mmu-miR-7680-3p antagomir | Oligonucleotides | |
| HY-RI04111 | mmu-miR-7680-5p inhibitor | Oligonucleotides | |
| HY-RI04111A | mmu-miR-7680-5p antagomir | Oligonucleotides | |
| HY-RI04112 | mmu-miR-7681-3p inhibitor | Oligonucleotides | |
| HY-RI04112A | mmu-miR-7681-3p antagomir | Oligonucleotides | |
| HY-RI04113 | mmu-miR-7681-5p inhibitor | Oligonucleotides | |
| HY-RI04113A | mmu-miR-7681-5p antagomir | Oligonucleotides | |
| HY-RI04114 | mmu-miR-7682-3p inhibitor | Oligonucleotides | |
| HY-RI04114A | mmu-miR-7682-3p antagomir | Oligonucleotides | |
| HY-RI04115 | mmu-miR-7682-5p inhibitor | Oligonucleotides | |
| HY-RI04115A | mmu-miR-7682-5p antagomir | Oligonucleotides | |
| HY-RI04116 | mmu-miR-7683-3p inhibitor | Oligonucleotides | |
| HY-RI04116A | mmu-miR-7683-3p antagomir | Oligonucleotides | |
| HY-RI04117 | mmu-miR-7683-5p inhibitor | Oligonucleotides | |
| HY-RI04117A | mmu-miR-7683-5p antagomir | Oligonucleotides | |
| HY-RI04118 | mmu-miR-7684-3p inhibitor | Oligonucleotides | |
| HY-RI04118A | mmu-miR-7684-3p antagomir | Oligonucleotides | |
| HY-RI04119 | mmu-miR-7684-5p inhibitor | Oligonucleotides | |
| HY-RI04119A | mmu-miR-7684-5p antagomir | Oligonucleotides | |
| HY-RI04120 | mmu-miR-7685-3p inhibitor | Oligonucleotides | |
| HY-RI04120A | mmu-miR-7685-3p antagomir | Oligonucleotides | |
| HY-RI04121 | mmu-miR-7685-5p inhibitor | Oligonucleotides | |
| HY-RI04121A | mmu-miR-7685-5p antagomir | Oligonucleotides | |
| HY-RI04122 | mmu-miR-7686-3p inhibitor | Oligonucleotides | |
| HY-RI04122A | mmu-miR-7686-3p antagomir | Oligonucleotides | |
| HY-RI04123 | mmu-miR-7686-5p inhibitor | Oligonucleotides | |
| HY-RI04123A | mmu-miR-7686-5p antagomir | Oligonucleotides | |
| HY-RI04124 | mmu-miR-7687-3p inhibitor | Oligonucleotides | |
| HY-RI04124A | mmu-miR-7687-3p antagomir | Oligonucleotides | |
| HY-RI04125 | mmu-miR-7687-5p inhibitor | Oligonucleotides | |
| HY-RI04125A | mmu-miR-7687-5p antagomir | Oligonucleotides | |
| HY-RI04126 | mmu-miR-7688-3p inhibitor | Oligonucleotides | |
| HY-RI04126A | mmu-miR-7688-3p antagomir | Oligonucleotides | |
| HY-RI04127 | mmu-miR-7688-5p inhibitor | Oligonucleotides | |
| HY-RI04127A | mmu-miR-7688-5p antagomir | Oligonucleotides | |
| HY-RI04128 | mmu-miR-7689-3p inhibitor | Oligonucleotides | |
| HY-RI04128A | mmu-miR-7689-3p antagomir | Oligonucleotides | |
| HY-RI04129 | mmu-miR-7689-5p inhibitor | Oligonucleotides | |
| HY-RI04129A | mmu-miR-7689-5p antagomir | Oligonucleotides | |
| HY-RI04130 | mmu-miR-770-3p inhibitor | Oligonucleotides | |
| HY-RI04130A | mmu-miR-770-3p antagomir | Oligonucleotides | |
| HY-RI04131 | mmu-miR-770-5p inhibitor | Oligonucleotides | |
| HY-RI04131A | mmu-miR-770-5p antagomir | Oligonucleotides | |
| HY-RI04132 | mmu-miR-7a-2-3p inhibitor | Oligonucleotides | |
| HY-RI04132A | mmu-miR-7a-2-3p antagomir | Oligonucleotides | |
| HY-RI04133 | mmu-miR-7a-5p inhibitor | Oligonucleotides | |
| HY-RI04133A | mmu-miR-7a-5p antagomir | Oligonucleotides | |
| HY-RI04134 | mmu-miR-7b-3p inhibitor | Oligonucleotides | |
| HY-RI04134A | mmu-miR-7b-3p antagomir | Oligonucleotides | |
| HY-RI04135 | mmu-miR-802-3p inhibitor | Oligonucleotides | |
| HY-RI04135A | mmu-miR-802-3p antagomir | Oligonucleotides | |
| HY-RI04136 | mmu-miR-802-5p inhibitor | Oligonucleotides | |
| HY-RI04136A | mmu-miR-802-5p antagomir | Oligonucleotides | |
| HY-RI04137 | mmu-miR-804 inhibitor | Oligonucleotides | |
| HY-RI04137A | mmu-miR-804 antagomir | Oligonucleotides | |
| HY-RI04138 | mmu-miR-8090 inhibitor | Oligonucleotides | |
| HY-RI04138A | mmu-miR-8090 antagomir | Oligonucleotides | |
| HY-RI04139 | mmu-miR-8091 inhibitor | Oligonucleotides | |
| HY-RI04139A | mmu-miR-8091 antagomir | Oligonucleotides | |
| HY-RI04140 | mmu-miR-8092 inhibitor | Oligonucleotides | |
| HY-RI04140A | mmu-miR-8092 antagomir | Oligonucleotides | |
| HY-RI04141 | mmu-miR-8093 inhibitor | Oligonucleotides | |
| HY-RI04141A | mmu-miR-8093 antagomir | Oligonucleotides | |
| HY-RI04142 | mmu-miR-8094 inhibitor | Oligonucleotides | |
| HY-RI04142A | mmu-miR-8094 antagomir | Oligonucleotides | |
| HY-RI04143 | mmu-miR-8095 inhibitor | Oligonucleotides | |
| HY-RI04143A | mmu-miR-8095 antagomir | Oligonucleotides | |
| HY-RI04144 | mmu-miR-8096 inhibitor | Oligonucleotides | |
| HY-RI04144A | mmu-miR-8096 antagomir | Oligonucleotides | |
| HY-RI04145 | mmu-miR-8097 inhibitor | Oligonucleotides | |
| HY-RI04145A | mmu-miR-8097 antagomir | Oligonucleotides | |
| HY-RI04146 | mmu-miR-8098 inhibitor | Oligonucleotides | |
| HY-RI04146A | mmu-miR-8098 antagomir | Oligonucleotides | |
| HY-RI04147 | mmu-miR-8099 inhibitor | Oligonucleotides | |
| HY-RI04147A | mmu-miR-8099 antagomir | Oligonucleotides | |
| HY-RI04148 | mmu-miR-8100 inhibitor | Oligonucleotides | |
| HY-RI04148A | mmu-miR-8100 antagomir | Oligonucleotides | |
| HY-RI04149 | mmu-miR-8101 inhibitor | Oligonucleotides | |
| HY-RI04149A | mmu-miR-8101 antagomir | Oligonucleotides | |
| HY-RI04150 | mmu-miR-8102 inhibitor | Oligonucleotides | |
| HY-RI04150A | mmu-miR-8102 antagomir | Oligonucleotides | |
| HY-RI04151 | mmu-miR-8103 inhibitor | Oligonucleotides | |
| HY-RI04151A | mmu-miR-8103 antagomir | Oligonucleotides | |
| HY-RI04152 | mmu-miR-8104 inhibitor | Oligonucleotides | |
| HY-RI04152A | mmu-miR-8104 antagomir | Oligonucleotides | |
| HY-RI04153 | mmu-miR-8105 inhibitor | Oligonucleotides | |
| HY-RI04153A | mmu-miR-8105 antagomir | Oligonucleotides | |
| HY-RI04154 | mmu-miR-8106 inhibitor | Oligonucleotides | |
| HY-RI04154A | mmu-miR-8106 antagomir | Oligonucleotides | |
| HY-RI04155 | mmu-miR-8107 inhibitor | Oligonucleotides | |
| HY-RI04155A | mmu-miR-8107 antagomir | Oligonucleotides | |
| HY-RI04156 | mmu-miR-8108 inhibitor | Oligonucleotides | |
| HY-RI04156A | mmu-miR-8108 antagomir | Oligonucleotides | |
| HY-RI04157 | mmu-miR-8109 inhibitor | Oligonucleotides | |
| HY-RI04157A | mmu-miR-8109 antagomir | Oligonucleotides | |
| HY-RI04158 | mmu-miR-8110 inhibitor | Oligonucleotides | |
| HY-RI04158A | mmu-miR-8110 antagomir | Oligonucleotides | |
| HY-RI04159 | mmu-miR-8111 inhibitor | Oligonucleotides | |
| HY-RI04159A | mmu-miR-8111 antagomir | Oligonucleotides | |
| HY-RI04160 | mmu-miR-8112 inhibitor | Oligonucleotides | |
| HY-RI04160A | mmu-miR-8112 antagomir | Oligonucleotides | |
| HY-RI04161 | mmu-miR-8113 inhibitor | Oligonucleotides | |
| HY-RI04161A | mmu-miR-8113 antagomir | Oligonucleotides | |
| HY-RI04162 | mmu-miR-8114 inhibitor | Oligonucleotides | |
| HY-RI04162A | mmu-miR-8114 antagomir | Oligonucleotides | |
| HY-RI04163 | mmu-miR-8115 inhibitor | Oligonucleotides | |
| HY-RI04163A | mmu-miR-8115 antagomir | Oligonucleotides | |
| HY-RI04164 | mmu-miR-8116 inhibitor | Oligonucleotides | |
| HY-RI04164A | mmu-miR-8116 antagomir | Oligonucleotides | |
| HY-RI04165 | mmu-miR-8117 inhibitor | Oligonucleotides | |
| HY-RI04165A | mmu-miR-8117 antagomir | Oligonucleotides | |
| HY-RI04166 | mmu-miR-8118 inhibitor | Oligonucleotides | |
| HY-RI04166A | mmu-miR-8118 antagomir | Oligonucleotides | |
| HY-RI04167 | mmu-miR-8119 inhibitor | Oligonucleotides | |
| HY-RI04167A | mmu-miR-8119 antagomir | Oligonucleotides | |
| HY-RI04168 | mmu-miR-8120 inhibitor | Oligonucleotides | |
| HY-RI04168A | mmu-miR-8120 antagomir | Oligonucleotides | |
| HY-RI04169 | mmu-miR-871-3p inhibitor | Oligonucleotides | |
| HY-RI04169A | mmu-miR-871-3p antagomir | Oligonucleotides | |
| HY-RI04170 | mmu-miR-871-5p inhibitor | Oligonucleotides | |
| HY-RI04170A | mmu-miR-871-5p antagomir | Oligonucleotides | |
| HY-RI04171 | mmu-miR-872-3p inhibitor | Oligonucleotides | |
| HY-RI04171A | mmu-miR-872-3p antagomir | Oligonucleotides | |
| HY-RI04172 | mmu-miR-873a-3p inhibitor | Oligonucleotides | |
| HY-RI04172A | mmu-miR-873a-3p antagomir | Oligonucleotides | |
| HY-RI04173 | mmu-miR-873b inhibitor | Oligonucleotides | |
| HY-RI04173A | mmu-miR-873b antagomir | Oligonucleotides | |
| HY-RI04174 | mmu-miR-874-5p inhibitor | Oligonucleotides | |
| HY-RI04174A | mmu-miR-874-5p antagomir | Oligonucleotides | |
| HY-RI04175 | mmu-miR-875-3p inhibitor | Oligonucleotides | |
| HY-RI04175A | mmu-miR-875-3p antagomir | Oligonucleotides | |
| HY-RI04176 | mmu-miR-876-3p inhibitor | Oligonucleotides | |
| HY-RI04176A | mmu-miR-876-3p antagomir | Oligonucleotides | |
| HY-RI04177 | mmu-miR-876-5p inhibitor | Oligonucleotides | |
| HY-RI04177A | mmu-miR-876-5p antagomir | Oligonucleotides | |
| HY-RI04178 | mmu-miR-877-3p inhibitor | Oligonucleotides | |
| HY-RI04178A | mmu-miR-877-3p antagomir | Oligonucleotides | |
| HY-RI04179 | mmu-miR-878-3p inhibitor | Oligonucleotides | |
| HY-RI04179A | mmu-miR-878-3p antagomir | Oligonucleotides | |
| HY-RI04180 | mmu-miR-878-5p inhibitor | Oligonucleotides | |
| HY-RI04180A | mmu-miR-878-5p antagomir | Oligonucleotides | |
| HY-RI04181 | mmu-miR-879-3p inhibitor | Oligonucleotides | |
| HY-RI04181A | mmu-miR-879-3p antagomir | Oligonucleotides | |
| HY-RI04182 | mmu-miR-879-5p inhibitor | Oligonucleotides | |
| HY-RI04182A | mmu-miR-879-5p antagomir | Oligonucleotides | |
| HY-RI04183 | mmu-miR-880-3p inhibitor | Oligonucleotides | |
| HY-RI04183A | mmu-miR-880-3p antagomir | Oligonucleotides | |
| HY-RI04184 | mmu-miR-880-5p inhibitor | Oligonucleotides | |
| HY-RI04184A | mmu-miR-880-5p antagomir | Oligonucleotides | |
| HY-RI04185 | mmu-miR-881-3p inhibitor | Oligonucleotides | |
| HY-RI04185A | mmu-miR-881-3p antagomir | Oligonucleotides | |
| HY-RI04186 | mmu-miR-881-5p inhibitor | Oligonucleotides | |
| HY-RI04186A | mmu-miR-881-5p antagomir | Oligonucleotides | |
| HY-RI04187 | mmu-miR-882 inhibitor | Oligonucleotides | |
| HY-RI04187A | mmu-miR-882 antagomir | Oligonucleotides | |
| HY-RI04188 | mmu-miR-883a-3p inhibitor | Oligonucleotides | |
| HY-RI04188A | mmu-miR-883a-3p antagomir | Oligonucleotides | |
| HY-RI04189 | mmu-miR-883a-5p inhibitor | Oligonucleotides | |
| HY-RI04189A | mmu-miR-883a-5p antagomir | Oligonucleotides | |
| HY-RI04190 | mmu-miR-883b-3p inhibitor | Oligonucleotides | |
| HY-RI04190A | mmu-miR-883b-3p antagomir | Oligonucleotides | |
| HY-RI04191 | mmu-miR-883b-5p inhibitor | Oligonucleotides | |
| HY-RI04191A | mmu-miR-883b-5p antagomir | Oligonucleotides | |
| HY-RI04192 | mmu-miR-92a-1-5p inhibitor | Oligonucleotides | |
| HY-RI04192A | mmu-miR-92a-1-5p antagomir | Oligonucleotides | |
| HY-RI04193 | mmu-miR-92a-2-5p inhibitor | Oligonucleotides | |
| HY-RI04193A | mmu-miR-92a-2-5p antagomir | Oligonucleotides | |
| HY-RI04194 | mmu-miR-92a-3p inhibitor | Oligonucleotides | |
| HY-RI04194A | mmu-miR-92a-3p antagomir | Oligonucleotides | |
| HY-RI04195 | mmu-miR-92b-5p inhibitor | Oligonucleotides | |
| HY-RI04195A | mmu-miR-92b-5p antagomir | Oligonucleotides | |
| HY-RI04196 | mmu-miR-935 inhibitor | Oligonucleotides | |
| HY-RI04196A | mmu-miR-935 antagomir | Oligonucleotides | |
| HY-RI04197 | mmu-miR-9768-3p inhibitor | Oligonucleotides | |
| HY-RI04197A | mmu-miR-9768-3p antagomir | Oligonucleotides | |
| HY-RI04198 | mmu-miR-9768-5p inhibitor | Oligonucleotides | |
| HY-RI04198A | mmu-miR-9768-5p antagomir | Oligonucleotides | |
| HY-RI04199 | mmu-miR-9769-3p inhibitor | Oligonucleotides | |
| HY-RI04199A | mmu-miR-9769-3p antagomir | Oligonucleotides | |
| HY-RI04200 | mmu-miR-9769-5p inhibitor | Oligonucleotides | |
| HY-RI04200A | mmu-miR-9769-5p antagomir | Oligonucleotides | |
| HY-RI04201 | mmu-miR-98-3p inhibitor | Oligonucleotides | |
| HY-RI04201A | mmu-miR-98-3p antagomir | Oligonucleotides | |
| HY-RI04202 | mmu-miR-99a-3p inhibitor | Oligonucleotides | |
| HY-RI04202A | mmu-miR-99a-3p antagomir | Oligonucleotides | |
| HY-RI04203 | mmu-miR-9b-3p inhibitor | Oligonucleotides | |
| HY-RI04203A | mmu-miR-9b-3p antagomir | Oligonucleotides | |
| HY-RI04204 | mmu-miR-9b-5p inhibitor | Oligonucleotides | |
| HY-RI04204A | mmu-miR-9b-5p antagomir | Oligonucleotides | |
| HY-RI04205 | rno-let-7f-1-3p inhibitor | Oligonucleotides | |
| HY-RI04205A | rno-let-7f-1-3p antagomir | Oligonucleotides | |
| HY-RI04206 | rno-miR-100-3p inhibitor | Oligonucleotides | |
| HY-RI04206A | rno-miR-100-3p antagomir | Oligonucleotides | |
| HY-RI04207 | rno-miR-101b-3p inhibitor | Oligonucleotides | |
| HY-RI04207A | rno-miR-101b-3p antagomir | Oligonucleotides | |
| HY-RI04208 | rno-miR-103-2-5p inhibitor | Oligonucleotides | |
| HY-RI04208A | rno-miR-103-2-5p antagomir | Oligonucleotides | |
| HY-RI04209 | rno-miR-105 inhibitor | Oligonucleotides | |
| HY-RI04209A | rno-miR-105 antagomir | Oligonucleotides | |
| HY-RI04210 | rno-miR-107-5p inhibitor | Oligonucleotides | |
| HY-RI04210A | rno-miR-107-5p antagomir | Oligonucleotides | |
| HY-RI04211 | rno-miR-10b-3p inhibitor | Oligonucleotides | |
| HY-RI04211A | rno-miR-10b-3p antagomir | Oligonucleotides | |
| HY-RI04212 | rno-miR-10b-5p inhibitor | Oligonucleotides | |
| HY-RI04212A | rno-miR-10b-5p antagomir | Oligonucleotides | |
| HY-RI04213 | rno-miR-1188-3p inhibitor | Oligonucleotides | |
| HY-RI04213A | rno-miR-1188-3p antagomir | Oligonucleotides | |
| HY-RI04214 | rno-miR-1193-3p inhibitor | Oligonucleotides | |
| HY-RI04214A | rno-miR-1193-3p antagomir | Oligonucleotides | |
| HY-RI04215 | rno-miR-1193-5p inhibitor | Oligonucleotides | |
| HY-RI04215A | rno-miR-1193-5p antagomir | Oligonucleotides | |
| HY-RI04216 | rno-miR-1199-3p inhibitor | Oligonucleotides | |
| HY-RI04216A | rno-miR-1199-3p antagomir | Oligonucleotides | |
| HY-RI04217 | rno-miR-1199-5p inhibitor | Oligonucleotides | |
| HY-RI04217A | rno-miR-1199-5p antagomir | Oligonucleotides | |
| HY-RI04218 | rno-miR-122-3p inhibitor | Oligonucleotides | |
| HY-RI04218A | rno-miR-122-3p antagomir | Oligonucleotides | |
| HY-RI04219 | rno-miR-122b inhibitor | Oligonucleotides | |
| HY-RI04219A | rno-miR-122b antagomir | Oligonucleotides | |
| HY-RI04220 | rno-miR-125b-2-3p inhibitor | Oligonucleotides | |
| HY-RI04220A | rno-miR-125b-2-3p antagomir | Oligonucleotides | |
| HY-RI04221 | rno-miR-126b inhibitor | Oligonucleotides | |
| HY-RI04221A | rno-miR-126b antagomir | Oligonucleotides | |
| HY-RI04222 | rno-miR-127-5p inhibitor | Oligonucleotides | |
| HY-RI04222A | rno-miR-127-5p antagomir | Oligonucleotides | |
| HY-RI04223 | rno-miR-128-2-5p inhibitor | Oligonucleotides | |
| HY-RI04223A | rno-miR-128-2-5p antagomir | Oligonucleotides | |
| HY-RI04224 | rno-miR-129-1-3p inhibitor | Oligonucleotides | |
| HY-RI04224A | rno-miR-129-1-3p antagomir | Oligonucleotides | |
| HY-RI04225 | rno-miR-1297 inhibitor | Oligonucleotides | |
| HY-RI04225A | rno-miR-1297 antagomir | Oligonucleotides | |
| HY-RI04226 | rno-miR-1306-3p inhibitor | Oligonucleotides | |
| HY-RI04226A | rno-miR-1306-3p antagomir | Oligonucleotides | |
| HY-RI04227 | rno-miR-133b-5p inhibitor | Oligonucleotides | |
| HY-RI04227A | rno-miR-133b-5p antagomir | Oligonucleotides | |
| HY-RI04228 | rno-miR-133c inhibitor | Oligonucleotides | |
| HY-RI04228A | rno-miR-133c antagomir | Oligonucleotides | |
| HY-RI04229 | rno-miR-134-3p inhibitor | Oligonucleotides | |
| HY-RI04229A | rno-miR-134-3p antagomir | Oligonucleotides | |
| HY-RI04230 | rno-miR-135a-3p inhibitor | Oligonucleotides | |
| HY-RI04230A | rno-miR-135a-3p antagomir | Oligonucleotides | |
| HY-RI04231 | rno-miR-137-5p inhibitor | Oligonucleotides | |
| HY-RI04231A | rno-miR-137-5p antagomir | Oligonucleotides | |
| HY-RI04232 | rno-miR-1-3p inhibitor | Oligonucleotides | |
| HY-RI04232A | rno-miR-1-3p antagomir | Oligonucleotides | |
| HY-RI04233 | rno-miR-141-5p inhibitor | Oligonucleotides | |
| HY-RI04233A | rno-miR-141-5p antagomir | Oligonucleotides | |
| HY-RI04234 | rno-miR-143-3p inhibitor | Oligonucleotides | |
| HY-RI04234A | rno-miR-143-3p antagomir | Oligonucleotides | |
| HY-RI04235 | rno-miR-145-3p inhibitor | Oligonucleotides | |
| HY-RI04235A | rno-miR-145-3p antagomir | Oligonucleotides | |
| HY-RI04236 | rno-miR-146a-3p inhibitor | Oligonucleotides | |
| HY-RI04236A | rno-miR-146a-3p antagomir | Oligonucleotides | |
| HY-RI04237 | rno-miR-146b-3p inhibitor | Oligonucleotides | |
| HY-RI04237A | rno-miR-146b-3p antagomir | Oligonucleotides | |
| HY-RI04238 | rno-miR-146b-5p inhibitor | Oligonucleotides | |
| HY-RI04238A | rno-miR-146b-5p antagomir | Oligonucleotides | |
| HY-RI04239 | rno-miR-148a-3p inhibitor | Oligonucleotides | |
| HY-RI04239A | rno-miR-148a-3p antagomir | Oligonucleotides | |
| HY-RI04240 | rno-miR-148a-5p inhibitor | Oligonucleotides | |
| HY-RI04240A | rno-miR-148a-5p antagomir | Oligonucleotides | |
| HY-RI04241 | rno-miR-148b-5p inhibitor | Oligonucleotides | |
| HY-RI04241A | rno-miR-148b-5p antagomir | Oligonucleotides | |
| HY-RI04242 | rno-miR-149-3p inhibitor | Oligonucleotides | |
| HY-RI04242A | rno-miR-149-3p antagomir | Oligonucleotides | |
| HY-RI04243 | rno-miR-150-3p inhibitor | Oligonucleotides | |
| HY-RI04243A | rno-miR-150-3p antagomir | Oligonucleotides | |
| HY-RI04244 | rno-miR-153-5p inhibitor | Oligonucleotides | |
| HY-RI04244A | rno-miR-153-5p antagomir | Oligonucleotides | |
| HY-RI04245 | rno-miR-15a-3p inhibitor | Oligonucleotides | |
| HY-RI04245A | rno-miR-15a-3p antagomir | Oligonucleotides | |
| HY-RI04246 | rno-miR-15a-5p inhibitor | Oligonucleotides | |
| HY-RI04246A | rno-miR-15a-5p antagomir | Oligonucleotides | |
| HY-RI04247 | rno-miR-1-5p inhibitor | Oligonucleotides | |
| HY-RI04247A | rno-miR-1-5p antagomir | Oligonucleotides | |
| HY-RI04248 | rno-miR-16-3p inhibitor | Oligonucleotides | |
| HY-RI04248A | rno-miR-16-3p antagomir | Oligonucleotides | |
| HY-RI04249 | rno-miR-17-1-3p inhibitor | Oligonucleotides | |
| HY-RI04249A | rno-miR-17-1-3p antagomir | Oligonucleotides | |
| HY-RI04250 | rno-miR-17-2-3p inhibitor | Oligonucleotides | |
| HY-RI04250A | rno-miR-17-2-3p antagomir | Oligonucleotides | |
| HY-RI04251 | rno-miR-181a-2-3p inhibitor | Oligonucleotides | |
| HY-RI04251A | rno-miR-181a-2-3p antagomir | Oligonucleotides | |
| HY-RI04252 | rno-miR-181b-2-3p inhibitor | Oligonucleotides | |
| HY-RI04252A | rno-miR-181b-2-3p antagomir | Oligonucleotides | |
| HY-RI04253 | rno-miR-181d-3p inhibitor | Oligonucleotides | |
| HY-RI04253A | rno-miR-181d-3p antagomir | Oligonucleotides | |
| HY-RI04254 | rno-miR-183-3p inhibitor | Oligonucleotides | |
| HY-RI04254A | rno-miR-183-3p antagomir | Oligonucleotides | |
| HY-RI04255 | rno-miR-1839-3p inhibitor | Oligonucleotides | |
| HY-RI04255A | rno-miR-1839-3p antagomir | Oligonucleotides | |
| HY-RI04256 | rno-miR-1843b-3p inhibitor | Oligonucleotides | |
| HY-RI04256A | rno-miR-1843b-3p antagomir | Oligonucleotides | |
| HY-RI04257 | rno-miR-1843b-5p inhibitor | Oligonucleotides | |
| HY-RI04257A | rno-miR-1843b-5p antagomir | Oligonucleotides | |
| HY-RI04258 | rno-miR-185-3p inhibitor | Oligonucleotides | |
| HY-RI04258A | rno-miR-185-3p antagomir | Oligonucleotides | |
| HY-RI04259 | rno-miR-186-3p inhibitor | Oligonucleotides | |
| HY-RI04259A | rno-miR-186-3p antagomir | Oligonucleotides | |
| HY-RI04260 | rno-miR-187-5p inhibitor | Oligonucleotides | |
| HY-RI04260A | rno-miR-187-5p antagomir | Oligonucleotides | |
| HY-RI04261 | rno-miR-188-3p inhibitor | Oligonucleotides | |
| HY-RI04261A | rno-miR-188-3p antagomir | Oligonucleotides | |
| HY-RI04262 | rno-miR-1896 inhibitor | Oligonucleotides | |
| HY-RI04262A | rno-miR-1896 antagomir | Oligonucleotides | |
| HY-RI04263 | rno-miR-18a-3p inhibitor | Oligonucleotides | |
| HY-RI04263A | rno-miR-18a-3p antagomir | Oligonucleotides | |
| HY-RI04264 | rno-miR-190b-3p inhibitor | Oligonucleotides | |
| HY-RI04264A | rno-miR-190b-3p antagomir | Oligonucleotides | |
| HY-RI04265 | rno-miR-190b-5p inhibitor | Oligonucleotides | |
| HY-RI04265A | rno-miR-190b-5p antagomir | Oligonucleotides | |
| HY-RI04266 | rno-miR-1912-3p inhibitor | Oligonucleotides | |
| HY-RI04266A | rno-miR-1912-3p antagomir | Oligonucleotides | |
| HY-RI04267 | rno-miR-1912-5p inhibitor | Oligonucleotides | |
| HY-RI04267A | rno-miR-1912-5p antagomir | Oligonucleotides | |
| HY-RI04268 | rno-miR-191b inhibitor | Oligonucleotides | |
| HY-RI04268A | rno-miR-191b antagomir | Oligonucleotides | |
| HY-RI04269 | rno-miR-192-3p inhibitor | Oligonucleotides | |
| HY-RI04269A | rno-miR-192-3p antagomir | Oligonucleotides | |
| HY-RI04270 | rno-miR-193b-3p inhibitor | Oligonucleotides | |
| HY-RI04270A | rno-miR-193b-3p antagomir | Oligonucleotides | |
| HY-RI04271 | rno-miR-193b-5p inhibitor | Oligonucleotides | |
| HY-RI04271A | rno-miR-193b-5p antagomir | Oligonucleotides | |
| HY-RI04272 | rno-miR-194-3p inhibitor | Oligonucleotides | |
| HY-RI04272A | rno-miR-194-3p antagomir | Oligonucleotides | |
| HY-RI04273 | rno-miR-1949 inhibitor | Oligonucleotides | |
| HY-RI04273A | rno-miR-1949 antagomir | Oligonucleotides | |
| HY-RI04274 | rno-miR-195-3p inhibitor | Oligonucleotides | |
| HY-RI04274A | rno-miR-195-3p antagomir | Oligonucleotides | |
| HY-RI04275 | rno-miR-1956-3p inhibitor | Oligonucleotides | |
| HY-RI04275A | rno-miR-1956-3p antagomir | Oligonucleotides | |
| HY-RI04276 | rno-miR-196b-3p inhibitor | Oligonucleotides | |
| HY-RI04276A | rno-miR-196b-3p antagomir | Oligonucleotides | |
| HY-RI04277 | rno-miR-196c-3p inhibitor | Oligonucleotides | |
| HY-RI04277A | rno-miR-196c-3p antagomir | Oligonucleotides | |
| HY-RI04278 | rno-miR-196c-5p inhibitor | Oligonucleotides | |
| HY-RI04278A | rno-miR-196c-5p antagomir | Oligonucleotides | |
| HY-RI04279 | rno-miR-19a-5p inhibitor | Oligonucleotides | |
| HY-RI04279A | rno-miR-19a-5p antagomir | Oligonucleotides | |
| HY-RI04280 | rno-miR-19b-1-5p inhibitor | Oligonucleotides | |
| HY-RI04280A | rno-miR-19b-1-5p antagomir | Oligonucleotides | |
| HY-RI04281 | rno-miR-19b-2-5p inhibitor | Oligonucleotides | |
| HY-RI04281A | rno-miR-19b-2-5p antagomir | Oligonucleotides | |
| HY-RI04282 | rno-miR-200a-5p inhibitor | Oligonucleotides | |
| HY-RI04282A | rno-miR-200a-5p antagomir | Oligonucleotides | |
| HY-RI04283 | rno-miR-200b-3p inhibitor | Oligonucleotides | |
| HY-RI04283A | rno-miR-200b-3p antagomir | Oligonucleotides | |
| HY-RI04284 | rno-miR-200c-3p inhibitor | Oligonucleotides | |
| HY-RI04284A | rno-miR-200c-3p antagomir | Oligonucleotides | |
| HY-RI04285 | rno-miR-200c-5p inhibitor | Oligonucleotides | |
| HY-RI04285A | rno-miR-200c-5p antagomir | Oligonucleotides | |
| HY-RI04286 | rno-miR-201-3p inhibitor | Oligonucleotides | |
| HY-RI04286A | rno-miR-201-3p antagomir | Oligonucleotides | |
| HY-RI04287 | rno-miR-201-5p inhibitor | Oligonucleotides | |
| HY-RI04287A | rno-miR-201-5p antagomir | Oligonucleotides | |
| HY-RI04288 | rno-miR-202-3p inhibitor | Oligonucleotides | |
| HY-RI04288A | rno-miR-202-3p antagomir | Oligonucleotides | |
| HY-RI04289 | rno-miR-202-5p inhibitor | Oligonucleotides | |
| HY-RI04289A | rno-miR-202-5p antagomir | Oligonucleotides | |
| HY-RI04290 | rno-miR-203a-5p inhibitor | Oligonucleotides | |
| HY-RI04290A | rno-miR-203a-5p antagomir | Oligonucleotides | |
| HY-RI04291 | rno-miR-204-3p inhibitor | Oligonucleotides | |
| HY-RI04291A | rno-miR-204-3p antagomir | Oligonucleotides | |
| HY-RI04292 | rno-miR-205 inhibitor | Oligonucleotides | |
| HY-RI04292A | rno-miR-205 antagomir | Oligonucleotides | |
| HY-RI04293 | rno-miR-206-5p inhibitor | Oligonucleotides | |
| HY-RI04293A | rno-miR-206-5p antagomir | Oligonucleotides | |
| HY-RI04294 | rno-miR-207 inhibitor | Oligonucleotides | |
| HY-RI04294A | rno-miR-207 antagomir | Oligonucleotides | |
| HY-RI04295 | rno-miR-208a-3p inhibitor | Oligonucleotides | |
| HY-RI04295A | rno-miR-208a-3p antagomir | Oligonucleotides | |
| HY-RI04296 | rno-miR-208b-3p inhibitor | Oligonucleotides | |
| HY-RI04296A | rno-miR-208b-3p antagomir | Oligonucleotides | |
| HY-RI04297 | rno-miR-208b-5p inhibitor | Oligonucleotides | |
| HY-RI04297A | rno-miR-208b-5p antagomir | Oligonucleotides | |
| HY-RI04298 | rno-miR-20a-3p inhibitor | Oligonucleotides | |
| HY-RI04298A | rno-miR-20a-3p antagomir | Oligonucleotides | |
| HY-RI04299 | rno-miR-20b-3p inhibitor | Oligonucleotides | |
| HY-RI04299A | rno-miR-20b-3p antagomir | Oligonucleotides | |
| HY-RI04300 | rno-miR-210-5p inhibitor | Oligonucleotides | |
| HY-RI04300A | rno-miR-210-5p antagomir | Oligonucleotides | |
| HY-RI04301 | rno-miR-211-3p inhibitor | Oligonucleotides | |
| HY-RI04301A | rno-miR-211-3p antagomir | Oligonucleotides | |
| HY-RI04302 | rno-miR-212-5p inhibitor | Oligonucleotides | |
| HY-RI04302A | rno-miR-212-5p antagomir | Oligonucleotides | |
| HY-RI04303 | rno-miR-214-3p inhibitor | Oligonucleotides | |
| HY-RI04303A | rno-miR-214-3p antagomir | Oligonucleotides | |
| HY-RI04304 | rno-miR-214-5p inhibitor | Oligonucleotides | |
| HY-RI04304A | rno-miR-214-5p antagomir | Oligonucleotides | |
| HY-RI04305 | rno-miR-215 inhibitor | Oligonucleotides | |
| HY-RI04305A | rno-miR-215 antagomir | Oligonucleotides | |
| HY-RI04306 | rno-miR-216b-3p inhibitor | Oligonucleotides | |
| HY-RI04306A | rno-miR-216b-3p antagomir | Oligonucleotides | |
| HY-RI04307 | rno-miR-217-3p inhibitor | Oligonucleotides | |
| HY-RI04307A | rno-miR-217-3p antagomir | Oligonucleotides | |
| HY-RI04308 | rno-miR-217-5p inhibitor | Oligonucleotides | |
| HY-RI04308A | rno-miR-217-5p antagomir | Oligonucleotides | |
| HY-RI04309 | rno-miR-218a-1-3p inhibitor | Oligonucleotides | |
| HY-RI04309A | rno-miR-218a-1-3p antagomir | Oligonucleotides | |
| HY-RI04310 | rno-miR-218b inhibitor | Oligonucleotides | |
| HY-RI04310A | rno-miR-218b antagomir | Oligonucleotides | |
| HY-RI04311 | rno-miR-221-5p inhibitor | Oligonucleotides | |
| HY-RI04311A | rno-miR-221-5p antagomir | Oligonucleotides | |
| HY-RI04312 | rno-miR-222-5p inhibitor | Oligonucleotides | |
| HY-RI04312A | rno-miR-222-5p antagomir | Oligonucleotides | |
| HY-RI04313 | rno-miR-223-3p inhibitor | Oligonucleotides | |
| HY-RI04313A | rno-miR-223-3p antagomir | Oligonucleotides | |
| HY-RI04314 | rno-miR-24-1-5p inhibitor | Oligonucleotides | |
| HY-RI04314A | rno-miR-24-1-5p antagomir | Oligonucleotides | |
| HY-RI04315 | rno-miR-25-5p inhibitor | Oligonucleotides | |
| HY-RI04315A | rno-miR-25-5p antagomir | Oligonucleotides | |
| HY-RI04316 | rno-miR-26a-3p inhibitor | Oligonucleotides | |
| HY-RI04316A | rno-miR-26a-3p antagomir | Oligonucleotides | |
| HY-RI04317 | rno-miR-27b-5p inhibitor | Oligonucleotides | |
| HY-RI04317A | rno-miR-27b-5p antagomir | Oligonucleotides | |
| HY-RI04318 | rno-miR-290 inhibitor | Oligonucleotides | |
| HY-RI04318A | rno-miR-290 antagomir | Oligonucleotides | |
| HY-RI04319 | rno-miR-291a-3p inhibitor | Oligonucleotides | |
| HY-RI04319A | rno-miR-291a-3p antagomir | Oligonucleotides | |
| HY-RI04320 | rno-miR-291b inhibitor | Oligonucleotides | |
| HY-RI04320A | rno-miR-291b antagomir | Oligonucleotides | |
| HY-RI04321 | rno-miR-292-3p inhibitor | Oligonucleotides | |
| HY-RI04321A | rno-miR-292-3p antagomir | Oligonucleotides | |
| HY-RI04322 | rno-miR-293-3p inhibitor | Oligonucleotides | |
| HY-RI04322A | rno-miR-293-3p antagomir | Oligonucleotides | |
| HY-RI04323 | rno-miR-293-5p inhibitor | Oligonucleotides | |
| HY-RI04323A | rno-miR-293-5p antagomir | Oligonucleotides | |
| HY-RI04324 | rno-miR-294 inhibitor | Oligonucleotides | |
| HY-RI04324A | rno-miR-294 antagomir | Oligonucleotides | |
| HY-RI04325 | rno-miR-295-3p inhibitor | Oligonucleotides | |
| HY-RI04325A | rno-miR-295-3p antagomir | Oligonucleotides | |
| HY-RI04326 | rno-miR-295-5p inhibitor | Oligonucleotides | |
| HY-RI04326A | rno-miR-295-5p antagomir | Oligonucleotides | |
| HY-RI04327 | rno-miR-297 inhibitor | Oligonucleotides | |
| HY-RI04327A | rno-miR-297 antagomir | Oligonucleotides | |
| HY-RI04328 | rno-miR-298-3p inhibitor | Oligonucleotides | |
| HY-RI04328A | rno-miR-298-3p antagomir | Oligonucleotides | |
| HY-RI04329 | rno-miR-2985 inhibitor | Oligonucleotides | |
| HY-RI04329A | rno-miR-2985 antagomir | Oligonucleotides | |
| HY-RI04330 | rno-miR-299b-3p inhibitor | Oligonucleotides | |
| HY-RI04330A | rno-miR-299b-3p antagomir | Oligonucleotides | |
| HY-RI04331 | rno-miR-299b-5p inhibitor | Oligonucleotides | |
| HY-RI04331A | rno-miR-299b-5p antagomir | Oligonucleotides | |
| HY-RI04332 | rno-miR-29b-1-5p inhibitor | Oligonucleotides | |
| HY-RI04332A | rno-miR-29b-1-5p antagomir | Oligonucleotides | |
| HY-RI04333 | rno-miR-301a-5p inhibitor | Oligonucleotides | |
| HY-RI04333A | rno-miR-301a-5p antagomir | Oligonucleotides | |
| HY-RI04334 | rno-miR-3064-3p inhibitor | Oligonucleotides | |
| HY-RI04334A | rno-miR-3064-3p antagomir | Oligonucleotides | |
| HY-RI04335 | rno-miR-3064-5p inhibitor | Oligonucleotides | |
| HY-RI04335A | rno-miR-3064-5p antagomir | Oligonucleotides | |
| HY-RI04336 | rno-miR-3065-3p inhibitor | Oligonucleotides | |
| HY-RI04336A | rno-miR-3065-3p antagomir | Oligonucleotides | |
| HY-RI04337 | rno-miR-3065-5p inhibitor | Oligonucleotides | |
| HY-RI04337A | rno-miR-3065-5p antagomir | Oligonucleotides | |
| HY-RI04338 | rno-miR-3068-5p inhibitor | Oligonucleotides | |
| HY-RI04338A | rno-miR-3068-5p antagomir | Oligonucleotides | |
| HY-RI04339 | rno-miR-3072 inhibitor | Oligonucleotides | |
| HY-RI04339A | rno-miR-3072 antagomir | Oligonucleotides | |
| HY-RI04340 | rno-miR-3075 inhibitor | Oligonucleotides | |
| HY-RI04340A | rno-miR-3075 antagomir | Oligonucleotides | |
| HY-RI04341 | rno-miR-3084a-1-5p inhibitor | Oligonucleotides | |
| HY-RI04341A | rno-miR-3084a-1-5p antagomir | Oligonucleotides | |
| HY-RI04342 | rno-miR-3084a-3p inhibitor | Oligonucleotides | |
| HY-RI04342A | rno-miR-3084a-3p antagomir | Oligonucleotides | |
| HY-RI04343 | rno-miR-3084b-3p inhibitor | Oligonucleotides | |
| HY-RI04343A | rno-miR-3084b-3p antagomir | Oligonucleotides | |
| HY-RI04344 | rno-miR-3084b-5p inhibitor | Oligonucleotides | |
| HY-RI04344A | rno-miR-3084b-5p antagomir | Oligonucleotides | |
| HY-RI04345 | rno-miR-3099 inhibitor | Oligonucleotides | |
| HY-RI04345A | rno-miR-3099 antagomir | Oligonucleotides | |
| HY-RI04346 | rno-miR-31b inhibitor | Oligonucleotides | |
| HY-RI04346A | rno-miR-31b antagomir | Oligonucleotides | |
| HY-RI04347 | rno-miR-322-3p inhibitor | Oligonucleotides | |
| HY-RI04347A | rno-miR-322-3p antagomir | Oligonucleotides | |
| HY-RI04348 | rno-miR-32-3p inhibitor | Oligonucleotides | |
| HY-RI04348A | rno-miR-32-3p antagomir | Oligonucleotides | |
| HY-RI04349 | rno-miR-324-3p inhibitor | Oligonucleotides | |
| HY-RI04349A | rno-miR-324-3p antagomir | Oligonucleotides | |
| HY-RI04350 | rno-miR-326-5p inhibitor | Oligonucleotides | |
| HY-RI04350A | rno-miR-326-5p antagomir | Oligonucleotides | |
| HY-RI04351 | rno-miR-327 inhibitor | Oligonucleotides | |
| HY-RI04351A | rno-miR-327 antagomir | Oligonucleotides | |
| HY-RI04352 | rno-miR-328a-5p inhibitor | Oligonucleotides | |
| HY-RI04352A | rno-miR-328a-5p antagomir | Oligonucleotides | |
| HY-RI04353 | rno-miR-328b-3p inhibitor | Oligonucleotides | |
| HY-RI04353A | rno-miR-328b-3p antagomir | Oligonucleotides | |
| HY-RI04354 | rno-miR-329-5p inhibitor | Oligonucleotides | |
| HY-RI04354A | rno-miR-329-5p antagomir | Oligonucleotides | |
| HY-RI04355 | rno-miR-331-5p inhibitor | Oligonucleotides | |
| HY-RI04355A | rno-miR-331-5p antagomir | Oligonucleotides | |
| HY-RI04356 | rno-miR-33-3p inhibitor | Oligonucleotides | |
| HY-RI04356A | rno-miR-33-3p antagomir | Oligonucleotides | |
| HY-RI04357 | rno-miR-336-3p inhibitor | Oligonucleotides | |
| HY-RI04357A | rno-miR-336-3p antagomir | Oligonucleotides | |
| HY-RI04358 | rno-miR-336-5p inhibitor | Oligonucleotides | |
| HY-RI04358A | rno-miR-336-5p antagomir | Oligonucleotides | |
| HY-RI04359 | rno-miR-337-3p inhibitor | Oligonucleotides | |
| HY-RI04359A | rno-miR-337-3p antagomir | Oligonucleotides | |
| HY-RI04360 | rno-miR-337-5p inhibitor | Oligonucleotides | |
| HY-RI04360A | rno-miR-337-5p antagomir | Oligonucleotides | |
| HY-RI04361 | rno-miR-339-3p inhibitor | Oligonucleotides | |
| HY-RI04361A | rno-miR-339-3p antagomir | Oligonucleotides | |
| HY-RI04362 | rno-miR-343 inhibitor | Oligonucleotides | |
| HY-RI04362A | rno-miR-343 antagomir | Oligonucleotides | |
| HY-RI04363 | rno-miR-344a-5p inhibitor | Oligonucleotides | |
| HY-RI04363A | rno-miR-344a-5p antagomir | Oligonucleotides | |
| HY-RI04364 | rno-miR-344b-1-3p inhibitor | Oligonucleotides | |
| HY-RI04364A | rno-miR-344b-1-3p antagomir | Oligonucleotides | |
| HY-RI04365 | rno-miR-344b-5p inhibitor | Oligonucleotides | |
| HY-RI04365A | rno-miR-344b-5p antagomir | Oligonucleotides | |
| HY-RI04366 | rno-miR-344g inhibitor | Oligonucleotides | |
| HY-RI04366A | rno-miR-344g antagomir | Oligonucleotides | |
| HY-RI04367 | rno-miR-344i inhibitor | Oligonucleotides | |
| HY-RI04367A | rno-miR-344i antagomir | Oligonucleotides | |
| HY-RI04368 | rno-miR-345-3p inhibitor | Oligonucleotides | |
| HY-RI04368A | rno-miR-345-3p antagomir | Oligonucleotides | |
| HY-RI04369 | rno-miR-345-5p inhibitor | Oligonucleotides | |
| HY-RI04369A | rno-miR-345-5p antagomir | Oligonucleotides | |
| HY-RI04370 | rno-miR-346 inhibitor | Oligonucleotides | |
| HY-RI04370A | rno-miR-346 antagomir | Oligonucleotides | |
| HY-RI04371 | rno-miR-347 inhibitor | Oligonucleotides | |
| HY-RI04371A | rno-miR-347 antagomir | Oligonucleotides | |
| HY-RI04372 | rno-miR-3473 inhibitor | Oligonucleotides | |
| HY-RI04372A | rno-miR-3473 antagomir | Oligonucleotides | |
| HY-RI04373 | rno-miR-349 inhibitor | Oligonucleotides | |
| HY-RI04373A | rno-miR-349 antagomir | Oligonucleotides | |
| HY-RI04374 | rno-miR-34a-3p inhibitor | Oligonucleotides | |
| HY-RI04374A | rno-miR-34a-3p antagomir | Oligonucleotides | |
| HY-RI04375 | rno-miR-350 inhibitor | Oligonucleotides | |
| HY-RI04375A | rno-miR-350 antagomir | Oligonucleotides | |
| HY-RI04376 | rno-miR-351-5p inhibitor | Oligonucleotides | |
| HY-RI04376A | rno-miR-351-5p antagomir | Oligonucleotides | |
| HY-RI04377 | rno-miR-352 inhibitor | Oligonucleotides | |
| HY-RI04377A | rno-miR-352 antagomir | Oligonucleotides | |
| HY-RI04378 | rno-miR-3541 inhibitor | Oligonucleotides | |
| HY-RI04378A | rno-miR-3541 antagomir | Oligonucleotides | |
| HY-RI04379 | rno-miR-3542 inhibitor | Oligonucleotides | |
| HY-RI04379A | rno-miR-3542 antagomir | Oligonucleotides | |
| HY-RI04380 | rno-miR-3543 inhibitor | Oligonucleotides | |
| HY-RI04380A | rno-miR-3543 antagomir | Oligonucleotides | |
| HY-RI04381 | rno-miR-3544 inhibitor | Oligonucleotides | |
| HY-RI04381A | rno-miR-3544 antagomir | Oligonucleotides | |
| HY-RI04382 | rno-miR-3546 inhibitor | Oligonucleotides | |
| HY-RI04382A | rno-miR-3546 antagomir | Oligonucleotides | |
| HY-RI04383 | rno-miR-3547 inhibitor | Oligonucleotides | |
| HY-RI04383A | rno-miR-3547 antagomir | Oligonucleotides | |
| HY-RI04384 | rno-miR-3548 inhibitor | Oligonucleotides | |
| HY-RI04384A | rno-miR-3548 antagomir | Oligonucleotides | |
| HY-RI04385 | rno-miR-3549 inhibitor | Oligonucleotides | |
| HY-RI04385A | rno-miR-3549 antagomir | Oligonucleotides | |
| HY-RI04386 | rno-miR-3550 inhibitor | Oligonucleotides | |
| HY-RI04386A | rno-miR-3550 antagomir | Oligonucleotides | |
| HY-RI04387 | rno-miR-3551-3p inhibitor | Oligonucleotides | |
| HY-RI04387A | rno-miR-3551-3p antagomir | Oligonucleotides | |
| HY-RI04388 | rno-miR-3551-5p inhibitor | Oligonucleotides | |
| HY-RI04388A | rno-miR-3551-5p antagomir | Oligonucleotides | |
| HY-RI04389 | rno-miR-3553 inhibitor | Oligonucleotides | |
| HY-RI04389A | rno-miR-3553 antagomir | Oligonucleotides | |
| HY-RI04390 | rno-miR-3556a inhibitor | Oligonucleotides | |
| HY-RI04390A | rno-miR-3556a antagomir | Oligonucleotides | |
| HY-RI04391 | rno-miR-3556b inhibitor | Oligonucleotides | |
| HY-RI04391A | rno-miR-3556b antagomir | Oligonucleotides | |
| HY-RI04392 | rno-miR-3557-3p inhibitor | Oligonucleotides | |
| HY-RI04392A | rno-miR-3557-3p antagomir | Oligonucleotides | |
| HY-RI04393 | rno-miR-3557-5p inhibitor | Oligonucleotides | |
| HY-RI04393A | rno-miR-3557-5p antagomir | Oligonucleotides | |
| HY-RI04394 | rno-miR-3558-3p inhibitor | Oligonucleotides | |
| HY-RI04394A | rno-miR-3558-3p antagomir | Oligonucleotides | |
| HY-RI04395 | rno-miR-3558-5p inhibitor | Oligonucleotides | |
| HY-RI04395A | rno-miR-3558-5p antagomir | Oligonucleotides | |
| HY-RI04396 | rno-miR-3559-3p inhibitor | Oligonucleotides | |
| HY-RI04396A | rno-miR-3559-3p antagomir | Oligonucleotides | |
| HY-RI04397 | rno-miR-3559-5p inhibitor | Oligonucleotides | |
| HY-RI04397A | rno-miR-3559-5p antagomir | Oligonucleotides | |
| HY-RI04398 | rno-miR-3560 inhibitor | Oligonucleotides | |
| HY-RI04398A | rno-miR-3560 antagomir | Oligonucleotides | |
| HY-RI04399 | rno-miR-3561-3p inhibitor | Oligonucleotides | |
| HY-RI04399A | rno-miR-3561-3p antagomir | Oligonucleotides | |
| HY-RI04400 | rno-miR-3561-5p inhibitor | Oligonucleotides | |
| HY-RI04400A | rno-miR-3561-5p antagomir | Oligonucleotides | |
| HY-RI04401 | rno-miR-3562 inhibitor | Oligonucleotides | |
| HY-RI04401A | rno-miR-3562 antagomir | Oligonucleotides | |
| HY-RI04402 | rno-miR-3564 inhibitor | Oligonucleotides | |
| HY-RI04402A | rno-miR-3564 antagomir | Oligonucleotides | |
| HY-RI04403 | rno-miR-3566 inhibitor | Oligonucleotides | |
| HY-RI04403A | rno-miR-3566 antagomir | Oligonucleotides | |
| HY-RI04404 | rno-miR-3568 inhibitor | Oligonucleotides | |
| HY-RI04404A | rno-miR-3568 antagomir | Oligonucleotides | |
| HY-RI04405 | rno-miR-3569 inhibitor | Oligonucleotides | |
| HY-RI04405A | rno-miR-3569 antagomir | Oligonucleotides | |
| HY-RI04406 | rno-miR-3570 inhibitor | Oligonucleotides | |
| HY-RI04406A | rno-miR-3570 antagomir | Oligonucleotides | |
| HY-RI04407 | rno-miR-3571 inhibitor | Oligonucleotides | |
| HY-RI04407A | rno-miR-3571 antagomir | Oligonucleotides | |
| HY-RI04408 | rno-miR-3572 inhibitor | Oligonucleotides | |
| HY-RI04408A | rno-miR-3572 antagomir | Oligonucleotides | |
| HY-RI04409 | rno-miR-3573-3p inhibitor | Oligonucleotides | |
| HY-RI04409A | rno-miR-3573-3p antagomir | Oligonucleotides | |
| HY-RI04410 | rno-miR-3573-5p inhibitor | Oligonucleotides | |
| HY-RI04410A | rno-miR-3573-5p antagomir | Oligonucleotides | |
| HY-RI04411 | rno-miR-3574 inhibitor | Oligonucleotides | |
| HY-RI04411A | rno-miR-3574 antagomir | Oligonucleotides | |
| HY-RI04412 | rno-miR-3575 inhibitor | Oligonucleotides | |
| HY-RI04412A | rno-miR-3575 antagomir | Oligonucleotides | |
| HY-RI04413 | rno-miR-3576 inhibitor | Oligonucleotides | |
| HY-RI04413A | rno-miR-3576 antagomir | Oligonucleotides | |
| HY-RI04414 | rno-miR-3577 inhibitor | Oligonucleotides | |
| HY-RI04414A | rno-miR-3577 antagomir | Oligonucleotides | |
| HY-RI04415 | rno-miR-3578 inhibitor | Oligonucleotides | |
| HY-RI04415A | rno-miR-3578 antagomir | Oligonucleotides | |
| HY-RI04416 | rno-miR-3579 inhibitor | Oligonucleotides | |
| HY-RI04416A | rno-miR-3579 antagomir | Oligonucleotides | |
| HY-RI04417 | rno-miR-3580-3p inhibitor | Oligonucleotides | |
| HY-RI04417A | rno-miR-3580-3p antagomir | Oligonucleotides | |
| HY-RI04418 | rno-miR-3580-5p inhibitor | Oligonucleotides | |
| HY-RI04418A | rno-miR-3580-5p antagomir | Oligonucleotides | |
| HY-RI04419 | rno-miR-3583-3p inhibitor | Oligonucleotides | |
| HY-RI04419A | rno-miR-3583-3p antagomir | Oligonucleotides | |
| HY-RI04420 | rno-miR-3583-5p inhibitor | Oligonucleotides | |
| HY-RI04420A | rno-miR-3583-5p antagomir | Oligonucleotides | |
| HY-RI04421 | rno-miR-3584-3p inhibitor | Oligonucleotides | |
| HY-RI04421A | rno-miR-3584-3p antagomir | Oligonucleotides | |
| HY-RI04422 | rno-miR-3584-5p inhibitor | Oligonucleotides | |
| HY-RI04422A | rno-miR-3584-5p antagomir | Oligonucleotides | |
| HY-RI04423 | rno-miR-3585-3p inhibitor | Oligonucleotides | |
| HY-RI04423A | rno-miR-3585-3p antagomir | Oligonucleotides | |
| HY-RI04424 | rno-miR-3585-5p inhibitor | Oligonucleotides | |
| HY-RI04424A | rno-miR-3585-5p antagomir | Oligonucleotides | |
| HY-RI04425 | rno-miR-3586-3p inhibitor | Oligonucleotides | |
| HY-RI04425A | rno-miR-3586-3p antagomir | Oligonucleotides | |
| HY-RI04426 | rno-miR-3586-5p inhibitor | Oligonucleotides | |
| HY-RI04426A | rno-miR-3586-5p antagomir | Oligonucleotides | |
| HY-RI04427 | rno-miR-3587 inhibitor | Oligonucleotides | |
| HY-RI04427A | rno-miR-3587 antagomir | Oligonucleotides | |
| HY-RI04428 | rno-miR-3588 inhibitor | Oligonucleotides | |
| HY-RI04428A | rno-miR-3588 antagomir | Oligonucleotides | |
| HY-RI04429 | rno-miR-3589 inhibitor | Oligonucleotides | |
| HY-RI04429A | rno-miR-3589 antagomir | Oligonucleotides | |
| HY-RI04430 | rno-miR-3590-3p inhibitor | Oligonucleotides | |
| HY-RI04430A | rno-miR-3590-3p antagomir | Oligonucleotides | |
| HY-RI04431 | rno-miR-3590-5p inhibitor | Oligonucleotides | |
| HY-RI04431A | rno-miR-3590-5p antagomir | Oligonucleotides | |
| HY-RI04432 | rno-miR-3592 inhibitor | Oligonucleotides | |
| HY-RI04432A | rno-miR-3592 antagomir | Oligonucleotides | |
| HY-RI04433 | rno-miR-3593-3p inhibitor | Oligonucleotides | |
| HY-RI04433A | rno-miR-3593-3p antagomir | Oligonucleotides | |
| HY-RI04434 | rno-miR-3593-5p inhibitor | Oligonucleotides | |
| HY-RI04434A | rno-miR-3593-5p antagomir | Oligonucleotides | |
| HY-RI04435 | rno-miR-3594-3p inhibitor | Oligonucleotides | |
| HY-RI04435A | rno-miR-3594-3p antagomir | Oligonucleotides | |
| HY-RI04436 | rno-miR-3594-5p inhibitor | Oligonucleotides | |
| HY-RI04436A | rno-miR-3594-5p antagomir | Oligonucleotides | |
| HY-RI04437 | rno-miR-3595 inhibitor | Oligonucleotides | |
| HY-RI04437A | rno-miR-3595 antagomir | Oligonucleotides | |
| HY-RI04438 | rno-miR-3596a inhibitor | Oligonucleotides | |
| HY-RI04438A | rno-miR-3596a antagomir | Oligonucleotides | |
| HY-RI04439 | rno-miR-3596b inhibitor | Oligonucleotides | |
| HY-RI04439A | rno-miR-3596b antagomir | Oligonucleotides | |
| HY-RI04440 | rno-miR-3596c inhibitor | Oligonucleotides | |
| HY-RI04440A | rno-miR-3596c antagomir | Oligonucleotides | |
| HY-RI04441 | rno-miR-3596d inhibitor | Oligonucleotides | |
| HY-RI04441A | rno-miR-3596d antagomir | Oligonucleotides | |
| HY-RI04442 | rno-miR-361-3p inhibitor | Oligonucleotides | |
| HY-RI04442A | rno-miR-361-3p antagomir | Oligonucleotides | |
| HY-RI04443 | rno-miR-363-3p inhibitor | Oligonucleotides | |
| HY-RI04443A | rno-miR-363-3p antagomir | Oligonucleotides | |
| HY-RI04444 | rno-miR-365-5p inhibitor | Oligonucleotides | |
| HY-RI04444A | rno-miR-365-5p antagomir | Oligonucleotides | |
| HY-RI04445 | rno-miR-370-5p inhibitor | Oligonucleotides | |
| HY-RI04445A | rno-miR-370-5p antagomir | Oligonucleotides | |
| HY-RI04446 | rno-miR-374-3p inhibitor | Oligonucleotides | |
| HY-RI04446A | rno-miR-374-3p antagomir | Oligonucleotides | |
| HY-RI04447 | rno-miR-376a-5p inhibitor | Oligonucleotides | |
| HY-RI04447A | rno-miR-376a-5p antagomir | Oligonucleotides | |
| HY-RI04448 | rno-miR-376c-5p inhibitor | Oligonucleotides | |
| HY-RI04448A | rno-miR-376c-5p antagomir | Oligonucleotides | |
| HY-RI04449 | rno-miR-377-3p inhibitor | Oligonucleotides | |
| HY-RI04449A | rno-miR-377-3p antagomir | Oligonucleotides | |
| HY-RI04450 | rno-miR-378b inhibitor | Oligonucleotides | |
| HY-RI04450A | rno-miR-378b antagomir | Oligonucleotides | |
| HY-RI04451 | rno-miR-379-3p inhibitor | Oligonucleotides | |
| HY-RI04451A | rno-miR-379-3p antagomir | Oligonucleotides | |
| HY-RI04452 | rno-miR-380-3p inhibitor | Oligonucleotides | |
| HY-RI04452A | rno-miR-380-3p antagomir | Oligonucleotides | |
| HY-RI04453 | rno-miR-381-3p inhibitor | Oligonucleotides | |
| HY-RI04453A | rno-miR-381-3p antagomir | Oligonucleotides | |
| HY-RI04454 | rno-miR-383-5p inhibitor | Oligonucleotides | |
| HY-RI04454A | rno-miR-383-5p antagomir | Oligonucleotides | |
| HY-RI04455 | rno-miR-409a-3p inhibitor | Oligonucleotides | |
| HY-RI04455A | rno-miR-409a-3p antagomir | Oligonucleotides | |
| HY-RI04456 | rno-miR-409b inhibitor | Oligonucleotides | |
| HY-RI04456A | rno-miR-409b antagomir | Oligonucleotides | |
| HY-RI04457 | rno-miR-411-3p inhibitor | Oligonucleotides | |
| HY-RI04457A | rno-miR-411-3p antagomir | Oligonucleotides | |
| HY-RI04458 | rno-miR-412-3p inhibitor | Oligonucleotides | |
| HY-RI04458A | rno-miR-412-3p antagomir | Oligonucleotides | |
| HY-RI04459 | rno-miR-412-5p inhibitor | Oligonucleotides | |
| HY-RI04459A | rno-miR-412-5p antagomir | Oligonucleotides | |
| HY-RI04460 | rno-miR-421-3p inhibitor | Oligonucleotides | |
| HY-RI04460A | rno-miR-421-3p antagomir | Oligonucleotides | |
| HY-RI04461 | rno-miR-421-5p inhibitor | Oligonucleotides | |
| HY-RI04461A | rno-miR-421-5p antagomir | Oligonucleotides | |
| HY-RI04462 | rno-miR-423-5p inhibitor | Oligonucleotides | |
| HY-RI04462A | rno-miR-423-5p antagomir | Oligonucleotides | |
| HY-RI04463 | rno-miR-425-3p inhibitor | Oligonucleotides | |
| HY-RI04463A | rno-miR-425-3p antagomir | Oligonucleotides | |
| HY-RI04464 | rno-miR-434-5p inhibitor | Oligonucleotides | |
| HY-RI04464A | rno-miR-434-5p antagomir | Oligonucleotides | |
| HY-RI04465 | rno-miR-448-3p inhibitor | Oligonucleotides | |
| HY-RI04465A | rno-miR-448-3p antagomir | Oligonucleotides | |
| HY-RI04466 | rno-miR-448-5p inhibitor | Oligonucleotides | |
| HY-RI04466A | rno-miR-448-5p antagomir | Oligonucleotides | |
| HY-RI04467 | rno-miR-449a-3p inhibitor | Oligonucleotides | |
| HY-RI04467A | rno-miR-449a-3p antagomir | Oligonucleotides | |
| HY-RI04468 | rno-miR-449c-3p inhibitor | Oligonucleotides | |
| HY-RI04468A | rno-miR-449c-3p antagomir | Oligonucleotides | |
| HY-RI04469 | rno-miR-450a-3p inhibitor | Oligonucleotides | |
| HY-RI04469A | rno-miR-450a-3p antagomir | Oligonucleotides | |
| HY-RI04470 | rno-miR-450a-5p inhibitor | Oligonucleotides | |
| HY-RI04470A | rno-miR-450a-5p antagomir | Oligonucleotides | |
| HY-RI04471 | rno-miR-450b-3p inhibitor | Oligonucleotides | |
| HY-RI04471A | rno-miR-450b-3p antagomir | Oligonucleotides | |
| HY-RI04472 | rno-miR-450b-5p inhibitor | Oligonucleotides | |
| HY-RI04472A | rno-miR-450b-5p antagomir | Oligonucleotides | |
| HY-RI04473 | rno-miR-451-3p inhibitor | Oligonucleotides | |
| HY-RI04473A | rno-miR-451-3p antagomir | Oligonucleotides | |
| HY-RI04474 | rno-miR-452-3p inhibitor | Oligonucleotides | |
| HY-RI04474A | rno-miR-452-3p antagomir | Oligonucleotides | |
| HY-RI04475 | rno-miR-452-5p inhibitor | Oligonucleotides | |
| HY-RI04475A | rno-miR-452-5p antagomir | Oligonucleotides | |
| HY-RI04476 | rno-miR-455-3p inhibitor | Oligonucleotides | |
| HY-RI04476A | rno-miR-455-3p antagomir | Oligonucleotides | |
| HY-RI04477 | rno-miR-463-3p inhibitor | Oligonucleotides | |
| HY-RI04477A | rno-miR-463-3p antagomir | Oligonucleotides | |
| HY-RI04478 | rno-miR-463-5p inhibitor | Oligonucleotides | |
| HY-RI04478A | rno-miR-463-5p antagomir | Oligonucleotides | |
| HY-RI04479 | rno-miR-465-3p inhibitor | Oligonucleotides | |
| HY-RI04479A | rno-miR-465-3p antagomir | Oligonucleotides | |
| HY-RI04480 | rno-miR-465-5p inhibitor | Oligonucleotides | |
| HY-RI04480A | rno-miR-465-5p antagomir | Oligonucleotides | |
| HY-RI04481 | rno-miR-466b-2-3p inhibitor | Oligonucleotides | |
| HY-RI04481A | rno-miR-466b-2-3p antagomir | Oligonucleotides | |
| HY-RI04482 | rno-miR-466b-3p inhibitor | Oligonucleotides | |
| HY-RI04482A | rno-miR-466b-3p antagomir | Oligonucleotides | |
| HY-RI04483 | rno-miR-466b-5p inhibitor | Oligonucleotides | |
| HY-RI04483A | rno-miR-466b-5p antagomir | Oligonucleotides | |
| HY-RI04484 | rno-miR-466c-3p inhibitor | Oligonucleotides | |
| HY-RI04484A | rno-miR-466c-3p antagomir | Oligonucleotides | |
| HY-RI04485 | rno-miR-466c-5p inhibitor | Oligonucleotides | |
| HY-RI04485A | rno-miR-466c-5p antagomir | Oligonucleotides | |
| HY-RI04486 | rno-miR-466d inhibitor | Oligonucleotides | |
| HY-RI04486A | rno-miR-466d antagomir | Oligonucleotides | |
| HY-RI04487 | rno-miR-471-3p inhibitor | Oligonucleotides | |
| HY-RI04487A | rno-miR-471-3p antagomir | Oligonucleotides | |
| HY-RI04488 | rno-miR-483-3p inhibitor | Oligonucleotides | |
| HY-RI04488A | rno-miR-483-3p antagomir | Oligonucleotides | |
| HY-RI04489 | rno-miR-485-3p inhibitor | Oligonucleotides | |
| HY-RI04489A | rno-miR-485-3p antagomir | Oligonucleotides | |
| HY-RI04490 | rno-miR-487b-5p inhibitor | Oligonucleotides | |
| HY-RI04490A | rno-miR-487b-5p antagomir | Oligonucleotides | |
| HY-RI04491 | rno-miR-489-3p inhibitor | Oligonucleotides | |
| HY-RI04491A | rno-miR-489-3p antagomir | Oligonucleotides | |
| HY-RI04492 | rno-miR-489-5p inhibitor | Oligonucleotides | |
| HY-RI04492A | rno-miR-489-5p antagomir | Oligonucleotides | |
| HY-RI04493 | rno-miR-493-3p inhibitor | Oligonucleotides | |
| HY-RI04493A | rno-miR-493-3p antagomir | Oligonucleotides | |
| HY-RI04494 | rno-miR-494-3p inhibitor | Oligonucleotides | |
| HY-RI04494A | rno-miR-494-3p antagomir | Oligonucleotides | |
| HY-RI04495 | rno-miR-496-3p inhibitor | Oligonucleotides | |
| HY-RI04495A | rno-miR-496-3p antagomir | Oligonucleotides | |
| HY-RI04496 | rno-miR-496-5p inhibitor | Oligonucleotides | |
| HY-RI04496A | rno-miR-496-5p antagomir | Oligonucleotides | |
| HY-RI04497 | rno-miR-497-3p inhibitor | Oligonucleotides | |
| HY-RI04497A | rno-miR-497-3p antagomir | Oligonucleotides | |
| HY-RI04498 | rno-miR-500-5p inhibitor | Oligonucleotides | |
| HY-RI04498A | rno-miR-500-5p antagomir | Oligonucleotides | |
| HY-RI04499 | rno-miR-501-3p inhibitor | Oligonucleotides | |
| HY-RI04499A | rno-miR-501-3p antagomir | Oligonucleotides | |
| HY-RI04500 | rno-miR-501-5p inhibitor | Oligonucleotides | |
| HY-RI04500A | rno-miR-501-5p antagomir | Oligonucleotides | |
| HY-RI04501 | rno-miR-503-3p inhibitor | Oligonucleotides | |
| HY-RI04501A | rno-miR-503-3p antagomir | Oligonucleotides | |
| HY-RI04502 | rno-miR-504 inhibitor | Oligonucleotides | |
| HY-RI04502A | rno-miR-504 antagomir | Oligonucleotides | |
| HY-RI04503 | rno-miR-505-3p inhibitor | Oligonucleotides | |
| HY-RI04503A | rno-miR-505-3p antagomir | Oligonucleotides | |
| HY-RI04504 | rno-miR-509-3p inhibitor | Oligonucleotides | |
| HY-RI04504A | rno-miR-509-3p antagomir | Oligonucleotides | |
| HY-RI04505 | rno-miR-509-5p inhibitor | Oligonucleotides | |
| HY-RI04505A | rno-miR-509-5p antagomir | Oligonucleotides | |
| HY-RI04506 | rno-miR-511-3p inhibitor | Oligonucleotides | |
| HY-RI04506A | rno-miR-511-3p antagomir | Oligonucleotides | |
| HY-RI04507 | rno-miR-511-5p inhibitor | Oligonucleotides | |
| HY-RI04507A | rno-miR-511-5p antagomir | Oligonucleotides | |
| HY-RI04508 | rno-miR-5132-3p inhibitor | Oligonucleotides | |
| HY-RI04508A | rno-miR-5132-3p antagomir | Oligonucleotides | |
| HY-RI04509 | rno-miR-5132-5p inhibitor | Oligonucleotides | |
| HY-RI04509A | rno-miR-5132-5p antagomir | Oligonucleotides | |
| HY-RI04510 | rno-miR-532-5p inhibitor | Oligonucleotides | |
| HY-RI04510A | rno-miR-532-5p antagomir | Oligonucleotides | |
| HY-RI04511 | rno-miR-539-3p inhibitor | Oligonucleotides | |
| HY-RI04511A | rno-miR-539-3p antagomir | Oligonucleotides | |
| HY-RI04512 | rno-miR-540-3p inhibitor | Oligonucleotides | |
| HY-RI04512A | rno-miR-540-3p antagomir | Oligonucleotides | |
| HY-RI04513 | rno-miR-541-3p inhibitor | Oligonucleotides | |
| HY-RI04513A | rno-miR-541-3p antagomir | Oligonucleotides | |
| HY-RI04514 | rno-miR-543-3p inhibitor | Oligonucleotides | |
| HY-RI04514A | rno-miR-543-3p antagomir | Oligonucleotides | |
| HY-RI04515 | rno-miR-544-3p inhibitor | Oligonucleotides | |
| HY-RI04515A | rno-miR-544-3p antagomir | Oligonucleotides | |
| HY-RI04516 | rno-miR-544-5p inhibitor | Oligonucleotides | |
| HY-RI04516A | rno-miR-544-5p antagomir | Oligonucleotides | |
| HY-RI04517 | rno-miR-547-3p inhibitor | Oligonucleotides | |
| HY-RI04517A | rno-miR-547-3p antagomir | Oligonucleotides | |
| HY-RI04518 | rno-miR-547-5p inhibitor | Oligonucleotides | |
| HY-RI04518A | rno-miR-547-5p antagomir | Oligonucleotides | |
| HY-RI04519 | rno-miR-551b-3p inhibitor | Oligonucleotides | |
| HY-RI04519A | rno-miR-551b-3p antagomir | Oligonucleotides | |
| HY-RI04520 | rno-miR-582-3p inhibitor | Oligonucleotides | |
| HY-RI04520A | rno-miR-582-3p antagomir | Oligonucleotides | |
| HY-RI04521 | rno-miR-598-5p inhibitor | Oligonucleotides | |
| HY-RI04521A | rno-miR-598-5p antagomir | Oligonucleotides | |
| HY-RI04522 | rno-miR-6215 inhibitor | Oligonucleotides | |
| HY-RI04522A | rno-miR-6215 antagomir | Oligonucleotides | |
| HY-RI04523 | rno-miR-6216 inhibitor | Oligonucleotides | |
| HY-RI04523A | rno-miR-6216 antagomir | Oligonucleotides | |
| HY-RI04524 | rno-miR-628 inhibitor | Oligonucleotides | |
| HY-RI04524A | rno-miR-628 antagomir | Oligonucleotides | |
| HY-RI04525 | rno-miR-6314 inhibitor | Oligonucleotides | |
| HY-RI04525A | rno-miR-6314 antagomir | Oligonucleotides | |
| HY-RI04526 | rno-miR-6315 inhibitor | Oligonucleotides | |
| HY-RI04526A | rno-miR-6315 antagomir | Oligonucleotides | |
| HY-RI04527 | rno-miR-6316 inhibitor | Oligonucleotides | |
| HY-RI04527A | rno-miR-6316 antagomir | Oligonucleotides | |
| HY-RI04528 | rno-miR-6317 inhibitor | Oligonucleotides | |
| HY-RI04528A | rno-miR-6317 antagomir | Oligonucleotides | |
| HY-RI04529 | rno-miR-6318 inhibitor | Oligonucleotides | |
| HY-RI04529A | rno-miR-6318 antagomir | Oligonucleotides | |
| HY-RI04530 | rno-miR-6319 inhibitor | Oligonucleotides | |
| HY-RI04530A | rno-miR-6319 antagomir | Oligonucleotides | |
| HY-RI04531 | rno-miR-632 inhibitor | Oligonucleotides | |
| HY-RI04531A | rno-miR-632 antagomir | Oligonucleotides | |
| HY-RI04532 | rno-miR-6320 inhibitor | Oligonucleotides | |
| HY-RI04532A | rno-miR-6320 antagomir | Oligonucleotides | |
| HY-RI04533 | rno-miR-6321 inhibitor | Oligonucleotides | |
| HY-RI04533A | rno-miR-6321 antagomir | Oligonucleotides | |
| HY-RI04534 | rno-miR-6322 inhibitor | Oligonucleotides | |
| HY-RI04534A | rno-miR-6322 antagomir | Oligonucleotides | |
| HY-RI04535 | rno-miR-6323 inhibitor | Oligonucleotides | |
| HY-RI04535A | rno-miR-6323 antagomir | Oligonucleotides | |
| HY-RI04536 | rno-miR-6324 inhibitor | Oligonucleotides | |
| HY-RI04536A | rno-miR-6324 antagomir | Oligonucleotides | |
| HY-RI04537 | rno-miR-6325 inhibitor | Oligonucleotides | |
| HY-RI04537A | rno-miR-6325 antagomir | Oligonucleotides | |
| HY-RI04538 | rno-miR-6326 inhibitor | Oligonucleotides | |
| HY-RI04538A | rno-miR-6326 antagomir | Oligonucleotides | |
| HY-RI04539 | rno-miR-6327 inhibitor | Oligonucleotides | |
| HY-RI04539A | rno-miR-6327 antagomir | Oligonucleotides | |
| HY-RI04540 | rno-miR-6328 inhibitor | Oligonucleotides | |
| HY-RI04540A | rno-miR-6328 antagomir | Oligonucleotides | |
| HY-RI04541 | rno-miR-6329 inhibitor | Oligonucleotides | |
| HY-RI04541A | rno-miR-6329 antagomir | Oligonucleotides | |
| HY-RI04542 | rno-miR-6330 inhibitor | Oligonucleotides | |
| HY-RI04542A | rno-miR-6330 antagomir | Oligonucleotides | |
| HY-RI04543 | rno-miR-6331 inhibitor | Oligonucleotides | |
| HY-RI04543A | rno-miR-6331 antagomir | Oligonucleotides | |
| HY-RI04544 | rno-miR-6332 inhibitor | Oligonucleotides | |
| HY-RI04544A | rno-miR-6332 antagomir | Oligonucleotides | |
| HY-RI04545 | rno-miR-6333 inhibitor | Oligonucleotides | |
| HY-RI04545A | rno-miR-6333 antagomir | Oligonucleotides | |
| HY-RI04546 | rno-miR-6334 inhibitor | Oligonucleotides | |
| HY-RI04546A | rno-miR-6334 antagomir | Oligonucleotides | |
| HY-RI04547 | rno-miR-652-5p inhibitor | Oligonucleotides | |
| HY-RI04547A | rno-miR-652-5p antagomir | Oligonucleotides | |
| HY-RI04548 | rno-miR-653-3p inhibitor | Oligonucleotides | |
| HY-RI04548A | rno-miR-653-3p antagomir | Oligonucleotides | |
| HY-RI04549 | rno-miR-653-5p inhibitor | Oligonucleotides | |
| HY-RI04549A | rno-miR-653-5p antagomir | Oligonucleotides | |
| HY-RI04550 | rno-miR-664-1-5p inhibitor | Oligonucleotides | |
| HY-RI04550A | rno-miR-664-1-5p antagomir | Oligonucleotides | |
| HY-RI04551 | rno-miR-664-2-5p inhibitor | Oligonucleotides | |
| HY-RI04551A | rno-miR-664-2-5p antagomir | Oligonucleotides | |
| HY-RI04552 | rno-miR-665 inhibitor | Oligonucleotides | |
| HY-RI04552A | rno-miR-665 antagomir | Oligonucleotides | |
| HY-RI04553 | rno-miR-666-3p inhibitor | Oligonucleotides | |
| HY-RI04553A | rno-miR-666-3p antagomir | Oligonucleotides | |
| HY-RI04554 | rno-miR-666-5p inhibitor | Oligonucleotides | |
| HY-RI04554A | rno-miR-666-5p antagomir | Oligonucleotides | |
| HY-RI04555 | rno-miR-667-3p inhibitor | Oligonucleotides | |
| HY-RI04555A | rno-miR-667-3p antagomir | Oligonucleotides | |
| HY-RI04556 | rno-miR-667-5p inhibitor | Oligonucleotides | |
| HY-RI04556A | rno-miR-667-5p antagomir | Oligonucleotides | |
| HY-RI04557 | rno-miR-672-3p inhibitor | Oligonucleotides | |
| HY-RI04557A | rno-miR-672-3p antagomir | Oligonucleotides | |
| HY-RI04558 | rno-miR-673-3p inhibitor | Oligonucleotides | |
| HY-RI04558A | rno-miR-673-3p antagomir | Oligonucleotides | |
| HY-RI04559 | rno-miR-673-5p inhibitor | Oligonucleotides | |
| HY-RI04559A | rno-miR-673-5p antagomir | Oligonucleotides | |
| HY-RI04560 | rno-miR-675-3p inhibitor | Oligonucleotides | |
| HY-RI04560A | rno-miR-675-3p antagomir | Oligonucleotides | |
| HY-RI04561 | rno-miR-676 inhibitor | Oligonucleotides | |
| HY-RI04561A | rno-miR-676 antagomir | Oligonucleotides | |
| HY-RI04562 | rno-miR-678 inhibitor | Oligonucleotides | |
| HY-RI04562A | rno-miR-678 antagomir | Oligonucleotides | |
| HY-RI04563 | rno-miR-679 inhibitor | Oligonucleotides | |
| HY-RI04563A | rno-miR-679 antagomir | Oligonucleotides | |
| HY-RI04564 | rno-miR-702-3p inhibitor | Oligonucleotides | |
| HY-RI04564A | rno-miR-702-3p antagomir | Oligonucleotides | |
| HY-RI04565 | rno-miR-709 inhibitor | Oligonucleotides | |
| HY-RI04565A | rno-miR-709 antagomir | Oligonucleotides | |
| HY-RI04566 | rno-miR-711 inhibitor | Oligonucleotides | |
| HY-RI04566A | rno-miR-711 antagomir | Oligonucleotides | |
| HY-RI04567 | rno-miR-741-3p inhibitor | Oligonucleotides | |
| HY-RI04567A | rno-miR-741-3p antagomir | Oligonucleotides | |
| HY-RI04568 | rno-miR-741-5p inhibitor | Oligonucleotides | |
| HY-RI04568A | rno-miR-741-5p antagomir | Oligonucleotides | |
| HY-RI04569 | rno-miR-742-3p inhibitor | Oligonucleotides | |
| HY-RI04569A | rno-miR-742-3p antagomir | Oligonucleotides | |
| HY-RI04570 | rno-miR-743a-3p inhibitor | Oligonucleotides | |
| HY-RI04570A | rno-miR-743a-3p antagomir | Oligonucleotides | |
| HY-RI04571 | rno-miR-743b-3p inhibitor | Oligonucleotides | |
| HY-RI04571A | rno-miR-743b-3p antagomir | Oligonucleotides | |
| HY-RI04572 | rno-miR-743b-5p inhibitor | Oligonucleotides | |
| HY-RI04572A | rno-miR-743b-5p antagomir | Oligonucleotides | |
| HY-RI04573 | rno-miR-7578 inhibitor | Oligonucleotides | |
| HY-RI04573A | rno-miR-7578 antagomir | Oligonucleotides | |
| HY-RI04574 | rno-miR-760-5p inhibitor | Oligonucleotides | |
| HY-RI04574A | rno-miR-760-5p antagomir | Oligonucleotides | |
| HY-RI04575 | rno-miR-762 inhibitor | Oligonucleotides | |
| HY-RI04575A | rno-miR-762 antagomir | Oligonucleotides | |
| HY-RI04576 | rno-miR-764-3p inhibitor | Oligonucleotides | |
| HY-RI04576A | rno-miR-764-3p antagomir | Oligonucleotides | |
| HY-RI04577 | rno-miR-764-5p inhibitor | Oligonucleotides | |
| HY-RI04577A | rno-miR-764-5p antagomir | Oligonucleotides | |
| HY-RI04578 | rno-miR-770-3p inhibitor | Oligonucleotides | |
| HY-RI04578A | rno-miR-770-3p antagomir | Oligonucleotides | |
| HY-RI04579 | rno-miR-7a-1-3p inhibitor | Oligonucleotides | |
| HY-RI04579A | rno-miR-7a-1-3p antagomir | Oligonucleotides | |
| HY-RI04580 | rno-miR-7b inhibitor | Oligonucleotides | |
| HY-RI04580A | rno-miR-7b antagomir | Oligonucleotides | |
| HY-RI04581 | rno-miR-802-3p inhibitor | Oligonucleotides | |
| HY-RI04581A | rno-miR-802-3p antagomir | Oligonucleotides | |
| HY-RI04582 | rno-miR-802-5p inhibitor | Oligonucleotides | |
| HY-RI04582A | rno-miR-802-5p antagomir | Oligonucleotides | |
| HY-RI04583 | rno-miR-871-3p inhibitor | Oligonucleotides | |
| HY-RI04583A | rno-miR-871-3p antagomir | Oligonucleotides | |
| HY-RI04584 | rno-miR-871-5p inhibitor | Oligonucleotides | |
| HY-RI04584A | rno-miR-871-5p antagomir | Oligonucleotides | |
| HY-RI04585 | rno-miR-874-5p inhibitor | Oligonucleotides | |
| HY-RI04585A | rno-miR-874-5p antagomir | Oligonucleotides | |
| HY-RI04586 | rno-miR-876 inhibitor | Oligonucleotides | |
| HY-RI04586A | rno-miR-876 antagomir | Oligonucleotides | |
| HY-RI04587 | rno-miR-878 inhibitor | Oligonucleotides | |
| HY-RI04587A | rno-miR-878 antagomir | Oligonucleotides | |
| HY-RI04588 | rno-miR-879-3p inhibitor | Oligonucleotides | |
| HY-RI04588A | rno-miR-879-3p antagomir | Oligonucleotides | |
| HY-RI04589 | rno-miR-880-3p inhibitor | Oligonucleotides | |
| HY-RI04589A | rno-miR-880-3p antagomir | Oligonucleotides | |
| HY-RI04590 | rno-miR-880-5p inhibitor | Oligonucleotides | |
| HY-RI04590A | rno-miR-880-5p antagomir | Oligonucleotides | |
| HY-RI04591 | rno-miR-881-3p inhibitor | Oligonucleotides | |
| HY-RI04591A | rno-miR-881-3p antagomir | Oligonucleotides | |
| HY-RI04592 | rno-miR-881-5p inhibitor | Oligonucleotides | |
| HY-RI04592A | rno-miR-881-5p antagomir | Oligonucleotides | |
| HY-RI04593 | rno-miR-883-5p inhibitor | Oligonucleotides | |
| HY-RI04593A | rno-miR-883-5p antagomir | Oligonucleotides | |
| HY-RI04594 | rno-miR-92a-2-5p inhibitor | Oligonucleotides | |
| HY-RI04594A | rno-miR-92a-2-5p antagomir | Oligonucleotides | |
| HY-RI04595 | rno-miR-92b-5p inhibitor | Oligonucleotides | |
| HY-RI04595A | rno-miR-92b-5p antagomir | Oligonucleotides | |
| HY-RI04596 | rno-miR-93-3p inhibitor | Oligonucleotides | |
| HY-RI04596A | rno-miR-93-3p antagomir | Oligonucleotides | |
| HY-RI04597 | rno-miR-96-3p inhibitor | Oligonucleotides | |
| HY-RI04597A | rno-miR-96-3p antagomir | Oligonucleotides | |
| HY-RI04598 | rno-miR-98-3p inhibitor | Oligonucleotides | |
| HY-RI04598A | rno-miR-98-3p antagomir | Oligonucleotides | |
| HY-RI04599 | rno-miR-99a-3p inhibitor | Oligonucleotides | |
| HY-RI04599A | rno-miR-99a-3p antagomir | Oligonucleotides | |
| HY-RI04600 | rno-miR-9b-3p inhibitor | Oligonucleotides | |
| HY-RI04600A | rno-miR-9b-3p antagomir | Oligonucleotides | |
| HY-RI04601 | rno-miR-9b-5p inhibitor | Oligonucleotides | |
| HY-RI04601A | rno-miR-9b-5p antagomir | Oligonucleotides | |
| HY-RI04602 | MicroRNA Inhibitor Negative Control | Oligonucleotides | |
| HY-RI04602A | MicroRNA Antagomir Negative Control | Oligonucleotides | |
| HY-RI04604 | mmu-miR-186-5p inhibitor | Oligonucleotides | |
| HY-RI04604A | mmu-miR-186-5p antagomir | Oligonucleotides | |
| HY-RI04605 | mmu-miR-378a-5p inhibitor | Oligonucleotides | |
| HY-RI04605A | mmu-miR-378a-5p antagomir | Oligonucleotides | |
| HY-RI04606 | hsa-miR-24-3p inhibitor | Oligonucleotides | |
| HY-RI04606A | hsa-miR-24-3p antagomir | Oligonucleotides | |
| HY-RI04607 | hsa-miR-134-3p inhibitor | Oligonucleotides | |
| HY-RI04607A | hsa-miR-134-3p antagomir | Oligonucleotides | |
| HY-RI04608 | hsa-miR-222-3p inhibitor | Oligonucleotides | |
| HY-RI04609 | rno-miR-34a-5p inhibitor | Oligonucleotides | |
| HY-RS00001 | ACE2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00002 | Pkd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00003 | PKD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00004 | Pkd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00005 | PKD1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00006 | PKD1L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00007 | PKD1L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00008 | A1BG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00009 | A1CF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00010 | A2M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00011 | A2ML1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00012 | A3GALT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00013 | A4GALT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00014 | A4GNT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00015 | AAAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00016 | AACS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00017 | AADAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00018 | AADAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00019 | AAGAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00020 | AAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00021 | Aak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00022 | Aak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00023 | AAMDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00024 | AAMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00025 | AANAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00026 | AAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00027 | AARD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00028 | AARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00029 | AARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00030 | AARSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00031 | AASDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00032 | AASDHPPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00033 | AASS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00034 | AATF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00035 | AATK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00036 | ABAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00037 | ABCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00038 | ABCA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00039 | ABCA12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00040 | ABCA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00041 | ABCA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00042 | ABCA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00043 | ABCA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00044 | ABCA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00045 | ABCA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00046 | ABCA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00047 | ABCA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00048 | ABCB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00049 | ABCB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00050 | ABCB11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00051 | ABCB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00052 | ABCB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00053 | ABCB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00054 | ABCB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00055 | ABCB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00056 | ABCB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00057 | ABCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00058 | ABCC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00059 | ABCC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00060 | ABCC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00061 | ABCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00062 | ABCC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00063 | ABCC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00064 | ABCC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00065 | ABCC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00066 | ABCC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00067 | ABCC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00068 | ABCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00069 | ABCD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00070 | ABCD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00071 | ABCD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00072 | ABCE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00073 | ABCF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00074 | ABCF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00075 | ABCF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00076 | ABCG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00077 | ABCG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00078 | Abcg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00079 | Abcg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00080 | ABCG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00081 | ABCG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00082 | ABCG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00083 | ABHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00084 | ABHD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00085 | ABHD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00086 | ABHD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00087 | ABHD12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00088 | ABHD14B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00089 | ABHD15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00090 | ABHD16A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00091 | ABHD17A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00092 | ABHD17C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00093 | ABHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00094 | ABHD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00095 | ABHD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00096 | ABHD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00097 | ABHD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00098 | ABI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00099 | ABI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00100 | ABI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00101 | ABI3BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00102 | ABL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00103 | Abl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00104 | ABL1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00105 | ABL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00106 | ABLIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00107 | ABLIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00108 | ABLIM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00109 | ABO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00110 | ABR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00111 | ABRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00112 | ABRACL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00113 | ABRAXAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00114 | ABT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00115 | ABTB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00116 | ABTB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00117 | ACAA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00118 | ACAA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00119 | ACACA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00120 | Acaca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00121 | Acaca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00122 | ACACB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00123 | ACAD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00124 | ACAD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00125 | ACAD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00126 | ACAD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00127 | ACADL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00128 | ACADM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00129 | ACADS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00130 | ACADSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00131 | ACADVL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00132 | ACAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00133 | ACAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00134 | ACAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00135 | ACAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00136 | ACAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00137 | Acat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00138 | Acat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00139 | ACAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00140 | Acat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00141 | ACAT2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00142 | ACBD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00143 | ACBD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00144 | ACBD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00145 | ACBD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00146 | ACCS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00147 | ACCSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00148 | ACD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00149 | ACE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00150 | Ace Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00151 | ACE Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00152 | ACE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00153 | ACER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00154 | ACER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00155 | ACER3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00156 | ACHE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00157 | Ache Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00158 | ACHE Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00159 | ACIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00160 | ACKR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00161 | ACKR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00162 | ACKR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00163 | Ackr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00164 | Ackr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00165 | ACKR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00166 | ACLY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00167 | Acly Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00168 | Acly Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00169 | ACMSD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00170 | ACO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00171 | ACO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00172 | ACOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00173 | ACOT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00174 | ACOT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00175 | ACOT12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00176 | ACOT13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00177 | ACOT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00178 | ACOT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00179 | ACOT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00180 | ACOT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00181 | ACOT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00182 | ACOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00183 | ACOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00184 | ACOX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00185 | ACOXL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00186 | ACP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00187 | ACP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00188 | ACP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00189 | ACP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00190 | ACP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00191 | ACP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00192 | ACP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00193 | ACR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00194 | ACRBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00195 | ACRV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00196 | ACSBG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00197 | ACSBG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00198 | ACSF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00199 | ACSF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00200 | ACSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00201 | ACSL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00202 | ACSL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00203 | ACSL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00204 | ACSL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00205 | ACSM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00206 | ACSM2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00207 | ACSM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00208 | ACSM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00209 | ACSM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00210 | ACSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00211 | ACSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00212 | ACSS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00213 | ACTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00214 | ACTA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00215 | ACTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00216 | ACTBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00217 | ACTC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00218 | ACTG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00219 | ACTG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00220 | ACTL6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00221 | ACTL6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00222 | ACTL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00223 | ACTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00224 | ACTN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00225 | ACTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00226 | ACTN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00227 | ACTR10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00228 | ACTR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00229 | ACTR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00230 | ACTR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00231 | ACTR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00232 | ACTR3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00233 | ACTR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00234 | ACTR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00235 | ACTR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00236 | ACVR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00237 | Acvr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00238 | Acvr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00239 | ACVR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00240 | Acvr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00241 | Acvr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00242 | ACVR1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00243 | Acvr1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00244 | Acvr1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00245 | ACVR2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00246 | Acvr2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00247 | Acvr2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00248 | ACVR2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00249 | Acvr2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00250 | Acvr2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00251 | ACVRL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00252 | Acvrl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00253 | Acvrl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00254 | ACY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00255 | ACY3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00256 | ACYP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00257 | ACYP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00258 | ADA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00259 | Ada Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00260 | Ada Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00261 | ADA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00262 | ADAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00263 | ADAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00264 | ADAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00265 | ADAM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00266 | Adam10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00267 | ADAM10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00268 | ADAM11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00269 | ADAM12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00270 | ADAM15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00271 | ADAM17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00272 | Adam17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00273 | Adam17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00274 | ADAM18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00275 | ADAM19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00276 | ADAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00277 | ADAM21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00278 | ADAM22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00279 | ADAM23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00280 | ADAM28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00281 | ADAM29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00282 | ADAM30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00283 | ADAM32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00284 | ADAM33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00285 | ADAM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00286 | ADAM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00287 | Adam8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00288 | Adam8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00289 | ADAM9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00290 | ADAMDEC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00291 | ADAMTS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00292 | ADAMTS10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00293 | ADAMTS12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00294 | ADAMTS13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00295 | ADAMTS14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00296 | ADAMTS15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00297 | ADAMTS16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00298 | ADAMTS17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00299 | ADAMTS18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00300 | ADAMTS19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00301 | ADAMTS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00302 | ADAMTS20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00303 | ADAMTS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00304 | ADAMTS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00305 | ADAMTS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00306 | ADAMTS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00307 | ADAMTS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00308 | ADAMTS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00309 | ADAMTS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00310 | ADAMTSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00311 | ADAMTSL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00312 | ADAMTSL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00313 | ADAMTSL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00314 | ADAMTSL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00315 | ADAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00316 | ADAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00317 | ADAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00318 | ADARB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00319 | ADARB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00320 | ADAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00321 | ADAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00322 | ADAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00323 | ADCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00324 | ADCK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00325 | ADCK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00326 | ADCY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00327 | ADCY10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00328 | ADCY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00329 | ADCY3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00330 | ADCY4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00331 | ADCY5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00332 | ADCY6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00333 | ADCY7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00334 | ADCY8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00335 | ADCY9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00336 | ADCYAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00337 | ADCYAP1R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00338 | ADD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00339 | ADD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00340 | ADD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00341 | ADGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00342 | ADGRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00343 | ADGRA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00344 | ADGRA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00345 | ADGRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00346 | ADGRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00347 | ADGRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00348 | ADGRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00349 | ADGRE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00350 | ADGRE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00351 | ADGRE5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00352 | ADGRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00353 | ADGRF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00354 | ADGRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00355 | ADGRG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00356 | ADGRG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00357 | ADGRG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00358 | ADGRG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00359 | ADGRG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00360 | ADGRG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00361 | ADGRL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00362 | ADGRL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00363 | ADGRL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00364 | ADGRL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00365 | ADGRV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00366 | ADH1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00367 | ADH1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00368 | ADH1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00369 | ADH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00370 | ADH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00371 | Adh5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00372 | Adh5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00373 | ADH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00374 | ADH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00375 | ADHFE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00376 | ADI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00377 | ADIG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00378 | ADIPOQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00379 | ADIPOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00380 | ADIPOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00381 | ADIRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00382 | ADISSP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00383 | ADK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00384 | Adk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00385 | Adk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00386 | ADM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00387 | ADM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00388 | ADM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00389 | ADNP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00390 | ADO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00391 | ADORA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00392 | Adora1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00393 | Adora1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00394 | ADORA2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00395 | Adora2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00396 | Adora2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00397 | ADORA2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00398 | Adora2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00399 | Adora2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00400 | ADORA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00401 | Adora3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00402 | ADORA3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00403 | ADPGK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00404 | ADPRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00405 | ADPRHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00406 | ADPRM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00407 | ADPRS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00408 | ADRA1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00409 | ADRA1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00410 | ADRA1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00411 | ADRA2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00412 | ADRA2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00413 | ADRA2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00414 | ADRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00415 | ADRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00416 | ADRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00417 | ADRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00418 | ADSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00419 | ADSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00420 | ADSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00421 | ADTRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00422 | AEBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00423 | AEBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00424 | AEN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00425 | AFAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00426 | AFAP1L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00427 | AFDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00428 | AFF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00429 | AFF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00430 | AFF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00431 | AFF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00432 | AFG3L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00433 | AFM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00434 | AFMID Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00435 | AFP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00436 | AGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00437 | AGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00438 | AGAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00439 | AGAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00440 | AGBL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00441 | AGBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00442 | AGBL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00443 | AGBL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00444 | AGER Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00445 | AGFG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00446 | AGFG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00447 | AGGF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00448 | AGK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00449 | AGL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00450 | AGMAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00451 | AGMO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00452 | AGO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00453 | AGO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00454 | AGO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00455 | AGO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00456 | AGPAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00457 | AGPAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00458 | AGPAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00459 | AGPAT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00460 | AGPAT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00461 | AGPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00462 | AGR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00463 | AGR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00464 | AGRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00465 | AGRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00466 | AGT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00467 | AGTPBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00468 | AGTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00469 | AGTR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00470 | Agtr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00471 | Agtr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00472 | AGTRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00473 | AGXT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00474 | AGXT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00475 | AHCTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00476 | AHCY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00477 | AHCYL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00478 | AHCYL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00479 | AHDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00480 | AHI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00481 | AHNAK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00482 | AHNAK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00483 | AHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00484 | AHRR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00485 | AHSA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00486 | AHSG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00487 | AHSP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00488 | AICDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00489 | AIDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00490 | AIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00491 | AIF1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00492 | AIFM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00493 | AIFM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00494 | AIFM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00495 | AIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00496 | AIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00497 | AIMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00498 | AIMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00499 | AIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00500 | AIPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00501 | AIRE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00502 | AJAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00503 | AJM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00504 | AJUBA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00505 | AK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00506 | AK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00507 | AK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00508 | AK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00509 | AK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00510 | AK8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00511 | AK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00512 | AKAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00513 | AKAP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00514 | AKAP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00515 | AKAP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00516 | AKAP13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00517 | AKAP17A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00518 | AKAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00519 | AKAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00520 | AKAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00521 | AKAP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00522 | AKAP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00523 | AKAP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00524 | AKAP8L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00525 | AKAP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00526 | AKIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00527 | AKIRIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00528 | AKIRIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00529 | AKNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00530 | AKNAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00531 | AKR1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00532 | AKR1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00533 | AKR1B10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00534 | AKR1C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00535 | AKR1C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00536 | AKR1C3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00537 | AKR1C4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00538 | AKR1D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00539 | AKR1E2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00540 | AKR7A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00541 | AKR7A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00542 | AKT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00543 | Akt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00544 | Akt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00545 | AKT1S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00546 | AKT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00547 | Akt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00548 | Akt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00549 | AKT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00550 | Akt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00551 | Akt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00552 | AKTIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00553 | ALAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00554 | ALAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00555 | ALAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00556 | ALB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00557 | ALCAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00558 | ALDH16A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00559 | ALDH18A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00560 | ALDH1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00561 | Aldh1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00562 | ALDH1A1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00563 | ALDH1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00564 | ALDH1A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00565 | ALDH1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00566 | ALDH1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00567 | ALDH1L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00568 | ALDH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00569 | Aldh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00570 | Aldh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00571 | ALDH3A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00572 | Aldh3a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00573 | Aldh3a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00574 | ALDH3A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00575 | ALDH3B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00576 | ALDH3B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00577 | ALDH4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00578 | ALDH5A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00579 | ALDH6A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00580 | ALDH7A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00581 | ALDH8A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00582 | ALDH9A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00583 | ALDOA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00584 | ALDOB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00585 | ALDOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00586 | ALG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00587 | ALG10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00588 | ALG11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00589 | ALG12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00590 | ALG13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00591 | ALG14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00592 | ALG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00593 | ALG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00594 | ALG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00595 | ALG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00596 | ALG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00597 | ALG9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00598 | ALK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00599 | Alk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00600 | ALK Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00601 | ALKAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00602 | ALKAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00603 | ALKBH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00604 | ALKBH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00605 | ALKBH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00606 | ALKBH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00607 | ALKBH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00608 | ALKBH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00609 | ALKBH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00610 | ALLC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00611 | ALMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00612 | ALOX12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00613 | Alox12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00614 | Alox12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00615 | ALOX12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00616 | ALOX15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00617 | Alox15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00618 | Alox15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00619 | ALOX15B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00620 | ALOX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00621 | Alox5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00622 | Alox5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00623 | ALOX5AP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00624 | Alox5ap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00625 | Alox5ap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00626 | ALOXE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00627 | ALPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00628 | ALPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00629 | ALPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00630 | ALPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00631 | ALPK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00632 | ALPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00633 | ALPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00634 | ALS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00635 | ALS2CL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00636 | ALX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00637 | ALX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00638 | ALX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00639 | ALYREF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00640 | AMACR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00641 | AMBN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00642 | AMBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00643 | AMBRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00644 | AMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00645 | AMDHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00646 | AMDHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00647 | AMELX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00648 | AMELY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00649 | AMER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00650 | AMER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00651 | AMER3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00652 | AMFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00653 | AMH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00654 | AMHR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00655 | Amhr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00656 | Amhr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00657 | AMIGO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00658 | AMIGO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00659 | AMIGO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00660 | AMMECR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00661 | AMN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00662 | AMN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00663 | AMOT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00664 | AMOTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00665 | AMOTL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00666 | AMPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00667 | AMPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00668 | AMPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00669 | AMPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00670 | AMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00671 | AMTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00672 | AMY1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00673 | AMY2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00674 | AMY2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00675 | AMZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00676 | AMZ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00677 | ANAPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00678 | ANAPC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00679 | ANAPC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00680 | ANAPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00681 | ANAPC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00682 | ANAPC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00683 | ANAPC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00684 | ANG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00685 | ANGEL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00686 | ANGEL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00687 | ANGPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00688 | ANGPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00689 | ANGPT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00690 | ANGPTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00691 | ANGPTL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00692 | ANGPTL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00693 | ANGPTL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00694 | ANGPTL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00695 | ANGPTL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00696 | ANGPTL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00697 | ANGPTL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00698 | ANHX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00699 | ANK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00700 | ANK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00701 | ANK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00702 | ANKAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00703 | ANKDD1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00704 | ANKFN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00705 | ANKFY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00706 | ANKH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00707 | ANKHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00708 | ANKK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00709 | ANKLE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00710 | ANKLE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00711 | ANKRA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00712 | ANKRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00713 | ANKRD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00714 | ANKRD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00715 | ANKRD13A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00716 | ANKRD17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00717 | ANKRD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00718 | ANKRD22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00719 | ANKRD26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00720 | ANKRD27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00721 | ANKRD28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00722 | ANKRD30A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00723 | ANKRD33B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00724 | ANKRD35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00725 | ANKRD36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00726 | ANKRD36C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00727 | ANKRD37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00728 | ANKRD40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00729 | ANKRD44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00730 | ANKRD50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00731 | ANKRD52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00732 | ANKRD55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00733 | ANKRD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00734 | ANKRD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00735 | ANKS1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00736 | ANKS1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00737 | ANKS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00738 | ANKZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00739 | ANLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00740 | ANO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00741 | ANO10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00742 | ANO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00743 | ANO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00744 | ANO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00745 | ANO5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00746 | ANO6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00747 | ANO7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00748 | ANO8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00749 | ANO9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00750 | ANOS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00751 | ANP32A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00752 | ANP32B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00753 | ANP32E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00754 | ANPEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00755 | ANTXR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00756 | ANTXR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00757 | ANXA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00758 | ANXA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00759 | ANXA11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00760 | ANXA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00761 | ANXA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00762 | ANXA2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00763 | ANXA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00764 | ANXA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00765 | ANXA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00766 | ANXA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00767 | ANXA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00768 | ANXA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00769 | ANXA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00770 | AOAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00771 | AOC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00772 | AOC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00773 | AOC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00774 | AOPEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00775 | AOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00776 | AP1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00777 | AP1G1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00778 | AP1G2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00779 | AP1M1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00780 | AP1M2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00781 | AP1S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00782 | AP1S2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00783 | AP1S3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00784 | AP2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00785 | AP2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00786 | AP2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00787 | AP2M1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00788 | AP2S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00789 | AP3B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00790 | AP3B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00791 | AP3D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00792 | AP3M1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00793 | AP3M2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00794 | AP3S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00795 | AP3S2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00796 | AP4B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00797 | AP4E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00798 | AP4M1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00799 | AP4S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00800 | AP5Z1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00801 | APAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00802 | APBA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00803 | APBA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00804 | APBB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00805 | APBB1IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00806 | APBB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00807 | APC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00808 | Apc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00809 | Apc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00810 | APC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00811 | APCDD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00812 | APCDD1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00813 | APEH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00814 | APELA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00815 | APEX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00816 | APEX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00817 | APH1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00818 | APH1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00819 | API5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00820 | APIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00821 | APLF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00822 | APLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00823 | APLNR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00824 | Aplnr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00825 | Aplnr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00826 | APLP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00827 | APLP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00828 | APMAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00829 | APOA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00830 | APOA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00831 | APOA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00832 | APOA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00833 | APOB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00834 | APOBEC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00835 | APOBEC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00836 | APOBEC3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00837 | APOBEC3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00838 | APOBEC3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00839 | APOBEC3F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00840 | APOBEC3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00841 | APOBEC3H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00842 | APOBEC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00843 | APOBR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00844 | APOC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00845 | APOC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00846 | APOC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00847 | APOC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00848 | APOD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00849 | APOE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00850 | Apoe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00851 | APOF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00852 | APOH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00853 | APOL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00854 | APOL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00855 | APOL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00856 | APOL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00857 | APOL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00858 | APOL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00859 | APOLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00860 | APOM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00861 | APOO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00862 | APOOL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00863 | APP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00864 | App Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00865 | App Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00866 | APPBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00867 | APPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00868 | APPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00869 | APRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00870 | APTX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00871 | AQP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00872 | AQP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00873 | AQP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00874 | AQP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00875 | AQP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00876 | AQP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00877 | AQP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00878 | AQP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00879 | AQP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00880 | AQP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00881 | AQP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00882 | AQR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00883 | AR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00884 | Ar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00885 | Ar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00886 | ARAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00887 | ARAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00888 | ARAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00889 | ARAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00890 | ARC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00891 | ARCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00892 | AREG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00893 | AREL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00894 | ARF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00895 | ARF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00896 | ARF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00897 | ARF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00898 | ARF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00899 | ARFGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00900 | ARFGAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00901 | ARFGAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00902 | ARFGEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00903 | ARFGEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00904 | ARFGEF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00905 | ARFIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00906 | ARFRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00907 | ARG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00908 | ARG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00909 | ARGFX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00910 | ARGLU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00911 | ARHGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00912 | ARHGAP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00913 | ARHGAP11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00914 | ARHGAP11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00915 | ARHGAP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00916 | ARHGAP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00917 | ARHGAP17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00918 | ARHGAP18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00919 | ARHGAP19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00920 | ARHGAP20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00921 | ARHGAP21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00922 | ARHGAP22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00923 | ARHGAP23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00924 | ARHGAP24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00925 | ARHGAP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00926 | ARHGAP26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00927 | ARHGAP27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00928 | ARHGAP29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00929 | ARHGAP30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00930 | ARHGAP31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00931 | ARHGAP32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00932 | ARHGAP33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00933 | ARHGAP35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00934 | ARHGAP36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00935 | ARHGAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00936 | ARHGAP42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00937 | ARHGAP44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00938 | ARHGAP45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00939 | ARHGAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00940 | ARHGAP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00941 | ARHGAP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00942 | ARHGAP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00943 | ARHGDIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00944 | ARHGDIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00945 | ARHGEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00946 | ARHGEF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00947 | ARHGEF10L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00948 | ARHGEF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00949 | ARHGEF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00950 | ARHGEF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00951 | ARHGEF16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00952 | ARHGEF17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00953 | ARHGEF18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00954 | ARHGEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00955 | ARHGEF25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00956 | ARHGEF26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00957 | ARHGEF28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00958 | ARHGEF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00959 | ARHGEF39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00960 | ARHGEF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00961 | ARHGEF40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00962 | ARHGEF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00963 | ARHGEF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00964 | ARHGEF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00965 | ARHGEF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00966 | ARID1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00967 | ARID1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00968 | ARID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00969 | ARID3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00970 | ARID3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00971 | ARID4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00972 | ARID4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00973 | ARID5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00974 | ARID5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00975 | ARIH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00976 | ARIH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00977 | ARL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00978 | ARL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00979 | ARL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00980 | ARL13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00981 | ARL14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00982 | ARL14EP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00983 | ARL15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00984 | ARL16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00985 | ARL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00986 | ARL2BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00987 | ARL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00988 | ARL4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00989 | ARL4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00990 | ARL4D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00991 | ARL5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00992 | ARL5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00993 | ARL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00994 | ARL6IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00995 | ARL6IP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00996 | ARL6IP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00997 | ARL6IP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00998 | ARL8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS00999 | ARL8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01000 | ARL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01001 | ARMC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01002 | ARMC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01003 | ARMC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01004 | ARMC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01005 | ARMC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01006 | ARMC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01007 | ARMCX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01008 | ARMCX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01009 | ARMCX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01010 | ARMS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01011 | ARNT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01012 | ARNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01013 | ARPC1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01014 | ARPC1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01015 | ARPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01016 | Arpc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01017 | Arpc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01018 | ARPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01019 | Arpc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01020 | Arpc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01021 | ARPC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01022 | ARPC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01023 | ARPC5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01024 | ARPIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01025 | ARPP19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01026 | ARPP21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01027 | ARR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01028 | ARRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01029 | ARRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01030 | ARRDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01031 | ARRDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01032 | ARRDC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01033 | ARRDC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01034 | ARSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01035 | ARSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01036 | ARSD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01037 | ARSF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01038 | ARSG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01039 | ARSH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01040 | ARSI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01041 | ARSJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01042 | ARSK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01043 | ARSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01044 | ART1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01045 | ART3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01046 | ART4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01047 | ART5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01048 | ARTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01049 | ARV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01050 | ARVCF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01051 | ARX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01052 | AS3MT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01053 | ASAH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01054 | ASAH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01055 | ASAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01056 | ASAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01057 | ASAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01058 | ASB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01059 | ASB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01060 | ASB11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01061 | ASB12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01062 | ASB13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01063 | ASB14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01064 | ASB15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01065 | ASB16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01066 | ASB18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01067 | ASB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01068 | ASB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01069 | ASB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01070 | ASB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01071 | ASB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01072 | ASB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01073 | ASB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01074 | ASB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01075 | ASCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01076 | ASCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01077 | ASCC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01078 | ASCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01079 | ASCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01080 | ASCL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01081 | ASCL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01082 | ASCL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01083 | ASF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01084 | ASF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01085 | ASGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01086 | ASGR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01087 | ASH1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01088 | ASH2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01089 | ASIC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01090 | ASIC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01091 | ASIC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01092 | ASIC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01093 | ASIC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01094 | ASIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01095 | ASL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01096 | ASMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01097 | ASMTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01098 | ASNS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01099 | ASPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01100 | ASPDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01101 | ASPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01102 | ASPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01103 | ASPHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01104 | ASPM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01105 | ASPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01106 | ASPRV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01107 | ASPSCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01108 | ASRGL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01109 | ASS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01110 | ASTE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01111 | ASTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01112 | ASTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01113 | ASTN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01114 | ASXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01115 | ASXL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01116 | ASXL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01117 | ASZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01118 | ATAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01119 | ATAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01120 | ATAD2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01121 | ATAD3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01122 | ATAD3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01123 | ATAD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01124 | ATAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01125 | ATCAY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01126 | ATE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01127 | ATF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01128 | ATF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01129 | ATF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01130 | ATF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01131 | ATF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01132 | ATF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01133 | Atf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01134 | Atf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01135 | ATF6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01136 | ATF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01137 | ATF7IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01138 | ATG10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01139 | ATG101 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01140 | ATG12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01141 | ATG13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01142 | ATG14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01143 | ATG16L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01144 | ATG16L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01145 | ATG2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01146 | ATG2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01147 | ATG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01148 | ATG4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01149 | ATG4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01150 | ATG4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01151 | ATG4D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01152 | ATG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01153 | ATG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01154 | ATG9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01155 | ATG9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01156 | ATIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01157 | ATL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01158 | ATL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01159 | ATL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01160 | ATM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01161 | Atm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01162 | Atm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01163 | ATMIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01164 | ATN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01165 | ATOH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01166 | ATOH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01167 | ATOH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01168 | ATOSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01169 | ATOSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01170 | ATOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01171 | ATP10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01172 | ATP10B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01173 | ATP10D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01174 | ATP11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01175 | ATP11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01176 | ATP11C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01177 | ATP12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01178 | ATP13A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01179 | ATP13A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01180 | ATP13A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01181 | ATP13A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01182 | ATP1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01183 | ATP1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01184 | ATP1A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01185 | ATP1A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01186 | ATP1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01187 | ATP1B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01188 | ATP1B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01189 | ATP1B4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01190 | ATP23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01191 | ATP2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01192 | ATP2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01193 | ATP2A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01194 | ATP2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01195 | ATP2B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01196 | ATP2B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01197 | ATP2B4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01198 | ATP2C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01199 | ATP2C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01200 | ATP4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01201 | ATP4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01202 | ATP5F1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01203 | ATP5F1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01204 | ATP5F1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01205 | ATP5F1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01206 | ATP5F1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01207 | ATP5IF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01208 | ATP5MC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01209 | ATP5MF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01210 | ATP5MG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01211 | ATP5PB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01212 | ATP5PF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01213 | ATP5PO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01214 | ATP6AP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01215 | ATP6AP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01216 | ATP6V0A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01217 | ATP6V0A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01218 | ATP6V0A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01219 | ATP6V0B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01220 | ATP6V0C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01221 | ATP6V0D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01222 | ATP6V0D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01223 | ATP6V1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01224 | ATP6V1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01225 | ATP6V1B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01226 | ATP6V1C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01227 | ATP6V1C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01228 | ATP6V1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01229 | ATP6V1E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01230 | ATP6V1F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01231 | ATP6V1G1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01232 | ATP6V1G2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01233 | ATP6V1G3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01234 | ATP6V1H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01235 | ATP7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01236 | ATP7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01237 | ATP8A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01238 | ATP8A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01239 | ATP8B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01240 | ATP8B4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01241 | ATP9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01242 | ATP9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01243 | ATPAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01244 | ATPAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01245 | ATR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01245A | ATR Human Pre-designed siRNA Set A-1 | Oligonucleotides | |
| HY-RS01246 | Atr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01247 | Atr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01248 | ATRAID Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01249 | ATRIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01250 | ATRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01251 | ATRNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01252 | ATRX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01253 | ATXN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01254 | ATXN10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01255 | ATXN1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01256 | ATXN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01257 | ATXN2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01258 | ATXN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01259 | ATXN3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01260 | ATXN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01261 | ATXN7L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01262 | ATXN7L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01263 | AUH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01264 | AUNIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01265 | AUP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01266 | AURKA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01267 | Aurka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01268 | Aurka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01269 | AURKAIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01270 | AURKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01271 | Aurkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01272 | Aurkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01273 | AURKC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01274 | Aurkc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01275 | AURKC Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01276 | AUTS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01277 | AVEN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01278 | AVIL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01279 | AVL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01280 | AVP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01281 | AVPR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01282 | Avpr1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01283 | Avpr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01284 | AVPR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01285 | Avpr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01286 | Avpr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01287 | AVPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01288 | Avpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01289 | Avpr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01290 | AXDND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01291 | AXIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01292 | AXIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01293 | AXL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01294 | AZGP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01295 | AZI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01296 | AZIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01297 | AZIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01298 | AZU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01299 | B2M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01300 | B3GALNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01301 | B3GALNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01302 | B3GALT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01303 | B3GALT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01304 | B3GALT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01305 | B3GALT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01306 | B3GALT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01307 | B3GAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01308 | B3GAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01309 | B3GLCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01310 | B3GNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01311 | B3GNT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01312 | B3GNT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01313 | B3GNT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01314 | B3GNT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01315 | B4GALNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01316 | B4GALNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01317 | B4GALNT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01318 | B4GALNT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01319 | B4GALT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01320 | B4GALT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01321 | B4GALT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01322 | B4GALT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01323 | B4GALT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01324 | B4GALT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01325 | B4GALT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01326 | B4GAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01327 | B9D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01328 | B9D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01329 | BAALC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01330 | BAAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01331 | BABAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01332 | BABAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01333 | BACE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01334 | Bace1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01335 | Bace1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01336 | BACE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01337 | Bace2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01338 | Bace2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01339 | BACH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01340 | BACH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01341 | BAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01342 | BAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01343 | BAG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01344 | BAG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01345 | BAG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01346 | BAG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01347 | BAG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01348 | BAGE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01349 | BAGE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01350 | BAGE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01351 | BAHCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01352 | BAHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01353 | BAIAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01354 | BAIAP2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01355 | BAIAP2L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01356 | BAIAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01357 | BAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01358 | Bak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01359 | Bak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01360 | BAMBI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01361 | BANF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01362 | BANK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01363 | BANP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01364 | BAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01365 | BARD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01366 | BARHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01367 | BARHL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01368 | BARX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01369 | BARX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01370 | BASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01371 | BATF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01372 | BATF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01373 | BATF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01374 | BAX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01375 | Bax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01376 | Bax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01377 | BAZ1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01378 | BAZ1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01379 | BAZ2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01380 | BAZ2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01381 | BBC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01382 | BBLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01383 | BBOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01384 | BBS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01385 | BBS10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01386 | BBS12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01387 | BBS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01388 | BBS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01389 | BBS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01390 | BBS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01391 | BBS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01392 | BBX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01393 | BCAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01394 | BCAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01395 | BCAP29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01396 | BCAP31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01397 | BCAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01398 | BCAR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01399 | BCAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01400 | BCAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01401 | BCAS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01402 | BCAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01403 | BCAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01404 | BCCIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01405 | BCDIN3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01406 | BCHE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01407 | Bche Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01408 | Bche Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01409 | BCKDHA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01410 | BCKDHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01411 | BCKDK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01412 | BCL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01413 | BCL11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01414 | BCL11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01415 | BCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01416 | Bcl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01417 | BCL2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01418 | BCL2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01419 | Bcl2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01420 | Bcl2a1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01421 | BCL2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01422 | Bcl2l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01423 | Bcl2l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01424 | BCL2L10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01425 | Bcl2l10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01426 | Bcl2l10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01427 | BCL2L11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01428 | Bcl2l11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01429 | Bcl2l11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01430 | BCL2L12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01431 | BCL2L13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01432 | BCL2L14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01433 | BCL2L15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01434 | BCL2L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01435 | Bcl2l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01436 | Bcl2l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01437 | BCL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01438 | BCL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01439 | BCL6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01440 | BCL7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01441 | BCL7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01442 | BCL7C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01443 | BCL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01444 | BCL9L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01445 | BCLAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01446 | BCO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01447 | BCO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01448 | BCOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01449 | BCORL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01450 | BCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01451 | BCS1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01452 | BDH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01453 | BDH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01454 | BDKRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01455 | Bdkrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01456 | Bdkrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01457 | BDKRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01458 | Bdkrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01459 | Bdkrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01460 | BDNF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01461 | BDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01462 | BEAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01463 | BECN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01464 | Becn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01465 | Becn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01466 | BECN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01467 | BEGAIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01468 | BEND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01469 | BEND3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01470 | BEND4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01471 | BEND5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01472 | BEND6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01473 | BEND7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01474 | BEST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01475 | BEST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01476 | BEST3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01477 | BEST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01478 | BET1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01479 | BET1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01480 | BEX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01481 | BEX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01482 | BEX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01483 | BEX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01484 | BEX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01485 | BFAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01486 | BFSP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01487 | BFSP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01488 | BGLAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01489 | BGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01490 | BHLHA15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01491 | BHLHA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01492 | BHLHE22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01493 | BHLHE40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01494 | BHLHE41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01495 | BHMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01496 | BHMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01497 | BICC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01498 | BICD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01499 | BICD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01500 | BICRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01501 | BICRAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01502 | BID Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01503 | BIK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01504 | BIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01505 | BIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01506 | BIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01507 | BIRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01508 | Birc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01509 | Birc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01510 | BIRC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01511 | Birc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01512 | Birc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01513 | BIRC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01514 | BIRC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01515 | BIRC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01516 | BIVM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01517 | BLCAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01518 | BLID Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01519 | BLK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01520 | BLM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01521 | BLMH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01522 | BLNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01523 | BLOC1S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01524 | BLOC1S2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01525 | BLOC1S6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01526 | BLVRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01527 | BLVRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01528 | BLZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01529 | BMAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01530 | BMAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01531 | BMF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01532 | BMI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01533 | BMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01534 | BMP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01535 | BMP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01536 | BMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01537 | BMP2K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01538 | BMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01539 | BMP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01540 | BMP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01541 | BMP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01542 | BMP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01543 | BMP8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01544 | BMP8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01545 | BMPER Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01546 | BMPR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01547 | Bmpr1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01548 | Bmpr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01549 | BMPR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01550 | Bmpr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01551 | Bmpr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01552 | BMPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01553 | Bmpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01554 | Bmpr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01555 | BMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01556 | BMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01557 | BMX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01558 | Bmx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01559 | Bmx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01560 | BNC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01561 | BNC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01562 | BNIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01563 | BNIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01564 | BNIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01565 | BNIP3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01566 | BNIPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01567 | BOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01568 | BOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01569 | BOD1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01570 | BOK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01571 | BOLA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01572 | BOLA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01573 | BOLA2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01574 | BOLA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01575 | BOLL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01576 | BOP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01577 | BORA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01578 | BPGM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01579 | BPHL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01580 | BPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01581 | BPIFA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01582 | BPIFA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01583 | BPIFB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01584 | BPIFB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01585 | BPNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01586 | BPTF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01587 | BPY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01588 | BRAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01589 | Braf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01590 | Braf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01591 | BRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01592 | BRAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01593 | BRCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01594 | BRCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01595 | BRCC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01596 | BRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01597 | BRD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01598 | Brd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01599 | BRD2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01600 | BRD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01601 | Brd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01602 | Brd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01603 | BRD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01604 | Brd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01605 | Brd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01606 | BRD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01607 | Brd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01608 | Brd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01609 | BRD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01610 | BRD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01611 | Brd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01612 | Brd9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01613 | BRDT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01614 | Brdt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01615 | Brdt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01616 | BRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01617 | BRF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01618 | BRI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01619 | BRI3BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01620 | BRINP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01621 | BRINP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01622 | BRINP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01623 | BRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01624 | BRIX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01625 | BRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01626 | BRMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01627 | BROX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01628 | BRPF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01629 | Brpf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01630 | Brpf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01631 | BRPF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01632 | Brpf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01633 | Brpf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01634 | BRS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01635 | Brs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01636 | Brs3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01637 | BRSK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01638 | BRSK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01639 | BRWD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01640 | BRWD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01641 | BSCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01642 | BSDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01643 | BSG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01644 | BSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01645 | BSND Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01646 | BSPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01647 | BSPRY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01648 | BST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01649 | BST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01650 | BSX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01651 | BTAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01652 | BTBD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01653 | BTBD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01654 | BTBD17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01655 | BTBD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01656 | BTBD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01657 | BTBD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01658 | BTBD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01659 | BTD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01660 | BTF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01661 | BTF3L4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01662 | BTG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01663 | BTG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01664 | BTG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01665 | BTG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01666 | BTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01667 | Btk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01668 | Btk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01669 | BTLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01670 | BTN1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01671 | BTN2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01672 | BTN2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01673 | BTN3A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01674 | BTN3A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01675 | BTN3A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01676 | BTNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01677 | BTNL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01678 | BTNL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01679 | BTNL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01680 | BTRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01681 | BUB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01682 | BUB1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01683 | BUB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01684 | BUD13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01685 | BUD23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01686 | BUD31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01687 | BVES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01688 | BYSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01689 | BZW1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01690 | BZW2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01691 | C10orf67 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01692 | C11orf65 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01693 | C11orf80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01694 | C11orf87 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01695 | C11orf96 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01696 | C12orf29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01697 | C12orf4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01698 | C12orf57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01699 | C12orf75 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01700 | C15orf48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01701 | C16orf54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01702 | C18orf25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01703 | C19orf12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01704 | C19orf33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01705 | C19orf53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01706 | C1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01707 | C1GALT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01708 | C1GALT1C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01709 | C1orf109 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01710 | C1orf112 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01711 | C1orf116 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01712 | C1orf127 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01713 | C1orf159 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01714 | C1orf167 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01715 | C1orf43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01716 | C1orf54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01717 | C1orf56 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01718 | C1QA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01719 | C1QB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01720 | C1QBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01721 | C1QC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01722 | C1QL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01723 | C1QL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01724 | C1QL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01725 | C1QL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01726 | C1QTNF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01727 | C1QTNF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01728 | C1QTNF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01729 | C1QTNF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01730 | C1QTNF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01731 | C1QTNF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01732 | C1QTNF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01733 | C1QTNF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01734 | C1QTNF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01735 | C1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01736 | C1RL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01737 | C1S Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01738 | C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01739 | C21orf58 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01740 | C2CD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01741 | C2CD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01742 | C2orf69 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01743 | C3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01744 | C3AR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01745 | C4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01746 | C4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01747 | C4BPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01748 | C4BPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01749 | C5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01750 | C5AR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01751 | C5AR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01752 | C6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01753 | C7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01754 | C7orf50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01755 | C8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01756 | C8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01757 | C8G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01758 | C8orf33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01759 | C9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01760 | C9orf72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01761 | C9orf78 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01762 | CA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01763 | CA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01764 | CA11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01765 | CA12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01766 | CA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01767 | CA14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01768 | CA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01769 | CA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01770 | CA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01771 | CA5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01772 | CA5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01773 | CA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01774 | CA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01775 | CA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01776 | CA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01777 | CAAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01778 | CAB39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01779 | CAB39L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01780 | CABIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01781 | CABLES1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01782 | CABLES2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01783 | CABP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01784 | CABP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01785 | CABP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01786 | CABP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01787 | CABS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01788 | CABYR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01789 | CACFD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01790 | CACHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01791 | CACNA1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01792 | CACNA1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01793 | CACNA1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01794 | CACNA1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01795 | CACNA1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01796 | CACNA1F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01797 | CACNA1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01798 | CACNA1H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01799 | CACNA1I Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01800 | CACNA1S Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01801 | CACNA2D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01802 | CACNA2D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01803 | CACNA2D3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01804 | CACNA2D4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01805 | CACNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01806 | CACNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01807 | CACNB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01808 | CACNB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01809 | CACNG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01810 | CACNG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01811 | CACNG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01812 | CACNG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01813 | CACNG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01814 | CACNG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01815 | CACNG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01816 | CACTIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01817 | CACYBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01818 | CAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01819 | CADM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01820 | CADM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01821 | CADM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01822 | CADM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01823 | CADPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01824 | CADPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01825 | CAGE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01826 | CALB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01827 | CALB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01828 | CALCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01829 | CALCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01830 | CALCOCO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01831 | CALCOCO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01832 | CALCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01833 | Calcr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01834 | Calcr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01835 | CALCRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01836 | CALD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01837 | CALHM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01838 | CALHM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01839 | CALHM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01840 | CALM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01841 | CALM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01842 | CALM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01843 | CALML3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01844 | CALML4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01845 | CALML5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01846 | CALN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01847 | CALR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01848 | CALR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01849 | CALU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01850 | CALY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01851 | CAMK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01852 | CAMK1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01853 | CAMK1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01854 | CAMK2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01855 | Camk2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01856 | Camk2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01857 | CAMK2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01858 | CAMK2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01859 | CAMK2G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01860 | Camk2g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01861 | CAMK2G Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01862 | CAMK2N1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01863 | CAMK2N2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01864 | CAMK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01865 | CAMKK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01866 | CAMKK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01867 | CAMKMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01868 | CAMKV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01869 | CAMLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01870 | CAMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01871 | CAMSAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01872 | CAMSAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01873 | CAMSAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01874 | CAMTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01875 | CAMTA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01876 | CAND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01877 | CAND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01878 | CANT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01879 | CANX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01880 | CAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01881 | CAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01882 | CAPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01883 | CAPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01884 | CAPN10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01885 | CAPN11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01886 | CAPN12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01887 | CAPN14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01888 | CAPN15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01889 | CAPN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01890 | CAPN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01891 | CAPN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01892 | CAPN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01893 | CAPN8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01894 | CAPN9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01895 | CAPNS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01896 | CAPNS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01897 | CAPRIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01898 | CAPRIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01899 | CAPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01900 | CAPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01901 | CAPSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01902 | CAPZA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01903 | CAPZA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01904 | CAPZB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01905 | Car1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01906 | Car1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01907 | Car12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01908 | Car12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01909 | Car2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01910 | Car2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01911 | Car4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01912 | Car4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01913 | Car9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01914 | Car9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01915 | CARD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01916 | CARD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01917 | CARD14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01918 | CARD16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01919 | CARD18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01920 | CARD19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01921 | CARD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01922 | CARD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01923 | CARD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01924 | CARF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01925 | CARHSP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01926 | CARM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01927 | Carm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01928 | Carm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01929 | CARMIL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01930 | CARMIL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01931 | CARNMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01932 | CARNS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01933 | CARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01934 | CARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01935 | CARTPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01936 | CASC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01937 | CASD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01938 | CASK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01939 | CASKIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01940 | CASKIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01941 | CASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01942 | Casp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01943 | Casp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01944 | CASP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01945 | CASP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01946 | Casp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01947 | Casp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01948 | CASP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01949 | CASP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01950 | Casp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01951 | Casp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01952 | CASP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01953 | Casp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01954 | Casp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01955 | CASP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01956 | Casp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01957 | Casp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01958 | CASP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01959 | CASP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01960 | Casp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01961 | CASP6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01962 | CASP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01963 | Casp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01964 | Casp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01965 | CASP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01966 | Casp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01967 | Casp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01968 | CASP8AP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01969 | CASP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01970 | Casp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01971 | Casp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01972 | CASQ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01973 | CASQ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01974 | CASR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01975 | Casr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01976 | Casr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01977 | CASS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01978 | CAST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01979 | CASTOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01980 | CASTOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01981 | CASZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01982 | CAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01983 | CATIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01984 | CATSPER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01985 | CATSPER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01986 | CAV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01987 | CAV2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01988 | CAV3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01989 | CAVIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01990 | CAVIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01991 | CAVIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01992 | CBARP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01993 | CBFA2T2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01994 | CBFA2T3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01995 | CBFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01996 | CBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01997 | CBLB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01998 | CBLC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS01999 | CBLIF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02000 | CBLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02001 | CBLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02002 | CBLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02003 | CBLN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02004 | CBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02005 | CBR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02006 | CBR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02007 | CBS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02008 | CBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02009 | CBX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02010 | CBX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02011 | CBX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02012 | CBX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02013 | CBX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02014 | CBX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02015 | CBX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02016 | CBY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02017 | CBY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02018 | CC2D1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02019 | CC2D2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02020 | CCAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02021 | CCAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02022 | CCBE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02023 | CCDC102B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02024 | CCDC103 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02025 | CCDC115 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02026 | CCDC124 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02027 | CCDC127 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02028 | CCDC134 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02029 | CCDC137 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02030 | CCDC14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02031 | CCDC141 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02032 | CCDC144A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02033 | CCDC146 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02034 | CCDC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02035 | CCDC152 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02036 | CCDC17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02037 | CCDC170 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02038 | CCDC18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02039 | CCDC22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02040 | CCDC24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02041 | CCDC25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02042 | CCDC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02043 | CCDC30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02044 | CCDC34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02045 | CCDC39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02046 | CCDC40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02047 | CCDC47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02048 | CCDC50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02049 | CCDC51 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02050 | CCDC57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02051 | CCDC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02052 | CCDC66 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02053 | CCDC69 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02054 | CCDC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02055 | CCDC71 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02056 | CCDC78 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02057 | CCDC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02058 | CCDC80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02059 | CCDC82 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02060 | CCDC86 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02061 | CCDC88A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02062 | CCDC88B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02063 | CCDC88C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02064 | CCDC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02065 | CCDC90B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02066 | CCDC91 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02067 | CCDC92 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02068 | CCDC93 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02069 | CCDC9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02070 | CCER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02071 | CCHCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02072 | CCIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02073 | CCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02074 | CCKAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02075 | Cckar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02076 | Cckar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02077 | CCKBR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02078 | Cckbr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02079 | Cckbr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02080 | CCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02081 | CCL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02082 | CCL13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02083 | CCL14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02084 | CCL15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02085 | CCL16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02086 | CCL17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02087 | CCL18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02088 | CCL19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02089 | CCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02090 | CCL20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02091 | CCL21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02092 | CCL22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02093 | CCL23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02094 | CCL24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02095 | CCL25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02096 | CCL26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02097 | CCL27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02098 | CCL28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02099 | CCL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02100 | CCL3L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02101 | CCL3L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02102 | CCL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02103 | CCL4L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02104 | CCL4L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02105 | CCL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02106 | CCL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02107 | CCL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02108 | CCM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02109 | CCM2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02110 | CCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02111 | CCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02112 | CCN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02113 | CCN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02114 | CCN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02115 | CCN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02116 | CCNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02117 | CCNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02118 | CCNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02119 | CCNB1IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02120 | CCNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02121 | CCNB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02122 | CCNC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02123 | CCND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02124 | CCND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02125 | CCND3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02126 | CCNDBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02127 | CCNE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02128 | CCNE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02129 | CCNF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02130 | CCNG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02131 | CCNG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02132 | CCNH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02133 | CCNI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02134 | CCNJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02135 | CCNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02136 | CCNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02137 | CCNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02138 | CCNO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02139 | CCNP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02140 | CCNQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02141 | CCNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02142 | CCNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02143 | CCNY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02144 | CCNYL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02145 | CCP110 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02146 | CCPG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02147 | CCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02148 | Ccr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02149 | Ccr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02150 | CCR10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02151 | CCR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02152 | Ccr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02153 | Ccr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02154 | CCR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02155 | Ccr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02156 | Ccr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02157 | CCR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02158 | Ccr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02159 | Ccr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02160 | CCR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02161 | Ccr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02162 | Ccr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02163 | CCR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02164 | Ccr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02165 | Ccr6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02166 | CCR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02167 | Ccr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02168 | Ccr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02169 | CCR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02170 | Ccr8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02171 | Ccr8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02172 | CCR9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02173 | Ccr9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02174 | Ccr9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02175 | CCRL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02176 | CCS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02177 | CCSAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02178 | CCSER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02179 | CCT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02180 | CCT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02181 | CCT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02182 | CCT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02183 | CCT6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02184 | CCT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02185 | CCT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02186 | CCZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02187 | CD101 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02188 | CD109 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02189 | CD14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02190 | CD151 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02191 | CD160 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02192 | CD163 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02193 | CD163L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02194 | CD164 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02195 | CD164L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02196 | CD177 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02197 | CD180 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02198 | CD19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02199 | CD1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02200 | CD1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02201 | CD1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02202 | CD1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02203 | CD1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02204 | CD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02205 | CD200 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02206 | CD200R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02207 | CD200R1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02208 | CD207 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02209 | CD209 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02210 | CD22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02211 | CD226 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02212 | CD24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02213 | CD244 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02214 | CD247 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02215 | CD248 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02216 | CD27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02217 | CD274 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02218 | Cd274 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02219 | Cd274 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02220 | CD276 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02221 | CD28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02222 | Cd28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02223 | Cd28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02224 | CD2AP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02225 | CD2BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02226 | CD300A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02227 | CD300C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02228 | CD300E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02229 | CD300LB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02230 | CD300LD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02231 | CD300LF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02232 | CD300LG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02233 | CD302 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02234 | CD320 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02235 | CD33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02236 | CD34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02237 | CD36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02238 | CD37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02239 | CD38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02240 | Cd38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02241 | Cd38 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02242 | CD3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02243 | CD3E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02244 | CD3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02245 | CD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02246 | CD40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02247 | CD40LG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02248 | CD44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02249 | CD46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02250 | CD47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02251 | CD48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02252 | CD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02253 | CD52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02254 | CD53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02255 | CD55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02256 | CD58 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02257 | CD59 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02258 | CD5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02259 | CD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02260 | CD63 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02261 | CD68 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02262 | CD69 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02263 | CD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02264 | CD70 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02265 | CD72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02266 | CD74 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02267 | CD79A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02268 | CD79B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02269 | CD80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02270 | CD81 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02271 | CD82 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02272 | CD83 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02273 | CD84 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02274 | CD86 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02275 | CD8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02276 | CD8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02277 | CD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02278 | CD93 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02279 | CD96 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02280 | CD99 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02281 | CD99L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02282 | CDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02283 | CDAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02284 | CDC123 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02285 | CDC14A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02286 | CDC14B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02287 | CDC16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02288 | CDC20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02289 | CDC20B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02290 | CDC23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02291 | CDC25A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02292 | CDC25B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02293 | CDC25C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02294 | CDC26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02295 | CDC27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02296 | CDC34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02297 | CDC37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02298 | CDC37L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02299 | CDC40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02300 | CDC42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02301 | CDC42BPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02302 | CDC42BPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02303 | CDC42EP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02304 | CDC42EP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02305 | CDC42EP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02306 | CDC45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02307 | CDC5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02308 | CDC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02309 | CDC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02310 | CDC73 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02311 | CDCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02312 | CDCA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02313 | CDCA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02314 | CDCA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02315 | CDCA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02316 | CDCA7L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02317 | CDCA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02318 | CDCP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02319 | CDCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02320 | CDH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02321 | CDH10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02322 | CDH11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02323 | CDH12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02324 | CDH13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02325 | CDH15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02326 | CDH16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02327 | CDH17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02328 | CDH18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02329 | CDH19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02330 | CDH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02331 | CDH20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02332 | CDH22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02333 | CDH23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02334 | CDH24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02335 | CDH26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02336 | CDH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02337 | CDH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02338 | CDH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02339 | CDH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02340 | CDH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02341 | CDH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02342 | CDH9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02343 | CDHR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02344 | CDHR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02345 | CDHR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02346 | CDHR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02347 | CDIPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02348 | CDK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02349 | Cdk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02350 | Cdk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02351 | CDK10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02352 | CDK11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02353 | CDK11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02354 | Cdk11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02355 | Cdk11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02356 | CDK12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02357 | Cdk12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02358 | Cdk12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02359 | CDK13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02360 | Cdk13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02361 | Cdk13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02362 | CDK14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02363 | Cdk14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02364 | Cdk14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02365 | CDK15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02366 | CDK16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02367 | Cdk16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02368 | Cdk16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02369 | CDK17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02370 | CDK18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02371 | CDK19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02372 | Cdk19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02373 | Cdk19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02374 | CDK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02375 | Cdk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02376 | Cdk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02377 | CDK20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02378 | CDK2AP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02379 | CDK2AP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02380 | CDK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02381 | CDK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02382 | Cdk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02383 | CDK4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02384 | CDK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02385 | Cdk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02386 | Cdk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02387 | CDK5R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02388 | CDK5R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02389 | CDK5RAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02390 | CDK5RAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02391 | CDK5RAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02392 | CDK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02393 | Cdk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02394 | Cdk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02395 | CDK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02396 | Cdk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02397 | Cdk7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02398 | CDK8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02399 | Cdk8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02400 | Cdk8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02401 | CDK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02402 | Cdk9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02403 | Cdk9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02404 | CDKAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02405 | CDKL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02406 | CDKL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02407 | CDKL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02408 | CDKL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02409 | CDKL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02410 | CDKN1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02411 | Cdkn1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02412 | CDKN1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02413 | CDKN1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02414 | CDKN2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02415 | CDKN2AIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02416 | CDKN2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02417 | CDKN2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02418 | CDKN2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02419 | CDKN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02420 | CDNF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02421 | CDO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02422 | CDON Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02423 | CDR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02424 | CDR2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02425 | CDS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02426 | CDSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02427 | CDT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02428 | CDV3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02429 | CDX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02430 | CDX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02431 | CDX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02432 | CDY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02433 | CDYL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02434 | CDYL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02435 | CEACAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02436 | CEACAM16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02437 | CEACAM20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02438 | CEACAM21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02439 | CEACAM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02440 | CEACAM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02441 | CEACAM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02442 | CEACAM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02443 | CEACAM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02444 | CEACAM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02445 | CEBPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02446 | CEBPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02447 | CEBPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02448 | CEBPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02449 | CEBPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02450 | CEBPZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02451 | CECR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02452 | Cecr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02453 | Cecr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02454 | CEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02455 | CELA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02456 | CELA2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02457 | CELA3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02458 | CELA3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02459 | CELF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02460 | CELF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02461 | CELF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02462 | CELF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02463 | CELF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02464 | CELF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02465 | CELSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02466 | CELSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02467 | CELSR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02468 | CEMIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02469 | CEMIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02470 | CEMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02471 | CENATAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02472 | CEND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02473 | CENPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02474 | CENPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02475 | CENPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02476 | CENPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02477 | Cenpe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02478 | Cenpe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02479 | CENPF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02480 | CENPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02481 | CENPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02482 | CENPJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02483 | CENPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02484 | CENPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02485 | CENPM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02486 | CENPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02487 | CENPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02488 | CENPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02489 | CENPQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02490 | CENPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02491 | CENPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02492 | CENPU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02493 | CENPV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02494 | CENPW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02495 | CENPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02496 | CEP104 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02497 | CEP112 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02498 | CEP120 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02499 | CEP128 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02500 | CEP131 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02501 | CEP135 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02502 | CEP152 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02503 | CEP162 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02504 | CEP164 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02505 | CEP170 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02506 | CEP170B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02507 | CEP19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02508 | CEP192 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02509 | CEP20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02510 | CEP250 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02511 | CEP290 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02512 | CEP295 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02513 | CEP350 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02514 | CEP41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02515 | CEP43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02516 | CEP44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02517 | CEP55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02518 | CEP57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02519 | CEP63 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02520 | CEP68 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02521 | CEP70 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02522 | CEP72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02523 | CEP76 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02524 | CEP78 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02525 | CEP83 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02526 | CEP85 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02527 | CEP85L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02528 | CEP89 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02529 | CEP95 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02530 | CEP97 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02531 | CEPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02532 | CER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02533 | CERCAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02534 | CERK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02535 | CERKL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02536 | CERS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02537 | CERS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02538 | CERS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02539 | CERS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02540 | CERS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02541 | CERS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02542 | CERT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02543 | CES1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02544 | CES2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02545 | CES3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02546 | CETN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02547 | CETN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02548 | CETN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02549 | CETP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02550 | CFAP100 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02551 | CFAP300 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02552 | CFAP410 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02553 | CFAP45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02554 | CFAP54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02555 | CFAP57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02556 | CFAP74 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02557 | CFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02558 | CFC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02559 | CFD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02560 | CFDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02561 | CFH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02562 | CFHR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02563 | CFHR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02564 | CFHR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02565 | CFHR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02566 | CFHR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02567 | CFI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02568 | CFL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02569 | CFL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02570 | CFLAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02571 | CFP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02572 | CFTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02573 | Cftr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02574 | Cftr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02575 | CGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02576 | CGAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02577 | Cgas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02578 | Cgas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02579 | CGB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02580 | CGB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02581 | CGB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02582 | CGB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02583 | CGB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02584 | CGGBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02585 | CGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02586 | CGNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02587 | CGREF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02588 | CGRRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02589 | CH25H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02590 | CHAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02591 | CHAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02592 | CHAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02593 | CHADL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02594 | CHAF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02595 | CHAF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02596 | CHAMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02597 | CHAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02598 | CHCHD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02599 | CHCHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02600 | CHCHD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02601 | CHCHD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02602 | CHCHD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02603 | CHCHD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02604 | CHCHD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02605 | CHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02606 | CHD1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02607 | CHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02608 | CHD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02609 | CHD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02610 | CHD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02611 | CHD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02612 | CHD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02613 | CHD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02614 | CHD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02615 | CHDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02616 | CHEK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02617 | Chek1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02618 | Chek1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02619 | CHEK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02620 | Chek2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02621 | Chek2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02622 | CHERP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02623 | CHFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02624 | CHGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02625 | CHGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02626 | CHI3L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02627 | CHI3L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02628 | CHIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02629 | CHIC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02630 | CHIC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02631 | CHID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02632 | CHIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02633 | CHKA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02634 | CHKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02635 | CHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02636 | CHM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02637 | CHML Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02638 | CHMP1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02639 | CHMP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02640 | CHMP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02641 | CHMP2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02642 | CHMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02643 | CHMP4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02644 | CHMP4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02645 | CHMP4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02646 | CHMP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02647 | CHMP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02648 | CHMP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02649 | CHN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02650 | CHN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02651 | CHODL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02652 | CHP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02653 | CHP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02654 | CHPF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02655 | CHPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02656 | CHRD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02657 | CHRDL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02658 | CHRDL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02659 | CHRFAM7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02660 | CHRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02661 | CHRM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02662 | CHRM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02663 | CHRM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02664 | CHRM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02665 | CHRNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02666 | CHRNA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02667 | CHRNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02668 | CHRNA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02669 | CHRNA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02670 | CHRNA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02671 | CHRNA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02672 | CHRNA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02673 | CHRNA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02674 | CHRNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02675 | CHRNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02676 | CHRNB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02677 | CHRNB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02678 | CHRND Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02679 | CHRNE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02680 | CHRNG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02681 | CHST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02682 | CHST10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02683 | CHST11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02684 | CHST12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02685 | CHST13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02686 | CHST14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02687 | CHST15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02688 | CHST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02689 | CHST3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02690 | CHST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02691 | CHST5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02692 | CHST6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02693 | CHST8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02694 | CHST9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02695 | CHSY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02696 | CHTF18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02697 | CHTOP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02698 | CHUK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02699 | Chuk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02700 | Chuk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02701 | CHURC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02702 | CIAO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02703 | CIAO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02704 | CIAPIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02705 | CIART Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02706 | CIB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02707 | CIB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02708 | CIB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02709 | CIB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02710 | CIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02711 | CIDEA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02712 | CIDEB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02713 | CIDEC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02714 | CIITA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02715 | CILP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02716 | CILP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02717 | CINP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02718 | CIP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02719 | CIPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02720 | CIR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02721 | CIRBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02722 | CIROP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02723 | CISD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02724 | CISD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02725 | CISD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02726 | CISH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02727 | CIT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02728 | CITED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02729 | CITED2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02730 | CITED4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02731 | CIZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02732 | CKAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02733 | CKAP2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02734 | CKAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02735 | CKAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02736 | CKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02737 | CKLF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02738 | CKM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02739 | CKMT1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02740 | CKMT1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02741 | CKMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02742 | CKS1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02743 | CKS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02744 | CLASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02745 | CLASP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02746 | CLASRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02747 | CLC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02748 | CLCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02749 | CLCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02750 | CLCA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02751 | CLCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02752 | CLCF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02753 | CLCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02754 | CLCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02755 | CLCN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02756 | CLCN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02757 | CLCN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02758 | CLCN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02759 | CLCN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02760 | CLCNKA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02761 | CLCNKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02762 | CLDN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02763 | CLDN10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02764 | CLDN11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02765 | CLDN14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02766 | CLDN15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02767 | CLDN16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02768 | CLDN18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02769 | CLDN19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02770 | CLDN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02771 | CLDN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02772 | CLDN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02773 | CLDN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02774 | CLDN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02775 | CLDN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02776 | CLDN8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02777 | CLDN9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02778 | CLDND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02779 | CLEC10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02780 | CLEC11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02781 | CLEC12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02782 | CLEC12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02783 | CLEC14A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02784 | CLEC16A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02785 | CLEC1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02786 | CLEC1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02787 | CLEC2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02788 | CLEC2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02789 | CLEC3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02790 | CLEC3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02791 | CLEC4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02792 | CLEC4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02793 | CLEC4D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02794 | CLEC4E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02795 | CLEC4F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02796 | CLEC4G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02797 | CLEC4M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02798 | CLEC5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02799 | CLEC6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02800 | CLEC7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02801 | CLEC9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02802 | CLGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02803 | CLIC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02804 | CLIC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02805 | CLIC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02806 | CLIC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02807 | CLIC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02808 | CLIC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02809 | CLINT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02810 | CLIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02811 | CLIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02812 | CLIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02813 | CLIP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02814 | CLK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02815 | Clk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02816 | Clk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02817 | CLK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02818 | CLK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02819 | CLK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02820 | CLMN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02821 | CLMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02822 | CLN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02823 | CLN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02824 | CLN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02825 | CLN8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02826 | CLNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02827 | CLNS1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02828 | CLOCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02829 | CLP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02830 | CLPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02831 | CLPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02832 | CLPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02833 | CLPTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02834 | CLPTM1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02835 | CLPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02836 | CLRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02837 | CLRN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02838 | CLRN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02839 | CLSPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02840 | CLSTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02841 | CLSTN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02842 | CLSTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02843 | CLTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02844 | CLTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02845 | CLTC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02846 | CLTCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02847 | CLTRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02848 | CLU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02849 | CLUAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02850 | CLUH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02851 | CLXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02852 | CLYBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02853 | CMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02854 | CMAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02855 | CMBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02856 | CMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02857 | CMC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02858 | CMC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02859 | CMIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02860 | CMKLR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02861 | CMPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02862 | CMPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02863 | CMSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02864 | CMTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02865 | CMTM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02866 | CMTM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02867 | CMTM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02868 | CMTM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02869 | CMTM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02870 | CMTM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02871 | CMTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02872 | CMTR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02873 | CMYA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02874 | CNBD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02875 | CNBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02876 | CNDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02877 | CNDP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02878 | CNFN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02879 | CNGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02880 | CNGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02881 | CNGA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02882 | CNGA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02883 | CNGB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02884 | CNGB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02885 | CNIH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02886 | CNIH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02887 | CNIH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02888 | CNKSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02889 | CNKSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02890 | CNKSR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02891 | CNMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02892 | CNN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02893 | CNN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02894 | CNN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02895 | CNNM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02896 | CNNM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02897 | CNNM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02898 | CNNM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02899 | CNOT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02900 | CNOT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02901 | CNOT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02902 | CNOT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02903 | CNOT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02904 | CNOT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02905 | CNOT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02906 | CNOT6L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02907 | CNOT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02908 | CNOT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02909 | CNOT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02910 | CNP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02911 | CNPY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02912 | CNPY3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02913 | CNPY4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02914 | CNR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02915 | Cnr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02916 | Cnr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02917 | CNR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02918 | Cnr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02919 | Cnr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02920 | CNRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02921 | CNST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02922 | CNTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02923 | CNTF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02924 | CNTFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02925 | CNTLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02926 | CNTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02927 | CNTN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02928 | CNTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02929 | CNTN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02930 | CNTN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02931 | CNTN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02932 | CNTNAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02933 | CNTNAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02934 | CNTNAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02935 | CNTNAP3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02936 | CNTNAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02937 | CNTNAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02938 | CNTRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02939 | COA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02940 | COA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02941 | COA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02942 | COA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02943 | COA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02944 | COA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02945 | COA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02946 | COASY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02947 | COBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02948 | COBLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02949 | COCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02950 | COG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02951 | COG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02952 | COG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02953 | COG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02954 | COG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02955 | COG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02956 | COG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02957 | COG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02958 | COIL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02959 | COL10A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02960 | COL11A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02961 | COL11A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02962 | COL12A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02963 | COL13A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02964 | COL14A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02965 | COL15A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02966 | COL16A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02967 | COL17A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02968 | COL18A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02969 | COL19A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02970 | COL1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02971 | COL1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02972 | COL20A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02973 | COL21A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02974 | COL22A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02975 | COL23A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02976 | COL24A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02977 | COL25A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02978 | COL26A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02979 | COL27A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02980 | COL28A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02981 | COL2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02982 | COL3A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02983 | COL4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02984 | COL4A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02985 | COL4A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02986 | COL4A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02987 | COL4A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02988 | COL4A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02989 | COL5A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02990 | COL5A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02991 | COL5A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02992 | COL6A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02993 | COL6A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02994 | COL6A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02995 | COL6A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02996 | COL6A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02997 | COL7A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02998 | COL8A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS02999 | COL8A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03000 | COL9A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03001 | COL9A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03002 | COL9A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03003 | COLEC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03004 | COLEC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03005 | COLEC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03006 | COLGALT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03007 | COLGALT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03008 | COLQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03009 | COMMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03010 | COMMD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03011 | COMMD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03012 | COMMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03013 | COMMD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03014 | COMMD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03015 | COMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03016 | COMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03017 | Comt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03018 | Comt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03019 | COMTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03020 | COP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03021 | COPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03022 | COPB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03023 | COPB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03024 | COPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03025 | COPG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03026 | COPRS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03027 | COPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03028 | COPS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03029 | COPS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03030 | COPS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03031 | COPS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03032 | COPS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03033 | COPS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03034 | COPZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03035 | COPZ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03036 | COQ10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03037 | COQ10B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03038 | COQ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03039 | COQ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03040 | COQ4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03041 | COQ5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03042 | COQ6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03043 | COQ7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03044 | COQ8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03045 | COQ8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03046 | COQ9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03047 | CORIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03048 | CORO1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03049 | CORO1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03050 | CORO1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03051 | CORO2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03052 | CORO6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03053 | CORO7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03054 | CORT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03055 | COTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03056 | COX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03057 | COX11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03058 | COX14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03059 | COX15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03060 | COX17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03061 | COX18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03062 | COX19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03063 | COX20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03064 | COX4I1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03065 | COX4I2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03066 | COX5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03067 | COX5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03068 | COX6A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03069 | COX6A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03070 | COX6B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03071 | COX6B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03072 | COX6C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03073 | COX7A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03074 | COX7A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03075 | COX7A2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03076 | COX7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03077 | COX7C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03078 | COX8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03079 | CP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03080 | CPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03081 | CPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03082 | CPA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03083 | CPA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03084 | CPA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03085 | CPA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03086 | CPAMD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03087 | CPB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03088 | CPB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03089 | CPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03090 | CPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03091 | CPEB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03092 | CPEB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03093 | CPEB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03094 | CPEB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03095 | CPED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03096 | CPLANE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03097 | CPLX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03098 | CPLX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03099 | CPLX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03100 | CPM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03101 | CPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03102 | CPN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03103 | CPNE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03104 | CPNE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03105 | CPNE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03106 | CPNE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03107 | CPNE5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03108 | CPNE6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03109 | CPNE7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03110 | CPNE8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03111 | CPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03112 | CPOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03113 | CPPED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03114 | CPQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03115 | CPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03116 | CPSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03117 | CPSF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03118 | CPSF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03119 | CPSF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03120 | CPSF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03121 | CPSF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03122 | CPT1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03123 | CPT1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03124 | CPT1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03125 | CPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03126 | CPTP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03127 | CPVL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03128 | CPXM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03129 | CPXM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03130 | CPZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03131 | CR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03132 | CR1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03133 | CR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03134 | CRABP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03135 | CRABP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03136 | CRACD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03137 | CRACR2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03138 | CRADD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03139 | CRAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03140 | CRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03141 | CRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03142 | CRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03143 | CRBN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03144 | CRCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03145 | Crcp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03146 | Crcp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03147 | CRCT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03148 | CREB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03149 | CREB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03150 | CREB3L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03151 | CREB3L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03152 | CREB3L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03153 | CREB3L4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03154 | CREB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03155 | CREBBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03156 | Crebbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03157 | Crebbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03158 | CREBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03159 | CREBRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03160 | CREBZF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03161 | CREG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03162 | CREG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03163 | CRELD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03164 | CRELD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03165 | CREM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03166 | CRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03167 | CRHBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03168 | CRHR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03169 | Crhr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03170 | Crhr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03171 | CRHR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03172 | Crhr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03173 | Crhr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03174 | CRIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03175 | CRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03176 | CRIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03177 | CRIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03178 | CRIPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03179 | CRISP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03180 | CRISP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03181 | CRISP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03182 | CRISPLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03183 | CRISPLD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03184 | CRK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03185 | CRKL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03186 | CRLF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03187 | CRLF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03188 | CRLF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03189 | CRLS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03190 | CRMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03191 | CRNKL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03192 | CRNN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03193 | CROCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03194 | CROT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03195 | CRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03196 | CRPPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03197 | CRTAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03198 | CRTAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03199 | CRTAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03200 | CRTC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03201 | CRTC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03202 | CRTC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03203 | CRX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03204 | CRY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03205 | CRY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03206 | CRYAA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03207 | CRYAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03208 | CRYBA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03209 | CRYBA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03210 | CRYBB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03211 | CRYBB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03212 | CRYGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03213 | CRYGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03214 | CRYGC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03215 | CRYGD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03216 | CRYGS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03217 | CRYL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03218 | CRYM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03219 | CRYZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03220 | CRYZL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03221 | CS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03222 | CSAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03223 | CSAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03224 | CSDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03225 | CSDE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03226 | CSE1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03227 | CSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03228 | CSF1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03229 | Csf1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03230 | Csf1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03231 | CSF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03232 | CSF2RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03233 | CSF2RB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03234 | CSF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03235 | CSF3R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03236 | CSH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03237 | CSH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03238 | CSK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03239 | CSMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03240 | CSMD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03241 | CSMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03242 | CSN1S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03243 | CSN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03244 | CSN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03245 | CSNK1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03246 | CSNK1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03247 | CSNK1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03248 | CSNK1G1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03249 | CSNK1G2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03250 | CSNK1G3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03251 | CSNK2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03252 | CSNK2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03253 | CSNK2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03254 | CSPG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03255 | CSPG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03256 | CSPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03257 | CSRNP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03258 | CSRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03259 | CSRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03260 | CSRP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03261 | CST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03262 | CST11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03263 | CST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03264 | CST3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03265 | CST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03266 | CST5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03267 | CST6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03268 | CST7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03269 | CST8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03270 | CST9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03271 | CSTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03272 | CSTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03273 | CSTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03274 | CSTF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03275 | CSTF2T Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03276 | CSTF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03277 | CT45A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03278 | CT55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03279 | CT83 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03280 | CTAG1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03281 | CTAG1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03282 | CTAG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03283 | CTBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03284 | CTBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03285 | CTBS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03286 | CTC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03287 | CTCF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03288 | CTCFL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03289 | CTDNEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03290 | CTDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03291 | CTDSP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03292 | CTDSP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03293 | CTDSPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03294 | CTDSPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03295 | CTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03296 | CTH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03297 | CTHRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03298 | CTIF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03299 | CTLA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03300 | Ctla4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03301 | Ctla4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03302 | CTNNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03303 | CTNNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03304 | CTNNA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03305 | CTNNAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03306 | CTNNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03307 | Ctnnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03308 | Ctnnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03309 | CTNNBIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03310 | CTNNBL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03311 | CTNND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03312 | CTNND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03313 | CTNS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03314 | CTPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03315 | CTPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03316 | CTR9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03317 | CTRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03318 | CTRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03319 | CTRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03320 | CTRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03321 | CTSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03322 | CTSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03323 | Ctsb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03324 | Ctsb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03325 | CTSC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03326 | Ctsc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03327 | Ctsc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03328 | CTSD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03329 | Ctsd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03330 | Ctsd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03331 | CTSE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03332 | Ctse Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03333 | Ctse Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03334 | CTSF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03335 | CTSG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03336 | CTSH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03337 | CTSK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03338 | Ctsk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03339 | Ctsk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03340 | CTSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03341 | Ctsl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03342 | Ctsl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03343 | CTSO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03344 | CTSS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03345 | Ctss Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03346 | Ctss Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03347 | CTSV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03348 | CTSW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03349 | CTSZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03350 | CTTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03351 | CTTNBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03352 | CTTNBP2NL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03353 | CTU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03354 | CTU2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03355 | CTXN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03356 | CUBN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03357 | CUEDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03358 | CUEDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03359 | CUL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03360 | CUL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03361 | CUL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03362 | CUL4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03363 | CUL4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03364 | CUL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03365 | CUL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03366 | CUL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03367 | CUTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03368 | CUTC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03369 | CUX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03370 | CUX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03371 | CUZD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03372 | CWC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03373 | CWC22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03374 | CWC25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03375 | CWC27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03376 | CWF19L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03377 | CWH43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03378 | CX3CL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03379 | CX3CR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03380 | Cx3cr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03381 | Cx3cr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03382 | CXADR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03383 | CXCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03384 | CXCL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03385 | CXCL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03386 | CXCL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03387 | CXCL13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03388 | CXCL14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03389 | CXCL16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03390 | CXCL17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03391 | CXCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03392 | CXCL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03393 | CXCL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03394 | CXCL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03395 | CXCL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03396 | CXCL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03397 | CXCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03398 | Cxcr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03399 | Cxcr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03400 | CXCR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03401 | Cxcr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03402 | Cxcr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03403 | CXCR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03404 | Cxcr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03405 | Cxcr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03406 | CXCR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03407 | Cxcr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03408 | Cxcr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03409 | CXCR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03410 | CXCR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03411 | Cxcr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03412 | Cxcr6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03413 | CXXC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03414 | CXXC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03415 | CXXC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03416 | CYB561 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03417 | CYB5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03418 | CYB5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03419 | CYB5R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03420 | CYB5R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03421 | CYB5R3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03422 | CYBA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03423 | CYBB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03424 | Cybb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03425 | Cybb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03426 | CYBC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03427 | CYBRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03428 | CYC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03429 | CYCS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03430 | CYFIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03431 | CYFIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03432 | CYGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03433 | CYLD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03434 | CYP11A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03435 | CYP11B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03436 | CYP11B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03437 | CYP17A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03438 | CYP19A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03439 | Cyp19a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03440 | CYP19A1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03441 | CYP1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03442 | CYP1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03443 | CYP1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03444 | CYP20A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03445 | CYP21A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03446 | CYP24A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03447 | CYP26A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03448 | CYP26B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03449 | CYP26C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03450 | CYP27A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03451 | CYP27B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03452 | CYP27C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03453 | CYP2A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03454 | CYP2A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03455 | CYP2A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03456 | CYP2B6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03457 | CYP2C18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03458 | CYP2C19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03459 | CYP2C8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03460 | CYP2C9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03461 | CYP2D6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03462 | CYP2D7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03463 | CYP2E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03464 | CYP2F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03465 | CYP2J2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03466 | CYP2R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03467 | CYP2S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03468 | CYP2U1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03469 | CYP2W1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03470 | CYP39A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03471 | CYP3A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03472 | CYP3A43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03473 | CYP3A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03474 | CYP3A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03475 | CYP46A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03476 | CYP4A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03477 | CYP4B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03478 | CYP4F11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03479 | CYP4F12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03480 | CYP4F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03481 | CYP4F22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03482 | CYP4F3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03483 | CYP4V2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03484 | CYP4X1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03485 | CYP4Z1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03486 | CYP51A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03487 | CYP7A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03488 | CYP7B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03489 | CYP8B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03490 | CYREN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03491 | CYRIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03492 | CYRIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03493 | CYS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03494 | CYSLTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03495 | Cysltr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03496 | Cysltr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03497 | CYSLTR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03498 | Cysltr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03499 | Cysltr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03500 | CYSTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03501 | CYTH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03502 | CYTH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03503 | CYTIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03504 | CYTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03505 | CYYR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03506 | CZIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03507 | D2HGDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03508 | DAAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03509 | DAAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03510 | DAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03511 | DAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03512 | DAB2IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03513 | DACH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03514 | DACH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03515 | DACT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03516 | DACT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03517 | DACT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03518 | DAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03519 | DAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03520 | DAGLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03521 | DAGLB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03522 | DAND5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03523 | DAO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03524 | DAOA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03525 | DAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03526 | DAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03527 | DAPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03528 | DAPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03529 | DAPK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03530 | DAPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03531 | DAPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03532 | DARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03533 | DARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03534 | DAW1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03535 | DAXX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03536 | DAZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03537 | DAZ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03538 | DAZ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03539 | DAZ4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03540 | DAZAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03541 | DAZAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03542 | DAZL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03543 | DBF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03544 | DBH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03545 | Dbh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03546 | Dbh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03547 | DBI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03548 | DBN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03549 | DBNDD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03550 | DBNDD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03551 | DBNL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03552 | DBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03553 | DBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03554 | DBT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03555 | DBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03556 | DBX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03557 | DCAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03558 | DCAF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03559 | DCAF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03560 | DCAF13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03561 | DCAF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03562 | DCAF16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03563 | DCAF17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03564 | DCAF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03565 | DCAF4L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03566 | DCAF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03567 | DCAF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03568 | DCAF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03569 | DCBLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03570 | DCBLD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03571 | DCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03572 | DCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03573 | DCDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03574 | DCDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03575 | DCHS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03576 | DCHS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03577 | DCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03578 | DCLK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03579 | DCLK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03580 | DCLK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03581 | DCLRE1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03582 | DCLRE1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03583 | DCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03584 | DCP1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03585 | DCP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03586 | DCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03587 | DCPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03588 | DCST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03589 | DCST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03590 | DCSTAMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03591 | DCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03592 | DCTD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03593 | DCTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03594 | DCTN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03595 | DCTN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03596 | DCTN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03597 | DCTPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03598 | DCUN1D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03599 | DCUN1D4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03600 | DCUN1D5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03601 | DCX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03602 | DCXR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03603 | DDA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03604 | DDAH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03605 | DDAH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03606 | DDB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03607 | DDB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03608 | DDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03609 | DDHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03610 | DDHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03611 | DDI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03612 | DDI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03613 | DDIAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03614 | DDIT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03615 | DDIT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03616 | DDIT4L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03617 | DDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03618 | DDO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03619 | DDOST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03620 | DDR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03621 | Ddr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03622 | Ddr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03623 | DDR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03624 | Ddr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03625 | Ddr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03626 | DDRGK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03627 | DDT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03628 | DDTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03629 | DDX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03630 | DDX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03631 | DDX11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03632 | DDX17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03633 | DDX18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03634 | DDX19A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03635 | DDX19B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03636 | DDX20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03637 | DDX21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03638 | DDX23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03639 | DDX24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03640 | DDX25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03641 | DDX27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03642 | DDX28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03643 | DDX31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03644 | DDX39A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03645 | DDX39B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03646 | DDX3X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03647 | DDX3Y Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03648 | DDX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03649 | DDX41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03650 | DDX42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03651 | DDX43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03652 | DDX46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03653 | DDX47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03654 | DDX49 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03655 | DDX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03656 | DDX50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03657 | DDX52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03658 | DDX53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03659 | DDX54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03660 | DDX55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03661 | DDX56 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03662 | DDX59 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03663 | DDX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03664 | DDX60 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03665 | DDX60L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03666 | DEAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03667 | DECR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03668 | DECR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03669 | DEDD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03670 | DEDD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03671 | DEF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03672 | DEF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03673 | DEFA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03674 | DEFA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03675 | DEFA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03676 | DEFA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03677 | DEFA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03678 | DEFB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03679 | DEFB103A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03680 | DEFB4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03681 | DEFB4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03682 | DEGS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03683 | DEGS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03684 | DELE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03685 | DENND1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03686 | DENND1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03687 | DENND3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03688 | DENND4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03689 | DENND4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03690 | DENND5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03691 | DENND5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03692 | DENR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03693 | DEPDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03694 | DEPDC1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03695 | DEPDC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03696 | DEPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03697 | DEPTOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03698 | DERA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03699 | DERL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03700 | DERL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03701 | DERL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03702 | DERPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03703 | DES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03704 | DESI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03705 | DESI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03706 | DET1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03707 | DEXI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03708 | DFFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03709 | DFFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03710 | DGAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03711 | DGAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03712 | DGCR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03713 | DGCR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03714 | DGCR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03715 | DGKA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03716 | DGKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03717 | DGKD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03718 | DGKE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03719 | DGKG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03720 | DGKH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03721 | DGKI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03722 | DGKK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03723 | DGKQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03724 | DGKZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03725 | DGUOK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03726 | DHCR24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03727 | DHCR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03728 | DHDDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03729 | DHDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03730 | DHFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03731 | Dhfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03732 | Dhfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03733 | DHH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03734 | DHODH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03735 | Dhodh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03736 | Dhodh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03737 | DHPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03738 | DHRS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03739 | DHRS11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03740 | DHRS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03741 | DHRS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03742 | DHRS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03743 | DHRS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03744 | DHRS7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03745 | DHRS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03746 | DHRSX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03747 | DHTKD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03748 | DHX15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03749 | DHX16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03750 | DHX29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03751 | DHX30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03752 | DHX33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03753 | DHX34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03754 | DHX35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03755 | DHX36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03756 | DHX37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03757 | DHX38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03758 | DHX40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03759 | DHX58 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03760 | DHX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03761 | DHX9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03762 | DIABLO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03763 | DIAPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03764 | DIAPH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03765 | DIAPH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03766 | DICER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03767 | DIDO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03768 | DIMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03769 | DIO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03770 | DIO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03771 | DIO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03772 | DIP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03773 | DIP2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03774 | DIP2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03775 | DIRAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03776 | DIRAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03777 | DIRAS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03778 | DIS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03779 | DIS3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03780 | DIS3L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03781 | DISC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03782 | DISP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03783 | DISP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03784 | DISP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03785 | DIXDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03786 | DKC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03787 | DKK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03788 | DKK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03789 | DKK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03790 | DKK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03791 | DKKL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03792 | DLAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03793 | DLC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03794 | DLD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03795 | DLEC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03796 | DLG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03797 | DLG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03798 | DLG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03799 | DLG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03800 | DLG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03801 | DLGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03802 | DLGAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03803 | DLGAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03804 | DLGAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03805 | DLGAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03806 | DLK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03807 | DLK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03808 | DLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03809 | DLL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03810 | DLL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03811 | DLST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03812 | DLX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03813 | DLX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03814 | DLX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03815 | DLX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03816 | DLX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03817 | DLX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03818 | DMAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03819 | DMAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03820 | DMBT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03821 | DMBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03822 | DMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03823 | DMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03824 | DMGDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03825 | DMKN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03826 | DMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03827 | DMPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03828 | DMRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03829 | DMRT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03830 | DMRT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03831 | DMRTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03832 | DMRTA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03833 | DMTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03834 | DMTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03835 | DMWD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03836 | DMXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03837 | DMXL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03838 | DNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03839 | DNAAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03840 | DNAAF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03841 | DNAAF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03842 | DNAH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03843 | DNAH10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03844 | DNAH11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03845 | DNAH12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03846 | DNAH14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03847 | DNAH17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03848 | DNAH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03849 | DNAH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03850 | DNAH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03851 | DNAH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03852 | DNAH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03853 | DNAH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03854 | DNAH9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03855 | DNAI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03856 | DNAI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03857 | DNAJA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03858 | DNAJA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03859 | DNAJA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03860 | DNAJA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03861 | DNAJB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03862 | Dnajb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03863 | Dnajb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03864 | DNAJB11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03865 | DNAJB12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03866 | DNAJB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03867 | DNAJB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03868 | DNAJB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03869 | DNAJB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03870 | DNAJB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03871 | DNAJB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03872 | DNAJC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03873 | DNAJC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03874 | DNAJC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03875 | DNAJC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03876 | DNAJC13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03877 | DNAJC14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03878 | DNAJC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03879 | DNAJC16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03880 | DNAJC19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03881 | DNAJC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03882 | DNAJC21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03883 | DNAJC27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03884 | DNAJC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03885 | DNAJC30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03886 | DNAJC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03887 | DNAJC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03888 | DNAJC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03889 | DNAJC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03890 | DNAJC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03891 | DNAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03892 | DNAL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03893 | DNALI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03894 | DNASE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03895 | DNASE1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03896 | DNASE1L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03897 | DNASE1L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03898 | DNASE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03899 | DND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03900 | DNER Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03901 | DNHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03902 | DNLZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03903 | DNM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03904 | DNM1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03905 | DNM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03906 | DNM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03907 | DNMBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03908 | DNMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03909 | Dnmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03910 | Dnmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03911 | DNMT3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03912 | DNMT3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03913 | DNMT3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03914 | DNPEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03915 | DNPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03916 | DNTT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03917 | DNTTIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03918 | DNTTIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03919 | DOC2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03920 | DOC2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03921 | DOCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03922 | DOCK10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03923 | DOCK11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03924 | DOCK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03925 | DOCK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03926 | DOCK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03927 | DOCK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03928 | DOCK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03929 | DOCK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03930 | DOCK8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03931 | DOCK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03932 | DOHH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03933 | DOK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03934 | DOK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03935 | DOK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03936 | DOK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03937 | DOK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03938 | DOK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03939 | DOK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03940 | DOLK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03941 | DONSON Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03942 | DOT1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03943 | Dot1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03944 | Dot1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03945 | DPAGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03946 | DPCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03947 | DPEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03948 | DPEP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03949 | DPF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03950 | DPF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03951 | DPF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03952 | DPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03953 | DPH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03954 | DPH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03955 | DPH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03956 | DPH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03957 | DPH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03958 | DPM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03959 | DPM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03960 | DPM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03961 | DPP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03962 | DPP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03963 | DPP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03964 | Dpp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03965 | Dpp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03966 | DPP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03967 | DPP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03968 | DPP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03969 | DPP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03970 | DPPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03971 | DPPA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03972 | DPPA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03973 | DPPA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03974 | DPRX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03975 | DPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03976 | DPY19L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03977 | DPY19L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03978 | DPY30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03979 | DPYD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03980 | DPYS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03981 | DPYSL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03982 | DPYSL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03983 | DPYSL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03984 | DPYSL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03985 | DQX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03986 | DR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03987 | DRAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03988 | DRAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03989 | DRAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03990 | DRAXIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03991 | DRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03992 | DRC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03993 | DRC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03994 | DRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03995 | Drd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03996 | Drd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03997 | DRD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03998 | Drd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS03999 | Drd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04000 | DRD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04001 | Drd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04002 | Drd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04003 | DRD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04004 | Drd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04005 | Drd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04006 | DRD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04007 | Drd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04008 | Drd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04009 | DRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04010 | DRG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04011 | DRGX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04012 | DROSHA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04013 | DRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04014 | DSC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04015 | DSC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04016 | DSC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04017 | DSCAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04018 | DSCAML1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04019 | DSCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04020 | DSEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04021 | DSG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04022 | DSG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04023 | DSG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04024 | DSG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04025 | DSN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04026 | DSP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04027 | DSPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04028 | DST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04029 | DSTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04030 | DSTYK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04031 | DTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04032 | DTD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04033 | DTHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04034 | DTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04035 | DTNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04036 | DTNB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04037 | DTNBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04038 | DTX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04039 | DTX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04040 | DTX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04041 | DTX3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04042 | DTX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04043 | DTYMK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04044 | DUOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04045 | DUOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04046 | DUOXA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04047 | DUOXA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04048 | DUS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04049 | DUS3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04050 | DUSP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04051 | DUSP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04052 | DUSP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04053 | DUSP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04054 | DUSP13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04055 | DUSP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04056 | DUSP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04057 | DUSP16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04058 | DUSP18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04059 | DUSP19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04060 | DUSP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04061 | DUSP22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04062 | DUSP23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04063 | DUSP26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04064 | DUSP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04065 | DUSP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04066 | DUSP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04067 | DUSP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04068 | DUSP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04069 | DUSP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04070 | DUSP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04071 | DUT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04072 | DUX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04073 | DUX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04074 | DUXA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04075 | DUXB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04076 | DVL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04077 | DVL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04078 | DVL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04079 | DXO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04080 | DYM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04081 | DYNAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04082 | DYNC1H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04083 | DYNC1I1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04084 | DYNC1I2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04085 | DYNC1LI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04086 | DYNC2H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04087 | DYNC2LI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04088 | DYNLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04089 | DYNLL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04090 | DYNLRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04091 | DYNLRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04092 | DYNLT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04093 | DYNLT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04094 | DYRK1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04095 | Dyrk1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04096 | Dyrk1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04097 | DYRK1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04098 | DYRK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04099 | Dyrk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04100 | Dyrk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04101 | DYRK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04102 | Dyrk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04103 | Dyrk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04104 | DYRK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04105 | DYSF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04106 | DYTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04107 | DZIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04108 | DZIP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04109 | DZIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04110 | E2F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04111 | E2F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04112 | E2F3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04113 | E2F4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04114 | E2F5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04115 | E2F6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04116 | E2F7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04117 | E2F8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04118 | E4F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04119 | EAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04120 | EAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04121 | EAPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04122 | EARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04123 | EBAG9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04124 | EBF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04125 | EBF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04126 | EBF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04127 | EBF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04128 | EBI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04129 | EBNA1BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04130 | EBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04131 | EBPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04132 | ECD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04133 | ECE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04134 | ECE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04135 | ECEL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04136 | ECH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04137 | ECHDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04138 | ECHDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04139 | ECHDC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04140 | ECHS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04141 | ECI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04142 | ECI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04143 | ECM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04144 | ECM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04145 | ECPAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04146 | ECRG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04147 | ECSCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04148 | ECSIT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04149 | ECT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04150 | ECT2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04151 | EDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04152 | EDA2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04153 | EDAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04154 | EDARADD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04155 | EDC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04156 | EDC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04157 | EDEM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04158 | EDEM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04159 | EDEM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04160 | EDF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04161 | EDIL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04162 | EDN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04163 | Edn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04164 | EDN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04165 | EDN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04166 | EDNRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04167 | Ednra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04168 | EDNRA Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04169 | EDNRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04170 | Ednrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04171 | Ednrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04172 | EEA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04173 | EED Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04174 | EEF1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04175 | EEF1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04176 | EEF1B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04177 | EEF1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04178 | EEF1E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04179 | EEF1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04180 | EEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04181 | EEF2K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04182 | EEFSEC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04183 | EEPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04184 | EFCAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04185 | EFEMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04186 | EFEMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04187 | EFHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04188 | EFHC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04189 | EFHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04190 | EFHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04191 | EFL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04192 | EFNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04193 | EFNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04194 | EFNA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04195 | EFNA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04196 | EFNA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04197 | EFNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04198 | EFNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04199 | EFNB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04200 | EFR3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04201 | EFR3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04202 | EFS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04203 | EFTUD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04204 | EGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04205 | EGFL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04206 | EGFL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04207 | EGFL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04208 | EGFLAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04209 | EGFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04210 | Egfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04211 | Egfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04212 | EGLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04213 | EGLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04214 | EGLN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04215 | EGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04216 | EGR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04217 | EGR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04218 | EGR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04219 | EHBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04220 | EHBP1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04221 | EHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04222 | EHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04223 | EHD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04224 | EHD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04225 | EHF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04226 | EHHADH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04227 | EHMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04228 | Ehmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04229 | EHMT1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04230 | EHMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04231 | Ehmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04232 | Ehmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04233 | EI24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04234 | EID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04235 | EID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04236 | EID3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04237 | EIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04238 | EIF1AX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04239 | EIF1AY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04240 | EIF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04241 | EIF2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04242 | EIF2AK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04243 | EIF2AK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04244 | EIF2AK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04245 | Eif2ak3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04246 | Eif2ak3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04247 | EIF2AK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04248 | EIF2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04249 | EIF2B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04250 | EIF2B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04251 | EIF2B4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04252 | EIF2B5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04253 | EIF2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04254 | EIF2S1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04255 | EIF2S2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04256 | EIF2S3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04257 | EIF3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04258 | EIF3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04259 | EIF3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04260 | EIF3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04261 | EIF3E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04262 | EIF3F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04263 | EIF3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04264 | EIF3H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04265 | EIF3I Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04266 | EIF3J Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04267 | EIF3K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04268 | EIF3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04269 | EIF3M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04270 | EIF4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04271 | EIF4A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04272 | EIF4A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04273 | EIF4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04274 | EIF4E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04275 | EIF4E2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04276 | EIF4E3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04277 | EIF4EBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04278 | EIF4EBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04279 | EIF4EBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04280 | EIF4ENIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04281 | EIF4G1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04282 | EIF4G2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04283 | EIF4G3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04284 | EIF4H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04285 | EIF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04286 | EIF5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04287 | EIF5A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04288 | EIF5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04289 | EIF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04290 | ELAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04291 | ELAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04292 | ELANE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04293 | ELAPOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04294 | ELAVL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04295 | ELAVL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04296 | ELAVL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04297 | ELAVL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04298 | ELF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04299 | ELF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04300 | ELF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04301 | ELF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04302 | ELF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04303 | ELFN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04304 | ELFN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04305 | ELK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04306 | ELK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04307 | ELK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04308 | ELL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04309 | ELL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04310 | ELL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04311 | ELMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04312 | ELMO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04313 | ELMO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04314 | ELMOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04315 | ELMOD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04316 | ELN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04317 | ELOA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04318 | ELOB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04319 | ELOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04320 | ELOF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04321 | ELOVL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04322 | ELOVL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04323 | ELOVL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04324 | ELOVL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04325 | ELOVL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04326 | ELOVL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04327 | ELOVL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04328 | ELP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04329 | ELP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04330 | ELP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04331 | ELP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04332 | ELP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04333 | ELP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04334 | EMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04335 | EMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04336 | EMC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04337 | EMC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04338 | EMC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04339 | EMC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04340 | EMC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04341 | EMC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04342 | EMC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04343 | EMC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04344 | EMCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04345 | EMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04346 | EME1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04347 | EME2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04348 | EMG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04349 | EMID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04350 | EMILIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04351 | EMILIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04352 | EMILIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04353 | EML1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04354 | EML2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04355 | EML3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04356 | EML4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04357 | EML5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04358 | EML6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04359 | EMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04360 | EMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04361 | EMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04362 | EMSY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04363 | EMX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04364 | EMX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04365 | EN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04366 | EN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04367 | ENAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04368 | ENAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04369 | ENC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04370 | ENDOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04371 | ENDOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04372 | ENDOU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04373 | ENDOV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04374 | ENG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04375 | ENGASE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04376 | ENHO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04377 | ENKUR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04378 | ENO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04379 | ENO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04380 | ENO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04381 | ENO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04382 | ENOPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04383 | ENOSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04384 | ENOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04385 | ENOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04386 | ENPEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04387 | ENPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04388 | ENPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04389 | ENPP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04390 | ENPP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04391 | ENPP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04392 | ENPP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04393 | ENPP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04394 | ENSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04395 | ENTPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04396 | ENTPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04397 | ENTPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04398 | ENTPD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04399 | ENTPD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04400 | ENTPD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04401 | ENTPD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04402 | ENY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04403 | EOGT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04404 | EOMES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04405 | EP300 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04406 | Ep300 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04407 | Ep300 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04408 | EP400 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04409 | EPAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04410 | EPB41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04411 | EPB41L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04412 | EPB41L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04413 | EPB41L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04414 | EPB41L4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04415 | EPB41L4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04416 | EPB41L5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04417 | EPB42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04418 | EPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04419 | EPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04420 | EPCAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04421 | EPDR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04422 | EPG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04423 | EPGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04424 | EPHA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04425 | EPHA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04426 | EPHA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04427 | EPHA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04428 | EPHA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04429 | EPHA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04430 | EPHA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04431 | EPHA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04432 | EPHA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04433 | EPHB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04434 | EPHB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04435 | EPHB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04436 | EPHB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04437 | EPHB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04438 | EPHX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04439 | EPHX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04440 | EPHX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04441 | EPM2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04442 | EPM2AIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04443 | EPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04444 | EPN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04445 | EPN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04446 | EPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04447 | EPOP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04448 | EPOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04449 | EPPIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04450 | EPPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04451 | EPRS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04452 | EPS15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04453 | EPS15L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04454 | EPS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04455 | EPS8L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04456 | EPS8L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04457 | EPS8L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04458 | EPSTI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04459 | EPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04460 | EPYC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04461 | EQTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04462 | ERAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04463 | ERAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04464 | ERAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04465 | ERAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04466 | ERBB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04467 | Erbb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04468 | ERBB2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04469 | ERBB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04470 | Erbb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04471 | Erbb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04472 | ERBB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04473 | Erbb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04474 | Erbb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04475 | ERBIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04476 | ERC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04477 | ERC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04478 | ERCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04479 | ERCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04480 | ERCC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04481 | ERCC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04482 | ERCC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04483 | ERCC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04484 | ERCC6L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04485 | ERCC6L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04486 | ERCC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04487 | EREG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04488 | ERF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04489 | ERFE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04490 | ERFL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04491 | ERG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04492 | ERG28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04493 | ERGIC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04494 | ERGIC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04495 | ERH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04496 | ERI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04497 | ERI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04498 | ERI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04499 | ERICH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04500 | ERLEC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04501 | ERLIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04502 | ERLIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04503 | ERMAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04504 | ERMARD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04505 | ERMN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04506 | ERMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04507 | ERN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04508 | Ern1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04509 | Ern1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04510 | ERN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04511 | ERO1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04512 | ERO1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04513 | ERP27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04514 | ERP29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04515 | ERP44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04516 | ERRFI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04517 | ERV3-1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04518 | ERVW-1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04519 | ESA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04520 | ESAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04521 | ESB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04522 | ESCO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04523 | ESCO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04524 | ESD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04525 | ESF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04526 | ESM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04527 | ESPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04528 | ESPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04529 | ESR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04530 | Esr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04531 | Esr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04532 | ESR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04533 | Esr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04534 | Esr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04535 | ESRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04536 | ESRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04537 | ESRRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04538 | Esrra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04539 | Esrra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04540 | ESRRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04541 | Esrrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04542 | ESRRB Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04543 | ESRRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04544 | Esrrg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04545 | Esrrg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04546 | ESS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04547 | ESX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04548 | ESYT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04549 | ESYT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04550 | ETAA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04551 | ETDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04552 | ETDB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04553 | ETDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04554 | ETF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04555 | ETFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04556 | ETFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04557 | ETFDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04558 | ETHE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04559 | ETNK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04560 | ETNK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04561 | ETNPPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04562 | ETS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04563 | ETS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04564 | ETV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04565 | ETV2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04566 | ETV3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04567 | ETV4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04568 | ETV5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04569 | ETV6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04570 | ETV7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04571 | EVA1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04572 | EVC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04573 | EVC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04574 | EVI2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04575 | EVI2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04576 | EVI5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04577 | EVL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04578 | EVPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04579 | EVX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04580 | EVX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04581 | EWSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04582 | EXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04583 | EXD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04584 | EXD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04585 | EXO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04586 | EXO5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04587 | EXOC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04588 | EXOC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04589 | EXOC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04590 | EXOC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04591 | EXOC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04592 | EXOC6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04593 | EXOC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04594 | EXOC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04595 | EXOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04596 | EXOSC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04597 | EXOSC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04598 | EXOSC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04599 | EXOSC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04600 | EXOSC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04601 | EXOSC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04602 | EXOSC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04603 | EXOSC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04604 | EXOSC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04605 | EXOSC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04606 | EXPH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04607 | EXT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04608 | EXT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04609 | EXTL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04610 | EXTL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04611 | EYA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04612 | EYA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04613 | EYA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04614 | EYA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04615 | EYS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04616 | EZH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04617 | Ezh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04618 | Ezh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04619 | EZH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04620 | Ezh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04621 | Ezh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04622 | EZHIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04623 | EZR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04624 | F10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04625 | F11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04626 | F11R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04627 | F12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04628 | F13A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04629 | F13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04630 | F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04631 | F2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04632 | F2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04633 | F2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04634 | F2RL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04635 | F2rl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04636 | F2rl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04637 | F2RL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04638 | F2rl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04639 | F2rl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04640 | F2RL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04641 | F2rl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04642 | F2rl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04643 | F3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04644 | F5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04645 | F7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04646 | F8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04647 | F8A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04648 | F9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04649 | FA2H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04650 | FAAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04651 | Faah Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04652 | Faah Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04653 | FAAH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04654 | FAAP100 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04655 | FAAP24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04656 | FABP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04657 | FABP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04658 | FABP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04659 | FABP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04660 | FABP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04661 | FABP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04662 | FABP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04663 | FABP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04664 | FABP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04665 | FADD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04666 | FADS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04667 | FADS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04668 | FADS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04669 | FADS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04670 | FAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04671 | FAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04672 | FAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04673 | FAHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04674 | FAIM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04675 | FAIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04676 | FAM107A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04677 | FAM107B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04678 | FAM111A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04679 | FAM111B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04680 | FAM117A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04681 | FAM120A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04682 | FAM120C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04683 | FAM135A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04684 | FAM135B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04685 | FAM136A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04686 | FAM13A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04687 | FAM151A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04688 | FAM161A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04689 | FAM162A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04690 | FAM167A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04691 | FAM168A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04692 | FAM169A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04693 | FAM171A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04694 | FAM171A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04695 | FAM171B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04696 | FAM172A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04697 | FAM174A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04698 | FAM174B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04699 | FAM177A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04700 | FAM178B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04701 | FAM180A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04702 | FAM181A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04703 | FAM184A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04704 | FAM20A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04705 | FAM20B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04706 | FAM20C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04707 | FAM210A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04708 | FAM210B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04709 | FAM222A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04710 | FAM32A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04711 | FAM3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04712 | FAM3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04713 | FAM3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04714 | FAM3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04715 | FAM43A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04716 | FAM50A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04717 | FAM53B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04718 | FAM72A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04719 | FAM76B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04720 | FAM81A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04721 | FAM83A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04722 | FAM83B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04723 | FAM83D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04724 | FAM83F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04725 | FAM83G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04726 | FAM83H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04727 | FAM89A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04728 | FAM8A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04729 | FAM98B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04730 | FAM9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04731 | FAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04732 | FANCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04733 | FANCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04734 | FANCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04735 | FANCD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04736 | FANCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04737 | FANCF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04738 | FANCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04739 | FANCI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04740 | FANCL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04741 | FANCM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04742 | FANK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04743 | FAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04744 | FAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04745 | FAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04746 | FARP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04747 | FARP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04748 | FARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04749 | FARSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04750 | FARSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04751 | FAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04752 | FASLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04753 | FASN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04754 | Fasn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04755 | Fasn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04756 | FASTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04757 | FASTKD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04758 | FASTKD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04759 | FASTKD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04760 | FAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04761 | FAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04762 | FAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04763 | FAT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04764 | FATE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04765 | FAU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04766 | FAXC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04767 | FBF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04768 | FBH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04769 | FBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04770 | FBLIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04771 | FBLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04772 | FBLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04773 | FBLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04774 | FBLN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04775 | FBLN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04776 | FBN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04777 | FBN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04778 | FBN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04779 | FBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04780 | FBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04781 | FBRS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04782 | FBRSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04783 | FBXL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04784 | FBXL14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04785 | FBXL16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04786 | FBXL17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04787 | FBXL18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04788 | FBXL19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04789 | FBXL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04790 | FBXL20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04791 | FBXL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04792 | FBXL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04793 | FBXL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04794 | FBXL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04795 | FBXO11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04796 | FBXO15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04797 | FBXO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04798 | FBXO21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04799 | FBXO22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04800 | FBXO25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04801 | FBXO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04802 | FBXO30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04803 | FBXO31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04804 | FBXO32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04805 | FBXO38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04806 | FBXO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04807 | FBXO40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04808 | FBXO42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04809 | FBXO44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04810 | FBXO47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04811 | FBXO5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04812 | FBXO6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04813 | FBXO7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04814 | FBXO8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04815 | FBXO9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04816 | FBXW11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04817 | FBXW5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04818 | FBXW7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04819 | FBXW8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04820 | FCAMR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04821 | FCAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04822 | FCER1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04823 | FCER1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04824 | FCER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04825 | FCF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04826 | FCGBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04827 | FCGR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04828 | FCGR2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04829 | FCGR2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04830 | FCGR2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04831 | FCGR3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04832 | FCGR3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04833 | FCGRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04834 | FCHO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04835 | FCHO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04836 | FCHSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04837 | FCHSD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04838 | FCMR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04839 | FCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04840 | FCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04841 | FCN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04842 | FCRL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04843 | FCRL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04844 | FCRL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04845 | FCRL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04846 | FCRL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04847 | FCRL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04848 | FCRLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04849 | FCRLB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04850 | FCSK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04851 | FDCSP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04852 | FDFT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04853 | FDPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04854 | FDX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04855 | FDX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04856 | FDXR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04857 | FECH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04858 | FEM1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04859 | FEM1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04860 | FEM1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04861 | FEN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04862 | FER Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04863 | FER1L6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04864 | FERMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04865 | FERMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04866 | FERMT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04867 | FES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04868 | FETUB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04869 | FEV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04870 | FEZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04871 | FEZ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04872 | FEZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04873 | FEZF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04874 | FFAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04875 | FFAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04876 | FFAR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04877 | FFAR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04878 | FGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04879 | FGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04880 | FGD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04881 | FGD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04882 | FGD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04883 | FGD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04884 | FGD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04885 | FGD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04886 | FGF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04887 | FGF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04888 | FGF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04889 | FGF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04890 | FGF13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04891 | FGF14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04892 | FGF16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04893 | FGF17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04894 | FGF18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04895 | FGF19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04896 | FGF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04897 | FGF20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04898 | FGF21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04899 | FGF22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04900 | FGF23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04901 | FGF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04902 | FGF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04903 | FGF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04904 | FGF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04905 | FGF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04906 | FGF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04907 | FGF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04908 | FGFBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04909 | FGFBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04910 | FGFBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04911 | FGFR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04912 | Fgfr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04913 | Fgfr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04914 | FGFR1OP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04915 | FGFR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04916 | Fgfr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04917 | Fgfr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04918 | FGFR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04919 | Fgfr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04920 | Fgfr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04921 | FGFR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04922 | Fgfr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04923 | Fgfr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04924 | FGFRL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04925 | FGG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04926 | FGGY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04927 | FGL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04928 | FGL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04929 | FGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04930 | FH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04931 | FHAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04932 | FHDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04933 | FHIT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04934 | FHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04935 | FHL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04936 | FHL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04937 | FHL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04938 | FHOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04939 | FHOD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04940 | FIBCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04941 | FIBIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04942 | FIBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04943 | FICD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04944 | FIG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04945 | FIGLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04946 | FIGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04947 | FIGNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04948 | FILIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04949 | FILIP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04950 | FIP1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04951 | FIS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04952 | FITM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04953 | FITM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04954 | FIZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04955 | FJX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04956 | FKBP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04957 | FKBP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04958 | FKBP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04959 | FKBP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04960 | FKBP1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04961 | FKBP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04962 | FKBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04963 | FKBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04964 | FKBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04965 | FKBP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04966 | FKBP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04967 | FKBP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04968 | FKBP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04969 | FKBP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04970 | FKBPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04971 | FKRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04972 | FKTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04973 | FLAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04974 | FLCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04975 | FLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04976 | FLG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04977 | FLI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04978 | FLII Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04979 | FLNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04980 | FLNB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04981 | FLNC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04982 | FLOT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04983 | FLOT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04984 | FLRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04985 | FLRT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04986 | FLRT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04987 | FLT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04988 | Flt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04989 | Flt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04990 | FLT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04991 | Flt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04992 | Flt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04993 | FLT3LG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04994 | FLT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04995 | Flt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04996 | Flt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04997 | FLVCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04998 | FLVCR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS04999 | FMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05000 | FMN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05001 | FMN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05002 | FMNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05003 | FMNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05004 | FMNL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05005 | FMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05006 | FMO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05007 | FMO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05008 | FMO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05009 | FMO5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05010 | FMOD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05011 | FMR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05012 | FMR1NB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05013 | FN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05014 | FN3K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05015 | FN3KRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05016 | FNBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05017 | FNBP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05018 | FNDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05019 | FNDC3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05020 | FNDC3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05021 | FNDC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05022 | FNDC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05023 | FNIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05024 | FNIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05025 | FNTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05026 | FNTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05027 | FOCAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05028 | FOLH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05029 | FOLR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05030 | FOLR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05031 | FOLR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05032 | FOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05033 | FOSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05034 | FOSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05035 | FOSL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05036 | FOXA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05037 | FOXA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05038 | FOXA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05039 | FOXB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05040 | FOXB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05041 | FOXC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05042 | FOXC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05043 | FOXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05044 | FOXD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05045 | FOXD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05046 | FOXD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05047 | FOXE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05048 | FOXE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05049 | FOXF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05050 | FOXF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05051 | FOXG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05052 | FOXH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05053 | FOXI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05054 | FOXI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05055 | FOXI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05056 | FOXJ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05057 | FOXJ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05058 | FOXJ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05059 | FOXK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05060 | FOXK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05061 | FOXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05062 | FOXL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05063 | FOXL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05064 | FOXM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05065 | FOXN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05066 | FOXN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05067 | FOXN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05068 | FOXN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05069 | FOXO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05070 | FOXO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05071 | FOXO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05072 | FOXO6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05073 | FOXP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05074 | FOXP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05075 | FOXP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05076 | FOXP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05077 | FOXQ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05078 | FOXR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05079 | FOXR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05080 | FOXRED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05081 | FOXRED2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05082 | FOXS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05083 | FPGS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05084 | FPGT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05085 | FPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05086 | FPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05087 | FPR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05088 | FRA10AC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05089 | FRAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05090 | FRAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05091 | FRAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05092 | FREM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05093 | FREM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05094 | FREM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05095 | FRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05096 | FRG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05097 | FRG2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05098 | FRK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05099 | FRMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05100 | FRMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05101 | FRMD4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05102 | FRMD4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05103 | FRMD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05104 | FRMD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05105 | FRMD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05106 | FRMD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05107 | FRMPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05108 | FRMPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05109 | FRMPD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05110 | FRRS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05111 | FRRS1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05112 | FRS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05113 | FRS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05114 | FRY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05115 | FRYL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05116 | FRZB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05117 | FSBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05118 | FSCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05119 | FSCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05120 | FSCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05121 | FSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05122 | FSD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05123 | FSHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05124 | FSHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05125 | FSIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05126 | FSIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05127 | FST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05128 | FSTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05129 | FSTL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05130 | FSTL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05131 | FSTL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05132 | FTCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05133 | FTH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05134 | FTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05135 | FTMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05136 | FTO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05137 | Fto Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05138 | Fto Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05139 | FTSJ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05140 | FTSJ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05141 | FUBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05142 | FUBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05143 | FUCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05144 | FUCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05145 | FUNDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05146 | FUNDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05147 | FUOM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05148 | FURIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05149 | FUS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05150 | FUT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05151 | FUT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05152 | FUT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05153 | FUT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05154 | FUT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05155 | FUT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05156 | FUT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05157 | FUT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05158 | FUT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05159 | FUT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05160 | FUT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05161 | FUZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05162 | FXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05163 | FXR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05164 | FXR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05165 | FXYD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05166 | FXYD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05167 | FXYD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05168 | FXYD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05169 | FXYD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05170 | FXYD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05171 | FXYD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05172 | FYB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05173 | FYCO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05174 | FYN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05175 | FYTTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05176 | FZD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05177 | FZD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05178 | FZD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05179 | FZD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05180 | FZD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05181 | FZD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05182 | FZD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05183 | FZD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05184 | FZD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05185 | FZD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05186 | FZR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05187 | G0S2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05188 | G2E3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05189 | G3BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05190 | G3BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05191 | G6PC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05192 | G6PC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05193 | G6PC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05194 | G6PD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05195 | G6PR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05196 | GAA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05197 | GAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05198 | GAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05199 | GAB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05200 | GAB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05201 | GABARAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05202 | GABARAPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05203 | GABARAPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05204 | GABBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05205 | GABBR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05206 | GABPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05207 | GABPB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05208 | GABPB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05209 | GABRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05210 | GABRA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05211 | GABRA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05212 | GABRA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05213 | GABRA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05214 | GABRA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05215 | GABRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05216 | GABRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05217 | GABRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05218 | GABRD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05219 | GABRE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05220 | GABRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05221 | GABRG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05222 | GABRG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05223 | GABRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05224 | GABRQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05225 | GABRR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05226 | GABRR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05227 | GAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05228 | GAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05229 | GADD45A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05230 | GADD45B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05231 | GADD45G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05232 | GADL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05233 | GAGE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05234 | GAGE8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05235 | GAK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05236 | Gak Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05237 | Gak Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05238 | GAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05239 | GAL3ST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05240 | GAL3ST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05241 | GALC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05242 | GALE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05243 | GALK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05244 | GALK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05245 | GALM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05246 | GALNS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05247 | GALNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05248 | GALNT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05249 | GALNT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05250 | GALNT12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05251 | GALNT13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05252 | GALNT14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05253 | GALNT15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05254 | GALNT17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05255 | GALNT18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05256 | GALNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05257 | GALNT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05258 | GALNT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05259 | GALNT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05260 | GALNT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05261 | GALNT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05262 | GALNTL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05263 | GALP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05264 | GALR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05265 | GALR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05266 | GALR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05267 | GALT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05268 | GAMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05269 | GAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05270 | GANAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05271 | GANC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05272 | GAP43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05273 | GAPDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05274 | GAPDHS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05275 | GAPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05276 | GAPVD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05277 | GAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05278 | GARIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05279 | GARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05280 | GART Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05281 | GAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05282 | GAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05283 | GAS2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05284 | GAS2L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05285 | GAS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05286 | GAS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05287 | GAS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05288 | GAST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05289 | GATA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05290 | GATA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05291 | GATA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05292 | GATA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05293 | GATA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05294 | GATA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05295 | GATAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05296 | GATAD2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05297 | GATAD2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05298 | GATB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05299 | GATC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05300 | GATM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05301 | GBA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05302 | GBA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05303 | GBA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05304 | GBE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05305 | GBF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05306 | GBGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05307 | GBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05308 | GBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05309 | GBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05310 | GBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05311 | GBP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05312 | GBP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05313 | GBP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05314 | GBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05315 | GBX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05316 | GC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05317 | GCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05318 | GCAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05319 | GCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05320 | GCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05321 | GCDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05322 | GCFC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05323 | GCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05324 | GCGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05325 | Gcgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05326 | Gcgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05327 | GCH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05328 | GCHFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05329 | GCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05330 | Gck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05331 | Gck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05332 | GCKR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05333 | GCLC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05334 | GCLM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05335 | GCM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05336 | GCM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05337 | GCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05338 | GCNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05339 | GCNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05340 | GCNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05341 | GCNT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05342 | GCNT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05343 | GCSAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05344 | GCSH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05345 | GDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05346 | GDAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05347 | GDAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05348 | GDE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05349 | GDF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05350 | GDF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05351 | GDF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05352 | GDF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05353 | GDF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05354 | GDF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05355 | GDF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05356 | GDF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05357 | GDF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05358 | GDF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05359 | GDI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05360 | GDI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05361 | GDNF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05362 | GDPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05363 | GDPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05364 | GDPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05365 | GDPD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05366 | GEM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05367 | GEMIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05368 | GEMIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05369 | GEMIN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05370 | GEMIN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05371 | GEMIN8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05372 | GEN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05373 | GET1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05374 | GET3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05375 | GET4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05376 | GFAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05377 | GFER Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05378 | GFI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05379 | GFI1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05380 | GFM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05381 | GFM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05382 | GFOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05383 | GFOD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05384 | GFPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05385 | GFPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05386 | GFRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05387 | GFRA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05388 | GFRA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05389 | GFRA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05390 | GFRAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05391 | GFUS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05392 | GFY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05393 | GGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05394 | GGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05395 | GGA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05396 | GGACT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05397 | GGCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05398 | GGCX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05399 | GGH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05400 | GGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05401 | GGNBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05402 | GGPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05403 | GGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05404 | GGT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05405 | GGT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05406 | GGT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05407 | GGTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05408 | GH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05409 | GH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05410 | GHDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05411 | GHITM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05412 | GHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05413 | GHRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05414 | GHRHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05415 | GHRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05416 | GHSR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05417 | Ghsr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05418 | Ghsr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05419 | GID4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05420 | GID8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05421 | GIGYF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05422 | GIGYF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05423 | GIMAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05424 | GIMAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05425 | GIMAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05426 | GIMAP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05427 | GIMAP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05428 | GIMAP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05429 | GIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05430 | GINS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05431 | GINS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05432 | GINS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05433 | GINS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05434 | GIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05435 | GIPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05436 | GIPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05437 | GIPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05438 | GIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05439 | GIT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05440 | GJA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05441 | GJA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05442 | GJA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05443 | GJA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05444 | GJA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05445 | GJA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05446 | GJB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05447 | GJB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05448 | GJB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05449 | GJB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05450 | GJB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05451 | GJB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05452 | GJC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05453 | GJC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05454 | GJC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05455 | GJD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05456 | GJD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05457 | GK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05458 | GK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05459 | GK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05460 | GKAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05461 | GKN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05462 | GKN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05463 | GLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05464 | GLB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05465 | GLB1L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05466 | GLCCI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05467 | GLCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05468 | GLDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05469 | GLDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05470 | GLE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05471 | GLG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05472 | GLI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05473 | Gli1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05474 | Gli1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05475 | GLI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05476 | GLI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05477 | GLI4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05478 | GLIPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05479 | GLIPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05480 | GLIS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05481 | GLIS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05482 | GLIS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05483 | GLMN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05484 | GLMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05485 | GLO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05486 | Glo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05487 | Glo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05488 | GLOD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05489 | GLOD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05490 | GLP1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05491 | GLP2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05492 | GLRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05493 | GLRA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05494 | GLRA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05495 | GLRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05496 | GLRX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05497 | GLRX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05498 | GLRX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05499 | GLRX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05500 | GLS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05501 | Gls Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05502 | Gls Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05503 | GLS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05504 | GLT1D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05505 | GLT8D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05506 | GLTP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05507 | GLUD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05508 | GLUD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05509 | GLUL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05510 | GLYAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05511 | GLYCTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05512 | GLYR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05513 | GM2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05514 | GMCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05515 | GMDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05516 | GMEB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05517 | GMEB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05518 | GMFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05519 | GMFG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05520 | GMIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05521 | GML Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05522 | GMNC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05523 | GMNN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05524 | GMPPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05525 | GMPPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05526 | GMPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05527 | GMPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05528 | GMPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05529 | GNA11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05530 | GNA12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05531 | GNA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05532 | GNA14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05533 | GNA15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05534 | GNAI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05535 | GNAI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05536 | GNAI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05537 | GNAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05538 | GNAO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05539 | GNAQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05540 | GNAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05541 | GNAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05542 | GNAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05543 | GNAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05544 | GNAZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05545 | GNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05546 | GNB1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05547 | GNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05548 | GNB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05549 | GNB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05550 | GNB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05551 | GNE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05552 | GNG10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05553 | GNG11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05554 | GNG12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05555 | GNG13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05556 | GNG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05557 | GNG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05558 | GNG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05559 | GNG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05560 | GNG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05561 | GNG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05562 | GNGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05563 | GNGT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05564 | GNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05565 | GNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05566 | GNL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05567 | GNL3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05568 | GNLY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05569 | GNMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05570 | GNPAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05571 | GNPDA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05572 | GNPDA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05573 | GNPNAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05574 | GNPTAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05575 | GNPTG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05576 | GNRH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05577 | GNRH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05578 | GNRHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05579 | Gnrhr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05580 | Gnrhr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05581 | GNS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05582 | GOLGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05583 | GOLGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05584 | GOLGA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05585 | GOLGA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05586 | GOLGA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05587 | GOLGA6L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05588 | GOLGA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05589 | GOLGA7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05590 | GOLGB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05591 | GOLIM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05592 | GOLM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05593 | GOLM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05594 | GOLPH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05595 | GOLPH3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05596 | GOLT1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05597 | GON4L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05598 | GON7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05599 | GOPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05600 | GORAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05601 | GORASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05602 | GORASP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05603 | GOSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05604 | GOSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05605 | GOT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05606 | GOT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05607 | GP1BA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05608 | GP1BB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05609 | GP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05610 | GP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05611 | GP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05612 | GP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05613 | GPA33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05614 | GPAA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05615 | GPAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05616 | GPAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05617 | GPAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05618 | GPAT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05619 | GPATCH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05620 | GPATCH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05621 | GPATCH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05622 | GPBAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05623 | Gpbar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05624 | Gpbar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05625 | GPBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05626 | GPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05627 | GPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05628 | GPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05629 | GPC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05630 | GPC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05631 | GPC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05632 | GPCPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05633 | GPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05634 | GPD1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05635 | GPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05636 | GPER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05637 | GPHA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05638 | GPHN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05639 | GPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05640 | GPIHBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05641 | GPKOW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05642 | GPLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05643 | GPM6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05644 | GPM6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05645 | GPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05646 | GPN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05647 | GPN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05648 | GPNMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05649 | GPR101 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05650 | GPR107 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05651 | GPR108 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05652 | GPR119 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05653 | Gpr119 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05654 | Gpr119 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05655 | GPR12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05656 | GPR132 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05657 | GPR135 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05658 | GPR137 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05659 | GPR137B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05660 | GPR139 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05661 | Gpr139 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05662 | Gpr139 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05663 | GPR141 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05664 | GPR142 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05665 | GPR143 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05666 | GPR146 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05667 | GPR149 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05668 | GPR15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05669 | GPR150 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05670 | GPR151 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05671 | GPR153 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05672 | GPR155 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05673 | GPR156 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05674 | GPR157 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05675 | GPR158 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05676 | GPR160 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05677 | GPR161 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05678 | GPR162 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05679 | GPR17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05680 | GPR171 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05681 | Gpr171 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05682 | Gpr171 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05683 | GPR173 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05684 | GPR174 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05685 | GPR176 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05686 | GPR179 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05687 | GPR18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05688 | GPR180 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05689 | GPR182 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05690 | GPR183 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05691 | Gpr183 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05692 | Gpr183 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05693 | GPR19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05694 | GPR20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05695 | GPR21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05696 | GPR22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05697 | GPR25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05698 | GPR26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05699 | GPR27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05700 | GPR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05701 | GPR31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05702 | GPR32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05703 | GPR33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05704 | GPR34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05705 | GPR35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05706 | Gpr35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05707 | Gpr35 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05708 | GPR36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05709 | GPR37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05710 | GPR37L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05711 | GPR39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05712 | GPR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05713 | Gpr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05714 | Gpr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05715 | GPR42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05716 | GPR45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05717 | GPR50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05718 | GPR52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05719 | Gpr52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05720 | Gpr52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05721 | GPR55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05722 | Gpr55 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05723 | Gpr55 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05724 | GPR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05725 | Gpr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05726 | Gpr6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05727 | GPR61 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05728 | GPR62 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05729 | GPR63 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05730 | GPR65 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05731 | GPR68 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05732 | Gpr68 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05733 | Gpr68 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05734 | GPR75 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05735 | GPR78 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05736 | GPR82 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05737 | GPR83 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05738 | GPR84 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05739 | Gpr84 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05740 | Gpr84 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05741 | GPR85 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05742 | GPR87 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05743 | GPR88 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05744 | Gpr88 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05745 | Gpr88 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05746 | GPR89A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05747 | GPRASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05748 | GPRASP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05749 | GPRC5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05750 | GPRC5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05751 | GPRC5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05752 | GPRC5D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05753 | GPRC6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05754 | GPRIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05755 | GPRIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05756 | GPRIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05757 | GPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05758 | GPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05759 | GPSM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05760 | GPSM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05761 | GPSM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05762 | GPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05763 | GPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05764 | GPX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05765 | GPX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05766 | GPX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05767 | GPX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05768 | GPX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05769 | GPX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05770 | GPX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05771 | GPX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05772 | GRAMD1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05773 | GRAMD1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05774 | GRAMD1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05775 | GRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05776 | GRAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05777 | GRAPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05778 | GRB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05779 | GRB14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05780 | GRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05781 | GRB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05782 | GREB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05783 | GREB1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05784 | GREM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05785 | GREM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05786 | GREP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05787 | GRHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05788 | GRHL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05789 | GRHL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05790 | GRHPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05791 | GRIA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05792 | GRIA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05793 | GRIA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05794 | GRIA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05795 | GRID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05796 | GRID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05797 | GRIFIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05798 | GRIK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05799 | GRIK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05800 | GRIK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05801 | GRIK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05802 | GRIK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05803 | GRIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05804 | GRIN2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05805 | GRIN2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05806 | GRIN3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05807 | GRIN3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05808 | GRINA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05809 | GRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05810 | GRIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05811 | GRIPAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05812 | GRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05813 | GRK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05814 | GRK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05815 | GRK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05816 | GRK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05817 | GRK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05818 | GRK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05819 | GRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05820 | Grm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05821 | Grm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05822 | GRM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05823 | Grm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05824 | Grm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05825 | GRM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05826 | Grm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05827 | Grm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05828 | GRM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05829 | Grm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05830 | Grm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05831 | GRM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05832 | Grm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05833 | Grm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05834 | GRM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05835 | Grm6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05836 | Grm6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05837 | GRM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05838 | Grm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05839 | Grm7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05840 | GRM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05841 | Grm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05842 | Grm8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05843 | GRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05844 | GRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05845 | GRPEL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05846 | GRPEL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05847 | GRPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05848 | GRSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05849 | GRTP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05850 | GRWD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05851 | GSAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05852 | GSC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05853 | GSC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05854 | GSDMA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05855 | GSDMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05856 | GSDMC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05857 | GSDMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05858 | GSDME Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05859 | GSE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05860 | GSG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05861 | GSG1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05862 | GSK3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05863 | Gsk3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05864 | Gsk3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05865 | GSK3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05866 | GSKIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05867 | GSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05868 | GSPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05869 | GSPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05870 | GSR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05871 | GSS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05872 | GSTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05873 | GSTA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05874 | GSTA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05875 | GSTA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05876 | GSTA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05877 | GSTCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05878 | GSTK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05879 | GSTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05880 | GSTM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05881 | GSTM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05882 | GSTM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05883 | GSTM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05884 | GSTO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05885 | GSTO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05886 | GSTP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05887 | GSTT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05888 | GSTT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05889 | GSTZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05890 | GSX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05891 | GSX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05892 | GTF2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05893 | GTF2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05894 | GTF2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05895 | GTF2E2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05896 | GTF2F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05897 | GTF2F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05898 | GTF2H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05899 | GTF2H2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05900 | GTF2H3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05901 | GTF2H4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05902 | GTF2H5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05903 | GTF2I Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05904 | GTF2IRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05905 | GTF3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05906 | GTF3C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05907 | GTF3C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05908 | GTPBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05909 | GTPBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05910 | GTPBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05911 | GTPBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05912 | GTPBP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05913 | GTSE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05914 | GTSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05915 | GUCA1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05916 | GUCA2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05917 | GUCA2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05918 | GUCY1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05919 | GUCY1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05920 | GUCY1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05921 | GUCY2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05922 | GUCY2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05923 | GUF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05924 | GUK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05925 | GUK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05926 | GULP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05927 | GUSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05928 | GXYLT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05929 | GXYLT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05930 | GYG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05931 | GYG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05932 | GYPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05933 | GYPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05934 | GYPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05935 | GYPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05936 | GYS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05937 | GYS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05938 | GZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05939 | GZMA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05940 | GZMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05941 | GZMH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05942 | GZMK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05943 | GZMM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05944 | H1-0 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05945 | H1-1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05946 | H1-10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05947 | H1-2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05948 | H1-3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05949 | H1-4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05950 | H1-5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05951 | H1-6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05952 | H1-7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05953 | H1-8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05954 | H2AB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05955 | H2AC18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05956 | H2AJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05957 | H2AX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05958 | H2AZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05959 | H2BC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05960 | H2BC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05961 | H3-3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05962 | H3-3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05963 | H3-4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05964 | H3-5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05965 | H3-7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05966 | H3C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05967 | H3C14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05968 | H3C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05969 | H3C3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05970 | H3C6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05971 | H3C7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05972 | H3C8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05973 | H3Y2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05974 | H4C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05975 | H4C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05976 | H4C3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05977 | H4C4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05978 | H4C6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05979 | H4C8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05980 | H6PD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05981 | HAAO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05982 | HABP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05983 | HABP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05984 | HACD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05985 | HACD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05986 | HACD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05987 | HACE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05988 | HACL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05989 | HADH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05990 | HADHA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05991 | HADHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05992 | HAGH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05993 | HAGHL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05994 | HAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05995 | HAMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05996 | HAND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05997 | HAND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05998 | HAO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS05999 | HAO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06000 | HAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06001 | HAPLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06002 | HAPLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06003 | HAPLN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06004 | HAPLN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06005 | HARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06006 | HAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06007 | HAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06008 | HAS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06009 | HASPIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06010 | Haspin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06011 | Haspin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06012 | HAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06013 | HAUS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06014 | HAUS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06015 | HAUS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06016 | HAUS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06017 | HAUS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06018 | HAUS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06019 | HAUS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06020 | HAUS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06021 | HAVCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06022 | HAVCR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06023 | HAX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06024 | HBA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06025 | HBA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06026 | HBB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06027 | HBD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06028 | HBE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06029 | HBEGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06030 | HBG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06031 | HBG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06032 | HBM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06033 | HBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06034 | HBQ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06035 | HBS1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06036 | HBZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06037 | HCAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06038 | HCAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06039 | Hcar2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06040 | Hcar2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06041 | HCAR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06042 | HCFC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06043 | HCG22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06044 | HCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06045 | HCLS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06046 | HCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06047 | HCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06048 | HCN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06049 | HCN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06050 | HCRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06051 | HCRTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06052 | Hcrtr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06053 | Hcrtr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06054 | HCRTR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06055 | Hcrtr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06056 | Hcrtr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06057 | HCST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06058 | HDAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06059 | Hdac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06060 | Hdac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06061 | HDAC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06062 | Hdac10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06063 | Hdac10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06064 | HDAC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06065 | Hdac11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06066 | Hdac11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06067 | HDAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06068 | Hdac2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06069 | HDAC2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06070 | HDAC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06071 | Hdac3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06072 | Hdac3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06073 | HDAC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06074 | Hdac4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06075 | Hdac4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06076 | HDAC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06077 | Hdac5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06078 | Hdac5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06079 | HDAC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06080 | Hdac6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06081 | HDAC6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06082 | HDAC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06083 | Hdac7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06084 | Hdac7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06085 | HDAC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06086 | Hdac8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06087 | HDAC8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06088 | HDAC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06089 | Hdac9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06090 | HDAC9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06091 | HDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06092 | HDDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06093 | HDDC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06094 | HDGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06095 | HDGFL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06096 | HDGFL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06097 | HDHD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06098 | HDHD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06099 | HDLBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06100 | HDX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06101 | HEATR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06102 | HEATR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06103 | HEATR5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06104 | HEBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06105 | HEBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06106 | HECA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06107 | HECTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06108 | HECTD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06109 | HECTD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06110 | HECTD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06111 | HECW1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06112 | HECW2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06113 | HEG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06114 | HELB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06115 | HELLS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06116 | HELQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06117 | HELT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06118 | HELZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06119 | HELZ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06120 | HEMGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06121 | HENMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06122 | HEPACAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06123 | HEPACAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06124 | HEPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06125 | HEPHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06126 | HERC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06127 | HERC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06128 | HERC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06129 | HERC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06130 | HERC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06131 | HERC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06132 | HERPUD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06133 | HERPUD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06134 | HES1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06135 | HES2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06136 | HES3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06137 | HES4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06138 | HES5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06139 | HES6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06140 | HES7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06141 | HESX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06142 | HEXA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06143 | HEXB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06144 | HEXD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06145 | HEXIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06146 | HEY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06147 | HEY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06148 | HEYL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06149 | HFE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06150 | HFM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06151 | HGD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06152 | HGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06153 | HGFAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06154 | HGH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06155 | HGS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06156 | HGSNAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06157 | HHAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06158 | HHATL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06159 | HHEX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06160 | HHIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06161 | HHIPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06162 | HHLA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06163 | HIBADH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06164 | HIBCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06165 | HIC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06166 | HIC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06167 | HID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06168 | HIF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06169 | HIF1AN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06170 | HIF3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06171 | HIGD1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06172 | HIGD1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06173 | HIKESHI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06174 | HILPDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06175 | HINFP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06176 | HINT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06177 | HINT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06178 | HINT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06179 | HIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06180 | HIP1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06181 | HIPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06182 | HIPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06183 | HIPK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06184 | HIPK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06185 | HIRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06186 | HIRIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06187 | HIVEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06188 | HIVEP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06189 | HIVEP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06190 | HJURP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06191 | HJV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06192 | HK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06193 | HK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06194 | HK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06195 | HKDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06196 | HLA-A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06197 | HLA-B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06198 | HLA-C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06199 | HLA-DMA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06200 | HLA-DMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06201 | HLA-DOA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06202 | HLA-DOB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06203 | HLA-DPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06204 | HLA-DPB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06205 | HLA-DQA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06206 | HLA-DQA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06207 | HLA-DQB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06208 | HLA-DQB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06209 | HLA-DQB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06210 | HLA-DRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06211 | HLA-DRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06212 | HLA-DRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06213 | HLA-DRB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06214 | HLA-DRB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06215 | HLA-E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06216 | HLA-F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06217 | HLA-G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06218 | HLCS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06219 | HLF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06220 | HLTF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06221 | HLX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06222 | HM13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06223 | HMBOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06224 | HMBS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06225 | HMCES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06226 | HMCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06227 | HMCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06228 | HMG20A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06229 | HMG20B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06230 | HMGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06231 | HMGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06232 | HMGB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06233 | HMGB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06234 | HMGB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06235 | HMGB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06236 | HMGCL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06237 | HMGCLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06238 | HMGCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06239 | Hmgcr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06240 | Hmgcr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06241 | HMGCS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06242 | HMGCS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06243 | HMGN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06244 | HMGN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06245 | HMGN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06246 | HMGN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06247 | HMGXB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06248 | HMMR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06249 | HMOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06250 | HMOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06251 | HMSD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06252 | HMX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06253 | HMX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06254 | HMX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06255 | HNF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06256 | HNF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06257 | HNF4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06258 | HNF4G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06259 | HNMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06260 | HNRNPA0 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06261 | HNRNPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06262 | HNRNPA2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06263 | HNRNPA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06264 | HNRNPAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06265 | HNRNPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06266 | HNRNPCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06267 | HNRNPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06268 | HNRNPDL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06269 | HNRNPF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06270 | HNRNPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06271 | HNRNPH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06272 | HNRNPH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06273 | HNRNPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06274 | HNRNPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06275 | HNRNPLL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06276 | HNRNPM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06277 | HNRNPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06278 | HNRNPU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06279 | HNRNPUL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06280 | HNRNPUL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06281 | HOATZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06282 | HOGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06283 | HOMER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06284 | HOMER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06285 | HOMER3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06286 | HOMEZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06287 | HOOK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06288 | HOOK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06289 | HOOK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06290 | HOPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06291 | HORMAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06292 | HORMAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06293 | HOXA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06294 | HOXA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06295 | HOXA11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06296 | HOXA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06297 | HOXA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06298 | HOXA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06299 | HOXA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06300 | HOXA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06301 | HOXA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06302 | HOXA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06303 | HOXA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06304 | HOXB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06305 | HOXB13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06306 | HOXB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06307 | HOXB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06308 | HOXB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06309 | HOXB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06310 | HOXB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06311 | HOXB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06312 | HOXB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06313 | HOXB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06314 | HOXC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06315 | HOXC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06316 | HOXC13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06317 | HOXC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06318 | HOXC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06319 | HOXC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06320 | HOXC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06321 | HOXC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06322 | HOXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06323 | HOXD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06324 | HOXD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06325 | HOXD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06326 | HOXD13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06327 | HOXD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06328 | HOXD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06329 | HOXD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06330 | HOXD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06331 | HP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06332 | HP1BP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06333 | HPCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06334 | HPCAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06335 | HPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06336 | HPDL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06337 | HPF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06338 | HPGD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06339 | Hpgd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06340 | Hpgd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06341 | HPGDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06342 | HPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06343 | HPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06344 | HPRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06345 | HPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06346 | HPS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06347 | HPS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06348 | HPS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06349 | HPS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06350 | HPSE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06351 | HPSE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06352 | HPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06353 | HR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06354 | HRAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06355 | Hras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06356 | Hras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06357 | HRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06358 | HRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06359 | HRH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06360 | Hrh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06361 | Hrh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06362 | HRH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06363 | Hrh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06364 | Hrh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06365 | HRH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06366 | Hrh3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06367 | Hrh3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06368 | HRH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06369 | Hrh4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06370 | Hrh4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06371 | HRK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06372 | HRNR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06373 | HROB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06374 | HRURF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06375 | HS1BP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06376 | HS2ST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06377 | HS3ST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06378 | HS3ST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06379 | HS3ST3B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06380 | HS3ST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06381 | HS3ST5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06382 | HS6ST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06383 | HS6ST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06384 | HS6ST3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06385 | HSBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06386 | HSCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06387 | HSD11B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06388 | HSD11B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06389 | HSD17B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06390 | HSD17B10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06391 | HSD17B11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06392 | HSD17B12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06393 | HSD17B13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06394 | HSD17B14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06395 | HSD17B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06396 | HSD17B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06397 | HSD17B4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06398 | HSD17B6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06399 | HSD17B7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06400 | HSD17B8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06401 | HSD3B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06402 | HSD3B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06403 | HSD3B7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06404 | HSDL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06405 | HSDL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06406 | HSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06407 | Hsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06408 | Hsf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06409 | HSF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06410 | HSF2BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06411 | HSF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06412 | HSF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06413 | HSFX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06414 | HSH2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06415 | HSP90AA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06416 | Hsp90aa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06417 | Hsp90aa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06418 | HSP90AB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06419 | HSP90B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06420 | HSPA12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06421 | HSPA12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06422 | HSPA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06423 | HSPA14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06424 | HSPA1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06425 | HSPA1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06426 | HSPA1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06427 | HSPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06428 | HSPA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06429 | Hspa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06430 | Hspa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06431 | HSPA4L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06432 | HSPA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06433 | Hspa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06434 | Hspa5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06435 | HSPA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06436 | HSPA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06437 | HSPA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06438 | HSPB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06439 | HSPB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06440 | HSPB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06441 | HSPB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06442 | HSPB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06443 | HSPB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06444 | HSPB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06445 | HSPBAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06446 | HSPBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06447 | HSPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06448 | HSPE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06449 | HSPG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06450 | HSPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06451 | Hsph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06452 | Hsph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06453 | HTATIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06454 | HTATSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06455 | HTD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06456 | HTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06457 | HTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06458 | HTR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06459 | Htr1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06460 | Htr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06461 | HTR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06462 | HTR1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06463 | HTR1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06464 | HTR1F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06465 | HTR2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06466 | Htr2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06467 | Htr2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06468 | HTR2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06469 | HTR2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06470 | HTR3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06471 | Htr3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06472 | Htr3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06473 | HTR3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06474 | HTR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06475 | Htr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06476 | Htr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06477 | HTR5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06478 | Htr5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06479 | Htr5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06480 | HTR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06481 | Htr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06482 | Htr6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06483 | HTR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06484 | Htr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06485 | HTR7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06486 | HTRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06487 | HTRA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06488 | HTRA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06489 | HTRA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06490 | HTT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06491 | HUNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06492 | HUS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06493 | HUWE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06494 | HVCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06495 | HYAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06496 | HYAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06497 | HYAL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06498 | HYAL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06499 | HYDIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06500 | HYI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06501 | HYKK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06502 | HYLS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06503 | HYOU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06504 | HYPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06505 | IAH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06506 | IAPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06507 | IARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06508 | IBA57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06509 | IBSP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06510 | IBTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06511 | ICA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06512 | ICAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06513 | ICAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06514 | ICAM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06515 | ICAM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06516 | ICAM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06517 | ICE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06518 | ICE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06519 | ICMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06520 | ICOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06521 | ICOSLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06522 | ID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06523 | ID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06524 | ID3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06525 | ID4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06526 | IDE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06527 | IDH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06528 | Idh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06529 | Idh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06530 | IDH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06531 | Idh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06532 | Idh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06533 | IDH3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06534 | IDH3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06535 | IDH3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06536 | IDI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06537 | IDI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06538 | IDNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06539 | IDO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06540 | Ido1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06541 | Ido1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06542 | IDO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06543 | Ido2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06544 | Ido2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06545 | IDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06546 | IDUA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06547 | IER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06548 | IER3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06549 | IER3IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06550 | IER5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06551 | IER5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06552 | IFI16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06553 | IFI27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06554 | IFI30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06555 | IFI35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06556 | IFI44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06557 | IFI44L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06558 | IFI6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06559 | IFIH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06560 | IFIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06561 | IFIT1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06562 | IFIT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06563 | IFIT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06564 | IFIT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06565 | IFITM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06566 | IFITM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06567 | IFITM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06568 | IFITM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06569 | IFITM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06570 | IFNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06571 | IFNA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06572 | IFNA14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06573 | IFNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06574 | IFNA21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06575 | IFNA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06576 | IFNA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06577 | IFNA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06578 | IFNA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06579 | IFNAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06580 | Ifnar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06581 | Ifnar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06582 | IFNAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06583 | Ifnar2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06584 | Ifnar2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06585 | IFNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06586 | IFNE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06587 | IFNG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06588 | IFNGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06589 | IFNGR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06590 | IFNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06591 | IFNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06592 | IFNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06593 | IFNL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06594 | IFNL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06595 | IFNLR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06596 | IFNW1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06597 | IFRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06598 | IFT122 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06599 | IFT140 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06600 | IFT172 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06601 | IFT20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06602 | IFT22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06603 | IFT25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06604 | IFT27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06605 | IFT43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06606 | IFT46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06607 | IFT57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06608 | IFT80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06609 | IFT81 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06610 | IFT88 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06611 | IFTAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06612 | IGBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06613 | IGDCC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06614 | IGF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06615 | IGF1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06616 | Igf1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06617 | Igf1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06618 | IGF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06619 | IGF2BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06620 | IGF2BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06621 | IGF2BP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06622 | IGF2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06623 | IGFALS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06624 | IGFBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06625 | IGFBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06626 | IGFBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06627 | IGFBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06628 | IGFBP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06629 | IGFBP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06630 | IGFBP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06631 | IGFBPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06632 | IGFL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06633 | IGFL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06634 | IGFL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06635 | IGFLR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06636 | IGFN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06637 | IGH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06638 | IGHMBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06639 | IGIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06640 | IGK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06641 | IGL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06642 | IGLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06643 | IGLL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06644 | IGLON5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06645 | IGSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06646 | IGSF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06647 | IGSF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06648 | IGSF21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06649 | IGSF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06650 | IGSF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06651 | IGSF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06652 | IGSF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06653 | IGSF9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06654 | IHH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06655 | IHO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06656 | IK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06657 | IKBIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06658 | IKBKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06659 | Ikbkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06660 | Ikbkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06661 | IKBKE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06662 | Ikbke Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06663 | Ikbke Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06664 | IKBKG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06665 | IKZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06666 | IKZF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06667 | IKZF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06668 | IKZF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06669 | IKZF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06670 | IL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06671 | Il10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06672 | Il10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06673 | IL10RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06674 | IL10RB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06675 | IL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06676 | IL11RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06677 | IL12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06678 | Il12a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06679 | Il12a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06680 | IL12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06681 | Il12b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06682 | Il12b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06683 | IL12RB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06684 | IL12RB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06685 | IL13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06686 | Il13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06687 | Il13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06688 | IL13RA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06689 | IL13RA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06690 | IL15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06691 | Il15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06692 | Il15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06693 | IL15RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06694 | IL16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06695 | IL17A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06696 | Il17a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06697 | Il17a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06698 | IL17B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06699 | IL17C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06700 | IL17D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06701 | IL17F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06702 | IL17RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06703 | IL17RB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06704 | IL17RC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06705 | IL17RD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06706 | IL17RE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06707 | IL17REL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06708 | IL18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06709 | IL18BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06710 | IL18R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06711 | IL18RAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06712 | IL19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06713 | IL1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06714 | Il1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06715 | Il1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06716 | IL1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06717 | Il1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06718 | Il1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06719 | IL1F10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06720 | IL1R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06721 | IL1R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06722 | IL1RAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06723 | IL1RAPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06724 | IL1RAPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06725 | IL1RL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06726 | IL1RL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06727 | IL1RN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06728 | IL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06729 | Il2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06730 | Il2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06731 | IL20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06732 | IL20RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06733 | IL20RB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06734 | IL21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06735 | IL21R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06736 | IL22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06737 | IL22RA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06738 | IL22RA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06739 | IL23A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06740 | Il23a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06741 | Il23a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06742 | IL23R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06743 | IL24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06744 | IL25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06745 | IL26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06746 | IL27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06747 | IL27RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06748 | IL2RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06749 | IL2RB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06750 | IL2RG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06751 | IL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06752 | Il3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06753 | Il3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06754 | IL31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06755 | IL31RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06756 | IL32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06757 | IL33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06758 | IL34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06759 | IL36A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06760 | IL36B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06761 | IL36G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06762 | IL36RN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06763 | IL37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06764 | IL3RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06765 | IL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06766 | Il4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06767 | Il4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06768 | IL4I1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06769 | IL4R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06770 | IL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06771 | Il5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06772 | Il5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06773 | IL5RA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06774 | IL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06775 | Il6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06776 | Il6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06777 | IL6R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06778 | IL6ST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06779 | IL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06780 | IL7R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06781 | IL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06782 | IL9R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06783 | ILDR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06784 | ILDR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06785 | ILF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06786 | ILF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06787 | ILK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06788 | ILKAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06789 | ILRUN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06790 | ILVBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06791 | IMMP2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06792 | IMMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06793 | IMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06794 | IMP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06795 | IMPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06796 | IMPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06797 | IMPACT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06798 | IMPDH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06799 | IMPDH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06800 | IMPG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06801 | IMPG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06802 | INA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06803 | INAVA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06804 | INCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06805 | INCENP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06806 | INF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06807 | ING1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06808 | ING2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06809 | ING3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06810 | ING4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06811 | ING5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06812 | INHA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06813 | INHBA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06814 | INHBB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06815 | INHBC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06816 | INHBE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06817 | INIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06818 | INKA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06819 | INKA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06820 | INMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06821 | INO80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06822 | INO80D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06823 | INO80E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06824 | INPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06825 | INPP4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06826 | INPP4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06827 | INPP5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06828 | INPP5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06829 | INPP5D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06830 | INPP5E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06831 | INPP5F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06832 | INPP5J Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06833 | INPP5K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06834 | INPPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06835 | INS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06836 | INSC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06837 | INSIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06838 | INSIG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06839 | INS-IGF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06840 | INSL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06841 | INSL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06842 | INSL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06843 | INSL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06844 | INSM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06845 | INSM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06846 | INSR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06847 | Insr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06848 | Insr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06849 | INSRR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06850 | INTS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06851 | INTS10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06852 | INTS11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06853 | INTS14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06854 | INTS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06855 | INTS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06856 | INTS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06857 | INTS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06858 | INTS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06859 | INTU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06860 | INVS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06861 | IP6K1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06862 | IP6K2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06863 | IP6K3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06864 | IPCEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06865 | IPMK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06866 | IPO11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06867 | IPO13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06868 | IPO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06869 | IPO5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06870 | IPO7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06871 | IPO8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06872 | IPO9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06873 | IPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06874 | IPPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06875 | IQCB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06876 | IQCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06877 | IQCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06878 | IQCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06879 | IQCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06880 | IQCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06881 | IQCJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06882 | IQCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06883 | IQCM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06884 | IQCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06885 | IQGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06886 | IQGAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06887 | IQGAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06888 | IQSEC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06889 | IQSEC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06890 | IQSEC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06891 | IQUB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06892 | IRAG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06893 | IRAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06894 | Irak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06895 | Irak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06896 | IRAK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06897 | IRAK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06898 | IRAK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06899 | Irak4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06900 | Irak4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06901 | IREB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06902 | IRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06903 | IRF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06904 | IRF2BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06905 | IRF2BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06906 | IRF2BPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06907 | IRF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06908 | IRF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06909 | IRF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06910 | IRF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06911 | IRF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06912 | IRF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06913 | IRF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06914 | IRGC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06915 | IRGM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06916 | IRGQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06917 | IRS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06918 | IRS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06919 | IRS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06920 | IRX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06921 | IRX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06922 | IRX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06923 | IRX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06924 | IRX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06925 | IRX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06926 | ISCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06927 | ISCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06928 | ISCU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06929 | ISG15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06930 | ISG20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06931 | ISL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06932 | ISL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06933 | ISLR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06934 | ISLR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06935 | ISM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06936 | ISM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06937 | ISOC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06938 | ISOC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06939 | IST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06940 | ISX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06941 | ISY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06942 | ISYNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06943 | ITCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06944 | ITFG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06945 | ITGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06946 | ITGA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06947 | ITGA11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06948 | ITGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06949 | ITGA2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06950 | ITGA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06951 | ITGA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06952 | ITGA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06953 | ITGA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06954 | ITGA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06955 | ITGA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06956 | ITGA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06957 | ITGAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06958 | ITGAE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06959 | ITGAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06960 | ITGAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06961 | ITGAV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06962 | ITGAX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06963 | ITGB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06964 | ITGB1BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06965 | ITGB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06966 | ITGB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06967 | ITGB3BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06968 | ITGB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06969 | ITGB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06970 | ITGB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06971 | ITGB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06972 | ITGB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06973 | ITGBL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06974 | ITIH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06975 | ITIH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06976 | ITIH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06977 | ITIH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06978 | ITIH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06979 | ITK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06980 | Itk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06981 | Itk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06982 | ITLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06983 | ITM2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06984 | ITM2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06985 | ITM2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06986 | ITPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06987 | ITPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06988 | ITPKA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06989 | ITPKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06990 | ITPKC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06991 | ITPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06992 | ITPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06993 | ITPR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06994 | ITPRID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06995 | ITPRIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06996 | ITPRIPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06997 | ITSN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06998 | ITSN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS06999 | IVD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07000 | IVL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07001 | IVNS1ABP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07002 | IWS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07003 | IYD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07004 | IZUMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07005 | IZUMO1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07006 | IZUMO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07007 | IZUMO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07008 | IZUMO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07009 | JADE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07010 | JADE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07011 | JADE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07012 | JAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07013 | JAG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07014 | JAGN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07015 | JAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07016 | Jak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07017 | Jak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07018 | JAK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07019 | Jak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07020 | Jak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07021 | JAK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07022 | Jak3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07023 | Jak3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07024 | JAKMIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07025 | JAKMIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07026 | JAKMIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07027 | JAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07028 | JAM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07029 | JAML Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07030 | JARID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07031 | JAZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07032 | JCAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07033 | JCHAIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07034 | JDP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07035 | JHY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07036 | JKAMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07037 | JMJD1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07038 | JMJD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07039 | JMJD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07040 | JMJD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07041 | JMJD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07042 | JMY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07043 | JOSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07044 | JOSD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07045 | JPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07046 | JPH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07047 | JPH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07048 | JPH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07049 | JPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07050 | JPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07051 | JRK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07052 | JRKL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07053 | JTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07054 | JUN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07055 | Jun Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07056 | Jun Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07057 | JUNB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07058 | Junb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07059 | Junb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07060 | JUND Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07061 | JUP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07062 | KALRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07063 | KANK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07064 | KANK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07065 | KANK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07066 | KANK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07067 | KANSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07068 | KANSL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07069 | KANSL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07070 | KANTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07071 | KARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07072 | KASH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07073 | KAT14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07074 | KAT2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07075 | Kat2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07076 | Kat2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07077 | KAT2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07078 | Kat2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07079 | KAT2B Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07080 | KAT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07081 | KAT6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07082 | KAT6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07083 | KAT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07084 | KAT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07085 | KATNAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07086 | KATNAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07087 | KATNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07088 | KATNIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07089 | KAZALD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07090 | KAZN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07091 | KBTBD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07092 | KBTBD13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07093 | KBTBD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07094 | KBTBD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07095 | KBTBD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07096 | KCMF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07097 | KCNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07098 | KCNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07099 | KCNA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07100 | KCNA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07101 | KCNA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07102 | KCNA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07103 | KCNAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07104 | KCNAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07105 | KCNAB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07106 | KCNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07107 | KCNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07108 | KCNC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07109 | KCNC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07110 | KCNC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07111 | KCNC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07112 | KCND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07113 | KCND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07114 | KCND3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07115 | KCNE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07116 | KCNE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07117 | KCNE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07118 | KCNE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07119 | KCNE5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07120 | KCNF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07121 | KCNG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07122 | KCNG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07123 | KCNG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07124 | KCNG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07125 | KCNH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07126 | KCNH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07127 | KCNH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07128 | KCNH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07129 | KCNH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07130 | KCNH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07131 | KCNH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07132 | KCNIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07133 | KCNIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07134 | KCNIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07135 | KCNIP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07136 | KCNJ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07137 | KCNJ10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07138 | KCNJ11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07139 | KCNJ12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07140 | KCNJ13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07141 | KCNJ14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07142 | KCNJ15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07143 | KCNJ16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07144 | KCNJ18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07145 | KCNJ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07146 | KCNJ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07147 | KCNJ4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07148 | KCNJ5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07149 | KCNJ6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07150 | KCNJ8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07151 | KCNJ9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07152 | KCNK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07153 | KCNK10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07154 | KCNK12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07155 | KCNK13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07156 | KCNK17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07157 | KCNK18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07158 | KCNK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07159 | KCNK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07160 | KCNK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07161 | KCNK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07162 | KCNK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07163 | KCNK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07164 | KCNMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07165 | KCNMB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07166 | KCNMB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07167 | KCNMB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07168 | KCNMB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07169 | KCNN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07170 | KCNN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07171 | KCNN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07172 | KCNN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07173 | KCNQ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07174 | KCNQ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07175 | KCNQ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07176 | KCNQ4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07177 | KCNQ5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07178 | KCNRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07179 | KCNS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07180 | KCNS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07181 | KCNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07182 | KCNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07183 | KCNV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07184 | KCNV2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07185 | KCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07186 | KCTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07187 | KCTD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07188 | KCTD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07189 | KCTD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07190 | KCTD13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07191 | KCTD14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07192 | KCTD15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07193 | KCTD16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07194 | KCTD17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07195 | KCTD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07196 | KCTD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07197 | KCTD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07198 | KCTD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07199 | KCTD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07200 | KCTD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07201 | KDELR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07202 | KDELR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07203 | KDELR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07204 | KDF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07205 | KDM1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07206 | Kdm1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07207 | Kdm1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07208 | KDM1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07209 | KDM2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07210 | KDM2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07211 | KDM3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07212 | KDM3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07213 | KDM4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07214 | KDM4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07215 | KDM4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07216 | KDM4D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07217 | KDM4E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07218 | KDM5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07219 | KDM5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07220 | KDM5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07221 | KDM5D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07222 | KDM6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07223 | KDM6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07224 | KDM7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07225 | KDM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07226 | KDR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07227 | Kdr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07228 | Kdr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07229 | KDSR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07230 | KEAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07231 | Keap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07232 | Keap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07233 | KEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07234 | KERA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07235 | KHDC3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07236 | KHDC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07237 | KHDRBS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07238 | KHDRBS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07239 | KHDRBS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07240 | KHK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07241 | KHNYN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07242 | KHSRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07243 | KIAA0040 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07244 | KIAA0319 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07245 | KIAA0319L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07246 | KIAA0513 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07247 | KIAA0586 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07248 | KIAA0753 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07249 | KIAA0930 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07250 | KIAA1217 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07251 | KIAA1522 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07252 | KIAA1549 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07253 | KIAA1671 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07254 | KIDINS220 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07255 | KIF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07256 | KIF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07257 | Kif12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07258 | Kif12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07259 | KIF13A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07260 | KIF13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07261 | KIF14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07262 | Kif14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07263 | Kif14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07264 | KIF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07265 | KIF16B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07266 | KIF17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07267 | KIF18A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07268 | KIF18B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07269 | KIF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07270 | KIF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07271 | KIF1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07272 | KIF20A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07273 | KIF20B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07274 | KIF21A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07275 | KIF21B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07276 | KIF22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07277 | KIF23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07278 | KIF24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07279 | KIF26A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07280 | KIF26B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07281 | KIF27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07282 | KIF2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07283 | KIF2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07284 | KIF2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07285 | KIF3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07286 | KIF3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07287 | KIF3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07288 | KIF4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07289 | KIF5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07290 | KIF5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07291 | KIF5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07292 | KIF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07293 | Kif6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07294 | Kif6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07295 | KIF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07296 | KIF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07297 | KIFAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07298 | KIFC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07299 | KIFC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07300 | KIFC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07301 | KIR2DL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07302 | KIR2DL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07303 | KIR2DL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07304 | KIR2DL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07305 | KIR2DS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07306 | KIR2DS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07307 | KIR2DS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07308 | KIR3DL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07309 | KIR3DL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07310 | KIR3DL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07311 | KIR3DS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07312 | KIRREL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07313 | KIRREL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07314 | KIRREL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07315 | KISS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07316 | KISS1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07317 | Kiss1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07318 | Kiss1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07319 | KIT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07320 | Kit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07321 | Kit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07322 | KITLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07323 | KIZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07324 | KL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07325 | KLB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07326 | KLC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07327 | KLC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07328 | KLC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07329 | KLC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07330 | KLF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07331 | KLF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07332 | KLF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07333 | KLF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07334 | KLF13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07335 | KLF14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07336 | KLF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07337 | KLF16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07338 | KLF17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07339 | KLF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07340 | KLF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07341 | KLF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07342 | KLF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07343 | KLF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07344 | KLF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07345 | KLF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07346 | KLF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07347 | KLHDC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07348 | KLHDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07349 | KLHDC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07350 | KLHDC7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07351 | KLHDC7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07352 | KLHDC8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07353 | KLHDC8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07354 | KLHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07355 | KLHL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07356 | KLHL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07357 | KLHL13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07358 | KLHL14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07359 | KLHL15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07360 | KLHL17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07361 | KLHL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07362 | KLHL20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07363 | KLHL22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07364 | KLHL24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07365 | KLHL29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07366 | KLHL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07367 | KLHL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07368 | KLHL40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07369 | KLHL41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07370 | KLHL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07371 | KLHL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07372 | KLHL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07373 | KLK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07374 | KLK10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07375 | KLK11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07376 | KLK12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07377 | KLK13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07378 | KLK14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07379 | KLK15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07380 | KLK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07381 | KLK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07382 | KLK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07383 | KLK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07384 | KLK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07385 | KLK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07386 | KLK8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07387 | KLK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07388 | KLKB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07389 | KLLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07390 | KLRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07391 | KLRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07392 | KLRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07393 | KLRC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07394 | KLRC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07395 | KLRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07396 | KLRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07397 | KLRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07398 | KLRG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07399 | KLRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07400 | KMO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07401 | KMT2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07402 | KMT2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07403 | KMT2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07404 | KMT2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07405 | KMT2E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07406 | KMT5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07407 | KMT5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07408 | KMT5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07409 | KNCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07410 | KNDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07411 | KNG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07412 | KNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07413 | KNSTRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07414 | KNTC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07415 | KPNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07416 | KPNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07417 | KPNA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07418 | KPNA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07419 | KPNA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07420 | KPNA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07421 | KPNA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07422 | KPNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07423 | KPRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07424 | KPTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07425 | KRAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07426 | Kras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07427 | Kras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07428 | KREMEN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07429 | KREMEN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07430 | KRI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07431 | KRIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07432 | KRR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07433 | KRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07434 | KRT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07435 | KRT12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07436 | KRT13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07437 | KRT14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07438 | KRT15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07439 | KRT16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07440 | KRT17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07441 | KRT18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07442 | KRT19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07443 | KRT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07444 | KRT20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07445 | Krt20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07446 | Krt20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07447 | KRT23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07448 | KRT24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07449 | KRT25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07450 | KRT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07451 | KRT31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07452 | KRT33B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07453 | KRT36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07454 | KRT38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07455 | KRT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07456 | KRT40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07457 | KRT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07458 | KRT6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07459 | KRT6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07460 | KRT6C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07461 | KRT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07462 | KRT71 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07463 | KRT75 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07464 | KRT77 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07465 | KRT78 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07466 | KRT79 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07467 | KRT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07468 | KRT80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07469 | KRT81 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07470 | KRT83 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07471 | KRT86 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07472 | KRT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07473 | KRTCAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07474 | KRTDAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07475 | KSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07476 | KSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07477 | KTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07478 | KXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07479 | KY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07480 | KYNU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07481 | L1CAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07482 | L1TD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07483 | L2HGDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07484 | L3MBTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07485 | L3MBTL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07486 | L3MBTL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07487 | LACC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07488 | LACRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07489 | LACTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07490 | LACTB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07491 | LAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07492 | LAG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07493 | LAGE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07494 | LAIR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07495 | LAIR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07496 | LALBA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07497 | LAMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07498 | LAMA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07499 | LAMA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07500 | LAMA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07501 | LAMA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07502 | LAMB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07503 | LAMB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07504 | LAMB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07505 | LAMB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07506 | LAMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07507 | LAMC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07508 | LAMC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07509 | LAMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07510 | LAMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07511 | LAMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07512 | LAMP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07513 | LAMTOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07514 | LAMTOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07515 | LAMTOR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07516 | LAMTOR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07517 | LAMTOR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07518 | LANCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07519 | LANCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07520 | LAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07521 | LAPTM4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07522 | LAPTM4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07523 | LAPTM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07524 | LARGE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07525 | LARGE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07526 | LARP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07527 | LARP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07528 | LARP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07529 | LARP4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07530 | LARP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07531 | LARP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07532 | LARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07533 | LARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07534 | LAS1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07535 | LASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07536 | LAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07537 | LAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07538 | LATS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07539 | LATS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07540 | LAX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07541 | LAYN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07542 | LBH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07543 | LBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07544 | Lbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07545 | LBR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07546 | LBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07547 | LBX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07548 | LCA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07549 | LCAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07550 | LCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07551 | LCLAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07552 | LCMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07553 | LCMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07554 | LCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07555 | LCN10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07556 | LCN12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07557 | LCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07558 | LCN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07559 | LCN8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07560 | LCN9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07561 | LCOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07562 | LCORL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07563 | LCP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07564 | LCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07565 | LCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07566 | LCTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07567 | LDAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07568 | LDB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07569 | LDB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07570 | LDB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07571 | LDHA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07572 | LDHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07573 | LDHC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07574 | LDHD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07575 | LDLR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07576 | LDLRAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07577 | LDLRAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07578 | LDLRAD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07579 | LDLRAD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07580 | LDLRAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07581 | LDOC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07582 | LEAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07583 | LECT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07584 | LEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07585 | LEFTY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07586 | LEFTY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07587 | LEMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07588 | LEMD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07589 | LEMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07590 | LENEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07591 | LENG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07592 | LEO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07593 | LEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07594 | LEPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07595 | LEPROT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07596 | LEPROTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07597 | LETM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07598 | LETM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07599 | LETMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07600 | LEXM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07601 | LFNG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07602 | LGALS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07603 | LGALS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07604 | LGALS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07605 | LGALS3BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07606 | LGALS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07607 | LGALS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07608 | LGALS7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07609 | LGALS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07610 | LGALS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07611 | LGALS9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07612 | LGALSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07613 | LGI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07614 | LGI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07615 | LGI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07616 | LGI4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07617 | LGMN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07618 | LGR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07619 | LGR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07620 | LGR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07621 | LGSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07622 | LGTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07623 | LHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07624 | LHCGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07625 | LHFPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07626 | LHFPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07627 | LHFPL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07628 | LHFPL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07629 | LHFPL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07630 | LHPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07631 | LHX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07632 | LHX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07633 | LHX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07634 | LHX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07635 | LHX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07636 | LHX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07637 | LHX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07638 | LHX9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07639 | LIAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07640 | LIF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07641 | LIFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07642 | LIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07643 | LIG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07644 | LIG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07645 | LILRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07646 | LILRA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07647 | LILRA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07648 | LILRA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07649 | LILRA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07650 | LILRA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07651 | LILRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07652 | LILRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07653 | LILRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07654 | LILRB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07655 | LILRB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07656 | LIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07657 | LIMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07658 | LIMCH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07659 | LIMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07660 | LIMD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07661 | LIME1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07662 | LIMK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07663 | Limk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07664 | Limk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07665 | LIMK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07666 | Limk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07667 | Limk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07668 | LIMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07669 | LIMS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07670 | LIMS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07671 | LIN28A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07672 | LIN28B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07673 | LIN37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07674 | LIN52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07675 | LIN54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07676 | LIN7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07677 | LIN7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07678 | LIN7C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07679 | LIN9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07680 | LINGO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07681 | LINGO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07682 | LINGO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07683 | LINGO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07684 | LIPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07685 | LIPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07686 | LIPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07687 | LIPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07688 | LIPF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07689 | LIPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07690 | LIPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07691 | LIPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07692 | LIPJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07693 | LIPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07694 | LIPM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07695 | LIPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07696 | LIPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07697 | LITAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07698 | LIX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07699 | LIX1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07700 | LLGL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07701 | LLGL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07702 | LLPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07703 | LMAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07704 | LMAN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07705 | LMAN2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07706 | LMBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07707 | LMBR1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07708 | LMBRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07709 | LMBRD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07710 | LMCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07711 | LMF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07712 | LMF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07713 | LMLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07714 | LMNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07715 | LMNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07716 | LMNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07717 | LMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07718 | LMO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07719 | LMO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07720 | LMO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07721 | LMO7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07722 | LMOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07723 | LMOD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07724 | LMOD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07725 | LMTK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07726 | LMTK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07727 | LMX1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07728 | LMX1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07729 | LNP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07730 | LNPEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07731 | LNPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07732 | LNX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07733 | LNX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07734 | LONP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07735 | LONP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07736 | LONRF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07737 | LONRF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07738 | LORICRIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07739 | LOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07740 | LOXHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07741 | LOXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07742 | LOXL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07743 | LOXL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07744 | LOXL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07745 | LPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07746 | LPAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07747 | Lpar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07748 | Lpar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07749 | LPAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07750 | Lpar2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07751 | Lpar2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07752 | LPAR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07753 | Lpar3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07754 | LPAR3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07755 | LPAR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07756 | Lpar4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07757 | Lpar4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07758 | LPAR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07759 | Lpar5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07760 | Lpar5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07761 | LPAR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07762 | Lpar6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07763 | Lpar6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07764 | LPCAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07765 | LPCAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07766 | LPCAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07767 | LPCAT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07768 | LPGAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07769 | LPIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07770 | LPIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07771 | LPIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07772 | LPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07773 | LPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07774 | LPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07775 | LPXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07776 | LRAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07777 | LRBA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07778 | LRCH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07779 | LRCH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07780 | LRCH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07781 | LRFN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07782 | LRFN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07783 | LRFN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07784 | LRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07785 | LRGUK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07786 | LRIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07787 | LRIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07788 | LRIG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07789 | LRIG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07790 | LRIT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07791 | LRMDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07792 | LRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07793 | LRP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07794 | LRP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07795 | LRP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07796 | LRP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07797 | LRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07798 | LRP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07799 | LRP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07800 | LRP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07801 | LRP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07802 | LRP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07803 | LRPAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07804 | LRPPRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07805 | LRR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07806 | LRRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07807 | LRRC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07808 | LRRC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07809 | LRRC17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07810 | LRRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07811 | LRRC23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07812 | LRRC25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07813 | LRRC26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07814 | LRRC31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07815 | LRRC32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07816 | LRRC37A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07817 | LRRC3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07818 | LRRC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07819 | LRRC41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07820 | LRRC47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07821 | LRRC4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07822 | LRRC4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07823 | LRRC55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07824 | LRRC58 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07825 | LRRC59 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07826 | LRRC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07827 | LRRC8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07828 | LRRC8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07829 | LRRC8C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07830 | LRRFIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07831 | LRRFIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07832 | LRRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07833 | LRRK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07834 | Lrrk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07835 | Lrrk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07836 | LRRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07837 | LRRN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07838 | LRRN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07839 | LRRN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07840 | LRRN4CL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07841 | LRRTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07842 | LRRTM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07843 | LRRTM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07844 | LRRTM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07845 | LRSAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07846 | LRTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07847 | LRTM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07848 | LRTOMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07849 | LRWD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07850 | LSAMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07851 | LSG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07852 | LSM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07853 | LSM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07854 | LSM11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07855 | LSM12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07856 | LSM14A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07857 | LSM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07858 | LSM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07859 | LSM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07860 | LSM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07861 | LSM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07862 | LSM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07863 | LSM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07864 | LSP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07865 | LSR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07866 | LSS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07867 | LST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07868 | LTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07869 | Lta Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07870 | LTA Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07871 | LTA4H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07872 | LTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07873 | LTB4R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07874 | Ltb4r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07875 | Ltb4r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07876 | LTB4R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07877 | LTBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07878 | LTBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07879 | LTBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07880 | LTBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07881 | LTBR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07882 | LTC4S Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07883 | LTF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07884 | LTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07885 | LTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07886 | LTO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07887 | LTV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07888 | LUC7L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07889 | LUC7L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07890 | LUC7L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07891 | LUM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07892 | LUZP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07893 | LUZP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07894 | LVRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07895 | LXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07896 | LY6D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07897 | LY6E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07898 | LY6G6C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07899 | LY6G6D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07900 | LY6G6F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07901 | LY6H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07902 | LY6K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07903 | LY6L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07904 | LY6S Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07905 | LY75 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07906 | LY86 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07907 | LY9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07908 | LY96 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07909 | LYAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07910 | LYG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07911 | LYG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07912 | LYL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07913 | LYN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07914 | LYNX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07915 | LYPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07916 | LYPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07917 | LYPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07918 | LYPD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07919 | LYPD6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07920 | LYPD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07921 | LYPLA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07922 | LYPLA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07923 | LYPLAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07924 | LYRM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07925 | LYRM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07926 | LYSMD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07927 | LYSMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07928 | LYST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07929 | LYVE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07930 | LYZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07931 | LZIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07932 | LZTFL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07933 | LZTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07934 | LZTS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07935 | LZTS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07936 | M1AP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07937 | M6PR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07938 | MAB21L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07939 | MAB21L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07940 | MAB21L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07941 | MACC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07942 | MACF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07943 | MACIR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07944 | MACO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07945 | MACROD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07946 | MACROD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07947 | MACROH2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07948 | MAD1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07949 | MAD2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07950 | MAD2L1BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07951 | MAD2L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07952 | MADCAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07953 | MADD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07954 | MAEA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07955 | MAEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07956 | MAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07957 | MAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07958 | MAFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07959 | MAFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07960 | MAFF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07961 | MAFG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07962 | MAFK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07963 | MAG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07964 | MAGEA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07965 | MAGEA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07966 | MAGEA12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07967 | MAGEA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07968 | MAGEA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07969 | MAGEA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07970 | MAGEA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07971 | MAGEB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07972 | MAGEB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07973 | MAGEC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07974 | MAGEC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07975 | MAGEC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07976 | MAGED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07977 | MAGED2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07978 | MAGEE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07979 | MAGEH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07980 | MAGEL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07981 | MAGI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07982 | MAGI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07983 | MAGI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07984 | MAGIX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07985 | MAGOH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07986 | MAGOHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07987 | MAGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07988 | MAJIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07989 | MAK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07990 | MAK16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07991 | MAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07992 | MAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07993 | MALL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07994 | MALRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07995 | MALT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07996 | Malt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07997 | Malt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07998 | MAMDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS07999 | MAML1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08000 | MAML2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08001 | MAML3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08002 | MAMLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08003 | MAMSTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08004 | MAN1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08005 | MAN1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08006 | MAN1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08007 | MAN1C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08008 | MAN2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08009 | MAN2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08010 | MAN2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08011 | MAN2B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08012 | MAN2C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08013 | MANBA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08014 | MANBAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08015 | MANEA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08016 | MANEAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08017 | MANF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08018 | MANSC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08019 | MAOA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08020 | Maoa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08021 | Maoa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08022 | MAOB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08023 | Maob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08024 | Maob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08025 | MAP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08026 | MAP1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08027 | MAP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08028 | MAP1LC3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08029 | MAP1LC3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08030 | MAP1LC3B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08031 | MAP1S Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08032 | MAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08033 | MAP2K1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08034 | Map2k1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08035 | Map2k1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08036 | MAP2K2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08037 | Map2k2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08038 | Map2k2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08039 | MAP2K3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08040 | MAP2K4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08041 | MAP2K5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08042 | Map2k5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08043 | Map2k5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08044 | MAP2K6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08045 | MAP2K7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08046 | MAP3K1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08047 | MAP3K10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08048 | MAP3K11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08049 | MAP3K12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08050 | MAP3K13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08051 | MAP3K14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08052 | MAP3K15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08053 | MAP3K19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08054 | MAP3K2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08055 | MAP3K20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08056 | MAP3K3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08057 | MAP3K4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08058 | MAP3K5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08059 | Map3k5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08060 | Map3k5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08061 | MAP3K6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08062 | MAP3K7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08063 | Map3k7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08064 | MAP3K7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08065 | MAP3K7CL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08066 | MAP3K8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08067 | Map3k8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08068 | Map3k8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08069 | MAP3K9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08070 | MAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08071 | MAP4K1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08072 | Map4k1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08073 | Map4k1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08074 | MAP4K2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08075 | Map4k2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08076 | Map4k2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08077 | MAP4K3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08078 | Map4k3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08079 | Map4k3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08080 | MAP4K4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08081 | Map4k4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08082 | Map4k4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08083 | MAP4K5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08084 | Map4k5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08085 | Map4k5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08086 | MAP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08087 | MAP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08088 | MAP7D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08089 | MAP7D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08090 | MAP7D3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08091 | MAP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08092 | MAPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08093 | Mapk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08094 | Mapk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08095 | MAPK10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08096 | Mapk10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08097 | Mapk10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08098 | MAPK11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08099 | Mapk11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08100 | Mapk11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08101 | MAPK12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08102 | Mapk12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08103 | Mapk12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08104 | MAPK13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08105 | Mapk13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08106 | Mapk13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08107 | MAPK14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08108 | Mapk14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08109 | Mapk14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08110 | MAPK15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08111 | Mapk15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08112 | Mapk15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08113 | MAPK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08114 | Mapk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08115 | Mapk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08116 | MAPK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08117 | MAPK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08118 | MAPK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08119 | Mapk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08120 | MAPK7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08121 | MAPK8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08122 | Mapk8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08123 | Mapk8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08124 | MAPK8IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08125 | MAPK8IP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08126 | MAPK8IP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08127 | MAPK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08128 | Mapk9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08129 | Mapk9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08130 | MAPKAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08131 | MAPKAPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08132 | Mapkapk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08133 | Mapkapk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08134 | MAPKAPK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08135 | MAPKAPK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08136 | MAPKBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08137 | MAPRE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08138 | MAPRE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08139 | MAPRE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08140 | MAPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08141 | Mapt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08142 | Mapt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08143 | MARCHF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08144 | MARCHF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08145 | MARCKS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08146 | MARCKSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08147 | MARCO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08148 | MARCOL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08149 | MARK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08150 | MARK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08151 | MARK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08152 | MARK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08153 | MARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08154 | MARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08155 | MARVELD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08156 | MARVELD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08157 | MAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08158 | MAS1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08159 | MASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08160 | MASP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08161 | MAST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08162 | MAST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08163 | MAST3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08164 | MAST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08165 | MASTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08166 | MAT1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08167 | MAT2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08168 | MAT2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08169 | MATK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08170 | MATN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08171 | MATN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08172 | MATN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08173 | MATN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08174 | MATR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08175 | MAU2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08176 | MAVS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08177 | MAX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08178 | MAZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08179 | MB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08180 | MB21D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08181 | MBD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08182 | MBD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08183 | MBD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08184 | MBD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08185 | MBD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08186 | MBD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08187 | MBIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08188 | MBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08189 | MBLAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08190 | MBNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08191 | MBNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08192 | MBNL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08193 | MBOAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08194 | MBOAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08195 | MBOAT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08196 | MBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08197 | MBTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08198 | MBTPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08199 | MBTPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08200 | MC1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08201 | Mc1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08202 | MC1R Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08203 | MC2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08204 | Mc2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08205 | Mc2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08206 | MC3R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08207 | Mc3r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08208 | Mc3r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08209 | MC4R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08210 | Mc4r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08211 | Mc4r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08212 | MC5R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08213 | Mc5r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08214 | Mc5r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08215 | MCAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08216 | MCAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08217 | MCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08218 | MCCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08219 | MCCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08220 | MCEE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08221 | MCEMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08222 | MCF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08223 | MCF2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08224 | MCFD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08225 | MCHR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08226 | Mchr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08227 | Mchr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08228 | MCHR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08229 | MCIDAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08230 | MCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08231 | Mcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08232 | Mcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08233 | MCM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08234 | MCM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08235 | MCM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08236 | MCM3AP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08237 | MCM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08238 | MCM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08239 | MCM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08240 | MCM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08241 | MCM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08242 | MCM9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08243 | MCMBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08244 | MCOLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08245 | MCOLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08246 | MCOLN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08247 | MCPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08248 | MCRS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08249 | MCTP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08250 | MCTP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08251 | MCTS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08252 | MCU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08253 | MCUB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08254 | MCUR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08255 | MDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08256 | MDFI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08257 | MDFIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08258 | MDGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08259 | MDGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08260 | MDH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08261 | MDH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08262 | MDK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08263 | MDM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08264 | MDM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08265 | Mdm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08266 | Mdm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08267 | MDM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08268 | MDN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08269 | MDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08270 | ME1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08271 | ME2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08272 | ME3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08273 | MEA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08274 | MEAF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08275 | MECOM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08276 | MECP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08277 | MECR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08278 | MED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08279 | MED10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08280 | MED11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08281 | MED12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08282 | MED12L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08283 | MED13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08284 | MED13L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08285 | MED14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08286 | MED15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08287 | MED16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08288 | MED17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08289 | MED18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08290 | MED19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08291 | MED20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08292 | MED21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08293 | MED22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08294 | MED23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08295 | MED24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08296 | MED25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08297 | MED26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08298 | MED27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08299 | MED28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08300 | MED29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08301 | MED30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08302 | MED31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08303 | MED4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08304 | MED6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08305 | MED7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08306 | MED8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08307 | MED9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08308 | MEDAG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08309 | MEF2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08310 | MEF2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08311 | MEF2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08312 | MEF2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08313 | MEFV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08314 | MEGF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08315 | MEGF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08316 | MEGF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08317 | MEGF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08318 | MEGF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08319 | MEI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08320 | MEI4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08321 | MEIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08322 | MEIKIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08323 | MEIOB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08324 | MEIOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08325 | MEIS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08326 | MEIS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08327 | MEIS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08328 | MELK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08329 | Melk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08330 | Melk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08331 | MELTF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08332 | MEMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08333 | MEN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08334 | MEOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08335 | MEOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08336 | MEP1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08337 | MEP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08338 | MEPCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08339 | MEPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08340 | MERTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08341 | MESD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08342 | MESP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08343 | MESP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08344 | MEST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08345 | MET Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08346 | Met Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08347 | Met Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08348 | METAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08349 | METAP1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08350 | METAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08351 | METRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08352 | METRNL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08353 | METTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08354 | METTL13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08355 | METTL14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08356 | METTL15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08357 | METTL16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08358 | METTL17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08359 | METTL18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08360 | METTL21A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08361 | METTL22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08362 | METTL23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08363 | METTL2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08364 | METTL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08365 | METTL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08366 | METTL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08367 | METTL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08368 | METTL7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08369 | METTL7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08370 | METTL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08371 | METTL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08372 | MEX3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08373 | MEX3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08374 | MEX3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08375 | MEX3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08376 | MFAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08377 | MFAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08378 | MFAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08379 | MFAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08380 | MFF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08381 | MFGE8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08382 | MFHAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08383 | MFN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08384 | MFN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08385 | MFNG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08386 | MFRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08387 | MFSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08388 | MFSD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08389 | MFSD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08390 | MFSD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08391 | MFSD2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08392 | MFSD2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08393 | MFSD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08394 | MFSD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08395 | MGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08396 | MGAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08397 | MGAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08398 | MGARP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08399 | MGAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08400 | MGAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08401 | Mgat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08402 | Mgat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08403 | MGAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08404 | MGAT4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08405 | MGAT4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08406 | MGAT4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08407 | MGAT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08408 | MGAT5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08409 | MGLL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08410 | MGME1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08411 | MGMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08412 | Mgmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08413 | Mgmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08414 | MGP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08415 | MGRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08416 | MGST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08417 | MGST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08418 | MGST3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08419 | MIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08420 | MIA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08421 | MIA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08422 | MIB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08423 | MIB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08424 | MICA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08425 | MICAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08426 | MICAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08427 | MICAL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08428 | MICALL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08429 | MICALL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08430 | MICB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08431 | MICU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08432 | MICU2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08433 | MICU3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08434 | MID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08435 | MID1IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08436 | MID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08437 | MIDEAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08438 | MIDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08439 | MIEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08440 | MIEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08441 | MIEN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08442 | MIER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08443 | MIER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08444 | MIER3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08445 | MIF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08446 | MIGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08447 | MIGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08448 | MIIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08449 | MILR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08450 | MINAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08451 | MINDY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08452 | MINDY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08453 | MINDY3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08454 | MINK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08455 | Mink1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08456 | Mink1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08457 | MINPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08458 | MIOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08459 | MIOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08460 | MIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08461 | MIPEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08462 | MIPOL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08463 | MIS12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08464 | MIS18BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08465 | MISP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08466 | MISP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08467 | MITF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08468 | MIX23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08469 | MIXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08470 | MKI67 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08471 | MKKS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08472 | MKLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08473 | MKNK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08474 | Mknk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08475 | Mknk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08476 | MKNK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08477 | Mknk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08478 | Mknk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08479 | MKRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08480 | MKRN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08481 | MKRN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08482 | MKS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08483 | MKX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08484 | MLANA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08485 | MLC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08486 | MLEC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08487 | MLF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08488 | MLF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08489 | MLH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08490 | MLH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08491 | MLIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08492 | MLKL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08493 | MLLT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08494 | MLLT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08495 | MLLT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08496 | MLLT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08497 | MLLT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08498 | MLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08499 | MLNR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08500 | Mlnr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08501 | MLPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08502 | MLST8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08503 | MLX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08504 | MLXIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08505 | MLXIPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08506 | MLYCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08507 | MMAA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08508 | MMAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08509 | MMACHC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08510 | MMADHC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08511 | MMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08512 | MMD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08513 | MME Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08514 | MMEL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08515 | MMGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08516 | MMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08517 | Mmp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08518 | MMP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08519 | Mmp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08520 | Mmp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08521 | MMP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08522 | MMP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08523 | Mmp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08524 | Mmp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08525 | MMP13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08526 | Mmp13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08527 | Mmp13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08528 | MMP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08529 | Mmp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08530 | Mmp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08531 | MMP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08532 | MMP16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08533 | MMP17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08534 | Mmp17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08535 | Mmp17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08536 | MMP19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08537 | MMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08538 | Mmp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08539 | Mmp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08540 | MMP20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08541 | MMP21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08542 | MMP23B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08543 | MMP24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08544 | MMP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08545 | MMP26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08546 | MMP27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08547 | MMP28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08548 | MMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08549 | Mmp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08550 | Mmp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08551 | MMP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08552 | Mmp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08553 | Mmp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08554 | MMP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08555 | Mmp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08556 | Mmp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08557 | MMP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08558 | Mmp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08559 | Mmp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08560 | MMRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08561 | MMRN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08562 | MMS19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08563 | MMS22L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08564 | MMUT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08565 | MN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08566 | MNAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08567 | MND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08568 | MNDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08569 | MNS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08570 | MNT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08571 | MNX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08572 | MOAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08573 | MOB1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08574 | MOB1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08575 | MOB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08576 | MOB3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08577 | MOB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08578 | MOBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08579 | MOCOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08580 | MOCS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08581 | MOCS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08582 | MOCS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08583 | MOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08584 | MOGAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08585 | MOGAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08586 | MOK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08587 | MON1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08588 | MON2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08589 | MORC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08590 | MORC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08591 | MORC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08592 | MORC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08593 | MORF4L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08594 | MORF4L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08595 | MORN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08596 | MORN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08597 | MORN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08598 | MOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08599 | MOSMO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08600 | MOSPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08601 | MOSPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08602 | MOSPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08603 | MOV10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08604 | MOV10L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08605 | MOXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08606 | MPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08607 | MPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08608 | MPDU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08609 | MPDZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08610 | MPEG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08611 | MPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08612 | MPHOSPH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08613 | MPHOSPH9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08614 | MPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08615 | MPIG6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08616 | MPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08617 | Mpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08618 | Mpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08619 | MPLKIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08620 | MPND Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08621 | MPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08622 | MPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08623 | MPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08624 | MPP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08625 | MPP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08626 | MPP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08627 | MPPED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08628 | MPPED2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08629 | MPRIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08630 | MPST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08631 | MPV17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08632 | MPV17L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08633 | MPZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08634 | MPZL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08635 | MPZL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08636 | MPZL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08637 | MR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08638 | MRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08639 | MRAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08640 | MRAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08641 | MRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08642 | MRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08643 | MRE11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08644 | MREG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08645 | MRFAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08646 | MRGBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08647 | MRGPRD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08648 | MRGPRE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08649 | MRGPRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08650 | MRGPRX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08651 | MRGPRX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08652 | MRGPRX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08653 | MRI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08654 | MRLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08655 | MRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08656 | MRM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08657 | MRM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08658 | MRNIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08659 | MRO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08660 | MROH2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08661 | MROH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08662 | MRPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08663 | MRPL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08664 | MRPL15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08665 | MRPL18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08666 | MRPL19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08667 | MRPL20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08668 | MRPL28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08669 | MRPL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08670 | MRPL32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08671 | MRPL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08672 | MRPL41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08673 | MRPL44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08674 | MRPS10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08675 | MRPS11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08676 | MRPS15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08677 | MRPS18B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08678 | MRPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08679 | MRPS22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08680 | MRPS23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08681 | MRPS25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08682 | MRPS27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08683 | MRPS28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08684 | MRPS30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08685 | MRPS31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08686 | MRPS34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08687 | MRPS35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08688 | MRPS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08689 | MRPS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08690 | MRPS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08691 | MRRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08692 | MRS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08693 | MRTFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08694 | MRTFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08695 | MRTO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08696 | MS4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08697 | Ms4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08698 | Ms4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08699 | MS4A15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08700 | MS4A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08701 | MS4A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08702 | MS4A4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08703 | MS4A4E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08704 | MS4A6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08705 | MS4A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08706 | MSANTD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08707 | MSC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08708 | MSGN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08709 | MSH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08710 | MSH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08711 | MSH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08712 | MSH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08713 | MSH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08714 | MSI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08715 | MSI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08716 | MSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08717 | MSL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08718 | MSL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08719 | MSLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08720 | MSMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08721 | MSMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08722 | MSMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08723 | MSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08724 | MSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08725 | MSRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08726 | MSRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08727 | MSRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08728 | MSRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08729 | MST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08730 | MST1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08731 | MSTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08732 | MSTO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08733 | MSX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08734 | MSX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08735 | MT1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08736 | MT1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08737 | MT1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08738 | MT1F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08739 | MT1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08740 | MT1H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08741 | MT1M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08742 | MT1X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08743 | MT2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08744 | MT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08745 | MT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08746 | MTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08747 | MTA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08748 | MTA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08749 | MTAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08750 | MTARC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08751 | MT-ATP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08752 | MT-ATP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08753 | MTBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08754 | MTCH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08755 | MTCH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08756 | MTCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08757 | MT-CO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08758 | MT-CO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08759 | MT-CO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08760 | MTCP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08761 | MT-CYB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08762 | MTDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08763 | MTERF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08764 | MTERF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08765 | MTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08766 | MTF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08767 | MTFMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08768 | MTFP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08769 | MTFR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08770 | MTFR1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08771 | MTFR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08772 | MTG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08773 | MTG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08774 | MTHFD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08775 | MTHFD1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08776 | MTHFD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08777 | MTHFD2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08778 | MTHFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08779 | MTHFS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08780 | MTHFSD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08781 | MTIF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08782 | MTIF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08783 | MTLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08784 | MTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08785 | MTMR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08786 | MTMR10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08787 | MTMR11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08788 | MTMR14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08789 | MTMR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08790 | MTMR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08791 | MTMR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08792 | MTMR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08793 | MTMR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08794 | MTMR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08795 | MTMR9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08796 | MT-ND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08797 | MT-ND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08798 | MT-ND3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08799 | MT-ND4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08800 | MT-ND4L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08801 | MT-ND5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08802 | MT-ND6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08803 | MTNR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08804 | Mtnr1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08805 | Mtnr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08806 | MTNR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08807 | Mtnr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08808 | Mtnr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08809 | MTO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08810 | MTOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08811 | Mtor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08812 | Mtor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08813 | MTPAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08814 | MTPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08815 | MTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08816 | MTREX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08817 | MTRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08818 | MTRF1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08819 | MTRR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08820 | MTSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08821 | MTSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08822 | MTTP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08823 | Mttp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08824 | Mttp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08825 | MTURN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08826 | MTUS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08827 | MTUS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08828 | MTX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08829 | MTX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08830 | MTX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08831 | MUC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08832 | MUC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08833 | MUC13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08834 | MUC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08835 | MUC16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08836 | MUC17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08837 | MUC19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08838 | MUC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08839 | MUC20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08840 | MUC21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08841 | MUC22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08842 | MUC3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08843 | MUC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08844 | MUC5AC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08845 | MUC5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08846 | MUC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08847 | MUC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08848 | MUC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08849 | MUCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08850 | MUL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08851 | MUS81 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08852 | MUSK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08853 | MUSTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08854 | MUTYH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08855 | MVB12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08856 | MVD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08857 | MVK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08858 | MVP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08859 | MX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08860 | MX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08861 | MXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08862 | MXD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08863 | MXD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08864 | MXI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08865 | MXRA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08866 | MXRA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08867 | MXRA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08868 | MYADM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08869 | MYB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08870 | MYBBP1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08871 | MYBL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08872 | MYBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08873 | MYBPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08874 | MYBPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08875 | MYBPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08876 | MYBPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08877 | MYC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08878 | Myc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08879 | Myc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08880 | MYCBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08881 | MYCBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08882 | MYCBPAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08883 | MYCL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08884 | MYCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08885 | MYCT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08886 | MYD88 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08887 | Myd88 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08888 | Myd88 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08889 | MYDGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08890 | MYEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08891 | MYEOV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08892 | MYF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08893 | MYF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08894 | MYG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08895 | MYH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08896 | MYH10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08897 | MYH11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08898 | MYH13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08899 | MYH14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08900 | MYH15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08901 | MYH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08902 | MYH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08903 | MYH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08904 | MYH6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08905 | MYH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08906 | MYH7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08907 | MYH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08908 | MYH9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08909 | MYL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08910 | MYL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08911 | MYL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08912 | MYL12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08913 | MYL12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08914 | MYL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08915 | MYL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08916 | MYL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08917 | MYL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08918 | MYL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08919 | MYL6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08920 | MYL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08921 | MYL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08922 | MYLIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08923 | MYLK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08924 | MYLK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08925 | MYLK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08926 | MYLK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08927 | MYMK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08928 | MYMX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08929 | MYNN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08930 | MYO10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08931 | MYO15A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08932 | MYO15B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08933 | MYO16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08934 | MYO18A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08935 | MYO18B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08936 | MYO19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08937 | MYO1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08938 | MYO1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08939 | MYO1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08940 | MYO1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08941 | MYO1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08942 | MYO1F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08943 | MYO1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08944 | MYO3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08945 | MYO3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08946 | MYO5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08947 | MYO5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08948 | MYO5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08949 | MYO6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08950 | MYO7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08951 | MYO7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08952 | MYO9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08953 | MYO9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08954 | MYOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08955 | MYOCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08956 | MYOCOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08957 | MYOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08958 | MYOF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08959 | MYOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08960 | MYOM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08961 | MYOM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08962 | MYOM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08963 | MYORG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08964 | MYOT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08965 | MYOZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08966 | MYOZ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08967 | MYPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08968 | MYPOP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08969 | MYRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08970 | MYRFL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08971 | MYRIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08972 | MYSM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08973 | MYT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08974 | MYT1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08975 | MYZAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08976 | MZB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08977 | MZT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08978 | MZT2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08979 | N4BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08980 | N4BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08981 | N4BP2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08982 | N4BP2L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08983 | N4BP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08984 | N6AMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08985 | NAA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08986 | NAA15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08987 | NAA16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08988 | NAA20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08989 | NAA30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08990 | NAA40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08991 | NAA50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08992 | NAA60 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08993 | NAAA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08994 | NAALAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08995 | NAALADL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08996 | NAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08997 | NAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08998 | NABP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS08999 | NACA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09000 | NACA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09001 | NACAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09002 | NACC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09003 | NACC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09004 | NADK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09005 | NADK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09006 | NADSYN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09007 | NAE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09008 | NAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09009 | NAGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09010 | NAGK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09011 | NAGLU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09012 | NAGPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09013 | NAGS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09014 | NAIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09015 | NALCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09016 | NAMPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09017 | Nampt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09018 | Nampt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09019 | NANOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09020 | NANOGP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09021 | NANOS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09022 | NANOS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09023 | NANOS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09024 | NANP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09025 | NANS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09026 | NAP1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09027 | NAP1L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09028 | NAP1L4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09029 | NAPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09030 | NAPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09031 | NAPEPLD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09032 | NAPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09033 | NAPRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09034 | NAPSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09035 | NARF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09036 | NARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09037 | NARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09038 | NASP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09039 | NAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09040 | NAT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09041 | NAT14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09042 | NAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09043 | NAT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09044 | NAT8L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09045 | NAT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09046 | NAV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09047 | NAV2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09048 | NAV3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09049 | NAXD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09050 | NAXE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09051 | NBAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09052 | NBDY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09053 | NBEA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09054 | NBEAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09055 | NBEAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09056 | NBL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09057 | NBN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09058 | NBPF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09059 | NBPF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09060 | NBPF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09061 | NBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09062 | NCALD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09063 | NCAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09064 | NCAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09065 | NCAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09066 | NCAPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09067 | NCAPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09068 | NCAPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09069 | NCAPG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09070 | NCAPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09071 | NCAPH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09072 | NCBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09073 | NCBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09074 | NCCRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09075 | NCDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09076 | NCEH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09077 | NCF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09078 | NCF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09079 | NCF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09080 | NCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09081 | NCK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09082 | NCKAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09083 | NCKAP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09084 | NCKAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09085 | NCKAP5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09086 | NCL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09087 | NCLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09088 | NCMAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09089 | NCOA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09090 | NCOA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09091 | NCOA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09092 | NCOA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09093 | NCOA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09094 | NCOA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09095 | NCOA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09096 | NCOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09097 | NCOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09098 | NCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09099 | NCR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09100 | NCR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09101 | NCR3LG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09102 | NCS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09103 | NCSTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09104 | NDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09105 | NDC80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09106 | NDE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09107 | NDEL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09108 | NDFIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09109 | NDFIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09110 | NDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09111 | NDNF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09112 | NDOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09113 | NDP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09114 | NDRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09115 | NDRG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09116 | NDRG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09117 | NDRG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09118 | NDST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09119 | NDST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09120 | NDST3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09121 | NDST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09122 | NDUFA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09123 | NDUFA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09124 | NDUFA11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09125 | NDUFA12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09126 | NDUFA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09127 | NDUFA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09128 | NDUFA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09129 | NDUFA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09130 | NDUFA4L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09131 | NDUFA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09132 | NDUFA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09133 | NDUFA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09134 | NDUFA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09135 | NDUFA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09136 | NDUFAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09137 | NDUFAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09138 | NDUFAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09139 | NDUFAF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09140 | NDUFAF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09141 | NDUFAF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09142 | NDUFAF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09143 | NDUFAF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09144 | NDUFB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09145 | NDUFB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09146 | NDUFB11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09147 | NDUFB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09148 | NDUFB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09149 | NDUFB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09150 | NDUFB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09151 | NDUFB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09152 | NDUFB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09153 | NDUFB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09154 | NDUFB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09155 | NDUFC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09156 | NDUFC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09157 | NDUFS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09158 | NDUFS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09159 | NDUFS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09160 | NDUFS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09161 | NDUFS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09162 | NDUFS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09163 | NDUFS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09164 | NDUFS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09165 | NDUFV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09166 | NDUFV2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09167 | NDUFV3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09168 | NEB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09169 | NEBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09170 | NECAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09171 | NECAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09172 | NECAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09173 | NECAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09174 | NECTIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09175 | NECTIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09176 | NECTIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09177 | NECTIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09178 | NEDD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09179 | NEDD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09180 | NEDD4L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09181 | NEDD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09182 | NEDD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09183 | NEFH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09184 | NEFL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09185 | NEFM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09186 | NEGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09187 | NEIL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09188 | NEIL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09189 | NEIL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09190 | NEK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09191 | NEK10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09192 | NEK11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09193 | NEK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09194 | NEK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09195 | NEK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09196 | NEK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09197 | NEK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09198 | NEK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09199 | NEK8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09200 | NEK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09201 | NELFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09202 | NELFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09203 | NELFE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09204 | NELL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09205 | NELL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09206 | NEMF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09207 | NEMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09208 | NENF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09209 | NEO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09210 | NEPRO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09211 | NES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09212 | NET1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09213 | NETO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09214 | NETO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09215 | NEU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09216 | NEU2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09217 | NEU3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09218 | NEU4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09219 | NEURL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09220 | NEURL1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09221 | NEURL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09222 | NEURL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09223 | NEURL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09224 | NEUROD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09225 | NEUROD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09226 | NEUROD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09227 | NEUROD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09228 | NEUROG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09229 | NEUROG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09230 | NEUROG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09231 | NEXMIF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09232 | NEXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09233 | NF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09234 | NF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09235 | NFAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09236 | NFASC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09237 | NFAT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09238 | NFATC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09239 | NFATC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09240 | NFATC2IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09241 | NFATC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09242 | NFATC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09243 | NFE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09244 | NFE2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09245 | NFE2L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09246 | Nfe2l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09247 | Nfe2l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09248 | NFE2L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09249 | NFIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09250 | NFIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09251 | NFIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09252 | NFIL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09253 | NFIX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09254 | NFKB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09255 | Nfkb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09256 | Nfkb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09257 | NFKB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09258 | Nfkb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09259 | Nfkb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09260 | NFKBIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09261 | NFKBIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09262 | NFKBID Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09263 | NFKBIE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09264 | NFKBIL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09265 | NFKBIZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09266 | NFRKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09267 | NFS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09268 | NFU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09269 | NFX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09270 | NFXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09271 | NFYA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09272 | NFYB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09273 | NFYC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09274 | NGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09275 | NGDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09276 | NGEF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09277 | NGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09278 | NGFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09279 | NGLY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09280 | NGRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09281 | NHEJ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09282 | NHERF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09283 | NHERF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09284 | NHLH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09285 | NHLH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09286 | NHLRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09287 | NHLRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09288 | NHLRC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09289 | NHP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09290 | NHS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09291 | NHSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09292 | NHSL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09293 | NIBAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09294 | NID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09295 | NID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09296 | NIFK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09297 | NIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09298 | NINJ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09299 | NINJ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09300 | NINL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09301 | NIP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09302 | NIPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09303 | NIPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09304 | NIPAL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09305 | NIPBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09306 | NIPSNAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09307 | NIPSNAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09308 | NIPSNAP3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09309 | NISCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09310 | NIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09311 | NIT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09312 | NKAIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09313 | NKAIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09314 | NKAIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09315 | NKAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09316 | NKAPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09317 | NKD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09318 | NKD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09319 | NKG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09320 | NKIRAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09321 | NKIRAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09322 | NKPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09323 | NKRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09324 | NKTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09325 | NKX1-1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09326 | NKX1-2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09327 | NKX2-1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09328 | NKX2-2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09329 | NKX2-3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09330 | NKX2-5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09331 | NKX2-6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09332 | NKX2-8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09333 | NKX3-1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09334 | NKX3-2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09335 | NKX6-1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09336 | NKX6-2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09337 | NKX6-3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09338 | NLE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09339 | NLGN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09340 | NLGN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09341 | NLGN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09342 | NLGN4X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09343 | NLGN4Y Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09344 | NLK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09345 | NLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09346 | NLRC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09347 | NLRC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09348 | NLRC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09349 | NLRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09350 | NLRP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09351 | NLRP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09352 | NLRP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09353 | NLRP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09354 | Nlrp1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09355 | Nlrp1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09356 | NLRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09357 | NLRP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09358 | Nlrp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09359 | Nlrp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09360 | NLRP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09361 | NLRP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09362 | NLRP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09363 | NLRP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09364 | NLRP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09365 | NLRX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09366 | Nlrx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09367 | Nlrx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09368 | NMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09369 | NMBR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09370 | NMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09371 | NME1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09372 | NME1-NME2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09373 | NME2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09374 | NME3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09375 | NME4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09376 | NME5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09377 | NME6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09378 | NME7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09379 | NME8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09380 | NME9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09381 | NMI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09382 | NMNAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09383 | NMNAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09384 | NMNAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09385 | NMRAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09386 | NMRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09387 | NMRK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09388 | NMS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09389 | NMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09390 | NMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09391 | NMU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09392 | NMUR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09393 | NMUR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09394 | NNAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09395 | NNMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09396 | NNT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09397 | NOA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09398 | NOB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09399 | NOBOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09400 | NOC2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09401 | NOC3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09402 | NOCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09403 | NOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09404 | Nod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09405 | Nod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09406 | NOD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09407 | Nod2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09408 | Nod2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09409 | NODAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09410 | NOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09411 | NOL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09412 | NOL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09413 | NOL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09414 | NOL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09415 | NOL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09416 | NOL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09417 | NOL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09418 | NOL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09419 | NOL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09420 | NOLC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09421 | NOM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09422 | NOMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09423 | NOMO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09424 | NOMO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09425 | NONO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09426 | NOP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09427 | NOP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09428 | NOP16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09429 | NOP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09430 | NOP56 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09431 | NOP58 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09432 | NOP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09433 | NOS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09434 | Nos1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09435 | Nos1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09436 | NOS1AP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09437 | NOS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09438 | Nos2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09439 | NOS2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09440 | NOS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09441 | Nos3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09442 | Nos3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09443 | NOSIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09444 | NOSTRIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09445 | NOTCH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09446 | Notch1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09447 | Notch1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09448 | NOTCH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09449 | NOTCH2NLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09450 | NOTCH2NLC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09451 | NOTCH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09452 | NOTCH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09453 | NOTO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09454 | NOTUM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09455 | NOVA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09456 | NOVA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09457 | NOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09458 | Nox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09459 | Nox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09460 | NOX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09461 | NOX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09462 | Nox4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09463 | Nox4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09464 | NOX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09465 | NOXA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09466 | NOXO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09467 | NPAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09468 | NPAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09469 | NPAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09470 | NPAS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09471 | NPAS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09472 | NPAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09473 | NPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09474 | NPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09475 | NPC1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09476 | NPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09477 | NPDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09478 | NPEPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09479 | NPEPPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09480 | NPFF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09481 | NPFFR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09482 | NPFFR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09483 | NPHP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09484 | NPHP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09485 | NPHP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09486 | NPHS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09487 | NPHS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09488 | NPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09489 | NPLOC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09490 | NPM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09491 | NPM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09492 | NPM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09493 | NPNT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09494 | NPPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09495 | NPPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09496 | NPPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09497 | NPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09498 | NPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09499 | NPR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09500 | NPRL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09501 | NPRL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09502 | NPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09503 | NPSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09504 | NPTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09505 | NPTX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09506 | NPTX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09507 | NPTXR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09508 | NPVF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09509 | NPW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09510 | NPY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09511 | NPY1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09512 | Npy1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09513 | Npy1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09514 | NPY2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09515 | Npy2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09516 | NPY2R Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09517 | NPY4R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09518 | Npy4r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09519 | Npy4r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09520 | NPY5R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09521 | Npy5r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09522 | Npy5r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09523 | NQO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09524 | NQO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09525 | NR0B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09526 | NR0B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09527 | NR1D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09528 | NR1D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09529 | NR1H2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09530 | NR1H3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09531 | NR1H4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09532 | Nr1h4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09533 | Nr1h4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09534 | NR1I2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09535 | NR1I3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09536 | NR2C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09537 | NR2C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09538 | NR2C2AP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09539 | NR2E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09540 | NR2E3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09541 | NR2F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09542 | NR2F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09543 | NR2F6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09544 | NR3C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09545 | Nr3c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09546 | Nr3c1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09547 | NR3C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09548 | Nr3c2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09549 | Nr3c2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09550 | NR4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09551 | NR4A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09552 | NR4A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09553 | NR5A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09554 | NR5A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09555 | NR6A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09556 | NRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09557 | NRARP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09558 | NRAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09559 | Nras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09560 | Nras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09561 | NRBF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09562 | NRBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09563 | NRCAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09564 | NRDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09565 | NRDE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09566 | NREP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09567 | NRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09568 | NRG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09569 | NRG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09570 | NRGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09571 | NRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09572 | NRIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09573 | NRIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09574 | NRK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09575 | NRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09576 | NRM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09577 | NRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09578 | NRN1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09579 | NRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09580 | NRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09581 | NRROS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09582 | NRTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09583 | NRXN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09584 | NRXN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09585 | NRXN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09586 | NSA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09587 | NSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09588 | NSD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09589 | NSD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09590 | NSDHL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09591 | NSF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09592 | NSFL1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09593 | NSG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09594 | NSG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09595 | NSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09596 | NSMAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09597 | NSMCE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09598 | NSMCE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09599 | NSMF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09600 | NSRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09601 | NSUN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09602 | NSUN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09603 | NSUN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09604 | NSUN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09605 | NSUN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09606 | NSUN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09607 | NT5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09608 | NT5C1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09609 | NT5C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09610 | NT5DC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09611 | NT5DC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09612 | NT5E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09613 | Nt5e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09614 | Nt5e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09615 | NT5M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09616 | NTF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09617 | NTF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09618 | NTHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09619 | NTM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09620 | NTMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09621 | NTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09622 | NTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09623 | NTN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09624 | NTN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09625 | NTNG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09626 | NTNG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09627 | NTPCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09628 | NTRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09629 | Ntrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09630 | Ntrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09631 | NTRK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09632 | Ntrk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09633 | Ntrk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09634 | NTRK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09635 | Ntrk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09636 | Ntrk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09637 | NTS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09638 | NTSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09639 | Ntsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09640 | Ntsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09641 | NTSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09642 | Ntsr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09643 | Ntsr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09644 | NUAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09645 | Nuak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09646 | Nuak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09647 | NUAK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09648 | Nuak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09649 | Nuak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09650 | NUB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09651 | NUBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09652 | NUBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09653 | NUBPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09654 | NUCB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09655 | NUCB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09656 | NUCKS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09657 | NUDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09658 | NUDCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09659 | NUDCD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09660 | NUDCD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09661 | NUDT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09662 | NUDT12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09663 | NUDT13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09664 | NUDT14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09665 | NUDT15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09666 | NUDT16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09667 | NUDT16L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09668 | NUDT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09669 | NUDT21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09670 | NUDT22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09671 | NUDT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09672 | NUDT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09673 | NUDT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09674 | NUDT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09675 | NUDT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09676 | NUF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09677 | NUFIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09678 | NUFIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09679 | NUGGC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09680 | NUMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09681 | NUMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09682 | NUMBL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09683 | NUP107 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09684 | NUP133 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09685 | NUP153 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09686 | NUP155 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09687 | NUP160 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09688 | NUP188 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09689 | NUP205 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09690 | NUP210 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09691 | NUP210L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09692 | NUP214 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09693 | NUP35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09694 | NUP43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09695 | NUP50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09696 | NUP54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09697 | NUP62 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09698 | NUP85 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09699 | NUP88 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09700 | NUP93 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09701 | NUP98 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09702 | NUPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09703 | NUS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09704 | NUSAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09705 | NUTF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09706 | NUTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09707 | NVL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09708 | NWD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09709 | NWD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09710 | NXF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09711 | NXF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09712 | NXF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09713 | NXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09714 | NXNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09715 | NXNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09716 | NXPE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09717 | NXPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09718 | NXPH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09719 | NXPH4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09720 | NXT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09721 | NXT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09722 | NYAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09723 | NYNRIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09724 | NYX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09725 | OAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09726 | OARD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09727 | OAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09728 | OAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09729 | OAS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09730 | OASL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09731 | OAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09732 | OAZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09733 | OAZ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09734 | OBI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09735 | OBP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09736 | OBSCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09737 | OBSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09738 | OC90 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09739 | OCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09740 | OCEL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09741 | OCIAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09742 | OCIAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09743 | OCLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09744 | OCM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09745 | OCM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09746 | OCRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09747 | OCSTAMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09748 | ODAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09749 | ODAPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09750 | ODC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09751 | ODF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09752 | ODF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09753 | ODF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09754 | ODF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09755 | ODR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09756 | OFD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09757 | OGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09758 | OGDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09759 | OGDHL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09760 | OGFOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09761 | OGFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09762 | OGFRL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09763 | OGG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09764 | OGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09765 | OGT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09766 | OIP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09767 | OIT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09768 | OLA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09769 | OLAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09770 | OLFM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09771 | OLFM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09772 | OLFM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09773 | OLFM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09774 | OLFML2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09775 | OLFML2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09776 | OLFML3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09777 | OLIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09778 | OLIG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09779 | OLIG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09780 | OLR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09781 | OMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09782 | OMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09783 | OMG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09784 | OMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09785 | ONECUT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09786 | ONECUT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09787 | ONECUT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09788 | OOEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09789 | OPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09790 | OPA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09791 | OPALIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09792 | OPCML Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09793 | OPHN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09794 | OPLAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09795 | OPN1LW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09796 | OPN1MW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09797 | OPN1SW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09798 | OPN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09799 | OPN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09800 | OPN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09801 | OPRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09802 | OPRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09803 | OPRL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09804 | Oprl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09805 | Oprl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09806 | OPRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09807 | OPRPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09808 | OPTC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09809 | OPTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09810 | OR1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09811 | OR1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09812 | OR2AT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09813 | OR2H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09814 | OR2M7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09815 | OR4F17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09816 | OR4F5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09817 | OR51E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09818 | OR51E2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09819 | OR5B21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09820 | OR6A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09821 | OR7D4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09822 | ORAI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09823 | ORAI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09824 | ORAI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09825 | ORC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09826 | ORC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09827 | ORC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09828 | ORC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09829 | ORC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09830 | ORC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09831 | ORM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09832 | ORM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09833 | ORMDL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09834 | OS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09835 | OSBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09836 | OSBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09837 | OSBPL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09838 | OSBPL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09839 | OSBPL1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09840 | OSBPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09841 | OSBPL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09842 | OSBPL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09843 | OSBPL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09844 | OSBPL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09845 | OSBPL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09846 | OSBPL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09847 | OSCAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09848 | OSGEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09849 | OSGIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09850 | OSM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09851 | OSMR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09852 | OSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09853 | OSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09854 | OST4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09855 | OSTC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09856 | OSTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09857 | OSTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09858 | OSTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09859 | OTC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09860 | OTOA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09861 | OTOF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09862 | OTOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09863 | OTOGL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09864 | OTOP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09865 | OTOP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09866 | OTOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09867 | OTOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09868 | OTP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09869 | OTUB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09870 | OTUB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09871 | OTUD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09872 | OTUD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09873 | OTUD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09874 | OTUD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09875 | OTUD6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09876 | OTUD7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09877 | OTUD7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09878 | OTULIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09879 | OTX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09880 | OTX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09881 | OVCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09882 | OVGP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09883 | OVOL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09884 | OVOL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09885 | OXA1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09886 | OXCT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09887 | OXER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09888 | OXGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09889 | OXLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09890 | OXR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09891 | OXSM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09892 | OXSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09893 | OXT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09894 | OXTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09895 | Oxtr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09896 | Oxtr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09897 | P2RX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09898 | P2rx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09899 | P2rx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09900 | P2RX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09901 | P2rx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09902 | P2rx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09903 | P2RX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09904 | P2rx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09905 | P2rx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09906 | P2RX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09907 | P2rx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09908 | P2rx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09909 | P2RX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09910 | P2RX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09911 | P2RX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09912 | P2rx7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09913 | P2RX7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09914 | P2RY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09915 | P2ry1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09916 | P2ry1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09917 | P2RY10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09918 | P2RY11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09919 | P2RY12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09920 | P2ry12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09921 | P2ry12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09922 | P2RY13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09923 | P2ry13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09924 | P2ry13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09925 | P2RY14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09926 | P2ry14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09927 | P2ry14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09928 | P2RY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09929 | P2ry2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09930 | P2ry2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09931 | P2RY4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09932 | P2ry4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09933 | P2ry4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09934 | P2RY6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09935 | P2ry6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09936 | P2ry6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09937 | P2RY8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09938 | P3H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09939 | P3H2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09940 | P3H3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09941 | P3H4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09942 | P4HA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09943 | P4HA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09944 | P4HA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09945 | P4HB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09946 | P4HTM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09947 | PA2G4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09948 | PABPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09949 | PABPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09950 | PABPC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09951 | PABPC4L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09952 | PABPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09953 | PACC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09954 | PACRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09955 | PACS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09956 | PACS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09957 | PACSIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09958 | PACSIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09959 | PACSIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09960 | PADI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09961 | PADI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09962 | PADI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09963 | PADI4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09964 | PADI6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09965 | PAEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09966 | PAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09967 | PAFAH1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09968 | PAFAH1B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09969 | PAFAH1B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09970 | PAFAH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09971 | PAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09972 | PAGE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09973 | PAGE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09974 | PAGE2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09975 | PAGE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09976 | PAGE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09977 | PAGE5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09978 | PAGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09979 | PAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09980 | PAICS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09981 | PAIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09982 | PAIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09983 | PAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09984 | Pak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09985 | Pak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09986 | PAK1IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09987 | PAK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09988 | Pak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09989 | PAK2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09990 | PAK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09991 | Pak3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09992 | Pak3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09993 | PAK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09994 | Pak4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09995 | Pak4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09996 | PAK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09997 | Pak5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09998 | Pak5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS09999 | PAK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10000 | Pak6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10001 | Pak6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10002 | PALB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10003 | PALD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10004 | PALLD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10005 | PALM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10006 | PALM2AKAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10007 | PALM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10008 | PALMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10009 | PALS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10010 | PALS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10011 | PAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10012 | PAM16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10013 | PAMR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10014 | PAN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10015 | PAN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10016 | PANK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10017 | PANK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10018 | PANK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10019 | PANK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10020 | PANO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10021 | PANX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10022 | PANX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10023 | PANX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10024 | PAOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10025 | PAPLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10026 | PAPOLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10027 | PAPOLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10028 | PAPPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10029 | PAPPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10030 | PAPSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10031 | PAPSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10032 | PAQR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10033 | PAQR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10034 | PAQR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10035 | PAQR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10036 | PAQR9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10037 | PARD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10038 | PARD6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10039 | PARD6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10040 | PARG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10041 | Parg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10042 | Parg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10043 | PARK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10044 | PARL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10045 | PARM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10046 | PARN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10047 | PARP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10048 | Parp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10049 | Parp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10050 | PARP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10051 | Parp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10052 | Parp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10053 | PARP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10054 | PARP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10055 | PARP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10056 | Parp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10057 | Parp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10058 | PARP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10059 | PARP16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10060 | PARP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10061 | Parp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10062 | Parp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10063 | PARP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10064 | Parp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10065 | Parp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10066 | PARP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10067 | Parp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10068 | Parp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10069 | PARP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10070 | PARP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10071 | PARP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10072 | PARPBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10073 | PARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10074 | PARVA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10075 | PARVB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10076 | PARVG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10077 | PASD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10078 | PASK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10079 | PATE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10080 | PATE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10081 | PATE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10082 | PATE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10083 | PATJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10084 | PATL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10085 | PATL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10086 | PATZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10087 | PAWR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10088 | PAX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10089 | PAX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10090 | PAX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10091 | PAX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10092 | PAX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10093 | PAX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10094 | PAX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10095 | PAX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10096 | PAX9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10097 | PAXBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10098 | PAXIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10099 | PAXX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10100 | PBDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10101 | PBK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10102 | Pbk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10103 | Pbk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10104 | PBLD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10105 | PBRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10106 | PBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10107 | PBX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10108 | PBX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10109 | PBX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10110 | PBXIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10111 | PC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10112 | PCARE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10113 | PCBD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10114 | PCBD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10115 | PCBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10116 | PCBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10117 | PCBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10118 | PCBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10119 | PCCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10120 | PCCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10121 | PCDH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10122 | PCDH10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10123 | PCDH11Y Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10124 | PCDH12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10125 | PCDH15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10126 | PCDH17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10127 | PCDH18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10128 | PCDH19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10129 | PCDH20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10130 | PCDH7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10131 | PCDH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10132 | PCDH9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10133 | PCDHA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10134 | PCDHA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10135 | PCDHA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10136 | PCDHB13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10137 | PCDHB16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10138 | PCDHB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10139 | PCDHB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10140 | PCDHGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10141 | PCDHGA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10142 | PCDHGC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10143 | PCDHGC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10144 | PCF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10145 | PCGF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10146 | PCGF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10147 | PCGF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10148 | PCGF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10149 | PCGF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10150 | PCID2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10151 | PCIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10152 | PCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10153 | PCK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10154 | PCLAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10155 | PCLO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10156 | PCM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10157 | PCMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10158 | PCMTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10159 | PCNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10160 | PCNP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10161 | PCNT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10162 | PCNX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10163 | PCOLCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10164 | Pcolce Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10165 | Pcolce Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10166 | PCOLCE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10167 | PCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10168 | PCP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10169 | PCP4L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10170 | PCSK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10171 | PCSK1N Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10172 | PCSK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10173 | PCSK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10174 | PCSK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10175 | PCSK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10176 | PCSK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10177 | PCSK9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10178 | PCTP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10179 | PCYOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10180 | PCYT1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10181 | PCYT1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10182 | PCYT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10183 | PDAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10184 | PDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10185 | PDCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10186 | Pdcd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10187 | Pdcd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10188 | PDCD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10189 | PDCD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10190 | PDCD1LG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10191 | PDCD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10192 | PDCD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10193 | PDCD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10194 | PDCD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10195 | PDCD6IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10196 | PDCL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10197 | PDCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10198 | PDCL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10199 | PDE10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10200 | Pde10a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10201 | Pde10a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10202 | PDE11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10203 | Pde11a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10204 | Pde11a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10205 | PDE12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10206 | Pde12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10207 | Pde12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10208 | PDE1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10209 | Pde1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10210 | PDE1A Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10211 | PDE1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10212 | PDE1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10213 | PDE2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10214 | Pde2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10215 | Pde2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10216 | PDE3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10217 | Pde3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10218 | Pde3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10219 | PDE3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10220 | PDE4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10221 | Pde4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10222 | Pde4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10223 | PDE4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10224 | PDE4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10225 | PDE4D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10226 | PDE4DIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10227 | PDE5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10228 | Pde5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10229 | Pde5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10230 | PDE6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10231 | Pde6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10232 | Pde6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10233 | PDE6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10234 | PDE6C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10235 | PDE6D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10236 | PDE6G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10237 | PDE6H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10238 | PDE7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10239 | Pde7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10240 | Pde7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10241 | PDE7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10242 | PDE8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10243 | Pde8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10244 | Pde8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10245 | PDE8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10246 | PDE9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10247 | Pde9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10248 | Pde9a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10249 | PDF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10250 | PDGFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10251 | PDGFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10252 | PDGFC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10253 | PDGFD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10254 | PDGFRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10255 | Pdgfra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10256 | PDGFRA Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10257 | PDGFRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10258 | Pdgfrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10259 | Pdgfrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10260 | PDGFRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10261 | PDHA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10262 | PDHA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10263 | PDHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10264 | PDHX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10265 | PDIA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10266 | PDIA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10267 | Pdia3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10268 | Pdia3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10269 | PDIA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10270 | PDIA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10271 | PDIA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10272 | PDIK1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10273 | PDK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10274 | Pdk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10275 | Pdk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10276 | PDK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10277 | PDK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10278 | PDK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10279 | PDLIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10280 | PDLIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10281 | PDLIM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10282 | PDLIM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10283 | PDLIM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10284 | PDLIM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10285 | PDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10286 | PDP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10287 | PDPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10288 | PDPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10289 | PDPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10290 | PDRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10291 | PDS5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10292 | PDS5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10293 | PDSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10294 | PDSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10295 | PDX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10296 | PDXDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10297 | PDXK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10298 | PDXP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10299 | PDYN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10300 | PDZD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10301 | PDZD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10302 | PDZD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10303 | PDZD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10304 | PDZD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10305 | PDZK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10306 | PDZK1IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10307 | PDZRN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10308 | PDZRN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10309 | PEA15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10310 | PEAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10311 | PEAK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10312 | PEAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10313 | PEBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10314 | PEBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10315 | PECAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10316 | PECR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10317 | PEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10318 | PEG10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10319 | PEG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10320 | PELI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10321 | PELI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10322 | PELI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10323 | PELO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10324 | PELP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10325 | PEMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10326 | PENK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10327 | PEPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10328 | PEPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10329 | PEPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10330 | PEPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10331 | PER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10332 | PER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10333 | PER3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10334 | PERM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10335 | PERP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10336 | PES1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10337 | PET100 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10338 | PET117 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10339 | PEX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10340 | PEX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10341 | PEX11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10342 | PEX11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10343 | PEX12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10344 | PEX13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10345 | PEX14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10346 | PEX16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10347 | PEX19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10348 | PEX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10349 | PEX26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10350 | PEX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10351 | PEX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10352 | PEX5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10353 | PEX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10354 | PEX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10355 | PF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10356 | PF4V1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10357 | PFAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10358 | PFDN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10359 | PFDN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10360 | PFDN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10361 | PFKFB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10362 | PFKFB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10363 | PFKFB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10364 | PFKFB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10365 | PFKL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10366 | PFKM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10367 | PFKP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10368 | PFN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10369 | PFN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10370 | PFN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10371 | PGA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10372 | PGA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10373 | PGA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10374 | PGAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10375 | PGAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10376 | PGAM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10377 | PGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10378 | PGAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10379 | PGBD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10380 | PGC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10381 | PGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10382 | PGGHG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10383 | PGGT1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10384 | PGK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10385 | PGK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10386 | PGLS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10387 | PGLYRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10388 | PGLYRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10389 | PGM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10390 | PGM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10391 | PGM2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10392 | PGM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10393 | PGM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10394 | PGP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10395 | PGPEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10396 | PGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10397 | Pgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10398 | Pgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10399 | PGRMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10400 | PGRMC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10401 | PGS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10402 | PHACTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10403 | PHACTR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10404 | PHACTR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10405 | PHACTR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10406 | PHAX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10407 | PHB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10408 | PHB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10409 | PHC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10410 | PHC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10411 | PHC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10412 | PHEX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10413 | PHF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10414 | PHF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10415 | PHF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10416 | PHF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10417 | PHF13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10418 | PHF14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10419 | PHF19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10420 | PHF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10421 | PHF20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10422 | PHF20L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10423 | PHF21A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10424 | PHF21B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10425 | PHF23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10426 | PHF24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10427 | PHF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10428 | PHF5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10429 | PHF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10430 | PHF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10431 | PHF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10432 | PHGDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10433 | Phgdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10434 | Phgdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10435 | PHGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10436 | PHIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10437 | PHKA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10438 | PHKA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10439 | PHKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10440 | PHKG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10441 | PHKG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10442 | PHLDA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10443 | PHLDA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10444 | PHLDA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10445 | PHLDB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10446 | PHLDB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10447 | PHLPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10448 | PHLPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10449 | PHOSPHO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10450 | PHOSPHO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10451 | PHOX2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10452 | PHOX2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10453 | PHPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10454 | PHRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10455 | PHTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10456 | PHTF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10457 | PHYH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10458 | PHYHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10459 | PHYHIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10460 | PHYHIPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10461 | PI15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10462 | PI16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10463 | PI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10464 | PI4K2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10465 | PI4K2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10466 | PI4KA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10467 | Pi4ka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10468 | Pi4ka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10469 | PI4KB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10470 | Pi4kb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10471 | Pi4kb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10472 | PIANP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10473 | PIAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10474 | PIAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10475 | PIAS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10476 | PIAS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10477 | PIBF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10478 | PICALM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10479 | PICK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10480 | PID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10481 | PIDD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10482 | PIERCE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10483 | PIEZO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10484 | PIEZO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10485 | PIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10486 | PIFO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10487 | PIGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10488 | PIGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10489 | PIGC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10490 | PIGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10491 | PIGG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10492 | PIGH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10493 | PIGK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10494 | PIGL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10495 | PIGM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10496 | PIGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10497 | PIGO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10498 | PIGP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10499 | PIGQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10500 | PIGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10501 | PIGS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10502 | PIGT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10503 | PIGU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10504 | PIGV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10505 | PIGW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10506 | PIGX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10507 | PIGY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10508 | PIGZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10509 | PIH1D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10510 | PIK3AP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10511 | PIK3C2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10512 | Pik3c2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10513 | Pik3c2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10514 | PIK3C2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10515 | Pik3c2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10516 | Pik3c2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10517 | PIK3C2G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10518 | Pik3c2g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10519 | Pik3c2g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10520 | PIK3C3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10521 | Pik3c3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10522 | Pik3c3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10523 | PIK3CA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10524 | Pik3ca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10525 | Pik3ca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10526 | PIK3CB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10527 | Pik3cb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10528 | PIK3CB Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10529 | PIK3CD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10530 | Pik3cd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10531 | Pik3cd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10532 | PIK3CG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10533 | Pik3cg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10534 | Pik3cg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10535 | PIK3IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10536 | PIK3R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10537 | PIK3R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10538 | PIK3R3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10539 | PIK3R4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10540 | PIK3R5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10541 | PIK3R6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10542 | PIKFYVE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10543 | Pikfyve Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10544 | Pikfyve Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10545 | PILRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10546 | PILRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10547 | PIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10548 | Pim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10549 | Pim1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10550 | PIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10551 | Pim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10552 | Pim2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10553 | PIM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10554 | Pim3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10555 | Pim3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10556 | PIMREG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10557 | PIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10558 | PIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10559 | PINK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10560 | PINX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10561 | PIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10562 | PIP4K2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10563 | PIP4K2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10564 | PIP4K2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10565 | PIP4P1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10566 | PIP5K1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10567 | PIP5K1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10568 | PIP5K1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10569 | PIP5KL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10570 | PIPOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10571 | PIR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10572 | PIRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10573 | PISD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10574 | PITPNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10575 | PITPNB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10576 | PITPNC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10577 | PITPNM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10578 | PITPNM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10579 | PITPNM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10580 | PITRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10581 | PITX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10582 | PITX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10583 | PITX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10584 | PIWIL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10585 | PIWIL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10586 | PIWIL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10587 | PIWIL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10588 | PJA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10589 | PJA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10590 | PJVK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10591 | PKD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10592 | Pkd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10593 | Pkd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10594 | PKD2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10595 | PKDCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10596 | PKHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10597 | PKHD1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10598 | PKIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10599 | PKIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10600 | PKIG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10601 | PKLR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10602 | PKM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10603 | Pkm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10604 | Pkm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10605 | PKMYT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10606 | PKN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10607 | PKN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10608 | PKN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10609 | PKNOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10610 | PKNOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10611 | PKP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10612 | PKP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10613 | PKP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10614 | PKP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10615 | PLA1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10616 | PLA2G10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10617 | PLA2G12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10618 | PLA2G12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10619 | PLA2G15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10620 | PLA2G1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10621 | PLA2G2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10622 | PLA2G2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10623 | PLA2G2E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10624 | PLA2G2F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10625 | PLA2G3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10626 | PLA2G4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10627 | PLA2G4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10628 | PLA2G4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10629 | PLA2G4D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10630 | PLA2G4E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10631 | PLA2G4F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10632 | PLA2G5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10633 | PLA2G6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10634 | PLA2G7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10635 | PLA2R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10636 | PLAA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10637 | PLAAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10638 | PLAAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10639 | PLAAT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10640 | PLAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10641 | PLAC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10642 | PLAC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10643 | PLAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10644 | PLAGL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10645 | PLAGL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10646 | PLAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10647 | PLAU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10648 | PLAUR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10649 | PLB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10650 | PLBD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10651 | PLBD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10652 | PLCB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10653 | PLCB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10654 | PLCB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10655 | PLCB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10656 | PLCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10657 | PLCD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10658 | PLCD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10659 | PLCE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10660 | PLCG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10661 | PLCG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10662 | PLCH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10663 | PLCH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10664 | PLCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10665 | PLCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10666 | PLCXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10667 | PLCXD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10668 | PLCXD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10669 | PLCZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10670 | PLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10671 | PLD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10672 | PLD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10673 | PLD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10674 | PLD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10675 | PLD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10676 | PLEC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10677 | PLEK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10678 | PLEK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10679 | PLEKHA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10680 | PLEKHA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10681 | PLEKHA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10682 | PLEKHA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10683 | PLEKHA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10684 | PLEKHA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10685 | PLEKHB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10686 | PLEKHB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10687 | PLEKHF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10688 | PLEKHF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10689 | PLEKHG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10690 | PLEKHG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10691 | PLEKHG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10692 | PLEKHG4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10693 | PLEKHG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10694 | PLEKHG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10695 | PLEKHH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10696 | PLEKHH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10697 | PLEKHM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10698 | PLEKHM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10699 | PLEKHN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10700 | PLEKHO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10701 | PLEKHO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10702 | PLEKHS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10703 | PLET1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10704 | PLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10705 | PLGRKT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10706 | PLIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10707 | PLIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10708 | PLIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10709 | PLIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10710 | PLIN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10711 | PLK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10712 | Plk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10713 | Plk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10714 | PLK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10715 | Plk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10716 | Plk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10717 | PLK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10718 | Plk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10719 | Plk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10720 | PLK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10721 | Plk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10722 | Plk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10723 | PLK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10724 | Plk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10725 | Plk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10726 | PLLP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10727 | PLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10728 | PLOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10729 | PLOD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10730 | PLOD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10731 | PLP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10732 | PLP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10733 | PLPBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10734 | PLPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10735 | PLPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10736 | PLPP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10737 | PLPP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10738 | PLRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10739 | PLS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10740 | PLS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10741 | PLSCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10742 | PLSCR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10743 | PLSCR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10744 | PLTP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10745 | PLVAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10746 | PLXDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10747 | PLXDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10748 | PLXNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10749 | PLXNA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10750 | PLXNA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10751 | PLXNA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10752 | PLXNB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10753 | PLXNB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10754 | PLXNB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10755 | PLXNC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10756 | PLXND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10757 | PM20D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10758 | PMAIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10759 | PMCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10760 | PMEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10761 | PMEPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10762 | PMF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10763 | PMFBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10764 | PMIS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10765 | PML Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10766 | PMM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10767 | PMM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10768 | PMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10769 | PMP22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10770 | PMPCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10771 | PMPCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10772 | PMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10773 | PMS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10774 | PMVK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10775 | PNCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10776 | PNISR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10777 | PNKD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10778 | PNKP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10779 | PNLDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10780 | PNLIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10781 | PNLIPRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10782 | PNLIPRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10783 | PNMA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10784 | PNMA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10785 | PNMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10786 | PNN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10787 | PNO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10788 | PNOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10789 | PNP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10790 | PNPLA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10791 | PNPLA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10792 | Pnpla2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10793 | PNPLA2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10794 | PNPLA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10795 | PNPLA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10796 | PNPLA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10797 | PNPLA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10798 | PNPLA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10799 | PNPLA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10800 | PNPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10801 | PNPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10802 | PNRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10803 | PNRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10804 | POC1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10805 | POC1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10806 | POC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10807 | PODN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10808 | PODXL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10809 | PODXL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10810 | POF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10811 | POFUT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10812 | POFUT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10813 | POGK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10814 | POGLUT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10815 | POGZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10816 | POLA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10817 | POLA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10818 | POLB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10819 | POLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10820 | POLD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10821 | POLD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10822 | POLD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10823 | POLDIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10824 | POLDIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10825 | POLE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10826 | POLE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10827 | POLE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10828 | POLE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10829 | POLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10830 | POLG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10831 | POLH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10832 | POLI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10833 | POLK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10834 | POLM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10835 | POLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10836 | POLQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10837 | POLR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10838 | POLR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10839 | POLR1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10840 | POLR1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10841 | POLR1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10842 | POLR2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10843 | POLR2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10844 | POLR2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10845 | POLR2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10846 | POLR2E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10847 | POLR2F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10848 | POLR2G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10849 | POLR2H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10850 | POLR2I Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10851 | POLR2J Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10852 | POLR2J3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10853 | POLR2K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10854 | POLR2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10855 | POLR3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10856 | POLR3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10857 | POLR3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10858 | POLR3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10859 | POLR3F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10860 | POLR3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10861 | POLR3H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10862 | POLR3K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10863 | POLRMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10864 | POM121 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10865 | POMC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10866 | POMGNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10867 | POMGNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10868 | POMK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10869 | POMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10870 | POMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10871 | POMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10872 | PON1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10873 | PON2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10874 | PON3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10875 | POP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10876 | POP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10877 | POP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10878 | POP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10879 | POPDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10880 | POR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10881 | PORCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10882 | Porcn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10883 | Porcn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10884 | POSTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10885 | POT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10886 | POTEA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10887 | POTEB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10888 | POTEC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10889 | POTED Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10890 | POTEE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10891 | POTEF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10892 | POTEG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10893 | POTEI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10894 | POTEJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10895 | POU1F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10896 | POU2AF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10897 | POU2F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10898 | POU2F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10899 | POU2F3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10900 | POU3F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10901 | POU3F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10902 | POU3F3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10903 | POU3F4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10904 | POU4F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10905 | POU4F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10906 | POU4F3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10907 | POU5F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10908 | Pou5f1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10909 | Pou5f1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10910 | POU5F1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10911 | POU5F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10912 | POU6F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10913 | POU6F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10914 | PPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10915 | PPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10916 | PPAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10917 | Ppan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10918 | Ppan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10919 | PPARA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10920 | Ppara Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10921 | Ppara Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10922 | PPARD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10923 | Ppard Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10924 | Ppard Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10925 | PPARG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10926 | Pparg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10927 | Pparg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10928 | PPARGC1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10929 | Ppargc1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10930 | Ppargc1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10931 | PPARGC1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10932 | PPAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10933 | PPBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10934 | PPCDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10935 | PPCS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10936 | PPDPF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10937 | PPEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10938 | PPEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10939 | PPFIA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10940 | PPFIA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10941 | PPFIA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10942 | PPFIA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10943 | PPFIBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10944 | PPFIBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10945 | PPHLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10946 | PPIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10947 | PPIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10948 | PPIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10949 | PPID Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10950 | PPIE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10951 | PPIF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10952 | PPIG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10953 | PPIH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10954 | PPIL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10955 | PPIL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10956 | PPIL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10957 | PPIL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10958 | PPIP5K2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10959 | PPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10960 | PPM1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10961 | PPM1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10962 | PPM1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10963 | PPM1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10964 | PPM1F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10965 | PPM1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10966 | PPM1H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10967 | PPM1J Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10968 | PPM1K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10969 | PPM1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10970 | PPM1M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10971 | PPME1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10972 | PPOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10973 | PPP1CA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10974 | PPP1CB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10975 | PPP1CC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10976 | PPP1R10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10977 | PPP1R11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10978 | PPP1R12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10979 | PPP1R12B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10980 | PPP1R12C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10981 | PPP1R13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10982 | PPP1R13L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10983 | PPP1R14A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10984 | PPP1R14B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10985 | PPP1R14C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10986 | PPP1R15A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10987 | PPP1R15B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10988 | PPP1R16A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10989 | PPP1R16B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10990 | PPP1R17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10991 | PPP1R18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10992 | PPP1R1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10993 | PPP1R1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10994 | PPP1R1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10995 | PPP1R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10996 | PPP1R21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10997 | PPP1R35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10998 | PPP1R3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS10999 | PPP1R3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11000 | PPP1R3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11001 | PPP1R3F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11002 | PPP1R3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11003 | PPP1R7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11004 | PPP1R8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11005 | PPP1R9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11006 | PPP1R9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11007 | PPP2CA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11008 | PPP2CB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11009 | PPP2R1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11010 | PPP2R1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11011 | PPP2R2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11012 | PPP2R2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11013 | PPP2R2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11014 | PPP2R2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11015 | PPP2R3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11016 | PPP2R3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11017 | PPP2R3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11018 | PPP2R5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11019 | PPP2R5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11020 | PPP2R5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11021 | PPP2R5D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11022 | PPP2R5E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11023 | PPP3CA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11024 | PPP3CB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11025 | PPP3CC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11026 | PPP3R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11027 | PPP3R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11028 | PPP4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11029 | PPP4R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11030 | PPP4R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11031 | PPP4R4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11032 | PPP5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11033 | PPP6C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11034 | PPP6R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11035 | PPP6R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11036 | PPP6R3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11037 | PPRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11038 | PPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11039 | PPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11040 | PPTC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11041 | PPWD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11042 | PPY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11043 | PQBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11044 | PRAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11045 | PRAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11046 | PRAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11047 | PRAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11048 | PRAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11049 | PRAME Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11050 | PRAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11051 | PRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11052 | PRB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11053 | PRB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11054 | PRB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11055 | PRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11056 | PRCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11057 | PRCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11058 | PRCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11059 | PRDM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11060 | PRDM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11061 | PRDM11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11062 | PRDM12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11063 | PRDM13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11064 | PRDM14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11065 | PRDM15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11066 | PRDM16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11067 | PRDM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11068 | PRDM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11069 | PRDM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11070 | PRDM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11071 | PRDM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11072 | PRDM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11073 | PRDM9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11074 | PRDX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11075 | PRDX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11076 | PRDX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11077 | PRDX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11078 | PRDX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11079 | PRDX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11080 | PREB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11081 | PRELID1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11082 | PRELP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11083 | PREP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11084 | PREPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11085 | PREX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11086 | PREX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11087 | PRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11088 | PRG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11089 | PRG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11090 | PRG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11091 | PRH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11092 | PRH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11093 | PRICKLE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11094 | PRICKLE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11095 | PRICKLE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11096 | PRIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11097 | PRIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11098 | PRIMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11099 | PRIMPOL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11100 | PRKAA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11101 | PRKAA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11102 | PRKAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11103 | PRKAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11104 | PRKACA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11105 | Prkaca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11106 | Prkaca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11107 | PRKACB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11108 | PRKACG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11109 | PRKAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11110 | PRKAG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11111 | PRKAG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11112 | PRKAR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11113 | PRKAR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11114 | PRKAR2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11115 | PRKAR2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11116 | PRKCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11117 | Prkca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11118 | Prkca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11119 | PRKCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11120 | Prkcb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11121 | Prkcb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11122 | PRKCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11123 | Prkcd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11124 | Prkcd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11125 | PRKCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11126 | Prkce Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11127 | Prkce Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11128 | PRKCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11129 | Prkcg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11130 | Prkcg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11131 | PRKCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11132 | Prkch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11133 | Prkch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11134 | PRKCI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11135 | Prkci Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11136 | Prkci Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11137 | PRKCQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11138 | Prkcq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11139 | Prkcq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11140 | PRKCSH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11141 | PRKCZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11142 | Prkcz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11143 | Prkcz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11144 | PRKD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11145 | Prkd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11146 | Prkd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11147 | PRKD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11148 | PRKD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11149 | Prkd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11150 | Prkd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11151 | PRKDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11152 | Prkdc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11153 | Prkdc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11154 | PRKG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11155 | PRKG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11156 | PRKN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11157 | PRKRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11158 | PRKRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11159 | PRKX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11160 | PRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11161 | PRLH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11162 | PRLHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11163 | PRLR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11164 | PRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11165 | PRM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11166 | PRM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11167 | PRMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11168 | Prmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11169 | Prmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11170 | PRMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11171 | PRMT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11172 | Prmt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11173 | Prmt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11174 | PRMT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11175 | Prmt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11176 | Prmt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11177 | PRMT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11178 | Prmt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11179 | PRMT6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11180 | PRMT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11181 | Prmt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11182 | Prmt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11183 | PRMT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11184 | Prmt8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11185 | Prmt8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11186 | PRMT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11187 | PRND Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11188 | PRNP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11189 | PROB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11190 | PROC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11191 | PROCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11192 | PRODH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11193 | PRODH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11194 | PROK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11195 | PROK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11196 | PROKR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11197 | PROKR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11198 | PROM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11199 | PROM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11200 | PROP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11201 | PRORP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11202 | PROS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11203 | PROX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11204 | PROX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11205 | PROZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11206 | PRPF19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11207 | PRPF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11208 | PRPF31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11209 | PRPF38B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11210 | PRPF39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11211 | PRPF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11212 | PRPF40A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11213 | PRPF40B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11214 | PRPF4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11215 | PRPF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11216 | PRPF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11217 | PRPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11218 | PRPH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11219 | PRPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11220 | PRPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11221 | PRPSAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11222 | PRR11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11223 | PRR12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11224 | PRR14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11225 | PRR15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11226 | PRR16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11227 | PRR20A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11228 | PRR21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11229 | PRR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11230 | PRR35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11231 | PRR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11232 | PRR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11233 | PRR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11234 | PRR9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11235 | PRRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11236 | PRRC2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11237 | PRRC2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11238 | PRRC2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11239 | PRRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11240 | PRRG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11241 | PRRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11242 | PRRT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11243 | PRRX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11244 | PRRX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11245 | PRSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11246 | PRSS12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11247 | PRSS16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11248 | PRSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11249 | PRSS21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11250 | PRSS22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11251 | PRSS23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11252 | PRSS27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11253 | PRSS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11254 | PRSS33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11255 | PRSS35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11256 | PRSS53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11257 | PRSS56 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11258 | PRSS57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11259 | PRSS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11260 | PRTFDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11261 | PRTG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11262 | PRTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11263 | PRUNE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11264 | PRUNE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11265 | PRX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11266 | PRXL2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11267 | PRY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11268 | PRY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11269 | PSAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11270 | PSAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11271 | PSCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11272 | PSD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11273 | PSD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11274 | PSD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11275 | PSD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11276 | PSEN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11277 | PSEN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11278 | PSENEN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11279 | PSG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11280 | PSG11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11281 | PSG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11282 | PSG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11283 | PSG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11284 | PSG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11285 | PSG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11286 | PSG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11287 | PSG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11288 | PSG9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11289 | PSIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11290 | PSKH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11291 | PSMA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11292 | PSMA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11293 | PSMA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11294 | PSMA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11295 | PSMA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11296 | PSMA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11297 | PSMA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11298 | PSMA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11299 | PSMB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11300 | PSMB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11301 | PSMB11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11302 | PSMB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11303 | PSMB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11304 | PSMB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11305 | PSMB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11306 | PSMB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11307 | PSMB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11308 | PSMB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11309 | PSMB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11310 | PSMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11311 | PSMC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11312 | PSMC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11313 | PSMC3IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11314 | PSMC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11315 | PSMC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11316 | PSMC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11317 | PSMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11318 | PSMD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11319 | PSMD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11320 | PSMD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11321 | PSMD13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11322 | PSMD14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11323 | PSMD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11324 | PSMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11325 | PSMD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11326 | PSMD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11327 | PSMD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11328 | PSMD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11329 | PSMD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11330 | PSMD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11331 | PSME1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11332 | PSME2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11333 | PSME3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11334 | PSME4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11335 | PSMF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11336 | PSMG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11337 | PSMG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11338 | PSMG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11339 | PSMG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11340 | PSPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11341 | PSPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11342 | PSPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11343 | PSRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11344 | PSTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11345 | PSTPIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11346 | PSTPIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11347 | PTAFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11348 | Ptafr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11349 | Ptafr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11350 | PTAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11351 | PTBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11352 | PTBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11353 | PTBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11354 | PTCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11355 | PTCD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11356 | PTCH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11357 | PTCH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11358 | PTCHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11359 | PTCHD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11360 | PTCRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11361 | PTDSS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11362 | PTDSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11363 | PTEN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11364 | Pten Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11365 | Pten Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11366 | PTER Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11367 | PTF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11368 | PTGDR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11369 | Ptgdr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11370 | PTGDR Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11371 | PTGDR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11372 | Ptgdr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11373 | Ptgdr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11374 | PTGDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11375 | PTGER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11376 | PTGER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11377 | PTGER3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11378 | PTGER4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11379 | PTGES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11380 | PTGES2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11381 | PTGES3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11382 | PTGFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11383 | Ptgfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11384 | Ptgfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11385 | PTGFRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11386 | PTGIR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11387 | Ptgir Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11388 | Ptgir Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11389 | PTGIS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11390 | PTGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11391 | PTGR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11392 | PTGS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11393 | PTGS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11394 | PTH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11395 | PTH1R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11396 | PTH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11397 | PTH2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11398 | PTHLH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11399 | PTK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11400 | Ptk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11401 | Ptk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11402 | PTK2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11403 | PTK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11404 | PTK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11405 | PTMA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11406 | PTMS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11407 | PTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11408 | PTOV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11409 | PTP4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11410 | PTP4A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11411 | PTP4A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11412 | PTPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11413 | PTPDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11414 | PTPMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11415 | PTPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11416 | PTPN11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11417 | PTPN12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11418 | PTPN13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11419 | PTPN14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11420 | PTPN18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11421 | PTPN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11422 | PTPN20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11423 | PTPN21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11424 | PTPN22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11425 | PTPN23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11426 | PTPN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11427 | PTPN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11428 | PTPN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11429 | PTPN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11430 | PTPN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11431 | PTPN9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11432 | PTPRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11433 | PTPRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11434 | PTPRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11435 | PTPRCAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11436 | PTPRD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11437 | PTPRE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11438 | PTPRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11439 | PTPRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11440 | PTPRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11441 | PTPRJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11442 | PTPRK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11443 | PTPRM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11444 | PTPRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11445 | PTPRN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11446 | PTPRO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11447 | PTPRQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11448 | PTPRR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11449 | PTPRS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11450 | PTPRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11451 | PTPRU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11452 | PTPRZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11453 | PTRH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11454 | PTRH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11455 | PTS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11456 | PTTG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11457 | PTX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11458 | PTX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11459 | PUDP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11460 | PUF60 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11461 | PUM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11462 | PUM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11463 | PUM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11464 | PURA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11465 | PURB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11466 | PURG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11467 | PUS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11468 | PUS10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11469 | PUS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11470 | PUS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11471 | PUSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11472 | PVALB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11473 | PVR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11474 | PVRIG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11475 | PWP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11476 | PWP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11477 | PWWP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11478 | PXDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11479 | PXDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11480 | PXDNL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11481 | PXK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11482 | PXMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11483 | PXMP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11484 | PXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11485 | PYCARD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11486 | PYCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11487 | PYCR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11488 | PYGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11489 | PYGL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11490 | PYGM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11491 | PYGO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11492 | PYGO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11493 | PYHIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11494 | PYM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11495 | PYROXD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11496 | PYURF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11497 | PYY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11498 | PZP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11499 | QDPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11500 | QKI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11501 | QPCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11502 | QPCTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11503 | QPRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11504 | QRFP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11505 | QRFPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11506 | QRICH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11507 | QRSL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11508 | QSER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11509 | QSOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11510 | QSOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11511 | QTRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11512 | R3HDM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11513 | R3HDML Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11514 | RAB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11515 | RAB11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11516 | RAB11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11517 | RAB11FIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11518 | RAB11FIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11519 | RAB11FIP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11520 | RAB11FIP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11521 | RAB12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11522 | RAB13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11523 | RAB14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11524 | RAB15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11525 | RAB17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11526 | RAB18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11527 | RAB19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11528 | RAB1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11529 | RAB1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11530 | RAB20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11531 | RAB21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11532 | RAB22A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11533 | RAB23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11534 | RAB24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11535 | RAB25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11536 | RAB26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11537 | RAB27A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11538 | RAB27B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11539 | RAB28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11540 | RAB29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11541 | RAB2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11542 | RAB2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11543 | RAB30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11544 | RAB31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11545 | RAB32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11546 | RAB33A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11547 | RAB33B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11548 | RAB34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11549 | RAB35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11550 | RAB36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11551 | RAB37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11552 | RAB38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11553 | RAB39A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11554 | RAB39B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11555 | RAB3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11556 | RAB3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11557 | RAB3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11558 | RAB3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11559 | RAB3GAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11560 | RAB3GAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11561 | RAB3IL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11562 | RAB3IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11563 | RAB40B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11564 | RAB40C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11565 | RAB41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11566 | RAB42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11567 | RAB43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11568 | RAB44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11569 | RAB4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11570 | RAB4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11571 | RAB5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11572 | RAB5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11573 | RAB5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11574 | RAB6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11575 | RAB6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11576 | RAB7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11577 | RAB7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11578 | RAB8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11579 | RAB8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11580 | RAB9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11581 | RABAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11582 | RABEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11583 | RABEP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11584 | RABGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11585 | RABGAP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11586 | RABGEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11587 | RABGGTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11588 | RABGGTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11589 | RABIF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11590 | RABL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11591 | RAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11592 | RAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11593 | RAC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11594 | RACGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11595 | RACK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11596 | RAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11597 | RAD17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11598 | RAD18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11599 | RAD21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11600 | RAD23A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11601 | RAD23B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11602 | RAD50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11603 | RAD51 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11604 | Rad51 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11605 | Rad51 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11606 | RAD51AP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11607 | RAD51B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11608 | RAD51C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11609 | RAD51D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11610 | RAD52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11611 | RAD54B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11612 | RAD54L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11613 | RAD54L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11614 | RAD9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11615 | RADIL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11616 | RADX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11617 | RAE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11618 | RAET1E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11619 | RAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11620 | Raf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11621 | Raf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11622 | RAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11623 | RAG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11624 | RAI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11625 | RAI14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11626 | RAI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11627 | RALA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11628 | RALB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11629 | RALBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11630 | RALGAPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11631 | RALGAPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11632 | RALGAPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11633 | RALGDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11634 | RALGPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11635 | RALY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11636 | RALYL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11637 | RAMAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11638 | RAMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11639 | RAMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11640 | RAMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11641 | RAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11642 | RANBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11643 | RANBP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11644 | RANBP17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11645 | RANBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11646 | RANBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11647 | RANBP3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11648 | RANBP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11649 | RANBP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11650 | RANGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11651 | RANGRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11652 | RAP1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11653 | RAP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11654 | RAP1GAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11655 | RAP1GAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11656 | RAP1GDS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11657 | RAP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11658 | RAP2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11659 | RAP2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11660 | RAPGEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11661 | RAPGEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11662 | RAPGEF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11663 | RAPGEF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11664 | RAPGEF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11665 | RAPGEF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11666 | RAPGEFL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11667 | RAPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11668 | RAPSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11669 | RARA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11670 | Rara Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11671 | Rara Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11672 | RARB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11673 | RARG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11674 | RARRES1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11675 | RARRES2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11676 | RARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11677 | RARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11678 | RASA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11679 | RASA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11680 | RASA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11681 | RASA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11682 | RASAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11683 | RASAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11684 | RASAL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11685 | RASD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11686 | RASD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11687 | RASEF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11688 | RASGEF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11689 | RASGEF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11690 | RASGEF1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11691 | RASGRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11692 | RASGRF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11693 | RASGRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11694 | RASGRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11695 | RASGRP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11696 | RASGRP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11697 | RASIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11698 | RASL11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11699 | RASL11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11700 | RASL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11701 | RASSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11702 | RASSF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11703 | RASSF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11704 | RASSF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11705 | RASSF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11706 | RASSF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11707 | RASSF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11708 | RASSF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11709 | RAVER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11710 | RAVER2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11711 | RAX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11712 | RAX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11713 | RB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11714 | RB1CC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11715 | RBAK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11716 | RBBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11717 | RBBP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11718 | RBBP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11719 | RBBP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11720 | RBBP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11721 | RBBP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11722 | RBCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11723 | RBFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11724 | RBFOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11725 | RBFOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11726 | RBFOX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11727 | RBIS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11728 | RBKS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11729 | RBL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11730 | RBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11731 | RBM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11732 | RBM11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11733 | RBM12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11734 | RBM14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11735 | RBM15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11736 | RBM15B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11737 | RBM17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11738 | RBM19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11739 | RBM20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11740 | RBM22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11741 | RBM23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11742 | RBM24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11743 | RBM25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11744 | RBM26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11745 | RBM27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11746 | RBM28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11747 | RBM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11748 | RBM33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11749 | RBM34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11750 | RBM38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11751 | RBM39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11752 | RBM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11753 | RBM43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11754 | RBM45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11755 | RBM47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11756 | RBM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11757 | RBM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11758 | RBM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11759 | RBM8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11760 | RBMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11761 | RBMS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11762 | RBMS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11763 | RBMX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11764 | RBMXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11765 | RBMXL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11766 | RBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11767 | RBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11768 | RBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11769 | RBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11770 | RBP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11771 | RBP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11772 | RBPJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11773 | RBPJL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11774 | RBPMS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11775 | RBSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11776 | RBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11777 | RC3H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11778 | RC3H2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11779 | RCAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11780 | RCAN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11781 | RCAN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11782 | RCBTB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11783 | RCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11784 | RCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11785 | RCE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11786 | RCHY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11787 | RCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11788 | RCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11789 | RCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11790 | RCN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11791 | RCOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11792 | RCOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11793 | RCOR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11794 | RCSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11795 | RCVRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11796 | RD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11797 | RD3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11798 | RDH10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11799 | RDH11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11800 | RDH12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11801 | RDH13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11802 | RDH16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11803 | RDH5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11804 | RDH8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11805 | RDM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11806 | RDX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11807 | REC114 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11808 | REC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11809 | RECK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11810 | RECQL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11811 | RECQL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11812 | RECQL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11813 | REEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11814 | REEP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11815 | REEP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11816 | REEP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11817 | REEP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11818 | REG1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11819 | REG1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11820 | REG3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11821 | REG3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11822 | REG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11823 | REL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11824 | Rel Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11825 | Rel Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11826 | RELA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11827 | Rela Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11828 | Rela Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11829 | RELB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11830 | Relb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11831 | Relb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11832 | RELCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11833 | RELL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11834 | RELL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11835 | RELN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11836 | RELT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11837 | REM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11838 | REM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11839 | REN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11840 | Ren Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11841 | Ren1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11842 | RENBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11843 | REP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11844 | REPIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11845 | REPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11846 | REPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11847 | RER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11848 | RERE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11849 | RERG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11850 | RERGL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11851 | RESF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11852 | RESP18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11853 | REST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11854 | RET Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11855 | Ret Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11856 | Ret Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11857 | RETN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11858 | RETNLB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11859 | RETREG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11860 | RETSAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11861 | REV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11862 | REV3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11863 | REXO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11864 | REXO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11865 | RFC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11866 | RFC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11867 | RFC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11868 | RFC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11869 | RFC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11870 | RFESD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11871 | RFFL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11872 | RFK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11873 | RFLNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11874 | RFLNB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11875 | RFNG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11876 | RFT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11877 | RFTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11878 | RFWD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11879 | RFX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11880 | RFX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11881 | RFX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11882 | RFX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11883 | RFX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11884 | RFX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11885 | RFX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11886 | RFX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11887 | RFXANK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11888 | RFXAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11889 | RGCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11890 | RGL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11891 | RGL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11892 | RGL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11893 | RGL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11894 | RGMA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11895 | RGMB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11896 | RGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11897 | RGP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11898 | RGPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11899 | RGPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11900 | RGPD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11901 | RGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11902 | RGS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11903 | RGS10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11904 | RGS11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11905 | RGS12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11906 | RGS13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11907 | RGS14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11908 | RGS16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11909 | Rgs16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11910 | Rgs16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11911 | RGS17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11912 | RGS18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11913 | RGS19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11914 | Rgs19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11915 | Rgs19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11916 | RGS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11917 | RGS20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11918 | RGS22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11919 | RGS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11920 | RGS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11921 | Rgs4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11922 | Rgs4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11923 | RGS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11924 | RGS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11925 | RGS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11926 | RGS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11927 | Rgs8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11928 | Rgs8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11929 | RGS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11930 | RHAG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11931 | RHBDD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11932 | RHBDD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11933 | RHBDD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11934 | RHBDF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11935 | RHBDF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11936 | RHBDL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11937 | RHBDL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11938 | RHBG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11939 | RHCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11940 | RHCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11941 | RHD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11942 | RHEB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11943 | RHEX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11944 | RHO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11945 | RHOA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11946 | RHOB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11947 | RHOBTB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11948 | RHOBTB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11949 | RHOBTB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11950 | RHOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11951 | RHOD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11952 | RHOF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11953 | RHOG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11954 | RHOH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11955 | RHOJ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11956 | RHOQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11957 | RHOT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11958 | RHOT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11959 | RHOU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11960 | RHOV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11961 | RHPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11962 | RHPN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11963 | RIBC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11964 | RIBC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11965 | RIC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11966 | RIC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11967 | RIC8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11968 | RIC8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11969 | RICTOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11970 | RIDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11971 | RIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11972 | RIGI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11973 | RILP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11974 | RILPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11975 | RILPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11976 | RIMBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11977 | RIMBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11978 | RIMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11979 | RIMS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11980 | RIMS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11981 | RIMS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11982 | RIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11983 | RIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11984 | RIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11985 | RING1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11986 | RINL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11987 | RINT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11988 | RIOK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11989 | RIOK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11990 | RIOK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11991 | RIOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11992 | RIPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11993 | Ripk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11994 | Ripk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11995 | RIPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11996 | Ripk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11997 | Ripk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11998 | RIPK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS11999 | Ripk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12000 | Ripk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12001 | RIPK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12002 | RIPOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12003 | RIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12004 | RIT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12005 | RITA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12006 | RLBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12007 | RLF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12008 | RLIM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12009 | RLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12010 | RLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12011 | RLN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12012 | RMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12013 | RMDN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12014 | RMI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12015 | RMI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12016 | RMND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12017 | RMND5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12018 | RNASE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12019 | RNASE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12020 | RNASE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12021 | RNASE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12022 | RNASE6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12023 | RNASE7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12024 | RNASEH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12025 | RNASEH2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12026 | RNASEH2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12027 | RNASEH2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12028 | RNASEK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12029 | RNASEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12030 | RNASET2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12031 | RND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12032 | RND2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12033 | RND3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12034 | RNF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12035 | RNF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12036 | RNF111 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12037 | RNF112 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12038 | RNF113A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12039 | RNF114 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12040 | RNF115 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12041 | RNF121 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12042 | RNF122 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12043 | RNF123 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12044 | RNF125 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12045 | RNF126 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12046 | RNF128 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12047 | RNF13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12048 | RNF130 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12049 | RNF135 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12050 | RNF138 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12051 | RNF139 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12052 | RNF14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12053 | RNF144A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12054 | RNF144B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12055 | RNF145 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12056 | RNF146 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12057 | RNF149 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12058 | RNF150 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12059 | RNF152 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12060 | RNF157 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12061 | RNF167 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12062 | RNF168 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12063 | RNF169 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12064 | RNF17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12065 | RNF170 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12066 | RNF181 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12067 | RNF182 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12068 | RNF183 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12069 | RNF185 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12070 | RNF186 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12071 | RNF187 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12072 | RNF19A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12073 | RNF19B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12074 | RNF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12075 | RNF20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12076 | RNF207 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12077 | RNF212 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12078 | RNF213 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12079 | RNF214 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12080 | RNF216 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12081 | RNF217 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12082 | RNF220 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12083 | RNF24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12084 | RNF25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12085 | RNF26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12086 | RNF31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12087 | RNF34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12088 | RNF38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12089 | RNF39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12090 | RNF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12091 | RNF40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12092 | RNF41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12093 | RNF43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12094 | RNF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12095 | RNF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12096 | RNF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12097 | RNF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12098 | RNFT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12099 | RNGTT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12100 | RNH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12101 | RNLS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12102 | RNMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12103 | RNPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12104 | RNPEP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12105 | Rnpep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12106 | Rnpep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12107 | RNPEPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12108 | RNPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12109 | RO60 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12110 | ROBO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12111 | ROBO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12112 | ROBO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12113 | ROBO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12114 | ROCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12115 | Rock1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12116 | Rock1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12117 | ROCK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12118 | Rock2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12119 | Rock2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12120 | ROGDI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12121 | ROM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12122 | ROMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12123 | ROPN1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12124 | ROR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12125 | ROR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12126 | RORA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12127 | Rora Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12128 | RORA Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12129 | RORB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12130 | Rorb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12131 | Rorb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12132 | RORC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12133 | Rorc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12134 | Rorc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12135 | ROS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12136 | Ros1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12137 | ROS1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12138 | RP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12139 | RP1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12140 | RP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12141 | RP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12142 | RPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12143 | RPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12144 | RPA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12145 | RPA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12146 | RPAIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12147 | RPAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12148 | RPAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12149 | RPAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12150 | RPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12151 | RPE65 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12152 | RPF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12153 | RPF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12154 | RPGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12155 | RPGRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12156 | RPGRIP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12157 | RPH3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12158 | RPH3AL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12159 | RPIA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12160 | RPL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12161 | RPL10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12162 | RPL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12163 | RPL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12164 | RPL13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12165 | RPL13A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12166 | RPL14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12167 | RPL15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12168 | RPL17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12169 | RPL18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12170 | RPL18A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12171 | RPL19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12172 | RPL21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12173 | RPL22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12174 | RPL22L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12175 | RPL23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12176 | RPL23A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12177 | RPL24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12178 | RPL26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12179 | RPL26L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12180 | RPL27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12181 | RPL27A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12182 | RPL28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12183 | RPL29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12184 | RPL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12185 | RPL30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12186 | RPL31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12187 | RPL32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12188 | RPL34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12189 | RPL35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12190 | RPL35A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12191 | RPL36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12192 | RPL36A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12193 | RPL37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12194 | RPL37A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12195 | RPL38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12196 | RPL39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12197 | RPL39L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12198 | RPL3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12199 | RPL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12200 | RPL41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12201 | RPL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12202 | RPL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12203 | RPL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12204 | RPL7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12205 | RPL8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12206 | RPL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12207 | RPLP0 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12208 | RPLP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12209 | RPLP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12210 | RPN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12211 | RPN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12212 | RPP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12213 | RPP21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12214 | RPP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12215 | RPP30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12216 | RPP40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12217 | RPRD1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12218 | RPRD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12219 | RPRM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12220 | RPS10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12221 | RPS11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12222 | RPS12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12223 | RPS13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12224 | RPS14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12225 | RPS15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12226 | RPS15A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12227 | RPS16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12228 | RPS17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12229 | RPS18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12230 | RPS19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12231 | RPS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12232 | RPS20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12233 | RPS21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12234 | RPS23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12235 | RPS24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12236 | RPS25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12237 | RPS26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12238 | RPS27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12239 | RPS27A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12240 | RPS28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12241 | RPS29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12242 | RPS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12243 | RPS3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12244 | RPS4X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12245 | RPS4Y1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12246 | RPS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12247 | RPS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12248 | RPS6KA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12249 | Rps6ka1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12250 | Rps6ka1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12251 | RPS6KA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12252 | Rps6ka2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12253 | Rps6ka2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12254 | RPS6KA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12255 | Rps6ka3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12256 | Rps6ka3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12257 | RPS6KA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12258 | RPS6KA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12259 | RPS6KA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12260 | Rps6ka6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12261 | Rps6ka6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12262 | RPS6KB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12263 | Rps6kb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12264 | Rps6kb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12265 | RPS6KB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12266 | Rps6kb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12267 | Rps6kb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12268 | RPS6KC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12269 | RPS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12270 | RPS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12271 | RPS9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12272 | RPSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12273 | RPTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12274 | RPTOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12275 | RRAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12276 | RRAGA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12277 | RRAGB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12278 | RRAGC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12279 | RRAGD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12280 | RRAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12281 | RRAS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12282 | RRBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12283 | RREB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12284 | RRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12285 | RRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12286 | RRM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12287 | RRM2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12288 | RRN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12289 | RRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12290 | RRP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12291 | RRP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12292 | RRP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12293 | RRP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12294 | RRS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12295 | RS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12296 | RSAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12297 | RSAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12298 | RSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12299 | RSKR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12300 | RSL1D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12301 | RSL24D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12302 | RSPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12303 | RSPH4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12304 | RSPH9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12305 | RSPO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12306 | RSPO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12307 | RSPO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12308 | RSPO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12309 | RSPRY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12310 | RSRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12311 | RSRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12312 | RSRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12313 | RSU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12314 | RTBDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12315 | RTCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12316 | RTCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12317 | RTEL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12318 | RTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12319 | RTF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12320 | RTKN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12321 | RTKN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12322 | RTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12323 | RTL10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12324 | RTL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12325 | RTL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12326 | RTL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12327 | RTL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12328 | RTL9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12329 | RTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12330 | RTN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12331 | RTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12332 | RTN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12333 | RTN4IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12334 | RTN4R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12335 | RTN4RL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12336 | RTP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12337 | RTP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12338 | RTP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12339 | RTP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12340 | RTP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12341 | RTRAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12342 | RTTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12343 | RUBCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12344 | RUFY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12345 | RUFY3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12346 | RUFY4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12347 | RUNDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12348 | RUNDC3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12349 | RUNX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12350 | RUNX1T1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12351 | RUNX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12352 | RUNX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12353 | RUSC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12354 | RUVBL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12355 | RUVBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12356 | RWDD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12357 | RXFP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12358 | RXFP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12359 | RXFP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12360 | RXFP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12361 | RXRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12362 | RXRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12363 | RXRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12364 | Rxrg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12365 | RXRG Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12366 | RYBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12367 | RYK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12368 | RYR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12369 | RYR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12370 | RYR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12371 | S100A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12372 | S100A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12373 | S100A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12374 | S100A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12375 | S100A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12376 | S100A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12377 | S100A16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12378 | S100A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12379 | S100A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12380 | S100A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12381 | S100A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12382 | S100A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12383 | S100A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12384 | S100A7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12385 | S100A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12386 | S100A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12387 | S100B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12388 | S100G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12389 | S100P Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12390 | S100Z Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12391 | S1PR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12392 | S1pr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12393 | S1pr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12394 | S1PR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12395 | S1pr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12396 | S1pr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12397 | S1PR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12398 | S1pr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12399 | S1pr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12400 | S1PR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12401 | S1pr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12402 | S1pr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12403 | S1PR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12404 | S1pr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12405 | S1pr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12406 | SAA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12407 | SAA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12408 | SAA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12409 | SAAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12410 | SACM1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12411 | SACS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12412 | SAE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12413 | SAFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12414 | SAFB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12415 | SAG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12416 | SAGE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12417 | SALL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12418 | SALL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12419 | SALL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12420 | SALL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12421 | SAMD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12422 | SAMD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12423 | SAMD11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12424 | SAMD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12425 | SAMD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12426 | SAMD4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12427 | SAMD4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12428 | SAMD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12429 | SAMD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12430 | SAMD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12431 | SAMD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12432 | SAMD9L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12433 | SAMHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12434 | SAMM50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12435 | SAMSN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12436 | SANBR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12437 | SAP130 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12438 | SAP18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12439 | SAP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12440 | SAP30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12441 | SAP30BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12442 | SAR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12443 | SAR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12444 | SARAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12445 | SARDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12446 | SARM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12447 | SARNP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12448 | SARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12449 | SARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12450 | SART1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12451 | SART3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12452 | SASH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12453 | SASH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12454 | SASS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12455 | SAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12456 | SAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12457 | SATB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12458 | SATB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12459 | SATL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12460 | SAV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12461 | SAXO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12462 | SAXO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12463 | SBDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12464 | SBF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12465 | SBF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12466 | SBK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12467 | SBK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12468 | SBK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12469 | SBNO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12470 | SBNO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12471 | SBSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12472 | SBSPON Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12473 | SC5D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12474 | SCAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12475 | SCAF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12476 | SCAF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12477 | SCAI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12478 | SCAMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12479 | SCAMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12480 | SCAMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12481 | SCAMP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12482 | SCAMP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12483 | SCAND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12484 | SCAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12485 | SCAPER Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12486 | SCARA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12487 | SCARA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12488 | SCARB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12489 | SCARB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12490 | SCARF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12491 | SCARF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12492 | SCART1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12493 | SCCPDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12494 | SCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12495 | Scd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12496 | Scd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12497 | SCD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12498 | SCEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12499 | SCFD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12500 | SCFD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12501 | SCG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12502 | SCG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12503 | SCG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12504 | SCGB1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12505 | SCGB2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12506 | SCGB2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12507 | SCGB3A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12508 | SCGB3A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12509 | SCGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12510 | SCHIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12511 | SCIMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12512 | SCIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12513 | SCLT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12514 | SCLY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12515 | SCMH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12516 | SCML1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12517 | SCML2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12518 | SCML4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12519 | SCN10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12520 | Scn10a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12521 | Scn10a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12522 | SCN11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12523 | Scn11a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12524 | Scn11a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12525 | SCN1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12526 | Scn1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12527 | SCN1A Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12528 | SCN1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12529 | SCN2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12530 | Scn2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12531 | Scn2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12532 | SCN2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12533 | SCN3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12534 | Scn3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12535 | Scn3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12536 | SCN3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12537 | SCN4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12538 | Scn4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12539 | Scn4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12540 | SCN4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12541 | SCN5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12542 | Scn5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12543 | Scn5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12544 | SCN7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12545 | SCN8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12546 | Scn8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12547 | Scn8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12548 | SCN9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12549 | Scn9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12550 | Scn9a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12551 | SCNM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12552 | SCNN1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12553 | SCNN1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12554 | SCNN1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12555 | SCNN1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12556 | SCO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12557 | SCO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12558 | SCOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12559 | SCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12560 | SCPEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12561 | SCRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12562 | SCRIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12563 | SCRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12564 | SCRN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12565 | SCRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12566 | SCRT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12567 | SCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12568 | SCTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12569 | Sctr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12570 | Sctr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12571 | SCUBE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12572 | SCUBE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12573 | SCUBE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12574 | SCX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12575 | SCYL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12576 | SCYL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12577 | SCYL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12578 | SDAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12579 | SDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12580 | SDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12581 | SDC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12582 | SDC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12583 | SDCBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12584 | SDCBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12585 | SDCCAG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12586 | SDE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12587 | SDF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12588 | SDF2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12589 | SDF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12590 | SDHA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12591 | SDHAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12592 | SDHAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12593 | SDHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12594 | SDHC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12595 | SDHD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12596 | SDK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12597 | SDR16C5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12598 | SDR9C7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12599 | SDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12600 | SDSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12601 | SEA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12602 | SEBOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12603 | SEC11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12604 | SEC11C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12605 | SEC13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12606 | SEC14L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12607 | SEC14L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12608 | SEC14L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12609 | SEC16A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12610 | SEC16B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12611 | SEC22B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12612 | SEC23A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12613 | SEC23B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12614 | SEC23IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12615 | SEC24A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12616 | SEC24B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12617 | SEC24C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12618 | SEC24D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12619 | SEC31A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12620 | SEC31B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12621 | SEC61A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12622 | SEC61B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12623 | SEC61G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12624 | SEC62 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12625 | SEC63 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12626 | SECISBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12627 | SECISBP2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12628 | SECTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12629 | SEH1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12630 | SEL1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12631 | SEL1L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12632 | SELE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12633 | SELENBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12634 | SELENOF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12635 | SELENOH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12636 | SELENOI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12637 | SELENOK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12638 | SELENOM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12639 | SELENON Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12640 | SELENOO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12641 | SELENOP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12642 | SELENOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12643 | SELENOT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12644 | SELENOV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12645 | SELENOW Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12646 | SELL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12647 | SELP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12648 | SELPLG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12649 | SEM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12650 | SEMA3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12651 | SEMA3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12652 | SEMA3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12653 | SEMA3D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12654 | SEMA3E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12655 | SEMA3F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12656 | SEMA3G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12657 | SEMA4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12658 | SEMA4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12659 | SEMA4C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12660 | SEMA4D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12661 | SEMA4F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12662 | SEMA4G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12663 | SEMA5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12664 | SEMA5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12665 | SEMA6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12666 | SEMA6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12667 | SEMA6D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12668 | SEMA7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12669 | SEMG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12670 | SEMG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12671 | SENP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12672 | SENP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12673 | SENP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12674 | SENP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12675 | SENP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12676 | SENP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12677 | SENP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12678 | SEPHS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12679 | SEPHS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12680 | SEPSECS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12681 | SEPTIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12682 | SEPTIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12683 | SEPTIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12684 | SEPTIN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12685 | SEPTIN9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12686 | SERAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12687 | SERBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12688 | SERF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12689 | SERGEF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12690 | SERINC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12691 | SERINC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12692 | SERINC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12693 | SERINC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12694 | SERP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12695 | SERP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12696 | SERPINA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12697 | SERPINA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12698 | SERPINA12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12699 | SERPINA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12700 | SERPINA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12701 | SERPINA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12702 | SERPINA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12703 | SERPINA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12704 | SERPINA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12705 | SERPINB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12706 | SERPINB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12707 | SERPINB11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12708 | SERPINB12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12709 | SERPINB13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12710 | SERPINB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12711 | SERPINB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12712 | SERPINB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12713 | SERPINB5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12714 | SERPINB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12715 | SERPINB7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12716 | SERPINB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12717 | SERPINB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12718 | SERPINC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12719 | SERPIND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12720 | SERPINE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12721 | Serpine1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12722 | Serpine1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12723 | SERPINE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12724 | SERPINE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12725 | SERPINF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12726 | SERPINF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12727 | SERPING1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12728 | SERPINH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12729 | SERPINI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12730 | SERPINI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12731 | SERTAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12732 | SERTAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12733 | SERTAD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12734 | SESN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12735 | SESN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12736 | SESN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12737 | SESTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12738 | SET Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12739 | SETBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12740 | SETD1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12741 | SETD1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12742 | SETD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12743 | SETD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12744 | SETD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12745 | SETD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12746 | SETD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12747 | SETD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12748 | SETDB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12749 | SETDB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12750 | SETMAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12751 | SETSIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12752 | SETX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12753 | SEZ6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12754 | SEZ6L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12755 | SEZ6L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12756 | SF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12757 | SF3A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12758 | SF3A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12759 | SF3A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12760 | SF3B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12761 | SF3B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12762 | SF3B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12763 | SF3B4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12764 | SF3B5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12765 | SF3B6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12766 | SFI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12767 | SFMBT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12768 | SFMBT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12769 | SFN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12770 | SFPQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12771 | SFR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12772 | SFRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12773 | Sfrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12774 | Sfrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12775 | SFRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12776 | SFRP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12777 | SFRP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12778 | SFSWAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12779 | SFTA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12780 | SFTPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12781 | SFTPA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12782 | SFTPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12783 | SFTPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12784 | SFTPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12785 | SFXN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12786 | SFXN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12787 | SFXN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12788 | SFXN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12789 | SFXN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12790 | SGCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12791 | SGCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12792 | SGCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12793 | SGCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12794 | SGCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12795 | SGCZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12796 | SGF29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12797 | SGIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12798 | SGK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12799 | Sgk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12800 | Sgk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12801 | SGK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12802 | SGK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12803 | Sgk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12804 | SGK3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12805 | SGMS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12806 | SGMS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12807 | SGO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12808 | SGO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12809 | SGPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12810 | SGPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12811 | SGPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12812 | SGSH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12813 | SGSM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12814 | SGSM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12815 | SGSM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12816 | SGTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12817 | SGTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12818 | SH2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12819 | SH2B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12820 | SH2B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12821 | SH2D1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12822 | SH2D1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12823 | SH2D2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12824 | SH2D3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12825 | SH2D4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12826 | SH3BGR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12827 | SH3BGRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12828 | SH3BGRL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12829 | SH3BGRL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12830 | SH3BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12831 | SH3BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12832 | SH3BP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12833 | SH3BP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12834 | SH3D19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12835 | SH3D21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12836 | SH3GL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12837 | SH3GL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12838 | SH3GL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12839 | SH3GLB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12840 | SH3GLB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12841 | SH3KBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12842 | SH3PXD2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12843 | SH3PXD2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12844 | SH3RF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12845 | SH3RF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12846 | SH3RF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12847 | SH3TC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12848 | SH3TC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12849 | SH3YL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12850 | SHANK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12851 | SHANK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12852 | SHANK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12853 | SHARPIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12854 | SHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12855 | SHBG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12856 | SHC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12857 | SHC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12858 | SHC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12859 | SHC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12860 | SHCBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12861 | SHD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12862 | SHE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12863 | SHF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12864 | SHFL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12865 | SHH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12866 | SHISA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12867 | SHISA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12868 | SHISA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12869 | SHISA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12870 | SHISA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12871 | SHISA9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12872 | SHKBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12873 | SHLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12874 | SHLD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12875 | SHLD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12876 | SHMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12877 | SHMT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12878 | SHOC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12879 | SHOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12880 | SHOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12881 | SHPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12882 | SHPRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12883 | SHQ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12884 | SHROOM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12885 | SHROOM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12886 | SHROOM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12887 | SHROOM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12888 | SHTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12889 | SI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12890 | SIAE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12891 | SIAH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12892 | SIAH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12893 | SIAH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12894 | SIDT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12895 | SIDT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12896 | SIGIRR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12897 | SIGLEC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12898 | SIGLEC10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12899 | SIGLEC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12900 | SIGLEC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12901 | SIGLEC14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12902 | SIGLEC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12903 | SIGLEC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12904 | SIGLEC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12905 | SIGLEC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12906 | SIGLEC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12907 | SIGLEC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12908 | SIGMAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12909 | Sigmar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12910 | Sigmar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12911 | SIK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12912 | Sik1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12913 | Sik1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12914 | SIK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12915 | Sik2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12916 | Sik2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12917 | SIK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12918 | Sik3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12919 | SIK3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12920 | SIKE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12921 | SIL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12922 | SIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12923 | SIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12924 | SIMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12925 | SIN3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12926 | SIN3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12927 | SINHCAF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12928 | SIPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12929 | SIPA1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12930 | SIPA1L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12931 | SIPA1L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12932 | SIRPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12933 | SIRPB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12934 | SIRPB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12935 | SIRPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12936 | SIRPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12937 | SIRT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12938 | Sirt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12939 | Sirt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12940 | SIRT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12941 | Sirt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12942 | Sirt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12943 | SIRT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12944 | Sirt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12945 | Sirt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12946 | SIRT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12947 | SIRT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12948 | Sirt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12949 | Sirt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12950 | SIRT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12951 | Sirt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12952 | Sirt6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12953 | SIRT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12954 | Sirt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12955 | Sirt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12956 | SIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12957 | SIVA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12958 | SIX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12959 | SIX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12960 | SIX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12961 | SIX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12962 | SIX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12963 | SIX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12964 | SKA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12965 | SKA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12966 | SKA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12967 | SKAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12968 | SKAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12969 | SKI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12970 | SKIL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12971 | SKOR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12972 | SKOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12973 | SKP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12974 | SKP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12975 | SLA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12976 | SLA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12977 | SLAIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12978 | SLAIN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12979 | SLAMF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12980 | SLAMF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12981 | SLAMF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12982 | SLAMF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12983 | SLAMF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12984 | SLBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12985 | SLC10A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12986 | SLC10A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12987 | Slc10a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12988 | Slc10a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12989 | SLC10A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12990 | SLC10A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12991 | SLC10A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12992 | SLC10A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12993 | SLC10A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12994 | SLC11A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12995 | SLC11A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12996 | SLC12A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12997 | SLC12A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12998 | SLC12A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS12999 | SLC12A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13000 | SLC12A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13001 | SLC12A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13002 | SLC12A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13003 | SLC12A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13004 | SLC12A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13005 | SLC13A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13006 | SLC13A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13007 | SLC13A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13008 | SLC13A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13009 | SLC13A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13010 | SLC14A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13011 | SLC14A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13012 | SLC15A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13013 | SLC15A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13014 | SLC15A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13015 | SLC15A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13016 | SLC16A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13017 | Slc16a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13018 | Slc16a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13019 | SLC16A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13020 | SLC16A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13021 | SLC16A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13022 | SLC16A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13023 | SLC16A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13024 | SLC16A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13025 | SLC16A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13026 | SLC16A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13027 | SLC16A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13028 | SLC16A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13029 | SLC16A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13030 | Slc16a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13031 | Slc16a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13032 | SLC16A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13033 | SLC16A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13034 | SLC17A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13035 | SLC17A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13036 | SLC17A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13037 | SLC17A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13038 | SLC17A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13039 | SLC17A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13040 | SLC17A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13041 | SLC17A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13042 | SLC17A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13043 | SLC18A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13044 | SLC18A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13045 | SLC18A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13046 | SLC18B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13047 | SLC19A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13048 | SLC19A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13049 | SLC19A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13050 | SLC1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13051 | SLC1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13052 | Slc1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13053 | Slc1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13054 | SLC1A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13055 | SLC1A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13056 | SLC1A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13057 | SLC1A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13058 | SLC1A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13059 | SLC20A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13060 | SLC20A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13061 | SLC22A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13062 | SLC22A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13063 | SLC22A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13064 | Slc22a12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13065 | Slc22a12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13066 | SLC22A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13067 | SLC22A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13068 | SLC22A15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13069 | SLC22A16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13070 | SLC22A17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13071 | SLC22A18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13072 | SLC22A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13073 | SLC22A23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13074 | SLC22A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13075 | SLC22A31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13076 | SLC22A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13077 | SLC22A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13078 | SLC22A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13079 | SLC22A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13080 | SLC22A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13081 | SLC23A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13082 | SLC23A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13083 | SLC23A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13084 | SLC24A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13085 | SLC24A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13086 | SLC24A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13087 | SLC24A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13088 | SLC24A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13089 | SLC25A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13090 | SLC25A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13091 | SLC25A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13092 | SLC25A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13093 | SLC25A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13094 | SLC25A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13095 | SLC25A15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13096 | SLC25A16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13097 | SLC25A17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13098 | SLC25A18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13099 | SLC25A19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13100 | SLC25A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13101 | SLC25A20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13102 | SLC25A21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13103 | SLC25A22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13104 | SLC25A23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13105 | SLC25A24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13106 | SLC25A25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13107 | SLC25A26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13108 | SLC25A27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13109 | SLC25A28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13110 | SLC25A29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13111 | SLC25A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13112 | SLC25A30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13113 | SLC25A31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13114 | SLC25A32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13115 | SLC25A33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13116 | SLC25A34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13117 | SLC25A35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13118 | SLC25A36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13119 | SLC25A37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13120 | SLC25A38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13121 | SLC25A39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13122 | SLC25A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13123 | SLC25A40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13124 | SLC25A42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13125 | SLC25A43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13126 | SLC25A44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13127 | SLC25A45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13128 | SLC25A46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13129 | SLC25A47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13130 | SLC25A48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13131 | SLC25A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13132 | SLC25A51 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13133 | SLC25A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13134 | SLC26A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13135 | SLC26A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13136 | SLC26A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13137 | SLC26A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13138 | SLC26A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13139 | SLC26A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13140 | SLC26A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13141 | SLC26A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13142 | SLC26A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13143 | SLC26A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13144 | SLC27A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13145 | SLC27A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13146 | SLC27A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13147 | SLC27A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13148 | SLC27A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13149 | SLC27A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13150 | SLC28A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13151 | SLC28A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13152 | SLC28A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13153 | SLC29A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13154 | SLC29A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13155 | SLC29A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13156 | SLC29A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13157 | SLC2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13158 | Slc2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13159 | Slc2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13160 | SLC2A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13161 | SLC2A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13162 | SLC2A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13163 | SLC2A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13164 | SLC2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13165 | Slc2a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13166 | Slc2a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13167 | SLC2A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13168 | Slc2a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13169 | SLC2A3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13170 | SLC2A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13171 | Slc2a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13172 | Slc2a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13173 | SLC2A4RG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13174 | SLC2A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13175 | SLC2A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13176 | SLC2A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13177 | SLC2A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13178 | SLC30A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13179 | SLC30A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13180 | SLC30A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13181 | SLC30A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13182 | SLC30A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13183 | SLC30A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13184 | SLC30A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13185 | SLC30A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13186 | SLC30A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13187 | SLC30A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13188 | SLC31A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13189 | SLC31A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13190 | SLC32A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13191 | SLC33A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13192 | SLC34A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13193 | SLC34A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13194 | SLC34A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13195 | SLC35A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13196 | SLC35A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13197 | SLC35A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13198 | SLC35B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13199 | SLC35B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13200 | SLC35C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13201 | SLC35D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13202 | SLC35D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13203 | SLC35D3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13204 | SLC35E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13205 | SLC35F1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13206 | SLC35F2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13207 | SLC35F3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13208 | SLC35F4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13209 | SLC35F6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13210 | SLC36A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13211 | SLC36A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13212 | SLC36A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13213 | SLC37A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13214 | SLC37A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13215 | SLC37A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13216 | SLC37A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13217 | SLC38A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13218 | SLC38A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13219 | SLC38A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13220 | SLC38A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13221 | SLC38A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13222 | SLC38A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13223 | SLC38A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13224 | SLC38A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13225 | SLC38A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13226 | SLC38A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13227 | SLC38A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13228 | SLC39A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13229 | SLC39A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13230 | SLC39A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13231 | SLC39A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13232 | SLC39A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13233 | SLC39A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13234 | SLC39A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13235 | SLC39A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13236 | SLC39A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13237 | SLC39A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13238 | SLC39A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13239 | SLC39A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13240 | SLC39A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13241 | SLC3A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13242 | SLC3A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13243 | SLC40A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13244 | Slc40a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13245 | SLC40A1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13246 | SLC41A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13247 | SLC41A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13248 | SLC43A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13249 | SLC43A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13250 | SLC43A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13251 | SLC44A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13252 | SLC44A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13253 | SLC44A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13254 | SLC44A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13255 | SLC44A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13256 | SLC45A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13257 | SLC45A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13258 | SLC45A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13259 | SLC45A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13260 | SLC46A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13261 | SLC46A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13262 | SLC46A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13263 | SLC47A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13264 | SLC47A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13265 | SLC4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13266 | SLC4A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13267 | SLC4A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13268 | SLC4A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13269 | SLC4A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13270 | SLC4A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13271 | SLC4A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13272 | SLC4A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13273 | SLC4A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13274 | SLC4A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13275 | SLC50A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13276 | SLC51B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13277 | SLC52A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13278 | SLC52A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13279 | SLC52A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13280 | SLC5A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13281 | Slc5a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13282 | Slc5a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13283 | SLC5A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13284 | SLC5A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13285 | SLC5A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13286 | SLC5A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13287 | Slc5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13288 | Slc5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13289 | SLC5A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13290 | SLC5A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13291 | SLC5A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13292 | SLC5A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13293 | SLC5A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13294 | SLC5A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13295 | SLC5A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13296 | SLC6A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13297 | SLC6A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13298 | SLC6A12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13299 | SLC6A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13300 | SLC6A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13301 | SLC6A15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13302 | SLC6A16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13303 | SLC6A17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13304 | SLC6A18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13305 | SLC6A19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13306 | SLC6A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13307 | SLC6A20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13308 | SLC6A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13309 | Slc6a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13310 | Slc6a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13311 | SLC6A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13312 | Slc6a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13313 | Slc6a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13314 | SLC6A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13315 | Slc6a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13316 | Slc6a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13317 | SLC6A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13318 | SLC6A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13319 | SLC6A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13320 | SLC6A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13321 | Slc6a9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13322 | Slc6a9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13323 | SLC7A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13324 | SLC7A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13325 | SLC7A11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13326 | SLC7A13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13327 | SLC7A14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13328 | SLC7A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13329 | SLC7A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13330 | SLC7A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13331 | SLC7A5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13332 | SLC7A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13333 | SLC7A6OS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13334 | SLC7A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13335 | SLC7A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13336 | SLC7A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13337 | SLC8A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13338 | SLC8A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13339 | SLC8A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13340 | SLC8B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13341 | SLC9A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13342 | SLC9A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13343 | SLC9A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13344 | SLC9A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13345 | SLC9A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13346 | SLC9A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13347 | SLC9A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13348 | SLC9A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13349 | SLC9B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13350 | SLC9B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13351 | SLCO1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13352 | SLCO1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13353 | SLCO1B3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13354 | SLCO1C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13355 | SLCO2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13356 | SLCO2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13357 | SLCO3A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13358 | SLCO4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13359 | SLCO4C1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13360 | SLCO5A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13361 | SLF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13362 | SLF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13363 | SLFN11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13364 | SLFN12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13365 | SLFN12L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13366 | SLFN13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13367 | SLFN14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13368 | SLFN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13369 | SLIRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13370 | SLIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13371 | SLIT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13372 | SLIT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13373 | SLITRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13374 | SLITRK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13375 | SLITRK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13376 | SLITRK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13377 | SLITRK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13378 | SLITRK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13379 | SLK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13380 | SLMAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13381 | SLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13382 | SLPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13383 | SLTM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13384 | SLU7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13385 | SLURP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13386 | SLURP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13387 | SLX1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13388 | SLX1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13389 | SLX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13390 | SLX4IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13391 | SLX9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13392 | SMAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13393 | SMAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13394 | SMAD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13395 | SMAD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13396 | SMAD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13397 | SMAD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13398 | SMAD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13399 | SMAD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13400 | SMAGP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13401 | SMAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13402 | SMAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13403 | SMARCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13404 | SMARCA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13405 | SMARCA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13406 | SMARCA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13407 | SMARCAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13408 | SMARCAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13409 | SMARCB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13410 | SMARCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13411 | SMARCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13412 | SMARCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13413 | SMARCD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13414 | SMARCD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13415 | SMARCE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13416 | SMC1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13417 | SMC1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13418 | SMC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13419 | SMC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13420 | SMC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13421 | SMC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13422 | SMC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13423 | SMCHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13424 | SMCO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13425 | SMCO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13426 | SMCO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13427 | SMCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13428 | SMCR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13429 | SMDT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13430 | SMG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13431 | SMG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13432 | SMG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13433 | SMG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13434 | SMG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13435 | SMG9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13436 | SMIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13437 | SMIM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13438 | SMN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13439 | SMN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13440 | SMNDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13441 | SMO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13442 | Smo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13443 | Smo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13444 | SMOC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13445 | SMOC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13446 | SMOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13447 | SMPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13448 | SMPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13449 | SMPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13450 | SMPD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13451 | SMPDL3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13452 | SMPDL3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13453 | SMPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13454 | SMS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13455 | SMTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13456 | SMTNL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13457 | SMU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13458 | SMUG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13459 | SMURF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13460 | SMURF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13461 | SMYD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13462 | SMYD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13463 | Smyd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13464 | Smyd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13465 | SMYD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13466 | Smyd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13467 | Smyd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13468 | SMYD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13469 | SMYD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13470 | SNAI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13471 | SNAI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13472 | SNAI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13473 | SNAP23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13474 | SNAP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13475 | SNAP29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13476 | SNAP47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13477 | SNAP91 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13478 | SNAPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13479 | SNAPC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13480 | SNAPC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13481 | SNAPIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13482 | SNCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13483 | Snca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13484 | Snca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13485 | SNCAIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13486 | SNCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13487 | SNCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13488 | SND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13489 | SNED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13490 | SNF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13491 | SNIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13492 | SNN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13493 | SNORC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13494 | SNPH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13495 | SNRK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13496 | SNRNP200 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13497 | SNRNP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13498 | SNRNP40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13499 | SNRNP70 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13500 | SNRPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13501 | SNRPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13502 | SNRPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13503 | SNRPB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13504 | SNRPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13505 | SNRPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13506 | SNRPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13507 | SNRPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13508 | SNRPE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13509 | SNRPF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13510 | SNRPG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13511 | SNRPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13512 | SNTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13513 | SNTB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13514 | SNTB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13515 | SNTG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13516 | SNTG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13517 | SNTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13518 | SNU13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13519 | SNUPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13520 | SNURF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13521 | SNW1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13522 | SNX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13523 | SNX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13524 | SNX11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13525 | SNX12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13526 | SNX13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13527 | SNX14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13528 | SNX15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13529 | SNX16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13530 | SNX17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13531 | SNX18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13532 | SNX19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13533 | SNX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13534 | SNX20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13535 | SNX22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13536 | SNX25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13537 | SNX27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13538 | SNX29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13539 | SNX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13540 | SNX30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13541 | SNX32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13542 | SNX33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13543 | SNX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13544 | SNX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13545 | SNX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13546 | SNX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13547 | SNX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13548 | SNX9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13549 | SOAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13550 | SOAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13551 | SOBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13552 | SOCS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13553 | SOCS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13554 | SOCS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13555 | SOCS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13556 | SOCS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13557 | SOCS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13558 | SOCS7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13559 | SOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13560 | SOD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13561 | SOD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13562 | SOGA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13563 | SOGA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13564 | SOHLH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13565 | SOHLH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13566 | SON Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13567 | SORBS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13568 | SORBS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13569 | SORBS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13570 | SORCS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13571 | SORCS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13572 | SORCS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13573 | SORD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13574 | SORL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13575 | SORT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13576 | SOS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13577 | SOS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13578 | SOST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13579 | SOSTDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13580 | SOWAHA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13581 | SOWAHC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13582 | SOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13583 | SOX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13584 | SOX11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13585 | SOX12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13586 | SOX13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13587 | SOX14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13588 | SOX15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13589 | SOX17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13590 | SOX18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13591 | SOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13592 | SOX21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13593 | SOX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13594 | SOX30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13595 | SOX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13596 | SOX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13597 | SOX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13598 | SOX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13599 | SOX9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13600 | SP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13601 | SP100 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13602 | SP110 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13603 | SP140 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13604 | SP140L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13605 | SP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13606 | SP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13607 | SP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13608 | SP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13609 | SP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13610 | SP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13611 | SP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13612 | SP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13613 | SPA17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13614 | SPAAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13615 | SPACA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13616 | SPACA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13617 | SPACA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13618 | SPACA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13619 | SPACDR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13620 | SPAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13621 | SPAG16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13622 | SPAG17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13623 | SPAG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13624 | SPAG5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13625 | SPAG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13626 | SPAG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13627 | SPAG9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13628 | SPAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13629 | SPANXC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13630 | SPANXD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13631 | SPARC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13632 | SPARCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13633 | SPART Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13634 | SPAST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13635 | SPATA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13636 | SPATA13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13637 | SPATA16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13638 | SPATA18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13639 | SPATA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13640 | SPATA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13641 | SPATA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13642 | SPATA5L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13643 | SPATA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13644 | SPATA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13645 | SPATS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13646 | SPATS2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13647 | SPC24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13648 | SPC25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13649 | SPCS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13650 | SPCS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13651 | SPCS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13652 | SPDEF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13653 | SPDL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13654 | SPDYA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13655 | SPECC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13656 | SPECC1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13657 | SPEF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13658 | SPEG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13659 | SPEM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13660 | SPEN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13661 | SPG11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13662 | SPG21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13663 | SPG7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13664 | SPHK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13665 | Sphk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13666 | Sphk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13667 | SPHK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13668 | Sphk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13669 | Sphk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13670 | SPHKAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13671 | SPI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13672 | SPIB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13673 | SPICE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13674 | SPIDR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13675 | SPIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13676 | SPIN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13677 | SPIN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13678 | SPINDOC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13679 | SPINK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13680 | SPINK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13681 | SPINK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13682 | SPINK5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13683 | SPINK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13684 | SPINK7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13685 | SPINT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13686 | SPINT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13687 | SPIRE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13688 | SPIRE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13689 | SPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13690 | SPNS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13691 | SPNS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13692 | SPNS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13693 | SPO11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13694 | SPOCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13695 | SPOCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13696 | SPOCK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13697 | SPOCK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13698 | SPON1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13699 | SPON2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13700 | SPOP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13701 | SPOPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13702 | SPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13703 | SPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13704 | SPPL2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13705 | SPPL2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13706 | SPPL2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13707 | SPPL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13708 | SPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13709 | SPRED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13710 | SPRED2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13711 | SPRING1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13712 | SPRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13713 | SPRR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13714 | SPRR1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13715 | SPRR2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13716 | SPRR2D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13717 | SPRR2F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13718 | SPRR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13719 | SPRR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13720 | SPRTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13721 | SPRY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13722 | SPRY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13723 | SPRY3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13724 | SPRY4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13725 | SPRYD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13726 | SPSB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13727 | SPSB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13728 | SPSB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13729 | SPTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13730 | SPTAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13731 | SPTB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13732 | SPTBN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13733 | SPTBN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13734 | SPTBN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13735 | SPTBN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13736 | SPTLC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13737 | SPTLC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13738 | SPTLC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13739 | SPTSSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13740 | SPTSSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13741 | SPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13742 | SPZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13743 | SQLE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13744 | SQOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13745 | SQSTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13746 | SRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13747 | SRARP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13748 | SRBD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13749 | SRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13750 | Src Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13751 | Src Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13752 | SRCAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13753 | SRCIN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13754 | SRD5A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13755 | SRD5A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13756 | SRD5A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13757 | SREBF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13758 | SREBF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13759 | SREK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13760 | SRF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13761 | SRFBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13762 | SRGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13763 | SRGAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13764 | SRGAP2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13765 | SRGAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13766 | SRGN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13767 | SRI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13768 | SRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13769 | SRM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13770 | SRMS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13771 | SRP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13772 | SRP19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13773 | SRP54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13774 | SRP68 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13775 | SRP72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13776 | SRP9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13777 | SRPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13778 | SRPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13779 | SRPK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13780 | SRPRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13781 | SRPRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13782 | SRPX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13783 | SRPX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13784 | SRR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13785 | SRRD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13786 | SRRM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13787 | SRRM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13788 | SRRM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13789 | SRRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13790 | SRSF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13791 | SRSF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13792 | SRSF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13793 | SRSF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13794 | SRSF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13795 | SRSF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13796 | SRSF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13797 | SRSF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13798 | SRSF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13799 | SRSF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13800 | SRXN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13801 | SRY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13802 | SS18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13803 | SS18L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13804 | SSB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13805 | SSBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13806 | SSBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13807 | SSBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13808 | SSC5D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13809 | SSH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13810 | SSH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13811 | SSH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13812 | SSNA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13813 | SSPN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13814 | SSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13815 | SSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13816 | SSR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13817 | SSR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13818 | SSRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13819 | SST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13820 | SSTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13821 | Sstr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13822 | Sstr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13823 | SSTR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13824 | Sstr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13825 | Sstr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13826 | SSTR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13827 | Sstr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13828 | Sstr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13829 | SSTR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13830 | Sstr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13831 | Sstr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13832 | SSTR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13833 | Sstr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13834 | Sstr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13835 | SSU72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13836 | SSX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13837 | SSX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13838 | SSX2IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13839 | SSX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13840 | SSX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13841 | SSX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13842 | SSX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13843 | ST13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13844 | ST14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13845 | ST18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13846 | ST3GAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13847 | ST3GAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13848 | ST3GAL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13849 | ST3GAL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13850 | ST3GAL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13851 | ST3GAL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13852 | ST6GAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13853 | ST6GAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13854 | ST7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13855 | ST7L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13856 | ST8SIA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13857 | ST8SIA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13858 | ST8SIA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13859 | ST8SIA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13860 | ST8SIA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13861 | STAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13862 | STAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13863 | STAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13864 | STAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13865 | STAC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13866 | STAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13867 | STAG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13868 | STAG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13869 | STAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13870 | STAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13871 | STAMBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13872 | STAMBPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13873 | STAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13874 | STAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13875 | STAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13876 | STARD10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13877 | STARD13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13878 | STARD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13879 | STARD3NL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13880 | STARD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13881 | STARD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13882 | STARD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13883 | STARD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13884 | STARD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13885 | STARD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13886 | STAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13887 | STAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13888 | STAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13889 | Stat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13890 | Stat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13891 | STAT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13892 | STAT5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13893 | STAT5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13894 | Stat5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13895 | Stat5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13896 | STAT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13897 | Stat6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13898 | Stat6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13899 | STATH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13900 | STAU1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13901 | STAU2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13902 | STBD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13903 | STC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13904 | STC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13905 | STEAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13906 | STEAP1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13907 | STEAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13908 | STEAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13909 | STEAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13910 | STEEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13911 | STH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13912 | STIL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13913 | STIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13914 | STIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13915 | STIMATE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13916 | STING1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13917 | Sting1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13918 | Sting1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13919 | STIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13920 | STK10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13921 | STK11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13922 | STK11IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13923 | STK16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13924 | STK17A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13925 | STK17B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13926 | STK19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13927 | STK24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13928 | STK25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13929 | STK26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13930 | STK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13931 | STK31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13932 | STK32A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13933 | STK32B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13934 | STK32C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13935 | STK33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13936 | STK35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13937 | STK36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13938 | STK38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13939 | STK38L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13940 | STK39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13941 | STK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13942 | STK40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13943 | STMN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13944 | STMN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13945 | STMN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13946 | STMN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13947 | STMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13948 | STN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13949 | STOM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13950 | STOML2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13951 | STOML3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13952 | STON1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13953 | STON2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13954 | STOX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13955 | STOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13956 | STPG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13957 | STRA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13958 | STRA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13959 | STRADA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13960 | STRADB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13961 | STRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13962 | STRBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13963 | STRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13964 | STRIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13965 | STRIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13966 | STRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13967 | STRN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13968 | STRN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13969 | STS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13970 | STT3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13971 | STT3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13972 | STUB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13973 | STUM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13974 | STX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13975 | STX11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13976 | STX12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13977 | STX16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13978 | STX17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13979 | STX18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13980 | STX1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13981 | STX1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13982 | STX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13983 | STX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13984 | STX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13985 | STX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13986 | STX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13987 | STX7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13988 | STX8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13989 | STXBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13990 | STXBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13991 | STXBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13992 | STXBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13993 | STXBP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13994 | STXBP5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13995 | STXBP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13996 | STYK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13997 | STYX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13998 | STYXL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS13999 | SUB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14000 | SUCLA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14001 | SUCLG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14002 | SUCLG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14003 | SUCNR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14004 | Sucnr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14005 | Sucnr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14006 | SUCO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14007 | SUFU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14008 | SUGCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14009 | SUGP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14010 | SUGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14011 | SULF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14012 | SULF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14013 | SULT1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14014 | SULT1A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14015 | SULT1A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14016 | SULT1B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14017 | SULT1C2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14018 | SULT1C4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14019 | SULT1E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14020 | SULT2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14021 | SULT2B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14022 | SULT4A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14023 | SUMF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14024 | SUMF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14025 | SUMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14026 | SUMO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14027 | SUMO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14028 | SUMO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14029 | SUN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14030 | SUN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14031 | SUN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14032 | SUN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14033 | SUOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14034 | SUPT16H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14035 | SUPT20H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14036 | SUPT3H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14037 | SUPT4H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14038 | SUPT5H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14039 | SUPT6H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14040 | SUPT7L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14041 | SUPV3L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14042 | SURF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14043 | SURF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14044 | SURF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14045 | SURF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14046 | SUSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14047 | SUSD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14048 | SUSD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14049 | SUSD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14050 | SUSD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14051 | SUV39H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14052 | SUV39H2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14053 | SUZ12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14054 | SV2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14055 | SV2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14056 | SV2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14057 | SVBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14058 | SVEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14059 | SVIL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14060 | SVIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14061 | SVOP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14062 | SVOPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14063 | SWAP70 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14064 | SWI5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14065 | SWT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14066 | SYAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14067 | SYBU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14068 | SYCE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14069 | SYCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14070 | SYCP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14071 | SYCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14072 | SYCP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14073 | SYDE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14074 | SYF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14075 | SYK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14076 | Syk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14077 | Syk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14078 | SYMPK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14079 | SYN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14080 | SYN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14081 | SYN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14082 | SYNCRIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14083 | SYNDIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14084 | SYNDIG1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14085 | SYNE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14086 | SYNE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14087 | SYNE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14088 | SYNE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14089 | SYNGAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14090 | SYNGR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14091 | SYNGR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14092 | SYNGR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14093 | SYNJ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14094 | SYNJ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14095 | SYNJ2BP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14096 | SYNM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14097 | SYNPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14098 | SYNPO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14099 | SYNPO2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14100 | SYNPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14101 | SYNRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14102 | SYP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14103 | SYPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14104 | SYPL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14105 | SYS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14106 | SYT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14107 | SYT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14108 | SYT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14109 | SYT12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14110 | SYT13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14111 | SYT14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14112 | SYT15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14113 | SYT17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14114 | SYT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14115 | SYT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14116 | SYT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14117 | SYT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14118 | SYT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14119 | SYT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14120 | SYT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14121 | SYT9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14122 | SYTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14123 | SYTL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14124 | SYTL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14125 | SYTL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14126 | SYTL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14127 | SYVN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14128 | SZRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14129 | SZT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14130 | TAAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14131 | TAAR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14132 | TAAR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14133 | TAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14134 | TAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14135 | TAB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14136 | TAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14137 | TAC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14138 | TAC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14139 | TACC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14140 | TACC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14141 | TACC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14142 | TACO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14143 | TACR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14144 | Tacr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14145 | Tacr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14146 | TACR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14147 | Tacr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14148 | Tacr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14149 | TACR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14150 | Tacr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14151 | Tacr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14152 | TACSTD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14153 | TADA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14154 | TADA2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14155 | TADA2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14156 | TADA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14157 | TAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14158 | TAF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14159 | TAF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14160 | TAF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14161 | TAF13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14162 | TAF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14163 | TAF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14164 | TAF1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14165 | TAF1D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14166 | TAF1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14167 | TAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14168 | TAF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14169 | TAF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14170 | TAF4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14171 | TAF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14172 | TAF5L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14173 | TAF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14174 | TAF6L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14175 | TAF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14176 | TAF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14177 | TAF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14178 | TAF9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14179 | TAFA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14180 | TAFA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14181 | TAFA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14182 | TAFA4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14183 | TAFA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14184 | TAFAZZIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14185 | TAGAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14186 | TAGLN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14187 | TAGLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14188 | TAGLN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14189 | TAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14190 | TAL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14191 | TALDO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14192 | TAMALIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14193 | TAMM41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14194 | TANC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14195 | TANC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14196 | TANGO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14197 | TANK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14198 | TAOK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14199 | TAOK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14200 | TAOK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14201 | TAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14202 | TAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14203 | TAPBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14204 | TAPBPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14205 | TAPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14206 | TARBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14207 | TARBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14208 | TARDBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14209 | TARM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14210 | TARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14211 | TARS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14212 | TAS1R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14213 | TAS1R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14214 | TAS1R3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14215 | TAS2R1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14216 | TAS2R10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14217 | TAS2R14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14218 | TAS2R38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14219 | TAS2R5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14220 | TAS2R7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14221 | TASL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14222 | TASOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14223 | TASOR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14224 | TASP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14225 | TAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14226 | TATDN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14227 | TAX1BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14228 | TAX1BP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14229 | TBATA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14230 | TBC1D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14231 | TBC1D10B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14232 | TBC1D15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14233 | TBC1D16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14234 | TBC1D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14235 | TBC1D20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14236 | TBC1D22A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14237 | TBC1D23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14238 | TBC1D24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14239 | TBC1D25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14240 | TBC1D2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14241 | TBC1D3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14242 | TBC1D31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14243 | TBC1D3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14244 | TBC1D4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14245 | TBC1D5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14246 | TBC1D7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14247 | TBC1D8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14248 | TBC1D8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14249 | TBC1D9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14250 | TBCA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14251 | TBCB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14252 | TBCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14253 | TBCD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14254 | TBCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14255 | TBCEL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14256 | TBCK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14257 | TBK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14258 | Tbk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14259 | Tbk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14260 | TBKBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14261 | TBL1X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14262 | TBL1XR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14263 | TBL1Y Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14264 | TBL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14265 | TBL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14266 | TBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14267 | TBPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14268 | TBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14269 | TBRG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14270 | TBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14271 | TBX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14272 | TBX15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14273 | TBX18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14274 | TBX19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14275 | TBX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14276 | TBX20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14277 | TBX21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14278 | TBX22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14279 | TBX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14280 | TBX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14281 | TBX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14282 | TBX6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14283 | TBXA2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14284 | Tbxa2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14285 | Tbxa2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14286 | TBXAS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14287 | TBXT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14288 | TC2N Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14289 | TCAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14290 | TCAIM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14291 | TCAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14292 | TCEA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14293 | TCEA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14294 | TCEAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14295 | TCEAL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14296 | TCEAL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14297 | TCERG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14298 | TCERG1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14299 | TCF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14300 | TCF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14301 | TCF19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14302 | TCF20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14303 | TCF21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14304 | TCF23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14305 | TCF25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14306 | TCF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14307 | TCF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14308 | TCF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14309 | TCF7L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14310 | TCF7L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14311 | TCFL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14312 | TCHH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14313 | TCHP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14314 | TCIM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14315 | TCIRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14316 | TCL1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14317 | TCL1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14318 | TCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14319 | TCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14320 | TCOF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14321 | TCP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14322 | TCP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14323 | TCP11L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14324 | TCP11L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14325 | TCTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14326 | TCTN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14327 | TCTN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14328 | TCTN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14329 | TDG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14330 | TDGF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14331 | TDO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14332 | TDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14333 | TDP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14334 | TDRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14335 | TDRD12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14336 | TDRD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14337 | TDRD5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14338 | TDRD7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14339 | TDRD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14340 | TDRKH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14341 | TDRP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14342 | TEAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14343 | TEAD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14344 | TEAD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14345 | TEAD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14346 | TEC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14347 | TECPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14348 | TECPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14349 | TECR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14350 | TECRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14351 | TECTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14352 | TEDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14353 | TEF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14354 | TEFM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14355 | TEK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14356 | TEKT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14357 | TEKT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14358 | TEKT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14359 | TEKT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14360 | TELO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14361 | TEN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14362 | TENM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14363 | TENM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14364 | TENM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14365 | TENM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14366 | TENT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14367 | TENT5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14368 | TENT5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14369 | TEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14370 | TEPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14371 | TEPSIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14372 | TERF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14373 | TERF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14374 | TERF2IP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14375 | TERT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14376 | Tert Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14377 | Tert Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14378 | TES Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14379 | TESC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14380 | TESK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14381 | TESK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14382 | TESMIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14383 | TESPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14384 | TET1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14385 | TET2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14386 | TET3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14387 | TEX10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14388 | TEX101 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14389 | TEX11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14390 | TEX12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14391 | TEX14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14392 | TEX15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14393 | TEX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14394 | TEX22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14395 | TEX264 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14396 | TEX28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14397 | TEX30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14398 | TEX37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14399 | TEX44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14400 | TEX45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14401 | TEX47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14402 | TEX48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14403 | TEX51 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14404 | TEX55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14405 | TEX9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14406 | TF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14407 | TFAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14408 | TFAP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14409 | TFAP2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14410 | TFAP2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14411 | TFAP2E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14412 | TFAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14413 | TFB1M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14414 | TFB2M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14415 | TFCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14416 | TFCP2L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14417 | TFDP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14418 | TFDP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14419 | TFE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14420 | TFEB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14421 | TFEC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14422 | TFF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14423 | TFF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14424 | TFF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14425 | TFG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14426 | TFIP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14427 | TFPI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14428 | TFPI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14429 | TFPT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14430 | TFR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14431 | TFRC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14432 | TG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14433 | TGDS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14434 | TGFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14435 | TGFB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14436 | Tgfb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14437 | Tgfb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14438 | TGFB1I1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14439 | TGFB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14440 | Tgfb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14441 | Tgfb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14442 | TGFB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14443 | TGFBI Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14444 | TGFBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14445 | Tgfbr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14446 | TGFBR1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14447 | TGFBR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14448 | Tgfbr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14449 | Tgfbr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14450 | TGFBR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14451 | Tgfbr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14452 | Tgfbr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14453 | TGFBR3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14454 | TGFBRAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14455 | TGIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14456 | TGIF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14457 | TGIF2LX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14458 | TGM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14459 | TGM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14460 | TGM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14461 | TGM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14462 | TGM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14463 | TGM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14464 | TGM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14465 | TGOLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14466 | TGS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14467 | TH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14468 | THADA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14469 | THAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14470 | THAP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14471 | THAP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14472 | THAP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14473 | THAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14474 | THAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14475 | THAP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14476 | THAP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14477 | THAP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14478 | THBD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14479 | THBS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14480 | THBS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14481 | THBS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14482 | THBS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14483 | THEG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14484 | THEGL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14485 | THEM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14486 | THEM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14487 | THEM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14488 | THEMIS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14489 | THEMIS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14490 | THG1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14491 | THOC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14492 | THOC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14493 | THOC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14494 | THOC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14495 | THOC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14496 | THOC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14497 | THOP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14498 | THPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14499 | THRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14500 | THRAP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14501 | THRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14502 | THRSP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14503 | THSD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14504 | THSD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14505 | THSD7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14506 | THSD7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14507 | THTPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14508 | THUMPD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14509 | THUMPD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14510 | THUMPD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14511 | THY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14512 | THYN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14513 | TIA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14514 | TIAL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14515 | TIAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14516 | TIAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14517 | TICAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14518 | TICAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14519 | TICRR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14520 | TIE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14521 | TIFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14522 | TIFAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14523 | TIGAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14524 | TIGIT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14525 | TIMD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14526 | TIMELESS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14527 | TIMM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14528 | TIMM13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14529 | TIMM17A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14530 | TIMM22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14531 | TIMM23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14532 | TIMM44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14533 | TIMM50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14534 | TIMM8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14535 | TIMM8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14536 | TIMM9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14537 | TIMMDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14538 | TIMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14539 | TIMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14540 | TIMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14541 | TIMP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14542 | TINAG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14543 | TINAGL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14544 | TINCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14545 | TINF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14546 | TIPARP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14547 | Tiparp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14548 | Tiparp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14549 | TIPIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14550 | TIPRL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14551 | TIRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14552 | TJAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14553 | TJP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14554 | TJP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14555 | TJP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14556 | TK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14557 | TK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14558 | TKFC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14559 | TKT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14560 | TKTL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14561 | TLCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14562 | TLCD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14563 | TLE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14564 | TLE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14565 | TLE3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14566 | TLE4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14567 | TLE5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14568 | TLE6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14569 | TLE7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14570 | TLK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14571 | TLK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14572 | TLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14573 | TLL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14574 | TLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14575 | TLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14576 | TLR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14577 | Tlr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14578 | Tlr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14579 | TLR10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14580 | TLR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14581 | Tlr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14582 | Tlr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14583 | TLR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14584 | Tlr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14585 | Tlr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14586 | TLR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14587 | Tlr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14588 | Tlr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14589 | TLR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14590 | TLR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14591 | Tlr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14592 | Tlr6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14593 | TLR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14594 | Tlr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14595 | Tlr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14596 | TLR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14597 | Tlr8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14598 | Tlr8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14599 | TLR9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14600 | Tlr9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14601 | Tlr9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14602 | TLX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14603 | TLX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14604 | TLX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14605 | TM2D3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14606 | TM4SF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14607 | TM4SF19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14608 | TM4SF20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14609 | TM4SF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14610 | TM4SF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14611 | TM6SF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14612 | TM7SF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14613 | TM9SF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14614 | TM9SF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14615 | TM9SF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14616 | TMA16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14617 | TMA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14618 | TMBIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14619 | TMBIM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14620 | TMBIM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14621 | TMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14622 | TMC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14623 | TMC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14624 | TMC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14625 | TMC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14626 | TMC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14627 | TMC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14628 | TMC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14629 | TMCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14630 | TMCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14631 | TMCC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14632 | TMCO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14633 | TMCO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14634 | TMED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14635 | TMED10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14636 | TMED2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14637 | TMED3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14638 | TMED4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14639 | TMED7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14640 | TMED9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14641 | TMEFF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14642 | TMEFF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14643 | TMEM100 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14644 | TMEM102 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14645 | TMEM106A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14646 | TMEM106B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14647 | TMEM106C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14648 | TMEM107 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14649 | TMEM108 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14650 | TMEM109 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14651 | TMEM11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14652 | TMEM115 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14653 | TMEM116 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14654 | TMEM117 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14655 | TMEM119 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14656 | TMEM120A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14657 | TMEM123 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14658 | TMEM126A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14659 | TMEM126B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14660 | TMEM127 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14661 | TMEM129 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14662 | TMEM131 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14663 | TMEM132A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14664 | TMEM132B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14665 | TMEM132C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14666 | TMEM132D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14667 | TMEM135 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14668 | TMEM140 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14669 | TMEM145 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14670 | TMEM147 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14671 | TMEM14C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14672 | TMEM150C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14673 | TMEM154 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14674 | TMEM158 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14675 | TMEM160 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14676 | TMEM161B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14677 | TMEM163 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14678 | TMEM164 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14679 | TMEM165 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14680 | TMEM17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14681 | TMEM170B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14682 | TMEM171 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14683 | TMEM175 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14684 | TMEM176A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14685 | TMEM176B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14686 | TMEM177 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14687 | TMEM178B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14688 | TMEM18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14689 | TMEM182 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14690 | TMEM184B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14691 | TMEM19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14692 | TMEM192 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14693 | TMEM199 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14694 | TMEM205 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14695 | TMEM208 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14696 | TMEM212 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14697 | TMEM213 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14698 | TMEM214 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14699 | TMEM216 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14700 | TMEM219 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14701 | TMEM222 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14702 | TMEM230 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14703 | TMEM231 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14704 | TMEM233 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14705 | TMEM236 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14706 | TMEM237 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14707 | TMEM240 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14708 | TMEM245 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14709 | TMEM25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14710 | TMEM252 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14711 | TMEM258 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14712 | TMEM259 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14713 | TMEM26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14714 | TMEM260 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14715 | TMEM263 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14716 | TMEM30A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14717 | TMEM33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14718 | TMEM37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14719 | TMEM38A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14720 | TMEM38B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14721 | TMEM39A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14722 | TMEM40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14723 | TMEM41B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14724 | TMEM43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14725 | TMEM44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14726 | TMEM45A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14727 | TMEM45B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14728 | TMEM47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14729 | TMEM50B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14730 | TMEM51 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14731 | TMEM59 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14732 | TMEM63A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14733 | TMEM63B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14734 | TMEM63C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14735 | TMEM64 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14736 | TMEM65 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14737 | TMEM67 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14738 | TMEM68 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14739 | TMEM70 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14740 | TMEM72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14741 | TMEM74 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14742 | TMEM79 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14743 | TMEM86A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14744 | TMEM87A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14745 | TMEM88 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14746 | TMEM9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14747 | TMEM91 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14748 | TMEM94 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14749 | TMEM95 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14750 | TMEM97 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14751 | Tmem97 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14752 | Tmem97 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14753 | TMEM98 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14754 | TMF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14755 | TMIE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14756 | TMIGD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14757 | TMIGD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14758 | TMLHE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14759 | TMOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14760 | TMOD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14761 | TMOD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14762 | TMPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14763 | TMPRSS11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14764 | TMPRSS11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14765 | TMPRSS11D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14766 | TMPRSS11E Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14767 | TMPRSS13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14768 | TMPRSS15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14769 | TMPRSS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14770 | TMPRSS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14771 | TMPRSS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14772 | TMPRSS5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14773 | TMPRSS6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14774 | TMSB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14775 | TMSB4X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14776 | TMTC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14777 | TMTC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14778 | TMTC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14779 | TMX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14780 | TMX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14781 | TMX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14782 | TMX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14783 | TNC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14784 | TNF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14785 | Tnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14786 | TNF Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14787 | TNFAIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14788 | TNFAIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14789 | TNFAIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14790 | TNFAIP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14791 | TNFAIP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14792 | TNFAIP8L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14793 | TNFAIP8L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14794 | TNFAIP8L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14795 | TNFRSF10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14796 | TNFRSF10B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14797 | TNFRSF10C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14798 | TNFRSF10D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14799 | TNFRSF11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14800 | Tnfrsf11a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14801 | Tnfrsf11a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14802 | TNFRSF11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14803 | TNFRSF12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14804 | TNFRSF13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14805 | TNFRSF13C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14806 | TNFRSF14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14807 | TNFRSF17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14808 | TNFRSF18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14809 | TNFRSF19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14810 | TNFRSF1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14811 | TNFRSF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14812 | TNFRSF21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14813 | TNFRSF25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14814 | TNFRSF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14815 | TNFRSF6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14816 | TNFRSF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14817 | TNFRSF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14818 | TNFSF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14819 | TNFSF11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14820 | Tnfsf11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14821 | TNFSF11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14822 | TNFSF12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14823 | TNFSF13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14824 | TNFSF13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14825 | TNFSF14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14826 | TNFSF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14827 | TNFSF18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14828 | TNFSF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14829 | TNFSF8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14830 | TNFSF9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14831 | TNIK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14832 | Tnik Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14833 | Tnik Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14834 | TNIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14835 | TNIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14836 | TNIP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14837 | TNK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14838 | TNK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14839 | TNKS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14840 | Tnks Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14841 | Tnks Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14842 | TNKS1BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14843 | TNKS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14844 | Tnks2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14845 | TNKS2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14846 | TNMD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14847 | TNN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14848 | TNNC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14849 | TNNC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14850 | TNNI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14851 | TNNI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14852 | TNNI3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14853 | TNNI3K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14854 | TNNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14855 | TNNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14856 | TNNT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14857 | TNP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14858 | TNP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14859 | TNPO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14860 | TNPO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14861 | TNPO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14862 | TNR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14863 | TNRC18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14864 | TNRC6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14865 | TNRC6B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14866 | TNRC6C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14867 | TNS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14868 | TNS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14869 | TNS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14870 | TNS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14871 | TNXB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14872 | TOB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14873 | TOB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14874 | TOE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14875 | TOLLIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14876 | TOM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14877 | TOM1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14878 | TOM1L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14879 | TOMM20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14880 | TOMM22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14881 | TOMM34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14882 | TOMM40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14883 | TOMM40L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14884 | TOMM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14885 | TOMM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14886 | TOMM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14887 | TOMM70 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14888 | TOMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14889 | TONSL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14890 | TOP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14891 | Top1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14892 | Top1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14893 | TOP1MT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14894 | TOP2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14895 | Top2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14896 | Top2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14897 | TOP2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14898 | TOP3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14899 | TOP3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14900 | TOPAZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14901 | TOPBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14902 | TOPORS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14903 | TOR1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14904 | TOR1AIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14905 | TOR1AIP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14906 | TOR3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14907 | TOR4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14908 | TOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14909 | TOX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14910 | TOX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14911 | TOX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14912 | TP53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14913 | Tp53 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14914 | TP53AIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14915 | TP53BP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14916 | TP53BP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14917 | TP53I11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14918 | TP53I13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14919 | TP53I3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14920 | TP53INP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14921 | TP53INP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14922 | TP53RK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14923 | TP63 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14924 | TP73 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14925 | TPBG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14926 | TPCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14927 | TPCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14928 | TPD52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14929 | TPD52L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14930 | TPD52L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14931 | TPGS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14932 | TPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14933 | TPH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14934 | TPI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14935 | TPK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14936 | TPM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14937 | TPM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14938 | TPM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14939 | TPM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14940 | TPMT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14941 | TPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14942 | TPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14943 | TPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14944 | TPPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14945 | TPPP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14946 | TPR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14947 | TPRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14948 | TPRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14949 | TPRKB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14950 | TPRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14951 | TPRX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14952 | TPSAB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14953 | TPSB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14954 | TPST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14955 | TPST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14956 | TPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14957 | TPTE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14958 | TPTE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14959 | TPX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14960 | TRA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14961 | TRA2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14962 | TRA2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14963 | TRABD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14964 | TRABD2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14965 | TRABD2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14966 | TRADD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14967 | TRAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14968 | TRAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14969 | TRAF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14970 | TRAF3IP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14971 | TRAF3IP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14972 | TRAF3IP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14973 | TRAF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14974 | TRAF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14975 | TRAF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14976 | TRAF7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14977 | TRAFD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14978 | TRAIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14979 | TRAK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14980 | TRAK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14981 | TRAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14982 | TRAM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14983 | TRANK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14984 | TRAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14985 | TRAPPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14986 | TRAPPC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14987 | TRAPPC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14988 | TRAPPC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14989 | TRAPPC2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14990 | TRAPPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14991 | TRAPPC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14992 | TRAPPC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14993 | TRAPPC6A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14994 | TRAPPC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14995 | TRAPPC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14996 | TRAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14997 | TRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14998 | TRD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS14999 | TRDMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15000 | TRDN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15001 | TREH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15002 | TREM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15003 | TREM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15004 | TREML1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15005 | TREML2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15006 | TREML4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15007 | TRERF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15008 | TREX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15009 | TREX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15010 | TRG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15011 | TRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15012 | TRHDE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15013 | TRHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15014 | TRIAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15015 | TRIB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15016 | TRIB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15017 | TRIB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15018 | TRIL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15019 | TRIM10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15020 | TRIM11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15021 | TRIM13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15022 | TRIM14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15023 | TRIM15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15024 | TRIM16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15025 | TRIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15026 | TRIM21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15027 | TRIM22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15028 | TRIM23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15029 | TRIM24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15030 | TRIM25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15031 | TRIM26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15032 | TRIM27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15033 | TRIM28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15034 | TRIM29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15035 | TRIM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15036 | TRIM31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15037 | TRIM32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15038 | TRIM33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15039 | TRIM35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15040 | TRIM36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15041 | TRIM37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15042 | TRIM38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15043 | TRIM39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15044 | TRIM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15045 | TRIM40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15046 | TRIM41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15047 | TRIM43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15048 | TRIM44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15049 | TRIM45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15050 | TRIM46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15051 | TRIM47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15052 | TRIM48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15053 | TRIM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15054 | TRIM52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15055 | TRIM54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15056 | TRIM55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15057 | TRIM56 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15058 | TRIM58 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15059 | TRIM59 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15060 | TRIM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15061 | TRIM60 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15062 | TRIM62 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15063 | TRIM63 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15064 | TRIM64 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15065 | TRIM65 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15066 | TRIM66 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15067 | TRIM67 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15068 | TRIM69 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15069 | TRIM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15070 | TRIM71 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15071 | TRIM72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15072 | TRIM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15073 | TRIM9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15074 | TRIO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15075 | TRIOBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15076 | TRIP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15077 | TRIP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15078 | TRIP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15079 | TRIP13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15080 | TRIP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15081 | TRIP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15082 | TRIQK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15083 | TRIR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15084 | TRIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15085 | TRMO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15086 | TRMT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15087 | TRMT10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15088 | TRMT10C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15089 | TRMT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15090 | TRMT112 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15091 | TRMT2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15092 | TRMT2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15093 | TRMT5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15094 | TRMT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15095 | TRMT61A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15096 | TRMT61B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15097 | TRMU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15098 | TRNP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15099 | TRNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15100 | TRO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15101 | TROAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15102 | Trp53 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15103 | TRPA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15104 | TRPC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15105 | TRPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15106 | TRPC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15107 | TRPC4AP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15108 | TRPC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15109 | TRPC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15110 | TRPC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15111 | TRPM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15112 | TRPM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15113 | TRPM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15114 | TRPM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15115 | TRPM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15116 | TRPM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15117 | TRPM7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15118 | TRPM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15119 | TRPS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15120 | TRPT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15121 | TRPV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15122 | TRPV2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15123 | TRPV3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15124 | TRPV4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15125 | TRPV5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15126 | TRPV6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15127 | TRRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15128 | TRUB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15129 | TSACC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15130 | TSBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15131 | TSC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15132 | TSC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15133 | TSC22D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15134 | TSC22D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15135 | TSC22D3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15136 | TSC22D4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15137 | TSEN15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15138 | TSEN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15139 | TSEN34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15140 | TSEN54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15141 | TSFM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15142 | TSG101 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15143 | TSGA10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15144 | TSHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15145 | TSHR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15146 | Tshr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15147 | Tshr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15148 | TSHZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15149 | TSHZ2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15150 | TSHZ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15151 | TSKS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15152 | TSKU Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15153 | TSLP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15154 | TSN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15155 | TSNARE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15156 | TSNAX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15157 | TSPAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15158 | TSPAN10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15159 | TSPAN11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15160 | TSPAN12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15161 | TSPAN13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15162 | TSPAN14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15163 | TSPAN15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15164 | TSPAN18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15165 | TSPAN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15166 | TSPAN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15167 | TSPAN31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15168 | TSPAN32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15169 | TSPAN33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15170 | TSPAN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15171 | TSPAN5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15172 | TSPAN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15173 | TSPAN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15174 | TSPAN8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15175 | TSPAN9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15176 | TSPEAR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15177 | TSPO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15178 | TSPO2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15179 | TSPOAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15180 | TSPY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15181 | TSPYL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15182 | TSPYL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15183 | TSPYL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15184 | TSR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15185 | TSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15186 | TSR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15187 | TSSC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15188 | TSSK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15189 | TSSK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15190 | TST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15191 | TSTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15192 | TSTD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15193 | TTBK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15194 | TTBK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15195 | TTC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15196 | TTC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15197 | TTC13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15198 | TTC14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15199 | TTC16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15200 | TTC17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15201 | TTC19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15202 | TTC21B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15203 | TTC24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15204 | TTC26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15205 | TTC27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15206 | TTC28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15207 | TTC29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15208 | TTC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15209 | TTC32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15210 | TTC34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15211 | TTC36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15212 | TTC38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15213 | TTC39B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15214 | TTC39C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15215 | TTC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15216 | TTC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15217 | TTC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15218 | TTC7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15219 | TTC7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15220 | TTC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15221 | TTC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15222 | TTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15223 | TTF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15224 | TTI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15225 | TTI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15226 | TTK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15227 | TTL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15228 | TTLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15229 | TTLL12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15230 | TTLL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15231 | TTLL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15232 | TTLL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15233 | TTLL6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15234 | TTLL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15235 | TTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15236 | TTPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15237 | TTPAL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15238 | TTR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15239 | Ttr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15240 | Ttr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15241 | TTYH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15242 | TTYH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15243 | TTYH3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15244 | TUB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15245 | TUBA1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15246 | TUBA1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15247 | TUBA1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15248 | TUBA4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15249 | TUBA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15250 | TUBB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15251 | TUBB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15252 | TUBB2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15253 | TUBB2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15254 | TUBB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15255 | TUBB4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15256 | TUBB4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15257 | TUBB6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15258 | TUBB8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15259 | TUBD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15260 | TUBE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15261 | TUBG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15262 | TUBGCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15263 | TUBGCP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15264 | TUBGCP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15265 | TUBGCP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15266 | TUBGCP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15267 | TUFM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15268 | TUFT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15269 | TUG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15270 | TULP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15271 | TULP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15272 | TULP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15273 | TULP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15274 | TUSC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15275 | TUSC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15276 | TUT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15277 | TUT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15278 | TUT7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15279 | TWF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15280 | TWF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15281 | TWIST1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15282 | TWIST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15283 | TWNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15284 | TWSG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15285 | TXK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15286 | TXLNA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15287 | TXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15288 | TXN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15289 | TXNDC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15290 | TXNDC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15291 | TXNDC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15292 | TXNDC16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15293 | TXNDC17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15294 | TXNDC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15295 | TXNIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15296 | TXNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15297 | TXNL4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15298 | TXNRD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15299 | TXNRD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15300 | TYK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15301 | Tyk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15302 | Tyk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15303 | TYMP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15304 | TYMS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15305 | Tyms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15306 | Tyms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15307 | TYR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15308 | TYRO3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15309 | TYROBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15310 | TYRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15311 | TYSND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15312 | TYW5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15313 | U2AF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15314 | U2AF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15315 | U2SURP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15316 | UACA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15317 | UAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15318 | UAP1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15319 | UBA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15320 | UBA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15321 | UBA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15322 | UBA5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15323 | UBA52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15324 | UBA6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15325 | UBA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15326 | UBAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15327 | UBAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15328 | UBAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15329 | UBAP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15330 | UBAP2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15331 | UBASH3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15332 | UBASH3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15333 | UBB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15334 | UBC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15335 | UBD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15336 | UBE2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15337 | UBE2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15338 | UBE2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15339 | UBE2D1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15340 | UBE2D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15341 | UBE2D3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15342 | UBE2E1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15343 | UBE2E2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15344 | UBE2E3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15345 | UBE2F Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15346 | UBE2G1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15347 | UBE2G2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15348 | UBE2H Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15349 | UBE2I Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15350 | UBE2J1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15351 | UBE2J2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15352 | UBE2K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15353 | UBE2L3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15354 | UBE2L6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15355 | UBE2M Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15356 | UBE2N Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15357 | UBE2O Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15358 | UBE2Q1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15359 | UBE2Q2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15360 | UBE2R2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15361 | UBE2S Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15362 | UBE2T Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15363 | UBE2U Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15364 | UBE2V1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15365 | UBE2V2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15366 | UBE2W Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15367 | UBE2Z Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15368 | UBE3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15369 | UBE3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15370 | UBE3C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15371 | UBE4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15372 | UBE4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15373 | UBIAD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15374 | UBL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15375 | UBL4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15376 | UBL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15377 | UBL7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15378 | UBLCP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15379 | UBN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15380 | UBN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15381 | UBOX5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15382 | UBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15383 | UBQLN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15384 | UBQLN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15385 | UBQLN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15386 | UBR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15387 | UBR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15388 | UBR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15389 | UBR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15390 | UBR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15391 | UBR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15392 | UBTD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15393 | UBTF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15394 | UBXN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15395 | UBXN11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15396 | UBXN2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15397 | UBXN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15398 | UBXN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15399 | UBXN7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15400 | UCHL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15401 | UCHL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15402 | UCHL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15403 | UCK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15404 | UCK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15405 | UCKL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15406 | UCMA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15407 | UCN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15408 | UCN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15409 | UCN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15410 | UCP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15411 | UCP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15412 | UCP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15413 | UFC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15414 | UFD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15415 | UFL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15416 | UFM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15417 | UFSP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15418 | UFSP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15419 | UGCG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15420 | Ugcg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15421 | Ugcg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15422 | UGDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15423 | UGGT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15424 | UGGT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15425 | UGP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15426 | UGT1A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15427 | UGT1A10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15428 | UGT1A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15429 | UGT1A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15430 | UGT1A6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15431 | UGT1A7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15432 | UGT1A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15433 | UGT1A9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15434 | UGT2A1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15435 | UGT2A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15436 | UGT2A3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15437 | UGT2B10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15438 | UGT2B15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15439 | UGT2B17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15440 | UGT2B4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15441 | UGT2B7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15442 | UGT3A2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15443 | UGT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15444 | UHMK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15445 | UHRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15446 | UHRF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15447 | UIMC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15448 | ULBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15449 | ULBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15450 | ULBP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15451 | ULK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15452 | Ulk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15453 | Ulk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15454 | ULK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15455 | Ulk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15456 | Ulk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15457 | ULK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15458 | ULK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15459 | UMOD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15460 | UMODL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15461 | UMPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15462 | UNC119 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15463 | UNC119B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15464 | UNC13A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15465 | UNC13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15466 | UNC13C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15467 | UNC13D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15468 | UNC45A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15469 | UNC45B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15470 | UNC50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15471 | UNC5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15472 | UNC5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15473 | UNC5C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15474 | UNC5D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15475 | UNC80 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15476 | UNC93B1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15477 | UNCX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15478 | UNG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15479 | UNK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15480 | UNKL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15481 | UPB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15482 | UPF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15483 | UPF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15484 | UPF3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15485 | UPF3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15486 | UPK1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15487 | UPK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15488 | UPK3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15489 | UPK3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15490 | UPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15491 | UPP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15492 | UPRT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15493 | UQCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15494 | UQCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15495 | UQCC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15496 | UQCR10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15497 | UQCR11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15498 | UQCRB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15499 | UQCRC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15500 | UQCRC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15501 | UQCRFS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15502 | UQCRH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15503 | UQCRQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15504 | URAD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15505 | URB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15506 | URB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15507 | URI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15508 | URM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15509 | UROD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15510 | UROS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15511 | USB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15512 | USE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15513 | USF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15514 | USF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15515 | USF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15516 | USH1C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15517 | USH1G Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15518 | USH2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15519 | USO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15520 | USP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15521 | USP10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15522 | USP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15523 | USP12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15524 | USP13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15525 | USP14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15526 | USP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15527 | USP16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15528 | USP18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15529 | USP19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15530 | USP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15531 | USP20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15532 | USP21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15533 | USP22 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15534 | USP24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15535 | USP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15536 | USP26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15537 | USP27X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15538 | USP28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15539 | USP29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15540 | USP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15541 | USP30 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15542 | USP31 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15543 | USP32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15544 | USP33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15545 | USP34 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15546 | USP35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15547 | USP36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15548 | USP37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15549 | USP38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15550 | USP39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15551 | USP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15552 | USP40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15553 | USP42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15554 | USP43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15555 | USP44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15556 | USP45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15557 | USP46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15558 | USP47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15559 | USP48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15560 | USP49 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15561 | USP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15562 | USP50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15563 | USP51 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15564 | USP53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15565 | USP54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15566 | USP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15567 | USP6NL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15568 | USP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15569 | USP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15570 | USP9X Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15571 | USP9Y Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15572 | USPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15573 | UST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15574 | UTF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15575 | UTP14A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15576 | UTP15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15577 | UTP20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15578 | UTP25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15579 | UTP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15580 | UTP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15581 | UTP6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15582 | UTRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15583 | UTS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15584 | UTS2R Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15585 | Uts2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15586 | Uts2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15587 | UTY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15588 | UVRAG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15589 | UVSSA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15590 | UXS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15591 | UXT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15592 | VAC14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15593 | VAMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15594 | VAMP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15595 | VAMP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15596 | VAMP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15597 | VAMP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15598 | VAMP7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15599 | VAMP8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15600 | VANGL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15601 | VANGL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15602 | VAPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15603 | VAPB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15604 | VARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15605 | VARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15606 | VASH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15607 | VASH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15608 | VASN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15609 | VASP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15610 | VAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15611 | VAT1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15612 | VAV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15613 | VAV2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15614 | VAV3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15615 | VAX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15616 | VAX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15617 | VBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15618 | VCAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15619 | VCAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15620 | VCL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15621 | VCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15622 | Vcp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15623 | Vcp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15624 | VCPIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15625 | VCX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15626 | VCX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15627 | VCX3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15628 | VCY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15629 | VDAC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15630 | VDAC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15631 | VDAC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15632 | VDR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15633 | Vdr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15634 | Vdr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15635 | VEGFA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15636 | VEGFB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15637 | VEGFC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15638 | VEGFD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15639 | VENTX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15640 | VEPH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15641 | VEZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15642 | VEZT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15643 | VGF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15644 | VGLL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15645 | VGLL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15646 | VGLL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15647 | VGLL4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15648 | VHL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15649 | VHLL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15650 | VIL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15651 | VILL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15652 | VIM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15653 | VIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15654 | VIPAS39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15655 | VIPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15656 | VIPR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15657 | VIRMA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15658 | VIT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15659 | VKORC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15660 | VKORC1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15661 | VLDLR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15662 | VMA21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15663 | VMAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15664 | VMO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15665 | VMP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15666 | VNN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15667 | VNN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15668 | VOPP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15669 | VPREB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15670 | VPREB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15671 | VPS11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15672 | VPS13A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15673 | VPS13B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15674 | VPS13C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15675 | VPS13D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15676 | VPS16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15677 | VPS18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15678 | VPS25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15679 | VPS26A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15680 | VPS26B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15681 | VPS28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15682 | VPS29 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15683 | VPS33A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15684 | VPS33B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15685 | VPS35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15686 | VPS35L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15687 | VPS36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15688 | VPS37A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15689 | VPS37B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15690 | VPS39 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15691 | VPS41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15692 | VPS45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15693 | VPS4A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15694 | VPS4B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15695 | VPS50 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15696 | VPS51 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15697 | VPS52 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15698 | VPS53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15699 | VPS54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15700 | VPS72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15701 | VPS8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15702 | VRK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15703 | VRK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15704 | VRK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15705 | VRTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15706 | VSIG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15707 | VSIG10L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15708 | VSIG2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15709 | VSIG4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15710 | VSIG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15711 | VSIR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15712 | VSNL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15713 | VSTM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15714 | VSTM2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15715 | VSTM2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15716 | VSTM2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15717 | VSTM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15718 | VSX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15719 | VSX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15720 | VTA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15721 | VTCN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15722 | VTI1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15723 | VTI1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15724 | VTN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15725 | VWA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15726 | VWA2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15727 | VWA3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15728 | VWA5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15729 | VWA5B2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15730 | VWA7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15731 | VWA8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15732 | VWC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15733 | VWCE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15734 | VWDE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15735 | VWF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15736 | VXN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15737 | WAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15738 | WAPL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15739 | WARS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15740 | WARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15741 | WAS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15742 | WASF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15743 | WASF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15744 | WASF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15745 | WASHC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15746 | WASHC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15747 | WASL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15748 | WBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15749 | WBP11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15750 | WBP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15751 | WBP2NL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15752 | WBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15753 | WDCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15754 | WDFY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15755 | WDFY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15756 | WDFY3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15757 | WDFY4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15758 | WDHD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15759 | WDPCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15760 | WDR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15761 | WDR11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15762 | WDR12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15763 | WDR13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15764 | WDR17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15765 | WDR18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15766 | WDR19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15767 | WDR20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15768 | WDR24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15769 | WDR25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15770 | WDR26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15771 | WDR27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15772 | WDR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15773 | WDR33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15774 | WDR35 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15775 | WDR36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15776 | WDR37 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15777 | WDR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15778 | WDR41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15779 | WDR43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15780 | WDR44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15781 | WDR45 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15782 | WDR46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15783 | WDR47 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15784 | WDR48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15785 | WDR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15786 | WDR54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15787 | WDR55 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15788 | WDR59 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15789 | WDR5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15790 | WDR6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15791 | WDR62 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15792 | WDR7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15793 | WDR72 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15794 | WDR73 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15795 | WDR74 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15796 | WDR75 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15797 | WDR76 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15798 | WDR77 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15799 | WDR81 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15800 | WDR82 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15801 | WDR89 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15802 | WDR90 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15803 | WDR91 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15804 | WDTC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15805 | WEE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15806 | Wee1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15807 | Wee1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15808 | WEE2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15809 | WFDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15810 | WFDC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15811 | WFDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15812 | WFIKKN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15813 | WFS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15814 | WHAMM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15815 | WHRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15816 | WIF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15817 | WIPF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15818 | WIPF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15819 | WIPI1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15820 | WIPI2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15821 | WIZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15822 | WLS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15823 | WNK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15824 | WNK2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15825 | WNK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15826 | WNK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15827 | WNT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15828 | WNT10A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15829 | WNT10B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15830 | WNT11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15831 | WNT16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15832 | WNT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15833 | WNT2B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15834 | WNT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15835 | WNT3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15836 | WNT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15837 | WNT5A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15838 | WNT5B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15839 | WNT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15840 | WNT7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15841 | WNT7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15842 | WNT8A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15843 | WNT8B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15844 | WNT9A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15845 | WNT9B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15846 | WRAP53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15847 | WRN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15848 | WRNIP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15849 | WSB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15850 | WSB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15851 | WSCD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15852 | WSCD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15853 | WT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15854 | WTAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15855 | WTIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15856 | WWC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15857 | WWC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15858 | WWC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15859 | WWOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15860 | WWP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15861 | WWP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15862 | WWTR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15863 | XAB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15864 | XAF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15865 | XBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15866 | XCL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15867 | XCL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15868 | XCR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15869 | XDH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15870 | Xdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15871 | Xdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15872 | XG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15873 | XIAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15874 | Xiap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15875 | XIAP Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15876 | XIRP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15877 | XIRP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15878 | XK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15879 | XKR4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15880 | XKR5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15881 | XKR8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15882 | XKR9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15883 | XKRX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15884 | XPA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15885 | XPC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15886 | XPNPEP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15887 | XPNPEP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15888 | XPNPEP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15889 | XPO1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15890 | XPO4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15891 | XPO5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15892 | XPO6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15893 | XPO7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15894 | XPOT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15895 | XPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15896 | XRCC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15897 | XRCC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15898 | XRCC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15899 | XRCC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15900 | XRCC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15901 | XRCC6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15902 | XRN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15903 | XRN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15904 | XRRA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15905 | XXYLT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15906 | XYLB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15907 | XYLT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15908 | XYLT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15909 | YAE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15910 | YAF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15911 | YAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15912 | Yap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15913 | Yap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15914 | YARS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15915 | YBEY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15916 | YBX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15917 | YBX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15918 | YBX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15919 | YDJC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15920 | YEATS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15921 | YEATS4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15922 | YES1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15923 | YIF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15924 | YIPF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15925 | YIPF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15926 | YIPF6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15927 | YKT6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15928 | YLPM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15929 | YME1L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15930 | YOD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15931 | YPEL2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15932 | YPEL3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15933 | YPEL5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15934 | YRDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15935 | YTHDC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15936 | YTHDC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15937 | YTHDF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15938 | YTHDF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15939 | YTHDF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15940 | YWHAB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15941 | YWHAE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15942 | YWHAG Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15942A | YWHAG Human Pre-designed siRNA Set A-3 | Oligonucleotides | |
| HY-RS15943 | YWHAH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15944 | YWHAQ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15945 | YWHAZ Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15946 | YY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15947 | YY1AP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15948 | YY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15949 | ZACN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15950 | ZAN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15951 | ZAP70 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15952 | ZAR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15953 | ZBBX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15954 | ZBED1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15955 | ZBED2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15956 | ZBED3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15957 | ZBED6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15958 | ZBP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15959 | ZBTB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15960 | ZBTB10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15961 | ZBTB11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15962 | ZBTB12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15963 | ZBTB14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15964 | ZBTB16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15965 | ZBTB17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15966 | ZBTB18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15967 | ZBTB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15968 | ZBTB20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15969 | ZBTB24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15970 | ZBTB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15971 | ZBTB32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15972 | ZBTB33 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15973 | ZBTB38 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15974 | ZBTB4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15975 | ZBTB40 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15976 | ZBTB43 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15977 | ZBTB46 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15978 | ZBTB48 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15979 | ZBTB7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15980 | ZBTB7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15981 | ZBTB7C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15982 | ZBTB9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15983 | ZC2HC1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15984 | ZC3H10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15985 | ZC3H11A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15986 | ZC3H12A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15987 | ZC3H12D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15988 | ZC3H13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15989 | ZC3H14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15990 | ZC3H15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15991 | ZC3H18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15992 | ZC3H3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15993 | ZC3H4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15994 | ZC3H6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15995 | ZC3H7B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15996 | ZC3H8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15997 | ZC3HAV1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15998 | ZC3HC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS15999 | ZC4H2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16000 | ZCCHC12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16001 | ZCCHC14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16002 | ZCCHC17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16003 | ZCCHC24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16004 | ZCCHC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16005 | ZCCHC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16006 | ZCCHC7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16007 | ZCCHC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16008 | ZCRB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16009 | ZCWPW1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16010 | ZDBF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16011 | ZDHHC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16012 | ZDHHC11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16013 | ZDHHC13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16014 | ZDHHC14 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16015 | ZDHHC15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16016 | ZDHHC17 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16017 | ZDHHC18 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16018 | ZDHHC19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16019 | ZDHHC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16020 | ZDHHC20 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16021 | ZDHHC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16022 | ZDHHC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16023 | ZDHHC8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16024 | ZDHHC9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16025 | ZEB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16026 | ZEB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16027 | ZER1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16028 | ZFAND1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16029 | ZFAND2A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16030 | ZFAND3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16031 | ZFAND5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16032 | ZFAND6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16033 | ZFAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16034 | ZFC3H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16035 | ZFHX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16036 | ZFHX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16037 | ZFHX4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16038 | ZFP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16039 | ZFP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16040 | ZFP36 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16041 | ZFP36L1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16042 | ZFP36L2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16043 | ZFP42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16044 | ZFP57 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16045 | ZFP64 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16046 | ZFP91 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16047 | ZFPL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16048 | ZFPM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16049 | ZFPM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16050 | ZFR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16051 | ZFR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16052 | ZFTA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16053 | ZFX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16054 | ZFY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16055 | ZFYVE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16056 | ZFYVE16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16057 | ZFYVE19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16058 | ZFYVE21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16059 | ZFYVE26 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16060 | ZFYVE27 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16061 | ZFYVE28 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16062 | ZFYVE9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16063 | ZG16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16064 | ZG16B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16065 | ZGLP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16066 | ZGPAT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16067 | ZGRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16068 | ZHX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16069 | ZHX2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16070 | Zhx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16071 | Zhx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16072 | ZHX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16073 | ZIC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16074 | ZIC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16075 | ZIC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16076 | ZIC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16077 | ZIC5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16078 | ZIK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16079 | ZIM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16080 | ZIM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16081 | ZKSCAN1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16082 | ZKSCAN3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16083 | ZKSCAN8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16084 | ZMAT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16085 | ZMAT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16086 | ZMAT4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16087 | ZMIZ1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16088 | ZMPSTE24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16089 | ZMYM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16090 | ZMYM3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16091 | ZMYM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16092 | ZMYM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16093 | ZMYND10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16094 | ZMYND11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16095 | ZMYND15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16096 | ZMYND8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16097 | ZNF10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16098 | ZNF106 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16099 | ZNF117 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16100 | ZNF132 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16101 | ZNF141 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16102 | ZNF142 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16103 | ZNF143 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16104 | ZNF148 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16105 | ZNF154 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16106 | ZNF165 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16107 | ZNF185 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16108 | ZNF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16109 | ZNF207 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16110 | ZNF217 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16111 | ZNF219 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16112 | ZNF225 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16113 | ZNF236 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16114 | ZNF24 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16115 | ZNF263 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16116 | ZNF274 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16117 | ZNF277 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16118 | ZNF280C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16119 | ZNF280D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16120 | ZNF281 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16121 | ZNF282 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16122 | ZNF292 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16123 | ZNF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16124 | ZNF318 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16125 | ZNF326 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16126 | ZNF331 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16127 | ZNF335 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16128 | ZNF341 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16129 | ZNF346 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16130 | ZNF354C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16131 | ZNF365 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16132 | ZNF367 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16133 | ZNF384 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16134 | ZNF385B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16135 | ZNF385D Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16136 | ZNF395 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16137 | ZNF407 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16138 | ZNF410 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16139 | ZNF423 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16140 | ZNF436 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16141 | ZNF44 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16142 | ZNF451 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16143 | ZNF460 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16144 | ZNF462 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16145 | ZNF467 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16146 | ZNF469 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16147 | ZNF503 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16148 | ZNF507 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16149 | ZNF512 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16150 | ZNF512B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16151 | ZNF521 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16152 | ZNF536 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16153 | ZNF558 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16154 | ZNF582 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16155 | ZNF592 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16156 | ZNF595 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16157 | ZNF598 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16158 | ZNF608 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16159 | ZNF609 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16160 | ZNF622 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16161 | ZNF638 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16162 | ZNF644 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16163 | ZNF652 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16164 | ZNF683 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16165 | ZNF687 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16166 | ZNF692 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16167 | ZNF703 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16168 | ZNF704 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16169 | ZNF711 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16170 | ZNF717 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16171 | ZNF740 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16172 | ZNF746 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16173 | ZNF750 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16174 | ZNF768 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16175 | ZNF77 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16176 | ZNF804A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16177 | ZNF827 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16178 | ZNF831 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16179 | ZNF92 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16180 | ZNFX1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16181 | ZNHIT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16182 | ZNHIT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16183 | ZNRF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16184 | ZNRF2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16185 | ZNRF3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16186 | ZP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16187 | ZP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16188 | ZP3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16189 | ZP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16190 | ZPBP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16191 | ZPLD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16192 | ZPR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16193 | ZRANB1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16194 | ZRANB2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16195 | ZRANB3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16196 | ZRSR2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16197 | ZSCAN10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16198 | ZSCAN12 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16199 | ZSCAN2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16200 | ZSCAN21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16201 | ZSCAN25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16202 | ZSCAN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16203 | ZSWIM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16204 | ZSWIM5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16205 | ZSWIM6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16206 | ZSWIM8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16207 | ZUP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16208 | ZW10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16209 | ZWILCH Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16210 | ZWINT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16211 | ZXDA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16212 | ZXDB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16213 | ZXDC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16214 | ZYG11B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16215 | ZYX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16216 | ZZEF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16217 | ZZZ3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16218 | SLC14A1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16219 | SPP1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16220 | Bdnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16221 | Nphs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16222 | Crk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16223 | Fdx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16224 | Ssbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16225 | GLYATL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16226 | TMEM178A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16227 | Pck2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16227A | Pck2 Mouse Pre-designed siRNA Set A-1 | Oligonucleotides | |
| HY-RS16228 | Stc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16229 | Slc6a6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16232 | Slc39a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16233 | Slc39a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16234 | TMEM215 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16235 | Map2k4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16236 | Wwtr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16237 | Gsta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16239 | Acod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16240 | Slc27a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16241 | Camp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16242 | Defb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16243 | Defb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16244 | Acsl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16245 | Lmbrd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16246 | Ddit4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16247 | Ins2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16248 | Cpt1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16249 | Jmjd1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16250 | Piezo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16251 | ST8SIA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16252 | Ybx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16253 | Ano5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16254 | Ano10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16255 | Acsl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16256 | Acsl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16257 | Ffar2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16258 | Lipt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16259 | Lias Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16260 | Socs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16261 | Trib3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16262 | ERLEC1Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16263 | ITGBL1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16264 | HIGD1B Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16265 | NGF Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16266 | NRK Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16267 | ISLR Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16269 | TANGO1-L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16270 | TANGO1-S Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16271 | Nrf-2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16273 | Human BLACAT1 Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16273A | Human BLACAT1 Pre-designed siRNA Set A-1 | Oligonucleotides | |
| HY-RS16274 | Human CDC27P10 Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16275 | Cxadr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16276 | KRT19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16277 | SLAMF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16278 | IL2RB Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16279 | Human CDC27P9 Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16280 | FAM-labeled P3H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16281 | BRD4 Sus scrofa Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16283 | FAM-labeled P3H3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16286 | MFAP5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16287 | CYP27B1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16288 | Mafg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16290 | Mitf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16291 | Bnip3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16292 | Lrp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16293 | Lrp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16294 | Med24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16295 | Macc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16296 | P16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16297 | P53 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16298 | Edc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16299 | Ehd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16300 | Rap1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16301 | Rap1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16302 | PKD2 Pig Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16303 | MRPS16 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16305 | Snai2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16306 | Lgi4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16307 | mt-Nd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16308 | mt-Co1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16309 | Rab27a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16310 | S100a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16311 | Herc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16312 | NRG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16313 | HT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16314 | HCC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16315 | ST2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16316 | COPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16317 | TCO Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16318 | ACTD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16319 | TRAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16320 | TAM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16321 | LAP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16322 | PSC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16323 | MMS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16324 | CPP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16325 | RLS3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16326 | XIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16327 | TRAC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16328 | PKD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16329 | MS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16330 | TERC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16331 | BTC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16332 | FIM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16333 | CCT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16334 | PGD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16335 | CYTOR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16336 | HPPD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16337 | ROCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16338 | EOS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16339 | ANCR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16340 | IV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16341 | SSD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16342 | MALAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16343 | CNE-2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16344 | NTT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16345 | AK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16346 | INE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16347 | NS2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16348 | IGHG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16349 | CRE1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16350 | IGKC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16351 | LCS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16352 | IGLC2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16353 | H19 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16354 | IGLC1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16355 | SF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16356 | CTD Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16357 | MSE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16358 | IGHE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16359 | MRT10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16360 | AIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16361 | BOP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16362 | UOX Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16363 | EPPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16364 | BGLT3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16365 | VV Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16366 | ACF Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16367 | UCA1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16368 | APBA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16369 | OA3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16370 | GSM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16371 | RNR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16372 | MRGPRX3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16373 | C19orf81 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16374 | KIN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16375 | CSP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16376 | YAM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16377 | KIF25 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16378 | SNHG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16379 | TSSK4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16380 | UGT1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16381 | FBXO10 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16382 | NPBWR1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16383 | OR10H1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16384 | TMEM92 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16385 | C17orf99 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16386 | DEK Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16387 | DHS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16388 | HEY Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16389 | PSS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16390 | APCS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16391 | DSPS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16392 | GAGE7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16393 | SNHG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16394 | TSSK3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16395 | URGCP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16396 | WDR87 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16397 | ADGRF4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16398 | HOTAIR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16399 | MFAP3L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16400 | MRPL21 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16401 | NT5C3A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16402 | PINLYP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16403 | SYCE1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16404 | UNC5CL Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16405 | ATP13A4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16406 | APOBEC3B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16407 | CSGALNACT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16408 | AN Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16409 | NM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16410 | DIP Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16411 | DSE Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16412 | CECR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16413 | CSP2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16414 | DBET Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16415 | LCDR Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16416 | MZF1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16417 | SPIC Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16418 | ABHD8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16419 | DCTN6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16420 | FBXW2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16421 | IFRD2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16422 | KYAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16423 | MITD1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16424 | PAQR3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16425 | RNF32 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16426 | RWDD4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16427 | TDRD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16428 | TIGD6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16429 | VWC2L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16430 | GLT8D2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16431 | GRIN2C Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16432 | IMMP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16433 | MRPL11 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16434 | MRPL13 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16435 | NBPF15 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16436 | RNF166 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16437 | UBAP1L Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16438 | ZNF605 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16439 | ABHD16B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16440 | ANKRD54 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16441 | BHLHE23 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16442 | FAM177B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16443 | FASTKD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16444 | SLC35E3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16445 | TDGF1P3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16446 | TMEM251 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16447 | NAALADL1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16448 | AK6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16449 | ECT Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16450 | MAA Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16451 | MHB Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16452 | PRS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16453 | SM1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16454 | THM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16455 | CDS1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16456 | HCCS Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16457 | IGHM Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16458 | MEG3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16459 | NXF5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16460 | RNY1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16461 | XIST Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16462 | ARMH1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16463 | CABP5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16464 | CCAT1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16465 | CHST7 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16466 | CMTM2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16467 | GIPC3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16468 | HEMK1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16469 | HMGN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16470 | KAAG1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16471 | LIPT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16472 | LRFN4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16473 | LUZP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16474 | MFSD9 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16475 | MS4A8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16476 | NIM1K Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16477 | NUDT8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16478 | NUP42 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16479 | NYAP1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16480 | OR1G1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16481 | OR2K2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16482 | OR2T4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16483 | OVCH2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16484 | PART1 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16485 | RNFT2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16486 | RRP7A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16487 | RUFY2 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16488 | SMIM4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16489 | SNHG6 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16490 | SPAG8 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16491 | SSBP4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16492 | TAF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16493 | TIGD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16494 | TMTC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16495 | UPK1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16496 | USP41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16497 | ZBED5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16498 | Egf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16499 | Sds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16500 | Hmgb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16501 | Trpv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16502 | Cd36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16503 | Ldha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16504 | Hgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16505 | Pcsk9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16506 | Gpx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16507 | Lox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16508 | Mettl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16509 | Vhl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16510 | Fgf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16511 | Bmp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16512 | Sag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16513 | Ace2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16514 | Ccl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16515 | Trpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16516 | Fap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16517 | Stat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16518 | Cxcl10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16519 | Gsdmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16520 | C3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16521 | Usp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16522 | Mif Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16523 | Gdnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16524 | Cxcl12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16525 | Sts Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16526 | Trem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16527 | Cd40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16528 | Igf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16529 | Nrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16530 | Gip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16531 | Lif Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16532 | Nhs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16533 | Ahr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16534 | Cck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16535 | Ccl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16536 | Cd44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16537 | Vegfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16538 | Wrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16539 | Fgf21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16540 | Cd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16541 | Crbn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16542 | Gdf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16543 | Dkk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16544 | Gspt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16545 | Enpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16546 | Npy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16547 | Osm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16548 | Cd47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16549 | Nqo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16550 | Tg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16551 | Slc7a11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16552 | Atf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16553 | Usp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16554 | Abca1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16555 | Cntf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16556 | Acsl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16557 | Bcl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16558 | Pfkfb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16559 | Foxo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16560 | Trem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16561 | Txnip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16562 | Sp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16563 | Mlkl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16564 | Fer Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16565 | Tigit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16566 | Epo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16567 | Usp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16568 | Sos1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16569 | Pam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16570 | Smarca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16571 | Igf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16572 | Lcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16573 | Nr4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16574 | Eno1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16575 | Angptl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16576 | Hk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16577 | Ogt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16578 | Lck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16579 | S100a9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16580 | Tfeb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16581 | Tat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16582 | Fpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16583 | Mat2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16584 | Gapdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16585 | Cd19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16586 | Vip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16587 | Irf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16588 | Ptpn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16589 | Aim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16590 | Fgf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16591 | Fdx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16592 | Pgk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16593 | S100a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16594 | Ccl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16595 | Trpc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16596 | Tpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16597 | Axl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16598 | Bcr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16599 | Shh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16600 | Cd74 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16601 | Wdr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16602 | Cxcl13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16603 | Cx3cl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16604 | Blm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16605 | Fabp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16606 | Egr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16607 | Klf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16608 | Pink1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16609 | Ccl20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16610 | Fgf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16611 | Nrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16612 | Kif18a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16613 | Cxcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16614 | Trpc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16615 | Ldlr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16616 | Rrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16617 | Pdk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16618 | Mpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16619 | Fpr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16620 | Cdcp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16621 | Fabp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16622 | Gpnmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16623 | Trpv4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16624 | Mbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16625 | Cp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16626 | Bmp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16627 | Loxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16628 | Tslp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16629 | Sfn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16630 | Gpc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16631 | Glp1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16632 | Foxo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16633 | Pth Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16634 | Usp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16635 | Fen1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16636 | Kdm5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16637 | pc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16638 | Usp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16639 | Cxcl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16640 | Cyp1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16641 | Foxm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16642 | Ccl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16643 | Gstp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16644 | H2ax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16645 | Cd86 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16646 | Il11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16647 | Anxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16648 | Mthfd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16649 | Fgf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16650 | Runx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16651 | Dtnb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16652 | Sox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16653 | Cxcl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16654 | Pde4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16655 | Bid Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16656 | Tet2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16657 | Dgat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16658 | Icam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16659 | Pla2g7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16660 | Th Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16661 | Brca1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16662 | Eed Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16663 | Traf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16664 | Kdm5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16665 | Cat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16666 | Il33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16667 | Dgat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16668 | Itgb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16669 | Crh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16670 | Lrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16671 | Mst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16672 | Pcna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16673 | Acss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16674 | Vegfc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16675 | Oga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16676 | Klf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16677 | Xbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16678 | Mertk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16679 | S100a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16680 | Mtap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16681 | Cdc42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16683 | Uhrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16684 | Bptf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16685 | Il18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16686 | Lag3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16687 | Zbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16688 | Mb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16689 | Id1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16690 | Cd22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16691 | Il21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16692 | Rspo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16693 | Cxcl16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16694 | Prdx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16695 | Alkbh5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16696 | Cdkn1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16697 | Setdb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16698 | Fgf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16699 | Trh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16700 | Xpo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16701 | Cpz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16702 | Aqp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16703 | Ccl22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16704 | Ikzf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16705 | Kdm6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16706 | Wnt3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16707 | Cxcl11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16708 | Ccl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16709 | Nat10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16710 | Erf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16711 | Erg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16712 | Fas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16713 | Yy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16714 | Fgf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16715 | Gas6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16716 | Irf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16717 | Jag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16718 | Hmox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16719 | Angpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16720 | Dll3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16721 | Tspo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16722 | Sarm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16723 | Cdkn2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16724 | Hr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16725 | Pnp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16726 | Cd14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16727 | Abhd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16728 | Blk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16729 | Mdk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16730 | Spr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16731 | Nsd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16732 | Prc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16733 | Ptpn11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16734 | Fgf23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16735 | Otub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16736 | Chi3l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16737 | Cyp1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16738 | Pkmyt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16739 | Tmprss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16740 | Hp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16741 | Cdc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16742 | Rac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16743 | Tfrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16744 | Usp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16745 | Uchl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16746 | Avp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16747 | Set Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16748 | Nnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16749 | Usp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16750 | Cs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16751 | Cd70 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16752 | Ghrh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16753 | Epha2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16754 | Itgav Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16755 | Trpm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16756 | Ilk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16757 | Ogg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16758 | Folr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16759 | Trpc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16760 | Csk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16761 | Emb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16762 | Cd63 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16763 | Dnmt3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16764 | Trim21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16765 | Gc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16766 | Ik Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16767 | Fn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16768 | Lyn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16769 | Clk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16770 | Smad3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16771 | Trpm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16772 | Dnmt3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16773 | Cd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16774 | Gne Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16775 | Mcu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16776 | Oat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16777 | Prl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16778 | Npc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16779 | Tet1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16780 | Ccnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16781 | Rack1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16782 | Ina Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16783 | Nsf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16784 | Cd34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16785 | Cry1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16786 | Csf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16787 | Nppb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16788 | Saa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16789 | Spop Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16790 | Gan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16791 | Pvr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16792 | Ttk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16793 | Mdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16794 | Hmgb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16795 | Il23r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16796 | Kdm2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16797 | Ugt1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16798 | S100a10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16799 | Ahcy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16800 | Irf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16801 | Ror1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16802 | Panx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16803 | Smarca4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16804 | Lbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16805 | Ifng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16806 | Lrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16807 | Phb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16808 | Tlr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16809 | C6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16810 | Cort Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16811 | Cd200 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16812 | Dapk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16813 | Kdm2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16814 | Taar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16815 | Fos Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16816 | Lat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16817 | Tes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16818 | Ccl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16819 | Icos Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16820 | Saa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16821 | Igfbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16822 | Igf2bp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16823 | Cd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16824 | Gca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16825 | Brca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16826 | Ccl17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16827 | Cdc20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16828 | Dusp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16829 | Ube2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16830 | Usp30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16831 | Slc1a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16832 | Ang Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16833 | Gem Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16834 | Ran Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16835 | Cd52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16836 | Cd55 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16837 | Irf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16838 | Nek2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16839 | Senp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16840 | Timp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16841 | Amh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16842 | F12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16843 | Ccl8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16844 | Cd27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16845 | Grk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16846 | Gsdme Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16847 | Itgb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16848 | Sparc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16849 | Igf2bp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16850 | Mrgprx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16851 | Ak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16852 | Rb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16853 | Csf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16854 | Il22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16855 | Anxa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16856 | Hipk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16857 | Kcnh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16858 | Kdm5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16859 | Traf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16860 | Trpv3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16861 | Mettl14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16862 | Fth1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16863 | Muc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16864 | Runx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16865 | Stim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16866 | Lgals9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16867 | F3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16868 | Mgll Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16869 | Fcgrt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16870 | Tead4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16871 | Usp20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16872 | Vdac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16873 | F2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16874 | Afp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16875 | Crp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16876 | Hck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16877 | Sf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16878 | Dll4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16879 | Ets1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16880 | Sv2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16881 | Zeb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16882 | Lgals3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16883 | Angptl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16884 | Nf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16885 | Comp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16886 | Ddx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16887 | Dpp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16888 | Rbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16889 | Tgm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16890 | Cyp2e1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16891 | Grp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16892 | Ltb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16893 | Gpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16894 | Il7r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16895 | Irs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16896 | Mdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16897 | Ccl11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16898 | Fads2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16899 | Foxp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16900 | Fstl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16901 | Itga5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16902 | Ptgs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16903 | Thbs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16904 | Aldh1a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16905 | F5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16906 | Cd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16907 | Mok Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16908 | Tyr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16909 | Atf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16910 | Dll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16911 | Kat7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16912 | Npff Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16913 | Abcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16914 | Cd226 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16915 | Fdft1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16916 | Fkbp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16917 | Trpm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16918 | Atp1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16919 | Slamf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16920 | Ide Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16921 | Cd80 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16922 | Erfe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16923 | Mdm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16924 | Pdk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16925 | Skp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16926 | Sod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16927 | Stom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16928 | Tnk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16929 | Atg4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16930 | Tacc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16931 | Sema4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16932 | F7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16933 | B2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16934 | Dap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16935 | Ddc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16936 | Ghr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16937 | Hrg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16938 | Btla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16939 | Sod2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16940 | Xcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16941 | Ccl19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16942 | Ncoa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16943 | Trpv6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16944 | Usp22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16945 | Cyp1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16946 | Gucy2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16947 | Ythdf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16948 | Adm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16949 | Eda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16950 | Mia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16951 | Csf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16952 | Irf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16953 | Oma1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16954 | Sdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16955 | Ucp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16956 | Adrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16957 | Ccl24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16958 | Cd163 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16959 | Hif1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16960 | Usp9x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16961 | Col1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16962 | Cit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16963 | Bap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16964 | Clk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16965 | Dkk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16966 | Ereg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16967 | Got1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16968 | Opa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16969 | Wnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16970 | Yes1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16971 | Fabp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16972 | Ffar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16973 | P4ha1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16974 | Postn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16975 | S100b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16976 | Setd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16977 | Tgfbi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16978 | Trpc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16979 | Cmklr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16980 | Tnfrsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16981 | Tnfrsf17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16982 | Asl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16983 | Cd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16984 | Mog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16985 | Omp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16986 | Plg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16987 | Rpe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16988 | Fshr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16989 | Ldhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16990 | Ltbr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16991 | Olr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16992 | Pfkp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16993 | Sost Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16994 | Asgr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16995 | Cxcr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16996 | Tgfb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16997 | Slc3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16998 | Steap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16999 | Cd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17000 | Gpt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17001 | Mal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17002 | Tox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17003 | Atf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17004 | Rhoa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17005 | Taf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17006 | Cd276 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17007 | Dusp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17008 | Hoxb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17009 | Jmjd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17010 | Igfbp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17011 | Cyp27a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17012 | Tnfrsf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17013 | Alb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17014 | Cbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17015 | Dbi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17016 | Mag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17017 | Msc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17018 | Pah Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17019 | Areg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17020 | Bub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17021 | Cd3e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17022 | Ebi3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17023 | Nae1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17024 | Pdpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17025 | Pin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17026 | Bach1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17027 | Pdpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17028 | Aldh1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17029 | Tnfsf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17030 | C2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17031 | Il7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17032 | Wt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17033 | Arg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17034 | Cd5l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17035 | Gfap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17036 | Il27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17037 | Mavs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17038 | Ppbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17039 | Gpr65 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17040 | Ikzf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17041 | Isg15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17042 | Lgals1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17043 | Ceacam5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17044 | Tnfaip3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17045 | Pgp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17046 | Tk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17047 | Tro Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17048 | Agr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17049 | Bmp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17050 | Cd68 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17051 | Cdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17052 | E2f1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17053 | Eras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17054 | Fgf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17055 | Rin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17056 | Tfam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17057 | Acox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17058 | Hbegf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17059 | Ifna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17060 | Lta4h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17061 | Shmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17062 | Ube2t Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17063 | Usp15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17064 | Arc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17065 | Fst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17066 | Hpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17067 | Nog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17068 | Por Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17069 | Slk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17070 | Hes1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17071 | Npm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17072 | Odc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17073 | Plat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17074 | Sdc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17075 | Actn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17076 | Aldoa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17077 | Apoa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17078 | Cxcl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17079 | Epcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17080 | Kat6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17081 | Nedd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17082 | Sf3b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17083 | Stub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17084 | Tead1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17085 | Tnfsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17086 | Tnfsf13b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17087 | Dsp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17088 | Ell Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17089 | Mcc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17090 | Mos Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17091 | Pgc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17092 | Rs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17093 | Cd33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17094 | Klf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17095 | Plau Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17096 | Tsc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17097 | Eif4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17098 | Mthfd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17099 | Tnfsf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17100 | Cbs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17101 | Des Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17102 | Dr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17103 | Ptn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17104 | Alad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17105 | Dlat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17106 | Fgl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17107 | Mall Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17108 | Mfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17109 | Itga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17110 | Kcnq2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17111 | Kdm3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17112 | Lamp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17113 | Ppm1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17114 | Vcam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17115 | Havcr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17116 | Nedd4l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17117 | fh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17118 | Cda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17119 | Cel Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17120 | Cpe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17121 | Hk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17122 | Ssb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17123 | Tdg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17124 | Atic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17125 | Cd81 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17126 | H6pd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17127 | Tph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17128 | Alcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17129 | Bmal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17130 | Bmp2k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17131 | Ccl25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17132 | Kdm4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17133 | Gprc5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17134 | Igfbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17135 | Mapkapk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17136 | C8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17137 | Nmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17138 | Fadd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17139 | Gast Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17140 | Hat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17141 | Rest Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17142 | Rsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17143 | Scap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17144 | Sqor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17145 | Camk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17146 | Nr5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17147 | Pdgfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17148 | Stat4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17149 | Suz12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17150 | Usp25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17151 | Trip13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17152 | Txnrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17153 | Csnk1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17154 | S100a11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17155 | Cfd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17156 | Gcg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17157 | Rho Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17158 | Sp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17159 | Sri Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17160 | Ccn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17161 | Eno2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17162 | Gpx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17163 | Grpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17164 | Gzma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17165 | Klk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17166 | Ngfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17167 | Proc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17168 | Slpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17169 | Cdh17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17170 | Gsk3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17171 | Kdm5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17172 | Lamp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17173 | Srpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17174 | Srsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17175 | Usp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17176 | Camkk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17177 | Cyp11b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17178 | Pik3ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17179 | Suv39h1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17180 | Gk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17181 | Abo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17182 | Cnp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17183 | Dcc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17184 | Lpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17185 | Me1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17186 | Brd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17187 | Dmpk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17188 | Etv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17189 | Fdps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17190 | Fut8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17191 | Fzd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17192 | Lifr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17193 | Msln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17194 | Spi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17195 | Upp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17196 | Wnt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17197 | Atad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17198 | Efna5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17199 | Ephb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17200 | Fgf18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17201 | Folr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17202 | Hspa8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17203 | Kdm6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17204 | Pick1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17205 | Ptpn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17206 | Qpctl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17207 | Sirpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17208 | Smad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17209 | Tradd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17210 | Trpm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17211 | Cyp7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17212 | Muc5ac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17213 | Notch3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17214 | Cad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17215 | Dcn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17216 | Ager Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17217 | Ass1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17218 | Bms1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17219 | Kynu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17220 | Nek7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17221 | Nsd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17222 | Tsc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17223 | Anxa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17224 | Apoc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17225 | Asic3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17226 | Bcat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17227 | Elane Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17228 | Foxo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17229 | Hpgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17230 | Il6st Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17231 | Masp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17232 | Nedd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17233 | Rbm39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17234 | Trpv2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17235 | Akr1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17236 | Igfbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17237 | Ythdf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17238 | Akr1b10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17239 | Tnfsf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17240 | C7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17241 | F11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17242 | Gaa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17243 | Gla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17244 | Id2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17245 | Pdf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17246 | Hrob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17247 | Poli Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17248 | Pomc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17249 | Ccl28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17250 | Clock Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17251 | Epha7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17252 | Fabp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17253 | Fndc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17254 | Lair1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17255 | Pvrig Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17256 | Alkbh3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17257 | Fancd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17258 | Sema3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17259 | Angptl8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17260 | Tnfsf18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17261 | Cth Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17262 | Fyn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17263 | Tnc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17264 | Ubd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17265 | Cd69 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17266 | Gzmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17267 | Il19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17268 | Lgmn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17269 | Psap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17270 | Rac2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17271 | Rbpj Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17272 | Selp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17273 | Ccne1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17274 | Cdh13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17275 | Efnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17276 | Sumo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17277 | Usp21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17278 | Cdc25a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17279 | Slc7a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17280 | Angptl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17281 | Slc31a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17282 | St6gal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17283 | Hsd17b13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17284 | Acd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17285 | Dbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17286 | Gal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17287 | Cd93 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17288 | Grk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17289 | Hdgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17290 | Klk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17291 | Lipa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17292 | Map2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17293 | Mycn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17294 | Pan2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17295 | Phb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17296 | Ppt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17297 | Rpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17298 | Tfpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17299 | Bcat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17300 | Dhcr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17301 | Ifnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17302 | Irak3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17303 | Mef2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17304 | Pdgfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17305 | Pola1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17306 | Ptpn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17307 | Stat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17308 | Stk11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17309 | Uchl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17310 | Zap70 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17311 | Dyrk1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17312 | Il1rl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17313 | Metap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17314 | Clec12a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17315 | Cyp11b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17316 | Tnfrsf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17317 | C9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17318 | Bad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17319 | Clu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17320 | Dbt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17321 | Mme Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17322 | Pxn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17323 | Tkt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17324 | Vim Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17325 | Acp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17326 | Ano1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17327 | Bag3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17328 | Cdo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17329 | Elk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17330 | Fzd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17331 | Gnal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17332 | Nbr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17333 | Nrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17334 | Qpct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17335 | Tbca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17336 | Trac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17337 | Brsk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17338 | Dclk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17339 | Foxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17340 | Gfral Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17341 | Grem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17342 | Il2rb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17343 | Lats1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17344 | Nr4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17345 | Pdcd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17346 | Smad4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17347 | Cthrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17348 | Cxcl14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17349 | Map3k1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17350 | Rictor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17351 | Sqstm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17352 | Tardbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17353 | Txndc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17354 | Tnfrsf13c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17355 | F8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17356 | Agl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17357 | Dhh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17358 | Emd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17359 | Fus Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17360 | Mpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17361 | Pln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17362 | Rp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17363 | Tst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17364 | Aoc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17365 | Cd37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17366 | Cd3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17367 | Crot Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17368 | Gad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17369 | Grk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17370 | Ist1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17371 | Lepr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17372 | Lrr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17373 | Nrg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17374 | Sat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17375 | Sox4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17376 | Sox9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17377 | Tpi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17378 | Baz2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17379 | Cisd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17380 | Csf3r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17381 | Enpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17382 | Ndrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17383 | Timp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17384 | Camk1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17385 | Dhcr24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17386 | S100a6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17387 | Ceacam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17388 | Mettl16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17389 | Slc34a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17390 | Tacstd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17391 | Tnfsf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17392 | Aip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17393 | Bsg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17394 | Cpm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17395 | Ipp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17396 | Lss Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17397 | Max Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17398 | Nf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17399 | Pdc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17400 | Pf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17401 | Pir Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17402 | Sms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17403 | Vwf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17404 | Arg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17405 | Chd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17406 | Edn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17407 | Grb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17408 | Kat5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17409 | Mcm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17410 | Nat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17411 | Nrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17412 | Ntn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17413 | Prlr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17414 | Rnf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17415 | Sele Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17416 | Tcf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17417 | Terc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17418 | Wtap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17419 | Cebpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17420 | Crtam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17421 | Masp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17422 | Plaur Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17423 | Prdx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17424 | Rspo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17425 | Trpm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17426 | Tssk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17427 | Tyro3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17428 | Usp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17429 | Usp13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17430 | Igfbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17431 | Il10ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17432 | Mettl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17433 | Piezo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17434 | Pla2g4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17435 | Tnfrsf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17436 | Ak7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17437 | Btc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17438 | Cfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17439 | Ckb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17440 | Dym Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17441 | Eng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17442 | Hbb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17443 | Nin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17444 | Sp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17445 | Aire Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17446 | Aqp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17447 | Aspn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17448 | Bst2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17449 | Cbx7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17450 | Cpb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17451 | Cpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17452 | Ecm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17453 | Ing1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17454 | Lcat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17455 | Musk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17456 | Npc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17457 | Thy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17458 | Aars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17459 | Cd101 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17460 | Cntn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17461 | Ffar3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17462 | Gpr17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17463 | Gpr75 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17464 | Gsto1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17465 | Il4i1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17466 | Inhba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17467 | Kdm4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17468 | Klrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17469 | Nupr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17470 | Prdx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17471 | Vtcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17472 | Arid1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17473 | Dnaja1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17474 | Ifngr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17475 | Metrnl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17476 | Pfkfb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17477 | Prima1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17478 | Ptprz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17479 | Cyp11a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17480 | Tnfrsf12a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17481 | Kl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17482 | Mgp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17483 | Nlk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17484 | Alpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17485 | Ambn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17486 | Cd8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17487 | Clk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17488 | Cps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17489 | Emp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17490 | Fim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17491 | Glul Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17492 | Has2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17493 | Hexa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17494 | Ogdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17495 | Ror2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17496 | Snd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17497 | Tgfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17498 | Usp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17499 | Abcg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17500 | Alpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17501 | Cd177 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17502 | Cdc37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17503 | Ddx3x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17504 | Fstl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17505 | Fzd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17506 | Hadha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17507 | Itgb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17508 | Nr2f6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17509 | Nr5a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17510 | Sfrp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17511 | Thbs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17512 | Trap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17513 | Chrna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17514 | Gpr132 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17515 | Npc1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17516 | Ptpn22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17517 | S100a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17518 | Igf2bp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17519 | Mrgprx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17520 | Smarcb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17521 | Aga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17522 | Cfh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17523 | Id3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17524 | Il9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17525 | Lum Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17526 | Nmu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17527 | Rgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17528 | sea Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17529 | Srf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17530 | Tec Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17531 | Ambp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17532 | Atg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17533 | Cav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17534 | Chd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17535 | Dlk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17536 | F13b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17537 | Fbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17538 | Il34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17539 | Klf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17540 | Nefl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17541 | Osmr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17542 | Ptk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17543 | Ptk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17544 | Acadm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17545 | Ccnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17546 | Efna3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17547 | Efnb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17548 | Fbxw7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17549 | Gpr39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17550 | Hmox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17551 | Htra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17552 | Ifna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17553 | Marco Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17554 | Pdia4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17555 | Pgam5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17556 | Ppm1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17557 | Ptprd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17558 | Rad52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17559 | Stk10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17560 | Vdac2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17561 | Vsig4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17562 | Adipoq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17563 | Anxa10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17564 | Ruvbl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17565 | Trim24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17566 | Aldh1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17567 | Pla2g2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17568 | Tnfsf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17569 | Ppp1r15a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17570 | Tnfrsf10b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17571 | Tnfrsf11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17572 | Abr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17573 | Acr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17574 | Nps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17575 | Pgd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17576 | She Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17577 | Tub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17578 | Aif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17579 | Atg7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17580 | Cap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17581 | Ccn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17582 | Cd83 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17583 | Cd99 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17584 | Cdh6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17585 | Dsg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17586 | Hunk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17587 | Kat8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17588 | Ncr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17589 | Nek6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17590 | Pck1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17591 | Rpa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17592 | Srgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17593 | Tap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17594 | Tff3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17595 | Thra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17596 | Tpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17597 | Vrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17598 | Adam9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17599 | Alas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17600 | Asic1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17601 | Atp7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17602 | Brcc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17603 | Cd164 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17604 | Cend1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17605 | Cox5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17606 | Enpep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17607 | Enpp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17608 | Hnf4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17609 | Mark2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17610 | Nfat5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17611 | Park7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17612 | Pde4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17613 | Prom1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17614 | Ptprf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17615 | Stx17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17616 | Wnt5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17617 | Clec2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17618 | Il1rap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17619 | Slamf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17620 | Tspan2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17621 | Gp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17622 | Lpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17623 | Lpp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17624 | Nts Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17625 | Omg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17626 | Sla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17627 | Sln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17628 | Tk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17629 | Uty Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17630 | Actb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17631 | Aox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17632 | Bcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17633 | Bdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17634 | Cdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17635 | Ctcf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17636 | Cyc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17637 | Fbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17638 | Fhl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17639 | Gnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17640 | Kng1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17641 | Ntn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17642 | Peg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17643 | Prep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17644 | Rcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17645 | Rem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17646 | Rheb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17647 | Rnf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17648 | St13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17649 | Stc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17650 | Tdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17651 | Tph2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17652 | C1qbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17653 | Cd320 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17654 | Chd1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17655 | Edil3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17656 | Efna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17657 | Ephb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17658 | Erap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17659 | Glud1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17660 | Gpr37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17661 | Gpr83 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17662 | Hmga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17663 | Hoxa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17664 | Il1rn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17665 | Klkb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17666 | Ptgr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17667 | Pth1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17668 | Angpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17669 | Cd40lg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17670 | Ruvbl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17671 | Slc6a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17672 | Csnk2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17673 | Slc16a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17674 | Boc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17675 | Ccs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17676 | Cic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17677 | Fga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17678 | Grn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17679 | Hgd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17680 | Me2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17681 | Vtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17682 | Adar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17683 | Ago2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17684 | Ddx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17685 | Dpp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17686 | Dsg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17687 | Eml2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17688 | Gclc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17689 | Iapp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17690 | Irf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17691 | Nrg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17692 | Pole Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17693 | Rbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17694 | Rps6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17695 | Scin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17696 | Six1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17697 | Ccnd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17698 | Dnm1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17699 | Dusp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17700 | Epha4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17701 | Fgf17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17702 | Hcls1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17703 | Il17f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17704 | Lypd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17705 | Mfap4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17706 | Mydgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17707 | Ncam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17708 | Nlrp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17709 | Pappa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17710 | Pdha1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17711 | Pgam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17712 | Socs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17713 | Ttbk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17714 | Usp46 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17715 | Usp47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17716 | Znrf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17717 | Abhd11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17718 | Adra2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17719 | Col3a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17720 | Fundc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17721 | Srebf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17722 | Prkar1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17723 | Tnfrsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17724 | F9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17725 | Agk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17726 | Agt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17727 | Hdc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17728 | Khk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17729 | Nes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17730 | Pyy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17731 | Rax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17732 | Ucn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17733 | Agrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17734 | Apob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17735 | Aqp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17736 | Arf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17737 | Aspa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17738 | Bbs4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17739 | Bst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17740 | Cd3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17741 | Ctf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17742 | Dlx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17743 | Fgf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17744 | Gnas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17745 | Hadh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17746 | Il24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17747 | Il31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17748 | Lrp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17749 | Mfn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17750 | Ptx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17751 | Sell Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17752 | Tff1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17753 | Tpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17754 | Uba1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17755 | Abcg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17756 | Aifm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17757 | Apaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17758 | Ash1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17759 | Bcas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17760 | Cirbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17761 | Dapk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17762 | Ephb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17763 | Fuca1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17764 | Gstm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17765 | Hipk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17766 | Itgax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17767 | Kmt2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17768 | Lamp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17769 | Nmur2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17770 | Olig2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17771 | Pnlip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17772 | Psmb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17773 | Ptbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17774 | Sftpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17775 | Spdef Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17776 | Trex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17777 | Usp18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17778 | Clec7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17779 | Cyp8b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17780 | Dusp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17781 | Impdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17782 | Map2k6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17783 | Samhd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17784 | Creb3l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17785 | Cyp17a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17786 | Gabarap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17787 | Serpini1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17788 | Bik Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17789 | Cga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17790 | Dct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17791 | Dcx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17792 | Ddt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17793 | F10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17794 | Fgg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17795 | Gp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17796 | Gss Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17797 | Ihh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17798 | Lep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17799 | Maf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17800 | Rp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17801 | Cd84 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17802 | Chl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17803 | Edar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17804 | Fbn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17805 | Fpr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17806 | Gale Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17807 | Gdf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17808 | Gls2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17809 | Got2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17810 | Hpca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17811 | Ibsp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17812 | Lap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17813 | Layn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17814 | Mbd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17815 | Nmbr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17816 | Paep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17817 | Pltp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17818 | Sod3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17819 | Thpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17820 | Trio Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17821 | Zeb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17822 | Aebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17823 | Bcl10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17824 | Cd79a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17825 | Cd79b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17826 | Cytl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17827 | Dock5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17828 | Efna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17829 | Eif4e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17830 | Fgf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17831 | Il36g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17832 | Itga4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17833 | Kdm4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17834 | Klrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17835 | Klrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17836 | Mbnl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17837 | Pde1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17838 | Phpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17839 | Plbd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17840 | Procr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17841 | Prss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17842 | Psat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17843 | Qsox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17844 | Rnf43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17845 | Ywhae Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17846 | Atp2a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17847 | Card11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17848 | Clec4e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17849 | Cyb5r3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17850 | Eif4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17851 | Insig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17852 | Lypla1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17853 | Metap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17854 | Recql5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17855 | Sema7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17856 | Snap25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17857 | Steap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17858 | Tcf7l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17859 | Tfap2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17860 | Tspan7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17861 | Gadd45a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17862 | Pla2g15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17863 | Adamdec1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17864 | Adamts13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17865 | Xk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17866 | En1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17867 | Fah Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17868 | Gk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17869 | Gp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17870 | Hal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17871 | Id4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17872 | Ltf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17873 | Mak Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17874 | Tfg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17875 | Ubc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17876 | Acan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17877 | Cap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17878 | Cast Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17879 | Ccn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17880 | Cd46 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17881 | Ctsz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17882 | Cyld Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17883 | Fgf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17884 | Gipr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17885 | Gmfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17886 | Hap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17887 | Inf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17888 | Itch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17889 | Jaml Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17890 | Pdk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17891 | Polq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17892 | Pomk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17893 | Psca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17894 | Rbm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17895 | Rpl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17896 | Skp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17897 | Stac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17898 | Tal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17899 | Tff2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17900 | Ucp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17901 | Abcd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17902 | Birc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17903 | Capn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17904 | Cd151 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17905 | Cdh16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17906 | Ch25h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17907 | Cryab Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17908 | Fabp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17909 | G3bp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17910 | Gata3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17911 | Gata6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17912 | Hmga1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17913 | Hspb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17914 | Kpna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17915 | Lhcgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17916 | Mark3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17917 | Nudt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17918 | Pbrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17919 | Prdx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17920 | Prss3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17921 | Akr1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17922 | Fcgr2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17923 | Hectd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17924 | Ifitm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17925 | Jchain Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17926 | Lancl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17927 | Lrrc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17928 | Lrrc32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17929 | Pecam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17930 | Tmsb4x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17931 | Tnfsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17932 | Il1rapl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17933 | Serpine2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17934 | Tnfrsf18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17935 | Ecd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17936 | Ncl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17937 | Otc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17938 | Prx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17939 | Sp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17940 | Vgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17941 | Zp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17942 | Als2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17943 | Aoc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17944 | Aqp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17945 | Aven Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17946 | Bmp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17947 | Calr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17948 | Cblb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17949 | Ccn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17950 | Cdnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17951 | Ddb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17952 | Fosb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17953 | Gbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17954 | Gpd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17955 | Gpr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17956 | Gys1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17957 | Hpse Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17958 | Ica1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17959 | Idua Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17960 | Imp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17961 | Klk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17962 | Lrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17963 | Map4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17964 | Mcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17965 | Pon1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17966 | Rxra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17967 | Sqle Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17968 | St14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17969 | Aldob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17970 | Asxl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17971 | Atg10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17972 | Atp7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17973 | Cadm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17974 | Clic3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17975 | Corin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17976 | Cript Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17977 | Efnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17978 | Fubp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17979 | Gpr18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17980 | Hmgb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17981 | Igf2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17982 | Inhbe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17983 | Itgb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17984 | Mapk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17985 | Mastl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17986 | Mrpl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17987 | Naa10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17988 | Nlrc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17989 | Orai1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17990 | Pdia6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17991 | Prdx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17992 | Sfrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17993 | Smoc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17994 | Smpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17995 | Srpx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17996 | Traf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17997 | Trpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17998 | Trpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17999 | Twsg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18000 | Ube2s Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18001 | Usp28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18002 | Vldlr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18003 | A4galt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18004 | Adcy10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18005 | Efemp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18006 | Ifngr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18007 | Megf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18008 | Nmnat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18009 | Parp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18010 | Plxdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18011 | S100a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18012 | Trim28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18013 | B4galt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18014 | Gadd45b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18015 | Pla2g1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18016 | Siglec1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18017 | Hsp90ab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18018 | Bmf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18019 | Dmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18020 | En2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18021 | Htt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18022 | Rrh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18023 | Sp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18024 | Sst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18025 | Tsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18026 | Ung Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18027 | Abat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18028 | Cct2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18029 | Chad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18030 | Cst3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18031 | Cygb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18032 | Dffa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18033 | E2f4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18034 | Hao1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18035 | Heph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18036 | Il16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18037 | Klk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18038 | Lad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18039 | M1ap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18040 | Manf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18041 | Mdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18042 | Phf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18043 | Pkn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18044 | Ppat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18045 | Ppia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18046 | Psph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18047 | Sae1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18048 | Sdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18049 | Tpbg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18050 | Tsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18051 | Uba5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18052 | Abcg8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18053 | Acss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18054 | Adrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18055 | Card9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18056 | Cd160 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18057 | Chit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18058 | Clcf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18059 | Ddit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18060 | Defb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18061 | Egfl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18062 | Ephb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18063 | Fam3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18064 | Fosl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18065 | Fosl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18066 | Gpa33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18067 | Grhpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18068 | Itgb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18069 | Kcnk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18070 | L1cam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18071 | Muc16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18072 | Nfil3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18073 | Nr1d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18075 | Pebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18076 | Psen1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18077 | Ptprc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18078 | Sdcbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18079 | Senp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18080 | Sirt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18081 | Spart Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18082 | Stk33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18083 | Vegfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18084 | Adam12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18085 | Antxr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18086 | Anxa13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18087 | Clec1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18088 | Clec4f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18089 | Csf2ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18090 | Csnk1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18091 | Cxcl17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18092 | Elovl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18093 | Hmgcs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18094 | Hspa1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18095 | Lrpap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18096 | Malat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18097 | Notch4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18098 | Scarb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18099 | Sigirr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18100 | Tnfsf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18101 | Tnni3k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18102 | Tspan3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18103 | Adamts4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18104 | Igfbpl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18105 | Nectin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18106 | S100a16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18107 | Sult1e1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18108 | Map1lc3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18109 | Tnfrsf21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18137 | Krt8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18138 | Lhpp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18139 | Lig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18140 | Men1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18141 | Mepe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18142 | Mstn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18143 | Napa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18144 | Nfe2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18145 | Nmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18146 | Optn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18147 | Osr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18148 | Pan3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18149 | Pld4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18150 | Rbx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18151 | Reln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18152 | Sim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18153 | Star Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18154 | Stk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18155 | Sufu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18156 | Vapb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18157 | Wif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18158 | Actr8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18159 | Aimp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18160 | Aldoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18161 | Anxa6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18162 | Arrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18163 | Asah1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18164 | Atg14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18165 | Baz2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18166 | Bglap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18167 | Camk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18168 | Ccna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18169 | Chrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18170 | Cntn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18171 | Cxxc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18172 | Dock2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18173 | Dtymk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18174 | Efna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18175 | Folh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18176 | Gata4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18177 | Ildr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18178 | Itgb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18179 | Kdm3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18180 | Khsrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18181 | Lats2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18182 | Mark4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18183 | Ms4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18184 | Pcbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18185 | Prss8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18186 | Prtn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18187 | Rbbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18188 | Rspo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18189 | Shmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18190 | Smad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18191 | Trim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18192 | Uchl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18193 | Unc5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18194 | Adam19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18195 | Amigo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18196 | Creld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18197 | Il17ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18198 | Impdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18199 | Lpcat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18200 | Ndufb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18201 | Plscr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18202 | Polrmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18203 | Selplg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18204 | Zbtb16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18205 | Atp5f1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18206 | C1qtnf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18207 | Eif2ak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18208 | Hnrnph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18209 | St3gal4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18210 | Pdcd1lg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18211 | Serpina5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18212 | Serpinc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18213 | Serpinf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18214 | Adcyap1r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18215 | C4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18216 | Gda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18217 | Gsc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18218 | Mga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18219 | Ogn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18220 | Omd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18221 | Psd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18222 | Son Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18223 | Sp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18224 | St7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18225 | Tbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18226 | Ahsg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18227 | Amph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18228 | Apom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18229 | Arf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18230 | Blmh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18231 | Bphl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18232 | Cd96 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18233 | Cdh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18234 | Cpa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18235 | Ctsh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18236 | Dgka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18237 | Dhx9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18238 | Eml1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18239 | Far1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18240 | Fhl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18241 | G0s2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18242 | Gdf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18243 | Gdf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18244 | Ggt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18245 | M6pr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18246 | Maff Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18247 | Med1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18248 | Msr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18249 | Myh9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18250 | Nab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18251 | Nadk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18252 | Nbl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18253 | Nrn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18254 | Pigr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18255 | Pklr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18256 | Rbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18257 | Rgmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18258 | Rigi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18259 | Sdhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18260 | Sez6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18261 | Thbd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18262 | Tifa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18263 | Tlk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18264 | Tmx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18265 | Wwp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18266 | Amy2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18267 | Azgp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18268 | Calca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18269 | Cldn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18270 | Creb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18271 | Ctps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18272 | Eda2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18273 | Ephx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18274 | Ercc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18275 | F13a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18276 | Fabp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18277 | Fam3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18278 | Fancm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18279 | Gdf11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18280 | Gp1bb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18281 | Gpr34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18282 | Habp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18283 | Hspb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18284 | Hspe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18285 | Ifna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18286 | Kcnq1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18287 | Kif5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18288 | Kmt5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18289 | Lonp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18290 | Med12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18291 | Mst1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18292 | Nr4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18293 | Padi4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18294 | Pdgfd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18295 | Prss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18296 | Riok2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18297 | Sp100 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18298 | Stmn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18299 | Tead3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18300 | Tiam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18301 | Timd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18302 | Timp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18303 | Ube2n Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18304 | Wfdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18305 | Celsr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18306 | Dcaf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18307 | Eef1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18308 | Elavl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18309 | Fkbp1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18310 | Il18bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18311 | Ptpmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18312 | Sema4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18313 | Slamf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18314 | Trim25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18315 | Yeats4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18316 | Ankrd22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18317 | Kirrel1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18318 | Pla2g2e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18319 | Suv39h2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18320 | Mapkapk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18321 | Tnfrsf13b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18322 | A2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18323 | Bok Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18324 | Bpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18325 | Dck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18326 | Gp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18327 | Gsr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18328 | Npl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18329 | Pgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18330 | Rlf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18331 | Sp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18332 | Srm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18333 | Ttn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18334 | Ust Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18335 | Aida Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18336 | Aqp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18337 | Atf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18338 | Bmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18339 | Brd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18340 | Canx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18341 | Cbr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18342 | Cd48 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18343 | Cdh3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18344 | Chd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18345 | Chrd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18346 | Ctsg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18347 | Cuta Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18348 | Dcxr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18349 | Dpp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18350 | Dpp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18351 | Dsc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18352 | Dsc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18353 | Dtx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18354 | Elf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18355 | Emp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18356 | Epor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18357 | Fli1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18358 | Fzd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18359 | Fzd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18360 | Fzd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18361 | Gba2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18362 | Gfer Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18363 | Paf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18364 | Pag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18365 | Parl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18366 | Pgm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18367 | Prnp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18368 | Reg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18369 | Rnf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18370 | Smc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18371 | Smox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18372 | Tank Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18373 | Tet3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18374 | Uck2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18375 | Ufm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18376 | Anxa7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18377 | C5ar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18378 | Cadm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18379 | Capn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18380 | Ccl26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18381 | Ccr10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18382 | Cdk10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18383 | Chst3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18384 | Cip2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18385 | Cndp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18386 | Ephb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18387 | Foxf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18388 | Galk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18389 | Gdf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18390 | Gfra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18391 | Huwe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18392 | Kcnq4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18393 | Klf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18394 | Map1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18395 | Map1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18396 | Mkrn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18397 | Nlgn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18398 | Ovgp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18399 | Pde3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18400 | Plod2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18401 | Ptgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18402 | Ptpn7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18403 | Ptprk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18404 | Rad50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18405 | Ring1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18406 | Robo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18407 | Smad6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18408 | Smad7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18409 | Stk38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18410 | Sumo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18411 | Tfpi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18412 | Trim5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18413 | Usp19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18414 | Vegfd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18415 | Akr1d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18416 | Apcdd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18417 | Btn2a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18418 | Chrdl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18419 | Clec5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18420 | Col4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18421 | Elovl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18422 | Fcer1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18423 | Fkbp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18424 | Hmgcs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18425 | Mblac2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18426 | Mcemp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18427 | Nfatc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18428 | Phlpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18429 | Psmd14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18430 | Scpep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18431 | Ythdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18432 | Adamts5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18433 | Bhlhe40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18434 | Cd200r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18435 | Clec10a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18436 | Col18a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18437 | Cyp46a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18438 | Il13ra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18439 | Kremen2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18440 | Pip4k2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18441 | St3gal3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18442 | Tmprss4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18443 | Serpina7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18444 | Serping1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18445 | Ak4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18446 | Dst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18447 | Fes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18448 | Fxn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18449 | Gsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18450 | Igl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18451 | Klb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18452 | Msn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18453 | Mvd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18454 | Mx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18455 | Nrm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18456 | Shb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18457 | Tpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18458 | Zp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18459 | Aco1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18460 | Aco2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18461 | Apln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18462 | Araf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18463 | Art1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18464 | Asph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18465 | Bnc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18466 | Cask Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18467 | Ccnk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18468 | Coq7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18469 | Cst7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18470 | Cstb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18471 | Ctrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18472 | Cul3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18473 | Ddb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18474 | Eno3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18475 | Esm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18476 | Flna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18477 | Fzd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18478 | Gamt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18479 | Gpx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18480 | Ing5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18481 | Isl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18482 | Kera Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18483 | Lipi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18484 | Mbl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18485 | Mpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18486 | Nat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18487 | Nol3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18488 | Nrtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18489 | Palm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18490 | Pemt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18491 | Pex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18492 | Plp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18493 | Pls3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18494 | Ppib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18495 | Pter Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18496 | Rmi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18497 | Rpl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18498 | Rttn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18499 | Sbds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18500 | Tap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18501 | Tcf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18502 | Tnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18503 | Tpm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18504 | Ubr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18505 | Upf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18506 | Wnk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18507 | Wwp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18508 | Asf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18509 | Atox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18510 | Cadm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18511 | Chodl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18512 | Cltrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18513 | Cntfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18514 | Creb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18515 | Csrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18516 | Fabp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18517 | Fbxo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18518 | Gper1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18519 | Hspa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18520 | Hspd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18521 | Ifih1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18522 | Igsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18523 | Itga6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18524 | Itgb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18525 | Itgb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18526 | Kif11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18527 | Kiss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18528 | Kmt2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18529 | Kpnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18530 | Krt17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18531 | Lamp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18532 | Naa50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18533 | Ninj1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18534 | Nr2f1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18535 | Nudt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18536 | Nxph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18537 | Parva Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18538 | Pcsk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18539 | Pdap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18540 | Pdcd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18541 | Pear1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18542 | Plin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18543 | Pold2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18544 | Pycr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18545 | Sez6l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18546 | Socs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18547 | Srpk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18548 | Stip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18549 | Stk16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18550 | Tafa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18551 | Taok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18552 | Tigar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18553 | Ube2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18554 | Usp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18555 | Usp24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18556 | Wfdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18557 | Zfp36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18558 | Celsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18559 | Col2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18560 | Col6a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18561 | Creld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18562 | Ehhadh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18563 | Entpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18564 | Glipr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18565 | Nfkbia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18566 | Ralgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18567 | S100a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18568 | Scarb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18569 | Sema4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18570 | Spint1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18571 | Tapbpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18572 | Tmigd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18573 | Tspan8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18574 | Atp6v1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18575 | L3mbtl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18576 | Pla2g2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18577 | Scgb1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18578 | Scgb3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18579 | Selenop Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18580 | Slc12a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18581 | Slc13a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18582 | Slc25a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18583 | Sult1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18584 | Tnfrsf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18585 | Xpnpep2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18586 | C4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18587 | Cpq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18588 | Cr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18589 | Flg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18590 | Hjv Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18591 | Npb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18592 | Pml Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18593 | Ski Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18594 | Sp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18595 | Spn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18596 | Tek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18597 | Vit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18598 | A1bg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18599 | Adh4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18600 | Apod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18601 | Astl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18602 | Bcl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18603 | Bmi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18604 | C1qb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18605 | Cbx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18606 | Cdx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18607 | Cfl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18608 | Clps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18609 | Cpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18610 | Cpb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18611 | Ece1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18612 | Elf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18613 | Fhl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18614 | Gpc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18615 | Gpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18616 | Hbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18617 | Hcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18618 | Iscu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18619 | Klc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18620 | Lef1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18621 | Lipe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18622 | Msh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18623 | Muc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18624 | Mylk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18625 | Nek1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18626 | Nono Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18627 | Npr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18628 | Nsd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18629 | Ntn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18630 | Parn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18631 | Pdxp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18632 | Perp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18633 | Pkn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18634 | Rgl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18635 | Rnls Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18636 | Rps3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18637 | Rrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18638 | Rtn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18639 | Tac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18640 | Tpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18641 | Tpm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18642 | Tpm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18643 | Tufm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18644 | Wfs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18645 | Wnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18646 | Abcb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18647 | Acaa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18648 | Anpep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18649 | Blvrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18650 | Camkv Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18651 | Cd207 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18652 | Cd302 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18653 | Cebpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18654 | Cep57 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18655 | Cnpy3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18656 | Cspg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18657 | Dapk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18658 | Dpep2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18659 | Egfl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18660 | Eif1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18661 | Epha5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18662 | Ephx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18663 | Ermap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18664 | Hadhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18665 | Hcar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18666 | Hoxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18667 | Ifna5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18668 | Lrrc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18669 | Muc17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18670 | Ncstn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18671 | Negr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18672 | Nucb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18673 | Ostm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18674 | P4ha2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18675 | P4ha3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18676 | Pcbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18677 | Prps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18678 | Ptch1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18679 | Ptprj Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18680 | Rasa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18681 | Rbm14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18682 | Rtn4r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18683 | Soat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18684 | Sox10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18685 | Spag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18686 | Tapbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18687 | U2af1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18688 | Usp16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18689 | Usp43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18690 | Ywhaz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18691 | Zwint Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18692 | Adam15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18693 | Adgre5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18694 | Alkbh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18695 | Antxr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18696 | B3gat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18697 | Bnip3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18698 | Cd300c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18699 | Cela2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18700 | Celsr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18701 | Cldn18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18702 | Clec3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18703 | Col4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18704 | Col7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18705 | Csf2rb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18706 | Cyp7b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18707 | Dcbld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18708 | Dlgap5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18709 | Fkbp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18710 | Igfbp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18711 | Lrrtm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18712 | Lypla2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18713 | Phlda2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18714 | Ralbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18715 | Sap130 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18716 | Slamf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18717 | Smurf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18718 | Stambp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18719 | Ube2d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18720 | Arl6ip6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18721 | Colec11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18722 | Csnk2a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18723 | Kirrel3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18724 | Ppp2r1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18725 | S100a13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18726 | Slc27a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18727 | Tinagl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18728 | Adamts18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18729 | Dnase1l3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18730 | Ak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18731 | Amn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18732 | Cgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18733 | Dao Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18734 | Fbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18735 | Ggh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18736 | Hpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18737 | Kmo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18738 | Mpg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18739 | Mvk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18740 | Nbn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18741 | Ntm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18742 | Oxt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18743 | Ryk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18744 | Abl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18745 | Arsa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18746 | Brap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18747 | C1qa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18748 | Cbfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18749 | Ccin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18750 | Cdh4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18751 | Cdh8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18752 | Ctsa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18753 | Ctsw Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18754 | Dhps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18755 | Eid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18756 | Fgl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18757 | Fmod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18758 | Gad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18759 | Galc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18760 | Galt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18761 | Gbp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18762 | Gja1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18763 | Gltp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18764 | Gmfg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18765 | Hnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18766 | Il9r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18767 | Irf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18768 | Jam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18769 | Klf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18770 | Klk8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18771 | Ly6e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18772 | Mdm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18773 | Mecr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18774 | Med9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18775 | Mtdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18776 | Naaa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18777 | Nck1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18778 | Nid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18779 | Orm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18780 | P4hb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18781 | Pfkl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18782 | Pif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18783 | Plp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18784 | Ppif Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18785 | Rgma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18786 | Rhoj Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18787 | Rrn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18788 | Rtn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18789 | Sav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18790 | Sdha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18791 | Smg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18792 | Speg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18793 | Sub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18794 | Tpmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18795 | Tpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18796 | Vasp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18797 | Vnn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18798 | Aadac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18799 | Ackr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18800 | Acmsd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18801 | Adprh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18802 | Anxa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18803 | Asb13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18804 | Bbox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18805 | Cdh10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18806 | Cdk17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18807 | Cldn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18808 | Cmpk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18809 | Crlf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18810 | Dpp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18811 | Ecscr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18812 | Egln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18813 | Epha3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18814 | Fads1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18815 | Fbxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18816 | Fcrl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18817 | Ffar4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18818 | Fgf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18819 | Fkbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18820 | Foxa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18821 | Gap43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18822 | Gnao1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18823 | Hebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18824 | Hprt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18825 | Il2ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18826 | Klrg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18827 | Lims1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18828 | Mgat5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18829 | Mnat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18830 | Otud1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18831 | Padi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18832 | Peli1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18833 | Pold1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18834 | Prdx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18835 | Pros1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18836 | Prps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18837 | Psmb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18838 | Rab2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18839 | Reg3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18840 | Riok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18841 | Robo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18842 | Setd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18843 | Srrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18844 | Srsf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18845 | Syvn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18846 | Trpc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18847 | Tyrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18848 | Ube2i Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18849 | Vipr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18850 | Vsig8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18851 | Angpt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18852 | Bpifb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18853 | Cdc25c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18854 | Cdkn2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18855 | Cgref1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18856 | Cnksr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18857 | Col4a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18858 | Col8a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18859 | Crabp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18860 | Dpysl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18861 | Elavl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18862 | Elovl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18863 | Entpd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18864 | Gpr174 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18865 | Ifna14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18866 | Ifnlr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18867 | Il36rn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18868 | Lefty2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18869 | Lgals4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18870 | Map3k3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18871 | Nmnat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18872 | Pik3r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18873 | Psmd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18874 | Ptger4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18875 | Rprd1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18876 | Sephs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18877 | Slamf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18878 | Taldo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18879 | Trim33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18880 | Uqcrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18881 | Colec12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18882 | Slc37a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18883 | Slc39a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18884 | Slc6a14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18885 | Sparcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18886 | Adamtsl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18887 | Gabarapl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18888 | Serpinb10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18889 | Ado Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18890 | Afm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18891 | Cpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18892 | Ebp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18893 | Fau Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18894 | Hfe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18895 | Ids Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18896 | Ivd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18897 | Lxn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18898 | Mtr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18899 | Nms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18900 | Ppl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18901 | Tnn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18902 | Tnr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18903 | Ubb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18904 | Acy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18905 | Add2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18906 | Ago1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18907 | Agr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18908 | Arnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18909 | Atg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18910 | Atl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18911 | Bag2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18912 | Bcan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18913 | Bin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18914 | Brf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18915 | Cdk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18916 | Cdsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18917 | Chd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18918 | Chga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18919 | Clgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18920 | Coch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18921 | Cop1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18922 | Dag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18923 | Dbf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18924 | Dlst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18925 | Drg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18926 | E2f7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18927 | Ecm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18928 | Edf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18929 | Eif5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18930 | Ell2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18931 | Fcmr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18932 | Fuom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18933 | Fut7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18934 | Gart Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18935 | Gbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18936 | Gclm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18937 | Gid4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18938 | Glb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18939 | Glrx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18940 | Gpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18941 | Gpx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18942 | Gypa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18943 | Hcrt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18944 | Hes5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18945 | Hmbs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18946 | Hps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18947 | Irf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18948 | Jpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18949 | Mas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18950 | Mest Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18951 | Mid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18952 | Mrap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18953 | Mras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18954 | Msmp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18955 | Myrf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18956 | Naca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18957 | Ndc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18958 | Net1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18959 | Neu1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18960 | Nmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18961 | Ola1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18962 | Pax8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18963 | Pepc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18964 | Pfkm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18965 | Pkib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18966 | Prkn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18967 | Ptma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18968 | Ptpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18969 | Relt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18970 | Rgs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18971 | Rom1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18972 | Rybp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18973 | Sord Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18974 | Stam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18975 | Stx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18976 | Tdo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18977 | Tpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18978 | Twf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18979 | Uap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18980 | Vasn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18981 | Vsir Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18982 | Abhd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18983 | Acsl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18984 | Ampd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18985 | Anxa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18986 | Apex2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18987 | Atad5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18988 | Cant1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18989 | Ccrl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18990 | Cd248 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18991 | Cebpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18992 | Cntn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18993 | Coasy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18994 | Ctdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18995 | Ddx17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18996 | Decr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18997 | Eif2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18998 | Epas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18999 | Etfdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19000 | Extl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19001 | Fetub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19002 | Fgf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19003 | Fgf20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19004 | Fscn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19005 | Gfpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19006 | Ghrhr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19007 | Grip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19008 | Gsdmc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19009 | Gstm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19010 | Hgfac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19011 | Htr2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19012 | Ifi27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19013 | Iglc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19014 | Il17c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19015 | Inhbb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19016 | Irak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19017 | Kifc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19018 | Klk14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19019 | Lacc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19020 | Lyve1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19021 | Mef2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19022 | Megf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19023 | Mfge8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19024 | Nlgn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19025 | Ntmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19026 | Otub2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19027 | Ppm1g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19028 | Prap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19029 | Pttg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19030 | Rab31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19031 | Ramp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19032 | Rbm15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19033 | Rpap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19034 | Rxfp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19035 | Slit2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19036 | Smad9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19037 | Soat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19038 | Spast Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19039 | Srpk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19040 | Sumf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19041 | Tnnc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19042 | Ube2k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19043 | Usp36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19044 | Usp39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19045 | Vamp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19046 | Ywhaq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19047 | Aarsd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19048 | Adam11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19049 | Adam32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19050 | Arid1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19051 | Atp5mg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19052 | Cd300a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19053 | Cdkn1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19054 | Chrna5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19055 | Clec1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19056 | Col4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19057 | Cox4i2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19058 | Ddx19a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19059 | Eef1b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19060 | Eif5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19061 | Glipr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19062 | Gprc6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19063 | Igsf11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19064 | Il17re Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19065 | Lpcat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19066 | Mansc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19067 | Nfatc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19068 | Nmral1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19069 | Nup210 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19070 | Otulin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19071 | Plxna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19072 | Ptger2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19073 | Sema4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19074 | Slc4a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19075 | Slc9a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19076 | Srd5a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19077 | Stat5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19078 | Tpsab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19079 | Treml2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19080 | Trim16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19081 | Trim62 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19082 | Tsg101 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19083 | Ugt1a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19084 | Adamts1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19085 | Adcyap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19086 | B4galt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19087 | Cd300lf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19088 | Cntnap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19089 | Colec10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19090 | Lamtor3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19091 | Madcam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19092 | Morf4l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19093 | Pglyrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19094 | Ppp1r1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19095 | Slc30a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19096 | Tmem219 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19097 | Tnfaip6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19098 | Adamts15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19099 | Adamts16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19100 | Adamts17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19101 | Aldh18a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19102 | Ppp1r15b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19103 | Siglec15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19104 | Ckm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19105 | CTD Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19106 | Ddo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19107 | Dld Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19108 | Dtl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19109 | Hrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19110 | Kel Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19111 | Ltk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19112 | Pzp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19113 | Sct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19114 | Abra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19115 | Acy3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19116 | Artn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19117 | Asns Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19118 | Atf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19119 | Bmp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19120 | Btf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19121 | Capg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19122 | Cbx8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19123 | Coq2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19124 | Crat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19125 | Csad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19126 | Dlc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19127 | Dsg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19128 | Dtd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19129 | Ech1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19130 | Ensa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19131 | Epyc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19132 | Fzd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19133 | Gas7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19134 | Gatm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19135 | Gcdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19136 | Gdf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19137 | Gmpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19138 | Gnaz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19139 | Gpc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19140 | Hcn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19141 | Hsf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19142 | Ing4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19143 | Ly86 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19144 | Mafb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19145 | Mcf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19146 | Mlh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19147 | Mnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19148 | Mzb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19149 | Npr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19150 | Orm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19151 | Pga5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19152 | Pld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19153 | Pmvk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19154 | Pop1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19155 | Qprt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19156 | Rcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19157 | Rida Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19158 | Ryr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19159 | Sbf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19160 | Scg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19161 | Sco1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19162 | Sgta Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19163 | Shbg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19164 | Stx7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19165 | Tab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19166 | Tcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19167 | Ubtf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19168 | Ykt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19169 | Acta2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19170 | Anxa8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19171 | Apoa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19172 | Asf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19173 | Atg4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19174 | Atg4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19175 | Bmp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19176 | Bmp15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19177 | Bola1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19178 | Cdh15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19179 | Cfhr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19180 | Chrm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19181 | Ciita Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19182 | Cplx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19183 | Crip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19184 | Ctps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19185 | Cyb5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19186 | Ddah1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19187 | Dpep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19188 | Echs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19189 | Endog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19190 | Epha1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19191 | Erp29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19192 | Fanca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19193 | Fcrl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19194 | Flrt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19195 | Fnip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19196 | Foxc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19197 | Furin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19198 | Gars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19199 | Gfpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19200 | Gfra3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19201 | Gng13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19202 | Gpr27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19203 | Hibch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19204 | Hjurp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19205 | Hmgn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19206 | Ifit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19207 | Il17d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19208 | Itih5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19209 | Itpka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19210 | Klf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19211 | Klk10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19212 | Klrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19213 | Kmt5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19214 | Lman2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19215 | Lrig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19216 | Mapk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19217 | Meis1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19218 | Metrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19219 | Mgst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19220 | Mmp25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19221 | Ngly1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19222 | Nodal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19223 | Oard1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19224 | Olfm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19225 | Otud5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19226 | Palb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19227 | Pclaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19228 | Pde1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19229 | Podxl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19230 | Prdm9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19231 | Ptgs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19232 | Ptpn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19233 | Rab6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19234 | Rcan2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19235 | Senp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19236 | Setd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19237 | Sgms2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19238 | Smap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19239 | Spon2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19240 | Tead2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19241 | Thop1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19242 | Tmed1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19243 | Tnni3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19244 | Traf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19245 | Ulbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19246 | Wnt8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19247 | Alyref Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19248 | Btn1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19249 | Ccdc25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19250 | Col6a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19251 | Cox4i1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19252 | Crisp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19253 | Dynll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19254 | Eif4g1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19255 | Entpd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19256 | Epha10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19257 | Gpr101 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19258 | Gprc5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19259 | Hoxa10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19260 | Hpcal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19261 | Hspa1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19262 | Il18r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19263 | Izumo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19264 | Lgals7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19265 | Nos1ap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19266 | Nt5c1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19267 | Rnf114 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19268 | Sema5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19269 | Spink1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19270 | Stxbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19271 | Tfap2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19272 | Tmed10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19273 | Ythdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19274 | Zbtb7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19275 | Atp6ap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19276 | Cd300lg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19277 | Dcun1d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19278 | Hsd17b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19279 | Il13ra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19280 | L3mbtl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19281 | Mid1ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19282 | Pip4k2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19283 | Pip5k1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19284 | Sharpin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19285 | Slc33a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19286 | Tmprss6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19287 | Tnfaip8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19288 | Trappc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19289 | Adamts20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19290 | Cacna2d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19291 | Ppp1r14a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19292 | Serpinf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19293 | Tnfrsf25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19294 | Serpina10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19295 | C8g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19296 | Gns Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19297 | Hk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19298 | Maz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19299 | Mff Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19300 | Mip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19301 | Mt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19302 | Ndp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19303 | Rfk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19304 | Uox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19305 | Acp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19306 | Acp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19307 | Atl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19308 | Batf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19309 | Bin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19310 | Cdc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19311 | Cks2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19312 | Clmp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19313 | Cma1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19314 | Cmbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19315 | Crkl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19316 | Ctrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19317 | Dab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19318 | Daxx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19319 | Dkc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19320 | Dna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19321 | E2f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19322 | E2f3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19323 | Eaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19324 | Ebf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19325 | Ece2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19326 | Eea1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19327 | Egr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19328 | Fgf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19329 | Fhit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19330 | Fibp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19331 | Fis1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19332 | Fmr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19333 | Frzb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19334 | Gcsh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19335 | Gfi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19336 | Gnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19337 | Gpx7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19338 | Gypc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19339 | Hey1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19340 | Hid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19341 | Ier3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19342 | Irs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19343 | Jag2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19344 | Jam3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19345 | Jund Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19346 | Krt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19347 | Lcp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19348 | Ldb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19349 | Lgr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19350 | Mal2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19351 | Mbd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19352 | Mcee Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19353 | Mpc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19354 | Mpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19355 | Mrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19356 | Nags Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19357 | Napg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19358 | Ncf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19359 | Nit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19360 | Nme2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19361 | Nop2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19362 | Otor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19363 | Penk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19364 | Phf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19365 | Phyh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19366 | Pi16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19367 | Plek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19368 | Pmm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19369 | Polb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19370 | Polg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19371 | Ppa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19372 | Ppid Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19373 | Raly Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19374 | Rbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19375 | Rcn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19376 | Rgs5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19377 | Rhoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19378 | Rif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19379 | Rps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19380 | Scg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19381 | Shpk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19382 | Sncg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19383 | Sox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19384 | Spp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19385 | Ss18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19386 | Tab3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19387 | Tbcb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19388 | Tfe3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19389 | Tgs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19390 | Tie1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19391 | Tppp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19392 | Txn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19393 | Uba6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19394 | Ubr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19395 | Ufl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19396 | Usb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19397 | Use1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19398 | USP6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19399 | Vmac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19400 | Wnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19401 | Acadl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19402 | Acox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19403 | Actr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19404 | Adrb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19405 | Aicda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19406 | Aifm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19407 | Alas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19408 | Apoa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19409 | Asah2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19410 | Asgr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19411 | Bambi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19412 | Btnl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19413 | Bub1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19414 | Cadm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19415 | Cd180 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19416 | Cdkl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19417 | Chrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19418 | Chst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19419 | Cidea Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19420 | Cisd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19421 | Ckap4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19422 | Cpne1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19423 | Cpsf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19424 | Creg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19425 | Crhbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19426 | Ctbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19427 | Dctn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19428 | Dmbt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19429 | Dtx3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19430 | Dusp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19431 | Dusp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19432 | Epdr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19433 | Espl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19434 | Fgf22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19435 | Ggta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19436 | Gngt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19437 | Golm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19438 | Gpr15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19439 | Gstt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19440 | Hipk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19441 | Hkdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19442 | Hyal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19443 | Hyou1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19444 | Icam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19445 | Ifi30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19446 | Ifnl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19447 | Impa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19448 | Insrr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19449 | Itga1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19450 | Itga8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19451 | Itpkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19452 | Kcnk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19453 | Klrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19454 | Loxl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19455 | Lpin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19456 | Lrrn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19457 | Mdga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19458 | Micu1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19459 | Mob1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19460 | Mpzl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19461 | Mpzl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19462 | Mtch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19463 | Nceh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19464 | Ncor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19465 | Nell2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19466 | Oscar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19467 | Oxsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19468 | Pam16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19469 | Pdcd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19470 | Plcg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19471 | Plcg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19472 | Ppm1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19473 | Ppp6c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19474 | Prdm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19475 | Prkd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19476 | Psma3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19477 | Psme2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19478 | Ptpra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19479 | Rps13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19480 | Rps19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19481 | Senp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19482 | Snrpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19483 | Spns2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19484 | Srsf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19485 | Thbs4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19486 | Tirap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19487 | Tppp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19488 | Tra2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19489 | Trib2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19490 | Trmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19491 | Tubb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19492 | Ube2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19493 | Usp38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19494 | Vsig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19495 | Ywhah Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19496 | Zbtb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19497 | Acot13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19498 | Adam28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19499 | Adam30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19500 | Arrdc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19501 | B3gnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19502 | Bcap31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19503 | Col4a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19504 | Cyb5r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19505 | Diablo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19506 | Fam20c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19507 | Gpr158 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19508 | Gpr161 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19509 | Guca1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19510 | Havcr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19511 | Hilpda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19512 | Hnrnpc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19513 | Lgals8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19514 | Lilra5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19515 | Lin28b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19516 | Map3k4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19517 | Necap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19518 | Pabpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19519 | Parp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19520 | Phlda1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19521 | Ppp3ca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19522 | Prdm16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19523 | Ptgfrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19524 | Pycard Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19525 | S100a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19526 | Setd1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19527 | Sez6l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19528 | Slc1a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19529 | Spink7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19530 | Spint2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19531 | Sptssb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19532 | Tomm20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19533 | Trdmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19534 | Ube2g2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19535 | Ube2j2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19536 | Unc119 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19537 | Adamts2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19538 | Aldh3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19539 | Cd300lb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19540 | Col11a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19541 | Cyp24a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19542 | Gpihbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19543 | Hnrnpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19544 | Lamtor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19545 | Metap1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19546 | Onecut2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19547 | Pip5k1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19548 | Pomgnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19549 | Rarres2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19550 | S100a14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19551 | Slc11a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19552 | Slc22a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19553 | Slc7a10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19554 | Sult2b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19555 | Tmem175 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19556 | Tsc22d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19557 | Xpnpep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19558 | Pla2g12b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19559 | Rad51ap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19560 | C1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19561 | Chm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19562 | Fgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19563 | Ly9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19564 | Me3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19565 | Mt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19566 | Neb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19567 | Nln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19568 | Rgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19569 | Ttl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19570 | Unk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19571 | Zyx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19572 | Adh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19573 | Ahrr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19574 | Ank3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19575 | Anln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19576 | Apoo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19577 | Atrx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19578 | Calu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19579 | Cblc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19580 | Cbx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19581 | Ccnh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19582 | Cd72 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19583 | Cerk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19584 | Cib1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19585 | Clp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19586 | Clpp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19587 | Coa6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19588 | Copa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19589 | Cpa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19590 | Cst5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19591 | Cst9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19592 | Cux1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19593 | Dok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19594 | Eif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19595 | Emg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19596 | Emp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19597 | Enam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19598 | Etv6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19599 | Eya2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19600 | F11r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19601 | Ftcd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19602 | Fut1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19603 | Gckr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19604 | Ggct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19605 | Git1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19606 | Gkn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19607 | H4c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19608 | Hcst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19609 | Ilf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19610 | Iqcg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19611 | Ksr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19612 | Lmf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19613 | Lsp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19614 | Ly96 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19615 | Mafa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19616 | Mbd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19617 | Med4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19618 | Mrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19619 | Myof Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19620 | Myt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19621 | Naga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19622 | Ncan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19623 | Nhp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19624 | Nppa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19625 | Ost4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19626 | Ostn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19627 | Pfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19628 | Phf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19629 | Pld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19630 | Pmm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19631 | Pnkp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19632 | Podn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19633 | Pon2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19634 | Prg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19635 | Rbks Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19636 | Rcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19637 | Rem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19638 | Rps7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19639 | Rtl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19640 | Saa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19641 | Scgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19642 | Srpx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19643 | St18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19644 | Tgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19645 | Tprn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19646 | Uba2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19647 | Ulk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19648 | Umps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19649 | Uprt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19650 | Urm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19651 | Usf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19652 | Vcan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19653 | Wnk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19654 | Xcr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19655 | Apba3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19656 | Atat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19657 | Bccip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19658 | Blvra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19659 | Calm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19660 | Cd109 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19661 | Cdh18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19662 | Cenpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19663 | Cenpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19664 | Cetn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19665 | Cfhr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19666 | Ckmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19667 | Clic1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19668 | Cnpy4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19669 | Cops5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19670 | Cox5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19671 | Crip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19672 | Crmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19673 | Cspg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19674 | Dhrs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19675 | Dhx36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19676 | Dnph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19677 | Dusp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19678 | Eif5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19679 | Eomes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19680 | Ercc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19681 | Ewsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19682 | Foxd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19683 | Foxp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19684 | Ggps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19685 | Gna14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19686 | Gstk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19687 | Gstz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19688 | Hcfc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19689 | Herc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19690 | Hnf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19691 | Hspg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19692 | Ifit2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19693 | Igsf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19694 | Il1r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19695 | Il36b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19696 | Il5ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19697 | Ino80 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19698 | Ip6k1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19699 | Itih3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19700 | Kcnq3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19701 | Kdm7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19702 | Kif15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19703 | Krt14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19704 | Krt18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19705 | Lmcd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19706 | Lmnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19707 | Loxl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19708 | Lrp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19709 | Ltbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19710 | Matr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19711 | Mcm10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19712 | Med10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19713 | Mef2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19714 | Mfap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19715 | Mien1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19716 | Mmgt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19717 | Mmp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19718 | Msrb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19719 | Mtss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19720 | Nanog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19721 | Ncoa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19722 | Ndc80 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19723 | Neil1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19724 | Nlrc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19725 | Nptx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19726 | Nr1h2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19727 | Nrros Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19728 | Otud3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19729 | Pdia5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19730 | Phkg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19731 | Plac8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19732 | Prmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19733 | Prox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19734 | Ptges Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19735 | Pvalb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19736 | Rab1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19737 | Reg3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19738 | Rxfp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19739 | Rxfp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19740 | Senp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19741 | Sfxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19742 | Snai1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19743 | Ssrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19744 | Stk40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19745 | Strap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19746 | Sulf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19747 | Tagln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19748 | Taok3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19749 | Trps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19750 | Txlna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19751 | Usp33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19752 | Usp51 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19753 | Vsnl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19754 | Wars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19755 | Wnt16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19756 | Xrcc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19757 | Ywhab Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19758 | Zbtb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19759 | Zfpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19760 | Acadvl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19761 | Adam23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19762 | Adgrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19763 | Adgrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19764 | Ankrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19765 | Calhm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19766 | Calml3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19767 | Cdc25b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19768 | Chrna7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19769 | Chst15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19770 | Ckap2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19771 | Clec4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19772 | Crisp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19773 | Dctpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19774 | Entpd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19775 | Errfi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19776 | Fgfbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19777 | Galnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19778 | Hapln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19779 | Igfbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19780 | Il15ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19781 | Il1f10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19782 | Itga2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19783 | Izumo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19784 | Jarid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19785 | Laptm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19786 | Lilra6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19787 | Ly6g6d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19788 | Mad2l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19789 | Man1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19790 | Map2k7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19791 | Mrgprd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19792 | Mybpc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19793 | N6amt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19794 | Ndufa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19795 | Nfe2l3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19796 | Notch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19797 | Npepl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19798 | Opalin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19799 | Pdcd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19800 | Phlpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19801 | Pik3r3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19802 | Polr2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19803 | Ppp1cc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19804 | Ptges2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19805 | Ptges3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19806 | Ptp4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19807 | Ptp4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19808 | Ptpn12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19809 | Rab11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19810 | Rnase6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19811 | Rnf168 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19812 | Sema3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19813 | Smndc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19814 | Sorcs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19815 | Spink4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19816 | Spock1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19817 | Sptbn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19818 | Srsf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19819 | Stard7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19820 | Thsd7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19821 | Tm4sf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19822 | Tmbim6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19823 | Tmem25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19824 | Trim27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19825 | Ube2d3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19826 | Ube2r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19827 | Vcpip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19828 | Ythdf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19829 | Adamts6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19830 | Adamts7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19831 | Adamts9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19832 | Atg16l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19833 | Atp5f1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19834 | Bloc1s2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19835 | C1qtnf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19836 | Castor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19837 | Fam167a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19838 | Gadd45g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19839 | Pacsin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19840 | Racgap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19841 | Slc22a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19842 | Slc26a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19843 | Slc27a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19844 | Slc43a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19845 | Tspan31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19846 | Adamts19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19847 | Lgals3bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19848 | Phospho1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19849 | Pnliprp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19850 | Serpina6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19851 | Serpinb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19852 | Tnfrsf19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19853 | Gabarapl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19854 | Tmprss11d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19855 | Ky Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19856 | Aen Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19857 | Ak3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19858 | Ak5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19859 | Esd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19860 | Ezr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19861 | Fgb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19862 | Igk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19863 | Jtb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19864 | Lct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19865 | Mn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19866 | Mnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19867 | Oaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19868 | Rd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19869 | Tef Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19870 | Vcl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19871 | Was Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19872 | Abi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19873 | Agrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19874 | Apof Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19875 | Art4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19876 | Atl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19877 | Bag4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19878 | Bdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19879 | C1qc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19880 | Ccnc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19881 | Cd53 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19882 | Cdon Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19883 | Cfl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19884 | Cib2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19885 | Cish Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19886 | Cope Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19887 | Cst6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19888 | Ctso Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19889 | Cutc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19890 | Cyba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19891 | Dkk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19892 | Dlx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19893 | Dmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19894 | Eapp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19895 | Egr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19896 | Faim Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19897 | Fdxr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19898 | Flnb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19899 | Fshb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19900 | Gdf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19901 | Gga3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19902 | Ggt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19903 | Gps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19904 | Haao Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19905 | Inha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19906 | Irf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19907 | Jdp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19908 | Klf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19909 | Lig4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19910 | Lmna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19911 | Lrp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19912 | Lrp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19913 | Lsm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19914 | Ltv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19915 | Ly6d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19916 | Lyg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19917 | Mdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19918 | Mesd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19919 | Mrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19920 | Msx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19921 | Mta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19922 | Mtf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19923 | Muc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19924 | Nip7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19925 | Nptn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19926 | Numb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19927 | Oas3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19928 | Osbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19929 | Pax3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19930 | Per1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19931 | Pfas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19932 | Pgm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19933 | Pigm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19934 | Pkn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19935 | Plec Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19936 | Pomp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19937 | Ppih Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19938 | Prf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19939 | Prg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19940 | Prg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19941 | Qdpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19942 | Rbm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19943 | Rce1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19944 | Reck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19945 | Retn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19946 | Rgs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19947 | Rnf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19948 | Rpl8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19949 | Rrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19950 | Ryr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19951 | Ryr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19952 | Scly Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19953 | Sgsh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19954 | Siae Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19955 | Six2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19956 | Snw1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19957 | Snx9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19958 | Sos2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19959 | Ssr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19960 | Stk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19961 | Tab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19962 | Tcp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19963 | Tle3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19964 | Tmx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19965 | Tpx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19966 | Tril Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19967 | Tsfm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19968 | Ucma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19969 | Ugdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19970 | Ugp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19971 | Upk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19972 | Uros Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19973 | Vsx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19974 | Wdr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19975 | Wdr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19976 | Aadat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19977 | Abcc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19978 | Abce1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19979 | Acss3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19980 | Adpgk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19981 | Amacr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19982 | Amelx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19983 | Apoa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19984 | Arpin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19985 | Atxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19986 | Bach2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19987 | Baz1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19988 | Bckdk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19989 | Calm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19990 | Casq1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19991 | Ccna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19992 | Ccnd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19993 | Cdh11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19994 | Cemip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19995 | Cers1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19996 | Cfhr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19997 | Chst5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19998 | Cnpy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19999 | Cntn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20000 | Cntn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20001 | Copz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20002 | Coro6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20003 | Cplx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20004 | Cradd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20005 | Cryaa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20006 | Ctrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20007 | Cytip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20008 | Daglb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20009 | Decr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20010 | Dhrs9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20011 | Dkkl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20012 | Dusp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20013 | Eef2k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20014 | Eif3k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20015 | Esrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20016 | Fam3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20017 | Fbxl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20018 | Fcrl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20019 | Flad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20020 | Flrt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20021 | Fndc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20022 | Foxd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20023 | Foxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20024 | Fxyd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20025 | Galk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20026 | Gata1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20027 | Gata2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20028 | Gfod2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20029 | Gp1ba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20030 | Gpha2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20031 | Gpr12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20032 | Gpr19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20033 | Gpr26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20034 | Gpr87 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20035 | Hells Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20036 | Hoxb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20037 | Ikzf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20038 | Il1r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20039 | Il2rg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20040 | Ilkap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20041 | Inpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20042 | Insm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20043 | Isg20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20044 | Itgam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20045 | Kcnj2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20046 | Kdm4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20047 | Klk15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20048 | Kmt2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20049 | Lactb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20050 | Lama3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20051 | Lmtk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20052 | Ltbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20053 | Mecp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20054 | Meltf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20055 | Mlana Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20056 | Msmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20057 | Mthfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20058 | Mthfs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20059 | Mybl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20060 | Ncoa6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20061 | Ndrg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20062 | Ndst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20063 | Nek11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20064 | Neto1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20065 | Nfasc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20066 | Nlrc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20067 | Nptxr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20068 | Nr1i3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20069 | Nr2f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20070 | Nrn1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20071 | Nrxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20072 | Nudt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20073 | Otud4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20074 | Parp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20075 | Pcbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20076 | Pdrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20077 | Pdzk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20078 | Peg10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20079 | Pex19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20080 | Pfdn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20081 | Pias1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20082 | Pilra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20083 | Pnrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20084 | Ppil1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20085 | Ppil2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20086 | Prelp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20087 | Prkg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20088 | Psme1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20089 | Ptgr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20090 | Pth2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20091 | Ptpn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20092 | Ptrh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20093 | Rad21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20094 | Rexo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20095 | Rnf20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20096 | Robo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20097 | Romo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20098 | Rpl10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20099 | Rps4x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20100 | Runx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20101 | Satb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20102 | Scn2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20103 | Sfrp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20104 | Sin3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20105 | Snx10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20106 | Srsf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20107 | Stk25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20108 | Sulf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20109 | Susd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20110 | Taok2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20111 | Terf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20112 | Tfcp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20113 | Tgif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20114 | Thsd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20115 | Timp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20116 | Tinag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20117 | Tnnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20118 | Tnpo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20119 | Top2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20120 | Tpsb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20121 | Trpv5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20122 | Ube2h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20123 | Ube2o Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20124 | Ube2w Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20125 | Unc5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20126 | Uqcrh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20127 | Usp26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20128 | Usp9y Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20129 | Vdac3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20130 | Xrcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20131 | Abhd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20132 | Acadsb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20133 | Adam29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20134 | Adam33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20135 | Adgrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20136 | Adra2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20137 | Alkal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20138 | Atf7ip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20139 | Bpifa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20140 | Calcrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20141 | Cdkn2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20142 | Chaf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20143 | Chrna3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20144 | Cldn11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20145 | Clec9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20146 | Clstn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20147 | Col1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20148 | Col9a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20149 | Crabp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20150 | Dnase1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20151 | Dpysl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20152 | Eif1ax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20153 | Eif4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20154 | Eps8l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20155 | Fbxo22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20156 | Fbxo32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20157 | Fgfrl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20158 | Galnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20159 | Galnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20160 | Galnt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20161 | Gpr142 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20162 | Gpr173 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20163 | Gprc5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20164 | Hnrnpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20165 | Ifitm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20166 | Igflr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20167 | Il17rd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20168 | Il1rl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20169 | Il27ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20170 | Iqgap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20171 | Itga10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20172 | Lactb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20173 | Lgals2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20174 | Lrrc4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20175 | Lrrtm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20176 | Man1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20177 | Mbtps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20178 | Mcoln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20179 | Mical2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20180 | Mpig6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20181 | mt-Co2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20182 | Ndufa8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20183 | Ndufa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20184 | Ndufv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20185 | Nfkbib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20186 | Otud7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20187 | Pfkfb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20188 | Pfkfb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20189 | Pi4k2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20190 | Plxnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20191 | Pofut1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20192 | Ptp4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20193 | Slc4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20194 | Slc6a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20195 | Slurp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20196 | Srfbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20197 | Trim14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20198 | Trim15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20199 | Trim29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20200 | Tspan1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20201 | Twist1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20202 | Txnl4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20203 | Ube2j1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20204 | Ube2v1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20205 | Vps13c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20206 | Abhd14b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20207 | Aldh7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20208 | Atp13a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20209 | Atp5if1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20210 | Gnpnat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20211 | Kir3dl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20212 | Lamtor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20213 | Map3k14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20214 | Mthfd1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20215 | Nectin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20216 | Slc25a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20217 | Slc36a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20218 | Slc38a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20219 | Slitrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20220 | Slitrk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20221 | Slitrk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20222 | Sult1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20223 | Tbl1xr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20224 | Trmt112 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20225 | Adamts10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20226 | Adamts14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20227 | Eif4ebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20228 | Il1rapl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20229 | Serpinb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20230 | Slc25a28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20231 | Slc25a51 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20232 | Tmem106b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20233 | Tmprss11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20234 | Btd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20235 | Dut Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20236 | Eln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20237 | Fev Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20238 | Ggn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20239 | Kin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20240 | Mvp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20241 | Nnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20242 | Pip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20243 | Pnn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20244 | Pts Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20245 | Xpc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20246 | Adm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20247 | Amtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20248 | Ano6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20249 | Apip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20250 | Aqp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20251 | Arf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20252 | Arl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20253 | Art3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20254 | Bpgm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20255 | Bzw2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20256 | Cav2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20257 | Cbx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20258 | Cdr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20259 | Chn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20260 | Cpn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20261 | Cpox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20262 | Cst8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20263 | Cul2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20264 | Cycs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20265 | Dab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20266 | Ddx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20267 | Denr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20268 | Dgkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20269 | Dkk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20270 | E2f6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20271 | Ebf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20272 | Elob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20273 | Emc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20274 | Emcn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20275 | Ets2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20276 | Fech Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20277 | Gbe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20278 | Gldc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20279 | Gopc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20280 | Gps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20281 | Gpx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20282 | Grk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20283 | Gzmk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20284 | H3c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20285 | Hagh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20286 | Hcn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20287 | Hes6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20288 | Hopx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20289 | Hsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20290 | Ifne Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20291 | Klc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20292 | Klk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20293 | Lcn8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20294 | Liph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20295 | Mbip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20296 | Mnx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20297 | Mob4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20298 | Mrs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20299 | Myl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20300 | Myoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20301 | Myog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20302 | Nans Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20303 | Nasp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20304 | Naxe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20305 | Ncf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20306 | Nek3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20307 | Nfya Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20308 | Nkd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20309 | Nme1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20310 | Nnat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20311 | Nppc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20312 | Nqo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20313 | Ntf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20314 | Ntn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20315 | Nudc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20316 | Oas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20317 | Oxr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20318 | Pax5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20319 | Pax6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20320 | Pbx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20321 | Pcp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20322 | Pepd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20323 | Per2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20324 | Pgm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20325 | Pigf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20326 | Pkp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20327 | Pmp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20328 | Ppie Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20329 | Prkx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20330 | Prr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20331 | Pxdn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20332 | Rad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20333 | Rfng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20334 | Rhoh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20335 | Rmi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20336 | Rpia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20337 | Rpn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20338 | Sox6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20339 | Spen Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20340 | Stn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20341 | Stx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20342 | Stx8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20343 | Syt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20344 | Tbx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20345 | Tcf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20346 | Thrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20347 | Tjp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20348 | Trhr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20349 | Ucp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20350 | Wsb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20351 | Ybx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20352 | Zic2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20353 | Zic3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20354 | Abcb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20355 | Abcc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20356 | Abhd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20357 | Acacb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20358 | Acer3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20359 | Acrv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20360 | Actn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20361 | Acyp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20362 | Acyp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20363 | Ahnak Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20364 | Aimp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20365 | Apoc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20366 | Appl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20367 | Bard1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20368 | Basp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20369 | Batf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20370 | Birc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20371 | Calr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20372 | Cdca7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20373 | Cdk15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20374 | Cenpf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20375 | Cep43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20376 | Cfhr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20377 | Chpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20378 | Ckap5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20379 | Cks1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20380 | Cldn9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20381 | Clic4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20382 | Clic5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20383 | Cndp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20384 | Cnnm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20385 | Cntn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20386 | Cpeb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20387 | Crlf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20388 | Ctcfl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20389 | Dcaf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20390 | Ddost Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20391 | Dhrs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20392 | Dhrs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20393 | Dhx15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20394 | Dnah6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20395 | Edem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20396 | Egln3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20397 | Epha6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20398 | Epha8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20399 | Eppk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20400 | Ercc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20401 | Erp27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20402 | Fancc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20403 | Fbln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20404 | Fgf16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20405 | Fkbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20406 | Fkbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20407 | Fkbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20408 | Fkbp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20409 | Flrt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20410 | Fmnl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20411 | G3bp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20412 | Gabrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20413 | Gnai3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20414 | Gpat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20415 | Gpld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20416 | Grik2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20417 | Gsdma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20418 | Gstm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20419 | Hars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20420 | Hmces Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20421 | Hoxb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20422 | Hoxc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20423 | Hspa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20424 | Htr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20425 | Ifit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20426 | Igsf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20427 | Impa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20428 | Insl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20429 | Itgal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20430 | Itln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20431 | Josd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20432 | Kcnn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20433 | Kif2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20434 | Kif2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20435 | Kifc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20436 | Kifc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20437 | Klhl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20438 | Klk13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20439 | Kpna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20440 | Lamc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20441 | Larp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20442 | Lrrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20443 | Lrrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20444 | Magi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20445 | Meox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20446 | Mep1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20447 | Mesp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20448 | Milr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20449 | Muc5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20450 | Ncald Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20451 | Ncoa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20452 | Ncor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20453 | Nell1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20454 | Npdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20455 | Nprl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20456 | Nptx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20457 | Nrcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20458 | Ntng1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20459 | Opcml Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20460 | Oxct1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20461 | Pa2g4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20462 | Pcsk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20463 | Plet1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20464 | Plpp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20465 | Ppef1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20466 | Prdm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20467 | Prmt9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20468 | Prrx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20469 | Pskh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20470 | Psma4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20471 | Psmb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20472 | Psme3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20473 | Ptk2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20474 | Ptpn9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20475 | Ptprn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20476 | Qsox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20477 | Ramp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20478 | Rbbp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20479 | Rbck1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20480 | Rcvrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20481 | Rgs12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20482 | Ripk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20483 | Rnf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20484 | Rplp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20485 | Rptor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20486 | Rsad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20487 | Sar1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20488 | Sesn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20489 | Sf3b3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20490 | Slit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20491 | Smad5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20492 | Smug1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20493 | Sox17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20494 | Sox18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20495 | Sp140 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20496 | Spg21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20497 | Stap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20498 | Stk26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20499 | Tada3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20500 | Tiprl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20501 | Tmed4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20502 | Traf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20503 | Trpm6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20504 | Tssk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20505 | Uba52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20506 | Ube2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20507 | Ube2f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20508 | Ube3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20509 | Uqcrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20510 | Usp35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20511 | Usp37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20512 | Usp40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20513 | Usp49 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20514 | Usp53 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20515 | Vps41 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20516 | Vps4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20517 | Vsig2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20518 | Vstm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20519 | Vti1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20520 | Wdr77 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20521 | Zbtb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20522 | Acad10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20523 | Adgrg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20524 | Atp2b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20525 | Atp2b4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20526 | B3gat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20527 | B3gnt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20528 | B3gnt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20529 | Bcl11a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20530 | Camk1g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20531 | Camk2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20532 | Capza2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20533 | Casp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20534 | Ccdc47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20535 | Cd300e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20536 | Cdk5r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20537 | Cdkn1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20538 | Cela3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20539 | Chrdl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20540 | Chst11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20541 | Col5a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20542 | Crtac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20543 | Csrnp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20544 | Ddx39b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20545 | Depdc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20546 | Dnajb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20547 | Elavl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20548 | Elovl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20549 | Fbxo10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20550 | Fkbp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20551 | Gabra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20552 | Gabra4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20553 | Gpr107 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20554 | Hectd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20555 | Hectd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20556 | Hs3st1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20557 | Il31ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20558 | Kansl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20559 | Kcnip3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20560 | Kcnma1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20561 | Kif20a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20562 | Lman2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20563 | Lrpprc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20564 | Lrrc25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20565 | Lrrc3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20566 | Mad2l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20567 | Map3k9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20568 | Mapre3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20569 | Mrpl44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20570 | mt-Nd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20572 | Npbwr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20573 | Nusap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20574 | Or10h1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20575 | Osbpl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20576 | Papss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20577 | Pgrmc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20578 | Pi4k2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20579 | Plxdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20580 | Pmaip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20581 | Pnpla6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20582 | Podxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20583 | Pou2f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20584 | Ppfia4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20585 | Ptdss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20586 | Ptger3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20587 | Ptpn18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20588 | Raet1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20589 | Recql4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20590 | Rnase1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20591 | Rnf126 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20592 | Rnf146 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20593 | Rps27a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20594 | Sema3f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20595 | Sema4g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20596 | Shcbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20597 | Slc7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20598 | Slc8b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20599 | Smurf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20600 | Spink2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20601 | Suclg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20602 | Tagln2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20603 | Tagln3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20604 | Thap11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20605 | Tmeff1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20606 | Tmem17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20607 | Tmem92 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20608 | Treml1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20609 | Trim23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20610 | Trim45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20611 | Trmt11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20612 | Tubb4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20613 | Txnrd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20614 | Ube2g1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20615 | Uqcr11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20616 | Usp6nl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20617 | Vps13d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20618 | Zc3h13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20619 | Zmynd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20620 | Adamts8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20621 | Aldh4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20622 | B3galt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20623 | B4galt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20624 | B4galt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20625 | Cacna1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20626 | Cacna1i Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20627 | Cdk2ap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20628 | Csnk1g2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20629 | Fam171b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20630 | Hepacam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20631 | Hsd11b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20632 | Hsd17b4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20633 | Il18rap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20634 | Kirrel2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20635 | Kremen1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20636 | Lyplal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20637 | Mab21l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20638 | Map3k11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20639 | Pglyrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20640 | Rtn4rl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20641 | Scgb3a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20642 | Selenom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20643 | Sinhcaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20644 | Slc11a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20645 | Slc22a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20646 | Slc39a6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20647 | Slc44a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20648 | Slc47a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20649 | Smarce1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20650 | Smpdl3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20651 | St3gal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20652 | St6gal2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20653 | Sult1c2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20654 | Sult2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20655 | Sult4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20656 | Syngap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20657 | Tmem41b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20658 | Txndc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20659 | Txndc17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20660 | Ubash3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20661 | Zfp36l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20662 | Adamts12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20663 | Arhgap22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20664 | Eif4ebp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20665 | Hepacam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20666 | Hsd17b12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20667 | Naaladl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20668 | Ppp1r13l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20669 | Serpinb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20670 | Serpinh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20671 | Serpini2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20672 | Slc25a12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20673 | Slc25a24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20674 | Slc39a14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20675 | Timeless Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20676 | Serpina12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20677 | Cfi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20678 | Cfp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20679 | Dek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20680 | Ehf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20681 | Frk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20682 | Lbh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20683 | Mmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20684 | Ppy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20685 | Sp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20686 | Syp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20687 | Zfx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20688 | Aatf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20689 | Ago3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20690 | Amfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20691 | Amot Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20692 | Apcs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20693 | Arl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20694 | Baat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20695 | Bet1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20696 | Bmp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20697 | Btg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20698 | Btg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20699 | Btrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20700 | Caly Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20701 | Cbr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20702 | Cbx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20703 | Cd82 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20704 | Cdt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20705 | Chd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20706 | Cir1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20707 | Cnmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20708 | Cnn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20709 | Cpvl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20710 | Crem Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20711 | Cul5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20712 | Dcps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20713 | Dgkh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20714 | Dlg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20715 | Dlx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20716 | Dner Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20717 | Dntt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20718 | Dpys Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20719 | Drc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20720 | Dvl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20721 | Dvl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20722 | Dysf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20723 | E2f5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20724 | Eaf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20725 | Eef2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20726 | Ehd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20727 | Elp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20728 | Emx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20729 | Etf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20730 | Evx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20731 | Exo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20732 | Faf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20733 | Fhl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20734 | Flnc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20735 | Ftmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20736 | Fxr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20737 | Gab3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20738 | Gba1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20739 | Gdf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20740 | Gdi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20741 | Ghrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20742 | Gjb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20743 | Gli2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20744 | Gmps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20745 | Gnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20746 | Gng4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20747 | Gpam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20748 | Grb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20749 | Grk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20750 | Gusb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20751 | Hes2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20752 | Hhat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20753 | Hira Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20754 | Immt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20755 | Imp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20756 | Irx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20757 | Ism1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20758 | Itpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20759 | Kdm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20760 | Lax1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20761 | Lcp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20762 | Lgi3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20763 | Lgr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20764 | Lhx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20765 | Lhx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20766 | Lhx9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20767 | Lipf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20768 | Lmo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20769 | Lsm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20770 | Mafk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20771 | Mcub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20772 | Mdn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20773 | Mefv Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20774 | Mpst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20775 | Msl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20776 | Mta2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20777 | Muc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20778 | Mycl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20779 | Myh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20780 | Nagk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20781 | Ncf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20782 | Nfia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20783 | Nme3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20784 | Nox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20785 | Npnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20786 | Nuf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20787 | Opn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20788 | Orc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20789 | Orc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20790 | Otx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20791 | P3h1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20792 | Pdx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20793 | Pfn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20794 | Pgk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20795 | Pld3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20796 | Pnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20797 | Pno1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20798 | Ppa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20799 | Ppic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20800 | Ppt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20801 | Prcp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20802 | Pspn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20803 | Pstk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20804 | Pus1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20805 | Pus7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20806 | Pygl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20807 | Rag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20808 | Rala Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20809 | Rbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20810 | Rev1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20811 | Rin3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20812 | Rpf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20813 | Rpn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20814 | Rtcb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20815 | Sbk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20816 | Sco2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20817 | Scp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20818 | Sdc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20819 | Sgk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20820 | Smc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20821 | Snrk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20822 | Sox5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20823 | Syt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20824 | Tbx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20825 | Tia1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20826 | Tkfc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20827 | Tle2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20828 | Tlk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20829 | Tmpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20830 | Tom1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20831 | Ttf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20832 | Twnk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20833 | Uts2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20834 | Vav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20835 | Vav3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20836 | Vbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20837 | Vwc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20838 | Wbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20839 | Xpo6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20840 | Xrn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20841 | Yod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20842 | Zg16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20843 | Abca3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20844 | Abcc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20845 | Abhd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20846 | Acad8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20847 | Acads Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20848 | Acap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20849 | Ackr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20850 | Acsl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20851 | Adcy3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20852 | Afmid Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20853 | Anxa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20854 | Aplp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20855 | Apoc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20856 | Arih1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20857 | Arrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20858 | Asap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20859 | Ascc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20860 | Ascl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20861 | Ascl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20862 | Atg2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20863 | Axin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20864 | Birc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20865 | Bmp8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20866 | Brip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20867 | Btnl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20868 | Calb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20869 | Capn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20870 | Cass4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20871 | Cbll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20872 | Ccdc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20873 | Cdc45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20874 | Cdca3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20875 | Cdca4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20876 | Cdhr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20877 | Cdhr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20878 | Cdkn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20879 | Cdyl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20880 | Cenpw Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20881 | Cept1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20882 | Cert1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20883 | Chac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20884 | Clcn7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20885 | Cldn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20886 | Clic6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20887 | Clip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20888 | Cmpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20889 | Cmtm6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20890 | Cnih2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20891 | Cox10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20892 | Cox17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20893 | Cox18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20894 | Cox7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20895 | Crls1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20896 | Csrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20897 | Ctbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20898 | Cyb5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20899 | Daam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20900 | Dars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20901 | Dcaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20902 | Dchs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20903 | Dclk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20904 | Ddhd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20905 | Ddx10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20906 | Ddx21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20907 | Ddx49 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20908 | Degs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20909 | Disp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20910 | Disp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20911 | Dock1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20912 | Dpy30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20913 | Duox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20914 | Ebag9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20915 | Ecsit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20916 | Eepd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20917 | Eif3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20918 | Eif3m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20919 | Ethe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20920 | Evi2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20921 | Evi2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20922 | Faim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20923 | Fcamr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20924 | Fcgbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20925 | Fcrla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20926 | Fgf11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20927 | Foxa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20928 | Foxd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20929 | Foxk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20930 | Foxq1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20931 | Fstl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20932 | G6pc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20933 | Galns Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20934 | Galr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20935 | Gfra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20936 | Gins1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20937 | Gmppa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20938 | Gna13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20939 | Gpr20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20940 | Gpr22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20941 | Gpr31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20942 | Gpr50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20943 | Gpr61 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20944 | Gpr85 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20945 | Grem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20946 | Grhl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20947 | Grik3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20948 | Grin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20949 | Gstm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20950 | Gtf2i Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20951 | Hacd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20952 | Hdlbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20953 | Hmgcl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20954 | Hmgn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20955 | Hmgn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20956 | Hspb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20957 | Htr2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20958 | Htra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20959 | Icam4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20960 | Icam5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20961 | Igsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20962 | Ikbip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20963 | Il36a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20964 | Inhbc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20965 | Insl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20966 | Ireb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20967 | Isca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20968 | Itga3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20969 | Itga7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20970 | Itih2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20971 | Itpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20972 | Kcnd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20973 | Kcnq5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20974 | Klk11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20975 | Kmt2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20976 | Lama1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20977 | Lama2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20978 | Lamb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20979 | Lamc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20980 | Litaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20981 | Lmod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20982 | Lrig2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20983 | Lrrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20984 | Lrrn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20985 | Magoh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20986 | Mat1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20987 | Mat2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20988 | Mgat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20989 | Mgme1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20990 | Mmp19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20991 | Mpeg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20992 | Mrto4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20993 | Ms4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20994 | Mtif3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20995 | Mxra8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20996 | Naa40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20997 | Ncam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20998 | Ncapg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20999 | Nhsl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21000 | Nipbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21001 | Notum Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21002 | Npas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21003 | Nr0b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21004 | Nrarp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21005 | Nubpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21006 | Oprk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21007 | Ovol1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21008 | Oxa1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21009 | Padi3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21010 | Paics Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21011 | Pank1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21012 | Pank2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21013 | Parp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21014 | Pcdh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21015 | Pcdh9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21016 | Pcsk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21017 | Pcyt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21018 | Pgam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21019 | Pgap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21020 | Pianp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21021 | Pias4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21022 | Pibf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21023 | Pitx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21024 | Pla1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21025 | Plac9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21026 | Plbd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21027 | Plod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21028 | Pnpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21029 | Ppm1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21030 | Prodh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21031 | Prok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21032 | Psmd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21033 | Pxdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21034 | Rbpms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21035 | Rhpn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21036 | Rnf31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21037 | Rnf40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21038 | Robo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21039 | Rpl23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21040 | Rplp0 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21041 | Rreb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21042 | Scn3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21043 | Scn4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21044 | Semg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21045 | Sfxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21046 | Siah2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21047 | Smpd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21048 | Snu13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21049 | Sort1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21050 | Spa17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21051 | Spsb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21052 | Spsb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21053 | Srsf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21054 | Srxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21055 | Ssc5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21056 | Stk19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21057 | Stk24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21058 | Stk39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21059 | Stra6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21060 | Tagap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21061 | Tarm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21062 | Tbx21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21063 | Tcf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21064 | Tcf21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21065 | Telo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21066 | Tfdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21067 | Thada Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21068 | Traf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21069 | Trim9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21070 | Tssk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21071 | Ttbk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21072 | Ube2z Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21073 | Ube4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21074 | Uhrf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21075 | Urgcp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21076 | Ush1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21077 | Usp29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21078 | Usp34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21079 | Usp44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21080 | Vamp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21081 | Virma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21082 | Vps18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21083 | Vps35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21084 | Wipi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21085 | Abcb10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21086 | Ablim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21087 | Adgrf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21088 | Adra1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21089 | Agpat4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21090 | Anapc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21091 | Anp32a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21092 | Arid3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21093 | Arl2bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21094 | Arpc1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21095 | Asrgl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21096 | Atad3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21097 | Atp1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21098 | B3glct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21099 | B3gnt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21100 | Bclaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21101 | Cc2d1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21102 | Cdkal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21103 | Cdkn2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21104 | Cela3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21105 | Chrnb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21106 | Cited2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21107 | Clstn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21108 | Col9a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21109 | Commd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21110 | Cox6b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21111 | Cox6b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21112 | Cox7a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21113 | Csnk1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21114 | Cyp2s1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21115 | Dcbld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21116 | Dnajb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21117 | Dnajc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21118 | Draxin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21119 | Dusp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21120 | Eftud2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21121 | Eif4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21122 | Elovl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21123 | Endod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21124 | Exosc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21125 | Faap24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21126 | Fam83d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21127 | Fbxo44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21128 | Fbxw11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21129 | Fermt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21130 | Fermt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21131 | Flvcr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21132 | Flvcr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21133 | Gabrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21134 | Gimap6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21135 | Gpr146 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21136 | Grin2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21137 | Hnrnpk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21138 | Hnrnpu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21139 | Homer1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21140 | Hotair Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21141 | Il17rc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21142 | Inpp5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21143 | Inpp5e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21144 | Itga11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21145 | Lgalsl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21146 | Lingo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21147 | Lpgat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21148 | Lrrc8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21149 | Magea1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21150 | Magea4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21151 | Map3k6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21152 | Mapre1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21153 | Mettl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21154 | Mfap3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21155 | Minpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21156 | Mlxipl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21157 | Mrpl21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21158 | Mrps10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21159 | mt-Nd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21160 | Mycbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21161 | Ndufa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21162 | Ndufs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21163 | Ndufs5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21164 | Ndufv2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21165 | Nfe2l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21166 | Nlrp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21167 | Osbpl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21168 | Pdzrn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21169 | Pggt1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21170 | Pgm2l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21171 | Pinlyp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21172 | Pou3f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21173 | Pou4f1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21174 | Ppp2ca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21175 | Ppp6r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21176 | Prdm13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21177 | Prkaa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21178 | Prss22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21179 | Prss23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21180 | Ptpn13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21181 | Ptpn14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21182 | Qrich1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21183 | Rab27b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21184 | Rassf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21185 | Rhbdl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21186 | Rnasek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21187 | Rnf145 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21188 | Rnf149 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21189 | Rpl23a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21190 | Scara3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21191 | Scube3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21192 | Sema6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21193 | Sema6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21194 | Setd1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21195 | Slc7a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21196 | Snap29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21197 | Snapc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21198 | Snrpd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21199 | Spock3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21200 | Steap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21201 | Stk32c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21202 | Suclg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21203 | Syce1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21204 | Tas1r3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21205 | Tgoln2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21206 | Tmeff2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21207 | Tollip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21208 | Trim32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21209 | Trim35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21210 | Trim47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21211 | Trim72 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21212 | Tspan6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21213 | Tuba1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21214 | Tubb4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21215 | Tyrobp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21216 | Unc13a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21217 | Unc5cl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21218 | Vangl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21219 | Yme1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21220 | Zbtb17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21221 | Zdhhc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21222 | Znhit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21223 | Adipor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21224 | Aldh1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21225 | Angptl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21226 | Angptl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21227 | Arl6ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21228 | Atp13a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21229 | Atp5f1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21230 | Atp6v1f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21231 | C1galt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21232 | Cacna1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21233 | Cacna1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21234 | Cacna1s Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21235 | Col10a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21236 | Emilin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21237 | Galnt10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21238 | Galnt14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21239 | Hsd17b8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21240 | Hsp90b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21241 | Il22ra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21242 | Izumo1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21243 | Ldlrad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21244 | Ldlrad3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21245 | Map3k13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21246 | Mybbp1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21247 | Nectin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21248 | Pcolce2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21249 | Pde4dip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21250 | Ppp1r9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21251 | Ppp2r5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21252 | Rapgef4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21253 | Selenoi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21254 | Septin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21255 | Slc15a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21256 | Slc26a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21257 | Slc37a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21258 | Slc52a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21259 | Slco2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21260 | Smarca5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21261 | Snrnp70 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21262 | Timm17a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21263 | Tmem119 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21264 | Tmem45a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21265 | Tmprss3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21266 | Trmt61b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21267 | Txndc12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21268 | Wfikkn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21269 | Zc3h12d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21270 | Zfp36l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21271 | Cd200r1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21272 | Colgalt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21273 | Map1lc3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21274 | Pafah1b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21275 | Pdzk1ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21276 | Pnliprp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21277 | Slc22a17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21278 | Slc25a33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21279 | Tmprss15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21280 | Csgalnact1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21281 | Ak9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21282 | Dse Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21283 | Evl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21284 | Hrk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21285 | Lsr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21286 | Nrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21287 | Qki Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21288 | Sry Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21289 | Acp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21290 | Aff4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21291 | Ajm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21292 | Alg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21293 | Alg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21294 | Alpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21295 | Asb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21296 | Aspm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21297 | Avil Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21298 | Bco2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21299 | Bcor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21300 | Blnk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21301 | Bora Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21302 | Bub3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21303 | Cbx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21304 | Ccn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21305 | Ccnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21306 | Ccno Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21307 | Cct8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21308 | Cds2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21309 | Cfc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21310 | Chd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21311 | Chka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21312 | Chp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21313 | Chpf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21314 | Cltc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21315 | Cnbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21316 | Coil Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21317 | Crnn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21318 | Cul1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21319 | Dap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21320 | Dbn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21321 | Def6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21322 | Dera Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21323 | Dlx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21324 | Dok7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21325 | Dpf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21326 | Dpm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21327 | Dpp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21328 | Dpyd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21329 | Dspp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21330 | Dtx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21331 | Ebpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21332 | Eci1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21333 | Elf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21334 | Elf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21335 | Emx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21336 | Etv2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21337 | Etv3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21338 | Etv5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21339 | Ext1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21340 | Fat4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21341 | Fjx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21342 | Flcn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21343 | Fut4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21344 | Fzd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21345 | Gatb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21346 | Gde1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21347 | Gdf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21348 | Glg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21349 | Gli3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21350 | Gmds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21351 | Gnb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21352 | Gng2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21353 | Gyg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21354 | Hhip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21355 | Idi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21356 | Idi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21357 | Ipmk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21358 | Irs4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21359 | Klf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21360 | Klf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21361 | Lat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21362 | Lcor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21363 | Ldhc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21364 | Lgr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21365 | Lhx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21366 | Lhx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21367 | Lmo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21368 | Lsm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21369 | Ly6h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21370 | Mael Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21371 | Mcat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21372 | Mcm6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21373 | Mcm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21374 | Mei1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21375 | Mfng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21376 | Mia2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21377 | Miip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21378 | Msi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21379 | Msx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21380 | Mto1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21381 | Mul1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21382 | Mxi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21383 | Myh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21384 | Myh6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21385 | Myl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21386 | Mzf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21387 | Nbea Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21388 | Nek8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21389 | Nek9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21390 | Nfic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21391 | Nfs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21392 | Nkg7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21393 | Nkrf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21394 | Npr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21395 | Nrep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21396 | Nt5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21397 | Nt5m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21398 | Oit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21399 | Opn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21400 | Pawr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21401 | Pcca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21402 | Pccb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21403 | Pdhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21404 | Pdhx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21405 | Pecr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21406 | Pex2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21407 | Pgm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21408 | Phip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21409 | Pid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21410 | Pin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21411 | Pon3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21412 | Purb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21413 | Rac3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21414 | Rarb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21415 | Rbl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21416 | Rbm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21417 | Rcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21418 | Rdm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21419 | Rec8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21420 | Rgl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21421 | Rgp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21422 | Rgs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21423 | Rhog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21424 | Rln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21425 | Rnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21426 | Rpa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21427 | Rrs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21428 | Rtp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21429 | Sdf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21430 | Sdhc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21431 | Sdhd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21432 | Shc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21433 | Six3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21434 | Six4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21435 | Six5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21436 | Spg7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21437 | Spic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21438 | Stx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21439 | Swi5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21440 | Tbx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21441 | Tfr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21442 | Tgm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21443 | Tle1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21444 | Tle4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21445 | Tmc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21446 | Tmc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21447 | Tns1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21448 | Trdn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21449 | Ttc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21450 | Ttf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21451 | Ucn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21452 | Upp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21453 | Urod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21454 | Usf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21455 | Uxs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21456 | Vill Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21457 | Vrk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21458 | Wnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21459 | Xaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21460 | Xpo7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21461 | Xrn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21462 | Zic1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21463 | Zic5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21464 | Zw10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21465 | Aars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21466 | Abcb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21467 | Abcb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21468 | Abcc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21469 | Abhd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21470 | Acot1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21471 | Actg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21472 | Actr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21473 | Adcy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21474 | Adcy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21475 | Agmat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21476 | Akap5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21477 | Akip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21478 | Alg11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21479 | Ampd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21480 | Apex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21481 | Aph1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21482 | Apmap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21483 | Arap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21484 | Arid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21485 | Asap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21486 | Ascl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21487 | Atad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21488 | Atg12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21489 | Atp23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21490 | Atxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21491 | Atxn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21492 | Aunip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21493 | Auts2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21494 | Banf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21495 | Bank1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21496 | Batf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21497 | Bcl9l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21498 | Best3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21499 | Bicc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21500 | C1ql1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21501 | C3ar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21502 | Calcb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21503 | Cald1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21504 | Cand1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21505 | Ccnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21506 | Ccnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21507 | Ccnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21508 | Cd247 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21509 | Cd2ap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21510 | Cdc5l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21511 | Cdca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21512 | Cdh19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21513 | Cdh23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21514 | Cdh24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21515 | Cdhr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21516 | Cdk18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21517 | Cdk20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21518 | Cdkl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21519 | Cebpe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21520 | Cebpg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21521 | Cenpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21522 | Cenpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21523 | Cep55 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21524 | Cep78 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21525 | Cflar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21526 | Chmp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21527 | Chrm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21528 | Chst9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21529 | Ciart Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21530 | Cideb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21531 | Clcn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21532 | Cldn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21533 | Cldn7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21534 | Cnnm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21535 | Cox14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21536 | Cox6c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21537 | Cpne3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21538 | Cpne5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21539 | Cpsf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21540 | Creb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21541 | Crim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21542 | Csde1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21543 | Cstf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21544 | Cyth3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21545 | Dars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21546 | Dctn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21547 | Ddx11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21548 | Ddx24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21549 | Ddx3y Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21550 | Ddx60 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21551 | Degs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21552 | Dgcr8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21553 | Dhx30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21554 | Dhx58 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21555 | Disc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21556 | Dmgdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21557 | Dmrt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21558 | Dock7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21559 | Dram1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21560 | Dscam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21561 | Dscc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21562 | Eif3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21563 | Eif3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21564 | Ero1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21565 | Etnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21566 | Extl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21567 | Fads3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21568 | Fanci Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21569 | Fbln2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21570 | Fbxo5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21571 | Fbxo6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21572 | Fbxw2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21573 | Fmnl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21574 | Foxe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21575 | Foxr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21576 | Frmd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21577 | Frmd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21578 | Fut10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21579 | Gcnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21580 | Gdpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21581 | Ggact Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21582 | Glis2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21583 | Glp2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21584 | Gmeb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21585 | Gnai2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21586 | Gpd1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21587 | Gpr21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21588 | Greb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21589 | Gria2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21590 | Gtf2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21591 | Hacd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21592 | Hdhd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21594 | Hint1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21595 | Hnf4g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21596 | Hoxb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21597 | Hoxb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21598 | Hoxc8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21599 | Hyls1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21600 | Ifi35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21601 | Ifrd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21602 | Ikzf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21603 | Itm2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21604 | Itpr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21605 | Jmjd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21606 | Kat14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21607 | Kcmf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21608 | Kcna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21609 | Kcnd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21610 | Kcnh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21611 | Kcnh8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21612 | Kcnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21613 | Kcnk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21614 | Kctd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21615 | Kdm1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21616 | Kif1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21617 | Kif22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21618 | Klf16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21619 | Kmt5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21620 | Kyat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21621 | Lalba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21622 | Lama4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21623 | Lama5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21624 | Lamb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21625 | Lamb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21626 | Larp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21627 | Lars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21628 | Lars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21629 | Limd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21630 | Lmnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21631 | Lmx1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21632 | Loxl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21633 | Lrfn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21634 | Lrp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21635 | Lrtm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21636 | Lsamp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21637 | Ltc4s Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21638 | Magt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21639 | Maml1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21640 | Mark1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21641 | Mast3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21642 | Matn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21643 | Mcfd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21644 | Mex3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21645 | Mgat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21646 | Mgst3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21647 | Micu2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21648 | Mitd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21649 | Mki67 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21650 | Mlycd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21651 | Mmrn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21652 | Mob1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21653 | Morc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21654 | Mprip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21655 | Mrtfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21656 | Ms4a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21657 | Muc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21658 | Mybl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21659 | Myo1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21660 | Mysm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21661 | Myt1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21662 | Nacc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21663 | Nedd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21664 | Nelfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21665 | Nomo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21666 | Noxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21667 | Npsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21668 | Nr0b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21669 | Nrxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21670 | Nrxn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21671 | Nsun3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21672 | Nsun7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21673 | Nt5c2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21674 | Nucb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21675 | Numa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21676 | Nup85 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21677 | Olfm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21678 | Padi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21679 | Panx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21680 | Paqr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21681 | Parm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21682 | Pcdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21683 | Pcmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21684 | Pdcd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21685 | Pde6c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21686 | Pdgfc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21687 | Pdzd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21688 | Pias3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21689 | Pidd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21690 | Plag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21691 | Plcb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21692 | Plcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21693 | Plin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21694 | Pold3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21695 | Ppcdc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21696 | Ppm1k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21697 | Prex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21698 | Prlhr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21699 | Prok2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21700 | Prpf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21701 | Psmb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21702 | Psmc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21703 | Ptcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21704 | Pthlh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21705 | Ptprb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21706 | Ptpre Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21707 | Ptprg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21708 | Ptprm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21709 | Ptprs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21710 | Rab10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21711 | Rab20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21712 | Rab32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21713 | Rab37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21714 | Rab3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21715 | Rab5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21716 | Rab5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21717 | Rab8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21718 | Rad9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21719 | Rasa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21720 | Rasa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21721 | Rasd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21722 | Rbbp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21723 | Rbbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21724 | Rbm22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21725 | Rbm43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21726 | Rbms2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21727 | Rc3h2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21728 | Rcan1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21729 | Rcor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21730 | Rdh10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21731 | Rgs17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21732 | Ribc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21733 | Rims2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21734 | Riok3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21735 | Rnf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21736 | Rnf25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21737 | Rnf32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21738 | Rpl36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21739 | Rplp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21740 | Rps10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21741 | Rps12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21742 | Rps14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21743 | Rps21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21744 | Rraga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21745 | Rragd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21746 | Rrm2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21747 | Rspo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21748 | Rtbdn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21749 | Sall2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21750 | Sall4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21751 | Sap30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21752 | Sec13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21753 | Sesn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21754 | Sftpc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21755 | Sgpl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21756 | Sin3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21757 | Slit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21758 | Smdt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21759 | Smyd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21760 | Smyd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21761 | Sntg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21762 | Snx20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21763 | Sorl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21764 | Sox11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21765 | Spag5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21766 | Spc25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21767 | Spry1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21768 | Srrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21769 | Srsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21770 | Stag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21771 | Stmn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21772 | Styk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21773 | Sumo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21774 | Susd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21775 | Svep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21776 | Sycp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21777 | Tada1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21778 | Taf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21779 | Tafa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21780 | Tbx19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21781 | Tcfl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21782 | Tctn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21783 | Tdrd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21784 | Tfap4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21785 | Tfb1m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21786 | Tfb2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21787 | Thsd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21788 | Tmed2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21789 | Tmed3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21790 | Tmed9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21791 | Top3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21792 | Tpd52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21793 | Tpst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21794 | Trak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21795 | Trat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21796 | Trim8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21797 | Trip6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21798 | Trit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21799 | Trpm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21800 | Ubap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21801 | Ufsp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21802 | Uqcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21803 | Usp48 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21804 | Veph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21805 | Vwc2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21806 | Wdr26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21807 | Wnt5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21808 | Wnt7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21809 | Ypel5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21810 | Zmym2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21811 | Abhd12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21812 | Actl6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21813 | Adgrb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21814 | Adgrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21815 | Adgrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21816 | Adgrf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21817 | Adgrg6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21818 | Agpat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21819 | Agtrap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21820 | Ambra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21821 | Atp11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21822 | Atp1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21823 | Atp1b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21824 | Atxn2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21825 | B3gnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21826 | Baiap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21827 | Bcl11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21828 | Brinp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21829 | Camkk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21830 | Camta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21831 | Cartpt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21832 | Cavin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21833 | Cavin3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21834 | Cd99l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21835 | Cep112 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21836 | Chaf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21837 | Chmp4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21838 | Clec3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21839 | Col5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21840 | Col5a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21841 | Coro1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21842 | Csnk2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21843 | Ddx19b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21844 | Dhtkd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21845 | Diaph3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21846 | Dnajc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21847 | Dusp18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21848 | Eef1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21849 | Efemp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21850 | Egflam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21851 | Eif2s1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21852 | Ercc6l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21853 | Exosc9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21854 | Fam20b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21855 | Fbxo11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21856 | Gabra5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21857 | Glcci1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21858 | Glt8d2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21859 | Glyctk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21860 | Gpr141 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21861 | Gpr182 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21862 | Grin2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21863 | Gxylt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21864 | Higd1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21865 | Hnrnpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21866 | Hsf2bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21867 | Hspa4l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21868 | Ifi44l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21869 | Ifitm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21870 | Il20ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21871 | Immp1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21872 | Immp2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21873 | Impact Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21874 | Incenp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21875 | Inpp4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21876 | Inpp5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21877 | Kif21a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21878 | Klhl24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21879 | Large2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21880 | Lmbr1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21881 | Ly6g6f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21882 | Map3k2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21883 | Mettl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21884 | Mettl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21886 | Mllt10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21887 | Mrgpre Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21888 | Mrpl11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21889 | Mrpl13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21890 | Mustn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21891 | Nanos1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21892 | Nap1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21893 | Ndufa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21894 | Ndufb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21895 | Ndufb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21896 | Ndufc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21897 | Ndufc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21898 | Ndufs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21899 | Nfatc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21900 | Npffr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21901 | Pcdh12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21902 | Pcdh17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21903 | Pdgfrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21904 | Pdlim5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21905 | Pdzd11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21906 | Pgrmc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21907 | Pik3r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21908 | Pitpna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21909 | Polr1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21910 | Polr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21911 | Polr1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21912 | Polr2g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21913 | Ppp3r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21914 | Prss27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21915 | Prss57 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21916 | Ptger1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21917 | Ptpdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21918 | Rassf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21919 | Rnf128 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21920 | Rnf166 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21921 | Rnf169 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21922 | Rnf186 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21923 | Rnf213 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21924 | Rpl27a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21925 | Samsn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21926 | Scarf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21927 | Sema3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21928 | Sephs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21929 | Setbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21930 | Sh2d1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21931 | Sh3bp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21932 | Sh3gl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21933 | Slc1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21934 | Slc1a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21935 | Slc1a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21936 | Slc4a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21937 | Slc4a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21938 | Slc5a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21939 | Slc6a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21940 | Slc7a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21941 | Sorbs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21942 | Sowaha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21943 | Sptlc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21944 | Srd5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21945 | Srd5a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21946 | Srebf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21947 | Stard4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21948 | Stoml3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21949 | Strip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21950 | Stxbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21951 | Sucla2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21952 | Syngr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21953 | Tas1r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21954 | Tbxas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21955 | Tcirg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21956 | Tex264 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21957 | Tm9sf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21958 | Trim13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21959 | Trim26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21960 | Trim31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21961 | Trim38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21962 | Trim44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21963 | Trim56 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21964 | Trip11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21965 | Trip12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21966 | Tsga10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21967 | Ttll12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21968 | Twist2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21969 | U2surp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21970 | Ubap1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21971 | Ube2l6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21972 | Ube2v2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21973 | Ubiad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21974 | Ugt1a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21975 | Unc13d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21976 | Yeats2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21977 | Zbtb12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21978 | Zcchc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21979 | Abhd16b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21980 | Adamts3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21981 | Adipor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21982 | Aldh3b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21983 | Ankrd54 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21984 | Arfgap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21985 | Arhgdib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21986 | Arhgef6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21987 | Arhgef7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21988 | Atp5f1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21989 | Bcl2l12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21990 | Bhlhe23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21991 | C9orf72 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21992 | Caskin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21993 | Ccdc134 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21994 | Ccdc88a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21995 | Clec11a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21996 | Clec14a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21997 | Clptm1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21998 | Col22a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21999 | Csnk1g1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22000 | Dnajc11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22001 | Dnttip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22002 | Eif2ak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22003 | Fam162a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22004 | Fam177b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22005 | Fastkd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22006 | Hmgcll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22007 | Il12rb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22008 | Laptm4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22009 | Mapkap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22010 | Mettl13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22011 | Micall2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22012 | Napepld Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22013 | Ndufaf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22014 | Ndufb11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22015 | Pacsin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22016 | Pik3ap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22017 | Plekhg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22018 | Ppp2r1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22019 | Ppp2r3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22020 | Prkar2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22021 | Prkar2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22022 | Rangap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22023 | Rasgrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22024 | Rnpepl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22025 | Rps6ka4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22026 | Rps6ka5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22027 | Serinc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22028 | Slc10a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22029 | Slc12a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22030 | Slc13a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22031 | Slc16a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22032 | Slc18a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22033 | Slc18a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22034 | Slc18b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22035 | Slc20a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22036 | Slc22a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22037 | Slc25a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22038 | Slc26a6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22039 | Slc29a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22040 | Slc35b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22041 | Slc35e3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22042 | Slc38a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22043 | Slc38a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22044 | Slc44a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22045 | Smarcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22046 | Sostdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22047 | St8sia1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22048 | Tax1bp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22049 | Tbc1d16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22050 | Tmem158 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22051 | Tsc22d3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22052 | Ubash3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22053 | Unc93b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22054 | Xpnpep3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22055 | Zc3hav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22056 | Zdhhc19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22057 | Arhgap30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22058 | Arhgap42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22059 | Arhgef40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22060 | Cacna2d3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22061 | Cacna2d4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22062 | Crispld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22063 | Ctnnbip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22064 | Hsd17b14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22065 | Mapk8ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22066 | Naaladl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22067 | Pafah1b3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22068 | Rap1gap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22069 | Serpinb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22070 | Sh3pxd2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22071 | Slc22a13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22072 | Slc25a13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22073 | Slc25a25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22074 | Slc25a29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22075 | Slc25a37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22076 | Slc25a39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22077 | Stambpl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22078 | Traf3ip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22079 | C1galt1c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22080 | Ak6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22081 | Mkx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22082 | Mpz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22083 | Nyx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22084 | Scx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22085 | Txk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22086 | Wiz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22087 | Wls Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22088 | Xpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22089 | Yy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22090 | A1cf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22091 | Aacs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22092 | Aard Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22093 | Aatk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22094 | Acp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22095 | Acp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22096 | Aff3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22097 | Agmo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22098 | Agps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22099 | Ahsp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22100 | Aig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22101 | Akna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22102 | Alg6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22103 | Ano2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22104 | Apeh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22105 | Aplf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22106 | Arf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22107 | Asb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22108 | Atf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22109 | Bag5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22110 | Bcl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22111 | Brox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22112 | Cbr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22113 | Cct4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22114 | Cds1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22115 | Chat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22116 | Chdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22117 | Chgb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22118 | Chkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22119 | Chn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22120 | Cilp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22121 | Cln3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22122 | Cln5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22123 | Cln6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22124 | Clpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22125 | Clpx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22126 | Cmas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22127 | Cnn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22128 | Cnn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22129 | Coq3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22130 | Coq5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22131 | Ctr9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22132 | Ctsf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22133 | Cttn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22134 | Cul9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22135 | Ddx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22136 | Dgki Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22137 | Dio3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22138 | Dlg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22139 | Dlx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22140 | Dlx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22141 | Dmtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22142 | Dnm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22143 | Dnm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22144 | Dok3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22145 | Dolk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22146 | Dpf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22147 | Dpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22148 | Drp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22149 | E2f8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22150 | Ect2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22151 | Edc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22152 | Edn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22153 | Ehd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22154 | Ei24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22155 | Elk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22156 | Elp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22157 | Emc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22158 | Emc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22159 | Enc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22160 | Eny2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22161 | Epg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22162 | Epn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22163 | Etfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22164 | Etv4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22165 | Eya1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22166 | Fan1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22167 | Far2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22168 | Fbn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22169 | Fgd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22170 | Fig4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22171 | Fmo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22172 | Fmo5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22173 | Fnta Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22174 | Frs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22175 | Fut9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22176 | Fzr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22177 | Gab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22178 | Gas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22179 | Gbf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22180 | Gbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22181 | Gbp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22182 | Gfm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22183 | Gjb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22184 | Gjb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22185 | Gjc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22186 | Gldn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22187 | Glrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22188 | Gnaq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22189 | Gnb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22190 | Gnb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22191 | Gng3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22192 | Gnl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22193 | Gpx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22194 | Gpx8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22195 | Guf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22196 | Hax1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22197 | Hccs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22198 | Hcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22199 | Hes7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22200 | Heyl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22201 | Hmx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22202 | Hpdl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22203 | Hpf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22204 | Hscb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22205 | Ier5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22206 | Ighm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22207 | Il25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22208 | Inmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22209 | Ipo9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22210 | Ippk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22211 | Iqub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22212 | Iws1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22213 | Kif7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22214 | Knl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22215 | Krt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22216 | Leo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22217 | Lfng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22218 | Lgi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22219 | Lgi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22220 | Lig3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22221 | Lipg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22222 | Lipk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22223 | Lmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22224 | Lrba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22225 | Lst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22226 | Ltn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22227 | Lyg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22228 | Mbd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22229 | Mbd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22230 | Mcm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22231 | Mcm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22232 | Mcm9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22233 | Mfrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22234 | Mib1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22235 | Miox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22236 | Misp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22237 | Mlf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22238 | Mmab Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22239 | Mpnd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22240 | Mrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22241 | Msh6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22242 | Msi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22243 | Mtf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22244 | Mtx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22245 | Mxd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22246 | Myf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22247 | Myl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22248 | Narf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22249 | Nefh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22250 | Neo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22251 | Neu2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22252 | Neu3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22253 | Nexn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22254 | Nfix Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22255 | Nfyb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22256 | Nid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22257 | Nit2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22258 | Nkap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22259 | Nktr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22260 | Nmd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22261 | Nme5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22262 | Noa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22263 | Noct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22264 | Nol4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22265 | Ocln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22266 | Oxsm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22267 | Pax1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22268 | Pax2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22269 | Pax9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22270 | Pbx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22271 | Pbx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22272 | Pclo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22273 | Pcp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22274 | Pdyn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22275 | Pex3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22276 | Pfn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22277 | Pgls Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22278 | Phkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22279 | Pigq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22280 | Pisd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22281 | Pllp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22282 | Pmch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22283 | Pnoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22284 | Pogz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22285 | Polh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22286 | Preb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22287 | Prnd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22288 | Prr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22289 | Ptms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22290 | Ptx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22291 | Pum2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22292 | Pus3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22293 | Pygb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22294 | Rarg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22295 | Rbm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22296 | Rbmx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22297 | Rfc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22298 | Rfc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22299 | Rfx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22300 | Rfx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22301 | Rfx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22302 | Rgcc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22303 | Rhag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22304 | Rhod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22305 | Rlim Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22306 | Rnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22307 | Rny1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22308 | Rpl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22309 | Rpl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22310 | Rprm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22311 | Rps5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22312 | Rpsa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22313 | Rras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22314 | Rsu1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22315 | Rtf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22316 | Rtn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22317 | Sbsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22318 | Scel Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22319 | Scg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22320 | Setx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22321 | Sfpq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22322 | Sgcz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22323 | Shc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22324 | Sit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22325 | Six6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22326 | Ska1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22327 | Slu7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22328 | Smn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22329 | Smtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22330 | Sox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22331 | Spib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22332 | Sra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22333 | Srms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22334 | Strn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22335 | Sun1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22336 | Suox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22337 | Syn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22338 | Syt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22339 | Tbx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22340 | Tbx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22341 | Tcap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22342 | Tecr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22343 | Tgm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22344 | Tjp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22345 | Tln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22346 | Tmie Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22347 | Tmx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22348 | Tns4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22349 | Tox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22350 | Trir Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22351 | Ubl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22352 | Ubn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22353 | Utf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22354 | Vav2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22355 | Vmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22356 | Vmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22357 | Vrk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22358 | Wbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22359 | Wdr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22360 | Wnt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22361 | Wwc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22362 | Zer1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22363 | Zup1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22364 | Abcc9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22365 | Abcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22366 | Abcd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22367 | Abcf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22368 | Abtb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22369 | Acad9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22370 | Acbd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22371 | Ackr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22372 | Acot2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22373 | Acot7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22374 | Acsf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22375 | Acta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22376 | Actr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22377 | Adam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22378 | Adat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22379 | Adcy5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22380 | Aebp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22381 | Agfg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22382 | Aipl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22383 | Akap6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22384 | Alg12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22385 | Alg13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22386 | Alg14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22387 | Alms1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22388 | Alpk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22389 | Ap1s2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22390 | Ap2m1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22391 | Apba2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22392 | Aph1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22393 | Aplp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22394 | Arcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22395 | Arl4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22396 | Arl8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22397 | Armh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22398 | Atg4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22399 | Atg9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22400 | Atg9b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22401 | Atrip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22402 | Axin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22403 | Barx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22404 | Baz1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22405 | Bcas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22406 | Bend5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22407 | Bmp8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22408 | Brms1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22409 | Bud31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22410 | C1ql3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22411 | Cabp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22412 | Capn8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22413 | Capn9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22414 | Cars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22415 | Casz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22416 | Cbln4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22417 | Ccar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22418 | Ccbe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22419 | Ccdc9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22420 | Ccne2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22421 | Ccpg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22422 | Cct6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22423 | Cdc23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22424 | Cdc34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22425 | Cdca8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22426 | Cdipt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22427 | Cdkl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22428 | Cdr2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22429 | Celf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22430 | Celf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22431 | Celf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22432 | Cenpm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22433 | Cenpx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22434 | Cep76 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22435 | Cers2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22436 | Chadl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22437 | Chid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22438 | Chrm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22439 | Chrnd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22440 | Chst7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22441 | Chtop Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22442 | Clcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22443 | Clcn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22444 | Cldn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22445 | Cldn8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22446 | Clip4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22447 | Cmya5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22448 | Cnga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22449 | Cnga3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22450 | Cnot1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22451 | Cnot7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22452 | Cox7c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22453 | Cox8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22454 | Cpeb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22455 | Cplx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22456 | Cpne4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22457 | Crocc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22458 | Crtap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22459 | Crtc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22460 | Cul4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22461 | Cul4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22462 | Cwc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22463 | Cxxc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22464 | Cyren Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22465 | Dcaf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22466 | Dctn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22467 | Ddx42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22468 | Dhx29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22469 | Dmac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22470 | Dmrt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22471 | Dmrt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22472 | Dnah9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22473 | Dstyk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22474 | Duox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22475 | Dusp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22476 | Dusp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22477 | Ears2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22478 | Edem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22479 | Edem3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22480 | Efhd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22481 | Eif3h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22482 | Eif5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22483 | Elfn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22484 | Elfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22485 | Elmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22486 | Endou Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22487 | Enpp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22488 | Epb41 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22489 | Eps15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22490 | Eral1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22491 | Ercc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22492 | Ercc8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22493 | Esyt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22494 | Esyt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22495 | Etaa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22496 | Eva1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22497 | Exoc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22498 | Exph5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22499 | Fam3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22500 | Fate1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22501 | Fbln5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22502 | Fbxl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22503 | Fbxo7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22504 | Fcho1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22505 | Fcrl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22506 | Fem1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22507 | Fhod3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22508 | Fibin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22509 | Fkbp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22510 | Fmnl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22511 | Fndc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22512 | Foxb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22513 | Foxc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22514 | Foxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22515 | Foxo6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22516 | Foxp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22517 | Fstl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22518 | Ftsj3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22519 | Fubp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22520 | Fut11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22521 | Fxyd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22522 | Fxyd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22523 | Galr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22524 | Ghitm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22525 | Gins2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22526 | Gipc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22527 | Glod4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22528 | Glra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22529 | Glrx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22530 | Glyr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22531 | Gmpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22532 | Gna15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22533 | Gnai1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22534 | Gng11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22535 | Gpm6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22536 | Gpr45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22537 | Gpr63 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22538 | Gpsm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22539 | Grb10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22540 | Grik1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22541 | Grsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22542 | Gstm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22543 | Gstt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22544 | Habp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22545 | Hacd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22546 | Hace1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22547 | Hacl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22548 | Hddc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22549 | Hecw1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22550 | Hemk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22551 | Herc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22552 | Hhatl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22553 | Hinfp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22554 | Hint2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22555 | Hmcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22556 | Hoga1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22557 | Hoxa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22558 | Hoxa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22559 | Hoxb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22560 | Hoxb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22561 | Hoxb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22562 | Hoxc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22563 | Htr1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22564 | Htra4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22565 | Hvcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22566 | Iars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22567 | Idh3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22568 | Idh3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22569 | Ifi44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22570 | Ifna6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22571 | Ifrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22572 | Igll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22573 | Il21r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22574 | Ilvbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22575 | Insm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22576 | Iqcb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22577 | Itgad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22578 | Itih4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22579 | Itm2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22580 | Itpkc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22581 | Jade3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22582 | Josd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22583 | Kat6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22584 | Kcna3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22585 | Kcnc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22586 | Kcne5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22587 | Kcnj3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22588 | Kcnj8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22589 | Kcns1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22590 | Kcnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22591 | Kcnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22592 | Kctd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22593 | Kctd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22594 | Kif2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22595 | Kif3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22596 | Kif3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22597 | Kif3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22598 | Kif5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22599 | Klf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22600 | Klf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22601 | Klhl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22602 | Kpna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22603 | Krt6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22604 | Krt81 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22605 | Lamc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22606 | Lasp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22607 | Lemd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22608 | Limd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22609 | Lin37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22610 | Lipt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22611 | Llgl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22612 | Lman1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22613 | Lpin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22614 | Lrfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22615 | Lrfn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22616 | Lrig3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22617 | Lrit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22618 | Lrp1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22619 | Luzp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22620 | Lzts1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22621 | Macf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22622 | Magi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22623 | Maml2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22624 | Maml3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22625 | Mast1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22626 | Mast4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22627 | Mbnl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22628 | Mccc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22629 | Mcf2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22630 | Mcur1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22631 | Med19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22632 | Medag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22633 | Megf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22634 | Megf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22635 | Meis2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22636 | Mex3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22637 | Mfsd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22638 | Mgst2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22639 | Mipep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22640 | Mixl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22641 | Mkrn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22642 | Mlst8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22643 | Mlxip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22644 | Mmp15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22645 | Mmp16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22646 | Mms19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22647 | Morc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22648 | Mov10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22649 | Mrap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22650 | Mrpl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22651 | Mtch1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22652 | Mtcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22653 | Mtif2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22654 | Mtmr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22655 | Mtus1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22656 | Muc13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22657 | Mus81 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22658 | Mutyh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22659 | Myadm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22660 | Myh10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22661 | Mylk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22662 | Mylk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22663 | Myo3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22664 | Myo3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22665 | Myo9b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22666 | Myoz2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22667 | Nabp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22668 | Nagpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22669 | Naprt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22670 | Nars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22671 | Nat8l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22672 | Ncoa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22673 | Ndrg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22674 | Ndrg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22675 | Ndst4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22676 | Neil3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22677 | Nfrkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22678 | Nim1k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22679 | Nlgn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22680 | Nmrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22681 | Nop14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22682 | Nop56 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22683 | Npas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22684 | Nr1h3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22685 | Nr1i2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22686 | Nr2c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22687 | Nr2c2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22688 | Nr6a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22689 | Nrbf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22690 | Nrip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22691 | Nsmaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22692 | Nsun4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22693 | Nsun5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22694 | Nsun6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22695 | Nudt8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22696 | Numbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22697 | Nup42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22698 | Nup88 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22699 | Nyap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22700 | Ogdhl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22701 | Or2k2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22702 | Orai2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22703 | Otogl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22704 | Ovch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22705 | Ovol2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22706 | Oxgr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22707 | Palmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22708 | Pank3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22709 | Pars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22710 | Pcgf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22711 | Pcsk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22712 | Pde6d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22713 | Pdia2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22714 | Pdss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22715 | Pdss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22716 | Pdzd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22717 | Pdzd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22718 | Pdzd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22719 | Peli2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22720 | Pfdn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22721 | Pgbd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22722 | Phf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22723 | Phf19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22724 | Phf23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22725 | Phf24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22726 | Phka1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22727 | Phkg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22728 | Phrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22729 | Pias2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22730 | Pitx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22731 | Plcb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22732 | Plek2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22733 | Plvap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22734 | Pole2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22735 | Polg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22736 | Ppm1f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22737 | Ppm1h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22738 | Ppm1j Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22739 | Ppp4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22740 | Pprc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22741 | Prdm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22742 | Prorp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22743 | Prrx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22744 | Psip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22745 | Psmb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22746 | Psmb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22747 | Psmc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22748 | Psmd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22749 | Psmd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22750 | Psmd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22751 | Ptch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22752 | Ptcra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22753 | Ptprq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22754 | Ptprr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22755 | Puf60 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22756 | Pxmp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22757 | Qrsl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22758 | Rab1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22759 | Rab21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22760 | Rab28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22761 | Rab34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22762 | Rab35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22763 | Rab42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22764 | Rab8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22765 | Rabl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22766 | Ralyl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22767 | Rasa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22768 | Rbm10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22769 | Rbm25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22770 | Rbm33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22771 | Rbm34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22772 | Rbms3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22773 | Rcor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22774 | Rell2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22775 | Rgs10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22776 | Rgs22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22777 | Rmdn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22778 | Rnf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22779 | Rnft2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22780 | Rpe65 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22781 | Rpl12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22782 | Rpl18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22783 | Rpl24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22784 | Rpl26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22785 | Rpl37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22786 | Rpl38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22787 | Rps15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22788 | Rps18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22789 | Rras2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22790 | Rrp7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22791 | Rsrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22792 | Rufy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22793 | Samd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22794 | Samd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22795 | Sardh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22796 | Scml4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22797 | Scn1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22798 | Scrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22799 | Sel1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22800 | Serf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22801 | Sf3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22802 | Sftpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22803 | Sgpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22804 | Sh2b3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22805 | Skap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22806 | Skap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22807 | Slfn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22808 | Slmap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22809 | Smc1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22810 | Snip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22811 | Snrpg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22812 | Snrpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22813 | Snta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22814 | Snx22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22815 | Sox15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22816 | Sp110 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22817 | Spag4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22818 | Spag6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22819 | Spag8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22820 | Spag9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22821 | Spam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22822 | Spcs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22823 | Spcs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22824 | Spcs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22825 | Spin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22826 | Spin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22827 | Spry2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22828 | Spry4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22829 | Spta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22830 | Srprb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22831 | Srsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22832 | Srsf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22833 | Ssbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22834 | Stim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22835 | Stk31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22836 | Stk35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22837 | Stmn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22838 | Stmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22839 | Stt3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22840 | Susd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22841 | Syne1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22842 | Taf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22843 | Taf1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22844 | Taf5l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22845 | Tafa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22846 | Tafa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22847 | Tbx18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22848 | Tcea3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22849 | Tcf19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22850 | Tctn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22851 | Tdrd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22852 | Tdrd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22853 | Tekt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22854 | Tenm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22855 | Tenm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22856 | Tesk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22857 | Tfdp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22858 | Thbs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22859 | Thyn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22860 | Tial1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22861 | Tigd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22862 | Timm9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22863 | Tinf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22864 | Tmod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22865 | Tmod3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22866 | Tmtc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22867 | Tnip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22868 | Tnni2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22869 | Tnnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22870 | Tomm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22871 | Tomm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22872 | Tor1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22873 | Traf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22874 | Trak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22875 | Tram2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22876 | Trex2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22877 | Trhde Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22878 | Trib1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22879 | Trim3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22880 | Trim7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22881 | Trip4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22882 | Trnp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22883 | Trrap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22884 | Tshz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22885 | Tshz2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22886 | Tssk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22887 | Ttc7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22888 | Tubb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22889 | Tuft1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22890 | U2af2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22891 | Ubac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22892 | Ube3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22893 | Ubl4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22894 | Ubxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22895 | Uhmk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22896 | Upk1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22897 | Uqcrq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22898 | Ush1g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22899 | Ush2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22900 | Usp31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22901 | Usp32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22902 | Usp42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22903 | Usp45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22904 | Usp50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22905 | Usp54 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22906 | Uvssa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22907 | Vac14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22908 | Vamp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22909 | Vamp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22910 | Vars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22911 | Vash2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22912 | Vat1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22913 | Vgll4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22914 | Vipr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22915 | Vps29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22916 | Vstm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22917 | Wasf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22918 | Wdfy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22919 | Wdhd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22920 | Wdr18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22921 | Wdr48 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22922 | Wnt2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22923 | Xrcc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22924 | Xrcc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22925 | Yars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22926 | Ywhag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22927 | Zbed5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22928 | Egf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22929 | Sds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22930 | Hmgb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22931 | Ngf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22932 | Bdnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22933 | Trpv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22934 | Cd36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22935 | Ldha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22936 | Hgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22937 | Pcsk9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22938 | Gpx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22939 | Lox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22940 | Mettl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22941 | Vhl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22942 | Fgf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22943 | Bmp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22944 | Sag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22945 | Ccl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22946 | Trpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22947 | Fap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22948 | Stat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22949 | Cxcl10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22950 | Gsdmd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22951 | C3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22952 | Usp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22953 | Mif Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22954 | Gdnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22955 | Cxcl12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22956 | Sts Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22957 | Trem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22958 | Cd40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22959 | Igf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22960 | Nrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22961 | Gip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22962 | Lif Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22963 | Nhs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22964 | Ahr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22965 | Cck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22966 | Ccl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22967 | Cd44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22968 | Vegfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22969 | C5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22970 | Wrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22971 | Fgf21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22972 | Cd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22973 | Crbn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22974 | Gdf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22975 | Dkk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22976 | Gspt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22977 | Enpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22978 | Npy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22979 | Osm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22980 | Spp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22981 | Cd47 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22982 | Nqo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22983 | Tg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22984 | Slc7a11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22985 | Atf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22986 | Usp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22987 | Abca1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22988 | Cntf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22989 | Bcl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22990 | Pfkfb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22991 | Foxo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22992 | Trem1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22993 | Txnip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22994 | Sp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22995 | Mlkl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22996 | Fer Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22997 | G6pd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22998 | Tigit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22999 | Epo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23000 | Usp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23001 | Sos1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23002 | Pam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23003 | Smarca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23004 | Igf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23005 | Lcn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23006 | Nr4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23007 | Eno1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23008 | Angptl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23009 | Hk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23010 | Ogt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23011 | Apoe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23012 | Lck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23013 | S100a9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23014 | Tfeb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23015 | Tat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23016 | Fpr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23017 | Mat2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23018 | Cd24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23019 | Gapdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23020 | Cd19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23021 | Vip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23022 | Irf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23023 | Ptpn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23024 | Aim2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23025 | Fgf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23026 | Pgk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23027 | S100a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23028 | Ccl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23029 | Trpc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23030 | Tpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23031 | Axl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23032 | Bcr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23033 | Shh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23034 | Cd74 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23035 | Wdr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23036 | Cxcl13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23037 | Cx3cl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23038 | Blm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23039 | Fabp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23040 | Egr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23041 | Klf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23042 | Pink1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23043 | Ccl20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23044 | Akr1c3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23045 | Fgf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23046 | Nrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23047 | Kif18a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23048 | Cxcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23049 | Trpc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23050 | Ldlr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23051 | Rrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23052 | Pdk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23053 | Mpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23054 | Fpr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23055 | Cdcp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23056 | Fabp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23057 | Gpnmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23058 | Trpv4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23059 | Mbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23060 | Cp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23061 | Bmp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23062 | Loxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23063 | Tslp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23064 | Sfn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23065 | Gpc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23066 | Glp1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23067 | Foxo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23068 | Pth Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23069 | Usp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23070 | Fen1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23071 | Kdm5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23072 | Pc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23073 | Usp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23074 | Cyp1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23075 | Foxm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23076 | Ccl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23077 | Gstp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23078 | H2ax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23079 | Cd86 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23080 | Il11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23081 | Anxa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23082 | Mthfd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23083 | Mln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23084 | Fgf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23085 | Runx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23086 | Dtnb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23087 | Sox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23088 | Cxcl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23089 | Pde4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23090 | Bid Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23091 | Tet2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23092 | Dgat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23093 | Icam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23094 | Pla2g7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23095 | Th Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23096 | Brca1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23097 | Eed Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23098 | Traf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23099 | Kdm5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23100 | Cat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23101 | Il33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23102 | Dgat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23103 | Itgb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23104 | Crh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23105 | Lrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23106 | Mst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23107 | Pcna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23108 | Acss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23109 | Vegfc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23110 | Oga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23111 | Klf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23112 | Xbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23113 | Mertk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23114 | S100a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23115 | Mtap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23116 | Cdc42 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23118 | Uhrf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23119 | Bptf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23120 | Il18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23121 | Lag3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23122 | Zbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23123 | Mb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23124 | Id1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23125 | Cd22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23126 | Il21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23127 | Rspo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23128 | Cxcl16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23129 | Prdx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23130 | Alkbh5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23131 | Setdb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23132 | Fgf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23133 | Trh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23134 | Xpo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23135 | Cpz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23136 | Aqp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23137 | Ccl22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23138 | Cpt1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23139 | Ikzf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23140 | Kdm6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23141 | Wnt3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23142 | Cxcl11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23143 | Ccl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23144 | Nat10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23145 | Erf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23146 | Erg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23147 | Fas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23148 | Yy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23149 | Fgf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23150 | Gas6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23151 | Irf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23152 | Jag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23153 | Hmox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23154 | Rab7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23155 | Angpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23156 | Dll3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23157 | Tspo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23158 | Sarm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23159 | Cdkn2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23160 | Hr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23161 | Pnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23162 | Cd14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23163 | Abhd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23164 | Blk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23165 | Mdk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23166 | Spr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23167 | Nsd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23168 | Prc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23169 | Ptpn11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23170 | Tf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23171 | Fgf23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23172 | Otub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23173 | Chi3l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23174 | Cyp1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23175 | Pkmyt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23176 | Tmprss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23177 | Hp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23178 | Cdc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23179 | Rac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23180 | Tfrc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23181 | Usp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23182 | Uchl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23183 | Avp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23184 | Gpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23185 | Set Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23186 | Nnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23187 | Usp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23188 | Ccl21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23189 | Cs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23190 | Cd70 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23191 | Ghrh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23192 | Epha2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23193 | Itgav Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23194 | Trpm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23195 | Ilk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23196 | Ogg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23197 | Folr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23198 | Trpc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23199 | Csk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23200 | Emb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23201 | Cd63 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23202 | Bnip3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23203 | Dnmt3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23204 | Trim21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23205 | Gc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23206 | Ik Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23207 | Fn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23208 | Lyn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23209 | Clk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23210 | Smad3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23211 | Trpm8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23212 | Dnmt3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23213 | Cd9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23214 | Gne Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23215 | Mcu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23216 | Oat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23217 | Prl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23218 | Npc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23219 | Tet1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23220 | Ccnd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23221 | Rack1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23222 | Ina Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23223 | Nsf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23224 | Cd34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23225 | Cry1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23226 | Csf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23227 | Nppb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23228 | Saa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23229 | Spop Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23230 | Gan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23231 | Pvr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23232 | Ttk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23233 | Mdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23234 | Fgf19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23235 | Hmgb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23236 | Il23r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23237 | Kdm2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23238 | Ugt1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23239 | S100a10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23240 | Ahcy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23241 | Irf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23242 | Ror1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23243 | Panx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23244 | Smarca4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23245 | Ifng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23246 | Lrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23247 | Phb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23248 | Tlr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23249 | C6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23250 | Cort Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23251 | Cd200 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23252 | Dapk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23253 | Kdm2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23254 | Taar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23255 | Fos Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23256 | Lat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23257 | Tes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23258 | Camp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23259 | Ccl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23260 | Icos Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23261 | Igfbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23262 | Igf2bp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23263 | Cd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23264 | Gca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23265 | Caps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23266 | Mitf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23267 | Brca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23268 | Ccl17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23269 | Cdc20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23270 | Dusp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23271 | Ube2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23272 | Usp30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23273 | Slc1a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23274 | Ang Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23275 | Gem Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23276 | Ran Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23277 | Cd52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23278 | Cd55 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23279 | Irf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23280 | Nek2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23281 | Senp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23282 | Timp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23283 | Amh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23284 | F12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23285 | Cd27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23286 | Grk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23287 | Gsdme Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23288 | Itgb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23289 | Sparc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23290 | Igf2bp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23291 | Mrgprx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23292 | Ak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23293 | Rb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23294 | Csf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23295 | Il22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23296 | Anxa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23297 | Hipk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23298 | Kcnh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23299 | Kdm5c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23300 | Traf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23301 | Trpv3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23302 | Mettl14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23303 | Fth1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23304 | Muc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23305 | Runx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23306 | Stim1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23307 | Lgals9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23308 | F3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23309 | Mgll Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23310 | Fcgrt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23311 | Tead4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23312 | Usp20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23313 | Vdac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23314 | F2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23315 | Si Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23316 | Afp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23317 | Crp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23318 | Hck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23319 | Sf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23320 | Dll4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23321 | Ets1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23322 | Sv2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23323 | Zeb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23324 | Lgals3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23325 | Angptl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23326 | Nf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23327 | Comp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23328 | Ddx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23329 | Dpp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23330 | Rbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23331 | Tgm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23332 | Cyp2e1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23333 | Grp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23334 | Ltb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23335 | Gpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23336 | Il7r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23337 | Irs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23338 | Mdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23339 | Ccl11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23340 | Fads2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23341 | Foxp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23342 | Fstl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23343 | Itga5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23344 | Ptgs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23345 | Thbs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23346 | Aldh1a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23347 | F5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23348 | Cd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23349 | Mok Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23350 | Tyr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23351 | Atf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23352 | Dll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23353 | Kat7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23354 | Npff Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23355 | Abcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23356 | Cd226 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23357 | Fdft1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23358 | Fkbp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23359 | Socs3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23360 | Trpm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23361 | Atp1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23362 | Slamf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23363 | Ide Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23364 | Cd80 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23365 | Erfe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23366 | Mdm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23367 | Pdk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23368 | Skp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23369 | Sod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23370 | Stom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23371 | Tnk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23372 | Atg4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23373 | Tacc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23374 | Sema4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23375 | F7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23376 | B2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23377 | Dap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23378 | Ddc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23379 | Ghr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23380 | Hrg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23381 | Btla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23382 | Sod2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23383 | Xcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23384 | Ccl19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23385 | Ncoa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23386 | Trpv6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23387 | Usp22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23388 | Cyp1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23389 | Gucy2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23390 | Ythdf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23391 | Adm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23392 | Eda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23393 | Mia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23394 | Csf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23395 | Irf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23396 | Oma1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23397 | Sdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23398 | Ucp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23399 | Adrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23400 | Ccl24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23401 | Cd163 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23402 | Hif1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23403 | Usp9x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23404 | Col1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23405 | Cit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23406 | Bap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23407 | Clk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23408 | Dkk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23409 | Ereg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23410 | Got1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23411 | Opa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23412 | Wnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23413 | Yes1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23414 | Fabp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23415 | Ffar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23416 | P4ha1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23417 | Postn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23418 | S100b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23419 | Setd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23420 | Tgfbi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23421 | Trpc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23422 | Cmklr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23423 | Tnfrsf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23424 | Tnfrsf17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23425 | Asl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23426 | Cd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23427 | Mog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23428 | Omp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23429 | Plg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23430 | Rpe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23431 | Fshr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23432 | Ldhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23433 | Ltbr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23434 | Olr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23435 | Pfkp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23436 | Sost Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23437 | Asgr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23438 | Cxcr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23439 | Tgfb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23440 | Slc3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23441 | Steap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23442 | Cd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23443 | Gpt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23444 | Mal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23445 | Tox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23446 | Atf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23447 | Rhoa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23448 | Taf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23449 | Cd276 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23450 | Dusp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23451 | Hoxb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23452 | Jmjd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23453 | Igfbp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23454 | Cyp27a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23455 | Tnfrsf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23456 | Alb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23457 | Cbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23458 | Dbi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23459 | Mag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23460 | Msc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23461 | Pah Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23462 | Areg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23463 | Bub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23464 | Cd3e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23465 | Ebi3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23466 | Nae1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23467 | Pdpn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23468 | Pin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23469 | Bach1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23470 | Pdpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23471 | Akr1c1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23472 | Aldh1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23473 | Tnfsf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23474 | C2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23475 | Il7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23476 | Wt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23477 | Arg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23478 | Cd5l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23479 | Gfap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23480 | Il27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23481 | Mavs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23482 | Ppbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23483 | Gpr65 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23484 | Ikzf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23485 | Isg15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23486 | Trib3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23487 | Lgals1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23488 | Tnfaip3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23489 | Pgp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23490 | Tk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23491 | Tro Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23492 | Agr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23493 | Bmp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23494 | Cd68 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23495 | Cdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23496 | E2f1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23497 | Eras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23498 | Fgf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23499 | Rin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23500 | Tfam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23501 | Acox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23502 | Hbegf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23503 | Ifna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23504 | Lta4h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23505 | Shmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23506 | Ube2t Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23507 | Usp15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23508 | Arc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23509 | Fst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23510 | Hpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23511 | Nog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23512 | Por Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23513 | Slk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23514 | Hes1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23515 | Npm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23516 | Odc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23517 | Plat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23518 | Sdc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23519 | Actn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23520 | Aldoa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23521 | Apoa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23522 | Cxcl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23523 | Epcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23524 | Kat6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23525 | Nedd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23526 | Sf3b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23527 | Stub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23528 | Tead1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23529 | Tnfsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23530 | Tnfsf13b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23531 | Dsp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23532 | Ell Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23533 | Mcc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23534 | Mos Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23535 | Pgc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23536 | Rs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23537 | Cd33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23538 | Klf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23539 | Plau Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23540 | Tsc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23541 | Eif4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23542 | Mthfd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23543 | Tnfsf12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23544 | Cbs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23545 | Des Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23546 | Dr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23547 | Ptn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23548 | Alad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23549 | Dlat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23550 | Fgl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23551 | Il4r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23552 | Mall Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23553 | Mfn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23554 | Itga2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23555 | Kcnq2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23556 | Kdm3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23557 | Lamp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23558 | Ppm1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23559 | Vcam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23560 | Havcr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23561 | Nedd4l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23562 | Fh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23563 | Cda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23564 | Cel Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23565 | Cpe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23566 | Hk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23567 | Ssb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23568 | Tdg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23569 | Atic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23570 | Cd81 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23571 | H6pd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23572 | Tph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23573 | Alcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23574 | Bmal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23575 | Bmp2k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23576 | Ccl25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23577 | Kdm4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23578 | Flt3lg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23579 | Gprc5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23580 | Igfbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23581 | Mapkapk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23582 | C8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23583 | Nmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23584 | Fadd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23585 | Gast Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23586 | Hat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23587 | Il6r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23588 | Rest Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23589 | Rsf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23590 | Scap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23591 | Sqor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23592 | Ybx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23593 | Camk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23594 | Cxadr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23595 | Nr5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23596 | Pdgfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23597 | Stat4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23598 | Suz12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23599 | Usp25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23600 | Dcaf16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23601 | Trip13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23602 | Txnrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23603 | Csnk1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23604 | S100a11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23605 | Cfd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23606 | Gcg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23607 | Rho Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23608 | Sp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23609 | Sri Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23610 | Ccn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23611 | Eno2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23612 | Gpx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23613 | Grpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23614 | Gzma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23615 | Klk7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23616 | Ngfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23617 | Proc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23618 | Slpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23619 | Cdh17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23620 | Gsk3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23621 | Kdm5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23622 | Lamp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23623 | Srpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23624 | Srsf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23625 | Usp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23626 | Camkk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23627 | Cyp11b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23628 | Pik3ip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23629 | Suv39h1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23630 | Serpina1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23631 | Gk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23632 | Abo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23633 | Cnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23634 | Dcc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23635 | Lpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23636 | Me1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23637 | Brd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23638 | Dmpk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23639 | Etv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23640 | Fdps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23641 | Fut8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23642 | Fzd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23643 | Lifr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23644 | Msln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23645 | Spi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23646 | Stc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23647 | Upp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23648 | Wnt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23649 | Atad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23650 | Efna5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23651 | Ephb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23652 | Fgf18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23653 | Folr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23654 | Hspa8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23655 | Kdm6b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23656 | Pick1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23657 | Ptpn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23658 | Qpctl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23659 | Sirpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23660 | Smad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23661 | Tradd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23662 | Trpm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23663 | Cyp7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23664 | Muc5ac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23665 | Notch3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23666 | Cad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23667 | Dcn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23668 | Ager Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23669 | Ass1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23670 | Bms1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23671 | Kynu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23672 | Lrp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23673 | Nek7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23674 | Nsd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23675 | Tsc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23676 | Anxa5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23677 | Apoc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23678 | Asic3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23679 | Bcat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23680 | Elane Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23681 | Foxo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23682 | Hpgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23683 | Il6st Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23684 | Masp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23685 | Nedd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23686 | Rbm39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23687 | Trpv2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23688 | Akr1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23689 | Igfbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23690 | Lilrb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23691 | Ythdf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23692 | Akr1b10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23693 | Tnfsf13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23694 | C7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23695 | F11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23696 | Gaa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23697 | Gla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23698 | Id2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23699 | Pdf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23700 | Hrob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23701 | Poli Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23702 | Pomc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23703 | Ccl28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23704 | Clock Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23705 | Epha7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23706 | Fabp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23707 | Fndc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23708 | Lair1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23709 | Pvrig Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23710 | Alkbh3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23711 | Fancd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23712 | Sema3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23713 | Angptl8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23714 | Tnfsf18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23715 | Cth Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23716 | Fyn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23717 | Tnc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23718 | Ubd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23719 | Cd69 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23720 | Gzmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23721 | Il19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23722 | Lgmn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23723 | Psap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23724 | Rac2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23725 | Rbpj Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23726 | Selp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23727 | Ccne1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23728 | Cdh13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23729 | Efnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23730 | Sumo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23731 | Usp21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23732 | Cdc25a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23733 | Fcgr2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23734 | Slc7a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23735 | Angptl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23736 | Slc31a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23737 | St6gal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23738 | Hsd17b13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23739 | Acd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23740 | Dbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23741 | Gal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23742 | Cd93 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23743 | Grk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23744 | Hdgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23745 | Klk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23746 | Lipa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23747 | Map2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23748 | Mycn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23749 | Pan2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23750 | Phb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23751 | Ppt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23752 | Rpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23753 | Tfpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23754 | Bcat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23755 | Dhcr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23756 | Ifnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23757 | Irak3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23758 | Mef2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23759 | Pdgfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23760 | Pola1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23761 | Ptpn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23762 | Stat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23763 | Stk11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23764 | Uchl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23765 | Zap70 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23766 | Dyrk1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23767 | Il1rl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23768 | Metap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23769 | Clec12a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23770 | Cyp11b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23771 | Tnfrsf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23772 | C9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23773 | Bad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23774 | Clu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23775 | Dbt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23776 | Mme Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23777 | Pxn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23778 | Tkt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23779 | Vim Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23780 | Acp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23781 | Ano1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23782 | Bag3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23783 | Cdo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23784 | Elk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23785 | Fzd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23786 | Gnal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23787 | Nbr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23788 | Nrf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23789 | Pck2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23790 | Qpct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23791 | Tbca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23792 | Brsk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23793 | Dclk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23794 | Foxa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23795 | Gfral Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23796 | Grem1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23797 | Lats1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23798 | Nr4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23799 | Pdcd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23800 | Smad4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23801 | Cthrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23802 | Cxcl14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23803 | Map3k1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23804 | Rictor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23805 | Sqstm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23806 | Tardbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23807 | Txndc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23808 | Tnfrsf13c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23809 | F8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23810 | Agl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23811 | Dhh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23812 | Emd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23813 | Fus Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23814 | Mpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23815 | Pln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23816 | Rp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23817 | Tst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23818 | Aoc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23819 | Cd37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23820 | Cd3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23821 | Crot Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23822 | Gad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23823 | Grk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23824 | Ist1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23825 | Lepr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23826 | Lrr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23827 | Nrg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23828 | Sat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23829 | Sox4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23830 | Sox9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23831 | Tpi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23832 | Baz2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23833 | Cisd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23834 | Csf3r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23835 | Ddit4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23836 | Enpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23837 | Ndrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23838 | Timp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23839 | Camk1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23840 | Dhcr24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23841 | S100a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23842 | Ceacam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23843 | Mettl16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23844 | Slc34a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23845 | Tacstd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23846 | Tnfsf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23847 | Aip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23848 | Bsg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23849 | Cpm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23850 | Ipp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23851 | Lss Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23852 | Max Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23853 | Nf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23854 | Pdc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23855 | Pf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23856 | Pir Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23857 | Sms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23858 | Vwf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23859 | Arg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23860 | Chd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23861 | Grb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23862 | Kat5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23863 | Mcm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23864 | Nat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23865 | Nrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23866 | Ntn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23867 | Prlr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23868 | Rnf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23869 | Sele Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23870 | Tcf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23871 | Terc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23872 | Wtap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23873 | Cebpb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23874 | Crtam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23875 | Kitlg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23876 | Masp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23877 | Plaur Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23878 | Prdx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23879 | Rspo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23880 | Trpm7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23881 | Tssk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23882 | Tyro3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23883 | Usp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23884 | Usp13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23885 | Igfbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23886 | Il10ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23887 | Mettl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23888 | Piezo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23889 | Pla2g4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23890 | Scgb2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23891 | Tnfrsf1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23892 | Ak7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23893 | Btc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23894 | Cfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23895 | Ckb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23896 | Dym Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23897 | Eng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23898 | Hbb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23899 | Nin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23900 | Sp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23901 | Aire Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23902 | Aqp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23903 | Aspn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23904 | Bst2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23905 | Cbx7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23906 | Cpb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23907 | Cpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23908 | Ecm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23909 | Ing1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23910 | Lcat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23911 | Mafg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23912 | Musk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23913 | Npc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23914 | Thy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23915 | Aars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23916 | Cd101 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23917 | Cntn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23918 | Ffar2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23919 | Ffar3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23920 | Gpr17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23921 | Gpr75 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23922 | Gsto1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23923 | Il4i1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23924 | Inhba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23925 | Kdm4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23926 | Klrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23927 | Nupr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23928 | Prdx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23929 | Vtcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23930 | Arid1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23931 | Dnaja1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23932 | Ifngr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23933 | Metrnl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23934 | Pfkfb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23935 | Prima1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23936 | Ptprz1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23937 | Cyp11a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23938 | Tnfrsf12a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23939 | Kl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23940 | Mgp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23941 | Nlk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23942 | Alpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23943 | Ambn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23944 | Cd8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23945 | Clk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23946 | Cps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23947 | Emp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23948 | Glul Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23949 | Has2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23950 | Hexa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23951 | Ogdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23952 | Ror2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23953 | Snd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23954 | Tgfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23955 | Usp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23956 | Abcg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23957 | Alpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23958 | Cd177 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23959 | Cdc37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23960 | Ddx3x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23961 | Fstl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23962 | Fzd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23963 | Hadha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23964 | Itgb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23965 | Nr2f6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23966 | Nr5a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23967 | Sfrp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23968 | Thbs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23969 | Trap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23970 | Chrna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23971 | Gpr132 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23972 | Npc1l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23973 | Ptpn22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23974 | S100a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23975 | Igf2bp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23976 | Smarcb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23977 | Aga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23978 | Cfh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23979 | Crk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23980 | Id3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23981 | Il9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23982 | Lum Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23983 | Nmu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23984 | Rgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23985 | Srf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23986 | Tec Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23987 | Adh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23988 | Ambp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23989 | Atg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23990 | Cav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23991 | Chd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23992 | Dlk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23993 | F13b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23994 | Fbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23995 | Il34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23996 | Klf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23997 | Micb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23998 | Nefl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23999 | Osmr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24000 | Ptk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24001 | Ptk7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24002 | Acadm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24003 | Acsl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24004 | Ccnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24005 | Efna3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24006 | Efnb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24007 | Fbxw7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24008 | Gpr39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24009 | Hmox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24010 | Htra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24011 | Marco Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24012 | Pdia4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24013 | Pgam5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24014 | Ppm1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24015 | Ptprd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24016 | Rad52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24017 | Stk10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24018 | Vdac2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24019 | Vsig4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24020 | Adipoq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24021 | Akr1c2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24022 | Anxa10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24023 | Lilrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24024 | Ruvbl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24025 | Trim24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24026 | Aldh1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24027 | Pla2g2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24028 | Tnfsf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24029 | Ppp1r15a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24030 | Tnfrsf10b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24031 | Tnfrsf11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24032 | Abr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24033 | Acr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24034 | Nps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24035 | Pgd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24036 | She Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24037 | Tub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24038 | Aif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24039 | Atg7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24040 | Cap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24041 | Ccn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24042 | Cd83 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24043 | Cd99 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24044 | Cdh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24045 | Dsg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24046 | Hunk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24047 | Kat8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24048 | Ncr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24049 | Nek6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24050 | Pck1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24051 | Rpa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24052 | Srgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24053 | Tap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24054 | Tff3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24055 | Thra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24056 | Tpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24057 | Vrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24058 | Adam9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24059 | Alas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24060 | Asic1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24061 | Atp7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24062 | Brcc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24063 | Cd164 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24064 | Cend1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24065 | Cox5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24066 | Enpep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24067 | Enpp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24068 | Hnf4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24069 | Mark2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24070 | Nfat5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24071 | Park7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24072 | Pde4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24073 | Prom1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24074 | Ptprf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24075 | Stx17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24076 | Wnt5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24077 | Clec2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24078 | Il1rap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24079 | Slamf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24080 | Tspan2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24081 | Gp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24082 | Lpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24083 | Lpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24084 | Nts Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24085 | Omg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24086 | Sla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24087 | Sln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24088 | Tk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24089 | Uty Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24090 | Actb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24091 | Aox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24092 | Bcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24093 | Bdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24094 | Cdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24095 | Ctcf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24096 | Cyc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24097 | Fbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24098 | Fhl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24099 | Gnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24100 | Kng1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24101 | Ntn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24102 | Peg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24103 | Prep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24104 | Rcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24105 | Rem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24106 | Rheb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24107 | Rnf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24108 | St13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24109 | Stc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24110 | Tdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24111 | Tph2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24112 | C1qbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24113 | Cd320 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24114 | Chd1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24115 | Cxcl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24116 | Edil3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24117 | Efna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24118 | Ephb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24119 | Erap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24120 | Glud1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24121 | Gpr37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24122 | Gpr83 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24123 | Hmga2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24124 | Hoxa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24125 | Il1rn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24126 | Klkb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24127 | Ptgr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24128 | Pth1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24129 | Angpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24130 | Cd40lg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24131 | Ruvbl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24132 | Slc6a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24133 | Csnk2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24134 | Slc16a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24135 | Boc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24136 | Ccs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24137 | Cic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24138 | Fga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24139 | Grn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24140 | Hgd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24141 | Me2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24142 | Vtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24143 | Adar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24144 | Ago2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24145 | Ddx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24146 | Dpp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24147 | Dsg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24148 | Eml2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24149 | Gbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24150 | Gclc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24151 | Iapp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24152 | Irf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24153 | Nrg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24154 | Pole Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24155 | Rbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24156 | Rps6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24157 | Scin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24158 | Six1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24159 | Ccnd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24160 | Dnm1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24161 | Dusp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24162 | Epha4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24163 | Faslg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24164 | Fcer2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24165 | Fgf17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24166 | Hcls1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24167 | Il17f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24168 | Lypd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24169 | Mfap4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24170 | Mre11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24171 | Mydgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24172 | Ncam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24173 | Nlrp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24174 | Pappa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24175 | Pdha1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24176 | Pgam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24177 | Socs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24178 | Ttbk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24179 | Usp46 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24180 | Usp47 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24181 | Znrf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24182 | Abhd11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24183 | Adra2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24184 | Col3a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24185 | Fundc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24186 | Srebf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24187 | Prkar1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24188 | Tnfrsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24189 | F9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24190 | Agk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24191 | Agt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24192 | Hdc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24193 | Khk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24194 | Nes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24195 | Pyy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24196 | Rax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24197 | Ucn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24198 | Agrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24199 | Apob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24200 | Aqp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24201 | Arf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24202 | Aspa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24203 | Bbs4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24204 | Bst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24205 | Cd3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24206 | Csta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24207 | Ctf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24208 | Dlx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24209 | Fgf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24210 | Gnas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24211 | Hadh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24212 | Il24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24213 | Il31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24214 | Lrp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24215 | Mfn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24216 | Prr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24217 | Ptx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24218 | Sell Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24219 | Tff1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24220 | Tpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24221 | Uba1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24222 | Abcg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24223 | Aifm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24224 | Apaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24225 | Ash1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24226 | Bcas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24227 | Cirbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24228 | Dapk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24229 | Ephb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24230 | Fuca1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24231 | Gstm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24232 | Hipk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24233 | Itgax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24234 | Kmt2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24235 | Lamp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24236 | Nmur2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24237 | Olig2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24238 | Pnlip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24239 | Psmb9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24240 | Ptbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24241 | Sftpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24242 | Spdef Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24243 | Trex1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24244 | Usp18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24245 | Clec7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24246 | Cyp8b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24247 | Dusp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24248 | Impdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24249 | Map2k6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24250 | Samhd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24251 | Creb3l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24252 | Cyp17a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24253 | Gabarap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24254 | Serpini1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24255 | Bik Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24256 | C1s Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24257 | Cga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24258 | Dct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24259 | Dcx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24260 | Ddt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24261 | F10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24262 | Fgg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24263 | Gp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24264 | Gss Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24265 | Ihh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24266 | Lep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24267 | Maf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24268 | Rp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24269 | Cd84 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24270 | Chl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24271 | Edar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24272 | Fbn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24273 | Fpr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24274 | Gale Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24275 | Gdf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24276 | Gls2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24277 | Got2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24278 | Hpca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24279 | Ibsp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24280 | Lap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24281 | Layn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24282 | Lrp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24283 | Mbd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24284 | Nmbr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24285 | Paep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24286 | Pltp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24287 | Sod3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24288 | Trio Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24289 | Zeb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24290 | Aebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24291 | Bcl10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24292 | Cd79a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24293 | Cd79b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24294 | Cytl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24295 | Dock5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24296 | Efna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24297 | Eif4e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24298 | Fgf12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24299 | Il36g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24300 | Itga4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24301 | Kdm4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24302 | Klrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24303 | Klrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24304 | Mbnl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24305 | Pde1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24306 | Phpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24307 | Plbd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24308 | Procr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24309 | Prss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24310 | Psat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24311 | Qsox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24312 | Rnf43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24313 | Ywhae Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24314 | Atp2a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24315 | Card11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24316 | Clec4e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24317 | Cyb5r3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24318 | Eif4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24319 | Insig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24320 | Lilrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24321 | Lypla1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24322 | Metap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24323 | Recql5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24324 | Sema7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24325 | Snap25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24326 | Steap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24327 | Tcf7l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24328 | Tfap2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24329 | Tspan7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24330 | Gadd45a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24331 | Pla2g15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24332 | Adamdec1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24333 | Adamts13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24334 | Xk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24335 | En1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24336 | Fah Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24337 | Gk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24338 | Gp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24339 | Hal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24340 | Id4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24341 | Ltf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24342 | Mak Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24343 | Tfg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24344 | Ubc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24345 | Acan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24346 | Cap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24347 | Cast Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24348 | Ccn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24349 | Cd46 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24350 | Ctsz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24351 | Cyld Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24352 | Fgf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24353 | Gipr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24354 | Gmfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24355 | Hap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24356 | Inf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24357 | Itch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24358 | Jaml Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24359 | Pdk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24360 | Polq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24361 | Pomk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24362 | Psca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24363 | Rbm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24364 | Rpl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24365 | Skp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24366 | Stac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24367 | Tal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24368 | Tff2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24369 | Ucp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24370 | Abcd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24371 | Birc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24372 | Capn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24373 | Cd151 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24374 | Cdh16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24375 | Ch25h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24376 | Cryab Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24377 | Fabp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24378 | G3bp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24379 | Gata3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24380 | Gata6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24381 | Hmga1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24382 | Hspb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24383 | Kpna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24384 | Lhcgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24385 | Mark3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24386 | Nudt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24387 | Pbrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24388 | Prdx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24389 | Reg1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24390 | Akr1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24391 | Clec4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24392 | Fcgr2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24393 | Hectd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24394 | Ifitm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24395 | Jchain Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24396 | Lancl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24397 | Lrrc15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24398 | Lrrc32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24399 | Pecam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24400 | Tmsb4x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24401 | Tnfsf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24402 | Il1rapl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24403 | Serpine2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24404 | Tnfrsf18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24405 | Ecd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24406 | Gh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24407 | Ncl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24408 | Otc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24409 | Prx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24410 | Sp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24411 | Vgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24412 | Zp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24413 | Als2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24414 | Aoc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24415 | Aqp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24416 | Aven Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24417 | Bmp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24418 | Calr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24419 | Cblb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24420 | Ccn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24421 | Cdnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24422 | Ddb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24423 | Fosb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24424 | Gbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24425 | Gpd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24426 | Gpr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24427 | Gys1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24428 | Hpse Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24429 | Ica1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24430 | Idua Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24431 | Imp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24432 | Klk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24433 | Lrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24434 | Map4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24435 | Mcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24436 | Pon1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24437 | Rxra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24438 | Sqle Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24439 | St14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24440 | Aldob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24441 | Asxl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24442 | Atg10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24443 | Atp7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24444 | Cadm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24445 | Clic3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24446 | Corin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24447 | Cript Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24448 | Efnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24449 | Fubp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24450 | Gpr18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24451 | Hmgb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24452 | Igf2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24453 | Inhbe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24454 | Itgb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24455 | Mapk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24456 | Mastl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24457 | Mrpl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24458 | Naa10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24459 | Nlrc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24460 | Orai1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24461 | Pdia6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24462 | Prdx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24463 | Sfrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24464 | Smoc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24465 | Smpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24466 | Srpx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24467 | Stath Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24468 | Traf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24469 | Trpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24470 | Trpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24471 | Twsg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24472 | Ube2s Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24473 | Usp28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24474 | Vldlr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24475 | A4galt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24476 | Adcy10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24477 | Efemp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24478 | Fcgr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24479 | Ifngr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24480 | Megf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24481 | Nmnat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24482 | Parp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24483 | Plxdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24485 | Trim28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24486 | B4galt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24487 | Gadd45b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24488 | Pla2g1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24489 | Siglec1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24490 | Hsp90ab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24491 | Bmf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24492 | Dmd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24493 | En2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24494 | Htt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24495 | Rrh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24496 | Sp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24497 | Sst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24498 | Tsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24499 | Ung Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24500 | Abat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24501 | Cct2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24502 | Ces2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24503 | Chad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24504 | Cst3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24505 | Cygb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24506 | Dffa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24507 | E2f4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24508 | Hao1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24509 | Heph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24510 | Il16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24511 | Klk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24512 | Lad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24513 | M1ap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24514 | Manf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24515 | Mdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24516 | Phf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24517 | Pkn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24518 | Ppat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24519 | Ppia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24520 | Psph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24521 | Sae1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24522 | Sdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24523 | Tpbg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24524 | Tsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24525 | Uba5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24526 | Abcg8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24527 | Acod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24528 | Acss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24529 | Adrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24530 | Card9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24531 | Cd160 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24532 | Chit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24533 | Clcf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24534 | Ddit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24535 | Defb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24536 | Egfl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24537 | Ephb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24538 | Fam3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24539 | Fosl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24540 | Fosl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24541 | Gpa33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24542 | Grhpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24543 | Itgb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24544 | Kcnk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24545 | L1cam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24546 | Muc16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24547 | Nfil3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24548 | Nr1d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24549 | Nsun2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24550 | Pebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24551 | Psen1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24552 | Ptprc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24553 | Sdcbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24554 | Senp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24555 | Sirt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24556 | Spart Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24557 | Vegfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24558 | Adam12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24559 | Antxr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24560 | Anxa13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24561 | Clec1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24562 | Clec4f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24563 | Csf2ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24564 | Csnk1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24565 | Cxcl17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24566 | Elovl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24567 | Fcgr3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24568 | Hmgcs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24569 | Hspa1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24570 | Lrpap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24571 | Notch4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24572 | Scarb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24573 | Sigirr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24574 | Tnfsf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24575 | Tnni3k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24576 | Tspan3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24577 | Adamts4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24578 | Igfbpl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24579 | Nectin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24580 | S100a16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24581 | Sult1e1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24582 | Map1lc3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24583 | Tnfrsf21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24584 | Hnrnpa2b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24585 | Amt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24586 | Auh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24587 | Bgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24588 | Dpt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24589 | Erh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24590 | Hlf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24591 | Hpx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24592 | Jup Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24593 | Mx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24594 | Myb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24595 | Rdx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24596 | Adnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24597 | Adsl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24598 | Amd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24599 | Apoh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24600 | Aprt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24601 | Cdh5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24602 | Cer1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24603 | Cptp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24604 | Esam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24605 | Fat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24606 | Fcar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24607 | Galm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24608 | Gch1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24609 | Gm2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24610 | Hexb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24611 | Il20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24612 | Krt8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24613 | Lhpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24614 | Lig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24615 | Men1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24616 | Mepe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24617 | Mstn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24618 | Napa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24619 | Nfe2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24620 | Nmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24621 | Optn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24622 | Osr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24623 | Pan3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24624 | Pld4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24625 | Rbx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24626 | Reln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24627 | Star Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24628 | Stk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24629 | Sufu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24630 | Vapb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24631 | Wif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24632 | Actr8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24633 | Aimp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24634 | Aldoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24635 | Anxa6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24636 | Arrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24637 | Asah1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24638 | Atg14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24639 | Baz2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24640 | Bglap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24641 | Camk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24642 | Ccna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24643 | Chrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24644 | Cntn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24645 | Cxxc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24646 | Dock2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24647 | Dtymk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24648 | Efna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24649 | Folh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24650 | Gata4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24651 | Ildr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24652 | Itgb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24653 | Kdm3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24654 | Khsrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24655 | Lats2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24656 | Mark4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24657 | Ms4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24658 | Pcbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24659 | Prss8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24660 | Prtn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24661 | Rbbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24662 | Rspo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24663 | Shmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24664 | Smad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24665 | Trim2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24666 | Uchl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24667 | Unc5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24668 | Adam19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24669 | Amigo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24670 | Creld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24671 | Il17ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24672 | Impdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24673 | Itgbl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24674 | Jmjd1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24675 | Lpcat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24676 | Ndufb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24677 | Plscr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24678 | Polrmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24679 | Selplg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24680 | Ube2d2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24681 | Zbtb16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24682 | Atp5f1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24683 | C1qtnf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24684 | Eif2ak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24685 | Hnrnph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24686 | St3gal4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24687 | Pdcd1lg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24688 | Serpina5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24689 | Serpinc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24690 | Serpinf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24691 | Adcyap1r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24692 | C4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24693 | Gda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24694 | Gsc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24695 | Mga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24696 | Ogn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24697 | Omd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24698 | Psd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24699 | Son Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24700 | Sp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24701 | St7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24702 | Tbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24703 | Ahsg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24704 | Alpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24705 | Amph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24706 | Ankh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24707 | Apom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24708 | Arf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24709 | Blmh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24710 | Bphl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24711 | Cd96 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24712 | Cdh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24713 | Cpa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24714 | Ctsh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24715 | Dgka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24716 | Dhx9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24717 | Eml1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24718 | Far1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24719 | Fhl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24720 | G0s2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24721 | Gdf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24722 | Gdf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24723 | Ggt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24724 | Hamp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24725 | M6pr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24726 | Maff Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24727 | Med1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24728 | Msr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24729 | Myh9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24730 | Nab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24731 | Nadk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24732 | Nbl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24733 | Nrn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24734 | Pigr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24735 | Pklr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24736 | Rbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24737 | Rgmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24738 | Sdhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24739 | Sez6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24740 | Thbd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24741 | Tifa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24742 | Tlk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24743 | Tmx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24744 | Wwp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24745 | Azgp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24746 | Calca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24747 | Cldn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24748 | Creb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24749 | Ctps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24750 | Eda2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24751 | Ephx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24752 | Ercc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24753 | F13a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24754 | Fabp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24755 | Fam3c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24756 | Fancm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24757 | Gdf11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24758 | Gp1bb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24759 | Gpr34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24760 | Habp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24761 | Hspb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24762 | Hspe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24763 | Ifna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24764 | Kcnq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24765 | Kif5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24766 | Kmt5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24767 | Lonp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24768 | Med12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24769 | Mst1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24770 | Nr4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24771 | Padi4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24772 | Pdgfd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24773 | Prss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24774 | Riok2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24775 | Sp100 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24776 | Stmn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24777 | Tead3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24778 | Tiam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24779 | Timd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24780 | Timp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24781 | Ube2n Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24782 | Wfdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24783 | Celsr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24784 | Dcaf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24785 | Eef1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24786 | Elavl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24787 | Fkbp1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24788 | Il18bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24789 | Ptpmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24790 | Sema4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24791 | Slamf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24792 | Trim25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24793 | Yeats4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24794 | Ankrd22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24795 | Kirrel1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24796 | Pla2g2e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24797 | Suv39h2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24798 | Mapkapk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24799 | Tnfrsf13b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24800 | A2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24801 | Bok Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24802 | Bpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24803 | C1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24804 | Dck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24805 | Gp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24806 | Gsr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24807 | Npl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24808 | Pgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24809 | Rlf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24810 | Sp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24811 | Srm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24812 | Ttn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24813 | Ust Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24814 | Aida Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24815 | Aqp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24816 | Atf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24817 | Bmp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24818 | Brd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24819 | Canx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24820 | Cbr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24821 | Cd48 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24822 | Cdh3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24823 | Chd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24824 | Chrd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24825 | Ctsg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24826 | Cuta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24827 | Dcxr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24828 | Dpp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24829 | Dpp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24830 | Dsc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24831 | Dsc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24832 | Dtx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24833 | Elf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24834 | Emp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24835 | Epor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24836 | Fli1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24837 | Fzd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24838 | Fzd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24839 | Fzd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24840 | Gba2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24841 | Gfer Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24842 | Paf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24843 | Pag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24844 | Parl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24845 | Pgm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24846 | Prnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24847 | Reg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24848 | Rnf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24849 | Smc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24850 | Smox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24851 | Tank Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24852 | Tet3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24853 | Tp63 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24854 | Uck2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24855 | Ufm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24856 | Anxa7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24857 | C5ar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24858 | Cadm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24859 | Capn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24860 | Ccl26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24861 | Ccr10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24862 | Cd244 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24863 | Cdk10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24864 | Chst3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24865 | Cip2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24866 | Cndp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24867 | Ephb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24868 | Foxf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24869 | Galk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24870 | Gdf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24871 | Gfra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24872 | Huwe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24873 | Kcnq4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24874 | Klf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24875 | Map1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24876 | Map1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24877 | Mfap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24878 | Mkrn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24879 | Nlgn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24880 | Pde3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24881 | Plod2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24882 | Ptgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24883 | Ptpn7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24884 | Ptprk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24885 | Rad50 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24886 | Ring1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24887 | Robo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24888 | Smad6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24889 | Smad7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24890 | Stk38 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24891 | Sumo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24892 | Tfpi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24893 | Trim5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24894 | Usp19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24895 | Vegfd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24896 | Akr1d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24897 | Apcdd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24898 | Btn2a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24899 | Chrdl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24900 | Clec5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24901 | Col4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24902 | Elovl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24903 | Fcer1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24904 | Fkbp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24905 | Hmgcs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24906 | Mblac2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24907 | Mcemp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24908 | Nfatc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24909 | Phlpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24910 | Psmd14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24911 | Scpep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24912 | Ythdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24913 | Adamts5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24914 | Bhlhe40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24915 | Cd200r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24916 | Ceacam6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24917 | Clec10a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24918 | Col18a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24919 | Cyp46a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24920 | Il13ra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24921 | Kremen2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24922 | Pip4k2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24923 | St3gal3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24924 | Tmprss4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24925 | Serpina7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24926 | Serping1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24927 | Ak4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24928 | Dst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24929 | Fes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24930 | Fxn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24931 | Gsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24932 | Klb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24933 | Msn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24934 | Mvd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24935 | Mx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24936 | Nrm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24937 | Shb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24938 | Tpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24939 | Zp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24940 | Aco1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24941 | Aco2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24942 | Apln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24943 | Araf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24944 | Art1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24945 | Asph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24946 | Bnc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24947 | Cask Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24948 | Ccnk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24949 | Coq7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24950 | Cst7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24951 | Cstb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24952 | Ctrc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24953 | Cul3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24954 | Ddb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24955 | Eno3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24956 | Esm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24957 | Flna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24958 | Fzd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24959 | Gamt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24960 | Gpx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24961 | Ing5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24962 | Isl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24963 | Kera Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24964 | Lias Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24965 | Lipi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24966 | Mbl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24967 | Mpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24968 | Nat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24969 | Nol3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24970 | Nrtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24971 | Palm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24972 | Pemt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24973 | Pex1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24974 | Plp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24975 | Pls3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24976 | Ppib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24977 | Pter Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24978 | Rmi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24979 | Rpl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24980 | Rttn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24981 | Sbds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24982 | Tap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24983 | Tcf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24984 | Tnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24985 | Tpm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24986 | Ubr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24987 | Upf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24988 | Wnk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24989 | Wwp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24990 | Asf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24991 | Atox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24992 | Cadm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24993 | Chodl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24994 | Cltrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24995 | Cntfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24996 | Creb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24997 | Csrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24998 | Fabp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24999 | Fbxo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25000 | Gper1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25001 | Hspa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25002 | Hspd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25003 | Ifih1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25004 | Igsf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25005 | Itga6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25006 | Itgb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25007 | Itgb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25008 | Kif11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25009 | Kiss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25010 | Kmt2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25011 | Kpnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25012 | Krt17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25013 | Lamp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25014 | Naa50 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25015 | Ninj1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25016 | Nr2f1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25017 | Nudt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25018 | Nxph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25019 | Parva Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25020 | Pcsk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25021 | Pdap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25022 | Pdcd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25023 | Pear1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25024 | Plin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25025 | Pold2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25026 | Pycr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25027 | Sez6l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25028 | Socs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25029 | Srpk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25030 | Stip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25031 | Stk16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25032 | Tafa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25033 | Taok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25034 | Tigar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25035 | Ube2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25036 | Usp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25037 | Usp24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25038 | Wfdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25039 | Zfp36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25040 | Celsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25041 | Col2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25042 | Col6a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25043 | Creld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25044 | Ehhadh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25045 | Entpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25046 | Glipr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25047 | Icoslg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25048 | Nfkbia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25049 | Ralgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25050 | Rnase3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25051 | S100a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25052 | Scarb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25053 | Sema4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25054 | Spint1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25055 | Tapbpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25056 | Tmigd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25057 | Tspan8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25058 | Atp6v1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25059 | L3mbtl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25060 | Pla2g2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25061 | Scgb1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25062 | Scgb3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25063 | Selenop Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25064 | Siglec8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25065 | Slc12a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25066 | Slc13a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25067 | Slc25a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25068 | Sult1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25069 | Tnfrsf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25070 | Xpnpep2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25071 | C4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25072 | Cpq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25073 | Cr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25074 | Flg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25075 | Hjv Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25076 | Npb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25077 | Pml Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25078 | Ski Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25079 | Sp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25080 | Spn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25081 | Tek Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25082 | Vit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25083 | A1bg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25084 | Adh4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25085 | Apod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25086 | Astl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25087 | Bcl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25088 | Bmi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25089 | C1qb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25090 | Cbx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25091 | Cd8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25092 | Cdx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25093 | Cfl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25094 | Clps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25095 | Cpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25096 | Cpb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25097 | Ece1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25098 | Elf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25099 | Fhl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25100 | Gpc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25101 | Gpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25102 | Hbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25103 | Hcn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25104 | Iscu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25105 | Klc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25106 | Lef1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25107 | Lipe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25108 | Msh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25109 | Muc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25110 | Mylk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25111 | Nek1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25112 | Nono Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25113 | Npr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25114 | Nsd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25115 | Ntn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25116 | Parn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25117 | Pdxp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25118 | Perp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25119 | Pkn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25120 | Rnls Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25121 | Rps3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25122 | Rrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25123 | Rtn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25124 | Tac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25125 | Tpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25126 | Tpm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25127 | Tpm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25128 | Tufm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25129 | Wfs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25130 | Wnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25131 | Abcb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25132 | Acaa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25133 | Anpep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25134 | Blvrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25135 | Camkv Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25136 | Ccl27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25137 | Cd207 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25138 | Cd302 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25139 | Cebpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25140 | Cep57 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25141 | Cnpy3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25142 | Cspg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25143 | Dapk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25144 | Dpep2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25145 | Egfl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25146 | Eif1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25147 | Epha5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25148 | Ephx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25149 | Ermap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25150 | Hadhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25151 | Hcar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25152 | Hoxa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25153 | Ighg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25154 | Lrrc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25155 | Muc17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25156 | Ncstn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25157 | Negr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25158 | Nucb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25159 | Ostm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25160 | P4ha2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25161 | P4ha3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25162 | Pcbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25163 | Prps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25164 | Ptch1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25165 | Ptprj Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25166 | Rasa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25167 | Rbm14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25168 | Rtn4r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25169 | Soat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25170 | Sox10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25171 | Spag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25172 | Tapbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25173 | U2af1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25174 | Usp16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25175 | Usp43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25176 | Ywhaz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25177 | Zg16b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25178 | Zwint Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25179 | Adam15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25180 | Adgre5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25181 | Alkbh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25182 | Antxr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25183 | B3gat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25184 | Bnip3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25185 | Cd300c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25186 | Cela2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25187 | Celsr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25188 | Cldn18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25189 | Clec3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25190 | Col4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25191 | Col7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25192 | Csf2rb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25193 | Cyp7b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25194 | Dcbld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25195 | Dlgap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25196 | Fkbp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25197 | Igfbp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25198 | Lrrtm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25199 | Lypla2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25200 | Phlda2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25201 | Ralbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25202 | Sap130 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25203 | Slamf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25204 | Smurf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25205 | Stambp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25206 | Ube2d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25207 | Arl6ip6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25208 | Colec11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25209 | Csnk2a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25210 | Kirrel3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25211 | Ppp2r1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25212 | S100a13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25213 | Slc27a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25214 | Tinagl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25215 | Adamts18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25216 | Dnase1l3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25217 | Ak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25218 | Amn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25219 | Cgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25220 | Dao Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25221 | Fbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25222 | Ggh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25223 | Hpn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25224 | Kmo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25225 | Mpg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25226 | Mvk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25227 | Nbn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25228 | Ntm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25229 | Oxt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25230 | Ryk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25231 | Abl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25232 | Arsa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25233 | Brap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25234 | C1qa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25235 | Cbfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25236 | Ccin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25237 | Cdh4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25238 | Cdh8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25239 | Ctsa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25240 | Ctsw Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25241 | Dhps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25242 | Eid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25243 | Fgl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25244 | Fmod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25245 | Gad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25246 | Galc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25247 | Galt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25248 | Gbp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25249 | Gja1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25250 | Gltp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25251 | Gmfg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25252 | Hnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25253 | Igkc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25254 | Il9r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25255 | Irf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25256 | Jam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25257 | Klf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25258 | Klk8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25259 | Ly6e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25260 | Mdm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25261 | Mecr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25262 | Med9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25263 | Mtdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25264 | Naaa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25265 | Nck1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25266 | Ncr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25267 | Nid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25268 | Orm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25269 | P4hb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25270 | Pfkl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25271 | Pif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25272 | Plp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25273 | Ppif Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25274 | Rgma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25275 | Rhoj Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25276 | Rrn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25277 | Rtn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25278 | Sav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25279 | Sdha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25280 | Smg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25281 | Speg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25282 | Sub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25283 | Tpmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25284 | Tpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25285 | Vasp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25286 | Vnn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25287 | Aadac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25288 | Ackr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25289 | Acmsd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25290 | Adprh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25291 | Anxa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25292 | Asb13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25293 | Bbox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25294 | Cdh10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25295 | Cdk17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25296 | Cldn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25297 | Clic2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25298 | Cmpk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25299 | Crlf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25300 | Dpp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25301 | Ecscr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25302 | Egln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25303 | Epha3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25304 | Fads1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25305 | Fbxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25306 | Fcrl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25307 | Ffar4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25308 | Fgf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25309 | Fkbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25310 | Foxa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25311 | Gap43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25312 | Gnao1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25313 | Hebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25314 | Hprt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25315 | Il2ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25316 | Klrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25317 | Klrg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25318 | Lims1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25319 | Mgat5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25320 | Mnat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25321 | Otud1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25322 | Padi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25323 | Pea15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25324 | Peli1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25325 | Pold1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25326 | Prdx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25327 | Pros1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25328 | Prps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25329 | Psmb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25330 | Rab2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25331 | Reg3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25332 | Riok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25333 | Robo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25334 | Setd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25335 | Srrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25336 | Srsf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25337 | Syvn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25338 | Trpc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25339 | Tyrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25340 | Ube2i Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25341 | Vipr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25342 | Vsig8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25343 | Angpt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25344 | Bpifb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25345 | Cdc25c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25346 | Cdkn2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25347 | Cgref1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25348 | Cnksr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25349 | Col4a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25350 | Col8a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25351 | Crabp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25352 | Dpysl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25353 | Elavl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25354 | Elovl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25355 | Entpd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25356 | Gpr174 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25357 | Ifnlr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25358 | Il36rn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25359 | Lefty2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25360 | Lgals4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25361 | Map3k3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25362 | Nmnat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25363 | Pik3r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25364 | Psmd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25365 | Ptger4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25366 | Rprd1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25367 | Sephs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25368 | Slamf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25369 | Taldo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25370 | Trim33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25371 | Uqcrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25372 | Colec12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25373 | Slc37a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25374 | Slc39a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25375 | Slc6a14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25376 | Sparcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25377 | Adamtsl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25378 | Gabarapl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25379 | Serpinb10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25380 | Ado Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25381 | Afm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25382 | Cpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25383 | Ebp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25384 | Fau Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25385 | Hfe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25386 | Ids Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25387 | Ivd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25388 | Lxn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25389 | Mtr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25390 | Nms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25391 | Ppl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25392 | Tnn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25393 | Tnr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25394 | Ubb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25395 | Acy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25396 | Add2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25397 | Ago1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25398 | Agr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25399 | Arnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25400 | Atg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25401 | Atl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25402 | Bag2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25403 | Bcan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25404 | Bin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25405 | Brf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25406 | Cdsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25407 | Chd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25408 | Chga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25409 | Clgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25410 | Coch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25411 | Cop1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25412 | Dag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25413 | Dbf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25414 | Dlst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25415 | Drg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25416 | E2f7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25417 | Ecm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25418 | Edf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25419 | Eif5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25420 | Ell2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25421 | Fcmr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25422 | Fuom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25423 | Fut7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25424 | Gart Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25425 | Gbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25426 | Gclm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25427 | Gid4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25428 | Glb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25429 | Glrx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25430 | Gpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25431 | Gpx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25432 | Gypa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25433 | Hcrt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25434 | Hes5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25435 | Hmbs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25436 | Hps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25437 | Irf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25438 | Jpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25439 | Mas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25440 | Mest Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25441 | Mid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25442 | Mrap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25443 | Mras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25444 | Msmp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25445 | Myrf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25446 | Naca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25447 | Ndc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25448 | Net1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25449 | Neu1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25450 | Nmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25451 | Ntf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25452 | Ola1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25453 | Pax8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25454 | Pfkm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25455 | Pkib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25456 | Prkn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25457 | Ptma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25458 | Ptpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25459 | Relt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25460 | Rgs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25461 | Rom1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25462 | Sord Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25463 | Stam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25464 | Stx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25465 | Tdo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25466 | Tpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25467 | Twf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25468 | Uap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25469 | Vasn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25470 | Vsir Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25471 | Abhd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25472 | Acsl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25473 | Ampd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25474 | Anxa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25475 | Apex2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25476 | Atad5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25477 | Cant1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25478 | Ccrl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25479 | Cd248 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25480 | Cebpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25481 | Cntn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25482 | Coasy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25483 | Ctdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25484 | Ddx17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25485 | Decr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25486 | Eif2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25487 | Epas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25488 | Etfdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25489 | Extl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25490 | Fetub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25491 | Fgf13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25492 | Fgf20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25493 | Fscn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25494 | Gfpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25495 | Ghrhr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25496 | Grip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25497 | Gsdmc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25498 | Gstm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25499 | Hgfac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25500 | Htr2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25501 | Ifi27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25502 | Iglc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25503 | Il17c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25504 | Inhbb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25505 | Irak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25506 | Kifc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25507 | Klk14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25508 | Lacc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25509 | Lyve1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25510 | Mef2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25511 | Megf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25512 | Mfge8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25513 | Nlgn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25514 | Ntmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25515 | Otub2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25516 | Ppm1g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25517 | Prap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25518 | Pttg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25519 | Rab31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25520 | Ramp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25521 | Rbm15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25522 | Rpap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25523 | Rxfp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25524 | Slit2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25525 | Smad9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25526 | Soat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25527 | Spast Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25528 | Srpk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25529 | Sumf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25530 | Tlr10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25531 | Tnnc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25532 | Ube2k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25533 | Usp36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25534 | Usp39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25535 | Vamp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25536 | Ywhaq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25537 | Aarsd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25538 | Adam11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25539 | Adam32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25540 | Arid1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25541 | Atp5mg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25542 | Cd300a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25543 | Cdkn1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25544 | Chrna5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25545 | Clec1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25546 | Col4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25547 | Cox4i2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25548 | Ddx19a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25549 | Eef1b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25550 | Eif5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25551 | Glipr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25552 | Gprc6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25553 | Igsf11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25554 | Il17re Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25555 | Lpcat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25556 | Mansc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25557 | Nfatc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25558 | Nmral1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25559 | Nup210 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25560 | Otulin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25561 | Plxna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25562 | Ptger2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25563 | Sema4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25564 | Slc4a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25565 | Slc6a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25566 | Slc9a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25567 | Srd5a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25568 | Stat5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25569 | Tpsab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25570 | Treml2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25571 | Trim16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25572 | Trim62 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25573 | Tsg101 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25574 | Adamts1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25575 | Adcyap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25576 | B4galt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25577 | Cd300lf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25578 | Cntnap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25579 | Colec10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25580 | Lamtor3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25581 | Madcam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25582 | Morf4l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25583 | Pglyrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25584 | Ppp1r1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25585 | Slc30a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25586 | Tnfaip6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25587 | Adamts15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25588 | Adamts16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25589 | Adamts17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25590 | Aldh18a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25591 | Ppp1r15b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25592 | Serpinb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25593 | Siglec15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25594 | Ckm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25595 | CTD Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25596 | Ddo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25597 | Dld Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25598 | Dtl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25599 | Hrc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25600 | Kel Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25601 | Ltk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25602 | Pzp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25603 | Sct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25604 | Abra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25605 | Acy3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25606 | Artn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25607 | Asns Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25608 | Atf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25609 | Bmp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25610 | Btf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25611 | Capg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25612 | Cbx8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25613 | Coq2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25614 | Crat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25615 | Csad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25616 | Dlc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25617 | Dsg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25618 | Dtd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25619 | Ech1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25620 | Ensa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25621 | Epyc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25622 | Fzd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25623 | Gas7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25624 | Gatm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25625 | Gcdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25626 | Gdf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25627 | Gmpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25628 | Gnaz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25629 | Gpc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25630 | Hbq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25631 | Hcn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25632 | Hsf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25633 | Ing4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25634 | Ly86 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25635 | Mafb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25636 | Mcf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25637 | Mlh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25638 | Mt1f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25639 | Mzb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25640 | Npr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25641 | Pld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25642 | Pmvk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25643 | Pop1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25644 | Qprt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25645 | Rcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25646 | Rida Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25647 | Ryr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25648 | Sbf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25649 | Scg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25650 | Sco1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25651 | Sgta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25652 | Shbg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25653 | Stx7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25654 | Tab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25655 | Tcn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25656 | Ubtf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25657 | Ykt6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25658 | Acta2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25659 | Anxa8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25660 | Apoa5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25661 | Asf1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25662 | Atg4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25663 | Atg4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25664 | Bmp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25665 | Bmp15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25666 | Bola1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25667 | Cdh15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25668 | Chrm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25669 | Ciita Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25670 | Cplx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25671 | Crip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25672 | Ctps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25673 | Cyb5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25674 | Ddah1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25675 | Dpep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25676 | Echs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25677 | Endog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25678 | Epha1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25679 | Erp29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25680 | Fanca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25681 | Fcrl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25682 | Flrt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25683 | Fnip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25684 | Foxc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25685 | Furin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25686 | Gars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25687 | Gfpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25688 | Gfra3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25689 | Gng13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25690 | Gpr27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25691 | Hibch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25692 | Hjurp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25693 | Hmgn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25694 | Ifit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25695 | Ifnl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25696 | Il17d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25697 | Itih5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25698 | Itpka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25699 | Klf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25700 | Klk10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25701 | Klrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25702 | Kmt5c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25703 | Lman2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25704 | Lrig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25705 | Mapk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25706 | Meis1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25707 | Metrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25708 | Mgst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25709 | Mmp25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25710 | Ngly1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25711 | Nodal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25712 | Oard1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25713 | Olfm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25714 | Otud5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25715 | Palb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25716 | Pclaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25717 | Pde1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25718 | Podxl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25719 | Prdm9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25720 | Ptgs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25721 | Ptpn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25722 | Rab6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25723 | Rcan2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25724 | Senp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25725 | Setd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25726 | Sgms2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25727 | Smap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25728 | Spon2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25729 | Tead2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25730 | Thop1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25731 | Tmed1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25732 | Tnni3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25733 | Traf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25734 | Ulbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25735 | Wnt8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25736 | Alyref Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25737 | Btn1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25738 | Ccdc25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25739 | Col6a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25740 | Cox4i1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25741 | Crisp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25742 | Dynll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25743 | Eif4g1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25744 | Entpd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25745 | Epha10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25746 | Gpr101 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25747 | Gprc5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25748 | Hoxa10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25749 | Hpcal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25750 | Hspa1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25751 | Il18r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25752 | Izumo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25753 | Lgals7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25754 | Nos1ap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25755 | Nt5c1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25756 | Rnf114 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25757 | Sema5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25758 | Spink1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25759 | Stxbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25760 | Tfap2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25761 | Tmed10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25762 | Ythdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25763 | Zbtb7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25764 | Atp6ap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25765 | Cd300lg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25766 | Cyp27b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25767 | Dcun1d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25768 | Hsd17b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25769 | Il13ra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25770 | L3mbtl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25771 | Mid1ip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25772 | Pip4k2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25773 | Pip5k1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25774 | Sharpin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25775 | Slc33a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25776 | Tmprss6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25777 | Tnfaip8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25778 | Trappc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25779 | Adamts20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25780 | Cacna2d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25781 | Ppp1r14a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25782 | Serpinf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25783 | Tnfrsf25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25784 | Serpina10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25785 | C8g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25786 | Cpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25787 | Gns Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25788 | Hk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25789 | Maz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25790 | Mff Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25791 | Mip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25792 | Mt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25793 | Ndp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25794 | Rfk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25795 | Uox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25796 | Acp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25797 | Acp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25798 | Atl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25799 | Batf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25800 | Bin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25801 | Cdc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25802 | Cks2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25803 | Clmp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25804 | Cma1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25805 | Cmbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25806 | Crkl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25807 | Ctrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25808 | Dab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25809 | Daxx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25810 | Dkc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25811 | Dna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25812 | E2f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25813 | E2f3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25814 | Eaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25815 | Ebf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25816 | Ece2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25817 | Eea1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25818 | Egr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25819 | Fgf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25820 | Fhit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25821 | Fibp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25822 | Fis1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25823 | Fmr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25824 | Frzb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25825 | Gcsh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25826 | Gfi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25827 | Gnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25828 | Gpx7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25829 | Gypc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25830 | Hey1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25831 | Hid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25832 | Ier3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25833 | Irs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25834 | Jag2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25835 | Jam3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25836 | Jund Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25837 | Krt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25838 | Lcp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25839 | Ldb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25840 | Lgr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25841 | Mal2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25842 | Mbd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25843 | Mcee Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25844 | Mpc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25845 | Mpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25846 | Mrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25847 | Nags Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25848 | Napg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25849 | Ncf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25850 | Ncr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25851 | Nit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25852 | Nme2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25853 | Nop2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25854 | Otor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25855 | Penk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25856 | Phf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25857 | Phyh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25858 | Pi16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25859 | Plek Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25860 | Pmm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25861 | Polb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25862 | Polg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25863 | Ppa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25864 | Ppid Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25865 | Raly Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25866 | Rbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25867 | Rcn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25868 | Rgs5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25869 | Rhoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25870 | Rif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25871 | Rps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25872 | Scg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25873 | Shpk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25874 | Sncg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25875 | Sox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25876 | Spp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25877 | Ss18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25878 | Tab3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25879 | Tbcb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25880 | Tfe3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25881 | Tgs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25882 | Tie1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25883 | Tppp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25884 | Txn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25885 | Uba6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25886 | Ubr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25887 | Ufl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25888 | Usb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25889 | Use1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25890 | USP6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25891 | Vmac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25892 | Wnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25893 | Acadl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25894 | Acox3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25895 | Actr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25896 | Adrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25897 | Aicda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25898 | Aifm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25899 | Alas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25900 | Apoa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25901 | Asah2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25902 | Asgr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25903 | Bambi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25904 | Btnl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25905 | Bub1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25906 | Cadm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25907 | Cd180 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25908 | Chrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25909 | Chst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25910 | Cidea Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25911 | Cisd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25912 | Ckap4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25913 | Cpne1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25914 | Cpsf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25915 | Creg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25916 | Crhbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25917 | Ctbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25918 | Dctn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25919 | Dmbt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25920 | Dtx3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25921 | Dusp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25922 | Dusp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25923 | Epdr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25924 | Espl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25925 | Fgf22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25926 | Ggta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25927 | Gngt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25928 | Golm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25929 | Gpr15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25930 | Gsta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25931 | Gstt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25932 | Hipk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25933 | Hkdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25934 | Hyal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25935 | Hyou1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25936 | Icam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25937 | Ifi30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25938 | Ifnl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25939 | Impa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25940 | Insrr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25941 | Itga1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25942 | Itga8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25943 | Itpkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25944 | Kcnk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25945 | Klrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25946 | Krt19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25947 | Loxl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25948 | Lpin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25949 | Lrrn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25950 | Mdga2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25951 | Micu1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25952 | Mob1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25953 | Mpzl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25954 | Mpzl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25955 | Mtch2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25956 | Nceh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25957 | Ncor2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25958 | Nell2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25959 | Oscar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25960 | Oxsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25961 | Pam16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25962 | Pdcd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25963 | Plcg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25964 | Plcg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25965 | Ppm1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25966 | Ppp6c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25967 | Prdm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25968 | Prkd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25969 | Psma3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25970 | Psme2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25971 | Ptpra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25972 | Rps13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25973 | Rps19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25974 | Senp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25975 | Snrpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25976 | Spns2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25977 | Srsf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25978 | Tcl1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25979 | Thbs4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25980 | Tirap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25981 | Tppp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25982 | Tra2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25983 | Trib2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25984 | Trmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25985 | Tubb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25986 | Ube2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25987 | Usp38 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25988 | Vsig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25989 | Ywhah Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25990 | Zbtb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25991 | Acot13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25992 | Adam28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25993 | Adam30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25994 | Arrdc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25995 | B3gnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25996 | Bcap31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25997 | Col4a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25998 | Cyb5r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25999 | Diablo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26000 | Fam20c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26001 | Gpr158 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26002 | Gpr161 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26003 | Guca1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26004 | Havcr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26005 | Hilpda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26006 | Hnrnpc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26007 | Lgals8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26008 | Lilra5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26009 | Lilrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26010 | Lin28b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26011 | Map3k4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26012 | Necap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26013 | Pabpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26014 | Parp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26015 | Phlda1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26016 | Ppp3ca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26017 | Prdm16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26018 | Ptgfrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26019 | Pycard Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26020 | S100a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26021 | Setd1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26022 | Sez6l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26023 | Slc1a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26024 | Spink7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26025 | Spint2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26026 | Sptssb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26027 | Tomm20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26028 | Tp53i3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26029 | Trdmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26030 | Ube2g2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26031 | Ube2j2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26032 | Unc119 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26033 | Adamts2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26034 | Aldh3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26035 | Cd300lb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26036 | Col11a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26037 | Cyp24a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26038 | Gpihbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26039 | Hnrnpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26040 | Lamtor2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26041 | Metap1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26042 | Onecut2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26043 | Pip5k1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26044 | Pomgnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26045 | Rarres2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26046 | S100a14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26047 | Slc11a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26048 | Slc22a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26049 | Slc7a10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26050 | Sult2b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26051 | Tmem175 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26052 | Tsc22d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26053 | Xpnpep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26054 | Pla2g12b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26055 | Rad51ap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26056 | C1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26057 | Chm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26058 | Fgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26059 | Ly9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26060 | Me3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26061 | Mt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26062 | Neb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26063 | Nln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26064 | Nrk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26065 | Rgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26066 | Ttl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26067 | Unk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26068 | Zyx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26069 | Adh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26070 | Ahrr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26071 | Ank3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26072 | Anln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26073 | Apoo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26074 | Atrx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26075 | Calu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26076 | Cblc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26077 | Cbx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26078 | Ccnh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26079 | Cd72 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26080 | Cerk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26081 | Cib1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26082 | Clp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26083 | Clpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26084 | Coa6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26085 | Copa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26086 | Cpa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26087 | Cst5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26088 | Cux1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26089 | Dok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26090 | Eif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26091 | Emg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26092 | Emp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26093 | Enam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26094 | Etv6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26095 | Eya2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26096 | F11r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26097 | Ftcd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26098 | Fut1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26099 | Gckr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26100 | Ggct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26101 | Git1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26102 | Gkn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26103 | Hcst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26104 | Ilf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26105 | Iqcg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26106 | Ksr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26107 | Lmf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26108 | Lsp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26109 | Ly96 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26110 | Mafa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26111 | Mbd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26112 | Med4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26113 | Mrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26114 | Myof Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26115 | Myt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26116 | Naga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26117 | Ncan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26118 | Nhp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26119 | Nppa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26120 | Oasl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26121 | Ost4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26122 | Ostn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26123 | Pfn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26124 | Pld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26125 | Pmm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26126 | Pnkp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26127 | Podn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26128 | Pon2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26129 | Prg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26130 | Rbks Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26131 | Rem1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26132 | Rps7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26133 | Rtl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26134 | Scgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26135 | Srpx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26136 | St18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26137 | Tgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26138 | Tprn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26139 | Uba2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26140 | Ulk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26141 | Umps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26142 | Uprt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26143 | Urm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26144 | Usf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26145 | Vcan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26146 | Wnk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26147 | Xcr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26148 | Apba3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26149 | Atat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26150 | Bccip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26151 | Blvra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26152 | Calm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26153 | Cd109 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26154 | Cdh18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26155 | Cenpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26156 | Cenpb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26157 | Cetn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26158 | Cfhr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26159 | Ckmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26160 | Clic1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26161 | Cnpy4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26162 | Cops5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26163 | Cox5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26164 | Crip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26165 | Crmp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26166 | Cspg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26167 | Dhrs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26168 | Dhx36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26169 | Dnph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26170 | Dusp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26171 | Eif5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26172 | Eomes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26173 | Ercc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26174 | Ewsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26175 | Foxd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26176 | Foxp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26177 | Ggps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26178 | Gna14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26179 | Gpr32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26180 | Gstk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26181 | Gstz1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26182 | Hcfc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26183 | Herc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26184 | Hhla2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26185 | Hnf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26186 | Hspg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26187 | Ifit2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26188 | Igsf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26189 | Il1r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26190 | Il36b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26191 | Il5ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26192 | Ino80 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26193 | Ip6k1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26194 | Itih3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26195 | Kcnq3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26196 | Kdm7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26197 | Kif15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26198 | Krt14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26199 | Krt18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26200 | Lipt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26201 | Lmcd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26202 | Lmnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26203 | Loxl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26204 | Lrp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26205 | Ltbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26206 | Matr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26207 | Mcm10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26208 | Med10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26209 | Mef2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26210 | Mfap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26211 | Mien1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26212 | Mmgt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26213 | Mmp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26214 | Msrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26215 | Mtss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26216 | Nanog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26217 | Ncoa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26218 | Ndc80 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26219 | Neil1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26220 | Nlrc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26221 | Nptx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26222 | Nr1h2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26223 | Nrros Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26224 | Otud3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26225 | Pdia5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26226 | Phkg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26227 | Plac8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26228 | Prmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26229 | Prox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26230 | Ptges Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26231 | Pvalb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26232 | Rab1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26233 | Reg3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26234 | Rxfp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26235 | Rxfp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26236 | Senp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26237 | Sfxn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26238 | Snai1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26239 | Ssbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26240 | Ssrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26241 | Stk40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26242 | Strap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26243 | Sulf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26244 | Tagln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26245 | Taok3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26246 | Trps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26247 | Txlna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26248 | Usp33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26249 | Usp51 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26250 | Vsnl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26251 | Wars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26252 | Wnt16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26253 | Xrcc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26254 | Ywhab Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26255 | Zbtb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26256 | Zfpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26257 | Acadvl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26258 | Adam23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26259 | Adgrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26260 | Adgrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26261 | Ankrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26262 | Calhm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26263 | Calml3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26264 | Cdc25b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26265 | Chrna7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26266 | Chst15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26267 | Ckap2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26268 | Clec4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26269 | Crisp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26270 | Dctpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26271 | Entpd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26272 | Errfi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26273 | Fgfbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26274 | Galnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26275 | Hapln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26276 | Igfbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26277 | Il15ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26278 | Il1f10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26279 | Itga2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26280 | Izumo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26281 | Jarid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26282 | Laptm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26283 | Ly6g6d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26284 | Mad2l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26285 | Man1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26286 | Map2k7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26287 | Mrgprd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26288 | Mybpc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26289 | N6amt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26290 | Ndufa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26291 | Nfe2l3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26292 | Notch2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26293 | Npepl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26294 | Opalin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26295 | Pdcd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26296 | Phlpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26297 | Pik3r3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26298 | Polr2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26299 | Ppp1cc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26300 | Ptges2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26301 | Ptges3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26302 | Ptp4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26303 | Ptp4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26304 | Ptpn12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26305 | Rab11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26306 | Rnase6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26307 | Rnf168 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26308 | Sema3c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26309 | Smndc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26310 | Sorcs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26311 | Spink4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26312 | Spock1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26313 | Sptbn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26314 | Srsf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26315 | Stard7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26316 | Thsd7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26317 | Tm4sf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26318 | Tmbim6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26319 | Tmem25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26320 | Trim27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26321 | Ube2d3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26322 | Ube2r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26323 | Ugt1a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26324 | Vcpip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26325 | Ythdf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26326 | Adamts6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26327 | Adamts7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26328 | Adamts9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26329 | Atg16l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26330 | Atp5f1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26331 | Bloc1s2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26332 | C1qtnf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26333 | Castor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26334 | Fam167a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26335 | Gadd45g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26336 | Pacsin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26337 | Racgap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26338 | Rnaset2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26339 | Slc22a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26340 | Slc26a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26341 | Slc27a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26342 | Slc43a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26343 | Tspan31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26344 | Adamts19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26345 | Lgals3bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26346 | Phospho1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26347 | Pnliprp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26348 | Serpina4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26349 | Serpina6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26350 | Serpinb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26351 | Siglec10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26352 | Tnfrsf19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26353 | Gabarapl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26354 | Tmprss11d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26355 | Ky Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26356 | Aen Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26357 | Ak3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26358 | Ak5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26359 | Esd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26360 | Ezr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26361 | Fgb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26362 | Jtb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26363 | Lct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26364 | Mn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26365 | Mnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26366 | Oaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26367 | Rd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26368 | Tef Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26369 | Vcl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26370 | Was Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26371 | Abi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26372 | Agrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26373 | Apof Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26374 | Art4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26375 | Atl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26376 | Bag4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26377 | Bdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26378 | C1qc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26379 | Ccnc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26380 | Cd53 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26381 | Cdon Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26382 | Cfl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26383 | Chia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26384 | Cib2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26385 | Cish Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26386 | Cope Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26387 | Cst6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26388 | Ctso Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26389 | Cutc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26390 | Cyba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26391 | Dkk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26392 | Dlx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26393 | Dmp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26394 | Dsg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26395 | Eapp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26396 | Egr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26397 | Faim Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26398 | Fdxr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26399 | Flnb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26400 | Fshb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26401 | Gdf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26402 | Gga3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26403 | Ggt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26404 | Gps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26405 | Haao Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26406 | Inha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26407 | Irf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26408 | Jdp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26409 | Klf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26410 | Lig4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26411 | Lmna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26412 | Lrp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26413 | Lrp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26414 | Lsm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26415 | Ltv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26416 | Ly6d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26417 | Lyg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26418 | Mdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26419 | Mesd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26420 | Mnda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26421 | Mrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26422 | Msx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26423 | Mta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26424 | Mtf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26425 | Muc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26426 | Nip7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26427 | Nptn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26428 | Numb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26429 | Oas3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26430 | Osbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26431 | Pax3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26432 | Per1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26433 | Pfas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26434 | Pgm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26435 | Pigm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26436 | Pkn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26437 | Plec Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26438 | Pomp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26439 | Ppih Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26440 | Prf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26441 | Prg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26442 | Prg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26443 | Qdpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26444 | Rbm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26445 | Rce1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26446 | Reck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26447 | Retn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26448 | Rgs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26449 | Rnf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26450 | Rpl8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26451 | Rrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26452 | Ryr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26453 | Ryr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26454 | Scly Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26455 | Sgsh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26456 | Siae Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26457 | Six2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26458 | Snw1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26459 | Snx9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26460 | Sos2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26461 | Ssr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26462 | Stk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26463 | Tab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26464 | Tcp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26465 | Tle3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26466 | Tmx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26467 | Tp73 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26468 | Tpx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26469 | Tril Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26470 | Tsfm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26471 | Ucma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26472 | Ugdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26473 | Ugp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26474 | Upk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26475 | Uros Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26476 | Vsx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26477 | Wdr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26478 | Wdr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26479 | Aadat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26480 | Abcc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26481 | Abce1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26482 | Acsl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26483 | Acss3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26484 | Adpgk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26485 | Amacr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26486 | Amelx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26487 | Apoa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26488 | Arpin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26489 | Atxn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26490 | Bach2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26491 | Baz1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26492 | Bckdk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26493 | Calm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26494 | Casq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26495 | Ccna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26496 | Ccnd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26497 | Cdh11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26498 | Cemip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26499 | Cers1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26500 | Cfhr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26501 | Cnpy2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26502 | Cntn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26503 | Cntn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26504 | Copz1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26505 | Coro6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26506 | Cplx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26507 | Cradd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26508 | Cryaa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26509 | Ctrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26510 | Cytip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26511 | Daglb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26512 | Decr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26513 | Dhrs9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26514 | Dkkl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26515 | Dusp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26516 | Eef2k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26517 | Eif3k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26518 | Esrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26519 | Fam3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26520 | Fbxl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26521 | Fcrl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26522 | Flad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26523 | Flrt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26524 | Fndc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26525 | Foxd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26526 | Foxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26527 | Fxyd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26528 | Galk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26529 | Gata1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26530 | Gata2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26531 | Gfod2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26532 | Gp1ba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26533 | Gpha2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26534 | Gpr12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26535 | Gpr19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26536 | Gpr26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26537 | Gpr87 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26538 | Hells Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26539 | Hoxb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26540 | Ikzf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26541 | Il1r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26542 | Il2rg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26543 | Ilkap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26544 | Inpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26545 | Insm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26546 | Isg20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26547 | Itgam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26548 | Kcnj2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26549 | Kdm4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26550 | Kif4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26551 | Klk15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26552 | Kmt2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26553 | Lactb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26554 | Lama3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26555 | Lmtk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26556 | Ltbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26557 | Mecp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26558 | Meltf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26559 | Mlana Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26560 | Msmo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26561 | Mthfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26562 | Mthfs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26563 | Mybl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26564 | Ncoa6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26565 | Ndrg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26566 | Ndst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26567 | Nek11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26568 | Neto1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26569 | Nfasc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26570 | Nlrc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26571 | Nptxr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26572 | Nr1i3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26573 | Nr2f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26574 | Nrn1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26575 | Nrxn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26576 | Nudt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26577 | Parp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26578 | Pcbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26579 | Pdrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26580 | Pdzk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26581 | Peg10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26582 | Pex19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26583 | Pfdn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26584 | Pias1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26585 | Pilra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26586 | Pnrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26587 | Ppil1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26588 | Ppil2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26589 | Prelp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26590 | Prkg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26591 | Psme1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26592 | Ptgr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26593 | Pth2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26594 | Ptpn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26595 | Ptrh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26596 | Rad21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26597 | Rexo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26598 | Rnf20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26599 | Robo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26600 | Romo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26601 | Rpl10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26602 | Rps4x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26603 | Runx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26604 | Satb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26605 | Scn2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26606 | Sfrp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26607 | Sin3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26608 | Snai2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26609 | Snx10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26610 | Srsf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26611 | Stk25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26612 | Sulf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26613 | Susd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26614 | Taok2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26615 | Terf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26616 | Tfcp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26617 | Tgif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26618 | Thsd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26619 | Timp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26620 | Tinag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26621 | Tnnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26622 | Tnpo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26623 | Top2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26624 | Tpsb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26625 | Trpv5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26626 | Ube2h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26627 | Ube2o Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26628 | Ube2w Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26629 | Unc5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26630 | Uqcrh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26631 | Usp26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26632 | Usp9y Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26633 | Vdac3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26634 | Xrcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26635 | Abhd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26636 | Acadsb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26637 | Adam33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26638 | Adgrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26639 | Adra2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26640 | Alkal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26641 | Atf7ip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26642 | Bpifa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26643 | Btn3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26644 | Calcrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26645 | Cdkn2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26646 | Chaf1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26647 | Chrna3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26648 | Cldn11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26649 | Clec9a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26650 | Clstn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26651 | Col1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26652 | Col9a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26653 | Crabp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26654 | Dnase1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26655 | Dpysl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26656 | Eif1ax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26657 | Eif4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26658 | Eps8l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26659 | Fbxo22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26660 | Fbxo32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26661 | Fgfrl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26662 | Galnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26663 | Galnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26664 | Galnt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26665 | Gpr142 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26666 | Gpr173 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26667 | Gprc5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26668 | Hnrnpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26669 | Ifitm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26670 | Igflr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26671 | Il17rd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26672 | Il1rl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26673 | Il27ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26674 | Iqgap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26675 | Itga10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26676 | Lactb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26677 | Lgals2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26678 | Lrrc4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26679 | Lrrtm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26680 | Man1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26681 | Mbtps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26682 | Mcoln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26683 | Mical2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26684 | Mpig6b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26685 | mt-Co2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26686 | Ndufa8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26687 | Ndufa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26688 | Ndufv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26689 | Nfkbib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26690 | Otud7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26691 | Pfkfb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26692 | Pfkfb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26693 | Pi4k2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26694 | Plxnd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26695 | Pofut1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26696 | Ptp4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26697 | Rnase2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26698 | Slc4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26699 | Slc6a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26700 | Slurp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26701 | Srfbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26702 | Trim14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26703 | Trim29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26704 | Tspan1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26705 | Twist1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26706 | Txnl4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26707 | Ube2j1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26708 | Ube2v1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26709 | Ugt2b7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26710 | Vps13c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26711 | Abhd14b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26712 | Aldh7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26713 | Atp13a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26714 | Atp5if1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26715 | Gnpnat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26716 | Kir3dl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26717 | Lamtor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26718 | Map3k14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26719 | Mrgprx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26720 | Mthfd1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26721 | Nectin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26722 | Prtfdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26723 | Slc25a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26724 | Slc36a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26725 | Slc38a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26726 | Slitrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26727 | Slitrk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26728 | Slitrk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26729 | Sult1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26730 | Tbl1xr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26731 | Trmt112 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26732 | Adamts10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26733 | Adamts14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26734 | Eif4ebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26735 | Il1rapl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26736 | Serpinb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26737 | Slc25a28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26738 | Slc25a51 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26739 | Tmem106b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26740 | Tmprss11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26741 | Btd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26742 | Dut Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26743 | Eln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26744 | Fev Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26745 | Ggn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26746 | Hbz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26747 | Kin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26748 | Mvp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26749 | Nnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26750 | Pip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26751 | Pnn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26752 | Pts Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26753 | Xpc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26754 | Adm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26755 | Amtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26756 | Ano6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26757 | Apip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26758 | Aqp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26759 | Arf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26760 | Arl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26761 | Art3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26762 | Bpgm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26763 | Bzw2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26764 | Cav2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26765 | Cbx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26766 | Cdr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26767 | Chn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26768 | Cpn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26769 | Cpox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26770 | Cst8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26771 | Cul2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26772 | Cycs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26773 | Dab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26774 | Ddx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26775 | Denr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26776 | Dgkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26777 | Dkk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26778 | E2f6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26779 | Ebf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26780 | Elob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26781 | Emc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26782 | Emcn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26783 | Ets2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26784 | Fech Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26785 | Gbe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26786 | Gldc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26787 | Gopc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26788 | Gps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26789 | Gpx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26790 | Grk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26791 | Gzmk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26792 | H3c1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26793 | Hagh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26794 | Hcn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26795 | Hes6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26796 | Hopx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26797 | Hsf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26798 | Ifne Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26799 | Klc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26800 | Klk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26801 | Lcn8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26802 | Liph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26803 | Mbip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26804 | Mnx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26805 | Mob4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26806 | Mrs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26807 | Myl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26808 | Myoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26809 | Myog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26810 | Nans Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26811 | Nasp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26812 | Naxe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26813 | Ncf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26814 | Nek3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26815 | Nfya Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26816 | Nkd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26817 | Nme1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26818 | Nnat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26819 | Nppc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26820 | Nqo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26821 | Ntf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26822 | Ntn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26823 | Nudc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26824 | Oas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26825 | Oxr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26826 | Pax5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26827 | Pax6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26828 | Pbx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26829 | Pcp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26830 | Pepd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26831 | Per2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26832 | Pgm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26833 | Pigf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26834 | Pkp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26835 | Pmp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26836 | Ppie Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26837 | Prkx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26838 | Prr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26839 | Pxdn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26840 | Rad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26841 | Rfng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26842 | Rhoh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26843 | Rmi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26844 | Rpia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26845 | Rpn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26846 | Sox6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26847 | Spen Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26848 | Stn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26849 | Stx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26850 | Stx8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26851 | Syt6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26852 | Tac3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26853 | Tbx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26854 | Tcf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26855 | Thrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26856 | Tjp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26857 | Trhr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26858 | Ucp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26859 | Wsb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26860 | Ybx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26861 | Zic2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26862 | Zic3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26863 | Abcb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26864 | Abcc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26865 | Abhd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26866 | Acacb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26867 | Acer3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26868 | Acrv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26869 | Actn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26870 | Acyp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26871 | Acyp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26872 | Ahnak Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26873 | Aimp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26874 | Apoc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26875 | Apol2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26876 | Appl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26877 | Bard1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26878 | Basp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26879 | Batf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26880 | Birc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26881 | Calr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26882 | Cdca7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26883 | Cdk15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26884 | Cenpf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26885 | Cep43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26886 | Cfhr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26887 | Chpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26888 | Ckap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26889 | Cks1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26890 | Cldn9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26891 | Clic4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26892 | Clic5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26893 | Cndp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26894 | Cnnm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26895 | Cntn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26896 | Cpeb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26897 | Crlf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26898 | Dcaf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26899 | Ddost Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26900 | Dhrs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26901 | Dhrs3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26902 | Dhx15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26903 | Dnah6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26904 | Edem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26905 | Egln3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26906 | Epha6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26907 | Epha8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26908 | Eppk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26909 | Ercc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26910 | Erp27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26911 | Fancc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26912 | Fbln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26913 | Fgf16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26914 | Fkbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26915 | Fkbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26916 | Fkbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26917 | Fkbp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26918 | Flrt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26919 | Fmnl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26920 | G3bp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26921 | Gabrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26922 | Gnai3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26923 | Gpat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26924 | Gpld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26925 | Grik2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26926 | Gsdma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26927 | Gstm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26928 | Hars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26929 | Hmces Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26930 | Hoxb9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26931 | Hoxc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26932 | Hspa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26933 | Htr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26934 | Ifit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26935 | Igsf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26936 | Impa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26937 | Insl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26938 | Itgal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26939 | Itln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26940 | Josd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26941 | Kcnn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26942 | Kif2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26943 | Kif2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26944 | Kifc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26945 | Kifc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26946 | Klhl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26947 | Klk13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26948 | Kpna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26949 | Lamc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26950 | Larp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26951 | Lrrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26952 | Lrrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26953 | Magi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26954 | Meox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26955 | Mep1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26956 | Mesp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26957 | Milr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26958 | Muc5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26959 | Ncald Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26960 | Ncoa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26961 | Ncor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26962 | Nell1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26963 | Npdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26964 | Nprl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26965 | Nptx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26966 | Nrcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26967 | Ntng1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26968 | Opcml Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26969 | Oxct1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26970 | Pa2g4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26971 | Pcsk7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26972 | Plet1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26973 | Plpp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26974 | Ppef1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26975 | Prdm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26976 | Prmt9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26977 | Prrx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26978 | Psma4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26979 | Psmb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26980 | Psme3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26981 | Ptk2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26982 | Ptpn9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26983 | Ptprn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26984 | Qsox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26985 | Ramp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26986 | Rbbp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26987 | Rbck1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26988 | Rcvrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26989 | Rgs12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26990 | Ripk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26991 | Rnf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26992 | Rplp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26993 | Rptor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26994 | Rsad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26995 | Sar1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26996 | Sesn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26997 | Sf3b3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26998 | Slit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26999 | Smad5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27000 | Smug1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27001 | Sox17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27002 | Sox18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27003 | Sp140 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27004 | Spg21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27005 | Stap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27006 | Stk26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27007 | Tada3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27008 | Tiprl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27009 | Tmed4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27010 | Traf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27011 | Trpm6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27012 | Tssk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27013 | Uba52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27014 | Ube2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27015 | Ube2f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27016 | Ube3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27017 | Ugt1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27018 | Uqcrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27019 | Usp35 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27020 | Usp37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27021 | Usp40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27022 | Usp49 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27023 | Usp53 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27024 | Vps41 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27025 | Vps4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27026 | Vsig2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27027 | Vstm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27028 | Vti1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27029 | Wdr77 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27030 | Zbtb9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27031 | Acad10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27032 | Adgrg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27033 | Atp2b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27034 | Atp2b4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27035 | B3gat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27036 | B3gnt6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27037 | B3gnt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27038 | Bcl11a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27039 | Camk1g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27040 | Camk2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27041 | Capza2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27042 | Casp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27043 | Ccdc47 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27044 | Cd300e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27045 | Cdk5r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27046 | Cdkn1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27047 | Chrdl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27048 | Chst11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27049 | Col5a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27050 | Crtac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27051 | Csrnp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27052 | Ddx39b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27053 | Depdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27054 | Depdc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27055 | Dnajb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27056 | Elavl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27057 | Elovl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27058 | Fbxo10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27059 | Fkbp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27060 | Gabra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27061 | Gabra4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27062 | Gpr107 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27063 | Hectd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27064 | Hectd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27065 | Hs3st1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27066 | Il31ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27067 | Kansl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27068 | Kcnip3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27069 | Kcnma1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27070 | Kif20a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27071 | Lman2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27072 | Lrpprc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27073 | Lrrc25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27074 | Lrrc3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27075 | Mad2l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27076 | Map3k9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27077 | Mapre3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27078 | mt-Nd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27079 | mt-Nd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27080 | Npbwr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27081 | Nusap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27082 | Or10h1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27083 | Osbpl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27084 | Papss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27085 | Pgrmc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27086 | Pi4k2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27087 | Plxdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27088 | Pmaip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27089 | Pnpla6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27090 | Podxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27091 | Pou2f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27092 | Ppfia4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27093 | Ptdss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27094 | Ptger3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27095 | Ptpn18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27096 | Raet1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27097 | Recql4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27098 | Rnase1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27099 | Rnf126 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27100 | Rnf146 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27101 | Rps27a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27102 | Sema3f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27103 | Sema4g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27104 | Shcbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27105 | Slc7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27106 | Slc8b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27107 | Smurf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27108 | Spink2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27109 | Suclg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27110 | Tagln2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27111 | Tagln3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27112 | Thap11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27113 | Tmeff1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27114 | Tmem17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27115 | Tmem92 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27116 | Treml1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27117 | Trim23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27118 | Trim45 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27119 | Trmt11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27120 | Tubb4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27121 | Txnrd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27122 | Ube2g1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27123 | Uqcr11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27124 | Usp6nl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27125 | Vps13d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27126 | Zc3h13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27127 | Zmynd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27128 | Adamts8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27129 | Aldh4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27130 | Alox15b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27131 | B3galt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27132 | B4galt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27133 | B4galt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27134 | Cacna1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27135 | Cacna1i Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27136 | Cdk2ap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27137 | Csnk1g2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27138 | Fam171b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27139 | Hepacam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27140 | Hsd11b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27141 | Hsd17b4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27142 | Il18rap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27143 | Kirrel2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27144 | Kremen1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27145 | Lyplal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27146 | Mab21l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27147 | Map3k11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27148 | Ncr3lg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27149 | Pglyrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27150 | Rtn4rl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27151 | Scgb3a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27152 | Selenom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27153 | Sinhcaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27154 | Slc11a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27155 | Slc22a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27156 | Slc27a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27157 | Slc39a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27158 | Slc44a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27159 | Slc47a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27160 | Smarce1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27161 | Smpdl3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27162 | St3gal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27163 | St6gal2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27216 | Chd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27217 | Cir1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27218 | Cnmd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27219 | Cnn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27220 | Cpvl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27221 | Crem Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27222 | Cul5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27223 | Dcps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27224 | Dgkh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27225 | Dlg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27226 | Dlx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27227 | Dner Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27228 | Dntt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27229 | Dpys Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27230 | Drc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27231 | Dux4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27232 | Dvl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27233 | Dvl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27234 | Dysf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27235 | E2f5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27236 | Eaf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27237 | Eef2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27238 | Ehd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27239 | Elp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27240 | Emx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27241 | Etf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27242 | Evx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27243 | Exo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27244 | Faf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27245 | Fhl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27246 | Flnc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27247 | Ftmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27248 | Fxr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27249 | Gba1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27250 | Gba3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27251 | Gdf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27252 | Gdi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27253 | Ghrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27254 | Gjb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27255 | Gli2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27256 | Gmps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27257 | Gnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27258 | Gng4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27259 | Gpam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27260 | Grb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27261 | Grk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27262 | Gusb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27263 | Hes2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27264 | Hhat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27265 | Hira Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27266 | Immt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27267 | Imp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27268 | Irgm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27269 | Irx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27270 | Ism1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27271 | Itpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27272 | Kdm8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27273 | Lax1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27274 | Lcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27275 | Lcp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27276 | Lgi3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27277 | Lgr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27278 | Lhx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27279 | Lhx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27280 | Lhx9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27281 | Lipf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27282 | Lmo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27283 | Lsm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27284 | Mafk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27285 | Mcub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27286 | Mdn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27287 | Mefv Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27288 | Mpst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27289 | Msl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27290 | Mta2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27291 | Muc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27292 | Mycl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27293 | Myh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27294 | Nagk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27295 | Ncf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27296 | Nfia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27297 | Nme3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27298 | Nox3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27299 | Npnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27300 | Nuf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27301 | Opn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27302 | Orc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27303 | Orc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27304 | Otx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27305 | P3h1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27306 | Pdx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27307 | Pfn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27308 | Pgk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27309 | Pld3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27310 | Pnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27311 | Pno1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27312 | Ppa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27313 | Ppic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27314 | Ppt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27315 | Prcp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27316 | Pspn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27317 | Pstk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27318 | Pus1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27319 | Pus7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27320 | Pygl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27321 | Rag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27322 | Rala Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27323 | Rbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27324 | Rev1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27325 | Rin3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27326 | Rpf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27327 | Rpn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27328 | Rtcb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27329 | Sbk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27330 | Sco2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27331 | Scp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27332 | Sdc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27333 | Sgk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27334 | Smc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27335 | Snrk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27336 | Sox5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27337 | Syt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27338 | Tbx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27339 | Tia1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27340 | Tkfc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27341 | Tle2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27342 | Tlk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27343 | Tmpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27344 | Tom1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27345 | Ttf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27346 | Twnk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27347 | Uts2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27348 | Vav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27349 | Vav3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27350 | Vbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27351 | Vwc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27352 | Wbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27353 | Xpo6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27354 | Xrn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27355 | Yod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27356 | Zg16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27357 | Abca3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27358 | Abcc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27359 | Abhd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27360 | Acad8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27361 | Acads Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27362 | Acap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27363 | Ackr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27364 | Acsl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27365 | Adcy3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27366 | Adh1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27367 | Afmid Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27368 | Anxa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27369 | Aplp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27370 | Apoc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27371 | Arih1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27372 | Arrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27373 | Asap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27374 | Ascc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27375 | Ascl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27376 | Ascl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27377 | Atg2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27378 | Axin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27379 | Birc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27380 | Bmp8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27381 | Brip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27382 | Btnl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27383 | Btnl8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27384 | C4bpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27385 | Calb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27386 | Capn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27387 | Cass4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27388 | Cbll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27389 | Ccdc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27390 | Cdc45 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27391 | Cdca3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27392 | Cdca4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27393 | Cdhr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27394 | Cdhr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27395 | Cdkn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27396 | Cdyl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27397 | Cenpw Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27398 | Cept1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27399 | Cert1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27400 | Chac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27401 | Clcn7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27402 | Cldn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27403 | Clic6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27404 | Clip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27405 | Cmpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27406 | Cmtm6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27407 | Cnih2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27408 | Cox10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27409 | Cox17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27410 | Cox18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27411 | Cox7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27412 | Crls1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27413 | Csrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27414 | Ctbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27415 | Cyb5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27416 | Daam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27417 | Dars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27418 | Dcaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27419 | Dchs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27420 | Dclk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27421 | Ddhd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27422 | Ddx10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27423 | Ddx21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27424 | Ddx49 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27425 | Degs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27426 | Disp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27427 | Disp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27428 | Dock1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27429 | Dpy30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27430 | Duox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27431 | Ebag9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27432 | Ecsit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27433 | Eepd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27434 | Eif3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27435 | Eif3m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27436 | Ethe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27437 | Evi2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27438 | Evi2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27439 | Faim2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27440 | Fcamr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27441 | Fcgbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27442 | Fcrla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27443 | Fgf11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27444 | Foxa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27445 | Foxd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27446 | Foxk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27447 | Foxq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27448 | Fstl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27449 | G6pc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27450 | Galns Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27451 | Galr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27452 | Gfra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27453 | Gins1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27454 | Gmppa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27455 | Gna13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27456 | Gpr20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27457 | Gpr22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27458 | Gpr31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27459 | Gpr50 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27460 | Gpr61 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27461 | Gpr85 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27462 | Grem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27463 | Grhl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27464 | Grik3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27465 | Grin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27466 | Gstm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27467 | Gtf2i Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27468 | Hacd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27469 | Hdlbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27470 | Hmgcl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27471 | Hmgn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27472 | Hmgn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27473 | Hspb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27474 | Htr2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27475 | Htra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27476 | Icam4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27477 | Icam5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27478 | Igsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27479 | Ikbip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27480 | Il36a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27481 | Inhbc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27482 | Insl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27483 | Ireb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27484 | Isca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27485 | Itga3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27486 | Itga7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27487 | Itih2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27488 | Itpr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27489 | Kcnd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27490 | Kcnq5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27491 | Klk11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27492 | Kmt2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27493 | Lama1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27494 | Lama2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27495 | Lamb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27496 | Lamc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27497 | Litaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27498 | Lmod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27499 | Lrig2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27500 | Lrrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27501 | Lrrn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27502 | Magoh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27503 | Mat1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27504 | Mat2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27505 | Mgat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27506 | Mgme1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27507 | Mmp19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27508 | Mpeg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27509 | Mrto4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27510 | Ms4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27511 | Mtif3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27512 | Mxra8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27513 | Naa40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27514 | Ncam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27515 | Ncapg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27516 | Nhsl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27517 | Nipbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27518 | Notum Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27519 | Npas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27520 | Nr0b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27521 | Nrarp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27522 | Nubpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27523 | Oprk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27524 | Ovol1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27525 | Oxa1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27526 | Padi3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27527 | Paics Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27528 | Pank1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27529 | Pank2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27530 | Parp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27531 | Pcdh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27532 | Pcdh9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27533 | Pcsk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27534 | Pcyt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27535 | Pgam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27536 | Pgap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27537 | Pianp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27538 | Pias4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27539 | Pibf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27540 | Pitx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27541 | Pla1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27542 | Plac9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27543 | Plbd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27544 | Plod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27545 | Pnpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27546 | Ppm1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27547 | Prodh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27548 | Prok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27549 | Psmd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27550 | Pxdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27551 | Rbpms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27552 | Rhpn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27553 | Rnf31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27554 | Rnf40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27555 | Robo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27556 | Rpl23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27557 | Rplp0 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27558 | Rps3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27559 | Rreb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27560 | Scn3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27561 | Scn4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27562 | Semg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27563 | Sfxn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27564 | Siah2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27565 | Smpd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27566 | Snu13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27567 | Sort1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27568 | Spa17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27569 | Spsb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27570 | Spsb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27571 | Srsf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27572 | Srxn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27573 | Ssc5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27574 | Stk24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27575 | Stk39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27576 | Stra6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27577 | Tagap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27578 | Tarm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27579 | Tbx21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27580 | Tcf12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27581 | Tcf21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27582 | Telo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27583 | Tfdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27584 | Thada Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27585 | Traf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27586 | Trim9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27587 | Tssk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27588 | Ttbk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27589 | Ube2z Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27590 | Ube4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27591 | Uhrf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27592 | Urgcp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27593 | Ush1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27594 | Usp29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27595 | Usp34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27596 | Usp44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27597 | Vamp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27598 | Virma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27599 | Vps18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27600 | Vps35 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27601 | Wdr87 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27602 | Wipi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27603 | Abcb10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27604 | Ablim1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27605 | Adgrf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27606 | Adra1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27607 | Agpat4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27608 | Anapc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27609 | Anp32a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27610 | Arid3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27611 | Arl2bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27612 | Arpc1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27613 | Asrgl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27614 | Atad3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27615 | Atp1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27616 | B3glct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27617 | B3gnt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27618 | Bclaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27619 | Calml5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27620 | Cc2d1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27621 | Cdkal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27622 | Cdkn2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27623 | Cela3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27624 | Chrnb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27625 | Cited2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27626 | Clstn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27627 | Col9a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27628 | Commd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27629 | Cox6b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27630 | Cox6b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27631 | Cox7a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27632 | Csnk1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27633 | Cyp2s1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27634 | Dcbld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27635 | Dnajb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27636 | Dnajc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27637 | Draxin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27638 | Dusp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27639 | Eftud2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27640 | Eif4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27641 | Elovl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27642 | Endod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27643 | Exosc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27644 | Fam83d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27645 | Fbxo44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27646 | Fbxw11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27647 | Fermt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27648 | Fermt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27649 | Flvcr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27650 | Flvcr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27651 | Gabrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27652 | Gimap6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27653 | Gpr146 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27654 | Grin2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27655 | Hnrnpk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27656 | Hnrnpu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27657 | Homer1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27658 | Il17rc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27659 | Inpp5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27660 | Inpp5e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27661 | Itga11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27662 | Lgalsl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27663 | Lingo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27664 | Lpgat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27665 | Lrrc8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27666 | Magea4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27667 | Map3k6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27668 | Mapre1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27669 | Mettl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27670 | Mfap3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27671 | Minpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27672 | Mlxipl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27673 | Mrpl21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27674 | Mrps10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27675 | mt-Nd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27676 | Mycbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27677 | Ndufa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27678 | Ndufs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27679 | Ndufs5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27680 | Ndufv2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27681 | Nfe2l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27682 | Nlrp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27683 | Nt5c3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27684 | Osbpl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27685 | Pdzrn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27686 | Pggt1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27687 | Pgm2l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27688 | Pinlyp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27689 | Pou3f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27690 | Pou4f1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27691 | Ppp2ca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27692 | Ppp6r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27693 | Prdm13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27694 | Prkaa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27695 | Prss22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27798 | Tmprss15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27799 | Csgalnact1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27800 | Ak9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27801 | Dse Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27802 | Evl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27803 | Hrk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27804 | Lsr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27805 | Nrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27806 | Qki Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27807 | Sry Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27808 | Acp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27809 | Aff4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27810 | Ajm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27811 | Alg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27812 | Alg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27813 | Alpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27814 | Asb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27815 | Aspm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27816 | Avil Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27817 | Bco2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27818 | Bcor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27819 | Blnk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27820 | Bora Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27821 | Bub3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27822 | Cbx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27823 | Ccn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27824 | Ccnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27825 | Ccno Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27826 | Cct8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27827 | Cds2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27828 | Cfc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27829 | Chd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27830 | Chka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27831 | Chp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27832 | Chpf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27833 | Cltc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27834 | Cnbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27835 | Coil Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27836 | Crnn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27837 | Cul1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27838 | Dap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27839 | Dbn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27840 | Def6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27841 | Dera Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27842 | Dlx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27843 | Dok7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27844 | Dpf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27845 | Dpm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27846 | Dpp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27847 | Dpyd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27848 | Dspp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27849 | Dtx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27850 | Ebpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27851 | Eci1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27852 | Elf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27853 | Elf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27854 | Emx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27855 | Etv2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27856 | Etv3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27857 | Etv5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27858 | Ext1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27859 | Fat4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27860 | Fjx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27861 | Flcn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27862 | Fut4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27863 | Fzd9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27864 | Gatb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27865 | Gde1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27866 | Gdf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27867 | Glg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27868 | Gli3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27869 | Gmds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27870 | Gnb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27871 | Gng2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27872 | Gyg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27873 | Hhip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27874 | Idi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27875 | Idi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27876 | Ipmk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27877 | Irs4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27878 | Klf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27879 | Klf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27880 | Lat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27881 | Lcor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27882 | Ldhc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27883 | Lgr6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27884 | Lhx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27885 | Lhx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27886 | Lmo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27887 | Lsm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27888 | Ly6h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27889 | Mael Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27890 | Mcat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27891 | Mcm6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27892 | Mcm7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27893 | Mei1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27894 | Mfng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27895 | Mia2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27896 | Miip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27897 | Msi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27898 | Msx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27899 | Mto1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27900 | Mul1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27901 | Mxi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27902 | Myh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27903 | Myh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27904 | Myl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27905 | Mzf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27906 | Nbea Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27907 | Nek8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27908 | Nek9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27909 | Nfic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27910 | Nfs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27911 | Nkg7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27912 | Nkrf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27913 | Npr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27914 | Nrep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27915 | Nt5c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27916 | Nt5m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27917 | Oit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27918 | Opn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27919 | Pawr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27920 | Pcca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27921 | Pccb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27922 | Pdhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27923 | Pdhx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27924 | Pecr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27925 | Pex2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27926 | Pgm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27927 | Phip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27928 | Pid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27929 | Pin4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27930 | Pon3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27931 | Purb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27932 | Rac3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27933 | Rarb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27934 | Rbl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27935 | Rbm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27936 | Rcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27937 | Rdm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27938 | Rec8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27939 | Rgp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27940 | Rgs3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27941 | Rhog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27942 | Rln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27943 | Rnd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27944 | Rpa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27945 | Rrs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27946 | Rtp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27947 | Sdf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27948 | Sdhc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27949 | Sdhd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27950 | Shc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27951 | Six3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27952 | Six4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27953 | Six5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27954 | Spg7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27955 | Spic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27956 | Stx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27957 | Swi5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27958 | Tbx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27959 | Tfr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27960 | Tgm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27961 | Tle1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27962 | Tle4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27963 | Tmc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27964 | Tmc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27965 | Tns1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27966 | Trdn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27967 | Ttc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27968 | Ttf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27969 | Ucn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27970 | Upp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27971 | Urod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27972 | Usf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27973 | Uxs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27974 | Vill Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27975 | Vrk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27976 | Wnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27977 | Xaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27978 | Xpo7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27979 | Xrn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27980 | Zic1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27981 | Zic5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27982 | Zw10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27983 | Aars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27984 | Abcb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27985 | Abcb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27986 | Abcc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27987 | Abhd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27988 | Acot1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27989 | Actg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27990 | Actr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27991 | Adcy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27992 | Adcy2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27993 | Agmat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27994 | Akap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27995 | Akip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27996 | Alg11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27997 | Ampd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27998 | Apex1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27999 | Aph1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28000 | Apmap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28001 | Arap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28002 | Arid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28003 | Asap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28004 | Ascl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28005 | Atad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28006 | Atg12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28007 | Atp23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28008 | Atxn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28009 | Atxn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28010 | Aunip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28011 | Auts2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28012 | Banf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28013 | Bank1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28014 | Batf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28015 | Bcl9l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28016 | Best3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28017 | Bicc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28018 | C1ql1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28019 | C3ar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28020 | Calcb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28021 | Cald1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28022 | Cand1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28023 | Ccnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28024 | Ccnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28025 | Ccnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28026 | Cd247 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28027 | Cd2ap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28028 | Cdc5l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28029 | Cdca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28030 | Cdh19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28031 | Cdh23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28032 | Cdh24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28033 | Cdhr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28034 | Cdk18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28035 | Cdk20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28036 | Cdkl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28037 | Cebpe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28038 | Cebpg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28039 | Cenpn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28040 | Cenpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28041 | Cep55 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28042 | Cep78 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28043 | Cflar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28044 | Chmp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28045 | Chrm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28046 | Chst9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28047 | Ciart Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28048 | Cideb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28049 | Clcn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28050 | Cldn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28051 | Cldn7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28052 | Cnnm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28053 | Cox14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28054 | Cox6c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28055 | Cpne3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28056 | Cpne5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28057 | Cpsf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28058 | Creb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28059 | Crim1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28060 | Csde1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28061 | Cstf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28062 | Cyth3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28063 | Dars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28064 | Dctn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28065 | Ddx11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28066 | Ddx24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28067 | Ddx3y Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28068 | Ddx60 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28069 | Degs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28070 | Dgcr8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28071 | Dhx30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28072 | Dhx58 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28073 | Disc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28074 | Dmgdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28075 | Dmrt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28076 | Dock7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28077 | Dram1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28078 | Dscam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28079 | Dscc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28080 | Eif3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28081 | Eif3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28082 | Ero1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28083 | Etnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28084 | Extl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28085 | Fads3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28086 | Fanci Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28087 | Fbln2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28088 | Fbxo5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28089 | Fbxo6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28090 | Fbxw2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28091 | Fmnl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28092 | Foxe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28093 | Foxr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28094 | Frmd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28095 | Frmd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28096 | Fut10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28097 | Gcnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28098 | Gdpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28099 | Ggact Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28100 | Glis2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28101 | Glp2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28102 | Gmeb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28103 | Gnai2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28104 | Gpd1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28105 | Gpr21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28106 | Greb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28107 | Gria2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28108 | Gtf2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28109 | Hacd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28110 | Hdhd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28111 | Herc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28112 | Hint1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28113 | Hnf4g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28114 | Hoxb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28115 | Hoxb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28116 | Hoxc8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28117 | Hyls1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28118 | Ifi35 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28119 | Ifrd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28120 | Ikzf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28121 | Itm2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28122 | Itpr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28123 | Jmjd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28124 | Kat14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28125 | Kcmf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28126 | Kcna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28127 | Kcnd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28128 | Kcnh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28129 | Kcnh8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28130 | Kcnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28131 | Kcnk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28132 | Kctd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28133 | Kdm1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28134 | Kif1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28135 | Kif22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28136 | Klf16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28137 | Kmt5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28138 | Kyat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28139 | Lalba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28140 | Lama4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28141 | Lama5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28142 | Lamb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28143 | Lamb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28144 | Larp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28145 | Lars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28146 | Lars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28147 | Limd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28148 | Lmnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28149 | Lmx1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28150 | Loxl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28151 | Lrfn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28152 | Lrp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28153 | Lrtm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28154 | Lsamp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28155 | Ltc4s Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28156 | Magt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28157 | Maml1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28158 | Mark1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28159 | Mast3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28160 | Matn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28161 | Mcfd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28162 | Mex3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28163 | Mgat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28164 | Mgst3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28165 | Micu2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28166 | Mitd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28167 | Mki67 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28168 | Mlycd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28232 | Rab3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28233 | Rab5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28234 | Rab5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28235 | Rab8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28236 | Rad9a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28237 | Rasa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28238 | Rasa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28239 | Rasd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28240 | Rbbp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28241 | Rbbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28242 | Rbm22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28243 | Rbms2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28244 | Rc3h2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28245 | Rcan1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28246 | Rcor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28247 | Rdh10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28248 | Rgs17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28249 | Ribc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28250 | Rims2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28251 | Riok3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28252 | Rnf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28253 | Rnf25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28254 | Rnf32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28255 | Rpl36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28256 | Rplp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28257 | Rps10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28258 | Rps12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28259 | Rps14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28260 | Rps21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28261 | Rraga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28262 | Rragd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28263 | Rrm2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28264 | Rspo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28265 | Rtbdn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28266 | Rwdd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28267 | Sall2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28268 | Sall4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28269 | Sap30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28270 | Sec13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28271 | Sesn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28272 | Sftpc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28273 | Sgpl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28274 | Sin3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28275 | Slit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28276 | Smdt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28277 | Smyd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28278 | Sntg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28279 | Snx20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28280 | Sorl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28281 | Sox11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28282 | Spag5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28283 | Spc25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28284 | Spry1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28285 | Srrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28286 | Srsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28287 | Stag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28288 | Stmn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28289 | Styk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28290 | Sumo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28291 | Susd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28292 | Svep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28293 | Sycp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28294 | Tada1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28295 | Taf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28296 | Tafa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28297 | Tbx19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28298 | Tcfl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28299 | Tctn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28300 | Tfap4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28301 | Tfb1m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28302 | Tfb2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28303 | Thsd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28304 | Tmed2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28305 | Tmed3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28306 | Tmed9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28307 | Top3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28308 | Tpd52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28309 | Tpst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28310 | Trak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28311 | Trat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28312 | Trim8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28313 | Trip6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28314 | Trit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28315 | Trpm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28316 | Ubap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28317 | Ufsp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28318 | Uqcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28319 | Usp48 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28320 | Veph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28321 | Vwc2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28322 | Wdr26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28323 | Wnt5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28324 | Wnt7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28325 | Ypel5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28326 | Zmym2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28327 | Abhd12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28328 | Actl6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28329 | Adgrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28330 | Adgrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28331 | Adgrf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28332 | Adgrf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28333 | Adgrg6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28334 | Agpat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28335 | Agtrap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28336 | Akr1e2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28337 | Ambra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28338 | Atp11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28339 | Atp1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28340 | Atp1b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28341 | Atxn2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28342 | B3gnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28343 | Baiap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28344 | Bcl11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28345 | Brinp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28346 | Camkk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28347 | Camta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28348 | Cartpt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28349 | Cavin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28350 | Cavin3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28351 | Cep112 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28352 | Chaf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28353 | Chmp4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28354 | Clec3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28355 | Col5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28356 | Col5a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28357 | Coro1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28358 | Csnk2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28359 | Ddx19b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28360 | Dhtkd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28361 | Diaph3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28362 | Dnajc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28363 | Dnase2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28364 | Dusp18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28365 | Eef1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28366 | Efemp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28367 | Egflam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28368 | Eif2s1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28369 | Ercc6l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28370 | Exosc9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28371 | Fam20b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28372 | Fbxo11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28373 | Gabra5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28374 | Glcci1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28375 | Glt8d2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28376 | Glyctk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28377 | Gpr141 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28378 | Gpr182 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28379 | Grin2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28380 | Gxylt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28381 | Higd1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28382 | Hnrnpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28383 | Hsf2bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28384 | Hspa4l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28385 | Ifi44l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28386 | Ifitm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28387 | Il20ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28388 | Immp1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28389 | Immp2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28390 | Impact Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28391 | Incenp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28392 | Inpp4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28393 | Inpp5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28394 | Kif21a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28395 | Klhl24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28396 | Large2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28397 | Lmbr1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28398 | Ly6g6f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28399 | Map3k2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28400 | Mettl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28401 | Mettl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28402 | Mfsd2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28403 | Mllt10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28404 | Mrgpre Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28405 | Mrpl11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28406 | Mrpl13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28407 | Mustn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28408 | Nanos1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28409 | Nap1l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28410 | Ndufa5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28411 | Ndufb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28412 | Ndufb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28413 | Ndufc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28414 | Ndufc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28415 | Ndufs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28416 | Nfatc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28417 | Npffr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28418 | Pcdh12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28419 | Pcdh17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28420 | Pdgfrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28421 | Pdlim5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28422 | Pdzd11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28423 | Pgrmc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28424 | Pik3r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28425 | Pitpna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28426 | Polr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28427 | Polr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28428 | Polr1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28429 | Polr2g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28430 | Ppp3r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28431 | Prss27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28432 | Prss57 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28433 | Ptger1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28434 | Rassf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28435 | Rnf128 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28436 | Rnf166 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28437 | Rnf169 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28438 | Rnf186 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28439 | Rnf213 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28440 | Rpl27a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28441 | Samsn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28442 | Scarf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28443 | Sema3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28444 | Sephs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28445 | Setbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28446 | Sh2d1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28447 | Sh3bp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28448 | Sh3gl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28449 | Slc1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28450 | Slc1a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28451 | Slc1a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28452 | Slc4a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28453 | Slc4a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28454 | Slc5a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28455 | Slc5a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28456 | Slc6a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28457 | Slc7a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28458 | Sorbs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28459 | Sowaha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28460 | Sptlc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28461 | Srd5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28462 | Srd5a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28463 | Srebf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28464 | Stard4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28465 | Stoml3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28466 | Strip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28467 | Stxbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28468 | Sucla2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28469 | Syngr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28470 | Tas1r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28471 | Tbxas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28472 | Tcirg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28473 | Tex264 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28474 | Tm9sf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28475 | Trim13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28476 | Trim26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28477 | Trim31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28478 | Trim38 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28479 | Trim44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28480 | Trim56 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28481 | Trip11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28482 | Trip12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28483 | Tsga10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28484 | Ttll12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28485 | Twist2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28486 | U2surp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28487 | Ubap1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28488 | Ube2l6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28489 | Ube2v2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28490 | Ubiad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28491 | Ugt1a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28492 | Unc13d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28493 | Yeats2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28494 | Zbtb12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28495 | Zcchc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28496 | Abhd16b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28497 | Adamts3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28498 | Adipor2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28499 | Aldh3b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28500 | Aldh6a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28501 | Ankrd54 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28502 | Arfgap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28503 | Arhgdib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28504 | Arhgef6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28505 | Arhgef7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28506 | Atp5f1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28507 | Bcl2l12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28508 | Bhlhe23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28509 | Caskin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28510 | Ccdc134 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28511 | Ccdc88a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28512 | Clec11a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28513 | Clec14a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28514 | Clptm1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28515 | Col22a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28516 | Csnk1g1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28517 | Dnajc11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28518 | Dnttip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28519 | Eif2ak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28520 | Fam162a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28521 | Fam177b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28522 | Fastkd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28523 | Glyatl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28524 | Hmgcll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28525 | Il12rb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28526 | Laptm4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28527 | Mapkap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28528 | Mettl13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28529 | Micall2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28530 | Napepld Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28531 | Ndufaf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28532 | Ndufb11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28533 | Pacsin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28534 | Pik3ap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28535 | Plekhg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28536 | Ppp2r1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28537 | Ppp2r3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28538 | Prkar2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28539 | Prkar2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28540 | Rangap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28541 | Rasgrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28542 | Rnpepl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28543 | Rps6ka4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28544 | Rps6ka5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28545 | Serinc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28546 | Slc10a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28547 | Slc12a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28548 | Slc13a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28549 | Slc16a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28550 | Slc18a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28551 | Slc18a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28552 | Slc20a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28553 | Slc22a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28554 | Slc25a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28555 | Slc26a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28556 | Slc29a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28557 | Slc35b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28558 | Slc35e3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28559 | Slc38a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28560 | Slc38a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28561 | Slc39a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28562 | Slc44a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28563 | Smarcd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28564 | Sostdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28565 | St8sia1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28566 | Tax1bp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28567 | Tbc1d16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28568 | Tmem158 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28569 | Tsc22d3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28570 | Ubash3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28571 | Unc93b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28572 | Xpnpep3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28573 | Zc3hav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28574 | Zdhhc19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28575 | Arhgap30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28576 | Arhgap42 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28577 | Arhgef40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28578 | Cacna2d3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28579 | Cacna2d4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28580 | Crispld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28581 | Ctnnbip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28582 | Hsd17b14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28583 | Mapk8ip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28584 | Naaladl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28585 | Pafah1b3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28586 | Rap1gap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28587 | Serpinb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28588 | Sh3pxd2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28589 | Slc22a13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28590 | Slc25a13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28591 | Slc25a25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28592 | Slc25a29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28593 | Slc25a37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28594 | Slc25a39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28595 | Stambpl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28596 | Tp53inp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28597 | Traf3ip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28598 | C1galt1c1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28599 | Kiaa0319l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28600 | Ak6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28601 | Mkx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28602 | Mpz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28603 | Nyx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28604 | Scx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28605 | Txk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28606 | Wiz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28607 | Wls Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28608 | Xpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28609 | Yy2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28610 | A1cf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28611 | Aacs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28612 | Aard Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28613 | Aatk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28614 | Acp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28615 | Acp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28616 | Aff3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28617 | Agmo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28618 | Agps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28619 | Ahsp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28620 | Aig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28621 | Akna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28622 | Alg6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28623 | Alpg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28624 | Ano2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28625 | Apeh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28626 | Aplf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28627 | Arf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28628 | Asb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28629 | Asip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28630 | Atf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28631 | Bag5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28632 | Bcl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28633 | Brox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28634 | Cbr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28635 | Cct4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28636 | Cds1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28637 | Chat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28638 | Chdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28639 | Chgb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28640 | Chkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28641 | Chn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28642 | Cilp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28643 | Cln3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28644 | Cln5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28645 | Cln6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28646 | Clpb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28647 | Clpx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28648 | Cmas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28649 | Cnn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28650 | Cnn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28651 | Coq3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28652 | Coq5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28653 | Ctr9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28654 | Ctsf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28655 | Cttn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28656 | Ddx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28657 | Dgki Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28658 | Dio3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28659 | Dlg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28660 | Dlx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28661 | Dlx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28662 | Dmtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28663 | Dnm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28664 | Dnm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28665 | Dok3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28666 | Dolk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28667 | Dpf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28668 | Dpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28669 | Drp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28670 | E2f8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28671 | Ect2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28672 | Edc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28673 | Edn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28674 | Ehd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28675 | Ehd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28676 | Ei24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28677 | Elk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28678 | Elp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28679 | Emc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28680 | Emc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28681 | Enc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28682 | Eny2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28683 | Epg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28684 | Epn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28685 | Etfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28686 | Etv4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28687 | Eya1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28688 | Fan1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28689 | Far2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28690 | Fbn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28691 | Fgd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28692 | Fig4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28693 | Fmo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28694 | Fmo5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28695 | Fnta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28696 | Frs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28697 | Fut9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28698 | Fzr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28699 | Gab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28700 | Gas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28701 | Gbf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28702 | Gbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28703 | Gbp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28704 | Gfm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28705 | Gjb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28706 | Gjb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28707 | Gjc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28708 | Gldn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28709 | Glrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28710 | Gnaq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28711 | Gnb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28712 | Gnb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28713 | Gng3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28714 | Gnl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28715 | Gpx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28716 | Gpx8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28717 | Guf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28718 | Hax1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28719 | Hccs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28720 | Hcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28721 | Hes7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28722 | Heyl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28723 | Hmx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28724 | Hpdl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28725 | Hpf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28726 | Hscb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28727 | Ier5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28728 | IGHM Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28729 | Il25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28730 | Inmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28731 | Ipo9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28732 | Ippk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28733 | Iqub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28734 | Iws1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28735 | Kif7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28736 | Knl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28737 | Krt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28738 | Leo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28739 | Lfng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28740 | Lgi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28741 | Lgi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28742 | Lig3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28743 | Lipg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28744 | Lipk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28745 | Lmo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28746 | Lrba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28747 | Lst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28748 | Ltn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28749 | Lyg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28750 | Mbd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28751 | Mbd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28752 | Mcm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28753 | Mcm8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28754 | Mcm9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28755 | Mfrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28756 | Mib1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28757 | Miox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28758 | Misp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28759 | Mlf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28760 | Mmab Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28761 | Mpnd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28762 | Mrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28763 | Msh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28764 | Msi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28765 | Mtf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28766 | Mtx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28767 | Mxd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28768 | Myf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28769 | Myl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28770 | Narf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28771 | Nefh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28772 | Neo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28773 | Neu2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28774 | Neu3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28775 | Nexn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28776 | Nfix Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28777 | Nfyb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28778 | Nid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28779 | Nit2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28780 | Nkap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28781 | Nktr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28782 | Nmd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28783 | Nme5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28784 | Noa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28785 | Noct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28786 | Nol4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28787 | Nxf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28788 | Ocln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28789 | Oxsm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28790 | Pax1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28791 | Pax2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28792 | Pax9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28793 | Pbx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28794 | Pbx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28795 | Pclo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28796 | Pcp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28797 | Pdyn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28798 | Pex3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28799 | Pfn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28800 | Pgls Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28801 | Phkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28802 | Pigq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28803 | Pisd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28804 | Pllp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28805 | Pmch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28806 | Pnoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28807 | Pogz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28808 | Polh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28809 | Preb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28810 | Prnd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28811 | Prr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28812 | Ptms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28813 | Ptx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28814 | Pum2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28815 | Pus3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28816 | Pygb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28817 | Rarg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28818 | Rbm7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28819 | Rbmx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28820 | Rfc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28821 | Rfc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28822 | Rfx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28823 | Rfx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28824 | Rfx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28825 | Rgcc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28826 | Rhag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28827 | Rhod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28828 | Rlim Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28829 | Rnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28830 | Rpl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28831 | Rpl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28832 | Rprm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28833 | Rps5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28834 | Rpsa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28835 | Rras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28836 | Rsu1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28837 | Rtf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28838 | Rtn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28839 | Sbsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28840 | Scel Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28841 | Scg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28842 | Setx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28843 | Sfpq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28844 | Sgcz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28845 | Shc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28846 | Sit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28847 | Six6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28848 | Ska1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28849 | Slu7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28850 | Smn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28851 | Smtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28852 | Sox3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28853 | Spib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28854 | Sra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28855 | Srms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28856 | Strn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28857 | Sun1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28858 | Suox Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28859 | Syn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28860 | Syt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28861 | Tbx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28862 | Tbx6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28863 | Tcap Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28864 | Tecr Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28865 | Tgm1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28866 | Tjp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28867 | Tln1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28868 | Tmie Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28869 | Tmx3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28870 | Tns4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28871 | Tox3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28872 | Trir Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28873 | Ubl5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28874 | Ubn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28875 | Utf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28876 | Vav2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28877 | Vmo1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28878 | Vmp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28879 | Vrk3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28880 | Wbp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28881 | Wdr4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28882 | Wnt6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28883 | Wwc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28884 | Wwc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28885 | XIST Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28886 | Zer1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28887 | Zup1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28888 | Abcc9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28889 | Abcd3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28890 | Abcd4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28891 | Abcf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28892 | Acad9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28893 | Acbd6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28894 | Ackr4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28895 | Acot2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28896 | Acot7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28897 | Acsf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28898 | Acsf3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28899 | Acta1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28900 | Actr6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28901 | Adam2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28902 | Adat1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28903 | Adcy5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28904 | Aebp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28905 | Agfg1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28906 | Aipl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28907 | Akap6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28908 | Alg12 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28909 | Alg13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28910 | Alg14 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28911 | Alms1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28912 | Alpk2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28913 | Ap1s2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28914 | Ap2m1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28915 | Apba2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28916 | Aph1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28917 | Aplp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28918 | Arcn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28919 | Arl4c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28920 | Arl8b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28921 | Armh1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28922 | Atg4d Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28923 | Atg9a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28924 | Atg9b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28925 | Atrip Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28926 | Axin1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28927 | Barx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28928 | Baz1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28929 | Bcas1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28930 | Bend5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28931 | Bmp8a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28932 | Brms1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28933 | Bud31 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28934 | C1ql3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28935 | Cabp5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28936 | Capn8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28937 | Cars2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28938 | Casz1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28939 | Cbln4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28940 | Ccar1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28941 | Ccbe1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28942 | Ccdc9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28943 | Ccne2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28944 | Ccpg1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28945 | Cct6a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28946 | Cdc23 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28947 | Cdc34 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28948 | Cdca8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28949 | Cdipt Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28950 | Cdkl4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28951 | Cdr2l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28952 | Celf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28953 | Celf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28954 | Celf4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28955 | Cenpm Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28956 | Cenpx Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28957 | Cep76 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28958 | Cers2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28959 | Chadl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28960 | Chid1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28961 | Chrm4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28962 | Chrnd Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28963 | Chst7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28964 | Chtop Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28965 | Clcn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28966 | Clcn6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28967 | Cldn5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28968 | Cldn8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28969 | Clip4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28970 | Cmya5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28971 | Cnga2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28972 | Cnga3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28973 | Cnot1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28974 | Cnot7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28975 | Cox7c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28976 | Cox8a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28977 | Cpeb2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28978 | Cplx1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28979 | Cpne4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28980 | Crocc Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28981 | Crtap Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28982 | Crtc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28983 | Cul4a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28984 | Cul4b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28985 | Cwc15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28986 | Cxxc4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28987 | Cyren Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28988 | Dcaf4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28989 | Dctn4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28990 | Ddx42 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28991 | Dhx29 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28992 | Dmac1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28993 | Dmrt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28994 | Dmrt3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28995 | Dnah9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28996 | Dstyk Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28997 | Duox1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28998 | Dusp8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28999 | Dusp9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29000 | Ears2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29001 | Edem1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29002 | Edem3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29003 | Efhd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29004 | Eif3h Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29005 | Eif5b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29006 | Elfn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29007 | Elfn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29008 | Elmo1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29009 | Endou Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29010 | Enpp5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29011 | Epb41 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29012 | Eps15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29013 | Eral1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29014 | Ercc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29015 | Ercc8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29016 | Esyt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29017 | Esyt2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29018 | Etaa1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29019 | Eva1a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29020 | Exoc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29021 | Exph5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29022 | Fam3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29023 | Fbln5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29024 | Fbxl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29025 | Fbxo7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29026 | Fcrl2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29027 | Fem1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29028 | Fhod3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29029 | Fibin Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29030 | Fkbp9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29031 | Fmnl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29032 | Fndc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29033 | Foxb1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29034 | Foxc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29035 | Foxn3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29036 | Foxo6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29037 | Foxp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29038 | Fstl4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29039 | Ftsj3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29040 | Fubp3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29041 | Fut11 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29042 | Fxyd5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29043 | Fxyd7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29044 | Galr3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29045 | Ghitm Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29046 | Gins2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29047 | Gipc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29048 | Glra1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29049 | Glrx5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29050 | Glyr1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29051 | Gmpr2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29052 | Gna15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29053 | Gnai1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29054 | Gng11 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29055 | Gpm6a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29056 | Gpr45 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29057 | Gpr63 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29058 | Gpsm2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29059 | Grb10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29060 | Grik1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29061 | Grsf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29062 | Gstm4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29063 | Gstt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29064 | Habp4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29065 | Hacd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29066 | Hace1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29067 | Hacl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29068 | Hddc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29069 | Hecw1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29070 | Hemk1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29071 | Herc4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29072 | Hhatl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29073 | Hinfp Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29074 | Hint2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29075 | Hmcn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29076 | Hoga1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29077 | Hoxa2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29078 | Hoxa3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29079 | Hoxb5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29080 | Hoxb6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29081 | Hoxb8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29082 | Hoxc6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29083 | Htra4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29084 | Hvcn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29085 | Iars2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29086 | Idh3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29087 | Idh3g Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29088 | Ifi44 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29089 | Ifrd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29090 | Igll1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29091 | Il21r Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29092 | Ilvbl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29093 | Insm2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29094 | Iqcb1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29095 | Itgad Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29096 | Itih4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29097 | Itm2a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29098 | Itpkc Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29099 | Josd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29100 | Kat6b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29101 | Kcna3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29102 | Kcnc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29103 | Kcne5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29104 | Kcnj3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29105 | Kcnj8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29106 | Kcns1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29107 | Kcnt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29108 | Kcnt2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29109 | Kctd4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29110 | Kctd9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29111 | Kif2b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29112 | Kif3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29113 | Kif3b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29114 | Kif3c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29115 | Kif5c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29116 | Klf13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29117 | Klf14 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29118 | Kpna1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29119 | Krt81 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29120 | Lamc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29121 | Lasp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29122 | Lemd3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29123 | Limd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29124 | Lin37 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29125 | Lipt2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29126 | Llgl2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29127 | Lman1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29128 | Lpin2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29129 | Lrfn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29130 | Lrfn4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29131 | Lrig3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29132 | Lrit3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29133 | Lrp1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29134 | Luzp4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29135 | Lzts1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29136 | Macf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29137 | Magi2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29138 | Maml2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29139 | Maml3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29140 | Mast1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29141 | Mast4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29142 | Mbnl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29143 | Mccc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29144 | Mcf2l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29145 | Mcur1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29146 | Med19 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29147 | Medag Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29148 | Megf6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29149 | Megf9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29150 | Meis2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29151 | Mex3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29152 | Mfsd9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29153 | Mgst2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29154 | Mipep Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29155 | Mixl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29156 | Mkrn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29157 | Mlst8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29158 | Mmp15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29159 | Mmp16 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29160 | Mms19 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29161 | Morc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29162 | Mov10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29163 | Mrap2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29164 | Mrpl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29165 | Ms4a8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29166 | Mtch1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29167 | Mtcl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29168 | Mtmr4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29169 | Mtus1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29170 | Muc13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29171 | Mus81 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29172 | Mutyh Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29173 | Myadm Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29174 | Myh10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29175 | Mylk3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29176 | Mylk4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29177 | Myo3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29178 | Myo3b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29179 | Myo9b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29180 | Myoz2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29181 | Nabp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29182 | Nagpa Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29183 | Naprt Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29184 | Nars1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29185 | Nat8l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29186 | Ncoa1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29187 | Ndrg3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29188 | Ndrg4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29189 | Ndst4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29190 | Neil3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29191 | Nfrkb Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29192 | Nim1k Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29193 | Nlgn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29194 | Nmrk1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29195 | Nop14 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29196 | Nop56 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29197 | Npas1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29198 | Nr1h3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29199 | Nr1i2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29200 | Nr2c1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29201 | Nr2c2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29202 | Nr6a1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29203 | Nrbf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29204 | Nrip1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29205 | Nsmaf Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29206 | Nsun4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29207 | Nsun5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29208 | Nsun6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29209 | Nudt8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29210 | Numbl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29211 | Nup42 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29212 | Nup88 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29213 | Nyap1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29214 | Ogdhl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29215 | Or2k2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29216 | Orai2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29217 | Otogl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29218 | Ovch2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29219 | Ovol2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29220 | Oxgr1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29221 | Palmd Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29222 | Pank3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29223 | Pars2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29224 | Pcgf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29225 | Pcsk6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29226 | Pde6d Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29227 | Pdia2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29228 | Pdss1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29229 | Pdss2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29230 | Pdzd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29231 | Pdzd4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29232 | Pdzd7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29233 | Peli2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29234 | Pfdn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29235 | Pgbd5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29236 | Phf12 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29237 | Phf19 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29238 | Phf23 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29239 | Phf24 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29240 | Phka1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29241 | Phkg2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29242 | Phrf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29243 | Pias2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29244 | Pitx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29245 | Plcb2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29246 | Plek2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29247 | Plvap Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29248 | Pole2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29249 | Polg2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29250 | Ppm1f Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29251 | Ppm1h Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29252 | Ppm1j Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29253 | Ppp4c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29254 | Pprc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29255 | Prdm8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29256 | Prorp Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29257 | Prrx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29258 | Psip1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29259 | Psmb1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29260 | Psmb7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29261 | Psmc5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29262 | Psmd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29263 | Psmd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29264 | Psmd3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29265 | Ptch2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29266 | Ptcra Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29267 | Ptprq Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29268 | Ptprr Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29269 | Puf60 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29270 | Pxmp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29271 | Qrsl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29272 | Rab1a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29273 | Rab21 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29274 | Rab28 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29275 | Rab34 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29276 | Rab35 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29277 | Rab42 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29278 | Rab8a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29279 | Rabl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29280 | Rap1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29281 | Rasa1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29282 | Rbm10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29283 | Rbm25 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29284 | Rbm33 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29285 | Rbm34 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29286 | Rbms3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29287 | Rcor2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29288 | Rell2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29289 | Rgs10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29290 | Rgs22 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29291 | Rmdn3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29292 | Rnf13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29293 | Rnft2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29294 | Rpe65 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29295 | Rpl12 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29296 | Rpl18 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29297 | Rpl24 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29298 | Rpl26 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29299 | Rpl37 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29300 | Rpl38 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29301 | Rps15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29302 | Rps18 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29303 | Rras2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29304 | Rrp7a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29305 | Rsrc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29306 | Samd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29307 | Samd5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29308 | Samd9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29309 | Sardh Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29310 | Scml4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29311 | Scn1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29312 | Scrg1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29313 | Sel1l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29314 | Serf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29315 | Sf3a2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29316 | Sftpb Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29317 | Sgpp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29318 | Sh2b3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29319 | Siah1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29320 | Skap1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29321 | Skap2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29322 | Slfn5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29442 | Nsun2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29442A | Nsun2 Mouse Pre-designed siRNA Set A-2 | Oligonucleotides | |
| HY-RS29443 | Tmtc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29445 | Ndufaf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29446 | ATP6V1A Monkey Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29447 | Plin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29447A | Plin4 Mouse Pre-designed siRNA Set A-2 | Oligonucleotides | |
| HY-RS29450 | Rab17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29451 | Actg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29452 | Plekhn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29453 | Ctnna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29454 | UBE2E1 Pig Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29455 | UBE2E2 Pig Pre-designed siRNA Set A | Oligonucleotides | |
| HY-T1000 | Fetal Bovine Serum (Superfine), Uruguay | Kits | |
| HY-U00001 | Phenglutarimid | 1156-05-4 | Reference compound |
| HY-U00001A | Phenglutarimid (hydrochloride) | 1674-96-0 | Reference compound |
| HY-U00001AR | Phenglutarimid (hydrochloride) (Standard) | 1674-96-0 | Reference Standards |
| HY-U00002 | ZD-4190 | 413599-62-9 | Reference compound |
| HY-U00002A | ZD-4190 (hydrochloride) | 257938-36-6 | Reference compound |
| HY-U00003 | ICAM-1-IN-1 | 251994-14-6 | Reference compound |
| HY-U00004 | OSIP-486823 | 200803-37-8 | Reference compound |
| HY-U00005 | AD 0261 | 145600-69-7 | Reference compound |
| HY-U00006 | Duoperone | 62030-88-0 | Reference compound |
| HY-U00007 | Stilbamidine | 122-06-5 | Reference compound |
| HY-U00007A | Stilbamidine (dihydrochloride) | 6935-63-3 | Reference compound |
| HY-U00008 | CP-28888 | 69938-75-6 | Reference compound |
| HY-U00010 | Dazopride | 70181-03-2 | Reference compound |
| HY-U00011 | Temarotene | 75078-91-0 | Reference compound |
| HY-U00012 | Glyhexamide | 451-71-8 | Reference compound |
| HY-U00013 | Nitroflurbiprofen | 158836-71-6 | Reference compound |
| HY-U00014 | AVE-8134 | 304025-09-0 | Reference compound |
| HY-U00015 | MAO-IN-1 | 124991-40-8 | Reference compound |
| HY-U00016 | Teoprolol | 65184-10-3 | Reference compound |
| HY-U00017 | Coumetarol | 4366-18-1 | Reference compound |
| HY-U00018 | (±)-Tazifylline | 79712-55-3 | Reference compound |
| HY-U00019 | Pamatolol | 59110-35-9 | Reference compound |
| HY-U00020 | AU-224 | 287399-47-7 | Reference compound |
| HY-U00021 | Clothixamide | 4177-58-6 | Reference compound |
| HY-U00022 | RWJ 63556 | 190967-35-2 | Reference compound |
| HY-U00023 | NCX 1000 | 401519-96-8 | Natural Products |
| HY-U00024 | Enazadrem | 107361-33-1 | Reference compound |
| HY-U00024A | Enazadrem (phosphate) | 132956-22-0 | Reference compound |
| HY-U00025 | FR 58664 | 117321-77-4 | Reference compound |
| HY-U00026 | Semotiadil (recemate fumarate) | 123388-25-0 | Reference compound |
| HY-U00027 | Quinotolast sodium | 101193-62-8 | Reference compound |
| HY-U00028 | T 82 | 252264-92-9 | Reference compound |
| HY-U00030 | Rispenzepine | 96449-05-7 | Reference compound |
| HY-U00031 | Axomadol | 187219-99-4 | Reference compound |
| HY-U00031A | Axomadol (hydrochloride) | 187219-95-0 | Reference compound |
| HY-U00033 | Iomazenil | 127985-21-1 | Reference compound |
| HY-U00034 | PCA50941 | 136941-85-0 | Reference compound |
| HY-U00035 | MGB-BP-3 | 1000277-08-6 | Reference compound |
| HY-U00035R | MGB-BP-3 (Standard) | 1000277-08-6 | Reference Standards |
| HY-U00036 | Naveglitazar (racemate) | 916085-47-7 | Reference compound |
| HY-U00036A | Naveglitazar | 476436-68-7 | Reference compound |
| HY-U00037 | Ecopladib | 381683-92-7 | Reference compound |
| HY-U00038 | ENS-163 phosphate | 117707-51-4 | Reference compound |
| HY-U00039 | Desethyl KBT-3022 | 101001-72-3 | Reference compound |
| HY-U00040 | PAF-AN-1 | 115621-84-6 | Reference compound |
| HY-U00041 | Pivalopril | 81045-50-3 | Reference compound |
| HY-U00042 | SKF96067 | 115607-61-9 | Reference compound |
| HY-U00043 | Triamcinolone Benetonide | 31002-79-6 | Reference compound |
| HY-U00044 | Anipamil | 83200-10-6 | Reference compound |
| HY-U00045 | Epsiprantel | 98123-83-2 | Reference compound |
| HY-U00046 | Apyramide | 68483-33-0 | Reference compound |
| HY-U00048 | Bucolome | 841-73-6 | Reference compound |
| HY-U00049 | Mioflazine | 79467-23-5 | Reference compound |
| HY-U00049A | Mioflazine (di(hydrochloride) hydrate) | 79467-24-6 | Reference compound |
| HY-U00049B | Mioflazine di(hydrochloride) | 83898-67-3 | Reference compound |
| HY-U00050 | (E)-10-Hydroxynortriptyline | 47132-16-1 | Reference compound |
| HY-U00050S | (E)-10-Hydroxynortriptyline-d3 | Isotope-Labeled Compounds | |
| HY-U00051 | Propiomazine | 362-29-8 | Reference compound |
| HY-U00051A | Propiomazine (hydrochloride) | 1240-15-9 | Reference compound |
| HY-U00051AS | Propiomazine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-U00051AS1 | (R)-Propiomazine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-U00051AS2 | (S)-Propiomazine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-U00052 | Silandrone | 5055-42-5 | Reference compound |
| HY-U00054 | LDL-IN-3 | 180908-67-2 | Reference compound |
| HY-U00055 | Temiverine hydrochloride | 136529-33-4 | Reference compound |
| HY-U00056 | Devapamil | 92302-55-1 | Reference compound |
| HY-U00057 | Buthalital | 468-65-5 | Reference compound |
| HY-U00058 | Diflucortolone valerate | 59198-70-8 | Reference compound |
| HY-U00058R | Diflucortolone valerate (Standard) | 59198-70-8 | Reference Standards |
| HY-U00059 | Pyrrole-derivative1 | 474006-30-9 | Reference compound |
| HY-U00062 | Tarazepide | 141374-81-4 | Reference compound |
| HY-U00063 | Tiopinac | 61220-69-7 | Reference compound |
| HY-U00064 | AZD2098 | 566203-88-1 | Reference compound |
| HY-U00065 | Tritoqualine | 14504-73-5 | Reference compound |
| HY-U00066 | Cicloprolol (hydrochloride) | 63686-79-3 | Reference compound |
| HY-U00067 | Ambutonium bromide | 115-51-5 | Reference compound |
| HY-U00068 | PPARα-MO-1 | 810677-36-2 | Reference compound |
| HY-U00070 | Dirlotapide | 481658-94-0 | Reference compound |
| HY-U00071 | Dobupride | 106707-51-1 | Reference compound |
| HY-U00072 | RS-601 | 207987-59-5 | Reference compound |
| HY-U00073 | Benin | 22181-94-8 | Reference compound |
| HY-U00074 | Rentiapril (racemate) | 72679-47-1 | Reference compound |
| HY-U00075 | Indanazoline | 40507-78-6 | Reference compound |
| HY-U00076 | MK-0249 | 862309-06-6 | Reference compound |
| HY-U00077 | Org-10490 | 83507-02-2 | Reference compound |
| HY-U00078 | Ro 22-3245 | 76988-39-1 | Reference compound |
| HY-U00079A | Vamicamide | 132373-81-0 | Reference compound |
| HY-U00079B | (S)-Vamicamide | 151851-72-8 | Reference compound |
| HY-U00080 | Amantanium bromide | 58158-77-3 | Reference compound |
| HY-U00081 | Pyrrolifene | 15686-97-2 | Reference compound |
| HY-U00082 | Tigloidin | 495-83-0 | Natural Products |
| HY-U00083 | Flosulide | 80937-31-1 | Reference compound |
| HY-U00084 | SUN 1334H | 607736-84-5 | Reference compound |
| HY-U00085 | Itameline | 145071-44-9 | Reference compound |
| HY-U00086 | Darodipine | 72803-02-2 | Reference compound |
| HY-U00087 | Tosylchloramide sodium trihydrate | 7080-50-4 | Reference compound |
| HY-U00088 | 3β,7β,17β-Trihydroxyandrost-5-ene | 2697-85-0 | Reference compound |
| HY-U00089 | Hydrocortisone cypionate | 508-99-6 | Reference compound |
| HY-U00090 | N-Methylmoranoline | 69567-10-8 | Reference compound |
| HY-U00091 | Gestonorone Capronate | 1253-28-7 | Reference compound |
| HY-U00092 | BAY-Y 3118 | 151213-16-0 | Reference compound |
| HY-U00092B | (R,R)-BAY-Y 3118 | 151213-22-8 | Reference compound |
| HY-U00094 | INO5042 | 14782-19-5 | Reference compound |
| HY-U00095 | Hepsulfam | 96892-57-8 | Reference compound |
| HY-U00096 | Ansofaxine hydrochloride | 916918-84-8 | Reference compound |
| HY-U00096A | Ansofaxine | 916918-80-4 | Reference compound |
| HY-U00097 | L-4-Oxalysine (hydrochloride) | 118021-35-5 | Reference compound |
| HY-U00098 | Prednisolone Tebutate | 7681-14-3 | Reference compound |
| HY-U00098R | Prednisolone Tebutate (Standard) | 7681-14-3 | Reference Standards |
| HY-U00100 | Parcetasal | 87549-36-8 | Reference compound |
| HY-U00101 | Octazamide | 56391-55-0 | Reference compound |
| HY-U00102 | Suclofenide | 30279-49-3 | Reference compound |
| HY-U00103 | Triamcinolone hexacetonide | 5611-51-8 | Reference compound |
| HY-U00103R | Triamcinolone hexacetonide (Standard) | 5611-51-8 | Reference Standards |
| HY-U00104 | YM-46303 | 171722-81-9 | Reference compound |
| HY-U00105 | Oxitropium (Bromide) | 30286-75-0 | Reference compound |
| HY-U00106 | Cimetropium (Bromide) | 51598-60-8 | Reference compound |
| HY-U00109 | Piridocaine (hydrochloride) | 6099-95-2 | Reference compound |
| HY-U00110 | MG 1 | 148274-76-4 | Reference compound |
| HY-U00111 | Timobesone | 87116-72-1 | Reference compound |
| HY-U00112 | Estradiol 3-sulfamate | 172377-52-5 | Reference compound |
| HY-U00113 | Bunaftide | 32421-46-8 | Reference compound |
| HY-U00114 | ZSET-845 | 324077-62-5 | Reference compound |
| HY-U00116 | GP531 | 142344-87-4 | Reference compound |
| HY-U00117 | Lusaperidone | 214548-46-6 | Reference compound |
| HY-U00118 | EF-5 | 152721-37-4 | Reference compound |
| HY-U00119 | Nuvenzepine | 96487-37-5 | Reference compound |
| HY-U00120 | Picloxydine | 5636-92-0 | Reference compound |
| HY-U00121 | Lintopride | 107429-63-0 | Reference compound |
| HY-U00121A | Lintopride (hydrochloride) | 268548-31-8 | Reference compound |
| HY-U00122 | Antiulcer Agent 1 | 76001-09-7 | Reference compound |
| HY-U00123 | Guanoxabenz | 24047-25-4 | Reference compound |
| HY-U00123A | Guanoxabenz (hydrochloride) | 23256-40-8 | Reference compound |
| HY-U00124 | Tromantadine | 53783-83-8 | Reference compound |
| HY-U00124B | Tromantadine (hydrochloride) | 41544-24-5 | Reference compound |
| HY-U00125 | CGP-53153 | 149281-19-6 | Reference compound |
| HY-U00126 | 5HT6-ligand-1 | 1038988-11-2 | Reference compound |
| HY-U00127 | Pyridazinediones-derivative-1 | 147493-44-5 | Reference compound |
| HY-U00128 | PPA-904 | 30189-85-6 | Reference compound |
| HY-U00129 | SC57666 | 158959-32-1 | Reference compound |
| HY-U00130 | 1-Acetyl-3-o-toluyl-5-fluorouracil | 71861-76-2 | Reference compound |
| HY-U00131 | Sulfabrom | 116-45-0 | Reference compound |
| HY-U00131S | Sulfabrom-d4 | 2374858-36-1 | Isotope-Labeled Compounds |
| HY-U00132 | Embramine | 3565-72-8 | Reference compound |
| HY-U00132A | Embramine (hydrochloride) | 13977-28-1 | Reference compound |
| HY-U00133 | HSR6071 | 111374-21-1 | Reference compound |
| HY-U00134 | Benzcyclane | 2179-37-5 | Reference compound |
| HY-U00135 | Calcium channel-modulator-1 | 136941-70-3 | Reference compound |
| HY-U00136 | Win-62005 | 152633-54-0 | Reference compound |
| HY-U00137 | YS-201 | 108852-42-2 | Reference compound |
| HY-U00139 | Cyclodrine (hydrochloride) | 78853-39-1 | Reference compound |
| HY-U00141 | ABTL-0812 | 57818-44-7 | Natural Products |
| HY-U00142 | A-802715 | 107767-58-8 | Reference compound |
| HY-U00143 | N-0861 (racemate) | 121241-87-0 | Reference compound |
| HY-U00145 | Digeranyl bisphosphonate | 878143-03-4 | Reference compound |
| HY-U00146 | FR-188582 | 189699-82-9 | Reference compound |
| HY-U00147 | Nicotinoyl cyclandelate | 39537-99-0 | Reference compound |
| HY-U00148 | KY-556 | 110816-78-9 | Reference compound |
| HY-U00149 | Drobuline (hydrochloride) | 68162-52-7 | Reference compound |
| HY-U00151 | Dopropidil | 79700-61-1 | Reference compound |
| HY-U00151A | Dopropidil (hydrochloride) | 117241-47-1 | Reference compound |
| HY-U00152 | Aminochlorthenoxazin | 3567-76-8 | Reference compound |
| HY-U00153 | Dixyrazine | 2470-73-7 | Reference compound |
| HY-U00153R | Dixyrazine (Standard) | 2470-73-7 | Reference Standards |
| HY-U00154 | Cefuracetime | 39685-31-9 | Reference compound |
| HY-U00154R | Cefuracetime (Standard) | 39685-31-9 | Reference Standards |
| HY-U00155 | NCI172112 | 56605-16-4 | Reference compound |
| HY-U00156 | Lonapalene | 91431-42-4 | Reference compound |
| HY-U00157 | Meseclazone | 29053-27-8 | Reference compound |
| HY-U00159 | McN3716 | 69207-52-9 | Reference compound |
| HY-U00160 | SP187 | 615253-61-7 | Reference compound |
| HY-U00161 | Betamethasone 17-benzoate | 22298-29-9 | Reference compound |
| HY-U00162 | SZ1676 | 159325-23-2 | Reference compound |
| HY-U00165 | Midaglizole (hydrochloride) | 79689-25-1 | Reference compound |
| HY-U00168 | KP136 | 76239-32-2 | Reference compound |
| HY-U00169 | Prednisolone farnesylate | 118244-44-3 | Reference compound |
| HY-U00170 | Bunaprolast | 99107-52-5 | Reference compound |
| HY-U00171 | SQ28603 | 100845-83-8 | Reference compound |
| HY-U00172 | Ipramidil | 83656-38-6 | Reference compound |
| HY-U00173 | U89232 | 134017-78-0 | Reference compound |
| HY-U00175 | Pamicogrel | 101001-34-7 | Reference compound |
| HY-U00176 | Org30958 | 99957-90-1 | Reference compound |
| HY-U00177 | GDP366 | 501698-03-9 | Reference compound |
| HY-U00178 | Idoxifene | 116057-75-1 | Reference compound |
| HY-U00179 | CDC801 | 192819-27-5 | Reference compound |
| HY-U00180 | KF21213 | 155271-17-3 | Reference compound |
| HY-U00181 | Fludazonium chloride | 53597-28-7 | Reference compound |
| HY-U00182 | DU717 | 59943-31-6 | Reference compound |
| HY-U00183 | Epanolol | 86880-51-5 | Reference compound |
| HY-U00184 | Timepidium bromide | 35035-05-3 | Reference compound |
| HY-U00185 | A-437203 | 220519-06-2 | Reference compound |
| HY-U00186 | K134 | 189362-06-9 | Reference compound |
| HY-U00187 | NCX1022 | 571186-50-0 | Reference compound |
| HY-U00188 | A81988 | 141887-34-5 | Reference compound |
| HY-U00189 | Sch412348 | 377727-26-9 | Reference compound |
| HY-U00190 | Deprodone propionate | 20424-00-4 | Reference compound |
| HY-U00191 | GP2-114 | 130783-39-0 | Reference compound |
| HY-U00192 | CGP11952 | 64078-09-7 | Reference compound |
| HY-U00193 | Ro18-5362 | 101387-97-7 | Reference compound |
| HY-U00194 | Vebufloxacin | 79644-90-9 | Reference compound |
| HY-U00195 | Piperylone | 2531-04-6 | Reference compound |
| HY-U00197 | Tilmacoxib | 180200-68-4 | Reference compound |
| HY-U00198 | Topterone | 60607-35-4 | Reference compound |
| HY-U00199 | Norzopiclone | 59878-63-6 | Reference compound |
| HY-U00199A | (S)-Norzopiclone | 151776-26-0 | Reference compound |
| HY-U00199S | N-Desmethyl zopiclone-d8 | 1189805-43-3 | Isotope-Labeled Compounds |
| HY-U00200 | Dicirenone | 41020-79-5 | Reference compound |
| HY-U00201 | KRN4884 | 152802-84-1 | Reference compound |
| HY-U00202 | LY285434 | 159748-08-0 | Reference compound |
| HY-U00203 | Tematropium | 113932-41-5 | Reference compound |
| HY-U00204 | Nisobamate | 25269-04-9 | Reference compound |
| HY-U00205 | Dopexamine hydrochloride | 86484-91-5 | Reference compound |
| HY-U00206 | D2343 | 72734-63-5 | Reference compound |
| HY-U00207 | MEN11467 | 214487-46-4 | Reference compound |
| HY-U00208 | Prinoxodan | 111786-07-3 | Reference compound |
| HY-U00209 | Benzofurodil | 3447-95-8 | Reference compound |
| HY-U00210 | D18024 | 110406-33-2 | Reference compound |
| HY-U00211 | CS476 | 41177-35-9 | Reference compound |
| HY-U00212 | Aranidipine | 86780-90-7 | Reference compound |
| HY-U00212R | Aranidipine (Standard) | 86780-90-7 | Reference Standards |
| HY-U00213 | Furaprofen | 67700-30-5 | Reference compound |
| HY-U00214 | Ibafloxacine | 91618-36-9 | Reference compound |
| HY-U00215 | Ro 41-3290 | 143943-72-0 | Reference compound |
| HY-U00216 | NNC45-0781 | 207277-66-5 | Reference compound |
| HY-U00217 | AZD 4407 | 166882-70-8 | Reference compound |
| HY-U00218 | McN5691 | 99254-95-2 | Reference compound |
| HY-U00220 | KAT681 | 373641-87-3 | Reference compound |
| HY-U00221 | Amifloxacin | 86393-37-5 | Reference compound |
| HY-U00222 | S3337 | 108499-48-5 | Reference compound |
| HY-U00223 | WD2000-012547 | 283172-68-9 | Reference compound |
| HY-U00224 | BRL44385 | 114778-60-8 | Reference compound |
| HY-U00225 | A7132 | 100490-21-9 | Reference compound |
| HY-U00226 | UP202-56 | 163838-04-8 | Reference compound |
| HY-U00227 | U91356 | 152886-85-6 | Reference compound |
| HY-U00228 | Rilmazafone hydrochloride | 85815-37-8 | Reference compound |
| HY-U00229 | Bifluranol | 34633-34-6 | Reference compound |
| HY-U00230 | CDD0102 | 146422-58-4 | Reference compound |
| HY-U00230A | CDD0102 (hydrochloride) | 1196130-86-5 | Reference compound |
| HY-U00231 | KF 13218 | 127654-03-9 | Reference compound |
| HY-U00232 | Bidisomide | 116078-65-0 | Reference compound |
| HY-U00233 | FG8119 | 106447-61-4 | Reference compound |
| HY-U00234 | Zatosetron (maleate) | 123482-23-5 | Reference compound |
| HY-U00235 | SR121566A | 180144-61-0 | Reference compound |
| HY-U00236 | PD0176078 | 248922-46-5 | Reference compound |
| HY-U00237 | L-771688 | 200050-59-5 | Reference compound |
| HY-U00237B | L-771688 (hydrochloride) | 200051-19-0 | Reference compound |
| HY-U00238 | FRG8701 | 108498-50-6 | Reference compound |
| HY-U00239 | SC58451 | 168433-84-9 | Reference compound |
| HY-U00240 | SA72 | 934809-60-6 | Reference compound |
| HY-U00241 | Carburazepam | 59009-93-7 | Reference compound |
| HY-U00242 | Indacrinone | 56049-88-8 | Reference compound |
| HY-U00243 | Alpertine | 27076-46-6 | Reference compound |
| HY-U00244 | Benzquinamide | 63-12-7 | Reference compound |
| HY-U00244A | Benzquinamide (hydrochloride) | 113-69-9 | Reference compound |
| HY-U00245 | L162441 | 154512-46-6 | Reference compound |
| HY-U00247 | MCI826 | 140646-80-6 | Reference compound |
| HY-U00248 | LMP744 | 308246-52-8 | Reference compound |
| HY-U00248A | LMP744 (hydrochloride) | 308246-57-3 | Reference compound |
| HY-U00249 | Saperconazole | 110588-57-3 | Reference compound |
| HY-U00250 | β-Amino Acid Imagabalin Hydrochloride | 610300-00-0 | Reference compound |
| HY-U00251 | KFM19 | 133058-72-7 | Reference compound |
| HY-U00252 | ONO4057 | 134578-96-4 | Reference compound |
| HY-U00253 | KP496 | 217799-03-6 | Reference compound |
| HY-U00254 | L791943 | 192767-01-4 | Reference compound |
| HY-U00255 | BO3482 | 198013-53-5 | Reference compound |
| HY-U00256 | ZD8321 | 182073-77-4 | Reference compound |
| HY-U00257 | AZD1979 | 1254035-84-1 | Reference compound |
| HY-U00258 | Minocromil | 85118-44-1 | Reference compound |
| HY-U00259 | BM152054 | 213411-84-8 | Reference compound |
| HY-U00260 | CMI977 | 175212-04-1 | Reference compound |
| HY-U00261 | L-689502 | 138483-63-3 | Reference compound |
| HY-U00262 | ACT 178882 | 1007392-69-9 | Reference compound |
| HY-U00263 | LY210073 | 148291-65-0 | Reference compound |
| HY-U00264 | 2-γ-Linolenoyl-1,3-dilinoleoyl-sn-glycerol | 174473-88-2 | Reference compound |
| HY-U00265 | 3-CPs | 20073-24-9 | Reference compound |
| HY-U00266 | Cefetrizole | 65307-12-2 | Reference compound |
| HY-U00268 | Telomerase-IN-1 | 666859-49-0 | Reference compound |
| HY-U00270 | CP-319340(free base) | 186390-35-2 | Reference compound |
| HY-U00271 | Pareptide monohydrochloride | 63236-23-7 | Reference compound |
| HY-U00273 | Anti-inflammatory agent 1 | 1096621-42-9 | Reference compound |
| HY-U00274 | Ropitoin | 56079-81-3 | Reference compound |
| HY-U00275 | COX-2-IN-1 | 787623-48-7 | Reference compound |
| HY-U00277 | JAK-IN-10 | 916741-98-5 | Reference compound |
| HY-U00278 | Deloxolone | 68635-50-7 | Reference compound |
| HY-U00279 | Nitracrine | 4533-39-5 | Reference compound |
| HY-U00279A | Nitracrine (dihydrochloride hydrate) | 55429-45-3 | Reference compound |
| HY-U00279B | Nitracrine (hydrochloride) | 6514-85-8 | Reference compound |
| HY-U00280 | Potassium Channel Activator 1 | 908608-06-0 | Reference compound |
| HY-U00281 | S16961 | 153874-14-7 | Reference compound |
| HY-U00282 | Chymase-IN-2 | 936366-22-2 | Reference compound |
| HY-U00283 | Falintolol, (Z)- | 106401-52-9 | Reference compound |
| HY-U00284 | AE0047 Hydrochloride | 116308-56-6 | Reference compound |
| HY-U00286 | 5-HT2A antagonist 1 | 204643-75-4 | Reference compound |
| HY-U00287 | BACE-IN-1 | 1254166-60-3 | Reference compound |
| HY-U00288 | Xanthine oxidase-IN-1 | 1071970-13-2 | Reference compound |
| HY-U00289 | Opigolix | 912587-25-8 | Reference compound |
| HY-U00290 | R-(+)-Mono-desmethylsibutramine | 229639-54-7 | Reference compound |
| HY-U00291 | Tauroxicum | 648922-41-2 | Reference compound |
| HY-U00292 | AMPK activator 1 | 1152423-98-7 | Reference compound |
| HY-U00293 | ZK-90055 (hydrochloride) | 84638-81-3 | Reference compound |
| HY-U00294 | NEP-In-1 | 465527-94-0 | Reference compound |
| HY-U00295 | Melarsonyl | 37526-80-0 | Reference compound |
| HY-U00295A | Melarsonyl (dipotassium) | 13355-00-5 | Reference compound |
| HY-U00298 | Amebucort | 83625-35-8 | Reference compound |
| HY-U00299 | LTB4-IN-1 | 133012-00-7 | Reference compound |
| HY-U00300 | Cancer-Targeting Compound 1 | 1007581-62-5 | Reference compound |
| HY-U00301 | Anti-hypertensive sulfonanilide 1 | 129280-22-4 | Reference compound |
| HY-U00302 | CHF5407 | 1004312-94-0 | Reference compound |
| HY-U00303 | Trecadrine | 90845-56-0 | Reference compound |
| HY-U00304 | Aurora B inhibitor 1 | 937276-52-3 | Reference compound |
| HY-U00305 | Cicloxilic acid | 57808-63-6 | Reference compound |
| HY-U00307 | Carabersat | 184653-84-7 | Reference compound |
| HY-U00308 | 5-LOX-IN-4 | 125235-15-6 | Reference compound |
| HY-U00309 | YM758 | 312752-85-5 | Reference compound |
| HY-U00310 | Neuromuscular-targeting compound 1 | 1178978-20-5 | Reference compound |
| HY-U00311 | Aliconazole | 63824-12-4 | Reference compound |
| HY-U00312 | MEK-IN-1 | 870600-45-6 | Reference compound |
| HY-U00313 | Tropodifene | 15790-02-0 | Reference compound |
| HY-U00314 | Anti-neurodegeneration agent 1 | 289893-23-8 | Reference compound |
| HY-U00315 | Gidazepam | 129186-29-4 | Reference compound |
| HY-U00315S | Gidazepam-d5 | Isotope-Labeled Compounds | |
| HY-U00316 | Vinconate | 70704-03-9 | Reference compound |
| HY-U00318 | JAK-IN-11 | 916742-11-5 | Reference compound |
| HY-U00319 | Lipid peroxidation inhibitor 1 | 142873-41-4 | Reference compound |
| HY-U00320 | Neurokinin antagonist 1 | 214487-45-3 | Reference compound |
| HY-U00321 | A2B receptor antagonist 1 | 531506-36-2 | Reference compound |
| HY-U00322 | 5-HT3 antagonist 3 | 120635-47-4 | Reference compound |
| HY-U00323 | Carbazole derivative 1 | 164914-28-7 | Reference compound |
| HY-U00324 | p38 MAPK-IN-2 | 635725-16-5 | Reference compound |
| HY-U00325 | 11β-HSD1-IN-1 | 1203956-47-1 | Reference compound |
| HY-U00326 | PI3Kα/mTOR-IN-1 | 1013098-90-2 | Reference compound |
| HY-U00327 | Prenyl-IN-1 | 360561-53-1 | Reference compound |
| HY-U00329 | Implitapide (Racemate) | 177277-99-5 | Reference compound |
| HY-U00330 | TRPV antagonist 1 | 1192871-27-4 | Reference compound |
| HY-U00331 | CCR3 antagonist 1 | 879399-82-3 | Reference compound |
| HY-U00332 | Hydrocarbon chain derivative 1 | 300762-25-8 | Reference compound |
| HY-U00333 | α1 adrenoceptor-MO-1 | 161905-64-2 | Reference compound |
| HY-U00334 | LH secretion antagonist 1 | 88531-67-3 | Reference compound |
| HY-U00335 | FR252384 | 447405-11-0 | Reference compound |
| HY-U00336 | NEP-IN-2 | 145775-14-0 | Reference compound |
| HY-U00337 | Datelliptium (chloride) | 105118-14-7 | Reference compound |
| HY-U00337A | Datelliptium (chloride hydrochloride) | 157000-76-5 | Reference compound |
| HY-U00338 | Verilopam | 68318-20-7 | Reference compound |
| HY-U00339 | H3 receptor-MO-1 | 1240914-03-7 | Reference compound |
| HY-U00340 | PPAR agonist 1 | 539813-69-9 | Reference compound |
| HY-U00341 | ST4206 | 1246018-36-9 | Reference compound |
| HY-U00343 | MAO-B-IN-1 | 1124198-17-9 | Reference compound |
| HY-U00344 | Theodrenaline | 13460-98-5 | Reference compound |
| HY-U00344A | Theodrenaline (hydrochloride) | 2572-61-4 | Reference compound |
| HY-U00345 | CHK-IN-1 | 1278405-51-8 | Reference compound |
| HY-U00346 | TS-021 (free base) | 625110-37-4 | Reference compound |
| HY-U00346A | TS-021 | 667865-69-2 | Reference compound |
| HY-U00347 | COX/5-LO-IN-1 | 154355-75-6 | Reference compound |
| HY-U00348 | Anticonvulsant agent 1 | 357336-17-5 | Reference compound |
| HY-U00350 | CCX354 | 1010073-75-2 | Reference compound |
| HY-U00351 | ROCK-IN-1 | 934387-35-6 | Reference compound |
| HY-U00352 | PDE IV-IN-1 | 225100-12-9 | Reference compound |
| HY-U00353 | MCHR1 antagonist 1 | 391610-37-0 | Reference compound |
| HY-U00354 | CP-060 | 180090-15-7 | Reference compound |
| HY-U00355 | YM158 (free base) | 179102-65-9 | Reference compound |
| HY-U00356 | Tertatolol | 83688-84-0 | Reference compound |
| HY-U00357 | Urinary Incontinence-Targeting Compound 1 | 137315-05-0 | Reference compound |
| HY-U00358 | Compound 2 | 872313-42-3 | Reference compound |
| HY-U00359 | LTD4 antagonist 1 | 136564-67-5 | Reference compound |
| HY-U00360 | (Rac)-Sograzepide | 168161-71-5 | Reference compound |
| HY-U00362 | Neurodegenerative Disorder-Targeting Compound 1 | 1254698-39-9 | Reference compound |
| HY-U00362A | (Rac)-Neurodegenerative Disorder-Targeting Compound 1 | 1254699-12-1 | Reference compound |
| HY-U00363 | CHEMBL333994 | 167820-10-2 | Reference compound |
| HY-U00364 | CI-949 | 104961-19-5 | Reference compound |
| HY-U00365 | 5-HT2 antagonist 1 | 191592-09-3 | Reference compound |
| HY-U00366 | S1PR1-MO-1 | 1149727-61-6 | Reference compound |
| HY-U00367 | (4E)-SUN9221 | 222318-55-0 | Reference compound |
| HY-U00368 | 5-HT3 antagonist 1 | 129294-09-3 | Reference compound |
| HY-U00369 | FCE 28654 | 169474-77-5 | Reference compound |
| HY-U00370 | Thrombin inhibitor 1 | 855998-46-8 | Reference compound |
| HY-U00371 | AR-08 | 226081-74-9 | Reference compound |
| HY-U00372 | 2: PN: US20040072744 SEQID: 2 claimed protein | 389572-87-6 | Peptides |
| HY-U00373 | Revexepride | 219984-49-3 | Reference compound |
| HY-U00374 | Sch59498 | 224157-99-7 | Reference compound |
| HY-U00375 | Gastrin/CCK antagonist 1 | 162271-52-5 | Reference compound |
| HY-U00376 | 5α-reductase-IN-1 | 119348-12-8 | Reference compound |
| HY-U00377 | Cathepsin Inhibitor 2 | 1017931-53-1 | Reference compound |
| HY-U00378 | Glycerol derivative 1 | 128400-55-5 | Reference compound |
| HY-U00379 | LM985 | 87626-56-0 | Reference compound |
| HY-U00380 | Tigemonam | 102507-71-1 | Reference compound |
| HY-U00382 | Substance P Receptor Antagonist 1 | 225526-17-0 | Reference compound |
| HY-U00383 | Rafigrelide | 1029711-88-3 | Reference compound |
| HY-U00384 | Diarylalkane derivative 1 | 191155-65-4 | Reference compound |
| HY-U00385 | Neuromuscular Disorder-Targeting Compound 1 | 374538-23-5 | Reference compound |
| HY-U00386 | Bometolol Hydrochloride | 65023-16-7 | Reference compound |
| HY-U00387 | CCK-A receptor inhibitor 1 | 137004-80-9 | Reference compound |
| HY-U00388 | α2δ ligand 1 | 313653-15-5 | Reference compound |
| HY-U00389 | WQ3810 | 888032-58-4 | Reference compound |
| HY-U00390 | JAK3-IN-7 | 1263774-57-7 | Reference compound |
| HY-U00391 | β3-AR agonist 2 | 340757-05-3 | Reference compound |
| HY-U00392 | Tachykinin angatonist 1 | 178310-77-5 | Reference compound |
| HY-U00393 | Arrhythmic-Targeting Compound 1 | 136079-82-8 | Reference compound |
| HY-U00394 | Oiligodendrocyte differentiation promoter 1 | 400760-25-0 | Reference compound |
| HY-U00395 | GPR40 Agonist 2 | 1147729-48-3 | Reference compound |
| HY-U00396 | MC-4R Agonist 1 | 455957-28-5 | Reference compound |
| HY-U00397 | CB1 antagonist 1 | 890037-68-0 | Reference compound |
| HY-U00398 | Bimoclomol | 130493-03-7 | Reference compound |
| HY-U00399 | Fiduxosin | 208993-54-8 | Reference compound |
| HY-U00399A | Fiduxosin (hydrochloride) | 208992-74-9 | Reference compound |
| HY-U00400 | PF-592379 | 710655-15-5 | Reference compound |
| HY-U00401 | (Rac)-CP-609754 | 439153-64-7 | Reference compound |
| HY-U00402 | Fenmetozole (Tosylate) | 83474-08-2 | Reference compound |
| HY-U00403 | Cipropride (S enantiomer) | 66183-70-8 | Reference compound |
| HY-U00404 | Phentolamine Analogue 1 | 47142-51-8 | Reference compound |
| HY-U00405 | Bronchospasmolytic agent 1 | 63516-10-9 | Reference compound |
| HY-U00406 | BTM-1086 | 72293-17-5 | Reference compound |
| HY-U00408 | 5-HT3 antagonist 2 | 128199-93-9 | Reference compound |
| HY-U00409 | Antiasthmatic Compound 1 | 63768-49-0 | Reference compound |
| HY-U00410 | PDE4 inhibitor intermediate 1 | 347850-26-4 | Reference compound |
| HY-U00411 | PSN-GK1 | 745051-61-0 | Reference compound |
| HY-U00412 | Asthma relating compound 1 | 120165-51-7 | Reference compound |
| HY-U00413 | 5-HT3-In-1 | 186348-68-5 | Reference compound |
| HY-U00414 | Antitumor agent-4 | 115767-64-1 | Reference compound |
| HY-U00415 | Benzamide Derivative 1 | 108226-05-7 | Reference compound |
| HY-U00416 | ARS-1323 | 1698024-73-5 | Reference compound |
| HY-U00417 | ARS-1630 | 1698055-86-5 | Reference compound |
| HY-U00418 | ARS-1620 | 1698055-85-4 | Reference compound |
| HY-U00420 | Opioid receptor modulator 1 | 77514-44-4 | Reference compound |
| HY-U00422 | K-756 | 130017-40-2 | Reference compound |
| HY-U00423 | CRTH2-IN-1 | 926661-54-3 | Reference compound |
| HY-U00424 | Chol-5-en-24-al-3β-ol | 27460-33-9 | Reference compound |
| HY-U00425 | PROTAC ERRα ligand 1 | 1264754-13-3 | Reference compound |
| HY-U00426 | BF738735 | 1436383-95-7 | Reference compound |
| HY-U00427 | PDE2/PDE10-IN-1 | 1426833-08-0 | Reference compound |
| HY-U00428 | GNE 220 | 1199590-75-4 | Reference compound |
| HY-U00428A | GNE 220 (hydrochloride) | 2448286-21-1 | Reference compound |
| HY-U00429 | NOT Receptor Modulator 1 | 1015231-98-7 | Reference compound |
| HY-U00430 | MGAT2-IN-2 | 1710630-11-7 | Reference compound |
| HY-U00431 | CCG 203769 | 410074-60-1 | Reference compound |
| HY-U00432 | S-MTC | 156719-41-4 | Reference compound |
| HY-U00432A | S-MTC (dihydrochloride) | 209589-59-3 | Reference compound |
| HY-U00432B | S-MTC (acetate) | 174063-92-4 | Reference compound |
| HY-U00433 | JMV 2959 | 925238-89-7 | Reference compound |
| HY-U00433A | JMV 2959 (hydrochloride) | 2448414-54-6 | Reference compound |
| HY-U00434 | 3BDO | 890405-51-3 | Reference compound |
| HY-U00435 | Neoseptin 3 | 1622863-21-1 | Reference compound |
| HY-U00436 | FASN-IN-3 | 2097262-60-5 | Reference compound |
| HY-U00437 | Pz-1 | 1800505-64-9 | Reference compound |
| HY-U00438 | LP117 | 1056468-55-3 | Reference compound |
| HY-U00439 | Protein kinase inhibitor 1 | 1365986-44-2 | Reference compound |
| HY-U00439A | Protein kinase inhibitor 1 (hydrochloride) | 2321337-71-5 | Reference compound |
| HY-U00440 | FHZ | 1883737-63-0 | Dye Reagents |
| HY-U00441 | DPBQ | 7029-89-2 | Reference compound |
| HY-U00442 | CTX1 | 501935-96-2 | Reference compound |
| HY-U00443 | SB 258719 | 195199-95-2 | Reference compound |
| HY-U00444 | 7rh | 1429617-90-2 | Reference compound |
| HY-U00446 | PBOX 6 | 290814-68-5 | Reference compound |
| HY-U00447 | PK11000 | 38275-34-2 | Reference compound |
| HY-U00448 | ADDA 5 hydrochloride | 473268-46-1 | Reference compound |
| HY-U00449 | AGN 193109 | 171746-21-7 | Reference compound |
| HY-U00449A | AGN 193109 (sodium) | 2319838-82-7 | Reference compound |
| HY-U00449G | AGN 193109 (GMP) | 171746-21-7 | GMP Small Molecules |
| HY-U00449S | AGN 193109-d7 | 1216429-25-2 | Isotope-Labeled Compounds |
| HY-U00450 | 4-O-Methyl honokiol | 68592-15-4 | Natural Products |
| HY-U00451 | ATP-Red 1 | 1847485-97-5 | Dye Reagents |
| HY-U00452 | PL553 | 1456872-74-4 | Dye Reagents |
| HY-U00453 | Soluble epoxide hydrolase inhibitor | 1241826-88-9 | Reference compound |
| HY-U00457 | TBK1/IKKε-IN-1 | 2058264-32-5 | Reference compound |
| HY-U00458 | K-80003 | 1292821-90-9 | Reference compound |
| HY-U00459 | GSK2850163 | 2121989-91-9 | Reference compound |
| HY-U00459A | GSK2850163 (S enantiomer) | 2309519-81-9 | Reference compound |
| HY-U00459B | GSK2850163 (hydrochloride) | 2319838-09-8 | Reference compound |
| HY-U00460 | 3,6-DMAD (hydrochloride) | Reference compound | |
| HY-U00460B | 3,6-DMAD (dihydrochloride) | 2226511-77-7 | Reference compound |
| HY-U00461 | PF-06835919 | 2102501-84-6 | Reference compound |
| HY-U00462 | D-Mannoheptulose | 3615-44-9 | Natural Products |
| HY-U00462S | D-Mannoheptulose-13C | Isotope-Labeled Compounds | |
| HY-W000133 | Metrizamide | 31112-62-6 | Reference compound |
| HY-W000284 | 8-Bromo-5’-O-(4-cyanobenzyl)-2’,3’-di-O-isopropylidene adenosine | 1134156-53-8 | Reference compound |
| HY-W000343 | 1-Tritylimidazole | 15469-97-3 | Reference compound |
| HY-W000344S | 4-Bromo-1-butanol-d8 | 136091-68-4 | Isotope-Labeled Compounds |
| HY-W000357 | 4-(Imidazol-1-yl)phenol | 10041-02-8 | Biochemical Assay Reagents |
| HY-W000383 | 2-Adamantanol | 700-57-2 | Biochemical Assay Reagents |
| HY-W000423 | DBCO-amine | 1255942-06-3 | ADC Related |
| HY-W000423G | DBCO-amine (GMP) | 1255942-06-3 | GMP Small Molecules |
| HY-W000427 | Ethyl Orsellinate | 2524-37-0 | Natural Products |
| HY-W000434 | Fmoc-NH-PEG4-CH2CH2COOH | 557756-85-1 | ADC Related |
| HY-W000438 | N-Boc-O-tosyl hydroxylamine | 105838-14-0 | Reference compound |
| HY-W000450 | 5-Aminolevulinic acid | 106-60-5 | Natural Products |
| HY-W000450S | 5-Aminolevulinic acid-13C | 123253-93-0 | Isotope-Labeled Compounds |
| HY-W000643 | 7-Azaindazole | 271-73-8 | Biochemical Assay Reagents |
| HY-W000665 | 2,6-Dimethyl-L-tyrosine | 123715-02-6 | Peptides |
| HY-W000793S | 5-Methoxy-1H-indole-3-carboxylic acid-d3 | Isotope-Labeled Compounds | |
| HY-W000795 | (S)-2-amino-3-(4-benzoylphenyl)propanoic acid | 104504-45-2 | Peptides |
| HY-W000800 | cis,cis-Muconic acid | 1119-72-8 | Natural Products |
| HY-W000800R | cis,cis-Muconic acid (Standard) | 1119-72-8 | Reference Standards |
| HY-W000808 | (4-Carbamoylphenyl)boronic acid | 123088-59-5 | Biochemical Assay Reagents |
| HY-W000830 | tert-Butyl 2-((tert-butoxycarbonyl)amino)acetate | 111652-20-1 | Peptides |
| HY-W000838 | 1-Hydroxyanthraquinone | 129-43-1 | Natural Products |
| HY-W000843 | (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid | 138797-71-4 | Peptides |
| HY-W000854 | 3-Methoxybenzeneboronic acid | 10365-98-7 | Biochemical Assay Reagents |
| HY-W000854S | 3-Methoxybenzeneboronic acid-d3 | 2241867-05-8 | Isotope-Labeled Compounds |
| HY-W000873 | 4-Benzyloxyphenylboronic acid | 146631-00-7 | Biochemical Assay Reagents |
| HY-W000874 | 2,6-Dichloropyridin-3-ylboronic acid | 148493-34-9 | Biochemical Assay Reagents |
| HY-W000887 | 4-Carboxyphenylboronic acid pinacol ester | 180516-87-4 | Biochemical Assay Reagents |
| HY-W000896 | 4-(Diphenylamino)benzeneboronic acid | 201802-67-7 | Biochemical Assay Reagents |
| HY-W000897 | 3-Aminophenylboronic acid monohydrate | 206658-89-1 | Biochemical Assay Reagents |
| HY-W000902 | 2,6-Dimethoxypyridine-3-boronic acid | 221006-70-8 | Biochemical Assay Reagents |
| HY-W000903 | (2-Bromophenyl)boronic acid | 244205-40-1 | Biochemical Assay Reagents |
| HY-W000913 | 4-(Boc-amino)benzeneboronic acid pinacol ester | 330793-01-6 | Biochemical Assay Reagents |
| HY-W000923 | (4-Boc-aminophenyl)boronic acid | 380430-49-9 | Biochemical Assay Reagents |
| HY-W000924 | 3-(N-Boc-amino)phenylboronic acid | 380430-68-2 | Biochemical Assay Reagents |
| HY-W000932 | Butylboronic acid | 4426-47-5 | Reference compound |
| HY-W000933 | Ethylboronic acid | 4433-63-0 | Biochemical Assay Reagents |
| HY-W000938 | 1,4-Phenylenediboronic acid | 4612-26-4 | Biochemical Assay Reagents |
| HY-W000939 | 2-Biphenylboronic acid | 4688-76-0 | Biochemical Assay Reagents |
| HY-W000949 | 4-(Hydroxymethyl)benzeneboronic acid | 59016-93-2 | Biochemical Assay Reagents |
| HY-W000955 | Cyclopentylboronic acid | 63076-51-7 | Biochemical Assay Reagents |
| HY-W000978 | 2-Methylpropylboronic acid | 84110-40-7 | Biochemical Assay Reagents |
| HY-W000978R | 2-Methylpropylboronic acid (Standard) | 84110-40-7 | Reference Standards |
| HY-W000981 | 1-Cyclopentenylboronic acid | 850036-28-1 | Biochemical Assay Reagents |
| HY-W000993 | Benzylboronic acid pinacol ester | 87100-28-5 | Biochemical Assay Reagents |
| HY-W000994 | (3-Fluoro-2-formylphenyl)boronic acid | 871126-15-7 | Biochemical Assay Reagents |
| HY-W001023 | 5-Amino-8-hydroxyquinoline | 13207-66-4 | Reference compound |
| HY-W001028 | 3-Fluoropyridine-2-carbaldehyde | 31224-43-8 | Biochemical Assay Reagents |
| HY-W001037 | 3,5-Diiodo-D-tyrosine | 16711-71-0 | Peptides |
| HY-W001066 | 3-Thienylboronic acid | 6165-69-1 | Biochemical Assay Reagents |
| HY-W001069 | RuCl(p-cymene)[(R,R)-Ts-DPEN] | 192139-92-7 | Biochemical Assay Reagents |
| HY-W001080 | 3,4-Dihydroxybenzeneacetic acid | 102-32-9 | Natural Products |
| HY-W001080R | 3,4-Dihydroxybenzeneacetic acid (Standard) | 102-32-9 | Reference Standards |
| HY-W001080S | 3,4-Dihydroxybenzeneacetic acid-d5 | 60696-39-1 | Isotope-Labeled Compounds |
| HY-W001080S1 | 3,4-Dihydroxybenzeneacetic acid-d3 | 68408-04-8 | Isotope-Labeled Compounds |
| HY-W001083 | 3-Hydroxyphenylacetic acid | 621-37-4 | Natural Products |
| HY-W001083R | 3-Hydroxyphenylacetic acid (Standard) | 621-37-4 | Reference Standards |
| HY-W001084 | Methyl 4-hydroxyphenylacetate | 14199-15-6 | Natural Products |
| HY-W001084R | Methyl 4-hydroxyphenylacetate (Standard) | 14199-15-6 | Reference Standards |
| HY-W001090 | Phenylboronic acid | 98-80-6 | Biochemical Assay Reagents |
| HY-W001094 | 2-Bromo-4-fluoroanisole | 452-08-4 | Biochemical Assay Reagents |
| HY-W001095 | N-Methoxy-N-methylacetamide | 78191-00-1 | Biochemical Assay Reagents |
| HY-W001095S | N-Methoxy-N-methylacetamide-d3 | 132289-60-2 | Isotope-Labeled Compounds |
| HY-W001114 | 4-Bromo-2-hydroxybenzaldehyde | 22532-62-3 | Biochemical Assay Reagents |
| HY-W001117 | 3,5-Dimethoxyphenol | 500-99-2 | Natural Products |
| HY-W001124S | 1-Bromo-3,5-difluorobenzene-d3 | 1219798-73-8 | Isotope-Labeled Compounds |
| HY-W001127 | 1,3-Bis(2,6-diisopropylphenyl)imidazolium (chloride) | 250285-32-6 | Biochemical Assay Reagents |
| HY-W001131 | 2-Amino-6-fluorobenzoic acid | 434-76-4 | Biochemical Assay Reagents |
| HY-W001132 | Indole | 120-72-9 | Natural Products |
| HY-W001132R | Indole (standard) | 120-72-9 | Reference Standards |
| HY-W001132S | Indole-d6 | 104959-27-5 | Isotope-Labeled Compounds |
| HY-W001132S1 | Indole-13C | 85597-55-3 | Isotope-Labeled Compounds |
| HY-W001132S2 | Indole-13C8,15N | 1337952-53-0 | Isotope-Labeled Compounds |
| HY-W001132S3 | Indole-15N | 40167-58-6 | Isotope-Labeled Compounds |
| HY-W001132S4 | Indole-d7 | 73509-20-3 | Isotope-Labeled Compounds |
| HY-W001137 | Bis(dibenzylideneacetone)palladium | 32005-36-0 | Biochemical Assay Reagents |
| HY-W001138 | 4-Bromobenzaldehyde | 1122-91-4 | Biochemical Assay Reagents |
| HY-W001138S | 4-Bromobenzaldehyde-13C6 | 1037620-59-9 | Isotope-Labeled Compounds |
| HY-W001140 | 3-Thiopheneacetic acid | 6964-21-2 | Biochemical Assay Reagents |
| HY-W001140R | 3-Thiopheneacetic acid (Standard) | 6964-21-2 | Reference Standards |
| HY-W001142 | 2-Thiopheneacetic acid | 1918-77-0 | Biochemical Assay Reagents |
| HY-W001146 | 3-Chloro-4-hydroxyphenylacetic acid | 33697-81-3 | Reference compound |
| HY-W001154 | Methyl 2,6-dihydroxybenzoate | 2150-45-0 | Natural Products |
| HY-W001158 | N,N-Dimethylglycine (hydrochloride) | 2491-06-7 | Peptides |
| HY-W001158S | N,N-Dimethylglycine-d6 (hydrochloride) | 347840-03-3 | Isotope-Labeled Compounds |
| HY-W001158S1 | N,N-Dimethylglycine-d3 (hydrochloride) | 1219795-14-8 | Isotope-Labeled Compounds |
| HY-W001160 | 5-Hydroxyindole | 1953-54-4 | Natural Products |
| HY-W001160R | 5-Hydroxyindole (Standard) | 1953-54-4 | Reference Standards |
| HY-W001165 | 3-Coumaranone | 7169-34-8 | Biochemical Assay Reagents |
| HY-W001168 | 3-Chloro-6-methoxypyridazine | 1722-10-7 | Biochemical Assay Reagents |
| HY-W001171 | 3-Hydroxyanthranilic acid | 548-93-6 | Natural Products |
| HY-W001171R | 3-Hydroxyanthranilic acid (Standard) | 548-93-6 | Reference Standards |
| HY-W001171S | 3-Hydroxyanthranilic acid-d3 | 1794970-56-1 | Isotope-Labeled Compounds |
| HY-W001174 | 2,5-Dihydroxyacetophenone | 490-78-8 | Natural Products |
| HY-W001179 | 2,5-Dihydroxybenzoic acid | 490-79-9 | Natural Products |
| HY-W001179R | 2,5-Dihydroxybenzoic acid (Standard) | 490-79-9 | Reference Standards |
| HY-W001187 | Tempo | 2564-83-2 | Reference compound |
| HY-W001187R | Tempo (Standard) | 2564-83-2 | Reference Standards |
| HY-W001187S | Tempo-d18 | 205679-68-1 | Isotope-Labeled Compounds |
| HY-W001189 | 1,3-Dithiane | 505-23-7 | Natural Products |
| HY-W001189S | 1,3-Dithiane-d2 | 71870-74-1 | Isotope-Labeled Compounds |
| HY-W001194 | 1,3-Propanesultam | 5908-62-3 | Reference compound |
| HY-W001196 | 5-Methoxy-1-indanone | 5111-70-6 | Biochemical Assay Reagents |
| HY-W001198 | 2,3,5-Trichloropyridine | 16063-70-0 | Biochemical Assay Reagents |
| HY-W001201 | 2-Isopropylimidazole | 36947-68-9 | Biochemical Assay Reagents |
| HY-W001210 | L-beta-Homoalanine hydrochloride | 58610-41-6 | Peptides |
| HY-W001213 | 2-Amino-4-methoxyphenol | 20734-76-3 | Natural Products |
| HY-W001214 | 3,3-Difluoroazetidine (hydrochloride) | 288315-03-7 | Biochemical Assay Reagents |
| HY-W001217 | 4-Hydroxy-1-indanone | 40731-98-4 | Biochemical Assay Reagents |
| HY-W001222 | 3-Furanboronic acid | 55552-70-0 | Biochemical Assay Reagents |
| HY-W001223 | 2-Bromothiazole | 3034-53-5 | Biochemical Assay Reagents |
| HY-W001232 | 2-Tolylboronic acid | 16419-60-6 | Biochemical Assay Reagents |
| HY-W001239S | N-Methyl pyrrole-d3 | 20687-13-2 | Isotope-Labeled Compounds |
| HY-W001239S1 | N-Methyl pyrrole-d4 | 190386-37-9 | Isotope-Labeled Compounds |
| HY-W001240 | 2-Fluorophenylboronic acid | 1993-03-9 | Biochemical Assay Reagents |
| HY-W001242 | 1-(Tetrahydropyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester | 903550-26-5 | Biochemical Assay Reagents |
| HY-W001249 | 2,6-Dimethoxybenzaldehyde | 3392-97-0 | Biochemical Assay Reagents |
| HY-W001251 | 3,5-Dimethoxybenzoic acid | 1132-21-4 | Natural Products |
| HY-W001260S | 3-Fluoro-4-(hydroxymethyl)benzonitrile-d2 | 2641114-12-5 | Isotope-Labeled Compounds |
| HY-W001288 | Indole-4-carboxaldehyde | 1074-86-8 | Biochemical Assay Reagents |
| HY-W001294 | (R)-(-)-N-Boc-3-pyrrolidinol | 109431-87-0 | Biochemical Assay Reagents |
| HY-W001297 | 3-Chloro-6-methylpyridazine | 1121-79-5 | Biochemical Assay Reagents |
| HY-W001440 | 4,4-Difluoropiperidine (hydrochloride) | 144230-52-4 | Biochemical Assay Reagents |
| HY-W001466 | 3,3-Difluoropyrrolidine hydrochloride | 163457-23-6 | Biochemical Assay Reagents |
| HY-W001472 | Dimethyl pimelate | 1732-08-7 | Natural Products |
| HY-W001472S | Dimethyl pimelate-d4 | 120811-82-7 | Isotope-Labeled Compounds |
| HY-W001478 | N-Boc-4-bromopiperidine | 180695-79-8 | Biochemical Assay Reagents |
| HY-W001484 | N-Boc-nortropinone | 185099-67-6 | Biochemical Assay Reagents |
| HY-W001536 | 7-Methoxyindole, 98% | 3189-22-8 | Biochemical Assay Reagents |
| HY-W001538 | S-Propargylcysteine | 3262-64-4 | Reference compound |
| HY-W001542 | 5-Hydroxyoxindole | 3416-18-0 | Natural Products |
| HY-W001570 | 3-Hydroxy-1-adamantanecarboxylic acid | 42711-75-1 | Biochemical Assay Reagents |
| HY-W001576 | 6-Nitroindole | 4769-96-4 | Biochemical Assay Reagents |
| HY-W001578 | 1-Adamantaneacetic acid | 4942-47-6 | Biochemical Assay Reagents |
| HY-W001583 | Manganese(salen) chloride | 53177-12-1 | Reference compound |
| HY-W001601 | Budipine | 57982-78-2 | Reference compound |
| HY-W001601A | Budipine (hydrochloride) | 63661-61-0 | Reference compound |
| HY-W001601R | Budipine (Standard) | 57982-78-2 | Reference Standards |
| HY-W001603 | Ethyl diethoxyacetate | 6065-82-3 | Biochemical Assay Reagents |
| HY-W001604 | Quinolin-5-amine | 611-34-7 | Biochemical Assay Reagents |
| HY-W001606 | 3-Fluoroazetidine (hydrochloride) | 617718-46-4 | Biochemical Assay Reagents |
| HY-W001639 | 4-Boc-2-Oxopiperazine | 76003-29-7 | Biochemical Assay Reagents |
| HY-W001663 | 4'-Hydroxy-3'-methylacetophenone | 876-02-8 | Natural Products |
| HY-W001692 | Ocinaplon | 96604-21-6 | Reference compound |
| HY-W001845 | 4-Azepanone (hydrochloride) | 50492-22-3 | Biochemical Assay Reagents |
| HY-W001851 | 1-Benzylpyrrole-2,5-dione | 1631-26-1 | Biochemical Assay Reagents |
| HY-W001857 | Octanohydroxamic acid | 7377-03-9 | Reference compound |
| HY-W001909 | Myosmine | 532-12-7 | Natural Products |
| HY-W001909R | Myosmine (Standard) | 532-12-7 | Reference Standards |
| HY-W001909S | Myosmine-d4 | 66148-17-2 | Isotope-Labeled Compounds |
| HY-W001925 | 7-Methoxy-1-tetralone | 6836-19-7 | Natural Products |
| HY-W001932S | 4-Methoxyphenylacetonitrile-d4 | 1219798-74-9 | Isotope-Labeled Compounds |
| HY-W001936 | 2,5-Dimethoxybenzoic acid | 2785-98-0 | Natural Products |
| HY-W001937 | 2-Phenylbenzoic acid | 947-84-2 | Biochemical Assay Reagents |
| HY-W001939 | 4-Acetylbenzoic acid | 586-89-0 | Biochemical Assay Reagents |
| HY-W001939R | 4-Acetylbenzoic acid (Standard) | 586-89-0 | Reference Standards |
| HY-W001940 | DL-m-Tyrosine | 775-06-4 | Natural Products |
| HY-W001940S | DL-m-Tyrosine-d3 | Isotope-Labeled Compounds | |
| HY-W001941 | D-Cystine | 349-46-2 | Reference compound |
| HY-W001942S | DL-2-Methyl-d3-butyric acid | 95926-92-4 | Isotope-Labeled Compounds |
| HY-W001942S1 | DL-2-Methylbutyric acid-d9 | 352431-44-8 | Isotope-Labeled Compounds |
| HY-W001942S2 | DL-2-Methylbutyric acid-13C2 | Isotope-Labeled Compounds | |
| HY-W001943 | 3-Benzoylpropionic acid | 2051-95-8 | Biochemical Assay Reagents |
| HY-W001943R | 3-Benzoylpropionic acid (Standard) | 2051-95-8 | Reference Standards |
| HY-W001947 | 3-Butyn-1-ol | 927-74-2 | Biochemical Assay Reagents |
| HY-W001950 | Bis(diphenylphosphino)methane | 2071-20-7 | Biochemical Assay Reagents |
| HY-W001951 | Dirhodium tetraacetate | 15956-28-2 | Biochemical Assay Reagents |
| HY-W001952 | 6-Bromo-2-naphthol | 15231-91-1 | Biochemical Assay Reagents |
| HY-W001953 | 2-Naphthalenemethanol | 1592-38-7 | Biochemical Assay Reagents |
| HY-W001954 | D-a-tert-Butyl-Gly-OH | 26782-71-8 | Peptides |
| HY-W001955S | 2-(4-Fluorophenyl)acetic acid-d2 | 113715-48-3 | Isotope-Labeled Compounds |
| HY-W001957 | Glurate | 3128-06-1 | Reference compound |
| HY-W001957R | Glurate (Standard) | 3128-06-1 | Reference Standards |
| HY-W001958 | Monomethyl octanoate | 3946-32-5 | Natural Products |
| HY-W001959 | D-Allothreonine | 24830-94-2 | Natural Products |
| HY-W001959R | D-Allothreonine (Standard) | 24830-94-2 | Reference Standards |
| HY-W001962 | 4,5-Dicyanoimidazole | 1122-28-7 | Biochemical Assay Reagents |
| HY-W001963 | Pyrrole-2-carboxylic acid | 634-97-9 | Natural Products |
| HY-W001963R | Pyrrole-2-carboxylic acid (Standard) | 634-97-9 | Reference Standards |
| HY-W001964 | 3-Amino-4-pyrazolecarbonitrile | 16617-46-2 | Biochemical Assay Reagents |
| HY-W001965 | 1-Tosylimidazole | 2232-08-8 | Biochemical Assay Reagents |
| HY-W001972 | 5-Methylindole | 614-96-0 | Biochemical Assay Reagents |
| HY-W001973 | 6-Chloroindole | 17422-33-2 | Biochemical Assay Reagents |
| HY-W001974 | 7-Nitroindole | 6960-42-5 | Biochemical Assay Reagents |
| HY-W001978 | 1-(4-Chlorobenzhydryl)piperazine | 303-26-4 | Biochemical Assay Reagents |
| HY-W001982 | 5-Bromouracil | 51-20-7 | Biochemical Assay Reagents |
| HY-W001987 | 4,6-Dichloropyrimidin-5-amine | 5413-85-4 | Biochemical Assay Reagents |
| HY-W001990 | 2-Piperazinopyridine | 34803-66-2 | Biochemical Assay Reagents |
| HY-W001992 | 2,6-Dichloro-3-nitropyridine | 16013-85-7 | Biochemical Assay Reagents |
| HY-W001993 | 2-Chloro-6-methylpyridine | 18368-63-3 | Biochemical Assay Reagents |
| HY-W001994 | 5-Amino-2-methoxypyridine | 6628-77-9 | Biochemical Assay Reagents |
| HY-W001995 | 2-Chloro-6-methoxypyridine | 17228-64-7 | Biochemical Assay Reagents |
| HY-W001996 | 6-Hydroxynicotinic acid | 5006-66-6 | Natural Products |
| HY-W001996R | 6-Hydroxynicotinic acid (Standard) | 5006-66-6 | Reference Standards |
| HY-W001998 | Di(pyridin-2-yl)methanone | 19437-26-4 | Biochemical Assay Reagents |
| HY-W002000 | Pyridine-3,5-dicarboxylic acid | 499-81-0 | Biochemical Assay Reagents |
| HY-W002001 | Ethyl 2-(pyridin-3-yl)acetate | 39931-77-6 | Biochemical Assay Reagents |
| HY-W002003 | 4,4'-Dimethyl-2,2'-bipyridine | 1134-35-6 | Biochemical Assay Reagents |
| HY-W002004 | 4-Amino-tempo | 14691-88-4 | Biochemical Assay Reagents |
| HY-W002004S | 4-Amino-2,2,6,6-tetramethylpiperidine-1-oxyl-d17,15N | 97461-87-5 | Isotope-Labeled Compounds |
| HY-W002004S1 | 4-Amino-2,2,6,6-tetramethylpiperidine-1-oxyl-d17 | 70588-04-4 | Isotope-Labeled Compounds |
| HY-W002007 | Tetrahydrothiopyran-4-one | 1072-72-6 | Biochemical Assay Reagents |
| HY-W002008 | 5-Nitrobarbituric acid | 480-68-2 | Reference compound |
| HY-W002011 | Quinoline-2-carboxylic acid | 93-10-7 | Natural Products |
| HY-W002011S | Quinoline-2-carboxylic acid-d6 | 1219802-18-2 | Isotope-Labeled Compounds |
| HY-W002014 | 1(2H)-Isoquinolinone | 491-30-5 | Biochemical Assay Reagents |
| HY-W002016 | Phthalazine | 253-52-1 | Reference compound |
| HY-W002016R | Phthalazine (Standard) | 253-52-1 | Reference Standards |
| HY-W002035 | 5-Hydroxyanthranilic acid | 394-31-0 | Biochemical Assay Reagents |
| HY-W002036 | 2-Amino-5-methylbenzoic acid | 2941-78-8 | Biochemical Assay Reagents |
| HY-W002038 | (-)-Phenylglycinol | 56613-80-0 | Peptides |
| HY-W002039 | 3-Amino-3-phenylpropionic acid | 614-19-7 | Biochemical Assay Reagents |
| HY-W002040 | (±)-3-Amino-1,2-propanediol, 97% | 616-30-8 | Biochemical Assay Reagents |
| HY-W002041 | 4-Aminobutan-1-ol | 13325-10-5 | Biochemical Assay Reagents |
| HY-W002060 | 4-Methyl-5-nitropyridin-2-amine | 21901-40-6 | Biochemical Assay Reagents |
| HY-W002062 | (S)-4-Isopropyl-2-oxazolidinone | 17016-83-0 | Biochemical Assay Reagents |
| HY-W002064 | 1H-Benzimidazole-6-carboxylic acid | 15788-16-6 | Biochemical Assay Reagents |
| HY-W002065 | 4-Carboxypyrazole | 37718-11-9 | Natural Products |
| HY-W002066 | Pyridazine-4-carboxylic acid | 50681-25-9 | Biochemical Assay Reagents |
| HY-W002068 | 2,4-Difluorobenzoic acid | 1583-58-0 | Biochemical Assay Reagents |
| HY-W002068S | 2,4-Difluorobenzoic acid-d3 | 1219804-63-3 | Isotope-Labeled Compounds |
| HY-W002071S | 2-Quinoxalinecarboxylic acid-d4 | 2244217-89-6 | Isotope-Labeled Compounds |
| HY-W002072 | Palladium (II) acetate | 3375-31-3 | Biochemical Assay Reagents |
| HY-W002074 | D-Cysteine hydrochloride | 32443-99-5 | Peptides |
| HY-W002087 | Bis(acetonitrile)palladium(II) dichloride | 14592-56-4 | Biochemical Assay Reagents |
| HY-W002094S | Cyclopropane-1,1-dicarboxylic acid-d4 | 136503-99-6 | Isotope-Labeled Compounds |
| HY-W002097 | 1-(5-Methylthiophen-2-yl)ethan-1-one | 13679-74-8 | Natural Products |
| HY-W002097R | 1-(5-Methylthiophen-2-yl)ethan-1-one (Standard) | 13679-74-8 | Reference Standards |
| HY-W002099 | [2,2'-Bipyridine]-4,4'-dicarboxylic acid | 6813-38-3 | Biochemical Assay Reagents |
| HY-W002105 | 2,5-Furandicarboxylic acid | 3238-40-2 | Natural Products |
| HY-W002105R | 2,5-Furandicarboxylic acid (Standard) | 3238-40-2 | Reference Standards |
| HY-W002108 | 3,4-Dihydroquinolin-2(1H)-one | 553-03-7 | Reference compound |
| HY-W002110 | Isohomovanillic acid | 1131-94-8 | Natural Products |
| HY-W002112 | (±)-Nornicotine | 5746-86-1 | Reference compound |
| HY-W002112R | (±)-Nornicotine (Standard) | 5746-86-1 | Reference Standards |
| HY-W002112S | (±)-Nornicotine-d4 | 66148-18-3 | Isotope-Labeled Compounds |
| HY-W002112S1 | (±)-Nornicotine-d7 | Isotope-Labeled Compounds | |
| HY-W002114 | 4-Amino-3-hydroxybenzoic acid | 2374-03-0 | Biochemical Assay Reagents |
| HY-W002116 | Methyl syringate | 884-35-5 | Natural Products |
| HY-W002116S | Methyl syringate-d6 | 1182838-09-0 | Isotope-Labeled Compounds |
| HY-W002128 | 2-(Ethoxycarbonyl)-5-bromo-indole | 16732-70-0 | Biochemical Assay Reagents |
| HY-W002136 | 2,6-Dichloro-3-pyridinamine | 62476-56-6 | Biochemical Assay Reagents |
| HY-W002138 | 5-Bromo-3-nitropyridin-2(1H)-one | 15862-34-7 | Biochemical Assay Reagents |
| HY-W002139 | 6-Methylpicolinic acid | 934-60-1 | Biochemical Assay Reagents |
| HY-W002144 | 8-Quinolinesulfonic acid | 85-48-3 | Reference compound |
| HY-W002155 | Tetrahydropyran-4-yl-carboxylic acid | 5337-03-1 | Biochemical Assay Reagents |
| HY-W002162 | 1,3-Dichloroisoquinoline | 7742-73-6 | Biochemical Assay Reagents |
| HY-W002168 | 1,3-Dimethylpyrazole | 694-48-4 | Natural Products |
| HY-W002169 | N-Boc-L-glutamic acid | 2419-94-5 | Peptides |
| HY-W002170 | 2-Amino-3-(2-chlorophenyl)propanoic acid | 14091-11-3 | Peptides |
| HY-W002172 | 2-Amino-5-chloro-2'-fluorobenzophenone | 784-38-3 | Reference compound |
| HY-W002173 | Boc-Ala-OMe | 28875-17-4 | Peptides |
| HY-W002175S | 2-Amino-4,6-dimethoxy-pyrimidine-d6 | 1219803-92-5 | Isotope-Labeled Compounds |
| HY-W002176 | N6-Carbobenzoxy-L-lysine benzyl ester hydrochloride | 6366-70-7 | Peptides |
| HY-W002177 | 4-Methoxyphenylboronic acid | 5720-07-0 | Biochemical Assay Reagents |
| HY-W002179 | 4-Iodobenzaldehyde | 15164-44-0 | Biochemical Assay Reagents |
| HY-W002191 | 6-Bromo-2,3-dihydrobenzo[b][1,4]dioxine | 52287-51-1 | Biochemical Assay Reagents |
| HY-W002198 | 2-Hydroxyacetophenone | 582-24-1 | Natural Products |
| HY-W002199 | 6:2 Fluorotelomer alcohol | 647-42-7 | Reference compound |
| HY-W002213 | N-Hydroxysulfosuccinimide (sodium) | 106627-54-7 | ADC Related |
| HY-W002216 | N-Benzylhydroxylamine (hydrochloride) | 29601-98-7 | Biochemical Assay Reagents |
| HY-W002226 | 4-Bromo-1H-imidazole | 2302-25-2 | Biochemical Assay Reagents |
| HY-W002227 | 2-Chloro-5-thiophenecarboxaldehyde | 7283-96-7 | Biochemical Assay Reagents |
| HY-W002231 | 2-Amino-5-bromo-3-nitropyridine | 6945-68-2 | Biochemical Assay Reagents |
| HY-W002235 | 2-Chlorophenylglycine | 88744-36-9 | Peptides |
| HY-W002236 | 2-Amino-2-(3-chlorophenyl)acetic acid | 7292-71-9 | Peptides |
| HY-W002237 | 2-Amino-2-(4-chlorophenyl)acetic acid | 6212-33-5 | Peptides |
| HY-W002251 | Benzo[b]thiophene-3-carbaldehyde | 5381-20-4 | Biochemical Assay Reagents |
| HY-W002255 | 2,4-Dimethylthiazole-5-carboxylic acid | 53137-27-2 | Reference compound |
| HY-W002270 | Propyl dodecanoate | 3681-78-5 | Natural Products |
| HY-W002271 | 6-Fluoroindole | 399-51-9 | Biochemical Assay Reagents |
| HY-W002272 | Isocytosine | 108-53-2 | Reference compound |
| HY-W002291 | p-Fluoro-L-phenylalanine | 1132-68-9 | Biochemical Assay Reagents |
| HY-W002292 | L-Homoserine | 672-15-1 | Natural Products |
| HY-W002292R | L-Homoserine (Standard) | 672-15-1 | Reference Standards |
| HY-W002294 | (tert-Butoxycarbonyl)-D-serine | 6368-20-3 | Peptides |
| HY-W002295 | (R)-1-Amino-2-propanol | 2799-16-8 | Biochemical Assay Reagents |
| HY-W002299 | Boc-D-Leucine (monohydrate) | 200937-17-3 | Peptides |
| HY-W002300 | Boc-L-Valine | 13734-41-3 | Peptides |
| HY-W002300S | Boc-L-Valine-d8 | 153568-33-3 | Isotope-Labeled Compounds |
| HY-W002301 | (2S)-4-(benzyloxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid | 86060-84-6 | Peptides |
| HY-W002302 | 2-Amino-3,3-dimethylbutanoic acid | 33105-81-6 | Peptides |
| HY-W002303 | L-Leucine benzyl ester p-toluenesulfonate | 1738-77-8 | Peptides |
| HY-W002304 | (R)-5-Oxopyrrolidine-2-carboxylic acid | 4042-36-8 | Natural Products |
| HY-W002304R | (R)-5-Oxopyrrolidine-2-carboxylic acid (Standard) | 4042-36-8 | Reference Standards |
| HY-W002314 | 2-Bromo-4'-hydroxyacetophenone | 2491-38-5 | Reference compound |
| HY-W002315 | 2-Bromo-3-nitrobenzoic acid | 573-54-6 | Biochemical Assay Reagents |
| HY-W002320 | (R)-4-Isopropyloxazolidin-2-one | 95530-58-8 | Biochemical Assay Reagents |
| HY-W002322 | tert-Butyl Diethylphosphonoacetate | 27784-76-5 | Biochemical Assay Reagents |
| HY-W002323 | 2,6-Dichloronicotinic acid | 38496-18-3 | Biochemical Assay Reagents |
| HY-W002326 | Boc-Asp(OtBu)-OH | 1676-90-0 | Peptides |
| HY-W002327 | Fmoc-Asn(Trt)-OH | 132388-59-1 | Biochemical Assay Reagents |
| HY-W002327S | Fmoc-Asn(Trt)-OH-13C4,15N2 | 1217456-18-2 | Isotope-Labeled Compounds |
| HY-W002327S1 | L-Asparagine-N-Fmoc,N-beta-trityl-15N2 | 204633-98-7 | Isotope-Labeled Compounds |
| HY-W002328 | Pyrazole-3-carboxylic acid | 1621-91-6 | Biochemical Assay Reagents |
| HY-W002336 | 2-Amino-2-(thiophen-3-yl)acetic acid | 38150-49-1 | Peptides |
| HY-W002338 | 5-Bromo-2-iodobenzoic acid | 21740-00-1 | Biochemical Assay Reagents |
| HY-W002339 | 3-Hydroxy-2-methylpyridine | 1121-25-1 | Natural Products |
| HY-W002343 | 3,5-Dimethylbenzaldehyde | 5779-95-3 | Reference compound |
| HY-W002351 | Ethyl 1,5-dimethyl-1H-pyrazole-3-carboxylate | 5744-51-4 | Biochemical Assay Reagents |
| HY-W002356 | 2-Pyridinecarbothioamide | 5346-38-3 | Reference compound |
| HY-W002364 | [1,1'-Biphenyl]-4-ylboronic acid | 5122-94-1 | Biochemical Assay Reagents |
| HY-W002375 | Methyl 4-amino-3-methylbenzoate | 18595-14-7 | Biochemical Assay Reagents |
| HY-W002386 | Ethyl 2-amino-4-methylthiazole-5-carboxylate | 7210-76-6 | Biochemical Assay Reagents |
| HY-W002404 | Pyrimidine-4-carboxylic acid | 31462-59-6 | Biochemical Assay Reagents |
| HY-W002410 | (S)-2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid | 109183-71-3 | Peptides |
| HY-W002412 | 2-Amino-3-chlorobenzoic acid | 6388-47-2 | Biochemical Assay Reagents |
| HY-W002416 | 4-Nitro-L-phenylalanine methyl ester hydrochloride | 17193-40-7 | Peptides |
| HY-W002421 | (R)-3-(Boc-amino)pyrrolidine | 122536-77-0 | Biochemical Assay Reagents |
| HY-W002436 | Fmoc-D-HoPhe-OH | 135944-09-1 | Peptides |
| HY-W002438 | 6-Hydroxyindole | 2380-86-1 | Biochemical Assay Reagents |
| HY-W002438R | 6-Hydroxyindole (Standard) | 2380-86-1 | Reference Standards |
| HY-W002441 | 2-Bromo-4-(trifluoromethyl)pyridine | 175205-81-9 | Biochemical Assay Reagents |
| HY-W002448 | 2-Methyl-3-(trifluoromethyl)aniline | 54396-44-0 | Biochemical Assay Reagents |
| HY-W002448R | 2-Methyl-3-(trifluoromethyl)aniline (Standard) | 54396-44-0 | Reference Standards |
| HY-W002449 | N2-(tert-Butoxycarbonyl)-N4-trityl-L-asparagine | 132388-68-2 | Peptides |
| HY-W002450 | L-Cyclohexylalanine | 27527-05-5 | Peptides |
| HY-W002457 | 3-Nitropyrazole | 26621-44-3 | Biochemical Assay Reagents |
| HY-W002458 | 4-Nitropyrazole | 2075-46-9 | Biochemical Assay Reagents |
| HY-W002461 | 3-Phenylpyrazole | 2458-26-6 | Biochemical Assay Reagents |
| HY-W002463 | 3-Chlorophenyl boronic acid | 63503-60-6 | Biochemical Assay Reagents |
| HY-W002464 | 3-Formylphenylboronic acid | 87199-16-4 | Biochemical Assay Reagents |
| HY-W002465 | 2-Nitrophenylboronic acid | 5570-19-4 | Biochemical Assay Reagents |
| HY-W002481 | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)acetic acid hydrate | 212651-47-3 | Peptides |
| HY-W002484 | 3-Hydroxy-4-methoxyacetophenone | 6100-74-9 | Natural Products |
| HY-W002484R | 3-Hydroxy-4-methoxyacetophenone (Standard) | 6100-74-9 | Reference Standards |
| HY-W002490 | 6-Methylpicolinonitrile | 1620-75-3 | Biochemical Assay Reagents |
| HY-W002494 | 3-Bromo-2-methylpyridine | 38749-79-0 | Biochemical Assay Reagents |
| HY-W002502 | (DHQ)2PHAL | 140924-50-1 | Biochemical Assay Reagents |
| HY-W002518 | Indazole-3-carboxylic acid | 4498-67-3 | Biochemical Assay Reagents |
| HY-W002519 | (S)-2-Amino-2-(4-fluorophenyl)acetic acid | 19883-57-9 | Peptides |
| HY-W002520 | Methyl 2-aminoisobutyrate (hydrochloride) | 15028-41-8 | Biochemical Assay Reagents |
| HY-W002530 | (1S,2R)-1-Aminoindan-2-ol | 126456-43-7 | Biochemical Assay Reagents |
| HY-W002530A | (1R,2R)-1-Aminoindan-2-ol | 163061-73-2 | Reference compound |
| HY-W002540 | 6-Aminopicolinic acid | 23628-31-1 | Biochemical Assay Reagents |
| HY-W002553 | 4,6-Dichloronicotinic acid | 73027-79-9 | Biochemical Assay Reagents |
| HY-W002555 | 4-Aminonicotinic acid | 7418-65-7 | Reference compound |
| HY-W002558 | Ethyl 4,6-dichloronicotinate | 40296-46-6 | Biochemical Assay Reagents |
| HY-W002559 | 5-Bromoquinoline | 4964-71-0 | Biochemical Assay Reagents |
| HY-W002564 | 4,4-Dimethylcyclohexanone | 4255-62-3 | Biochemical Assay Reagents |
| HY-W002569 | 2-Methoxyphenylboronic acid | 5720-06-9 | Biochemical Assay Reagents |
| HY-W002570 | 2-Naphthylboronic acid | 32316-92-0 | Biochemical Assay Reagents |
| HY-W002570S | 2-Naphthylboronic acid-d7 | 1453542-02-3 | Isotope-Labeled Compounds |
| HY-W002578 | N-Carbobenzyloxy--amino-L-alanine | 35761-26-3 | Peptides |
| HY-W002585 | O6-Benzylguanine | 19916-73-5 | Reference compound |
| HY-W002586 | 1-Chloro-2-ethynylbenzene | 873-31-4 | Biochemical Assay Reagents |
| HY-W002587 | 4-Hydroxy-3-methylbenzoic acid | 499-76-3 | Natural Products |
| HY-W002588 | (R)-3-(4-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid | 79561-82-3 | Peptides |
| HY-W002593 | 2-Acetyl-6-bromopyridine | 49669-13-8 | Biochemical Assay Reagents |
| HY-W002597 | (S)-(-)-4-Hydroxy-2-pyrrolidinone | 68108-18-9 | Biochemical Assay Reagents |
| HY-W002603 | Benzyl piperazine-1-carboxylate | 31166-44-6 | Biochemical Assay Reagents |
| HY-W002616 | 5-Bromoindolin-2-one | 20870-78-4 | Biochemical Assay Reagents |
| HY-W002620 | Emoxypine | 2364-75-2 | Biochemical Assay Reagents |
| HY-W002620A | Emoxypine (succinate) | 127464-43-1 | Reference compound |
| HY-W002620S | Emoxypine-d5 | Isotope-Labeled Compounds | |
| HY-W002623 | 1,4-Benzodioxane-6-carboxylic acid | 4442-54-0 | Biochemical Assay Reagents |
| HY-W002625 | Ethyl 2-bromothiazole-5-carboxylate | 41731-83-3 | Biochemical Assay Reagents |
| HY-W002651 | 4,7-Dibromo-2,1,3-benzothiadiazole | 15155-41-6 | Biochemical Assay Reagents |
| HY-W002668 | 5-Bromo-2-iodopyridine | 223463-13-6 | Biochemical Assay Reagents |
| HY-W002677 | Fluoroquinolonic acid | 86393-33-1 | Reference compound |
| HY-W002677R | Fluoroquinolonic acid (Standard) | 86393-33-1 | Reference Standards |
| HY-W002680 | (2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | 114676-69-6 | ADC Related |
| HY-W002687 | 7-Bromo-1H-indole | 51417-51-7 | Biochemical Assay Reagents |
| HY-W002688 | 2,6-Dichloro-5-fluoronicotinic acid | 82671-06-5 | Biochemical Assay Reagents |
| HY-W002698 | 1-Benzoylpiperazine | 13754-38-6 | Biochemical Assay Reagents |
| HY-W002698S | 1-Benzoylpiperazine-d8 | 1219805-49-8 | Isotope-Labeled Compounds |
| HY-W002711 | 5-Azaindole | 271-34-1 | Biochemical Assay Reagents |
| HY-W002718 | 2,4,6-Trichloropyridine | 16063-69-7 | Biochemical Assay Reagents |
| HY-W002725 | 2,6-Dimethylphenylboronic acid | 100379-00-8 | Biochemical Assay Reagents |
| HY-W002727 | 4-Bromo-2-nitrobenzoic acid | 99277-71-1 | Biochemical Assay Reagents |
| HY-W002733 | 2-Hydroxyphenylboronic acid | 89466-08-0 | Biochemical Assay Reagents |
| HY-W002734 | (3-Hydroxyphenyl)boronic acid | 87199-18-6 | Biochemical Assay Reagents |
| HY-W002736 | N,N'-Di-Boc-1H-pyrazole-1-carboximidamide | 152120-54-2 | Biochemical Assay Reagents |
| HY-W002751 | 6-Methylsalicylic acid | 567-61-3 | Natural Products |
| HY-W002762 | Dibenzothiophene-4-boronic acid | 108847-20-7 | Biochemical Assay Reagents |
| HY-W002765 | 2-Hydroxy-isonicotinic acid | 22282-72-0 | Biochemical Assay Reagents |
| HY-W002767 | 5-Bromo-2-chloropyridine | 53939-30-3 | Biochemical Assay Reagents |
| HY-W002773 | Methyl isovanillate | 6702-50-7 | Natural Products |
| HY-W002798 | Cyclopropanesulfonyl chloride | 139631-62-2 | Biochemical Assay Reagents |
| HY-W002801 | 2-Benzyloxyphenylboronic acid | 190661-29-1 | Biochemical Assay Reagents |
| HY-W002802 | 4-Iodo-1H-imidazole | 71759-89-2 | Biochemical Assay Reagents |
| HY-W002805 | 2-Bromoisonicotinic acid | 66572-56-3 | Biochemical Assay Reagents |
| HY-W002820 | 2-Amino-5-phenylpyridine | 33421-40-8 | Natural Products |
| HY-W002849 | Cyjohnphos | 247940-06-3 | Biochemical Assay Reagents |
| HY-W002855 | 4-Pyridin-2-yl-benzaldehyde | 127406-56-8 | Biochemical Assay Reagents |
| HY-W002858 | 2-Chloro-5-iodopyridine | 69045-79-0 | Biochemical Assay Reagents |
| HY-W002860 | Cycloheptane-1,3-dione | 1194-18-9 | Biochemical Assay Reagents |
| HY-W002863 | 5-Bromo-6-chloronicotinic acid | 29241-62-1 | Biochemical Assay Reagents |
| HY-W002864 | 6-Bromonicotinic acid | 6311-35-9 | Biochemical Assay Reagents |
| HY-W002874 | Methyl 3-aminopyridine-4-carboxylate | 55279-30-6 | Biochemical Assay Reagents |
| HY-W002878 | TsDPEN | 144222-34-4 | Biochemical Assay Reagents |
| HY-W002879 | 4-Hydroxyphenylboronic acid pinacol ester | 269409-70-3 | Biochemical Assay Reagents |
| HY-W002886 | N-Boc-cis-4-hydroxy-L-proline | 87691-27-8 | ADC Related |
| HY-W002887 | N-Boc-cis-4-Hydroxy-D-proline | 135042-12-5 | ADC Related |
| HY-W002899 | (S)-Boc-nipecotic acid | 88495-54-9 | Biochemical Assay Reagents |
| HY-W002900 | Boc-D-Nip-OH | 163438-09-3 | Biochemical Assay Reagents |
| HY-W002908 | 2-Methoxycarbonylphenylboronic acid | 374538-03-1 | Biochemical Assay Reagents |
| HY-W002914 | 5-Fluoro-2-oxoindoline | 56341-41-4 | Biochemical Assay Reagents |
| HY-W002924 | 6-Chloro-2-fluoro-9H-purine | 1651-29-2 | Biochemical Assay Reagents |
| HY-W002925 | DavePhos | 213697-53-1 | Biochemical Assay Reagents |
| HY-W002945 | 4-Amino-3-iodopyridine | 88511-27-7 | Biochemical Assay Reagents |
| HY-W002950 | Erlotinib lactam impurity | 179688-29-0 | Reference compound |
| HY-W002967 | 3-Bromopyridine-2-carbonitrile | 55758-02-6 | Biochemical Assay Reagents |
| HY-W002971 | 4-Chloro-2-fluorobenzeneboronic acid | 160591-91-3 | Biochemical Assay Reagents |
| HY-W003017 | 5-Quinolinylboronic acid | 355386-94-6 | Biochemical Assay Reagents |
| HY-W003027 | 2-Bromo-5-iodopyridine | 73290-22-9 | Biochemical Assay Reagents |
| HY-W003037 | 5-Bromonicotinaldehyde | 113118-81-3 | Biochemical Assay Reagents |
| HY-W003041 | 2,6-Dichloro-3-cyanopyridine | 40381-90-6 | Biochemical Assay Reagents |
| HY-W003045 | 3-Bromopyridin-2-ol | 13466-43-8 | Biochemical Assay Reagents |
| HY-W003049 | 3-Carboxyphenylboronic acid pinacol ester | 269409-73-6 | Biochemical Assay Reagents |
| HY-W003050 | 2-Isopropylbenzeneboronic acid | 89787-12-2 | Biochemical Assay Reagents |
| HY-W003093 | 2-Amino-4-bromobenzoic acid | 20776-50-5 | Biochemical Assay Reagents |
| HY-W003112 | 4-Fluororesorcinol | 103068-41-3 | Dye Reagents |
| HY-W003129 | 2-Bromo-4-chloropyridine | 22918-01-0 | Biochemical Assay Reagents |
| HY-W003140 | tert-Butyl 3-hydroxypyrrolidine-1-carboxylate | 103057-44-9 | Biochemical Assay Reagents |
| HY-W003145 | Methyl 2-aminoisonicotinate | 6937-03-7 | Biochemical Assay Reagents |
| HY-W003162 | 2-Amino-6-fluoropyridine | 1597-32-6 | Biochemical Assay Reagents |
| HY-W003165 | 3-Bromo-5-chloropyridine | 73583-39-8 | Biochemical Assay Reagents |
| HY-W003177 | tert-Butyl 4-iodopiperidine-1-carboxylate | 301673-14-3 | Biochemical Assay Reagents |
| HY-W003178 | 6-Bromo-2-chloroquinoline | 1810-71-5 | Biochemical Assay Reagents |
| HY-W003182 | 6-Bromobenzo[d]thiazole | 53218-26-1 | Biochemical Assay Reagents |
| HY-W003222 | N-tert-Boc-cis-4-fluoro-L-proline | 203866-13-1 | Peptides |
| HY-W003225 | 3-Bromo-DL-phenylalanine | 30163-20-3 | Peptides |
| HY-W003233 | 1-Boc-pyrazole-4-boronic acid pinacol ester | 552846-17-0 | Biochemical Assay Reagents |
| HY-W003282 | 3,6-Dibromo-2-methylpyridine | 39919-65-8 | Biochemical Assay Reagents |
| HY-W003318 | (R)-2-Amino-3-(3-bromophenyl)propanoic acid | 99295-78-0 | Peptides |
| HY-W003321 | (S)-tert-Butyl 5-oxopyrrolidine-2-carboxylate | 35418-16-7 | Biochemical Assay Reagents |
| HY-W003365 | (2-Chloro-4-pyridinyl)methanol | 100704-10-7 | Biochemical Assay Reagents |
| HY-W003371 | CGP 44 645 | 134521-16-7 | Reference compound |
| HY-W003371R | CGP 44 645 (Standard) | 134521-16-7 | Reference Standards |
| HY-W003396 | 4-Bromotetrahydropyran | 25637-16-5 | Biochemical Assay Reagents |
| HY-W003445 | 4-Bromo-3-hydroxybenzoic acid | 14348-38-0 | Reference compound |
| HY-W003467 | Rabeprazole Sulfide | 117977-21-6 | Reference compound |
| HY-W003467R | Rabeprazole Sulfide (Standard) | 117977-21-6 | Reference Standards |
| HY-W003486 | 5,7-Dichloropyrazolo[1,5-a]pyrimidine | 57489-77-7 | Reference compound |
| HY-W003499 | (S)-3-Benzyloxycarbonylamino-2-(Boc-amino)propionic acid | 65710-57-8 | Peptides |
| HY-W003511 | tans-4-Hydroxy-D-proline (hydrochloride) | 142347-81-7 | ADC Related |
| HY-W003561 | DHFR-IN-3 | 137553-43-6 | Reference compound |
| HY-W003575 | 3-Amino-5-bromo-2-methylpyridine | 914358-73-9 | Biochemical Assay Reagents |
| HY-W003576 | ACHE-IN-38 (hydrochloride) | 120013-39-0 | Reference compound |
| HY-W003576R | ACHE-IN-38 (hydrochloride) (Standard) | 120013-39-0 | Reference Standards |
| HY-W003592A | L-Orinithine lactam (hydrochloride) | 42538-31-8 | Reference compound |
| HY-W003601 | 2-Bromo-4-fluoropyridine | 357927-50-5 | Biochemical Assay Reagents |
| HY-W003603S | 2-Bromo-9,9-dimethylfluorene-d7 | 2778350-02-8 | Isotope-Labeled Compounds |
| HY-W003605 | Boc-D-Pyr-Oet | 144978-35-8 | Peptides |
| HY-W003605A | 1-Boc-DL-Pyroglutamic acid ethyl ester | 251924-83-1 | Peptides |
| HY-W003607 | 3-O-Ethyl-L-ascorbic acid | 86404-04-8 | Reference compound |
| HY-W003607R | 3-O-Ethyl-L-ascorbic acid (Standard) | 86404-04-8 | Reference Standards |
| HY-W003686 | 5-Bromo-6-chloropyrazin-2-amine | 173253-42-4 | Reference compound |
| HY-W003696 | tert-Butyl 5-bromoisoindoline-2-carboxylate | 201940-08-1 | Reference compound |
| HY-W003793 | Ethyl 6-bromo-1H-indole-3-carboxylate | 103858-55-5 | Natural Products |
| HY-W003836 | 7-Methyl-1-naphthyl acetic acid | 6836-22-2 | Natural Products |
| HY-W003903 | Methyl benzyl-DL-serinate | 144001-42-3 | Peptides |
| HY-W003903A | Methyl benzyl-L-serinate | 123639-56-5 | Peptides |
| HY-W003943 | 6-Hydroxypyridin-3-ylboronic acid | 903899-13-8 | Reference compound |
| HY-W003969 | Aminopicoline | 695-34-1 | Reference compound |
| HY-W003969R | Aminopicoline (Standard) | 695-34-1 | Reference Standards |
| HY-W003971 | 2-Bromo-4-fluorophenol | 496-69-5 | Biochemical Assay Reagents |
| HY-W003972 | 2,6-Dimethoxyphenol | 91-10-1 | Reference compound |
| HY-W003972R | 2,6-Dimethoxyphenol (Standard) | 91-10-1 | Reference Standards |
| HY-W003972S | 2,6-Dimethoxyphenol-d3 | 2484091-60-1 | Isotope-Labeled Compounds |
| HY-W003972S1 | 2,6-Dimethoxyphenol-d6 | Isotope-Labeled Compounds | |
| HY-W003977 | Methyl 4-boronobenzoate | 99768-12-4 | Biochemical Assay Reagents |
| HY-W003985 | N-Boc-3-(2-pyridyl)-L-alanine | 71239-85-5 | Peptides |
| HY-W003991 | N-Benzyl-N-Cbz-glycine | 76315-01-0 | Peptides |
| HY-W003995 | Ethyl 2-chloropyrimidine-5-carboxylate | 89793-12-4 | Biochemical Assay Reagents |
| HY-W004029 | 5-Quinolinecarboxylic acid | 7250-53-5 | Biochemical Assay Reagents |
| HY-W004048 | Sodium 4-methylbenzenesulfonate | 657-84-1 | Biochemical Assay Reagents |
| HY-W004049 | 3-Hydroxybenzoic acid | 99-06-9 | Natural Products |
| HY-W004049R | 3-Hydroxybenzoic acid (Standard) | 99-06-9 | Reference Standards |
| HY-W004051S | 1-Bromo-2-chlorobenzene-d4 | 1219795-51-3 | Isotope-Labeled Compounds |
| HY-W004056 | 4-Methoxyphenethyl alcohol | 702-23-8 | Natural Products |
| HY-W004059 | Benzhydrol | 91-01-0 | Biochemical Assay Reagents |
| HY-W004059S | Diphenylmethanol-d5 | 95450-78-5 | Isotope-Labeled Compounds |
| HY-W004063 | (S)-3-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)propanoic acid | 23680-31-1 | Peptides |
| HY-W004064 | N-Boc-O-Benzyl-D-serine | 47173-80-8 | Peptides |
| HY-W004066 | Ac-Ala-OH | 97-69-8 | Natural Products |
| HY-W004066R | Ac-Ala-OH (Standard) | 97-69-8 | Reference Standards |
| HY-W004066S | Ac-Ala-OH-d3 | 1485548-36-4 | Isotope-Labeled Compounds |
| HY-W004066S1 | Ac-Ala-OH-d4 | 2230887-18-8 | Isotope-Labeled Compounds |
| HY-W004078 | 4-Hydroxybenzylamine | 696-60-6 | Natural Products |
| HY-W004082 | 2-Bromo-2'-fluoroacetophenone | 655-15-2 | Biochemical Assay Reagents |
| HY-W004083 | Boc-D-Asp(OBzl)-OH | 51186-58-4 | Peptides |
| HY-W004091 | Methyl 3-boronobenzoate | 99769-19-4 | Biochemical Assay Reagents |
| HY-W004098 | Boc-D-Met-OH | 5241-66-7 | Peptides |
| HY-W004101 | Fmoc-D-Abu-OH | 170642-27-0 | Peptides |
| HY-W004104 | 4-Ethynylanisole | 768-60-5 | Biochemical Assay Reagents |
| HY-W004110 | BOC-O-Benzyl-L-threonine | 15260-10-3 | Peptides |
| HY-W004113S | 3,5-Dichlorophenol-d3 | 124286-06-2 | Isotope-Labeled Compounds |
| HY-W004114 | N-Acetyl-L-proline | 68-95-1 | Peptides |
| HY-W004116 | 2-Benzofurylboronic acid | 98437-24-2 | Biochemical Assay Reagents |
| HY-W004121 | 4-Biphenylsulfonyl chloride | 1623-93-4 | Biochemical Assay Reagents |
| HY-W004126 | 2-Iodopyridine | 5029-67-4 | Biochemical Assay Reagents |
| HY-W004128 | 4-(Hydroxymethyl)phenylacetic acid | 73401-74-8 | Reference compound |
| HY-W004131 | 3-Bromomethylpyridine (hydrobromide) | 4916-55-6 | Biochemical Assay Reagents |
| HY-W004148S | 1-(2-Pyrimidinyl)piperazine-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W004153 | S-(Acetamidomethyl)-N-(tert-butoxycarbonyl)-L-cysteine | 19746-37-3 | Peptides |
| HY-W004154 | 2-Ethylbutyric acid | 88-09-5 | Natural Products |
| HY-W004154R | 2-Ethylbutyric acid (Standard) | 88-09-5 | Reference Standards |
| HY-W004206 | 2-(4-Methoxyphenyl)acetic acid | 104-01-8 | Natural Products |
| HY-W004212 | 4-(Trifluoromethyl)-1H-pyrazole | 52222-73-8 | Biochemical Assay Reagents |
| HY-W004260 | Arachidic acid | 506-30-9 | Natural Products |
| HY-W004260A | Arachidate (sodium) | 13257-34-6 | Natural Products |
| HY-W004260B | Dieicosanoin | 60586-60-9 | Natural Products |
| HY-W004260R | Arachidic acid (Standard) | 506-30-9 | Reference Standards |
| HY-W004260S | Arachidic acid-d2 | 232600-70-3 | Isotope-Labeled Compounds |
| HY-W004260S1 | Arachidic acid-d39 | 39756-32-6 | Isotope-Labeled Compounds |
| HY-W004260S2 | Arachidic acid-d3 | 202480-70-4 | Isotope-Labeled Compounds |
| HY-W004260S4 | Arachidic acid-d4 | 1219803-69-6 | Isotope-Labeled Compounds |
| HY-W004260S5 | Arachidic acid-d4-1 | 2483831-15-6 | Isotope-Labeled Compounds |
| HY-W004261 | Nonadecanoic acid | 646-30-0 | Natural Products |
| HY-W004261R | Nonadecanoic acid (Standard) | 646-30-0 | Reference Standards |
| HY-W004261S | Nonadecanoic acid-d37 | 1219798-49-8 | Isotope-Labeled Compounds |
| HY-W004262 | Methyl nonadecanoate | 1731-94-8 | Reference compound |
| HY-W004263 | 1-Eicosanol | 629-96-9 | Natural Products |
| HY-W004263R | 1-Eicosanol (Standard) | 629-96-9 | Reference Standards |
| HY-W004263S | 1-Eicosanol-d41 | 349553-89-5 | Isotope-Labeled Compounds |
| HY-W004264S | Tetrahydro-2H-pyran-4-ol-d5 | 1219795-46-6 | Isotope-Labeled Compounds |
| HY-W004282 | Undecanoic acid | 112-37-8 | Natural Products |
| HY-W004282R | Undecanoic acid (Standard) | 112-37-8 | Reference Standards |
| HY-W004282S | Undecanoic acid-d21 | 60658-40-4 | Isotope-Labeled Compounds |
| HY-W004282S1 | Undecanoic acid-d3 | 1219802-11-5 | Isotope-Labeled Compounds |
| HY-W004282S2 | Undecanoic acid-d2 | 64118-43-0 | Isotope-Labeled Compounds |
| HY-W004283 | Pentadecanoic acid | 1002-84-2 | Natural Products |
| HY-W004283R | Pentadecanoic acid (Standard) | 1002-84-2 | Reference Standards |
| HY-W004283S | Pentadecanoic acid-d29 | 130348-95-7 | Isotope-Labeled Compounds |
| HY-W004283S1 | Pentadecanoic acid-d3 | 352431-40-4 | Isotope-Labeled Compounds |
| HY-W004283S2 | Pentadecanoic acid-d2 | 64118-45-2 | Isotope-Labeled Compounds |
| HY-W004284 | Heptadecanoic acid | 506-12-7 | Natural Products |
| HY-W004284R | Heptadecanoic acid (Standard) | 506-12-7 | Reference Standards |
| HY-W004284S | Heptadecanoic acid-d3 | 202528-95-8 | Isotope-Labeled Compounds |
| HY-W004284S1 | Heptadecanoic acid-d33 | 352431-41-5 | Isotope-Labeled Compounds |
| HY-W004285 | Methyl undecanoate | 1731-86-8 | Natural Products |
| HY-W004285R | Methyl undecanoate (Standard) | 1731-86-8 | Reference Standards |
| HY-W004285S | Methyl undecanoate-d21 | 1219804-96-2 | Isotope-Labeled Compounds |
| HY-W004286 | Methyl laurate | 111-82-0 | Natural Products |
| HY-W004286R | Methyl laurate (Standard) | 111-82-0 | Reference Standards |
| HY-W004287 | Methyl tridecanoate | 1731-88-0 | Natural Products |
| HY-W004287R | Methyl tridecanoate (Standard) | 1731-88-0 | Reference Standards |
| HY-W004287S | Methyl tridecanoate-d25 | 1219804-90-6 | Isotope-Labeled Compounds |
| HY-W004288 | Methyl myristate | 124-10-7 | Natural Products |
| HY-W004288R | Methyl myristate (Standard) | 124-10-7 | Reference Standards |
| HY-W004288S | Methyl tetradecanoate-d27 | 434349-93-6 | Isotope-Labeled Compounds |
| HY-W004289 | Methyl pentadecanoate | 7132-64-1 | Natural Products |
| HY-W004289S | Methyl pentadecanoate-d29 | 68060-02-6 | Isotope-Labeled Compounds |
| HY-W004290 | Methyl heptadecanoate | 1731-92-6 | Natural Products |
| HY-W004290R | Methyl heptadecanoate (Standard) | 1731-92-6 | Reference Standards |
| HY-W004290S | Methyl heptadecanoate-d33 | 1219804-81-5 | Isotope-Labeled Compounds |
| HY-W004291 | Methyl arachidate | 1120-28-1 | Natural Products |
| HY-W004291R | Methyl arachidate (Standard) | 1120-28-1 | Reference Standards |
| HY-W004292 | 1-Undecanol | 112-42-5 | Natural Products |
| HY-W004292R | 1-Undecanol (Standard) | 112-42-5 | Reference Standards |
| HY-W004292S | 1-Undecanol-d23 | 349553-88-4 | Isotope-Labeled Compounds |
| HY-W004292S1 | 1-Undecanol-d4 | 1219803-47-0 | Isotope-Labeled Compounds |
| HY-W004293 | 1-Tridecanol | 112-70-9 | Biochemical Assay Reagents |
| HY-W004293S | 1-Tridecanol-d27 | 203633-18-5 | Isotope-Labeled Compounds |
| HY-W004294 | 1-Tetradecanol | 112-72-1 | Natural Products |
| HY-W004294R | 1-Tetradecanol (Standard) | 112-72-1 | Reference Standards |
| HY-W004294S | 1-Tetradecanol-d29 | 284474-78-8 | Isotope-Labeled Compounds |
| HY-W004294S1 | 1-Tetradecanol-d2 | 169398-02-1 | Isotope-Labeled Compounds |
| HY-W004295 | 1-Pentadecanol | 629-76-5 | Natural Products |
| HY-W004295R | 1-Pentadecanol (Standard) | 629-76-5 | Reference Standards |
| HY-W004295S | 1-Pentadecanol-d31 | 349553-87-3 | Isotope-Labeled Compounds |
| HY-W004296 | 1-Heptadecanol | 1454-85-9 | Natural Products |
| HY-W004297 | 1-Nonadecanol | 1454-84-8 | Natural Products |
| HY-W004297R | 1-Nonadecanol (Standard) | 1454-84-8 | Reference Standards |
| HY-W004298 | 10-Undecen-1-ol,98% (stabilized with MEHQ) | 112-43-6 | Reference compound |
| HY-W004298R | 10-Undecen-1-ol (Standard) | 112-43-6 | Reference Standards |
| HY-W004301 | Dodecanal | 112-54-9 | Natural Products |
| HY-W004305 | Hexadecanal | 629-80-1 | Natural Products |
| HY-W004305R | Hexadecanal (Standard) | 629-80-1 | Reference Standards |
| HY-W004305S | Hexadecanal-d5 | 2703602-66-6 | Isotope-Labeled Compounds |
| HY-W004307 | Octadecanal | 638-66-4 | Natural Products |
| HY-W004311 | 6-Chloro-1-tetralone | 26673-31-4 | Biochemical Assay Reagents |
| HY-W004316 | 2-Methyl-1-tetralone | 1590-08-5 | Biochemical Assay Reagents |
| HY-W004328S | Piperidin-4-ol-d5 | 1219799-35-5 | Isotope-Labeled Compounds |
| HY-W004328S1 | Piperidin-4-ol-d9 | 1219799-39-9 | Isotope-Labeled Compounds |
| HY-W004328S2 | Piperidin-4-ol-d4 | 1014695-51-2 | Isotope-Labeled Compounds |
| HY-W004330S | Piperidin-4-amine-d5 | 1219803-60-7 | Isotope-Labeled Compounds |
| HY-W004333 | 1-Indanone | 83-33-0 | Biochemical Assay Reagents |
| HY-W004337 | 6-Bromonicotinonitrile | 139585-70-9 | Biochemical Assay Reagents |
| HY-W004338 | 1-Methylcyclohexene | 591-49-1 | Natural Products |
| HY-W004356S | (Rac)-Tenofovir alafenamide-d5 | Isotope-Labeled Compounds | |
| HY-W004360 | BIBR 1087 SE | 212321-78-3 | Reference compound |
| HY-W004392S | 2-Ethylhexyl bromide-d17 | 1398065-97-8 | Isotope-Labeled Compounds |
| HY-W004412 | Olanzapine-lactam | 221176-49-4 | Reference compound |
| HY-W004412R | Olanzapine-lactam (Standard) | 221176-49-4 | Reference Standards |
| HY-W004425 | DMPX | 14114-46-6 | Reference compound |
| HY-W004432 | 7-Bromoquinoline | 4965-36-0 | Biochemical Assay Reagents |
| HY-W004440 | 2,2'-(Piperazine-1,4-diyl)diethanamine | 6531-38-0 | Reference compound |
| HY-W004447 | Pentaethylene glycol di(p-toluenesulfonate) | 41024-91-3 | Reference compound |
| HY-W004461 | S-Methyl thiomethanesulfonate | 2949-92-0 | Reference compound |
| HY-W004464 | 2-(1-Piperazinyl)pyrimidine | 20980-22-7 | Reference compound |
| HY-W004464R | 2-(1-Piperazinyl)pyrimidine (Standard) | 20980-22-7 | Reference Standards |
| HY-W004464S | 2-(1-Piperazinyl)pyrimidine-d8 | 1309283-31-5 | Isotope-Labeled Compounds |
| HY-W004486 | Gallic aldehyde | 13677-79-7 | Reference compound |
| HY-W004494 | 2-Aminoindan-2-phosphonic acid | 141120-17-4 | Reference compound |
| HY-W004500 | All-trans-retinal | 116-31-4 | Natural Products |
| HY-W004515 | 3-Pyridylacetic acid (hydrochloride) | 6419-36-9 | Reference compound |
| HY-W004515R | 3-Pyridylacetic acid (hydrochloride) (Standard) | 6419-36-9 | Reference Standards |
| HY-W004515S | 3-Pyridylacetic acid-d4 (hydrochloride) | 1219802-37-5 | Isotope-Labeled Compounds |
| HY-W004520 | Phenazine (methylsulfate) | 299-11-6 | Reference compound |
| HY-W004520R | Phenazine (methylsulfate) (Standard) | 299-11-6 | Reference Standards |
| HY-W004544 | o-Phenanthroline | 66-71-7 | Biochemical Assay Reagents |
| HY-W004544S | o-Phenanthroline-d8 | 90412-47-8 | Isotope-Labeled Compounds |
| HY-W004546 | Abametapir | 1762-34-1 | Reference compound |
| HY-W004546R | Abametapir (Standard) | 1762-34-1 | Reference Standards |
| HY-W004547 | (NH2)2bpy | 18511-69-8 | Biochemical Assay Reagents |
| HY-W004563 | Neocuproine | 484-11-7 | Biochemical Assay Reagents |
| HY-W004564 | 5,6-Diamino-1,10-phenanthroline | 168646-54-6 | Reference compound |
| HY-W004570 | 5-Nitro-1,10-phenanthroline | 4199-88-6 | Reference compound |
| HY-W004580 | 5,5'-Dicarboxy-2,2'-bipyridine | 1802-30-8 | Reference compound |
| HY-W004599 | Bicinchoninic acid | 1245-13-2 | Reference compound |
| HY-W004615 | Thiophene-3-carboxylic acid | 88-13-1 | Biochemical Assay Reagents |
| HY-W004615R | Thiophene-3-carboxylic acid (Standard) | 88-13-1 | Reference Standards |
| HY-W004640 | N-Boc-C1-PEG3-C3-NH2 | 194920-62-2 | Reference compound |
| HY-W004643 | Akardite II | 13114-72-2 | Reference compound |
| HY-W004649 | Tris-BOC-cyclen | 175854-39-4 | Biochemical Assay Reagents |
| HY-W004650 | TETA (hydrochloride hydrate) | 207737-99-3 | Biochemical Assay Reagents |
| HY-W004660 | 4-Ethynylaniline | 14235-81-5 | Biochemical Assay Reagents |
| HY-W004661 | 1,4-Dioxane-2,5-diol | 23147-58-2 | Natural Products |
| HY-W004663S | 4-Bromobenzonitrile-d4 | 771534-56-6 | Isotope-Labeled Compounds |
| HY-W004675 | 2-Aminoterephthalic acid | 10312-55-7 | Biochemical Assay Reagents |
| HY-W004678 | (2-Iodophenyl)methanol | 5159-41-1 | Biochemical Assay Reagents |
| HY-W004681S | 5-Hydroxy-2-methylpyridine-d6 | 2645412-74-2 | Isotope-Labeled Compounds |
| HY-W004691S | 4-Methylbenzenesulfonhydrazide-d3 | 109333-73-5 | Isotope-Labeled Compounds |
| HY-W004695 | (S)-3-Fluoropyrrolidine (hydrochloride) | 136725-53-6 | Biochemical Assay Reagents |
| HY-W004697 | Boc-GABA-OH | 57294-38-9 | Reference compound |
| HY-W004698 | (2-Methoxypyrimidin-5-yl)boronic acid | 628692-15-9 | Biochemical Assay Reagents |
| HY-W004701 | Br-C3-methyl ester | 4897-84-1 | Reference compound |
| HY-W004702 | Methyl methanesulfonate | 66-27-3 | Biochemical Assay Reagents |
| HY-W004702R | Methyl methanesulfonate (Standard) | 66-27-3 | Reference Standards |
| HY-W004702S | Methyl methanesulfonate-d3 | 91419-94-2 | Isotope-Labeled Compounds |
| HY-W004705 | (2-Aminophenyl)methanol | 5344-90-1 | Biochemical Assay Reagents |
| HY-W004710 | NH2-C5-NH-Boc | 51644-96-3 | Reference compound |
| HY-W004713 | 5′-Chloro-2′-hydroxyacetophenone | 1450-74-4 | Biochemical Assay Reagents |
| HY-W004715 | 3-Bromophenylboronic acid | 89598-96-9 | Biochemical Assay Reagents |
| HY-W004721 | 5-Hydroxyisoquinoline | 2439-04-5 | Biochemical Assay Reagents |
| HY-W004756 | 3,4-Dibromo-1H-pyrrole-2,5-dione | 1122-10-7 | Biochemical Assay Reagents |
| HY-W004758 | 1-(4-Chlorophenyl)piperazine | 38212-33-8 | Reference compound |
| HY-W004761 | Tetrahydroxydiboron | 13675-18-8 | Biochemical Assay Reagents |
| HY-W004766 | 3-Bromophenylacetic acid | 1878-67-7 | Biochemical Assay Reagents |
| HY-W004767 | Isoindolinone | 480-91-1 | Biochemical Assay Reagents |
| HY-W004784 | 3-Butynoic acid | 2345-51-9 | Biochemical Assay Reagents |
| HY-W004788 | 5-Bromotetralone | 68449-30-9 | Reference compound |
| HY-W004801 | Benzofuran-3-carbaldehyde | 4687-25-6 | Reference compound |
| HY-W004812 | BOC-(1R,3S)-3-aminocyclopentane carboxylic acid | 161660-94-2 | Reference compound |
| HY-W004816 | Bis-Tos-PEG4 | 37860-51-8 | Reference compound |
| HY-W004843 | 3-Amino-1,2,4-triazine | 1120-99-6 | Reference compound |
| HY-W004850 | Aminoacetone (hydrochloride) | 7737-17-9 | Reference compound |
| HY-W004855 | Quinoline-6-carboxylic acid | 10349-57-2 | Biochemical Assay Reagents |
| HY-W004860 | 4-Bromopicolinic acid | 30766-03-1 | Biochemical Assay Reagents |
| HY-W004861 | 2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid | 54895-12-4 | Peptides |
| HY-W004863 | 4-Bromo-2-methylbenzoic acid | 68837-59-2 | Biochemical Assay Reagents |
| HY-W004864 | Fmoc-(S)-2-(4-pentenyl)Ala-OH | 288617-73-2 | Peptides |
| HY-W004868 | 1-Cbz-azetidine-3-carboxylic acid | 97628-92-7 | ADC Related |
| HY-W004874 | 2,6-Dimethylhydroquinone | 654-42-2 | Natural Products |
| HY-W004882 | 6-Hydroxy-1-tetralone | 3470-50-6 | Biochemical Assay Reagents |
| HY-W004883 | 3-Amino-4,6-dimethylpyridine | 1193-71-1 | Reference compound |
| HY-W004896 | Boc-NH-PEG2 | 139115-91-6 | Reference compound |
| HY-W004924 | 5-Hydroxymethyluracil | 4433-40-3 | Natural Products |
| HY-W004924S | 5-Hydroxymethyluracil-d3 | 352438-73-4 | Isotope-Labeled Compounds |
| HY-W004925 | 3-Oxetanemethanol | 6246-06-6 | Biochemical Assay Reagents |
| HY-W004945 | 3,6-Dioxaoctanedioic acid | 23243-68-7 | Reference compound |
| HY-W004963 | Tetrabutylammonium difluorotriphenylsilicate(IV) | 163931-61-1 | Biochemical Assay Reagents |
| HY-W004978 | 1,5-Dimethyl-1H-pyrazole-3-carboxylic acid | 5744-59-2 | Biochemical Assay Reagents |
| HY-W004980 | 5-Bromo-2-chloro-4-methoxypyrimidine | 57054-92-9 | Reference compound |
| HY-W005012 | 1,3-Dibromo-2,2-dimethoxypropane | 22094-18-4 | Biochemical Assay Reagents |
| HY-W005014 | Methyl 2-amino-2-cyclopropylacetate hydrochloride | 535936-86-8 | Peptides |
| HY-W005028 | 1-Methylguanidine (monohydrochloride) | 21770-81-0 | Natural Products |
| HY-W005056 | Boc-NH-PEG2-CH2COOH | 108466-89-3 | Reference compound |
| HY-W005085 | 5-Fluoro-2-methoxybenzaldehyde | 19415-51-1 | Biochemical Assay Reagents |
| HY-W005117 | H-DL-Gly-OBzl (hydrochloride) | 2462-31-9 | Peptides |
| HY-W005118 | 2-Amino-4-fluoropyridine | 944401-77-8 | Biochemical Assay Reagents |
| HY-W005130 | 2,4,6-Trihydroxybenzaldehyde | 487-70-7 | Natural Products |
| HY-W005143 | (S)-2-((tert-Butoxycarbonyl)amino)-5-methoxy-5-oxopentanoic acid | 45214-91-3 | Peptides |
| HY-W005144 | Boc-Lys(Fmoc)-OH | 84624-27-1 | Peptides |
| HY-W005148 | 3-Amino-2-naphthoic acid | 5959-52-4 | Biochemical Assay Reagents |
| HY-W005151S | 1-(3,4-Dimethoxyphenyl)ethanone-d3 | 350818-54-1 | Isotope-Labeled Compounds |
| HY-W005174A | 1-(4-Trifluoromethylphenyl)piperazine (hydrochloride) | 2640680-83-5 | Reference compound |
| HY-W005176 | Methyl 3-oxohexanoate | 30414-54-1 | Biochemical Assay Reagents |
| HY-W005178 | Octadecanedioic acid | 871-70-5 | Natural Products |
| HY-W005178R | Octadecanedioic acid (Standard) | 871-70-5 | Reference Standards |
| HY-W005186 | 6-Bromocoumarin | 19063-55-9 | Reference compound |
| HY-W005223 | (R)-Tetrahydrofuran-2-carboxylic acid | 87392-05-0 | Biochemical Assay Reagents |
| HY-W005226 | 2-Amino-2-(4-hydroxyphenyl)acetic acid | 938-97-6 | Peptides |
| HY-W005241 | 5-Hydroxymethyl-2-furancarboxylic acid | 6338-41-6 | Natural Products |
| HY-W005241R | 5-Hydroxymethyl-2-furancarboxylic acid (Standard) | 6338-41-6 | Reference Standards |
| HY-W005255 | 3-(3-Hydroxyphenyl)propionic acid | 621-54-5 | Natural Products |
| HY-W005255R | 3-(3-Hydroxyphenyl)propionic acid (Standard) | 621-54-5 | Reference Standards |
| HY-W005266 | 5-Azabenzimidazole | 272-97-9 | Biochemical Assay Reagents |
| HY-W005288 | 4-Vinylphenol (10% in Propylene glycol) | 2628-17-3 | Natural Products |
| HY-W005288S | 4-Vinylphenol-d4 | Isotope-Labeled Compounds | |
| HY-W005295 | H-Lys(Boc)-OtBu.HCl | 13288-57-8 | Peptides |
| HY-W005308 | N-BOC-DL-serine methyl ester | 69942-12-7 | Peptides |
| HY-W005327 | 1-Hydroxy-2-butanone | 5077-67-8 | Natural Products |
| HY-W005327R | 1-Hydroxy-2-butanone (Standard) | 5077-67-8 | Reference Standards |
| HY-W005355 | Sodium 2-oxobutanoate | 2013-26-5 | Biochemical Assay Reagents |
| HY-W005355S | Sodium 2-oxobutanoate-13C4,d2 (hydrate) | 1049736-26-6 | Isotope-Labeled Compounds |
| HY-W005355S1 | Sodium 2-oxobutanoate-d2 (hydrate) | Isotope-Labeled Compounds | |
| HY-W005355S10 | Sodium 2-oxobutanoate-13C4,d2 | 360769-17-1 | Isotope-Labeled Compounds |
| HY-W005355S2 | Sodium 2-oxobutanoate-13C (hydrate) | 634908-43-3 | Isotope-Labeled Compounds |
| HY-W005355S7 | Sodium 2-oxobutanoate-13C,d2 | 1189500-69-3 | Isotope-Labeled Compounds |
| HY-W005355S8 | Sodium 2-oxobutanoate-13C,d4 | 2483824-49-1 | Isotope-Labeled Compounds |
| HY-W005355S9 | Sodium 2-oxobutanoate-13C4 | 2483736-24-7 | Isotope-Labeled Compounds |
| HY-W005379 | DGM | 162401-62-9 | Natural Products |
| HY-W005388 | (S)-2-(Methylamino)-3-phenylpropanoic acid | 2566-30-5 | Peptides |
| HY-W005394 | 2-Phenylpropan-1-amine (hydrochloride) | 20388-87-8 | Reference compound |
| HY-W005394S | (±)-1-Amino-2-phenylpropane-1,1,3,3,3-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W005435S | 2,3,4,5-Tetrahydro-1H-benzo[b]azepine-d2 | 3061606-57-0 | Isotope-Labeled Compounds |
| HY-W005458 | Methyl picolinate | 2459-07-6 | Biochemical Assay Reagents |
| HY-W005482 | 6-Bromovanillin | 60632-40-8 | Biochemical Assay Reagents |
| HY-W005485 | Tetra-O-benzyl-δ-D-Gluconolactone | 13096-62-3 | Biochemical Assay Reagents |
| HY-W005507 | 1-Methylimidazolidin-2-one | 694-32-6 | Biochemical Assay Reagents |
| HY-W005513 | N,N-Bis(2-hydroxyethyl)dodecanamide | 120-40-1 | Reference compound |
| HY-W005540 | 1-Cyclopentenecarboxylic acid | 1560-11-8 | Biochemical Assay Reagents |
| HY-W005541S1 | 3-Ethylphenylboronic acid-d5 | 2241866-92-0 | Isotope-Labeled Compounds |
| HY-W005558 | 6-Aminopyridine-3-boronic acid | 851524-96-4 | Reference compound |
| HY-W005561 | H-Dab(Boc)-OMe (hydrochloride) | 3350-15-0 | Peptides |
| HY-W005592 | 3-Hydroxyphthalic anhydride | 37418-88-5 | Biochemical Assay Reagents |
| HY-W005598 | 2-Hydroxyquinoline | 59-31-4 | Biochemical Assay Reagents |
| HY-W005627 | Linoleyl alcohol | 506-43-4 | Natural Products |
| HY-W005627R | Linoleyl alcohol (Standard) | 506-43-4 | Reference Standards |
| HY-W005629 | Leelamine | 1446-61-3 | Reference compound |
| HY-W005637 | Orthocaine | 536-25-4 | Reference compound |
| HY-W005720 | H-Phg(4-Cl)-OH | 67336-19-0 | Peptides |
| HY-W005749 | (R)-4-Amino-3-hydroxybutyric acid | 7013-07-2 | Reference compound |
| HY-W005759 | H-Cyclopropyl-Gly-OH | 49606-99-7 | Peptides |
| HY-W005815 | Fmoc-HoArg(Pbf)-OH | 1159680-21-3 | Peptides |
| HY-W005824 | 2,6-Dichloropurine riboside | 13276-52-3 | Reference compound |
| HY-W005828 | 9-(Boc-amino)nonanoic acid | 173435-78-4 | Reference compound |
| HY-W005846 | 2-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | 51301-86-1 | Peptides |
| HY-W005864 | 3-Hydroxyphenylboronic acid pinacol ester | 214360-76-6 | Biochemical Assay Reagents |
| HY-W005883 | H-Thr-Obzl.HCl | 33645-24-8 | Peptides |
| HY-W005891 | H-D-Glu-OtBu | 25456-76-2 | Peptides |
| HY-W005913 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpent-4-enoic acid | 288617-76-5 | Peptides |
| HY-W005963 | Methyl 5-hydroxypyridine-2-carboxylate | 30766-12-2 | Natural Products |
| HY-W006000 | Tetrachlorocatechol | 1198-55-6 | Reference compound |
| HY-W006000R | Tetrachlorocatechol (Standard) | 1198-55-6 | Reference Standards |
| HY-W006057 | 3-Methyl-2-oxobutanoic acid | 759-05-7 | Natural Products |
| HY-W006057A | Sodium 3-methyl-2-oxobutanoate | 3715-29-5 | Reference compound |
| HY-W006057AR | Sodium 3-methyl-2-oxobutanoate (Standard) | 3715-29-5 | Reference Standards |
| HY-W006057AS | Sodium 3-methyl-2-oxobutanoate-13C2,d1 | 1216972-87-0 | Isotope-Labeled Compounds |
| HY-W006057AS1 | Sodium 3-methyl-2-oxobutanoate-d1 hydrate | Isotope-Labeled Compounds | |
| HY-W006057AS13 | Sodium 3-methyl-2-oxobutanoate-13C4,d3 | 1215605-14-3 | Isotope-Labeled Compounds |
| HY-W006057AS14 | Sodium 3-methyl-2-oxobutanoate-13C,d4 | 1202865-40-4 | Isotope-Labeled Compounds |
| HY-W006057AS15 | Sodium 3-methyl-2-oxobutanoate-13C,d4-1 | 2483824-45-7 | Isotope-Labeled Compounds |
| HY-W006057AS16 | Sodium 3-methyl-2-oxobutanoate-13C5 | 1173018-24-0 | Isotope-Labeled Compounds |
| HY-W006057AS17 | Sodium 3-Methyl-2-oxobutanoic acid-13C2 | 634908-42-2 | Isotope-Labeled Compounds |
| HY-W006057AS18 | Sodium 3-methyl-2-oxobutanoate-d7 | 2483831-46-3 | Isotope-Labeled Compounds |
| HY-W006057AS2 | Sodium 3-methyl-2-oxobutanoate-13C4,d4 | 1185115-88-1 | Isotope-Labeled Compounds |
| HY-W006057AS3 | Sodium 3-methyl-2-oxobutanoate-13C2,d4 | 1007477-29-3 | Isotope-Labeled Compounds |
| HY-W006057R | 3-Methyl-2-oxobutanoic acid (Standard) | 759-05-7 | Reference Standards |
| HY-W006062 | H-Phg-OtBu.HCl | 161879-12-5 | Peptides |
| HY-W006063 | (R)-3-Amino-4-hydroxybutanoic acid | 16504-56-6 | Peptides |
| HY-W006064 | (S)-2-Aminopent-4-ynoic acid | 23235-01-0 | Peptides |
| HY-W006069 | H-Phe(3,5-DiF)-OH | 31105-91-6 | Peptides |
| HY-W006093 | H-Chpro-OH.HCl | 90657-55-9 | Peptides |
| HY-W006093R | H-Chpro-OH.HCl (Standard) | 90657-55-9 | Reference Standards |
| HY-W006102 | Bz-rA Phosphoramidite | 104992-55-4 | Oligonucleotides |
| HY-W006103 | I-bu-rG Phosphoramidite | 147201-04-5 | Biochemical Assay Reagents |
| HY-W006152 | (S)-Methyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate hydrochloride | 181228-33-1 | Peptides |
| HY-W006185 | (S)-5-Benzyl 1-tert-butyl 2-aminopentanedioate hydrochloride | 105590-97-4 | Peptides |
| HY-W006187 | 2-Amino-2-(p-tolyl)acetic acid | 13227-01-5 | Peptides |
| HY-W006202 | BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid | 261165-05-3 | Reference compound |
| HY-W006205 | (2R,2'R)-Di-tert-butyl 3,3'-disulfanediylbis(2-aminopropanoate) dihydrochloride | 38261-78-8 | Peptides |
| HY-W006212 | 1,4,7-Triazonane | 4730-54-5 | Reference compound |
| HY-W006230 | Anthraflavic acid | 84-60-6 | Reference compound |
| HY-W006267 | 4-Chloroindole-3-acetic acid | 2519-61-1 | Natural Products |
| HY-W006371 | (2-Aminoethyl)phosphonic acid | 2041-14-7 | Natural Products |
| HY-W006371R | (2-Aminoethyl)phosphonic acid (Standard) | 2041-14-7 | Reference Standards |
| HY-W006395 | 1-Methylcytosine | 1122-47-0 | Reference compound |
| HY-W006397 | 9-Bromonon-1-ene | 89359-54-6 | Reference compound |
| HY-W006398S | Pivalate-d3 (sodium) | 39230-37-0 | Isotope-Labeled Compounds |
| HY-W006405 | Isoflavone | 574-12-9 | Natural Products |
| HY-W006405R | Isoflavone (Standard) | 574-12-9 | Reference Standards |
| HY-W006416 | 1,2,3,4-Tetramethylbenzene | 488-23-3 | Reference compound |
| HY-W006429 | L-Uridine | 26287-69-4 | Natural Products |
| HY-W006443 | 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl trichloroacetimidate, 98%(N) | 92052-29-4 | Biochemical Assay Reagents |
| HY-W006445 | N-Boc-PEG2-bromide | 165963-71-3 | ADC Related |
| HY-W006449 | PNU-105368 | 168828-90-8 | Reference compound |
| HY-W006454 | 5,6-Dihydropyridin-2(1H)-one | 6052-73-9 | Natural Products |
| HY-W006492 | 5a-Pregnane-3,20-dione | 566-65-4 | Natural Products |
| HY-W006492S | 5a-Pregnane-3,20-dione-d6 | 203850-92-4 | Isotope-Labeled Compounds |
| HY-W006524 | H2N-PEG2-CH2COOH | 134978-97-5 | Reference compound |
| HY-W006550S1 | 2-Phenoxy-1-phenylethanol-d1 | 2098469-11-3 | Isotope-Labeled Compounds |
| HY-W006550S2 | 2-Phenoxy-1-phenylethanol-d2 | 2221082-85-3 | Isotope-Labeled Compounds |
| HY-W006566 | 5-AIQ | 93117-08-9 | Reference compound |
| HY-W006566A | 5-AIQ (hydrochloride) | 93117-07-8 | Reference compound |
| HY-W006629 | (4S)-4-Hydroxy-D-proline methyl ester (hydrochloride) | 481704-21-6 | ADC Related |
| HY-W006635 | Bpin-Cyclohexene-COOEt | 1049004-32-1 | Reference compound |
| HY-W006646 | Methyl 5-bromo-1H-pyrrole-2-carboxylate | 934-07-6 | Reference compound |
| HY-W006672 | Dibenzo[b,e]oxepin-11(6H)-one | 4504-87-4 | Reference compound |
| HY-W006886 | Fmoc-(R)-2-(7-octenyl)Ala-OH | 945212-26-0 | Peptides |
| HY-W006923 | O-(tert-Butyl)-N-Fmoc-L-allothreonine | 201481-37-0 | Peptides |
| HY-W006937 | Boc-D-(4-fmoc)-aminophenylalanine | 173054-11-0 | Peptides |
| HY-W006957 | N6-(2-Hydroxyethyl)adenosine | 4338-48-1 | Reference compound |
| HY-W007017A | Benzyl N-acetyl-4,6-O-benzylidenemuramic acid | 2862-03-5 | Biochemical Assay Reagents |
| HY-W007020 | Fmoc-Lys-OAll.HCl | 815619-80-8 | Peptides |
| HY-W007035 | H-Val-Ala-OH | 27493-61-4 | Natural Products |
| HY-W007052 | Fmoc-alpha-allyl-L-alanine | 288617-71-0 | Peptides |
| HY-W007056 | Fmoc-N-me-Trp(Boc)-OH | 197632-75-0 | Peptides |
| HY-W007077 | (2-Amino-5-bromophenyl)(pyridin-2-yl)methanone | 1563-56-0 | Reference compound |
| HY-W007087 | Valerate (sodium) | 6106-41-8 | Natural Products |
| HY-W007102S | 4-Methoxy-N,N-dimethylaniline-d2 | 3047059-88-8 | Isotope-Labeled Compounds |
| HY-W007108 | Fmoc-Asp(ODMAB)-OH | 269066-08-2 | Peptides |
| HY-W007136 | (S)-methyl 2-amino-3-cyclohexylpropanoate hydrochloride | 17193-39-4 | Peptides |
| HY-W007140 | 2-Hydroxymethyl-5-hydroxypyridine | 40222-77-3 | Natural Products |
| HY-W007161 | 8-Desmethoxy-8-fluoro Moxifloxacin | 151213-15-9 | Reference compound |
| HY-W007174A | 1,4-Anhydro-D-xylitol | 53448-53-6 | Biochemical Assay Reagents |
| HY-W007223 | D-5-Hydroxytryptophan | 4350-07-6 | Peptides |
| HY-W007273 | 11-Dodecyn-1-ol | 18202-10-3 | Reference compound |
| HY-W007287 | 5-Methoxyquinolin-8-amine | 30465-68-0 | Reference compound |
| HY-W007317 | 8-Aminoquinoline | 578-66-5 | Biochemical Assay Reagents |
| HY-W007318 | 2-Iodoaniline | 615-43-0 | Reference compound |
| HY-W007318S | 2-Iodoaniline-13C6 | 1261170-87-9 | Isotope-Labeled Compounds |
| HY-W007319 | Phenylpropiolic acid | 637-44-5 | Natural Products |
| HY-W007321 | 1H-Imidazole-2-carbaldehyde | 10111-08-7 | Biochemical Assay Reagents |
| HY-W007322 | Boc-NH-PEG1-OH | 26690-80-2 | Reference compound |
| HY-W007323 | JohnPhos | 224311-51-7 | Biochemical Assay Reagents |
| HY-W007324 | Maleimide | 541-59-3 | Natural Products |
| HY-W007328 | 5-Methoxyindole | 1006-94-6 | Biochemical Assay Reagents |
| HY-W007329 | Isoxazol-3-amine | 1750-42-1 | Biochemical Assay Reagents |
| HY-W007330 | 2-Bromoacetamide | 683-57-8 | Reference compound |
| HY-W007331 | 5-Fluorosalicylaldehyde | 347-54-6 | Biochemical Assay Reagents |
| HY-W007333 | Palladium (trifluoroacetate) | 42196-31-6 | Biochemical Assay Reagents |
| HY-W007337 | 3-Bromopropan-1-ol | 627-18-9 | Biochemical Assay Reagents |
| HY-W007337S | 3-Bromopropan-1-ol-d6 | 284474-43-7 | Isotope-Labeled Compounds |
| HY-W007341 | Pentaethylene glycol | 4792-15-8 | Reference compound |
| HY-W007341R | Pentaethylene glycol (Standard) | 4792-15-8 | Reference Standards |
| HY-W007346 | m-Anisaldehyde | 591-31-1 | Natural Products |
| HY-W007346R | m-Anisaldehyde (Standard) | 591-31-1 | Reference Standards |
| HY-W007346S | m-Anisaldehyde-d3 | 1219795-07-9 | Isotope-Labeled Compounds |
| HY-W007347 | 1,2-Cyclohexanedione | 765-87-7 | Natural Products |
| HY-W007349 | 6-Methyl-1H-indole | 3420-02-8 | Biochemical Assay Reagents |
| HY-W007352 | 1-Bromo-3,5-dimethoxybenzene | 20469-65-2 | Biochemical Assay Reagents |
| HY-W007353 | 2-Bromo-5-methylpyridine | 3510-66-5 | Biochemical Assay Reagents |
| HY-W007354 | Boc-Glu-OtBu | 24277-39-2 | Peptides |
| HY-W007355 | Skatole | 83-34-1 | Natural Products |
| HY-W007355R | Skatole (Standard) | 83-34-1 | Reference Standards |
| HY-W007355S | Skatole-d3 | 111399-60-1 | Isotope-Labeled Compounds |
| HY-W007355S1 | Skatole-d8 | 697807-03-7 | Isotope-Labeled Compounds |
| HY-W007357S1 | Serinol-d5 | 2708287-37-8 | Isotope-Labeled Compounds |
| HY-W007359 | Thiomorpholine | 123-90-0 | Biochemical Assay Reagents |
| HY-W007361 | 3-Acetylthiophene | 1468-83-3 | Biochemical Assay Reagents |
| HY-W007364 | m-Iodophenol | 626-02-8 | Reference compound |
| HY-W007367 | 2,6-Dichloropurine | 5451-40-1 | Biochemical Assay Reagents |
| HY-W007369A | BARF (sodium dihydrate) | 2573808-57-6 | Biochemical Assay Reagents |
| HY-W007371 | Quinoline-8-carboxylic acid | 86-59-9 | Biochemical Assay Reagents |
| HY-W007374S | 2-Bromo-1,3-difluorobenzene-d3 | 1219803-73-2 | Isotope-Labeled Compounds |
| HY-W007376 | Indole-3-carboxaldehyde | 487-89-8 | Natural Products |
| HY-W007376R | Indole-3-carboxaldehyde (Standard) | 487-89-8 | Reference Standards |
| HY-W007376S | Indole-3-carboxaldehyde-13C | 1093452-52-8 | Isotope-Labeled Compounds |
| HY-W007381 | 3-Tolylboronic acid | 17933-03-8 | Biochemical Assay Reagents |
| HY-W007382S | 1-Acetylpiperazine-d4 | 1398065-90-1 | Isotope-Labeled Compounds |
| HY-W007384 | 5-Chloroindole | 17422-32-1 | Biochemical Assay Reagents |
| HY-W007388 | Benzyl 2-bromoethyl ether | 1462-37-9 | Biochemical Assay Reagents |
| HY-W007389 | 4-tert-Butylphenylboronic acid | 123324-71-0 | Biochemical Assay Reagents |
| HY-W007390 | Methyl 2-amino-5-bromobenzoate | 52727-57-8 | Reference compound |
| HY-W007392 | Methyl 4-bromo-1H-pyrrole-2-carboxylate | 934-05-4 | Biochemical Assay Reagents |
| HY-W007398 | 5,6-Dichloronicotinic acid | 41667-95-2 | Biochemical Assay Reagents |
| HY-W007399 | Boc-Asp(OMe)-OH | 59768-74-0 | Peptides |
| HY-W007401 | (1R,2S)-1-Amino-2-indanol | 136030-00-7 | Biochemical Assay Reagents |
| HY-W007403 | 6-Bromoquinoline | 5332-25-2 | Biochemical Assay Reagents |
| HY-W007404 | 6-Aminoquinoline | 580-15-4 | Biochemical Assay Reagents |
| HY-W007408 | tert-Butyl 2-aminoacetate | 6456-74-2 | Peptides |
| HY-W007410 | 2,4-Difluorobenzaldehyde | 1550-35-2 | Reference compound |
| HY-W007412 | 1,4-Diiodobenzene | 624-38-4 | Biochemical Assay Reagents |
| HY-W007413 | 3-Nitrophenylboronic acid | 13331-27-6 | Biochemical Assay Reagents |
| HY-W007416 | 3,5-Dihydroxybenzaldehyde | 26153-38-8 | Reference compound |
| HY-W007418 | (3-Hydroxymethyl)phenylboronic acid | 87199-15-3 | Biochemical Assay Reagents |
| HY-W007423 | 3-Ethynylaniline | 54060-30-9 | Biochemical Assay Reagents |
| HY-W007426 | N-Methylbenzylamine | 103-67-3 | Natural Products |
| HY-W007426S | N-Methylbenzylamine-d3 | 122025-09-6 | Isotope-Labeled Compounds |
| HY-W007427 | 3-Bromo-5-methoxypyridine | 50720-12-2 | Biochemical Assay Reagents |
| HY-W007428 | 3-Fluoro-2-nitropyridine | 54231-35-5 | Biochemical Assay Reagents |
| HY-W007430 | 2-Bromo-5-hydroxybenzaldehyde | 2973-80-0 | Biochemical Assay Reagents |
| HY-W007432 | RuPhos | 787618-22-8 | Biochemical Assay Reagents |
| HY-W007437 | 2-Naphthoic acid | 93-09-4 | Biochemical Assay Reagents |
| HY-W007447 | 4-Bromo-2-methylpyridine | 22282-99-1 | Biochemical Assay Reagents |
| HY-W007449S | Ethyl 3-Bromopropionate-2,2,3,3-d4 | 14341-55-0 | Isotope-Labeled Compounds |
| HY-W007451 | 15-Crown-5 | 33100-27-5 | Biochemical Assay Reagents |
| HY-W007454 | 2-Nitrobenzaldehyde | 552-89-6 | Biochemical Assay Reagents |
| HY-W007465 | 4-Aminobenzyl alcohol | 623-04-1 | Biochemical Assay Reagents |
| HY-W007466 | Cyclohexane-1,3-dione | 504-02-9 | Biochemical Assay Reagents |
| HY-W007470 | Propylboronic acid | 17745-45-8 | Biochemical Assay Reagents |
| HY-W007481 | 6-Chloropyridin-3-amine | 5350-93-6 | Biochemical Assay Reagents |
| HY-W007482 | 3-Fluorocatechol | 363-52-0 | Biochemical Assay Reagents |
| HY-W007494 | Pyridazine | 289-80-5 | Biochemical Assay Reagents |
| HY-W007497S | H-β-Ala-NH2.-d4HCl | 1276197-35-3 | Isotope-Labeled Compounds |
| HY-W007499 | 3-Chloro-2-pyrazinamine | 6863-73-6 | Biochemical Assay Reagents |
| HY-W007500 | 2,6-Di-tert-butyl-4-methylpyridine | 38222-83-2 | Biochemical Assay Reagents |
| HY-W007501 | 2-Bromo-3-methoxypyridine | 24100-18-3 | Biochemical Assay Reagents |
| HY-W007502 | 2-(Chloromethyl)pyridine (hydrochloride) | 6959-47-3 | Biochemical Assay Reagents |
| HY-W007509 | 1H-Indol-5-amine | 5192-03-0 | Biochemical Assay Reagents |
| HY-W007511 | 4-Methyl-1-pentanol | 626-89-1 | Natural Products |
| HY-W007517S | (Bromomethyl)cyclohexane-d11 | 1219794-79-2 | Isotope-Labeled Compounds |
| HY-W007518 | 4-Bromo-3-fluorobenzaldehyde | 133059-43-5 | Biochemical Assay Reagents |
| HY-W007524 | 2-Aminoquinoline | 580-22-3 | Reference compound |
| HY-W007529 | Boc-6-aminohexanoic acid | 6404-29-1 | Reference compound |
| HY-W007531 | 2-Fluoro-5-iodopyridine | 171197-80-1 | Biochemical Assay Reagents |
| HY-W007533 | 4-Ethynylbenzoic acid | 10602-00-3 | Biochemical Assay Reagents |
| HY-W007536 | 2,6-Dichloroisonicotinic acid | 5398-44-7 | Biochemical Assay Reagents |
| HY-W007537S | 2-Bromonaphthalene-d7 | 1359833-48-9 | Isotope-Labeled Compounds |
| HY-W007539 | 2,4-Dihydroxybenzaldehyde | 95-01-2 | Natural Products |
| HY-W007539R | 2,4-Dihydroxybenzaldehyde (Standard) | 95-01-2 | Reference Standards |
| HY-W007542 | 4-Bromophenylacetylene | 766-96-1 | Biochemical Assay Reagents |
| HY-W007545 | NH2-PEG3 | 6338-55-2 | Reference compound |
| HY-W007549 | 5-Fluoroisatin | 443-69-6 | Biochemical Assay Reagents |
| HY-W007556 | 2-Methylindole | 95-20-5 | Biochemical Assay Reagents |
| HY-W007566 | 5-Methoxyindole-3-acetic acid | 3471-31-6 | Natural Products |
| HY-W007569 | 1,4-Bis(diphenylphosphino)butane | 7688-25-7 | Biochemical Assay Reagents |
| HY-W007573 | (S)-4-(tert-Butoxy)-3-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid | 34582-32-6 | Peptides |
| HY-W007577 | 4-Nitrobenzaldehyde | 555-16-8 | Biochemical Assay Reagents |
| HY-W007578 | H-β-Ala-OtBu.HCl | 58620-93-2 | Peptides |
| HY-W007579 | 2-Bromo-4-methylpyridine | 4926-28-7 | Biochemical Assay Reagents |
| HY-W007584 | 2,4-Dimethoxybenzyl alcohol | 7314-44-5 | Reference compound |
| HY-W007585 | 4-Isopropoxyphenylboronic acid | 153624-46-5 | Biochemical Assay Reagents |
| HY-W007586 | 1-Boc-L-azetidine-2-carboxylic acid | 51077-14-6 | Biochemical Assay Reagents |
| HY-W007587 | 9-Bromononanoic acid | 41059-02-3 | Reference compound |
| HY-W007593 | 5-Bromo-1H-indole-2-carboxylic acid | 7254-19-5 | Biochemical Assay Reagents |
| HY-W007596 | Tris(2-phenylpyridinato-C2,N)iridium(III) | 94928-86-6 | Reference compound |
| HY-W007599 | (S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid | 2483-46-7 | Peptides |
| HY-W007599S | L-Lysine-bis-N-t-BOC-d4 | 1314753-85-9 | Isotope-Labeled Compounds |
| HY-W007603 | 4-Chloroquinoline | 611-35-8 | Biochemical Assay Reagents |
| HY-W007606 | Tyramine | 51-67-2 | Natural Products |
| HY-W007606R | Tyramine (Standard) | 51-67-2 | Reference Standards |
| HY-W007613 | 7-Fluoro-1H-indole | 387-44-0 | Biochemical Assay Reagents |
| HY-W007614 | 3-Fluoro-4-methoxybenzaldehyde | 351-54-2 | Biochemical Assay Reagents |
| HY-W007615 | H-Phe(4-I)-OH | 24250-85-9 | Peptides |
| HY-W007616 | Diphenylmethanimine | 1013-88-3 | Biochemical Assay Reagents |
| HY-W007618 | Boc-Lys-OH | 13734-28-6 | Biochemical Assay Reagents |
| HY-W007619 | Methyl 5-bromo-2-methylbenzoate | 79669-50-4 | Biochemical Assay Reagents |
| HY-W007620 | (S)-3-(4-Aminophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid | 55533-24-9 | Peptides |
| HY-W007626 | 3,5-Dimethoxybenzaldehyde | 7311-34-4 | Biochemical Assay Reagents |
| HY-W007632 | 4-(Aminomethyl)pyridine | 3731-53-1 | Biochemical Assay Reagents |
| HY-W007634 | 4-Methoxypyridine | 620-08-6 | Biochemical Assay Reagents |
| HY-W007642 | 6-Benzyloxyindole | 15903-94-3 | Biochemical Assay Reagents |
| HY-W007647 | 5-Bromopicolinonitrile | 97483-77-7 | Biochemical Assay Reagents |
| HY-W007648 | Methyl 3-aminopropanoate (hydrochloride) | 3196-73-4 | Reference compound |
| HY-W007655 | Fmoc-D-Lys(Boc)-OH | 92122-45-7 | Biochemical Assay Reagents |
| HY-W007656 | Cyclen | 294-90-6 | Natural Products |
| HY-W007662 | 2-Bromo-3-chloropyridine | 96424-68-9 | Biochemical Assay Reagents |
| HY-W007664 | (R)-4-Benzyl-2-oxazolidinone | 102029-44-7 | Biochemical Assay Reagents |
| HY-W007667 | 5-Bromophthalide | 64169-34-2 | Biochemical Assay Reagents |
| HY-W007669 | 4-Cyanoindole | 16136-52-0 | Biochemical Assay Reagents |
| HY-W007670 | 7-Methylindole | 933-67-5 | Biochemical Assay Reagents |
| HY-W007671 | H-Tyr-OMe | 1080-06-4 | Natural Products |
| HY-W007679 | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-nitrophenyl)propanoic acid | 33305-77-0 | Peptides |
| HY-W007681 | 4-Bromo-1H-pyrazol-3-amine | 16461-94-2 | Biochemical Assay Reagents |
| HY-W007685 | Methyl 1H-1,2,4-triazole-5-carboxylate | 4928-88-5 | Biochemical Assay Reagents |
| HY-W007686 | Imidazoleacetic acid (hydrochloride) | 3251-69-2 | Natural Products |
| HY-W007686R | Imidazoleacetic acid (hydrochloride) (Standard) | 3251-69-2 | Reference Standards |
| HY-W007689 | 2'-Bromoacetophenone | 2142-69-0 | Biochemical Assay Reagents |
| HY-W007690 | Pyridin-4-ol | 626-64-2 | Biochemical Assay Reagents |
| HY-W007690S | Pyridin-4-ol-d5 | 45503-33-1 | Isotope-Labeled Compounds |
| HY-W007692 | Acetylpyrazine | 22047-25-2 | Reference compound |
| HY-W007692R | Acetylpyrazine (Standard) | 22047-25-2 | Reference Standards |
| HY-W007692S | Acetylpyrazine-d3 | 106162-18-9 | Isotope-Labeled Compounds |
| HY-W007695 | 1H-Imidazole-4-carboxylic acid | 1072-84-0 | Biochemical Assay Reagents |
| HY-W007700 | 8-Bromooctanoic acid | 17696-11-6 | Reference compound |
| HY-W007704 | Methyl cyclohexanecarboxylate | 4630-82-4 | Natural Products |
| HY-W007704R | Methyl cyclohexanecarboxylate (Standard) | 4630-82-4 | Reference Standards |
| HY-W007706 | Fmoc-Thr(tBu)-OH | 71989-35-0 | Peptides |
| HY-W007706S | Fmoc-Thr(tBu)-OH-13C4,15N | 1485528-28-6 | Isotope-Labeled Compounds |
| HY-W007708 | 3-Furanmethanol | 4412-91-3 | Natural Products |
| HY-W007712 | 2-Bromo-3-methylpyridine | 3430-17-9 | Biochemical Assay Reagents |
| HY-W007713 | Fmoc-8-amino-3,6-dioxaoctanoic acid | 166108-71-0 | ADC Related |
| HY-W007714 | 7-Bromoheptanoic acid | 30515-28-7 | Biochemical Assay Reagents |
| HY-W007719 | 7-Methylisatin | 1127-59-9 | Biochemical Assay Reagents |
| HY-W007720 | Fmoc-Ser-OH | 73724-45-5 | Peptides |
| HY-W007720S | Fmoc-Ser-OH-d3 | 1380308-48-4 | Isotope-Labeled Compounds |
| HY-W007720S1 | Fmoc-Ser-OH-15N | 2137490-19-6 | Isotope-Labeled Compounds |
| HY-W007722 | H-Ala-OtBu.HCl | 13404-22-3 | Peptides |
| HY-W007722A | tert-Butyl alaninate hydrochloride | 69320-88-3 | Peptides |
| HY-W007729 | Boc-L-Alaninol | 79069-13-9 | Biochemical Assay Reagents |
| HY-W007730S | Ethyl 4-bromobenzoate-d4 | 787624-25-3 | Isotope-Labeled Compounds |
| HY-W007732B | Cyclohexane-1,4-diamine | 3114-70-3 | Reference compound |
| HY-W007732BS | 1,4-Cyclohexane-d10 | 1219802-80-8 | Isotope-Labeled Compounds |
| HY-W007743 | Boc-Pip-OH | 26250-84-0 | Biochemical Assay Reagents |
| HY-W007746 | 1-Cyclohexeneboronic acid pinacol ester | 141091-37-4 | Biochemical Assay Reagents |
| HY-W007750 | H-Lys(Z)-OH | 1155-64-2 | Peptides |
| HY-W007750S | H-Lys(Z)-OH-d3 | Isotope-Labeled Compounds | |
| HY-W007752 | 3-Oxopentanedioic acid | 542-05-2 | Natural Products |
| HY-W007753 | 3-Bromothiophene-2-carboxaldehyde | 930-96-1 | Biochemical Assay Reagents |
| HY-W007766 | 2-((tert-Butoxycarbonyl)amino)-2-methylpropanoic acid | 30992-29-1 | Peptides |
| HY-W007771 | Acridone | 578-95-0 | Natural Products |
| HY-W007771R | Acridone (Standard) | 578-95-0 | Reference Standards |
| HY-W007791 | Chloropurine riboside | 5399-87-1 | Reference compound |
| HY-W007794 | 2-Amino-3-hydroxypyridine | 16867-03-1 | Biochemical Assay Reagents |
| HY-W007794R | 2-Amino-3-hydroxypyridine (Standard) | 16867-03-1 | Reference Standards |
| HY-W007798 | Fmoc-Cys(Trt)-OH | 103213-32-7 | Peptides |
| HY-W007798S | Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N | 360795-94-4 | Isotope-Labeled Compounds |
| HY-W007798S1 | Fmoc-Cys(Trt)-OH-d2 | 360565-11-3 | Isotope-Labeled Compounds |
| HY-W007801 | Tetrapropylammonium perruthenate | 114615-82-6 | Biochemical Assay Reagents |
| HY-W007803 | Boc-NH-C4-Br | 164365-88-2 | Reference compound |
| HY-W007807 | 4-Hydroxy-3,5-dimethylbenzaldehyde | 2233-18-3 | Biochemical Assay Reagents |
| HY-W007809 | 4-(Aminomethyl)benzonitrile hydrochloride | 15996-76-6 | Biochemical Assay Reagents |
| HY-W007822 | 1-Benzyl-4-piperidone | 3612-20-2 | Biochemical Assay Reagents |
| HY-W007825 | (1R,2S)-2-Amino-1,2-diphenylethanol | 23190-16-1 | Biochemical Assay Reagents |
| HY-W007828 | Methyl 3-phenylpropanoate | 103-25-3 | Natural Products |
| HY-W007828R | Methyl 3-phenylpropanoate (Standard) | 103-25-3 | Reference Standards |
| HY-W007842 | Z-Ser-OH | 1145-80-8 | Peptides |
| HY-W007846 | 2-Iodobenzaldehyde | 26260-02-6 | Biochemical Assay Reagents |
| HY-W007847 | 4-Amino-2-fluorobenzoic acid | 446-31-1 | Biochemical Assay Reagents |
| HY-W007853 | 2-(Benzyloxy)ethanol | 622-08-2 | Reference compound |
| HY-W007854 | 5-Bromoisoquinoline | 34784-04-8 | Biochemical Assay Reagents |
| HY-W007856 | 5-Methoxysalicylic acid | 2612-02-4 | Natural Products |
| HY-W007858 | 2-Bromo-5-nitropyridine | 4487-59-6 | Biochemical Assay Reagents |
| HY-W007860 | 3,4,5-Trimethoxyaniline | 24313-88-0 | Biochemical Assay Reagents |
| HY-W007865 | 4-Bromo-2-methoxyphenol | 7368-78-7 | Biochemical Assay Reagents |
| HY-W007872 | N-Methyliminodiacetic acid | 4408-64-4 | Biochemical Assay Reagents |
| HY-W007872S | N-Methyliminodiacetic acid-d4 | 1219803-27-6 | Isotope-Labeled Compounds |
| HY-W007875 | Boc-Glu-OBzl | 30924-93-7 | Peptides |
| HY-W007880 | (R)-D2PM | 22348-32-9 | Reference compound |
| HY-W007880A | (R)-D2PM (hydrochloride) | 172152-19-1 | Reference compound |
| HY-W007888 | 2-Hydroxy-4-methylbenzaldehyde | 698-27-1 | Reference compound |
| HY-W007888R | 2-Hydroxy-4-methylbenzaldehyde (Standard) | 698-27-1 | Reference Standards |
| HY-W007894 | Dimethylmalonic acid | 595-46-0 | Natural Products |
| HY-W007894R | Dimethylmalonic acid (Standard) | 595-46-0 | Reference Standards |
| HY-W007905 | 3,5-Dibromophenol | 626-41-5 | Biochemical Assay Reagents |
| HY-W007914 | 2-Chloro-4-methoxypyridine | 17228-69-2 | Biochemical Assay Reagents |
| HY-W007926 | 2-Oxobutanoic acid | 600-18-0 | Natural Products |
| HY-W007926R | 2-Oxobutanoic acid (Standard) | 600-18-0 | Reference Standards |
| HY-W007927 | 1-Methyl-1H-indazole-3-carboxylic acid | 50890-83-0 | Biochemical Assay Reagents |
| HY-W007927R | 1-Methyl-1H-indazole-3-carboxylic acid (Standard) | 50890-83-0 | Reference Standards |
| HY-W007928S | 1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C | 335595-58-9 | Isotope-Labeled Compounds |
| HY-W007928S1 | 1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C-1 | 54447-56-2 | Isotope-Labeled Compounds |
| HY-W007931 | Z-Tyr-OH | 1164-16-5 | Peptides |
| HY-W007934 | 2-Hydroxy-3-methylbenzaldehyde | 824-42-0 | Biochemical Assay Reagents |
| HY-W007941 | Fmoc-Ser(tBu)-OH | 71989-33-8 | Peptides |
| HY-W007941S | Fmoc-Ser(tBu)-OH-13C3,15N | 1217448-78-6 | Isotope-Labeled Compounds |
| HY-W007941S1 | Fmoc-Ser(tBu)-OH-15N | 387867-79-0 | Isotope-Labeled Compounds |
| HY-W007942 | Fmoc-β-Ala-OH | 35737-10-1 | Peptides |
| HY-W007957 | 6-Amino-1-hexanol | 4048-33-3 | Biochemical Assay Reagents |
| HY-W007966 | Dimethyl pyridine-2,6-dicarboxylate | 5453-67-8 | Biochemical Assay Reagents |
| HY-W007967 | 4-Chloro-1-naphthol | 604-44-4 | Reference compound |
| HY-W007970 | H-Phe-Phe-OH | 2577-40-4 | Natural Products |
| HY-W007972 | Methyl 3-methoxyacrylate | 34846-90-7 | Natural Products |
| HY-W007972R | Methyl 3-methoxyacrylate (Standard) | 34846-90-7 | Reference Standards |
| HY-W007977 | 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline | 183322-18-1 | Reference compound |
| HY-W007978 | (R)-[1,1'-Binaphthalene]-2,2'-diamine | 18741-85-0 | Reference compound |
| HY-W007978A | (S)-[1,1'-Binaphthalene]-2,2'-diamine | 18531-95-8 | Biochemical Assay Reagents |
| HY-W007978B | 1,1'-Binaphthyl-2,2'-diamine | 4488-22-6 | Reference compound |
| HY-W007980 | Antifungal agent 98 | 4771-50-0 | Reference compound |
| HY-W007986 | H-D-Ala-OMe (hydrochloride) | 14316-06-4 | Peptides |
| HY-W007993 | Boc-cycloleucine | 35264-09-6 | Biochemical Assay Reagents |
| HY-W007997 | Ethyl 3-amino-1H-pyrazole-4-carboxylate | 6994-25-8 | Biochemical Assay Reagents |
| HY-W007997R | Ethyl 3-amino-1H-pyrazole-4-carboxylate (Standard) | 6994-25-8 | Reference Standards |
| HY-W008003 | 2-Hydroxybenzimidazole | 615-16-7 | Biochemical Assay Reagents |
| HY-W008003R | 2-Hydroxybenzimidazole (Standard) | 615-16-7 | Reference Standards |
| HY-W008005 | Amino-PEG4-alcohol | 86770-74-3 | ADC Related |
| HY-W008008 | Methyl 2-amino-5-chlorobenzoate | 5202-89-1 | Biochemical Assay Reagents |
| HY-W008013 | 1H-Indole-7-carbaldehyde | 1074-88-0 | Biochemical Assay Reagents |
| HY-W008015 | 3-Aminophenylacetic acid | 14338-36-4 | Reference compound |
| HY-W008016 | Fmoc-Tyr(tBu)-OH | 71989-38-3 | Peptides |
| HY-W008016S | Fmoc-Tyr(tBu)-OH-13C9,15N | 1217442-53-9 | Isotope-Labeled Compounds |
| HY-W008017 | 5-Bromopyrimidine | 4595-59-9 | Biochemical Assay Reagents |
| HY-W008021 | Fmoc-D-Leu-OH | 114360-54-2 | Peptides |
| HY-W008022 | Boc-Ser(Me)-OH | 51293-47-1 | Peptides |
| HY-W008024 | Fmoc-Dab(Boc)-OH | 125238-99-5 | Peptides |
| HY-W008027 | 3-Fluoro-4-formylphenylboronic acid | 248270-25-9 | Biochemical Assay Reagents |
| HY-W008028 | (S)-2-Amino-3-cyclopropylpropanoic acid | 102735-53-5 | Peptides |
| HY-W008029 | H-Lys(Z)-OtBu.HCl | 5978-22-3 | Peptides |
| HY-W008030S | 3-Aminobiphenyl-d9 | 1020718-93-7 | Isotope-Labeled Compounds |
| HY-W008033 | (DHQD)2PHAL | 140853-10-7 | Reference compound |
| HY-W008034 | Fmoc-L-Trp(Boc)-OH | 143824-78-6 | Biochemical Assay Reagents |
| HY-W008038 | NMDAR antagonist 3 | 39512-49-7 | Reference compound |
| HY-W008039 | Tetrabutylammonium (acetate) | 10534-59-5 | Biochemical Assay Reagents |
| HY-W008048 | 2',3'-O-Isopropylideneadenosine | 362-75-4 | Reference compound |
| HY-W008059 | Isoquinolin-4-amine | 23687-25-4 | Biochemical Assay Reagents |
| HY-W008061 | H-Leu-OtBu.HCl | 2748-02-9 | Peptides |
| HY-W008064 | Fmoc-Cit-OH | 133174-15-9 | Peptides |
| HY-W008072 | Fmoc-D-Ala-OH | 79990-15-1 | Peptides |
| HY-W008072S | Fmoc-D-Ala-OH-d3 | Isotope-Labeled Compounds | |
| HY-W008075 | Fmoc-Asp(OAll)-OH | 146982-24-3 | Peptides |
| HY-W008077 | (S)-2-Amino-3,3-diphenylpropanoic acid | 149597-92-2 | Peptides |
| HY-W008079 | (S)-2-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid | 2418-95-3 | Peptides |
| HY-W008080 | 3,5-Difluoropicolinonitrile | 298709-29-2 | Biochemical Assay Reagents |
| HY-W008086 | H-Thr-OMe (hydrochloride) | 39994-75-7 | Peptides |
| HY-W008086A | (Rac)-H-Thr-OMe (hydrochloride) | 2170123-34-7 | Peptides |
| HY-W008088 | 4-Fluoro-3-nitrobenzonitrile | 1009-35-4 | Biochemical Assay Reagents |
| HY-W008091 | 5-Methylcytosine | 554-01-8 | Natural Products |
| HY-W008091A | 5-Methylcytosine (hydrochloride) | 58366-64-6 | Reference compound |
| HY-W008091R | 5-Methylcytosine (Standard) | 554-01-8 | Reference Standards |
| HY-W008091S | 5-Methylcytosine-d4 | 1219795-15-9 | Isotope-Labeled Compounds |
| HY-W008096 | 2-Nitrobenzenesulfonamide | 5455-59-4 | Biochemical Assay Reagents |
| HY-W008097 | 3,3-Dimethylglutaric acid | 4839-46-7 | Natural Products |
| HY-W008097R | 3,3-Dimethylglutaric acid (Standard) | 4839-46-7 | Reference Standards |
| HY-W008103 | o-Phenylenediacetic acid | 7500-53-0 | Biochemical Assay Reagents |
| HY-W008113 | Boc-L-Homoserine | 41088-86-2 | Peptides |
| HY-W008119 | 3-Methoxypyridine | 7295-76-3 | Biochemical Assay Reagents |
| HY-W008125 | Acetobromo-α-D-glucuronic acid methyl ester, 98% | 21085-72-3 | Biochemical Assay Reagents |
| HY-W008125S | Acetobromo-a-D-glucuronic acid-13C6 methyl ester | Isotope-Labeled Compounds | |
| HY-W008129 | H-D-cis-Hyp-OH | 2584-71-6 | Natural Products |
| HY-W008134 | N-tert-Butyloxycarbonyl-L-histidine | 17791-52-5 | Peptides |
| HY-W008137 | 5-Bromo-2-fluoropyrimidine | 62802-38-4 | Biochemical Assay Reagents |
| HY-W008145 | Sodium tetrachloropalladate(II) | 13820-53-6 | Biochemical Assay Reagents |
| HY-W008150 | 2-Hydroxy-3-methylbutanoic acid | 4026-18-0 | Natural Products |
| HY-W008150R | 2-Hydroxy-3-methylbutanoic acid (Standard) | 4026-18-0 | Reference Standards |
| HY-W008151 | Diphenyl Phosphate | 838-85-7 | Reference compound |
| HY-W008151S | Diphenyl Phosphate-d10 | 1477494-97-5 | Isotope-Labeled Compounds |
| HY-W008156 | Fmoc-D-Ser(tBu)-OH | 128107-47-1 | Peptides |
| HY-W008168 | Quinoline-2-carboxaldehyde | 5470-96-2 | Biochemical Assay Reagents |
| HY-W008176 | Fmoc-Lys-OH | 105047-45-8 | Peptides |
| HY-W008178 | (R)-2-((tert-Butoxycarbonyl)amino)-3-(tritylthio)propanoic acid | 21947-98-8 | Peptides |
| HY-W008179 | Z-Ser-OMe | 1676-81-9 | Peptides |
| HY-W008182 | H-Lys(Z)-OMe.HCl | 27894-50-4 | Peptides |
| HY-W008183 | 3-Bromo-L-phenylalanine | 82311-69-1 | Peptides |
| HY-W008185 | Boc-D-alaninol | 106391-86-0 | Biochemical Assay Reagents |
| HY-W008186 | 4-Fluoro-2-hydroxybenzoic acid | 345-29-9 | Biochemical Assay Reagents |
| HY-W008187 | 4-Fluoro-3-nitrobenzaldehyde | 42564-51-2 | Biochemical Assay Reagents |
| HY-W008188 | 3-Hydroxy-4-aminopyridine | 52334-53-9 | Natural Products |
| HY-W008196 | H-Lys(Fmoc)-OH | 84624-28-2 | Peptides |
| HY-W008199 | 2,6-Dichloro-4-pyridinamine | 2587-02-2 | Biochemical Assay Reagents |
| HY-W008201 | tert-Butyl 3-formylpyrrolidine-1-carboxylate | 59379-02-1 | Biochemical Assay Reagents |
| HY-W008205 | Fmoc-Hyp-OH | 88050-17-3 | Biochemical Assay Reagents |
| HY-W008206 | (±)-Boc-α-phosphonoglycine trimethyl ester | 89524-98-1 | Biochemical Assay Reagents |
| HY-W008213 | 2-Chloro-5-methylbenzoic acid | 6342-60-5 | Biochemical Assay Reagents |
| HY-W008216 | HMMNI | 936-05-0 | Reference compound |
| HY-W008216R | HMMNI (Standard) | 936-05-0 | Reference Standards |
| HY-W008216S | HMMNI-d3 | 1015855-78-3 | Isotope-Labeled Compounds |
| HY-W008219 | Methyl 1-aminocyclopropanecarboxylate hydrochloride | 72784-42-0 | Peptides |
| HY-W008226 | Phloracetophenone | 480-66-0 | Natural Products |
| HY-W008226R | Phloracetophenone (Standard) | 480-66-0 | Reference Standards |
| HY-W008232 | 6-Azauracil | 461-89-2 | Biochemical Assay Reagents |
| HY-W008233 | Z-Asn-OH | 2304-96-3 | Peptides |
| HY-W008234 | N-Phthaloyl-β-alanine | 3339-73-9 | Reference compound |
| HY-W008235 | Fmoc-N-Me-Ala-OH | 84000-07-7 | Reference compound |
| HY-W008240 | 2′,3′-Isopropylideneguanosine | 362-76-5 | Reference compound |
| HY-W008242S | 4-Aminopyrazole-d2 | 2241865-21-2 | Isotope-Labeled Compounds |
| HY-W008245 | Ethyl 7-bromoheptanoate | 29823-18-5 | Biochemical Assay Reagents |
| HY-W008253 | 5-Hydroxyindole-3-acetic acid | 54-16-0 | Natural Products |
| HY-W008253R | 5-Hydroxyindole-3-acetic acid (Standard) | 54-16-0 | Reference Standards |
| HY-W008253S | 5-Hydroxyindole-3-acetic acid-d2 | 56209-31-5 | Isotope-Labeled Compounds |
| HY-W008253S1 | 5-Hydroxyindole-3-acetic acid-d6 | 2748469-82-9 | Isotope-Labeled Compounds |
| HY-W008253S2 | 5-Hydroxyindole-3-acetic acid-d5 | 81587-11-3 | Isotope-Labeled Compounds |
| HY-W008253S3 | 5-Hydroxyindole-3-acetic acid-13C6 | 2733322-34-2 | Isotope-Labeled Compounds |
| HY-W008254 | H-Ser-NH2.HCl | 65414-74-6 | Peptides |
| HY-W008255 | Z-Glu-OBzl | 3705-42-8 | Peptides |
| HY-W008256 | Fmoc-Glu(OMe)-OH | 145038-50-2 | Peptides |
| HY-W008260 | [Ir(cod)Cl]2 | 12112-67-3 | Biochemical Assay Reagents |
| HY-W008261 | (S)-2-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid | 37736-82-6 | Peptides |
| HY-W008269 | H-D-2-Nal-OH | 76985-09-6 | Peptides |
| HY-W008269R | H-D-2-Nal-OH (Standard) | 76985-09-6 | Reference Standards |
| HY-W008270 | 2(5H)-Furanone | 497-23-4 | Natural Products |
| HY-W008270R | 2(5H)-Furanone (Standard) | 497-23-4 | Reference Standards |
| HY-W008273 | Fmoc-D-Nle-OH | 112883-41-7 | Peptides |
| HY-W008279 | Amino-PEG2-NH-Boc | 127828-22-2 | Reference compound |
| HY-W008292 | Carbostyril 124 | 19840-99-4 | Dye Reagents |
| HY-W008293 | Himic anhydride | 2746-19-2 | Reference compound |
| HY-W008294 | 3-Hydroxyglutaric acid dimethyl ester | 7250-55-7 | Reference compound |
| HY-W008296 | NH2-C6-NH-Boc | 51857-17-1 | Reference compound |
| HY-W008297 | Z-Thr-OMe | 57224-63-2 | Peptides |
| HY-W008308 | H-Ser(Bzl)-OH | 4726-96-9 | Peptides |
| HY-W008315 | L-Allothreonine | 28954-12-3 | Natural Products |
| HY-W008315R | L-Allothreonine (Standard) | 28954-12-3 | Reference Standards |
| HY-W008321 | 6-Bromo-3,4-dihydro-1(2H)-naphthalenone | 66361-67-9 | Biochemical Assay Reagents |
| HY-W008325 | Boc-L-Dap-OH | 73259-81-1 | Biochemical Assay Reagents |
| HY-W008326 | Z-Glu(OtBu)-OH | 3886-08-6 | Peptides |
| HY-W008333 | 6-Methylnicotinic acid | 3222-47-7 | Biochemical Assay Reagents |
| HY-W008333R | 6-Methylnicotinic acid (Standard) | 3222-47-7 | Reference Standards |
| HY-W008335 | 1,2:5,6-Bis-O-(1-methylethylidene)-α-D-allofuranose | 2595-05-3 | Biochemical Assay Reagents |
| HY-W008341 | 5-Chloroisoquinoline | 5430-45-5 | Reference compound |
| HY-W008343 | 1,3-Dimethyluracil | 874-14-6 | Natural Products |
| HY-W008344 | 2-Chloroadenosine | 146-77-0 | Reference compound |
| HY-W008350 | (+)-Sparteine | 492-08-0 | Natural Products |
| HY-W008351 | L-Ribose | 24259-59-4 | Biochemical Assay Reagents |
| HY-W008351R | L-Ribose (Standard) | 24259-59-4 | Reference Standards |
| HY-W008351S | L-Ribose-13C | Isotope-Labeled Compounds | |
| HY-W008352 | Boc-NH-PEG4-CH2CH2NH2 | 811442-84-9 | ADC Related |
| HY-W008353 | H-1-Nal-OH | 55516-54-6 | Peptides |
| HY-W008355 | 1,3-Dimesitylimidazolium (chloride) | 141556-45-8 | Biochemical Assay Reagents |
| HY-W008356 | 2-Fluoro-4-iodobenzonitrile | 137553-42-5 | Reference compound |
| HY-W008359 | Z-D-Lys(Boc)-OH | 66845-42-9 | Peptides |
| HY-W008360 | Fmoc-Asp-Obzl | 86060-83-5 | Peptides |
| HY-W008364 | Olivetol | 500-66-3 | Natural Products |
| HY-W008364R | Olivetol (Standard) | 500-66-3 | Reference Standards |
| HY-W008370 | Z-Hyp-OMe | 64187-48-0 | Peptides |
| HY-W008371 | Fmoc-Met-OH | 71989-28-1 | Peptides |
| HY-W008371S | Fmoc-Met-OH-15N | 934183-50-3 | Isotope-Labeled Compounds |
| HY-W008371S1 | Fmoc-Met-OH-13C5,15N | 1217437-64-3 | Isotope-Labeled Compounds |
| HY-W008371S2 | Fmoc-Met-OH-d3 | 502692-58-2 | Isotope-Labeled Compounds |
| HY-W008378 | 5-Methoxy-2-benzimidazolethiol | 37052-78-1 | Reference compound |
| HY-W008378R | 5-Methoxy-2-benzimidazolethiol (Standard) | 37052-78-1 | Reference Standards |
| HY-W008378S | 5-Methoxy-2-benzimidazolethiol-d3 | 1219804-80-4 | Isotope-Labeled Compounds |
| HY-W008379 | H-2-Nal-OH | 58438-03-2 | Peptides |
| HY-W008382 | Boc-Lys(Z)-OSu | 34404-36-9 | Peptides |
| HY-W008383 | H-Glu(OtBu)-OMe.HCl | 6234-01-1 | Peptides |
| HY-W008385 | H-HoArg-OH | 156-86-5 | Natural Products |
| HY-W008385S | H-HoArg-OH-d4 | 1332075-41-8 | Isotope-Labeled Compounds |
| HY-W008386 | Fmoc-Lys(Fmoc)-OH | 78081-87-5 | Peptides |
| HY-W008388 | Bz-rA | 4546-55-8 | Reference compound |
| HY-W008389 | Boc-Arg(Pbf)-OH | 200124-22-7 | Peptides |
| HY-W008393 | (-)-Corey lactone diol | 32233-40-2 | Reference compound |
| HY-W008395 | Fmoc-D-Pra-OH | 220497-98-3 | Peptides |
| HY-W008398 | 2-Bromo-4-iodopyridine | 100523-96-4 | Biochemical Assay Reagents |
| HY-W008425 | 7-Bromo-1-heptanol | 10160-24-4 | Biochemical Assay Reagents |
| HY-W008426 | Fmoc-D-Tyr(tBu)-OH | 118488-18-9 | Peptides |
| HY-W008429 | m-PEG2-Amine | 31576-51-9 | ADC Related |
| HY-W008432 | Boc-D-Ala(3,3-diphenyl)-OH | 143060-31-5 | Peptides |
| HY-W008437 | (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid dihydrate | 18835-59-1 | Natural Products |
| HY-W008440S | DL-Cycloserine-15N,d3 | 1219176-26-7 | Isotope-Labeled Compounds |
| HY-W008446 | (2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | 176486-63-8 | Peptides |
| HY-W008449 | 1-Methylxanthine | 6136-37-4 | Natural Products |
| HY-W008449R | 1-Methylxanthine (Standard) | 6136-37-4 | Reference Standards |
| HY-W008449S | 1-Methylxanthine-13C,d3 | Isotope-Labeled Compounds | |
| HY-W008449S1 | 1-Methylxanthine-13C4,15N3 | 1173018-69-3 | Isotope-Labeled Compounds |
| HY-W008449S2 | 1-Methylxanthine-d3 | 1216430-61-3 | Isotope-Labeled Compounds |
| HY-W008452 | H-Tyr(3-I)-OH | 70-78-0 | Natural Products |
| HY-W008452S | H-Tyr(3-I)-OH-13C6 | 2483735-06-2 | Isotope-Labeled Compounds |
| HY-W008464 | H-Thr(Me)-OH | 4144-02-9 | Peptides |
| HY-W008467 | (S)-2-amino-3-hydroxy-2-methylpropanoic acid | 16820-18-1 | Peptides |
| HY-W008469 | 2-Fluoroadenine | 700-49-2 | Reference compound |
| HY-W008472 | 4-Amino-3-bromobenzoic acid | 6311-37-1 | Biochemical Assay Reagents |
| HY-W008474 | Boc-NH-PEG2-C2-NH2 | 153086-78-3 | Reference compound |
| HY-W008475 | Fmoc-Glu-OAll | 144120-54-7 | Peptides |
| HY-W008486 | Boc-Phe(4-Cl)-OH | 68090-88-0 | Peptides |
| HY-W008487 | Z-Arg(Z)2-OH | 14611-34-8 | Peptides |
| HY-W008489 | (R)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid | 76985-10-9 | Peptides |
| HY-W008495 | Z-D-Glu(OtBu)-OH | 51644-83-8 | Peptides |
| HY-W008497 | 2-Chloro-5-nitrobenzene sulfonamide | 96-72-0 | Biochemical Assay Reagents |
| HY-W008504 | L-(−)-Glyceraldehyde | 497-09-6 | Natural Products |
| HY-W008507 | (R)-2,3-Dihydroxypropanal, 80% | 453-17-8 | Biochemical Assay Reagents |
| HY-W008507S | (R)-2,3-Dihydroxypropanal-3-13C | 478529-50-9 | Isotope-Labeled Compounds |
| HY-W008507S1 | (R)-2,3-Dihydroxypropanal-d2 | 478529-58-7 | Isotope-Labeled Compounds |
| HY-W008507S2 | (R)-2,3-Dihydroxypropanal-d4 | 478529-60-1 | Isotope-Labeled Compounds |
| HY-W008507S3 | (R)-2,3-Dihydroxypropanal-d | 478529-64-5 | Isotope-Labeled Compounds |
| HY-W008517 | 6-Hydroxytropinone | 5932-53-6 | Natural Products |
| HY-W008517R | 6-Hydroxytropinone (Standard) | 5932-53-6 | Reference Standards |
| HY-W008522 | H-D-Phe-OtBu.HCl | 3403-25-6 | Peptides |
| HY-W008523 | Methyl tetra-O-acetyl-β-D-glucopyranuronate | 7355-18-2 | Biochemical Assay Reagents |
| HY-W008525 | Tris(perfluorophenyl)borane | 1109-15-5 | Biochemical Assay Reagents |
| HY-W008527 | Fmoc-Phe(4-CN)-OH | 173963-93-4 | Peptides |
| HY-W008529 | Fmoc-N-Me-Glu(OtBu)-OH | 200616-40-6 | Peptides |
| HY-W008530 | H-Cyclopentyl-Gly-OH | 2521-84-8 | Peptides |
| HY-W008531 | 7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one | 179688-01-8 | Biochemical Assay Reagents |
| HY-W008542 | Methyl 4-vinylbenzoate | 1076-96-6 | Biochemical Assay Reagents |
| HY-W008544 | D-Isovaline | 3059-97-0 | Peptides |
| HY-W008548 | Di(adamantan-1-yl)phosphine | 131211-27-3 | Reference compound |
| HY-W008549 | Z-Glu-OtBu | 5891-45-2 | Peptides |
| HY-W008550 | 8-Azaadenine | 1123-54-2 | Reference compound |
| HY-W008552 | 2-Iodoadenosine | 35109-88-7 | Reference compound |
| HY-W008554 | 7-Octyn-1-ol | 871-91-0 | Reference compound |
| HY-W008555 | Fmoc-N-Me-Ile-OH | 138775-22-1 | Reference compound |
| HY-W008558 | Fmoc-N-Me-Leu-OH | 103478-62-2 | Reference compound |
| HY-W008559 | L-Tyrosinamide | 4985-46-0 | Reference compound |
| HY-W008560 | Fmoc-Gly(allyl)-OH | 146549-21-5 | Peptides |
| HY-W008563 | Bapta tetraethyl ester | 73630-07-6 | Biochemical Assay Reagents |
| HY-W008566 | Norharmane | 244-63-3 | Natural Products |
| HY-W008566R | Norharmane (Standard) | 244-63-3 | Reference Standards |
| HY-W008567 | N-Deschlorobenzoyl indomethacin | 2882-15-7 | Reference compound |
| HY-W008568 | Fmoc-amino-PEG3-CH2COOH | 139338-72-0 | Reference compound |
| HY-W008574 | TGN-020 | 51987-99-6 | Reference compound |
| HY-W008574A | TGN-020 (sodium) | 1313731-99-5 | Reference compound |
| HY-W008575 | N-Fmoc-N-methoxy-3-aminopropionic acid | 247021-90-5 | Reference compound |
| HY-W008579S | 1,5-Bis(3,4-dimethoxyphenyl)penta-1,4-dien-3-one-d12 | Isotope-Labeled Compounds | |
| HY-W008582 | (Z)-Methyl heptadec-10-enoate | 75190-82-8 | Reference compound |
| HY-W008585 | Benzo-15-crown-5-ether | 14098-44-3 | Biochemical Assay Reagents |
| HY-W008594 | 1-Bromoadamantane | 768-90-1 | Biochemical Assay Reagents |
| HY-W008596 | 2,2,2-Trifluoro-N-(6-hydroxyhexyl)acetamide | 40248-34-8 | Biochemical Assay Reagents |
| HY-W008598 | 2-Bromo-4'-fluoroacetophenone | 403-29-2 | Reference compound |
| HY-W008598S | 2-Bromo-1-(4-fluorophenyl)ethanone-d4 | 1219803-30-1 | Isotope-Labeled Compounds |
| HY-W008599 | (S)-2-Amino-3-methyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)butanamide 2,2,2-trifluoroacetate | 191723-67-8 | Peptides |
| HY-W008600 | Sodium octane-1-sulfonate | 5324-84-5 | Biochemical Assay Reagents |
| HY-W008600R | Sodium octane-1-sulfonate (Standard) | 5324-84-5 | Reference Standards |
| HY-W008606 | Sodium citrate monobasic | 18996-35-5 | Biochemical Assay Reagents |
| HY-W008608 | N-Dodecyl-N,N-dimethyldodecan-1-aminium (bromide) | 3282-73-3 | Biochemical Assay Reagents |
| HY-W008608S | N-Dodecyl-N,N-dimethyldodecan-1-aminium-d25 (bromide) | 918897-30-0 | Isotope-Labeled Compounds |
| HY-W008608S1 | N-Dodecyl-N,N-dimethyldodecan-1-aminium-d5 (bromide) | 1219799-21-9 | Isotope-Labeled Compounds |
| HY-W008610 | GBR 12783 | 67469-57-2 | Reference compound |
| HY-W008613 | Pamoic acid | 130-85-8 | Reference compound |
| HY-W008613A | Amitriptyline (pamoate) | 17086-03-2 | Reference compound |
| HY-W008613R | Pamoic acid (Standard) | 130-85-8 | Reference Standards |
| HY-W008614 | Lansoprazole sulfone | 131926-99-3 | Reference compound |
| HY-W008614R | Lansoprazole sulfone (Standard) | 131926-99-3 | Reference Standards |
| HY-W008614S | Lansoprazole sulfone-d4 | 1184999-77-6 | Isotope-Labeled Compounds |
| HY-W008614S1 | Lansoprazole sulfone-13C6 | 1261398-50-8 | Isotope-Labeled Compounds |
| HY-W008615 | 5-Iodo-cytidine | 1147-23-5 | Reference compound |
| HY-W008621A | Potassium oleate, 98% | 143-18-0 | Biochemical Assay Reagents |
| HY-W008621S | Oleic acid-13C (potassium) | 360769-20-6 | Isotope-Labeled Compounds |
| HY-W008625S | 1-Bromohexadecane-16,16,16-d3 | 284474-40-4 | Isotope-Labeled Compounds |
| HY-W008625S1 | 1-Bromohexadecane-d33 | 284474-41-5 | Isotope-Labeled Compounds |
| HY-W008628S | Bisphenol AP-d5 | 2469555-57-3 | Isotope-Labeled Compounds |
| HY-W008629 | (E, E)-Farnesyl bromide | 28290-41-7 | Reference compound |
| HY-W008630 | Decyltrimethylammonium (bromide) | 2082-84-0 | Biochemical Assay Reagents |
| HY-W008630S | Decyltrimethylammonium-d21 (bromide) | 1515861-67-2 | Isotope-Labeled Compounds |
| HY-W008633 | Boc-3-Pal-OH | 117142-26-4 | Peptides |
| HY-W008634 | Bropirimine | 56741-95-8 | Reference compound |
| HY-W008635 | Tetrabutylammonium (tetrahydroborate) | 33725-74-5 | Biochemical Assay Reagents |
| HY-W008638 | 2'-Deoxyinosine | 890-38-0 | Natural Products |
| HY-W008638R | 2'-Deoxyinosine (Standard) | 890-38-0 | Reference Standards |
| HY-W008642 | Leu-Leu-OH | 3303-31-9 | Peptides |
| HY-W008642S | (Leu-13C6,15N)-Leu-OH (TFA) | Isotope-Labeled Compounds | |
| HY-W008645 | NCS-382 (sodium) | 131733-92-1 | Reference compound |
| HY-W008646 | 7,8-Dihydro-L-biopterin | 6779-87-9 | Natural Products |
| HY-W008646R | 7,8-Dihydro-L-biopterin (Standard) | 6779-87-9 | Reference Standards |
| HY-W008658 | [1,4-Bis(diphenylphosphino)butane](norbornadiene)rhodium (tetrafluoroborate) | 82499-43-2 | Reference compound |
| HY-W008661 | Deoxyguanosine triphosphate (trisodium) solution (100mM) | 93919-41-6 | Biochemical Assay Reagents |
| HY-W008662 | 2'-Deoxy-5'-O-DMT-2'-fluorouridine | 146954-74-7 | Reference compound |
| HY-W008667 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid hydrate | 204251-24-1 | Peptides |
| HY-W008678S | Triphenyl(propyl)phosphonium-d5 (bromide) | 1703757-22-5 | Isotope-Labeled Compounds |
| HY-W008680 | 4,4'-Bis(4-aminophenoxy)biphenyl | 13080-85-8 | Reference compound |
| HY-W008685 | Z-Asp-OBzl | 4779-31-1 | Peptides |
| HY-W008688 | Fmoc-L-Norleucine | 77284-32-3 | Peptides |
| HY-W008689 | Fmoc-ε-Acp-OH | 88574-06-5 | Biochemical Assay Reagents |
| HY-W008694 | N-Benzoyl-L-arginine ethyl ester hydrochloride | 2645-08-1 | Peptides |
| HY-W008696 | Fmoc-Thr-OH | 73731-37-0 | Peptides |
| HY-W008707 | Tris(4-fluorophenyl)phosphine | 18437-78-0 | Biochemical Assay Reagents |
| HY-W008709 | 4-(4,5-Diphenyl-1H-imidazol-2-yl)phenol | 1752-94-9 | Biochemical Assay Reagents |
| HY-W008719 | MPP+ (iodide) | 36913-39-0 | Reference compound |
| HY-W008719S | MPP+-d3(iodide) | 207556-07-8 | Isotope-Labeled Compounds |
| HY-W008721 | 4,4'-Biphthalic anhydride | 2420-87-3 | Biochemical Assay Reagents |
| HY-W008731 | 2-(2-(((Benzyloxy)carbonyl)amino)acetamido)acetic acid | 2566-19-0 | Peptides |
| HY-W008733 | L-Phenylalanyl-L-valine | 3918-90-9 | Peptides |
| HY-W008741 | Phenyl β-D-galactopyranoside | 2818-58-8 | Biochemical Assay Reagents |
| HY-W008753 | Z-L-Val-OH | 1149-26-4 | Biochemical Assay Reagents |
| HY-W008756 | 1,3-Dipropyl-7-methylxanthine | 31542-63-9 | Biochemical Assay Reagents |
| HY-W008758 | 1-Bromododecane | 143-15-7 | Natural Products |
| HY-W008758S | 1-Bromododecane-d25 | 204259-66-5 | Isotope-Labeled Compounds |
| HY-W008758S1 | 1-Bromododecane-d3 | 204259-68-7 | Isotope-Labeled Compounds |
| HY-W008766 | H-Trp-NH2.HCl | 5022-65-1 | Natural Products |
| HY-W008769 | Ethychlozate | 27512-72-7 | Reference compound |
| HY-W008770 | trans-2,3,4-Trimethoxycinnamic acid | 33130-03-9 | Natural Products |
| HY-W008771 | H-Glu-Obzl | 13030-09-6 | Peptides |
| HY-W008772 | 4-Hydroxymephenytoin | 61837-65-8 | Natural Products |
| HY-W008772R | 4-Hydroxymephenytoin (Standard) | 61837-65-8 | Reference Standards |
| HY-W008772S | 4-Hydroxymephenytoin-d3 | 1173022-56-4 | Isotope-Labeled Compounds |
| HY-W008784 | 3,5-Di(trifluoromethyl)aniline | 328-74-5 | Biochemical Assay Reagents |
| HY-W008787 | H-Asp(Oet)-OEt.HCl | 16115-68-7 | Peptides |
| HY-W008794 | Normetanephrine (hydrochloride) | 1011-74-1 | Natural Products |
| HY-W008794R | Normetanephrine (hydrochloride) (Standard) | 1011-74-1 | Reference Standards |
| HY-W008794S | Normetanephrine-d3 (hydrochloride) | 1085333-97-6 | Isotope-Labeled Compounds |
| HY-W008800 | Boc-D-Thr-OH | 55674-67-4 | Peptides |
| HY-W008806 | N-(3-Oxohexanoyl)-L-homoserine lactone | 143537-62-6 | Reference compound |
| HY-W008807 | Phosphoenolpyruvic acid (potassium) | 4265-07-0 | Natural Products |
| HY-W008807R | Phosphoenolpyruvic acid (potassium) (Standard) | 4265-07-0 | Reference Standards |
| HY-W008807S | Phosphoenolpyruvic acid (potassium)-13C2 | 201996-39-6 | Isotope-Labeled Compounds |
| HY-W008813 | 1-(3-Methoxyphenyl)piperazine | 16015-71-7 | Reference compound |
| HY-W008814 | Diphenylmethane | 101-81-5 | Biochemical Assay Reagents |
| HY-W008814S | Diphenylmethane-d2 | 3947-98-6 | Isotope-Labeled Compounds |
| HY-W008816 | Nonanol | 143-08-8 | Natural Products |
| HY-W008816S | Nonan-1-ol-d19 | 349553-86-2 | Isotope-Labeled Compounds |
| HY-W008816S1 | Nonan-1-ol-d4 | 33975-46-1 | Isotope-Labeled Compounds |
| HY-W008818 | 4'-Aminoacetophenone | 99-92-3 | Biochemical Assay Reagents |
| HY-W008819S2 | 3-Mercaptohexan-1-ol-d5 | Isotope-Labeled Compounds | |
| HY-W008820 | Glutaric acid | 110-94-1 | Natural Products |
| HY-W008820R | Glutaric acid (Standard) | 110-94-1 | Reference Standards |
| HY-W008820S | Glutaric acid-d6 | 154184-99-3 | Isotope-Labeled Compounds |
| HY-W008820S1 | Glutaric acid-d4 | 19136-99-3 | Isotope-Labeled Compounds |
| HY-W008820S2 | Glutaric acid-d2 | 43087-19-0 | Isotope-Labeled Compounds |
| HY-W008821 | 1,7-Heptanediamine | 646-19-5 | Reference compound |
| HY-W008822 | 5-Chloro-2(1H)-pyridinone | 4214-79-3 | Biochemical Assay Reagents |
| HY-W008833 | 3-Aminobutanoic acid | 541-48-0 | Reference compound |
| HY-W008836S | (E)-Hex-3-en-1-ol-d2 | 144369-19-7 | Isotope-Labeled Compounds |
| HY-W008840 | Propan-2-one oxime | 127-06-0 | Biochemical Assay Reagents |
| HY-W008841S | N-Methylformamide-d3 | 87955-92-8 | Isotope-Labeled Compounds |
| HY-W008841S1 | N-Methylformamide-d5 | 863653-47-8 | Isotope-Labeled Compounds |
| HY-W008841S2 | N-Methylformamide-d4 | 110505-55-0 | Isotope-Labeled Compounds |
| HY-W008841S3 | N-Methylformamide-d1 | 26103-38-8 | Isotope-Labeled Compounds |
| HY-W008848 | DMT-dG(ib) Phosphoramidite | 93183-15-4 | Biochemical Assay Reagents |
| HY-W008848A | DMT-L-dG(ib) Phosphoramidite | 141846-56-2 | Oligonucleotides |
| HY-W008848S | DMT-dG(ib) Phosphoramidite-13C10,15N5 | 2483830-16-4 | Isotope-Labeled Compounds |
| HY-W008848S1 | DMT-dG(ib) Phosphoramidite-15N5 | Isotope-Labeled Compounds | |
| HY-W008849 | DMT-dC(bz) Phosphoramidite | 102212-98-6 | Biochemical Assay Reagents |
| HY-W008849S | DMT-dC(bz) Phosphoramidite-13C9,15N3 | 2483830-14-2 | Isotope-Labeled Compounds |
| HY-W008852 | Tetrakis (4-carboxyphenyl) porphyrin | 14609-54-2 | Reference compound |
| HY-W008859 | Tetrac | 67-30-1 | Natural Products |
| HY-W008864 | Lactose octaacetate | 6291-42-5 | Biochemical Assay Reagents |
| HY-W008865 | PIPES (sesquisodium) | 100037-69-2 | Biochemical Assay Reagents |
| HY-W008866 | Fmoc-β-HoArg(Pbf)-OH | 401915-53-5 | Peptides |
| HY-W008867 | Fmoc-Tyr(3,5-I2)-OH | 103213-31-6 | Peptides |
| HY-W008869 | Fmoc-His(MMt)-OH | 133367-33-6 | Peptides |
| HY-W008870 | MTOA-TFSI | 375395-33-8 | Biochemical Assay Reagents |
| HY-W008872 | Fmoc-Lys(Mtt)-OH | 167393-62-6 | Peptides |
| HY-W008876 | Fmoc-Pen(Trt)-OH | 201531-88-6 | Peptides |
| HY-W008879 | Mal-amido-PEG6-NHS ester | 1137109-21-7 | Reference compound |
| HY-W008884 | 25-NBD Cholesterol | 105539-27-3 | Dye Reagents |
| HY-W008887 | Z-Tyr(tBu)-OH.DCHA | 16879-90-6 | Peptides |
| HY-W008888 | N-Xantphos | 261733-18-0 | Biochemical Assay Reagents |
| HY-W008896 | Tris(pentafluorophenyl)phosphine | 1259-35-4 | Biochemical Assay Reagents |
| HY-W008907 | 5'-O-Tritylthymidine | 7791-71-1 | Biochemical Assay Reagents |
| HY-W008908 | Fmoc-Tyr(H2PO3)-OH | 147762-53-6 | Peptides |
| HY-W008914 | (E/Z)-CP-724714 | 537705-08-1 | Reference compound |
| HY-W008915 | Cytidine 5'-diphosphate (trisodium salt) | 34393-59-4 | Natural Products |
| HY-W008915R | Cytidine 5'-diphosphate (trisodium salt) (Standard) | 34393-59-4 | Reference Standards |
| HY-W008917S1 | Estrone β-D-glucuronide-d4 (sodium) | Isotope-Labeled Compounds | |
| HY-W008919 | Boc-Lys(Boc)-Onp | 2592-19-0 | Peptides |
| HY-W008922 | Fmoc-D-3,3-diphenylalanine | 189937-46-0 | Peptides |
| HY-W008923 | Doxycycline (monohydrate) | 17086-28-1 | Reference compound |
| HY-W008923R | Doxycycline (monohydrate) (Standard) | 17086-28-1 | Reference Standards |
| HY-W008926 | Fmoc-Glu(OBzl)-OH | 123639-61-2 | Peptides |
| HY-W008927A | (Z)-Fluoxastrobin | 887973-21-9 | Reference compound |
| HY-W008936 | N-Benzylquinidinium (chloride) | 77481-82-4 | Biochemical Assay Reagents |
| HY-W008940 | Cytidine 5'-diphosphate (disodium salt) | 54394-90-0 | Reference compound |
| HY-W008940R | Cytidine 5'-diphosphate (disodium salt) (Standard) | 54394-90-0 | Reference Standards |
| HY-W008942 | Z-Leu-OH.DCHA | 53363-87-4 | Peptides |
| HY-W008947 | SEW2871 | 256414-75-2 | Reference compound |
| HY-W008948 | Bis(L-tartaric acid) 18-crown-6 | 61696-54-6 | Biochemical Assay Reagents |
| HY-W008951 | Ethylenediaminetetra(methylenephosphonic acid) | 1429-50-1 | Biochemical Assay Reagents |
| HY-W008951A | Ethylenediaminetetra(methylenephosphonic acid) (sodium) | 7651-99-2 | Reference compound |
| HY-W008953 | N-Benzoyl-DL-arginine-4-nitroanilide (hydrochloride) | 911-77-3 | Biochemical Assay Reagents |
| HY-W008954 | Tris(2-ethylhexyl) phosphate | 78-42-2 | Reference compound |
| HY-W008954S | Tris(2-ethylhexyl) phosphate-d17 | 1259188-37-8 | Isotope-Labeled Compounds |
| HY-W008956 | Myoseverin | 267402-71-1 | Reference compound |
| HY-W008958 | Fmoc-MeSer(Bzl)-OH | 84000-14-6 | Peptides |
| HY-W008963 | Fmoc-D-Trp-OH | 86123-11-7 | Biochemical Assay Reagents |
| HY-W008971 | Fmoc-Phe(4-Cl)-OH | 175453-08-4 | Peptides |
| HY-W008972 | Fmoc-D-Phe(2-Cl)-OH | 205526-22-3 | Peptides |
| HY-W008974 | Sulfobetaine-18 | 13177-41-8 | Biochemical Assay Reagents |
| HY-W008977 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-(phenylmethyl)-L-serine | 83792-48-7 | Peptides |
| HY-W008981 | Z-Lys(Z)-OH | 405-39-0 | Peptides |
| HY-W008986 | Fmoc-Lys(Ac)-OH | 159766-56-0 | Peptides |
| HY-W008990 | Xanthosine 5'-monophosphate (sodium salt) | 25899-70-1 | Reference compound |
| HY-W008992 | Quinolin-8-ol (sulfate hydrate) | 207386-91-2 | Biochemical Assay Reagents |
| HY-W008995 | Fmoc-Phe(4-F)-OH | 169243-86-1 | Peptides |
| HY-W008996 | Fmoc-D-Phe(4-F)-OH | 177966-64-2 | Peptides |
| HY-W008997 | Fmoc-D-Phe(3-F)-OH | 198545-72-1 | Peptides |
| HY-W008999 | Fmoc-Phe(2-F)-OH | 205526-26-7 | Peptides |
| HY-W009001 | Cholesteryl chloride | 910-31-6 | Reference compound |
| HY-W009003 | Fmoc-Tyr-OH | 92954-90-0 | Peptides |
| HY-W009004 | Trilysine | 13184-14-0 | Peptides |
| HY-W009004B | Trilysine (TFA) | 3018057-84-3 | Peptides |
| HY-W009005 | Fmoc-HoPhe-OH | 132684-59-4 | Peptides |
| HY-W009006 | Fmoc-B-HoPhe-OH | 193954-28-8 | Peptides |
| HY-W009008 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(tert-butyl)-L-cysteine | 67436-13-9 | Peptides |
| HY-W009009 | L-838417 | 286456-42-6 | Reference compound |
| HY-W009016 | 2’,3’,5’-Tri-O-acetyl adenosine | 7387-57-7 | Reference compound |
| HY-W009020 | β-D-Glucopyranose,2-(acetylamino)-2-deoxy,1,3,4,6-tetraacetate | 7772-79-4 | Biochemical Assay Reagents |
| HY-W009022 | Diantipyrylmethane | 1251-85-0 | Biochemical Assay Reagents |
| HY-W009023 | Fmoc-D-4-Pal-OH | 205528-30-9 | Peptides |
| HY-W009027 | Indoramin (hydrochloride) | 38821-52-2 | Reference compound |
| HY-W009030 | N-Fmoc-8-aminooctanoic acid | 126631-93-4 | Reference compound |
| HY-W009033 | Cbz-Lys(Boc)-OH | 2389-60-8 | Reference compound |
| HY-W009034 | Fmoc-Suberol | 212783-75-0 | Reference compound |
| HY-W009037 | Maleimide-C10-NHS ester | 87981-04-2 | Reference compound |
| HY-W009038 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(furan-2-yl)propanoic acid | 220497-85-8 | Peptides |
| HY-W009048 | Dicyclohexano-18-crown-6-ether | 16069-36-6 | Biochemical Assay Reagents |
| HY-W009049 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-methionine | 112883-40-6 | Peptides |
| HY-W009049S | D-Methionine-N-fmoc-d3 | Isotope-Labeled Compounds | |
| HY-W009051 | Decamethylcyclopentasiloxane | 541-02-6 | Reference compound |
| HY-W009051R | Decamethylcyclopentasiloxane (Standard) | 541-02-6 | Reference Standards |
| HY-W009052S | Bis(2-ethylhexyl) adipate-d8 | 1214718-98-5 | Isotope-Labeled Compounds |
| HY-W009056 | Fmoc-7-amino-heptanoic acid | 127582-76-7 | Reference compound |
| HY-W009062 | MePhos | 251320-86-2 | Biochemical Assay Reagents |
| HY-W009066 | 2-Ethylhexyl diphenyl phosphate | 1241-94-7 | Reference compound |
| HY-W009071 | 1,5-Naphthalenedisulfonic acid (tetrahydrate) | 211366-30-2 | Reference compound |
| HY-W009078 | 4-S-β-D-Glucopyranosyl-4-thio-D-glucose | 80951-92-4 | Biochemical Assay Reagents |
| HY-W009081 | Tricosanoic acid | 2433-96-7 | Natural Products |
| HY-W009081R | Tricosanoic acid (Standard) | 2433-96-7 | Reference Standards |
| HY-W009082 | Methyl behenate | 929-77-1 | Natural Products |
| HY-W009082R | Methyl behenate (Standard) | 929-77-1 | Reference Standards |
| HY-W009085 | Fmoc-Asn-OH | 71989-16-7 | Peptides |
| HY-W009088 | Fmoc-Tle-OH | 132684-60-7 | Peptides |
| HY-W009109 | Antimalarial agent 1 | 84176-65-8 | Reference compound |
| HY-W009110 | (S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid | 261165-06-4 | Peptides |
| HY-W009117 | Dimethyl 3,3'-disulfanediyl(2R,2'R)-bis(2-aminopropanoate) dihydrochloride | 32854-09-4 | Peptides |
| HY-W009118 | Fmoc-5-Ava-OH | 123622-48-0 | Peptides |
| HY-W009119 | Fmoc-D-Val-OH | 84624-17-9 | Peptides |
| HY-W009121 | Cbz-D-Trp-OH | 2279-15-4 | Reference compound |
| HY-W009122 | 4-Methylumbelliferyl-α-d-mannoside | 28541-83-5 | Biochemical Assay Reagents |
| HY-W009123 | Erucamide | 112-84-5 | Natural Products |
| HY-W009123R | Erucamide (Standard) | 112-84-5 | Reference Standards |
| HY-W009124 | Fmoc-D-Pro-OH | 101555-62-8 | Peptides |
| HY-W009139 | N4-Benzoyl-2'-deoxycytidine | 4836-13-9 | Reference compound |
| HY-W009140S | 2,4,6-Tribromophenol-d2 | 1219795-42-2 | Isotope-Labeled Compounds |
| HY-W009141 | 1-Monopalmitin | 542-44-9 | Natural Products |
| HY-W009141R | 1-Monopalmitin (Standard) | 542-44-9 | Reference Standards |
| HY-W009142 | Dicyclohexyl phthalate | 84-61-7 | Biochemical Assay Reagents |
| HY-W009142S | Dicyclohexyl phthalate-d4 | 358731-25-6 | Isotope-Labeled Compounds |
| HY-W009144 | Tosyl-L-arginine | 1159-15-5 | Peptides |
| HY-W009145S | 1,12-Dibromododecane-d24 | 1044544-84-4 | Isotope-Labeled Compounds |
| HY-W009151 | Fmoc-Abu-OH | 135112-27-5 | Peptides |
| HY-W009154 | 3,6-Dibromocarbazole | 6825-20-3 | Biochemical Assay Reagents |
| HY-W009156 | Citric acid (tripotassium hydrate) | 6100-05-6 | Natural Products |
| HY-W009156R | Citric acid (tripotassium hydrate) (Standard) | 6100-05-6 | Reference Standards |
| HY-W009160S | 2-Benzotriazol-4-tert-octylphenol-d4 (UV-329-d4) | Isotope-Labeled Compounds | |
| HY-W009162 | Cytidine 5'-monophosphate | 63-37-6 | Natural Products |
| HY-W009162R | Cytidine 5'-monophosphate (Standard) | 63-37-6 | Reference Standards |
| HY-W009162S | Cytidine 5′-monophosphate-15N3 (disodium) | Isotope-Labeled Compounds | |
| HY-W009162S1 | Cytidine 5′-monophosphate-13C9 (dilithium) | Isotope-Labeled Compounds | |
| HY-W009162S2 | Cytidine 5′-monophosphate-d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W009162S3 | Cytidine 5′-monophosphate-15N3,d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W009162S4 | Cytidine 5′-monophosphate-15N3 (dilithium) | Isotope-Labeled Compounds | |
| HY-W009162S5 | Cytidine 5′-monophosphate-13C9,15N3 (dilithium) | 2483830-57-3 | Isotope-Labeled Compounds |
| HY-W009163 | 5-Bromouridine | 957-75-5 | Reference compound |
| HY-W009165 | (Z)-9-Tricosene | 27519-02-4 | Natural Products |
| HY-W009165R | (Z)-9-Tricosene (Standard) | 27519-02-4 | Reference Standards |
| HY-W009168 | Tazobactam (sodium) | 89785-84-2 | Reference compound |
| HY-W009168R | Tazobactam (sodium) (Standard) | 89785-84-2 | Reference Standards |
| HY-W009169 | Benzophenonetetracarboxylic dianhydride | 2421-28-5 | Reference compound |
| HY-W009172 | Lauroylcholine (chloride) | 25234-60-0 | Biochemical Assay Reagents |
| HY-W009177 | S-Methylglutathione | 2922-56-7 | Reference compound |
| HY-W009190 | 1,1-Dimethyl-4-phenylpiperazinium (iodide) | 54-77-3 | Biochemical Assay Reagents |
| HY-W009194 | (R)-(+)-Trityl glycidyl ether | 65291-30-7 | Reference compound |
| HY-W009197 | (S)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid | 55447-00-2 | Peptides |
| HY-W009202 | Tetrapropylammonium (iodide) | 631-40-3 | Biochemical Assay Reagents |
| HY-W009203 | L-Cystine (dihydrochloride) | 30925-07-6 | Peptides |
| HY-W009204 | Fmoc-Ala-OH | 35661-39-3 | Peptides |
| HY-W009204S | Fmoc-Ala-OH-15N | 117398-49-9 | Isotope-Labeled Compounds |
| HY-W009204S1 | Fmoc-Ala-OH-3,3,3-d3 | 225101-67-7 | Isotope-Labeled Compounds |
| HY-W009204S2 | Fmoc-Ala-OH-1-13C | 202326-53-2 | Isotope-Labeled Compounds |
| HY-W009204S3 | Fmoc-Ala-OH-3-13C | 201489-21-6 | Isotope-Labeled Compounds |
| HY-W009204S4 | Fmoc-Ala-OH-13C3,15N | 865720-15-6 | Isotope-Labeled Compounds |
| HY-W009204S5 | Fmoc-Ala-OH-13C3 | 765259-05-0 | Isotope-Labeled Compounds |
| HY-W009204S6 | Fmoc-Ala-OH-d4 | 225101-69-9 | Isotope-Labeled Compounds |
| HY-W009204S8 | Fmoc-Ala-OH-d1 | 225101-64-4 | Isotope-Labeled Compounds |
| HY-W009208 | Calcium L-Threonate | 70753-61-6 | Natural Products |
| HY-W009211 | Z-D-Arg-OH | 6382-93-0 | Peptides |
| HY-W009213 | 3-Nitrophenyl disulfide | 537-91-7 | Reference compound |
| HY-W009215 | H-Met-Ala-Ser-OH | 17351-33-6 | Peptides |
| HY-W009216 | 2'-Deoxycytidine-5'-monophosphoric acid | 1032-65-1 | Natural Products |
| HY-W009216R | 2'-Deoxycytidine-5'-monophosphoric acid (Standard) | 1032-65-1 | Reference Standards |
| HY-W009216S | 2'-Deoxycytidine-5'-monophosphoric acid-15N3 | Isotope-Labeled Compounds | |
| HY-W009216S1 | 2'-Deoxycytidine-5'-monophosphoric acid-13C9,15N3 (dilithium) | Isotope-Labeled Compounds | |
| HY-W009216S2 | 2'-Deoxycytidine-5'-monophosphoric acid-15N3,d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W009216S3 | 2'-Deoxycytidine-5'-monophosphoric acid-d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W009229 | Boc-Glu(OtBu)-OH | 13726-84-6 | Peptides |
| HY-W009234 | 6-Chloroguanineriboside | 2004-07-1 | Reference compound |
| HY-W009235 | Tetraethylammonium p-toluenesulfonate | 733-44-8 | Biochemical Assay Reagents |
| HY-W009236 | Butyrylcholine (iodide) | 2494-56-6 | Biochemical Assay Reagents |
| HY-W009240S | 1,10-Dibromodecane-d20 | 150017-88-2 | Isotope-Labeled Compounds |
| HY-W009244 | ((Benzyloxy)carbonyl)-D-phenylalanine | 2448-45-5 | Peptides |
| HY-W009245 | Bz-RS-iSer(3-Ph)-OMe | 32981-85-4 | Reference compound |
| HY-W009247 | N-Desmethylolanzapine | 161696-76-0 | Reference compound |
| HY-W009247R | N-Desmethylolanzapine (Standard) | 161696-76-0 | Reference Standards |
| HY-W009247S | N-Desmethylolanzapine-d8 | 786686-82-6 | Isotope-Labeled Compounds |
| HY-W009247S1 | N-Desmethylolanzapine-d8 (hydrochloride) | 2711722-81-3 | Isotope-Labeled Compounds |
| HY-W009248 | Phenethyl ferulate | 71835-85-3 | Natural Products |
| HY-W009253 | Lophine | 484-47-9 | Dye Reagents |
| HY-W009257 | Benzyl (tert-butoxycarbonyl)-D-serinate | 141527-78-8 | Peptides |
| HY-W009258 | Boc-Tyr(Me)-OH | 53267-93-9 | Peptides |
| HY-W009260 | Boc-D-Tyr(Me)-OH | 68856-96-2 | Peptides |
| HY-W009262 | N-Benzyloxycarbonyl-L-glutamic acid 1-methyl ester | 5672-83-3 | Peptides |
| HY-W009265 | 4-Octylphenol diethoxylate | 2315-61-9 | Reference compound |
| HY-W009267 | 2-Amino-5-bromo-2′-fluorobenzophenone | 1479-58-9 | Reference compound |
| HY-W009271 | 1-Deoxy-1-(octylamino)-D-glucitol | 23323-37-7 | Biochemical Assay Reagents |
| HY-W009274 | N-Acetylmuramic acid | 10597-89-4 | Biochemical Assay Reagents |
| HY-W009276 | γ-Linolenic Acid methyl ester | 16326-32-2 | Reference compound |
| HY-W009276R | γ-Linolenic Acid methyl ester (Standard) | 16326-32-2 | Reference Standards |
| HY-W009283 | 2-(2-(Diphenylphosphino)ethyl)pyridine | 10150-27-3 | Reference compound |
| HY-W009284 | H-DL-Phe(4-I)-OH | 14173-41-2 | Peptides |
| HY-W009293S | 1-(Bis(4-fluorophenyl)methyl)piperazine-d4 | Isotope-Labeled Compounds | |
| HY-W009296S | Tri-p-tolylamine-d21 | 201944-90-3 | Isotope-Labeled Compounds |
| HY-W009296S1 | Tri-p-tolylamine-N15 | 311761-87-2 | Isotope-Labeled Compounds |
| HY-W009299S | Octadecane-1-thiol-d37 | 668433-57-6 | Isotope-Labeled Compounds |
| HY-W009300 | 4-Hydroxyestrone | 3131-23-5 | Natural Products |
| HY-W009300S | 4-Hydroxyestrone-d4 | 81586-98-3 | Isotope-Labeled Compounds |
| HY-W009300S1 | 4-Hydroxyestrone-13C6 | Isotope-Labeled Compounds | |
| HY-W009301 | 6-Ketoestradiol | 571-92-6 | Reference compound |
| HY-W009301R | 6-Ketoestradiol (Standard) | 571-92-6 | Reference Standards |
| HY-W009304 | Methylarbutin | 6032-32-2 | Natural Products |
| HY-W009310 | 9-cis-Retinal | 514-85-2 | Natural Products |
| HY-W009310R | 9-cis-Retinal (Standard) | 514-85-2 | Reference Standards |
| HY-W009311 | Thiomichler's ketone | 1226-46-6 | Biochemical Assay Reagents |
| HY-W009313 | 2',3'-O-Isopropylideneuridine | 362-43-6 | Biochemical Assay Reagents |
| HY-W009320 | Z-D-Met-OH | 28862-80-8 | Peptides |
| HY-W009321 | Z-DL-Met-OH | 4434-61-1 | Peptides |
| HY-W009322 | (R)-2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid | 57292-45-2 | Peptides |
| HY-W009326 | Laurocapram | 59227-89-3 | Reference compound |
| HY-W009326S | Laurocapram-15N | Isotope-Labeled Compounds | |
| HY-W009328 | Z-Asp-OMe | 4668-42-2 | Peptides |
| HY-W009329 | Z-D-Glu-OH | 63648-73-7 | Peptides |
| HY-W009330 | TAPSO (sodium) | 105140-25-8 | Biochemical Assay Reagents |
| HY-W009335 | Iodopropynyl butylcarbamate | 55406-53-6 | Reference compound |
| HY-W009337 | Z-Lys-OH | 2212-75-1 | Peptides |
| HY-W009338 | H-Val-Tyr-OH | 3061-91-4 | Natural Products |
| HY-W009339 | Z-Gln-OH | 2650-64-8 | Peptides |
| HY-W009343 | (S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoic acid | 82717-96-2 | Peptides |
| HY-W009343R | (S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoic acid (Standard) | 82717-96-2 | Reference Standards |
| HY-W009345 | L-Phenylalanylglycylglycine | 23576-42-3 | Peptides |
| HY-W009347 | COX-1-IN-3 | 20170-32-5 | Reference compound |
| HY-W009350 | Diazolidinyl urea | 78491-02-8 | Reference compound |
| HY-W009354 | Di-tert-butyl diisopropylphosphoramidite | 137348-86-8 | Reference compound |
| HY-W009356 | L-Cystine (hydrochloride) | 34760-60-6 | Peptides |
| HY-W009356A | L-Cystine (monohydrochloride) | 438633-05-7 | Biochemical Assay Reagents |
| HY-W009362 | DL-Isocitric acid (trisodium salt) | 1637-73-6 | Natural Products |
| HY-W009362AS | DL-Isocitric acid-13C4 (trisodium hydrate) | Isotope-Labeled Compounds | |
| HY-W009362R | DL-Isocitric acid (trisodium salt) (Standard) | 1637-73-6 | Reference Standards |
| HY-W009362S | DL-Isocitric acid-13C4 (trisodium salt) | Isotope-Labeled Compounds | |
| HY-W009371 | D-Ribose 5-phosphate (disodium) | 18265-46-8 | Reference compound |
| HY-W009371A | D-Ribose 5-phosphate | 4300-28-1 | Natural Products |
| HY-W009371C | D-Ribose 5-phosphate (disodium dihydrate) | 207671-46-3 | Reference compound |
| HY-W009378 | (Lauryldimethylammonio)acetate | 683-10-3 | Biochemical Assay Reagents |
| HY-W009379 | N-Lauroyl-L-alanine | 52558-74-4 | Peptides |
| HY-W009379A | N-Lauroyl-L-alanine (sodium) | 55535-58-5 | Reference compound |
| HY-W009381 | H-Tyr(Bzl)-OH | 16652-64-5 | Peptides |
| HY-W009384 | 1,4-Dioxacycloheptadecane-5,17-dione | 105-95-3 | Biochemical Assay Reagents |
| HY-W009390 | DL-Homocystine | 870-93-9 | Natural Products |
| HY-W009390A | 4,4'-Disulfanediylbis(2-aminobutanoic acid) | 462-10-2 | Natural Products |
| HY-W009390S | DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8 | 108641-82-3 | Isotope-Labeled Compounds |
| HY-W009392 | His-Leu | 7763-65-7 | Peptides |
| HY-W009400 | (2-Dodecen-1-yl)succinic anhydride | 19780-11-1 | Natural Products |
| HY-W009401 | Boc-Ala(4-pyridyl)-OH | 37535-57-2 | Peptides |
| HY-W009402 | Boc-D-4-Pal-OH | 37535-58-3 | Peptides |
| HY-W009403 | Boc-D-2-Pal-OH | 98266-32-1 | Peptides |
| HY-W009406 | 2-Amino-2',5-dichlorobenzophenone | 2958-36-3 | Biochemical Assay Reagents |
| HY-W009410 | Amphos | 932710-63-9 | Biochemical Assay Reagents |
| HY-W009411 | Dansyl hydrazine | 33008-06-9 | Biochemical Assay Reagents |
| HY-W009412 | Boc-D-Phe-OH | 18942-49-9 | Peptides |
| HY-W009412S | D-Phenyl-alanine-N-t-Boc-d5 | 1213661-19-8 | Isotope-Labeled Compounds |
| HY-W009417 | Cedryl acetate | 77-54-3 | Natural Products |
| HY-W009417R | Cedryl acetate (Standard) | 77-54-3 | Reference Standards |
| HY-W009418S | 1-Methylnicotinamide-13C,d3 (iodide) | Isotope-Labeled Compounds | |
| HY-W009418S1 | 1-Methylnicotinamide-d4 (iodide) | Isotope-Labeled Compounds | |
| HY-W009423 | Trimethylphenylammonium (iodide) | 98-04-4 | Biochemical Assay Reagents |
| HY-W009425 | N,N-Diethyl-p-phenylenediamine Sulfate | 6283-63-2 | Biochemical Assay Reagents |
| HY-W009425R | N,N-Diethyl-p-phenylenediamine Sulfate (Standard) | 6283-63-2 | Reference Standards |
| HY-W009431 | AChE-IN-84 | 3779-42-8 | Reference compound |
| HY-W009439 | Glucosamine 6-sulfate | 91674-26-9 | Biochemical Assay Reagents |
| HY-W009443 | Diethyl decanedioate | 110-40-7 | Biochemical Assay Reagents |
| HY-W009443R | Diethyl decanedioate (Standard) | 110-40-7 | Reference Standards |
| HY-W009444 | 5-Methyluridine | 1463-10-1 | Natural Products |
| HY-W009444R | 5-Methyluridine (Standard) | 1463-10-1 | Reference Standards |
| HY-W009444S | 5-Methyluridine-d4 | 82845-85-0 | Isotope-Labeled Compounds |
| HY-W009444S1 | 5-Methyluridine-1′-13C | 201996-60-3 | Isotope-Labeled Compounds |
| HY-W009444S2 | 5-Methyluridine-2′-13C | 478510-98-4 | Isotope-Labeled Compounds |
| HY-W009444S3 | 5-Methyluridine-3′-13C | 478511-00-1 | Isotope-Labeled Compounds |
| HY-W009444S4 | 5-Methyluridine-5′-13C | 478511-02-3 | Isotope-Labeled Compounds |
| HY-W009454 | Potassium p-nitrophenyl sulfate | 6217-68-1 | Dye Reagents |
| HY-W009455S | 9-Bromoanthracene-d9 | 183486-02-4 | Isotope-Labeled Compounds |
| HY-W009456 | Adrenergic a2C receptor agonist-1 | 24155-42-8 | Reference compound |
| HY-W009458 | 3-Indoxyl phosphate (sodium) | 3318-43-2 | Reference compound |
| HY-W009472 | L-Pyroglutamic acid β-naphthylamide | 22155-91-5 | Peptides |
| HY-W009477 | (S)-6-Amino-2-((S)-2-aminopropanamido)hexanoic acid hydrochloride | 68973-27-3 | Peptides |
| HY-W009486 | H-Tyr-Ala-OH | 730-08-5 | Reference compound |
| HY-W009488S | Butyraldehyde 2,4-dinitrophenylhydrazone-d3 | 259824-54-9 | Isotope-Labeled Compounds |
| HY-W009490S | 2,4-Dibromophenol-d3 | 1219805-97-6 | Isotope-Labeled Compounds |
| HY-W009497 | Dowicil 200 | 51229-78-8 | Reference compound |
| HY-W009498 | 2,5-Dibromo-4-methylpyridine | 3430-26-0 | Biochemical Assay Reagents |
| HY-W009502 | (tert-Butoxycarbonyl)-L-methionine | 2488-15-5 | Peptides |
| HY-W009503 | Cbz-L-Aspartic anhydride | 4515-23-5 | Peptides |
| HY-W009512 | CVT-2738 | 5294-61-1 | Natural Products |
| HY-W009512R | CVT-2738 (Standard) | 5294-61-1 | Reference Standards |
| HY-W009512S | N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide-d8 | 2749349-06-0 | Isotope-Labeled Compounds |
| HY-W009512S1 | N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide-d6 | 1054624-93-9 | Isotope-Labeled Compounds |
| HY-W009516 | Dibenzyl disulfide | 150-60-7 | Natural Products |
| HY-W009516R | Dibenzyl disulfide (Standard) | 150-60-7 | Reference Standards |
| HY-W009520S | Diallyl phthalate-d4 | 2514944-45-5 | Isotope-Labeled Compounds |
| HY-W009534 | Boc-N-Me-Leu-OH | 53363-89-6 | Peptides |
| HY-W009535 | N-(tert-Butoxycarbonyl)-N-methyl-D-leucine | 89536-84-5 | Peptides |
| HY-W009538 | 5-Fluoro-5'-deoxycytidine | 66335-38-4 | Reference compound |
| HY-W009538R | 5-Fluoro-5'-deoxycytidine (Standard) | 66335-38-4 | Reference Standards |
| HY-W009538S | 5-Fluoro-5'-deoxycytidine-d3 | Isotope-Labeled Compounds | |
| HY-W009538S1 | 5-Fluoro-5'-deoxycytidine-13C5 | Isotope-Labeled Compounds | |
| HY-W009544 | 3-Hydroxytetradecanoic acid | 1961-72-4 | Biochemical Assay Reagents |
| HY-W009545 | Sodium decane-1-sulfonate | 13419-61-9 | Biochemical Assay Reagents |
| HY-W009545R | Sodium decane-1-sulfonate (Standard) | 13419-61-9 | Reference Standards |
| HY-W009560 | Di(ethylene glycol) dimethacrylate | 2358-84-1 | Biochemical Assay Reagents |
| HY-W009562 | H-Met-OtBu.HCl | 91183-71-0 | Peptides |
| HY-W009592 | Glycyl-L-tyrosine | 658-79-7 | Natural Products |
| HY-W009592A | Glycyltyrosine dihydrate | 39630-46-1 | Peptides |
| HY-W009592R | Glycyl-L-tyrosine (Standard) | 658-79-7 | Reference Standards |
| HY-W009597S | 1,5-Dichloro-2,4-dinitrobenzene-13C6 | 335081-12-4 | Isotope-Labeled Compounds |
| HY-W009602 | Phenylalanylalanine | 3918-87-4 | Natural Products |
| HY-W009630 | (R)-2-Amino-3-(3-(trifluoromethyl)phenyl)propanoic acid | 14464-67-6 | Peptides |
| HY-W009631 | H-Lys-OMe.2HCl | 26348-70-9 | Peptides |
| HY-W009632 | Adenine phosphate | 70700-30-0 | Biochemical Assay Reagents |
| HY-W009640 | Mofebutazone | 2210-63-1 | Reference compound |
| HY-W009640A | Mofebutazone (sodium) | 41468-34-2 | Reference compound |
| HY-W009641 | 1-Pyrenemethanol | 24463-15-8 | Reference compound |
| HY-W009648 | O-tert-Butylthreoninetert-butyl ester | 5854-78-4 | Peptides |
| HY-W009658S | 1,1':2',1''-Terphenyl-d14 | 5142-67-6 | Isotope-Labeled Compounds |
| HY-W009659S | 1,1':3',1''-Terphenyl-d14 | 17714-84-0 | Isotope-Labeled Compounds |
| HY-W009666 | 6-Chloro-5-(2-chloroethyl)oxindole | 118289-55-7 | Reference compound |
| HY-W009671 | 3-Chloroiminodibenzyl | 32943-25-2 | Reference compound |
| HY-W009673 | Boc-Pyr-OH | 53100-44-0 | Biochemical Assay Reagents |
| HY-W009681 | 1-(2-Methoxyphenyl)piperazine (hydrochloride) | 5464-78-8 | Reference compound |
| HY-W009682 | S-(Acetamidomethyl)-L-cysteine hydrochloride | 28798-28-9 | Peptides |
| HY-W009684 | Ethyl Laurate | 106-33-2 | Biochemical Assay Reagents |
| HY-W009684R | Ethyl Laurate (Standard) | 106-33-2 | Reference Standards |
| HY-W009684S | Ethyl Laurate-d23 | 1219795-35-3 | Isotope-Labeled Compounds |
| HY-W009686 | L-Prolyl-L-leucine | 52899-07-7 | Peptides |
| HY-W009686F | 5-FAM-Pro-Leu-OH | 1360812-71-0 | Peptides |
| HY-W009688 | Dibutyl maleate | 105-76-0 | Natural Products |
| HY-W009689 | TbPTR1 inhibitor 2 | 17557-67-4 | Reference compound |
| HY-W009693 | (S)-2-Amino-3-(4-nitrophenyl)propanoic acid hydrate | 207591-86-4 | Peptides |
| HY-W009694 | 3,5-Dinitrosalicylic acid | 609-99-4 | Biochemical Assay Reagents |
| HY-W009706 | Alclofenac | 22131-79-9 | Reference compound |
| HY-W009706A | Alclofenac (sodium) | 24049-18-1 | Reference compound |
| HY-W009706B | Alclofenac (lysinate) | 59960-34-8 | Reference compound |
| HY-W009708 | Bis(2-methyl-3-furyl)disulfide | 28588-75-2 | Natural Products |
| HY-W009708R | Bis(2-methyl-3-furyl)disulfide (Standard) | 28588-75-2 | Reference Standards |
| HY-W009713 | 3,4,5-Trimethoxyphenylacetic acid | 951-82-6 | Reference compound |
| HY-W009713R | 3,4,5-Trimethoxyphenylacetic acid (Standard) | 951-82-6 | Reference Standards |
| HY-W009713S | 3,4,5-Trimethoxyphenylacetic acid-d2 | 344299-45-2 | Isotope-Labeled Compounds |
| HY-W009719S | 1-Bromo-2,3-dichlorobenzene-d3 | 1219805-59-0 | Isotope-Labeled Compounds |
| HY-W009722 | Sodium diethylcarbamodithioate trihydrate | 20624-25-3 | Biochemical Assay Reagents |
| HY-W009722A | Sodium diethylcarbamodithioate trihydrate, ACS, 99.0% | 20624-25-3 | Biochemical Assay Reagents |
| HY-W009724 | 2-Aminoethyl diphenylborinate | 524-95-8 | Reference compound |
| HY-W009731 | Dibenzoylmethane | 120-46-7 | Natural Products |
| HY-W009731R | Dibenzoylmethane (Standard) | 120-46-7 | Reference Standards |
| HY-W009732 | Sinapinic acid | 530-59-6 | Natural Products |
| HY-W009734 | H-Ile-OtBu.HCl | 69320-89-4 | Peptides |
| HY-W009749 | L-Cystathionine | 56-88-2 | Natural Products |
| HY-W009749A | DL-Cystathionine | 535-34-2 | Reference compound |
| HY-W009749AS | DL-Cystathionine-d4 | 146764-57-0 | Isotope-Labeled Compounds |
| HY-W009749B | DL-Cystathionine (dihydrochloride) | Reference compound | |
| HY-W009749C | L-Cystathionine (dihydrochloride) | 61125-50-6 | Reference compound |
| HY-W009749CR | L-Cystathionine (dihydrochloride) (Standard) | 61125-50-6 | Reference Standards |
| HY-W009749CS | (S)-Cystathionine-d4 | Isotope-Labeled Compounds | |
| HY-W009754 | Antidepressant agent 10 | 87691-87-0 | Reference compound |
| HY-W009756 | N-Phenylnaphthalen-1-amine | 90-30-2 | Dye Reagents |
| HY-W009757 | Ethyl 5-hydroxy-2-methyl-1H-indole-3-carboxylate | 7598-91-6 | Reference compound |
| HY-W009762 | H-Lys-OH.2HCl | 657-26-1 | Peptides |
| HY-W009762S | L-Lysine-13C6,15N2 (dihydrochloride) | 202406-54-0 | Isotope-Labeled Compounds |
| HY-W009762S1 | L-Lysine6-13C (dihydrochloride) | 1217466-44-8 | Isotope-Labeled Compounds |
| HY-W009762S2 | L-Lysine-d4 (dihydrochloride) | 203633-22-1 | Isotope-Labeled Compounds |
| HY-W009762S3 | L-Lysine-d8 (dihydrochloride) | 2330877-90-0 | Isotope-Labeled Compounds |
| HY-W009762S4 | L-Lysine-d9 (dihydrochloride) | 2483831-52-1 | Isotope-Labeled Compounds |
| HY-W009762S5 | L-Lysine-15N2,d9 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W009762S6 | L-Lysine-15N2 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W009762S7 | L-Lysine-15N (dihydrochloride) | 204451-50-3 | Isotope-Labeled Compounds |
| HY-W009770 | H-Ser(tBu)-OMe.HCl | 17114-97-5 | Peptides |
| HY-W009775 | (S)-2-((S)-2-Amino-3-methylbutanamido)-3-hydroxypropanoic acid | 13588-94-8 | Peptides |
| HY-W009776 | Suberoyl bis-hydroxamic acid | 38937-66-5 | Reference compound |
| HY-W009783 | 1-Deoxymannojirimycin (hydrochloride) | 73465-43-7 | Natural Products |
| HY-W009783A | Deoxymannojirimycin hydrochloride | 84444-90-6 | Biochemical Assay Reagents |
| HY-W009787 | 1-Bromo-6-chlorohexane | 6294-17-3 | Reference compound |
| HY-W009794 | 3-Fluoro-DL-tyrosine | 403-90-7 | Peptides |
| HY-W009811 | 2-Tridecanone | 593-08-8 | Natural Products |
| HY-W009815S | 6-Heptyltetrahydro-2H-pyran-2-one-d2 | 1082581-84-7 | Isotope-Labeled Compounds |
| HY-W009815S1 | 6-Heptyltetrahydro-2H-pyran-2-one-d4 | 1394230-38-6 | Isotope-Labeled Compounds |
| HY-W009815S2 | 6-Heptyltetrahydro-2H-pyran-2-one-d7 | Isotope-Labeled Compounds | |
| HY-W009823 | Phenyl benzoate | 93-99-2 | Reference compound |
| HY-W009823R | Phenyl benzoate (Standard) | 93-99-2 | Reference Standards |
| HY-W009840 | H-Asp(ome)-OMe HCl | 32213-95-9 | Peptides |
| HY-W009841 | H-β-HoGlu-OH.HCl | 61884-74-0 | Peptides |
| HY-W009849 | 2-Aminobenzophenone | 2835-77-0 | Biochemical Assay Reagents |
| HY-W009861 | Aviglycine (hydrochloride) | 55720-26-8 | Reference compound |
| HY-W009861R | Aviglycine (hydrochloride) (Standard) | 55720-26-8 | Reference Standards |
| HY-W009876 | 9-Fluorenylmethanol | 24324-17-2 | Reference compound |
| HY-W009877 | 4-Acetylbiphenyl | 92-91-1 | Biochemical Assay Reagents |
| HY-W009884 | Acetosyringone | 2478-38-8 | Natural Products |
| HY-W009884R | Acetosyringone (Standard) | 2478-38-8 | Reference Standards |
| HY-W009886 | 3,4,5-Trimethoxybenzaldehyde | 86-81-7 | Natural Products |
| HY-W009886S | 3,4,5-Trimethoxybenzaldehyde-d3 | 1219805-17-0 | Isotope-Labeled Compounds |
| HY-W009892 | H-Leu-OEt.HCl | 2743-40-0 | Peptides |
| HY-W009906 | 2-(2′-Pyridyl)benzimidazole | 1137-68-4 | Reference compound |
| HY-W009908 | O-Benzyl-D-serine | 10433-52-0 | Peptides |
| HY-W009911 | (S)-3-(4-Hydroxyphenyl)-2-(methylamino)propanoic acid | 537-49-5 | Peptides |
| HY-W009912 | H-Tyr(Me)-OH | 6230-11-1 | Peptides |
| HY-W009913 | 2-((Carboxymethyl)amino)benzoic acid | 612-42-0 | Peptides |
| HY-W009934 | 2-Phenyl-2-(2-pyridyl)acetonitrile | 5005-36-7 | Reference compound |
| HY-W009934R | 2-Phenyl-2-(2-pyridyl)acetonitrile (Standard) | 5005-36-7 | Reference Standards |
| HY-W009938 | Anthrone | 90-44-8 | Biochemical Assay Reagents |
| HY-W009946 | 1,4-Benzenediacetic acid | 7325-46-4 | Reference compound |
| HY-W009948 | Vanillin acetate | 881-68-5 | Reference compound |
| HY-W009948R | Vanillin acetate (Standard) | 881-68-5 | Reference Standards |
| HY-W009970 | Ethyl 2-(benzylamino)acetate | 6436-90-4 | Peptides |
| HY-W009973S | 4-Anilino-4-oxobutanoic acid-d5 | 840529-98-8 | Isotope-Labeled Compounds |
| HY-W009981S | 1-Bromo-2,4-difluorobenzene-d3 | 1219803-87-8 | Isotope-Labeled Compounds |
| HY-W009986S | 9-Methylanthracene-d12 | 6406-97-9 | Isotope-Labeled Compounds |
| HY-W009993 | 3,4-Methylenedioxycinnamic acid | 2373-80-0 | Natural Products |
| HY-W010018 | (S)-L-DABA (dihydrochloride) | 1883-09-6 | Biochemical Assay Reagents |
| HY-W010019S | DL-2,4-Diaminobutyric acid-2,3,3,4,4-d5 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W010023 | 2-Amino-3-bromo-5-fluoropyridine | 869557-43-7 | Biochemical Assay Reagents |
| HY-W010028 | (R)-2-Amino-3-(2-fluorophenyl)propanoic acid | 97731-02-7 | Peptides |
| HY-W010031 | 1-Methyluric acid | 708-79-2 | Natural Products |
| HY-W010031S1 | 1-Methyluric acid-d3 | 1189480-64-5 | Isotope-Labeled Compounds |
| HY-W010037 | 2-(tert-Butyl)-4-methoxyphenol | 121-00-6 | Biochemical Assay Reagents |
| HY-W010037R | 2-(tert-Butyl)-4-methoxyphenol (Standard) | 121-00-6 | Reference Standards |
| HY-W010037S | 2-(tert-Butyl)-4-methoxyphenol-d3 | 85013-37-2 | Isotope-Labeled Compounds |
| HY-W010040 | 4-Hydroxyphenylpyruvic acid | 156-39-8 | Natural Products |
| HY-W010040R | 4-?Hydroxyphenylpyruvic acid (Standard) | 156-39-8 | Reference Standards |
| HY-W010041 | Scyllo-Inositol | 488-59-5 | Natural Products |
| HY-W010042 | L-Glucose | 921-60-8 | Reference compound |
| HY-W010042S | L-Glucose-13C | 478519-02-7 | Isotope-Labeled Compounds |
| HY-W010042S1 | L-Glucose-13C-1 | 478519-05-0 | Isotope-Labeled Compounds |
| HY-W010042S2 | L-Glucose-13C-2 | Isotope-Labeled Compounds | |
| HY-W010042S3 | L-Glucose-13C6 | Isotope-Labeled Compounds | |
| HY-W010056 | Diethyl fumarate | 623-91-6 | Natural Products |
| HY-W010062 | 4-Chlorophenylacetic acid | 1878-66-6 | Reference compound |
| HY-W010062R | 4-Chlorophenylacetic acid (Standard) | 1878-66-6 | Reference Standards |
| HY-W010066 | 4-(1,2-Dihydroxyethyl)benzene-1,2-diol | 28822-73-3 | Natural Products |
| HY-W010066R | 4-(1,2-Dihydroxyethyl)benzene-1,2-diol (Standard) | 28822-73-3 | Reference Standards |
| HY-W010076 | Methyl 2,4-dihydroxybenzoate | 2150-47-2 | Reference compound |
| HY-W010077 | H-Val-OMe.HCl | 6306-52-1 | Peptides |
| HY-W010078 | Ethyl 4-aminobutanoate hydrochloride | 6937-16-2 | Biochemical Assay Reagents |
| HY-W010098 | Terephthalic acid | 100-21-0 | Natural Products |
| HY-W010098R | Terephthalic acid (Standard) | 100-21-0 | Reference Standards |
| HY-W010098S | Terephthalic acid-d4 | 60088-54-2 | Isotope-Labeled Compounds |
| HY-W010098S1 | Terephthalic acid-13C2 | 121191-53-5 | Isotope-Labeled Compounds |
| HY-W010104 | L-Methionine sulfoxide | 3226-65-1 | Natural Products |
| HY-W010104A | Methionine sulfoxide | 62697-73-8 | Natural Products |
| HY-W010104AR | Methionine sulfoxide (Standard) | 62697-73-8 | Reference Standards |
| HY-W010105 | Ethyl 2-methylnicotinate | 1721-26-2 | Biochemical Assay Reagents |
| HY-W010106 | Methyl 3-amino-4-methylbenzoate | 18595-18-1 | Biochemical Assay Reagents |
| HY-W010106R | Methyl 3-amino-4-methylbenzoate (Standard) | 18595-18-1 | Reference Standards |
| HY-W010108 | DL-Glutamic acid (hydrate) | 19285-83-7 | Biochemical Assay Reagents |
| HY-W010112S | 4-Pentylphenol-d5 | 126839-95-0 | Isotope-Labeled Compounds |
| HY-W010112S1 | 4-Pentylphenol-d11 | 1219805-30-7 | Isotope-Labeled Compounds |
| HY-W010112S2 | 4-Pentylphenol-d16 | 1219805-40-9 | Isotope-Labeled Compounds |
| HY-W010119 | 4-Methyl-2-phenyl-1,3-dioxolane | 2568-25-4 | Biochemical Assay Reagents |
| HY-W010128 | 6-(Dimethylamino)purine | 938-55-6 | Reference compound |
| HY-W010130 | 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone | 22246-18-0 | Reference compound |
| HY-W010130R | 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone (Standard) | 22246-18-0 | Reference Standards |
| HY-W010132 | 5-Nitrobenzimidazole | 94-52-0 | Biochemical Assay Reagents |
| HY-W010143 | (R,S)-Norcotinine | 17708-87-1 | Reference compound |
| HY-W010143S | (R,S)-Norcotinine-d4 | 1020719-70-3 | Isotope-Labeled Compounds |
| HY-W010144 | Phenidone | 92-43-3 | Reference compound |
| HY-W010153S | 3-(Trifluoromethyl)phenol-d4 | 1219798-47-6 | Isotope-Labeled Compounds |
| HY-W010155 | Tryptophol | 526-55-6 | Natural Products |
| HY-W010155R | Tryptophol (Standard) | 526-55-6 | Reference Standards |
| HY-W010156 | O-(tert-Butyl)-L-serine | 18822-58-7 | Peptides |
| HY-W010162 | H-Ala-Ala-OH | 1948-31-8 | Biochemical Assay Reagents |
| HY-W010162R | H-Ala-Ala-OH (Standard) | 1948-31-8 | Reference Standards |
| HY-W010164 | 4-Hydroxybenzoate (sodium) | 114-63-6 | Biochemical Assay Reagents |
| HY-W010164R | 4-Hydroxybenzoate (sodium) (Standard) | 114-63-6 | Reference Standards |
| HY-W010169 | Sodium 4-aminobenzoate | 555-06-6 | Biochemical Assay Reagents |
| HY-W010174 | 2-Chloro-4-nitropyridine | 23056-36-2 | Biochemical Assay Reagents |
| HY-W010176 | 3,7-Dimethyl-1-octanol | 106-21-8 | Biochemical Assay Reagents |
| HY-W010177 | Ethyl heptanoate | 106-30-9 | Biochemical Assay Reagents |
| HY-W010178 | 4-Methyloctanoic acid | 54947-74-9 | Natural Products |
| HY-W010178R | 4-Methyloctanoic acid (Standard) | 54947-74-9 | Reference Standards |
| HY-W010179 | 2-Methoxynaphthalene | 93-04-9 | Biochemical Assay Reagents |
| HY-W010179S | 2-Methoxynaphthalene-d7 | 1219795-25-1 | Isotope-Labeled Compounds |
| HY-W010179S1 | 2-Methoxynaphthalene-d2 | 2071645-84-4 | Isotope-Labeled Compounds |
| HY-W010184 | 4,6-Dioxoheptanoic acid | 51568-18-4 | Natural Products |
| HY-W010184S | 4,6-Dioxoheptanoic acid-13C5 | 881835-86-5 | Isotope-Labeled Compounds |
| HY-W010195 | 2,6-Dimethylquinoline | 877-43-0 | Natural Products |
| HY-W010197 | (R)-2-Amino-2-(thiophen-2-yl)acetic acid | 65058-23-3 | Peptides |
| HY-W010201 | Citronellol | 106-22-9 | Natural Products |
| HY-W010201R | Citronellol (Standard) | 106-22-9 | Reference Standards |
| HY-W010201S | Citronellol-d6 | 220687-53-6 | Isotope-Labeled Compounds |
| HY-W010202 | Dihydrolinalool | 18479-51-1 | Natural Products |
| HY-W010203S | Decan-2-one-d5 | Isotope-Labeled Compounds | |
| HY-W010209 | DL-Histidine | 4998-57-6 | Peptides |
| HY-W010209R | DL-Histidine (Standard) | 4998-57-6 | Reference Standards |
| HY-W010209S | DL-Histidine-13C6,15N3 | 2414511-65-0 | Isotope-Labeled Compounds |
| HY-W010209S1 | DL-Histidine-15N | 287484-37-1 | Isotope-Labeled Compounds |
| HY-W010209S2 | DL-Histidine-d3 | 344299-50-9 | Isotope-Labeled Compounds |
| HY-W010216S | 4-(tert-Butyl)cyclohexanone-d9 | 1220905-42-9 | Isotope-Labeled Compounds |
| HY-W010221 | Phenyltrimethylammonium hydroxide | 1899-02-1 | Biochemical Assay Reagents |
| HY-W010223 | N4-Acetylcytosine | 14631-20-0 | Biochemical Assay Reagents |
| HY-W010224 | 3-Amino-4-hydroxybenzoic acid | 1571-72-8 | Natural Products |
| HY-W010224R | 3-Amino-4-hydroxybenzoic acid (Standard) | 1571-72-8 | Reference Standards |
| HY-W010235 | 3,5-Dimethoxytoluene | 4179-19-5 | Natural Products |
| HY-W010235R | 3,5-Dimethoxytoluene (Standard) | 4179-19-5 | Reference Standards |
| HY-W010236S | 2-Isopropoxyphenol-d7 | Isotope-Labeled Compounds | |
| HY-W010243 | Methylisothiazolinone (hydrochloride) | 26172-54-3 | Reference compound |
| HY-W010243S | Methylisothiazolinone-d3 (hydrochloride) | 1329509-49-0 | Isotope-Labeled Compounds |
| HY-W010248 | 2-Phenylglycine | 2835-06-5 | Natural Products |
| HY-W010248S | 2-Phenylglycine-d5 | 358731-96-1 | Isotope-Labeled Compounds |
| HY-W010249 | H-D-Phg-OH | 875-74-1 | Peptides |
| HY-W010249S | D-α-Phenyl-glycine-d5 | 1246817-98-0 | Isotope-Labeled Compounds |
| HY-W010253 | Benzylurea | 538-32-9 | Natural Products |
| HY-W010254 | 4′-Hydroxy-2′-methylacetophenone | 875-59-2 | Natural Products |
| HY-W010255 | Phenylglyoxylic acid | 611-73-4 | Natural Products |
| HY-W010255A | Phenylglyoxylic acid (sodium) | 43165-51-1 | Reference compound |
| HY-W010255AS | Phenylglyoxylic acid-d5(sodium) | 2708283-39-8 | Isotope-Labeled Compounds |
| HY-W010255R | Phenylglyoxylic acid (Standard) | 611-73-4 | Reference Standards |
| HY-W010255S | Phenylglyoxylic acid-d5 | 1217089-53-6 | Isotope-Labeled Compounds |
| HY-W010256 | D-Xylulose | 551-84-8 | Natural Products |
| HY-W010256S | D-Xylulose-1-13C | 131771-46-5 | Isotope-Labeled Compounds |
| HY-W010256S1 | D-Xylulose-2-13C | 131771-47-6 | Isotope-Labeled Compounds |
| HY-W010256S3 | D-Xylulose-13C5 | Isotope-Labeled Compounds | |
| HY-W010260 | 2,6-Dichloropyrazine | 4774-14-5 | Biochemical Assay Reagents |
| HY-W010265 | Butyrophenone | 495-40-9 | Natural Products |
| HY-W010265R | Butyrophenone (Standard) | 495-40-9 | Reference Standards |
| HY-W010265S | Butyrophenone-d5 | 39058-44-1 | Isotope-Labeled Compounds |
| HY-W010269S | 5-Methoxy-1H-benzo[d]imidazole-d3 | 1219805-69-2 | Isotope-Labeled Compounds |
| HY-W010271 | (2S,3R,4S)-4-Hydroxyisoleucine | 55399-93-4 | Natural Products |
| HY-W010276 | Gly-Sar | 29816-01-1 | Peptides |
| HY-W010277 | (S)-2-(2-Aminopropanamido)acetic acid | 687-69-4 | Peptides |
| HY-W010299S | 1-Chloro-4-methoxybenzene-d4 | 1219804-86-0 | Isotope-Labeled Compounds |
| HY-W010305S | 5-Ethyl-3-hydroxy-4-methylfuran-2(5H)-one-d4 | Isotope-Labeled Compounds | |
| HY-W010309 | 2-Chloroisonicotinaldehyde | 101066-61-9 | Biochemical Assay Reagents |
| HY-W010312 | D-2,3-Diaminopropionic acid monohydrochloride | 6018-56-0 | Biochemical Assay Reagents |
| HY-W010319S | 2-Amino-4-methoxy-6-methyl-1,3,5-triazine-d3 | 2377723-87-8 | Isotope-Labeled Compounds |
| HY-W010320 | Ethyl maltol | 4940-11-8 | Reference compound |
| HY-W010320R | Ethyl maltol (Standard) | 4940-11-8 | Reference Standards |
| HY-W010320S | Ethyl maltol-d5 | Isotope-Labeled Compounds | |
| HY-W010321 | Furfuryl acetate | 623-17-6 | Reference compound |
| HY-W010321R | Furfuryl acetate (Standard) | 623-17-6 | Reference Standards |
| HY-W010323 | 2,5-Dihydroxy-1,4-benzoquinone | 615-94-1 | Reference compound |
| HY-W010324 | H-DL-Ala-OMe.HCl | 13515-97-4 | Peptides |
| HY-W010341 | 2-Pyridinecarbohydrazide | 1452-63-7 | Reference compound |
| HY-W010342 | 6-Aminonicotinamide | 329-89-5 | Reference compound |
| HY-W010347 | L-Homocysteine | 6027-13-0 | Natural Products |
| HY-W010347R | L-Homocysteine (Standard) | 6027-13-0 | Reference Standards |
| HY-W010347S | DL-Homocysteine-d4 | 416845-90-4 | Isotope-Labeled Compounds |
| HY-W010348 | Betaine (monohydrate) | 590-47-6 | Biochemical Assay Reagents |
| HY-W010361 | Tetramethylammonium (acetate) | 10581-12-1 | Biochemical Assay Reagents |
| HY-W010365 | Rhodanine | 141-84-4 | Biochemical Assay Reagents |
| HY-W010366 | N-Methyl-L-threonine | 2812-28-4 | Peptides |
| HY-W010378 | D-Asparagine | 2058-58-4 | Reference compound |
| HY-W010378R | D-Asparagine (Standard) | 2058-58-4 | Reference Standards |
| HY-W010381 | 2-Methylsuccinic acid | 498-21-5 | Natural Products |
| HY-W010381R | 2-Methylsuccinic acid (Standard) | 498-21-5 | Reference Standards |
| HY-W010381S | 2-Methylsuccinic acid-d6 | 347840-08-8 | Isotope-Labeled Compounds |
| HY-W010382 | Oxaloacetic acid | 328-42-7 | Natural Products |
| HY-W010382R | Oxaloacetic acid (Standard) | 328-42-7 | Reference Standards |
| HY-W010382S | Oxaloacetic acid-13C4 | 161096-82-8 | Isotope-Labeled Compounds |
| HY-W010383 | 3-Diethylamino-1-propanol | 622-93-5 | Reference compound |
| HY-W010386 | (R)-2-amino-2,3-dimethylbutanoic acid | 53940-82-2 | Peptides |
| HY-W010387S | 2-Morpholinoethanol-d4 | 1185052-90-7 | Isotope-Labeled Compounds |
| HY-W010388 | Creatine | 57-00-1 | Natural Products |
| HY-W010388AS | Creatine-d3 (hydrate) | 284664-86-4 | Isotope-Labeled Compounds |
| HY-W010388R | Creatine (Standard) | 57-00-1 | Reference Standards |
| HY-W010388S | Creatine-13C | 687996-99-2 | Isotope-Labeled Compounds |
| HY-W010388S1 | Creatine-d3 | 143827-19-4 | Isotope-Labeled Compounds |
| HY-W010389S | N-Acetyl-DL-alanine-d7 | Isotope-Labeled Compounds | |
| HY-W010389S2 | Ac-DL-Ala-OH-d4 | Isotope-Labeled Compounds | |
| HY-W010392S | Ethyl 2-methylbutanoate-d9 | 2708286-78-4 | Isotope-Labeled Compounds |
| HY-W010392S1 | Ethyl 2-methylbutanoate-13C2 | Isotope-Labeled Compounds | |
| HY-W010394 | Methyl 3-oxopentanoate | 30414-53-0 | Biochemical Assay Reagents |
| HY-W010396 | Pantolactone | 599-04-2 | Natural Products |
| HY-W010396R | Pantolactone (Standard) | 599-04-2 | Reference Standards |
| HY-W010407 | Cyanuric acid | 108-80-5 | Biochemical Assay Reagents |
| HY-W010407R | Cyanuric acid (Standard) | 108-80-5 | Reference Standards |
| HY-W010407S | Cyanuric acid-13C3 | 201996-37-4 | Isotope-Labeled Compounds |
| HY-W010407S2 | Cyanuric acid-13C3,15N3 | Isotope-Labeled Compounds | |
| HY-W010409 | 2-Octanone | 111-13-7 | Natural Products |
| HY-W010409S | Octan-2-one-d5 | 17827-52-0 | Isotope-Labeled Compounds |
| HY-W010410 | Oct-1-en-3-ol | 3391-86-4 | Natural Products |
| HY-W010410R | Oct-1-en-3-ol (Standard) | 3391-86-4 | Reference Standards |
| HY-W010410S | Oct-1-en-3-ol-d3 | 1335435-98-7 | Isotope-Labeled Compounds |
| HY-W010417 | 4-Thiouracil | 591-28-6 | Reference compound |
| HY-W010420S | 2,4-Difluoro-1-methylbenzene-d3 | 1219798-79-4 | Isotope-Labeled Compounds |
| HY-W010421S | Ammelide-13C3 | 1173021-81-2 | Isotope-Labeled Compounds |
| HY-W010423 | 2-Chloro-4-methylpyridine | 3678-62-4 | Biochemical Assay Reagents |
| HY-W010435 | Sulcatone | 110-93-0 | Natural Products |
| HY-W010435R | Sulcatone (Standard) | 110-93-0 | Reference Standards |
| HY-W010448 | Imidazol-1-yl-acetic acid | 22884-10-2 | Natural Products |
| HY-W010448R | Imidazol-1-yl-acetic acid (Standard) | 22884-10-2 | Reference Standards |
| HY-W010450 | Thymine | 65-71-4 | Natural Products |
| HY-W010450R | Thymine (Standard) | 65-71-4 | Reference Standards |
| HY-W010450S | Thymine-d4 | 200496-79-3 | Isotope-Labeled Compounds |
| HY-W010450S2 | Thymine-15N2 | Isotope-Labeled Compounds | |
| HY-W010450S3 | Thymine-13C | 200417-68-1 | Isotope-Labeled Compounds |
| HY-W010450S4 | Thymine-d4-1 | 156054-85-2 | Isotope-Labeled Compounds |
| HY-W010450S5 | Thymine-13C5,15N2 | 2483830-13-1 | Isotope-Labeled Compounds |
| HY-W010451 | 1,2,4-Trihydroxybenzene | 533-73-3 | Natural Products |
| HY-W010451R | 1,2,4-Trihydroxybenzene (Standard) | 533-73-3 | Reference Standards |
| HY-W010452 | 3-Hydroxybutyric acid (sodium) | 150-83-4 | Reference compound |
| HY-W010452S | 3-Hydroxybutyric acid-d2 (sodium) | 352439-00-0 | Isotope-Labeled Compounds |
| HY-W010452S1 | 3-Hydroxybutyric acid-13C4 (sodium) | 287111-43-7 | Isotope-Labeled Compounds |
| HY-W010452S2 | 3-Hydroxybutyric acid-13C2 (sodium) | 287389-35-9 | Isotope-Labeled Compounds |
| HY-W010465S | N,N-Dimethylsulfamide-d6 | 1189689-95-9 | Isotope-Labeled Compounds |
| HY-W010469 | 2,6-Dimethyl-4H-pyran-4-one | 1004-36-0 | Biochemical Assay Reagents |
| HY-W010476 | 2,3,5-Trimethylpyrazine | 14667-55-1 | Natural Products |
| HY-W010476R | 2,3,5-Trimethylpyrazine (Standard) | 14667-55-1 | Reference Standards |
| HY-W010476S | 2,3,5-Trimethylpyrazine-d9 | 85735-49-5 | Isotope-Labeled Compounds |
| HY-W010476S1 | 2,3,5-Trimethylpyrazine-d3 | 1082582-30-6 | Isotope-Labeled Compounds |
| HY-W010479 | Propane sultone | 1120-71-4 | Biochemical Assay Reagents |
| HY-W010479R | Propane sultone (Standard) | 1120-71-4 | Reference Standards |
| HY-W010482S | 3-Ethylaniline-d5 | 1643538-19-5 | Isotope-Labeled Compounds |
| HY-W010486S | Bromocyclopropane-d4 | 1398065-55-8 | Isotope-Labeled Compounds |
| HY-W010488 | Dithiooxamide | 79-40-3 | Biochemical Assay Reagents |
| HY-W010489S1 | 2-Phenylacetaldehyde-13C2 | 1083053-39-7 | Isotope-Labeled Compounds |
| HY-W010489S2 | 2-Phenylacetaldehyde-d5 | 879549-73-2 | Isotope-Labeled Compounds |
| HY-W010499 | H-D-Homoser-OH | 6027-21-0 | Peptides |
| HY-W010505 | Hexane-1,6-diol | 629-11-8 | Biochemical Assay Reagents |
| HY-W010505S | Hexane-1,6-diol-d4 | 6843-76-1 | Isotope-Labeled Compounds |
| HY-W010507 | (R)-Methyl 3-hydroxybutanoate | 3976-69-0 | Biochemical Assay Reagents |
| HY-W010510 | DL-Norvaline | 760-78-1 | Natural Products |
| HY-W010510R | DL-Norvaline (Standard) | 760-78-1 | Reference Standards |
| HY-W010513 | 3-Methylvaleric Acid | 105-43-1 | Natural Products |
| HY-W010513R | 3-Methylvaleric acid (Standard) | 105-43-1 | Reference Standards |
| HY-W010514 | trans-Cyclohexane-1,2-diol | 1460-57-7 | Natural Products |
| HY-W010516 | 2-Methylvaleric acid | 97-61-0 | Natural Products |
| HY-W010516R | 2-Methylvaleric acid (Standard) | 97-61-0 | Reference Standards |
| HY-W010517S | 1-Methyl-5-mercapto-1,2,3,4-tetrazole-d3 | 345909-96-8 | Isotope-Labeled Compounds |
| HY-W010519 | 2-(Pyrrolidin-1-yl)ethanol | 2955-88-6 | Biochemical Assay Reagents |
| HY-W010520 | Methylisothiazolinone | 2682-20-4 | Reference compound |
| HY-W010520R | Methylisothiazolinone (Standard) | 2682-20-4 | Reference Standards |
| HY-W010526S | Cyclohexanemethanol-d11 | 1215077-50-1 | Isotope-Labeled Compounds |
| HY-W010529S | 2-Methylfuran-3-thiol-d3 | 136430-23-4 | Isotope-Labeled Compounds |
| HY-W010531 | trans-Hex-2-enoic acid | 13419-69-7 | Biochemical Assay Reagents |
| HY-W010532 | trans-3-Hexenoic acid | 1577-18-0 | Biochemical Assay Reagents |
| HY-W010533 | (E)-2-Methyl-2-pentenoic acid | 16957-70-3 | Reference compound |
| HY-W010537S | 3-Chloropyridine-d4 | 1001003-95-7 | Isotope-Labeled Compounds |
| HY-W010538 | trans-4-Methylcyclohexanamine | 2523-55-9 | Reference compound |
| HY-W010542 | Azepan-2-one | 105-60-2 | Biochemical Assay Reagents |
| HY-W010542R | Azepan-2-one (Standard) | 105-60-2 | Reference Standards |
| HY-W010542S | Azepan-2-one-d10 | 169297-53-4 | Isotope-Labeled Compounds |
| HY-W010543S | N-Isopropylacrylamide-d7 | 1219803-32-3 | Isotope-Labeled Compounds |
| HY-W010549 | 2-Methylcyclohexanone | 583-60-8 | Natural Products |
| HY-W010549R | 2-Methylcyclohexanone (Standard) | 583-60-8 | Reference Standards |
| HY-W010553 | 2,5-Dimethyl-3(2H)-furanone | 14400-67-0 | Reference compound |
| HY-W010554 | 1,4-Cyclohexanedione | 637-88-7 | Biochemical Assay Reagents |
| HY-W010555S | 3-Methylcyclopentane-1,2-dione-d6 | Isotope-Labeled Compounds | |
| HY-W010562 | 2-Methoxypyrazine | 3149-28-8 | Reference compound |
| HY-W010562R | 2-Methoxypyrazine (Standard) | 3149-28-8 | Reference Standards |
| HY-W010562S | 2-Methoxypyrazine-d3 | 32046-21-2 | Isotope-Labeled Compounds |
| HY-W010566 | 5-Methylpyridin-2(1H)-one | 1003-68-5 | Biochemical Assay Reagents |
| HY-W010572 | 1-Thioglycerol | 96-27-5 | Biochemical Assay Reagents |
| HY-W010572R | 1-Thioglycerol (Standard) | 96-27-5 | Reference Standards |
| HY-W010574S | 2,3-Dimethylpyridine-d9 | 350818-65-4 | Isotope-Labeled Compounds |
| HY-W010575S | (2R)-3-Amino-2-fluoropropanoic acid-13C3 | 1217608-72-4 | Isotope-Labeled Compounds |
| HY-W010583S | 2-(2-Aminoethylamino)ethanol-d4 | 1246819-88-4 | Isotope-Labeled Compounds |
| HY-W010589 | H-Abu-OH | 1492-24-6 | Natural Products |
| HY-W010589R | H-Abu-OH (Standard) | 1492-24-6 | Reference Standards |
| HY-W010589S | H-Abu-OH-d3 | 929202-07-3 | Isotope-Labeled Compounds |
| HY-W010589S1 | H-Abu-OH-d2 | 352431-37-9 | Isotope-Labeled Compounds |
| HY-W010589S2 | H-Abu-OH-d6 | 1276197-51-3 | Isotope-Labeled Compounds |
| HY-W010590 | H-DL-Abu-OH | 2835-81-6 | Peptides |
| HY-W010590R | H-DL-Abu-OH (Standard) | 2835-81-6 | Reference Standards |
| HY-W010590S | (Rac)-2-Aminobutyric acid-d3 | 1219373-19-9 | Isotope-Labeled Compounds |
| HY-W010590S1 | H-DL-Abu-OH-d6 | 350820-17-6 | Isotope-Labeled Compounds |
| HY-W010591 | H-N-Me-DL-Ala-OH | 600-21-5 | Peptides |
| HY-W010593 | Ethylenethiourea | 96-45-7 | Reference compound |
| HY-W010593R | Ethylenethiourea (Standard) | 96-45-7 | Reference Standards |
| HY-W010593S | Ethylenethiourea-d4 | 352431-28-8 | Isotope-Labeled Compounds |
| HY-W010594 | Tetrahydrothiophen-3-one | 1003-04-9 | Reference compound |
| HY-W010600 | (S)-Tetrahydrofurfurylamine | 7175-81-7 | Biochemical Assay Reagents |
| HY-W010601 | (R)-Tetrahydrofuran-2-yl-methylamine | 7202-43-9 | Reference compound |
| HY-W010607 | cis-3-Hexen-1-ol | 928-96-1 | Natural Products |
| HY-W010607R | cis-3-Hexen-1-ol (Standard) | 928-96-1 | Reference Standards |
| HY-W010608 | 2-Methyltetrahydrofuran-3-one | 3188-00-9 | Natural Products |
| HY-W010608R | 2-Methyltetrahydrofuran-3-one (Standard) | 3188-00-9 | Reference Standards |
| HY-W010611 | 3,3-Dimethylacrylic acid | 541-47-9 | Natural Products |
| HY-W010611R | 3,3-Dimethylacrylic acid (Standard) | 541-47-9 | Reference Standards |
| HY-W010615 | 2-Methylthiophene | 554-14-3 | Natural Products |
| HY-W010615R | 2-Methylthiophene (Standard) | 554-14-3 | Reference Standards |
| HY-W010619S | O-Ethylhydroxylamine-d5 (hydrochloride) | 118087-07-3 | Isotope-Labeled Compounds |
| HY-W010625 | Lithium 2-hydroxypropanoate | 867-55-0 | Biochemical Assay Reagents |
| HY-W010628 | Azetidine (hydrochloride) | 36520-39-5 | Biochemical Assay Reagents |
| HY-W010629 | 2-Chloroacetamide | 79-07-2 | Reference compound |
| HY-W010629R | 2-Chloroacetamide (Standard) | 79-07-2 | Reference Standards |
| HY-W010629S | 2-Chloroacetamide-d4 | 122775-20-6 | Isotope-Labeled Compounds |
| HY-W010639 | 4-Penten-1-ol | 821-09-0 | Biochemical Assay Reagents |
| HY-W010642 | Pent-4-yn-1-ol | 5390-04-5 | Reference compound |
| HY-W010643 | 2-Cyclopentenone | 930-30-3 | Biochemical Assay Reagents |
| HY-W010646 | D-Alaninol | 35320-23-1 | Biochemical Assay Reagents |
| HY-W010649 | Isoxazole | 288-14-2 | Reference compound |
| HY-W010649R | Isoxazole (Standard) | 288-14-2 | Reference Standards |
| HY-W010653 | Antioxidant 1010 | 6683-19-8 | Reference compound |
| HY-W010653R | Antioxidant 1010 (Standard) | 6683-19-8 | Reference Standards |
| HY-W010655 | Fasiglifam (hemihydrate) | 1374598-80-7 | Reference compound |
| HY-W010663 | 1,2-Dilinoleoyl-3-oleoyl-rac-glycerol | 2190-21-8 | Biochemical Assay Reagents |
| HY-W010663R | 1,2-Dilinoleoyl-3-oleoyl-rac-glycerol (Standard) | 2190-21-8 | Reference Standards |
| HY-W010667 | (Z)-2-(Oleoyloxy)propane-1,3-diyl dipalmitate | 2190-25-2 | Reference compound |
| HY-W010668 | Quinine (sulfate hydrate) | 6119-70-6 | Natural Products |
| HY-W010668R | Quinine (sulfate hydrate) (Standard) | 6119-70-6 | Reference Standards |
| HY-W010669 | L-Thyroxine sodium xhydrate | 25416-65-3 | Biochemical Assay Reagents |
| HY-W010669R | L-Thyroxine sodium xhydrate (Standard) | 25416-65-3 | Reference Standards |
| HY-W010681A | 3'-O-DMTr-thymidine 5'-CE phosphoramidite | 134031-86-0 | Oligonucleotides |
| HY-W010685 | [1,4-BIs(diphenylphosphino)butane](1,5-cyclooctadiene)rhodium(I) (tetrafluoroborate) | 79255-71-3 | Reference compound |
| HY-W010686 | PdCl2(Amphos)2 | 887919-35-9 | Biochemical Assay Reagents |
| HY-W010695 | Cholesteryl stearate | 35602-69-8 | Biochemical Assay Reagents |
| HY-W010695S | Cholesterol stearate-d6 | 2692624-28-3 | Isotope-Labeled Compounds |
| HY-W010696 | Reverse T3 | 5817-39-0 | Reference compound |
| HY-W010696AS | Reverse T3-13C6 (hydrochloride) | 1217676-14-6 | Isotope-Labeled Compounds |
| HY-W010696R | Reverse T3 (Standard) | 5817-39-0 | Reference Standards |
| HY-W010697 | Cholesteryl linoleate | 604-33-1 | Natural Products |
| HY-W010697S | Cholesteryl linoleate-d11 | Isotope-Labeled Compounds | |
| HY-W010698 | Fmoc-D-Arg(Pbf)-OH | 187618-60-6 | Peptides |
| HY-W010702 | 5'-O-DMT-N2-ibu-dG | 68892-41-1 | Oligonucleotides |
| HY-W010706 | N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine | 67219-55-0 | Oligonucleotides |
| HY-W010708 | Cholesteryl palmitate | 601-34-3 | Natural Products |
| HY-W010708R | Cholesteryl palmitate (Standard) | 601-34-3 | Reference Standards |
| HY-W010708S | Cholesteryl palmitate-d9 | Isotope-Labeled Compounds | |
| HY-W010708S1 | Cholesteryl palmitate-d7 | 1416275-32-5 | Isotope-Labeled Compounds |
| HY-W010708S2 | Cholesteryl palmitate-d31 | 71826-32-9 | Isotope-Labeled Compounds |
| HY-W010710 | IPrAuCl | 852445-83-1 | Reference compound |
| HY-W010712 | Fmoc-His(Trt)-OH | 109425-51-6 | Peptides |
| HY-W010712S1 | Fmoc-His(Trt)-OH-15N3 | 1217696-12-2 | Isotope-Labeled Compounds |
| HY-W010713 | Meso-tetraphenylchlorin | 2669-65-0 | Reference compound |
| HY-W010714 | Fmoc-D-Gln(Trt)-OH | 200623-62-7 | Peptides |
| HY-W010719 | Fmoc-D-Asn(Trt)-OH | 180570-71-2 | Peptides |
| HY-W010721 | Fmoc-Lys(Biotin)-OH | 146987-10-2 | Peptides |
| HY-W010724 | Fmoc-D-Cys(Trt)-OH | 167015-11-4 | Peptides |
| HY-W010729 | Fmoc-Arg(Mts)-OH | 88743-97-9 | Peptides |
| HY-W010731 | Dicetyldimonium (bromide) | 70755-47-4 | Biochemical Assay Reagents |
| HY-W010732 | Fmoc-L-Lys(ivDde)-OH | 204777-78-6 | Peptides |
| HY-W010734 | Fmoc-Ser(Trt)-OH | 111061-56-4 | Peptides |
| HY-W010735 | ATP (disodium salt hydrate) | 34369-07-8 | Natural Products |
| HY-W010735R | ATP (disodium salt hydrate) (Standard) | 34369-07-8 | Reference Standards |
| HY-W010736 | 1,2-Dipalmitoyl-sn-glycerol | 30334-71-5 | Natural Products |
| HY-W010736A | 1,2-Dipalmitoyl-rac-glycerol | 40290-32-2 | Biochemical Assay Reagents |
| HY-W010736S | 1,2-Dipalmitoyl-sn-glycerol-d9 | 1872379-48-0 | Isotope-Labeled Compounds |
| HY-W010737 | Guanosine-5'-triphosphate (disodium salt) | 56001-37-7 | Oligonucleotides |
| HY-W010744 | DMT-dI | 93778-57-5 | Oligonucleotides |
| HY-W010745 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-Nw-tosyl-L-arginine | 83792-47-6 | Peptides |
| HY-W010747 | (S)-2,3-Bis((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid | 201473-90-7 | Peptides |
| HY-W010750S | Trioctyl trimellitate-d6 | Isotope-Labeled Compounds | |
| HY-W010751 | 2,3,4,6-Tetra-O-benzyl-D-glucopyranose | 4132-28-9 | Biochemical Assay Reagents |
| HY-W010752 | 2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranose | 6564-72-3 | Biochemical Assay Reagents |
| HY-W010754 | Melezitose monohydrate | 10030-67-8 | Biochemical Assay Reagents |
| HY-W010756 | FMOC-AM | 126828-35-1 | Reference compound |
| HY-W010757 | 6-Chloro-2-iodo-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)purine | 5987-76-8 | Reference compound |
| HY-W010758 | Fmoc-Lys(2-Cl-Z)-OH | 133970-31-7 | Peptides |
| HY-W010759 | Inosine-5′-monophosphate disodium salt octahydrate | 20813-76-7 | Biochemical Assay Reagents |
| HY-W010764 | Biotin-PEG2-Mal | 305372-39-8 | Reference compound |
| HY-W010770 | Fmoc-Thr[PO(OBzl)OH]-OH | 175291-56-2 | Peptides |
| HY-W010771 | Deoxycytidine triphosphate (disodium) | 102783-51-7 | Biochemical Assay Reagents |
| HY-W010772 | Bis(tri-tert-butylphosphine)palladium(0) | 53199-31-8 | Biochemical Assay Reagents |
| HY-W010774S | Bis(1,2,2,6,6-pentamethylpiperidin-4-yl) decanedioate-d6 | Isotope-Labeled Compounds | |
| HY-W010775 | (Z-Cys-OH)2 | 6968-11-2 | Peptides |
| HY-W010778 | N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-iodoquinazolin-4-amine | 231278-20-9 | Natural Products |
| HY-W010782 | Fmoc-Lys(Z)-OH | 86060-82-4 | Peptides |
| HY-W010783 | Boc-L-Lys(Z)-pNA | 51078-31-0 | Biochemical Assay Reagents |
| HY-W010784 | 2,3,5-Triiodobenzoic acid | 88-82-4 | Biochemical Assay Reagents |
| HY-W010785 | Dibenzyl L-glutamate tosylate | 2791-84-6 | Peptides |
| HY-W010788 | Boc-His(Trt)-OH | 32926-43-5 | Peptides |
| HY-W010789 | L-Lysyl-L-tyrosine-α-L-lysine | 35193-18-1 | Peptides |
| HY-W010791 | Adenosine 5'-diphosphate (sodium salt) | 20398-34-9 | Natural Products |
| HY-W010793 | Fmoc-Bpa-OH | 117666-96-3 | Peptides |
| HY-W010794 | Fmoc-D-Bpa-OH | 117666-97-4 | Peptides |
| HY-W010795 | Tetraheptylammonium (bromide) (>98%,BC) | 4368-51-8 | Biochemical Assay Reagents |
| HY-W010800 | Cholesteryl hemisuccinate | 1510-21-0 | Reference compound |
| HY-W010800A | Cholesterol hemisuccinate (Tris salt) | 102601-49-0 | Reference compound |
| HY-W010800R | Cholesteryl hemisuccinate (Standard) | 1510-21-0 | Reference Standards |
| HY-W010807 | Hexadecyl palmitate | 540-10-3 | Biochemical Assay Reagents |
| HY-W010807R | Hexadecyl palmitate (Standard) | 540-10-3 | Reference Standards |
| HY-W010807S | Hexadecyl palmitate-d3 | 1398066-15-3 | Isotope-Labeled Compounds |
| HY-W010811 | Fmoc-Phe(F5)-OH | 205526-32-5 | Peptides |
| HY-W010820 | Uridine 5'-diphosphate (sodium salt) | 21931-53-3 | Natural Products |
| HY-W010824 | n-Nonyl β-D-maltopyranoside | 106402-05-5 | Biochemical Assay Reagents |
| HY-W010825 | Fmoc-Phe(2-Br)-OH | 220497-47-2 | Peptides |
| HY-W010830 | Fmoc-Lys(Tfa)-OH | 76265-69-5 | Peptides |
| HY-W010832 | Uridine-5'-diphosphate disodium salt | 27821-45-0 | Natural Products |
| HY-W010835 | Boc-D-Cys(Trt)-OH | 87494-13-1 | Peptides |
| HY-W010836 | Fmoc-Bip(4,4')-OH | 199110-64-0 | Peptides |
| HY-W010837 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3,3-diphenylpropanoic acid | 201484-50-6 | Peptides |
| HY-W010838 | Fmoc-D-Bip(4,4’)-OH | 205526-38-1 | Peptides |
| HY-W010839 | Fmoc-Gly-Opfp | 86060-85-7 | Peptides |
| HY-W010841 | Levocetirizine (dihydrochloride) | 130018-87-0 | Reference compound |
| HY-W010841R | Levocetirizine (dihydrochloride) (Standard) | 130018-87-0 | Reference Standards |
| HY-W010850 | Fmoc-D-Phe(3,4-DiCl)-OH | 177966-58-4 | Peptides |
| HY-W010851 | Hexadecyltrimethylammonium (p-toluenesulfonate) | 138-32-9 | Biochemical Assay Reagents |
| HY-W010854 | 2'-Deoxyadenosine 5'-di-phos-phate (disodium) | 72003-83-9 | Biochemical Assay Reagents |
| HY-W010856 | Fmoc-Orn(Boc)-OH | 109425-55-0 | Biochemical Assay Reagents |
| HY-W010857 | Boc-Orn(Fmoc)-OH | 150828-96-9 | Reference compound |
| HY-W010860 | Copper(II) Gluconate | 527-09-3 | Reference compound |
| HY-W010861 | 2'-Deoxycytidine-5'-diphosphate (trisodium) | 151151-32-5 | Natural Products |
| HY-W010862 | Fmoc-Lys(Alloc)-OH | 146982-27-6 | Peptides |
| HY-W010865 | N-Benzylquinine (chloride) | 67174-25-8 | Biochemical Assay Reagents |
| HY-W010869 | GR 55562 (hydrochloride) | 172854-55-6 | Reference compound |
| HY-W010871 | Fmoc-Cys(4-MeBzl)-OH | 136050-67-4 | Peptides |
| HY-W010873 | Z-Pro-Leu-Gly-OEt | 7784-82-9 | Peptides |
| HY-W010875S | Didecyl phthalate-d4 | 1276197-18-2 | Isotope-Labeled Compounds |
| HY-W010876 | 1,2-Bis(phenylsulfinyl)ethanepalladium(II) acetate | 858971-43-4 | Reference compound |
| HY-W010880 | Fmoc-3-Ala(3-benzothienyl)-OH | 177966-60-8 | Peptides |
| HY-W010882S | (4-Carboxybutyl-d4)triphenylphosphonium (bromide) | 42932-63-8 | Isotope-Labeled Compounds |
| HY-W010888 | Fmoc-β-HoGlu(OtBu)-OH | 203854-49-3 | Peptides |
| HY-W010892 | Scopolamine (hydrobromide trihydrate) | 6533-68-2 | Natural Products |
| HY-W010892R | Scopolamine (hydrobromide trihydrate) (Standard) | 6533-68-2 | Reference Standards |
| HY-W010892S | Scopolamine-d3 (hydrobromide) | 1279037-70-5 | Isotope-Labeled Compounds |
| HY-W010893 | Fmoc-2-Nal-OH | 112883-43-9 | Peptides |
| HY-W010894 | Fmoc-D-2-Nal-OH | 138774-94-4 | Peptides |
| HY-W010895 | Fmoc-1-Nal-OH | 96402-49-2 | Peptides |
| HY-W010900 | Tetrahexylammonium (bromide) | 4328-13-6 | Biochemical Assay Reagents |
| HY-W010907 | Pamoic acid (disodium) | 6640-22-8 | Reference compound |
| HY-W010913 | (S)-2-((tert-Butoxycarbonyl)amino)-5-(3-tosylguanidino)pentanoic acid | 13836-37-8 | Peptides |
| HY-W010917 | 2′,3′,5′-Tri-O-acetyl-6-chloroguanosine | 16321-99-6 | Reference compound |
| HY-W010918 | Adenosine 5'-diphosphate | 58-64-0 | Natural Products |
| HY-W010918R | Adenosine 5'-diphosphate (Standard) | 58-64-0 | Reference Standards |
| HY-W010922 | Fmoc-Dap(Boc)-OH | 162558-25-0 | Peptides |
| HY-W010924 | Fmoc-β-HoAsp(OtBu)-OH | 209252-17-5 | Peptides |
| HY-W010926 | Fmoc-Phe(3,4-DiF)-OH | 198560-43-9 | Peptides |
| HY-W010927 | Fmoc-Phe(3,5-DiF)-OH | 205526-24-5 | Peptides |
| HY-W010929 | PYR14-TFSI | 223437-11-4 | Biochemical Assay Reagents |
| HY-W010930 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chlorophenyl)propanoic acid | 142994-19-2 | Peptides |
| HY-W010931 | Fmoc-Phe(2-Cl)-OH | 198560-41-7 | Peptides |
| HY-W010932 | N-Benzylcinchonium (chloride) | 69221-14-3 | Biochemical Assay Reagents |
| HY-W010933 | N-Benzylcinchonidinium (chloride) | 69257-04-1 | Biochemical Assay Reagents |
| HY-W010934 | 3β,5α,6β-Trihydroxycholestane | 1253-84-5 | Biochemical Assay Reagents |
| HY-W010934S | 3β,5α,6β-Trihydroxycholestane-d7 | 127684-07-5 | Isotope-Labeled Compounds |
| HY-W010936 | Nitrobenzylthioinosine | 38048-32-7 | Reference compound |
| HY-W010937 | 1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide | 174899-83-3 | Reference compound |
| HY-W010943 | Fmoc-Tyr(Me)-OH | 77128-72-4 | Peptides |
| HY-W010946 | Boc-Lys(2-Cl-Z)-OH | 54613-99-9 | Peptides |
| HY-W010947 | 4-Methylumbelliferyl palmitate | 17695-48-6 | Dye Reagents |
| HY-W010948 | Diethylene glycol bis(p-toluenesulfonate) | 7460-82-4 | Reference compound |
| HY-W010949 | 1,2-Bis(4-(benzo[d]oxazol-2-yl)phenyl)ethene | 1533-45-5 | Biochemical Assay Reagents |
| HY-W010950 | Flecainide | 54143-55-4 | Reference compound |
| HY-W010950A | Flecainide (hydrochloride) | 57415-44-8 | Reference compound |
| HY-W010950R | Flecainide (Standard) | 54143-55-4 | Reference Standards |
| HY-W010950S | Flecainide-d3 | 127413-31-4 | Isotope-Labeled Compounds |
| HY-W010951 | HCTU | 330645-87-9 | Biochemical Assay Reagents |
| HY-W010955 | Z-Phe-Leu-OH | 4313-73-9 | Peptides |
| HY-W010957 | Fmoc-D-Phe(4-CN)-OH | 205526-34-7 | Peptides |
| HY-W010958 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-cyanophenyl)propanoic acid | 205526-36-9 | Peptides |
| HY-W010959 | Fmoc-Asp-OtBu | 129460-09-9 | Peptides |
| HY-W010962 | Fmoc-Dap(Alloc)-OH | 188970-92-5 | Peptides |
| HY-W010964 | Fmoc-Hyp(tBu)-OH | 122996-47-8 | Peptides |
| HY-W010965 | Fmoc-Glu(OAll)-OH | 133464-46-7 | Peptides |
| HY-W010968 | 5'-Adenylic acid (sodium hydrate) | 149022-20-8 | Biochemical Assay Reagents |
| HY-W010970 | 5'-Guanylic acid (disodium salt) | 5550-12-9 | Natural Products |
| HY-W010973 | 5-Hydroxytryptamine creatinine sulfate monohydrate | 61-47-2 | Natural Products |
| HY-W010973S | 5-Hydroxytryptamine-d4 creatinine sulfate monohydrate | 2687960-56-9 | Isotope-Labeled Compounds |
| HY-W010974 | Fmoc-D-Phe(2-F)-OH | 198545-46-9 | Peptides |
| HY-W010975 | Fmoc-Lys-OH (hydrochloride) | 139262-23-0 | ADC Related |
| HY-W010976 | Fmoc-D-Lys-OH.HCl | 201002-47-3 | Peptides |
| HY-W010981 | Acetyl tributyl citrate | 77-90-7 | Reference compound |
| HY-W010981R | Acetyl tributyl citrate (Standard) | 77-90-7 | Reference Standards |
| HY-W010981S | Tributyl 2-acetoxypropane-1,2,3-tricarboxylate-d3 | 1794753-49-3 | Isotope-Labeled Compounds |
| HY-W010982 | Fmoc-Phe(4-NH2)-OH | 95753-56-3 | Peptides |
| HY-W010983 | SC-236 | 170569-86-5 | Reference compound |
| HY-W010984 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid | 211637-75-1 | Peptides |
| HY-W010986 | Fmoc-N-Me-Phe-OH | 77128-73-5 | Reference compound |
| HY-W010989 | Gly-His-Lys (acetate) | 72957-37-0 | Reference compound |
| HY-W010991 | N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly | 64967-39-1 | Dye Reagents |
| HY-W010995 | 2,5-Dimethylcelecoxib | 457639-26-8 | Reference compound |
| HY-W010995S | 2,5-Dimethylcelecoxib-d4 | 1346603-87-9 | Isotope-Labeled Compounds |
| HY-W010997 | Fmoc-L-(4-thiazolyl)-Alanine | 205528-32-1 | Peptides |
| HY-W011000 | Fmoc-Cha-OH | 135673-97-1 | Peptides |
| HY-W011001 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclohexylpropanoic acid | 144701-25-7 | Peptides |
| HY-W011002 | Fmoc-3-Ala(2-thienyl)-OH | 130309-35-2 | Peptides |
| HY-W011003 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-3-yl)propanoic acid | 220497-90-5 | Peptides |
| HY-W011004 | (S)-4-Amino-5-(((S)-1-(((S)-1-carboxy-2-phenylethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid | 31461-61-7 | Peptides |
| HY-W011009 | PTCDA | 128-69-8 | Biochemical Assay Reagents |
| HY-W011012 | Adenosine 5'-monophosphate (disodium) | 4578-31-8 | Biochemical Assay Reagents |
| HY-W011012R | Adenosine 5'-monophosphate (disodium) (Standard) | 4578-31-8 | Reference Standards |
| HY-W011012S | Adenosine 5'-monophosphate-13C (disodium) | Isotope-Labeled Compounds | |
| HY-W011012S1 | Adenosine 5'-monophosphate-d2 (disodium) | Isotope-Labeled Compounds | |
| HY-W011012S2 | Adenosine-5'-monophosphate-15N5 (disodium) | 1257642-75-3 | Isotope-Labeled Compounds |
| HY-W011013 | 3,5-Diiodo-4-hydroxybenzoic | 618-76-8 | Biochemical Assay Reagents |
| HY-W011019 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-3-yl)propanoic acid | 142994-45-4 | Peptides |
| HY-W011020 | Fmoc-3-Pal-OH | 175453-07-3 | Peptides |
| HY-W011021 | Fmoc-2-D-Pal-OH | 185379-39-9 | Peptides |
| HY-W011024 | (2R,3S)-N-Cbz-6-oxo-2,3-diphenylmorpholine | 100516-54-9 | Reference compound |
| HY-W011026 | Fmoc-D-Phe-OH | 86123-10-6 | Peptides |
| HY-W011026S | Fmoc-D-Phe-OH-d5 | 2714483-74-4 | Isotope-Labeled Compounds |
| HY-W011026S1 | Fmoc-D-Phe-OH-d8 | Isotope-Labeled Compounds | |
| HY-W011033 | Boc-N-Me-Tyr(Bzl)-OH | 64263-81-6 | Peptides |
| HY-W011035 | Dodecamethylpentasiloxane | 141-63-9 | Reference compound |
| HY-W011035R | Dodecamethylpentasiloxane (Standard) | 141-63-9 | Reference Standards |
| HY-W011038 | Hexadecylpyridinium (bromide) | 140-72-7 | Biochemical Assay Reagents |
| HY-W011038S | 1-Hexadecylpyridin-1-ium bromide-d5 | 143715-91-7 | Isotope-Labeled Compounds |
| HY-W011040 | LY320135 | 176977-56-3 | Reference compound |
| HY-W011044 | CID 5951923 | 749872-43-3 | Reference compound |
| HY-W011048 | 2,2-Bis(3-phenyl-4-hydroxyphenyl)propane | 24038-68-4 | Reference compound |
| HY-W011048R | 2,2-Bis(3-phenyl-4-hydroxyphenyl)propane (Standard) | 24038-68-4 | Reference Standards |
| HY-W011049 | (S)-6-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoic acid | 2389-45-9 | Peptides |
| HY-W011051 | 2-Arachidonoylglycerol | 53847-30-6 | Natural Products |
| HY-W011051S | 2-Arachidonoylglycerol-d8 | 924894-97-3 | Isotope-Labeled Compounds |
| HY-W011051S1 | 2-Arachidonoylglycerol-d5 | 2522598-88-3 | Isotope-Labeled Compounds |
| HY-W011051S2 | 2-Arachidonoylglycerol-d11 | 2260670-54-8 | Isotope-Labeled Compounds |
| HY-W011052 | Tetrapentylammonium (bromide) | 866-97-7 | Biochemical Assay Reagents |
| HY-W011053 | Neotame | 165450-17-9 | Reference compound |
| HY-W011053A | Neotame (Excipient) | 165450-17-9 | Reference compound |
| HY-W011053R | Neotame (Standard) | 165450-17-9 | Reference Standards |
| HY-W011053S | (R)-Neotame-d3 | Isotope-Labeled Compounds | |
| HY-W011054 | Z-Ile-Ile-OH | 42538-01-2 | Peptides |
| HY-W011055A | 6-Hydroxycortisol | 3078-34-0 | Natural Products |
| HY-W011056 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(furan-2-yl)propanoic acid | 159611-02-6 | Peptides |
| HY-W011060 | Cryptand 2.2.2 | 23978-09-8 | Biochemical Assay Reagents |
| HY-W011060R | Cryptand 2.2.2 (Standard) | 23978-09-8 | Reference Standards |
| HY-W011061 | 2'-Deoxyinosine 5'-monophosphate (disodium) | 14999-52-1 | Biochemical Assay Reagents |
| HY-W011063 | Gly-Phe-β-naphthylamide | 21438-66-4 | Reference compound |
| HY-W011064 | Boc-His(Bom)-OH | 79950-65-5 | Peptides |
| HY-W011073 | Boc-Tyr(Bzl)-OH | 2130-96-3 | Peptides |
| HY-W011074 | Z-Glu(OBzl)-OH | 5680-86-4 | Peptides |
| HY-W011075 | Z-D-Glu-Obzl | 65706-99-2 | Peptides |
| HY-W011078 | Methyl 2,3:4,6-di-O-benzylidene-α-D-mannopryanoside | 4148-71-4 | Biochemical Assay Reagents |
| HY-W011079 | 5-Iodouridine | 1024-99-3 | Reference compound |
| HY-W011081 | Fmoc-Glu-OH | 121343-82-6 | Peptides |
| HY-W011082 | NLRP3-IN-2 | 16673-34-0 | Reference compound |
| HY-W011082R | NLRP3-IN-2 (Standard) | 16673-34-0 | Reference Standards |
| HY-W011084 | Fmoc-L-glutamine | 71989-20-3 | Peptides |
| HY-W011085 | CP-471474 | 210755-45-6 | Reference compound |
| HY-W011086 | Tri-O-tolyl phosphate | 78-30-8 | Biochemical Assay Reagents |
| HY-W011087 | Benzyldimethyltetradecylammonium (chloride) | 139-08-2 | Biochemical Assay Reagents |
| HY-W011087R | Benzyldimethyltetradecylammonium (chloride) (Standard) | 139-08-2 | Reference Standards |
| HY-W011088 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-D-leucine | 103478-63-3 | Peptides |
| HY-W011089 | Fmoc-β-HoLeu-OH | 193887-44-4 | Peptides |
| HY-W011090S | ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 (sodium) | Isotope-Labeled Compounds | |
| HY-W011092 | Boc-Orn(Z)-OH | 2480-93-5 | Biochemical Assay Reagents |
| HY-W011094 | Win 18446 | 1477-57-2 | Reference compound |
| HY-W011095 | Chloro 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-glucopyranose | 3068-34-6 | Biochemical Assay Reagents |
| HY-W011100 | Cyclofenil | 2624-43-3 | Reference compound |
| HY-W011100R | Cyclofenil (Standard) | 2624-43-3 | Reference Standards |
| HY-W011102 | S-Trityl-L-cysteine | 2799-07-7 | Reference compound |
| HY-W011103 | Diheptyl phthalate | 3648-21-3 | Biochemical Assay Reagents |
| HY-W011103S | Diheptyl phthalate-d4 | 358731-41-6 | Isotope-Labeled Compounds |
| HY-W011108 | Obidoxime (dichloride) | 114-90-9 | Reference compound |
| HY-W011109 | CKI-7 | 1177141-67-1 | Reference compound |
| HY-W011112 | Hydrindantin hydrate | 5950-69-6 | Biochemical Assay Reagents |
| HY-W011114 | Clopidogrel-related Compound B (hydrochloride) | 144750-52-7 | Reference compound |
| HY-W011116 | (S)-2-((S)-2-((S)-2-Amino-4-methylpentanamido)-4-methylpentanamido)-4-methylpentanoic acid | 10329-75-6 | Peptides |
| HY-W011117 | Danofloxacin | 112398-08-0 | Reference compound |
| HY-W011117R | Danofloxacin (Standard) | 112398-08-0 | Reference Standards |
| HY-W011117S | Danofloxacin-d3 | 1825377-28-3 | Isotope-Labeled Compounds |
| HY-W011117S1 | Danofloxacin-d3-1 | 1217683-55-0 | Isotope-Labeled Compounds |
| HY-W011118 | DTPA anhydride | 23911-26-4 | Reference compound |
| HY-W011120 | Ethyl docosa-4,7,10,13,16,19-hexaenoate | 84494-72-4 | Reference compound |
| HY-W011120R | Ethyl docosa-4,7,10,13,16,19-hexaenoate (Standard) | 84494-72-4 | Reference Standards |
| HY-W011121 | 2-Oleoylglycerol | 3443-84-3 | Natural Products |
| HY-W011122 | Tributylbenzylammonium (bromide) | 25316-59-0 | Biochemical Assay Reagents |
| HY-W011123 | N-Succinimidyl 4-[4-maleimidophenyl]butyrate | 79886-55-8 | Reference compound |
| HY-W011125 | Bz-dA | 4546-72-9 | Reference compound |
| HY-W011126 | Fmoc-D-Asp-OH | 136083-57-3 | Peptides |
| HY-W011133S | Trioctylamine-d6 | 1219798-90-9 | Isotope-Labeled Compounds |
| HY-W011134 | Palmitic acid N-hydroxysuccinimide | 14464-31-4 | Enzyme |
| HY-W011135 | Fmoc-D-Isoleucine | 143688-83-9 | Peptides |
| HY-W011137 | (S)-4-Nitrophenyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | 4587-33-1 | Peptides |
| HY-W011138 | Ibacitabine | 611-53-0 | Biochemical Assay Reagents |
| HY-W011142 | 2'-Deoxyuridine 5'-monophosphate (disodium) | 42155-08-8 | Oligonucleotides |
| HY-W011151 | trans-Zeatinriboside | 6025-53-2 | Natural Products |
| HY-W011151S | trans-Zeatinriboside-d5 | 72963-21-4 | Isotope-Labeled Compounds |
| HY-W011152 | 2'-Deoxycytidine-5'-monophosphoric acid (disodium) | 13085-50-2 | Biochemical Assay Reagents |
| HY-W011154 | Z-D-2-Nal-OH | 143218-10-4 | Peptides |
| HY-W011155 | L-Proline p-nitroanilide (TFA) | 108321-19-3 | Peptides |
| HY-W011156 | Mpa(Trt) | 27144-18-9 | Peptides |
| HY-W011165 | L-Lysyl-L-lysine (dihydrochloride) | 52123-30-5 | Reference compound |
| HY-W011167 | Boc-Met-OSu | 3845-64-5 | Peptides |
| HY-W011168 | 8-Bromo-2'-deoxyguanosine | 13389-03-2 | Reference compound |
| HY-W011175 | Batilol | 544-62-7 | Natural Products |
| HY-W011176 | (S)-3-Hydroxypropane-1,2-diyl dioctanoate | 60514-48-9 | Reference compound |
| HY-W011178 | Boc-Phe(4-Br)-OH | 62129-39-9 | Peptides |
| HY-W011180 | Vitamin A Propionate | 7069-42-3 | Reference compound |
| HY-W011183 | 4-Nitrophenyl-N-acetyl-β-D-glucosaminide | 3459-18-5 | Biochemical Assay Reagents |
| HY-W011184 | 6-Phosphogluconic acid (trisodium) | 53411-70-4 | Reference compound |
| HY-W011184R | 6-Phosphogluconic acid (trisodium) (Standard) | 53411-70-4 | Reference Standards |
| HY-W011186 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-threonine | 157355-81-2 | Peptides |
| HY-W011187 | Butyl stearate | 123-95-5 | Biochemical Assay Reagents |
| HY-W011188 | Glycidyl stearate | 7460-84-6 | Biochemical Assay Reagents |
| HY-W011188S | Glycidyl stearate-d5 | 1346598-19-3 | Isotope-Labeled Compounds |
| HY-W011195 | Calcium 2-hydroxy-4-(methylthio)butanoate | 4857-44-7 | Natural Products |
| HY-W011197 | Cbz-L-Trp-OH | 7432-21-5 | Reference compound |
| HY-W011199 | Boc-Tyr(tBu)-OH | 47375-34-8 | Peptides |
| HY-W011200 | H-Gly-OBzl.TosOH | 1738-76-7 | Peptides |
| HY-W011201 | Boc-D-Glu-OBzl | 34404-30-3 | Peptides |
| HY-W011203 | (S)-2-(5-Amino-2-(((benzyloxy)carbonyl)amino)-5-oxopentanamido)acetic acid | 6610-42-0 | Peptides |
| HY-W011208 | 9,10-Dibromoanthracene | 523-27-3 | Biochemical Assay Reagents |
| HY-W011209 | N6-Isopentenyladenosine | 7724-76-7 | Reference compound |
| HY-W011210 | Fmoc-Pra-OH | 198561-07-8 | Peptides |
| HY-W011215 | Dihexyl phthalate | 84-75-3 | Natural Products |
| HY-W011215S | Dihexyl phthalate-3,4,5,6-d4 | 1015854-55-3 | Isotope-Labeled Compounds |
| HY-W011216 | Undecyl β-D-glucopyranoside | 70005-86-6 | Biochemical Assay Reagents |
| HY-W011218 | (R)-2-((tert-Butoxycarbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid | 114873-13-1 | Peptides |
| HY-W011220 | Ciglitazone | 74772-77-3 | Reference compound |
| HY-W011222S | 1-Bromooctadecane-d37 | 187826-28-4 | Isotope-Labeled Compounds |
| HY-W011222S1 | 1-Bromooctadecane-18,18,18-d3 | 349553-85-1 | Isotope-Labeled Compounds |
| HY-W011223 | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid | 114873-07-3 | Peptides |
| HY-W011235 | Norfluoxetine (hydrochloride) | 57226-68-3 | Reference compound |
| HY-W011235R | Norfluoxetine (hydrochloride) (Standard) | 57226-68-3 | Reference Standards |
| HY-W011235S | Norfluoxetine-d5 (hydrochloride) | 1188265-34-0 | Isotope-Labeled Compounds |
| HY-W011238 | Oleyl bromide | 6110-53-8 | Reference compound |
| HY-W011239 | Fenbendazole sulfone | 54029-20-8 | Reference compound |
| HY-W011239R | Fenbendazole sulfone (Standard) | 54029-20-8 | Reference Standards |
| HY-W011240 | Hydroflumethiazide | 135-09-1 | Reference compound |
| HY-W011240R | Hydroflumethiazide (Standard) | 135-09-1 | Reference Standards |
| HY-W011240S | Hydroflumethiazide-13C,d2 | 1189877-11-9 | Isotope-Labeled Compounds |
| HY-W011240S1 | Hydroflumethiazide-15N2,13C,d2 | Isotope-Labeled Compounds | |
| HY-W011241 | Cinchonine (hydrochloride) | 5949-11-1 | Natural Products |
| HY-W011243 | 11alpha-Hydroxyprogesterone | 80-75-1 | Reference compound |
| HY-W011245 | Ranitidine S-oxide | 73851-70-4 | Reference compound |
| HY-W011245R | Ranitidine S-oxide (Standard) | 73851-70-4 | Reference Standards |
| HY-W011246 | Velnacrine (maleate) | 118909-22-1 | Reference compound |
| HY-W011249 | Phosphorylcholine chloride calcium salt tetrahydrate | 72556-74-2 | Natural Products |
| HY-W011254 | Ac-VAD-CHO | 147837-52-3 | Peptides |
| HY-W011255 | Z-Ser(Bzl)-OH | 20806-43-3 | Peptides |
| HY-W011256 | Adenosine 2',3'-cyclic phosphate (sodium) | 37063-35-7 | Reference compound |
| HY-W011258 | H-Tyr-Phe-OH | 17355-11-2 | Peptides |
| HY-W011266 | JNJ-10198409 | 627518-40-5 | Reference compound |
| HY-W011267 | (Z)-Methyl icos-11-enoate | 2390-09-2 | Biochemical Assay Reagents |
| HY-W011267R | (Z)-Methyl icos-11-enoate (Standard) | 2390-09-2 | Reference Standards |
| HY-W011269 | Eicosapentaenoic Acid (sodium) | 73167-03-0 | Natural Products |
| HY-W011271 | PIPES (monosodium) | 10010-67-0 | Biochemical Assay Reagents |
| HY-W011277 | Fmoc-azetidine-3-carboxylic acid | 193693-64-0 | ADC Related |
| HY-W011278 | Z-Asp(OtBu)-OH | 5545-52-8 | Peptides |
| HY-W011279 | Z-D-Asp(OtBu)-OH | 71449-08-6 | Peptides |
| HY-W011280 | (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid | 57105-50-7 | Peptides |
| HY-W011280S | (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid-d4 | Isotope-Labeled Compounds | |
| HY-W011291 | Hexadecyltrimethylammonium chloride | 112-02-7 | Biochemical Assay Reagents |
| HY-W011291S | N,N,N-Trimethylhexadecan-1-aminium-d42 (chloride) | 2095863-88-8 | Isotope-Labeled Compounds |
| HY-W011293 | DTA | 654-62-6 | Reference compound |
| HY-W011293R | DTA (Standard) | 654-62-6 | Reference Standards |
| HY-W011297 | Methyl arachidonate | 2566-89-4 | Natural Products |
| HY-W011297S | Methyl arachidonate-d5 | 123167-39-5 | Isotope-Labeled Compounds |
| HY-W011297S1 | Methyl arachidonate-d8 | 19245-55-7 | Isotope-Labeled Compounds |
| HY-W011297S2 | Methyl arachidonate-13C4 | 2692624-39-6 | Isotope-Labeled Compounds |
| HY-W011297S3 | Methyl arachidonate-13C5 | Isotope-Labeled Compounds | |
| HY-W011303 | Phytosphingosine | 554-62-1 | Reference compound |
| HY-W011303A | (Rac)-Phytosphingosine | 13552-11-9 | Natural Products |
| HY-W011303R | Phytosphingosine (Standard) | 554-62-1 | Reference Standards |
| HY-W011303S | Phytosphingosine-d7 | Isotope-Labeled Compounds | |
| HY-W011309 | 1-O-Hexadecylglycerol | 6145-69-3 | Natural Products |
| HY-W011309A | 1-O-Hexadecyl-sn-glycerol | 506-03-6 | Reference compound |
| HY-W011311 | Eicosapentaenoic acid methyl ester | 2734-47-6 | Natural Products |
| HY-W011311R | Eicosapentaenoic acid methyl ester (Standard) | 2734-47-6 | Reference Standards |
| HY-W011311S | Eicosapentaenoic acid methyl ester-d5 | 2755644-32-5 | Isotope-Labeled Compounds |
| HY-W011321 | Boc-2-Nal-OH | 58438-04-3 | Peptides |
| HY-W011322 | (R)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid | 76932-48-4 | Peptides |
| HY-W011324 | (S)-2-((tert-Butoxycarbonyl)amino)-4-(cyclohexyloxy)-4-oxobutanoic acid | 73821-95-1 | Peptides |
| HY-W011325 | Z-D-tyrosine | 64205-12-5 | Peptides |
| HY-W011331 | 2-Chlorotrityl chloride | 42074-68-0 | Biochemical Assay Reagents |
| HY-W011334 | Methyl 12-oxooctadecanoate | 2380-27-0 | Natural Products |
| HY-W011336 | PDE5-IN-7 | 139756-21-1 | Reference compound |
| HY-W011337 | D-Leucyl-L-tyrosine | 3303-29-5 | Peptides |
| HY-W011338 | Benzyl butyl phthalate | 85-68-7 | Reference compound |
| HY-W011338R | Benzyl butyl phthalate (Standard) | 85-68-7 | Reference Standards |
| HY-W011338S | Benzyl butyl phthalate-d4 | 93951-88-3 | Isotope-Labeled Compounds |
| HY-W011340 | 5-Hydroxy flunixin | 75369-61-8 | Reference compound |
| HY-W011340R | 5-Hydroxy flunixin (Standard) | 75369-61-8 | Reference Standards |
| HY-W011340S | 5-Hydroxy flunixin-d3 (Major) | 1185088-54-3 | Isotope-Labeled Compounds |
| HY-W011342 | Fmoc-Sar-OH | 77128-70-2 | Peptides |
| HY-W011346 | 1,4-Bis(2-methylstyryl)-benzene,99% | 13280-61-0 | Biochemical Assay Reagents |
| HY-W011354 | O-tert-Butyl-N-carbobenzoxy-L-serine methyl ester | 1872-59-9 | Peptides |
| HY-W011359 | Z-Arg-OH | 1234-35-1 | Peptides |
| HY-W011370 | Pelargonidin (chloride) | 134-04-3 | Natural Products |
| HY-W011374 | Z-Gly-Osu | 2899-60-7 | Peptides |
| HY-W011376 | 5-Bromo-2'-deoxycytidine | 1022-79-3 | Biochemical Assay Reagents |
| HY-W011383 | Tri-p-tolylphosphine | 1038-95-5 | Biochemical Assay Reagents |
| HY-W011391 | GPNA (hydrochloride) | 67953-08-6 | Reference compound |
| HY-W011391A | L-γ-Glutamyl-p-nitroanilide | 7300-59-6 | Reference compound |
| HY-W011393 | L-Anserine nitrate | 10030-52-1 | Natural Products |
| HY-W011398 | Linoleate sodium | 822-17-3 | Biochemical Assay Reagents |
| HY-W011400 | TLR1 | 566914-00-9 | Reference compound |
| HY-W011404 | Tributyrin | 60-01-5 | Reference compound |
| HY-W011410 | 4-Nitrophenyl β-D-mannopyranoside | 35599-02-1 | Biochemical Assay Reagents |
| HY-W011411 | 4-Nitrophenyl a-D-glucopyranoside | 3767-28-0 | Biochemical Assay Reagents |
| HY-W011412 | TSTU | 105832-38-0 | Biochemical Assay Reagents |
| HY-W011416S | Coronene-d12 | 16083-32-2 | Isotope-Labeled Compounds |
| HY-W011417 | Cinnabarinic acid | 606-59-7 | Reference compound |
| HY-W011417R | Cinnabarinic acid (Standard) | 606-59-7 | Reference Standards |
| HY-W011422 | 2,6-Dibromo-4-(chloroimino)cyclohexa-2,5-dienone | 537-45-1 | Dye Reagents |
| HY-W011423 | Z-Phe-OH | 1161-13-3 | Peptides |
| HY-W011425 | NTPO | 6419-19-8 | Reference compound |
| HY-W011425A | NTPO (trisodium) | 7611-50-9 | Biochemical Assay Reagents |
| HY-W011426 | Isopropyl palmitate | 142-91-6 | Natural Products |
| HY-W011426R | Isopropyl palmitate (Standard) | 142-91-6 | Reference Standards |
| HY-W011428 | Olomoucine | 101622-51-9 | Reference compound |
| HY-W011433 | N-(1-Pyrenyl)maleimide | 42189-56-0 | Biochemical Assay Reagents |
| HY-W011434 | Triglycidyl isocyanurate | 2451-62-9 | Reference compound |
| HY-W011434R | Triglycidyl isocyanurate (Standard) | 2451-62-9 | Reference Standards |
| HY-W011435 | Ethyl 6-bromo-3-coumarincarboxylate | 2199-90-8 | Reference compound |
| HY-W011443 | Z-Ser-OtBu | 1676-75-1 | Peptides |
| HY-W011444 | Z-D-Ser(TBu)-OH | 65806-90-8 | Peptides |
| HY-W011445 | Indoxyl β-D-galactopyranoside | 126787-65-3 | Biochemical Assay Reagents |
| HY-W011458 | 3,5-Dinitro-L-tyrosine (sodium) | 502481-30-3 | Peptides |
| HY-W011469 | Tetradecyltrimethylammonium (chloride) | 4574-04-3 | Biochemical Assay Reagents |
| HY-W011471S | N-Acetyl sulfapyridine-d4 | 1189732-52-2 | Isotope-Labeled Compounds |
| HY-W011472 | H-D-Phe(4-I)-OH | 62561-75-5 | Peptides |
| HY-W011474 | Geranylgeraniol | 24034-73-9 | Natural Products |
| HY-W011474R | Geranylgeraniol (Standard) | 24034-73-9 | Reference Standards |
| HY-W011488 | Z-D-His-OH | 67424-93-5 | Peptides |
| HY-W011500 | TCEP (hydrochloride) | 51805-45-9 | Reference compound |
| HY-W011500S | TCEP-d16 (hydrochloride) | 1174025-33-2 | Isotope-Labeled Compounds |
| HY-W011509 | CyPPA | 73029-73-9 | Reference compound |
| HY-W011517 | 2-Fluoroadenosine | 146-78-1 | Biochemical Assay Reagents |
| HY-W011518 | 2′-Deoxy-2′-fluoroguanosine | 78842-13-4 | Reference compound |
| HY-W011522 | Taurolidine | 19388-87-5 | Reference compound |
| HY-W011522R | Taurolidine (Standard) | 19388-87-5 | Reference Standards |
| HY-W011527 | Xanthosine | 146-80-5 | Natural Products |
| HY-W011527R | Xanthosine (Standard) | 146-80-5 | Reference Standards |
| HY-W011537 | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid | 41153-30-4 | Peptides |
| HY-W011539 | EcMetAP1-IN-1 | 24683-26-9 | Reference compound |
| HY-W011540 | 8-Hydroxy-2'-deoxyguanosine | 88847-89-6 | Natural Products |
| HY-W011540S | 8-Hydroxy-2'-deoxyguanosine-15N5 | 569649-11-2 | Isotope-Labeled Compounds |
| HY-W011541 | SIA Crosslinker | 39028-27-8 | ADC Related |
| HY-W011547 | Methyl 4,6-O-Benzylidene-α-D-glucopyranoside | 3162-96-7 | Biochemical Assay Reagents |
| HY-W011548 | 2-Aminoadenosine | 2096-10-8 | Reference compound |
| HY-W011552 | 2'-O-Methyladenosine | 2140-79-6 | Natural Products |
| HY-W011552R | 2'-O-Methyladenosine (Standard) | 2140-79-6 | Reference Standards |
| HY-W011553 | Z-Asp(OMe)-OH | 3160-47-2 | Peptides |
| HY-W011556 | N,N,N',N'-Tetramethylchloroformamidinium hexafluorophosphate | 94790-35-9 | Biochemical Assay Reagents |
| HY-W011560 | 3-Methylflavone-8-carboxylic acid | 3468-01-7 | Biochemical Assay Reagents |
| HY-W011560S | 3-Methylflavone-8-carboxylic acid-d5 | 1189883-79-1 | Isotope-Labeled Compounds |
| HY-W011561 | Boc-NH-C6-Br | 142356-33-0 | ADC Related |
| HY-W011565S | 3,6-Di-tert-butyl-9H-carbazole-d6 | 2650519-91-6 | Isotope-Labeled Compounds |
| HY-W011567 | (S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-4-methylpentanoic acid | 33099-08-0 | Peptides |
| HY-W011577 | Benzo[f]tetraphene | 215-58-7 | Reference compound |
| HY-W011577S1 | Dibenzo[a,c]anthracene-13C6 | Isotope-Labeled Compounds | |
| HY-W011579 | 4-Benzoyl-3-methyl-1-phenyl-5-pyrazolone | 4551-69-3 | Biochemical Assay Reagents |
| HY-W011588S | 2-Ethylhexyl 4-(dimethylamino)benzoate-d6 | Isotope-Labeled Compounds | |
| HY-W011589S | Ethyl 2-cyano-3,3-diphenylacrylate-d10 | 2196199-15-0 | Isotope-Labeled Compounds |
| HY-W011591S | 1-Bromotetradecane-d29 | 347841-80-9 | Isotope-Labeled Compounds |
| HY-W011591S1 | 1-Bromotetradecane-d3 | 347840-09-9 | Isotope-Labeled Compounds |
| HY-W011591S2 | 1-Bromotetradecane-d4 | 1219798-81-8 | Isotope-Labeled Compounds |
| HY-W011596 | 2-Amino-2'-chloro-5-nitrobenzophenone | 2011-66-7 | Reference compound |
| HY-W011599 | Diphenyl(p-tolyl)phosphine | 1031-93-2 | Biochemical Assay Reagents |
| HY-W011602 | Triethyl citrate | 77-93-0 | Reference compound |
| HY-W011602R | Triethyl citrate (Standard) | 77-93-0 | Reference Standards |
| HY-W011606 | Boc-Thr(tBu)-OH | 13734-40-2 | Peptides |
| HY-W011607 | L-Alanyl-L-tryptophan | 16305-75-2 | Reference compound |
| HY-W011616 | Cardionogen 1 | 577696-37-8 | Reference compound |
| HY-W011618 | N-(9-Acridinyl)maleimide | 49759-20-8 | Dye Reagents |
| HY-W011636 | Pentadecanedioic acid | 1460-18-0 | Natural Products |
| HY-W011637 | Methyl brassylate | 1472-87-3 | Natural Products |
| HY-W011640 | 7,8,9,10-Tetrahydrobenzo[pqr]tetraphen-7-ol | 6272-55-5 | Reference compound |
| HY-W011641 | (±)-Naringenin | 67604-48-2 | Natural Products |
| HY-W011641R | (±)-Naringenin (Standard) | 67604-48-2 | Reference Standards |
| HY-W011651 | Carbutamide | 339-43-5 | Reference compound |
| HY-W011651R | Carbutamide (Standard) | 339-43-5 | Reference Standards |
| HY-W011652 | (S)-2-((tert-Butoxycarbonyl)amino)-3-(thiophen-2-yl)propanoic acid | 56675-37-7 | Peptides |
| HY-W011654 | 4-Aminophenyl-β-D-galactopyranoside, 98% | 5094-33-7 | Biochemical Assay Reagents |
| HY-W011655 | p-Nitrophenyl α-D-xylopyranoside | 10238-28-5 | Biochemical Assay Reagents |
| HY-W011657 | tert-Butyl 4-(bromomethyl)benzoate | 108052-76-2 | Reference compound |
| HY-W011664 | 1,3-Diphenylisobenzofuran | 5471-63-6 | Dye Reagents |
| HY-W011683 | 2'-Deoxyadenosine monohydrate | 16373-93-6 | Natural Products |
| HY-W011683R | 2'-Deoxyadenosine monohydrate (Standard) | 16373-93-6 | Reference Standards |
| HY-W011683S | 2'-Deoxyadenosine monohydrate-1′-13C | 446276-63-7 | Isotope-Labeled Compounds |
| HY-W011683S1 | 2'-Deoxyadenosine monohydrate-2′-13C | Isotope-Labeled Compounds | |
| HY-W011683S2 | 2'-Deoxyadenosine monohydrate-3′-13C | Isotope-Labeled Compounds | |
| HY-W011683S3 | 2'-Deoxyadenosine monohydrate-5′-13C | 478510-77-9 | Isotope-Labeled Compounds |
| HY-W011683S6 | 2'-Deoxyadenosine monohydrate-13C10,15N5 (hydrate) | 2483830-27-7 | Isotope-Labeled Compounds |
| HY-W011683S7 | 2'-Deoxyadenosine monohydrate-15N5 | Isotope-Labeled Compounds | |
| HY-W011686 | H-Tyr(3-NH2)-OH.2HCl | 23279-22-3 | Peptides |
| HY-W011688 | Methyl palmitoleate | 1120-25-8 | Natural Products |
| HY-W011688R | Methyl palmitoleate (Standard) | 1120-25-8 | Reference Standards |
| HY-W011689 | 6PPD | 793-24-8 | Reference compound |
| HY-W011690 | L-Homocystine | 626-72-2 | Natural Products |
| HY-W011690S | L-Homocystine-d8 | 182755-41-5 | Isotope-Labeled Compounds |
| HY-W011692 | 1,2-Phenylene-bis-maleimide | 13118-04-2 | Biochemical Assay Reagents |
| HY-W011693 | 1,4-Phenylenebismaleimide | 3278-31-7 | Biochemical Assay Reagents |
| HY-W011696 | Oleylamine, 80-90% | 112-90-3 | Biochemical Assay Reagents |
| HY-W011701 | H-Glu-pNA | 24032-35-7 | Peptides |
| HY-W011703 | Z-Asp-OH | 1152-61-0 | Peptides |
| HY-W011704 | Phosphoenolpyruvic acid (cyclohexylammonium salt) | 10526-80-4 | Biochemical Assay Reagents |
| HY-W011704A | Phosphoenolpyruvic acid (tricyclohexylammonium salt) | 35556-70-8 | Natural Products |
| HY-W011711 | Benzarone | 1477-19-6 | Reference compound |
| HY-W011711R | Benzarone (Standard) | 1477-19-6 | Reference Standards |
| HY-W011712 | 2'-Amino-2'-deoxyadenosine | 10414-81-0 | Reference compound |
| HY-W011713 | (4-Aminobenzoyl)-L-glutamic acid | 4271-30-1 | Peptides |
| HY-W011713R | (4-Aminobenzoyl)-L-glutamic acid (Standard) | 4271-30-1 | Reference Standards |
| HY-W011713S | N-(4-Aminobenzoyl)-L-glutamic acid-d4 | 461426-34-6 | Isotope-Labeled Compounds |
| HY-W011722 | N-((Benzyloxy)carbonyl)-N-methyl-L-valine | 42417-65-2 | Peptides |
| HY-W011725 | N-6-Methyl-2-deoxyadenosine | 2002-35-9 | Reference compound |
| HY-W011726 | 1-(4-Methoxyphenyl)piperazine (hydrochloride) | 38869-47-5 | Reference compound |
| HY-W011727 | Pyridoxal 5'-phosphate (hydrate) | 853645-22-4 | Natural Products |
| HY-W011727A | Pyridoxal 5'-phosphate (monohydrate) | 41468-25-1 | Natural Products |
| HY-W011727AR | Pyridoxal 5'-?phosphate (monohydrate) (Standard) | 41468-25-1 | Reference Standards |
| HY-W011727S | Pyridoxal Phosphate-d3 | 1354560-58-9 | Isotope-Labeled Compounds |
| HY-W011730 | Leucylproline (hydrochloride) | 87178-63-0 | Reference compound |
| HY-W011733 | Tulobuterol (hydrochloride) | 56776-01-3 | Reference compound |
| HY-W011733R | Tulobuterol (hydrochloride) (Standard) | 56776-01-3 | Reference Standards |
| HY-W011734 | Tetramethylfluoroformamidinium (hexafluorophosphate) | 164298-23-1 | Biochemical Assay Reagents |
| HY-W011750 | Z-Pyr-OH | 32159-21-0 | Peptides |
| HY-W011757 | Neocuproine hydrochloride monohydrate, 99% | 303136-82-5 | Biochemical Assay Reagents |
| HY-W011762 | VK3-OCH3 | 255906-59-3 | Reference compound |
| HY-W011762R | VK3-OCH3 (Standard) | 255906-59-3 | Reference Standards |
| HY-W011773 | H-Cys(Bzl)-OMe.HCl | 16741-80-3 | Peptides |
| HY-W011774 | N-(p-Chlorobenzoyl)-p-anisidine | 4018-82-0 | Reference compound |
| HY-W011777 | Tricaine (methanesulfonate) | 886-86-2 | Reference compound |
| HY-W011777R | Tricaine (methanesulfonate) (Standard) | 886-86-2 | Reference Standards |
| HY-W011777S | Tricaine-d5 (methanesulfonate) | Isotope-Labeled Compounds | |
| HY-W011778 | H-Tyr(H2PO3)-OH | 21820-51-9 | Peptides |
| HY-W011784S | 1-Chlorohexadecane-d33 | 352431-13-1 | Isotope-Labeled Compounds |
| HY-W011786 | 2-Chloro-1-(4-fluorobenzyl)-1H-benzo[d]imidazole | 84946-20-3 | Natural Products |
| HY-W011787 | DPPD | 74-31-7 | Reference compound |
| HY-W011788 | Triphenylmethanol | 76-84-6 | Reference compound |
| HY-W011792 | Diacetone-β-D-fructose | 20880-92-6 | Biochemical Assay Reagents |
| HY-W011792R | Diacetone-β-D-fructose (Standard) | 20880-92-6 | Reference Standards |
| HY-W011793 | 4-Thiouridine | 13957-31-8 | Reference compound |
| HY-W011814S | Hexadecane-1-thiol-d33 | 218956-22-0 | Isotope-Labeled Compounds |
| HY-W011816 | 1,2-Hexadecanediol | 6920-24-7 | Reference compound |
| HY-W011817 | 6-Acetyl-1,1,2,4,4,7-hexamethyltetraline | 21145-77-7 | Reference compound |
| HY-W011817S | 1-(3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone-d3 | 1396967-82-0 | Isotope-Labeled Compounds |
| HY-W011819 | Tetradecanedioic acid | 821-38-5 | Natural Products |
| HY-W011819R | Tetradecanedioic acid (Standard) | 821-38-5 | Reference Standards |
| HY-W011819S | Tetradecanedioic acid-d24 | 130348-88-8 | Isotope-Labeled Compounds |
| HY-W011824 | 2′-O-Methyluridine | 2140-76-3 | Natural Products |
| HY-W011824S | 2′-O-Methyluridine-d3 | Isotope-Labeled Compounds | |
| HY-W011830 | H-Phe-OtBu.HCl | 15100-75-1 | Peptides |
| HY-W011831 | NDSB-256 | 81239-45-4 | Biochemical Assay Reagents |
| HY-W011832 | Boc-D-Chg-OH | 70491-05-3 | Peptides |
| HY-W011834 | 2'-O-Methylcytidine | 2140-72-9 | Oligonucleotides |
| HY-W011834S | 2'-O-Methylcytidine-d3 | 2653209-08-4 | Isotope-Labeled Compounds |
| HY-W011845 | DMBA | 57-97-6 | Reference compound |
| HY-W011848 | Monobenzyl phthalate | 2528-16-7 | Reference compound |
| HY-W011848R | Monobenzyl phthalate (Standard) | 2528-16-7 | Reference Standards |
| HY-W011848S | Monobenzyl phthalate-d4 | 478954-83-5 | Isotope-Labeled Compounds |
| HY-W011849 | Phenyl β-D-glucopyranoside | 1464-44-4 | Natural Products |
| HY-W011873 | Palmitoleic acid | 373-49-9 | Natural Products |
| HY-W011873A | Palmitoleic acid (sodium) | 6610-24-8 | Reference compound |
| HY-W011873R | Palmitoleic acid (Standard) | 373-49-9 | Reference Standards |
| HY-W011873S | Palmitoleic acid-d14 | 184708-66-5 | Isotope-Labeled Compounds |
| HY-W011873S1 | Palmitoleic acid-d13 | 2692623-92-8 | Isotope-Labeled Compounds |
| HY-W011873S2 | Palmitoleic acid-13C16 | 2483735-57-3 | Isotope-Labeled Compounds |
| HY-W011875 | 2-Isopropylthioxanthone | 5495-84-1 | Reference compound |
| HY-W011875S | 2-Isopropylthioxanthone-d7 | 1173019-24-3 | Isotope-Labeled Compounds |
| HY-W011883S | 1,3-Dibromo-5-fluorobenzene-d3 | 1219805-87-4 | Isotope-Labeled Compounds |
| HY-W011885S | 1-Dodecylpyrrolidin-2-one-d6 | 2249814-87-5 | Isotope-Labeled Compounds |
| HY-W011886S | N2-(tert-Butyl)-N4-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine-d9 | 1189926-01-9 | Isotope-Labeled Compounds |
| HY-W011889 | Actinoquinol | 15301-40-3 | Reference compound |
| HY-W011890 | Cridanimod | 38609-97-1 | Reference compound |
| HY-W011890A | Cridanimod (sodium) | 58880-43-6 | Reference compound |
| HY-W011892 | Z-D-Thr-OH | 80384-27-6 | Peptides |
| HY-W011893S | Bis(4-chlorophenyl-2,3,5,6)methyl Alcohol-d4 | 1219805-85-2 | Isotope-Labeled Compounds |
| HY-W011900S | Benzo[b]fluoranthene-d12 | 93951-98-5 | Isotope-Labeled Compounds |
| HY-W011903 | H-Ala-Tyr-OH | 3061-88-9 | Peptides |
| HY-W011910 | Potassium 1H-indol-3-yl sulfate | 2642-37-7 | Natural Products |
| HY-W011910S | Indoxyl sulfate-d4 (potassium) | 1346601-03-3 | Isotope-Labeled Compounds |
| HY-W011911 | L-Leucyl-4-nitroanilide | 4178-93-2 | Biochemical Assay Reagents |
| HY-W011913 | Boc-Phg-OH | 2900-27-8 | Peptides |
| HY-W011916 | Muramic acid | 1114-41-6 | Natural Products |
| HY-W011918 | 4,4'-Dichlorobenzophenone | 90-98-2 | Biochemical Assay Reagents |
| HY-W011918S | Bis(4-chlorophenyl)methanone-d8 | 1219806-01-5 | Isotope-Labeled Compounds |
| HY-W011926 | Diisopropyl phthalate | 605-45-8 | Reference compound |
| HY-W011926R | Diisopropyl phthalate (Standard) | 605-45-8 | Reference Standards |
| HY-W011926S | Diisopropyl phthalate-d4 | 2708282-44-2 | Isotope-Labeled Compounds |
| HY-W011927 | 4,4'-Sulfonyldiphenol | 80-09-1 | Biochemical Assay Reagents |
| HY-W011927R | 4,4'-Sulfonyldiphenol (Standard) | 80-09-1 | Reference Standards |
| HY-W011927S | 4,4'-Sulfonyldiphenol-d8 | 2483831-28-1 | Isotope-Labeled Compounds |
| HY-W011931 | H-D-Phe(4-Cl)OMe.HCl | 33965-47-8 | Peptides |
| HY-W011934 | 1,3-Dibromo-5-methylbenzene | 1611-92-3 | Biochemical Assay Reagents |
| HY-W011938S | O-((Perfluorophenyl)methyl)hydroxylamine-d2 (hydrochloride) | 358730-85-5 | Isotope-Labeled Compounds |
| HY-W011940S | 4'-Pentyl-[1,1'-biphenyl]-4-carbonitrile-d11 | 57078-20-3 | Isotope-Labeled Compounds |
| HY-W011943S | N-Boc-phenyl-alaninal-d5 | 1217724-86-1 | Isotope-Labeled Compounds |
| HY-W011950 | Acridin-9-amine hydrochloride hydrate | 52417-22-8 | Biochemical Assay Reagents |
| HY-W011954 | Isopentyl 3-(4-methoxyphenyl)acrylate | 71617-10-2 | Reference compound |
| HY-W011954R | Isopentyl 3-(4-methoxyphenyl)acrylate (Standard) | 71617-10-2 | Reference Standards |
| HY-W011955 | 8-Cyclopentyl-1,3-dimethylxanthine | 35873-49-5 | Reference compound |
| HY-W011956 | 6-Hydroxymelatonin | 2208-41-5 | Natural Products |
| HY-W011956R | 6-Hydroxymelatonin (Standard) | 2208-41-5 | Reference Standards |
| HY-W011957 | 1,4-Bis-maleimidobutane | 28537-70-4 | Biochemical Assay Reagents |
| HY-W011963 | Melevodopa (hydrochloride) | 1421-65-4 | Reference compound |
| HY-W011972 | Bromocholine (bromide) | 2758-06-7 | Biochemical Assay Reagents |
| HY-W011977 | Boc-D-Lys-OH | 106719-44-2 | Peptides |
| HY-W011978 | N-Acetyl-L-tryptophan | 1218-34-4 | Natural Products |
| HY-W011978R | N-Acetyl-L-tryptophan (Standard) | 1218-34-4 | Reference Standards |
| HY-W011982 | Ac-DL-Trp-OH | 87-32-1 | Natural Products |
| HY-W011982R | Ac-DL-Trp-OH (Standard) | 87-32-1 | Reference Standards |
| HY-W011983 | 5-Amino-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid | 61348-28-5 | Peptides |
| HY-W011985 | H-Arg-NH2 (hydrochloride) | 14975-30-5 | Reference compound |
| HY-W011991 | 5-Chloro-2-(methylamino)benzophenone | 1022-13-5 | Biochemical Assay Reagents |
| HY-W011991R | 5-Chloro-2-(methylamino)benzophenone (Standard) | 1022-13-5 | Reference Standards |
| HY-W011992 | H-Ser(Bzl)-OMe.HCl | 19525-87-2 | Peptides |
| HY-W011993 | H-Tyr-OEt.HCl | 4089-07-0 | Peptides |
| HY-W011996 | 2-Methylthiophenothiazine | 7643-08-5 | Reference compound |
| HY-W011998S | Triphenylamine-d15 | 880462-20-4 | Isotope-Labeled Compounds |
| HY-W012000 | Boc-N-methyl-L-isoleucine | 52498-32-5 | Peptides |
| HY-W012001 | N-Boc-7-aminoheptanoic acid | 60142-89-4 | Reference compound |
| HY-W012002 | Methyl (tert-butoxycarbonyl)-L-leucinate | 63096-02-6 | Peptides |
| HY-W012003 | (S)-2-(2-(2-Amino-4-methylpentanamido)acetamido)acetic acid | 1187-50-4 | Peptides |
| HY-W012009 | 2'-Deoxy-2'-fluorocytidine | 10212-20-1 | Reference compound |
| HY-W012017 | 2-Hydroxytetradecanoic acid | 2507-55-3 | Biochemical Assay Reagents |
| HY-W012019 | Triphenylmethane | 519-73-3 | Biochemical Assay Reagents |
| HY-W012030 | 2-Amino-3-(4-bromophenyl)propanoic acid | 14091-15-7 | Peptides |
| HY-W012037 | 8-Hydroxyquinoline (hemisulfate) | 134-31-6 | Reference compound |
| HY-W012037R | 8-Hydroxyquinoline (hemisulfate) (Standard) | 134-31-6 | Reference Standards |
| HY-W012064 | H-Lys(Tfa)-OH | 10009-20-8 | Peptides |
| HY-W012071 | (S)-Benzyl pyrrolidine-2-carboxylate hydrochloride | 16652-71-4 | Biochemical Assay Reagents |
| HY-W012075 | H-Cys(pMeOBzl)-OH | 2544-31-2 | Peptides |
| HY-W012078 | 5-Methyl-2'-deoxycytidine | 838-07-3 | Natural Products |
| HY-W012081 | 2,4-Diaminophenoxyethanol (dihydrochloride) | 66422-95-5 | Reference compound |
| HY-W012088 | (Z)-Methyl tetradec-9-enoate | 56219-06-8 | Reference compound |
| HY-W012092 | Ethyl 3,4,5-trimethoxybenzoate | 6178-44-5 | Natural Products |
| HY-W012098 | H-Glu(OEt)-OEt.HCl | 1118-89-4 | Peptides |
| HY-W012104 | Z-D-Ser-OH | 6081-61-4 | Peptides |
| HY-W012123 | 3,4,5-Trimethoxycinnamic acid | 90-50-6 | Natural Products |
| HY-W012126 | 2,6-Dichlorodiphenylamine | 15307-93-4 | Reference compound |
| HY-W012126R | 2,6-Dichlorodiphenylamine (Standard) | 15307-93-4 | Reference Standards |
| HY-W012133 | (S)-2-Amino-3-(4-(tert-butoxy)phenyl)propanoic acid | 18822-59-8 | Peptides |
| HY-W012137 | Z-Aib-OH | 15030-72-5 | Peptides |
| HY-W012138 | H-D-Glu(OBzl)-OH | 2578-33-8 | Peptides |
| HY-W012139 | Z-Ala-OMe | 28819-05-8 | Peptides |
| HY-W012145 | TMPD (dihydrochloride) | 637-01-4 | Reference compound |
| HY-W012149 | 2-Bromo-4,5-difluorobenzoic acid | 64695-84-7 | Biochemical Assay Reagents |
| HY-W012159 | Methionylserine | 14517-43-2 | Peptides |
| HY-W012161 | Alanylphenylalanine | 3061-90-3 | Natural Products |
| HY-W012166 | N-Succinimidyl bromoacetate | 42014-51-7 | Reference compound |
| HY-W012167 | Decyltrimethylammonium (chloride) | 10108-87-9 | Biochemical Assay Reagents |
| HY-W012168 | 4-Chloro-3-sulfamoylbenzoic acid | 1205-30-7 | Reference compound |
| HY-W012179 | Phenylpiperazine (hydrochloride) | 4004-95-9 | Reference compound |
| HY-W012184 | CDAP | 59016-56-7 | Biochemical Assay Reagents |
| HY-W012185 | (-)-Sparteine | 90-39-1 | Natural Products |
| HY-W012185A | (-)-Sparteine (hydroiodide) | 352224-02-3 | Reference compound |
| HY-W012185R | (-)-Sparteine (Standard) | 90-39-1 | Reference Standards |
| HY-W012187 | 3,5-Di-tert-butyl-4-hydroxybenzaldehyde | 1620-98-0 | Natural Products |
| HY-W012187R | 3,5-Di-tert-butyl-4-hydroxybenzaldehyde (Standard) | 1620-98-0 | Reference Standards |
| HY-W012192 | trans,trans-Dibenzylideneacetone | 35225-79-7 | Reference compound |
| HY-W012206 | (Rac)-Metanephrine (hydrochloride) | 881-95-8 | Biochemical Assay Reagents |
| HY-W012206S | (rac)-Metanephrine-d3 (hydrochloride) | 1215507-88-2 | Isotope-Labeled Compounds |
| HY-W012206S1 | DL-Metanephrine (hydrochloride) (a,b,b-d3, 98%) | 1085333-94-3 | Isotope-Labeled Compounds |
| HY-W012207S | 4-Acetamidobenzene-1-sulfonyl chloride D4 | 77435-44-0 | Isotope-Labeled Compounds |
| HY-W012214 | (S)-2-Amino-3-(2-(trifluoromethyl)phenyl)propanoic acid | 119009-47-1 | Peptides |
| HY-W012218 | (±)-Camphor-10-sulfonic acid | 5872-08-2 | Biochemical Assay Reagents |
| HY-W012218R | (±)-Camphor-10-sulfonic acid (Standard) | 5872-08-2 | Reference Standards |
| HY-W012220 | (R)-4-Amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid | 75647-01-7 | Peptides |
| HY-W012228 | H-Tyr-OMe.HCl | 3417-91-2 | Peptides |
| HY-W012241 | Dodecanedioic acid | 693-23-2 | Natural Products |
| HY-W012241R | Dodecanedioic acid (Standard) | 693-23-2 | Reference Standards |
| HY-W012241S | Dodecanedioic acid-d20 | 89613-32-1 | Isotope-Labeled Compounds |
| HY-W012241S1 | Dodecanedioic acid-d4 | 97543-02-7 | Isotope-Labeled Compounds |
| HY-W012248 | KG-655 | 349-58-6 | Reference compound |
| HY-W012255 | Ethyl L-phenylalaninate hydrochloride | 3182-93-2 | Peptides |
| HY-W012258 | 2-Methoxyphenothiazine | 1771-18-2 | Reference compound |
| HY-W012264 | 3-O-Methyldopa (monohydrate) | 200630-46-2 | Reference compound |
| HY-W012267 | 2-Bromo-2'-methoxyacetophenone | 31949-21-0 | Reference compound |
| HY-W012276 | N,N′-Diphenylthiourea | 102-08-9 | Biochemical Assay Reagents |
| HY-W012276R | N,N′-Diphenylthiourea (Standard) | 102-08-9 | Reference Standards |
| HY-W012278S | Benz[a]anthracene-d12 | 1718-53-2 | Isotope-Labeled Compounds |
| HY-W012282 | 3′-Deoxyuridine | 7057-27-4 | Reference compound |
| HY-W012282R | 3′-Deoxyuridine (Standard) | 7057-27-4 | Reference Standards |
| HY-W012293 | 3'-Deoxycytidine | 7057-33-2 | Reference compound |
| HY-W012294S | (4-Nitrophenyl)(phenyl)methanone-d5 | 93496-61-8 | Isotope-Labeled Compounds |
| HY-W012308 | 2′-Hydroxydihydrochalcone | 3516-95-8 | Reference compound |
| HY-W012311 | 3′-Deoxythymidine | 3416-05-5 | Reference compound |
| HY-W012313 | 2,2'-Anhydrouridine | 3736-77-4 | Reference compound |
| HY-W012321S | 1-Bromo-3,5-dichlorobenzene-d3 | 1219803-83-4 | Isotope-Labeled Compounds |
| HY-W012340 | H-HomoArg-OH.HCl | 1483-01-8 | Natural Products |
| HY-W012340S | L-Homoarginine-13C7,15N4 (hydrochloride) | 2483830-23-3 | Isotope-Labeled Compounds |
| HY-W012349 | 2′-Hydroxychalcone | 1214-47-7 | Reference compound |
| HY-W012351S | Tripropyl phosphate-d21 | 1219794-92-9 | Isotope-Labeled Compounds |
| HY-W012352 | 2-Hydroxyanthraquinone | 605-32-3 | Natural Products |
| HY-W012361 | 6-Bromo-1H-indole-3-carbaldehyde | 17826-04-9 | Biochemical Assay Reagents |
| HY-W012379 | Z-β-Ala-OH | 2304-94-1 | Peptides |
| HY-W012381 | 2-(((Benzyloxy)carbonyl)amino)propanoic acid | 4132-86-9 | Peptides |
| HY-W012382 | N-Acetyl-L-tyrosine | 537-55-3 | Natural Products |
| HY-W012382R | N-Acetyl-L-tyrosine (Standard) | 537-55-3 | Reference Standards |
| HY-W012382S | N-Acetyl-L-tyrosine-d3 | Isotope-Labeled Compounds | |
| HY-W012383 | 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone | 86404-63-9 | Biochemical Assay Reagents |
| HY-W012383R | 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone (Standard) | 86404-63-9 | Reference Standards |
| HY-W012386 | 2-Fluoropyridine-5-boronic acid pinacol ester | 444120-95-0 | Biochemical Assay Reagents |
| HY-W012392 | 3-Fluoro-4-iodopyridine | 22282-75-3 | Biochemical Assay Reagents |
| HY-W012399 | 2,5-Di-tert-butylhydroquinone | 88-58-4 | Reference compound |
| HY-W012399R | 2,5-Di-tert-butylhydroquinone (Standard) | 88-58-4 | Reference Standards |
| HY-W012408 | (4-(tert-Butoxycarbonyl)phenyl)boronic acid | 850568-54-6 | Biochemical Assay Reagents |
| HY-W012412 | Tetrapropylammonium (chloride) | 5810-42-4 | Biochemical Assay Reagents |
| HY-W012416 | 5-Bromo-2-chloroanisole | 16817-43-9 | Biochemical Assay Reagents |
| HY-W012428 | 2-(3-Pyridyl)-4-methyl-thiazole-5-carboxylic acid | 39091-01-5 | Reference compound |
| HY-W012437 | Boc-Thr-OH | 2592-18-9 | Peptides |
| HY-W012440 | (1S)-(+)-Menthyl chloroformate | 7635-54-3 | Natural Products |
| HY-W012444 | Glyceryl 1-monooctanoate | 502-54-5 | Reference compound |
| HY-W012446 | Boc-Nva-OH | 53308-95-5 | Peptides |
| HY-W012450 | Trimethylphenylammonium (bromide) | 16056-11-4 | Biochemical Assay Reagents |
| HY-W012451 | H-β-HoPhe-OH.HCl | 138165-77-2 | Peptides |
| HY-W012467 | 5-Bromo-2,4-diamino-6-hydroxypyrimidine | 6312-72-7 | Biochemical Assay Reagents |
| HY-W012469 | O-(4-Nitrobenzyl)hydroxylamine (hydrochloride) | 2086-26-2 | Biochemical Assay Reagents |
| HY-W012472 | 1,3,5-Triisopropylbenzene | 717-74-8 | Reference compound |
| HY-W012477S | 1-Hydroxycyclohexyl phenyl ketone-d5 | Isotope-Labeled Compounds | |
| HY-W012478S | 6-Phenyl-2-thiouracil-13C,15N2 | Isotope-Labeled Compounds | |
| HY-W012479 | H-D-Trp-OH | 153-94-6 | Natural Products |
| HY-W012479R | H-D-Trp-OH (Standard) | 153-94-6 | Reference Standards |
| HY-W012479S | H-D-Trp-OH-d5 | 1202359-57-6 | Isotope-Labeled Compounds |
| HY-W012480 | DL-Tryptophan | 54-12-6 | Natural Products |
| HY-W012480S | DL-Tryptophan-d3 | 340257-61-6 | Isotope-Labeled Compounds |
| HY-W012480S1 | DL-Tryptophan-d8 | 1233395-85-1 | Isotope-Labeled Compounds |
| HY-W012481 | Nirvanol | 631-07-2 | Reference compound |
| HY-W012481S | Nirvanol-d5 | 119458-27-4 | Isotope-Labeled Compounds |
| HY-W012482 | 5-(tert-Butyl)isobenzofuran-1,3-dione | 32703-79-0 | Dye Reagents |
| HY-W012485 | H-D-Phe(4-Cl)-OH | 14091-08-8 | Peptides |
| HY-W012485R | H-D-Phe(4-Cl)-OH (Standard) | 14091-08-8 | Reference Standards |
| HY-W012486 | H-D-Phe(2-Cl)-OH | 80126-50-7 | Peptides |
| HY-W012487 | H-Phe(3-Cl)-OH | 80126-51-8 | Peptides |
| HY-W012497 | N-Acetyl-D-methionine | 1509-92-8 | Peptides |
| HY-W012497S | N-Acetyl-D-methionine-d4 | Isotope-Labeled Compounds | |
| HY-W012498 | N-Acetylpenicillamine | 15537-71-0 | Peptides |
| HY-W012499 | N-Acetyl-L-methionine | 65-82-7 | Natural Products |
| HY-W012499R | N-Acetyl-L-methionine (Standard) | 65-82-7 | Reference Standards |
| HY-W012499S | N-Acetyl-L-methionine-d3 | Isotope-Labeled Compounds | |
| HY-W012507S | 2,6-Dichlorobenzoic acid-d3 | 1219805-50-1 | Isotope-Labeled Compounds |
| HY-W012507S1 | 2,6-Dichlorobenzoic acid-13C6 | Isotope-Labeled Compounds | |
| HY-W012509S | 2,5-Dichlorobenzoic acid-d3 | Isotope-Labeled Compounds | |
| HY-W012510S | 2,4-Dichlorobenzoic acid-d3 | 1398065-99-0 | Isotope-Labeled Compounds |
| HY-W012515 | 1,3-Dihydroxyacetone dimer | 62147-49-3 | Biochemical Assay Reagents |
| HY-W012518 | Methyl 2,5-dihydroxybenzoate | 2150-46-1 | Biochemical Assay Reagents |
| HY-W012519 | H-DL-Val-OMe.HCl | 5619-05-6 | Peptides |
| HY-W012523 | 2,5-Pyridinedicarboxylic acid | 100-26-5 | Biochemical Assay Reagents |
| HY-W012523R | 2,5-Pyridinedicarboxylic acid (Standard) | 100-26-5 | Reference Standards |
| HY-W012530 | Phenylpyruvic acid | 156-06-9 | Natural Products |
| HY-W012530R | Phenylpyruvic acid (Standard) | 156-06-9 | Reference Standards |
| HY-W012530S | Phenylpyruvic acid-13C6 (sodium) | Isotope-Labeled Compounds | |
| HY-W012531 | 2-Hydroxycinnamic acid | 614-60-8 | Natural Products |
| HY-W012531R | 2-Hydroxycinnamic acid (Standard) | 614-60-8 | Reference Standards |
| HY-W012531S2 | 2-Hydroxycinnamic acid-d4 | Isotope-Labeled Compounds | |
| HY-W012537 | (2S,4R)-2-amino-4-hydroxypentanedioic acid | 2485-33-8 | Peptides |
| HY-W012550 | D-Carnitine | 541-14-0 | Biochemical Assay Reagents |
| HY-W012550R | D-Carnitine (Standard) | 541-14-0 | Reference Standards |
| HY-W012558 | 2,3-Dihydroxynaphthalene | 92-44-4 | Biochemical Assay Reagents |
| HY-W012564 | 2-Chloro-5-nitropyridine | 4548-45-2 | Biochemical Assay Reagents |
| HY-W012566S | Naphthalene-1,5-diamine-15N2 | Isotope-Labeled Compounds | |
| HY-W012568 | 1-Methoxynaphthalene | 2216-69-5 | Reference compound |
| HY-W012570 | Decyl aldehyde | 112-31-2 | Natural Products |
| HY-W012570R | Decyl aldehyde (Standard) | 112-31-2 | Reference Standards |
| HY-W012570S | Decyl aldehyde-d2 | 1335435-55-6 | Isotope-Labeled Compounds |
| HY-W012572 | D-Histidine | 351-50-8 | Reference compound |
| HY-W012572R | D-Histidine (Standard) | 351-50-8 | Reference Standards |
| HY-W012575 | 2,4-Dihydroxybenzoic acid | 89-86-1 | Natural Products |
| HY-W012575R | 2,4-Dihydroxybenzoic acid (Standard) | 89-86-1 | Reference Standards |
| HY-W012578S | 2-Isopropyl-3-methoxypyrazine-d3 | 588732-60-9 | Isotope-Labeled Compounds |
| HY-W012578S1 | 2-Isopropyl-3-methoxypyrazine-13C3 | Isotope-Labeled Compounds | |
| HY-W012578S2 | 2-Isopropyl-3-methoxypyrazine-d7 | Isotope-Labeled Compounds | |
| HY-W012581 | 2-Amino-3-methylbenzoic acid | 4389-45-1 | Biochemical Assay Reagents |
| HY-W012583S | 2,2'-Thiodiacetic acid-d4 | 132090-51-8 | Isotope-Labeled Compounds |
| HY-W012584S | L-Arabinopyranose-13C | Isotope-Labeled Compounds | |
| HY-W012584S1 | L-Arabinopyranose-13C-1 | Isotope-Labeled Compounds | |
| HY-W012591 | 2,3-Dichloropyridine | 2402-77-9 | Biochemical Assay Reagents |
| HY-W012595 | Benzylideneacetone | 122-57-6 | Natural Products |
| HY-W012595A | trans-Benzylideneacetone | 1896-62-4 | Natural Products |
| HY-W012595AR | trans-Benzylideneacetone (Standard) | 1896-62-4 | Reference Standards |
| HY-W012595R | Benzylideneacetone (Standard) | 122-57-6 | Reference Standards |
| HY-W012606 | 1,5,5-Trimethylhydantoin | 6851-81-6 | Reference compound |
| HY-W012615S | 4-Methoxy-N-methylaniline-d3 | 51657-88-6 | Isotope-Labeled Compounds |
| HY-W012617 | Nicotinohydrazide | 553-53-7 | Reference compound |
| HY-W012618 | 1-Phenyl-1-propanol | 93-54-9 | Reference compound |
| HY-W012618R | 1-Phenyl-1-propanol (Standard) | 93-54-9 | Reference Standards |
| HY-W012626S | 2-Ethyl-6-methylaniline-d13 | 1219794-93-0 | Isotope-Labeled Compounds |
| HY-W012634 | Benzothiazole | 95-16-9 | Reference compound |
| HY-W012634R | Benzothiazole (Standard) | 95-16-9 | Reference Standards |
| HY-W012634S | Benzothiazole-d4 | 194423-51-3 | Isotope-Labeled Compounds |
| HY-W012637 | 3-Acetylaniline | 99-03-6 | Biochemical Assay Reagents |
| HY-W012642 | 2-Aminopurine | 452-06-2 | Dye Reagents |
| HY-W012642A | 2-Aminopurine (dihydrochloride) | 1428126-74-2 | Dye Reagents |
| HY-W012652S | 1,2,3,4-Tetrahydroquinoxaline-d4 | 1822872-69-4 | Isotope-Labeled Compounds |
| HY-W012653 | 4'-Methylacetophenone | 122-00-9 | Natural Products |
| HY-W012653R | 4'-Methylacetophenone (Standard) | 122-00-9 | Reference Standards |
| HY-W012653S | 4'-Methylacetophenone-d10 | 358730-83-3 | Isotope-Labeled Compounds |
| HY-W012653S1 | 4'-Methylacetophenone-d3 | 114379-92-9 | Isotope-Labeled Compounds |
| HY-W012657 | 4-Ethylbenzaldehyde | 4748-78-1 | Natural Products |
| HY-W012657R | 4-Ethylbenzaldehyde (Standard) | 4748-78-1 | Reference Standards |
| HY-W012658 | 2-Methylacetophenone | 577-16-2 | Natural Products |
| HY-W012658R | 2-Methylacetophenone (Standard) | 577-16-2 | Reference Standards |
| HY-W012669 | Phthalaldehyde | 643-79-8 | Biochemical Assay Reagents |
| HY-W012669R | Phthalaldehyde (Standard) | 643-79-8 | Reference Standards |
| HY-W012670 | 2-Deoxy-L-ribose | 18546-37-7 | Biochemical Assay Reagents |
| HY-W012675 | 2-Amino-5-mercapto-1,3,4-thiadiazole | 2349-67-9 | Biochemical Assay Reagents |
| HY-W012676 | L-Thioproline | 34592-47-7 | Peptides |
| HY-W012683 | Iminodiacetic acid | 142-73-4 | Natural Products |
| HY-W012684S | Ethane-1,2-diamine-13C2 (dihydrochloride) | 77435-60-0 | Isotope-Labeled Compounds |
| HY-W012689S | 2-Methyl-2-propylpropane-1,3-diol-d3 | 1185023-23-7 | Isotope-Labeled Compounds |
| HY-W012699 | (+)-Solketal | 22323-82-6 | Biochemical Assay Reagents |
| HY-W012701 | Ethyl 3-hydroxybutyrate | 5405-41-4 | Natural Products |
| HY-W012701R | Ethyl 3-hydroxybutyrate (Standard) | 5405-41-4 | Reference Standards |
| HY-W012705 | Ethyl 2-(dimethylamino)acetate | 33229-89-9 | Peptides |
| HY-W012706 | DL-Isoleucine | 443-79-8 | Peptides |
| HY-W012707 | (S)-2-Amino-2,3-dimethylbutanoic acid | 53940-83-3 | Peptides |
| HY-W012708 | 3-Amino-4-methylpentanoic acid | 5699-54-7 | Natural Products |
| HY-W012709 | H-DL-Nle-OH | 616-06-8 | Peptides |
| HY-W012709S | DL-2-Aminohexanoic acid-d9 | 2243004-88-6 | Isotope-Labeled Compounds |
| HY-W012713 | Ac-D-Ala-OH | 19436-52-3 | Peptides |
| HY-W012713S | Ac-D-Ala-OH-d4 | 2708343-30-8 | Isotope-Labeled Compounds |
| HY-W012717 | 1-Ethyl-4-ethynylbenzene | 40307-11-7 | Biochemical Assay Reagents |
| HY-W012722 | 4-Methyl-2-oxopentanoic acid | 816-66-0 | Natural Products |
| HY-W012722BS | 4-Methyl-2-oxopentanoic acid-d7 (sodium) | 1795020-84-6 | Isotope-Labeled Compounds |
| HY-W012722BS1 | 4-Methyl-2-oxopentanoic acid-13C (sodium) | 93523-70-7 | Isotope-Labeled Compounds |
| HY-W012722R | 4-Methyl-2-oxopentanoic acid (Standard) | 816-66-0 | Reference Standards |
| HY-W012723 | 2-Hydroxyethyl methacrylate | 868-77-9 | Reference compound |
| HY-W012725 | 2,4-Difluorophenol | 367-27-1 | Biochemical Assay Reagents |
| HY-W012728 | 1-(2-Hydroxyethyl)piperidine | 3040-44-6 | Biochemical Assay Reagents |
| HY-W012732 | Isoquinoline | 119-65-3 | Reference compound |
| HY-W012732R | Isoquinoline (Standard) | 119-65-3 | Reference Standards |
| HY-W012732S | Isoquinoline-d7 | 17157-12-9 | Isotope-Labeled Compounds |
| HY-W012734 | L-Pipecolic acid | 3105-95-1 | Natural Products |
| HY-W012734R | L-Pipecolic acid (Standard) | 3105-95-1 | Reference Standards |
| HY-W012735 | (+)-Nipecotic acid | 59045-82-8 | Reference compound |
| HY-W012738 | DL-Pyroglutamic acid | 149-87-1 | Reference compound |
| HY-W012738S | DL-Pyroglutamic acid-d5 | 352431-30-2 | Isotope-Labeled Compounds |
| HY-W012744 | Isopropylpiperazine | 4318-42-7 | Biochemical Assay Reagents |
| HY-W012748S | Piperidine-4-carboxamide-d9 | 1219803-20-9 | Isotope-Labeled Compounds |
| HY-W012777S | 3,5-Dimethyl-d6-cyclohexanone-3,4,4,5-d4 | 1219804-55-3 | Isotope-Labeled Compounds |
| HY-W012779 | 5-Methylhept-2-en-4-one | 81925-81-7 | Biochemical Assay Reagents |
| HY-W012788 | Maltol | 118-71-8 | Natural Products |
| HY-W012788R | Maltol (Standard) | 118-71-8 | Reference Standards |
| HY-W012788S | Maltol-d3 | 132331-92-1 | Isotope-Labeled Compounds |
| HY-W012790 | Sodium 2-hydroxybutanoate | 5094-24-6 | Natural Products |
| HY-W012790S | Sodium 2-hydroxybutanoate-d3 | 1219798-97-6 | Isotope-Labeled Compounds |
| HY-W012791 | 2-(Methylamino)acetic acid hydrochloride | 637-96-7 | Peptides |
| HY-W012791S | 2-(Methylamino)acetic acid-d3 (hydrochloride) | 347840-04-4 | Isotope-Labeled Compounds |
| HY-W012791S1 | 2-(Methylamino)acetic acid-d5 (hydrochloride) | 1219794-62-3 | Isotope-Labeled Compounds |
| HY-W012802 | Methyl 1H-pyrrole-2-carboxylate | 1193-62-0 | Biochemical Assay Reagents |
| HY-W012808S | 2-Fluoro-1,3-bis(methyl)benzene-d6 | 2913220-03-6 | Isotope-Labeled Compounds |
| HY-W012814 | 4-Methylcatechol | 452-86-8 | Natural Products |
| HY-W012814R | 4-Methylcatechol (Standard) | 452-86-8 | Reference Standards |
| HY-W012814S | 4-Methylcatechol-d3 | 83719-41-9 | Isotope-Labeled Compounds |
| HY-W012814S1 | 4-Methylcatechol-d8 | 1219803-18-5 | Isotope-Labeled Compounds |
| HY-W012814S2 | 4-Methylcatechol-d6 | 1219804-79-1 | Isotope-Labeled Compounds |
| HY-W012815 | 3-Methylcatechol | 488-17-5 | Natural Products |
| HY-W012815R | 3-Methylcatechol (Standard) | 488-17-5 | Reference Standards |
| HY-W012817 | Methylhydroquinone | 95-71-6 | Natural Products |
| HY-W012817R | Methylhydroquinone (Standard) | 95-71-6 | Reference Standards |
| HY-W012821SA | Morpholine-d4 (hydrochloride) | 1115228-35-7 | Isotope-Labeled Compounds |
| HY-W012824 | 4-Amino-m-cresol | 2835-99-6 | Reference compound |
| HY-W012832S | 2-Ethyl-3-methylpyrazine-d3 | 1335401-33-6 | Isotope-Labeled Compounds |
| HY-W012835 | 4-Methylanisole | 104-93-8 | Natural Products |
| HY-W012835S | 4-Methylanisole-d4 | 350818-57-4 | Isotope-Labeled Compounds |
| HY-W012835S1 | 4-Methylanisole-d3 | 14202-49-4 | Isotope-Labeled Compounds |
| HY-W012835S2 | 4-Methylanisole-13C | 117923-70-3 | Isotope-Labeled Compounds |
| HY-W012835S3 | 4-Methylanisole-d7 | 1036431-36-3 | Isotope-Labeled Compounds |
| HY-W012835S4 | 4-Methylanisole-d7-1 | 1219798-94-3 | Isotope-Labeled Compounds |
| HY-W012836 | 4-Ethylphenol | 123-07-9 | Natural Products |
| HY-W012836R | 4-Ethylphenol (Standard) | 123-07-9 | Reference Standards |
| HY-W012836S | 4-Ethylphenol-d5 | 340256-40-8 | Isotope-Labeled Compounds |
| HY-W012836S1 | 4-Ethylphenol-d10 | 352431-18-6 | Isotope-Labeled Compounds |
| HY-W012836S2 | 4-Ethylphenol-d2 | 1335401-68-7 | Isotope-Labeled Compounds |
| HY-W012837S | Benzylmethylether-d2 | 170464-05-8 | Isotope-Labeled Compounds |
| HY-W012843 | Isonicotinamide | 1453-82-3 | Biochemical Assay Reagents |
| HY-W012843R | Isonicotinamide (Standard) | 1453-82-3 | Reference Standards |
| HY-W012843S | Isonicotinamide-d4 | 1219799-40-2 | Isotope-Labeled Compounds |
| HY-W012845A | (E)-3-(2-Furyl)acrolein | 39511-08-5 | Biochemical Assay Reagents |
| HY-W012846 | D-Threitol | 2418-52-2 | Natural Products |
| HY-W012846A | L-Threitol | 2319-57-5 | Biochemical Assay Reagents |
| HY-W012846R | D-Threitol (Standard) | 2418-52-2 | Reference Standards |
| HY-W012848 | 1-Phenylethanamine | 618-36-0 | Reference compound |
| HY-W012850 | 2-Amino-3-mercaptopropanoic acid | 3374-22-9 | Peptides |
| HY-W012850S1 | DL-Cysteine-d1 | Isotope-Labeled Compounds | |
| HY-W012851S | 2-Fluorobenzonitrile-d4 | 2256740-46-0 | Isotope-Labeled Compounds |
| HY-W012855S | 3-Mercapto-3-methylbutan-1-ol-d6 | 162404-35-5 | Isotope-Labeled Compounds |
| HY-W012856S | 1-Ethyl-3-methylbenzene-d5 | 1398065-64-9 | Isotope-Labeled Compounds |
| HY-W012860 | p-Tolualdehyde | 104-87-0 | Natural Products |
| HY-W012860R | p-Tolualdehyde (Standard) | 104-87-0 | Reference Standards |
| HY-W012860S | p-Tolualdehyde-d7 | 1219805-23-8 | Isotope-Labeled Compounds |
| HY-W012860S1 | p-Tolualdehyde-d4 | 1219804-07-5 | Isotope-Labeled Compounds |
| HY-W012862 | Methyl-PEG2-alcohol | 111-77-3 | Reference compound |
| HY-W012864S | (2S,3R)-2,3,4-Trihydroxybutanal-13C | 70849-20-6 | Isotope-Labeled Compounds |
| HY-W012864S1 | (2S,3R)-2,3,4-Trihydroxybutanal-13C-1 | 478506-49-9 | Isotope-Labeled Compounds |
| HY-W012864S2 | (2S,3R)-2,3,4-Trihydroxybutanal-13C-2 | 90913-09-0 | Isotope-Labeled Compounds |
| HY-W012869 | 2-Hydroxybenzonitrile | 611-20-1 | Biochemical Assay Reagents |
| HY-W012870 | DL-Homoserine | 1927-25-9 | Biochemical Assay Reagents |
| HY-W012871 | 2-Amino-3-methoxypropanoic acid | 19794-53-7 | Peptides |
| HY-W012872 | H-N-Me-Ser-OH | 2480-26-4 | Peptides |
| HY-W012873 | 2-Amino-3-hydroxy-2-methylpropanoic acid | 5424-29-3 | Peptides |
| HY-W012874 | D-Threonine | 632-20-2 | Reference compound |
| HY-W012874S | D-Threonine-d2 | Isotope-Labeled Compounds | |
| HY-W012875 | 3-Nitropropanoic acid | 504-88-1 | Natural Products |
| HY-W012875R | 3-Nitropropanoic acid (Standard) | 504-88-1 | Reference Standards |
| HY-W012883 | 2-((2-Aminoethyl)amino)acetic acid | 24123-14-6 | Peptides |
| HY-W012885 | (S)-Methyl 3-hydroxybutanoate | 53562-86-0 | Biochemical Assay Reagents |
| HY-W012887 | Oxalyldihydrazide | 996-98-5 | Biochemical Assay Reagents |
| HY-W012888 | D-Leucinol | 53448-09-2 | Reference compound |
| HY-W012889 | DL-Valine | 516-06-3 | Peptides |
| HY-W012889R | DL-Valine (Standard) | 516-06-3 | Reference Standards |
| HY-W012889S | DL-Valine-d8 | 203784-63-8 | Isotope-Labeled Compounds |
| HY-W012889S2 | DL-Valine-d1 | 14246-21-0 | Isotope-Labeled Compounds |
| HY-W012889S3 | DL-Valine-d1-1 | 79168-24-4 | Isotope-Labeled Compounds |
| HY-W012889S4 | DL-Valine-d2 | 83181-79-7 | Isotope-Labeled Compounds |
| HY-W012890 | Pentanehydrazide | 38291-82-6 | Reference compound |
| HY-W012896 | 2-Thiohydantoin | 503-87-7 | Reference compound |
| HY-W012898 | Dimethylglyoxime | 95-45-4 | Biochemical Assay Reagents |
| HY-W012901S | 2-Chloroethanamine-d4hydrochloride | 172333-26-5 | Isotope-Labeled Compounds |
| HY-W012905 | 5-Thiazolemethanol | 38585-74-9 | Biochemical Assay Reagents |
| HY-W012906 | L-Allylglycine | 16338-48-0 | Peptides |
| HY-W012907 | H-D-Gly(allyl)-OH | 54594-06-8 | Peptides |
| HY-W012908 | H-DL-Pro-OH | 609-36-9 | Peptides |
| HY-W012908S | H-DL-Pro-OH-d7 | 65807-21-8 | Isotope-Labeled Compounds |
| HY-W012908S1 | DL-Proline-2-d1 | 282729-06-0 | Isotope-Labeled Compounds |
| HY-W012908S2 | H-DL-Pro-OH-d3 | 784086-28-8 | Isotope-Labeled Compounds |
| HY-W012911 | 2,6-Difluoropyridine | 1513-65-1 | Biochemical Assay Reagents |
| HY-W012921 | (R)-Pyrrolidine-2-carboxamide | 62937-45-5 | Peptides |
| HY-W012922 | 2-Methyl-4-pentenoic Acid | 1575-74-2 | Natural Products |
| HY-W012922R | 2-Methyl-4-pentenoic Acid (Standard) | 1575-74-2 | Reference Standards |
| HY-W012926 | Dihydrouracil | 504-07-4 | Natural Products |
| HY-W012926R | Dihydrouracil (Standard) | 504-07-4 | Reference Standards |
| HY-W012926S | Dihydrouracil-13C4,15N2 | 360769-22-8 | Isotope-Labeled Compounds |
| HY-W012926S1 | Dihydrouracil-d4 | 334473-41-5 | Isotope-Labeled Compounds |
| HY-W012927 | 4-Hydroxy-5-methylfuran-3(2H)-one | 19322-27-1 | Biochemical Assay Reagents |
| HY-W012927S | 4-Hydroxy-5-methylfuran-3(2H)-one-d3 | 1335401-45-0 | Isotope-Labeled Compounds |
| HY-W012932S | 2,4-Dimethylthiazole-13C3 | 1335402-15-7 | Isotope-Labeled Compounds |
| HY-W012934S | 1-Ethylpyrrolidin-2-one-d5 | Isotope-Labeled Compounds | |
| HY-W012935 | Piperidine-4-carbaldehyde | 50675-20-2 | Reference compound |
| HY-W012937 | 3-Hydroxymethyl-5-methylisoxazole | 35166-33-7 | Biochemical Assay Reagents |
| HY-W012941 | 2-Thiophenecarboxaldehyde | 98-03-3 | Natural Products |
| HY-W012941R | 2-Thiophenecarboxaldehyde (Standard) | 98-03-3 | Reference Standards |
| HY-W012944 | 2-Methylcyclopentane-1,3-dione | 765-69-5 | Natural Products |
| HY-W012946 | 2-Furoic acid | 88-14-2 | Natural Products |
| HY-W012946R | 2-Furoic acid (Standard) | 88-14-2 | Reference Standards |
| HY-W012946S | 2-Furoic acid-d3 | 40073-83-4 | Isotope-Labeled Compounds |
| HY-W012952 | (2E,4E)-Hepta-2,4-dienal | 4313-03-5 | Biochemical Assay Reagents |
| HY-W012952R | (2E,4E)-Hepta-2,4-dienal (Standard) | 4313-03-5 | Reference Standards |
| HY-W012954B | TMA chloride, for molecular biology, 99%(T) | 75-57-0 | Biochemical Assay Reagents |
| HY-W012954S | Tetramethylammonium-d12 (chloride) | 23789-03-9 | Isotope-Labeled Compounds |
| HY-W012956 | 2-Acetylpyrrole | 1072-83-9 | Natural Products |
| HY-W012956R | 2-Acetylpyrrole (Standard) | 1072-83-9 | Reference Standards |
| HY-W012966 | 3-Amino-2-hydroxypropanoic acid | 565-71-9 | Peptides |
| HY-W012967 | L-Isoserine | 632-13-3 | Peptides |
| HY-W012971 | 5-Amino-1-pentanol | 2508-29-4 | Reference compound |
| HY-W012974 | 3-Aminoisobutyric acid | 144-90-1 | Natural Products |
| HY-W012974R | 3-Aminoisobutyric acid (Standard) | 144-90-1 | Reference Standards |
| HY-W012974S | 3-Amino-2-methylpropanoic acid-d3 | 1219803-65-2 | Isotope-Labeled Compounds |
| HY-W012977 | 3,3-Dimethyl-1-butanol | 624-95-3 | Reference compound |
| HY-W012980 | Isovaleric acid | 503-74-2 | Natural Products |
| HY-W012980R | Isovaleric acid (Standard) | 503-74-2 | Reference Standards |
| HY-W012980S | Isovaleric acid-d9 | 344298-81-3 | Isotope-Labeled Compounds |
| HY-W012980S1 | Isovaleric acid-13C | 87994-84-1 | Isotope-Labeled Compounds |
| HY-W012980S2 | Isovaleric acid-d2 | 95927-02-9 | Isotope-Labeled Compounds |
| HY-W012980S3 | Isovaleric acid-d7 | 1219805-32-9 | Isotope-Labeled Compounds |
| HY-W012982 | 3-Amino-2-oxazolidinone | 80-65-9 | Reference compound |
| HY-W012982R | 3-Amino-2-oxazolidinone (Standard) | 80-65-9 | Reference Standards |
| HY-W012982S | 3-Amino-2-oxazolidinone-d4 | 1188331-23-8 | Isotope-Labeled Compounds |
| HY-W012991 | 3-Mercapto-1,2,4-triazole | 3179-31-5 | Biochemical Assay Reagents |
| HY-W012995 | 5-Hexen-1-ol | 821-41-0 | Biochemical Assay Reagents |
| HY-W012997 | Tetrahydro-2H-pyran-2-one | 542-28-9 | Natural Products |
| HY-W012997S | Tetrahydro-2H-pyran-2-one-d4 | 42932-61-6 | Isotope-Labeled Compounds |
| HY-W012998 | 2,3-Pentanedione | 600-14-6 | Natural Products |
| HY-W012998R | 2,3-Pentanedione (Standard) | 600-14-6 | Reference Standards |
| HY-W012998S | 2,3-Pentanedione-d5 | 352431-46-0 | Isotope-Labeled Compounds |
| HY-W012998S1 | 2,3-Pentanedione-13C2 | Isotope-Labeled Compounds | |
| HY-W012998S2 | 2,3-Pentanedione-d3 | 150678-00-5 | Isotope-Labeled Compounds |
| HY-W012999 | Tiglic acid | 80-59-1 | Natural Products |
| HY-W012999R | Tiglic acid (Standard) | 80-59-1 | Reference Standards |
| HY-W013007 | 4-Hexen-3-one | 2497-21-4 | Reference compound |
| HY-W013014 | 3-Methyl-2-cyclopenten-1-one | 2758-18-1 | Natural Products |
| HY-W013014R | 3-Methyl-2-cyclopenten-1-one (Standard) | 2758-18-1 | Reference Standards |
| HY-W013014S | 3-Methyl-2-cyclopenten-1-one-d3 | 208519-89-5 | Isotope-Labeled Compounds |
| HY-W013015S | 2-Ethylfuran-d5 | 2477520-26-4 | Isotope-Labeled Compounds |
| HY-W013021 | Norbornene | 498-66-8 | Natural Products |
| HY-W013027 | 2-Amino-2-methyl-1-propanol | 124-68-5 | Biochemical Assay Reagents |
| HY-W013027A | 2-Amino-2-methylpropan-1-ol (hydrochloride) | 3207-12-3 | Biochemical Assay Reagents |
| HY-W013027S | 2-Amino-2-methyl-1-propanol-d11 | 1435933-80-4 | Isotope-Labeled Compounds |
| HY-W013032 | Oxamic acid | 471-47-6 | Reference compound |
| HY-W013032A | Oxamic acid (sodium) | 565-73-1 | Reference compound |
| HY-W013032R | Oxamic acid (Standard) | 471-47-6 | Reference Standards |
| HY-W013035 | 3-Methyl-2-buten-1-ol | 556-82-1 | Natural Products |
| HY-W013035R | 3-Methyl-2-buten-1-ol (Standard) | 556-82-1 | Reference Standards |
| HY-W013040 | Pyrazine | 290-37-9 | Reference compound |
| HY-W013040S | Pyrazine-d4 | 1758-62-9 | Isotope-Labeled Compounds |
| HY-W013042 | Cyclobutanol | 2919-23-5 | Biochemical Assay Reagents |
| HY-W013046 | Phosphoribosyl pyrophosphate (pentasodium) | 108321-05-7 | Reference compound |
| HY-W013048 | Boc-β-HoGlu(OBzl)-OH | 218943-30-7 | Peptides |
| HY-W013049 | Docosanoic acid | 112-85-6 | Natural Products |
| HY-W013049S | Docosanoic acid-d4 | 1208430-53-8 | Isotope-Labeled Compounds |
| HY-W013049S1 | Docosanoic acid-d43 | 29823-26-5 | Isotope-Labeled Compounds |
| HY-W013049S2 | Docosanoic acid-d2 | 71607-34-6 | Isotope-Labeled Compounds |
| HY-W013049S3 | Docosanoic acid-d3 | 1193721-67-3 | Isotope-Labeled Compounds |
| HY-W013049S4 | Docosanoic acid-d4-1 | 1219804-98-4 | Isotope-Labeled Compounds |
| HY-W013049S5 | Docosanoic acid-d4-2 | 1193721-65-1 | Isotope-Labeled Compounds |
| HY-W013052 | 8-Bromo-2'-deoxyadenosine | 14985-44-5 | Reference compound |
| HY-W013053 | Dibenz[a,h]anthracene | 53-70-3 | Reference compound |
| HY-W013053R | Dibenz[a,h]anthracene (Standard) | 53-70-3 | Reference Standards |
| HY-W013053S | Dibenz[a,h]anthracene-d14 | 13250-98-1 | Isotope-Labeled Compounds |
| HY-W013058 | Decabromodiphenyl ethane | 84852-53-9 | Reference compound |
| HY-W013058S | 1,2-Bis(pentabromophenyl)ethane-13C14 | Isotope-Labeled Compounds | |
| HY-W013059 | DMT-dA(bz) Phosphoramidite | 98796-53-3 | Biochemical Assay Reagents |
| HY-W013059A | DMT-L-dA(bz) Phosphoramidite | 141846-54-0 | Oligonucleotides |
| HY-W013059R | DMT-dA(bz) Phosphoramidite (Standard) | 98796-53-3 | Reference Standards |
| HY-W013059S | DMT-dA(bz) Phosphoramidite-13C10,15N5 | 2483830-15-3 | Isotope-Labeled Compounds |
| HY-W013059S1 | DMT-dA(bz) Phosphoramidite-15N5 | Isotope-Labeled Compounds | |
| HY-W013059S2 | DMT-dA(bz) Phosphoramidite-d9 | Isotope-Labeled Compounds | |
| HY-W013060 | (Rac)-1,2-Dilinoleoyl-3-palmitoyl-glycerol | 2190-15-0 | Biochemical Assay Reagents |
| HY-W013061 | Propane-1,2,3-triyl tripalmitate | 555-44-2 | Natural Products |
| HY-W013061R | Propane-1,2,3-triyl tripalmitate (Standard) | 555-44-2 | Reference Standards |
| HY-W013061S | Propane-1,2,3-triyl tripalmitate-d9 | 2738376-70-8 | Isotope-Labeled Compounds |
| HY-W013061S1 | Propane-1,2,3-triyl tripalmitate-13C3 | 168294-57-3 | Isotope-Labeled Compounds |
| HY-W013061S10 | Propane-1,2,3-triyl tripalmitate-13C | Isotope-Labeled Compounds | |
| HY-W013061S11 | Tripalmitin (Glycerol 13C3,13C 99%) | 1246739-65-0 | Isotope-Labeled Compounds |
| HY-W013061S2 | Propane-1,2,3-triyl tripalmitate-d31 | 241157-04-0 | Isotope-Labeled Compounds |
| HY-W013061S3 | Propane-1,2,3-triyl tripalmitate-d5 | 60763-98-6 | Isotope-Labeled Compounds |
| HY-W013061S4 | Propane-1,2,3-triyl tripalmitate-13C3-1 | 201996-42-1 | Isotope-Labeled Compounds |
| HY-W013061S5 | Propane-1,2,3-triyl tripalmitate-13C2 | 339080-65-8 | Isotope-Labeled Compounds |
| HY-W013061S6 | Propane-1,2,3-triyl tripalmitate-d98 | 1219803-85-6 | Isotope-Labeled Compounds |
| HY-W013061S7 | Propane-1,2,3-triyl tripalmitate-d27 | 1219804-91-7 | Isotope-Labeled Compounds |
| HY-W013061S8 | Propane-1,2,3-triyl tripalmitate-d9-1 | 285979-78-4 | Isotope-Labeled Compounds |
| HY-W013061S9 | Propane-1,2,3-triyl tripalmitate-d6 | 241157-06-2 | Isotope-Labeled Compounds |
| HY-W013063 | 1,2-Dilinoleoyl-sn-glycero-3-phosphocholine | 998-06-1 | Biochemical Assay Reagents |
| HY-W013066 | Pd(Xantphos)Cl2 | 205319-10-4 | Biochemical Assay Reagents |
| HY-W013068 | DMT-dT Phosphoramidite | 98796-51-1 | Biochemical Assay Reagents |
| HY-W013068S | DMT-dT Phosphoramidite-13C10,15N2 | 2483830-17-5 | Isotope-Labeled Compounds |
| HY-W013068S1 | DMT-dT Phosphoramidite-15N2 | Isotope-Labeled Compounds | |
| HY-W013068S2 | DMT-dT Phosphoramidite-13C | 115653-31-1 | Isotope-Labeled Compounds |
| HY-W013068S3 | DMT-dT Phosphoramidite-d11 | Isotope-Labeled Compounds | |
| HY-W013070 | α-D-Glucopyranose, 98% | 22415-91-4 | Biochemical Assay Reagents |
| HY-W013075 | Rutin (trihydrate) | 250249-75-3 | Reference compound |
| HY-W013075R | Rutin (trihydrate) (Standard) | 250249-75-3 | Reference Standards |
| HY-W013076 | Tetrakis(decyl)ammonium (bromide) | 14937-42-9 | Biochemical Assay Reagents |
| HY-W013077 | N6-Benzoyl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyadenosine | 64325-78-6 | Reference compound |
| HY-W013078 | (2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl ditetradecanoate | 998-07-2 | Natural Products |
| HY-W013078R | (2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl ditetradecanoate (Standard) | 998-07-2 | Reference Standards |
| HY-W013078S | (2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl ditetradecanoate-d54 | 326495-41-4 | Isotope-Labeled Compounds |
| HY-W013081 | Fmoc-Gln(Trt)-OH | 132327-80-1 | Biochemical Assay Reagents |
| HY-W013083 | Fmoc-His(Fmoc)-OH | 98929-98-7 | Peptides |
| HY-W013093 | Uridine triphosphate (trisodium salt) | 19817-92-6 | Natural Products |
| HY-W013093R | Uridine triphosphate (trisodium salt) (Standard) | 19817-92-6 | Reference Standards |
| HY-W013097 | Boc-Arg(di-Z)-OH | 51219-19-3 | Peptides |
| HY-W013098 | 2'-Deoxyadenosine 5'-triphosphate (disodium) | 74299-50-6 | Biochemical Assay Reagents |
| HY-W013100 | Cytidine-5'-triphosphate (disodium) | 36051-68-0 | Natural Products |
| HY-W013100R | Cytidine-5'-triphosphate (disodium) (Standard) | 36051-68-0 | Reference Standards |
| HY-W013105 | Sodium glycocholate hydrate, 98% | 338950-81-5 | Biochemical Assay Reagents |
| HY-W013108 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoic acid | 174132-31-1 | Peptides |
| HY-W013113 | BTMPS | 52829-07-9 | Reference compound |
| HY-W013113S | Bis(2,2,6,6-tetramethylpiperidin-4-yl) decanedioate-d24 | Isotope-Labeled Compounds | |
| HY-W013118 | Fmoc-Cys(pMeOBzl)-OH | 141892-41-3 | Peptides |
| HY-W013122 | Cholesteryl n-butyrate | 521-13-1 | Biochemical Assay Reagents |
| HY-W013123 | Fmoc-D-Phe(4-CF3)-OH | 238742-88-6 | Peptides |
| HY-W013128 | Cholesteryl propionate | 633-31-8 | Biochemical Assay Reagents |
| HY-W013136 | Triheptanoin | 620-67-7 | Reference compound |
| HY-W013136R | Triheptanoin (Standard) | 620-67-7 | Reference Standards |
| HY-W013140A | Azomethine-H (sodium hydrate) | 206752-32-1 | Biochemical Assay Reagents |
| HY-W013143 | Fmoc-Cys(Acm)-OH | 86060-81-3 | Peptides |
| HY-W013144 | Fmoc-D-Asp(OtBu)-OH | 112883-39-3 | Peptides |
| HY-W013145 | Fmoc-D-Asp-OtBu | 134098-70-7 | Peptides |
| HY-W013150 | Alpidem | 82626-01-5 | Reference compound |
| HY-W013151 | 1-Pyrenebutyric acid N-hydroxysuccinimide ester | 114932-60-4 | Reference compound |
| HY-W013152 | Fmoc-Phe(3-Me)-OH | 211637-74-0 | Peptides |
| HY-W013153 | Fmoc-D-Tic-OH | 130309-33-0 | Peptides |
| HY-W013154 | Fmoc-Tic-OH | 136030-33-6 | Peptides |
| HY-W013155 | H-His(Trt)-OH | 35146-32-8 | Peptides |
| HY-W013156 | 2′,3′,5′-Triacetylinosine | 3181-38-2 | Reference compound |
| HY-W013158 | Trimethyloctadecylammonium (bromide) | 1120-02-1 | Reference compound |
| HY-W013159 | 2'-Deoxyguanosine 5'-monophosphate (disodium) | 33430-61-4 | Oligonucleotides |
| HY-W013159S | 2'-Deoxyguanosine 5'-monophosphate-13C10,15N5 (disodium) | Isotope-Labeled Compounds | |
| HY-W013160S | Dioctyl Terepthalate-d4 | Isotope-Labeled Compounds | |
| HY-W013162 | Fmoc-4-Pal-OH | 169555-95-7 | Peptides |
| HY-W013163 | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoic acid | 220498-02-2 | Peptides |
| HY-W013164 | SC-58125 | 162054-19-5 | Reference compound |
| HY-W013165 | 1,3,4,6-Tetra-O-acetyl-2-amino-2-desoxy-β-D-glucopyranose (hydrochloride) | 10034-20-5 | Biochemical Assay Reagents |
| HY-W013166 | MTSEA-biotin | 162758-04-5 | Reference compound |
| HY-W013168 | 4-Nitrophenyl palmitate | 1492-30-4 | Reference compound |
| HY-W013170 | MGK-264 | 113-48-4 | Reference compound |
| HY-W013170R | MGK-264 (Standard) | 113-48-4 | Reference Standards |
| HY-W013172 | Norgestimate | 35189-28-7 | Reference compound |
| HY-W013172R | Norgestimate (Standard) | 35189-28-7 | Reference Standards |
| HY-W013175 | Uridine 5'-monophosphate (disodium salt) | 3387-36-8 | Oligonucleotides |
| HY-W013175R | Uridine 5'-monophosphate (disodium salt) (Standard) | 3387-36-8 | Reference Standards |
| HY-W013175S2 | Uridine 5'-monophosphate-13C9,15N2 (disodium) | Isotope-Labeled Compounds | |
| HY-W013178 | DCTA (monohydrate) | 125572-95-4 | Biochemical Assay Reagents |
| HY-W013179 | 18-Hydroxycorticosterone | 561-65-9 | Natural Products |
| HY-W013179S | 18-Hydroxycorticosterone-d4 | 1257742-38-3 | Isotope-Labeled Compounds |
| HY-W013182 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-aspartic acid | 119062-05-4 | Peptides |
| HY-W013185 | Fmoc-β-HoVal-OH | 172695-33-9 | Peptides |
| HY-W013186 | Lansoprazole sulfide | 103577-40-8 | Reference compound |
| HY-W013186S | Lansoprazole sulfide-d4 | 1216682-38-0 | Isotope-Labeled Compounds |
| HY-W013186S1 | Lansoprazole sulfide-13C6 | 1261392-56-6 | Isotope-Labeled Compounds |
| HY-W013190 | Fmoc-HoPro-OH | 86069-86-5 | Peptides |
| HY-W013195 | 8-Bromoadenosine | 2946-39-6 | Reference compound |
| HY-W013198 | Z-Thr(Bzl)-OH | 69863-36-1 | Peptides |
| HY-W013200 | Coumachlor | 81-82-3 | Reference compound |
| HY-W013201 | (S)-1-((S)-2-Amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:1) | 67320-92-7 | Peptides |
| HY-W013203 | Ethyl icosanoate | 18281-05-5 | Biochemical Assay Reagents |
| HY-W013205 | Bis(4-nitrophenyl) phosphate | 645-15-8 | Reference compound |
| HY-W013205B | Sodium bis(4-nitrophenyl) phosphate | 4043-96-3 | Biochemical Assay Reagents |
| HY-W013205R | Bis(4-nitrophenyl) phosphate (Standard) | 645-15-8 | Reference Standards |
| HY-W013207 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)pentanoic acid | 135112-28-6 | Peptides |
| HY-W013210 | Boc-β-HoAsp(OBzl)-OH | 254101-10-5 | Peptides |
| HY-W013214 | Ethyl arachidonate | 1808-26-0 | Reference compound |
| HY-W013214S | Ethyl arachidonate-d11 | Isotope-Labeled Compounds | |
| HY-W013215 | Adrenic acid | 28874-58-0 | Natural Products |
| HY-W013215S | Adrenic acid-d8 | Isotope-Labeled Compounds | |
| HY-W013222 | Ethyl ricinoleate | 55066-53-0 | Biochemical Assay Reagents |
| HY-W013231 | N-Benzyl-N,N-diethylethanaminium iodide | 5400-94-2 | Biochemical Assay Reagents |
| HY-W013239 | Bz-Tyr-OEt | 3483-82-7 | Peptides |
| HY-W013241 | (R)-3-(Benzylthio)-2-((tert-butoxycarbonyl)amino)propanoic acid | 5068-28-0 | Peptides |
| HY-W013242 | Gondoic acid | 5561-99-9 | Natural Products |
| HY-W013242R | Gondoic acid (Standard) | 5561-99-9 | Reference Standards |
| HY-W013249 | Boc-piperazine-benzoic acid | 162046-66-4 | Reference compound |
| HY-W013253 | Boc-11-aminoundecanoic acid | 10436-25-6 | Reference compound |
| HY-W013254 | 2-Nitrophenyl β-D-glucopyranoside | 2816-24-2 | Biochemical Assay Reagents |
| HY-W013256 | Foscarnet (trisodium hexahydrate) | 34156-56-4 | Reference compound |
| HY-W013256R | Foscarnet (trisodium hexahydrate) (Standard) | 34156-56-4 | Reference Standards |
| HY-W013259 | 6-Methylmercaptopurine riboside | 342-69-8 | Reference compound |
| HY-W013260 | 2'-O-Methylguanosine | 2140-71-8 | Oligonucleotides |
| HY-W013260S1 | 2'-O-Methylguanosine-d3 | Isotope-Labeled Compounds | |
| HY-W013264A | Tetrabutylammonium (chloride monohydrate) | 88641-55-8 | Reference compound |
| HY-W013266 | N4-Acetylsulfamethoxazole | 21312-10-7 | Reference compound |
| HY-W013266R | N4-Acetylsulfamethoxazole (Standard) | 21312-10-7 | Reference Standards |
| HY-W013266S | N4-Acetylsulfamethoxazole-d4 | 1215530-54-3 | Isotope-Labeled Compounds |
| HY-W013268 | (S)-(+)-N-3-Benzylnirvanol | 790676-40-3 | Reference compound |
| HY-W013272 | Hydroxyflutamide | 52806-53-8 | Reference compound |
| HY-W013272R | Hydroxyflutamide (Standard) | 52806-53-8 | Reference Standards |
| HY-W013274 | CPTH2 | 357649-93-5 | Reference compound |
| HY-W013274A | CPTH2 (hydrochloride) | 2108899-91-6 | Reference compound |
| HY-W013275 | MCLA hydrochloride | 128322-44-1 | Dye Reagents |
| HY-W013280 | Z-His-OH | 14997-58-1 | Peptides |
| HY-W013286 | Z-Met-OH | 1152-62-1 | Peptides |
| HY-W013289 | 2'-O-Methylinosine | 3881-21-8 | Reference compound |
| HY-W013291 | H-Asp(OtBu)-OtBu.HCl | 1791-13-5 | Peptides |
| HY-W013291A | H-D-Asp(OtBu)-OtBu·HCl | 135904-71-1 | Peptides |
| HY-W013292 | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid | 3978-80-1 | Peptides |
| HY-W013293 | Boc-D-Tyr-OH | 70642-86-3 | Peptides |
| HY-W013293R | Boc-D-Tyr-OH (Standard) | 70642-86-3 | Reference Standards |
| HY-W013297 | Z-D-Lys-OH | 70671-54-4 | Peptides |
| HY-W013300 | Boc-N-Me-Phe-OH | 37553-65-4 | Peptides |
| HY-W013305 | (S)-2-((tert-Butoxycarbonyl)amino)-5-guanidinopentanoic acid | 13726-76-6 | Peptides |
| HY-W013316 | Lasamide | 2736-23-4 | Reference compound |
| HY-W013316R | Lasamide (Standard) | 2736-23-4 | Reference Standards |
| HY-W013322 | Ac-Tyr-OEt.H2O | 36546-50-6 | Peptides |
| HY-W013326S | Bisphenol Z-d6 | 2733972-12-6 | Isotope-Labeled Compounds |
| HY-W013327 | Cyclohexyldiphenylphosphine | 6372-42-5 | Biochemical Assay Reagents |
| HY-W013330 | 3′-Deoxyguanosine | 3608-58-0 | Reference compound |
| HY-W013331 | Deoxy artemisinin | 72826-63-2 | Natural Products |
| HY-W013332 | 3-Deazaadenosine | 6736-58-9 | Reference compound |
| HY-W013332A | 3-Deazaadenosine (hydrochloride) | 86583-19-9 | Reference compound |
| HY-W013343 | 2-(Diphenylphosphino)pyridine | 37943-90-1 | Biochemical Assay Reagents |
| HY-W013353 | (RS)-Salsolinol (hydrobromide) | 59709-57-8 | Reference compound |
| HY-W013359 | Dimethyl dodecanedioate | 1731-79-9 | Natural Products |
| HY-W013372 | 7,8-Dihydroxyflavone | 38183-03-8 | Natural Products |
| HY-W013373 | H-Ser(tBu)-OtBu.HCl | 51537-21-4 | Peptides |
| HY-W013375 | Thiorphan | 76721-89-6 | Reference compound |
| HY-W013375S | Thiorphan-d7 | 1276297-68-7 | Isotope-Labeled Compounds |
| HY-W013375S1 | Thiorphan-d5 | 2183240-70-0 | Isotope-Labeled Compounds |
| HY-W013376 | Norcyclizine | 841-77-0 | Reference compound |
| HY-W013376S | Norcyclizine-d8 | 1330188-81-2 | Isotope-Labeled Compounds |
| HY-W013378 | Carbamazepine 10,11-epoxide | 36507-30-9 | Reference compound |
| HY-W013378R | Carbamazepine 10,11-epoxide (Standard) | 36507-30-9 | Reference Standards |
| HY-W013378S | Carbamazepine 10,11 epoxide-d2 | 1185025-41-5 | Isotope-Labeled Compounds |
| HY-W013378S1 | Carbamazepine 10,11 epoxide-d10 | 1219804-16-6 | Isotope-Labeled Compounds |
| HY-W013378S2 | Carbamazepine 10,11-epoxide-13C,d2 | 1189497-48-0 | Isotope-Labeled Compounds |
| HY-W013378S3 | Carbamazepine 10,11-epoxide-13C-15N | 122842-78-8 | Isotope-Labeled Compounds |
| HY-W013378S4 | Carbamazepine 10,11-epoxide-13C | 67411-80-7 | Isotope-Labeled Compounds |
| HY-W013378S5 | Carbamazepine 10,11-epoxide-13C-1 | 1374855-73-8 | Isotope-Labeled Compounds |
| HY-W013381 | 10-Bromodecanoic acid | 50530-12-6 | Reference compound |
| HY-W013386 | LY83583 | 91300-60-6 | Reference compound |
| HY-W013388S | Crotonaldehyde 2,4-dinitrophenylhydrazone-d3 | 259824-64-1 | Isotope-Labeled Compounds |
| HY-W013396 | 4-Iodobenzoic acid | 619-58-9 | Biochemical Assay Reagents |
| HY-W013396S | 4-Iodobenzoic Acid-13C6 | Isotope-Labeled Compounds | |
| HY-W013401 | Methyl Cedryl Ketone | 32388-55-9 | Biochemical Assay Reagents |
| HY-W013403 | 2'-Deoxy-2'-fluorouridine | 784-71-4 | Reference compound |
| HY-W013403S | 2'-Deoxy-2'-fluorouridine-d2 | 362049-50-1 | Isotope-Labeled Compounds |
| HY-W013406 | H-D-Tyr-OEt.HCl | 23234-43-7 | Peptides |
| HY-W013407 | α-Methyltyrosine methyl ester (hydrochloride) | 7361-31-1 | Peptides |
| HY-W013409 | 2,4-Dichlorobenzenesulfonyl chloride | 16271-33-3 | Reference compound |
| HY-W013411 | (E/Z)-Locostatin | 133812-16-5 | Reference compound |
| HY-W013411A | Locostatin | 90719-30-5 | Reference compound |
| HY-W013416 | (R)-Ethyl 2-amino-4-phenylbutanoate hydrochloride | 90940-54-8 | Peptides |
| HY-W013423 | 5-Methylchrysene | 3697-24-3 | Reference compound |
| HY-W013424S | Bis(4-Methoxyphenyl)methanone-d8 | 350818-55-2 | Isotope-Labeled Compounds |
| HY-W013425S | 2-Hydroxy-5-(phenyldiazenyl)benzoic acid-d5 | 1331662-16-8 | Isotope-Labeled Compounds |
| HY-W013429 | 4-Glycidyloxycarbazole | 51997-51-4 | Reference compound |
| HY-W013430 | 4-Amino-3-hydroxynaphthalene-1-sulfonic acid | 116-63-2 | Dye Reagents |
| HY-W013435 | 1,2-Diaminoanthraquinone | 1758-68-5 | Dye Reagents |
| HY-W013436 | Ethyl 2-(diethoxyphosphoryl)propanoate | 3699-66-9 | Biochemical Assay Reagents |
| HY-W013441 | 2',3'-Dideoxyadenosine | 4097-22-7 | Reference compound |
| HY-W013441R | 2',3'-Dideoxyadenosine (Standard) | 4097-22-7 | Reference Standards |
| HY-W013458 | Bis(2-bromoethyl) ether | 5414-19-7 | Reference compound |
| HY-W013460 | Ala-Ala-Ala | 5874-90-8 | Peptides |
| HY-W013466 | Dimethyl decanedioate | 106-79-6 | Biochemical Assay Reagents |
| HY-W013473 | Boc-D-HoPro-OH | 28697-17-8 | Biochemical Assay Reagents |
| HY-W013478 | PTP inhibitor 1 | 2632-13-5 | Reference compound |
| HY-W013482 | Benzyl 4-hydroxybenzoate | 94-18-8 | Reference compound |
| HY-W013482R | Benzyl 4-hydroxybenzoate (Standard) | 94-18-8 | Reference Standards |
| HY-W013482S | Benzyl 4-hydroxybenzoate-d4 | 1219805-81-8 | Isotope-Labeled Compounds |
| HY-W013482S1 | Benzyl Paraben-d7 | 1216916-40-3 | Isotope-Labeled Compounds |
| HY-W013494 | L-Carnosine | 305-84-0 | Natural Products |
| HY-W013494R | L-Carnosine (Standard) | 305-84-0 | Reference Standards |
| HY-W013494S | L-Carnosine-d4 | 2714339-90-7 | Isotope-Labeled Compounds |
| HY-W013495 | Porphobilinogen | 487-90-1 | Natural Products |
| HY-W013495S | Porphobilinogen-13C2 | Isotope-Labeled Compounds | |
| HY-W013500 | (1-Nitroethene-1,2-diyl)dibenzene | 1215-07-2 | Reference compound |
| HY-W013504S | 1-Bromo-4-(trifluoromethyl)benzene-d4 | 1219799-09-3 | Isotope-Labeled Compounds |
| HY-W013507 | Methyl 2-(3-oxo-2-(pent-2-en-1-yl)cyclopentyl)acetate | 39924-52-2 | Natural Products |
| HY-W013507R | Methyl 2-(3-oxo-2-(pent-2-en-1-yl)cyclopentyl)acetate (Standard) | 39924-52-2 | Reference Standards |
| HY-W013508 | I2959 | 106797-53-9 | Biochemical Assay Reagents |
| HY-W013510 | 2-(Chloromethyl)-3,4-dimethoxypyridine (hydrochloride) | 72830-09-2 | Biochemical Assay Reagents |
| HY-W013514 | 2-Acetamidofluorene | 53-96-3 | Reference compound |
| HY-W013517 | Z-Sar-OH | 39608-31-6 | Peptides |
| HY-W013522 | Me-PEG4-Me | 143-24-8 | Reference compound |
| HY-W013522R | Me-PEG4-Me (Standard) | 143-24-8 | Reference Standards |
| HY-W013523 | 2-NP | 65182-56-1 | Reference compound |
| HY-W013538 | 1,2-Bis(maleimido)ethane | 5132-30-9 | Reference compound |
| HY-W013549 | 6-Aminopenicillanic acid | 551-16-6 | Reference compound |
| HY-W013549R | 6-Aminopenicillanic acid (Standard) | 551-16-6 | Reference Standards |
| HY-W013555 | 1,2-Dianilinoethane | 150-61-8 | Biochemical Assay Reagents |
| HY-W013557 | 3-Hydroxyxanthone | 3722-51-8 | Reference compound |
| HY-W013570 | Acenaphthylene | 208-96-8 | Natural Products |
| HY-W013570R | Acenaphthylene (Standard) | 208-96-8 | Reference Standards |
| HY-W013570S | Acenaphthylene-d8 | 93951-97-4 | Isotope-Labeled Compounds |
| HY-W013571 | 4-Isopropylbenzoic acid | 536-66-3 | Natural Products |
| HY-W013573 | S-Allyl-L-cysteine | 21593-77-1 | Natural Products |
| HY-W013573R | S-Allyl-L-cysteine (Standard) | 21593-77-1 | Reference Standards |
| HY-W013576 | Methyl 2-Octynoate | 111-12-6 | Reference compound |
| HY-W013576R | Methyl 2-Octynoate (Standard) | 111-12-6 | Reference Standards |
| HY-W013576S | Methyl 2-Octynoate-d5 | Isotope-Labeled Compounds | |
| HY-W013579 | (S)-(+)-Carvone | 2244-16-8 | Natural Products |
| HY-W013579R | (S)-(+)-Carvone (Standard) | 2244-16-8 | Reference Standards |
| HY-W013580 | 1H-Indene-1,2(3H)-dione | 16214-27-0 | Biochemical Assay Reagents |
| HY-W013591 | 6-O-Methyl-guanine | 20535-83-5 | Biochemical Assay Reagents |
| HY-W013591R | 6-O-Methyl-guanine (Standard) | 20535-83-5 | Reference Standards |
| HY-W013591S | 6-O-Methyl-guanine-d3 | 50704-43-3 | Isotope-Labeled Compounds |
| HY-W013598 | Sodium benzenesulfinate | 873-55-2 | Biochemical Assay Reagents |
| HY-W013605A | 4-Methoxycinnamaldehyde | 1963-36-6 | Natural Products |
| HY-W013605AR | 4-Methoxycinnamaldehyde (Standard) | 1963-36-6 | Reference Standards |
| HY-W013607 | Benzoylacetone | 93-91-4 | Biochemical Assay Reagents |
| HY-W013616 | Propyl hexanoate | 626-77-7 | Biochemical Assay Reagents |
| HY-W013622 | H-DL-Ser-OMe.HCl | 5619-04-5 | Peptides |
| HY-W013627 | trans,trans-2,4-Decadienal | 25152-84-5 | Natural Products |
| HY-W013627S | trans,trans-2,4-Decadienal-d4 | 1335436-29-7 | Isotope-Labeled Compounds |
| HY-W013631 | 7H-Purine-2,6-diamine | 1904-98-9 | Biochemical Assay Reagents |
| HY-W013636 | 2-Ketoglutaric acid | 328-50-7 | Natural Products |
| HY-W013636A | 2-Ketoglutaric acid (Sodium) | 22202-68-2 | Natural Products |
| HY-W013636AR | 2-Ketoglutaric acid (Sodium) (Standard) | 22202-68-2 | Reference Standards |
| HY-W013636B | Calcium 2-oxoglutarate | 71686-01-6 | Natural Products |
| HY-W013636C | 2-Ketoglutaric acid (potassium) | 997-43-3 | Biochemical Assay Reagents |
| HY-W013636R | 2-Ketoglutaric acid (Standard) | 328-50-7 | Reference Standards |
| HY-W013636S | 2-Ketoglutaric acid-13C5 | 161096-83-9 | Isotope-Labeled Compounds |
| HY-W013636S1 | 2-Ketoglutaric acid-d4 | 1381759-60-9 | Isotope-Labeled Compounds |
| HY-W013636S2 | 2-Ketoglutaric acid-d6 | 1173021-86-7 | Isotope-Labeled Compounds |
| HY-W013636S3 | 2-Ketoglutaric acid-13C | 108395-15-9 | Isotope-Labeled Compounds |
| HY-W013636S4 | 2-Ketoglutaric acid-13C2 | 123953-28-6 | Isotope-Labeled Compounds |
| HY-W013638 | tert-Butyl 2-(methylamino)acetate | 5616-81-9 | Peptides |
| HY-W013644 | 5-Formyluracil | 1195-08-0 | Biochemical Assay Reagents |
| HY-W013651 | H-DL-Cys.HCl | 10318-18-0 | Peptides |
| HY-W013652 | (E)-2-(2-Methylbut-2-enamido)acetic acid | 35842-45-6 | Peptides |
| HY-W013652S | N-Tigloylglycine-2,2-d2 | 1219806-44-6 | Isotope-Labeled Compounds |
| HY-W013659 | Fmoc-Asp(OcHex)-OH | 130304-80-2 | Peptides |
| HY-W013665 | (S)-2-Aminohexanedioic acid | 1118-90-7 | Biochemical Assay Reagents |
| HY-W013665R | (S)-2-Aminohexanedioic acid (Standard) | 1118-90-7 | Reference Standards |
| HY-W013665S2 | (S)-2-Aminohexanedioic acid-d4 | Isotope-Labeled Compounds | |
| HY-W013673 | 2,3-Diaminopropionic acid hydrochloride | 1482-97-9 | Reference compound |
| HY-W013674 | 2,3-Diaminopropanoic acid hydrochloride | 54897-59-5 | Natural Products |
| HY-W013675 | 2-Methoxyhydroquinone | 824-46-4 | Natural Products |
| HY-W013677 | 4-Fluorobenzoic acid | 456-22-4 | Biochemical Assay Reagents |
| HY-W013677S | 4-Fluorobenzoic acid-13C6 | Isotope-Labeled Compounds | |
| HY-W013678 | H-Glu(OMe)-OH | 1499-55-4 | Peptides |
| HY-W013678A | H-Glu(OMe)-OH (hydrochloride) | 3077-51-8 | Reference compound |
| HY-W013678R | H-Glu(OMe)-OH (Standard) | 1499-55-4 | Reference Standards |
| HY-W013686 | tert-Butyl D-leucinate hydrochloride | 13081-32-8 | Peptides |
| HY-W013696 | α-D-Cellobiose octaacetate, 98% | 5346-90-7 | Biochemical Assay Reagents |
| HY-W013699 | Chlorhexidine (diacetate) | 56-95-1 | Reference compound |
| HY-W013699R | Chlorhexidine (diacetate) (Standard) | 56-95-1 | Reference Standards |
| HY-W013706 | Inosine-5'-triphosphate (trisodium salt) | 35908-31-7 | Natural Products |
| HY-W013707 | Cytidine-5'-triphosphate (disodium dihydrate) | 81012-87-5 | Reference compound |
| HY-W013712 | GI-530159 | 69563-88-8 | Reference compound |
| HY-W013713 | Riboflavin phosphate (sodium hydrate) | 6184-17-4 | Biochemical Assay Reagents |
| HY-W013714 | Fmoc-Phe(4-I)-OH | 82565-68-2 | Peptides |
| HY-W013715A | Deoxythymidine-5'-triphosphate (trisodium) solution (100mM) | 27821-54-1 | Biochemical Assay Reagents |
| HY-W013718 | TTHA | 869-52-3 | Biochemical Assay Reagents |
| HY-W013719 | H-Asp(OBzl)-Obzl.TosOH | 2886-33-1 | Peptides |
| HY-W013724S | Inosine-5'-diphosphoric acid-15N4 (dilithium) | Isotope-Labeled Compounds | |
| HY-W013726 | Fmoc-Phe(4-Br)-OH | 198561-04-5 | Peptides |
| HY-W013727 | UK-78282 (hydrochloride) | 136647-02-4 | Reference compound |
| HY-W013728 | 1,3,5-Tri-O-benzoyl-a-D-ribofuranose | 22224-41-5 | Reference compound |
| HY-W013731 | Triethylene glycol bis(p-toluenesulfonate) | 19249-03-7 | Reference compound |
| HY-W013734 | N,N'-Di-BOC-L-cystine | 10389-65-8 | Peptides |
| HY-W013735 | Fmoc-D-1-Nal-OH | 138774-93-3 | Peptides |
| HY-W013740 | Fmoc-N-Me-Asp(OtBu)-OH | 152548-66-8 | Peptides |
| HY-W013741 | CME-carbodiimide | 2491-17-0 | Biochemical Assay Reagents |
| HY-W013744 | S-Octylglutathione | 24435-27-6 | Reference compound |
| HY-W013745 | Fmoc-N-Me-Thr(tBu)-OH | 117106-20-4 | Peptides |
| HY-W013749 | Fmoc-N-Me-Ser(tBu)-OH | 197632-77-2 | Peptides |
| HY-W013750 | Fmoc-Arg-OH | 91000-69-0 | Reference compound |
| HY-W013751 | Fmoc-Gly-Val-OH | 86895-14-9 | Peptides |
| HY-W013754 | S-Hexylglutathione | 24425-56-7 | Reference compound |
| HY-W013755 | Dioctyl phthalate | 117-84-0 | Natural Products |
| HY-W013755S | Dioctyl phthalate-d4 | 93952-13-7 | Isotope-Labeled Compounds |
| HY-W013758 | TMB-PS (sodium) | 102062-46-4 | Biochemical Assay Reagents |
| HY-W013760 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylacetic acid | 111524-95-9 | Peptides |
| HY-W013762 | Tributyl citrate | 77-94-1 | Reference compound |
| HY-W013762R | Tributyl citrate (Standard) | 77-94-1 | Reference Standards |
| HY-W013763 | Syringaldazine | 14414-32-5 | Biochemical Assay Reagents |
| HY-W013766 | Pipemidic acid (trihydrate) | 72571-82-5 | Biochemical Assay Reagents |
| HY-W013766R | Pipemidic acid (trihydrate) (Standard) | 72571-82-5 | Reference Standards |
| HY-W013767 | Thiodicarb | 59669-26-0 | Reference compound |
| HY-W013767R | Thiodicarb (Standard) | 59669-26-0 | Reference Standards |
| HY-W013769 | Fmoc-D-N-Me-Val-OH | 103478-58-6 | Peptides |
| HY-W013772 | Tris(4-methoxyphenyl)phosphine | 855-38-9 | Biochemical Assay Reagents |
| HY-W013774 | Z-Val-Osu | 3496-11-5 | Peptides |
| HY-W013775 | N-Desmethyl ofloxacin | 82419-52-1 | Biochemical Assay Reagents |
| HY-W013775R | N-Desmethyl ofloxacin (Standard) | 82419-52-1 | Reference Standards |
| HY-W013776 | meta-Fluoxetine (hydrochloride) | 79088-29-2 | Reference compound |
| HY-W013777 | Dibenzyl N,N-diisopropylphosphoramidite | 108549-23-1 | Biochemical Assay Reagents |
| HY-W013779 | Fmoc-D-Gly(allyl)-OH | 170642-28-1 | Peptides |
| HY-W013780 | Fmoc-Pro-OH | 71989-31-6 | Peptides |
| HY-W013780S | Fmoc-Pro-OH-1-13C | 2306051-40-9 | Isotope-Labeled Compounds |
| HY-W013780S1 | Fmoc-Pro-OH-13C5,15N | 1217452-48-6 | Isotope-Labeled Compounds |
| HY-W013780S2 | Fmoc-Pro-OH-15N | 204523-24-0 | Isotope-Labeled Compounds |
| HY-W013780S3 | Fmoc-Pro-OH-d3 | Isotope-Labeled Compounds | |
| HY-W013781 | Boc-Glu(OBzl)-OH | 13574-13-5 | Peptides |
| HY-W013788 | 2-Palmitoylglycerol | 23470-00-0 | Natural Products |
| HY-W013788R | 2-Palmitoylglycerol (Standard) | 23470-00-0 | Reference Standards |
| HY-W013793 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-serine | 116861-26-8 | Peptides |
| HY-W013794 | Salcomine | 14167-18-1 | Reference compound |
| HY-W013803 | Xanthosine (dihydrate) | 5968-90-1 | Oligonucleotides |
| HY-W013807 | Dibutyl sebacate | 109-43-3 | Reference compound |
| HY-W013807R | Dibutyl sebacate (Standard) | 109-43-3 | Reference Standards |
| HY-W013809 | Ethyl stearate | 111-61-5 | Biochemical Assay Reagents |
| HY-W013809R | Ethyl stearate (Standard) | 111-61-5 | Reference Standards |
| HY-W013809S | Ethyl stearate-d35 | 1219795-49-9 | Isotope-Labeled Compounds |
| HY-W013810 | (tert-Butoxycarbonyl)-L-arginine hydrochloride | 35897-34-8 | Peptides |
| HY-W013812 | Ethyl linoleate | 544-35-4 | Natural Products |
| HY-W013812R | Ethyl linoleate (Standard) | 544-35-4 | Reference Standards |
| HY-W013812S | Ethyl linoleate-13C18 | 202114-63-4 | Isotope-Labeled Compounds |
| HY-W013812S1 | Ethyl linoleate-d5 | 1169764-57-1 | Isotope-Labeled Compounds |
| HY-W013812S2 | Ethyl linoleate-d2 | 1404475-07-5 | Isotope-Labeled Compounds |
| HY-W013812S3 | Ethyl linoleate-d11 | Isotope-Labeled Compounds | |
| HY-W013815 | 8-Quinolinyl β-D-galactopyranoside | 113079-84-8 | Biochemical Assay Reagents |
| HY-W013816 | Dipentyl phthalate | 131-18-0 | Reference compound |
| HY-W013816R | Dipentyl phthalate (Standard) | 131-18-0 | Reference Standards |
| HY-W013816S | Dipentyl phthalate-3,4,5,6-d4 | 358730-89-9 | Isotope-Labeled Compounds |
| HY-W013824 | Boc-D-Phe(3,4-DiF)-OH | 205445-51-8 | Peptides |
| HY-W013826 | Carboxytolbutamide | 2224-10-4 | Reference compound |
| HY-W013826S | Carboxytolbutamide-d6 | 1184973-50-9 | Isotope-Labeled Compounds |
| HY-W013826S1 | Carboxytolbutamide-d9 | 1219802-95-5 | Isotope-Labeled Compounds |
| HY-W013827 | Isomannide | 641-74-7 | Biochemical Assay Reagents |
| HY-W013844 | Z-Phenylalaninol | 6372-14-1 | Peptides |
| HY-W013849S | Bis(2-methoxyethyl) phthalate-3,4,5,6-d4 | 1398065-54-7 | Isotope-Labeled Compounds |
| HY-W013850 | H-D-Lys(Z)-OH | 34404-32-5 | Peptides |
| HY-W013851 | EDTA-OH | 150-39-0 | Biochemical Assay Reagents |
| HY-W013852 | PKC-IN-6 | 152460-10-1 | Reference compound |
| HY-W013854 | 5α-Androstan-3β-ol | 1224-92-6 | Reference compound |
| HY-W013857 | Lavendustin C | 125697-93-0 | Reference compound |
| HY-W013863 | Djalonensone | 23452-05-3 | Natural Products |
| HY-W013863S | Djalonensone-d3 | 2468774-90-3 | Isotope-Labeled Compounds |
| HY-W013864 | (S)-2-(Benzylamino)-3-(4-hydroxyphenyl)propanoic acid | 75768-66-0 | Peptides |
| HY-W013865 | 2-Nitrophenyl b-D-xylopyranoside | 10238-27-4 | Biochemical Assay Reagents |
| HY-W013870 | (S)-2-(2-(2-Aminoacetamido)acetamido)-3-(1H-imidazol-4-yl)propanoic acid | 7451-76-5 | Peptides |
| HY-W013874 | Boc-D-3-Pal-OH | 98266-33-2 | Peptides |
| HY-W013886 | Captopril EP Impurity J | 64838-55-7 | Reference compound |
| HY-W013905 | Cbz-D-Valine | 1685-33-2 | Peptides |
| HY-W013906 | Boc-DL-Phg-OH | 3601-66-9 | Peptides |
| HY-W013923 | 2-(2-(2-Amino-4-methylpentanamido)acetamido)acetic acid | 4337-37-5 | Peptides |
| HY-W013935 | Bisphenol B | 77-40-7 | Reference compound |
| HY-W013935R | Bisphenol B (Standard) | 77-40-7 | Reference Standards |
| HY-W013937 | 4,4'-Bibenzoic acid | 787-70-2 | Biochemical Assay Reagents |
| HY-W013940 | DL-Cystine | 923-32-0 | Peptides |
| HY-W013940S | DL-Cystine-d4 | 108641-83-4 | Isotope-Labeled Compounds |
| HY-W013940S1 | DL-Cystine-d6 | 352431-53-9 | Isotope-Labeled Compounds |
| HY-W013948S | 1-(2,4-Dinitrophenyl)-2-propylidenehydrazine-d3 | 259824-53-8 | Isotope-Labeled Compounds |
| HY-W013962 | 4-(Trifluoromethyl)-L-phenylalanine | 114926-38-4 | Peptides |
| HY-W013964 | 4-Iodobenzylamine | 39959-59-6 | Reference compound |
| HY-W013967 | 1,6-Diphenylhexa-1,3,5-triene | 1720-32-7 | Dye Reagents |
| HY-W013968 | Boc-Gly-Gly-OH | 31972-52-8 | Peptides |
| HY-W013973 | p-Terphenyl | 92-94-4 | Biochemical Assay Reagents |
| HY-W013973R | p-Terphenyl (Standard) | 92-94-4 | Reference Standards |
| HY-W013973S | p-Terphenyl-d14 | 1718-51-0 | Isotope-Labeled Compounds |
| HY-W013976 | 3-(Acetylthio)propionic acid N-succinimidyl ester | 84271-78-3 | Reference compound |
| HY-W013989 | 1,3-Dicyclohexylurea | 2387-23-7 | Reference compound |
| HY-W013989R | 1,3-Dicyclohexylurea (Standard) | 2387-23-7 | Reference Standards |
| HY-W013998 | Glycyl-L-phenylalanine | 3321-03-7 | Peptides |
| HY-W014000 | Glycyl-DL-phenylalanine | 721-66-4 | Peptides |
| HY-W014004 | m-Carboxycinnamic acid bishydroxamide | 174664-65-4 | Reference compound |
| HY-W014018 | 2,5-Diphenyloxazole | 92-71-7 | Biochemical Assay Reagents |
| HY-W014048 | Boc-N-Me-Ser-OH | 101772-29-6 | Peptides |
| HY-W014049 | N'-Nitro-D-arginine | 66036-77-9 | Peptides |
| HY-W014069 | 11-Mercaptoundecanoic acid | 71310-21-9 | Biochemical Assay Reagents |
| HY-W014075 | 1-Hydroxypyrene | 5315-79-7 | Natural Products |
| HY-W014075R | 1-Hydroxypyrene (Standard) | 5315-79-7 | Reference Standards |
| HY-W014075S | 1-Hydroxypyrene-d9 | 132603-37-3 | Isotope-Labeled Compounds |
| HY-W014076 | (2S,3R)-2-((S)-2-Amino-3-methylbutanamido)-3-hydroxybutanoic acid | 72636-02-3 | Peptides |
| HY-W014078 | 4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid | 60875-16-3 | Reference compound |
| HY-W014081 | Ethyl 3-coumarincarboxylate | 1846-76-0 | Reference compound |
| HY-W014092 | 1,3-Dibromo-2-propanol | 96-21-9 | Biochemical Assay Reagents |
| HY-W014097 | Boc-Leucinol | 82010-31-9 | Peptides |
| HY-W014099 | Boc-NH-C4-acid | 27219-07-4 | Reference compound |
| HY-W014100 | (R)-2-((tert-Butoxycarbonyl)amino)pentanoic acid | 57521-85-4 | Peptides |
| HY-W014102 | L-Alanyl-L-glutamine | 39537-23-0 | Peptides |
| HY-W014102R | L-Alanyl-L-glutamine (Standard) | 39537-23-0 | Reference Standards |
| HY-W014106 | Tetraethylammonium (tetrafluoroborate) | 429-06-1 | Biochemical Assay Reagents |
| HY-W014109 | (E)-5-(2-Bromovinyl)pyrimidine-2,4(1H,3H)-dione | 69304-49-0 | Reference compound |
| HY-W014114 | (2-Chlorophenyl)(phenyl)methanone | 5162-03-8 | Biochemical Assay Reagents |
| HY-W014118 | α-Hexylcinnamaldehyde | 101-86-0 | Natural Products |
| HY-W014118R | α-Hexylcinnamaldehyde (Standard) | 101-86-0 | Reference Standards |
| HY-W014118S | α-Hexylcinnamaldehyde-d5 | Isotope-Labeled Compounds | |
| HY-W014120 | Thianthrene | 92-85-3 | Reference compound |
| HY-W014120R | Thianthrene (Standard) | 92-85-3 | Reference Standards |
| HY-W014125 | Undecanedioic acid | 1852-04-6 | Natural Products |
| HY-W014125R | Undecanedioic acid (Standard) | 1852-04-6 | Reference Standards |
| HY-W014130 | N-Acetyl-L-arginine | 155-84-0 | Natural Products |
| HY-W014130A | N-Acetyl-L-arginine (dihydrate) | 210545-23-6 | Natural Products |
| HY-W014134 | p-APMSF (hydrochloride) | 74938-88-8 | Reference compound |
| HY-W014141 | 5,6-O-Isopropylidene-L-ascorbic acid | 15042-01-0 | Biochemical Assay Reagents |
| HY-W014159 | 1-Bromo-2-methyl-3-nitrobenzene | 55289-35-5 | Biochemical Assay Reagents |
| HY-W014168 | D-(-)-α-Phenylglycine ethyl ester (hydrochloride) | 17609-48-2 | Peptides |
| HY-W014180 | N-Acetyl-L-histidine (monohydrate) | 39145-52-3 | Natural Products |
| HY-W014203S | 8-Chlorotheophylline-d6 | 1346598-95-5 | Isotope-Labeled Compounds |
| HY-W014206 | Isopentyl octanoate | 2035-99-6 | Biochemical Assay Reagents |
| HY-W014207 | Ethyl undecanoate | 627-90-7 | Biochemical Assay Reagents |
| HY-W014208 | NGX-267 | 503431-81-0 | Reference compound |
| HY-W014217 | 7-Aminodeacetoxycephalosporanic acid | 22252-43-3 | Reference compound |
| HY-W014217R | 7-Aminodeacetoxycephalosporanic acid (Standard) | 22252-43-3 | Reference Standards |
| HY-W014222 | 4-Nitrodiphenylamine | 836-30-6 | Reference compound |
| HY-W014223 | 2,4′-Dihydroxybenzophenone | 131-56-6 | Reference compound |
| HY-W014223R | 2,4′-Dihydroxybenzophenone (Standard) | 131-56-6 | Reference Standards |
| HY-W014223S | 2,4-Dihydroxybenzophenone-13C6 | 2731164-01-3 | Isotope-Labeled Compounds |
| HY-W014223S1 | 2,4′-Dihydroxybenzophenone-d5 | 91586-06-0 | Isotope-Labeled Compounds |
| HY-W014225 | 3-Phenoxybenzoic acid | 3739-38-6 | Natural Products |
| HY-W014225R | 3-Phenoxybenzoic acid (Standard) | 3739-38-6 | Reference Standards |
| HY-W014225S | 3-Phenoxybenzoic acid-13C6 | 1793055-05-6 | Isotope-Labeled Compounds |
| HY-W014226 | 4,4'-Dihydroxybenzophenone | 611-99-4 | Biochemical Assay Reagents |
| HY-W014230 | 1,4-Bis(trifluoromethyl)benzene | 433-19-2 | Reference compound |
| HY-W014233 | L-Histidinol (dihydrochloride) | 1596-64-1 | Natural Products |
| HY-W014238 | S-tert-Butyl-L-cysteine hydrochloride | 2481-09-6 | Peptides |
| HY-W014240 | Chlorpropham | 101-21-3 | Reference compound |
| HY-W014240R | Chlorpropham (Standard) | 101-21-3 | Reference Standards |
| HY-W014240S1 | Chlorpropham-d7 | 2140327-49-5 | Isotope-Labeled Compounds |
| HY-W014258 | (R)-2-((tert-Butoxycarbonyl)amino)pent-4-ynoic acid | 63039-46-3 | Peptides |
| HY-W014259 | (S)-2-((tert-Butoxycarbonyl)amino)pent-4-ynoic acid | 63039-48-5 | Peptides |
| HY-W014282 | 4-Cumylphenol | 599-64-4 | Reference compound |
| HY-W014286 | 1,3-Diphenylurea | 102-07-8 | Biochemical Assay Reagents |
| HY-W014286R | 1,3-Diphenylurea (Standard) | 102-07-8 | Reference Standards |
| HY-W014286S | 1,3-Diphenylurea-d10 | 108009-46-7 | Isotope-Labeled Compounds |
| HY-W014290 | 4,4′-Diaminobenzophenone | 611-98-3 | Reference compound |
| HY-W014292S | 3-Benzyloxybenzaldehyde-α-d1 | 1219805-34-1 | Isotope-Labeled Compounds |
| HY-W014295 | 2-Benzylbenzoic acid | 612-35-1 | Reference compound |
| HY-W014303 | (S)-2-(2-Aminoacetamido)-3-(1H-imidazol-4-yl)propanoic acid | 2489-13-6 | Peptides |
| HY-W014304 | (S)-2-(2-Amino-3-(1H-imidazol-4-yl)propanamido)acetic acid | 2578-58-7 | Peptides |
| HY-W014306 | 2',3'-Dideoxyuridine | 5983-09-5 | Reference compound |
| HY-W014316 | 5-Bromo-5-nitro-1,3-dioxane | 30007-47-7 | Reference compound |
| HY-W014316R | 5-Bromo-5-nitro-1,3-dioxane (Standard) | 30007-47-7 | Reference Standards |
| HY-W014325 | TRPM8 agonist WS-3 | 39711-79-0 | Reference compound |
| HY-W014325R | TRPM8 agonist WS-3 (Standard) | 39711-79-0 | Reference Standards |
| HY-W014329 | H-Cys(Bzl)-OH | 3054-01-1 | Peptides |
| HY-W014332 | 1,3-Diphenylguanidine | 102-06-7 | Reference compound |
| HY-W014332R | 1,3-Diphenylguanidine (Standard) | 102-06-7 | Reference Standards |
| HY-W014334 | Carbazole-9-ethanol | 1484-14-6 | Biochemical Assay Reagents |
| HY-W014338 | Phenyl(9H-purin-6-yl)amine | 1210-66-8 | Biochemical Assay Reagents |
| HY-W014340S | 2-Nitro-9H-fluorene-d9 | 128008-87-7 | Isotope-Labeled Compounds |
| HY-W014355 | Sodium 2-bromoethanesulfonate | 4263-52-9 | Biochemical Assay Reagents |
| HY-W014373 | L-Lysine ethyl ester dihydrochloride | 3844-53-9 | Peptides |
| HY-W014375 | Arginine (hydrochloride) | 32042-43-6 | Peptides |
| HY-W014375S | Arginine-15N4,d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W014375S1 | Arginine-13C6,15N4,d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W014375S2 | Arginine-13C6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W014375S3 | Arginine-d7 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W014375S4 | Arginine-13C6,15N4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W014386 | 3-Amino-9-ethylcarbazole | 132-32-1 | Biochemical Assay Reagents |
| HY-W014389S | 9,9-Dimethyl-9H-xanthene-d2 | 161265-02-7 | Isotope-Labeled Compounds |
| HY-W014394 | Vanillyl butyl ether | 82654-98-6 | Natural Products |
| HY-W014394R | Vanillyl butyl ether (Standard) | 82654-98-6 | Reference Standards |
| HY-W014395 | Dithiodipropionic acid | 1119-62-6 | Reference compound |
| HY-W014405 | H-DL-Phe(4-NO2)-OH | 2922-40-9 | Peptides |
| HY-W014406 | (R)-2-Amino-3-(4-nitrophenyl)propanoic acid | 56613-61-7 | Peptides |
| HY-W014408 | Tetraethylammonium (bromide) | 71-91-0 | Biochemical Assay Reagents |
| HY-W014410 | Mucic acid | 526-99-8 | Natural Products |
| HY-W014410R | Mucic acid (Standard) | 526-99-8 | Reference Standards |
| HY-W014418 | H-D-Val-OtBu.HCl | 104944-18-5 | Peptides |
| HY-W014419 | Butyrylcholine (chloride) | 2963-78-2 | Biochemical Assay Reagents |
| HY-W014421 | AP-18 | 55224-94-7 | Reference compound |
| HY-W014423 | L-Histidine (hydrochloride hydrate) | 5934-29-2 | Natural Products |
| HY-W014423R | L-Histidine (hydrochloride hydrate) (Standard) | 5934-29-2 | Reference Standards |
| HY-W014423S | L-Histidine-13C (hydrochloride hydrate) | 2483735-43-7 | Isotope-Labeled Compounds |
| HY-W014423S1 | L-Histidine-13C6,15N3,d5 (hydrochloride hydrate) | 2483829-32-7 | Isotope-Labeled Compounds |
| HY-W014423S2 | L-Histidine-13C6 (hydrochloride hydrate) | 201740-88-7 | Isotope-Labeled Compounds |
| HY-W014423S3 | L-Histidine-13C6,15N3 (hydrochloride hydrate) | 202468-43-7 | Isotope-Labeled Compounds |
| HY-W014423S4 | L-Histidine-d5 (hydrochloride hydrate) | 2483831-75-8 | Isotope-Labeled Compounds |
| HY-W014423S5 | L-Histidine-15N3 (hydrochloride hydrate) | Isotope-Labeled Compounds | |
| HY-W014423S6 | L-Histidine-15N (hydrochloride hydrate) | Isotope-Labeled Compounds | |
| HY-W014423S7 | L-Histidine-d3 (hydrochloride hydrate) | Isotope-Labeled Compounds | |
| HY-W014423S8 | L-Histidine-15N3,d5 (hydrochloride hydrate) | Isotope-Labeled Compounds | |
| HY-W014431S | 1-Bromo-3-chloro-5-fluorobenzene-d3 | 1219805-00-1 | Isotope-Labeled Compounds |
| HY-W014437 | 1,1,2-Trimethyl-1H-benz[e]indole | 41532-84-7 | Biochemical Assay Reagents |
| HY-W014449 | 4-Nitrophenyl butyrate | 2635-84-9 | Biochemical Assay Reagents |
| HY-W014502 | D-Kynurenine | 13441-51-5 | Natural Products |
| HY-W014502R | D-Kynurenine (Standard) | 13441-51-5 | Reference Standards |
| HY-W014504 | 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid | 343-65-7 | Natural Products |
| HY-W014504R | 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid (Standard) | 343-65-7 | Reference Standards |
| HY-W014504S1 | 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid-d7 | Isotope-Labeled Compounds | |
| HY-W014505 | N-(4-Aminobenzoyl)-beta-alanine | 7377-08-4 | Peptides |
| HY-W014507 | 9,10-Phenanthrenequinone | 84-11-7 | Reference compound |
| HY-W014514 | Sodium 1-Naphthaleneacetate | 61-31-4 | Biochemical Assay Reagents |
| HY-W014522 | Dichlormid | 37764-25-3 | Reference compound |
| HY-W014522R | Dichlormid (Standard) | 37764-25-3 | Reference Standards |
| HY-W014536 | N,N,N-Trimethyloctan-1-aminium (chloride) | 10108-86-8 | Biochemical Assay Reagents |
| HY-W014539 | [2-(Methacryloyloxy)ethyl]trimethylammonium chloride | 5039-78-1 | Biochemical Assay Reagents |
| HY-W014540 | L-Proline tert-butyl ester (hydrochloride) | 5497-76-7 | Biochemical Assay Reagents |
| HY-W014553 | N-Acetyl-D-phenylalanine | 10172-89-1 | Peptides |
| HY-W014559S | 1-Bromononane-d19 | 1219805-90-9 | Isotope-Labeled Compounds |
| HY-W014559S1 | 1-Bromononane-d3 | 1219799-20-8 | Isotope-Labeled Compounds |
| HY-W014559S2 | 1-Bromononane-d4 | 1219805-44-3 | Isotope-Labeled Compounds |
| HY-W014559S3 | 1-Bromononane-d4-1 | 284474-44-8 | Isotope-Labeled Compounds |
| HY-W014566 | 4-Nitro-3-(trifluoromethyl)phenol | 88-30-2 | Reference compound |
| HY-W014566R | 4-Nitro-3-(trifluoromethyl)phenol (Standard) | 88-30-2 | Reference Standards |
| HY-W014584 | 5-Bromo-2-chloro-4-methylpyridine | 778611-64-6 | Biochemical Assay Reagents |
| HY-W014589 | 2,4-Di-tert-butylphenol | 96-76-4 | Natural Products |
| HY-W014589R | 2,4-Di-tert-butylphenol (Standard) | 96-76-4 | Reference Standards |
| HY-W014590 | (S)-Thioctic acid | 1077-27-6 | Biochemical Assay Reagents |
| HY-W014599 | L-Methionylglycine | 14486-03-4 | Peptides |
| HY-W014605 | Diphenylcyclopropenone | 886-38-4 | Reference compound |
| HY-W014605R | Diphenylcyclopropenone (Standard) | 886-38-4 | Reference Standards |
| HY-W014606 | L-Lysine (acetate) | 57282-49-2 | Reference compound |
| HY-W014606R | L-Lysine (acetate) (Standard) | 57282-49-2 | Reference Standards |
| HY-W014608S | Ethyl 2-oxo-4-phenylbutanoate-d5 | 1189911-53-2 | Isotope-Labeled Compounds |
| HY-W014609 | 4-Propoxycinnamic acid | 69033-81-4 | Biochemical Assay Reagents |
| HY-W014612 | Eugenol acetate | 93-28-7 | Natural Products |
| HY-W014612R | Eugenol acetate (Standard) | 93-28-7 | Reference Standards |
| HY-W014612S | Eugenol acetate-d3 | Isotope-Labeled Compounds | |
| HY-W014622 | CRT0044876 | 6960-45-8 | Reference compound |
| HY-W014626 | 4-Nitro-3-(trifluoromethyl)aniline | 393-11-3 | Biochemical Assay Reagents |
| HY-W014626R | 4-Nitro-3-(trifluoromethyl)aniline (Standard) | 393-11-3 | Reference Standards |
| HY-W014632 | 4-Trifluoromethylsalicylic acid | 328-90-5 | Reference compound |
| HY-W014632R | 4-Trifluoromethylsalicylic acid (Standard) | 328-90-5 | Reference Standards |
| HY-W014632S | 4-Trifluoromethylsalicylic acid-13C6 | 1246817-12-8 | Isotope-Labeled Compounds |
| HY-W014633S | 4-(Trifluoromethoxy)benzoic acid-d4 | 2741881-05-8 | Isotope-Labeled Compounds |
| HY-W014633S1 | 4-(Trifluoromethoxy)benzoic acid-13C | Isotope-Labeled Compounds | |
| HY-W014663 | (S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid | 3262-72-4 | Peptides |
| HY-W014663S | (S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid-d3 | Isotope-Labeled Compounds | |
| HY-W014665 | N-Phthaloylglycine | 4702-13-0 | Reference compound |
| HY-W014666 | Xanthurenic acid | 59-00-7 | Natural Products |
| HY-W014666R | Xanthurenic acid (Standard) | 59-00-7 | Reference Standards |
| HY-W014666S | Xanthurenic acid-d4 | 1329611-28-0 | Isotope-Labeled Compounds |
| HY-W014674 | 2,6-Dichlorophenylacetic acid | 6575-24-2 | Reference compound |
| HY-W014674S | (2,6-Dichlorophenyl)acetic-2,2-d2 | 1219803-63-0 | Isotope-Labeled Compounds |
| HY-W014684 | Lilial | 80-54-6 | Reference compound |
| HY-W014684R | Lilial (Standard) | 80-54-6 | Reference Standards |
| HY-W014692 | Boc-D-2,3-diaminopropionic acid | 76387-70-7 | Peptides |
| HY-W014700 | Glycyl-L-glutamic acid | 7412-78-4 | Peptides |
| HY-W014701 | 1,4-Dihydroxy-2-naphthoic acid | 31519-22-9 | Natural Products |
| HY-W014701R | 1,4-Dihydroxy-2-naphthoic acid (Standard) | 31519-22-9 | Reference Standards |
| HY-W014726 | DL-Phenylephrine (hydrochloride) | 154-86-9 | Reference compound |
| HY-W014728 | N-Methyldopamine (hydrochloride) | 62-32-8 | Reference compound |
| HY-W014742 | (S)-2-Amino-5-(tert-butoxy)-5-oxopentanoic acid | 2419-56-9 | Peptides |
| HY-W014750 | 3-Acetamidocoumarin | 779-30-6 | Reference compound |
| HY-W014779 | Dodecane-1,12-diol | 5675-51-4 | Biochemical Assay Reagents |
| HY-W014779S | Dodecane-1,12-diol-d24 | 1219802-88-6 | Isotope-Labeled Compounds |
| HY-W014780 | α-Amylcinnamaldehyde | 122-40-7 | Reference compound |
| HY-W014780S | 2-Benzylideneheptanal-d5 | 2734302-95-3 | Isotope-Labeled Compounds |
| HY-W014786 | 2-(2-Aminopropanamido)-4-methylpentanoic acid | 1999-42-4 | Peptides |
| HY-W014787 | Decanedioic acid | 111-20-6 | Natural Products |
| HY-W014787R | Decanedioic acid (Standard) | 111-20-6 | Reference Standards |
| HY-W014787S | Decanedioic acid-d4 | 339080-77-2 | Isotope-Labeled Compounds |
| HY-W014787S1 | Decanedioic acid-d16 | 73351-71-0 | Isotope-Labeled Compounds |
| HY-W014789 | Diethyl propylmalonate | 2163-48-6 | Reference compound |
| HY-W014792 | Sodium heptane-1-sulfonate | 22767-50-6 | Biochemical Assay Reagents |
| HY-W014793 | Metamitron | 41394-05-2 | Reference compound |
| HY-W014793R | Metamitron (Standard) | 41394-05-2 | Reference Standards |
| HY-W014796 | 2-Naphthoxyacetic acid | 120-23-0 | Reference compound |
| HY-W014799 | Diethyl 3-oxopentanedioate | 105-50-0 | Biochemical Assay Reagents |
| HY-W014815 | BPBA | 223463-14-7 | Reference compound |
| HY-W014824 | H-D-Phg-OMe.HCl | 19883-41-1 | Peptides |
| HY-W014831 | 11-Aminoundecanoic acid | 2432-99-7 | Reference compound |
| HY-W014837 | NDSB-201 | 15471-17-7 | Biochemical Assay Reagents |
| HY-W014839 | Cyclamic acid (sodium) | 139-05-9 | Reference compound |
| HY-W014839R | Cyclamic acid (sodium) (Standard) | 139-05-9 | Reference Standards |
| HY-W014839S | Cyclamic acid-d11 (sodium) | Isotope-Labeled Compounds | |
| HY-W014839S1 | Cyclamic acid-d4 (sodium) | 1627119-76-9 | Isotope-Labeled Compounds |
| HY-W014841 | Sodium hippurate, 98% | 532-94-5 | Biochemical Assay Reagents |
| HY-W014861 | Tetramethylammonium (iodide) | 75-58-1 | Biochemical Assay Reagents |
| HY-W014866 | Potassium (bromomethyl)trifluoroborate | 888711-44-2 | Biochemical Assay Reagents |
| HY-W014873S | Methyl 5-chloro-2-methoxybenzoate-d3 | 1219803-33-4 | Isotope-Labeled Compounds |
| HY-W014883 | 1,12-Dodecanediamine | 2783-17-7 | Reference compound |
| HY-W014884 | Ethyl decanoate | 110-38-3 | Biochemical Assay Reagents |
| HY-W014885 | Decyl acetate | 112-17-4 | Natural Products |
| HY-W014887 | 2-Butyloctanoic acid | 27610-92-0 | Natural Products |
| HY-W014888S | Benzy(phenyl)sulfane-d2 | 2845106-76-3 | Isotope-Labeled Compounds |
| HY-W014895 | Ethyl 4-methylbenzenesulfonate | 80-40-0 | Biochemical Assay Reagents |
| HY-W014895S | Ethyl tosylate-d5 | 59034-23-0 | Isotope-Labeled Compounds |
| HY-W014896S | 4,4'-Oxydianiline-d12 | 106426-62-4 | Isotope-Labeled Compounds |
| HY-W014901 | 4,4'-Dihydroxydiphenylmethane | 620-92-8 | Natural Products |
| HY-W014901R | 4,4'-Dihydroxydiphenylmethane (Standard) | 620-92-8 | Reference Standards |
| HY-W014901S | 4,4'-Dihydroxydiphenylmethane-13C6 | 1410794-06-7 | Isotope-Labeled Compounds |
| HY-W014901S1 | 4,4'-Dihydroxydiphenylmethane-13C12 | 1410794-08-9 | Isotope-Labeled Compounds |
| HY-W014904 | 1,1-Cyclohexanediaceticacid | 4355-11-7 | Biochemical Assay Reagents |
| HY-W014913 | (S)-3-Amino-1-chloro-5-methylhexan-2-one hydrochloride | 54518-92-2 | Peptides |
| HY-W014915 | 3-Acetyl-5-bromopyridine | 38940-62-4 | Biochemical Assay Reagents |
| HY-W014916 | L-Methionine methyl ester hydrochloride | 2491-18-1 | Peptides |
| HY-W014917 | H-D-Met-OMe.HCl | 69630-60-0 | Peptides |
| HY-W014919 | H-Phe(2-Cl)-OH | 103616-89-3 | Peptides |
| HY-W014928 | Anabasine (hydrochloride) | 53912-89-3 | Reference compound |
| HY-W014930 | DL-5-Hydroxylysine (hydrochloride) | 13204-98-3 | Natural Products |
| HY-W014930R | DL-5-Hydroxylysine (hydrochloride) (Standard) | 13204-98-3 | Reference Standards |
| HY-W014933 | cis-3-Hexenyl Hexanoate | 31501-11-8 | Natural Products |
| HY-W014937 | 4-Hydroxybenzophenone | 1137-42-4 | Reference compound |
| HY-W014937S | 4-Hydroxybenzophenone-d4 | 93496-64-1 | Isotope-Labeled Compounds |
| HY-W014937S1 | 4-Hydroxybenzophenone-d5 | 76478-47-2 | Isotope-Labeled Compounds |
| HY-W014940 | Ethylene glycol dimethacrylate | 97-90-5 | Reference compound |
| HY-W014941 | (R)-(-)-α-Methylhistamine (dihydrochloride) | 75614-89-0 | Reference compound |
| HY-W014967 | 5-Bromoanthranilonitrile | 39263-32-6 | Reference compound |
| HY-W014971 | Tryptamine (hydrochloride) | 343-94-2 | Biochemical Assay Reagents |
| HY-W014983 | Neryl acetate | 141-12-8 | Natural Products |
| HY-W014983R | Neryl acetate (Standard) | 141-12-8 | Reference Standards |
| HY-W014989 | Thioglucose | 20408-97-3 | Biochemical Assay Reagents |
| HY-W014993 | 1,3-Dimethyluric acid | 944-73-0 | Natural Products |
| HY-W014993R | 1,3-Dimethyluric acid (Standard) | 944-73-0 | Reference Standards |
| HY-W014993S | 1,3-Dimethyluric acid-13C4,15N3 | 1173019-16-3 | Isotope-Labeled Compounds |
| HY-W014993S1 | 1,3-Dimethyluric acid-d3 | Isotope-Labeled Compounds | |
| HY-W015003 | 9-Ethylcarbazole | 86-28-2 | Reference compound |
| HY-W015007 | Metyrosine | 672-87-7 | Reference compound |
| HY-W015007R | Metyrosine (Standard) | 672-87-7 | Reference Standards |
| HY-W015007S | Metyrosine-13C9,15N,d7 | 1994331-23-5 | Isotope-Labeled Compounds |
| HY-W015026 | Isobutylparaben | 4247-02-3 | Reference compound |
| HY-W015026R | Isobutylparaben (Standard) | 4247-02-3 | Reference Standards |
| HY-W015026S | Isobutylparaben-d4 | 1219805-33-0 | Isotope-Labeled Compounds |
| HY-W015028 | Dimethyl isophthalate | 1459-93-4 | Biochemical Assay Reagents |
| HY-W015028R | Dimethyl isophthalate (Standard) | 1459-93-4 | Reference Standards |
| HY-W015028S | Dimethyl Isophthalate-2,4,5,6-d4 | 1007509-57-0 | Isotope-Labeled Compounds |
| HY-W015042 | 3-Ethoxycarbonylphenylboronic acid | 4334-87-6 | Biochemical Assay Reagents |
| HY-W015052 | Diphenylacetonitrile | 86-29-3 | Biochemical Assay Reagents |
| HY-W015060 | 2-(2-Methylbenzamido)acetic acid | 42013-20-7 | Natural Products |
| HY-W015060S | 2-(2-Methylbenzamido)acetic acid-d7 | 1216430-90-8 | Isotope-Labeled Compounds |
| HY-W015060S1 | 2-(2-Methylbenzamido)acetic acid-d2 | 1185100-98-4 | Isotope-Labeled Compounds |
| HY-W015061 | Phenylacetylglycine | 500-98-1 | Natural Products |
| HY-W015061R | Phenylacetylglycine (Standard) | 500-98-1 | Reference Standards |
| HY-W015061S | N-(Phenylacetyl-d5)glycine | 1189920-31-7 | Isotope-Labeled Compounds |
| HY-W015069 | 4-Nitrocinnamic acid | 619-89-6 | Natural Products |
| HY-W015079S | 1-Bromo-3,4-difluorobenzene-d3 | 1219799-14-0 | Isotope-Labeled Compounds |
| HY-W015082 | 3-Chloro-2,4-difluorobenzoic acid | 154257-75-7 | Biochemical Assay Reagents |
| HY-W015084 | β-Ionone | 14901-07-6 | Natural Products |
| HY-W015084A | (E)-β-Ionone | 79-77-6 | Natural Products |
| HY-W015084AR | (E)-β-Ionone (Standard) | 79-77-6 | Reference Standards |
| HY-W015084AS | (E)-β-Ionone-d3 | 53163-45-4 | Isotope-Labeled Compounds |
| HY-W015084R | β-Ionone (Standard) | 14901-07-6 | Reference Standards |
| HY-W015084S | β-Ionone-13C3 | Isotope-Labeled Compounds | |
| HY-W015088 | Amino-PEG3-C2-Amine | 929-75-9 | Reference compound |
| HY-W015114 | L-2-Hydroxyglutaric acid (disodium) | 63512-50-5 | Reference compound |
| HY-W015114R | L-2-Hydroxyglutaric acid (disodium) (Standard) | 63512-50-5 | Reference Standards |
| HY-W015121S | 2-Chlorobenzenesulfonamide-d4 | Isotope-Labeled Compounds | |
| HY-W015131 | 3-(4-(Dimethylamino)phenyl)acrylic acid | 1552-96-1 | Natural Products |
| HY-W015139S | 3,4-Dichlorobenzoic acid-d3 | 350818-53-0 | Isotope-Labeled Compounds |
| HY-W015158 | 1-Benzyl-3-methylpiperazine | 3138-90-7 | Reference compound |
| HY-W015160 | 1-(3-Methylbenzyl)piperazine | 5321-48-2 | Reference compound |
| HY-W015169 | 5-Methoxytryptamine | 608-07-1 | Reference compound |
| HY-W015169A | 5-Methoxytryptamine (hydrochloride) | 66-83-1 | Reference compound |
| HY-W015169S | 5-Methoxytryptamine-d4 | 96236-05-4 | Isotope-Labeled Compounds |
| HY-W015175 | p-Toluenesulfonic acid (monohydrate) | 6192-52-5 | Reference compound |
| HY-W015175R | p-Toluenesulfonic acid (monohydrate) (Standard) | 6192-52-5 | Reference Standards |
| HY-W015175S | p-Toluenesulfonic acid-d7 (monohydrate) | 1219795-22-8 | Isotope-Labeled Compounds |
| HY-W015177 | H-Phe(3-CN)-OH | 57213-48-6 | Peptides |
| HY-W015179 | 1,2-O-Isopropylidene-alpha-D-xylofuranose | 20031-21-4 | Biochemical Assay Reagents |
| HY-W015198 | 4-(Trifluoromethyl)benzoic acid | 455-24-3 | Biochemical Assay Reagents |
| HY-W015198S | 4-(Trifluoromethyl)benzoic acid-13C6 | 2731552-41-1 | Isotope-Labeled Compounds |
| HY-W015205 | 4-Amino-5-bromopyrimidin-2(1H)-one | 2240-25-7 | Biochemical Assay Reagents |
| HY-W015210 | 4-Deoxypyridoxine (hydrochloride) | 148-51-6 | Biochemical Assay Reagents |
| HY-W015210R | 4-Deoxypyridoxine (hydrochloride) (Standard) | 148-51-6 | Reference Standards |
| HY-W015211 | Vanillylamine (hydrochloride) | 7149-10-2 | Biochemical Assay Reagents |
| HY-W015213 | Adenine monohydrochloride hemihydrate | 6055-72-7 | Natural Products |
| HY-W015213S | Adenine monohydrochloride hemihydrate-15N5 | Isotope-Labeled Compounds | |
| HY-W015224 | Methyl 2-(1H-indol-3-yl)acetate | 1912-33-0 | Natural Products |
| HY-W015224R | Methyl 2-(1H-indol-3-yl)acetate (Standard) | 1912-33-0 | Reference Standards |
| HY-W015224S | Methyl 2-(1H-indol-3-yl)acetate-d5 | 102415-39-4 | Isotope-Labeled Compounds |
| HY-W015229 | 3-Indolepropionic acid | 830-96-6 | Natural Products |
| HY-W015229R | 3-Indolepropionic acid (Standard) | 830-96-6 | Reference Standards |
| HY-W015229S | 3-Indolepropionic acid-d2 | 2469257-98-3 | Isotope-Labeled Compounds |
| HY-W015230 | Boc-Sar-OH | 13734-36-6 | Peptides |
| HY-W015231 | Boc-β-Ala-OH | 3303-84-2 | Peptides |
| HY-W015233 | H-D-Asp(OtBu)-OH | 64960-75-4 | Peptides |
| HY-W015236 | H-Gly-Gly-Gly-OH | 556-33-2 | Biochemical Assay Reagents |
| HY-W015236R | H-Gly-Gly-Gly-OH (Standard) | 556-33-2 | Reference Standards |
| HY-W015239 | KAT8-IN-1 | 605-62-9 | Reference compound |
| HY-W015240 | N-Acetyl-L-glutamic acid | 1188-37-0 | Natural Products |
| HY-W015240R | N-Acetyl-L-glutamic acid (Standard) | 1188-37-0 | Reference Standards |
| HY-W015240S | N-Acetyl-L-glutamic acid-d5 | Isotope-Labeled Compounds | |
| HY-W015240S1 | N-Acetyl-L-glutamic acid-d4 | Isotope-Labeled Compounds | |
| HY-W015241 | Ac-D-Glu-OH | 19146-55-5 | Peptides |
| HY-W015241S | Ac-D-Glu-OH-d5 | 14341-87-8 | Isotope-Labeled Compounds |
| HY-W015267S | 2-Chlorobiphenyl-2′,3′,4′,5′,6′-d5 | 51624-35-2 | Isotope-Labeled Compounds |
| HY-W015273 | 3-Indoleacrylic acid | 1204-06-4 | Reference compound |
| HY-W015273A | trans-3-Indoleacrylic acid | 29953-71-7 | Natural Products |
| HY-W015273AR | trans-3-Indoleacrylic acid (Standard) | 29953-71-7 | Reference Standards |
| HY-W015273S | 3-Indoleacrylic acid-d4 | Isotope-Labeled Compounds | |
| HY-W015279 | H-D-Phe(4-F)-OH | 18125-46-7 | Peptides |
| HY-W015300 | Suberic acid | 505-48-6 | Natural Products |
| HY-W015300R | Suberic acid (Standard) | 505-48-6 | Reference Standards |
| HY-W015300S | Suberic acid-d4 | 19031-57-3 | Isotope-Labeled Compounds |
| HY-W015300S1 | Suberic acid-d12 | 169397-99-3 | Isotope-Labeled Compounds |
| HY-W015301 | Dimethyl adipate | 627-93-0 | Natural Products |
| HY-W015301R | Dimethyl adipate (Standard) | 627-93-0 | Reference Standards |
| HY-W015301S | Dimethyl adipate-d4 | 76785-05-2 | Isotope-Labeled Compounds |
| HY-W015301S1 | Dimethyl adipate-d4-1 | 55724-08-8 | Isotope-Labeled Compounds |
| HY-W015301S2 | Dimethyl adipate-d8 | 52089-64-2 | Isotope-Labeled Compounds |
| HY-W015302 | 2-Aminobenzenesulfonic acid | 88-21-1 | Natural Products |
| HY-W015304S | 2-Ethylhexyl acetate-d17 | 1219802-70-6 | Isotope-Labeled Compounds |
| HY-W015305 | Ethyl octanoate | 106-32-1 | Biochemical Assay Reagents |
| HY-W015305S | Ethyl octanoate-d15 | 1219798-38-5 | Isotope-Labeled Compounds |
| HY-W015307 | 4-Ethyloctanoic acid | 16493-80-4 | Natural Products |
| HY-W015307S | 4-Ethyloctanoic acid-13C2 | Isotope-Labeled Compounds | |
| HY-W015308 | Methyl nonanoate | 1731-84-6 | Biochemical Assay Reagents |
| HY-W015308R | Methyl nonanoate (Standard) | 1731-84-6 | Reference Standards |
| HY-W015309 | Decanoic acid | 334-48-5 | Natural Products |
| HY-W015309R | Decanoic acid (Standard) | 334-48-5 | Reference Standards |
| HY-W015309S | Decanoic acid-d3 | 102611-15-4 | Isotope-Labeled Compounds |
| HY-W015309S1 | Decanoic acid-d19 | 88170-22-3 | Isotope-Labeled Compounds |
| HY-W015309S2 | Decanoic acid-d2 | 62716-49-8 | Isotope-Labeled Compounds |
| HY-W015309S3 | Decanoic acid-d5 | 1219803-00-5 | Isotope-Labeled Compounds |
| HY-W015318 | 1-(3-Chlorophenyl)propan-1-one | 34841-35-5 | Biochemical Assay Reagents |
| HY-W015326 | 3-Hydroxymandelic Acid | 17119-15-2 | Natural Products |
| HY-W015332 | Captopril EP Impurity D | 56970-78-6 | Reference compound |
| HY-W015332R | Captopril EP Impurity D (Standard) | 56970-78-6 | Reference Standards |
| HY-W015333 | 2-Bromobutanoic acid | 80-58-0 | Biochemical Assay Reagents |
| HY-W015333R | 2-Bromobutanoic acid (Standard) | 80-58-0 | Reference Standards |
| HY-W015333S | 2-Bromobutanoic acid-d6 | 1219799-08-2 | Isotope-Labeled Compounds |
| HY-W015339 | Octanoate, 99% (sodium) | 1984-06-1 | Biochemical Assay Reagents |
| HY-W015339S | Octanoate-13C (sodium) | 201612-61-5 | Isotope-Labeled Compounds |
| HY-W015339S1 | Octanoate-d3 (sodium) | 1219795-01-3 | Isotope-Labeled Compounds |
| HY-W015339S2 | Octanoate-d15 (sodium) | 56408-90-3 | Isotope-Labeled Compounds |
| HY-W015340 | H-D-2-Pal-OH | 37535-52-7 | Peptides |
| HY-W015342 | Methyl anisate | 121-98-2 | Natural Products |
| HY-W015342R | Methyl anisate (Standard) | 121-98-2 | Reference Standards |
| HY-W015343 | 3-Methoxyphenylacetic acid | 1798-09-0 | Natural Products |
| HY-W015343R | 3-Methoxyphenylacetic acid (Standard) | 1798-09-0 | Reference Standards |
| HY-W015346 | Desaminotyrosine | 501-97-3 | Natural Products |
| HY-W015346R | Desaminotyrosine (Standard) | 501-97-3 | Reference Standards |
| HY-W015349 | 4-Fluorophthalic anhydride | 319-03-9 | Biochemical Assay Reagents |
| HY-W015359 | 2-(Benzylamino)acetic acid | 17136-36-6 | Peptides |
| HY-W015366 | (S)-3-Amino-2-oxo-azepane (hydrochloride) | 26081-07-2 | Biochemical Assay Reagents |
| HY-W015370 | L-Lysine hydrate | 39665-12-8 | Reference compound |
| HY-W015370R | L-Lysine hydrate (Standard) | 39665-12-8 | Reference Standards |
| HY-W015380 | 4-Propylphenylboronic acid | 134150-01-9 | Biochemical Assay Reagents |
| HY-W015388 | 3,6-Dichloro-4-methylpyridazine | 19064-64-3 | Biochemical Assay Reagents |
| HY-W015399 | 4-Methylcinnamic acid | 1866-39-3 | Reference compound |
| HY-W015410 | Disodium succinate | 150-90-3 | Natural Products |
| HY-W015410R | Disodium succinate (Standard) | 150-90-3 | Reference Standards |
| HY-W015410S | Disodium succinate-13C2 | 83587-80-8 | Isotope-Labeled Compounds |
| HY-W015410S2 | Disodium succinate-d4 | 203633-14-1 | Isotope-Labeled Compounds |
| HY-W015420 | 1H-Indole-6-carboxylic acid | 1670-82-2 | Biochemical Assay Reagents |
| HY-W015422 | 1,5-Isoquinolinediol | 5154-02-9 | Reference compound |
| HY-W015424 | N-Methyl-DL-glutamic acid | 35989-16-3 | Peptides |
| HY-W015425 | H-Glu-OMe | 6384-08-3 | Peptides |
| HY-W015426S | (R)-2-Aminohexanedioic acid-d4 | Isotope-Labeled Compounds | |
| HY-W015427S | 1,2-Dichloro-3-methylbenzene-d3 | 1219798-57-8 | Isotope-Labeled Compounds |
| HY-W015444 | 2-Hydroxyoctanoic acid | 617-73-2 | Natural Products |
| HY-W015444R | 2-Hydroxyoctanoic acid (Standard) | 617-73-2 | Reference Standards |
| HY-W015445 | SD-169 | 1670-87-7 | Reference compound |
| HY-W015449 | 2-(2-Aminopropanamido)propanoic acid | 2867-20-1 | Peptides |
| HY-W015450 | D-Ala-D-Ala | 923-16-0 | Peptides |
| HY-W015450R | D-Ala-D-Ala (Standard) | 923-16-0 | Reference Standards |
| HY-W015451 | 2,7-Dihydroxynaphthalene | 582-17-2 | Biochemical Assay Reagents |
| HY-W015451R | 2,7-Dihydroxynaphthalene (Standard) | 582-17-2 | Reference Standards |
| HY-W015457 | β-Chloro-D-alanine hydrochloride | 51887-88-8 | Peptides |
| HY-W015461 | 2-Aminooctanoic acid | 644-90-6 | Reference compound |
| HY-W015462 | LANA-IN-1 | 2221-00-3 | Reference compound |
| HY-W015464 | N-Isovaleroylglycine | 16284-60-9 | Natural Products |
| HY-W015464R | N-Isovaleroylglycine (Standard) | 16284-60-9 | Reference Standards |
| HY-W015464S | N-Isovalerylglycine-d9 | 1330037-21-2 | Isotope-Labeled Compounds |
| HY-W015464S1 | N-Isovaleroylglycine-d2 | 1219795-09-1 | Isotope-Labeled Compounds |
| HY-W015465 | N-Acetyl-D-valine | 17916-88-0 | Peptides |
| HY-W015466 | Acetylvaline | 96-81-1 | Natural Products |
| HY-W015466S | Acetylvaline-15N | 355808-21-8 | Isotope-Labeled Compounds |
| HY-W015466S1 | Acetylvaline-13C2 | Isotope-Labeled Compounds | |
| HY-W015467 | Pyridine-3-sulfonic acid | 636-73-7 | Biochemical Assay Reagents |
| HY-W015472 | 3,4-Difluoronitrobenzene | 369-34-6 | Biochemical Assay Reagents |
| HY-W015477 | 2-Chloro-6-fluorobenzaldehyde | 387-45-1 | Biochemical Assay Reagents |
| HY-W015482 | Isoamyl butyrate | 106-27-4 | Natural Products |
| HY-W015487 | Ethyl butyrylacetate | 3249-68-1 | Biochemical Assay Reagents |
| HY-W015490 | 1,4-Naphthoquinone | 130-15-4 | Reference compound |
| HY-W015490S | 1,4-Naphthoquinone-d6 | 26473-08-5 | Isotope-Labeled Compounds |
| HY-W015495 | L-Dihydroorotic acid | 5988-19-2 | Natural Products |
| HY-W015495R | L-Dihydroorotic acid (Standard) | 5988-19-2 | Reference Standards |
| HY-W015496S | 3,5-Difluorobenzoic acid-d3 | 934397-71-4 | Isotope-Labeled Compounds |
| HY-W015514 | N-(3-Aminopropyl)cyclohexylamine | 3312-60-5 | Reference compound |
| HY-W015515 | L-Citronellol | 7540-51-4 | Natural Products |
| HY-W015533 | H-D-Ser-OMe.HCl | 5874-57-7 | Peptides |
| HY-W015533R | H-D-Ser-OMe.HCl (Standard) | 5874-57-7 | Reference Standards |
| HY-W015546 | β-N-methylamino-L-alanine (hydrochloride) | 16012-55-8 | Natural Products |
| HY-W015546R | β-N-methylamino-L-alanine (hydrochloride) (Standard) | 16012-55-8 | Reference Standards |
| HY-W015548S | 1-(4-Chlorophenyl)ethanone-d4 | 284474-50-6 | Isotope-Labeled Compounds |
| HY-W015548S1 | 1-(4-Chlorophenyl)ethanone-d7 | 1174565-85-5 | Isotope-Labeled Compounds |
| HY-W015551 | trans-2-Decenal | 3913-81-3 | Biochemical Assay Reagents |
| HY-W015551R | trans-2-Decenal (Standard) | 3913-81-3 | Reference Standards |
| HY-W015551S | trans-2-Decenal-d2 | 1335436-39-9 | Isotope-Labeled Compounds |
| HY-W015553 | 2-Vinylnaphthalene | 827-54-3 | Biochemical Assay Reagents |
| HY-W015560 | 3,5-Dihydroxybenzoic acid | 99-10-5 | Natural Products |
| HY-W015560R | 3,5-Dihydroxybenzoic acid (Standard) | 99-10-5 | Reference Standards |
| HY-W015569 | 2-Nitrobenzyl alcohol | 612-25-9 | Biochemical Assay Reagents |
| HY-W015570 | 4-Nitrobenzyl alcohol (4-Nitrobenzenemathanol) | 619-73-8 | Biochemical Assay Reagents |
| HY-W015575 | 2-Chlorobenzimidazole | 4857-06-1 | Biochemical Assay Reagents |
| HY-W015579 | (-)-Camphor | 464-48-2 | Natural Products |
| HY-W015580 | (+)-Fenchone | 4695-62-9 | Natural Products |
| HY-W015580R | (+)-Fenchone (Standard) | 4695-62-9 | Reference Standards |
| HY-W015590 | 2-Hydroxyphenylacetic acid | 614-75-5 | Natural Products |
| HY-W015590R | 2-Hydroxyphenylacetic acid (Standard) | 614-75-5 | Reference Standards |
| HY-W015591 | Mandelic acid | 90-64-2 | Natural Products |
| HY-W015591R | Mandelic acid (Standard) | 90-64-2 | Reference Standards |
| HY-W015591S | Mandelic acid-2,3,4,5,6-d5 | 70838-71-0 | Isotope-Labeled Compounds |
| HY-W015593 | Methylhexanamine (hydrochloride) | 13803-74-2 | Reference compound |
| HY-W015595 | L-Allylglycine (hydrochloride) | 195316-72-4 | Peptides |
| HY-W015597S | rel-3a,4,7,7a-Tetrahydro-1H-isoindole-1,3(2H)-dione-d6 | 203578-24-9 | Isotope-Labeled Compounds |
| HY-W015600 | 2-Acetamidophenol | 614-80-2 | Reference compound |
| HY-W015600R | 2-Acetamidophenol (Standard) | 614-80-2 | Reference Standards |
| HY-W015603S | Pentyl carbonochloridate-d11 | 1398065-67-2 | Isotope-Labeled Compounds |
| HY-W015604S | 2,3-Diethyl-5-methylpyrazine-13C2 | Isotope-Labeled Compounds | |
| HY-W015604S1 | 2,3-Diethyl-5-methylpyrazine-d7 | 1082581-83-6 | Isotope-Labeled Compounds |
| HY-W015608 | 2-Phenylpropionic acid | 492-37-5 | Natural Products |
| HY-W015608R | 2-Phenylpropionic acid (Standard) | 492-37-5 | Reference Standards |
| HY-W015609S | 1-(2-Methoxyphenyl)ethanone-d3 | 1332363-11-7 | Isotope-Labeled Compounds |
| HY-W015611 | L-(+)-Arabinose | 5328-37-0 | Natural Products |
| HY-W015611R | L-(+)-Arabinose (Standard) | 5328-37-0 | Reference Standards |
| HY-W015616 | Benzylacetone | 2550-26-7 | Natural Products |
| HY-W015618 | 2',4'-Dimethylacetophenone | 89-74-7 | Natural Products |
| HY-W015618R | 2',4'-Dimethylacetophenone (Standard) | 89-74-7 | Reference Standards |
| HY-W015624S | 2-Nitrobenzonitrile-d4 | 1219795-50-2 | Isotope-Labeled Compounds |
| HY-W015626 | 2,5-Dichloropyridine | 16110-09-1 | Biochemical Assay Reagents |
| HY-W015627 | 3,5-Dichloropyridine | 2457-47-8 | Biochemical Assay Reagents |
| HY-W015634S | 1-Ethyl-3-methylimidazolium chloride-d11 | 160203-52-1 | Isotope-Labeled Compounds |
| HY-W015635 | Diallyl disulfide | 2179-57-9 | Natural Products |
| HY-W015635R | Diallyl disulfide (Standard) | 2179-57-9 | Reference Standards |
| HY-W015641 | 2,2-Dimethylsuccinic acid | 597-43-3 | Natural Products |
| HY-W015641R | 2,2-Dimethylsuccinic acid (Standard) | 597-43-3 | Reference Standards |
| HY-W015650 | Indole-2-carbaldehyde | 19005-93-7 | Biochemical Assay Reagents |
| HY-W015651 | Ethyl acetylglycinate | 1906-82-7 | Peptides |
| HY-W015658 | 4-Chlororesorcinol | 95-88-5 | Biochemical Assay Reagents |
| HY-W015658R | 4-Chlororesorcinol (Standard) | 95-88-5 | Reference Standards |
| HY-W015664 | 2-Methylheptanoic acid | 1188-02-9 | Natural Products |
| HY-W015667 | Ethyl 2-methylpentanoate | 39255-32-8 | Biochemical Assay Reagents |
| HY-W015669 | Ethyl 3-methylpentanoate | 5870-68-8 | Biochemical Assay Reagents |
| HY-W015671 | 4-Phenylimidazole | 670-95-1 | Biochemical Assay Reagents |
| HY-W015675 | 4-Hydroxycyclohexanecarboxylic acid | 17419-81-7 | Natural Products |
| HY-W015675R | 4-Hydroxycyclohexanecarboxylic acid (Standard) | 17419-81-7 | Reference Standards |
| HY-W015695 | 4-Methyl-5-thiazoleethanol | 137-00-8 | Reference compound |
| HY-W015695R | 4-Methyl-5-thiazoleethanol (Standard) | 137-00-8 | Reference Standards |
| HY-W015710S | cis-3-Hexenyl Acetate-d2 | Isotope-Labeled Compounds | |
| HY-W015715 | 5-Methylresorcinol monohydrate | 6153-39-5 | Biochemical Assay Reagents |
| HY-W015740 | Dimedone | 126-81-8 | Biochemical Assay Reagents |
| HY-W015752 | 5-Methoxyresorcinol | 2174-64-3 | Reference compound |
| HY-W015753 | 3-Fluorobenzoic acid | 455-38-9 | Biochemical Assay Reagents |
| HY-W015761 | Ammonium benzoate | 1863-63-4 | Biochemical Assay Reagents |
| HY-W015764 | T-1105 | 55321-99-8 | Reference compound |
| HY-W015773 | 2-Amino-5-methylthiophene-3-carbonitrile | 138564-58-6 | Reference compound |
| HY-W015777 | 4-Methoxybenzyl alcohol | 105-13-5 | Biochemical Assay Reagents |
| HY-W015777R | 4-Methoxybenzyl alcohol (Standard) | 105-13-5 | Reference Standards |
| HY-W015777S | (4-Methoxyphenyl)methanol-d2 | 35693-15-3 | Isotope-Labeled Compounds |
| HY-W015778S | 2-Methoxy-5-methylphenol-d3 | Isotope-Labeled Compounds | |
| HY-W015780 | 1,4-Dimethoxybenzene | 150-78-7 | Natural Products |
| HY-W015780R | 1,4-Dimethoxybenzene (Standard) | 150-78-7 | Reference Standards |
| HY-W015780S | 1,4-Dimethoxybenzene-d10 | 74079-00-8 | Isotope-Labeled Compounds |
| HY-W015780S1 | 1,4-Dimethoxybenzene-d4 | 21383-12-0 | Isotope-Labeled Compounds |
| HY-W015782 | 4-Ethylresorcinol | 2896-60-8 | Natural Products |
| HY-W015784S | 1,4-Benzenedimethanol-d4 | 1158734-28-1 | Isotope-Labeled Compounds |
| HY-W015786 | 4-Ethoxyphenol | 622-62-8 | Reference compound |
| HY-W015786R | 4-Ethoxyphenol (Standard) | 622-62-8 | Reference Standards |
| HY-W015788 | 1-Phenylethane-1,2-diol | 93-56-1 | Natural Products |
| HY-W015788R | 1-Phenylethane-1,2-diol (Standard) | 93-56-1 | Reference Standards |
| HY-W015793 | 6-Aminonicotinic acid | 3167-49-5 | Reference compound |
| HY-W015798 | 2-Iminothiolane (hydrochloride) | 4781-83-3 | Biochemical Assay Reagents |
| HY-W015800 | L-Homoserine lactone hydrochloride | 2185-03-7 | Peptides |
| HY-W015801S | Benzothioamide-d5 | 1219804-59-7 | Isotope-Labeled Compounds |
| HY-W015805 | 3-Pyridylamide oxime | 1594-58-7 | Reference compound |
| HY-W015806 | 3-Pyridineacetic acid | 501-81-5 | Natural Products |
| HY-W015810 | 2-Phenyl-2-propanol | 617-94-7 | Biochemical Assay Reagents |
| HY-W015812 | 2,3,5-Trimethylphenol | 697-82-5 | Reference compound |
| HY-W015812S | 2,3,5-Trimethylphenol-d11 | 362049-46-5 | Isotope-Labeled Compounds |
| HY-W015813S | N-Methyl-N-phenylnitrous amide-13C,d3,15N | Isotope-Labeled Compounds | |
| HY-W015815 | 6-Methylnicotinamide | 6960-22-1 | Natural Products |
| HY-W015816 | 2,6-Dimethylbenzoquinone | 527-61-7 | Natural Products |
| HY-W015818 | 2-Benzoxazolinone | 59-49-4 | Natural Products |
| HY-W015818R | 2-Benzoxazolinone (Standard) | 59-49-4 | Reference Standards |
| HY-W015820 | Phthalide | 87-41-2 | Natural Products |
| HY-W015820R | Phthalide (Standard) | 87-41-2 | Reference Standards |
| HY-W015823 | 4-Hydroxybenzyl cyanide | 14191-95-8 | Natural Products |
| HY-W015824 | DL-Aspartic acid | 617-45-8 | Biochemical Assay Reagents |
| HY-W015824R | DL-Aspartic acid (Standard) | 617-45-8 | Reference Standards |
| HY-W015824S | DL-Aspartic acid-13C | 137168-39-9 | Isotope-Labeled Compounds |
| HY-W015824S1 | DL-Aspartic acid-13C,15N | 98532-13-9 | Isotope-Labeled Compounds |
| HY-W015824S2 | DL-Aspartic acid-3-13C | 202326-56-5 | Isotope-Labeled Compounds |
| HY-W015824S3 | DL-Aspartic acid-13C1 | 68315-35-5 | Isotope-Labeled Compounds |
| HY-W015824S5 | DL-Aspartic acid-13C,15N-1 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W015828 | Ompenaclid | 353-09-3 | Reference compound |
| HY-W015829S | N1,N1,N3,N3-Tetramethylpropane-1,3-diamine-d18 | 1398065-52-5 | Isotope-Labeled Compounds |
| HY-W015849S | 1-Fluoro-4-methoxybenzene-d4 | 1219802-94-4 | Isotope-Labeled Compounds |
| HY-W015851 | (R)-3-Hydroxybutanoic acid (sodium) | 13613-65-5 | Natural Products |
| HY-W015851R | (R)-3-Hydroxybutanoic acid (sodium) (Standard) | 13613-65-5 | Reference Standards |
| HY-W015851S | 3-Hydroxybutanoic acid-13C (sodium) | 1173022-79-1 | Isotope-Labeled Compounds |
| HY-W015851S2 | (R)-3-Hydroxybutanoic acid-13C4 (sodium) | 2483735-72-2 | Isotope-Labeled Compounds |
| HY-W015854 | Ethyl methanesulfonate | 62-50-0 | Biochemical Assay Reagents |
| HY-W015854S | Ethyl methanesulfonate-d5 | 1219795-44-4 | Isotope-Labeled Compounds |
| HY-W015855S | 2-Methoxy-3-methylpyrazine-d3 | Isotope-Labeled Compounds | |
| HY-W015874 | 2-Hydroxy-2-methylbutanoic acid | 3739-30-8 | Natural Products |
| HY-W015874R | 2-Hydroxy-2-methylbutanoic acid (Standard) | 3739-30-8 | Reference Standards |
| HY-W015875 | (2S,3S)-2-amino-3-methylpentan-1-ol | 24629-25-2 | Biochemical Assay Reagents |
| HY-W015876 | L-Leucinol | 7533-40-6 | Reference compound |
| HY-W015878 | 5-Aminovaleric acid | 660-88-8 | Natural Products |
| HY-W015878R | 5-Aminovaleric acid (Standard) | 660-88-8 | Reference Standards |
| HY-W015879 | 2-Heptanol | 543-49-7 | Natural Products |
| HY-W015879R | 2-Heptanol (Standard) | 543-49-7 | Reference Standards |
| HY-W015879S | 2-Heptanol-d5 | Isotope-Labeled Compounds | |
| HY-W015881 | Dimebutic acid | 595-37-9 | Reference compound |
| HY-W015881A | Dimebutic acid (sodium) | 3934-02-9 | Reference compound |
| HY-W015881R | Dimebutic acid (Standard) | 595-37-9 | Reference Standards |
| HY-W015881S | 2,2-Dimethylbutanoic acid-d11 | 1219804-04-2 | Isotope-Labeled Compounds |
| HY-W015882 | 4-Methylpentanoic acid | 646-07-1 | Natural Products |
| HY-W015882R | 4-Methylpentanoic acid (Standard) | 646-07-1 | Reference compound |
| HY-W015882S | 4-Methylpentanoic acid-d12 | 116287-57-1 | Isotope-Labeled Compounds |
| HY-W015882S1 | 4-Methylpentanoic acid-d11 | 344298-98-2 | Isotope-Labeled Compounds |
| HY-W015883 | Fumaric acid | 110-17-8 | Natural Products |
| HY-W015883A | Fumaric acid (disodium) | 17013-01-3 | Biochemical Assay Reagents |
| HY-W015883AS | Fumaric acid2,3-13C2 (disodium) | 287389-39-3 | Isotope-Labeled Compounds |
| HY-W015883R | Fumaric acid (Standard) | 110-17-8 | Reference Standards |
| HY-W015883S | Fumaric acid-13C4 | 201595-62-2 | Isotope-Labeled Compounds |
| HY-W015883S2 | Fumaric acid-13C2,d2 | 100858-52-4 | Isotope-Labeled Compounds |
| HY-W015883S3 | Fumaric acid-d2 | 24461-32-3 | Isotope-Labeled Compounds |
| HY-W015883S4 | Fumaric acid-d4 | 194160-45-7 | Isotope-Labeled Compounds |
| HY-W015891 | ε-Caprolactone | 502-44-3 | Natural Products |
| HY-W015891S | ε-Caprolactone-d6 | 1219802-08-0 | Isotope-Labeled Compounds |
| HY-W015892 | γ-Hexalactone | 695-06-7 | Natural Products |
| HY-W015892R | γ-Hexalactone (Standard) | 695-06-7 | Reference Standards |
| HY-W015897 | 3,4-Dehydro-L-proline | 4043-88-3 | Peptides |
| HY-W015902 | 4,6-Dihydroxypyrimidine | 1193-24-4 | Biochemical Assay Reagents |
| HY-W015912 | 2-Acetylfuran | 1192-62-7 | Reference compound |
| HY-W015912R | 2-Acetylfuran (Standard) | 1192-62-7 | Reference Standards |
| HY-W015912S | 2-Acetylfuran-d3 | Isotope-Labeled Compounds | |
| HY-W015913 | Sodium 2-oxopropanoate | 113-24-6 | Biochemical Assay Reagents |
| HY-W015913R | Sodium 2-oxopropanoate (Standard) | 113-24-6 | Reference Standards |
| HY-W015913S | Sodium 2-oxopropanoate-13C3 | 142014-11-7 | Isotope-Labeled Compounds |
| HY-W015913S1 | Sodium 2-oxopropanoate-d3 | 1316291-18-5 | Isotope-Labeled Compounds |
| HY-W015913S3 | Sodium 2-oxopropanoate-13C | 124052-04-6 | Isotope-Labeled Compounds |
| HY-W015913S4 | 2-Oxopropanoate-13c2 (sodium) | 89196-78-1 | Isotope-Labeled Compounds |
| HY-W015914 | 2,3-Dimethylpyrazine | 5910-89-4 | Biochemical Assay Reagents |
| HY-W015915 | Aminoiminomethanesulphinic acid | 1758-73-2 | Biochemical Assay Reagents |
| HY-W015915R | Aminoiminomethanesulphinic acid (Standard) | 1758-73-2 | Reference Standards |
| HY-W015924 | 2-Hydroxyisobutyric acid | 594-61-6 | Natural Products |
| HY-W015924R | 2-Hydroxyisobutyric acid (Standard) | 594-61-6 | Reference Standards |
| HY-W015924S | 2-Hydroxyisobutyric acid-d6 | 40662-45-1 | Isotope-Labeled Compounds |
| HY-W015926 | H-N-Me-Ala-OH | 3913-67-5 | Peptides |
| HY-W015933S | 2-Methylpiperazine-d10 | 2363789-19-7 | Isotope-Labeled Compounds |
| HY-W015933S1 | 2-Methylpiperazine-d6 | 19803-89-0 | Isotope-Labeled Compounds |
| HY-W015933S2 | 2-Methylpiperazine-d7 | 1219802-98-8 | Isotope-Labeled Compounds |
| HY-W015936 | (E)-Hex-2-en-1-ol | 928-95-0 | Biochemical Assay Reagents |
| HY-W015938 | gamma-Valerolactone | 108-29-2 | Biochemical Assay Reagents |
| HY-W015938R | gamma-Valerolactone (Standard) | 108-29-2 | Reference Standards |
| HY-W015946 | Sodium 2-aminoacetate | 6000-44-8 | Peptides |
| HY-W015954 | (2R,3R)-Butane-2,3-diol | 24347-58-8 | Natural Products |
| HY-W015954R | (2R,3R)-Butane-2,3-diol (Standard) | 24347-58-8 | Reference Standards |
| HY-W015967 | Glycolic acid | 79-14-1 | Natural Products |
| HY-W015967R | Glycolic acid (Standard) | 79-14-1 | Reference Standards |
| HY-W015967S | Glycolic acid-d2 | 75502-10-2 | Isotope-Labeled Compounds |
| HY-W015969 | 1-Aminopropan-2-ol | 78-96-6 | Reference compound |
| HY-W015969R | 1-Aminopropan-2-ol (Standard) | 78-96-6 | Reference Standards |
| HY-W015971S | 1-Methylureal-d6 | 56683-43-3 | Isotope-Labeled Compounds |
| HY-W015987 | 9-Fluorenylmethyl carbamate | 84418-43-9 | Peptides |
| HY-W015993 | Nonyl β-D-glucopyranoside | 69984-73-2 | Biochemical Assay Reagents |
| HY-W015996 | 4-Nitrophenyl-N-acetyl-α-D-galactosaminide | 23646-68-6 | Dye Reagents |
| HY-W015998 | (R)-(+)-Warfarin | 5543-58-8 | Biochemical Assay Reagents |
| HY-W015998S | (R)-(+)-Warfarin-d5 | 773005-79-1 | Isotope-Labeled Compounds |
| HY-W016009 | 2'-Deoxyadenosine-5'-monophosphate | 653-63-4 | Natural Products |
| HY-W016009R | 2'-Deoxyadenosine-5'-monophosphate (Standard) | 653-63-4 | Reference Standards |
| HY-W016009S | 2'-Deoxyadenosine-5'-monophosphate-d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W016009S1 | 2'-Deoxyadenosine-5'-monophosphate-15N5,d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W016009S2 | 2'-Deoxyadenosine-5'-monophosphate-15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-W016009S3 | 2'-Deoxyadenosine-5'-monophosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-W016009S4 | 2'-Deoxyadenosine-5'-monophosphate-13C10,15N5 (dilithium) | 2483830-51-7 | Isotope-Labeled Compounds |
| HY-W016011 | iBu-dG | 68892-42-2 | Reference compound |
| HY-W016012 | Glu-Glu | 3929-61-1 | Peptides |
| HY-W016018 | Boc-D-Phe(4-Cl)-OH | 57292-44-1 | Peptides |
| HY-W016021 | Trimethyloctadecylammonium chloride | 112-03-8 | Biochemical Assay Reagents |
| HY-W016028 | Fmoc-D-Phe(4-I)-OH | 205526-29-0 | Peptides |
| HY-W016030 | X-GlcNAc | 4264-82-8 | Biochemical Assay Reagents |
| HY-W016031 | Fmoc-Phe(4-Me)-OH | 199006-54-7 | Peptides |
| HY-W016032 | Fmoc-3-Ala(3-thienyl)-OH | 186320-06-9 | Peptides |
| HY-W016033 | Pantoprazole sulfide | 102625-64-9 | Reference compound |
| HY-W016034 | Acetaminophen glucuronide (sodium salt) | 120595-80-4 | Reference compound |
| HY-W016034R | Acetaminophen glucuronide (sodium salt) (Standard) | 120595-80-4 | Reference Standards |
| HY-W016034S | Acetaminophen glucuronide-d3 (sodium salt) | 1260619-61-1 | Isotope-Labeled Compounds |
| HY-W016035 | (R)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid | 261380-20-5 | Peptides |
| HY-W016041 | 2-Amino-2'-deoxyadenosine | 4546-70-7 | Oligonucleotides |
| HY-W016042 | N-Cbz-hydroxy-L-proline | 13504-85-3 | Biochemical Assay Reagents |
| HY-W016067 | Cyclohexyl phenyl ketone | 712-50-5 | Biochemical Assay Reagents |
| HY-W016069 | Methyl 9-hydroxynonanoate | 34957-73-8 | Biochemical Assay Reagents |
| HY-W016075 | H-Leu-Gly-OH | 686-50-0 | Peptides |
| HY-W016077 | Glycyl-L-leucine | 869-19-2 | Natural Products |
| HY-W016077R | Glycyl-L-leucine (Standard) | 869-19-2 | Reference Standards |
| HY-W016083 | Anavenol | 93-20-9 | Reference compound |
| HY-W016087 | Monoethyl pimelate | 33018-91-6 | Reference compound |
| HY-W016091 | Sodium hexane-1-sulfonate | 2832-45-3 | Biochemical Assay Reagents |
| HY-W016099 | 3-Methyl-2-quinoxalinecarboxylic acid | 74003-63-7 | Reference compound |
| HY-W016099R | 3-Methyl-2-quinoxalinecarboxylic acid (Standard) | 74003-63-7 | Reference Standards |
| HY-W016099S | 3-Methyl-2-quinoxalinecarboxylic acid-d4 | 2244217-93-2 | Isotope-Labeled Compounds |
| HY-W016103 | 1-Hydroxy-2-naphthoic acid | 86-48-6 | Natural Products |
| HY-W016116 | (6-Bromopyridin-3-yl)methanol | 122306-01-8 | Biochemical Assay Reagents |
| HY-W016141 | Methyl quinaldate | 19575-07-6 | Reference compound |
| HY-W016145 | L-Glutamic acid (monosodium) (hydrate) | 6106-04-3 | Reference compound |
| HY-W016145S | L-Glutamic acid-13C5 (hydrate salt) | 202114-62-3 | Isotope-Labeled Compounds |
| HY-W016149 | 4,5-Dichloro-3H-1,2-dithiol-3-one | 1192-52-5 | Biochemical Assay Reagents |
| HY-W016152S | 1-Bromo-3-methoxybenzene-d3 | 873928-72-4 | Isotope-Labeled Compounds |
| HY-W016153 | 2-Bromo-4-methylphenol | 6627-55-0 | Biochemical Assay Reagents |
| HY-W016155 | 2-Butyl-4-chloro-5-formylimidazole | 83857-96-9 | Biochemical Assay Reagents |
| HY-W016155R | 2-Butyl-4-chloro-5-formylimidazole (Standard) | 83857-96-9 | Reference Standards |
| HY-W016172 | Methyl decanoate | 110-42-9 | Biochemical Assay Reagents |
| HY-W016172R | Methyl decanoate (Standard) | 110-42-9 | Reference Standards |
| HY-W016172S1 | Methyl decanoate-d19 | 1219804-67-7 | Isotope-Labeled Compounds |
| HY-W016172S2 | Methyl dodecanoate-d23 | 1219804-72-4 | Isotope-Labeled Compounds |
| HY-W016174S | Diphenylsulfane-d1 | 180802-01-1 | Isotope-Labeled Compounds |
| HY-W016181 | Phenylhydroquinone | 1079-21-6 | Reference compound |
| HY-W016187 | 2-(Naphthalen-2-yl)acetic acid | 581-96-4 | Biochemical Assay Reagents |
| HY-W016188 | 1-Naphthyl acetate | 830-81-9 | Reference compound |
| HY-W016189 | 4,4'-Dihydroxybiphenyl | 92-88-6 | Biochemical Assay Reagents |
| HY-W016189S | 4,4'-Dihydroxybiphenyl-d8 | 612480-60-1 | Isotope-Labeled Compounds |
| HY-W016194 | 1-(Carboxymethyl)cyclohexanecarboxylic acid | 67950-95-2 | Reference compound |
| HY-W016194R | 1-(Carboxymethyl)cyclohexanecarboxylic acid (Standard) | 67950-95-2 | Reference Standards |
| HY-W016203 | Phenylpyruvic acid (sodium) | 114-76-1 | Natural Products |
| HY-W016203S | Phenylpyruvic acid-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-W016215 | 5-Chloro-2-benzothiazolinone | 20600-44-6 | Reference compound |
| HY-W016216 | Ethyl 2-chloronicotinate | 1452-94-4 | Biochemical Assay Reagents |
| HY-W016216R | Ethyl 2-chloronicotinate (Standard) | 1452-94-4 | Reference Standards |
| HY-W016221 | 6-Hydroxy Chlorzoxazone | 1750-45-4 | Reference compound |
| HY-W016221R | 6-Hydroxy Chlorzoxazone (Standard) | 1750-45-4 | Reference Standards |
| HY-W016221S | 6-Hydroxy Chlorzoxazone-d2 | 1432065-00-3 | Isotope-Labeled Compounds |
| HY-W016221S1 | 6-Hydroxy Chlorzoxazone-15N,d2 | 1784060-40-7 | Isotope-Labeled Compounds |
| HY-W016232 | Ethyl-2,4-dimethyl-thiazole-5-carboxylate | 7210-77-7 | Reference compound |
| HY-W016254S | (1-Bromoethyl)benzene-d3 | 23088-42-8 | Isotope-Labeled Compounds |
| HY-W016256 | L-Methioninamide (hydrochloride) | 16120-92-6 | Peptides |
| HY-W016278 | Gamma-undecalactone | 104-67-6 | Biochemical Assay Reagents |
| HY-W016286 | 2,6-Dithiopurine | 5437-25-2 | Reference compound |
| HY-W016288 | Naphthalene-2,3-Dicarboxaldehyde | 7149-49-7 | Reference compound |
| HY-W016289 | Antiarol | 642-71-7 | Natural Products |
| HY-W016298 | trans-3,4-Difluorocinnamic acid | 112897-97-9 | Biochemical Assay Reagents |
| HY-W016306 | 3-Iodooxetane | 26272-85-5 | Biochemical Assay Reagents |
| HY-W016312 | 2,4-Dimethoxypyrimidine-5-boronic acid | 89641-18-9 | Biochemical Assay Reagents |
| HY-W016319 | (S)-2-aminopentanedioic acid hydrochloride | 138-15-8 | Peptides |
| HY-W016321 | N-Benzylaniline | 103-32-2 | Reference compound |
| HY-W016321S | N-Benzylaniline-d2 | 136295-03-9 | Isotope-Labeled Compounds |
| HY-W016324S | Diphenyl-2,2′,4,4′,6,6′-methylamine-d6 | 79825-74-4 | Isotope-Labeled Compounds |
| HY-W016330 | H-His(1-Me)-OMe | 57519-09-2 | Peptides |
| HY-W016331 | 9H-Carbazol-4-ol | 52602-39-8 | Biochemical Assay Reagents |
| HY-W016336 | 2-Fluoro-L-phenylalanine | 19883-78-4 | Peptides |
| HY-W016339 | H-DL-Phe(3-F)-OH | 456-88-2 | Peptides |
| HY-W016340 | 2-Amino-3-(4-fluorophenyl)propanoic acid | 51-65-0 | Peptides |
| HY-W016342 | 2-amino-4-sulfobutanoic acid | 504-33-6 | Peptides |
| HY-W016342S | 2-Amino-4-sulfobutanoic acid-d4 | 157203-91-3 | Isotope-Labeled Compounds |
| HY-W016349 | Chelidamic acid | 138-60-3 | Reference compound |
| HY-W016352 | 2-Hydroxy-5-nitrobenzoic acid, 99% | 96-97-9 | Biochemical Assay Reagents |
| HY-W016352R | 2-Hydroxy-5-nitrobenzoic acid, 99% (Standard) | 96-97-9 | Reference Standards |
| HY-W016363 | (S)-2-amino-3-guanidinopropanoic acid hydrochloride | 1482-99-1 | Peptides |
| HY-W016366 | 2-Chlorocinnamic acid | 3752-25-8 | Reference compound |
| HY-W016371 | 3,4,5-Trichloropyridine | 33216-52-3 | Biochemical Assay Reagents |
| HY-W016388 | 9-Fluorenol | 1689-64-1 | Reference compound |
| HY-W016388R | 9-Fluorenol (Standard) | 1689-64-1 | Reference Standards |
| HY-W016389S | 9H-Fluoren-2-ol-d9 | 922510-18-7 | Isotope-Labeled Compounds |
| HY-W016393 | Dihydroconiferyl alcohol | 2305-13-7 | Natural Products |
| HY-W016407 | Methyl 3,4-dihydroxyphenylacetate | 25379-88-8 | Reference compound |
| HY-W016409 | Ethyl 3,4-dihydroxybenzoate | 3943-89-3 | Natural Products |
| HY-W016409R | Ethyl 3,4-dihydroxybenzoate (Standard) | 3943-89-3 | Reference Standards |
| HY-W016412 | Coenzyme Q0 | 605-94-7 | Biochemical Assay Reagents |
| HY-W016413 | 4-(Hydroxymethyl)phenoxyacetic acid | 68858-21-9 | Reference compound |
| HY-W016414 | Triethyl phosphate | 78-40-0 | Reference compound |
| HY-W016414S | Triethyl phosphatel-d15 | 135942-11-9 | Isotope-Labeled Compounds |
| HY-W016415 | 7-Methyluric acid | 612-37-3 | Reference compound |
| HY-W016420 | Fosfomycin (sodium) | 26016-99-9 | Natural Products |
| HY-W016420R | Fosfomycin (sodium) (Standard) | 26016-99-9 | Reference Standards |
| HY-W016423 | H-Ile-OMe.HCl | 18598-74-8 | Peptides |
| HY-W016424 | H-β-HoIle-OH (hydrochloride) | 219310-10-8 | Peptides |
| HY-W016425 | (R)-methyl 2-amino-4-methylpentanoate hydrochloride | 5845-53-4 | Peptides |
| HY-W016426 | H-D-Ala-OtBu.HCl | 59531-86-1 | Peptides |
| HY-W016427 | H-Leu-OMe.HCl | 7517-19-3 | Peptides |
| HY-W016429 | H-cis-Hyp-OMe (hydrochloride) | 40126-30-5 | ADC Related |
| HY-W016433 | 2-Aminofluorene | 153-78-6 | Reference compound |
| HY-W016433S | 2-Aminofluorene-13C | 335081-08-8 | Isotope-Labeled Compounds |
| HY-W016433S1 | 2-Aminofluorene-d11 | 347841-44-5 | Isotope-Labeled Compounds |
| HY-W016443 | L-m-Tyrosine | 587-33-7 | Reference compound |
| HY-W016445 | D-Glucamine, 98% | 488-43-7 | Biochemical Assay Reagents |
| HY-W016450 | 5-Methyl-2-nitrobenzoic acid | 3113-72-2 | Biochemical Assay Reagents |
| HY-W016454 | 5-Aminoisophthalic acid | 99-31-0 | Biochemical Assay Reagents |
| HY-W016455 | 6-Bromo-1-hexanol | 4286-55-9 | Reference compound |
| HY-W016456 | 5-Bromopentanoic acid | 2067-33-6 | Reference compound |
| HY-W016456S | 5-Bromopentanoic-3,3,4,4 Acid-d4 | 42932-62-7 | Isotope-Labeled Compounds |
| HY-W016473 | Adamantane-carboxylic acid | 828-51-3 | Biochemical Assay Reagents |
| HY-W016473S | Adamantane-carboxylic Acid-d15 | 33830-12-5 | Isotope-Labeled Compounds |
| HY-W016474A | 1-(4-Fluorophenyl)piperazine (hydrochloride) | 64090-19-3 | Reference compound |
| HY-W016477 | Phenazine | 92-82-0 | Biochemical Assay Reagents |
| HY-W016480 | 4-Amino-L-phenylalanine | 943-80-6 | Reference compound |
| HY-W016481S | 4-Methoxybenzyl acetate-d3 | 1394230-53-5 | Isotope-Labeled Compounds |
| HY-W016482 | 3-(3-Methoxyphenyl)propionic acid | 10516-71-9 | Natural Products |
| HY-W016483 | Ethyl (4-hydroxyphenyl)acetate | 17138-28-2 | Biochemical Assay Reagents |
| HY-W016484 | Benzyl lactate | 2051-96-9 | Reference compound |
| HY-W016491 | Isopropyl 4-hydroxybenzoate | 4191-73-5 | Biochemical Assay Reagents |
| HY-W016491R | Isopropyl 4-hydroxybenzoate (Standard) | 4191-73-5 | Reference Standards |
| HY-W016491S | Isopropyl 4-hydroxybenzoate-d4 | 1219798-72-7 | Isotope-Labeled Compounds |
| HY-W016498 | Paraxanthine | 611-59-6 | Natural Products |
| HY-W016498R | Paraxanthine (Standard) | 611-59-6 | Reference Standards |
| HY-W016498S | Paraxanthine-d6 | 117490-41-2 | Isotope-Labeled Compounds |
| HY-W016498S1 | Paraxanthine-13C4,15N3 | 1173018-79-5 | Isotope-Labeled Compounds |
| HY-W016508 | L-Mannose | 10030-80-5 | Natural Products |
| HY-W016508S1 | L-(-)-Mannose-13C-1 | Isotope-Labeled Compounds | |
| HY-W016509 | epi-Inositol | 488-58-4 | Reference compound |
| HY-W016509R | epi-Inositol (Standard) | 488-58-4 | Reference Standards |
| HY-W016510 | Benzenesulfonate (sodium) | 515-42-4 | Biochemical Assay Reagents |
| HY-W016547 | (R)-2-Amino-3-(m-tolyl)propanoic acid | 114926-39-5 | Peptides |
| HY-W016552 | (S)-2-Amino-2-methyl-3-phenylpropanoic acid | 23239-35-2 | Peptides |
| HY-W016555 | H-Phe(2-Me)-OH | 80126-53-0 | Peptides |
| HY-W016562 | Hippuric acid | 495-69-2 | Natural Products |
| HY-W016562R | Hippuric acid (Standard) | 495-69-2 | Reference Standards |
| HY-W016562S | Hippuric acid-d5 | 53518-98-2 | Isotope-Labeled Compounds |
| HY-W016562S1 | Hippuric acid-d2 | 208928-78-3 | Isotope-Labeled Compounds |
| HY-W016562S3 | Hippuric acid-15N | 93627-88-4 | Isotope-Labeled Compounds |
| HY-W016568 | Isoxanthopterin | 529-69-1 | Natural Products |
| HY-W016577S | 1-Bromoheptane-d15 | 98195-42-7 | Isotope-Labeled Compounds |
| HY-W016577S1 | 1-Bromoheptane-d3 | 344253-18-5 | Isotope-Labeled Compounds |
| HY-W016577S2 | 1-Bromoheptane-d5 | 1219805-66-9 | Isotope-Labeled Compounds |
| HY-W016577S3 | 1-Bromoheptane-d7 | 1219802-55-7 | Isotope-Labeled Compounds |
| HY-W016577S4 | 1-Bromoheptane-d1 | 38007-40-8 | Isotope-Labeled Compounds |
| HY-W016582 | Methyl 2-(bromomethyl)acrylate | 4224-69-5 | Reference compound |
| HY-W016584 | 4,5-Dichlorocatechol | 3428-24-8 | Reference compound |
| HY-W016586 | Acivicin | 42228-92-2 | Natural Products |
| HY-W016586A | Acivicin (hydrochloride) | 161922-40-3 | Natural Products |
| HY-W016586AR | Acivicin (hydrochloride) (Standard) | 161922-40-3 | Reference Standards |
| HY-W016586R | Acivicin (Standard) | 42228-92-2 | Reference Standards |
| HY-W016591 | 2,4-Diisopropylphenol | 2934-05-6 | Reference compound |
| HY-W016597S | 1,2-Diphenylethyne-d10 | 19339-46-9 | Isotope-Labeled Compounds |
| HY-W016598 | 1-Phenylethyl propionate | 120-45-6 | Biochemical Assay Reagents |
| HY-W016599 | Butyl benzoate | 136-60-7 | Natural Products |
| HY-W016604 | 4'-Hydroxyvalerophenone | 2589-71-1 | Reference compound |
| HY-W016613 | Tri(ethylene glycol) monoethyl ether | 112-50-5 | Biochemical Assay Reagents |
| HY-W016618 | Ethyl phenylglyoxylate | 1603-79-8 | Reference compound |
| HY-W016618R | Ethyl phenylglyoxylate (Standard) | 1603-79-8 | Reference Standards |
| HY-W016620 | 3-Acetylphenyl acetate | 2454-35-5 | Reference compound |
| HY-W016621 | 3,4-Methylenedioxypropiophenone | 28281-49-4 | Reference compound |
| HY-W016622 | Watermelon ketone | 28940-11-6 | Reference compound |
| HY-W016622R | Watermelon ketone (Standard) | 28940-11-6 | Reference Standards |
| HY-W016628 | L-Gulono-1,4-lactone | 1128-23-0 | Natural Products |
| HY-W016628R | L-Gulono-1,4-lactone (Standard) | 1128-23-0 | Reference Standards |
| HY-W016638 | 1-Butyl-1-methylpyrrolidinium (chloride) | 479500-35-1 | Biochemical Assay Reagents |
| HY-W016642 | 2,6-Diisopropylaniline | 24544-04-5 | Biochemical Assay Reagents |
| HY-W016644 | (S)-1-Benzylpyrrolidin-3-ol | 101385-90-4 | Reference compound |
| HY-W016645 | 4-Diethylaminobenzaldehyde | 120-21-8 | Reference compound |
| HY-W016647 | For-Met-OH | 4289-98-9 | Natural Products |
| HY-W016647R | For-Met-OH (Standard) | 4289-98-9 | Reference Standards |
| HY-W016656 | 4-Phenylurazole | 15988-11-1 | Biochemical Assay Reagents |
| HY-W016657 | Isoluminol | 3682-14-2 | Biochemical Assay Reagents |
| HY-W016664 | 4-(Trifluoromethoxy)aniline | 461-82-5 | Biochemical Assay Reagents |
| HY-W016664R | 4-(Trifluoromethoxy)aniline (Standard) | 461-82-5 | Reference Standards |
| HY-W016689 | 2-Amino-4-phenylthiazole | 2010-06-2 | Reference compound |
| HY-W016693 | 12-Crown-4 | 294-93-9 | Reference compound |
| HY-W016704 | 2,5-Dihydroxybenzoic acid (sodium) | 4955-90-2 | Reference compound |
| HY-W016710 | 3,5-Dichloroisonicotinaldehyde | 136590-83-5 | Biochemical Assay Reagents |
| HY-W016715 | L-Cysteine (hydrochloride hydrate) | 7048-04-6 | Natural Products |
| HY-W016715R | L-Cysteine (hydrochloride hydrate) (Standard) | 7048-04-6 | Reference Standards |
| HY-W016716 | 2-Amino-3-mercaptopropanoic acid hydrochloride hydrate | 96998-61-7 | Peptides |
| HY-W016718 | Chlorodimethoxytriazine | 3140-73-6 | Biochemical Assay Reagents |
| HY-W016729 | 4-(Dimethylamino)cinnamaldehyde | 6203-18-5 | Biochemical Assay Reagents |
| HY-W016730S | tert-Butyl (1-hydroxypropan-2-yl)carbamate-d6 | 2243764-35-2 | Isotope-Labeled Compounds |
| HY-W016731 | H-Thr(tBu)-OH | 4378-13-6 | Peptides |
| HY-W016733 | D-Citrulline | 13594-51-9 | Peptides |
| HY-W016734 | 2-Amino-5-ureidopentanoic acid | 627-77-0 | Natural Products |
| HY-W016734R | 2-Amino-5-ureidopentanoic acid (Standard) | 627-77-0 | Reference Standards |
| HY-W016735 | Azido-PEG3-alcohol | 86520-52-7 | Reference compound |
| HY-W016739 | Methyl 1H-indole-6-carboxylate | 50820-65-0 | Biochemical Assay Reagents |
| HY-W016748 | PTAD | 4233-33-4 | Reference compound |
| HY-W016749 | N-Acetyl-DL-aspartic acid | 2545-40-6 | Peptides |
| HY-W016749S | N-Acetyl-DL-aspartic acid-2,3,3-d3 | 89829-69-6 | Isotope-Labeled Compounds |
| HY-W016750 | Pentane-1,5-diamine (dihydrochloride) | 1476-39-7 | Natural Products |
| HY-W016754 | 4-Bromo-3,5-dimethylpyrazole | 3398-16-1 | Biochemical Assay Reagents |
| HY-W016769 | 4-Chloro-2-fluorobenzoic acid | 446-30-0 | Biochemical Assay Reagents |
| HY-W016773 | 1,10-Decanediol | 112-47-0 | Natural Products |
| HY-W016773S | 1,10-Decanediol-d20 | Isotope-Labeled Compounds | |
| HY-W016779 | Cyclopentyl phenyl ketone | 5422-88-8 | Reference compound |
| HY-W016781 | D-Arginine | 157-06-2 | Reference compound |
| HY-W016784 | Indole-3-acetamide | 879-37-8 | Natural Products |
| HY-W016784R | Indole-3-acetamide (Standard) | 879-37-8 | Reference Standards |
| HY-W016784S | Indole-3-acetamide-d5 | 1204700-53-7 | Isotope-Labeled Compounds |
| HY-W016785 | Glycyl-L-valine | 1963-21-9 | Natural Products |
| HY-W016791 | Sodium pentanesulfonate, 98% | 22767-49-3 | Biochemical Assay Reagents |
| HY-W016794 | NSC3852 | 3565-26-2 | Reference compound |
| HY-W016798 | (S)-2-acetamido-4-amino-4-oxobutanoic acid | 4033-40-3 | Natural Products |
| HY-W016801 | Dimethyl acetone-1,3-dicarboxylate | 1830-54-2 | Biochemical Assay Reagents |
| HY-W016802 | 1,3-Diethyl 2-oxopropanedioate | 609-09-6 | Biochemical Assay Reagents |
| HY-W016806 | Sodium methylparaben, 99% | 5026-62-0 | Biochemical Assay Reagents |
| HY-W016806R | Sodium methylparaben, 99% (Standard) | 5026-62-0 | Reference Standards |
| HY-W016812 | Orotic acid (hydrate) | 50887-69-9 | Natural Products |
| HY-W016812S | Orotic acid-15N2 (hydrate) | Isotope-Labeled Compounds | |
| HY-W016813 | trans-Aconitic acid | 4023-65-8 | Natural Products |
| HY-W016813R | trans-Aconitic acid (Standard) | 4023-65-8 | Reference Standards |
| HY-W016814 | (Z)-Aconitic acid | 585-84-2 | Natural Products |
| HY-W016814A | Aconitic acid | 499-12-7 | Natural Products |
| HY-W016814R | (Z)-Aconitic acid (Standard) | 585-84-2 | Reference Standards |
| HY-W016814S | (Z)-Aconitic acid-13C6 | 2456413-64-0 | Isotope-Labeled Compounds |
| HY-W016819 | 5-Fluoroorotic acid | 703-95-7 | Reference compound |
| HY-W016819B | 5-Fluoroorotic acid (monohydrate) | 220141-70-8 | Reference compound |
| HY-W016823 | Tyramine (hydrochloride) | 60-19-5 | Natural Products |
| HY-W016823R | Tyramine (hydrochloride) (Standard) | 60-19-5 | Reference Standards |
| HY-W016823S | p-Tyramine-d4 (hydrochloride) | 1189884-47-6 | Isotope-Labeled Compounds |
| HY-W016825 | 2-(Pyridin-2-yl)acetic acid hydrochloride | 16179-97-8 | Biochemical Assay Reagents |
| HY-W016825S | 2-(Pyridin-2-yl)acetic acid-d6 (hydrochloride) | 1329799-67-8 | Isotope-Labeled Compounds |
| HY-W016825S1 | 2-(Pyridin-2-yl)acetic acid-d4 (hydrochloride) | 2748471-29-4 | Isotope-Labeled Compounds |
| HY-W016825S2 | 2-(Pyridin-2-yl)acetic acid-d2 (hydrochloride) | 1219802-51-3 | Isotope-Labeled Compounds |
| HY-W016835 | (2S,3S)-2-Acetamido-3-methylpentanoic acid | 3077-46-1 | Peptides |
| HY-W016836 | Metanilic acid | 121-47-1 | Reference compound |
| HY-W016840 | 8-Hydroxyquinoline-2-carbaldehyde | 14510-06-6 | Biochemical Assay Reagents |
| HY-W016849 | 6-Bromopyridin-3-amine | 13534-97-9 | Biochemical Assay Reagents |
| HY-W016857 | 2-(4-Chlorophenoxy)ethanol | 1892-43-9 | Reference compound |
| HY-W016859 | 5-Chlororesorcinol dimethyl ether | 7051-16-3 | Reference compound |
| HY-W016866 | 5-Chloro-2-hydroxybenzoic acid | 321-14-2 | Biochemical Assay Reagents |
| HY-W016867 | 4-Chlorosalicylic acid | 5106-98-9 | Reference compound |
| HY-W016867R | 4-Chlorosalicylic acid (Standard) | 5106-98-9 | Reference Standards |
| HY-W016868 | 3-Chloro-5-hydroxybenzoic acid | 53984-36-4 | Reference compound |
| HY-W016876 | 2-(Naphthalen-1-yl)ethanol | 773-99-9 | Biochemical Assay Reagents |
| HY-W016887 | Glycyl-L-proline | 704-15-4 | Peptides |
| HY-W016887R | Glycyl-L-proline (Standard) | 704-15-4 | Reference Standards |
| HY-W016889 | CFL-137 | 708-06-5 | Reference compound |
| HY-W016916 | Trifluoromethanesulfonic acid (sodium) | 2926-30-9 | Biochemical Assay Reagents |
| HY-W016923 | N,N,N-Trimethylbenzenaminium (chloride) | 138-24-9 | Biochemical Assay Reagents |
| HY-W016925 | 4-Amino-2-chlorobenzoic acid | 2457-76-3 | Biochemical Assay Reagents |
| HY-W016931S | 1-Bromo-4-chlorobutane-d8 | 1219803-72-1 | Isotope-Labeled Compounds |
| HY-W016948 | TFA-Gly-OH | 383-70-0 | Peptides |
| HY-W016961 | Bis(trimethylsilyl)acetylene | 14630-40-1 | Biochemical Assay Reagents |
| HY-W016963 | (3-Chloro-4-methylphenyl)boronic acid | 175883-63-3 | Biochemical Assay Reagents |
| HY-W016969 | 2-Undecanone | 112-12-9 | Natural Products |
| HY-W016969R | 2-Undecanone (Standard) | 112-12-9 | Reference Standards |
| HY-W016976 | Allyl heptanoate | 142-19-8 | Biochemical Assay Reagents |
| HY-W016979 | δ-Decalactone | 705-86-2 | Natural Products |
| HY-W016979R | δ-Decalactone (Standard) | 705-86-2 | Reference Standards |
| HY-W016993 | 2,3,4-Trihydroxybenzoic acid | 610-02-6 | Natural Products |
| HY-W016996 | H-Ser-OEt.HCl | 26348-61-8 | Peptides |
| HY-W016999 | 2-Chloroadenine | 1839-18-5 | Biochemical Assay Reagents |
| HY-W016999R | 2-Chloroadenine (Standard) | 1839-18-5 | Reference Standards |
| HY-W017006 | 1-Methyl-L-histidine | 332-80-9 | Natural Products |
| HY-W017006R | 1-Methyl-L-histidine (Standard) | 332-80-9 | Reference Standards |
| HY-W017006S | 1-Methyl-L-histidine-d3 | 91037-48-8 | Isotope-Labeled Compounds |
| HY-W017007 | 3-Methyl-L-histidine | 368-16-1 | Natural Products |
| HY-W017007S | 3-Methyl-L-histidine-d3 | 144868-18-8 | Isotope-Labeled Compounds |
| HY-W017007SA | 3-Methyl-L-histidine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W017007SB | 3-Methyl-D-histidine-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W017018 | L-Ornithine (hydrochloride) | 3184-13-2 | Natural Products |
| HY-W017018R | L-Ornithine (hydrochloride) (Standard) | 3184-13-2 | Reference Standards |
| HY-W017018S | L-Ornithine-d6 (hydrochloride) | 347841-40-1 | Isotope-Labeled Compounds |
| HY-W017018S1 | L-Ornithine-1,2-13C2 (hydrochloride) | 224054-19-7 | Isotope-Labeled Compounds |
| HY-W017018S2 | L-Ornithine-1,2,3,4,5-13C5 (hydrochloride) | 943962-21-8 | Isotope-Labeled Compounds |
| HY-W017018S3 | L-Ornithine-d2 (hydrochloride) | 2483831-42-9 | Isotope-Labeled Compounds |
| HY-W017018S4 | L-Ornithine-d7 (hydrochloride) | 2483831-57-6 | Isotope-Labeled Compounds |
| HY-W017018S5 | L-Ornithine-15N2 (hydrochloride) | 360565-59-9 | Isotope-Labeled Compounds |
| HY-W017032 | 1H-Pyrazole-1-carboximidamide (hydrochloride) | 4023-02-3 | Biochemical Assay Reagents |
| HY-W017038 | Piazthiole | 273-13-2 | Biochemical Assay Reagents |
| HY-W017041 | 4-Aminobenzamide | 2835-68-9 | Biochemical Assay Reagents |
| HY-W017044 | 1-Phenylurea | 64-10-8 | Biochemical Assay Reagents |
| HY-W017049S | Trifluoroacetic acid-13C2 (sodium) | 1794767-05-7 | Isotope-Labeled Compounds |
| HY-W017050 | 2-Hydroxypropyl acrylate | 999-61-1 | Reference compound |
| HY-W017054 | 2-Amino-2-methyl-1,3-propanediol | 115-69-5 | Biochemical Assay Reagents |
| HY-W017061 | 1,6-Bismaleimidohexane | 4856-87-5 | Biochemical Assay Reagents |
| HY-W017068 | dUTP (trisodium) | 102814-08-4 | Reference compound |
| HY-W017068A | dUTP (sodium) | 94736-09-1 | Reference compound |
| HY-W017069 | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(allyloxy)-4-oxobutanoic acid | 144120-53-6 | Peptides |
| HY-W017072 | 1-Dodecene | 112-41-4 | Natural Products |
| HY-W017072S | 1-Dodecene-1,2-13C2 | 198332-88-6 | Isotope-Labeled Compounds |
| HY-W017077 | 4-Methylbiphenyl | 644-08-6 | Natural Products |
| HY-W017077S | 4-Methylbiphenyl-d3 | 94367-56-3 | Isotope-Labeled Compounds |
| HY-W017086 | Dibenzo[b,d]furan | 132-64-9 | Biochemical Assay Reagents |
| HY-W017086S | Dibenzo[b,d]furan-d8 | 93952-04-6 | Isotope-Labeled Compounds |
| HY-W017086S1 | Dibenzo[b,d]furan-d2 | 133850-83-6 | Isotope-Labeled Compounds |
| HY-W017086S2 | Dibenzo[b,d]furan-13C12 | Isotope-Labeled Compounds | |
| HY-W017092 | 1,2,3-Trimethoxybenzene | 634-36-6 | Reference compound |
| HY-W017093 | 3,5-Dimethoxybenzyl alcohol | 705-76-0 | Natural Products |
| HY-W017100 | 2-Hydroxy-6-methoxybenzoic acid | 3147-64-6 | Natural Products |
| HY-W017105 | Pyrazine-2,3-dicarboxylic acid | 89-01-0 | Biochemical Assay Reagents |
| HY-W017105R | Pyrazine-2,3-dicarboxylic acid (Standard) | 89-01-0 | Reference Standards |
| HY-W017113 | 2-Mercaptobenzothiazole | 149-30-4 | Natural Products |
| HY-W017113R | 2-Mercaptobenzothiazole (Standard) | 149-30-4 | Reference Standards |
| HY-W017115 | 4-Methoxybenzenecarbothioamide | 2362-64-3 | Reference compound |
| HY-W017118A | 2,6-Dimethoxybenzylamine (hydrochloride) | 34967-23-2 | Reference compound |
| HY-W017122 | 7-Deaza-2-mercaptohypoxanthine | 67831-84-9 | Biochemical Assay Reagents |
| HY-W017132 | 2,4-PDCA | 499-80-9 | Reference compound |
| HY-W017140 | 2-Sec-butyl-3-methoxypyrazine | 24168-70-5 | Natural Products |
| HY-W017140R | 2-Sec-butyl-3-methoxypyrazine (Standard) | 24168-70-5 | Reference Standards |
| HY-W017140S | 2-Sec-butyl-3-methoxypyrazine-d3 | 1335436-01-5 | Isotope-Labeled Compounds |
| HY-W017141 | 2-Isobutyl-3-methoxypyrazine | 24683-00-9 | Natural Products |
| HY-W017141R | 2-Isobutyl-3-methoxypyrazine (Standard) | 24683-00-9 | Reference Standards |
| HY-W017141S | 2-Isobutyl-3-methoxypyrazine-d3 | 588732-63-2 | Isotope-Labeled Compounds |
| HY-W017141S1 | 2-Isobutyl-3-methoxypyrazine-d9 | Isotope-Labeled Compounds | |
| HY-W017145S | 4-(tert-Butyl)benzene-1,2-diol-d12 | Isotope-Labeled Compounds | |
| HY-W017150 | H-3-Pal-OH | 64090-98-8 | Peptides |
| HY-W017158 | Melilotic acid | 495-78-3 | Natural Products |
| HY-W017158R | Melilotic acid (Standard) | 495-78-3 | Reference Standards |
| HY-W017162 | DL-3-Phenyllactic acid | 828-01-3 | Natural Products |
| HY-W017162R | DL-3-Phenyllactic acid (Standard) | 828-01-3 | Reference Standards |
| HY-W017162S | DL-3-Phenyllactic acid-d3 | 490034-49-6 | Isotope-Labeled Compounds |
| HY-W017163 | 7-Methylxanthine | 552-62-5 | Natural Products |
| HY-W017163R | 7-Methylxanthine (Standard) | 552-62-5 | Reference Standards |
| HY-W017163S | 7-Methylxanthine-2,4,5,6-13C4, 1,3-15N2 (with variable 15N labeling at N9) | Isotope-Labeled Compounds | |
| HY-W017163S1 | 7-Methylxanthine-d3 | 1185878-99-2 | Isotope-Labeled Compounds |
| HY-W017165 | Sodium malonate hydrate | 26522-85-0 | Biochemical Assay Reagents |
| HY-W017171 | 1,1-Bis(methylthio)-2-nitroethylene | 13623-94-4 | Biochemical Assay Reagents |
| HY-W017186 | ALDH1A3-IN-3 | 18962-05-5 | Reference compound |
| HY-W017187 | 2-tert-Butyl-1,4-benzoquinone | 3602-55-9 | Reference compound |
| HY-W017189 | 3-Phenylbutyric acid | 4593-90-2 | Natural Products |
| HY-W017193S | 2-Hydroxy-2-methylpropiophenone-d5 | Isotope-Labeled Compounds | |
| HY-W017194 | 2-Phenylbutanoic acid | 90-27-7 | Natural Products |
| HY-W017194R | 2-Phenylbutanoic acid (Standard) | 90-27-7 | Reference Standards |
| HY-W017195 | Isopropyl benzoate | 939-48-0 | Biochemical Assay Reagents |
| HY-W017199S | N-Benzyl-2-methylpropan-2-amine-d9 | 1060688-77-8 | Isotope-Labeled Compounds |
| HY-W017200 | L-Ethionine | 13073-35-3 | Peptides |
| HY-W017202 | 2-Amino-4-(ethylthio)butanoic acid | 67-21-0 | Peptides |
| HY-W017206 | 1-Phenyl-2-nitropropene | 705-60-2 | Reference compound |
| HY-W017209S | Bromocyclohexane-d11 | 35558-49-7 | Isotope-Labeled Compounds |
| HY-W017212 | Methyl cinnamate | 103-26-4 | Natural Products |
| HY-W017212S | Methyl cinnamate-d7 | Isotope-Labeled Compounds | |
| HY-W017213 | Phenyl methacrylate | 2177-70-0 | Reference compound |
| HY-W017224 | Sodium butane-1-sulfonate | 2386-54-1 | Biochemical Assay Reagents |
| HY-W017227 | Alloxan (hydrate) | 2244-11-3 | Reference compound |
| HY-W017230 | L-Cysteinesulfinic acid (monohydrate) | 207121-48-0 | Reference compound |
| HY-W017232 | 6-Methoxyquinoline | 5263-87-6 | Biochemical Assay Reagents |
| HY-W017241 | 1-Naphthalenemethanol | 4780-79-4 | Natural Products |
| HY-W017241R | 1-Naphthalenemethanol (Standard) | 4780-79-4 | Reference Standards |
| HY-W017249 | 2-Chloronicotinic acid | 2942-59-8 | Biochemical Assay Reagents |
| HY-W017254 | (R)-2-Amino-2-(thiophen-3-yl)acetic acid | 1194-86-1 | Peptides |
| HY-W017255 | (S)-3-Thienylglycine | 1194-87-2 | Peptides |
| HY-W017256 | (S)-2-Amino-2-(thiophen-2-yl)acetic acid | 43189-45-3 | Peptides |
| HY-W017258 | N-Acetyl-D-proline | 59785-68-1 | Biochemical Assay Reagents |
| HY-W017265 | 5-Nitrouracil | 611-08-5 | Biochemical Assay Reagents |
| HY-W017277 | (+)-Menthol | 15356-60-2 | Natural Products |
| HY-W017277R | (+)-Menthol (Standard) | 15356-60-2 | Reference Standards |
| HY-W017280S | 2,6-Dimethylnaphthalene-d12 | 350820-12-1 | Isotope-Labeled Compounds |
| HY-W017281S | 5-Pentyldihydrofuran-2(3H)-one-d4 | 1394230-27-3 | Isotope-Labeled Compounds |
| HY-W017284 | δ-Nonalactone | 3301-94-8 | Natural Products |
| HY-W017289 | 4,4′-Dipyridyl | 553-26-4 | Biochemical Assay Reagents |
| HY-W017289S | 4,4′-Dipyridyl-d8 | 132125-39-4 | Isotope-Labeled Compounds |
| HY-W017310S | 3-Bromopropane-1,2-diol-d5 | 1246820-48-3 | Isotope-Labeled Compounds |
| HY-W017316 | Terpinen-4-ol | 562-74-3 | Natural Products |
| HY-W017316R | Terpinen-4-ol (Standard) | 562-74-3 | Reference Standards |
| HY-W017330 | Methacrylic anhydride | 760-93-0 | Reference compound |
| HY-W017350 | D-Alanine ethyl ester hydrochloride | 6331-09-5 | Peptides |
| HY-W017353 | Pseudopelletierine | 552-70-5 | Biochemical Assay Reagents |
| HY-W017370 | Carveol | 99-48-9 | Natural Products |
| HY-W017370R | Carveol (Standard) | 99-48-9 | Reference Standards |
| HY-W017374S | 4-Ethyl-2-methoxyphenol-d5 | 1219803-12-9 | Isotope-Labeled Compounds |
| HY-W017374S1 | 4-Ethyl-2-methoxyphenol-d3 | Isotope-Labeled Compounds | |
| HY-W017374S2 | 4-Ethyl-2-methoxyphenol-d2 | 1335401-59-6 | Isotope-Labeled Compounds |
| HY-W017378 | Trimethylhydroquinone | 700-13-0 | Reference compound |
| HY-W017378R | Trimethylhydroquinone (Standard) | 700-13-0 | Reference Standards |
| HY-W017382 | 4-Hydrazinobenzoic acid | 619-67-0 | Biochemical Assay Reagents |
| HY-W017382R | 4-Hydrazinobenzoic acid (Standard) | 619-67-0 | Reference Standards |
| HY-W017384 | 4-(Hydroxymethyl)benzoic acid | 3006-96-0 | Biochemical Assay Reagents |
| HY-W017384R | 4-(Hydroxymethyl)benzoic acid (Standard) | 3006-96-0 | Reference Standards |
| HY-W017386 | 3-Methyl-2-oxovaleric acid (sodium) | 3715-31-9 | Biochemical Assay Reagents |
| HY-W017386S | 3-Methyl-2-oxovaleric acid-d8 (sodium) | 1795037-03-4 | Isotope-Labeled Compounds |
| HY-W017387 | Sodium α-ketoisocaproate | 4502-00-5 | Reference compound |
| HY-W017387S | Sodium α-ketoisocaproate-d3 | 93523-67-2 | Isotope-Labeled Compounds |
| HY-W017387S1 | Sodium α-ketoisocaproic acid-13C2 | 2483736-09-8 | Isotope-Labeled Compounds |
| HY-W017387S2 | Sodium α-ketoisocaproic acid-13C5 | 2483736-03-2 | Isotope-Labeled Compounds |
| HY-W017387S3 | α-Ketoisocaproic acid-d7 | 92751-20-7 | Isotope-Labeled Compounds |
| HY-W017389 | Xanthine | 69-89-6 | Natural Products |
| HY-W017389R | Xanthine (Standard) | 69-89-6 | Reference Standards |
| HY-W017389S | Xanthine-13C,15N2 | 1262670-81-4 | Isotope-Labeled Compounds |
| HY-W017389S1 | Xanthine-15N2 | 161770-53-2 | Isotope-Labeled Compounds |
| HY-W017390 | 4-Chlorobenzyl cyanide | 140-53-4 | Biochemical Assay Reagents |
| HY-W017390S | 4-Chlorobenzyl cyanide-d4 | 1219804-00-8 | Isotope-Labeled Compounds |
| HY-W017393 | 4-Methylbenzothioamide | 2362-62-1 | Reference compound |
| HY-W017395 | 2-(Benzylamino)ethanol | 104-63-2 | Biochemical Assay Reagents |
| HY-W017398 | D-Penylalaninol | 5267-64-1 | Biochemical Assay Reagents |
| HY-W017401 | Benzisothiazolone | 2634-33-5 | Reference compound |
| HY-W017401R | Benzisothiazolone (Standard) | 2634-33-5 | Reference Standards |
| HY-W017401S | Benzisothiazolinone-13C5 | 1329616-16-1 | Isotope-Labeled Compounds |
| HY-W017404 | (2R)-2-Amino-3-(methylsulfinyl)propanoic acid | 6853-87-8 | Peptides |
| HY-W017406 | H-Phg-OH | 2935-35-5 | Peptides |
| HY-W017406S | L-α-Phenyl-glycine-d5 | 1246820-68-7 | Isotope-Labeled Compounds |
| HY-W017408S | Methyl 3-aminobenzoate-d4 | 911132-57-5 | Isotope-Labeled Compounds |
| HY-W017410 | 3-Nitrobenzaldehyde | 99-61-6 | Biochemical Assay Reagents |
| HY-W017413 | (S)-Pyrrolidine-2-carboxamide hydrochloride | 42429-27-6 | Peptides |
| HY-W017423 | (-)-Carvone | 6485-40-1 | Natural Products |
| HY-W017423R | (-)-Carvone (Standard) | 6485-40-1 | Reference Standards |
| HY-W017424 | Benzo[d]thiazol-2-amine | 136-95-8 | Reference compound |
| HY-W017424R | Benzo[d]thiazol-2-amine (Standard) | 136-95-8 | Reference Standards |
| HY-W017425 | N'-Phenylacetohydrazide | 114-83-0 | Biochemical Assay Reagents |
| HY-W017434 | 3,4-Dimethylbenzoic acid | 619-04-5 | Natural Products |
| HY-W017434R | 3,4-Dimethylbenzoic acid (Standard) | 619-04-5 | Reference Standards |
| HY-W017439 | Ethyl benzoate | 93-89-0 | Natural Products |
| HY-W017439R | Ethyl benzoate (Standard) | 93-89-0 | Reference Standards |
| HY-W017440 | Triethylene glycol | 112-27-6 | Reference compound |
| HY-W017440R | Triethylene glycol (Standard) | 112-27-6 | Reference Standards |
| HY-W017441 | hUP1-IN-1 | 5444-02-0 | Reference compound |
| HY-W017441A | hUP1-IN-1 (potassium) | 118803-30-8 | Reference compound |
| HY-W017442 | DL-Asparagine | 3130-87-8 | Natural Products |
| HY-W017443 | L-Asparagine (monohydrate) | 5794-13-8 | Natural Products |
| HY-W017443R | L-Asparagine (monohydrate) (Standard) | 5794-13-8 | Reference Standards |
| HY-W017443S | L-Asparagine-13C4,15N2 (monohydrate) | 202406-87-9 | Isotope-Labeled Compounds |
| HY-W017443S1 | L-Asparagine-amide-15N (monohydrate) | 204451-47-8 | Isotope-Labeled Compounds |
| HY-W017443S2 | L-Asparagine-13C4,15N2,d3 (monohydrate) | 2483829-30-5 | Isotope-Labeled Compounds |
| HY-W017443S3 | L-Asparagine-15N2,d3 (monohydrate) | Isotope-Labeled Compounds | |
| HY-W017443S4 | L-Asparagine-1,2,3,4-13C4 (monohydrate) | 768348-44-3 | Isotope-Labeled Compounds |
| HY-W017444 | D-Asparagine monohydrate | 5794-24-1 | Biochemical Assay Reagents |
| HY-W017445 | Homogentisic acid lactone | 2688-48-4 | Natural Products |
| HY-W017446 | 4-Formylbenzoic acid | 619-66-9 | Biochemical Assay Reagents |
| HY-W017448 | Mepiquat chloride | 24307-26-4 | Biochemical Assay Reagents |
| HY-W017448R | Mepiquat chloride (Standard) | 24307-26-4 | Reference Standards |
| HY-W017455S | 2,6-Diethylaniline-d15 | 285132-89-0 | Isotope-Labeled Compounds |
| HY-W017455S1 | 2,6-Diethylaniline-N15 | 287488-24-8 | Isotope-Labeled Compounds |
| HY-W017456S | 4-(tert-Butyl)aniline-d15 | 1219794-71-4 | Isotope-Labeled Compounds |
| HY-W017457 | DL-Penicillamine | 52-66-4 | Reference compound |
| HY-W017457R | DL-Penicillamine (Standard) | 52-66-4 | Reference Standards |
| HY-W017462 | Creatine (monohydrate) | 6020-87-7 | Natural Products |
| HY-W017462R | Creatine (monohydrate) (Standard) | 6020-87-7 | Reference Standards |
| HY-W017462S | Creatine-d5 (monohydrate) | Isotope-Labeled Compounds | |
| HY-W017463 | trans-3-(3-Pyridyl)acrylic acid | 19337-97-4 | Reference compound |
| HY-W017464 | NAPQI | 50700-49-7 | Reference compound |
| HY-W017469 | Mesitaldehyde | 487-68-3 | Reference compound |
| HY-W017474 | Methyl 3,3-dimethoxypropionate | 7424-91-1 | Biochemical Assay Reagents |
| HY-W017475S | 4-Nitrobenzonitrile-d4 | 1219798-46-5 | Isotope-Labeled Compounds |
| HY-W017490 | 3-Methylindolin-2-one | 1504-06-9 | Reference compound |
| HY-W017495 | Cinnamamide | 621-79-4 | Biochemical Assay Reagents |
| HY-W017499 | H-Asp-OMe | 17812-32-7 | Peptides |
| HY-W017500 | N-Methyl-DL-aspartic acid | 17833-53-3 | Reference compound |
| HY-W017501 | 2-Amino-3-methylsuccinic acid | 6667-60-3 | Peptides |
| HY-W017508 | 1,8-Octanediol | 629-41-4 | Biochemical Assay Reagents |
| HY-W017511 | 5,6-Dimethyl-1H-benzo[d]imidazole | 582-60-5 | Natural Products |
| HY-W017511R | 5,6-Dimethyl-1H-benzo[d]imidazole (Standard) | 582-60-5 | Reference Standards |
| HY-W017519 | 2-Quinoxalinol | 1196-57-2 | Reference compound |
| HY-W017522 | Adipic acid | 124-04-9 | Natural Products |
| HY-W017522R | Adipic acid (Standard) | 124-04-9 | Reference Standards |
| HY-W017522S | Adipic acid-d10 | 25373-21-1 | Isotope-Labeled Compounds |
| HY-W017522S1 | Adipic acid-13C6 | 942037-55-0 | Isotope-Labeled Compounds |
| HY-W017522S2 | Adipic acid-d4 | 121311-78-2 | Isotope-Labeled Compounds |
| HY-W017522S3 | Adipic acid-13C | 2708283-72-9 | Isotope-Labeled Compounds |
| HY-W017522S4 | Adipic acid-d8 | 52089-65-3 | Isotope-Labeled Compounds |
| HY-W017522S5 | Adipic acid-d4-1 | 19031-55-1 | Isotope-Labeled Compounds |
| HY-W017522S6 | Adipic acid-13C2 | 133954-44-6 | Isotope-Labeled Compounds |
| HY-W017523 | 5-Methoxy-5-oxopentanoic acid | 1501-27-5 | Natural Products |
| HY-W017524 | 2-Methylpentanedioic acid | 617-62-9 | Natural Products |
| HY-W017524R | 2-Methylpentanedioic acid (Standard) | 617-62-9 | Reference Standards |
| HY-W017529S | 6-Chloro-1,3,5-triazine-2,4-diamine-13C3 | 1216850-33-7 | Isotope-Labeled Compounds |
| HY-W017540 | Cyclocreatine | 35404-50-3 | Reference compound |
| HY-W017542 | L-Pyrohomoglutamic acid | 34622-39-4 | Reference compound |
| HY-W017551 | 2-Amino-3,3,3-trifluoropropanoic acid | 17463-43-3 | Peptides |
| HY-W017554S | 1-Chloro-2-methoxybenzene-d3 | 1398065-46-7 | Isotope-Labeled Compounds |
| HY-W017558 | (Z)-Non-6-en-1-ol | 35854-86-5 | Biochemical Assay Reagents |
| HY-W017562S | 5-Butyldihydrofuran-2(3H)-one-d7 | 1104979-28-3 | Isotope-Labeled Compounds |
| HY-W017567 | Ethyl (E)-2-hexenoate | 27829-72-7 | Biochemical Assay Reagents |
| HY-W017588 | N-(2-Hydroxyethyl)maleimide | 1585-90-6 | Biochemical Assay Reagents |
| HY-W017597 | 2,6-Pyridinedimethanol | 1195-59-1 | Biochemical Assay Reagents |
| HY-W017604 | 3-Aminophenylboronic acid | 30418-59-8 | Reference compound |
| HY-W017610 | (R)-1-Phenyl-2-propanol | 1572-95-8 | Reference compound |
| HY-W017611S | 4-Propylphenol-d12 | 352431-21-1 | Isotope-Labeled Compounds |
| HY-W017613 | (Ethoxymethyl)benzene | 539-30-0 | Natural Products |
| HY-W017613R | (Ethoxymethyl)benzene (Standard) | 539-30-0 | Reference Standards |
| HY-W017617 | Fmoc-Ser(HPO3Bzl)-OH | 158171-14-3 | Peptides |
| HY-W017657 | 4-Methylumbelliferyl stearate | 79408-85-8 | Biochemical Assay Reagents |
| HY-W017690 | (2E,4E)-Hexa-2,4-dien-1-ol | 17102-64-6 | Biochemical Assay Reagents |
| HY-W017708S | Triphenylene-d12 | 17777-56-9 | Isotope-Labeled Compounds |
| HY-W017749 | 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil | 69123-94-0 | Reference compound |
| HY-W017755 | (R)-Azetidine-2-carboxylic acid | 7729-30-8 | ADC Related |
| HY-W017757 | (R)-BINAP | 76189-55-4 | Biochemical Assay Reagents |
| HY-W017758 | 1,3-Propanediol | 504-63-2 | Natural Products |
| HY-W017758R | 1,3-Propanediol (Standard) | 504-63-2 | Reference Standards |
| HY-W017758S | 1,3-Propanediol-d6 | 284474-77-7 | Isotope-Labeled Compounds |
| HY-W017758S1 | 1,3-Propanediol-d8 | 285978-25-8 | Isotope-Labeled Compounds |
| HY-W017758S2 | 1,3-Propanediol-d2 | 38645-14-6 | Isotope-Labeled Compounds |
| HY-W017763S | Tetrahydrofuran-2-carboxylic acid-d7 | 1219798-42-1 | Isotope-Labeled Compounds |
| HY-W017764 | 7,8-Dihydro-2,5(1H,6H)-quinolinedione | 15450-69-8 | Reference compound |
| HY-W017765A | (S)-1,1'-Bi-2,2'-naphthol | 18531-99-2 | Biochemical Assay Reagents |
| HY-W017766 | Poly(hexamethylenebiguanide) (hydrochloride) | 32289-58-0 | Reference compound |
| HY-W017767 | Polyaniline | 25233-30-1 | Reference compound |
| HY-W017769 | 4-Pyrimidine methanamine | 45588-79-2 | Reference compound |
| HY-W017770 | S-Adenosyl-L-methionine (disulfate tosylate) | 97540-22-2 | Natural Products |
| HY-W017772 | Boc-NH-PEG3 | 139115-92-7 | Reference compound |
| HY-W017782 | 2,5-Furandimethanol | 1883-75-6 | Natural Products |
| HY-W017788 | Boc-D-Homoserine | 745011-75-0 | Peptides |
| HY-W017825 | Pyrimidin-4-yl-methanol | 33581-98-5 | Reference compound |
| HY-W017829 | 1,7-Bis-Boc-1,4,7-triazaheptane | 117499-16-8 | Reference compound |
| HY-W017831 | 2-Maleimido acetic acid | 25021-08-3 | Reference compound |
| HY-W017834 | 2-(Benzyloxy)-1-ethanamine | 38336-04-8 | Reference compound |
| HY-W017851 | 4-Phenyl-2-pyrrolidinone | 1198-97-6 | Reference compound |
| HY-W017873 | 9-Fluorenylmethyl carbazate | 35661-51-9 | Dye Reagents |
| HY-W017882 | (2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | 135042-17-0 | ADC Related |
| HY-W017894 | TPO-L | 84434-11-7 | Biochemical Assay Reagents |
| HY-W017930 | 5,7-Dichlorothiazolo[5,4-d]pyrimidine | 13479-88-4 | Reference compound |
| HY-W017933 | Octahydroisoindole | 21850-12-4 | Natural Products |
| HY-W017960 | Diludine | 1149-23-1 | Reference compound |
| HY-W017960R | Diludine (Standard) | 1149-23-1 | Reference Standards |
| HY-W017970 | Boc-C2-NH2 | 15231-41-1 | Reference compound |
| HY-W017982 | Kathon 886MW | 55965-84-9 | Reference compound |
| HY-W018004 | L-Homocitrulline | 1190-49-4 | Natural Products |
| HY-W018004S | L-Homocitrulline-d3 | Isotope-Labeled Compounds | |
| HY-W018025 | 5,6-Dihydroxyindole | 3131-52-0 | Natural Products |
| HY-W018025R | 5,6-Dihydroxyindole (Standard) | 3131-52-0 | Reference Standards |
| HY-W018026 | Oxfenicine | 32462-30-9 | Reference compound |
| HY-W018035 | DL-Glyceric Acid (20% in water) | 473-81-4 | Natural Products |
| HY-W018045 | Methyl 2-((diphenylmethylene)amino)acetate | 81167-39-7 | Peptides |
| HY-W018050 | (S)-2-((tert-Butoxycarbonyl)amino)pent-4-enoic acid | 90600-20-7 | Peptides |
| HY-W018059 | Phytic acid (potassium) | 129832-03-7 | Natural Products |
| HY-W018061 | Traxoprodil | 134234-12-1 | Reference compound |
| HY-W018061A | Traxoprodil (mesylate) | 188591-67-5 | Reference compound |
| HY-W018061C | (R,R)-Traxoprodil | 134234-13-2 | Reference compound |
| HY-W018062 | H-Sar-OtBu.HCl | 136088-69-2 | Peptides |
| HY-W018077 | H-Glu(OBzl)-OBzl.HCl | 4561-10-8 | Peptides |
| HY-W018151S | 2-Benzotriazol-2-yl-4,6-di-tert-butylphenol-d4 | Isotope-Labeled Compounds | |
| HY-W018154 | H-Glu-OtBu | 45120-30-7 | ADC Related |
| HY-W018156 | Triazinetriethanol | 4719-04-4 | Reference compound |
| HY-W018158 | DHICA | 4790-08-3 | Reference compound |
| HY-W018161 | Hexadecanedioic acid | 505-54-4 | Natural Products |
| HY-W018161R | Hexadecanedioic acid (Standard) | 505-54-4 | Reference Standards |
| HY-W018161S | Hexadecanedioic acid-d28 | 130348-90-2 | Isotope-Labeled Compounds |
| HY-W018171 | 3,5,6-Trichloro-2-pyridinol | 6515-38-4 | Reference compound |
| HY-W018171R | 3,5,6-Trichloro-2-pyridinol (Standard) | 6515-38-4 | Reference Standards |
| HY-W018174 | m-PEG3-Amine | 74654-07-2 | ADC Related |
| HY-W018179 | 5'-DMT-3'-TBDMS-Bz-rA | 81256-88-4 | Oligonucleotides |
| HY-W018197 | 2-Phenylacetamide | 103-81-1 | Natural Products |
| HY-W018197R | 2-Phenylacetamide (Standard) | 103-81-1 | Reference Standards |
| HY-W018238 | H-Val-Obzl.HCl | 2462-34-2 | Peptides |
| HY-W018291 | Mal-C6-amine (TFA) | 731862-92-3 | Reference compound |
| HY-W018324 | 5-Hydroxymethylcytosine | 1123-95-1 | Reference compound |
| HY-W018324S | 5-Hydroxymethylcytosine-13C,d2 | Isotope-Labeled Compounds | |
| HY-W018326 | Temozolomide acid | 113942-30-6 | Reference compound |
| HY-W018334 | beta-D-Ribofuranose 1,2,3,5-tetraacetate | 13035-61-5 | Biochemical Assay Reagents |
| HY-W018339 | 2-Aminopyrimidin-5-ol | 143489-45-6 | Reference compound |
| HY-W018365 | Tetraethylene glycol monomethyl ether | 23783-42-8 | Reference compound |
| HY-W018366 | Boc-D-Ser(tBu)-OH | 248921-66-6 | Peptides |
| HY-W018386 | 3-Bromo-L-tyrosine | 38739-13-8 | Peptides |
| HY-W018386A | 3-Bromo-L-tyrosine (TFA) | 2320428-62-2 | Peptides |
| HY-W018386AS | 3-Bromo-L-tyrosine-13C9,15N (TFA) | 2704853-65-4 | Isotope-Labeled Compounds |
| HY-W018386S | 3-Bromo-L-tyrosine-13C6 | Isotope-Labeled Compounds | |
| HY-W018386S1 | 3-Bromo-L-tyrosine-13C9 | 1842379-72-9 | Isotope-Labeled Compounds |
| HY-W018392 | Mono-(2-ethylhexyl) phthalate | 4376-20-9 | Natural Products |
| HY-W018392R | Mono-(2-ethylhexyl) phthalate (Standard) | 4376-20-9 | Reference Standards |
| HY-W018392S | Mono-(2-ethylhexyl) phthalate-d4 | 1276197-22-8 | Isotope-Labeled Compounds |
| HY-W018397 | Tiliquinol | 5541-67-3 | Reference compound |
| HY-W018420 | Sodium 2-((hydroxymethyl)amino)acetate | 70161-44-3 | Peptides |
| HY-W018452 | Methyl diethylphosphonoacetate | 1067-74-9 | Biochemical Assay Reagents |
| HY-W018454 | Benzyltrimethylammonium tribromide | 111865-47-5 | Biochemical Assay Reagents |
| HY-W018464 | N-Boc-serinol | 125414-41-7 | Reference compound |
| HY-W018475 | Rizatriptan | 144034-80-0 | Reference compound |
| HY-W018475B | Rizatriptan (hemisulfate hemihydrate) | 159776-67-7 | Reference compound |
| HY-W018489 | H-Asp(OtBu)-OMe.HCl | 2673-19-0 | Peptides |
| HY-W018499 | (S)-2-Hydroxybutanoic acid | 3347-90-8 | Natural Products |
| HY-W018499R | (S)-2-Hydroxybutanoic acid (Standard) | 3347-90-8 | Reference Standards |
| HY-W018501 | Methyl p-tert-butylphenylacetate | 3549-23-3 | Natural Products |
| HY-W018501R | Methyl p-tert-butylphenylacetate (Standard) | 3549-23-3 | Reference Standards |
| HY-W018502 | 4-Aminobutylphosphonic acid | 35622-27-6 | Peptides |
| HY-W018512 | 7-Ketolithocholic acid | 4651-67-6 | Natural Products |
| HY-W018512R | 7-Ketolithocholic acid (Standard) | 4651-67-6 | Reference Standards |
| HY-W018528 | N2,N6-Bis(tert-butoxycarbonyl)-D-lysine | 65360-27-2 | Peptides |
| HY-W018555 | D-Cysteine | 921-01-7 | Natural Products |
| HY-W018555R | D-Cysteine (Standard) | 921-01-7 | Reference Standards |
| HY-W018574 | Tetraoctylammonium (bromide) | 14866-33-2 | Biochemical Assay Reagents |
| HY-W018582 | N-Phenylacrylamide | 2210-24-4 | Reference compound |
| HY-W018587S | Bis(2-Ethylhexyl)-tetrabromo phthalate-13C6,d34 | Isotope-Labeled Compounds | |
| HY-W018601 | Nortropine | 538-09-0 | Natural Products |
| HY-W018603 | 5-(Trifluoromethyl)uracil | 54-20-6 | Biochemical Assay Reagents |
| HY-W018603S | 5-(Trifluoromethyl)uracil-13C,15N2 | 1397206-73-3 | Isotope-Labeled Compounds |
| HY-W018604 | 2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone | 55094-52-5 | Reference compound |
| HY-W018620 | Diphenylmethylene-glycine benzyl ester | 81477-91-0 | Peptides |
| HY-W018626 | 1-Methylpiperidin-4-ol | 106-52-5 | Biochemical Assay Reagents |
| HY-W018628 | (S)-2-((tert-Butoxycarbonyl)amino)-2-cyclopentylacetic acid | 109183-72-4 | Peptides |
| HY-W018629 | Antibacterial agent 265 | 112811-72-0 | Natural Products |
| HY-W018643 | Ferulic acid methyl ester | 2309-07-1 | Natural Products |
| HY-W018643A | (E)-Ferulic acid methyl ester | 22329-76-6 | Natural Products |
| HY-W018645 | 4-Nitrophthalonitrile | 31643-49-9 | Biochemical Assay Reagents |
| HY-W018650 | Boc-Thr(Me)-OH | 48068-25-3 | Peptides |
| HY-W018653 | Cyclohexaneacetic acid | 5292-21-7 | Natural Products |
| HY-W018653R | Cyclohexaneacetic acid (Standard) | 5292-21-7 | Reference Standards |
| HY-W018667 | 3-Acetylindole | 703-80-0 | Reference compound |
| HY-W018677S | Quinoxaline-d4 | 64252-08-0 | Isotope-Labeled Compounds |
| HY-W018678 | 8-Aminooctanoic acid | 1002-57-9 | Natural Products |
| HY-W018678R | 8-Aminooctanoic acid (Standard) | 1002-57-9 | Reference Standards |
| HY-W018679S | 2-Benzylideneheptan-1-ol-d5 | Isotope-Labeled Compounds | |
| HY-W018710S | 2(3H)-Benzothiazolone-d4 | Isotope-Labeled Compounds | |
| HY-W018717 | Boc-Gly-Pro-OH | 14296-92-5 | Peptides |
| HY-W018723 | 4-Aminobenzamidine (dihydrochloride) | 2498-50-2 | Reference compound |
| HY-W018728S | 3,5-Dimethylbenzoic acid-d9 | 1335014-65-7 | Isotope-Labeled Compounds |
| HY-W018733S | 4-Chlorobenzamide-d4 | 1219794-65-6 | Isotope-Labeled Compounds |
| HY-W018741 | Boc-Asp-OMe | 98045-03-5 | Peptides |
| HY-W018744 | 4-Amino-2,6-dichloropyrimidine | 10132-07-7 | Biochemical Assay Reagents |
| HY-W018745 | Tetraethylene glycol | 112-60-7 | Reference compound |
| HY-W018746 | EDTA (disodium) | 139-33-3 | Biochemical Assay Reagents |
| HY-W018746R | EDTA (disodium) (Standard) | 139-33-3 | Reference Standards |
| HY-W018749 | Clopyralid | 1702-17-6 | Reference compound |
| HY-W018749R | Clopyralid (Standard) | 1702-17-6 | Reference Standards |
| HY-W018755S | 3,4-Difluoroaniline-d2 | 1061566-62-8 | Isotope-Labeled Compounds |
| HY-W018758 | 1-Phenylpropane-1,2-dione | 579-07-7 | Natural Products |
| HY-W018759 | 3-Ethylphenol | 620-17-7 | Natural Products |
| HY-W018772 | D-Ribose(mixture of isomers) | 50-69-1 | Natural Products |
| HY-W018772R | D-Ribose(mixture of isomers) (Standard) | 50-69-1 | Reference Standards |
| HY-W018772S | D-Ribose-18O | 3276-17-3 | Isotope-Labeled Compounds |
| HY-W018772S1 | D-Ribose-13C | 70849-24-0 | Isotope-Labeled Compounds |
| HY-W018772S10 | D-Ribose-d2 | 478506-32-0 | Isotope-Labeled Compounds |
| HY-W018772S12 | D-Ribose-d6 | Isotope-Labeled Compounds | |
| HY-W018772S14 | D-Ribose-d5 | Isotope-Labeled Compounds | |
| HY-W018772S15 | D-Ribose(mixture of isomers)-13C5 | 202114-47-4 | Isotope-Labeled Compounds |
| HY-W018772S16 | D-Ribose-1,2-13C2 | 209909-88-6 | Isotope-Labeled Compounds |
| HY-W018772S2 | D-Ribose-13C-1 | 83379-40-2 | Isotope-Labeled Compounds |
| HY-W018772S3 | D-Ribose-13C-2 | 211947-12-5 | Isotope-Labeled Compounds |
| HY-W018772S4 | D-Ribose-13C-3 | 139657-62-8 | Isotope-Labeled Compounds |
| HY-W018772S5 | D-Ribose-13C-4 | Isotope-Labeled Compounds | |
| HY-W018772S6 | D-Ribose-d | 119540-50-0 | Isotope-Labeled Compounds |
| HY-W018772S7 | D-Ribose-d-1 | 202480-69-1 | Isotope-Labeled Compounds |
| HY-W018772S8 | D-Ribose-d-2 | 169783-76-0 | Isotope-Labeled Compounds |
| HY-W018772S9 | D-Ribose-d-3 | 478506-29-5 | Isotope-Labeled Compounds |
| HY-W018778 | 2-Methyl-1,3-cyclohexanedione | 1193-55-1 | Reference compound |
| HY-W018781 | Benzamidine (hydrochloride) | 1670-14-0 | Reference compound |
| HY-W018789 | 3-Chloro-N,N-dimethylpropan-1-amine hydrochloride | 5407-04-5 | Biochemical Assay Reagents |
| HY-W018789S | 3-Chloro-N,N-dimethylpropan-1-amine-d6 (hydrochloride) | 1219799-04-8 | Isotope-Labeled Compounds |
| HY-W018790S | 4-Dimethylamino benzoic acid-d6 | 1175002-09-1 | Isotope-Labeled Compounds |
| HY-W018791 | Bifendate | 73536-69-3 | Reference compound |
| HY-W018800 | 4(3H)-Quinazolinone | 491-36-1 | Natural Products |
| HY-W018801 | 5-Nitroisoquinoline | 607-32-9 | Reference compound |
| HY-W018811 | Antibacterial agent 268 | 114457-94-2 | Reference compound |
| HY-W018811S | N-Pyrazinylcarbonylphenylalanine-d8 | 1331912-47-0 | Isotope-Labeled Compounds |
| HY-W018829 | 10-Undecenal | 112-45-8 | Biochemical Assay Reagents |
| HY-W018845 | [Ir(Cp-)Cl2]2 | 12354-84-6 | Biochemical Assay Reagents |
| HY-W018847 | Fmoc-(R)-2-(pentenyl)Ala-OH | 288617-77-6 | Peptides |
| HY-W018849 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,3-dimethylbutanoic acid | 169566-81-8 | Peptides |
| HY-W018850 | L-Isovaline | 595-40-4 | Peptides |
| HY-W018864 | Tris(dibenzylideneacetonyl)bis-palladium | 51364-51-3 | Biochemical Assay Reagents |
| HY-W018865 | Methyl D-cysteinate hydrochloride | 70361-61-4 | Peptides |
| HY-W018931 | DDR Inhibitor | 1644069-80-6 | Reference compound |
| HY-W019028 | Fmoc-Lys-OMe.HCl | 847658-45-1 | Peptides |
| HY-W019032 | Fmoc-D-Dab(Boc)-OH | 114360-56-4 | Peptides |
| HY-W019033 | 8-Bromoguanosine | 4016-63-1 | Reference compound |
| HY-W019095 | tert-Butyl 4-hydroxybutanoate | 59854-12-5 | Reference compound |
| HY-W019151 | Meconine | 569-31-3 | Natural Products |
| HY-W019151R | Meconine (Standard) | 569-31-3 | Reference Standards |
| HY-W019151S | Meconin-d3 | 29809-15-2 | Isotope-Labeled Compounds |
| HY-W019205 | (4S)-1-Boc-4-amino-D-proline | 132622-78-7 | Peptides |
| HY-W019213 | cis-4-Hydroxy-L-proline (hydrochloride) | 441067-49-8 | ADC Related |
| HY-W019226 | Methyl 1-Cbz-azetidine-3-carboxylate | 757239-60-4 | ADC Related |
| HY-W019263 | 2-Amino-4,4,4-trifluorobutyric acid | 15959-93-0 | Peptides |
| HY-W019265 | 3-Amino-N-(benzyloxycarbonyl)-L-alanine methyl ester hydrochloride | 35761-27-4 | Peptides |
| HY-W019306 | N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline (hydrochloride) | 63857-00-1 | Reference compound |
| HY-W019321 | 3-Butenylamine hydrochloride | 17875-18-2 | Biochemical Assay Reagents |
| HY-W019334 | 3,4-Dimethylpyrazole (phosphate) | 202842-98-6 | Reference compound |
| HY-W019358 | 2-Hydroxymethyl benzoic acid | 612-20-4 | Reference compound |
| HY-W019543 | Disuccinimidyl suberate Crosslinker | 68528-80-3 | ADC Related |
| HY-W019596S | Ethyl 4-(dimethylamino)benzoate-d6 | 853783-69-4 | Isotope-Labeled Compounds |
| HY-W019599 | 4-Chloro-L-phenylalanine | 14173-39-8 | Peptides |
| HY-W019606 | 2-Chlorobenzoxazole | 615-18-9 | Biochemical Assay Reagents |
| HY-W019610S1 | 9,9-Dimethylfluoren-2-amine-d7 | 2837147-38-1 | Isotope-Labeled Compounds |
| HY-W019623 | (Boc-aminooxy)acetic acid | 42989-85-5 | Biochemical Assay Reagents |
| HY-W019627 | 3-Phenoxypropyl bromide | 588-63-6 | Biochemical Assay Reagents |
| HY-W019633 | Benzothiazole-5-boronic acid pinacol ester | 1073354-91-2 | Reference compound |
| HY-W019670 | N4-Acetylcytidine | 3768-18-1 | Natural Products |
| HY-W019676 | Boc-Tyr-OtBu | 18938-60-8 | Peptides |
| HY-W019679 | (S)-N-Methylpyrrolidine-2-methanol | 34381-71-0 | Biochemical Assay Reagents |
| HY-W019683 | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-ethoxyphenyl)propanoic acid | 76757-91-0 | Peptides |
| HY-W019684 | (S)-2-(2-((tert-Butoxycarbonyl)amino)propanamido)acetic acid | 28782-78-7 | Peptides |
| HY-W019696 | Monoethyl fumarate | 2459-05-4 | Reference compound |
| HY-W019700 | PNU-100440 | 168828-82-8 | Reference compound |
| HY-W019704 | N-Acetyl-DL-methionine | 1115-47-5 | Natural Products |
| HY-W019704R | N-Acetyl-DL-methionine (Standard) | 1115-47-5 | Reference Standards |
| HY-W019710 | (E,E)-RGFP966 | 1396841-57-8 | Reference compound |
| HY-W019711 | trans-Cinnamaldehyde | 14371-10-9 | Natural Products |
| HY-W019711R | trans-Cinnamaldehyde (Standard) | 14371-10-9 | Reference Standards |
| HY-W019714 | (S)-(+)-2-Phenylglycine methyl ester hydrochloride | 15028-39-4 | Peptides |
| HY-W019715 | trans-4-(Trifluoromethyl)cinnamic acid | 16642-92-5 | Natural Products |
| HY-W019720 | 1-Methylguanidine (hydrochloride) | 22661-87-6 | Reference compound |
| HY-W019721 | Cyclosporin D | 63775-96-2 | Peptides |
| HY-W019721R | Cyclosporin D (Standard) | 63775-96-2 | Reference Standards |
| HY-W019724 | 2,2-Dihydroxyacetic acid | 563-96-2 | Natural Products |
| HY-W019726 | Dehydro Nifedipine | 67035-22-7 | Reference compound |
| HY-W019726R | Dehydro Nifedipine (Standard) | 67035-22-7 | Reference Standards |
| HY-W019726S | Dehydro Nifedipine-d6 | 125464-52-0 | Isotope-Labeled Compounds |
| HY-W019726S1 | Dehydro Nifedipine-13C,d3 | 325484-33-1 | Isotope-Labeled Compounds |
| HY-W019727 | (S)-4-Phenyloxazolidin-2-one | 99395-88-7 | Biochemical Assay Reagents |
| HY-W019727R | (S)-4-Phenyloxazolidin-2-one (Standard) | 99395-88-7 | Reference Standards |
| HY-W019734 | [Rh(Cp-)Cl2]2 | 12354-85-7 | Biochemical Assay Reagents |
| HY-W019773 | Albendazole sulfone | 75184-71-3 | Reference compound |
| HY-W019773R | Albendazole sulfone (Standard) | 75184-71-3 | Reference Standards |
| HY-W019773S | Albendazole sulfone-d7 | Isotope-Labeled Compounds | |
| HY-W019773S1 | Albendazole sulfone-d3 | 1448345-60-5 | Isotope-Labeled Compounds |
| HY-W019776 | Sudan I-d5 | 752211-63-5 | Isotope-Labeled Compounds |
| HY-W019781 | Biotinylated sphingosine | 752987-57-8 | Reference compound |
| HY-W019787 | BAM-12P | 75513-71-2 | Peptides |
| HY-W019793 | m-PEG8-NHS ester | 756525-90-3 | ADC Related |
| HY-W019794 | Mal-PEG16-NHS ester | Reference compound | |
| HY-W019795 | m-PEGn-NHS ester | 174569-25-6 | Reference compound |
| HY-W019796 | Cbz-NH-PEG4-C2-acid | 756526-00-8 | Reference compound |
| HY-W019798 | NH2-PEG8-acid | 756526-04-2 | ADC Related |
| HY-W019799 | Amino-PEG8-Boc | 756526-06-4 | ADC Related |
| HY-W019803 | Diclobutrazol | 75736-33-3 | Reference compound |
| HY-W019803R | Diclobutrazol (Standard) | 75736-33-3 | Reference Standards |
| HY-W019806 | Lacto-N-fucopentaose I | 7578-25-8 | Natural Products |
| HY-W019810 | 3-(Dansylamino)phenylboronic acid | 75806-94-9 | Dye Reagents |
| HY-W019814 | Phthalic Acid Anhydride-d4 | 75935-32-9 | Isotope-Labeled Compounds |
| HY-W019815 | N-Ethyl-N-nitrosourea | 759-73-9 | Reference compound |
| HY-W019816S | S-Ethyl dipropylthiocarbamate-d14 | 1219794-88-3 | Isotope-Labeled Compounds |
| HY-W019817 | 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol | 76014-81-8 | Natural Products |
| HY-W019817S1 | 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol-d3 | 1020719-61-2 | Isotope-Labeled Compounds |
| HY-W019821 | 23:2 Diyne PC [DC(8,9)PC] | 76078-28-9 | Biochemical Assay Reagents |
| HY-W019823 | 4-MUNANA | 76204-02-9 | Dye Reagents |
| HY-W019825S | 2-Chloropropionyl chloride-d4 | 1219794-98-5 | Isotope-Labeled Compounds |
| HY-W019828 | Allyltrimethylsilane | 762-72-1 | Reference compound |
| HY-W019829 | Polyphyllin C | 76296-71-4 | Natural Products |
| HY-W019830 | Polyphyllin F | 76296-74-7 | Natural Products |
| HY-W019831 | Silicon dioxide | 7631-86-9 | Natural Products |
| HY-W019832 | Glucosamine 3-sulfate | 76330-20-6 | Biochemical Assay Reagents |
| HY-W019833 | MSPC | 76343-22-1 | Reference compound |
| HY-W019834 | L-Allose | 7635-11-2 | Biochemical Assay Reagents |
| HY-W019838 | D-Erythro-dihydrosphingosine | 764-22-7 | Natural Products |
| HY-W019838S | D-Erythro-dihydrosphingosine-d7 | 1246304-35-7 | Isotope-Labeled Compounds |
| HY-W019847 | Azamulin | 76530-44-4 | Reference compound |
| HY-W019852 | Flutriafol | 76674-21-0 | Reference compound |
| HY-W019852R | Flutriafol (Standard) | 76674-21-0 | Reference Standards |
| HY-W019854 | 14:1 (Δ9-Trans) PC | 76733-52-3 | Biochemical Assay Reagents |
| HY-W019868 | 1-O-Hexadecyl-2-O-acetyl-sn-glycerol | 77133-35-8 | Reference compound |
| HY-W019870 | Glufosinate (ammonium) | 77182-82-2 | Reference compound |
| HY-W019870A | Glufosinate | 51276-47-2 | Reference compound |
| HY-W019870R | Glufosinate (ammonium) (Standard) | 77182-82-2 | Reference Standards |
| HY-W019872 | Ammonium dihydrogen phosphate | 7722-76-1 | Biochemical Assay Reagents |
| HY-W019872R | Ammonium dihydrogen phosphate (Standard) | 7722-76-1 | Reference Standards |
| HY-W019877 | Sodium sulfate decahydrate | 7727-73-3 | Reference compound |
| HY-W019878 | β-Endorphin, rat | 59887-17-1 | Peptides |
| HY-W019880 | Lactofen | 77501-63-4 | Reference compound |
| HY-W019883 | Dipotassium hydrogen phosphate | 7758-11-4 | Reference compound |
| HY-W019885 | Sodium tripolyphosphate (STPP), 85% | 7758-29-4 | Biochemical Assay Reagents |
| HY-W019885A | Sodium tripolyphosphate (STPP), 98% | 7758-29-4 | Biochemical Assay Reagents |
| HY-W019894 | Manganese (chloride) | 7773-01-5 | Reference compound |
| HY-W019895 | Tetradecylphosphocholine | 77733-28-9 | Reference compound |
| HY-W019895S | Tetradecylphosphocholine-d42 | 869638-98-2 | Isotope-Labeled Compounds |
| HY-W019901B | Anhydrous calcium sulfate (97%) | 7778-18-9 | Biochemical Assay Reagents |
| HY-W019909 | Molybdic acid, 85% MoO3 basis | 7782-91-4 | Biochemical Assay Reagents |
| HY-W019917 | Ammonium thiosulfate | 7783-18-8 | Biochemical Assay Reagents |
| HY-W019922 | Magnesium fluoride | 7783-40-6 | Biochemical Assay Reagents |
| HY-W019927 | Ammonium iron(III) sulfate dodecahydrate, 99% | 7783-83-7 | Biochemical Assay Reagents |
| HY-W019929 | Silver chloride, 99.5% | 7783-90-6 | Biochemical Assay Reagents |
| HY-W019930 | Silver iodide | 7783-96-2 | Biochemical Assay Reagents |
| HY-W019939 | Hydroxy-PEG10-Boc | 778596-26-2 | ADC Related |
| HY-W019940 | 2-Methoxy-4-vinylphenol | 7786-61-0 | Natural Products |
| HY-W019940R | 2-Methoxy-4-vinylphenol (Standard) | 7786-61-0 | Reference Standards |
| HY-W019950 | Chromium(Ⅲ) potassium sulfate dodecahydrate (98%) | 7788-99-0 | Biochemical Assay Reagents |
| HY-W019956 | Deuterium oxide | 7789-20-0 | Isotope-Labeled Compounds |
| HY-W019962 | Calcium fluoride | 7789-75-5 | Biochemical Assay Reagents |
| HY-W019970 | Potassium pyrosulfate | 7790-62-7 | Biochemical Assay Reagents |
| HY-W019972 | Calcium pyrophosphate | 7790-76-3 | Biochemical Assay Reagents |
| HY-W019976 | Cadmium sulfate hydrate,99.995% trace metals basis | 7790-84-3 | Biochemical Assay Reagents |
| HY-W019981B | Magnesium chloride hexahydrate, for molecular biology | 7791-18-6 | Biochemical Assay Reagents |
| HY-W019981C | Magnesium chloride hexahydrate, for cell culture | 7791-18-6 | Biochemical Assay Reagents |
| HY-W019997 | PDAM | 78377-23-8 | Reference compound |
| HY-W019999 | 1,2-Dimyristoyl-d54-sn-glycero-3-phosphocholine | 78415-49-3 | Isotope-Labeled Compounds |
| HY-W020005 | 2-Carboxyphenol-d4 | 78646-17-0 | Isotope-Labeled Compounds |
| HY-W020005R | 2-Carboxyphenol-d4 (Standard) | 78646-17-0 | Reference Standards |
| HY-W020012 | Fluoresterol | 78949-95-8 | Dye Reagents |
| HY-W020014 | Pyruvic aldehyde (42% in water) | 78-98-8 | Natural Products |
| HY-W020018S | N-Methylacetamide-d6 | 3669-73-6 | Isotope-Labeled Compounds |
| HY-W020018S1 | N-Methylacetamide-d1 | 3669-70-3 | Isotope-Labeled Compounds |
| HY-W020018S2 | N-Methylacetamide-d3 | 3669-71-4 | Isotope-Labeled Compounds |
| HY-W020018S3 | N-Methylacetamide-d3-1 | 3669-69-0 | Isotope-Labeled Compounds |
| HY-W020018S4 | N-Methylacetamide-d7 | 3669-74-7 | Isotope-Labeled Compounds |
| HY-W020020 | Thifensulfuron-methyl | 79277-27-3 | Reference compound |
| HY-W020020R | Thifensulfuron-methyl (Standard) | 79277-27-3 | Reference Standards |
| HY-W020027 | Methacrylamide | 79-39-0 | Reference compound |
| HY-W020027R | Methacrylamide (Standard) | 79-39-0 | Reference Standards |
| HY-W020030 | 4-Amino-3,6-disulfonaphthalic anhydride (dipotassium) | 79539-35-8 | Dye Reagents |
| HY-W020033 | Lanosterol | 79-63-0 | Natural Products |
| HY-W020033R | Lanosterol (Standard) | 79-63-0 | Reference Standards |
| HY-W020033S | Lanosterol-d6 | 28290-39-3 | Isotope-Labeled Compounds |
| HY-W020035 | L-α-lysophosphatidylinositol (Soy) (sodium) | 796963-91-2 | Reference compound |
| HY-W020041 | CP 53631 | 79836-56-9 | Reference compound |
| HY-W020043 | Pyribencarb | 799247-52-2 | Reference compound |
| HY-W020043R | Pyribencarb (Standard) | 799247-52-2 | Reference Standards |
| HY-W020044 | DL-alpha-Tocopherol | 10191-41-0 | Natural Products |
| HY-W020044R | DL-alpha-Tocopherol (Standard) | 10191-41-0 | Reference Standards |
| HY-W020044S | DL-alpha-Tocopherol-13C3 | Isotope-Labeled Compounds | |
| HY-W020044S1 | DL-alpha-Tocopherol-d9 | 131230-17-6 | Isotope-Labeled Compounds |
| HY-W020050 | Cystamine (dihydrochloride) | 56-17-7 | Reference compound |
| HY-W020050S | Cystamine-d8 (dihydrochloride) | 2712126-51-5 | Isotope-Labeled Compounds |
| HY-W020086 | 2,3-Diaminophenazine | 655-86-7 | Dye Reagents |
| HY-W020087S | Didodecyldimethylammonium-d6 (chloride) | Isotope-Labeled Compounds | |
| HY-W020098 | 2'-C-methyluridine | 31448-54-1 | Reference compound |
| HY-W020111 | 7-Chloro-4-(piperazin-1-yl)quinoline | 837-52-5 | Reference compound |
| HY-W020182 | α-Terpinene | 99-86-5 | Natural Products |
| HY-W020182R | α-Terpinene (Standard) | 99-86-5 | Reference Standards |
| HY-W020183 | γ-Terpinene | 99-85-4 | Natural Products |
| HY-W020183R | γ-Terpinene (Standard) | 99-85-4 | Reference Standards |
| HY-W020183S | γ-Terpinene-d3 | Isotope-Labeled Compounds | |
| HY-W020211 | Benzo Red Violet 4B | 992-59-6 | Biochemical Assay Reagents |
| HY-W020214 | Antioxidant 25 | 991-84-4 | Reference compound |
| HY-W020215 | Tricarballylic acid | 99-14-9 | Natural Products |
| HY-W020215R | Tricarballylic acid (Standard) | 99-14-9 | Reference Standards |
| HY-W020246 | Tetramethylthiuram monosulfide | 97-74-5 | Reference compound |
| HY-W020249 | Sodium ionophore X | 97600-39-0 | Reference compound |
| HY-W020361 | 2'-C-Ethynyluridine | 188413-98-1 | Reference compound |
| HY-W020420 | 6-Chloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purine | 135473-15-3 | Reference compound |
| HY-W020468 | Linopirdine | 105431-72-9 | Reference compound |
| HY-W020546 | DBCO-amine (TFA) | 2007915-94-6 | Reference compound |
| HY-W020576 | Rivastigmine metabolite | 139306-10-8 | Reference compound |
| HY-W020576R | Rivastigmine metabolite (Standard) | 139306-10-8 | Reference Standards |
| HY-W020576S | Rivastigmine metabolite-d6 | 1217706-31-4 | Isotope-Labeled Compounds |
| HY-W020655 | (R)-Benzyl mandelate | 97415-09-3 | Reference compound |
| HY-W020658 | L-α-Phosphatidylinositol | 97281-52-2 | Natural Products |
| HY-W020671S | N-[3-[3-(Dimethylamino)-1-oxo-2-propenyl]phenyl]-N-ethylacetamide-d3 | 1104483-92-2 | Isotope-Labeled Compounds |
| HY-W020678 | 2-Methylbutanal | 96-17-3 | Natural Products |
| HY-W020678S | 2-Methylbutanal-13C2 | Isotope-Labeled Compounds | |
| HY-W020678S1 | 2-Methylbutanal-d3 | 87019-40-7 | Isotope-Labeled Compounds |
| HY-W020729 | Dichloroindophenol | 956-48-9 | Biochemical Assay Reagents |
| HY-W020729R | Dichloroindophenol (Standard) | 956-48-9 | Reference Standards |
| HY-W020755 | Thiohexam | 95-33-0 | Reference compound |
| HY-W020755R | Thiohexam (Standard) | 95-33-0 | Reference Standards |
| HY-W020768 | Fullerene-C60 | 99685-96-8 | Reference compound |
| HY-W020772 | Aminoguanidine (hemisulfate) | 996-19-0 | Reference compound |
| HY-W020772AS | Aminoguanidine-13C,15N2 sulfate (1:2) | Isotope-Labeled Compounds | |
| HY-W020772AS1 | Aminoguanidine-13C,15N4 sulfate (1:2) | Isotope-Labeled Compounds | |
| HY-W020772S | Aminoguanidine sulfate-13C,15N2 | Isotope-Labeled Compounds | |
| HY-W020772S1 | Aminoguanidine sulfate-13C,15N4 | Isotope-Labeled Compounds | |
| HY-W020777 | Triflumizole | 68694-11-1 | Reference compound |
| HY-W020777R | Triflumizole (Standard) | 68694-11-1 | Reference Standards |
| HY-W020780 | mPEG-Mal (MW 5000) | 724722-89-8 | Biochemical Assay Reagents |
| HY-W020780A | mPEG-Mal (MW 350) | 724722-89-8 | Biochemical Assay Reagents |
| HY-W020780B | mPEG-Mal (MW 750) | 724722-89-8 | Biochemical Assay Reagents |
| HY-W020780C | mPEG-Mal (MW 3400) | 724722-89-8 | Biochemical Assay Reagents |
| HY-W020784 | 3-(N-Maleimidopropionyl)biocytin | 102849-12-7 | Reference compound |
| HY-W020785 | Fosthiazate | 98886-44-3 | Reference compound |
| HY-W020785R | Fosthiazate (Standard) | 98886-44-3 | Reference Standards |
| HY-W020788 | Benoxacor | 98730-04-2 | Reference compound |
| HY-W020788R | Benoxacor (Standard) | 98730-04-2 | Reference Standards |
| HY-W020790 | Sialyl-Lewis X | 98603-84-0 | Reference compound |
| HY-W020795 | Hexadecyl β-D-maltoside | 98064-96-1 | Biochemical Assay Reagents |
| HY-W020798 | 1-Palmitoyl-2-[3-(diphenylhexatriene)propanoyl]-sn-phosphatidylcholine | 98014-38-1 | Dye Reagents |
| HY-W020809 | C18(Plasm) LPC | 97802-55-6 | Reference compound |
| HY-W020826 | S-Phenylcysteine | 34317-61-8 | Peptides |
| HY-W020887 | [IrCl(COE)2]2 | 12246-51-4 | Reference compound |
| HY-W020952 | Palladium(Ⅱ) acetylacetonate | 14024-61-4 | Biochemical Assay Reagents |
| HY-W020955 | Triphenylphosphinechlorogold | 14243-64-2 | Biochemical Assay Reagents |
| HY-W020958 | Ru(acac)3 | 14284-93-6 | Biochemical Assay Reagents |
| HY-W020983 | Trifluoromethanesulfonic acid (silver) | 2923-28-6 | Biochemical Assay Reagents |
| HY-W020985 | Bis[1,2-bis(diphenylphosphino)ethane]palladium(0) | 31277-98-2 | Biochemical Assay Reagents |
| HY-W021005 | Silver bis(trifluoromethanesulfonyl)imide | 189114-61-2 | Biochemical Assay Reagents |
| HY-W021008S | 3-Hydroxy-4,5-dimethylfuran-2(5H)-one-d2 | Isotope-Labeled Compounds | |
| HY-W021016 | (+)-1,2-Bis((2S,5S)-2,5-diphenylphospholano)ethane | 824395-67-7 | Reference compound |
| HY-W021022 | Iridium(III) chloride (hydrate) | 14996-61-3 | Biochemical Assay Reagents |
| HY-W021040 | Fludioxonil | 131341-86-1 | Biochemical Assay Reagents |
| HY-W021040R | Fludioxonil (Standard) | 131341-86-1 | Reference Standards |
| HY-W021040S | Fludioxonil-13C3 | 1185003-07-9 | Isotope-Labeled Compounds |
| HY-W021042 | Tris(3-hydroxypropyltriazolylmethyl)amine | 760952-88-3 | Biochemical Assay Reagents |
| HY-W021068 | 3-Maleimidobenzoic acid N-hydroxysuccinimide ester | 58626-38-3 | Reference compound |
| HY-W021162 | Guanylate cyclase-IN-1 | 1361569-23-4 | Reference compound |
| HY-W021265 | Cyclohexane-1,2,3,4,5,6-hexaol | 6917-35-7 | Biochemical Assay Reagents |
| HY-W021267 | 3-Demethylcolchicine | 7336-33-6 | Natural Products |
| HY-W021267R | 3-Demethylcolchicine (Standard) | 7336-33-6 | Reference Standards |
| HY-W021293 | 4-Methyl-3-nitrobenzoic acid | 96-98-0 | Biochemical Assay Reagents |
| HY-W021299 | 3-Aminooxolan-2-one hydrobromide | 6305-38-0 | Peptides |
| HY-W021358 | N,N,N′,N′-Tetramethyl-p-phenylenediamine | 100-22-1 | Reference compound |
| HY-W021377 | Exatecan Intermediate 2 | 182182-31-6 | Reference compound |
| HY-W021377A | Exatecan Intermediate 2 (hydrochloride) | 2437603-23-9 | Reference compound |
| HY-W021377B | Exatecan Intermediate 4 | 2436720-50-0 | Reference compound |
| HY-W021377C | Exatecan Intermediate 4 (dihydrochloride) | Reference compound | |
| HY-W021399S | Lidocaine impurity 5-d6 | Isotope-Labeled Compounds | |
| HY-W021400S | Sodium 2-Methylpropionate-1-13C | 71105-51-6 | Isotope-Labeled Compounds |
| HY-W021401 | Amino-PEG3-C2-Azido | 134179-38-7 | Reference compound |
| HY-W021425 | D-Mannosamine (hydrochloride) | 5505-63-5 | Natural Products |
| HY-W021448 | Glycocyamine | 352-97-6 | Natural Products |
| HY-W021448S | Glycocyamine-d2 | 1173020-63-7 | Isotope-Labeled Compounds |
| HY-W021448S1 | Glycocyamine-15N,13C2 | 2483829-93-0 | Isotope-Labeled Compounds |
| HY-W021450A | DL-Fluorocitric acid (barium) | 100929-81-5 | Reference compound |
| HY-W021482 | (4S)-1-Boc-4-fluoro-D-proline | 681128-50-7 | Peptides |
| HY-W021597 | N-Boc-5-bromoindole | 182344-70-3 | Reference compound |
| HY-W021787 | NH2-PEG4-CH2CH2COOH | 663921-15-1 | ADC Related |
| HY-W021790 | 2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid | 35264-05-2 | Peptides |
| HY-W021879 | DSRM-3716 | 58142-99-7 | Reference compound |
| HY-W022036 | 2-Ethoxyphenol | 94-71-3 | Biochemical Assay Reagents |
| HY-W022036S | 2-Ethoxyphenol-d5 | 117320-30-6 | Isotope-Labeled Compounds |
| HY-W022039S | (Benzyloxy)benzene-d2 | 124781-15-3 | Isotope-Labeled Compounds |
| HY-W022047 | nNOS-IN-1 | 945762-00-5 | Reference compound |
| HY-W022134 | N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methylalanine | 1362858-88-5 | Peptides |
| HY-W022137 | 2-((tert-Butoxycarbonyl)(methyl)amino)propanoic acid | 13734-31-1 | Peptides |
| HY-W022138 | N-Tert-Butoxycarbonyl-(4S)-4-Methoxymethyl-L-proline | 1378388-16-9 | Peptides |
| HY-W022164 | 7-Bromoquinoline-4-carboxylic acid | 31009-04-8 | Reference compound |
| HY-W022220 | H-His(trt)-OMe hydrochloride | 32946-56-8 | Peptides |
| HY-W022223 | Fmoc-3-Chloro-L-phenylalanine | 198560-44-0 | Peptides |
| HY-W022224 | 3,6-Diiodo-9H-carbazole | 57103-02-3 | Reference compound |
| HY-W022226 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-(phenylmethyl)-D-serine | 122889-11-6 | Peptides |
| HY-W022227 | Fmoc-D-Tyr(Me)-OH | 201335-88-8 | Peptides |
| HY-W022228 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine | 206060-40-4 | Peptides |
| HY-W022232 | Boc-NH-PEG5-CH2CH2COOH | 1347750-78-0 | Reference compound |
| HY-W022240 | NH2-PEG5-C2-NH-Boc | 189209-27-6 | Reference compound |
| HY-W022250 | Z-Tyr-OtBu | 16881-33-7 | Peptides |
| HY-W022255 | Fmoc-D-Glu-OH | 104091-09-0 | Peptides |
| HY-W022281 | Fmoc-N-Me-D-Ala-OH | 138774-92-2 | Peptides |
| HY-W022290 | 5-Bromocytidine | 3066-86-2 | Reference compound |
| HY-W022362 | 2-Aminotetralin | 2954-50-9 | Reference compound |
| HY-W022390 | 3-(3,4,5-Trimethoxyphenyl)propanoic acid | 25173-72-2 | Natural Products |
| HY-W022404 | H-D-4-Pal-OH.2HCl | 174096-41-4 | Peptides |
| HY-W022405 | (S)-2-Amino-3-(pyridin-4-yl)propanoic acid dihydrochloride | 178933-04-5 | Peptides |
| HY-W022444 | Z-N-Me-Ala-OH | 21691-41-8 | Peptides |
| HY-W022446 | Z-β-D-HomoAla-OH | 67843-72-5 | Peptides |
| HY-W022447 | Z-D-MeAla-OH | 68223-03-0 | Peptides |
| HY-W022471 | (S)-2-Amino-3-(3-chlorophenyl)propanoic acid hydrochloride | 123053-22-5 | Peptides |
| HY-W022536 | (R)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate | 1146954-88-2 | Peptides |
| HY-W022593 | (R)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylbutanoic acid | 89536-85-6 | Peptides |
| HY-W022630 | 2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid | 811460-95-4 | Peptides |
| HY-W022657 | H-Met-OiPr (hydrochloride) | 85391-05-5 | Peptides |
| HY-W022759 | 9-Acridinecarboxylic acid | 5336-90-3 | Reference compound |
| HY-W022796 | (S)-2-Amino-3-(benzo[b]thiophen-3-yl)propanoic acid | 72120-71-9 | Peptides |
| HY-W022823 | 2-Amino-2-(3-(trifluoromethyl)phenyl)acetic acid | 242475-26-9 | Peptides |
| HY-W022973 | Trinexapac-ethyl | 95266-40-3 | Reference compound |
| HY-W022973R | Trinexapac-ethyl (Standard) | 95266-40-3 | Reference Standards |
| HY-W023023 | 3-Carboxy-6-hydroxycoumarin | 56437-16-2 | Reference compound |
| HY-W023121 | Fmoc-Gly-Gly-OH | 35665-38-4 | ADC Related |
| HY-W023144 | Tris(1-chloro-2-propyl) phosphate | 13674-84-5 | Reference compound |
| HY-W023144S | Tris(1-chloro-2-propyl) phosphate-d18 | 1447569-78-9 | Isotope-Labeled Compounds |
| HY-W023145 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-L-cysteine | 73724-43-3 | Peptides |
| HY-W023253 | Biclotymol | 15686-33-6 | Reference compound |
| HY-W023443S | 2-Isopropyl-5-methylpyrazine-d3 | 1335401-30-3 | Isotope-Labeled Compounds |
| HY-W023493 | DL-Allylglycine | 7685-44-1 | Peptides |
| HY-W023573 | 5-Aminothalidomide | 191732-76-0 | Biochemical Assay Reagents |
| HY-W023757 | N-Hydroxyisonicotinamidine | 1594-57-6 | Reference compound |
| HY-W023758 | HDGFRP2/PSIP1-IN-1 | 166196-54-9 | Reference compound |
| HY-W023983 | Chalcone dibromide | 611-91-6 | Reference compound |
| HY-W024067 | WAY-608119 | 50362-93-1 | Reference compound |
| HY-W024104S | 2-(4-Fluorophenyl)pyridine-d8 | Isotope-Labeled Compounds | |
| HY-W024241 | Tidiacic | 30097-06-4 | Reference compound |
| HY-W024297 | VP-4509 | 2190144-51-3 | Reference compound |
| HY-W024354 | 2-[4-(2-Bromo-1-oxopropyl)phenoxy]acetic acid | 33254-93-2 | Biochemical Assay Reagents |
| HY-W024365 | 3-tert-Butyl-4-methoxyphenol | 88-32-4 | Reference compound |
| HY-W024365R | 3-tert-Butyl-4-methoxyphenol (Standard) | 88-32-4 | Reference Standards |
| HY-W024365S | 2-tert-Butyl-4-hydroxyanisole-d3 | 1794892-02-6 | Isotope-Labeled Compounds |
| HY-W024485 | SARS-CoV-2-IN-86 | 368866-07-3 | Peptides |
| HY-W024554 | AC-Asp(OtBU)-OH | 117833-18-8 | Peptides |
| HY-W024604 | 4,4-Dimethyl-2-cyclopenten-1-one | 22748-16-9 | Natural Products |
| HY-W024644 | Hydroxyethylthio Vitamine K3 | 59147-84-1 | Reference compound |
| HY-W024692 | Indomethacin methylester | 1601-18-9 | Reference compound |
| HY-W024698 | β-Cyclogeraniol | 472-20-8 | Natural Products |
| HY-W024881 | Potassium;2,3,3-Trimethylindole-5-sulfonate | 184351-56-2 | Dye Reagents |
| HY-W024939 | 2-Amino-3-(2-chlorobenzoyl)-5-ethylthiophene | 50508-60-6 | Reference compound |
| HY-W024975 | 2-Propylheptanol | 10042-59-8 | Reference compound |
| HY-W024986S | 4-(4-Hexoxyphenyl)benzonitrile-13C6 | Isotope-Labeled Compounds | |
| HY-W024997S | N,N-Diethyl-2-hydroxyacetamide-d10 | 2733271-12-8 | Isotope-Labeled Compounds |
| HY-W025062 | Diethyl pyridine-2,4-dicarboxylate | 41438-38-4 | Reference compound |
| HY-W025074 | BML-278 | 120533-76-8 | Reference compound |
| HY-W025101S | Ethyl 3-hydroxy-3-methylbutanoate-d6 | 30385-86-5 | Isotope-Labeled Compounds |
| HY-W025371 | Dihydrosinapyl alcohol | 20736-25-8 | Natural Products |
| HY-W025438 | 5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine | 103285-22-9 | Reference compound |
| HY-W025443 | 6-(4-Methoxyphenyl)pyridazin-3-amine | 4776-87-8 | Reference compound |
| HY-W025445 | Spiro-MeOTAD | 207739-72-8 | Reference compound |
| HY-W025616 | 5-Hydroxypyrazinecarboxamide | 13924-96-4 | Biochemical Assay Reagents |
| HY-W025723 | N-Carbobenzoxy-L-homoserine | 35677-88-4 | Reference compound |
| HY-W025723A | N-Carbobenzoxy-D-homoserine | 41088-85-1 | Reference compound |
| HY-W025784 | Kalibor | 143-66-8 | Biochemical Assay Reagents |
| HY-W025784R | Kalibor (Standard) | 143-66-8 | Reference Standards |
| HY-W025785 | Methyl yellow | 60-11-7 | Reference compound |
| HY-W025785S | Methyl yellow-d5 | 1398109-08-4 | Isotope-Labeled Compounds |
| HY-W025799 | N-Benzylideneaniline | 538-51-2 | Reference compound |
| HY-W025807 | Fmoc-His(Boc)-OH | 81379-52-4 | Peptides |
| HY-W025811 | 1-(tert-Butyl) 5-methyl L-glutamate hydrochloride | 34582-33-7 | Peptides |
| HY-W025812 | Boc-NH-PEG2-CH2CH2COOH | 1365655-91-9 | Reference compound |
| HY-W025817 | Citrazinic acid | 99-11-6 | Dye Reagents |
| HY-W025830 | 2-(1-(2-Amino-2-oxoethyl)cyclohexyl)acetic acid | 99189-60-3 | Biochemical Assay Reagents |
| HY-W025896 | Boc-NH-PEG4 | 106984-09-2 | Reference compound |
| HY-W025916 | Methanol-d1 | 1455-13-6 | Reference compound |
| HY-W026029 | Cyclohexyl ethyl ketone | 1123-86-0 | Biochemical Assay Reagents |
| HY-W026038 | (Z)-Non-2-en-1-ol | 41453-56-9 | Reference compound |
| HY-W026072 | (1H-Pyrrole-2-carbonyl)glycine | 98276-81-4 | Peptides |
| HY-W026082 | 4-Ketobenztriazine-CH2COOH | 97609-01-3 | Reference compound |
| HY-W026109 | FTO-IN-12 | 955328-22-0 | Reference compound |
| HY-W026467 | MMV665916 | 896356-25-5 | Reference compound |
| HY-W026508 | 1-[(3,5-Dimethylisoxazol-4-yl)sulfonyl]proline | 890169-54-7 | Peptides |
| HY-W026644 | Acridine-9-carboxaldehyde | 885-23-4 | Reference compound |
| HY-W026772 | Fluorene | 86-73-7 | Dye Reagents |
| HY-W026772R | Fluorene (Standard) | 86-73-7 | Dye Reagents |
| HY-W026772S | Fluorene-d10 | 81103-79-9 | Isotope-Labeled Compounds |
| HY-W026772S1 | Fluorene-d8 | 35782-21-9 | Isotope-Labeled Compounds |
| HY-W026894 | 2-Amino-2-(2-fluorophenyl)acetic acid | 84145-28-8 | Peptides |
| HY-W027038 | Ethyl mandelate | 774-40-3 | Reference compound |
| HY-W027126 | Hepatoprotective agent-2 | 74873-41-9 | Reference compound |
| HY-W027208 | 1,4-Bis(3-aminopropyl)piperazine | 7209-38-3 | Reference compound |
| HY-W027230 | N-[4-(Morpholin-4-ylsulfonyl)benzoyl]glycine | 712344-24-6 | Peptides |
| HY-W027251 | DL-Lysine Monohydrochloride | 70-53-1 | Peptides |
| HY-W027340 | ARM1 | 68729-05-5 | Reference compound |
| HY-W027382 | SEP-227900 | 67268-37-5 | Reference compound |
| HY-W027446 | Pyridoxal hydrochloride | 65-22-5 | Natural Products |
| HY-W027446R | Pyridoxal hydrochloride (Standard) | 65-22-5 | Reference Standards |
| HY-W027544 | MCA | 62935-72-2 | Dye Reagents |
| HY-W027544S | MCA-d3 | Isotope-Labeled Compounds | |
| HY-W027544S1 | Dansyl propargylamine-d6 | Isotope-Labeled Compounds | |
| HY-W027553 | Ipidacrine | 62732-44-9 | Reference compound |
| HY-W027555 | Ethoxyacetic acid | 627-03-2 | Natural Products |
| HY-W027592 | 1H-1,2,4-Triazol-3-amine | 61-82-5 | Biochemical Assay Reagents |
| HY-W027592R | 1H-1,2,4-Triazol-3-amine (Standard) | 61-82-5 | Reference Standards |
| HY-W027595 | N-Benzyl-6-chloropyrimidin-4-amine | 61667-16-1 | Reference compound |
| HY-W027631 | cis-2-Butene-1,4-diol | 6117-80-2 | Reference compound |
| HY-W027751 | 2-Methylanisole | 578-58-5 | Reference compound |
| HY-W027751R | 2-Methylanisole (Standard) | 578-58-5 | Reference Standards |
| HY-W027751S | 2-Methylanisole-d3 | 258832-47-2 | Isotope-Labeled Compounds |
| HY-W027773 | 7-Methoxy-4-(trifluoromethyl)coumarin | 575-04-2 | Reference compound |
| HY-W027829 | ((3-Chlorophenyl)sulfonyl)glycine | 565198-64-3 | Peptides |
| HY-W027857 | Coumarin 314 | 55804-66-5 | Dye Reagents |
| HY-W027872 | Piperonyl acetone | 55418-52-5 | Reference compound |
| HY-W027951 | N,N'-Dimethylthiourea | 534-13-4 | Natural Products |
| HY-W027968 | Coumarin-3-carboxylic Acid | 531-81-7 | Reference compound |
| HY-W028026S | Methacetin-methoxy-13C | 72156-70-8 | Isotope-Labeled Compounds |
| HY-W028047 | JFD01307SC | 51070-56-5 | Reference compound |
| HY-W028108 | Piperonyl alcohol | 495-76-1 | Reference compound |
| HY-W028127 | IKKβ-IN-4 | 4815-35-4 | Reference compound |
| HY-W028142 | Quipazine | 4774-24-7 | Reference compound |
| HY-W028145 | TGF-βRI inhibitor 2 | 476474-11-0 | Reference compound |
| HY-W028160 | 5-(2-Aminopyridyl)amide oxime | 468068-28-2 | Reference compound |
| HY-W028185 | 3-(4-Fluorophenyl)propanoic acid | 459-31-4 | Biochemical Assay Reagents |
| HY-W028210 | O-Phthalimide-C5-acid | 4443-26-9 | Reference compound |
| HY-W028263 | 6-Hydroxyflavanone | 4250-77-5 | Natural Products |
| HY-W028350 | NSC727447 | 40106-12-5 | Reference compound |
| HY-W028389 | Pyrazolam | 39243-02-2 | Reference compound |
| HY-W028389S | Pyrazolam-d7 | Isotope-Labeled Compounds | |
| HY-W028393 | Indole-3-pyruvic acid | 392-12-1 | Reference compound |
| HY-W028393R | Indole-3-pyruvic acid (Standard) | 392-12-1 | Reference Standards |
| HY-W028475 | 1-(2,5-Dimethoxybenzyl)piperazine (hydrochloride) | 374897-99-1 | Reference compound |
| HY-W028600S | Norphensuximide-d5 | Isotope-Labeled Compounds | |
| HY-W028684 | 2,4′-Dichloroacetanilide | 3289-75-6 | Reference compound |
| HY-W028690 | DNMDP | 328104-79-6 | Reference compound |
| HY-W028714 | 2,3-Diphenylquinoxaline-6-carboxylic acid | 32387-96-5 | Reference compound |
| HY-W028793 | N-(2,1,3-Benzothiadiazol-4-ylsulfonyl)glycine | 312591-21-2 | Peptides |
| HY-W028809 | 5-Methyl-4-phenyl-2-thiazolamine | 30709-67-2 | Reference compound |
| HY-W028813 | Acetobromo-α-D-galactose | 3068-32-4 | Reference compound |
| HY-W028943S | (E)-3-Methyl-2-hexenoic acid-d5 | Isotope-Labeled Compounds | |
| HY-W028991 | N-(4-Nitrobenzoyl)glycine | 2645-07-0 | Peptides |
| HY-W029411 | 4-(Benzo[d]oxazol-2-yl)aniline | 20934-81-0 | Reference compound |
| HY-W029450S | Tetrahydropyrimidine-2(1H)-thione-d6 | 1219802-05-7 | Isotope-Labeled Compounds |
| HY-W029600 | 6,7-Dimethylisatin | 20205-43-0 | Reference compound |
| HY-W029652 | ((2,6-Dichlorophenyl)sulfonyl)glycine | 19818-06-5 | Peptides |
| HY-W029659 | 1-Benzyl-1,2,3,4-tetrahydro-isoquinoline | 19716-56-4 | Reference compound |
| HY-W029719 | [5-(2-Thienyl)-3-isoxazolyl]methanol | 194491-44-6 | Reference compound |
| HY-W030112 | 2-Pyridinecarboxamidoxime | 1772-01-6 | Reference compound |
| HY-W030120 | 2-(1-(4-Fluorobenzyl)-1H-indol-3-yl)acetic acid | 176204-51-6 | Reference compound |
| HY-W030266 | 3-Aminocoumarin | 1635-31-0 | Reference compound |
| HY-W030286 | Butyl 3-mercaptopropionate | 16215-21-7 | Biochemical Assay Reagents |
| HY-W030319 | Methyl 2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetate | 15991-13-6 | Dye Reagents |
| HY-W030321 | ((4-(tert-Butyl)phenyl)sulfonyl)phenylalanine | 159856-01-6 | Peptides |
| HY-W030338 | aPKC-IN-2 | 15854-08-7 | Reference compound |
| HY-W030347 | cis-2-Penten-1-ol | 1576-95-0 | Biochemical Assay Reagents |
| HY-W030545 | (4-Oxo-4H-quinazolin-3-yl)-acetic acid | 14663-53-7 | Reference compound |
| HY-W030573 | ((4'-Chloro-[1,1'-biphenyl]-4-yl)sulfonyl)phenylalanine | 1449133-06-5 | Peptides |
| HY-W030771 | ((4-(tert-Butyl)phenyl)sulfonyl)methionine | 1393654-69-7 | Peptides |
| HY-W030778 | Nitrilotriacetic acid | 139-13-9 | Reference compound |
| HY-W030778R | Nitrilotriacetic acid (Standard) | 139-13-9 | Reference Standards |
| HY-W030778S | Nitrilotriacetic acid-d9 | 807630-34-8 | Isotope-Labeled Compounds |
| HY-W030796 | Lactisole (free acid) | 13794-15-5 | Reference compound |
| HY-W030796A | Lactisole | 150436-68-3 | Reference compound |
| HY-W030796AR | Lactisole (Standard) | 150436-68-3 | Reference Standards |
| HY-W030796R | Lactisole (free acid) (Standard) | 13794-15-5 | Reference Standards |
| HY-W031110 | 2-Methyl-tetrahydro-β-carboline | 13100-00-0 | Reference compound |
| HY-W031126 | 7-Hydroxyisoflavone | 13057-72-2 | Natural Products |
| HY-W031230 | N4-Acetylsulfamerazine | 127-73-1 | Reference compound |
| HY-W031307 | Topoisomerase IIα-IN-8 | 1251578-67-2 | Reference compound |
| HY-W031471A | Pyrazine-2-amidoxime | 51285-05-3 | Reference compound |
| HY-W031510 | 3,6-Dihydroxyxanthone | 1214-24-0 | Reference compound |
| HY-W031519 | Chloraminophenamide | 121-30-2 | Reference compound |
| HY-W031536 | 2-Imidazolidone, 96% | 120-93-4 | Biochemical Assay Reagents |
| HY-W031536R | 2-Imidazolidone, 96% (Standard) | 120-93-4 | Reference Standards |
| HY-W031620 | VGSCs-IN-1 | 1204296-79-6 | Reference compound |
| HY-W031727 | Hydroxychloroquine | 118-42-3 | Reference compound |
| HY-W031727S | Hydroxychloroquine-d4-1 (sulfate) | 1216432-56-2 | Isotope-Labeled Compounds |
| HY-W031727S1 | Hydroxychloroquine-d5 | Isotope-Labeled Compounds | |
| HY-W031757 | Anthraquinone-2-carboxylic acid | 117-78-2 | Natural Products |
| HY-W032013 | 1-Octanol | 111-87-5 | Natural Products |
| HY-W032013R | 1-Octanol (Standard) | 111-87-5 | Reference Standards |
| HY-W032013S | 1-Octanol-d17 | 153336-13-1 | Isotope-Labeled Compounds |
| HY-W032013S1 | 1-Octanol-d2 | 78510-02-8 | Isotope-Labeled Compounds |
| HY-W032013S2 | 1-Octanol-d2-1 | 1335435-64-7 | Isotope-Labeled Compounds |
| HY-W032013S3 | 1-Octanol-d5 | Isotope-Labeled Compounds | |
| HY-W032014 | Octylamine | 111-86-4 | Reference compound |
| HY-W032014S | Octan-1-amine-d17 | 1173022-14-4 | Isotope-Labeled Compounds |
| HY-W032015 | 1-Bromooctane | 111-83-1 | Reference compound |
| HY-W032015S | 1-Bromooctane-d17 | 126840-36-6 | Isotope-Labeled Compounds |
| HY-W032015S1 | 1-Bromooctane-1,1-d2 | 86423-34-9 | Isotope-Labeled Compounds |
| HY-W032015S2 | 1-Bromooctane-8,8,8-d3 | 69373-25-7 | Isotope-Labeled Compounds |
| HY-W032015S3 | 1-Bromooctane-d4 | 1219803-37-8 | Isotope-Labeled Compounds |
| HY-W032022 | 1-Hexanol | 111-27-3 | Natural Products |
| HY-W032022R | 1-Hexanol (Standard) | 111-27-3 | Reference Standards |
| HY-W032022S | 1-Hexanol-d13 | 204244-84-8 | Isotope-Labeled Compounds |
| HY-W032022S1 | 1-Hexanol-d11 | 2159-18-4 | Isotope-Labeled Compounds |
| HY-W032022S2 | 1-Hexanol-d3 | 52598-04-6 | Isotope-Labeled Compounds |
| HY-W032022S3 | 1-Hexanol-d5 | 64118-18-9 | Isotope-Labeled Compounds |
| HY-W032022S4 | 1-Hexanol-d2 | 1335436-46-8 | Isotope-Labeled Compounds |
| HY-W032349S | 1,2-Propylene-d6 carbonate | 202480-74-8 | Isotope-Labeled Compounds |
| HY-W032375S | 3-Mercaptopropionic acid-d4 | 1141488-67-6 | Isotope-Labeled Compounds |
| HY-W032681 | N-(2,5-Dimethylphenylsulfonyl)-DL-leucine | 1009793-82-1 | Peptides |
| HY-W032689 | N-(2,3,5,6-Tetramethylphenylsulfonyl)-DL-alanine | 1009671-00-4 | Peptides |
| HY-W032848 | Tinoridine | 24237-54-5 | Reference compound |
| HY-W032915 | 5-Phenylvaleric acid | 2270-20-4 | Natural Products |
| HY-W032915R | 5-Phenylvaleric acid (Standard) | 2270-20-4 | Reference Standards |
| HY-W032970 | Isomaltitol | 534-73-6 | Reference compound |
| HY-W033010 | Pseudotropine | 135-97-7 | Natural Products |
| HY-W033027 | BGT1-IN-1 | 406947-32-8 | Reference compound |
| HY-W033049 | DABCO-Bis(sulfur dioxide) | 119752-83-9 | Biochemical Assay Reagents |
| HY-W033132 | N-(2-Methoxyethyl)-N-methylglycine | 915925-21-2 | Peptides |
| HY-W033277 | Tetrakis(acetonitrile)palladium(II) (tetrafluoroborate) | 21797-13-7 | Reference compound |
| HY-W033312 | Dichlorobis(tricyclohexylphosphine)palladium(II) | 29934-17-6 | Biochemical Assay Reagents |
| HY-W033466 | Dichloro(benzene)ruthenium(II) dimer | 37366-09-9 | Biochemical Assay Reagents |
| HY-W033559 | Carbonylhydrido(tetrahydroborato)[bis(2-diphenylphosphinoethyl) aMino]ruthenium(II) | 1295649-41-0 | Reference compound |
| HY-W033573 | Hexaammineruthenium(II) (chloride) | 15305-72-3 | Reference compound |
| HY-W033577 | Tricarbonyldichlororuthenium(II) dimer | 22594-69-0 | Reference compound |
| HY-W033813 | Caspase-3/7 Inhibitor I | 1110670-49-9 | Reference compound |
| HY-W033823 | Rhodium(III) oxide | 12036-35-0 | Reference compound |
| HY-W033831 | Rhodium(II) triphenylacetate dimer | 142214-04-8 | Reference compound |
| HY-W034041 | Ir(p-F-ppy)3 | 370878-69-6 | Reference compound |
| HY-W034065 | 3,5-Dihydroxyacetophenone | 51863-60-6 | Reference compound |
| HY-W034067 | Silver nitrite | 7783-99-5 | Biochemical Assay Reagents |
| HY-W034097S | trans-Trismethoxy Resveratrol-d4 | 1089051-64-8 | Isotope-Labeled Compounds |
| HY-W034099 | (1R,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester | 1124175-25-2 | Reference compound |
| HY-W034154 | Dihydridotetrakis(triphenylphosphine)ruthenium(II) | 19529-00-1 | Reference compound |
| HY-W034344 | Sodium methanesulfonate | 2386-57-4 | Biochemical Assay Reagents |
| HY-W034344S | Sodium methanesulfonate-d3 | 1610056-71-7 | Isotope-Labeled Compounds |
| HY-W034392 | Stewart-Grubbs catalyst | 927429-61-6 | Reference compound |
| HY-W034419 | STIMA-1 | 91634-12-7 | Reference compound |
| HY-W034551 | DOTA-tri(t-butyl ester) | 137076-54-1 | Reference compound |
| HY-W034566 | Hexacyclen | 296-35-5 | Biochemical Assay Reagents |
| HY-W034566A | Hexacyclen (trisulfate) | 56187-09-8 | Biochemical Assay Reagents |
| HY-W034576 | Hexacyclen (hexahydrochloride) | 58105-91-2 | Biochemical Assay Reagents |
| HY-W034595 | Eicosanedioic acid | 2424-92-2 | ADC Related |
| HY-W034596 | Nonadecanedioic acid | 6250-70-0 | Biochemical Assay Reagents |
| HY-W034597 | 20-(tert-Butoxy)-20-oxoicosanoic acid | 683239-16-9 | ADC Related |
| HY-W034599 | Boc-C14-COOH | 843666-27-3 | ADC Related |
| HY-W034606 | 2-[2-(Dicyclohexylphosphino)phenyl]-1-methyl-1H-indole | 1067883-58-2 | Reference compound |
| HY-W034627 | 5,10,15-Tri(pentafluorophenyl)corrole | 262280-80-8 | Biochemical Assay Reagents |
| HY-W034674 | Silver diethyldithiocarbamate | 1470-61-7 | Biochemical Assay Reagents |
| HY-W034796 | Cobaltocene hexafluorophosphate | 12427-42-8 | Biochemical Assay Reagents |
| HY-W034801 | Copper(II) acetylacetonate | 13395-16-9 | Reference compound |
| HY-W034918 | Docosanedioic acid | 505-56-6 | ADC Related |
| HY-W034953 | Bathocuproine disulfonate (disodium) | 52698-84-7 | Biochemical Assay Reagents |
| HY-W034976 | Decamethylzirconocene dichloride | 54039-38-2 | Reference compound |
| HY-W034985 | Tetrakis(triphenylphosphine)platinum | 14221-02-4 | Biochemical Assay Reagents |
| HY-W035051 | TSPP (tetrasodium) | 39050-26-5 | Biochemical Assay Reagents |
| HY-W035090 | Chloro(trimethylphosphine)gold(I) | 15278-97-4 | Reference compound |
| HY-W035091 | Tetrachloroauric acid | 16903-35-8 | Reference compound |
| HY-W035129 | endo-BCN-NHS carbonate | 1426827-79-3 | Reference compound |
| HY-W035133 | 5,10,15,20-Tetrakis(p-tolyl)porphyrin | 14527-51-6 | Biochemical Assay Reagents |
| HY-W035136 | Meso-tetrakis(4-aminophenyl)porphyrin | 22112-84-1 | Reference compound |
| HY-W035137 | 5,15-Diphenylporphyrin | 22112-89-6 | Reference compound |
| HY-W035138 | Tetra(p-bromophenyl)porphyrin | 29162-73-0 | Dye Reagents |
| HY-W035139 | 5,10,15,20-Tetrakis(2,6-dichlorophenyl)-21H,23H-porphine | 37083-37-7 | Biochemical Assay Reagents |
| HY-W035140 | 5,10,15,20-Tetrakis(4-hydroxyphenyl)porphyrin | 51094-17-8 | Biochemical Assay Reagents |
| HY-W035141 | 5,10,15,20-Tetrakis(2,4,6-trimethylphenyl)porphyrin | 56396-12-4 | Biochemical Assay Reagents |
| HY-W035155 | (1,5-Cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) (hexafluorophosphate) | 38465-86-0 | Reference compound |
| HY-W035178 | 2-Methylthio-4-(tributylstannyl)pyrimidine | 123061-49-4 | Biochemical Assay Reagents |
| HY-W035214 | Hydroxyisohexyl 3-cyclohexene carboxaldehyde | 31906-04-4 | Reference compound |
| HY-W035305 | Methyl 2-(6-bromo-1H-indol-3-yl)acetate | 152213-63-3 | Natural Products |
| HY-W035309 | 5-Bromo-3-indoxylacetate | 17357-14-1 | Reference compound |
| HY-W035361S | (Aminomethyl)phosphonic acid-d2 | 30926-24-0 | Isotope-Labeled Compounds |
| HY-W035362 | ω-Pentadecalactone | 106-02-5 | Natural Products |
| HY-W035375 | Mephedrone metabolite (hydrochloride) ((±)-ephedrine stereochemistry) | 117342-78-6 | Reference compound |
| HY-W035376 | m-PEG6-CH2CH2CHO | 1058691-77-2 | ADC Related |
| HY-W035378 | Fmoc-N-methyl-PEG3-CH2CH2COOH | 1807518-77-9 | ADC Related |
| HY-W035384 | MAO-B ligand-1 | 1010879-39-6 | Reference compound |
| HY-W035399S | D-Lysine-d8 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W035399S1 | D-Lysine-d4 (dihydrochloride) | 2708340-91-2 | Isotope-Labeled Compounds |
| HY-W035404 | 1-(1,3-Diphenylpropan-2-yl)pyrrolidine (hydrochloride) | 102009-66-5 | Reference compound |
| HY-W035409 | RPW-24 | 1001625-82-6 | Reference compound |
| HY-W035417 | Diethyl 7-bromoheptylphosphonate | 100462-73-5 | Reference compound |
| HY-W035520 | HBED (dihydrochloride) | 35369-53-0 | Biochemical Assay Reagents |
| HY-W035599 | Ir[p-F(t-Bu)-ppy]3 | 1311386-93-2 | Reference compound |
| HY-W035709 | Hydrocinchonine | 485-65-4 | Reference compound |
| HY-W035886 | Benzyl D-serinate hydrochloride | 151651-44-4 | Peptides |
| HY-W035903 | Ethanolamine (hydrochloride) | 2002-24-6 | Biochemical Assay Reagents |
| HY-W035903S | Ethanolamine-13C2 (hydrochloride) | 1173019-25-4 | Isotope-Labeled Compounds |
| HY-W035903S2 | Ethanolamine-d4 (hydrochloride) | 2483832-03-5 | Isotope-Labeled Compounds |
| HY-W035904 | Tropone | 539-80-0 | Natural Products |
| HY-W035914 | N-((Benzyloxy)carbonyl)-N-methyl-L-isoleucine | 42417-66-3 | Peptides |
| HY-W036034A | GRK-IN-1 | 5423-98-3 | Reference compound |
| HY-W036121 | (1H-Indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 895152-66-6 | Reference compound |
| HY-W036160 | N-Fmoc-O-ethyl-L-homoserine | 1932074-99-1 | Peptides |
| HY-W036167 | DMT-2'-F-dA Phosphoramidite | 252770-65-3 | Reference compound |
| HY-W036222 | Dodecyl glycinate | 13827-65-1 | Peptides |
| HY-W036238S | N,N-Diisopropylnitrous amide-d14 | Isotope-Labeled Compounds | |
| HY-W036320 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-Nw-((4-methoxy-2,3,6-trimethylphenyl)sulfonyl)-N2-methyl-L-arginine | 214750-72-8 | Peptides |
| HY-W036322 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-S-trityl-L-cysteine | 944797-51-7 | Peptides |
| HY-W036324 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-benzyl-N-methyl-L-threonine | 198561-81-8 | Peptides |
| HY-W036329 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-L-threonine | 252049-06-2 | Peptides |
| HY-W036333 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-N2-methyl-L-lysine | 197632-76-1 | Peptides |
| HY-W036352 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-allylglycine | 222725-35-1 | Peptides |
| HY-W036388 | Phenylmethyl 2-(acetylamino)-2-deoxy-α-D-glucopyranoside | 13343-62-9 | Biochemical Assay Reagents |
| HY-W036410 | Aminopropyltrimethoxysilane | 13822-56-5 | Biochemical Assay Reagents |
| HY-W036553 | 6-Hydroxypyridin-2(1H)-one hydrochloride | 10357-84-3 | Natural Products |
| HY-W036579 | Methioninol | 502-83-0 | Biochemical Assay Reagents |
| HY-W036647 | 1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose | 4064-06-6 | Biochemical Assay Reagents |
| HY-W036701 | 6-Oxaspiro[3.4]octan-2-one | 1638771-98-8 | Reference compound |
| HY-W036733 | 4-Hydroxy-4-methylcyclohexanone | 17429-02-6 | Biochemical Assay Reagents |
| HY-W036734 | Tetrabutylammonium (hydrogen difluoride) | 23868-34-0 | Biochemical Assay Reagents |
| HY-W037120 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-((4-methoxyphenyl)diphenylmethyl)-D-cysteine | 1198791-73-9 | Peptides |
| HY-W037193 | Calcium Channel antagonist 5 | 21829-09-4 | Reference compound |
| HY-W037200 | 2,3,5-Tri-O-benzyl-D-ribose | 54623-25-5 | Biochemical Assay Reagents |
| HY-W037282 | O-Desmethyl quinidine | 70877-75-7 | Reference compound |
| HY-W037331 | 4,4-Difluorobenzhydrol | 365-24-2 | Reference compound |
| HY-W037355 | 4-Maleimidobutyric acid | 57078-98-5 | Reference compound |
| HY-W037417 | DAO-IN-1 | 51856-25-8 | Reference compound |
| HY-W037441 | N-Boc-L-3,5-difluorophenylalanine | 205445-52-9 | Peptides |
| HY-W037443 | Methyl L-valinate | 4070-48-8 | Peptides |
| HY-W037443S | Methyl L-valinate-d8 | Isotope-Labeled Compounds | |
| HY-W037451 | Methyl L-leucinate | 2666-93-5 | Peptides |
| HY-W037483 | D-(-)-Tartaric acid diisopropyl ester | 62961-64-2 | Biochemical Assay Reagents |
| HY-W037549 | 5,5,5-Trifluoro-DL-leucine | 2792-72-5 | Peptides |
| HY-W037619 | Pteridine-2,4(1H,3H)-dione | 487-21-8 | Natural Products |
| HY-W037817 | Dimethyl L-glutamate | 6525-53-7 | Peptides |
| HY-W037819 | 6-Methylpterin | 708-75-8 | Reference compound |
| HY-W037822 | 6,7-Dimethylpterin | 611-55-2 | Reference compound |
| HY-W037823 | Pterin-6-carboxylic acid | 948-60-7 | Reference compound |
| HY-W037825 | Pterin | 2236-60-4 | Reference compound |
| HY-W037848 | Adamantan-1-ylmethanamine | 17768-41-1 | Reference compound |
| HY-W037875 | α-Acetamidocinnamic acid | 5469-45-4 | Natural Products |
| HY-W037893 | METTL3 activator-1 | 122323-88-0 | Reference compound |
| HY-W037976 | Tyrosinase-IN-22 | 25369-78-2 | Reference compound |
| HY-W037980 | Succinamic acid | 638-32-4 | Reference compound |
| HY-W038001 | DOTA-benzene | 123317-52-2 | Reference compound |
| HY-W038237 | 2-(4-Hydroxyphenyl)-5-pyrimidinol | 142172-97-2 | Dye Reagents |
| HY-W038287 | 2-Methylbenzoxazole | 95-21-6 | Natural Products |
| HY-W038287R | 2-Methylbenzoxazole (Standard) | 95-21-6 | Reference Standards |
| HY-W038500S | Hexamethylbenzene-d18 | 4342-40-9 | Isotope-Labeled Compounds |
| HY-W038627 | 3,5-Dibromo-4-methoxybenzoic acid | 4073-35-2 | Natural Products |
| HY-W038702 | Boc-Val-Cit-OH | 870487-08-4 | ADC Related |
| HY-W038703 | (tert-Butoxycarbonyl)-L-valyl-L-alanine | 70396-18-8 | Peptides |
| HY-W038771 | THP-PEG1-alcohol | 2162-31-4 | Reference compound |
| HY-W038786 | 2,4,6-Trimethylphenol | 527-60-6 | Natural Products |
| HY-W038786R | 2,4,6-Trimethylphenol (Standard) | 527-60-6 | Reference Standards |
| HY-W038786S | 2,4,6-Trimethylphenol-d11 | 362049-45-4 | Isotope-Labeled Compounds |
| HY-W038873 | Ethyl glycylmethioninate hydrochloride | 1397000-76-8 | Peptides |
| HY-W038985 | 1,3-Oxazolidine-2-thione | 5840-81-3 | Reference compound |
| HY-W039017 | (-)-1,4-Di-O-tosyl-2,3-O-isopropylidene-L-threitol | 37002-45-2 | Biochemical Assay Reagents |
| HY-W039102 | N-Fmoc-N,O-dimethyl-L-serine | 1569103-64-5 | Peptides |
| HY-W039112 | Fmoc-L-b-methylisoleucine | 1227750-73-3 | Peptides |
| HY-W039116 | Thalidomide-4-Br | 2093536-12-8 | Reference compound |
| HY-W039153S | (3-Nitrophenyl)methanol-d6 | 1219795-18-2 | Isotope-Labeled Compounds |
| HY-W039157 | 2-Acetyl-3-ethylpyrazine | 32974-92-8 | Reference compound |
| HY-W039157R | 2-Acetyl-3-ethylpyrazine (Standard) | 32974-92-8 | Reference Standards |
| HY-W039168 | Bromo-PEG3-C2-acid | 782475-35-8 | Reference compound |
| HY-W039169 | 4-Chloroguaiacol | 16766-30-6 | Reference compound |
| HY-W039173S | 4-(Methylamino)butanoic acid-d9 hydrochloride | 1219805-36-3 | Isotope-Labeled Compounds |
| HY-W039178 | Hydroxy-PEG4-(CH2)2-Boc | 518044-32-1 | ADC Related |
| HY-W039180 | Methyl (tert-butoxycarbonyl)-D-leucinate | 133467-01-3 | Peptides |
| HY-W039197 | Acid-PEG4-mono-methyl ester | 2028284-75-3 | Reference compound |
| HY-W039233 | Lenalidomide-F | 2359705-88-5 | Reference compound |
| HY-W039271 | 2-Chloro-6-methoxypurine riboside | 15465-92-6 | Reference compound |
| HY-W039272 | 2-Thio-6-azauridine | 27089-56-1 | Biochemical Assay Reagents |
| HY-W039275 | 5′-Deoxy-5′-iodoguanosine | 68200-68-0 | Reference compound |
| HY-W039315 | 2,5-Anhydro-D-mannitol, 97% | 41107-82-8 | Biochemical Assay Reagents |
| HY-W039379 | Methyl (E)-oct-2-enoate | 7367-81-9 | Biochemical Assay Reagents |
| HY-W039386 | (2S,2′S)-2,2′-Bipyrrolidine | 124779-66-4 | Reference compound |
| HY-W039425 | N-Trityl-morpholino-T-5'-O-phosphoramidite | 2434654-73-4 | Reference compound |
| HY-W039426 | N-Trityl-N4-benzoyl-morpholino-C-5'-O-phosphoramidite | 2434794-97-3 | Reference compound |
| HY-W039427 | N-Trityl-N2-isobutyryl-morpholino-G-5'-O-phosphoramidite | 2434795-03-4 | Reference compound |
| HY-W039428 | N-Trityl-N6-benzoyl-morpholino-A-5'-O-phosphoramidite | 2434795-08-9 | Reference compound |
| HY-W039442 | 2′-Deoxy-2′-fluoroadenosine | 64183-27-3 | Oligonucleotides |
| HY-W039449 | BOC-D-GLU-OH | 34404-28-9 | Peptides |
| HY-W039454 | 2,4-Dichlorobenzyl alcohol | 1777-82-8 | Reference compound |
| HY-W039454R | 2,4-Dichlorobenzyl alcohol (Standard) | 1777-82-8 | Reference Standards |
| HY-W039458 | 10-(tert-Butoxy)-10-oxodecanoic acid | 234081-96-0 | Reference compound |
| HY-W039519 | 7-Methoxycoumarin-3-carboxylic acid | 20300-59-8 | Dye Reagents |
| HY-W039695 | (tert-Butoxycarbonyl)-L-valylglycine | 45233-75-8 | Peptides |
| HY-W039722 | 5-Fluorocytidine | 2341-22-2 | Reference compound |
| HY-W039724 | Thioxanthone | 492-22-8 | Reference compound |
| HY-W039726 | 3-Nitrosalicylic acid | 85-38-1 | Biochemical Assay Reagents |
| HY-W039726R | 3-Nitrosalicylic acid (Standard) | 85-38-1 | Reference Standards |
| HY-W039729 | 5-(Boc-amino)-1-pentanol | 75178-90-4 | Reference compound |
| HY-W039756 | Boc-Ala-Ala-OH | 27317-69-7 | Peptides |
| HY-W039758 | Methyl (tert-butoxycarbonyl)-D-phenylalaninate | 77119-84-7 | Peptides |
| HY-W039759 | (tert-Butoxycarbonyl)-L-leucylglycine | 32991-17-6 | Peptides |
| HY-W039760 | Choline (iodide) | 17773-10-3 | Biochemical Assay Reagents |
| HY-W039763 | 2-Amino-3-(naphthalen-1-yl)propanoic acid | 28095-56-9 | Peptides |
| HY-W039848 | α-D-Glucopyranoside,ethyl 1-thio,2,3,4,6-tetraacetate | 41670-79-5 | Biochemical Assay Reagents |
| HY-W039849 | Ethyl-α-D-thioglucopyranoside | 13533-58-9 | Biochemical Assay Reagents |
| HY-W039854 | 1,2,3,4-Tetra-O-acetyl-β-D-glucopyranose, 96% | 13100-46-4 | Biochemical Assay Reagents |
| HY-W039855A | 1,2,3,4-Tetra-O-benzyl-β-D-glucopyranoside, 98% | 27851-29-2 | Biochemical Assay Reagents |
| HY-W039859 | 2-Chloro-4-nitrophenyl β-D-glucopyranoside, 98% | 120221-14-9 | Biochemical Assay Reagents |
| HY-W039863 | D-Glucose-6-phosphate (dipotassium hydrate) | 207727-36-4 | Biochemical Assay Reagents |
| HY-W039865 | 1-Thio-beta-D-glucose tetraacetate | 19879-84-6 | Biochemical Assay Reagents |
| HY-W039873 | Ethyl 2-deoxy-2-phthalimido-β-D-thioglucopyranoside | 130539-43-4 | Biochemical Assay Reagents |
| HY-W039883 | 1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-α-D-glucopyranose sulfate | 738583-70-5 | Biochemical Assay Reagents |
| HY-W039885 | 2,3,4-Tri-O-acetyl-D-glucuronide methyl ester | 3082-95-9 | Biochemical Assay Reagents |
| HY-W039887 | β-D-Glucopyranosiduronic acid,methyl,methyl ester,2,3,4-triacetate | 34213-34-8 | Biochemical Assay Reagents |
| HY-W039888 | Ethyl 2,3,4-tri-O-acetyl-β-D-glucuronide methyl ester | 77392-66-6 | Biochemical Assay Reagents |
| HY-W039890 | 1-(2,2,2-Trifluoro-N-phenylacetimidate)-2,3,4-tri-O-acetyl-D-glucuronic acid methyl ester | 869996-05-4 | Biochemical Assay Reagents |
| HY-W039891 | β-D-Glucopyranosiduronic acid,2-formyl-4-nitrophenyl,methyl ester,2,3,4-triacetate | 148579-83-3 | Biochemical Assay Reagents |
| HY-W039892 | 4-Nitrophenyl β-D-glucuronide | 10344-94-2 | Reference compound |
| HY-W039893 | 4-Nitrophenyl β-D-glucuronide (sodium) | 89772-41-8 | Biochemical Assay Reagents |
| HY-W039896 | Propargyl a-D-mannopyranoside | 854262-01-4 | Biochemical Assay Reagents |
| HY-W039897 | Methyl α-D-mannopyranoside | 617-04-9 | Reference compound |
| HY-W039897R | Methyl α-D-mannopyranoside (Standard) | 617-04-9 | Reference Standards |
| HY-W039898 | α-D-Mannose pentaacetate | 4163-65-9 | Biochemical Assay Reagents |
| HY-W039899 | 1,2,3,4,6-Penta-O-acetyl-D-mannopyranose, 97% | 25941-03-1 | Biochemical Assay Reagents |
| HY-W039903 | Acetofluoro-α-D-mannose | 2823-44-1 | Biochemical Assay Reagents |
| HY-W039909S | Tri-O-acetyl-D-galactal-13C | 478518-74-0 | Isotope-Labeled Compounds |
| HY-W039909S1 | Tri-O-acetyl-D-galactal-13C-1 | 478518-76-2 | Isotope-Labeled Compounds |
| HY-W039910 | 3,4,6-Tri-O-acetyl-2-azido-2-deoxy-D-galactose, 96% | 83025-10-9 | Biochemical Assay Reagents |
| HY-W039911 | 4-Nitrophenyl α-D-galactopyranoside | 7493-95-0 | Biochemical Assay Reagents |
| HY-W039912 | 4-Methylphenyl tetra-O-acetyl-α-D-galactopyranoside | 52730-14-0 | Biochemical Assay Reagents |
| HY-W039913 | 4-Methylphenyl tetra-O-acetyl-β-D-galactopyranoside | 3520-64-7 | Biochemical Assay Reagents |
| HY-W039914 | 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide, 98% | 13992-26-2 | Biochemical Assay Reagents |
| HY-W039915 | Allylα-D-galactopyranoside | 48149-72-0 | Biochemical Assay Reagents |
| HY-W039917 | 2-Azido-2-deoxy-D-galactose, 98% | 68733-26-6 | Biochemical Assay Reagents |
| HY-W039919 | 4-Methoxyphenyl β-D-galactopyranoside 2,3,4,6-tetraacetate | 2872-65-3 | Biochemical Assay Reagents |
| HY-W039920 | 1-Amino-1-deoxy-β-D-galactose, 98% | 74867-91-7 | Biochemical Assay Reagents |
| HY-W039921 | 2-[(Azidoacety)amino]-2-deoxy-D-galactose | 869186-83-4 | Biochemical Assay Reagents |
| HY-W039923 | β-D-Galactose pentaacetate | 4163-60-4 | Biochemical Assay Reagents |
| HY-W039924 | N-Azidoacetylmannosamine | 361154-23-6 | Reference compound |
| HY-W039925 | 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl azide | 53784-29-5 | Biochemical Assay Reagents |
| HY-W039926 | Ethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-1-thio-β-D-galactopyranoside | 144218-98-4 | Biochemical Assay Reagents |
| HY-W039927 | 1,3,4,6-Tetra-O-acetyl-β-D-galacosamine (hydrochloride) | 34948-62-4 | Biochemical Assay Reagents |
| HY-W039928 | 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl chloride | 41355-44-6 | Biochemical Assay Reagents |
| HY-W039930 | Methyl β-D-ribofuranoside | 7473-45-2 | Biochemical Assay Reagents |
| HY-W039931 | Thiotolyl β-D-ribofuranoside | 1131610-84-8 | Biochemical Assay Reagents |
| HY-W039933 | α-D-Arabinofuranoside,methyl,2,3,5-tribenzoate | 7473-42-9 | Biochemical Assay Reagents |
| HY-W039934 | 2,3,5-Tri-O-benzoyl-α-D-arabinofuranosyl bromide | 4348-68-9 | Biochemical Assay Reagents |
| HY-W039936 | 2,3,4,6-Tetra-O-acetyl-β-D-mannopyranosyl azide | 65864-60-0 | Biochemical Assay Reagents |
| HY-W039937 | α-Acetobromo-D-xylose, 95% | 3068-31-3 | Biochemical Assay Reagents |
| HY-W039938 | 4-Nitrophenyl β-D-xylopyranoside | 2001-96-9 | Dye Reagents |
| HY-W039939 | 2-Azido-2-deoxy-D-glucose, 98% | 56883-39-7 | Biochemical Assay Reagents |
| HY-W039943 | Acetyl-cyclosporin A aldehyde | 121584-52-9 | Reference compound |
| HY-W039945 | 3,4,6-Tri-O-acetyl-2-deoxy-2-phthalimido-α-D-glucopyranosyl azide | 102816-25-1 | Biochemical Assay Reagents |
| HY-W039947 | N6-[(2E)-1-Oxo-2-buten-1-yl]-L-lysine | 1399861-03-0 | Peptides |
| HY-W039950 | 2-[(Azidoacetyl)amino]-2-deoxy-D-glucose, 98% | 92659-90-0 | Biochemical Assay Reagents |
| HY-W039953 | Ac4GlcNAz | 98924-81-3 | Reference compound |
| HY-W040019 | Dipotassium oxodioxalatotitanate(IV) dihydrate | 14402-67-6 | Biochemical Assay Reagents |
| HY-W040022 | Cefcapene pivoxil (hydrochloride hydrate) | 147816-24-8 | Reference compound |
| HY-W040022R | Cefcapene pivoxil (hydrochloride hydrate) (Standard) | 147816-24-8 | Reference Standards |
| HY-W040024 | Fmoc-Lys(Dnp)-OH | 148083-64-1 | Peptides |
| HY-W040028 | Cartap (hydrochloride) | 15263-52-2 | Reference compound |
| HY-W040028R | Cartap (hydrochloride) (Standard) | 15263-52-2 | Reference Standards |
| HY-W040030 | Hematin | 15489-90-4 | Reference compound |
| HY-W040040 | γ-Cyclodextrin | 17465-86-0 | Natural Products |
| HY-W040040A | γ-Cyclodextrin (hydrate) | 91464-90-3 | Biochemical Assay Reagents |
| HY-W040040R | γ-Cyclodextrin (Standard) | 17465-86-0 | Reference Standards |
| HY-W040045 | Callistephin (chloride) | 18466-51-8 | Natural Products |
| HY-W040045R | Callistephin (chloride) (Standard) | 18466-51-8 | Reference Standards |
| HY-W040046 | Nafoxidine (hydrochloride) | 1847-63-8 | Reference compound |
| HY-W040047 | Pregnanediol 3-glucuronide | 1852-49-9 | Natural Products |
| HY-W040047S | Pregnanediol 3-glucuronide-13C5 | Isotope-Labeled Compounds | |
| HY-W040055 | Neopterin | 2009-64-5 | Natural Products |
| HY-W040055A | L-(-)-Neopterin | 2277-43-2 | Reference compound |
| HY-W040055R | Neopterin (Standard) | 2009-64-5 | Reference Standards |
| HY-W040055S | Neopterin-13C5 | 1217632-04-6 | Isotope-Labeled Compounds |
| HY-W040067 | Boc-Arg(NO2)-OH | 2188-18-3 | Peptides |
| HY-W040073 | Nifurtimox | 23256-30-6 | Reference compound |
| HY-W040073R | Nifurtimox (Standard) | 23256-30-6 | Reference Standards |
| HY-W040073S | Nifurtimox-d4 | Isotope-Labeled Compounds | |
| HY-W040074 | Glycylglycine (hydrochloride hydrate) | 23273-91-8 | Biochemical Assay Reagents |
| HY-W040081 | Burgess reagent | 29684-56-8 | Biochemical Assay Reagents |
| HY-W040088 | L-Alanyl-L-leucine | 3303-34-2 | Natural Products |
| HY-W040094 | Cellobiosan | 35405-71-1 | Reference compound |
| HY-W040113 | 6-(N-Boc)caproic acid NHS | 51513-80-5 | Reference compound |
| HY-W040116 | MUF-diNAG | 53643-12-2 | Biochemical Assay Reagents |
| HY-W040118 | Galloflavin | 568-80-9 | Reference compound |
| HY-W040124 | DL-Propargylglycine | 50428-03-0 | Peptides |
| HY-W040127 | Peonidin 3-O-glucoside (chloride) | 6906-39-4 | Natural Products |
| HY-W040128 | Kanamycins (sulfate) | 70560-51-9 | Reference compound |
| HY-W040129 | Chromomycin A3 | 7059-24-7 | Reference compound |
| HY-W040129R | Chromomycin A3 (Standard) | 7059-24-7 | Reference Standards |
| HY-W040132 | Boc-NH-PEG4-CH2CH2COOH | 756525-91-4 | ADC Related |
| HY-W040133 | Mal-amido-PEG8-NHS ester | 756525-93-6 | Reference compound |
| HY-W040134 | Mal-amido-PEG4-NHS ester | 756525-99-2 | Reference compound |
| HY-W040135 | Fmoc-NH-PEG8-CH2CH2COOH | 756526-02-0 | ADC Related |
| HY-W040140 | D-manno-Heptose | 7634-39-1 | Biochemical Assay Reagents |
| HY-W040141 | L-Arabinitol | 7643-75-6 | Natural Products |
| HY-W040141R | L-Arabinitol (Standard) | 7643-75-6 | Reference Standards |
| HY-W040143 | 2',7'-Dichlorofluorescein | 76-54-0 | Dye Reagents |
| HY-W040144 | Bromocresol green | 76-60-8 | Biochemical Assay Reagents |
| HY-W040146 | Propionylpromazine (hydrochloride) | 7681-67-6 | Reference compound |
| HY-W040146R | Propionylpromazine (hydrochloride) (Standard) | 7681-67-6 | Reference Standards |
| HY-W040146S | Propionylpromazine-d6 (hydrochloride) | 1262770-67-1 | Isotope-Labeled Compounds |
| HY-W040147 | PIPES (disodium) | 76836-02-7 | Biochemical Assay Reagents |
| HY-W040149 | Tetramethrin | 7696-12-0 | Reference compound |
| HY-W040149R | Tetramethrin (Standard) | 7696-12-0 | Reference Standards |
| HY-W040150 | (24S,25)-Epoxycholesterol | 77058-74-3 | Reference compound |
| HY-W040154 | Cyclic N-Acetyl-D-mannosamine | 7772-94-3 | Natural Products |
| HY-W040155 | Ammonium sulfamate | 7773-06-0 | Biochemical Assay Reagents |
| HY-W040156 | Oxadixyl | 77732-09-3 | Natural Products |
| HY-W040156R | Oxadixyl (Standard) | 77732-09-3 | Reference Standards |
| HY-W040160 | Cesiumiodide | 7789-17-5 | Biochemical Assay Reagents |
| HY-W040165 | Amino-PEG3-C2-acid | 784105-33-5 | ADC Related |
| HY-W040166 | Heptyl β-D-glucopyranoside | 78617-12-6 | Biochemical Assay Reagents |
| HY-W040168 | Amino-PEG2-C2-acid | 791028-27-8 | ADC Related |
| HY-W040171S | Tefluthrin-d5 | Isotope-Labeled Compounds | |
| HY-W040172 | 06:0 Diether PC | 79645-39-9 | Biochemical Assay Reagents |
| HY-W040173 | MOPSO (sodium) | 79803-73-9 | Biochemical Assay Reagents |
| HY-W040184 | Tetramethylammonium (hydrogensulfate) | 80526-82-5 | Biochemical Assay Reagents |
| HY-W040185 | 1,2-Dimyristoyl-sn-glycero-3-phosphate (monosodium) | 80724-31-8 | Biochemical Assay Reagents |
| HY-W040185S | (R)-2,3-Bis(tetradecanoyloxy)propyl phosphate-d54 (sodium) | 327178-99-4 | Isotope-Labeled Compounds |
| HY-W040186 | 1-Naphthenyl phosphate (hydrate sodium) | 81012-89-7 | Biochemical Assay Reagents |
| HY-W040188 | Fosfructose (trisodium octahydrate) | 81028-91-3 | Biochemical Assay Reagents |
| HY-W040189 | Imazaquin | 81335-37-7 | Reference compound |
| HY-W040189R | Imazaquin (Standard) | 81335-37-7 | Reference Standards |
| HY-W040193 | DSPC | 816-94-4 | Oligonucleotides |
| HY-W040193A | DSPC (Excipient) | 816-94-4 | Reference compound |
| HY-W040193S | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d70 | 56952-01-3 | Isotope-Labeled Compounds |
| HY-W040193S1 | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d74 | 326495-38-9 | Isotope-Labeled Compounds |
| HY-W040193S2 | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d79 | 326495-39-0 | Isotope-Labeled Compounds |
| HY-W040193S3 | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d83 | 326495-40-3 | Isotope-Labeled Compounds |
| HY-W040193S4 | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d4 | 326495-35-6 | Isotope-Labeled Compounds |
| HY-W040193S5 | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9 | 326495-36-7 | Isotope-Labeled Compounds |
| HY-W040193S6 | 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d13 | 326495-37-8 | Isotope-Labeled Compounds |
| HY-W040194 | Clomazone | 81777-89-1 | Reference compound |
| HY-W040194R | Clomazone (Standard) | 81777-89-1 | Reference Standards |
| HY-W040195 | m-PEG5-acid | 81836-43-3 | Reference compound |
| HY-W040196 | 1,3-Benzodioxole-5,6-diamine (dihydrochloride) | 81864-15-5 | Biochemical Assay Reagents |
| HY-W040198 | Phenosafranine | 81-93-6 | Dye Reagents |
| HY-W040201 | CHAPSO | 82473-24-3 | Biochemical Assay Reagents |
| HY-W040202 | Octyl β-D-maltopyranoside | 82494-08-4 | Biochemical Assay Reagents |
| HY-W040203 | Decyl β-D-maltopyranoside | 82494-09-5 | Biochemical Assay Reagents |
| HY-W040206 | Diflufenican | 83164-33-4 | Reference compound |
| HY-W040206R | Diflufenican (Standard) | 83164-33-4 | Reference Standards |
| HY-W040206S | Diflufenican-d3 | 1185009-29-3 | Isotope-Labeled Compounds |
| HY-W040209 | 2-(Naphthalen-1-yl)-5-phenyloxazole | 846-63-9 | Dye Reagents |
| HY-W040214 | m-PEG4-Amine | 85030-56-4 | ADC Related |
| HY-W040216 | MEGA-9 | 85261-19-4 | Biochemical Assay Reagents |
| HY-W040217 | MEGA-10 | 85261-20-7 | Biochemical Assay Reagents |
| HY-W040218 | MEGA-8 | 85316-98-9 | Biochemical Assay Reagents |
| HY-W040221 | Butanoyl PAF | 85405-03-4 | Reference compound |
| HY-W040222 | m-PEG11-Amine | 854601-60-8 | ADC Related |
| HY-W040223 | n-Heptyl β-D-thioglucoside | 85618-20-8 | Biochemical Assay Reagents |
| HY-W040224 | Octyl β-D-thioglucopyranoside | 85618-21-9 | Biochemical Assay Reagents |
| HY-W040226 | Indigo carmine | 860-22-0 | Dye Reagents |
| HY-W040226R | Indigo carmine (Standard) | 860-22-0 | Dye Reagents |
| HY-W040228 | BnO-PEG4-OH | 86259-87-2 | Reference compound |
| HY-W040230 | Acrylodan | 86636-92-2 | Dye Reagents |
| HY-W040231 | Fmoc-NH-PEG3-CH2CH2COOH | 867062-95-1 | ADC Related |
| HY-W040233 | L-Lactic acid (sodium) | 867-56-1 | Reference compound |
| HY-W040233B | L-Lactic acid (sodium) (purity≥90%) | 867-56-1 | Reference compound |
| HY-W040233R | L-Lactic acid (sodium) (Standard) | 867-56-1 | Reference Standards |
| HY-W040233S | L-Lactic acid-d3 (sodium) | 285979-84-2 | Isotope-Labeled Compounds |
| HY-W040233S1 | L-Lactic acid-2-d1 (sodium) | 285979-83-1 | Isotope-Labeled Compounds |
| HY-W040235 | Fluazuron | 86811-58-7 | Reference compound |
| HY-W040236 | m-PEG8-Amine | 869718-81-0 | ADC Related |
| HY-W040238 | Fmoc-NH-PEG2-CH2CH2COOH | 872679-70-4 | ADC Related |
| HY-W040239 | m-PEG6-CH2CH2COOH | 874208-91-0 | Reference compound |
| HY-W040240 | (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one | 87-79-6 | Natural Products |
| HY-W040240R | (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one (Standard) | 87-79-6 | Reference Standards |
| HY-W040240S | (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C | 478506-34-2 | Isotope-Labeled Compounds |
| HY-W040240S1 | (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-1 | 478506-36-4 | Isotope-Labeled Compounds |
| HY-W040240S2 | (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 | 478506-38-6 | Isotope-Labeled Compounds |
| HY-W040244 | Boc-NH-PEG6-CH2CH2COOH | 882847-13-4 | ADC Related |
| HY-W040245 | Fmoc-amino-PEG5-acid | 882847-32-7 | Reference compound |
| HY-W040246 | Fmoc-NH-PEG6-CH2CH2COOH | 882847-34-9 | ADC Related |
| HY-W040252 | 2,3,5-Tri-O-benzyl-β-L-arabinofuranose | 89615-42-9 | Biochemical Assay Reagents |
| HY-W040254 | Biotin-LC-LC-NHS | 89889-52-1 | Dye Reagents |
| HY-W040255 | 1-Palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine | 89947-79-5 | Biochemical Assay Reagents |
| HY-W040256 | Acid phosphatase, wheat | 9001-77-8 | Enzyme |
| HY-W040257 | NH2-PEG6-CH2CH2COOH | 905954-28-1 | ADC Related |
| HY-W040258 | 3,3'-Diethyloxacarbocyanine (iodide) | 905-96-4 | Reference compound |
| HY-W040262 | Chlorimuron-ethyl | 90982-32-4 | Reference compound |
| HY-W040262R | Chlorimuron-ethyl (Standard) | 90982-32-4 | Reference Standards |
| HY-W040263 | 3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]-1-Propanesulfonic acid sodium salt | 91000-53-2 | Biochemical Assay Reagents |
| HY-W040264 | 24,25-Dihydrolanosterol | 911660-54-3 | Natural Products |
| HY-W040265 | Fenamic acid | 91-40-7 | Reference compound |
| HY-W040268 | 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine | 923-61-5 | Natural Products |
| HY-W040268S | 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-d62 | 326495-42-5 | Isotope-Labeled Compounds |
| HY-W040268S1 | 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-d9 | 2747990-85-6 | Isotope-Labeled Compounds |
| HY-W040269 | Dehydrothio-p-toluidine | 92-36-4 | Dye Reagents |
| HY-W040270 | Amino-PEG10-amine | 928292-69-7 | Reference compound |
| HY-W040271 | N-3-Hydroxydecanoyl-DL-homoserine lactone | 929222-14-0 | Reference compound |
| HY-W040273S | 2,3,6-Trichlorophenol-d2 | 93951-81-6 | Isotope-Labeled Compounds |
| HY-W040276 | Diafen NN | 93-46-9 | Reference compound |
| HY-W040276R | Diafen NN (Standard) | 93-46-9 | Reference Standards |
| HY-W040277 | 5-Bromo-6-chloro-3-indolyl-β-D-glucopyranoside | 93863-89-9 | Biochemical Assay Reagents |
| HY-W040280 | L-Methionine 7-amido-4-methylcoumarin (trifluoroacetate) | 94367-35-8 | Biochemical Assay Reagents |
| HY-W040286 | Cinosulfuron | 94593-91-6 | Reference compound |
| HY-W040286R | Cinosulfuron (Standard) | 94593-91-6 | Reference Standards |
| HY-W040287S | 4-(2,4-Dichlorophenoxy)butanoic acid-d3 | 1219802-46-6 | Isotope-Labeled Compounds |
| HY-W040288A | L-Threose (solution),0.5M | 95-44-3 | Reference compound |
| HY-W040289 | Mal-amido-PEG2-NHS ester | 955094-26-5 | ADC Related |
| HY-W040291 | 7-Hydroxy-4-methylcoumarin-3-acetic acid, SE | 96735-88-5 | Dye Reagents |
| HY-W040292 | 08:0 PE | 96760-44-0 | Biochemical Assay Reagents |
| HY-W040293 | 06:0 PE | 96893-06-0 | Reference compound |
| HY-W040294 | Methyl α-D-glucoside | 97-30-3 | Biochemical Assay Reagents |
| HY-W040295 | Fast Red ITR | 97-35-8 | Reference compound |
| HY-W040297 | 2-Methyl-5-(p-tolyldiazenyl)aniline | 97-56-3 | Biochemical Assay Reagents |
| HY-W040297R | 2-Methyl-5-(p-tolyldiazenyl)aniline (Standard) | 97-56-3 | Reference Standards |
| HY-W040298 | Ciprofloxacin (lactate) | 97867-33-9 | Reference compound |
| HY-W040298R | Ciprofloxacin (lactate) (Standard) | 97867-33-9 | Reference Standards |
| HY-W040299 | 5-Difluoromethoxy-2-mercaptobenzimidazole | 97963-62-7 | Biochemical Assay Reagents |
| HY-W040302 | Decyl 1-thio-β-D-glucopyranoside | 98854-16-1 | Biochemical Assay Reagents |
| HY-W040303 | Flumetsulam | 98967-40-9 | Reference compound |
| HY-W040303R | Flumetsulam (Standard) | 98967-40-9 | Reference Standards |
| HY-W040304 | Alkynyl Palmitic Acid | 99208-90-9 | Reference compound |
| HY-W040306 | Chlorotriethylsilane | 994-30-9 | Reference compound |
| HY-W040307 | Saccharopine | 997-68-2 | Reference compound |
| HY-W040307B | Saccharopine (hydrochloride) | Reference compound | |
| HY-W040313 | 2-(Undecyloxy)ethanol | 38471-47-5 | Natural Products |
| HY-W040329 | 2'-Deoxyadenosine | 958-09-8 | Natural Products |
| HY-W040329R | 2'-Deoxyadenosine (Standard) | 958-09-8 | Reference Standards |
| HY-W040329S | 2'-Deoxyadenosine-13C10,15N5 | 1987883-24-8 | Isotope-Labeled Compounds |
| HY-W040329S1 | 2'-Deoxyadenosine-13C10 | Isotope-Labeled Compounds | |
| HY-W040329S2 | 2'-Deoxyadenosine-d13 | Isotope-Labeled Compounds | |
| HY-W040329S3 | 2'-Deoxyadenosine-15N5,d13 | Isotope-Labeled Compounds | |
| HY-W040333 | (2S,3R)-Ethyl 2-amino-3-hydroxybutanoate hydrochloride | 39994-70-2 | Peptides |
| HY-W040416 | (S)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid | 78553-51-2 | Peptides |
| HY-W040417 | Boc-L-cyclobutylglycine | 155905-77-4 | Peptides |
| HY-W040430 | (S)-Nornicotine | 494-97-3 | Natural Products |
| HY-W040430A | (S)-Nornicotine (hydrochloride) | 101832-65-9 | Reference compound |
| HY-W040430R | (S)-Nornicotine (Standard) | 494-97-3 | Reference Standards |
| HY-W040432 | (S)-3-Amino-4-hydroxybutanoic acid | 16504-57-7 | Peptides |
| HY-W040438 | (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoate | 37169-36-1 | Peptides |
| HY-W040441 | (S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride | 34260-72-5 | Peptides |
| HY-W040468 | 2-Phenyl-2-(1-piperidinyl)propane | 92321-29-4 | Reference compound |
| HY-W040471 | 3′,5′-Dimethoxyacetophenone | 39151-19-4 | Natural Products |
| HY-W040491 | 1-(4-Bromophenyl)piperazine (hydrochloride) | 68104-62-1 | Reference compound |
| HY-W040527 | Bromo-PEG4-bromide | 57602-02-5 | Reference compound |
| HY-W040672 | Ibufenac | 1553-60-2 | Reference compound |
| HY-W040681 | 7-Dimethylaminocoumarin-4-acetic acid | 80883-54-1 | Dye Reagents |
| HY-W040686 | 2-(Bis(2-(tert-butoxy)-2-oxoethyl)amino)acetic acid | 171557-31-6 | Peptides |
| HY-W040705 | 2-(Methylamino)benzoic acid | 119-68-6 | Peptides |
| HY-W040705R | 2-(Methylamino)benzoic acid (Standard) | 119-68-6 | Reference Standards |
| HY-W040723 | 2-(tert-Butylamino)acetic acid hydrochloride | 6939-23-7 | Peptides |
| HY-W040734 | (tert-Butoxycarbonyl)glycylglycylglycine | 28320-73-2 | Peptides |
| HY-W040790 | 2,6-Dimethylpyrazine | 108-50-9 | Natural Products |
| HY-W040790R | 2,6-Dimethylpyrazine (Standard) | 108-50-9 | Reference Standards |
| HY-W040790S | 2,6-Dimethylpyrazine-d6 | 1335402-00-0 | Isotope-Labeled Compounds |
| HY-W040795 | N2-Acetylguanine | 19962-37-9 | Reference compound |
| HY-W040801 | 2-Amino-2-(2-methoxyphenyl)acetic acid | 271583-17-6 | Peptides |
| HY-W040802 | AC-94149 | 13893-53-3 | Reference compound |
| HY-W040803 | 2-Amino-2-cyclopentylacetic acid | 933-95-9 | Peptides |
| HY-W040804 | 2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride | 4876-14-6 | Peptides |
| HY-W040821 | DL-Homocysteine | 454-29-5 | Natural Products |
| HY-W040821R | DL-Homocysteine (Standard) | 454-29-5 | Reference Standards |
| HY-W040886 | 2-Bromo-6-nitrophenol | 13073-25-1 | Reference compound |
| HY-W040948 | 2-Ethylpyrazine | 13925-00-3 | Natural Products |
| HY-W040948R | 2-Ethylpyrazine (Standard) | 13925-00-3 | Reference Standards |
| HY-W040948S | 2-Ethylpyrazine-d5 | 1276197-45-5 | Isotope-Labeled Compounds |
| HY-W040971 | Creosol | 93-51-6 | Natural Products |
| HY-W040971R | Creosol (Standard) | 93-51-6 | Reference Standards |
| HY-W040971S | Creosol-d4 | 20189-08-6 | Isotope-Labeled Compounds |
| HY-W040996 | 2-Octyldodecanol | 5333-42-6 | Reference compound |
| HY-W040996R | 2-Octyldodecanol (Standard) | 5333-42-6 | Reference Standards |
| HY-W041019 | 5-Hydroxytryptophol | 154-02-9 | Natural Products |
| HY-W041019S | 5-Hydroxytryptophol-d4 | 66640-87-7 | Isotope-Labeled Compounds |
| HY-W041076 | 3,5-Difluoro-DL-phenylalanine | 32133-37-2 | Peptides |
| HY-W041080 | 3,5-Di-tert-butylphenol | 1138-52-9 | Natural Products |
| HY-W041080R | 3,5-Di-tert-butylphenol (Standard) | 1138-52-9 | Reference Standards |
| HY-W041171 | 3-Chloro-L-tyrosine | 7423-93-0 | Natural Products |
| HY-W041171S | 3-Chloro-L-tyrosine-13C6 | Isotope-Labeled Compounds | |
| HY-W041194 | Tropic acid | 552-63-6 | Natural Products |
| HY-W041194R | Tropic acid (Standard) | 552-63-6 | Reference Standards |
| HY-W041195S | 3-Hydroxy-3-methylhexanoic acid-d5 | Isotope-Labeled Compounds | |
| HY-W041232 | 5-Phenyl-1H-pyrazol-3-amine | 1572-10-7 | Biochemical Assay Reagents |
| HY-W041300S | p-Tolylpinacolboronate-d3 | 2235417-07-7 | Isotope-Labeled Compounds |
| HY-W041301 | (±)-Dihydroactinidiolide | 15356-74-8 | Natural Products |
| HY-W041301R | (±)-Dihydroactinidiolide (Standard) | 15356-74-8 | Reference Standards |
| HY-W041308 | DCOIT | 64359-81-5 | Reference compound |
| HY-W041308R | DCOIT (Standard) | 64359-81-5 | Reference Standards |
| HY-W041315 | CFL-120 | 18711-15-4 | Reference compound |
| HY-W041324 | Glimepiride sulfonamide | 119018-29-0 | Natural Products |
| HY-W041324R | Glimepiride sulfonamide (Standard) | 119018-29-0 | Reference Standards |
| HY-W041333 | Phenibut (hydrochloride) | 3060-41-1 | Reference compound |
| HY-W041343 | 4-Benzoylbenzoic acid | 611-95-0 | Reference compound |
| HY-W041357 | 4-Bromo-2-nitrotoluene | 60956-26-5 | Biochemical Assay Reagents |
| HY-W041470 | 4-Methyl-1-phenyl-2-pentanone | 5349-62-2 | Reference compound |
| HY-W041470R | 4-Methyl-1-phenyl-2-pentanone (Standard) | 5349-62-2 | Reference Standards |
| HY-W041489 | Chelidonic acid | 99-32-1 | Natural Products |
| HY-W041489R | Chelidonic acid (Standard) | 99-32-1 | Reference Standards |
| HY-W041498 | 4-O-Methyldopamine (hydrochloride) | 645-33-0 | Reference compound |
| HY-W041608 | Methylchloroisothiazolinone | 26172-55-4 | Reference compound |
| HY-W041608S | 5-Chloro-2-methylisothiazol-3(2H)-one-d3 | 1329611-34-8 | Isotope-Labeled Compounds |
| HY-W041676 | 5-Methylisoxazol-3-amine | 1072-67-9 | Biochemical Assay Reagents |
| HY-W041703 | 6-Amino-5-bromoquinoxaline | 50358-63-9 | Reference compound |
| HY-W041831 | Oxalic acid (ammonium) | 1113-38-8 | Reference compound |
| HY-W041856 | N-Boc-8-amino-octanoic acid | 30100-16-4 | Reference compound |
| HY-W041857 | Boc-Cys(tBu)-OH | 56976-06-8 | Peptides |
| HY-W041862 | Boc-Gly-OMe | 31954-27-5 | Peptides |
| HY-W041864 | Boc-L-Alanine benzyl ester | 51814-54-1 | Peptides |
| HY-W041866 | Boc-Phe(3-Br)-OH | 82278-73-7 | Peptides |
| HY-W041867 | Boc-Ser-OtBu | 7738-22-9 | Peptides |
| HY-W041892 | Dimethyl itaconate | 617-52-7 | Biochemical Assay Reagents |
| HY-W041895 | DL-Glutamic acid | 617-65-2 | Natural Products |
| HY-W041895R | DL-Glutamic acid (Standard) | 617-65-2 | Reference Standards |
| HY-W041895S | DL-Glutamic acid-d5 | 14341-79-8 | Isotope-Labeled Compounds |
| HY-W041895S1 | DL-Glutamic acid-d3 | 96927-56-9 | Isotope-Labeled Compounds |
| HY-W041970 | Ethyl 6-bromohexanoate | 25542-62-5 | Reference compound |
| HY-W041982 | Fmoc-Asp-OMe | 145038-52-4 | Peptides |
| HY-W041983 | Fmoc-Cpa-OH | 371770-32-0 | Peptides |
| HY-W041984 | Fmoc-Cpg-OH | 220497-61-0 | Peptides |
| HY-W041985 | Fmoc-D-Allo-Ile-OH | 118904-37-3 | Peptides |
| HY-W041986 | Fmoc-D-Lys(Aloc)-OH | 214750-75-1 | Peptides |
| HY-W041987 | Fmoc-L-Lys(Dde)-OH | 150629-67-7 | Peptides |
| HY-W041988 | Fmoc-Glu-OMe | 145038-49-9 | Peptides |
| HY-W041989 | Fmoc-Oic-OH | 130309-37-4 | Peptides |
| HY-W041990 | Fmoc-Pro-Pro-OH | 129223-22-9 | Peptides |
| HY-W041991 | Fmoc-Ser-Obzl | 73724-46-6 | Peptides |
| HY-W041992 | Fmoc-β-cyclopropyl-L-Alanine | 214750-76-2 | Peptides |
| HY-W041994 | GMBS | 80307-12-6 | Reference compound |
| HY-W041996 | H-Asp(Obzl)-OtBu.HCl | 52615-97-1 | Peptides |
| HY-W041997 | H-Cys(Z)-OH | 1625-72-5 | Peptides |
| HY-W041999 | H-D-Asp(OMe)-OMe.HCl | 69630-50-8 | Peptides |
| HY-W042000 | H-D-Glu(OMe)-OH | 6461-04-7 | Peptides |
| HY-W042001 | H-DL-Phe(4-Me)-OH | 4599-47-7 | Peptides |
| HY-W042002 | H-DL-Phe-OMe.HCl | 5619-07-8 | Peptides |
| HY-W042005 | H-D-Phe(3,4-DiCl)-OH | 52794-98-6 | Peptides |
| HY-W042006 | H-D-Phe(4-CN)-OH | 263396-44-7 | Peptides |
| HY-W042007 | H-D-Phe(4-Me)-OH | 49759-61-7 | Peptides |
| HY-W042008 | H-D-Phg(4-Cl)-OH | 43189-37-3 | Peptides |
| HY-W042009A | (R)-Phenylglycine tert-butyl ester hydrochloride | 256478-95-2 | Peptides |
| HY-W042010 | H-D-Ser-OEt.HCl | 104055-46-1 | Peptides |
| HY-W042013 | H-Thr(tBu)-OMe.HCl | 71989-43-0 | Peptides |
| HY-W042016 | (S)-2-Amino-3-(3,5-dichloro-4-hydroxyphenyl)propanoic acid | 15106-62-4 | Peptides |
| HY-W042027 | Isothiazole-5-carboxylic acid | 10271-85-9 | Biochemical Assay Reagents |
| HY-W042039 | Methyl homoveratrate | 15964-79-1 | Reference compound |
| HY-W042057 | DL-Threonine methyl ester hydrochloride | 62076-66-8 | Peptides |
| HY-W042156 | Aegeline | 456-12-2 | Natural Products |
| HY-W042156R | Aegeline (Standard) | 456-12-2 | Reference Standards |
| HY-W042164S | N,4-Dimethylaniline-d3 | 922543-66-6 | Isotope-Labeled Compounds |
| HY-W042181 | N-Decyl-N,N-dimethyldecan-1-aminium (chloride) | 7173-51-5 | Reference compound |
| HY-W042181R | N-Decyl-N,N-dimethyldecan-1-aminium (chloride) (Standard) | 7173-51-5 | Reference Standards |
| HY-W042181S | N-Decyl-N,N-dimethyldecan-1-aminium-d6 (chloride) | Isotope-Labeled Compounds | |
| HY-W042191 | Oxychlororaphine | 550-89-0 | Natural Products |
| HY-W042191R | Oxychlororaphine (Standard) | 550-89-0 | Reference Standards |
| HY-W042192 | 2-Benzoylpyridine | 91-02-1 | Biochemical Assay Reagents |
| HY-W042193 | 2-Piperidone | 675-20-7 | Natural Products |
| HY-W042206S | Pyrrolidin-3-ol-d5 | 1219805-52-3 | Isotope-Labeled Compounds |
| HY-W042214 | Ritalinic acid | 19395-41-6 | Reference compound |
| HY-W042216 | Sodium Sulphanilate | 515-74-2 | Reference compound |
| HY-W042284 | Tetradecyl acetate | 638-59-5 | Natural Products |
| HY-W042284R | Tetradecyl acetate (Standard) | 638-59-5 | Reference Standards |
| HY-W042301 | Xipamide | 14293-44-8 | Reference compound |
| HY-W042301R | Xipamide (Standard) | 14293-44-8 | Reference Standards |
| HY-W042312S | 1-Phenylcyclohexanamine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W042337 | 3-Methyl-4-nitrophenol | 2581-34-2 | Reference compound |
| HY-W042357 | Ac-rC Phosphoramidite | 121058-88-6 | Oligonucleotides |
| HY-W042357S | Ac-rC Phosphoramidite-15N | 1799795-94-0 | Isotope-Labeled Compounds |
| HY-W042357S1 | Ac-rC Phosphoramidite-15N2 | Isotope-Labeled Compounds | |
| HY-W042357S2 | Ac-rC Phosphoramidite-15N3 | Isotope-Labeled Compounds | |
| HY-W042357S3 | Ac-rC Phosphoramidite-13C2,d1 | Isotope-Labeled Compounds | |
| HY-W042357S4 | Ac-rC Phosphoramidite-13C9 | Isotope-Labeled Compounds | |
| HY-W042357S5 | Ac-rC Phosphoramidite-13C,d1 | Isotope-Labeled Compounds | |
| HY-W042357S6 | Ac-rC Phosphoramidite-13C9,15N3 | Isotope-Labeled Compounds | |
| HY-W042416 | N,N-Dimethylacetamide | 127-19-5 | Biochemical Assay Reagents |
| HY-W042416R | N,N-Dimethylacetamide (Standard) | 127-19-5 | Reference Standards |
| HY-W042416S | N,N-Dimethylacetamide-d9 | 16727-10-9 | Isotope-Labeled Compounds |
| HY-W042416S1 | N,N-Dimethylacetamide-d6 | 31591-08-9 | Isotope-Labeled Compounds |
| HY-W042416S2 | N,N-Dimethylacetamide-d3 | 20255-66-7 | Isotope-Labeled Compounds |
| HY-W042417S | 2-(Benzyl(methyl)amino)ethanol-d4 | 1219803-10-7 | Isotope-Labeled Compounds |
| HY-W042438 | Bis(2,4,6-trichlorophenyl) oxalate | 1165-91-9 | Biochemical Assay Reagents |
| HY-W042478 | (S)-3-(Boc-amino)-4-phenylbutyric acid | 51871-62-6 | Peptides |
| HY-W042501 | m-PEG5-Tos | 80755-67-5 | Reference compound |
| HY-W042557 | Tetrabutylammonium (trifluoromethanesulfonate) | 35895-70-6 | Biochemical Assay Reagents |
| HY-W042558 | N-Succinimidyl myristate | 69888-86-4 | Biochemical Assay Reagents |
| HY-W042579 | TBDMS-PEG4-OH | 134179-40-1 | Reference compound |
| HY-W042583 | Deoxynojirimycin tetrabenzyl ether | 69567-11-9 | Reference compound |
| HY-W042625 | Hexaethylene glycol monomethyl ether | 23601-40-3 | Reference compound |
| HY-W042648 | 4,5,6,7-Tetrabromo-1H-benzimidazole | 577779-57-8 | Reference compound |
| HY-W042654 | BnO-PEG6-OH | 24342-68-5 | ADC Related |
| HY-W042657 | Octaethylene glycol monomethyl ether | 25990-96-9 | Reference compound |
| HY-W042713 | Pentaethylene glycol monomethyl ether | 23778-52-1 | Reference compound |
| HY-W042714 | BnO-PEG5-OH | 57671-28-0 | Reference compound |
| HY-W042853 | N-(2-Hydroxyethyl)-2-phenylacetamide | 6269-99-4 | Dye Reagents |
| HY-W042920A | TDIQ (hydrochloride) | 15052-05-8 | Reference compound |
| HY-W042985 | 1-Benzylimidazole | 4238-71-5 | Biochemical Assay Reagents |
| HY-W043105 | N-Phenylpivalamide | 6625-74-7 | Reference compound |
| HY-W043170 | PRL3-CNNM4 interaction-IN-1 | 40133-06-0 | Reference compound |
| HY-W043277 | m-PEG3-Tos | 62921-74-8 | Reference compound |
| HY-W043285 | 2-Hydroxy-3,4-dimethoxybenzoic acid | 5653-46-3 | Reference compound |
| HY-W043311 | Methyl pyrimidine-4-carboxylate | 2450-08-0 | Reference compound |
| HY-W043333 | β-keto Phentermine (hydrochloride) | 6946-08-3 | Reference compound |
| HY-W043423 | (R)-2-((Methoxycarbonyl)amino)-2-phenylacetic acid | 50890-96-5 | Peptides |
| HY-W043437 | Isopropyl benzenesulfonate | 6214-18-2 | Reference compound |
| HY-W043473 | Fmoc-Lys(ipr,Boc)-OH | 201003-48-7 | Peptides |
| HY-W043676 | Dibenzosuberol | 1210-34-0 | Reference compound |
| HY-W043725 | m-PEG2-CH2CH2COOH | 209542-49-4 | Reference compound |
| HY-W043748 | 2,5-Dioxopyrrolidin-1-yl acrylate | 38862-24-7 | Reference compound |
| HY-W043840 | m-PEG5-CH2CH2COOH | 1347750-72-4 | Reference compound |
| HY-W043841 | Benzyl-PEG2-Tos | 98627-22-6 | Reference compound |
| HY-W044001 | Z-Ser-obzl | 21209-51-8 | Biochemical Assay Reagents |
| HY-W044078 | N-Boc-diethanolamine | 103898-11-9 | ADC Related |
| HY-W044155 | Azido-PEG2-azide | 59559-06-7 | Reference compound |
| HY-W044258 | Phenylmethyl β-D-arabinopyranoside | 5329-50-0 | Biochemical Assay Reagents |
| HY-W044276 | 2,5-Dioxopyrrolidin-1-yl dodecanoate | 14565-47-0 | Biochemical Assay Reagents |
| HY-W044285 | Fmoc-D-4-Aph(cBm)-OH | 324017-22-3 | Peptides |
| HY-W044459 | Triethylene glycol monobenzyl ether | 55489-58-2 | Reference compound |
| HY-W044525 | Phyllodulcin | 21499-23-0 | Reference compound |
| HY-W044573 | N-Dodecanoyl-DL-homoserine lactone | 18627-38-8 | Peptides |
| HY-W044620 | (2S,4R)-4-Fluoropyrrolidine-2-carboxylic acid | 2507-61-1 | Peptides |
| HY-W044764 | 2-Benzylsuccinic acid | 884-33-3 | Reference compound |
| HY-W044805 | 2-Amino-4-(4-pyridyl)-thiazole | 30235-28-0 | Reference compound |
| HY-W045058S | 4-Bromo-N-methylaniline-d3 | 1185310-26-2 | Isotope-Labeled Compounds |
| HY-W045071 | N-Hexanoyl-DL-homoserine lactone | 106983-28-2 | Reference compound |
| HY-W045072 | N-Decanoyl-DL-homoserine lactone | 106983-36-2 | Peptides |
| HY-W045132 | N-Desbutyl Bupivacaine | 15883-20-2 | Reference compound |
| HY-W045221 | (R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid | 193693-61-7 | Peptides |
| HY-W045268 | Ethyl-2-amino-4-phenyl thiophene-3-carboxylate | 4815-36-5 | Reference compound |
| HY-W045271 | Imidazole-5-propionic acid | 1074-59-5 | Reference compound |
| HY-W045376 | 2-Bromo-4'-chloropropiophenone | 877-37-2 | Reference compound |
| HY-W045537 | 5-Bromo-4-chloro-1H-indol-3-yl phosphate (sodium) | 102185-33-1 | Biochemical Assay Reagents |
| HY-W045598 | Boc-C16-COOH | 843666-40-0 | ADC Related |
| HY-W045822 | Fmoc-Lys(Pal-Glu-OtBu)-OH | 1491158-62-3 | ADC Related |
| HY-W045998 | 1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose | 75096-60-5 | Reference compound |
| HY-W046063 | O-Phthalimide-C3-acid | 3130-75-4 | Reference compound |
| HY-W046071 | N-Boc-trans-4-fluoro-L-proline | 203866-14-2 | Peptides |
| HY-W046161 | 4-Aminomethylindole | 3468-18-6 | Reference compound |
| HY-W046325 | DEAE-Cellulose | 9013-34-7 | Biochemical Assay Reagents |
| HY-W046346 | D44 | 826998-10-1 | Reference compound |
| HY-W046348 | 22-(tert-Butoxy)-22-oxodocosanoic acid | 1642333-05-8 | ADC Related |
| HY-W046349 | N,N-didesmethyl AH 7921 | 1580956-92-8 | Reference compound |
| HY-W046352 | (Cyclohexanecarbonyl)-L-leucine | 157116-68-2 | Peptides |
| HY-W046353 | 2-Methoxycinnamaldehyde | 1504-74-1 | Natural Products |
| HY-W046353R | 2-Methoxycinnamaldehyde (Standard) | 1504-74-1 | Reference Standards |
| HY-W046355 | Fmoc-D-Dap(Boc)-OH | 198544-42-2 | Peptides |
| HY-W046406 | Z-Phe-Ala-OH | 21881-18-5 | Reference compound |
| HY-W046471 | N-Boc-PEG4-bromide | 1076199-21-7 | ADC Related |
| HY-W046676 | 2-Piperazineacetic acid | 14566-74-6 | Biochemical Assay Reagents |
| HY-W046685 | 3-Azathalidomide | 31804-66-7 | Reference compound |
| HY-W046704 | 1-Methoxycyclopropanecarboxylic acid | 100683-08-7 | Reference compound |
| HY-W046786 | Benzylisatin | 1217-89-6 | Reference compound |
| HY-W046846 | Corannulene | 5821-51-2 | Reference compound |
| HY-W046906 | (E)-Oct-2-enoic acid | 1871-67-6 | Natural Products |
| HY-W046906R | (E)-Oct-2-enoic acid (Standard) | 1871-67-6 | Reference Standards |
| HY-W046907 | Ethyl (E)-oct-2-enoate | 7367-82-0 | Biochemical Assay Reagents |
| HY-W047156 | Allantoxanamide | 69391-08-8 | Reference compound |
| HY-W047187 | Lavandoside | 117405-51-3 | Natural Products |
| HY-W047191 | D-Glucono-1,4-lactone | 1198-69-2 | Biochemical Assay Reagents |
| HY-W047223 | 5-Deoxy-D-ribose | 13039-75-3 | Natural Products |
| HY-W047299 | Phenyl 2,3,4,6-tetra-O-acetyl-β-D-thioglucopyranoside, 98% | 23661-28-1 | Biochemical Assay Reagents |
| HY-W047324 | 4-Aminophenyl-α-D-mannopyranoside, 98% | 34213-86-0 | Biochemical Assay Reagents |
| HY-W047388 | 1-Deoxy-1-morpholino-D-fructose | 6291-16-3 | Biochemical Assay Reagents |
| HY-W047393 | Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside | 64363-77-5 | Reference compound |
| HY-W047405 | Allylα-D-glucopyranoside | 7464-56-4 | Biochemical Assay Reagents |
| HY-W047428 | 4-Hydroxy-3,3-dimethylcyclohexanone | 888325-29-9 | Reference compound |
| HY-W047478 | 3-Methylcarbazole | 4630-20-0 | Natural Products |
| HY-W047496 | AN-12-H5 intermediate-2 | 756486-14-3 | Reference compound |
| HY-W047688 | tert-Butyl (10-aminodecyl)carbamate | 216961-61-4 | Reference compound |
| HY-W047709 | N,N,N',N'-Tetrakis(2-hydroxyethyl)ethylenediamine | 140-07-8 | Reference compound |
| HY-W047710 | D-Galactal | 21193-75-9 | Biochemical Assay Reagents |
| HY-W047788 | H-Dab(Boc)-OH | 10270-94-7 | Peptides |
| HY-W047794 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(2,4-dimethoxybenzyl)glycine | 166881-42-1 | Peptides |
| HY-W047799 | Boc-Dap(Boc)-OH | 88971-40-8 | Peptides |
| HY-W047845 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(2-hydroxy-4-methoxybenzyl)glycine | 148515-78-0 | Peptides |
| HY-W047901 | N-Methyl-N-phenylglycine | 40643-55-8 | Peptides |
| HY-W047902 | L-Isoleucylglycine | 868-28-0 | Peptides |
| HY-W048199 | (S)-N-FMoc-2-(6'-heptenyl)alanine | 1311933-83-1 | Peptides |
| HY-W048203 | N6-(But-2-enoyl)-L-lysine | 1338823-35-0 | Peptides |
| HY-W048205 | N6-Diazo-L-Fmoc-lysine | 159610-89-6 | Peptides |
| HY-W048207 | N6-Propionyl-L-lysine | 1974-17-0 | Peptides |
| HY-W048209 | Fmoc-Lys(Palmitoyl)-OH | 201004-46-8 | Peptides |
| HY-W048215 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetyl)-L-lysine | 386213-32-7 | Peptides |
| HY-W048217 | N6-Butyryl-L-lysine | 75396-30-4 | Peptides |
| HY-W048231 | 4-Methoxyphenyl α-D-mannopyranoside | 28541-75-5 | Biochemical Assay Reagents |
| HY-W048232 | Allyl α-D-mannopyranoside | 41308-76-3 | Biochemical Assay Reagents |
| HY-W048245 | (2R,3S,4R)-2-(Hydroxymethyl)tetrahydrothiophene-3,4-diol | 190315-43-6 | Reference compound |
| HY-W048283 | Benzoyl-DL-Valine | 2901-80-6 | Peptides |
| HY-W048286 | S-Allyl-D-cysteine | 770742-93-3 | Peptides |
| HY-W048303 | L-Azatyrosine | 58525-82-9 | Natural Products |
| HY-W048312 | 2'-Hydroxy-1'-acetonaphthone | 574-19-6 | Reference compound |
| HY-W048332 | Boc-Tyr(Boc)-OH | 20866-48-2 | Peptides |
| HY-W048334 | Methyl N6-((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-L-lysinate | 73548-77-3 | Peptides |
| HY-W048341 | 3-Ethoxybenzoic acid | 621-51-2 | Natural Products |
| HY-W048404 | Bortezomib impurity A | 289472-80-6 | Reference compound |
| HY-W048449 | L-Biotin | 21788-37-4 | Natural Products |
| HY-W048457 | Palladium hydroxide on activated carbon(20%)(wetted with ca. 55% Water) | 12135-22-7 | Reference compound |
| HY-W048476 | 2',3'-Dideoxy-5-iodouridine | 105784-83-6 | Biochemical Assay Reagents |
| HY-W048478 | 2',3'-Dideoxy-5-iodocytidine | 114748-57-1 | Biochemical Assay Reagents |
| HY-W048479 | 7-Iodo-2',3'-dideoxy-7-deaza-guanosine | 114748-67-3 | Biochemical Assay Reagents |
| HY-W048480 | 7-Iodo-2',3'-dideoxy-7-deazaadenosine | 114748-70-8 | Biochemical Assay Reagents |
| HY-W048482 | rU Phosphoramidite | 118362-03-1 | Reference compound |
| HY-W048482S | rU Phosphoramidite-13C2,d1 | Isotope-Labeled Compounds | |
| HY-W048482S1 | rU Phosphoramidite-13C9,15N2 | Isotope-Labeled Compounds | |
| HY-W048482S2 | rU Phosphoramidite-13C9 | Isotope-Labeled Compounds | |
| HY-W048482S3 | rU Phosphoramidite-15N2 | Isotope-Labeled Compounds | |
| HY-W048482S4 | rU Phosphoramidite-15N | 1193204-41-9 | Isotope-Labeled Compounds |
| HY-W048483 | Bz-rC Phosphoramidite | 118380-84-0 | Oligonucleotides |
| HY-W048487 | N6-Benzoyl-7’-OH-morpholino adenine | 139290-78-1 | Reference compound |
| HY-W048488 | 2'-O-MOE-5-Me-rU | 163759-49-7 | Oligonucleotides |
| HY-W048490 | 7-Deaza-2'-deoxy-7-iodoadenosine | 166247-63-8 | Biochemical Assay Reagents |
| HY-W048491 | 2′-O-(2-Methoxyethyl)adenosine | 168427-74-5 | Oligonucleotides |
| HY-W048492 | 7-Iodo-7-deaza-2'-deoxyguanosine | 172163-62-1 | Biochemical Assay Reagents |
| HY-W048495 | 2'-O-(2-Methoxyethyl)-uridine | 223777-15-9 | Oligonucleotides |
| HY-W048496 | 2'-O-(2-Methoxyethyl)-cytidine | 223777-16-0 | Oligonucleotides |
| HY-W048497 | 2'-O-MOE-5-Me-rC | 244105-55-3 | Oligonucleotides |
| HY-W048500 | 2-Thiothymidine | 28585-51-5 | Reference compound |
| HY-W048502 | 8-Mercaptoadenosine | 3001-45-4 | Reference compound |
| HY-W048504 | 1-[3’-O-[(4,4’-Dimethoxytriphenyl)methyl]-a-L-threofuranosyl]-N4-benzoylcytosine | 325683-91-8 | Reference compound |
| HY-W048510 | Epiquinidine | 572-59-8 | Natural Products |
| HY-W048512 | 2',3'-Didehydro-2',3'-dideoxyuridine | 5974-93-6 | Reference compound |
| HY-W048513 | 7-Deaza-2'-deoxyadenosine | 60129-59-1 | Biochemical Assay Reagents |
| HY-W048543 | Methyl 1,2,3,4-tetra-O-acetyl-D-glucopyranuronate | 3082-96-0 | Biochemical Assay Reagents |
| HY-W048545 | 2,3,4-Tri-O-acetyl-β-D-glucuronide methyl ester | 73464-50-3 | Reference compound |
| HY-W048546 | 2,3,4-Tri-O-acetyl-α-D-glucuronic acid methyl ester | 72692-06-9 | Biochemical Assay Reagents |
| HY-W048668 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-trityl-L-homoserine | 111061-55-3 | Peptides |
| HY-W048671 | Fmoc-Thr(TBDMS)-OH | 146346-82-9 | Peptides |
| HY-W048673 | Fmoc-Phe(4-CONH2)-OH | 204716-17-6 | Peptides |
| HY-W048674 | Fmoc-Ser(Ac)-OH | 171778-17-9 | Peptides |
| HY-W048677 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-trityl-L-lysine | 111061-54-2 | Peptides |
| HY-W048680 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-allothreonine | 146306-75-4 | Peptides |
| HY-W048681 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(4-(tert-butoxy)-4-oxobutyl)-L-cysteine | 102971-73-3 | Peptides |
| HY-W048682 | Fmoc-1-methyl-L-histidine | 202920-22-7 | Reference compound |
| HY-W048688 | Fmoc-Trp(Me)-OH | 1334509-86-2 | Reference compound |
| HY-W048691 | N2,N6-Bis(((9H-fluoren-9-yl)methoxy)carbonyl)-D-lysine | 75932-02-4 | Peptides |
| HY-W048693 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-serine | 146346-81-8 | Peptides |
| HY-W048697 | Fmoc-D-Pen(Trt)-OH | 201532-01-6 | Peptides |
| HY-W048700 | FMOC-D-Allo-THR(TBU)-OH | 170643-02-4 | Peptides |
| HY-W048701 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-histidine | 157355-79-8 | Peptides |
| HY-W048703 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-tyrosine | 112883-29-1 | Peptides |
| HY-W048704 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-((4-methoxyphenyl)diphenylmethyl)-L-lysine | 159857-60-0 | Peptides |
| HY-W048708 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-methyl-L-cysteine | 138021-87-1 | Peptides |
| HY-W048718 | Fmoc-D-Tle-OH | 198543-64-5 | Peptides |
| HY-W048722 | Fmoc-D-Thi-OH | 201532-42-5 | Peptides |
| HY-W048724 | Fmoc-D-Lys(biotin)-OH | 110990-09-5 | Peptides |
| HY-W048727 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-cysteine | 135248-89-4 | Peptides |
| HY-W048730 | Fmoc-Phe(4-tBu)-OH | 213383-02-9 | Peptides |
| HY-W048733 | Fmoc-Asu(OtBu)-OH | 276869-41-1 | Peptides |
| HY-W048739 | Fmoc-α-Me-Leu-OH | 312624-65-0 | Peptides |
| HY-W048825 | Fmoc-Ala-Ala-OH | 87512-31-0 | Peptides |
| HY-W048828 | ((Benzyloxy)carbonyl)-L-alanyl-L-valine | 14550-79-9 | Peptides |
| HY-W048829 | Boc-Phe-Gly-OH | 25616-33-5 | Peptides |
| HY-W048830 | Z-Val-Gly-OH | 2790-84-3 | Peptides |
| HY-W048831 | (tert-Butoxycarbonyl)-L-valyl-L-valine | 69209-73-0 | Peptides |
| HY-W048838 | Acetyl-L-lysine | 1946-82-3 | Natural Products |
| HY-W048839 | N-(tert-Butoxycarbonyl)-N-methyl-L-threonine | 101759-72-2 | Peptides |
| HY-W048840 | Gly-Gly-Leu | 14857-82-0 | Reference compound |
| HY-W048911 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-L-histidine | 116611-64-4 | Peptides |
| HY-W048913 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N2-(2-((5-sulfonaphthalen-1-yl)amino)ethyl)-L-glutamine | 193475-66-0 | Peptides |
| HY-W048918 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-trityl-L-homocysteine | 167015-23-8 | Peptides |
| HY-W048972 | 2,6,6-Trimethylbicyclo[3.1.1]heptan-3-ol | 473-61-0 | Natural Products |
| HY-W048995 | D-6-Oxo-pipecolinic acid | 72002-30-3 | Reference compound |
| HY-W049311 | 4-Methyl-5,6,7,8-tetrahydroquinoline | 28971-03-1 | Natural Products |
| HY-W049312 | 7-Methoxytacrine | 5778-80-3 | Reference compound |
| HY-W049335 | 6,9-Dichloro-1,2,3,4-tetrahydroacridine | 5396-25-8 | Reference compound |
| HY-W049364S | (3-Bromopyridin-2-yl)methanol-d2 | 2170188-53-9 | Isotope-Labeled Compounds |
| HY-W049706 | α-D-Glucose pentaacetate | 604-68-2 | Biochemical Assay Reagents |
| HY-W049706R | α-D-Glucose pentaacetate (Standard) | 604-68-2 | Reference Standards |
| HY-W049713 | 4-Methoxyphenyl 3,4-O-isopropylidene-β-D-galactopyranoside | 159922-67-5 | Biochemical Assay Reagents |
| HY-W049715 | 3,6,9,12-Tetraoxaeicosan-1-ol | 19327-39-0 | Biochemical Assay Reagents |
| HY-W049735 | N,N,O-Tridesmethylvenlafaxine | 149289-29-2 | Natural Products |
| HY-W049735R | N,N,O-Tridesmethylvenlafaxine (Standard) | 149289-29-2 | Reference Standards |
| HY-W049802 | N-((Allyloxy)carbonyl)-N-methyl-L-alanine | 918531-01-8 | Peptides |
| HY-W049875 | Nitroxynil | 1689-89-0 | Reference compound |
| HY-W049875R | Nitroxynil (Standard) | 1689-89-0 | Reference Standards |
| HY-W049881 | 9-Methyl-β-carboline | 2521-07-5 | Reference compound |
| HY-W049970 | Carvacrol methyl ether | 6379-73-3 | Natural Products |
| HY-W049970R | Carvacrol methyl ether (Standard) | 6379-73-3 | Reference Standards |
| HY-W050000 | OR-1855 | 101328-85-2 | Reference compound |
| HY-W050000R | OR-1855 (Standard) | 101328-85-2 | Reference Standards |
| HY-W050023 | (S)-2-Amino-2-(2-chlorophenyl)acetic acid | 141315-50-6 | Peptides |
| HY-W050025 | 6-Chloro-L-tryptophan | 33468-35-8 | Peptides |
| HY-W050026 | Phenylacetylglutamine | 28047-15-6 | Natural Products |
| HY-W050026R | Phenylacetylglutamine (Standard) | 28047-15-6 | Reference Standards |
| HY-W050026S | Phenylacetylglutamine-d5 | 1331909-01-3 | Isotope-Labeled Compounds |
| HY-W050031 | (S)-3-Hydroxybutanoic acid | 6168-83-8 | Natural Products |
| HY-W050031R | (S)-3-Hydroxybutanoic acid (Standard) | 6168-83-8 | Reference Standards |
| HY-W050044 | L-Azetidine-2-carboxylic acid | 2133-34-8 | Natural Products |
| HY-W050049 | 2-Deoxy-2,2-difluoro-D-erythro-pentonic acid γ-Lactone 3,5-dibenzoate | 122111-01-7 | Biochemical Assay Reagents |
| HY-W050087 | Octaethylene glycol | 5117-19-1 | Reference compound |
| HY-W050088 | Isoxepac | 55453-87-7 | Reference compound |
| HY-W050088R | Isoxepac (Standard) | 55453-87-7 | Reference Standards |
| HY-W050088S | Isoxepac-d6 | 2012598-71-7 | Isotope-Labeled Compounds |
| HY-W050122 | S-(+)-GABOB | 7013-05-0 | Reference compound |
| HY-W050145 | Levoglucosan | 498-07-7 | Natural Products |
| HY-W050145R | Levoglucosan (Standard) | 498-07-7 | Reference Standards |
| HY-W050145S | Levoglucosan-d7 | 2483832-05-7 | Isotope-Labeled Compounds |
| HY-W050145S2 | Levoglucosan-13C6 | 1375293-81-4 | Isotope-Labeled Compounds |
| HY-W050151 | 2,5-Di-tert-butyl-1,4-benzoquinone | 2460-77-7 | Reference compound |
| HY-W050154 | Kojic acid | 501-30-4 | Natural Products |
| HY-W050154R | Kojic acid (Standard) | 501-30-4 | Reference Standards |
| HY-W050154S | Kojic acid-13C6 | Isotope-Labeled Compounds | |
| HY-W050162 | (E)-3,4,5-Trimethoxycinnamic acid | 20329-98-0 | Reference compound |
| HY-W050216 | TP-4748 | 1150114-62-7 | Reference compound |
| HY-W050444 | Methyl 2-amino-3,3,3-trifluoropropanoate hydrochloride | 134297-36-2 | Peptides |
| HY-W050493 | (R)-2-Amino-3-(3-nitrophenyl)propanoic acid | 169530-97-6 | Peptides |
| HY-W050494 | (S)-2-Amino-3-(3-nitrophenyl)propanoic acid | 19883-74-0 | Peptides |
| HY-W050782 | Boc-N-Ethylglycine | 149794-10-5 | Peptides |
| HY-W050785 | H-D-Chg-OH.HCl | 61367-40-6 | Peptides |
| HY-W050803 | H-D-Cys(Bzl)-OH | 23032-53-3 | Peptides |
| HY-W051093 | (S)-1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid | 103336-06-7 | Peptides |
| HY-W051140 | Silver sulfate | 10294-26-5 | Biochemical Assay Reagents |
| HY-W051164 | 5-Hydroxyvanillin | 3934-87-0 | Reference compound |
| HY-W051173 | (Methoxycarbonyl)-L-valyl-L-proline | 181827-47-4 | Reference compound |
| HY-W051189S | (4-Fluorophenyl)methanol-d4 | 93111-26-3 | Isotope-Labeled Compounds |
| HY-W051189S1 | (4-Fluorophenyl)methanol-d6 | 1071809-48-7 | Isotope-Labeled Compounds |
| HY-W051229 | Morin hydrate | 654055-01-3 | Biochemical Assay Reagents |
| HY-W051271 | Titanium(IV) oxide | 13463-67-7 | Reference compound |
| HY-W051287 | 4-Hydroxy-2-butanone | 590-90-9 | Natural Products |
| HY-W051298 | Distearin | 1323-83-7 | Natural Products |
| HY-W051299 | Diethylglycine | 1606-01-5 | Peptides |
| HY-W051350 | H-D-Thr(tBu)-OH | 201274-81-9 | Peptides |
| HY-W051351 | H-allo-Thr(tBu)-OH | 201353-89-1 | Peptides |
| HY-W051391 | 1,4,7-Trimethyl-1,4,7-triazonane | 96556-05-7 | Biochemical Assay Reagents |
| HY-W051418 | (R)-2-Amino-2-(4-fluorophenyl)acetic acid | 93939-74-3 | Peptides |
| HY-W051513 | 2-Methylquinazolin-4-ol | 1769-24-0 | Natural Products |
| HY-W051513R | 2-Methylquinazolin-4-ol (Standard) | 1769-24-0 | Reference Standards |
| HY-W051568 | (R)-2-Amino-3-(furan-2-yl)propanoic acid | 110772-46-8 | Peptides |
| HY-W051612 | DL-Propargylglycine (hydrochloride) | 16900-57-5 | Reference compound |
| HY-W051624S | (Rac)-2-Aminothiazoline-4-carboxylic acid-13C,15N2 | 1346599-59-4 | Isotope-Labeled Compounds |
| HY-W051634 | Propargyl-PEG2-amine | 944561-44-8 | ADC Related |
| HY-W051723 | (R)-3-Hydroxybutanoic acid | 625-72-9 | Natural Products |
| HY-W051723R | (R)-3-Hydroxybutanoic acid (Standard) | 625-72-9 | Reference Standards |
| HY-W051937 | Boc-D-His(Trt)-OH | 393568-74-6 | Peptides |
| HY-W052006 | m-PEG7-thiol | 651042-82-9 | Reference compound |
| HY-W052011 | Ruzinurad | 1638327-48-6 | Reference compound |
| HY-W052051 | N-Benzylacetamide | 588-46-5 | Reference compound |
| HY-W052066 | tert-Butyl (3-chloropropyl)carbamate | 116861-31-5 | Reference compound |
| HY-W052144 | (±) Anabasine | 13078-04-1 | Natural Products |
| HY-W052144S | (±) Anabasine-d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W052190 | 4-(4-chlorophenyl)thiazol-2-amine | 2103-99-3 | Reference compound |
| HY-W052212 | Ethyl L-methioninate hydrochloride | 2899-36-7 | Peptides |
| HY-W052227 | Fmoc-DL-Ala-OH | 35661-38-2 | Peptides |
| HY-W052227S | Fmoc-DL-Ala-OH-d1 | Isotope-Labeled Compounds | |
| HY-W052234 | 4-Fluorophenoxyacetic acid | 405-79-8 | Reference compound |
| HY-W052246 | (tert-Butoxycarbonyl)-D-histidine | 50654-94-9 | Peptides |
| HY-W052248 | RU 23686 (free base) | 52157-82-1 | Reference compound |
| HY-W052249 | 1-Methyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one | 5334-56-5 | Biochemical Assay Reagents |
| HY-W052253S | 2-(Piperazin-1-yl)pyrimidin-5-ol-d8 (diTFA) | Isotope-Labeled Compounds | |
| HY-W052289 | Methyl 6-bromo-1H-indole-3-carboxylate | 868656-97-7 | Natural Products |
| HY-W052309 | (tert-Butoxycarbonyl)methionine | 93000-03-4 | Peptides |
| HY-W052310 | Methyl ((benzyloxy)carbonyl)-D-serinate | 93204-36-5 | Peptides |
| HY-W052408 | H-DL-Phe-OtBu.HCl | 75898-47-4 | Peptides |
| HY-W052493 | 2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid | 66-02-4 | Peptides |
| HY-W052508 | Norquetiapine | 5747-48-8 | Reference compound |
| HY-W052508S | Norquetiapine-d8 | 1189866-35-0 | Isotope-Labeled Compounds |
| HY-W052512 | Antitrypanosomal agent 1 | 75144-12-6 | Reference compound |
| HY-W052529 | Boc-Hyp-OEt | 37813-30-2 | Peptides |
| HY-W052600 | Ethyl azetidine-3-carboxylate (hydrochloride) | 405090-31-5 | ADC Related |
| HY-W052750 | 5-Carboxy-2-thiouracil | 23945-50-8 | Biochemical Assay Reagents |
| HY-W053503 | (S)-3-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid | 500770-78-5 | Peptides |
| HY-W053507 | m-Tolylacetic acid | 621-36-3 | Natural Products |
| HY-W053507R | m-Tolylacetic acid (Standard) | 621-36-3 | Reference Standards |
| HY-W053516 | (9E,12E)-Methyl octadeca-9,12-dienoate | 2566-97-4 | Biochemical Assay Reagents |
| HY-W053519 | DL-Pantolactone | 79-50-5 | Natural Products |
| HY-W053519R | DL-Pantolactone (Standard) | 79-50-5 | Reference Standards |
| HY-W053531 | H-Hyp(tBu)-OH | 79775-07-8 | Peptides |
| HY-W053550 | H-D-Cys(Trt)-OH | 25840-82-8 | Peptides |
| HY-W053583 | Tetraxetan | 60239-18-1 | Biochemical Assay Reagents |
| HY-W053583R | Tetraxetan (Standard) | 60239-18-1 | Reference Standards |
| HY-W053587 | Triazolopyridinone | 6969-71-7 | Reference compound |
| HY-W053678 | Benzyl-L-serine | 17136-45-7 | Peptides |
| HY-W053699 | N-p-Tosylglycine | 1080-44-0 | Peptides |
| HY-W053701 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-((5-(dimethylamino)naphthalen-1-yl)sulfonyl)-L-lysine | 118584-90-0 | Peptides |
| HY-W053702 | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-trityl-D-serine | 212688-51-2 | Peptides |
| HY-W053705 | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid | 135837-63-7 | Peptides |
| HY-W053709 | Tetrazine-Amine | 1092689-33-2 | Reference compound |
| HY-W053709A | Tetrazine-Amine (monohydrochloride) | 1416711-59-5 | Reference compound |
| HY-W053741 | 1,2,3,4,6-Penta-O-benzoyl-D-mannopyranose | 96996-90-6 | Biochemical Assay Reagents |
| HY-W053787 | 1-Methylhistamine (dihydrochloride) | 6481-48-7 | Natural Products |
| HY-W053787S | 1-Methylhistamine-d3 (dihydrochloride) | 344299-49-6 | Isotope-Labeled Compounds |
| HY-W053801 | tert-Butyl benzylglycinate | 7662-76-2 | Peptides |
| HY-W053842 | tert-Butyl 3-iodopropylcarbamate | 167479-01-8 | Reference compound |
| HY-W053871 | 4-Methylphthalimide | 40314-06-5 | Dye Reagents |
| HY-W054064 | 6-Chloro-7-deazapurine-β-D-riboside | 16754-80-6 | Oligonucleotides |
| HY-W054074 | 5-Bromo-2',3',5'-tri-O-acetyluridine | 105659-32-3 | Reference compound |
| HY-W054146 | RAMB4 | 145888-79-5 | Reference compound |
| HY-W054223 | N-Methyl lactam | 116212-46-5 | Reference compound |
| HY-W054259 | BFMO | 69010-90-8 | Biochemical Assay Reagents |
| HY-W054292 | tert-Butyl-DCL | 1025796-31-9 | Biochemical Assay Reagents |
| HY-W055811 | D-Cysteine hydrochloride hydrate | 207121-46-8 | Peptides |
| HY-W055845 | 4-Methylbenzamide oxime | 19227-13-5 | Reference compound |
| HY-W055861 | Fmoc-NH-PEG1-CH2COOH | 260367-12-2 | ADC Related |
| HY-W055870 | Hydroxy-PEG1-(CH2)2-Boc | 671802-00-9 | Reference compound |
| HY-W055872 | Erythromycylamine | 26116-56-3 | Reference compound |
| HY-W055872R | Erythromycylamine (Standard) | 26116-56-3 | Reference Standards |
| HY-W055872S | Erythromycylamine-d3 | Isotope-Labeled Compounds | |
| HY-W055872S1 | Erythromycylamine-13C,d3 | Isotope-Labeled Compounds | |
| HY-W056267 | 3-Boc-3-azaspiro[5.5]undecane-9-carbaldehyde | 1416176-14-1 | Reference compound |
| HY-W056964S | Naphthalene-2,6-dicarboxylic acid-d6 | 682321-46-6 | Isotope-Labeled Compounds |
| HY-W057434 | Methyl N-(tert-butoxycarbonyl)-O-methyl-L-serinate | 134167-07-0 | Peptides |
| HY-W057450 | (S)-3-Oxo-cyclopentanecarboxylic acid methyl ester | 132076-32-5 | Reference compound |
| HY-W057459 | (R)-3-Oxo-cyclopentanecarboxylic acid methyl ester | 132076-27-8 | Reference compound |
| HY-W057465 | 1,4,4-Trimethyl-L-proline | 1443245-02-0 | Peptides |
| HY-W058182 | 7-Chlorothieno[2,3-c]pyridine | 28948-58-5 | Reference compound |
| HY-W058849 | MT 63-78 | 1179347-65-9 | Reference compound |
| HY-W059210 | Ruxolitinib impurity-1 | 952518-97-7 | Reference compound |
| HY-W059342 | Etoxazole | 153233-91-1 | Biochemical Assay Reagents |
| HY-W059342R | Etoxazole (Standard) | 153233-91-1 | Reference Standards |
| HY-W059342S | Etoxazole-d5 | Isotope-Labeled Compounds | |
| HY-W059917 | AP24600 | 1300690-48-5 | Reference compound |
| HY-W060074 | 1-Acetyl-β-carboline | 50892-83-6 | Natural Products |
| HY-W060216 | N-Acetyl-DL-penicillamine | 59-53-0 | Biochemical Assay Reagents |
| HY-W060316 | β-Thujaplicinol | 29346-20-1 | Reference compound |
| HY-W060470 | 1-Methyl-4-imidazoleacetic acid (hydrochloride) | 35454-39-8 | Reference compound |
| HY-W060779 | (4R)-1-Cbz-4-hydroxy-D-proline methyl ester | 155075-23-3 | Peptides |
| HY-W061043 | DOV-216,303 | 86215-36-3 | Reference compound |
| HY-W061399 | (S)-Tetrahydrofuran-3-ylamine | 104530-79-2 | Reference compound |
| HY-W061531 | (3aR,5R,6aS)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)-2,2-dimethyldihydrofuro[2,3-d][1,3]dioxol-6(3aH)-one | 75783-45-8 | Reference compound |
| HY-W061571 | H-Gly-Hyp-OH | 24587-32-4 | Reference compound |
| HY-W061614 | (4R)-1-Boc-4-fluoro-D-proline | 681128-51-8 | Peptides |
| HY-W061616 | Tri-O-benzyl-D-glucal, 97% | 55628-54-1 | Biochemical Assay Reagents |
| HY-W061629 | D-Pyroaspartic acid | 62860-12-2 | Reference compound |
| HY-W061650 | (R)-1-Benzylpyrrolidine-2-carboxylic acid | 56080-99-0 | Peptides |
| HY-W061674 | trans-2-Pentenoic acid | 13991-37-2 | Biochemical Assay Reagents |
| HY-W061761 | (1R,3S)-3-Aminocyclopentane carboxylic acid | 71830-08-5 | Reference compound |
| HY-W062109 | Olopatadine | 113806-05-6 | Reference compound |
| HY-W062109S | Olopatadine-d6 | 1231979-85-3 | Isotope-Labeled Compounds |
| HY-W062171 | Cyclo-(Pro-Gly) | 19179-12-5 | Natural Products |
| HY-W062216 | 2-Aminoimidazole | 7720-39-0 | Natural Products |
| HY-W062274A | 4-epi-Edoxaban (tosylate) | 2852734-47-3 | Reference compound |
| HY-W062304 | Boc-D-Arg(Pbf)-OH | 186698-61-3 | Peptides |
| HY-W062542 | 1-Methylhistamine | 501-75-7 | Natural Products |
| HY-W062695 | (R)-Acalabrutinib | 1952316-43-6 | Reference compound |
| HY-W062696 | BC-1382 | 1013753-99-5 | Reference compound |
| HY-W062697 | HTL14242 | 1644645-32-8 | Reference compound |
| HY-W062700 | STS-E412 | 1609980-39-3 | Reference compound |
| HY-W062702 | BMS-933043 | 1221973-93-8 | Reference compound |
| HY-W062703S | (Rac)-Ruxolitinib-d9 | 2469553-67-9 | Isotope-Labeled Compounds |
| HY-W062703S1 | (Rac)-Ruxolitinib-d8 | 1794791-38-0 | Isotope-Labeled Compounds |
| HY-W062835 | CGP77675 | 234772-64-6 | Reference compound |
| HY-W062835A | CGP77675 (hydrate) | Reference compound | |
| HY-W062836 | BAY 41-8543 | 256498-66-5 | Reference compound |
| HY-W062904 | Laquinimod (sodium) | 248282-07-7 | Reference compound |
| HY-W063149 | (1S,3R)-3-Aminocyclopentanol | 1036260-18-0 | Reference compound |
| HY-W063197 | Adenosine receptor antagonist 4 | 133240-06-9 | Reference compound |
| HY-W063269 | (S)-1-Benzyl 2-methyl 4-oxopyrrolidine-1,2-dicarboxylate | 16217-15-5 | Peptides |
| HY-W063924 | Bpin-Cyclohexene-C-COOEt | 1166829-70-4 | Reference compound |
| HY-W063968 | RO8191 | 691868-88-9 | Reference compound |
| HY-W064657 | Momelotinib (dihydrochloride) | 1380317-28-1 | Reference compound |
| HY-W064677 | Methyl 5-hydroxy-1H-indole-3-carboxylate | 112332-96-4 | Natural Products |
| HY-W065053 | trans-N-Methyl-4-methoxyproline | 131559-49-4 | Peptides |
| HY-W065835 | 2-Bromoaldisine | 96562-96-8 | Natural Products |
| HY-W066890 | 4-Nitrocatechol | 3316-09-4 | Natural Products |
| HY-W066915 | Nortropine (hydrochloride) | 14383-51-8 | Reference compound |
| HY-W067028S | Semicarbazide-13C,15N2 (hydrochloride) | 1173020-16-0 | Isotope-Labeled Compounds |
| HY-W067056 | Methyl (E)-cinnamate | 1754-62-7 | Natural Products |
| HY-W067056R | Methyl (E)-cinnamate (Standard) | 1754-62-7 | Reference Standards |
| HY-W067056S | Methyl (E)-cinnamate-d5 | 61764-82-7 | Isotope-Labeled Compounds |
| HY-W067056S1 | Methyl(E)-cinnamate-d7 | 2022152-96-9 | Isotope-Labeled Compounds |
| HY-W067061 | Hydroxy-PEG2-(CH2)2-Boc | 133803-81-3 | ADC Related |
| HY-W067091 | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)propanoic acid | 172965-84-3 | Peptides |
| HY-W067159 | 6-Bromo-1-methyl-1H-benzo[d]imidazol-2(3H)-one | 305790-48-1 | Reference compound |
| HY-W067358 | 2-Methylpyrazine | 109-08-0 | Natural Products |
| HY-W067358R | 2-Methylpyrazine (Standard) | 109-08-0 | Reference Standards |
| HY-W067358S | 2-Methylpyrazine-d6 | 1219804-84-8 | Isotope-Labeled Compounds |
| HY-W067360 | 2-(((Benzyloxy)carbonyl)amino)-3-hydroxypropanoic acid | 2768-56-1 | Peptides |
| HY-W067425 | 2-(4-Hydroxyphenyl)propionic acid | 938-96-5 | Reference compound |
| HY-W067427 | BAY32-5915 | 1571-30-8 | Reference compound |
| HY-W067445 | N-(4-Formylphenyl)acetamide | 122-85-0 | Biochemical Assay Reagents |
| HY-W067478 | DL-Aspartic acid dimethyl ester hydrochloride | 14358-33-9 | Peptides |
| HY-W067479 | (E)-Cinnamamide | 22031-64-7 | Natural Products |
| HY-W067489 | NH2-PEG1-CH2CH2-Boc | 1260092-46-3 | Reference compound |
| HY-W067509 | m-PEG3-CH2CH2COOH | 67319-28-2 | ADC Related |
| HY-W067572 | Stobadine | 85202-17-1 | Reference compound |
| HY-W067583 | Norharmine | 6253-19-6 | Reference compound |
| HY-W067615 | Phenyl-boronic acid-d5 | 215527-70-1 | Reference compound |
| HY-W067636S | 1-Chloroadamantane-d15 | 352431-55-1 | Isotope-Labeled Compounds |
| HY-W067673 | 4-Methoxycoumarin | 20280-81-3 | Reference compound |
| HY-W067705 | 3,6,9-Trioxaundecanedioic Acid | 13887-98-4 | Reference compound |
| HY-W067716 | Spinacine | 59981-63-4 | Natural Products |
| HY-W068035 | (E,E)-2,4-Hexadienal | 142-83-6 | Biochemical Assay Reagents |
| HY-W068119A | N-(2-Aminoethyl)maleimide (hydrochloride) | 134272-64-3 | Biochemical Assay Reagents |
| HY-W068212 | 16-Hydroxyhexadecanoic acid | 506-13-8 | Natural Products |
| HY-W068214 | Methyl undec-10-enoate | 111-81-9 | Biochemical Assay Reagents |
| HY-W068215A | Methyl 12-aminododecanoate (hydrochloride) | 4271-86-7 | Biochemical Assay Reagents |
| HY-W068420 | Antioxidant agent-4 | 50901-34-3 | Reference compound |
| HY-W068430 | 5,7-Dimethoxy-2,2-dimethylchromene | 21421-66-9 | Natural Products |
| HY-W068682 | 1-Hydroxyphenazine | 528-71-2 | Reference compound |
| HY-W068697 | 3-Butenoic acid | 625-38-7 | Reference compound |
| HY-W068697R | 3-Butenoic acid (Standard) | 625-38-7 | Reference Standards |
| HY-W068700 | Methyl sorbate | 1515-80-6 | Biochemical Assay Reagents |
| HY-W068771 | (E)-3-(4-Methoxyphenyl)acrylic acid | 943-89-5 | Natural Products |
| HY-W068783 | (E)-3,4-(Methylenedioxy)cinnamic acid | 38489-76-8 | Natural Products |
| HY-W068839 | L-Phenylalanyl-L-leucine | 3303-55-7 | Peptides |
| HY-W069177 | Benzylthiouracil | 6336-50-1 | Reference compound |
| HY-W069504S | n-Propyl-amine-d7 (Hydrochloride) | 344298-88-0 | Isotope-Labeled Compounds |
| HY-W069504S1 | n-Propyl-amine-d3 (Hydrochloride) | 478702-86-2 | Isotope-Labeled Compounds |
| HY-W069504S2 | Propan-1-amine-d5 hydrochloride | 1398065-66-1 | Isotope-Labeled Compounds |
| HY-W069508 | 3-(Aminomethyl)phenol | 73604-31-6 | Reference compound |
| HY-W069604 | Thalidomide-5-Br | 26166-92-7 | Reference compound |
| HY-W069715 | 2-Amino-6-chloro-9-[(2,3,5-tri-O-benzoyl-2-C-Methyl-beta-D-ribofuranosyl)]-9H-purine | 641571-44-0 | Reference compound |
| HY-W069721 | N-Acetylsulfanilamide | 121-61-9 | Reference compound |
| HY-W069721S1 | N-Acetylsulfanilamide-13C6 | 1655498-04-6 | Isotope-Labeled Compounds |
| HY-W070093 | KKJ00626 | 51646-17-4 | Reference compound |
| HY-W070294 | 8-Azahypoxanthine | 2683-90-1 | Reference compound |
| HY-W070306 | PDK1-IN-1 | 1207836-10-9 | Reference compound |
| HY-W070753 | LIMK1 inhibitor 2 | 67795-42-0 | Reference compound |
| HY-W070813 | 3-Fluoro-2-(tributylstannyl)pyridine | 573675-60-2 | Reference compound |
| HY-W071006 | PPC-NHS ester | 107348-47-0 | ADC Related |
| HY-W071007 | NO2-SPDMV | 663598-98-9 | ADC Related |
| HY-W071148 | Ethyl 4-oxo-3H-phthalazin-1-ylacetate | 25947-13-1 | Reference compound |
| HY-W071201S | N,N-Dimethyl-2-sulfamoylnicotinamide-d6 | Isotope-Labeled Compounds | |
| HY-W071581 | Glucocorticoid receptor activator 1 | 14593-25-0 | Reference compound |
| HY-W071583 | N-Boc-PEG9-alcohol | 2112731-44-7 | ADC Related |
| HY-W071584 | N-Boc-PEG6-alcohol | 331242-61-6 | ADC Related |
| HY-W071685 | 6,7-Dimethyl-5,6,7,8-tetrahydropterin (hydrochloride) | 945-43-7 | Reference compound |
| HY-W071686 | 6-Methyltetrahydropterin (dihydrochloride) | 69113-63-9 | Enzyme |
| HY-W071746 | Linolelaidic acid | 506-21-8 | Natural Products |
| HY-W071746R | Linolelaidic acid (Standard) | 506-21-8 | Reference Standards |
| HY-W071967 | Alloc-Val-Ala-pAB | 1343407-91-9 | Reference compound |
| HY-W072009 | 5,7-Dihydroxycoumarin | 2732-18-5 | Natural Products |
| HY-W072147 | Fmoc-Ser-OMe | 82911-78-2 | Peptides |
| HY-W072177 | Methyl acetyl-D-phenylalaninate | 21156-62-7 | Peptides |
| HY-W072274 | (S)-Desoxy-D2PM (hydrochloride) | 188398-87-0 | Reference compound |
| HY-W072385 | 1,2-Dibromo-4,5-methylenedioxybenzene | 5279-32-3 | Reference compound |
| HY-W072459 | 6'-Hydroxydihydrocinchonidine | 5962-19-6 | Reference compound |
| HY-W072496 | 10-(3,5-Di-OMe-Ph)-9-mesityl-(1,3,6,8-tetra-OMe-acridinium) (tetrafluoroborate) | 1965330-59-9 | Reference compound |
| HY-W072598 | N-(tert-Butoxycarbonyl)-O-(tetrahydro-2H-pyran-2-yl)-L-serine | 130465-47-3 | Peptides |
| HY-W072701 | N6-Benzoyl-2'-fluoro-2'-deoxyarabinoadenosine | 144924-99-2 | Reference compound |
| HY-W072732 | N-Fmoc-N-benzyl-L-alanine | 672917-68-9 | Peptides |
| HY-W072752 | endo-BCN-PEG2-NH2 | 1263166-93-3 | Reference compound |
| HY-W072940 | Anticancer agent 7 | 2088956-21-0 | Reference compound |
| HY-W072954 | Lenalidomide-5-Br | 1010100-26-1 | Reference compound |
| HY-W072979 | Mesoporphyrin dimethyl ester | 1263-63-4 | Reference compound |
| HY-W073013 | Cobalt(II) TPP | 14172-90-8 | Biochemical Assay Reagents |
| HY-W073023 | Pyroporphyrin dimethyl ester | 10589-94-3 | Biochemical Assay Reagents |
| HY-W073069 | Coproporphyrin I tetramethyl ester | 25767-20-8 | Biochemical Assay Reagents |
| HY-W073074 | Mesoporphyrin IX (dihydrochloride) | 68938-72-7 | Reference compound |
| HY-W073080 | Coproporphyrin I (dihydrochloride) | 69477-27-6 | Biochemical Assay Reagents |
| HY-W073082 | Nitrilotriacetic acid (disodium salt) | 15467-20-6 | Biochemical Assay Reagents |
| HY-W073099 | Bis(acetylacetonato)dioxomolybdenum(VI) | 17524-05-9 | Reference compound |
| HY-W073128 | Perfluorotetradecanoic acid | 376-06-7 | Reference compound |
| HY-W073147 | 1H,1H,2H,2H-Perfluoro-1-decanol | 678-39-7 | Reference compound |
| HY-W073183 | Dibenzo-24-crown-8-ether | 14174-09-5 | Biochemical Assay Reagents |
| HY-W073189 | Magnesium(II) meso-tetraphenylporphine | 14640-21-2 | Biochemical Assay Reagents |
| HY-W073196 | Gold(Ⅲ) chloride hydrate (48% Au basis) | 27988-77-8 | Biochemical Assay Reagents |
| HY-W073196A | Gold(Ⅲ) chloride hydrate (50% Au basis) | 27988-77-8 | Biochemical Assay Reagents |
| HY-W073196B | Gold(Ⅲ) chloride hydrate (52% Au basis) | 27988-77-8 | Biochemical Assay Reagents |
| HY-W073206 | Copper(II) tartrate hydrate | 815-82-7 | Biochemical Assay Reagents |
| HY-W073265 | 2,2,3,3,3-Pentafluoro-1-propanol | 422-05-9 | Biochemical Assay Reagents |
| HY-W073314 | 2,2,2-Trifluoroethoxyamine (hydrochloride) | 68401-66-1 | Reference compound |
| HY-W073336A | 1-(3-Fluorophenyl)piperazine (hydrochloride) | 76835-10-4 | Reference compound |
| HY-W073382 | 4-(3-Tosyl-2-(tosylmethyl)propanoyl)benzoic acid | 124243-00-1 | Reference compound |
| HY-W073501A | Glutaconic acid | 1724-02-3 | Reference compound |
| HY-W073524 | DFAME | 1420815-55-9 | Dye Reagents |
| HY-W073687 | 2,4,6-Triiodophenol | 609-23-4 | Reference compound |
| HY-W073709 | NH2-PEG1-C1-Boc | 1155811-37-2 | Reference compound |
| HY-W073762 | FBnG | 2241669-86-1 | Reference compound |
| HY-W073825 | N2-iso-Butyryl-2'-O-(2-methoxyethyl)guanosine | 440327-50-4 | Reference compound |
| HY-W074006 | Tris(2-cyanoethyl)phosphine | 4023-53-4 | Reference compound |
| HY-W074081 | (CAAC-Cy)Rh(COD)Cl | 1801869-83-9 | Reference compound |
| HY-W074143 | Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium(II) dichloride | 36309-88-3 | Dye Reagents |
| HY-W074326 | Diglycolic anhydride | 4480-83-5 | Biochemical Assay Reagents |
| HY-W074486 | 1-(4-Chlorophenyl)ethanol | 3391-10-4 | Biochemical Assay Reagents |
| HY-W074514 | 4-Allyltoluene | 3333-13-9 | Reference compound |
| HY-W074541 | Girard’s reagent T | 123-46-6 | Biochemical Assay Reagents |
| HY-W074648 | Antibacterial agent 18 | 1239602-35-7 | Reference compound |
| HY-W074785 | Carboxyl diazirine alkyne | 1450754-37-6 | Biochemical Assay Reagents |
| HY-W074888 | N-Lauroyl-L-glutamic acid | 3397-65-7 | Reference compound |
| HY-W074889 | N-Myristoylglycine | 14246-55-0 | Peptides |
| HY-W074890 | Palmitoylglycine | 2441-41-0 | Natural Products |
| HY-W074890R | Palmitoylglycine (Standard) | 2441-41-0 | Reference Standards |
| HY-W074890S | Palmitoylglycine-d31 | Isotope-Labeled Compounds | |
| HY-W074914 | N-Fmoc-5,5,5-trifluoro-L-norvaline | 144207-41-0 | Peptides |
| HY-W074930 | (S)-Tenofovir | 147127-19-3 | Reference compound |
| HY-W074930R | (S)-Tenofovir (Standard) | 147127-19-3 | Reference Standards |
| HY-W074953 | tert-Butyl hydrogen tetradecanedioate | 234082-00-9 | Reference compound |
| HY-W074975 | CL 5343 | 14949-00-9 | Reference compound |
| HY-W074975R | CL 5343 (Standard) | 14949-00-9 | Reference Standards |
| HY-W074978 | 3-Fluoro-DL-valine | 43163-94-6 | Reference compound |
| HY-W075032 | Acrinathrin | 101007-06-1 | Reference compound |
| HY-W075176 | Transfluthrin | 118712-89-3 | Reference compound |
| HY-W075176R | Transfluthrin (Standard) | 118712-89-3 | Reference Standards |
| HY-W075183S | 2,4,6-Tri([1,1'-biphenyl]-4-yl)-1,3,5-triazine-d10 | Isotope-Labeled Compounds | |
| HY-W075256 | Isotianil | 224049-04-1 | Reference compound |
| HY-W075353 | TPPS | 35218-75-8 | Reference compound |
| HY-W075425 | 5,10,15,20-Tetra(pyridin-2-yl)porphyrin | 40904-90-3 | Biochemical Assay Reagents |
| HY-W075433 | 5,15-Di(4-Pyridyl)-10,20-diphenylporphyrin | 71410-72-5 | Biochemical Assay Reagents |
| HY-W075517 | ZIF-8 | 59061-53-9 | Reference compound |
| HY-W075603 | 2,6-Diiodo-BODIPY 493/503 | 1031443-55-6 | Dye Reagents |
| HY-W075674 | Butane-1,4-diyldiphosphonic acid | 4671-77-6 | Reference compound |
| HY-W075707 | FeTCPP chloride | 55266-17-6 | Biochemical Assay Reagents |
| HY-W075744 | SK-J002-1n | 2049086-34-0 | Reference compound |
| HY-W075745 | SK-J003-1n | 2049086-35-1 | Reference compound |
| HY-W075747 | SK-J014-1n | 2049086-37-3 | Reference compound |
| HY-W075766 | Nickel(II) fluoride | 10028-18-9 | Biochemical Assay Reagents |
| HY-W075770 | Nickel(II) oxide | 1313-99-1 | Reference compound |
| HY-W075791 | Copper(II) perchlorate hexahydrate | 10294-46-9 | Biochemical Assay Reagents |
| HY-W075836 | Ferrocenylmethyltrimethylammonium (iodide) | 12086-40-7 | Biochemical Assay Reagents |
| HY-W075885 | trans-Platinum(II)diammine dichloride | 14913-33-8 | Biochemical Assay Reagents |
| HY-W075885R | trans-Platinum(II)diammine dichloride (Standard) | 14913-33-8 | Reference Standards |
| HY-W075903 | Hexaamminecobalt(III) chloride | 10534-89-1 | Biochemical Assay Reagents |
| HY-W076030 | Lanthanum(Ⅲ) chloride | 10099-58-8 | Biochemical Assay Reagents |
| HY-W076042 | Sodium tetrakis(4-fluorophenyl)borate dihydrate | 207683-22-5 | Biochemical Assay Reagents |
| HY-W076067 | Ammonium tetrathiomolybdate | 15060-55-6 | Reference compound |
| HY-W076083 | Sodium molybdate dihydrate, for cell culture, 99.5% | 10102-40-6 | Biochemical Assay Reagents |
| HY-W076148D | Cerium oxide, 99.99% metals basis, <5 μm | 1306-38-3 | Biochemical Assay Reagents |
| HY-W076166C | Lead (II) iodide | 10101-63-0 | Biochemical Assay Reagents |
| HY-W076298 | Remdesivir intermediate-1 | 1354823-36-1 | Reference compound |
| HY-W076313 | 2-(2,6-Dioxopiperidin-3-yl)-4-iodoisoindoline-1,3-dione | 959150-64-2 | Reference compound |
| HY-W076441 | Ethyl (S)-3-hydroxybutanoate | 56816-01-4 | Biochemical Assay Reagents |
| HY-W076543 | 5-(Biotinamido)pentylamine | 115416-38-1 | Reference compound |
| HY-W076556 | Alloc-Val-Ala-OH | 330970-70-2 | Reference compound |
| HY-W076696 | 3-(4-Hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 1061604-41-8 | Reference compound |
| HY-W076740 | 8-Bromoadenine | 6974-78-3 | Biochemical Assay Reagents |
| HY-W076778 | Monoethyl itaconate | 57718-07-7 | Reference compound |
| HY-W076778R | Monoethyl itaconate (Standard) | 57718-07-7 | Reference Standards |
| HY-W076794 | 3-Bromo-1H-pyrrole-2,5-dione | 98026-79-0 | Reference compound |
| HY-W076836 | 4-Aminobenzaldehyde | 556-18-3 | Biochemical Assay Reagents |
| HY-W076898A | Hydroxyethyl disulfide | 1892-29-1 | Reference compound |
| HY-W076903 | 4-Aminobenzophenone | 1137-41-3 | Biochemical Assay Reagents |
| HY-W076915 | Trimethyl[3-(triethoxysilyl)propyl]ammonium (chloride) | 84901-27-9 | Biochemical Assay Reagents |
| HY-W076971 | Ethyl pivaloylacetate | 17094-34-7 | Natural Products |
| HY-W077028 | N-(2-Hydroxypropyl)methacrylamide | 21442-01-3 | Reference compound |
| HY-W077074S | 1-Ethyl-1H-pyrazole-5-carboxylic acid-d5 | 2735654-39-2 | Isotope-Labeled Compounds |
| HY-W077219 | Boc-L-Arg(Mtr)-OH | 102185-38-6 | Peptides |
| HY-W077223 | (3-Aminopropyl)glycine | 2875-41-4 | Peptides |
| HY-W077226 | AChE-IN-23 | 6297-14-9 | Reference compound |
| HY-W077242 | 1,4-Anthraquinone | 635-12-1 | Reference compound |
| HY-W077257 | 5-Bromo-DL-tryptophan | 6548-09-0 | Natural Products |
| HY-W077275 | 5,6-Isopropylidene-L-gulonic acid γ-lactone | 94697-68-4 | Biochemical Assay Reagents |
| HY-W077279 | 5'-O-DMT-N4-Ac-dC | 100898-63-3 | Biochemical Assay Reagents |
| HY-W077292 | 2,4,6-Trihydroxybenzoic acid | 83-30-7 | Natural Products |
| HY-W077359 | 7-(Dimethylamino)-4-methylcoumarin | 87-01-4 | Reference compound |
| HY-W077436S | 2,6-Di-(tert-butyl)-4-methoxyphenol-3,5-d20 | 1219799-34-4 | Isotope-Labeled Compounds |
| HY-W077477 | IHCH-7113 | 313368-85-3 | Reference compound |
| HY-W077589 | Lenalidomide-5-aminomethyl (hydrochloride) | 1158264-69-7 | Reference compound |
| HY-W077589A | Lenalidomide-5-aminomethyl | 1010100-28-3 | Reference compound |
| HY-W077634 | 3-Amino-5-hydroxybenzoic acid | 76045-71-1 | Reference compound |
| HY-W077671 | 2,2,6-Trimethylcyclohexanone | 2408-37-9 | Reference compound |
| HY-W077680 | Girard's P reagent | 1126-58-5 | Reference compound |
| HY-W077917 | 6-Chlorovanillin | 18268-76-3 | Reference compound |
| HY-W078435 | 1-Ethyl-4-formyl-1h-pyrrole-2-carbonitrile | 1268334-86-6 | Reference compound |
| HY-W078632 | 2-Mercapto-4,6-dimethylnicotinonitrile | 54585-47-6 | Reference compound |
| HY-W078656 | 4-(Maleimido)benzophenone | 92944-71-3 | Biochemical Assay Reagents |
| HY-W078844 | PfDHODH-IN-2 | 425629-94-3 | Reference compound |
| HY-W079315 | 5-Phenylthieno[2,3-d]pyrimidin-4-amine | 195193-10-3 | Reference compound |
| HY-W080443 | O-allylvanillin | 22280-95-1 | Reference compound |
| HY-W080797 | 4,4,5,5,6,6,6-Heptafluorohexanoic acid | 356-02-5 | Reference compound |
| HY-W081030 | Perfluoro-2,5-dimethyl-3,6-dioxanonanoic acid | 13252-14-7 | Reference compound |
| HY-W081067 | Perfluoro(2-methyl-3-oxahexanoic) acid | 13252-13-6 | Reference compound |
| HY-W081085 | 2H,2H,3H,3H-Perfluorooctanoic acid | 914637-49-3 | Reference compound |
| HY-W081348 | 1-(4-Methoxyphenyl)-3-methyl-1H-pyrazol-5(4H)-one | 60798-06-3 | Reference compound |
| HY-W081595 | Ethyl 3-oxoheptanoate | 7737-62-4 | Biochemical Assay Reagents |
| HY-W082430 | CYP2A6-IN-2 | 912291-11-3 | Reference compound |
| HY-W082452S | N-Boc-N-methoxy-N-methyl-L-phenyl-alaninamide-d5 | 1217640-14-6 | Isotope-Labeled Compounds |
| HY-W082785A | L6H21 | 24533-47-9 | Reference compound |
| HY-W082856A | Butein tetramethyl ether | 155048-06-9 | Reference compound |
| HY-W082859A | (E)-2′,4′-Dimethoxychalcone | 69470-87-7 | Reference compound |
| HY-W083026 | (E)-CHBO4 | 126473-61-8 | Reference compound |
| HY-W083062 | hMAO-B-IN-5 | 358343-63-2 | Reference compound |
| HY-W083373 | (E)-3,4-Dimethoxychalcone | 53744-27-7 | Reference compound |
| HY-W083373A | 3,4-Dimethoxychalcone | 5416-71-7 | Natural Products |
| HY-W083376A | 4-Methoxychalcone-1 | 959-33-1 | Natural Products |
| HY-W086181 | Boc-piperazine-pyridine-COOH | 201809-22-5 | Reference compound |
| HY-W086896 | α-Demethylnaproxen | 23981-47-7 | Reference compound |
| HY-W086896R | α-Demethylnaproxen (Standard) | 23981-47-7 | Reference Standards |
| HY-W086901S | 2-Methyl-3-propylpyrazine-d3 | Isotope-Labeled Compounds | |
| HY-W086988 | 5-Methyl-1H-benzotriazole | 136-85-6 | Biochemical Assay Reagents |
| HY-W086988R | 5-Methyl-1H-benzotriazole (Standard) | 136-85-6 | Reference Standards |
| HY-W086988S | 5-Methyl-1H-benzotriazole-d6 | 1246820-65-4 | Isotope-Labeled Compounds |
| HY-W087008 | 7-Hydroxyflavanone | 6515-36-2 | Natural Products |
| HY-W087019 | ACDQ | 23680-84-4 | Reference compound |
| HY-W087024S | 1-Phenylpentane-d5 | 68639-73-6 | Isotope-Labeled Compounds |
| HY-W087027 | Maleimide-NOTA | 1295584-83-6 | Reference compound |
| HY-W087027A | Maleimide-NOTA (TFA) | Biochemical Assay Reagents | |
| HY-W087028 | NOTA-NHS ester | 1338231-09-6 | Reference compound |
| HY-W087043 | N-Allylaniline | 589-09-3 | Reference compound |
| HY-W087048S | 2,3-Dichloro-1-propanol-d5 | 1189730-34-4 | Isotope-Labeled Compounds |
| HY-W087187 | DOTAGA-anhydride | 1375475-53-8 | Reference compound |
| HY-W087194 | p-Ethylhydratropic acid | 3585-52-2 | Reference compound |
| HY-W087195 | Biprofen | 6341-72-6 | Reference compound |
| HY-W087199 | N6-Benzoyl-2'-deoxy-5'-O-DMT-a-adenosine 3'-CE phosphoramidite | 152695-84-6 | Reference compound |
| HY-W087207 | Loxoprofen L-menthol ester | 1091621-63-4 | Reference compound |
| HY-W087383 | Thalidomide 5-fluoride | 835616-61-0 | Reference compound |
| HY-W087426 | 2-Amino-5-bromobenzophenone | 39859-36-4 | Reference compound |
| HY-W087433 | Ethyl 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylate | 28705-46-6 | Reference compound |
| HY-W087444A | (S)-1-(4-Hydroxyphenyl)ethane-1,2-diol | 622854-00-6 | Natural Products |
| HY-W087830 | L-p-Boronophenylalanine | 76410-58-7 | Peptides |
| HY-W087861 | 5-Methyl-5H-dibenzo[b,d]thiophen-5-ium trifluoromethanesulfonate-d3 | 2251781-83-4 | Isotope-Labeled Compounds |
| HY-W087892 | Barium diphenylamine-4-sulfonate | 6211-24-1 | Biochemical Assay Reagents |
| HY-W087892R | Barium diphenylamine-4-sulfonate (Standard) | 6211-24-1 | Reference Standards |
| HY-W087904 | α-Lactose (hydrate) | 5989-81-1 | Reference compound |
| HY-W087904R | α-Lactose (hydrate) (Standard) | 5989-81-1 | Reference Standards |
| HY-W087905 | 2,3-Dimethyl-2,3-diphenylbutane | 1889-67-4 | Reference compound |
| HY-W087907 | Acetylsalicylsalicylic acid | 530-75-6 | Reference compound |
| HY-W087913 | alpha-Naphtholphthalein | 596-01-0 | Biochemical Assay Reagents |
| HY-W087919 | 5-Methyl-2-furanmethanol | 3857-25-8 | Natural Products |
| HY-W087919R | 5-Methyl-2-furanmethanol (Standard) | 3857-25-8 | Reference Standards |
| HY-W087928 | Bromocresol purple | 115-40-2 | Biochemical Assay Reagents |
| HY-W087930S | N-(4-Nitrophenyl)acetamide-d4 | 68239-25-8 | Isotope-Labeled Compounds |
| HY-W087937 | Benzamidine (hydrochloride hydrate) | 206752-36-5 | Biochemical Assay Reagents |
| HY-W087940S | Benzene-1,2,4,5-tetracarboxylic acid-d6 | 344298-79-9 | Isotope-Labeled Compounds |
| HY-W087942 | Naphthalen-1-yl phosphate (sodium hydrate) | 207569-06-0 | Biochemical Assay Reagents |
| HY-W087943 | Methyl octanoate | 111-11-5 | Natural Products |
| HY-W087943R | Methyl octanoate (Standard) | 111-11-5 | Reference Standards |
| HY-W087943S | Methyl octanoate-d15 | 1219798-91-0 | Isotope-Labeled Compounds |
| HY-W087947 | EDTA (dihydrate tripotassium) | 65501-24-8 | Biochemical Assay Reagents |
| HY-W087952 | (R)-(-)-2-Butanol | 14898-79-4 | Natural Products |
| HY-W087952R | (R)-(-)-2-Butanol (Standard) | 14898-79-4 | Reference Standards |
| HY-W087960S | Pentan-3-amine-d5 | 1219802-43-3 | Isotope-Labeled Compounds |
| HY-W087962 | Phenylphosphonic acid | 1571-33-1 | Reference compound |
| HY-W087964 | Dodecanedioyl dichloride | 4834-98-4 | Biochemical Assay Reagents |
| HY-W087967S | 4-Nitropyridine N-oxide-d4 | 119673-94-8 | Isotope-Labeled Compounds |
| HY-W087983S | N-Methylethanamine-d2 | 223459-63-0 | Isotope-Labeled Compounds |
| HY-W087983S1 | N-Methylethanamine-d3 | 223459-64-1 | Isotope-Labeled Compounds |
| HY-W087983S2 | N-Methylethanamine-d5 | 1219804-73-5 | Isotope-Labeled Compounds |
| HY-W087985S | Isopentyl isobutyrate-d7 | 1335401-86-9 | Isotope-Labeled Compounds |
| HY-W087988 | 3-Pentanol | 584-02-1 | Natural Products |
| HY-W087988R | 3-Pentanol (Standard) | 584-02-1 | Reference Standards |
| HY-W087988S | 3-Pentanol-d5 | 144032-75-7 | Isotope-Labeled Compounds |
| HY-W087995 | 1,2-O-Isopropylidene-alpha-d-glucofuranose | 18549-40-1 | Biochemical Assay Reagents |
| HY-W088001 | Bromophenol blue (sodium) | 34725-61-6 | Biochemical Assay Reagents |
| HY-W088011B | Sodium glycolate, 98% | 2836-32-0 | Biochemical Assay Reagents |
| HY-W088014 | L-Leucinamide (hydrochloride) | 10466-61-2 | Peptides |
| HY-W088017S | 4-Amyloxybenzaldehyde-d1 | 342611-09-0 | Isotope-Labeled Compounds |
| HY-W088037 | Tridecane | 629-50-5 | Natural Products |
| HY-W088037R | Tridecane (Standard) | 629-50-5 | Reference Standards |
| HY-W088037S | Tridecane-d28 | 121578-12-9 | Isotope-Labeled Compounds |
| HY-W088065 | Sodium formate | 141-53-7 | Biochemical Assay Reagents |
| HY-W088065S | Formate-13C (sodium) | 23102-86-5 | Isotope-Labeled Compounds |
| HY-W088065S1 | Sodium formate-13C,d1 | 1215684-17-5 | Isotope-Labeled Compounds |
| HY-W088065S2 | Sodium formate-d | 3996-15-4 | Isotope-Labeled Compounds |
| HY-W088066 | Trisodium phosphate (dodecahydrate) | 10101-89-0 | Reference compound |
| HY-W088066A | Trisodium phosphate dodecahydrate, 98% | 10101-89-0 | Biochemical Assay Reagents |
| HY-W088068 | Wright's stain | 68988-92-1 | Dye Reagents |
| HY-W088069 | Dipotassium hydrogen phosphate (trihydrate) | 16788-57-1 | Biochemical Assay Reagents |
| HY-W088070A | Agarose,Low melting point | 9012-36-6 | Biochemical Assay Reagents |
| HY-W088071 | Litmus | 1393-92-6 | Biochemical Assay Reagents |
| HY-W088074A | Chromium(III)oxide, 99.9% trace metals basis | 1308-38-9 | Biochemical Assay Reagents |
| HY-W088075 | Acriflavine (hydrochloride) | 69235-50-3 | Reference compound |
| HY-W088089 | ICG-carboxylic acid | 181934-09-8 | Dye Reagents |
| HY-W088097 | N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine | 181951-92-8 | Peptides |
| HY-W088100 | Boc-N-gamma-trityl-D-asparagin | 210529-01-4 | Peptides |
| HY-W088147 | Z-L-2-Nal-OH | 65365-16-4 | Biochemical Assay Reagents |
| HY-W088151 | Boc-Arg(Boc)2-OH | 97745-69-2 | Reference compound |
| HY-W088152 | 8-Bromotheophylline | 10381-75-6 | Reference compound |
| HY-W088152R | 8-Bromotheophylline (Standard) | 10381-75-6 | Reference Standards |
| HY-W088178S | N,N-Dimethylbenzenesulfonamide-d2 | 3044018-13-2 | Isotope-Labeled Compounds |
| HY-W088190 | Dicyclohexyl ketone | 119-60-8 | Reference compound |
| HY-W088191 | 4-Hydroxybenzamide | 619-57-8 | Reference compound |
| HY-W088238 | Methyl α-D-galactopyranoside | 3396-99-4 | Biochemical Assay Reagents |
| HY-W088319 | Butyramide | 541-35-5 | Biochemical Assay Reagents |
| HY-W088320 | 4-Hydroxydiphenylamine | 122-37-2 | Reference compound |
| HY-W088325 | 2-Fluorophenyl cyclopentyl ketone | 111982-45-7 | Reference compound |
| HY-W088413 | DOTA-amide | 157599-02-5 | Biochemical Assay Reagents |
| HY-W088413A | DOTA-amide (dihydrate) | Biochemical Assay Reagents | |
| HY-W088426S | Heptylbenzene-d5 | 1219799-19-5 | Isotope-Labeled Compounds |
| HY-W088426S2 | Heptylbenzene-d20 | 634897-84-0 | Isotope-Labeled Compounds |
| HY-W088456 | tert-Butyl N-[3-(piperazin-1-yl)propyl]carbamate | 874831-60-4 | Reference compound |
| HY-W088501 | (E)-3-Pentenoic acid | 1617-32-9 | Biochemical Assay Reagents |
| HY-W088558 | Benzyl (1R,3R)-3-hydroxycyclopentane-1-carboxylate | 946152-80-3 | Reference compound |
| HY-W088589S | (S)-3-Aminopiperidine-2,6-dione-d1 hydrochloride | 1398112-31-6 | Isotope-Labeled Compounds |
| HY-W088629 | D-2-Aminoglutarimide (hydrochloride) | 1801140-47-5 | Reference compound |
| HY-W088629S | (R)-3-Aminopiperidine-2,6-dione-d1 hydrochloride | 2708341-27-7 | Isotope-Labeled Compounds |
| HY-W088712 | Benzyl N6-(t-Boc)-L-lysinate | 133170-57-7 | Reference compound |
| HY-W088805 | Fmoc-NIP-OH | 158922-07-7 | Reference compound |
| HY-W088846 | 7-Aminonimetazepam | 4959-16-4 | Reference compound |
| HY-W088872S | (R)-2-Methylbutanoic acid-d3 | 1346617-08-0 | Isotope-Labeled Compounds |
| HY-W088875 | Deschlorodiazepam | 3034-65-9 | Reference compound |
| HY-W088929 | H-Glu(OtBu)-NH2 (hydrochloride) | 108607-02-9 | Reference compound |
| HY-W089014 | Dimethyl glutarate | 1119-40-0 | Natural Products |
| HY-W089091 | Cispentacin | 122672-46-2 | Reference compound |
| HY-W089229 | N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-carbamimidoyl-L-lysine | 776277-76-0 | Peptides |
| HY-W089230 | Boc-His(Boc)-OH | 20866-46-0 | Peptides |
| HY-W089232 | Boc-10-Aminodecanoic acid | 173606-50-3 | Reference compound |
| HY-W089233 | Boc-D-Glu-OtBu | 73872-71-6 | Peptides |
| HY-W089288 | 2'-F-Bz-A | 136834-20-3 | Reference compound |
| HY-W089292 | 1-Boc-3,3-difluoro-D-proline | 2165637-44-3 | Peptides |
| HY-W089353 | 8-Phenyl-BODIPY 505/515 | 194235-40-0 | Dye Reagents |
| HY-W089538 | 2-Ethyl-6-methylphenol | 1687-64-5 | Natural Products |
| HY-W089645 | 2,2,2-Trifluoro-N-methyl-N-(trimethylsilyl)acetamide | 24589-78-4 | Natural Products |
| HY-W089645S | N-Methyl-N-(trimethylsilyl)trifluoroacetamide-d9 | 945623-67-6 | Isotope-Labeled Compounds |
| HY-W089775 | Potassium phosphate tribasic monohydrate,90% | 27176-10-9 | Biochemical Assay Reagents |
| HY-W089777 | 3-Glycidyloxypropyltrimethoxysilane | 2530-83-8 | Biochemical Assay Reagents |
| HY-W089785 | Methyl α-D-galactopyranoside (monohydrate) | 34004-14-3 | Biochemical Assay Reagents |
| HY-W089800 | trans-2-Nonenal | 18829-56-6 | Biochemical Assay Reagents |
| HY-W089800R | trans-2-Nonenal (Standard) | 18829-56-6 | Reference Standards |
| HY-W089832S | 1,1-Dimethylurea-d6 | 1219802-32-0 | Isotope-Labeled Compounds |
| HY-W089835 | Sodium taurodeoxycholate hydrate | 207737-97-1 | Reference compound |
| HY-W089835R | Sodium taurodeoxycholate hydrate (Standard) | 207737-97-1 | Reference Standards |
| HY-W089837 | β-D-Glucopyranose,1,6-anhydro,2,3,4-triacetate | 13242-55-2 | Biochemical Assay Reagents |
| HY-W089845 | Heneicosane | 629-94-7 | Natural Products |
| HY-W089845R | Heneicosane (Standard) | 629-94-7 | Reference Standards |
| HY-W089845S | Heneicosane-d44 | 39756-37-1 | Isotope-Labeled Compounds |
| HY-W089856 | Chlorobutanol (hemihydrate) | 6001-64-5 | Reference compound |
| HY-W089856R | Chlorobutanol (hemihydrate) (Standard) | 6001-64-5 | Reference Standards |
| HY-W089922 | D-erythro-Sphingosine (hydrochloride) | 2673-72-5 | Reference compound |
| HY-W090065 | Pyren-1-ylmethanamine (hydrochloride) | 93324-65-3 | Biochemical Assay Reagents |
| HY-W090090 | BODIPY 493/503 | 121207-31-6 | Dye Reagents |
| HY-W090103 | 3,4,6-Tri-O-benzyl-D-galactal | 80040-79-5 | Biochemical Assay Reagents |
| HY-W090151 | Silyl-ether based ROMP monomer iPrSi | 2396521-63-2 | Biochemical Assay Reagents |
| HY-W090210 | 3-Mercapto-1-propanol | 19721-22-3 | Reference compound |
| HY-W090292 | Olivetolic acid | 491-72-5 | Reference compound |
| HY-W090294 | Perylene | 198-55-0 | Biochemical Assay Reagents |
| HY-W090294S | Perylene-d12 | 1520-96-3 | Isotope-Labeled Compounds |
| HY-W090299 | N1-Boc-2,2′-iminodiethylamine | 193206-49-4 | Biochemical Assay Reagents |
| HY-W090309 | Monosodium 2-sulfoterephthalate | 19089-60-2 | Reference compound |
| HY-W090421 | Z-D-Dab(Boc)-OH (dicyclohexylamine) | 214852-61-6 | Peptides |
| HY-W090446 | 4-Boc-amino-2,2-dimethylbutyric acid | 153039-17-9 | Reference compound |
| HY-W090623 | Tos-PEG2-OH | 118591-58-5 | Reference compound |
| HY-W090625S | 5H-Benzofuro[3,2-c]carbazole-d10 | 2607949-29-9 | Isotope-Labeled Compounds |
| HY-W090626 | (((9H-Fluoren-9-yl)methoxy)carbonyl)-D-lysine | 110990-08-4 | Peptides |
| HY-W090637 | N,N-Bis(phenylmethyl)-L-serine methyl ester | 88099-67-6 | Biochemical Assay Reagents |
| HY-W090915 | Norspermine | 4605-14-5 | Natural Products |
| HY-W090915S | N1,N1'-(Propane-1,3-diyl)bis(propane-1,3-diamine)-d12 | 1219804-74-6 | Isotope-Labeled Compounds |
| HY-W090915S1 | N1,N1'-(Propane-1,3-diyl)bis(propane-1,3-diamine)-d24 | 1219794-67-8 | Isotope-Labeled Compounds |
| HY-W090940 | H-Gly-Gly-Phe-OH | 6234-26-0 | Reference compound |
| HY-W090942 | Z-Gly-Gly-Phe-OH | 13171-93-2 | Reference compound |
| HY-W091039S | N-Acetyl-α-neuraminic acid-13C3 | 1172608-56-8 | Isotope-Labeled Compounds |
| HY-W091169 | N-Methyl-2-HOBA (hydrochloride) | 63989-87-7 | Reference compound |
| HY-W091249 | Tri(ethylene glycol) divinyl ether | 765-12-8 | Biochemical Assay Reagents |
| HY-W091365 | Boc-Asn(Xan)-OH | 65420-40-8 | Peptides |
| HY-W091541 | 4-Hydroxy-1H-indole-3-carbaldehyde | 81779-27-3 | Natural Products |
| HY-W091636 | 3,3'-Azanediyldipropanoic acid | 505-47-5 | Reference compound |
| HY-W091636S | 3,3'-Azanediyldipropionic acid-d8 | 1219803-81-2 | Isotope-Labeled Compounds |
| HY-W091728S | 2,4,6-Tribromoanisole-d5 | 1219795-33-1 | Isotope-Labeled Compounds |
| HY-W091734 | Methyl 4-iodo-L-phenylalaninate (hydrochloride) | 158686-46-5 | Peptides |
| HY-W091739 | Ethanol-d6 | 1516-08-1 | Reference compound |
| HY-W091754 | 5'-O-Dmt-n2-isobutyryl-2'-o-methyl-d-guanosine | 114745-26-5 | Reference compound |
| HY-W091784 | 3'-O-Methylguanosine | 10300-27-3 | Reference compound |
| HY-W091788 | (2S,3R,5S)-7-Deaza-2'-deoxy-7-iodoadenosine | 908130-61-0 | Reference compound |
| HY-W092043 | TLR4-IN-C34-C2-COOH | 1159408-54-4 | Reference compound |
| HY-W092078 | tert-Butyl (4-iodobutyl)carbamate | 262278-40-0 | Reference compound |
| HY-W092107 | Dibenzyl aspartate 4-methylbenzenesulfonate | 4079-62-3 | Peptides |
| HY-W092109 | H-Phe-Trp-OH | 24587-41-5 | Natural Products |
| HY-W092111 | N6-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N2-((benzyloxy)carbonyl)-L-lysine | 105751-18-6 | Peptides |
| HY-W092115 | N6-Carbobenzoxy-L-lysine N-carboxyanhydride | 1676-86-4 | Peptides |
| HY-W092176 | 1,9-Bis-boc-1,5,9-triazanonane | 82409-02-7 | Reference compound |
| HY-W092202 | Dde-Lys(Fmoc)-OH | 156648-40-7 | Peptides |
| HY-W092298S | Methyl 4-(2-hydroxyethyl)benzoate-13C6,d2 | 2071199-89-6 | Isotope-Labeled Compounds |
| HY-W092344 | 1,5-Bis-boc-1,5,9-triazanonane | 122248-82-2 | Reference compound |
| HY-W092533 | 6-Fluorotryptophan | 7730-20-3 | Reference compound |
| HY-W092549 | 5-Hydroxyisatin | 116569-09-6 | Reference compound |
| HY-W092778S | 4,4′-Dibromo diphenyl ether-13C12 | 488710-17-4 | Isotope-Labeled Compounds |
| HY-W092895 | Cyclohexane-PEG1-Br | 131665-94-6 | Reference compound |
| HY-W093017 | 4-Chloropyridine | 626-61-9 | Reference compound |
| HY-W093067 | KTX-582 intermediate-4 | 1000373-79-4 | Reference compound |
| HY-W093086 | DMT-2'-F-Bz-dA | 136834-21-4 | Biochemical Assay Reagents |
| HY-W093104 | (S)-(-)-2-Methylbutanol | 1565-80-6 | Reference compound |
| HY-W093149 | (-)-Menthyloxyacetic acid | 40248-63-3 | Biochemical Assay Reagents |
| HY-W093183 | Palmitic anhydride | 623-65-4 | Biochemical Assay Reagents |
| HY-W093254A | Poly(ethylene glycol) bis(carboxymethyl) ether (Mn 250) | 39927-08-7 | Biochemical Assay Reagents |
| HY-W093254B | Poly(ethylene glycol) bis(carboxymethyl) ether (Mn 600) | 39927-08-7 | Biochemical Assay Reagents |
| HY-W093272 | Thalidomide-5,6-F | 1496997-41-1 | Reference compound |
| HY-W093282 | Epoxidized soya bean oil | 8013-07-8 | Biochemical Assay Reagents |
| HY-W093286 | Aluminum fluoride trihydrate | 15098-87-0 | Biochemical Assay Reagents |
| HY-W093399 | Ammonium bicarbonate,AR,99% | 1066-33-7 | Biochemical Assay Reagents |
| HY-W093399S | Ammonium bicarbonate-15N | Isotope-Labeled Compounds | |
| HY-W093833 | Benzyl-PEG9-alcohol | 868594-48-3 | Reference compound |
| HY-W094047 | 5-Chloro-1-methyl-4-nitroimidazole | 4897-25-0 | Biochemical Assay Reagents |
| HY-W094047R | 5-Chloro-1-methyl-4-nitroimidazole (Standard) | 4897-25-0 | Reference Standards |
| HY-W094114 | Ammonium fluoborate,98% | 13826-83-0 | Biochemical Assay Reagents |
| HY-W094155 | Methyl (1S)-3-oxocyclopentaneacetate | 2630-38-8 | Reference compound |
| HY-W094280 | Diethylphosphine oxide | 7215-33-0 | Reference compound |
| HY-W094307 | Methyl-PEG3-bromide | 72593-77-2 | Reference compound |
| HY-W094349A | Calcium silicate, 99% | 1344-95-2 | Biochemical Assay Reagents |
| HY-W094350 | Calcium sulfate dihydrate (99%) | 10101-41-4 | Biochemical Assay Reagents |
| HY-W094353 | Calcium acetate hydrate | 114460-21-8 | Biochemical Assay Reagents |
| HY-W094381 | Sodium hexanitrocobaltate(III) | 13600-98-1 | Biochemical Assay Reagents |
| HY-W094464 | Lithium sulfate | 10377-48-7 | Reference compound |
| HY-W094474 | Lithium chloride hydrate | 85144-11-2 | Reference compound |
| HY-W094475C | Magnesium sulfate heptahydrate, for cell culture | 10034-99-8 | Biochemical Assay Reagents |
| HY-W094475D | Magnesium sulfate heptahydrate, meets analytical specification of Ph. Eur. BP USP FCC | 10034-99-8 | Biochemical Assay Reagents |
| HY-W094475E | Magnesium sulfate heptahydrate, United States Pharmacopeia (USP) Reference Standard | 10034-99-8 | Biochemical Assay Reagents |
| HY-W094477D | Magnesium sulfate heptahydrate, for molecular biology | 10034-99-8 | Biochemical Assay Reagents |
| HY-W094492 | Manganese acetate tetrahydrate | 6156-78-1 | Biochemical Assay Reagents |
| HY-W094497 | Sodium dihydrogen phosphate monohydrate | 10049-21-5 | Biochemical Assay Reagents |
| HY-W094497B | Sodium dihydrogen phosphate monohydrate, for molecular biology | 10049-21-5 | Biochemical Assay Reagents |
| HY-W094497C | Sodium dihydrogen phosphate monohydrate, for electrophoresis | 10049-21-5 | Biochemical Assay Reagents |
| HY-W094505 | Sodium bismuthate (NaBiO3), 80% | 12232-99-4 | Biochemical Assay Reagents |
| HY-W094507 | Sodium selenide | 1313-85-5 | Reference compound |
| HY-W094510 | Sodium pyrophosphate decahydrate | 13472-36-1 | Biochemical Assay Reagents |
| HY-W094511 | Tetrachloroaurate(III) (sodium dihydrate) | 13874-02-7 | Biochemical Assay Reagents |
| HY-W094516 | Disodium succinate hexahydrate | 6106-21-4 | Biochemical Assay Reagents |
| HY-W094517 | Sodium phosphate dibasic heptahydrate | 7782-85-6 | Biochemical Assay Reagents |
| HY-W094581 | Gold(III) chloride trihydrate | 16961-25-4 | Biochemical Assay Reagents |
| HY-W094665 | 7-(Diethylamino)-4-(hydroxymethyl)coumarin | 54711-38-5 | Reference compound |
| HY-W094695 | Starch soluble | 9005-84-9 | Biochemical Assay Reagents |
| HY-W094707 | Calcium phosphate monobasic monohydrate | 10031-30-8 | Biochemical Assay Reagents |
| HY-W094708C | Sodium phosphate dibasic dihydrate, for molecular biology | 10028-24-7 | Biochemical Assay Reagents |
| HY-W094708D | Sodium phosphate dibasic dihydrate, meets analytical specification of Ph. Eur. BP | 10028-24-7 | Biochemical Assay Reagents |
| HY-W094709 | Zinc sulfate monohydrate | 7446-19-7 | Biochemical Assay Reagents |
| HY-W094710 | Sodium diacetate | 126-96-5 | Reference compound |
| HY-W094712 | Potassium oxalate monohydrate | 6487-48-5 | Biochemical Assay Reagents |
| HY-W094717 | Molybdenum sulfide | 1317-33-5 | Biochemical Assay Reagents |
| HY-W094718 | Sodium phosphomolybdate | 1313-30-0 | Biochemical Assay Reagents |
| HY-W094747A | Benzalazine | 588-68-1 | Reference compound |
| HY-W094748S | Dibenzo[b,e][1,4]dioxin-d8 | 69699-83-8 | Isotope-Labeled Compounds |
| HY-W094748S1 | Dibenzo-p-dioxin-13C12 | 125749-32-8 | Isotope-Labeled Compounds |
| HY-W094751 | 1-Pyrenamin | 1606-67-3 | Biochemical Assay Reagents |
| HY-W094751S | 1-Pyrenamin-d9 | 128008-86-6 | Isotope-Labeled Compounds |
| HY-W094755 | 1-Nitropyrene | 5522-43-0 | Reference compound |
| HY-W094755S | 1-Nitropyrene-d9 | 93487-20-8 | Isotope-Labeled Compounds |
| HY-W094758A | 4-Di-1-ASP | 959-81-9 | Dye Reagents |
| HY-W094846 | Tetradecane | 629-59-4 | Natural Products |
| HY-W094846R | Tetradecane (Standard) | 629-59-4 | Reference Standards |
| HY-W094846S | Tetradecane-d30 | 204244-81-5 | Isotope-Labeled Compounds |
| HY-W094847 | Eicosane | 112-95-8 | Natural Products |
| HY-W094847R | Eicosane (Standard) | 112-95-8 | Reference Standards |
| HY-W094847S | N-Eicosane-d42 | 62369-67-9 | Isotope-Labeled Compounds |
| HY-W095029 | Cbz-Gly-Pro-OH | 1160-54-9 | Reference compound |
| HY-W095198 | N-(2-Hydroxyethyl)acrylamide | 7646-67-5 | Biochemical Assay Reagents |
| HY-W095200 | GPR109 receptor agonist-2 | 957129-38-3 | Reference compound |
| HY-W095499 | Corydaldine | 493-49-2 | Natural Products |
| HY-W095635 | Tetramethylammonium fluoride (tetrahydrate) | 17787-40-5 | Biochemical Assay Reagents |
| HY-W095697 | N-Acetylhistidine | 2497-02-1 | Reference compound |
| HY-W095705A | 3-Hydroxypropionic acid (sodium) | 6487-38-3 | Reference compound |
| HY-W096066 | Benzyl-PEG8-THP | 1611489-00-9 | Reference compound |
| HY-W096067 | Benzyl-PEG7-alcohol | 423763-19-3 | Reference compound |
| HY-W096068 | Propargyl-PEG4-mesyl ester | 1233816-83-5 | Reference compound |
| HY-W096069 | Hydroxy-PEG3-MS | 139115-89-2 | Reference compound |
| HY-W096070 | Benzyl-PEG6-azide | 86770-73-2 | Reference compound |
| HY-W096071 | Bromo-PEG2-THP | 152065-54-8 | Reference compound |
| HY-W096072 | Benzyl-PEG2-MS | 150272-33-6 | Reference compound |
| HY-W096073 | Benzyl-PEG4-amine | 86770-76-5 | Reference compound |
| HY-W096074 | MS-PEG4-THP | 145927-73-7 | Reference compound |
| HY-W096075 | Benzyl-PEG5-THP | 230620-74-3 | Reference compound |
| HY-W096076 | Bis-PEG6-t-butyl ester | 439114-12-2 | Reference compound |
| HY-W096077 | Benzyl-PEG7-amine | 868594-43-8 | Reference compound |
| HY-W096078 | Bromo-PEG7-azide | 1056969-61-9 | Reference compound |
| HY-W096079 | BCN-endo-PEG4-NHS | 1702356-19-1 | Reference compound |
| HY-W096080 | t-Butyl acetate-PEG2-CH2COOH | 883564-93-0 | Reference compound |
| HY-W096081 | Benzyl-PEG10-alcohol | 908258-44-6 | Reference compound |
| HY-W096082 | t-Butyl acetate-PEG3-CH2COOH | 1442466-57-0 | Reference compound |
| HY-W096083 | Ethyl-PEG4-alcohol | 5650-20-4 | Reference compound |
| HY-W096085 | Diethylene glycol diacetate | 628-68-2 | Reference compound |
| HY-W096086 | Ethyl acetate-PEG1 | 2093-20-1 | Reference compound |
| HY-W096089 | Benzyl-PEG3-acid | 127457-63-0 | Reference compound |
| HY-W096090 | Benzyl-PEG4-MS | 477781-69-4 | Reference compound |
| HY-W096091S | 1,1-Diethoxypentane-d10 | Isotope-Labeled Compounds | |
| HY-W096092 | BocNH-PEG5-CH2CH2Br | 1392499-33-0 | Reference compound |
| HY-W096093 | 2-(2-(6-chlorohexyloxy)ethoxy)ethanamine (hydrochloride) | 1035373-85-3 | Reference compound |
| HY-W096094 | Fmoc-N-amido-PEG2-alcohol | 299430-87-8 | Reference compound |
| HY-W096096 | Tetraethylene glycol monohexadecyl ether | 5274-63-5 | Reference compound |
| HY-W096097 | Butofilolol | 58930-32-8 | Reference compound |
| HY-W096098 | Biotin-PEG3-CH2COOH | 1189560-96-0 | Reference compound |
| HY-W096099 | Nonylbenzene-PEG8-OH | 41506-14-3 | Reference compound |
| HY-W096105 | Nonylbenzene-PEG5-OH | 20636-48-0 | Reference compound |
| HY-W096106 | CH2COOH-PEG6-CH2COOH | 83824-29-7 | Reference compound |
| HY-W096107 | Benzyl-PEG8-alcohol | 477775-73-8 | Reference compound |
| HY-W096111A | Trt-PEG4-C2-acid (hydrate) | 1189873-11-7 | Reference compound |
| HY-W096112 | TFP-PEG3-TFP | 1446282-34-3 | Reference compound |
| HY-W096113 | m-PEG2-O-Ph-NH2 | 65673-48-5 | Reference compound |
| HY-W096114 | Acid-PEG8-S-S-PEG8-acid | 873013-93-5 | Reference compound |
| HY-W096116 | PEG2-Cl | 78925-46-9 | Reference compound |
| HY-W096118 | m-PEG2-O-Ph-3-NH2 | 126415-02-9 | Reference compound |
| HY-W096120 | Azide-PEG3-Desthiobiotin | 1426828-06-9 | Reference compound |
| HY-W096121 | PEG3 | 67439-82-1 | Reference compound |
| HY-W096122 | DTSSP Crosslinker (disodium) | 142702-31-6 | Reference compound |
| HY-W096124 | Sulfo-EGS (disodium) | 142702-32-7 | Reference compound |
| HY-W096125 | Desthiobiotin-PEG4-propargyl | 1951424-89-7 | Reference compound |
| HY-W096127 | Biotin-sar-oh | 154024-76-7 | ADC Related |
| HY-W096128 | Fmoc-NH-PEG3-amide-CH2OCH2COOH | 489427-26-1 | Reference compound |
| HY-W096129 | Cl-PEG4-acid | 158553-98-1 | Reference compound |
| HY-W096131 | Chloro-PEG5-chloride | 5197-65-9 | Reference compound |
| HY-W096132 | Dimethylamino-PEG2-C2-NH2 | 692782-62-0 | Reference compound |
| HY-W096133 | Biotin-PEG1-azide | 1204085-48-2 | ADC Related |
| HY-W096134 | Benzyloxy-C5-PEG1 | 159028-70-3 | Reference compound |
| HY-W096135 | Biotin-PEG1-NH2 | 811442-85-0 | ADC Related |
| HY-W096138 | m-PEG20-alcohol | 1059605-06-9 | Reference compound |
| HY-W096139 | Br-PEG3-ethyl acetate | 308085-31-6 | Reference compound |
| HY-W096140 | Propargyl-PEG5-1-o-(b-cyanoethyl-n,n-diisopropyl)phosphoramidite | 1682657-14-2 | Reference compound |
| HY-W096141 | Propargyl-PEG3-1-o-(b-cyanoethyl-N,N-diisopropyl)phosphoramidite | 1391728-01-0 | Reference compound |
| HY-W096142 | Benzyl-PEG2-acid | 91555-65-6 | Reference compound |
| HY-W096143 | NH2-PEG3 (hydrochloride) | 92505-84-5 | Reference compound |
| HY-W096144 | Acid-PEG2-ethyl propionate | 886362-90-9 | Reference compound |
| HY-W096145 | Chloro-PEG2-Boc | 1442085-43-9 | Reference compound |
| HY-W096146 | Propynyl-PEG1-Ac | 944561-45-9 | Reference compound |
| HY-W096147 | S-acetyl-PEG6 | 1352221-63-6 | Reference compound |
| HY-W096148 | Biotin-C4-amide-C5-NH2 | 151294-96-1 | ADC Related |
| HY-W096149 | exo-BCN-NHS carbonate | 1493802-77-9 | Reference compound |
| HY-W096150 | Dimethylamino-PEG3 | 2741-30-2 | Reference compound |
| HY-W096151 | Chloroacetamido-C-PEG3-C3-NHBoc | 934164-55-3 | Reference compound |
| HY-W096152 | Chloroacetamido-C4-NHBoc | 133264-58-1 | Reference compound |
| HY-W096153 | m-PEG3-phosphonic acid | 96962-42-4 | Reference compound |
| HY-W096154 | Hydroxy-PEG3-ethyl acetate | 118988-04-8 | Reference compound |
| HY-W096155 | Methyl acetate-PEG1 | 58349-37-4 | Reference compound |
| HY-W096156 | I-PEG6-OH | 136399-07-0 | Reference compound |
| HY-W096157 | I-PEG5-OH | 1883516-31-1 | Reference compound |
| HY-W096158 | Ph-PEG3 | 7204-16-2 | Reference compound |
| HY-W096159 | D-Biotinol | 53906-36-8 | Reference compound |
| HY-W096160 | Bis-acrylate-PEG5 | 59256-52-9 | Reference compound |
| HY-W096161 | Bis-methacrylate-PEG5 | 13497-24-0 | Reference compound |
| HY-W096162 | NH2-PEG2-methyl acetate | 741235-80-3 | Reference compound |
| HY-W096162A | NH2-PEG2-methyl acetate (hydrochloride) | 208647-73-8 | Reference compound |
| HY-W096164 | Propargyl-PEG2-bromide | 1287660-82-5 | Reference compound |
| HY-W096165 | t-Boc-N-amido-PEG6-Tos | 1264015-76-0 | Reference compound |
| HY-W096166 | Bis-acrylate-PEG6 | 85136-58-9 | Reference compound |
| HY-W096169D | Platinum | 7440-06-4 | Reference compound |
| HY-W096171 | D-Dopa | 5796-17-8 | Peptides |
| HY-W096178B | Silica sand, 1-2mm | 14808-60-7 | Biochemical Assay Reagents |
| HY-W096178C | Silica sand, 2-7mm | 14808-60-7 | Biochemical Assay Reagents |
| HY-W096561 | Amiquinsin | 13425-92-8 | Reference compound |
| HY-W096600 | 2F-Peracetyl-Fucose | 188783-78-0 | Reference compound |
| HY-W096638 | Glycerylphosphorylcholine | 563-24-6 | Reference compound |
| HY-W096638A | Glycerophosphocholine | 4217-84-9 | Natural Products |
| HY-W096906 | Naphthacene | 92-24-0 | Reference compound |
| HY-W096982A | Tetrabutylammonium (phosphate) | 5574-97-0 | Biochemical Assay Reagents |
| HY-W096983 | DTAC,for IPC,≥99% | 112-00-5 | Biochemical Assay Reagents |
| HY-W096988A | Sodium 1-hexanesulfonate (monohydrate) | 207300-91-2 | Biochemical Assay Reagents |
| HY-W096989 | Sodium 1-heptanesulfonate monohydrate, for Ion-Pair Chromatography | 207300-90-1 | Biochemical Assay Reagents |
| HY-W096990A | Sodium 1-octanesulfonate monohydrate, 97%(T) | 207596-29-0 | Biochemical Assay Reagents |
| HY-W096993A | TPABr, 98% | 1941-30-6 | Biochemical Assay Reagents |
| HY-W096993S | TPABr-d28 | 284474-84-6 | Isotope-Labeled Compounds |
| HY-W096993S1 | TPABr-N15 | 287476-16-8 | Isotope-Labeled Compounds |
| HY-W096994A | Tetramethylammonium Sulphate,for IPC,≥99% | 14190-16-0 | Biochemical Assay Reagents |
| HY-W096997A | Sodium octyl sulfate (SOS), 95% | 142-31-4 | Biochemical Assay Reagents |
| HY-W096997S | Sodium octyl sulfate(Reagent for Ion-Pair Chromatography,99%)-d17 | 1219802-16-0 | Isotope-Labeled Compounds |
| HY-W097000 | 1-Propanesulfonic acid (sodium hydrate) | 304672-01-3 | Biochemical Assay Reagents |
| HY-W097009 | Violuric acid | 87-39-8 | Reference compound |
| HY-W097018 | Iomeprol intermediate-1 | 76801-93-9 | Reference compound |
| HY-W097018R | Iomeprol intermediate-1 (Standard) | 76801-93-9 | Reference Standards |
| HY-W097026 | H-His-Tyr-OH | 35979-00-1 | Reference compound |
| HY-W097054 | Fmoc-L-cysteic acid | 751470-47-0 | Peptides |
| HY-W097085 | 3-Maleimidopropionic acid hydrazonium (trifluoroacetate) | 359436-61-6 | Biochemical Assay Reagents |
| HY-W097086 | 3-Maleimidylpropanoyl hydrazide (hydrochloride) | 293298-33-6 | Reference compound |
| HY-W097106 | (S)-3-N-Cbz-Amino-succinimide | 60846-91-5 | Reference compound |
| HY-W097109A | Fmoc-(D-Phe)-OSu | 182410-73-7 | Reference compound |
| HY-W097110 | Fmoc-11-aminoundecanoic acid | 88574-07-6 | Reference compound |
| HY-W097114 | Benzyl (6-bromohexyl)carbamate | 116784-97-5 | Biochemical Assay Reagents |
| HY-W097122 | Fmoc-Gly-Gly-Gly-OH | 170941-79-4 | Reference compound |
| HY-W097128 | Fmoc-12-aminododecanoic acid | 128917-74-8 | Reference compound |
| HY-W097163 | Fmoc-DL-Phe-OH | 126727-04-6 | Peptides |
| HY-W097167 | N-Cbz-DL-tryptophan | 13058-16-7 | Reference compound |
| HY-W097197S | (R)-2-((R)-2-Amino-3-phenylpropanamido)-3-phenylpropanoic acid-d5 | Isotope-Labeled Compounds | |
| HY-W097200 | 1,3-Dibenzylurea | 1466-67-7 | Reference compound |
| HY-W097232 | Fmoc-Aph(Hor)-OH | 1253282-31-3 | Peptides |
| HY-W097331 | Salicylamide-O-acetic acid | 25395-22-6 | Reference compound |
| HY-W097453 | 6-(Methylthio)purine | 50-66-8 | Reference compound |
| HY-W097453S | 6-(Methylthio)purine-13C,d3 | Isotope-Labeled Compounds | |
| HY-W097453S1 | 6-(Methylthio)purine-d3 | Isotope-Labeled Compounds | |
| HY-W097453S2 | 6-(Methylthio)purine-d3-1 | 33312-93-5 | Isotope-Labeled Compounds |
| HY-W097491 | L-Methionine sulfone | 7314-32-1 | Peptides |
| HY-W097565S | Pyroxsulam Metabolite ADTP-d6 | Isotope-Labeled Compounds | |
| HY-W097570 | Sulfamonomethoxine (sodium) | 38006-08-5 | Reference compound |
| HY-W097570R | Sulfamonomethoxine (sodium) (Standard) | 38006-08-5 | Reference Standards |
| HY-W097612 | P2X4 antagonist-5 | 28721-09-7 | Reference compound |
| HY-W097625 | 6-Methoxyflavone | 26964-24-9 | Natural Products |
| HY-W097659 | Antileishmanial agent-32 | 16929-60-5 | Reference compound |
| HY-W097734 | N-(4-Methoxyphenyl)maleimide | 1081-17-0 | Reference compound |
| HY-W097753 | 4-MDM | 834-14-0 | Reference compound |
| HY-W097775 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine | 81352-25-2 | Reference compound |
| HY-W097785 | 4-Methoxybenzamidine | 22265-37-8 | Reference compound |
| HY-W097792 | 5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyuridine | 23669-79-6 | Biochemical Assay Reagents |
| HY-W097858 | 2-Hydroxy-4-methoxybenzoic acid (potassium) | 152312-71-5 | Reference compound |
| HY-W097867 | 3-Desmethyl Gatifloxacin | 112811-57-1 | Reference compound |
| HY-W097899 | Vanillylamine | 1196-92-5 | Natural Products |
| HY-W097910S | 3,4-Dihydro-6-methoxy-7-isoquinolinol-d3 | Isotope-Labeled Compounds | |
| HY-W097929S | 2,4,6-Trichloroanisole-d5 | 352439-08-8 | Isotope-Labeled Compounds |
| HY-W097960 | 1,2-Diamino-4,5-dimethoxybenzene (hydrochloride) | 131076-14-7 | Reference compound |
| HY-W097994 | DHMB | 4055-69-0 | Reference compound |
| HY-W098008 | Fenbendazole analog-1 | 20367-38-8 | Reference compound |
| HY-W098021 | 2,2-Dimethoxy-2-phenylacetophenone | 24650-42-8 | Reference compound |
| HY-W098047 | Dimethyl octadecanedioate | 1472-93-1 | Natural Products |
| HY-W098048 | Dimethyl hexadecanedioate | 19102-90-0 | Natural Products |
| HY-W098049 | Dimethyl tetradecanedioate | 5024-21-5 | Natural Products |
| HY-W098053 | Dimethyl octanedioate | 1732-09-8 | Natural Products |
| HY-W098059 | H-DL-Glu(Ome)-OMe.HCl | 13515-99-6 | Peptides |
| HY-W098060 | H-DL-Glu(Ome)-OH | 14487-45-7 | Peptides |
| HY-W098127S | Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d2 | 1346597-78-1 | Isotope-Labeled Compounds |
| HY-W098273 | Methyl 2-amino-3-chloropropanoate hydrochloride | 33646-31-0 | Peptides |
| HY-W098280 | Phenylglycine methyl ester | 26682-99-5 | Biochemical Assay Reagents |
| HY-W098319 | Dimethyl suberimidate (dihydrochloride) | 34490-86-3 | Biochemical Assay Reagents |
| HY-W098322 | Z-Lys-OMe (hydrochloride) | 26348-68-5 | Reference compound |
| HY-W098348 | N-Methyltaurine | 107-68-6 | Reference compound |
| HY-W098448S | 1-Methylazepan-2-one-d3 | 203645-60-7 | Isotope-Labeled Compounds |
| HY-W098556 | 4-Hydroxyhygric acid | 4252-82-8 | Natural Products |
| HY-W098697S | Dimethyldithiocarbamate-d6 (sodium dihydrate) | Isotope-Labeled Compounds | |
| HY-W098721 | Z-Gly-Sar-OH | 7801-91-4 | Reference compound |
| HY-W098722S | 3-(4-Chlorophenyl)-1-methoxy-1-methylurea-d6 | 2733145-11-2 | Isotope-Labeled Compounds |
| HY-W098756 | Thionordiazepam | 4547-02-8 | Reference compound |
| HY-W098764 | Allyl (2-aminoethyl)carbamate (hydrochloride) | 1049722-41-9 | Reference compound |
| HY-W098792 | Candesartan methyl ester | 139481-69-9 | Reference compound |
| HY-W098901 | Benzoin ethyl ether | 574-09-4 | Biochemical Assay Reagents |
| HY-W099110S | Ethyl 4-methoxybenzoate-d3 | 27914-53-0 | Isotope-Labeled Compounds |
| HY-W099116S | Ethyl 4-(((methyl(phenyl)amino)methylene)amino)benzoate-d3 | Isotope-Labeled Compounds | |
| HY-W099118 | Sodium ethylparaben | 35285-68-8 | Biochemical Assay Reagents |
| HY-W099118R | Sodium ethylparaben (Standard) | 35285-68-8 | Reference Standards |
| HY-W099247 | H-DL-Ala-OEt.HCl | 617-27-6 | Peptides |
| HY-W099254 | H-DL-Val-OEt.HCl | 23358-42-1 | Peptides |
| HY-W099255 | Ethyl 4,4,4,4',4',4'-hexafluoro-DL-valinate | 78185-92-9 | Peptides |
| HY-W099276 | Ethyl (2R,4R)-4-methylpiperidine-2-carboxylate-Arg(NO2) (hydrochloride) | 74874-08-1 | Reference compound |
| HY-W099331 | Monoethylglycinexylidide (hydrochloride) | 7729-94-4 | Reference compound |
| HY-W099331R | Monoethylglycinexylidide (hydrochloride) (Standard) | 7729-94-4 | Reference Standards |
| HY-W099337 | N-Ethyl-D-glucamine | 14216-22-9 | Biochemical Assay Reagents |
| HY-W099352 | (2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)butanoic acid | 79276-23-6 | Reference compound |
| HY-W099393 | 2-(4-Diethylamino-2-hydroxybenzoyl)benzoicacid | 5809-23-4 | Reference compound |
| HY-W099437 | Diethylene glycol monobutyl ether acetate | 124-17-4 | Reference compound |
| HY-W099438S | n-Butoxyacetic acid-d9 | 669720-55-2 | Isotope-Labeled Compounds |
| HY-W099479 | Insect repellent M 3535 | 52304-36-6 | Reference compound |
| HY-W099479R | Insect repellent M 3535 (Standard) | 52304-36-6 | Reference Standards |
| HY-W099488 | Capecitabine 2',3'-diacetate | 162204-20-8 | Reference compound |
| HY-W099489S | Potassium O-pentyl carbonodithioate-d5 | Isotope-Labeled Compounds | |
| HY-W099490 | Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate | 30431-54-0 | Dye Reagents |
| HY-W099503 | Heptyl acetate | 112-06-1 | Natural Products |
| HY-W099504 | 1-Heptanol | 111-70-6 | Biochemical Assay Reagents |
| HY-W099504S | n-Heptyl Alcohol-d15 | 194793-95-8 | Isotope-Labeled Compounds |
| HY-W099504S1 | 1-Heptanol-d7 | 1219804-99-5 | Isotope-Labeled Compounds |
| HY-W099504S2 | 1-Heptanol-d1 | 38007-42-0 | Isotope-Labeled Compounds |
| HY-W099521S | 1-Chlorooctane-d17 | 1219803-93-6 | Isotope-Labeled Compounds |
| HY-W099523S | 2-((Decyloxy)carbonyl)benzoic acid-d4 | 2732762-53-5 | Isotope-Labeled Compounds |
| HY-W099525 | Didecylamine | 1120-49-6 | Reference compound |
| HY-W099531S | Diundecyl phthalate-d4 | 2708278-18-4 | Isotope-Labeled Compounds |
| HY-W099535 | Lithium dodecyl sulfate | 2044-56-6 | Biochemical Assay Reagents |
| HY-W099536 | PEG 4 lauryl ether | 5274-68-0 | Reference compound |
| HY-W099536R | PEG 4 lauryl ether (Standard) | 5274-68-0 | Reference Standards |
| HY-W099538 | Dilauryl thiodipropionate | 123-28-4 | Biochemical Assay Reagents |
| HY-W099538R | Dilauryl thiodipropionate (Standard) | 123-28-4 | Reference Standards |
| HY-W099540 | OES2-0017 | 5538-95-4 | Reference compound |
| HY-W099547 | Dihexadecyl hydrogen phosphate | 2197-63-9 | Biochemical Assay Reagents |
| HY-W099558 | Sodium stearyl fumarate | 4070-80-8 | Reference compound |
| HY-W099558R | Sodium stearyl fumarate (Standard) | 4070-80-8 | Reference Standards |
| HY-W099563 | 4-Nitrophenyl stearate | 14617-86-8 | Biochemical Assay Reagents |
| HY-W099565 | Propylene glycol monostearate | 1323-39-3 | Reference compound |
| HY-W099569 | Zinc stearate | 557-05-1 | Reference compound |
| HY-W099570 | Stearate (sodium) | 822-16-2 | Biochemical Assay Reagents |
| HY-W099570S | Stearate-d35 (sodium) | 1219794-97-4 | Isotope-Labeled Compounds |
| HY-W099571 | Lithium stearate | 4485-12-5 | Reference compound |
| HY-W099575 | Sulfobetaine-16 | 2281-11-0 | Biochemical Assay Reagents |
| HY-W099576 | Ethylhexadecyldimethylammonium (bromide) | 124-03-8 | Reference compound |
| HY-W099577 | N-Hexadecyltrimethylammonium (hexafluorophosphate) | 101079-29-2 | Biochemical Assay Reagents |
| HY-W099578 | Pal-Glu(OSu)-OtBu | 204521-63-1 | Peptides |
| HY-W099579 | Kojic acid dipalmitate | 79725-98-7 | Reference compound |
| HY-W099579R | Kojic acid dipalmitate (Standard) | 79725-98-7 | Reference Standards |
| HY-W099580 | Hexadecane | 544-76-3 | Biochemical Assay Reagents |
| HY-W099580R | Hexadecane (Standard) | 544-76-3 | Reference Standards |
| HY-W099580S | Hexadecane-1,2-13C2 | 158563-27-0 | Isotope-Labeled Compounds |
| HY-W099580S1 | N-hexadecane-d34 | 15716-08-2 | Isotope-Labeled Compounds |
| HY-W099581 | Sulfobetaine-14 | 14933-09-6 | Biochemical Assay Reagents |
| HY-W099581R | Sulfobetaine-14 (Standard) | 14933-09-6 | Reference Standards |
| HY-W099582 | Myristamidopropyl dimethylamine | 45267-19-4 | Reference compound |
| HY-W099582S | N-(3-(Dimethylamino)propyl)tetradecanamide-d5 | Isotope-Labeled Compounds | |
| HY-W099583 | Myristic amide | 638-58-4 | Natural Products |
| HY-W099584 | Butyl tetradecanoate | 110-36-1 | Biochemical Assay Reagents |
| HY-W099585 | Myristicacid isobutylester | 25263-97-2 | Biochemical Assay Reagents |
| HY-W099586 | Ethyl tetradecanoate | 124-06-1 | Natural Products |
| HY-W099586S | Ethyl tetradecanoate-d27 | 1113009-11-2 | Isotope-Labeled Compounds |
| HY-W099594 | Benzalkonium (bromide) | 7281-04-1 | Biochemical Assay Reagents |
| HY-W099594S | Benzalkonium-d5 (bromide) | Isotope-Labeled Compounds | |
| HY-W099595 | Ethyl Lauroyl Arginate Hydrochloride | 60372-77-2 | Peptides |
| HY-W099598 | Amyl laurate | 5350-03-8 | Biochemical Assay Reagents |
| HY-W099600 | Lauric anhydride | 645-66-9 | Biochemical Assay Reagents |
| HY-W099601 | Sodium dodecanoate, 99-100% | 629-25-4 | Biochemical Assay Reagents |
| HY-W099602 | Dodecane | 112-40-3 | Natural Products |
| HY-W099602R | Dodecane (Standard) | 112-40-3 | Reference Standards |
| HY-W099602S | Dodecane-d26 | 16416-30-1 | Isotope-Labeled Compounds |
| HY-W099613S | 1-Bromodecane-d21 | 98195-39-2 | Isotope-Labeled Compounds |
| HY-W099613S1 | 1-Bromodecane-d3 | 284474-47-1 | Isotope-Labeled Compounds |
| HY-W099613S2 | 1-Bromodecane-d5 | 1219802-02-4 | Isotope-Labeled Compounds |
| HY-W099613S3 | 1-Bromodecane-d4 | 1219805-58-9 | Isotope-Labeled Compounds |
| HY-W099617 | 2,3-Dihydroxypropyl decanoate | 2277-23-8 | Reference compound |
| HY-W099618 | Isobutyl decanoate | 30673-38-2 | Biochemical Assay Reagents |
| HY-W099624S | Octylbenzene-d5 | 1219799-23-1 | Isotope-Labeled Compounds |
| HY-W099624S1 | Octylbenzene-d22 | 1219799-28-6 | Isotope-Labeled Compounds |
| HY-W099630 | Heptadecan-9-ol | 624-08-8 | Reference compound |
| HY-W099632 | 2-Hexyldecanoic acid | 25354-97-6 | Reference compound |
| HY-W099632R | 2-Hexyldecanoic acid (Standard) | 25354-97-6 | Reference Standards |
| HY-W099634 | 9-Heptadecanone | 540-08-9 | Reference compound |
| HY-W099640 | Tetraoctylammonium (iodide) | 16829-91-7 | Biochemical Assay Reagents |
| HY-W099641 | Methyltrioctylammonium hydrogen (sulfate) | 59158-14-4 | Biochemical Assay Reagents |
| HY-W099642 | Trimethyloctylammonium (bromide) | 2083-68-3 | Biochemical Assay Reagents |
| HY-W099643 | Cis-13-docosenol | 629-98-1 | Biochemical Assay Reagents |
| HY-W099644 | Ethyl docos-13-enoate | 37910-77-3 | Biochemical Assay Reagents |
| HY-W099645 | (Z)-Methyl docos-13-enoate | 1120-34-9 | Biochemical Assay Reagents |
| HY-W099646S | N-Octanoyl-d15-glycine | Isotope-Labeled Compounds | |
| HY-W099646S1 | N-Octanoylglycine-2,2-d2 | 1219805-51-2 | Isotope-Labeled Compounds |
| HY-W099648 | 4-Methylumbelliferyl octanoate | 20671-66-3 | Reference compound |
| HY-W099677 | 4-Decenoic Acid | 26303-90-2 | Biochemical Assay Reagents |
| HY-W099680S1 | Hexyltriphenylphosphonium-d5 bromide | 1169764-53-7 | Isotope-Labeled Compounds |
| HY-W099682 | Hexyltrimethylammonium (bromide) | 2650-53-5 | Biochemical Assay Reagents |
| HY-W099689 | 3-Octanol | 589-98-0 | Reference compound |
| HY-W099696 | N-Caproicacid (sodium) | 10051-44-2 | Biochemical Assay Reagents |
| HY-W099696S | N-Caproicacid-d11 (sodium) | 340257-58-1 | Isotope-Labeled Compounds |
| HY-W099696S1 | N-Caproicacid-d3 (sodium) | 1219794-91-8 | Isotope-Labeled Compounds |
| HY-W099724 | Trans-2-octen-1-ol | 18409-17-1 | Biochemical Assay Reagents |
| HY-W099729 | Ethylhexylglycerin | 70445-33-9 | Reference compound |
| HY-W099730 | Bemotrizinol | 187393-00-6 | Reference compound |
| HY-W099730R | Bemotrizinol (Standard) | 187393-00-6 | Reference Standards |
| HY-W099735 | Bis(2-ethylhexyl) maleate | 142-16-5 | Reference compound |
| HY-W099735R | Bis(2-ethylhexyl) maleate (Standard) | 142-16-5 | Reference Standards |
| HY-W099744 | 4-Methyl-5-nonanol | 154170-44-2 | Natural Products |
| HY-W099747 | Valericanhydride | 2082-59-9 | Biochemical Assay Reagents |
| HY-W099750 | Methyl 3-oxoheptanoate | 39815-78-6 | Biochemical Assay Reagents |
| HY-W099757 | (±)-Coniine (hydrochloride) | 15991-59-0 | Natural Products |
| HY-W099761 | Sildenafil chlorosulfonyl | 139756-22-2 | Reference compound |
| HY-W099790 | N-butyl-N-methyl-piperidinium bromide | 94280-72-5 | Biochemical Assay Reagents |
| HY-W099792 | Tetrabutylammonium (triiodide) | 13311-45-0 | Biochemical Assay Reagents |
| HY-W099859S | 2-Ethylnaphthalene-d5 | 1219805-14-7 | Isotope-Labeled Compounds |
| HY-W099862S | 2-Ethylphenol-d10 | 721429-63-6 | Isotope-Labeled Compounds |
| HY-W099862S1 | 2-Ethylphenol-d2 | 1335401-65-4 | Isotope-Labeled Compounds |
| HY-W099871 | Methyl 4-ethylbenzoate | 7364-20-7 | Biochemical Assay Reagents |
| HY-W099878A | Desmethylclotiazepam Uncyclized Intermediate (hydrochloride) | 74422-48-3 | Reference compound |
| HY-W099906S | 2-Ethyl-3-methoxypyrazine-d5 | Isotope-Labeled Compounds | |
| HY-W099915S | 3-Ethyl-2,5-dimethylpyrazine-d5 | 1428898-15-0 | Isotope-Labeled Compounds |
| HY-W099926 | 1-Methyl-1-propylpiperidinium (bromide) | 88840-42-0 | Biochemical Assay Reagents |
| HY-W099927 | [C3MPr]NTf2 | 223437-05-6 | Biochemical Assay Reagents |
| HY-W099929 | N-Ethyl-N,N-dipropylpropan-1-aminium (iodide) | 15066-80-5 | Biochemical Assay Reagents |
| HY-W099930 | N,N,N-Trimethylpropan-1-aminium (bromide) | 2650-50-2 | Biochemical Assay Reagents |
| HY-W1000105 | Geranial | 141-27-5 | Natural Products |
| HY-W100026 | Galaxolide | 1222-05-5 | Reference compound |
| HY-W100186 | Win 47338 | 80047-24-1 | Reference compound |
| HY-W100209 | 5Me3F4AP | 13958-85-5 | Reference compound |
| HY-W100215 | 5-Methylcyclocytidine hydrochloride | 51391-96-9 | Reference compound |
| HY-W100234 | 5-Methyl-2′-O-methyl-uridine | 55486-09-4 | Reference compound |
| HY-W100249 | MMAI | 136468-19-4 | Reference compound |
| HY-W100287 | Murrayafoline A | 4532-33-6 | Natural Products |
| HY-W100312S | o-Toluidine-13C6 (hydrochloride) | 1398044-44-4 | Isotope-Labeled Compounds |
| HY-W1003189 | E3 ligase Ligand 42 | 2753651-18-0 | Reference compound |
| HY-W100403 | Choline tosylate | 55357-38-5 | Biochemical Assay Reagents |
| HY-W100404 | Tetramethylammonium (4-methylbenzenesulfonate) | 3983-91-3 | Biochemical Assay Reagents |
| HY-W100443S | Trimethyl(p-tolyl)silane-d3 | 1514864-14-2 | Isotope-Labeled Compounds |
| HY-W1004786 | CRBN ligand-13 | 3050687-70-9 | Reference compound |
| HY-W1005067 | EN171 | 2191110-79-7 | Reference compound |
| HY-W1006349 | 1,2,3,4,6,7,8-Heptachlorodibenzofuran | 67562-39-4 | Reference compound |
| HY-W1006471 | Estrogen receptor-agonist-1 | 263717-32-4 | Reference compound |
| HY-W1006706 | E3 Ligase Ligand-linker Conjugate 157 | 2502189-47-9 | Reference compound |
| HY-W1006753 | 2-Methoxy-3-methylcarbazole | 24224-28-0 | Natural Products |
| HY-W1006754 | NNMT-IN-7 | 1973504-60-7 | Reference compound |
| HY-W100681 | 2'-Hydroxy-5'-methylacetophenone | 1450-72-2 | Reference compound |
| HY-W100681R | 2'-Hydroxy-5'-methylacetophenone (Standard) | 1450-72-2 | Reference Standards |
| HY-W100715 | 4-Methylsyringol | 6638-05-7 | Reference compound |
| HY-W1007773 | Acaricidal agent-1 | 123293-78-7 | Reference compound |
| HY-W100784 | 2,6-Dimethylphenylthiourea | 6396-76-5 | Reference compound |
| HY-W1008609 | (R)-GNA-A(Bz) phosphoramidite | 182625-87-2 | Reference compound |
| HY-W1008618 | (R)-GNA-C(Bz)-phosphoramidite | 2023779-58-8 | Reference compound |
| HY-W1008621 | GalNAc-THA C6 phosphoramidite | 2058062-52-3 | Biochemical Assay Reagents |
| HY-W1008626 | (S)-GNA-U-phosphoramidite | 494784-15-5 | Reference compound |
| HY-W1009348 | RR-11055 | 3026009-09-3 | Reference compound |
| HY-W100942 | Fmoc-D-2-Me-Trp-OH | 196808-79-4 | Peptides |
| HY-W100945 | 2,4,5-Trimethylthiazole | 13623-11-5 | Biochemical Assay Reagents |
| HY-W100990 | 4-Aminoantipyrine (hydrochloride) | 22198-72-7 | Biochemical Assay Reagents |
| HY-W101056S | 2,6-Dimethylaniline-d6 (hydrochloride) | 2748480-14-8 | Isotope-Labeled Compounds |
| HY-W101129 | 2,3:5,6-Di-O-isopropylidene-α-D-mannofuranose | 14131-84-1 | Biochemical Assay Reagents |
| HY-W101130S | 2,2-Dimethylbenzo[d][1,3]dioxole-d2 | 3047060-02-3 | Isotope-Labeled Compounds |
| HY-W101253 | Tetraethylammonium (iodide) | 68-05-3 | Biochemical Assay Reagents |
| HY-W101255 | Triethylmethylammonium chloride | 10052-47-8 | Biochemical Assay Reagents |
| HY-W101256 | N,N-Diethyl-N-methylethanaminium (tetrafluoroborate) | 69444-47-9 | Biochemical Assay Reagents |
| HY-W101257 | N,N,N-Trimethylethanaminium (iodide) | 51-93-4 | Biochemical Assay Reagents |
| HY-W101298 | L-Leucyl-L-isoleucine | 36077-41-5 | Reference compound |
| HY-W101298S | (Leu-13C6,15N)-Ile-OH (TFA) | Isotope-Labeled Compounds | |
| HY-W101301 | cis-5-Octen-1-ol | 64275-73-6 | Biochemical Assay Reagents |
| HY-W101305 | Fmoc-Pen(Acm)-OH | 201531-76-2 | Peptides |
| HY-W101311 | 2-(2-Acetamidoacetamido)acetic acid | 5687-48-9 | Reference compound |
| HY-W101363 | Acetyl-DL-phenylglycine | 15962-46-6 | Biochemical Assay Reagents |
| HY-W101366 | AC-PHE-OME | 3618-96-0 | Reference compound |
| HY-W101367S | N-Acetyl-S-benzyl-L-cysteine-d5 | 1955496-81-7 | Isotope-Labeled Compounds |
| HY-W101377 | N-Acetyl-L-tryptophanamide | 2382-79-8 | Peptides |
| HY-W101381 | Phenylmethyl 2-(acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-α-D-glucopyranoside | 13343-63-0 | Biochemical Assay Reagents |
| HY-W101382 | 5-Bromo-6-chloro-3-indolyl-N-acetyl-β-D-glucosaminide, 98% | 5609-91-6 | Biochemical Assay Reagents |
| HY-W101384 | Ac-D-2-Nal-OH | 37440-01-0 | Peptides |
| HY-W101391 | DMT-2'O-Methyl-rU Phosphoramidite | 110764-79-9 | Reference compound |
| HY-W101415 | 1-Phenyl-2-propanol | 698-87-3 | Natural Products |
| HY-W101415R | 1-Phenyl-2-propanol (Standard) | 698-87-3 | Reference Standards |
| HY-W101419 | Ibuprofenamide | 59512-17-3 | Reference compound |
| HY-W101437 | 1-(6-Methoxy-2-naphthyl)ethanol | 77301-42-9 | Biochemical Assay Reagents |
| HY-W101437R | 1-(6-Methoxy-2-naphthyl)ethanol (Standard) | 77301-42-9 | Reference Standards |
| HY-W101459 | Bisphenol E | 2081-08-5 | Reference compound |
| HY-W101495 | Boc-Leu-OH (hydrate) | 200936-87-4 | Peptides |
| HY-W101495S | Boc-Leu-OH·H2O-13C | 201740-80-9 | Isotope-Labeled Compounds |
| HY-W101495S1 | Boc-Leu-OH·H2O-d3 | 203645-42-5 | Isotope-Labeled Compounds |
| HY-W101495S2 | Boc-Leu-OH·H2O-d10 | 2483831-34-9 | Isotope-Labeled Compounds |
| HY-W101495S3 | Boc-Leu-OH·H2O-d7 | Isotope-Labeled Compounds | |
| HY-W101497 | Boc-Gly-Leu-OH | 51871-42-2 | Reference compound |
| HY-W101499 | L-a-Aspartyl-L-leucine | 3062-14-4 | Reference compound |
| HY-W101563S | Propan-2-amine-d6 (hydrochloride) | 126794-59-0 | Isotope-Labeled Compounds |
| HY-W101563S1 | Propan-2-amine-d7 (hydrochloride) | 106658-10-0 | Isotope-Labeled Compounds |
| HY-W101563S2 | Propan-2-amine-d9 (hydrochloride) | 1219798-50-1 | Isotope-Labeled Compounds |
| HY-W101581S | 2-Methylpropan-1-amine-d9 (hydrochloride) | 1219799-03-7 | Isotope-Labeled Compounds |
| HY-W101584S | Diisopentyl phthalate-d4 | 1346597-80-5 | Isotope-Labeled Compounds |
| HY-W101586 | Isoamyl 4-(dimethylamino)benzoate | 21245-01-2 | Reference compound |
| HY-W101587S | Bis(6-methylheptyl) Phthalate-3,4,5,6-d4 | 2209087-06-7 | Isotope-Labeled Compounds |
| HY-W101588 | 6-Methylheptanoic acid | 929-10-2 | Natural Products |
| HY-W101602S | 2-Isobutyl-3-methylpyrazine-d3 | 1335435-95-4 | Isotope-Labeled Compounds |
| HY-W101642S | 1,3-Diisopropylbenzene-d18 | 1398065-59-2 | Isotope-Labeled Compounds |
| HY-W101666 | 3-Isopropylcatechol | 2138-48-9 | Reference compound |
| HY-W101673 | Dipropofol | 2416-95-7 | Reference compound |
| HY-W101673R | Dipropofol (Standard) | 2416-95-7 | Reference Standards |
| HY-W101682 | (S)-Pregabalin methyl ester (hydrochloride) | 714230-22-5 | Reference compound |
| HY-W101713 | 3-(Maleimidopropane-1-carbonyl-1-(tert-butyl)carbazate | 1076198-38-3 | Biochemical Assay Reagents |
| HY-W101718 | Fmoc-N-(2-Boc-aminoethyl)-Gly-OH | 141743-15-9 | ADC Related |
| HY-W101722 | tert-Butyl (9-aminononyl)carbamate | 510754-90-2 | Reference compound |
| HY-W101723 | Boc-12-Ado-OH | 18934-81-1 | Reference compound |
| HY-W101772 | Fmoc-D-Phe(4-NHBoc)-OH | 214750-77-3 | Peptides |
| HY-W101889 | Boc-Gln(Xan)-OH | 55260-24-7 | Peptides |
| HY-W101891 | Boc-2-nitro-L-phenylalanine | 185146-84-3 | Biochemical Assay Reagents |
| HY-W101935 | N-Boc-D-Arg (hydrochloride) | 113712-06-4 | Peptides |
| HY-W101954 | (Fmoc-Cys-OtBu)2 (disulfide bridge) | 139592-37-3 | Reference compound |
| HY-W101987S1 | Bisphenol A bis(2,3-dihydroxypropyl) ether-d14 | Isotope-Labeled Compounds | |
| HY-W101987S2 | Bisphenol A bis(2,3-dihydroxypropyl) ether-d6 | Isotope-Labeled Compounds | |
| HY-W102278S | Tinuvin-327-d3 | Isotope-Labeled Compounds | |
| HY-W1023070 | 4-fluoro MBZP | 144734-44-1 | Reference compound |
| HY-W102322 | 5'-O-DMT-2'-TBDMS-Uridine | 81246-80-2 | Oligonucleotides |
| HY-W102336S | Methyl 2-bromopropanoate-d4 | 1398065-68-3 | Isotope-Labeled Compounds |
| HY-W102356 | Phenethyl acetate | 103-45-7 | Natural Products |
| HY-W102356R | Phenethyl acetate (Standard) | 103-45-7 | Reference Standards |
| HY-W102356S | Phenethyl acetate-d3 | 1219805-43-2 | Isotope-Labeled Compounds |
| HY-W102356S1 | Phenethyl acetate-13C2 | 1335402-21-5 | Isotope-Labeled Compounds |
| HY-W102356S2 | Phenethyl acetate-d5 | Isotope-Labeled Compounds | |
| HY-W102375 | 4-Acetoxycinnamic acid | 15486-19-8 | Natural Products |
| HY-W102383 | 1-O-Acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose | 14215-97-5 | Biochemical Assay Reagents |
| HY-W102386 | Methyl 2,3,4,6-Tetra-O-acetyl-1-thio-α-D-mannopyranoside | 64550-71-6 | Biochemical Assay Reagents |
| HY-W102387 | D-Galactose pentaacetate | 25878-60-8 | Biochemical Assay Reagents |
| HY-W102449S | 4-Acetyl-N-methylaniline-13C,d3 | Isotope-Labeled Compounds | |
| HY-W102453 | 3-(4-Acetylphenyl)-2-aminopropanoic acid (hydrochloride) | 1360436-95-8 | Reference compound |
| HY-W102456 | H-Phe(4-Ac)-OH | 122555-04-8 | Reference compound |
| HY-W102471 | 3-Acetylbenzophenone | 66067-44-5 | Reference compound |
| HY-W102516 | 6-Dehydroprogesterone | 1162-56-7 | Reference compound |
| HY-W102532 | Boc-Thr(Fmoc-Val)-OH | 887707-95-1 | Reference compound |
| HY-W102534 | Boc-Val-Pro-OH | 23361-28-6 | Reference compound |
| HY-W102545 | Diaza-15-crown-5 | 31249-95-3 | Biochemical Assay Reagents |
| HY-W102585 | HEPPSO (sodium) | 89648-37-3 | Biochemical Assay Reagents |
| HY-W102590 | DOTMP | 91987-74-5 | Biochemical Assay Reagents |
| HY-W102666 | AD-67 | 71526-07-3 | Biochemical Assay Reagents |
| HY-W102669 | Spiro[4.5]decane-7,9-dione | 82683-51-0 | Reference compound |
| HY-W102677 | Dicyclohexyl carbonate | 4427-97-8 | Reference compound |
| HY-W102681 | 3-(cyclohexylamino)-1-Propanesulfonic acid sodium salt | 105140-23-6 | Biochemical Assay Reagents |
| HY-W102684 | N,N-Dicyclohexyl-2-benzothiazolesulfenamide | 4979-32-2 | Reference compound |
| HY-W102709 | 3-DL-Cpa-OH | 96539-87-6 | Peptides |
| HY-W102714 | 1,2-Cyclohexylenedinitrilotetraacetic acid | 482-54-2 | Reference compound |
| HY-W102714R | 1,2-Cyclohexylenedinitrilotetraacetic acid (Standard) | 482-54-2 | Reference Standards |
| HY-W102799 | 1,2,5,6-Tetrabromocyclooctane | 3194-57-8 | Reference compound |
| HY-W102890S | Furan-2-carboxamide-d3 | 1219799-31-1 | Isotope-Labeled Compounds |
| HY-W102931 | 6,7-Dichloroquinoline-5,8-dione | 6541-19-1 | Reference compound |
| HY-W102981 | 4,10-Dioxatri cyclo[5.2. 1.02.6]dec-8-ene-3,5-dione | 5426-09-5 | Reference compound |
| HY-W103047 | 1-Pyrenebutyric acid | 3443-45-6 | Dye Reagents |
| HY-W103105 | R 29676 | 53786-28-0 | Reference compound |
| HY-W103170 | 1,8-Dichloroanthraquinone | 82-43-9 | Reference compound |
| HY-W103183 | Ferron | 547-91-1 | Reference compound |
| HY-W103183R | Ferron (Standard) | 547-91-1 | Reference Standards |
| HY-W103245 | Benzo-18-crown-6-ether | 14098-24-9 | Biochemical Assay Reagents |
| HY-W103287 | 2-Hydroxyisoquinoline-1,3(2H,4H)-dione | 6890-08-0 | Reference compound |
| HY-W103332S | 3-Phenanthrol-d9 | 922510-20-1 | Isotope-Labeled Compounds |
| HY-W103365 | 2-(3-Chloropropyl)isoindoline-1,3-dione | 42251-84-3 | Reference compound |
| HY-W103372 | Vasorelaxant agent-2 | 53242-88-9 | Reference compound |
| HY-W103463 | 1-Phenyl-2-pyrrolidinone | 4641-57-0 | Reference compound |
| HY-W103488 | Chloridazon | 1698-60-8 | Reference compound |
| HY-W103488S | Chloridazon-d5 | 1246818-99-4 | Isotope-Labeled Compounds |
| HY-W103571 | 2,3,5-Tris-O-(phenylmethyl)-α-D-ribofuranose | 89615-45-2 | Biochemical Assay Reagents |
| HY-W103577 | 1-(Cbz-amino)cyclopentanecarboxylic acid | 17191-44-5 | Reference compound |
| HY-W103826 | (5,10,15,20-Tetraphenylporphinato)manganese(III) chloride | 32195-55-4 | Reference compound |
| HY-W103882 | 2-(Benzhydrylsulfinyl)acetic acid | 63547-24-0 | Biochemical Assay Reagents |
| HY-W103882S | 2-(Benzhydrylsulfinyl)acetic acid-d5 | 1185142-72-6 | Isotope-Labeled Compounds |
| HY-W103928S | Benzophenone-7-d5 | Isotope-Labeled Compounds | |
| HY-W103932 | Potassium benzoate | 582-25-2 | Biochemical Assay Reagents |
| HY-W103935S | 2,2-Bis(((2-cyano-3,3-diphenylacryloyl)oxy)methyl)propane-1,3-diyl bis(2-cyano-3,3-diphenylacrylate)-d40 | Isotope-Labeled Compounds | |
| HY-W103960 | Mirabegron impurity-1 | 391901-45-4 | Reference compound |
| HY-W103960R | Mirabegron impurity-1 (Standard) | 391901-45-4 | Reference Standards |
| HY-W103964 | HCV-IN-47 | 300543-56-0 | Reference compound |
| HY-W104010S | 2-Chloroaniline hydrochloride-13C6 | 1261170-86-8 | Isotope-Labeled Compounds |
| HY-W104012 | 2,2'-(Ethane-1,2-diyl)dianiline | 34124-14-6 | Biochemical Assay Reagents |
| HY-W104012R | 2,2'-(Ethane-1,2-diyl)dianiline (Standard) | 34124-14-6 | Reference Standards |
| HY-W104075 | 2-Amino-5-bromo-2’-chlorobenzophenone | 60773-49-1 | Reference compound |
| HY-W104076 | 2-Amino-2'-fluoro-5-nitrobenzophenone | 344-80-9 | Reference compound |
| HY-W104195A | Proflavine hydrochloride, 98% | 952-23-8 | Biochemical Assay Reagents |
| HY-W104304 | 2-(3-Trifluoromethylphenyl)glycine (hydrochloride) | 1134915-25-5 | Peptides |
| HY-W104368 | Nicotinic acid riboside | 17720-18-2 | Natural Products |
| HY-W104379 | Arprinocid | 55779-18-5 | Biochemical Assay Reagents |
| HY-W104379S | Arprinocid-15N3 | Isotope-Labeled Compounds | |
| HY-W104467 | (+/-)-Epicatechin | 13392-26-2 | Reference compound |
| HY-W104477 | 3-Fluoro-L-tyrosine | 7423-96-3 | Reference compound |
| HY-W104518 | Potassium 2,5-dihydroxybenzenesulfonate | 21799-87-1 | Biochemical Assay Reagents |
| HY-W104549S | 3,6-Dichloro-2-hydroxybenzoic acid-13C6 | 1173019-34-5 | Isotope-Labeled Compounds |
| HY-W104635 | 6-Bromo-2-naphthyl-β-D-galactopyranoside | 15572-30-2 | Biochemical Assay Reagents |
| HY-W104752 | 5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol | 15264-63-8 | Reference compound |
| HY-W104758 | Elastase-IN-3 | 15015-57-3 | Reference compound |
| HY-W104816 | L-Tyrosyl-L-glutamic acid | 2545-89-3 | Reference compound |
| HY-W104819 | 4-Hydroxyphenylglyoxylate | 15573-67-8 | Reference compound |
| HY-W104821 | Rosolic acid | 603-45-2 | Biochemical Assay Reagents |
| HY-W104848 | 4-Maleimidobenzoic acid | 17057-04-4 | Reference compound |
| HY-W104862 | 4-Amino-D-phenylalanine | 102281-45-8 | Reference compound |
| HY-W1049136E | N3-PEG-N3, MW:1000 | 82055-94-5 | Biochemical Assay Reagents |
| HY-W105101 | 3,5-Dibromotyrosine | 300-38-9 | Reference compound |
| HY-W105111S | 1-Bromo-2,3,5-trichlorobenzene-d2 | 1219803-86-7 | Isotope-Labeled Compounds |
| HY-W105135 | 2,6-Dichloroquinone-4-chloroimide | 101-38-2 | Reference compound |
| HY-W105272 | 2′-Deoxyadenosine 5′-monophosphate (disodium) | 2922-74-9 | Oligonucleotides |
| HY-W105272R | 2′-Deoxyadenosine 5′-monophosphate (disodium) (Standard) | 2922-74-9 | Reference Standards |
| HY-W105272S | 2′-Deoxyadenosine 5′-monophosphate-13C10,15N5 (disodium) | Isotope-Labeled Compounds | |
| HY-W105310A | Croconic acid (disodium) | 14379-00-1 | Reference compound |
| HY-W105318 | Pentabromophenol | 608-71-9 | Reference compound |
| HY-W105359 | 9-Decen-1-ol | 13019-22-2 | Biochemical Assay Reagents |
| HY-W105411 | N,N'-Diacryloylpiperazine | 6342-17-2 | Biochemical Assay Reagents |
| HY-W105426 | 3-(Trimethoxysilyl)propyl methacrylate | 2530-85-0 | Biochemical Assay Reagents |
| HY-W105447 | 3'-TBDMS-ibu-rG Phosphoramidite | 1445905-51-0 | Reference compound |
| HY-W105497S | Benzyltrimethylsilane-d2 | 78808-66-9 | Isotope-Labeled Compounds |
| HY-W105505 | SAMe-1,4-Butanedisulfonate | 101020-79-5 | Biochemical Assay Reagents |
| HY-W105506 | Dimethylpropiothetin hydrochloride | 4337-33-1 | Natural Products |
| HY-W105506R | Dimethylpropiothetin hydrochloride (Standard) | 4337-33-1 | Reference Standards |
| HY-W105506S | Dimethylpropiothetin hydrochloride-d6 | 1246274-70-3 | Isotope-Labeled Compounds |
| HY-W105516 | N-Benzyl-N,N-dimethylbenzenaminium (chloride) | 3204-68-0 | Biochemical Assay Reagents |
| HY-W105518 | L-Carnitine (tartrate) | 36687-82-8 | Biochemical Assay Reagents |
| HY-W105518R | L-Carnitine (tartrate) (Standard) | 36687-82-8 | Reference Standards |
| HY-W105531 | Fmoc-Ala-Ala-Pro-OH | 161220-53-7 | Reference compound |
| HY-W105601 | 5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine | 161599-46-8 | Reference compound |
| HY-W105634 | Strombine | 56857-47-7 | Peptides |
| HY-W105639A | Calcium L-lactate pentahydrate, meets USP testing specifications | 865717-20-0 | Biochemical Assay Reagents |
| HY-W105664S | Aurinamide-15N,d2 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W105681 | Bis-Tris (hydrochloride) | 124763-51-5 | Biochemical Assay Reagents |
| HY-W105686 | MOPS hemisodium salt, 98% | 117961-20-3 | Biochemical Assay Reagents |
| HY-W105694 | 3-Aminopropylphosphonic acid | 13138-33-5 | Reference compound |
| HY-W105699 | EDTA (tetrasodium tetrahydrate) | 13235-36-4 | Biochemical Assay Reagents |
| HY-W105700 | Ethylenediaminetetraacetic acid (sodium hydrate) | 10378-23-1 | Biochemical Assay Reagents |
| HY-W105704 | HEPBS | 161308-36-7 | Biochemical Assay Reagents |
| HY-W105718 | 6-Mercapto-1-hexanol | 1633-78-9 | Biochemical Assay Reagents |
| HY-W105727 | 9-Aminononanoic acid | 1120-12-3 | Reference compound |
| HY-W105731 | 1,10-Diiododecane | 16355-92-3 | Reference compound |
| HY-W105734 | 15-Hydroxypentadecanoic acid | 4617-33-8 | Biochemical Assay Reagents |
| HY-W105735 | 1,16-Hexadecanediol | 7735-42-4 | Natural Products |
| HY-W105737 | 18-Methoxy-18-oxooctadecanoic acid | 72849-35-5 | Reference compound |
| HY-W105739 | 18-Hydroxyoctadecanoic acid | 3155-42-8 | Natural Products |
| HY-W105740 | 12-Aminododecanoic acid | 693-57-2 | Peptides |
| HY-W105741 | 12-Bromododecanoic acid | 73367-80-3 | Reference compound |
| HY-W105744 | 10-Aminodecanoic acid | 13108-19-5 | Reference compound |
| HY-W105750 | 6-Hydroxyhexanoic acid | 1191-25-9 | Biochemical Assay Reagents |
| HY-W105775 | Diammonium succinate | 2226-88-2 | Biochemical Assay Reagents |
| HY-W105804 | Selenocystamine (dihydrochloride) | 3542-13-0 | Peptides |
| HY-W105832S | Diglycolic acid-d4 | 1032504-39-4 | Isotope-Labeled Compounds |
| HY-W105835 | Magnesium citrate | 3344-18-1 | Reference compound |
| HY-W105853 | Ammonium trifluoroacetate | 3336-58-1 | Biochemical Assay Reagents |
| HY-W105855 | Potassium tetraoxalate dihydrate, 99% | 6100-20-5 | Biochemical Assay Reagents |
| HY-W105856 | Tin(II) oxalate | 814-94-8 | Biochemical Assay Reagents |
| HY-W105860S | Guanidine-15N3 (hydrobromide) | 2726423-31-8 | Isotope-Labeled Compounds |
| HY-W105875 | Iron(II) D-gluconate dihydrate, 98% | 22830-45-1 | Biochemical Assay Reagents |
| HY-W105876 | D-Mannonic acid-1,4-lactone | 26301-79-1 | Biochemical Assay Reagents |
| HY-W105884 | H-Asp-OH.Mg | 2068-80-6 | Peptides |
| HY-W105970 | Sodium pyrophosphate | 7758-16-9 | Biochemical Assay Reagents |
| HY-W105974 | Potassium phosphate trihydrate | 22763-03-7 | Biochemical Assay Reagents |
| HY-W106012 | Aluminum sulfate hexadecahydrate | 16828-11-8 | Biochemical Assay Reagents |
| HY-W106014S | [1,1'-Biphenyl]-3-amine-13C6 (hydrochloride) | 2703451-46-9 | Isotope-Labeled Compounds |
| HY-W106057 | 11β-HSD1-IN-7 | 728-86-9 | Reference compound |
| HY-W106234 | 4-(Phenyldiazenyl)benzoic acid | 1562-93-2 | Reference compound |
| HY-W106306 | H-Leu-Lys(Z)-OH | 34990-61-9 | Reference compound |
| HY-W106311 | Fmoc-Val-Ala-OH | 150114-97-9 | Reference compound |
| HY-W106322 | Methyl nadic anhydride | 25134-21-8 | Biochemical Assay Reagents |
| HY-W106325 | Fmoc-N-Me-D-Trp(Boc)-OH | 2044709-90-0 | Peptides |
| HY-W106405 | 1,4-Butanediol,diacrylate | 1070-70-8 | Biochemical Assay Reagents |
| HY-W106411 | DTME | 71865-37-7 | Reference compound |
| HY-W106424 | VinylLaurate(stabilizedwithMEHQ) | 2146-71-6 | Biochemical Assay Reagents |
| HY-W106425 | Ethenyl 10-undecenoate | 5299-57-0 | Biochemical Assay Reagents |
| HY-W106426 | Vinyl stearate | 111-63-7 | Biochemical Assay Reagents |
| HY-W106427 | Vinyl palmitate | 693-38-9 | Biochemical Assay Reagents |
| HY-W106434 | VinylMyristate(stabilizedwithMEHQ) | 5809-91-6 | Biochemical Assay Reagents |
| HY-W106445 | Vinyl decanoate | 4704-31-8 | Biochemical Assay Reagents |
| HY-W106456 | 3-Methoxy-9H-Carbazole | 18992-85-3 | Reference compound |
| HY-W106466 | Vinyl octanoate | 818-44-0 | Biochemical Assay Reagents |
| HY-W106467 | Trimethylvinylammonium (bromide) | 10603-92-6 | Biochemical Assay Reagents |
| HY-W106486 | Diallyldimethylammonium (chloride) (60% in water) | 7398-69-8 | Biochemical Assay Reagents |
| HY-W106487 | (+)-N,N'-Diallyl-L-tartardiamide | 58477-85-3 | Biochemical Assay Reagents |
| HY-W106550 | α-D-Galactose pentaacetate | 4163-59-1 | Biochemical Assay Reagents |
| HY-W106551 | 2,3,4,6-Tetra-O-acetyl-D-galactopyranose | 47339-09-3 | Biochemical Assay Reagents |
| HY-W106629 | 3-Octenoic acid | 1577-19-1 | Biochemical Assay Reagents |
| HY-W106641 | (Z)-7-Dodecen-1-ol | 20056-92-2 | Natural Products |
| HY-W106688 | Triisopropyl phosphate | 513-02-0 | Reference compound |
| HY-W106724S | Diethylamine-d10hydrobromide | 1219803-53-8 | Isotope-Labeled Compounds |
| HY-W106746 | Sodium bismuthate dihydrate, 85% | 12380-79-9 | Biochemical Assay Reagents |
| HY-W106785 | N-Benzylcyclohexylamine (hydrochloride) | 16350-96-2 | Reference compound |
| HY-W106835S1 | N-(3-Hydroxybenzyl)adenosine-15N,d2 | Isotope-Labeled Compounds | |
| HY-W106860 | 9H-Carbazole-3-carbaldehyde | 51761-07-0 | Natural Products |
| HY-W107024 | BMS-986260 | 2001559-19-7 | Reference compound |
| HY-W107077 | INF55 | 4993-87-7 | Reference compound |
| HY-W107080S | 5-carboxypentan-1-olate-d6 (sodium) | 1219794-58-7 | Isotope-Labeled Compounds |
| HY-W107202 | Biotin methyl ester | 608-16-2 | Reference compound |
| HY-W107263 | 4-Hydroxypentanoate (sodium) | 56279-37-9 | Reference compound |
| HY-W107409 | Meridianin C | 213473-00-8 | Natural Products |
| HY-W107464 | G6PDi-1 | 2457232-14-1 | Reference compound |
| HY-W107466 | 4-((4-((4-Aminophenyl)sulfonyl)phenyl)amino)-4-oxobutanoic acid | 5934-14-5 | Reference compound |
| HY-W107585 | β-Glutamic acid | 1948-48-7 | Peptides |
| HY-W107616 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 7541-49-3 | Natural Products |
| HY-W107869 | 2-Heptenoic acid | 18999-28-5 | Biochemical Assay Reagents |
| HY-W107935 | Hsp90-IN-37 | 1383133-23-0 | Reference compound |
| HY-W108126S | 2-(2H-Benzotriazol-2-yl)-6-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)phenol-d4 | Isotope-Labeled Compounds | |
| HY-W108137 | Boc-Gly-Sar-OH | 133498-97-2 | Reference compound |
| HY-W108219 | Benzyl-PEG4-Ots | 89346-82-7 | Reference compound |
| HY-W108220 | Benzyl-PEG5-Ots | 129086-10-8 | Reference compound |
| HY-W108399 | 3’-O-t-Bulyldimethylsilylthymidine | 40733-27-5 | Reference compound |
| HY-W108415 | Z12-Tetradecenyl acetate | 35153-20-9 | Natural Products |
| HY-W108418 | (Z)-8-Dodecen-1-ol | 40642-40-8 | Natural Products |
| HY-W108635 | N-[S-Trityl-L-cysteinyl]glycine | 26988-61-4 | Reference compound |
| HY-W108746 | Ethyl α-D-glucopyranoside | 34625-23-5 | Biochemical Assay Reagents |
| HY-W108801 | α-D-Glucoheptonic acid (sodium) | 10094-62-9 | Biochemical Assay Reagents |
| HY-W108867 | N-Fmoc-ethylenediamine (hydrobromide) | 352351-55-4 | Reference compound |
| HY-W108875 | Mupirocin (lithium) | 73346-79-9 | Reference compound |
| HY-W108875R | Mupirocin (lithium) (Standard) | 73346-79-9 | Reference Standards |
| HY-W108953 | Myristoyl tetrapeptide-12 | 959610-24-3 | Peptides |
| HY-W108953A | Myristoyl tetrapeptide-12 (dihydrochloride) | Peptides | |
| HY-W109102 | 1-Palmitoyl-sn-glycerol | 32899-41-5 | Biochemical Assay Reagents |
| HY-W109214 | Fmoc-L-Dap(Boc,Me)-OH | 446847-80-9 | Peptides |
| HY-W109324 | E12-Tetradecenyl acetate | 35153-21-0 | Natural Products |
| HY-W109401 | SIRT-IN-6 | 1431411-18-5 | Reference compound |
| HY-W109442 | 5Br-INACA | 1799421-04-7 | Reference compound |
| HY-W109470S | 2-(((9H-Purin-6-yl)amino)methyl)phenol-d4 | Isotope-Labeled Compounds | |
| HY-W109513 | Boc-Lys(Z)-OH (DCHA) | 16948-04-2 | Peptides |
| HY-W109523 | 2-Butylbenzo[d]isothiazol-3(2H)-one | 4299-07-4 | Reference compound |
| HY-W109564S | Bis(2-hydroxyethyl) phthalate-d8 | Isotope-Labeled Compounds | |
| HY-W109613 | Methyl dehydroabietate | 1235-74-1 | Reference compound |
| HY-W109754 | 2',4'-Dihydroxylchalcone | 1776-30-3 | Reference compound |
| HY-W109760 | FmocNH-PEG2-CH2CONH-PEG2-CH2COOH | 560088-89-3 | Reference compound |
| HY-W109812 | Sinapyl alcohol | 537-33-7 | Reference compound |
| HY-W109812R | Sinapyl alcohol (Standard) | 537-33-7 | Reference Standards |
| HY-W109812S | Sinapyl alcohol-d3 | 934634-29-4 | Isotope-Labeled Compounds |
| HY-W109973 | L-Tartaric acid (diammonium) | 3164-29-2 | Biochemical Assay Reagents |
| HY-W109978 | Tetrabutylammonium perrhenate | 16385-59-4 | Biochemical Assay Reagents |
| HY-W110126 | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid | 219967-68-7 | Peptides |
| HY-W110146 | (3aS,4S,6aR)-Biotin-PEG4-Alkyne | 1262681-31-1 | Reference compound |
| HY-W110148S | Amitrole-13C,15N2 | 1346603-92-6 | Isotope-Labeled Compounds |
| HY-W110166 | Hexyl acrylate | 2499-95-8 | Reference compound |
| HY-W110242A | (S)-CPP (sodium) | 194979-70-9 | Reference compound |
| HY-W110331A | Polyethylene glycol bis(3-aminopropyl) ether (Mn 1500) | 34901-14-9 | Biochemical Assay Reagents |
| HY-W110493 | Divarin | 500-49-2 | Reference compound |
| HY-W110540 | Poly(ethylene glycol) dimethacrylate (MW 550) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540A | Poly(ethylene glycol) dimethacrylate (MW 750) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540C | Poly(ethylene glycol) dimethacrylate (MW 1000) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540D | Poly(ethylene glycol) dimethacrylate (MW 2000) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540H | Poly(ethylene glycol) dimethacrylate (MW 3400) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540I | Poly(ethylene glycol) dimethacrylate (MW 4000) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540J | Poly(ethylene glycol) dimethacrylate (MW 6000) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540K | Poly(ethylene glycol) dimethacrylate (MW 10000) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110540L | Poly(ethylene glycol) dimethacrylate (MW 20000) | 25852-47-5 | Biochemical Assay Reagents |
| HY-W110542D | Poly(ethylene glycol) diacrylate (MW 1000) | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542G | Poly(ethylene glycol) diacrylate (MW 6000) | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542H | Poly(ethylene glycol) diacrylate (MW 10000) | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542J | Poly(ethylene glycol) diacrylate (MW 700) | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542K | Poly(ethylene glycol) diacrylate (MW 1500) | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542L | Poly(ethylene glycol) diacrylate (MW 3500) | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542M | Poly(ethylene glycol) diacrylate (MW 20000) | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542N | Poly(ethylene glycol) diacrylate (MW 250),MEHQ as inhibitor | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542O | Poly(ethylene glycol) diacrylate (MW 575),MEHQ as inhibitor | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110542P | Poly(ethylene glycol) diacrylate (MW 4000), MEHQ as inhibitor | 26570-48-9 | Biochemical Assay Reagents |
| HY-W110548 | Poly(ethylene glycol) methyl ether methacrylate (MW 500) | 26915-72-0 | Biochemical Assay Reagents |
| HY-W110548A | Poly(ethylene glycol) methyl ether methacrylate (MW 300) | 26915-72-0 | Biochemical Assay Reagents |
| HY-W110548B | Poly(ethylene glycol) methyl ether methacrylate (MW 950) | 26915-72-0 | Biochemical Assay Reagents |
| HY-W110548C | Poly(ethylene glycol) methyl ether methacrylate (MW 1500) | 26915-72-0 | Biochemical Assay Reagents |
| HY-W110548D | Poly(ethylene glycol) methyl ether methacrylate (MW 4000) | 26915-72-0 | Biochemical Assay Reagents |
| HY-W110551 | 2-Methacryloyloxyethyl phosphorylcholine | 67881-98-5 | Biochemical Assay Reagents |
| HY-W110584 | Carboxybetaine methacrylate | 24249-95-4 | Biochemical Assay Reagents |
| HY-W110589 | (3-Acrylamidopropyl)trimethylammonium (chloride) | 45021-77-0 | Biochemical Assay Reagents |
| HY-W110662 | Transtorine | 13593-94-7 | Natural Products |
| HY-W110698 | Undecylamine | 7307-55-3 | Reference compound |
| HY-W110698S | Undecylamine-d23 | 1219805-57-8 | Isotope-Labeled Compounds |
| HY-W110699 | 1-Undecanethiol | 5332-52-5 | Reference compound |
| HY-W110702S | 1-Bromotridecane-d27 | 349553-91-9 | Isotope-Labeled Compounds |
| HY-W110702S1 | 1-Bromotridecane-d4 | 284474-45-9 | Isotope-Labeled Compounds |
| HY-W110703S | Tetradecylamine-d29 | 204244-82-6 | Isotope-Labeled Compounds |
| HY-W110705S | 1-Bromopentadecane-1-13C | 2708283-81-0 | Isotope-Labeled Compounds |
| HY-W110705S1 | 1-Bromopentadecane-d31 | 349553-93-1 | Isotope-Labeled Compounds |
| HY-W110705S3 | 1-Bromopentadecane-d3 | 1219805-83-0 | Isotope-Labeled Compounds |
| HY-W110707 | Cetylamine | 143-27-1 | Reference compound |
| HY-W110707S | Cetylamine-d33 | 1191245-82-5 | Isotope-Labeled Compounds |
| HY-W110726S | 1-Octen-3-one-d5 | Isotope-Labeled Compounds | |
| HY-W110726S1 | 1-Octen-3-one-d3 | 213595-56-3 | Isotope-Labeled Compounds |
| HY-W110772 | Coumarin153 | 53518-18-6 | Reference compound |
| HY-W110780 | Methyl Red sodium salt | 845-10-3 | Biochemical Assay Reagents |
| HY-W110781 | Basic Blue 20 | 82-94-0 | Reference compound |
| HY-W110783 | Methyl violet indicator | 8004-87-3 | Biochemical Assay Reagents |
| HY-W110784 | Ethyl red, 98% | 76058-33-8 | Biochemical Assay Reagents |
| HY-W110789 | Ethyl Orange (sodium), indicator grade | 62758-12-7 | Biochemical Assay Reagents |
| HY-W110790 | Bromocresol purple (sodium) | 62625-30-3 | Biochemical Assay Reagents |
| HY-W110791 | Sodium diphenylamine-4-sulfonate | 6152-67-6 | Biochemical Assay Reagents |
| HY-W110793 | Dithizone | 60-10-6 | Biochemical Assay Reagents |
| HY-W110794 | Crystal violet indicator (0.0-2.0), IND | 548-62-9 | Biochemical Assay Reagents |
| HY-W110798 | Bromophenol blue indicator (3.0-4.6) | 115-39-9 | Biochemical Assay Reagents |
| HY-W110882 | Thorin, IND | 3688-92-4 | Biochemical Assay Reagents |
| HY-W110883 | Xylenol orange tetrasodium salt, IND | 3618-43-7 | Dye Reagents |
| HY-W110884 | Eriochrome cyanine R indicator (C.I. 43820) | 3564-18-9 | Dye Reagents |
| HY-W110885 | Erichrome blue black B | 3564-14-5 | Biochemical Assay Reagents |
| HY-W110888 | Brilliant Yellow | 3051-11-4 | Reference compound |
| HY-W110896 | Phthalate complexing agent [Chelation indicator] | 2411-89-4 | Biochemical Assay Reagents |
| HY-W110898 | Nile blue chloride | 2381-85-3 | Dye Reagents |
| HY-W110904 | Methylthymol blue (tetrasodium) | 1945-77-3 | Dye Reagents |
| HY-W110905 | Naphthol green B | 19381-50-1 | Dye Reagents |
| HY-W110908 | Thymolphthalein complexone | 1913-93-5 | Biochemical Assay Reagents |
| HY-W110909 | Thiazole Yellow G, for microscopy | 1829-00-1 | Biochemical Assay Reagents |
| HY-W110910 | Eriochrome black T, Indicator | 1787-61-7 | Biochemical Assay Reagents |
| HY-W110914A | Xylenol orange,indicator (disodium) | 1202864-39-8 | Biochemical Assay Reagents |
| HY-W110917 | Dimethylsulfonazo III | 14979-11-4 | Reference compound |
| HY-W110925 | Alkali blue 6B monosodium(IND) | 1324-80-7 | Biochemical Assay Reagents |
| HY-W110926 | Alkali blue | 1324-76-1 | Biochemical Assay Reagents |
| HY-W110927 | Alizarin Red S Indicator (4.3-6.3), IND | 130-22-3 | Biochemical Assay Reagents |
| HY-W110929 | Patent Blue V | 129-17-9 | Biochemical Assay Reagents |
| HY-W110999S | 9-Nitroanthracene-d9 | 220381-38-4 | Isotope-Labeled Compounds |
| HY-W111005 | 1-Chloromethylpyrene | 1086-00-6 | Reference compound |
| HY-W111121 | Terbium(III) carbonate hydrate | 100587-96-0 | Biochemical Assay Reagents |
| HY-W111141 | BCN-OH | 1263166-90-0 | Biochemical Assay Reagents |
| HY-W111144 | T-1330 | 106461-41-0 | Reference compound |
| HY-W1111591 | m-PEG-OH (MW 350) | 9004-74-4 | Biochemical Assay Reagents |
| HY-W111168 | Acid chrome blue K | 3270-25-5 | Biochemical Assay Reagents |
| HY-W1111714 | 3-(5-Bromo-2-chlorophenyl)piperidine-2,6-dione | 2990057-63-9 | Reference compound |
| HY-W111193A | Phosphotungstic acid hydrate,WO3 85% | 12501-23-4 | Biochemical Assay Reagents |
| HY-W111209 | 4-Nitrophenyl ((benzyloxy)carbonyl)glycinate | 1738-86-9 | Peptides |
| HY-W111211 | (R)-2-Amino-4-methylpentanamide hydrochloride | 80970-09-8 | Peptides |
| HY-W111214 | Benzyl (tert-butoxycarbonyl)-L-tyrosinate | 19391-35-6 | Peptides |
| HY-W111226 | Fmoc-His(3-Me)-OH | 252049-16-4 | Peptides |
| HY-W111228 | Fmoc-9-Aminononanoic acid | 212688-52-3 | Reference compound |
| HY-W1113139 | H2N-PEG4-C3-OH | 306771-83-5 | Reference compound |
| HY-W111370 | 2-Nitroamino-2-imidazoline | 5465-96-3 | Reference compound |
| HY-W111375 | (E)-Pent-2-enal | 1576-87-0 | Biochemical Assay Reagents |
| HY-W111382 | 2,2'-((((9H-Fluoren-9-yl)methoxy)carbonyl)azanediyl)diacetic acid | 112918-82-8 | Peptides |
| HY-W111436 | Tetrabutylammonium tetraphenylborate | 15522-59-5 | Biochemical Assay Reagents |
| HY-W111461 | Tetrabutylammonium thiocyanate | 3674-54-2 | Biochemical Assay Reagents |
| HY-W111467S | 1-Bromoeicosane-d41 | 202480-71-5 | Isotope-Labeled Compounds |
| HY-W111467S1 | 1-Bromoicosane-d3 | 202480-72-6 | Isotope-Labeled Compounds |
| HY-W111522 | Sodium phosphite dibasic pentahydrate, 98% | 13517-23-2 | Biochemical Assay Reagents |
| HY-W111581 | Copper(II) diethyldithiocarbamate | 13681-87-3 | Reference compound |
| HY-W111589F | Kieselguhr, soda ash flux-calcined | 68855-54-9 | Biochemical Assay Reagents |
| HY-W1116287 | N-Acetyl-Sar24 | 2313534-28-8 | Peptides |
| HY-W111687 | Bismuth(Ⅲ) citrate, 99.99% trace metals basis | 813-93-4 | Biochemical Assay Reagents |
| HY-W111692 | Sodium polyphosphate, crystal,+200 mesh, 96% | 68915-31-1 | Biochemical Assay Reagents |
| HY-W111720 | Trans-2-dodecenal | 20407-84-5 | Biochemical Assay Reagents |
| HY-W111830 | Diethyl terephthalate | 636-09-9 | Reference compound |
| HY-W111879S | Oxamic acid hydrazide-15N3 | Isotope-Labeled Compounds | |
| HY-W111893 | 2-Methyl-2-hexanol | 625-23-0 | Biochemical Assay Reagents |
| HY-W111907 | 3,3-Diethylthiacarbocyanine (iodide) | 905-97-5 | Dye Reagents |
| HY-W111914 | 4-Methyl-1,3-dioxane | 1120-97-4 | Natural Products |
| HY-W111969 | 2-(1,3-Dioxoisoindolin-2-yl)pentanedioic acid | 6349-98-0 | Peptides |
| HY-W111999 | 1-Benzyl-3-phenylthiourea | 726-25-0 | Reference compound |
| HY-W112005 | Benzyltrimethylammonium tetrachloroiodate | 121309-88-4 | Biochemical Assay Reagents |
| HY-W112021 | 2,5-DMBQ | 3117-03-1 | Reference compound |
| HY-W112057 | Fmoc-S-3-amino-4,4-diphenyl-butyric acid | 332062-08-5 | Peptides |
| HY-W112090 | Palladium meso-tetra(pentafluorophenyl)porphyrin | 72076-09-6 | Reference compound |
| HY-W112166 | (E/Z)-4,4'-Dicyanostilbene | 6292-62-2 | Reference compound |
| HY-W112166A | 4,4'-Dicyanostilbene | 5216-37-5 | Reference compound |
| HY-W112239 | BDPI | 1083009-44-2 | Reference compound |
| HY-W112276 | 5,10,15,20-Tetrakis[4-(1,1-dimethylethyl)phenyl]-21H,23H-porphine | 110452-48-7 | Biochemical Assay Reagents |
| HY-W112277 | 5,10,15,20-Tetrakis(4-methoxyphenyl)-21H,23H-porphine iron(III) chloride | 36995-20-7 | Reference compound |
| HY-W112280 | meso-Tetra-(3,5-di-t-butylphenyl)porphine | 89372-90-7 | Biochemical Assay Reagents |
| HY-W112281 | 5,10,15,20-Tetrakis(2-methylphenyl)-21H,23H-porphine | 37083-40-2 | Biochemical Assay Reagents |
| HY-W112346 | 4-Amino-2-hydroxybenzohydrazide | 6946-29-8 | Reference compound |
| HY-W112545 | m-TMPyP (tetrachloride) | 94343-62-1 | Biochemical Assay Reagents |
| HY-W112651 | 2,4,6-Triphenylaniline | 6864-20-6 | Reference compound |
| HY-W112932 | BDPBr | 910823-84-6 | Reference compound |
| HY-W112936 | Pd(II)TMPyP (tetrachloride) | 110314-07-3 | Biochemical Assay Reagents |
| HY-W112937 | Zn(II)TMPyP (tetrachloride) | 28850-44-4 | Biochemical Assay Reagents |
| HY-W112938 | 5,10,15,20-Tetrakis(1-methylpyridinium-4-yl)porphyrin tetrachloride | 92739-63-4 | Biochemical Assay Reagents |
| HY-W112939 | Fe(III)(TDCPP) (chloride) | 91042-27-2 | Biochemical Assay Reagents |
| HY-W112941 | (meso-Tetraphenylporphinato)platinum | 14187-14-5 | Biochemical Assay Reagents |
| HY-W113081 | 4′-Thiouridine | 6741-73-7 | Reference compound |
| HY-W113615 | 4-Phenyl-1H-1,2,3-triazole | 1680-44-0 | Reference compound |
| HY-W113965 | β-D-Maltose octaacetate | 22352-19-8 | Biochemical Assay Reagents |
| HY-W113972 | 2'-F-iBu-G | 80681-25-0 | Reference compound |
| HY-W114255 | 4-Methylpentan-2-amine hydrochloride | 71776-70-0 | Reference compound |
| HY-W114255S | 4-Methyl-2-pentanamine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W114327 | N4-Acetyl-2'-O-methylcytidine | 113886-71-8 | Reference compound |
| HY-W114328 | DMT-OMe-rC(Ac) | 199593-08-3 | Reference compound |
| HY-W114419 | Bisphenol C | 79-97-0 | Reference compound |
| HY-W114420 | 3-Methyl-L-tyrosine | 17028-03-4 | Reference compound |
| HY-W114581 | Ethyl2-hydroxy-4-methylpentanoate | 10348-47-7 | Biochemical Assay Reagents |
| HY-W114750 | MPTP | 28289-54-5 | Reference compound |
| HY-W114781 | 4-Fluoro-N-methylbenzylamine | 405-66-3 | Biochemical Assay Reagents |
| HY-W114787 | N4-Benzoyl-2’-O-methylcytidine | 52571-45-6 | Reference compound |
| HY-W114886 | DMT-OMe-rA(Bz) | 110764-72-2 | Reference compound |
| HY-W114954 | Guaiacylglycerol-beta-guaiacyl ether | 7382-59-4 | Reference compound |
| HY-W115186 | DMT-2'-OMe-Bz-C | 110764-74-4 | Reference compound |
| HY-W115276 | Fenticonazole | 72479-26-6 | Reference compound |
| HY-W115309 | DMT-2'-F-iBu-G | 144089-96-3 | Reference compound |
| HY-W115607 | PEG-bis-amine (MW 8000) | 24991-53-5 | Biochemical Assay Reagents |
| HY-W115609 | N-Phenylbenzamide | 93-98-1 | Biochemical Assay Reagents |
| HY-W115716 | Sorbitan trioleate | 26266-58-0 | Biochemical Assay Reagents |
| HY-W115718 | Cuprizone | 370-81-0 | Reference compound |
| HY-W115721 | Rhodizonic acid disodium | 523-21-7 | Biochemical Assay Reagents |
| HY-W115724 | Thioglycolate (sodium) | 367-51-1 | Biochemical Assay Reagents |
| HY-W115727 | Polyacrylamide,Anion,Mw 10-12 million | 9003-05-8 | Biochemical Assay Reagents |
| HY-W115727A | Polyacrylamide,Anion,Mw 14-16 million | 9003-05-8 | Biochemical Assay Reagents |
| HY-W115727B | Polyacrylamide,Anion,Mw 18 million | 9003-05-8 | Biochemical Assay Reagents |
| HY-W115727C | Polyacrylamide,Nonionic,Mw 5-6 million | 9003-05-8 | Biochemical Assay Reagents |
| HY-W115727D | Polyacrylamide,average Mn 40000 | 9003-05-8 | Biochemical Assay Reagents |
| HY-W115727E | Polyacrylamide,average Mn 150000 | 9003-05-8 | Biochemical Assay Reagents |
| HY-W115728 | Lead acetate basic | 51404-69-4 | Biochemical Assay Reagents |
| HY-W115731 | Dextrin | 9004-53-9 | Biochemical Assay Reagents |
| HY-W115738 | PAR | 1141-59-9 | Dye Reagents |
| HY-W115743 | Sulfonated castor oil | 8002-33-3 | Biochemical Assay Reagents |
| HY-W115746 | Ethyl cellulose | 9004-57-3 | Reference compound |
| HY-W115746A | Ethyl cellulose (viscosity 10 cP) | 9004-57-3 | Biochemical Assay Reagents |
| HY-W115746B | Ethyl cellulose (viscosity 300 cP) | 9004-57-3 | Biochemical Assay Reagents |
| HY-W115752 | Hydrazine sulfate (99%) | 10034-93-2 | Biochemical Assay Reagents |
| HY-W115757 | Magnesium trisilicate | 14987-04-3 | Biochemical Assay Reagents |
| HY-W115763S | Dodecanoate-d2 (potassium) | 82867-25-2 | Isotope-Labeled Compounds |
| HY-W115763S1 | Dodecanoate-d23 (potassium) | 51732-20-8 | Isotope-Labeled Compounds |
| HY-W115767 | Nickel(II) sulfamate tetrahydrate | 124594-15-6 | Biochemical Assay Reagents |
| HY-W115775 | Potassium hydrogen oxalate | 127-95-7 | Biochemical Assay Reagents |
| HY-W115786 | Kaolin | 1332-58-7 | Reference compound |
| HY-W115788S | Tetradecanoate-d2 (potassium) | 352438-85-8 | Isotope-Labeled Compounds |
| HY-W115788S1 | Tetradecanoate-d27 (potassium) | 352438-87-0 | Isotope-Labeled Compounds |
| HY-W115789 | Sodium silicate | 1344-09-8 | Biochemical Assay Reagents |
| HY-W115798 | Trimagnesium dicitrate nonahydrate, 99% | 153531-96-5 | Biochemical Assay Reagents |
| HY-W115799 | EDTA (disodium manganese) | 15375-84-5 | Biochemical Assay Reagents |
| HY-W115818 | Polyoxyethylene Sorbitan Monostearate | 9005-67-8 | Biochemical Assay Reagents |
| HY-W115819 | Polysorbate 40 | 9005-66-7 | Biochemical Assay Reagents |
| HY-W115882 | Methoxymethyltrimethylsilane | 14704-14-4 | Biochemical Assay Reagents |
| HY-W115895 | 6-O-(Triisopropylsilyl)-D-galactal | 166021-01-8 | Biochemical Assay Reagents |
| HY-W116007 | Octamethylcyclotetrasiloxane | 556-67-2 | Reference compound |
| HY-W116007S | Octamethylcyclotetrasiloxane-d12 | Isotope-Labeled Compounds | |
| HY-W116335A | Dried aluminum hydroxide gel,United States Pharmacopeia (USP) Reference Standard | 21645-51-2 | Biochemical Assay Reagents |
| HY-W116336B | Zinc oxide, 99.99% metals basis | 1314-13-2 | Biochemical Assay Reagents |
| HY-W116336D | Zinc oxide, <100 nm particle size | 1314-13-2 | Biochemical Assay Reagents |
| HY-W116433 | SK609 | 144887-95-6 | Reference compound |
| HY-W116478S | D-Leucine-N-fmoc-d10 | 2714483-30-2 | Isotope-Labeled Compounds |
| HY-W116576 | 3-Methoxycatechol | 934-00-9 | Reference compound |
| HY-W116594 | X-GalNAc | 129572-48-1 | Dye Reagents |
| HY-W116598 | 5-Bromo-3-indolyl phosphate (p-toluidine) | 80008-69-1 | Biochemical Assay Reagents |
| HY-W116606 | Coumarin boronic acid | 1357078-03-5 | Dye Reagents |
| HY-W117485 | (4-((Neopentyloxy)sulfonyl)phenyl)boronic acid | 957060-74-1 | Reference compound |
| HY-W117986 | Aβ aggregation-IN-1 | 352525-91-8 | Reference compound |
| HY-W121901 | Naproxen glucuronide | 41945-43-1 | Reference compound |
| HY-W123001 | Bis[2-(succinimidooxycarbonyloxy)ethyl] sulfone | 57683-72-4 | Biochemical Assay Reagents |
| HY-W123003 | Dimethyl 3,3′-dithiopropionimidate (dihydrochloride) | 38285-78-8 | Biochemical Assay Reagents |
| HY-W123004 | PEG NHS ester disulfide | 947601-98-1 | Biochemical Assay Reagents |
| HY-W123005 | Dimethyl pimelimidate (dihydrochloride) | 58537-94-3 | Reference compound |
| HY-W123006 | CBTF (sodium) | 1644038-87-8 | Reference compound |
| HY-W123008 | N-Succinimidyl (4-iodoacetyl)aminobenzoate | 72252-96-1 | Biochemical Assay Reagents |
| HY-W123009 | Sulfo-KMUS (sodium salt) | 211236-68-9 | Biochemical Assay Reagents |
| HY-W123012 | APN-Azide | 1643841-88-6 | Reference compound |
| HY-W123015 | 6-Azidohexanoic acid | 79598-53-1 | Natural Products |
| HY-W123017 | 4-Maleimidophenyl isocyanate | 123457-83-0 | Biochemical Assay Reagents |
| HY-W123019 | DBCO-Sulfo-Link-biotin (TEA) | 1485489-28-8 | Reference compound |
| HY-W123023 | 4-(N-Succinimidylcarboxy)benzophenone | 91990-88-4 | Biochemical Assay Reagents |
| HY-W123028 | Sulfo-SANPAH (sodium) | 144672-60-6 | Reference compound |
| HY-W123029 | p-Azidophenacyl bromide | 57018-46-9 | Biochemical Assay Reagents |
| HY-W123031 | 1,8-Bismaleimidotriethyleneglycol | 115597-84-7 | Biochemical Assay Reagents |
| HY-W123052 | Linseed oil | 8001-26-1 | Biochemical Assay Reagents |
| HY-W123056 | Candelilla wax | 8006-44-8 | Biochemical Assay Reagents |
| HY-W124995S | 2-Cyclopropylethan-1-amine-d4 | 1219795-00-2 | Isotope-Labeled Compounds |
| HY-W125014 | Octahydrocyclopenta[c]pyrrole | 5661-03-0 | Reference compound |
| HY-W125188 | 2-Isobutoxyacetic acid | 24133-46-8 | Reference compound |
| HY-W125425 | Methyl piperazine-2-carboxylate | 2758-98-7 | Reference compound |
| HY-W125501 | (2R)-2-[(3,5-Dinitrobenzoyl)amino]-2-phenyl-acetic acid | 74927-72-3 | Peptides |
| HY-W125504 | AEEA-AEEA | 1143516-05-5 | ADC Related |
| HY-W127316 | Cholesteryl trans-9-hexadecenoate | 102679-72-1 | Biochemical Assay Reagents |
| HY-W127317 | Inositol 1,3,4,5-tetraphosphate | 102850-29-3 | Biochemical Assay Reagents |
| HY-W127318 | 3-(Hexyloxy)propane-1,2-diol | 10305-38-1 | Biochemical Assay Reagents |
| HY-W127319 | Erucic anhydride | 103213-60-1 | Biochemical Assay Reagents |
| HY-W127320 | (Z)-3-Nonen-1-ol | 10340-23-5 | Biochemical Assay Reagents |
| HY-W127321 | L-α-Phosphatidylcholine β-(pyren-1-yl)hexanoyl-γ-palmitoyl | 103625-33-8 | Biochemical Assay Reagents |
| HY-W127322 | 2,3,4,6-Tetra-O-acetyl-PtdGlc(di-acyl Chain) | 1037195-49-5 | Biochemical Assay Reagents |
| HY-W127323 | cis-9-Hexadecenol | 10378-01-5 | Biochemical Assay Reagents |
| HY-W127324 | Ganglioside GM3 (phyto-type) | 1046791-63-2 | Biochemical Assay Reagents |
| HY-W127325 | 2-Nitrophenyl palmitate | 104809-26-9 | Biochemical Assay Reagents |
| HY-W127326 | 2-Nitrophenyl stearate | 104809-27-0 | Biochemical Assay Reagents |
| HY-W127328 | 3-O-Hexadecyl-sn-glycerol | 10550-58-0 | Biochemical Assay Reagents |
| HY-W127329 | 12-Hydroxystearic acid | 106-14-9 | Reference compound |
| HY-W127329R | 12-Hydroxystearic acid (Standard) | 106-14-9 | Reference Standards |
| HY-W127329S | 12-Hydroxystearic acid-d5 | 2468637-39-8 | Isotope-Labeled Compounds |
| HY-W127329S1 | 2-Hydroxy-Octadecanoic acid-d34 | Isotope-Labeled Compounds | |
| HY-W127330 | Butyl Laurate | 106-18-3 | Biochemical Assay Reagents |
| HY-W127331 | Cholesterol hexanoate | 1062-96-0 | Biochemical Assay Reagents |
| HY-W127332 | 6-OAc PtdGlc(di-acyl Chain) | 1065483-61-5 | Biochemical Assay Reagents |
| HY-W127334 | N-Palmitoyl phosphatidylethanolamine | 108321-22-8 | Biochemical Assay Reagents |
| HY-W127335 | Lauryl palmitoleate | 108321-49-9 | Biochemical Assay Reagents |
| HY-W127336 | (E)-12-hydroxyoctadec-9-enoic acid (sodium) | 108321-51-3 | Biochemical Assay Reagents |
| HY-W127337 | Isobutyl Palmitate | 110-34-9 | Biochemical Assay Reagents |
| HY-W127338 | Butyl Palmitate | 111-06-8 | Biochemical Assay Reagents |
| HY-W127341 | Phytanic acid methyl ester | 1118-77-0 | Biochemical Assay Reagents |
| HY-W127342 | Decanoyl chloride | 112-13-0 | Natural Products |
| HY-W127343 | Dodecyl acetate | 112-66-3 | Biochemical Assay Reagents |
| HY-W127344 | Oleoyl Chloride | 112-77-6 | Biochemical Assay Reagents |
| HY-W127346 | Pentaerythrityl tetrastearate | 115-83-3 | Biochemical Assay Reagents |
| HY-W127347 | 1,2-Dioleoyl-sn-glycero-3-phosphoric acid (disodium) | 116004-31-0 | Biochemical Assay Reagents |
| HY-W127348 | Cholesteryl heptanoate | 1182-07-6 | Biochemical Assay Reagents |
| HY-W127349 | Cholesterol n-Octanoate | 1182-42-9 | Biochemical Assay Reagents |
| HY-W127349R | Cholesterol n-Octanoate (Standard) | 1182-42-9 | Reference Standards |
| HY-W127350 | Cholesterol Pelargonate | 1182-66-7 | Biochemical Assay Reagents |
| HY-W127351 | Cholesterol decanoate | 1183-04-6 | Biochemical Assay Reagents |
| HY-W127352 | Docosapentaenoic acid ethyl ester | 119818-40-5 | Biochemical Assay Reagents |
| HY-W127354 | N-Tetracosanoyl-D-sphingosine 1-benzoate | 123446-98-0 | Biochemical Assay Reagents |
| HY-W127355 | Kdo2-Lipid A | 123621-04-5 | Biochemical Assay Reagents |
| HY-W127356 | (Rac)-1,2-Distearoyl-3-chloropropanediol-d5 | 1246818-85-8 | Isotope-Labeled Compounds |
| HY-W127357 | Tripelargonin | 126-53-4 | Biochemical Assay Reagents |
| HY-W127358 | Behenyl oleate | 127566-70-5 | Biochemical Assay Reagents |
| HY-W127359 | (S)-1,2-Dilauroyl-sn-glycero-3-phosphocholine | 127641-86-5 | Biochemical Assay Reagents |
| HY-W127360 | Sialyl Neolactotetraosylceramide | 128529-29-3 | Biochemical Assay Reagents |
| HY-W127362 | 8-Nonen-1-ol | 13038-21-6 | Biochemical Assay Reagents |
| HY-W127363 | (Rac)-1,2-Dihexadecylglycerol | 13071-60-8 | Biochemical Assay Reagents |
| HY-W127364 | Pentaerythritol distearate (mixture) | 13081-97-5 | Biochemical Assay Reagents |
| HY-W127365 | Dimethyl-DL-2,3-distearoyloxypropyl(2-hydroxyethyl)ammonium (acetate) | 13106-14-4 | Biochemical Assay Reagents |
| HY-W127366 | 7-Octen-1-ol | 13175-44-5 | Biochemical Assay Reagents |
| HY-W127367 | Sodium eicosyl sulfate | 13177-49-6 | Biochemical Assay Reagents |
| HY-W127368 | 2-Linoleoyl-1-palmitoyl-sn-glycero-3-phosphoethanolamine | 13206-00-3 | Biochemical Assay Reagents |
| HY-W127369 | 1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine | 132213-85-5 | Reference compound |
| HY-W127370 | cis-7,10,13,16-Docosatetraenoic acid methyl ester | 13487-42-8 | Biochemical Assay Reagents |
| HY-W127371 | 1,4-Cyclohexanedimethanol Dilaurate | 135025-34-2 | Biochemical Assay Reagents |
| HY-W127372 | DL-1,3-Dihydroxy-2-amino-octadecane | 13552-09-5 | Biochemical Assay Reagents |
| HY-W127373 | Methyl O-Acetylricinoleate | 140-03-4 | Biochemical Assay Reagents |
| HY-W127374 | Ethyl heptadecanoate | 14010-23-2 | Biochemical Assay Reagents |
| HY-W127375 | Sodium nonanoate | 14047-60-0 | Biochemical Assay Reagents |
| HY-W127376 | Methyl 12-hydroxystearate | 141-23-1 | Biochemical Assay Reagents |
| HY-W127376R | Methyl 12-hydroxystearate (Standard) | 141-23-1 | Reference Standards |
| HY-W127377 | Butyl oleate | 142-77-8 | Biochemical Assay Reagents |
| HY-W127378 | DOTAP (methylsulfate) | 144189-73-1 | Biochemical Assay Reagents |
| HY-W127379 | Methyl petroselaidate | 14620-36-1 | Biochemical Assay Reagents |
| HY-W127380 | Arachidonoyl thio-PC | 146797-82-2 | Biochemical Assay Reagents |
| HY-W127382 | Butyl ricinoleate | 151-13-3 | Biochemical Assay Reagents |
| HY-W127383 | N-Stearoyl-DL-dihydrolactocerebroside | 15373-20-3 | Biochemical Assay Reagents |
| HY-W127384 | 3-Decenoic acid | 15469-77-9 | Biochemical Assay Reagents |
| HY-W127386 | 1-O-Dodecylglycerol | 1561-07-5 | Biochemical Assay Reagents |
| HY-W127387 | (Z,Z,Z)-17-Bromo-3,6,9-heptadecatriene | 156559-07-8 | Biochemical Assay Reagents |
| HY-W127388 | DHOG | 161466-45-1 | Biochemical Assay Reagents |
| HY-W127389 | Decyl decanoate | 1654-86-0 | Biochemical Assay Reagents |
| HY-W127390 | Nonanoic anhydride | 1680-36-0 | Biochemical Assay Reagents |
| HY-W127391 | 1,2-Dilaurin | 17598-94-6 | Biochemical Assay Reagents |
| HY-W127392 | Stearyl oleate | 17673-49-3 | Biochemical Assay Reagents |
| HY-W127393 | N-Nonanoyl-L-homoserine lactone | 177158-21-3 | Biochemical Assay Reagents |
| HY-W127395 | Ethyl nonadecanoate | 18281-04-4 | Biochemical Assay Reagents |
| HY-W127396 | Cholesteryl N-(trimethylammonioethyl)carbamate (chloride) | 188022-80-2 | Biochemical Assay Reagents |
| HY-W127398 | trans-2-Heptenal | 18829-55-5 | Biochemical Assay Reagents |
| HY-W127399 | Valeryl Bromide | 1889-26-5 | Biochemical Assay Reagents |
| HY-W127400 | Cholesteryl dodecanoate | 1908-11-8 | Biochemical Assay Reagents |
| HY-W127401 | Triethylene glycol monooctyl ether | 19327-38-9 | Biochemical Assay Reagents |
| HY-W127403 | Cholesteryl elaidate | 19485-76-8 | Biochemical Assay Reagents |
| HY-W127404 | 4-Nitrophenyl decanoate | 1956-09-8 | Biochemical Assay Reagents |
| HY-W127405 | Glycidyl Laurate | 1984-77-6 | Biochemical Assay Reagents |
| HY-W127406 | cis-3-Octen-1-ol | 20125-84-2 | Biochemical Assay Reagents |
| HY-W127407 | Glycerophospho-N-arachidonoyl ethanolamine | 201738-25-2 | Biochemical Assay Reagents |
| HY-W127408 | Tripalmitolein | 20246-55-3 | Biochemical Assay Reagents |
| HY-W127409 | 1,2-Dimyristoyl-rac-glycerol | 20255-94-1 | Biochemical Assay Reagents |
| HY-W127410 | Hexanoic anhydride | 2051-49-2 | Biochemical Assay Reagents |
| HY-W127411 | Methyl trans-3-Pentenoate | 20515-19-9 | Biochemical Assay Reagents |
| HY-W127412 | Decanoic anhydride | 2082-76-0 | Biochemical Assay Reagents |
| HY-W127413 | Palmityl laurate | 20834-06-4 | Biochemical Assay Reagents |
| HY-W127414 | Behenoyl chloride | 21132-76-3 | Natural Products |
| HY-W127415 | rac-1-Stearoyl-3-chloropropanediol | 22094-20-8 | Biochemical Assay Reagents |
| HY-W127416 | Myristyl laurate | 22412-97-1 | Biochemical Assay Reagents |
| HY-W127417 | Behenyl stearate | 22413-03-2 | Biochemical Assay Reagents |
| HY-W127418 | Stearyl arachidate | 22432-79-7 | Biochemical Assay Reagents |
| HY-W127419 | Propylene glycol dilaurate | 22788-19-8 | Biochemical Assay Reagents |
| HY-W127420 | Isopropyl linoleate | 22882-95-7 | Biochemical Assay Reagents |
| HY-W127421 | Isoamyl decanoate | 2306-91-4 | Biochemical Assay Reagents |
| HY-W127422 | Isopropyl decanoate | 2311-59-3 | Biochemical Assay Reagents |
| HY-W127423 | Methyl 2-hydroxyoctadecanoate | 2420-35-1 | Biochemical Assay Reagents |
| HY-W127424 | Stearyl behenate | 24271-12-3 | Biochemical Assay Reagents |
| HY-W127425 | Ethyl lignocerate | 24634-95-5 | Biochemical Assay Reagents |
| HY-W127425S1 | Ethyl lignocerate-d4 | Isotope-Labeled Compounds | |
| HY-W127426 | DOTAP (mesylate) | 252769-92-9 | Biochemical Assay Reagents |
| HY-W127427 | Heptanoyl chloride | 2528-61-2 | Natural Products |
| HY-W127428 | Pentyl isovalerate | 25415-62-7 | Biochemical Assay Reagents |
| HY-W127430 | Stearyl palmitate | 2598-99-4 | Biochemical Assay Reagents |
| HY-W127431 | Methyl (3α,5α)-3-(acetyloxy)-6-oxocholan-24-oate | 2616-79-7 | Biochemical Assay Reagents |
| HY-W127433 | Isostearic acid | 2724-58-5 | Natural Products |
| HY-W127433R | Isostearic acid (Standard) | 2724-58-5 | Reference Standards |
| HY-W127434 | 1,12-Octadecanediol | 2726-73-0 | Biochemical Assay Reagents |
| HY-W127434A | (12R)-1,12-Octadecanediol | 1466461-81-3 | Biochemical Assay Reagents |
| HY-W127435 | Methyl vernolate | 2733-91-7 | Biochemical Assay Reagents |
| HY-W127436 | Methyl cis-6-Octadecenoate | 2777-58-4 | Biochemical Assay Reagents |
| HY-W127436R | Methyl cis-6-Octadecenoate (Standard) | 2777-58-4 | Reference Standards |
| HY-W127437 | Stearyl Stearate | 2778-96-3 | Biochemical Assay Reagents |
| HY-W127438 | Monoerucin | 28063-42-5 | Biochemical Assay Reagents |
| HY-W127439 | Ethyl Tridecanoate | 28267-29-0 | Biochemical Assay Reagents |
| HY-W127440 | i-Cholesteryl methyl ether | 2867-93-8 | Biochemical Assay Reagents |
| HY-W127441 | Nonenylsuccinic anhydride | 28928-97-4 | Biochemical Assay Reagents |
| HY-W127442 | Etzadroxil | 2983-38-2 | Reference compound |
| HY-W127442R | Etzadroxil (Standard) | 2983-38-2 | Reference Standards |
| HY-W127443 | 3-Heptenoic acid | 29901-85-7 | Biochemical Assay Reagents |
| HY-W127444 | N,N-Dimethyldodecanamide | 3007-53-2 | Biochemical Assay Reagents |
| HY-W127445 | Behenamide | 3061-75-4 | Biochemical Assay Reagents |
| HY-W127446 | Cholesteryl 10-undecenoate | 30948-01-7 | Biochemical Assay Reagents |
| HY-W127447 | Maleate trihydrate (sodium) | 3105-55-3 | Biochemical Assay Reagents |
| HY-W127448 | 1-Tricosanol | 3133-01-5 | Biochemical Assay Reagents |
| HY-W127449 | trans-2-Nonen-1-ol | 31502-14-4 | Biochemical Assay Reagents |
| HY-W127451 | trans-2-Hepten-1-ol | 33467-76-4 | Biochemical Assay Reagents |
| HY-W127452 | Undecylenate (sodium) | 3398-33-2 | Biochemical Assay Reagents |
| HY-W127455 | Ethyl petroselaidate | 34302-53-9 | Biochemical Assay Reagents |
| HY-W127456 | 1-Stearoyl-2-linoleoyl-sn-glycerol | 34487-26-8 | Biochemical Assay Reagents |
| HY-W127457 | 1,2-Dihexanoyl-sn-glycero-3-phosphocholine | 34506-67-7 | Biochemical Assay Reagents |
| HY-W127457S | 1,2-Dihexanoyl-sn-glycero-3-phosphocholine-d22 | 328946-18-5 | Isotope-Labeled Compounds |
| HY-W127458 | Tin(II) palmitate | 35104-88-2 | Biochemical Assay Reagents |
| HY-W127459 | 2,3-Dipalmitoyl-sn-glycero-1-phosphocholine, 95% | 35418-55-4 | Biochemical Assay Reagents |
| HY-W127459A | 2,3-Dipalmitoyl-sn-glycero-1-phosphocholine, 99% | 35418-55-4 | Biochemical Assay Reagents |
| HY-W127460 | Azelaoyl PAF | 354583-69-0 | Biochemical Assay Reagents |
| HY-W127461 | Ganglioside GM2, Asialo | 35960-33-9 | Biochemical Assay Reagents |
| HY-W127462 | Lauryl oleate | 36078-10-1 | Biochemical Assay Reagents |
| HY-W127463 | 1,2-O,O-Ditetradecyl-rac-glycerol | 36314-51-9 | Biochemical Assay Reagents |
| HY-W127464 | Arachidyl Laurate | 36617-18-2 | Biochemical Assay Reagents |
| HY-W127465 | Oleyl Ricinoleate | 36781-75-6 | Biochemical Assay Reagents |
| HY-W127466 | Oleyl oleate | 3687-45-4 | Biochemical Assay Reagents |
| HY-W127468 | 2-Nonenoic Acid | 3760-11-0 | Biochemical Assay Reagents |
| HY-W127469 | Isobutyl Laurate | 37811-72-6 | Biochemical Assay Reagents |
| HY-W127470 | 10-Undecenoyl chloride | 38460-95-6 | Natural Products |
| HY-W127471 | Heptadecanoyl chloride | 40480-10-2 | Natural Products |
| HY-W127472 | Methyl nonacosanoate | 4082-55-7 | Biochemical Assay Reagents |
| HY-W127473 | Methyl lesquerolate | 4102-96-9 | Biochemical Assay Reagents |
| HY-W127474 | Ethyl pentadecanoate | 41114-00-5 | Biochemical Assay Reagents |
| HY-W127475 | 6-Hepten-1-ol | 4117-10-6 | Biochemical Assay Reagents |
| HY-W127476 | 3-Nonenoic Acid | 4124-88-3 | Biochemical Assay Reagents |
| HY-W127477 | Triacontyl acetate | 41755-58-2 | Biochemical Assay Reagents |
| HY-W127479 | Dodecyl arachidate | 42232-82-6 | Biochemical Assay Reagents |
| HY-W127480 | Myristyl behenate | 42233-09-0 | Biochemical Assay Reagents |
| HY-W127481 | Nonacosanoic Acid | 4250-38-8 | Biochemical Assay Reagents |
| HY-W127482 | Myristoylcholine chloride | 4277-89-8 | Biochemical Assay Reagents |
| HY-W127483 | 19-Iodocholesterol 3-acetate | 4561-90-4 | Biochemical Assay Reagents |
| HY-W127484 | Isopalmitic acid | 4669-02-7 | Natural Products |
| HY-W127485 | cis-9,10-Methyleneoctadecanoic Acid | 4675-61-0 | Biochemical Assay Reagents |
| HY-W127486 | N-3-oxo-Hexadec-11Z-enoyl-L-homoserine lactone | 479050-91-4 | Biochemical Assay Reagents |
| HY-W127487 | N-Octadecanoyl-L-homoserine lactone | 479050-96-9 | Biochemical Assay Reagents |
| HY-W127488 | 5β-Cholestane | 481-20-9 | Biochemical Assay Reagents |
| HY-W127489 | 3-Pentadecylphenol | 501-24-6 | Biochemical Assay Reagents |
| HY-W127490 | Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-β-D-glucopyranoside | 50605-12-4 | Biochemical Assay Reagents |
| HY-W127491 | trans-9-Octadecenol | 506-42-3 | Biochemical Assay Reagents |
| HY-W127492 | Lignoceryl alcohol | 506-51-4 | Biochemical Assay Reagents |
| HY-W127492R | Lignoceryl alcohol (Standard) | 506-51-4 | Reference Standards |
| HY-W127493 | 1-Hexacosanol | 506-52-5 | Biochemical Assay Reagents |
| HY-W127493R | 1-Hexacosanol (Standard) | 506-52-5 | Reference Standards |
| HY-W127494 | 1,2-Distearoyl-rac-glycerol | 51063-97-9 | Biochemical Assay Reagents |
| HY-W127495 | Methyl 10-methylundecanoate | 5129-56-6 | Biochemical Assay Reagents |
| HY-W127496 | Methyl 13-methyltetradecanoate | 5129-59-9 | Biochemical Assay Reagents |
| HY-W127497 | Methyl 12-Methyltetradecanoate | 5129-66-8 | Biochemical Assay Reagents |
| HY-W127498 | Epicoprostanol | 516-92-7 | Natural Products |
| HY-W127498R | Epicoprostanol (Standard) | 516-92-7 | Reference Standards |
| HY-W127498S | Epicoprostanol-d5 | Isotope-Labeled Compounds | |
| HY-W127499 | 1,2-Dierucoyl-sn-glycero-3-phosphocholine | 51779-95-4 | Oligonucleotides |
| HY-W127500 | Ethyl 2-Hydroxybutyrate | 52089-54-0 | Biochemical Assay Reagents |
| HY-W127501 | Prostaglandin G1 | 52162-11-5 | Biochemical Assay Reagents |
| HY-W127502 | 1-Hexadecylglycero-3-phosphate | 52603-03-9 | Biochemical Assay Reagents |
| HY-W127503 | Dodecyl Stearate | 5303-25-3 | Biochemical Assay Reagents |
| HY-W127504 | Sodium ricinoleate | 5323-95-5 | Biochemical Assay Reagents |
| HY-W127504A | Rac-Sodium ricinoleate | 475680-30-9 | Natural Products |
| HY-W127505 | trans-2-Undecenal | 53448-07-0 | Biochemical Assay Reagents |
| HY-W127505S | trans-2-Undecenal-d5 | Isotope-Labeled Compounds | |
| HY-W127506 | Trielaidin | 537-39-3 | Biochemical Assay Reagents |
| HY-W127507 | cis-11-Hexadecenal | 53939-28-9 | Biochemical Assay Reagents |
| HY-W127508 | α,α'-Dilaurin | 539-93-5 | Biochemical Assay Reagents |
| HY-W127510 | Isopropyl octanoate | 5458-59-3 | Biochemical Assay Reagents |
| HY-W127511 | Isobutyl caprylate | 5461-06-3 | Biochemical Assay Reagents |
| HY-W127512 | 5β-Cholanic acid | 546-18-9 | Reference compound |
| HY-W127513 | Methyl heptacosanoate | 55682-91-2 | Biochemical Assay Reagents |
| HY-W127515 | Trans-2,cis-6-Nonadienal | 557-48-2 | Biochemical Assay Reagents |
| HY-W127515R | trans-2,cis-6-Nonadienal (Standard) | 557-48-2 | Reference Standards |
| HY-W127515S | trans-2,cis-6-Nonadienal-13C2 | 1083053-38-6 | Isotope-Labeled Compounds |
| HY-W127516 | trans-5-Decen-1-ol | 56578-18-8 | Biochemical Assay Reagents |
| HY-W127517 | 11-Methyllauric acid | 5681-98-1 | Biochemical Assay Reagents |
| HY-W127518 | cis-4-Decen-1-ol | 57074-37-0 | Biochemical Assay Reagents |
| HY-W127519 | Arachidonoyl chloride | 57303-04-5 | Natural Products |
| HY-W127520 | Butyl octanoate | 589-75-3 | Biochemical Assay Reagents |
| HY-W127521 | trans,trans-2,4-Nonadienal | 5910-87-2 | Biochemical Assay Reagents |
| HY-W127522 | Amyl decanoate | 5933-87-9 | Biochemical Assay Reagents |
| HY-W127523 | p-Tolyl octanoate | 59558-23-5 | Biochemical Assay Reagents |
| HY-W127524 | 8-Methylnonanoic acid | 5963-14-4 | Biochemical Assay Reagents |
| HY-W127525 | 19-Methyleicosanoic acid | 59708-73-5 | Biochemical Assay Reagents |
| HY-W127526 | 2-Nitrophenyl tetradecanoate | 59986-46-8 | Biochemical Assay Reagents |
| HY-W127527 | D-threo-Dihydrosphingosine | 6036-86-8 | Biochemical Assay Reagents |
| HY-W127528 | Cholesterol nervonate | 60758-73-8 | Biochemical Assay Reagents |
| HY-W127529 | 2,3-Dipalmitoyl-sn-glycerol | 6076-30-8 | Biochemical Assay Reagents |
| HY-W127530 | α-Tocopherol phosphate (disodium) | 60934-46-5 | Biochemical Assay Reagents |
| HY-W127530R | α-Tocopherol phosphate (disodium) (Standard) | 60934-46-5 | Reference Standards |
| HY-W127532 | cis-4-Hepten-1-ol | 6191-71-5 | Biochemical Assay Reagents |
| HY-W127532S | cis-4-Hepten-1-ol-d2 | Isotope-Labeled Compounds | |
| HY-W127533 | 1-O-Propyl-rac-glycerol | 61940-71-4 | Biochemical Assay Reagents |
| HY-W127534 | Tricaproin | 621-70-5 | Biochemical Assay Reagents |
| HY-W127534R | Tricaproin (Standard) | 621-70-5 | Reference Standards |
| HY-W127535 | Propyl n-octanoate | 624-13-5 | Biochemical Assay Reagents |
| HY-W127536 | 18-Methylnonadecanoic acid | 6250-72-2 | Biochemical Assay Reagents |
| HY-W127537 | Myristic anhydride | 626-29-9 | Biochemical Assay Reagents |
| HY-W127538 | Methyl 3-hydroxydecanoate | 62675-82-5 | Biochemical Assay Reagents |
| HY-W127539 | Pentadecyl acetate | 629-58-3 | Biochemical Assay Reagents |
| HY-W127540 | Palmityl acetate | 629-70-9 | Biochemical Assay Reagents |
| HY-W127541 | Methyl melissate | 629-83-4 | Biochemical Assay Reagents |
| HY-W127542 | Isoamyl laurate | 6309-51-9 | Biochemical Assay Reagents |
| HY-W127544 | 2-Naphthyl laurate | 6343-73-3 | Biochemical Assay Reagents |
| HY-W127545 | Phenyl stearate | 637-55-8 | Biochemical Assay Reagents |
| HY-W127546 | Methyl 2-oxovalerate | 6376-59-6 | Biochemical Assay Reagents |
| HY-W127547 | Stearic anhydride | 638-08-4 | Biochemical Assay Reagents |
| HY-W127548 | Pentyl octanoate | 638-25-5 | Biochemical Assay Reagents |
| HY-W127549 | Petroselinic acid (sodium) | 6697-77-4 | Biochemical Assay Reagents |
| HY-W127550 | 1,2-Dipalmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) (sodium) | 67232-81-9 | Biochemical Assay Reagents |
| HY-W127554 | trans-2-Tridecen-1-ol | 68480-25-1 | Biochemical Assay Reagents |
| HY-W127556 | 4-Methylumbelliferyl elaidate | 69003-01-6 | Biochemical Assay Reagents |
| HY-W127557 | trans-2-Dodecenol | 69064-37-5 | Biochemical Assay Reagents |
| HY-W127558 | Cholesterol-PEG 600 | 69068-97-9 | Biochemical Assay Reagents |
| HY-W127559 | Ethyl 10-undecenoate | 692-86-4 | Biochemical Assay Reagents |
| HY-W127560 | Methyl 15-methylhexadecanoate | 6929-04-0 | Biochemical Assay Reagents |
| HY-W127561 | Oleyl acetate | 693-80-1 | Biochemical Assay Reagents |
| HY-W127562 | 2-Tridecenoic acid | 6969-16-0 | Biochemical Assay Reagents |
| HY-W127564 | Cholesteryl 9,12-octadecadienoate | 70190-89-5 | Biochemical Assay Reagents |
| HY-W127565 | Hexatetracontane | 7098-24-0 | Biochemical Assay Reagents |
| HY-W127565R | Hexatetracontane (Standard) | 7098-24-0 | Reference Standards |
| HY-W127566 | Heptacosanoic acid | 7138-40-1 | Biochemical Assay Reagents |
| HY-W127567 | 1,2-Dipalmitoyl-sn-glycero-3-phosphate (calcium) | 71640-91-0 | Biochemical Assay Reagents |
| HY-W127569 | Methyl 9(E)-tetradecenoate | 72025-18-4 | Biochemical Assay Reagents |
| HY-W127570 | rac-1,2-Distearoyl-3-chloropropanediol | 72468-92-9 | Biochemical Assay Reagents |
| HY-W127571 | 2-Naphthyl myristate | 7262-80-8 | Biochemical Assay Reagents |
| HY-W127572 | Glycerol-d8 | 7325-17-9 | Isotope-Labeled Compounds |
| HY-W127573 | Ethyl trans-2-decenoate | 7367-88-6 | Biochemical Assay Reagents |
| HY-W127574 | Linoleoyl chloride | 7459-33-8 | Natural Products |
| HY-W127575 | Cholesta-3,5-diene | 747-90-0 | Biochemical Assay Reagents |
| HY-W127576 | Allyl nonanoate | 7493-72-3 | Biochemical Assay Reagents |
| HY-W127577 | Cholesteryl isoamyl ether | 74996-30-8 | Biochemical Assay Reagents |
| HY-W127578 | Glycidyl palmitate | 7501-44-2 | Biochemical Assay Reagents |
| HY-W127578S | Glycidyl Palmitate-d5 | 1794941-80-2 | Isotope-Labeled Compounds |
| HY-W127579 | Cholesterylaniline | 7510-04-5 | Biochemical Assay Reagents |
| HY-W127580 | Thiopalmitic acid | 7530-93-0 | Biochemical Assay Reagents |
| HY-W127581 | N-Lignoceroyldihydrogalactocerebroside | 76334-09-3 | Biochemical Assay Reagents |
| HY-W127582 | Nonanoyl chloride | 764-85-2 | Natural Products |
| HY-W127583 | Ethyl trans-4-decenoate | 76649-16-6 | Biochemical Assay Reagents |
| HY-W127584 | S-(3)-Hydroxymyristic acid, methyl ester | 76835-67-1 | Biochemical Assay Reagents |
| HY-W127585 | Cholesteryl n-valerate | 7726-03-6 | Biochemical Assay Reagents |
| HY-W127586 | 5β-Cholanic acid 3,7-dione methyl ester | 7753-72-2 | Biochemical Assay Reagents |
| HY-W127587 | Sodium Sorbate | 7757-81-5 | Biochemical Assay Reagents |
| HY-W127588 | 1,3-Dimyristoyl-glycerol | 7770-09-4 | Biochemical Assay Reagents |
| HY-W127588S | 1,3-Dimyristoyl-glycerol-d5 | 1246523-63-6 | Isotope-Labeled Compounds |
| HY-W127601 | Lard oil | 8016-28-2 | Biochemical Assay Reagents |
| HY-W127603 | Doconexent (sodium) | 81926-93-4 | Biochemical Assay Reagents |
| HY-W127604 | Sodium myristate | 822-12-8 | Biochemical Assay Reagents |
| HY-W127605 | Stearyl acetate | 822-23-1 | Biochemical Assay Reagents |
| HY-W127606 | Behenyl acetate | 822-26-4 | Biochemical Assay Reagents |
| HY-W127608 | 2-Methoxy-3-octadecoxypropan-1-ol | 84337-43-9 | Biochemical Assay Reagents |
| HY-W127609 | 1-O-Hexadecyl-2-palmitoyl-rac-glycero-3-phosphocholine | 64710-48-1 | Biochemical Assay Reagents |
| HY-W127610 | N-hexadecanoyl-L-Homoserine lactone | 87206-01-7 | Biochemical Assay Reagents |
| HY-W127611 | 3-Isoamyl-6-methyl-2-heptyl myristate | 88332-30-3 | Biochemical Assay Reagents |
| HY-W127616 | β-Sitosterol acetate, 40% (contains Campesterol acetate) | 915-05-9 | Biochemical Assay Reagents |
| HY-W127616A | β-Sitosterol acetate, 95% | 915-05-9 | Biochemical Assay Reagents |
| HY-W127617 | cis-4-Hexen-1-ol | 928-91-6 | Biochemical Assay Reagents |
| HY-W127618 | cis-2-Hexen-1-ol | 928-94-9 | Biochemical Assay Reagents |
| HY-W127619 | Cholesteryl (pyren-1-yl)hexanoate | 96886-70-3 | Biochemical Assay Reagents |
| HY-W127620 | Sulfobetaine-12 | 14933-08-5 | Biochemical Assay Reagents |
| HY-W127621 | Sulfobetaine-8 | 15178-76-4 | Biochemical Assay Reagents |
| HY-W127622 | NDSB 256-4T | 570412-84-9 | Biochemical Assay Reagents |
| HY-W127623 | Tris dodecyl sulfate | 50996-85-5 | Biochemical Assay Reagents |
| HY-W127624 | Brij-C20 | 9004-95-9 | Biochemical Assay Reagents |
| HY-W127624A | PEG 18 cetostearyl ether | 31832-14-1 | Reference compound |
| HY-W127624B | PEG 25 cetostearyl ether | 874945-84-3 | Reference compound |
| HY-W127624C | PEG 20 cetostearyl ether | 198563-32-5 | Reference compound |
| HY-W127624D | PEG 12 cetostearyl ether | 13149-83-2 | Reference compound |
| HY-W127627 | Tween 85 | 9005-70-3 | Biochemical Assay Reagents |
| HY-W127628 | Decyl β-D-glucopyranoside | 58846-77-8 | Biochemical Assay Reagents |
| HY-W127629 | MOBS | 115724-21-5 | Biochemical Assay Reagents |
| HY-W127630 | AMPSO | 68399-79-1 | Biochemical Assay Reagents |
| HY-W127631 | Tetrahexylammonium (hydroxide) | 17756-56-8 | Biochemical Assay Reagents |
| HY-W127633 | 3-(Trifluoromethyl)phenyltrimethylammonium (hydroxide) | 68254-41-1 | Biochemical Assay Reagents |
| HY-W127634 | Benzyltriethylammonium (hydroxide) | 1836-42-6 | Biochemical Assay Reagents |
| HY-W127635 | Tetraethylammonium (fluoride trihydrofluoride) | 42539-97-9 | Biochemical Assay Reagents |
| HY-W127636 | Tetraethylammonium (fluoride tetrahydrofluoride) | 145826-81-9 | Biochemical Assay Reagents |
| HY-W127637 | Tetraamylammonium (chloride) | 4965-17-7 | Biochemical Assay Reagents |
| HY-W127639 | Benzoylcholine (chloride) | 2964-09-2 | Biochemical Assay Reagents |
| HY-W127640 | Phosphocholine (chloride disodium) | 16904-96-4 | Biochemical Assay Reagents |
| HY-W127641 | β-Methylcholine (chloride) | 2382-43-6 | Biochemical Assay Reagents |
| HY-W127641R | β-Methylcholine (chloride) (Standard) | 2382-43-6 | Reference Standards |
| HY-W127642 | Bis(2-hydroxyethyl)dimethylammonium (chloride) | 38402-02-7 | Biochemical Assay Reagents |
| HY-W127643 | (2-Methoxyethoxymethyl)triethylammonium (chloride) | 60043-43-8 | Biochemical Assay Reagents |
| HY-W127644 | Trimethyl[2,3-(dioleyloxy)propyl]ammonium (chloride) | 104162-48-3 | Biochemical Assay Reagents |
| HY-W127647 | Nonyltrimethylammonium (bromide) | 1943-11-9 | Biochemical Assay Reagents |
| HY-W127648 | Heptadecyltrimethylammonium (bromide) | 21424-24-8 | Biochemical Assay Reagents |
| HY-W127649 | 3-(Trifluoromethyl)phenyltrimethylammonium (bromide) | 262608-95-7 | Biochemical Assay Reagents |
| HY-W127650 | Hexyldimethyloctylammonium (bromide) | 187731-26-6 | Biochemical Assay Reagents |
| HY-W127651 | Dimethyldioctylammonium (bromide) | 3026-69-5 | Biochemical Assay Reagents |
| HY-W127652 | Didecyldimethylammonium (bromide) | 2390-68-3 | Biochemical Assay Reagents |
| HY-W127653 | Dimethyldimyristylammonium (bromide) | 68105-02-2 | Biochemical Assay Reagents |
| HY-W127654 | (Ferrocenylmethyl)trimethylammonium (bromide) | 106157-30-6 | Biochemical Assay Reagents |
| HY-W127655 | (Ferrocenylmethyl)dodecyldimethylammonium (bromide) | 98778-40-6 | Biochemical Assay Reagents |
| HY-W127656 | Choline (bromide) | 1927-06-6 | Biochemical Assay Reagents |
| HY-W127656S | Choline-1,1,2,2-d4 (bromide) | 285979-69-3 | Isotope-Labeled Compounds |
| HY-W127656S1 | Choline-d13 (bromide) | 203645-64-1 | Isotope-Labeled Compounds |
| HY-W127656S2 | Choline-d9 (bromide) | 285979-71-7 | Isotope-Labeled Compounds |
| HY-W127657 | Benzoylcholine (bromide) | 24943-60-0 | Biochemical Assay Reagents |
| HY-W127659 | Tetraamylammonium (iodide) | 2498-20-6 | Biochemical Assay Reagents |
| HY-W127660 | Tetrahexylammonium (iodide) | 2138-24-1 | Biochemical Assay Reagents |
| HY-W127661 | Tetraheptylammonium (iodide) | 3535-83-9 | Biochemical Assay Reagents |
| HY-W127662 | Dimethyldioctadecylammonium (iodide) | 7206-39-5 | Biochemical Assay Reagents |
| HY-W127663 | 3-(Trifluoromethyl)phenyltrimethylammonium (iodide) | 27389-57-7 | Biochemical Assay Reagents |
| HY-W127665 | Triethylphenylammonium (iodide) | 1010-19-1 | Biochemical Assay Reagents |
| HY-W127666 | Benzoylcholine (iodide) | 17518-43-3 | Biochemical Assay Reagents |
| HY-W127667 | β-Methylcholine (iodide) | 26112-50-5 | Biochemical Assay Reagents |
| HY-W127668 | Triethylcholine iodide | 5957-17-5 | Biochemical Assay Reagents |
| HY-W127669 | Benzoylthiocholine (iodide) | 10561-14-5 | Biochemical Assay Reagents |
| HY-W127670 | Decamethonium (iodide) | 1420-40-2 | Biochemical Assay Reagents |
| HY-W127671 | Tetramethylammonium (perchlorate) | 2537-36-2 | Biochemical Assay Reagents |
| HY-W127672 | Tetramethylammonium (tetrafluoroborate) | 661-36-9 | Biochemical Assay Reagents |
| HY-W127673 | Tetramethylammonium (hexafluorophosphate) | 558-32-7 | Biochemical Assay Reagents |
| HY-W127674 | Tetramethylammonium (dichloroiodate) | 1838-41-1 | Biochemical Assay Reagents |
| HY-W127676 | Tetraethylammonium (perchlorate) | 2567-83-1 | Biochemical Assay Reagents |
| HY-W127677 | Tetraethylammonium (nitrate) | 1941-26-0 | Biochemical Assay Reagents |
| HY-W127678 | Tetraethylammonium (trifluoromethanesulfonate) | 35895-69-3 | Biochemical Assay Reagents |
| HY-W127679 | Bis(tetrabutylammonium) (dichromate) | 56660-19-6 | Biochemical Assay Reagents |
| HY-W127680 | Tetrabutylammonium (perchlorate) | 1923-70-2 | Biochemical Assay Reagents |
| HY-W127681 | Tetrabutylammonium (dichlorobromide) | 13053-75-3 | Biochemical Assay Reagents |
| HY-W127682 | Tetrabutylammonium (dibromochloride) | 64531-21-1 | Biochemical Assay Reagents |
| HY-W127683 | Tetrabutylammonium (dibromoaurate) | 50481-01-1 | Biochemical Assay Reagents |
| HY-W127684 | Tetrabutylammonium (dibromoiodide) | 15802-00-3 | Biochemical Assay Reagents |
| HY-W127685 | Tetrabutylammonium (dichloroaurate) | 50480-99-4 | Biochemical Assay Reagents |
| HY-W127686 | Tetrabutylammonium (difluorotriphenylstannate) | 139353-88-1 | Biochemical Assay Reagents |
| HY-W127687 | Tetrabutylammonium (dihydrogen trifluoride) | 99337-56-1 | Biochemical Assay Reagents |
| HY-W127688 | Tetrabutylammonium (p-nitrophenoxide) | 3002-48-0 | Biochemical Assay Reagents |
| HY-W127689 | Bis(tetrabutylammonium) (dihydrogen pyrophosphate) | 857447-79-1 | Biochemical Assay Reagents |
| HY-W127690 | TCNDQ (tetrabutylammonium) | 68271-98-7 | Biochemical Assay Reagents |
| HY-W127691 | Tetrabutylammonium (bromodiiodide) | 3419-99-6 | Biochemical Assay Reagents |
| HY-W127692 | Tetrabutylammonium (salicylate) | 22307-72-8 | Biochemical Assay Reagents |
| HY-W127694 | Hexadecyltrimethylammonium (perchlorate) | 6941-37-3 | Biochemical Assay Reagents |
| HY-W127695 | Hexadecyltrimethylammonium (tetrafluoroborate) | 73257-08-6 | Biochemical Assay Reagents |
| HY-W127697 | Benzyltriethylammonium (tetrahydroborate) | 85874-45-9 | Biochemical Assay Reagents |
| HY-W127699 | Propionylcholine (p-toluenesulfonate) | 1866-13-3 | Biochemical Assay Reagents |
| HY-W127700 | N-Ethyl-N-methylpyrrolidinium (tetrafluoroborate) | 117947-85-0 | Biochemical Assay Reagents |
| HY-W127701 | [Bmpip][NTf2] | 623580-02-9 | Biochemical Assay Reagents |
| HY-W127702 | Scopolamine (nitrate) | 6106-46-3 | Biochemical Assay Reagents |
| HY-W127703 | Octadecyl Rhodamine B (chloride) | 65603-19-2 | Dye Reagents |
| HY-W127704 | IR 754 Carboxylic Acid | 2311980-68-2 | Biochemical Assay Reagents |
| HY-W127705 | Quinacrine mustard (dihydrochloride) | 4213-45-0 | Dye Reagents |
| HY-W127706 | 4-Methylumbelliferyl α-L-iduronide (sodium) | 89157-94-8 | Biochemical Assay Reagents |
| HY-W127708 | 4-Methylumbelliferyl α-L-iduronide | 66966-09-4 | Biochemical Assay Reagents |
| HY-W127709 | Chlorophyll b | 519-62-0 | Natural Products |
| HY-W127711 | Fast Blue B Salt, Dye content ~95% | 14263-94-6 | Biochemical Assay Reagents |
| HY-W127712 | 4-Methylumbelliferyl a-L-idopyranosiduronic acid 2-sulphate (disodium) | 1045020-74-3 | Biochemical Assay Reagents |
| HY-W127714 | 1-Pyrenesulfonic acid (sodium) | 59323-54-5 | Biochemical Assay Reagents |
| HY-W127715 | Lucifer Yellow CH (dipotassium salt) | 71206-95-6 | Dye Reagents |
| HY-W127716 | Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 | 136724-73-7 | Dye Reagents |
| HY-W127717 | Fluorinert FC-40 | 51142-49-5 | Biochemical Assay Reagents |
| HY-W127718 | Chrysoidine R | 4438-16-8 | Biochemical Assay Reagents |
| HY-W127719 | Photobiotin (acetate) | 96087-38-6 | Biochemical Assay Reagents |
| HY-W127720 | Cyanine 3 bihexanoic acid dye (potassium) | 762260-71-9 | Dye Reagents |
| HY-W127721 | Tetrasulfophthalocyanine | 33308-41-7 | Dye Reagents |
| HY-W127722 | Direct Red 75 (tetrasodium) | 2829-43-8 | Dye Reagents |
| HY-W127723 | Fluoresceinamine maleic acid monoamide | 75900-74-2 | Dye Reagents |
| HY-W127725 | Thymolphthalexon (tetrasodium) | 62698-55-9 | Dye Reagents |
| HY-W127726 | Allo-inositol | 643-10-7 | Biochemical Assay Reagents |
| HY-W127728 | Tricholine citrate (65% in water) | 546-63-4 | Biochemical Assay Reagents |
| HY-W127729 | Pyridoxine dicaprylate | 106483-04-9 | Biochemical Assay Reagents |
| HY-W127730 | Pyridoxine 3,4-dipalmitate | 992-42-7 | Biochemical Assay Reagents |
| HY-W127731 | Pyridoxylideneisoleucine | 57212-58-5 | Biochemical Assay Reagents |
| HY-W127733 | Glyceryl ascorbate | 1120360-13-5 | Biochemical Assay Reagents |
| HY-W127734 | L-Ascorbic acid, 2,6-dibutanoate | 4337-04-6 | Biochemical Assay Reagents |
| HY-W127735 | 2,6-Di-O-palmitoyl-L-ascorbic acid | 4218-81-9 | Biochemical Assay Reagents |
| HY-W127737 | Methylcobalamin (hydrate) | 288315-09-3 | Biochemical Assay Reagents |
| HY-W127738 | 6-O-Stearoyl-L-ascorbic acid | 10605-09-1 | Biochemical Assay Reagents |
| HY-W127739 | Zineb | 12122-67-7 | Biochemical Assay Reagents |
| HY-W127740 | α-Cetone | 127-51-5 | Biochemical Assay Reagents |
| HY-W127740R | α-Cetone (Standard) | 127-51-5 | Reference Standards |
| HY-W127744 | Chlorophyll a | 479-61-8 | Biochemical Assay Reagents |
| HY-W127744R | Chlorophyll a (Standard) | 479-61-8 | Reference Standards |
| HY-W127745 | Isophytol | 505-32-8 | Biochemical Assay Reagents |
| HY-W127746 | Picrolonic acid | 550-74-3 | Biochemical Assay Reagents |
| HY-W127758 | Alginic acid | 9005-32-7 | Natural Products |
| HY-W127769 | Rose-β-D-Gal | 138182-21-5 | Dye Reagents |
| HY-W127770 | Pararosaniline (hydrochloride) | 569-61-9 | Dye Reagents |
| HY-W127771 | Fast Blue RR Salt | 55663-99-5 | Biochemical Assay Reagents |
| HY-W127772 | Fast Black K Salt | 64071-86-9 | Reference compound |
| HY-W127773 | KNI-1293 Biotin | 2071715-99-4 | Biochemical Assay Reagents |
| HY-W127774 | EDTA (hydrate sodium) | 85715-60-2 | Biochemical Assay Reagents |
| HY-W127775 | Demethyl Rhod-2 AM | 129787-64-0 | Dye Reagents |
| HY-W127776 | Zn(Ⅱ)-EDTA (disodium tetrahydrate) | 176736-49-5 | Biochemical Assay Reagents |
| HY-W127777 | Potassium D-tartrate monobasic | 57341-16-9 | Biochemical Assay Reagents |
| HY-W127778 | Ammonium disodium pentacyanoammineferrate(II) | 36682-41-4 | Biochemical Assay Reagents |
| HY-W127779 | Deferasirox iron complex | 554445-58-8 | Biochemical Assay Reagents |
| HY-W127780 | Rhodamine 6G perchlorate | 13161-28-9 | Biochemical Assay Reagents |
| HY-W127781 | RHOD 2 (triammonium) | 129787-65-1 | Biochemical Assay Reagents |
| HY-W127782 | Aminocaproic nitrilotriacetic acid | 1043881-31-7 | Biochemical Assay Reagents |
| HY-W127783 | N-(2-Hydroxyethyl)iminodiacetic Acid | 93-62-9 | Peptides |
| HY-W127785 | N-ethyl-N-oxido-dodecan-1-amine | 1643-20-5 | Biochemical Assay Reagents |
| HY-W127785R | N-ethyl-N-oxido-dodecan-1-amine (Standard) | 1643-20-5 | Reference Standards |
| HY-W127786 | Hematoporphyrin IX dimethyl ester | 5594-29-6 | Biochemical Assay Reagents |
| HY-W127787 | Tartaric acid (sodium hydrate) | 6131-98-2 | Biochemical Assay Reagents |
| HY-W127788 | 2,4-Diacetyl deuteroporphyrin IX dimethyl ester | 10591-31-8 | Biochemical Assay Reagents |
| HY-W127789 | Ethylenediaminetetraacetic acid (diammonium) | 20824-56-0 | Biochemical Assay Reagents |
| HY-W127790 | Bathophenanthrolinedisulfonic acid (disodium) | 52746-49-3 | Biochemical Assay Reagents |
| HY-W127792 | 4-Amino-D,L-benzylsuccinic Acid | 75043-31-1 | Biochemical Assay Reagents |
| HY-W127793 | EDTA-p-Bromoacetamido benzyl | 81677-64-7 | Biochemical Assay Reagents |
| HY-W127794 | Quin II | 83014-44-2 | Biochemical Assay Reagents |
| HY-W127795 | Fluo-3 (ammonium) | 134907-84-9 | Biochemical Assay Reagents |
| HY-W127796 | BAPTA-APM | 352000-08-9 | Biochemical Assay Reagents |
| HY-W127797 | Zinpyr-4 | 1216690-79-7 | Biochemical Assay Reagents |
| HY-W127798 | [S-Methanethiosulfonylcysteaminyl]ethylenediamine-N,N,N',N'-tetraacetic acid | 832733-28-5 | Biochemical Assay Reagents |
| HY-W127799 | Ethylenediaminetetraacetic acid (dilithium) | 14531-56-7 | Biochemical Assay Reagents |
| HY-W127800 | Etioporphyrin I | 448-71-5 | Biochemical Assay Reagents |
| HY-W127801 | Ethylenediaminetetraacetic acid (trisodium hydrate) | 10378-22-0 | Biochemical Assay Reagents |
| HY-W127802 | (Rac)-EDTA-bromoacetamidophenylmethyl | 84256-91-7 | Biochemical Assay Reagents |
| HY-W127803 | BAPTA tetramethyl ester | 125367-34-2 | Biochemical Assay Reagents |
| HY-W127804 | Tetraacetoxymethyl bis(2-aminoethyl) ether N,N,N',N'-tetraacetic acid | 887407-56-9 | Biochemical Assay Reagents |
| HY-W127805 | Pentacarboxylporphyrin I (dihydrochloride) | 141407-11-6 | Biochemical Assay Reagents |
| HY-W127806 | TPPS (dihydrochloride) | 139050-15-0 | Biochemical Assay Reagents |
| HY-W127807 | TMAP (tetrachloride) | 92739-64-5 | Biochemical Assay Reagents |
| HY-W127808 | Mesobiliverdin | 493-88-9 | Biochemical Assay Reagents |
| HY-W127809 | Chlorin e4 | 550-52-7 | Biochemical Assay Reagents |
| HY-W127810 | 3,3',3''-Nitrilotripropionic Acid | 817-11-8 | Biochemical Assay Reagents |
| HY-W127811 | Ethylenediamine-N,N,N,N-tetraacetic Acid Tetraethyl Ester | 3626-00-4 | Biochemical Assay Reagents |
| HY-W127812 | Phthalate ionophore I | 25777-43-9 | Biochemical Assay Reagents |
| HY-W127813 | Iron(III) octaethylporphine (chloride) | 28755-93-3 | Biochemical Assay Reagents |
| HY-W127814 | Ethylenediamine-N,N′-diglutaric acid | 34747-66-5 | Biochemical Assay Reagents |
| HY-W127815 | Pd(II) Mesoporphyrin IX | 40680-45-3 | Biochemical Assay Reagents |
| HY-W127816 | Cr(III) Protoporphyrin IX (chloride) | 41628-83-5 | Biochemical Assay Reagents |
| HY-W127817 | Sn(IV) meso-tetra (4-pyridyl) porphine (dichloride) | 87261-83-4 | Biochemical Assay Reagents |
| HY-W127818 | Phytic acid (hexabarium) | 90940-73-1 | Biochemical Assay Reagents |
| HY-W127819 | Phenyleneethylenetriamine pentaacetic acid | 126736-75-2 | Biochemical Assay Reagents |
| HY-W127820 | H2TMpyP-2 (chloride) | 129051-18-9 | Dye Reagents |
| HY-W127821 | Pt(II) Octaethylporphine ketone | 1262590-31-7 | Biochemical Assay Reagents |
| HY-W127822 | 5,10,15-Triphenylcorrole | 246231-45-8 | Biochemical Assay Reagents |
| HY-W127823 | 3-Hydroxy-2-(5-hydroxypentyl)chromen-4-one | 267400-83-9 | Biochemical Assay Reagents |
| HY-W127824 | 5,10,15-Tris(4-nitrophenyl)corrole | 326472-00-8 | Biochemical Assay Reagents |
| HY-W127826 | Perfluorododecylthio Tetra Fluorophenyl Porphyrin | 956790-67-3 | Biochemical Assay Reagents |
| HY-W127827 | 5,10,15-Tris(4-tert-butylphenyl) corrole | 958259-08-0 | Biochemical Assay Reagents |
| HY-W127828 | t-Boc-aminocaproicnitrilotriacetic acid | 1039123-88-0 | Biochemical Assay Reagents |
| HY-W127831 | 2-Aminomethyl-15-crown-5 | 83585-56-2 | Biochemical Assay Reagents |
| HY-W127832 | Ru(dpp)3(PF6)2 | 123148-15-2 | Biochemical Assay Reagents |
| HY-W127834 | Disulfiram-d20 | 1216403-88-1 | Reference compound |
| HY-W127835 | EDTA (iron sodium hydrate) | 149022-26-4 | Biochemical Assay Reagents |
| HY-W127836 | EDTA-(S)-1-(4-Aminoxyacetamidobenzyl) | 1217704-71-6 | Biochemical Assay Reagents |
| HY-W127837 | 2-Aminooxyethyliminodiacetic acid (hydrochloride) | 156491-84-8 | Biochemical Assay Reagents |
| HY-W127838 | (+)-3-(Trifluoroacetyl)camphor | 51800-98-7 | Biochemical Assay Reagents |
| HY-W127839 | EDTA (dipotassium magnesium) | 15708-48-2 | Biochemical Assay Reagents |
| HY-W127840 | Ethylene-d4-diamine | 37164-19-5 | Isotope-Labeled Compounds |
| HY-W127841 | Citric acid-2,4-13C2 | 121633-50-9 | Isotope-Labeled Compounds |
| HY-W127842 | N,N-Dimethyldecylamine N-oxide | 2605-79-0 | Biochemical Assay Reagents |
| HY-W127843 | Mag-Indo-1 tetrapotassium salt | 132299-21-9 | Dye Reagents |
| HY-W127846 | 4',4''(5'')-Di-tert-butyldibenzo-18-crown-6 | 29471-17-8 | Biochemical Assay Reagents |
| HY-W127847 | Nitrilotriacetic acid (trisodium salt) | 5064-31-3 | Biochemical Assay Reagents |
| HY-W127848 | 2,4-Octanedione | 14090-87-0 | Biochemical Assay Reagents |
| HY-W127849 | 2'-Deoxymugineic acid | 74235-24-8 | Biochemical Assay Reagents |
| HY-W127850 | 10,10'-Dimethyl-9,9'-biacridinium bis(monomethyl Terephthalate) | 469865-01-8 | Biochemical Assay Reagents |
| HY-W127851 | CLA | 19953-58-3 | Biochemical Assay Reagents |
| HY-W127852 | Red-CLA | 886840-56-8 | Biochemical Assay Reagents |
| HY-W127853 | FCLA | 133118-06-6 | Biochemical Assay Reagents |
| HY-W127854 | Bis(pentafluorophenyl) oxalate | 16536-48-4 | Biochemical Assay Reagents |
| HY-W127900 | 2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-alpha-D-glucopyranose | 14086-90-9 | Biochemical Assay Reagents |
| HY-W128028 | (S)-4-Methyl-2-(methylamino)pentanoic acid hydrochloride | 66866-69-1 | Peptides |
| HY-W128037 | (S)-N-(1-Amino-5-guanidino-1-oxopentan-2-yl)benzamide hydrochloride | 4299-03-0 | Peptides |
| HY-W128112 | 1-(a-D-ribofuranosyl)uracil | 3258-07-9 | Reference compound |
| HY-W128203 | 1-Naphthyl β-D-glucopyranoside | 19939-82-3 | Biochemical Assay Reagents |
| HY-W128222 | 2,4'-Dihydroxydiphenyl sulfone | 5397-34-2 | Reference compound |
| HY-W128255S | 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-methoxyphenol-d5 | Isotope-Labeled Compounds | |
| HY-W128255S1 | 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-methoxyphenol-d3 | Isotope-Labeled Compounds | |
| HY-W128312 | 1,3-Diaminopropane-N,N,N',N'-tetraacetic acid | 1939-36-2 | Biochemical Assay Reagents |
| HY-W128313 | Alpha-(trichloromethyl)benzyl acetate | 90-17-5 | Biochemical Assay Reagents |
| HY-W128333S | 2,3,6-Trimethylphenol-d11 | 347841-83-2 | Isotope-Labeled Compounds |
| HY-W128400 | 3′-Deoxy-3′-fluoroguanosine | 123402-21-1 | Reference compound |
| HY-W128408 | 2-Benzamido-4-(methylthio)butanoic acid | 4703-38-2 | Peptides |
| HY-W128417S | 4-(Dimethylamino)phenacyl bromide-13C2,d6 | Isotope-Labeled Compounds | |
| HY-W128417S1 | 4-(Dimethylamino)phenacyl bromide-d6 | Isotope-Labeled Compounds | |
| HY-W128525 | Menadiol | 481-85-6 | Reference compound |
| HY-W128525R | Menadiol (Standard) | 481-85-6 | Reference Standards |
| HY-W128529 | 2-Naphthyl b-D-galactopyranoside | 33993-25-8 | Biochemical Assay Reagents |
| HY-W128579 | 2-Pyrimidinepropanoic acid | 439108-20-0 | Reference compound |
| HY-W128619 | 3-Aminobenzothioamide | 78950-36-4 | Reference compound |
| HY-W128657S | 3-Chloro-2-hydroxypropanoic acid-13C3 | Isotope-Labeled Compounds | |
| HY-W128788 | 2’-Deoxy-2’-fluoro-b-D-arabinocytidine | 56632-83-8 | Reference compound |
| HY-W128788A | 2’-Deoxy-2’-fluoro-b-D-arabinocytidine (hydrochloride) | 25183-22-6 | Oligonucleotides |
| HY-W128916S | Prasugrel metabolite-d4 | Isotope-Labeled Compounds | |
| HY-W129161 | Acetyl tetrapeptide-3 | 827306-88-7 | Peptides |
| HY-W129181 | Benzyl dodecanoate | 140-25-0 | Biochemical Assay Reagents |
| HY-W129194 | Boc-His(Boc)-OH (DCHA) | 31687-58-8 | Peptides |
| HY-W129233 | Dihydroartemisinin (mixture of α and β isomers) | 131175-87-6 | Reference compound |
| HY-W129359 | 11β-HSD1-IN-8 | 386704-15-0 | Reference compound |
| HY-W129394 | 6-Amino-6-deoxy-β-cyclodextrin | 29390-67-8 | Reference compound |
| HY-W129395 | Mono-(6-p-toluenesulfonyl)-β-cyclodextrin | 67217-55-4 | Biochemical Assay Reagents |
| HY-W129420S | N,N'-(Hexane-1,6-diyl)bis(N-(2,2,6,6-tetramethylpiperidin-4-yl)formamide)-d24 | Isotope-Labeled Compounds | |
| HY-W129441 | N-Acetyl-4-S-cysteaminylphenol | 91281-32-2 | Reference compound |
| HY-W129448 | N-Boc-S-benzyl-D-cysteine | 102830-49-9 | Peptides |
| HY-W129456 | Isaxonine | 4214-72-6 | Reference compound |
| HY-W129470S | Pent-1-en-3-ol-d2 | 397857-00-0 | Isotope-Labeled Compounds |
| HY-W129471 | 2-Pentadecanone | 2345-28-0 | Natural Products |
| HY-W129471R | 2-Pentadecanone (Standard) | 2345-28-0 | Reference Standards |
| HY-W129499 | ADA (sodium) | 7415-22-7 | Biochemical Assay Reagents |
| HY-W129509 | HEPES hemisodium salt, 99%(T) | 103404-87-1 | Biochemical Assay Reagents |
| HY-W129513 | Sorbitan monopalmitate | 26266-57-9 | Biochemical Assay Reagents |
| HY-W129533 | tert-Butyl 1H-indol-4-ylcarbamate | 819850-13-0 | Reference compound |
| HY-W129585 | Trt-Gly-OH | 5893-05-0 | Peptides |
| HY-W129587 | Z-Lys(Z)-OSu | 21160-83-8 | Peptides |
| HY-W129593 | Sorbitan monooctadecanoate | 1338-41-6 | Reference compound |
| HY-W129596 | Policresulen | 101418-00-2 | Reference compound |
| HY-W129633 | 2,6-Dichlorophenolindophenol (sodium hydrate) | 1266615-56-8 | Biochemical Assay Reagents |
| HY-W129661 | Pyrazine-2-carbothioamide | 4604-72-2 | Reference compound |
| HY-W129790 | N-Decylphosphorylcholine, 98% | 70504-28-8 | Biochemical Assay Reagents |
| HY-W129818S | 1-(4-Chlorophenyl)biguanide-d4 hydrochloride | 1794816-89-9 | Isotope-Labeled Compounds |
| HY-W129833 | H-Asp-Gly-OH | 3790-51-0 | Reference compound |
| HY-W129869 | Biotin sulfoxide | 3376-83-8 | Biochemical Assay Reagents |
| HY-W129872 | Thalidomide-5-CH2-NH2 (hydrochloride) | 1010100-22-7 | Reference compound |
| HY-W129975 | Boric anhydride,99.98% trace metals basis | 1303-86-2 | Biochemical Assay Reagents |
| HY-W129988 | Sorbitan monododecanoate | 1338-39-2 | Biochemical Assay Reagents |
| HY-W130025 | p-Xylene bis(pyridinium bromide) | 14208-10-7 | Reference compound |
| HY-W130052 | D-Lyxono-1,4-lactone | 15384-34-6 | Biochemical Assay Reagents |
| HY-W130074 | α-Pinene oxide | 1686-14-2 | Natural Products |
| HY-W130128 | m-Methyl red | 20691-84-3 | Biochemical Assay Reagents |
| HY-W130177 | Iodocholine iodide | 28508-22-7 | Reference compound |
| HY-W130190 | Iomeprol hydrolysate-1 | 31127-80-7 | Reference compound |
| HY-W130190R | Iomeprol hydrolysate-1 (Standard) | 31127-80-7 | Reference Standards |
| HY-W130204 | N-Acetyl-2′-deoxycytidine | 32909-05-0 | Reference compound |
| HY-W130212 | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid | 352523-15-0 | Peptides |
| HY-W130232 | Diformylphloroglucinol | 4396-13-8 | Natural Products |
| HY-W130236 | Methylene Violet 3RAX | 4569-86-2 | Reference compound |
| HY-W130303S | Diacetamide-d7 | 33945-50-5 | Isotope-Labeled Compounds |
| HY-W130305S | 1-Iodooctane-d17 | 340256-37-3 | Isotope-Labeled Compounds |
| HY-W130305S1 | 1-Iodooctane-d2 | 89232-08-6 | Isotope-Labeled Compounds |
| HY-W130307 | Tricosane | 638-67-5 | Natural Products |
| HY-W130307R | Tricosane (Standard) | 638-67-5 | Reference Standards |
| HY-W130307S | Tricosane-d48 | 203784-75-2 | Isotope-Labeled Compounds |
| HY-W130309 | H-Pro-Ala-OH | 6422-36-2 | Reference compound |
| HY-W130354 | Cucurbituril | 80262-44-8 | Biochemical Assay Reagents |
| HY-W130364 | H-Pro-Asp-OH | 85227-98-1 | Reference compound |
| HY-W130397 | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid | 941296-80-6 | Peptides |
| HY-W130431 | Tetramethylammonium (acetate hydrate) | 1266615-86-4 | Biochemical Assay Reagents |
| HY-W130442 | N-Isopropyl-N'-phenyl-p-phenylenediamine | 101-72-4 | Reference compound |
| HY-W130466 | N4-Methylcytidine | 10578-79-7 | Reference compound |
| HY-W130478S | 1-Phenylhexane-d5 | 1219799-07-1 | Isotope-Labeled Compounds |
| HY-W130500A | Ethylene glycol monohexyl ether, 99% | 112-25-4 | Biochemical Assay Reagents |
| HY-W130532S | 2,4,6-Trifluorbenzyl alcohol-d2 | 2411681-53-1 | Isotope-Labeled Compounds |
| HY-W130607 | Biotinyl-8-amino-3, 6-dioxaoctanoic acid | 1238575-77-3 | Reference compound |
| HY-W130610 | Stearamide | 124-26-5 | Natural Products |
| HY-W130610R | Stearamide (Standard) | 124-26-5 | Reference Standards |
| HY-W130648 | Sodium 2-ethylhexyl sulfate (40% in water) | 126-92-1 | Biochemical Assay Reagents |
| HY-W130828S | 2,3-Diethylpyrazine-d5 | Isotope-Labeled Compounds | |
| HY-W130844 | Fmoc-Thr(tBu)-Thr(Psi(Me, Me)Pro)-OH | 1676104-73-6 | Reference compound |
| HY-W130878 | 4-Octylphenol | 1806-26-4 | Reference compound |
| HY-W130878S | 4-Octylphenol-d17 | 1219794-55-4 | Isotope-Labeled Compounds |
| HY-W130901 | 5-Phenyl-1-pentyne | 1823-14-9 | Reference compound |
| HY-W130929 | Pentaethylene glycol monooctyl ether | 19327-40-3 | Biochemical Assay Reagents |
| HY-W130965 | 1-Formyl-beta-carboline | 20127-63-3 | Natural Products |
| HY-W131101 | Sorbitan tristearate | 26658-19-5 | Biochemical Assay Reagents |
| HY-W131122 | 1,3,4-Oxadiazole | 288-99-3 | Reference compound |
| HY-W131135 | Butyl decanoate | 30673-36-0 | Reference compound |
| HY-W131155 | Stearyl myristate | 3234-81-9 | Natural Products |
| HY-W131158S | 2-(2-Ethoxyphenoxy)acetic acid-d5 | 2708280-58-2 | Isotope-Labeled Compounds |
| HY-W131180S | 2,3,5,6-Tetrachloroaniline-d3 | 1219806-05-9 | Isotope-Labeled Compounds |
| HY-W131227 | Ethyl 3,5-dihydroxybenzoate | 4142-98-7 | Reference compound |
| HY-W131282 | Antimalarial agent 39 | 5407-57-8 | Reference compound |
| HY-W131296 | Ethyl 4-Methyloctanoate | 56196-53-3 | Natural Products |
| HY-W131302 | Ethylenediaminediacetic acid | 5657-17-0 | Reference compound |
| HY-W131303 | 6-N-Hydroxylaminopurine | 5667-20-9 | Reference compound |
| HY-W131351 | N-Heptadecane | 629-78-7 | Natural Products |
| HY-W131351R | N-Heptadecane (Standard) | 629-78-7 | Reference Standards |
| HY-W131351S | N-heptadecane-d36 | 39756-35-9 | Isotope-Labeled Compounds |
| HY-W131352 | Hexacosane | 630-01-3 | Natural Products |
| HY-W131352R | Hexacosane (Standard) | 630-01-3 | Reference Standards |
| HY-W131352S | N-Hexacosane-d54 | 1219803-91-4 | Isotope-Labeled Compounds |
| HY-W131353 | Hexatriacontane | 630-06-8 | Natural Products |
| HY-W131353R | Hexatriacontane (Standard) | 630-06-8 | Reference Standards |
| HY-W131353S | Hexatriacontane-d74 | 16416-34-5 | Isotope-Labeled Compounds |
| HY-W131398 | D,L-Azatryptophan (hydrate) | 7146-37-4 | Peptides |
| HY-W131444 | Insecticidal agent 15 | 790-75-0 | Reference compound |
| HY-W131494S | (N)-Methyl omeprazole-d3 | Isotope-Labeled Compounds | |
| HY-W131541 | N-Boc-undecane-1,11-diamine | 937367-26-5 | Reference compound |
| HY-W131725 | (+)-Norfenfluramine | 19036-73-8 | Reference compound |
| HY-W131753 | 2'-F-Ac-C | 159414-97-8 | Reference compound |
| HY-W131797 | 1-Iodoethane-1,1,2,2,2-d5 | 6485-58-1 | Isotope-Labeled Compounds |
| HY-W131845 | Ethephon | 16672-87-0 | Biochemical Assay Reagents |
| HY-W131845R | Ethephon (Standard) | 16672-87-0 | Reference Standards |
| HY-W131845S | Ethephon-d4 | 1020719-29-2 | Isotope-Labeled Compounds |
| HY-W131866 | Methyl acetyl-L-lysinate hydrochloride | 20911-93-7 | Peptides |
| HY-W132960 | 2-Carboxythiophene-3-boronic acid | 5503-74-2 | Reference compound |
| HY-W133627 | dCeMM1 | 118719-16-7 | Reference compound |
| HY-W133891 | Peptone from soya | 91079-46-8 | Biochemical Assay Reagents |
| HY-W133892 | Acetylcellulose | 9004-35-7 | Biochemical Assay Reagents |
| HY-W133894 | Cedar oil | 8000-27-9 | Biochemical Assay Reagents |
| HY-W133897 | tert-Butylamine borane | 7337-45-3 | Reference compound |
| HY-W133898 | Tryptone | 73049-73-7 | Biochemical Assay Reagents |
| HY-W133908S | Chlorocyclohexane-d11 | 119206-70-1 | Isotope-Labeled Compounds |
| HY-W133912 | Bismuth (potassium iodide) | 41944-01-8 | Biochemical Assay Reagents |
| HY-W133919 | Aniline Blue (sodium) | 28631-66-5 | Dye Reagents |
| HY-W133919A | Aniline blue (alcohol soluble) | 8004-91-9 | Biochemical Assay Reagents |
| HY-W133920 | Polypropylene glycol 2000 | 25322-69-4 | Biochemical Assay Reagents |
| HY-W133934A | EDTA magnesium disodium,99% | 14402-88-1 | Biochemical Assay Reagents |
| HY-W133950 | Diethylene glycol monohexyl ether | 112-59-4 | Biochemical Assay Reagents |
| HY-W133953 | 1-Methoxy-2-propyl acetate | 108-65-6 | Biochemical Assay Reagents |
| HY-W133954 | Sodium metaborate tetrahydrate, 99% | 10555-76-7 | Biochemical Assay Reagents |
| HY-W133962 | Potassium L-tartaric acid | 921-53-9 | Biochemical Assay Reagents |
| HY-W133963 | Carboxyl methylstarch (sodium) | 9063-38-1 | Biochemical Assay Reagents |
| HY-W133967 | Calcium alginate | 9005-35-0 | Reference compound |
| HY-W133974 | Beeswax | 8012-89-3 | Biochemical Assay Reagents |
| HY-W133982 | Corn steep powder | 66071-94-1 | Biochemical Assay Reagents |
| HY-W133986 | Potassium stearate, 98% | 593-29-3 | Biochemical Assay Reagents |
| HY-W133986S | Stearate-d2 (potassium) | 352438-86-9 | Isotope-Labeled Compounds |
| HY-W133986S1 | Stearate-d35 (potassium) | 352438-89-2 | Isotope-Labeled Compounds |
| HY-W133997 | Chromotrope 2R | 4197-07-3 | Dye Reagents |
| HY-W134002 | Ammonium bismuth citrate, 99% | 31886-41-6 | Biochemical Assay Reagents |
| HY-W134004 | L-Tartaric acid (ammonium) | 3095-65-6 | Biochemical Assay Reagents |
| HY-W134005 | Mg(Ⅱ)-EDTA (disodium tetrahydrate) | 29932-54-5 | Biochemical Assay Reagents |
| HY-W134007S | Hexadecanoate-13C (potassium ) | 201612-58-0 | Isotope-Labeled Compounds |
| HY-W134007S1 | Hexadecanoate-13C16 (potassium) | 1458714-74-3 | Isotope-Labeled Compounds |
| HY-W134007S2 | Hexadecanoate-d2 (potassium) | 203805-86-1 | Isotope-Labeled Compounds |
| HY-W134007S3 | Hexadecanoate-d31 (potassium) | 63074-47-5 | Isotope-Labeled Compounds |
| HY-W134020 | Semixylenol orange | 19329-67-0 | Biochemical Assay Reagents |
| HY-W134021 | Manganese dihydrogen phosphate | 18718-07-5 | Biochemical Assay Reagents |
| HY-W134051 | 3,4-Di-O-acetyl-L-rhamnal | 34819-86-8 | Biochemical Assay Reagents |
| HY-W134072 | Tetrasodium glutamate diacetate,46% in water | 51981-21-6 | Reference compound |
| HY-W134141 | 2,3,4,6-Tetra-O-benzyl-D-galactopyranose | 6386-24-9 | Biochemical Assay Reagents |
| HY-W134163S | (E)-Oct-2-enal-d2 | 1335401-75-6 | Isotope-Labeled Compounds |
| HY-W134259S | Triphenyltin chloride-d15 | 358731-94-9 | Isotope-Labeled Compounds |
| HY-W134301 | Aluminum potassium sulfate | 10043-67-1 | Reference compound |
| HY-W134309 | Nickel(II) carbonate (hydroxide tetrahydrate) | 12244-51-8 | Biochemical Assay Reagents |
| HY-W134326 | Polydextrose | 68424-04-4 | Biochemical Assay Reagents |
| HY-W134327 | DEAE-dextran (MW 40000) | 9015-73-0 | Biochemical Assay Reagents |
| HY-W134327A | DEAE-dextran (MW 500000) | 9015-73-0 | Biochemical Assay Reagents |
| HY-W134328 | Blue dextran (MW 2000000) | 87915-38-6 | Biochemical Assay Reagents |
| HY-W134389 | Potassium p-toluenethiosulfonate, 98% | 28519-50-8 | Biochemical Assay Reagents |
| HY-W134402 | Osmium(III) chloride hydrate | 14996-60-2 | Reference compound |
| HY-W134422 | (1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol X-114 | 9036-19-5 | Biochemical Assay Reagents |
| HY-W134423 | Agar, microbiology tested, for cell culture (powder) | 9002-18-0 | Biochemical Assay Reagents |
| HY-W134423A | Agar, microbiology tested, for cell culture (granular) | 9002-18-0 | Biochemical Assay Reagents |
| HY-W134423B | Agar, meets USP testing specifications | 9002-18-0 | Biochemical Assay Reagents |
| HY-W134546S | Dicamba methyl ester-d6 | Isotope-Labeled Compounds | |
| HY-W140203 | 2-(2′-Hydroxyphenyl)benzimidazole | 2963-66-8 | Dye Reagents |
| HY-W140227 | (Z,Z)-4,7-Decadienol | 104188-11-6 | Natural Products |
| HY-W140236 | Quinhydrone | 106-34-3 | Biochemical Assay Reagents |
| HY-W140249 | Angiogenin Fragment (108-123) | 112173-48-5 | Peptides |
| HY-W140282 | Angiotensin II antipeptide | 121379-63-3 | Peptides |
| HY-W140284S | 6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate-d8 (hydrochloride) | 1189719-74-1 | Isotope-Labeled Compounds |
| HY-W140339 | 4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside | 14581-81-8 | Biochemical Assay Reagents |
| HY-W140351 | 2-Methyl-2-thiazoline-4-carboxylic acid (sodium) | 15058-19-2 | Reference compound |
| HY-W140401 | Dimethyl nonanedioate | 1732-10-1 | Natural Products |
| HY-W140401R | Dimethyl nonanedioate (Standard) | 1732-10-1 | Reference Standards |
| HY-W140439 | 1-Oleoyl-sn-glycero-3-phosphocholine | 19420-56-5 | Reference compound |
| HY-W140439S1 | 1-Oleoyl-sn-glycero-3-phosphocholine-d7 | 2097561-13-0 | Isotope-Labeled Compounds |
| HY-W140446 | L-Valyl-L-isoleucine | 20556-14-3 | Reference compound |
| HY-W140465 | L-Homotyrosine | 221243-01-2 | Reference compound |
| HY-W140480 | Monostearyl maleate | 2424-62-6 | Natural Products |
| HY-W140480R | Monostearyl maleate (Standard) | 2424-62-6 | Reference Standards |
| HY-W140488 | 1,2-Didecanoyl-sn-glycero-3-phosphoethanolamine | 253685-27-7 | Biochemical Assay Reagents |
| HY-W140502 | 4-Hexadecylphenol | 2589-78-8 | Reference compound |
| HY-W140535 | Tetrasodium,4-(1,10-phenanthrolin-4-yl)benzenesulfonate,ruthenium((II)) | 301206-84-8 | Dye Reagents |
| HY-W140537 | EDTA diammonium salt hydrate, 97% | 304675-80-7 | Biochemical Assay Reagents |
| HY-W140545S | 3,3',4,4'-Tetrachloro-1,1'-biphenyl-d6 | 93952-23-9 | Isotope-Labeled Compounds |
| HY-W140555 | 5,7-Dimethoxyphthalide | 3465-69-8 | Reference compound |
| HY-W140566S | N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide-d4 | Isotope-Labeled Compounds | |
| HY-W140598S | Triphenylsulfonium-d5 (chloride) | Isotope-Labeled Compounds | |
| HY-W140616 | Ethyl 4'-hydroxy-[1,1'-biphenyl]-4-carboxylate | 50670-76-3 | Reference compound |
| HY-W140713 | (R)-Methyl 3-hydroxytetradecanoate | 76062-97-0 | Natural Products |
| HY-W140731 | Copperoxalate | 814-91-5 | Biochemical Assay Reagents |
| HY-W140740S | Hexabromobenzene-13C6 | 2483735-50-6 | Isotope-Labeled Compounds |
| HY-W140760 | Ceftriaxone (sodium) | 958633-51-7 | Reference compound |
| HY-W140794 | Fmoc-D-Lys(Ivdde)-OH | 1272755-33-5 | Peptides |
| HY-W140799 | Dichloroxylenol | 133-53-9 | Reference compound |
| HY-W140852 | Decanenitrile | 1975-78-6 | Natural Products |
| HY-W140869 | 3-Acetyl-6-bromocoumarin | 2199-93-1 | Reference compound |
| HY-W140881 | (3R,4R)-4-(benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid | 254101-11-6 | Peptides |
| HY-W140883 | Tris[3-(trimethoxysilyl)propyl] isocyanurate | 26115-70-8 | Biochemical Assay Reagents |
| HY-W140887S | 2-Methoxy-4-propylphenol-d3 | Isotope-Labeled Compounds | |
| HY-W140896 | Dodecylheptaglycol | 3055-97-8 | Reference compound |
| HY-W140897 | N6-Benzoyl-2'-deoxyadenosine monohydrate | 305808-19-9 | Reference compound |
| HY-W140900 | Sodium (S)-3-amino-3-carboxypropanoate hydrate | 323194-76-9 | Biochemical Assay Reagents |
| HY-W140928 | Tetrabromophenol blue, IND | 4430-25-5 | Biochemical Assay Reagents |
| HY-W140934 | Tris(4-aminophenyl)methanol | 467-62-9 | Biochemical Assay Reagents |
| HY-W140953 | Acetylthiocholine (chloride) | 6050-81-3 | Biochemical Assay Reagents |
| HY-W140974 | SN-001 | 727699-84-5 | Reference compound |
| HY-W141038S | 2-Ethyl-5-methylpyrazine-d5 | 1335401-80-3 | Isotope-Labeled Compounds |
| HY-W141077 | 1-Nitrosopyrrolidine | 930-55-2 | Biochemical Assay Reagents |
| HY-W141077R | 1-Nitrosopyrrolidine (Standard) | 930-55-2 | Reference Standards |
| HY-W141077S | 1-Nitrosopyrrolidine-d8 | 1219802-09-1 | Isotope-Labeled Compounds |
| HY-W141127 | 1-(Bromomethyl)pyrene | 2595-90-6 | Reference compound |
| HY-W141338 | 2′-Bromo-2′-deoxyuridine | 4753-02-0 | Reference compound |
| HY-W141374 | CB096 | 108883-90-5 | Reference compound |
| HY-W141392 | 2'-Fluoro-5'-O-DMT-2'-deoxyinosine-3'-CE-phosphoramidite | 2245842-16-2 | Reference compound |
| HY-W141393 | 2'-OMe-dmf-G-CE-Phosphoramidite | 128219-77-2 | Reference compound |
| HY-W141394 | Bz-OMe-rA | 85079-00-1 | Reference compound |
| HY-W141589 | (R)-3-Aminopiperidin-2-one | 88763-76-2 | Reference compound |
| HY-W141704 | N-(3-Aminopropyl)acetamide | 4078-13-1 | Reference compound |
| HY-W141765 | Fmoc-Cit-PAB-OH | 870487-04-0 | Reference compound |
| HY-W141770 | DL-Phenylmercapturic Acid | 20640-68-0 | Peptides |
| HY-W141770S | DL-Phenylmercapturic acid-d2 | Isotope-Labeled Compounds | |
| HY-W141770S1 | DL-Phenylmercapturic acid-d5 | Isotope-Labeled Compounds | |
| HY-W141771 | N-Acetyl-S-benzyl-D-cysteine | 161512-71-6 | Peptides |
| HY-W141772S | N-Acetyl-S-benzyl-2,3,4,5,6-d5-DL-cysteine | Isotope-Labeled Compounds | |
| HY-W141774 | S-(2-Carboxyethyl)-L-cysteine | 4033-46-9 | Peptides |
| HY-W141779 | Boc-Cys(Npys)-OH | 76880-29-0 | Peptides |
| HY-W141781 | Cysteamine S-phosphate (sodium) | 3724-89-8 | Peptides |
| HY-W141786 | Magnesium L-glutamate | 18543-68-5 | Peptides |
| HY-W141788 | N-Butyryl-DL-homocysteine thiolactone | 39837-08-6 | Peptides |
| HY-W141789 | Pam3-Cys-OH | 87420-41-5 | Peptides |
| HY-W141791 | S-tert-Butylmercapto-L-cysteine | 30044-51-0 | Peptides |
| HY-W141795 | N-Chloroacetyl-DL-phenylalanine | 7765-11-9 | Peptides |
| HY-W141801 | (R)-Boc-2-methyl-β-Phe-OH | 500770-86-5 | Peptides |
| HY-W141810 | 4-Amino-L-phenylalanine (hydrochloride) | 62040-55-5 | Peptides |
| HY-W141812 | Boc-2-methoxy-L-phenylalanine | 143415-63-8 | Peptides |
| HY-W141814 | Boc-D-Pen(Mob)-OH | 106306-57-4 | Peptides |
| HY-W141815 | Boc-Pen(Mob)-OH | 120944-75-4 | Peptides |
| HY-W141817 | Fmoc-D-Phe(2,4-Cl2)-OH | 352351-61-2 | Peptides |
| HY-W141820 | Fmoc-Phe(bis-Boc-4-guanidino)-OH | 187283-25-6 | Peptides |
| HY-W141821 | Fmoc-Phe(CF2PO3)-OH | 160751-44-0 | Peptides |
| HY-W141825 | N-Acetyl-DL-phenylalanine β-naphthyl ester | 20874-31-1 | Dye Reagents |
| HY-W141831 | α-Methyl-DL-phenylalanine | 1132-26-9 | Peptides |
| HY-W141835 | N-Chloroacetyl-DL-alanine | 1190-32-5 | Peptides |
| HY-W141842 | 3-(2-Thienyl)-DL-alanine | 2021-58-1 | Peptides |
| HY-W141845 | Boc-3-(3-quinolyl)-DL-Ala-OH | 1100747-96-3 | Peptides |
| HY-W141852 | Dansyl-L-alanine cyclohexylammonium salt | 53332-27-7 | Peptides |
| HY-W141853 | DL-Alanine-2-d1 | 31024-91-6 | Reference compound |
| HY-W141857 | L-Alanine-2-d1 | 21386-65-2 | Reference compound |
| HY-W141858 | N-(3-Indolylacetyl)-L-alanine | 57105-39-2 | Peptides |
| HY-W141858S | N-(3-Indolylacetyl)-L-alanine-d4 | Isotope-Labeled Compounds | |
| HY-W141859 | Phenylalanine-4′-azobenzene HCl | 2137036-84-9 | Peptides |
| HY-W141862 | β-(1,2,4-Triazol-3-yl)-DL-alanine | 10109-05-4 | Peptides |
| HY-W141863 | DL-Methionine Sulfone | 820-10-0 | Peptides |
| HY-W141871 | DL-Thyronine | 1034-10-2 | Biochemical Assay Reagents |
| HY-W141876 | DL-2-Aminopimelic Acid | 627-76-9 | Reference compound |
| HY-W141879 | N-Ethylglycine | 627-01-0 | Peptides |
| HY-W141880 | N-Lauroylglycine | 7596-88-5 | Natural Products |
| HY-W141880S | N-Dodecanoyl-d23-glycine | Isotope-Labeled Compounds | |
| HY-W141881 | N-Lauroylsarcosine | 97-78-9 | Peptides |
| HY-W141885 | N-(4-Hydroxyphenyl)glycine | 122-87-2 | Peptides |
| HY-W141889 | Dansylglycine | 1091-85-6 | Peptides |
| HY-W141891 | N-(2-Cyanoethyl)glycine | 3088-42-4 | Peptides |
| HY-W141893 | N-Formylglycine Ethyl Ester | 3154-51-6 | Peptides |
| HY-W141895 | (R)-(−)-N-Benzyl-2-phenylglycinol | 14231-57-3 | Peptides |
| HY-W141899 | 4-(Trifluoromethyl)-L-phenylglycine | 144789-75-3 | Peptides |
| HY-W141907 | Fmoc-N-(4-Boc-aminobutyl)-Gly-OH | 171856-09-0 | Peptides |
| HY-W141910 | Gly-Ala | 3695-73-6 | Peptides |
| HY-W141911 | Gly-Asp | 4685-12-5 | Peptides |
| HY-W141912 | Glycine sodium salt hydrate | 207300-76-3 | Peptides |
| HY-W141916 | Pentaglycine | 7093-67-6 | Peptides |
| HY-W141918 | Gly-Leu-Tyr | 4306-24-5 | Peptides |
| HY-W141919 | N-(2-Methylbutyryl)glycine | 52320-67-9 | Peptides |
| HY-W141919S | (±)-N-(2-Methylbutyryl)glycine-2,2-d2 | 2469035-10-5 | Isotope-Labeled Compounds |
| HY-W141919S1 | 2-Methylbutyrylglycine-d9 | 1219798-77-2 | Isotope-Labeled Compounds |
| HY-W141922 | N-(Methylsulfonyl)glycine | 35688-18-7 | Peptides |
| HY-W141923 | N-[2-(Fmoc-amino)-ethyl]-Gly-O-tBu hydrochloride | 169396-88-7 | Peptides |
| HY-W141927 | N-Heptanoylglycine | 23783-23-5 | Peptides |
| HY-W141927S | N-Heptanoylglycine-d2 | 3008541-77-0 | Isotope-Labeled Compounds |
| HY-W141928 | N-Isobutyrylglycine | 15926-18-8 | Peptides |
| HY-W141928S | N-Isobutyryl-glycine-d7 | 1330037-23-4 | Isotope-Labeled Compounds |
| HY-W141928S1 | N-Isobutyrylglycine-d2 | 1219795-05-7 | Isotope-Labeled Compounds |
| HY-W141930 | N-Pivaloylglycine | 23891-96-5 | Peptides |
| HY-W141932 | N-Stearoylglycine | 6333-54-6 | Peptides |
| HY-W141933 | N-Succinylglycine | 5694-33-7 | Peptides |
| HY-W141934 | N-Valerylglycine | 24003-66-5 | Peptides |
| HY-W141934S | N-Valerylglycine-d2 | 3008541-76-9 | Isotope-Labeled Compounds |
| HY-W141936 | Phe-Gly | 721-90-4 | Peptides |
| HY-W141940 | DL-2-Methylglutamic acid | 71-90-9 | Peptides |
| HY-W141942 | 4-Fluoro-DL-glutamic acid | 2708-77-2 | Peptides |
| HY-W141944 | Fmoc-Glu(biotinyl-PEG)-OH | 817169-73-6 | Peptides |
| HY-W141945 | Fmoc-Glu(O-2-PhiPr)-OH | 200616-39-3 | Peptides |
| HY-W141946 | Fmoc-Glu(ODmab)-OH | 268730-86-5 | Peptides |
| HY-W141948 | Fmoc-Glu-ODmab | 172611-75-5 | Peptides |
| HY-W141949 | L-Glutamic acid potassium salt monohydrate | 6382-01-0 | Peptides |
| HY-W141952 | N-(4-Aminobenzoyl)-L-glutamic acid diethyl ester | 13726-52-8 | Peptides |
| HY-W141955 | γ-Carboxy-DL-glutamic acid | 56271-99-9 | Peptides |
| HY-W141960 | DL-β-Homomethionine | 158570-14-0 | Peptides |
| HY-W141961 | Fmoc-L-photo-methionine | 945859-89-2 | Peptides |
| HY-W141962 | L-Methionine p-nitroanilide | 6042-04-2 | Peptides |
| HY-W141963 | N-Phthaloyl-DL-methionine | 52881-96-6 | Peptides |
| HY-W141975 | Nε-Formyl-L-lysine | 1190-48-3 | Peptides |
| HY-W141978S | DL-Lysine2-15N (dihydrochloride) | 2747-89-9 | Isotope-Labeled Compounds |
| HY-W141978S1 | DL-Lysine-d8 (dihydrochloride) | 284664-87-5 | Isotope-Labeled Compounds |
| HY-W141978S2 | DL-Lysine-d9 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W141985 | Fmoc-hLys(Boc)-OH | 194718-17-7 | Peptides |
| HY-W141986 | Fmoc-L-Lys(Nvoc)-OH | 150571-28-1 | Peptides |
| HY-W141987 | Fmoc-L-Photo-Lysine | 2250437-42-2 | Peptides |
| HY-W141990 | L-Allysine ethylene acetal | 215054-80-1 | Peptides |
| HY-W142000 | L-Tyrosine Hydrazide | 7662-51-3 | Peptides |
| HY-W142003 | 3-Nitro-L-tyrosine ethyl ester hydrochloride | 66737-54-0 | Peptides |
| HY-W142008 | Fmoc-Tyr(SO3nP)-OH | 878408-63-0 | Peptides |
| HY-W142009 | L-Tyrosine β-naphthylamide | 4357-95-3 | Peptides |
| HY-W142014 | N,O-Didansyl-L-tyrosine (cyclohexylammonium) | 102783-47-1 | Peptides |
| HY-W142015 | Hexa-L-Tyrosine | 6934-38-9 | Peptides |
| HY-W142019 | Benzoyl-DL-leucine | 17966-67-5 | Peptides |
| HY-W142023 | (+)-Men-Leu-OH | 1047650-51-0 | Peptides |
| HY-W142025 | 6-Diazo-5-oxo-D-norleucine | 71629-86-2 | Peptides |
| HY-W142030 | Fmoc-L-photo-leucine | 1360651-24-6 | Peptides |
| HY-W142035 | N-Benzoyl-L-leucine | 1466-83-7 | Peptides |
| HY-W142039 | Z-Nle-OH | 39608-30-5 | Peptides |
| HY-W142044 | 3,4-Dehydro-L-proline methyl ester hydrochloride | 51827-12-4 | Peptides |
| HY-W142047 | Boc-(R)-4-[4-(trifluoromethyl)benzyl]-L-proline | 957311-17-0 | Peptides |
| HY-W142062 | cis-Fmoc-Pro(4-N3)-OH | 263847-08-1 | Peptides |
| HY-W142064 | Fmoc-L-photo-proline | 1266778-58-8 | Peptides |
| HY-W142071 | Tos-Pro-OH | 51077-01-1 | Peptides |
| HY-W142072 | 6-Methyl-DL-tryptophan | 2280-85-5 | Biochemical Assay Reagents |
| HY-W142073 | 7-Methyl-DL-tryptophan | 17332-70-6 | Peptides |
| HY-W142080 | α-Methyl-DL-tryptophan | 153-91-3 | Peptides |
| HY-W142081 | N-(2,4-Dinitrophenyl)-L-serine | 1655-64-7 | Peptides |
| HY-W142083 | DL-3-Phenylserine hydrate | 207605-47-8 | Peptides |
| HY-W142086 | Fmoc-Ser(PO(NHPr)2)-OH | 216061-08-4 | Peptides |
| HY-W142089 | L-Serine (hydrochloride) | 16428-75-4 | Peptides |
| HY-W142092 | N-Acetyl-DL-serine | 97-14-3 | Peptides |
| HY-W142093 | N-Tetradecanoyl-DL-homoserine lactone | 98206-80-5 | Peptides |
| HY-W142107 | O-Phospho-DL-threonine | 27530-80-9 | Peptides |
| HY-W142111 | Boc-Asp-NH2 | 74244-17-0 | Peptides |
| HY-W142113 | DL-Aspartic acid potassium salt | 14434-35-6 | Peptides |
| HY-W142115 | Fmoc-Asp(CSY)-OH | 2379679-90-8 | Peptides |
| HY-W142117 | H-Asp(AMC)-OH | 133628-73-6 | Dye Reagents |
| HY-W142119 | α-Methyl-DL-aspartic acid | 2792-66-7 | Peptides |
| HY-W142120 | β-Asp-Phe methyl ester | 22839-61-8 | Peptides |
| HY-W142126 | N-Carbobenzoxy-DL-norvaline | 21691-43-0 | Peptides |
| HY-W142133 | DL-3-Hydroxynorvaline | 2280-42-4 | Peptides |
| HY-W142139 | (S)-Boc-2-amino-5-azido-pentanoic acid (dicyclohexylammonium) | 1485528-98-0 | Peptides |
| HY-W142140 | N-Methyl-DL-valine | 2566-32-7 | Peptides |
| HY-W142140A | N-Methyl-DL-valine (hydrochloride) | Reference compound | |
| HY-W142151 | N-(3-Indolylacetyl)-L-isoleucine | 57105-45-0 | Peptides |
| HY-W142156 | D-Histidine monohydrochloride | 6341-24-8 | Peptides |
| HY-W142161 | Fmoc-N-Me-His(Trt)-OH | 1217840-61-3 | Peptides |
| HY-W142162 | L-Histidine (dihydrochloride) | 6027-02-7 | Peptides |
| HY-W142163 | L-Histidine β-naphthylamide | 7424-15-9 | Peptides |
| HY-W142169 | N-Formyl-L-histidine | 15191-21-6 | Peptides |
| HY-W142171 | Nα-Fmoc-N(im)-trityl-L-histidine pentafluorophenyl ester | 109434-24-4 | Peptides |
| HY-W142175S | 1-Butynylbenzene-d5 | 1219803-38-9 | Isotope-Labeled Compounds |
| HY-W142194 | Benzyl (5-hydroxypentyl)carbamate | 87905-98-4 | Reference compound |
| HY-W142308 | Diammonium dithiodiglycolate | 68223-93-8 | Biochemical Assay Reagents |
| HY-W142313 | Dodecylethyldimethylammonium bromide (EDDAB), 98%(T) | 68207-00-1 | Biochemical Assay Reagents |
| HY-W142374 | 5-Bromogramine | 830-93-3 | Reference compound |
| HY-W142395 | 6-TAMRA (free acid) | 150322-06-8 | Reference compound |
| HY-W142395S | 6-TAMRA-d12 (free acid) | Isotope-Labeled Compounds | |
| HY-W142410 | 2-Dodecanol | 10203-28-8 | Reference compound |
| HY-W142428 | PEG 2 lauryl ether | 3055-93-4 | Reference compound |
| HY-W142432 | Perfluoroundecanoic acid | 2058-94-8 | Reference compound |
| HY-W142432R | Perfluoroundecanoic acid (Standard) | 2058-94-8 | Reference Standards |
| HY-W142434S | D-Galactose-13C-1 | 314062-47-0 | Isotope-Labeled Compounds |
| HY-W142446S | 2,6-Dichlorobenzamide-3,4,5-d3 | 1219804-28-0 | Isotope-Labeled Compounds |
| HY-W142459 | Naphthol AS-D | 135-61-5 | Reference compound |
| HY-W142467 | Tetraglycine | 637-84-3 | Peptides |
| HY-W142467A | Tetraglycine (hydrochloride) | 38126-71-5 | Peptides |
| HY-W142478 | 2,2-Diethoxyacetophenone | 6175-45-7 | Biochemical Assay Reagents |
| HY-W142506 | Triethylene glycol monododecyl ether | 3055-94-5 | Reference compound |
| HY-W142525 | Didodecylamine | 3007-31-6 | Reference compound |
| HY-W142578S | Pentadecylbenzene-d36 | Isotope-Labeled Compounds | |
| HY-W142596 | 1,2-DImyristoyl-rac-glycero-3-phosphocholine | 18656-38-7 | Reference compound |
| HY-W142618 | D-Glucal | 13265-84-4 | Biochemical Assay Reagents |
| HY-W142631 | 4-(Phenylazo)diphenylamine | 101-75-7 | Dye Reagents |
| HY-W142647S | 2,2'-Dihydroxy-4,4'-dimethoxybenzophenone-d6 | Isotope-Labeled Compounds | |
| HY-W142663 | Bisphenol M | 13595-25-0 | Reference compound |
| HY-W142667S | 1-Isopropyl-4-nitrobenzene-d4 | 1219803-36-7 | Isotope-Labeled Compounds |
| HY-W142692 | Dodecyl β-D-glucopyranoside | 59122-55-3 | Biochemical Assay Reagents |
| HY-W142702 | 1,2-Epoxydecane | 2404-44-6 | Reference compound |
| HY-W142791S | Cholamine-d9 | 945713-44-0 | Isotope-Labeled Compounds |
| HY-W142820S | 1,1,3,3-Tetraethoxypropane-d2 | 105479-86-5 | Isotope-Labeled Compounds |
| HY-W142823S | N-(3-Indolylacetyl)-L-valine-d4 | Isotope-Labeled Compounds | |
| HY-W142855 | Triacontane | 638-68-6 | Natural Products |
| HY-W142855R | Triacontane (Standard) | 638-68-6 | Reference Standards |
| HY-W142855S | Triacontane-d62 | 93952-07-9 | Isotope-Labeled Compounds |
| HY-W142867 | S-β-(4-Pyridylethyl)-L-cysteine | 28809-04-3 | Biochemical Assay Reagents |
| HY-W142906 | Methyl β-D-arabinopyranoside | 5328-63-2 | Biochemical Assay Reagents |
| HY-W142921S | Allyl methyl disulfide-d3 | Isotope-Labeled Compounds | |
| HY-W142936 | Methyl D-galacturonate | 16048-08-1 | Biochemical Assay Reagents |
| HY-W142961 | D-Lyxonic acid (potassium) | 78138-87-1 | Biochemical Assay Reagents |
| HY-W142997 | Decylcyclohexane | 1795-16-0 | Natural Products |
| HY-W143007 | Aceticacidn-heptadecylester | 822-20-8 | Natural Products |
| HY-W143071S | 1-(Methylthio)-pentane-d3 | Isotope-Labeled Compounds | |
| HY-W143136 | 6-(N-Trifluoroacetyl)caproic acid NHS | 117032-51-6 | Biochemical Assay Reagents |
| HY-W143205 | Cyanomethyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside | 61145-33-3 | Biochemical Assay Reagents |
| HY-W143208 | p-Nitrophenylacetic acid N-hydroxyuccinimide ester | 68123-33-1 | Biochemical Assay Reagents |
| HY-W143216 | Azure C | 531-57-7 | Reference compound |
| HY-W143230 | 4-(Benzyloxy)butanal | 5470-84-8 | Reference compound |
| HY-W143238S | 4-Hydroxybenzoic acid n-nonyl ester-d4 | 2708281-34-7 | Isotope-Labeled Compounds |
| HY-W143241 | H-Gly-Trp-OH | 2390-74-1 | Reference compound |
| HY-W143303S | 3-Hydroxy-3-methylvaleric acid-d5 | Isotope-Labeled Compounds | |
| HY-W143403A | (-)-Isopinocampheol | 1196-00-5 | Natural Products |
| HY-W143484 | Fmoc-PEG3-alcohol | 560088-66-6 | Reference compound |
| HY-W143531 | Perfluorohexyloctane | 133331-77-8 | Reference compound |
| HY-W143698 | PDGFRα kinase inhibitor 2 | 404844-11-7 | Reference compound |
| HY-W143822 | 6-(Tritylthio)hexanoic acid | 80441-55-0 | Reference compound |
| HY-W143890 | Etifenin | 63245-28-3 | Reference compound |
| HY-W144021S | 1-Hexen-3-one-d3 | 1335436-53-7 | Isotope-Labeled Compounds |
| HY-W144037 | Valeramide | 626-97-1 | Reference compound |
| HY-W144096 | Methyl 2,4,6-trihydroxybenzoate | 3147-39-5 | Natural Products |
| HY-W144276 | 6-Bromo-2-naphthyl β-D-xylopyranoside | 69594-75-8 | Biochemical Assay Reagents |
| HY-W144281 | N'-Hydroxy-3-methylbenzenecarboximidamide | 40067-82-1 | Reference compound |
| HY-W144308 | Tetrachlorohydroquinone | 87-87-6 | Reference compound |
| HY-W144308R | Tetrachlorohydroquinone (Standard) | 87-87-6 | Reference Standards |
| HY-W144406 | Methyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside | 13350-45-3 | Biochemical Assay Reagents |
| HY-W144430S | 2-[3-(Trifluoromethyl)phenoxy]nicotinic acid-d3 | Isotope-Labeled Compounds | |
| HY-W144683S | 4-Butylphenol-d5 | 1219795-04-6 | Isotope-Labeled Compounds |
| HY-W144703 | Heptadecan-9-amine | 3241-20-1 | Reference compound |
| HY-W144704 | Dihydrophytol | 645-72-7 | Reference compound |
| HY-W145053 | ChloraMine-T hydrate | 149358-73-6 | Reference compound |
| HY-W145076 | 2-Azaadamantane-N-oxyl | 57625-08-8 | Reference compound |
| HY-W145090 | 4-Dimethylaminopyridine N-oxide | 1005-31-8 | Reference compound |
| HY-W145108 | Methyl red (hydrochloride) | 63451-28-5 | Biochemical Assay Reagents |
| HY-W145116 | [Ru(phen)3]Cl2 | 23570-43-6 | Reference compound |
| HY-W145129 | Crocein orange G | 1934-20-9 | Biochemical Assay Reagents |
| HY-W145436 | Thalidomide-Piperazine 5-fluoride (hydrochloride) | 2222114-23-8 | Reference compound |
| HY-W145481 | D-Galacto-D-mannan | 11078-30-1 | Biochemical Assay Reagents |
| HY-W145482 | 3-O-Methyl-D-glucopyranose | 13224-94-7 | Biochemical Assay Reagents |
| HY-W145482S1 | 3-O-Methyl-D-glucopyranose-13C6 | Isotope-Labeled Compounds | |
| HY-W145483 | Heparin IV-A (sodium) | 133686-69-8 | Biochemical Assay Reagents |
| HY-W145484 | D-(+)-Galacturonic acid (sodium) | 14984-39-5 | Biochemical Assay Reagents |
| HY-W145485 | 4-(2-Pyridylazo)resorcinol (monosodium hydrate) | 16593-81-0 | Biochemical Assay Reagents |
| HY-W145486 | Calcium gluconate | 299-28-5 | Biochemical Assay Reagents |
| HY-W145486R | Calcium gluconate (Standard) | 299-28-5 | Reference Standards |
| HY-W145487 | D-Xylono-1,4-lactone | 18423-66-0 | Biochemical Assay Reagents |
| HY-W145488 | L-Altrose | 1949-88-8 | Biochemical Assay Reagents |
| HY-W145489 | Maltotriose (hydrate) | 207511-08-8 | Biochemical Assay Reagents |
| HY-W14549 | D-(+)-Cellotriose | 33404-34-1 | Natural Products |
| HY-W145490 | 4-Aminophenyl β-D-glucopyranoside | 20818-25-1 | Biochemical Assay Reagents |
| HY-W145491 | 4-O-β-Galactopyranosyl-D-mannopyranose | 20869-27-6 | Biochemical Assay Reagents |
| HY-W145492 | D-(+)-Talose | 2595-98-4 | Biochemical Assay Reagents |
| HY-W145492S2 | D-(+)-Talose-13C | 70849-29-5 | Isotope-Labeled Compounds |
| HY-W145492S3 | D-(+)-Talose-13C-1 | 83379-36-6 | Isotope-Labeled Compounds |
| HY-W145493 | Glycofurol | 31692-85-0 | Biochemical Assay Reagents |
| HY-W145494 | Sucrose monodecanoate | 31835-06-0 | Biochemical Assay Reagents |
| HY-W145496 | Laminaribiose | 34980-39-7 | Biochemical Assay Reagents |
| HY-W145497 | D-(+)-Sorbose | 3615-56-3 | Reference compound |
| HY-W145498 | D-(+)-Cellotetraose | 38819-01-1 | Natural Products |
| HY-W145499 | Zinc Gluconate | 4468-02-4 | Reference compound |
| HY-W145500 | Sedoheptulose anhydride | 469-90-9 | Biochemical Assay Reagents |
| HY-W145501 | Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin | 55216-11-0 | Biochemical Assay Reagents |
| HY-W145514 | Maltotetraitol | 66767-99-5 | Biochemical Assay Reagents |
| HY-W145515 | Gum ghatti | 9000-28-6 | Biochemical Assay Reagents |
| HY-W145516 | Guar gum | 9000-30-0 | Biochemical Assay Reagents |
| HY-W145517 | Karaya gum | 9000-36-6 | Biochemical Assay Reagents |
| HY-W145518 | Pectin | 9000-69-5 | Natural Products |
| HY-W145519 | Hydroxyethyl starch | 9005-27-0 | Biochemical Assay Reagents |
| HY-W145520 | Amylopectin | 9037-22-3 | Biochemical Assay Reagents |
| HY-W145521 | β-1,3-Glucan | 9051-97-2 | Biochemical Assay Reagents |
| HY-W145522 | Pullulan, Viscosity(10%):15-180mPa.s | 9057-02-7 | Biochemical Assay Reagents |
| HY-W145523 | ι-Carrageenan | 9062-07-1 | Biochemical Assay Reagents |
| HY-W145524 | Gal[246Bn,3All]-β-SPh | 1017587-57-3 | Biochemical Assay Reagents |
| HY-W145525 | DL-Glyceraldehyde diethyl acetal | 10487-05-5 | Biochemical Assay Reagents |
| HY-W145526 | Methyl 2,3,4-tri-O-benzyl-1-thio-β-L-fucopyranoside | 107802-80-2 | Biochemical Assay Reagents |
| HY-W145527 | Phenyl 1-thio-α-D-mannopyranoside 2,3,4,6-tetraacetate | 108032-93-5 | Biochemical Assay Reagents |
| HY-W145530 | 2,3,4,6-Tetra-O-benzoyl-D-mannopyranose | 113544-59-5 | Biochemical Assay Reagents |
| HY-W145531 | Neu5GcAc[1Me,478Ac,9N3]-β-SPh | 1195053-25-8 | Biochemical Assay Reagents |
| HY-W145532 | 3A-Amino-3A-deoxy-(2AS,3AS)-α-cyclodextrin | 121916-94-7 | Biochemical Assay Reagents |
| HY-W145533 | 2,3,4,6-Tetrakis-O-(phenylmethyl)-D-glucopyranosyl fluoride | 122741-44-0 | Biochemical Assay Reagents |
| HY-W145534 | GlcNAcβ(1-3)GalNAc-α-pNP | 125455-64-3 | Biochemical Assay Reagents |
| HY-W145535 | Sialyl lewis x-lactose | 127923-85-7 | Biochemical Assay Reagents |
| HY-W145537 | 4-Methoxyphenyl 3,6-Di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside | 129575-89-9 | Biochemical Assay Reagents |
| HY-W145538 | Nonasaccharide Glc4Xyl3Gal2 | 129865-06-1 | Biochemical Assay Reagents |
| HY-W145539 | GlcNAcβ(1-3)[GlcNAcβ(1-6)]GalNAc-α-Thr | 1304646-03-4 | Biochemical Assay Reagents |
| HY-W145540 | Galβ(1-3)[Neu5Acα(2-6)]GalNAc-α-pNP | 1316822-90-8 | Biochemical Assay Reagents |
| HY-W145542 | 3,4,6-Tri-O-benzyl-2-deoxy-D-glucopyranose | 132732-60-6 | Biochemical Assay Reagents |
| HY-W145544 | 6-O-(Triisopropylsilyl)-D-glucal | 137915-37-8 | Biochemical Assay Reagents |
| HY-W145545 | 4-Methoxyphenyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranoside | 138906-41-9 | Biochemical Assay Reagents |
| HY-W145547 | 2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranoside | 140428-81-5 | Biochemical Assay Reagents |
| HY-W145548 | GlcNPhth[36Bn,4Ac]-β-MP | 140615-77-6 | Biochemical Assay Reagents |
| HY-W145549 | 2-Azidoethyl 2-Acetamido-2-deoxy-β-D-glucopyranoside | 142072-12-6 | Biochemical Assay Reagents |
| HY-W145550 | 4-Methoxyphenyl 2-azido-4,6-O-benzylidene-2-deoxy-β-D-glucopyranoside | 1430068-18-0 | Biochemical Assay Reagents |
| HY-W145551 | 4-Methoxyphenyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside | 143536-99-6 | Biochemical Assay Reagents |
| HY-W145552 | 4-Methoxyphenyl 3-O-allyl-β-D-galactopyranoside | 144985-19-3 | Biochemical Assay Reagents |
| HY-W145553 | GalNAcβ(1-3)GlcNAc-β-pNP | 1456553-26-6 | Biochemical Assay Reagents |
| HY-W145554 | Methyl α-L-fucopyranoside | 14687-15-1 | Biochemical Assay Reagents |
| HY-W145556 | Galβ(1-3)GlcNAcβ(1-3)Galβ(1-4)Glc-β-pNP | 148705-09-3 | Biochemical Assay Reagents |
| HY-W145557 | 4-Methoxyphenyl 3,4-O-isopropylidene-2,6-bis-O-(4-methylbenzoyl)-β-D-galactopyranoside | 1496536-69-6 | Biochemical Assay Reagents |
| HY-W145558 | Galβ(1-4)Glc-β-MP | 150412-80-9 | Biochemical Assay Reagents |
| HY-W145559 | Gal[236Bn]β(1-4)Glc[236Bn]-β-MP | 150412-81-0 | Biochemical Assay Reagents |
| HY-W145560 | 4-Methoxyphenyl 2,6-Di-O-benzyl-β-D-galactopyranoside | 159922-50-6 | Biochemical Assay Reagents |
| HY-W145561 | Neu5Acα(2-3)Galβ MP glycoside | 159922-54-0 | Biochemical Assay Reagents |
| HY-W145563 | 2-Azidoethyl β-D-glucopyranoside | 165331-08-8 | Biochemical Assay Reagents |
| HY-W145564 | Phenyl 2,3,4-tri-O-benzyl-1-thio-β-L-fucopyranoside | 167612-35-3 | Biochemical Assay Reagents |
| HY-W145565 | 2-Acetamido-4,6-O-benzylidene-2-deoxy-β-D-glucopyranosyl | 168397-51-1 | Biochemical Assay Reagents |
| HY-W145567 | 4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside | 17042-40-9 | Biochemical Assay Reagents |
| HY-W145568 | Mono-6-O-mesitylenesulfonyl-γ-cyclodextrin | 174010-62-9 | Biochemical Assay Reagents |
| HY-W145569 | 2,3,4,6-Tetra-O-acetyl-D-mannopyranosyl fluoride | 174511-17-2 | Biochemical Assay Reagents |
| HY-W145570 | L-Tagatose | 17598-82-2 | Biochemical Assay Reagents |
| HY-W145571 | 3A-Amino-3A-deoxy-(2AS,3AS)-γ-cyclodextrin | 189307-64-0 | Biochemical Assay Reagents |
| HY-W145572 | Phenyl 2,4,6-tri-O-acetyl-3-O-allyl-1-thio-β-D-glucopyranoside | 197005-22-4 | Biochemical Assay Reagents |
| HY-W145573 | N-Hexanoyl-D-glucosamine | 19817-88-0 | Biochemical Assay Reagents |
| HY-W145574 | Diphenylthioxostannane | 20332-10-9 | Biochemical Assay Reagents |
| HY-W145575 | 1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose | 20881-04-3 | Biochemical Assay Reagents |
| HY-W145578 | 1,2,3,4,6-Penta-O-pivaloyl-D-mannopyranose | 220017-47-0 | Biochemical Assay Reagents |
| HY-W145579 | Cellopentaose | 2240-27-9 | Natural Products |
| HY-W145580 | L-Talose | 23567-25-1 | Biochemical Assay Reagents |
| HY-W145581 | Triacetyl-β-cyclodextrin | 23739-88-0 | Biochemical Assay Reagents |
| HY-W145582 | Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside | 24404-53-3 | Biochemical Assay Reagents |
| HY-W145583 | 2,3-O-Isopropylidene-D-erythronolactone | 25581-41-3 | Biochemical Assay Reagents |
| HY-W145584 | D-Iditol | 25878-23-3 | Reference compound |
| HY-W145584S | D-Iditol-13C | Isotope-Labeled Compounds | |
| HY-W145586 | GlcNAcβ(1-3)GalNAc-α-Thr | 286959-52-2 | Biochemical Assay Reagents |
| HY-W145588 | 4-Methoxyphenyl 2,4,6-Tri-O-acetyl-3-O-benzyl-β-D-glucopyranoside | 303127-79-9 | Biochemical Assay Reagents |
| HY-W145589 | 4-Methoxyphenyl 3-O-benzyl-β-D-glucopyranoside | 303127-80-2 | Biochemical Assay Reagents |
| HY-W145590 | 4-Methoxyphenyl 3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside | 303127-81-3 | Biochemical Assay Reagents |
| HY-W145591 | Mono-6-O-(p-toluenesulfonyl)-α-cyclodextrin | 32860-56-3 | Biochemical Assay Reagents |
| HY-W145592 | 1L-epi-2-Inosose | 33471-33-9 | Biochemical Assay Reagents |
| HY-W145593 | Methyl 2,3,4-Tri-O-benzoyl-α-D-glucopyranoside | 34234-44-1 | Biochemical Assay Reagents |
| HY-W145594 | Gal[26Bn]β(1-4)Glc[236Bn]-β-MP | 358681-61-5 | Biochemical Assay Reagents |
| HY-W145595 | Methyl 2,3,6-Tri-O-benzoyl-α-D-galactopyranoside | 3601-36-3 | Biochemical Assay Reagents |
| HY-W145596 | N-Trifluoroacetyl-D-glucosamine | 36875-26-0 | Biochemical Assay Reagents |
| HY-W145597 | D-Glucuronamide | 3789-97-7 | Reference compound |
| HY-W145598 | 4-Methoxyphenyl 3-O-Benzyl-β-D-galactopyranoside | 383905-60-0 | Biochemical Assay Reagents |
| HY-W145599 | 1,6:2,3-Dianhydro-β-D-mannopyranose | 3868-03-9 | Biochemical Assay Reagents |
| HY-W145600 | 1,2,4,6-Tetra-O-acetyl-3-O-allyl-β-D-glucopyranose | 39698-00-5 | Biochemical Assay Reagents |
| HY-W145601 | 4-Methoxyphenyl 3-O-Allyl-4,6-O-benzylidene-β-D-galactopyranoside | 400091-05-6 | Biochemical Assay Reagents |
| HY-W145603 | Phenyl α-D-glucopyranoside | 4630-62-0 | Biochemical Assay Reagents |
| HY-W145604 | Calcium lactobionate | 5001-51-4 | Biochemical Assay Reagents |
| HY-W145605 | D-Glucosamine oxime (hydrochloride) | 54947-34-1 | Biochemical Assay Reagents |
| HY-W145606 | D-Glucose-6-Phosphate (barium salt heptahydrate) | 60816-50-4 | Biochemical Assay Reagents |
| HY-W145607 | Galβ(1-3)GalNAc-β-pNP | 59837-15-9 | Biochemical Assay Reagents |
| HY-W145608 | L-Talitol | 60660-58-4 | Biochemical Assay Reagents |
| HY-W145609 | Neu5Troc[1Me,4789Ac]α(2-3)Gal[26Bn]-β-MP | 610763-72-9 | Biochemical Assay Reagents |
| HY-W145610 | Methyl (phenyl 2,3,4-Tri-O-acetyl-1-thio-β-D-glucopyranosid)uronate | 62812-42-4 | Biochemical Assay Reagents |
| HY-W145611 | N-Valeryl-D-glucosamine | 63223-57-4 | Biochemical Assay Reagents |
| HY-W145612 | D-Talitol | 643-03-8 | Biochemical Assay Reagents |
| HY-W145612S | D-Talitol-1-13C | Isotope-Labeled Compounds | |
| HY-W145613 | N-Benzoyl-D-glucosamine | 655-42-5 | Biochemical Assay Reagents |
| HY-W145614 | 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-α-D-mannopyranose | 65556-30-1 | Biochemical Assay Reagents |
| HY-W145615 | Methyl 2,3-Di-O-benzoyl-4,6-O-benzylidene-α-D-glucopyranoside | 6748-91-0 | Biochemical Assay Reagents |
| HY-W145616 | 1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-α-D-mannopyranose | 68733-20-0 | Biochemical Assay Reagents |
| HY-W145617 | 3,4,6-Tri-O-acetyl-2-deoxy-D-glucopyranose | 69503-94-2 | Biochemical Assay Reagents |
| HY-W145618 | Trisodium Glycyrrhizinate | 71277-78-6 | Biochemical Assay Reagents |
| HY-W145619 | 4-Nitrophenyl α-D-Glucuronide | 71484-85-0 | Biochemical Assay Reagents |
| HY-W145620 | Gal[246Bn]β(1-4)Glc[236Bn]-β-MP | 717132-49-5 | Biochemical Assay Reagents |
| HY-W145621 | Gal[2346Bn]-β-SPh | 74801-29-9 | Biochemical Assay Reagents |
| HY-W145622 | Galβ(1-3)[Neu5Acα(2-6)]GlcNAc-β-pNP | 754954-71-7 | Biochemical Assay Reagents |
| HY-W145623 | 2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl fluoride | 78153-79-4 | Biochemical Assay Reagents |
| HY-W145624 | Methyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside | 79528-48-6 | Biochemical Assay Reagents |
| HY-W145625 | 2-Acetamido-3-O-benzyl-4,6-O-benzylidene-2-deoxy-β-D-glucopyranosyl azide | 80887-27-0 | Biochemical Assay Reagents |
| HY-W145626 | β-D-Glucopyranose 1-phosphate (disodium salt) | 83833-15-2 | Biochemical Assay Reagents |
| HY-W145627 | Mono-2-O-(p-toluenesulfonyl)-β-cyclodextrin | 84216-71-7 | Biochemical Assay Reagents |
| HY-W145628 | 4,7,8,9-Tetra-O-acetyl-N-acetylneuraminic acid methyl ester | 84380-10-9 | Biochemical Assay Reagents |
| HY-W145629 | Methyl 2,3,4-Tri-O-acetyl-1-thio-β-L-fucopyranoside | 84635-54-1 | Biochemical Assay Reagents |
| HY-W145630 | 2,4-Bis(benzyloxy)-6-chloro-1,3,5-triazine | 851030-18-7 | Biochemical Assay Reagents |
| HY-W145631 | GalNAcβ(1-4)GlcNAc-β-pNP | 872578-72-8 | Biochemical Assay Reagents |
| HY-W145632 | Phenyl 4,6-O-Benzylidene-1-thio-β-D-glucopyranoside | 87508-17-6 | Biochemical Assay Reagents |
| HY-W145636 | 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl fluoride | 89025-46-7 | Biochemical Assay Reagents |
| HY-W145637 | Gb3-β-MP | 898826-64-7 | Biochemical Assay Reagents |
| HY-W145639 | Mono-2-O-(p-toluenesulfonyl)-α-cyclodextrin | 93184-10-2 | Biochemical Assay Reagents |
| HY-W145641 | 3,4,6-Tri-O-benzyl-2-deoxy-D-galactopyranose | 94189-64-7 | Biochemical Assay Reagents |
| HY-W145642 | Mono-2-O-(p-toluenesulfonyl)-γ-cyclodextrin | 97227-32-2 | Biochemical Assay Reagents |
| HY-W145643 | Mono-6-O-(p-toluenesulfonyl)-γ-cyclodextrin | 97227-33-3 | Biochemical Assay Reagents |
| HY-W145645 | Fucosyl-lacto-N-sialylpentaose c | 111216-36-5 | Biochemical Assay Reagents |
| HY-W145646 | Fmoc-L-Ser((Ac)4-β-D-Glc)-OH | 118358-38-6 | Biochemical Assay Reagents |
| HY-W145647 | 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | 13992-25-1 | Biochemical Assay Reagents |
| HY-W145648 | Methyl-β-D-thiogalactoside | 155-30-6 | Biochemical Assay Reagents |
| HY-W145649 | Ribose-5-phosphate (barium salt) | 15673-79-7 | Biochemical Assay Reagents |
| HY-W145650 | Trimethylsilyldulcitol | 18919-39-6 | Biochemical Assay Reagents |
| HY-W145651 | Isopropyl β-D-thioglucopyranoside | 19165-11-8 | Biochemical Assay Reagents |
| HY-W145652 | D-Altrose | 1990-29-0 | Biochemical Assay Reagents |
| HY-W145652S | D-Altrose-1-13C | 70849-27-3 | Isotope-Labeled Compounds |
| HY-W145652S1 | D-Altrose-2-13C | Isotope-Labeled Compounds | |
| HY-W145653 | 1,2:3,5-Di-O-isopropylidene-α-D-apiose | 25904-06-7 | Biochemical Assay Reagents |
| HY-W145654 | Methyl 2,3-anhydro-4,6-O-benzylidene-α-D-allopyranoside | 3150-15-0 | Biochemical Assay Reagents |
| HY-W145655 | Gal-β1,3-GalNAc-α1-OBn | 3554-96-9 | Biochemical Assay Reagents |
| HY-W145656 | α,β-Trehalose | 585-91-1 | Biochemical Assay Reagents |
| HY-W145656S | α,β-Trehalose-d2 | 2028292-29-5 | Isotope-Labeled Compounds |
| HY-W145657 | Trehalose 6,6′-dimycolate | 61512-20-7 | Biochemical Assay Reagents |
| HY-W145658 | De-N-sulfated heparin (sodium salt) | 61932-66-9 | Biochemical Assay Reagents |
| HY-W145659 | Di(β-D-xylopyranosyl)amine | 62983-70-4 | Biochemical Assay Reagents |
| HY-W145660 | Neoagarohexaitol | 68289-59-8 | Biochemical Assay Reagents |
| HY-W145661 | Gum storax | 8046-19-3 | Biochemical Assay Reagents |
| HY-W145662 | Octadecylthioethyl 4-O-α-D-galactopyranosyl-β-D-galactopyranoside | 87019-34-9 | Biochemical Assay Reagents |
| HY-W145663 | Gal-β1,3-GalNAc-β-OMe | 88274-25-3 | Biochemical Assay Reagents |
| HY-W145665 | Amylose | 9005-82-7 | Biochemical Assay Reagents |
| HY-W145667 | Mannan | 9036-88-8 | Biochemical Assay Reagents |
| HY-W145668 | Heptakis(2,3,6-tri-O-ethyl)-β-cyclodextrin | 111689-01-1 | Biochemical Assay Reagents |
| HY-W145669 | Heptakis-(2,6-di-O-ethyl)-β-cyclodextrin | 111689-03-3 | Biochemical Assay Reagents |
| HY-W145671 | 3A-Amino-3A-deoxy-(2AS,3AS)-β-cyclodextrin | 117194-77-1 | Biochemical Assay Reagents |
| HY-W145672 | D-Galactose-4-O-sulfate (sodium salt) | 125113-68-0 | Biochemical Assay Reagents |
| HY-W145673 | D-Galactose-6-O-sulfate (sodium salt) | 125455-62-1 | Biochemical Assay Reagents |
| HY-W145675 | Phenyl N-acetyl-α-D-galactosaminide | 13089-18-4 | Biochemical Assay Reagents |
| HY-W145676 | (+)-epi-Quercitol | 131435-06-8 | Biochemical Assay Reagents |
| HY-W145677 | Acetobromocellobiose | 14227-66-8 | Biochemical Assay Reagents |
| HY-W145682 | Blood group H disaccharide | 16741-18-7 | Biochemical Assay Reagents |
| HY-W145684 | Trimethylsilyl-meso-inositol | 2582-79-8 | Biochemical Assay Reagents |
| HY-W145685 | Rutinose Heptaacetate | 29202-64-0 | Biochemical Assay Reagents |
| HY-W145686 | Laminarihexaose | 29842-30-6 | Biochemical Assay Reagents |
| HY-W145687 | Diosgenin-3-O-β-D-sodium glucuronide | 32471-99-1 | Biochemical Assay Reagents |
| HY-W145688 | D-Hamamelose | 4573-78-8 | Biochemical Assay Reagents |
| HY-W145689 | (+)-proto-Quercitol | 488-73-3 | Biochemical Assay Reagents |
| HY-W145690 | Blood group A pentasaccharide | 50624-46-9 | Natural Products |
| HY-W145691 | Methyl 2,3,4,6-tetra-O-acetyl-β-D-thiogalactopyranoside | 55722-48-0 | Biochemical Assay Reagents |
| HY-W145692 | 1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-α-D-glucopyranose | 56883-33-1 | Biochemical Assay Reagents |
| HY-W145693 | Difucosyl-para-lacto-N-hexaose | 64309-01-9 | Biochemical Assay Reagents |
| HY-W145694 | N-Acetyl-D-galactosamine-4-O-sulfate (sodium salt) | 660839-03-2 | Biochemical Assay Reagents |
| HY-W145695 | Chitoheptaose | 68232-35-9 | Biochemical Assay Reagents |
| HY-W145696 | Phenoxyacetylcellulose | 68332-77-4 | Biochemical Assay Reagents |
| HY-W145697 | Hexakis (2,3,6-tri-O-methyl)-α-cyclodextrin | 68715-56-0 | Biochemical Assay Reagents |
| HY-W145698 | 1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-β-D-galactopyranose | 68733-19-7 | Biochemical Assay Reagents |
| HY-W145699 | D-myo-Inositol 4-monophosphate | 69256-52-6 | Biochemical Assay Reagents |
| HY-W145700 | 2-O-Benzyl-1,3,4,6-tetra-O-acetyl-α-D-mannopyranose | 80779-87-9 | Biochemical Assay Reagents |
| HY-W145701 | 4-O-Methyl-α-D-glucurono-β-D-xylan | 9062-57-1 | Biochemical Assay Reagents |
| HY-W145762 | Fmoc-N-Me-D-Arg(Pbf)-OH | 2044710-57-6 | Peptides |
| HY-W145783 | Heptakis(2,3,6-tri-O-benzoyl)-β-cyclodextrin | 23666-43-5 | Biochemical Assay Reagents |
| HY-W150053S | N-Octyl 4-hydroxybenzoate-d4 | 2708282-26-0 | Isotope-Labeled Compounds |
| HY-W150112 | trans-2-Hexenyl butyrate | 53398-83-7 | Reference compound |
| HY-W150166 | 2-Isopropylnaphthalene | 2027-17-0 | Biochemical Assay Reagents |
| HY-W150251 | Dulcin | 150-69-6 | Reference compound |
| HY-W150273 | 6-Aminocoumarin (hydrochloride) | 63989-79-7 | Biochemical Assay Reagents |
| HY-W150287S | 2,2'-(1,4-Phenylene)bis-4H-3,1-benzoxazin-4-one-d4 | Isotope-Labeled Compounds | |
| HY-W150340 | β-Lactose | 5965-66-2 | Biochemical Assay Reagents |
| HY-W150598S | N-Nitrosopiperidine-d10 | 960049-21-2 | Isotope-Labeled Compounds |
| HY-W150644S | Benzaldehyde diethyl acetal-d10 | Isotope-Labeled Compounds | |
| HY-W150677 | BioA-IN-1 | 77820-11-2 | Reference compound |
| HY-W150693 | Methyl 2-acetamido-2-deoxy-alpha-d-glucopyranoside | 6082-04-8 | Biochemical Assay Reagents |
| HY-W150752 | Triphenylethylene | 58-72-0 | Reference compound |
| HY-W150866S | Hexyl 4-hydroxybenzoate-d4 | 2241800-08-6 | Isotope-Labeled Compounds |
| HY-W150903S | N-Heptyl 4-hydroxybenzoate-d4 | 2708280-12-8 | Isotope-Labeled Compounds |
| HY-W150928 | Tridecyl acetate | 1072-33-9 | Natural Products |
| HY-W150958S | Backebergine-d6 | Isotope-Labeled Compounds | |
| HY-W151136S | 1-Methyladenosine hydroiodide-d3 | Isotope-Labeled Compounds | |
| HY-W151168 | 1,2-O-Cyclohexylidene-myo-inositol | 6763-47-9 | Biochemical Assay Reagents |
| HY-W151206 | Hydroxy naphthol blue (disodium) | 165660-27-5 | Dye Reagents |
| HY-W151617A | Desethoxy Quetiapine (dihydrochloride) | 329218-14-6 | Reference compound |
| HY-W151629A | Ferrozine (sodium hydrate) | 1266615-85-3 | Dye Reagents |
| HY-W151832 | Methyl 2-acetamido-2-deoxy-β-D-glucopyranoside | 3946-01-8 | Biochemical Assay Reagents |
| HY-W152146 | Methylxanthoxylin | 23121-32-6 | Natural Products |
| HY-W152363 | 1,2,3,4-Tetra-O-acetyl-alpha-L-fucopyranose | 64913-16-2 | Biochemical Assay Reagents |
| HY-W152405 | D-Alanyl-L-phenylalanine | 3061-95-8 | Reference compound |
| HY-W152601 | Calcium-D-arabinoate | 22373-09-7 | Biochemical Assay Reagents |
| HY-W152604 | Cyclo(glycyl-L-leucyl) | 5845-67-0 | Peptides |
| HY-W152813S | 3',4'-Dichloro-4-biphenylol-13C12 | Isotope-Labeled Compounds | |
| HY-W152854S | 1,1-Diethoxy-3-methylbutane-d4 | Isotope-Labeled Compounds | |
| HY-W152862S | Beta-cypermethrin-d5 | Isotope-Labeled Compounds | |
| HY-W153159 | N-Methyltyramine (hydrochloride) | 13062-76-5 | Reference compound |
| HY-W153459 | N-Cyclopropyl-4-iodobenzamide | 794539-14-3 | Reference compound |
| HY-W153502 | MeNH-PEG2-OH | 85475-01-0 | Reference compound |
| HY-W153540 | Methyl 4,6-O-Benzylidene-β-D-glucopyranoside | 14155-23-8 | Biochemical Assay Reagents |
| HY-W153793 | Glycylglycine ethyl ester (hydrochloride) | 2087-41-4 | Reference compound |
| HY-W153810 | 2-Methyl-4-phenyl thiazole | 1826-16-0 | Reference compound |
| HY-W153847 | Benzyl β-D-glucopyranoside | 4304-12-5 | Biochemical Assay Reagents |
| HY-W153897 | N-Methyltyramine | 370-98-9 | Natural Products |
| HY-W153897R | N-Methyltyramine (Standard) | 370-98-9 | Reference Standards |
| HY-W153917 | Diatrizoic acid EP impurity A | 1713-07-1 | Reference compound |
| HY-W154172 | 2′-Chloro-2′-deoxyuridine | 4753-04-2 | Reference compound |
| HY-W154175 | Boc-DODA | 275823-77-3 | Reference compound |
| HY-W154216 | Butyl α-D-glucopyranoside | 25320-93-8 | Biochemical Assay Reagents |
| HY-W154265 | 2,2′-Dihydroxychalcone | 15131-80-3 | Reference compound |
| HY-W154267S | 3-Aminoisobutyric acid-d3 (hydrochloride) | 1346602-62-7 | Isotope-Labeled Compounds |
| HY-W154295 | Purple-β-D-Gal | 36473-36-6 | Dye Reagents |
| HY-W154327 | N-Methyl-L-norleucine | 17343-27-0 | Reference compound |
| HY-W154333 | H-Arg-OtBu (dihydrochloride) | 87459-72-1 | Reference compound |
| HY-W154341 | 3-Indolyl-β-D-glucuronide (cyclohexanamine) | 216971-58-3 | Reference compound |
| HY-W154351 | 4-Nitrophenyl β-L-arabinopyranoside | 72732-54-8 | Biochemical Assay Reagents |
| HY-W154367 | p-Aminophenyl α-D-glucopyranoside | 31302-52-0 | Biochemical Assay Reagents |
| HY-W154397 | Permethrinic acid methyl ester | 61898-95-1 | Reference compound |
| HY-W154568 | 6-Methylpurine riboside | 14675-48-0 | Reference compound |
| HY-W155121 | Big CHAP | 86303-22-2 | Biochemical Assay Reagents |
| HY-W155446 | Decyl beta-d-thiomaltopyranoside | 148565-56-4 | Biochemical Assay Reagents |
| HY-W155493 | L-Galactono-1,4-lactone | 1668-08-2 | Biochemical Assay Reagents |
| HY-W156324 | Biotin-PEGn-NHS ester | 365441-71-0 | Reference compound |
| HY-W156412S | (2S)-2-(Acetylamino)-N,4-dimethylpentanamide-d16 | 1276197-56-8 | Isotope-Labeled Compounds |
| HY-W156438 | α-D-Mannopyranoside,phenylmethyl 3-amino-3-deoxy (hydrochloride) | 172838-30-1 | Biochemical Assay Reagents |
| HY-W156511S | Diacetylsulfanilamide-13C6 | Isotope-Labeled Compounds | |
| HY-W156596 | 3-Methoxybenzothioamide | 64559-06-4 | Reference compound |
| HY-W156811 | 5-Methyl-1,4,5,6-tetrahydro-1,3,5-triazine-2-thiol | 6746-27-6 | Reference compound |
| HY-W156840S | OTNE-13C3 | Isotope-Labeled Compounds | |
| HY-W156961 | LS-75 | 885-70-1 | Reference compound |
| HY-W157144S | (Ethyldisulfanyl)ethane-d6 | 52754-14-0 | Isotope-Labeled Compounds |
| HY-W157189 | Methyl 2-cyclohexyl-2-hydroxyphenylacetate | 10399-13-0 | Biochemical Assay Reagents |
| HY-W157189R | Methyl 2-cyclohexyl-2-hydroxyphenylacetate (Standard) | 10399-13-0 | Reference Standards |
| HY-W157316S | 1,4-bUtanedithiol-d8 | 1219805-46-5 | Isotope-Labeled Compounds |
| HY-W157376 | PAMAM Dendrimer G0.0 amine (20% in methanol) | 155773-72-1 | Reference compound |
| HY-W157689 | IDE-IN-2 | 49619-58-1 | Reference compound |
| HY-W158030 | 2-Guanidinobezimidazole | 5418-95-1 | Reference compound |
| HY-W158160 | AGS1286 (sodium) | 144254-93-3 | Reference compound |
| HY-W158234 | N-Methylbenzo[d]oxazol-2-amine | 19776-98-8 | Reference compound |
| HY-W158239 | 4-Methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylic acid | 144059-86-9 | Biochemical Assay Reagents |
| HY-W158945 | 3-Chloroamphetamine (hydrochloride) | 35378-15-5 | Reference compound |
| HY-W159102 | 8CN | 40106-14-7 | Reference compound |
| HY-W159303 | 7-Hydroxy-2,2-dimethyl-4-chromanone | 17771-33-4 | Reference compound |
| HY-W159754 | Chavicol | 501-92-8 | Reference compound |
| HY-W159870 | N-Nitrosodibenzylamine | 5336-53-8 | Reference compound |
| HY-W159870R | N-Nitrosodibenzylamine (Standard) | 5336-53-8 | Reference Standards |
| HY-W159917 | 1,4-Di(5-Phenyl-2-oxazolyl)benzene | 1806-34-4 | Biochemical Assay Reagents |
| HY-W160298 | N-Cbz-7-Aminoheptanoic acid | 23434-37-9 | Reference compound |
| HY-W160560 | 4-Vinylsyringol | 28343-22-8 | Reference compound |
| HY-W160628S | 1,1,1-Trimethoxypropane-d5 | 1219803-49-2 | Isotope-Labeled Compounds |
| HY-W160631S | 2-Ethenylpyrazine-d3 | 1082582-36-2 | Isotope-Labeled Compounds |
| HY-W160679 | 7-(Carboxymethoxy)-4-methylcoumarin | 64700-15-8 | Reference compound |
| HY-W162983 | 3,4-Diphenyl-5H-furan-2-one | 5635-16-5 | Natural Products |
| HY-W164451 | N-(2-hydroxy-2-phenylethyl)acetamide | 3306-05-6 | Natural Products |
| HY-W164560 | RDR 03785 | 289657-30-3 | Reference compound |
| HY-W165085 | 1,10-Bis(pyridinium)decane | 6266-40-6 | Reference compound |
| HY-W165608 | 5-(3'-Hydroxyphenyl)-γ-valerolactone | 21618-91-7 | Natural Products |
| HY-W165722 | Tris(hydroxymethyl)methylammonium dihydrogen phosphate | 6992-39-8 | Biochemical Assay Reagents |
| HY-W166297 | Esculin (sesquihydrate) | 66778-17-4 | Reference compound |
| HY-W166764 | 5-Nitrotryptophan | 6525-46-8 | Reference compound |
| HY-W167398 | Phenosulfazole | 515-54-8 | Reference compound |
| HY-W167708 | 2-Ethyl-5-methylphenol | 1687-61-2 | Reference compound |
| HY-W167769 | (±)-Mellein | 1200-93-7 | Reference compound |
| HY-W167979 | 3-Amino-1,2,4-triazin-5(2H)-one | 1121-90-0 | Reference compound |
| HY-W168754 | DB28 | 16296-42-7 | Reference compound |
| HY-W168915S | 1-(3-Fluorophenyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid-d3 | Isotope-Labeled Compounds | |
| HY-W170020 | PTCA | 871326-47-5 | Reference compound |
| HY-W170255 | Sodium mercaptopyruvate | 10255-67-1 | Biochemical Assay Reagents |
| HY-W171071 | Phenylethynylcarbinol carbamate | 3567-38-2 | Reference compound |
| HY-W171611 | PDE-IN-3 | 56344-53-7 | Reference compound |
| HY-W171983 | Notum-IN-1 | 338419-11-7 | Reference compound |
| HY-W172241 | Boc-Phe-Gly-Ome | 7625-57-2 | Reference compound |
| HY-W173049 | 3-(2-Carboxyethanesulfinyl)propanoic acid | 3680-08-8 | Reference compound |
| HY-W173146 | ALKBH5-IN-4 | 37510-29-5 | Reference compound |
| HY-W173220 | Clopirac | 42779-82-8 | Reference compound |
| HY-W173257 | Theophylline EP impurity C | 7597-60-6 | Reference compound |
| HY-W173309 | Lonazolac | 53808-88-1 | Reference compound |
| HY-W173408 | 4-Chlorocathinone (hydrochloride) | 23184-97-6 | Reference compound |
| HY-W173921 | 1-Azidohexane | 6926-45-0 | Reference compound |
| HY-W174279 | Tyrphostin 8 | 3785-90-8 | Reference compound |
| HY-W174489 | N-Benzenesulfonyltryptamine | 32585-54-9 | Reference compound |
| HY-W174661 | tert-Butyl 6-hydroxyhexanoate | 73839-20-0 | Reference compound |
| HY-W175543 | Methoxyurea | 3272-27-3 | Reference compound |
| HY-W175580 | Phenylfluorone | 975-17-7 | Biochemical Assay Reagents |
| HY-W176012 | Glycolate oxidase-IN-1 | 330977-65-6 | Reference compound |
| HY-W176171 | PU.1-IN-1 | 873588-27-3 | Reference compound |
| HY-W176199 | DPPD-Q | 3421-08-7 | Reference compound |
| HY-W176465 | BTA-2 | 10205-62-6 | Reference compound |
| HY-W176477 | 2-Octyldecanoic acid | 619-39-6 | Reference compound |
| HY-W176557 | TGN-073 | 877459-36-4 | Reference compound |
| HY-W176576 | Falimint | 553-20-8 | Reference compound |
| HY-W176629 | Hydrocotarnine | 550-10-7 | Reference compound |
| HY-W176660S | 3-Methylbut-2-ene-1-thiol-d6 | 1189879-84-2 | Isotope-Labeled Compounds |
| HY-W177335 | D-Mannopyranose | 530-26-7 | Natural Products |
| HY-W177546 | CD00509 | 27430-18-8 | Reference compound |
| HY-W178011 | Topoisomerase IIα-IN-9 | 16346-97-7 | Reference compound |
| HY-W178327 | 8-Chloro caffeine | 4921-49-7 | Reference compound |
| HY-W178414 | Methoxycarbonyl isocyanate | 5843-42-5 | Reference compound |
| HY-W178441 | 4-Azidophenol | 24541-43-3 | Reference compound |
| HY-W178704S | 2-(Ethylamino)-1-phenylpropan-1-ol-d5 | Isotope-Labeled Compounds | |
| HY-W178868S | Lodoxamide impurity 1-d5 | Isotope-Labeled Compounds | |
| HY-W179096 | 6-Phenyldihydrouracil | 6300-95-4 | Reference compound |
| HY-W179109 | 4-Methyl-3-hexanol | 615-29-2 | Natural Products |
| HY-W179151 | N-Octanoyl dopamine | 105026-81-1 | Reference compound |
| HY-W179181 | MSNBA | 852702-51-3 | Reference compound |
| HY-W179417 | Methacrolein-2,4-dinitrophenylhydrazone | 5077-73-6 | Dye Reagents |
| HY-W179801 | 1,3-Diphenethylurea | 5467-84-5 | Reference compound |
| HY-W180804 | Coumarin 334 | 55804-67-6 | Reference compound |
| HY-W181026 | KLF10-IN-1 | 1197834-98-2 | Reference compound |
| HY-W181102 | NFAT Inhibitor-2 | 422546-87-0 | Reference compound |
| HY-W181530 | NCT02 | 790245-61-3 | Reference compound |
| HY-W181626 | Tiprenolol | 26481-51-6 | Reference compound |
| HY-W181626A | Tiprenolol (hydrochloride) | 13379-87-8 | Reference compound |
| HY-W181871 | Piperidione | 77-03-2 | Reference compound |
| HY-W182770 | GPR84 agonist-1 | 489403-70-5 | Reference compound |
| HY-W183178 | (Pentyloxy)benzene | 2050-04-6 | Reference compound |
| HY-W184800 | MuRF1-IN-2 | 937891-74-2 | Reference compound |
| HY-W184837 | m-Nisoldipine | 113578-26-0 | Reference compound |
| HY-W185139S | 2-Hydroxy-3-(4-methylphenyl)propanoic acid-d3 | Isotope-Labeled Compounds | |
| HY-W185208S | Chloridazon metabolite B1-d3 | 2732916-21-9 | Isotope-Labeled Compounds |
| HY-W186242 | PDE4-IN-16 | 223500-15-0 | Reference compound |
| HY-W186989 | Homarylamine (hydrochloride) | 533-10-8 | Reference compound |
| HY-W187279 | Karrikin 2 | 857054-03-6 | Reference compound |
| HY-W187305 | MASM7 | 920868-45-7 | Reference compound |
| HY-W187973 | 3-Methylchromone | 85-90-5 | Reference compound |
| HY-W188178 | N-Mitrososarcosine | 13256-22-9 | Reference compound |
| HY-W188178S | 2-[Methyl(nitroso)amino]acetic acid-d3 | 1189871-94-0 | Isotope-Labeled Compounds |
| HY-W189564 | 4-(Pyrrolidin-1-yl)butanoic acid (hydrochloride) | 49637-21-0 | Reference compound |
| HY-W189682S | (±)-N′-Nitrosonornicotine-2,4,5,6-d4 | 66148-19-4 | Isotope-Labeled Compounds |
| HY-W190720 | Fmoc-NH-PEG4-HZ-BOC | 1263044-77-4 | Reference compound |
| HY-W190728 | Bis-PEG4-TFP ester | 1446282-42-3 | Reference compound |
| HY-W190729 | Thiol-PEG3-acetic acid | 200291-35-6 | Reference compound |
| HY-W190737 | NHS-S-S-dPEG4-biotin (cleavable) | 1260247-51-5 | Reference compound |
| HY-W190738 | Azide-PEG8-Tos | 857892-34-3 | Reference compound |
| HY-W190752 | m-PEG13-acid | 2170098-33-4 | Reference compound |
| HY-W190753 | BocNH-PEG8-CH2CH2COONHS | 2009357-80-4 | Reference compound |
| HY-W190761 | Amino-PEG11-t-butyl ester | 2428400-08-0 | Reference compound |
| HY-W190766 | dPEG(R)8-SATA | 1070798-99-0 | Reference compound |
| HY-W190786 | Bromoacetamido-PEG2-azide | 932741-12-3 | Reference compound |
| HY-W190795 | Benzyl-PEG3-amine | 86770-75-4 | Reference compound |
| HY-W190796 | Mal-PEG3-NH2 | 2170654-70-1 | Reference compound |
| HY-W190796A | Mal-PEG3-NH2 (TFA) | 2830214-77-0 | Reference compound |
| HY-W190808 | Tos-PEG11-t-butyl ester | 778596-20-6 | Reference compound |
| HY-W190816 | Acid-PEG7-t-butyl ester | 2134235-86-0 | Reference compound |
| HY-W190824 | Biotin-PEG8-azide | 2363756-34-5 | Reference compound |
| HY-W190836 | N3-PEG2-Tos | 182347-24-6 | Reference compound |
| HY-W190842 | m-PEG2-NHS ester | 1127247-34-0 | Reference compound |
| HY-W190843 | Bromo-PEG2-acetic acid | 2409962-85-0 | Reference compound |
| HY-W190857 | N-Boc-PEG10-alcohol | 2238844-74-9 | Reference compound |
| HY-W190881 | N3-PEG11-CH2CH2Br | 2098982-00-2 | Reference compound |
| HY-W190901 | Amino-PEG11-acid | 1616426-12-0 | Reference compound |
| HY-W190904 | 2-Amino-1,3-bis(tert-butyldimethylsilanoxy)propane | 188538-25-2 | Reference compound |
| HY-W190905 | N4,N9-di-Boc-spermine | 177213-61-5 | Reference compound |
| HY-W190906 | 6-(tert-Butoxy)-6-oxohexanoic NHS ester | 402958-62-7 | Reference compound |
| HY-W190907 | Trifluoroacetamidoethyl-SS-propionic NHS ester | 2380318-60-3 | Reference compound |
| HY-W190908 | Desthiobiotin-PEG3-NHS ester | 2411681-92-8 | Reference compound |
| HY-W190910 | AZD-PEG2-acid | 1807518-70-2 | Reference compound |
| HY-W190911 | Cyclooct-4-en-1-yl(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate | 2566420-12-8 | Reference compound |
| HY-W190912 | AZD-PEG2-PFP | 1807537-41-2 | Reference compound |
| HY-W190913 | DBCO-PEG4-Val-Cit-PAB-PNP | 2226472-28-0 | Reference compound |
| HY-W190914 | Tco-PEG2-Tco | 2411687-18-6 | Reference compound |
| HY-W190915 | 4,7,10,13,16-Pentaoxanonadecane-1,19-diamine | 869308-34-9 | Reference compound |
| HY-W190916 | 3-((2-(4-Azidobenzamido)ethyl)disulfanyl)propanoic acid | 179763-60-1 | Reference compound |
| HY-W190917 | N1, N4-Bisazidospermine bistosylate | 2250433-79-3 | Reference compound |
| HY-W190918 | endo-BCN-PEG4-amine | 1898221-77-6 | Reference compound |
| HY-W190920 | t-Butoxycarbonyl-PEG2-NHS ester | 2411681-93-9 | Reference compound |
| HY-W190921 | t-Butyl 3-(hydroxypropoxyl)-propanoate | 2100306-78-1 | Reference compound |
| HY-W190922 | Mal-PEG4-amine | 2221042-92-6 | Reference compound |
| HY-W190923 | MMAF-methyl ester | 2353409-70-6 | Reference compound |
| HY-W190924 | Mal-amido-PEG8-val-gly | 2353409-54-6 | Reference compound |
| HY-W190925 | APN-C3-biotin | 2170240-97-6 | Reference compound |
| HY-W190926 | 2, 5-Dioxo-1-pyrrolidinyl 11-azidoundecanoate | 850080-13-6 | Reference compound |
| HY-W190927 | MC-Val-Cit-Doxorubicin | 159857-70-2 | Reference compound |
| HY-W190928 | 2-(Azido-PEG2-amido)-1,3-bis-(tert-butyldimethylsilanoxy)propane | 1398044-56-8 | Reference compound |
| HY-W190929 | Diethyl 4-aminoheptanedioate | 759438-10-3 | Reference compound |
| HY-W190930 | t-Butyl 1,5-di(ethoxycarbonyl)pentan-3-ylcarbamate | 848242-87-5 | Reference compound |
| HY-W190932 | TAMRA-PEG2-Maleimide | 2304558-24-3 | Dye Reagents |
| HY-W190933 | Bis-PEG6-TFP ester | 1818294-37-9 | Reference compound |
| HY-W190934 | Fmoc-Ala-Pro-OH | 186023-44-9 | Reference compound |
| HY-W190935 | Tris(O-TBDMS)3 | 102522-47-4 | Reference compound |
| HY-W190936 | Thalidomide-O-PEG5-tosyl | 2414905-34-1 | Reference compound |
| HY-W190937 | PC Azido-PEG3-NHS carbonate ester | 1802907-96-5 | Reference compound |
| HY-W190939 | C11-PEG9-alcohol | 35056-97-4 | Reference compound |
| HY-W190940 | Biotin-PEG4-S-S-acid | 1380166-80-2 | Reference compound |
| HY-W190941 | C11-PEG6-alcohol | 92691-26-4 | Reference compound |
| HY-W190942 | (S,R.S)-AHPC-PEG8-acid | 2428400-60-4 | Reference compound |
| HY-W190943 | Azido-PEG4-Val-Cit-PAB-MMAE | 1869126-64-6 | ADC Related |
| HY-W190944 | DM1-MCC-PEG3-Biotin | 2183472-94-6 | Reference compound |
| HY-W190945 | Biotin-PEG6-NH-Boc | 1292268-20-2 | Reference compound |
| HY-W190946 | Hydroxy-PEG3-2-methylacrylate | 2351-42-0 | Reference compound |
| HY-W190947 | Iodoacetamido-PEG8-acid | 1698019-88-3 | Reference compound |
| HY-W190948 | 10-(tert-Butoxy)-10-oxodecanoic NHS ester | 905735-81-1 | Reference compound |
| HY-W190950 | AZD-PEG5-PFP | 1609569-75-6 | Reference compound |
| HY-W190951 | 3-((2-(2,2,2-Trifluoroacetamido)ethyl)disulfanyl)propanoic acid | 2401831-98-7 | Reference compound |
| HY-W190952 | Bis-sulfone-PEG4-NHS ester | 2055047-19-1 | Reference compound |
| HY-W190953 | N1,N12-Di-Boc-spermine | 140652-55-7 | Reference compound |
| HY-W190954 | Ethylene glycol bis(succinic acid) | 35415-14-6 | Reference compound |
| HY-W190955 | N-(t-Butyl ester-PEG3)-N-bis(PEG3-amine) | 2183440-29-9 | Reference compound |
| HY-W190956 | (S,R,S)-AHPC-PEG4-acid | 2172820-12-9 | Reference compound |
| HY-W190958 | Boc-NH-Tri-(carbonylethoxymethyl)-methane | 220431-61-8 | Reference compound |
| HY-W190959 | m-PEG15-acetic acid | 2417256-16-5 | Reference compound |
| HY-W190960 | Amino-PEG6-acetic acid | 1104083-46-6 | Reference compound |
| HY-W190961 | FmocNH-PEG3-CH2CH2NH2 (hydrochloride) | 906079-91-2 | Reference compound |
| HY-W190962 | t-Boc-N-amido-PEG5-acetic acid | 890152-41-7 | Reference compound |
| HY-W190963 | Boc-NH-PEG7-acetic acid | 141282-29-3 | Reference compound |
| HY-W190966 | t-Boc-Aminooxy-PEG4-t-butyl ester | 1872433-64-1 | Reference compound |
| HY-W190968 | Cbz-PEG2-bromide | 2100283-00-7 | Reference compound |
| HY-W190969 | Br-PEG6-CH2COOtBu | 297162-48-2 | Reference compound |
| HY-W190970 | Biotin-PEG9-amine | 960132-48-3 | Reference compound |
| HY-W190971 | Triethylene glycol monodecyl ether | 4669-23-2 | Reference compound |
| HY-W190972 | 3-(3-Nitrophenyl)-5-phenyl-1,2,4-oxadiazole | 20844-48-8 | Reference compound |
| HY-W190974 | 3-Ethynylperylene | 132196-66-8 | Reference compound |
| HY-W190976 | 5-Vinyl-2'-deoxyuridine | 55520-67-7 | Reference compound |
| HY-W190984 | Desthiobiotin-PEG4-alkyne | 1802907-99-8 | Biochemical Assay Reagents |
| HY-W190985 | AZD-PEG5-methyl ester | 2055014-59-8 | Reference compound |
| HY-W191560S | N1-(4-Nitrophenyl)sulfanilamide-d4 | Isotope-Labeled Compounds | |
| HY-W191692 | Phentolamine (acetate) | 249607-96-3 | Reference compound |
| HY-W192171 | BRD4 Inhibitor-34 | 1095051-68-5 | Reference compound |
| HY-W192446 | Nicotinoyl azide | 4013-72-3 | Reference compound |
| HY-W192474S | 1-(Furan-2-yl)ethane-1-thiol-d3 | 1082582-03-3 | Isotope-Labeled Compounds |
| HY-W193398 | N-2-Cyclohexylethyl-N-methylamine | 62141-38-2 | Natural Products |
| HY-W193545A | ERG240 | 1415683-79-2 | Reference compound |
| HY-W193844 | MLS001006105 | 455310-36-8 | Reference compound |
| HY-W193853 | ML67 | 300816-42-6 | Reference compound |
| HY-W194107 | Antitumor agent-152 | 1209784-87-1 | Reference compound |
| HY-W194810 | MCU-i11 | 902903-59-7 | Reference compound |
| HY-W194842 | Harmalan | 525-41-7 | Natural Products |
| HY-W194846 | Linoelaidate (sodium) | 57431-47-7 | Natural Products |
| HY-W195039 | 5-Heptylresorcinol | 500-67-4 | Reference compound |
| HY-W195048 | Tetradecyl sulfate (sodium) | 1191-50-0 | Reference compound |
| HY-W195509 | Debrisoquin (hydroiodide) | 1052540-65-4 | Reference compound |
| HY-W195933 | 6-Aminopyridine-3-thioamide | 53268-33-0 | Reference compound |
| HY-W195984 | Z57346765 | 1016340-64-9 | Reference compound |
| HY-W196368 | Thymohydroquinone | 2217-60-9 | Reference compound |
| HY-W196467A | 2,4,6-TMPEA (hydrochloride) | 3166-90-3 | Reference compound |
| HY-W196803 | Dipropyl disulfide | 629-19-6 | Reference compound |
| HY-W197328 | Isonicotinaldehyde 2-pyridin | 2241017-37-6 | Reference compound |
| HY-W197430 | Ethyl 6-azidohexanoate | 65374-10-9 | Reference compound |
| HY-W197533 | 3-Hydroxymethyl-β-carboline | 65474-79-5 | Reference compound |
| HY-W197713 | 2-Amino-N-phenylpropanamide (hydrochloride) | 153973-14-9 | Reference compound |
| HY-W198670 | 1,2-Diacetylbenzene | 704-00-7 | Reference compound |
| HY-W198678S | 6-Methylthioguanine-13C,d3 | Isotope-Labeled Compounds | |
| HY-W199117S | 1,1-Diethoxypropane-d10 | Isotope-Labeled Compounds | |
| HY-W199190 | 2-CEES | 693-07-2 | Reference compound |
| HY-W200249 | Meta-methyl 4-anilino-1-Boc-piperidine | 679409-60-0 | Reference compound |
| HY-W200545 | 1M6 | 4693-01-0 | Reference compound |
| HY-W200993S | 3-Methylfuran-d3 | 105855-05-8 | Isotope-Labeled Compounds |
| HY-W201317 | E17241 | 1060968-92-4 | Reference compound |
| HY-W201367S | (1-Phenylpropan-2-yl)(prop-2-yn-1-yl)amine-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W201842 | Octamylamine | 502-59-0 | Reference compound |
| HY-W201842A | Octamylamine (sulfamate) | 96296-56-9 | Reference compound |
| HY-W201842B | Octamylamine (hydrochloride) | 5964-56-7 | Reference compound |
| HY-W202230 | Buclosamide | 575-74-6 | Reference compound |
| HY-W202854 | Methiopropamine 3’-thiophene isomer (hydrochloride) | 857361-90-1 | Reference compound |
| HY-W203147 | 1-Azidopentane | 26330-06-3 | Reference compound |
| HY-W203683 | Perfluorononanoic acid | 375-95-1 | Reference compound |
| HY-W203728 | L-β-Imidazolelactic acid | 14403-45-3 | Biochemical Assay Reagents |
| HY-W204613 | 3-Allylphenol | 1446-24-8 | Reference compound |
| HY-W205320 | β,3-Dihydroxytyrosine | 492-46-6 | Peptides |
| HY-W205529 | RO 16-6491 (free base) | 87235-61-8 | Reference compound |
| HY-W206016 | 3-Aminosalicylic acid | 570-23-0 | Reference compound |
| HY-W206016S | 3-Aminosalicylic acid-d3 | Isotope-Labeled Compounds | |
| HY-W206911 | Erythrosin B (sodium salt) | 568-63-8 | Dye Reagents |
| HY-W207195 | 7-Hydroxy-4-phenylcoumarin | 2555-30-8 | Reference compound |
| HY-W209106 | ADPRT-IN-1 | 109164-47-8 | Reference compound |
| HY-W209628 | Methyl 2-acetoxybenzoate | 580-02-9 | Reference compound |
| HY-W210476 | Somantadine | 79594-24-4 | Reference compound |
| HY-W210953S | 3-(Bromomethyl)-2-methylpentane-d7 | 1219805-84-1 | Isotope-Labeled Compounds |
| HY-W212029 | D-Alanyl-L-leucine | 67113-60-4 | Peptides |
| HY-W212902 | 2-Pyrimidin-2-yl-propionic acid | 819850-16-3 | Reference compound |
| HY-W213592S | (±)-β-Methylphenethylamine-d9 | Isotope-Labeled Compounds | |
| HY-W214058 | Ac-2-Nal-OH | 37439-99-9 | Peptides |
| HY-W214059S | N-Acetyl-S-methyl-L-cysteine-d3 | 1279039-06-3 | Isotope-Labeled Compounds |
| HY-W215071S | 2-Acetamido-N-methylacetamide-d8 | 1219802-57-9 | Isotope-Labeled Compounds |
| HY-W216585 | Glycyl-l-isoleucine | 19461-38-2 | Reference compound |
| HY-W216621 | Pinacyanol (iodide) | 605-91-4 | Dye Reagents |
| HY-W220536 | Salsoline | 76419-97-1 | Reference compound |
| HY-W220946S | 2-Chlorobutanoic acid-d6 | 1219802-13-7 | Isotope-Labeled Compounds |
| HY-W221508 | 4-Azidoaniline (hydrochloride) | 91159-79-4 | Reference compound |
| HY-W224327 | Pheniprazine | 55-52-7 | Reference compound |
| HY-W224327A | Pheniprazine (hydrochloride) | 66-05-7 | Reference compound |
| HY-W224855 | WAY-634964 | 157842-34-7 | Reference compound |
| HY-W229874 | EN106 | 757192-67-9 | Reference compound |
| HY-W230975 | (E/Z)-Piperine | 7780-20-3 | Reference compound |
| HY-W233505 | Iophenoxic acid | 96-84-4 | Reference compound |
| HY-W235043 | Methyl 3-oxodecanoate | 22348-96-5 | Reference compound |
| HY-W236261 | N-Acetyl-L-tyrosine ethyl ester | 840-97-1 | Biochemical Assay Reagents |
| HY-W236273 | (E)-Ethyl cinnamate | 4192-77-2 | Natural Products |
| HY-W236847AS | 3-Ethoxy-4-methoxy-Dopamine-d4 (hydrochloride) | 1398066-01-7 | Isotope-Labeled Compounds |
| HY-W236847AS1 | 3-Ethoxy-4-methoxy-Dopamine-d7 (hydrochloride) | 1398065-60-5 | Isotope-Labeled Compounds |
| HY-W237498 | Urease-IN-17 | 4322-58-1 | Reference compound |
| HY-W240028A | N-Methylmescaline (hydrochloride) | 6308-81-2 | Reference compound |
| HY-W240322 | PSF-IN-1 | 370582-94-8 | Reference compound |
| HY-W241315 | Methyl 2,3-O-isopropylidene-α-L-rhamnopyranoside | 14133-63-2 | Biochemical Assay Reagents |
| HY-W241345 | DOTA-bis(tert-butyl)ester | 913542-71-9 | Reference compound |
| HY-W241635 | Thalidomide acid | 1547163-38-1 | Reference compound |
| HY-W242709 | 4-Chloroquinolin-8-ol | 57334-36-8 | Reference compound |
| HY-W242724 | 1,4-Dibromo-butane-1,1,2,2,3,3,4,4-d8 | 68375-92-8 | Isotope-Labeled Compounds |
| HY-W242735 | 4-Aminobenzimidamide (Hydrochloride) | 7761-72-0 | Reference compound |
| HY-W242821 | Methyl 3,4-dimethoxycinnamate | 5396-64-5 | Natural Products |
| HY-W242887 | D-Gulose | 4205-23-6 | Biochemical Assay Reagents |
| HY-W242887S2 | D-Gulose-13C | 478529-73-6 | Isotope-Labeled Compounds |
| HY-W242887S3 | D-Gulose-1-13C | 70849-25-1 | Isotope-Labeled Compounds |
| HY-W243002 | Acetyl-L-homoserine lactone | 51524-71-1 | Reference compound |
| HY-W243018S | 1,2:5,6-Di-O-isopropylidene-a-D-glucofuranose-1,2,3,4,5,6-13C6 | 126590-65-6 | Isotope-Labeled Compounds |
| HY-W243217 | Acetamide-2,2,2-d3 | 23724-60-9 | Isotope-Labeled Compounds |
| HY-W243244 | β-Ionone acid | 14393-45-4 | Reference compound |
| HY-W243303A | Poly(acrylic acid) (MW 2000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303B | Poly(acrylic acid) (Mv 3000000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303C | Poly(acrylic acid) (Mv 4000000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303D | Poly(acrylic acid) (Mv 1250000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303E | Poly(acrylic acid) (MW 450000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303J | Poly(acrylic acid) (MW 250000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303K | Poly(acrylic acid) (MW 1000000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303L | Poly(acrylic acid) (Mv 8000000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303M | Poly(acrylic acid) (Mv 100000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303N | Poly(acrylic acid) (Mv 500000) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243303O | Poly(acrylic acid) (Mv 1250000) (viscous liquid) | 9003-01-4 | Biochemical Assay Reagents |
| HY-W243404 | 3-(6-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 2304513-76-4 | Reference compound |
| HY-W243405 | 3-(7-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 2229976-08-1 | Reference compound |
| HY-W243408C | Calcium carbonate, 99% | 471-34-1 | Biochemical Assay Reagents |
| HY-W243408D | Calcium carbonate, for cell culture | 471-34-1 | Biochemical Assay Reagents |
| HY-W243408DR | Calcium carbonate, for cell culture (Standard) | 471-34-1 | Reference Standards |
| HY-W243408S | Calcium carbonate-13C | Isotope-Labeled Compounds | |
| HY-W243460 | EDTA copper(II) disodium salt, 97% | 39208-15-6 | Biochemical Assay Reagents |
| HY-W243653 | 11-Dodecenyl acetate | 35153-10-7 | Natural Products |
| HY-W243879 | Tetraphenyldibenzoperiflanthene | 175606-05-0 | Reference compound |
| HY-W243914S | tert-Butylamine-d9Hydrobromide | 134071-63-9 | Isotope-Labeled Compounds |
| HY-W244282 | Thalidomide-pinacolborane | 2229725-98-6 | Reference compound |
| HY-W244382 | Alanine-2,3,3,3-d4 | 53795-92-9 | Isotope-Labeled Compounds |
| HY-W244384 | 1,3,5-Tribromobenzene-d3 | 52921-77-4 | Isotope-Labeled Compounds |
| HY-W244398 | 2-Thiocytidine | 13239-97-9 | Reference compound |
| HY-W244524 | Corey lactone aldehyde benzoate | 39746-01-5 | Reference compound |
| HY-W244657 | 3-(6-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 191732-74-8 | Reference compound |
| HY-W245311 | E3 ligase Ligand 51 | 2703915-71-1 | Reference compound |
| HY-W245465 | 2-Nitrobenzoic acid-d4 | 855997-63-6 | Isotope-Labeled Compounds |
| HY-W246043 | 3-Pyridine-2,4,5,6-d4-carboxylic acid, ethyl ester | 66148-16-1 | Isotope-Labeled Compounds |
| HY-W247098 | Dihydrorhodamine 6G | 217176-83-5 | Dye Reagents |
| HY-W247103 | Rhodamine 19 (perchlorate) | 62669-66-3 | Dye Reagents |
| HY-W247130 | 6-Methoxy-N-ethylquinoliniumiodide | 34373-76-7 | Reference compound |
| HY-W247131 | DASPEI | 3785-01-1 | Dye Reagents |
| HY-W247437 | E3 ligase Ligand 56 | 1472731-41-1 | Reference compound |
| HY-W247614 | D 131 | 652145-29-4 | Dye Reagents |
| HY-W247616 | (4-Aminobenzyl)phosphonic acid | 5424-27-1 | Reference compound |
| HY-W248115 | Pyrromethene 597 | 137829-79-9 | Dye Reagents |
| HY-W248118 | Pyrromethene 556 | 121461-69-6 | Dye Reagents |
| HY-W248119 | 8-(4-Iodophenyl)-1,3,5,7-tetramethyl BODIPY | 250734-47-5 | Reference compound |
| HY-W248248 | tert-Butyl 9-aminononanoate | 134857-22-0 | Reference compound |
| HY-W248583 | Pyrromethene 650 | 157410-23-6 | Dye Reagents |
| HY-W248587 | Cryptocyanine | 4727-50-8 | Dye Reagents |
| HY-W248594 | IR 813 (tosylate) | 134127-48-3 | Dye Reagents |
| HY-W248665A | Thalidomide-pyrrolidine (hydrochloride) | 2616553-35-4 | Reference compound |
| HY-W248726 | tert-Butyl (6-iodohexyl)carbamate | 172846-36-5 | Reference compound |
| HY-W248907 | Gentisyl alcohol | 495-08-9 | Reference compound |
| HY-W249257 | 4-Bromobenzoic acid-d4 | 787624-24-2 | Isotope-Labeled Compounds |
| HY-W249500 | 2-Methoxyphenyl dihydrouracil | 2377643-33-7 | Reference compound |
| HY-W249514 | 1-Methyl-1H-pyrazole-4-boronic acid pinacol ester-d3 | 1022151-50-3 | Reference compound |
| HY-W250096S | 1-Iodopropane-d7 | 59012-23-6 | Isotope-Labeled Compounds |
| HY-W250110 | Polyethylenimine (branched) (30% in water) | 9002-98-6 | Biochemical Assay Reagents |
| HY-W250110A | Polyethylenimine (linear, average Mn 10000, PDI≤1.3) | 9002-98-6 | Biochemical Assay Reagents |
| HY-W250110B | Polyethylenimine (linear, average Mn 2100, PDI<1.3) | 9002-98-6 | Biochemical Assay Reagents |
| HY-W250110C | Polyethylenimine (linear, average Mn 5000, PDI≤1.3) | 9002-98-6 | Biochemical Assay Reagents |
| HY-W250110E | Polyethylenimine (linear, average Mn 25000, PDI≤1.3) | 9002-98-6 | Biochemical Assay Reagents |
| HY-W250111 | Carboxymethyl chitosan | 83512-85-0 | Biochemical Assay Reagents |
| HY-W250112 | Lignin alkali | 8068-05-1 | Biochemical Assay Reagents |
| HY-W250113 | Zymosan A | 58856-93-2 | Biochemical Assay Reagents |
| HY-W250115 | Triethy benzyl ammonium tribromide | 120379-52-4 | Biochemical Assay Reagents |
| HY-W250116 | Co(III) protoporphyrin IX chloride | 102601-60-5 | Biochemical Assay Reagents |
| HY-W250117 | Casein phosphopeptide | 691364-49-5 | Biochemical Assay Reagents |
| HY-W250118 | Phosphatidylethanolamine | 90989-93-8 | Biochemical Assay Reagents |
| HY-W250119 | Calcium disodium edetate (hydrate) | 23411-34-9 | Biochemical Assay Reagents |
| HY-W250120 | Konjac glucomannan (Viscosity≥15000mPa.s) | 37220-17-0 | Biochemical Assay Reagents |
| HY-W250121 | Tragacanth gum | 9000-65-1 | Biochemical Assay Reagents |
| HY-W250122 | Glutamic acid (sodium salt) | 32221-81-1 | Biochemical Assay Reagents |
| HY-W250123 | Dibutyl sulfide | 544-40-1 | Biochemical Assay Reagents |
| HY-W250123R | Dibutyl sulfide (Standard) | 544-40-1 | Reference Standards |
| HY-W250124 | Ribonucleic acid (yeast) | 63231-63-0 | Biochemical Assay Reagents |
| HY-W250125 | Caramel | 8028-89-5 | Dye Reagents |
| HY-W250126 | Ethylene-vinyl acetate copolymer | 24937-78-8 | Biochemical Assay Reagents |
| HY-W250127 | Disodium terephthalate | 10028-70-3 | Biochemical Assay Reagents |
| HY-W250128 | Dodecenylsuccinic anhydride (mixture of isomers) | 26544-38-7 | Biochemical Assay Reagents |
| HY-W250129 | 2,3,4,5-Tetrafluorobenzoyl chloride | 94695-48-4 | Biochemical Assay Reagents |
| HY-W250140 | Boc-D-phenylalanyl-D-phenylalanine | 125511-90-2 | Reference compound |
| HY-W250143 | Toluidine blue (ZnCl2) | 6586-04-5 | Dye Reagents |
| HY-W250144 | Dodecylbenzenesulfonic acid | 27176-87-0 | Biochemical Assay Reagents |
| HY-W250145 | Acid Black 2 | 8005-03-6 | Dye Reagents |
| HY-W250146 | Locust bean gum, from Ceratonia siliqua seeds | 9000-40-2 | Biochemical Assay Reagents |
| HY-W250147 | Basic blue 26 | 2580-56-5 | Dye Reagents |
| HY-W250148 | Solvent black 5 | 11099-03-9 | Dye Reagents |
| HY-W250149 | Chlorophosphonazo III | 1914-99-4 | Biochemical Assay Reagents |
| HY-W250150 | Fast blue bb salt (hemi(zinc chloride) salt) | 5486-84-0 | Dye Reagents |
| HY-W250151 | Leishman's stain | 12627-53-1 | Dye Reagents |
| HY-W250152 | Polycytidylic acid (potassium) | 26936-40-3 | Biochemical Assay Reagents |
| HY-W250153 | Adenosine 3'-phosphate 5'-phosphosulfate (lithium) | 109434-21-1 | Biochemical Assay Reagents |
| HY-W250153A | Adenosine 3'-phosphate 5'-phosphosulfate (lithium, hydrate) | Biochemical Assay Reagents | |
| HY-W250154 | β-Nicotinamide adenine dinucleotide reduced (dipotassium) | 104809-32-7 | Biochemical Assay Reagents |
| HY-W250156 | 3-Acetylpyridine adenine dinucleotide (disodium) | 102029-93-6 | Biochemical Assay Reagents |
| HY-W250161 | 7-Deaza-2′-deoxyguanosine 5′-triphosphate | 101515-08-6 | Reference compound |
| HY-W250162 | dUTP | 1173-82-6 | Reference compound |
| HY-W250163 | NAD+ (lithium) | 64417-72-7 | Biochemical Assay Reagents |
| HY-W250166 | Polyoxyethylene tridecyl ether | 78330-21-9 | Biochemical Assay Reagents |
| HY-W250167 | PPG-9-ethylhexeth-5 | 64366-70-7 | Biochemical Assay Reagents |
| HY-W250168 | Polyoxyethylene(10) oleyl ether | 9004-98-2 | Biochemical Assay Reagents |
| HY-W250168A | Polyoxyethylene(20) oleyl ether | 9004-98-2 | Biochemical Assay Reagents |
| HY-W250168B | Polyoxyethylene(2) oleyl ether | Biochemical Assay Reagents | |
| HY-W250168C | Polyoxyethylene(7) oleyl ether | 9004-98-2 | Biochemical Assay Reagents |
| HY-W250168D | Polyoxyethylene(50) oleyl ether | 9004-98-2 | Biochemical Assay Reagents |
| HY-W250169 | Secondary alcohol polyoxyethylene ether | 84133-50-6 | Biochemical Assay Reagents |
| HY-W250170 | Decyl glucoside (60% in water) | 68515-73-1 | Biochemical Assay Reagents |
| HY-W250171 | Octaethylene glycol monohexadecyl ether | 5698-39-5 | Biochemical Assay Reagents |
| HY-W250172 | Polyethylene glycol tert-octylphenyl ether X-405 | 92046-34-9 | Biochemical Assay Reagents |
| HY-W250173 | Deoxy-bigchap | 86303-23-3 | Biochemical Assay Reagents |
| HY-W250174 | Lithium 3,5-diiodosalicylate | 653-14-5 | Biochemical Assay Reagents |
| HY-W250175 | Methoxypolyethylene glycol succinimidyl succinate | 78274-32-5 | Biochemical Assay Reagents |
| HY-W250176 | Polyethylene glycol trimethylnonyl ether | 60828-78-6 | Biochemical Assay Reagents |
| HY-W250177 | Tridodecylmethylammonium chloride | 7173-54-8 | Biochemical Assay Reagents |
| HY-W250178 | Octaethylene glycol monodecyl ether | 24233-81-6 | Biochemical Assay Reagents |
| HY-W250179 | Hexaethylene glycol monohexadecyl ether | 5168-91-2 | Biochemical Assay Reagents |
| HY-W250181 | Octyl thiomaltoside | 148616-91-5 | Biochemical Assay Reagents |
| HY-W250182 | Methyl 6-O-(N-heptylcarbamoyl)-α-d-glucopyranoside | 115457-83-5 | Biochemical Assay Reagents |
| HY-W250183 | Polyoxyethylene (10) stearyl ether | 9005-00-9 | Biochemical Assay Reagents |
| HY-W250183A | Polyoxyethylene (100) stearyl ether | 9005-00-9 | Biochemical Assay Reagents |
| HY-W250183B | Polyoxyethylene (20) stearyl ether | 9005-00-9 | Biochemical Assay Reagents |
| HY-W250183C | Polyoxyethylene (2) stearyl ether | 9005-00-9 | Biochemical Assay Reagents |
| HY-W250185 | Pentaethylene glycol monodecyl ether | 23244-49-7 | Biochemical Assay Reagents |
| HY-W250186 | Myristyl dimethylamine oxide | 3332-27-2 | Biochemical Assay Reagents |
| HY-W250187 | DDMAB | 15163-30-1 | Biochemical Assay Reagents |
| HY-W250189 | Tween 65 | 9005-71-4 | Biochemical Assay Reagents |
| HY-W250190 | Myristyl betaine | 2601-33-4 | Biochemical Assay Reagents |
| HY-W250191 | Tergitol | 68439-51-0 | Biochemical Assay Reagents |
| HY-W250192 | Ethanesulfonic acid (sodium salt monohydrate) | 308103-56-2 | Biochemical Assay Reagents |
| HY-W250193 | Dicyclohexyl sulfosuccinate (sodium) | 23386-52-9 | Biochemical Assay Reagents |
| HY-W250194 | Luviquat FC 550 | 95144-24-4 | Biochemical Assay Reagents |
| HY-W250195 | Hexaethylene glycol monotetradecyl ether | 5157-04-0 | Biochemical Assay Reagents |
| HY-W250196 | Nonyl-β-D-1-thiomaltoside | 148565-55-3 | Biochemical Assay Reagents |
| HY-W250197 | ASB-16 | 52562-29-5 | Biochemical Assay Reagents |
| HY-W250198 | Hexaethylene glycol monododecyl ether | 3055-96-7 | Biochemical Assay Reagents |
| HY-W250199 | Polyethylene glycol monooctyl ether | 27252-75-1 | Biochemical Assay Reagents |
| HY-W250300 | 2-(Dodecyloxy)ethanol | 4536-30-5 | Biochemical Assay Reagents |
| HY-W250301 | Coceth-3 | 61791-13-7 | Biochemical Assay Reagents |
| HY-W250302 | Methylbenzethonium (chloride) | 25155-18-4 | Biochemical Assay Reagents |
| HY-W250302R | Methylbenzethonium (chloride) (Standard) | 25155-18-4 | Reference Standards |
| HY-W250303 | Malic acid (disodium salt) | 676-46-0 | Biochemical Assay Reagents |
| HY-W250303A | Malic acid (disodium hydrate) | 63474-37-3 | Biochemical Assay Reagents |
| HY-W250304 | ANS (ammonium hydrate) | 206659-00-9 | Biochemical Assay Reagents |
| HY-W250305 | Calcium malate | 16426-50-9 | Biochemical Assay Reagents |
| HY-W250306 | Carbol fuchsin | 4197-24-4 | Dye Reagents |
| HY-W250307 | Diphenyliodonium (iodide) | 2217-79-0 | Biochemical Assay Reagents |
| HY-W250308 | ε-Poly-L-lysine (MW 3800-4200) | 28211-04-3 | Biochemical Assay Reagents |
| HY-W250308A | ε-Poly-L-lysine (hydrochloride) (MV 2000-5000) | Biochemical Assay Reagents | |
| HY-W250309 | Pentaerythritol tetra(3-mercaptopropionate) | 7575-23-7 | Biochemical Assay Reagents |
| HY-W250310 | L-Arginine α-ketoglutarate | 16856-18-1 | Biochemical Assay Reagents |
| HY-W250311 | DL-Aspartic acid (hemimagnesium salt) | 1187-91-3 | Biochemical Assay Reagents |
| HY-W250313 | Polylactic acid | 26100-51-6 | Biochemical Assay Reagents |
| HY-W250315 | Polypectate (sodium) | 9049-37-0 | Natural Products |
| HY-W250316 | Alpha-d-Glucopyranoside, beta-d-fructofuranosyl, octadecanoate | 37318-31-3 | Biochemical Assay Reagents |
| HY-W250381S1 | Sodium deuteroxide, (D,99.5%, basicity 30%) | 14014-06-3 | Isotope-Labeled Compounds |
| HY-W250408 | Fmoc-NMe-Val-Val-Dil-Dap-OH | 1352202-13-1 | Reference compound |
| HY-W250446 | (R)-Methyl 3-hydroxydecanoate | 56618-58-7 | Reference compound |
| HY-W250466 | Ethylene glycol monohexadecyl ether | 2136-71-2 | Biochemical Assay Reagents |
| HY-W250541 | Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH | 2414254-47-8 | Reference compound |
| HY-W250574 | NOTA-bis(tBu)ester | 1161415-28-6 | Biochemical Assay Reagents |
| HY-W250580 | Dimethicone | 9006-65-9 | Reference compound |
| HY-W250610S | 2,4′-Dichlorobiphenyl-d8 | 1219795-19-3 | Isotope-Labeled Compounds |
| HY-W250714 | DL-Ala-DL-Val-OH | 1999-46-8 | Reference compound |
| HY-W250715 | H-Ala-d-Ala-OH | 3695-80-5 | Peptides |
| HY-W250721 | Carbomer 980 | 9007-20-9 | Biochemical Assay Reagents |
| HY-W250721A | Carbomer 940 | 9007-20-9 | Biochemical Assay Reagents |
| HY-W250721B | Carbomer 934 | 9007-20-9 | Biochemical Assay Reagents |
| HY-W250721C | Carbomer 941 | 9007-20-9 | Biochemical Assay Reagents |
| HY-W250721D | Carbomer | 9007-20-9 | Reference compound |
| HY-W250721E | Carbomer copolymer | 9007-20-9 | Reference compound |
| HY-W250721F | Carbomer homopolymer | 9007-20-9 | Reference compound |
| HY-W250721G | Carbomer interpolymer | 9007-20-9 | Reference compound |
| HY-W250725 | H-GLU-AMC-OH | 98516-76-8 | Reference compound |
| HY-W250727 | TNS (sodium) | 53313-85-2 | Biochemical Assay Reagents |
| HY-W250735 | NHS-PEG4-biotinidase resistant biotin | 1334172-61-0 | Reference compound |
| HY-W250743 | Cresyl diphenyl phosphate | 26444-49-5 | Reference compound |
| HY-W250795 | Maltodextrin, dextrose equivalent 16.5-19.5 | 9050-36-6 | Reference compound |
| HY-W250795A | Maltodextrin, dextrose equivalent 13.0-17.0 | 9050-36-6 | Biochemical Assay Reagents |
| HY-W250795B | Maltodextrin, dextrose equivalent 5.0-8.0 | 9050-36-6 | Biochemical Assay Reagents |
| HY-W250844A | DO3A (trisodium) | 217973-03-0 | Biochemical Assay Reagents |
| HY-W250928A | Biotin-PEG-azide (MW 600) | 956494-20-5 | Reference compound |
| HY-W250928B | Biotin-PEG-azide (MW 1000) | 956494-20-5 | Reference compound |
| HY-W250928C | Biotin-PEG-azide (MW 2000) | 956494-20-5 | Dye Reagents |
| HY-W250928D | Biotin-PEG-azide (MW 3400) | 956494-20-5 | Dye Reagents |
| HY-W250928E | Biotin-PEG-azide (MW 5000) | 956494-20-5 | Reference compound |
| HY-W250929 | Maleimido-mono-amide-DOTA-tris(t-Bu ester) | 1613382-10-7 | Biochemical Assay Reagents |
| HY-W250971 | 16-DOXYL-stearic Acid Free Radical | 53034-38-1 | Reference compound |
| HY-W250973 | Galvinoxyl free radical | 2370-18-5 | Reference compound |
| HY-W250978 | Ovalbumins | 9006-59-1 | Biochemical Assay Reagents |
| HY-W250978A | Ovalbumin, low endotoxin | 9006-59-1 | Biochemical Assay Reagents |
| HY-W250992 | Boc-L-Lys(N3)-OH (CHA) | 2098497-30-2 | Reference compound |
| HY-W251143 | N,N′-Bis(2,5-di-tert-butylphenyl)-3,4,9,10-perylenedicarboximide | 83054-80-2 | Reference compound |
| HY-W251144 | N,N′-Dipentyl-3,4,9,10-perylenedicarboximide | 76372-75-3 | Reference compound |
| HY-W251181 | Isobutylamido thiazolyl resorcinol | 1428450-95-6 | Reference compound |
| HY-W251284A | 3-Anilinopiperidine (dihydrochloride) | 2751621-53-9 | Reference compound |
| HY-W251393 | S-(2-Carboxypropyl)-L-cysteine | 6852-42-2 | Reference compound |
| HY-W251428 | Phosphatidylglycerols (egg) (sodium salt) | 383907-64-0 | Biochemical Assay Reagents |
| HY-W251598B | Sodium bicarbonate, for molecular biology | 144-55-8 | Biochemical Assay Reagents |
| HY-W251598C | Sodium bicarbonate, for cell culture | 144-55-8 | Biochemical Assay Reagents |
| HY-W251598I | Sodium bicarbonate, meets analytical specification of Ph. Eur., BP, USP, FCC, E500 | 144-55-8 | Biochemical Assay Reagents |
| HY-W251598J | Sodium bicarbonate, United States Pharmacopeia (USP) Reference Standard | 144-55-8 | Biochemical Assay Reagents |
| HY-W251598JR | Sodium bicarbonate, United States Pharmacopeia (USP) Reference Standard (Standard) | 144-55-8 | Reference Standards |
| HY-W251598S | Bicarbonate-13C (sodium) | 87081-58-1 | Isotope-Labeled Compounds |
| HY-W251687 | 2'-Deoxy-2'-fluoroarabinoadenosine | 20227-41-2 | Reference compound |
| HY-W251756 | 3-(2-Iodoethoxy)prop-1-yne | 164118-56-3 | Reference compound |
| HY-W251779 | 3-Sulfopropanoic acid | 44826-45-1 | Natural Products |
| HY-W251781 | 4-Thio-2’-deoxyuridine | 5580-20-1 | Reference compound |
| HY-W259250S | 5-Chloropyridin-3,4,6-d3-2-amine | 1093384-99-6 | Isotope-Labeled Compounds |
| HY-W259489S | Picolinic acid-d4 | 284487-61-2 | Isotope-Labeled Compounds |
| HY-W259542 | O-Proparagyl-N-Boc-ethanolamine | 634926-63-9 | Reference compound |
| HY-W259668 | Homopropargylglycine | 215160-72-8 | Reference compound |
| HY-W259767 | 3-Iodo-L-phenylalanine | 20846-39-3 | Reference compound |
| HY-W259888 | (R)-2-Hydroxysuccinic acid methyl ester | 83540-94-7 | Biochemical Assay Reagents |
| HY-W259932 | Lenalidomide 5'-piperazine | 2222120-31-0 | Reference compound |
| HY-W261325 | FGFR1 inhibitor-15 | 459137-97-4 | Reference compound |
| HY-W263279 | (E)-Guanabenz | 60329-03-5 | Reference compound |
| HY-W264038 | 4-Fluorohippuric acid | 366-79-0 | Biochemical Assay Reagents |
| HY-W264306 | (2,4,6-Trimethyl-phenoxy)-acetic acid | 13333-81-8 | Biochemical Assay Reagents |
| HY-W264347 | DCN1-UBC12-IN-4 | 26028-65-9 | Reference compound |
| HY-W264526 | N-Boc-L-alanyl-L-alanine methyl ester | 19794-10-6 | Reference compound |
| HY-W264744 | 3-Maleimidobenzoic acid | 17057-07-7 | Reference compound |
| HY-W265730 | N-(2-Aminoethyl)piperazine-1,4-diethylamine | 31295-54-2 | Reference compound |
| HY-W265757 | 4-Ethylcatechol | 1124-39-6 | Reference compound |
| HY-W265821 | 1,4-Diaminoanthraquinone | 128-95-0 | Biochemical Assay Reagents |
| HY-W265951 | 3-Methylcarbostyril | 2721-59-7 | Reference compound |
| HY-W265961 | Squoxin | 1096-84-0 | Reference compound |
| HY-W267062A | BI SF3 (hydrochloride) | 1801257-24-8 | Reference compound |
| HY-W267205 | 3-Acetyl-7-Hydroxycoumarin | 10441-27-7 | Reference compound |
| HY-W267364 | Coumarin 343 | 55804-65-4 | Reference compound |
| HY-W267393 | 4,6-Dimethyl-7-ethylaminocoumarin | 26078-25-1 | Dye Reagents |
| HY-W267444 | Pentyl 4-hydroxybenzoate | 6521-29-5 | Reference compound |
| HY-W267444S | Pentyl 4-hydroxybenzoate-d4 | 1219798-66-9 | Isotope-Labeled Compounds |
| HY-W267446 | 6-Methoxy-4-methylcoumarin | 6295-35-8 | Reference compound |
| HY-W267459 | 2,3-Diphenylmaleic anhydride | 4808-48-4 | Reference compound |
| HY-W267897 | 7-Benzyloxy-4-(trifluoromethyl)coumarin | 220001-53-6 | Reference compound |
| HY-W267932 | WAY-271999 | 147920-34-1 | Reference compound |
| HY-W267959 | Diethyl 2,6-dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate | 1165-06-6 | Reference compound |
| HY-W268109S | 3-Mercaptopentan-2-one-d2 | 136430-26-7 | Isotope-Labeled Compounds |
| HY-W268155 | 3,4'-Dihydroxypropiophenone | 53170-93-7 | Natural Products |
| HY-W268197 | Coumarin 480 | 41267-76-9 | Reference compound |
| HY-W268334 | 1,2,3,4-Tetrahydronorharman-1-one | 17952-82-8 | Natural Products |
| HY-W268542 | 4-Acetylaminoantipyrine | 83-15-8 | Reference compound |
| HY-W268542R | 4-Acetylaminoantipyrine (Standard) | 83-15-8 | Reference Standards |
| HY-W268542S | 4-Acetamidoantipyrine-d3 | Isotope-Labeled Compounds | |
| HY-W268942 | 4-Nitrosodiphenylamine | 156-10-5 | Reference compound |
| HY-W269179 | 4-Bromomethyl-6,7-dimethoxycoumarin | 88404-25-5 | Dye Reagents |
| HY-W269306 | Bonaphthone | 6954-48-9 | Reference compound |
| HY-W269368 | Heptacosane | 593-49-7 | Natural Products |
| HY-W269368R | Heptacosane (Standard) | 593-49-7 | Reference Standards |
| HY-W269387 | 1,6-Dimethylnaphthalene | 575-43-9 | Reference compound |
| HY-W269511 | NW-1689 | 405-85-6 | Reference compound |
| HY-W269593 | Perfluorodecanoic acid | 335-76-2 | Reference compound |
| HY-W269693S | 5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-d5,13C3 | Isotope-Labeled Compounds | |
| HY-W269700S | Ile-(Leu-13C6,15N)-OH (TFA) | Isotope-Labeled Compounds | |
| HY-W269747 | 4,4'-Dimethoxyoctafluorobiphenyl | 2200-71-7 | Reference compound |
| HY-W269799 | 4-Pentenyl isothiocyanate | 18060-79-2 | Natural Products |
| HY-W269799R | 4-Pentenyl isothiocyanate (Standard) | 18060-79-2 | Reference Standards |
| HY-W269867 | Tetratriacontane | 14167-59-0 | Natural Products |
| HY-W269867R | Tetratriacontane (Standard) | 14167-59-0 | Reference Standards |
| HY-W269867S | Tetratriacontane-d70 | 1219805-47-6 | Isotope-Labeled Compounds |
| HY-W270557S | Lodoxamide impurity 2-d10 | Isotope-Labeled Compounds | |
| HY-W270591 | 2-Methoxyphenyl benzoate | 531-37-3 | Reference compound |
| HY-W270730 | Dec-2-yn-1-ol | 4117-14-0 | Reference compound |
| HY-W270810 | Nurr1 agonist 8 | 360778-55-8 | Reference compound |
| HY-W271064 | 1-Methylpyrene | 2381-21-7 | Dye Reagents |
| HY-W271517 | N-Acetyl-α-D-glucosamine | 10036-64-3 | Biochemical Assay Reagents |
| HY-W272058 | Isometronidazole | 705-19-1 | Reference compound |
| HY-W272058R | Isometronidazole (Standard) | 705-19-1 | Reference Standards |
| HY-W272058S | Isometronidazole-d4 | 2469037-64-5 | Isotope-Labeled Compounds |
| HY-W272058S1 | Isometronidazole-d4 (hydrochloride) | 2748356-10-5 | Isotope-Labeled Compounds |
| HY-W272217 | Octacosane | 630-02-4 | Reference compound |
| HY-W272217R | Octacosane (Standard) | 630-02-4 | Reference Standards |
| HY-W272217S | Octacosane-d58 | 16416-33-4 | Isotope-Labeled Compounds |
| HY-W272390S | 1,8-Dimethylnaphthalene-d12 | 104489-29-4 | Isotope-Labeled Compounds |
| HY-W272401 | 4-Methyl-2-oxo-2H-chromene-6,7-diyl diacetate | 55939-28-1 | Biochemical Assay Reagents |
| HY-W272699 | Utrophin activator-1 | 381208-40-8 | Reference compound |
| HY-W273130 | Glycyl-L-asparagine | 1999-33-3 | Reference compound |
| HY-W273133 | Henicosan-11-one | 19781-72-7 | Natural Products |
| HY-W273209 | Pentamethoxy red | 1755-51-7 | Biochemical Assay Reagents |
| HY-W273281 | 6,6′-Dithiodinicotinic acid | 15658-35-2 | Reference compound |
| HY-W273413 | 4-Hydrazino-7-nitro-benzofurazan hydrazine adduct | 131467-87-3 | Dye Reagents |
| HY-W273690 | Pentifylline | 1028-33-7 | Reference compound |
| HY-W274194 | Antioxidant agent-7 | 82408-04-6 | Reference compound |
| HY-W274501 | 2-Nonyl alcohol | 628-99-9 | Natural Products |
| HY-W274569 | Hexyl-β-D-glucopyranoside, 98% | 59080-45-4 | Reference compound |
| HY-W275039 | Phenylquinone | 363-03-1 | Reference compound |
| HY-W275048 | MAO-A inhibitor 3 | 35924-44-8 | Reference compound |
| HY-W275220 | PEA-NBOMe (hydrochloride) | 3241-03-0 | Reference compound |
| HY-W275290S | Ethyl 4-isocyanatobenzoate-d4 | 1219802-91-1 | Isotope-Labeled Compounds |
| HY-W275295 | Perfluorododecanoic acid | 307-55-1 | Reference compound |
| HY-W275481S | 5-Octyldihydrofuran-2(3H)-one-d2 | 1082581-85-8 | Isotope-Labeled Compounds |
| HY-W275481S1 | 5-Octyldihydrofuran-2(3H)-one-d4 | Isotope-Labeled Compounds | |
| HY-W275481S2 | 5-Octyldihydrofuran-2(3H)-one-d7 | 1104979-35-2 | Isotope-Labeled Compounds |
| HY-W275547 | 5-Bromo-4-chloro-1H-indol-3-yl β-D-xylopyranoside | 207606-55-1 | Biochemical Assay Reagents |
| HY-W275553 | 4-Decanol | 2051-31-2 | Natural Products |
| HY-W275616 | 4-Methylumbelliferyl nonanoate | 18319-93-2 | Reference compound |
| HY-W276106 | KM02894 | 116850-74-9 | Reference compound |
| HY-W276164 | Sodium octadecyl sulfate | 1120-04-3 | Biochemical Assay Reagents |
| HY-W276446 | 1,1-Diphenyl-4-(pyrrolidin-1-yl)but-2-yn-1-ol | 968-63-8 | Reference compound |
| HY-W276819 | PLK1-IN-9 | 893772-67-3 | Reference compound |
| HY-W277691 | 2-Naphthalenyl β-D-glucopyranoside | 6044-30-0 | Biochemical Assay Reagents |
| HY-W277900 | 2-Methoxy-2,4-diphenylfuran-3-one | 50632-57-0 | Dye Reagents |
| HY-W278021 | BTA-1 | 439858-28-3 | Reference compound |
| HY-W278072 | Calcium Channel antagonist 1 | 43067-01-2 | Reference compound |
| HY-W278072R | Calcium Channel antagonist 1 (Standard) | 43067-01-2 | Reference Standards |
| HY-W278232 | Urease-IN-6 | 362502-79-2 | Reference compound |
| HY-W278362S | 2-Acetamidobenzamide-d3 | Isotope-Labeled Compounds | |
| HY-W278566 | Saluamine | 3086-91-7 | Reference compound |
| HY-W278566R | Saluamine (Standard) | 3086-91-7 | Reference Standards |
| HY-W278582 | Topoisomerase II inhibitor 14 | 305343-00-4 | Reference compound |
| HY-W278706 | N-[4-(2-Benzimidazolyl)phenyl]maleimide | 27030-97-3 | Dye Reagents |
| HY-W278777 | Monohexyl phthalate | 24539-57-9 | Reference compound |
| HY-W278861S | Desoxy-Mequindox-13C6 | Isotope-Labeled Compounds | |
| HY-W278867 | trans-3,5-Dimethoxystilbene | 21956-56-9 | Natural Products |
| HY-W278906 | Ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 209538-87-4 | Reference compound |
| HY-W278944 | Antiproliferative agent-15 | 19819-18-2 | Reference compound |
| HY-W279140S | Pirlindole-d4 (hydrochloride) | 1801617-88-8 | Isotope-Labeled Compounds |
| HY-W279150 | 6-Chloro-3-indoxyl phosphate (p-toluidine) | 159954-33-3 | Biochemical Assay Reagents |
| HY-W279223 | Potassium tetrakis(4-chlorophenyl)borate | 14680-77-4 | Reference compound |
| HY-W279260 | APOBEC3G-IN-1 | 14261-92-8 | Reference compound |
| HY-W280197 | 5-Bromo-4-chloro-3-indolyl-α-D-glucopyranoside, 98% | 108789-36-2 | Biochemical Assay Reagents |
| HY-W280214S | n-Nonylbenzene-2,3,4,5,6-d5 | 20216-93-7 | Isotope-Labeled Compounds |
| HY-W280214S1 | Nonylbenzene-d24 | 1219799-13-9 | Isotope-Labeled Compounds |
| HY-W280349 | 1-Phenylsemicarbazide | 103-03-7 | Reference compound |
| HY-W280531S | DNSAH-13C6 | Isotope-Labeled Compounds | |
| HY-W280531S1 | DNSAH-15N2 | 1346598-09-1 | Isotope-Labeled Compounds |
| HY-W280618S | 4-(4-Chloro-2-methylphenoxy)butanoic acid-d3 | 1219803-42-5 | Isotope-Labeled Compounds |
| HY-W280622 | N-Ethyl-4-methoxyamphetamine (hydrochloride) | 93963-24-7 | Reference compound |
| HY-W281364 | 2-Ammo-3-memyl-imidazo-[4,5-f]-quinoIine | 76180-96-6 | Reference compound |
| HY-W281713 | 3,6-Dichlorofluorescein | 630-88-6 | Reference compound |
| HY-W281799 | 2,3-Bis(octadecyloxy)propan-1-ol | 6076-38-6 | Biochemical Assay Reagents |
| HY-W281862 | Sequifenadine | 57734-69-7 | Reference compound |
| HY-W281950 | 2-(Carbamimidoylsulfanyl)acetic acid (hydrochloride) | 5425-78-5 | Reference compound |
| HY-W282259 | PTH-tyrosine | 4332-95-0 | Biochemical Assay Reagents |
| HY-W282368 | 3-Hydroxynonanoic acid | 40165-87-5 | Natural Products |
| HY-W282615 | Antibacterial agent 117 | 341944-06-7 | Reference compound |
| HY-W282663 | Henicosan-11-ol | 3381-26-8 | Natural Products |
| HY-W282887S | 2-(4-Nonylphenoxy)acetic acid-d2 | 1219798-75-0 | Isotope-Labeled Compounds |
| HY-W283166 | n-Undecyl β-D-maltopyranoside | 253678-67-0 | Biochemical Assay Reagents |
| HY-W283245 | 4-Nitrophenyl β-L-fucopyranoside | 22153-71-5 | Biochemical Assay Reagents |
| HY-W283271 | 3-Methylcyclohex-2-en-1-ol | 21378-21-2 | Natural Products |
| HY-W283336S | 2,5-Di-(tert-butyl)-4-methoxyphenol-3,6-d20 | 1219802-07-9 | Isotope-Labeled Compounds |
| HY-W283359 | 4-Methylumbelliferyl β-D-ribofuranoside | 195385-93-4 | Biochemical Assay Reagents |
| HY-W283556 | DO2A-tert-butyl ester | 162148-48-3 | Biochemical Assay Reagents |
| HY-W283596S | p-Azoxyanisole-d6 | 34172-21-9 | Isotope-Labeled Compounds |
| HY-W283704 | Fmoc-(Dmb)Ala-OH | 1425938-66-4 | Peptides |
| HY-W283888 | 5-Bromo-4-chloro-1H-indol-3-yl nonanoate | 133950-77-3 | Biochemical Assay Reagents |
| HY-W283889 | Blue caprate | 133950-71-7 | Biochemical Assay Reagents |
| HY-W284558 | Sodium hexadecyl sulfate | 1120-01-0 | Reference compound |
| HY-W284558S | Sodium hexadecyl sulfate-d33 | 2708287-31-2 | Isotope-Labeled Compounds |
| HY-W285163S | 1-Cyclopropyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid-d8 | Isotope-Labeled Compounds | |
| HY-W285243 | 3′-Hydroxyflavanone | 92496-65-6 | Reference compound |
| HY-W285602 | (4-Aminophenyl)(4-(2-fluorophenyl)piperazin-1-yl)methanone | 885949-71-3 | Reference compound |
| HY-W286059 | 2-Aminohexadecanoic acid | 7769-79-1 | Biochemical Assay Reagents |
| HY-W286073 | Hexaethylene glycol decyl ether | 5168-89-8 | Reference compound |
| HY-W286101 | Methyl 15-hydroxypentadecanoate | 76529-42-5 | Natural Products |
| HY-W286307 | Haloxyfop-methyl | 69806-40-2 | Reference compound |
| HY-W286307R | Haloxyfop-methyl (Standard) | 69806-40-2 | Reference Standards |
| HY-W286362 | Palmitanilide | 6832-98-0 | Reference compound |
| HY-W286423 | L-Pyroglutamic acid 7-amido-4-methylcoumarin | 66642-36-2 | Biochemical Assay Reagents |
| HY-W286489 | 2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranose | 64768-20-3 | Reference compound |
| HY-W286613 | N-Boc-Biocytin | 62062-43-5 | Reference compound |
| HY-W286614 | RSK2-IN-4 | 62001-32-5 | Reference compound |
| HY-W286743 | Nε-(Carboxymethyl)-L-lysine | 5746-04-3 | Biochemical Assay Reagents |
| HY-W286743S | CML-d4 | 936233-18-0 | Isotope-Labeled Compounds |
| HY-W286743S1 | CML-d3 | 2699607-49-1 | Isotope-Labeled Compounds |
| HY-W286805 | Perinaphthenone | 548-39-0 | Reference compound |
| HY-W286906 | Mcl1-IN-15 | 518303-27-0 | Reference compound |
| HY-W286910 | 3-Decyn-1-ol | 51721-39-2 | Reference compound |
| HY-W286946 | 2-(Acetylamino)-2-deoxy-4,6-O-(1-methylethylidene)-D-glucose | 50605-09-9 | Biochemical Assay Reagents |
| HY-W287494 | Antitumor agent-202 | 38470-63-2 | Reference compound |
| HY-W287569 | STK683963 | 370073-65-7 | Reference compound |
| HY-W287589S | 1,1-Diethoxyhexane-d10 | Isotope-Labeled Compounds | |
| HY-W288025 | ALXR-agonist-6 | 325850-26-8 | Reference compound |
| HY-W288196 | 4,6-Dibenzoylresorcinol | 3088-15-1 | Reference compound |
| HY-W288349 | 8-Quinolinyl β-D-glucopyranoside | 29266-96-4 | Biochemical Assay Reagents |
| HY-W288375 | (R)-3-Hydroxytetradecanoic acid | 28715-21-1 | Natural Products |
| HY-W288587S | 3-Methyloctane-d20 | 345909-08-2 | Isotope-Labeled Compounds |
| HY-W288603 | WAY-324572 | 219988-92-8 | Reference compound |
| HY-W288642 | 6-(3,4,5-Trimethoxybenzamido)hexanoic acid | 21434-91-3 | Reference compound |
| HY-W288676 | 6-Fluoro-3-indolyl-β-D-galactopyranoside | 207727-11-5 | Biochemical Assay Reagents |
| HY-W288788S | 5-Methylheptan-3-ol-d18 | 2708283-13-8 | Isotope-Labeled Compounds |
| HY-W288838 | 1,7-Dioxaspiro[5.5]undecane | 180-84-7 | Natural Products |
| HY-W288857 | Docosyl docosanoate | 17671-27-1 | Natural Products |
| HY-W288951 | FMP-API-1 | 16523-28-7 | Reference compound |
| HY-W289054S | (S)-Metolachlor metabolite CGA 50720-d3 | Isotope-Labeled Compounds | |
| HY-W289064 | 1-Hexadecanesulfonic acid sodium salt, 98% | 15015-81-3 | Biochemical Assay Reagents |
| HY-W289164 | Nonyl acetate | 143-13-5 | Natural Products |
| HY-W290273 | 2-Nitrophenyl-β-D-thiogalactopyranoside | 1158-17-4 | Biochemical Assay Reagents |
| HY-W290527 | 2-Isopropyl-5-methylanisole | 1076-56-8 | Reference compound |
| HY-W290532 | (Rac)-Dapoxetine (hydrochloride) | 1071929-03-7 | Reference compound |
| HY-W290839 | N4-Acetylsulfamethazine | 100-90-3 | Reference compound |
| HY-W291131 | Isatin-β-thiosemicarbazone | 27830-79-1 | Reference compound |
| HY-W291634 | H-D-Glu-OtBu (hydrochloride) | 200616-62-2 | Reference compound |
| HY-W291642 | Bis[2-(4-azidosalicylamido)ethyl] disulfide | 199804-21-2 | Biochemical Assay Reagents |
| HY-W291721 | 3-(2,3-Dimethylphenyl)-2-methylquinazolin-4-one | 1915-79-3 | Reference compound |
| HY-W291944 | 5-Bromo-4-chloro-3-indolyl-α-L-fucopyranoside | 171869-92-4 | Biochemical Assay Reagents |
| HY-W292085 | 6-Chloro-1H-indol-3-yl β-D-glucopyranoside | 159954-28-6 | Biochemical Assay Reagents |
| HY-W292263S | 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-(hexyloxy)phenol-d5 | Isotope-Labeled Compounds | |
| HY-W292927 | (E)-Antiviral agent 67 | 132603-49-7 | Reference compound |
| HY-W293109 | AB-PINACA 3-Carboxyindazole metabolite | 1283576-17-9 | Reference compound |
| HY-W293502 | 2-Chloro-4-nitrophenyl-β-D-galactopyranoside | 123706-60-5 | Biochemical Assay Reagents |
| HY-W294348 | Prenderol | 115-76-4 | Reference compound |
| HY-W294556S | 1-Benzyl-4-methylenepiperidine-13C, d6 | Isotope-Labeled Compounds | |
| HY-W294889 | OUL245 | 1023814-45-0 | Reference compound |
| HY-W295201 | ROCK-IN-11 | 445267-51-6 | Reference compound |
| HY-W295339S | N-Desmethyl venlafaxine-d3 | 1189980-40-2 | Isotope-Labeled Compounds |
| HY-W295873 | Cyclo(Phe-Gly) | 5037-75-2 | Natural Products |
| HY-W296398 | 5-Bromo-N,N-dimethyltryptamine | 17274-65-6 | Reference compound |
| HY-W297348 | (Rac)-Cl-amidine | 1965308-76-2 | Reference compound |
| HY-W297421 | (S)-Tomoxetine hydrochloride | 82857-39-4 | Reference compound |
| HY-W297715 | 7-Acetoxy-4-bromomethylcoumarin | 2747-04-8 | Dye Reagents |
| HY-W298929 | Fmoc-Gly-Phe-OH | 117370-45-3 | Reference compound |
| HY-W300403A | Cinfenoac (disodium) | 68461-38-1 | Reference compound |
| HY-W302789 | p-Nitrophenyl 2-acetamido-3,4,6-tri-O-acetyl-β-D-glucopyranoside | 13089-27-5 | Biochemical Assay Reagents |
| HY-W302791 | Ethyl 3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-α-D-thioglucopyranoside | 49810-41-5 | Biochemical Assay Reagents |
| HY-W303130S | Sinapic acid ethyl ester-d3 | Isotope-Labeled Compounds | |
| HY-W303135 | EMPO | 61856-99-3 | Reference compound |
| HY-W303895 | Luteolin (monohydrate) | 6113-16-2 | Reference compound |
| HY-W306065 | hCAI/II/XII-IN-1 | 100142-87-8 | Reference compound |
| HY-W309130 | (S)-Tolterodine | 124937-53-7 | Reference compound |
| HY-W312068 | TMB (dihydrochloride hydrate) | 312693-82-6 | Biochemical Assay Reagents |
| HY-W317373 | Z-Phe-gly-oh | 13122-99-1 | Reference compound |
| HY-W317408 | (+)-Menthyl acetate | 5157-89-1 | Biochemical Assay Reagents |
| HY-W317414 | Indole-3-acetylglycine | 13113-08-1 | Biochemical Assay Reagents |
| HY-W317469 | 6-Bromo-2-naphthalenyl α-D-galactopyranoside | 25997-59-5 | Biochemical Assay Reagents |
| HY-W317470 | 2,3,5-Tri-O-benzoyl-β-D-ribofuranosyl cyanide | 23316-67-8 | Biochemical Assay Reagents |
| HY-W317471 | 5-Bromo-6-chloro-3-indolyl a-D-glucopyranoside | 878495-64-8 | Biochemical Assay Reagents |
| HY-W317473 | Ethyl 1-thio-β-D-galactopyranoside tetraacetate | 55722-49-1 | Biochemical Assay Reagents |
| HY-W317853 | Protonstatin-1 | 521972-99-6 | Reference compound |
| HY-W318448 | Ortho-fluoro 4-ANBP | 416876-71-6 | Reference compound |
| HY-W318577 | 4-Hydroxy-1-(2-phenylethyl)piperidine | 3518-76-1 | Reference compound |
| HY-W319094 | 4′-Hydroxyflavone | 4143-63-9 | Reference compound |
| HY-W319189 | 2-(Chloromethyl)-3-(2-methylphenyl)quinazolin-4(3H)-one | 3166-54-9 | Reference compound |
| HY-W319335 | 2,4,6-Tribromo-3-methylphenol | 4619-74-3 | Reference compound |
| HY-W319374 | 2-(Methylsulfonyl)ethyl n-succinimidyl carbonate | 57903-15-8 | Reference compound |
| HY-W319671S | 2-Methoxy-4,5-dihydro-1H-imidazole-d4 | 402788-68-5 | Isotope-Labeled Compounds |
| HY-W319939 | 3-(4-Hydroxy-3-methoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one | 104236-73-9 | Reference compound |
| HY-W320032 | 5-Bromo-1H-indol-3-yl octanoate | 133950-69-3 | Dye Reagents |
| HY-W320239 | QDPR-IN-1 | 29415-71-2 | Reference compound |
| HY-W320276 | Dill apiole | 484-31-1 | Reference compound |
| HY-W320397 | 4-(2-Aminoethylamino)-7-(N,N-dimethylsulfamoyl)benzofurazan | 189373-41-9 | Dye Reagents |
| HY-W320538 | Benz[g]isoquinoline-5,10-dione | 46492-08-4 | Reference compound |
| HY-W320659 | 11-Dodecenoic acid | 65423-25-8 | Reference compound |
| HY-W320685 | (S)-N-Boc-L-homoserine ethyl ester | 147325-09-5 | Reference compound |
| HY-W321016S | SWEP-d3 | Isotope-Labeled Compounds | |
| HY-W321446 | Dansyl ethylenediamine | 35060-08-3 | Dye Reagents |
| HY-W322022 | Disodium phenyl phosphate | 3279-54-7 | Biochemical Assay Reagents |
| HY-W322222 | Ethyl (E,Z)-2,4-decadienoate | 3025-30-7 | Natural Products |
| HY-W322225 | 1,2-Dilauroyl-sn-glycero-3-phosphoethanolamine | 59752-57-7 | Reference compound |
| HY-W322231 | 2-Naphthalenyl 6-deoxy-α-L-galactopyranoside | 63503-05-9 | Biochemical Assay Reagents |
| HY-W322573 | (R)-Ketoprofen | 56105-81-8 | Reference compound |
| HY-W322575 | 1,2-Diheptadecanoyl-sn-glycero-3-phosphorylcholine | 70897-27-7 | Reference compound |
| HY-W324220 | 11β-HSD1-IN-10 | 849021-37-0 | Reference compound |
| HY-W324243 | 11β-HSD1-IN-9 | 88283-34-5 | Reference compound |
| HY-W324382 | 2,2-Dibromomalonamide | 73003-80-2 | Reference compound |
| HY-W324391 | Coumarin 106 | 41175-45-5 | Reference compound |
| HY-W324406 | 1,2-Diamino-3,4-ethylenedioxybenzene | 320386-55-8 | Dye Reagents |
| HY-W324424 | 2,4-Dimethoxytoluene | 38064-90-3 | Biochemical Assay Reagents |
| HY-W324458 | MCA succinimidyl ester | 359436-89-8 | Dye Reagents |
| HY-W324882 | Salinazid | 495-84-1 | Reference compound |
| HY-W325322 | 3,4,5-Trimethylphenol | 527-54-8 | Reference compound |
| HY-W325356 | tert-Butyl 3,5-dinitrobenzoate | 5342-97-2 | Reference compound |
| HY-W325509 | AH 8532 | 786581-55-3 | Reference compound |
| HY-W325699 | HIV-1 inhibitor-48 | 374067-85-3 | Reference compound |
| HY-W326021 | Phenolphthalol | 81-92-5 | Reference compound |
| HY-W326094 | Dinaline | 58338-59-3 | Reference compound |
| HY-W326260 | AH 8529 | 41805-00-9 | Reference compound |
| HY-W326740 | 5-Bromo-4-methylpyrimidin-2-ol | 69849-34-9 | Reference compound |
| HY-W327027 | 7-(2,4-Dinitrophenoxy)-4-methyl-2H-chromen-2-one | 314742-00-2 | Reference compound |
| HY-W327038 | 7-Piperazin-1-yl-thieno[2,3-c] pyridine (hydrochloride) | 850734-85-9 | Reference compound |
| HY-W327122 | BAP1-IN-1 | 353495-21-3 | Reference compound |
| HY-W327145 | Lysylglutamic acid | 45234-02-4 | Reference compound |
| HY-W327449 | Feruloylputrescine | 501-13-3 | Reference compound |
| HY-W327655 | 4-(2-Diethylaminoethyl)pyridine | 67580-61-4 | Reference compound |
| HY-W327808 | DL-Lanthionine | 3183-08-2 | Reference compound |
| HY-W327865S | 2-(Methylthio)naphthalene-d3 | 1354703-39-1 | Isotope-Labeled Compounds |
| HY-W327886 | PIPES (dipotassium) | 108321-27-3 | Biochemical Assay Reagents |
| HY-W327895S | Tris(4-chlorophenyl)methanol-13C19 | Isotope-Labeled Compounds | |
| HY-W328125 | Deisopropylatrazine | 1007-28-9 | Reference compound |
| HY-W328317 | Fast garnet GBC sulfate salt, 90% | 101-89-3 | Biochemical Assay Reagents |
| HY-W328332 | Fluorescein β-D-galactopyranoside | 102286-67-9 | Biochemical Assay Reagents |
| HY-W328402 | (Rac)-LB-100 | 2061038-65-9 | Reference compound |
| HY-W328408 | DIPSO (sodium) | 102783-62-0 | Biochemical Assay Reagents |
| HY-W328438 | Mefenamic acyl-β-D-glucuronide | 102623-18-7 | Biochemical Assay Reagents |
| HY-W328493 | β-D-Glucopyranoside,phenylmethyl,2,3,4,6-tetraacetate | 10343-13-2 | Biochemical Assay Reagents |
| HY-W328494 | Allyl-tetra-O-acetyl-β-D-glucopyranoside,98% | 10343-15-4 | Biochemical Assay Reagents |
| HY-W328599 | 2-Naphthalenyl octanoate | 10251-17-9 | Biochemical Assay Reagents |
| HY-W328882 | 3-(2-Aminopropyl)phenol | 1075-61-2 | Reference compound |
| HY-W329071 | Rose Bengal | 11121-48-5 | Reference compound |
| HY-W329112 | POPSO (sodium) | 108321-07-9 | Biochemical Assay Reagents |
| HY-W329113 | L-Phenylalanine 7-amido-4-methylcoumarin (trifluoroacetate) | 108321-84-2 | Biochemical Assay Reagents |
| HY-W329161 | Calcein sodium salt | 108750-13-6 | Biochemical Assay Reagents |
| HY-W329175 | N-Despropyl Ropinirole | 106916-16-9 | Reference compound |
| HY-W329357 | 15:0 Lyso PC | 108273-89-8 | Biochemical Assay Reagents |
| HY-W329372 | 2-Hydroxyethyl stearate | 111-60-4 | Natural Products |
| HY-W329522 | Ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate | 1138444-37-7 | Reference compound |
| HY-W329824 | Spirazidine | 1158-80-1 | Reference compound |
| HY-W329835S | 2-((1H-1,2,4-Triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile-d5 | 1398066-06-2 | Isotope-Labeled Compounds |
| HY-W330097 | N-Dodecyl alpha-D-maltoside | 116183-64-3 | Reference compound |
| HY-W330469 | Phospho-L-arginine | 1189-11-3 | Peptides |
| HY-W330621 | 2-Chloro-4-nitrophenyl-α-D-glucopyranoside | 119047-14-2 | Dye Reagents |
| HY-W330702 | 1-(4-Fluorophenyl)-2-methylpropan-2-amine | 1200-27-7 | Reference compound |
| HY-W331017 | 1-Hexacosanoyl-sn-glycero-3-phosphocholine | 1213783-80-2 | Biochemical Assay Reagents |
| HY-W331198 | Tralopyril | 122454-29-9 | Reference compound |
| HY-W331502 | Chlorophenol Red (sodium) | 123333-64-2 | Dye Reagents |
| HY-W331649 | 1-Docosanoyl-sn-glycero-3-phosphocholine | 125146-65-8 | Biochemical Assay Reagents |
| HY-W331786 | Ipconazole | 125225-28-7 | Reference compound |
| HY-W331786R | Ipconazole (Standard) | 125225-28-7 | Reference Standards |
| HY-W331804 | 5-Bromo-4-chloro-3-indolyl β-L-fucopyranoside | 125328-84-9 | Biochemical Assay Reagents |
| HY-W331816 | myo-Inositol,hexaacetate | 1254-38-2 | Biochemical Assay Reagents |
| HY-W331971 | 4-Methylumbelliferyl phosphate (dilithium) | 125328-83-8 | Biochemical Assay Reagents |
| HY-W332206 | Cafenstrole | 125306-83-4 | Reference compound |
| HY-W332335 | Sulfosuccinimidyl-6-(biotinamido)hexanoate (sodium) | 127062-22-0 | Reference compound |
| HY-W332361 | 4-Methoxyphenyl 2-amino-3,6-di-O-benzyl-2-deoxy-β-D-glucopyranoside | 1272755-07-3 | Biochemical Assay Reagents |
| HY-W332454 | AMPSO (sodium) | 102029-60-7 | Biochemical Assay Reagents |
| HY-W332536 | α-D-Galactopyranoside,ethyl 1-thio,2,3,4,6-tetraacetate | 126187-25-5 | Biochemical Assay Reagents |
| HY-W333389 | 4-Biphenylthio carboxamide | 13363-50-3 | Reference compound |
| HY-W333469 | Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside 3-acetate | 13343-64-1 | Biochemical Assay Reagents |
| HY-W334098 | 2-Nitrophenyl β-D-glucopyranosiduronic acid | 137629-36-8 | Biochemical Assay Reagents |
| HY-W334680 | 9-β-D-[2'-Fluoro-2'-deoxy-arabinofuranosyl]-guanin | 103884-98-6 | Reference compound |
| HY-W334800S | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 | 1334376-68-9 | Isotope-Labeled Compounds |
| HY-W334800S1 | (2S,6S)-2,6-Diaminoheptanedioic acid-15N2 | Isotope-Labeled Compounds | |
| HY-W334800S2 | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7 | Isotope-Labeled Compounds | |
| HY-W335254 | Deltarasin (trihydrochloride) | 1440898-82-7 | Reference compound |
| HY-W335576 | 3-(Methylphosphinico)propionic acid | 15090-23-0 | Reference compound |
| HY-W335656 | 6-Methyl-2-pyridyl 2-acetamido-2-deoxy-b-D-thioglucopyranoside | 149263-94-5 | Biochemical Assay Reagents |
| HY-W335735 | N,N-dimethyl-N-((phenyl-d5)methyl)tetradecan-1-aminium bromide | 1515861-68-3 | Isotope-Labeled Compounds |
| HY-W335896 | 4-(2-Octylamino)diphenylamine | 15233-47-3 | Reference compound |
| HY-W335927 | MAO-B-IN-19 | 152897-41-1 | Reference compound |
| HY-W335972 | N-Lauryldiethanolamine | 1541-67-9 | Reference compound |
| HY-W335976 | Almotriptan (hydrochloride) | 154323-46-3 | Reference compound |
| HY-W336012S | Metoprolol EP impurity O-d7 (hydrochloride) | 2673270-18-1 | Isotope-Labeled Compounds |
| HY-W336015 | 1,2-Diheptadecanoyl-sn-glycero-3-phosphatidic acid (sodium) | 154804-54-3 | Natural Products |
| HY-W336094 | 1,3-Glyceryl dilinoleate | 15818-46-9 | Reference compound |
| HY-W336145 | 3,4,6-Tris-O-(phenylmethyl)-2-deoxy-D-arabino-hexopyranose | 160549-11-1 | Biochemical Assay Reagents |
| HY-W336192 | (3E,8Z,11Z)-3,8,11-Tetradecatrienyl acetate | 163041-94-9 | Natural Products |
| HY-W336192R | (3E,8Z,11Z)-3,8,11-Tetradecatrienyl acetate (Standard) | 163041-94-9 | Reference Standards |
| HY-W336271 | 6-Benzylaminopurine, 98% (hydrochloride) | 162714-86-5 | Biochemical Assay Reagents |
| HY-W336281 | Fmoc-Cys(npys)-OH | 159700-51-3 | Reference compound |
| HY-W336328 | 3-Azido-L-alanine (hydrochloride) | 1620171-64-3 | Reference compound |
| HY-W336372 | Dnp-Pro-OH | 1655-55-6 | Biochemical Assay Reagents |
| HY-W336442 | H-His-Ala-OH | 16874-75-2 | Reference compound |
| HY-W336559 | 5-Me-DMT-2'-O-Me-C(Bz)-CE-Phosphoramidite | 166593-57-3 | Reference compound |
| HY-W336992 | 2-(7-Octyn-1-yl)-1H-isoindole-1,3-dione | 17170-26-2 | Reference compound |
| HY-W337103S | Acetyl-L-threonine-d5-1 | Isotope-Labeled Compounds | |
| HY-W337116S | Phenyl isopropylcarbamate-d7 | 1329835-22-4 | Isotope-Labeled Compounds |
| HY-W337198 | Methyl 2,3,4,6-tetrakis-O-(phenylmethyl)-α-D-glucopyranoside | 17791-37-6 | Biochemical Assay Reagents |
| HY-W337201 | 5-Bromo-4-chloro-3-indolyl β-D-cellobioside | 177966-52-8 | Dye Reagents |
| HY-W337335 | 1-Palmitoyl-sn-glycerol 3-phosphate (sodium salt) | 17618-08-5 | Natural Products |
| HY-W337358 | N-(3-Hydroxyphenyl)-arachidonoyl amide | 183718-75-4 | Reference compound |
| HY-W337569 | (±)-Voriconazole | 188416-29-7 | Reference compound |
| HY-W337618 | 7-Aminocoumarin | 19063-57-1 | Dye Reagents |
| HY-W337644 | Fmoc-L-Homoarg(Et)2-OH (hydrochloride) | 1864003-26-8 | Peptides |
| HY-W337672 | H-Pro-Hyp-OH | 18684-24-7 | Reference compound |
| HY-W337673 | 3-O-Benzyl-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose | 18685-18-2 | Biochemical Assay Reagents |
| HY-W337680 | N-3-Hydroxydecanoyl-L-homoserine lactone | 192883-12-8 | Reference compound |
| HY-W337739 | L-Glutamic acid (monopotassium salt) | 19473-49-5 | Reference compound |
| HY-W337863 | 5-Bromo-6-chloro-1H-indol-3-yl α-D-galactopyranoside | 198402-60-7 | Biochemical Assay Reagents |
| HY-W337872 | N-(3-Hydroxyoctanoyl)-L-homoserine lactone | 192883-14-0 | Reference compound |
| HY-W337886S | 2-Ethylhexyl 2,3,4,5-tetrabromobenzoate-13C6,d17 | Isotope-Labeled Compounds | |
| HY-W337894 | Methyl 9-oxooctadecanoate | 1842-70-2 | Reference compound |
| HY-W337897 | Tetradecyl-β-D-maltoside | 18449-82-6 | Biochemical Assay Reagents |
| HY-W338079 | Ac-Asp-Glu-Val-Asp-pNA | 189684-50-2 | Reference compound |
| HY-W338125 | Phenylmethyl 2,3-O-(1-methylethylidene)-α-D-mannofuranoside | 20689-03-6 | Biochemical Assay Reagents |
| HY-W338128 | 6-Chloro-1H-indol-3-yl palmitate | 209347-96-6 | Biochemical Assay Reagents |
| HY-W338140 | Methionine sulfoximine | 1982-67-8 | Reference compound |
| HY-W338150 | 1-Methyl-3-indolyl-β-D-galactopyranoside | 207598-26-3 | Biochemical Assay Reagents |
| HY-W338244 | 2-Amino-4-(1-adamantyl)thiazole | 19735-74-1 | Reference compound |
| HY-W338247 | Imidaclothiz | 105843-36-5 | Reference compound |
| HY-W338247R | Imidaclothiz (Standard) | 105843-36-5 | Reference Standards |
| HY-W338294S | 2'-Deoxycytidine-13C (monohydrate) | 478510-83-7 | Isotope-Labeled Compounds |
| HY-W338294S1 | 2'-Deoxycytidine-13C-2 (monohydrate) | 478511-23-8 | Isotope-Labeled Compounds |
| HY-W338294S2 | 2'-Deoxyguanosine-13C (monohydrate) | 478511-26-1 | Isotope-Labeled Compounds |
| HY-W338294S3 | 2'-Deoxycytidine-d2 (monohydrate) | 478511-25-0 | Isotope-Labeled Compounds |
| HY-W338446 | BF-170 | 22191-97-5 | Reference compound |
| HY-W338516 | Fmoc-L-Homoarginine (hydrochloride) | 208174-14-5 | Peptides |
| HY-W338581 | 4-tert-Octylphenol monoethoxylate | 2315-67-5 | Reference compound |
| HY-W338584 | Hydroxycitric acid (tripotassium) | 232281-44-6 | Biochemical Assay Reagents |
| HY-W338764 | AHR agonist 3 | 23749-58-8 | Reference compound |
| HY-W338768 | Acetylsalicylic acid acyl-β-D-glucuronide | 24719-72-0 | Biochemical Assay Reagents |
| HY-W338792 | 1-Decanoyl-sn-glycero-3-phosphocholine | 22248-63-1 | Natural Products |
| HY-W338810 | S-(5'-Adenosyl)-L-methionine (chloride) | 24346-00-7 | Natural Products |
| HY-W338810S | S-(5'-Adenosyl)-L-methionine-13C5 (sulfate) | Isotope-Labeled Compounds | |
| HY-W338852 | Gentisuric acid | 25351-24-0 | Reference compound |
| HY-W338852R | Gentisuric acid (Standard) | 25351-24-0 | Reference Standards |
| HY-W338856 | 1-Adamantylthiourea | 25444-82-0 | Biochemical Assay Reagents |
| HY-W338859 | Levofloxacin (mesylate) | 226578-51-4 | Reference compound |
| HY-W338901 | Azocarmine G | 25641-18-3 | Biochemical Assay Reagents |
| HY-W339206 | 1,2-Dinonanoyl-sn-glycero-3-phosphocholine | 27869-45-0 | Reference compound |
| HY-W339231 | 6-Bromo-2-naphthalenyl α-D-mannopyranoside | 28541-84-6 | Biochemical Assay Reagents |
| HY-W339331 | Flubendiamide | 272451-65-7 | Reference compound |
| HY-W339331R | Flubendiamide (Standard) | 272451-65-7 | Reference Standards |
| HY-W339358 | 11:0 PC | 27869-47-2 | Biochemical Assay Reagents |
| HY-W339410 | p-Aminophenyl-β-D-thiogalactopyranoside | 29558-05-2 | Biochemical Assay Reagents |
| HY-W339484 | 1-Ethyl-2-methyl-3-hydroxypyrid-4-one | 30652-12-1 | Reference compound |
| HY-W339545A | α-Ketoglutaric acid (disodium hydrate) | Biochemical Assay Reagents | |
| HY-W339603 | 4-O-Acetyl-3,6-di-O-(tert-butyldiphenylsilyl)-D-glucal | 308103-44-8 | Biochemical Assay Reagents |
| HY-W339645 | Naproxen ethyl ester | 31220-35-6 | Reference compound |
| HY-W339757 | Dioctanoylphosphatidic acid (sodium) | 321883-54-9 | Reference compound |
| HY-W339758 | 10:0 PA (sodium) | 321883-64-1 | Biochemical Assay Reagents |
| HY-W339764 | 1,2-Didecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium) | 322647-25-6 | Biochemical Assay Reagents |
| HY-W339816 | (S,R)-Bis(monomyristoylglycero)phosphate (ammonium) | 325466-03-3 | Reference compound |
| HY-W339833 | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate (sodium) | 325465-45-0 | Biochemical Assay Reagents |
| HY-W339834 | 1-Stearoyl-sn-glycerol 3-phosphate (sodium) | 325465-92-7 | Reference compound |
| HY-W339838 | 1-Myristoyl-2-hydroxy-sn-glycero-3-PG (sodium) | 326495-21-0 | Reference compound |
| HY-W339957S | 2,6-Dichlorobiphenyl-2′,3′,4′,5′,6′-d5 | 1276197-38-6 | Isotope-Labeled Compounds |
| HY-W339978S | 2,3,5,6-Tetrachloro-1,1'-biphenyl-d5 | 1219794-80-5 | Isotope-Labeled Compounds |
| HY-W340009 | (E)-9-Oxodec-2-enoic acid | 334-20-3 | Natural Products |
| HY-W340037 | 1,2-Dibutyryl-sn-glycero-3-phosphocholine | 3355-26-8 | Biochemical Assay Reagents |
| HY-W340093 | Probenecid acyl β-D-glucuronide | 34017-15-7 | Biochemical Assay Reagents |
| HY-W340113 | 15:0 PC | 3355-27-9 | Biochemical Assay Reagents |
| HY-W340190 | 2'-O-Methyl-5-iodouridine | 34218-84-3 | Reference compound |
| HY-W340234 | 4,5-Dibromo-2-pyrrolic acid | 34649-21-3 | Natural Products |
| HY-W340290 | 2-(3-(Aminomethyl)phenyl)acetic acid | 113520-43-7 | Reference compound |
| HY-W340313 | p53-MDM2-IN-4 | 350678-63-6 | Reference compound |
| HY-W340326 | (4′-Hydroxy)phenoxybenzoic acid | 35065-12-4 | Reference compound |
| HY-W340432 | Dansylamidoethyl methanethiosulfonate | 355115-41-2 | Biochemical Assay Reagents |
| HY-W340471 | N-Biotinyl-4-aminobutanoic acid | 35924-87-9 | Biochemical Assay Reagents |
| HY-W340583S | (2-(1H-indol-3-yl)acetyl)-L-leucine-d4 | Isotope-Labeled Compounds | |
| HY-W340832 | 18:1 Biotinyl Cap PE | 384835-51-2 | Biochemical Assay Reagents |
| HY-W340839 | p53-MDM2-IN-1 | 381717-91-5 | Reference compound |
| HY-W340872 | Triamcinolone acetonide acetate | 3870-07-3 | Biochemical Assay Reagents |
| HY-W340872R | Triamcinolone acetonide acetate (Standard) | 3870-07-3 | Reference Standards |
| HY-W340893S | 3,4',5-Trichloro-1,1'-biphenyl-d4 | 1276197-48-8 | Isotope-Labeled Compounds |
| HY-W340894S | 3,4,4'-Trichloro-1,1'-biphenyl-d4 | 1276197-27-3 | Isotope-Labeled Compounds |
| HY-W340933 | 1,6:3,4-Dianhydro-β-D-altropyranose | 3868-04-0 | Biochemical Assay Reagents |
| HY-W341090 | Phenylmethyl 4,6-O-(phenylmethylene)-α-D-mannopyranoside | 40983-94-6 | Biochemical Assay Reagents |
| HY-W341125 | Methyl-4,6-O-benzylidene-α-D-mannopyranoside | 4148-58-7 | Biochemical Assay Reagents |
| HY-W341133 | 1-Naphthalenyl β-D-galactopyranoside | 41335-32-4 | Biochemical Assay Reagents |
| HY-W341151 | Woodward's Reagent K | 4156-16-5 | Biochemical Assay Reagents |
| HY-W341259 | Isazofos | 42509-80-8 | Reference compound |
| HY-W341301 | 2-(Acetylamino)-2-deoxy-β-D-glucopyranosylamine | 4229-38-3 | Biochemical Assay Reagents |
| HY-W341421 | 3-Indoxyl butyrate | 4346-15-0 | Biochemical Assay Reagents |
| HY-W341455 | Iodophenol blue | 4430-24-4 | Biochemical Assay Reagents |
| HY-W341497 | Solvent red 26 | 4477-79-6 | Biochemical Assay Reagents |
| HY-W341499 | 5-Formyl-2'-deoxyuridine | 4494-26-2 | Reference compound |
| HY-W341547 | 3,4-Dihydro-6,7-isoquinolinediol | 4602-83-9 | Reference compound |
| HY-W341583 | Acid green 3 | 4680-78-8 | Biochemical Assay Reagents |
| HY-W341625 | Trihexosylceramide (d18:1/12:0) | 474943-80-1 | Natural Products |
| HY-W341962 | Halometasone | 50629-82-8 | Reference compound |
| HY-W341997 | 9-Octadecynoic acid | 506-24-1 | Natural Products |
| HY-W342021 | Thr-Leu | 50299-12-2 | Reference compound |
| HY-W342082 | 11-Ketoprogesterone | 516-15-4 | Reference compound |
| HY-W342092 | 1,3,4,6-Tetrachloro-3α,6α-diphenylglycouril | 51592-06-4 | Reference compound |
| HY-W342120 | Phenolphthalein (disodium), 95% | 518-51-4 | Biochemical Assay Reagents |
| HY-W342178 | 1,6-Anhydro-3,4-O-(1-methylethylidene)-β-D-galactopyranose | 52579-97-2 | Biochemical Assay Reagents |
| HY-W342193 | 3-Nitrophenyl α-D-galactopyranoside | 52571-71-8 | Biochemical Assay Reagents |
| HY-W342243 | D-Xylonic acid | 526-91-0 | Reference compound |
| HY-W342261S | 1,2,3,5-Tetramethylbenzene-d14 | 1219795-11-5 | Isotope-Labeled Compounds |
| HY-W342283 | Diminazene | 536-71-0 | Reference compound |
| HY-W342316 | MSHFBA | 53296-64-3 | Reference compound |
| HY-W342440S | 1,1-Diethoxynonane-d10 | Isotope-Labeled Compounds | |
| HY-W342441 | Monosialoganglioside GM3 (bovine) | 54827-14-4 | Reference compound |
| HY-W342450S | 1,1-Diethoxyoctane-d10 | Isotope-Labeled Compounds | |
| HY-W342458 | Betamethasone 17-Propionate | 5534-13-4 | Biochemical Assay Reagents |
| HY-W342458S | Betamethasone 17-propionate-d4 | Isotope-Labeled Compounds | |
| HY-W342471 | Nordiazepam uncyclized intermediate (hydrochloride) | 5504-72-3 | Reference compound |
| HY-W342499 | 3-Hydroxy myristic acid methyl ester | 55682-83-2 | Reference compound |
| HY-W342590 | CRBN ligand-9 | 55003-81-1 | Reference compound |
| HY-W342604 | N-Acetylputrescine | 5699-41-2 | Reference compound |
| HY-W342604R | N-Acetylputrescine (Standard) | 5699-41-2 | Reference Standards |
| HY-W342632 | Phenylmethyl 4,6-O-(phenylmethylene)-β-D-glucopyranoside | 58006-32-9 | Biochemical Assay Reagents |
| HY-W342664 | 2'-Deoxy-2'-fluoro-5-iodouridine | 55612-21-0 | Reference compound |
| HY-W342700 | PIPPS | 5625-56-9 | Biochemical Assay Reagents |
| HY-W342709S | 2,2',4,6,6'-Pentachloro-1,1'-biphenyl-d3 | 1219794-64-5 | Isotope-Labeled Compounds |
| HY-W342779 | 4-Bromoamphetamine (hydrochloride) | 58400-88-7 | Reference compound |
| HY-W342830 | 4-Aminophenyl 1-thio-β-D-glucopyranoside | 58737-22-7 | Biochemical Assay Reagents |
| HY-W342904 | 2’-O-Methyl-5’-O-DMTr-5-iodouridine | 588691-24-1 | Reference compound |
| HY-W342926 | (E)-8-Methyl-6-nonenoic acid | 59320-77-3 | Reference compound |
| HY-W342930 | Bordeaux Red | 5858-33-3 | Biochemical Assay Reagents |
| HY-W342932S | Ethyl 4-(((benzyl(4-(ethoxycarbonyl)phenyl)amino)methylene)amino)benzoate-d5 | Isotope-Labeled Compounds | |
| HY-W342979 | Petroselaidic acid | 593-40-8 | Reference compound |
| HY-W342983 | ATBTA-Eu3+ | 601494-52-4 | Biochemical Assay Reagents |
| HY-W343009 | rel-Biotin methyl ester | 60562-11-0 | Reference compound |
| HY-W343275 | β-D-Galactopyranosylamine | 6318-23-6 | Biochemical Assay Reagents |
| HY-W343292S | 2-Methylbutyl acetate-13C2 | 1335402-10-2 | Isotope-Labeled Compounds |
| HY-W343292S1 | 2-Methylbutyl acetate-d3 | Isotope-Labeled Compounds | |
| HY-W343304 | Pentatriacontane | 630-07-9 | Natural Products |
| HY-W343384 | Methyl 4,6-O-benzylidene-2-deoxy-α-D-erythro-hexopyranosid-3-ulose oxime | 63598-32-3 | Biochemical Assay Reagents |
| HY-W343538S | 2-Methyl-3-(methyldisulfanyl)furan-d3 | 1335436-10-6 | Isotope-Labeled Compounds |
| HY-W343597 | N-Biotinyl-1,6-hexanediaMine | 65953-56-2 | Biochemical Assay Reagents |
| HY-W343736 | 1,3-Dipalmitoyl-glycero-2-phosphoethanolamine | 67303-93-9 | Biochemical Assay Reagents |
| HY-W343750 | [Tyr4]-Bombesin | 67338-70-9 | Peptides |
| HY-W343816 | D,L-Tryptophanamide hydrochloride | 67607-61-8 | Biochemical Assay Reagents |
| HY-W344044 | Levomepromazine (maleate) | 7104-38-3 | Reference compound |
| HY-W344074 | Cytarabine 5’-monophosphate | 7075-11-8 | Reference compound |
| HY-W344380 | Tetrahydro-2,5-dioxo-3-furansulfonic acid, (sodium) | 73464-18-3 | Biochemical Assay Reagents |
| HY-W344461 | N-Butyroyl-D-sphingosine | 74713-58-9 | Natural Products |
| HY-W344468S | Adipate-13C6 (sodium) | 2483735-36-8 | Isotope-Labeled Compounds |
| HY-W344522 | 2,4-Dimethyl-1,3-dioxane | 766-20-1 | Natural Products |
| HY-W344602 | Substance P, [Met-OMet11] | 76260-78-1 | Peptides |
| HY-W344875 | Sodium ligninsulfonate | 8061-51-6 | Biochemical Assay Reagents |
| HY-W344927 | 1,2-Diheptadecanoyl-sn-Glycero-3-Phosphatidylglycerol (sodium) | 799268-52-3 | Natural Products |
| HY-W344938 | C.I. Acid yellow 3 | 8004-92-0 | Biochemical Assay Reagents |
| HY-W344938R | C.I. Acid yellow 3 (Standard) | 8004-92-0 | Dye Reagents |
| HY-W345015 | 2-Methyl-3-pyrimidin-2-yl-propionic acid | 819850-14-1 | Reference compound |
| HY-W345036 | 2-(Acetylamino)-2-deoxy-4-O-β-D-galactopyranosyl-D-galactose | 82535-18-0 | Biochemical Assay Reagents |
| HY-W345051 | Phthalic acid (sodium) | 827-27-0 | Biochemical Assay Reagents |
| HY-W345072 | (S)-2-methoxy-3-(octadecyloxy)propan-1-ol | 83167-59-3 | Natural Products |
| HY-W345102 | 4-Methylumbelliferyl β-cellotrioside | 84325-18-8 | Dye Reagents |
| HY-W345103 | 4-Methylumbelliferyl β-D-cellotetroside | 84325-19-9 | Biochemical Assay Reagents |
| HY-W345136S | Didesmethylsibutramine-d7 | 1188331-25-0 | Isotope-Labeled Compounds |
| HY-W345148 | 2-Naphthylamine-6,8-disulfonic acid (potassium) | 842-15-9 | Dye Reagents |
| HY-W345359 | PAF C-18:1 | 85966-90-1 | Reference compound |
| HY-W345393 | Trh-gly | 85344-77-0 | Peptides |
| HY-W345421 | L-γ-Glutamyl-p-nitroanilide (hydrate) | 122864-94-2 | Peptides |
| HY-W345492 | Methyl-1-(cyclohexylmethyl)-1H-indole-3-carboxylate | 858515-82-9 | Reference compound |
| HY-W345510 | Opiorphin | 864084-88-8 | Peptides |
| HY-W345885 | Saccharic acid | 87-73-0 | Reference compound |
| HY-W346639 | 4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic acid methyl ester | 873108-81-7 | Reference compound |
| HY-W346935 | 3-Hydroxytetracosanoic acid | 91297-89-1 | Natural Products |
| HY-W347315 | 6-(Biotinamido)hexylazide | 952091-45-1 | Reference compound |
| HY-W347368 | 9Z,11E,13Z-Octadecatrienoicacid, methylester | 95497-55-5 | Reference compound |
| HY-W347470A | Nb-Feruloyltryptamine | 53905-13-8 | Natural Products |
| HY-W347492 | 6-O-Methyldeoxyguanosine | 964-21-6 | Reference compound |
| HY-W347540 | oxy-Arachidonoyl ethanolamide | 883296-70-6 | Reference compound |
| HY-W347669 | 7,17-Dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid | 887752-13-8 | Natural Products |
| HY-W347776 | 1-Benzyl-2-methylpiperazine (hydrochloride) | 93138-53-5 | Reference compound |
| HY-W347825 | 4-O-[4,6-O-(Phenylmethylene)-α-D-glucopyranosyl]-D-glucose | 93417-41-5 | Biochemical Assay Reagents |
| HY-W347953 | Methyl 21-hydroxyhenicosanoate | 94035-98-0 | Natural Products |
| HY-W347990 | 5-Bromo-5-deoxy-2,3-isopropylidene-D-ribonolactone | 94324-23-9 | Biochemical Assay Reagents |
| HY-W348072 | SARS-CoV-2-IN-59 | 850786-33-3 | Reference compound |
| HY-W348170 | tert-Butyl((5-iodopentyl)oxy)dimethylsilane | 85514-45-0 | Reference compound |
| HY-W348226 | MMDPPA | 858215-05-1 | Reference compound |
| HY-W348348 | CbzNH-PEG3-CH2CH2NH2 | 863973-20-0 | Reference compound |
| HY-W348476 | 3-Hydroxydocosanoic acid | 89946-08-7 | Natural Products |
| HY-W348485 | WRX606 | 899937-47-4 | Reference compound |
| HY-W348503 | (5Z,8Z,14Z)-5,8,14-Eicosatrienoic acid | 90105-02-5 | Biochemical Assay Reagents |
| HY-W348896 | Fmoc-Dha-OH | 261522-33-2 | Reference compound |
| HY-W349628 | Dibutyl 3-hydroxybutyl phosphate | 89197-69-3 | Reference compound |
| HY-W350004 | (+)-Arabinogalactan,from larch wood, 80% | 9036-66-2 | Biochemical Assay Reagents |
| HY-W350212 | 2-Propyn-1-yl α-D-galactopyranoside | 913074-13-2 | Biochemical Assay Reagents |
| HY-W350486 | 16:0 Phosphatidylmethanol (sodium) | 92609-89-7 | Biochemical Assay Reagents |
| HY-W350804 | 3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-propionic acid | 936643-76-4 | Reference compound |
| HY-W350880 | 8-(1-Piperazinyl)-isoquinoline (hydrochloride) | 936643-79-7 | Reference compound |
| HY-W351110 | 3-Phenylpropionylglycine | 126794-92-1 | Natural Products |
| HY-W351294 | N-GlcNAc-Biotin | 1272755-69-7 | Biochemical Assay Reagents |
| HY-W351339 | BAPTA-TMFM | 96315-11-6 | Dye Reagents |
| HY-W351340 | 4-(Benzyloxy)-2-nitrophenol | 96315-18-3 | Dye Reagents |
| HY-W351380 | (-)-Anicyphos | 98674-83-0 | Reference compound |
| HY-W351428 | 1-(3-Chloro-4-fluorophenyl)piperazine (hydrochloride) | 95884-48-3 | Reference compound |
| HY-W351592 | Boc-Pen(Acm)-OH | 129972-45-8 | Peptides |
| HY-W351759 | 3-Indoxyl caprylate | 133950-66-0 | Biochemical Assay Reagents |
| HY-W351849 | 4-Chloro-3-indolyl β-D-galactopyranoside | 135313-63-2 | Biochemical Assay Reagents |
| HY-W352344 | 2'-Deoxy-L-adenosine | 14365-45-8 | Oligonucleotides |
| HY-W352408 | 1,2,3-Tri-α-linolenoyl glycerol | 14465-68-0 | Reference compound |
| HY-W352585 | 1,5-Anhydro-4,6-O-benzylidene-3-deoxy-D-glucitol | 152613-20-2 | Biochemical Assay Reagents |
| HY-W352643 | Phenylmethyl α-D-mannopyranoside | 15548-45-5 | Biochemical Assay Reagents |
| HY-W352713 | 6-Chloro-3-indoxyl butyrate | 159954-34-4 | Biochemical Assay Reagents |
| HY-W352828 | 1,2-O-Cyclohexylidene-α-D-glucofuranose | 16832-21-6 | Biochemical Assay Reagents |
| HY-W352966 | Mal-PEG2-CH2COOH | 173323-23-4 | Reference compound |
| HY-W353006 | Desmethyl Lacosamide | 175481-38-6 | Reference compound |
| HY-W353102 | Estradiol 17-(β-D-Glucuronide) | 1806-98-0 | Reference compound |
| HY-W353258 | Moxifloxacin (hydrochloride monohydrate) | 192927-63-2 | Biochemical Assay Reagents |
| HY-W353258R | Moxifloxacin (hydrochloride monohydrate) (Standard) | 192927-63-2 | Reference Standards |
| HY-W353469 | 2-O-(α-D-Glucopyranosyl)glycerol (55% in water) | 22160-26-5 | Natural Products |
| HY-W353555S | Di-n-dodecyl Phthalate-3,4,5,6-d4 | 2708280-31-1 | Isotope-Labeled Compounds |
| HY-W353572 | 2-O-(6-Deoxy-α-L-galactopyranosyl)-D-galactose | 24656-24-4 | Biochemical Assay Reagents |
| HY-W353602 | Aleoe-emodin triacetate | 25395-11-3 | Natural Products |
| HY-W353607 | Bromochlorophenol blue | 2553-71-1 | Biochemical Assay Reagents |
| HY-W353607A | Bromochlorophenol Blue sodium salt | 102185-52-4 | Biochemical Assay Reagents |
| HY-W353622 | 2,5-Dioxopyrrolidin-1-yl 4-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)butanoate | 258289-54-2 | Reference compound |
| HY-W353732 | 2-(Acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-D-glucopyranose | 29776-43-0 | Biochemical Assay Reagents |
| HY-W353804 | 2′-Deoxy-β-L-uridine | 31501-19-6 | Oligonucleotides |
| HY-W353862 | Boc-Phe-Leu-OH | 33014-68-5 | Reference compound |
| HY-W353880 | 2-Acetamido-2-deoxy-6-O-(α-L-fucopyranosyl)-D-glucopyranose | 33639-80-4 | Biochemical Assay Reagents |
| HY-W353908 | 5-Bromo-4-chloro-3-indoxyl palmitate | 341972-98-3 | Biochemical Assay Reagents |
| HY-W353946S | Mono-iso-Propyl Phthalate-3,4,5,6-d4 | 2733160-00-2 | Isotope-Labeled Compounds |
| HY-W353970S | 2,2',5,5'-Tetrachloro-1,1'-biphenyl-d3 | 1219794-74-7 | Isotope-Labeled Compounds |
| HY-W353980 | 6-Amino-N-(6-deoxy-β-L-galactopyranosyl)hexanamide | 35978-97-3 | Biochemical Assay Reagents |
| HY-W354035S | 2,3',5'-Trichloro-1,1'-biphenyl-d4 | Isotope-Labeled Compounds | |
| HY-W354066 | Biochanin A-7-O-β-D-glucuronide | 38482-76-7 | Biochemical Assay Reagents |
| HY-W354105S | 3,3',4,5,5'-Pentachloro biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-W354252 | 2-Amino-9-β-D-ribofuranosylpurine | 4546-54-7 | Reference compound |
| HY-W354369 | 1-(4-Fluorobenzyl)-1H-indazole-3-carboxylic acid | 50264-63-6 | Reference compound |
| HY-W354410 | 2-Deoxy-2-[[(4-methoxyphenyl)methylene]amino]-β-D-glucopyranose | 51471-40-0 | Biochemical Assay Reagents |
| HY-W354444 | 2-Acetamido-2-deoxy-3-O-(α-L-fucopyranosyl)-D-glucopyranose | 52630-68-9 | Biochemical Assay Reagents |
| HY-W354479 | 6-Thioinosine Phosphate | 53-83-8 | Reference compound |
| HY-W354498 | L-Octanoylcarnitine (hydrochloride) | 54377-02-5 | Reference compound |
| HY-W354583 | Clopyralid(2-hydroxyethyl)ammonium | 57754-85-5 | Biochemical Assay Reagents |
| HY-W354603 | D-Ribofuranose,2,3,5-tris-O-(phenylmethyl)-,1-acetate | 58381-23-0 | Biochemical Assay Reagents |
| HY-W354610S | N-(4-Hydroxy-3-methoxybenzyl)stearamide-d3 | Isotope-Labeled Compounds | |
| HY-W354635 | N-Methyl-2-phenylpropan-1-amine (hydrochloride) | 5969-39-1 | Reference compound |
| HY-W354644 | 1-(β-D-Ribofuranosyl)-5-nitropyrine-2(1H)-one | 59892-36-3 | Reference compound |
| HY-W354693 | 2,4-Diaminoanisole | 615-05-4 | Reference compound |
| HY-W354753 | Homatropine (hydrochloride) | 637-21-8 | Biochemical Assay Reagents |
| HY-W354753R | Homatropine (hydrochloride) (Standard) | 637-21-8 | Reference Standards |
| HY-W354821 | 4-Methylumbelliferyl Decanoate | 66185-70-4 | Dye Reagents |
| HY-W354851 | Pisiferic acid | 67494-15-9 | Biochemical Assay Reagents |
| HY-W354925 | Lumiracoxib acyl-β-D-glucuronide | 697287-17-5 | Biochemical Assay Reagents |
| HY-W354937S | 2,4,4'-Trichloro-1,1'-biphenyl-d4 | 1219799-32-2 | Isotope-Labeled Compounds |
| HY-W354971 | Amisulpride N-oxide | 71676-01-2 | Reference compound |
| HY-W355001 | Cholic acid (sodium monohydrate) | 73163-53-8 | Biochemical Assay Reagents |
| HY-W355043S | 2,3,4,4',5-Pentachloro-1,1'-biphenyl-d4 | 1219799-24-2 | Isotope-Labeled Compounds |
| HY-W355093 | 2-(Acetylamino)-2-deoxy-4-O-(6-deoxy-α-L-galactopyranosyl)-D-glucose | 76211-71-7 | Biochemical Assay Reagents |
| HY-W355129 | MeIQx | 77500-04-0 | Reference compound |
| HY-W355129S | MeIQx-d3 | 122457-31-2 | Isotope-Labeled Compounds |
| HY-W355140 | alpha-Methyl ionone | 7779-30-8 | Biochemical Assay Reagents |
| HY-W355141 | Isopulegol | 7786-67-6 | Reference compound |
| HY-W355196 | Benzyl 2-deoxy-2-phthalimido-4,6-O-benzylidene-β-D-glucopyranoside | 80035-33-2 | Biochemical Assay Reagents |
| HY-W355231 | MEAI (hydrochloride) | 81593-54-6 | Reference compound |
| HY-W355238S | Sec-butyl butyrate-d2 | 1335436-14-0 | Isotope-Labeled Compounds |
| HY-W355280 | α-D-Glucopyranoside,methyl 4-deoxy-4-fluoro,2,3,6-tribenzoate | 84065-98-5 | Biochemical Assay Reagents |
| HY-W355311 | 3,4-Dimethoxy-α-Pyrrolidinopentiophenone (hydrochloride) | 850351-99-4 | Reference compound |
| HY-W355463 | 3-Demethylthiocolchicine | 87424-25-7 | Reference compound |
| HY-W355700 | 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine | 89576-29-4 | Reference compound |
| HY-W355779 | Gliadins | 9007-90-3 | Biochemical Assay Reagents |
| HY-W355779A | Hydrolyzed Gliadin | 9007-90-3 | Biochemical Assay Reagents |
| HY-W356116 | C6 NBD Ceramide | 94885-02-6 | Dye Reagents |
| HY-W356117 | C6 NBD Glucosylceramide | 94885-03-7 | Dye Reagents |
| HY-W357090S | L-Idose-13C-3 | Isotope-Labeled Compounds | |
| HY-W357096 | 4-Deoxy-4-fluoro-D-glucose | 29218-07-3 | Biochemical Assay Reagents |
| HY-W357102 | 1,2,4,6-Tetra-O-acetyl-3-O-benzyl-β-D-glucopyranose | 39686-94-7 | Biochemical Assay Reagents |
| HY-W357103 | 3-O-(Phenylmethyl)-D-glucose | 10230-17-8 | Biochemical Assay Reagents |
| HY-W357105 | 3,5,6-tri-O-Benzyl-1,2-O-isopropylidene-D-glucofuranose | 53928-30-6 | Biochemical Assay Reagents |
| HY-W357105R | 3,5,6-tri-O-Benzyl-1,2-O-isopropylidene-D-glucofuranose (Standard) | 53928-30-6 | Reference Standards |
| HY-W357106 | 3-O-Benzyl-1,2:5,6-di-O-isopropylidene-a-D-allofuranose | 22331-21-1 | Biochemical Assay Reagents |
| HY-W357109 | 1,2:3,4-Di-O-isopropylidene-6-deoxy-6-nitro-α-D-galactopyranose | 90367-90-1 | Biochemical Assay Reagents |
| HY-W357110 | Phenylmethyl 2,3:5,6-bis-O-(1-methylethylidene)-α-D-mannofuranoside | 20689-02-5 | Biochemical Assay Reagents |
| HY-W357116 | Methyl-2,3,4,6-tetrakis-O-(phenylmethyl)-α-D-mannopyranoside | 61330-62-9 | Biochemical Assay Reagents |
| HY-W357119 | Phenylmethyl 2,3,4-tris-O-(phenylmethyl)-α-D-mannopyranoside | 57783-76-3 | Biochemical Assay Reagents |
| HY-W357122 | Benzyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | 13343-67-4 | Biochemical Assay Reagents |
| HY-W357125 | 4-Methylphenyl 1-thio-β-D-glucopyranoside | 1152-39-2 | Biochemical Assay Reagents |
| HY-W357128 | 4-Methylphenyl 4,6-O-benzylidene-β-D-thiogalactopyranoside | 161007-96-1 | Biochemical Assay Reagents |
| HY-W357132 | 4-Nitrophenyl 1-thio-β-D-galactopyranoside | 1230-27-9 | Biochemical Assay Reagents |
| HY-W357133 | 3,4,6-Tri-O-acetyl-β-D-mannopyranose 1,2-(methyl orthoacetate) | 4435-05-6 | Biochemical Assay Reagents |
| HY-W357136 | 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-glucopyranosylamine | 4515-24-6 | Biochemical Assay Reagents |
| HY-W357137 | L-Threonolactone | 21730-93-8 | Reference compound |
| HY-W357141S | MeSA 2-O-b-D-glucoside-d3 | Isotope-Labeled Compounds | |
| HY-W357141S1 | MeSA 2-O-b-D-glucoside-d7 | Isotope-Labeled Compounds | |
| HY-W357141S2 | MeSA 2-O-b-D-glucoside-d4 | Isotope-Labeled Compounds | |
| HY-W357142 | 3-Acetylumbelliferyl β-D-Glucopyranoside | 20943-16-2 | Dye Reagents |
| HY-W357145 | (4-Nitrophenyl)methyl 1-thio-β-D-galactopyranoside | 35785-19-4 | Biochemical Assay Reagents |
| HY-W357146 | 2-Phenylethyl β-D-galactopyranoside | 14861-16-6 | Reference compound |
| HY-W357147 | 4-Trifluoromethylumbelliferyl-ß-D-galactopyranoside | 117153-55-6 | Biochemical Assay Reagents |
| HY-W357149 | 6-Chloro-3-indolyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 156117-44-1 | Biochemical Assay Reagents |
| HY-W357150 | 2-Nitrophenyl 2-(acetylamino)-2-deoxy-α-D-glucopyranoside | 10139-01-2 | Biochemical Assay Reagents |
| HY-W357151 | 6-Chloro-3-indoxyl-α-D-mannopyranoside | 425427-88-9 | Dye Reagents |
| HY-W357152 | 2-Naphthyl-β-D-glucuronic acid (sodium) | 20838-64-6 | Biochemical Assay Reagents |
| HY-W357153 | 4-Methylumbelliferyl-α-L-rhamnopyranoside | 106488-05-5 | Biochemical Assay Reagents |
| HY-W357154 | 4-Methylumbelliferyl β-L-fucoside | 72601-82-2 | Biochemical Assay Reagents |
| HY-W357155 | Gal1-β-3GlcNAc-β-PNP | 57467-13-7 | Biochemical Assay Reagents |
| HY-W357161 | α-D-Galactopyranoside,4-nitrophenyl,2,3,4,6-tetraacetate | 17042-39-6 | Biochemical Assay Reagents |
| HY-W357162 | Methyl3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-glucopyranoside | 76101-13-8 | Biochemical Assay Reagents |
| HY-W357200 | N6-Benzoyl-7’-OH-N-trityl morpholino adenine | 956139-16-5 | Reference compound |
| HY-W357201 | N4-Benzoyl-7’-OH-N-trityl morpholino cytosine | 125515-31-3 | Reference compound |
| HY-W357202 | 7’-OH-N-trityl morpholinothymine | 914361-76-5 | Reference compound |
| HY-W357329 | Acetobromo-α-maltose,98% | 14257-35-3 | Biochemical Assay Reagents |
| HY-W357413 | Chinifur | 70762-66-2 | Reference compound |
| HY-W357642 | Cirsiumaldehyde | 7389-38-0 | Natural Products |
| HY-W357738 | Urease-IN-14 | 74901-20-5 | Reference compound |
| HY-W357818 | Glycinexylidide | 18865-38-8 | Biochemical Assay Reagents |
| HY-W357919 | 3-Thio-pheneacrylic acid methyl ester | 135835-43-7 | Reference compound |
| HY-W362839 | Binospirone | 102908-59-8 | Reference compound |
| HY-W364575 | Methyl-4-oxoretinoate | 38030-58-9 | Reference compound |
| HY-W366582 | 7-Methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine | 1032570-74-3 | Reference compound |
| HY-W369099 | HJC0152 (free base) | 1420290-88-5 | Reference compound |
| HY-W370556 | (Rac)-LM11A-31 | 289475-77-0 | Reference compound |
| HY-W370605 | 5-(Morpholin-4-yl)pentanoic acid | 4441-14-9 | Reference compound |
| HY-W371164 | C1s-IN-1 | 1016866-61-7 | Reference compound |
| HY-W371165 | C1s-IN-1 (trihydrochloride) | 1376162-36-5 | Reference compound |
| HY-W373206 | Triampyzine | 6503-95-3 | Reference compound |
| HY-W376701 | Guanadrel | 40580-59-4 | Reference compound |
| HY-W377440 | 2-(Methyl-d3)phenol | 70837-27-3 | Isotope-Labeled Compounds |
| HY-W377454 | 1-Beta-D-arabinofuranosyl-5-iodouracil | 3052-06-0 | Reference compound |
| HY-W377455 | 2',5-Difluoro-2'-deoxy-1-arabinosyluracil | 69123-95-1 | Reference compound |
| HY-W378559 | 4-(Methyl(phenyl)amino)butanoic acid | 26488-79-9 | Reference compound |
| HY-W378863 | Methyl 2,3,5-tri-O-benzyl-β-D-ribofuranoside | 55725-85-4 | Biochemical Assay Reagents |
| HY-W380450 | Viloxazine | 46817-91-8 | Reference compound |
| HY-W382009 | 7-Azaspiro[3.5]nonane-2-ethanol | 1370211-12-3 | Reference compound |
| HY-W382038 | E3 ligase Ligand 32 | 2300099-98-1 | Reference compound |
| HY-W382140 | 4′-C-Fluoro-2′-C-methyluridine | 1613589-04-0 | Reference compound |
| HY-W391506 | Poly(methyl methacrylate) | 9011-14-7 | Reference compound |
| HY-W391574 | 3-Chlorocathinone (hydrochloride) | 2227990-16-9 | Reference compound |
| HY-W391625 | (Rac)-Dehydrocostus Lactone | 74299-48-2 | Reference compound |
| HY-W391635 | 3-Oxo deoxycholic acid | 4185-01-7 | Reference compound |
| HY-W391641 | F8BT | 210347-52-7 | Reference compound |
| HY-W391671 | Poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine] | 1333317-99-9 | Reference compound |
| HY-W391701 | Pomalidomide-COCH2Cl | 444287-84-7 | Reference compound |
| HY-W391940 | (Rac)-Amorolfine (hydrochloride) | 106614-68-0 | Reference compound |
| HY-W392026 | Polyhexamethyleneguanidine (hydrochloride) | 57028-96-3 | Reference compound |
| HY-W392083S | (1,3E,5E)-Undeca-1,3,5-triene-d5 | Isotope-Labeled Compounds | |
| HY-W392083S1 | (1,3E,5Z)-Undeca-1,3,5-triene-d5 | Isotope-Labeled Compounds | |
| HY-W392100A | Polycaprolactone diol (MW 530) | 36890-68-3 | Biochemical Assay Reagents |
| HY-W392100B | Polycaprolactone diol (MW 2000) | 36890-68-3 | Biochemical Assay Reagents |
| HY-W392100C | Polycaprolactone diol (MW 10000) | 36890-68-3 | Biochemical Assay Reagents |
| HY-W392173 | Lauryl glucoside | 110615-47-9 | Biochemical Assay Reagents |
| HY-W392209A | Copovidone (50% in ethanol) | 25086-89-9 | Reference compound |
| HY-W392246 | α-D-Glucose (monohydrate) | 5996-10-1 | Biochemical Assay Reagents |
| HY-W392263 | Glycerophosphate (disodium hydrate) | 55073-41-1 | Biochemical Assay Reagents |
| HY-W392413 | Glutathione monoethyl ester | 118421-50-4 | Reference compound |
| HY-W392514 | Nickel octaethylporphyrin | 24803-99-4 | Reference compound |
| HY-W392548 | 1-O-(4-Hydroxybenzoyl)-glycerol | 93778-15-5 | Natural Products |
| HY-W392808 | Spacer phosphoramidite C3 | 110894-23-0 | Reference compound |
| HY-W392809 | 5-Methyl-2′-O-methylcytidine | 113886-70-7 | Reference compound |
| HY-W392836 | 2'-O-Methyl-5'-O-dmt-inosine-3'-CE-phosphoramidite | 128219-85-2 | Reference compound |
| HY-W392857 | (S)-NH2-Pyridine-piperazine(Me)-Boc | 1433849-58-1 | Reference compound |
| HY-W392925 | (R)-(+)-Aminoglutethimide | 55511-44-9 | Reference compound |
| HY-W392933S | Thymidine 5'-monophosphate-15N2 | Isotope-Labeled Compounds | |
| HY-W392933S1 | Thymidine 5'-monophosphate-15N2,d13 (dilithium) | Isotope-Labeled Compounds | |
| HY-W392933S2 | Thymidine 5'-monophosphate-15N2 (dilithium) | Isotope-Labeled Compounds | |
| HY-W392933S3 | Thymidine 5'-monophosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-W392933S4 | Thymidine 5'-monophosphate-13C10,15N2 (dilithium) | 2483830-49-3 | Isotope-Labeled Compounds |
| HY-W392933S5 | Thymidine 5'-monophosphate-d13 (dilithium) | Isotope-Labeled Compounds | |
| HY-W393115 | Diethyl (6-bromohexyl)phosphonate | 100462-72-4 | Reference compound |
| HY-W393243 | 3′-O-Methyladenosine | 10300-22-8 | Reference compound |
| HY-W393317 | 5-Methoxycarbonylmethyl-2'-O-methyluridine | 60197-31-1 | Reference compound |
| HY-W393372 | TRIS (maleate) | 72200-76-1 | Biochemical Assay Reagents |
| HY-W393498 | Phenyl 2,4,6-tri-O-acetyl-3-O-allyl-β-D-thiogalactopyranoside | 1820572-28-8 | Biochemical Assay Reagents |
| HY-W393741 | Phenyl 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-b-D-galactopyranoside | 183875-28-7 | Biochemical Assay Reagents |
| HY-W393870 | (-)-Dihydrocarvyl acetate | 20777-49-5 | Natural Products |
| HY-W393970S | 2′-Deoxyguanosine 5′-monophosphate-15N5,d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W393970S1 | 2′-Deoxyguanosine 5′-monophosphate-d12 (dilithium) | Isotope-Labeled Compounds | |
| HY-W393970S2 | 2′-Deoxyguanosine 5′-monophosphate-13C10 (dilithium) | Isotope-Labeled Compounds | |
| HY-W393970S3 | 2′-Deoxyguanosine 5′-monophosphate-13C10,15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-W393970S4 | 2′-Deoxyguanosine 5′-monophosphate-15N5 (dilithium) | Isotope-Labeled Compounds | |
| HY-W394006 | 2'-Deoxyuridine 5'-monophosphate | 964-26-1 | Reference compound |
| HY-W394025 | Biotinyl-6-aminoquinoline | 91853-89-3 | Biochemical Assay Reagents |
| HY-W394106 | 5-Hydroxymethyl uridine | 30414-00-7 | Biochemical Assay Reagents |
| HY-W394282 | 1-(Ethynyl-d)benzene-2,3,4,5,6-d5 | 25837-47-2 | Isotope-Labeled Compounds |
| HY-W394293 | 5-Methyl-2-thiouridine | 32738-09-3 | Reference compound |
| HY-W394419 | 3’-dC(Bz)-2’-phosphor amidite | 157327-96-3 | Reference compound |
| HY-W394432 | 9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine | 16006-64-7 | Reference compound |
| HY-W394551 | Methyl 3,4-dibromo-2,5-dioxo-2,5-dihydro-1H-pyrrole-1-carboxylate | 1442447-48-4 | Reference compound |
| HY-W394612 | (1R,3S)-3-Hydroxycyclopentane carboxylic acid methyl ester | 174292-59-2 | Reference compound |
| HY-W394717 | BGC-20-1531 | 1186532-61-5 | Reference compound |
| HY-W394793 | 2-Amino-6-chloropurine-9-beta-D-(2’-deoxy)riboside | 120595-72-4 | Reference compound |
| HY-W394903 | GS-829845 | 1257705-09-1 | Reference compound |
| HY-W394903R | GS-829845 (Standard) | 1257705-09-1 | Reference Standards |
| HY-W394935 | Dixylyl disulphide | 13616-83-6 | Reference compound |
| HY-W395015 | 5’-O-(4,4-Dimethoxytrityl)-2’-O-methyl inosine | 128219-84-1 | Reference compound |
| HY-W395122 | Mal-PEG1-PNP-carbonate | 1345681-74-4 | Reference compound |
| HY-W395204 | 1-Phenylethylamine (hydrochloride) | 13437-79-1 | Reference compound |
| HY-W395410 | 2-Acetyldibenzofuran | 13761-32-5 | Reference compound |
| HY-W395613 | TY-011 | 1389439-77-3 | Reference compound |
| HY-W395779 | EBOV-IN-1 | 1335113-30-8 | Reference compound |
| HY-W396250 | p-Nitrophenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside | 13242-51-8 | Biochemical Assay Reagents |
| HY-W396413 | (4-Chlorobutoxy)trimethylsilane | 13617-19-1 | Reference compound |
| HY-W396714 | Succinic acid (sodium) | 14047-56-4 | Reference compound |
| HY-W396889 | (R)-N-(1-Hydroxypropan-2-yl)palmitamide | 142128-47-0 | Reference compound |
| HY-W397503 | 5’-O-DMTr-5-iodo-2’-deoxyuridine | 104375-88-4 | Reference compound |
| HY-W398166 | (Z)-Hexadec-9-enamide | 106010-22-4 | Natural Products |
| HY-W398341 | Methyl 1,2,3,4-Tetra-O-acetyl-α-L-idopyranuronate | 108032-41-3 | Biochemical Assay Reagents |
| HY-W398395 | 1-Methoxy-2-deoxy-3,5-di-O-benzoylribofuranose | 108647-88-7 | Biochemical Assay Reagents |
| HY-W398806 | (2-Aminoethyl)carbamic acid | 109-58-0 | Reference compound |
| HY-W399035 | Pantoic acid | 1112-33-0 | Reference compound |
| HY-W399186 | Methylclonazepam | 5527-71-9 | Reference compound |
| HY-W399188 | 2-Nitrophenyl 2,3,4-Tri-O-acetyl-β-D-glucuronide,methyl ester | 55274-44-7 | Biochemical Assay Reagents |
| HY-W399193 | PGF2α 1,9-lactone | 55314-48-2 | Reference compound |
| HY-W399270 | 2-Chlorooctadecanoic acid | 56279-49-3 | Reference compound |
| HY-W399277 | 3-Cyano-4,6-dimethylcoumarin | 56394-28-6 | Biochemical Assay Reagents |
| HY-W399297 | Isodeoxycholic acid | 566-17-6 | Reference compound |
| HY-W399297R | Isodeoxycholic acid (Standard) | 566-17-6 | Reference Standards |
| HY-W399439 | Aurantiogliocladin | 483-54-5 | Reference compound |
| HY-W399538 | Para-methyl 4-anilino-1-boc-piperidine | 501673-99-0 | Reference compound |
| HY-W399633 | Octyl 1-thio-β-D-galactopyranoside | 42891-16-7 | Biochemical Assay Reagents |
| HY-W399770 | Benzyl 2,3,4-Tri-O-benzyl-D-glucuronate | 4539-78-0 | Biochemical Assay Reagents |
| HY-W399827 | 4,6-Dichloro-3-formylcoumarin | 51069-87-5 | Biochemical Assay Reagents |
| HY-W399914 | tert-Butyl methyl adipate | 52221-08-6 | Reference compound |
| HY-W399940 | Actiphenol | 526-02-3 | Natural Products |
| HY-W400159 | 5-Methoxy cytidine | 37805-90-6 | Reference compound |
| HY-W400424 | (-)-6α-Hydroxy cannabidiol | 58940-28-6 | Reference compound |
| HY-W400427 | α-D-Glucose-1-phosphate | 59-56-3 | Reference compound |
| HY-W400496 | Valproic acid β-D-glucuronide | 60113-83-9 | Reference compound |
| HY-W400574 | 6-Iodohexan-1-ol | 40145-10-6 | Reference compound |
| HY-W400722 | Sodium 3-methyl-2-oxobutanoate-13C5,d1 | 420095-74-5 | Isotope-Labeled Compounds |
| HY-W400801 | Denfivontinib (hydrochloride) | 1457983-33-3 | Reference compound |
| HY-W400925 | Sulfo-Cy5-N3 | 1481447-40-8 | Dye Reagents |
| HY-W401056 | 2-Azido-2-deoxy-D-glucose tetraacetate | 171032-74-9 | Biochemical Assay Reagents |
| HY-W401062 | 2-Undecyloxirane | 1713-31-1 | Reference compound |
| HY-W401143 | 15-Aminopentadecanoic acid | 17437-21-7 | Reference compound |
| HY-W401407 | Diosmetin-3-O-glucuronide | 152503-50-9 | Reference compound |
| HY-W401531S | (R)-3-O-Methyldopa-d3 | 1259947-39-1 | Isotope-Labeled Compounds |
| HY-W401531S1 | (R)-3-O-Methyldopa-d3 (hydrochloride) | 2714485-35-3 | Isotope-Labeled Compounds |
| HY-W401797 | 5-Hydroxy-6,7,8-trimethoxycoumarin | 1581248-32-9 | Natural Products |
| HY-W402032 | Bis-Cbz-cyclen | 162148-45-0 | Biochemical Assay Reagents |
| HY-W402064 | N-Acetyladenosine | 16265-37-5 | Reference compound |
| HY-W402074 | 5-Acetamide-Butenolide | 16275-44-8 | Reference compound |
| HY-W402148 | 10-Methyl-9-(phenoxycarbonyl)acridinium (fluorosulfonate) | 149300-54-9 | Dye Reagents |
| HY-W402286 | β-D-Glucopyranuronic acid,methyl ester,1,2,3,4-tetrakis(2-methylpropanoate) | 150607-94-6 | Biochemical Assay Reagents |
| HY-W402597 | α-L-Galactopyranosyl bromide,6-deoxy,2,3,4-triacetate | 16741-27-8 | Biochemical Assay Reagents |
| HY-W402682 | SXC2023 | 1695562-36-7 | Reference compound |
| HY-W403046 | D-myo-Inositol-4-phosphate (ammonium) | 142760-33-6 | Biochemical Assay Reagents |
| HY-W403047 | Methyl 2,3,4-Tri-O-benzyl-α-D-glucuronic Acid, Benzyl Ester | 142797-33-9 | Biochemical Assay Reagents |
| HY-W403075 | N-(3-Methoxybenzyl)stearamide | 1429659-99-3 | Reference compound |
| HY-W403327 | CbzNH-PEG4-CH2COOH | 1451362-51-8 | Reference compound |
| HY-W403633 | Hexahydrohippuric acid | 32377-88-1 | Natural Products |
| HY-W403732 | 8-Iodooct-7-yn-1-ol | 333754-13-5 | Reference compound |
| HY-W403930 | Sulclamide | 2455-92-7 | Reference compound |
| HY-W403933 | 12-Ketochenodeoxycholic acid | 2458-08-4 | Reference compound |
| HY-W403933R | 12-Ketochenodeoxycholic acid (Standard) | 2458-08-4 | Reference Standards |
| HY-W404002 | BR102910 | 2505339-54-6 | Reference compound |
| HY-W404399 | 3-Deoxy-1,2:5,6-bis-O-(1-methylethylidene)-α-D-xylo-hexofuranose | 2774-29-0 | Biochemical Assay Reagents |
| HY-W404543 | β-D-Ribofuranoside,methyl,tris(4-chlorobenzoate) | 29755-00-8 | Biochemical Assay Reagents |
| HY-W404583 | 9,10-12,13-Diepoxyoctadecanoic acid | 3012-69-9 | Natural Products |
| HY-W404916 | Probenecid (sodium) | 23795-03-1 | Reference compound |
| HY-W405064 | 11-Mercaptoundecanoate-NHS | 240125-70-6 | Reference compound |
| HY-W406070 | 2'-O,4'-C-Methyleneguanosine | 207131-16-6 | Oligonucleotides |
| HY-W408239 | N-Pentadecanoyl-L-homoserine lactone | 182359-66-6 | Reference compound |
| HY-W408607 | N-Benzylacetamidine (hydrobromide) | 186545-76-6 | Reference compound |
| HY-W408789 | 2-Acetamido-2-deoxy-D-glucono-1,5-lactone, 90% | 19026-22-3 | Biochemical Assay Reagents |
| HY-W408830 | 4-Iodobutyl benzoate | 19097-44-0 | Reference compound |
| HY-W408856 | 12(Z),15(Z)-Heneicosadienoic acid | 191545-08-1 | Reference compound |
| HY-W408869 | 8-iso-13,14-dihydro-15-keto Prostaglandin F2α | 191919-02-5 | Reference compound |
| HY-W408969 | 4-Methoxy PCE (hydrochloride) | 1933-15-9 | Reference compound |
| HY-W408972 | PCPr (hydrochloride) | 1934-55-0 | Reference compound |
| HY-W409181 | (Rac)-PD 151746 | 179461-52-0 | Reference compound |
| HY-W409806 | Cholesterylamine | 2126-93-4 | Reference compound |
| HY-W410002 | Pomalidomide-propargyl | 2154342-25-1 | Reference compound |
| HY-W410706 | 1-Salicylate glucuronide | 7695-70-7 | Reference compound |
| HY-W410950 | α-D-Mannopyranoside,ethyl 1-thio,2,3,4,6-tetraacetate | 79389-52-9 | Biochemical Assay Reagents |
| HY-W410995 | Benzyl 2-deoxy-2-phthalimido-3,4,6-tri-O-acetyl-β-D-glucopyranoside | 80035-31-0 | Biochemical Assay Reagents |
| HY-W411215 | 1,4-Diacetoxy-2,3-dicyanobenzene | 83619-73-2 | Dye Reagents |
| HY-W411236 | Methyl 3-hydroxynonanoate | 83968-06-3 | Natural Products |
| HY-W411295 | 5-Methyl-2'-O,4'-C-methylenecytidine | 847650-87-7 | Reference compound |
| HY-W411296 | 6α-Chloro testosterone | 847674-32-2 | Reference compound |
| HY-W411332 | 2-NMC | 849642-09-7 | Reference compound |
| HY-W411361 | Pyridine-2-carboxaldehyde 4-nitrophenylhydrazone | 70421-66-8 | Dye Reagents |
| HY-W411439 | 1-O-p-Coumaroyl-β-D-glucose | 7139-64-2 | Natural Products |
| HY-W411442 | 2-Hydroxy-3-methoxychalcone | 7146-86-3 | Reference compound |
| HY-W411510 | 5-O-(Phenylmethyl)-D-ribose | 72369-89-2 | Biochemical Assay Reagents |
| HY-W411604 | tert-Butyl hex-5-ynoate | 73448-14-3 | Reference compound |
| HY-W411827 | 1H,1H,2H,2H-Perfluorohexanesulfonic acid | 757124-72-4 | Reference compound |
| HY-W411837 | 4-(4-Diethylaminophenylazo)-1-(4-nitrobenzyl)pyridinium (bromide) | 75902-86-2 | Reference compound |
| HY-W411889 | α-D-Mannofuranose, cyclic 2,3-carbonate | 76548-27-1 | Biochemical Assay Reagents |
| HY-W412175 | Coproporphyrin III (dihydrochloride) | 68938-73-8 | Reference compound |
| HY-W412215 | TTMAPP | 69458-20-4 | Reference compound |
| HY-W412264 | Pim-1/2 kinase inhibitor 1 | 6320-51-0 | Reference compound |
| HY-W412313 | Methyl 3,5-di-O-(2,4-dichlorobenzyl)-D-ribofuranoside | 636581-81-2 | Reference compound |
| HY-W412469 | α-D-Mannopyranose, 3-O-(phenylmethyl)-, 1,2,4,6-tetraacetate | 65827-58-9 | Biochemical Assay Reagents |
| HY-W412546 | 3’-O-Methyluridine | 6038-59-1 | Reference compound |
| HY-W412723 | 1,2,3,4-Tetra-O-acetyl-β-D-glucuronic acid | 62133-77-1 | Biochemical Assay Reagents |
| HY-W413662 | 4-((4-Methoxybenzyl)oxy)butan-1-ol | 119649-45-5 | Reference compound |
| HY-W414069 | Thiocholesterol | 1249-81-6 | Biochemical Assay Reagents |
| HY-W414321 | Fructosamine (hydrochloride) | 39002-30-7 | Reference compound |
| HY-W414355 | Acid Blue 7 | 3486-30-4 | Biochemical Assay Reagents |
| HY-W414380 | Bdp tr nhs ester | 150152-65-1 | Dye Reagents |
| HY-W414390 | 2-Cyclohexylethyl-4-O-(α-D-glucopyranosyl)-β-D-glucopyranoside, 98% | 260804-65-7 | Biochemical Assay Reagents |
| HY-W414406 | CABS | 161308-34-5 | Biochemical Assay Reagents |
| HY-W414447 | Disperse blue 1 | 2475-45-8 | Reference compound |
| HY-W414455 | 1-desoxymethylsphinganine | 1219484-98-6 | Biochemical Assay Reagents |
| HY-W414466 | C20-Dihydrosphingosine | 24006-62-0 | Natural Products |
| HY-W414498 | 1-Deoxysphingosine | 193222-34-3 | Reference compound |
| HY-W414548 | 7α,27-Dihydroxycholesterol | 4725-24-0 | Reference compound |
| HY-W414549 | FAM alkyne, 6-isomer | 478801-49-9 | Dye Reagents |
| HY-W414581 | 7-Keto-27-hydroxycholesterol | 240129-30-0 | Biochemical Assay Reagents |
| HY-W414591 | L-alpha-lysophosphatidylcholine, lauroyl | 20559-18-6 | Natural Products |
| HY-W414697 | 4-Hydroxysphinganine (C17 base) | 40289-37-0 | Reference compound |
| HY-W414724 | Methabenzthiazuron | 18691-97-9 | Reference compound |
| HY-W414724R | Methabenzthiazuron (Standard) | 18691-97-9 | Reference Standards |
| HY-W414749 | 08:0 Lyso PC | 45287-18-1 | Biochemical Assay Reagents |
| HY-W414781S | 2,4',5-Trichlorobiphenyl-d4 | 1219794-87-2 | Isotope-Labeled Compounds |
| HY-W414799 | Nε,Nε-Dimethyl-L-lysine (monohydrochloride) | 79416-87-8 | Reference compound |
| HY-W414805S | Prometon-d14 | 1219803-45-8 | Isotope-Labeled Compounds |
| HY-W414805S1 | Prometon-d3 | 1219803-43-6 | Isotope-Labeled Compounds |
| HY-W414823 | 24,25-Epoxycholesterol | 72542-49-5 | Reference compound |
| HY-W414824 | 3β,7β-Dihydroxy-5-cholestenoic acid | 1246298-66-7 | Reference compound |
| HY-W414826S | 2,4,6-Trichlorobiphenyl-2′,3′,4′,5′,6′-d5 | 1219794-85-0 | Isotope-Labeled Compounds |
| HY-W414833S | 3,4-Dichlorobiphenyl-d5 | 1276197-19-3 | Isotope-Labeled Compounds |
| HY-W414846S | 2,3,4'-Trichlorobiphenyl-d4 | Isotope-Labeled Compounds | |
| HY-W414851 | cis-Zeatin | 32771-64-5 | Biochemical Assay Reagents |
| HY-W414878S | Thiophanat-ethyl-d10 | 1398066-16-4 | Isotope-Labeled Compounds |
| HY-W414898 | Zinc dihydrogen phosphate | 13598-37-3 | Biochemical Assay Reagents |
| HY-W414915 | Valsartan methyl ester | 137863-17-3 | Reference compound |
| HY-W414915R | Valsartan methyl ester (Standard) | 137863-17-3 | Reference Standards |
| HY-W414920 | 2-Keto-d-gluconic acid (hemicalcium monohydrate) | 3470-37-9 | Biochemical Assay Reagents |
| HY-W415004 | ACHE-IN-38 | 120014-30-4 | Reference compound |
| HY-W415007 | Isopropyl stearate | 112-10-7 | Natural Products |
| HY-W415060 | Myristylmyristate | 3234-85-3 | Natural Products |
| HY-W415090S | Orange OT-d6 | Isotope-Labeled Compounds | |
| HY-W415104 | D&C Red No. 31 | 6371-76-2 | Reference compound |
| HY-W415108 | 10-Methyl-9-(phenoxycarbonyl) acridinium (trifluoromethanesulfonate) | 161006-14-0 | Dye Reagents |
| HY-W415113S | Methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate-d3 | Isotope-Labeled Compounds | |
| HY-W415119 | 2',3'-Di-O-acetyl-D-uridine | 29108-90-5 | Reference compound |
| HY-W415121 | Bupivacaine (hydrochloride monohydrate) | 73360-54-0 | Reference compound |
| HY-W415121R | Bupivacaine (hydrochloride monohydrate) (Standard) | 73360-54-0 | Reference Standards |
| HY-W415273 | Caspase-3-IN-2 | 62252-25-9 | Reference compound |
| HY-W415287 | DL-Thyroxine | 300-30-1 | Reference compound |
| HY-W415791 | D-Lactal | 65207-55-8 | Biochemical Assay Reagents |
| HY-W415798 | Ac4GalNAlk | 1810852-60-8 | Reference compound |
| HY-W415799 | (2S)-Ac4GalNAl | 1658458-26-4 | Reference compound |
| HY-W415806 | 2'-Chloro-4'-nitrophenyl β-D-cellobioside | 135743-28-1 | Biochemical Assay Reagents |
| HY-W415807 | 6-Chloro-3-indoxyl-β-D-cellobioside | 425427-87-8 | Biochemical Assay Reagents |
| HY-W415809 | 2-Chloro-4-nitrophenyl-β-D-lactoside | 120583-41-7 | Biochemical Assay Reagents |
| HY-W415811 | 4-Aminophenyl 2-(acetylamino)-2-deoxy-β-D-glucopyranoside | 14419-59-1 | Biochemical Assay Reagents |
| HY-W415813 | 6-Amino-N-β-D-galactopyranosylhexanamide | 38822-56-9 | Biochemical Assay Reagents |
| HY-W415818 | Oxanosine | 80394-72-5 | Reference compound |
| HY-W415824A | Mannomustine (dihydrochloride) | 551-74-6 | Reference compound |
| HY-W415836 | Methyl N-acetyl-1-O-(phenylmethyl)-4,6-O-(phenylmethylene)-α-muramate | 104371-51-9 | Biochemical Assay Reagents |
| HY-W415837 | Benzyl β-D-Lactoside Heptaacetate | 67310-53-6 | Biochemical Assay Reagents |
| HY-W415887 | 6-Deoxy-L-talose | 7658-10-8 | Biochemical Assay Reagents |
| HY-W415909 | Maltulose monohydrate | 207511-09-9 | Biochemical Assay Reagents |
| HY-W415910 | 3,6-Di-O-(α-D-mannopyranosyl)-D-mannopyrannose | 121123-33-9 | Biochemical Assay Reagents |
| HY-W415916 | L-Glycero-D-mannoheptose | 4305-74-2 | Biochemical Assay Reagents |
| HY-W415917 | D-Glycero-D-mannoheptose | 1961-73-5 | Biochemical Assay Reagents |
| HY-W415921 | 1-Deoxy-D-threo-pentulose | 60299-43-6 | Biochemical Assay Reagents |
| HY-W415923 | rel-6-Deoxy-6-fluoroglucopyranose | 447-25-6 | Biochemical Assay Reagents |
| HY-W415930 | 3-Deoxy-3-fluoro-D-galactose | 52904-86-6 | Biochemical Assay Reagents |
| HY-W415931 | 3-Deoxy-3-fluoro-D-mannose | 87764-46-3 | Biochemical Assay Reagents |
| HY-W415934 | 4-Deoxy-4-fluoro-D-mannose | 87764-47-4 | Biochemical Assay Reagents |
| HY-W415938 | 1,2,3,4,6-Penta-O-benzoyl-D-glucopyranoside | 3006-49-3 | Biochemical Assay Reagents |
| HY-W415939 | 1,2,3,4,6-Penta-O-benzoyl-D-galactopyranoside | 3006-48-2 | Biochemical Assay Reagents |
| HY-W415940 | α-D-Maltose octaacetate | 6920-00-9 | Biochemical Assay Reagents |
| HY-W415942 | D-Xylopyranose,1,2,3,4-tetraacetate | 62446-93-9 | Biochemical Assay Reagents |
| HY-W415946 | 2-Deoxy-D-glucose-tetraacetate | 69515-91-9 | Biochemical Assay Reagents |
| HY-W415953 | Periplanetin | 21056-52-0 | Natural Products |
| HY-W415973 | D-Mannopyranose,2,3,4,6-tetrabenzoate | 627466-98-2 | Biochemical Assay Reagents |
| HY-W415975 | 3-Chloro-3-deoxy-1,2,4,6-tetra-O-acetyl-D-glucopyranose | 104013-04-9 | Biochemical Assay Reagents |
| HY-W415981 | β-Gentiobiose octaacetate | 4613-78-9 | Biochemical Assay Reagents |
| HY-W416007 | 1,2:5,6-Di-O-isopropylidene-3-O-tosyl-α-D-gulofuranose | 19131-06-7 | Biochemical Assay Reagents |
| HY-W416016 | 3-O-(Phenylmethyl)-α-D-mannopyranose | 65877-63-6 | Biochemical Assay Reagents |
| HY-W416032 | α-D-Glucopyranoside,methyl,2,3,4,6-tetraacetate | 604-70-6 | Biochemical Assay Reagents |
| HY-W416041 | α-D-Glucopyranoside,methyl 4,6-O-(phenylmethylene),2-benzoate | 28642-64-0 | Biochemical Assay Reagents |
| HY-W416063 | Methyl 6-O-(triphenylmethyl)-α-D-galactopyranoside | 35920-83-3 | Biochemical Assay Reagents |
| HY-W416106 | Phenylmethyl 2,3,6-tris-O-(phenylmethyl)-β-D-glucopyranoside | 67831-42-9 | Biochemical Assay Reagents |
| HY-W416107 | Phenylmethyl 3,4,6-tris-O-(phenylmethyl)-β-D-galactopyranoside | 61820-04-0 | Biochemical Assay Reagents |
| HY-W416111 | Phenylmethyl 4,6-O-(phenylmethylene)-β-D-galactopyranoside | 56341-65-2 | Biochemical Assay Reagents |
| HY-W416118 | Benzyl 2,3,4-tri-O-benzyl-L-rhamnopyranose | 353754-90-2 | Biochemical Assay Reagents |
| HY-W416131 | 2-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)thiopseudourea (hydrobromide) | 51224-13-6 | Biochemical Assay Reagents |
| HY-W416138 | Phenyl 2,3,4,6-tetra-O-acetyl-α-D-thiomannopyranoside | 13992-16-0 | Biochemical Assay Reagents |
| HY-W416153 | 2-Deoxy-D-arabino-hexose propylene dithioacetal | 91294-63-2 | Biochemical Assay Reagents |
| HY-W416162 | α-D-Glucopyranuronic acid,1-bromo-1-deoxy,methyl ester,2,3,4-tribenzoate | 103674-69-7 | Biochemical Assay Reagents |
| HY-W416168 | α-D-Galactopyranosyl chloride,2,3,4,6-tetraacetate | 14227-87-3 | Biochemical Assay Reagents |
| HY-W416177 | 2,3,4,6-Tetra-O-benzoyl-α-D-galactopyranoside trichloroacetimidate | 138479-78-4 | Biochemical Assay Reagents |
| HY-W416178 | Ethyl 6-deoxy-2,3,4-tris-O-(phenylmethyl)-1-thio-L-galactopyranoside | 169532-17-6 | Biochemical Assay Reagents |
| HY-W416179 | 2,3,4,6-Tetra-O-acetyl-β-D-glucose | 23202-66-6 | Biochemical Assay Reagents |
| HY-W416182 | α-D-Glucopyranose,1,2-O-(1-ethoxyethylidene)-,3,4,6-triacetate | 3254-17-9 | Biochemical Assay Reagents |
| HY-W416183 | α-D-Galactopyranose,1,2-O-(1-methoxyethylidene),3,4,6-triacetate | 50801-29-1 | Biochemical Assay Reagents |
| HY-W416185 | 3,4,6-Tri-O-benzyl-α-D-galactopyranose 1,2-(methyl orthoacetate) | 68779-52-2 | Biochemical Assay Reagents |
| HY-W416187 | 3-Amino-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose | 24384-84-7 | Biochemical Assay Reagents |
| HY-W416188 | N-Carbobenzyloxy mannosamine | 137157-50-7 | Biochemical Assay Reagents |
| HY-W416196 | 2,3,5-Tris-O-(phenylmethyl)-D-arabinose | 37776-25-3 | Biochemical Assay Reagents |
| HY-W416204 | 2,3,4,6-Tetra-O-benzyl-D-galactono-1,5-lactone | 82598-84-3 | Biochemical Assay Reagents |
| HY-W416216 | D-Gulonic acid,γ-lactone,2,3,5,6-tetraacetate | 136345-68-1 | Biochemical Assay Reagents |
| HY-W416222 | Methyl β-D-glucuronide sodium | 58189-74-5 | Biochemical Assay Reagents |
| HY-W416228 | 1-O-Caffeoyl-β-D-glucopyranose | 14364-08-0 | Natural Products |
| HY-W416240 | 4-Methylumbelliferyl 2-Amino-2-deoxy-α-D-glucopyranoside | 137687-00-4 | Biochemical Assay Reagents |
| HY-W416241 | 6-Chloro-3-indoxyl-N-acetyl-β-D-galactosaminide | 501432-61-7 | Biochemical Assay Reagents |
| HY-W416243 | 2-Nitrophenyl N-acetyl-α-D-galactosaminide | 23646-67-5 | Biochemical Assay Reagents |
| HY-W416244 | 5-Bromo-4-chloro-3-indolyl 2-acetamido-2-deoxy-α-D-galactopyranoside | 210110-89-7 | Biochemical Assay Reagents |
| HY-W416249 | 4-Nitrophenyl β-D-thiomannopyranoside | 55385-51-8 | Biochemical Assay Reagents |
| HY-W416250 | p-Cresol glucuronide | 17680-99-8 | Reference compound |
| HY-W416254 | 4-Nitrophenyl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside | 16790-33-3 | Biochemical Assay Reagents |
| HY-W416255 | 4-Nitrophenyl 3-O-β-D-glucopyranosyl-β-D-glucopyranoside | 26255-70-9 | Biochemical Assay Reagents |
| HY-W416257 | Methyl 3-O-β-D-galactopyranosyl-β-D-galactopyranoside | 81131-46-6 | Biochemical Assay Reagents |
| HY-W416264 | 2-Aminophenyl β-D-glucuronide | 15959-03-2 | Biochemical Assay Reagents |
| HY-W416265 | p-Aminophenyl β-D-cellobioside | 42935-24-0 | Biochemical Assay Reagents |
| HY-W416270 | Octyl D-glucopyranoside, 95% | 41444-50-2 | Biochemical Assay Reagents |
| HY-W416271 | Dodecyl α-D-glucopyranoside | 29980-16-3 | Biochemical Assay Reagents |
| HY-W416273 | Hexyl 1-thio-β-D-glucopyranoside | 85618-19-5 | Biochemical Assay Reagents |
| HY-W416274 | N-β-D-Glucopyranosyloctanamide | 134403-86-4 | Biochemical Assay Reagents |
| HY-W416275 | Isopropyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 78341-33-0 | Biochemical Assay Reagents |
| HY-W416278 | Pentyl 2-(acetylamino)-2-deoxy-β-D-glucopyranoside | 94483-64-4 | Biochemical Assay Reagents |
| HY-W416285 | Octyl 2-(acetylamino)-2-deoxy-β-D-galactopyranoside | 383417-49-0 | Biochemical Assay Reagents |
| HY-W416287 | Octyl 4-O-β-D-galactopyranosyl-β-D-glucopyranoside | 74513-17-0 | Biochemical Assay Reagents |
| HY-W416291 | Polyadenylic acid (potassium) | 26763-19-9 | Reference compound |
| HY-W416300 | 6-Methoxypurine arabinoside | 91969-06-1 | Reference compound |
| HY-W416311 | β-D-Glucopyranoside,2-chloro-4-nitrophenyl,2,3,4,6-tetraacetate | 35023-71-3 | Biochemical Assay Reagents |
| HY-W416316 | β-D-Glucopyranoside,2-bromoethyl,2,3,4,6-tetraacetate | 16977-78-9 | Biochemical Assay Reagents |
| HY-W416318 | 4-Methylumbelliferyl 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranoside | 67945-53-3 | Biochemical Assay Reagents |
| HY-W416322 | 4-Nitrophenyl2,6-di-O-benzoyl-a-D-galactopyranoside | 135216-30-7 | Biochemical Assay Reagents |
| HY-W416323 | p-Nitrophenyl 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-glucopyranoside | 13089-23-1 | Biochemical Assay Reagents |
| HY-W416325 | p-Nitrophenyl 2-acetamido-2-deoxy-3-O-acetyl-β-D-glucopyranoside | 23262-57-9 | Biochemical Assay Reagents |
| HY-W416326 | p-Nitrophenyl 2-acetamido-2-deoxy-4,6-benzylidene-β-D-glucopyranoside | 19234-58-3 | Biochemical Assay Reagents |
| HY-W416327 | β-D-Galactopyranoside,4-nitrophenyl,3,4,6-triacetate | 62346-04-7 | Biochemical Assay Reagents |
| HY-W416336 | Phenylmethyl 2-(acetylamino)-2-deoxy-3-O-methyl-α-D-glucopyranoside | 93215-41-9 | Biochemical Assay Reagents |
| HY-W416344 | 4-Nitrophenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside | 5987-78-0 | Biochemical Assay Reagents |
| HY-W416350 | β-D-Galactopyranoside, methyl 4,6-O-(phenylmethylene)-, dibenzoate | 53598-03-1 | Biochemical Assay Reagents |
| HY-W416353 | Methyl 2,3-O-diallyl-4,6-O-benzylidene-α-D-mannopyranoside | 359437-00-6 | Biochemical Assay Reagents |
| HY-W416357 | Methyl 2-acetamido-2-deoxy-4,6-O-benzlydene-O-β-D-glucopryanoside | 10300-76-2 | Biochemical Assay Reagents |
| HY-W416359 | Methyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-N-phthalimido- β-D-glucopyranoside | 97276-96-5 | Biochemical Assay Reagents |
| HY-W416364 | β-D-Galactopyranoside,2-nitrophenyl,2,3,4,6-tetraacetate | 3053-17-6 | Biochemical Assay Reagents |
| HY-W416366 | 2,3,4,6-Tetra-O-acetyl linamarin | 66432-53-9 | Biochemical Assay Reagents |
| HY-W416378S | 4-Fluoro-N,N-diisopropylbenzamide-d4 | 3047412-98-3 | Isotope-Labeled Compounds |
| HY-W416440 | Esmolol acid (hydrochloride) | 83356-60-9 | Reference compound |
| HY-W417914 | 4-Methylamphetamine (hydrochloride) | 41632-56-8 | Reference compound |
| HY-W419044A | Calcein (calcium potassium) | 36352-49-5 | Reference compound |
| HY-W419324 | Fmoc-Aph(Cbm)-OH | 324017-23-4 | Peptides |
| HY-W419331 | Methionyl-methionine | 52715-93-2 | Reference compound |
| HY-W419374 | ivDde-Lys(Fmoc)-OH | 1446752-60-8 | Peptides |
| HY-W419403 | Boc-D-Aza-OH (CHA) | 2098496-96-7 | Reference compound |
| HY-W419440 | H-Lys-Leu-OH | 7369-79-1 | Reference compound |
| HY-W419570 | (Rac)-BX 048 | 478005-11-7 | Reference compound |
| HY-W419589 | Xanthomicrol | 16545-23-6 | Reference compound |
| HY-W419643 | Drometrizole trisiloxane | 155633-54-8 | Reference compound |
| HY-W419643R | Drometrizole trisiloxane (Standard) | 155633-54-8 | Reference Standards |
| HY-W419700 | L-Glutamic acid (ammonium) | 7558-63-6 | Reference compound |
| HY-W419942 | Propyldiethanolamine | 6735-35-9 | Biochemical Assay Reagents |
| HY-W419989 | Fmoc-Asu(Oall)-OH | 167368-90-3 | Peptides |
| HY-W420002 | N-Isopropylbenzylamine (hydrochloride) | 18354-85-3 | Reference compound |
| HY-W420033 | (S)-(+)-Etomoxir | 828934-40-3 | Reference compound |
| HY-W420336 | Fluopicolide | 239110-15-7 | Reference compound |
| HY-W420336R | Fluopicolide (Standard) | 239110-15-7 | Reference Standards |
| HY-W420337 | Fluopimomide | 1309859-39-9 | Reference compound |
| HY-W420344 | Dehydroindapamide | 63968-75-2 | Reference compound |
| HY-W420344R | Dehydroindapamide (Standard) | 63968-75-2 | Reference Standards |
| HY-W420462 | Naphthol AS-BI phosphate (sodium) | 530-79-0 | Biochemical Assay Reagents |
| HY-W421778S | 1,4-Bis(methylthio)benzene-d6 | 2762389-12-6 | Isotope-Labeled Compounds |
| HY-W421970 | Tup (hydrochloride) | 1200041-11-7 | Reference compound |
| HY-W422288 | (Rac)-Ketoconazole | 79156-75-5 | Reference compound |
| HY-W422359A | 2-Aminopurine-O-Ph-NHCO-C3-COOH (hydrochloride) | Reference compound | |
| HY-W422400 | Fluoroglutamine (2S,4R) | 238418-71-8 | Reference compound |
| HY-W422402 | Foramsulfuron | 173159-57-4 | Reference compound |
| HY-W422402R | Foramsulfuron (Standard) | 173159-57-4 | Reference Standards |
| HY-W422419 | Cetearyl alcohol | 67762-27-0 | Reference compound |
| HY-W422491S | (R)-2-phenyl-2-((R)-piperidin-2-yl)acetic acid-d5 (TFA) | Isotope-Labeled Compounds | |
| HY-W423080 | TAMRA alkyne,5-isomer | 945928-17-6 | Reference compound |
| HY-W423183 | 2-(Morpholin-4-yl)ethane-1-sulfonamide | 4945-80-6 | Reference compound |
| HY-W423191 | Maltobionic acid | 534-42-9 | Biochemical Assay Reagents |
| HY-W423245S | 2,5-Diethyl-3-methylpyrazine-d3 | 1335401-22-3 | Isotope-Labeled Compounds |
| HY-W423489 | SARS-CoV-2-IN-76 | 58976-18-4 | Reference compound |
| HY-W423502 | WS5 | 68489-14-5 | Reference compound |
| HY-W423530S | Bis(2-propylheptyl) phthalate-d4 | 1346601-46-4 | Isotope-Labeled Compounds |
| HY-W423573 | N,S-Diacetylcysteine methyl ester | 19547-88-7 | Reference compound |
| HY-W423578 | LDLR regulator-1 | 6656-19-5 | Reference compound |
| HY-W423595 | BEBT-109 | 2050906-40-4 | Reference compound |
| HY-W424017A | Lophophine (hydrochloride) | 77158-52-2 | Reference compound |
| HY-W424730 | HA-966 (hydrochloride) | 42585-88-6 | Reference compound |
| HY-W424779 | 5-Carboxy-2′-deoxyuridine | 14599-46-3 | Enzyme |
| HY-W424779R | 5-Carboxy-2′-deoxyuridine (Standard) | 14599-46-3 | Reference Standards |
| HY-W424788S | N-(2,6-Dimethylphenyl)-1-isopropylpiperidine-2-carboxamide-d7 | 1276197-11-5 | Isotope-Labeled Compounds |
| HY-W424792A | O-Desmethyl Brinzolamide (hydrochloride) | 2967475-56-3 | Reference compound |
| HY-W424839 | Probucol dithiobisphenol | 6386-58-9 | Reference compound |
| HY-W424851 | DPQ (hydrochloride) | 84050-22-6 | Reference compound |
| HY-W424918 | Opromazine (hydrochloride) | 316-07-4 | Reference compound |
| HY-W425093 | (S)-DMT-glycidol-T | 168332-12-5 | Reference compound |
| HY-W425099 | 2'-Deoxyguanosine-(N-iBu)-3'-methyl-phosphoramidite | 84416-84-2 | Reference compound |
| HY-W425671 | N-Isobutyryl-L-cysteine | 124529-02-8 | Reference compound |
| HY-W425676 | Pinoxaden | 243973-20-8 | Reference compound |
| HY-W425676R | Pinoxaden (Standard) | 243973-20-8 | Reference Standards |
| HY-W426106 | Gly-NH-CH2-Boc | 14664-05-2 | Reference compound |
| HY-W436250 | 1,6-Anhydro-2,3-O-(1-methylethylidene)-β-D-mannopyranose | 14440-51-8 | Biochemical Assay Reagents |
| HY-W436265 | O-Methyl-N-acetyl-2-deoxy-α-D-galactosamine | 6082-22-0 | Biochemical Assay Reagents |
| HY-W436270 | Bulbocapnine (hydrochloride) | 632-47-3 | Reference compound |
| HY-W436275 | Methyl β-D-mannopyranoside isopropylate | 911673-07-9 | Biochemical Assay Reagents |
| HY-W436420 | WAY-299375 | 1005086-69-0 | Reference compound |
| HY-W436424 | DAM-IN-1 | 935279-95-1 | Reference compound |
| HY-W436428 | V-161 | 69570-95-2 | Reference compound |
| HY-W436471 | H-Ala-Pro-AFC | 125791-92-6 | Peptides |
| HY-W436472 | 6-O-(tert-Butyldimethylsilyl)-D-galactal | 124751-19-5 | Biochemical Assay Reagents |
| HY-W436478 | (+)-2,5-epi-Goniothalesdiol | 887927-59-5 | Reference compound |
| HY-W436495 | 6,15-Diketo-13,14-dihydro prostaglandin F1α | 63983-53-9 | Reference compound |
| HY-W436499 | 1,5-Anhydro-2-deoxy-D-lyxo-hex-1-enitol tribenzoate | 34948-79-3 | Biochemical Assay Reagents |
| HY-W436777 | (±)-p-Menthane-3,8-trans-diol | 3564-98-5 | Natural Products |
| HY-W437569 | Melicopine | 568-01-4 | Natural Products |
| HY-W437745 | Desthiobiotin-NHS ester | 80750-24-9 | Biochemical Assay Reagents |
| HY-W438351 | 1,3-Dibenzyl-5-fluorouracil | 75500-02-6 | Reference compound |
| HY-W438378 | 4-Hydroxy-3-methoxyphenylglycol (piperazine) | 67423-45-4 | Natural Products |
| HY-W439487 | 7,9-Dimethylguanine | 524-35-6 | Reference compound |
| HY-W439855 | 10-Norparvulenone | 618104-32-8 | Natural Products |
| HY-W440039 | Methyl 2-(2,4-dihydroxyphenyl)acetate | 67828-42-6 | Natural Products |
| HY-W440238 | 22-Hydroxydocosanoic acid | 506-45-6 | Natural Products |
| HY-W440239 | 4-Fluorobenzoic-2,3,5,6-d4 acid | 93111-25-2 | Isotope-Labeled Compounds |
| HY-W440240 | 4-Chlorobenzoic acid-d4 | 85577-25-9 | Isotope-Labeled Compounds |
| HY-W440247 | CRBN ligand-109 | 2758533-77-4 | Reference compound |
| HY-W440303 | 1,1',3,3,3',3'-Hexamethylindotricarbocyanine (perchlorate) | 16595-48-5 | Dye Reagents |
| HY-W440408 | Poly(oxyethyleneoxyterephthaloyl) | 25038-59-9 | Reference compound |
| HY-W440409 | 2,2′-Bipyridine-d8 | 32190-42-4 | Isotope-Labeled Compounds |
| HY-W440436S | 2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(tert-butyl)phenol-d4 | Isotope-Labeled Compounds | |
| HY-W440454 | 2-Phenylpyridine-d9 | 403724-67-4 | Isotope-Labeled Compounds |
| HY-W440548 | Ethylene glycol diacrylate | 2274-11-5 | Reference compound |
| HY-W440681 | C13-112-tri-tail | 1381861-96-6 | Biochemical Assay Reagents |
| HY-W440682 | C13-113-tri-tail | 1381861-86-4 | Biochemical Assay Reagents |
| HY-W440683 | C13-112-tetra-tail | 1381861-92-2 | Biochemical Assay Reagents |
| HY-W440684 | C13-113-tetra-tail | 1381861-97-7 | Biochemical Assay Reagents |
| HY-W440690 | Cholesterol-PEG-Amine (MW 2000) | Biochemical Assay Reagents | |
| HY-W440691 | Cholesterol-PEG-amine (MW 3400) | Biochemical Assay Reagents | |
| HY-W440692 | Cholesterol-PEG-amine (MW 5000) | Biochemical Assay Reagents | |
| HY-W440693 | Cholesterol-PEG-azide (MW 1000) | Biochemical Assay Reagents | |
| HY-W440695 | Cholesterol-PEG-azide (MW 3400) | Biochemical Assay Reagents | |
| HY-W440696 | Cholesterol-PEG-azide (MW 5000) | Biochemical Assay Reagents | |
| HY-W440697 | Cholesterol-PEG-NHS (MW 1000) | Biochemical Assay Reagents | |
| HY-W440698 | Cholesterol-PEG-Acid (MW 2000) | Biochemical Assay Reagents | |
| HY-W440699 | Cholesterol-PEG-acid (MW 3400) | Biochemical Assay Reagents | |
| HY-W440700 | Cholesterol-PEG-acid (MW 5000) | Biochemical Assay Reagents | |
| HY-W440702 | Cholesterol-PEG-NHS (MW 2000) | Biochemical Assay Reagents | |
| HY-W440703 | Cholesterol-PEG-NHS (MW 3400) | Biochemical Assay Reagents | |
| HY-W440704 | Cholesterol-PEG-NHS (MW 5000) | Biochemical Assay Reagents | |
| HY-W440705 | Cholesterol-PEG-alcohol (MW 1000) | Biochemical Assay Reagents | |
| HY-W440706 | Cholesterol-PEG-alcohol (MW 2000) | Biochemical Assay Reagents | |
| HY-W440707 | Cholesterol-PEG-alcohol (MW 3400) | Biochemical Assay Reagents | |
| HY-W440708 | Cholesterol-PEG-alcohol (MW 5000) | Biochemical Assay Reagents | |
| HY-W440709 | Cholesterol-PEG-alcohol (MW 10000) | Biochemical Assay Reagents | |
| HY-W440711 | Cholesterol-PEG-Biotin (MW 2000) | Biochemical Assay Reagents | |
| HY-W440712 | Cholesterol-PEG-Biotin (MW 3400) | Biochemical Assay Reagents | |
| HY-W440713 | Cholesterol-PEG-Biotin (MW 5000) | Biochemical Assay Reagents | |
| HY-W440714 | Cholesterol-PEG-Folate (MW 1000) | Biochemical Assay Reagents | |
| HY-W440715 | Cholesterol-PEG-Folate, MW 2000 | Biochemical Assay Reagents | |
| HY-W440716 | Cholesterol-PEG-Folate (MW 3400) | Biochemical Assay Reagents | |
| HY-W440717 | Cholesterol-PEG-Folate (MW 5000) | Biochemical Assay Reagents | |
| HY-W440718 | Cholesterol-PEG-Mal (MW 1000) | Biochemical Assay Reagents | |
| HY-W440719 | Cholesterol-PEG-MAL (MW 2000) | Reference compound | |
| HY-W440720 | Cholesterol-PEG-Mal (MW 3400) | Biochemical Assay Reagents | |
| HY-W440721 | Cholesterol-PEG-Mal (MW 5000) | Biochemical Assay Reagents | |
| HY-W440722 | Cholesterol-PEG-Thiol (MW 1000) | Biochemical Assay Reagents | |
| HY-W440723 | Cholesterol-PEG-Thiol (MW 2000) | Biochemical Assay Reagents | |
| HY-W440724 | Cholesterol-PEG-Thiol (MW 3400) | Biochemical Assay Reagents | |
| HY-W440725 | Cholesterol-PEG-Thiol (MW 5000) | Biochemical Assay Reagents | |
| HY-W440726 | Cholesterol-PEG-Vinylsulfone (MW 1000) | Biochemical Assay Reagents | |
| HY-W440727 | Cholesterol-PEG-Vinylsulfone (MW 2000) | Biochemical Assay Reagents | |
| HY-W440728 | Cholesterol-PEG-Vinylsulfone (MW 3400) | Biochemical Assay Reagents | |
| HY-W440729 | Cholesterol-PEG-Vinylsulfone (MW 5000) | Biochemical Assay Reagents | |
| HY-W440807 | Oleoyl-Gly-Lys-(m-PEG11)-NH2 | 2353409-68-2 | Reference compound |
| HY-W440809 | Nonyl 8-bromooctanoate | 2089253-38-1 | Reference compound |
| HY-W440810 | Undecyl 6-bromohexanoate | 959040-06-3 | Biochemical Assay Reagents |
| HY-W440811 | 6-Bromohexyl 2-hexyldecanoate | 2644752-91-8 | Biochemical Assay Reagents |
| HY-W440813 | Heptadecan-9-yl 8-bromooctanoate | 2089253-22-3 | Oligonucleotides |
| HY-W440815 | 6-((4-Hydroxybutyl)amino)hexyl 2-hexyldecanoate | 2644752-88-3 | Biochemical Assay Reagents |
| HY-W440816 | Heptadecan-9-yl 8-((2-hydroxyethyl)amino)octanoate | 2089253-23-4 | Biochemical Assay Reagents |
| HY-W440817 | 4,4-Bis(octyloxy)butanenitrile | 1627510-69-3 | Reference compound |
| HY-W440820 | Bis(bis(2-carboxyethyl)aminopropyl)methylamine | 692250-70-7 | Biochemical Assay Reagents |
| HY-W440821 | m-PEG-DMG (MW 2000) | 1019000-64-6 | Biochemical Assay Reagents |
| HY-W440823A | DSPE-PEG-Amine, MW 1000 (ammonium) | 474922-26-4 | Biochemical Assay Reagents |
| HY-W440823B | DSPE-PEG2000-amine (sodium) | 1292302-96-5 | Reference compound |
| HY-W440825 | DSPE-PEG-COOH (MW 1000) | Biochemical Assay Reagents | |
| HY-W440826 | DOPE-PEG-COOH (MW 1000) | Biochemical Assay Reagents | |
| HY-W440827 | DOPE-PEG-COOH (MW 2000) | Reference compound | |
| HY-W440828 | DOPE-PEG-COOH (MW 3400) | Biochemical Assay Reagents | |
| HY-W440829 | DOPE-PEG-COOH (MW 5000) | Biochemical Assay Reagents | |
| HY-W440830 | DSPE-PEG-COOH (MW 3400) | Biochemical Assay Reagents | |
| HY-W440831 | DSPE-PEG-azide (MW 1000) | Biochemical Assay Reagents | |
| HY-W440832 | DSPE-PEG-Azide, MW 2000 | Reference compound | |
| HY-W440833 | DSPE-PEG-azide (MW 3400) | Biochemical Assay Reagents | |
| HY-W440834 | DSPE-PEG-azide (MW 5000) | Biochemical Assay Reagents | |
| HY-W440835 | DSPE-PEG-DBCO, MW 2000 | Reference compound | |
| HY-W440881 | DSPE-PEG-DBCO (sodium) (MW 3400) | Biochemical Assay Reagents | |
| HY-W440883 | DSPE-PEG-Ald, MW 2000 | Biochemical Assay Reagents | |
| HY-W440884 | DSPE-PEG-Ald (MW 3400) | Biochemical Assay Reagents | |
| HY-W440885 | DSPE-PEG-Ald (MW 5000) | Biochemical Assay Reagents | |
| HY-W440886 | DSPE-PEG-Biotin, MW 3400 | Biochemical Assay Reagents | |
| HY-W440888 | DSPE-PEG-Folate, MW 2000 | Reference compound | |
| HY-W440890 | DSPE-PEG-Folate, MW 5000 | Oligonucleotides | |
| HY-W440891 | DSPE-PEG-OH (MW 1000) | Biochemical Assay Reagents | |
| HY-W440892 | DSPE-PEG-OH (MW 3400) | Biochemical Assay Reagents | |
| HY-W440893 | DSPE-PEG-OH (MW 5000) | Biochemical Assay Reagents | |
| HY-W440894 | DSPE-PEG-DBCO (sodium) (MW 5000) | Biochemical Assay Reagents | |
| HY-W440895 | DSPE-PEG-SH (MW 1000) | Biochemical Assay Reagents | |
| HY-W440896 | DSPE-PEG-SH, MW 2000 | Oligonucleotides | |
| HY-W440897 | DSPE-PEG-SH (MW 3400) | Biochemical Assay Reagents | |
| HY-W440898 | DSPE-PEG-SH (MW 5000) | Biochemical Assay Reagents | |
| HY-W440899 | DSPE-PEG-SPDP (MW 1000) | Biochemical Assay Reagents | |
| HY-W440900 | DSPE-PEG-SPDP (MW 3400) | Biochemical Assay Reagents | |
| HY-W440901 | DSPE-PEG-SPDP (MW 5000) | Biochemical Assay Reagents | |
| HY-W440902 | DSPE-PEG-IA (MW 3400) | Biochemical Assay Reagents | |
| HY-W440903 | DSPE-PEG-IA (MW 5000) | Biochemical Assay Reagents | |
| HY-W440904 | DSPE-PEG-Vinylsulfone (MW 1000) | Biochemical Assay Reagents | |
| HY-W440905 | DSPE-PEG-Vinylsulfone (MW 2000) | Biochemical Assay Reagents | |
| HY-W440906 | DSPE-PEG-Vinylsulfone (MW 3400) | Biochemical Assay Reagents | |
| HY-W440907 | DSPE-PEG-Vinylsulfone (MW 5000) | Biochemical Assay Reagents | |
| HY-W440908 | DSPE-PEG-Cy3, MW 2000 | Biochemical Assay Reagents | |
| HY-W440909 | DSPE-PEG-Cy3, MW 3400 | Biochemical Assay Reagents | |
| HY-W440910 | DSPE-PEG-Cy3, MW 5000 | Biochemical Assay Reagents | |
| HY-W440911 | DSPE-PEG-Cy5, MW 2000 | Biochemical Assay Reagents | |
| HY-W440912 | DSPE-PEG-Cy5, MW 3400 | Biochemical Assay Reagents | |
| HY-W440913 | DSPE-PEG-Cy5, MW 5000 | Biochemical Assay Reagents | |
| HY-W440914 | DSPE-PEG-FITC (MW 1000) | 1000788-53-3 | Reference compound |
| HY-W440914A | DSPE-PEG-FITC (MW 400) | 1000788-53-3 | Dye Reagents |
| HY-W440914B | DSPE-PEG-FITC (MW 10000) | 1000788-53-3 | Dye Reagents |
| HY-W440915 | DSPE-PEG-FITC (MW 2000) | 1000788-53-3 | Oligonucleotides |
| HY-W440916 | DSPE-PEG-FITC (MW 3400) | 1000788-53-3 | Biochemical Assay Reagents |
| HY-W440917 | DSPE-PEG-FITC (MW 5000) | 1000788-53-3 | Biochemical Assay Reagents |
| HY-W440919 | DSPE-PEG-Rhodamine, MW 2000 | Biochemical Assay Reagents | |
| HY-W440920 | DSPE-PEG-Rhodamine, MW 3400 | Biochemical Assay Reagents | |
| HY-W440921 | DSPE-PEG-Rhodamine, MW 5000 | Biochemical Assay Reagents | |
| HY-W440922 | m-PEG-DSPE (sodium) (MW 1000) | Biochemical Assay Reagents | |
| HY-W440924 | m-PEG-DSPE (sodium) (MW 3000) | Biochemical Assay Reagents | |
| HY-W440925 | m-PEG-DSPE (sodium) (MW 5000) | Biochemical Assay Reagents | |
| HY-W440926 | Stearic acid-PEG-NHS (MW 1000) | Biochemical Assay Reagents | |
| HY-W440927 | Stearic acid-PEG-NHS, MW 2000 | Biochemical Assay Reagents | |
| HY-W440928 | Stearic acid-PEG-NHS (MW 3400) | Biochemical Assay Reagents | |
| HY-W440930 | Stearic acid-mPEG (MW 1000) | Biochemical Assay Reagents | |
| HY-W440931 | MPEG2000-DMG | Biochemical Assay Reagents | |
| HY-W440932 | Stearic acid-mPEG (MW 5000) | Biochemical Assay Reagents | |
| HY-W440934 | Stearic acid-PEG-Rhodamine, MW 2000 | Biochemical Assay Reagents | |
| HY-W440935 | Stearic acid-PEG-Rhodamine, MW 3400 | Biochemical Assay Reagents | |
| HY-W440936 | Stearic acid-PEG-Rhodamine, MW 5000 | Biochemical Assay Reagents | |
| HY-W440938 | Stearic acid-PEG-FITC, MW 2000 | Biochemical Assay Reagents | |
| HY-W440939 | Stearic acid-PEG-FITC, MW 3400 | Biochemical Assay Reagents | |
| HY-W440940 | Stearic acid-PEG-FITC, MW 5000 | Biochemical Assay Reagents | |
| HY-W440941 | Pentacosadiynoic acid-mPEG (MW 1000) | Biochemical Assay Reagents | |
| HY-W440942 | Pentacosadiynoic acid-mPEG (MW 2000) | Biochemical Assay Reagents | |
| HY-W440943 | Pentacosadiynoic acid-mPEG (MW 5000) | Biochemical Assay Reagents | |
| HY-W440945 | Stearic acid-PEG-amine, MW 2000 | Biochemical Assay Reagents | |
| HY-W440949 | Stearic acid-PEG-Mal (MW 1000) | Biochemical Assay Reagents | |
| HY-W440950 | Stearic acid-PEG-Mal, MW 2000 | Biochemical Assay Reagents | |
| HY-W440951 | Stearic acid-PEG-Mal (MW 3400) | Biochemical Assay Reagents | |
| HY-W440952 | Stearic acid-PEG-Mal (MW 5000) | Biochemical Assay Reagents | |
| HY-W440953 | Stearic acid-PEG-CH2CO2H (MW 1000) | Biochemical Assay Reagents | |
| HY-W440954 | Stearic acid-PEG-CH2CO2H, MW 2000 | Biochemical Assay Reagents | |
| HY-W440955 | Stearic acid-PEG-CH2CO2H (MW 3400) | Biochemical Assay Reagents | |
| HY-W440956 | Stearic acid-PEG-CH2CO2H (MW 5000) | Biochemical Assay Reagents | |
| HY-W440957 | PMPC | 69441-09-4 | Biochemical Assay Reagents |
| HY-W440958 | 1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine | 59403-51-9 | Biochemical Assay Reagents |
| HY-W440981 | SPPC | 59403-53-1 | Biochemical Assay Reagents |
| HY-W440982 | SOPC | 56421-10-4 | Reference compound |
| HY-W440983 | SDPC | 59403-52-0 | Biochemical Assay Reagents |
| HY-W440985 | DLPS | 208757-51-1 | Biochemical Assay Reagents |
| HY-W440986 | Distearoylphosphatidylserine (sodium) | 321595-13-5 | Biochemical Assay Reagents |
| HY-W440986S | Distearoylphosphatidylserine-d70 (sodium) | 327178-95-0 | Isotope-Labeled Compounds |
| HY-W440987 | DOPE-mPEG (MW 1000) | Biochemical Assay Reagents | |
| HY-W440988 | DOPE-mPEG, MW 2000 | Reference compound | |
| HY-W440989 | DOPE-mPEG (MW 5000) | Biochemical Assay Reagents | |
| HY-W440991 | DOPE-PEG-Amine (MW 2000) | Biochemical Assay Reagents | |
| HY-W440992 | DOPE-PEG-Amine (MW 3400) | Biochemical Assay Reagents | |
| HY-W440993 | DOPE-PEG-Amine (MW 5000) | Biochemical Assay Reagents | |
| HY-W440994 | DOPE-PEG-Mal (MW 1000) | Biochemical Assay Reagents | |
| HY-W440995 | DOPE-PEG-Mal (MW 2000) | Biochemical Assay Reagents | |
| HY-W440996 | DOPE-PEG-Mal (MW 3400) | Biochemical Assay Reagents | |
| HY-W440997 | DOPE-PEG-Mal (MW 5000) | Biochemical Assay Reagents | |
| HY-W440998 | DSPE-alkyne | 2933227-70-2 | Biochemical Assay Reagents |
| HY-W440999 | DSPE-N3 | 2839508-98-2 | Reference compound |
| HY-W441000 | DSPE-Biotin | 133695-76-8 | Reference compound |
| HY-W441001 | DSPE-Fluorescein | 2933358-06-4 | Biochemical Assay Reagents |
| HY-W441002 | DSPE-succinic acid | 248253-94-3 | Oligonucleotides |
| HY-W441002R | DSPE-succinic acid (Standard) | 248253-94-3 | Reference Standards |
| HY-W441003 | DSPE-PEG-IA (MW 2000) | Biochemical Assay Reagents | |
| HY-W441004 | DSPE-Thiol | 144735-82-0 | Reference compound |
| HY-W441005 | Amino-Gly-Gly-DSPE (hydrochloride) | 2446375-49-9 | Biochemical Assay Reagents |
| HY-W441006 | DSPE-glutaric acid | 1009838-54-3 | Biochemical Assay Reagents |
| HY-W441007 | DSPE-Mal | 1360858-99-6 | Reference compound |
| HY-W441009A | DSPE-PEG-Maleimide (MW 3400) (ammonium) | Biochemical Assay Reagents | |
| HY-W441011 | DSPE-NHS | 1383932-86-2 | Reference compound |
| HY-W441012 | DSPE-PEG-NHS, MW 600 | Biochemical Assay Reagents | |
| HY-W441013 | DSPE-PEG-NHS, MW 1000 | Biochemical Assay Reagents | |
| HY-W441014 | DSPE-PEG-NHS, MW 2000 | Reference compound | |
| HY-W441015A | DSPE-m-PEG-NHS (MW 3400) | Biochemical Assay Reagents | |
| HY-W441016 | DSPE-PEG-NHS, MW 5000 | Biochemical Assay Reagents | |
| HY-W441017 | DSPE-SPDP | 144735-79-5 | Biochemical Assay Reagents |
| HY-W441021 | DSPE-Pyrene | 2933318-11-5 | Biochemical Assay Reagents |
| HY-W441022 | DSPE-Rhodamine | Biochemical Assay Reagents | |
| HY-W441174 | 3-Chlorobenzoic acid-d4 | 2098655-72-0 | Isotope-Labeled Compounds |
| HY-W441271 | Deoxy-thalidomide-5-iodine | 2291364-01-5 | Reference compound |
| HY-W441330 | L-Erythrulose | 533-50-6 | Biochemical Assay Reagents |
| HY-W441376 | Thalidomide-1-Me,4-OH | 2244568-06-5 | Reference compound |
| HY-W441531 | 2,3,7,8,12,13,17,18-Octaethyl-21H,23H-porphine manganese(III) chloride | 28265-17-0 | Reference compound |
| HY-W441766 | 3-Nitrobenzaldoxime | 3431-62-7 | Dye Reagents |
| HY-W441968 | L-threo-β-Hydroxyaspartic acid | 7298-98-8 | Reference compound |
| HY-W442085 | 1,4-Di(3-hydroxypropoxy)butane | 2052305-98-1 | Reference compound |
| HY-W442183 | Benzyl 2,2,2-trifluoro-N-phenylacetimidate | 952057-61-3 | Biochemical Assay Reagents |
| HY-W442217 | 4-Fluorobenzaldehyde-2,3,5,6-d4 | 93111-27-4 | Isotope-Labeled Compounds |
| HY-W442295 | Dipyrrometheneboron difluoride | 138026-71-8 | Dye Reagents |
| HY-W450322S | 2-Naphthalen-1,3,4,5,6,7,8-d7-amine | 93951-94-1 | Isotope-Labeled Compounds |
| HY-W450789S | Phenylmethan-d2-ol | 21175-64-4 | Isotope-Labeled Compounds |
| HY-W450931 | 2,3-Naphthalenedicarboximide | 4379-54-8 | Biochemical Assay Reagents |
| HY-W451211 | Thalidomide-5-carbaldehyde | 1447701-63-4 | Reference compound |
| HY-W451242 | 1-Methylpiperazine-2,2,3,3,5,5,6,6-d8 | 917358-65-7 | Isotope-Labeled Compounds |
| HY-W451275 | HG106 | 928712-10-1 | Reference compound |
| HY-W451405 | 2,5-Dioxopyrrolidin-1-yl hept-6-ynoate | 917222-23-2 | Reference compound |
| HY-W451433 | OTs-PEG1-NHCbz | 144208-62-8 | Reference compound |
| HY-W451440 | Butyne-DOTA-tris(t-butyl ester) | 2125661-54-1 | Biochemical Assay Reagents |
| HY-W451460 | 2,5-Dioxopyrrolidin-1-yl 2-(prop-2-yn-1-yloxy)acetate | 1858242-47-3 | Reference compound |
| HY-W451820 | AN-12-H5 intermediate-3 | 851314-03-9 | Reference compound |
| HY-W452285 | Isoplumbagin | 14777-17-4 | Natural Products |
| HY-W453397 | Aberrant tau ligand 1 | 1892461-96-9 | Reference compound |
| HY-W453545 | 4-Chlorobenzen-2,3,5,6-D4-amine | 191656-33-4 | Isotope-Labeled Compounds |
| HY-W453715 | Thalidomide-4-F,5-Br | 2740657-28-5 | Reference compound |
| HY-W454632 | Thalidomide-5-Cl | 835616-62-1 | Reference compound |
| HY-W454678 | 5-Bromomethylthalidomide | 1312023-72-5 | Reference compound |
| HY-W454729S | tert-Butyl 4-hydroxypiperidine-1-carboxylate-3,3,4,5,5-d5 | 1523606-18-9 | Isotope-Labeled Compounds |
| HY-W454906 | tDHU, acid | 2377643-37-1 | Reference compound |
| HY-W454945S | tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8 | 1126621-86-0 | Isotope-Labeled Compounds |
| HY-W454989 | Hept-6-yn-1-yl 4-methylbenzenesulfonate | 87462-63-3 | Reference compound |
| HY-W455884 | 3,5-Dichloro-2-hydroxybenzenesulfonic acid | 26281-43-6 | Biochemical Assay Reagents |
| HY-W456272 | 8(4'-Bromophenyl)-1,3,5,7-tetramethyl-BODIPY | 850534-66-6 | Reference compound |
| HY-W457085 | PD-1/PD-L1-IN-29 intermediate-2 | 59859-77-7 | Reference compound |
| HY-W457757 | 1,2-Di-O-isopropylidene-3-O-methyl-D-ribofuranose | 35506-61-7 | Reference compound |
| HY-W457949 | Pomalidomide 4'-alkylC4-azide | 2758431-96-6 | Reference compound |
| HY-W457950 | Thalidomide-5-propargyl | 2226303-74-6 | Reference compound |
| HY-W457953 | tert-Butyl N-(4-azidobutyl)carbamate | 129392-85-4 | Reference compound |
| HY-W457960 | 2-(2,6-Dioxopiperidin-3-yl)-5-ethynylisoindoline-1,3-dione | 2154356-63-3 | Reference compound |
| HY-W458018 | Thalidomide-4-Br,7-F | 2740657-30-9 | Reference compound |
| HY-W458061 | 3-(7-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 191732-75-9 | Reference compound |
| HY-W458364 | 1-(Isothiazol-3-yl)ethan-1-one | 88511-35-7 | Reference compound |
| HY-W459522 | 7-Bromohept-1-yne | 81216-14-0 | Reference compound |
| HY-W460072 | tert-Butyl 7-hydroxyheptanoate | 86013-78-7 | Reference compound |
| HY-W460118 | N-Biotinyl-5-methoxytryptamine | 2193462-87-0 | Reference compound |
| HY-W460119 | Dimethyl pentadecanedioate | 36575-82-3 | Natural Products |
| HY-W460133 | tert-Butyl (2-(2-(2-iodoethoxy)ethoxy)ethyl)carbamate | 1820026-89-8 | Reference compound |
| HY-W460141 | Thalidomide 4-chloro | 244057-36-1 | Reference compound |
| HY-W460193 | N-Me-Thalidomide 4-fluoride | 2244520-92-9 | Reference compound |
| HY-W460227 | Lenalidomide-4-Br-7-fluoro | 2438239-34-8 | Reference compound |
| HY-W460267 | N2,2'-O-Dimethylguanosine | 135023-21-1 | Reference compound |
| HY-W460274 | 4-Aminobutyl-DOTA-tris(t-butyl ester) | 1402393-59-2 | Biochemical Assay Reagents |
| HY-W460275 | t-Boc-N-amido-PEG5-Tos | 1404111-69-8 | Reference compound |
| HY-W460407 | N,N'-Dimethylhydrazine dihydrochloride | 306-37-6 | Biochemical Assay Reagents |
| HY-W460471 | Tris Buffered Saline | Biochemical Assay Reagents | |
| HY-W460507 | Methyl 3,4-O-isopropylidene-L-threonate | 92973-40-5 | Biochemical Assay Reagents |
| HY-W460871S | Apramycin-d7 (acetate) | Isotope-Labeled Compounds | |
| HY-W470415 | Alfalone | 970-48-9 | Reference compound |
| HY-W471937 | α1B-AR antagonist 1 | 874129-03-0 | Reference compound |
| HY-W471938 | Antiproliferative agent-35 | 82747-36-2 | Reference compound |
| HY-W472509 | 11-HETE | 73804-65-6 | Reference compound |
| HY-W472959 | Bis-PEG3-phthalimide | 159655-96-6 | Reference compound |
| HY-W473763 | 3-Methoxy-2,5-toluquinone | 611-68-7 | Reference compound |
| HY-W474200 | trans-4-Phenyl-4-piperidinocyclohexanol | 78165-07-8 | Reference compound |
| HY-W474473 | 3-(N-Phthalimidoylmethylthio)propanoic acid | 91570-07-9 | Reference compound |
| HY-W476434 | meso-2,6-Diaminopimelic acid | 922-54-3 | Reference compound |
| HY-W477324S | N,N-Dimethyl-4-(methylthio) aniline-d3 | 4019-62-9 | Isotope-Labeled Compounds |
| HY-W477511 | D-Phenylalanine 4-nitroanilide | 14235-18-8 | Biochemical Assay Reagents |
| HY-W478102 | CDK2-IN-13 | 101622-53-1 | Reference compound |
| HY-W479025 | Fmoc-DODA (hydrochloride) | 1274891-99-4 | Reference compound |
| HY-W479534 | Decanoyl m-Nitroaniline | 72298-61-4 | Reference compound |
| HY-W480392 | 1,9-Dimethylxanthine | 33073-01-7 | Biochemical Assay Reagents |
| HY-W480799 | H-Gly-Gly-Tyr-OH | 17343-07-6 | Reference compound |
| HY-W482407 | 1,2-O-Dihexadecyl-sn-glycerol | 67337-03-5 | Reference compound |
| HY-W483854 | N-Formyl-2-aminophenol | 2843-27-8 | Reference compound |
| HY-W484263 | hnNOS-IN-3 | 163490-78-6 | Reference compound |
| HY-W488004 | KKII5 | 6381-55-1 | Reference compound |
| HY-W488088 | Pyrimidine-4-carboxylic acid (sodium) | 819850-18-5 | Biochemical Assay Reagents |
| HY-W488109 | Genite | 97-16-5 | Reference compound |
| HY-W488791S | (4-Methoxyphenyl)trimethylsilane-d2 | 3047059-87-7 | Isotope-Labeled Compounds |
| HY-W489121 | YTK-105 | 774192-20-0 | Reference compound |
| HY-W491891 | 1,6-Dimethoxyphenazine | 13398-79-3 | Reference compound |
| HY-W495759 | 2,3,4,5-Tetrachlorophenol | 4901-51-3 | Reference compound |
| HY-W497648 | Undecyl acetate | 1731-81-3 | Natural Products |
| HY-W497908 | 1-Benzyl-2,3-O-isopropylidene glycerol | 15028-56-5 | Biochemical Assay Reagents |
| HY-W501565 | Sodium 1-undecyl sulfate | 1072-24-8 | Biochemical Assay Reagents |
| HY-W502657 | ZH8667 | 910387-04-1 | Reference compound |
| HY-W504391 | Nitrovin | 804-36-4 | Reference compound |
| HY-W504836 | Deuteroporphyrin IX (dihydrochloride) | 68929-05-5 | Biochemical Assay Reagents |
| HY-W505108 | 2,3-Dihydroxypropyl pentadecanoate | 62927-08-6 | Reference compound |
| HY-W505131 | 2-Monostearin | 621-61-4 | Biochemical Assay Reagents |
| HY-W505131R | 2-Monostearin (Standard) | 621-61-4 | Reference Standards |
| HY-W505344 | Bromo-dragonFLY (hydrochloride) | 219986-78-4 | Reference compound |
| HY-W505389 | Calcium D-saccharate | 5793-88-4 | Biochemical Assay Reagents |
| HY-W505469 | 6-O-(tert-Butyldimethylsilyl)-D-glucal | 58871-09-3 | Biochemical Assay Reagents |
| HY-W505771 | Seselin | 523-59-1 | Natural Products |
| HY-W505800 | 8-Azaxanthine (monohydrate) | 59840-67-4 | Biochemical Assay Reagents |
| HY-W505984 | TPNA10168 | 957942-34-6 | Reference compound |
| HY-W506071 | 3,7-Dimethyluric acid | 13087-49-5 | Natural Products |
| HY-W506116 | Ostruthin | 148-83-4 | Reference compound |
| HY-W506356 | 2,3-MDMA (hydrochloride) | 168968-01-2 | Reference compound |
| HY-W507009 | L-Arginyl-L-alanine | 40968-45-4 | Reference compound |
| HY-W507252 | HIV-1 integrase inhibitor 11 | 54030-51-2 | Reference compound |
| HY-W507393 | Dipropylenetriamine NONOate | 146724-95-0 | Reference compound |
| HY-W509178 | MDBP (hydrochloride) | 38063-96-6 | Reference compound |
| HY-W509381 | 4-Hydroxyindole-3-acetic acid | 56395-08-5 | Reference compound |
| HY-W509563 | Frataxin-IN-1 | 102616-64-8 | Reference compound |
| HY-W509797 | 5-(3',4'-Dihydroxyphenyl)-γ-valerolactone | 21618-92-8 | Reference compound |
| HY-W509915 | PIPBS | 16045-14-0 | Biochemical Assay Reagents |
| HY-W510032 | 9-Ethoxy-9-oxononanoic acid | 1593-55-1 | Reference compound |
| HY-W510159 | 5-O-Methylembelin | 56005-10-8 | Reference compound |
| HY-W510941 | Hesperetin dihydrochalcone | 35400-60-3 | Reference compound |
| HY-W513778 | (+)-trans-Chrysanthemic acid | 4638-92-0 | Reference compound |
| HY-W514708 | H-Ala-Gis-OH | 3253-17-6 | Reference compound |
| HY-W514721 | D13 | 321945-27-1 | Reference compound |
| HY-W516943 | CI-624 | 700-07-2 | Reference compound |
| HY-W517076 | 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin | 57653-85-7 | Reference compound |
| HY-W517076S | 1,2,3,6,7,8-Hexachloro dibenzo-p-dioxin-13C12 | 109719-81-5 | Isotope-Labeled Compounds |
| HY-W517092 | 1,2,3,4,7,8,9-Heptachlorodibenzofuran | 55673-89-7 | Reference compound |
| HY-W517163 | MK-2295 | 573678-04-3 | Reference compound |
| HY-W517264 | Carazolol (hydrochloride) | 51997-43-4 | Reference compound |
| HY-W520748 | MJC13 | 200709-97-3 | Reference compound |
| HY-W539427 | BRM/BRG1 ligand 1 | 1893977-70-2 | Reference compound |
| HY-W539754 | 2'-Deoxy-2'-fluoro-4-thiouridine | 10212-16-5 | Oligonucleotides |
| HY-W539799 | 2,6-Lutidine N-oxide | 1073-23-0 | Reference compound |
| HY-W539893 | NODAGA-tris(t-Bu ester) | 1190101-34-8 | Biochemical Assay Reagents |
| HY-W539916 | Azido-mono-amide-DOTA | 1227407-76-2 | Biochemical Assay Reagents |
| HY-W539944 | Argipressin (acetate) | 129979-57-3 | Peptides |
| HY-W539978 | Nistose (trihydrate) | 139523-49-2 | Biochemical Assay Reagents |
| HY-W539998S | 1-Decanethiol-d21 | 239090-36-9 | Isotope-Labeled Compounds |
| HY-W540000 | Graphitic carbon nitride | 143334-20-7 | Reference compound |
| HY-W540023 | endo-BCN-Fmoc-L-Lysine | 1493802-95-1 | Reference compound |
| HY-W540122 | Fmoc-PNA-C(Bhoc)-OH | 186046-81-1 | Reference compound |
| HY-W540188 | Calcium mesoxalate | 21085-60-9 | Reference compound |
| HY-W540188A | Calcium mesoxalate trihydrate | Reference compound | |
| HY-W540192 | SCO-PEG2-Maleimide | 2141976-23-8 | ADC Related |
| HY-W540219 | DOP-DEDA | 2247753-10-0 | Biochemical Assay Reagents |
| HY-W540232 | 4-Methoxyphenyl isothiocyanate | 2284-20-0 | Reference compound |
| HY-W540252S | 2-Methylbutyl isobutyrate-d7 | 1335401-84-7 | Isotope-Labeled Compounds |
| HY-W540356 | 3,6-Bis(chloromethyl)durene | 3022-16-0 | Biochemical Assay Reagents |
| HY-W540496S | 3-Mercapto-2-butanone-d3 | 1335436-52-6 | Isotope-Labeled Compounds |
| HY-W540509 | N-Tetracontane | 4181-95-7 | Natural Products |
| HY-W540509R | N-Tetracontane (Standard) | 4181-95-7 | Reference Standards |
| HY-W540600 | Thaumatins | 53850-34-3 | Reference compound |
| HY-W540661 | Hyaluronic acid tetrasaccharide, 98% | 57282-61-8 | Biochemical Assay Reagents |
| HY-W540662 | Hyaluronate decasaccharide | 57282-62-9 | Biochemical Assay Reagents |
| HY-W540680 | 2-Bromovaleric acid | 584-93-0 | Biochemical Assay Reagents |
| HY-W540687 | Disialyloctasaccharide | 58902-60-6 | Biochemical Assay Reagents |
| HY-W540784 | β-D-Glucopyranosyl azide,2-(acetylamino)-2-deoxy,3,4,6-triacetate | 6205-69-2 | Biochemical Assay Reagents |
| HY-W540836 | Tritriacontane | 630-05-7 | Natural Products |
| HY-W540836R | Tritriacontane (Standard) | 630-05-7 | Reference Standards |
| HY-W540864 | Pentacontane | 6596-40-3 | Natural Products |
| HY-W540873 | Potassium indigotrisulfonate | 67627-18-3 | Biochemical Assay Reagents |
| HY-W540905 | Tetratetracontane | 7098-22-8 | Natural Products |
| HY-W540905R | Tetratetracontane (Standard) | 7098-22-8 | Reference Standards |
| HY-W540926 | Dimethylglyoxime (sodium hydrate) | 75006-64-3 | Biochemical Assay Reagents |
| HY-W540962 | Acid red 9 | 8003-59-6 | Biochemical Assay Reagents |
| HY-W540972 | Primulin | 8064-60-6 | Biochemical Assay Reagents |
| HY-W540978 | 3-Azido-7-hydroxycoumarin | 817638-68-9 | Reference compound |
| HY-W541025 | Deoxyribonucleic acid | 9007-49-2 | Biochemical Assay Reagents |
| HY-W543065 | CPhos Pd G2 | 2230788-62-0 | Reference compound |
| HY-W543082 | P(o-tol)3 Pd G2 ChemBeads | 1416422-78-0 | Reference compound |
| HY-W543137 | PT-ttpy | 727721-37-1 | Reference compound |
| HY-W543676 | N,N'-Di-o-tolyl-p-phenylenediamine | 15017-02-4 | Reference compound |
| HY-W543743 | 1-Ethenylpyrene | 17088-21-0 | Reference compound |
| HY-W544503 | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine | 205171-04-6 | Oligonucleotides |
| HY-W544504 | 2,6-Dichloro-9-(2-c-methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine | 205171-10-4 | Oligonucleotides |
| HY-W544595 | Methyltetrazine-PEG5-sulfo-NHS ester (sodium) | 2055646-24-5 | Biochemical Assay Reagents |
| HY-W545104 | N6-Bz-5'-O-DMTr-3'-deoxyadenosine-2'-O-CED-phosphoramidite | 207347-42-0 | Oligonucleotides |
| HY-W545234 | H-Tyr(3-NH2)-OH (dihydrochloride hydrate) | 208588-19-6 | Reference compound |
| HY-W545294 | RORγ-IN-2 | 2088333-58-6 | Reference compound |
| HY-W546498 | N-Boc-Biotinylethylenediamine | 225797-46-6 | Biochemical Assay Reagents |
| HY-W546894 | 6-Bromo-2-naphthalenyl β-D-glucopyranosiduronic acid | 22720-35-0 | Biochemical Assay Reagents |
| HY-W547585 | 4-Hydroxy-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2(1H)-pyridinone | 23220-74-8 | Oligonucleotides |
| HY-W548095 | Anticancer agent 170 | 24126-98-5 | Reference compound |
| HY-W548477 | H-Lys(Fmoc)-OH (hydrochloride) | 253138-02-2 | Peptides |
| HY-W548481 | Chloro 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranoside | 25320-59-6 | Biochemical Assay Reagents |
| HY-W548692 | Palmityl myristate | 2599-01-1 | Natural Products |
| HY-W549233S | Tris(4-chlorophenyl)methane-13C19 | Isotope-Labeled Compounds | |
| HY-W549438 | Cyclo(Phe-Phe) | 2862-51-3 | Peptides |
| HY-W549451 | Phenyl α-D-galactopyranoside | 2871-15-0 | Biochemical Assay Reagents |
| HY-W549538 | tert-Butyl β-D-glucopyranoside | 29074-04-2 | Biochemical Assay Reagents |
| HY-W549871 | Methyl 2-(acetylamino)-2-deoxy-D-glucopyranoside | 3055-46-7 | Biochemical Assay Reagents |
| HY-W549903 | p67phox-IN-1 | 306969-25-5 | Reference compound |
| HY-W549985 | Oleoyl-L-carnitine (chloride) | 31062-78-9 | Reference compound |
| HY-W550311 | Stearyl laurate | 3234-84-2 | Natural Products |
| HY-W550365 | 1-(alpha-L-Threofuranosyl)thymine | 325683-84-9 | Oligonucleotides |
| HY-W550484 | 2,6-Dichloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-D-arabinofuranosyl)-9H-purine | 329187-80-6 | Oligonucleotides |
| HY-W550739 | Acesulfame | 33665-90-6 | Reference compound |
| HY-W550907 | 5-Bromo-4-chloro-3-indolyl-α-D-maltotrioside | 341972-94-9 | Biochemical Assay Reagents |
| HY-W550918 | 5-Bromo-2'-O-methyluridine | 34218-83-2 | Oligonucleotides |
| HY-W551230 | 2-Amino-6-chloropurine-9-beta-D-(2’-deoxy-3’,5’-di-O-(p-toluoyl))riboside | 35095-93-3 | Oligonucleotides |
| HY-W551386 | 4-O-(α-D-Mannopyranosyl)-D-mannose | 35438-40-5 | Reference compound |
| HY-W551412 | β-D-Galactosyl-(1→3)-N-acetyl-D-galactosamine | 3554-90-3 | Biochemical Assay Reagents |
| HY-W551703S | 1,1-Diethoxybutane-d10 | Isotope-Labeled Compounds | |
| HY-W551974 | 2’,3’,5’-Tri-O-benzoyl-5-methoxyuridine | 37805-86-0 | Oligonucleotides |
| HY-W552067 | 5-(Hydroxymethyl)-2′,3′-O-(1-methylethylidene)uridine | 3816-77-1 | Oligonucleotides |
| HY-W552130 | Benzyl 2-acetamido-3,4,6-tri-O-benzyl-2-deoxy-α-D-glucopyranoside | 38416-56-7 | Biochemical Assay Reagents |
| HY-W552133 | Propyl linoleate | 38433-95-3 | Natural Products |
| HY-W552229S | 2,8-Dichloro dibenzo-p-dioxin-13C12 | Isotope-Labeled Compounds | |
| HY-W552257 | Hydroxypyruvic acid phosphate | 3913-50-6 | Reference compound |
| HY-W552365 | 2,3:5,6-Di-O-isopropylidene-D-mannitol | 3969-61-7 | Biochemical Assay Reagents |
| HY-W552419 | N6-Benzoyl-2',3'-isopropylidene adenosine | 39947-04-1 | Oligonucleotides |
| HY-W552525 | Deoxyadenosine diphosphate (sodium) | 402491-35-4 | Reference compound |
| HY-W552594 | Octylβ-D-galactopyranoside, 98% | 40427-75-6 | Biochemical Assay Reagents |
| HY-W552702 | Tyrosinase-IN-29 | 408335-66-0 | Reference compound |
| HY-W553070 | 1-Thio-β-D-galactose, Sodium Salt | 42891-22-5 | Biochemical Assay Reagents |
| HY-W553071 | Cytoxazone | 42902-32-9 | Natural Products |
| HY-W553514 | DL-α-Phosphatidylcholine, distearoyl | 4539-70-2 | Biochemical Assay Reagents |
| HY-W553730 | 2’-Deoxy-2’-iodouridine; 2’-Iodo-2’-deoxyuridine | 4753-03-1 | Oligonucleotides |
| HY-W553914 | N-Acetylneuraminic acid 2,4,7,8,9-pentaacetate | 4887-11-0 | Biochemical Assay Reagents |
| HY-W554410 | Methyl 8-methylnonanoate | 5129-54-4 | Natural Products |
| HY-W554423 | Naphthol AS-BI β-D-galactopyranoside | 51349-63-4 | Biochemical Assay Reagents |
| HY-W554443 | 4,6-O-Isopropylidene-D-glucal | 51450-36-3 | Biochemical Assay Reagents |
| HY-W554514 | D-Homoserine lactone | 51744-82-2 | Reference compound |
| HY-W554624 | Methyl 3-O-methyl-4,6-O-(phenylmethylene)-α-D-mannopyranoside | 52260-48-7 | Biochemical Assay Reagents |
| HY-W554649 | p-Aminophenyl phosphate | 52331-30-3 | Reference compound |
| HY-W554739 | D-Ribofuranoside,methyl,2,3,5-triacetate | 52554-28-6 | Biochemical Assay Reagents |
| HY-W554764 | Cyclo(-asp-gly) | 52661-97-9 | Reference compound |
| HY-W554799 | S-Benzyl-L-cysteine ethyl ester (hydrochloride) | 52844-67-4 | Biochemical Assay Reagents |
| HY-W554893 | Behenate (sodium) | 5331-77-1 | Natural Products |
| HY-W555010 | Phosphoenolpyruvic acid (monosodium) | 53823-68-0 | Reference compound |
| HY-W555109 | 1,6-Dideoxy-1,1-bis(ethylsulfonyl)-L-mannitol | 54253-49-5 | Biochemical Assay Reagents |
| HY-W555382 | Pseudane IX | 55396-45-7 | Natural Products |
| HY-W555382S | Pseudane IX-d4 | Isotope-Labeled Compounds | |
| HY-W555447 | (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-(isopropylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate | 55692-87-0 | Reference compound |
| HY-W555551 | 5-Ethyl cytidine | 56367-98-7 | Oligonucleotides |
| HY-W555583 | 3’,5’-Di-O-acetyl-2’-deoxy-2’-fluoro-5-iodouridine | 565226-18-8 | Oligonucleotides |
| HY-W555915 | 4-Nitrophenyl 4,6-O-(phenylmethylene)-α-D-mannopyranoside | 58056-41-0 | Biochemical Assay Reagents |
| HY-W555976 | 5-Hydroxymethyl-2',3'-O-isopropylidene-2-thiouridine | 58479-71-3 | Oligonucleotides |
| HY-W555991 | 2',3'-O-Isopropylidene-6-mercaptopurine riboside | 5856-48-4 | Biochemical Assay Reagents |
| HY-W556168 | Ethyl docosanoate | 5908-87-2 | Natural Products |
| HY-W556276 | 1,4-Anhydro-2,3-di-O-isopropylidene-4-thio-D-ribitol | 596103-06-9 | Oligonucleotides |
| HY-W556301 | 2′,3′-O-Isopropylideneisocytidine | 5975-05-3 | Oligonucleotides |
| HY-W556327 | 5-Nitro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2(1H)-pyridinone | 59892-37-4 | Oligonucleotides |
| HY-W556338 | α-D-Glucose 1-phosphate (dipotassium) | 5996-14-5 | Biochemical Assay Reagents |
| HY-W556584 | 2,3,4,6-Tetra-O-benzyl-D-mannopyranose | 61330-61-8 | Biochemical Assay Reagents |
| HY-W556631 | LZTR1-KRAS modulator 1 | 61563-45-9 | Reference compound |
| HY-W556870 | OT-551 | 627085-15-8 | Reference compound |
| HY-W556877 | D-Galactopyranose,2,3,4,6-tetrabenzoate | 627466-84-6 | Biochemical Assay Reagents |
| HY-W557481 | 1,5-Anhydro-4,6-O-(phenylmethylene)-D-glucitol | 65190-39-8 | Biochemical Assay Reagents |
| HY-W557556 | 2',5'-Bis-O-(triphenylMethyl)uridine | 6554-11-6 | Oligonucleotides |
| HY-W557662 | 6-O-α-D-Mannopyranosyl-D-mannose | 6614-35-3 | Biochemical Assay Reagents |
| HY-W557739 | L-Leucine-7-amido-4-methylcoumarin | 66447-31-2 | Biochemical Assay Reagents |
| HY-W558285 | Methyl 3,6-di-O-(α-D-mannopyranosyl)-α-D-mannopyranoside | 68601-74-1 | Biochemical Assay Reagents |
| HY-W558351 | Z-Lys-OBzl (benzenesulfonate) | 68973-36-4 | Reference compound |
| HY-W558459 | 3’-O-t-Butyldimethylsilyladenosine | 69504-14-9 | Oligonucleotides |
| HY-W558568 | Tris hemisulfate,98% | 6992-38-7 | Biochemical Assay Reagents |
| HY-W558867 | 2-Amino-N-2-naphthalenylacetamide | 716-94-9 | Biochemical Assay Reagents |
| HY-W558950 | D-Sorbitol hexaacetate | 7208-47-1 | Biochemical Assay Reagents |
| HY-W559069 | D-Xylonic acid calcium salt | 72656-08-7 | Biochemical Assay Reagents |
| HY-W559143 | Methyl-4,6-O-benzylidene-α-D-galactopyranoside | 72904-85-9 | Biochemical Assay Reagents |
| HY-W559353 | 1-(3-Beta-amino-2,3-dideoxy-beta-d-threopenta-furanosyl)thymine | 73971-79-6 | Oligonucleotides |
| HY-W559951 | 4-(N-Iodoacetamide)benzophenone | 76809-63-7 | Biochemical Assay Reagents |
| HY-W560112 | Phenyl α-D-thiomannopyranoside | 77481-62-0 | Biochemical Assay Reagents |
| HY-W560402 | α-Irone | 79-69-6 | Reference compound |
| HY-W560574 | Xanthine oxidase-IN-14 | 80025-67-8 | Reference compound |
| HY-W560593 | S-Benzyl-L-cysteine 7-amido-4-methylcoumarin | 80173-27-9 | Biochemical Assay Reagents |
| HY-W560689 | DNA polymerase-IN-1 | 809234-33-1 | Reference compound |
| HY-W560803 | 5'-DMTr-2,2'-anhydrothymidine | 817623-11-3 | Oligonucleotides |
| HY-W560806 | 5’-O-(4,4’-Dimethoxytrityl)-3’-O-t-butyldimethylsilyl adenosine | 81794-12-9 | Oligonucleotides |
| HY-W560807 | 5’-O-(4,4’-Dimethoxytrityl)-2’-O-t-butyldimethylsilyl adenosine | 81794-13-0 | Oligonucleotides |
| HY-W560875 | Icosyl acetate | 822-24-2 | Natural Products |
| HY-W560922 | Piperazine-Ac-OMe | 82516-17-4 | Reference compound |
| HY-W560961 | 3',5'-TIPS-N-Ac-Adenosine | 828247-65-0 | Oligonucleotides |
| HY-W561088 | 1-Naphthyl-β-D-glucuronide (sodium) | 83833-12-9 | Biochemical Assay Reagents |
| HY-W561401 | Blattellaquinone | 849762-24-9 | Reference compound |
| HY-W562116 | Boc-Lys(ivdde)-OH | 862847-44-7 | Peptides |
| HY-W564067 | 2,3,5-Tris-O-(phenylmethyl)-β-D-ribofuranose | 89361-52-4 | Biochemical Assay Reagents |
| HY-W564313 | 2',3'-O-Isopropylidene-5-pyrrolidinomethyl-2-thiouridine | 89845-82-9 | Oligonucleotides |
| HY-W564704 | (p-Hydroxybenzyl)malonic acid | 90844-16-9 | Reference compound |
| HY-W565157 | 3,5-O-Ditoluoyl 6-chloropurine-9-β-D-deoxyriboside | 91713-46-1 | Oligonucleotides |
| HY-W567260 | 1,2:4,5-Bis-O-(1-methylethylidene)-myo-inositol | 98974-89-1 | Biochemical Assay Reagents |
| HY-W567866 | 4-Aminophenyl β-D-glucuronide | 21080-66-0 | Biochemical Assay Reagents |
| HY-W568314 | Vericiguat impurity-1 | 2135333-04-7 | Reference compound |
| HY-W568453 | 5'-O-Acetyl adenosine | 2140-25-2 | Biochemical Assay Reagents |
| HY-W568899 | 6-Chloro-3-indolyl b-D-glucuronide (sodium) | 216971-56-1 | Biochemical Assay Reagents |
| HY-W569842 | N-Succinimidoxycarbonyl-β-alanine N-succinimidyl ester | 21994-89-8 | Biochemical Assay Reagents |
| HY-W569932 | (R)-(4-Bromophenyl)(phenyl)methanamine | 220441-81-6 | Reference compound |
| HY-W570884 | 5-Me-dC(Ac) amidite | 1873306-74-1 | Oligonucleotides |
| HY-W570885 | 2'-O-MOE-rC | 251647-54-8 | Oligonucleotides |
| HY-W570886 | 2'-O-MOE-U | 163759-97-5 | Oligonucleotides |
| HY-W570887 | LNA-A(Bz) amidite | 206055-79-0 | Reference compound |
| HY-W570888 | 2'-O,4'-C-Methylenecytidine | 206055-69-8 | Reference compound |
| HY-W570889 | DMT-LNA-5mA phosphoramidite | 1184723-53-2 | Reference compound |
| HY-W570890 | 2'-O-MOE-5-Me-C(Bz) | 163759-94-2 | Oligonucleotides |
| HY-W570891 | DMTr-LNA-C(Bz)-3-CED-phosphoramidite | 206055-78-9 | Reference compound |
| HY-W570892 | DMTr-LNA-U-3-CED-Phosphora | 206055-76-7 | Reference compound |
| HY-W570893 | DMT-LNA-G phosphoramidite | 207131-17-7 | Reference compound |
| HY-W571253 | 4-Deoxypyridoxine | 61-67-6 | Reference compound |
| HY-W572421 | trans-1-Octen-1-ylboronic acid pinacol ester | 83947-55-1 | Biochemical Assay Reagents |
| HY-W572763 | Tos-PEG6-acid | 2803338-37-4 | Reference compound |
| HY-W573700 | Methyl everninate | 520-43-4 | Natural Products |
| HY-W574509 | Tos-PEG2-acid | 2111895-60-2 | Reference compound |
| HY-W575291 | tert-Butyl oct-7-yn-1-ylcarbamate | 1451262-84-2 | Reference compound |
| HY-W576312 | N,N-Dimethyltryptamine N-oxide | 948-19-6 | Reference compound |
| HY-W576440 | α-Cytidine | 13913-16-1 | Reference compound |
| HY-W576589 | (±)-Myrtenol | 515-00-4 | Reference compound |
| HY-W576868 | Thalidomide-4,5-F | 2222115-19-5 | Reference compound |
| HY-W577257 | Thalidomide-1-Me,5-F | 2230957-36-3 | Reference compound |
| HY-W578187 | 7-Tridecanol | 927-45-7 | Reference compound |
| HY-W578275 | 3′-O-Methylcytidine | 20594-00-7 | Oligonucleotides |
| HY-W578278 | tert-Butyl (2-(pyridin-2-yldisulfanyl)ethyl)carbamate | 535943-48-7 | Reference compound |
| HY-W578976S | N-Boc-piperazine-d4 | 1126621-87-1 | Isotope-Labeled Compounds |
| HY-W579346 | POPSO (sesquisodium) | 108321-08-0 | Biochemical Assay Reagents |
| HY-W579407 | DMT-2'-OMe-dA(bz) phosphoramidite | 2659239-32-2 | Oligonucleotides |
| HY-W579408 | DMT-2'-F-dA(bz) phosphoramidite | 2659239-37-7 | Oligonucleotides |
| HY-W579410 | DMT-2'-F-6-chloro-dA phosphoramidite | 2803878-95-5 | Oligonucleotides |
| HY-W579772 | Tetrabutylammonium (nitrite) | 26501-54-2 | Reference compound |
| HY-W579918 | 3-(4-Bromophenyl)-3-(trifluoromethyl)-3H-diazirine | 952143-02-1 | Biochemical Assay Reagents |
| HY-W580021 | Thalidomide-o-PEG2-acid | 2488752-64-1 | Reference compound |
| HY-W580022 | Pomalidomide-5'-PEG8-C2-COOH | 2138440-78-3 | ADC Related |
| HY-W580721 | 4-Methylhistamine | 36507-31-0 | Reference compound |
| HY-W580721A | 4-Methylhistamine (hydrochloride) | 84103-51-5 | Reference compound |
| HY-W580812 | (R)-3-Aminopyrrolidine-2,5-dione | 404887-22-5 | Reference compound |
| HY-W580836 | (S)-3-Aminopyrrolidine-2,5-dione | 73537-92-5 | Reference compound |
| HY-W581819 | Ferric glycinate | 34369-82-9 | Reference compound |
| HY-W582400 | (T-4)-Copper(1+), bis[2,9-bis(4-methoxyphenyl)-1,10-phenanthroline-κN1,κN10]-, chloride | 1392109-17-9 | Biochemical Assay Reagents |
| HY-W582564 | Cu(Ⅱ)-EDTA (disodium tetrahydrate) | 36703-61-4 | Biochemical Assay Reagents |
| HY-W582827 | RuPhos Pd G1 methyl t-butyl ether adduct (MTBE) | 2361069-97-6 | Reference compound |
| HY-W583212 | Zn(II) Mesoporphyrin IX | 14354-67-7 | Biochemical Assay Reagents |
| HY-W583271 | Zn(II) Deuteroporphyrin IX 2,4 bis ethylene glycol | 119700-81-1 | Biochemical Assay Reagents |
| HY-W583317 | sSPhos Pd G2 | 2375242-78-5 | Reference compound |
| HY-W583685 | 1-Oleoyl-3-palmitoylglycerol | 3343-30-4 | Reference compound |
| HY-W583749 | 6:2 Cl-PFAES | 73606-19-6 | Reference compound |
| HY-W583868 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PE | 26662-94-2 | Oligonucleotides |
| HY-W583869 | 1-Stearoyl-2-oleoyl-sn-glycerol-3-phosphoethanolamine | 6418-95-7 | Biochemical Assay Reagents |
| HY-W583870 | 18:1 (Δ9-Trans) PE | 19805-18-6 | Biochemical Assay Reagents |
| HY-W584173 | D-Glyceric acid (calcium hydrate) | 6000-41-5 | Biochemical Assay Reagents |
| HY-W584477 | 4,6-Dichloro-N-methylnicotinamide-d3 | 1609531-34-1 | Isotope-Labeled Compounds |
| HY-W584512 | Thalidomide-NH-CH2-COO(t-Bu) | 2093386-23-1 | Reference compound |
| HY-W584513 | Thalidomide-NH-(CH2)2-NH-Boc | 1957235-57-2 | Reference compound |
| HY-W584514 | Thalidomide-NH-(CH2)2-NH2 (TFA) | 1957235-67-4 | Reference compound |
| HY-W584515 | Thalidomide-NH-(CH2)3-NH-Boc | 2093386-36-6 | Reference compound |
| HY-W584516 | Thalidomide-5-NH-CH2-COO(t-Bu) | 2412056-28-9 | Reference compound |
| HY-W584517 | Thalidomide-5-O-CH2-COO(t-Bu) | 2682112-10-1 | Reference compound |
| HY-W584518 | Thalidomide-5-O-CH2-COOH | 2467425-53-0 | Reference compound |
| HY-W584520 | Thalidomide-4-NH-PEG1-NH-Boc | 2154342-17-1 | Reference compound |
| HY-W584521 | Thalidomide-4-NH-PEG1-NH2 (TFA) | 2490499-21-1 | Reference compound |
| HY-W584522 | Thalidomide-4-NH-PEG1-COO(t-Bu) | 2140807-19-6 | Reference compound |
| HY-W584523 | Thalidomide-4-NH-PEG1-COOH (TFA) | 2140807-20-9 | Reference compound |
| HY-W584524 | Thalidomide-4-NH-PEG2-COO(t-Bu) | 2140807-16-3 | Reference compound |
| HY-W584525 | VH032-NH-CO-CH2-NHBoc | 2010986-19-1 | Reference compound |
| HY-W584527 | VH032 analogue-1 | 2111829-84-4 | Reference compound |
| HY-W584528 | VH032 analogue-2 | 1448189-66-9 | Reference compound |
| HY-W584529 | VH032-C2-NH-Boc | 2361119-87-9 | Reference compound |
| HY-W584530 | VH032-C4-NH-Boc | 2412055-00-4 | Reference compound |
| HY-W584531 | VH032-C6-NH-Boc | 2306389-02-4 | Reference compound |
| HY-W584532 | VH032-O-C2-NH-Boc | 2409007-41-4 | Reference compound |
| HY-W584533 | VH032-PEG2-NH-BOC | 2162120-75-2 | Reference compound |
| HY-W584534 | VH032-CH2-Boc | 2827750-24-1 | Reference compound |
| HY-W584535 | VH032-C3-Boc | 2827750-25-2 | Reference compound |
| HY-W584986 | Thalidomide-(2)piperidine | 2616553-33-2 | Reference compound |
| HY-W585377 | 1-Palmitoyl-2-(dipyrrometheneboron difluoride)undecanoyl-sn-glycero-3-phosphocholine | 1246355-63-4 | Biochemical Assay Reagents |
| HY-W585383 | BDP TR hydrazide (hydrochloride) | 2183473-49-4 | Dye Reagents |
| HY-W585384 | BDP 558/568 carboxylic acid | 150173-72-1 | Dye Reagents |
| HY-W585386 | BDP TMR amine (hydrochloride) | 2183473-09-6 | Dye Reagents |
| HY-W585390 | BDP 581/591 hydrazide (hydrochloride) | 2183473-40-5 | Dye Reagents |
| HY-W585396 | BDP TR maleimide | 2183473-37-0 | Dye Reagents |
| HY-W585403 | BDP 630/650 hydrazide (hydrochloride) | 2183473-43-8 | Dye Reagents |
| HY-W585407 | BDP TMR carboxylic acid | 287384-28-5 | Reference compound |
| HY-W585442 | 5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine | 105528-25-4 | Reference compound |
| HY-W585809 | 1,3-Distearoyl-2-chloropropanediol | 26787-56-4 | Natural Products |
| HY-W585809R | 1,3-Distearoyl-2-chloropropanediol (Standard) | 26787-56-4 | Reference Standards |
| HY-W585809S | 2-Chloropropane-1,3-diyl distearate-d5 | 1329796-49-7 | Isotope-Labeled Compounds |
| HY-W585809S1 | 2-Chloropropane-1,3-diyl distearate-d5 (major) | 1329796-49-7 | Isotope-Labeled Compounds |
| HY-W585815S | (S)-1-Chloro-3-(hexadecyloxy)propan-2-ol-d5 | 1346599-60-7 | Isotope-Labeled Compounds |
| HY-W585819 | 3-Chloropropane-1,2-diol dipalmitate | 51930-97-3 | Reference compound |
| HY-W585819R | 3-Chloropropane-1,2-diol dipalmitate (Standard) | 51930-97-3 | Reference Standards |
| HY-W585819S | 3-Chloropropane-1,2-diol dipalmitate-13C3 | Isotope-Labeled Compounds | |
| HY-W585825 | Selenoethionine | 2578-27-0 | Reference compound |
| HY-W585827 | 2-Chloro-1,3-propanediol | 497-04-1 | Natural Products |
| HY-W585827R | 2-Chloro-1,3-propanediol (Standard) | 497-04-1 | Reference Standards |
| HY-W585827S | 2-Chloro-1,3-propanediol-d5 | 1216764-05-4 | Isotope-Labeled Compounds |
| HY-W585827S1 | 2-Chloro-1,3-propanediol-d5 (major) | 1216764-05-4 | Isotope-Labeled Compounds |
| HY-W585834 | Fipronil desulfinyl | 205650-65-3 | Reference compound |
| HY-W585834R | Fipronil desulfinyl (Standard) | 205650-65-3 | Reference Standards |
| HY-W585837 | 3-Benzylidenecamphor | 15087-24-8 | Reference compound |
| HY-W585839S | Bis(2-chloroethyl) phosphate-d8 | 1477495-02-5 | Isotope-Labeled Compounds |
| HY-W585842 | Estradiol 3-glucuronide | 15270-30-1 | Natural Products |
| HY-W585843 | 1,1′-Ethylidenebis[L-tryptophan] | 132685-02-0 | Reference compound |
| HY-W585858S | Nordiphenhydramine-d5 | Isotope-Labeled Compounds | |
| HY-W585865 | UDP-3-O-acyl-GlcNAc (Tris) | 112710-84-6 | Reference compound |
| HY-W585866 | Alternariol, methyl ether | 26894-49-5 | Reference compound |
| HY-W585866S | Alternariol, methyl ether-13C15 | Isotope-Labeled Compounds | |
| HY-W585869 | Amorphadiene | 92692-39-2 | Natural Products |
| HY-W585874 | Nε-(Carboxyethyl)lysine | 5746-03-2 | Reference compound |
| HY-W585874S | Nε-(Carboxyethyl)lysine-d4 | Isotope-Labeled Compounds | |
| HY-W585876 | Chenodeoxycholic acid 3-glucuronide | 58814-71-4 | Reference compound |
| HY-W585887 | Fructose-L-tryptophan | 25020-15-9 | Biochemical Assay Reagents |
| HY-W585890S | Benzo[pqr]tetraphen-3-ol-13C6 | 2704248-82-6 | Isotope-Labeled Compounds |
| HY-W585893 | Endrin ketone | 53494-70-5 | Reference compound |
| HY-W585893R | Endrin ketone (Standard) | 53494-70-5 | Reference Standards |
| HY-W585905 | Trimethylammonium chloride-13C3 | 286013-00-1 | Isotope-Labeled Compounds |
| HY-W585906S | 3-O-Acetyltylosin-d3 | Isotope-Labeled Compounds | |
| HY-W585914S | 2-(3-Sec-butyl-5-tert-butyl-2-hydroxyphenyl)benzotriazole-d4 | Isotope-Labeled Compounds | |
| HY-W585918S | 4,4'-Dihydroxydiphenylmethane-d10 | 1794786-93-8 | Isotope-Labeled Compounds |
| HY-W585920 | Chenodeoxycholic acid 24-acyl-β-D-glucuronide | 208038-27-1 | Reference compound |
| HY-W585922 | 3β-Cholic acid | 3338-16-7 | Natural Products |
| HY-W585933S | Fructose-alanine-13C6 | 1083053-41-1 | Isotope-Labeled Compounds |
| HY-W585934S | Fructose-phenylalanine-13C6 | 1083053-44-4 | Isotope-Labeled Compounds |
| HY-W585935 | Glycidyl oleate | 5431-33-4 | Natural Products |
| HY-W585943 | 6-Methyl-1,4-naphthoquinone | 605-93-6 | Biochemical Assay Reagents |
| HY-W585948 | 1-Palmitoyl-2-oleoyl-rac-glycerol | 3123-73-7 | Biochemical Assay Reagents |
| HY-W585956 | Triclocarban-13C6 | 1216457-76-9 | Isotope-Labeled Compounds |
| HY-W585980S | Bis(2-butoxyethyl) 2-hydroxyethyl phosphate-d4 | 2469195-92-2 | Isotope-Labeled Compounds |
| HY-W585982 | Bisphenol A-β-D-glucuronide | 267244-08-6 | Reference compound |
| HY-W585982S | Bisphenol A β-D-Glucuronide-13C12 | 1313730-08-3 | Isotope-Labeled Compounds |
| HY-W586082 | N-Isobutyryl-2', 3'-acetyl-guanosine | 163586-86-5 | Reference compound |
| HY-W586320 | Thalidomide-5-Br,6-F | 2803445-69-2 | Reference compound |
| HY-W586329 | Thalidomide-4-carbaldehyde | 2369068-46-0 | Reference compound |
| HY-W586331 | Thalidomide-iodo | 2509137-01-1 | Reference compound |
| HY-W586475 | Fluorescein-triazole-PEG5-DOTA | ADC Related | |
| HY-W586821 | Thalidomide-1-Me-5-NH2 | 1468761-60-5 | Reference compound |
| HY-W586822 | Pomalidomide-methyl | 1352827-50-9 | Reference compound |
| HY-W587082 | Cr(III) Mesoporphyrin IX chloride | 70948-71-9 | Biochemical Assay Reagents |
| HY-W587352 | 7-Iodohept-1-yne | 87462-66-6 | Reference compound |
| HY-W587397S | Benzoic acid, 4,4′-[[6-[[4-[[(1,1-dimethy-d4 | Isotope-Labeled Compounds | |
| HY-W587411S | Mono[2-(carboxymethyl)hexyl] phthalate-d4 | 1794811-42-9 | Isotope-Labeled Compounds |
| HY-W587414 | Neospiramycin I | 70253-62-2 | Reference compound |
| HY-W587420 | 1-Palmitoyl-3-chloropropanediol | 30557-04-1 | Natural Products |
| HY-W587423S | 2,2′,3,3′,4,4′,5,5′,6-Nonabromo diphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-W587426S | 1-Hydroxyphenanthrene-d9 | 922510-23-4 | Isotope-Labeled Compounds |
| HY-W587430 | Glycolithocholic acid 3-sulfate (disodium) | 64936-82-9 | Reference compound |
| HY-W587441 | Chloramphenicol 3-O-β-D-glucuronide | 39751-33-2 | Biochemical Assay Reagents |
| HY-W587468 | all-trans-3,4-Didehydro retinoic acid | 4159-20-0 | Biochemical Assay Reagents |
| HY-W587476 | 3-Chloro-1,2-propanediol dilinoleate | 74875-96-0 | Natural Products |
| HY-W587485 | N-acetyl-S-(trichlorovinyl)-L-cysteine | 111348-61-9 | Reference compound |
| HY-W587486 | N-Acetyltaurine | 19213-70-8 | Reference compound |
| HY-W587486R | N-Acetyltaurine (Standard) | 19213-70-8 | Reference Standards |
| HY-W587488 | Adenosine 3′-monophosphate | 84-21-9 | Reference compound |
| HY-W587489 | RL-603 | 444904-63-6 | Natural Products |
| HY-W587499 | 2-Arachidonoyl-sn-glycero-3-phosphocholine | 67341-29-1 | Biochemical Assay Reagents |
| HY-W587506 | Biotin-d-sulfoxide | 10406-89-0 | Reference compound |
| HY-W587507 | 1,2-Dilauroyl-3-chloropropanediol | 1051389-99-1 | Natural Products |
| HY-W587519 | Bisphenol A bis(3-chloro-2-hydroxypropyl) ether | 4809-35-2 | Reference compound |
| HY-W587519S | Bisphenol A bis(3-chloro-2-hydroxypropyl) ether-d14 | Isotope-Labeled Compounds | |
| HY-W587524 | Carboxyphosphamide | 22788-18-7 | Reference compound |
| HY-W587530 | 6-Oxolithocholic acid | 2393-61-5 | Reference compound |
| HY-W587542 | (1S,4S)-N-Desmethyl Sertraline (hydrochloride) | 675126-10-0 | Reference compound |
| HY-W587552 | 1,3-Diolein | 2465-32-9 | Reference compound |
| HY-W587554 | Ethyl (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate | 142828-41-9 | Natural Products |
| HY-W587559 | Fenthion sulfone | 3761-42-0 | Reference compound |
| HY-W587559R | Fenthion sulfone (Standard) | 3761-42-0 | Reference Standards |
| HY-W587663 | 4′-DTMP | 21253-58-7 | Reference compound |
| HY-W587683 | D-Erythro-imidazoleglycerol phosphate monohydrate | 210241-69-3 | Biochemical Assay Reagents |
| HY-W587691 | 16-Ketoestradiol | 566-75-6 | Reference compound |
| HY-W587701 | Methacycline | 914-00-1 | Reference compound |
| HY-W587715S | (Rac)-1,2-Dioleoyl-3-chloropropanediol-d5 | 1246833-00-0 | Isotope-Labeled Compounds |
| HY-W587719S | (E/Z)-Glycidyl Linoleate-d5 | 1246834-15-0 | Isotope-Labeled Compounds |
| HY-W587724S | 6β-Hydroxy Cortisol-d4 | 1261254-51-6 | Isotope-Labeled Compounds |
| HY-W587725 | Drotaveraldine | 54088-62-9 | Reference compound |
| HY-W587731S | N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine-d7 | 1240398-27-9 | Isotope-Labeled Compounds |
| HY-W587733 | 17α,20β-Dihydroxy-4-pregnen-3-one | 1662-06-2 | Reference compound |
| HY-W587743 | N1-Acetyl-5-methoxykynuramine (hydrochloride) | 1215711-91-3 | Reference compound |
| HY-W587749 | D-Galactosan | 644-76-8 | Biochemical Assay Reagents |
| HY-W587753 | Bacitracin A | 22601-59-8 | Natural Products |
| HY-W587768 | Metoxadiazone | 60589-06-2 | Reference compound |
| HY-W587768R | Metoxadiazone (Standard) | 60589-06-2 | Reference Standards |
| HY-W587779 | o-Nitrophenyl β-D-galactopyranoside-6-phosphate (cyclohexylammonium) | 25405-62-3 | Biochemical Assay Reagents |
| HY-W587780 | Sulfamethoxazole-NO | 29699-89-6 | Reference compound |
| HY-W587800 | 4-Pregnen-17α,20α-diol-3-one | 652-69-7 | Biochemical Assay Reagents |
| HY-W587803 | Propionylglycine | 21709-90-0 | Peptides |
| HY-W587803R | Propionylglycine (Standard) | 21709-90-0 | Reference Standards |
| HY-W587805 | Perfluorohexane sulfonamide | 41997-13-1 | Reference compound |
| HY-W587806 | 9-cis Retinol | 22737-97-9 | Reference compound |
| HY-W587807 | 11-cis-Retinol | 22737-96-8 | Reference compound |
| HY-W587816 | Stigmasta-3,5-diene | 4970-37-0 | Biochemical Assay Reagents |
| HY-W587829 | 4-Thiothymidine | 7236-57-9 | Oligonucleotides |
| HY-W587839 | 4,8-Dioxa-3H-perfluorononanoic acid | 919005-14-4 | Reference compound |
| HY-W587841 | D-Xylulose 5-phosphate | 4212-65-1 | Natural Products |
| HY-W587861 | 5β-Dihydroprogesterone | 128-23-4 | Natural Products |
| HY-W587874 | Disperse orange 3 | 730-40-5 | Reference compound |
| HY-W587877 | Triundecanoin | 13552-80-2 | Reference compound |
| HY-W587878 | Thujopsene | 470-40-6 | Reference compound |
| HY-W587888 | MCPD dioleate | 69161-73-5 | Natural Products |
| HY-W587889 | 1,3-Dipalmitoyl-2-chloropropanediol | 169471-41-4 | Natural Products |
| HY-W587889S | 1,3-Dipalmitoyl-2-chloropropanediol-d5 | 1426395-62-1 | Isotope-Labeled Compounds |
| HY-W587891 | 1-Docosahexaenoyl-sn-glycero-3-phosphocholine | 162440-05-3 | Natural Products |
| HY-W587907 | 5-Formylcytidine | 148608-53-1 | Oligonucleotides |
| HY-W587908 | Glycidyl caprate | 26411-50-7 | Natural Products |
| HY-W587909 | Glycidyl caprylate | 24412-91-7 | Natural Products |
| HY-W587910 | Linolenic acid glycidyl ester | 51554-07-5 | Natural Products |
| HY-W587911 | Glycochenodeoxycholic acid 3-sulfate (disodium) | 66874-09-7 | Biochemical Assay Reagents |
| HY-W587916 | (Z)-11-Hexadecenoic acid | 2416-20-8 | Natural Products |
| HY-W587927 | α-Hydroxymethyl atropine | 2515-36-8 | Reference compound |
| HY-W587956 | α-Guaiene | 3691-12-1 | Reference compound |
| HY-W587957 | Gypsogenic acid | 5143-05-5 | Reference compound |
| HY-W587959 | 6-O-Sulfo-β-cyclodextrin (sodium) | 197587-31-8 | Reference compound |
| HY-W587960 | Hercynine | 534-30-5 | Natural Products |
| HY-W587974 | 8-Hydroxygeraniol | 26488-97-1 | Reference compound |
| HY-W587977 | 3-Hydroxypalmitoylcarnitine | 195207-76-2 | Biochemical Assay Reagents |
| HY-W587978 | 12β-Hydroxyisocholic acid | 71883-64-2 | Natural Products |
| HY-W588183 | C14-Dihydroceramide | 61389-70-6 | Natural Products |
| HY-W588184 | (Rac)-C22-Ceramide | 869501-30-4 | Reference compound |
| HY-W588187 | Coprostanone | 601-53-6 | Reference compound |
| HY-W588192S | 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4 | 2703688-58-6 | Isotope-Labeled Compounds |
| HY-W588193S | Cortol-d5 | Isotope-Labeled Compounds | |
| HY-W588194S | (rac)-Cotinine-N-β-Glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-W588212 | trans-Permethrin | 61949-77-7 | Reference compound |
| HY-W588220 | rel-cis-Pinic acid | 61774-58-1 | Reference compound |
| HY-W588241 | Serotonin glucuronide | 18186-43-1 | Reference compound |
| HY-W588247 | S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine | 364083-21-6 | Reference compound |
| HY-W588248 | DL-Sulforaphane glutathione | 289711-21-3 | Reference compound |
| HY-W588250 | Surfactin C1 | 24730-31-2 | Reference compound |
| HY-W588255 | Tetrahydro-11-dehydrocorticosterone | 566-03-0 | Reference compound |
| HY-W588256 | 12-Tridecenoic acid | 6006-06-0 | Reference compound |
| HY-W588257 | (+)-Thienamycin | 59995-64-1 | Natural Products |
| HY-W588258S1 | Para-topolin-d4 | Isotope-Labeled Compounds | |
| HY-W588263 | Indole-3-acetyl glutamate | 57105-48-3 | Reference compound |
| HY-W588263S1 | Indole-3-acetyl glutamate-d4 | Isotope-Labeled Compounds | |
| HY-W588266 | Isopropyl 5-(diphenylphosphoryl)pentanoate | 2088449-88-9 | Reference compound |
| HY-W588292S | 6α-Methylprednisolone 17-propionate-d6 | Isotope-Labeled Compounds | |
| HY-W588293 | 3-Methylthymidine | 958-74-7 | Enzyme |
| HY-W588299S | Mono-(7-carboxy-4-methylheptyl) phthalate-d4 | 1332966-02-5 | Isotope-Labeled Compounds |
| HY-W588311 | 1-Oleoyl-3-chloropropanediol | 10311-82-7 | Natural Products |
| HY-W588315 | 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol | 2680-59-3 | Biochemical Assay Reagents |
| HY-W588704 | 4-Azidobutyric acid | 54447-68-6 | Reference compound |
| HY-W588717 | DBCO-Tetraacetyl mannosamine | Biochemical Assay Reagents | |
| HY-W588722 | ICG-DBCO | Dye Reagents | |
| HY-W588725 | N3-Cho | 1239916-55-2 | Reference compound |
| HY-W588725A | N3-Cho (bromide) | 2059973-54-3 | Reference compound |
| HY-W589849 | 6-Isothiocyanato-Fluorescein | 3012-71-3 | Biochemical Assay Reagents |
| HY-W590531 | 80-O16B | 1624618-02-5 | Biochemical Assay Reagents |
| HY-W590532 | 306-O12B | 2566523-06-4 | Oligonucleotides |
| HY-W590535 | 19:0 PC | 95416-27-6 | Biochemical Assay Reagents |
| HY-W590536 | 1,2-PLPC | 82765-47-7 | Biochemical Assay Reagents |
| HY-W590537 | LC10 | Biochemical Assay Reagents | |
| HY-W590538 | HAPC-Chol | 1027801-73-5 | Biochemical Assay Reagents |
| HY-W590538A | HAPC-Chol (hydroiodide) | Reference compound | |
| HY-W590539 | ω-azido-C6 Ceramide | 2108102-18-5 | Natural Products |
| HY-W590543 | Dodecyl azide | 13733-78-3 | Reference compound |
| HY-W590544 | 1-Azidodecane | 62103-13-3 | Reference compound |
| HY-W590545 | Octyl azide | 7438-05-3 | Reference compound |
| HY-W590546 | Nonyl 7-bromoheptanoate | 3027870-95-4 | Biochemical Assay Reagents |
| HY-W590547 | (6-(4-Hydroxybutylamino)hexyl)carbamic undecyl | Biochemical Assay Reagents | |
| HY-W590548 | ATX-001 | 1777792-33-2 | Biochemical Assay Reagents |
| HY-W590549 | Dioleyldimethylammonium (chloride) | 7212-69-3 | Reference compound |
| HY-W590551 | Adenosine 5′-O-(1-thiotriphosphate) | 29220-54-0 | Oligonucleotides |
| HY-W590551A | Adenosine 5′-O-(1-thiotriphosphate) (disodium) | Oligonucleotides | |
| HY-W590555 | Thiol-PEG-DMG, MW 2000 | Biochemical Assay Reagents | |
| HY-W590561 | Fmoc-Asp(biotinyl-PEG)-OH | 2241747-15-7 | Reference compound |
| HY-W590564 | Bis-PEG3-biotin | 194920-54-2 | Reference compound |
| HY-W590569 | Azido-PEG12-amine | 2803478-25-1 | Reference compound |
| HY-W590572 | N-Butyroyl Phytosphingosine | 409085-57-0 | Reference compound |
| HY-W590573 | C3 Ceramide | 362678-52-2 | Biochemical Assay Reagents |
| HY-W590574 | Propargyl-PEG4-Ms | 173205-72-6 | Reference compound |
| HY-W590575 | Azido-PEG3-flouride | 1233816-91-5 | Reference compound |
| HY-W590583 | (S,R,S)-Ahpc-PEG6-azide | 2767219-19-0 | Reference compound |
| HY-W590586 | Mal-PEG4-NH-Boc | 2517592-97-9 | Biochemical Assay Reagents |
| HY-W590588 | Diethyl acetal-PEG4-amine | 672305-35-0 | Reference compound |
| HY-W590592 | Azido-PEG12-azide | 361543-08-0 | Reference compound |
| HY-W590593 | mPEG-Cholesterol (MW 2000) | Biochemical Assay Reagents | |
| HY-W590664 | C2 Dihydroceramide | 13031-64-6 | Reference compound |
| HY-W590665 | C4 Dihydroceramide | 202467-76-3 | Biochemical Assay Reagents |
| HY-W590666 | N-Hexanoyldihydrosphingosine | 171039-13-7 | Natural Products |
| HY-W590667 | C2 Ceramide-1-phosphate | 151729-55-4 | Biochemical Assay Reagents |
| HY-W590669 | C16-Dihydroceramide | 5966-29-0 | Natural Products |
| HY-W590670 | C20-Dihydroceramide | 121459-06-1 | Biochemical Assay Reagents |
| HY-W590672 | C22-Dihydroceramide | 147492-65-7 | Reference compound |
| HY-W590674 | C26-Ceramide | 121459-09-4 | Natural Products |
| HY-W590676 | Tetramyristoylcardiolipin | 63988-20-5 | Biochemical Assay Reagents |
| HY-W590679 | 113-O16B | 2566523-07-5 | Biochemical Assay Reagents |
| HY-W590681 | 113-O12B | 2803699-72-9 | Biochemical Assay Reagents |
| HY-W590683 | 9A1P9 | 2760467-57-8 | Oligonucleotides |
| HY-W590845 | Ethyl (E)-ferulate | 28028-62-8 | Reference compound |
| HY-W590849 | F1874-108 | 335223-43-3 | Reference compound |
| HY-W590911 | Indole-3-amidoxime | 95649-37-9 | Reference compound |
| HY-W591060 | Bis(bipyridine)-(5-aminophenanthroline) | 84537-86-0 | Reference compound |
| HY-W591272 | Me-Tet-PEG3-NH2 | 2141976-28-3 | ADC Related |
| HY-W591286 | Alkyne-Val-Cit-PAB-PNP | 2748039-77-0 | ADC Related |
| HY-W591307 | P131 | 2360561-66-4 | Reference compound |
| HY-W591308 | 3-[2-(3-Hydroxypropoxy)ethoxy]propan-1-ol | 92144-80-4 | Reference compound |
| HY-W591314 | M-PEG11-Ms | 502487-25-4 | Reference compound |
| HY-W591317 | (R)-NODAGA-tris(t-Bu ester) | 1252799-47-5 | Biochemical Assay Reagents |
| HY-W591325 | 4-((5-Nitropyridin-2-yl)disulfanyl)pentanoic acid | 663598-55-8 | Reference compound |
| HY-W591332 | DMPE-mPEG, MW 2000 | 1254157-61-3 | Biochemical Assay Reagents |
| HY-W591335 | Biotin-PEG5-OH | 1778736-31-4 | Reference compound |
| HY-W591336 | Alloc-Val-Ala-PAB-PNP | 1884578-27-1 | ADC Related |
| HY-W591338A | HO-PEG-CH2COOH (MW 10000) | Reference compound | |
| HY-W591338B | HO-PEG-CH2COOH (MW 35000) | Reference compound | |
| HY-W591352 | Thalidomide-5-(C6-amine) | 1950635-17-2 | Reference compound |
| HY-W591353 | Thalidomide-5-(PEG2-amine) | 2550398-08-6 | Reference compound |
| HY-W591360 | Iodoacetamido-PEG6-azide | 1240737-77-2 | Reference compound |
| HY-W591373 | DBCO-PEG4-Val-Ala-PAB | 2348405-92-3 | ADC Related |
| HY-W591374 | DBCO-PEG4-Val-Ala-PAB-PNP | 2348405-93-4 | ADC Related |
| HY-W591376 | Azido-PEG19-azide | 2201825-22-9 | Reference compound |
| HY-W591379 | Amino-PEG19-amine | 1260522-55-1 | Biochemical Assay Reagents |
| HY-W591381 | DSG-PEG (MW 2000) | 308805-39-2 | Reference compound |
| HY-W591390 | 6-Azidohexanoic acid STP ester | 2586197-38-6 | Biochemical Assay Reagents |
| HY-W591393 | Biotin Azide Plus | 2669097-31-6 | Reference compound |
| HY-W591402 | 3,4-Dibromo-Mal-PEG4-Acid | 2434639-17-3 | ADC Related |
| HY-W591408 | DBCO-Val-Cit-PAB-MMAE | 2768446-73-5 | ADC Related |
| HY-W591424 | m-PEG-NHS ester (MW 2000) | 92451-01-9 | Biochemical Assay Reagents |
| HY-W591438 | Mc-Phe-Lys(Boc)-PAB | 756487-18-0 | Reference compound |
| HY-W591439 | Fmoc-Lys(Boc)-PAB-PNP | 870487-07-3 | Reference compound |
| HY-W591440 | Fmoc-Cit-PAB-PNP | 870487-05-1 | Reference compound |
| HY-W591441 | Fmoc-Ala-PAB-PNP | 1491136-21-0 | Reference compound |
| HY-W591448 | DOPE-PEG-Azide (MW 1000) | Biochemical Assay Reagents | |
| HY-W591449 | DOPE-PEG-Azide, MW 2000 | Biochemical Assay Reagents | |
| HY-W591450 | DOPE-PEG-Azide (MW 3400) | Biochemical Assay Reagents | |
| HY-W591451 | DOPE-PEG-Azide (MW 5000) | Biochemical Assay Reagents | |
| HY-W591461 | DSPE-PEG-COOH, MW 2000 | Biochemical Assay Reagents | |
| HY-W591476 | m-PEG-thiol (MW 1000) | 134874-49-0 | Biochemical Assay Reagents |
| HY-W591476A | m-PEG-thiol (MW 3400) | 134874-49-0 | Biochemical Assay Reagents |
| HY-W591476B | m-PEG-thiol (MW 750) | 134874-49-0 | Biochemical Assay Reagents |
| HY-W591476C | m-PEG-thiol (MW 550) | 134874-49-0 | Biochemical Assay Reagents |
| HY-W591476D | m-PEG-thiol (MW 350) | 134874-49-0 | Biochemical Assay Reagents |
| HY-W591479 | MC-val-ala-nhs ester | 1895916-22-9 | ADC Related |
| HY-W591632 | PEG-bis-amine (MW 1000) | 24991-53-5 | Biochemical Assay Reagents |
| HY-W591768 | (E)-4-(4-(Dimethylamino)styryl)-1-methylpyridin-1-ium (iodide) | 68971-03-9 | Reference compound |
| HY-W591818 | Sunitinib carboxylic acid | 452105-33-8 | Reference compound |
| HY-W591838 | Perfluoropentanesulfonic acid | 2706-91-4 | Reference compound |
| HY-W591891 | Cholesterol-PEG-acid (MW 1000) | Biochemical Assay Reagents | |
| HY-W591912 | Cholesterol-PEG-methoxy (MW 1000) | Biochemical Assay Reagents | |
| HY-W591913 | Cholesterol-PEG-methoxy, MW 2000 | Biochemical Assay Reagents | |
| HY-W591914 | Cholesterol-PEG-methoxy (MW 5000) | Biochemical Assay Reagents | |
| HY-W591962 | 5-Azidopentan-1-ol | 170220-11-8 | Reference compound |
| HY-W591963 | 5-Azidopentyl 4-methylbenzenesulfonate | 1407974-54-2 | Reference compound |
| HY-W591964 | t-Boc-aminooxy-pentane-azide | 2496687-07-9 | Reference compound |
| HY-W591965 | t-Boc-aminooxy-pentane-amine | 848349-01-9 | Reference compound |
| HY-W591967 | N-Boc-15-aminopentadecanoic acid | 1661040-68-1 | Reference compound |
| HY-W591968 | 14-(Fmoc-amino)-tetradecanoic acid | 1931109-55-5 | Reference compound |
| HY-W591969 | Benzyl (6-oxohexyl)carbamate | 98648-05-6 | Reference compound |
| HY-W591970 | 8-Bromooct-1-yne | 81216-13-9 | Reference compound |
| HY-W591971 | 5-((tert-Butoxycarbonyl)amino)pentyl 4-methylbenzenesulfonate | 118811-34-0 | Reference compound |
| HY-W591972 | 6-Hydroxyhexyl 4-methylbenzenesulfonate | 75351-33-6 | Reference compound |
| HY-W591973 | OTs-C6-NHBoc | 86536-92-7 | Reference compound |
| HY-W591975 | Alkyne maleimide | 2785323-77-3 | Reference compound |
| HY-W591977 | Boc-5-aminopentanoic NHS ester | 82518-79-4 | Reference compound |
| HY-W591982 | t-Boc-N-amido-PEG12-acid | 187848-68-6 | Reference compound |
| HY-W591992 | PEG17 | 4669-05-0 | Reference compound |
| HY-W592008 | C18-PEG5-acid | 1807534-83-3 | Biochemical Assay Reagents |
| HY-W592010 | C18-PEG4-Azide | 1807539-11-2 | Reference compound |
| HY-W592627 | N,N-Diethyl-p-toluamide | 2728-05-4 | Reference compound |
| HY-W592871 | 10-Hydroxy-2-decenoic acid | 765-01-5 | Natural Products |
| HY-W593287 | Carboxyethyl-γ-aminobutyric acid | 4386-03-2 | Biochemical Assay Reagents |
| HY-W594833 | 7-Pentadecanol | 4104-59-0 | Reference compound |
| HY-W594851 | Biphenyl-3′,3,4,4′-tetrol | 3598-30-9 | Reference compound |
| HY-W595340 | E3 ubiquitin ligase binder-1 | 2446913-99-9 | Reference compound |
| HY-W596474A | Poly-L-glutamic acid sodium salt (MW 3000) | 26247-79-0 | Biochemical Assay Reagents |
| HY-W596474B | Poly-L-glutamic acid sodium salt (MW 7500) | 26247-79-0 | Biochemical Assay Reagents |
| HY-W596474C | Poly-L-glutamic acid sodium salt (MW 15000) | 26247-79-0 | Biochemical Assay Reagents |
| HY-W596474D | Poly-L-glutamic acid sodium salt (MW 30000) | 26247-79-0 | Biochemical Assay Reagents |
| HY-W596474E | Poly-L-glutamic acid sodium salt (MW 45000) | 26247-79-0 | Biochemical Assay Reagents |
| HY-W596474H | Poly-L-glutamic acid sodium salt (MW 60000) | 26247-79-0 | Biochemical Assay Reagents |
| HY-W596474I | Poly-L-glutamic acid sodium salt (MW 120000) | 26247-79-0 | Biochemical Assay Reagents |
| HY-W596782 | Chaetochromin A | 75514-37-3 | Natural Products |
| HY-W597209 | 2,6-Diethyl-4-fluoroaniline | 117336-04-6 | Reference compound |
| HY-W598178 | 93-O17O | 2227214-78-8 | Biochemical Assay Reagents |
| HY-W598183 | 2-(5-Azidopentyl)isoindoline-1,3-dione | 595607-72-0 | Reference compound |
| HY-W598189 | 2-(6-Azidohexyl)isoindoline-1, 3-dione | 595607-73-1 | Reference compound |
| HY-W598191 | tert-Butyl (3-azidopropyl)carbamate | 129392-84-3 | Reference compound |
| HY-W598192 | 1-Butanol, 4-azido-, 1-benzoate | 1184934-40-4 | Reference compound |
| HY-W598193 | [(5-Azidopentyl)oxy](1,1-dimethylethyl)dimethylsilane | 749252-71-9 | Reference compound |
| HY-W598194 | 1-((4-Azidobutoxy)methyl)-4-methoxybenzene | 1355510-12-1 | Reference compound |
| HY-W598195 | 11-Azido-1-undecanol | 122161-09-5 | Reference compound |
| HY-W598196 | 2-(3-azidopropyl)-isoindole-1, 3-dione | 88192-21-6 | Reference compound |
| HY-W598197 | 5-Azidopentanoic acid ethyl ester | 89896-39-9 | Reference compound |
| HY-W598198 | Ethyl 3-azidopropanoate | 40139-55-7 | Reference compound |
| HY-W598199 | Ethyl 4-azidobutyrate | 51453-79-3 | Reference compound |
| HY-W598230A | m-PEG-NH2 (hydrochloride) (MW 2000) | Biochemical Assay Reagents | |
| HY-W598456 | Brigimadlin intermediate-1 | 1149388-04-4 | ADC Related |
| HY-W599025 | 5-Br-4-Cl-Pyrrolo-pyroxypyridine | 2914920-46-8 | Reference compound |
| HY-W601362 | N-Acetyl-D-galactosamine-6-phosphate (disodium) | 102029-88-9 | Reference compound |
| HY-W601451 | 3,6-Di-O-acetyl-5-S-acetyl-5-deoxy-1,2-O-isopropylidene-α-D-glucofuranose | 10227-17-5 | Biochemical Assay Reagents |
| HY-W601637 | 1,2-Di-O-acetyl-5-Benzoyl-3-O-Methyl-D-ribofuranose | 10300-21-7 | Oligonucleotides |
| HY-W602640 | 2'-Deoxyisoguanosine | 106449-56-3 | Oligonucleotides |
| HY-W603111 | 5-Thio-D-glucose-6-phosphate diammonium salt | 108391-99-7 | Biochemical Assay Reagents |
| HY-W603112 | β-D-Glucopyranosyl 1-thio-β-D-glucopyranoside | 108392-13-8 | Biochemical Assay Reagents |
| HY-W603690 | 2'-Deoxy-N6-phenoxyacetyladenosine | 110522-74-2 | Oligonucleotides |
| HY-W604427 | 5′-O-[(4-Cyanophenyl)methyl]-2′,3′-O-(1-methylethylidene)adenosine | 1134156-51-6 | Oligonucleotides |
| HY-W604882 | Orthonitrophenyl-β-D-fucopyranoside, 98% | 1154-94-5 | Biochemical Assay Reagents |
| HY-W605328 | Pentanedioic acid | 116920-04-8 | Biochemical Assay Reagents |
| HY-W605935 | 2-Amino-6-chloropurine-9-beta-d-(2'-deoxy-3',5'-di-o-benzoyl-2'-fluoro)arabinoriboside | 118373-61-8 | Oligonucleotides |
| HY-W605942 | Methyl N-succinimidyl adipate | 118380-06-6 | Biochemical Assay Reagents |
| HY-W606687 | N-(2-Phenoxyacetyl)adenosine | 119824-65-6 | Oligonucleotides |
| HY-W608384 | Bis(2-(trimethylsilyl)ethyl) diisopropylphosphoramidite | 121373-20-4 | Oligonucleotides |
| HY-W609639 | 2’-Deoxyisocytidine | 123075-23-0 | Oligonucleotides |
| HY-W611212 | 1-(3-Fluorophenyl)propan-2-one | 1737-19-5 | Reference compound |
| HY-W611263 | Methyl 2-bromo-3,3,3-trifluoropropionate | 113816-36-7 | Biochemical Assay Reagents |
| HY-W612269S | Isonicotinoyl chloride-d4 | Isotope-Labeled Compounds | |
| HY-W612338 | 9-Oxononanoic acid | 2553-17-5 | Natural Products |
| HY-W612372 | 4-(Bromomethyl)benzenesulfonyl fluoride | 7612-88-6 | Reference compound |
| HY-W612387 | Suberaldehydic acid | 929-48-6 | Natural Products |
| HY-W612419 | D-Tryptophan, N-D-tryptophyl | 58607-72-0 | Reference compound |
| HY-W612784 | 4-Bromobutyryl chloride | 927-58-2 | Biochemical Assay Reagents |
| HY-W612975 | 4-Dodecylmorpholine | 1541-81-7 | Reference compound |
| HY-W613220 | MDH1/2-IN-1 | 2143473-95-2 | Reference compound |
| HY-W613261 | α-D-Galactopyranose,2-(acetylamino)-2-deoxy-,1,3,4,6-tetraacetate | 10385-50-9 | Biochemical Assay Reagents |
| HY-W613428 | N-octatriacontane | 7194-85-6 | Natural Products |
| HY-W613607 | HO-PEG3-(CH2)6-Cl | 1355955-95-1 | Reference compound |
| HY-W613915 | (±)-Ipsdienol | 14434-41-4 | Natural Products |
| HY-W613934 | (E)-10-Hexadecenal | 72698-30-7 | Natural Products |
| HY-W613967 | Hexacosanedioicacid | 3365-67-1 | Natural Products |
| HY-W614112 | (-)-Chloroquine | 58175-87-4 | Reference compound |
| HY-W614135 | 7-Methyl-8-oxononanoic acid | 407627-97-8 | Reference compound |
| HY-W614180 | 3-Amino-2-sulfopropanoic acid | 15924-28-4 | Reference compound |
| HY-W614269 | DOTA-GA(tBu)4 | 306776-79-4 | Reference compound |
| HY-W614443 | Lauryl laurate | 13945-76-1 | Natural Products |
| HY-W614507 | Dihydronicotinamide riboside | 19132-12-8 | Reference compound |
| HY-W614632 | γ-Glu-Val-Gly | 38837-70-6 | ADC Related |
| HY-W614724 | 21-Hydroxyhenicosanoic acid | 89160-04-3 | Natural Products |
| HY-W614725 | Apcin-A (monohydrochloride) | 1683535-53-6 | Reference compound |
| HY-W614753 | Biotin-naphthylamine | 2375201-60-6 | Biochemical Assay Reagents |
| HY-W614925 | 4-Hydroxyphenylacetaldehyde | 7339-87-9 | Natural Products |
| HY-W614957 | Capecitabine-2',3'-cyclic carbonate | 921769-65-5 | Reference compound |
| HY-W614957R | Capecitabine-2',3'-cyclic carbonate (Standard) | 921769-65-5 | Reference Standards |
| HY-W615095 | Biotin-PEG2-alkyne | 2227450-68-0 | Reference compound |
| HY-W615104 | BTTP | 1341215-17-5 | Reference compound |
| HY-W615108B | β-Nicotinamide mononucleotide, reduced form (disodium) | 108347-85-9 | Enzyme |
| HY-W615141 | Desmethyltrimipramine | 2293-21-2 | Reference compound |
| HY-W615153 | Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH | 1662688-20-1 | Reference compound |
| HY-W615166 | Thalidomide-NH-C2-alkyne | 2154356-73-5 | Reference compound |
| HY-W615173 | NHS ester-C2-NHCO-C2-NHS | 2512227-14-2 | Biochemical Assay Reagents |
| HY-W615327 | Bis-sulfone NHS ester | 899452-51-8 | Reference compound |
| HY-W615671 | 4,4'-(Cyclohexylidenemethylene)diphenol | 5189-40-2 | Reference compound |
| HY-W615853 | 5-HT1A modulator 4 | 145208-86-2 | Reference compound |
| HY-W616313 | Cyprosulfamide | 221667-31-8 | Reference compound |
| HY-W616313S | Cyprosulfamide-d4 | Isotope-Labeled Compounds | |
| HY-W616468 | Sulfosuccinic acid | 5138-18-1 | Biochemical Assay Reagents |
| HY-W616620 | N1-(2-Methoxy-4-methylbenzyl)-N2-(2-(5-methylpyridin-2-yl)ethyl)oxalamide | 745047-94-3 | Reference compound |
| HY-W616732 | 5′-Fluoro-5′-deoxyadenosine | 731-98-6 | Reference compound |
| HY-W616806 | Sodium 6-oxo-3,6-dihydropurin-7-ide | 45738-97-4 | Biochemical Assay Reagents |
| HY-W617979S | 3,4-Dichlorodiphenyl ether-13C12 | Isotope-Labeled Compounds | |
| HY-W630479S | 1,4-Diphenylbutane-d4 | 220332-28-5 | Isotope-Labeled Compounds |
| HY-W634602 | (R)-RO5263397 | 1357266-80-8 | Reference compound |
| HY-W634748 | Desalkylgidazepam | 2894-61-3 | Reference compound |
| HY-W634748S | Desalkylgidazepam-d5 | 1782531-89-8 | Isotope-Labeled Compounds |
| HY-W636234 | GSK2636771 methyl | 1372540-24-3 | Reference compound |
| HY-W638077 | 6-Chloro-3-indoxyl caprylate | 159954-35-5 | Biochemical Assay Reagents |
| HY-W641445 | ELP-004 | 15533-81-0 | Reference compound |
| HY-W641593S | 1,1-Diethoxy-2-methylbutane-d10 | Isotope-Labeled Compounds | |
| HY-W641639S | 2-Cyano-3,3-diphenylacrylic acid-d10 | Isotope-Labeled Compounds | |
| HY-W642858 | 5-Bromo-4-chloro-1H-indol-3-yl-β-D-mannopyranoside | 129787-67-3 | Biochemical Assay Reagents |
| HY-W643127 | TABS | 54960-65-5 | Biochemical Assay Reagents |
| HY-W643128 | Carlina oxide | 502-22-7 | Natural Products |
| HY-W643129 | 1-(3,5-Di-tert-butyl-4-hydroxyphenyl)ethane-1,2-diol | 125489-21-6 | Reference compound |
| HY-W643167 | 1,2,3-Tritridecanoylglycerol | 26536-12-9 | Reference compound |
| HY-W643348 | 4-Bromoiodobenzene-d4 | 1147565-46-5 | Isotope-Labeled Compounds |
| HY-W644133 | 1-(2,4-Dihydroxy-3,6-dimethoxyphenyl)-3-phenylpropan-1-one | 54299-52-4 | Natural Products |
| HY-W647305 | 4-(5-(3-Hydroxypropyl)-7-methoxybenzofuran-2-yl)-2-methoxyphenol | 144735-57-9 | Natural Products |
| HY-W650530 | Ethyl 8-chloro-4-oxo-4H-quinolizine-3-carboxlate | 139161-20-9 | Biochemical Assay Reagents |
| HY-W650803 | Nemazoline | 130759-56-7 | Reference compound |
| HY-W650834 | 3-Acetamido-3-deoxy-D-glucose | 14086-88-5 | Biochemical Assay Reagents |
| HY-W650842 | Boc-Asp(OBzl)-CMK | 172702-58-8 | Peptides |
| HY-W651036 | 2-Caren-10-al | 6909-19-9 | Natural Products |
| HY-W653424 | Propyl stearate | 3634-92-2 | Natural Products |
| HY-W653718 | o-Cresol-d7 | 202325-50-6 | Isotope-Labeled Compounds |
| HY-W653721 | (R,S)-N-Nitroso anabasine-d4 | 1020719-68-9 | Isotope-Labeled Compounds |
| HY-W653723 | N-Nitrosodicyclohexylamine | 947-92-2 | Reference compound |
| HY-W653723R | N-Nitrosodicyclohexylamine (Standard) | 947-92-2 | Reference Standards |
| HY-W653728 | Acrylamide-d3 | 122775-19-3 | Isotope-Labeled Compounds |
| HY-W653733 | L-Homocysteine-d4 | 331665-12-4 | Isotope-Labeled Compounds |
| HY-W653751 | 2-Benzothiazolethiol-d4 | 1346598-64-8 | Isotope-Labeled Compounds |
| HY-W653760 | Carbofuran-d3 | 1007459-98-4 | Isotope-Labeled Compounds |
| HY-W653760R | Carbofuran-d3 (Standard) | 1007459-98-4 | Reference Standards |
| HY-W653762 | Cetirizine N-oxide | 1076199-80-8 | Reference compound |
| HY-W653769 | "Deltamethrin-d5 (Mixture of Diastereomers)" | 1217633-23-2 | Isotope-Labeled Compounds |
| HY-W653780 | Dimethyl phosphorothioate | 1112-38-5 | Reference compound |
| HY-W653803 | Lamotrigine N2-Oxide | 136565-76-9 | Reference compound |
| HY-W653809 | Mephentermine (hydrochloride) | 3978-34-5 | Reference compound |
| HY-W653822 | (2'S)-Nicotine 1-oxide | 2820-55-5 | Reference compound |
| HY-W653842 | Taurocholic acid-d8 (sodium) | 1351996-69-4 | Isotope-Labeled Compounds |
| HY-W653849 | 2,4-Xylidine-d6 | 1071170-27-8 | Isotope-Labeled Compounds |
| HY-W653853 | Ritonavir-13C3 | 1217673-23-8 | Reference compound |
| HY-W653871 | Florfenicol amine-d3 | 3023974-39-9 | Isotope-Labeled Compounds |
| HY-W653875 | Azithromycin-d5 | Isotope-Labeled Compounds | |
| HY-W653882 | Carbamazepine-d2,15N | Isotope-Labeled Compounds | |
| HY-W653885 | rac 3,4-Dihydroxymandelic Acid-d3 | Isotope-Labeled Compounds | |
| HY-W653893 | Taurocholic acid-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-W653894 | Tentoxin-d3 | 1426437-58-2 | Isotope-Labeled Compounds |
| HY-W653896 | Alternariol-d2 | 2469262-26-6 | Isotope-Labeled Compounds |
| HY-W653905 | Amantadine-d15 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W653912A | Leucovorin-d4 (calcium hydrate), >90% | Isotope-Labeled Compounds | |
| HY-W653916 | 8-Hydroxy-2'-deoxyguanosine-13C,15N2 | Isotope-Labeled Compounds | |
| HY-W653919 | SN-38 glucuronide-d3 | Isotope-Labeled Compounds | |
| HY-W653920 | Tauro 6-ethlchenodeoxycholic acid-d5(sodium） | Isotope-Labeled Compounds | |
| HY-W653921 | Tenuazonic acid-d13 | 2714417-30-6 | Isotope-Labeled Compounds |
| HY-W653925 | (Aminomethyl)phosphonic acid-13C,15N | 2727464-25-5 | Isotope-Labeled Compounds |
| HY-W653929 | Bis(1-chloro-2-propyl) phosphate-d12 | 1870073-89-4 | Isotope-Labeled Compounds |
| HY-W653930 | 4,4'-Sulfonyldiphenol-13C12 | 1991267-29-8 | Reference compound |
| HY-W653936 | Cephalexin-d5 (hydrate) | Isotope-Labeled Compounds | |
| HY-W653942 | Docetaxel-d5 | Isotope-Labeled Compounds | |
| HY-W653944 | Epalrestat-d5 | 2755644-33-6 | Isotope-Labeled Compounds |
| HY-W653962 | Triclosan-13C6 | 2726926-25-4 | Reference compound |
| HY-W653963 | Tris(2-butyloxyethyl)phosphate-d27 | Isotope-Labeled Compounds | |
| HY-W653969 | Arotinolol-d5 (hydrochloride) | 2514848-16-7 | Isotope-Labeled Compounds |
| HY-W653970 | 5-Azacytidine-15N4 | 2139283-40-0 | Reference compound |
| HY-W653977 | Chlortetracycline-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W653978 | Cinacalcet-d4 (hydrochloride) | 2514927-75-2 | Isotope-Labeled Compounds |
| HY-W653982 | Coproporphyrin I-15N4 | Reference compound | |
| HY-W653989 | Desonide-13C3 | Isotope-Labeled Compounds | |
| HY-W653994 | Ethyl Paraben-13C6 | 2075718-25-9 | Reference compound |
| HY-W653999 | Glycodeoxycholic acid-d5 | Isotope-Labeled Compounds | |
| HY-W654000 | Cyclic GMP-13C,15N2 | Reference compound | |
| HY-W654002 | (3R)-3-Hydroxybutyric acid-1-13C | Reference compound | |
| HY-W654004 | 8-Hydroxy guanosine-13C,15N2 | Reference compound | |
| HY-W654009 | Loxoprofen-d3 | Isotope-Labeled Compounds | |
| HY-W654010 | Lurasidone-d8-1 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W654013 | Minocycline-d7 | Isotope-Labeled Compounds | |
| HY-W654020 | Propyl paraben-13C6 | 2075718-26-0 | Reference compound |
| HY-W654023 | Tazobactam-15N3 (sodium) | Isotope-Labeled Compounds | |
| HY-W654025 | 2,2′,4,4′-Tetrahydroxybenzophenone-d4 | 2484091-67-8 | Isotope-Labeled Compounds |
| HY-W654041 | Adenosine monophosphate-13C5 | Reference compound | |
| HY-W654058 | L-Arginine-13C,d4 (dihydrochloride) | Isotope-Labeled Compounds | |
| HY-W654064 | Azithromycin-13C,d3-1 | Isotope-Labeled Compounds | |
| HY-W654066 | Beclomethasone 17-Propionate-d5 | Isotope-Labeled Compounds | |
| HY-W654073 | Bifenthrin-d5 | Isotope-Labeled Compounds | |
| HY-W654077 | Bisphenol AF-d4 | Isotope-Labeled Compounds | |
| HY-W654078 | Bisphenol AF-13C12 | 2411504-31-7 | Isotope-Labeled Compounds |
| HY-W654080 | Bisphenol P-13C4 | 2731660-12-9 | Reference compound |
| HY-W654081 | Bisphenol P-d16 | 2469196-09-4 | Isotope-Labeled Compounds |
| HY-W654082 | Bisphenol e-13C6 | Reference compound | |
| HY-W654087 | 9-Bromophenanthrene-d9 | 2055815-26-2 | Isotope-Labeled Compounds |
| HY-W654091 | (R)-Butyryl carnitine-d5 chloride | Isotope-Labeled Compounds | |
| HY-W654098 | Cefazolin-13C2,15N (sodium) | 1346602-30-9 | Reference compound |
| HY-W654100 | Cefepime-d3 (sulfate) | Isotope-Labeled Compounds | |
| HY-W654101 | Cefotaxime-d3 | Isotope-Labeled Compounds | |
| HY-W654105 | C18-Ceramide-13C2,d2 | Isotope-Labeled Compounds | |
| HY-W654118 | Cloxacillin-13C4 (sodium) | Reference compound | |
| HY-W654119 | CMPF-d3 | Isotope-Labeled Compounds | |
| HY-W654120 | Creatine-13C3 | Isotope-Labeled Compounds | |
| HY-W654121 | p-Cresol sulfate-d4 (potassium) | Isotope-Labeled Compounds | |
| HY-W654123 | 1,2-Cyclohexanedicarboxylic acid mono 4-methyl-7-carboxy-heptyl ester-d8 | Isotope-Labeled Compounds | |
| HY-W654126 | Cytarabine-13C3 | Isotope-Labeled Compounds | |
| HY-W654127 | Cytarabine-13C3 5'-monophosphate | Reference compound | |
| HY-W654130 | Daunorubicin-13C,d3 | Isotope-Labeled Compounds | |
| HY-W654136 | 2'-Deoxycytidine-2'-13C | Reference compound | |
| HY-W654139 | 5'-Deoxy-5'-(methylthio)adenosine-d3 | 2699607-01-5 | Isotope-Labeled Compounds |
| HY-W654154 | Dexmedetomidine-d4 L-tartrate (-d4-major) | 2714432-36-5 | Isotope-Labeled Compounds |
| HY-W654156 | Diclazuril-13C3,15N2 | Reference compound | |
| HY-W654157 | Dicloxacillin-13C4 (sodium hydrate) | Isotope-Labeled Compounds | |
| HY-W654165 | Diisobutyl hydrogen phosphate-d14 | Isotope-Labeled Compounds | |
| HY-W654175 | Duloxetine-d7 (maleate) | Isotope-Labeled Compounds | |
| HY-W654190 | Fipronil sulfone-13C2,15N2 | Isotope-Labeled Compounds | |
| HY-W654191 | Fipronil detrifluoromethylsulfinyl-13C2,15N2 | Reference compound | |
| HY-W654195 | 3-Hydroxyfluorene-d9 | Isotope-Labeled Compounds | |
| HY-W654199 | 5-Formyltetrahydropteroic acid (hydrochloride) | 2469007-14-3 | Reference compound |
| HY-W654209 | "Glycopyrrolate iodide-d3 (mixture of diastereomers)" | Isotope-Labeled Compounds | |
| HY-W654210 | Glycopyrrolate-d3 (bromide) | Isotope-Labeled Compounds | |
| HY-W654214 | 4-Hydroxy nonenal mercapturic acid-d3 | Isotope-Labeled Compounds | |
| HY-W654221 | Hydroxychloroquine O-sulfate (sodium) | 2740402-74-6 | Reference compound |
| HY-W654227 | 7-Hydroxy methotrexate-d3 (ammonium salt) | Isotope-Labeled Compounds | |
| HY-W654228 | 5-Hydroxymethyl-2'-deoxycytidine-d3 | 1585142-60-4 | Isotope-Labeled Compounds |
| HY-W654232 | L-Hydroxyproline-d4 | 2734920-51-3 | Isotope-Labeled Compounds |
| HY-W654238 | Imidaclothiz-d4 | Isotope-Labeled Compounds | |
| HY-W654241 | Isopentenyl pyrophosphate-13C2 | Isotope-Labeled Compounds | |
| HY-W654243 | Isovalerylcarnitine-d9-1 (chloride) | Isotope-Labeled Compounds | |
| HY-W654244 | Ivermectin-d2 | Isotope-Labeled Compounds | |
| HY-W654254 | Malachite green-d5 (oxalate) | Isotope-Labeled Compounds | |
| HY-W654258 | 6-Mercaptopurine-13C,15N2 (hydrochloride) | Reference compound | |
| HY-W654262 | 10α-Methoxy-9,10-dihydrolysergol-d3 | Isotope-Labeled Compounds | |
| HY-W654264 | 2-Methylbutyrylcarnitine (chloride) | Reference compound | |
| HY-W654267 | Medrate-d3 | 1262969-27-6 | Isotope-Labeled Compounds |
| HY-W654269 | 1-(4-Methyl-7-oxooctyl) 1,2-cyclohexanedicarboxylate-d8 | Isotope-Labeled Compounds | |
| HY-W654278 | Monoisodecyl Phthalate-d4 | Isotope-Labeled Compounds | |
| HY-W654282 | Myclobutanil-d9 | Isotope-Labeled Compounds | |
| HY-W654288 | NAD+-d4 | Isotope-Labeled Compounds | |
| HY-W654301 | Oseltamivir-d5 Phosphate | Isotope-Labeled Compounds | |
| HY-W654304 | Oxonic Acid -13C2,15N3 (potassium salt hydrate) | Reference compound | |
| HY-W654305 | Palbociclib-d4 | 1628752-63-5 | Isotope-Labeled Compounds |
| HY-W654306 | 1-Palmitoyl-2-oleoyl-3-chloropropanediol-d5 | Isotope-Labeled Compounds | |
| HY-W654314 | S-Phenyl-d5-mercapturic Acid | 2519846-58-1 | Isotope-Labeled Compounds |
| HY-W654319 | Tri-p-tolyl phosphate-d21 | 2469244-63-9 | Isotope-Labeled Compounds |
| HY-W654320 | Piperin-d10 | Isotope-Labeled Compounds | |
| HY-W654329 | Protionamide-d7 | 2468639-68-9 | Isotope-Labeled Compounds |
| HY-W654330 | Pyraclostrobin-d6 | Isotope-Labeled Compounds | |
| HY-W654334 | 9-cis-Retinol-d5 | Isotope-Labeled Compounds | |
| HY-W654335 | Rivastigmine-d4 (tartrate) | Isotope-Labeled Compounds | |
| HY-W654336 | (S)-Rivastigmine-d4 | Isotope-Labeled Compounds | |
| HY-W654341 | Simvastatin-d6 hydroxy acid (ammonium) | Isotope-Labeled Compounds | |
| HY-W654342 | Spermine-d20 | Isotope-Labeled Compounds | |
| HY-W654343 | D-Erythro-sphingosine-1-phosphate-13C2,d2 | 2734928-88-0 | Isotope-Labeled Compounds |
| HY-W654353 | Tauro-α-muricholic acid-d4-1 (sodium) | Isotope-Labeled Compounds | |
| HY-W654362 | (R)-2-Thioxothiazolidine-4-carboxylic acid-13C3 | 2704345-00-4 | Isotope-Labeled Compounds |
| HY-W654373S | 4-((Hydrazinyl)methyl)benzene-1,2,3-triol-15N2 (oxalate) | Isotope-Labeled Compounds | |
| HY-W654395 | Methyl jasmonate-d5 (mixture of diastereomers) | Isotope-Labeled Compounds | |
| HY-W654397 | Deflazacort-d3 | 2280940-17-0 | Isotope-Labeled Compounds |
| HY-W654409 | 1,1,1,3,3,3-Hexafluoropropan-2-ol-d2 | 38701-74-5 | Isotope-Labeled Compounds |
| HY-W654495 | 1,2-Dibromoethyltrichlorosilane | 4170-50-7 | Biochemical Assay Reagents |
| HY-W655179 | 1,4-Dimethylpiperidine | 695-15-8 | Reference compound |
| HY-W655727 | (-)-2-Phenylpropylamine | 17596-79-1 | Reference compound |
| HY-W658339A | Methyl threo-9,10-dihydroxyoctadecanoate | 3639-31-4 | Natural Products |
| HY-W659059 | N-Methyl-1-phenylpropan-1-amine (hydrochloride) | 76605-79-3 | Reference compound |
| HY-W661016 | 1-Azido-1-deoxy-β-D-galactopyranoside, 97% | 35899-89-9 | Biochemical Assay Reagents |
| HY-W661499 | Orellanine | 37338-80-0 | Reference compound |
| HY-W662572S | Pyroxsulam-d6 | Isotope-Labeled Compounds | |
| HY-W662579 | N-Desmethyl clotiazepam | 33671-37-3 | Reference compound |
| HY-W662724 | 3-Ethyl-2-phenylmorpholine (hydrochloride) | 1956382-42-5 | Reference compound |
| HY-W663230 | Eugenitin | 480-12-6 | Natural Products |
| HY-W663232 | Anthragallol-2-methyl ether | 10383-63-8 | Natural Products |
| HY-W663527 | Gly-Asp (hydrate) | 1366384-20-4 | Reference compound |
| HY-W663740 | 1-Methyl-4-nitrosopiperazine | 16339-07-4 | Reference compound |
| HY-W663938 | Cyflumetofen | 400882-07-7 | Reference compound |
| HY-W663938R | Cyflumetofen (Standard) | 400882-07-7 | Reference Standards |
| HY-W664016 | Difluoroheptylazidosulfinate (sodium) | 1450912-63-6 | Reference compound |
| HY-W664041 | Noncatechol agonist-1 | 1609580-99-5 | Reference compound |
| HY-W664824 | Desalkylquazepam | 1645-32-5 | Reference compound |
| HY-W665338 | 3,6-Dimethoxy-9H-xanthen-9-one | 15007-07-5 | Reference compound |
| HY-W665660 | Myristyl stearate | 17661-50-6 | Natural Products |
| HY-W665796 | N-Methyl-N-nitroso-2-propanamine | 30533-08-5 | Reference compound |
| HY-W666088 | (2-Phenylethyl)hydrazine (dihydrochloride) | 16904-30-6 | Reference compound |
| HY-W667666 | Anthragallol 1,2-dimethyl ether | 10383-62-7 | Natural Products |
| HY-W667667 | 5-Hydroxyalizarin 1-methyl ether | 34425-63-3 | Natural Products |
| HY-W668407 | Oleyl stearate | 17673-50-6 | Natural Products |
| HY-W668661 | 2-Allyl-4-methylphenol | 6628-06-4 | Biochemical Assay Reagents |
| HY-W668708 | Dimethyl undecanedioate | 4567-98-0 | Natural Products |
| HY-W668749 | 3BP-3580 | 2374782-82-6 | Reference compound |
| HY-W668775 | Quin-C7 | 871100-12-8 | Reference compound |
| HY-W669241 | Dimethenamide-P | 163515-14-8 | Reference compound |
| HY-W669241R | Dimethenamide-P (Standard) | 163515-14-8 | Reference Standards |
| HY-W669548 | Antitumor agent-193 | 102362-49-2 | Reference compound |
| HY-W670044 | 9-Oxooctadecanoic acid | 4114-74-3 | Natural Products |
| HY-W670564A | (4S)-10-Nor-calamenen-10-one | 1270089-06-9 | Natural Products |
| HY-W670700 | 2,5-Dihydroxy-4-methoxyacetophenone | 22089-12-9 | Natural Products |
| HY-W671129 | Frenolicin B | 68930-68-7 | Natural Products |
| HY-W671434A | Candicine (chloride) | 3761-58-8 | Natural Products |
| HY-W671472 | 10-Oxononadecanedioic acid | 18197-46-1 | Reference compound |
| HY-W671745 | Entadamide A 2'-O-(6''-O-β-D-glucopyranosyl)-β-D-glucopyranoside | 1427191-48-7 | Natural Products |
| HY-W671746 | Thevetin A | 37933-66-7 | Natural Products |
| HY-W673588 | 2,3-Dichlorobiphenyl | 16605-91-7 | Reference compound |
| HY-W673588S | 2,3-Dichlorobiphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-W673589 | Hexacosane, 2-Methyl- | 1561-02-0 | Reference compound |
| HY-W674002 | 1-Adamantylphosphaethyne | 101055-70-3 | Reference compound |
| HY-W674036 | 11-Mercaptoundecylphosphoric acid | 188678-49-1 | Reference compound |
| HY-W674037 | cis-Verbenol | 18881-04-4 | Natural Products |
| HY-W674039 | 6-Azido-6-deoxy-D-glucose, 95% | 20847-05-6 | Biochemical Assay Reagents |
| HY-W674057 | (Z)-3-Dodecen-1-ol | 32451-95-9 | Natural Products |
| HY-W674112 | Magnesium ionophore I | 75513-72-3 | Reference compound |
| HY-W674124 | Tripentadecanoin | 7370-46-9 | Reference compound |
| HY-W674127 | N-Biotinyl-N'-Boc-1,6-hexanediamine | 153162-70-0 | Biochemical Assay Reagents |
| HY-W674169 | Perfluorobutanesulfonamide | 30334-69-1 | Reference compound |
| HY-W674241 | 4-Ethylphenyl sulfate | 85734-98-1 | Reference compound |
| HY-W674241A | 4-Ethylphenyl sulfate (sodium) | Reference compound | |
| HY-W674257 | WAY-658674 | 42310-54-3 | Reference compound |
| HY-W674261 | WAY-620521 | 315693-33-5 | Reference compound |
| HY-W674266 | Benzyl N-acetyl-4,6-O-benzylidene normuranic acid | 14595-22-3 | Biochemical Assay Reagents |
| HY-W674268 | WAY-312084 | 335209-06-8 | Reference compound |
| HY-W674276 | WAY-325485 | 177937-81-4 | Reference compound |
| HY-W674311 | 2,6-Dimethylheptanoic acid | 7494-12-4 | Natural Products |
| HY-W674324 | Thalidomide-5-NH-C-alkyne | 2357110-24-6 | Reference compound |
| HY-W674381 | 5-(2-Chloroacetamide) thalidomide | 1957235-51-6 | Reference compound |
| HY-W674435 | 5-Hydroxy-2-(1-methyl-2,6-dioxopiperidin-3-yl)isoindole-1,3-dione | 2589697-74-3 | Reference compound |
| HY-W674436 | (S)-Thalidomide-4-OH | 2357105-36-1 | Reference compound |
| HY-W674603 | WAY-351783 | 460994-47-2 | Reference compound |
| HY-W674612 | WAY-297848 | 404360-27-6 | Reference compound |
| HY-W674624 | WAY-312858 | 620570-09-4 | Reference compound |
| HY-W674641 | WAY-648936 | 796888-73-8 | Reference compound |
| HY-W675848 | N4-Bz-C-(S)-GNA phosphoramidite | 885322-06-5 | Reference compound |
| HY-W676362 | Perfluoro-N-Butane | 355-25-9 | Reference compound |
| HY-W676492 | 4-Methyl-3-phenylcoumarin | 23028-23-1 | Biochemical Assay Reagents |
| HY-W676876 | Oxynitidine | 548-31-2 | Natural Products |
| HY-W677042 | α-Androstenol | 1153-51-1 | Reference compound |
| HY-W677684 | Nurr1 agonist 2 | 742058-34-0 | Reference compound |
| HY-W678394 | DOTA-Thiol | 865470-67-3 | Biochemical Assay Reagents |
| HY-W679754 | Pentacosafluorotridecanoic Acid | 72629-94-8 | Reference compound |
| HY-W679754R | Pentacosafluorotridecanoic Acid (Standard) | 72629-94-8 | Reference Standards |
| HY-W679758 | 1H,1H,2H,2H-Perfluorodecanesulfonic acid | 39108-34-4 | Reference compound |
| HY-W679796 | PBITC | 61499-10-3 | Reference compound |
| HY-W679891 | N-Nitroso-N-methyl-4-aminobutyric acid | 61445-55-4 | Reference compound |
| HY-W679892 | N-(2,3-Dichlorophenyl)urea | 13142-51-3 | Reference compound |
| HY-W679967 | trans-2-Decen-1-ol | 18409-18-2 | Biochemical Assay Reagents |
| HY-W679971 | (Z)-6-Heneicosen-11-one | 54844-65-4 | Natural Products |
| HY-W680647 | MDL 72527 (free base) | 99207-33-7 | Reference compound |
| HY-W681014 | 5-Fluoro-α-methyltryptamine (hydrochloride) | 776-56-7 | Reference compound |
| HY-W681071 | BRS-3 receptor agonist-2 | 1021937-07-4 | Reference compound |
| HY-W681659 | Flutoprazepam | 25967-29-7 | Reference compound |
| HY-W681674 | para-Methylaminorex | 959249-62-8 | Reference compound |
| HY-W681822 | (R,S,S)-Dihydrotetrabenazine | 924854-62-6 | Reference compound |
| HY-W681949 | Antibacterial agent 248 | 63788-59-0 | Reference compound |
| HY-W683479 | (Z)-Octadec-13-enoic acid | 13126-39-1 | Reference compound |
| HY-W683499 | Lauryl hydroxysultaine | 13197-76-7 | Biochemical Assay Reagents |
| HY-W683651 | Methyl 2-Hydroxydocosanoate | 13980-17-1 | Natural Products |
| HY-W683681 | 16α-Hydroxy etiocholanolone | 14167-50-1 | Reference compound |
| HY-W683760 | N-Nitrosonornicotine | 16543-55-8 | Reference compound |
| HY-W683849A | N-Benzylmethcathinone (hydrochloride) | 16735-26-5 | Reference compound |
| HY-W683864 | Menthyl isovalerate | 16409-46-4 | Reference compound |
| HY-W683872 | Talastine | 16188-61-7 | Reference compound |
| HY-W683876 | Desmethylmoramide | 1767-88-0 | Reference compound |
| HY-W683885 | Dimabefylline | 1703-48-6 | Reference compound |
| HY-W683887 | 9-Methylundecanoic acid | 17001-17-1 | Natural Products |
| HY-W683986 | Methyl 2-Hydroxyicosanoate | 16742-49-7 | Natural Products |
| HY-W684274 | 4-Methyl-1-piperazinepentanoic acid | 931930-84-6 | Reference compound |
| HY-W684904 | LY550410 | 737791-20-7 | Reference compound |
| HY-W685561 | 3-Oxo-C8-HSL | 216596-70-2 | Oligonucleotides |
| HY-W685943 | Heptaminol | 372-66-7 | Reference compound |
| HY-W686186 | Prasugrel hydroxy thiolactone | 947502-66-1 | Reference compound |
| HY-W686216 | VK-28 | 312611-92-0 | Reference compound |
| HY-W686605 | Iodoacetic anhydride | 54907-61-8 | Reference compound |
| HY-W686760A | Bromamphenicol | 17371-30-1 | Reference compound |
| HY-W686763 | Triacetylphloroglucinol | 2161-87-7 | Reference compound |
| HY-W686970 | D-Galactopyranose,2-azido-2-deoxy-,1,3,4,6-tetraacetate | 84278-00-2 | Biochemical Assay Reagents |
| HY-W687022A | Chloroethene (polymer) | 9002-86-2 | Reference compound |
| HY-W687022AR | Chloroethene (polymer) (Standard) | 9002-86-2 | Reference Standards |
| HY-W687114 | 3-Azido-3-deoxy-4-hydroxy-methyl-1,2-O-isopropylidene-α-D-ribofuranose | 247025-10-1 | Biochemical Assay Reagents |
| HY-W687132 | Magnesium formate dihydrate | 6150-82-9 | Biochemical Assay Reagents |
| HY-W687143 | 2-Acetamido-2-deoxy-β-D-glucopyranosyl azide | 29847-23-2 | Biochemical Assay Reagents |
| HY-W687162 | 6-Azido-6-deoxy-2,3-O-(1-methylethylidene)-α-L-sorbofuranose | 126210-25-1 | Biochemical Assay Reagents |
| HY-W687496 | Methyl retinoate | 339-16-2 | Reference compound |
| HY-W687950 | β-Phenyl GHB (sodium) | 40951-19-7 | Reference compound |
| HY-W688436S | 1,1-Diethoxyheptane-d10 | Isotope-Labeled Compounds | |
| HY-W688565 | (2S)-2-Amino-1-hydroxyoctadecan-3-one | 18944-28-0 | Natural Products |
| HY-W688687 | XIE62-1004-A | 2421146-32-7 | Reference compound |
| HY-W688732 | 2-Chloro-4,4,5,5-tetramethyl-1,3,2-dioxaphospholane | 14812-59-0 | Biochemical Assay Reagents |
| HY-W689801 | A-1208746 | 1668553-23-8 | Reference compound |
| HY-W691498 | Sodiumα-glucoheptonate，97% | 13007-85-7 | Biochemical Assay Reagents |
| HY-W693175 | Octyl β-D-mannopyranoside | 140147-38-2 | Biochemical Assay Reagents |
| HY-W693342 | D-Ribofuranose,2,3-O-(1-methylethylidene),1,5-diacetate | 141979-56-8 | Biochemical Assay Reagents |
| HY-W694291 | Clibucaine | 15302-10-0 | Reference compound |
| HY-W694629 | Triethylammonium bicarbonate | 15715-58-9 | Biochemical Assay Reagents |
| HY-W695196 | α-D-Glucofuranose,1,2:5,6-bis-O-(1-methylethylidene),3-acetate | 16713-80-7 | Biochemical Assay Reagents |
| HY-W697671S | Paroxetine-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W698250 | 3-Ferrocenylpropionic anhydride | 132098-76-1 | Reference compound |
| HY-W698254 | Fluopsin F | 31323-26-9 | Natural Products |
| HY-W698255 | Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III) | 39916-28-4 | Reference compound |
| HY-W698286 | Iron(II) gluconate | 699014-53-4 | Biochemical Assay Reagents |
| HY-W698343 | NG-Hydroxy-L-arginine (acetate) | 53598-01-9 | Reference compound |
| HY-W698344 | Lewis X Trisaccharide,Methyl Glycoside | 176106-81-3 | Biochemical Assay Reagents |
| HY-W698347 | 1,1-Methanediyl bismethanethiosulfonate | 22418-52-6 | Biochemical Assay Reagents |
| HY-W698353 | Fuc1-α-3GlcNAc1-β-Ome | 169151-24-0 | Biochemical Assay Reagents |
| HY-W698354 | Gal1-β-3GlcNAc1-β-Ome | 100836-88-2 | Biochemical Assay Reagents |
| HY-W698356 | Methyl 2-O-allyl-3-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside | 210297-54-4 | Biochemical Assay Reagents |
| HY-W698357 | Methyl4,6-O-(phenylmethylene)-2-O-2-propen-1-yl-α-D-mannopyranoside | 82228-09-9 | Biochemical Assay Reagents |
| HY-W698361 | Methyl 2-deoxy-2-N-phthalimido-β-D-glucopyranoside | 76101-14-9 | Biochemical Assay Reagents |
| HY-W698362 | α-D-threo-Hex-2-enopyranoside,methyl 2,3-dideoxy-4,6-diacetate | 6605-29-4 | Biochemical Assay Reagents |
| HY-W698363 | Methyl 3,6-Di-O-benzyl-2-deoxy-2-N-phthalimido-β-D-glucopyranoside | 97242-79-0 | Biochemical Assay Reagents |
| HY-W698364 | Methyl 3,4-bis-O-(phenylmethyl)-α-D-mannopyranoside | 79218-87-4 | Biochemical Assay Reagents |
| HY-W698374 | β-D-Mannopyranoside, methyl, 2,3,4,6-tetraacetate | 5019-25-0 | Biochemical Assay Reagents |
| HY-W698379 | Gal1-b-4GlcNAc-α-PNP | 184377-56-8 | Biochemical Assay Reagents |
| HY-W698382 | Nojirimycin 1-sulfonic acid | 114417-84-4 | Biochemical Assay Reagents |
| HY-W698384 | 1-Oleoyl-sn-glycerol | 129784-87-8 | Biochemical Assay Reagents |
| HY-W698390 | 3′-Sialyl-N-acetyllactosamine | 81693-22-3 | Biochemical Assay Reagents |
| HY-W698405 | Methyl 2,3-di-O-methyl-α-D-glucopyranoside | 14048-30-7 | Biochemical Assay Reagents |
| HY-W698411 | GlcNAc1-β-6GalNAc-α-PNP | 235752-73-5 | Biochemical Assay Reagents |
| HY-W698417 | N-5-Carboxypentyl-deoxymannojirimycin | 104154-10-1 | Biochemical Assay Reagents |
| HY-W698422 | 2-O-α-D-Glucopyranosyl-D-galactose | 7368-73-2 | Biochemical Assay Reagents |
| HY-W698426 | D-Galactonic acid,2-(acetylamino)-2-deoxy,γ-lactone | 28876-38-2 | Biochemical Assay Reagents |
| HY-W698427 | D-Mannonic acid,2-(acetylamino)-2-deoxy,γ-lactone | 28876-37-1 | Biochemical Assay Reagents |
| HY-W698432 | D-(+)-Cellohexose eicosaacetate | 355012-91-8 | Biochemical Assay Reagents |
| HY-W698433 | D-(+)-Cellotetraose tetradecaacetate | 83058-25-7 | Biochemical Assay Reagents |
| HY-W698459 | Benzophenone-4-carboxamidocysteine methanethiosulfonate | 317821-69-5 | Biochemical Assay Reagents |
| HY-W698462 | (S)-3-Hydroxymyristic acid | 35683-15-9 | Natural Products |
| HY-W698471 | Methyl 4,6-O-(phenylmethylene)-3-O-2-propen-1-yl-α-D-mannopyranoside | 82228-10-2 | Biochemical Assay Reagents |
| HY-W698474 | 4-Azido-2-hydroxy-N-[2-(2-pyridinyldithio)ethyl]benzamide | 164575-82-0 | Biochemical Assay Reagents |
| HY-W698494 | 2,5-Anhydro-D-glucitol | 27826-73-9 | Biochemical Assay Reagents |
| HY-W698497 | D-Galactofuranose,1,2,3,5,6-pentabenzoate | 138811-45-7 | Biochemical Assay Reagents |
| HY-W698498 | Benzyl 2-Acetamido-2-deoxy-3-O-(β-D-galactopyranosyl)-α-D-glucopyranoside | 50692-66-5 | Biochemical Assay Reagents |
| HY-W698499 | Benzyl 2-acetamido-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-2-deoxy-α-D-glucopyranoside | 60831-31-4 | Biochemical Assay Reagents |
| HY-W698501 | Benzyl 2-O-Benzyl-4,6-O-benzylidene-α-D-mannopyranoside | 40983-95-7 | Biochemical Assay Reagents |
| HY-W698504 | 3-Azido-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose | 13964-23-3 | Biochemical Assay Reagents |
| HY-W698505 | Benzyl 4,6-O-benzylidene-2,3-di-O-benzyl-β-D-galactpyranoside | 57783-80-9 | Biochemical Assay Reagents |
| HY-W698516 | Benzyl 2-acetamido-2-deoxy-6-O-(β-D-galactopyranosyl)-α-D-galactopyranoside | 93496-44-7 | Biochemical Assay Reagents |
| HY-W698521 | 8-Methoxycarbonyloctyl-2-deoxy-2-phthalimido-β-D-glucopyranoside | 106445-25-4 | Biochemical Assay Reagents |
| HY-W698535 | p-Aminophenyl β-D-lactopyranoside | 17691-02-0 | Biochemical Assay Reagents |
| HY-W698539 | n-Octyl 3,6-Di-O-(α-D-mannopyranosyl)-β-D-mannopyranoside | 140147-36-0 | Biochemical Assay Reagents |
| HY-W698542 | β-D-Galactopyranoside, phenylmethyl 3,4,6-tris-O-(phenylmethyl)-, acetate | 61820-03-9 | Biochemical Assay Reagents |
| HY-W698547 | 2-(Acetylamino)-2-deoxy-3-O-α-D-galactopyranosyl-D-galactose | 60283-31-0 | Biochemical Assay Reagents |
| HY-W698551 | 4-Acetylamino-2,6-anhydro-3,4-dideoxy-d-glycero-d-galactonon-2-enonicacid | 263155-11-9 | Biochemical Assay Reagents |
| HY-W698571 | Lactose-3'-sulfate | 159358-51-7 | Biochemical Assay Reagents |
| HY-W698574 | Dansylamidoethyl mercaptan | 5354-61-0 | Biochemical Assay Reagents |
| HY-W698586 | (R)-Lotaustralin | 534-67-8 | Reference compound |
| HY-W698610 | 4-Isothiocyanatophenyl β-D-glucopyranoside | 20581-41-3 | Biochemical Assay Reagents |
| HY-W698621 | Benzyl N-acetyl-6-O-benzyl-α-D-muramic acid methyl mster | 107671-54-5 | Biochemical Assay Reagents |
| HY-W698627 | 2-Deoxy-1,3:4,5-di-O-isopropylidene-2-oxamoylamino-D-mannitol | 128741-75-3 | Biochemical Assay Reagents |
| HY-W698637 | 1,2:4,6-Bis-O-(1-methylethylidene)-L-sorbofuranose | 62133-03-3 | Biochemical Assay Reagents |
| HY-W698639 | Methyl 4-Azido-2,3-di-O-benzoyl-4-deoxy-6-O-trityl-α-D-glucopyranoside | 26511-50-2 | Biochemical Assay Reagents |
| HY-W698657 | 3-Deoxy-D-erythro-hexos-2-ulose bis(2-benzoylhydrazone) | 32443-70-2 | Biochemical Assay Reagents |
| HY-W698686 | β-Galactosyl-C18-ceramide | 36271-49-5 | Biochemical Assay Reagents |
| HY-W698686S | β-Galactosyl-C18-ceramide-d35 | 145176-92-7 | Isotope-Labeled Compounds |
| HY-W698709 | 3-O-(Phenylmethyl)-D-mannose | 65926-00-3 | Biochemical Assay Reagents |
| HY-W698711 | α-L-xylo-Hexopyranose,4,6-dideoxy,tribenzoate | 132867-80-2 | Biochemical Assay Reagents |
| HY-W698718 | N-Acetyl-2-O-methyl-β-neuraminic acid | 23755-35-3 | Biochemical Assay Reagents |
| HY-W698721 | N-Acetylmuramic acid methyl ester | 99689-20-0 | Biochemical Assay Reagents |
| HY-W698731 | 2-(Acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-D-galactose | 420118-03-2 | Biochemical Assay Reagents |
| HY-W698763 | β-D-Glucopyranosiduronic acid, 4-(acetylamino)phenyl, methyl ester | 570394-17-1 | Biochemical Assay Reagents |
| HY-W698765 | Methyl p-nitrophenyl 2,3,4-tri-O-acetyl-β-D-glucouronate | 18472-49-6 | Biochemical Assay Reagents |
| HY-W698776 | 6-N-Biotinylaminohexanol | 106451-92-7 | Biochemical Assay Reagents |
| HY-W698782 | 4′-O-(β-D-2″,3″,4″,6″-Tetraacetyl-glucopyranosyl)-4-nitrophloretin | 82628-87-3 | Biochemical Assay Reagents |
| HY-W698802 | N-[(ε-Benzyloxycarbonylamino)caproyl]-β-L-fucopyranosylamine | 35978-96-2 | Biochemical Assay Reagents |
| HY-W698822 | D-Ribopyranosylamine | 43179-09-5 | Biochemical Assay Reagents |
| HY-W698823 | Laminaribiose octaacetate | 51157-42-7 | Biochemical Assay Reagents |
| HY-W698846 | 2-(N-Hexadecanoylamino)-4-nitrophenylphosphocholine hydroxide | 60438-73-5 | Biochemical Assay Reagents |
| HY-W698856 | Methyl 4,6-O-(1-methylethylidene)-α-D-mannopyranoside | 63167-67-9 | Biochemical Assay Reagents |
| HY-W698871 | (±) Anabasine-d4 | 1020719-08-7 | Isotope-Labeled Compounds |
| HY-W698874 | 2-Acetamido-4,6-O-benzylidene-2-deoxy-D-gluconohydroximo-1,5-lactone | 132063-03-7 | Biochemical Assay Reagents |
| HY-W698876 | Methyl 2,4-bis-O-(phenylmethyl)-α-D-mannopyranoside | 67381-29-7 | Biochemical Assay Reagents |
| HY-W698881 | Methyl N-acetyl-2-O-methyl-β-neuraminate | 6730-43-4 | Biochemical Assay Reagents |
| HY-W698901 | β-D-Glucopyranoside,octyl 2-(acetylamino)-2-deoxy,3,4,6-triacetate | 173725-22-9 | Biochemical Assay Reagents |
| HY-W698908 | GalNAc1-b-3Gal-α-Ome | 109303-71-1 | Biochemical Assay Reagents |
| HY-W698923 | α-D-Glucopyranoside, 2-chloro-4-nitrophenyl, 2,3,4,6-tetraacetate | 153823-58-6 | Biochemical Assay Reagents |
| HY-W698946 | N-Succinimidyloxycarbonylheptyl methanethiosulfonate | 887407-50-3 | Biochemical Assay Reagents |
| HY-W698947 | N-Succinimidyloxycarbonylpentyl methanethiosulfonate | 76078-81-4 | Biochemical Assay Reagents |
| HY-W698948 | N-Succinimidyloxycarbonylpentadecyl methanethiosulfonate | 887407-52-5 | Biochemical Assay Reagents |
| HY-W698952S | 3β hydroxy Tibolone-d5 | Isotope-Labeled Compounds | |
| HY-W698964 | 2′-Hydroxy-5′-nitrohexadecanamide | 60301-87-3 | Biochemical Assay Reagents |
| HY-W698970 | Ethyl 4,6-(4-methoxybenzylidene)-β-D-thiogalactopyranoside | 311797-19-0 | Biochemical Assay Reagents |
| HY-W698980 | 4-O-Acetyl-2,5-anhydro-1,3-O-isopropylidene-D-glucitol | 70128-28-8 | Biochemical Assay Reagents |
| HY-W698981 | 4-O-Acetyl-2,5-anhydro-1,3-O-isopropylidene-6-trityl-D-glucitol | 65729-83-1 | Biochemical Assay Reagents |
| HY-W699010 | 2-(Dimethylamino)ethyl dodecanoate | 34839-10-6 | Reference compound |
| HY-W699023 | p-Nitrophenyl 2-acetamido-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-α-D-galactopyranoside | 59837-13-7 | Biochemical Assay Reagents |
| HY-W699037 | 2-(Acetylamino)-2-deoxy-4-O-β-D-mannopyranosyl-D-glucose | 55637-63-3 | Biochemical Assay Reagents |
| HY-W699040 | 1,2-Isopropylidene-3-oleoyl-sn-glycerol | 33001-45-5 | Biochemical Assay Reagents |
| HY-W699042 | 4-n-Octylbenzoylamido-propyl-dimethylammoniosulfobetaine | 216667-49-1 | Biochemical Assay Reagents |
| HY-W699077 | 3,4-Di-O-acetyl-1,6-anhydro-2-O-p-toluenesulfonyl-β-D-glucopyranose | 84207-46-5 | Biochemical Assay Reagents |
| HY-W699102 | Methyl fucopyranoside | 65310-00-1 | Biochemical Assay Reagents |
| HY-W699103 | 4-Nitrobenzyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopryranoside | 35785-42-3 | Biochemical Assay Reagents |
| HY-W699112 | α-D-Mannopyranose,1,2,3,6-tetrabenzoate | 56994-11-7 | Biochemical Assay Reagents |
| HY-W699141 | Methyl 2,3-O-(1-methylethylidene)-5-O-(phenylmethyl)-β-D-ribofuranoside | 33019-63-5 | Biochemical Assay Reagents |
| HY-W699163 | 1-Lauroyl-3-chloropropanediol | 20542-96-5 | Natural Products |
| HY-W699164 | Gal1-β-4GlcNAc-β-Bn | 53167-38-7 | Biochemical Assay Reagents |
| HY-W699174 | 2'-Nitrophenyl 2,3-di-O-acetyl-4-O-triethylsilyl-β-D-xylopyranoside | 162088-90-6 | Biochemical Assay Reagents |
| HY-W699180 | Fuc1-α-2Gal1-β-3GlcNAc-β-PNP | 93496-53-8 | Biochemical Assay Reagents |
| HY-W699186 | Benzyl 2,3-Di-O-benzyl-β-D-galactopyranoside | 74801-06-2 | Biochemical Assay Reagents |
| HY-W699194 | (R)-3-Benzyloxy myristic acid | 87357-67-3 | Biochemical Assay Reagents |
| HY-W699196 | (4R,4S)-Benzyl-4-deoxy-4-C-nitromethyl-β-D-arabinopyranoside | 383173-66-8 | Biochemical Assay Reagents |
| HY-W699197 | Phenylmethyl 4-deoxy-4-(nitromethyl)-β-D-arabinopyranoside | 383173-71-5 | Biochemical Assay Reagents |
| HY-W699199 | Benzyl 2,3,4-Tri-O-acetyl-4-nitromethyl-β-D-arabinopyranoside | 383173-65-7 | Biochemical Assay Reagents |
| HY-W699200 | Phenylmethyl 4-C-(nitromethyl)-β-D-arabinopyranoside | 383173-64-6 | Biochemical Assay Reagents |
| HY-W699225 | 1-Hydroxypyrene β-D-glucuronide | 154717-05-2 | Biochemical Assay Reagents |
| HY-W699238 | S-(-)-Aminoglutethimide (D-tartrate) | 57288-04-7 | Biochemical Assay Reagents |
| HY-W699259 | Phenylmethyl 2-(acetylamino)-2,4-dideoxy-4-fluoro-α-D-glucopyranoside | 290819-73-7 | Biochemical Assay Reagents |
| HY-W699260 | Benzyl 2-acetamido-3,6-di-O-benzoyl-2,4-dideoxy-4-fluoro-α-D-glucopyranose | 290819-68-0 | Biochemical Assay Reagents |
| HY-W699261 | Benzyl 2-acetamido-3,6-di-O-benzoyl-2-deoxy-α-D-galactopyranoside | 141019-70-7 | Biochemical Assay Reagents |
| HY-W699276 | p-Nitrophenyl 2-acetamido-2-deoxy-3,6-di-O-acetyl-β-D-glucopyranoside | 61891-87-0 | Biochemical Assay Reagents |
| HY-W699287 | 2,5-Dioxo-1-pyrrolidinyl 4-azido-2-hydroxybenzoate | 96602-46-9 | Biochemical Assay Reagents |
| HY-W699293 | Benzyl 2-acetamido-2-deoxy-4,6-O-benzylidene-α-D-galactopyranoside | 3554-91-4 | Biochemical Assay Reagents |
| HY-W699294 | Benzyl 2-acetamido-2-deoxy-3-O-(2',3',4',6'-tetra- O-acetyl-β-D-galactopyranosyl)-α-D-galactopyranoside | 90754-57-7 | Biochemical Assay Reagents |
| HY-W699317 | 5-(2-Aminoethyl)dithio-2-nitrobenzoic acid | 71899-86-0 | Biochemical Assay Reagents |
| HY-W699318 | 1-Oleoyl-2-palmitoylglycerol | 3331-34-8 | Reference compound |
| HY-W699344 | 4-Nitrophenyl 2-O-α-D-glucopyranosyl-α-D-glucopyranoside | 147103-31-9 | Biochemical Assay Reagents |
| HY-W699369 | 1-Palmitoyl-3-O-benzyl-rac-glycerol | 1487-51-0 | Biochemical Assay Reagents |
| HY-W699398 | Eicosyltriethylammonium bromide | 75222-49-0 | Biochemical Assay Reagents |
| HY-W699426 | D-Galactopyranose,4-deoxy-4-fluoro,tetraacetate | 183506-73-2 | Biochemical Assay Reagents |
| HY-W699430 | Norverapamil-d6 (hydrochloride) | 1329651-21-9 | Isotope-Labeled Compounds |
| HY-W699477 | Anthrose | 769959-88-8 | Biochemical Assay Reagents |
| HY-W699493 | Methyl 3-deoxy-D-arabino-heptulopyranoside-7-phosphate | 91382-81-9 | Biochemical Assay Reagents |
| HY-W699494 | Methyl (methyl 3-deoxy-D-arabino-heptulopyranosid)onate-7-phosphate | 91382-80-8 | Biochemical Assay Reagents |
| HY-W699497 | α-D-Galactopyranoside,phenylmethyl (2-acetylamino)-2-deoxy,3,4-diacetate | 55652-76-1 | Biochemical Assay Reagents |
| HY-W699500 | N-Maleimidomethanol | 5063-96-7 | Biochemical Assay Reagents |
| HY-W699503 | N-Boc-1,5-imino-D-glucitol | 122371-65-7 | Biochemical Assay Reagents |
| HY-W699511 | Benzyl 2,3-O-Isopropylidene-6-O-trityl-5-keto-α-D-mannofuranose | 91364-12-4 | Biochemical Assay Reagents |
| HY-W699533 | 4-Hydroxy valsartan | 188259-69-0 | Reference compound |
| HY-W699540 | 3-Hydroxykynurenine-O-β-glucoside | 23224-46-6 | Biochemical Assay Reagents |
| HY-W699602 | Phenyl 6-deoxy-2-O-(phenylmethyl)-1-thio-α-L-mannopyranoside | 849938-16-5 | Biochemical Assay Reagents |
| HY-W699613 | α-D-Galactopyranoside, β-D-fructofuranosyl, 6-acetate | 936001-72-8 | Biochemical Assay Reagents |
| HY-W699702 | D-Glucuronic acid,methyl ester,2,3,4-tribenzoate | 50767-71-0 | Biochemical Assay Reagents |
| HY-W699750 | 6-α-D-Glucopyranosyl maltotriose | 35175-16-7 | Biochemical Assay Reagents |
| HY-W699751 | 6-α-D-Glucopyranosylmaltotriose tetradecaacetate | 852311-55-8 | Biochemical Assay Reagents |
| HY-W699766 | Benzyl 2-deoxy-2-phthalimido-3,6-di-O-benzyl-β-D-glucopyranoside | 80035-36-5 | Biochemical Assay Reagents |
| HY-W699792 | R-(3)-Benzyloxymyristic acid methyl ester | 114264-01-6 | Biochemical Assay Reagents |
| HY-W699795 | N-Benzyl-2,3,4,6-tetra-O-benzyl-1,5-dideoxy-imino-L-iditol | 151963-95-0 | Biochemical Assay Reagents |
| HY-W699843 | Benzyl dibenzylidene-α-D-mannopyranoside | 58650-53-6 | Biochemical Assay Reagents |
| HY-W699888 | α-Neuraminic acid,N-acetyl-2-O-(4-nitrophenyl) (sodium) | 123549-14-4 | Biochemical Assay Reagents |
| HY-W699926 | (R)-Naproxen acyl-β-D-glucuronide | 112828-15-6 | Biochemical Assay Reagents |
| HY-W699936 | 6β-Hydroxy androstenedione | 63-00-3 | Natural Products |
| HY-W699942 | 3-(2-Hydroxy-2-(methyl-d3)propyl-3,3,3-d3) 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 1189945-12-7 | Isotope-Labeled Compounds |
| HY-W699949 | 1,2,3,6-Tetra-O-pivaloyl-α-D-galactofuranoside | 220017-49-2 | Biochemical Assay Reagents |
| HY-W699956 | Methyl 2,3,4-Tri-O-benzyl-D-galactopyranoside | 641635-63-4 | Biochemical Assay Reagents |
| HY-W699983 | Imidazole-15N2 | 74362-46-2 | Isotope-Labeled Compounds |
| HY-W699990 | 4-(1,2-Dihydroxyethyl)benzene-1,2-diol-d5 | 1794783-36-0 | Isotope-Labeled Compounds |
| HY-W700019 | α-D-Glucopyranoside,methyl 6-O-(phenylmethyl),2,3-diacetate | 162284-50-6 | Biochemical Assay Reagents |
| HY-W700029 | 7-Methyl-1-(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione | 188297-90-7 | Isotope-Labeled Compounds |
| HY-W700069 | Gatifloxacin-d4 | 1190043-25-4 | Isotope-Labeled Compounds |
| HY-W700094 | 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Ethylxanthate | 13639-54-8 | Biochemical Assay Reagents |
| HY-W700150 | β-D-Mannopyranoside,octyl,2,3,4,6-tetraacetate | 128299-96-7 | Biochemical Assay Reagents |
| HY-W700155 | β-D-Glucopyranoside,2-naphthalenyl,2,3,4,6-tetraacetate | 14581-89-6 | Biochemical Assay Reagents |
| HY-W700159 | Ethyl 1-thio-D-glucopyranosiduronic acid | 755710-39-5 | Biochemical Assay Reagents |
| HY-W700165 | 4,5-Desisopropylidene topiramate | 106881-41-8 | Reference compound |
| HY-W700174 | 3-(4-Chlorophenyl)-4-hydroxybutyric acid (sodium) | 1346603-21-1 | Reference compound |
| HY-W700190 | 2,4,7,8,9-Pentaacetyl-D-N-acetylglycolylneuraminic acid methyl ester | 118865-38-6 | Biochemical Assay Reagents |
| HY-W700195 | Phenylmethyl 3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-α-D-mannopyranoside | 62774-16-7 | Biochemical Assay Reagents |
| HY-W700218 | 4-Hydroxy propofol 4-O-β-D-Glucuronide | 115005-78-2 | Biochemical Assay Reagents |
| HY-W700240 | Triazolomethylindole-3-acetic acid | 177270-91-6 | Reference compound |
| HY-W700241 | Norharman-d7 | 1216503-21-7 | Isotope-Labeled Compounds |
| HY-W700289 | Mycophenolic acid phenolic β-D-glucoside | 55533-52-3 | Biochemical Assay Reagents |
| HY-W700319 | (Rac)-5-Carboxy tolterodine | 1076199-77-3 | Reference compound |
| HY-W700344 | o-Desmethyl ranolazine | 172430-45-4 | Reference compound |
| HY-W700345 | Desmethyl ranolazine β-D-glucuronide | 172300-93-5 | Biochemical Assay Reagents |
| HY-W700346 | D,L-Mevalonic acid (dicyclohexylammonium) | 1215802-31-5 | Biochemical Assay Reagents |
| HY-W700350 | Sucrose 4,6-methyl orthoester | 116015-72-6 | Biochemical Assay Reagents |
| HY-W700392 | IMPDH-IN-2 | 31858-65-8 | Reference compound |
| HY-W700422 | 1,2-O-Ethylidene-β-D-mannopyranoside triacetate | 630102-81-7 | Biochemical Assay Reagents |
| HY-W700423 | Allyl 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranoside | 28738-44-5 | Biochemical Assay Reagents |
| HY-W700429 | Methyl 3-acetylamino-2,3-dideoxy-4,6-O-benzylidene-α-D-ribo-hexopyranoside | 23819-31-0 | Biochemical Assay Reagents |
| HY-W700431 | Methyl 3-acetamido-4,6-O-benzylidene-2,3-dideoxy-α-D-arabino-hexopyranoside | 4115-63-3 | Biochemical Assay Reagents |
| HY-W700437 | threo-9,10-Dihydroxystearic acid | 2391-05-1 | Biochemical Assay Reagents |
| HY-W700448 | Muraglitazar glucuronide | 875430-26-5 | Reference compound |
| HY-W700451 | 4'-Hydroxy atomoxetine β-D-glucuronide | 540729-08-6 | Biochemical Assay Reagents |
| HY-W700460 | 9-β-D-Arabinofuranosyl-2-fluorohypoxanthine | 83480-48-2 | Biochemical Assay Reagents |
| HY-W700465 | Etodolac acyl glucuronide | 79541-43-8 | Reference compound |
| HY-W700484 | 4-Acetylphenyl 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranoside | 25876-45-3 | Biochemical Assay Reagents |
| HY-W700491 | AalphaC-15N3 | 1189920-50-0 | Reference compound |
| HY-W700524 | Methyl 6-deoxy-2-O-methyl-3-O-benzyl-α-D-galactopyranoside | 110594-91-7 | Biochemical Assay Reagents |
| HY-W700527 | α-D-Galactopyranoside,methyl 6-O-(triphenylmethyl)-,triacetate | 38982-56-8 | Biochemical Assay Reagents |
| HY-W700539S | N1-Acetyl triethylenetetramine-d4 | 2732980-39-9 | Isotope-Labeled Compounds |
| HY-W700549 | DMT-dT | 112501-53-8 | Oligonucleotides |
| HY-W700578 | 4-Nitrophenyl 4,6-O-(1-methylethylidene)-α-D-galactopyranoside | 29781-31-5 | Biochemical Assay Reagents |
| HY-W700579 | Allyl 2-(acetylamino)-2-deoxy-3,6-bis-O-benzyl-β-D-glucopyranoside | 65730-02-1 | Biochemical Assay Reagents |
| HY-W700582 | 2-Propen-1-yl 2-(acetylamino)-2-deoxy-3-O-(phenylmethyl)-β-D-glucopyranoside | 65730-00-9 | Biochemical Assay Reagents |
| HY-W700583 | Allyl 2-(acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-α-D-glucopyranoside | 63064-49-3 | Biochemical Assay Reagents |
| HY-W700620 | Hydroxymethyl dasatinib | 910297-58-4 | Reference compound |
| HY-W700621 | TCEP-d12 (hydrochloride) | 1189959-10-1 | Isotope-Labeled Compounds |
| HY-W700638A | Benafentrine (maleate) | 76166-55-7 | Reference compound |
| HY-W700639 | Tolafentrine | 139308-65-9 | Reference compound |
| HY-W700643 | Di-N-desethyl amiodarone (hydrochloride) | 757220-04-5 | Reference compound |
| HY-W700649 | 9-(β-D-Galactopyranosyloxy)nonanoic acid | 83345-63-5 | Biochemical Assay Reagents |
| HY-W700665 | 5-Hydroxy indomethacin | 2504-32-7 | Reference compound |
| HY-W700684 | N-Didesmethyl Loperamide | 66164-06-5 | Reference compound |
| HY-W700710 | (Rac)-7-Methoxy propranolol | 76275-53-1 | Reference compound |
| HY-W700741 | 2-(2-Aminoethyl)-3-(4-chlorophenyl)-3-hydroxyisoindol-1-one (hydrochloride) | 13473-53-5 | Reference compound |
| HY-W700742 | 1,1-Dimethyl-1-propanol-d6 | 75295-95-3 | Isotope-Labeled Compounds |
| HY-W700770 | DTAC-d3 | 1219337-20-8 | Isotope-Labeled Compounds |
| HY-W700793 | 2-Methyl-3-(trifluoromethyl)aniline-d3 | 1189989-60-3 | Isotope-Labeled Compounds |
| HY-W700800 | Flu-6 | 39235-51-3 | Reference compound |
| HY-W700821 | Pramipexole impurity 38-d3 | 1217680-69-7 | Isotope-Labeled Compounds |
| HY-W700834 | Harman-d3 | 1216708-84-7 | Isotope-Labeled Compounds |
| HY-W700861 | N-Acetyl-2-O-methyl-α-neuraminic acid methyl ester 4,7,8,9-tetraacetate | 73208-80-7 | Biochemical Assay Reagents |
| HY-W700866S | 4-Hydroxyclonidine-d4 (acetate) | Isotope-Labeled Compounds | |
| HY-W700927 | N-Formyl-L-leucine-d3 | 1356930-28-3 | Isotope-Labeled Compounds |
| HY-W700970 | Methyl 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylate | 38934-69-9 | Biochemical Assay Reagents |
| HY-W700975 | 12-Ketostearic acid (sodium) | 73536-57-9 | Reference compound |
| HY-W700995 | Methyl α-L-Idopyranosiduronic Acid Sodium Salt | 134355-31-0 | Biochemical Assay Reagents |
| HY-W701008 | Pentaerythritol dibromide-d8 | 1216413-92-1 | Isotope-Labeled Compounds |
| HY-W701013 | Propofol beta-D-glucuronide-d17 | 2734920-06-8 | Isotope-Labeled Compounds |
| HY-W701069 | Isomyosmine | 53844-46-5 | Natural Products |
| HY-W701205 | 4-Epitetracycline-d6 | Isotope-Labeled Compounds | |
| HY-W701220 | 4,5-O-(1-Methylethylidene)-β-D-fructopyranose | 912456-61-2 | Biochemical Assay Reagents |
| HY-W701232 | epi-Sancycline (hydrochloride) | 906364-48-5 | Biochemical Assay Reagents |
| HY-W701251 | Ethylparaben-d5 | 126070-21-1 | Isotope-Labeled Compounds |
| HY-W701323 | Itopride N-Oxide | 141996-98-7 | Reference compound |
| HY-W701359 | 2-(Tetraacetylglucosido)glycerol | 157024-67-4 | Biochemical Assay Reagents |
| HY-W701360 | β-D-Galactopyranoside,2-phenyl-1,3-dioxan-5-yl,2,3,4,6-tetraacetate | 213264-93-8 | Biochemical Assay Reagents |
| HY-W701437 | 1,5-Anhydro-D-mannitol peracetate | 13121-61-4 | Biochemical Assay Reagents |
| HY-W701464 | N-Desalkylflurazepam-d4 | 1286430-01-0 | Isotope-Labeled Compounds |
| HY-W701470 | W140 (hydrobromide) | 1246817-25-3 | Reference compound |
| HY-W701599 | Oxiran-2-ylmethyl hexadecanoate-d31 | 1246819-24-8 | Isotope-Labeled Compounds |
| HY-W701635 | Meclizine N-oxide | 114624-69-0 | Reference compound |
| HY-W701743 | 3,4-Dihydroxyamphetamine (hydrochloride) | 828-06-8 | Reference compound |
| HY-W701762 | D-Maltotriose peracetate | 93911-20-7 | Biochemical Assay Reagents |
| HY-W701771 | D-Mannitol,2,5-anhydro,1,3,4,6-tetraacetate | 65729-88-6 | Biochemical Assay Reagents |
| HY-W701787 | Phenyl-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside | 2872-72-2 | Biochemical Assay Reagents |
| HY-W701834S | 4-Hydroxymethylambrisentan-d5 | 2012598-50-2 | Isotope-Labeled Compounds |
| HY-W701835 | (E,E)-10,12-Hexadecadienal | 69977-24-8 | Natural Products |
| HY-W701842 | 3-Chloro-2-hydroxypropyl-1,1,2,3,3-d5 oleate | 2489623-84-7 | Isotope-Labeled Compounds |
| HY-W701858 | 1-Oleoyl-2-stearoyl-3-chloropropanediol | 1336935-05-7 | Natural Products |
| HY-W701859 | 3-Chloro-2-(stearoyloxy)propyl-1,1,2,3,3-d5 oleate | 2489621-82-9 | Isotope-Labeled Compounds |
| HY-W701862 | 5-Azido-6-(tert-butyldimethylsilyl)-2,3-O-isopropylidene L-gulono-1,4-lactone | 118464-49-6 | Biochemical Assay Reagents |
| HY-W701864 | 2-Mercaptoethyl 2-(acetylamino)-2-deoxy-β-D-galactopyranoside | 95074-13-8 | Biochemical Assay Reagents |
| HY-W701877 | Latanoprost tris(triethylsilyl) ether | 477884-78-9 | Reference compound |
| HY-W701918 | Vonedrine-d3 (hydrochloride) | 1246820-88-1 | Isotope-Labeled Compounds |
| HY-W701936 | 2-O-Desmethyl cisapride | 102671-04-5 | Reference compound |
| HY-W701954 | Ribofuranose,2-deoxy,3,5-dibenzoate | 112137-63-0 | Biochemical Assay Reagents |
| HY-W701984 | 11β-Hydroxyetiocholanolone | 739-26-4 | Reference compound |
| HY-W701990 | Propylcathinone (hydrochloride) | 879667-46-6 | Reference compound |
| HY-W702027 | Deterenol (hydrochloride) | 23239-36-3 | Reference compound |
| HY-W702068 | 7-Hydroxygranisetron (hydrochloride) | 133841-04-0 | Reference compound |
| HY-W702106 | 2-Methyl estradiol | 1818-12-8 | Natural Products |
| HY-W702174 | Glycidyl myristate | 7460-80-2 | Natural Products |
| HY-W702290 | 2-Methyldecanenitrile | 69300-15-8 | Reference compound |
| HY-W702292 | (R)-(+)-Verapamil-d6 (hydrochloride) | 1795786-09-2 | Isotope-Labeled Compounds |
| HY-W702637 | 3-(Trimethylsilyl)propanoic acid-d4 (sodium) | 24493-21-8 | Isotope-Labeled Compounds |
| HY-W702646 | Hydroxymethyl tolperisone (hydrochloride) | 352233-14-8 | Reference compound |
| HY-W702712 | 3-Hydroxy xylazine | 145356-33-8 | Reference compound |
| HY-W702728 | rac 1-Palmitoyl-2-chloropropanediol | 63326-63-6 | Reference compound |
| HY-W702781 | 1,3-Distearin | 504-40-5 | Reference compound |
| HY-W702826 | 1-Nitrosopyrrolidine-d4 | 57371-40-1 | Isotope-Labeled Compounds |
| HY-W702834 | Tetratriacontanol | 28484-70-0 | Natural Products |
| HY-W702986 | Hydroxy darunavir | 1130635-75-4 | Reference compound |
| HY-W703016 | Benzyl N-acetyl-4,6-O-benzylidene-α-isomuramic acid | 730911-70-3 | Biochemical Assay Reagents |
| HY-W703019 | 7-Epi lincomycin (hydrochloride) | 26389-84-4 | Biochemical Assay Reagents |
| HY-W703021 | Diethyl chloromaleate | 626-10-8 | Biochemical Assay Reagents |
| HY-W703201 | N-Acetyl glyphosate-d3 | 1346604-36-1 | Isotope-Labeled Compounds |
| HY-W703279 | (R)-(+)-Pantoprazole (sodium) | 160098-11-3 | Reference compound |
| HY-W703398 | Monopropyl phthalate | 4376-19-6 | Reference compound |
| HY-W703425 | 17α-Ethynyl-19-nor-Δ-5(6)-androsten-17β-ol-3-one | 22933-71-7 | Reference compound |
| HY-W703429S | 2,3,6,7-Tetrachloro-naphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-W703502 | 12-(Methyl-d3)tridecanal-12,13,13,13-d4 | 1794760-14-7 | Isotope-Labeled Compounds |
| HY-W703540 | Deracoxib-d4 | 1794780-24-7 | Isotope-Labeled Compounds |
| HY-W703549 | Aderbasib-d3 | Isotope-Labeled Compounds | |
| HY-W703810 | N'-(4-Aminophenyl)-N,N-dimethylacetimidamide-d6 | 1795133-90-2 | Isotope-Labeled Compounds |
| HY-W703826 | Benzyl 2-acetamido-2,6-dideoxy-3-O-β-D-galactopyranosyl α-D-galactopyranoside | 141020-28-2 | Biochemical Assay Reagents |
| HY-W703869 | 5-Hydroxy NMT (oxalate) | 1975-81-1 | Reference compound |
| HY-W704076 | Glyceryl monostearate-d5 | 1432065-28-5 | Isotope-Labeled Compounds |
| HY-W704079 | 1-Stearoyl-sn-glycerol | 22610-61-3 | Reference compound |
| HY-W704091 | α-Amino-β-methylaminopropionic acid-d3 (hydrochloride) | 1794713-10-2 | Isotope-Labeled Compounds |
| HY-W704138 | 2-Hydroxy-atrazine | 2163-68-0 | Reference compound |
| HY-W704138R | 2-Hydroxy-atrazine (Standard) | 2163-68-0 | Reference Standards |
| HY-W704321 | Diploicin | 527-93-5 | Reference compound |
| HY-W704574 | Mergetpa | 77102-28-4 | Reference compound |
| HY-W704596 | Methyl 3-hydroxyheptadecanoate | 112538-92-8 | Natural Products |
| HY-W704597 | 1-(Palmitoyloxy)-3-(stearoyloxy)propan-2-yl oleate | 2190-27-4 | Reference compound |
| HY-W704598 | Methyl 3-hydroxydodecanoate | 72864-23-4 | Natural Products |
| HY-W704600 | 1,3-Distearoyl-2-oleoyl glycerol | 2846-04-0 | Reference compound |
| HY-W704603 | 3-(Stearoyloxy)propane-1,2-diyl dioleate | 2410-28-8 | Reference compound |
| HY-W704657 | Monobutyl phosphate-d9 | 156213-20-6 | Isotope-Labeled Compounds |
| HY-W704676 | Tetradecyl palmitate | 4536-26-9 | Natural Products |
| HY-W704677 | Palmityl stearate | 1190-63-2 | Natural Products |
| HY-W704749 | 7-Hydroxychlorpromazine (hydrochloride) | 51938-11-5 | Reference compound |
| HY-W704772 | S-Methyl-D-penicillamine | 29913-84-6 | Reference compound |
| HY-W704813 | 2,3,4-Tris-O-(trimethylsilyl) 7-epi clindamycin | 25399-48-8 | Biochemical Assay Reagents |
| HY-W704850 | 4-Methyl PCP (hydrochloride) | 1934-42-5 | Reference compound |
| HY-W704866 | Glycidyl caprylate-d15 | 2514835-46-0 | Isotope-Labeled Compounds |
| HY-W704867 | Oxiran-2-ylmethyl hexanoate | 17526-74-8 | Natural Products |
| HY-W704916 | 3-Methylbuphedrone (hydrochloride) | 1797911-07-9 | Reference compound |
| HY-W704938 | Amlodipine metabolite | 113994-45-9 | Reference compound |
| HY-W704961 | BSTFA-TMCS | 152571-61-4 | Reference compound |
| HY-W704966 | 2-Stearoyl-sn-glycero-3-phosphocholine | 4421-58-3 | Biochemical Assay Reagents |
| HY-W704968 | 2-Oxo-zoniporide (hydrochloride) | 372078-42-7 | Reference compound |
| HY-W704973 | F-ara-EdU | 95740-26-4 | Reference compound |
| HY-W705067 | Phenylpiperazine-d4 | 2089332-74-9 | Isotope-Labeled Compounds |
| HY-W705106 | (-)-Coclaurine (hydrochloride) | 3422-42-2 | Natural Products |
| HY-W705140A | Monohydroxy melphalan (hydrochloride) | 2707535-88-2 | Reference compound |
| HY-W705252 | D-Talonic acid,γ-lactone | 23666-11-7 | Biochemical Assay Reagents |
| HY-W705331 | Spaglumic acid-d3 | Isotope-Labeled Compounds | |
| HY-W705354 | Vismodegib-d4 | 1450990-33-6 | Isotope-Labeled Compounds |
| HY-W705371 | α-Hydroxy etizolam | 64546-10-7 | Reference compound |
| HY-W705390 | Disuccinimidyl suberate Crosslinker-d4 | 2242802-42-0 | Isotope-Labeled Compounds |
| HY-W705415A | N-Methylcoclaurine | 3423-07-2 | Reference compound |
| HY-W705479 | Pazopanib-d3 (hydrochloride) | 2469755-67-5 | Isotope-Labeled Compounds |
| HY-W705485 | N-Methylmethan-d3-amine (hydrochloride) | 120033-84-3 | Isotope-Labeled Compounds |
| HY-W705503 | 3-Carbamoyl-1-methylpyridin-1-ium-d3 (iodide) | 1998140-72-9 | Isotope-Labeled Compounds |
| HY-W705589 | Rimeporide-15N3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W705651 | Econazole nitrate-d6 | 2469273-41-2 | Isotope-Labeled Compounds |
| HY-W705777 | 2-Chloropropane-1,3-diyl dioleate | 1639207-42-3 | Natural Products |
| HY-W705791 | Metconazole-d6 | 2469554-74-1 | Isotope-Labeled Compounds |
| HY-W705884 | Dipalmitoylphosphatidylethanolamine | 5681-36-7 | Biochemical Assay Reagents |
| HY-W706112 | Chloramphenicol-d5-2 | Isotope-Labeled Compounds | |
| HY-W706161 | Kresoxim-methyl-d7 | Isotope-Labeled Compounds | |
| HY-W706180 | (±)-Triadimefon-d4 | Isotope-Labeled Compounds | |
| HY-W706234 | Nonanoyl-CoA-d17 | Isotope-Labeled Compounds | |
| HY-W706302 | D-Glucose,2-(acetylamino)-2-deoxy,3-acetate | 51449-93-5 | Biochemical Assay Reagents |
| HY-W706303 | 2-(Acetylamino)-2-deoxy-6-O-β-D-galactopyranosyl-D-galactopyranose | 209977-51-5 | Biochemical Assay Reagents |
| HY-W706304 | Gal1-β-4GlcNAc1-β-6Gal | 20331-45-7 | Biochemical Assay Reagents |
| HY-W706305 | 3-O-[2-Acetamido-2-deoxy-β-D-glucopyranosyl]-D-mannopyranose | 210036-24-1 | Biochemical Assay Reagents |
| HY-W706312 | D-Mannose,3-amino-3-deoxy (hydrochloride) | 69880-85-9 | Biochemical Assay Reagents |
| HY-W706319 | 2-Amino-3-methyl-3H-imidazo[4,5-f]quinoline-d3 | 82050-10-0 | Isotope-Labeled Compounds |
| HY-W706329 | 2,5-Anhydro-2,5-imino-D-glucitol | 132295-44-4 | Biochemical Assay Reagents |
| HY-W706346 | Benzyl N,N′-diacetyl-β-chitobioside | 19272-52-7 | Biochemical Assay Reagents |
| HY-W706350 | Bromo 2-deoxy-2-N-phthalimido-3,4,6-tri-O-acetyl-α,β-D-glucopyranoside | 70831-94-6 | Biochemical Assay Reagents |
| HY-W706358 | D-Glucopyranose,2,3,4-tris-O-(phenylmethyl),1,6-diacetate | 59433-13-5 | Biochemical Assay Reagents |
| HY-W706361 | α-D-Glucopyranose,2,4-bis-O-(phenylmethyl),triacetate | 79414-66-7 | Biochemical Assay Reagents |
| HY-W706371 | N-Ethyldeoxynojirimycin (hydrochloride) | 210241-65-9 | Biochemical Assay Reagents |
| HY-W706466 | 3',5,5'-Trichlorosalicylanilide | 106480-60-8 | Reference compound |
| HY-W706470 | (-)-Bornyl ferulate | 55511-07-4 | Natural Products |
| HY-W706595 | N,α-Diethylphenethylamine (hydrochloride) | 29805-52-5 | Reference compound |
| HY-W706672 | Propane-1,2,3-triyl tritricosanoate | 86850-72-8 | Reference compound |
| HY-W706672R | Propane-1,2,3-triyl tritricosanoate (Standard) | 86850-72-8 | Reference Standards |
| HY-W706729 | myo-Inositol 1,3,5-orthoformate | 98510-20-4 | Biochemical Assay Reagents |
| HY-W706955 | 1,2-Dimyristoyl-3-chloropropanediol | 1051390-02-3 | Natural Products |
| HY-W707056 | Latanoprost acid-d4 | 1224443-47-3 | Isotope-Labeled Compounds |
| HY-W707119 | RepSox (hydrochloride) | 2319939-07-4 | Reference compound |
| HY-W707126 | 4-Methoxy PV8 (hydrochloride) | 2749302-60-9 | Reference compound |
| HY-W707158 | Norfenfluramine (hydrochloride) | 673-18-7 | Reference compound |
| HY-W707365 | Docosyl trans-ferulate | 101927-24-6 | Reference compound |
| HY-W707384 | Candesartan Cilexetil-d11 | 1261393-19-4 | Isotope-Labeled Compounds |
| HY-W707407 | Bisoprolol-d7 | 1310012-16-8 | Isotope-Labeled Compounds |
| HY-W707416S | N-(2,6-Dimethylphenyl)-N-(2-(methoxy-d3)acetyl)alanine | Isotope-Labeled Compounds | |
| HY-W707517 | Famotidine-d4 | 2707433-64-3 | Isotope-Labeled Compounds |
| HY-W707527 | (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl-d10)ethoxy)phenyl)methanone hydrochloride | Isotope-Labeled Compounds | |
| HY-W707618 | (Z)-3-Hydroxynon-6-enoic acid | 1263035-69-3 | Natural Products |
| HY-W707624 | 3-Hydroxy-4(E)-nonenoic acid | 1263035-59-1 | Natural Products |
| HY-W707819 | 2-(Methoxy-d3)-4-vinylphenol | 1335436-42-4 | Isotope-Labeled Compounds |
| HY-W707850 | N-trans-Feruloylputrescine | 91000-11-2 | Natural Products |
| HY-W707900 | Erythro-hydro bupropion-d9 (enantiomer)(hydrochloride) | Isotope-Labeled Compounds | |
| HY-W707957 | Intermedine N-oxide | 95462-14-9 | Natural Products |
| HY-W707989S | 3,4-Dimethyl-2-pentylfuran-d4 | 1335401-72-3 | Isotope-Labeled Compounds |
| HY-W708023 | 5-APDI (hydrochloride) | 152623-95-5 | Reference compound |
| HY-W708033 | 25E-NBOMe (hydrochloride) | 1539266-39-1 | Reference compound |
| HY-W708061 | Benoxaprofen glucuronide | 67472-42-8 | Biochemical Assay Reagents |
| HY-W708160S | 1,2,3-Tribromo-4-(2,4,5-tribromophenoxy)benzene-13C12 | 1401355-57-4 | Isotope-Labeled Compounds |
| HY-W708177 | 10-Methyloctadecanoic acid | 542-47-2 | Natural Products |
| HY-W708197 | Tolterodine dimer | 854306-72-2 | Reference compound |
| HY-W708286 | α-Pyrrolidinobutiothiophenone (hydrochloride) | 2518265-88-6 | Reference compound |
| HY-W708288 | Ethyl 2-(methyl-d3)butanoate | 181878-39-7 | Isotope-Labeled Compounds |
| HY-W708308 | 2-(Methyl-d3)propanal-2,3,3,3-d4 | 122684-65-5 | Isotope-Labeled Compounds |
| HY-W708309 | 2-Methoxy ketamine (hydrochloride) | 6728-62-7 | Reference compound |
| HY-W708317 | (9Z,12Z)-15-Hydroxyoctadeca-9,12-dienoic acid | 177931-23-6 | Natural Products |
| HY-W708369 | Daminozide-d4 | Isotope-Labeled Compounds | |
| HY-W708469 | Resolvin D2 methyl ester | 810668-53-2 | Reference compound |
| HY-W708953S | 3-Ethyl-5-methyl-2-vinylpyrazine-d3 | Isotope-Labeled Compounds | |
| HY-W709166 | 2-(Ethyl-d5)-3,5-dimethylpyrazine | 1082581-96-1 | Isotope-Labeled Compounds |
| HY-W709203S | 2-(N-(1-Carboxyethyl)-2-(methoxy-d3)acetamido)-3-methylbenzoic acid | Isotope-Labeled Compounds | |
| HY-W709349 | Flupirtine (hydrochloride) | 33400-45-2 | Reference compound |
| HY-W709553 | Glyceryl Triformate | 32765-69-8 | Reference compound |
| HY-W709575 | Spermidine-d6 (trihydrochloride) | Isotope-Labeled Compounds | |
| HY-W709579 | AB-CHMINACA metabolite M5A | 2207957-90-0 | Reference compound |
| HY-W709760 | 7-hydroxychlorpromazine | 2095-62-7 | Reference compound |
| HY-W709830 | α-Propylaminopentiophenone (hydrochloride) | 18268-15-0 | Reference compound |
| HY-W709856 | Dodeca-2E,4E,8Z,10Z/E-N-tetraenoic acid isobutylamide | 866602-52-0 | Natural Products |
| HY-W709961 | 5-OAHSA | 1997286-66-4 | Reference compound |
| HY-W709998 | Palmitoylethanolamide-d4-1 | 946524-34-1 | Isotope-Labeled Compounds |
| HY-W710194 | (E)-3-(2-(Methoxy-d3)phenyl)acrylaldehyde | Isotope-Labeled Compounds | |
| HY-W710314 | 3,4-Dimethoxy-1,2-dimethyl-9H-carbazole | 75139-39-8 | Reference compound |
| HY-W710380 | 3-(Oleoyloxy)propane-1,2-diyl distearate | 2190-29-6 | Reference compound |
| HY-W710384S | 1,2,3,4,5,6,7-Heptachloro naphthalene-13C10 | 219526-49-5 | Isotope-Labeled Compounds |
| HY-W710399 | 2-Hydroxy-3-(palmitoyloxy)propyl stearate | 17708-08-6 | Reference compound |
| HY-W710422 | 1-O-Octadecyl-2-O-benzyl-rac-glycerol | 86008-21-1 | Reference compound |
| HY-W710427 | Dimyristoylphosphatidylglycerol (sodium) | 67232-80-8 | Biochemical Assay Reagents |
| HY-W710440 | 1,2-Distearoyl-3-palmitoyl-rac-glycerol | 2177-99-3 | Reference compound |
| HY-W710495 | N-Acetyl-L-aspartic acid-d3-1 | 1383929-94-9 | Isotope-Labeled Compounds |
| HY-W710512 | Propane-1,2,3-triyl tritricosanoate-d5 | Isotope-Labeled Compounds | |
| HY-W710540 | Guanidine-15N3 (hydrochloride) | 121616-39-5 | Isotope-Labeled Compounds |
| HY-W710663 | Bis(2,3-dibromopropyl) phosphate-d10 | Isotope-Labeled Compounds | |
| HY-W710681S | (E)-2-(2-((6-(2-Cyanophenoxy)pyrimidin-4-yl)oxy)phenyl)-3-methoxyacrylic acid-d4 | 1885255-09-7 | Isotope-Labeled Compounds |
| HY-W710697 | Triclopyr ester | 64700-56-7 | Reference compound |
| HY-W710753 | D,L-Sulforaphane glutathione-d5 | Isotope-Labeled Compounds | |
| HY-W710914A | rel-HDMP 28 (hydrochloride) | 219915-69-2 | Reference compound |
| HY-W710928 | 2-(2-Methylenecyclopropyl)acetic acid | 1073-00-3 | Natural Products |
| HY-W710954 | Pidobenzone | 138506-45-3 | Reference compound |
| HY-W710976 | 4-Methyl-5-nonanone | 35900-26-6 | Natural Products |
| HY-W711166 | 4-(2-Acetoxyacetyl)phenyl acetate | 42528-99-4 | Reference compound |
| HY-W711852 | Benzamide-d5 | 1235489-47-0 | Isotope-Labeled Compounds |
| HY-W712314 | 4-Arm PEG-amine (MW 5000) | 169501-65-9 | Reference compound |
| HY-W712327 | D-Xylulose 5-phosphate (sodium) | 105931-44-0 | Natural Products |
| HY-W712501 | Methyl-d3 2-hydroxybenzoate | 1335435-40-9 | Isotope-Labeled Compounds |
| HY-W712534 | N-Acetyl lenalidomide | 1421593-80-7 | Reference compound |
| HY-W712567 | Adenine-15N5 (hydrochloride) | 2095709-78-5 | Isotope-Labeled Compounds |
| HY-W712650 | Triethylsilane-d1 | 1631-33-0 | Isotope-Labeled Compounds |
| HY-W712674 | HMG-CoA | 1553-55-5 | Enzyme |
| HY-W713076 | Dihydrozeatin riboside | 22663-55-4 | Reference compound |
| HY-W713076S | Dihydrozeatin riboside-d3 | 175733-31-0 | Isotope-Labeled Compounds |
| HY-W713312 | 2,6-DMA (hydrochloride) | 3904-11-8 | Reference compound |
| HY-W713313 | 3,5-DMA (hydrochloride) | 24973-29-3 | Reference compound |
| HY-W713365 | Eltrombopag-d3 | 1133710-20-9 | Isotope-Labeled Compounds |
| HY-W713414 | (Z)-Non-3-enal | 31823-43-5 | Natural Products |
| HY-W713416 | Isoleukotoxin diol | 73889-55-1 | Reference compound |
| HY-W713855 | (4-Aminobenzoyl)-D-glutamic acid | 5959-18-2 | Reference compound |
| HY-W713875 | Naphthol AS-MX phosphate disodium salt | 96189-12-7 | Biochemical Assay Reagents |
| HY-W713878 | Ac-VDVAD-pNA | 189684-53-5 | Peptides |
| HY-W713900 | MCPA-d3-1 | 2469242-78-0 | Isotope-Labeled Compounds |
| HY-W713923 | Methyl 9-maleinimido-8-methoxy-6,7-benzocumarin-3-carboxylate | 168639-87-0 | Biochemical Assay Reagents |
| HY-W713925 | Diheptanoyl Thio-PC | 89019-63-6 | Reference compound |
| HY-W713926 | 1-Pyrenedecanoic acid | 64701-47-9 | Biochemical Assay Reagents |
| HY-W714002 | Feglymycin | 209335-49-9 | Peptides |
| HY-W714006 | Cochliodinol | 11051-88-0 | Natural Products |
| HY-W714019 | Tetracycline 10-O-ß-D-galactopyranoside | 319426-63-6 | Reference compound |
| HY-W714076 | Ametoctradin | 865318-97-4 | Reference compound |
| HY-W714076R | Ametoctradin (Standard) | 865318-97-4 | Reference Standards |
| HY-W714108 | Metrazoline | 221225-04-3 | Reference compound |
| HY-W714117 | GBR-12879 (methanesulfonate) | 77862-93-2 | Reference compound |
| HY-W714121 | Germicidin A | 151271-57-7 | Natural Products |
| HY-W714137 | (6-Isothiocyanatohexyl)(methyl)sulfane | 4430-39-1 | Reference compound |
| HY-W714151 | Ganglioside ga1 | 71012-19-6 | Natural Products |
| HY-W714168S | (rac)-Metolachlor metabolite CGA 351916-d3 | Isotope-Labeled Compounds | |
| HY-W714171 | Propoxycarbazone (sodium) | 181274-15-7 | Reference compound |
| HY-W714171R | Propoxycarbazone (sodium) (Standard) | 181274-15-7 | Reference Standards |
| HY-W714177S | Desisopropylatraton-d3 | Isotope-Labeled Compounds | |
| HY-W714203S | Propachlor OA-d5 | Isotope-Labeled Compounds | |
| HY-W714205S | Desethyl terbumeton-d3 | Isotope-Labeled Compounds | |
| HY-W714225 | Sodium methylarsonate | 2163-80-6 | Reference compound |
| HY-W714228S | 2-(2-Hydroxy-N-(2-(methoxy-d3)ethyl)acetamido)-3-methylbenzoic acid | Isotope-Labeled Compounds | |
| HY-W714229 | Pyrasulfotole | 365400-11-9 | Biochemical Assay Reagents |
| HY-W714229R | Pyrasulfotole (Standard) | 365400-11-9 | Reference Standards |
| HY-W714232 | Dodecyldimethylphosphine oxide | 871-95-4 | Biochemical Assay Reagents |
| HY-W714234 | Endo-BCN CE-phosphoramidite | 1352811-59-6 | Reference compound |
| HY-W714356 | N-6-Methyl-2-deoxyadenosine-d3 | 1354782-02-7 | Isotope-Labeled Compounds |
| HY-W714366 | AB-CHMINACA metabolite M4-d4 | 2703812-37-5 | Isotope-Labeled Compounds |
| HY-W714389 | Cannabifuran | 56154-58-6 | Reference compound |
| HY-W714396 | bk-EABDI (hydrochloride) | 2726084-56-4 | Reference compound |
| HY-W714406 | Methoxmetamine (hydrochloride) | 1781829-56-8 | Reference compound |
| HY-W714505 | AH 7563 | 63886-94-2 | Reference compound |
| HY-W714509 | AH 8507 | 41805-63-4 | Reference compound |
| HY-W714524 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (sodium) | 321863-21-2 | Oligonucleotides |
| HY-W714574S | 2,2′,3,3′,4,4′,5-Heptachloro biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-W714675 | Glucoiberin | 554-88-1 | Natural Products |
| HY-W714702S | 2-((2,6-Dimethylphenyl)(2-(methoxy-d3)ethyl)amino)-2-oxoacetic acid | Isotope-Labeled Compounds | |
| HY-W714703S | Sodium 2-((2,6-dimethylphenyl)(2-(methoxy-d3)ethyl)amino)-2-oxoethane-1-sulfonate | Isotope-Labeled Compounds | |
| HY-W714705S | (S)-Metolachlor metabolite CGA 368208-d3 sodium salt | Isotope-Labeled Compounds | |
| HY-W714710 | Teopranitol | 81792-35-0 | Reference compound |
| HY-W714795 | Fluorescent brightener 71-d10 (sodium) | Isotope-Labeled Compounds | |
| HY-W714833 | 2-(2-Hydroxypropionylamino)-benzamide | 18326-27-7 | Natural Products |
| HY-W714837 | 5-Phenyllevulinic acid | 3183-15-1 | Reference compound |
| HY-W714845 | 1-(2-Trifluoromethylphenyl)piperazine (hydrochloride) | 40160-26-7 | Reference compound |
| HY-W714863 | Arohynapene B | 154445-09-7 | Natural Products |
| HY-W714951S | β-D-GlcUA-Bezafibrate-d6 | Isotope-Labeled Compounds | |
| HY-W715044 | 1-(2-Fluorophenyl)piperazine (hydrochloride) | 76835-09-1 | Reference compound |
| HY-W715084 | 2-Chloroethcathinone (hydrochloride) | 879660-23-8 | Reference compound |
| HY-W715121S | 2,3,7,8-Tetrabromo dibenzo-p-dioxin-13C12 | 125749-35-1 | Isotope-Labeled Compounds |
| HY-W715180S | 2,3-Dibromo-7,8-dichloro dibenzo-p-dioxin-13C12 | 176761-26-5 | Isotope-Labeled Compounds |
| HY-W715183 | 6α-Oxycodol N-oxide | 71539-53-2 | Reference compound |
| HY-W715184S | 8-Bromo-2,3-dichlorodibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-W715187S | 3-Bromo-2,7,8-trichloro dibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-W715198S | 4-Bromo-2,3,7,8-tetrachlorodibenzofuran-13C12 | Isotope-Labeled Compounds | |
| HY-W715199S | Pentabromo benzene-13C6 | Isotope-Labeled Compounds | |
| HY-W715311S | 2,2',3,3',4',5,5'-Heptachloro-4-biphenylol-13C12 | Isotope-Labeled Compounds | |
| HY-W715341 | RO-1-5237 | 31034-86-3 | Reference compound |
| HY-W715341R | RO-1-5237 (Standard) | 31034-86-3 | Reference Standards |
| HY-W715351S | 1,2,4,5,7,8-Hexachloro naphthalene-13C10 | Isotope-Labeled Compounds | |
| HY-W715357S | 3,3′,4,4′-Tetrabromo diphenyl ether-13C12 | 1401355-55-2 | Isotope-Labeled Compounds |
| HY-W715358 | Flucetosulfuron-d6 | Isotope-Labeled Compounds | |
| HY-W715361S | 2,4,6,8-Tetrachloro dibenzothiophene-13C12 | Isotope-Labeled Compounds | |
| HY-W715365S | 1,2,3-Tribromo-5-(3,4-dibromophenoxy)benzene-13C12 | 1401355-56-3 | Isotope-Labeled Compounds |
| HY-W715372 | Pyraoxystrobin | 862588-11-2 | Reference compound |
| HY-W715372R | Pyraoxystrobin (Standard) | 862588-11-2 | Reference Standards |
| HY-W715444 | Mucidin | 52110-55-1 | Reference compound |
| HY-W715511 | N-Desethyl-N-methyl vardenafil | 224785-87-9 | Reference compound |
| HY-W715538 | Rhetsinine | 526-43-2 | Natural Products |
| HY-W715630 | Salvicine | 240423-23-8 | Reference compound |
| HY-W715783 | Divarinic acid | 4707-50-0 | Reference compound |
| HY-W716030 | Prosulfuron-d3 | Isotope-Labeled Compounds | |
| HY-W716411S | 1,2,3,4,5-Pentabromo-6-(2,3-dibromophenoxy)benzene-13C12 | Isotope-Labeled Compounds | |
| HY-W716523 | Diethyl adipate-d10 | Isotope-Labeled Compounds | |
| HY-W716673 | Ftivazide | 149-17-7 | Reference compound |
| HY-W716673R | Ftivazide (Standard) | 149-17-7 | Reference Standards |
| HY-W716728 | 3-Hydroxy-3-(3-hydroxyphenyl-2,4,5,6-d4)propanoic acid | Isotope-Labeled Compounds | |
| HY-W716849S | 2-(N-(Carbamimidoylcarbamoyl)sulfamoyl)-N,N-dimethylnicotinamide-d6 | Isotope-Labeled Compounds | |
| HY-W716865 | CBNQ | 731773-46-9 | Reference compound |
| HY-W716866 | 10α-Hydroxy-exo-THC | 56986-42-6 | Reference compound |
| HY-W716889 | 2,6,10,14-Tetramethylhexadecane | 638-36-8 | Natural Products |
| HY-W716916 | Vismodegib-d7 | 2733145-73-6 | Isotope-Labeled Compounds |
| HY-W717125 | 1-Palmitoyl-2-oleoyl-glycero-3-phosphoethanol (sodium) | 322647-55-2 | Natural Products |
| HY-W717329 | EC33 | 232261-88-0 | Reference compound |
| HY-W717406 | CH5468924-d4 | Isotope-Labeled Compounds | |
| HY-W717504 | Glucosylceramide, plant | 497155-61-0 | Natural Products |
| HY-W717530 | Retene | 483-65-8 | Reference compound |
| HY-W717548 | Safinamide acid | 1160513-60-9 | Reference compound |
| HY-W717623 | N,N-Dimethylundecan-1-amine oxide | 15178-71-9 | Reference compound |
| HY-W717654 | 1-Deoxy-D-xylulose 5-phosphate | 190079-18-6 | Reference compound |
| HY-W717661 | 4-Hydroxyphenyl diphenyl phosphate-d10 | Isotope-Labeled Compounds | |
| HY-W717735 | Monononadecanoin | 112340-30-4 | Reference compound |
| HY-W717742 | p-NO2-Bn-Cyclen | 116052-94-9 | Biochemical Assay Reagents |
| HY-W717743 | DOTAM-mono-acid | 913528-04-8 | Biochemical Assay Reagents |
| HY-W717760 | p-NH2-Bn-DOTA-tetra(t-Bu ester) | 446061-19-4 | Biochemical Assay Reagents |
| HY-W717779 | 4-Aminobutyl-DOTA | 753421-63-5 | Biochemical Assay Reagents |
| HY-W717781A | p-NH₂-Bn-DTPA (hydrochloride) | Biochemical Assay Reagents | |
| HY-W717782 | Bz-DTPA (hydrochloride) | 2614335-77-0 | Biochemical Assay Reagents |
| HY-W717800A | NO2A-Azide (trihydrochloride) | 2435782-92-4 | Biochemical Assay Reagents |
| HY-W717830 | CB-Cyclam | 130701-19-8 | Biochemical Assay Reagents |
| HY-W717833 | NO2A-(t-Bu ester) | 174137-97-4 | Biochemical Assay Reagents |
| HY-W717863 | Oximino Oxamyl-d6 | 2734501-51-8 | Isotope-Labeled Compounds |
| HY-W717924 | (Z)-14-Methyl-8-hexadecenal | 60609-53-2 | Natural Products |
| HY-W718023 | 1,2-Dioctanoyl-3-chloropropanediol | 95610-54-1 | Natural Products |
| HY-W718024 | 3-Chloro-2-hydroxypropyl decanoate | 3537-37-9 | Natural Products |
| HY-W718033 | 1,2-Didecanoyl-3-chloropropanediol | 2241680-20-4 | Natural Products |
| HY-W718034 | 1,2-Didecanoyl-3-chloropropanediol-d5 | 2714473-28-4 | Isotope-Labeled Compounds |
| HY-W718035 | 1-Chloro-3-(octanoyloxy)propan-2-yl decanoate | 2468770-96-7 | Natural Products |
| HY-W718036 | 3-Chloro-2-(octanoyloxy)propyl decanoate | 2692623-39-3 | Natural Products |
| HY-W718041 | 1-Lauroyl-2-decanoyl-3-chloropropanediol | 2692623-40-6 | Natural Products |
| HY-W718081 | Isopentedrone (hydrochloride) | 1429402-13-0 | Reference compound |
| HY-W718122 | α-D-Glucopyranose,1-(dihydrogen phosphate) (potassium) | 6736-77-2 | Biochemical Assay Reagents |
| HY-W718136 | D-Glucosamine 6-phosphate (sodium) | 70442-23-8 | Biochemical Assay Reagents |
| HY-W718137 | 6-Azido-6-deoxy-D-galactose，95% | 66927-03-5 | Biochemical Assay Reagents |
| HY-W718141 | Triglycerol monostearate | 26855-43-6 | Biochemical Assay Reagents |
| HY-W718145 | D-Mannose,6-(dihydrogen phosphate) (sodium) | 70442-25-0 | Biochemical Assay Reagents |
| HY-W718146 | Tremuloidin | 529-66-8 | Natural Products |
| HY-W718156 | Kanamycin (disulfate) | 64013-70-3 | Biochemical Assay Reagents |
| HY-W718179 | Hydroxypropyl starch | 9049-76-7 | Reference compound |
| HY-W718223 | DL-Dipalmitoylphosphatidylcholine | 2644-64-6 | Biochemical Assay Reagents |
| HY-W718227 | Levan from Erwinia herbicola, 98% | 9013-95-0 | Biochemical Assay Reagents |
| HY-W718300 | Indole-3-pyruvic acid-d5 | 85163-57-1 | Isotope-Labeled Compounds |
| HY-W718316 | 5,6-Chrysenedione | 2051-10-7 | Reference compound |
| HY-W718351 | (Z)-Octadec-8-enoic acid | 5684-71-9 | Reference compound |
| HY-W718352 | (7Z)-7-Nonadecenoic acid | 118020-79-4 | Reference compound |
| HY-W718356 | (E)-Nonadec-7-enoic acid | 191544-99-7 | Reference compound |
| HY-W718357 | 10(E)-Nonadecenoic acid | 147527-21-7 | Reference compound |
| HY-W718375 | cis-17-Hexacosenoic acid | 66274-43-9 | Biochemical Assay Reagents |
| HY-W718383 | 7(Z),10(Z),13(Z)-Hexadecatrienoic acid | 7561-64-0 | Reference compound |
| HY-W718405 | (5Z,14Z)-5,14-Eicosadienoic acid | 122055-58-7 | Reference compound |
| HY-W718408 | Juniperonic acid | 18016-45-0 | Biochemical Assay Reagents |
| HY-W718418 | 3-Ketoadipic acid | 689-31-6 | Natural Products |
| HY-W718420 | 7(R)-Hydroxyhexadecanoic acid | 1046116-41-9 | Natural Products |
| HY-W718422 | 6-Hydroxyhexadecanoic acid | 58763-57-8 | Natural Products |
| HY-W718424 | 6-Hydroxyoctadecanoic acid | 3158-47-2 | Natural Products |
| HY-W718425 | (S)-13-Hydroxyoctadecanoic acid | 1383929-95-0 | Natural Products |
| HY-W718426 | 12-Hydroxy-9(E)-octadecenoic acid | 82188-83-8 | Natural Products |
| HY-W718447 | 2-Oxooctadecanoic acid | 4468-17-1 | Natural Products |
| HY-W718472S | 3,3′-Dichloro biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-W718518S | 2,3,4,4′-Tetrachloro biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-W718525S | 2,3′,4′,5-Tetrachloro biphenyl-13C12 | 208263-81-4 | Isotope-Labeled Compounds |
| HY-W718532S | 3,3′,4,5′-Tetrachloro biphenyl-13C12 | 1027415-81-1 | Isotope-Labeled Compounds |
| HY-W718588S | 2,2',3,3',5,5'-Hexachlorobiphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-W718614S | 2,3,3′,4,5,5′-Hexachloro biphenyl-13C12 | Isotope-Labeled Compounds | |
| HY-W718754 | N-Boc norketamine | 2177263-88-4 | Reference compound |
| HY-W718787 | Fenoxycarb-d3 | 2468639-22-5 | Isotope-Labeled Compounds |
| HY-W718796 | DL-Serine-15N | 31948-88-6 | Isotope-Labeled Compounds |
| HY-W718894 | (R)-Dihydrolipoic acid | 119365-69-4 | Reference compound |
| HY-W719011 | N-Propyl buphedrone (hydrochloride) | 18267-91-9 | Reference compound |
| HY-W719025 | α-Ethylaminopentiophenone (hydrochloride) | 18268-16-1 | Reference compound |
| HY-W719074 | Sulfisomidin-d4 | 2732915-77-2 | Isotope-Labeled Compounds |
| HY-W719396S | 3,5-Dimethyl-2-vinylpyrazine-d3 | 1082581-88-1 | Isotope-Labeled Compounds |
| HY-W719475 | Quinoline-d7 | 34071-94-8 | Isotope-Labeled Compounds |
| HY-W719518 | 2,6-Diphenyl-4H-thiopyran-4-one | 1029-96-5 | Biochemical Assay Reagents |
| HY-W719560S | Flupyrsulfuron-methyl-d6 | Isotope-Labeled Compounds | |
| HY-W719646 | Naphthol AS phosphate, 99%(TLC） | 13989-98-5 | Biochemical Assay Reagents |
| HY-W719653 | Oil Blue N | 2646-15-3 | Biochemical Assay Reagents |
| HY-W719721 | 1H-Indole-2,4,5,6,7-d5 | 73509-21-4 | Isotope-Labeled Compounds |
| HY-W719722 | Chloraminophenamide-15N2 | 446877-58-3 | Isotope-Labeled Compounds |
| HY-W719799 | Suc-Ala-Leu-Pro-Phe-AMC | 142997-31-7 | Peptides |
| HY-W719847 | Orbifloxacin-d4 | 2714415-07-1 | Isotope-Labeled Compounds |
| HY-W719862 | 16:0 PDP PE | 474944-16-6 | Biochemical Assay Reagents |
| HY-W719959 | 3a,6a-Dihydroxy-7-oxo-5b-cholan-24-oic acid | 88725-42-2 | Natural Products |
| HY-W719989 | γ-Carotene | 472-93-5 | Natural Products |
| HY-W719997 | ε-Carotene | 472-89-9 | Biochemical Assay Reagents |
| HY-W720146 | Ethylbenzene-d10 | 25837-05-2 | Isotope-Labeled Compounds |
| HY-W720219S | 2-Amino-2-methylpropane-1-sulfonic acid-d6 | Isotope-Labeled Compounds | |
| HY-W720313 | 4-Methyl-α-ethylaminobutiophenone (hydrochloride) | 18268-19-4 | Reference compound |
| HY-W720337 | 25iP-NBOMe (hydrochloride) | 2725318-60-3 | Reference compound |
| HY-W720532 | N,N-Dimethyl-L-tryptophan (hydrochloride) | 2253893-37-5 | Reference compound |
| HY-W720736 | Tinazoline | 62882-99-9 | Reference compound |
| HY-W720850S | 2-(Methylamino)-1-(P-tolyl)propan-1-ol-d3 (hydrochloride) | 1781417-49-9 | Isotope-Labeled Compounds |
| HY-W720927 | Tetracosanoyl chloride | 58576-73-1 | Natural Products |
| HY-W721117 | N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine-d3 | Isotope-Labeled Compounds | |
| HY-W721119 | 7-Methylsulfinylheptyl isothiocyanate | 129244-98-0 | Natural Products |
| HY-W721249 | 5-Methoxy NMT | 2009-03-2 | Reference compound |
| HY-W721259 | 2-Bromoamphetamine (hydrochloride) | 861006-36-2 | Reference compound |
| HY-W721295S | N-(1-Deoxy-D-fructos-1-yl)-L-methionine-13C6 | 1083053-42-2 | Isotope-Labeled Compounds |
| HY-W721302 | 2-APB (hydrochloride) | 3710-48-3 | Reference compound |
| HY-W721402 | 5-Phenyl-5-(phenyl-d5)imidazolidine-2,4-dione | 63435-68-7 | Isotope-Labeled Compounds |
| HY-W721480 | HC-067047 (hydrochloride) | 1481646-76-7 | Reference compound |
| HY-W721484 | Stercobilinogen | 17095-63-5 | Reference compound |
| HY-W721505 | 4-Chloro-N-butylcathinone (hydrochloride) | 2748591-11-7 | Reference compound |
| HY-W721582 | β,β-Trehalose | 499-23-0 | Natural Products |
| HY-W721596 | Pentadecanoyl ethanolamide | 53832-58-9 | Reference compound |
| HY-W721656 | Triclacetamol | 6340-87-0 | Reference compound |
| HY-W721659 | Pirquinozol | 65950-99-4 | Reference compound |
| HY-W722081 | Baumycin C1 | 63084-42-4 | Natural Products |
| HY-W722107 | Timonacic-d4 | 3066050-54-9 | Isotope-Labeled Compounds |
| HY-W722115 | 5-HO-Ehdpp-d10 | Isotope-Labeled Compounds | |
| HY-W722155 | 25H-NBOH (hydrochloride) | 2595087-21-9 | Reference compound |
| HY-W722177 | β-Methoxy 2C-D (hydrochloride) | 98537-38-3 | Reference compound |
| HY-W722221 | Colterol (acetate) | 10255-14-8 | Reference compound |
| HY-W722239 | Methyl 2-(methyl-d3)butanoate | Isotope-Labeled Compounds | |
| HY-W722275 | 12-Heptacosanone | 31534-85-7 | Natural Products |
| HY-W722276 | 12-Pentacosanone | 22026-18-2 | Natural Products |
| HY-W722289S | (rac)-Metolachlor metabolite CGA 50267-d3 | Isotope-Labeled Compounds | |
| HY-W722328 | N-Desmethylthiamethoxam-d4 | Isotope-Labeled Compounds | |
| HY-W722841 | Despropionyl carfentanil | 61085-55-0 | Reference compound |
| HY-W723152 | Poly(D,L-lactide-co-glycolide) | 26780-50-7 | Reference compound |
| HY-W723562 | Pteleine | 2221-41-2 | Natural Products |
| HY-W723695 | Aniline-d2 | 1122-59-4 | Isotope-Labeled Compounds |
| HY-W723740 | Heptane-d16 | 33838-52-7 | Isotope-Labeled Compounds |
| HY-W723771 | 4-Aminobiphenyl-d9 | 344298-96-0 | Isotope-Labeled Compounds |
| HY-W723876 | 2-Phenyl-d5-ethylamine | 912627-99-7 | Isotope-Labeled Compounds |
| HY-W724091 | PB-22 N-pentanoic acid metabolite | 2071638-22-5 | Reference compound |
| HY-W724347 | Nitenpyram-d3 | 2749978-80-9 | Isotope-Labeled Compounds |
| HY-W724743 | Losartan azide | 727718-93-6 | Reference compound |
| HY-W724779 | Lactobacillic acid | 19625-10-6 | Natural Products |
| HY-W724781A | Methyl cis-9,10-methylenehexadecanoate | 36254-90-7 | Natural Products |
| HY-W725077S | Benalaxyl metabolite F4-d9 | Isotope-Labeled Compounds | |
| HY-W725080S | N-(2,6-Dimethylphenyl)-N-(2-sulfoacetyl)glycine-d9 | Isotope-Labeled Compounds | |
| HY-W725113 | N-Nitroso fluoxetine | 150494-06-7 | Reference compound |
| HY-W725179 | VK-2019 | 2044520-06-9 | Reference compound |
| HY-W725181 | Methyl 2-phenyl-2-(pyrrolidin-1-yl)acetate (hydrochloride) | 27594-60-1 | Reference compound |
| HY-W725184 | 3,4-Dimethoxy-α-pyrrolidinopropiophenone (hydrochloride) | 28117-93-3 | Reference compound |
| HY-W725190 | Piperidylthiambutene (hydrochloride) | 64037-51-0 | Reference compound |
| HY-W725190A | Piperidylthiambutene | 54160-31-5 | Oligonucleotides |
| HY-W725197 | 3,4-Difluoro-N,N-didesmethyl U-47700 (TFA) | 2751977-98-5 | Reference compound |
| HY-W725198 | 3,4-Difluoro U-49900 (hydrochloride) | 2743078-88-6 | Reference compound |
| HY-W725208 | 2-(Di-sec-butylamino)-1-(1-(2-fluorobenzyl)-1H-pyrrol-2-yl)ethan-1-ol | 63880-43-3 | Reference compound |
| HY-W725213 | α-ethyl 2C-D (hydrochloride) | 54690-19-6 | Reference compound |
| HY-W725295 | 1-(5-Fluoropentyl)-1H-indazole-3-carboxylic acid | 1535166-43-8 | Reference compound |
| HY-W725309 | 18:0-18:1 PA (sodium) | 384833-24-3 | Biochemical Assay Reagents |
| HY-W725327 | 1,2-Dipropionyl-sn-glycero-3-phosphocholine | 66414-33-3 | Biochemical Assay Reagents |
| HY-W725385 | Cypyrafluone | 1855929-45-1 | Reference compound |
| HY-W725397 | 23:0 PC | 112241-60-8 | Biochemical Assay Reagents |
| HY-W725399 | 1,2-Dilignoceroyl-sn-glycero-3-phosphocholine | 91742-11-9 | Oligonucleotides |
| HY-W725473 | Oxyfluorfen-d5 | 2140327-69-9 | Isotope-Labeled Compounds |
| HY-W725480 | Carfentrazon-ethyl-d5 | 2140327-60-0 | Isotope-Labeled Compounds |
| HY-W725496 | D-Fructose 6-phosphate (dipotassium) | 103213-47-4 | Biochemical Assay Reagents |
| HY-W725632 | 7-Hydroxy etodolac | 101901-07-9 | Reference compound |
| HY-W725641 | Tricyclazole-d3 | Isotope-Labeled Compounds | |
| HY-W725649 | Chlorfenapyr-d7 | Isotope-Labeled Compounds | |
| HY-W725745 | Tris(6-isocyanatohexyl)isocyanurate | 3779-63-3 | Biochemical Assay Reagents |
| HY-W725928 | DOPR (hydrochloride) | 53581-55-8 | Reference compound |
| HY-W725954 | Triheneicosanoin | 26536-14-1 | Reference compound |
| HY-W725955 | Fostemsavir (sodium) | 864953-31-1 | Reference compound |
| HY-W726076 | 3α,6α-Mannopentaose | 112828-69-0 | Biochemical Assay Reagents |
| HY-W726078 | 4-O-β-D-Galactopyranosyl-D-galactopyranose | 2152-98-9 | Biochemical Assay Reagents |
| HY-W726084 | 1,2:5,6-Di-O-isopropylidene-L-chiro-inositol | 65556-81-2 | Biochemical Assay Reagents |
| HY-W726091 | 5-Ethynyl-DU CEP | 615288-66-9 | Reference compound |
| HY-W726127 | Propamocarb (hydrochloride) | 25606-41-1 | Reference compound |
| HY-W726137 | Potassium 1,2-naphthoquinone-4-sulphonate | 5908-27-0 | Reference compound |
| HY-W726164 | Gentamicin A | 13291-74-2 | Natural Products |
| HY-W726201 | 5'-DMT-5-F-2'-dU Phosphoramidite | 142246-63-7 | Reference compound |
| HY-W726384 | Phenylsilane-d3 | 18164-03-9 | Isotope-Labeled Compounds |
| HY-W726390 | 2-(4-(2-Hydroxy-3-(isopropyl(nitroso)amino)propoxy)phenyl)acetamide | 134720-04-0 | Reference compound |
| HY-W726392 | N-Nitrosometoprolol | 138768-62-4 | Reference compound |
| HY-W726470 | N-trans-p-Coumaroyltyrosine | 77201-66-2 | Natural Products |
| HY-W726640 | Peraquinsin | 35265-50-0 | Reference compound |
| HY-W726709 | Propachlor ESA-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-W726767 | DO2A | Biochemical Assay Reagents | |
| HY-W726893 | ATTO 425 | 652966-03-5 | Dye Reagents |
| HY-W727031 | 2-Methylamino-1-phenylbutane (hydrochloride) | 84952-63-6 | Reference compound |
| HY-W727144 | 2-Heptyl-4,6-dihydroxybenzoic acid | 6121-76-2 | Reference compound |
| HY-W727224 | 1-Oleoyl-3-bromopropanediol | 30334-62-4 | Natural Products |
| HY-W727319 | Tetracosyl acetate | 822-29-7 | Natural Products |
| HY-W727373 | 2-(Cyclopropyl(methyl)amino)-5-phenyloxazol-4(5H)-one | 14461-92-8 | Reference compound |
| HY-W727522 | 1,2,3,7,8-Pentachlorodibenzo-p-dioxin | 40321-76-4 | Reference compound |
| HY-W727525 | Donepezil-d7 | 1215071-00-3 | Isotope-Labeled Compounds |
| HY-W727627 | 5-O-Coumaroylquinic acid | 87099-71-6 | Natural Products |
| HY-W727768 | Salicylic acid 2-O-β-D-glucoside-d4 | 1174218-98-4 | Isotope-Labeled Compounds |
| HY-W727879 | Upadacitinib-15N,d2 | Isotope-Labeled Compounds | |
| HY-W727893 | Taurine-15N | 127041-63-8 | Isotope-Labeled Compounds |
| HY-W727999 | Koenimbine | 21087-98-9 | Natural Products |
| HY-W728005 | Covidcil-19 | 1225177-95-6 | Reference compound |
| HY-W728085 | CPPD-Q | 68054-78-4 | Reference compound |
| HY-W728096 | Migalastat-d5 | Isotope-Labeled Compounds | |
| HY-W728110 | 5-MeO-pyr-T | 3949-14-2 | Reference compound |
| HY-W728151 | 3-O-Caffeoylshikimic acid | 180981-12-8 | Natural Products |
| HY-W728206S | Chlorothalonil Metabolite SYN507900-15N2 | Isotope-Labeled Compounds | |
| HY-W728451 | URB694 | 904672-77-1 | Reference compound |
| HY-W728503S | N-Nitroso Vonoprazan-13C,d3 | Isotope-Labeled Compounds | |
| HY-W728531 | Ac4ManNAz | 1213701-11-1 | Reference compound |
| HY-W728545 | Labetalol-d6 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W728631 | 2-(3-Fluorophenyl)-2-(methylamino)cyclohexan-1-one hydrochloride | 2657761-24-3 | Reference compound |
| HY-W728761 | Voxelotor-d7 | Isotope-Labeled Compounds | |
| HY-W728879 | 5-Aminoisotonitazene | 2732926-25-7 | Reference compound |
| HY-W729010 | Fmoc-D-Ala(Bth)-OH | 1263047-16-0 | Reference compound |
| HY-W729030 | Fmoc-Lys(biotinyl-e-aminocaproyl)-OH | 160158-05-4 | Biochemical Assay Reagents |
| HY-W729138 | Fmoc-D-homoArg(Et)2-OH (hydrochloride) | 2098497-24-4 | Peptides |
| HY-W731085 | MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH | 2626930-84-3 | ADC Related |
| HY-W733176 | E3 ligase Ligand 50 | 2758531-98-3 | Reference compound |
| HY-W733885 | E3 ligase Ligand 38 | 2883704-45-6 | Reference compound |
| HY-W735205 | (1R,4R)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | 675126-09-7 | Reference compound |
| HY-W736195 | 5-Hydroxy-4-oxo-L-norvaline | 26911-39-7 | Natural Products |
| HY-W736950 | H-L-Cys(MDNPE)-OH | 1551078-43-3 | Reference compound |
| HY-W736950A | H-L-Cys(MDNPE)-OH (hydrochloride) | Reference compound | |
| HY-W737103 | Flutomidate | 84962-75-4 | Reference compound |
| HY-W738256 | Maleimide-DTPA | 180152-82-3 | ADC Related |
| HY-W738281 | Chlorhexidine-d8 | 1246816-96-5 | Isotope-Labeled Compounds |
| HY-W738314 | Heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin tetradecaacetate | 123172-94-1 | Biochemical Assay Reagents |
| HY-W738358 | Chlorproguanil (hydrochloride) | 6001-93-0 | Reference compound |
| HY-W738465 | N,N-Dimethylamidino Urea | 98026-16-5 | Reference compound |
| HY-W738582S | N-(1-Deoxy-D-fructos-1-yl)-L-threonine-13C6 | 1083053-43-3 | Isotope-Labeled Compounds |
| HY-W738639 | 18-Hydroxy-11-deoxy corticosterone | 379-68-0 | Reference compound |
| HY-W738774A | Astra Blue (acetate) | 82864-57-1 | Biochemical Assay Reagents |
| HY-W738852 | Hydroxylysylpyridinoline-d6 | Isotope-Labeled Compounds | |
| HY-W738979 | Silicon naphthalocyanine dichloride | 92396-91-3 | Reference compound |
| HY-W738987 | β-Cyclodextrin (phosphate sodium) | 199684-61-2 | Biochemical Assay Reagents |
| HY-W739056 | SAMe-1,4-Butanedisulfonate-d3 | Isotope-Labeled Compounds | |
| HY-W739065 | 2-Mercaptoethanol-d6 | 203645-37-8 | Isotope-Labeled Compounds |
| HY-W739149 | Rifapentine-d8 | Isotope-Labeled Compounds | |
| HY-W739302 | Sodium Oxyhyponitrite | 13826-64-7 | Reference compound |
| HY-W739308 | Trimethylsilyl-D-(+)-trehalose | 42390-78-3 | Biochemical Assay Reagents |
| HY-W739372 | Poly(sodium 4-styrenesulfonate) | 25704-18-1 | Biochemical Assay Reagents |
| HY-W739372A | Poly(sodium 4-styrenesulfonate) (MW 70000) | 25704-18-1 | Biochemical Assay Reagents |
| HY-W739372B | Poly(sodium 4-styrenesulfonate) (MW 1000000) | 25704-18-1 | Biochemical Assay Reagents |
| HY-W739379 | 2,3-O-(1-Methylethylidene)-α-L-sorbofuranose | 17682-71-2 | Biochemical Assay Reagents |
| HY-W739382 | Methyl-α-L-acosamine | 54623-23-3 | Biochemical Assay Reagents |
| HY-W739388 | 4-Methylumbelliferyl 6-sulfo-2-acetamido-2-deoxy-α-D-glucopyranoside (potassium) | 210357-37-2 | Biochemical Assay Reagents |
| HY-W739389 | p-Nitrophenyl 2-azido-2-deoxy-α-D-galactopyranoside | 210418-04-5 | Biochemical Assay Reagents |
| HY-W739391 | 1,3-Propanediyl bismethanethiosulfonate | 55-96-9 | Biochemical Assay Reagents |
| HY-W739396 | 3,6,9-Trioxaundecane-1,11-diyl-bismethanethiosulfonate | 212262-02-7 | Biochemical Assay Reagents |
| HY-W739406 | D-Cellopentose heptadecaacetate | 83058-38-2 | Biochemical Assay Reagents |
| HY-W739411 | 11-Maleimidoundecanoic acid hydrazide | 359436-62-7 | Biochemical Assay Reagents |
| HY-W739412 | 1,6-Hexane-bis-[3-(2-pyridyldithio)propionamide] | 359435-46-4 | Biochemical Assay Reagents |
| HY-W739418 | N-(Iodoacetylaminoethyl)-8-naphthylamine-1-sulfonic acid | 36930-64-0 | Biochemical Assay Reagents |
| HY-W739420 | 4-Chloro-2-cyclopentylphenyl β-D-galactopyranoside | 24718-43-2 | Biochemical Assay Reagents |
| HY-W739438 | 4-Methylumbelliferyl β-D-cellopentoside | 84325-20-2 | Biochemical Assay Reagents |
| HY-W739441 | 1,2-O-Ethylidene-β-D-mannopyranose | 230953-16-9 | Biochemical Assay Reagents |
| HY-W739443 | 4-Amino-2,6-anhydro-3,4-dideoxy-D-glycero-D-galacto-non-2-enoic acid | 263155-12-0 | Biochemical Assay Reagents |
| HY-W739460 | N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid methyl ester | 25875-99-4 | Biochemical Assay Reagents |
| HY-W739486 | 10,12-Octadecadienoic acid | 22880-03-1 | Reference compound |
| HY-W739491 | Methyl 2-O-(α-D-mannopyranosyl)-α-D-mannopyranoside | 59571-75-4 | Biochemical Assay Reagents |
| HY-W739494 | 3-(Benzophenone-4-carboxamido)-2-maleimidopropanoic acid | 887352-68-3 | Biochemical Assay Reagents |
| HY-W739497 | 1,2,3-Tri-O-benzoyl-4,6-dideoxy-4-iodo-α-L-glucopyranose | 132867-78-8 | Biochemical Assay Reagents |
| HY-W739502 | MHBMA-d6 | Isotope-Labeled Compounds | |
| HY-W739507 | 5-Azido-5-deoxy-D-fructose | 94801-02-2 | Biochemical Assay Reagents |
| HY-W739509 | 3,4-Di-O-acetyl-1,2-O-isopropylidene-5-O-tosyl-α-L-sorbose | 53821-66-2 | Biochemical Assay Reagents |
| HY-W739513 | Fluorescein 6-maleimide | 161598-40-9 | Biochemical Assay Reagents |
| HY-W739517 | 6-N-Biotinylaminohexyl hydrogenphosphonate | 224583-35-1 | Biochemical Assay Reagents |
| HY-W739521 | N-Desethyloxybutynin (hydrochloride) | 81039-77-2 | Reference compound |
| HY-W739549 | 4-Methylumbelliferyl 3,4,6-tri-O-acetyl-2-deoxy-2-trifluoroacetamido-α-D-glucopyranoside | 137686-92-1 | Biochemical Assay Reagents |
| HY-W739550 | 4-Methylumbelliferyl 2-trifluoroacetyl-3,4,6-O-triacetyl-2-deoxy-β-D-glucopyranoside | 137686-93-2 | Biochemical Assay Reagents |
| HY-W739581 | β-D-Mannopyranoside,4-nitrophenyl 4,6-O-cyclohexylidene,3-benzoate | 102717-17-9 | Biochemical Assay Reagents |
| HY-W739586 | 4-Nitrophenyl 6-O-α-D-mannopyranosyl-α-D-mannopyranoside | 72647-96-2 | Biochemical Assay Reagents |
| HY-W739603 | Cy5-bifunctional dye (potassium) | 252255-42-8 | Dye Reagents |
| HY-W739643 | Methyl 4-deoxy-4-fluoro-α-D-glucose | 56926-53-5 | Biochemical Assay Reagents |
| HY-W739644 | 1-Linoleoyl-2-oleoyl-3-stearoyl-rac-glycerol | 135092-48-7 | Biochemical Assay Reagents |
| HY-W739652 | 1-Linoleoyl-2-oleoyl-rac-glycerol | 2632-59-9 | Biochemical Assay Reagents |
| HY-W739681 | Bromo 2,3,4-Tri-O-benzoyl-L-fucopyranose | 855662-12-3 | Biochemical Assay Reagents |
| HY-W739682 | L-Galactose,6-deoxy-,2,3,4-tribenzoate | 485821-70-3 | Biochemical Assay Reagents |
| HY-W739683 | 1,2,3,4-Tetra-O-benzoyl-L-fucopyranose | 140223-15-0 | Biochemical Assay Reagents |
| HY-W739692 | 1,2:4,5-Di-O-cyclohexylidene-myo-inositol | 104873-71-4 | Biochemical Assay Reagents |
| HY-W739700 | (R)-(+)-Aminoglutethimide (L-Tartrate) | 57344-88-4 | Reference compound |
| HY-W739713 | N-Desmethylterbinafine | 99473-11-7 | Biochemical Assay Reagents |
| HY-W739717 | 3-O-tert-Butyldimethylsilyl-D-erythro-sphingosylphosphorylcholine | 168411-99-2 | Biochemical Assay Reagents |
| HY-W739747 | Nitrophenyl 2-O-(2,3,4,6-Tri-O-acetyl-α-D-mannopyranosyl)-α-D-mannopyranoside | 26255-69-6 | Biochemical Assay Reagents |
| HY-W739754 | Ergosterol acetate | 2418-45-3 | Natural Products |
| HY-W739762 | 2,3-O-Isopropylidene-1,6-ditosyl-L-sorbose | 2484-55-1 | Biochemical Assay Reagents |
| HY-W739769 | all-trans-13,14-Dihydroretinol | 115797-14-3 | Reference compound |
| HY-W739772 | 6β-Hydroxy budesonide | 88411-77-2 | Biochemical Assay Reagents |
| HY-W739789 | (6R)-Tetrahydro-L-biopterin (sulfate) | 103130-44-5 | Biochemical Assay Reagents |
| HY-W739797 | 4,6-O-Benzylidene-N-(tert-butoxycarbonyl)-1,5-imino-D-glucitol | 133697-16-2 | Biochemical Assay Reagents |
| HY-W739800 | N-Boc-1-pivaloyl-D-erythro-sphingosine | 342649-71-2 | Biochemical Assay Reagents |
| HY-W739801 | Benzyl 2,3-O-Isopropylidene-6-O-trityl-α-D-mannofuranose | 91364-11-3 | Biochemical Assay Reagents |
| HY-W739812 | Carboxy finasteride | 116285-37-1 | Reference compound |
| HY-W739814 | 11-Maleimidoundecane-1-carbonyl-1-(t-butyl)carbazate | 1076198-39-4 | Biochemical Assay Reagents |
| HY-W739832 | p-Nitrophenyl β-D-cellobioside heptacetate | 69948-03-4 | Biochemical Assay Reagents |
| HY-W739835 | Para Red-d4 | 1185235-75-9 | Isotope-Labeled Compounds |
| HY-W739840 | Valganciclovir-d5 (Hydrochloride) | Isotope-Labeled Compounds | |
| HY-W739856 | 1,8-Octadiyl bismethanethiosulfonate | 4356-71-2 | Biochemical Assay Reagents |
| HY-W739861 | α-Hydroxytriazolam | 37115-45-0 | Reference compound |
| HY-W739862 | Tris-(2-methanethiosulfonylethyl)amine | 18365-77-0 | Biochemical Assay Reagents |
| HY-W739876 | 3-Acetyl-1,2-O-isopropylidene-6-O-trityl-α-D-galactofuranose | 109680-97-9 | Biochemical Assay Reagents |
| HY-W739877 | α-D-Galactofuranose,1,2-O-(1-methylethylidene),3-acetate | 109680-96-8 | Biochemical Assay Reagents |
| HY-W739878 | α-D-Galactofuranose,1,2:5,6-bis-O-(1-methylethylidene),acetate | 38166-65-3 | Biochemical Assay Reagents |
| HY-W739883 | 4-Methylumbelliferyl-β-D-cellobiose heptaacetate | 122147-95-9 | Biochemical Assay Reagents |
| HY-W739899 | 5'-Ethylcarboxamido-2',3'-isopropylidene adenosine | 39491-53-7 | Biochemical Assay Reagents |
| HY-W739930 | Desmethyl ofloxacin (hydrochloride) | 402930-70-5 | Reference compound |
| HY-W739944 | Ambroxol-d5 | 1246818-80-3 | Isotope-Labeled Compounds |
| HY-W739948 | Naltrexone-d3 | 1261080-26-5 | Isotope-Labeled Compounds |
| HY-W739949 | Imidaprilat-d3 | 1356019-69-6 | Isotope-Labeled Compounds |
| HY-W739985 | 7α-(Thiomethyl)spironolactone | 38753-77-4 | Reference compound |
| HY-W740014 | N-Desmethyl Zolmitriptan | 139264-35-0 | Reference compound |
| HY-W740027 | 5-Methyl-2'-deoxycytidine-d3 | 1160707-78-7 | Isotope-Labeled Compounds |
| HY-W740028 | Cefditoren-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-W740051 | 13-cis Retinoyl β-D-glucuronide | 78147-42-9 | Biochemical Assay Reagents |
| HY-W740053 | Meropenem (sodium) | 211238-34-5 | Biochemical Assay Reagents |
| HY-W740060 | Dipyridamole Mono-O-β-D-glucuronide | 63912-02-7 | Reference compound |
| HY-W740061 | 2-Hydroxymethylene ethisterone | 2787-02-2 | Biochemical Assay Reagents |
| HY-W740075 | 3-(Aminomethyl)-proxyl | 54606-49-4 | Biochemical Assay Reagents |
| HY-W740076 | 1,2,3,4,6-Pentakis-O-(trimethylsilyl)-D-mannopyranose | 55529-69-6 | Biochemical Assay Reagents |
| HY-W740078 | Picaridin-d3 | 2928067-33-6 | Isotope-Labeled Compounds |
| HY-W740088 | Adrenochrome monoguanylhydrazone (methanesulfonate) | 4009-68-1 | Reference compound |
| HY-W740094 | Chitotetraose Tetradecaacetate | 117399-51-6 | Biochemical Assay Reagents |
| HY-W740133 | Rhein 8-β-D-glucuronide | 70793-10-1 | Biochemical Assay Reagents |
| HY-W740149 | Phenyl 4,6-O-benzylidene-1-thio-α-D-mannopyranoside | 159407-19-9 | Biochemical Assay Reagents |
| HY-W740165 | Desmethyl Levofloxacin (hydrochloride) | 2254176-11-7 | Reference compound |
| HY-W740171 | Ethynylestradiol 3-sulfate (sodium) | 724762-79-2 | Natural Products |
| HY-W740175 | 6b-Hydroxy triamcinolone acetonide | 3869-32-7 | Reference compound |
| HY-W740216 | N-Demethyl Mifepristone | 104004-96-8 | Reference compound |
| HY-W740240 | trans-9,10-Epoxy-octadecanoic acid | 13980-07-9 | Natural Products |
| HY-W740244 | 4’-Hydroxy Trazodone | 53818-10-3 | Reference compound |
| HY-W740271 | Deoxypyridinoline (chloride trihydrochloride) | 204074-56-6 | Biochemical Assay Reagents |
| HY-W740309 | Methyl 6-deoxy-2-O-methyl-3,4-O-(1-methylethylidene)-α-D-galactopyranoside | 74135-23-2 | Biochemical Assay Reagents |
| HY-W740310 | Methyl 6-deoxy-3,4-O-(1-methylethylidene)-α-D-galactopyranoside | 71772-35-5 | Biochemical Assay Reagents |
| HY-W740311 | Methyl 3,4-O-isopropylidene-α-D-galactopyranoside | 40269-01-0 | Biochemical Assay Reagents |
| HY-W740337 | 4-Nitrophenyl 3,4-O-(1-methylethylidene)-α-D-galactopyranoside | 29781-32-6 | Biochemical Assay Reagents |
| HY-W740363 | 5-Aminofluorescein (hydrochloride) | 53360-53-5 | Biochemical Assay Reagents |
| HY-W740378 | 1,2,3,4-Tetrahydro Staurosporin | 220038-19-7 | Reference compound |
| HY-W740380 | 21-Carboxylic acid triamcinolone acetonide | 53962-41-7 | Reference compound |
| HY-W740434 | 1-Palmitoyl-2-linoleoyl-rac-glycerol | 73649-99-7 | Biochemical Assay Reagents |
| HY-W740449 | Eicosapentaenoic acid ethyl ester-d5-1 | 2483831-19-0 | Isotope-Labeled Compounds |
| HY-W740572 | O-Desmethyl-N-deschlorobenzoyl Indomethacin | 50995-53-4 | Reference compound |
| HY-W740628 | Nicorandil pyridine oxide | 107833-98-7 | Reference compound |
| HY-W740630 | 8-Hydroxy mirtazapine | 102335-57-9 | Reference compound |
| HY-W740674 | 4-Ketocyclophosphamide | 27046-19-1 | Reference compound |
| HY-W740685 | Deferasirox acyl-β-D-glucuronide | 1233196-91-2 | Biochemical Assay Reagents |
| HY-W740723 | 4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside | 67909-25-5 | Biochemical Assay Reagents |
| HY-W740740 | 1,3,4,6-Tetra-O-acetyl-2-(α-L-fucopyranosyl)-α-D-galactopyranose | 56822-34-5 | Biochemical Assay Reagents |
| HY-W740764 | Isopropyl 4-hydroxybenzoate-d7 | 1432063-95-0 | Isotope-Labeled Compounds |
| HY-W740769 | N-Trifluoroacetamido-4′-p-nitrobenzoyl daunorubicin | 52583-24-1 | Biochemical Assay Reagents |
| HY-W740784S | 5-Hydroxy lornoxicam-d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W740884 | Rutin-d3 | Isotope-Labeled Compounds | |
| HY-W740946 | 1-Hydroxyethyl-2′-deoxyadenosine | 142997-59-9 | Biochemical Assay Reagents |
| HY-W740999 | 2-Palmitoyl-3-chloropropanediol | 20618-92-2 | Natural Products |
| HY-W741017S | 21-Desacetyl difluprednate-d6 | Isotope-Labeled Compounds | |
| HY-W741041 | Fluoxastrobin-d4 | 1246833-67-9 | Isotope-Labeled Compounds |
| HY-W741062 | 15-Methylhexadeca Sphinganine | 26048-10-2 | Reference compound |
| HY-W741075 | 1-Linolenoyl-3-chloropropanediol | 74875-99-3 | Natural Products |
| HY-W741093 | N-Nitroso desloratadine | 1246819-22-6 | Reference compound |
| HY-W741106 | 5-Hydroxybuspirone | 105496-33-1 | Reference compound |
| HY-W741165 | N-Demethyl methylone (hydrochloride) | 38061-37-9 | Reference compound |
| HY-W741191 | (2E,13Z)-Octadecadienal | 99577-57-8 | Natural Products |
| HY-W741222S | N-Desmethyl Olopatadine-d6 | 2012601-51-1 | Isotope-Labeled Compounds |
| HY-W741441 | Tetrahydro Aldosterone | 13489-75-3 | Reference compound |
| HY-W741491 | 6-O-Demethyl griseofulvin | 20168-88-1 | Reference compound |
| HY-W741510 | 21-Deoxy Cortisone | 1882-82-2 | Reference compound |
| HY-W741523 | 1,2:4,5-Di-O-cyclohexylidene-D-myo-inositol | 55123-26-7 | Biochemical Assay Reagents |
| HY-W741546S | L-threo-Ritalinic Acid-d5 (TFA) | 2012598-85-3 | Isotope-Labeled Compounds |
| HY-W741555 | Dechlorogriseofulvin | 3680-32-8 | Reference compound |
| HY-W741556 | Dehydrogriseofulvin | 3573-90-8 | Reference compound |
| HY-W741557 | Griseofulvic Acid | 469-54-5 | Reference compound |
| HY-W741560 | 4,4-Dimethyl retinoic acid | 104182-09-4 | Biochemical Assay Reagents |
| HY-W741573 | N-Biotinyl p-aminophenyl arsenic acid | 212391-23-6 | Dye Reagents |
| HY-W741575 | Iloperidone carboxylic acid | 475110-48-6 | Reference compound |
| HY-W741611 | Dehydro Warfarin | 67588-18-5 | Reference compound |
| HY-W741626 | N-Desmethyl selegiline-d5 | 1217977-04-2 | Isotope-Labeled Compounds |
| HY-W741706 | Butopamine (hydrochloride) | 74432-68-1 | Reference compound |
| HY-W741718 | 3-O-Methyl Colterol-d9 | 1346599-83-4 | Isotope-Labeled Compounds |
| HY-W741803 | 1,3-Dilinoleoyl-2-chloropropanediol | 1432592-04-5 | Natural Products |
| HY-W741839 | Aripiprazole N,N-Dioxide | 573691-13-1 | Reference compound |
| HY-W741886 | 5-Methoxy-N-isopropyl tryptamine | 109921-55-3 | Reference compound |
| HY-W741922 | 17β-Acetoxy-2α-bromo-5α-androstan-3-one | 6173-35-9 | Biochemical Assay Reagents |
| HY-W741999 | Metaproterenol-d7-1 (hemisulfate) | Isotope-Labeled Compounds | |
| HY-W742012 | Clencyclohexerol-d10 | 1346599-61-8 | Isotope-Labeled Compounds |
| HY-W742014 | Hydroxymethyl clenbuterol-d6 | 1346601-00-0 | Isotope-Labeled Compounds |
| HY-W742103 | 21-Deacetoxy deflazacort-d3 | Isotope-Labeled Compounds | |
| HY-W742180 | Shikimate-3-phosphate trisodium | 143393-03-7 | Biochemical Assay Reagents |
| HY-W742256 | N-Nitroso nebivolol (mixture of diastereomers) | 1391051-68-5 | Reference compound |
| HY-W742274 | Biotin-4-Fluorescein | 1032732-74-3 | Biochemical Assay Reagents |
| HY-W742300 | Pipazethate (hydrochloride) | 6056-11-7 | Reference compound |
| HY-W742324S | Pyriofenone-d9 | Isotope-Labeled Compounds | |
| HY-W742358 | 4'-Hydroxy pyrimethanil-d4 | 1794897-91-8 | Isotope-Labeled Compounds |
| HY-W742416 | 3-Mercapto-3-methylbutyl-d6 Formate | 162404-32-2 | Isotope-Labeled Compounds |
| HY-W742417 | Tazarotenic acid-d8 | Isotope-Labeled Compounds | |
| HY-W742484 | 1-Linoleoyl-(2S)-glycerol | 67968-46-1 | Reference compound |
| HY-W742532 | ETH-LAD | 65527-62-0 | Reference compound |
| HY-W742564 | Acacetin-7-O-β-D-galactopyranoside | 80443-15-8 | Natural Products |
| HY-W742595 | (E,E)-10,12-Hexadecadienol | 765-19-5 | Natural Products |
| HY-W742736 | Fusidic acid acyl β-D-glucuronide | 13013-66-6 | Biochemical Assay Reagents |
| HY-W742821 | (Z)-11-Octadecenal | 4273-95-4 | Natural Products |
| HY-W742900 | Mesulfenfos-d6 | 2733270-79-4 | Isotope-Labeled Compounds |
| HY-W742957 | Pregnanolone sulfate (pyridinium) | 124107-39-7 | Reference compound |
| HY-W742981 | Budesonide-d6 | 1134189-63-1 | Isotope-Labeled Compounds |
| HY-W743021 | 4-Methyl-α-ethyltryptamine | 28289-30-7 | Reference compound |
| HY-W743300 | 2,3-MDA (hydrochloride) | 86029-48-3 | Reference compound |
| HY-W743379 | (S)-N-Nitroso anatabine-d4 | 1426174-82-4 | Isotope-Labeled Compounds |
| HY-W743390 | 4-Methylimidazolidine-2-thione-d6 | 2512193-20-1 | Isotope-Labeled Compounds |
| HY-W743435 | Phosmet-d6 | 2083623-41-8 | Isotope-Labeled Compounds |
| HY-W743521 | Phlorisovalerophenone | 26103-97-9 | Natural Products |
| HY-W743525 | (±)-p-Fluoro pseudoephedrine (hydrochloride) | 7799-73-7 | Reference compound |
| HY-W743562 | Crotamiton-d5 | Isotope-Labeled Compounds | |
| HY-W743654 | Capsorubin | 470-38-2 | Natural Products |
| HY-W743654R | Capsorubin (Standard) | 470-38-2 | Reference Standards |
| HY-W743691 | 2,4'-Dihydroxydiphenyl sulfone-d8 | Isotope-Labeled Compounds | |
| HY-W743741 | N-Allyloxycarbonyl-β-lactosamine | 209977-55-9 | Biochemical Assay Reagents |
| HY-W743744 | 2-Aminophthalylhydrazido-N-acetyl-β-D-glucosaminide | 128879-80-1 | Biochemical Assay Reagents |
| HY-W743746 | 1,4-Butanediyl bismethanethiosulfonate | 55-99-2 | Biochemical Assay Reagents |
| HY-W743751 | 2-Deoxy-2-fluoro-D-galactose | 51146-53-3 | Biochemical Assay Reagents |
| HY-W743756 | 1,2-Ethanediyl bismethanethiosulfonate | 55-95-8 | Biochemical Assay Reagents |
| HY-W743760 | 1,6-Hexanediyl bismethanethiosulfonate | 56-01-9 | Biochemical Assay Reagents |
| HY-W743774 | gamma-Cyhalothrin-(phenoxy-d5) | 2140302-00-5 | Isotope-Labeled Compounds |
| HY-W743781 | N-Nitrosonornicotine-d4 | 1426174-36-8 | Isotope-Labeled Compounds |
| HY-W743804 | Aclidinium-d5 (bromide) | Isotope-Labeled Compounds | |
| HY-W743822 | Tetragalacturonic acid | 24008-75-1 | Biochemical Assay Reagents |
| HY-W743870 | 5α-Dihydrodeoxycorticosterone | 298-36-2 | Reference compound |
| HY-W743888 | AL-LAD | 65527-61-9 | Reference compound |
| HY-W743944 | Tilivalline | 80279-24-9 | Reference compound |
| HY-W743954 | Nicergoline impurity 11-d3 | Isotope-Labeled Compounds | |
| HY-W743988 | Cilastatin (ammonium salt) | 877674-82-3 | Reference compound |
| HY-W744098 | 1-Dehydrocorticosterone 21-acetate | 58652-04-3 | Reference compound |
| HY-W744124 | 4'-Fluoroacetophenone-d4 | 1335333-86-2 | Isotope-Labeled Compounds |
| HY-W744160 | Stigmasterol-d6 | Isotope-Labeled Compounds | |
| HY-W744212 | N-Nitroso desloratadine-d4 | 2733579-31-0 | Isotope-Labeled Compounds |
| HY-W744216 | Trestolone acetate | 6157-87-5 | Reference compound |
| HY-W744225 | Tyramine-d4 (hydrochloride) | 1188266-06-9 | Isotope-Labeled Compounds |
| HY-W744249 | Isotretinoin-d5-1 | Isotope-Labeled Compounds | |
| HY-W744264 | Flumazenil-d5 | 2700278-14-2 | Isotope-Labeled Compounds |
| HY-W744459 | DeBoc-Cabazitaxel | 1638286-64-2 | ADC Related |
| HY-W744592 | 4-Desacetamido-4-fluoro Andarine-d4 | Isotope-Labeled Compounds | |
| HY-W744599 | Desoxymetasone-d5 | Isotope-Labeled Compounds | |
| HY-W744643 | Butylphthalide-d9 | 2251692-52-9 | Isotope-Labeled Compounds |
| HY-W744647 | cis-4-Heptenal-D2 | 1335436-36-6 | Isotope-Labeled Compounds |
| HY-W744666 | β-Dimorphecolic acid | 18104-44-4 | Natural Products |
| HY-W744699 | Larixol | 1438-66-0 | Natural Products |
| HY-W744720 | Linaclotide-d4 | Isotope-Labeled Compounds | |
| HY-W744745 | Linagliptin methyldimer | 1418133-47-7 | Reference compound |
| HY-W744780 | Docosahexaenoic acid N-succinimide | 160801-26-3 | Reference compound |
| HY-W744867 | Pinolenic acid methyl ester | 38406-57-4 | Reference compound |
| HY-W744872 | Elaidic acid ethyl ester | 6114-18-7 | Natural Products |
| HY-W744953 | Carbimazole-d3 | Isotope-Labeled Compounds | |
| HY-W744966 | Mandipropamid | 374726-62-2 | Reference compound |
| HY-W744966R | Mandipropamid (Standard) | 374726-62-2 | Reference Standards |
| HY-W745090 | Isomaltulose (monohydrate) | 58024-13-8 | Biochemical Assay Reagents |
| HY-W745139 | 5-Octyl D-Glutamate | 149332-65-0 | Peptides |
| HY-W745164 | 3,3′-Bisdemethylpinoresinol | 340167-81-9 | Natural Products |
| HY-W745349 | rel-(1S,2R)-Dihydro bupropion-d9 (hydrochloride) | 2517771-79-6 | Isotope-Labeled Compounds |
| HY-W745504 | 2-Phenylphenol-d5 | 64420-98-0 | Isotope-Labeled Compounds |
| HY-W745574 | Glyceryl tripalmitelaidate | 134907-85-0 | Reference compound |
| HY-W745615 | Triundecanoin-d5 | Isotope-Labeled Compounds | |
| HY-W745644 | (Z)-7-Hexadecenal | 56797-40-1 | Natural Products |
| HY-W745655 | 1-Lauroyl-2-myristoyl-3-chloropropanediol | 2828775-74-0 | Natural Products |
| HY-W745661 | Palmitoyldocosahexaenoyl Phosphatidylcholine-d9 | Isotope-Labeled Compounds | |
| HY-W745779 | Dienogest-d8 | 2376035-92-4 | Isotope-Labeled Compounds |
| HY-W746031 | WAY-181187 (hydrochloride) | 554403-08-6 | Reference compound |
| HY-W746074S | Alternariol-3-sulfate-d3 (ammonium) | Isotope-Labeled Compounds | |
| HY-W746075A | (±)-Darifenacin N-Oxide | 2416229-88-2 | Reference compound |
| HY-W746163 | Nervonoyl chloride | 145411-43-4 | Natural Products |
| HY-W746164 | Urolithin E | 1453297-45-4 | Reference compound |
| HY-W746372S | cis,cis-3,6-Nonadienal-d4 | 150677-98-8 | Isotope-Labeled Compounds |
| HY-W746555S | Metazachlor metabolite BH479-4-d9 | Isotope-Labeled Compounds | |
| HY-W746625 | all-cis-4,7,10,13,16-Docosapentaenoic acid methyl ester | 31930-67-3 | Reference compound |
| HY-W746683 | Sebaleic acid | 22733-46-6 | Biochemical Assay Reagents |
| HY-W746708 | FK-565 | 79335-75-4 | Reference compound |
| HY-W746828 | Oxindole-3-acetic acid-13C6 | 2724918-56-1 | Isotope-Labeled Compounds |
| HY-W746888 | 17-Phenyl trinor prostaglandin F2α diethyl amide | 1176637-26-5 | Reference compound |
| HY-W746944S | N-[2-(1H-Indol-3-yl)acetyl]-L-phenylalanine methyl ester-d4 | Isotope-Labeled Compounds | |
| HY-W746984 | (±)-Tuberonic Acid | 221682-86-6 | Reference compound |
| HY-W747072 | 3-Sulfo-taurocholic Acid Disodium Salt | 71781-33-4 | Reference compound |
| HY-W747086 | (Z)-5-Dodecen-1-ol | 40642-38-4 | Natural Products |
| HY-W747088 | (2Z,13Z)-Octadecadienyl acetate | 86252-65-5 | Natural Products |
| HY-W747097 | Sacubitrilat-13C4 | Isotope-Labeled Compounds | |
| HY-W747104 | (9E)-Tetradecen-1-ol | 52957-16-1 | Natural Products |
| HY-W747105 | (2E,13Z)-Octadecadienyl acetate | 86252-74-6 | Natural Products |
| HY-W747112 | (Z)-10-Hexadecenal | 68279-24-3 | Natural Products |
| HY-W747206 | Traumatin | 65410-38-0 | Natural Products |
| HY-W747214 | Thymine-15N2,13C | Isotope-Labeled Compounds | |
| HY-W747311 | Ritipenem | 84845-57-8 | Reference compound |
| HY-W747366 | Fmoc-L-Glu-pNA | 185547-51-7 | Biochemical Assay Reagents |
| HY-W747445 | 3,4-Cyclohexenoesculetin β-D-galactopyranoside | 182805-65-8 | Biochemical Assay Reagents |
| HY-W747491 | Triclosan-13C12 | 1365620-36-5 | Isotope-Labeled Compounds |
| HY-W747504 | TAN-420E | 91700-93-5 | Natural Products |
| HY-W747507 | Reveromycin D | 144860-70-8 | Reference compound |
| HY-W747516 | Butylcycloheptylprodigiosin | 352304-41-7 | Natural Products |
| HY-W747533 | C8 Ceramine, D-erythro | 170926-06-4 | Reference compound |
| HY-W747548 | 12(S)-HEPE | 116180-17-7 | Reference compound |
| HY-W747562 | Leukotriene A 3 methyl ester | 83851-38-1 | Reference compound |
| HY-W747563 | 11-trans Leukotriene D4 | 79768-40-4 | Reference compound |
| HY-W747564 | (+/-)12-HpETE | 71030-35-8 | Reference compound |
| HY-W747565 | Leukotriene B4-3-aminopropylamide | 89596-43-0 | Reference compound |
| HY-W747567 | Leukotriene E4 methyl ester | 89461-65-4 | Reference compound |
| HY-W747572 | (+)-Perillyl alcohol | 57717-97-2 | Reference compound |
| HY-W747573 | N-Linolenoylethanolamine | 57086-93-8 | Reference compound |
| HY-W747575 | (+/-)13-HODE cholesteryl ester | 167354-91-8 | Reference compound |
| HY-W747581 | Deoxycorticosterone 21-glucoside | 4319-56-6 | Biochemical Assay Reagents |
| HY-W747583 | Apocholic acid | 641-81-6 | Natural Products |
| HY-W747594 | SDZ PCO 400 | 121055-10-5 | Reference compound |
| HY-W747597 | Ganglioside GD1b Disodium Salt (Bovine Brain) | 19553-76-5 | Reference compound |
| HY-W747599 | Ganglioside GQ1b (bovine) (sodium) | 68652-37-9 | Natural Products |
| HY-W747611S | Thiacloprid-amide-d4 | Isotope-Labeled Compounds | |
| HY-W747621 | Ethyl formate-13C | 73222-61-4 | Isotope-Labeled Compounds |
| HY-W747631 | Diethylene glycol monopentyl ether | 18912-81-7 | Biochemical Assay Reagents |
| HY-W747639 | Glycidyl Stearate-13C3 | 2725395-41-3 | Isotope-Labeled Compounds |
| HY-W747648 | (+)-Norgestrel | 797-64-8 | Reference compound |
| HY-W747682 | Cilnidipine-d3 | 2714484-05-4 | Isotope-Labeled Compounds |
| HY-W747703 | Hippuric acid-13C6 | 1163160-18-6 | Isotope-Labeled Compounds |
| HY-W747736 | BVdUMP | 80860-82-8 | Reference compound |
| HY-W747737 | BVDU 5′-Triphosphate | 77222-61-8 | Reference compound |
| HY-W747737A | BVDU 5′-Triphosphate (ammonium) | Reference compound | |
| HY-W747757 | N-Arachidonoyl-L-serine-d8 | 2699607-45-7 | Isotope-Labeled Compounds |
| HY-W747795 | Digitoxin-d3 | Isotope-Labeled Compounds | |
| HY-W747868 | Molidustat (sodium) | 1375799-59-9 | Reference compound |
| HY-W747994 | Atramycin A | 137109-48-9 | Natural Products |
| HY-W748000 | Kocurin | 1374772-61-8 | Peptides |
| HY-W748013 | Cervinomycin A2 | 82658-22-8 | Natural Products |
| HY-W748023 | Cryptosporiopsin A | 1402990-52-6 | Natural Products |
| HY-W748030 | Griseoviridin | 53216-90-3 | Natural Products |
| HY-W748035 | Etamycin A | 299-20-7 | Natural Products |
| HY-W748107 | (Rac)-Fosfomycin-d5 (benzylamine) | Isotope-Labeled Compounds | |
| HY-W748196S | 1,2,3,4,6,7-Hexachloro dibenzo-p-dioxin-13C12 | 910107-83-4 | Isotope-Labeled Compounds |
| HY-W748204 | 1,2,3,7,8-Pentachloro dibenzo-p-dioxin-13C12 | 109719-79-1 | Isotope-Labeled Compounds |
| HY-W748282 | 2,3,3',4,4',5,5',6-Octachloro-1,1'-biphenyl-13C12 | 234446-64-1 | Isotope-Labeled Compounds |
| HY-W748284 | 2,4,4'-Trichloro-1,1'-biphenyl-13C12 | 208263-76-7 | Isotope-Labeled Compounds |
| HY-W748290 | 3,4,4',5-Tetrachloro-1,1'-biphenyl-13C12 | 208461-24-9 | Isotope-Labeled Compounds |
| HY-W748291 | 2,3,4,4',5-Pentachloro-1,1'-biphenyl-13C12 | 208263-63-2 | Isotope-Labeled Compounds |
| HY-W748297 | NK 19 (diiodide) | 3571-88-8 | Dye Reagents |
| HY-W748299 | 1,2,3,6,7,8-Hexachloro-dibenzofuran-13C12 | 116843-03-9 | Isotope-Labeled Compounds |
| HY-W748303 | 1,2,3,7,8,9-Hexachloro-dibenzofuran-13C12 | 116843-04-0 | Isotope-Labeled Compounds |
| HY-W748312 | 1,?2,?3,?4,?7,?8,?9-Heptachloro-dibenzofuran-?13C12 | 109719-94-0 | Isotope-Labeled Compounds |
| HY-W748314 | 2,2',6-Trichloro-1,1'-biphenyl-13C12 | 234432-87-2 | Isotope-Labeled Compounds |
| HY-W748319 | K 101-13C12 | 104130-39-4 | Isotope-Labeled Compounds |
| HY-W748320 | 2,2',3,3',4,5,5',6,6'-Nonachloro-1,1'-biphenyl-13C12 | 234432-92-9 | Isotope-Labeled Compounds |
| HY-W748321 | 2,2',3,4',5,6,6'-heptachloro-1,1'-biphenyl-13C12 | 234432-91-8 | Isotope-Labeled Compounds |
| HY-W748322 | 1,?2,?3,?4,?7,?8-?Hexachloro-dibenzofuran-?13C12 | 114423-98-2 | Isotope-Labeled Compounds |
| HY-W748327 | 2,5-Dichloro-1,1'-biphenyl-13C12 | 250694-89-4 | Isotope-Labeled Compounds |
| HY-W748328 | Ixazomib-13C2,15N | Isotope-Labeled Compounds | |
| HY-W748332 | PCB118-13C12 | 104130-40-7 | Isotope-Labeled Compounds |
| HY-W748343 | 2,2',5,5'-Tetrachloro-1,1'-biphenyl-13C12 | 208263-80-3 | Isotope-Labeled Compounds |
| HY-W748345 | 2,3',4,4',5,5'-Hexachloro-1,1'-biphenyl-13C12 | 208263-69-8 | Isotope-Labeled Compounds |
| HY-W748346 | 2,2′,3,3′,5,5′,6-Heptachloro biphenyl-13C12 | 232919-67-4 | Isotope-Labeled Compounds |
| HY-W748349 | 2,2',3,3',4,4',5,5'-Octachloro-1,1'-biphenyl-13C12 | 208263-74-5 | Isotope-Labeled Compounds |
| HY-W748350 | 2,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenyl-13C12 | 208263-75-6 | Isotope-Labeled Compounds |
| HY-W748354 | 2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl-13C12 | 234432-90-7 | Isotope-Labeled Compounds |
| HY-W748355 | 2,2',3,3',5,5',6,6'-Octachloro-1,1'-biphenyl-13C12 | 105600-26-8 | Isotope-Labeled Compounds |
| HY-W748361 | Sulfo-Cy3(Me)COOH (sodium) | 1941997-61-0 | Dye Reagents |
| HY-W748362 | 1-(1-Methyl-1H-indol-3-yl)-2-(1-naphthalenyl)ethanone | 1638677-49-2 | Reference compound |
| HY-W748412 | Dantrolene-d4 | 2749234-17-9 | Isotope-Labeled Compounds |
| HY-W748456 | Apigenin-7-O-sulfate (potassium) | 120562-19-8 | Natural Products |
| HY-W748509 | Pipernonaline | 88660-10-0 | Natural Products |
| HY-W748514 | (4-(Bromomethyl)phenyl)(4-(prop-2-yn-1-yloxy)phenyl)methanone | 1695554-80-3 | Reference compound |
| HY-W748591 | Cannflavin A | 76735-57-4 | Natural Products |
| HY-W748591R | Cannflavin A (Standard) | 76735-57-4 | Reference Standards |
| HY-W748594 | Apigenin triacetate | 3316-46-9 | Natural Products |
| HY-W748705 | Aminomethanephosphonic acid-13C,15N | Isotope-Labeled Compounds | |
| HY-W748840 | 1-Stearoyl-3-oleoyl-2-chloropropanediol | 1639207-45-6 | Natural Products |
| HY-W748956 | Exemestane-13C,d3 | Isotope-Labeled Compounds | |
| HY-W748961 | Norethindrone Acetate-2,2,4,6,6,10-d6 | Isotope-Labeled Compounds | |
| HY-W749012 | (2,4,6-Trichlorophenoxy)acetic acid-13C6 | Isotope-Labeled Compounds | |
| HY-W749072 | BP Fluor 568 NHS ester | 2227463-25-2 | Reference compound |
| HY-W749117 | Inosine 5′-diphosphate (sodium) | 81012-88-6 | Reference compound |
| HY-W749143 | Bombykal | 63024-98-6 | Natural Products |
| HY-W749146 | Raja 42 | 1198782-86-3 | Oligonucleotides |
| HY-W749169 | FAM tetrazine, 5-isomer | 1619222-85-3 | Dye Reagents |
| HY-W749209 | Sodium Acetate-1,2-13C2 | 56374-56-2 | Isotope-Labeled Compounds |
| HY-W749242 | Paclobutrazol-d4 | Isotope-Labeled Compounds | |
| HY-W749251 | 5-Aminolevulinic acid-13C2,15N (hydrochloride) | 113639-01-3 | Isotope-Labeled Compounds |
| HY-W749297 | Bleomycin B2 | 9060-10-0 | Natural Products |
| HY-W749323 | 21-Hydroxyeplerenone | 334678-67-0 | Reference compound |
| HY-W749374 | 1,2-Bis(2,4,6-tribromophenoxy)ethane-13C12 | 2724878-45-7 | Isotope-Labeled Compounds |
| HY-W749404 | Clobetasone 17-Propionate | 25122-56-9 | Reference compound |
| HY-W749411 | Malondialdehyde tetrabutylammonium | 100683-54-3 | Reference compound |
| HY-W749442 | 7a-Hydroxyfrullanolide | 105578-87-8 | Natural Products |
| HY-W749498 | Metrafenone-d9 | 2140327-64-4 | Isotope-Labeled Compounds |
| HY-W749510 | Spiroxamine-d4 | 2469272-82-8 | Isotope-Labeled Compounds |
| HY-W749520 | Zymosterone | 27192-37-6 | Natural Products |
| HY-W749558 | 2′-Hydroxyformononetin | 1890-99-9 | Reference compound |
| HY-W749562 | Gossyplure | 50933-33-0 | Natural Products |
| HY-W749569 | Vaccenic acid chloride | 117485-96-8 | Natural Products |
| HY-W749603 | Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) | 479081-06-6 | Biochemical Assay Reagents |
| HY-W749614 | NO2A-Butyne-bis(t-Butyl ester) | 2125661-91-6 | Biochemical Assay Reagents |
| HY-W749617 | Poly(ethylene glycol) Monooleate (MW=860) | 9004-96-0 | Biochemical Assay Reagents |
| HY-W749627 | NO2A-Butyne | 2089035-56-1 | Biochemical Assay Reagents |
| HY-W749636 | N-De-2,4-difluorobenzyl dolutegravir | 1485081-26-2 | Reference compound |
| HY-W749641 | (7Z,9E)-Dodecadienyl acetate | 55774-32-8 | Natural Products |
| HY-W749649 | Neomenthoglycol | 3564-95-2 | Natural Products |
| HY-W749691 | (S)-Velpatasvir-13c,d3 | Isotope-Labeled Compounds | |
| HY-W749694 | Cannflavin B | 76735-58-5 | Natural Products |
| HY-W749756 | rac-1,2-Distearoyl-3-chloropropanediol-13C3 | 2740880-40-2 | Isotope-Labeled Compounds |
| HY-W749784 | 1-Decanoyl-2-lauroyl-3-chloropropanediol | 2468637-80-9 | Natural Products |
| HY-W749797 | Nitrazolam | 28910-99-8 | Reference compound |
| HY-W749852 | Xanthine (sodium), 98% | 1196-43-6 | Biochemical Assay Reagents |
| HY-W749852A | Xanthine sodium, for cell culture | 1196-43-6 | Biochemical Assay Reagents |
| HY-W749867 | Ca(II)-EDTA (disodium dihydrate) | 6766-87-6 | Biochemical Assay Reagents |
| HY-W749873 | D-Sphingosine sulfate | 56607-20-6 | Natural Products |
| HY-W749874 | Qingdainone | 97457-31-3 | Natural Products |
| HY-W749884 | Isogalactinol | 16908-86-4 | Biochemical Assay Reagents |
| HY-W749927 | (Z)-9-Heptadecenoic Acid | 1981-50-6 | Reference compound |
| HY-W749928 | trans-2-Octadecenoic acid | 2825-79-8 | Biochemical Assay Reagents |
| HY-W749948 | Acephate-d6 | 2109699-73-0 | Isotope-Labeled Compounds |
| HY-W749966 | Octocrylene-d10 | 2714435-95-5 | Isotope-Labeled Compounds |
| HY-W749979 | (-)-Vernolic acid | 32381-42-3 | Natural Products |
| HY-W749980 | Coronaric acid | 16833-56-0 | Natural Products |
| HY-W749982 | Coronaric acid methyl ester | 6084-72-6 | Natural Products |
| HY-W750129 | (3E,8Z)-3,8-Tetradecadienyl acetate | 163041-87-0 | Natural Products |
| HY-W750155 | Tetramethrin-d6 | 2714421-39-1 | Isotope-Labeled Compounds |
| HY-W750190 | L-Arginine 7-amido-4-methylcoumarin (dihydrochloride) | 113712-08-6 | Biochemical Assay Reagents |
| HY-W750196 | Acetic acid-13C,d3 (sodium) | 102212-93-1 | Isotope-Labeled Compounds |
| HY-W750197 | 2-Octanoyl-1,3-distearin-octanoic-1-13C | 121043-30-9 | Isotope-Labeled Compounds |
| HY-W750265 | Dexamethasone Phosphate-d5 | Isotope-Labeled Compounds | |
| HY-W750297 | p,p'-DDD-13C12 | 1571957-95-3 | Isotope-Labeled Compounds |
| HY-W750342 | Tryptophol-d4 | 75238-45-8 | Isotope-Labeled Compounds |
| HY-W750432 | Para red-d6 | 1014689-16-7 | Isotope-Labeled Compounds |
| HY-W750435 | New Red | 220658-76-4 | Dye Reagents |
| HY-W750451 | Reptoside | 53839-03-5 | Natural Products |
| HY-W750458 | Acid Violet 7 | 4321-69-1 | Biochemical Assay Reagents |
| HY-W750459 | Fluorescent brightener 28 (Technical Grade) | 4404-43-7 | Dye Reagents |
| HY-W750551 | Glyphosate-13C,15N | 285978-24-7 | Isotope-Labeled Compounds |
| HY-W750583 | (11Z,14Z)-Ethyl icosa-11,14-dienoate | 103213-62-3 | Natural Products |
| HY-W750595 | 6-(L-1,2,3-Trihydroxybutyl)-pterin | 13392-24-0 | Reference compound |
| HY-W750599 | Boron-10 | 14798-12-0 | Isotope-Labeled Compounds |
| HY-W750600 | Acetonitrile-15N | 14149-39-4 | Isotope-Labeled Compounds |
| HY-W750674 | Indole-3-carboxaldehyde-13C8 | Isotope-Labeled Compounds | |
| HY-W750676 | (rac./meso)-Astaxanthin | 7542-45-2 | Natural Products |
| HY-W750676R | (rac./meso)-Astaxanthin (Standard) | 7542-45-2 | Reference Standards |
| HY-W750792 | Acetic acid-13C,d3-1 (sodium) | 85355-10-8 | Isotope-Labeled Compounds |
| HY-W750796 | Butyric acid-13C4 (sodium) | 312623-84-0 | Isotope-Labeled Compounds |
| HY-W750822 | 7-APB (hydrochloride) | 286834-86-4 | Reference compound |
| HY-W750902 | Oxymatrine-d3 | 2714484-46-3 | Isotope-Labeled Compounds |
| HY-W750960 | Biotinylated isoxazole | 1377605-22-5 | Reference compound |
| HY-W750960R | Biotinylated isoxazole (Standard) | 1377605-22-5 | Reference Standards |
| HY-W751072 | Hexamethylenimine-d4 | 2089332-67-0 | Isotope-Labeled Compounds |
| HY-W751098 | Aldosterone-13C3 | Isotope-Labeled Compounds | |
| HY-W751099 | Corticosterone-13C3 | Isotope-Labeled Compounds | |
| HY-W751145 | Diphenyl ether-13C12 | 2483735-44-8 | Isotope-Labeled Compounds |
| HY-W751152 | α,β-Thujone | 76231-76-0 | Natural Products |
| HY-W751152R | α,β-Thujone (Standard) | 76231-76-0 | Reference Standards |
| HY-W751165 | Uridine-13C9,15N2 | 202406-84-6 | Isotope-Labeled Compounds |
| HY-W751198 | Vitamin D-C22 acid | 99518-38-4 | Reference compound |
| HY-W751295S | Bisphenol A diglycidyl ether phenol-diol-d14 | Isotope-Labeled Compounds | |
| HY-W751295S1 | Bisphenol A diglycidyl ether phenol-diol-d6 | Isotope-Labeled Compounds | |
| HY-W751322 | α-Amylcinnamaldehyde dimethyl acetal | 91-87-2 | Reference compound |
| HY-W751400 | Solasodine (hydrochloride) | 6106-33-8 | Natural Products |
| HY-W751418 | N-Nervonoyl taurine | 1942003-30-6 | Natural Products |
| HY-W751431 | (E,Z)-4,7-Tridecadienyl acetate | 57981-60-9 | Natural Products |
| HY-W751574 | Elagolix-d6 (sodium) | Isotope-Labeled Compounds | |
| HY-W751734 | HU 433 | 1220887-84-2 | Reference compound |
| HY-W751820 | 1,2:5,6-Bis-O-(1-methylethylidene)-D-chiro-inositol | 40617-60-5 | Biochemical Assay Reagents |
| HY-W751835 | Baloxavir-d4 | 2415027-80-2 | Isotope-Labeled Compounds |
| HY-W751874 | Acetyl methylene blue | 3763-06-2 | Reference compound |
| HY-W751899 | 10-Heneicosanone | 22026-16-0 | Natural Products |
| HY-W751932 | Carboxy-EG6-undecanethiol | 221222-49-7 | Biochemical Assay Reagents |
| HY-W751961 | 2'-Deoxyadenosine-15N5 | Isotope-Labeled Compounds | |
| HY-W752039 | (9Z,12Z,15Z,18Z,21Z)–Tetracosapentaenoic acid | 68378-48-3 | Reference compound |
| HY-W752053 | 6-Hydroxygenistein | 13539-26-9 | Natural Products |
| HY-W752055 | (Rac)-Nebivolol-d4 (hydrochloride) | 2701283-32-9 | Isotope-Labeled Compounds |
| HY-W752582 | Cortisol-1,2-d2 | 79037-25-5 | Isotope-Labeled Compounds |
| HY-W752582R | Cortisol-1,2-d2 (Standard) | 79037-25-5 | Reference Standards |
| HY-W752631 | Furfuryl-d5 alcohol | 1398065-62-7 | Isotope-Labeled Compounds |
| HY-W752884 | Phenyltin-d5 (chloride) | Isotope-Labeled Compounds | |
| HY-W753141 | p,p'-DDE-13C12 | 201612-50-2 | Isotope-Labeled Compounds |
| HY-W753270S | Metazachlor metabolite BH479-12-d3 | Isotope-Labeled Compounds | |
| HY-W753281 | Dexamethasone metasulfobenzoate (sodium) | 3936-02-5 | Reference compound |
| HY-W753281R | Dexamethasone metasulfobenzoate (sodium) (Standard) | 3936-02-5 | Reference Standards |
| HY-W753325 | α-Hydroxy flualprazolam | 37115-46-1 | Reference compound |
| HY-W753326 | N-Isopropyl hexylone (hydrochloride) | 27912-43-2 | Reference compound |
| HY-W753375 | Fluindapyr | 1383809-87-7 | Reference compound |
| HY-W753375R | Fluindapyr (Standard) | 1383809-87-7 | Reference Standards |
| HY-W753376 | Cinnabarinic acid-d4 | Isotope-Labeled Compounds | |
| HY-W753474 | 1,2-Dipalmitelaidoyl-sn-glycero-3-phosphocholine | 56816-00-3 | Biochemical Assay Reagents |
| HY-W753479 | Cannflavin C | 1086463-05-9 | Natural Products |
| HY-W753500 | (E,E)-9,11-Tetradecadienyl acetate | 54664-98-1 | Natural Products |
| HY-W753521 | Deleobuvir (sodium) | 1370023-80-5 | Reference compound |
| HY-W753532 | Bisphenol B-13C12 | Isotope-Labeled Compounds | |
| HY-W753582 | 1-Methyl-2-azaadamantane-N-oxyl | 872598-44-2 | Reference compound |
| HY-W753602 | Acetamiprid-N-desmethyl-13C,d3 | Isotope-Labeled Compounds | |
| HY-W753671 | 2,6-Diaminoheptanedioic acid-13C7 | 1485529-87-0 | Isotope-Labeled Compounds |
| HY-W753672 | 2'-O-Methyladenosine-d3 | 1195030-24-0 | Isotope-Labeled Compounds |
| HY-W753709 | γ-Linolenyl alcohol | 24149-05-1 | Natural Products |
| HY-W753724 | N-Ethyl 2C-B (hydrochloride) | 155638-84-9 | Reference compound |
| HY-W753726 | Dihydromonacolin L | 86827-77-2 | Reference compound |
| HY-W753765 | Heparin disaccharide IV-H | 123228-39-7 | Biochemical Assay Reagents |
| HY-W753779 | 8-Hydroxygenistein | 13539-27-0 | Natural Products |
| HY-W753791 | (±)-Perillaldehyde | 2111-75-3 | Reference compound |
| HY-W753806 | Doxazosin (hydrochloride) | 70918-01-3 | Reference compound |
| HY-W753807 | 1,3-Dielaidin | 98168-52-6 | Biochemical Assay Reagents |
| HY-W753808 | Diosmetinidin (chloride) | 64670-94-6 | Natural Products |
| HY-W753820A | Boc-LRR-AMC (TFA) | Peptides | |
| HY-W753904 | Pradofloxacin | 195532-12-8 | Reference compound |
| HY-W753927 | 9(Z),12(E)-Octadecadienoic Acid | 2420-42-0 | Reference compound |
| HY-W753983 | Pyruvic acid-13C3 | 378785-77-4 | Isotope-Labeled Compounds |
| HY-W754020 | Elbanizine | 110629-41-9 | Reference compound |
| HY-W754025 | Pre-vitamin D3 decanoate | 927822-18-2 | Reference compound |
| HY-W754135 | Indoxacarb-d3 | Isotope-Labeled Compounds | |
| HY-W754151 | N-Desmethyl apalutamide-d4 | Isotope-Labeled Compounds | |
| HY-W754220 | Scutellarein-d6 | Isotope-Labeled Compounds | |
| HY-W754588 | exo-BCN-L-Lysine | 1384100-45-1 | Reference compound |
| HY-W754600 | BZO-CHMOXIZID | 1048973-67-6 | Reference compound |
| HY-W754640 | Isopropyl 2-hydroxybenzoate-d7 | Isotope-Labeled Compounds | |
| HY-W754691 | Glaziovine | 6808-72-6 | Natural Products |
| HY-W754708 | Ouabagenin | 508-52-1 | Natural Products |
| HY-W754718 | Azepinomycin | 89354-15-4 | Natural Products |
| HY-W754764S | 11-(4-Nitrosopiperazin-1-yl)dibenzo[b,f][1,4]thiazepine-d8 | Isotope-Labeled Compounds | |
| HY-W754777 | IPPD-Q | 68054-73-9 | Reference compound |
| HY-W754811 | Trifluoroacetic acid-13C (sodium) | 286425-32-9 | Isotope-Labeled Compounds |
| HY-W754842 | Saxagliptin-13C,d2-1 (hydrochloride) | 2699827-95-5 | Isotope-Labeled Compounds |
| HY-W754878 | Pemigatinib-d6 | 2649492-49-7 | Isotope-Labeled Compounds |
| HY-W754911 | Avapritinib-d3 | 2408934-57-4 | Isotope-Labeled Compounds |
| HY-W754950 | 6PPD-d5 | Isotope-Labeled Compounds | |
| HY-W755003 | Guanosine-13C5 | 159496-14-7 | Isotope-Labeled Compounds |
| HY-W755033 | NH2-PEG4-DOTA | 2090232-34-9 | Reference compound |
| HY-W755036 | Oxytetracycline-13C,d3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W755107 | (1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester | 1292307-06-2 | Reference compound |
| HY-W755222 | (S)-NODAGA-tris(t-Bu ester) | 438553-50-5 | Biochemical Assay Reagents |
| HY-W755252 | N-Butyl-N-(4-hydroxybutyl)nitrosamine | 3817-11-6 | Reference compound |
| HY-W755262 | Benzyl 2-acetamido-2-deoxy-3,6-di-O-benzyl-β-D-glucopyranoside | 62867-63-4 | Biochemical Assay Reagents |
| HY-W755295 | Mabuterol (hydrochloride) | 54240-36-7 | Reference compound |
| HY-W755295R | Mabuterol (hydrochloride) (Standard) | 54240-36-7 | Reference Standards |
| HY-W755338 | 4-Chloro-α-cyanocinnamic acid | 20374-46-3 | Reference compound |
| HY-W755726 | Sodium 2-((4-fluorophenyl)(isopropyl)amino)-2-oxoethane-1-sulfonate-d7 | Isotope-Labeled Compounds | |
| HY-W756041 | rel-(1S,2S)-Dihydro bupropion-d9 (hydrochloride) | 1392209-60-7 | Isotope-Labeled Compounds |
| HY-W756134 | Chenodeoxycholic acid 24-acyl-β-D-glucuronide-d5 (sodium) | Isotope-Labeled Compounds | |
| HY-W756217 | (R)-Monepantel | 887148-70-1 | Reference compound |
| HY-W756596 | 1,2-Dioctanoyl-3-chloropropanediol-d5 | 2714417-65-7 | Isotope-Labeled Compounds |
| HY-W756654 | Homoglutathione (TFA) | Reference compound | |
| HY-W756790 | MDMB-FUBINACA metabolite M1 | 2693397-47-4 | Reference compound |
| HY-W757743 | Acalabrutinib-d3 | Isotope-Labeled Compounds | |
| HY-W758126 | (R)-Brivanib alaninate-d4 | Isotope-Labeled Compounds | |
| HY-W759404 | Clascoterone-d5 | Isotope-Labeled Compounds | |
| HY-W759629 | Selpercatinib-d3 | 2433775-55-2 | Isotope-Labeled Compounds |
| HY-W759845 | Aficamten-d3 | Isotope-Labeled Compounds | |
| HY-W759873S | ADB-5'Br-BUTINACA-d9 (CRM) | Isotope-Labeled Compounds | |
| HY-W759947 | 24-Nor ursodeoxycholic acid-d5 acyl-b-D-glucuronide | Isotope-Labeled Compounds | |
| HY-W760183 | EM12-SO2F | 2803819-61-4 | Reference compound |
| HY-W760342 | 5-Bromo-1-methyl-1H-indazole-d3 | 1976004-20-2 | Isotope-Labeled Compounds |
| HY-W760546 | SARS-CoV-2 3CLpro-IN-15 | 3156-41-0 | Reference compound |
| HY-W760733 | 2,4-Decadienal | 2363-88-4 | Biochemical Assay Reagents |
| HY-W761299 | PD 4'-oxyacetic acid | 2633633-12-0 | Reference compound |
| HY-W762011 | BDE 47 | 5436-43-1 | Reference compound |
| HY-W762011R | BDE 47 (Standard) | 5436-43-1 | Reference Standards |
| HY-W762012 | Octachlorodibenzo-p-dioxin | 3268-87-9 | Reference compound |
| HY-W762012S | Octachlorodibenzo-p-dioxin-13C12 | 114423-97-1 | Isotope-Labeled Compounds |
| HY-W762015 | 1,2,3,6,7,8-Hexachlorodibenzofuran | 57117-44-9 | Reference compound |
| HY-W762018 | 2,3,4,6,7,8-Hexachlorodibenzofuran | 60851-34-5 | Reference compound |
| HY-W762019 | 1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin | 39227-28-6 | Reference compound |
| HY-W762019S | 1,2,3,4,7,8-Hexachloro dibenzo-p-dioxin-13C12 | 109719-80-4 | Isotope-Labeled Compounds |
| HY-W762060 | Metiram | 9006-42-2 | Reference compound |
| HY-W763546A | Poly(ethylene glycol) diglycidyl ether (MW 500) | 26403-72-5 | Biochemical Assay Reagents |
| HY-W763546B | Poly(ethylene glycol) diglycidyl ether (MW 2000) | 26403-72-5 | Biochemical Assay Reagents |
| HY-W763546C | Poly(ethylene glycol) diglycidyl ether (MW 6000) | 26403-72-5 | Biochemical Assay Reagents |
| HY-W763546D | Poly(ethylene glycol) diglycidyl ether (MW 1000) | 26403-72-5 | Biochemical Assay Reagents |
| HY-W763557A | Poly(ethylene glycol) methacrylate (MW 360) | 25736-86-1 | Biochemical Assay Reagents |
| HY-W763557B | Poly(ethylene glycol) methacrylate (MW 500) | 25736-86-1 | Biochemical Assay Reagents |
| HY-W763560 | Sorbitan Sesquioleate | 8007-43-0 | Biochemical Assay Reagents |
| HY-W763562 | Tridecanol (mixture of isomers) | 26248-42-0 | Biochemical Assay Reagents |
| HY-W763569 | Gluten, Wheat | 8002-80-0 | Biochemical Assay Reagents |
| HY-W763569A | Hydrolyzed Glutenin | 8002-80-0 | Biochemical Assay Reagents |
| HY-W763575 | Canada Balsam filtered | 8007-47-4 | Biochemical Assay Reagents |
| HY-W763582 | GelMA, 30% methacrylation | 2280018-77-9 | Biochemical Assay Reagents |
| HY-W763582A | GelMA, 60% methacrylation | 2280018-77-9 | Biochemical Assay Reagents |
| HY-W763582B | GelMA, 90% methacrylation | 2280018-77-9 | Biochemical Assay Reagents |
| HY-W763591A | Polyethylene glycol dimethyl ether (MW=250) | 24991-55-7 | Biochemical Assay Reagents |
| HY-W763591B | Polyethylene glycol dimethyl ether (MW=500) | 24991-55-7 | Biochemical Assay Reagents |
| HY-W763591C | Polyethylene glycol dimethyl ether (MW=1000) | 24991-55-7 | Biochemical Assay Reagents |
| HY-W763591D | Polyethylene glycol dimethyl ether (MW=2000) | 24991-55-7 | Biochemical Assay Reagents |
| HY-W763597 | Poly(ethylene glycol) phenyl ether acrylate (MW 320) | 56641-05-5 | Biochemical Assay Reagents |
| HY-W763598B | Polyethylene glycol distearate (Mn 930) | 9005-08-7 | Biochemical Assay Reagents |
| HY-W763706A | Tamarind Gum from Tamarind seed, 98% | 39386-78-2 | Biochemical Assay Reagents |
| HY-W763806 | Zein | 9010-66-6 | Biochemical Assay Reagents |
| HY-W764182 | Cephalosporinase,bacillus | 9012-26-4 | Enzyme |
| HY-W764183 | Carboxymethyldextran sodium salt (MW 10000) | 39422-83-8 | Biochemical Assay Reagents |
| HY-W764183A | Carboxymethyldextran sodium salt (MW 40000) | 39422-83-8 | Biochemical Assay Reagents |
| HY-W764737 | Methylboronic acid pinacol ester-d3 | 2413695-26-6 | Isotope-Labeled Compounds |
| HY-W764758 | 3-OH-Kynurenamine (dihydroiodide) | 2155855-77-7 | Reference compound |
| HY-W765182 | Emamectin-d3 | Isotope-Labeled Compounds | |
| HY-W766569 | N-Acetyl S-(1,2-dichlorovinyl)-L-cysteine-13C,d3 | Isotope-Labeled Compounds | |
| HY-W766769 | Cyproterone Acetate-13C2,d3 | Isotope-Labeled Compounds | |
| HY-W766801 | rac-1-Linoleoyl-3-chloropropanediol-d5 | 2489621-72-7 | Isotope-Labeled Compounds |
| HY-W766807 | rac-1,2-Dilinoleoyl-3-chloropropanediol-d5 | 2489622-06-0 | Isotope-Labeled Compounds |
| HY-W766831 | rac 1-oleoyl-2-linoleoyl-3-chloropropanediol-d5 | 2489623-58-5 | Isotope-Labeled Compounds |
| HY-W767228 | Decitabine-15N4 | Isotope-Labeled Compounds | |
| HY-W767484 | Nicotinamide riboside-d4 (triflate) | Isotope-Labeled Compounds | |
| HY-W767656 | Dropropizine-d4 | 2514953-45-6 | Isotope-Labeled Compounds |
| HY-W767866 | N-Acetyl-S-(2-carboxyethyl)cysteine-13C3 (dicyclohexylamine) | Isotope-Labeled Compounds | |
| HY-W768291 | [1-13Cgal]Lactose (monohydrate) | Isotope-Labeled Compounds | |
| HY-W768338 | Sucrose-13C | Isotope-Labeled Compounds | |
| HY-W768340 | Sucrose-13C6-1 | Isotope-Labeled Compounds | |
| HY-W768345 | D-(+)-Trehalose-13C12 | 1313730-07-2 | Isotope-Labeled Compounds |
| HY-W768398 | Ethephon-13C2 | 2724727-43-7 | Isotope-Labeled Compounds |
| HY-W768581 | Acetoin-13C4 | Isotope-Labeled Compounds | |
| HY-W768607 | 5-Fluoro PB-22 8-hydroxyisoquinoline isomer | 2365470-99-9 | Reference compound |
| HY-W768883 | β-Nicotyrine-d3 | Isotope-Labeled Compounds | |
| HY-W769017 | Thiothiamine-13C3 | Isotope-Labeled Compounds | |
| HY-W769279 | Felodipine-13C4,d3 | Isotope-Labeled Compounds | |
| HY-W769381 | Lycopsamine N-oxide-d7 | Isotope-Labeled Compounds | |
| HY-W769576 | Tetrabromobisphenol A-d6 | Isotope-Labeled Compounds | |
| HY-W769714 | Favipiravir-13C3 | Isotope-Labeled Compounds | |
| HY-W769935 | 5-POHSA | 2161370-68-7 | Reference compound |
| HY-W769938 | FUB-NPB-22 | 2244864-90-0 | Reference compound |
| HY-W770183 | Uric acid-13C3 | 2832998-22-6 | Isotope-Labeled Compounds |
| HY-W770278 | Bisphenol Z-13C12 | Isotope-Labeled Compounds | |
| HY-W770295 | 2,3,4,5-Tetrabromobenzoic acid-13C6 | 2710628-49-0 | Isotope-Labeled Compounds |
| HY-W770410 | 9-PAHSA-13C4 | 2748638-71-1 | Isotope-Labeled Compounds |
| HY-W770434 | Octrizole-13C6 | Isotope-Labeled Compounds | |
| HY-W771599 | ASC-69 | 1216665-50-7 | Reference compound |
| HY-W772341 | Acetic acid-1-13c | 1563-79-7 | Isotope-Labeled Compounds |
| HY-W772772 | Tributylchlorogermane | 2117-36-4 | Biochemical Assay Reagents |
| HY-W772850 | Fenclonine (hydrochloride) | 23633-07-0 | Reference compound |
| HY-W772863 | 13-Oxo-octadecanoic acid | 2389-06-2 | Natural Products |
| HY-W772974 | 3-Dimethylaminooxalyl-4-acetylindole | 30000-66-9 | Reference compound |
| HY-W773183 | Methyl betulonate | 4356-31-4 | Reference compound |
| HY-W773487 | FtsZ-IN-10 | 676995-91-8 | Reference compound |
| HY-W773779 | GSK3-IN-9 | 748145-12-2 | Reference compound |
| HY-W774881 | Thiabendazole-d6 | 1262551-89-2 | Isotope-Labeled Compounds |
| HY-W774905 | Diallate | 2303-16-4 | Reference compound |
| HY-W774917S | trans Chlordane-13C10 | 1262969-05-0 | Isotope-Labeled Compounds |
| HY-W774918 | Oxaziclomefone | 153197-14-9 | Reference compound |
| HY-W774918R | Oxaziclomefone (Standard) | 153197-14-9 | Reference Standards |
| HY-W774926 | Permethrin-d6 | 82523-59-9 | Isotope-Labeled Compounds |
| HY-W774934 | Isopyrazam | 881685-58-1 | Oligonucleotides |
| HY-W774970 | Ethyl heneicosanoate | 28898-67-1 | Natural Products |
| HY-W774974 | Methyl 16-methylheptadecanoat | 5129-61-3 | Natural Products |
| HY-W775009 | Imidazole salicylate | 36364-49-5 | Reference compound |
| HY-W775009R | Imidazole salicylate (Standard) | 36364-49-5 | Reference Standards |
| HY-W775174 | Citrus red 2 | 6358-53-8 | Reference compound |
| HY-W775186 | Tolprocarb | 911499-62-2 | Reference compound |
| HY-W775262 | Δ9-Tetrahydrocannabinolic acid | 23978-85-0 | Reference compound |
| HY-W775306 | Cannabidivarinic acid | 31932-13-5 | Natural Products |
| HY-W775308 | Cannabicyclolic acid | 40524-99-0 | Reference compound |
| HY-W775317 | Benzpyrimoxan | 1449021-97-9 | Reference compound |
| HY-W775325 | 7-Hydroxycannabidiol | 50725-17-2 | Reference compound |
| HY-W775325S | 7-Hydroxycannabidiol-d10 | Isotope-Labeled Compounds | |
| HY-W775346 | Delta8-THC acetate | 23050-54-6 | Reference compound |
| HY-W775348 | Tetrahydrocannabiphorol | 54763-99-4 | Reference compound |
| HY-W775354 | 1,2,3,4,7,8-Hexachlorodibenzofuran | 70648-26-9 | Reference compound |
| HY-W775385 | Metcamifen | 129531-12-0 | Reference compound |
| HY-W776810 | Methyl 4,6-O-benzylidene-2-deoxy-2-N-phthalimido-β-D | 97276-95-4 | Biochemical Assay Reagents |
| HY-W776820 | 1-Oxyl-2,2,5,5-tetramethylpyrroline-3-carboxylate NHS ester | 37558-29-5 | Reference compound |
| HY-W776824 | 2-Phthalimidolactosamine,heptaacetate (mixture of isomers) | 129647-37-6 | Biochemical Assay Reagents |
| HY-W776829 | 2,3-O-Carbonyl-1,4,6-tri-O-acetyl-α-D-mannopyranose | 53958-20-6 | Biochemical Assay Reagents |
| HY-W776843 | 4-Nitrophenyl 2-O-(6-deoxy-α-L-galactopyranosyl)-α-D-galactopyranoside | 383417-46-7 | Biochemical Assay Reagents |
| HY-W776847 | 3-(2-Iodoacetamido)-proxyl | 27048-01-7 | Reference compound |
| HY-W776848 | p-Nitrophenyl 2-O-(α-L-fucopyranosyl)-β-D-galactopyranoside | 66347-27-1 | Biochemical Assay Reagents |
| HY-W776851 | S-[2-(Iodo-4-azidosalicylamido)ethylthio]-2-thiopyridine | 175093-14-8 | Biochemical Assay Reagents |
| HY-W776852 | 2-O-Methyl-β-neuraminic acid | 56144-08-2 | Biochemical Assay Reagents |
| HY-W776853 | 4-Methylumbelliferyl β-D-N,N',N'',N'''-tetraacetylchitotetraoside | 53643-14-4 | Biochemical Assay Reagents |
| HY-W776856 | 1,2:5,6-Di-O-isopropylidene-3-O-p-toluenesulfonyl-α-D-allofuranose | 13964-21-1 | Biochemical Assay Reagents |
| HY-W776866 | 1,2:3,4-Di-O-isopropylidene-6-deoxy-6-azido-α-D-galactopyranose | 4711-00-6 | Biochemical Assay Reagents |
| HY-W776873 | 6-Azido-6-deoxy-1,2-O-(1-methylethylidene)-α-D-glucofuranose | 65371-16-6 | Biochemical Assay Reagents |
| HY-W776875 | p-Nitrophenyl 3-O-α-D-mannopyranosyl-α-D-mannopyranoside | 93979-06-7 | Biochemical Assay Reagents |
| HY-W776885 | O-n-Butanoyl-2,3,5,6-O-diisopropylidene-α-D-mannofuranoside | 177562-07-1 | Biochemical Assay Reagents |
| HY-W776886 | Benzyl 2,3-O-isopropylidene-α-D-mannopentenofuranoside-6-aldehyde | 102854-75-1 | Biochemical Assay Reagents |
| HY-W776899 | 2,5-Anhydro-1,3-O-isopropylidene-6-O-trityl-D-glucitol | 65758-50-1 | Biochemical Assay Reagents |
| HY-W776908 | 5-Azido-5-deoxy-1,2-O-(1-methylethylidene)-β-D-fructopyranose | 94801-01-1 | Biochemical Assay Reagents |
| HY-W776909 | 5-Azido-5-deoxy-3,4-di-O-acetyl-1,2-O-isopropylidene-β-D-fructose | 94801-00-0 | Biochemical Assay Reagents |
| HY-W776928 | α-D-Mannopyranoside,methyl 4,6-O-(1-methylethylidene),cyclic carbonate | 74948-73-5 | Biochemical Assay Reagents |
| HY-W776972 | N-d-Biotinyl-7-amino-4-methylcoumarin | 191223-35-5 | Biochemical Assay Reagents |
| HY-W776979 | 4-Nitrophenyl 2-benzoyl-4,6-O-benzylidene-α-D-mannopyranoside | 94063-92-0 | Biochemical Assay Reagents |
| HY-W777009 | 1,2,3-Tri-O-benzoyl-α-L-fucopyranose,Trichloroacetimidate | 180476-30-6 | Biochemical Assay Reagents |
| HY-W777012 | Acridinium C2 NHS ester | 177332-37-5 | Biochemical Assay Reagents |
| HY-W777017 | Conduritol B tetraacetate | 25348-63-4 | Biochemical Assay Reagents |
| HY-W777032 | (p-Azidosalicylamido)ethyl-1,3′-dithiopropionic acid | 107426-70-0 | Biochemical Assay Reagents |
| HY-W777041 | 4-Nitrophenyl 6-O-α-D-glucopyranosyl-α-D-glucopyranoside | 136734-56-0 | Biochemical Assay Reagents |
| HY-W777046 | 4-Nitrophenyl 3-O-α-D-glucopyranosyl-α-D-glucopyranoside | 136632-95-6 | Biochemical Assay Reagents |
| HY-W777050 | 1-Palmitoyl-2-oleoyl-3-chloropropanediol | 1363153-60-9 | Natural Products |
| HY-W777072 | 4-Isocyanato-TEMPO,Technical grade | 88418-69-3 | Reference compound |
| HY-W777089 | Benzyl 5-amino-5-deoxy-2,3-O-isopropyl-α-D-mannofuranoside | 91364-19-1 | Biochemical Assay Reagents |
| HY-W777090 | Benzyl 5-amino-5-deoxy-2,3-O-isopropylidene-6-O-trityl-α-D-mannofuranoside | 91364-15-7 | Biochemical Assay Reagents |
| HY-W777103 | (Rac)-1-Oleoyl-3-linoleoyl-glycerol | 104346-53-4 | Biochemical Assay Reagents |
| HY-W777107 | 1-Oleoyl-2-linoleoyl-rac-glycerol | 106292-55-1 | Reference compound |
| HY-W777110 | 7-(Triethylsilyl)baccatin III | 115437-21-3 | Reference compound |
| HY-W777125 | 2-Chloro-3-deazaadenosine | 40656-71-1 | Reference compound |
| HY-W777138 | rel-(1S,2R)-Dihydro bupropion-d9 | 1217684-77-9 | Isotope-Labeled Compounds |
| HY-W777148 | Anagrelide-13C3 | 1219531-58-4 | Isotope-Labeled Compounds |
| HY-W777156 | Carazolol-d6 (hydrochloride) | 1184973-07-6 | Isotope-Labeled Compounds |
| HY-W777161 | Lamivudine-15N2,13C | 1217746-03-6 | Isotope-Labeled Compounds |
| HY-W777166 | Aprepitant-13C2,d2 (Major) | 1217676-37-3 | Isotope-Labeled Compounds |
| HY-W777188 | 6-Hydroxy Chlorzoxazone-13C6 | 475295-90-0 | Isotope-Labeled Compounds |
| HY-W777192 | Keto-D-fructose phthalazin-1-ylhydrazone | 1082040-10-5 | Biochemical Assay Reagents |
| HY-W777199 | Tianeptine metabolite MC5 (sodium salt) | 115220-11-6 | Reference compound |
| HY-W777237 | Diethylstilbestrol monoglucuronide | 2408-40-4 | Biochemical Assay Reagents |
| HY-W777241 | Dexamethasone β-D-glucuronide (sodium) | 105088-08-2 | Biochemical Assay Reagents |
| HY-W777286 | rac-Lenalidomide-13C5 | 1219332-91-8 | Isotope-Labeled Compounds |
| HY-W777292 | Ethynyl estradiol 17-β-D-glucuronide | 75803-39-3 | Biochemical Assay Reagents |
| HY-W777335 | Zanamivir-13C,15N2 | 1276528-62-1 | Isotope-Labeled Compounds |
| HY-W777345 | Moperone | 1050-79-9 | Reference compound |
| HY-W777360 | Harman-13C2,15N | 1189461-56-0 | Isotope-Labeled Compounds |
| HY-W777372 | Methyl 4-azido-4,6-dideoxy-2-O-methyl-3-O-(phenylmethyl)-α-D-glucopyranoside | 861819-28-5 | Biochemical Assay Reagents |
| HY-W777374 | Methyl 2-O-methyl-3,4-O-(1-methylethylidene)-α-D-galactopyranoside | 34698-22-1 | Biochemical Assay Reagents |
| HY-W777377 | Methyl 3,4-O-Isopropylidene-6-O-trityl-α-D-galactopyranoside | 53685-07-7 | Biochemical Assay Reagents |
| HY-W777418 | Isosorbide mononitrate-13C6 | 1217604-00-6 | Isotope-Labeled Compounds |
| HY-W777429 | Ceratamine B | 634151-16-9 | Biochemical Assay Reagents |
| HY-W777433 | Cyclobenzaprine b-D-glucuronide | 67324-97-4 | Reference compound |
| HY-W777456 | Phenanthrene-13C6 | 1189955-53-0 | Isotope-Labeled Compounds |
| HY-W777457 | Anthracene-13C6 | 189811-60-7 | Isotope-Labeled Compounds |
| HY-W777526 | Nitisinone-13C6 | 1246815-63-3 | Isotope-Labeled Compounds |
| HY-W777533 | N-Acetyl sulfadiazine-13C6 | 1217089-17-2 | Isotope-Labeled Compounds |
| HY-W777535 | Naphthalene-13C10 | 219526-41-7 | Isotope-Labeled Compounds |
| HY-W777535S | Naphthalene-13C6 | 1192501-11-3 | Isotope-Labeled Compounds |
| HY-W777581 | 4-tert-Octylphenol-diethoxylate-13C6 | 1173020-69-3 | Isotope-Labeled Compounds |
| HY-W777582 | 4-tert-Octylphenol monoethoxylate-13C6 | 1173019-48-1 | Isotope-Labeled Compounds |
| HY-W777583 | 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 | 1173019-61-8 | Isotope-Labeled Compounds |
| HY-W777599 | (±)-Naproxen-13C,d3-1 | 1216704-11-8 | Isotope-Labeled Compounds |
| HY-W777640 | 6-Hexadecanoylamino-4-methylumbelliferyl β-D-galactopyranoside | 94452-17-2 | Biochemical Assay Reagents |
| HY-W777649 | Oxypurinol-13C,15N2-1 | 1217036-71-9 | Isotope-Labeled Compounds |
| HY-W777656 | Varenicline crbamoyl β-D-glucuronide | 535920-98-0 | Biochemical Assay Reagents |
| HY-W777679 | 6-Azido-1,6-dideoxy-3,4-O-isopropylidene-D-lyxo-2-hexulofuranose | 122194-05-2 | Biochemical Assay Reagents |
| HY-W777681 | Triflusal-13C6 | 1276355-35-1 | Isotope-Labeled Compounds |
| HY-W777682 | (Rac)-1-Linoleoyl-2,3-isopropylidene-glycerol | 127592-95-4 | Biochemical Assay Reagents |
| HY-W777702 | 2,2',3,4',5,5',6-Heptachloro-4-biphenylol-13C12 | 1285867-65-3 | Isotope-Labeled Compounds |
| HY-W777865 | 1-Linoleoyl-3-chloropropanediolte | 74875-98-2 | Natural Products |
| HY-W777866 | (Rac)-1-Linoleoyl-2-stearoyl-3-chloropropanediol | 1246833-46-4 | Reference compound |
| HY-W777866A | 3-Chloro-2-(stearoyloxy)propyl (9Z,12Z)-octadeca-9,12-dienoate | 1336935-07-9 | Natural Products |
| HY-W777869 | 1,2-Dilinolenoyl-3-chloropropanediol | 74875-97-1 | Natural Products |
| HY-W777870 | 1-Palmitoyl-2-linoleoyl-3-chloropropanediol | 1363153-57-4 | Natural Products |
| HY-W777872 | 1-Palmitoyl-2-linolenoyl-3-chloropropanediol | 1246833-14-6 | Natural Products |
| HY-W777893 | 1-Oleoyl-2-linoleoyl-3-chloropropanediol | 1336935-03-5 | Natural Products |
| HY-W777894 | 1-Linoleoyl-2-linolenoyl-3-chloropropanediol | 1612870-93-5 | Natural Products |
| HY-W777963 | (2E)-Octadecenal | 51534-37-3 | Natural Products |
| HY-W777964 | Phloroglucinol-13C6 | 1329497-24-6 | Isotope-Labeled Compounds |
| HY-W777979 | Frutinone A | 38210-27-4 | Natural Products |
| HY-W777986 | 1-Eicosapentaenoyl-sn-glycerol-3-phosphocholine | 162440-04-2 | Natural Products |
| HY-W777995 | Clindamycin B | 18323-43-8 | Reference compound |
| HY-W778058 | Guanosine-13C,15N2 | 197227-95-5 | Isotope-Labeled Compounds |
| HY-W778064 | L-threo-Droxidopa-13C2,15N | 1276295-04-5 | Isotope-Labeled Compounds |
| HY-W778080 | 25-O-Deacetyl-23-O-acetyl Rifabutin | 1242076-43-2 | Reference compound |
| HY-W778086 | 2-Isobutyramido guanosine 2′,3′,5′-tris(isobutanoate) | 70337-80-3 | Biochemical Assay Reagents |
| HY-W778140 | Diethyl phosphate-13C4 (sodium) | 1329613-90-2 | Isotope-Labeled Compounds |
| HY-W778142 | Dimethyl Phosphate-13C2 (sodium) | 157487-95-1 | Isotope-Labeled Compounds |
| HY-W778144 | O,O-Diethyl Thiophosphate-13C4 (ammonium) | 1330162-89-4 | Isotope-Labeled Compounds |
| HY-W778148 | O,O-Diethyl dithiophosphate-13C4 (ammonium) | 1329641-22-6 | Isotope-Labeled Compounds |
| HY-W778150 | O,O-Dimethyl Phosphorothionate-d6 (ammonium) | 1330162-95-2 | Isotope-Labeled Compounds |
| HY-W778154 | O,O-Dimethyl dithiophosphate-13C2 (ammonium) | 1329610-82-3 | Isotope-Labeled Compounds |
| HY-W778183 | 3,5,6-Trichloro-2-pyridinol-13C5 | 1330171-47-5 | Isotope-Labeled Compounds |
| HY-W778187 | rac 2-Oleoyl-3-chloropropanediol-d5,95% | 1331669-45-4 | Isotope-Labeled Compounds |
| HY-W778188 | 2-Linolenoyl-3-chloropropanediol | 1470071-08-9 | Natural Products |
| HY-W778189 | rac-2-Linoleoyl-3-chloropropanediol-d5,95% | 1331636-39-5 | Isotope-Labeled Compounds |
| HY-W778203 | Glycolic acid-13C2 | 111389-68-5 | Isotope-Labeled Compounds |
| HY-W778207 | 2'-Deoxyadenosine-13C5 (monohydrate) | 478510-79-1 | Isotope-Labeled Compounds |
| HY-W778225 | Vanillic acid-13C6 | 201612-56-8 | Isotope-Labeled Compounds |
| HY-W778336 | Girard's Reagent P-d5 | 1505505-87-2 | Isotope-Labeled Compounds |
| HY-W778340 | 16α-Hydroxy-11-keto prednisolone | 3754-05-0 | Reference compound |
| HY-W778391 | Bisphenol A-13C2 | 263261-64-9 | Isotope-Labeled Compounds |
| HY-W778393 | cis-Tranexamic acid-13C2,15N | 1557000-06-2 | Isotope-Labeled Compounds |
| HY-W778423 | [Pt(DACH)(OH)2(ox)] | 111321-67-6 | Reference compound |
| HY-W778471 | rac-1-Linoleoyl-3-linolenoyl-propanetriol | 126374-41-2 | Reference compound |
| HY-W778521 | Acetic acid-13C2,d3 (sodium) | 123333-80-2 | Isotope-Labeled Compounds |
| HY-W778538 | Alphadolone 21-β-D-glucuronide | 36707-55-8 | Biochemical Assay Reagents |
| HY-W778546 | 7-epi-10-Deacetyl baccatin III | 71629-92-0 | Natural Products |
| HY-W778547 | 7-epi-10-Oxo-10-deacetyl baccatin III | 151636-94-1 | Natural Products |
| HY-W778555 | Diclofenamide-13C6 | 1391054-76-4 | Isotope-Labeled Compounds |
| HY-W778562 | 10-Deacetyl-13-oxobaccatin III | 92950-42-0 | Natural Products |
| HY-W778608 | Quercetin 7-glucuronide | 38934-20-2 | Natural Products |
| HY-W778608R | Quercetin 7-glucuronide (Standard) | 38934-20-2 | Reference Standards |
| HY-W778830 | Bodipy C12-ceramide | 1246355-58-7 | Reference compound |
| HY-W778833 | (Z)-11-Octadecen-1-ol | 62972-93-4 | Natural Products |
| HY-W778834 | (Z)-13-Octadecen-1-ol | 69820-27-5 | Natural Products |
| HY-W778986 | L-Allono-1,4-lactone | 78184-43-7 | Biochemical Assay Reagents |
| HY-W779002 | alpha-D-glucose-13C2-1 | 261728-61-4 | Isotope-Labeled Compounds |
| HY-W779009 | [1-13Cglc]Lactose (monohydrate) | 287100-62-3 | Isotope-Labeled Compounds |
| HY-W779015 | 5-Methyluridine-13C5 | 159496-17-0 | Isotope-Labeled Compounds |
| HY-W779017 | Thymidine-13C5 | 156968-81-9 | Isotope-Labeled Compounds |
| HY-W779019 | Xylose-13C5 | 1262683-58-8 | Isotope-Labeled Compounds |
| HY-W779021 | Adenosine-15N | 41547-82-4 | Isotope-Labeled Compounds |
| HY-W779068 | Chenodeoxycholic acid 3-sulfate (disodium) | 60237-34-5 | Natural Products |
| HY-W779188 | GlcNAc1-β-3GalNAc | 95673-98-6 | Biochemical Assay Reagents |
| HY-W779193 | 2-Amino-3-methyl-3H-imidazo[4,5-f]quinoline-2-13C | 210049-11-9 | Isotope-Labeled Compounds |
| HY-W779201 | 2,3:4,6-Di-O-cyclohexylidene-α-D-mannopyranose | 70835-78-8 | Biochemical Assay Reagents |
| HY-W779204 | rac-3-Hexadecanamido-2-methoxypropan-1-ol phosphocholine (hydrate) | 163751-35-7 | Biochemical Assay Reagents |
| HY-W779296 | Potassium thiocyanate-13C,15N | 143673-61-4 | Isotope-Labeled Compounds |
| HY-W779345 | Reverse T3-13C6 | 1213055-23-2 | Isotope-Labeled Compounds |
| HY-W779377 | Erythromycin B | 527-75-3 | Natural Products |
| HY-W779504 | b-Cortolone | 667-66-3 | Reference compound |
| HY-W779529 | Cerberin | 25633-33-4 | Reference compound |
| HY-W779534 | 4,5-Dimethyl-3-hydroxy-2(5H)-furanone-13C2 | 156420-66-5 | Isotope-Labeled Compounds |
| HY-W779542 | (2E,4E,6E)-2,4,6-Nonatrienal-13C2 | 1335402-19-1 | Isotope-Labeled Compounds |
| HY-W779575 | cis-9,10-Epoxystearic acid methyl ester | 2566-91-8 | Natural Products |
| HY-W779640 | 25I-NBOMe 4-methoxy isomer (hydrochloride) | 1566571-64-9 | Reference compound |
| HY-W779800 | D-α-Hydroxyglutaric acid-13C5 (disodium) | 1648909-80-1 | Isotope-Labeled Compounds |
| HY-W780142 | 7-Hydroxy-3-oxo-Cholest-4-en-26-oic acid | 115538-85-7 | Natural Products |
| HY-W780150 | 1-Bromobenzene-13C6 | 112630-77-0 | Isotope-Labeled Compounds |
| HY-W780153 | 1-Lauroyl-2-linoleoyl-3-chloropropanediol | 2134114-60-4 | Natural Products |
| HY-W780175 | 1-Stearo-3-linolein | 126301-96-0 | Reference compound |
| HY-W780180 | Tetrabromobisphenol A-13C12 | 1352876-39-1 | Isotope-Labeled Compounds |
| HY-W780198 | Endophenazine A | 86125-71-5 | Natural Products |
| HY-W780199 | Endophenazine B | 479415-40-2 | Natural Products |
| HY-W780205 | (Rac)-Hesperetin 3'-O-β-D-glucuronide | 1237479-05-8 | Biochemical Assay Reagents |
| HY-W780275S | Alternariol-9-monomethylether sulfate-d3 (ammonium) | Isotope-Labeled Compounds | |
| HY-W780779 | (Z)-12-Nonadecen-9-one | 63408-45-7 | Natural Products |
| HY-W780780 | (13Z)-Eicosen-10-one | 63408-44-6 | Natural Products |
| HY-W780784 | (Z,Z)-3,13-Octadecadien-1-ol | 66410-24-0 | Natural Products |
| HY-W780787 | (E,Z)-3,13-Octadecadienyl acetate | 53120-26-6 | Natural Products |
| HY-W780790 | (Z,Z)-3,13-Octadecadienyl acetate | 53120-27-7 | Reference compound |
| HY-W780803 | (Z,E)-9,12-Tetradecadienol | 42521-46-0 | Natural Products |
| HY-W780808 | (E)-10-Dodecenol | 35237-63-9 | Natural Products |
| HY-W780813 | (Z)-3-Decenol | 10340-22-4 | Natural Products |
| HY-W781133 | cDPCP | 106343-54-8 | Reference compound |
| HY-W781148 | Suptopin-2 | 331852-66-5 | Reference compound |
| HY-W781265 | BE 24566B | 149466-04-6 | Reference compound |
| HY-W781271 | Antitumor agent-160 | 1262489-36-0 | Reference compound |
| HY-W781921 | BP Fluor 488 Alkyne | 1006592-47-7 | Dye Reagents |
| HY-W781963 | 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one | 62659-65-8 | Reference compound |
| HY-W782032 | 3D-Monophosphoryl Lipid A-5 | 1699735-79-9 | Biochemical Assay Reagents |
| HY-W782032A | 3D-Monophosphoryl Lipid A-5 (free acid) | 1465797-24-3 | Reference compound |
| HY-W782032B | 3D-Monophosphoryl Lipid A-5 (triethylamine) | Reference compound | |
| HY-W782075 | p-NO2-Bn-DOTA | 116052-88-1 | Biochemical Assay Reagents |
| HY-W782078 | Butyne-DOTA | 2125661-62-1 | Biochemical Assay Reagents |
| HY-W782079 | Geraniol-d6 (Major) | 1660976-93-1 | Isotope-Labeled Compounds |
| HY-W782080 | p-NH2-Bn-oxo-DO3A | 2125661-90-5 | Biochemical Assay Reagents |
| HY-W782081 | p-SCN-Bn-oxo-DO3A | 1370442-99-1 | Biochemical Assay Reagents |
| HY-W782083 | p-SCN-Bn-NOTA (trihydrochloride) | 1583289-85-3 | Biochemical Assay Reagents |
| HY-W782087A | p-SCN-Bn-PCTA (hydrochloride) | 2649490-34-4 | Biochemical Assay Reagents |
| HY-W782088A | p-NH₂-Bn-PCTA (hydrochloride) | Biochemical Assay Reagents | |
| HY-W782096 | Salvianolic acid H | 444179-57-1 | Natural Products |
| HY-W782122 | Photoclick cholesterol | 1485490-47-8 | Reference compound |
| HY-W782153 | Acetophenone-13C6 | 125770-94-7 | Isotope-Labeled Compounds |
| HY-W782236 | cis-12,13-Epoxy-9(Z)-octadecenoic acid | 17966-13-1 | Natural Products |
| HY-W782236A | 12(S),13(R)-Epoxy-9(Z)-octadecenoic acid | 503-07-1 | Natural Products |
| HY-W782391 | Linolenyl alcohol | 506-44-5 | Natural Products |
| HY-W782391R | Linolenyl alcohol (Standard) | 506-44-5 | Reference Standards |
| HY-W782399 | CORM-A1 | 17363-08-5 | Reference compound |
| HY-W782607 | 5α-Cholesta-8,14-dien-3β-ol | 19431-20-0 | Reference compound |
| HY-W782635 | DL-5-Indolylmethylhydantoin | 21753-16-2 | Reference compound |
| HY-W782762 | Dihydro FF-MAS | 19456-83-8 | Reference compound |
| HY-W783168 | Taiwanin C | 14944-34-4 | Natural Products |
| HY-W783254 | C18 LPA | 799279-67-7 | Oligonucleotides |
| HY-W783267 | α-Glucosidase-IN-35 | 24672-84-2 | Natural Products |
| HY-W783268 | Matriptase-IN-2 (free base) | 1268874-08-3 | Reference compound |
| HY-W783268A | Matriptase-IN-2 | 1268874-09-4 | Reference compound |
| HY-W783407 | Ac-rG Phosporamidite | 944138-03-8 | Oligonucleotides |
| HY-W783421 | FXIIIa-IN-1 (sodium) | 17095-24-8 | Reference compound |
| HY-W783623 | 1,3-Didocosahexaenoyl glycerol | 140670-42-4 | Reference compound |
| HY-W783639 | Bzo-poxizid | 1048973-64-3 | Reference compound |
| HY-W783639S | Bzo-poxizid-d9 | Isotope-Labeled Compounds | |
| HY-W783643 | Hericenone B | 1416052-89-5 | Natural Products |
| HY-W783671 | Perlolyrin | 29700-20-7 | Natural Products |
| HY-W783680 | Potassium ionophore III | 99348-39-7 | Reference compound |
| HY-W783741 | Isomurrayafoline B | 107903-15-1 | Natural Products |
| HY-W783742 | Murrayamine O | 166990-10-9 | Natural Products |
| HY-W783771 | (8β)-N,N,6-Triethyl-9,10-didehydro-1-(1-oxopropyl)ergoline-8-carboxamide | 2230715-45-2 | Reference compound |
| HY-W783822 | Cabazitaxel intermediate | 1354900-65-4 | Natural Products |
| HY-W783829 | (2E)-Hexenoyl-CoA | 10018-93-6 | Enzyme |
| HY-W783917 | Lead Ionophore IV | 145237-46-3 | Reference compound |
| HY-W783987 | Hyaluronate hexasaccharide | 73603-40-4 | Biochemical Assay Reagents |
| HY-W784030A | (S,E)-N-TCO-L-lysine | Reference compound | |
| HY-W784030B | (R,E)-N-TCO-L-lysine | Reference compound | |
| HY-W784347 | 5-Bromo-2-methyl-2H-indazole-d3 | 2447686-91-9 | Isotope-Labeled Compounds |
| HY-W784549 | N6-Me-rA phosphoramidite | 588698-79-7 | Reference compound |
| HY-W784557 | O-DMT-2,2-di(ethoxycarbonyl)propan-1,3-diol | 171285-25-9 | Oligonucleotides |
| HY-W784565 | 5-Fluorouridine 5'-phosphate | 796-66-7 | Reference compound |
| HY-W784573A | dATPαS (sodium) | Biochemical Assay Reagents | |
| HY-W784574A | dCTPαS (sodium) | 177966-80-2 | Biochemical Assay Reagents |
| HY-W784575A | dGTPαS (sodium) | 178036-66-3 | Biochemical Assay Reagents |
| HY-W787458 | 4-Methylumbelliferyl-β-D-glucuronide (trihydrate) | 199329-67-4 | Biochemical Assay Reagents |
| HY-W787537 | Leucoberbelin blue I | 52748-86-4 | Biochemical Assay Reagents |
| HY-W787630 | Naphthol AS phosphate disodium salt | 69815-54-9 | Biochemical Assay Reagents |
| HY-W787717 | 12-Methoxydodecanoic acid | 92169-28-3 | Reference compound |
| HY-W787749 | L-Histidyl-L-lysine (hydrobromide) | 151151-29-0 | Biochemical Assay Reagents |
| HY-W787880 | D-myo-Inositol-1,2-diphosphate (sodium) | 208584-51-4 | Reference compound |
| HY-W787896 | PDE4-IN-25 | 346440-86-6 | Reference compound |
| HY-W788039 | D-Myo-inositol-1,3,5-triphosphate (ammonium) | 1246355-67-8 | Biochemical Assay Reagents |
| HY-W788583 | Inositol 1,3-bisphosphate (sodium) | 208584-52-5 | Reference compound |
| HY-W788728 | 5-Chloro-1-(β-D-arabinofuranosyl)cytidine | 17676-65-2 | Biochemical Assay Reagents |
| HY-W790014 | Z-FG-NHO-BzOME | 180313-86-4 | Peptides |
| HY-W790266 | Polygodial pyridazine | 1810726-08-9 | Reference compound |
| HY-W790474 | D-myo-Inositol 1,3,4-tris-phosphate | 93133-76-7 | Biochemical Assay Reagents |
| HY-W790758 | Tripropylammonium (hexafluorophosphate) | 92416-28-9 | Biochemical Assay Reagents |
| HY-W791535 | 4-Hydroxy propofol 1-O-β-D-glucuronide | 114991-25-2 | Biochemical Assay Reagents |
| HY-W791717 | L-Idaric acid | 80876-58-0 | Biochemical Assay Reagents |
| HY-W791727 | 7-Methyladenosine (perchlorate) | 81319-59-7 | Biochemical Assay Reagents |
| HY-W791770 | Methyl 2,3,4,6-tetrakis-O-(phenylmethyl)-D-mannopyranoside | 83462-67-3 | Biochemical Assay Reagents |
| HY-W791782 | 4-Nitrophenyl thymidine-5′-monophosphate (ammonium) | 83918-61-0 | Biochemical Assay Reagents |
| HY-W792078 | Methyl 2-acetamido-2-deoxy-3,6-di-O-benzyl-α-D-glucopyranoside | 85193-92-6 | Biochemical Assay Reagents |
| HY-W792146 | Phenylmethyl 2,3,6-tris-O-(phenylmethyl)-α-D-galactopyranoside | 53929-38-7 | Biochemical Assay Reagents |
| HY-W792213 | N-Cyclopropyl-N′-hydroxyguanidine | 551935-92-3 | Biochemical Assay Reagents |
| HY-W792412 | Z-YVAD-CMK | 402474-85-5 | Peptides |
| HY-W792458 | MADAM | 411208-45-2 | Reference compound |
| HY-W792491 | Perfluoropropanesulfonic acid | 423-41-6 | Reference compound |
| HY-W792513 | WAY-620147 | 515866-67-8 | Reference compound |
| HY-W792683 | Homovanillic Acid Sulfate | 38339-06-9 | Natural Products |
| HY-W793155 | N6-Benzoyl-2'-deoxy-3'-O-DMT-adenosine | 140712-79-4 | Reference compound |
| HY-W793297 | Phenyl β-D-thioglucuronide | 26399-82-6 | Biochemical Assay Reagents |
| HY-W793473 | WAY-301398 | 312607-68-4 | Reference compound |
| HY-W793474 | 2-Naphthyl-β-D-galactopyranoside hydrate | 312693-81-5 | Biochemical Assay Reagents |
| HY-W793477 | D-myo-Inositol 1-monophosphate (dipotassium) | 313263-16-0 | Biochemical Assay Reagents |
| HY-W793502 | 3-Indoxyl phosphate (p-toluidine) | 31699-61-3 | Biochemical Assay Reagents |
| HY-W793605 | (Rac)-Glycerol 1-phosphate (disodium hexahydrate) | 34363-28-5 | Biochemical Assay Reagents |
| HY-W793608S | N-(1-Deoxy-D-fructos-1-yl)-L-asparagine-13C6 | 1083053-46-6 | Isotope-Labeled Compounds |
| HY-W793613 | Drimendiol | 34437-62-2 | Natural Products |
| HY-W793693 | Sucrose 6′-monophosphate (dipotassium) | 36064-19-4 | Biochemical Assay Reagents |
| HY-W794030 | D-Xylo-hexulosonic acid | 16533-48-5 | Biochemical Assay Reagents |
| HY-W794121 | Amyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 146288-30-4 | Biochemical Assay Reagents |
| HY-W794132 | 4-Hydroxy-9h-xanthen-9-one | 14686-63-6 | Natural Products |
| HY-W794205 | D-myo-Inositol 4-monophosphate (biscyclohexylammonium) | 16006-20-5 | Biochemical Assay Reagents |
| HY-W794315 | α-D-Glucopyranosiduronic acid,β-D-arabino-2-hexulofuranosonosyld | 155533-83-8 | Biochemical Assay Reagents |
| HY-W794363 | D-myo-Inositol-1,4,5,6-tetraphosphate (sodium) | 157542-47-7 | Reference compound |
| HY-W794390 | 2,3,4-Tri-O-benzoyl-α-D-glucuronic acid methyl ester,trichloroacetimidate | 169557-99-7 | Biochemical Assay Reagents |
| HY-W794623 | Methyl 6-deoxy-2-O-methyl-α-D-galactopyranoside | 59981-27-0 | Biochemical Assay Reagents |
| HY-W794663 | Cyanomethyl-2,3,4,6-tetra-O-acetyl-α-D-thiomannopyranoside | 61145-39-9 | Biochemical Assay Reagents |
| HY-W794772 | Methyl 2,3-O-(1-methylethylidene)-α-D-mannopyranoside | 63167-69-1 | Biochemical Assay Reagents |
| HY-W794825 | Basic Green 5 | 6722-15-2 | Biochemical Assay Reagents |
| HY-W794998 | Cedarwood terpenes | 68608-32-2 | Natural Products |
| HY-W795027 | Anatoxin-a | 64285-06-9 | Natural Products |
| HY-W795031 | Arsenobetaine | 64436-13-1 | Reference compound |
| HY-W795244 | ω-Benzoyl oxyphloracetophenone | 65982-77-6 | Natural Products |
| HY-W795264 | FR900098 | 66508-32-5 | Reference compound |
| HY-W795464 | 3-Phosphono pyruvic acid | 5824-58-8 | Biochemical Assay Reagents |
| HY-W795499 | D-Erythro-L-talo-octonic acid,γ-lactone | 6968-62-3 | Biochemical Assay Reagents |
| HY-W795507 | Cyanopindolol | 69906-85-0 | Reference compound |
| HY-W795652 | Calcium α-D-heptagluconate hydrate | 10030-53-2 | Biochemical Assay Reagents |
| HY-W795740 | (R)-Mono-ethyl 3-acetoxyglutarate | 113036-11-6 | Biochemical Assay Reagents |
| HY-W795829 | Mentholglucuronic acid (ammonium) | 104874-25-1 | Biochemical Assay Reagents |
| HY-W795955 | Tris phosphate dibasic | 108321-11-5 | Biochemical Assay Reagents |
| HY-W795960 | D-Myo-inositol 1,4,5-trisphosphate sodium salt | 108340-81-4 | Biochemical Assay Reagents |
| HY-W795962 | 6-Phosphogluconic acid (tricyclohexylammonium) | 108347-81-5 | Biochemical Assay Reagents |
| HY-W796158 | Z-DEVD-CMK | 250584-13-5 | Peptides |
| HY-W796728S | 1,2-Bis(methylthio)benzene-d6 | Isotope-Labeled Compounds | |
| HY-W797143 | α-L-Idopyranose,1,2,3,4,6-pentaacetate | 2152-77-4 | Biochemical Assay Reagents |
| HY-W797329 | (3S)Lenalidomide-5-Br | 2829898-76-0 | Reference compound |
| HY-W797383 | Phthalimidinoglutarimide-6-piperazine | 2229723-92-4 | Reference compound |
| HY-W799435 | Tosufloxacin (hydrate) | 107097-79-0 | Reference compound |
| HY-W799437 | Ioversol hydrolysate-1 | 77868-40-7 | Reference compound |
| HY-W800162 | VEGFR-2-IN-37 | 298207-77-9 | Reference compound |
| HY-W800446 | LNA-Guanosine 3'-CE phosphoramidite | 709641-79-2 | Reference compound |
| HY-W800610 | AZD-PEG13-PFP | 2600517-85-7 | Biochemical Assay Reagents |
| HY-W800616 | C11-PEG4-alcohol | 88299-47-2 | Reference compound |
| HY-W800617 | NH2-PEG1-Val-Cit-PAB-OH | 2055024-63-8 | ADC Related |
| HY-W800618 | NH2-PEG3-Val-Cit-PAB-OH | 2055024-62-7 | ADC Related |
| HY-W800619 | NH2-PEG4-Val-Cit-PAB-OH | 2055024-61-6 | ADC Related |
| HY-W800620 | NH2-PEG6-Val-Cit-PAB-OH | 2055024-60-5 | ADC Related |
| HY-W800621 | Fmoc-PEG2-Val-Cit-PAB-OH | 2055024-59-2 | ADC Related |
| HY-W800622 | Fmoc-PEG4-Val-Cit-PAB-OH | 2055024-58-1 | ADC Related |
| HY-W800623 | Fmoc-PEG6-Val-Cit-PAB-OH | 2055024-57-0 | ADC Related |
| HY-W800624 | Boc-PEG2-Val-Cit-PAB-OH | 2055024-55-8 | ADC Related |
| HY-W800625 | Boc-PEG4-Val-Cit-PAB-OH | 2055024-54-7 | ADC Related |
| HY-W800627 | Bis-sulfone-PEG8-NHS ester | 2363757-66-6 | Reference compound |
| HY-W800630 | Hydroxy-PEG4-CH2COOH (sodium salt) | 73349-20-9 | Reference compound |
| HY-W800631 | Benzyl N1-(PEG1-acid)-N6-(t-Boc)-L-lysinate | 2639400-45-4 | Reference compound |
| HY-W800632 | 4-Azide-TFP-amide-SS-propionic acid | 191163-45-8 | Reference compound |
| HY-W800635 | 4-Azide-TFP-amide-PEG4-acid | 2566404-74-6 | Reference compound |
| HY-W800648 | Mal-PEG2-amide | 2639395-35-8 | Reference compound |
| HY-W800649 | Aminooxy-PEG2-amine (hydrochloride) | 2582757-03-5 | Reference compound |
| HY-W800650 | Aminooxy-PEG1-amine | 1510385-08-6 | Reference compound |
| HY-W800651 | Biotin-SS-Amine (hydrochloride) | 2098496-90-1 | Reference compound |
| HY-W800652 | (S,R,S)-AHPC-PEG4-tosyl | 2839806-91-4 | Reference compound |
| HY-W800653 | N-(Azido-PEG3)-NH-PEG3-t-butyl ester | 2758724-73-9 | Reference compound |
| HY-W800654 | Mal-PEG5-amine | 2170654-73-4 | Biochemical Assay Reagents |
| HY-W800655 | Thalidomide-O-PEG4-acid | 2446382-02-9 | Reference compound |
| HY-W800656 | Fmoc-PEG5-alcohol | 2496687-06-8 | Biochemical Assay Reagents |
| HY-W800657 | Azido-PEG1-hydrazide (hydrochloride) | 2446382-04-1 | Reference compound |
| HY-W800658 | DBCO-PEG6-NH-Boc | 2828433-65-2 | Reference compound |
| HY-W800659 | Boc-Gly-Gly-NHS ester | 29248-48-4 | Reference compound |
| HY-W800660 | endo-BCN-PEG4-Boc-amine | 2468686-11-3 | Reference compound |
| HY-W800661 | Tos-PEG3-methyl ester | 2468714-93-2 | Reference compound |
| HY-W800662 | Bromo-PEG2-methyl ester | 2468714-95-4 | Biochemical Assay Reagents |
| HY-W800664 | 5-(Azido-PEG4)-pent-2-yn-1-ol | 2468714-96-5 | Reference compound |
| HY-W800666 | 5-(Tetrahydro-2H-pyran-2-yloxy)pent-3-yn-1-peg4-azide | 2468714-97-6 | Biochemical Assay Reagents |
| HY-W800667 | Hydroxy-PEG4-acid (sodium) | 2468714-92-1 | Reference compound |
| HY-W800668 | (S,R,S)-AHPC-PEG4-NHS ester | 2757045-59-1 | Reference compound |
| HY-W800669 | (S,R,S)-AHPC-PEG2-NHS ester | 2757045-58-0 | Reference compound |
| HY-W800670 | Mal-amido-PEG5-alkyne | 2496687-04-6 | Reference compound |
| HY-W800671 | 1,5-Diazidopentane | 17607-21-5 | Biochemical Assay Reagents |
| HY-W800675 | AZD-PEG2-azide | 2639395-36-9 | Reference compound |
| HY-W800676 | DBCO-N-bis(PEG4-acid) | 2639395-37-0 | Reference compound |
| HY-W800678 | Bromoacetamido-PEG2-AZD | 2639395-43-8 | Reference compound |
| HY-W800679 | Mal-Cyclohexyl-PEG3-Biotin | 2639395-45-0 | Reference compound |
| HY-W800680 | BP Fluor 488 DBCO | 2423960-92-1 | Dye Reagents |
| HY-W800681 | Benzyloxy carbonyl-PEG4-acid | 2250278-48-7 | Reference compound |
| HY-W800682 | Bis-sulfone-PEG4-acid | 2639395-49-4 | Biochemical Assay Reagents |
| HY-W800683 | 4-Azide-TFP-amide-SS-Sulfo-NHS | 220446-74-2 | Reference compound |
| HY-W800684 | Benzyloxy carbonyl-PEG4-NHS ester | 2639395-44-9 | Biochemical Assay Reagents |
| HY-W800685 | Thalidomide-O-PEG2-NHS ester | 2639395-34-7 | Reference compound |
| HY-W800686 | Acid-PEG4-NHS ester | 2639395-41-6 | Reference compound |
| HY-W800687 | Tetra(3-methoxy-n-(prop-2-ynyl)propanamide) methane | 2639395-47-2 | Reference compound |
| HY-W800688 | Acid-PEG5-Amide-Tri (3-methoxypropanamide-PEG4-Azide) Methane | 2803119-03-9 | Reference compound |
| HY-W800689 | Tri(propargyl-NHCO-ethyloxyethyl)amine | 2639395-46-1 | Reference compound |
| HY-W800691 | BP Fluor 350 picolyl azide | 2644752-83-8 | Dye Reagents |
| HY-W800692 | BP Fluor 350 azide | 2644752-84-9 | Dye Reagents |
| HY-W800693 | BP Fluor 405 picolyl azide | 2841143-99-3 | Dye Reagents |
| HY-W800694 | BP Fluor 405 alkyne (triTEA) | 2006335-63-1 | Dye Reagents |
| HY-W800695 | BP Fluor 405 DBCO | 2362006-29-7 | Dye Reagents |
| HY-W800696 | BP Fluor 430 azide | 2644752-86-1 | Dye Reagents |
| HY-W800697 | BP Fluor 430 picolyl azide | 2644752-87-2 | Dye Reagents |
| HY-W800698 | BP Fluor 430 alkyne | 2006309-79-9 | Dye Reagents |
| HY-W800699 | BP Fluor 430 DBCO | 2644752-85-0 | Dye Reagents |
| HY-W800700 | BP Fluor 488 azide | 1006592-63-7 | Dye Reagents |
| HY-W800701 | BP Fluor 546 DBCO | 2762752-63-4 | Reference compound |
| HY-W800702 | BP Fluor 555 azide | 2770422-53-0 | Dye Reagents |
| HY-W800703 | Alexa Fluor 594 azide | 1872449-19-8 | Reference compound |
| HY-W800704 | BP Fluor 594 alkyne | 1962073-89-7 | Dye Reagents |
| HY-W800705 | Tamra azide | 1006592-61-5 | Dye Reagents |
| HY-W800706 | Azidobutanamide-tri-(carboxyethoxymethyl)-methane | 2644752-90-7 | Biochemical Assay Reagents |
| HY-W800708 | N-(TCO)-N-bis(PEG4-acid) | 2644769-96-8 | Reference compound |
| HY-W800709 | N-(acid-PEG10)-N-bis(PEG10-azide) | 2803119-06-2 | Reference compound |
| HY-W800711 | SPDP-Gly-Pro-NHS ester | 2655501-79-2 | Biochemical Assay Reagents |
| HY-W800712 | t-Boc-N-Amido-PEG11-Tos | 1556847-56-3 | Reference compound |
| HY-W800713 | SPDP-Gly-Pro-acid | 2655501-78-1 | Reference compound |
| HY-W800714 | SPDP-Gly-Gly-methoxy | 2655474-48-7 | Reference compound |
| HY-W800715 | (Acid-PEG10)-Tri-(Azide-PEG10-ethoxymethyl)-methane | 2803119-05-1 | Reference compound |
| HY-W800716 | Tri(Azide-PEG10-NHCO-ethyloxyethyl)amine | 2375600-60-3 | Reference compound |
| HY-W800717 | Tetra-(amido-PEG10-azide) | 2375600-75-0 | Reference compound |
| HY-W800718 | Methyltetrazine-amido-Tri-(acid-PEG1-ethoxymethyl)-methane | 2665664-66-2 | Biochemical Assay Reagents |
| HY-W800719 | N-Boc-N'-(PEG1-t-butyl ester)-L-Lysine-amido-Mal | 2665661-79-8 | Reference compound |
| HY-W800720 | S-(Pyridin-2-ylthio)-L-homocysteine | 2668173-78-0 | Biochemical Assay Reagents |
| HY-W800721 | Methyltetrazine-amido-bis-(carboxyethoxymethyl)-methane | 2698339-32-9 | Reference compound |
| HY-W800722 | N-(PEG1-acid)-L-Lysine-amido-Mal | 2698339-21-6 | Biochemical Assay Reagents |
| HY-W800723 | Methyltetrazine-PEG2-DBCO | 2698340-95-1 | Reference compound |
| HY-W800724 | Methyltetrazine-PEG4-DBCO | 2698339-24-9 | Reference compound |
| HY-W800725 | m-PEG2-DBCO | 2698341-01-2 | Reference compound |
| HY-W800726 | BB1-NHS ester | 2082771-52-4 | Reference compound |
| HY-W800727 | BB1-acid | 2026591-80-8 | Reference compound |
| HY-W800728 | 1,1'-[2-(Hydroxymethyl)-1,3-propanediyl] dilinoleate | 1799317-34-2 | Biochemical Assay Reagents |
| HY-W800732 | 1,2-Dilinoleoyl-sn-glycero-3-PC | 6542-05-8 | Biochemical Assay Reagents |
| HY-W800733 | DLPG | 73548-69-3 | Biochemical Assay Reagents |
| HY-W800734 | 1-Myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine | 69525-80-0 | Biochemical Assay Reagents |
| HY-W800740 | Nonyl 6-bromohexanoate | 959249-23-1 | Biochemical Assay Reagents |
| HY-W800741 | Undecyl 8-bromooctanoate | 2707440-34-2 | Biochemical Assay Reagents |
| HY-W800742 | Heptadecan-9-yl 6-bromohexanoate | 2096984-35-7 | Biochemical Assay Reagents |
| HY-W800743 | Heptyl 6-bromohexanoate | 959265-07-7 | Reference compound |
| HY-W800744 | Heptadecan-9-yl 8-(3-hydroxypropylamino)octanoate | 2101533-78-0 | Biochemical Assay Reagents |
| HY-W800750 | TCO-PEG2-acid | 2250217-31-1 | Reference compound |
| HY-W800751 | (9Z,12Z)-3-(4,4-bis(Octyloxy)butanoyloxy)-2-(hydroxymethyl)propyl octadeca-9,12-dienoate | 1799317-46-6 | Reference compound |
| HY-W800753 | 2,5-Dioxopyrrolidin-1-yl 6-bromohexanoate | 42014-54-0 | Reference compound |
| HY-W800754 | 8-Bromo-octanoic acid 2,5-dioxo-pyrrolidin-1-yl ester | 1155387-35-1 | Reference compound |
| HY-W800760 | (S,R,S)-AHPC-PEG6-Tos | 2839806-94-7 | Reference compound |
| HY-W800763 | 8-Bromo-N, N-dioctyloctanamide | 2089253-49-4 | Biochemical Assay Reagents |
| HY-W800764 | 7-Bromoheptyl 2-hexyldecanoate | 2795216-34-9 | Reference compound |
| HY-W800768 | BP Fluor 350 Azide Plus | 2669097-42-9 | Dye Reagents |
| HY-W800769 | BP Fluor 532 azide plus | 2669097-24-7 | Dye Reagents |
| HY-W800770 | MB 543 DBCO | 2563610-26-2 | Dye Reagents |
| HY-W800775 | BP Fluor 647 Alkyne | 2770422-56-3 | Dye Reagents |
| HY-W800776 | DORI | 153312-59-5 | Biochemical Assay Reagents |
| HY-W800777 | 6-(3-Hydroxypropylamino)hexyl 2-hexyldecanoate | 2795212-31-4 | Biochemical Assay Reagents |
| HY-W800778 | Bis(2-butyloctyl) 10-oxononadecanedioate | 2036272-58-7 | Biochemical Assay Reagents |
| HY-W800779 | Heptadecan-9-yl 10-bromodecanoate | 2761458-99-3 | Biochemical Assay Reagents |
| HY-W800780 | (6Z,16Z)-12-((Z)-Dec-4-enyl)docosa-6,16-dien-11-ol | 1450888-61-5 | Biochemical Assay Reagents |
| HY-W800781 | (6Z,15Z)-6,15-Heneicosadien-11-ol | 1450888-53-5 | Biochemical Assay Reagents |
| HY-W800782 | DC-6-14 | 107086-76-0 | Biochemical Assay Reagents |
| HY-W800783 | DSTAP (chloride) | 220609-41-6 | Biochemical Assay Reagents |
| HY-W800784 | 23:2 Diyne PE [DC(8,9)PE] | 144750-73-2 | Biochemical Assay Reagents |
| HY-W800785 | 16:0-23:2 Diyne PC | 84271-00-1 | Biochemical Assay Reagents |
| HY-W800786 | 16:0 PE MCC | 384832-87-5 | Biochemical Assay Reagents |
| HY-W800787 | 18:1 PE MCC | 384847-49-8 | Biochemical Assay Reagents |
| HY-W800788 | 18:1 MPB PE | 384835-49-8 | Biochemical Assay Reagents |
| HY-W800789 | 16:0 MPB PE | 384835-50-1 | Biochemical Assay Reagents |
| HY-W800790 | 18:1 Caproylamine PE | 110796-31-1 | Biochemical Assay Reagents |
| HY-W800791 | 16:0 Caproylamine PE | 115288-21-6 | Biochemical Assay Reagents |
| HY-W800792 | 18:1 Succinyl PE | 111613-33-3 | Biochemical Assay Reagents |
| HY-W800793 | 16:0 Succinyl PE | 186800-61-3 | Biochemical Assay Reagents |
| HY-W800794 | 16:0 Glutaryl PE | 474923-45-0 | Biochemical Assay Reagents |
| HY-W800795 | 18:1 Dodecanyl PE | 474923-47-2 | Biochemical Assay Reagents |
| HY-W800796 | 18:1 Biotinyl PE | 384835-53-4 | Biochemical Assay Reagents |
| HY-W800797 | 16:0 Biotinyl PE | 384835-54-5 | Biochemical Assay Reagents |
| HY-W800798 | 16:0 Cyanur PE | 1246304-37-9 | Biochemical Assay Reagents |
| HY-W800803 | Mal-PEG5-NH-Boc | 2170654-72-3 | Reference compound |
| HY-W800804 | Fmoc-Ala-PAB-OH | 873923-24-1 | Reference compound |
| HY-W800805 | DOPE-Mal | 2295813-15-7 | Oligonucleotides |
| HY-W800806 | Heptyl 8-bromooctanoate | 612842-05-4 | Reference compound |
| HY-W800807 | R6G azide, 5-isomer | 2135330-71-9 | Dye Reagents |
| HY-W800808 | ROX azide, 5-isomer | 2628213-67-0 | Dye Reagents |
| HY-W800809 | FAM DBCO, 6-isomer | 2768977-07-5 | Dye Reagents |
| HY-W800813 | Carboxy-Amido-PEG5-N-Boc | 1415145-86-6 | Reference compound |
| HY-W800814 | Azido-PEG8-Amido-Val-Cit-PAB | 2356229-77-9 | ADC Related |
| HY-W800815 | Nonyl 10-bromodecanoate | 2102499-36-3 | Biochemical Assay Reagents |
| HY-W800816 | 1,2-Di-O-tetradecyl-rac-glycerol | 1561-55-3 | Reference compound |
| HY-W800817 | TCO-PEG4-maleimide | 2748945-56-2 | Reference compound |
| HY-W800818 | (Z)-Non-2-enyl 6-bromohexanoate | 2230212-02-7 | Biochemical Assay Reagents |
| HY-W800819 | Arachidic acid N-hydroxysuccinimide ester | 69888-87-5 | Reference compound |
| HY-W800821 | cis-8,11,14-Eicosatrienoic acid ethyl ester | 55968-21-3 | Natural Products |
| HY-W800822 | Lactic acid dodecyl ester | 6283-92-7 | Reference compound |
| HY-W800825 | Octadecanedioic acid mono-L-carnitine ester | 123233-50-1 | Biochemical Assay Reagents |
| HY-W800826 | 2-Oleoyl-3-chloropropanediol | 915297-48-2 | Natural Products |
| HY-W800828 | Iodoacetamido-PEG3-NHS ester | 2512227-27-7 | Reference compound |
| HY-W800829 | S-Undecyl 6-bromohexanethioate | 816464-82-1 | Biochemical Assay Reagents |
| HY-W800830 | DMG-Nitrophenyl carbonate | 2172921-69-4 | Reference compound |
| HY-W800831 | Tetra-sulfo-Cy7 DBCO | 2714419-16-4 | Dye Reagents |
| HY-W800832 | MB 660R DBCO | 2883125-82-2 | Dye Reagents |
| HY-W800833 | Benzyl N-[2-(prop-2-enamido)ethyl]carbamate | 55946-27-5 | Reference compound |
| HY-W800835 | Bromo-PEG3-Amine | 2680821-50-3 | Biochemical Assay Reagents |
| HY-W800837 | t-Boc-N-amido-PEG4-Val-Cit | 2231240-82-5 | ADC Related |
| HY-W800838 | BP Fluor 488 Tetrazine | 1466419-80-6 | Dye Reagents |
| HY-W800839 | TCO-PEG4-TFP ester | 2268817-73-6 | Reference compound |
| HY-W800840 | Alkyne sphinganine | 1417790-98-7 | Reference compound |
| HY-W800842 | 1-Ethylnonyl 8-bromooctanoate | 2244716-51-4 | Reference compound |
| HY-W800843 | tert-Butyl 3-(7-((undecan-3-yloxy)carbonyl)heptylamino)propylcarbamate | 2627085-42-9 | Biochemical Assay Reagents |
| HY-W800844 | NH-bis(PEG8-OH) | 2793446-59-8 | Reference compound |
| HY-W800846 | Fmoc-Amido-Tri-(carboxyethoxymethyl)-methane | 1240500-35-9 | Reference compound |
| HY-W800847 | Mal-Amide-PEG4-Val-Cit-PAB-PNP | 2003260-12-4 | ADC Related |
| HY-W800848 | 3,3'-[Dithiobis[2,1-ethanediyl(methylimino)]]bis[1-propanol] | 1436860-67-1 | Reference compound |
| HY-W801296 | Boc-Pyr-OtBu | 91237-84-2 | Peptides |
| HY-W801893 | FGFR1 inhibitor-13 | 670266-26-9 | Reference compound |
| HY-W802013 | DOTA-4AMP | 254444-71-8 | Biochemical Assay Reagents |
| HY-W802269 | 3,6,2',3',4',6'-Hexa-O-acetyl-D-lactal | 51450-24-9 | Biochemical Assay Reagents |
| HY-W802699 | α-Ketoglutaric acid (disodium dihydrate) | 1282616-74-3 | Biochemical Assay Reagents |
| HY-W803134 | (E/Z)-SIS3 (free base) | 1009104-85-1 | Reference compound |
| HY-W803223 | α-D-Mannopyranosyl chloride, 2,3,4,6-tetraacetate | 14257-40-0 | Biochemical Assay Reagents |
| HY-W803324 | 2,4,6,8-Decatetraenoic acid | 17016-39-6 | Biochemical Assay Reagents |
| HY-W803822 | 6-O-(Triphenylmethyl)-D-glucose | 67919-34-0 | Biochemical Assay Reagents |
| HY-W803860 | N-Depropylpropafenone | 86383-21-3 | Reference compound |
| HY-W803862 | Tripotassium citrate | 866-84-2 | Biochemical Assay Reagents |
| HY-W806047 | BRD4 Inhibitor-37 | 1095051-79-8 | Reference compound |
| HY-W806655 | Cy3.5 carboxylic acid | 1144107-79-8 | Dye Reagents |
| HY-W808757 | Biotin-maleimide | 116919-18-7 | Biochemical Assay Reagents |
| HY-W811579 | Bensuldazic acid | 1219-77-8 | Reference compound |
| HY-W811579A | Bensuldazic acid (sodium) | 1950-15-8 | Reference compound |
| HY-W814315 | Alectinib analog | 1256577-71-5 | Reference compound |
| HY-W814363 | Octadec-9-enoic acid-13C5 | 1255644-48-4 | Isotope-Labeled Compounds |
| HY-W815518 | Ethyl 3-O-benzyl-4,6-O-benzylidene-2-phthalimido-2-deoxy-1-thio-β-D-glucopyranoside | 129519-27-3 | Biochemical Assay Reagents |
| HY-W818693 | 3-Hydroxy-3-phenylpentanamide | 131802-69-2 | Reference compound |
| HY-W819785 | Benzyl (8-hydroxyoctyl)carbamate | 134477-39-7 | Reference compound |
| HY-W822030 | 2-Hydroxypropyl stearate | 142-75-6 | Natural Products |
| HY-W823500 | GLP-1 Receptor modulator 1 | 1461715-47-8 | Reference compound |
| HY-W826489 | D-Glucopyranose, 98% | 20429-79-2 | Biochemical Assay Reagents |
| HY-W834174 | Thalidomide-5-piperazine | 2154342-61-5 | Reference compound |
| HY-W834359 | (±)-Longamide | 219783-00-3 | Reference compound |
| HY-W835175 | Neramexane (hydrochloride) | 209185-99-9 | Reference compound |
| HY-W835383 | Sulfo Cy5.5-COOH | 210834-26-7 | Dye Reagents |
| HY-W835525 | N-(Biotinoyl)-N''-(iodoacetyl)ethylenediamine | 216393-53-2 | Biochemical Assay Reagents |
| HY-W835723 | 1-(2,6-Dimethoxyphenyl)-3-(4-hydroxyphenyl)propan-1-one | 221696-69-1 | Reference compound |
| HY-W835767 | Hexadecyl oleate | 22393-86-8 | Natural Products |
| HY-W835768 | Myristyl Oleate | 22393-85-7 | Natural Products |
| HY-W835848 | Nerolidol acetate | 2306-78-7 | Reference compound |
| HY-W835928 | 1,2:5,6-Di-O-cyclohexylidene-α-D-glucofuranose | 23397-76-4 | Biochemical Assay Reagents |
| HY-W836186 | Cyclo(Leu-Ala) | 24676-83-3 | Reference compound |
| HY-W836817 | 10-Methylundecanoic acid | 2724-56-3 | Natural Products |
| HY-W837135 | 5-Hydrazinyl thalidomide (hydrochloride) | 2803460-96-8 | Reference compound |
| HY-W837864 | PDK1 allosteric modulator 1 | 303134-93-2 | Reference compound |
| HY-W838042 | Hedgehog IN-8 | 314041-83-3 | Reference compound |
| HY-W838254 | 1,2-Dipentadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium) | 322647-32-5 | Natural Products |
| HY-W838632 | Antibacterial agent 266 | 34116-16-0 | Reference compound |
| HY-W838814 | ERK1/2 inhibitor 12 | 350509-85-2 | Reference compound |
| HY-W838865 | 11-Dodecenol | 35289-31-7 | Natural Products |
| HY-W839203 | 22:0 PC | 37070-48-7 | Oligonucleotides |
| HY-W839261 | Tyrosine kinase-IN-9 | 370854-75-4 | Reference compound |
| HY-W839383 | 2,3-Diphenylquinoxaline-6-sulphonamide | 380347-87-5 | Reference compound |
| HY-W840196 | Hex-5-ynehydrazide | 4230-19-7 | Reference compound |
| HY-W840250 | 3,5-Dimethyl-4-phenylisoxazole | 4345-46-4 | Reference compound |
| HY-W840382 | CK1δ-IN-8 | 438018-70-3 | Reference compound |
| HY-W840791 | 1-(2-Bromoethyl)piperazine | 494798-96-8 | Reference compound |
| HY-W841840 | SR94 | 550301-63-8 | Reference compound |
| HY-W842364 | CK1δ-IN-3 | 571174-12-4 | Reference compound |
| HY-W843265 | PIN1 inhibitor 6 | 637325-53-2 | Reference compound |
| HY-W843885 | H-Glu-Thr-OH | 6875-80-5 | Reference compound |
| HY-W844141 | 2,5-Dimethylchroman-4-one | 69687-87-2 | Natural Products |
| HY-W844543 | Protein kinase inhibitor 12 | 721964-48-3 | Reference compound |
| HY-W844558 | Protein kinase inhibitor 11 | 721964-51-8 | Reference compound |
| HY-W844796 | 2-Amino-5-methyl-5-hexenoic acid | 73322-75-5 | Reference compound |
| HY-W845607 | Milacemide | 76990-56-2 | Reference compound |
| HY-W846144 | ETP-45835 | 794510-70-6 | Reference compound |
| HY-W848341 | Clomesone | 88343-72-0 | Reference compound |
| HY-W848699 | FAM NHS ester, 6-isomer | 890090-41-2 | Dye Reagents |
| HY-W850170 | 12-Oxo-octadecanoic acid | 925-44-0 | Natural Products |
| HY-W850994 | Tridecyl β-D-maltopyranoside | 93911-12-7 | Biochemical Assay Reagents |
| HY-W854187 | 2'-Ome-Ac-G Phosporamidite | 909033-40-5 | Oligonucleotides |
| HY-W854275 | (H2IPr)(Cl)2Ru=CH(o-iPrOC6H4) | 635679-24-2 | Reference compound |
| HY-W854294 | 3,4-Seco-3-oxobisabol-10-ene-4,1-olide | 1564265-85-5 | Natural Products |
| HY-W854295 | Phosphatidylinositol-1,2-dioctanoyl (sodium) | 899827-36-2 | Reference compound |
| HY-W854301 | Phenylmethyl 2-(β-D-glucopyranosyloxy)-6-hydroxybenzoate | 403857-21-6 | Natural Products |
| HY-W854341 | Chitotriose | 41708-93-4 | Reference compound |
| HY-W854345 | 3-Deoxy-D-glucose | 2490-91-7 | Biochemical Assay Reagents |
| HY-W854349 | 3-Chloro-3-deoxy-D-glucose | 22933-89-7 | Biochemical Assay Reagents |
| HY-W854354 | Hepta-O-acetyl-β-lactosyl azide | 30854-62-7 | Biochemical Assay Reagents |
| HY-W854355 | D-Mannose-6-phosphate (disodium) | 33068-18-7 | Biochemical Assay Reagents |
| HY-W854356 | 4,6-O-(Phenylmethylene)-D-galactopyranose | 3006-41-5 | Biochemical Assay Reagents |
| HY-W854371 | D-Arabinofuranose,2-deoxy-2-fluoro,1,3,5-triacetate | 444586-86-1 | Biochemical Assay Reagents |
| HY-W854385 | Sialyl Lewis A | 92448-22-1 | Reference compound |
| HY-W854386 | B-Pentasaccharide | 72468-43-0 | Biochemical Assay Reagents |
| HY-W854390 | β-L-Allopyranose | 39392-62-6 | Biochemical Assay Reagents |
| HY-W854392 | 3-Carboxyumbelliferyl-β-D-glucuronide (dipotassium) | 216672-17-2 | Biochemical Assay Reagents |
| HY-W854396 | β-D-Lactopyranosylphenyl isothiocyanate | 96324-93-5 | Biochemical Assay Reagents |
| HY-W854408 | 1,2:3,4-Di-O-isopropylidene-6-deoxy-6-tosyl-α-D-galactopyranose | 70932-39-7 | Biochemical Assay Reagents |
| HY-W854413 | β-D-Galactopyranose,2,3,4,6-tetrakis-O-(phenylmethyl),1-acetate | 3866-62-4 | Biochemical Assay Reagents |
| HY-W854445 | Lewis-b tetrasaccharide | 80081-06-7 | Biochemical Assay Reagents |
| HY-W854549 | Heparin pentasaccharide | 104993-28-4 | Reference compound |
| HY-W854630 | 60-Fulleroacetic acid | 155116-19-1 | Reference compound |
| HY-W854649 | [Au(TPP)]Cl | 15695-27-9 | Reference compound |
| HY-W854659 | Chlorin e6 (trisodium) | 72984-36-2 | Biochemical Assay Reagents |
| HY-W854721 | Mn(III) Protoporphyrin IX chloride | 120389-54-0 | Reference compound |
| HY-W854727 | N-Methylfulleropyrrolidine | 151872-44-5 | Reference compound |
| HY-W855075A | Methyl coenzyme M (ammonium) | 53501-94-3 | Enzyme |
| HY-W856375 | BSPOTPE | 953792-48-8 | Dye Reagents |
| HY-W856375A | (E/Z)-BSPOTPE | 2046513-40-8 | Reference compound |
| HY-W856812 | Penicillanic acid (sodium) | 4027-62-7 | Reference compound |
| HY-W865379 | (S)-Avadomide-d1 | 1620055-10-8 | Isotope-Labeled Compounds |
| HY-W867679S | 5,12-Dihydro-12-phenylindolo[3,2-a]carbazole-d16 | 2569012-78-6 | Isotope-Labeled Compounds |
| HY-W867704 | 4-Me-Thalidomide | 244057-31-6 | Reference compound |
| HY-W869159S | 2-Fluorobenzyl olaparib-d4 | 2732919-14-9 | Isotope-Labeled Compounds |
| HY-W871891 | Fmoc-Glu(Otbu)-Gly-OH | 866044-63-5 | Reference compound |
| HY-W872575 | TCO4-PEG3-Maleimide | 1914971-04-2 | Reference compound |
| HY-W872575A | (R)-TCO4-PEG3-Maleimide | Reference compound | |
| HY-W873634 | TRAP | 1242003-07-1 | ADC Related |
| HY-W874018 | SMARCA2 ligand-8 | 2933254-33-0 | Reference compound |
| HY-W874392 | Tubulin polymerization-IN-74 | 54491-43-9 | Reference compound |
| HY-W874850 | Fluorodifen | 15457-05-3 | Reference compound |
| HY-W874850R | Fluorodifen (Standard) | 15457-05-3 | Reference Standards |
| HY-W874892 | Cannabidiphorol | 55824-13-0 | Reference compound |
| HY-W874904 | C.I. Solvent Yellow 33 | 8003-22-3 | Biochemical Assay Reagents |
| HY-W877850 | Mal-C5-N-bis(PEG2-C2-acid) | 3026691-12-0 | Reference compound |
| HY-W877989 | BWA-522 intermediate-1 | 2241315-66-0 | Reference compound |
| HY-W878608 | Cyanine7 azide | Dye Reagents | |
| HY-W878813 | Tos-PEG22-Tos | 35164-96-6 | Reference compound |
| HY-W878827 | Bis-sulfone-PEG12-NHS ester | 2055105-51-4 | Reference compound |
| HY-W878943 | FAM azide, 5-isomer | 510758-23-3 | Dye Reagents |
| HY-W879006 | N-Boc-N'-(mPEG24)-L-Lysine-OH | 2353409-83-1 | Reference compound |
| HY-W879007 | ICG-azide | Dye Reagents | |
| HY-W879008 | DiSulfo-ICG-azide (disodium) | Dye Reagents | |
| HY-W879048 | DBCO-PEG24-Maleimide | 2924872-84-2 | Reference compound |
| HY-W879093 | SiR-DBCO | 2259859-41-9 | Dye Reagents |
| HY-W879228 | Disulfo-ICG-DBCO (disodium) | Dye Reagents | |
| HY-W879234 | TriSulfo-Cy5.5 DBCO | Dye Reagents | |
| HY-W879342 | ICG-Tetrazine | Dye Reagents | |
| HY-W879370 | Disulfo-ICG-alkyne (disodium) | Reference compound | |
| HY-W881216 | (S)-GNA-T-phosphoramidite | 168332-13-6 | Reference compound |
| HY-W881219 | N6-Bz-A-(S)-GNA phosphoramidite | 851050-24-3 | Reference compound |
| HY-W881439 | 1-(1,1-Dimethylethyl) tridecanedioate | 2703752-86-5 | Reference compound |
| HY-W881450 | (2S,3R,E)-2-Aminohexadec-4-ene-1,3-diol | 6982-09-8 | Natural Products |
| HY-W881463 | N4-Ac-C-(S)-GNA phosphoramidite | 1159174-80-7 | Reference compound |
| HY-W882667 | Pregn-5-en-3β-ol | 2862-58-0 | Reference compound |
| HY-W882740 | 4-Nitrophenyl 11,16-dioxo-14,14-bis(3-oxo-3-((2-(2-(prop-2-yn-1-yloxy)ethoxy)ethyl)amino)propyl)-4,7-dioxa-10,15-diazaicos-1-yn-20-oate | 2320479-61-4 | Reference compound |
| HY-W883690 | LacK (free acid) | 1227379-69-2 | Reference compound |
| HY-W888514 | mPEG-CHO | 125061-88-3 | Reference compound |
| HY-W888515 | mPEG-PCL | Natural Products | |
| HY-W888521 | mPEG-PLLA | Natural Products | |
| HY-W888970 | 3-(4-Bromo-2-fluorophenyl)piperidine-2,6-dione | 2924092-66-8 | Reference compound |
| HY-W889109 | 3-(Dimethoxymethyl)-1-oxa-8-azaspiro[4.5]decane | 3026011-77-5 | Reference compound |
| HY-W890109S | Spiramycin I-d3-1 | 1355452-20-8 | Isotope-Labeled Compounds |
| HY-W890189 | E3 ligase Ligand 54 | 2413038-90-9 | Reference compound |
| HY-W890392 | (1r,4r)-tert-Butyl 4-(bromomethyl)cyclohexanecarboxylate | 2866254-09-1 | Reference compound |
| HY-W892911 | AV-5080 | 1448435-38-8 | Reference compound |
| HY-W893194 | CRBN ligand-110 | 2924092-72-6 | Reference compound |
| HY-W894385B | 3'-Azidomethyi-dGTP (sodium) | Biochemical Assay Reagents | |
| HY-W895359 | Photoclick myristic acid | 2707485-30-9 | Reference compound |
| HY-W898983 | CRBN ligand-181 | 3036607-12-9 | Reference compound |
| HY-W898985 | CRBN ligand-148 | 3036607-19-6 | Reference compound |
| HY-W898987 | CRBN ligand-83 | 3036607-28-7 | Reference compound |
| HY-W898989 | 3-(4-Bromo-2-chlorophenyl)piperidine-2,6-dione | 2923549-60-2 | Reference compound |
| HY-W898991 | CRBN ligand-112 | 3036607-49-2 | Reference compound |
| HY-W898997 | CRBN ligand-111 | 3036607-67-4 | Reference compound |
| HY-W898998 | CRBN ligand-164 | 3036607-71-0 | Reference compound |
| HY-W899000 | CRBN ligand-162 | 3036607-75-4 | Reference compound |
| HY-W899002 | CRBN ligand-108 | 3036607-80-1 | Reference compound |
| HY-W899994 | 2,5-Diaminobenzoic acid-d3 | Isotope-Labeled Compounds | |
| HY-W900572 | 12-Tridecenol | 16339-75-6 | Natural Products |
| HY-W900879 | Dihexadecylamine | 16724-63-3 | Reference compound |
| HY-W901051 | N-Biotinoyl-1,2-dioleyoylphosphatidylethanolamine | 165191-88-8 | Natural Products |
| HY-W904851 | Boc-Piperidine-piperazine-Cbz | 177276-40-3 | Reference compound |
| HY-W909149 | TAAR1 agonist 3 | 1804129-70-1 | Reference compound |
| HY-W909173 | TAAR1 agonist 2 | 1804128-38-8 | Reference compound |
| HY-W909314 | t-Butyoxycarboxy-PEG4-para-nitrophenyl carbonate | 1807537-39-8 | Biochemical Assay Reagents |
| HY-W909319 | 2-(t-Butyloxycarbonyl-PEG4)isoindoline-1,3-dione | 1807530-13-7 | Biochemical Assay Reagents |
| HY-W922811 | DL-Willardiine | 19772-76-0 | Reference compound |
| HY-W923132 | Fluorescein O-acrylate | 193419-86-2 | Reference compound |
| HY-W923150 | 1,2-Diheptadecanoyl-sn-glycero-3-phosphatidylethanolamine | 140219-78-9 | Natural Products |
| HY-W923154 | Glyceryl trinonadecanoate | 26536-13-0 | Biochemical Assay Reagents |
| HY-W923189 | Neral | 106-26-3 | Natural Products |
| HY-W923198 | Fluorescein O-methacrylate | 480439-15-4 | Reference compound |
| HY-W923274 | Phosphatidyl Glycerol (plant) sodium | 322647-44-9 | Natural Products |
| HY-W923277 | Sodium sesquicarbonate (hydrate) | 6106-20-3 | Biochemical Assay Reagents |
| HY-W923355 | 1,2,3-Trieicosapentaenoyl glycerol | 99660-94-3 | Reference compound |
| HY-W923357 | 9(Z),11(Z)-Conjugated linoleic acid methyl ester | 822-10-6 | Reference compound |
| HY-W923366 | Magnesium ionophore III | 119110-38-2 | Reference compound |
| HY-W923483 | C16-18:1 PC | 95403-34-2 | Natural Products |
| HY-W923487 | (Rac)-Bifenthrin | 99267-18-2 | Reference compound |
| HY-W923496 | all-cis-4,7,10,13,16-Docosapentaenoic acid ethyl ester | 142828-42-0 | Natural Products |
| HY-W923632 | (Z)-Tetradec-9-en-1-ol | 35153-15-2 | Natural Products |
| HY-W923636 | N-Oleoyl sphinganine | 34227-83-3 | Natural Products |
| HY-W923642 | Sphingomyelin (d18:1/12:0) | 474923-21-2 | Natural Products |
| HY-W923645 | Fluorescein O,O′-diacrylate | 7262-39-7 | Reference compound |
| HY-W923646 | C24:1-Dihydro-ceramide | 352518-80-0 | Natural Products |
| HY-W923661 | 1-Octadecyl lysophosphatidic acid | 52977-29-4 | Reference compound |
| HY-W924597 | Nonanoyl-N-hydroxyethylglucamide | 869653-90-7 | Biochemical Assay Reagents |
| HY-W924948 | Pomalidomide-PEG3-OH | 2140807-36-7 | Reference compound |
| HY-W924949 | Pomalidomide-PEG2-OH | 2143097-10-1 | Reference compound |
| HY-W925660 | (+)-Potassium Ds-threo-isocitrate monobasic | 20226-99-7 | Reference compound |
| HY-W925682 | Bidwillol A | 161099-42-9 | Natural Products |
| HY-W926789 | (E)-GW7604 | 195611-82-6 | Reference compound |
| HY-W926978 | Bromophenol red (sodium) | 102185-50-2 | Biochemical Assay Reagents |
| HY-W927157 | Disperse Red 1 acrylate | 13695-46-0 | Reference compound |
| HY-W927359 | Fluorescein hydrazide (3,6-Dihydroxyxanthane) | 109653-47-6 | Reference compound |
| HY-W927376 | Boc-Val-Arg-AMC | 113865-96-6 | Peptides |
| HY-W927849 | Magnesium dodecyl sulfate | 3097-08-3 | Biochemical Assay Reagents |
| HY-W928231 | Demethoxyencecalinol | 71822-00-9 | Natural Products |
| HY-W928283 | L-Hydroxyproline 7-amido-4-methylcoumarin (hydrochloride) | 1135372-06-3 | Biochemical Assay Reagents |
| HY-W928314 | 1,2-Dipalmitoyl-rac-glycero-3-PG (ammonium salt) | 73548-70-6 | Reference compound |
| HY-W928469 | 18-Hydroxytritriacontan-16-one | 97191-42-9 | Natural Products |
| HY-W928617 | Spectinomycin (sulfate hydrate) | 64058-48-6 | Reference compound |
| HY-W928623 | 2-Acetylthiophene thiosemicarbazone | 5351-71-3 | Reference compound |
| HY-W928653 | L-Seryl-L-leucyl-L-leucyl-L-lysine | 464924-27-4 | Peptides |
| HY-W929472 | 13(S)-HOTrE | 87984-82-5 | Natural Products |
| HY-W930939 | (2S,3R,E)-2-Aminopentadec-4-ene-1,3-diol | 86555-28-4 | Natural Products |
| HY-W931056 | AMG-628 | 862269-93-0 | Reference compound |
| HY-W940797 | Thalidomide-O-amido-C7-NH2 | 2716123-52-1 | Reference compound |
| HY-W942561 | Cyclo(D-Val-L-Pro) | 27483-18-7 | Natural Products |
| HY-W951189 | (10Z,13Z)-Nonadeca-10,13-dienoic acid | 29204-20-4 | Reference compound |
| HY-W956235 | (S,R,S)-AHPC-CO-C-piperazine | 2940856-78-8 | Reference compound |
| HY-W957284 | DCAF11 ligand 1 | 2940939-13-7 | Reference compound |
| HY-W957364 | Pomalidomide-C2-Br | 2940940-74-7 | Reference compound |
| HY-W960552A | 5-Methoxy-cytidine-5'-triphosphate (trisodium) | Oligonucleotides | |
| HY-W966282 | Aplindore | 189681-70-7 | Reference compound |
| HY-W967441 | 5-(3-Iodopropoxy)-2-nitrobenzenemethanol | 185994-27-8 | Biochemical Assay Reagents |
| HY-W969553 | Sebacamic acid | 6249-07-6 | Reference compound |
| HY-W969907 | GSK3-IN-7 | 1062138-03-7 | Reference compound |
| HY-W970428 | 15-Methylheptadecanoic acid | 29709-08-8 | Natural Products |
| HY-W971376 | Cyclo(Ala-Tyr) | 21754-26-7 | Natural Products |
| HY-W972380 | Methyl 2,6,10,14-tetramethylpentadecanoate | 1001-80-5 | Natural Products |
| HY-W975617 | 4',5,7,8-Tetrahydroxyflavanone | 479-54-9 | Reference compound |
| HY-W975966 | CPDT | 14085-33-7 | Reference compound |
| HY-W976322 | Cyclo(Tyr-Hpro) | 813461-21-1 | Natural Products |
| HY-W979008 | (+)-Isopinocampheol | 24041-60-9 | Natural Products |
| HY-W979493 | TC-2216 | 646055-67-6 | Reference compound |
| HY-W981453 | 1,3-o-(S)-Benzylidene-D-arabitol | 80924-06-7 | Biochemical Assay Reagents |
| HY-W982688 | Palmitoleyl methane sulfonate | 93135-85-4 | Natural Products |
| HY-W983015 | Davidigenin | 23130-26-9 | Natural Products |
| HY-W984122 | CFTR corrector 17 | 912790-04-6 | Reference compound |
| HY-W986917 | Decyl methanesulfonate | 41233-29-8 | Natural Products |
| HY-W988083 | Decarestrictin B | 127393-91-3 | Natural Products |
| HY-W989120 | cis-6,9,12-Hexadecatrienoic acid | 29428-96-4 | Biochemical Assay Reagents |
| HY-W990229 | Thalidomide-O-PEG1-OH | 2416234-31-4 | Reference compound |
| HY-W992384 | (S,9E,11Z,14Z)-8-Hydroxyicosa-9,11,14-trienoic acid | 889573-69-7 | Natural Products |
| HY-W992515 | 9,10,16-Trihydroxyhexadecanoic acid | 6949-98-0 | Natural Products |
| HY-W992934S | Indolylacryloylglycine-d2 | Isotope-Labeled Compounds | |
| HY-W993077 | Ricinoleyl alcohol | 540-11-4 | Reference compound |
| HY-W994722 | ISO24 | 473707-40-3 | Reference compound |
| HY-W995025 | Actinobolin | 24397-89-5 | Reference compound |
| HY-W995025A | Actinobolin (hemisulfate) | 18802-17-0 | Reference compound |
| HY-W995229 | Ro 31-6840 | 119555-47-4 | Reference compound |
| HY-W995241 | BPD | 213481-12-0 | Reference compound |
| HY-W997026 | Glucokinase activator 7 | 66780-67-4 | Reference compound |
| HY-W997836 | 4-Amino-3-hydroxyphenylalanine | 74923-08-3 | Natural Products |
| HY-W998034 | (2,6-Dihydroxy-4-methoxyphenyl)(4-hydroxyphenyl)methanone | 55051-85-9 | Natural Products |
| HY-W998262 | Pomalidomide 5-piperidylamine | 2636798-55-3 | Reference compound |
| HY-W998281 | 3-(4-(5-Hydroxypent-1-yn-1-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 2138441-30-0 | Reference compound |
| HY-W998345 | SMART1 | Reference compound | |
| HY-W998643 | 6, 8-Difluoro-7-hydroxy-4-methylcoumarin NHS ester | 215868-29-4 | Dye Reagents |
| HY-W998658 | BODIPY 564/570 | 150173-89-0 | Reference compound |
| HY-W998662 | Coumarin 343 X carboxylic acid | 946123-11-1 | Dye Reagents |
| HY-W998675 | 5-FITC-Tetrazine | 2264035-11-0 | Dye Reagents |
| HY-W998679 | Biotin (5-fluorescein) conjugate | 957494-27-8 | Reference compound |
| HY-W998687 | Cy5 dimethyl | 54268-70-1 | Dye Reagents |
| HY-W998707 | TAMRA amine, 5-isomer (hydrochloride) | 2158336-48-0 | Dye Reagents |
| HY-W999766 | Propargyl-NOTA(tBu)2 | 1924677-40-6 | ADC Related |
| HY-W999782 | Propargyl-DOTA-tris(tBu)ester | 911197-00-7 | ADC Related |
| HY-WAA0093 | 2-Amino-5-methylthiazole | 7305-71-7 | Biochemical Assay Reagents |
| HY-WAA0093R | 2-Amino-5-methylthiazole (Standard) | 7305-71-7 | Reference Standards |
| HY-WAA0112 | Ethyl 2-((2-((tert-butoxycarbonyl)amino)ethyl)amino)acetate hydrochloride | 347890-34-0 | Peptides |
| HY-WAA0142 | L-Prolylglycine | 2578-57-6 | Natural Products |
| HY-WAA0142R | L-Prolylglycine (Standard) | 2578-57-6 | Reference Standards |
| HY-WAA0253 | L-Proline monohydrochloride | 7776-34-3 | Peptides |
| HY-WAA0302 | 1,4-Bis-boc-1,4,7-triazaheptane | 120131-72-8 | Reference compound |
| HY-X0009 | Tambiciclib | 2247481-08-7 | Reference compound |
| HY-X0009A | JSH-009 (dimaleate) | 2559759-04-3 | Reference compound |
| HY-X0150 | JSH-150 | 2247481-21-4 | Reference compound |
| HY-Y0001 | Cyclopropylcarboxylic acid | 1759-53-1 | Biochemical Assay Reagents |
| HY-Y0001S | Cyclopropylcarboxylic acid-d4 | 89924-82-3 | Isotope-Labeled Compounds |
| HY-Y0001S1 | Cyclopropylcarboxylic acid-d1 | 19136-94-8 | Isotope-Labeled Compounds |
| HY-Y0003 | (Rac)-BINAP | 98327-87-8 | Reference compound |
| HY-Y0004 | 2-Pyridinemethanol | 586-98-1 | Reference compound |
| HY-Y0006 | XPhos | 564483-18-7 | Biochemical Assay Reagents |
| HY-Y0007 | N-[(Benzyloxy)carbonyl]-L-alanine | 1142-20-7 | Peptides |
| HY-Y0012S | 4-Butylaniline-d6 | 1219794-75-8 | Isotope-Labeled Compounds |
| HY-Y0012S1 | 4-Butylaniline-d9 | 1219794-78-1 | Isotope-Labeled Compounds |
| HY-Y0012S2 | 4-Butylaniline-d15 | 1219794-89-4 | Isotope-Labeled Compounds |
| HY-Y0013S | 4-Ethylaniline-d11 | 1219802-96-6 | Isotope-Labeled Compounds |
| HY-Y0015 | p-Dimethylaminobenzaldehyde | 100-10-7 | Reference compound |
| HY-Y0015R | p-Dimethylaminobenzaldehyde (Standard) | 100-10-7 | Reference Standards |
| HY-Y0016 | Rhodamine B | 81-88-9 | Dye Reagents |
| HY-Y0016R | Rhodamine B (Standard) | 81-88-9 | Dye Reagents |
| HY-Y0017 | L-Norleucine | 327-57-1 | Natural Products |
| HY-Y0017R | L-Norleucine (Standard) | 327-57-1 | Reference Standards |
| HY-Y0017S | L-Norleucine-d9 | 1331889-36-1 | Isotope-Labeled Compounds |
| HY-Y0024 | 4-Methoxyacetophenone | 100-06-1 | Biochemical Assay Reagents |
| HY-Y0024R | 4-Methoxyacetophenone (Standard) | 100-06-1 | Reference Standards |
| HY-Y0026 | 3-Hydroxy-4-methylbenzoic acid | 586-30-1 | Biochemical Assay Reagents |
| HY-Y0028 | (S)-2-(tert-Butoxycarbonylamino)succinic acid benzyl ester | 30925-18-9 | Peptides |
| HY-Y0029 | Boc-D-Asp-OBzl | 92828-64-3 | Peptides |
| HY-Y0030 | 3-Hydroxypicolinic acid | 874-24-8 | Natural Products |
| HY-Y0030A | 3-Hydroxypicolinic acid, matrix substance for MALDI-MS | 874-24-8 | Biochemical Assay Reagents |
| HY-Y0032 | Thiosemicarbazide | 79-19-6 | Reference compound |
| HY-Y0035 | 4,4-Dimethoxy-2-butanone | 5436-21-5 | Reference compound |
| HY-Y0035R | 4,4-Dimethoxy-2-butanone (Standard) | 5436-21-5 | Reference Standards |
| HY-Y0037 | Potassium hydrogen phthalate | 877-24-7 | Biochemical Assay Reagents |
| HY-Y0037R | Potassium hydrogen phthalate (Standard) | 877-24-7 | Reference Standards |
| HY-Y0038 | 2-Bromo-6-methoxynaphthalene | 5111-65-9 | Reference compound |
| HY-Y0038R | 2-Bromo-6-methoxynaphthalene (Standard) | 5111-65-9 | Reference Standards |
| HY-Y0045 | 2-Acetylthiazole | 24295-03-2 | Biochemical Assay Reagents |
| HY-Y0045S | 2-Acetylthiazole-13C2 | Isotope-Labeled Compounds | |
| HY-Y0047 | 3-Picolylamine | 3731-52-0 | Reference compound |
| HY-Y0051 | 5-Hydroxymethylfurfural | 67-47-0 | Natural Products |
| HY-Y0051R | 5-Hydroxymethylfurfural (Standard) | 67-47-0 | Reference Standards |
| HY-Y0051S | 5-Hydroxymethylfurfural-13C6 | 1219193-98-2 | Isotope-Labeled Compounds |
| HY-Y0054S | Isocyanic acid, p-tolyl ester-d7 | 1219798-59-0 | Isotope-Labeled Compounds |
| HY-Y0055 | Phenothiazine | 92-84-2 | Reference compound |
| HY-Y0055R | Phenothiazine (Standard) | 92-84-2 | Reference Standards |
| HY-Y0055S | Phenothiazine-d8 | 1219803-41-4 | Isotope-Labeled Compounds |
| HY-Y0057 | NSC 13138 | 486-74-8 | Natural Products |
| HY-Y0061 | Oxindole | 59-48-3 | Natural Products |
| HY-Y0061R | Oxindole (Standard) | 59-48-3 | Reference Standards |
| HY-Y0068 | N-Acetyl-L-phenylalanine | 2018-61-3 | Natural Products |
| HY-Y0068R | N-Acetyl-L-phenylalanine (Standard) | 2018-61-3 | Reference Standards |
| HY-Y0069 | N-Acetylglycine | 543-24-8 | Natural Products |
| HY-Y0069R | N-Acetylglycine (Standard) | 543-24-8 | Reference Standards |
| HY-Y0069S | N-Acetylglycine-d5 | 1219805-82-9 | Isotope-Labeled Compounds |
| HY-Y0069S1 | N-Acetylglycine-d2 | 4905-36-6 | Isotope-Labeled Compounds |
| HY-Y0073 | 4-Hydroxyacetophenone | 99-93-4 | Natural Products |
| HY-Y0073R | 4-Hydroxyacetophenone (Standard) | 99-93-4 | Reference Standards |
| HY-Y0075 | 2-Naphthaldehyde | 66-99-9 | Biochemical Assay Reagents |
| HY-Y0077S | 4-Isopropylaniline-d4 | 1219804-95-1 | Isotope-Labeled Compounds |
| HY-Y0078 | Cinnamyl Alcohol | 104-54-1 | Natural Products |
| HY-Y0078R | Cinnamyl Alcohol (Standard) | 104-54-1 | Reference Standards |
| HY-Y0078S | Cinnamyl Alcohol-d5 | 1044940-87-5 | Isotope-Labeled Compounds |
| HY-Y0078S1 | Cinnamyl Alcohol-d9 | Isotope-Labeled Compounds | |
| HY-Y0079 | D-Phenylalanine | 673-06-3 | Natural Products |
| HY-Y0079R | D-Phenylalanine (Standard) | 673-06-3 | Reference Standards |
| HY-Y0079S | D-Phenylalanine-d5 | 362049-55-6 | Isotope-Labeled Compounds |
| HY-Y0079S1 | D-Phenylalanine-d8 | 1202064-02-5 | Isotope-Labeled Compounds |
| HY-Y0080 | Methyl trioctyl ammonium chloride | 5137-55-3 | Biochemical Assay Reagents |
| HY-Y0084 | 3,4,5-Trimethoxybenzoic acid | 118-41-2 | Natural Products |
| HY-Y0084S | 3,4,5-Trimethoxybenzoic acid-d3 | 84759-05-7 | Isotope-Labeled Compounds |
| HY-Y0085S | NSC 190686-d3 | 1219798-70-5 | Isotope-Labeled Compounds |
| HY-Y0086S | 3-Pyridinecarboxaldehyde-d4 | 258854-80-7 | Isotope-Labeled Compounds |
| HY-Y0087S | 3-Bromopyridine-d4 | 66148-14-9 | Isotope-Labeled Compounds |
| HY-Y0091 | Xantphos | 161265-03-8 | Biochemical Assay Reagents |
| HY-Y0093S | NSC 5416-d14 | 1219805-89-6 | Isotope-Labeled Compounds |
| HY-Y0094 | 2-Chloro-5-nitrobenzaldehyde | 6361-21-3 | Biochemical Assay Reagents |
| HY-Y0095 | Isethionic acid (80% in water) | 107-36-8 | Natural Products |
| HY-Y0100 | N,N'-Dimethyltrimethyleneurea | 7226-23-5 | Biochemical Assay Reagents |
| HY-Y0102 | Thiosalicylic acid | 147-93-3 | Biochemical Assay Reagents |
| HY-Y0106 | 2,6-Dihydroxyacetophenone | 699-83-2 | Natural Products |
| HY-Y0106R | 2,6-Dihydroxyacetophenone (Standard) | 699-83-2 | Reference Standards |
| HY-Y0109 | Chloropyrazine | 14508-49-7 | Reference compound |
| HY-Y0110 | 2-Naphthol | 135-19-3 | Natural Products |
| HY-Y0110R | 2-Naphthol (Standard) | 135-19-3 | Reference Standards |
| HY-Y0110S | 2-Naphthol-d8 | 78832-61-8 | Isotope-Labeled Compounds |
| HY-Y0110S1 | 2-Naphthol-d7 | 78832-54-9 | Isotope-Labeled Compounds |
| HY-Y0117 | (+)-Di-p-toluoyl-D-tartaric Acid | 32634-68-7 | Biochemical Assay Reagents |
| HY-Y0117R | (+)-Di-p-toluoyl-D-tartaric Acid (Standard) | 32634-68-7 | Reference Standards |
| HY-Y0120 | Tributylmethylammonium (chloride) | 56375-79-2 | Biochemical Assay Reagents |
| HY-Y0121 | Ethyl cinnamate | 103-36-6 | Natural Products |
| HY-Y0121R | Ethyl cinnamate (Standard) | 103-36-6 | Reference Standards |
| HY-Y0121S | Ethyl cinnamate-d5 | 856765-68-9 | Isotope-Labeled Compounds |
| HY-Y0121S1 | Ethyl cinnamate-d7 | 1336882-58-6 | Isotope-Labeled Compounds |
| HY-Y0123 | DL-Tyrosine | 556-03-6 | Natural Products |
| HY-Y0123S | DL-Tyrosine-13C9,15N | 202407-26-9 | Isotope-Labeled Compounds |
| HY-Y0123S1 | DL-Tyrosine-d7 | 402835-78-3 | Isotope-Labeled Compounds |
| HY-Y0123S2 | DL-Tyrosine-d2 | 35693-18-6 | Isotope-Labeled Compounds |
| HY-Y0123S3 | DL-Tyrosine-d3 | 73036-42-7 | Isotope-Labeled Compounds |
| HY-Y0124 | NSC 16590 | 62-57-7 | Natural Products |
| HY-Y0124R | NSC 16590 (Standard) | 62-57-7 | Reference Standards |
| HY-Y0124S | NSC 16590-d6 | 50348-93-1 | Isotope-Labeled Compounds |
| HY-Y0127 | D(-)-2-Aminobutyric acid | 2623-91-8 | Natural Products |
| HY-Y0127R | D(-)-2-Aminobutyric acid (Standard) | 2623-91-8 | Reference Standards |
| HY-Y0127S | D(-)-2-Aminobutyric acid-d6 | 1276197-57-9 | Isotope-Labeled Compounds |
| HY-Y0131 | Pyrazine-2-carbonitrile | 19847-12-2 | Biochemical Assay Reagents |
| HY-Y0134 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid | 71989-18-9 | Peptides |
| HY-Y0134S | Fmoc-Glu(OtBu)-OH-15N | 191925-20-9 | Isotope-Labeled Compounds |
| HY-Y0135 | Tropinone | 532-24-1 | Reference compound |
| HY-Y0135R | Tropinone (Standard) | 532-24-1 | Reference Standards |
| HY-Y0136 | 3-Indoleacetonitrile | 771-51-7 | Natural Products |
| HY-Y0136R | 3-Indoleacetonitrile (Standard) | 771-51-7 | Reference Standards |
| HY-Y0136S1 | 3-Indoleacetonitrile-d4 | 927182-31-8 | Isotope-Labeled Compounds |
| HY-Y0139 | 3-Aminopropan-1-ol | 156-87-6 | Reference compound |
| HY-Y0139S | 3-Aminopropan-1-ol-d6 | 59720-07-9 | Isotope-Labeled Compounds |
| HY-Y0141 | 3-Amino-6-chloropyridazine | 5469-69-2 | Biochemical Assay Reagents |
| HY-Y0147 | (Trifluoromethyl)trimethylsilane | 81290-20-2 | Biochemical Assay Reagents |
| HY-Y0148 | 10-Hydroxydecanoic acid | 1679-53-4 | Natural Products |
| HY-Y0148R | 10-Hydroxydecanoic acid (Standard) | 1679-53-4 | Reference Standards |
| HY-Y0149S | 3,4-Dimethoxyphenylacetonitrile-α,α-d2 | 1219803-34-5 | Isotope-Labeled Compounds |
| HY-Y0152 | Cinchonine | 118-10-5 | Natural Products |
| HY-Y0152A | Cinchonine (monohydrochloride hydrate) | 206986-88-1 | Natural Products |
| HY-Y0152R | Cinchonine (Standard) | 118-10-5 | Reference Standards |
| HY-Y0159 | 1-Bromo-2,4-dimethoxybenzene | 17715-69-4 | Biochemical Assay Reagents |
| HY-Y0162S | 4-Hydroxy biphenyl-d5 | 1126389-67-0 | Isotope-Labeled Compounds |
| HY-Y0162S1 | [1,1'-Biphenyl]-4-ol-d9 | 126840-28-6 | Isotope-Labeled Compounds |
| HY-Y0168 | L-(-)-Phenylalaninol | 3182-95-4 | Peptides |
| HY-Y0172 | Butylated hydroxytoluene | 128-37-0 | Reference compound |
| HY-Y0172R | Butylated hydroxytoluene (Standard) | 128-37-0 | Reference Standards |
| HY-Y0172S | Butylated hydroxytoluene-d21 | 64502-99-4 | Isotope-Labeled Compounds |
| HY-Y0172S1 | Butylated hydroxytoluene-d24 | 1219805-92-1 | Isotope-Labeled Compounds |
| HY-Y0172S2 | Butylated hydroxytoluene-d3 | 86819-59-2 | Isotope-Labeled Compounds |
| HY-Y0178 | 4-Chloropyridine (hydrochloride) | 7379-35-3 | Biochemical Assay Reagents |
| HY-Y0179 | 4-Acetylpyridine | 1122-54-9 | Biochemical Assay Reagents |
| HY-Y0181 | D-Pipecolinic acid | 1723-00-8 | Natural Products |
| HY-Y0185 | 4'-Nitroacetophenone | 100-19-6 | Biochemical Assay Reagents |
| HY-Y0188 | 3-Bromobenzoic acid | 585-76-2 | Biochemical Assay Reagents |
| HY-Y0189 | Methyl Salicylate | 119-36-8 | Natural Products |
| HY-Y0189R | Methyl Salicylate (Standard) | 119-36-8 | Reference Standards |
| HY-Y0189S | Methyl Salicylate-d4 | 1219802-12-6 | Isotope-Labeled Compounds |
| HY-Y0190 | (2R,3R)-Diethyl 2,3-dihydroxysuccinate | 87-91-2 | Biochemical Assay Reagents |
| HY-Y0191 | α-Pyridone | 142-08-5 | Natural Products |
| HY-Y0191R | α-Pyridone (Standard) | 142-08-5 | Reference Standards |
| HY-Y0194S | 2-Aminohexane-d6 | 1219802-28-4 | Isotope-Labeled Compounds |
| HY-Y0195S | Methyl 3-bromopropanoate-d4 | 1219803-82-3 | Isotope-Labeled Compounds |
| HY-Y0197 | 4-Fluorobenzaldehyde | 459-57-4 | Biochemical Assay Reagents |
| HY-Y0198 | 2,6-Diaminopyridine | 141-86-6 | Biochemical Assay Reagents |
| HY-Y0198R | 2,6-Diaminopyridine (Standard) | 141-86-6 | Reference Standards |
| HY-Y0199 | (2-Bromoethyl)benzene | 103-63-9 | Biochemical Assay Reagents |
| HY-Y0199S | (2-Bromoethyl)benzene-d5 | 35845-64-8 | Isotope-Labeled Compounds |
| HY-Y0202 | Pyrocatechuic acid | 303-38-8 | Natural Products |
| HY-Y0202R | Pyrocatechuic acid (Standard) | 303-38-8 | Reference Standards |
| HY-Y0203S | 2,4-Dichloropyrimidine-d2 | 2259315-63-2 | Isotope-Labeled Compounds |
| HY-Y0219 | 1,2,4-Triazole | 288-88-0 | Biochemical Assay Reagents |
| HY-Y0219A | 1,2,4-Triazole (sodium) | 41253-21-8 | Reference compound |
| HY-Y0219R | 1,2,4-Triazole (Standard) | 288-88-0 | Reference Standards |
| HY-Y0219S | 1,2,4-Triazole-13C2,15N3 | 1261170-82-4 | Isotope-Labeled Compounds |
| HY-Y0219S1 | 1,2,4-Triazole-d3 | 43088-92-2 | Isotope-Labeled Compounds |
| HY-Y0225S | p-Fluorophenol-d6 | 1219804-93-9 | Isotope-Labeled Compounds |
| HY-Y0226S | Cyclopropyl-1 Methyl-Ketone-d4 | 95249-93-7 | Isotope-Labeled Compounds |
| HY-Y0226S1 | NSC 1940-d8 | 1219799-33-3 | Isotope-Labeled Compounds |
| HY-Y0226S2 | NSC 1940-d4 | 350818-63-2 | Isotope-Labeled Compounds |
| HY-Y0232 | Meldrum's acid | 2033-24-1 | Biochemical Assay Reagents |
| HY-Y0235 | 6'-Methoxy-2'-acetonaphthone | 3900-45-6 | Biochemical Assay Reagents |
| HY-Y0235R | 6'-Methoxy-2'-acetonaphthone (Standard) | 3900-45-6 | Reference Standards |
| HY-Y0236 | 1-Naphthoic acid | 86-55-5 | Biochemical Assay Reagents |
| HY-Y0238 | 2-Bromoisobutyryl bromide | 20769-85-1 | Biochemical Assay Reagents |
| HY-Y0241 | 2-Cyanopyrimidine | 14080-23-0 | Reference compound |
| HY-Y0244 | 2-Chloropyridin-3-amine | 6298-19-7 | Biochemical Assay Reagents |
| HY-Y0245S | α-Cyanopyridine-d4 | 1219795-17-1 | Isotope-Labeled Compounds |
| HY-Y0247 | 6-Chloropurine | 87-42-3 | Reference compound |
| HY-Y0248 | (E,E)-Farnesol | 106-28-5 | Biochemical Assay Reagents |
| HY-Y0248A | Farnesol | 4602-84-0 | Natural Products |
| HY-Y0248AR | Farnesol (Standard) | 4602-84-0 | Reference Standards |
| HY-Y0248AS | (E,E)-Farnesol-d6 | 166447-71-8 | Isotope-Labeled Compounds |
| HY-Y0248R | (E,?E)?-?Farnesol (Standard) | 106-28-5 | Reference Standards |
| HY-Y0251 | 3-Nitrophthalic acid | 603-11-2 | Biochemical Assay Reagents |
| HY-Y0251S | 3-Nitrophthalic acid-d3 | 1386387-74-1 | Isotope-Labeled Compounds |
| HY-Y0252 | L-Proline | 147-85-3 | Natural Products |
| HY-Y0252R | L-Proline (Standard) | 147-85-3 | Reference Standards |
| HY-Y0252S | L-Proline-13C5 | 201740-83-2 | Isotope-Labeled Compounds |
| HY-Y0252S1 | L-Proline-d3 | 65807-22-9 | Isotope-Labeled Compounds |
| HY-Y0252S2 | L-Proline-15N | 59681-31-1 | Isotope-Labeled Compounds |
| HY-Y0252S3 | L-Proline-13C | 81202-06-4 | Isotope-Labeled Compounds |
| HY-Y0252S4 | L-Proline-13C5,15N | 202407-23-6 | Isotope-Labeled Compounds |
| HY-Y0252S5 | L-Proline-d7 | 39063-89-3 | Isotope-Labeled Compounds |
| HY-Y0252S6 | L-Proline-13C5,15N,d7 | 1500092-11-4 | Isotope-Labeled Compounds |
| HY-Y0252S7 | L-Proline-15N,d7 | Isotope-Labeled Compounds | |
| HY-Y0258 | Benzocaine | 94-09-7 | Reference compound |
| HY-Y0258A | Benzocaine (hydrochloride) | 23239-88-5 | Reference compound |
| HY-Y0258R | Benzocaine (Standard) | 94-09-7 | Reference Standards |
| HY-Y0258S | Benzocaine-d4 | 342611-08-9 | Isotope-Labeled Compounds |
| HY-Y0258S1 | Benzocaine-(ethyl-d5) | 1219803-76-5 | Isotope-Labeled Compounds |
| HY-Y0260 | 4-Chloro-6,7-dimethoxyquinazoline | 13790-39-1 | Biochemical Assay Reagents |
| HY-Y0261A | Ammonium sulphate,≥99.0%,AR | 7783-20-2 | Reference compound |
| HY-Y0261AS | Ammonium sulphate-d8 | 13814-01-2 | Isotope-Labeled Compounds |
| HY-Y0261AS1 | Ammonium sulphate,≥99.0%,AR-N152 | 43086-58-4 | Isotope-Labeled Compounds |
| HY-Y0262 | Oxalic acid, 99% | 144-62-7 | Natural Products |
| HY-Y0262A | Oxalic acid (diammonium monohydrate) | 6009-70-7 | Biochemical Assay Reagents |
| HY-Y0262B | Sodium oxalate,ACS,99.5% | 62-76-0 | Biochemical Assay Reagents |
| HY-Y0262BS | Oxalic Acid-13C2 (disodium) | 260429-91-2 | Isotope-Labeled Compounds |
| HY-Y0262D | Oxalic acid (calcium monohydrate),99% | 5794-28-5 | Biochemical Assay Reagents |
| HY-Y0262H | Oxalic acid (cobalt) | 814-89-1 | Biochemical Assay Reagents |
| HY-Y0262R | Oxalic acid, 99% (Standard) | 144-62-7 | Reference Standards |
| HY-Y0262S | Oxalic Acid-d2 | 2065-73-8 | Isotope-Labeled Compounds |
| HY-Y0262S1 | Oxalic acid-13C2 | 62654-02-8 | Isotope-Labeled Compounds |
| HY-Y0264 | 4-Hydroxybenzoic acid | 99-96-7 | Natural Products |
| HY-Y0264R | 4-Hydroxybenzoic acid (Standard) | 99-96-7 | Reference Standards |
| HY-Y0264S | 4-Hydroxybenzoic acid-13C6 | 287399-29-5 | Isotope-Labeled Compounds |
| HY-Y0264S1 | 4-Hydroxybenzoic acid-d4 | 152404-47-2 | Isotope-Labeled Compounds |
| HY-Y0264S2 | 4-Hydroxybenzoic acid-13c | 146672-02-8 | Isotope-Labeled Compounds |
| HY-Y0265 | Isatin | 91-56-5 | Natural Products |
| HY-Y0265R | Isatin (Standard) | 91-56-5 | Reference Standards |
| HY-Y0267 | Phenoxyacetic acid | 122-59-8 | Natural Products |
| HY-Y0267R | Phenoxyacetic acid (Standard) | 122-59-8 | Reference Standards |
| HY-Y0267S | Phenoxyacetic acid-d5 | 154492-74-7 | Isotope-Labeled Compounds |
| HY-Y0271 | Urea | 57-13-6 | Natural Products |
| HY-Y0271R | Urea (Standard) | 57-13-6 | Reference Standards |
| HY-Y0271S | Urea-15N2 | 2067-80-3 | Isotope-Labeled Compounds |
| HY-Y0271S1 | Urea-d4 | 1433-11-0 | Isotope-Labeled Compounds |
| HY-Y0271S2 | Urea-13C,15N2 | 58069-83-3 | Isotope-Labeled Compounds |
| HY-Y0272 | Saccharin | 81-07-2 | Reference compound |
| HY-Y0272R | Saccharin (Standard) | 81-07-2 | Reference Standards |
| HY-Y0272S | Saccharin-d4 | 1189466-17-8 | Isotope-Labeled Compounds |
| HY-Y0278 | Chloranil | 118-75-2 | Reference compound |
| HY-Y0278R | Chloranil (Standard) | 118-75-2 | Reference Standards |
| HY-Y0283 | Potassium iodide ,meet Ch.P | 7681-11-0 | Biochemical Assay Reagents |
| HY-Y0284 | Diethyl phthalate | 84-66-2 | Natural Products |
| HY-Y0284R | Diethyl phthalate (Standard) | 84-66-2 | Reference Standards |
| HY-Y0284S | Diethyl phthalate-d4 | 93952-12-6 | Isotope-Labeled Compounds |
| HY-Y0284S1 | Diethyl phthalate-d10 | 1817006-92-0 | Isotope-Labeled Compounds |
| HY-Y0284S2 | Diethyl phthalate-d14 | 99873-99-1 | Isotope-Labeled Compounds |
| HY-Y0286 | Ammonium carbonate, 99% | 506-87-6 | Biochemical Assay Reagents |
| HY-Y0286A | Diammonium carbonate, 99.999% trace metals basis | 506-87-6 | Biochemical Assay Reagents |
| HY-Y0287AS | Calcium carbonate,99.8%,PT-13c | 287389-46-2 | Isotope-Labeled Compounds |
| HY-Y0289 | 1-Dodecanol | 112-53-8 | Natural Products |
| HY-Y0289R | 1-Dodecanol (Standard) | 112-53-8 | Reference Standards |
| HY-Y0289S | 1-Dodecanol-13C | 88170-32-5 | Isotope-Labeled Compounds |
| HY-Y0289S1 | 1-Dodecanol-d25 | 160776-83-0 | Isotope-Labeled Compounds |
| HY-Y0289S2 | 1-Dodecanol-d26 | 38086-03-2 | Isotope-Labeled Compounds |
| HY-Y0289S3 | 1-Dodecanol-d1 | 14848-65-8 | Isotope-Labeled Compounds |
| HY-Y0292 | Lithium carbonate | 554-13-2 | Biochemical Assay Reagents |
| HY-Y0293 | L-Tartaric acid | 87-69-4 | Natural Products |
| HY-Y0293R | L-Tartaric acid (Standard) | 87-69-4 | Reference Standards |
| HY-Y0302 | Diammonium phosphate | 7783-28-0 | Reference compound |
| HY-Y0302S | Diammonium phosphate-15N2 | Isotope-Labeled Compounds | |
| HY-Y0304 | Dibutyl phthalate | 84-74-2 | Natural Products |
| HY-Y0304R | Dibutyl phthalate (Standard) | 84-74-2 | Reference Standards |
| HY-Y0304S | Dibutyl phthalate-3,4,5,6-d4 | 93952-11-5 | Isotope-Labeled Compounds |
| HY-Y0304S1 | Dibutyl phthalate-d22 | 358731-15-4 | Isotope-Labeled Compounds |
| HY-Y0306S | Ammonium bromide-d4 | 12265-06-4 | Isotope-Labeled Compounds |
| HY-Y0308 | Disodium phosphate | 7558-79-4 | Reference compound |
| HY-Y0308D | Sodium phosphate dibasic, meets analytical specification of Ph. Eur. BP USP FCC E339 | 7558-79-4 | Biochemical Assay Reagents |
| HY-Y0308E | Sodium phosphate dibasic, for cell culture | 7558-79-4 | Biochemical Assay Reagents |
| HY-Y0308H | Sodium phosphate dibasic, for molecular biology | 7558-79-4 | Biochemical Assay Reagents |
| HY-Y0308S | Phosphate dibasic-d1(sodium) | 107632-22-4 | Isotope-Labeled Compounds |
| HY-Y0313 | p-Hydroxybenzaldehyde | 123-08-0 | Natural Products |
| HY-Y0313R | p-Hydroxybenzaldehyde (Standard) | 123-08-0 | Reference Standards |
| HY-Y0313S | p-Hydroxybenzaldehyde-d4 | 284474-52-8 | Isotope-Labeled Compounds |
| HY-Y0313S1 | p-Hydroxybenzaldehyde-13C | 152404-52-9 | Isotope-Labeled Compounds |
| HY-Y0313S2 | p-Hydroxybenzaldehyde-d5 | 298704-22-0 | Isotope-Labeled Compounds |
| HY-Y0315S | 2,5-Hexanedione-d10 | 97135-07-4 | Isotope-Labeled Compounds |
| HY-Y0316 | Sodium dodecyl sulfate | 151-21-3 | Reference compound |
| HY-Y0316B | Sodium dodecyl sulfate for electrophoresis | 151-21-3 | Biochemical Assay Reagents |
| HY-Y0316BR | Sodium dodecyl sulfate for electrophoresis (Standard) | 151-21-3 | Reference Standards |
| HY-Y0316S | Sodium-dodecyl sulfate-d25 | 110863-24-6 | Isotope-Labeled Compounds |
| HY-Y0317E | Sodium sulfate anhydrous, United States Pharmacopeia (USP) Reference Standard | 7757-82-6 | Biochemical Assay Reagents |
| HY-Y0317H | Sodium sulfate anhydrous, for cell culture | 7757-82-6 | Biochemical Assay Reagents |
| HY-Y0317I | Sodium sulfate anhydrous, meets analytical specification of Ph. Eur. BP USP | 7757-82-6 | Biochemical Assay Reagents |
| HY-Y0317IR | Sodium sulfate anhydrous, meets analytical specification of Ph. Eur. BP USP (Standard) | 7757-82-6 | Reference Standards |
| HY-Y0319B | Acetic acid (potassium 99%) | 127-08-2 | Biochemical Assay Reagents |
| HY-Y0319B1 | Potassium acetate, for molecular biology | 127-08-2 | Biochemical Assay Reagents |
| HY-Y0319B2 | Potassium acetate, United States Pharmacopeia (USP) Reference Standard | 127-08-2 | Biochemical Assay Reagents |
| HY-Y0319B3 | Potassium acetate, meets analytical specification of Ph. Eur. BP E261 | 127-08-2 | Biochemical Assay Reagents |
| HY-Y0319C1 | Calcium acetate, United States Pharmacopeia (USP) Reference Standard | 62-54-4 | Biochemical Assay Reagents |
| HY-Y0319D | Acetic acid (lead) | 546-67-8 | Reference compound |
| HY-Y0319G | Magnesium acetate tetrahydrate | 16674-78-5 | Biochemical Assay Reagents |
| HY-Y0319G1 | Magnesium acetate tetrahydrate, for molecular biology | 16674-78-5 | Biochemical Assay Reagents |
| HY-Y0320 | Dimethyl sulfoxide, meets analytical specification of Ch.P. | 67-68-5 | Biochemical Assay Reagents |
| HY-Y0320C | Dimethyl sulfoxide | 67-68-5 | Biochemical Assay Reagents |
| HY-Y0320D | Dimethyl sulfoxide, cryoprotectant vitrification agent | 67-68-5 | Biochemical Assay Reagents |
| HY-Y0320G | Dimethyl sulfoxide (GMP) | 67-68-5 | GMP Small Molecules |
| HY-Y0320R | Dimethyl sulfoxide (Standard) | 67-68-5 | Reference Standards |
| HY-Y0329G | Iron(III) nitrate nonahydrate, for cell culture | 7782-61-8 | Biochemical Assay Reagents |
| HY-Y0332B | Potassium dihydrogen phosphate, AR,99.5% | 7778-77-0 | Biochemical Assay Reagents |
| HY-Y0332BR | Potassium dihydrogen phosphate, AR,99.5% (Standard) | 7778-77-0 | Reference Standards |
| HY-Y0332BS | Phosphate monobasic-d2 (potassium) | 13761-79-0 | Isotope-Labeled Compounds |
| HY-Y0332C | Phosphoric acid (sodium hydrate),≥99.0% | 13472-35-0 | Biochemical Assay Reagents |
| HY-Y0332G | Potassium dihydrogen phosphate, for molecular biology | 7778-77-0 | Biochemical Assay Reagents |
| HY-Y0332H | Sodium dihydrogen phosphate dihydrate, for molecular biology | 13472-35-0 | Biochemical Assay Reagents |
| HY-Y0332J | Potassium dihydrogen phosphate, United States Pharmacopeia (USP) Reference Standard | 7778-77-0 | Biochemical Assay Reagents |
| HY-Y0332K | Potassium dihydrogen phosphate, for cell culture | 7778-77-0 | Biochemical Assay Reagents |
| HY-Y0332L | Potassium dihydrogen phosphate, meets analytical specification of Ph. Eur., NF, E340 | 7778-77-0 | Biochemical Assay Reagents |
| HY-Y0335 | 1,3-Dihydroxyacetone | 96-26-4 | Natural Products |
| HY-Y0335R | 1,3-Dihydroxyacetone (Standard) | 96-26-4 | Reference Standards |
| HY-Y0337 | L-Cysteine | 52-90-4 | Natural Products |
| HY-Y0337A | L-Cysteine (hydrochloride) | 52-89-1 | Natural Products |
| HY-Y0337AR | L-Cysteine (hydrochloride) (Standard) | 52-89-1 | Reference Standards |
| HY-Y0337R | L-Cysteine (Standard) | 52-90-4 | Reference Standards |
| HY-Y0337S | L-Cysteine-13C3,15N | 202406-97-1 | Isotope-Labeled Compounds |
| HY-Y0337S1 | L-Cysteine-15N | 204523-09-1 | Isotope-Labeled Compounds |
| HY-Y0337S2 | L-Cysteine-3-13C | 201612-57-9 | Isotope-Labeled Compounds |
| HY-Y0337S3 | L-Cysteine-1-13C | 224054-24-4 | Isotope-Labeled Compounds |
| HY-Y0337S4 | L-Cysteine-13C3 | 202114-66-7 | Isotope-Labeled Compounds |
| HY-Y0337S5 | L-Cysteine-d3 | 214782-32-8 | Isotope-Labeled Compounds |
| HY-Y0337S6 | L-Cysteine-d2 | 130633-02-2 | Isotope-Labeled Compounds |
| HY-Y0337S7 | L-Cysteine-d3,15N | 1795787-05-1 | Isotope-Labeled Compounds |
| HY-Y0338 | Ethylene glycol,98% | 107-21-1 | Natural Products |
| HY-Y0338R | Ethylene glycol,98% (Standard) | 107-21-1 | Reference Standards |
| HY-Y0338S | Ethylene glycol-(OD)2 | 2219-52-5 | Isotope-Labeled Compounds |
| HY-Y0338S1 | Ethylene glycol-13C2 | 104700-12-1 | Isotope-Labeled Compounds |
| HY-Y0338S2 | Ethylene glycol-d4 | 2219-51-4 | Isotope-Labeled Compounds |
| HY-Y0338S3 | Ethylene Glycol-d6 | 15054-86-1 | Isotope-Labeled Compounds |
| HY-Y0339S | Diphenyl ether-d10 | 93952-05-7 | Isotope-Labeled Compounds |
| HY-Y0339S1 | Diphenyl ether-d4 | 20369-38-4 | Isotope-Labeled Compounds |
| HY-Y0344D | Sodium chloride, for cell culture | 7647-14-5 | Biochemical Assay Reagents |
| HY-Y0344H | Sodium chloride, United States Pharmacopeia (USP) Reference Standard | 7647-14-5 | Biochemical Assay Reagents |
| HY-Y0344I | Sodium chloride, meets analytical specification of Ph. Eur. BP USP, ≤0.00002% Al | 7647-14-5 | Biochemical Assay Reagents |
| HY-Y0344J | Sodium chloride, for molecular biology | 7647-14-5 | Biochemical Assay Reagents |
| HY-Y0350S | 1,4-Dibromobutane-2,2,3,3-d4 | 52089-63-1 | Isotope-Labeled Compounds |
| HY-Y0350S1 | 1,4-Dibromobutane-d4 | 36684-45-4 | Isotope-Labeled Compounds |
| HY-Y0351 | Phenylthiourea | 103-85-5 | Reference compound |
| HY-Y0356S | Ethyltriphenylphosphonium-d3 (bromide) | 1560-55-0 | Isotope-Labeled Compounds |
| HY-Y0357 | 2-Fluorophenylacetic acid | 451-82-1 | Biochemical Assay Reagents |
| HY-Y0363S | 1-Methyl-4-oxopiperidine-d4 | 1189723-14-5 | Isotope-Labeled Compounds |
| HY-Y0364 | Ethyl 2-chloroacetoacetate | 609-15-4 | Reference compound |
| HY-Y0366 | Lauric acid | 143-07-7 | Natural Products |
| HY-Y0366R | Lauric acid (Standard) | 143-07-7 | Reference Standards |
| HY-Y0366S | Lauric acid-13C | 93639-08-8 | Isotope-Labeled Compounds |
| HY-Y0366S1 | Lauric acid-d23 | 59154-43-7 | Isotope-Labeled Compounds |
| HY-Y0366S2 | Lauric acid-d2 | 64118-39-4 | Isotope-Labeled Compounds |
| HY-Y0366S3 | Lauric acid-d3 | 79050-22-9 | Isotope-Labeled Compounds |
| HY-Y0366S4 | Lauric acid-13C-1 | 287100-78-1 | Isotope-Labeled Compounds |
| HY-Y0366S5 | Lauric acid-d5 | 1219804-38-2 | Isotope-Labeled Compounds |
| HY-Y0367 | Maleic Acid | 110-16-7 | Natural Products |
| HY-Y0367R | Maleic Acid (Standard) | 110-16-7 | Reference Standards |
| HY-Y0367S | Maleic Acid-d2 | 24461-33-4 | Isotope-Labeled Compounds |
| HY-Y0373 | tert-Butyl carbazate | 870-46-2 | Reference compound |
| HY-Y0376S | DMPA-d7 | 1219802-03-5 | Isotope-Labeled Compounds |
| HY-Y0378 | D-Leucine | 328-38-1 | Natural Products |
| HY-Y0378R | D-Leucine (Standard) | 328-38-1 | Reference Standards |
| HY-Y0378S | D-Leucine-d10 | 271247-12-2 | Isotope-Labeled Compounds |
| HY-Y0383 | Dimethyl terephthalate | 120-61-6 | Biochemical Assay Reagents |
| HY-Y0383R | Dimethyl terephthalate (Standard) | 120-61-6 | Reference Standards |
| HY-Y0383S | Dimethyl terephthalate-d4 | 74079-01-9 | Isotope-Labeled Compounds |
| HY-Y0383S2 | Dimethyl terephthalate-13C2-1 | 432028-02-9 | Isotope-Labeled Compounds |
| HY-Y0384S | Iodochloromethane-d2 | 129933-14-8 | Isotope-Labeled Compounds |
| HY-Y0395 | 3-Carboxyphenylboronic acid | 25487-66-5 | Biochemical Assay Reagents |
| HY-Y0396 | N-Hydroxyphthalimide | 524-38-9 | Biochemical Assay Reagents |
| HY-Y0396R | N-Hydroxyphthalimide (Standard) | 524-38-9 | Reference Standards |
| HY-Y0399 | L-Norvaline | 6600-40-4 | Natural Products |
| HY-Y0399S | L-Norvaline-d5 | 1202936-50-2 | Isotope-Labeled Compounds |
| HY-Y0400S | 2-Bromoethylammonium-d4 bromide | 918633-70-2 | Isotope-Labeled Compounds |
| HY-Y0403 | 3-Chlorobenzoic acid | 535-80-8 | Reference compound |
| HY-Y0403R | 3-Chlorobenzoic acid (Standard) | 535-80-8 | Reference Standards |
| HY-Y0406E | Calcium chloride anhydrous, for cell culture | 10043-52-4 | Biochemical Assay Reagents |
| HY-Y0406H | Calcium chloride anhydrous, powder, 97% | 10043-52-4 | Biochemical Assay Reagents |
| HY-Y0407A | Tetrapropylammonium hydroxide (40% w/w in water) | 4499-86-9 | Biochemical Assay Reagents |
| HY-Y0410 | 2-Aminobenzimidazole | 934-32-7 | Biochemical Assay Reagents |
| HY-Y0413 | Biacetyl monoxime | 57-71-6 | Reference compound |
| HY-Y0415 | Tetraethylammonium (fluoride) | 665-46-3 | Biochemical Assay Reagents |
| HY-Y0416 | Potassium ferrocyanide trihydrate, 98.5% | 14459-95-1 | Biochemical Assay Reagents |
| HY-Y0417S | 2-(2-Ethoxyethoxy)ethanol-d5 | 1219804-11-1 | Isotope-Labeled Compounds |
| HY-Y0418 | Dulcite | 608-66-2 | Natural Products |
| HY-Y0418R | Dulcite (Standard) | 608-66-2 | Reference Standards |
| HY-Y0418S | Dulcite-13C | 2484171-11-9 | Isotope-Labeled Compounds |
| HY-Y0418S1 | Dulcite-13C-1 | Isotope-Labeled Compounds | |
| HY-Y0418S2 | Dulcite-13C-2 | Isotope-Labeled Compounds | |
| HY-Y0418S3 | Dulcite-13C-3 | Isotope-Labeled Compounds | |
| HY-Y0418S4 | Dulcite-d2 | 91992-02-8 | Isotope-Labeled Compounds |
| HY-Y0421 | Adamantanone | 700-58-3 | Reference compound |
| HY-Y0425 | Terephthalaldehyde | 623-27-8 | Biochemical Assay Reagents |
| HY-Y0426 | 2,4-Dihydroxypyridine | 626-03-9 | Natural Products |
| HY-Y0429 | 2-Amino-6-chloropurine | 10310-21-1 | Biochemical Assay Reagents |
| HY-Y0442 | 2-Methylbenzaldehyde | 529-20-4 | Isotope-Labeled Compounds |
| HY-Y0442S | 2-Methylbenzaldehyde-13C | 138151-99-2 | Isotope-Labeled Compounds |
| HY-Y0444 | D-Tyrosine | 556-02-5 | Natural Products |
| HY-Y0444S | D-Tyrosine-d2 | 1202064-22-9 | Isotope-Labeled Compounds |
| HY-Y0444S1 | D-Tyrosine-d4 | 944386-47-4 | Isotope-Labeled Compounds |
| HY-Y0444S2 | D-Tyrosine-d7 | 1426174-46-0 | Isotope-Labeled Compounds |
| HY-Y0445A | Sodium dichloroacetate | 2156-56-1 | Reference compound |
| HY-Y0449C | Ammonium thiocyanate, 99.99% trace metals basis | 1762-95-4 | Biochemical Assay Reagents |
| HY-Y0453S | 4-Carboethoxypiperidine-d9 | 1219803-75-4 | Isotope-Labeled Compounds |
| HY-Y0469 | 1-Aminohydantoin (hydrochloride) | 2827-56-7 | Reference compound |
| HY-Y0469R | 1-Aminohydantoin (hydrochloride) (Standard) | 2827-56-7 | Reference Standards |
| HY-Y0470 | Semicarbazide (hydrochloride) | 563-41-7 | Reference compound |
| HY-Y0470R | Semicarbazide (hydrochloride) (Standard) | 563-41-7 | Reference Standards |
| HY-Y0479 | L-Lactic acid | 79-33-4 | Natural Products |
| HY-Y0479AS | L-Lactic acid-13C3 (sodium) (20% in water) | 201595-71-3 | Isotope-Labeled Compounds |
| HY-Y0479AS2 | L-Lactate-13C (sodium) | 201595-69-9 | Isotope-Labeled Compounds |
| HY-Y0479S | L-Lactic acid-13C3 | 87684-87-5 | Isotope-Labeled Compounds |
| HY-Y0479S3 | L-Lactic acid-2-13C1 | 740788-63-0 | Isotope-Labeled Compounds |
| HY-Y0481 | Anhydrous stannous chloride, 98% | 7772-99-8 | Reference compound |
| HY-Y0481A | Tin(II) chloride dihydrate | 10025-69-1 | Biochemical Assay Reagents |
| HY-Y0484S | 1-Indanamine-d9 (hydrochloride) | 2012598-74-0 | Isotope-Labeled Compounds |
| HY-Y0488A | Formic acid (ammonium) | 540-69-2 | Natural Products |
| HY-Y0488AR | Formic acid (ammonium) (Standard) | 540-69-2 | Reference Standards |
| HY-Y0491 | 3,5-Dibromopyridine | 625-92-3 | Biochemical Assay Reagents |
| HY-Y0491S | 3,5-Dibromopyridine-d3 | 1219799-05-9 | Isotope-Labeled Compounds |
| HY-Y0493 | HODHBt | 28230-32-2 | Reference compound |
| HY-Y0494S | 4-Chlorothiobenzamide-d4 | 1219802-58-0 | Isotope-Labeled Compounds |
| HY-Y0496 | 1,4-Dichlorobenzene | 106-46-7 | Reference compound |
| HY-Y0496R | 1,4-Dichlorobenzene (Standard) | 106-46-7 | Reference Standards |
| HY-Y0496S | 1,4-Dichlorobenzene-d4 | 3855-82-1 | Isotope-Labeled Compounds |
| HY-Y0498 | Aluminum oxide | 1344-28-1 | Reference compound |
| HY-Y0503S | Methyltriphenylphosphonium iodide-d3 | 1560-56-1 | Isotope-Labeled Compounds |
| HY-Y0504 | Trimethylammonium chloride | 593-81-7 | Natural Products |
| HY-Y0504R | Trimethylammonium chloride (Standard) | 593-81-7 | Reference Standards |
| HY-Y0504S | Trimethylammonium chloride-13c3,d9 | 2483824-12-8 | Isotope-Labeled Compounds |
| HY-Y0504S1 | Trimethylammonium chloride-d10 | 107766-37-0 | Isotope-Labeled Compounds |
| HY-Y0504S2 | Trimethylammonium chloride-15N | 108451-51-0 | Isotope-Labeled Compounds |
| HY-Y0504S3 | Trimethylammonium chloride-d9 | 18856-86-5 | Isotope-Labeled Compounds |
| HY-Y0504S4 | Trimethylammonium chloride-d6 | 347840-14-6 | Isotope-Labeled Compounds |
| HY-Y0507 | DL-Serine | 302-84-1 | Natural Products |
| HY-Y0507R | DL-Serine (Standard) | 302-84-1 | Reference Standards |
| HY-Y0507S | DL-Serine-2,3,3-d3 | 70094-78-9 | Isotope-Labeled Compounds |
| HY-Y0509S | p-Fluorobenzylamine-d4 | 1219798-96-5 | Isotope-Labeled Compounds |
| HY-Y0510 | Nitrofungin | 619-08-9 | Reference compound |
| HY-Y0511 | N,N-Dimethylglycine | 1118-68-9 | Natural Products |
| HY-Y0511R | N,N-Dimethylglycine (Standard) | 1118-68-9 | Reference Standards |
| HY-Y0519 | Pyrimidine | 289-95-2 | Natural Products |
| HY-Y0519R | Pyrimidine (Standard) | 289-95-2 | Reference Standards |
| HY-Y0520 | Itaconic acid | 97-65-4 | Natural Products |
| HY-Y0520R | Itaconic acid (Standard) | 97-65-4 | Reference Standards |
| HY-Y0520S | Itaconic acid-13C5 | 2095777-38-9 | Isotope-Labeled Compounds |
| HY-Y0525 | AAPH | 2997-92-4 | Reference compound |
| HY-Y0530 | Azetidine-3-carboxylic acid | 36476-78-5 | ADC Related |
| HY-Y0531 | 1-Adamantanol | 768-95-6 | Biochemical Assay Reagents |
| HY-Y0531S | 1-Adamantanol-d15 | 33830-11-4 | Isotope-Labeled Compounds |
| HY-Y0532 | N-Chlorosuccinimide | 128-09-6 | Reference compound |
| HY-Y0533 | L-Aspartic acid 4-tert-butyl ester | 3057-74-7 | Peptides |
| HY-Y0534S | Sodium cyanoboronhydride-d3 | 25895-62-9 | Isotope-Labeled Compounds |
| HY-Y0537 | Potassium chloride, AR, 99.5% | 7447-40-7 | Biochemical Assay Reagents |
| HY-Y0537B | Potassium chloride, for molecular biology | 7447-40-7 | Biochemical Assay Reagents |
| HY-Y0537C | Potassium chloride, ≥99.99% trace metals basis | 7447-40-7 | Biochemical Assay Reagents |
| HY-Y0537E | Potassium chloride, for cell culture | 7447-40-7 | Biochemical Assay Reagents |
| HY-Y0537I | Potassium chloride, United States Pharmacopeia (USP) Reference Standard | 7447-40-7 | Biochemical Assay Reagents |
| HY-Y0537J | Potassium chloride, meets analytical specification of Ph. Eur., BP, USP, FCC, E508, ≤0.0001% Al | 7447-40-7 | Biochemical Assay Reagents |
| HY-Y0537K | Potassium chloride, ACS, 99.0% | 7447-40-7 | Biochemical Assay Reagents |
| HY-Y0543 | 5-Methylfurfural | 620-02-0 | Natural Products |
| HY-Y0543R | 5-Methylfurfural (Standard) | 620-02-0 | Reference Standards |
| HY-Y0544S | N-Methyl-N-nitrosotoluene-4-sulfonamide-d3 | 42366-72-3 | Isotope-Labeled Compounds |
| HY-Y0546 | Benzophenone | 119-61-9 | Natural Products |
| HY-Y0546R | Benzophenone (Standard) | 119-61-9 | Reference Standards |
| HY-Y0546S | Benzophenone-d10 | 22583-75-1 | Isotope-Labeled Compounds |
| HY-Y0546S1 | Benzophenone-d5 | 2694-78-2 | Isotope-Labeled Compounds |
| HY-Y0546S2 | Benzophenone-13C | 32488-48-5 | Isotope-Labeled Compounds |
| HY-Y0549 | Diphenylacetic acid | 117-34-0 | Biochemical Assay Reagents |
| HY-Y0553S | 4-Fluorobenzyl chloride-d7 | 1219804-18-8 | Isotope-Labeled Compounds |
| HY-Y0553S1 | 4-Fluorobenzyl chloride-d4 | 1219804-10-0 | Isotope-Labeled Compounds |
| HY-Y0553S2 | 4-Fluorobenzyl chloride-d6 | 1219804-13-3 | Isotope-Labeled Compounds |
| HY-Y0555 | N-[(Phenylmethoxy)carbonyl]-L-leucine | 2018-66-8 | Peptides |
| HY-Y0555A | D-N-(Benzyloxycarbonyl)leucine | 28862-79-5 | Peptides |
| HY-Y0566 | 1,4-Diazabicyclo[2.2.2]octane | 280-57-9 | Biochemical Assay Reagents |
| HY-Y0566S | 1,4-Diazabicyclo[2.2.2]octane-d12 | 119451-78-4 | Isotope-Labeled Compounds |
| HY-Y0569 | D-Gluconic acid (solution) (51.205% in water) | 526-95-4 | Natural Products |
| HY-Y0569B | D-Gluconic acid (calcium hydrate) | 66905-23-5 | Reference compound |
| HY-Y0569BR | D-Gluconic acid (calcium hydrate) (Standard) | 66905-23-5 | Reference Standards |
| HY-Y0569C | D-Gluconic acid (potassium) | 299-27-4 | Reference compound |
| HY-Y0569CR | D-Gluconic acid (potassium) (Standard) | 299-27-4 | Reference Standards |
| HY-Y0569H | Magnesium D-gluconate hydrate, 98% | Biochemical Assay Reagents | |
| HY-Y0585 | D-(-)-Mandelic acid | 611-71-2 | Natural Products |
| HY-Y0585R | D-(-)-Mandelic acid (Standard) | 611-71-2 | Reference Standards |
| HY-Y0586 | 2,4,5-Trimethoxybenzoic acid | 490-64-2 | Natural Products |
| HY-Y0588 | Carbobenzoxyproline | 1148-11-4 | Reference compound |
| HY-Y0589S | m-Cyanobenzoic acid-13C6 | Isotope-Labeled Compounds | |
| HY-Y0598 | trans-Chalcone | 614-47-1 | Natural Products |
| HY-Y0600S | Thioanisole-d3 | 826-07-3 | Isotope-Labeled Compounds |
| HY-Y0601 | 3,5-Dichlorobenzoic acid | 51-36-5 | Biochemical Assay Reagents |
| HY-Y0603 | 3-Hydroxyacetophenone | 121-71-1 | Natural Products |
| HY-Y0606 | (+)-Camphor-10-sulfonic acid | 3144-16-9 | Biochemical Assay Reagents |
| HY-Y0607 | 4-Nitrobenzoic acid | 62-23-7 | Biochemical Assay Reagents |
| HY-Y0607R | 4-Nitrobenzoic acid (Standard) | 62-23-7 | Reference Standards |
| HY-Y0607S | 4-Nitrobenzoic acid-d4 | 171777-66-5 | Isotope-Labeled Compounds |
| HY-Y0607S1 | 4-Nitrobenzoic acid-d2 | 117868-95-8 | Isotope-Labeled Compounds |
| HY-Y0621 | 4′-tert-Butylacetophenone | 943-27-1 | Biochemical Assay Reagents |
| HY-Y0622S | 4-Chlorobenzaldehyde-2,3,5,6-d4 | 62285-59-0 | Isotope-Labeled Compounds |
| HY-Y0623 | N-Hydroxysuccinimide | 6066-82-6 | Biochemical Assay Reagents |
| HY-Y0624 | 4-Pentenoic acid | 591-80-0 | Reference compound |
| HY-Y0624R | 4-Pentenoic acid (Standard) | 591-80-0 | Reference Standards |
| HY-Y0626S | Acetohydrazide-d3 | 1028333-41-6 | Isotope-Labeled Compounds |
| HY-Y0641 | 3-Phenoxybenzaldehyde | 39515-51-0 | Reference compound |
| HY-Y0643 | Pivaloyloxymethyl chloride | 18997-19-8 | Biochemical Assay Reagents |
| HY-Y0649 | Lithium chloride, 99.3%-T | 7447-41-8 | Biochemical Assay Reagents |
| HY-Y0649D | Lithium chloride, for molecular biology, 99% | 7447-41-8 | Biochemical Assay Reagents |
| HY-Y0651 | Sodium sulfite | 7757-83-7 | Biochemical Assay Reagents |
| HY-Y0651R | Sodium sulfite (Standard) | 7757-83-7 | Reference Standards |
| HY-Y0658 | Tetramethylammonium (bromide) | 64-20-0 | Biochemical Assay Reagents |
| HY-Y0658S | Tetramethyl-ammonium Bromide-d12 | 284474-82-4 | Isotope-Labeled Compounds |
| HY-Y0659S | 1,2,3,4-Hydroquinoline-d2 | 20668-18-2 | Isotope-Labeled Compounds |
| HY-Y0667 | Benzyltriethylammonium (chloride) | 56-37-1 | Biochemical Assay Reagents |
| HY-Y0669 | Pipecolic acid | 535-75-1 | Biochemical Assay Reagents |
| HY-Y0669R | Pipecolic acid (Standard) | 535-75-1 | Reference Standards |
| HY-Y0669S | Pipecolic acid-d9 | 790612-94-1 | Isotope-Labeled Compounds |
| HY-Y0674S | Dicyandiamide-13C2,15N2 | Isotope-Labeled Compounds | |
| HY-Y0677 | Triethyl phosphonoacetate | 867-13-0 | Biochemical Assay Reagents |
| HY-Y0677S | Carbethoxymethyldiethyl phosphonate-C13 | 100940-60-1 | Isotope-Labeled Compounds |
| HY-Y0678 | 1,3,5-Trimethoxybenzene | 621-23-8 | Natural Products |
| HY-Y0678S | 1,3,5-Trimethoxybenzene-d3 | 35564-11-5 | Isotope-Labeled Compounds |
| HY-Y0680 | 3-Chloro-4-fluoroaniline | 367-21-5 | Biochemical Assay Reagents |
| HY-Y0682 | Ethylenediaminetetraacetic acid | 60-00-4 | Biochemical Assay Reagents |
| HY-Y0682A | Ethylenediaminetetraacetic acid (disodium dihydrate) | 6381-92-6 | Biochemical Assay Reagents |
| HY-Y0682AR | Ethylenediaminetetraacetic acid (disodium dihydrate) (Standard) | 6381-92-6 | Reference Standards |
| HY-Y0682B | Ethylenediaminetetraacetic acid (tetrasodium) | 64-02-8 | Biochemical Assay Reagents |
| HY-Y0682R | Ethylenediaminetetraacetic acid (Standard) | 60-00-4 | Reference Standards |
| HY-Y0682S | Ethylenediaminetetraacetic acid-d12 | 203806-08-0 | Isotope-Labeled Compounds |
| HY-Y0682S1 | Ethylenediaminetetraacetic acid-d16 | 203805-96-3 | Isotope-Labeled Compounds |
| HY-Y0683A | Petrolatum (white) | 8009-03-8 | Reference compound |
| HY-Y0683B | Petrolatum (yellow) | 8009-03-8 | Reference compound |
| HY-Y0688S | 1H-Benzotriazole-4,5,6,7-d4 | 1185072-03-0 | Isotope-Labeled Compounds |
| HY-Y0694 | 2',4'-Dihydroxyacetophenone | 89-84-9 | Natural Products |
| HY-Y0695 | Amido Black 10B | 1064-48-8 | Dye Reagents |
| HY-Y0698 | Thioacetamide | 62-55-5 | Reference compound |
| HY-Y0699 | Methyl red | 493-52-7 | Biochemical Assay Reagents |
| HY-Y0699R | Methyl red (Standard) | 493-52-7 | Dye Reagents |
| HY-Y0700 | Calconcarboxylic acid | 3737-95-9 | Dye Reagents |
| HY-Y0701B | Ammonium molybdate tetrahydrate, for cell culture | 12054-85-2 | Biochemical Assay Reagents |
| HY-Y0703 | Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) | 9004-32-4 | Biochemical Assay Reagents |
| HY-Y0703A | Sodium carboxymethyl cellulose (Viscosity:1200-1400 mPa.s) | 9004-32-4 | Biochemical Assay Reagents |
| HY-Y0703C | Sodium carboxymethyl cellulose (Viscosity:300-800mpa.s) | 9004-32-4 | Biochemical Assay Reagents |
| HY-Y0703D | Sodium carboxymethyl cellulose (average Mw 90000) | 9004-32-4 | Biochemical Assay Reagents |
| HY-Y0703E | Sodium carboxymethyl cellulose (Viscosity:2500-6000mpa.s) | 9004-32-4 | Biochemical Assay Reagents |
| HY-Y0708 | Calcium hydrogen phosphate (dihydrate) | 7789-77-7 | Reference compound |
| HY-Y0721S | 3-Bromofluorobenzene-13C6 | 1173020-50-2 | Isotope-Labeled Compounds |
| HY-Y0727S | 1,5-Dibromopentane-d4 | 1219803-90-3 | Isotope-Labeled Compounds |
| HY-Y0727S1 | 1,5-Dibromopentane-d10 | 1219802-90-0 | Isotope-Labeled Compounds |
| HY-Y0729 | 4-Chlorocinnamic acid | 1615-02-7 | Reference compound |
| HY-Y0735 | N-Benzylglycine hydrochloride | 7689-50-1 | Peptides |
| HY-Y0740 | 4-Methoxybenzaldehyde | 123-11-5 | Natural Products |
| HY-Y0740R | 4-Methoxybenzaldehyde (Standard) | 123-11-5 | Reference Standards |
| HY-Y0740S | 4-Methoxybenzaldehyde-d1 | 19486-71-6 | Isotope-Labeled Compounds |
| HY-Y0740S1 | 4-Methoxybenzaldehyde-d3 | 342611-04-5 | Isotope-Labeled Compounds |
| HY-Y0740S2 | 4-Methoxybenzaldehyde-d2 | 95307-67-8 | Isotope-Labeled Compounds |
| HY-Y0743S | 1-(Pyridin-2-yl)ethan-1-one-d6 | Isotope-Labeled Compounds | |
| HY-Y0747 | Iodobenzene | 591-50-4 | Biochemical Assay Reagents |
| HY-Y0747S | Iodobenzene-d5 | 7379-67-1 | Isotope-Labeled Compounds |
| HY-Y0747S1 | Iodobenzene-d2 | 51209-48-4 | Isotope-Labeled Compounds |
| HY-Y0749 | Glutamic acid dimethyl ester hydrochloride | 23150-65-4 | Peptides |
| HY-Y0749A | Dimethyl D-glutamate hydrochloride | 27025-25-8 | Peptides |
| HY-Y0750 | Z-Phg-OH | 53990-33-3 | Peptides |
| HY-Y0754 | Methyl L-histidinate dihydrochloride | 7389-87-9 | Peptides |
| HY-Y0755 | N-Boc-4-hydroxy-L-proline methyl ester | 102195-79-9 | ADC Related |
| HY-Y0760 | 3-Methoxybenzoic acid | 586-38-9 | Natural Products |
| HY-Y0760R | 3-Methoxybenzoic acid (Standard) | 586-38-9 | Reference Standards |
| HY-Y0771 | 3,4-Dimethoxyphenylacetic acid | 93-40-3 | Natural Products |
| HY-Y0771S | 3,4-Dimethoxyphenylacetic acid-d2 | 19031-58-4 | Isotope-Labeled Compounds |
| HY-Y0772S | 2-Bromopyridine-d4 | 70766-71-1 | Isotope-Labeled Compounds |
| HY-Y0775 | 1-Bromo-2,5-pyrrolidinedione | 128-08-5 | Biochemical Assay Reagents |
| HY-Y0775R | 1-Bromo-2,5-pyrrolidinedione (Standard) | 128-08-5 | Reference Standards |
| HY-Y0779 | 4'-Fluoroacetophenone | 403-42-9 | Biochemical Assay Reagents |
| HY-Y0781 | Pyruvic acid | 127-17-3 | Natural Products |
| HY-Y0781R | Pyruvic acid (Standard) | 127-17-3 | Reference Standards |
| HY-Y0781S | Pyruvic acid-13C (sodium) | 87976-70-3 | Isotope-Labeled Compounds |
| HY-Y0781S1 | Pyruvic acid-13C | 99124-30-8 | Isotope-Labeled Compounds |
| HY-Y0781S3 | Pyruvic acid-13C-2 (sodium) | 87976-71-4 | Isotope-Labeled Compounds |
| HY-Y0781S5 | Pyruvic acid-13C,d4 | Isotope-Labeled Compounds | |
| HY-Y0785 | Glyoxal | 107-22-2 | Reference compound |
| HY-Y0786 | 1,3-Dibromo-5,5-dimethylhydantoin | 77-48-5 | Reference compound |
| HY-Y0788 | Indoline | 496-15-1 | Biochemical Assay Reagents |
| HY-Y0790 | Cuminaldehyde | 122-03-2 | Natural Products |
| HY-Y0790R | Cuminaldehyde (Standard) | 122-03-2 | Reference Standards |
| HY-Y0790S | Cuminaldehyde-d8 | 3028869-74-8 | Isotope-Labeled Compounds |
| HY-Y0791 | Tetrabutylammonium (iodide) | 311-28-4 | Biochemical Assay Reagents |
| HY-Y0801 | 2,6-Dihydroxybenzoic acid | 303-07-1 | Natural Products |
| HY-Y0801R | 2,6-Dihydroxybenzoic acid (Standard) | 303-07-1 | Reference Standards |
| HY-Y0808 | Dimethyl succinate | 106-65-0 | Biochemical Assay Reagents |
| HY-Y0808S | Dimethyl succinate-d4 | 30994-23-1 | Isotope-Labeled Compounds |
| HY-Y0816 | (S)-Mandelic acid | 17199-29-0 | Biochemical Assay Reagents |
| HY-Y0827 | Barium carbonate,AR,99% | 513-77-9 | Biochemical Assay Reagents |
| HY-Y0827S | Carbonate-13C (barium) | 51956-33-3 | Isotope-Labeled Compounds |
| HY-Y0836 | Diethyl succinate | 123-25-1 | Natural Products |
| HY-Y0836R | Diethyl succinate (Standard) | 123-25-1 | Reference Standards |
| HY-Y0836S | Diethyl succinate-13C4 | 1628796-56-4 | Isotope-Labeled Compounds |
| HY-Y0836S1 | Diethyl succinate-d4 | 52089-62-0 | Isotope-Labeled Compounds |
| HY-Y0837 | L-Alaninol | 2749-11-3 | Biochemical Assay Reagents |
| HY-Y0837S | L-Alaninol-d3 | 352438-84-7 | Isotope-Labeled Compounds |
| HY-Y0839 | Levulinic acid | 123-76-2 | Natural Products |
| HY-Y0839R | Levulinic acid (Standard) | 123-76-2 | Reference Standards |
| HY-Y0839S | Levulinic acid-d5 | 1206185-52-5 | Isotope-Labeled Compounds |
| HY-Y0842 | Formamide | 75-12-7 | Biochemical Assay Reagents |
| HY-Y0842B | Formamide (deionizde) | 75-12-7 | Biochemical Assay Reagents |
| HY-Y0842R | Formamide (Standard) | 75-12-7 | Reference Standards |
| HY-Y0842S | Formamide-13C | 51284-91-4 | Isotope-Labeled Compounds |
| HY-Y0842S1 | Formamide-d3 | 43380-64-9 | Isotope-Labeled Compounds |
| HY-Y0842S2 | Formamide-13C,15N | 285977-74-4 | Isotope-Labeled Compounds |
| HY-Y0842S3 | Formamide-15N | 1449-77-0 | Isotope-Labeled Compounds |
| HY-Y0842S4 | Formamide-d1 | 35692-88-7 | Isotope-Labeled Compounds |
| HY-Y0842S5 | Formamide-d2 | 35645-04-6 | Isotope-Labeled Compounds |
| HY-Y0847S | Potassium thiocyanate-13C | 143827-33-2 | Isotope-Labeled Compounds |
| HY-Y0849C | Ammonium acetate, for molecular biology, 98% | 631-61-8 | Biochemical Assay Reagents |
| HY-Y0849S | Ammonium-d4 acetate | Isotope-Labeled Compounds | |
| HY-Y0849S1 | Acetate-d7 (ammonium) | 194787-05-8 | Isotope-Labeled Compounds |
| HY-Y0850 | Polyvinyl alcohol (Mw 146000-186000, 99+% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850A2 | Polyvinyl alcohol, MW 40000 (Excipient) | 9002-89-5 | Reference compound |
| HY-Y0850A2R | Polyvinyl alcohol, MW 40000 (Excipient) (Standard) | 9002-89-5 | Reference Standards |
| HY-Y0850A3 | Polyvinyl alcohol, MW 64000 (Excipient) | 9002-89-5 | Reference compound |
| HY-Y0850A4 | Polyvinyl alcohol, MW 96000 (Excipient) | 9002-89-5 | Reference compound |
| HY-Y0850A5 | Polyvinyl alcohol, MW 135000 (Excipient) | 9002-89-5 | Reference compound |
| HY-Y0850A6 | Polyvinyl alcohol, MW 164000 (Excipient) | 9002-89-5 | Reference compound |
| HY-Y0850A7 | Polyvinyl alcohol, MW 94000 (Excipient) | 9002-89-5 | Reference compound |
| HY-Y0850E | Polyvinyl alcohol (Mw 30000-70000, 87-90% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850H | Polyvinyl alcohol (Mw 89000-98000, 99+% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850I | Polyvinyl alcohol (Mw 9000-10000, 80% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850J | Polyvinyl alcohol (Mw 13000-23000, 87-89% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850K | Polyvinyl alcohol (Mw 31000-50000, 98-99% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850L | Polyvinyl alcohol (Mw 85000-124000, 99+% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850M | Polyvinyl alcohol (Mw 85000-124000, 87-89% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850N | Polyvinyl alcohol (Mw 13000-23000, 98% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850O | Polyvinyl alcohol (Mw 31000-50000, 87-89% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850P | Polyvinyl alcohol (Mw 146000-186000, 87-89% hydrolyzed) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U | PVA (Mw 31000, 87-89% hydrolyzed, ～630 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U1 | PVA (Mw 61000, 98-99% hydrolyzed, ～1400 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U2 | PVA (Mw 130000, 87-89% hydrolyzed, ～2700 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U3 | PVA (Mw 125000, 98-99% hydrolyzed, ～2800 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U4 | PVA (Mw 145000, 99+% hydrolyzed, ～3300 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U5 | PVA (Mw 27000, 98-99% hydrolyzed, ～600 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U6 | PVA (Mw 205000) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U7 | PVA (Mw 195000, 98-99% hydrolyzed, ～4300 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U8 | PVA (Mw 47000, 98-99% hydrolyzed, ～1000 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0850U9 | PVA (Mw 67000, 87-89% hydrolyzed, ～1400 polymerization) | 9002-89-5 | Biochemical Assay Reagents |
| HY-Y0858S1 | N,N-Dimethylethylenediamine-d4 | 1818845-47-4 | Isotope-Labeled Compounds |
| HY-Y0860S | 1,6-Dibromo-n-hexane-d12 | 169397-96-0 | Isotope-Labeled Compounds |
| HY-Y0869S | 4-Methoxybenzylamine-d3 | 2289707-21-5 | Isotope-Labeled Compounds |
| HY-Y0870 | Cupric carbonate basic | 12069-69-1 | Biochemical Assay Reagents |
| HY-Y0872 | 1,1-Dimethoxyacetone | 6342-56-9 | Reference compound |
| HY-Y0873 | PEG300 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A | PEG400 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A1 | PEG100000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A2 | PEG600000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A3 | PEG1000000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A4 | PEG4000000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A5 | PEG200000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A6 | PEG400000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A7 | PEG900000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A8 | PEG5000000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873A9 | PEG2000000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873B | PEG2000 | 25322-68-3 | Reference compound |
| HY-Y0873B1 | PEG8000000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873C | PEG3350 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873E | PEG1500 | 25322-68-3 | Reference compound |
| HY-Y0873ER | PEG1500 (Standard) | 25322-68-3 | Reference Standards |
| HY-Y0873F | PEG600 | 25322-68-3 | Reference compound |
| HY-Y0873G | PEG1000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873H | PEG4000 | 25322-68-3 | Reference compound |
| HY-Y0873I | PEG6000 | 25322-68-3 | Reference compound |
| HY-Y0873J | PEG8000 | 25322-68-3 | Reference compound |
| HY-Y0873K | PEG200 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873L | PEG800 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873M | PEG500 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873N | PEG3000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873O | PEG35000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873P | PEG10000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0873Q | PEG20000 | 25322-68-3 | Biochemical Assay Reagents |
| HY-Y0881 | Bis(2-chloroethyl)amine (hydrochloride) | 821-48-7 | Biochemical Assay Reagents |
| HY-Y0881S | Bis(2-chloroethyl)amine-1,1,2,2-d4 (hydrochloride) | 352431-06-2 | Isotope-Labeled Compounds |
| HY-Y0881S2 | Bis(2-Chloroethyl)amine hydrochloride-d8 | 102092-04-6 | Isotope-Labeled Compounds |
| HY-Y0882 | Hydroxylamine (hydrochloride) | 5470-11-1 | Reference compound |
| HY-Y0882R | Hydroxylamine (hydrochloride) (Standard) | 5470-11-1 | Reference Standards |
| HY-Y0882S1 | Hydroxylamine-d3 (hydrochloride) | 15588-23-5 | Isotope-Labeled Compounds |
| HY-Y0889 | 1-(2,3-Dichlorphenyl)piperazine | 41202-77-1 | Reference compound |
| HY-Y0889A | 1-(2,3-Dichlorphenyl)piperazine (hydrochloride) | 119532-26-2 | Reference compound |
| HY-Y0891 | 2-Nitrobenzoic acid | 552-16-9 | Biochemical Assay Reagents |
| HY-Y0892 | 4-Hydroxybenzyl alcohol | 623-05-2 | Natural Products |
| HY-Y0892R | 4-Hydroxybenzyl alcohol (Standard) | 623-05-2 | Reference Standards |
| HY-Y0895 | N-(Hydroxymethyl)phthalimide | 118-29-6 | Biochemical Assay Reagents |
| HY-Y0896S | Methy-d3 (toluenesulfonate) | 7575-93-1 | Isotope-Labeled Compounds |
| HY-Y0912 | HBTU | 94790-37-1 | Reference compound |
| HY-Y0920 | tert-Butoxycarbonyl-DL-alanine | 3744-87-4 | Peptides |
| HY-Y0921 | (±)-1,2-Propanediol | 57-55-6 | Biochemical Assay Reagents |
| HY-Y0921R | (±)-1,2-Propanediol (Standard) | 57-55-6 | Reference Standards |
| HY-Y0921S | (±)-1,2-Propanediol-d8 | 80156-55-4 | Isotope-Labeled Compounds |
| HY-Y0921S1 | (±)-1,2-Propanediol-d2 | 58161-11-8 | Isotope-Labeled Compounds |
| HY-Y0921S2 | (±)-1,2-Propanediol-d6 | 52910-80-2 | Isotope-Labeled Compounds |
| HY-Y0921S3 | (±)-1,2-Propanediol-13C3 | Isotope-Labeled Compounds | |
| HY-Y0925 | 5-Hexynoic acid | 53293-00-8 | Reference compound |
| HY-Y0931 | 3-Iodobenzoic acid | 618-51-9 | Biochemical Assay Reagents |
| HY-Y0931S | 3-Iodobenzoic Acid-13C6 | Isotope-Labeled Compounds | |
| HY-Y0932 | Isophorone | 78-59-1 | Natural Products |
| HY-Y0932R | Isophorone (Standard) | 78-59-1 | Reference Standards |
| HY-Y0932S | Isophorone-d5 | 1262769-87-8 | Isotope-Labeled Compounds |
| HY-Y0932S1 | Isophorone-d8 | 14397-59-2 | Isotope-Labeled Compounds |
| HY-Y0936S | 1-Bromo-4-chlorobenzene-d4 | 134415-42-2 | Isotope-Labeled Compounds |
| HY-Y0939 | Zinc diperchlorate hexahydrate | 10025-64-6 | Biochemical Assay Reagents |
| HY-Y0945B | Iron (III) sulfate hydrate,for plant cell culture | 15244-10-7 | Biochemical Assay Reagents |
| HY-Y0946 | Acetamide | 60-35-5 | Natural Products |
| HY-Y0946R | Acetamide (Standard) | 60-35-5 | Reference Standards |
| HY-Y0946S | Acetamide-15N | 1449-72-5 | Isotope-Labeled Compounds |
| HY-Y0946S2 | Acetamide-d5 | 33675-83-1 | Isotope-Labeled Compounds |
| HY-Y0949 | Methyl 2-furoate | 611-13-2 | Natural Products |
| HY-Y0949R | Methyl 2-furoate (Standard) | 611-13-2 | Reference Standards |
| HY-Y0957S | 2,5-Difluorobenzoic acid-d3 | 1219798-63-6 | Isotope-Labeled Compounds |
| HY-Y0958 | Methoxyamine (hydrochloride) | 593-56-6 | Reference compound |
| HY-Y0958R | Methoxyamine (hydrochloride) (Standard) | 593-56-6 | Reference Standards |
| HY-Y0958S | Methoxyamine-d3 (Hydrochloride) | 110220-55-8 | Isotope-Labeled Compounds |
| HY-Y0961 | Cuprous iodide | 7681-65-4 | Biochemical Assay Reagents |
| HY-Y0966 | Glycine | 56-40-6 | Natural Products |
| HY-Y0966R | Glycine (Standard) | 56-40-6 | Reference Standards |
| HY-Y0966S | Glycine-15N | 7299-33-4 | Isotope-Labeled Compounds |
| HY-Y0966S1 | Glycine-d2 | 4896-75-7 | Isotope-Labeled Compounds |
| HY-Y0966S10 | Glycine-d3 | 4896-76-8 | Isotope-Labeled Compounds |
| HY-Y0966S11 | Glycine-13C2,15N,d2 | 1984075-49-1 | Isotope-Labeled Compounds |
| HY-Y0966S2 | Glycine-2-13C | 20220-62-6 | Isotope-Labeled Compounds |
| HY-Y0966S3 | Glycine-13C2 | 67836-01-5 | Isotope-Labeled Compounds |
| HY-Y0966S4 | Glycine-1-13C | 20110-59-2 | Isotope-Labeled Compounds |
| HY-Y0966S5 | Glycine-1-13C,15N | 112898-03-0 | Isotope-Labeled Compounds |
| HY-Y0966S6 | Glycine-13C2,15N | 211057-02-2 | Isotope-Labeled Compounds |
| HY-Y0966S7 | Glycine-2-13C,15N | 91795-59-4 | Isotope-Labeled Compounds |
| HY-Y0966S8 | Glycine-d5 | 4896-77-9 | Isotope-Labeled Compounds |
| HY-Y0966S9 | Glycine-15N,d2 | 2732915-89-6 | Isotope-Labeled Compounds |
| HY-Y0967 | Z-Glycine | 1138-80-3 | Peptides |
| HY-Y0971 | Tetrabutylammonium (fluoride) (solution),1M in THF | 429-41-4 | Biochemical Assay Reagents |
| HY-Y0973 | BOP (hexafluorophosphate) | 56602-33-6 | Biochemical Assay Reagents |
| HY-Y0978 | Boc-Glycine | 4530-20-5 | Peptides |
| HY-Y0978S | Boc-Glycine-15N | 106665-75-2 | Isotope-Labeled Compounds |
| HY-Y0978S1 | Boc-Glycine-d2 | 42492-65-9 | Isotope-Labeled Compounds |
| HY-Y0978S2 | Boc-Glycine-2-13C | 145143-02-8 | Isotope-Labeled Compounds |
| HY-Y0978S3 | Boc-Glycine-13C | 97352-64-2 | Isotope-Labeled Compounds |
| HY-Y0982 | (S)-BINAP | 76189-56-5 | Reference compound |
| HY-Y0989 | Acetophenone | 98-86-2 | Natural Products |
| HY-Y0989R | Acetophenone (Standard) | 98-86-2 | Reference Standards |
| HY-Y0989S | Acetophenone-(phenyl-d5) | 28077-64-7 | Isotope-Labeled Compounds |
| HY-Y0989S1 | Acetophenone-d8 | 19547-00-3 | Isotope-Labeled Compounds |
| HY-Y0989S2 | Acetophenone-1,2-13C2 | 190314-15-9 | Isotope-Labeled Compounds |
| HY-Y0989S3 | Acetophenone-13C | 71777-36-1 | Isotope-Labeled Compounds |
| HY-Y0989S4 | Acetophenone-d3 | 17537-31-4 | Isotope-Labeled Compounds |
| HY-Y0994A | Potassium osmate(VI) dihydrate,99% | 10022-66-9 | Reference compound |
| HY-Y0995 | Methanesulfonamide | 3144-09-0 | Biochemical Assay Reagents |
| HY-Y0998 | Potassium hexacyanoferrate(III), 99.5% | 13746-66-2 | Biochemical Assay Reagents |
| HY-Y0999S | Heptyl methyl ketone-d5 | 1398065-76-3 | Isotope-Labeled Compounds |
| HY-Y1002S | Methionol-d3 | 1082582-04-4 | Isotope-Labeled Compounds |
| HY-Y1004 | 1-Decanol | 112-30-1 | Natural Products |
| HY-Y1004R | 1-Decanol (Standard) | 112-30-1 | Reference Standards |
| HY-Y1004S2 | 1-Decanol-d21 | 110510-78-6 | Isotope-Labeled Compounds |
| HY-Y1004S3 | 1-Decanol-d5 | 57368-00-0 | Isotope-Labeled Compounds |
| HY-Y1004S4 | 1-Decanol-d4 | 57367-97-2 | Isotope-Labeled Compounds |
| HY-Y1004S6 | 1-Decanol-d2-2 | 1335435-63-6 | Isotope-Labeled Compounds |
| HY-Y1005 | Triammonium phosphate trihydrate | 25447-33-0 | Biochemical Assay Reagents |
| HY-Y1009 | Methoxyacetic acid | 625-45-6 | Natural Products |
| HY-Y1009S | Methoxyacetic acid-d3 | 345910-00-1 | Isotope-Labeled Compounds |
| HY-Y1010 | Oxiran-2-ylmethanol | 556-52-5 | Natural Products |
| HY-Y1010R | Oxiran-2-ylmethanol (Standard) | 556-52-5 | Reference Standards |
| HY-Y1010S | Oxiran-2-ylmethanol-d5 | 1246819-20-4 | Isotope-Labeled Compounds |
| HY-Y1011S | 2-Ethylhexan-1-ol-d17 | 202480-75-9 | Isotope-Labeled Compounds |
| HY-Y1013 | 5-Bromonicotinic acid | 20826-04-4 | Biochemical Assay Reagents |
| HY-Y1013R | 5-Bromonicotinic acid (Standard) | 20826-04-4 | Reference Standards |
| HY-Y1019S | Trimethylsilyl N-(trimethylsilyl)acetimidate-d18 | 203784-65-0 | Isotope-Labeled Compounds |
| HY-Y1024 | Pyridine-2,6-dicarboxylic acid | 499-83-2 | Biochemical Assay Reagents |
| HY-Y1027S | 2-Chlorobenzoic Acid-13C7 | Isotope-Labeled Compounds | |
| HY-Y1027S1 | 2-Chlorobenzoic acid-13C6 | 125970-63-0 | Isotope-Labeled Compounds |
| HY-Y1027S2 | 2-Chlorobenzoic acid-d4 | 1219795-28-4 | Isotope-Labeled Compounds |
| HY-Y1030 | tert-Butyl L-valinate hydrochloride | 13518-40-6 | Peptides |
| HY-Y1031 | 3-Ethoxy-3-oxopropanoic acid | 1071-46-1 | Natural Products |
| HY-Y1031A | 3-Ethoxy-3-oxopropanoic acid (potassium) | 6148-64-7 | Reference compound |
| HY-Y1031R | 3-Ethoxy-3-oxopropanoic acid (Standard) | 1071-46-1 | Reference Standards |
| HY-Y1033S | Methyl-triphenylphosphonium-d3 (bromide) | 1787-44-6 | Isotope-Labeled Compounds |
| HY-Y1039 | 1-Stearoyl-rac-glycerol | 123-94-4 | Biochemical Assay Reagents |
| HY-Y1039R | 1-Stearoyl-rac-glycerol (Standard) | 123-94-4 | Reference Standards |
| HY-Y1039S | 1-Stearoyl-rac-glycerol-d40 | 2692624-09-0 | Isotope-Labeled Compounds |
| HY-Y1039S1 | 1-Stearoyl-rac-glycerol-d35 | 333748-53-1 | Isotope-Labeled Compounds |
| HY-Y1042S | 4-Cyanophenol-d4 | 1025089-21-7 | Isotope-Labeled Compounds |
| HY-Y1044S | 1,5-Dihydroxypentane-d10 | 1219804-42-8 | Isotope-Labeled Compounds |
| HY-Y1045 | Tetrabutylammonium (hydrogensulfate) | 32503-27-8 | Biochemical Assay Reagents |
| HY-Y1049 | 2-Amino-6-bromopyridine | 19798-81-3 | Reference compound |
| HY-Y1051S | (Chlorocarbonyl)cyclohexane-d11 | 2708286-89-7 | Isotope-Labeled Compounds |
| HY-Y1052S | N-Dodecylbenzene-d30 | 352431-29-9 | Isotope-Labeled Compounds |
| HY-Y1054 | Magnesium stearate | 557-04-0 | Reference compound |
| HY-Y1054R | Magnesium stearate (Standard) | 557-04-0 | Reference Standards |
| HY-Y1055 | Guanine | 73-40-5 | Natural Products |
| HY-Y1055A | Guanine (hydrochloride) | 635-39-2 | Natural Products |
| HY-Y1055R | Guanine (Standard) | 73-40-5 | Reference Standards |
| HY-Y1055S | Guanine-13C | 201489-20-5 | Isotope-Labeled Compounds |
| HY-Y1055S1 | Guanine-13C,15N2 | 202407-12-3 | Isotope-Labeled Compounds |
| HY-Y1055S2 | Guanine-13C5,15N5 | Isotope-Labeled Compounds | |
| HY-Y1055S3 | Guanine-15N5 | Isotope-Labeled Compounds | |
| HY-Y1055S4 | Guanine-13C5 | Isotope-Labeled Compounds | |
| HY-Y1058 | Benzohydroxamic acid | 495-18-1 | Reference compound |
| HY-Y1067 | Dibenzylamine | 103-49-1 | Biochemical Assay Reagents |
| HY-Y1067S | Dibenzylamine-d10 | 923282-09-1 | Isotope-Labeled Compounds |
| HY-Y1067S1 | Dibenzylamine-d4 | 20002-22-6 | Isotope-Labeled Compounds |
| HY-Y1069 | (S)-Malic acid | 97-67-6 | Natural Products |
| HY-Y1069R | (S)-Malic acid (Standard) | 97-67-6 | Reference Standards |
| HY-Y1069S | (S)-Malic acid-d3 | 59652-74-3 | Isotope-Labeled Compounds |
| HY-Y1069S3 | (S)-Malic acid-13C4 | 150992-96-4 | Isotope-Labeled Compounds |
| HY-Y1074 | Ethyl salicylate | 118-61-6 | Reference compound |
| HY-Y1075S1 | Cyclopropylamine-d5 | 153557-95-0 | Isotope-Labeled Compounds |
| HY-Y1075S2 | Cyclopropyl-2,2,3,3-amine-d4 | 1051418-97-3 | Isotope-Labeled Compounds |
| HY-Y1078 | DMF-DMA | 4637-24-5 | Reference compound |
| HY-Y1080 | N-Acetyl-R-leucine | 19764-30-8 | Peptides |
| HY-Y1083C | Potassium sulfate, for cell culture | 7778-80-5 | Biochemical Assay Reagents |
| HY-Y1083H | Potassium sulfate, 99% | 7778-80-5 | Biochemical Assay Reagents |
| HY-Y1088 | Hydrocinnamic acid | 501-52-0 | Natural Products |
| HY-Y1088R | Hydrocinnamic acid (Standard) | 501-52-0 | Reference Standards |
| HY-Y1088S | Hydrocinnamic acid-2,3-13C2 | 286367-71-3 | Isotope-Labeled Compounds |
| HY-Y1088S1 | Hydrocinnamic acid-d2 | 19136-97-1 | Isotope-Labeled Compounds |
| HY-Y1088S2 | Hydrocinnamic acid-d9 | 93131-15-8 | Isotope-Labeled Compounds |
| HY-Y1088S3 | Hydrocinnamic acid-d5 | 35845-62-6 | Isotope-Labeled Compounds |
| HY-Y1089 | 4-Dimethylaminopyridine | 1122-58-3 | Biochemical Assay Reagents |
| HY-Y1089R | 4-Dimethylaminopyridine (Standard) | 1122-58-3 | Reference Standards |
| HY-Y1091 | D-Lysine | 923-27-3 | Peptides |
| HY-Y1092 | N,N-Dicyclohexylcarbodiimide(DCC) | 538-75-0 | Biochemical Assay Reagents |
| HY-Y1092R | N,N-Dicyclohexylcarbodiimide(DCC) (Standard) | 538-75-0 | Reference Standards |
| HY-Y1093 | Ethyl acetoacetate | 141-97-9 | Reference compound |
| HY-Y1093R | Ethyl acetoacetate (Standard) | 141-97-9 | Reference Standards |
| HY-Y1093S1 | Ethyl acetoacetate-13C4 | 84508-55-4 | Isotope-Labeled Compounds |
| HY-Y1093S2 | Ethyl acetoacetate-d5 | 55514-60-8 | Isotope-Labeled Compounds |
| HY-Y1093S3 | Ethyl acetoacetate-13c | 61973-42-0 | Isotope-Labeled Compounds |
| HY-Y1093S4 | Ethyl acetoacetate-d3 | 1565868-21-4 | Isotope-Labeled Compounds |
| HY-Y1097 | Monomethyl phthalate | 4376-18-5 | Natural Products |
| HY-Y1097R | Monomethyl phthalate (Standard) | 4376-18-5 | Reference Standards |
| HY-Y1097S | Monomethyl phthalate-d4 | 1276197-40-0 | Isotope-Labeled Compounds |
| HY-Y1100 | Cyclopropylmethyl bromide | 7051-34-5 | Biochemical Assay Reagents |
| HY-Y1100S | Cyclopropylmethyl bromide-d4 | 1219805-93-2 | Isotope-Labeled Compounds |
| HY-Y1100S1 | Cyclopropylmethyl bromide-d3 | 1219799-17-3 | Isotope-Labeled Compounds |
| HY-Y1102A | Copper(II) acetate, 99.99% trace metals basis | 142-71-2 | Biochemical Assay Reagents |
| HY-Y1103 | Iron(II) sulfate heptahydrate, 99% | 7782-63-0 | Biochemical Assay Reagents |
| HY-Y1103A | Iron(II) sulfate heptahydrate, for cell culture, 99% | 7782-63-0 | Biochemical Assay Reagents |
| HY-Y1106 | Tripotassium phosphate | 7778-53-2 | Biochemical Assay Reagents |
| HY-Y1108 | (S,S)-TsDPEN | 167316-27-0 | Biochemical Assay Reagents |
| HY-Y1110H | Magnesium chloride anhydrous, suitable for insect cell culture | 7786-30-3 | Biochemical Assay Reagents |
| HY-Y1110I | Magnesium chloride, for insect cell culture, 97% | 7786-30-3 | Biochemical Assay Reagents |
| HY-Y1115 | 2-Fluorobenzoic acid | 445-29-4 | Biochemical Assay Reagents |
| HY-Y1115S | 2-Fluorobenzoic acid-d4 | 646502-89-8 | Isotope-Labeled Compounds |
| HY-Y1117 | Melamine | 108-78-1 | Natural Products |
| HY-Y1117R | Melamine (Standard) | 108-78-1 | Reference Standards |
| HY-Y1117S | Melamine-15N3 | 287476-11-3 | Isotope-Labeled Compounds |
| HY-Y1117S1 | Melamine-13C3 | 1173022-88-2 | Isotope-Labeled Compounds |
| HY-Y1117S2 | Melamine-15N3,13C3 | 1246816-14-7 | Isotope-Labeled Compounds |
| HY-Y1118 | 6,7-Dihydroquinolin-8(5H)-one | 56826-69-8 | Reference compound |
| HY-Y1119 | 1-Bromonaphthalene | 90-11-9 | Biochemical Assay Reagents |
| HY-Y1119R | 1-Bromonaphthalene (Standard) | 90-11-9 | Reference Standards |
| HY-Y1119S | 1-Bromonaphthalene-d7 | 37621-57-1 | Isotope-Labeled Compounds |
| HY-Y1123 | 2-Aminoacetamide hydrochloride | 1668-10-6 | Biochemical Assay Reagents |
| HY-Y1124S | 4-Methyl-imidazole-d3 | 1219805-95-4 | Isotope-Labeled Compounds |
| HY-Y1125 | 6-Methyluracil | 626-48-2 | Natural Products |
| HY-Y1126 | (2S)-2-Pyrrolidinemethanol | 23356-96-9 | Biochemical Assay Reagents |
| HY-Y1126R | (2S)-2-Pyrrolidinemethanol (Standard) | 23356-96-9 | Reference Standards |
| HY-Y1129 | 3-Hydroxypyridine | 109-00-2 | Natural Products |
| HY-Y1129R | 3-Hydroxypyridine (Standard) | 109-00-2 | Reference Standards |
| HY-Y1129S | 3-Hydroxypyridine-d4 | Isotope-Labeled Compounds | |
| HY-Y1131 | Ethyl (R)-3-hydroxybutyrate | 24915-95-5 | Biochemical Assay Reagents |
| HY-Y1132 | 2-Amino-6-chlorobenzoic acid | 2148-56-3 | Biochemical Assay Reagents |
| HY-Y1133 | 2'-Fluoroacetophenone | 445-27-2 | Biochemical Assay Reagents |
| HY-Y1134 | D-Tartaric acid | 147-71-7 | Biochemical Assay Reagents |
| HY-Y1134R | D-Tartaric acid (Standard) | 147-71-7 | Reference Standards |
| HY-Y1138S | 2-Bromobenzoic acid-d4 | 2133385-73-4 | Isotope-Labeled Compounds |
| HY-Y1139 | Pimelic acid | 111-16-0 | Natural Products |
| HY-Y1139R | Pimelic acid (Standard) | 111-16-0 | Reference Standards |
| HY-Y1139S | Pimelic acid-d4 | 19031-56-2 | Isotope-Labeled Compounds |
| HY-Y1144 | Sarcosine ethyl ester hydrochloride | 52605-49-9 | Peptides |
| HY-Y1147 | Diethyl maleate | 141-05-9 | Biochemical Assay Reagents |
| HY-Y1150S2 | Pivalic acid-d9 | 42983-07-3 | Isotope-Labeled Compounds |
| HY-Y1153 | Ethyl 3-aminopropionate hydrochloride | 4244-84-2 | Peptides |
| HY-Y1155 | Hexamethylphosphoramide | 680-31-9 | Biochemical Assay Reagents |
| HY-Y1155S | Hexamethylphosphoramide-d18 | 51219-90-0 | Isotope-Labeled Compounds |
| HY-Y1162 | 1-Methylindole | 603-76-9 | Biochemical Assay Reagents |
| HY-Y1164 | N-tert-Butoxycarbonyl-D-alanine | 7764-95-6 | Peptides |
| HY-Y1164S | D-Alanine-3,3,3-N-t-Boc-d3 | 177614-70-9 | Isotope-Labeled Compounds |
| HY-Y1164S1 | D-Alanine-3,3,3-N-t-Boc-d4 | Isotope-Labeled Compounds | |
| HY-Y1166 | N-(9-Fluorenylmethoxycarbonyl)glutamic acid α-tert-butyl ester | 84793-07-7 | Peptides |
| HY-Y1167 | N-tert-Butoxycarbonyl-N-methylalanine | 16948-16-6 | Peptides |
| HY-Y1168 | DMTMM | 3945-69-5 | Biochemical Assay Reagents |
| HY-Y1169 | Fmoc-Asp(OtBu)-OH | 71989-14-5 | Peptides |
| HY-Y1169S1 | Fmoc-Asp(OtBu)-OH-13C4,15N | 1160760-08-6 | Isotope-Labeled Compounds |
| HY-Y1169S2 | Fmoc-Asp(OtBu)-OH-d3 | Isotope-Labeled Compounds | |
| HY-Y1173 | Isethionic acid sodium salt | 1562-00-1 | Natural Products |
| HY-Y1175A | Calcium acetate monohydrate，ACS, 99% | 5743-26-0 | Biochemical Assay Reagents |
| HY-Y1176 | Isonipecotic acid | 498-94-2 | Reference compound |
| HY-Y1176S | Isonipecotic acid-d9 | 1219798-43-2 | Isotope-Labeled Compounds |
| HY-Y1177 | Diphenyl disulfide | 882-33-7 | Reference compound |
| HY-Y1177R | Diphenyl disulfide (Standard) | 882-33-7 | Reference Standards |
| HY-Y1184B | Potassium bicarbonate, 99.5%(T) | 298-14-6 | Biochemical Assay Reagents |
| HY-Y1184C | Potassium bicarbonate, meets analytical specification of Ph. Eur., BP, USP, E501, 99.5%(T) | 298-14-6 | Biochemical Assay Reagents |
| HY-Y1191 | EEDQ | 16357-59-8 | Biochemical Assay Reagents |
| HY-Y1212 | Celite | 61790-53-2 | Reference compound |
| HY-Y1212A | Purified Siliceous Earth, for injection | 61790-53-2 | Biochemical Assay Reagents |
| HY-Y1213 | Carbon | 7440-44-0 | Reference compound |
| HY-Y1213S | Carbon-13C | 14762-74-4 | Isotope-Labeled Compounds |
| HY-Y1217 | 1-Cyclohexanol | 108-93-0 | Biochemical Assay Reagents |
| HY-Y1217R | 1-Cyclohexanol (Standard) | 108-93-0 | Reference Standards |
| HY-Y1217S | 1-Cyclohexanol-d12 | 66522-78-9 | Isotope-Labeled Compounds |
| HY-Y1217S1 | 1-Cyclohexanol-d11 | 93131-17-0 | Isotope-Labeled Compounds |
| HY-Y1219C | Silica gel, high-purity grade, 220-440 mesh | 112926-00-8 | Biochemical Assay Reagents |
| HY-Y1219D | Silica gel, high-purity grade, 35-70 mesh | 112926-00-8 | Biochemical Assay Reagents |
| HY-Y1219E | Silica gel, high-purity grade, 130-270 mesh | 112926-00-8 | Biochemical Assay Reagents |
| HY-Y1219H | Silica gel, high-purity grade, 200-400 mesh | 112926-00-8 | Biochemical Assay Reagents |
| HY-Y1219I | Silica gel, high-purity grade, 70-230 mesh | 112926-00-8 | Biochemical Assay Reagents |
| HY-Y1220D | Anhydrous potassium carbonate, 99.995% metals basis | 584-08-7 | Biochemical Assay Reagents |
| HY-Y1220J | Potassium carbonate, 99% | 584-08-7 | Biochemical Assay Reagents |
| HY-Y1220S | Potassium carbonate-13C | 122570-45-0 | Isotope-Labeled Compounds |
| HY-Y1230 | 4-Pentynoic acid | 6089-09-4 | Reference compound |
| HY-Y1237 | DPPF | 12150-46-8 | Biochemical Assay Reagents |
| HY-Y1239S | Trihydro(tetrahydrofuran)boron-d3 | 96220-57-4 | Isotope-Labeled Compounds |
| HY-Y1242 | Choline hydroxide (44% in water) | 123-41-1 | Biochemical Assay Reagents |
| HY-Y1242A | Choline hydroxide (46% in water) | 123-41-1 | Biochemical Assay Reagents |
| HY-Y1250 | Fmoc-Gly-OH | 29022-11-5 | Peptides |
| HY-Y1250S | Fmoc-Gly-OH-15N | 125700-33-6 | Isotope-Labeled Compounds |
| HY-Y1250S1 | Fmoc-Gly-OH-2-13C,15N | 285978-12-3 | Isotope-Labeled Compounds |
| HY-Y1250S2 | Fmoc-Gly-OH-2,2-d2 | 284665-11-8 | Isotope-Labeled Compounds |
| HY-Y1250S3 | Fmoc-Gly-OH-13C | 175453-19-7 | Isotope-Labeled Compounds |
| HY-Y1250S4 | Fmoc-Gly-OH-1-13C | 197965-68-7 | Isotope-Labeled Compounds |
| HY-Y1250S5 | Fmoc-Gly-OH-13C2 | 286460-80-8 | Isotope-Labeled Compounds |
| HY-Y1250S6 | Fmoc-Gly-OH-13C2,15N | 285978-13-4 | Isotope-Labeled Compounds |
| HY-Y1267 | Magnesium sulfate | 7487-88-9 | Biochemical Assay Reagents |
| HY-Y1267D | Magnesium sulfate, for cell culture | 7487-88-9 | Biochemical Assay Reagents |
| HY-Y1269 | Ammonium chloride, AR, 99.5% | 12125-02-9 | Biochemical Assay Reagents |
| HY-Y1269AS | Ammonium chloride-d4 | 12015-14-4 | Isotope-Labeled Compounds |
| HY-Y1269C | Ammonium chloride, for cell culture | 12125-02-9 | Biochemical Assay Reagents |
| HY-Y1269D | Ammonium chloride, for molecular biology | 12125-02-9 | Biochemical Assay Reagents |
| HY-Y1269H | Ammonium chloride, meets analytical specification of Ph. Eur. BP USP FCC | 12125-02-9 | Biochemical Assay Reagents |
| HY-Y1269I | Ammonium chloride, United States Pharmacopeia (USP) Reference Standard | 12125-02-9 | Biochemical Assay Reagents |
| HY-Y1269S | Ammonium chloride-15N | 39466-62-1 | Isotope-Labeled Compounds |
| HY-Y1275 | N-Methylpyrrolidone | 872-50-4 | Biochemical Assay Reagents |
| HY-Y1275S | N-Methylpyrrolidone-d9 | 185964-60-7 | Isotope-Labeled Compounds |
| HY-Y1275S1 | N-Methylpyrrolidone-d3 | 933-86-8 | Isotope-Labeled Compounds |
| HY-Y1282 | Sodium tetraborate decahydrate | 1303-96-4 | Reference compound |
| HY-Y1297 | Oxalic acid dihydrate | 6153-56-6 | Natural Products |
| HY-Y1297R | Oxalic acid dihydrate (Standard) | 6153-56-6 | Reference Standards |
| HY-Y1298 | Methyl acetylacetate | 105-45-3 | Natural Products |
| HY-Y1298R | Methyl acetylacetate (Standard) | 105-45-3 | Reference Standards |
| HY-Y1298S | Methyl acetylacetate-13C4 | 107694-17-7 | Isotope-Labeled Compounds |
| HY-Y1298S1 | Methyl acetylacetate-d3 | 65491-21-6 | Isotope-Labeled Compounds |
| HY-Y1300S | Ethylene carbonate-d4 | 362049-63-6 | Isotope-Labeled Compounds |
| HY-Y1309 | 1-Naphthol | 90-15-3 | Natural Products |
| HY-Y1309R | 1-Naphthol (Standard) | 90-15-3 | Reference Standards |
| HY-Y1309S | 1-Naphthol-d8 | 207569-03-7 | Isotope-Labeled Compounds |
| HY-Y1309S1 | 1-Naphthol-d7 | 124251-84-9 | Isotope-Labeled Compounds |
| HY-Y1310 | Sodium alginate | 9005-38-3 | Natural Products |
| HY-Y1310A | Sodium alginate (Viscosity 200±20mpa.s) | 9005-38-3 | Biochemical Assay Reagents |
| HY-Y1311 | Malic acid | 6915-15-7 | Biochemical Assay Reagents |
| HY-Y1311R | Malic acid (Standard) | 6915-15-7 | Reference Standards |
| HY-Y1311S | Malic acid-d3 | 104596-63-6 | Isotope-Labeled Compounds |
| HY-Y1312 | 2-Phenylimidazole | 670-96-2 | Reference compound |
| HY-Y1313 | 3-Nitrobenzoic acid | 121-92-6 | Biochemical Assay Reagents |
| HY-Y1313S | 3-Nitrobenzoic acid-d4 | 78399-78-7 | Isotope-Labeled Compounds |
| HY-Y1314 | Dimethyl sulfone | 67-71-0 | Natural Products |
| HY-Y1314R | Dimethyl sulfone (Standard) | 67-71-0 | Reference Standards |
| HY-Y1314S | Dimethyl sulfone-d6 | 22230-82-6 | Isotope-Labeled Compounds |
| HY-Y1315 | DL-Tartaric acid | 133-37-9 | Reference compound |
| HY-Y1315R | DL-Tartaric acid (Standard) | 133-37-9 | Reference Standards |
| HY-Y1315S | DL-Tartaric acid-d2 | 181376-62-5 | Isotope-Labeled Compounds |
| HY-Y1316 | Sodium benzoate | 532-32-1 | Reference compound |
| HY-Y1316R | Sodium benzoate (Standard) | 532-32-1 | Reference Standards |
| HY-Y1316S | Benzoate-d5 (sodium) | 62790-26-5 | Isotope-Labeled Compounds |
| HY-Y1322 | Triphenyl phosphate | 115-86-6 | Reference compound |
| HY-Y1322S | Triphenyl phosphate-d15 | 1173020-30-8 | Isotope-Labeled Compounds |
| HY-Y1324 | Sodium phosphate dibasic dodecahydrate | 10039-32-4 | Biochemical Assay Reagents |
| HY-Y1325E | Sodium acetate trihydrate, United States Pharmacopeia (USP) Reference Standard | 6131-90-4 | Biochemical Assay Reagents |
| HY-Y1325H | Sodium acetate trihydrate, meets analytical specification of Ph. Eur. BP USP FCC E262, ≤0.00002% Al | 6131-90-4 | Biochemical Assay Reagents |
| HY-Y1325I | Sodium acetate trihydrate, 99.5% | 6131-90-4 | Biochemical Assay Reagents |
| HY-Y1325IR | Sodium acetate trihydrate, 99.5% (Standard) | 6131-90-4 | Reference Standards |
| HY-Y1326 | Sodium metabisulfite | 7681-57-4 | Reference compound |
| HY-Y1326R | Sodium metabisulfite (Standard) | 7681-57-4 | Reference Standards |
| HY-Y1329 | Trisodium phosphate | 7601-54-9 | Biochemical Assay Reagents |
| HY-Y1332 | Rochelle salt | 6381-59-5 | Biochemical Assay Reagents |
| HY-Y1332R | Rochelle salt (Standard) | 6381-59-5 | Reference Standards |
| HY-Y1347 | Piperonylonitrile | 4421-09-4 | Biochemical Assay Reagents |
| HY-Y1352S | Potassium cyanate-13C | 69545-33-1 | Isotope-Labeled Compounds |
| HY-Y1352S1 | Potassium cyanate-13C,15N | Isotope-Labeled Compounds | |
| HY-Y1353 | Di-tert-butyl dicarbonate | 24424-99-5 | Reference compound |
| HY-Y1354S | Dimethylamine-d6 (hydrochloride) | 53170-19-7 | Isotope-Labeled Compounds |
| HY-Y1359S | 2-Methylimidazole-d6 | 1173022-19-9 | Isotope-Labeled Compounds |
| HY-Y1361 | Diethyl D-(-)-tartrate | 13811-71-7 | Biochemical Assay Reagents |
| HY-Y1362 | Ethyl pyruvate | 617-35-6 | Reference compound |
| HY-Y1362R | Ethyl pyruvate (Standard) | 617-35-6 | Reference Standards |
| HY-Y1362S | Ethyl pyruvate-d3 | 66966-38-9 | Isotope-Labeled Compounds |
| HY-Y1365 | Gelatins | 9000-70-8 | Biochemical Assay Reagents |
| HY-Y1366 | Hydroxyacetone | 116-09-6 | Natural Products |
| HY-Y1369C | Manganese sulfate monohydrate, for cell culture | 10034-96-5 | Biochemical Assay Reagents |
| HY-Y1372S | 2,2-Dimethyl-1,3-dioxolane-4-methanol-d5 | 74300-14-4 | Isotope-Labeled Compounds |
| HY-Y1373 | Cyclohexanecarboxylic acid | 98-89-5 | Natural Products |
| HY-Y1373R | Cyclohexanecarboxylic acid (Standard) | 98-89-5 | Reference Standards |
| HY-Y1373S | Cyclohexanecarboxylic acid-d1 | 933-37-9 | Isotope-Labeled Compounds |
| HY-Y1373S1 | Cyclohexanecarboxylic acid-d11 | 93131-16-9 | Isotope-Labeled Compounds |
| HY-Y1374 | Benzoic anhydride | 93-97-0 | Biochemical Assay Reagents |
| HY-Y1374R | Benzoic anhydride (Standard) | 93-97-0 | Reference Standards |
| HY-Y1394 | H-Phe-OMe.hydrochloride | 7524-50-7 | Peptides |
| HY-Y1401 | Methyl carbamate | 598-55-0 | Biochemical Assay Reagents |
| HY-Y1401R | Methyl carbamate (Standard) | 598-55-0 | Reference Standards |
| HY-Y1401S | Methyl carbamate-d3 | 124522-32-3 | Isotope-Labeled Compounds |
| HY-Y1405 | Sodium tungstate dihydrate, 99% | 10213-10-2 | Biochemical Assay Reagents |
| HY-Y1410 | Triisopropylsilane, 98% | 6485-79-6 | Biochemical Assay Reagents |
| HY-Y1413 | Sodium diethylglycinate | 5426-55-1 | Peptides |
| HY-Y1416 | 3-(1-Cyanoethyl)benzoic acid | 5537-71-3 | Reference compound |
| HY-Y1416R | 3-(1-Cyanoethyl)benzoic acid (Standard) | 5537-71-3 | Reference Standards |
| HY-Y1422 | Triacylglycerol lipase | 9001-62-1 | Enzyme |
| HY-Y1422A | Lipase, Human Pancreas | 9001-62-1 | Enzyme |
| HY-Y1422B | Lipase (MS grade) | 9001-62-1 | Enzyme |
| HY-Y1422C | Lipase, Chromobacterium viscosum | 9001-62-1 | Enzyme |
| HY-Y1422D | Lipase 435 | 9001-62-1 | Enzyme |
| HY-Y1422E | Lipase AS | 9001-62-1 | Enzyme |
| HY-Y1422H | Lipase AYS | 9001-62-1 | Enzyme |
| HY-Y1422I | Lipase AK | 9001-62-1 | Enzyme |
| HY-Y1422J | Lipase PS-SD | 9001-62-1 | Enzyme |
| HY-Y1422K | Lipase PS-IM | 9001-62-1 | Enzyme |
| HY-Y1426 | 2'-Hydroxyacetophenone | 118-93-4 | Natural Products |
| HY-Y1426R | 2'-Hydroxyacetophenone (Standard) | 118-93-4 | Reference Standards |
| HY-Y1620 | 3-(3,4-Dimethoxyphenyl)propanoic acid | 2107-70-2 | Reference compound |
| HY-Y1620S | 3-(3,4-Dimethoxyphenyl)propanoic acid-d10 | 1398065-72-9 | Isotope-Labeled Compounds |
| HY-Y1624 | 1,1'-(Azodicarbonyl)-dipiperidine | 10465-81-3 | Reference compound |
| HY-Y1630S | NSC 10281-d4 | 1219802-01-3 | Isotope-Labeled Compounds |
| HY-Y1634 | 4-Hydroxy-6-methyl-2-pyrone | 675-10-5 | Biochemical Assay Reagents |
| HY-Y1636 | Fmoc-Arg(Pbf)-OH | 154445-77-9 | Peptides |
| HY-Y1636S1 | Fmoc-Arg(Pbf)-OH-13C6 | Isotope-Labeled Compounds | |
| HY-Y1641S | 1,2-Ethanedithiol-d4 | 100189-81-9 | Isotope-Labeled Compounds |
| HY-Y1644 | (E)-Crotonic acid | 107-93-7 | Natural Products |
| HY-Y1644R | (E)-Crotonic acid (Standard) | 107-93-7 | Reference Standards |
| HY-Y1644S | 3,3-Dimethylacrylic acid-d6 | 21386-86-7 | Isotope-Labeled Compounds |
| HY-Y1661 | Methyl N-methylglycinate hydrochloride | 13515-93-0 | Peptides |
| HY-Y1662 | D-Aminoacylase | 65979-42-2 | Enzyme |
| HY-Y1666 | 2,2′-Dipyridyl disulfide | 2127-03-9 | Reference compound |
| HY-Y1667 | 2,6-Dibromophenol | 608-33-3 | Natural Products |
| HY-Y1667S | 2,6-Dibromophenol-d3 | 1219803-14-1 | Isotope-Labeled Compounds |
| HY-Y1673 | Potassium bromide, 99% | 7758-02-3 | Biochemical Assay Reagents |
| HY-Y1675S | NSC 65593-d4 | 1219798-58-9 | Isotope-Labeled Compounds |
| HY-Y1681 | 2-Amino-5-nitrobenzoic acid | 616-79-5 | Biochemical Assay Reagents |
| HY-Y1683 | DL-Menthol | 89-78-1 | Natural Products |
| HY-Y1683R | DL-Menthol (Standard) | 89-78-1 | Reference Standards |
| HY-Y1685 | 2,4-Dihydroxyquinoline | 86-95-3 | Biochemical Assay Reagents |
| HY-Y1699 | Tetrabutylammonium hexafluorophosphate | 3109-63-5 | Biochemical Assay Reagents |
| HY-Y1702 | 3-Amino-2-pyrazinecarboxylic acid | 5424-01-1 | Biochemical Assay Reagents |
| HY-Y1703 | HATU | 148893-10-1 | Biochemical Assay Reagents |
| HY-Y1713 | 2-Amino-3-nitrobenzoic acid | 606-18-8 | Biochemical Assay Reagents |
| HY-Y1716 | Bis(benzonitrile)palladium chloride | 14220-64-5 | Biochemical Assay Reagents |
| HY-Y1718 | Tridecanoic acid | 638-53-9 | Natural Products |
| HY-Y1718R | Tridecanoic acid (Standard) | 638-53-9 | Reference Standards |
| HY-Y1718S | Tridecanoic acid-d2 | 64118-44-1 | Isotope-Labeled Compounds |
| HY-Y1718S1 | Tridecanoic acid-d25 | 202529-03-1 | Isotope-Labeled Compounds |
| HY-Y1718S2 | Tridecanoic acid-d9 | Isotope-Labeled Compounds | |
| HY-Y1725 | 1,5-Naphthalenedisulfonic acid | 81-04-9 | Biochemical Assay Reagents |
| HY-Y1738 | Tetrakis(triphenylphosphine)palladium | 14221-01-3 | Biochemical Assay Reagents |
| HY-Y1747 | 4-Bromo-2,6-difluorobenzaldehyde | 537013-51-7 | Biochemical Assay Reagents |
| HY-Y1750 | β-Aminopropionitrile | 151-18-8 | Natural Products |
| HY-Y1750A | β-Aminopropionitrile (hydrochloride) | 646-03-7 | Reference compound |
| HY-Y1754 | 2,2,6,6-Tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid | 15871-57-5 | Biochemical Assay Reagents |
| HY-Y1770S | 2-Amino-5-bromopyridine-d3 | 952109-91-0 | Isotope-Labeled Compounds |
| HY-Y1771 | 2-Carboxybenzaldehyde | 119-67-5 | Reference compound |
| HY-Y1771R | 2-Carboxybenzaldehyde (Standard) | 119-67-5 | Reference Standards |
| HY-Y1772S | 1-Iodo-4-methylbenzene-d7 | 1039678-66-4 | Isotope-Labeled Compounds |
| HY-Y1777 | 2-Phenylacetophenone | 451-40-1 | Reference compound |
| HY-Y1778 | N-(Diphenylmethylene)glycine tert-butyl ester | 81477-94-3 | Dye Reagents |
| HY-Y1783 | 2-(Methylamino)ethanol | 109-83-1 | Natural Products |
| HY-Y1787 | Dimethyl malonate | 108-59-8 | Natural Products |
| HY-Y1789 | Methyl 2-aminoacetate hydrochloride | 5680-79-5 | Peptides |
| HY-Y1801 | β-Methyl L-aspartate hydrochloride | 16856-13-6 | Peptides |
| HY-Y1804 | D-Lysine (monohydrochloride) | 7274-88-6 | Peptides |
| HY-Y1804S | D-Lysine-d4 (monohydrochloride) | 2714413-18-8 | Isotope-Labeled Compounds |
| HY-Y1805S | 1,2,3,4-Tetrahydronaphthalene-d4 | 92633-06-2 | Isotope-Labeled Compounds |
| HY-Y1806 | 1,3-Dibromopropane | 109-64-8 | Reference compound |
| HY-Y1809 | 1-Hydroxyoctadecane | 112-92-5 | Natural Products |
| HY-Y1809R | 1-Hydroxyoctadecane (Standard) | 112-92-5 | Reference Standards |
| HY-Y1809S | 1-Hydroxyoctadecane-d37 | 204259-62-1 | Isotope-Labeled Compounds |
| HY-Y1809S1 | 1-Hydroxyoctadecane-d2 | 86369-69-9 | Isotope-Labeled Compounds |
| HY-Y1810 | Diethylene glycol diethyl ether | 112-36-7 | Biochemical Assay Reagents |
| HY-Y1818 | Benzyltrimethylammonium (chloride) | 56-93-9 | Biochemical Assay Reagents |
| HY-Y1819 | 2-Acetonaphthone | 93-08-3 | Natural Products |
| HY-Y1824 | N-9-Fluorenylmethoxycarbonylaspartic acid β-methyl ester | 145038-53-5 | Peptides |
| HY-Y1825 | Benzimidazole | 51-17-2 | Biochemical Assay Reagents |
| HY-Y1825R | Benzimidazole (Standard) | 51-17-2 | Reference Standards |
| HY-Y1832 | o-Vanillin | 148-53-8 | Reference compound |
| HY-Y1838S | Methoxytrimethylsilane-d3 | 19108-51-1 | Isotope-Labeled Compounds |
| HY-Y1840 | 3-Methoxyphenol | 150-19-6 | Natural Products |
| HY-Y1840R | 3-Methoxyphenol (Standard) | 150-19-6 | Reference Standards |
| HY-Y1840S | 3-Methoxyphenol-d3 | Isotope-Labeled Compounds | |
| HY-Y1841 | o-Phenanthroline (monohydrate) | 5144-89-8 | Biochemical Assay Reagents |
| HY-Y1844 | Fmoc-D-Glu(OtBu)-OH | 104091-08-9 | Peptides |
| HY-Y1856 | N-(tert-Butoxycarbonyl)-N-methyl-D-alanine | 19914-38-6 | Peptides |
| HY-Y1863 | 3-Chlorobenzaldehyde | 587-04-2 | Biochemical Assay Reagents |
| HY-Y1875 | L-Cysteine ethyl ester HCl | 868-59-7 | Peptides |
| HY-Y1876 | Guaiacol Carbonate | 553-17-3 | Reference compound |
| HY-Y1877 | Lead carbonate(II) | 598-63-0 | Biochemical Assay Reagents |
| HY-Y1878 | Copper(Ⅱ) sulfate | 7758-98-7 | Biochemical Assay Reagents |
| HY-Y1878C | Copper sulfate anhydrous, 99% | 7758-98-7 | Biochemical Assay Reagents |
| HY-Y1881A | Copper sulfate pentahydrate, 99.9% | 7758-99-8 | Biochemical Assay Reagents |
| HY-Y1881B | Copper sulfate pentahydrate, for cell culture, 98% | 7758-99-8 | Biochemical Assay Reagents |
| HY-Y1883 | Polyethylene glycol mono(4-tert-octylphenyl) ether surfactant | 9002-93-1 | Biochemical Assay Reagents |
| HY-Y1883A | Polyethylene glycol mono(4-tert-octylphenyl) ether | 9002-93-1 | Reference compound |
| HY-Y1885 | Tetrasodium pyrophosphate | 7722-88-5 | Biochemical Assay Reagents |
| HY-Y1887 | Cottonseed oil | 8001-29-4 | Biochemical Assay Reagents |
| HY-Y1888 | Corn oil | 8001-30-7 | Biochemical Assay Reagents |
| HY-Y1889 | Sodium carboxymethyl cellulose (Viscosity:5000-15000 mPa.s) | 9004-32-4 | Biochemical Assay Reagents |
| HY-Y1889A | Sodium carboxymethyl cellulose (MW 250000) | 9004-32-4 | Biochemical Assay Reagents |
| HY-Y1890 | Cremophor EL-40 | 61791-12-6 | Biochemical Assay Reagents |
| HY-Y1891 | Tween 80 | 9005-65-6 | Biochemical Assay Reagents |
| HY-Y1892 | Gelucire 44/14 | 121548-04-7 | Biochemical Assay Reagents |
| HY-Y1893 | Solutol HS-15 | 61909-81-7 | Biochemical Assay Reagents |
| HY-Y1903 | Phosal 50 PG | 774594-96-6 | Biochemical Assay Reagents |
| HY-Y1911 | Mid-chain triglyceride of caprylic/caprolic acid | Biochemical Assay Reagents | |
| HY-Y1913 | Potassium tetraborate tetrahydrate, 99.5% | 12045-78-2 | Biochemical Assay Reagents |
| HY-Y1918 | Potassium diphosphate | 7320-34-5 | Biochemical Assay Reagents |
| HY-Y1939A | Metaphosphoric acid, 33.5-36.5% | 37267-86-0 | Biochemical Assay Reagents |
| HY-Y1968A | Sterile 10 mM Histidine, pH 5.5 buffer | Biochemical Assay Reagents | |
| HY-Y1977 | 100mM Pro-Ac, 20 mM Arg, pH 5.0 buffer | ADC Related | |
| HY-Z0031 | (R)-(-)-1,2-Propanediol | 4254-14-2 | Natural Products |
| HY-Z0031R | (R)-(-)-1,2-Propanediol (Standard) | 4254-14-2 | Reference Standards |
| HY-Z0056S | Bromobenzene-d5 | 4165-57-5 | Isotope-Labeled Compounds |
| HY-Z0075 | (Z)2S,4R-Sacubitril | Reference compound | |
| HY-Z0075R | (Z)2S,4R-Sacubitril (Standard) | Reference Standards | |
| HY-Z0081 | 2S,4R-Sacubitril | 2307668-79-5 | Reference compound |
| HY-Z0085 | 2-Chloro-N-methyl-N-(4-nitrophenyl)acetamide | 2653-16-9 | Reference compound |
| HY-Z0155 | Triphenylphosphine oxide | 791-28-6 | Biochemical Assay Reagents |
| HY-Z0275 | HOAT | 39968-33-7 | Reference compound |
| HY-Z0283 | Benzamide | 55-21-0 | Reference compound |
| HY-Z0283R | Benzamide (Standard) | 55-21-0 | Reference Standards |
| HY-Z0283S | Benzamide-15N | 31656-62-9 | Isotope-Labeled Compounds |
| HY-Z0290 | Phenylphosphoric acid | 701-64-4 | Reference compound |
| HY-Z0291 | L-Alanine isopropyl ester | 39825-33-7 | Peptides |
| HY-Z0424 | (S)-2-[(tert-Butoxycarbonyl)amino]-3-iodopropionic acid methyl ester | 170848-34-7 | Peptides |
| HY-Z0425 | (S)-Methyl 2-oxooxazolidine-4-carboxylate | 132682-22-5 | Reference compound |
| HY-Z0438 | Boc-L-Ile-OH | 13139-16-7 | Peptides |
| HY-Z0478 | (-)-Limonene | 5989-54-8 | Natural Products |
| HY-Z0478R | (-)-Limonene (Standard) | 5989-54-8 | Reference Standards |
| HY-Z0548 | Methyl 3,4-dihydroxybenzoate | 2150-43-8 | Natural Products |
| HY-Z0548R | Methyl 3,4-dihydroxybenzoate (Standard) | 2150-43-8 | Reference Standards |
| HY-Z0548S1 | Methyl 3,4-dihydroxybenzoate-d3-1 | 2733147-54-9 | Isotope-Labeled Compounds |
| HY-Z0615 | (2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid | 7536-58-5 | Peptides |
| HY-Z0711 | L-Serine isopropyl ester hydrochloride | 37592-53-3 | Peptides |
| HY-Z0790 | (R)-3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid | 261360-77-4 | Peptides |
| HY-Z0792S | 4-O-Methyldopa-d3 | 586954-11-2 | Isotope-Labeled Compounds |
| HY-Z0816 | Dehydronitrosonisoldipine | 87375-91-5 | Reference compound |
| HY-Z0833 | Bazedoxifene N-Oxide | 1174289-22-5 | Reference compound |
| HY-Z0922 | (R,R)-MC-Val-Cit-PAB | Reference compound | |
| HY-Z10518 | ((3R,5R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate) calcium(II) | 1422515-55-6 | Reference compound |
| HY-Z1085 | Deschloro-Zopiclone | 1348046-61-6 | Reference compound |
| HY-Z1145 | 6-Methoxytryptamine | 3610-36-4 | Reference compound |
| HY-Z1146 | 7-Methoxytryptamine | 2436-04-6 | Reference compound |
| HY-Z11724 | Semaglutide Main Chain (9-37) | 1169630-82-3 | Peptides |
| HY-Z12728 | (R)-Azelastine | 143228-84-6 | Reference compound |
| HY-Z14061 | Doxazosin impurity 12 | 2066-93-5 | Reference compound |
| HY-Z1430S | (3R,4S)-Paroxetine-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-Z15868 | 5-Hydroxycytidine | 39638-73-8 | Reference compound |
| HY-Z16212 | Neomycin F | 51795-47-2 | Natural Products |
| HY-Z17187 | Feudomycin A | 79466-09-4 | Natural Products |
| HY-Z1769 | S-Desmethyl-S-(2-hydroxy-2-methylpropyl) Rosuvastatin (calcium) | 1714147-47-3 | Reference compound |
| HY-Z18056 | Norpropranolol (hydrochloride) | 62618-09-1 | Reference compound |
| HY-Z1917S | (S)-1-(6-amino-9H-purin-9-yl)propan-2-ol-d6 | 1217617-88-3 | Isotope-Labeled Compounds |
| HY-Z2106S | Vonoprazan impurity 11-d5 (fumarate) | Isotope-Labeled Compounds | |
| HY-Z2337 | Rabeprazole sulfone | 117976-47-3 | Reference compound |
| HY-Z2338 | 5-O-Desmethyl omeprazole | 151602-49-2 | Reference compound |
| HY-Z2483S | Clopidogrel-MP endo derivative-13C,d3 | 1346597-76-9 | Isotope-Labeled Compounds |
| HY-Z2493 | Aripiprazole N1-oxide | 573691-09-5 | Reference compound |
| HY-Z3151 | 3'-(2-Fluorophenyl) ezetimibe | 1798008-25-9 | Reference compound |
| HY-Z3203S | N-Desmethyl Rosuvastatin-d6 (disodium) | Isotope-Labeled Compounds | |
| HY-Z3421S | Vonoprazan-d3 (fumarate) | Isotope-Labeled Compounds | |
| HY-Z3421S1 | Vonoprazan-d4 (fumarate) | Isotope-Labeled Compounds | |
| HY-Z3637 | (–)-Sitagliptin carbamoyl glucuronide | 940002-59-5 | Reference compound |
| HY-Z3832 | N-Methylparoxetine | 110429-36-2 | Reference compound |
| HY-Z4466 | Olanzapine ketolactam | 1017241-34-7 | Reference compound |
| HY-Z4467 | Olanzapine thiolactam | 1017241-36-9 | Reference compound |
| HY-Z4483 | 6-Deoxypenciclovir | 104227-86-3 | Reference compound |
| HY-Z4488 | 5-Dibromomethyl anastrozole | 1027160-12-8 | Reference compound |
| HY-Z4561S | Bortezomib trimer-d15 | Isotope-Labeled Compounds | |
| HY-Z4690 | Zolmitriptan N-Oxide | 251451-30-6 | Reference compound |
| HY-Z4707 | Etoricoxib N1'-oxide | 325855-74-1 | Reference compound |
| HY-Z5058A | (3S,5S)-Fluvastatin (sodium) | 194935-01-8 | Reference compound |
| HY-Z5058S | (3R,5S)-Fluvastatin-d7 (sodium) | 1260178-87-7 | Isotope-Labeled Compounds |
| HY-Z6430 | Des-4-fluorobenzyl mosapride | 152013-26-8 | Reference compound |
| HY-Z6544 | N-(2,6-dimethylphenyl)-2-(ethyl(methyl)amino)acetamide (hydrochloride) | 50295-20-0 | Reference compound |
| HY-Z6663 | Salbutamol methyl ether | 870076-72-5 | Reference compound |
| HY-Z6848 | (R)-(+)-Bupivacaine (hydrochloride) | 27262-46-0 | Reference compound |
| HY-Z7082 | Perindopril (L-arginine) | 612548-45-5 | Reference compound |
| HY-Z7147 | Efinaconazole analogue-1 | 86386-77-8 | Reference compound |
| HY-Z7429 | 3-Hydroxy-4-methyl-2(5H)-thiophenone | 34876-35-2 | Reference compound |
| HY-Z7555 | Cefazolin impurity H | 56842-77-4 | Reference compound |
| HY-Z7592 | (E)-Cefodizime | 97180-26-2 | Reference compound |
| HY-Z7640 | 4-Desmethyl-2-methyl celecoxib | 170569-99-0 | Reference compound |
| HY-Z7659 | Lansoprazole sulfone N-Oxide | 953787-54-7 | Reference compound |
| HY-Z7660 | Lansoprazole N-oxide | 213476-12-1 | Reference compound |
| HY-Z7721 | (Rac)-Beraprost (sodium) | 88475-69-8 | Reference compound |
| HY-Z7733 | O-Desmethylcarvedilol | 72956-44-6 | Reference compound |
| HY-Z8025 | Deprodone | 20423-99-8 | Reference compound |
| HY-Z8033 | N-Desmethyl diltiazem (hydrochloride) | 130606-60-9 | Reference compound |
| HY-Z8143 | 3-Keto fusidic acid | 4680-37-9 | Reference compound |
| HY-Z8381 | Ramipril diketopiperazine | 108731-95-9 | Reference compound |
| HY-Z8410 | Rizatriptan N-oxide | 260435-42-5 | Reference compound |
| HY-Z8447 | 9(E)-Erythromycin A oxime | 111321-02-9 | Reference compound |
| HY-Z8472 | Dihydromevinolin | 77517-29-4 | Reference compound |
| HY-Z8487 | 2-(2-Chlorophenyl)-2-hydroxycyclohexanone | 1823362-29-3 | Reference compound |
| HY-Z8537 | Desmethyl mirtazapine (hydrochloride) | 1188265-41-9 | Reference compound |
| HY-Z8643 | HCTZ-CH2-HCTZ | 402824-96-8 | Reference compound |
| HY-Z8648 | Δ14-Triamcinolone acetonide | 1260149-96-9 | Reference compound |
| HY-Z9063 | 1-epi-Regadenoson | 2015222-31-6 | Reference compound |
| HY-Z9064 | 1-epi-Regadenoson ethyl ester | 2015222-44-1 | Reference compound |
| HY-Z9065 | 1-epi-Regadenoson hydrazone | 2015222-41-8 | Reference compound |
| HY-Z9082 | Dihydroxy melphatalan | 72143-20-5 | Reference compound |
| HY-Z9100 | rac N-Demethyl promethazine (hydrochloride) | 60113-77-1 | Reference compound |
| HY-Z9101 | Promethazine sulfoxide | 7640-51-9 | Reference compound |
| HY-Z9464 | Fluprostenol lactone diol | 53872-60-9 | Reference compound |
| HY-100015R | Mivebresib (Standard) | 1445993-26-9 | Reference Standards |
| HY-100029AR | Bay 41-4109 (racemate) (Standard) | 298708-79-9 | Reference Standards |
| HY-100064R | O-Desmethyl gefitinib (Standard) | 847949-49-9 | Reference Standards |
| HY-10008R | SNS-032 (Standard) | 345627-80-7 | Reference Standards |
| HY-10009R | Semagacestat (Standard) | 425386-60-3 | Reference Standards |
| HY-10012R | AZD-5438 (Standard) | 602306-29-6 | Reference Standards |
| HY-100140R | Pipequaline (Standard) | 77472-98-1 | Reference Standards |
| HY-100144R | Pirozadil (Standard) | 54110-25-7 | Reference Standards |
| HY-10015R | PAP-1 (Standard) | 870653-45-5 | Reference Standards |
| HY-100168AR | BAPTA (tetrasodium) (Standard) | 126824-24-6 | Reference Standards |
| HY-100168R | BAPTA (Standard) | 85233-19-8 | Reference Standards |
| HY-100176R | PF-4878691 (Standard) | 532959-63-0 | Reference Standards |
| HY-10019AR | Varenicline (dihydrochloride) (Standard) | 866823-63-4 | Reference Standards |
| HY-10019R | Varenicline (Standard) | 249296-44-4 | Reference Standards |
| HY-10019S2 | Varenicline-13C15N | 2140265-12-7 | Isotope-Labeled Compounds |
| HY-10020R | Varenicline (Hydrochloride) (Standard) | 230615-23-3 | Reference Standards |
| HY-100223R | Calpeptin (Standard) | 117591-20-5 | Reference Standards |
| HY-100229R | Aloxistatin (Standard) | 88321-09-9 | Reference Standards |
| HY-100242R | Mivotilate (Standard) | 130112-42-4 | Reference Standards |
| HY-100353R | C12-Ceramide (Standard) | 74713-60-3 | Reference Standards |
| HY-100355R | C18-Ceramide (Standard) | 2304-81-6 | Reference Standards |
| HY-100369AR | DMCM (hydrochloride) (Standard) | 1215833-62-7 | Reference Standards |
| HY-100371R | (RS)-MCPG (Standard) | 146669-29-6 | Reference Standards |
| HY-10037R | Quiflapon (Standard) | 136668-42-3 | Reference Standards |
| HY-100388AR | SHP099 (monohydrochloride) (Standard) | 2200214-93-1 | Reference Standards |
| HY-100388R | SHP099 (Standard) | 1801747-42-1 | Reference Standards |
| HY-100396R | SQ22536 (Standard) | 17318-31-9 | Reference Standards |
| HY-100399AR | Nevanimibe hydrochloride (Standard) | 133825-81-7 | Reference Standards |
| HY-100400AR | K-604 (dihydrochloride) (Standard) | 217094-32-1 | Reference Standards |
| HY-100410R | FCCP (Standard) | 370-86-5 | Reference Standards |
| HY-100412R | Linaprazan (Standard) | 248919-64-4 | Reference Standards |
| HY-100428R | Netoglitazone (Standard) | 161600-01-7 | Reference Standards |
| HY-100442R | Paquinimod (Standard) | 248282-01-1 | Reference Standards |
| HY-100471R | Esaxerenone (Standard) | 1632006-28-0 | Reference Standards |
| HY-100490AR | Rilmenidine (hemifumarate) (Standard) | 207572-68-7 | Reference Standards |
| HY-100490R | Rilmenidine (Standard) | 54187-04-1 | Reference Standards |
| HY-100507R | Avadomide (Standard) | 1015474-32-4 | Reference Standards |
| HY-100516R | Cimicoxib (Standard) | 265114-23-6 | Reference Standards |
| HY-100532R | CD437 (Standard) | 125316-60-1 | Reference Standards |
| HY-10053R | Maropitant (Standard) | 147116-67-4 | Reference Standards |
| HY-100542R | D-α-Hydroxyglutaric acid (disodium) (Standard) | 103404-90-6 | Reference Standards |
| HY-100545R | BAPTA-AM (Standard) | 126150-97-8 | Reference Standards |
| HY-100561R | Tempol (Standard) | 2226-96-2 | Reference Standards |
| HY-100571A | (+)-5-trans Cloprostenol isopropyl ester | Reference compound | |
| HY-100583R | (-)-(S)-Equol (Standard) | 531-95-3 | Reference Standards |
| HY-100585R | Splitomicin (Standard) | 5690-03-9 | Reference Standards |
| HY-100586R | Ibuprofen (L-lysine) (Standard) | 57469-77-9 | Reference Standards |
| HY-100592R | Nicaraven (Standard) | 79455-30-4 | Reference Standards |
| HY-100609R | 4-P-PDOT (Standard) | 134865-74-0 | Reference Standards |
| HY-10064S1 | Ticagrelor-d4 | 1265911-54-3 | Isotope-Labeled Compounds |
| HY-100666R | Fosfluconazole (Standard) | 194798-83-9 | Reference Standards |
| HY-100675R | JTE-013 (Standard) | 383150-41-2 | Reference Standards |
| HY-100678R | CGS 15943 (Standard) | 104615-18-1 | Reference Standards |
| HY-100679R | Pirlindole (Standard) | 60762-57-4 | Reference Standards |
| HY-100689R | Propyl pyrazole triol (Standard) | 263717-53-9 | Reference Standards |
| HY-100713R | Temocapril (Standard) | 111902-57-9 | Reference Standards |
| HY-100714CR | DL-AP5 (sodium) (Standard) | 1303993-72-7 | Reference Standards |
| HY-100714R | DL-AP5 (Standard) | 76326-31-3 | Reference Standards |
| HY-100725R | BM212 (Standard) | 146204-42-4 | Reference Standards |
| HY-100732R | Cambinol (Standard) | 14513-15-6 | Reference Standards |
| HY-100740R | Lanabecestat (Standard) | 1383982-64-6 | Reference Standards |
| HY-100743R | DL-AP4 (Standard) | 6323-99-5 | Reference Standards |
| HY-100768R | HTHQ (Standard) | 148081-72-5 | Reference Standards |
| HY-100775AR | Fezagepras (Standard) | 1002101-19-0 | Reference Standards |
| HY-100775R | Fezagepras (sodium) (Standard) | 1254472-97-3 | Reference Standards |
| HY-100777R | DACA (Standard) | 89459-25-6 | Reference Standards |
| HY-100784R | Dihydrokainic acid (Standard) | 52497-36-6 | Reference Standards |
| HY-100788R | 2-PMPA (Standard) | 173039-10-6 | Reference Standards |
| HY-100792R | URB602 (Standard) | 565460-15-3 | Reference Standards |
| HY-10079R | CHS-828 (Standard) | 200484-11-3 | Reference Standards |
| HY-100804R | L-Cysteinesulfinic acid (Standard) | 1115-65-7 | Reference Standards |
| HY-100805S1 | D-Glutamic acid-13C5,15N | 1202063-56-6 | Isotope-Labeled Compounds |
| HY-100805S2 | D-Glutamic acid-13C5 | 1202063-54-4 | Isotope-Labeled Compounds |
| HY-100811AR | 7-Chlorokynurenic acid (sodium salt) (Standard) | 1263094-00-3 | Reference Standards |
| HY-100811R | 7-Chlorokynurenic acid (Standard) | 18000-24-3 | Reference Standards |
| HY-100813R | Saclofen (Standard) | 125464-42-8 | Reference Standards |
| HY-100815BR | (RS)-AMPA (Standard) | 77521-29-0 | Reference Standards |
| HY-10082S1 | Triapine-d3 | Isotope-Labeled Compounds | |
| HY-100831R | YM-58483 (Standard) | 223499-30-7 | Reference Standards |
| HY-100834R | 5,7-Dichlorokynurenic acid (Standard) | 131123-76-7 | Reference Standards |
| HY-100875R | Bisantrene (Standard) | 78186-34-2 | Reference Standards |
| HY-10087R | Navitoclax (Standard) | 923564-51-6 | Reference Standards |
| HY-100881R | TUG-891 (Standard) | 1374516-07-0 | Reference Standards |
| HY-10088R | Zibotentan (Standard) | 186497-07-4 | Reference Standards |
| HY-100908R | N-Acetyltryptamine (Standard) | 1016-47-3 | Reference Standards |
| HY-100919R | Ambenonium (chloride) (Standard) | 115-79-7 | Reference Standards |
| HY-100927R | Ro 20-1724 (Standard) | 29925-17-5 | Reference Standards |
| HY-100936R | Etazolate (hydrochloride) (Standard) | 35838-58-5 | Reference Standards |
| HY-100937R | DPCPX (Standard) | 102146-07-6 | Reference Standards |
| HY-100941R | CCCP (Standard) | 555-60-2 | Reference Standards |
| HY-100954R | 2,4-Diamino-6-hydroxypyrimidine (Standard) | 56-06-4 | Reference Standards |
| HY-100957R | Dilazep (dihydrochloride) (Standard) | 20153-98-4 | Reference Standards |
| HY-100959R | 3,5-Dinitrocatechol (Standard) | 7659-29-2 | Reference Standards |
| HY-100973AR | Adenosine 5′-diphosphoribose (sodium) (Standard) | 68414-18-6 | Reference Standards |
| HY-100983R | Protein kinase inhibitor H-7 (dihydrochloride) (Standard) | 108930-17-2 | Reference Standards |
| HY-100991R | FG 7142 (Standard) | 78538-74-6 | Reference Standards |
| HY-101006R | Methyl 2,5-dihydroxycinnamate (Standard) | 63177-57-1 | Reference Standards |
| HY-101012R | NPPB (Standard) | 107254-86-4 | Reference Standards |
| HY-101018R | Propionyl-DL-carnitine (chloride) (Standard) | 18828-58-5 | Reference Standards |
| HY-101055R | Kinetin riboside (Standard) | 4338-47-0 | Reference Standards |
| HY-101059R | FGIN 1-27 (Standard) | 142720-24-9 | Reference Standards |
| HY-101086R | Acetylcholine (iodide) (Standard) | 2260-50-6 | Reference Standards |
| HY-10108AR | LY294002 (hydrochloride) (Standard) | 934389-88-5 | Reference Standards |
| HY-10108R | LY294002 (Standard) | 154447-36-6 | Reference Standards |
| HY-10110R | IC-87114 (Standard) | 371242-69-2 | Reference Standards |
| HY-101139AR | Xanthine amine congener (hydrochloride) (Standard) | 1783977-95-6 | Reference Standards |
| HY-10114R | TGX-221 (Standard) | 663619-89-4 | Reference Standards |
| HY-10115AR | PI-103 (Hydrochloride) (Standard) | 371935-79-4 | Reference Standards |
| HY-10115R | PI-103 (Standard) | 371935-74-9 | Reference Standards |
| HY-101170R | BU224 (hydrochloride) (Standard) | 205437-64-5 | Reference Standards |
| HY-101176R | 2-Iodomelatonin (Standard) | 93515-00-5 | Reference Standards |
| HY-101179R | Tesmilifene (fumarate) (Standard) | 1185241-83-1 | Reference Standards |
| HY-101184R | T807 (Standard) | 1415379-56-4 | Reference Standards |
| HY-101193R | Zinc Protoporphyrin (Standard) | 15442-64-5 | Reference Standards |
| HY-10121S4 | Asenapine-d3,13C | 1217729-73-1 | Isotope-Labeled Compounds |
| HY-101232R | Tiotidine (Standard) | 69014-14-8 | Reference Standards |
| HY-101238R | Agmatine (sulfate) (Standard) | 2482-00-0 | Reference Standards |
| HY-101250R | Glemanserin (Standard) | 107703-78-6 | Reference Standards |
| HY-101251R | AMT (hydrochloride) (Standard) | 21463-31-0 | Reference Standards |
| HY-101254R | Luzindole (Standard) | 117946-91-5 | Reference Standards |
| HY-101255R | ODQ (Standard) | 41443-28-1 | Reference Standards |
| HY-101277S1 | Vadadustat-13C6 | Isotope-Labeled Compounds | |
| HY-10127R | Barasertib (Standard) | 722543-31-9 | Reference Standards |
| HY-101291R | Iberdomide (Standard) | 1323403-33-3 | Reference Standards |
| HY-10129R | Veliparib (Standard) | 912444-00-9 | Reference Standards |
| HY-101300R | Cirazoline (hydrochloride) (Standard) | 40600-13-3 | Reference Standards |
| HY-101312R | Cilostamide (Standard) | 68550-75-4 | Reference Standards |
| HY-101318 | β-Funaltrexamine (hydrochloride) | 72786-10-8 | Reference compound |
| HY-101321AR | Immepip (dihydrobromide) (Standard) | 164391-47-3 | Reference Standards |
| HY-101323R | Olvanil (Standard) | 58493-49-5 | Reference Standards |
| HY-101324AR | MK-212 (monohydrochloride) (Standard) | 61655-58-1 | Reference Standards |
| HY-101329R | Anthracene-9-carboxylic acid (Standard) | 723-62-6 | Reference Standards |
| HY-101331R | Phenylbiguanide (Standard) | 102-02-3 | Reference Standards |
| HY-101348R | L-741626 (Standard) | 81226-60-0 | Reference Standards |
| HY-101355AR | CGP 20712 (dihydrochloride) (Standard) | 1216905-73-5 | Reference Standards |
| HY-101355BR | CGP 20712 A (Standard) | 105737-62-0 | Reference Standards |
| HY-101357AR | CP 93129 (dihydrochloride) (Standard) | 879089-64-2 | Reference Standards |
| HY-101363R | 1-BCP (Standard) | 34023-62-6 | Reference Standards |
| HY-101364AR | CHPG (sodium salt) (Standard) | 1303993-73-8 | Reference Standards |
| HY-101365AR | RS-102221 (hydrochloride) (Standard) | 187397-18-8 | Reference Standards |
| HY-101373AR | Zolantidine (dimaleate) (Standard) | 104076-39-3 | Reference Standards |
| HY-101402AR | Cyclo(his-pro) (TFA) (Standard) | 936749-56-3 | Reference Standards |
| HY-101409AR | O-Acetyl-L-serine (hydrochloride) (Standard) | 66638-22-0 | Reference Standards |
| HY-101414R | L-DABA (Standard) | 1758-80-1 | Reference Standards |
| HY-101417R | Diethyl phosphate (Standard) | 598-02-7 | Reference Standards |
| HY-101433R | N-Acetylprocainamide (hydrochloride) (Standard) | 34118-92-8 | Reference Standards |
| HY-101435 | Centpropazine | 91315-34-3 | Reference compound |
| HY-101436AR | Sematilide (hydrochloride) (Standard) | 101526-62-9 | Reference Standards |
| HY-101437R | Ralfinamide (Standard) | 133865-88-0 | Reference Standards |
| HY-101442R | SR9238 (Standard) | 1416153-62-2 | Reference Standards |
| HY-101478R | Fenobam (Standard) | 57653-26-6 | Reference Standards |
| HY-101481R | Flurbiprofen axetil (Standard) | 91503-79-6 | Reference Standards |
| HY-101482R | Ibuprofen piconol (Standard) | 64622-45-3 | Reference Standards |
| HY-101484AR | NE-100 (hydrochloride) (Standard) | 149409-57-4 | Reference Standards |
| HY-101499AR | GKT136901 (hydrochloride) (Standard) | 1254507-01-1 | Reference Standards |
| HY-101499R | GKT136901 (Standard) | 955272-06-7 | Reference Standards |
| HY-10158S1 | Bosutinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-101604R | Atrimustine (Standard) | 75219-46-4 | Reference Standards |
| HY-101630R | Deramciclane (Standard) | 120444-71-5 | Reference Standards |
| HY-101713R | Ilacirnon (Standard) | 1100318-47-5 | Reference Standards |
| HY-101722R | Melinamide (Standard) | 14417-88-0 | Reference Standards |
| HY-10172R | IMD-0354 (Standard) | 978-62-1 | Reference Standards |
| HY-101772R | Ziritaxestat (Standard) | 1628260-79-6 | Reference Standards |
| HY-101775AR | 9-Hydroxyellipticine (hydrochloride) (Standard) | 52238-35-4 | Reference Standards |
| HY-101797R | Veralipride (Standard) | 66644-81-3 | Reference Standards |
| HY-10179R | Danusertib (Standard) | 827318-97-8 | Reference Standards |
| HY-10180R | MLN8054 (Standard) | 869363-13-3 | Reference Standards |
| HY-101813R | Laflunimus (Standard) | 147076-36-6 | Reference Standards |
| HY-10181AR | Dasatinib (hydrochloride) (Standard) | 854001-07-3 | Reference Standards |
| HY-101820R | Simotinib (Standard) | 944258-89-3 | Reference Standards |
| HY-10182AR | Laduviglusib (monohydrochloride) (Standard) | 1797989-42-4 | Reference Standards |
| HY-10182BR | Laduviglusib (trihydrochloride) (Standard) | 1782235-14-6 | Reference Standards |
| HY-101840AR | EIPA (hydrochloride) (Standard) | 1345839-28-2 | Reference Standards |
| HY-101840R | EIPA (Standard) | 1154-25-2 | Reference Standards |
| HY-101849R | Fasentin (Standard) | 392721-37-8 | Reference Standards |
| HY-101869R | MK-0343 (Standard) | 233275-76-8 | Reference Standards |
| HY-101877R | Statine (Standard) | 49642-07-1 | Reference Standards |
| HY-101903AR | BMS-309403 (sodium) (Standard) | 2802523-05-1 | Reference Standards |
| HY-101903R | BMS-309403 (Standard) | 300657-03-8 | Reference Standards |
| HY-101916R | Heparan Sulfate (Standard) | 9050-30-0 | Reference Standards |
| HY-10191R | Linsitinib (Standard) | 867160-71-2 | Reference Standards |
| HY-101957R | AG 1295 (Standard) | 71897-07-9 | Reference Standards |
| HY-101958R | Tyrphostin 25 (Standard) | 118409-58-8 | Reference Standards |
| HY-10195R | Ruboxistaurin (Standard) | 169939-94-0 | Reference Standards |
| HY-102013R | Omilancor (Standard) | 1912399-75-7 | Reference Standards |
| HY-102015R | 6-Biopterin (Standard) | 22150-76-1 | Reference Standards |
| HY-10202AR | Tandutinib (hydrochloride) (Standard) | 2438900-70-8 | Reference Standards |
| HY-10202R | Tandutinib (Standard) | 387867-13-2 | Reference Standards |
| HY-102032AR | (RS)-Butyryltimolol (Standard) | 2320274-78-8 | Reference Standards |
| HY-102040R | Hispidol (Standard) | 5786-54-9 | Reference Standards |
| HY-10206R | Amuvatinib (Standard) | 850879-09-3 | Reference Standards |
| HY-10207R | Dovitinib (lactate) (Standard) | 692737-80-7 | Reference Standards |
| HY-102093R | ZD 7155(hydrochloride) (Standard) | 146709-78-6 | Reference Standards |
| HY-10209AR | Masitinib (mesylate) (Standard) | 1048007-93-7 | Reference Standards |
| HY-10212R | BIIB021 (Standard) | 848695-25-0 | Reference Standards |
| HY-10215R | Luminespib (Standard) | 747412-49-3 | Reference Standards |
| HY-10218S1 | Everolimus-13C2,d4 | 1661009-29-5 | Isotope-Labeled Compounds |
| HY-10228R | Motesanib (Standard) | 453562-69-1 | Reference Standards |
| HY-10229R | Motesanib (Diphosphate) (Standard) | 857876-30-3 | Reference Standards |
| HY-10232R | THIP (Standard) | 64603-91-4 | Reference Standards |
| HY-10233R | Gaboxadol (hydrochloride) (Standard) | 85118-33-8 | Reference Standards |
| HY-10234AR | Saracatinib (difumarate) (Standard) | 893428-72-3 | Reference Standards |
| HY-10234R | Saracatinib (Standard) | 379231-04-6 | Reference Standards |
| HY-10240R | Mericitabine (Standard) | 940908-79-2 | Reference Standards |
| HY-10256AR | Adezmapimod (hydrochloride) (Standard) | 869185-85-3 | Reference Standards |
| HY-10256R | Adezmapimod (Standard) | 152121-47-6 | Reference Standards |
| HY-10268R | Betrixaban (Standard) | 330942-05-7 | Reference Standards |
| HY-10268S1 | Betrixaban-d4 | 2098655-55-9 | Isotope-Labeled Compounds |
| HY-10268S2 | Betrixaban-13C6 | Isotope-Labeled Compounds | |
| HY-10274R | Dabigatran etexilate (Standard) | 211915-06-9 | Reference Standards |
| HY-10284S4 | Linagliptin-d5 | Isotope-Labeled Compounds | |
| HY-10284S5 | Linagliptin-d6 | Isotope-Labeled Compounds | |
| HY-10285AR | Saxagliptin (hydrate) (Standard) | 945667-22-1 | Reference Standards |
| HY-10285S2 | Saxagliptin-13C2 | Isotope-Labeled Compounds | |
| HY-10295AR | SB 202190 (hydrochloride) (Standard) | 350228-36-3 | Reference Standards |
| HY-10295R | SB 202190 (Standard) | 152121-30-7 | Reference Standards |
| HY-10300R | Narlaprevir (Standard) | 865466-24-6 | Reference Standards |
| HY-10309R | Sibrafiban (Standard) | 172927-65-0 | Reference Standards |
| HY-103107R | LY334370 (Standard) | 182563-08-2 | Reference Standards |
| HY-103137R | Zacopride (hydrochloride) (Standard) | 101303-98-4 | Reference Standards |
| HY-103152R | GR 113808 (Standard) | 144625-51-4 | Reference Standards |
| HY-103153R | SB 204741 (Standard) | 152239-46-8 | Reference Standards |
| HY-103157R | PD146176 (Standard) | 4079-26-9 | Reference Standards |
| HY-103169R | SCH442416 (Standard) | 316173-57-6 | Reference Standards |
| HY-103171R | BAY 60-6583 (Standard) | 910487-58-0 | Reference Standards |
| HY-103173R | 5'-N-Ethylcarboxamidoadenosine (Standard) | 35920-39-9 | Reference Standards |
| HY-103182R | PSB-1115 (Standard) | 152529-79-8 | Reference Standards |
| HY-103183R | CV1808 (Standard) | 53296-10-9 | Reference Standards |
| HY-103185R | CCPA (Standard) | 37739-05-2 | Reference Standards |
| HY-103186R | MRS-1706 (Standard) | 264622-53-9 | Reference Standards |
| HY-103197R | 2-Methoxyidazoxan (monohydrochloride) (Standard) | 109544-45-8 | Reference Standards |
| HY-10320R | Doramapimod (Standard) | 285983-48-4 | Reference Standards |
| HY-103213R | JP1302 dihydrochloride (Standard) | 1259314-65-2 | Reference Standards |
| HY-103214R | Bucindolol (Standard) | 71119-11-4 | Reference Standards |
| HY-10321R | PD173074 (Standard) | 219580-11-7 | Reference Standards |
| HY-103224R | PIT-1 (Standard) | 53501-41-0 | Reference Standards |
| HY-103227R | Desidustat (Standard) | 1616690-16-4 | Reference Standards |
| HY-10322R | Falnidamol (Standard) | 196612-93-8 | Reference Standards |
| HY-103234AR | GYKI 52466 (dihydrochloride) (Standard) | 2319722-40-0 | Reference Standards |
| HY-103243R | TCPOBOP (Standard) | 76150-91-9 | Reference Standards |
| HY-103261R | SCH28080 (Standard) | 76081-98-6 | Reference Standards |
| HY-103267R | S32826 (disodium) (Standard) | 1103672-43-0 | Reference Standards |
| HY-103275R | Adaphostin (Standard) | 241127-58-2 | Reference Standards |
| HY-103307R | FPL64176 (Standard) | 120934-96-5 | Reference Standards |
| HY-103315R | Bepridil hydrochloride (Standard) | 68099-86-5 | Reference Standards |
| HY-103315S | Bepridil-d5 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-103345R | 2-MPPA (Standard) | 254737-29-6 | Reference Standards |
| HY-103347R | M50054 (Standard) | 54135-60-3 | Reference Standards |
| HY-103352R | L-006235 (Standard) | 294623-49-7 | Reference Standards |
| HY-103354R | Proglumide (sodium) (Standard) | 99247-33-3 | Reference Standards |
| HY-103364AR | C-021 (dihydrochloride) (Standard) | 1784252-84-1 | Reference Standards |
| HY-103364R | C-021 (Standard) | 864289-85-0 | Reference Standards |
| HY-10336R | Brivanib (alaninate) (Standard) | 649735-63-7 | Reference Standards |
| HY-103370R | Talniflumate (Standard) | 66898-62-2 | Reference Standards |
| HY-103377R | Antalarmin (hydrochloride) (Standard) | 220953-69-5 | Reference Standards |
| HY-103385R | NCX4040 (Standard) | 287118-97-2 | Reference Standards |
| HY-103389R | 1-Aminobenzotriazole (Standard) | 1614-12-6 | Reference Standards |
| HY-10338R | Foretinib (Standard) | 849217-64-7 | Reference Standards |
| HY-103396R | Trimetrexate (glucuronate) (Standard) | 82952-64-5 | Reference Standards |
| HY-103400R | 8-Chloroadenosine (Standard) | 34408-14-5 | Reference Standards |
| HY-10340AR | Tirbanibulin (dihydrochloride) (Standard) | 1038395-65-1 | Reference Standards |
| HY-10340BR | Tirbanibulin (Mesylate) (Standard) | 1080645-95-9 | Reference Standards |
| HY-10340R | Tirbanibulin (Standard) | 897016-82-9 | Reference Standards |
| HY-103410R | Carmoxirole (hydrochloride) (Standard) | 115092-85-8 | Reference Standards |
| HY-103414R | Raclopride (Standard) | 84225-95-6 | Reference Standards |
| HY-10342R | Enzastaurin (Standard) | 170364-57-5 | Reference Standards |
| HY-103444R | ARP-100 (Standard) | 704888-90-4 | Reference Standards |
| HY-103447S2 | Zearalenone-13C7 | Isotope-Labeled Compounds | |
| HY-103456R | PHTPP (Standard) | 805239-56-9 | Reference Standards |
| HY-103476R | Ro15-4513 (Standard) | 91917-65-6 | Reference Standards |
| HY-103490R | Takinib (Standard) | 1111556-37-6 | Reference Standards |
| HY-10349AR | WAY-100635 (maleate) (Standard) | 1092679-51-0 | Reference Standards |
| HY-10349R | WAY-100635 (Standard) | 162760-96-5 | Reference Standards |
| HY-103530R | CGP35348 (Standard) | 123690-79-9 | Reference Standards |
| HY-103533R | Gabazine (Standard) | 104104-50-9 | Reference Standards |
| HY-10353AS2 | Raltegravir-d4 (potassium) | Isotope-Labeled Compounds | |
| HY-103565AR | AMN082 (free base) (Standard) | 83027-13-8 | Reference Standards |
| HY-103565R | AMN082 (Standard) | 97075-46-2 | Reference Standards |
| HY-103595R | Epirizole (Standard) | 18694-40-1 | Reference Standards |
| HY-103658 | Myramistin | 15809-19-5 | Reference compound |
| HY-10367AR | Canertinib (dihydrochloride) (Standard) | 289499-45-2 | Reference Standards |
| HY-10367R | Canertinib (Standard) | 267243-28-7 | Reference Standards |
| HY-103683R | PF-06409577 (Standard) | 1467057-23-3 | Reference Standards |
| HY-103697AR | Gardiquimod (diTFA) (Standard) | 1159840-61-5 | Reference Standards |
| HY-103697R | Gardiquimod (Standard) | 1020412-43-4 | Reference Standards |
| HY-103701AR | L-Ascorbic acid 2-phosphate (magnesium) (Standard) | 113170-55-1 | Reference Standards |
| HY-103702 | TIP48/49-IN-1 | 1807337-58-1 | Reference compound |
| HY-103711R | Estramustine (Standard) | 2998-57-4 | Reference Standards |
| HY-10392S | Sutezolid-13C4 | Isotope-Labeled Compounds | |
| HY-10396R | Emricasan (Standard) | 254750-02-2 | Reference Standards |
| HY-10401R | VX-702 (Standard) | 745833-23-2 | Reference Standards |
| HY-10402R | Losmapimod (Standard) | 585543-15-3 | Reference Standards |
| HY-104031R | tCFA15 (Standard) | 220757-88-0 | Reference Standards |
| HY-10404R | Dilmapimod (Standard) | 444606-18-2 | Reference Standards |
| HY-10405R | Pamapimod (Standard) | 449811-01-2 | Reference Standards |
| HY-10409AR | Fedratinib (hydrochloride hydrate) (Standard) | 1374744-69-0 | Reference Standards |
| HY-10409R | Fedratinib (Standard) | 936091-26-8 | Reference Standards |
| HY-10418R | AH 6809 (Standard) | 33458-93-4 | Reference Standards |
| HY-10424R | Milciclib (Standard) | 802539-81-7 | Reference Standards |
| HY-10435AR | SKF-82958 (hydrobromide) (Standard) | 74115-01-8 | Reference Standards |
| HY-10443R | Balapiravir (Standard) | 690270-29-2 | Reference Standards |
| HY-10446R | Pralatrexate (Standard) | 146464-95-1 | Reference Standards |
| HY-10450S2 | Dapagliflozin-d4 | 1224234-25-6 | Isotope-Labeled Compounds |
| HY-10450S3 | Dapagliflozin-13C6 | Isotope-Labeled Compounds | |
| HY-10461R | PF-573228 (Standard) | 869288-64-2 | Reference Standards |
| HY-10466R | Daclatasvir (Standard) | 1009119-64-5 | Reference Standards |
| HY-10468R | NM107 (Standard) | 20724-73-6 | Reference Standards |
| HY-10469R | GSK256066 (Standard) | 801312-28-7 | Reference Standards |
| HY-10474R | Torkinib (Standard) | 1092351-67-1 | Reference Standards |
| HY-10498R | Lexibulin (Standard) | 917111-44-5 | Reference Standards |
| HY-105014R | Tecastemizole (Standard) | 75970-99-9 | Reference Standards |
| HY-105022R | Sabeluzole (Standard) | 104383-17-7 | Reference Standards |
| HY-105064DR | Zoniporide (hydrochloride hydrate) (Standard) | 863406-85-3 | Reference Standards |
| HY-105064R | Zoniporide (Standard) | 241800-98-6 | Reference Standards |
| HY-105090R | Lerisetron (Standard) | 143257-98-1 | Reference Standards |
| HY-105117R | Fantofarone (Standard) | 114432-13-2 | Reference Standards |
| HY-105124AR | Bufuralol (hydrochloride) (Standard) | 60398-91-6 | Reference Standards |
| HY-105129AR | Pimonidazole (Standard) | 70132-50-2 | Reference Standards |
| HY-105129R | Pimonidazole (hydrochloride) (Standard) | 70132-51-3 | Reference Standards |
| HY-10512R | AR-A014418 (Standard) | 487021-52-3 | Reference Standards |
| HY-105182AR | Xanomeline (tartrate) (Standard) | 152854-19-8 | Reference Standards |
| HY-105182R | Xanomeline (Standard) | 131986-45-3 | Reference Standards |
| HY-105182S1 | Xanomeline-d3 | 175615-28-8 | Isotope-Labeled Compounds |
| HY-105185B | (Rac)-Fidarestat | 105300-43-4 | Reference compound |
| HY-10521R | Darapladib (Standard) | 356057-34-6 | Reference Standards |
| HY-105272R | Loreclezole (Standard) | 117857-45-1 | Reference Standards |
| HY-10527CR | Telatinib (mesylate) (Standard) | 332013-26-0 | Reference Standards |
| HY-10527R | Telatinib (Standard) | 332012-40-5 | Reference Standards |
| HY-105285R | Piromelatine (Standard) | 946846-83-9 | Reference Standards |
| HY-10528R | Tasquinimod (Standard) | 254964-60-8 | Reference Standards |
| HY-105321R | PBT 1033 (Standard) | 747408-78-2 | Reference Standards |
| HY-10532R | SRT 1720 (Standard) | 925434-55-5 | Reference Standards |
| HY-10533R | Eniluracil (Standard) | 59989-18-3 | Reference Standards |
| HY-105350 | Pristinamycin IB | 57206-54-9 | Reference compound |
| HY-105454R | Recainam (Standard) | 74738-24-2 | Reference Standards |
| HY-105477 | Maniwamycin A | 122566-70-5 | Reference compound |
| HY-10550AR | Tariquidar (methanesulfonate, hydrate) (Standard) | 625375-83-9 | Reference Standards |
| HY-10550R | Tariquidar (Standard) | 206873-63-4 | Reference Standards |
| HY-10560R | Temanogrel (Standard) | 887936-68-7 | Reference Standards |
| HY-10562AR | Ketanserin (tartrate) (Standard) | 83846-83-7 | Reference Standards |
| HY-10564R | Sarpogrelate (hydrochloride) (Standard) | 135159-51-2 | Reference Standards |
| HY-10569R | Ponesimod (Standard) | 854107-55-4 | Reference Standards |
| HY-10570S2 | Nevirapine-d8 | 1051418-86-0 | Isotope-Labeled Compounds |
| HY-10570S3 | Nevirapine-d5 | 1189717-29-0 | Isotope-Labeled Compounds |
| HY-10571AR | Delavirdine (mesylate) (Standard) | 147221-93-0 | Reference Standards |
| HY-10571R | Delavirdine (Standard) | 136817-59-9 | Reference Standards |
| HY-10574R | Rilpivirine (Standard) | 500287-72-9 | Reference Standards |
| HY-10574S1 | Rilpivirine-13C6 | Isotope-Labeled Compounds | |
| HY-105762 | Etamiphyllin | 314-35-2 | Reference compound |
| HY-105808R | Furobufen (Standard) | 38873-55-1 | Reference Standards |
| HY-105832 | Fenbenicillin (potassium) | 1177-30-6 | Reference compound |
| HY-10588R | Bay K 8644 (Standard) | 71145-03-4 | Reference Standards |
| HY-10590R | TWS119 (Standard) | 601514-19-6 | Reference Standards |
| HY-106019CR | Liarozole (dihydrochloride) (Standard) | 1883548-96-6 | Reference Standards |
| HY-106019R | Liarozole (Standard) | 115575-11-6 | Reference Standards |
| HY-106067AR | Dazoxiben (hydrochloride) (Standard) | 74226-22-5 | Reference Standards |
| HY-106080AR | Furegrelate (sodium) (Standard) | 85666-17-7 | Reference Standards |
| HY-106100AR | Roxindole (hydrochloride) (Standard) | 108050-82-4 | Reference Standards |
| HY-106139R | Bimosiamose (Standard) | 187269-40-5 | Reference Standards |
| HY-10617AR | Rucaparib (Standard) | 283173-50-2 | Reference Standards |
| HY-10617AS | Rucaparib-d8 | Isotope-Labeled Compounds | |
| HY-10617R | Rucaparib (phosphate) (Standard) | 459868-92-9 | Reference Standards |
| HY-106225R | Rotigaptide (Standard) | 355151-12-1 | Reference Standards |
| HY-10626R | T0901317 (Standard) | 293754-55-9 | Reference Standards |
| HY-10627AR | GW3965 (hydrochloride) (Standard) | 405911-17-3 | Reference Standards |
| HY-106291 | Cefclidin | 105239-91-6 | Reference compound |
| HY-106296R | WIN 54954 (Standard) | 107355-45-3 | Reference Standards |
| HY-10629R | LXR-623 (Standard) | 875787-07-8 | Reference Standards |
| HY-106328R | Fluasterone (Standard) | 112859-71-9 | Reference Standards |
| HY-106339R | Lymecycline (Standard) | 992-21-2 | Reference Standards |
| HY-10634R | AMG 517 (Standard) | 659730-32-2 | Reference Standards |
| HY-106353R | Smilagenin (Standard) | 126-18-1 | Reference Standards |
| HY-106358R | Andolast (free base) (Standard) | 132640-22-3 | Reference Standards |
| HY-106376BR | DL-Buthionine-(S,R)-sulfoximine (hydrochloride) (Standard) | Reference Standards | |
| HY-106376R | DL-Buthionine-(S,R)-sulfoximine (Standard) | 5072-26-4 | Reference Standards |
| HY-106392R | Lucerastat (Standard) | 141206-42-0 | Reference Standards |
| HY-106395 | Telinavir | 143224-34-4 | Reference compound |
| HY-106405R | Nebicapone (Standard) | 274925-86-9 | Reference Standards |
| HY-106406R | Benzylacyclouridine (Standard) | 82857-69-0 | Reference Standards |
| HY-106431R | Olpadronic acid (Standard) | 63132-39-8 | Reference Standards |
| HY-106446R | Rentiapril (Standard) | 80830-42-8 | Reference Standards |
| HY-106467BR | Caroverine (hydrochloride) (Standard) | 55750-05-5 | Reference Standards |
| HY-106469 | Taltrimide | 81428-04-8 | Reference compound |
| HY-106506R | Desciclovir (Standard) | 84408-37-7 | Reference Standards |
| HY-106509R | Velaresol (Standard) | 77858-21-0 | Reference Standards |
| HY-106518 | Adimolol (free base) | 78459-19-5 | Reference compound |
| HY-106538R | Cadralazine (Standard) | 64241-34-5 | Reference Standards |
| HY-106542AR | Eberconazole nitrate (Standard) | 130104-32-4 | Reference Standards |
| HY-10655AR | Palosuran (hydrochloride) (Standard) | 2469274-58-4 | Reference Standards |
| HY-10655R | Palosuran (Standard) | 540769-28-6 | Reference Standards |
| HY-106572 | Cefbuperazone | 76610-84-9 | Reference compound |
| HY-106577S | Cibenzoline-d4 | Isotope-Labeled Compounds | |
| HY-106577S1 | Cibenzoline-d5 | Isotope-Labeled Compounds | |
| HY-106590 | Saccharocin | 86630-31-1 | Reference compound |
| HY-106628R | Sudoxicam (Standard) | 34042-85-8 | Reference Standards |
| HY-106638S | Voclosporin-d4 | Isotope-Labeled Compounds | |
| HY-10664R | SB-611812 (Standard) | 345892-71-9 | Reference Standards |
| HY-106702A | Fostriecin | 87810-56-8 | Reference compound |
| HY-106801 | Girolline | 110883-46-0 | Reference compound |
| HY-107211 | Echinocandin B nucleus | 79411-15-7 | Natural Products |
| HY-107370S | Atomoxetine-d7 | 919104-07-7 | Isotope-Labeled Compounds |
| HY-107370S1 | Atomoxetine-d5 | 1129478-03-0 | Isotope-Labeled Compounds |
| HY-108506S4 | Licarbazepine-d8 | 1261393-17-2 | Isotope-Labeled Compounds |
| HY-108685S | Alendronate-d4 (sodium) | 1309283-09-7 | Isotope-Labeled Compounds |
| HY-108993 | Fujianmycin B | 130548-09-3 | Reference compound |
| HY-109037S4 | Mavacamten-d7 | Isotope-Labeled Compounds | |
| HY-109044S | Tapinarof-d5 | 2748997-80-8 | Isotope-Labeled Compounds |
| HY-10913S | Danegaptide-d5 | Isotope-Labeled Compounds | |
| HY-109171S | Elinzanetant-d3 | Isotope-Labeled Compounds | |
| HY-10984S4 | Pomalidomide-13C5 | 1416575-79-5 | Isotope-Labeled Compounds |
| HY-110169 | (E/Z)-3PO | 13309-08-5 | Reference compound |
| HY-111182 | Estrone acetate | 901-93-9 | Reference compound |
| HY-113046S1 | 5-Methyltetrahydrofolic acid-13C6 | 212248-92-5 | Isotope-Labeled Compounds |
| HY-113159A | Docosapentaenoic acid (22n-3) (sodium) | 2983837-44-9 | Reference compound |
| HY-113376 | Etiocholanolone glucuronide | 3602-09-3 | Reference compound |
| HY-113407C | D-Fructose-6-phosphate (disodium monohydrate) | Natural Products | |
| HY-113407CR | D-Fructose-6-phosphate (disodium monohydrate) (Standard) | Reference Standards | |
| HY-113561 | Biphenomycin A | 100296-21-7 | Natural Products |
| HY-113759 | Saquayamycin A | 99260-65-8 | Reference compound |
| HY-113771 | Saquayamycin C | 99260-70-5 | Reference compound |
| HY-114118S3 | Semaglutide-13C6,15N (TFA) | Isotope-Labeled Compounds | |
| HY-114277S2 | Sotorasib-d3 | Isotope-Labeled Compounds | |
| HY-114370S | Selpercatinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-114508 | Dihydrochalcone | 1083-30-3 | Reference compound |
| HY-114551 | Streptothricin E | 3776-38-3 | Reference compound |
| HY-114703S1 | Eslicarbazepine-d4 | Isotope-Labeled Compounds | |
| HY-114816R | N-Butanoyl-L-homoserine lactone (Standard) | 67605-85-0 | Reference Standards |
| HY-115615 | VUF11207 (TFA) | 1492153-74-8 | Reference compound |
| HY-115736A | Xanthosine-5'-Triphosphate (trisodium) | 105931-36-0 | Reference compound |
| HY-116047S | Anisylacetone-d5 | 2676886-20-5 | Isotope-Labeled Compounds |
| HY-116738 | Trimecaine | 616-68-2 | Reference compound |
| HY-117259S | Valiltramiprosate-d6 | Isotope-Labeled Compounds | |
| HY-117285 | Medermycin | 60227-09-0 | Reference compound |
| HY-117985S | Evogliptin-d9 | Isotope-Labeled Compounds | |
| HY-118009 | Azotochelin | 23369-85-9 | Natural Products |
| HY-118553 | Saframycin D | 66082-30-2 | Reference compound |
| HY-118697R | N-Dodecanoyl-L-homoserine lactone (Standard) | 137173-46-7 | Reference Standards |
| HY-118797 | Malioxamycin | 73020-27-6 | Reference compound |
| HY-118828B | 12-Oxo phytodienoic acid (≥90%) | 85551-10-6 | Natural Products |
| HY-118861S1 | Enclomiphene-d4 | Isotope-Labeled Compounds | |
| HY-119188 | Saframycin A | 66082-27-7 | Reference compound |
| HY-119440 | Xanthinol | 2530-97-4 | Reference compound |
| HY-119521S | Mexiletine-d3 | Isotope-Labeled Compounds | |
| HY-119521S1 | Mexiletine-d6 | 1330267-50-9 | Isotope-Labeled Compounds |
| HY-119583 | Furanomycin | 18455-25-9 | Reference compound |
| HY-119695S | Simvastatin acid-d6 | 2747915-75-7 | Isotope-Labeled Compounds |
| HY-119708S | Ensifentrine-d6 | Isotope-Labeled Compounds | |
| HY-119713 | Khellinol | 478-42-2 | Natural Products |
| HY-119968 | Granaticin | 19879-06-2 | Reference compound |
| HY-120117 | Rumbrin | 148528-19-2 | Reference compound |
| HY-120311 | Benadrostin | 117241-60-8 | Natural Products |
| HY-120417 | JP-153 | 1802937-26-3 | Reference compound |
| HY-120601A | Alizarin Red S | 83-61-4 | Reference compound |
| HY-121148 | Mutalomycin | 62618-08-0 | Reference compound |
| HY-121309S1 | Doxorubicinone-13C,d3 | Isotope-Labeled Compounds | |
| HY-121319 | Chloranocryl | 2164-09-2 | Reference compound |
| HY-121399 | Gizzerosine | 89238-78-8 | Reference compound |
| HY-121442 | Enpiperate | 3608-67-1 | Reference compound |
| HY-121467S1 | Acotiamide-d4 | Isotope-Labeled Compounds | |
| HY-121595 | 5,5-Diphenylbarbituric acid | 21914-07-8 | Reference compound |
| HY-12199S1 | Pitolisant-d6 | 2416991-77-8 | Isotope-Labeled Compounds |
| HY-122016A | BRD-4592 | 2119598-24-0 | Reference compound |
| HY-122326 | Ioglycamic acid | 2618-25-9 | Reference compound |
| HY-122466 | Lonomycin A | 58785-63-0 | Reference compound |
| HY-122503 | Guamecycline | 16545-11-2 | Reference compound |
| HY-122583 | D-G23 | 1225141-73-0 | Reference compound |
| HY-123190 | Safracin A | 87578-98-1 | Natural Products |
| HY-123335A | L-796778 (acetate) | 2922280-21-3 | Reference compound |
| HY-123339 | Sannamycin G | 73522-72-2 | Reference compound |
| HY-12365S2 | Namodenoson-d5 | Isotope-Labeled Compounds | |
| HY-12388S | N-Desmethyl clomipramine-d7 | Isotope-Labeled Compounds | |
| HY-12388S1 | N-Desmethyl clomipramine-d6 | Isotope-Labeled Compounds | |
| HY-124111 | 10-Deoxymethymycin | 36826-66-1 | Reference compound |
| HY-124237AR | N-Octanoyl-L-homoserine lactone (Standard) | 147852-84-4 | Reference Standards |
| HY-124339 | JNJ525 | 2092913-64-7 | Reference compound |
| HY-124463S1 | Epiallopregnanolone-d5 | Isotope-Labeled Compounds | |
| HY-124533 | Trimethylolmelamine | 1017-56-7 | Reference compound |
| HY-124723 | Gerfelin | 627545-07-7 | Reference compound |
| HY-125597 | Glabrocoumarone A | 178330-48-8 | Natural Products |
| HY-125857A | Cytochrome C (equine heart) | 9007-43-6 | Biochemical Assay Reagents |
| HY-125857B | Cytochrome C (Saccharomyces cerevisiae) | 9007-43-6 | Biochemical Assay Reagents |
| HY-125857C | Cytochrome C (bovine heart) | 9007-43-6 | Biochemical Assay Reagents |
| HY-125922S | (22R)-Budesonide-d6 | Isotope-Labeled Compounds | |
| HY-126042S4 | (±)-Lisofylline-d4 | 1185879-05-3 | Isotope-Labeled Compounds |
| HY-126151 | Heneicomycin | 66170-37-4 | Reference compound |
| HY-126469 | Janthinocin B | 131086-53-8 | Reference compound |
| HY-126579 | Dactylocycline E | 146064-01-9 | Reference compound |
| HY-126660 | Cinerubin A | 34044-10-5 | Reference compound |
| HY-126802 | Saquayamycin B1 | 99260-68-1 | Reference compound |
| HY-126845 | 3-cis-Hydroxyglibenclamide | 23074-02-4 | Reference compound |
| HY-12689C | Mitapivat (hydrochloride) | 2559738-69-9 | Reference compound |
| HY-127014 | Julimycin B2 | 18126-05-1 | Reference compound |
| HY-127048 | Trichodermol | 2198-93-8 | Reference compound |
| HY-12767S2 | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol-13C6 | Isotope-Labeled Compounds | |
| HY-12769S2 | Mebeverine acid-d3 | Isotope-Labeled Compounds | |
| HY-12770S1 | Mebeverine alcohol-d3 | Isotope-Labeled Compounds | |
| HY-12772S3 | Hydroxy Itraconazole-d6 | Isotope-Labeled Compounds | |
| HY-128045 | Fenoxazoline | 4846-91-7 | Reference compound |
| HY-128174 | β-CCM | 69954-48-9 | Reference compound |
| HY-128429S | trans-2-Hexenal-d2-1 | 164791-70-2 | Isotope-Labeled Compounds |
| HY-128509 | Dioxidine | 17311-31-8 | Reference compound |
| HY-128514 | Minimycin | 32388-21-9 | Reference compound |
| HY-12857S2 | Brigatinib-d11 | 2055306-76-6 | Isotope-Labeled Compounds |
| HY-129280 | Janthinocin A | 131086-52-7 | Reference compound |
| HY-129670 | KMUP-1 | 81996-46-5 | Reference compound |
| HY-13001S | Quizartinib-d8 | 1300734-19-3 | Isotope-Labeled Compounds |
| HY-130059 | Guanine-7-oxide | 5227-68-9 | Reference compound |
| HY-13017S4 | Ivacaftor-13C6 | Isotope-Labeled Compounds | |
| HY-130368 | W-7 | 65595-90-6 | Reference compound |
| HY-130468 | Leptosin J | 160550-15-2 | Reference compound |
| HY-130471 | Sannamycin C | 73522-71-1 | Reference compound |
| HY-130671A | L-DPPG | 1190099-61-6 | Reference compound |
| HY-130671B | (S,S)-DPPG | Reference compound | |
| HY-13101B | (S)-MCOPPB | 1108147-70-1 | Reference compound |
| HY-131829 | N6-(2-Aminoethyl)-NAD+ | 59587-50-7 | Reference compound |
| HY-132031 | Mal-Val-Ala-PAB(C2-glucuronic acid)-DMEA-PNU-159682 | 2682939-53-1 | Reference compound |
| HY-132257 | Rovalpituzumab tesirine | 1613313-09-9 | Reference compound |
| HY-13243S1 | Alvimopan-d7 | 1261396-48-8 | Isotope-Labeled Compounds |
| HY-133060 | Sannamycin B | 72503-80-1 | Reference compound |
| HY-133540G | Maleimide-DOTA (GMP) | 1006711-90-5 | GMP Small Molecules |
| HY-133684R | N-Tetradecanoyl-L-homoserine lactone (Standard) | 202284-87-5 | Reference Standards |
| HY-133685R | N-Hexanoyl-L-homoserine lactone (Standard) | 147852-83-3 | Reference Standards |
| HY-13458S2 | Droxidopa-13C6 | 1261397-37-8 | Isotope-Labeled Compounds |
| HY-134913 | Rhodblock 1a | 701226-08-6 | Reference compound |
| HY-134940S | Quabodepistat-d7 | Isotope-Labeled Compounds | |
| HY-13502AS1 | Mitoxantrone-d8 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-135137 | Leptosin I | 160472-96-8 | Reference compound |
| HY-13553S1 | Anidulafungin-13C6 | Isotope-Labeled Compounds | |
| HY-135563 | Oxoprolintane | 35259-27-9 | Reference compound |
| HY-135643 | Sanglifehrin A | 187148-13-6 | Reference compound |
| HY-135649 | Tremorine | 51-73-0 | Reference compound |
| HY-13578S | Brivudine-13C, 15N2 | Isotope-Labeled Compounds | |
| HY-13599S | Cladribine-d4 | Isotope-Labeled Compounds | |
| HY-13599S1 | Cladribine-13C5,15N2 | Isotope-Labeled Compounds | |
| HY-13599S2 | Cladribine-15N | 1360874-38-9 | Isotope-Labeled Compounds |
| HY-136081A | Hexamidine (diisethionate) | 659-40-5 | Reference compound |
| HY-13632S6 | Exemestane-d4 | Isotope-Labeled Compounds | |
| HY-136705 | MeO-Suc-Ala-Ala-Pro-Ala-CMK | 111682-13-4 | Reference compound |
| HY-13673S | Goserelin-d10 | Isotope-Labeled Compounds | |
| HY-13673S1 | Goserelin-d7 | Isotope-Labeled Compounds | |
| HY-136840 | (±)-Apomorphine | 61503-74-0 | Reference compound |
| HY-13749S3 | Sitagliptin-d6 | 1133211-99-0 | Isotope-Labeled Compounds |
| HY-137522AS1 | Zidovudine Glucuronide-13C6 | Isotope-Labeled Compounds | |
| HY-137557 | Florzolotau | 1565797-16-1 | Reference compound |
| HY-13756S2 | Tacrolimus-d3 | Isotope-Labeled Compounds | |
| HY-137592A | Nicotinamide 1,N6-ethenoadenine dinucleotide (sodium) | Reference compound | |
| HY-137604A | (γ-AmNS)UTP (trisodium) | Reference compound | |
| HY-138037 | Aminopeptidase N inhibitor 1 | 596108-59-7 | Reference compound |
| HY-138687S1 | Nirmatrelvir-d6 | 2861202-75-5 | Isotope-Labeled Compounds |
| HY-138796 | Griseolutein A | 573-84-2 | Reference compound |
| HY-138797 | Griseolutein B | 2072-68-6 | Reference compound |
| HY-138993A | NNMT-IN-6 (hydrochloride) | 3031756-18-7 | Reference compound |
| HY-139201C | Poly-D-lysine hydrobromide (MW 1000-5000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-139201D | Poly-D-lysine hydrobromide (MW 4000-15000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-139201E | Poly-D-lysine hydrobromide (MW 150000-300000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-139201H | Poly-D-lysine hydrobromide (MW ≥300000) | 27964-99-4 | Biochemical Assay Reagents |
| HY-141411B | (R)-Zevaquenabant | Reference compound | |
| HY-14171S2 | Bexarotene-13C6 | Isotope-Labeled Compounds | |
| HY-14198S | Selegiline-d5 | 1217976-51-6 | Isotope-Labeled Compounds |
| HY-14199S | Selegiline-d5 (hydrochloride) | 1217705-21-9 | Isotope-Labeled Compounds |
| HY-142058 | Feudomycin B | 79438-97-4 | Reference compound |
| HY-14268S2 | Febuxostat-d3 | Isotope-Labeled Compounds | |
| HY-14268S3 | Febuxostat-d5 | Isotope-Labeled Compounds | |
| HY-142690A | HDAC-IN-27 (dihydrochloride) | 3069831-25-7 | Reference compound |
| HY-14275S | Verapamil-d3 | 152561-91-6 | Isotope-Labeled Compounds |
| HY-14275S2 | Verapamil-d6 | Isotope-Labeled Compounds | |
| HY-14283S | Luliconazole-13C7 | Isotope-Labeled Compounds | |
| HY-14283S1 | Luliconazole-d3 | Isotope-Labeled Compounds | |
| HY-14291S5 | Vildagliptin-d6 | Isotope-Labeled Compounds | |
| HY-14300S2 | Vilanterol-d12 | Isotope-Labeled Compounds | |
| HY-143209B | DSPE-PEG3400 | 145035-96-7 | Biochemical Assay Reagents |
| HY-143613A | THR-β agonist 2 (diacetate) | Reference compound | |
| HY-14397S3 | Indomethacin-13C6 | Isotope-Labeled Compounds | |
| HY-144000A | DSPE-PEG2000-PDP | 474922-24-2 | Biochemical Assay Reagents |
| HY-14520S1 | Tetrahydrofolic acid-13C5 | Isotope-Labeled Compounds | |
| HY-14520S2 | Tetrahydrofolic acid-13C6 | 212248-88-9 | Isotope-Labeled Compounds |
| HY-145603S | Vanzacaftor-d4 | Isotope-Labeled Compounds | |
| HY-14566S3 | Donepezil-d4 | 1219908-72-1 | Isotope-Labeled Compounds |
| HY-145799A | 5A2-SC8 (TFA) | Reference compound | |
| HY-14656S2 | Diltiazem-d6 (hydrochloride) | 1309283-34-8 | Isotope-Labeled Compounds |
| HY-14667S1 | Lomitapide-d4 | 857296-42-5 | Isotope-Labeled Compounds |
| HY-14740S2 | Elvitegravir-13C6 | Isotope-Labeled Compounds | |
| HY-14768S | Favipiravir-13C15N | Isotope-Labeled Compounds | |
| HY-14771S | Imeglimin-d3 | Isotope-Labeled Compounds | |
| HY-14773S1 | Mirabegron-d8 | Isotope-Labeled Compounds | |
| HY-14773S3 | Mirabegron-d5 | 1258889-45-0 | Isotope-Labeled Compounds |
| HY-14779S3 | Riociguat-d3 | 1304478-72-5 | Isotope-Labeled Compounds |
| HY-14781S3 | Levomefolic acid-d3 | Isotope-Labeled Compounds | |
| HY-14806S2 | Teneligliptin-d5 | Isotope-Labeled Compounds | |
| HY-14818S1 | Laninamivir-13C,15N2 | Isotope-Labeled Compounds | |
| HY-148301 | 6α-Hydroxyestradiol | 1229-24-9 | Reference compound |
| HY-14832S1 | Ataluren-13C6 | Isotope-Labeled Compounds | |
| HY-14854S | Tecarfarin-13C,d3 | Isotope-Labeled Compounds | |
| HY-148664 | eIF4E-IN-4 | 1373822-39-9 | Reference compound |
| HY-14877S1 | Anagliptin-d7 | Isotope-Labeled Compounds | |
| HY-148874A | FXR antagonist 2 (hydrochloride) | Reference compound | |
| HY-14946S | Amifampridine-d3 | 2732980-95-7 | Isotope-Labeled Compounds |
| HY-150124A | K34c (hydrochloride) | 2986315-25-5 | Reference compound |
| HY-15025S3 | Sildenafil-d5 | 951385-70-9 | Isotope-Labeled Compounds |
| HY-151232 | Rilzabrutinib | 1575591-66-0 | Reference compound |
| HY-15149S2 | Romidepsin-d7 | Isotope-Labeled Compounds | |
| HY-15202S3 | Binimetinib-d4 | 2890696-60-1 | Isotope-Labeled Compounds |
| HY-15204S | Tonabersat-d6 | 1329837-33-3 | Isotope-Labeled Compounds |
| HY-15206S2 | Glibenclamide-13C6 | Isotope-Labeled Compounds | |
| HY-15258S1 | Lesinurad-d4 | 1850305-60-0 | Isotope-Labeled Compounds |
| HY-152909 | Nystatin A2 | 65086-32-0 | Natural Products |
| HY-152925 | FA-15 | 4932-15-4 | Reference compound |
| HY-15307S | Belumosudil-d7 | Isotope-Labeled Compounds | |
| HY-15388S2 | Tazarotene-13C6 | Isotope-Labeled Compounds | |
| HY-15388S3 | Tazarotene-d6 | 1246815-76-8 | Isotope-Labeled Compounds |
| HY-15409S1 | Empagliflozin-13C6 | Isotope-Labeled Compounds | |
| HY-15409S2 | Empagliflozin-d6 | Isotope-Labeled Compounds | |
| HY-15440AS | Fostemsavir-d8 | Isotope-Labeled Compounds | |
| HY-15448S1 | Tezacaftor-d6 | 1961280-94-3 | Isotope-Labeled Compounds |
| HY-15463S3 | Imatinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-154812 | Gintemetostat | 2604513-16-6 | Reference compound |
| HY-154825 | 20-Hydroxyvitamin D3 | 651734-12-2 | Natural Products |
| HY-155215 | Tenilapine | 82650-83-7 | Reference compound |
| HY-15531S1 | Venetoclax-d6 | Isotope-Labeled Compounds | |
| HY-15536B | Cebranopadol (hemicitrate) | 863513-92-2 | Reference compound |
| HY-15602S1 | Ledipasvir-d16 | Isotope-Labeled Compounds | |
| HY-156671A | RMC-4998 (formic) | Reference compound | |
| HY-156693A | MTvkPABC-P5 (TFA) | ADC Related | |
| HY-156751A | GDC-2992 | 2753651-10-2 | Reference compound |
| HY-156872 | MTX-216 | 1952236-19-9 | Reference compound |
| HY-15790S | Elobixibat-d5 | Isotope-Labeled Compounds | |
| HY-15851S1 | Revefenacin-d9 | Isotope-Labeled Compounds | |
| HY-15851S2 | Revefenacin-d3 | Isotope-Labeled Compounds | |
| HY-15851S3 | Revefenacin-d4 | Isotope-Labeled Compounds | |
| HY-159928 | Neuroprotective agent 8 | Reference compound | |
| HY-159929 | Antibiotic adjuvant 2 | Reference compound | |
| HY-159930 | Antibiotic adjuvant 3 | 2972593-21-6 | Reference compound |
| HY-159931 | HW161023 | 2920698-73-1 | Reference compound |
| HY-159932 | SARS-CoV-2 Mpro-IN-30 | Reference compound | |
| HY-159933 | SARS-CoV-2-IN-105 | Reference compound | |
| HY-159934 | QI-18 | Reference compound | |
| HY-159935 | Top1-IN-2 | Reference compound | |
| HY-159936 | CS4 | Reference compound | |
| HY-159937 | PKMYT1-IN-7 | 2986404-30-0 | Reference compound |
| HY-159938 | p38α inhibitor 6 | Reference compound | |
| HY-159940 | Ferroptosis/apoptosis inducer-2 | 2869886-85-9 | Reference compound |
| HY-160065F | FAM-sgc8c aptamer (sodium) | Dye Reagents | |
| HY-160719 | NHS-activated 2-octynoic acid-BSA | Reference compound | |
| HY-16106S1 | Talazoparib-d4 | Isotope-Labeled Compounds | |
| HY-161794A | SP3N (hydrochloride) | Reference compound | |
| HY-16197 | Epicochlioquinone A | 147384-57-4 | Reference compound |
| HY-163480 | PF-06835375 | 2796997-12-9 | Inhibitory Antibodies |
| HY-164995 | L1BC8 | 2417370-68-2 | Reference compound |
| HY-16504S | Treprostinil-13C2-d1 (Sodium) | Isotope-Labeled Compounds | |
| HY-165483 | Nothramicin | 205752-47-2 | Natural Products |
| HY-165537 | Siphonaxanthin | 28526-44-5 | Reference compound |
| HY-165603 | Si5-N14 | 3006860-57-4 | Reference compound |
| HY-165604 | C14-490 | 2639634-82-3 | Reference compound |
| HY-165605 | Homogeraniol | 459-88-1 | Reference compound |
| HY-16560R | Camptothecin (Standard) | 7689-03-4 | Reference Standards |
| HY-166341S | S 8849-1-d4 (free base) | 1330822-91-7 | Isotope-Labeled Compounds |
| HY-166363S | Beraprost-d3 | Isotope-Labeled Compounds | |
| HY-166478S | O-Desmethyl carvedilol-d5 | 1794817-24-5 | Isotope-Labeled Compounds |
| HY-166670S | Ketoconazole carbonyl-13C | Isotope-Labeled Compounds | |
| HY-167256 | Gentamicin C1 | 25876-10-2 | Natural Products |
| HY-16752S1 | Relebactam-d9 | Isotope-Labeled Compounds | |
| HY-167628 | Metamizole (hemimagnesium) | 6150-97-6 | Reference compound |
| HY-167631 | Desfluoro nebivolol | 99200-13-2 | Reference compound |
| HY-167635 | Decarbamoylmitomycin C | 26909-37-5 | Reference compound |
| HY-167637 | 4-Hydroxyclonidine | 57101-48-1 | Reference compound |
| HY-167639 | (S)-Ramosetron | 132036-90-9 | Reference compound |
| HY-167643 | Hydroxy tipelukast | 1027597-04-1 | Reference compound |
| HY-16774S2 | Vericiguat-d6 | Isotope-Labeled Compounds | |
| HY-168955 | Antibacterial agent 269 | Reference compound | |
| HY-168958 | Ferroptosis-IN-18 | 2247525-20-6 | Reference compound |
| HY-168992 | UNC6535 | Reference compound | |
| HY-169501 | WIN 62577 | 138091-43-7 | Reference compound |
| HY-169566 | EGFR-IN-146 | 166039-38-9 | Reference compound |
| HY-169596 | Arphamenine A | 96551-81-4 | Reference compound |
| HY-169626 | VEGFR-IN-6 | 683235-34-9 | Reference compound |
| HY-169724 | RBx-0597 | 929105-33-9 | Reference compound |
| HY-16973S4 | Fluralaner-d3 | Isotope-Labeled Compounds | |
| HY-16973S5 | Fluralaner-d2 | Isotope-Labeled Compounds | |
| HY-17007S2 | Saquinavir-13C6 | Isotope-Labeled Compounds | |
| HY-17016S3 | Oseltamivir-13C,d3 (phosphate) | 2734920-81-9 | Isotope-Labeled Compounds |
| HY-170218 | NLRP3-IN-76 | Reference compound | |
| HY-170219 | RMM23 | Reference compound | |
| HY-170224 | dNTP Mixture,10 mM Solution,PCR Grade | Biochemical Assay Reagents | |
| HY-170226 | BET-IN-28 | Reference compound | |
| HY-170227 | Autotaxin-IN-7 | Reference compound | |
| HY-170228 | c-Kit-IN-9 | Reference compound | |
| HY-170232 | RIPK1-IN-29 | Reference compound | |
| HY-170233 | NLRP3-IN-75 | Reference compound | |
| HY-170236 | nNOS-IN-5 | 2945955-27-9 | Reference compound |
| HY-170237 | SIK2/3-IN-1 | 3038863-24-7 | Reference compound |
| HY-17025S1 | Rifabutin-d6 | Isotope-Labeled Compounds | |
| HY-17042B | (S)-Cetirizine (dihydrochloride) | 163837-48-7 | Reference compound |
| HY-17043S3 | Loratadine-13C6 | Isotope-Labeled Compounds | |
| HY-170565 | CHD-1 | 3041166-70-2 | Reference compound |
| HY-171331 | AB-3PRGD2 | 2416165-76-7 | Reference compound |
| HY-171334A | P1D-34 | Reference compound | |
| HY-171417 | 6-Alkyne-F-araNAD | 1119281-04-7 | Reference compound |
| HY-171442 | PIN1 ligand-2 | 2957895-02-0 | Reference compound |
| HY-171442A | (R)-PIN1 ligand-2 | Reference compound | |
| HY-171443 | Lyso-Monosialoganglioside GM3 | 94458-63-6 | Reference compound |
| HY-171446 | TAK-075 | 667931-33-1 | Reference compound |
| HY-171447 | LPT99 | 1263477-83-3 | Reference compound |
| HY-171448 | SU-740 | 134336-72-4 | Reference compound |
| HY-171449 | SCH 211803 | 331765-50-5 | Reference compound |
| HY-171450 | VMD-928 | 1802770-18-8 | Reference compound |
| HY-171451 | RMGPa-IN-1 | 958237-73-5 | Reference compound |
| HY-171454 | DA-1241 | 1914136-10-9 | Reference compound |
| HY-171456 | PD-224378 | 466678-44-4 | Reference compound |
| HY-171457 | WR-27653 | 6042-36-0 | Reference compound |
| HY-171458 | U-104067 | 172035-69-7 | Reference compound |
| HY-171459 | LEQ803 | 1211441-59-6 | Reference compound |
| HY-171460 | Win 45164 | 83880-39-1 | Reference compound |
| HY-171461 | CGS 24592 | 147923-04-4 | Reference compound |
| HY-171462 | SMW139 | 2133010-38-3 | Reference compound |
| HY-171463 | AC-271337 | 1246494-36-9 | Reference compound |
| HY-171464 | Lp(a)-IN-5 | 2924841-79-0 | Reference compound |
| HY-171465 | Lp(a)-IN-6 | 2566425-77-0 | Reference compound |
| HY-171467 | MRS7799 | 224040-19-1 | Reference compound |
| HY-171469 | SKP-451 | 181137-41-7 | Reference compound |
| HY-171470 | RS-57067 | 179382-91-3 | Reference compound |
| HY-171471 | SKF 10810 | 22196-65-2 | Reference compound |
| HY-171472 | A-86929 | 171961-95-8 | Reference compound |
| HY-171476 | CP-865569 | 478833-25-9 | Reference compound |
| HY-171477 | Metahexestrol | 71953-72-5 | Reference compound |
| HY-171478 | SQ 11,447 | 33406-68-7 | Reference compound |
| HY-171481 | Thio-acridone | 6540-78-9 | Reference compound |
| HY-171489 | Mal-VC-PAB-EDA-N-Ac-Calicheamicin | 2028299-61-6 | ADC Related |
| HY-171493 | mCherry mRNA(N1-Me-Pseudo UTP) | Oligonucleotides | |
| HY-171507 | Mal-Val-Ala-amide-(3)PEA-PNU-159682 | 2682939-56-4 | ADC Related |
| HY-171508 | Mal-PNU-159682 | 1204819-90-8 | Reference compound |
| HY-171509 | Mal-N(Me)-C6-N(Me)-PNU-159682 | 2682939-57-5 | ADC Related |
| HY-171540 | AnCDA-IN-1 | 1185081-36-0 | Reference compound |
| HY-171541 | CDA-IN-1 | 354562-11-1 | Reference compound |
| HY-171542 | CDA-IN-2 | 2559404-67-8 | Reference compound |
| HY-171543 | PARP1-IN-37 | 952474-39-4 | Reference compound |
| HY-171544 | AGS-16C3F | ADC Related | |
| HY-171558 | PI3K-IN-56 | 2633645-58-4 | Reference compound |
| HY-171559 | TCO-PEG5-NHS ester | 2714310-77-5 | Reference compound |
| HY-171561 | DOTAM-Maleimide (triTFA) | Biochemical Assay Reagents | |
| HY-171561G | DOTAM-Maleimide (triTFA) (GMP) | GMP Small Molecules | |
| HY-171562 | Cholesterol-SA-PEG-Azide (MW 2000) | Biochemical Assay Reagents | |
| HY-171580 | Mc-PEG4-Val-Ala-PAB-Exatecan | ADC Related | |
| HY-171647 | RNAP-σ interaction inhibitor-1 | 2408055-45-6 | Reference compound |
| HY-171648 | RNAP-σ interaction inhibitor-2 | 3077454-53-3 | Reference compound |
| HY-172224 | PARP1/CDK12-IN-1 | Reference compound | |
| HY-172250 | 8-Hydroxyerythromycin A | 51433-35-3 | Reference compound |
| HY-172265 | FKBP12 PROTAC FM4 | Reference compound | |
| HY-172271 | DSPE-PEG1000-LyP-1 | Biochemical Assay Reagents | |
| HY-172271A | DSPE-PEG2000-LyP-1 | Biochemical Assay Reagents | |
| HY-172271B | DSPE-PEG3000-LyP-1 | Biochemical Assay Reagents | |
| HY-172272 | DSPE-PEG1000-A7R | Biochemical Assay Reagents | |
| HY-172272A | DSPE-PEG2000-A7R | Biochemical Assay Reagents | |
| HY-172272B | DSPE-PEG5000-A7R | Biochemical Assay Reagents | |
| HY-172273 | DSPE-PEG1000-M2pep | Biochemical Assay Reagents | |
| HY-172273A | DSPE-PEG2000-M2pep | Biochemical Assay Reagents | |
| HY-172273B | DSPE-PEG5000-M2pep | Biochemical Assay Reagents | |
| HY-172274 | DSPE-PEG1000-APRPG | Biochemical Assay Reagents | |
| HY-172274A | DSPE-PEG2000-APRPG | Biochemical Assay Reagents | |
| HY-172274B | DSPE-PEG5000-APRPG | Biochemical Assay Reagents | |
| HY-172275 | DSPE-PEG1000-pPB | Biochemical Assay Reagents | |
| HY-172275A | DSPE-PEG2000-pPB | Biochemical Assay Reagents | |
| HY-172275B | DSPE-PEG5000-pPB | Biochemical Assay Reagents | |
| HY-172276 | DSPE-PEG1000-R8 | Biochemical Assay Reagents | |
| HY-172276A | DSPE-PEG2000-R8 | Biochemical Assay Reagents | |
| HY-172276B | DSPE-PEG5000-R8 | Biochemical Assay Reagents | |
| HY-172277 | DSPE-PEG1000-R9 | Biochemical Assay Reagents | |
| HY-172277A | DSPE-PEG2000-R9 | Biochemical Assay Reagents | |
| HY-172277B | DSPE-PEG5000-R9 | Biochemical Assay Reagents | |
| HY-172278 | DSPE-PEG1000-CGKRK | Biochemical Assay Reagents | |
| HY-172278A | DSPE-PEG2000-CGKRK | Biochemical Assay Reagents | |
| HY-172278B | DSPE-PEG5000-CGKRK | Biochemical Assay Reagents | |
| HY-172279 | DSPE-PEG1000-TAT | Biochemical Assay Reagents | |
| HY-172279A | DSPE-PEG2000-TAT | Biochemical Assay Reagents | |
| HY-172279B | DSPE-PEG3000-TAT | Biochemical Assay Reagents | |
| HY-172280 | DSPE-PEG1000-octreotide | Biochemical Assay Reagents | |
| HY-172280A | DSPE-PEG2000-octreotide | Biochemical Assay Reagents | |
| HY-172280B | DSPE-PEG5000-octreotide | Biochemical Assay Reagents | |
| HY-172281 | DSPE-PEG1000-CCK8 | Biochemical Assay Reagents | |
| HY-172281A | DSPE-PEG2000-CCK8 | Biochemical Assay Reagents | |
| HY-172281B | DSPE-PEG5000-CCK8 | Biochemical Assay Reagents | |
| HY-172299 | Delmadinone acetate | 13698-49-2 | Reference compound |
| HY-172348 | BRD-9327 | Reference compound | |
| HY-172349 | JNJ-2901 | 2059985-55-4 | Reference compound |
| HY-172350 | WEHI-P8 | Reference compound | |
| HY-172364 | PLK1-IN-12 | Reference compound | |
| HY-172401 | CDC20-IN-2 | Reference compound | |
| HY-172447 | 1,5-Dideoxy-1,5-imino-D-mannitol | 146747-37-7 | Reference compound |
| HY-172448 | YY2201 | Reference compound | |
| HY-172449 | GLI1-IN-3 | Reference compound | |
| HY-172452 | RSV L-protein-6 | Reference compound | |
| HY-172463 | DSPE-PEG1000-cRGD | Biochemical Assay Reagents | |
| HY-172464 | DSPE-PEG2000-cRGD | Biochemical Assay Reagents | |
| HY-172465 | DSPE-PEG5000-cRGD | Biochemical Assay Reagents | |
| HY-172466 | DSPE-PEG1000-CTT2 | Biochemical Assay Reagents | |
| HY-172467 | DSPE-PEG2000-CTT2 | Biochemical Assay Reagents | |
| HY-172468 | DSPE-PEG5000-CTT2 | Biochemical Assay Reagents | |
| HY-172469 | DSPE-PEG1000-GE11 | Biochemical Assay Reagents | |
| HY-172470 | DSPE-PEG2000-GE11 | Biochemical Assay Reagents | |
| HY-172471 | DSPE-PEG5000-GE11 | Biochemical Assay Reagents | |
| HY-172472 | DSPE-PEG1000-NGR | Biochemical Assay Reagents | |
| HY-172473 | DSPE-PEG2000-NGR | Biochemical Assay Reagents | |
| HY-172474 | DSPE-PEG5000-NGR | Biochemical Assay Reagents | |
| HY-172475 | DSPE-PEG1000-YIGSR | Biochemical Assay Reagents | |
| HY-172476 | DSPE-PEG2000-YIGSR | Biochemical Assay Reagents | |
| HY-172477 | DSPE-PEG5000-YIGSR | Biochemical Assay Reagents | |
| HY-172478 | DSPE-PEG1000-F3 | Biochemical Assay Reagents | |
| HY-172479 | DSPE-PEG2000-F3 | Biochemical Assay Reagents | |
| HY-172480 | DSPE-PEG5000-F3 | Biochemical Assay Reagents | |
| HY-172481 | DSPE-PEG1000-TAASGVRSMH | Biochemical Assay Reagents | |
| HY-172482 | DSPE-PEG2000-TAASGVRSMH | Biochemical Assay Reagents | |
| HY-172483 | DSPE-PEG3000-TAASGVRSMH | Biochemical Assay Reagents | |
| HY-172484 | DSPE-PEG1000-LTLRWVGLMS | Biochemical Assay Reagents | |
| HY-172485 | DSPE-PEG2000-LTLRWVGLMS | Biochemical Assay Reagents | |
| HY-172486 | DSPE-PEG5000-LTLRWVGLMS | Biochemical Assay Reagents | |
| HY-172487 | DSPE-PEG1000-K237 | Biochemical Assay Reagents | |
| HY-172488 | DSPE-PEG2000-K237 | Biochemical Assay Reagents | |
| HY-172489 | DSPE-PEG5000-K237 | Biochemical Assay Reagents | |
| HY-172490 | DSPE-PEG1000-ESBP | Biochemical Assay Reagents | |
| HY-172491 | DSPE-PEG2000-ESBP | Biochemical Assay Reagents | |
| HY-172492 | DSPE-PEG5000-ESBP | Biochemical Assay Reagents | |
| HY-172493 | DSPE-PEG1000-iRGD | Biochemical Assay Reagents | |
| HY-172494 | DSPE-PEG2000-iRGD | Biochemical Assay Reagents | |
| HY-172495 | DSPE-PEG3000-iRGD | Biochemical Assay Reagents | |
| HY-172496 | DSPE-PEG1000-CREKA | Biochemical Assay Reagents | |
| HY-172497 | DSPE-PEG2000-CREKA | Biochemical Assay Reagents | |
| HY-172498 | DSPE-PEG5000-CREKA | Biochemical Assay Reagents | |
| HY-172499 | DSPE-PEG1000-SP94 | Biochemical Assay Reagents | |
| HY-172500 | DSPE-PEG2000-SP94 | Biochemical Assay Reagents | |
| HY-172501 | DSPE-PEG5000-SP94 | Biochemical Assay Reagents | |
| HY-172502 | DSPE-PEG1000-KAA | Biochemical Assay Reagents | |
| HY-172503 | DSPE-PEG2000-KAA | Biochemical Assay Reagents | |
| HY-172504 | DSPE-PEG5000-KAA | Biochemical Assay Reagents | |
| HY-172514 | (1R,2S,3R)-Aprepitant | 1185502-97-9 | Reference compound |
| HY-172515 | ent-Oseltamivir | 1035895-88-5 | Reference compound |
| HY-172523 | CDA-IN-3 | 932889-57-1 | Reference compound |
| HY-172542 | TTBK1/2-IN-1 | 2342571-09-7 | Reference compound |
| HY-172543 | TTBK1/2-IN-2 | 2857982-35-3 | Reference compound |
| HY-172544 | TTBK1/2-IN-3 | 2857982-34-2 | Reference compound |
| HY-172545 | AMG28 | 1202764-07-5 | Reference compound |
| HY-172562 | BTR2004 | Reference compound | |
| HY-172564 | BTR2000-Gly-Gly-Gly | Reference compound | |
| HY-172594 | HPK1-IN-57 | Reference compound | |
| HY-172601 | HDAC3-IN-7 | Reference compound | |
| HY-172603 | HIV-1 inhibitor-82 | 43099-56-5 | Reference compound |
| HY-172604 | Neuroprotective agent 10 | Reference compound | |
| HY-172606 | NagZ-IN-1 | Reference compound | |
| HY-172609 | SL-176 | 1809556-48-6 | Reference compound |
| HY-172615 | AMPTX-1 | 3033019-04-1 | Reference compound |
| HY-172619 | BS-153 | 1935692-54-8 | Reference compound |
| HY-172622 | α-Amylase/α-Glucosidase-IN-19 | 223505-23-5 | Reference compound |
| HY-172623 | EGFR/HER2-IN-17 | Reference compound | |
| HY-172680 | DSPE-PEG1000-VIP | Biochemical Assay Reagents | |
| HY-172681 | DSPE-PEG2000-VIP | Biochemical Assay Reagents | |
| HY-172682 | DSPE-PEG5000-VIP | Biochemical Assay Reagents | |
| HY-172683 | DSPE-PEG1000-GRGDS | Biochemical Assay Reagents | |
| HY-172684 | DSPE-PEG2000-GRGDS | Biochemical Assay Reagents | |
| HY-172685 | DSPE-PEG5000-GRGDS | Biochemical Assay Reagents | |
| HY-172686 | DSPE-PEG1000-CSTSMLKAC | Biochemical Assay Reagents | |
| HY-172687 | DSPE-PEG2000-CSTSMLKAC | Biochemical Assay Reagents | |
| HY-172688 | DSPE-PEG5000-CSTSMLKAC | Biochemical Assay Reagents | |
| HY-172689 | DSPE-PEG1000-THRPPMWSPVWP | Biochemical Assay Reagents | |
| HY-172690 | DSPE-PEG2000-THRPPMWSPVWP | Biochemical Assay Reagents | |
| HY-172691 | DSPE-PEG5000-THRPPMWSPVWP | Biochemical Assay Reagents | |
| HY-172692 | DSPE-PEG1000-TH | Biochemical Assay Reagents | |
| HY-172693 | DSPE-PEG2000-TH | Biochemical Assay Reagents | |
| HY-172694 | DSPE-PEG5000-TH | Biochemical Assay Reagents | |
| HY-172695 | DSPE-PEG1000-WYRGRL | Biochemical Assay Reagents | |
| HY-172696 | DSPE-PEG2000-WYRGRL | Biochemical Assay Reagents | |
| HY-172697 | DSPE-PEG5000-WYRGRL | Biochemical Assay Reagents | |
| HY-172698 | DSPE-PEG1000-ANG | Biochemical Assay Reagents | |
| HY-172699 | DSPE-PEG2000-ANG | Biochemical Assay Reagents | |
| HY-172700 | DSPE-PEG5000-ANG | Biochemical Assay Reagents | |
| HY-172701 | DSPE-PEG1000-NYZL1 | Biochemical Assay Reagents | |
| HY-172702 | DSPE-PEG2000-NYZL1 | Biochemical Assay Reagents | |
| HY-172703 | DSPE-PEG5000-NYZL1 | Biochemical Assay Reagents | |
| HY-172704 | DSPE-PEG1000-RVG29 | Biochemical Assay Reagents | |
| HY-172705 | DSPE-PEG2000-RVG29 | Biochemical Assay Reagents | |
| HY-172706 | DSPE-PEG5000-RVG29 | Biochemical Assay Reagents | |
| HY-172707 | DSPE-PEG1000-PP1 | Biochemical Assay Reagents | |
| HY-172708 | DSPE-PEG2000-PP1 | Biochemical Assay Reagents | |
| HY-172709 | DSPE-PEG5000-PP1 | Biochemical Assay Reagents | |
| HY-172710 | DSPE-PEG1000-R6H4 | Biochemical Assay Reagents | |
| HY-172711 | DSPE-PEG2000-R6H4 | Biochemical Assay Reagents | |
| HY-172712 | DSPE-PEG3000-R6H4 | Biochemical Assay Reagents | |
| HY-172713 | DSPE-PEG1000-MPG | Biochemical Assay Reagents | |
| HY-172714 | DSPE-PEG2000-MPG | Biochemical Assay Reagents | |
| HY-172715 | DSPE-PEG5000-MPG | Biochemical Assay Reagents | |
| HY-172722 | DSPE-PEG1000-T7 | Biochemical Assay Reagents | |
| HY-172723 | DSPE-PEG2000-T7 | Biochemical Assay Reagents | |
| HY-172724 | DSPE-PEG5000-T7 | Biochemical Assay Reagents | |
| HY-172725 | DSPE-PEG1000-EB1 | Biochemical Assay Reagents | |
| HY-172726 | DSPE-PEG2000-EB1 | Biochemical Assay Reagents | |
| HY-172727 | DSPE-PEG5000-EB1 | Biochemical Assay Reagents | |
| HY-172731 | 8-Oxo-dATP | 3056945-23-1 | Natural Products |
| HY-172732 | PRMT5-IN-50 | 3002409-47-1 | Reference compound |
| HY-172733 | PRMT5-MTA-IN-3 | 3028674-29-2 | Reference compound |
| HY-172733S | PRMT5-MTA-IN-3-d3 | 3052146-54-7 | Isotope-Labeled Compounds |
| HY-172738 | E3 Ligase Ligand-linker Conjugate 175 | Reference compound | |
| HY-172739 | E3 Ligase Ligand-linker Conjugate 176 | 3005273-99-1 | Reference compound |
| HY-172740 | BCL6 ligand-3 | Reference compound | |
| HY-172757 | α-Glucosidase-IN-88 | Reference compound | |
| HY-172758 | α-Glucosidase-IN-89 | Reference compound | |
| HY-172759 | PKMYT1-IN-9 | 3055031-36-9 | Reference compound |
| HY-172760 | CIM-834 | Reference compound | |
| HY-172761 | AX-53802 | 1008482-71-0 | Reference compound |
| HY-172762 | S234984 | Reference compound | |
| HY-172769 | CM112 | Reference compound | |
| HY-172770 | KMG-1068 | Reference compound | |
| HY-172772 | Anti-PEDV agent 1 | Reference compound | |
| HY-172773 | PAA-38 | Reference compound | |
| HY-172774 | TRPV1 antagonist 10 | 896584-55-7 | Reference compound |
| HY-172775 | Spirovirimat | Reference compound | |
| HY-172777 | SDH-IN-25 | 3052432-15-9 | Reference compound |
| HY-172778 | HNW005 | Reference compound | |
| HY-172779 | AURKA-IN-2 | Reference compound | |
| HY-172782 | BuChE-IN-20 | Reference compound | |
| HY-172783 | Aromatase-IN-5 | Reference compound | |
| HY-172784 | Anticancer agent 273 | Reference compound | |
| HY-172785 | PI3K-IN-57 | Reference compound | |
| HY-172789 | mTOR inhibitor-27 | 457086-01-0 | Reference compound |
| HY-172800 | (S,R,S)-AHPC-Me-8-Sulfamoyloctanoic acid | Reference compound | |
| HY-172803 | Ferroptosis inducer-7 | Reference compound | |
| HY-172804 | SDH-IN-26 | Reference compound | |
| HY-172805 | Glycogen phosphorylase-IN-2 | Reference compound | |
| HY-172806 | PARP14 inhibitor 1 | 3035493-13-8 | Reference compound |
| HY-172808 | BNS808 | 2836313-12-1 | Reference compound |
| HY-172809 | LSD1-IN-42 | Reference compound | |
| HY-172820 | Trastuzumab envedotin | ADC Related | |
| HY-172822 | TLT8 | Reference compound | |
| HY-172825 | KL4-219A | Reference compound | |
| HY-172828 | BRD4 ligand 7 | Reference compound | |
| HY-172835 | Rapavir | Reference compound | |
| HY-172836S | GLP-1 receptor agonist 17-d3 | 3074098-20-4 | Isotope-Labeled Compounds |
| HY-173022 | BDM_92499 | Reference compound | |
| HY-173057 | BMX-IN-3 | 2657662-64-9 | Reference compound |
| HY-173097 | (S,R,S)-AHPC-Boc derivative 1 | 2086298-33-9 | Reference compound |
| HY-173114 | Anti-inflammatory agent 96 | Reference compound | |
| HY-173119 | SKLB-D18 | Reference compound | |
| HY-173120 | HBV-IN-51 | Reference compound | |
| HY-173121 | KR019 | Reference compound | |
| HY-173122 | Akt1-IN-8 | 2247688-87-3 | Reference compound |
| HY-173123 | LSD1-IN-40 | Reference compound | |
| HY-173124 | CDK2/FLT4/PDGFRA-IN-1 | Reference compound | |
| HY-173127 | E3 Ligase Ligand-linker Conjugate 171 | Reference compound | |
| HY-173129 | Anti-inflammatory agent 97 | Reference compound | |
| HY-173134 | SARS-CoV-2 RdRp-IN-1 | Reference compound | |
| HY-173135 | PROTAC KDM4 degrader-1 | Reference compound | |
| HY-173136 | KDM4 ligand-1 | Reference compound | |
| HY-173138 | FCOB02 | 3064236-41-2 | Reference compound |
| HY-173140 | Anticancer agent 268 | Reference compound | |
| HY-173151 | BRCA2-IN-1 | Reference compound | |
| HY-173154 | NK7-902 | Reference compound | |
| HY-173175 | 5'-O-DMT-2'-O-TBDMS-2-Thiouridine 3'-CE phosphoramidite | 163496-21-7 | Reference compound |
| HY-173177 | PSF-IN-2 | 185418-37-5 | Reference compound |
| HY-173178 | LNS8801 | 925419-55-2 | Reference compound |
| HY-173180 | 5-LOX-IN-8 | Reference compound | |
| HY-173181 | Anticonvulsant agent 10 | Reference compound | |
| HY-173182 | Antitumor agent-200 | 3046118-64-0 | Reference compound |
| HY-173183 | α-Glucosidase-IN-87 | Reference compound | |
| HY-173184 | HDAC6-IN-53 | Reference compound | |
| HY-173185 | RIP1-IN-1 | Reference compound | |
| HY-173186 | TLK1-IN-1 | Reference compound | |
| HY-173187 | Keap1-Nrf2-IN-27 | Reference compound | |
| HY-173188 | EGFR-IN-154 | Reference compound | |
| HY-173190 | Antibacterial agent 271 | Reference compound | |
| HY-173192 | Antibacterial agent 272 | Reference compound | |
| HY-173194 | Carbonic anhydrase inhibitor 29 | Reference compound | |
| HY-173197 | PBP4-IN-1 | Reference compound | |
| HY-173198 | Kaiso-IN-1 | Reference compound | |
| HY-173199 | PRRSV-IN-1 | 801220-43-9 | Reference compound |
| HY-173203 | CDK2-IN-43 | Reference compound | |
| HY-173204 | Influenza virus-IN-9 | Reference compound | |
| HY-173205 | Antimycobacterial agent-11 | Reference compound | |
| HY-173206 | Antifungal agent 128 | Reference compound | |
| HY-173207 | Antiplatelet agent 3 | 1623073-71-1 | Reference compound |
| HY-173209 | NLRP3-IN-73 | Reference compound | |
| HY-173210 | TNF-α-IN-22 | 2251689-60-6 | Reference compound |
| HY-173211 | anti-TNBC agent-8 | Reference compound | |
| HY-173212 | PLK1-IN-13 | 3038489-48-1 | Reference compound |
| HY-173213 | Antileishmanial agent-33 | Reference compound | |
| HY-173214 | FLT3-ITD-IN-3 | 3018150-80-3 | Reference compound |
| HY-173216 | Pseudorabies virus-IN-1 | Reference compound | |
| HY-173217 | PPARα agonist 5 | Reference compound | |
| HY-173218 | anti-NSCLC agent-1 | Reference compound | |
| HY-173219 | SrtA-IN-1 | Reference compound | |
| HY-173220 | DHFR-IN-23 | Reference compound | |
| HY-173221 | MJ210 | Reference compound | |
| HY-173222 | P-gp inhibitor 28 | Reference compound | |
| HY-173223 | Tyrosinase-IN-41 | Reference compound | |
| HY-173224 | CDK2/PIM1-IN-1 | Reference compound | |
| HY-173225 | MRSA/VRE-IN-1 | Reference compound | |
| HY-173226 | BACE1-IN-15 | Reference compound | |
| HY-173227 | TrkC-IN-1 | 1877313-32-0 | Reference compound |
| HY-173228 | Anticancer agent 269 | Reference compound | |
| HY-173230 | ABCA1 inducer 2 | 2451589-46-9 | Reference compound |
| HY-173231 | hURAT1 inhibitor 2 | 1402818-99-8 | Reference compound |
| HY-173232 | VEGFR-2-IN-66 | Reference compound | |
| HY-173233 | PLK1-IN-14 | Reference compound | |
| HY-173234 | GI-Y2 | 1008710-58-4 | Reference compound |
| HY-173235 | Galectin-3-IN-6 | 2604662-64-6 | Reference compound |
| HY-173236 | STAT4-IN-1 | Reference compound | |
| HY-173237 | CDK4/6/BRD4-IN-1 | Reference compound | |
| HY-173238 | Antibacterial agent 273 | Reference compound | |
| HY-173239 | Antibacterial agent 274 | Reference compound | |
| HY-173240 | IPMCL-28b | Reference compound | |
| HY-173241 | Poly-L-lysine-Ahx-FITC (MW 15000-30000) | Biochemical Assay Reagents | |
| HY-173241A | Poly-L-lysine-Ahx-FITC (MW 30000-70000) | Biochemical Assay Reagents | |
| HY-173246 | GalNAc-NAG25 phosphoramidite | 2130036-52-9 | Biochemical Assay Reagents |
| HY-173247 | GalNAc-NAG37 phosphoramidite | 2199491-27-3 | Biochemical Assay Reagents |
| HY-173248 | GalNAc-NAG15 phosphoramidite | 2920438-06-6 | Biochemical Assay Reagents |
| HY-173249 | Poly-L-lysine,succinylated (MW >50000) | Biochemical Assay Reagents | |
| HY-173250 | YN14-H | Reference compound | |
| HY-173251S | ENX-101 | Isotope-Labeled Compounds | |
| HY-173253 | E3 Ligase Ligand-linker Conjugate 173 | 2907682-88-4 | Reference compound |
| HY-173254 | MurA-IN-6 | 333740-13-9 | Reference compound |
| HY-173255 | DAO-dBET1 | Reference compound | |
| HY-173256 | Hyp-dBET1 | Reference compound | |
| HY-173257 | Cath-L-dBET1 | Reference compound | |
| HY-173258 | 5-Carboxy-2′-deoxycytidine | 1210427-59-0 | Oligonucleotides |
| HY-173259 | PARP7-IN-23 | 3071875-24-3 | Reference compound |
| HY-173262 | PARP7-IN-24 | 3072866-54-4 | Reference compound |
| HY-173263 | AChE-IN-86 | Reference compound | |
| HY-173264 | SDH-IN-24 | Reference compound | |
| HY-173265 | CypB-IN-1 | Reference compound | |
| HY-173266 | TO-1187 | Reference compound | |
| HY-173267 | hCES2A-IN-2 | Reference compound | |
| HY-173268 | UNC9426 | 3051784-94-9 | Reference compound |
| HY-173269 | 5-HT2A receptor agonist-7 | 3066340-41-5 | Reference compound |
| HY-173270 | Antibacterial synergist 3 | Reference compound | |
| HY-173271 | GHSR-1a agonist-1 | 3060887-25-1 | Reference compound |
| HY-173272 | BT-114143 | 2796343-04-7 | Reference compound |
| HY-173273 | YJZ5118 | 3031861-18-1 | Reference compound |
| HY-173274 | CB039 | 3056259-55-0 | Reference compound |
| HY-173275 | PDGFRα kinase inhibitor 3 | Reference compound | |
| HY-173276 | SARM1-IN-4 | 3069378-18-0 | Reference compound |
| HY-173277 | FtsZ-IN-13 | 914357-88-3 | Reference compound |
| HY-173278 | AIC263282 | Reference compound | |
| HY-173279 | CYP19A1-IN-1 | 889959-22-2 | Reference compound |
| HY-173280 | Brefeldin A 4-O-nicotinate | 3035018-34-6 | Reference compound |
| HY-173281 | MAT2A-IN-24 | 3031093-57-6 | Reference compound |
| HY-173282 | Aβ aggregation-IN-2 | Reference compound | |
| HY-173283 | Antifungal agent 129 | Reference compound | |
| HY-173284 | DDR1-IN-11 | 639089-54-6 | Reference compound |
| HY-173285 | SARS-CoV-2 Mpro-IN-38 | Reference compound | |
| HY-173288 | MAO-B-IN-40 | 2486914-15-0 | Reference compound |
| HY-173290 | PDE4D inhibitor 1 | Reference compound | |
| HY-173291 | Tau ligand-1 | 3063166-64-0 | Reference compound |
| HY-173293 | ASK1-IN-8 | 2570985-89-4 | Reference compound |
| HY-173294 | NLRP3-IN-74 | Reference compound | |
| HY-173296 | MAGL-IN-222 | 877804-65-4 | Reference compound |
| HY-173298 | PDHK1-IN-2 | 2870691-38-4 | Reference compound |
| HY-173301 | PDHK1-IN-3 | Reference compound | |
| HY-173302 | sEH inhibitor-20 | Reference compound | |
| HY-173305 | Mpro/PLPro-IN-2 | Reference compound | |
| HY-173307 | Nrf2 activator 19 | Reference compound | |
| HY-173309 | P53/TLR2 modulator-1 | Reference compound | |
| HY-173310 | CDK2-IN-44 | 3051587-93-7 | Reference compound |
| HY-173311 | Cbl-b-IN-28 | Reference compound | |
| HY-173312 | Antimalarial agent 49 | Reference compound | |
| HY-173313 | Ferroptosis-IN-19 | 3025114-13-7 | Reference compound |
| HY-173314 | EGFR-IN-155 | Reference compound | |
| HY-173315 | pan-BET/BD2-IN-1 | Reference compound | |
| HY-173316 | STING-IN-12 | Reference compound | |
| HY-173317 | STING-IN-13 | Reference compound | |
| HY-173318 | Anti-MRSA agent 25 | Reference compound | |
| HY-173319 | FAP-IN-5 | Reference compound | |
| HY-173320 | HEMTAC WEE1 degrader-1 | 3002417-64-0 | Reference compound |
| HY-173321 | PAD4-IN-5 | 3071873-52-1 | Reference compound |
| HY-173322 | Lp(a)-IN-8 | 3070206-18-4 | Reference compound |
| HY-173323 | Lp(a)-IN-7 | 3070232-49-1 | Reference compound |
| HY-173324 | LPA2 antagonist 5 | 3070072-52-2 | Reference compound |
| HY-173325 | LPA2 antagonist 6 | 3072671-88-3 | Reference compound |
| HY-173326 | STING-IN-14 | 3070953-78-2 | Reference compound |
| HY-173327 | BRD4 degrader-6 | 3055207-38-7 | Reference compound |
| HY-173329 | KRAS inhibitor-41 | 3056974-50-3 | Reference compound |
| HY-173330 | HDAC-IN-89 | Reference compound | |
| HY-173331 | Antitumor agent-201 | Reference compound | |
| HY-173332 | 15-LOX-1 inhibitor 2 | Reference compound | |
| HY-173333 | PROTAC SMARCA2/4 degrader-38 | Reference compound | |
| HY-173334 | hMAO-B-IN-11 | Reference compound | |
| HY-173335 | PLA2-IN-1 | Reference compound | |
| HY-173336 | MAO-B-IN-42 | 2568016-10-2 | Reference compound |
| HY-173337 | HSP90α-IN-1 | 184897-90-3 | Reference compound |
| HY-173338 | MSRV-IN-1 | 1438403-50-9 | Reference compound |
| HY-173339 | VIP36 | Reference compound | |
| HY-173340 | LRH-1 agonist-1 | Reference compound | |
| HY-173341 | SOF-436 | 2224491-20-5 | Reference compound |
| HY-173342 | Neocryptolepine-Cl | 1150313-15-7 | Reference compound |
| HY-173344 | DB-10 | Reference compound | |
| HY-173345 | BRCA2-RAD51-IN-2 | Reference compound | |
| HY-173347 | BLINK11 | Reference compound | |
| HY-173348 | BLINK15 | Reference compound | |
| HY-173349 | TDI-012804 | Reference compound | |
| HY-173350 | Ran-IN-1 | 2301869-11-2 | Reference compound |
| HY-173351 | G-6599 | 2901806-51-5 | Reference compound |
| HY-173352 | USP7 activator 1 | 868940-26-5 | Reference compound |
| HY-173355 | RCB18350 | 3052630-27-7 | Reference compound |
| HY-173356 | Antiparasitic agent-26 | Reference compound | |
| HY-173357 | TYD-68 | Reference compound | |
| HY-173358 | E3 Ligase Ligand-linker Conjugate 174 | 2703765-01-7 | Reference compound |
| HY-173360 | PDE10A-IN-5 | Reference compound | |
| HY-173361 | Anticancer agent 270 | Reference compound | |
| HY-173362 | SARS-CoV-2 Mpro-IN-39 | Reference compound | |
| HY-173363 | CHEMBL4444839 | 2316841-82-2 | Reference compound |
| HY-173364 | EB-TCIP | Reference compound | |
| HY-173365 | VEGFR-2-IN-67 | Reference compound | |
| HY-173366 | dGEM3 | Reference compound | |
| HY-173367 | Anticancer agent 271 | Reference compound | |
| HY-173368 | Antiproliferative agent-67 | Reference compound | |
| HY-173369 | PROTAC MAGL degrader-1 | Reference compound | |
| HY-173371 | BRI-50460 | Reference compound | |
| HY-173372 | PROTAC AR Degrader-10 | Reference compound | |
| HY-173373 | AR ligand-39 | 2156591-18-1 | Reference compound |
| HY-173374 | DOTAGA-FAP-2286-ALB | Reference compound | |
| HY-173375 | Mycobacterium Tuberculosis-IN-8 | Reference compound | |
| HY-173376 | C12 DG PEG (MW 2000) | Biochemical Assay Reagents | |
| HY-173379 | C10 DG PEG 2000 | Biochemical Assay Reagents | |
| HY-173380 | C8 DG PEG 2000 | Biochemical Assay Reagents | |
| HY-173381 | Cholesteryl-PEG2000-Biotin | Biochemical Assay Reagents | |
| HY-173381A | Cholesteryl-PEG1000-Biotin | Biochemical Assay Reagents | |
| HY-173383 | DOPE-DOTA sodium | Biochemical Assay Reagents | |
| HY-173384 | DSPE-DOTA sodium | Biochemical Assay Reagents | |
| HY-173385 | Cholesteryl-PEG1000-Azide | Biochemical Assay Reagents | |
| HY-173387 | 4F-Docetaxel | 912272-09-4 | Natural Products |
| HY-173388 | Nitric oxide production-IN-2 | 1019984-44-1 | Reference compound |
| HY-173390 | BCN-E-BCN | 2059099-03-3 | Reference compound |
| HY-173463 | Sirtuin modulator 8 | 925437-38-3 | Reference compound |
| HY-173552 | TCIP3 | 3067681-36-8 | Reference compound |
| HY-17359S1 | Deferasirox-13C6 | 1261392-79-3 | Isotope-Labeled Compounds |
| HY-173625 | P5(PEG12)-VC-PAB-Exatecan | 2928571-52-0 | ADC Related |
| HY-173626 | EN1441 | 2196448-47-0 | Reference compound |
| HY-173629 | RMC-5127 | Reference compound | |
| HY-173630 | BMS-986449 | Reference compound | |
| HY-173631 | (S)-dHTC1 | 3081383-46-9 | Reference compound |
| HY-173632 | AMG410 | 3040175-17-2 | Reference compound |
| HY-173633 | BrAc-Val-Ala | ADC Related | |
| HY-173634 | Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB-Exatecan | 3059991-66-8 | ADC Related |
| HY-173635 | Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB | ADC Related | |
| HY-173637 | AZD0022 | 2958627-18-2 | Reference compound |
| HY-173639 | AZD0516 | Reference compound | |
| HY-173640 | ID11916 | 2785317-21-5 | Reference compound |
| HY-173641 | MNN-02-155 | 3067681-22-2 | Reference compound |
| HY-173642 | NCGC00238624 | 2768230-55-1 | Reference compound |
| HY-17367S5 | Atazanavir-d24 | 1092540-58-3 | Isotope-Labeled Compounds |
| HY-17373S2 | Posaconazole-d3 | Isotope-Labeled Compounds | |
| HY-17373S3 | Posaconazole-d7 | Isotope-Labeled Compounds | |
| HY-17395AS1 | Terbinafine-d3 | 1133210-36-2 | Isotope-Labeled Compounds |
| HY-17404S1 | Cilnidipine-d4 | Isotope-Labeled Compounds | |
| HY-17410S2 | Iloperidone-13C,d3 | Isotope-Labeled Compounds | |
| HY-17426S1 | Famciclovir-d6 | 2587293-47-6 | Isotope-Labeled Compounds |
| HY-17427S4 | Emtricitabine-d2 | Isotope-Labeled Compounds | |
| HY-17430S2 | Amprenavir-13C6 | Isotope-Labeled Compounds | |
| HY-17452AS | Cefditoren Pivoxil-d3 | Isotope-Labeled Compounds | |
| HY-17464S2 | Cilostazol-d2 | 1073608-03-3 | Isotope-Labeled Compounds |
| HY-17464S3 | Cilostazol-d6 | 1246641-05-3 | Isotope-Labeled Compounds |
| HY-17469S | Gimeracil-13C3,15N | 1261394-32-4 | Isotope-Labeled Compounds |
| HY-17474S1 | Parecoxib-d5 | Isotope-Labeled Compounds | |
| HY-17498S1 | Atenolol-d6 | 81346-72-7 | Isotope-Labeled Compounds |
| HY-17498S3 | Atenolol-13C6 | Isotope-Labeled Compounds | |
| HY-17504AS1 | Rosuvastatin-d6 | 2070009-40-2 | Isotope-Labeled Compounds |
| HY-17507S2 | Pantoprazole-d8 | 934294-34-5 | Isotope-Labeled Compounds |
| HY-17507S4 | Pantoprazole-d4 | 934294-71-0 | Isotope-Labeled Compounds |
| HY-176000 | Sulphostin | Reference compound | |
| HY-176001 | DPP8/9-IN-1 | Reference compound | |
| HY-176007 | Fluprostenol methyl amide | Reference compound | |
| HY-176008 | Lauric acid leelamide | 2095306-47-9 | Reference compound |
| HY-176009 | 15-keto Cloprostenol isopropyl ester | Reference compound | |
| HY-176010 | Dehydroepiandrosterone sulfate 17-(O-carboxymethyl)oxime (sodium) | Reference compound | |
| HY-176014 | 17-Phenyl trinor prostaglandin F2α glycinamide | Reference compound | |
| HY-176017 | 2,3-Dinor fluprostenol | Reference compound | |
| HY-176019 | Methylcarbamyl PAF C-8 | Reference compound | |
| HY-176020 | Cumyl-chsinaca | Reference compound | |
| HY-176024 | 2'-Deoxy-3'-O-isovaleryladenosine-5'-O-triphosphate (triethylammonium) | Reference compound | |
| HY-176036 | MS1262 | 3070323-06-4 | Reference compound |
| HY-176039 | TUG-2181 | 2653994-24-0 | Reference compound |
| HY-176040 | IXA62 | 956783-34-9 | Reference compound |
| HY-176041 | Troponin modulator 1 | 1448792-38-8 | Reference compound |
| HY-176043 | PCSK9 autophagic degrader 2 | 2974497-11-3 | Reference compound |
| HY-176044 | PCSK9 ligand 2 | 3039841-82-9 | Reference compound |
| HY-176045 | LC3B ligand 2 | Reference compound | |
| HY-176046 | E3 Ligase Ligand-linker Conjugate 183 | 3081572-35-9 | Reference compound |
| HY-176057 | S118 | 2677041-36-8 | Reference compound |
| HY-176058 | HDAC6-IN-57 | Reference compound | |
| HY-176059 | HBV-IN-52 | Reference compound | |
| HY-17605S4 | Bictegravir-d7 | 2171092-56-9 | Isotope-Labeled Compounds |
| HY-176060 | Platelet aggregation-IN-3 | 1029802-21-8 | Reference compound |
| HY-176062 | PPARγ modulator-3 | Reference compound | |
| HY-176067 | LO-4-25 | Reference compound | |
| HY-176068 | 3-Cl-Pyridine-amide-acrylaldehyde-piperazine | Reference compound | |
| HY-176070 | HRG038 | Reference compound | |
| HY-17609S | Difelikefalin-d5 | Isotope-Labeled Compounds | |
| HY-17637S2 | Lumateperone-d4 | 2102683-55-4 | Isotope-Labeled Compounds |
| HY-18206S1 | (S)-Lisinopril-d5 (sodium) | 1356847-28-3 | Isotope-Labeled Compounds |
| HY-18206S2 | Lisinopril-13C5,15N | Isotope-Labeled Compounds | |
| HY-18252S3 | Avanafil-13C5 | Isotope-Labeled Compounds | |
| HY-18342S1 | Diflunisal-13C6 | Isotope-Labeled Compounds | |
| HY-18681S | Voxelotor-d6 | 2170187-39-8 | Isotope-Labeled Compounds |
| HY-18767S2 | Ivosidenib-13C5 | Isotope-Labeled Compounds | |
| HY-18767S3 | Ivosidenib-d5 | 2329582-02-5 | Isotope-Labeled Compounds |
| HY-19436S | Solabegron-d8 | 1250988-09-0 | Isotope-Labeled Compounds |
| HY-202399 | TCO-PEG2-NHS ester | 2250217-33-3 | Reference compound |
| HY-21999 | tert-Butyl 6-aminocaproate | 5514-98-7 | Reference compound |
| HY-22445 | MY05 | 667909-97-9 | Reference compound |
| HY-27861S | 3,4-Dihydro-7-methoxy-6-isoquinolinol-d3 | Isotope-Labeled Compounds | |
| HY-32348S1 | Doxercalciferol-d6 | Isotope-Labeled Compounds | |
| HY-32709S | Telcagepant-d8 | 1132641-75-8 | Isotope-Labeled Compounds |
| HY-32854 | 4-Bromo-3-(trifluoromethyl)aniline | 393-36-2 | Reference compound |
| HY-33040 | 2,2',4'-Trichloroacetophenone | 4252-78-2 | Reference compound |
| HY-34449S | Methylboronic acid-d3 | 1332481-37-4 | Isotope-Labeled Compounds |
| HY-40019S | 1-Boc-4-piperidone-d4 | 1014695-53-4 | Isotope-Labeled Compounds |
| HY-403544 | CbzNH-(C5-O)2-C4-Boc | 2324147-95-5 | Reference compound |
| HY-40354S1 | Tofacitinib-13C3,15N | Isotope-Labeled Compounds | |
| HY-40354S2 | Tofacitinib-13C,d3 | Isotope-Labeled Compounds | |
| HY-40354S3 | Tofacitinib-13C | Isotope-Labeled Compounds | |
| HY-40354S5 | Tofacitinib-d3 | Isotope-Labeled Compounds | |
| HY-47733 | CDK1/2/4-IN-2 | 677701-62-1 | Reference compound |
| HY-48682 | AKT ligand-2 | 2376139-61-4 | Reference compound |
| HY-50878S1 | Crizotinib-d8 | 1523579-82-9 | Isotope-Labeled Compounds |
| HY-50878S2 | Crizotinib-d9 | 1523580-59-7 | Isotope-Labeled Compounds |
| HY-50892 | (Rac)-Roscovitine | 186692-44-4 | Reference compound |
| HY-50896S2 | Erlotinib-d4 | 1130852-41-3 | Isotope-Labeled Compounds |
| HY-50896S3 | Erlotinib-d8 | 1266656-97-6 | Isotope-Labeled Compounds |
| HY-50898S4 | Lapatinib-d7 | 1009307-23-6 | Isotope-Labeled Compounds |
| HY-66011AS5 | Moxifloxacin-d5 | 1092356-43-8 | Isotope-Labeled Compounds |
| HY-70057S4 | Safinamide-d5 | Isotope-Labeled Compounds | |
| HY-76251S3 | Etodolac-d4 | Isotope-Labeled Compounds | |
| HY-76520S | Sitaxsentan-13C6 | Isotope-Labeled Compounds | |
| HY-76847S4 | Chenodeoxycholic acid-d2 | 57770-00-0 | Isotope-Labeled Compounds |
| HY-77910 | 4-(4-Bromophenyl)-4-hydroxypiperidine | 57988-58-6 | Reference compound |
| HY-78096 | O-Deshydroxyethyl bosentan | 174227-14-6 | Reference compound |
| HY-78726S2 | Fosamprenavir-13C6 | Isotope-Labeled Compounds | |
| HY-79128S2 | Fmoc-L-Lys (Boc)-OH-13C | 1242058-72-5 | Isotope-Labeled Compounds |
| HY-90010S | Tolterodine tartrate-d14 | 1191280-48-4 | Isotope-Labeled Compounds |
| HY-A0003S3 | Lenalidomide-d4 | 1130061-52-7 | Isotope-Labeled Compounds |
| HY-A0004S | Decitabine-13C5 | Isotope-Labeled Compounds | |
| HY-A0016S3 | Dronedarone-d6 | 1132693-87-8 | Isotope-Labeled Compounds |
| HY-A0082S | Diphenidol-d10 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-A0118S | Naloxegol-13C,d3 | Isotope-Labeled Compounds | |
| HY-A0118S1 | Naloxegol-13C,d2 | Isotope-Labeled Compounds | |
| HY-A0132S14 | N-Acetyl-D-glucosamine-d3 | 77369-11-0 | Isotope-Labeled Compounds |
| HY-A0163D | trans-Clopenthixol | 53772-84-2 | Reference compound |
| HY-A0294S | Ertapenem-d4 | 1356992-95-4 | Isotope-Labeled Compounds |
| HY-B0071AS | Granisetron-d6 (Hydrochloride) | Isotope-Labeled Compounds | |
| HY-B0071S1 | Granisetron-d4 | 1224925-90-9 | Isotope-Labeled Compounds |
| HY-B0071S2 | Granisetron-d6 | 1224925-80-7 | Isotope-Labeled Compounds |
| HY-B0083S1 | Leflunomide-13C6 | Isotope-Labeled Compounds | |
| HY-B0089S | Acarbose-d4 | 1260619-60-0 | Isotope-Labeled Compounds |
| HY-B0102S | Fluoxetine-d6 | 2319722-07-9 | Isotope-Labeled Compounds |
| HY-B0104S3 | Glimepiride-d4-2 | 1131981-32-2 | Isotope-Labeled Compounds |
| HY-B0113S5 | Omeprazole-d6 | 922731-02-0 | Isotope-Labeled Compounds |
| HY-B0114S3 | Oxcarbazepine-d10 | 2749432-28-6 | Isotope-Labeled Compounds |
| HY-B0122S1 | Topiramate-13C | Isotope-Labeled Compounds | |
| HY-B0124S2 | Zonisamide-13C6 | Isotope-Labeled Compounds | |
| HY-B0130S1 | Perindopril-d5 | Isotope-Labeled Compounds | |
| HY-B0134S1 | Bestatin-d10 | Isotope-Labeled Compounds | |
| HY-B0149S2 | Tranexamic acid-13C6 | Isotope-Labeled Compounds | |
| HY-B0150S3 | Nicotinamide-d3 | 2162970-00-3 | Isotope-Labeled Compounds |
| HY-B0157S1 | Ketotifen-d3 | 126939-17-1 | Isotope-Labeled Compounds |
| HY-B0161S3 | Duloxetine-d5 (oxalate) | 1276197-53-5 | Isotope-Labeled Compounds |
| HY-B0180S2 | Imiquimod-d7 | Isotope-Labeled Compounds | |
| HY-B0185S2 | Lidocaine-d6 | 1215823-29-2 | Isotope-Labeled Compounds |
| HY-B0192S3A | Alfuzosin (hydrochloride)-d6 | 1006717-24-3 | Isotope-Labeled Compounds |
| HY-B0196S3 | Venlafaxine-d10 | 940297-16-5 | Isotope-Labeled Compounds |
| HY-B0211S1 | Riluzole-13C6 | Isotope-Labeled Compounds | |
| HY-B0214S3 | Prednisone-13C2,d2 | Isotope-Labeled Compounds | |
| HY-B0227S3 | Ketoprofen-13C6 | 1261392-46-4 | Isotope-Labeled Compounds |
| HY-B0250S2 | Lamivudine-13C,15N3 | 1261394-64-2 | Isotope-Labeled Compounds |
| HY-B0251S1 | Eplerenone-13C,d3 | Isotope-Labeled Compounds | |
| HY-B0285S | Amiloride-15N3 | 1217169-93-1 | Isotope-Labeled Compounds |
| HY-B0286S1 | Chlorpheniramine-d4 | 1216414-56-0 | Isotope-Labeled Compounds |
| HY-B0286S2 | Chlorpheniramine-d6 | 1185054-60-7 | Isotope-Labeled Compounds |
| HY-B0331S1 | Enalapril-d3 | 1356847-94-3 | Isotope-Labeled Compounds |
| HY-B0334S | Sulbactam-d3 | Isotope-Labeled Compounds | |
| HY-B0356S2 | Ciprofloxacin-d4 | Isotope-Labeled Compounds | |
| HY-B0363S1 | Nimesulide-13C6 | Isotope-Labeled Compounds | |
| HY-B0368C | epi-D-Captopril | 112243-88-6 | Reference compound |
| HY-B0368S1 | Captopril-13C5,15N | Isotope-Labeled Compounds | |
| HY-B0374S2 | Moxonidine-d3 | Isotope-Labeled Compounds | |
| HY-B0377S1 | Famotidine-13C | Isotope-Labeled Compounds | |
| HY-B0391S2 | Naftopidil-d7 | Isotope-Labeled Compounds | |
| HY-B0395D | (1R,2S,7R)-Sitafloxacin | 127254-10-8 | Reference compound |
| HY-B0411S2 | Domperidone-13C6 | Isotope-Labeled Compounds | |
| HY-B0448S2 | Phenytoin-d5 | Isotope-Labeled Compounds | |
| HY-B0456S5 | Riboflavin-d8 | Isotope-Labeled Compounds | |
| HY-B0477AS2 | Quinapril-d4 | Isotope-Labeled Compounds | |
| HY-B0482S1 | Acemetacin-13C6 | Isotope-Labeled Compounds | |
| HY-B0495S7 | Lamotrigine-13C | 2140316-15-8 | Isotope-Labeled Compounds |
| HY-B0495S8 | Lamotrigine-13C7,15N | Isotope-Labeled Compounds | |
| HY-B0497S2 | Niclosamide-d3 | 2665663-60-3 | Isotope-Labeled Compounds |
| HY-B0506S1 | Nadifloxacin-d5 | Isotope-Labeled Compounds | |
| HY-B0511S3 | Biotin-13C5 | Isotope-Labeled Compounds | |
| HY-B0512S1 | Sulfamerazine-13C6 | 1196157-80-8 | Isotope-Labeled Compounds |
| HY-B0554S2 | Norethindrone-d8 | Isotope-Labeled Compounds | |
| HY-B0579S5 | Cyclosporin A-d12 | Isotope-Labeled Compounds | |
| HY-B0580S2 | Ketorolac-13C6 | Isotope-Labeled Compounds | |
| HY-B0584S2 | Travoprost-d7 | Isotope-Labeled Compounds | |
| HY-B0607S | Nitisinone-d3 | Isotope-Labeled Compounds | |
| HY-B0623S1 | Ropinirole-d3 | 1132746-02-1 | Isotope-Labeled Compounds |
| HY-B0632B | (2R,3R)-Diltiazem (hydrochloride) | 42399-54-2 | Reference compound |
| HY-B0637S2 | Bezafibrate-13C6 | Isotope-Labeled Compounds | |
| HY-B0656AS3 | Rabeprazole-13C,d3 (sodium) | Isotope-Labeled Compounds | |
| HY-B0688S3 | Dapsone-15N2 | 287476-19-1 | Isotope-Labeled Compounds |
| HY-B0689S1 | Indinavir-13C4,15N | Isotope-Labeled Compounds | |
| HY-B0690S | Fosinopril-d5 | Isotope-Labeled Compounds | |
| HY-B0696S | Tiagabine-d6 | 1217672-34-8 | Isotope-Labeled Compounds |
| HY-B0696S1 | Tiagabine-d4 | Isotope-Labeled Compounds | |
| HY-B0715S3 | Pentoxifylline-d3 | 1185878-97-0 | Isotope-Labeled Compounds |
| HY-B0723S2 | Ospemifene-d5 | Isotope-Labeled Compounds | |
| HY-B0732AS | Itopride-d6 | 1346746-82-4 | Isotope-Labeled Compounds |
| HY-B0760S1 | Fenofibric acid-13C8 | Isotope-Labeled Compounds | |
| HY-B0760S2 | Fenofibric acid-d4 | Isotope-Labeled Compounds | |
| HY-B0823A | (E/Z)-Acetamiprid | 160430-64-8 | Reference compound |
| HY-B0956A | Paromomycin | 7542-37-2 | Natural Products |
| HY-B1035C | ent-Levobunolol (hydrochloride) | 27867-05-6 | Reference compound |
| HY-B1125S | Glucosamine-13C6 | Isotope-Labeled Compounds | |
| HY-B1159S1 | Nitroxoline-d5 | Isotope-Labeled Compounds | |
| HY-B1176S1 | Equilin-d2 | Isotope-Labeled Compounds | |
| HY-B1190S2 | Cefadroxil-13C6 | Isotope-Labeled Compounds | |
| HY-B1204S1 | Histamine-d4 | 751471-48-4 | Isotope-Labeled Compounds |
| HY-B1225S | Promazine-d6 (hydrochloride) | 1246819-33-9 | Isotope-Labeled Compounds |
| HY-B1258S | Intermediate of tranexamic Acid-13C2,15N | Isotope-Labeled Compounds | |
| HY-B1299 | Cephalosporin C | 61-24-5 | Reference compound |
| HY-B1328S2 | Pyridoxine-d2 | 5027-84-9 | Isotope-Labeled Compounds |
| HY-B1328S3 | Pyridoxine-13C4 | Isotope-Labeled Compounds | |
| HY-B1363S1 | Bendroflumethiazide-d7 | Isotope-Labeled Compounds | |
| HY-B1374S2 | Florfenicol-13C6 | Isotope-Labeled Compounds | |
| HY-B1396S3 | Nefazodone-d4 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1418S2 | Tazobactam-15N,d2 | Isotope-Labeled Compounds | |
| HY-B1438S2 | Canrenone-d7 | Isotope-Labeled Compounds | |
| HY-B1473S1 | Serotonin-13C2,15N (hydrochloride) | Isotope-Labeled Compounds | |
| HY-B1480S | Ethoxzolamide-d5 | 3054664-97-7 | Isotope-Labeled Compounds |
| HY-B1506AS | Acepromazine-d6 (maleate) | 1331655-50-5 | Isotope-Labeled Compounds |
| HY-B1788S2 | Taurocholic acid-d5 | 2044276-13-1 | Isotope-Labeled Compounds |
| HY-B1833S | Afloqualone-d7 | Isotope-Labeled Compounds | |
| HY-B1895S1 | Levodropropizine-d5 | Isotope-Labeled Compounds | |
| HY-B1971S1 | Deltamethrin-d6 | 2483831-10-1 | Isotope-Labeled Compounds |
| HY-B2137S | S-(+)-Ketoprofen-d3 | 2747914-77-6 | Isotope-Labeled Compounds |
| HY-B2235C | L-α-Lecithin (soybean) | 8002-43-5 | Biochemical Assay Reagents |
| HY-CE00479 | (6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA | 676656-93-2 | Enzyme |
| HY-D0110B | Fura-2 (pentasodium) | Dye Reagents | |
| HY-D0184S6 | 2'-Deoxycytidine-13C,15N3 | Isotope-Labeled Compounds | |
| HY-D0205AS1 | Carbocisteine-13C3-1 | 1391068-19-1 | Isotope-Labeled Compounds |
| HY-D0205AS2 | Carbocisteine-d3 | Isotope-Labeled Compounds | |
| HY-D2730 | N14G-Fe | Dye Reagents | |
| HY-D2734 | Heparin-Cy3 | Dye Reagents | |
| HY-D2775 | Cobalt(II) ions probe 1 | 3047612-66-5 | Dye Reagents |
| HY-D2776 | Primary antibody and secondary antibody eluent, specially for mIHC experiments | Dye Reagents | |
| HY-D2794 | FITC-PEG-NH2 (MW 400) | Dye Reagents | |
| HY-D2794A | FITC-PEG-NH2 (MW 1000) | Dye Reagents | |
| HY-D2794B | FITC-PEG-NH2 (MW 5000) | Dye Reagents | |
| HY-D2794C | FITC-PEG-NH2 (MW 10000) | Dye Reagents | |
| HY-D2795 | FITC-PEG-COOH (MW 400) | Dye Reagents | |
| HY-D2795A | FITC-PEG-COOH (MW 1000) | Dye Reagents | |
| HY-D2795B | FITC-PEG-COOH (MW 5000) | Dye Reagents | |
| HY-D2795C | FITC-PEG-COOH (MW 10000) | Dye Reagents | |
| HY-D2796 | FITC-PEG-OH (MW 400) | Dye Reagents | |
| HY-D2796A | FITC-PEG-OH (MW 1000) | Dye Reagents | |
| HY-D2796B | FITC-PEG-OH (MW 5000) | Dye Reagents | |
| HY-D2796C | FITC-PEG-OH (MW 10000) | Dye Reagents | |
| HY-D2797 | Chitosan-Cy7 (MW 2000) | Dye Reagents | |
| HY-D2798 | FITC-PEG-SH (MW 400) | Dye Reagents | |
| HY-D2798A | FITC-PEG-SH (MW 1000) | Dye Reagents | |
| HY-D2798B | FITC-PEG-SH (MW 5000) | Dye Reagents | |
| HY-D2798C | FITC-PEG-SH (MW 10000) | Dye Reagents | |
| HY-D2799 | Chitosan-Cy7 (MW 7000) | Dye Reagents | |
| HY-D2800 | FITC-PEG-MAL (MW 400) | Dye Reagents | |
| HY-D2800A | FITC-PEG-MAL (MW 1000) | Dye Reagents | |
| HY-D2800B | FITC-PEG-MAL (MW 3400) | Dye Reagents | |
| HY-D2800C | FITC-PEG-MAL (MW 5000) | Dye Reagents | |
| HY-D2800D | FITC-PEG-MAL (MW 10000) | Dye Reagents | |
| HY-D2801 | FITC-PEG-NHS (MW 400) | Dye Reagents | |
| HY-D2801A | FITC-PEG-NHS (MW 1000) | Dye Reagents | |
| HY-D2801B | FITC-PEG-NHS (MW 3400) | Dye Reagents | |
| HY-D2801C | FITC-PEG-NHS (MW 5000) | Dye Reagents | |
| HY-D2802 | FITC-PEG-N3 (MW 400) | Dye Reagents | |
| HY-D2802A | FITC-PEG-N3 (MW 1000) | Dye Reagents | |
| HY-D2802B | FITC-PEG-N3 (MW 3400) | Dye Reagents | |
| HY-D2802C | FITC-PEG-N3 (MW 5000) | Dye Reagents | |
| HY-D2802D | FITC-PEG-N3 (MW 10000) | Dye Reagents | |
| HY-D2804 | Chitosan-Cy7 (MW 10000) | Dye Reagents | |
| HY-D2814 | Chitosan-Cy7 (MW 100000) | Dye Reagents | |
| HY-D2816 | Chitosan-Cy7.5 (MW 2000) | Dye Reagents | |
| HY-D2817 | FITC-PLL | Dye Reagents | |
| HY-D2820 | Chitosan-Cy7.5 (MW 75000) | Dye Reagents | |
| HY-D2824 | Chitosan-Cy7.5 (MW 10000) | Dye Reagents | |
| HY-D2825 | Chitosan-Cy7.5 (MW 100000) | Dye Reagents | |
| HY-D2826 | FITC-Chitosan (MW 100000) | Dye Reagents | |
| HY-D2826A | FITC-Chitosan (MW 40000) | Dye Reagents | |
| HY-D2826B | FITC-Chitosan (MW 20000) | Dye Reagents | |
| HY-D2826C | FITC-Chitosan (MW 10000) | Dye Reagents | |
| HY-D2826D | FITC-Chitosan (MW 5000) | Dye Reagents | |
| HY-D2826E | FITC-Chitosan (MW 2000) | Dye Reagents | |
| HY-D2835 | m-PEG1000-PEI-Cy5 | Dye Reagents | |
| HY-D2836 | FITC-HA (MW 1000000) | Dye Reagents | |
| HY-D2836A | FITC-HA (MW 500000) | Dye Reagents | |
| HY-D2836B | FITC-HA (MW 200000) | Dye Reagents | |
| HY-D2836C | FITC-HA (MW 100000) | Dye Reagents | |
| HY-D2836D | FITC-HA (MW 50000) | Dye Reagents | |
| HY-D2836E | FITC-HA (MW 10000) | Dye Reagents | |
| HY-D2836H | FITC-HA (MW 7000) | Dye Reagents | |
| HY-D2836I | FITC-HA (MW 5000) | Dye Reagents | |
| HY-D2836J | FITC-HA (MW 3000) | Dye Reagents | |
| HY-D2837 | m-PEG2000-PEI-Cy5 | Dye Reagents | |
| HY-D2838 | m-PEG5000-PEI-Cy5 | Dye Reagents | |
| HY-D2839 | m-PEG10000-PEI-Cy5 | Dye Reagents | |
| HY-D2840 | FITC-mPEG (MW 350) | Dye Reagents | |
| HY-D2840A | FITC-mPEG (MW 550) | Dye Reagents | |
| HY-D2840B | FITC-mPEG (MW 750) | Dye Reagents | |
| HY-D2840C | FITC-mPEG (MW 1000) | Dye Reagents | |
| HY-D2840D | FITC-mPEG (MW 2000) | Dye Reagents | |
| HY-D2840E | FITC-mPEG (MW 5000) | Dye Reagents | |
| HY-D2840H | FITC-mPEG (MW 10000) | Dye Reagents | |
| HY-D2840I | FITC-mPEG (MW 20000) | Dye Reagents | |
| HY-D2841 | FITC-Heparin | Dye Reagents | |
| HY-D2842 | FITC-PEG-biotin (MW 400) | Dye Reagents | |
| HY-D2842A | FITC-PEG-biotin (MW 1000) | Dye Reagents | |
| HY-D2842B | FITC-PEG-biotin (MW 2000) | Dye Reagents | |
| HY-D2842C | FITC-PEG-biotin (MW 3400) | Dye Reagents | |
| HY-D2842D | FITC-PEG-biotin (MW 5000) | Dye Reagents | |
| HY-D2842E | FITC-PEG-biotin (MW 10000) | Dye Reagents | |
| HY-D2844 | FITC-PEG-FA (MW 400) | Dye Reagents | |
| HY-D2844A | FITC-PEG-FA (MW 1000) | Dye Reagents | |
| HY-D2844B | FITC-PEG-FA (MW 2000) | Dye Reagents | |
| HY-D2844C | FITC-PEG-FA (MW 3400) | Dye Reagents | |
| HY-D2844D | FITC-PEG-FA (MW 5000) | Dye Reagents | |
| HY-D2844E | FITC-PEG-FA (MW 10000) | Dye Reagents | |
| HY-D2845 | 4-arm-PEG-FITC (MW 2000) | Dye Reagents | |
| HY-D2845A | 4-arm-PEG-FITC (MW 5000) | Dye Reagents | |
| HY-D2845B | 4-arm-PEG-FITC (MW 10000) | Dye Reagents | |
| HY-E70558 | 5α-reductase, Rat(Sprague-Dawley) Liver | Enzyme | |
| HY-E70558A | 5α-reductase, Rat(Sprague-Dawley) Testis | Enzyme | |
| HY-E70559 | Prostaglandin D synthase | 65802-85-9 | Enzyme |
| HY-I0603 | (R)-Ramelteon | 196597-27-0 | Reference compound |
| HY-I0786 | (2S,4R)-Teneligliptin | 1404559-15-4 | Reference compound |
| HY-K0001 | Exosome Protein Lysis Buffer | Kits | |
| HY-K1063A | Exosome Isolation and Purification Plus Kit (From Plasma and Serum) | Kits | |
| HY-K1067 | Exosome Isolation and Purification Kit (From Tissue) | Kits | |
| HY-K1068 | Exosome Protein Detection Kit (CD81) | Kits | |
| HY-K1069 | Lentivirus Solution Buffer | Kits | |
| HY-K1098 | Exosome Isolation and Purification Kit (From Milk) | Kits | |
| HY-N0001S2 | (-)-Epicatechin-13C3 | Isotope-Labeled Compounds | |
| HY-N0005S1 | Curcumin-d3 | Isotope-Labeled Compounds | |
| HY-N0105S2 | Rhein-13C4 | 1189928-10-6 | Isotope-Labeled Compounds |
| HY-N0112S | Dihydromyricetin-d4 | Isotope-Labeled Compounds | |
| HY-N0229S19 | L-Alanine-1,2-13C2 | 920314-10-9 | Isotope-Labeled Compounds |
| HY-N0230S5 | β-Alanine-13C | 65138-34-3 | Isotope-Labeled Compounds |
| HY-N0344R | Farrerol (Standard) | 24211-30-1 | Reference Standards |
| HY-N0359A | (E)-Cynarin | 212891-05-9 | Natural Products |
| HY-N0390S15 | L-Glutamine-d4 | Isotope-Labeled Compounds | |
| HY-N0411S4 | β-Carotene-13C10 | 301150-50-5 | Isotope-Labeled Compounds |
| HY-N10337 | Norjuziphine | 74119-87-2 | Natural Products |
| HY-N11408 | Bagougeramine A | 104840-35-9 | Natural Products |
| HY-N11535 | Enacyloxin IIa | 126518-41-0 | Natural Products |
| HY-N11554 | (-)-Codonopsine | 26989-20-8 | Natural Products |
| HY-N11698 | Bakuchicin | 4412-93-5 | Natural Products |
| HY-N11857 | Gentamicin C2 | 25876-11-3 | Natural Products |
| HY-N11882 | Plastoquinone | 4299-57-4 | Natural Products |
| HY-N12421 | Paulomycin A | 81988-77-4 | Natural Products |
| HY-N12675 | Phoslactomycin F | 122856-30-8 | Natural Products |
| HY-N12676 | Phoslactomycin E | 159991-62-5 | Natural Products |
| HY-N12679 | Phoslactomycin D | 122856-28-4 | Natural Products |
| HY-N12680 | Phoslactomycin B | 122856-26-2 | Natural Products |
| HY-N12681 | Phoslactomycin A | 159991-67-0 | Natural Products |
| HY-N12682 | Phoslactomycin C | 159991-59-0 | Natural Products |
| HY-N12866 | Monensin C | 31980-87-7 | Natural Products |
| HY-N13075 | Mycoplanecin A | 72993-51-2 | Natural Products |
| HY-N13259 | Fluopsin C | 31323-25-8 | Natural Products |
| HY-N13798 | ADHPE | 138870-97-0 | Natural Products |
| HY-N13868 | Saquayamycin C1 | 99260-69-2 | Natural Products |
| HY-N13870 | Saquayamycin A1 | 99260-66-9 | Natural Products |
| HY-N13873 | Saricandin | 178494-90-1 | Natural Products |
| HY-N13888 | Schizostatin | 163564-55-4 | Natural Products |
| HY-N13915 | Scorodonin | 74660-77-8 | Natural Products |
| HY-N13918 | Scyphostatin | 169062-93-5 | Natural Products |
| HY-N13922 | Scytalol A | 208183-19-1 | Natural Products |
| HY-N13929 | Scytalidin | 39012-16-3 | Natural Products |
| HY-N13930 | Azicemicin A | 154163-93-6 | Natural Products |
| HY-N13931 | Azicemicin B | 162857-75-2 | Natural Products |
| HY-N13934 | Scytalol B | 208183-20-4 | Natural Products |
| HY-N13937 | Scytalol C | 208183-22-6 | Natural Products |
| HY-N13938 | Azinomycin A | 106486-77-5 | Natural Products |
| HY-N13941 | Baciphelacin | 57765-71-6 | Natural Products |
| HY-N13943 | Scytalol D | 208183-24-8 | Natural Products |
| HY-N13946 | Pyralomicin 1a | 139636-03-6 | Natural Products |
| HY-N13947 | Pyralomicin 1b | 139636-04-7 | Natural Products |
| HY-N13949 | Seitomycin | 630391-05-8 | Natural Products |
| HY-N13950 | Bacithrocin A | 160433-47-6 | Natural Products |
| HY-N13953 | Pyralomicin 1c | 139635-99-7 | Natural Products |
| HY-N13954 | Pyralomicin 1d | 139635-98-6 | Natural Products |
| HY-N13955 | Bacithrocin B | 160433-51-2 | Natural Products |
| HY-N13957 | Bacithrocin C | 160433-50-1 | Natural Products |
| HY-N13959 | Seldomycin factor 1 | 56276-04-1 | Natural Products |
| HY-N13961 | Seldomycin factor 2 | 54333-78-7 | Natural Products |
| HY-N13962 | Bagremycin A | 377775-45-6 | Natural Products |
| HY-N13963 | Bagremycin B | 93316-63-3 | Natural Products |
| HY-N13964 | Seldomycin factor 3 | 56276-05-2 | Natural Products |
| HY-N13966 | Pyralomicin 2a | 139636-00-3 | Natural Products |
| HY-N13967 | Pyralomicin 2b | 139635-97-5 | Natural Products |
| HY-N13968 | Pyralomicin 2c | 139636-01-4 | Natural Products |
| HY-N13971 | Bamicetin | 43043-14-7 | Natural Products |
| HY-N13973 | Baumycin A1 | 64314-28-9 | Natural Products |
| HY-N13974 | Baumycin B1 | 64253-72-1 | Natural Products |
| HY-N13975 | Belactosin A | 189871-53-2 | Natural Products |
| HY-N13976 | Belactosin C | 189871-55-4 | Natural Products |
| HY-N13977 | Carpetimycin A | 76025-73-5 | Natural Products |
| HY-N13978 | Carpetimycin B | 76094-36-5 | Natural Products |
| HY-N13979 | Carpetimycin C | 87695-64-5 | Natural Products |
| HY-N13980 | Carpetimycin D | 87139-37-5 | Natural Products |
| HY-N13986 | Seldomycin factor 5 | 56276-26-7 | Natural Products |
| HY-N13990 | Senfolomycin A | 11017-36-0 | Natural Products |
| HY-N13991 | Senfolomycin B | 11031-56-4 | Natural Products |
| HY-N13992 | Barbamide | 174630-03-6 | Natural Products |
| HY-N13994 | Clavamycin A | 103059-93-4 | Natural Products |
| HY-N13995 | Serratamolide | 5285-25-6 | Natural Products |
| HY-N13996 | Clavamycin B | 103080-36-0 | Natural Products |
| HY-N13997 | Clavamycin C | 103059-94-5 | Natural Products |
| HY-N13999 | Clavamycin D | 103059-95-6 | Natural Products |
| HY-N14005 | Cephamycin A | 34279-78-2 | Natural Products |
| HY-N14007 | Cephamycin B | 34279-77-1 | Natural Products |
| HY-N14009 | Carzinophillin A | 106486-76-4 | Natural Products |
| HY-N14010 | Cationomycin | 80394-65-6 | Natural Products |
| HY-N14011 | Cedarmycin A | 363624-69-5 | Natural Products |
| HY-N14012 | Cedarmycin B | 363624-70-8 | Natural Products |
| HY-N14013 | Chondramide A | 172430-60-3 | Natural Products |
| HY-N14015 | Cerexin A | 55467-31-7 | Natural Products |
| HY-N14016 | Chaetiacandin | 96989-32-1 | Natural Products |
| HY-N14017 | Chelocardin | 29144-42-1 | Natural Products |
| HY-N14018 | Glidobactin A | 108351-50-4 | Natural Products |
| HY-N14019 | Glidobactin B | 108351-51-5 | Natural Products |
| HY-N14020 | Glidobactin C | 108351-52-6 | Natural Products |
| HY-N14022 | Glidobactin F | 119259-72-2 | Natural Products |
| HY-N14023 | Glidobactin G | 119259-71-1 | Natural Products |
| HY-N14025 | Chicamycin B | 89675-39-8 | Natural Products |
| HY-N14027 | Chondramide B | 172430-61-4 | Natural Products |
| HY-N14028 | Coriolin A | 33404-85-2 | Natural Products |
| HY-N14029 | Coriolin B | 33400-89-4 | Natural Products |
| HY-N14030 | Coriolin C | 33400-90-7 | Natural Products |
| HY-N14031 | Chimeramycin A | 87084-47-7 | Natural Products |
| HY-N14032 | Chimeramycin B | 87092-83-9 | Natural Products |
| HY-N14037 | Chondramide C | 172430-62-5 | Natural Products |
| HY-N14038 | Crocacin A | 157698-34-5 | Natural Products |
| HY-N14040 | Crocacin B | 237425-37-5 | Natural Products |
| HY-N14043 | Crocacin C | 237425-38-6 | Natural Products |
| HY-N14044 | Crocacin D | 237425-39-7 | Natural Products |
| HY-N14049 | Cepacin B | 91682-94-9 | Natural Products |
| HY-N14050 | Cinatrin A | 136266-33-6 | Natural Products |
| HY-N14054 | Chondramide D | 172430-63-6 | Natural Products |
| HY-N14056 | Chrolactomycin | 227606-82-8 | Natural Products |
| HY-N14057 | Cycloheptamycin | 30270-78-1 | Natural Products |
| HY-N14058 | Halymecin A | 165561-10-4 | Natural Products |
| HY-N14059 | Halymecin B | 167173-81-1 | Natural Products |
| HY-N14060 | Halymecin C | 167173-82-2 | Natural Products |
| HY-N14061 | Halymecin D | 167173-83-3 | Natural Products |
| HY-N14062 | Halymecin E | 167173-84-4 | Natural Products |
| HY-N14063 | Cycloleucomelone | 112209-48-0 | Natural Products |
| HY-N14068 | Cytosaminomycin B | 157878-03-0 | Natural Products |
| HY-N14069 | Cytosaminomycin C | 157878-04-1 | Natural Products |
| HY-N14085 | Chrymutasin A | 155213-40-4 | Natural Products |
| HY-N14086 | Chrymutasin B | 155213-41-5 | Natural Products |
| HY-N14087 | Chrymutasin C | 155232-80-7 | Natural Products |
| HY-N14088 | Chrysospermin A | 160824-57-7 | Natural Products |
| HY-N14089 | Chrysospermin B | 160791-54-8 | Natural Products |
| HY-N14090 | Chrysospermin C | 160791-55-9 | Natural Products |
| HY-N14091 | Chrysospermin D | 160791-56-0 | Natural Products |
| HY-N14095 | Curromycin A | 97412-76-5 | Natural Products |
| HY-N14101 | Cinatrin B | 136266-34-7 | Natural Products |
| HY-N14102 | Chlorflavonin | 23363-64-6 | Natural Products |
| HY-N14106 | Cinerubin R | 147657-35-0 | Natural Products |
| HY-N14108 | Chlorocardicin | 95927-71-2 | Natural Products |
| HY-N14109 | Chloronectrin | 38965-84-3 | Natural Products |
| HY-N14110 | Curromycin B | 97412-77-6 | Natural Products |
| HY-N14114 | Curvularol | 339293-67-3 | Natural Products |
| HY-N14115 | γ-Chloronorvaline | 76265-38-8 | Natural Products |
| HY-N14117 | Curvulic acid | 652-55-1 | Natural Products |
| HY-N14118 | Chloropolysporin B | 105650-11-1 | Natural Products |
| HY-N14119 | Chloropolysporin C | 105650-12-2 | Natural Products |
| HY-N14121 | Cladosporide A | 310897-84-8 | Natural Products |
| HY-N14122 | Cladosporide B | 376368-81-9 | Natural Products |
| HY-N14123 | Cladosporide C | 376368-82-0 | Natural Products |
| HY-N14124 | Cladosporide D | 376368-83-1 | Natural Products |
| HY-N14125 | Chloroquinocin | 585533-78-4 | Natural Products |
| HY-N14126 | Chlovalicin | 179799-38-3 | Natural Products |
| HY-N14127 | Cirramycin A1 | 25339-90-6 | Natural Products |
| HY-N14128 | Cirramycin B1 | 57425-25-9 | Natural Products |
| HY-N14129 | Citreamicin β | 128999-30-4 | Natural Products |
| HY-N14130 | Cyclothialidine B | 194276-76-1 | Natural Products |
| HY-N14131 | Cyclothialidine D | 194276-78-3 | Natural Products |
| HY-N14132 | Cyclothialidine E | 194276-79-4 | Natural Products |
| HY-N14133 | Enaminomycin A | 68330-49-4 | Natural Products |
| HY-N14135 | Cystothiazole A | 207399-36-8 | Natural Products |
| HY-N14136 | Cinnatriacetin A | 244277-14-3 | Natural Products |
| HY-N14137 | Cinnatriacetin B | 244277-15-4 | Natural Products |
| HY-N14138 | Diolmycin A1 | 150408-69-8 | Natural Products |
| HY-N14139 | Dioxamycin | 134861-62-4 | Natural Products |
| HY-N14140 | Dioxolamycin | 91432-46-1 | Natural Products |
| HY-N14141 | Citreamicin γ | 128999-31-5 | Natural Products |
| HY-N14142 | Citreamicin ξ | 1092776-20-9 | Natural Products |
| HY-N14143 | Citreamicin η | 128969-88-0 | Natural Products |
| HY-N14144 | Cremimycin | 182285-29-6 | Natural Products |
| HY-N14150 | Darlucin A | 162341-15-3 | Natural Products |
| HY-N14151 | Darlucin B | 162341-16-4 | Natural Products |
| HY-N14153 | Enaminomycin B | 68245-17-0 | Natural Products |
| HY-N14154 | Enaminomycin C | 68245-16-9 | Natural Products |
| HY-N14155 | Epelmycin A | 107807-25-0 | Natural Products |
| HY-N14156 | Epelmycin B | 107807-24-9 | Natural Products |
| HY-N14157 | Epelmycin C | 107807-23-8 | Natural Products |
| HY-N14158 | Epelmycin D | 130852-65-2 | Natural Products |
| HY-N14159 | Epelmycin E | 76264-93-2 | Natural Products |
| HY-N14163 | Diperamycin | 220766-06-3 | Natural Products |
| HY-N14165 | Endusamycin | 100242-41-9 | Natural Products |
| HY-N14166 | Empedopeptin | 87551-98-2 | Natural Products |
| HY-N14167 | Ekatetrone | 12794-19-3 | Natural Products |
| HY-N14171 | Epicorazine A | 62256-05-7 | Natural Products |
| HY-N14172 | Epicorazine B | 69176-72-3 | Natural Products |
| HY-N14173 | Epiderstatin | 126602-16-2 | Natural Products |
| HY-N14174 | Epithienamycin A | 63582-78-5 | Natural Products |
| HY-N14175 | Epithienamycin C | 63599-16-6 | Natural Products |
| HY-N14176 | Cyathin A3 | 38598-35-5 | Natural Products |
| HY-N14177 | Cyathin A4 | 12626-14-1 | Natural Products |
| HY-N14178 | Cyclacidin | 749-18-8 | Natural Products |
| HY-N14179 | Cytovaricin | 79553-45-0 | Natural Products |
| HY-N14181 | Ditrisarubicin A | 87399-21-1 | Natural Products |
| HY-N14189 | Hynapene A | 155111-89-0 | Natural Products |
| HY-N14197 | Hynapene B | 155111-88-9 | Natural Products |
| HY-N14198 | Hynapene C | 155111-90-3 | Natural Products |
| HY-N14200 | Maridomycin II | 35908-45-3 | Natural Products |
| HY-N14201 | Maridomycin IV | 35942-56-4 | Natural Products |
| HY-N14202 | Maridomycin V | 35942-57-5 | Natural Products |
| HY-N14203 | Maridomycin VI | 35775-66-7 | Natural Products |
| HY-N14206 | Cytosporin B | 175413-74-8 | Natural Products |
| HY-N14209 | Epithienamycin D | 65322-98-7 | Natural Products |
| HY-N14210 | Epithienamycin F | 79057-45-7 | Natural Products |
| HY-N14219 | Enactin Ⅴa | 130640-31-2 | Natural Products |
| HY-N14224 | Enteromycin | 3552-16-7 | Natural Products |
| HY-N14225 | Fumifungin | 110231-33-9 | Natural Products |
| HY-N14232 | Inactone | 487-34-3 | Natural Products |
| HY-N14233 | Inosamycin A | 91421-97-5 | Natural Products |
| HY-N14234 | Isohematinic acid | 86408-37-9 | Natural Products |
| HY-N14239 | Jietacin A | 109766-61-2 | Natural Products |
| HY-N14242 | Jietacin B | 109766-62-3 | Natural Products |
| HY-N14247 | Exfoliazone | 132627-73-7 | Natural Products |
| HY-N14248 | Melithiazole A | 170894-30-1 | Natural Products |
| HY-N14249 | Melithiazole B | 170894-31-2 | Natural Products |
| HY-N14250 | Melithiazole C | 214420-47-0 | Natural Products |
| HY-N14251 | Melithiazole K | 248938-47-8 | Natural Products |
| HY-N14252 | Melithiazole N | 248938-54-7 | Natural Products |
| HY-N14254 | Hypelcin A-Ⅰ | 93397-17-2 | Natural Products |
| HY-N14258 | Kerriamycin A | 98474-20-5 | Natural Products |
| HY-N14259 | Kerriamycin C | 98495-38-6 | Natural Products |
| HY-N14260 | Hypelcin A-II | 93397-16-1 | Natural Products |
| HY-N14262 | Kinamycin A | 35303-12-9 | Natural Products |
| HY-N14263 | Kirrothricin | 79190-00-4 | Natural Products |
| HY-N14264 | Kistamicin A | 155683-50-4 | Natural Products |
| HY-N14265 | Kistamicin B | 155683-51-5 | Natural Products |
| HY-N14266 | Hypelcin A-IV | 93397-15-0 | Natural Products |
| HY-N14268 | Ezomycin A1 | 39422-19-0 | Natural Products |
| HY-N14269 | Ezomycin A2 | 54328-22-2 | Natural Products |
| HY-N14274 | Miyakamide A1 | 497252-38-7 | Natural Products |
| HY-N14275 | Miyakamide A2 | 497252-39-8 | Natural Products |
| HY-N14276 | Miyakamide B1 | 497182-82-8 | Natural Products |
| HY-N14277 | Miyakamide B2 | 497182-83-9 | Natural Products |
| HY-N14283 | Ezomycin D2 | 57973-11-2 | Natural Products |
| HY-N14284 | Mniopetal A | 158760-98-6 | Natural Products |
| HY-N14285 | Mniopetal B | 158760-99-7 | Natural Products |
| HY-N14286 | Mniopetal C | 158761-00-3 | Natural Products |
| HY-N14287 | Mniopetal D | 158761-01-4 | Natural Products |
| HY-N14288 | Mniopetal E | 158761-02-5 | Natural Products |
| HY-N14289 | Mniopetal F | 158761-03-6 | Natural Products |
| HY-N14317 | Feigrisolide A | 313949-16-5 | Natural Products |
| HY-N14318 | Feigrisolide B | 313949-17-6 | Natural Products |
| HY-N14319 | Feigrisolide C | 313949-18-7 | Natural Products |
| HY-N14320 | Lactaroviolin | 85-33-6 | Natural Products |
| HY-N14321 | Feigrisolide D | 313949-19-8 | Natural Products |
| HY-N14322 | Mollisin | 667-92-5 | Natural Products |
| HY-N14323 | Madindoline A | 184877-64-3 | Natural Products |
| HY-N14325 | Madindoline B | 184877-65-4 | Natural Products |
| HY-N14327 | Ferensimycin B | 135501-80-3 | Natural Products |
| HY-N14329 | Maniwamycin B | 122547-71-1 | Natural Products |
| HY-N14330 | Fibrostatin A | 91776-42-0 | Natural Products |
| HY-N14331 | Fibrostatin B | 91776-48-6 | Natural Products |
| HY-N14332 | Fibrostatin D | 91776-46-4 | Natural Products |
| HY-N14333 | Halomicin A | 56411-51-9 | Natural Products |
| HY-N14334 | Halomicin B | 54356-09-1 | Natural Products |
| HY-N14335 | Halomicin C | 64419-06-3 | Natural Products |
| HY-N14336 | Halomicin D | 56413-94-6 | Natural Products |
| HY-N14338 | Sannamycin L | 83946-32-1 | Natural Products |
| HY-N14339 | Fibrostatin E | 91776-44-2 | Natural Products |
| HY-N14340 | Fibrostatin F | 91776-45-3 | Natural Products |
| HY-N14341 | Mannosyl glucosaminide | 14510-04-4 | Natural Products |
| HY-N14342 | Manumycin E | 156250-43-0 | Natural Products |
| HY-N14343 | Manumycin F | 156317-47-4 | Natural Products |
| HY-N14344 | Manumycin G | 156250-44-1 | Natural Products |
| HY-N14345 | Marcellomycin | 63710-10-1 | Natural Products |
| HY-N14359 | Megovalicin B | 89759-26-2 | Natural Products |
| HY-N14360 | Megovalicin H | 115932-37-1 | Natural Products |
| HY-N14367 | Fluoropolyoxin L | 50355-67-4 | Natural Products |
| HY-N14370 | Menoxymycin A | 160492-65-9 | Natural Products |
| HY-N14371 | Menoxymycin B | 160523-76-2 | Natural Products |
| HY-N14372 | Methymycin | 497-72-3 | Natural Products |
| HY-N14373 | Mycelianamide | 22775-52-6 | Natural Products |
| HY-N14374 | Mycoplanecin B | 81018-84-0 | Natural Products |
| HY-N14375 | Mycoplanecin C | 81018-83-9 | Natural Products |
| HY-N14380 | Sannamycin K | 83919-30-6 | Natural Products |
| HY-N14381 | Leptofuranin A | 183017-80-3 | Natural Products |
| HY-N14382 | Leptofuranin B | 183017-81-4 | Natural Products |
| HY-N14383 | Leptofuranin C | 183017-82-5 | Natural Products |
| HY-N14384 | Leptofuranin D | 183017-83-6 | Natural Products |
| HY-N14392 | Fluoropolyoxin M | 50355-68-5 | Natural Products |
| HY-N14393 | Fomecin A | 1403-56-1 | Natural Products |
| HY-N14394 | Fusicoccin H | 50906-51-9 | Natural Products |
| HY-N14395 | Formadicin A | 99150-60-4 | Natural Products |
| HY-N14396 | Sannamycin F | 83931-91-3 | Natural Products |
| HY-N14399 | Fortimicin B | 54783-95-8 | Natural Products |
| HY-N14401 | Salfredin B11 | 165467-63-0 | Natural Products |
| HY-N14402 | Mycoplanecin D | 89355-38-4 | Natural Products |
| HY-N14404 | Fosfadecin | 120909-50-4 | Natural Products |
| HY-N14408 | Fosfazinomycin B | 87423-11-8 | Natural Products |
| HY-N14409 | Mycoversilin | 88527-18-8 | Natural Products |
| HY-N14411 | Myxovirescin A | 85279-97-6 | Natural Products |
| HY-N14412 | Napyradiomycin A2 | 111216-62-7 | Natural Products |
| HY-N14413 | Narbomycin | 6036-25-5 | Natural Products |
| HY-N14415 | Cochleamycin A | 134769-19-0 | Natural Products |
| HY-N14416 | Parvodicin A | 110882-81-0 | Natural Products |
| HY-N14418 | Parvodicin B1 | 110882-82-1 | Natural Products |
| HY-N14419 | Salfredin C3 | 139542-58-8 | Natural Products |
| HY-N14420 | Parvodicin B2 | 110882-83-2 | Natural Products |
| HY-N14426 | Concanamycin F | 144539-92-4 | Natural Products |
| HY-N14427 | Concanamycin G | 144730-82-5 | Natural Products |
| HY-N14428 | Fosfocytocin | 126986-25-2 | Natural Products |
| HY-N14429 | Fredericamycin A | 80455-68-1 | Natural Products |
| HY-N14431 | Salfredin C2 | 139542-57-7 | Natural Products |
| HY-N14432 | Fujianmycin A | 96695-57-7 | Natural Products |
| HY-N14433 | Fumigatin | 484-89-9 | Natural Products |
| HY-N14434 | Pradimicin B | 117704-66-2 | Natural Products |
| HY-N14435 | Pradimicin Q | 141869-53-6 | Natural Products |
| HY-N14436 | Pradimicin Tl | 149598-64-1 | Natural Products |
| HY-N14437 | Pradimicin T2 | 149598-63-0 | Natural Products |
| HY-N14438 | Furaquinocin A | 125108-66-9 | Natural Products |
| HY-N14439 | Furaquinocin B | 125224-54-6 | Natural Products |
| HY-N14440 | Furaquinocin C | 134984-98-8 | Natural Products |
| HY-N14445 | Sakyomicin D | 86413-77-6 | Natural Products |
| HY-N14447 | Salfredin A3 | 139542-53-3 | Natural Products |
| HY-N14449 | Salfredin A4 | 139542-54-4 | Natural Products |
| HY-N14450 | Salfredin A7 | 139542-55-5 | Natural Products |
| HY-N14451 | Salfredin C1 | 139542-56-6 | Natural Products |
| HY-N14469 | Sakyomicin C | 86413-76-5 | Natural Products |
| HY-N14471 | Fusacandin A | 166407-33-6 | Natural Products |
| HY-N14472 | Fusacandin B | 166407-34-7 | Natural Products |
| HY-N14473 | Fusarin C | 79748-81-5 | Natural Products |
| HY-N14474 | Fusarubin | 1702-77-8 | Natural Products |
| HY-N14475 | Sakyomicin B | 86470-27-1 | Natural Products |
| HY-N14477 | Saframycin Mx2 | 113036-79-6 | Natural Products |
| HY-N14478 | Saframycin Mx1 | 113036-78-5 | Natural Products |
| HY-N14485 | Nebramycin Ⅳ | 51736-76-6 | Natural Products |
| HY-N14486 | Neihumicin | 111451-12-8 | Natural Products |
| HY-N14487 | Nemotin | 502-12-5 | Natural Products |
| HY-N14488 | Nemotinic acid | 539-98-0 | Natural Products |
| HY-N14489 | Neocopiamycin A | 89989-28-6 | Natural Products |
| HY-N14490 | Coumamidine γ1 | 121634-35-3 | Natural Products |
| HY-N14491 | Coumamidine γ2 | 121634-34-2 | Natural Products |
| HY-N14492 | Coumermycin A2 | 3130-60-7 | Natural Products |
| HY-N14494 | Neoviridogrisein Ⅰ | 66002-39-9 | Natural Products |
| HY-N14495 | Nidulal | 185853-14-9 | Natural Products |
| HY-N14496 | Nisamycin | 150829-93-9 | Natural Products |
| HY-N14497 | Nocardicyclin A | 199173-81-4 | Natural Products |
| HY-N14499 | Saframycin H | 92569-01-2 | Natural Products |
| HY-N14502 | Gambierol | 146763-62-4 | Natural Products |
| HY-N14506 | Gibbestatin B | 89687-34-3 | Natural Products |
| HY-N14513 | Pyrrolomycin A | 79763-01-2 | Natural Products |
| HY-N14514 | Gentamicin X2 | 36889-17-5 | Natural Products |
| HY-N14515 | Saframycin G | 92569-02-3 | Natural Products |
| HY-N14516 | Saframycin F | 92569-03-4 | Natural Products |
| HY-N14522 | Gilvocarcin E | 80937-34-4 | Natural Products |
| HY-N14523 | Gilvusmycin | 195052-09-6 | Natural Products |
| HY-N14524 | Gladiolic acid | 478-05-7 | Natural Products |
| HY-N14525 | Glisoprenin A | 144376-62-5 | Natural Products |
| HY-N14526 | Octacosamicin A | 122005-25-8 | Natural Products |
| HY-N14527 | Octacosamicin B | 122005-24-7 | Natural Products |
| HY-N14528 | Oganomycin A | 75794-94-4 | Natural Products |
| HY-N14529 | Oganomycin B | 75794-96-6 | Natural Products |
| HY-N14530 | Cremeomycin | 11050-22-9 | Natural Products |
| HY-N14532 | Pyrrolomycin E | 87376-16-7 | Natural Products |
| HY-N14538 | Saframycin E | 66082-31-3 | Natural Products |
| HY-N14539 | Pyrromycin | 668-17-7 | Natural Products |
| HY-N14541 | Saframycin B | 66082-28-8 | Natural Products |
| HY-N14542 | Oleficin | 12764-54-4 | Natural Products |
| HY-N14543 | Olivomycin A | 6988-58-5 | Natural Products |
| HY-N14544 | Orchinol | 41060-20-2 | Natural Products |
| HY-N14545 | Oxamicetin | 52665-75-5 | Natural Products |
| HY-N14546 | Oxirapentyn | 88205-90-7 | Natural Products |
| HY-N14547 | Crotocin | 21284-11-7 | Natural Products |
| HY-N14549 | Cycloepoxydon | 193481-66-2 | Natural Products |
| HY-N14550 | Cyclogregatin | 120167-25-1 | Natural Products |
| HY-N14551 | Roseorubicin B | 70559-01-2 | Natural Products |
| HY-N14552 | Quadrilineatin | 642-27-3 | Natural Products |
| HY-N14560 | Cyclopaldic acid | 477-99-6 | Natural Products |
| HY-N14561 | Cyclophellitol | 126661-83-4 | Natural Products |
| HY-N14562 | Cyclo (D-Pro-L-Val) | 156617-55-9 | Natural Products |
| HY-N14563 | Cycloviracin B1 | 142382-45-4 | Natural Products |
| HY-N14565 | Cymbimicin A | 200563-97-9 | Natural Products |
| HY-N14566 | Cymbimicin B | 200564-07-4 | Natural Products |
| HY-N14567 | Cytochalasin F | 36084-18-1 | Natural Products |
| HY-N14568 | Cytochalasin G | 54874-57-6 | Natural Products |
| HY-N14569 | Cytochalasin L | 79637-87-9 | Natural Products |
| HY-N14571 | Quinomycin B | 13602-52-3 | Natural Products |
| HY-N14572 | Roseorubicin A | 70559-00-1 | Natural Products |
| HY-N14573 | Glisoprenin B | 144376-63-6 | Natural Products |
| HY-N14574 | Glisoprenin C | 205594-88-3 | Natural Products |
| HY-N14578 | Roselipin 2B | 232258-27-4 | Natural Products |
| HY-N14579 | Racemomycin D | 3776-36-1 | Natural Products |
| HY-N14580 | Roselipin 2A | 232258-26-3 | Natural Products |
| HY-N14581 | Roselipin 1A | 232258-17-2 | Natural Products |
| HY-N14582 | Glomosporin | 288631-37-8 | Natural Products |
| HY-N14583 | Glucoallosamidin A | 136236-41-4 | Natural Products |
| HY-N14584 | Roselipin 1B | 232258-18-3 | Natural Products |
| HY-N14585 | Ramulosin | 29914-01-0 | Natural Products |
| HY-N14586 | Roridin J | 74072-83-6 | Natural Products |
| HY-N14587 | Oxypyrrolnitrin | 15345-51-4 | Natural Products |
| HY-N14588 | Pacidamycin 2 | 121264-06-0 | Natural Products |
| HY-N14589 | Resorcinomycin A | 100234-70-6 | Natural Products |
| HY-N14593 | Roridin D | 14682-29-2 | Natural Products |
| HY-N14595 | Resorcinomycin B | 100234-69-3 | Natural Products |
| HY-N14596 | Glucolipsin A | 222613-92-5 | Natural Products |
| HY-N14597 | Glucolipsin B | 222613-93-6 | Natural Products |
| HY-N14598 | Glucopiericidin B | 108073-61-6 | Natural Products |
| HY-N14599 | Resorthiomycin | 126651-92-1 | Natural Products |
| HY-N14600 | Stambomycin A | 1263082-06-9 | Natural Products |
| HY-N14602 | Rifamycin W | 53904-81-7 | Natural Products |
| HY-N14603 | Chandrananimycin A | 664355-12-8 | Natural Products |
| HY-N14604 | Chandrananimycin B | 664355-13-9 | Natural Products |
| HY-N14605 | Chandrananimycin C | 664355-11-7 | Natural Products |
| HY-N14606 | Pacidamycin 3 | 121280-49-7 | Natural Products |
| HY-N14607 | Pacidamycin 5 | 122855-43-0 | Natural Products |
| HY-N14608 | Pacidamycin D | 287107-95-3 | Natural Products |
| HY-N14609 | Respinomycin A2 | 151233-04-4 | Natural Products |
| HY-N14610 | Grahamimycin B | 883434-90-0 | Natural Products |
| HY-N14611 | Pyrazomycin Ⅱ | 41855-21-4 | Natural Products |
| HY-N14612 | Griseochelin | 91920-88-6 | Natural Products |
| HY-N14613 | Rhodomycin B | 1404-52-0 | Natural Products |
| HY-N14614 | Pyripyropene B | 151519-44-7 | Natural Products |
| HY-N14615 | Pyrisulfoxin A | 187337-07-1 | Natural Products |
| HY-N14616 | Reumycin | 5016-18-2 | Natural Products |
| HY-N14617 | Rhodirubin A | 64253-73-2 | Natural Products |
| HY-N14619 | Rhodirubin B | 64502-82-5 | Natural Products |
| HY-N14621 | Harzialacton A | 321868-49-9 | Natural Products |
| HY-N14623 | Paulomycin B | 81988-76-3 | Natural Products |
| HY-N14624 | Pelagiomicin B | 173485-81-9 | Natural Products |
| HY-N14625 | Harziphilone | 183239-75-0 | Natural Products |
| HY-N14626 | Pelagiomicin C | 173485-82-0 | Natural Products |
| HY-N14627 | Liposidomycin A | 99751-55-0 | Natural Products |
| HY-N14628 | Liposidomycin B | 99751-53-8 | Natural Products |
| HY-N14629 | Liposidomycin C | 99751-54-9 | Natural Products |
| HY-N14630 | Lividomycin B | 37636-51-4 | Natural Products |
| HY-N14632 | Louisianin A | 171784-03-5 | Natural Products |
| HY-N14633 | Louisianin B | 1192169-18-8 | Natural Products |
| HY-N14634 | Louisianin C | 171784-05-7 | Natural Products |
| HY-N14635 | Paeciloquinone A | 162797-33-3 | Natural Products |
| HY-N14636 | Paeciloquinone B | 162797-34-4 | Natural Products |
| HY-N14637 | Paeciloquinone C | 92439-42-4 | Natural Products |
| HY-N14638 | Paeciloquinone D | 162797-35-5 | Natural Products |
| HY-N14639 | Paeciloquinone E | 162797-36-6 | Natural Products |
| HY-N14640 | Paeciloquinone F | 162797-37-7 | Natural Products |
| HY-N14641 | Panclicin A | 160669-37-4 | Natural Products |
| HY-N14642 | Panclicin B | 160700-42-5 | Natural Products |
| HY-N14643 | Panclicin C | 160669-43-2 | Natural Products |
| HY-N14644 | Hazimycin 5 | 84894-71-3 | Natural Products |
| HY-N14646 | Panclicin D | 160669-44-3 | Natural Products |
| HY-N14647 | Panclicin E | 160669-45-4 | Natural Products |
| HY-N14648 | Purpactin B | 133806-60-7 | Natural Products |
| HY-N14649 | Purpactin C | 133806-61-8 | Natural Products |
| HY-N14650 | Hazimycin 6 | 84885-57-4 | Natural Products |
| HY-N14651 | Glucosylquestiomycin | 218150-62-0 | Natural Products |
| HY-N14652 | Glycocinnasperimicin D | 99260-73-8 | Natural Products |
| HY-N14653 | Glysperin A | 78213-56-6 | Natural Products |
| HY-N14654 | Glysperin B | 78213-55-5 | Natural Products |
| HY-N14655 | Paulomenol A | 94739-81-8 | Natural Products |
| HY-N14656 | Paulomenol B | 97670-28-5 | Natural Products |
| HY-N14657 | Paulomycin A2 | 101411-68-1 | Natural Products |
| HY-N14658 | Phosmidosine B | 146425-23-2 | Natural Products |
| HY-N14659 | Pilatin | 119525-97-2 | Natural Products |
| HY-N14660 | Granaticin B | 19879-03-9 | Natural Products |
| HY-N14662 | Griseolic acid B | 98890-01-8 | Natural Products |
| HY-N14664 | Actithiazic acid | 539-35-5 | Natural Products |
| HY-N14667 | Cladospolide A | 77663-54-8 | Natural Products |
| HY-N14668 | Cladospolide B | 96443-55-9 | Natural Products |
| HY-N14669 | Cladospolide D | 371229-61-7 | Natural Products |
| HY-N14670 | Pentenocin A | 249283-62-3 | Natural Products |
| HY-N14671 | Hedamycin | 11048-97-8 | Natural Products |
| HY-N14672 | Pentenocin B | 249283-63-4 | Natural Products |
| HY-N14673 | Helvecardin A | 119979-33-8 | Natural Products |
| HY-N14674 | Permetin A | 71888-70-5 | Natural Products |
| HY-N14675 | Helvecardin B | 119979-34-9 | Natural Products |
| HY-N14676 | Phenochalasin B | 207679-46-7 | Natural Products |
| HY-N14677 | Pillaromycin A | 30361-37-6 | Natural Products |
| HY-N14678 | Piloquinone | 25414-26-0 | Natural Products |
| HY-N14679 | Pinselin | 476-53-9 | Natural Products |
| HY-N14680 | Glysperin C | 78213-54-4 | Natural Products |
| HY-N14681 | Griseorhodin A | 11048-91-2 | Natural Products |
| HY-N14682 | Helvolinic acid | 10072-61-4 | Natural Products |
| HY-N14683 | Griseusin A | 59554-11-9 | Natural Products |
| HY-N14684 | Griseusin B | 59554-12-0 | Natural Products |
| HY-N14685 | Heptaibin | 291311-47-2 | Natural Products |
| HY-N14686 | Phencomycin | 146615-53-4 | Natural Products |
| HY-N14687 | Herbicidin B | 55353-32-7 | Natural Products |
| HY-N14688 | Phenylpyropene B | 556013-83-3 | Natural Products |
| HY-N14689 | Hibarimicin D | 208588-87-8 | Natural Products |
| HY-N14690 | Piperazinomycin | 83858-82-6 | Natural Products |
| HY-N14691 | Platenomycin C3 | 35908-44-2 | Natural Products |
| HY-N14692 | Pluracidomycin A1 | 82138-64-5 | Natural Products |
| HY-N14693 | Pluracidomycin B | 82138-65-6 | Natural Products |
| HY-N14694 | Pluracidomycin C1 | 82138-66-7 | Natural Products |
| HY-N14696 | Cytochalasin M | 79648-73-0 | Natural Products |
| HY-N14698 | Cytotrienin A | 208527-57-5 | Natural Products |
| HY-N14701 | 2-Hydroxygentamicin A3 | 78874-52-9 | Natural Products |
| HY-N14702 | 2-Hydroxygentamicin B | 78874-50-7 | Natural Products |
| HY-N14703 | 2-Hydroxygentamicin B1 | 78874-51-8 | Natural Products |
| HY-N14704 | 2-Hydroxygentamicin C1 | 60609-40-7 | Natural Products |
| HY-N14705 | 2-Hydroxygentamicin C2 | 60768-15-2 | Natural Products |
| HY-N14706 | Kibdelin A | 103528-50-3 | Natural Products |
| HY-N14707 | Kibdelin B | 103528-49-0 | Natural Products |
| HY-N14708 | Kibdelin C1 | 103549-47-9 | Natural Products |
| HY-N14709 | Kibdelin C2 | 105997-85-1 | Natural Products |
| HY-N14710 | Kibdelin D | 105997-86-2 | Natural Products |
| HY-N14711 | Himalomycin A | 701915-10-8 | Natural Products |
| HY-N14713 | Gualamycin | 161017-23-8 | Natural Products |
| HY-N14714 | Gunacin | 73341-70-5 | Natural Products |
| HY-N14715 | Gypsetin | 155114-38-8 | Natural Products |
| HY-N14716 | Haematocin | 262425-39-8 | Natural Products |
| HY-N14717 | Polymyxin M | 6683-17-6 | Natural Products |
| HY-N14718 | Porothramycin A | 110652-73-8 | Natural Products |
| HY-N14719 | Porothramycin B | 110652-72-7 | Natural Products |
| HY-N14722 | Lactonamycin | 182234-02-2 | Natural Products |
| HY-N14726 | Primocarcin | 3750-26-3 | Natural Products |
| HY-N14728 | Homoalanosine | 114707-36-7 | Natural Products |
| HY-N14733 | 31-Homorifamycin W | 157049-51-9 | Natural Products |
| HY-N14740 | Lanopylin A1 | 608135-01-9 | Natural Products |
| HY-N14741 | Lanopylin A2 | 679411-84-8 | Natural Products |
| HY-N14743 | Lanopylin B1 | 608135-02-0 | Natural Products |
| HY-N14744 | Lanopylin B2 | 679411-86-0 | Natural Products |
| HY-N14745 | Elaiomycin | 23315-05-1 | Natural Products |
| HY-N14746 | Elizabethin | 78361-81-6 | Natural Products |
| HY-N14747 | Elloramycin | 97218-42-3 | Natural Products |
| HY-N14748 | Elsamicin B | 97068-31-0 | Natural Products |
| HY-N14749 | Emerin | 40581-18-8 | Natural Products |
| HY-N14750 | Emimycin | 3735-46-4 | Natural Products |
| HY-N14752 | Hydroxymycotrienin A | 178550-61-3 | Natural Products |
| HY-N14753 | Juglomycin A | 38637-88-6 | Natural Products |
| HY-N14754 | Juglomycin B | 38637-89-7 | Natural Products |
| HY-N14755 | Juvenimicin A2 | 61417-47-8 | Natural Products |
| HY-N14759 | Matlystatin B | 140923-32-6 | Natural Products |
| HY-N14760 | Leucomycin A9 | 18361-49-4 | Natural Products |
| HY-N14761 | Matlystatin D | 140638-25-1 | Natural Products |
| HY-N14762 | Leucomycin V | 22875-15-6 | Natural Products |
| HY-N14764 | 2-Hydroxyaclacinomycin A | 79127-36-9 | Natural Products |
| HY-N14767 | Naphthablin | 167568-51-6 | Natural Products |
| HY-N14770 | Matlystatin E | 140638-26-2 | Natural Products |
| HY-N14771 | Matlystatin F | 140667-42-1 | Natural Products |
| HY-N14772 | Laccaridione A | 320369-80-0 | Natural Products |
| HY-N14773 | Laccaridione B | 320369-81-1 | Natural Products |
| HY-N14774 | Lactoquinomycin B | 101342-94-3 | Natural Products |
| HY-N14775 | Lavanduquinocin | 167114-85-4 | Natural Products |
| HY-N14777 | Hydroxyakalone | 182056-35-5 | Natural Products |
| HY-N14779 | Mureidomycin A | 114797-04-5 | Natural Products |
| HY-N14780 | Pochonin D | 544712-82-5 | Natural Products |
| HY-N14784 | Dechloromycorrhizin A | 161815-17-4 | Natural Products |
| HY-N14785 | Deflectin 1a | 79495-61-7 | Natural Products |
| HY-N14786 | 2-Hydroxy-5-iminoazacyclopent-3-ene | 71765-74-7 | Natural Products |
| HY-N14787 | Basidalin | 82501-56-2 | Natural Products |
| HY-N14788 | Cephemimycin | 34279-51-1 | Natural Products |
| HY-N14790 | Mureidomycin B | 114797-05-6 | Natural Products |
| HY-N14795 | Leucomentin-5 | 300662-10-6 | Natural Products |
| HY-N14796 | Leucomentin-6 | 300662-28-6 | Natural Products |
| HY-N14797 | Macquarimicin A | 165561-14-8 | Natural Products |
| HY-N14798 | Macquarimicin B | 165561-13-7 | Natural Products |
| HY-N14799 | Mycobacillin | 18524-67-9 | Natural Products |
| HY-N14800 | 5-Hydroxymethylblasticidin S | 123067-52-7 | Natural Products |
| HY-N14803 | Nanaomycin B | 52934-85-7 | Natural Products |
| HY-N14815 | Nanaomycin D | 60325-08-8 | Natural Products |
| HY-N14819 | Defucogilvocarcin V | 80155-95-9 | Natural Products |
| HY-N14825 | Erythroskyrine | 4987-27-3 | Natural Products |
| HY-N14826 | Nanaomycin E | 72660-52-7 | Natural Products |
| HY-N14829 | Naphthoquinomycin A | 101190-62-9 | Natural Products |
| HY-N14830 | 3-Hydroxyrifamycin S | 75922-14-4 | Natural Products |
| HY-N14833 | Naphthoquinomycin B | 101190-61-8 | Natural Products |
| HY-N14836 | Macquarimicin C | 165561-12-6 | Natural Products |
| HY-N14837 | Lymphostin | 191474-39-2 | Natural Products |
| HY-N14838 | Neoenactin A | 88231-85-0 | Natural Products |
| HY-N14839 | Neoenactin B2 | 88231-87-2 | Natural Products |
| HY-N14840 | 1-Hydroxysulfurmycin A | 79234-80-3 | Natural Products |
| HY-N14841 | Naphthyridinomycin | 54913-26-7 | Natural Products |
| HY-N14844 | Napyradiomycin C2 | 103106-19-0 | Natural Products |
| HY-N14845 | Napsamycin A | 126049-03-4 | Natural Products |
| HY-N14847 | 1-Hydroxyauramycin B | 79206-72-7 | Natural Products |
| HY-N14849 | 1-Hydroxyauramycin A | 79217-17-7 | Natural Products |
| HY-N14850 | Napsamycin B | 144408-86-6 | Natural Products |
| HY-N14851 | Napsamycin C | 144379-26-0 | Natural Products |
| HY-N14852 | Napsamycin D | 144379-27-1 | Natural Products |
| HY-N14853 | Ossamycin | 2057463-74-6 | Natural Products |
| HY-N14859 | 4-Hydroxybaumycinol A1 | 78919-31-0 | Natural Products |
| HY-N14860 | Milbemycin β3 | 56198-39-1 | Natural Products |
| HY-N14870 | Ostreogrycin B3 | 31508-69-7 | Natural Products |
| HY-N14877 | Enactin Ia | 130640-30-1 | Natural Products |
| HY-N14878 | Enactin Ⅰb | 137252-26-7 | Natural Products |
| HY-N14880 | Oudenone | 31323-50-9 | Natural Products |
| HY-N14887 | Phleomycin E | 11031-13-3 | Natural Products |
| HY-N14888 | Phyllosinol | 24292-29-3 | Natural Products |
| HY-N14891 | Pristinamycin ⅠC | 28979-74-0 | Natural Products |
| HY-N14892 | Cetoniacytone A | 496775-48-5 | Natural Products |
| HY-N14893 | Cetoniacytone B | 496775-49-6 | Natural Products |
| HY-N14894 | Promothiocin B | 156737-06-3 | Natural Products |
| HY-N14895 | Chitinovorin A | 95041-98-8 | Natural Products |
| HY-N14896 | Chitinovorin C | 95230-98-1 | Natural Products |
| HY-N14900 | Milbemycin β1 | 51596-16-8 | Natural Products |
| HY-N14902 | Mimosamycin | 59493-94-6 | Natural Products |
| HY-N14905 | α-Prumycin hydrochloride | 54612-75-8 | Natural Products |
| HY-N14912 | β-Prumycin hydrochloride | 54612-74-7 | Natural Products |
| HY-N14916 | Quinomycin C | 11001-74-4 | Natural Products |
| HY-N14925 | Citrinin hydrate | 157643-56-6 | Natural Products |
| HY-N14964 | Epihygromycin | 75081-92-4 | Natural Products |
| HY-N14967 | Epicillin | 26774-90-3 | Natural Products |
| HY-N14968 | Enniatin F | 144446-20-8 | Natural Products |
| HY-N14986 | Methylenomycin A | 52775-76-5 | Natural Products |
| HY-N14987 | Methylenomycin B | 52775-77-6 | Natural Products |
| HY-N14989 | Fluostatin A | 160219-74-9 | Natural Products |
| HY-N14992 | Melleolide L | 298702-67-7 | Natural Products |
| HY-N14997 | Fulvoplumierin | 20867-01-0 | Natural Products |
| HY-N14998 | Damavaricin D | 59556-95-5 | Natural Products |
| HY-N15000 | Lipomycin β | 51053-41-9 | Natural Products |
| HY-N15001 | Gabaculine | 59556-18-2 | Natural Products |
| HY-N15004 | Galactostatin | 107537-94-0 | Natural Products |
| HY-N15009 | Kynapcin-13 | 476337-32-3 | Natural Products |
| HY-N15010 | Kynapcin-28 | 476337-33-4 | Natural Products |
| HY-N15011 | Ganoderic acid W | 86377-49-3 | Natural Products |
| HY-N15012 | 6-O-Demethyl-5-deoxyfusarubin | 132899-05-9 | Natural Products |
| HY-N15016 | 4-Deoxybostrycin | 21879-83-4 | Natural Products |
| HY-N15017 | Katanosin A | 116103-86-7 | Natural Products |
| HY-N15019 | Glycothiohexide α | 158446-31-2 | Natural Products |
| HY-N15020 | Izumenolide | 76265-39-9 | Natural Products |
| HY-N15022 | Azirinomycin | 31772-89-1 | Natural Products |
| HY-N15023 | Azoxybacilin | 157998-96-4 | Natural Products |
| HY-N15025 | Hydroxynybomycin | 63582-81-0 | Natural Products |
| HY-N15026 | 13-Hydroxyglucopiericidin A | 132150-13-1 | Natural Products |
| HY-N15027 | Istamycin B | 72523-64-9 | Natural Products |
| HY-N15030 | Diatretyne Ⅰ | 544-04-7 | Natural Products |
| HY-N15031 | Fumarprotocetraric acid | 489-50-9 | Natural Products |
| HY-N15033 | Ganoderic acid U | 86377-51-7 | Natural Products |
| HY-N15034 | 7-Hydroxyguanine | 16870-91-0 | Natural Products |
| HY-N15035 | Bis(N-methylthioformohydroxamate)nickel (II) | 31541-90-9 | Natural Products |
| HY-N15038 | Haloquinone | 80902-01-8 | Natural Products |
| HY-N15039 | 5-Hydroxymethyltubercidin | 49558-38-5 | Natural Products |
| HY-N15041 | Hitachimycin | 77642-19-4 | Natural Products |
| HY-N15042 | 9-Hydroxyoudemansin A | 225937-85-9 | Natural Products |
| HY-N15046 | Barminomycin I | 108147-17-7 | Natural Products |
| HY-N15047 | Barminomycin II | 108089-33-4 | Natural Products |
| HY-N15049 | Cefminox | 84305-41-9 | Natural Products |
| HY-N15050 | Cervicarcin | 18700-78-2 | Natural Products |
| HY-N15051 | Harveynone | 142435-66-3 | Natural Products |
| HY-N15052 | Monorden C | 544712-80-3 | Natural Products |
| HY-N15056 | Chainin | 38264-25-4 | Natural Products |
| HY-N15057 | Chivosazol A | 169181-40-2 | Natural Products |
| HY-N15058 | Chlorogentisylquinone | 333344-08-4 | Natural Products |
| HY-N15059 | Cissetin | 691407-97-3 | Natural Products |
| HY-N15060 | 2-Hydroxybutirosin | 59867-75-3 | Natural Products |
| HY-N15062 | 2-Hydroxymethylclavam | 66036-39-3 | Natural Products |
| HY-N15063 | 10-Hydroxyundeca-2,4,6,8-tetraynamide | 83475-37-0 | Natural Products |
| HY-N15066 | 16-Hydroxyroridin L-2 | 87292-18-0 | Natural Products |
| HY-N15068 | 1-Hydroxyoxaunomycin | 145165-10-2 | Natural Products |
| HY-N15070 | Polyozellin | 197703-46-1 | Natural Products |
| HY-N15076 | Herbimycin B | 76207-83-5 | Natural Products |
| HY-N15077 | 11-Deacetoxywortmannin | 31652-69-4 | Natural Products |
| HY-N15078 | 4-Chlorothreonine | 142698-80-4 | Natural Products |
| HY-N15082 | Hypnophilin | 80677-96-9 | Natural Products |
| HY-N15083 | Iodinin | 68-81-5 | Natural Products |
| HY-N15084 | Isocycloheximide | 6746-42-5 | Natural Products |
| HY-N15085 | Leucomycin A6 | 18361-48-3 | Natural Products |
| HY-N15086 | Leucomycin U | 31642-61-2 | Natural Products |
| HY-N15087 | Lunatoic acid A | 65745-48-4 | Natural Products |
| HY-N15088 | Lunatoic acid B | 65745-49-5 | Natural Products |
| HY-N15089 | Melleolide M | 264229-82-5 | Natural Products |
| HY-N15100 | Pristinamycin ⅡB | 21102-49-8 | Natural Products |
| HY-N15101 | Rifamycin L | 26117-02-2 | Natural Products |
| HY-N15103 | Hydroxymycotrienin B | 178550-62-4 | Natural Products |
| HY-N15104 | 11-Deoxy-13-deoxodaunorubicin | 71800-92-5 | Natural Products |
| HY-N15106 | 11-Deoxy-13-dihydrodaunorubicin | 71800-90-3 | Natural Products |
| HY-N15124 | 1-Deamino-1-hydroxysagamicin | 72614-86-9 | Natural Products |
| HY-N15125 | 1-Deamino-1-hydroxygentamicin C2 | 72854-56-9 | Natural Products |
| HY-N15126 | 1-Deamino-1-hydroxygentamicin C1a | 66065-96-1 | Natural Products |
| HY-N15127 | 3-O-Demethyl-2'-N-glylfortimicin B | 71640-65-8 | Natural Products |
| HY-N15128 | 7β,8β-Epoxyroridin H | 64687-85-0 | Natural Products |
| HY-N15129 | 7β,8β-2′,3′-Diepoxyroridin H | 64687-84-9 | Natural Products |
| HY-N15351 | Flavokermesic acid | 18499-84-8 | Natural Products |
| HY-N15353 | 1-Palmitoyl-2-linoleoyl-sn-glycerol | 51621-26-2 | Natural Products |
| HY-N15354 | Jujubasaponin IV | 146445-93-4 | Natural Products |
| HY-N15356 | 9-Oxooctadecanedioic acid | 2489590-40-9 | Natural Products |
| HY-N15357 | Falcarindiol 3-acetate | 22526-53-0 | Natural Products |
| HY-N15376 | 12-Hydroxydihydrochelirubine | 131984-77-5 | Natural Products |
| HY-N15389 | Noformicin | 155-38-4 | Natural Products |
| HY-N15390 | Cerexin B1 | 70943-81-6 | Natural Products |
| HY-N15391 | 1-Hydroxy-2-nonyn-4-one | 81474-56-8 | Natural Products |
| HY-N15392 | Lactonamycin Z | 709032-67-7 | Natural Products |
| HY-N15393 | Cerexin B4 | 70943-84-9 | Natural Products |
| HY-N15394 | Cerexin D4 | 70943-88-3 | Natural Products |
| HY-N15395 | Dermadin | 12698-52-1 | Natural Products |
| HY-N15396 | Exophilin A | 172703-87-6 | Natural Products |
| HY-N15398 | Chaetoglobosin E | 55945-74-9 | Natural Products |
| HY-N15418 | Mikanolide | 17928-61-9 | Natural Products |
| HY-N15420 | Leucomycin A7 | 18361-47-2 | Natural Products |
| HY-N15421 | Leucomycin A8 | 18361-50-7 | Natural Products |
| HY-N15422 | Glucoputranjivin | 18432-16-1 | Natural Products |
| HY-N15423 | Acrophylline | 18904-40-0 | Natural Products |
| HY-N15424 | Himachalol | 1891-45-8 | Natural Products |
| HY-N15426 | Herbicidal agent 9 | 19467-61-9 | Natural Products |
| HY-N15440 | Mutatochrome | 515-06-0 | Natural Products |
| HY-N15443 | Mevalocidin | 887028-34-4 | Natural Products |
| HY-N15444 | Bullatenone | 493-71-0 | Natural Products |
| HY-N15447 | Visnaginone | 484-27-5 | Natural Products |
| HY-N15448 | Dihydrosamidin | 6005-18-1 | Natural Products |
| HY-N15449 | Vicanicin | 33211-22-2 | Natural Products |
| HY-N15450 | Undulatine | 6882-09-3 | Natural Products |
| HY-N15451 | Deoxytopsentin | 112515-42-1 | Natural Products |
| HY-N15452 | Eseramine | 6091-57-2 | Natural Products |
| HY-N15453 | Asperenone | 18810-05-4 | Natural Products |
| HY-N15454 | Altenuisol | 1188382-26-4 | Natural Products |
| HY-N15456 | Cryptolepinone | 178884-07-6 | Natural Products |
| HY-N15473 | Isopaucifloral F | 1001259-00-2 | Natural Products |
| HY-N15496 | Fusaproliferin | 152469-17-5 | Natural Products |
| HY-N15500 | Trichodermoside | 3074780-91-6 | Natural Products |
| HY-N15501 | Trichaspside F | 3075431-03-4 | Natural Products |
| HY-N15502 | Cycloneroside A | 3075431-04-5 | Natural Products |
| HY-N15503 | Cycloneroside B | 3075431-05-6 | Natural Products |
| HY-N15504 | Cycloneroside C | 3075431-06-7 | Natural Products |
| HY-N15505 | Cycloneroside D | 3075431-07-8 | Natural Products |
| HY-N15506 | Cycloneroside E | 3075431-08-9 | Natural Products |
| HY-N15507 | Harzianoside A | 3075431-09-0 | Natural Products |
| HY-N15508 | Harzianoside B | 3075431-10-3 | Natural Products |
| HY-N15509 | Harzianol K | 3038319-61-5 | Natural Products |
| HY-N15510 | Harzianol J | 2671032-64-5 | Natural Products |
| HY-N15522 | Bi-magnolignan | 2883117-61-9 | Natural Products |
| HY-N2362S8 | DL-Alanine-d7 | Isotope-Labeled Compounds | |
| HY-N2362S9 | DL-Alanine-13C2,15N | 221080-39-3 | Isotope-Labeled Compounds |
| HY-N3422A | (rac)-Khellactone | 518-76-3 | Natural Products |
| HY-N5174 | Azetomycin II | 59481-55-9 | Natural Products |
| HY-N5175 | Cephaibol A | 304911-38-4 | Natural Products |
| HY-N5176 | Cephaibol B | 304911-39-5 | Natural Products |
| HY-N5177 | Cephaibol D | 280774-64-3 | Natural Products |
| HY-N5178 | Chloropeptin I | 160219-64-7 | Natural Products |
| HY-N5179 | Chloropeptin II | 69598-75-0 | Natural Products |
| HY-N5185 | Cyclothiazomycin | 133352-26-8 | Natural Products |
| HY-N5186 | Cypemycin | 154277-21-1 | Natural Products |
| HY-N5187 | Edeine A1 | 27656-72-0 | Natural Products |
| HY-N5188 | Emerimicin III | 52931-42-7 | Natural Products |
| HY-N5189 | Emerimicin IV | 52931-43-8 | Natural Products |
| HY-N5190 | Enamidonin | 2271109-33-0 | Natural Products |
| HY-N5191 | Epidermin | 99165-17-0 | Natural Products |
| HY-N5192 | Galacardin A | 137801-55-9 | Natural Products |
| HY-N5193 | Galacardin B | 137801-54-8 | Natural Products |
| HY-N5194 | Lipohexin | 193751-58-5 | Natural Products |
| HY-N5202 | Aspochalasin A | 72363-48-5 | Natural Products |
| HY-N5203 | Ala0-Actagardine | 223465-14-3 | Natural Products |
| HY-N5204 | Clavalanine | 74758-63-7 | Natural Products |
| HY-N7046S | Silybin B-d3 | Isotope-Labeled Compounds | |
| HY-N7101S1 | Cefpodoxime Proxetil-d6 | Isotope-Labeled Compounds | |
| HY-N7515A | (E)-Pinocembrin chalcone | 82451-30-7 | Natural Products |
| HY-N8253S | Quercetin 4'-Glucoside-d3 | Isotope-Labeled Compounds | |
| HY-N8543 | Gliocladic acid | 82425-48-7 | Natural Products |
| HY-N9468 | Gentamicin C2a | 59751-72-3 | Natural Products |
| HY-N9629 | Cyclooctatin | 139552-97-9 | Natural Products |
| HY-N9720 | Herbarin | 36379-67-6 | Natural Products |
| HY-NP077A | Phaseolus vulgaris Lectin-P | Biochemical Assay Reagents | |
| HY-NP077B | Phaseolus vulgaris Lectin-M | Biochemical Assay Reagents | |
| HY-NP078A | Pisum Sativum Agglutinin (FITC) | Biochemical Assay Reagents | |
| HY-NP083A | Wisteria Floribunda Lectin (Biotin) | Biochemical Assay Reagents | |
| HY-NP090A | Ulex Europaeus Agglutinin I (peroxidase) | Biochemical Assay Reagents | |
| HY-NP186 | Helix pomatia Agglutinin | Biochemical Assay Reagents | |
| HY-NP186A | Helix pomatia Agglutinin (Biotin) | Biochemical Assay Reagents | |
| HY-NP187 | Phytolacca americana Lectin | Biochemical Assay Reagents | |
| HY-NP188 | Lycopersicon esculentum (Tomato) Lectin (FITC) | Biochemical Assay Reagents | |
| HY-NP189 | Human Immunoglobulin G | Biochemical Assay Reagents | |
| HY-NP191 | Human Immunoglobulin M | Biochemical Assay Reagents | |
| HY-NP192 | Sericin | Biochemical Assay Reagents | |
| HY-P0009S1 | Cetrorelix-d10 | Isotope-Labeled Compounds | |
| HY-P0036S2 | Octreotide-d8 | 1240797-41-4 | Isotope-Labeled Compounds |
| HY-P0036S3 | Octreotide-13C9,15N | Isotope-Labeled Compounds | |
| HY-P0036S4 | Octreotide-d8 (acetate) | Isotope-Labeled Compounds | |
| HY-P10358A | TAT-CBD3A6K (acetate) | Peptides | |
| HY-P10496A | MAGE-A1-derived peptide (acetate) | Peptides | |
| HY-P10501A | FRα-targeting peptide C7 (TFA) | Peptides | |
| HY-P10638A | TAT-CN21 (scrambled) | Peptides | |
| HY-P10708A | SVS-1 peptide (acetate) | Peptides | |
| HY-P10737A | CGGK (acetate) | Peptides | |
| HY-P10798A | Eloralintide (sodium) | Peptides | |
| HY-P10915 | Linear daptomycin | 883991-21-7 | Peptides |
| HY-P10918 | F11R peptide (TFA) | Peptides | |
| HY-P10923 | KYS-1 | 592544-81-5 | Peptides |
| HY-P10933 | PRO20 | Peptides | |
| HY-P10935 | Amilo-5MER | 1860001-61-1 | Peptides |
| HY-P10935A | Amilo-5MER (TFA) | Peptides | |
| HY-P10936 | AQP4 (201-220) | 2104700-59-4 | Peptides |
| HY-P10936A | AQP4 (201-220) (TFA) | Peptides | |
| HY-P10937 | AQP4 (205-215) | 2891466-35-4 | Peptides |
| HY-P10937A | AQP4 (205-215) (TFA) | Peptides | |
| HY-P10939 | Ac-DMLD-CMK | 2588354-33-8 | Peptides |
| HY-P10940 | Ac-RFAAKAA-COOH | 845727-63-1 | Peptides |
| HY-P10944 | Unlabeled FXX489 | 3076330-05-4 | Peptides |
| HY-P10945 | FAP targeting peptide for FXX489 | 3076328-74-7 | Peptides |
| HY-P10946 | FAP targeting peptide-PEG2 conjugate | 3076328-71-4 | Peptides |
| HY-P1681A | GpTx-1 (TFA) | Peptides | |
| HY-P4056A | CIGB-300 (acetate) | Peptides | |
| HY-P4091A | LSD (acetate) | Peptides | |
| HY-P4428A | Z-Val-Lys-Met-AMC (TFA) | Peptides | |
| HY-P4464A | Ala-Phe-Pro-pNA (TFA) | Peptides | |
| HY-P5392A | Apelin-16, human, bovine (acetate) | Peptides | |
| HY-P5592A | Temporin B (acetate) | Peptides | |
| HY-P5925A | Ssm spooky toxin (TFA) | Peptides | |
| HY-P6443 | NTPA (TFA) | Peptides | |
| HY-P702498 | ADAM10, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704017 | Cathepsin C/DPPI, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704021 | Dihydroorotate Dehydrogenase, Human (C-His) | Recombinant Proteins | |
| HY-P704130 | IL-22, Canine (HEK293, His) | Recombinant Proteins | |
| HY-P704131 | MMP-14, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704132 | CBX5, Human (His, Myc) | Recombinant Proteins | |
| HY-P704133 | IL-22, Rabbit (HEK293, His) | Recombinant Proteins | |
| HY-P704134 | IL-22, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P704135 | FGF-1, Human (Biotinylated, His, Avi) | Recombinant Proteins | |
| HY-P704136 | ALK-7, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704137 | ALK-7, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704138 | LRG1, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P704139 | LSR, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704140 | IL-6, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704141 | Cadherin-17, Human (105a.a, HEK293, mFc) | Recombinant Proteins | |
| HY-P704142 | CD79, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704143 | NPR1/NPRA, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704144 | IL-22, Pig (HEK293, His) | Recombinant Proteins | |
| HY-P704145 | CEACAM6, Cynomolgus (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704146 | IL-31R alpha, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704147 | Cadherin-6/KCAD, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704148 | FABP3, Human | Recombinant Proteins | |
| HY-P704149 | ALK-7, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704150 | ROBO1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704151 | TRBC2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704152 | TRBC2, Human (Biotinylated, HEK293, His, Avi) | Recombinant Proteins | |
| HY-P704153 | TRBC1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704154 | TRDC, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704155 | TMEM119, Human (P. pastoris, His) | Recombinant Proteins | |
| HY-P704156 | EMAP-II, Human (His) | Recombinant Proteins | |
| HY-P704157 | RNF182, Human (His) | Recombinant Proteins | |
| HY-P704158 | SLC1A5, Human (HEK293, His, TrxA) | Recombinant Proteins | |
| HY-P704159 | STEAP1, Human (HEK293, His, Twin-Strep) | Recombinant Proteins | |
| HY-P704160 | Gremlin-1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704161 | PADI3, Human (Sf9, His) | Recombinant Proteins | |
| HY-P704162 | OLFML3, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704163 | NPTX2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704164 | Neurogranin, Human (His) | Recombinant Proteins | |
| HY-P704165 | PLD6, Human | Recombinant Proteins | |
| HY-P704166 | ATP6, Human (His) | Recombinant Proteins | |
| HY-P704167 | FGF-20, Mouse (His) | Recombinant Proteins | |
| HY-P704168 | MARCHF1, Human (His) | Recombinant Proteins | |
| HY-P704169 | SLC25A4, Human (His) | Recombinant Proteins | |
| HY-P704170 | Integrin alpha V beta 7, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704171 | Integrin alpha V beta 7, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704172 | TYK2, Human (Active, sf9, His) | Recombinant Proteins | |
| HY-P704173 | FLT3 Ligand, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704174 | EphA2, Rat (HEK293, His) | Recombinant Proteins | |
| HY-P704175 | Glypican-4/GPC4, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704176 | NTN1, Human (HEK293, His) | Recombinant Proteins | |
| HY-P704177 | KRAS, Human (Active, G13D, His) | Recombinant Proteins | |
| HY-P704178 | Mucin-1/MUC1, Mouse (HEK293, His) | Recombinant Proteins | |
| HY-P704179 | P5CS, Human | Recombinant Proteins | |
| HY-P704180 | SLC16A3, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P704181 | Decorin/PGS2, Bovine (His) | Recombinant Proteins | |
| HY-P704182 | SPRR4, Mouse (His) | Recombinant Proteins | |
| HY-P704183 | ATP2A1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P704184 | ZBP1, Mouse (HEK293, His, Flag) | Recombinant Proteins | |
| HY-P704185 | Gastrin-71, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704187 | AHR, Human (His) | Recombinant Proteins | |
| HY-P704188 | ZBP1, Human (His, Myc) | Recombinant Proteins | |
| HY-P704189 | SLC39A1, Human (GST) | Recombinant Proteins | |
| HY-P704190 | DOT1L, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P704191 | SLC40A1, Human (HEK293) | Recombinant Proteins | |
| HY-P704192 | PLY, Streptococcus pneumoniae serotype 4 | Recombinant Proteins | |
| HY-P704193 | SOS1, (Active, sf9, His) | Recombinant Proteins | |
| HY-P704194 | GPBAR1, Human (Cell-Free, His) | Recombinant Proteins | |
| HY-P704195 | CSNK1E, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P704196 | FOXC1, Human (C-His) | Recombinant Proteins | |
| HY-P704197 | EGFR, Human (L861Q, Active, sf9, GST) | Recombinant Proteins | |
| HY-P704198 | Zaire ebolavirus VP30 (His) | Recombinant Proteins | |
| HY-P704199 | PPP1CB, Human (Active, sf9, GST) | Recombinant Proteins | |
| HY-P704200 | RIPK1, Mouse (C-His) | Recombinant Proteins | |
| HY-P704201 | IL-39, Human (HEK293, Fc) | Recombinant Proteins | |
| HY-P704202 | VCAM-1, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P704203 | Ara h 1, Arachis hypogaea (His) | Recombinant Proteins | |
| HY-P704204 | CDKN1A, Mouse (His) | Recombinant Proteins | |
| HY-P70699A | PDGF-BB, Mouse (C-His) | Recombinant Proteins | |
| HY-P7346A | FGF-8e, Human (193a.a) | Recombinant Proteins | |
| HY-P74829A | IL-17F, Rat (sf9, His) | Recombinant Proteins | |
| HY-P7529A | APOC2, Human (His) | Recombinant Proteins | |
| HY-P78575 | PADI2, Cynomolgus (sf9, His) | Recombinant Proteins | |
| HY-P78587 | GPA33, Cynomolgus (HEK293, His) | Recombinant Proteins | |
| HY-P78757 | Plexin B2, Human (HEK293, His) | Recombinant Proteins | |
| HY-P81749A | Phospho-p27 Kip 1 (Ser10) Antibody (YA1494) | Antibodies | |
| HY-P83748A | Digoxigenin Antibody(YA3475) | Antibodies | |
| HY-P83761 | Phospho-HER2(Tyr1221/Tyr1222) Antibody | Antibodies | |
| HY-P83762 | alpha Actinin Antibody(YA3561) | Antibodies | |
| HY-P83763 | EIF2S1 Antibody(YA3562) | Antibodies | |
| HY-P83764 | pan Cytokeratin Antibody(YA3563) | Antibodies | |
| HY-P83765 | K Cadherin Antibody(YA3564) | Antibodies | |
| HY-P83766 | eRF3a Antibody | Antibodies | |
| HY-P83767 | Phospho-S6 Ribosomal Protein (Ser235/Ser236) Antibody | Antibodies | |
| HY-P83768 | CD11c Antibody(YA3565) | Antibodies | |
| HY-P83769 | SLFN11 Antibody | Antibodies | |
| HY-P83770 | DLL3 Antibody(YA3566) | Antibodies | |
| HY-P83771 | Phospho-Smad1/5/9 (S463/S465/S467)Antibody(YA3567) | Antibodies | |
| HY-P83772 | Phospho-SMAD2 (S465+467)Antibody(YA3568) | Antibodies | |
| HY-P83773 | CFTR Antibody(YA3569) | Antibodies | |
| HY-P83774 | Phospho-MAPKAPK2 (Thr334) Antibody | Antibodies | |
| HY-P83775 | HNF 4 alpha Antibody (YA3571) | Antibodies | |
| HY-P83776 | Goat Anti-Human IgG H&L (AF488) | Antibodies | |
| HY-P83777 | SYP121 Antibody | Antibodies | |
| HY-P83778 | Phospho-Tau (T217) Antibody (YA3476) | Antibodies | |
| HY-P83779 | Phospho-Tau (T231) Antibody (YA3477) | Antibodies | |
| HY-P83780 | OPN3 Antibody | Antibodies | |
| HY-P83781 | Mouse anti Human Kappa Light Chain | Reference compound | |
| HY-P991110 | Anti-Mouse CD25 Antibody (7D4) | Inhibitory Antibodies | |
| HY-P991111 | Anti-Mouse TIGIT Antibody (10A7) | Inhibitory Antibodies | |
| HY-P991112 | Anti-Mouse CD8α Antibody (YTS169.4) | Inhibitory Antibodies | |
| HY-P991115 | Adimanebart | 3011838-77-7 | Inhibitory Antibodies |
| HY-P991116 | Amdokitug | 3012586-05-6 | Inhibitory Antibodies |
| HY-P991117 | Amrecibart | 3008610-20-3 | Inhibitory Antibodies |
| HY-P991118 | Arumakimig | 3018901-76-0 | Inhibitory Antibodies |
| HY-P991119 | Balekafusp alfa | 2866185-77-3 | Inhibitory Antibodies |
| HY-P991121 | Baloncibart | 2988795-75-9 | Inhibitory Antibodies |
| HY-P991125 | Cenzestotug | 3014361-58-8 | Inhibitory Antibodies |
| HY-P991126 | Ciltistotug | 3014361-59-9 | Inhibitory Antibodies |
| HY-P991127 | Claseprubart | 2922766-89-8 | Inhibitory Antibodies |
| HY-P991128 | Cliramitug | 2965214-50-8 | Inhibitory Antibodies |
| HY-P991129 | Crusekitug | 2956768-50-4 | Inhibitory Antibodies |
| HY-P991130 | Dalidnetug | 2991369-43-6 | Inhibitory Antibodies |
| HY-P991131 | Daretabart | 3011830-62-6 | Inhibitory Antibodies |
| HY-P991132 | Efclarofusp alfa | 3053638-35-7 | Inhibitory Antibodies |
| HY-P991133 | Efranarelaxin alfa | 2969217-22-7 | Inhibitory Antibodies |
| HY-P991134 | Elegrobart | 2832924-76-0 | Inhibitory Antibodies |
| HY-P991135 | Enzelkitug | 2999644-88-9 | Inhibitory Antibodies |
| HY-P991136 | Etuptamig | 3009874-10-3 | Inhibitory Antibodies |
| HY-P991137 | Exerenibart | 2996101-49-4 | Inhibitory Antibodies |
| HY-P991138 | Firsekibart | 2981430-39-9 | Inhibitory Antibodies |
| HY-P991139 | Futermestotug | 3014361-57-7 | Inhibitory Antibodies |
| HY-P991140 | Garetatug | 3023285-05-1 | Inhibitory Antibodies |
| HY-P991141 | Inlecitug | 2997627-68-4 | Inhibitory Antibodies |
| HY-P991142 | Isuventatug | 2986317-23-9 | Inhibitory Antibodies |
| HY-P991143 | Ixotatug | 3018936-99-4 | Inhibitory Antibodies |
| HY-P991144 | Lasrekibart | 3021525-26-5 | Inhibitory Antibodies |
| HY-P991145 | Laventatug | 3009829-91-5 | Inhibitory Antibodies |
| HY-P991146 | Lecankitug | 2923284-76-6 | Inhibitory Antibodies |
| HY-P991147 | Ledostomig | 2769743-01-1 | Inhibitory Antibodies |
| HY-P991148 | Moflerafusp alfa | 2983848-20-8 | Inhibitory Antibodies |
| HY-P991149 | Nesfrotamig | 2966936-23-0 | Inhibitory Antibodies |
| HY-P991150 | Ompekimig | 2981477-39-6 | Inhibitory Antibodies |
| HY-P991151 | Opamtistomig | 2923499-76-5 | Inhibitory Antibodies |
| HY-P991152 | Oturkibart | 2956767-43-2 | Inhibitory Antibodies |
| HY-P991153 | Potravitug | 2923558-06-7 | Inhibitory Antibodies |
| HY-P991154 | Pumitamig | 2999726-97-3 | Inhibitory Antibodies |
| HY-P991155 | Ramantamig | 2988886-91-3 | Inhibitory Antibodies |
| HY-P991156 | Rapaprutug | 2994192-38-8 | Inhibitory Antibodies |
| HY-P991157 | Retavibart | 3023741-03-6 | Inhibitory Antibodies |
| HY-P991158 | Rinvatercept | 2996105-98-5 | Inhibitory Antibodies |
| HY-P991159 | Ruzaltatug | 2981438-63-3 | Inhibitory Antibodies |
| HY-P991160 | Suvonstobart | 2983834-87-1 | Inhibitory Antibodies |
| HY-P991161 | Tanruprubart | 2065212-40-8 | Inhibitory Antibodies |
| HY-P991162 | Tilrekimig | 2981469-90-1 | Inhibitory Antibodies |
| HY-P991163 | Tixentamig | 2969220-04-8 | Inhibitory Antibodies |
| HY-P991164 | Torvutatug | 2975630-15-8 | Inhibitory Antibodies |
| HY-P991165 | Trovostobart | 3006784-09-1 | Inhibitory Antibodies |
| HY-P991166 | Ubletamig | 3008247-27-3 | Inhibitory Antibodies |
| HY-P991167 | Vecantoxatug | 2956766-52-0 | Inhibitory Antibodies |
| HY-P991168 | Velaprumig | 2988741-17-7 | Inhibitory Antibodies |
| HY-P991169 | Zemocimig | 2955620-21-8 | Inhibitory Antibodies |
| HY-P991170 | Ibramvibart | 3031270-42-2 | Inhibitory Antibodies |
| HY-P991171 | Anti-CD4 Antibody (Hu5A8) | Inhibitory Antibodies | |
| HY-P991172 | JNJ-70218902 | Inhibitory Antibodies | |
| HY-P991173 | AMG-119 | Inhibitory Antibodies | |
| HY-P991174 | Anti-TREM2 Antibody (AL2p-58) | Inhibitory Antibodies | |
| HY-P991175 | Anti-Dectin-1 Antibody (2M24) | Inhibitory Antibodies | |
| HY-P991176 | RG-6333 | Inhibitory Antibodies | |
| HY-P991177 | Anti-c-Met/HGFR Antibody | Inhibitory Antibodies | |
| HY-P991178 | BMS-986156 | Inhibitory Antibodies | |
| HY-P991180 | TRX-518 | Inhibitory Antibodies | |
| HY-P991182 | Anti-CCR8 Antibody (10A11) | Inhibitory Antibodies | |
| HY-P991184 | Anti-LY6G6D Antibody (1G4) | Inhibitory Antibodies | |
| HY-P991185 | Anti-MST1R Antibody (MOR07692) | Inhibitory Antibodies | |
| HY-P991187 | Anti-TM4SF1 Antibody (AGX-A07) | Inhibitory Antibodies | |
| HY-P991194 | HFB-200301 | Inhibitory Antibodies | |
| HY-P991196 | Anti-CD24 Antibody (SWA11) | Inhibitory Antibodies | |
| HY-P991197 | Anti-GPRC5D Antibody | Inhibitory Antibodies | |
| HY-P991198 | M6903 | Inhibitory Antibodies | |
| HY-P991200 | OM-7D3-B3 | Inhibitory Antibodies | |
| HY-P991201 | REGN-7257 | Inhibitory Antibodies | |
| HY-P991202 | Anti-TSHR Antibody (M22) | Inhibitory Antibodies | |
| HY-P991204 | Anti-PSMA Antibody | Inhibitory Antibodies | |
| HY-P991206 | Human IgG2 lambda, Isotype Control | Inhibitory Antibodies | |
| HY-P991207 | Human IgG1 (L234A/L235A) kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P991502 | Armenian hamster IgG1 kappa, Isotype Control | Inhibitory Antibodies | |
| HY-P9937 | Arcitumomab | 154361-48-5 | Inhibitory Antibodies |
| HY-P9S0008 | Cetuximab (PBS) | Inhibitory Antibodies | |
| HY-R04612 | 4o8G-miR-592 | Oligonucleotides | |
| HY-RI04609 | rno-miR-34a-5p inhibitor | Oligonucleotides | |
| HY-RS01245A | ATR Human Pre-designed siRNA Set A-1 | Oligonucleotides | |
| HY-RS16492 | TAF1B Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16493 | TIGD3 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16494 | TMTC4 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16495 | UPK1A Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16496 | USP41 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16497 | ZBED5 Human Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16498 | Egf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16499 | Sds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16500 | Hmgb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16501 | Trpv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16502 | Cd36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16503 | Ldha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16504 | Hgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16505 | Pcsk9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16506 | Gpx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16507 | Lox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16508 | Mettl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16509 | Vhl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16510 | Fgf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16511 | Bmp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16512 | Sag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16513 | Ace2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16514 | Ccl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16515 | Trpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16516 | Fap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16517 | Stat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16518 | Cxcl10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16519 | Gsdmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16520 | C3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16521 | Usp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16522 | Mif Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16523 | Gdnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16524 | Cxcl12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16525 | Sts Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16526 | Trem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16527 | Cd40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16528 | Igf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16529 | Nrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16530 | Gip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16531 | Lif Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16532 | Nhs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16533 | Ahr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16534 | Cck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16535 | Ccl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16536 | Cd44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16537 | Vegfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16538 | Wrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16539 | Fgf21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16540 | Cd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16541 | Crbn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16542 | Gdf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16543 | Dkk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16544 | Gspt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16545 | Enpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16546 | Npy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16547 | Osm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16548 | Cd47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16549 | Nqo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16550 | Tg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16551 | Slc7a11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16552 | Atf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16553 | Usp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16554 | Abca1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16555 | Cntf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16556 | Acsl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16557 | Bcl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16558 | Pfkfb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16559 | Foxo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16560 | Trem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16561 | Txnip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16562 | Sp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16563 | Mlkl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16564 | Fer Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16565 | Tigit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16566 | Epo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16567 | Usp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16568 | Sos1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16569 | Pam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16570 | Smarca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16571 | Igf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16572 | Lcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16573 | Nr4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16574 | Eno1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16575 | Angptl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16576 | Hk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16577 | Ogt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16578 | Lck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16579 | S100a9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16580 | Tfeb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16581 | Tat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16582 | Fpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16583 | Mat2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16584 | Gapdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16585 | Cd19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16586 | Vip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16587 | Irf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16588 | Ptpn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16589 | Aim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16590 | Fgf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16591 | Fdx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16592 | Pgk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16593 | S100a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16594 | Ccl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16595 | Trpc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16596 | Tpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16597 | Axl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16598 | Bcr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16599 | Shh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16600 | Cd74 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16601 | Wdr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16602 | Cxcl13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16603 | Cx3cl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16604 | Blm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16605 | Fabp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16606 | Egr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16607 | Klf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16608 | Pink1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16609 | Ccl20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16610 | Fgf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16611 | Nrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16612 | Kif18a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16613 | Cxcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16614 | Trpc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16615 | Ldlr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16616 | Rrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16617 | Pdk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16618 | Mpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16619 | Fpr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16620 | Cdcp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16621 | Fabp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16622 | Gpnmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16623 | Trpv4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16624 | Mbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16625 | Cp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16626 | Bmp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16627 | Loxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16628 | Tslp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16629 | Sfn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16630 | Gpc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16631 | Glp1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16632 | Foxo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16633 | Pth Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16634 | Usp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16635 | Fen1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16636 | Kdm5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16637 | pc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16638 | Usp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16639 | Cxcl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16640 | Cyp1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16641 | Foxm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16642 | Ccl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16643 | Gstp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16644 | H2ax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16645 | Cd86 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16646 | Il11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16647 | Anxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16648 | Mthfd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16649 | Fgf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16651 | Dtnb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16652 | Sox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16653 | Cxcl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16654 | Pde4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16655 | Bid Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16656 | Tet2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16657 | Dgat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16658 | Icam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16659 | Pla2g7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16660 | Th Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16661 | Brca1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16662 | Eed Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16663 | Traf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16664 | Kdm5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16665 | Cat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16666 | Il33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16667 | Dgat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16668 | Itgb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16669 | Crh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16670 | Lrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16671 | Mst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16672 | Pcna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16673 | Acss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16674 | Vegfc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16675 | Oga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16676 | Klf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16677 | Xbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16678 | Mertk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16679 | S100a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16680 | Mtap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16681 | Cdc42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16683 | Uhrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16684 | Bptf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16685 | Il18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16686 | Lag3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16687 | Zbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16688 | Mb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16689 | Id1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16690 | Cd22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16691 | Il21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16692 | Rspo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16693 | Cxcl16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16694 | Prdx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16695 | Alkbh5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16696 | Cdkn1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16697 | Setdb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16698 | Fgf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16699 | Trh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16700 | Xpo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16701 | Cpz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16702 | Aqp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16703 | Ccl22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16704 | Ikzf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16705 | Kdm6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16706 | Wnt3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16707 | Cxcl11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16708 | Ccl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16709 | Nat10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16710 | Erf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16711 | Erg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16712 | Fas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16713 | Yy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16714 | Fgf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16715 | Gas6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16716 | Irf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16717 | Jag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16718 | Hmox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16719 | Angpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16720 | Dll3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16721 | Tspo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16722 | Sarm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16723 | Cdkn2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16724 | Hr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16725 | Pnp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16726 | Cd14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16727 | Abhd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16728 | Blk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16729 | Mdk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16730 | Spr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16731 | Nsd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16732 | Prc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16733 | Ptpn11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16734 | Fgf23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16735 | Otub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16736 | Chi3l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16737 | Cyp1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16738 | Pkmyt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16739 | Tmprss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16740 | Hp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16741 | Cdc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16742 | Rac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16743 | Tfrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16744 | Usp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16745 | Uchl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16746 | Avp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16747 | Set Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16748 | Nnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16749 | Usp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16750 | Cs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16751 | Cd70 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16752 | Ghrh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16753 | Epha2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16754 | Itgav Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16755 | Trpm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16756 | Ilk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16757 | Ogg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16758 | Folr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16759 | Trpc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16760 | Csk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16761 | Emb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16762 | Cd63 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16763 | Dnmt3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16764 | Trim21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16765 | Gc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16766 | Ik Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16767 | Fn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16768 | Lyn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16769 | Clk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16770 | Smad3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16771 | Trpm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16772 | Dnmt3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16773 | Cd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16774 | Gne Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16775 | Mcu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16776 | Oat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16777 | Prl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16778 | Npc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16779 | Tet1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16780 | Ccnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16781 | Rack1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16782 | Ina Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16783 | Nsf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16784 | Cd34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16785 | Cry1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16786 | Csf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16787 | Nppb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16788 | Saa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16789 | Spop Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16790 | Gan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16791 | Pvr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16792 | Ttk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16793 | Mdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16794 | Hmgb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16795 | Il23r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16796 | Kdm2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16797 | Ugt1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16798 | S100a10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16799 | Ahcy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16800 | Irf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16801 | Ror1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16802 | Panx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16803 | Smarca4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16804 | Lbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16805 | Ifng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16806 | Lrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16807 | Phb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16808 | Tlr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16809 | C6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16810 | Cort Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16811 | Cd200 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16812 | Dapk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16813 | Kdm2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16814 | Taar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16815 | Fos Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16816 | Lat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16817 | Tes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16818 | Ccl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16819 | Icos Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16820 | Saa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16821 | Igfbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16822 | Igf2bp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16823 | Cd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16824 | Gca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16825 | Brca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16826 | Ccl17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16827 | Cdc20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16828 | Dusp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16829 | Ube2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16830 | Usp30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16831 | Slc1a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16832 | Ang Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16833 | Gem Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16834 | Ran Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16835 | Cd52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16836 | Cd55 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16837 | Irf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16838 | Nek2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16839 | Senp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16840 | Timp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16841 | Amh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16842 | F12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16843 | Ccl8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16844 | Cd27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16845 | Grk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16846 | Gsdme Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16847 | Itgb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16848 | Sparc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16849 | Igf2bp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16850 | Mrgprx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16851 | Ak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16852 | Rb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16853 | Csf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16854 | Il22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16855 | Anxa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16856 | Hipk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16857 | Kcnh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16858 | Kdm5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16859 | Traf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16860 | Trpv3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16861 | Mettl14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16862 | Fth1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16863 | Muc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16864 | Runx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16865 | Stim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16866 | Lgals9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16867 | F3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16868 | Mgll Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16869 | Fcgrt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16870 | Tead4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16871 | Usp20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16872 | Vdac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16873 | F2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16874 | Afp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16875 | Crp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16876 | Hck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16877 | Sf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16878 | Dll4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16879 | Ets1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16880 | Sv2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16881 | Zeb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16882 | Lgals3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16883 | Angptl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16884 | Nf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16885 | Comp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16886 | Ddx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16887 | Dpp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16888 | Rbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16889 | Tgm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16890 | Cyp2e1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16891 | Grp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16892 | Ltb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16893 | Gpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16894 | Il7r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16895 | Irs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16896 | Mdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16897 | Ccl11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16898 | Fads2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16899 | Foxp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16900 | Fstl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16901 | Itga5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16902 | Ptgs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16903 | Thbs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16904 | Aldh1a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16905 | F5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16906 | Cd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16907 | Mok Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16908 | Tyr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16909 | Atf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16910 | Dll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16911 | Kat7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16912 | Npff Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16913 | Abcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16914 | Cd226 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16915 | Fdft1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16916 | Fkbp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16917 | Trpm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16918 | Atp1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16919 | Slamf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16920 | Ide Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16921 | Cd80 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16922 | Erfe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16923 | Mdm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16924 | Pdk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16925 | Skp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16926 | Sod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16927 | Stom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16928 | Tnk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16929 | Atg4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16930 | Tacc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16931 | Sema4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16932 | F7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16933 | B2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16934 | Dap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16935 | Ddc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16936 | Ghr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16937 | Hrg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16938 | Btla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16939 | Sod2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16940 | Xcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16941 | Ccl19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16942 | Ncoa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16943 | Trpv6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16944 | Usp22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16945 | Cyp1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16946 | Gucy2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16947 | Ythdf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16948 | Adm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16949 | Eda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16950 | Mia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16951 | Csf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16952 | Irf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16953 | Oma1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16954 | Sdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16956 | Adrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16957 | Ccl24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16958 | Cd163 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16959 | Hif1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16960 | Usp9x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16961 | Col1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16962 | Cit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16963 | Bap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16964 | Clk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16965 | Dkk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16966 | Ereg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16967 | Got1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16968 | Opa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16969 | Wnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16970 | Yes1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16971 | Fabp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16972 | Ffar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16973 | P4ha1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16974 | Postn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16975 | S100b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16976 | Setd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16977 | Tgfbi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16978 | Trpc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16979 | Cmklr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16980 | Tnfrsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16981 | Tnfrsf17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16982 | Asl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16983 | Cd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16984 | Mog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16985 | Omp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16986 | Plg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16987 | Rpe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16988 | Fshr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16989 | Ldhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16990 | Ltbr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16991 | Olr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16992 | Pfkp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16993 | Sost Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16994 | Asgr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16995 | Cxcr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16996 | Tgfb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16997 | Slc3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16998 | Steap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS16999 | Cd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17000 | Gpt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17001 | Mal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17002 | Tox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17003 | Atf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17004 | Rhoa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17005 | Taf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17006 | Cd276 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17007 | Dusp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17008 | Hoxb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17009 | Jmjd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17010 | Igfbp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17011 | Cyp27a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17012 | Tnfrsf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17013 | Alb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17014 | Cbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17015 | Dbi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17016 | Mag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17017 | Msc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17018 | Pah Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17019 | Areg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17020 | Bub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17021 | Cd3e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17022 | Ebi3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17023 | Nae1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17024 | Pdpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17025 | Pin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17026 | Bach1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17027 | Pdpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17028 | Aldh1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17029 | Tnfsf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17030 | C2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17031 | Il7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17032 | Wt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17033 | Arg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17034 | Cd5l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17035 | Gfap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17036 | Il27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17037 | Mavs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17038 | Ppbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17039 | Gpr65 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17040 | Ikzf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17041 | Isg15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17042 | Lgals1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17043 | Ceacam5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17044 | Tnfaip3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17045 | Pgp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17046 | Tk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17047 | Tro Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17048 | Agr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17049 | Bmp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17050 | Cd68 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17051 | Cdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17052 | E2f1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17053 | Eras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17054 | Fgf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17055 | Rin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17056 | Tfam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17057 | Acox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17058 | Hbegf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17059 | Ifna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17060 | Lta4h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17061 | Shmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17062 | Ube2t Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17063 | Usp15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17064 | Arc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17065 | Fst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17066 | Hpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17067 | Nog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17068 | Por Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17069 | Slk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17070 | Hes1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17071 | Npm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17072 | Odc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17073 | Plat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17074 | Sdc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17075 | Actn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17076 | Aldoa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17077 | Apoa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17078 | Cxcl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17079 | Epcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17080 | Kat6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17081 | Nedd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17082 | Sf3b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17083 | Stub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17084 | Tead1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17085 | Tnfsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17086 | Tnfsf13b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17087 | Dsp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17088 | Ell Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17089 | Mcc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17090 | Mos Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17091 | Pgc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17092 | Rs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17093 | Cd33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17094 | Klf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17095 | Plau Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17096 | Tsc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17097 | Eif4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17098 | Mthfd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17099 | Tnfsf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17100 | Cbs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17101 | Des Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17102 | Dr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17103 | Ptn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17104 | Alad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17105 | Dlat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17106 | Fgl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17107 | Mall Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17108 | Mfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17109 | Itga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17110 | Kcnq2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17111 | Kdm3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17112 | Lamp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17113 | Ppm1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17114 | Vcam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17115 | Havcr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17116 | Nedd4l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17117 | fh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17118 | Cda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17119 | Cel Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17120 | Cpe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17121 | Hk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17122 | Ssb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17123 | Tdg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17124 | Atic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17125 | Cd81 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17126 | H6pd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17127 | Tph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17128 | Alcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17129 | Bmal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17130 | Bmp2k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17131 | Ccl25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17132 | Kdm4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17133 | Gprc5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17134 | Igfbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17135 | Mapkapk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17136 | C8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17137 | Nmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17138 | Fadd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17139 | Gast Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17140 | Hat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17141 | Rest Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17142 | Rsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17143 | Scap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17144 | Sqor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17145 | Camk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17146 | Nr5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17147 | Pdgfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17148 | Stat4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17149 | Suz12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17150 | Usp25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17151 | Trip13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17152 | Txnrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17153 | Csnk1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17154 | S100a11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17155 | Cfd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17156 | Gcg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17157 | Rho Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17158 | Sp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17159 | Sri Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17160 | Ccn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17161 | Eno2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17162 | Gpx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17163 | Grpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17164 | Gzma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17165 | Klk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17166 | Ngfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17167 | Proc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17168 | Slpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17169 | Cdh17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17170 | Gsk3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17171 | Kdm5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17172 | Lamp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17173 | Srpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17174 | Srsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17175 | Usp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17176 | Camkk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17177 | Cyp11b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17178 | Pik3ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17179 | Suv39h1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17180 | Gk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17181 | Abo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17182 | Cnp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17183 | Dcc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17184 | Lpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17185 | Me1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17186 | Brd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17187 | Dmpk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17188 | Etv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17189 | Fdps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17190 | Fut8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17191 | Fzd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17192 | Lifr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17193 | Msln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17194 | Spi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17195 | Upp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17196 | Wnt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17197 | Atad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17198 | Efna5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17199 | Ephb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17200 | Fgf18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17201 | Folr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17202 | Hspa8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17203 | Kdm6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17204 | Pick1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17205 | Ptpn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17206 | Qpctl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17207 | Sirpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17208 | Smad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17209 | Tradd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17210 | Trpm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17211 | Cyp7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17212 | Muc5ac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17213 | Notch3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17214 | Cad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17215 | Dcn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17216 | Ager Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17217 | Ass1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17218 | Bms1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17219 | Kynu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17220 | Nek7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17221 | Nsd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17222 | Tsc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17223 | Anxa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17224 | Apoc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17225 | Asic3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17226 | Bcat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17227 | Elane Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17228 | Foxo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17229 | Hpgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17230 | Il6st Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17231 | Masp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17232 | Nedd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17233 | Rbm39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17234 | Trpv2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17235 | Akr1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17236 | Igfbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17237 | Ythdf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17238 | Akr1b10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17239 | Tnfsf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17240 | C7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17241 | F11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17242 | Gaa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17243 | Gla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17244 | Id2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17245 | Pdf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17246 | Hrob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17247 | Poli Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17248 | Pomc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17249 | Ccl28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17250 | Clock Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17251 | Epha7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17252 | Fabp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17253 | Fndc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17254 | Lair1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17255 | Pvrig Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17256 | Alkbh3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17257 | Fancd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17258 | Sema3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17259 | Angptl8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17260 | Tnfsf18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17261 | Cth Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17262 | Fyn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17263 | Tnc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17264 | Ubd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17265 | Cd69 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17266 | Gzmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17267 | Il19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17268 | Lgmn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17269 | Psap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17270 | Rac2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17271 | Rbpj Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17272 | Selp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17273 | Ccne1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17274 | Cdh13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17275 | Efnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17276 | Sumo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17277 | Usp21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17278 | Cdc25a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17279 | Slc7a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17280 | Angptl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17281 | Slc31a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17282 | St6gal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17283 | Hsd17b13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17284 | Acd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17285 | Dbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17286 | Gal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17287 | Cd93 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17288 | Grk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17289 | Hdgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17290 | Klk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17291 | Lipa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17292 | Map2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17293 | Mycn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17294 | Pan2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17295 | Phb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17296 | Ppt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17297 | Rpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17298 | Tfpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17299 | Bcat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17300 | Dhcr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17301 | Ifnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17302 | Irak3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17303 | Mef2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17304 | Pdgfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17305 | Pola1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17306 | Ptpn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17307 | Stat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17308 | Stk11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17309 | Uchl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17310 | Zap70 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17311 | Dyrk1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17312 | Il1rl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17313 | Metap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17314 | Clec12a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17315 | Cyp11b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17316 | Tnfrsf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17317 | C9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17318 | Bad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17319 | Clu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17320 | Dbt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17321 | Mme Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17322 | Pxn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17323 | Tkt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17324 | Vim Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17325 | Acp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17326 | Ano1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17327 | Bag3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17328 | Cdo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17329 | Elk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17330 | Fzd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17331 | Gnal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17332 | Nbr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17333 | Nrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17334 | Qpct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17335 | Tbca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17336 | Trac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17337 | Brsk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17338 | Dclk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17339 | Foxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17340 | Gfral Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17341 | Grem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17342 | Il2rb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17343 | Lats1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17344 | Nr4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17345 | Pdcd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17346 | Smad4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17347 | Cthrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17348 | Cxcl14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17349 | Map3k1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17350 | Rictor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17351 | Sqstm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17352 | Tardbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17353 | Txndc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17354 | Tnfrsf13c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17355 | F8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17356 | Agl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17357 | Dhh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17358 | Emd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17359 | Fus Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17360 | Mpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17361 | Pln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17362 | Rp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17363 | Tst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17364 | Aoc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17365 | Cd37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17366 | Cd3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17367 | Crot Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17368 | Gad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17369 | Grk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17370 | Ist1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17371 | Lepr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17372 | Lrr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17373 | Nrg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17374 | Sat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17375 | Sox4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17376 | Sox9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17377 | Tpi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17378 | Baz2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17379 | Cisd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17380 | Csf3r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17381 | Enpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17382 | Ndrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17383 | Timp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17384 | Camk1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17385 | Dhcr24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17386 | S100a6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17387 | Ceacam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17388 | Mettl16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17389 | Slc34a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17390 | Tacstd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17391 | Tnfsf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17392 | Aip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17393 | Bsg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17394 | Cpm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17395 | Ipp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17396 | Lss Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17397 | Max Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17398 | Nf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17399 | Pdc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17400 | Pf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17401 | Pir Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17402 | Sms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17403 | Vwf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17404 | Arg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17405 | Chd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17406 | Edn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17407 | Grb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17408 | Kat5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17409 | Mcm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17410 | Nat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17411 | Nrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17412 | Ntn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17413 | Prlr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17414 | Rnf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17415 | Sele Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17416 | Tcf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17417 | Terc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17418 | Wtap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17419 | Cebpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17420 | Crtam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17421 | Masp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17422 | Plaur Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17423 | Prdx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17424 | Rspo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17425 | Trpm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17426 | Tssk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17427 | Tyro3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17428 | Usp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17429 | Usp13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17430 | Igfbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17431 | Il10ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17432 | Mettl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17433 | Piezo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17434 | Pla2g4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17435 | Tnfrsf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17436 | Ak7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17437 | Btc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17438 | Cfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17439 | Ckb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17440 | Dym Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17441 | Eng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17442 | Hbb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17443 | Nin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17444 | Sp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17445 | Aire Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17446 | Aqp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17447 | Aspn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17448 | Bst2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17449 | Cbx7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17450 | Cpb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17451 | Cpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17452 | Ecm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17453 | Ing1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17454 | Lcat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17455 | Musk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17456 | Npc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17457 | Thy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17458 | Aars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17459 | Cd101 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17460 | Cntn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17461 | Ffar3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17462 | Gpr17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17463 | Gpr75 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17464 | Gsto1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17465 | Il4i1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17466 | Inhba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17467 | Kdm4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17468 | Klrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17469 | Nupr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17470 | Prdx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17471 | Vtcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17472 | Arid1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17473 | Dnaja1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17474 | Ifngr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17475 | Metrnl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17476 | Pfkfb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17477 | Prima1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17478 | Ptprz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17479 | Cyp11a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17480 | Tnfrsf12a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17481 | Kl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17482 | Mgp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17483 | Nlk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17484 | Alpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17485 | Ambn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17486 | Cd8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17487 | Clk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17488 | Cps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17489 | Emp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17490 | Fim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17491 | Glul Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17492 | Has2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17493 | Hexa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17494 | Ogdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17495 | Ror2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17496 | Snd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17497 | Tgfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17498 | Usp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17499 | Abcg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17500 | Alpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17501 | Cd177 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17502 | Cdc37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17503 | Ddx3x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17504 | Fstl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17505 | Fzd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17506 | Hadha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17507 | Itgb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17508 | Nr2f6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17509 | Nr5a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17510 | Sfrp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17511 | Thbs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17512 | Trap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17513 | Chrna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17514 | Gpr132 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17515 | Npc1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17516 | Ptpn22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17517 | S100a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17518 | Igf2bp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17519 | Mrgprx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17520 | Smarcb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17521 | Aga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17522 | Cfh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17523 | Id3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17524 | Il9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17525 | Lum Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17526 | Nmu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17527 | Rgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17528 | sea Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17529 | Srf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17530 | Tec Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17531 | Ambp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17532 | Atg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17533 | Cav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17534 | Chd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17535 | Dlk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17536 | F13b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17537 | Fbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17538 | Il34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17539 | Klf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17540 | Nefl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17541 | Osmr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17542 | Ptk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17543 | Ptk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17544 | Acadm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17545 | Ccnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17546 | Efna3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17547 | Efnb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17548 | Fbxw7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17549 | Gpr39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17550 | Hmox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17551 | Htra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17552 | Ifna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17553 | Marco Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17554 | Pdia4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17555 | Pgam5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17556 | Ppm1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17557 | Ptprd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17558 | Rad52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17559 | Stk10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17560 | Vdac2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17561 | Vsig4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17562 | Adipoq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17563 | Anxa10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17564 | Ruvbl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17565 | Trim24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17566 | Aldh1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17567 | Pla2g2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17568 | Tnfsf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17569 | Ppp1r15a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17570 | Tnfrsf10b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17571 | Tnfrsf11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17572 | Abr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17573 | Acr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17574 | Nps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17575 | Pgd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17576 | She Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17577 | Tub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17578 | Aif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17579 | Atg7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17580 | Cap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17581 | Ccn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17582 | Cd83 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17583 | Cd99 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17584 | Cdh6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17585 | Dsg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17586 | Hunk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17587 | Kat8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17588 | Ncr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17589 | Nek6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17590 | Pck1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17591 | Rpa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17592 | Srgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17593 | Tap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17594 | Tff3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17595 | Thra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17596 | Tpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17597 | Vrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17598 | Adam9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17599 | Alas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17600 | Asic1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17601 | Atp7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17602 | Brcc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17603 | Cd164 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17604 | Cend1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17605 | Cox5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17606 | Enpep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17607 | Enpp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17608 | Hnf4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17609 | Mark2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17610 | Nfat5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17611 | Park7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17612 | Pde4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17613 | Prom1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17614 | Ptprf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17615 | Stx17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17616 | Wnt5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17617 | Clec2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17618 | Il1rap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17619 | Slamf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17620 | Tspan2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17621 | Gp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17622 | Lpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17623 | Lpp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17624 | Nts Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17625 | Omg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17626 | Sla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17627 | Sln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17628 | Tk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17629 | Uty Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17630 | Actb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17631 | Aox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17632 | Bcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17633 | Bdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17634 | Cdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17635 | Ctcf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17636 | Cyc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17637 | Fbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17638 | Fhl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17639 | Gnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17640 | Kng1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17641 | Ntn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17642 | Peg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17643 | Prep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17644 | Rcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17645 | Rem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17646 | Rheb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17647 | Rnf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17648 | St13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17649 | Stc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17650 | Tdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17651 | Tph2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17652 | C1qbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17653 | Cd320 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17654 | Chd1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17655 | Edil3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17656 | Efna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17657 | Ephb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17658 | Erap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17659 | Glud1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17660 | Gpr37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17661 | Gpr83 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17662 | Hmga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17663 | Hoxa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17664 | Il1rn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17665 | Klkb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17666 | Ptgr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17667 | Pth1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17668 | Angpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17669 | Cd40lg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17670 | Ruvbl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17671 | Slc6a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17672 | Csnk2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17673 | Slc16a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17674 | Boc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17675 | Ccs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17676 | Cic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17677 | Fga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17678 | Grn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17679 | Hgd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17680 | Me2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17681 | Vtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17682 | Adar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17683 | Ago2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17684 | Ddx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17685 | Dpp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17686 | Dsg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17687 | Eml2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17688 | Gclc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17689 | Iapp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17690 | Irf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17691 | Nrg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17692 | Pole Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17693 | Rbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17694 | Rps6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17695 | Scin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17696 | Six1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17697 | Ccnd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17698 | Dnm1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17699 | Dusp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17700 | Epha4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17701 | Fgf17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17702 | Hcls1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17703 | Il17f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17704 | Lypd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17705 | Mfap4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17706 | Mydgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17707 | Ncam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17708 | Nlrp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17709 | Pappa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17710 | Pdha1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17711 | Pgam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17712 | Socs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17713 | Ttbk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17714 | Usp46 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17715 | Usp47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17716 | Znrf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17717 | Abhd11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17718 | Adra2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17719 | Col3a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17720 | Fundc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17721 | Srebf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17722 | Prkar1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17723 | Tnfrsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17724 | F9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17725 | Agk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17726 | Agt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17727 | Hdc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17728 | Khk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17729 | Nes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17730 | Pyy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17731 | Rax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17732 | Ucn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17733 | Agrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17734 | Apob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17735 | Aqp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17736 | Arf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17737 | Aspa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17738 | Bbs4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17739 | Bst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17740 | Cd3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17741 | Ctf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17742 | Dlx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17743 | Fgf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17744 | Gnas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17745 | Hadh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17746 | Il24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17747 | Il31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17748 | Lrp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17749 | Mfn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17750 | Ptx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17751 | Sell Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17752 | Tff1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17753 | Tpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17754 | Uba1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17755 | Abcg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17756 | Aifm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17757 | Apaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17758 | Ash1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17759 | Bcas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17760 | Cirbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17761 | Dapk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17762 | Ephb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17763 | Fuca1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17764 | Gstm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17765 | Hipk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17766 | Itgax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17767 | Kmt2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17768 | Lamp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17769 | Nmur2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17770 | Olig2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17771 | Pnlip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17772 | Psmb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17773 | Ptbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17774 | Sftpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17775 | Spdef Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17776 | Trex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17777 | Usp18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17778 | Clec7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17779 | Cyp8b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17780 | Dusp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17781 | Impdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17782 | Map2k6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17783 | Samhd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17784 | Creb3l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17785 | Cyp17a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17786 | Gabarap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17787 | Serpini1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17788 | Bik Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17789 | Cga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17790 | Dct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17791 | Dcx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17792 | Ddt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17793 | F10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17794 | Fgg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17795 | Gp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17796 | Gss Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17797 | Ihh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17798 | Lep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17799 | Maf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17800 | Rp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17801 | Cd84 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17802 | Chl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17803 | Edar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17804 | Fbn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17805 | Fpr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17806 | Gale Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17807 | Gdf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17808 | Gls2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17809 | Got2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17810 | Hpca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17811 | Ibsp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17812 | Lap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17813 | Layn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17814 | Mbd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17815 | Nmbr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17816 | Paep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17817 | Pltp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17818 | Sod3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17819 | Thpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17820 | Trio Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17821 | Zeb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17822 | Aebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17823 | Bcl10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17824 | Cd79a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17825 | Cd79b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17826 | Cytl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17827 | Dock5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17828 | Efna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17829 | Eif4e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17830 | Fgf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17831 | Il36g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17832 | Itga4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17833 | Kdm4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17834 | Klrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17835 | Klrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17836 | Mbnl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17837 | Pde1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17838 | Phpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17839 | Plbd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17840 | Procr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17841 | Prss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17842 | Psat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17843 | Qsox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17844 | Rnf43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17845 | Ywhae Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17846 | Atp2a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17847 | Card11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17848 | Clec4e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17849 | Cyb5r3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17850 | Eif4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17851 | Insig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17852 | Lypla1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17853 | Metap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17854 | Recql5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17855 | Sema7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17856 | Snap25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17857 | Steap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17858 | Tcf7l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17859 | Tfap2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17860 | Tspan7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17861 | Gadd45a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17862 | Pla2g15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17863 | Adamdec1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17864 | Adamts13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17865 | Xk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17866 | En1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17867 | Fah Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17868 | Gk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17869 | Gp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17870 | Hal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17871 | Id4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17872 | Ltf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17873 | Mak Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17874 | Tfg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17875 | Ubc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17876 | Acan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17877 | Cap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17878 | Cast Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17879 | Ccn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17880 | Cd46 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17881 | Ctsz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17882 | Cyld Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17883 | Fgf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17884 | Gipr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17885 | Gmfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17886 | Hap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17887 | Inf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17888 | Itch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17889 | Jaml Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17890 | Pdk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17891 | Polq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17892 | Pomk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17893 | Psca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17894 | Rbm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17895 | Rpl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17896 | Skp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17897 | Stac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17898 | Tal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17899 | Tff2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17900 | Ucp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17901 | Abcd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17902 | Birc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17903 | Capn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17904 | Cd151 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17905 | Cdh16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17906 | Ch25h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17907 | Cryab Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17908 | Fabp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17909 | G3bp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17910 | Gata3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17911 | Gata6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17912 | Hmga1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17913 | Hspb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17914 | Kpna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17915 | Lhcgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17916 | Mark3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17917 | Nudt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17918 | Pbrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17919 | Prdx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17920 | Prss3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17921 | Akr1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17922 | Fcgr2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17923 | Hectd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17924 | Ifitm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17925 | Jchain Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17926 | Lancl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17927 | Lrrc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17928 | Lrrc32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17929 | Pecam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17930 | Tmsb4x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17931 | Tnfsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17932 | Il1rapl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17933 | Serpine2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17934 | Tnfrsf18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17935 | Ecd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17936 | Ncl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17937 | Otc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17938 | Prx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17939 | Sp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17940 | Vgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17941 | Zp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17942 | Als2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17943 | Aoc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17944 | Aqp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17945 | Aven Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17946 | Bmp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17947 | Calr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17948 | Cblb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17949 | Ccn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17950 | Cdnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17951 | Ddb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17952 | Fosb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17953 | Gbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17954 | Gpd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17955 | Gpr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17956 | Gys1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17957 | Hpse Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17958 | Ica1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17959 | Idua Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17960 | Imp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17961 | Klk5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17962 | Lrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17963 | Map4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17964 | Mcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17965 | Pon1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17966 | Rxra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17967 | Sqle Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17968 | St14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17969 | Aldob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17970 | Asxl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17971 | Atg10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17972 | Atp7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17973 | Cadm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17974 | Clic3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17975 | Corin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17976 | Cript Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17977 | Efnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17978 | Fubp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17979 | Gpr18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17980 | Hmgb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17981 | Igf2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17982 | Inhbe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17983 | Itgb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17984 | Mapk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17985 | Mastl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17986 | Mrpl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17987 | Naa10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17988 | Nlrc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17989 | Orai1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17990 | Pdia6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17991 | Prdx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17992 | Sfrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17993 | Smoc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17994 | Smpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17995 | Srpx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17996 | Traf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17997 | Trpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17998 | Trpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS17999 | Twsg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18000 | Ube2s Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18001 | Usp28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18002 | Vldlr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18003 | A4galt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18004 | Adcy10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18005 | Efemp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18006 | Ifngr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18007 | Megf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18008 | Nmnat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18009 | Parp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18010 | Plxdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18011 | S100a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18012 | Trim28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18013 | B4galt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18014 | Gadd45b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18015 | Pla2g1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18016 | Siglec1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18017 | Hsp90ab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18018 | Bmf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18019 | Dmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18020 | En2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18021 | Htt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18022 | Rrh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18023 | Sp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18024 | Sst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18025 | Tsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18026 | Ung Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18027 | Abat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18028 | Cct2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18029 | Chad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18030 | Cst3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18031 | Cygb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18032 | Dffa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18033 | E2f4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18034 | Hao1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18035 | Heph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18036 | Il16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18037 | Klk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18038 | Lad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18039 | M1ap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18040 | Manf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18041 | Mdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18042 | Phf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18043 | Pkn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18044 | Ppat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18045 | Ppia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18046 | Psph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18047 | Sae1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18048 | Sdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18049 | Tpbg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18050 | Tsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18051 | Uba5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18052 | Abcg8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18053 | Acss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18054 | Adrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18055 | Card9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18056 | Cd160 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18057 | Chit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18058 | Clcf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18059 | Ddit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18060 | Defb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18061 | Egfl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18062 | Ephb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18063 | Fam3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18064 | Fosl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18065 | Fosl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18066 | Gpa33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18067 | Grhpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18068 | Itgb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18069 | Kcnk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18070 | L1cam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18071 | Muc16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18072 | Nfil3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18073 | Nr1d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18075 | Pebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18076 | Psen1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18077 | Ptprc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18078 | Sdcbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18079 | Senp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18080 | Sirt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18081 | Spart Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18082 | Stk33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18083 | Vegfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18084 | Adam12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18085 | Antxr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18086 | Anxa13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18087 | Clec1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18088 | Clec4f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18089 | Csf2ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18090 | Csnk1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18091 | Cxcl17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18092 | Elovl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18093 | Hmgcs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18094 | Hspa1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18095 | Lrpap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18096 | Malat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18097 | Notch4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18098 | Scarb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18099 | Sigirr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18100 | Tnfsf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18101 | Tnni3k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18102 | Tspan3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18103 | Adamts4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18104 | Igfbpl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18105 | Nectin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18106 | S100a16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18107 | Sult1e1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18108 | Map1lc3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18109 | Tnfrsf21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18137 | Krt8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18138 | Lhpp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18139 | Lig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18140 | Men1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18141 | Mepe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18142 | Mstn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18143 | Napa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18144 | Nfe2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18145 | Nmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18146 | Optn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18147 | Osr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18148 | Pan3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18149 | Pld4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18150 | Rbx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18151 | Reln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18152 | Sim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18153 | Star Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18154 | Stk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18155 | Sufu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18156 | Vapb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18157 | Wif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18158 | Actr8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18159 | Aimp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18160 | Aldoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18161 | Anxa6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18162 | Arrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18163 | Asah1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18164 | Atg14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18165 | Baz2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18166 | Bglap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18167 | Camk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18168 | Ccna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18169 | Chrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18170 | Cntn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18171 | Cxxc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18172 | Dock2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18173 | Dtymk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18174 | Efna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18175 | Folh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18176 | Gata4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18177 | Ildr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18178 | Itgb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18179 | Kdm3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18180 | Khsrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18181 | Lats2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18182 | Mark4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18183 | Ms4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18184 | Pcbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18185 | Prss8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18186 | Prtn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18187 | Rbbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18188 | Rspo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18189 | Shmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18190 | Smad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18191 | Trim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18192 | Uchl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18193 | Unc5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18194 | Adam19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18195 | Amigo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18196 | Creld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18197 | Il17ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18198 | Impdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18199 | Lpcat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18200 | Ndufb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18201 | Plscr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18202 | Polrmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18203 | Selplg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18204 | Zbtb16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18205 | Atp5f1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18206 | C1qtnf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18207 | Eif2ak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18208 | Hnrnph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18209 | St3gal4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18210 | Pdcd1lg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18211 | Serpina5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18212 | Serpinc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18213 | Serpinf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18214 | Adcyap1r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18215 | C4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18216 | Gda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18217 | Gsc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18218 | Mga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18219 | Ogn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18220 | Omd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18221 | Psd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18222 | Son Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18223 | Sp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18224 | St7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18225 | Tbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18226 | Ahsg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18227 | Amph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18228 | Apom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18229 | Arf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18230 | Blmh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18231 | Bphl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18232 | Cd96 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18233 | Cdh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18234 | Cpa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18235 | Ctsh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18236 | Dgka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18237 | Dhx9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18238 | Eml1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18239 | Far1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18240 | Fhl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18241 | G0s2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18242 | Gdf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18243 | Gdf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18244 | Ggt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18245 | M6pr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18246 | Maff Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18247 | Med1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18248 | Msr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18249 | Myh9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18250 | Nab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18251 | Nadk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18252 | Nbl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18253 | Nrn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18254 | Pigr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18255 | Pklr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18256 | Rbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18257 | Rgmb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18258 | Rigi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18259 | Sdhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18260 | Sez6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18261 | Thbd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18262 | Tifa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18263 | Tlk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18264 | Tmx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18265 | Wwp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18266 | Amy2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18267 | Azgp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18268 | Calca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18269 | Cldn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18270 | Creb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18271 | Ctps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18272 | Eda2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18273 | Ephx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18274 | Ercc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18275 | F13a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18276 | Fabp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18277 | Fam3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18278 | Fancm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18279 | Gdf11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18280 | Gp1bb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18281 | Gpr34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18282 | Habp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18283 | Hspb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18284 | Hspe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18285 | Ifna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18286 | Kcnq1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18287 | Kif5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18288 | Kmt5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18289 | Lonp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18290 | Med12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18291 | Mst1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18292 | Nr4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18293 | Padi4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18294 | Pdgfd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18295 | Prss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18296 | Riok2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18297 | Sp100 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18298 | Stmn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18299 | Tead3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18300 | Tiam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18301 | Timd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18302 | Timp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18303 | Ube2n Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18304 | Wfdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18305 | Celsr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18306 | Dcaf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18307 | Eef1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18308 | Elavl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18309 | Fkbp1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18310 | Il18bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18311 | Ptpmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18312 | Sema4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18313 | Slamf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18314 | Trim25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18315 | Yeats4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18316 | Ankrd22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18317 | Kirrel1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18318 | Pla2g2e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18319 | Suv39h2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18320 | Mapkapk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18321 | Tnfrsf13b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18322 | A2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18323 | Bok Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18324 | Bpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18325 | Dck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18326 | Gp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18327 | Gsr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18328 | Npl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18329 | Pgf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18330 | Rlf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18331 | Sp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18332 | Srm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18333 | Ttn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18334 | Ust Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18335 | Aida Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18336 | Aqp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18337 | Atf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18338 | Bmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18339 | Brd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18340 | Canx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18341 | Cbr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18342 | Cd48 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18343 | Cdh3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18344 | Chd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18345 | Chrd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18346 | Ctsg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18347 | Cuta Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18348 | Dcxr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18349 | Dpp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18350 | Dpp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18351 | Dsc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18352 | Dsc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18353 | Dtx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18354 | Elf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18355 | Emp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18356 | Epor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18357 | Fli1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18358 | Fzd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18359 | Fzd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18360 | Fzd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18361 | Gba2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18362 | Gfer Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18363 | Paf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18364 | Pag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18365 | Parl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18366 | Pgm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18367 | Prnp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18368 | Reg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18369 | Rnf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18370 | Smc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18371 | Smox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18372 | Tank Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18373 | Tet3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18374 | Uck2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18375 | Ufm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18376 | Anxa7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18377 | C5ar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18378 | Cadm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18379 | Capn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18380 | Ccl26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18381 | Ccr10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18382 | Cdk10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18383 | Chst3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18384 | Cip2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18385 | Cndp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18386 | Ephb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18387 | Foxf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18388 | Galk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18389 | Gdf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18390 | Gfra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18391 | Huwe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18392 | Kcnq4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18393 | Klf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18394 | Map1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18395 | Map1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18396 | Mkrn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18397 | Nlgn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18398 | Ovgp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18399 | Pde3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18400 | Plod2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18401 | Ptgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18402 | Ptpn7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18403 | Ptprk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18404 | Rad50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18405 | Ring1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18406 | Robo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18407 | Smad6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18408 | Smad7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18409 | Stk38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18410 | Sumo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18411 | Tfpi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18412 | Trim5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18413 | Usp19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18414 | Vegfd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18415 | Akr1d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18416 | Apcdd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18417 | Btn2a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18418 | Chrdl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18419 | Clec5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18420 | Col4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18421 | Elovl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18422 | Fcer1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18423 | Fkbp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18424 | Hmgcs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18425 | Mblac2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18426 | Mcemp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18427 | Nfatc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18428 | Phlpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18429 | Psmd14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18430 | Scpep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18431 | Ythdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18432 | Adamts5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18433 | Bhlhe40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18434 | Cd200r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18435 | Clec10a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18436 | Col18a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18437 | Cyp46a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18438 | Il13ra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18439 | Kremen2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18440 | Pip4k2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18441 | St3gal3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18442 | Tmprss4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18443 | Serpina7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18444 | Serping1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18445 | Ak4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18446 | Dst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18447 | Fes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18448 | Fxn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18449 | Gsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18450 | Igl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18451 | Klb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18452 | Msn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18453 | Mvd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18454 | Mx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18455 | Nrm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18456 | Shb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18457 | Tpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18458 | Zp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18459 | Aco1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18460 | Aco2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18461 | Apln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18462 | Araf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18463 | Art1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18464 | Asph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18465 | Bnc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18466 | Cask Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18467 | Ccnk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18468 | Coq7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18469 | Cst7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18470 | Cstb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18471 | Ctrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18472 | Cul3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18473 | Ddb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18474 | Eno3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18475 | Esm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18476 | Flna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18477 | Fzd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18478 | Gamt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18479 | Gpx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18480 | Ing5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18481 | Isl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18482 | Kera Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18483 | Lipi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18484 | Mbl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18485 | Mpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18486 | Nat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18487 | Nol3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18488 | Nrtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18489 | Palm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18490 | Pemt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18491 | Pex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18492 | Plp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18493 | Pls3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18494 | Ppib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18495 | Pter Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18496 | Rmi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18497 | Rpl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18498 | Rttn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18499 | Sbds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18500 | Tap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18501 | Tcf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18502 | Tnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18503 | Tpm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18504 | Ubr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18505 | Upf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18506 | Wnk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18507 | Wwp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18508 | Asf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18509 | Atox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18510 | Cadm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18511 | Chodl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18512 | Cltrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18513 | Cntfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18514 | Creb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18515 | Csrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18516 | Fabp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18517 | Fbxo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18518 | Gper1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18519 | Hspa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18520 | Hspd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18521 | Ifih1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18522 | Igsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18523 | Itga6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18524 | Itgb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18525 | Itgb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18526 | Kif11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18527 | Kiss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18528 | Kmt2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18529 | Kpnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18530 | Krt17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18531 | Lamp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18532 | Naa50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18533 | Ninj1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18534 | Nr2f1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18535 | Nudt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18536 | Nxph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18537 | Parva Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18538 | Pcsk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18539 | Pdap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18540 | Pdcd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18541 | Pear1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18542 | Plin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18543 | Pold2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18544 | Pycr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18545 | Sez6l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18546 | Socs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18547 | Srpk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18548 | Stip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18549 | Stk16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18550 | Tafa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18551 | Taok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18552 | Tigar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18553 | Ube2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18554 | Usp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18555 | Usp24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18556 | Wfdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18557 | Zfp36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18558 | Celsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18559 | Col2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18560 | Col6a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18561 | Creld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18562 | Ehhadh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18563 | Entpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18564 | Glipr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18565 | Nfkbia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18566 | Ralgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18567 | S100a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18568 | Scarb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18569 | Sema4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18570 | Spint1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18571 | Tapbpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18572 | Tmigd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18573 | Tspan8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18574 | Atp6v1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18575 | L3mbtl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18576 | Pla2g2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18577 | Scgb1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18578 | Scgb3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18579 | Selenop Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18580 | Slc12a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18581 | Slc13a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18582 | Slc25a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18583 | Sult1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18584 | Tnfrsf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18585 | Xpnpep2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18586 | C4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18587 | Cpq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18588 | Cr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18589 | Flg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18590 | Hjv Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18591 | Npb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18592 | Pml Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18593 | Ski Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18594 | Sp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18595 | Spn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18596 | Tek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18597 | Vit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18598 | A1bg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18599 | Adh4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18600 | Apod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18601 | Astl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18602 | Bcl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18603 | Bmi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18604 | C1qb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18605 | Cbx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18606 | Cdx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18607 | Cfl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18608 | Clps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18609 | Cpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18610 | Cpb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18611 | Ece1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18612 | Elf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18613 | Fhl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18614 | Gpc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18615 | Gpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18616 | Hbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18617 | Hcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18618 | Iscu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18619 | Klc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18620 | Lef1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18621 | Lipe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18622 | Msh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18623 | Muc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18624 | Mylk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18625 | Nek1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18626 | Nono Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18627 | Npr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18628 | Nsd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18629 | Ntn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18630 | Parn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18631 | Pdxp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18632 | Perp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18633 | Pkn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18634 | Rgl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18635 | Rnls Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18636 | Rps3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18637 | Rrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18638 | Rtn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18639 | Tac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18640 | Tpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18641 | Tpm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18642 | Tpm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18643 | Tufm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18644 | Wfs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18645 | Wnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18646 | Abcb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18647 | Acaa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18648 | Anpep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18649 | Blvrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18650 | Camkv Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18651 | Cd207 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18652 | Cd302 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18653 | Cebpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18654 | Cep57 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18655 | Cnpy3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18656 | Cspg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18657 | Dapk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18658 | Dpep2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18659 | Egfl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18660 | Eif1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18661 | Epha5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18662 | Ephx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18663 | Ermap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18664 | Hadhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18665 | Hcar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18666 | Hoxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18667 | Ifna5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18668 | Lrrc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18669 | Muc17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18670 | Ncstn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18671 | Negr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18672 | Nucb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18673 | Ostm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18674 | P4ha2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18675 | P4ha3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18676 | Pcbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18677 | Prps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18678 | Ptch1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18679 | Ptprj Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18680 | Rasa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18681 | Rbm14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18682 | Rtn4r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18683 | Soat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18684 | Sox10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18685 | Spag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18686 | Tapbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18687 | U2af1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18688 | Usp16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18689 | Usp43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18690 | Ywhaz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18691 | Zwint Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18692 | Adam15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18693 | Adgre5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18694 | Alkbh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18695 | Antxr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18696 | B3gat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18697 | Bnip3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18698 | Cd300c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18699 | Cela2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18700 | Celsr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18701 | Cldn18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18702 | Clec3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18703 | Col4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18704 | Col7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18705 | Csf2rb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18706 | Cyp7b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18707 | Dcbld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18708 | Dlgap5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18709 | Fkbp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18710 | Igfbp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18711 | Lrrtm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18712 | Lypla2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18713 | Phlda2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18714 | Ralbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18715 | Sap130 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18716 | Slamf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18717 | Smurf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18718 | Stambp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18719 | Ube2d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18720 | Arl6ip6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18721 | Colec11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18722 | Csnk2a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18723 | Kirrel3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18724 | Ppp2r1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18725 | S100a13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18726 | Slc27a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18727 | Tinagl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18728 | Adamts18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18729 | Dnase1l3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18730 | Ak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18731 | Amn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18732 | Cgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18733 | Dao Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18734 | Fbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18735 | Ggh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18736 | Hpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18737 | Kmo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18738 | Mpg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18739 | Mvk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18740 | Nbn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18741 | Ntm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18742 | Oxt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18743 | Ryk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18744 | Abl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18745 | Arsa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18746 | Brap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18747 | C1qa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18748 | Cbfb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18749 | Ccin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18750 | Cdh4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18751 | Cdh8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18752 | Ctsa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18753 | Ctsw Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18754 | Dhps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18755 | Eid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18756 | Fgl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18757 | Fmod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18758 | Gad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18759 | Galc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18760 | Galt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18761 | Gbp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18762 | Gja1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18763 | Gltp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18764 | Gmfg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18765 | Hnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18766 | Il9r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18767 | Irf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18768 | Jam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18769 | Klf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18770 | Klk8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18771 | Ly6e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18772 | Mdm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18773 | Mecr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18774 | Med9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18775 | Mtdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18776 | Naaa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18777 | Nck1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18778 | Nid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18779 | Orm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18780 | P4hb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18781 | Pfkl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18782 | Pif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18783 | Plp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18784 | Ppif Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18785 | Rgma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18786 | Rhoj Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18787 | Rrn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18788 | Rtn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18789 | Sav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18790 | Sdha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18791 | Smg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18792 | Speg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18793 | Sub1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18794 | Tpmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18795 | Tpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18796 | Vasp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18797 | Vnn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18798 | Aadac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18799 | Ackr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18800 | Acmsd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18801 | Adprh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18802 | Anxa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18803 | Asb13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18804 | Bbox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18805 | Cdh10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18806 | Cdk17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18807 | Cldn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18808 | Cmpk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18809 | Crlf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18810 | Dpp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18811 | Ecscr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18812 | Egln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18813 | Epha3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18814 | Fads1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18815 | Fbxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18816 | Fcrl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18817 | Ffar4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18818 | Fgf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18819 | Fkbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18820 | Foxa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18821 | Gap43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18822 | Gnao1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18823 | Hebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18824 | Hprt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18825 | Il2ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18826 | Klrg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18827 | Lims1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18828 | Mgat5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18829 | Mnat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18830 | Otud1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18831 | Padi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18832 | Peli1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18833 | Pold1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18834 | Prdx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18835 | Pros1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18836 | Prps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18837 | Psmb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18838 | Rab2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18839 | Reg3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18840 | Riok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18841 | Robo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18842 | Setd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18843 | Srrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18844 | Srsf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18845 | Syvn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18846 | Trpc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18847 | Tyrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18848 | Ube2i Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18849 | Vipr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18850 | Vsig8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18851 | Angpt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18852 | Bpifb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18853 | Cdc25c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18854 | Cdkn2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18855 | Cgref1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18856 | Cnksr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18857 | Col4a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18858 | Col8a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18859 | Crabp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18860 | Dpysl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18861 | Elavl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18862 | Elovl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18863 | Entpd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18864 | Gpr174 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18865 | Ifna14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18866 | Ifnlr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18867 | Il36rn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18868 | Lefty2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18869 | Lgals4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18870 | Map3k3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18871 | Nmnat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18872 | Pik3r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18873 | Psmd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18874 | Ptger4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18875 | Rprd1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18876 | Sephs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18877 | Slamf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18878 | Taldo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18879 | Trim33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18880 | Uqcrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18881 | Colec12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18882 | Slc37a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18883 | Slc39a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18884 | Slc6a14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18885 | Sparcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18886 | Adamtsl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18887 | Gabarapl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18888 | Serpinb10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18889 | Ado Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18890 | Afm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18891 | Cpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18892 | Ebp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18893 | Fau Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18894 | Hfe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18895 | Ids Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18896 | Ivd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18897 | Lxn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18898 | Mtr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18899 | Nms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18900 | Ppl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18901 | Tnn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18902 | Tnr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18903 | Ubb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18904 | Acy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18905 | Add2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18906 | Ago1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18907 | Agr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18908 | Arnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18909 | Atg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18910 | Atl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18911 | Bag2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18912 | Bcan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18913 | Bin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18914 | Brf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18915 | Cdk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18916 | Cdsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18917 | Chd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18918 | Chga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18919 | Clgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18920 | Coch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18921 | Cop1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18922 | Dag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18923 | Dbf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18924 | Dlst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18925 | Drg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18926 | E2f7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18927 | Ecm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18928 | Edf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18929 | Eif5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18930 | Ell2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18931 | Fcmr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18932 | Fuom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18933 | Fut7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18934 | Gart Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18935 | Gbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18936 | Gclm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18937 | Gid4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18938 | Glb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18939 | Glrx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18940 | Gpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18941 | Gpx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18942 | Gypa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18943 | Hcrt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18944 | Hes5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18945 | Hmbs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18946 | Hps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18947 | Irf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18948 | Jpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18949 | Mas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18950 | Mest Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18951 | Mid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18952 | Mrap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18953 | Mras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18954 | Msmp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18955 | Myrf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18956 | Naca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18957 | Ndc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18958 | Net1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18959 | Neu1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18960 | Nmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18961 | Ola1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18962 | Pax8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18963 | Pepc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18964 | Pfkm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18965 | Pkib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18966 | Prkn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18967 | Ptma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18968 | Ptpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18969 | Relt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18970 | Rgs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18971 | Rom1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18972 | Rybp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18973 | Sord Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18974 | Stam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18975 | Stx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18976 | Tdo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18977 | Tpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18978 | Twf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18979 | Uap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18980 | Vasn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18981 | Vsir Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18982 | Abhd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18983 | Acsl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18984 | Ampd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18985 | Anxa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18986 | Apex2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18987 | Atad5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18988 | Cant1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18989 | Ccrl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18990 | Cd248 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18991 | Cebpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18992 | Cntn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18993 | Coasy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18994 | Ctdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18995 | Ddx17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18996 | Decr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18997 | Eif2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18998 | Epas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS18999 | Etfdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19000 | Extl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19001 | Fetub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19002 | Fgf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19003 | Fgf20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19004 | Fscn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19005 | Gfpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19006 | Ghrhr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19007 | Grip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19008 | Gsdmc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19009 | Gstm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19010 | Hgfac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19011 | Htr2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19012 | Ifi27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19013 | Iglc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19014 | Il17c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19015 | Inhbb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19016 | Irak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19017 | Kifc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19018 | Klk14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19019 | Lacc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19020 | Lyve1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19021 | Mef2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19022 | Megf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19023 | Mfge8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19024 | Nlgn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19025 | Ntmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19026 | Otub2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19027 | Ppm1g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19028 | Prap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19029 | Pttg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19030 | Rab31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19031 | Ramp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19032 | Rbm15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19033 | Rpap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19034 | Rxfp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19035 | Slit2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19036 | Smad9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19037 | Soat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19038 | Spast Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19039 | Srpk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19040 | Sumf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19041 | Tnnc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19042 | Ube2k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19043 | Usp36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19044 | Usp39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19045 | Vamp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19046 | Ywhaq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19047 | Aarsd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19048 | Adam11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19049 | Adam32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19050 | Arid1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19051 | Atp5mg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19052 | Cd300a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19053 | Cdkn1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19054 | Chrna5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19055 | Clec1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19056 | Col4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19057 | Cox4i2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19058 | Ddx19a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19059 | Eef1b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19060 | Eif5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19061 | Glipr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19062 | Gprc6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19063 | Igsf11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19064 | Il17re Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19065 | Lpcat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19066 | Mansc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19067 | Nfatc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19068 | Nmral1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19069 | Nup210 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19070 | Otulin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19071 | Plxna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19072 | Ptger2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19073 | Sema4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19074 | Slc4a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19075 | Slc9a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19076 | Srd5a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19077 | Stat5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19078 | Tpsab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19079 | Treml2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19080 | Trim16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19081 | Trim62 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19082 | Tsg101 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19083 | Ugt1a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19084 | Adamts1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19085 | Adcyap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19086 | B4galt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19087 | Cd300lf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19088 | Cntnap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19089 | Colec10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19090 | Lamtor3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19091 | Madcam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19092 | Morf4l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19093 | Pglyrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19094 | Ppp1r1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19095 | Slc30a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19096 | Tmem219 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19097 | Tnfaip6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19098 | Adamts15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19099 | Adamts16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19100 | Adamts17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19101 | Aldh18a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19102 | Ppp1r15b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19103 | Siglec15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19104 | Ckm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19105 | CTD Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19106 | Ddo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19107 | Dld Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19108 | Dtl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19109 | Hrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19110 | Kel Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19111 | Ltk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19112 | Pzp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19113 | Sct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19114 | Abra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19115 | Acy3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19116 | Artn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19117 | Asns Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19118 | Atf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19119 | Bmp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19120 | Btf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19121 | Capg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19122 | Cbx8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19123 | Coq2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19124 | Crat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19125 | Csad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19126 | Dlc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19127 | Dsg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19128 | Dtd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19129 | Ech1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19130 | Ensa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19131 | Epyc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19132 | Fzd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19133 | Gas7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19134 | Gatm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19135 | Gcdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19136 | Gdf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19137 | Gmpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19138 | Gnaz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19139 | Gpc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19140 | Hcn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19141 | Hsf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19142 | Ing4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19143 | Ly86 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19144 | Mafb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19145 | Mcf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19146 | Mlh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19147 | Mnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19148 | Mzb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19149 | Npr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19150 | Orm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19151 | Pga5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19152 | Pld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19153 | Pmvk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19154 | Pop1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19155 | Qprt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19156 | Rcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19157 | Rida Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19158 | Ryr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19159 | Sbf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19160 | Scg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19161 | Sco1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19162 | Sgta Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19163 | Shbg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19164 | Stx7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19165 | Tab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19166 | Tcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19167 | Ubtf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19168 | Ykt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19169 | Acta2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19170 | Anxa8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19171 | Apoa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19172 | Asf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19173 | Atg4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19174 | Atg4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19175 | Bmp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19176 | Bmp15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19177 | Bola1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19178 | Cdh15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19179 | Cfhr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19180 | Chrm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19181 | Ciita Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19182 | Cplx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19183 | Crip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19184 | Ctps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19185 | Cyb5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19186 | Ddah1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19187 | Dpep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19188 | Echs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19189 | Endog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19190 | Epha1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19191 | Erp29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19192 | Fanca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19193 | Fcrl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19194 | Flrt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19195 | Fnip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19196 | Foxc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19197 | Furin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19198 | Gars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19199 | Gfpt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19200 | Gfra3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19201 | Gng13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19202 | Gpr27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19203 | Hibch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19204 | Hjurp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19205 | Hmgn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19206 | Ifit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19207 | Il17d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19208 | Itih5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19209 | Itpka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19210 | Klf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19211 | Klk10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19212 | Klrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19213 | Kmt5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19214 | Lman2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19215 | Lrig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19216 | Mapk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19217 | Meis1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19218 | Metrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19219 | Mgst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19220 | Mmp25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19221 | Ngly1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19222 | Nodal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19223 | Oard1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19224 | Olfm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19225 | Otud5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19226 | Palb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19227 | Pclaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19228 | Pde1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19229 | Podxl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19230 | Prdm9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19231 | Ptgs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19232 | Ptpn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19233 | Rab6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19234 | Rcan2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19235 | Senp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19236 | Setd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19237 | Sgms2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19238 | Smap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19239 | Spon2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19240 | Tead2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19241 | Thop1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19242 | Tmed1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19243 | Tnni3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19244 | Traf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19245 | Ulbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19246 | Wnt8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19247 | Alyref Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19248 | Btn1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19249 | Ccdc25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19250 | Col6a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19251 | Cox4i1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19252 | Crisp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19253 | Dynll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19254 | Eif4g1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19255 | Entpd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19256 | Epha10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19257 | Gpr101 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19258 | Gprc5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19259 | Hoxa10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19260 | Hpcal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19261 | Hspa1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19262 | Il18r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19263 | Izumo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19264 | Lgals7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19265 | Nos1ap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19266 | Nt5c1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19267 | Rnf114 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19268 | Sema5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19269 | Spink1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19270 | Stxbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19271 | Tfap2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19272 | Tmed10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19273 | Ythdc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19274 | Zbtb7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19275 | Atp6ap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19276 | Cd300lg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19277 | Dcun1d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19278 | Hsd17b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19279 | Il13ra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19280 | L3mbtl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19281 | Mid1ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19282 | Pip4k2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19283 | Pip5k1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19284 | Sharpin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19285 | Slc33a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19286 | Tmprss6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19287 | Tnfaip8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19288 | Trappc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19289 | Adamts20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19290 | Cacna2d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19291 | Ppp1r14a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19292 | Serpinf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19293 | Tnfrsf25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19294 | Serpina10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19295 | C8g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19296 | Gns Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19297 | Hk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19298 | Maz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19299 | Mff Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19300 | Mip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19301 | Mt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19302 | Ndp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19303 | Rfk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19304 | Uox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19305 | Acp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19306 | Acp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19307 | Atl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19308 | Batf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19309 | Bin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19310 | Cdc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19311 | Cks2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19312 | Clmp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19313 | Cma1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19314 | Cmbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19315 | Crkl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19316 | Ctrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19317 | Dab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19318 | Daxx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19319 | Dkc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19320 | Dna2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19321 | E2f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19322 | E2f3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19323 | Eaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19324 | Ebf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19325 | Ece2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19326 | Eea1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19327 | Egr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19328 | Fgf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19329 | Fhit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19330 | Fibp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19331 | Fis1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19332 | Fmr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19333 | Frzb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19334 | Gcsh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19335 | Gfi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19336 | Gnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19337 | Gpx7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19338 | Gypc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19339 | Hey1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19340 | Hid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19341 | Ier3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19342 | Irs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19343 | Jag2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19344 | Jam3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19345 | Jund Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19346 | Krt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19347 | Lcp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19348 | Ldb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19349 | Lgr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19350 | Mal2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19351 | Mbd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19352 | Mcee Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19353 | Mpc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19354 | Mpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19355 | Mrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19356 | Nags Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19357 | Napg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19358 | Ncf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19359 | Nit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19360 | Nme2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19361 | Nop2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19362 | Otor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19363 | Penk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19364 | Phf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19365 | Phyh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19366 | Pi16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19367 | Plek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19368 | Pmm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19369 | Polb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19370 | Polg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19371 | Ppa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19372 | Ppid Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19373 | Raly Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19374 | Rbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19375 | Rcn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19376 | Rgs5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19377 | Rhoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19378 | Rif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19379 | Rps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19380 | Scg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19381 | Shpk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19382 | Sncg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19383 | Sox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19384 | Spp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19385 | Ss18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19386 | Tab3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19387 | Tbcb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19388 | Tfe3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19389 | Tgs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19390 | Tie1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19391 | Tppp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19392 | Txn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19393 | Uba6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19394 | Ubr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19395 | Ufl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19396 | Usb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19397 | Use1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19398 | USP6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19399 | Vmac Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19400 | Wnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19401 | Acadl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19402 | Acox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19403 | Actr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19404 | Adrb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19405 | Aicda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19406 | Aifm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19407 | Alas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19408 | Apoa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19409 | Asah2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19410 | Asgr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19411 | Bambi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19412 | Btnl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19413 | Bub1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19414 | Cadm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19415 | Cd180 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19416 | Cdkl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19417 | Chrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19418 | Chst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19419 | Cidea Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19420 | Cisd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19421 | Ckap4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19422 | Cpne1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19423 | Cpsf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19424 | Creg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19425 | Crhbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19426 | Ctbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19427 | Dctn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19428 | Dmbt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19429 | Dtx3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19430 | Dusp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19431 | Dusp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19432 | Epdr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19433 | Espl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19434 | Fgf22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19435 | Ggta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19436 | Gngt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19437 | Golm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19438 | Gpr15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19439 | Gstt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19440 | Hipk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19441 | Hkdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19442 | Hyal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19443 | Hyou1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19444 | Icam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19445 | Ifi30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19446 | Ifnl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19447 | Impa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19448 | Insrr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19449 | Itga1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19450 | Itga8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19451 | Itpkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19452 | Kcnk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19453 | Klrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19454 | Loxl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19455 | Lpin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19456 | Lrrn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19457 | Mdga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19458 | Micu1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19459 | Mob1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19460 | Mpzl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19461 | Mpzl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19462 | Mtch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19463 | Nceh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19464 | Ncor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19465 | Nell2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19466 | Oscar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19467 | Oxsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19468 | Pam16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19469 | Pdcd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19470 | Plcg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19471 | Plcg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19472 | Ppm1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19473 | Ppp6c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19474 | Prdm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19475 | Prkd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19476 | Psma3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19477 | Psme2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19478 | Ptpra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19479 | Rps13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19480 | Rps19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19481 | Senp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19482 | Snrpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19483 | Spns2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19484 | Srsf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19485 | Thbs4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19486 | Tirap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19487 | Tppp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19488 | Tra2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19489 | Trib2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19490 | Trmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19491 | Tubb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19492 | Ube2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19493 | Usp38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19494 | Vsig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19495 | Ywhah Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19496 | Zbtb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19497 | Acot13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19498 | Adam28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19499 | Adam30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19500 | Arrdc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19501 | B3gnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19502 | Bcap31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19503 | Col4a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19504 | Cyb5r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19505 | Diablo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19506 | Fam20c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19507 | Gpr158 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19508 | Gpr161 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19509 | Guca1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19510 | Havcr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19511 | Hilpda Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19512 | Hnrnpc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19513 | Lgals8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19514 | Lilra5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19515 | Lin28b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19516 | Map3k4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19517 | Necap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19518 | Pabpc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19519 | Parp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19520 | Phlda1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19521 | Ppp3ca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19522 | Prdm16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19523 | Ptgfrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19524 | Pycard Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19525 | S100a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19526 | Setd1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19527 | Sez6l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19528 | Slc1a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19529 | Spink7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19530 | Spint2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19531 | Sptssb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19532 | Tomm20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19533 | Trdmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19534 | Ube2g2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19535 | Ube2j2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19536 | Unc119 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19537 | Adamts2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19538 | Aldh3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19539 | Cd300lb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19540 | Col11a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19541 | Cyp24a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19542 | Gpihbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19543 | Hnrnpa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19544 | Lamtor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19545 | Metap1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19546 | Onecut2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19547 | Pip5k1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19548 | Pomgnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19549 | Rarres2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19550 | S100a14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19551 | Slc11a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19552 | Slc22a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19553 | Slc7a10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19554 | Sult2b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19555 | Tmem175 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19556 | Tsc22d1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19557 | Xpnpep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19558 | Pla2g12b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19559 | Rad51ap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19560 | C1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19561 | Chm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19562 | Fgr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19563 | Ly9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19564 | Me3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19565 | Mt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19566 | Neb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19567 | Nln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19568 | Rgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19569 | Ttl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19570 | Unk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19571 | Zyx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19572 | Adh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19573 | Ahrr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19574 | Ank3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19575 | Anln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19576 | Apoo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19577 | Atrx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19578 | Calu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19579 | Cblc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19580 | Cbx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19581 | Ccnh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19582 | Cd72 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19583 | Cerk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19584 | Cib1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19585 | Clp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19586 | Clpp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19587 | Coa6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19588 | Copa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19589 | Cpa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19590 | Cst5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19591 | Cst9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19592 | Cux1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19593 | Dok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19594 | Eif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19595 | Emg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19596 | Emp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19597 | Enam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19598 | Etv6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19599 | Eya2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19600 | F11r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19601 | Ftcd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19602 | Fut1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19603 | Gckr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19604 | Ggct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19605 | Git1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19606 | Gkn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19607 | H4c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19608 | Hcst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19609 | Ilf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19610 | Iqcg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19611 | Ksr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19612 | Lmf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19613 | Lsp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19614 | Ly96 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19615 | Mafa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19616 | Mbd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19617 | Med4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19618 | Mrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19619 | Myof Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19620 | Myt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19621 | Naga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19622 | Ncan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19623 | Nhp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19624 | Nppa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19625 | Ost4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19626 | Ostn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19627 | Pfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19628 | Phf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19629 | Pld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19630 | Pmm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19631 | Pnkp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19632 | Podn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19633 | Pon2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19634 | Prg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19635 | Rbks Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19636 | Rcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19637 | Rem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19638 | Rps7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19639 | Rtl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19640 | Saa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19641 | Scgn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19642 | Srpx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19643 | St18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19644 | Tgds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19645 | Tprn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19646 | Uba2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19647 | Ulk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19648 | Umps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19649 | Uprt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19650 | Urm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19651 | Usf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19652 | Vcan Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19653 | Wnk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19654 | Xcr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19655 | Apba3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19656 | Atat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19657 | Bccip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19658 | Blvra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19659 | Calm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19660 | Cd109 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19661 | Cdh18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19662 | Cenpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19663 | Cenpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19664 | Cetn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19665 | Cfhr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19666 | Ckmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19667 | Clic1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19668 | Cnpy4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19669 | Cops5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19670 | Cox5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19671 | Crip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19672 | Crmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19673 | Cspg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19674 | Dhrs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19675 | Dhx36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19676 | Dnph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19677 | Dusp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19678 | Eif5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19679 | Eomes Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19680 | Ercc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19681 | Ewsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19682 | Foxd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19683 | Foxp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19684 | Ggps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19685 | Gna14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19686 | Gstk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19687 | Gstz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19688 | Hcfc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19689 | Herc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19690 | Hnf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19691 | Hspg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19692 | Ifit2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19693 | Igsf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19694 | Il1r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19695 | Il36b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19696 | Il5ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19697 | Ino80 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19698 | Ip6k1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19699 | Itih3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19700 | Kcnq3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19701 | Kdm7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19702 | Kif15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19703 | Krt14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19704 | Krt18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19705 | Lmcd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19706 | Lmnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19707 | Loxl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19708 | Lrp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19709 | Ltbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19710 | Matr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19711 | Mcm10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19712 | Med10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19713 | Mef2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19714 | Mfap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19715 | Mien1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19716 | Mmgt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19717 | Mmp11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19718 | Msrb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19719 | Mtss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19720 | Nanog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19721 | Ncoa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19722 | Ndc80 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19723 | Neil1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19724 | Nlrc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19725 | Nptx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19726 | Nr1h2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19727 | Nrros Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19728 | Otud3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19729 | Pdia5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19730 | Phkg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19731 | Plac8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19732 | Prmt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19733 | Prox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19734 | Ptges Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19735 | Pvalb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19736 | Rab1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19737 | Reg3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19738 | Rxfp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19739 | Rxfp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19740 | Senp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19741 | Sfxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19742 | Snai1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19743 | Ssrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19744 | Stk40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19745 | Strap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19746 | Sulf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19747 | Tagln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19748 | Taok3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19749 | Trps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19750 | Txlna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19751 | Usp33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19752 | Usp51 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19753 | Vsnl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19754 | Wars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19755 | Wnt16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19756 | Xrcc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19757 | Ywhab Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19758 | Zbtb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19759 | Zfpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19760 | Acadvl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19761 | Adam23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19762 | Adgrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19763 | Adgrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19764 | Ankrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19765 | Calhm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19766 | Calml3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19767 | Cdc25b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19768 | Chrna7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19769 | Chst15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19770 | Ckap2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19771 | Clec4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19772 | Crisp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19773 | Dctpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19774 | Entpd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19775 | Errfi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19776 | Fgfbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19777 | Galnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19778 | Hapln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19779 | Igfbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19780 | Il15ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19781 | Il1f10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19782 | Itga2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19783 | Izumo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19784 | Jarid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19785 | Laptm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19786 | Lilra6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19787 | Ly6g6d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19788 | Mad2l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19789 | Man1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19790 | Map2k7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19791 | Mrgprd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19792 | Mybpc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19793 | N6amt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19794 | Ndufa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19795 | Nfe2l3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19796 | Notch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19797 | Npepl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19798 | Opalin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19799 | Pdcd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19800 | Phlpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19801 | Pik3r3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19802 | Polr2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19803 | Ppp1cc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19804 | Ptges2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19805 | Ptges3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19806 | Ptp4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19807 | Ptp4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19808 | Ptpn12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19809 | Rab11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19810 | Rnase6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19811 | Rnf168 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19812 | Sema3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19813 | Smndc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19814 | Sorcs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19815 | Spink4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19816 | Spock1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19817 | Sptbn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19818 | Srsf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19819 | Stard7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19820 | Thsd7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19821 | Tm4sf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19822 | Tmbim6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19823 | Tmem25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19824 | Trim27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19825 | Ube2d3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19826 | Ube2r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19827 | Vcpip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19828 | Ythdf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19829 | Adamts6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19830 | Adamts7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19831 | Adamts9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19832 | Atg16l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19833 | Atp5f1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19834 | Bloc1s2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19835 | C1qtnf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19836 | Castor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19837 | Fam167a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19838 | Gadd45g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19839 | Pacsin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19840 | Racgap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19841 | Slc22a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19842 | Slc26a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19843 | Slc27a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19844 | Slc43a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19845 | Tspan31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19846 | Adamts19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19847 | Lgals3bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19848 | Phospho1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19849 | Pnliprp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19850 | Serpina6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19851 | Serpinb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19852 | Tnfrsf19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19853 | Gabarapl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19854 | Tmprss11d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19855 | Ky Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19856 | Aen Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19857 | Ak3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19858 | Ak5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19859 | Esd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19860 | Ezr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19861 | Fgb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19862 | Igk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19863 | Jtb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19864 | Lct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19865 | Mn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19866 | Mnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19867 | Oaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19868 | Rd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19869 | Tef Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19870 | Vcl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19871 | Was Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19872 | Abi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19873 | Agrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19874 | Apof Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19875 | Art4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19876 | Atl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19877 | Bag4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19878 | Bdh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19879 | C1qc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19880 | Ccnc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19881 | Cd53 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19882 | Cdon Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19883 | Cfl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19884 | Cib2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19885 | Cish Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19886 | Cope Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19887 | Cst6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19888 | Ctso Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19889 | Cutc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19890 | Cyba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19891 | Dkk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19892 | Dlx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19893 | Dmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19894 | Eapp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19895 | Egr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19896 | Faim Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19897 | Fdxr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19898 | Flnb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19899 | Fshb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19900 | Gdf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19901 | Gga3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19902 | Ggt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19903 | Gps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19904 | Haao Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19905 | Inha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19906 | Irf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19907 | Jdp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19908 | Klf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19909 | Lig4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19910 | Lmna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19911 | Lrp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19912 | Lrp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19913 | Lsm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19914 | Ltv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19915 | Ly6d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19916 | Lyg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19917 | Mdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19918 | Mesd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19919 | Mrm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19920 | Msx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19921 | Mta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19922 | Mtf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19923 | Muc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19924 | Nip7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19925 | Nptn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19926 | Numb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19927 | Oas3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19928 | Osbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19929 | Pax3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19930 | Per1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19931 | Pfas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19932 | Pgm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19933 | Pigm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19934 | Pkn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19935 | Plec Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19936 | Pomp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19937 | Ppih Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19938 | Prf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19939 | Prg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19940 | Prg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19941 | Qdpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19942 | Rbm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19943 | Rce1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19944 | Reck Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19945 | Retn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19946 | Rgs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19947 | Rnf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19948 | Rpl8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19949 | Rrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19950 | Ryr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19951 | Ryr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19952 | Scly Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19953 | Sgsh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19954 | Siae Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19955 | Six2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19956 | Snw1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19957 | Snx9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19958 | Sos2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19959 | Ssr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19960 | Stk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19961 | Tab1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19962 | Tcp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19963 | Tle3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19964 | Tmx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19965 | Tpx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19966 | Tril Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19967 | Tsfm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19968 | Ucma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19969 | Ugdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19970 | Ugp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19971 | Upk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19972 | Uros Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19973 | Vsx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19974 | Wdr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19975 | Wdr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19976 | Aadat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19977 | Abcc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19978 | Abce1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19979 | Acss3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19980 | Adpgk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19981 | Amacr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19982 | Amelx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19983 | Apoa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19984 | Arpin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19985 | Atxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19986 | Bach2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19987 | Baz1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19988 | Bckdk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19989 | Calm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19990 | Casq1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19991 | Ccna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19992 | Ccnd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19993 | Cdh11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19994 | Cemip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19995 | Cers1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19996 | Cfhr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19997 | Chst5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19998 | Cnpy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS19999 | Cntn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20000 | Cntn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20001 | Copz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20002 | Coro6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20003 | Cplx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20004 | Cradd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20005 | Cryaa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20006 | Ctrb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20007 | Cytip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20008 | Daglb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20009 | Decr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20010 | Dhrs9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20011 | Dkkl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20012 | Dusp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20013 | Eef2k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20014 | Eif3k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20015 | Esrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20016 | Fam3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20017 | Fbxl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20018 | Fcrl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20019 | Flad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20020 | Flrt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20021 | Fndc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20022 | Foxd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20023 | Foxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20024 | Fxyd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20025 | Galk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20026 | Gata1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20027 | Gata2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20028 | Gfod2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20029 | Gp1ba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20030 | Gpha2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20031 | Gpr12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20032 | Gpr19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20033 | Gpr26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20034 | Gpr87 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20035 | Hells Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20036 | Hoxb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20037 | Ikzf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20038 | Il1r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20039 | Il2rg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20040 | Ilkap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20041 | Inpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20042 | Insm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20043 | Isg20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20044 | Itgam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20045 | Kcnj2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20046 | Kdm4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20047 | Klk15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20048 | Kmt2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20049 | Lactb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20050 | Lama3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20051 | Lmtk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20052 | Ltbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20053 | Mecp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20054 | Meltf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20055 | Mlana Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20056 | Msmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20057 | Mthfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20058 | Mthfs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20059 | Mybl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20060 | Ncoa6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20061 | Ndrg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20062 | Ndst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20063 | Nek11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20064 | Neto1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20065 | Nfasc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20066 | Nlrc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20067 | Nptxr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20068 | Nr1i3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20069 | Nr2f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20070 | Nrn1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20071 | Nrxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20072 | Nudt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20073 | Otud4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20074 | Parp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20075 | Pcbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20076 | Pdrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20077 | Pdzk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20078 | Peg10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20079 | Pex19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20080 | Pfdn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20081 | Pias1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20082 | Pilra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20083 | Pnrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20084 | Ppil1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20085 | Ppil2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20086 | Prelp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20087 | Prkg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20088 | Psme1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20089 | Ptgr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20090 | Pth2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20091 | Ptpn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20092 | Ptrh2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20093 | Rad21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20094 | Rexo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20095 | Rnf20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20096 | Robo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20097 | Romo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20098 | Rpl10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20099 | Rps4x Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20100 | Runx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20101 | Satb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20102 | Scn2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20103 | Sfrp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20104 | Sin3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20105 | Snx10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20106 | Srsf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20107 | Stk25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20108 | Sulf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20109 | Susd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20110 | Taok2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20111 | Terf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20112 | Tfcp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20113 | Tgif1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20114 | Thsd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20115 | Timp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20116 | Tinag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20117 | Tnnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20118 | Tnpo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20119 | Top2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20120 | Tpsb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20121 | Trpv5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20122 | Ube2h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20123 | Ube2o Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20124 | Ube2w Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20125 | Unc5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20126 | Uqcrh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20127 | Usp26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20128 | Usp9y Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20129 | Vdac3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20130 | Xrcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20131 | Abhd10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20132 | Acadsb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20133 | Adam29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20134 | Adam33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20135 | Adgrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20136 | Adra2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20137 | Alkal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20138 | Atf7ip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20139 | Bpifa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20140 | Calcrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20141 | Cdkn2d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20142 | Chaf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20143 | Chrna3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20144 | Cldn11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20145 | Clec9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20146 | Clstn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20147 | Col1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20148 | Col9a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20149 | Crabp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20150 | Dnase1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20151 | Dpysl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20152 | Eif1ax Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20153 | Eif4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20154 | Eps8l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20155 | Fbxo22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20156 | Fbxo32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20157 | Fgfrl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20158 | Galnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20159 | Galnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20160 | Galnt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20161 | Gpr142 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20162 | Gpr173 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20163 | Gprc5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20164 | Hnrnpr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20165 | Ifitm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20166 | Igflr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20167 | Il17rd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20168 | Il1rl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20169 | Il27ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20170 | Iqgap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20171 | Itga10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20172 | Lactb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20173 | Lgals2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20174 | Lrrc4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20175 | Lrrtm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20176 | Man1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20177 | Mbtps1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20178 | Mcoln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20179 | Mical2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20180 | Mpig6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20181 | mt-Co2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20182 | Ndufa8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20183 | Ndufa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20184 | Ndufv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20185 | Nfkbib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20186 | Otud7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20187 | Pfkfb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20188 | Pfkfb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20189 | Pi4k2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20190 | Plxnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20191 | Pofut1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20192 | Ptp4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20193 | Slc4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20194 | Slc6a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20195 | Slurp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20196 | Srfbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20197 | Trim14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20198 | Trim15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20199 | Trim29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20200 | Tspan1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20201 | Twist1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20202 | Txnl4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20203 | Ube2j1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20204 | Ube2v1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20205 | Vps13c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20206 | Abhd14b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20207 | Aldh7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20208 | Atp13a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20209 | Atp5if1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20210 | Gnpnat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20211 | Kir3dl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20212 | Lamtor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20213 | Map3k14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20214 | Mthfd1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20215 | Nectin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20216 | Slc25a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20217 | Slc36a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20218 | Slc38a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20219 | Slitrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20220 | Slitrk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20221 | Slitrk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20222 | Sult1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20223 | Tbl1xr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20224 | Trmt112 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20225 | Adamts10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20226 | Adamts14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20227 | Eif4ebp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20228 | Il1rapl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20229 | Serpinb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20230 | Slc25a28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20231 | Slc25a51 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20232 | Tmem106b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20233 | Tmprss11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20234 | Btd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20235 | Dut Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20236 | Eln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20237 | Fev Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20238 | Ggn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20239 | Kin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20240 | Mvp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20241 | Nnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20242 | Pip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20243 | Pnn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20244 | Pts Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20245 | Xpc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20246 | Adm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20247 | Amtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20248 | Ano6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20249 | Apip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20250 | Aqp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20251 | Arf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20252 | Arl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20253 | Art3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20254 | Bpgm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20255 | Bzw2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20256 | Cav2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20257 | Cbx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20258 | Cdr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20259 | Chn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20260 | Cpn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20261 | Cpox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20262 | Cst8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20263 | Cul2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20264 | Cycs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20265 | Dab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20266 | Ddx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20267 | Denr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20268 | Dgkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20269 | Dkk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20270 | E2f6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20271 | Ebf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20272 | Elob Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20273 | Emc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20274 | Emcn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20275 | Ets2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20276 | Fech Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20277 | Gbe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20278 | Gldc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20279 | Gopc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20280 | Gps2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20281 | Gpx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20282 | Grk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20283 | Gzmk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20284 | H3c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20285 | Hagh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20286 | Hcn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20287 | Hes6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20288 | Hopx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20289 | Hsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20290 | Ifne Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20291 | Klc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20292 | Klk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20293 | Lcn8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20294 | Liph Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20295 | Mbip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20296 | Mnx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20297 | Mob4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20298 | Mrs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20299 | Myl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20300 | Myoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20301 | Myog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20302 | Nans Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20303 | Nasp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20304 | Naxe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20305 | Ncf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20306 | Nek3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20307 | Nfya Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20308 | Nkd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20309 | Nme1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20310 | Nnat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20311 | Nppc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20312 | Nqo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20313 | Ntf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20314 | Ntn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20315 | Nudc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20316 | Oas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20317 | Oxr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20318 | Pax5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20319 | Pax6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20320 | Pbx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20321 | Pcp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20322 | Pepd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20323 | Per2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20324 | Pgm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20325 | Pigf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20326 | Pkp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20327 | Pmp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20328 | Ppie Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20329 | Prkx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20330 | Prr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20331 | Pxdn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20332 | Rad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20333 | Rfng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20334 | Rhoh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20335 | Rmi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20336 | Rpia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20337 | Rpn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20338 | Sox6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20339 | Spen Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20340 | Stn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20341 | Stx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20342 | Stx8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20343 | Syt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20344 | Tbx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20345 | Tcf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20346 | Thrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20347 | Tjp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20348 | Trhr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20349 | Ucp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20350 | Wsb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20351 | Ybx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20352 | Zic2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20353 | Zic3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20354 | Abcb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20355 | Abcc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20356 | Abhd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20357 | Acacb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20358 | Acer3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20359 | Acrv1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20360 | Actn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20361 | Acyp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20362 | Acyp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20363 | Ahnak Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20364 | Aimp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20365 | Apoc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20366 | Appl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20367 | Bard1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20368 | Basp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20369 | Batf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20370 | Birc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20371 | Calr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20372 | Cdca7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20373 | Cdk15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20374 | Cenpf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20375 | Cep43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20376 | Cfhr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20377 | Chpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20378 | Ckap5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20379 | Cks1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20380 | Cldn9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20381 | Clic4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20382 | Clic5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20383 | Cndp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20384 | Cnnm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20385 | Cntn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20386 | Cpeb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20387 | Crlf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20388 | Ctcfl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20389 | Dcaf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20390 | Ddost Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20391 | Dhrs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20392 | Dhrs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20393 | Dhx15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20394 | Dnah6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20395 | Edem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20396 | Egln3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20397 | Epha6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20398 | Epha8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20399 | Eppk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20400 | Ercc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20401 | Erp27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20402 | Fancc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20403 | Fbln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20404 | Fgf16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20405 | Fkbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20406 | Fkbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20407 | Fkbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20408 | Fkbp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20409 | Flrt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20410 | Fmnl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20411 | G3bp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20412 | Gabrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20413 | Gnai3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20414 | Gpat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20415 | Gpld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20416 | Grik2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20417 | Gsdma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20418 | Gstm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20419 | Hars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20420 | Hmces Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20421 | Hoxb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20422 | Hoxc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20423 | Hspa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20424 | Htr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20425 | Ifit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20426 | Igsf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20427 | Impa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20428 | Insl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20429 | Itgal Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20430 | Itln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20431 | Josd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20432 | Kcnn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20433 | Kif2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20434 | Kif2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20435 | Kifc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20436 | Kifc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20437 | Klhl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20438 | Klk13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20439 | Kpna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20440 | Lamc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20441 | Larp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20442 | Lrrc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20443 | Lrrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20444 | Magi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20445 | Meox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20446 | Mep1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20447 | Mesp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20448 | Milr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20449 | Muc5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20450 | Ncald Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20451 | Ncoa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20452 | Ncor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20453 | Nell1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20454 | Npdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20455 | Nprl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20456 | Nptx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20457 | Nrcam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20458 | Ntng1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20459 | Opcml Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20460 | Oxct1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20461 | Pa2g4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20462 | Pcsk7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20463 | Plet1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20464 | Plpp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20465 | Ppef1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20466 | Prdm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20467 | Prmt9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20468 | Prrx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20469 | Pskh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20470 | Psma4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20471 | Psmb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20472 | Psme3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20473 | Ptk2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20474 | Ptpn9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20475 | Ptprn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20476 | Qsox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20477 | Ramp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20478 | Rbbp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20479 | Rbck1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20480 | Rcvrn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20481 | Rgs12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20482 | Ripk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20483 | Rnf10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20484 | Rplp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20485 | Rptor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20486 | Rsad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20487 | Sar1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20488 | Sesn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20489 | Sf3b3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20490 | Slit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20491 | Smad5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20492 | Smug1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20493 | Sox17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20494 | Sox18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20495 | Sp140 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20496 | Spg21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20497 | Stap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20498 | Stk26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20499 | Tada3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20500 | Tiprl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20501 | Tmed4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20502 | Traf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20503 | Trpm6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20504 | Tssk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20505 | Uba52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20506 | Ube2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20507 | Ube2f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20508 | Ube3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20509 | Uqcrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20510 | Usp35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20511 | Usp37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20512 | Usp40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20513 | Usp49 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20514 | Usp53 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20515 | Vps41 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20516 | Vps4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20517 | Vsig2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20518 | Vstm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20519 | Vti1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20520 | Wdr77 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20521 | Zbtb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20522 | Acad10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20523 | Adgrg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20524 | Atp2b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20525 | Atp2b4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20526 | B3gat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20527 | B3gnt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20528 | B3gnt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20529 | Bcl11a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20530 | Camk1g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20531 | Camk2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20532 | Capza2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20533 | Casp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20534 | Ccdc47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20535 | Cd300e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20536 | Cdk5r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20537 | Cdkn1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20538 | Cela3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20539 | Chrdl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20540 | Chst11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20541 | Col5a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20542 | Crtac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20543 | Csrnp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20544 | Ddx39b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20545 | Depdc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20546 | Dnajb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20547 | Elavl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20548 | Elovl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20549 | Fbxo10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20550 | Fkbp14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20551 | Gabra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20552 | Gabra4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20553 | Gpr107 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20554 | Hectd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20555 | Hectd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20556 | Hs3st1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20557 | Il31ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20558 | Kansl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20559 | Kcnip3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20560 | Kcnma1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20561 | Kif20a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20562 | Lman2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20563 | Lrpprc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20564 | Lrrc25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20565 | Lrrc3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20566 | Mad2l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20567 | Map3k9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20568 | Mapre3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20569 | Mrpl44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20570 | mt-Nd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20572 | Npbwr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20573 | Nusap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20574 | Or10h1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20575 | Osbpl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20576 | Papss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20577 | Pgrmc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20578 | Pi4k2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20579 | Plxdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20580 | Pmaip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20581 | Pnpla6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20582 | Podxl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20583 | Pou2f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20584 | Ppfia4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20585 | Ptdss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20586 | Ptger3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20587 | Ptpn18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20588 | Raet1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20589 | Recql4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20590 | Rnase1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20591 | Rnf126 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20592 | Rnf146 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20593 | Rps27a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20594 | Sema3f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20595 | Sema4g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20596 | Shcbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20597 | Slc7a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20598 | Slc8b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20599 | Smurf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20600 | Spink2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20601 | Suclg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20602 | Tagln2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20603 | Tagln3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20604 | Thap11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20605 | Tmeff1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20606 | Tmem17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20607 | Tmem92 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20608 | Treml1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20609 | Trim23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20610 | Trim45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20611 | Trmt11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20612 | Tubb4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20613 | Txnrd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20614 | Ube2g1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20615 | Uqcr11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20616 | Usp6nl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20617 | Vps13d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20618 | Zc3h13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20619 | Zmynd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20620 | Adamts8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20621 | Aldh4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20622 | B3galt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20623 | B4galt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20624 | B4galt4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20625 | Cacna1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20626 | Cacna1i Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20627 | Cdk2ap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20628 | Csnk1g2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20629 | Fam171b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20630 | Hepacam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20631 | Hsd11b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20632 | Hsd17b4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20633 | Il18rap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20634 | Kirrel2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20635 | Kremen1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20636 | Lyplal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20637 | Mab21l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20638 | Map3k11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20639 | Pglyrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20640 | Rtn4rl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20641 | Scgb3a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20642 | Selenom Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20643 | Sinhcaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20644 | Slc11a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20645 | Slc22a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20646 | Slc39a6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20647 | Slc44a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20648 | Slc47a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20649 | Smarce1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20650 | Smpdl3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20651 | St3gal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20652 | St6gal2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20653 | Sult1c2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20654 | Sult2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20655 | Sult4a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20656 | Syngap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20657 | Tmem41b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20658 | Txndc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20659 | Txndc17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20660 | Ubash3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20661 | Zfp36l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20662 | Adamts12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20663 | Arhgap22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20664 | Eif4ebp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20665 | Hepacam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20666 | Hsd17b12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20667 | Naaladl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20668 | Ppp1r13l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20669 | Serpinb9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20670 | Serpinh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20671 | Serpini2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20672 | Slc25a12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20673 | Slc25a24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20674 | Slc39a14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20675 | Timeless Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20676 | Serpina12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20677 | Cfi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20678 | Cfp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20679 | Dek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20680 | Ehf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20681 | Frk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20682 | Lbh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20683 | Mmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20684 | Ppy Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20685 | Sp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20686 | Syp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20687 | Zfx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20688 | Aatf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20689 | Ago3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20690 | Amfr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20691 | Amot Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20692 | Apcs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20693 | Arl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20694 | Baat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20695 | Bet1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20696 | Bmp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20697 | Btg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20698 | Btg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20699 | Btrc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20700 | Caly Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20701 | Cbr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20702 | Cbx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20703 | Cd82 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20704 | Cdt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20705 | Chd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20706 | Cir1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20707 | Cnmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20708 | Cnn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20709 | Cpvl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20710 | Crem Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20711 | Cul5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20712 | Dcps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20713 | Dgkh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20714 | Dlg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20715 | Dlx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20716 | Dner Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20717 | Dntt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20718 | Dpys Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20719 | Drc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20720 | Dvl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20721 | Dvl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20722 | Dysf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20723 | E2f5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20724 | Eaf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20725 | Eef2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20726 | Ehd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20727 | Elp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20728 | Emx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20729 | Etf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20730 | Evx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20731 | Exo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20732 | Faf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20733 | Fhl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20734 | Flnc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20735 | Ftmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20736 | Fxr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20737 | Gab3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20738 | Gba1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20739 | Gdf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20740 | Gdi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20741 | Ghrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20742 | Gjb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20743 | Gli2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20744 | Gmps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20745 | Gnb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20746 | Gng4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20747 | Gpam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20748 | Grb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20749 | Grk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20750 | Gusb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20751 | Hes2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20752 | Hhat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20753 | Hira Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20754 | Immt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20755 | Imp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20756 | Irx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20757 | Ism1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20758 | Itpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20759 | Kdm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20760 | Lax1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20761 | Lcp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20762 | Lgi3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20763 | Lgr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20764 | Lhx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20765 | Lhx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20766 | Lhx9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20767 | Lipf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20768 | Lmo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20769 | Lsm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20770 | Mafk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20771 | Mcub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20772 | Mdn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20773 | Mefv Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20774 | Mpst Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20775 | Msl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20776 | Mta2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20777 | Muc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20778 | Mycl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20779 | Myh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20780 | Nagk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20781 | Ncf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20782 | Nfia Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20783 | Nme3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20784 | Nox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20785 | Npnt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20786 | Nuf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20787 | Opn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20788 | Orc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20789 | Orc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20790 | Otx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20791 | P3h1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20792 | Pdx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20793 | Pfn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20794 | Pgk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20795 | Pld3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20796 | Pnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20797 | Pno1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20798 | Ppa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20799 | Ppic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20800 | Ppt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20801 | Prcp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20802 | Pspn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20803 | Pstk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20804 | Pus1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20805 | Pus7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20806 | Pygl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20807 | Rag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20808 | Rala Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20809 | Rbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20810 | Rev1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20811 | Rin3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20812 | Rpf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20813 | Rpn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20814 | Rtcb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20815 | Sbk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20816 | Sco2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20817 | Scp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20818 | Sdc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20819 | Sgk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20820 | Smc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20821 | Snrk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20822 | Sox5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20823 | Syt7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20824 | Tbx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20825 | Tia1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20826 | Tkfc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20827 | Tle2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20828 | Tlk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20829 | Tmpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20830 | Tom1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20831 | Ttf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20832 | Twnk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20833 | Uts2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20834 | Vav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20835 | Vav3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20836 | Vbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20837 | Vwc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20838 | Wbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20839 | Xpo6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20840 | Xrn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20841 | Yod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20842 | Zg16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20843 | Abca3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20844 | Abcc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20845 | Abhd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20846 | Acad8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20847 | Acads Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20848 | Acap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20849 | Ackr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20850 | Acsl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20851 | Adcy3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20852 | Afmid Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20853 | Anxa9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20854 | Aplp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20855 | Apoc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20856 | Arih1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20857 | Arrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20858 | Asap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20859 | Ascc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20860 | Ascl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20861 | Ascl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20862 | Atg2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20863 | Axin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20864 | Birc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20865 | Bmp8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20866 | Brip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20867 | Btnl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20868 | Calb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20869 | Capn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20870 | Cass4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20871 | Cbll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20872 | Ccdc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20873 | Cdc45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20874 | Cdca3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20875 | Cdca4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20876 | Cdhr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20877 | Cdhr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20878 | Cdkn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20879 | Cdyl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20880 | Cenpw Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20881 | Cept1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20882 | Cert1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20883 | Chac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20884 | Clcn7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20885 | Cldn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20886 | Clic6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20887 | Clip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20888 | Cmpk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20889 | Cmtm6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20890 | Cnih2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20891 | Cox10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20892 | Cox17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20893 | Cox18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20894 | Cox7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20895 | Crls1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20896 | Csrp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20897 | Ctbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20898 | Cyb5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20899 | Daam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20900 | Dars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20901 | Dcaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20902 | Dchs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20903 | Dclk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20904 | Ddhd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20905 | Ddx10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20906 | Ddx21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20907 | Ddx49 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20908 | Degs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20909 | Disp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20910 | Disp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20911 | Dock1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20912 | Dpy30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20913 | Duox2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20914 | Ebag9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20915 | Ecsit Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20916 | Eepd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20917 | Eif3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20918 | Eif3m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20919 | Ethe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20920 | Evi2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20921 | Evi2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20922 | Faim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20923 | Fcamr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20924 | Fcgbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20925 | Fcrla Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20926 | Fgf11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20927 | Foxa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20928 | Foxd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20929 | Foxk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20930 | Foxq1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20931 | Fstl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20932 | G6pc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20933 | Galns Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20934 | Galr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20935 | Gfra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20936 | Gins1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20937 | Gmppa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20938 | Gna13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20939 | Gpr20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20940 | Gpr22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20941 | Gpr31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20942 | Gpr50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20943 | Gpr61 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20944 | Gpr85 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20945 | Grem2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20946 | Grhl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20947 | Grik3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20948 | Grin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20949 | Gstm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20950 | Gtf2i Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20951 | Hacd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20952 | Hdlbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20953 | Hmgcl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20954 | Hmgn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20955 | Hmgn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20956 | Hspb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20957 | Htr2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20958 | Htra2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20959 | Icam4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20960 | Icam5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20961 | Igsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20962 | Ikbip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20963 | Il36a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20964 | Inhbc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20965 | Insl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20966 | Ireb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20967 | Isca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20968 | Itga3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20969 | Itga7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20970 | Itih2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20971 | Itpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20972 | Kcnd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20973 | Kcnq5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20974 | Klk11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20975 | Kmt2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20976 | Lama1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20977 | Lama2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20978 | Lamb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20979 | Lamc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20980 | Litaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20981 | Lmod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20982 | Lrig2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20983 | Lrrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20984 | Lrrn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20985 | Magoh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20986 | Mat1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20987 | Mat2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20988 | Mgat3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20989 | Mgme1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20990 | Mmp19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20991 | Mpeg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20992 | Mrto4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20993 | Ms4a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20994 | Mtif3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20995 | Mxra8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20996 | Naa40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20997 | Ncam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20998 | Ncapg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS20999 | Nhsl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21000 | Nipbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21001 | Notum Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21002 | Npas2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21003 | Nr0b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21004 | Nrarp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21005 | Nubpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21006 | Oprk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21007 | Ovol1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21008 | Oxa1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21009 | Padi3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21010 | Paics Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21011 | Pank1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21012 | Pank2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21013 | Parp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21014 | Pcdh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21015 | Pcdh9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21016 | Pcsk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21017 | Pcyt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21018 | Pgam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21019 | Pgap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21020 | Pianp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21021 | Pias4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21022 | Pibf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21023 | Pitx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21024 | Pla1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21025 | Plac9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21026 | Plbd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21027 | Plod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21028 | Pnpt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21029 | Ppm1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21030 | Prodh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21031 | Prok1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21032 | Psmd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21033 | Pxdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21034 | Rbpms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21035 | Rhpn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21036 | Rnf31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21037 | Rnf40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21038 | Robo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21039 | Rpl23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21040 | Rplp0 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21041 | Rreb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21042 | Scn3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21043 | Scn4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21044 | Semg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21045 | Sfxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21046 | Siah2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21047 | Smpd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21048 | Snu13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21049 | Sort1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21050 | Spa17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21051 | Spsb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21052 | Spsb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21053 | Srsf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21054 | Srxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21055 | Ssc5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21056 | Stk19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21057 | Stk24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21058 | Stk39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21059 | Stra6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21060 | Tagap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21061 | Tarm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21062 | Tbx21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21063 | Tcf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21064 | Tcf21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21065 | Telo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21066 | Tfdp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21067 | Thada Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21068 | Traf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21069 | Trim9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21070 | Tssk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21071 | Ttbk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21072 | Ube2z Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21073 | Ube4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21074 | Uhrf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21075 | Urgcp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21076 | Ush1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21077 | Usp29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21078 | Usp34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21079 | Usp44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21080 | Vamp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21081 | Virma Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21082 | Vps18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21083 | Vps35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21084 | Wipi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21085 | Abcb10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21086 | Ablim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21087 | Adgrf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21088 | Adra1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21089 | Agpat4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21090 | Anapc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21091 | Anp32a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21092 | Arid3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21093 | Arl2bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21094 | Arpc1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21095 | Asrgl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21096 | Atad3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21097 | Atp1b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21098 | B3glct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21099 | B3gnt5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21100 | Bclaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21101 | Cc2d1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21102 | Cdkal1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21103 | Cdkn2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21104 | Cela3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21105 | Chrnb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21106 | Cited2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21107 | Clstn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21108 | Col9a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21109 | Commd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21110 | Cox6b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21111 | Cox6b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21112 | Cox7a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21113 | Csnk1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21114 | Cyp2s1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21115 | Dcbld1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21116 | Dnajb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21117 | Dnajc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21118 | Draxin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21119 | Dusp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21120 | Eftud2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21121 | Eif4a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21122 | Elovl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21123 | Endod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21124 | Exosc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21125 | Faap24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21126 | Fam83d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21127 | Fbxo44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21128 | Fbxw11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21129 | Fermt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21130 | Fermt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21131 | Flvcr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21132 | Flvcr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21133 | Gabrb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21134 | Gimap6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21135 | Gpr146 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21136 | Grin2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21137 | Hnrnpk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21138 | Hnrnpu Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21139 | Homer1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21140 | Hotair Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21141 | Il17rc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21142 | Inpp5d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21143 | Inpp5e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21144 | Itga11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21145 | Lgalsl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21146 | Lingo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21147 | Lpgat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21148 | Lrrc8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21149 | Magea1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21150 | Magea4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21151 | Map3k6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21152 | Mapre1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21153 | Mettl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21154 | Mfap3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21155 | Minpp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21156 | Mlxipl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21157 | Mrpl21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21158 | Mrps10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21159 | mt-Nd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21160 | Mycbp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21161 | Ndufa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21162 | Ndufs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21163 | Ndufs5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21164 | Ndufv2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21165 | Nfe2l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21166 | Nlrp12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21167 | Osbpl7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21168 | Pdzrn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21169 | Pggt1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21170 | Pgm2l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21171 | Pinlyp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21172 | Pou3f2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21173 | Pou4f1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21174 | Ppp2ca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21175 | Ppp6r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21176 | Prdm13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21177 | Prkaa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21178 | Prss22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21179 | Prss23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21180 | Ptpn13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21181 | Ptpn14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21182 | Qrich1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21183 | Rab27b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21184 | Rassf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21185 | Rhbdl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21186 | Rnasek Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21187 | Rnf145 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21188 | Rnf149 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21189 | Rpl23a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21190 | Scara3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21191 | Scube3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21192 | Sema6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21193 | Sema6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21194 | Setd1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21195 | Slc7a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21196 | Snap29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21197 | Snapc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21198 | Snrpd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21199 | Spock3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21200 | Steap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21201 | Stk32c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21202 | Suclg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21203 | Syce1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21204 | Tas1r3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21205 | Tgoln2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21206 | Tmeff2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21207 | Tollip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21208 | Trim32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21209 | Trim35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21210 | Trim47 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21211 | Trim72 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21212 | Tspan6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21213 | Tuba1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21214 | Tubb4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21215 | Tyrobp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21216 | Unc13a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21217 | Unc5cl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21218 | Vangl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21219 | Yme1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21220 | Zbtb17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21221 | Zdhhc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21222 | Znhit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21223 | Adipor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21224 | Aldh1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21225 | Angptl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21226 | Angptl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21227 | Arl6ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21228 | Atp13a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21229 | Atp5f1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21230 | Atp6v1f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21231 | C1galt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21232 | Cacna1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21233 | Cacna1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21234 | Cacna1s Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21235 | Col10a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21236 | Emilin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21237 | Galnt10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21238 | Galnt14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21239 | Hsd17b8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21240 | Hsp90b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21241 | Il22ra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21242 | Izumo1r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21243 | Ldlrad2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21244 | Ldlrad3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21245 | Map3k13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21246 | Mybbp1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21247 | Nectin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21248 | Pcolce2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21249 | Pde4dip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21250 | Ppp1r9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21251 | Ppp2r5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21252 | Rapgef4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21253 | Selenoi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21254 | Septin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21255 | Slc15a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21256 | Slc26a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21257 | Slc37a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21258 | Slc52a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21259 | Slco2a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21260 | Smarca5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21261 | Snrnp70 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21262 | Timm17a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21263 | Tmem119 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21264 | Tmem45a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21265 | Tmprss3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21266 | Trmt61b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21267 | Txndc12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21268 | Wfikkn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21269 | Zc3h12d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21270 | Zfp36l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21271 | Cd200r1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21272 | Colgalt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21273 | Map1lc3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21274 | Pafah1b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21275 | Pdzk1ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21276 | Pnliprp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21277 | Slc22a17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21278 | Slc25a33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21279 | Tmprss15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21280 | Csgalnact1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21281 | Ak9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21282 | Dse Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21283 | Evl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21284 | Hrk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21285 | Lsr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21286 | Nrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21287 | Qki Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21288 | Sry Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21289 | Acp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21290 | Aff4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21291 | Ajm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21292 | Alg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21293 | Alg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21294 | Alpi Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21295 | Asb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21296 | Aspm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21297 | Avil Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21298 | Bco2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21299 | Bcor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21300 | Blnk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21301 | Bora Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21302 | Bub3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21303 | Cbx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21304 | Ccn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21305 | Ccnf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21306 | Ccno Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21307 | Cct8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21308 | Cds2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21309 | Cfc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21310 | Chd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21311 | Chka Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21312 | Chp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21313 | Chpf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21314 | Cltc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21315 | Cnbp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21316 | Coil Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21317 | Crnn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21318 | Cul1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21319 | Dap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21320 | Dbn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21321 | Def6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21322 | Dera Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21323 | Dlx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21324 | Dok7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21325 | Dpf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21326 | Dpm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21327 | Dpp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21328 | Dpyd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21329 | Dspp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21330 | Dtx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21331 | Ebpl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21332 | Eci1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21333 | Elf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21334 | Elf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21335 | Emx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21336 | Etv2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21337 | Etv3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21338 | Etv5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21339 | Ext1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21340 | Fat4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21341 | Fjx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21342 | Flcn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21343 | Fut4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21344 | Fzd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21345 | Gatb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21346 | Gde1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21347 | Gdf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21348 | Glg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21349 | Gli3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21350 | Gmds Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21351 | Gnb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21352 | Gng2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21353 | Gyg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21354 | Hhip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21355 | Idi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21356 | Idi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21357 | Ipmk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21358 | Irs4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21359 | Klf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21360 | Klf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21361 | Lat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21362 | Lcor Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21363 | Ldhc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21364 | Lgr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21365 | Lhx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21366 | Lhx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21367 | Lmo2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21368 | Lsm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21369 | Ly6h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21370 | Mael Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21371 | Mcat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21372 | Mcm6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21373 | Mcm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21374 | Mei1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21375 | Mfng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21376 | Mia2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21377 | Miip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21378 | Msi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21379 | Msx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21380 | Mto1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21381 | Mul1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21382 | Mxi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21383 | Myh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21384 | Myh6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21385 | Myl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21386 | Mzf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21387 | Nbea Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21388 | Nek8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21389 | Nek9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21390 | Nfic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21391 | Nfs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21392 | Nkg7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21393 | Nkrf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21394 | Npr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21395 | Nrep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21396 | Nt5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21397 | Nt5m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21398 | Oit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21399 | Opn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21400 | Pawr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21401 | Pcca Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21402 | Pccb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21403 | Pdhb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21404 | Pdhx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21405 | Pecr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21406 | Pex2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21407 | Pgm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21408 | Phip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21409 | Pid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21410 | Pin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21411 | Pon3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21412 | Purb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21413 | Rac3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21414 | Rarb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21415 | Rbl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21416 | Rbm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21417 | Rcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21418 | Rdm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21419 | Rec8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21420 | Rgl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21421 | Rgp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21422 | Rgs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21423 | Rhog Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21424 | Rln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21425 | Rnd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21426 | Rpa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21427 | Rrs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21428 | Rtp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21429 | Sdf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21430 | Sdhc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21431 | Sdhd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21432 | Shc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21433 | Six3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21434 | Six4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21435 | Six5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21436 | Spg7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21437 | Spic Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21438 | Stx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21439 | Swi5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21440 | Tbx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21441 | Tfr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21442 | Tgm3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21443 | Tle1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21444 | Tle4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21445 | Tmc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21446 | Tmc7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21447 | Tns1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21448 | Trdn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21449 | Ttc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21450 | Ttf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21451 | Ucn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21452 | Upp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21453 | Urod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21454 | Usf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21455 | Uxs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21456 | Vill Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21457 | Vrk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21458 | Wnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21459 | Xaf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21460 | Xpo7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21461 | Xrn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21462 | Zic1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21463 | Zic5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21464 | Zw10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21465 | Aars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21466 | Abcb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21467 | Abcb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21468 | Abcc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21469 | Abhd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21470 | Acot1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21471 | Actg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21472 | Actr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21473 | Adcy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21474 | Adcy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21475 | Agmat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21476 | Akap5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21477 | Akip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21478 | Alg11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21479 | Ampd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21480 | Apex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21481 | Aph1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21482 | Apmap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21483 | Arap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21484 | Arid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21485 | Asap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21486 | Ascl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21487 | Atad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21488 | Atg12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21489 | Atp23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21490 | Atxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21491 | Atxn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21492 | Aunip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21493 | Auts2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21494 | Banf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21495 | Bank1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21496 | Batf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21497 | Bcl9l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21498 | Best3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21499 | Bicc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21500 | C1ql1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21501 | C3ar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21502 | Calcb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21503 | Cald1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21504 | Cand1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21505 | Ccnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21506 | Ccnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21507 | Ccnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21508 | Cd247 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21509 | Cd2ap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21510 | Cdc5l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21511 | Cdca2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21512 | Cdh19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21513 | Cdh23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21514 | Cdh24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21515 | Cdhr5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21516 | Cdk18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21517 | Cdk20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21518 | Cdkl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21519 | Cebpe Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21520 | Cebpg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21521 | Cenpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21522 | Cenpo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21523 | Cep55 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21524 | Cep78 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21525 | Cflar Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21526 | Chmp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21527 | Chrm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21528 | Chst9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21529 | Ciart Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21530 | Cideb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21531 | Clcn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21532 | Cldn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21533 | Cldn7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21534 | Cnnm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21535 | Cox14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21536 | Cox6c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21537 | Cpne3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21538 | Cpne5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21539 | Cpsf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21540 | Creb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21541 | Crim1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21542 | Csde1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21543 | Cstf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21544 | Cyth3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21545 | Dars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21546 | Dctn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21547 | Ddx11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21548 | Ddx24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21549 | Ddx3y Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21550 | Ddx60 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21551 | Degs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21552 | Dgcr8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21553 | Dhx30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21554 | Dhx58 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21555 | Disc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21556 | Dmgdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21557 | Dmrt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21558 | Dock7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21559 | Dram1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21560 | Dscam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21561 | Dscc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21562 | Eif3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21563 | Eif3l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21564 | Ero1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21565 | Etnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21566 | Extl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21567 | Fads3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21568 | Fanci Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21569 | Fbln2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21570 | Fbxo5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21571 | Fbxo6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21572 | Fbxw2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21573 | Fmnl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21574 | Foxe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21575 | Foxr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21576 | Frmd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21577 | Frmd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21578 | Fut10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21579 | Gcnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21580 | Gdpd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21581 | Ggact Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21582 | Glis2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21583 | Glp2r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21584 | Gmeb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21585 | Gnai2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21586 | Gpd1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21587 | Gpr21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21588 | Greb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21589 | Gria2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21590 | Gtf2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21591 | Hacd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21592 | Hdhd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21594 | Hint1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21595 | Hnf4g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21596 | Hoxb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21597 | Hoxb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21598 | Hoxc8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21599 | Hyls1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21600 | Ifi35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21601 | Ifrd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21602 | Ikzf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21603 | Itm2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21604 | Itpr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21605 | Jmjd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21606 | Kat14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21607 | Kcmf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21608 | Kcna4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21609 | Kcnd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21610 | Kcnh7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21611 | Kcnh8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21612 | Kcnk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21613 | Kcnk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21614 | Kctd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21615 | Kdm1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21616 | Kif1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21617 | Kif22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21618 | Klf16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21619 | Kmt5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21620 | Kyat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21621 | Lalba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21622 | Lama4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21623 | Lama5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21624 | Lamb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21625 | Lamb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21626 | Larp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21627 | Lars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21628 | Lars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21629 | Limd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21630 | Lmnb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21631 | Lmx1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21632 | Loxl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21633 | Lrfn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21634 | Lrp10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21635 | Lrtm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21636 | Lsamp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21637 | Ltc4s Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21638 | Magt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21639 | Maml1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21640 | Mark1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21641 | Mast3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21642 | Matn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21643 | Mcfd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21644 | Mex3d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21645 | Mgat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21646 | Mgst3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21647 | Micu2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21648 | Mitd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21649 | Mki67 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21650 | Mlycd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21651 | Mmrn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21652 | Mob1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21653 | Morc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21654 | Mprip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21655 | Mrtfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21656 | Ms4a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21657 | Muc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21658 | Mybl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21659 | Myo1c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21660 | Mysm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21661 | Myt1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21662 | Nacc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21663 | Nedd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21664 | Nelfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21665 | Nomo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21666 | Noxa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21667 | Npsr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21668 | Nr0b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21669 | Nrxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21670 | Nrxn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21671 | Nsun3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21672 | Nsun7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21673 | Nt5c2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21674 | Nucb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21675 | Numa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21676 | Nup85 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21677 | Olfm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21678 | Padi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21679 | Panx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21680 | Paqr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21681 | Parm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21682 | Pcdh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21683 | Pcmt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21684 | Pdcd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21685 | Pde6c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21686 | Pdgfc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21687 | Pdzd8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21688 | Pias3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21689 | Pidd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21690 | Plag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21691 | Plcb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21692 | Plcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21693 | Plin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21694 | Pold3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21695 | Ppcdc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21696 | Ppm1k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21697 | Prex1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21698 | Prlhr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21699 | Prok2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21700 | Prpf8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21701 | Psmb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21702 | Psmc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21703 | Ptcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21704 | Pthlh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21705 | Ptprb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21706 | Ptpre Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21707 | Ptprg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21708 | Ptprm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21709 | Ptprs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21710 | Rab10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21711 | Rab20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21712 | Rab32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21713 | Rab37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21714 | Rab3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21715 | Rab5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21716 | Rab5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21717 | Rab8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21718 | Rad9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21719 | Rasa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21720 | Rasa4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21721 | Rasd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21722 | Rbbp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21723 | Rbbp7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21724 | Rbm22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21725 | Rbm43 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21726 | Rbms2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21727 | Rc3h2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21728 | Rcan1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21729 | Rcor1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21730 | Rdh10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21731 | Rgs17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21732 | Ribc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21733 | Rims2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21734 | Riok3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21735 | Rnf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21736 | Rnf25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21737 | Rnf32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21738 | Rpl36 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21739 | Rplp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21740 | Rps10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21741 | Rps12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21742 | Rps14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21743 | Rps21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21744 | Rraga Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21745 | Rragd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21746 | Rrm2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21747 | Rspo4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21748 | Rtbdn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21749 | Sall2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21750 | Sall4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21751 | Sap30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21752 | Sec13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21753 | Sesn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21754 | Sftpc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21755 | Sgpl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21756 | Sin3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21757 | Slit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21758 | Smdt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21759 | Smyd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21760 | Smyd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21761 | Sntg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21762 | Snx20 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21763 | Sorl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21764 | Sox11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21765 | Spag5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21766 | Spc25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21767 | Spry1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21768 | Srrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21769 | Srsf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21770 | Stag1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21771 | Stmn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21772 | Styk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21773 | Sumo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21774 | Susd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21775 | Svep1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21776 | Sycp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21777 | Tada1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21778 | Taf15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21779 | Tafa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21780 | Tbx19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21781 | Tcfl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21782 | Tctn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21783 | Tdrd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21784 | Tfap4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21785 | Tfb1m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21786 | Tfb2m Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21787 | Thsd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21788 | Tmed2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21789 | Tmed3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21790 | Tmed9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21791 | Top3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21792 | Tpd52 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21793 | Tpst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21794 | Trak2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21795 | Trat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21796 | Trim8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21797 | Trip6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21798 | Trit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21799 | Trpm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21800 | Ubap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21801 | Ufsp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21802 | Uqcc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21803 | Usp48 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21804 | Veph1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21805 | Vwc2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21806 | Wdr26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21807 | Wnt5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21808 | Wnt7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21809 | Ypel5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21810 | Zmym2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21811 | Abhd12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21812 | Actl6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21813 | Adgrb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21814 | Adgrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21815 | Adgrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21816 | Adgrf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21817 | Adgrg6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21818 | Agpat2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21819 | Agtrap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21820 | Ambra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21821 | Atp11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21822 | Atp1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21823 | Atp1b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21824 | Atxn2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21825 | B3gnt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21826 | Baiap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21827 | Bcl11b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21828 | Brinp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21829 | Camkk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21830 | Camta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21831 | Cartpt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21832 | Cavin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21833 | Cavin3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21834 | Cd99l2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21835 | Cep112 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21836 | Chaf1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21837 | Chmp4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21838 | Clec3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21839 | Col5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21840 | Col5a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21841 | Coro1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21842 | Csnk2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21843 | Ddx19b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21844 | Dhtkd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21845 | Diaph3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21846 | Dnajc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21847 | Dusp18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21848 | Eef1a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21849 | Efemp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21850 | Egflam Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21851 | Eif2s1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21852 | Ercc6l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21853 | Exosc9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21854 | Fam20b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21855 | Fbxo11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21856 | Gabra5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21857 | Glcci1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21858 | Glt8d2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21859 | Glyctk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21860 | Gpr141 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21861 | Gpr182 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21862 | Grin2c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21863 | Gxylt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21864 | Higd1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21865 | Hnrnpd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21866 | Hsf2bp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21867 | Hspa4l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21868 | Ifi44l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21869 | Ifitm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21870 | Il20ra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21871 | Immp1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21872 | Immp2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21873 | Impact Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21874 | Incenp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21875 | Inpp4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21876 | Inpp5a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21877 | Kif21a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21878 | Klhl24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21879 | Large2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21880 | Lmbr1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21881 | Ly6g6f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21882 | Map3k2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21883 | Mettl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21884 | Mettl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21886 | Mllt10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21887 | Mrgpre Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21888 | Mrpl11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21889 | Mrpl13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21890 | Mustn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21891 | Nanos1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21892 | Nap1l1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21893 | Ndufa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21894 | Ndufb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21895 | Ndufb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21896 | Ndufc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21897 | Ndufc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21898 | Ndufs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21899 | Nfatc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21900 | Npffr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21901 | Pcdh12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21902 | Pcdh17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21903 | Pdgfrl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21904 | Pdlim5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21905 | Pdzd11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21906 | Pgrmc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21907 | Pik3r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21908 | Pitpna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21909 | Polr1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21910 | Polr1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21911 | Polr1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21912 | Polr2g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21913 | Ppp3r1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21914 | Prss27 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21915 | Prss57 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21916 | Ptger1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21917 | Ptpdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21918 | Rassf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21919 | Rnf128 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21920 | Rnf166 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21921 | Rnf169 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21922 | Rnf186 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21923 | Rnf213 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21924 | Rpl27a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21925 | Samsn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21926 | Scarf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21927 | Sema3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21928 | Sephs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21929 | Setbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21930 | Sh2d1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21931 | Sh3bp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21932 | Sh3gl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21933 | Slc1a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21934 | Slc1a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21935 | Slc1a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21936 | Slc4a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21937 | Slc4a8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21938 | Slc5a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21939 | Slc6a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21940 | Slc7a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21941 | Sorbs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21942 | Sowaha Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21943 | Sptlc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21944 | Srd5a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21945 | Srd5a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21946 | Srebf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21947 | Stard4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21948 | Stoml3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21949 | Strip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21950 | Stxbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21951 | Sucla2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21952 | Syngr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21953 | Tas1r2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21954 | Tbxas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21955 | Tcirg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21956 | Tex264 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21957 | Tm9sf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21958 | Trim13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21959 | Trim26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21960 | Trim31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21961 | Trim38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21962 | Trim44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21963 | Trim56 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21964 | Trip11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21965 | Trip12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21966 | Tsga10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21967 | Ttll12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21968 | Twist2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21969 | U2surp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21970 | Ubap1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21971 | Ube2l6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21972 | Ube2v2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21973 | Ubiad1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21974 | Ugt1a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21975 | Unc13d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21976 | Yeats2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21977 | Zbtb12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21978 | Zcchc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21979 | Abhd16b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21980 | Adamts3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21981 | Adipor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21982 | Aldh3b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21983 | Ankrd54 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21984 | Arfgap3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21985 | Arhgdib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21986 | Arhgef6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21987 | Arhgef7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21988 | Atp5f1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21989 | Bcl2l12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21990 | Bhlhe23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21991 | C9orf72 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21992 | Caskin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21993 | Ccdc134 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21994 | Ccdc88a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21995 | Clec11a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21996 | Clec14a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21997 | Clptm1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21998 | Col22a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS21999 | Csnk1g1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22000 | Dnajc11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22001 | Dnttip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22002 | Eif2ak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22003 | Fam162a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22004 | Fam177b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22005 | Fastkd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22006 | Hmgcll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22007 | Il12rb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22008 | Laptm4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22009 | Mapkap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22010 | Mettl13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22011 | Micall2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22012 | Napepld Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22013 | Ndufaf3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22014 | Ndufb11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22015 | Pacsin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22016 | Pik3ap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22017 | Plekhg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22018 | Ppp2r1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22019 | Ppp2r3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22020 | Prkar2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22021 | Prkar2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22022 | Rangap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22023 | Rasgrp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22024 | Rnpepl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22025 | Rps6ka4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22026 | Rps6ka5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22027 | Serinc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22028 | Slc10a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22029 | Slc12a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22030 | Slc13a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22031 | Slc16a5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22032 | Slc18a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22033 | Slc18a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22034 | Slc18b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22035 | Slc20a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22036 | Slc22a7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22037 | Slc25a4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22038 | Slc26a6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22039 | Slc29a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22040 | Slc35b2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22041 | Slc35e3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22042 | Slc38a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22043 | Slc38a3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22044 | Slc44a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22045 | Smarcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22046 | Sostdc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22047 | St8sia1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22048 | Tax1bp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22049 | Tbc1d16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22050 | Tmem158 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22051 | Tsc22d3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22052 | Ubash3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22053 | Unc93b1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22054 | Xpnpep3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22055 | Zc3hav1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22056 | Zdhhc19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22057 | Arhgap30 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22058 | Arhgap42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22059 | Arhgef40 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22060 | Cacna2d3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22061 | Cacna2d4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22062 | Crispld2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22063 | Ctnnbip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22064 | Hsd17b14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22065 | Mapk8ip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22066 | Naaladl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22067 | Pafah1b3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22068 | Rap1gap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22069 | Serpinb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22070 | Sh3pxd2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22071 | Slc22a13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22072 | Slc25a13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22073 | Slc25a25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22074 | Slc25a29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22075 | Slc25a37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22076 | Slc25a39 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22077 | Stambpl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22078 | Traf3ip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22079 | C1galt1c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22080 | Ak6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22081 | Mkx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22082 | Mpz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22083 | Nyx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22084 | Scx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22085 | Txk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22086 | Wiz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22087 | Wls Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22088 | Xpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22089 | Yy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22090 | A1cf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22091 | Aacs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22092 | Aard Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22093 | Aatk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22094 | Acp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22095 | Acp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22096 | Aff3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22097 | Agmo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22098 | Agps Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22099 | Ahsp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22100 | Aig1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22101 | Akna Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22102 | Alg6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22103 | Ano2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22104 | Apeh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22105 | Aplf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22106 | Arf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22107 | Asb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22108 | Atf7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22109 | Bag5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22110 | Bcl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22111 | Brox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22112 | Cbr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22113 | Cct4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22114 | Cds1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22115 | Chat Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22116 | Chdh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22117 | Chgb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22118 | Chkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22119 | Chn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22120 | Cilp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22121 | Cln3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22122 | Cln5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22123 | Cln6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22124 | Clpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22125 | Clpx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22126 | Cmas Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22127 | Cnn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22128 | Cnn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22129 | Coq3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22130 | Coq5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22131 | Ctr9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22132 | Ctsf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22133 | Cttn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22134 | Cul9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22135 | Ddx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22136 | Dgki Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22137 | Dio3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22138 | Dlg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22139 | Dlx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22140 | Dlx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22141 | Dmtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22142 | Dnm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22143 | Dnm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22144 | Dok3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22145 | Dolk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22146 | Dpf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22147 | Dpm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22148 | Drp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22149 | E2f8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22150 | Ect2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22151 | Edc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22152 | Edn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22153 | Ehd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22154 | Ei24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22155 | Elk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22156 | Elp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22157 | Emc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22158 | Emc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22159 | Enc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22160 | Eny2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22161 | Epg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22162 | Epn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22163 | Etfa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22164 | Etv4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22165 | Eya1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22166 | Fan1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22167 | Far2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22168 | Fbn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22169 | Fgd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22170 | Fig4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22171 | Fmo3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22172 | Fmo5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22173 | Fnta Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22174 | Frs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22175 | Fut9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22176 | Fzr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22177 | Gab2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22178 | Gas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22179 | Gbf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22180 | Gbp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22181 | Gbp6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22182 | Gfm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22183 | Gjb3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22184 | Gjb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22185 | Gjc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22186 | Gldn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22187 | Glrb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22188 | Gnaq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22189 | Gnb4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22190 | Gnb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22191 | Gng3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22192 | Gnl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22193 | Gpx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22194 | Gpx8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22195 | Guf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22196 | Hax1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22197 | Hccs Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22198 | Hcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22199 | Hes7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22200 | Heyl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22201 | Hmx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22202 | Hpdl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22203 | Hpf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22204 | Hscb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22205 | Ier5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22206 | Ighm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22207 | Il25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22208 | Inmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22209 | Ipo9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22210 | Ippk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22211 | Iqub Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22212 | Iws1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22213 | Kif7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22214 | Knl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22215 | Krt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22216 | Leo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22217 | Lfng Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22218 | Lgi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22219 | Lgi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22220 | Lig3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22221 | Lipg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22222 | Lipk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22223 | Lmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22224 | Lrba Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22225 | Lst1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22226 | Ltn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22227 | Lyg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22228 | Mbd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22229 | Mbd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22230 | Mcm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22231 | Mcm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22232 | Mcm9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22233 | Mfrp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22234 | Mib1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22235 | Miox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22236 | Misp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22237 | Mlf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22238 | Mmab Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22239 | Mpnd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22240 | Mrm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22241 | Msh6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22242 | Msi1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22243 | Mtf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22244 | Mtx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22245 | Mxd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22246 | Myf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22247 | Myl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22248 | Narf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22249 | Nefh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22250 | Neo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22251 | Neu2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22252 | Neu3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22253 | Nexn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22254 | Nfix Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22255 | Nfyb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22256 | Nid2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22257 | Nit2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22258 | Nkap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22259 | Nktr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22260 | Nmd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22261 | Nme5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22262 | Noa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22263 | Noct Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22264 | Nol4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22265 | Ocln Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22266 | Oxsm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22267 | Pax1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22268 | Pax2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22269 | Pax9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22270 | Pbx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22271 | Pbx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22272 | Pclo Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22273 | Pcp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22274 | Pdyn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22275 | Pex3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22276 | Pfn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22277 | Pgls Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22278 | Phkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22279 | Pigq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22280 | Pisd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22281 | Pllp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22282 | Pmch Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22283 | Pnoc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22284 | Pogz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22285 | Polh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22286 | Preb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22287 | Prnd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22288 | Prr7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22289 | Ptms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22290 | Ptx4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22291 | Pum2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22292 | Pus3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22293 | Pygb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22294 | Rarg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22295 | Rbm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22296 | Rbmx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22297 | Rfc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22298 | Rfc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22299 | Rfx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22300 | Rfx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22301 | Rfx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22302 | Rgcc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22303 | Rhag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22304 | Rhod Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22305 | Rlim Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22306 | Rnmt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22307 | Rny1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22308 | Rpl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22309 | Rpl9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22310 | Rprm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22311 | Rps5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22312 | Rpsa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22313 | Rras Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22314 | Rsu1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22315 | Rtf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22316 | Rtn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22317 | Sbsn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22318 | Scel Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22319 | Scg5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22320 | Setx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22321 | Sfpq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22322 | Sgcz Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22323 | Shc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22324 | Sit1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22325 | Six6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22326 | Ska1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22327 | Slu7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22328 | Smn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22329 | Smtn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22330 | Sox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22331 | Spib Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22332 | Sra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22333 | Srms Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22334 | Strn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22335 | Sun1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22336 | Suox Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22337 | Syn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22338 | Syt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22339 | Tbx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22340 | Tbx6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22341 | Tcap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22342 | Tecr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22343 | Tgm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22344 | Tjp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22345 | Tln1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22346 | Tmie Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22347 | Tmx3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22348 | Tns4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22349 | Tox3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22350 | Trir Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22351 | Ubl5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22352 | Ubn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22353 | Utf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22354 | Vav2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22355 | Vmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22356 | Vmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22357 | Vrk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22358 | Wbp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22359 | Wdr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22360 | Wnt6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22361 | Wwc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22362 | Zer1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22363 | Zup1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22364 | Abcc9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22365 | Abcd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22366 | Abcd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22367 | Abcf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22368 | Abtb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22369 | Acad9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22370 | Acbd6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22371 | Ackr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22372 | Acot2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22373 | Acot7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22374 | Acsf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22375 | Acta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22376 | Actr6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22377 | Adam2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22378 | Adat1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22379 | Adcy5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22380 | Aebp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22381 | Agfg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22382 | Aipl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22383 | Akap6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22384 | Alg12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22385 | Alg13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22386 | Alg14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22387 | Alms1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22388 | Alpk2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22389 | Ap1s2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22390 | Ap2m1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22391 | Apba2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22392 | Aph1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22393 | Aplp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22394 | Arcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22395 | Arl4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22396 | Arl8b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22397 | Armh1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22398 | Atg4d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22399 | Atg9a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22400 | Atg9b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22401 | Atrip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22402 | Axin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22403 | Barx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22404 | Baz1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22405 | Bcas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22406 | Bend5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22407 | Bmp8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22408 | Brms1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22409 | Bud31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22410 | C1ql3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22411 | Cabp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22412 | Capn8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22413 | Capn9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22414 | Cars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22415 | Casz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22416 | Cbln4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22417 | Ccar1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22418 | Ccbe1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22419 | Ccdc9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22420 | Ccne2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22421 | Ccpg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22422 | Cct6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22423 | Cdc23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22424 | Cdc34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22425 | Cdca8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22426 | Cdipt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22427 | Cdkl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22428 | Cdr2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22429 | Celf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22430 | Celf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22431 | Celf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22432 | Cenpm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22433 | Cenpx Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22434 | Cep76 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22435 | Cers2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22436 | Chadl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22437 | Chid1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22438 | Chrm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22439 | Chrnd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22440 | Chst7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22441 | Chtop Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22442 | Clcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22443 | Clcn6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22444 | Cldn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22445 | Cldn8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22446 | Clip4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22447 | Cmya5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22448 | Cnga2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22449 | Cnga3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22450 | Cnot1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22451 | Cnot7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22452 | Cox7c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22453 | Cox8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22454 | Cpeb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22455 | Cplx1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22456 | Cpne4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22457 | Crocc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22458 | Crtap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22459 | Crtc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22460 | Cul4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22461 | Cul4b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22462 | Cwc15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22463 | Cxxc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22464 | Cyren Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22465 | Dcaf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22466 | Dctn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22467 | Ddx42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22468 | Dhx29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22469 | Dmac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22470 | Dmrt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22471 | Dmrt3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22472 | Dnah9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22473 | Dstyk Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22474 | Duox1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22475 | Dusp8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22476 | Dusp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22477 | Ears2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22478 | Edem1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22479 | Edem3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22480 | Efhd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22481 | Eif3h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22482 | Eif5b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22483 | Elfn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22484 | Elfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22485 | Elmo1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22486 | Endou Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22487 | Enpp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22488 | Epb41 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22489 | Eps15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22490 | Eral1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22491 | Ercc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22492 | Ercc8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22493 | Esyt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22494 | Esyt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22495 | Etaa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22496 | Eva1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22497 | Exoc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22498 | Exph5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22499 | Fam3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22500 | Fate1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22501 | Fbln5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22502 | Fbxl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22503 | Fbxo7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22504 | Fcho1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22505 | Fcrl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22506 | Fem1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22507 | Fhod3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22508 | Fibin Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22509 | Fkbp9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22510 | Fmnl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22511 | Fndc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22512 | Foxb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22513 | Foxc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22514 | Foxn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22515 | Foxo6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22516 | Foxp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22517 | Fstl4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22518 | Ftsj3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22519 | Fubp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22520 | Fut11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22521 | Fxyd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22522 | Fxyd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22523 | Galr3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22524 | Ghitm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22525 | Gins2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22526 | Gipc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22527 | Glod4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22528 | Glra1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22529 | Glrx5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22530 | Glyr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22531 | Gmpr2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22532 | Gna15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22533 | Gnai1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22534 | Gng11 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22535 | Gpm6a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22536 | Gpr45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22537 | Gpr63 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22538 | Gpsm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22539 | Grb10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22540 | Grik1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22541 | Grsf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22542 | Gstm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22543 | Gstt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22544 | Habp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22545 | Hacd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22546 | Hace1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22547 | Hacl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22548 | Hddc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22549 | Hecw1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22550 | Hemk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22551 | Herc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22552 | Hhatl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22553 | Hinfp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22554 | Hint2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22555 | Hmcn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22556 | Hoga1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22557 | Hoxa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22558 | Hoxa3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22559 | Hoxb5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22560 | Hoxb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22561 | Hoxb8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22562 | Hoxc6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22563 | Htr1e Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22564 | Htra4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22565 | Hvcn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22566 | Iars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22567 | Idh3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22568 | Idh3g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22569 | Ifi44 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22570 | Ifna6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22571 | Ifrd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22572 | Igll1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22573 | Il21r Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22574 | Ilvbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22575 | Insm2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22576 | Iqcb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22577 | Itgad Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22578 | Itih4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22579 | Itm2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22580 | Itpkc Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22581 | Jade3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22582 | Josd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22583 | Kat6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22584 | Kcna3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22585 | Kcnc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22586 | Kcne5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22587 | Kcnj3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22588 | Kcnj8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22589 | Kcns1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22590 | Kcnt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22591 | Kcnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22592 | Kctd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22593 | Kctd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22594 | Kif2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22595 | Kif3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22596 | Kif3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22597 | Kif3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22598 | Kif5c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22599 | Klf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22600 | Klf14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22601 | Klhl6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22602 | Kpna1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22603 | Krt6b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22604 | Krt81 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22605 | Lamc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22606 | Lasp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22607 | Lemd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22608 | Limd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22609 | Lin37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22610 | Lipt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22611 | Llgl2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22612 | Lman1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22613 | Lpin2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22614 | Lrfn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22615 | Lrfn4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22616 | Lrig3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22617 | Lrit3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22618 | Lrp1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22619 | Luzp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22620 | Lzts1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22621 | Macf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22622 | Magi2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22623 | Maml2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22624 | Maml3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22625 | Mast1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22626 | Mast4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22627 | Mbnl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22628 | Mccc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22629 | Mcf2l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22630 | Mcur1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22631 | Med19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22632 | Medag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22633 | Megf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22634 | Megf9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22635 | Meis2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22636 | Mex3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22637 | Mfsd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22638 | Mgst2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22639 | Mipep Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22640 | Mixl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22641 | Mkrn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22642 | Mlst8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22643 | Mlxip Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22644 | Mmp15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22645 | Mmp16 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22646 | Mms19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22647 | Morc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22648 | Mov10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22649 | Mrap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22650 | Mrpl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22651 | Mtch1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22652 | Mtcl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22653 | Mtif2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22654 | Mtmr4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22655 | Mtus1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22656 | Muc13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22657 | Mus81 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22658 | Mutyh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22659 | Myadm Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22660 | Myh10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22661 | Mylk3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22662 | Mylk4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22663 | Myo3a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22664 | Myo3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22665 | Myo9b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22666 | Myoz2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22667 | Nabp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22668 | Nagpa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22669 | Naprt Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22670 | Nars1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22671 | Nat8l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22672 | Ncoa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22673 | Ndrg3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22674 | Ndrg4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22675 | Ndst4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22676 | Neil3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22677 | Nfrkb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22678 | Nim1k Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22679 | Nlgn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22680 | Nmrk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22681 | Nop14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22682 | Nop56 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22683 | Npas1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22684 | Nr1h3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22685 | Nr1i2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22686 | Nr2c1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22687 | Nr2c2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22688 | Nr6a1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22689 | Nrbf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22690 | Nrip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22691 | Nsmaf Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22692 | Nsun4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22693 | Nsun5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22694 | Nsun6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22695 | Nudt8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22696 | Numbl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22697 | Nup42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22698 | Nup88 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22699 | Nyap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22700 | Ogdhl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22701 | Or2k2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22702 | Orai2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22703 | Otogl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22704 | Ovch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22705 | Ovol2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22706 | Oxgr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22707 | Palmd Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22708 | Pank3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22709 | Pars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22710 | Pcgf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22711 | Pcsk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22712 | Pde6d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22713 | Pdia2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22714 | Pdss1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22715 | Pdss2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22716 | Pdzd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22717 | Pdzd4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22718 | Pdzd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22719 | Peli2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22720 | Pfdn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22721 | Pgbd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22722 | Phf12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22723 | Phf19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22724 | Phf23 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22725 | Phf24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22726 | Phka1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22727 | Phkg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22728 | Phrf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22729 | Pias2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22730 | Pitx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22731 | Plcb2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22732 | Plek2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22733 | Plvap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22734 | Pole2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22735 | Polg2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22736 | Ppm1f Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22737 | Ppm1h Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22738 | Ppm1j Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22739 | Ppp4c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22740 | Pprc1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22741 | Prdm8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22742 | Prorp Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22743 | Prrx2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22744 | Psip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22745 | Psmb1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22746 | Psmb7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22747 | Psmc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22748 | Psmd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22749 | Psmd2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22750 | Psmd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22751 | Ptch2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22752 | Ptcra Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22753 | Ptprq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22754 | Ptprr Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22755 | Puf60 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22756 | Pxmp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22757 | Qrsl1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22758 | Rab1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22759 | Rab21 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22760 | Rab28 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22761 | Rab34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22762 | Rab35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22763 | Rab42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22764 | Rab8a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22765 | Rabl3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22766 | Ralyl Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22767 | Rasa1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22768 | Rbm10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22769 | Rbm25 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22770 | Rbm33 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22771 | Rbm34 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22772 | Rbms3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22773 | Rcor2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22774 | Rell2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22775 | Rgs10 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22776 | Rgs22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22777 | Rmdn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22778 | Rnf13 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22779 | Rnft2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22780 | Rpe65 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22781 | Rpl12 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22782 | Rpl18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22783 | Rpl24 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22784 | Rpl26 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22785 | Rpl37 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22786 | Rpl38 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22787 | Rps15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22788 | Rps18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22789 | Rras2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22790 | Rrp7a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22791 | Rsrc2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22792 | Rufy2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22793 | Samd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22794 | Samd5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22795 | Sardh Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22796 | Scml4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22797 | Scn1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22798 | Scrg1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22799 | Sel1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22800 | Serf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22801 | Sf3a2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22802 | Sftpb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22803 | Sgpp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22804 | Sh2b3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22805 | Skap1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22806 | Skap2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22807 | Slfn5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22808 | Slmap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22809 | Smc1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22810 | Snip1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22811 | Snrpg Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22812 | Snrpn Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22813 | Snta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22814 | Snx22 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22815 | Sox15 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22816 | Sp110 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22817 | Spag4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22818 | Spag6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22819 | Spag8 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22820 | Spag9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22821 | Spam1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22822 | Spcs1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22823 | Spcs2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22824 | Spcs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22825 | Spin1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22826 | Spin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22827 | Spry2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22828 | Spry4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22829 | Spta1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22830 | Srprb Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22831 | Srsf4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22832 | Srsf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22833 | Ssbp4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22834 | Stim2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22835 | Stk31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22836 | Stk35 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22837 | Stmn3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22838 | Stmp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22839 | Stt3b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22840 | Susd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22841 | Syne1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22842 | Taf1b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22843 | Taf1d Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22844 | Taf5l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22845 | Tafa2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22846 | Tafa5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22847 | Tbx18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22848 | Tcea3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22849 | Tcf19 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22850 | Tctn2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22851 | Tdrd7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22852 | Tdrd9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22853 | Tekt1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22854 | Tenm1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22855 | Tenm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22856 | Tesk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22857 | Tfdp2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22858 | Thbs3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22859 | Thyn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22860 | Tial1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22861 | Tigd3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22862 | Timm9 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22863 | Tinf2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22864 | Tmod1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22865 | Tmod3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22866 | Tmtc4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22867 | Tnip2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22868 | Tnni2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22869 | Tnnt2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22870 | Tomm5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22871 | Tomm7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22872 | Tor1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22873 | Traf5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22874 | Trak1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22875 | Tram2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22876 | Trex2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22877 | Trhde Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22878 | Trib1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22879 | Trim3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22880 | Trim7 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22881 | Trip4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22882 | Trnp1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22883 | Trrap Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22884 | Tshz1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22885 | Tshz2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22886 | Tssk6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22887 | Ttc7b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22888 | Tubb6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22889 | Tuft1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22890 | U2af2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22891 | Ubac1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22892 | Ube3c Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22893 | Ubl4a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22894 | Ubxn1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22895 | Uhmk1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22896 | Upk1a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22897 | Uqcrq Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22898 | Ush1g Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22899 | Ush2a Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22900 | Usp31 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22901 | Usp32 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22902 | Usp42 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22903 | Usp45 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22904 | Usp50 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22905 | Usp54 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22906 | Uvssa Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22907 | Vac14 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22908 | Vamp3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22909 | Vamp5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22910 | Vars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22911 | Vash2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22912 | Vat1l Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22913 | Vgll4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22914 | Vipr1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22915 | Vps29 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22916 | Vstm4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22917 | Wasf1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22918 | Wdfy1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22919 | Wdhd1 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22920 | Wdr18 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22921 | Wdr48 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22922 | Wnt2b Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22923 | Xrcc3 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22924 | Xrcc5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22925 | Yars2 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22926 | Ywhag Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22927 | Zbed5 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22929 | Sds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22930 | Hmgb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22931 | Ngf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22932 | Bdnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22933 | Trpv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22934 | Cd36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22935 | Ldha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22936 | Hgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22937 | Pcsk9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22938 | Gpx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22939 | Lox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22940 | Mettl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22941 | Vhl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22942 | Fgf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22943 | Bmp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22944 | Sag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22945 | Ccl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22946 | Trpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22947 | Fap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22948 | Stat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22949 | Cxcl10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22950 | Gsdmd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22951 | C3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22952 | Usp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22953 | Mif Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22954 | Gdnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22955 | Cxcl12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22956 | Sts Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22957 | Trem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22958 | Cd40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22959 | Igf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22960 | Nrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22961 | Gip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22962 | Lif Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22963 | Nhs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22964 | Ahr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22965 | Cck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22966 | Ccl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22967 | Cd44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22968 | Vegfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22969 | C5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22970 | Wrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22971 | Fgf21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22972 | Cd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22973 | Crbn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22974 | Gdf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22975 | Dkk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22976 | Gspt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22977 | Enpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22978 | Npy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22979 | Osm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22980 | Spp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22981 | Cd47 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22982 | Nqo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22983 | Tg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22984 | Slc7a11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22985 | Atf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22986 | Usp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22987 | Abca1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22988 | Cntf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22989 | Bcl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22990 | Pfkfb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22991 | Foxo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22992 | Trem1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22993 | Txnip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22994 | Sp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22995 | Mlkl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22996 | Fer Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22997 | G6pd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22998 | Tigit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS22999 | Epo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23000 | Usp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23001 | Sos1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23002 | Pam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23003 | Smarca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23004 | Igf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23005 | Lcn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23006 | Nr4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23007 | Eno1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23008 | Angptl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23009 | Hk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23010 | Ogt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23011 | Apoe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23012 | Lck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23013 | S100a9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23014 | Tfeb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23015 | Tat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23016 | Fpr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23017 | Mat2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23018 | Cd24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23019 | Gapdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23020 | Cd19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23021 | Vip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23022 | Irf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23023 | Ptpn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23024 | Aim2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23025 | Fgf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23026 | Pgk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23027 | S100a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23028 | Ccl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23029 | Trpc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23030 | Tpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23031 | Axl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23032 | Bcr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23033 | Shh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23034 | Cd74 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23035 | Wdr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23036 | Cxcl13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23037 | Cx3cl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23038 | Blm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23039 | Fabp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23040 | Egr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23041 | Klf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23042 | Pink1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23043 | Ccl20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23044 | Akr1c3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23045 | Fgf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23046 | Nrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23047 | Kif18a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23048 | Cxcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23049 | Trpc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23050 | Ldlr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23051 | Rrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23052 | Pdk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23053 | Mpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23054 | Fpr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23055 | Cdcp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23056 | Fabp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23057 | Gpnmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23058 | Trpv4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23059 | Mbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23060 | Cp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23061 | Bmp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23062 | Loxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23063 | Tslp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23064 | Sfn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23065 | Gpc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23066 | Glp1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23067 | Foxo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23068 | Pth Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23069 | Usp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23070 | Fen1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23071 | Kdm5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23072 | Pc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23073 | Usp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23074 | Cyp1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23075 | Foxm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23076 | Ccl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23077 | Gstp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23078 | H2ax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23079 | Cd86 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23080 | Il11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23081 | Anxa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23082 | Mthfd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23083 | Mln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23084 | Fgf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23085 | Runx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23086 | Dtnb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23087 | Sox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23088 | Cxcl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23089 | Pde4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23090 | Bid Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23091 | Tet2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23092 | Dgat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23093 | Icam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23094 | Pla2g7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23095 | Th Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23096 | Brca1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23097 | Eed Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23098 | Traf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23099 | Kdm5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23100 | Cat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23101 | Il33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23102 | Dgat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23103 | Itgb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23104 | Crh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23105 | Lrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23106 | Mst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23107 | Pcna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23108 | Acss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23109 | Vegfc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23110 | Oga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23111 | Klf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23112 | Xbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23113 | Mertk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23114 | S100a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23115 | Mtap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23116 | Cdc42 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23118 | Uhrf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23119 | Bptf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23120 | Il18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23121 | Lag3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23122 | Zbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23123 | Mb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23124 | Id1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23125 | Cd22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23126 | Il21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23127 | Rspo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23128 | Cxcl16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23129 | Prdx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23130 | Alkbh5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23131 | Setdb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23132 | Fgf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23133 | Trh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23134 | Xpo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23135 | Cpz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23136 | Aqp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23137 | Ccl22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23138 | Cpt1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23139 | Ikzf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23140 | Kdm6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23141 | Wnt3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23142 | Cxcl11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23143 | Ccl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23144 | Nat10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23145 | Erf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23146 | Erg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23147 | Fas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23148 | Yy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23149 | Fgf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23150 | Gas6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23151 | Irf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23152 | Jag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23153 | Hmox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23154 | Rab7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23155 | Angpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23156 | Dll3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23157 | Tspo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23158 | Sarm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23159 | Cdkn2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23160 | Hr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23161 | Pnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23162 | Cd14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23163 | Abhd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23164 | Blk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23165 | Mdk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23166 | Spr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23167 | Nsd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23168 | Prc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23169 | Ptpn11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23170 | Tf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23171 | Fgf23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23172 | Otub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23173 | Chi3l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23174 | Cyp1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23175 | Pkmyt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23176 | Tmprss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23177 | Hp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23178 | Cdc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23179 | Rac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23180 | Tfrc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23181 | Usp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23182 | Uchl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23183 | Avp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23184 | Gpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23185 | Set Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23186 | Nnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23187 | Usp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23188 | Ccl21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23189 | Cs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23190 | Cd70 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23191 | Ghrh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23192 | Epha2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23193 | Itgav Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23194 | Trpm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23195 | Ilk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23196 | Ogg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23197 | Folr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23198 | Trpc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23199 | Csk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23200 | Emb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23201 | Cd63 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23202 | Bnip3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23203 | Dnmt3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23204 | Trim21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23205 | Gc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23206 | Ik Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23207 | Fn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23208 | Lyn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23209 | Clk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23210 | Smad3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23211 | Trpm8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23212 | Dnmt3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23213 | Cd9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23214 | Gne Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23215 | Mcu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23216 | Oat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23217 | Prl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23218 | Npc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23219 | Tet1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23220 | Ccnd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23221 | Rack1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23222 | Ina Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23223 | Nsf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23224 | Cd34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23225 | Cry1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23226 | Csf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23227 | Nppb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23228 | Saa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23229 | Spop Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23230 | Gan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23231 | Pvr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23232 | Ttk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23233 | Mdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23234 | Fgf19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23235 | Hmgb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23236 | Il23r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23237 | Kdm2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23238 | Ugt1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23239 | S100a10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23240 | Ahcy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23241 | Irf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23242 | Ror1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23243 | Panx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23244 | Smarca4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23245 | Ifng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23246 | Lrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23247 | Phb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23248 | Tlr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23249 | C6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23250 | Cort Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23251 | Cd200 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23252 | Dapk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23253 | Kdm2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23254 | Taar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23255 | Fos Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23256 | Lat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23257 | Tes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23258 | Camp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23259 | Ccl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23260 | Icos Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23261 | Igfbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23262 | Igf2bp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23263 | Cd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23264 | Gca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23265 | Caps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23266 | Mitf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23267 | Brca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23268 | Ccl17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23269 | Cdc20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23270 | Dusp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23271 | Ube2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23272 | Usp30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23273 | Slc1a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23274 | Ang Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23275 | Gem Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23276 | Ran Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23277 | Cd52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23278 | Cd55 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23279 | Irf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23280 | Nek2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23281 | Senp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23282 | Timp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23283 | Amh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23284 | F12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23285 | Cd27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23286 | Grk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23287 | Gsdme Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23288 | Itgb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23289 | Sparc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23290 | Igf2bp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23291 | Mrgprx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23292 | Ak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23293 | Rb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23294 | Csf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23295 | Il22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23296 | Anxa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23297 | Hipk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23298 | Kcnh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23299 | Kdm5c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23300 | Traf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23301 | Trpv3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23302 | Mettl14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23303 | Fth1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23304 | Muc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23305 | Runx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23306 | Stim1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23307 | Lgals9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23308 | F3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23309 | Mgll Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23310 | Fcgrt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23311 | Tead4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23312 | Usp20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23313 | Vdac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23314 | F2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23315 | Si Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23316 | Afp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23317 | Crp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23318 | Hck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23319 | Sf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23320 | Dll4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23321 | Ets1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23322 | Sv2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23323 | Zeb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23324 | Lgals3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23325 | Angptl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23326 | Nf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23327 | Comp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23328 | Ddx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23329 | Dpp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23330 | Rbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23331 | Tgm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23332 | Cyp2e1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23333 | Grp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23334 | Ltb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23335 | Gpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23336 | Il7r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23337 | Irs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23338 | Mdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23339 | Ccl11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23340 | Fads2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23341 | Foxp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23342 | Fstl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23343 | Itga5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23344 | Ptgs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23345 | Thbs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23346 | Aldh1a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23347 | F5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23348 | Cd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23349 | Mok Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23350 | Tyr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23351 | Atf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23352 | Dll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23353 | Kat7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23354 | Npff Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23355 | Abcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23356 | Cd226 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23357 | Fdft1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23358 | Fkbp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23359 | Socs3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23360 | Trpm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23361 | Atp1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23362 | Slamf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23363 | Ide Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23364 | Cd80 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23365 | Erfe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23366 | Mdm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23367 | Pdk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23368 | Skp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23369 | Sod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23370 | Stom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23371 | Tnk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23372 | Atg4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23373 | Tacc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23374 | Sema4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23375 | F7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23376 | B2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23377 | Dap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23378 | Ddc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23379 | Ghr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23380 | Hrg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23381 | Btla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23382 | Sod2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23383 | Xcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23384 | Ccl19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23385 | Ncoa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23386 | Trpv6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23387 | Usp22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23388 | Cyp1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23389 | Gucy2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23390 | Ythdf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23391 | Adm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23392 | Eda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23393 | Mia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23394 | Csf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23395 | Irf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23396 | Oma1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23397 | Sdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23398 | Ucp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23399 | Adrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23400 | Ccl24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23401 | Cd163 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23402 | Hif1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23403 | Usp9x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23404 | Col1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23405 | Cit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23406 | Bap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23407 | Clk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23408 | Dkk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23409 | Ereg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23410 | Got1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23411 | Opa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23412 | Wnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23413 | Yes1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23414 | Fabp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23415 | Ffar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23416 | P4ha1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23417 | Postn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23418 | S100b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23419 | Setd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23420 | Tgfbi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23421 | Trpc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23422 | Cmklr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23423 | Tnfrsf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23424 | Tnfrsf17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23425 | Asl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23426 | Cd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23427 | Mog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23428 | Omp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23429 | Plg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23430 | Rpe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23431 | Fshr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23432 | Ldhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23433 | Ltbr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23434 | Olr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23435 | Pfkp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23436 | Sost Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23437 | Asgr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23438 | Cxcr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23439 | Tgfb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23440 | Slc3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23441 | Steap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23442 | Cd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23443 | Gpt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23444 | Mal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23445 | Tox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23446 | Atf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23447 | Rhoa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23448 | Taf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23449 | Cd276 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23450 | Dusp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23451 | Hoxb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23452 | Jmjd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23453 | Igfbp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23454 | Cyp27a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23455 | Tnfrsf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23456 | Alb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23457 | Cbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23458 | Dbi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23459 | Mag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23460 | Msc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23461 | Pah Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23462 | Areg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23463 | Bub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23464 | Cd3e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23465 | Ebi3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23466 | Nae1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23467 | Pdpn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23468 | Pin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23469 | Bach1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23470 | Pdpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23471 | Akr1c1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23472 | Aldh1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23473 | Tnfsf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23474 | C2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23475 | Il7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23476 | Wt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23477 | Arg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23478 | Cd5l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23479 | Gfap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23480 | Il27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23481 | Mavs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23482 | Ppbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23483 | Gpr65 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23484 | Ikzf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23485 | Isg15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23486 | Trib3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23487 | Lgals1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23488 | Tnfaip3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23489 | Pgp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23490 | Tk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23491 | Tro Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23492 | Agr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23493 | Bmp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23494 | Cd68 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23495 | Cdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23496 | E2f1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23497 | Eras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23498 | Fgf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23499 | Rin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23500 | Tfam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23501 | Acox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23502 | Hbegf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23503 | Ifna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23504 | Lta4h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23505 | Shmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23506 | Ube2t Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23507 | Usp15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23508 | Arc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23509 | Fst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23510 | Hpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23511 | Nog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23512 | Por Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23513 | Slk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23514 | Hes1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23515 | Npm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23516 | Odc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23517 | Plat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23518 | Sdc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23519 | Actn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23520 | Aldoa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23521 | Apoa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23522 | Cxcl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23523 | Epcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23524 | Kat6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23525 | Nedd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23526 | Sf3b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23527 | Stub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23528 | Tead1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23529 | Tnfsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23530 | Tnfsf13b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23531 | Dsp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23532 | Ell Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23533 | Mcc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23534 | Mos Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23535 | Pgc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23536 | Rs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23537 | Cd33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23538 | Klf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23539 | Plau Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23540 | Tsc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23541 | Eif4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23542 | Mthfd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23543 | Tnfsf12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23544 | Cbs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23545 | Des Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23546 | Dr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23547 | Ptn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23548 | Alad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23549 | Dlat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23550 | Fgl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23551 | Il4r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23552 | Mall Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23553 | Mfn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23554 | Itga2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23555 | Kcnq2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23556 | Kdm3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23557 | Lamp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23558 | Ppm1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23559 | Vcam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23560 | Havcr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23561 | Nedd4l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23562 | Fh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23563 | Cda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23564 | Cel Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23565 | Cpe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23566 | Hk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23567 | Ssb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23568 | Tdg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23569 | Atic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23570 | Cd81 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23571 | H6pd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23572 | Tph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23573 | Alcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23574 | Bmal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23575 | Bmp2k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23576 | Ccl25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23577 | Kdm4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23578 | Flt3lg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23579 | Gprc5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23580 | Igfbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23581 | Mapkapk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23582 | C8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23583 | Nmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23584 | Fadd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23585 | Gast Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23586 | Hat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23587 | Il6r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23588 | Rest Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23589 | Rsf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23590 | Scap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23591 | Sqor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23592 | Ybx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23593 | Camk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23594 | Cxadr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23595 | Nr5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23596 | Pdgfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23597 | Stat4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23598 | Suz12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23599 | Usp25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23600 | Dcaf16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23601 | Trip13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23602 | Txnrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23603 | Csnk1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23604 | S100a11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23605 | Cfd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23606 | Gcg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23607 | Rho Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23608 | Sp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23609 | Sri Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23610 | Ccn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23611 | Eno2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23612 | Gpx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23613 | Grpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23614 | Gzma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23615 | Klk7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23616 | Ngfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23617 | Proc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23618 | Slpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23619 | Cdh17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23620 | Gsk3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23621 | Kdm5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23622 | Lamp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23623 | Srpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23624 | Srsf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23625 | Usp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23626 | Camkk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23627 | Cyp11b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23628 | Pik3ip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23629 | Suv39h1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23630 | Serpina1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23631 | Gk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23632 | Abo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23633 | Cnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23634 | Dcc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23635 | Lpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23636 | Me1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23637 | Brd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23638 | Dmpk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23639 | Etv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23640 | Fdps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23641 | Fut8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23642 | Fzd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23643 | Lifr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23644 | Msln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23645 | Spi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23646 | Stc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23647 | Upp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23648 | Wnt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23649 | Atad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23650 | Efna5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23651 | Ephb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23652 | Fgf18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23653 | Folr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23654 | Hspa8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23655 | Kdm6b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23656 | Pick1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23657 | Ptpn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23658 | Qpctl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23659 | Sirpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23660 | Smad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23661 | Tradd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23662 | Trpm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23663 | Cyp7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23664 | Muc5ac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23665 | Notch3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23666 | Cad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23667 | Dcn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23668 | Ager Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23669 | Ass1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23670 | Bms1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23671 | Kynu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23672 | Lrp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23673 | Nek7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23674 | Nsd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23675 | Tsc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23676 | Anxa5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23677 | Apoc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23678 | Asic3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23679 | Bcat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23680 | Elane Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23681 | Foxo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23682 | Hpgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23683 | Il6st Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23684 | Masp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23685 | Nedd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23686 | Rbm39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23687 | Trpv2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23688 | Akr1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23689 | Igfbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23690 | Lilrb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23691 | Ythdf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23692 | Akr1b10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23693 | Tnfsf13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23694 | C7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23695 | F11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23696 | Gaa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23697 | Gla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23698 | Id2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23699 | Pdf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23700 | Hrob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23701 | Poli Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23702 | Pomc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23703 | Ccl28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23704 | Clock Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23705 | Epha7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23706 | Fabp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23707 | Fndc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23708 | Lair1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23709 | Pvrig Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23710 | Alkbh3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23711 | Fancd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23712 | Sema3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23713 | Angptl8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23714 | Tnfsf18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23715 | Cth Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23716 | Fyn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23717 | Tnc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23718 | Ubd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23719 | Cd69 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23720 | Gzmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23721 | Il19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23722 | Lgmn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23723 | Psap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23724 | Rac2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23725 | Rbpj Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23726 | Selp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23727 | Ccne1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23728 | Cdh13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23729 | Efnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23730 | Sumo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23731 | Usp21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23732 | Cdc25a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23733 | Fcgr2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23734 | Slc7a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23735 | Angptl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23736 | Slc31a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23737 | St6gal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23738 | Hsd17b13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23739 | Acd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23740 | Dbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23741 | Gal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23742 | Cd93 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23743 | Grk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23744 | Hdgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23745 | Klk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23746 | Lipa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23747 | Map2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23748 | Mycn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23749 | Pan2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23750 | Phb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23751 | Ppt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23752 | Rpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23753 | Tfpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23754 | Bcat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23755 | Dhcr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23756 | Ifnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23757 | Irak3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23758 | Mef2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23759 | Pdgfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23760 | Pola1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23761 | Ptpn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23762 | Stat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23763 | Stk11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23764 | Uchl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23765 | Zap70 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23766 | Dyrk1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23767 | Il1rl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23768 | Metap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23769 | Clec12a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23770 | Cyp11b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23771 | Tnfrsf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23772 | C9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23773 | Bad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23774 | Clu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23775 | Dbt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23776 | Mme Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23777 | Pxn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23778 | Tkt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23779 | Vim Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23780 | Acp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23781 | Ano1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23782 | Bag3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23783 | Cdo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23784 | Elk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23785 | Fzd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23786 | Gnal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23787 | Nbr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23788 | Nrf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23789 | Pck2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23790 | Qpct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23791 | Tbca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23792 | Brsk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23793 | Dclk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23794 | Foxa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23795 | Gfral Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23796 | Grem1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23797 | Lats1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23798 | Nr4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23799 | Pdcd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23800 | Smad4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23801 | Cthrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23802 | Cxcl14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23803 | Map3k1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23804 | Rictor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23805 | Sqstm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23806 | Tardbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23807 | Txndc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23808 | Tnfrsf13c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23809 | F8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23810 | Agl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23811 | Dhh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23812 | Emd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23813 | Fus Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23814 | Mpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23815 | Pln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23816 | Rp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23817 | Tst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23818 | Aoc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23819 | Cd37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23820 | Cd3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23821 | Crot Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23822 | Gad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23823 | Grk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23824 | Ist1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23825 | Lepr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23826 | Lrr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23827 | Nrg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23828 | Sat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23829 | Sox4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23830 | Sox9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23831 | Tpi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23832 | Baz2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23833 | Cisd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23834 | Csf3r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23835 | Ddit4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23836 | Enpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23837 | Ndrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23838 | Timp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23839 | Camk1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23840 | Dhcr24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23841 | S100a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23842 | Ceacam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23843 | Mettl16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23844 | Slc34a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23845 | Tacstd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23846 | Tnfsf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23847 | Aip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23848 | Bsg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23849 | Cpm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23850 | Ipp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23851 | Lss Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23852 | Max Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23853 | Nf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23854 | Pdc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23855 | Pf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23856 | Pir Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23857 | Sms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23858 | Vwf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23859 | Arg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23860 | Chd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23861 | Grb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23862 | Kat5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23863 | Mcm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23864 | Nat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23865 | Nrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23866 | Ntn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23867 | Prlr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23868 | Rnf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23869 | Sele Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23870 | Tcf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23871 | Terc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23872 | Wtap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23873 | Cebpb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23874 | Crtam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23875 | Kitlg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23876 | Masp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23877 | Plaur Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23878 | Prdx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23879 | Rspo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23880 | Trpm7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23881 | Tssk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23882 | Tyro3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23883 | Usp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23884 | Usp13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23885 | Igfbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23886 | Il10ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23887 | Mettl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23888 | Piezo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23889 | Pla2g4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23890 | Scgb2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23891 | Tnfrsf1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23892 | Ak7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23893 | Btc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23894 | Cfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23895 | Ckb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23896 | Dym Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23897 | Eng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23898 | Hbb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23899 | Nin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23900 | Sp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23901 | Aire Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23902 | Aqp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23903 | Aspn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23904 | Bst2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23905 | Cbx7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23906 | Cpb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23907 | Cpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23908 | Ecm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23909 | Ing1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23910 | Lcat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23911 | Mafg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23912 | Musk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23913 | Npc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23914 | Thy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23915 | Aars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23916 | Cd101 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23917 | Cntn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23918 | Ffar2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23919 | Ffar3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23920 | Gpr17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23921 | Gpr75 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23922 | Gsto1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23923 | Il4i1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23924 | Inhba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23925 | Kdm4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23926 | Klrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23927 | Nupr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23928 | Prdx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23929 | Vtcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23930 | Arid1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23931 | Dnaja1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23932 | Ifngr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23933 | Metrnl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23934 | Pfkfb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23935 | Prima1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23936 | Ptprz1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23937 | Cyp11a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23938 | Tnfrsf12a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23939 | Kl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23940 | Mgp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23941 | Nlk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23942 | Alpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23943 | Ambn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23944 | Cd8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23945 | Clk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23946 | Cps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23947 | Emp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23948 | Glul Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23949 | Has2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23950 | Hexa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23951 | Ogdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23952 | Ror2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23953 | Snd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23954 | Tgfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23955 | Usp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23956 | Abcg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23957 | Alpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23958 | Cd177 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23959 | Cdc37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23960 | Ddx3x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23961 | Fstl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23962 | Fzd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23963 | Hadha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23964 | Itgb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23965 | Nr2f6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23966 | Nr5a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23967 | Sfrp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23968 | Thbs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23969 | Trap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23970 | Chrna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23971 | Gpr132 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23972 | Npc1l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23973 | Ptpn22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23974 | S100a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23975 | Igf2bp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23976 | Smarcb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23977 | Aga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23978 | Cfh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23979 | Crk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23980 | Id3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23981 | Il9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23982 | Lum Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23983 | Nmu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23984 | Rgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23985 | Srf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23986 | Tec Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23987 | Adh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23988 | Ambp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23989 | Atg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23990 | Cav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23991 | Chd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23992 | Dlk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23993 | F13b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23994 | Fbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23995 | Il34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23996 | Klf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23997 | Micb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23998 | Nefl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS23999 | Osmr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24000 | Ptk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24001 | Ptk7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24002 | Acadm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24003 | Acsl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24004 | Ccnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24005 | Efna3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24006 | Efnb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24007 | Fbxw7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24008 | Gpr39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24009 | Hmox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24010 | Htra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24011 | Marco Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24012 | Pdia4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24013 | Pgam5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24014 | Ppm1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24015 | Ptprd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24016 | Rad52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24017 | Stk10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24018 | Vdac2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24019 | Vsig4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24020 | Adipoq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24021 | Akr1c2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24022 | Anxa10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24023 | Lilrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24024 | Ruvbl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24025 | Trim24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24026 | Aldh1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24027 | Pla2g2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24028 | Tnfsf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24029 | Ppp1r15a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24030 | Tnfrsf10b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24031 | Tnfrsf11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24032 | Abr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24033 | Acr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24034 | Nps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24035 | Pgd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24036 | She Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24037 | Tub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24038 | Aif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24039 | Atg7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24040 | Cap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24041 | Ccn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24042 | Cd83 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24043 | Cd99 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24044 | Cdh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24045 | Dsg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24046 | Hunk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24047 | Kat8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24048 | Ncr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24049 | Nek6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24050 | Pck1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24051 | Rpa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24052 | Srgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24053 | Tap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24054 | Tff3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24055 | Thra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24056 | Tpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24057 | Vrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24058 | Adam9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24059 | Alas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24060 | Asic1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24061 | Atp7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24062 | Brcc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24063 | Cd164 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24064 | Cend1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24065 | Cox5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24066 | Enpep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24067 | Enpp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24068 | Hnf4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24069 | Mark2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24070 | Nfat5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24071 | Park7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24072 | Pde4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24073 | Prom1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24074 | Ptprf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24075 | Stx17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24076 | Wnt5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24077 | Clec2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24078 | Il1rap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24079 | Slamf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24080 | Tspan2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24081 | Gp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24082 | Lpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24083 | Lpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24084 | Nts Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24085 | Omg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24086 | Sla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24087 | Sln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24088 | Tk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24089 | Uty Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24090 | Actb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24091 | Aox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24092 | Bcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24093 | Bdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24094 | Cdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24095 | Ctcf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24096 | Cyc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24097 | Fbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24098 | Fhl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24099 | Gnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24100 | Kng1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24101 | Ntn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24102 | Peg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24103 | Prep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24104 | Rcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24105 | Rem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24106 | Rheb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24107 | Rnf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24108 | St13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24109 | Stc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24110 | Tdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24111 | Tph2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24112 | C1qbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24113 | Cd320 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24114 | Chd1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24115 | Cxcl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24116 | Edil3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24117 | Efna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24118 | Ephb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24119 | Erap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24120 | Glud1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24121 | Gpr37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24122 | Gpr83 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24123 | Hmga2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24124 | Hoxa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24125 | Il1rn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24126 | Klkb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24127 | Ptgr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24128 | Pth1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24129 | Angpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24130 | Cd40lg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24131 | Ruvbl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24132 | Slc6a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24133 | Csnk2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24134 | Slc16a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24135 | Boc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24136 | Ccs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24137 | Cic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24138 | Fga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24139 | Grn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24140 | Hgd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24141 | Me2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24142 | Vtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24143 | Adar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24144 | Ago2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24145 | Ddx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24146 | Dpp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24147 | Dsg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24148 | Eml2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24149 | Gbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24150 | Gclc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24151 | Iapp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24152 | Irf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24153 | Nrg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24154 | Pole Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24155 | Rbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24156 | Rps6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24157 | Scin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24158 | Six1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24159 | Ccnd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24160 | Dnm1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24161 | Dusp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24162 | Epha4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24163 | Faslg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24164 | Fcer2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24165 | Fgf17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24166 | Hcls1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24167 | Il17f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24168 | Lypd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24169 | Mfap4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24170 | Mre11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24171 | Mydgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24172 | Ncam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24173 | Nlrp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24174 | Pappa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24175 | Pdha1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24176 | Pgam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24177 | Socs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24178 | Ttbk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24179 | Usp46 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24180 | Usp47 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24181 | Znrf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24182 | Abhd11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24183 | Adra2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24184 | Col3a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24185 | Fundc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24186 | Srebf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24187 | Prkar1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24188 | Tnfrsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24189 | F9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24190 | Agk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24191 | Agt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24192 | Hdc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24193 | Khk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24194 | Nes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24195 | Pyy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24196 | Rax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24197 | Ucn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24198 | Agrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24199 | Apob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24200 | Aqp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24201 | Arf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24202 | Aspa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24203 | Bbs4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24204 | Bst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24205 | Cd3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24206 | Csta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24207 | Ctf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24208 | Dlx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24209 | Fgf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24210 | Gnas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24211 | Hadh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24212 | Il24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24213 | Il31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24214 | Lrp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24215 | Mfn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24216 | Prr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24217 | Ptx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24218 | Sell Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24219 | Tff1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24220 | Tpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24221 | Uba1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24222 | Abcg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24223 | Aifm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24224 | Apaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24225 | Ash1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24226 | Bcas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24227 | Cirbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24228 | Dapk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24229 | Ephb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24230 | Fuca1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24231 | Gstm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24232 | Hipk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24233 | Itgax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24234 | Kmt2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24235 | Lamp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24236 | Nmur2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24237 | Olig2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24238 | Pnlip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24239 | Psmb9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24240 | Ptbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24241 | Sftpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24242 | Spdef Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24243 | Trex1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24244 | Usp18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24245 | Clec7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24246 | Cyp8b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24247 | Dusp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24248 | Impdh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24249 | Map2k6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24250 | Samhd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24251 | Creb3l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24252 | Cyp17a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24253 | Gabarap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24254 | Serpini1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24255 | Bik Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24256 | C1s Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24257 | Cga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24258 | Dct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24259 | Dcx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24260 | Ddt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24261 | F10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24262 | Fgg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24263 | Gp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24264 | Gss Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24265 | Ihh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24266 | Lep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24267 | Maf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24268 | Rp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24269 | Cd84 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24270 | Chl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24271 | Edar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24272 | Fbn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24273 | Fpr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24274 | Gale Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24275 | Gdf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24276 | Gls2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24277 | Got2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24278 | Hpca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24279 | Ibsp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24280 | Lap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24281 | Layn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24282 | Lrp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24283 | Mbd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24284 | Nmbr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24285 | Paep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24286 | Pltp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24287 | Sod3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24288 | Trio Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24289 | Zeb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24290 | Aebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24291 | Bcl10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24292 | Cd79a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24293 | Cd79b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24294 | Cytl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24295 | Dock5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24296 | Efna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24297 | Eif4e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24298 | Fgf12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24299 | Il36g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24300 | Itga4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24301 | Kdm4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24302 | Klrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24303 | Klrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24304 | Mbnl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24305 | Pde1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24306 | Phpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24307 | Plbd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24308 | Procr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24309 | Prss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24310 | Psat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24311 | Qsox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24312 | Rnf43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24313 | Ywhae Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24314 | Atp2a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24315 | Card11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24316 | Clec4e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24317 | Cyb5r3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24318 | Eif4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24319 | Insig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24320 | Lilrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24321 | Lypla1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24322 | Metap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24323 | Recql5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24324 | Sema7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24325 | Snap25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24326 | Steap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24327 | Tcf7l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24328 | Tfap2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24329 | Tspan7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24330 | Gadd45a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24331 | Pla2g15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24332 | Adamdec1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24333 | Adamts13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24334 | Xk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24335 | En1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24336 | Fah Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24337 | Gk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24338 | Gp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24339 | Hal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24340 | Id4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24341 | Ltf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24342 | Mak Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24343 | Tfg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24344 | Ubc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24345 | Acan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24346 | Cap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24347 | Cast Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24348 | Ccn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24349 | Cd46 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24350 | Ctsz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24351 | Cyld Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24352 | Fgf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24353 | Gipr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24354 | Gmfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24355 | Hap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24356 | Inf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24357 | Itch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24358 | Jaml Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24359 | Pdk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24360 | Polq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24361 | Pomk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24362 | Psca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24363 | Rbm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24364 | Rpl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24365 | Skp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24366 | Stac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24367 | Tal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24368 | Tff2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24369 | Ucp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24370 | Abcd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24371 | Birc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24372 | Capn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24373 | Cd151 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24374 | Cdh16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24375 | Ch25h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24376 | Cryab Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24377 | Fabp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24378 | G3bp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24379 | Gata3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24380 | Gata6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24381 | Hmga1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24382 | Hspb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24383 | Kpna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24384 | Lhcgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24385 | Mark3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24386 | Nudt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24387 | Pbrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24388 | Prdx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24389 | Reg1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24390 | Akr1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24391 | Clec4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24392 | Fcgr2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24393 | Hectd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24394 | Ifitm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24395 | Jchain Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24396 | Lancl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24397 | Lrrc15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24398 | Lrrc32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24399 | Pecam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24400 | Tmsb4x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24401 | Tnfsf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24402 | Il1rapl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24403 | Serpine2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24404 | Tnfrsf18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24405 | Ecd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24406 | Gh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24407 | Ncl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24408 | Otc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24409 | Prx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24410 | Sp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24411 | Vgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24412 | Zp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24413 | Als2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24414 | Aoc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24415 | Aqp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24416 | Aven Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24417 | Bmp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24418 | Calr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24419 | Cblb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24420 | Ccn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24421 | Cdnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24422 | Ddb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24423 | Fosb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24424 | Gbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24425 | Gpd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24426 | Gpr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24427 | Gys1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24428 | Hpse Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24429 | Ica1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24430 | Idua Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24431 | Imp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24432 | Klk5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24433 | Lrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24434 | Map4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24435 | Mcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24436 | Pon1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24437 | Rxra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24438 | Sqle Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24439 | St14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24440 | Aldob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24441 | Asxl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24442 | Atg10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24443 | Atp7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24444 | Cadm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24445 | Clic3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24446 | Corin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24447 | Cript Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24448 | Efnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24449 | Fubp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24450 | Gpr18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24451 | Hmgb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24452 | Igf2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24453 | Inhbe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24454 | Itgb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24455 | Mapk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24456 | Mastl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24457 | Mrpl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24458 | Naa10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24459 | Nlrc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24460 | Orai1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24461 | Pdia6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24462 | Prdx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24463 | Sfrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24464 | Smoc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24465 | Smpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24466 | Srpx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24467 | Stath Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24468 | Traf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24469 | Trpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24470 | Trpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24471 | Twsg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24472 | Ube2s Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24473 | Usp28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24474 | Vldlr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24475 | A4galt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24476 | Adcy10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24477 | Efemp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24478 | Fcgr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24479 | Ifngr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24480 | Megf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24481 | Nmnat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24482 | Parp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24483 | Plxdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24485 | Trim28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24486 | B4galt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24487 | Gadd45b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24488 | Pla2g1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24489 | Siglec1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24490 | Hsp90ab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24491 | Bmf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24492 | Dmd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24493 | En2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24494 | Htt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24495 | Rrh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24496 | Sp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24497 | Sst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24498 | Tsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24499 | Ung Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24500 | Abat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24501 | Cct2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24502 | Ces2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24503 | Chad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24504 | Cst3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24505 | Cygb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24506 | Dffa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24507 | E2f4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24508 | Hao1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24509 | Heph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24510 | Il16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24511 | Klk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24512 | Lad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24513 | M1ap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24514 | Manf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24515 | Mdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24516 | Phf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24517 | Pkn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24518 | Ppat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24519 | Ppia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24520 | Psph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24521 | Sae1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24522 | Sdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24523 | Tpbg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24524 | Tsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24525 | Uba5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24526 | Abcg8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24527 | Acod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24528 | Acss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24529 | Adrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24530 | Card9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24531 | Cd160 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24532 | Chit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24533 | Clcf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24534 | Ddit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24535 | Defb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24536 | Egfl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24537 | Ephb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24538 | Fam3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24539 | Fosl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24540 | Fosl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24541 | Gpa33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24542 | Grhpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24543 | Itgb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24544 | Kcnk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24545 | L1cam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24546 | Muc16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24547 | Nfil3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24548 | Nr1d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24549 | Nsun2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24550 | Pebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24551 | Psen1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24552 | Ptprc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24553 | Sdcbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24554 | Senp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24555 | Sirt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24556 | Spart Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24557 | Vegfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24558 | Adam12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24559 | Antxr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24560 | Anxa13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24561 | Clec1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24562 | Clec4f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24563 | Csf2ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24564 | Csnk1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24565 | Cxcl17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24566 | Elovl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24567 | Fcgr3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24568 | Hmgcs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24569 | Hspa1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24570 | Lrpap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24571 | Notch4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24572 | Scarb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24573 | Sigirr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24574 | Tnfsf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24575 | Tnni3k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24576 | Tspan3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24577 | Adamts4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24578 | Igfbpl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24579 | Nectin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24580 | S100a16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24581 | Sult1e1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24582 | Map1lc3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24583 | Tnfrsf21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24584 | Hnrnpa2b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24585 | Amt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24586 | Auh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24587 | Bgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24588 | Dpt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24589 | Erh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24590 | Hlf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24591 | Hpx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24592 | Jup Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24593 | Mx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24594 | Myb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24595 | Rdx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24596 | Adnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24597 | Adsl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24598 | Amd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24599 | Apoh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24600 | Aprt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24601 | Cdh5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24602 | Cer1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24603 | Cptp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24604 | Esam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24605 | Fat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24606 | Fcar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24607 | Galm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24608 | Gch1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24609 | Gm2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24610 | Hexb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24611 | Il20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24612 | Krt8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24613 | Lhpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24614 | Lig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24615 | Men1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24616 | Mepe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24617 | Mstn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24618 | Napa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24619 | Nfe2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24620 | Nmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24621 | Optn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24622 | Osr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24623 | Pan3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24624 | Pld4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24625 | Rbx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24626 | Reln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24627 | Star Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24628 | Stk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24629 | Sufu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24630 | Vapb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24631 | Wif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24632 | Actr8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24633 | Aimp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24634 | Aldoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24635 | Anxa6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24636 | Arrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24637 | Asah1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24638 | Atg14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24639 | Baz2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24640 | Bglap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24641 | Camk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24642 | Ccna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24643 | Chrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24644 | Cntn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24645 | Cxxc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24646 | Dock2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24647 | Dtymk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24648 | Efna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24649 | Folh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24650 | Gata4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24651 | Ildr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24652 | Itgb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24653 | Kdm3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24654 | Khsrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24655 | Lats2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24656 | Mark4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24657 | Ms4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24658 | Pcbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24659 | Prss8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24660 | Prtn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24661 | Rbbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24662 | Rspo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24663 | Shmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24664 | Smad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24665 | Trim2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24666 | Uchl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24667 | Unc5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24668 | Adam19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24669 | Amigo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24670 | Creld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24671 | Il17ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24672 | Impdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24673 | Itgbl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24674 | Jmjd1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24675 | Lpcat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24676 | Ndufb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24677 | Plscr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24678 | Polrmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24679 | Selplg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24680 | Ube2d2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24681 | Zbtb16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24682 | Atp5f1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24683 | C1qtnf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24684 | Eif2ak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24685 | Hnrnph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24686 | St3gal4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24687 | Pdcd1lg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24688 | Serpina5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24689 | Serpinc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24690 | Serpinf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24691 | Adcyap1r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24692 | C4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24693 | Gda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24694 | Gsc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24695 | Mga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24696 | Ogn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24697 | Omd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24698 | Psd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24699 | Son Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24700 | Sp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24701 | St7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24702 | Tbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24703 | Ahsg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24704 | Alpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24705 | Amph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24706 | Ankh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24707 | Apom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24708 | Arf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24709 | Blmh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24710 | Bphl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24711 | Cd96 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24712 | Cdh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24713 | Cpa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24714 | Ctsh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24715 | Dgka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24716 | Dhx9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24717 | Eml1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24718 | Far1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24719 | Fhl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24720 | G0s2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24721 | Gdf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24722 | Gdf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24723 | Ggt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24724 | Hamp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24725 | M6pr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24726 | Maff Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24727 | Med1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24728 | Msr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24729 | Myh9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24730 | Nab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24731 | Nadk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24732 | Nbl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24733 | Nrn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24734 | Pigr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24735 | Pklr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24736 | Rbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24737 | Rgmb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24738 | Sdhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24739 | Sez6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24740 | Thbd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24741 | Tifa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24742 | Tlk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24743 | Tmx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24744 | Wwp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24745 | Azgp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24746 | Calca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24747 | Cldn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24748 | Creb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24749 | Ctps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24750 | Eda2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24751 | Ephx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24752 | Ercc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24753 | F13a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24754 | Fabp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24755 | Fam3c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24756 | Fancm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24757 | Gdf11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24758 | Gp1bb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24759 | Gpr34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24760 | Habp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24761 | Hspb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24762 | Hspe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24763 | Ifna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24764 | Kcnq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24765 | Kif5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24766 | Kmt5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24767 | Lonp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24768 | Med12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24769 | Mst1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24770 | Nr4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24771 | Padi4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24772 | Pdgfd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24773 | Prss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24774 | Riok2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24775 | Sp100 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24776 | Stmn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24777 | Tead3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24778 | Tiam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24779 | Timd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24780 | Timp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24781 | Ube2n Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24782 | Wfdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24783 | Celsr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24784 | Dcaf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24785 | Eef1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24786 | Elavl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24787 | Fkbp1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24788 | Il18bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24789 | Ptpmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24790 | Sema4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24791 | Slamf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24792 | Trim25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24793 | Yeats4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24794 | Ankrd22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24795 | Kirrel1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24796 | Pla2g2e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24797 | Suv39h2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24798 | Mapkapk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24799 | Tnfrsf13b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24800 | A2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24801 | Bok Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24802 | Bpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24803 | C1r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24804 | Dck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24805 | Gp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24806 | Gsr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24807 | Npl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24808 | Pgf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24809 | Rlf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24810 | Sp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24811 | Srm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24812 | Ttn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24813 | Ust Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24814 | Aida Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24815 | Aqp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24816 | Atf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24817 | Bmp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24818 | Brd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24819 | Canx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24820 | Cbr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24821 | Cd48 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24822 | Cdh3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24823 | Chd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24824 | Chrd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24825 | Ctsg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24826 | Cuta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24827 | Dcxr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24828 | Dpp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24829 | Dpp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24830 | Dsc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24831 | Dsc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24832 | Dtx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24833 | Elf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24834 | Emp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24835 | Epor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24836 | Fli1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24837 | Fzd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24838 | Fzd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24839 | Fzd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24840 | Gba2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24841 | Gfer Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24842 | Paf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24843 | Pag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24844 | Parl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24845 | Pgm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24846 | Prnp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24847 | Reg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24848 | Rnf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24849 | Smc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24850 | Smox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24851 | Tank Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24852 | Tet3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24853 | Tp63 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24854 | Uck2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24855 | Ufm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24856 | Anxa7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24857 | C5ar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24858 | Cadm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24859 | Capn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24860 | Ccl26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24861 | Ccr10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24862 | Cd244 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24863 | Cdk10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24864 | Chst3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24865 | Cip2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24866 | Cndp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24867 | Ephb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24868 | Foxf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24869 | Galk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24870 | Gdf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24871 | Gfra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24872 | Huwe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24873 | Kcnq4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24874 | Klf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24875 | Map1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24876 | Map1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24877 | Mfap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24878 | Mkrn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24879 | Nlgn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24880 | Pde3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24881 | Plod2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24882 | Ptgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24883 | Ptpn7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24884 | Ptprk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24885 | Rad50 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24886 | Ring1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24887 | Robo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24888 | Smad6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24889 | Smad7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24890 | Stk38 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24891 | Sumo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24892 | Tfpi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24893 | Trim5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24894 | Usp19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24895 | Vegfd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24896 | Akr1d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24897 | Apcdd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24898 | Btn2a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24899 | Chrdl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24900 | Clec5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24901 | Col4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24902 | Elovl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24903 | Fcer1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24904 | Fkbp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24905 | Hmgcs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24906 | Mblac2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24907 | Mcemp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24908 | Nfatc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24909 | Phlpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24910 | Psmd14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24911 | Scpep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24912 | Ythdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24913 | Adamts5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24914 | Bhlhe40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24915 | Cd200r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24916 | Ceacam6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24917 | Clec10a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24918 | Col18a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24919 | Cyp46a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24920 | Il13ra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24921 | Kremen2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24922 | Pip4k2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24923 | St3gal3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24924 | Tmprss4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24925 | Serpina7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24926 | Serping1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24927 | Ak4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24928 | Dst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24929 | Fes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24930 | Fxn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24931 | Gsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24932 | Klb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24933 | Msn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24934 | Mvd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24935 | Mx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24936 | Nrm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24937 | Shb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24938 | Tpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24939 | Zp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24940 | Aco1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24941 | Aco2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24942 | Apln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24943 | Araf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24944 | Art1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24945 | Asph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24946 | Bnc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24947 | Cask Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24948 | Ccnk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24949 | Coq7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24950 | Cst7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24951 | Cstb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24952 | Ctrc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24953 | Cul3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24954 | Ddb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24955 | Eno3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24956 | Esm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24957 | Flna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24958 | Fzd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24959 | Gamt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24960 | Gpx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24961 | Ing5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24962 | Isl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24963 | Kera Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24964 | Lias Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24965 | Lipi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24966 | Mbl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24967 | Mpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24968 | Nat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24969 | Nol3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24970 | Nrtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24971 | Palm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24972 | Pemt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24973 | Pex1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24974 | Plp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24975 | Pls3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24976 | Ppib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24977 | Pter Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24978 | Rmi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24979 | Rpl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24980 | Rttn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24981 | Sbds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24982 | Tap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24983 | Tcf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24984 | Tnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24985 | Tpm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24986 | Ubr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24987 | Upf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24988 | Wnk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24989 | Wwp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24990 | Asf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24991 | Atox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24992 | Cadm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24993 | Chodl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24994 | Cltrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24995 | Cntfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24996 | Creb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24997 | Csrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24998 | Fabp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS24999 | Fbxo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25000 | Gper1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25001 | Hspa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25002 | Hspd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25003 | Ifih1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25004 | Igsf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25005 | Itga6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25006 | Itgb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25007 | Itgb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25008 | Kif11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25009 | Kiss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25010 | Kmt2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25011 | Kpnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25012 | Krt17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25013 | Lamp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25014 | Naa50 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25015 | Ninj1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25016 | Nr2f1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25017 | Nudt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25018 | Nxph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25019 | Parva Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25020 | Pcsk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25021 | Pdap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25022 | Pdcd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25023 | Pear1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25024 | Plin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25025 | Pold2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25026 | Pycr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25027 | Sez6l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25028 | Socs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25029 | Srpk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25030 | Stip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25031 | Stk16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25032 | Tafa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25033 | Taok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25034 | Tigar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25035 | Ube2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25036 | Usp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25037 | Usp24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25038 | Wfdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25039 | Zfp36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25040 | Celsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25041 | Col2a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25042 | Col6a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25043 | Creld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25044 | Ehhadh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25045 | Entpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25046 | Glipr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25047 | Icoslg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25048 | Nfkbia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25049 | Ralgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25050 | Rnase3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25051 | S100a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25052 | Scarb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25053 | Sema4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25054 | Spint1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25055 | Tapbpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25056 | Tmigd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25057 | Tspan8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25058 | Atp6v1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25059 | L3mbtl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25060 | Pla2g2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25061 | Scgb1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25062 | Scgb3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25063 | Selenop Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25064 | Siglec8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25065 | Slc12a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25066 | Slc13a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25067 | Slc25a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25068 | Sult1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25069 | Tnfrsf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25070 | Xpnpep2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25071 | C4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25072 | Cpq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25073 | Cr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25074 | Flg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25075 | Hjv Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25076 | Npb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25077 | Pml Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25078 | Ski Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25079 | Sp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25080 | Spn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25081 | Tek Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25082 | Vit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25083 | A1bg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25084 | Adh4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25085 | Apod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25086 | Astl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25087 | Bcl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25088 | Bmi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25089 | C1qb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25090 | Cbx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25091 | Cd8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25092 | Cdx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25093 | Cfl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25094 | Clps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25095 | Cpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25096 | Cpb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25097 | Ece1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25098 | Elf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25099 | Fhl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25100 | Gpc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25101 | Gpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25102 | Hbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25103 | Hcn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25104 | Iscu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25105 | Klc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25106 | Lef1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25107 | Lipe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25108 | Msh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25109 | Muc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25110 | Mylk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25111 | Nek1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25112 | Nono Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25113 | Npr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25114 | Nsd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25115 | Ntn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25116 | Parn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25117 | Pdxp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25118 | Perp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25119 | Pkn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25120 | Rnls Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25121 | Rps3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25122 | Rrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25123 | Rtn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25124 | Tac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25125 | Tpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25126 | Tpm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25127 | Tpm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25128 | Tufm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25129 | Wfs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25130 | Wnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25131 | Abcb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25132 | Acaa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25133 | Anpep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25134 | Blvrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25135 | Camkv Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25136 | Ccl27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25137 | Cd207 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25138 | Cd302 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25139 | Cebpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25140 | Cep57 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25141 | Cnpy3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25142 | Cspg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25143 | Dapk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25144 | Dpep2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25145 | Egfl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25146 | Eif1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25147 | Epha5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25148 | Ephx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25149 | Ermap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25150 | Hadhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25151 | Hcar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25152 | Hoxa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25153 | Ighg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25154 | Lrrc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25155 | Muc17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25156 | Ncstn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25157 | Negr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25158 | Nucb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25159 | Ostm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25160 | P4ha2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25161 | P4ha3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25162 | Pcbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25163 | Prps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25164 | Ptch1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25165 | Ptprj Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25166 | Rasa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25167 | Rbm14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25168 | Rtn4r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25169 | Soat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25170 | Sox10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25171 | Spag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25172 | Tapbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25173 | U2af1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25174 | Usp16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25175 | Usp43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25176 | Ywhaz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25177 | Zg16b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25178 | Zwint Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25179 | Adam15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25180 | Adgre5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25181 | Alkbh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25182 | Antxr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25183 | B3gat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25184 | Bnip3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25185 | Cd300c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25186 | Cela2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25187 | Celsr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25188 | Cldn18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25189 | Clec3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25190 | Col4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25191 | Col7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25192 | Csf2rb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25193 | Cyp7b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25194 | Dcbld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25195 | Dlgap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25196 | Fkbp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25197 | Igfbp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25198 | Lrrtm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25199 | Lypla2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25200 | Phlda2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25201 | Ralbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25202 | Sap130 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25203 | Slamf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25204 | Smurf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25205 | Stambp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25206 | Ube2d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25207 | Arl6ip6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25208 | Colec11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25209 | Csnk2a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25210 | Kirrel3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25211 | Ppp2r1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25212 | S100a13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25213 | Slc27a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25214 | Tinagl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25215 | Adamts18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25216 | Dnase1l3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25217 | Ak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25218 | Amn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25219 | Cgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25220 | Dao Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25221 | Fbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25222 | Ggh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25223 | Hpn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25224 | Kmo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25225 | Mpg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25226 | Mvk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25227 | Nbn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25228 | Ntm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25229 | Oxt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25230 | Ryk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25231 | Abl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25232 | Arsa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25233 | Brap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25234 | C1qa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25235 | Cbfb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25236 | Ccin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25237 | Cdh4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25238 | Cdh8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25239 | Ctsa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25240 | Ctsw Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25241 | Dhps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25242 | Eid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25243 | Fgl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25244 | Fmod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25245 | Gad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25246 | Galc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25247 | Galt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25248 | Gbp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25249 | Gja1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25250 | Gltp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25251 | Gmfg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25252 | Hnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25253 | Igkc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25254 | Il9r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25255 | Irf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25256 | Jam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25257 | Klf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25258 | Klk8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25259 | Ly6e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25260 | Mdm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25261 | Mecr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25262 | Med9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25263 | Mtdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25264 | Naaa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25265 | Nck1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25266 | Ncr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25267 | Nid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25268 | Orm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25269 | P4hb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25270 | Pfkl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25271 | Pif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25272 | Plp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25273 | Ppif Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25274 | Rgma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25275 | Rhoj Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25276 | Rrn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25277 | Rtn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25278 | Sav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25279 | Sdha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25280 | Smg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25281 | Speg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25282 | Sub1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25283 | Tpmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25284 | Tpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25285 | Vasp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25286 | Vnn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25287 | Aadac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25288 | Ackr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25289 | Acmsd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25290 | Adprh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25291 | Anxa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25292 | Asb13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25293 | Bbox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25294 | Cdh10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25295 | Cdk17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25296 | Cldn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25297 | Clic2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25298 | Cmpk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25299 | Crlf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25300 | Dpp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25301 | Ecscr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25302 | Egln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25303 | Epha3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25304 | Fads1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25305 | Fbxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25306 | Fcrl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25307 | Ffar4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25308 | Fgf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25309 | Fkbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25310 | Foxa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25311 | Gap43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25312 | Gnao1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25313 | Hebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25314 | Hprt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25315 | Il2ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25316 | Klrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25317 | Klrg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25318 | Lims1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25319 | Mgat5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25320 | Mnat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25321 | Otud1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25322 | Padi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25323 | Pea15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25324 | Peli1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25325 | Pold1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25326 | Prdx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25327 | Pros1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25328 | Prps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25329 | Psmb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25330 | Rab2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25331 | Reg3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25332 | Riok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25333 | Robo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25334 | Setd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25335 | Srrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25336 | Srsf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25337 | Syvn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25338 | Trpc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25339 | Tyrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25340 | Ube2i Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25341 | Vipr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25342 | Vsig8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25343 | Angpt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25344 | Bpifb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25345 | Cdc25c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25346 | Cdkn2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25347 | Cgref1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25348 | Cnksr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25349 | Col4a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25350 | Col8a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25351 | Crabp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25352 | Dpysl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25353 | Elavl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25354 | Elovl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25355 | Entpd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25356 | Gpr174 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25357 | Ifnlr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25358 | Il36rn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25359 | Lefty2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25360 | Lgals4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25361 | Map3k3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25362 | Nmnat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25363 | Pik3r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25364 | Psmd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25365 | Ptger4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25366 | Rprd1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25367 | Sephs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25368 | Slamf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25369 | Taldo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25370 | Trim33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25371 | Uqcrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25372 | Colec12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25373 | Slc37a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25374 | Slc39a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25375 | Slc6a14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25376 | Sparcl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25377 | Adamtsl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25378 | Gabarapl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25379 | Serpinb10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25380 | Ado Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25381 | Afm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25382 | Cpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25383 | Ebp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25384 | Fau Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25385 | Hfe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25386 | Ids Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25387 | Ivd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25388 | Lxn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25389 | Mtr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25390 | Nms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25391 | Ppl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25392 | Tnn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25393 | Tnr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25394 | Ubb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25395 | Acy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25396 | Add2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25397 | Ago1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25398 | Agr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25399 | Arnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25400 | Atg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25401 | Atl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25402 | Bag2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25403 | Bcan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25404 | Bin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25405 | Brf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25406 | Cdsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25407 | Chd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25408 | Chga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25409 | Clgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25410 | Coch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25411 | Cop1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25412 | Dag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25413 | Dbf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25414 | Dlst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25415 | Drg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25416 | E2f7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25417 | Ecm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25418 | Edf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25419 | Eif5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25420 | Ell2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25421 | Fcmr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25422 | Fuom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25423 | Fut7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25424 | Gart Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25425 | Gbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25426 | Gclm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25427 | Gid4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25428 | Glb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25429 | Glrx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25430 | Gpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25431 | Gpx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25432 | Gypa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25433 | Hcrt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25434 | Hes5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25435 | Hmbs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25436 | Hps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25437 | Irf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25438 | Jpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25439 | Mas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25440 | Mest Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25441 | Mid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25442 | Mrap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25443 | Mras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25444 | Msmp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25445 | Myrf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25446 | Naca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25447 | Ndc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25448 | Net1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25449 | Neu1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25450 | Nmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25451 | Ntf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25452 | Ola1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25453 | Pax8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25454 | Pfkm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25455 | Pkib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25456 | Prkn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25457 | Ptma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25458 | Ptpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25459 | Relt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25460 | Rgs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25461 | Rom1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25462 | Sord Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25463 | Stam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25464 | Stx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25465 | Tdo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25466 | Tpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25467 | Twf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25468 | Uap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25469 | Vasn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25470 | Vsir Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25471 | Abhd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25472 | Acsl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25473 | Ampd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25474 | Anxa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25475 | Apex2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25476 | Atad5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25477 | Cant1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25478 | Ccrl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25479 | Cd248 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25480 | Cebpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25481 | Cntn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25482 | Coasy Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25483 | Ctdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25484 | Ddx17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25485 | Decr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25486 | Eif2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25487 | Epas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25488 | Etfdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25489 | Extl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25490 | Fetub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25491 | Fgf13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25492 | Fgf20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25493 | Fscn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25494 | Gfpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25495 | Ghrhr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25496 | Grip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25497 | Gsdmc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25498 | Gstm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25499 | Hgfac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25500 | Htr2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25501 | Ifi27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25502 | Iglc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25503 | Il17c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25504 | Inhbb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25505 | Irak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25506 | Kifc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25507 | Klk14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25508 | Lacc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25509 | Lyve1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25510 | Mef2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25511 | Megf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25512 | Mfge8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25513 | Nlgn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25514 | Ntmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25515 | Otub2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25516 | Ppm1g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25517 | Prap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25518 | Pttg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25519 | Rab31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25520 | Ramp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25521 | Rbm15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25522 | Rpap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25523 | Rxfp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25524 | Slit2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25525 | Smad9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25526 | Soat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25527 | Spast Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25528 | Srpk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25529 | Sumf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25530 | Tlr10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25531 | Tnnc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25532 | Ube2k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25533 | Usp36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25534 | Usp39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25535 | Vamp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25536 | Ywhaq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25537 | Aarsd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25538 | Adam11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25539 | Adam32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25540 | Arid1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25541 | Atp5mg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25542 | Cd300a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25543 | Cdkn1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25544 | Chrna5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25545 | Clec1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25546 | Col4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25547 | Cox4i2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25548 | Ddx19a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25549 | Eef1b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25550 | Eif5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25551 | Glipr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25552 | Gprc6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25553 | Igsf11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25554 | Il17re Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25555 | Lpcat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25556 | Mansc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25557 | Nfatc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25558 | Nmral1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25559 | Nup210 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25560 | Otulin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25561 | Plxna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25562 | Ptger2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25563 | Sema4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25564 | Slc4a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25565 | Slc6a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25566 | Slc9a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25567 | Srd5a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25568 | Stat5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25569 | Tpsab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25570 | Treml2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25571 | Trim16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25572 | Trim62 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25573 | Tsg101 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25574 | Adamts1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25575 | Adcyap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25576 | B4galt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25577 | Cd300lf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25578 | Cntnap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25579 | Colec10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25580 | Lamtor3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25581 | Madcam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25582 | Morf4l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25583 | Pglyrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25584 | Ppp1r1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25585 | Slc30a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25586 | Tnfaip6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25587 | Adamts15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25588 | Adamts16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25589 | Adamts17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25590 | Aldh18a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25591 | Ppp1r15b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25592 | Serpinb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25593 | Siglec15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25594 | Ckm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25595 | CTD Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25596 | Ddo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25597 | Dld Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25598 | Dtl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25599 | Hrc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25600 | Kel Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25601 | Ltk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25602 | Pzp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25603 | Sct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25604 | Abra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25605 | Acy3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25606 | Artn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25607 | Asns Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25608 | Atf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25609 | Bmp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25610 | Btf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25611 | Capg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25612 | Cbx8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25613 | Coq2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25614 | Crat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25615 | Csad Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25616 | Dlc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25617 | Dsg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25618 | Dtd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25619 | Ech1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25620 | Ensa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25621 | Epyc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25622 | Fzd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25623 | Gas7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25624 | Gatm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25625 | Gcdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25626 | Gdf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25627 | Gmpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25628 | Gnaz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25629 | Gpc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25630 | Hbq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25631 | Hcn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25632 | Hsf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25633 | Ing4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25634 | Ly86 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25635 | Mafb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25636 | Mcf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25637 | Mlh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25638 | Mt1f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25639 | Mzb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25640 | Npr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25641 | Pld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25642 | Pmvk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25643 | Pop1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25644 | Qprt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25645 | Rcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25646 | Rida Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25647 | Ryr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25648 | Sbf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25649 | Scg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25650 | Sco1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25651 | Sgta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25652 | Shbg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25653 | Stx7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25654 | Tab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25655 | Tcn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25656 | Ubtf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25657 | Ykt6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25658 | Acta2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25659 | Anxa8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25660 | Apoa5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25661 | Asf1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25662 | Atg4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25663 | Atg4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25664 | Bmp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25665 | Bmp15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25666 | Bola1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25667 | Cdh15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25668 | Chrm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25669 | Ciita Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25670 | Cplx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25671 | Crip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25672 | Ctps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25673 | Cyb5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25674 | Ddah1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25675 | Dpep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25676 | Echs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25677 | Endog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25678 | Epha1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25679 | Erp29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25680 | Fanca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25681 | Fcrl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25682 | Flrt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25683 | Fnip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25684 | Foxc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25685 | Furin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25686 | Gars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25687 | Gfpt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25688 | Gfra3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25689 | Gng13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25690 | Gpr27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25691 | Hibch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25692 | Hjurp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25693 | Hmgn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25694 | Ifit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25695 | Ifnl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25696 | Il17d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25697 | Itih5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25698 | Itpka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25699 | Klf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25700 | Klk10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25701 | Klrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25702 | Kmt5c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25703 | Lman2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25704 | Lrig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25705 | Mapk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25706 | Meis1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25707 | Metrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25708 | Mgst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25709 | Mmp25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25710 | Ngly1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25711 | Nodal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25712 | Oard1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25713 | Olfm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25714 | Otud5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25715 | Palb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25716 | Pclaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25717 | Pde1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25718 | Podxl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25719 | Prdm9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25720 | Ptgs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25721 | Ptpn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25722 | Rab6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25723 | Rcan2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25724 | Senp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25725 | Setd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25726 | Sgms2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25727 | Smap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25728 | Spon2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25729 | Tead2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25730 | Thop1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25731 | Tmed1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25732 | Tnni3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25733 | Traf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25734 | Ulbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25735 | Wnt8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25736 | Alyref Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25737 | Btn1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25738 | Ccdc25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25739 | Col6a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25740 | Cox4i1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25741 | Crisp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25742 | Dynll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25743 | Eif4g1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25744 | Entpd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25745 | Epha10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25746 | Gpr101 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25747 | Gprc5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25748 | Hoxa10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25749 | Hpcal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25750 | Hspa1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25751 | Il18r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25752 | Izumo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25753 | Lgals7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25754 | Nos1ap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25755 | Nt5c1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25756 | Rnf114 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25757 | Sema5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25758 | Spink1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25759 | Stxbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25760 | Tfap2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25761 | Tmed10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25762 | Ythdc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25763 | Zbtb7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25764 | Atp6ap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25765 | Cd300lg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25766 | Cyp27b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25767 | Dcun1d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25768 | Hsd17b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25769 | Il13ra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25770 | L3mbtl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25771 | Mid1ip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25772 | Pip4k2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25773 | Pip5k1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25774 | Sharpin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25775 | Slc33a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25776 | Tmprss6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25777 | Tnfaip8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25778 | Trappc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25779 | Adamts20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25780 | Cacna2d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25781 | Ppp1r14a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25782 | Serpinf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25783 | Tnfrsf25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25784 | Serpina10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25785 | C8g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25786 | Cpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25787 | Gns Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25788 | Hk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25789 | Maz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25790 | Mff Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25791 | Mip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25792 | Mt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25793 | Ndp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25794 | Rfk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25795 | Uox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25796 | Acp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25797 | Acp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25798 | Atl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25799 | Batf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25800 | Bin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25801 | Cdc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25802 | Cks2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25803 | Clmp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25804 | Cma1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25805 | Cmbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25806 | Crkl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25807 | Ctrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25808 | Dab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25809 | Daxx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25810 | Dkc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25811 | Dna2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25812 | E2f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25813 | E2f3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25814 | Eaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25815 | Ebf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25816 | Ece2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25817 | Eea1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25818 | Egr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25819 | Fgf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25820 | Fhit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25821 | Fibp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25822 | Fis1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25823 | Fmr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25824 | Frzb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25825 | Gcsh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25826 | Gfi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25827 | Gnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25828 | Gpx7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25829 | Gypc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25830 | Hey1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25831 | Hid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25832 | Ier3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25833 | Irs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25834 | Jag2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25835 | Jam3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25836 | Jund Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25837 | Krt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25838 | Lcp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25839 | Ldb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25840 | Lgr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25841 | Mal2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25842 | Mbd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25843 | Mcee Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25844 | Mpc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25845 | Mpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25846 | Mrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25847 | Nags Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25848 | Napg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25849 | Ncf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25850 | Ncr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25851 | Nit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25852 | Nme2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25853 | Nop2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25854 | Otor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25855 | Penk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25856 | Phf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25857 | Phyh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25858 | Pi16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25859 | Plek Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25860 | Pmm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25861 | Polb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25862 | Polg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25863 | Ppa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25864 | Ppid Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25865 | Raly Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25866 | Rbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25867 | Rcn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25868 | Rgs5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25869 | Rhoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25870 | Rif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25871 | Rps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25872 | Scg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25873 | Shpk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25874 | Sncg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25875 | Sox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25876 | Spp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25877 | Ss18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25878 | Tab3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25879 | Tbcb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25880 | Tfe3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25881 | Tgs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25882 | Tie1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25883 | Tppp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25884 | Txn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25885 | Uba6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25886 | Ubr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25887 | Ufl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25888 | Usb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25889 | Use1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25890 | USP6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25891 | Vmac Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25892 | Wnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25893 | Acadl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25894 | Acox3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25895 | Actr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25896 | Adrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25897 | Aicda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25898 | Aifm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25899 | Alas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25900 | Apoa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25901 | Asah2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25902 | Asgr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25903 | Bambi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25904 | Btnl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25905 | Bub1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25906 | Cadm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25907 | Cd180 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25908 | Chrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25909 | Chst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25910 | Cidea Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25911 | Cisd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25912 | Ckap4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25913 | Cpne1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25914 | Cpsf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25915 | Creg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25916 | Crhbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25917 | Ctbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25918 | Dctn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25919 | Dmbt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25920 | Dtx3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25921 | Dusp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25922 | Dusp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25923 | Epdr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25924 | Espl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25925 | Fgf22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25926 | Ggta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25927 | Gngt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25928 | Golm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25929 | Gpr15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25930 | Gsta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25931 | Gstt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25932 | Hipk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25933 | Hkdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25934 | Hyal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25935 | Hyou1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25936 | Icam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25937 | Ifi30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25938 | Ifnl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25939 | Impa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25940 | Insrr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25941 | Itga1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25942 | Itga8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25943 | Itpkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25944 | Kcnk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25945 | Klrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25946 | Krt19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25947 | Loxl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25948 | Lpin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25949 | Lrrn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25950 | Mdga2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25951 | Micu1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25952 | Mob1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25953 | Mpzl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25954 | Mpzl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25955 | Mtch2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25956 | Nceh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25957 | Ncor2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25958 | Nell2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25959 | Oscar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25960 | Oxsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25961 | Pam16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25962 | Pdcd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25963 | Plcg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25964 | Plcg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25965 | Ppm1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25966 | Ppp6c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25967 | Prdm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25968 | Prkd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25969 | Psma3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25970 | Psme2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25971 | Ptpra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25972 | Rps13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25973 | Rps19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25974 | Senp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25975 | Snrpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25976 | Spns2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25977 | Srsf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25978 | Tcl1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25979 | Thbs4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25980 | Tirap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25981 | Tppp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25982 | Tra2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25983 | Trib2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25984 | Trmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25985 | Tubb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25986 | Ube2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25987 | Usp38 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25988 | Vsig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25989 | Ywhah Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25990 | Zbtb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25991 | Acot13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25992 | Adam28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25993 | Adam30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25994 | Arrdc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25995 | B3gnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25996 | Bcap31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25997 | Col4a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25998 | Cyb5r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS25999 | Diablo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26000 | Fam20c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26001 | Gpr158 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26002 | Gpr161 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26003 | Guca1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26004 | Havcr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26005 | Hilpda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26006 | Hnrnpc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26007 | Lgals8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26008 | Lilra5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26009 | Lilrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26010 | Lin28b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26011 | Map3k4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26012 | Necap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26013 | Pabpc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26014 | Parp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26015 | Phlda1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26016 | Ppp3ca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26017 | Prdm16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26018 | Ptgfrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26019 | Pycard Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26020 | S100a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26021 | Setd1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26022 | Sez6l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26023 | Slc1a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26024 | Spink7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26025 | Spint2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26026 | Sptssb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26027 | Tomm20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26028 | Tp53i3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26029 | Trdmt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26030 | Ube2g2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26031 | Ube2j2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26032 | Unc119 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26033 | Adamts2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26034 | Aldh3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26035 | Cd300lb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26036 | Col11a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26037 | Cyp24a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26038 | Gpihbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26039 | Hnrnpa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26040 | Lamtor2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26041 | Metap1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26042 | Onecut2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26043 | Pip5k1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26044 | Pomgnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26045 | Rarres2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26046 | S100a14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26047 | Slc11a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26048 | Slc22a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26049 | Slc7a10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26050 | Sult2b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26051 | Tmem175 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26052 | Tsc22d1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26053 | Xpnpep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26054 | Pla2g12b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26055 | Rad51ap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26056 | C1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26057 | Chm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26058 | Fgr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26059 | Ly9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26060 | Me3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26061 | Mt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26062 | Neb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26063 | Nln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26064 | Nrk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26065 | Rgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26066 | Ttl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26067 | Unk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26068 | Zyx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26069 | Adh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26070 | Ahrr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26071 | Ank3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26072 | Anln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26073 | Apoo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26074 | Atrx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26075 | Calu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26076 | Cblc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26077 | Cbx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26078 | Ccnh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26079 | Cd72 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26080 | Cerk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26081 | Cib1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26082 | Clp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26083 | Clpp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26084 | Coa6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26085 | Copa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26086 | Cpa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26087 | Cst5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26088 | Cux1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26089 | Dok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26090 | Eif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26091 | Emg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26092 | Emp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26093 | Enam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26094 | Etv6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26095 | Eya2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26096 | F11r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26097 | Ftcd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26098 | Fut1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26099 | Gckr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26100 | Ggct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26101 | Git1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26102 | Gkn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26103 | Hcst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26104 | Ilf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26105 | Iqcg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26106 | Ksr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26107 | Lmf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26108 | Lsp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26109 | Ly96 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26110 | Mafa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26111 | Mbd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26112 | Med4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26113 | Mrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26114 | Myof Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26115 | Myt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26116 | Naga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26117 | Ncan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26118 | Nhp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26119 | Nppa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26120 | Oasl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26121 | Ost4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26122 | Ostn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26123 | Pfn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26124 | Pld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26125 | Pmm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26126 | Pnkp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26127 | Podn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26128 | Pon2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26129 | Prg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26130 | Rbks Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26131 | Rem1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26132 | Rps7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26133 | Rtl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26134 | Scgn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26135 | Srpx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26136 | St18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26137 | Tgds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26138 | Tprn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26139 | Uba2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26140 | Ulk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26141 | Umps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26142 | Uprt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26143 | Urm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26144 | Usf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26145 | Vcan Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26146 | Wnk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26147 | Xcr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26148 | Apba3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26149 | Atat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26150 | Bccip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26151 | Blvra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26152 | Calm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26153 | Cd109 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26154 | Cdh18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26155 | Cenpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26156 | Cenpb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26157 | Cetn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26158 | Cfhr4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26159 | Ckmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26160 | Clic1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26161 | Cnpy4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26162 | Cops5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26163 | Cox5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26164 | Crip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26165 | Crmp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26166 | Cspg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26167 | Dhrs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26168 | Dhx36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26169 | Dnph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26170 | Dusp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26171 | Eif5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26172 | Eomes Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26173 | Ercc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26174 | Ewsr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26175 | Foxd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26176 | Foxp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26177 | Ggps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26178 | Gna14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26179 | Gpr32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26180 | Gstk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26181 | Gstz1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26182 | Hcfc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26183 | Herc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26184 | Hhla2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26185 | Hnf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26186 | Hspg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26187 | Ifit2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26188 | Igsf8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26189 | Il1r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26190 | Il36b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26191 | Il5ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26192 | Ino80 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26193 | Ip6k1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26194 | Itih3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26195 | Kcnq3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26196 | Kdm7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26197 | Kif15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26198 | Krt14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26199 | Krt18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26200 | Lipt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26201 | Lmcd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26202 | Lmnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26203 | Loxl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26204 | Lrp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26205 | Ltbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26206 | Matr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26207 | Mcm10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26208 | Med10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26209 | Mef2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26210 | Mfap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26211 | Mien1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26212 | Mmgt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26213 | Mmp11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26214 | Msrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26215 | Mtss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26216 | Nanog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26217 | Ncoa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26218 | Ndc80 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26219 | Neil1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26220 | Nlrc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26221 | Nptx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26222 | Nr1h2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26223 | Nrros Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26224 | Otud3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26225 | Pdia5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26226 | Phkg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26227 | Plac8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26228 | Prmt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26229 | Prox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26230 | Ptges Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26231 | Pvalb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26232 | Rab1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26233 | Reg3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26234 | Rxfp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26235 | Rxfp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26236 | Senp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26237 | Sfxn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26238 | Snai1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26239 | Ssbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26240 | Ssrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26241 | Stk40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26242 | Strap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26243 | Sulf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26244 | Tagln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26245 | Taok3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26246 | Trps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26247 | Txlna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26248 | Usp33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26249 | Usp51 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26250 | Vsnl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26251 | Wars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26252 | Wnt16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26253 | Xrcc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26254 | Ywhab Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26255 | Zbtb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26256 | Zfpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26257 | Acadvl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26258 | Adam23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26259 | Adgrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26260 | Adgrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26261 | Ankrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26262 | Calhm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26263 | Calml3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26264 | Cdc25b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26265 | Chrna7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26266 | Chst15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26267 | Ckap2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26268 | Clec4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26269 | Crisp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26270 | Dctpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26271 | Entpd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26272 | Errfi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26273 | Fgfbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26274 | Galnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26275 | Hapln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26276 | Igfbp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26277 | Il15ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26278 | Il1f10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26279 | Itga2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26280 | Izumo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26281 | Jarid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26282 | Laptm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26283 | Ly6g6d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26284 | Mad2l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26285 | Man1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26286 | Map2k7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26287 | Mrgprd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26288 | Mybpc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26289 | N6amt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26290 | Ndufa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26291 | Nfe2l3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26292 | Notch2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26293 | Npepl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26294 | Opalin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26295 | Pdcd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26296 | Phlpp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26297 | Pik3r3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26298 | Polr2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26299 | Ppp1cc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26300 | Ptges2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26301 | Ptges3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26302 | Ptp4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26303 | Ptp4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26304 | Ptpn12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26305 | Rab11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26306 | Rnase6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26307 | Rnf168 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26308 | Sema3c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26309 | Smndc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26310 | Sorcs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26311 | Spink4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26312 | Spock1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26313 | Sptbn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26314 | Srsf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26315 | Stard7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26316 | Thsd7a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26317 | Tm4sf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26318 | Tmbim6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26319 | Tmem25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26320 | Trim27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26321 | Ube2d3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26322 | Ube2r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26323 | Ugt1a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26324 | Vcpip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26325 | Ythdf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26326 | Adamts6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26327 | Adamts7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26328 | Adamts9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26329 | Atg16l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26330 | Atp5f1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26331 | Bloc1s2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26332 | C1qtnf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26333 | Castor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26334 | Fam167a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26335 | Gadd45g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26336 | Pacsin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26337 | Racgap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26338 | Rnaset2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26339 | Slc22a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26340 | Slc26a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26341 | Slc27a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26342 | Slc43a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26343 | Tspan31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26344 | Adamts19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26345 | Lgals3bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26346 | Phospho1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26347 | Pnliprp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26348 | Serpina4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26349 | Serpina6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26350 | Serpinb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26351 | Siglec10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26352 | Tnfrsf19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26353 | Gabarapl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26354 | Tmprss11d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26355 | Ky Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26356 | Aen Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26357 | Ak3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26358 | Ak5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26359 | Esd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26360 | Ezr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26361 | Fgb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26362 | Jtb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26363 | Lct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26364 | Mn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26365 | Mnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26366 | Oaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26367 | Rd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26368 | Tef Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26369 | Vcl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26370 | Was Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26371 | Abi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26372 | Agrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26373 | Apof Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26374 | Art4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26375 | Atl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26376 | Bag4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26377 | Bdh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26378 | C1qc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26379 | Ccnc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26380 | Cd53 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26381 | Cdon Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26382 | Cfl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26383 | Chia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26384 | Cib2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26385 | Cish Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26386 | Cope Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26387 | Cst6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26388 | Ctso Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26389 | Cutc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26390 | Cyba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26391 | Dkk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26392 | Dlx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26393 | Dmp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26394 | Dsg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26395 | Eapp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26396 | Egr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26397 | Faim Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26398 | Fdxr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26399 | Flnb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26400 | Fshb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26401 | Gdf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26402 | Gga3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26403 | Ggt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26404 | Gps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26405 | Haao Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26406 | Inha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26407 | Irf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26408 | Jdp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26409 | Klf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26410 | Lig4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26411 | Lmna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26412 | Lrp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26413 | Lrp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26414 | Lsm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26415 | Ltv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26416 | Ly6d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26417 | Lyg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26418 | Mdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26419 | Mesd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26420 | Mnda Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26421 | Mrm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26422 | Msx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26423 | Mta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26424 | Mtf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26425 | Muc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26426 | Nip7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26427 | Nptn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26428 | Numb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26429 | Oas3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26430 | Osbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26431 | Pax3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26432 | Per1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26433 | Pfas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26434 | Pgm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26435 | Pigm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26436 | Pkn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26437 | Plec Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26438 | Pomp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26439 | Ppih Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26440 | Prf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26441 | Prg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26442 | Prg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26443 | Qdpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26444 | Rbm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26445 | Rce1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26446 | Reck Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26447 | Retn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26448 | Rgs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26449 | Rnf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26450 | Rpl8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26451 | Rrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26452 | Ryr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26453 | Ryr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26454 | Scly Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26455 | Sgsh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26456 | Siae Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26457 | Six2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26458 | Snw1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26459 | Snx9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26460 | Sos2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26461 | Ssr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26462 | Stk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26463 | Tab1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26464 | Tcp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26465 | Tle3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26466 | Tmx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26467 | Tp73 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26468 | Tpx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26469 | Tril Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26470 | Tsfm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26471 | Ucma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26472 | Ugdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26473 | Ugp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26474 | Upk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26475 | Uros Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26476 | Vsx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26477 | Wdr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26478 | Wdr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26479 | Aadat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26480 | Abcc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26481 | Abce1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26482 | Acsl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26483 | Acss3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26484 | Adpgk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26485 | Amacr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26486 | Amelx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26487 | Apoa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26488 | Arpin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26489 | Atxn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26490 | Bach2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26491 | Baz1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26492 | Bckdk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26493 | Calm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26494 | Casq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26495 | Ccna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26496 | Ccnd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26497 | Cdh11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26498 | Cemip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26499 | Cers1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26500 | Cfhr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26501 | Cnpy2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26502 | Cntn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26503 | Cntn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26504 | Copz1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26505 | Coro6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26506 | Cplx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26507 | Cradd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26508 | Cryaa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26509 | Ctrb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26510 | Cytip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26511 | Daglb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26512 | Decr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26513 | Dhrs9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26514 | Dkkl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26515 | Dusp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26516 | Eef2k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26517 | Eif3k Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26518 | Esrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26519 | Fam3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26520 | Fbxl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26521 | Fcrl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26522 | Flad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26523 | Flrt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26524 | Fndc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26525 | Foxd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26526 | Foxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26527 | Fxyd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26528 | Galk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26529 | Gata1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26530 | Gata2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26531 | Gfod2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26532 | Gp1ba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26533 | Gpha2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26534 | Gpr12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26535 | Gpr19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26536 | Gpr26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26537 | Gpr87 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26538 | Hells Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26539 | Hoxb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26540 | Ikzf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26541 | Il1r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26542 | Il2rg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26543 | Ilkap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26544 | Inpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26545 | Insm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26546 | Isg20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26547 | Itgam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26548 | Kcnj2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26549 | Kdm4d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26550 | Kif4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26551 | Klk15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26552 | Kmt2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26553 | Lactb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26554 | Lama3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26555 | Lmtk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26556 | Ltbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26557 | Mecp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26558 | Meltf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26559 | Mlana Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26560 | Msmo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26561 | Mthfr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26562 | Mthfs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26563 | Mybl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26564 | Ncoa6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26565 | Ndrg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26566 | Ndst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26567 | Nek11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26568 | Neto1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26569 | Nfasc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26570 | Nlrc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26571 | Nptxr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26572 | Nr1i3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26573 | Nr2f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26574 | Nrn1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26575 | Nrxn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26576 | Nudt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26577 | Parp9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26578 | Pcbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26579 | Pdrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26580 | Pdzk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26581 | Peg10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26582 | Pex19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26583 | Pfdn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26584 | Pias1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26585 | Pilra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26586 | Pnrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26587 | Ppil1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26588 | Ppil2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26589 | Prelp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26590 | Prkg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26591 | Psme1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26592 | Ptgr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26593 | Pth2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26594 | Ptpn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26595 | Ptrh2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26596 | Rad21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26597 | Rexo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26598 | Rnf20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26599 | Robo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26600 | Romo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26601 | Rpl10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26602 | Rps4x Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26603 | Runx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26604 | Satb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26605 | Scn2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26606 | Sfrp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26607 | Sin3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26608 | Snai2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26609 | Snx10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26610 | Srsf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26611 | Stk25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26612 | Sulf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26613 | Susd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26614 | Taok2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26615 | Terf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26616 | Tfcp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26617 | Tgif1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26618 | Thsd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26619 | Timp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26620 | Tinag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26621 | Tnnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26622 | Tnpo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26623 | Top2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26624 | Tpsb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26625 | Trpv5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26626 | Ube2h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26627 | Ube2o Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26628 | Ube2w Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26629 | Unc5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26630 | Uqcrh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26631 | Usp26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26632 | Usp9y Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26633 | Vdac3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26634 | Xrcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26635 | Abhd10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26636 | Acadsb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26637 | Adam33 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26638 | Adgrg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26639 | Adra2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26640 | Alkal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26641 | Atf7ip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26642 | Bpifa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26643 | Btn3a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26644 | Calcrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26645 | Cdkn2d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26646 | Chaf1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26647 | Chrna3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26648 | Cldn11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26649 | Clec9a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26650 | Clstn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26651 | Col1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26652 | Col9a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26653 | Crabp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26654 | Dnase1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26655 | Dpysl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26656 | Eif1ax Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26657 | Eif4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26658 | Eps8l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26659 | Fbxo22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26660 | Fbxo32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26661 | Fgfrl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26662 | Galnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26663 | Galnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26664 | Galnt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26665 | Gpr142 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26666 | Gpr173 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26667 | Gprc5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26668 | Hnrnpr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26669 | Ifitm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26670 | Igflr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26671 | Il17rd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26672 | Il1rl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26673 | Il27ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26674 | Iqgap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26675 | Itga10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26676 | Lactb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26677 | Lgals2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26678 | Lrrc4c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26679 | Lrrtm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26680 | Man1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26681 | Mbtps1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26682 | Mcoln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26683 | Mical2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26684 | Mpig6b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26685 | mt-Co2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26686 | Ndufa8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26687 | Ndufa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26688 | Ndufv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26689 | Nfkbib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26690 | Otud7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26691 | Pfkfb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26692 | Pfkfb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26693 | Pi4k2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26694 | Plxnd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26695 | Pofut1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26696 | Ptp4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26697 | Rnase2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26698 | Slc4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26699 | Slc6a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26700 | Slurp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26701 | Srfbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26702 | Trim14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26703 | Trim29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26704 | Tspan1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26705 | Twist1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26706 | Txnl4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26707 | Ube2j1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26708 | Ube2v1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26709 | Ugt2b7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26710 | Vps13c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26711 | Abhd14b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26712 | Aldh7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26713 | Atp13a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26714 | Atp5if1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26715 | Gnpnat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26716 | Kir3dl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26717 | Lamtor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26718 | Map3k14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26719 | Mrgprx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26720 | Mthfd1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26721 | Nectin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26722 | Prtfdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26723 | Slc25a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26724 | Slc36a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26725 | Slc38a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26726 | Slitrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26727 | Slitrk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26728 | Slitrk6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26729 | Sult1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26730 | Tbl1xr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26731 | Trmt112 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26732 | Adamts10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26733 | Adamts14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26734 | Eif4ebp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26735 | Il1rapl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26736 | Serpinb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26737 | Slc25a28 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26738 | Slc25a51 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26739 | Tmem106b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26740 | Tmprss11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26741 | Btd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26742 | Dut Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26743 | Eln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26744 | Fev Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26745 | Ggn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26746 | Hbz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26747 | Kin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26748 | Mvp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26749 | Nnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26750 | Pip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26751 | Pnn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26752 | Pts Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26753 | Xpc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26754 | Adm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26755 | Amtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26756 | Ano6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26757 | Apip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26758 | Aqp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26759 | Arf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26760 | Arl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26761 | Art3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26762 | Bpgm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26763 | Bzw2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26764 | Cav2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26765 | Cbx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26766 | Cdr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26767 | Chn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26768 | Cpn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26769 | Cpox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26770 | Cst8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26771 | Cul2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26772 | Cycs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26773 | Dab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26774 | Ddx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26775 | Denr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26776 | Dgkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26777 | Dkk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26778 | E2f6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26779 | Ebf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26780 | Elob Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26781 | Emc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26782 | Emcn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26783 | Ets2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26784 | Fech Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26785 | Gbe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26786 | Gldc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26787 | Gopc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26788 | Gps2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26789 | Gpx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26790 | Grk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26791 | Gzmk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26792 | H3c1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26793 | Hagh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26794 | Hcn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26795 | Hes6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26796 | Hopx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26797 | Hsf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26798 | Ifne Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26799 | Klc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26800 | Klk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26801 | Lcn8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26802 | Liph Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26803 | Mbip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26804 | Mnx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26805 | Mob4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26806 | Mrs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26807 | Myl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26808 | Myoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26809 | Myog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26810 | Nans Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26811 | Nasp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26812 | Naxe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26813 | Ncf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26814 | Nek3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26815 | Nfya Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26816 | Nkd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26817 | Nme1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26818 | Nnat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26819 | Nppc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26820 | Nqo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26821 | Ntf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26822 | Ntn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26823 | Nudc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26824 | Oas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26825 | Oxr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26826 | Pax5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26827 | Pax6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26828 | Pbx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26829 | Pcp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26830 | Pepd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26831 | Per2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26832 | Pgm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26833 | Pigf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26834 | Pkp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26835 | Pmp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26836 | Ppie Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26837 | Prkx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26838 | Prr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26839 | Pxdn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26840 | Rad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26841 | Rfng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26842 | Rhoh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26843 | Rmi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26844 | Rpia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26845 | Rpn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26846 | Sox6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26847 | Spen Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26848 | Stn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26849 | Stx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26850 | Stx8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26851 | Syt6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26852 | Tac3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26853 | Tbx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26854 | Tcf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26855 | Thrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26856 | Tjp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26857 | Trhr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26858 | Ucp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26859 | Wsb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26860 | Ybx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26861 | Zic2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26862 | Zic3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26863 | Abcb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26864 | Abcc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26865 | Abhd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26866 | Acacb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26867 | Acer3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26868 | Acrv1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26869 | Actn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26870 | Acyp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26871 | Acyp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26872 | Ahnak Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26873 | Aimp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26874 | Apoc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26875 | Apol2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26876 | Appl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26877 | Bard1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26878 | Basp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26879 | Batf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26880 | Birc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26881 | Calr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26882 | Cdca7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26883 | Cdk15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26884 | Cenpf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26885 | Cep43 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26886 | Cfhr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26887 | Chpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26888 | Ckap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26889 | Cks1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26890 | Cldn9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26891 | Clic4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26892 | Clic5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26893 | Cndp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26894 | Cnnm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26895 | Cntn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26896 | Cpeb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26897 | Crlf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26898 | Dcaf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26899 | Ddost Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26900 | Dhrs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26901 | Dhrs3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26902 | Dhx15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26903 | Dnah6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26904 | Edem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26905 | Egln3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26906 | Epha6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26907 | Epha8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26908 | Eppk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26909 | Ercc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26910 | Erp27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26911 | Fancc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26912 | Fbln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26913 | Fgf16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26914 | Fkbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26915 | Fkbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26916 | Fkbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26917 | Fkbp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26918 | Flrt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26919 | Fmnl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26920 | G3bp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26921 | Gabrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26922 | Gnai3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26923 | Gpat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26924 | Gpld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26925 | Grik2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26926 | Gsdma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26927 | Gstm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26928 | Hars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26929 | Hmces Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26930 | Hoxb9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26931 | Hoxc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26932 | Hspa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26933 | Htr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26934 | Ifit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26935 | Igsf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26936 | Impa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26937 | Insl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26938 | Itgal Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26939 | Itln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26940 | Josd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26941 | Kcnn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26942 | Kif2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26943 | Kif2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26944 | Kifc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26945 | Kifc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26946 | Klhl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26947 | Klk13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26948 | Kpna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26949 | Lamc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26950 | Larp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26951 | Lrrc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26952 | Lrrk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26953 | Magi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26954 | Meox1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26955 | Mep1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26956 | Mesp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26957 | Milr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26958 | Muc5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26959 | Ncald Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26960 | Ncoa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26961 | Ncor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26962 | Nell1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26963 | Npdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26964 | Nprl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26965 | Nptx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26966 | Nrcam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26967 | Ntng1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26968 | Opcml Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26969 | Oxct1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26970 | Pa2g4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26971 | Pcsk7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26972 | Plet1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26973 | Plpp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26974 | Ppef1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26975 | Prdm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26976 | Prmt9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26977 | Prrx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26978 | Psma4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26979 | Psmb8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26980 | Psme3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26981 | Ptk2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26982 | Ptpn9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26983 | Ptprn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26984 | Qsox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26985 | Ramp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26986 | Rbbp8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26987 | Rbck1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26988 | Rcvrn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26989 | Rgs12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26990 | Ripk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26991 | Rnf10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26992 | Rplp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26993 | Rptor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26994 | Rsad2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26995 | Sar1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26996 | Sesn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26997 | Sf3b3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26998 | Slit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS26999 | Smad5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27000 | Smug1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27001 | Sox17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27002 | Sox18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27003 | Sp140 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27004 | Spg21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27005 | Stap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27006 | Stk26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27007 | Tada3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27008 | Tiprl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27009 | Tmed4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27010 | Traf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27011 | Trpm6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27012 | Tssk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27013 | Uba52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27014 | Ube2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27015 | Ube2f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27016 | Ube3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27017 | Ugt1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27018 | Uqcrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27019 | Usp35 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27020 | Usp37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27021 | Usp40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27022 | Usp49 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27023 | Usp53 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27024 | Vps41 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27025 | Vps4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27026 | Vsig2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27027 | Vstm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27028 | Vti1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27029 | Wdr77 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27030 | Zbtb9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27031 | Acad10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27032 | Adgrg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27033 | Atp2b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27034 | Atp2b4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27035 | B3gat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27036 | B3gnt6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27037 | B3gnt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27038 | Bcl11a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27039 | Camk1g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27040 | Camk2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27041 | Capza2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27042 | Casp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27043 | Ccdc47 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27044 | Cd300e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27045 | Cdk5r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27046 | Cdkn1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27047 | Chrdl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27048 | Chst11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27049 | Col5a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27050 | Crtac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27051 | Csrnp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27052 | Ddx39b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27053 | Depdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27054 | Depdc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27055 | Dnajb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27056 | Elavl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27057 | Elovl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27058 | Fbxo10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27059 | Fkbp14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27060 | Gabra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27061 | Gabra4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27062 | Gpr107 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27063 | Hectd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27064 | Hectd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27065 | Hs3st1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27066 | Il31ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27067 | Kansl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27068 | Kcnip3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27069 | Kcnma1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27070 | Kif20a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27071 | Lman2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27072 | Lrpprc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27073 | Lrrc25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27074 | Lrrc3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27075 | Mad2l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27076 | Map3k9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27077 | Mapre3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27078 | mt-Nd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27079 | mt-Nd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27080 | Npbwr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27081 | Nusap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27082 | Or10h1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27083 | Osbpl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27084 | Papss2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27085 | Pgrmc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27086 | Pi4k2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27087 | Plxdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27088 | Pmaip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27089 | Pnpla6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27090 | Podxl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27091 | Pou2f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27092 | Ppfia4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27093 | Ptdss1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27094 | Ptger3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27095 | Ptpn18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27096 | Raet1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27097 | Recql4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27098 | Rnase1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27099 | Rnf126 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27100 | Rnf146 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27101 | Rps27a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27102 | Sema3f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27103 | Sema4g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27104 | Shcbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27105 | Slc7a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27106 | Slc8b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27107 | Smurf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27108 | Spink2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27109 | Suclg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27110 | Tagln2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27111 | Tagln3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27112 | Thap11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27113 | Tmeff1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27114 | Tmem17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27115 | Tmem92 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27116 | Treml1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27117 | Trim23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27118 | Trim45 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27119 | Trmt11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27120 | Tubb4a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27121 | Txnrd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27122 | Ube2g1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27123 | Uqcr11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27124 | Usp6nl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27125 | Vps13d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27126 | Zc3h13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27127 | Zmynd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27128 | Adamts8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27129 | Aldh4a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27130 | Alox15b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27131 | B3galt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27132 | B4galt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27133 | B4galt4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27134 | Cacna1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27135 | Cacna1i Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27136 | Cdk2ap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27137 | Csnk1g2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27138 | Fam171b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27139 | Hepacam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27140 | Hsd11b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27141 | Hsd17b4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27142 | Il18rap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27143 | Kirrel2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27144 | Kremen1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27145 | Lyplal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27146 | Mab21l2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27147 | Map3k11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27148 | Ncr3lg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27149 | Pglyrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27150 | Rtn4rl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27151 | Scgb3a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27152 | Selenom Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27153 | Sinhcaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27154 | Slc11a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27155 | Slc22a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27156 | Slc27a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27157 | Slc39a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27158 | Slc44a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27159 | Slc47a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27160 | Smarce1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27161 | Smpdl3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27162 | St3gal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27163 | St6gal2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27216 | Chd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27217 | Cir1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27218 | Cnmd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27219 | Cnn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27220 | Cpvl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27221 | Crem Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27222 | Cul5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27223 | Dcps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27224 | Dgkh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27225 | Dlg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27226 | Dlx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27227 | Dner Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27228 | Dntt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27229 | Dpys Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27230 | Drc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27231 | Dux4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27232 | Dvl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27233 | Dvl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27234 | Dysf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27235 | E2f5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27236 | Eaf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27237 | Eef2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27238 | Ehd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27239 | Elp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27240 | Emx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27241 | Etf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27242 | Evx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27243 | Exo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27244 | Faf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27245 | Fhl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27246 | Flnc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27247 | Ftmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27248 | Fxr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27249 | Gba1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27250 | Gba3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27251 | Gdf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27252 | Gdi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27253 | Ghrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27254 | Gjb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27255 | Gli2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27256 | Gmps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27257 | Gnb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27258 | Gng4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27259 | Gpam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27260 | Grb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27261 | Grk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27262 | Gusb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27263 | Hes2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27264 | Hhat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27265 | Hira Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27266 | Immt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27267 | Imp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27268 | Irgm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27269 | Irx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27270 | Ism1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27271 | Itpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27272 | Kdm8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27273 | Lax1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27274 | Lcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27275 | Lcp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27276 | Lgi3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27277 | Lgr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27278 | Lhx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27279 | Lhx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27280 | Lhx9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27281 | Lipf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27282 | Lmo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27283 | Lsm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27284 | Mafk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27285 | Mcub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27286 | Mdn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27287 | Mefv Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27288 | Mpst Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27289 | Msl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27290 | Mta2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27291 | Muc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27292 | Mycl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27293 | Myh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27294 | Nagk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27295 | Ncf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27296 | Nfia Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27297 | Nme3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27298 | Nox3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27299 | Npnt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27300 | Nuf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27301 | Opn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27302 | Orc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27303 | Orc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27304 | Otx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27305 | P3h1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27306 | Pdx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27307 | Pfn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27308 | Pgk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27309 | Pld3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27310 | Pnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27311 | Pno1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27312 | Ppa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27313 | Ppic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27314 | Ppt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27315 | Prcp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27316 | Pspn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27317 | Pstk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27318 | Pus1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27319 | Pus7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27320 | Pygl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27321 | Rag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27322 | Rala Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27323 | Rbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27324 | Rev1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27325 | Rin3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27326 | Rpf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27327 | Rpn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27328 | Rtcb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27329 | Sbk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27330 | Sco2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27331 | Scp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27332 | Sdc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27333 | Sgk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27334 | Smc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27335 | Snrk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27336 | Sox5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27337 | Syt7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27338 | Tbx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27339 | Tia1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27340 | Tkfc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27341 | Tle2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27342 | Tlk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27343 | Tmpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27344 | Tom1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27345 | Ttf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27346 | Twnk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27347 | Uts2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27348 | Vav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27349 | Vav3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27350 | Vbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27351 | Vwc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27352 | Wbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27353 | Xpo6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27354 | Xrn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27355 | Yod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27356 | Zg16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27357 | Abca3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27358 | Abcc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27359 | Abhd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27360 | Acad8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27361 | Acads Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27362 | Acap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27363 | Ackr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27364 | Acsl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27365 | Adcy3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27366 | Adh1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27367 | Afmid Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27368 | Anxa9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27369 | Aplp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27370 | Apoc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27371 | Arih1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27372 | Arrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27373 | Asap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27374 | Ascc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27375 | Ascl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27376 | Ascl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27377 | Atg2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27378 | Axin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27379 | Birc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27380 | Bmp8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27381 | Brip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27382 | Btnl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27383 | Btnl8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27384 | C4bpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27385 | Calb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27386 | Capn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27387 | Cass4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27388 | Cbll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27389 | Ccdc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27390 | Cdc45 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27391 | Cdca3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27392 | Cdca4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27393 | Cdhr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27394 | Cdhr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27395 | Cdkn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27396 | Cdyl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27397 | Cenpw Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27398 | Cept1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27399 | Cert1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27400 | Chac1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27401 | Clcn7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27402 | Cldn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27403 | Clic6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27404 | Clip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27405 | Cmpk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27406 | Cmtm6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27407 | Cnih2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27408 | Cox10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27409 | Cox17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27410 | Cox18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27411 | Cox7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27412 | Crls1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27413 | Csrp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27414 | Ctbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27415 | Cyb5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27416 | Daam1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27417 | Dars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27418 | Dcaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27419 | Dchs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27420 | Dclk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27421 | Ddhd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27422 | Ddx10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27423 | Ddx21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27424 | Ddx49 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27425 | Degs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27426 | Disp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27427 | Disp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27428 | Dock1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27429 | Dpy30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27430 | Duox2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27431 | Ebag9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27432 | Ecsit Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27433 | Eepd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27434 | Eif3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27435 | Eif3m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27436 | Ethe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27437 | Evi2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27438 | Evi2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27439 | Faim2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27440 | Fcamr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27441 | Fcgbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27442 | Fcrla Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27443 | Fgf11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27444 | Foxa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27445 | Foxd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27446 | Foxk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27447 | Foxq1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27448 | Fstl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27449 | G6pc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27450 | Galns Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27451 | Galr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27452 | Gfra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27453 | Gins1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27454 | Gmppa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27455 | Gna13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27456 | Gpr20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27457 | Gpr22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27458 | Gpr31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27459 | Gpr50 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27460 | Gpr61 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27461 | Gpr85 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27462 | Grem2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27463 | Grhl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27464 | Grik3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27465 | Grin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27466 | Gstm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27467 | Gtf2i Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27468 | Hacd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27469 | Hdlbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27470 | Hmgcl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27471 | Hmgn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27472 | Hmgn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27473 | Hspb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27474 | Htr2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27475 | Htra2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27476 | Icam4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27477 | Icam5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27478 | Igsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27479 | Ikbip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27480 | Il36a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27481 | Inhbc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27482 | Insl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27483 | Ireb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27484 | Isca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27485 | Itga3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27486 | Itga7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27487 | Itih2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27488 | Itpr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27489 | Kcnd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27490 | Kcnq5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27491 | Klk11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27492 | Kmt2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27493 | Lama1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27494 | Lama2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27495 | Lamb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27496 | Lamc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27497 | Litaf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27498 | Lmod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27499 | Lrig2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27500 | Lrrc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27501 | Lrrn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27502 | Magoh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27503 | Mat1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27504 | Mat2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27505 | Mgat3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27506 | Mgme1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27507 | Mmp19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27508 | Mpeg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27509 | Mrto4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27510 | Ms4a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27511 | Mtif3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27512 | Mxra8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27513 | Naa40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27514 | Ncam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27515 | Ncapg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27516 | Nhsl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27517 | Nipbl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27518 | Notum Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27519 | Npas2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27520 | Nr0b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27521 | Nrarp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27522 | Nubpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27523 | Oprk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27524 | Ovol1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27525 | Oxa1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27526 | Padi3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27527 | Paics Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27528 | Pank1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27529 | Pank2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27530 | Parp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27531 | Pcdh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27532 | Pcdh9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27533 | Pcsk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27534 | Pcyt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27535 | Pgam2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27536 | Pgap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27537 | Pianp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27538 | Pias4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27539 | Pibf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27540 | Pitx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27541 | Pla1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27542 | Plac9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27543 | Plbd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27544 | Plod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27545 | Pnpt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27546 | Ppm1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27547 | Prodh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27548 | Prok1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27549 | Psmd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27550 | Pxdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27551 | Rbpms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27552 | Rhpn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27553 | Rnf31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27554 | Rnf40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27555 | Robo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27556 | Rpl23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27557 | Rplp0 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27558 | Rps3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27559 | Rreb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27560 | Scn3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27561 | Scn4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27562 | Semg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27563 | Sfxn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27564 | Siah2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27565 | Smpd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27566 | Snu13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27567 | Sort1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27568 | Spa17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27569 | Spsb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27570 | Spsb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27571 | Srsf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27572 | Srxn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27573 | Ssc5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27574 | Stk24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27575 | Stk39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27576 | Stra6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27577 | Tagap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27578 | Tarm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27579 | Tbx21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27580 | Tcf12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27581 | Tcf21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27582 | Telo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27583 | Tfdp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27584 | Thada Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27585 | Traf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27586 | Trim9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27587 | Tssk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27588 | Ttbk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27589 | Ube2z Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27590 | Ube4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27591 | Uhrf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27592 | Urgcp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27593 | Ush1c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27594 | Usp29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27595 | Usp34 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27596 | Usp44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27597 | Vamp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27598 | Virma Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27599 | Vps18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27600 | Vps35 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27601 | Wdr87 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27602 | Wipi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27603 | Abcb10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27604 | Ablim1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27605 | Adgrf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27606 | Adra1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27607 | Agpat4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27608 | Anapc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27609 | Anp32a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27610 | Arid3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27611 | Arl2bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27612 | Arpc1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27613 | Asrgl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27614 | Atad3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27615 | Atp1b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27616 | B3glct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27617 | B3gnt5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27618 | Bclaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27619 | Calml5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27620 | Cc2d1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27621 | Cdkal1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27622 | Cdkn2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27623 | Cela3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27624 | Chrnb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27625 | Cited2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27626 | Clstn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27627 | Col9a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27628 | Commd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27629 | Cox6b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27630 | Cox6b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27631 | Cox7a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27632 | Csnk1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27633 | Cyp2s1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27634 | Dcbld1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27635 | Dnajb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27636 | Dnajc5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27637 | Draxin Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27638 | Dusp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27639 | Eftud2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27640 | Eif4a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27641 | Elovl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27642 | Endod1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27643 | Exosc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27644 | Fam83d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27645 | Fbxo44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27646 | Fbxw11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27647 | Fermt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27648 | Fermt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27649 | Flvcr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27650 | Flvcr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27651 | Gabrb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27652 | Gimap6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27653 | Gpr146 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27654 | Grin2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27655 | Hnrnpk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27656 | Hnrnpu Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27657 | Homer1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27658 | Il17rc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27659 | Inpp5d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27660 | Inpp5e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27661 | Itga11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27662 | Lgalsl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27663 | Lingo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27664 | Lpgat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27665 | Lrrc8a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27666 | Magea4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27667 | Map3k6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27668 | Mapre1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27669 | Mettl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27670 | Mfap3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27671 | Minpp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27672 | Mlxipl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27673 | Mrpl21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27674 | Mrps10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27675 | mt-Nd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27676 | Mycbp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27677 | Ndufa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27678 | Ndufs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27679 | Ndufs5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27680 | Ndufv2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27681 | Nfe2l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27682 | Nlrp12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27683 | Nt5c3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27684 | Osbpl7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27685 | Pdzrn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27686 | Pggt1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27687 | Pgm2l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27688 | Pinlyp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27689 | Pou3f2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27690 | Pou4f1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27691 | Ppp2ca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27692 | Ppp6r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27693 | Prdm13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27694 | Prkaa2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27695 | Prss22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27798 | Tmprss15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27799 | Csgalnact1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27800 | Ak9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27801 | Dse Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27802 | Evl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27803 | Hrk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27804 | Lsr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27805 | Nrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27806 | Qki Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27807 | Sry Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27808 | Acp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27809 | Aff4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27810 | Ajm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27811 | Alg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27812 | Alg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27813 | Alpi Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27814 | Asb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27815 | Aspm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27816 | Avil Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27817 | Bco2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27818 | Bcor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27819 | Blnk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27820 | Bora Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27821 | Bub3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27822 | Cbx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27823 | Ccn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27824 | Ccnf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27825 | Ccno Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27826 | Cct8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27827 | Cds2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27828 | Cfc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27829 | Chd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27830 | Chka Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27831 | Chp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27832 | Chpf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27833 | Cltc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27834 | Cnbp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27835 | Coil Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27836 | Crnn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27837 | Cul1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27838 | Dap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27839 | Dbn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27840 | Def6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27841 | Dera Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27842 | Dlx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27843 | Dok7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27844 | Dpf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27845 | Dpm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27846 | Dpp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27847 | Dpyd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27848 | Dspp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27849 | Dtx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27850 | Ebpl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27851 | Eci1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27852 | Elf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27853 | Elf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27854 | Emx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27855 | Etv2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27856 | Etv3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27857 | Etv5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27858 | Ext1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27859 | Fat4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27860 | Fjx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27861 | Flcn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27862 | Fut4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27863 | Fzd9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27864 | Gatb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27865 | Gde1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27866 | Gdf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27867 | Glg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27868 | Gli3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27869 | Gmds Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27870 | Gnb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27871 | Gng2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27872 | Gyg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27873 | Hhip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27874 | Idi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27875 | Idi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27876 | Ipmk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27877 | Irs4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27878 | Klf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27879 | Klf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27880 | Lat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27881 | Lcor Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27882 | Ldhc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27883 | Lgr6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27884 | Lhx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27885 | Lhx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27886 | Lmo2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27887 | Lsm4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27888 | Ly6h Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27889 | Mael Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27890 | Mcat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27891 | Mcm6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27892 | Mcm7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27893 | Mei1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27894 | Mfng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27895 | Mia2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27896 | Miip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27897 | Msi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27898 | Msx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27899 | Mto1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27900 | Mul1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27901 | Mxi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27902 | Myh1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27903 | Myh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27904 | Myl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27905 | Mzf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27906 | Nbea Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27907 | Nek8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27908 | Nek9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27909 | Nfic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27910 | Nfs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27911 | Nkg7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27912 | Nkrf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27913 | Npr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27914 | Nrep Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27915 | Nt5c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27916 | Nt5m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27917 | Oit3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27918 | Opn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27919 | Pawr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27920 | Pcca Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27921 | Pccb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27922 | Pdhb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27923 | Pdhx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27924 | Pecr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27925 | Pex2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27926 | Pgm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27927 | Phip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27928 | Pid1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27929 | Pin4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27930 | Pon3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27931 | Purb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27932 | Rac3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27933 | Rarb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27934 | Rbl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27935 | Rbm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27936 | Rcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27937 | Rdm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27938 | Rec8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27939 | Rgp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27940 | Rgs3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27941 | Rhog Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27942 | Rln1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27943 | Rnd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27944 | Rpa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27945 | Rrs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27946 | Rtp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27947 | Sdf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27948 | Sdhc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27949 | Sdhd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27950 | Shc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27951 | Six3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27952 | Six4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27953 | Six5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27954 | Spg7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27955 | Spic Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27956 | Stx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27957 | Swi5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27958 | Tbx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27959 | Tfr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27960 | Tgm3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27961 | Tle1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27962 | Tle4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27963 | Tmc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27964 | Tmc7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27965 | Tns1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27966 | Trdn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27967 | Ttc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27968 | Ttf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27969 | Ucn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27970 | Upp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27971 | Urod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27972 | Usf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27973 | Uxs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27974 | Vill Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27975 | Vrk2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27976 | Wnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27977 | Xaf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27978 | Xpo7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27979 | Xrn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27980 | Zic1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27981 | Zic5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27982 | Zw10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27983 | Aars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27984 | Abcb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27985 | Abcb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27986 | Abcc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27987 | Abhd8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27988 | Acot1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27989 | Actg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27990 | Actr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27991 | Adcy1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27992 | Adcy2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27993 | Agmat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27994 | Akap5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27995 | Akip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27996 | Alg11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27997 | Ampd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27998 | Apex1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS27999 | Aph1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28000 | Apmap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28001 | Arap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28002 | Arid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28003 | Asap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28004 | Ascl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28005 | Atad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28006 | Atg12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28007 | Atp23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28008 | Atxn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28009 | Atxn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28010 | Aunip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28011 | Auts2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28012 | Banf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28013 | Bank1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28014 | Batf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28015 | Bcl9l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28016 | Best3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28017 | Bicc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28018 | C1ql1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28019 | C3ar1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28020 | Calcb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28021 | Cald1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28022 | Cand1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28023 | Ccnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28024 | Ccnt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28025 | Ccnt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28026 | Cd247 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28027 | Cd2ap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28028 | Cdc5l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28029 | Cdca2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28030 | Cdh19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28031 | Cdh23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28032 | Cdh24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28033 | Cdhr5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28034 | Cdk18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28035 | Cdk20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28036 | Cdkl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28037 | Cebpe Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28038 | Cebpg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28039 | Cenpn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28040 | Cenpo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28041 | Cep55 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28042 | Cep78 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28043 | Cflar Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28044 | Chmp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28045 | Chrm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28046 | Chst9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28047 | Ciart Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28048 | Cideb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28049 | Clcn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28050 | Cldn4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28051 | Cldn7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28052 | Cnnm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28053 | Cox14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28054 | Cox6c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28055 | Cpne3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28056 | Cpne5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28057 | Cpsf6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28058 | Creb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28059 | Crim1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28060 | Csde1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28061 | Cstf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28062 | Cyth3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28063 | Dars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28064 | Dctn6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28065 | Ddx11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28066 | Ddx24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28067 | Ddx3y Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28068 | Ddx60 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28069 | Degs1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28070 | Dgcr8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28071 | Dhx30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28072 | Dhx58 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28073 | Disc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28074 | Dmgdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28075 | Dmrt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28076 | Dock7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28077 | Dram1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28078 | Dscam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28079 | Dscc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28080 | Eif3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28081 | Eif3l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28082 | Ero1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28083 | Etnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28084 | Extl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28085 | Fads3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28086 | Fanci Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28087 | Fbln2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28088 | Fbxo5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28089 | Fbxo6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28090 | Fbxw2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28091 | Fmnl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28092 | Foxe1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28093 | Foxr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28094 | Frmd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28095 | Frmd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28096 | Fut10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28097 | Gcnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28098 | Gdpd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28099 | Ggact Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28100 | Glis2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28101 | Glp2r Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28102 | Gmeb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28103 | Gnai2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28104 | Gpd1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28105 | Gpr21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28106 | Greb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28107 | Gria2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28108 | Gtf2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28109 | Hacd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28110 | Hdhd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28111 | Herc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28112 | Hint1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28113 | Hnf4g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28114 | Hoxb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28115 | Hoxb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28116 | Hoxc8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28117 | Hyls1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28118 | Ifi35 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28119 | Ifrd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28120 | Ikzf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28121 | Itm2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28122 | Itpr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28123 | Jmjd7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28124 | Kat14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28125 | Kcmf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28126 | Kcna4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28127 | Kcnd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28128 | Kcnh7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28129 | Kcnh8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28130 | Kcnk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28131 | Kcnk4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28132 | Kctd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28133 | Kdm1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28134 | Kif1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28135 | Kif22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28136 | Klf16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28137 | Kmt5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28138 | Kyat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28139 | Lalba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28140 | Lama4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28141 | Lama5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28142 | Lamb1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28143 | Lamb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28144 | Larp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28145 | Lars1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28146 | Lars2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28147 | Limd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28148 | Lmnb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28149 | Lmx1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28150 | Loxl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28151 | Lrfn5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28152 | Lrp10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28153 | Lrtm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28154 | Lsamp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28155 | Ltc4s Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28156 | Magt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28157 | Maml1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28158 | Mark1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28159 | Mast3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28160 | Matn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28161 | Mcfd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28162 | Mex3d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28163 | Mgat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28164 | Mgst3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28165 | Micu2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28166 | Mitd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28167 | Mki67 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28168 | Mlycd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28232 | Rab3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28233 | Rab5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28234 | Rab5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28235 | Rab8b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28236 | Rad9a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28237 | Rasa3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28238 | Rasa4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28239 | Rasd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28240 | Rbbp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28241 | Rbbp7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28242 | Rbm22 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28243 | Rbms2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28244 | Rc3h2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28245 | Rcan1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28246 | Rcor1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28247 | Rdh10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28248 | Rgs17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28249 | Ribc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28250 | Rims2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28251 | Riok3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28252 | Rnf14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28253 | Rnf25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28254 | Rnf32 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28255 | Rpl36 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28256 | Rplp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28257 | Rps10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28258 | Rps12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28259 | Rps14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28260 | Rps21 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28261 | Rraga Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28262 | Rragd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28263 | Rrm2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28264 | Rspo4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28265 | Rtbdn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28266 | Rwdd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28267 | Sall2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28268 | Sall4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28269 | Sap30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28270 | Sec13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28271 | Sesn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28272 | Sftpc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28273 | Sgpl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28274 | Sin3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28275 | Slit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28276 | Smdt1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28277 | Smyd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28278 | Sntg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28279 | Snx20 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28280 | Sorl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28281 | Sox11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28282 | Spag5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28283 | Spc25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28284 | Spry1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28285 | Srrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28286 | Srsf9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28287 | Stag1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28288 | Stmn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28289 | Styk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28290 | Sumo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28291 | Susd2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28292 | Svep1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28293 | Sycp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28294 | Tada1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28295 | Taf15 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28296 | Tafa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28297 | Tbx19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28298 | Tcfl5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28299 | Tctn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28300 | Tfap4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28301 | Tfb1m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28302 | Tfb2m Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28303 | Thsd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28304 | Tmed2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28305 | Tmed3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28306 | Tmed9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28307 | Top3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28308 | Tpd52 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28309 | Tpst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28310 | Trak2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28311 | Trat1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28312 | Trim8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28313 | Trip6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28314 | Trit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28315 | Trpm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28316 | Ubap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28317 | Ufsp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28318 | Uqcc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28319 | Usp48 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28320 | Veph1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28321 | Vwc2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28322 | Wdr26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28323 | Wnt5b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28324 | Wnt7b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28325 | Ypel5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28326 | Zmym2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28327 | Abhd12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28328 | Actl6a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28329 | Adgrb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28330 | Adgrd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28331 | Adgrf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28332 | Adgrf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28333 | Adgrg6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28334 | Agpat2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28335 | Agtrap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28336 | Akr1e2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28337 | Ambra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28338 | Atp11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28339 | Atp1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28340 | Atp1b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28341 | Atxn2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28342 | B3gnt3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28343 | Baiap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28344 | Bcl11b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28345 | Brinp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28346 | Camkk1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28347 | Camta1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28348 | Cartpt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28349 | Cavin1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28350 | Cavin3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28351 | Cep112 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28352 | Chaf1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28353 | Chmp4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28354 | Clec3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28355 | Col5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28356 | Col5a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28357 | Coro1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28358 | Csnk2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28359 | Ddx19b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28360 | Dhtkd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28361 | Diaph3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28362 | Dnajc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28363 | Dnase2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28364 | Dusp18 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28365 | Eef1a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28366 | Efemp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28367 | Egflam Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28368 | Eif2s1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28369 | Ercc6l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28370 | Exosc9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28371 | Fam20b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28372 | Fbxo11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28373 | Gabra5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28374 | Glcci1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28375 | Glt8d2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28376 | Glyctk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28377 | Gpr141 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28378 | Gpr182 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28379 | Grin2c Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28380 | Gxylt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28381 | Higd1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28382 | Hnrnpd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28383 | Hsf2bp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28384 | Hspa4l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28385 | Ifi44l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28386 | Ifitm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28387 | Il20ra Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28388 | Immp1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28389 | Immp2l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28390 | Impact Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28391 | Incenp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28392 | Inpp4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28393 | Inpp5a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28394 | Kif21a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28395 | Klhl24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28396 | Large2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28397 | Lmbr1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28398 | Ly6g6f Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28399 | Map3k2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28400 | Mettl4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28401 | Mettl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28402 | Mfsd2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28403 | Mllt10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28404 | Mrgpre Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28405 | Mrpl11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28406 | Mrpl13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28407 | Mustn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28408 | Nanos1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28409 | Nap1l1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28410 | Ndufa5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28411 | Ndufb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28412 | Ndufb7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28413 | Ndufc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28414 | Ndufc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28415 | Ndufs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28416 | Nfatc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28417 | Npffr2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28418 | Pcdh12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28419 | Pcdh17 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28420 | Pdgfrl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28421 | Pdlim5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28422 | Pdzd11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28423 | Pgrmc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28424 | Pik3r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28425 | Pitpna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28426 | Polr1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28427 | Polr1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28428 | Polr1e Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28429 | Polr2g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28430 | Ppp3r1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28431 | Prss27 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28432 | Prss57 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28433 | Ptger1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28434 | Rassf4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28435 | Rnf128 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28436 | Rnf166 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28437 | Rnf169 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28438 | Rnf186 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28439 | Rnf213 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28440 | Rpl27a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28441 | Samsn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28442 | Scarf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28443 | Sema3g Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28444 | Sephs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28445 | Setbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28446 | Sh2d1a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28447 | Sh3bp5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28448 | Sh3gl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28449 | Slc1a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28450 | Slc1a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28451 | Slc1a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28452 | Slc4a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28453 | Slc4a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28454 | Slc5a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28455 | Slc5a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28456 | Slc6a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28457 | Slc7a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28458 | Sorbs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28459 | Sowaha Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28460 | Sptlc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28461 | Srd5a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28462 | Srd5a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28463 | Srebf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28464 | Stard4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28465 | Stoml3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28466 | Strip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28467 | Stxbp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28468 | Sucla2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28469 | Syngr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28470 | Tas1r2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28471 | Tbxas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28472 | Tcirg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28473 | Tex264 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28474 | Tm9sf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28475 | Trim13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28476 | Trim26 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28477 | Trim31 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28478 | Trim38 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28479 | Trim44 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28480 | Trim56 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28481 | Trip11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28482 | Trip12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28483 | Tsga10 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28484 | Ttll12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28485 | Twist2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28486 | U2surp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28487 | Ubap1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28488 | Ube2l6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28489 | Ube2v2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28490 | Ubiad1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28491 | Ugt1a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28492 | Unc13d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28493 | Yeats2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28494 | Zbtb12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28495 | Zcchc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28496 | Abhd16b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28497 | Adamts3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28498 | Adipor2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28499 | Aldh3b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28500 | Aldh6a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28501 | Ankrd54 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28502 | Arfgap3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28503 | Arhgdib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28504 | Arhgef6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28505 | Arhgef7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28506 | Atp5f1d Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28507 | Bcl2l12 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28508 | Bhlhe23 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28509 | Caskin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28510 | Ccdc134 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28511 | Ccdc88a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28512 | Clec11a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28513 | Clec14a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28514 | Clptm1l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28515 | Col22a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28516 | Csnk1g1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28517 | Dnajc11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28518 | Dnttip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28519 | Eif2ak1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28520 | Fam162a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28521 | Fam177b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28522 | Fastkd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28523 | Glyatl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28524 | Hmgcll1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28525 | Il12rb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28526 | Laptm4b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28527 | Mapkap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28528 | Mettl13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28529 | Micall2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28530 | Napepld Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28531 | Ndufaf3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28532 | Ndufb11 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28533 | Pacsin2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28534 | Pik3ap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28535 | Plekhg3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28536 | Ppp2r1b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28537 | Ppp2r3a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28538 | Prkar2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28539 | Prkar2b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28540 | Rangap1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28541 | Rasgrp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28542 | Rnpepl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28543 | Rps6ka4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28544 | Rps6ka5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28545 | Serinc2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28546 | Slc10a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28547 | Slc12a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28548 | Slc13a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28549 | Slc16a5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28550 | Slc18a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28551 | Slc18a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28552 | Slc20a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28553 | Slc22a7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28554 | Slc25a4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28555 | Slc26a6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28556 | Slc29a1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28557 | Slc35b2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28558 | Slc35e3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28559 | Slc38a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28560 | Slc38a3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28561 | Slc39a8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28562 | Slc44a2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28563 | Smarcd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28564 | Sostdc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28565 | St8sia1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28566 | Tax1bp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28567 | Tbc1d16 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28568 | Tmem158 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28569 | Tsc22d3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28570 | Ubash3b Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28571 | Unc93b1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28572 | Xpnpep3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28573 | Zc3hav1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28574 | Zdhhc19 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28575 | Arhgap30 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28576 | Arhgap42 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28577 | Arhgef40 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28578 | Cacna2d3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28579 | Cacna2d4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28580 | Crispld2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28581 | Ctnnbip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28582 | Hsd17b14 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28583 | Mapk8ip1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28584 | Naaladl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28585 | Pafah1b3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28586 | Rap1gap2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28587 | Serpinb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28588 | Sh3pxd2a Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28589 | Slc22a13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28590 | Slc25a13 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28591 | Slc25a25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28592 | Slc25a29 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28593 | Slc25a37 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28594 | Slc25a39 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28595 | Stambpl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28596 | Tp53inp1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28597 | Traf3ip2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28598 | C1galt1c1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28599 | Kiaa0319l Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28600 | Ak6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28601 | Mkx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28602 | Mpz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28603 | Nyx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28604 | Scx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28605 | Txk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28606 | Wiz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28607 | Wls Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28608 | Xpa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28609 | Yy2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28610 | A1cf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28611 | Aacs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28612 | Aard Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28613 | Aatk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28614 | Acp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28615 | Acp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28616 | Aff3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28617 | Agmo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28618 | Agps Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28619 | Ahsp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28620 | Aig1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28621 | Akna Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28622 | Alg6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28623 | Alpg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28624 | Ano2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28625 | Apeh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28626 | Aplf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28627 | Arf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28628 | Asb2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28629 | Asip Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28630 | Atf7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28631 | Bag5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28632 | Bcl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28633 | Brox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28634 | Cbr3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28635 | Cct4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28636 | Cds1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28637 | Chat Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28638 | Chdh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28639 | Chgb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28640 | Chkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28641 | Chn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28642 | Cilp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28643 | Cln3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28644 | Cln5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28645 | Cln6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28646 | Clpb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28647 | Clpx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28648 | Cmas Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28649 | Cnn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28650 | Cnn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28651 | Coq3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28652 | Coq5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28653 | Ctr9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28654 | Ctsf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28655 | Cttn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28656 | Ddx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28657 | Dgki Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28658 | Dio3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28659 | Dlg4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28660 | Dlx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28661 | Dlx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28662 | Dmtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28663 | Dnm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28664 | Dnm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28665 | Dok3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28666 | Dolk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28667 | Dpf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28668 | Dpm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28669 | Drp2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28670 | E2f8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28671 | Ect2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28672 | Edc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28673 | Edn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28674 | Ehd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28675 | Ehd4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28676 | Ei24 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28677 | Elk3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28678 | Elp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28679 | Emc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28680 | Emc6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28681 | Enc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28682 | Eny2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28683 | Epg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28684 | Epn3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28685 | Etfa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28686 | Etv4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28687 | Eya1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28688 | Fan1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28689 | Far2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28690 | Fbn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28691 | Fgd6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28692 | Fig4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28693 | Fmo3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28694 | Fmo5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28695 | Fnta Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28696 | Frs2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28697 | Fut9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28698 | Fzr1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28699 | Gab2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28700 | Gas1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28701 | Gbf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28702 | Gbp3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28703 | Gbp6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28704 | Gfm2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28705 | Gjb3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28706 | Gjb6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28707 | Gjc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28708 | Gldn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28709 | Glrb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28710 | Gnaq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28711 | Gnb4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28712 | Gnb5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28713 | Gng3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28714 | Gnl2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28715 | Gpx6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28716 | Gpx8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28717 | Guf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28718 | Hax1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28719 | Hccs Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28720 | Hcn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28721 | Hes7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28722 | Heyl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28723 | Hmx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28724 | Hpdl Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28725 | Hpf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28726 | Hscb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28727 | Ier5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28728 | IGHM Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28729 | Il25 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28730 | Inmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28731 | Ipo9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28732 | Ippk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28733 | Iqub Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28734 | Iws1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28735 | Kif7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28736 | Knl1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28737 | Krt2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28738 | Leo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28739 | Lfng Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28740 | Lgi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28741 | Lgi2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28742 | Lig3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28743 | Lipg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28744 | Lipk Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28745 | Lmo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28746 | Lrba Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28747 | Lst1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28748 | Ltn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28749 | Lyg2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28750 | Mbd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28751 | Mbd5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28752 | Mcm5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28753 | Mcm8 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28754 | Mcm9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28755 | Mfrp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28756 | Mib1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28757 | Miox Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28758 | Misp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28759 | Mlf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28760 | Mmab Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28761 | Mpnd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28762 | Mrm1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28763 | Msh6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28764 | Msi1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28765 | Mtf2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28766 | Mtx1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28767 | Mxd1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28768 | Myf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28769 | Myl6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28770 | Narf Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28771 | Nefh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28772 | Neo1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28773 | Neu2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28774 | Neu3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28775 | Nexn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28776 | Nfix Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28777 | Nfyb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28778 | Nid2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28779 | Nit2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28780 | Nkap Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28781 | Nktr Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28782 | Nmd3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28783 | Nme5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28784 | Noa1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28785 | Noct Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28786 | Nol4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28787 | Nxf5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28788 | Ocln Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28789 | Oxsm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28790 | Pax1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28791 | Pax2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28792 | Pax9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28793 | Pbx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28794 | Pbx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28795 | Pclo Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28796 | Pcp4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28797 | Pdyn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28798 | Pex3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28799 | Pfn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28800 | Pgls Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28801 | Phkb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28802 | Pigq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28803 | Pisd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28804 | Pllp Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28805 | Pmch Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28806 | Pnoc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28807 | Pogz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28808 | Polh Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28809 | Preb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28810 | Prnd Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28811 | Prr7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28812 | Ptms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28813 | Ptx4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28814 | Pum2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28815 | Pus3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28816 | Pygb Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28817 | Rarg Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28818 | Rbm7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28819 | Rbmx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28820 | Rfc1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28821 | Rfc4 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28822 | Rfx2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28823 | Rfx3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28824 | Rfx5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28825 | Rgcc Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28826 | Rhag Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28827 | Rhod Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28828 | Rlim Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28829 | Rnmt Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28830 | Rpl3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28831 | Rpl9 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28832 | Rprm Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28833 | Rps5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28834 | Rpsa Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28835 | Rras Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28836 | Rsu1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28837 | Rtf1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28838 | Rtn2 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28839 | Sbsn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28840 | Scel Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28841 | Scg5 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28842 | Setx Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28843 | Sfpq Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28844 | Sgcz Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28845 | Shc3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28846 | Sit1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28847 | Six6 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28848 | Ska1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28849 | Slu7 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28850 | Smn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28851 | Smtn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28852 | Sox3 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28853 | Spib Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28854 | Sra1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28855 | Srms Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28856 | Strn Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28857 | Sun1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS28858 | Suox Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28859 | Syn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28860 | Syt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28861 | Tbx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28862 | Tbx6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28863 | Tcap Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28864 | Tecr Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28865 | Tgm1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28866 | Tjp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28867 | Tln1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28868 | Tmie Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28869 | Tmx3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28870 | Tns4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28871 | Tox3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28872 | Trir Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28873 | Ubl5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28874 | Ubn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28875 | Utf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28876 | Vav2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28877 | Vmo1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28878 | Vmp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28879 | Vrk3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28880 | Wbp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28881 | Wdr4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28882 | Wnt6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28883 | Wwc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28884 | Wwc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28885 | XIST Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28886 | Zer1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28887 | Zup1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28888 | Abcc9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28889 | Abcd3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28890 | Abcd4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28891 | Abcf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28892 | Acad9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28893 | Acbd6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28894 | Ackr4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28895 | Acot2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28896 | Acot7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28897 | Acsf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28898 | Acsf3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28899 | Acta1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28900 | Actr6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28901 | Adam2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28902 | Adat1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28903 | Adcy5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28904 | Aebp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28905 | Agfg1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28906 | Aipl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28907 | Akap6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28908 | Alg12 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28909 | Alg13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28910 | Alg14 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28911 | Alms1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28912 | Alpk2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28913 | Ap1s2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28914 | Ap2m1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28915 | Apba2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28916 | Aph1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28917 | Aplp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28918 | Arcn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28919 | Arl4c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28920 | Arl8b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28921 | Armh1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28922 | Atg4d Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28923 | Atg9a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28924 | Atg9b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28925 | Atrip Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28926 | Axin1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28927 | Barx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28928 | Baz1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28929 | Bcas1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28930 | Bend5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28931 | Bmp8a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28932 | Brms1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28933 | Bud31 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28934 | C1ql3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28935 | Cabp5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28936 | Capn8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28937 | Cars2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28938 | Casz1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28939 | Cbln4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28940 | Ccar1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28941 | Ccbe1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28942 | Ccdc9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28943 | Ccne2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28944 | Ccpg1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28945 | Cct6a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28946 | Cdc23 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28947 | Cdc34 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28948 | Cdca8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28949 | Cdipt Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28950 | Cdkl4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28951 | Cdr2l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28952 | Celf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28953 | Celf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28954 | Celf4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28955 | Cenpm Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28956 | Cenpx Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28957 | Cep76 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28958 | Cers2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28959 | Chadl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28960 | Chid1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28961 | Chrm4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28962 | Chrnd Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28963 | Chst7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28964 | Chtop Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28965 | Clcn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28966 | Clcn6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28967 | Cldn5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28968 | Cldn8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28969 | Clip4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28970 | Cmya5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28971 | Cnga2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28972 | Cnga3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28973 | Cnot1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28974 | Cnot7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28975 | Cox7c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28976 | Cox8a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28977 | Cpeb2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28978 | Cplx1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28979 | Cpne4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28980 | Crocc Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28981 | Crtap Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28982 | Crtc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28983 | Cul4a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28984 | Cul4b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28985 | Cwc15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28986 | Cxxc4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28987 | Cyren Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28988 | Dcaf4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28989 | Dctn4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28990 | Ddx42 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28991 | Dhx29 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28992 | Dmac1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28993 | Dmrt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28994 | Dmrt3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28995 | Dnah9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28996 | Dstyk Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28997 | Duox1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28998 | Dusp8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS28999 | Dusp9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29000 | Ears2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29001 | Edem1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29002 | Edem3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29003 | Efhd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29004 | Eif3h Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29005 | Eif5b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29006 | Elfn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29007 | Elfn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29008 | Elmo1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29009 | Endou Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29010 | Enpp5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29011 | Epb41 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29012 | Eps15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29013 | Eral1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29014 | Ercc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29015 | Ercc8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29016 | Esyt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29017 | Esyt2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29018 | Etaa1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29019 | Eva1a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29020 | Exoc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29021 | Exph5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29022 | Fam3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29023 | Fbln5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29024 | Fbxl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29025 | Fbxo7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29026 | Fcrl2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29027 | Fem1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29028 | Fhod3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29029 | Fibin Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29030 | Fkbp9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29031 | Fmnl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29032 | Fndc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29033 | Foxb1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29034 | Foxc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29035 | Foxn3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29036 | Foxo6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29037 | Foxp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29038 | Fstl4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29039 | Ftsj3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29040 | Fubp3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29041 | Fut11 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29042 | Fxyd5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29043 | Fxyd7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29044 | Galr3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29045 | Ghitm Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29046 | Gins2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29047 | Gipc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29048 | Glra1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29049 | Glrx5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29050 | Glyr1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29051 | Gmpr2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29052 | Gna15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29053 | Gnai1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29054 | Gng11 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29055 | Gpm6a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29056 | Gpr45 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29057 | Gpr63 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29058 | Gpsm2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29059 | Grb10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29060 | Grik1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29061 | Grsf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29062 | Gstm4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29063 | Gstt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29064 | Habp4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29065 | Hacd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29066 | Hace1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29067 | Hacl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29068 | Hddc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29069 | Hecw1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29070 | Hemk1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29071 | Herc4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29072 | Hhatl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29073 | Hinfp Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29074 | Hint2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29075 | Hmcn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29076 | Hoga1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29077 | Hoxa2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29078 | Hoxa3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29079 | Hoxb5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29080 | Hoxb6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29081 | Hoxb8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29082 | Hoxc6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29083 | Htra4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29084 | Hvcn1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29085 | Iars2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29086 | Idh3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29087 | Idh3g Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29088 | Ifi44 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29089 | Ifrd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29090 | Igll1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29091 | Il21r Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29092 | Ilvbl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29093 | Insm2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29094 | Iqcb1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29095 | Itgad Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29096 | Itih4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29097 | Itm2a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29098 | Itpkc Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29099 | Josd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29100 | Kat6b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29101 | Kcna3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29102 | Kcnc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29103 | Kcne5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29104 | Kcnj3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29105 | Kcnj8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29106 | Kcns1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29107 | Kcnt1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29108 | Kcnt2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29109 | Kctd4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29110 | Kctd9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29111 | Kif2b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29112 | Kif3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29113 | Kif3b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29114 | Kif3c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29115 | Kif5c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29116 | Klf13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29117 | Klf14 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29118 | Kpna1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29119 | Krt81 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29120 | Lamc3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29121 | Lasp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29122 | Lemd3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29123 | Limd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29124 | Lin37 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29125 | Lipt2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29126 | Llgl2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29127 | Lman1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29128 | Lpin2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29129 | Lrfn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29130 | Lrfn4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29131 | Lrig3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29132 | Lrit3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29133 | Lrp1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29134 | Luzp4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29135 | Lzts1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29136 | Macf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29137 | Magi2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29138 | Maml2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29139 | Maml3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29140 | Mast1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29141 | Mast4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29142 | Mbnl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29143 | Mccc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29144 | Mcf2l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29145 | Mcur1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29146 | Med19 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29147 | Medag Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29148 | Megf6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29149 | Megf9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29150 | Meis2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29151 | Mex3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29152 | Mfsd9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29153 | Mgst2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29154 | Mipep Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29155 | Mixl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29156 | Mkrn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29157 | Mlst8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29158 | Mmp15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29159 | Mmp16 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29160 | Mms19 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29161 | Morc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29162 | Mov10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29163 | Mrap2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29164 | Mrpl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29165 | Ms4a8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29166 | Mtch1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29167 | Mtcl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29168 | Mtmr4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29169 | Mtus1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29170 | Muc13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29171 | Mus81 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29172 | Mutyh Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29173 | Myadm Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29174 | Myh10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29175 | Mylk3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29176 | Mylk4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29177 | Myo3a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29178 | Myo3b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29179 | Myo9b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29180 | Myoz2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29181 | Nabp1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29182 | Nagpa Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29183 | Naprt Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29184 | Nars1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29185 | Nat8l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29186 | Ncoa1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29187 | Ndrg3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29188 | Ndrg4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29189 | Ndst4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29190 | Neil3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29191 | Nfrkb Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29192 | Nim1k Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29193 | Nlgn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29194 | Nmrk1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29195 | Nop14 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29196 | Nop56 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29197 | Npas1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29198 | Nr1h3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29199 | Nr1i2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29200 | Nr2c1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29201 | Nr2c2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29202 | Nr6a1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29203 | Nrbf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29204 | Nrip1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29205 | Nsmaf Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29206 | Nsun4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29207 | Nsun5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29208 | Nsun6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29209 | Nudt8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29210 | Numbl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29211 | Nup42 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29212 | Nup88 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29213 | Nyap1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29214 | Ogdhl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29215 | Or2k2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29216 | Orai2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29217 | Otogl Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29218 | Ovch2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29219 | Ovol2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29220 | Oxgr1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29221 | Palmd Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29222 | Pank3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29223 | Pars2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29224 | Pcgf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29225 | Pcsk6 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29226 | Pde6d Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29227 | Pdia2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29228 | Pdss1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29229 | Pdss2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29230 | Pdzd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29231 | Pdzd4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29232 | Pdzd7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29233 | Peli2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29234 | Pfdn2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29235 | Pgbd5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29236 | Phf12 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29237 | Phf19 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29238 | Phf23 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29239 | Phf24 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29240 | Phka1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29241 | Phkg2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29242 | Phrf1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29243 | Pias2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29244 | Pitx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29245 | Plcb2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29246 | Plek2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29247 | Plvap Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29248 | Pole2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29249 | Polg2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29250 | Ppm1f Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29251 | Ppm1h Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29252 | Ppm1j Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29253 | Ppp4c Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29254 | Pprc1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29255 | Prdm8 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29256 | Prorp Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29257 | Prrx2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29258 | Psip1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29259 | Psmb1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29260 | Psmb7 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29261 | Psmc5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29262 | Psmd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29263 | Psmd2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29264 | Psmd3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29265 | Ptch2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29266 | Ptcra Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29267 | Ptprq Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29268 | Ptprr Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29269 | Puf60 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29270 | Pxmp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29271 | Qrsl1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29272 | Rab1a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29273 | Rab21 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29274 | Rab28 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29275 | Rab34 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29276 | Rab35 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29277 | Rab42 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29278 | Rab8a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29279 | Rabl3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29280 | Rap1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29281 | Rasa1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29282 | Rbm10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29283 | Rbm25 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29284 | Rbm33 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29285 | Rbm34 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29286 | Rbms3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29287 | Rcor2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29288 | Rell2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29289 | Rgs10 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29290 | Rgs22 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29291 | Rmdn3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29292 | Rnf13 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29293 | Rnft2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29294 | Rpe65 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29295 | Rpl12 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29296 | Rpl18 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29297 | Rpl24 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29298 | Rpl26 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29299 | Rpl37 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29300 | Rpl38 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29301 | Rps15 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29302 | Rps18 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29303 | Rras2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29304 | Rrp7a Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29305 | Rsrc2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29306 | Samd1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29307 | Samd5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29308 | Samd9 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29309 | Sardh Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29310 | Scml4 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29311 | Scn1b Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29312 | Scrg1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29313 | Sel1l Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29314 | Serf2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29315 | Sf3a2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29316 | Sftpb Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29317 | Sgpp2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29318 | Sh2b3 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29319 | Siah1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29320 | Skap1 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29321 | Skap2 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29322 | Slfn5 Rat Pre-designed siRNA Set A | Reference compound | |
| HY-RS29442A | Nsun2 Mouse Pre-designed siRNA Set A-2 | Oligonucleotides | |
| HY-RS29445 | Ndufaf6 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29447 | Plin4 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29447A | Plin4 Mouse Pre-designed siRNA Set A-2 | Oligonucleotides | |
| HY-RS29450 | Rab17 Mouse Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29451 | Actg1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29452 | Plekhn1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29453 | Ctnna1 Rat Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29454 | UBE2E1 Pig Pre-designed siRNA Set A | Oligonucleotides | |
| HY-RS29455 | UBE2E2 Pig Pre-designed siRNA Set A | Oligonucleotides | |
| HY-W007732B | Cyclohexane-1,4-diamine | 3114-70-3 | Reference compound |
| HY-W008125S | Acetobromo-a-D-glucuronic acid-13C6 methyl ester | Isotope-Labeled Compounds | |
| HY-W008614S1 | Lansoprazole sulfone-13C6 | 1261398-50-8 | Isotope-Labeled Compounds |
| HY-W009071 | 1,5-Naphthalenedisulfonic acid (tetrahydrate) | 211366-30-2 | Reference compound |
| HY-W011565S | 3,6-Di-tert-butyl-9H-carbazole-d6 | 2650519-91-6 | Isotope-Labeled Compounds |
| HY-W011577S1 | Dibenzo[a,c]anthracene-13C6 | Isotope-Labeled Compounds | |
| HY-W011657 | tert-Butyl 4-(bromomethyl)benzoate | 108052-76-2 | Reference compound |
| HY-W012890 | Pentanehydrazide | 38291-82-6 | Reference compound |
| HY-W014230 | 1,4-Bis(trifluoromethyl)benzene | 433-19-2 | Reference compound |
| HY-W014883 | 1,12-Dodecanediamine | 2783-17-7 | Reference compound |
| HY-W014895S | Ethyl tosylate-d5 | 59034-23-0 | Isotope-Labeled Compounds |
| HY-W018475B | Rizatriptan (hemisulfate hemihydrate) | 159776-67-7 | Reference compound |
| HY-W021040S | Fludioxonil-13C3 | 1185003-07-9 | Isotope-Labeled Compounds |
| HY-W024986S | 4-(4-Hexoxyphenyl)benzonitrile-13C6 | Isotope-Labeled Compounds | |
| HY-W025916 | Methanol-d1 | 1455-13-6 | Reference compound |
| HY-W026772S1 | Fluorene-d8 | 35782-21-9 | Isotope-Labeled Compounds |
| HY-W067615 | Phenyl-boronic acid-d5 | 215527-70-1 | Reference compound |
| HY-W089091 | Cispentacin | 122672-46-2 | Reference compound |
| HY-W091739 | Ethanol-d6 | 1516-08-1 | Reference compound |
| HY-W094747A | Benzalazine | 588-68-1 | Reference compound |
| HY-W1008621 | GalNAc-THA C6 phosphoramidite | 2058062-52-3 | Biochemical Assay Reagents |
| HY-W1116287 | N-Acetyl-Sar24 | 2313534-28-8 | Peptides |
| HY-W114750 | MPTP | 28289-54-5 | Reference compound |
| HY-W150958S | Backebergine-d6 | Isotope-Labeled Compounds | |
| HY-W158030 | 2-Guanidinobezimidazole | 5418-95-1 | Reference compound |
| HY-W175543 | Methoxyurea | 3272-27-3 | Reference compound |
| HY-W248907 | Gentisyl alcohol | 495-08-9 | Reference compound |
| HY-W249514 | 1-Methyl-1H-pyrazole-4-boronic acid pinacol ester-d3 | 1022151-50-3 | Reference compound |
| HY-W250381S1 | Sodium deuteroxide, (D,99.5%, basicity 30%) | 14014-06-3 | Isotope-Labeled Compounds |
| HY-W275220 | PEA-NBOMe (hydrochloride) | 3241-03-0 | Reference compound |
| HY-W286362 | Palmitanilide | 6832-98-0 | Reference compound |
| HY-W287494 | Antitumor agent-202 | 38470-63-2 | Reference compound |
| HY-W319939 | 3-(4-Hydroxy-3-methoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one | 104236-73-9 | Reference compound |
| HY-W329071 | Rose Bengal | 11121-48-5 | Reference compound |
| HY-W419331 | Methionyl-methionine | 52715-93-2 | Reference compound |
| HY-W440914A | DSPE-PEG-FITC (MW 400) | 1000788-53-3 | Dye Reagents |
| HY-W440914B | DSPE-PEG-FITC (MW 10000) | 1000788-53-3 | Dye Reagents |
| HY-W441009A | DSPE-PEG-Maleimide (MW 3400) (ammonium) | Biochemical Assay Reagents | |
| HY-W441968 | L-threo-β-Hydroxyaspartic acid | 7298-98-8 | Reference compound |
| HY-W473763 | 3-Methoxy-2,5-toluquinone | 611-68-7 | Reference compound |
| HY-W516943 | CI-624 | 700-07-2 | Reference compound |
| HY-W553071 | Cytoxazone | 42902-32-9 | Natural Products |
| HY-W588187 | Coprostanone | 601-53-6 | Reference compound |
| HY-W613220 | MDH1/2-IN-1 | 2143473-95-2 | Reference compound |
| HY-W664041 | Noncatechol agonist-1 | 1609580-99-5 | Reference compound |
| HY-W671129 | Frenolicin B | 68930-68-7 | Natural Products |
| HY-W698254 | Fluopsin F | 31323-26-9 | Natural Products |
| HY-W700793 | 2-Methyl-3-(trifluoromethyl)aniline-d3 | 1189989-60-3 | Isotope-Labeled Compounds |
| HY-W700927 | N-Formyl-L-leucine-d3 | 1356930-28-3 | Isotope-Labeled Compounds |
| HY-W702106 | 2-Methyl estradiol | 1818-12-8 | Natural Products |
| HY-W703279 | (R)-(+)-Pantoprazole (sodium) | 160098-11-3 | Reference compound |
| HY-W703540 | Deracoxib-d4 | 1794780-24-7 | Isotope-Labeled Compounds |
| HY-W703549 | Aderbasib-d3 | Isotope-Labeled Compounds | |
| HY-W704076 | Glyceryl monostearate-d5 | 1432065-28-5 | Isotope-Labeled Compounds |
| HY-W704866 | Glycidyl caprylate-d15 | 2514835-46-0 | Isotope-Labeled Compounds |
| HY-W705479 | Pazopanib-d3 (hydrochloride) | 2469755-67-5 | Isotope-Labeled Compounds |
| HY-W705589 | Rimeporide-15N3 (hydrochloride) | Isotope-Labeled Compounds | |
| HY-W707384 | Candesartan Cilexetil-d11 | 1261393-19-4 | Isotope-Labeled Compounds |
| HY-W710512 | Propane-1,2,3-triyl tritricosanoate-d5 | Isotope-Labeled Compounds | |
| HY-W710753 | D,L-Sulforaphane glutathione-d5 | Isotope-Labeled Compounds | |
| HY-W711852 | Benzamide-d5 | 1235489-47-0 | Isotope-Labeled Compounds |
| HY-W713365 | Eltrombopag-d3 | 1133710-20-9 | Isotope-Labeled Compounds |
| HY-W714121 | Germicidin A | 151271-57-7 | Natural Products |
| HY-W715538 | Rhetsinine | 526-43-2 | Natural Products |
| HY-W717863 | Oximino Oxamyl-d6 | 2734501-51-8 | Isotope-Labeled Compounds |
| HY-W722081 | Baumycin C1 | 63084-42-4 | Natural Products |
| HY-W722107 | Timonacic-d4 | 3066050-54-9 | Isotope-Labeled Compounds |
| HY-W726164 | Gentamicin A | 13291-74-2 | Natural Products |
| HY-W727525 | Donepezil-d7 | 1215071-00-3 | Isotope-Labeled Compounds |
| HY-W727893 | Taurine-15N | 127041-63-8 | Isotope-Labeled Compounds |
| HY-W728096 | Migalastat-d5 | Isotope-Labeled Compounds | |
| HY-W736195 | 5-Hydroxy-4-oxo-L-norvaline | 26911-39-7 | Natural Products |
| HY-W739944 | Ambroxol-d5 | 1246818-80-3 | Isotope-Labeled Compounds |
| HY-W740028 | Cefditoren-d3 (sodium) | Isotope-Labeled Compounds | |
| HY-W743781 | N-Nitrosonornicotine-d4 | 1426174-36-8 | Isotope-Labeled Compounds |
| HY-W744124 | 4'-Fluoroacetophenone-d4 | 1335333-86-2 | Isotope-Labeled Compounds |
| HY-W747097 | Sacubitrilat-13C4 | Isotope-Labeled Compounds | |
| HY-W747703 | Hippuric acid-13C6 | 1163160-18-6 | Isotope-Labeled Compounds |
| HY-W748030 | Griseoviridin | 53216-90-3 | Natural Products |
| HY-W748035 | Etamycin A | 299-20-7 | Natural Products |
| HY-W749297 | Bleomycin B2 | 9060-10-0 | Natural Products |
| HY-W749691 | (S)-Velpatasvir-13c,d3 | Isotope-Labeled Compounds | |
| HY-W750342 | Tryptophol-d4 | 75238-45-8 | Isotope-Labeled Compounds |
| HY-W750902 | Oxymatrine-d3 | 2714484-46-3 | Isotope-Labeled Compounds |
| HY-W751574 | Elagolix-d6 (sodium) | Isotope-Labeled Compounds | |
| HY-W754718 | Azepinomycin | 89354-15-4 | Natural Products |
| HY-W754911 | Avapritinib-d3 | 2408934-57-4 | Isotope-Labeled Compounds |
| HY-W759629 | Selpercatinib-d3 | 2433775-55-2 | Isotope-Labeled Compounds |
| HY-W759845 | Aficamten-d3 | Isotope-Labeled Compounds | |
| HY-W765182 | Emamectin-d3 | Isotope-Labeled Compounds | |
| HY-W767656 | Dropropizine-d4 | 2514953-45-6 | Isotope-Labeled Compounds |
| HY-W774926 | Permethrin-d6 | 82523-59-9 | Isotope-Labeled Compounds |
| HY-W777166 | Aprepitant-13C2,d2 (Major) | 1217676-37-3 | Isotope-Labeled Compounds |
| HY-W779019 | Xylose-13C5 | 1262683-58-8 | Isotope-Labeled Compounds |
| HY-W779021 | Adenosine-15N | 41547-82-4 | Isotope-Labeled Compounds |
| HY-W780198 | Endophenazine A | 86125-71-5 | Natural Products |
| HY-W780199 | Endophenazine B | 479415-40-2 | Natural Products |
| HY-W992934S | Indolylacryloylglycine-d2 | Isotope-Labeled Compounds | |
| HY-W998675 | 5-FITC-Tetrazine | 2264035-11-0 | Dye Reagents |
| HY-Y0785 | Glyoxal | 107-22-2 | Reference compound |
| HY-Y1058 | Benzohydroxamic acid | 495-18-1 | Reference compound |
| HY-Y1275S | N-Methylpyrrolidone-d9 | 185964-60-7 | Isotope-Labeled Compounds |
| HY-Z16212 | Neomycin F | 51795-47-2 | Natural Products |
| HY-Z17187 | Feudomycin A | 79466-09-4 | Natural Products |
| HY-Z4707 | Etoricoxib N1'-oxide | 325855-74-1 | Reference compound |
| HY-Z5058A | (3S,5S)-Fluvastatin (sodium) | 194935-01-8 | Reference compound |
| HY-Z6848 | (R)-(+)-Bupivacaine (hydrochloride) | 27262-46-0 | Reference compound |
| HY-Z7082 | Perindopril (L-arginine) | 612548-45-5 | Reference compound |
| HY-Z7592 | (E)-Cefodizime | 97180-26-2 | Reference compound |
| HY-Z7640 | 4-Desmethyl-2-methyl celecoxib | 170569-99-0 | Reference compound |
| HY-101177 | Naltrindole (hydrochloride) | 111469-81-9 | Reference compound |
| HY-102022G | α-Galactosylceramide (GMP) | 158021-47-7 | Reference compound |
| HY-103701G | L-Ascorbic acid 2-phosphate (GMP) | 23313-12-4 | Reference compound |
| HY-104024 | MMP-9-IN-10 | 1177749-58-4 | Reference compound |
| HY-106950AR | Fosfructose (trisodium) (Standard) | 38099-82-0 | Reference compound |
| HY-107222 | Lysionotin1 | 152743-19-6 | Reference compound |
| HY-107299 | Trichilinin D | 220698-24-8 | Reference compound |
| HY-107383R | Tetrahydrobiopterin (Standard) | 17528-72-2 | Reference compound |
| HY-10787S | Ximelagatran-d11 | Reference compound | |
| HY-108729 | Tripeptidyl aminopeptidase | 151662-36-1 | Reference compound |
| HY-109155 | Paltusotine | 2172870-89-0 | Reference compound |
| HY-109155A | Paltusotine (hydrochloride) | 2172875-40-8 | Reference compound |
| HY-109545S | Isopropyl unoprostone-d15 | Reference compound | |
| HY-109551 | Lutropin | 152923-57-4 | Reference compound |
| HY-112490R | Atorvastatin (calcium hydrate) (Standard) | 344423-98-9 | Reference compound |
| HY-113159R | Docosapentaenoic acid (22n-3) (Standard) | 24880-45-3 | Reference compound |
| HY-113325R | NADP (Standard) | 53-59-8 | Reference compound |
| HY-113607 | Asimicin | 102989-24-2 | Reference compound |
| HY-116538R | (10E,12Z)-Octadeca-10,12-dienoic acid (Standard) | 2420-56-6 | Reference compound |
| HY-116659 | Melianone | 6553-27-1 | Reference compound |
| HY-116738S | Trimecaine-d10 (hydrochloride) | 1346603-63-1 | Reference compound |
| HY-117215R | β-Ocimene (Standard) | 13877-91-3 | Reference compound |
| HY-117506B | SBFI-26 | 1541207-06-0 | Reference compound |
| HY-117882S | Piperiacetildenafil-d10 | Reference compound | |
| HY-118333 | Regelin | 109974-21-2 | Reference compound |
| HY-121222R | alpha-Bisabolol (Standard) | 515-69-5 | Reference compound |
| HY-121472 | (+)-Ledene | 21747-46-6 | Reference compound |
| HY-121615R | α-Phellandrene (Standard) | 99-83-2 | Reference compound |
| HY-122807 | Quadrone | 66550-08-1 | Reference compound |
| HY-123224 | Rabdoternin B | 128887-81-0 | Reference compound |
| HY-123439S | FTY720-C2-d4 | 2732981-54-1 | Reference compound |
| HY-125337 | SC4453 | 59712-21-9 | Reference compound |
| HY-125781 | Carbocyclic thromboxane A2 | 74034-56-3 | Reference compound |
| HY-127057 | Lambertianic acid | 4966-13-6 | Reference compound |
| HY-128449R | Cephradine (monohydrate) (Standard) | 75975-70-1 | Reference compound |
| HY-128477 | AUTEN-67 (inner salt) | 301154-74-5 | Reference compound |
| HY-130067 | Lolitrem B | 81771-19-9 | Reference compound |
| HY-132330S | 4-Hydroxy alverine-d5 | 1216415-67-6 | Reference compound |
| HY-132414S | Melatonin-d3-1 | 60418-64-6 | Reference compound |
| HY-132603 | AB-729 | 2634739-74-3 | Reference compound |
| HY-132603A | AB-729 (sodium) | 2826248-50-2 | Reference compound |
| HY-133648 | Bromochloroacetaldehyde | 98136-99-3 | Reference compound |
| HY-135171 | Antibiotic JI 20A | 51846-97-0 | Reference compound |
| HY-13678R | Meropenem (Standard) | 96036-03-2 | Reference compound |
| HY-13715CR | Norepinephrine (tartrate) (Standard) | 51-40-1 | Reference compound |
| HY-13756AR | Tacrolimus (monohydrate) (Standard) | 109581-93-3 | Reference compound |
| HY-138022 | Orobanchyl acetate | 1413843-71-6 | Reference compound |
| HY-138800R | Spinosad (Standard) | 168316-95-8 | Reference compound |
| HY-139450 | Atirmociclib | 2380321-51-5 | Reference compound |
| HY-142109S | Dimethyl N-(p-aminobenzoyl)-L-glutamate-d4 | Reference compound | |
| HY-142110S | N-Carbamoyl Oxcarbazepine-d4 | Reference compound | |
| HY-142136S | N-Didestethyl chloroquine phthalimide-d4 | Natural Products | |
| HY-142138S | N-Boc-(p-aminobenzoyl)-L-glutamic acid dimethyl ester-d4 | Natural Products | |
| HY-142148S | Flurbiprofen acyl-β-D-glucuronide-d3 | Natural Products | |
| HY-142166S | (Rac)-cis-N-Desmethyl Sertraline-d4 (hydrochloride) | Natural Products | |
| HY-142206S | 10-O-Acetyl SN-38-d3 | Natural Products | |
| HY-142385S | Meprednisone 17,21-dipropionate-d10 | Natural Products | |
| HY-142439S | 21-O-Acetyl 6α-hydroxy cortisol-d4 | Reference compound | |
| HY-142747S | o-Tolyl phosphorochloridate-d14 | Reference compound | |
| HY-142787S | Di-m-tolyl phosphate-d14 | Reference compound | |
| HY-143209 | DSPE-PEG | 145035-96-7 | Reference compound |
| HY-144342S | N-Acetyl-S-(2,2-dichloroethenyl)-L-cysteine-13C,d3 | 1795787-09-5 | Reference compound |
| HY-14542AR | Ziprasidone (hydrochloride) (Standard) | 122883-93-6 | Reference compound |
| HY-146255 | Apoptosis inducer 10 | 2379310-39-9 | Reference compound |
| HY-147403S | Tebideutorexant | 1637681-55-0 | Reference compound |
| HY-149066 | Diaporthein B | 577705-64-7 | Reference compound |
| HY-14956R | Nemonoxacin (Standard) | 378746-64-6 | Reference compound |
| HY-150216 | ODN 105871 | 1965342-41-9 | Reference compound |
| HY-150216A | ODN 105871 (sodium) | Reference compound | |
| HY-150351 | HOSU-53 | 2659233-17-5 | Reference compound |
| HY-153572 | Homo-BacPROTAC7 | Reference compound | |
| HY-153639 | Tyrosine-PEG4-aminooxy-MMAF | Reference compound | |
| HY-156877 | Bcl-2-IN-16 | 2858632-01-4 | Reference compound |
| HY-157474 | (-)-Verrucarol | 2198-92-7 | Reference compound |
| HY-158081 | Atumelnant | 2392970-97-5 | Reference compound |
| HY-158710 | 1-Palmitoyl-2-pyropheophorbide a-sn-glycero-3-pc | 1287795-07-6 | Reference compound |
| HY-159702 | Eudragit RS 100 | 33434-24-1 | Reference compound |
| HY-159719 | NLRP3-IN-51 | 3067572-29-3 | Reference compound |
| HY-160024 | XIAP BIR2/BIR2-3 inhibitor-2 | 1609384-83-9 | Reference compound |
| HY-160574 | CoPoP | 2805223-60-1 | Reference compound |
| HY-161032 | IP6K2-IN-1 | 2926679-10-7 | Reference compound |
| HY-161592 | Tramadol/BSA | Reference compound | |
| HY-162556 | (+)-Desmethylxestospongin B | 144789-03-7 | Reference compound |
| HY-163557 | Ketamine/BSA | Reference compound | |
| HY-16403S | Polythiazide-d3 | 2124275-40-5 | Reference compound |
| HY-165542 | 9-cis-Astaxanthin | 113085-04-4 | Reference compound |
| HY-165917 | 1,2-Dipalmitoleoyl-sn-glycero-3-phosphatidylcholine | 56815-99-7 | Reference compound |
| HY-166673 | DSPE-PEG-Cy5.5 (MW 2000) | Reference compound | |
| HY-167001 | PLGA10000-PEG1000-VS | Reference compound | |
| HY-168000 | TREX1-IN-2 | 2580192-18-1 | Reference compound |
| HY-169121 | DA-143 | Reference compound | |
| HY-169417 | Euphjatrophane M | Reference compound | |
| HY-169712 | FGFR1 inhibitor-12 | 956782-57-3 | Reference compound |
| HY-169747 | Benfooxythiamine | 909542-99-0 | Reference compound |
| HY-170876 | UX4O | 25747-29-9 | Reference compound |
| HY-173157 | Analgesic/antidepressant agent-1 | Reference compound | |
| HY-173346 | Mandimycin | Reference compound | |
| HY-17409R | Nystatin (Standard) | 1400-61-9 | Reference compound |
| HY-17566R | Capreomycin (sulfate) (Standard) | 1405-37-4 | Reference compound |
| HY-17571AR | Oxytocin (acetate) (Standard) | 6233-83-6 | Reference compound |
| HY-19792S1 | Mertansine-d9 | Reference compound | |
| HY-42326S | 4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-(isobutyl-d9)benzenesulfonamide | 1146967-60-3 | Reference compound |
| HY-76022S | 2,5-Bis(2,2,2-trifluoroethoxy)benzoic acid-d4 | Reference compound | |
| HY-77918S | O-Desbromo-pyrimidinyl Macitentan-d4 | Reference compound | |
| HY-78816S | 2-[(2,6-Dichlorobenzyl)oxy]ethanol-d4 | Reference compound | |
| HY-A0013R | Bosentan (Standard) | 147536-97-8 | Reference compound |
| HY-A0104H | HPMC (Type II,Viscosity:15000mPa.s) | 9004-65-3 | Reference compound |
| HY-B0166GLR | L-Ascorbic acid (GMP Like) (Standard) | 50-81-7 | Reference compound |
| HY-B0419S1 | S-(+)-Manidipine-d4 | 1217836-12-8 | Reference compound |
| HY-B0617S1 | S-Adenosyl-L-methionine-13C | 74084-24-5 | Reference compound |
| HY-B0765S | Dehydroepiandrosterone sulfate (sodium)-13C3 | Reference compound | |
| HY-B2003 | Ethyln valerate | 539-82-2 | Reference compound |
| HY-D0110 | Fura-2 | 96314-98-6 | Reference compound |
| HY-D0848A | N,N'-Methylenebisacrylamide,for electrophoresis,≥99.0% | 110-26-9 | Reference compound |
| HY-D1005A18 | Poloxamer 288 (F98) | 9003-11-6 | Reference compound |
| HY-D1638 | Biocytin Lucifer Yellow (potassium) | Reference compound | |
| HY-D2319 | Mito Flipper-TR 27 | 2334078-40-7 | Reference compound |
| HY-D2422 | Cy7-Paclitaxel | Reference compound | |
| HY-E70195 | α-Lytic protease | 37288-76-9 | Reference compound |
| HY-I0344S2 | Benzenamine-d7 | 14545-23-4 | Reference compound |
| HY-N0052R | Sanguinarine (Standard) | 2447-54-3 | Reference compound |
| HY-N0184S | Glycyrrhizic acid-d3 | Reference compound | |
| HY-N0689 | Evodine | 6989-38-4 | Reference compound |
| HY-N0708S | Vanillic acid-d3 | 2733717-19-4 | Reference compound |
| HY-N0776S | Isorhamnetin-d3 | Reference compound | |
| HY-N10072 | Gardenolic acid B | 108864-53-5 | Reference compound |
| HY-N10428 | Ganoapplanoid F | 2758812-34-7 | Reference compound |
| HY-N10558 | PM050489 | 960210-97-3 | Reference compound |
| HY-N10562 | Mutabilol | Reference compound | |
| HY-N10932 | Lucidenic acid K | 110241-31-1 | Reference compound |
| HY-N1104 | Vandrikidine | 50656-92-3 | Reference compound |
| HY-N11271 | γ-Muurolene | 30021-74-0 | Reference compound |
| HY-N11858 | Demethomycin | 127984-76-3 | Reference compound |
| HY-N12089 | Polyoxin A | 19396-03-3 | Reference compound |
| HY-N12214 | Sartorypyrone D | 1801167-48-5 | Reference compound |
| HY-N1273 | Secaubrytriol | 925932-10-1 | Reference compound |
| HY-N12969 | 1,3,8-p-Menthatriene | 18368-95-1 | Reference compound |
| HY-N12983 | β-Bourbonene | 5208-59-3 | Reference compound |
| HY-N13201 | 12-Deoxyphorbol 13-palmitate | 66583-59-3 | Reference compound |
| HY-N13872 | Ammocidin | 376590-20-4 | Reference compound |
| HY-N13910 | Alnumycin | 207225-51-2 | Reference compound |
| HY-N13914 | Alteichin | 88899-62-1 | Reference compound |
| HY-N14695 | Korormicin | 200433-05-2 | Reference compound |
| HY-N14727 | Primycin | 47917-41-9 | Reference compound |
| HY-N14939 | Australifungin | 155468-85-2 | Reference compound |
| HY-N1497S | Plumbagin-d3 | 2733215-81-9 | Reference compound |
| HY-N15252 | Eutypenes I | Reference compound | |
| HY-N15274 | Cicutoxin | 505-75-9 | Reference compound |
| HY-N15361 | Palythine | 67731-19-5 | Reference compound |
| HY-N1860S | 3-O-Methylquercetin-d3 | Reference compound | |
| HY-N2042 | Cimigenol-3-O-α-L-arabinoside | 161207-05-2 | Reference compound |
| HY-N2629 | Erigoster B | 849777-61-3 | Reference compound |
| HY-N2727 | 6-O-p-Methoxycinnamoylcatalpol | 121710-02-9 | Reference compound |
| HY-N3130 | Oplodiol | 13902-62-0 | Reference compound |
| HY-N3178 | Norfluorocurarine | 6880-54-2 | Reference compound |
| HY-N3313 | Masticadienolic acid | 472-30-0 | Reference compound |
| HY-N3930 | Gardenoin J | 1345109-46-7 | Peptides |
| HY-N6696 | Aflatoxin B2 | 7220-81-7 | Peptides |
| HY-N6697 | Aflatoxin G1 | 1165-39-5 | Peptides |
| HY-N6697S | Aflatoxin G1-13C17 | 1217444-07-9 | Peptides |
| HY-N6698S | Aflatoxin G2-13C17 | 1217462-49-1 | Peptides |
| HY-N6999 | Soyasaponin Ac | 133882-74-3 | Peptides |
| HY-N7036S | Rhamnetin-d3 | Reference compound | |
| HY-N7382 | Laburnetin | 166375-17-3 | Reference compound |
| HY-N7446 | Orobanchol | 220493-65-2 | Reference compound |
| HY-N7723 | Avenacin A-1 | 90547-90-3 | Reference compound |
| HY-N7726 | 26-O-Acetylsootepin A | 1772588-99-4 | Reference compound |
| HY-N7767 | Ergocornine | 564-36-3 | Reference compound |
| HY-N8350 | Uncarinic acid E | 277751-61-8 | Reference compound |
| HY-N8524 | 6-Ethoxygeniposide | 1264496-61-8 | Reference compound |
| HY-N8592 | 4-O-Galloylquinic acid | 110170-37-1 | Reference compound |
| HY-N9038 | 4',4''-Dihydroxyanigorootin | 448949-11-9 | Reference compound |
| HY-P10890 | HBpep(RPY)-SP | Reference compound | |
| HY-P10890A | HBpep(RPY)-SP (TFA) | Reference compound | |
| HY-P1653 | EC-1456 | 1602487-16-0 | Reference compound |
| HY-P2364 | Leucinostatin B | 76663-52-0 | Reference compound |
| HY-P4200 | Lugdunin | 1989698-37-4 | Reference compound |
| HY-P6020 | HBpep-SA | Reference compound | |
| HY-P6020A | HBpep-SA (TFA) | Reference compound | |
| HY-P6020B | HBpep-SA (acetate) | Reference compound | |
| HY-P6021 | HBpep-SP | Reference compound | |
| HY-P6021A | HBpep-SP (TFA) | Reference compound | |
| HY-P700590 | CSNK1E, Human (P. pastoris, His) | Reference compound | |
| HY-P700596 | CSNK2A1, Human (His-SUMO) | Reference compound | |
| HY-P700643 | HER2/CD340, Human (Biotinylated, Domain 4, HEK 293, His-Avi) | Reference compound | |
| HY-P701257 | PE-Labeled HLA-A*0201 NY-ESO-1 Complex Tetramer, Human (SLLMWITQV, HEK293) | Reference compound | |
| HY-P701510 | TRIM69, Human (GST) | Reference compound | |
| HY-P701798 | MAP2K7, Human (Sf9) | Reference compound | |
| HY-P701799 | MAP2K7, Human (Sf9, His, GST) | Reference compound | |
| HY-P702024 | SLC40A1, Human (Sf9, His, MBP, FLAG) | Reference compound | |
| HY-P702200 | ADIPOR1, Human (Cell-Free, His, Flag) | Reference compound | |
| HY-P702785 | FOXC1, Human (His) | Reference compound | |
| HY-P702813 | NLRP6, Human (Sf9, His, MBP) | Reference compound | |
| HY-P703085 | ARG, Human (Sf9, GST) | Reference compound | |
| HY-P703110 | CYLD, Human (Sf9, GST) | Reference compound | |
| HY-P703294 | SLC7A9, Human (HEK293, His, MBP, Flag) | Reference compound | |
| HY-P704091 | F-spondin, Mouse | Reference compound | |
| HY-P71171 | NRG1-beta 1, Human (65a.a) | Reference compound | |
| HY-P7128 | Adiponectin/Acrp30, Human | Reference compound | |
| HY-P71531 | SKP2, Human (His-SUMO) | Reference compound | |
| HY-P72058 | Enterotoxin type E, S. aureus (sf9, His) | Reference compound | |
| HY-P73556A | VEGF145 Protein, Human (HEK293) | Reference compound | |
| HY-P76081 | SMYD3, Human (HEK293, His-Flag) | Reference compound | |
| HY-P76218 | CD299, Human (HEK293) | Reference compound | |
| HY-P78957 | Dihydroorotate Dehydrogenase, Human (His) | Reference compound | |
| HY-P7S1169 | IL-4, Canine (Biotinylated, Avi) | Reference compound | |
| HY-P990375 | Anti-Clusterin Antibody (AB-16B5) | Reference compound | |
| HY-P990509 | Anti-SIRPg/CD172g Antibody (KWAR23) | Reference compound | |
| HY-P990626 | MEDI-51171 | 2226654-05-1 | Reference compound |
| HY-P990779 | Zalfermin | 1958040-66-8 | Reference compound |
| HY-P991096 | EMB-021 | Reference compound | |
| HY-P99593A | Sofituzumab vedotin (solution) | 1418200-58-4 | Reference compound |
| HY-P99933 | Eftilagimod alfa | 1800476-36-1 | Reference compound |
| HY-W001160S | 5-Hydroxyindole-d5 | 916979-23-2 | Reference compound |
| HY-W004260S3 | Arachidic acid-13C | 335080-96-1 | Reference compound |
| HY-W009389S | 1,3-Diethyl-1,3-diphenylurea-d10 | 2514951-22-3 | Reference compound |
| HY-W010777 | (S)-2-((S)-2-((S)-2-Amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid | 7390-78-5 | Reference compound |
| HY-W012980S4 | Isovaleric acid-13C2 | Reference compound | |
| HY-W013273S | Triethylenetetramine-d4 (tetrahydrochloride) | Reference compound | |
| HY-W019901 | Anhydrous calcium sulfate | 7778-18-9 | Reference compound |
| HY-W019901C | Anhydrous calcium sulfate (with indicator, 8 mesh) | 7778-18-9 | Reference compound |
| HY-W019901D | Anhydrous calcium sulfate (with indicator, 10-20 mesh) | 7778-18-9 | Reference compound |
| HY-W019980D | Cobalt (ll) chloride hexahydrate, for cell culture | 7791-13-1 | Reference compound |
| HY-W021409 | Tetramethylammonium triacetoxyborohydride | 109704-53-2 | Reference compound |
| HY-W080797 | 4,4,5,5,6,6,6-Heptafluorohexanoic acid | 356-02-5 | Reference compound |
| HY-W089800S | trans-2-Nonenal-d2 | 213595-54-1 | Reference compound |
| HY-W100414S | 1,5-Dimethyl-2-(p-tolyl)-1H-pyrazol-3(2H)-one-d3 | 2734011-14-2 | Reference compound |
| HY-W1115156 | 4-Fluoro-3,3-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | 3067144-12-8 | Reference compound |
| HY-W1115157 | 5-Fluoro-3-hydroxy-3-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | 3067144-14-0 | Reference compound |
| HY-W111524 | Barium chloride dihydrate, 99.5% | 10326-27-9 | Reference compound |
| HY-W115740 | D-Lactose (hydrate) | 10039-26-6 | Reference compound |
| HY-W115740R | D-Lactose (hydrate) (Standard) | 10039-26-6 | Reference compound |
| HY-W145529 | GalNAcβ(1-3)Galα(1-4)Galβ(1-4)Glc-β-pNP | 1134635-03-2 | Reference compound |
| HY-W245513S | Thiophene-d4 | 2036-39-7 | Reference compound |
| HY-W440694 | Cholesterol-PEG-Azide (MW 2000) | Reference compound | |
| HY-W441009 | DSPE-PEG-Maleimide (MW 3400) | Reference compound | |
| HY-W654270 | Calcium N5-methyltetrahydrofolate-d3 | Reference compound | |
| HY-Y0683AR | Petrolatum (white) (Standard) | 8009-03-8 | Reference compound |
| HY-Y1883AR | Polyethylene glycol mono(4-tert-octylphenyl) ether (Standard) | 9002-93-1 | Reference compound |
| HY-Z2474S | Fingolimod EP impurity H-d4 | 2732869-28-0 | Reference compound |
| Reference compound | |||
| Natural Products | |||
| Biochemical Assay Reagents | |||
| Isotope-Labeled Compounds | |||
| Dye Reagents | |||
| HY-101394 | Spermine NONOate | 136587-13-8 | Reference compound |
| HY-103334 | MAFP | 188404-10-6 | Reference compound |
| HY-110004 | ACEA | 220556-69-4 | Reference compound |
| HY-112023 | Lumisterol 3 (>90%) | 5226-01-7 | Reference compound |
| HY-128904 | MC-Val-Cit-PAB-duocarmycin (chloride) | 2055896-98-3 | Reference compound |
| HY-136097 | Maleimide-PEG2-hydrazide (TFA) | Reference compound | |
| HY-138298A | Trastuzumab deruxtecan | 1826843-81-5 | Reference compound |
| HY-14618 | Zingiberene | 495-60-3 | Reference compound |
| HY-148067 | XMT-1519 conjugate-1 | 2720500-19-4 | Reference compound |
| HY-101519 | BETd-260 | 2093388-62-4 | Reference compound |
| HY-101953 | β-Apo-13-carotenone | 17974-57-1 | Reference compound |
| HY-103608 | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl | 1835705-61-7 | Reference compound |
| HY-10432G | A 83-01 (GMP) | 909910-43-6 | Reference compound |
| HY-107541 | O-1602 | 317321-41-8 | Reference compound |
| HY-108786 | Asfotase alfa | 1174277-80-5 | Reference compound |
| HY-108831A | Natalizumab (Solution) | 189261-10-7 | Reference compound |
| HY-108852 | Basiliximab | 179045-86-4 | Reference compound |
| HY-112732B | Sparfosic acid (trisodium) | 70962-66-2 | Reference compound |
| HY-113044R | Uridine diphosphate glucose (Standard) | 133-89-1 | Reference compound |
| HY-10182G | Laduviglusib (GMP) | 252917-06-9 | Reference compound |
| HY-10583G | Y-27632 (dihydrochloride) (GMP) | 129830-38-2 | Reference compound |
| HY-108746 | Defibrotide (sodium) | 83712-60-1 | Reference compound |
| HY-12326A | c-di-AMP (disodium) | 2734909-87-4 | Reference compound |
| HY-12412 | ML132 | 1230628-71-3 | Reference compound |
| HY-125527A | 17(R)-Resolvin D1 | 528583-91-7 | Reference compound |
| HY-126166 | NOC-5 | 146724-82-5 | Reference compound |
| HY-133852A | FD-1080 (free acid) | 1151888-25-3 | Reference compound |
| HY-138298 | Trastuzumab deruxtecan (solution) | 1826843-81-5 | Reference compound |
| HY-150097 | Recombinant Human Serum Albumin(rHSA) | Reference compound | |
| HY-153084 | CD19 CAR mRNA (Mouse) | Reference compound | |
| HY-153231 | eGFP mRNA-LNP | Reference compound | |
| HY-160428 | DMTr-5-fluoro-2'-deoxycytidine-phosphoramidite | 143774-48-5 | Reference compound |
| HY-16261 | Aldoxorubicin | 1361644-26-9 | Reference compound |
| HY-16405 | PR-104 | 851627-62-8 | Reference compound |
| HY-164669 | ADC Control Human IgG1-DM4 | Reference compound | |
| HY-164702 | BL-B01D1 | Reference compound | |
| HY-164734 | Raludotatug Deruxtecan | Reference compound | |
| HY-171135 | Cetuximab MMAE | Reference compound | |
| HY-E70033 | D-galactosyl-β1-3-N-acetyl-D-hexosamine phosphorylase (BiGalHexNAcP) | Reference compound | |
| HY-12053AS | Vinorelbine-d3 (ditartrate) | Reference compound | |
| HY-125904 | 4-Hydroxyretinoic acid | 66592-72-1 | Reference compound |
| HY-130989 | SuO-Glu-Val-Cit-PAB-MMAE | 1895916-24-1 | Reference compound |
| HY-13442A | Eribulin (mesylate) | 441045-17-6 | Reference compound |
| HY-139165A | AT-9010 (tetrasodium) | 1621884-18-1 | Reference compound |
| HY-141540 | Lactyl-CoA | 1926-57-4 | Reference compound |
| HY-151613A | MS15 (TFA) | Reference compound | |
| HY-15162G | Monomethyl auristatin E (GMP) | 474645-27-7 | Reference compound |
| HY-153079 | eGFP mRNA(N1-Me-Pseudo UTP) | Reference compound | |
| HY-10065S | Axitinib-13C,d3 | 1261432-00-1 | Reference compound |
| HY-101070 | SMCC-DM1 | 1228105-51-8 | Reference compound |
| HY-105049 | T-91825 | 189345-04-8 | Reference compound |
| HY-108730A | Avelumab (anti-PD-L1) | 1537032-82-8 | Natural Products |
| HY-112540B | Acetoacetic acid (sodium) | 623-58-5 | Natural Products |
| HY-113509 | Lipoxin A4 | 89663-86-5 | Natural Products |
| HY-126303C | GS-443902 (trisodium) | 1355050-21-3 | Natural Products |
| HY-135867E | NHC-triphosphate (tetraammonium) | Natural Products | |
| HY-140903 | Biotin-PEG4-TFP ester | 2985664-57-9 | Natural Products |
| HY-141598 | Datopotamab deruxtecan | 2238831-60-0 | Reference compound |
| HY-145626 | Ozuriftamab | 2460399-44-2 | Reference compound |
| HY-151223 | D-Glyceraldehyde 3-phosphate | 591-57-1 | Reference compound |
| HY-15327 | 1alpha, 25-Dihydroxy VD2-d6 | 216244-04-1 | Reference compound |
| HY-154825 | 20-Hydroxyvitamin D3 | 651734-12-2 | Reference compound |
| HY-15870 | SR 11302 | 160162-42-5 | Reference compound |
| HY-164954 | ADC Control Human IgG1-McMMAF | Reference compound | |
| HY-16980A | Eravacycline (dihydrochloride) | 1334714-66-7 | Reference compound |
| HY-27787 | α-Eleostearic acid | 506-23-0 | Reference compound |
| HY-B1342S | Vitamin A-d8 | 212848-81-2 | Reference compound |
| HY-B2156S | Menaquinone-4-d7 | 1233937-25-1 | Reference compound |
| HY-K3012 | N-2 Supplement (100×), Sterile | Reference compound | |
| HY-K3013A | Bi-27 Serum-free Supplement (50×) | Reference compound | |
| HY-K3014 | Bi-27 Supplement (50×), Vitamin A-Free, Sterile | Reference compound | |
| HY-K6005 | Basement Membrane Matrix HC (Phenol Red) | Reference compound | |
| HY-P70007 | Cyclophilin A, Mouse (solution) | Reference compound | |
| HY-P70038 | Deoxyhypusine synthase/DHS, Human (His) | Reference compound | |
| HY-P70041 | Cyclin-H/CCNH, Human (His) | Reference compound | |
| HY-P700636 | CNR2-VLP, Human (HEK293) | Reference compound | |
| HY-P701311AF | Animal-Free Laminin 521, Human | Reference compound | |
| HY-141602 | Pinatuzumab vedotin | 1313706-14-7 | Reference compound |
| HY-141607 | Indatuximab ravtansine | 1238517-16-2 | Reference compound |
| HY-14520 | Tetrahydrofolic acid | 135-16-0 | Reference compound |
| HY-153084A | CD19 CAR mRNA (Human) | Reference compound | |
| HY-15575G | VcMMAE (GMP) | 646502-53-6 | Reference compound |
| HY-156712 | Depatuxizumab MMAE | Reference compound | |
| HY-158714 | 3'-ONH2-dCTP (sodium) solution (100mM) | Reference compound | |
| HY-159774 | ADC Control human IgG1-DM1 | Reference compound | |
| HY-164152A | ADC Control Human IgG1-Deruxtecan (DAR 8) | Reference compound | |
| HY-K0552 | Mycoplasma Detection Kit (PCR) | Reference compound | |
| HY-K6017 | 3D Cell-ATP Viability Detection Kit | Reference compound | |
| HY-N0644 | Carnosic acid | 3650-09-7 | Reference compound |
| HY-N7495 | all-trans-Anhydro Retinol | 1224-78-8 | Reference compound |
| HY-P3021 | Human milk lysozyme | 12671-19-1 | Reference compound |
| HY-P700004 | PAEP, Human (HEK293, His) | Reference compound | |
| HY-P70025 | Cystathionine gamma-lyase/CTH, Human | Reference compound | |
| HY-P700724 | GAS6, Human (630a.a, HEK293, His) | Reference compound | |
| HY-P701378 | KIF11, Human | Reference compound | |
| HY-153229 | Firefly luciferase mRNA-LNP | Reference compound | |
| HY-15331 | VD3-d6 | 118584-54-6 | Reference compound |
| HY-15398S3 | Vitamin D3-d3 | 80666-48-4 | Reference compound |
| HY-155870B | DL-01 (TFA) | Reference compound | |
| HY-158109 | M3554 | Reference compound | |
| HY-158713 | 3'-ONH2-dGTP (sodium) solution (100mM) | Reference compound | |
| HY-164152 | ADC Control Human IgG1-Deruxtecan (DAR 4) | Reference compound | |
| HY-164957 | SGN-B6A | Reference compound | |
| HY-B1960 | Canthaxanthin | 514-78-3 | Reference compound |
| HY-D0041 | Calcein-AM | 148504-34-1 | Reference compound |
| HY-108845 | Tenecteplase | 191588-94-0 | Reference compound |
| HY-109539 | Gemtuzumab ozogamicin | 220578-59-6 | Reference compound |
| HY-111880 | γ-Sanshool | 78886-65-4 | Reference compound |
| HY-112495 | VH032-PEG5-C6-Cl | 1799506-06-1 | Reference compound |
| HY-114988S | tetranor-PGEM-d6 | 1240398-16-6 | Reference compound |
| HY-117433S | 4-Hydroperoxy Cyclophosphamide-d4 | 1246816-71-6 | Reference compound |
| HY-126823 | Phen Green SK diacetate (5/6-mixture) | 234075-45-7 | Reference compound |
| HY-129602 | SD-36 | 2429877-44-9 | Reference compound |
| HY-131925 | Diethylamine NONOate (diethylammonium salt) | 372965-00-9 | Reference compound |
| HY-132177A | α-1-2 Fucosidase, bifidobacterium longum | 9037-65-4 | Reference compound |
| HY-P70132 | SARS-CoV-2 Guanine-N7 methyltransferase (His) | Reference compound | |
| HY-P701380 | KIFC1, Human | Reference compound | |
| HY-P701397 | PXR, Human (His) | Reference compound | |
| HY-P701446 | USP28, Human (Sf9) | Reference compound | |
| HY-P70146 | Ketohexokinase/KHK, Human (HEK293, His) | Reference compound | |
| HY-P701483 | OTUD5, Human (His, FLAG) | Reference compound | |
| HY-P701512 | SMURF2, Human (His) | Reference compound | |
| HY-P701567 | SF3B3, Human (Sf9, His, Strep) | Reference compound | |
| HY-164762 | Trastuzumab rezetecan | 2924909-11-3 | Reference compound |
| HY-E70558 | 5α-reductase, Rat(Sprague-Dawley) Liver | Reference compound | |
| HY-K0551 | Mycoplasma Detection Kit (Luminescence) | Reference compound | |
| HY-K6007 | Basement Membrane Matrix for Organoid Culture | Reference compound | |
| HY-K6010 | Tissue Storage Solution | Reference compound | |
| HY-N7032 | Uridine 5′-diphosphoglucose (disodium salt) | 28053-08-9 | Reference compound |
| HY-P2780A | Cathepsin B, Human Liver | Reference compound | |
| HY-P2953 | Heparitin sulfate lyase | 37290-86-1 | Reference compound |
| HY-P3239 | Belantamab mafodotin | 2050232-20-5 | Reference compound |
| HY-P70005 | CTRB1, Human (HEK293, His) | Reference compound | |
| HY-P70144 | Kallikrein-1, Human (244a.a, HEK293, His, solution) | Reference compound | |
| HY-P701477 | AMSH-LP, Human | Reference compound | |
| HY-P701594 | MDM2, Human (His) | Reference compound | |
| HY-P701682 | FAK1, Human (Sf9, GST) | Reference compound | |
| HY-P701692 | HCK, Human (Sf9, His) | Reference compound | |
| HY-P701732 | PAK6, Human | Reference compound | |
| HY-P701754 | PKCz, Human (Sf9, GST) | Reference compound | |
| HY-P70178 | FLT3, Human (HEK293, Fc, solution) | Reference compound | |
| HY-101141 | sulfo-SPDB-DM4 | 1626359-59-8 | Reference compound |
| HY-101952G | Prostaglandin E2 (GMP) | 363-24-6 | Reference compound |
| HY-10431G | SB-431542 (GMP) | 301836-41-9 | Reference compound |
| HY-106014 | Tezacitabine | 130306-02-4 | Reference compound |
| HY-108649A | MRS2768 (tetrasodium salt) | 2567869-47-8 | Reference compound |
| HY-110382 | Cyclic-di-GMP (disodium) | 2222132-40-1 | Reference compound |
| HY-112169A | 10-Formyltetrahydrofolic acid (disodium) | 914800-65-0 | Reference compound |
| HY-114164A | Human α-Thrombin | 9002-04-4 | Reference compound |
| HY-119412 | Biliatresone | 1801433-90-8 | Reference compound |
| HY-101151 | sulfo-SPDB | 1193111-39-5 | Reference compound |
| HY-103602 | (S,R,S)-AHPC-PEG3-NH2 (hydrochloride) | 2097971-11-2 | Reference compound |
| HY-108738 | Daclizumab | 152923-56-3 | Reference compound |
| HY-108801A | Aflibercept (VEGF Trap) | 862111-32-8 | Reference compound |
| HY-108810 | Canakinumab | 914613-48-2 | Reference compound |
| HY-111815A | N4-Acetylcytidine triphosphate (sodium) | 2803886-33-9 | Reference compound |
| HY-112582C | N1-Methylpseudouridine-5′-triphosphate (trisodium) solution (100mM) | Peptides | |
| HY-12053A | Vinorelbine (ditartrate) | 125317-39-7 | Peptides |
| HY-D1421 | PKH 67 | 257277-27-3 | Peptides |
| HY-E70052 | alpha-1,3-Galactosyltransferase (a1,3GalT) | 128449-51-4 | Peptides |
| HY-E70234 | Sortase A, S. aureus | 9033-39-0 | Peptides |
| HY-K3101 | Human Neuroblastoma Cell Culture Medium | Peptides | |
| HY-N1446S | Oleic acid-13C | 82005-44-5 | Reference compound |
| HY-P4073 | ANG1005 | 1075214-55-9 | Reference compound |
| HY-P70011 | Cyclophilin B/PPIB, Human (HEK293, C-His, solution) | Reference compound | |
| HY-P700275 | PPAR gamma, Human (C-His, solution) | Reference compound | |
| HY-P70066 | CDO1/Cysteine dioxygenase type 1, Human (His) | Reference compound | |
| HY-126685 | Mal-PEG4-VA-PBD | 1342820-68-1 | Reference compound |
| HY-128957 | Vc-seco-DUBA | 1345681-58-4 | Reference compound |
| HY-130705 | Previtamin D3 | 1173-13-3 | Reference compound |
| HY-132253 | Polatuzumab vedotin | 1313206-42-6 | Reference compound |
| HY-134279 | 8-Br-NAD+ (sodium) | 2022926-16-3 | Reference compound |
| HY-134636 | PAPA NONOate | 146672-58-4 | Reference compound |
| HY-135057 | Lauroylamide propylbetaine (35% in water) | 4292-10-8 | Reference compound |
| HY-136278 | DETA NONOate | 146724-94-9 | Reference compound |
| HY-141604 | Glembatumumab vedotin | 1182215-65-1 | Reference compound |
| HY-14769 | Folitixorin | 3432-99-3 | Reference compound |
| HY-P701827 | NEK9, Human (Sf9, GST) | Reference compound | |
| HY-P701972 | Aldose-reductase, Human | Reference compound | |
| HY-P701976 | SHMT2, Human | Reference compound | |
| HY-P702056 | MYD88, Human | Reference compound | |
| HY-P702063 | USP11, Human (Sf9) | Reference compound | |
| HY-P702070 | CUL5, Human (Sf9) | Reference compound | |
| HY-P70208 | GAS7, Human (His) | Reference compound | |
| HY-P70214 | IDH1, Human (HEK293, His, Solution) | Reference compound | |
| HY-P70010 | CD73/5'-Nucleotidase, Human (HEK293, His) | Reference compound | |
| HY-P70019 | DCK/Deoxycytidine kinase, Human (His-T7) | Reference compound | |
| HY-P700303 | Bcl-2-like 11, Human (His) | Reference compound | |
| HY-P70033 | CTRL-1, Human (HEK293, His) | Reference compound | |
| HY-P70045 | Claudin-18/CLDN18.1, Human (His) | Reference compound | |
| HY-P70087 | DTD1, Human (HEK293, His) | Reference compound | |
| HY-P701013 | IL-27R alpha/TCCR, Human (HEK293, His) | Reference compound | |
| HY-P701139 | HNF4A, Human (His, solution) | Reference compound | |
| HY-P701153 | EBP50/SLC9A3R1, Human (HEK293, His, solution) | Reference compound | |
| HY-P70128 | SARS-CoV-2 NSP2 (His) | Reference compound | |
| HY-P70130 | SARS-CoV-2 NSP8 (His) | Reference compound | |
| HY-P701339 | BCAT2, Human | Reference compound | |
| HY-P701340 | BCAT2, Human (His, Strep) | Reference compound | |
| HY-P701385 | HSPA2, Human (His) | Reference compound | |
| HY-P701406 | UCHL5, Human | Reference compound | |
| HY-12460 | SPDB-DM4 | 1626359-62-3 | Reference compound |
| HY-130705A | Tachysterol 3 | 17592-07-3 | Reference compound |
| HY-132254A | Sacituzumab govitecan (solution) | 1491917-83-9 | Reference compound |
| HY-132258A | Mirvetuximab soravtansine (solution) | 1453084-37-1 | Reference compound |
| HY-134216 | MAHMA NONOate | 146724-86-9 | Reference compound |
| HY-139482 | tri-GalNAc-COOH | 1953146-81-0 | Reference compound |
| HY-145633 | Sozinibercept | 2568358-31-4 | Reference compound |
| HY-153232 | eGFP circRNA-LNP | Reference compound | |
| HY-155870A | DL-01 (formic) | 2964513-44-6 | Reference compound |
| HY-164202 | ORM-5029 | Reference compound | |
| HY-164992 | Trastuzumab vedotin | Reference compound | |
| HY-153231A | eGFP mRNA-LNP (500 ng/μL) | Reference compound | |
| HY-153233 | CD19 car mRNA (Mouse)-LNP | Reference compound | |
| HY-153601 | MC-VC-PAB-Cyclohexanediamine-Thailanstatin A | 1609108-96-4 | Reference compound |
| HY-153892 | Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide | 2750623-07-3 | Reference compound |
| HY-15398S | Vitamin D3-d7 | 1627523-19-6 | Reference compound |
| HY-158712 | 3'-ONH2-dATP (sodium) solution (100mM) | Reference compound | |
| HY-158799 | Poly(ADP-ribose) Polymer/pADPr | Reference compound | |
| HY-161541 | Estradiol/BSA | Reference compound | |
| HY-164153 | ADC Control Human IgG1-vcMMAE | Reference compound | |
| HY-164154 | ADC Control Human IgG1-vcMMAF | Reference compound | |
| HY-D2449 | DQ-BSA-RED | Reference compound | |
| HY-E70229 | Cyclooxygenase 1, sheep | 329967-85-3 | Reference compound |
| HY-132178 | Cytochrome P450 | 9035-51-2 | Reference compound |
| HY-132253A | Polatuzumab vedotin (solution) | 1313206-42-6 | Reference compound |
| HY-132254 | Sacituzumab govitecan | 1491917-83-9 | Reference compound |
| HY-132259 | Depatuxizumab mafodotin | 1585973-65-4 | Reference compound |
| HY-132334S | 9-cis-Retinoic acid-d5 | Reference compound | |
| HY-133433 | DBCO-PEG4-VA-PBD | 2241644-09-5 | Reference compound |
| HY-141481 | DP-C-4 | Reference compound | |
| HY-141601 | Telisotuzumab vedotin | 1714088-51-3 | Reference compound |
| HY-145645 | Paridiprubart | 2641646-59-3 | Reference compound |
| HY-153235 | COVID-19 Spike Protein mRNA-LNP | Reference compound | |
| HY-15379 | Atevirdine | 136816-75-6 | Reference compound |
| HY-157424 | 3′-Phosphoadenosine 5′-phosphosulfate (tetralithium salt) | 102029-54-9 | Reference compound |
| HY-P701411 | USP15, Human (sf9) | Reference compound | |
| HY-P701441 | USP21, Human | Reference compound | |
| HY-P701593 | MDM2, Human | Reference compound | |
| HY-P701625 | MYST1, Human | Reference compound | |
| HY-P70163 | Kallikrein-7, Human (HEK293, His, solution) | Reference compound | |
| HY-P701646 | TNIK, Human (Sf9) | Reference compound | |
| HY-P701667 | DYRK1A, Human | Reference compound | |
| HY-P701737 | PDK4, Human (GST) | Reference compound | |
| HY-P701788 | IKKε, Human (Sf9, GST) | Reference compound | |
| HY-P701882 | FASN, Human (Sf9, His) | Reference compound | |
| HY-P701888 | FTO, Human (His) | Reference compound | |
| HY-P701961 | PDE4D, Human (His) | Reference compound | |
| HY-P701993 | Sox2, Human | Reference compound | |
| HY-P702154 | birA, E.coli (His) | Reference compound | |
| HY-P70244 | Hemopexin, Human (HEK293, His) | Reference compound | |
| HY-P702603 | USP7, Human (His) | Reference compound | |
| HY-17026E | Gemcitabine triphosphate (trisodium) | Reference compound | |
| HY-19639 | E-982 | 858102-78-0 | Reference compound |
| HY-K0302 | Cell-ATP Viability Detection Kit | Reference compound | |
| HY-K3012A | N-2 Serum-free Supplement (100×) | Reference compound | |
| HY-K3014A | Bi-27 Serum-free Supplement (50×), Vitamin A-Free | Reference compound | |
| HY-K6006 | Basement Membrane Matrix IPSC-qualified | Reference compound | |
| HY-N0411S1 | β-Carotene-d8 | 53163-44-3 | Reference compound |
| HY-N0743 | Senkyunolide A | 63038-10-8 | Reference compound |
| HY-NP139 | Mouse Laminin | Reference compound | |
| HY-P2813 | Hirudin | 8001-27-2 | Reference compound |
| HY-P700253AF | Animal-Free RSPO1/R-spondin-1, Human (243a.a, HEK293, His, SUMO) | Reference compound | |
| HY-E70397 | Dipeptidyl peptidase IV | 54249-88-6 | Reference compound |
| HY-K0316 | Serum Replacement | Reference compound | |
| HY-K6001 | Basement Membrane Matrix (Phenol Red) | Reference compound | |
| HY-N0287 | Lycopene | 502-65-8 | Reference compound |
| HY-N0684S3 | Vitamin K1-13C6 | Reference compound | |
| HY-N6580 | Ginsenoside Rg4 | 126223-28-7 | Reference compound |
| HY-N7395 | Cyclic ADP-ribose | 119340-53-3 | Reference compound |
| HY-N8357 | Vitamin D3 octanoate | 927822-16-0 | Reference compound |
| HY-P3371 | Ifinatamab deruxtecan | 2484870-92-8 | Reference compound |
| HY-P70024 | HPD/HPPDase, Human (His) | Reference compound | |
| HY-P700957 | BPIFA1, Human | Natural Products | |
| HY-P701645 | TNIK, Human (Sf9, His) | Natural Products | |
| HY-P701752 | PK3C3, Human (Sf9, His, GST) | Natural Products | |
| HY-P701769 | ROCK1, Human (Sf9) | Reference compound | |
| HY-P701982 | MCD, Human (His) | Reference compound | |
| HY-P702076 | RBCK1, Human | Reference compound | |
| HY-P70211 | GGCT, Human (His) | Reference compound | |
| HY-P70225 | LDHA, Human (His) | Reference compound | |
| HY-P70242 | Hemoglobin subunit zeta/HBAZ, Human (His) | Reference compound | |
| HY-P70262 | Gastric lipase, Human (HEK293, His, solution) | Reference compound | |
| HY-P702825 | CRBN-DDB1, Human (sf9, His, Avi) | Reference compound | |
| HY-P702850 | CRBN-DDB1 Protein, Human (Biotinylated, sf9, Avi) | Reference compound | |
| HY-P702862 | GAK, Human (GST) | Reference compound | |
| HY-P702921 | BRAF, Human (sf9, GST, His) | Reference compound | |
| HY-P703137 | GRK5, Human (Sf9, His, GST) | Reference compound | |
| HY-P703163 | Menin, Human (His, M327I) | Reference compound | |
| HY-158715 | 3'-ONH2-dTTP (sodium) solution (100mM) | Reference compound | |
| HY-164668 | ADC Control Human IgG1-SN-38 | Reference compound | |
| HY-19915B | Contezolid acefosamil (sodium) | 1807365-35-0 | Reference compound |
| HY-42484 | ER-076349 | 253128-15-3 | Reference compound |
| HY-B1342S3 | Vitamin A-13C3 | Reference compound | |
| HY-B1342S4 | Vitamin A-d5 | 1185244-58-9 | Reference compound |
| HY-E70452 | Recombinant microbial transglutaminase | 80146-85-6 | Reference compound |
| HY-K3013 | Bi-27 Supplement (50×), Sterile | Reference compound | |
| HY-K6004 | Basement Membrane Matrix GFR | Reference compound | |
| HY-P70026 | dUTPase/DUT, Human | Reference compound | |
| HY-P700300 | Ribonuclease R (rnr), E.coli (His) | Reference compound | |
| HY-P70051 | Aminopeptidase N/APN, Mouse (HEK293, His) | Reference compound | |
| HY-P70053 | Cytochrome c/CYCS, Human (His) | Reference compound | |
| HY-P70065 | AOC3, Human (HEK293, His) | Reference compound | |
| HY-P700692 | Claudin-6/CLDN6-VLP, Mouse (HEK293) | Reference compound | |
| HY-P70082 | L-xylulose reductase/DCXR, Human (His) | Reference compound | |
| HY-P700995 | FNDC1, Human (His) | Reference compound | |
| HY-P701028 | Notch 4, Mouse (HEK293, His) | Reference compound | |
| HY-P701118 | NIP30 Protein, Human (His) | Reference compound | |
| HY-P701259 | PE-Labeled Mesothelin, Human (HEK293, His) | Reference compound | |
| HY-P701266 | FITC-Labeled CD47, Human (HEK293, His) | Reference compound | |
| HY-P701349 | USP2, Human | Reference compound | |
| HY-P701368 | CDK6-CCND2 Heterodimer, Human (Sf9, GST, FLAG, His) | Reference compound | |
| HY-100566 | SuO-Val-Cit-PAB-MMAE | Reference compound | |
| HY-111382 | Diphenylterazine | 344940-63-2 | Reference compound |
| HY-112210 | Shield-1 | 914805-33-7 | Reference compound |
| HY-112942A | CMP-Sialic acid (sodium salt) | 1007117-62-5 | Reference compound |
| HY-114988 | PGE-M | 24769-56-0 | Reference compound |
| HY-122218 | JHU-083 | 1998725-11-3 | Biochemical Assay Reagents |
| HY-124313 | 1-Methyl-1,4-dihydronicotinamide | 17750-23-1 | Biochemical Assay Reagents |
| HY-129603 | SI-109 | 2429877-30-3 | Biochemical Assay Reagents |
| HY-130704 | Isotachysterol 3 | 22350-43-2 | Biochemical Assay Reagents |
| HY-132184 | 5,6-Epoxyeicosatrienoic acid | 87173-80-6 | Biochemical Assay Reagents |
| HY-P702687 | CDK6-CCND1 Heterodimer, Human (sf9, GST, Flag, His) | Biochemical Assay Reagents | |
| HY-P702696 | CDK16-CCNY, Human (sf9, GST, Flag) | Biochemical Assay Reagents | |
| HY-P702747 | PAK4, Human (His) | Reference compound | |
| HY-P70275 | FBP1, Human (HEK293, His) | Reference compound | |
| HY-P702765 | SPHK1/Sphingosine Kinase 1, Human (sf9, 363a.a) | Reference compound | |
| HY-P702779 | CDK1, Human (sf9) | Reference compound | |
| HY-P702835A | STAT6, Human (536a.a, His) | Reference compound | |
| HY-P702866 | PARP3, Human (His, Strep) | Reference compound | |
| HY-P702952 | SIRT6, Human (GST) | Reference compound | |
| HY-P703076 | Caspase-1/CASP1, Human (Active, T388A, His) | Reference compound | |
| HY-P703313 | SAMHD1, Human (Sf9, His, Strep) | Reference compound | |
| HY-P703402 | cGAS, MOUSE (Biotinylated) | Reference compound | |
| HY-P70350 | MDH2, Human (HEK293, His) | Reference compound | |
| HY-P703586 | MEK1, Human (Inactive, Sf9, His) | Reference compound | |
| HY-P70372 | Ribonuclease UK114/HRSP12, Human (His) | Reference compound | |
| HY-P703942 | GPX4, Human (HEK293, Flag) | Reference compound | |
| HY-P703952 | IL-4R alpha/CD124, Cynomolgus (Biotinylated, HEK293, His) | Reference compound | |
| HY-P70545 | PCSK9, Human (HEK293, V474I, G670E, His) | Reference compound | |
| HY-P70658 | Lipocalin-2/NGAL, Mouse (HEK293, His) | Reference compound | |
| HY-P70696 | Galectin-9/LGALS9, Human (GST) | Reference compound | |
| HY-P701373 | CDK8-CCNC-MED12, Human (Sf9, GST, FLAG, His) | Reference compound | |
| HY-P701386 | HSPBP1, Human | Reference compound | |
| HY-P701419 | USP46, Human | Reference compound | |
| HY-P701422 | USP48, Human (Sf9, FLAG) | Reference compound | |
| HY-P701595 | NEDD4L, Human | Reference compound | |
| HY-P701610 | SIRT3, Human (His, SUMO) | Reference compound | |
| HY-P701631 | TNKS1, Human (His) | Reference compound | |
| HY-P701720 | CaMKII delta/CAMK2D, Human (Sf9, GST) | Reference compound | |
| HY-P701744 | PIK3R3, Human (Sf9, His, GST) | Reference compound | |
| HY-P701923 | ACSS2, Human (His) | Reference compound | |
| HY-P701962 | PGAM1, Human | Reference compound | |
| HY-P701998 | LGP2, Human (HEK293, FLAG) | Reference compound | |
| HY-P702022 | SLC12A2, Human (HEK293, His, Strep, FLAG) | Reference compound | |
| HY-P702042 | SLC44A1, Human (Sf9, His, MBP, FLAG) | Reference compound | |
| HY-P70229 | LALBA, Human (HEK293, His) | Reference compound | |
| HY-P700985 | TAFA5/FAM19A5, Mouse (His) | Reference compound | |
| HY-P701025 | MDK/Midkine, Mouse (His) | Isotope-Labeled Compounds | |
| HY-P701239AF | Animal-Free SUMO Protease , Saccharomyces cerevisiae (His) | Reference compound | |
| HY-P701321 | Src, Human (His) | Reference compound | |
| HY-P70133 | CELA3A, Human (HEK293, His) | Reference compound | |
| HY-P701353 | UBE1L2/UBA6, Human (Sf9, His, Strep) | Reference compound | |
| HY-P70141 | NAD kinase/NADK, Human (His) | Reference compound | |
| HY-N0644R | Carnosic acid (Standard) | 3650-09-7 | Natural Products |
| HY-N0729S2 | Linoleic acid-13C18 | 287111-25-5 | Natural Products |
| HY-NP0194 | C1q Protein (human) | Natural Products | |
| HY-P70012 | Thymidylate, Human (HEK293, His) | Reference compound | |
| HY-P70047 | Peptidyl-prolyl cis-trans isomerase A/CYPA, Human | Reference compound | |
| HY-P70059 | ECH1, Human (His) | Reference compound | |
| HY-P700638 | METTL11A, Human (His) | Reference compound | |
| HY-P70098 | CTRC, Human (HEK293, His) | Reference compound | |
| HY-P70317 | Kallikrein-2, Human (HEK293, His) | Reference compound | |
| HY-P703271 | DCAF1, Human (Sf9, His, Strep) | Reference compound | |
| HY-P703274 | USP3, Human (Sf9, GST) | Reference compound | |
| HY-P703329 | TRPM4, Human (HEK293, Flag) | Reference compound | |
| HY-P703382 | SLC22A12, Human (HEK293) | Reference compound | |
| HY-P70342 | MMP-12, Mouse (HEK293, His) | Reference compound | |
| HY-P703641 | DPP9, Human (Sf9) | Reference compound | |
| HY-P70243 | Myoglobin, Human (His) | Reference compound | |
| HY-P702588 | SARS-CoV-2 S1 (Delta, B.1.617.2, His) | Reference compound | |
| HY-P702642 | PRKCD, Human (sf9, GST) | Reference compound | |
| HY-P702707 | EphA3, Human (sf9, GST) | Reference compound | |
| HY-P702716 | ABL1, Human (sf9) | Reference compound | |
| HY-P702728 | SYK, Human (Biotinylated, sf9, Avi) | Reference compound | |
| HY-P702730 | BTK, Human (Biotinylated, sf9, His, Avi) | Reference compound | |
| HY-P701005 | HTRA1, Human (His) | Natural Products | |
| HY-P70121 | TPBG/5T4, Mouse (HEK293, His) | Natural Products | |
| HY-P701235 | Cas9, S. pyogenes (NLS) | Natural Products | |
| HY-P701327 | NOV/CCN3, Human (sf9, His) | Natural Products | |
| HY-P701357 | ABCA1, Human (HEK293, His, Strep, FLAG) | Natural Products | |
| HY-P701361 | CDK12-CCNK Heterodimer, Human (Sf9, GST, FLAG) | Natural Products | |
| HY-P701376 | CDK9-CCNT1 Heterodimer, Human (Sf9) | Natural Products | |
| HY-P701004 | HSP70/HSPA1A, Human (E110D, His) | Natural Products | |
| HY-P701026 | NCAM-1/CD56, Cynomolgus (HEK293, His) | Natural Products | |
| HY-P701030 | PADI4, Human (Biotinylated, His) | Natural Products | |
| HY-P701068 | PKA/PRKACA, Canine (His) | Natural Products | |
| HY-P70112 | Dipeptidyl peptidase 3/DPP3, Human (His) | Natural Products | |
| HY-P70122 | SARS-CoV-2 PLpro | Natural Products | |
| HY-P70129 | SARS-CoV-2 NSP7 (His) | Reference compound | |
| HY-P70727 | CD39, Mouse (HEK293, His) | Reference compound | |
| HY-P70807 | PVR/CD155, Human (HEK293, His) | Reference compound | |
| HY-P70830 | Cathepsin B, Human (His) | Reference compound | |
| HY-P70847 | IA2, Human (293a.a, His, solution) | Reference compound | |
| HY-P70863 | IDO-2, Human (His) | Reference compound | |
| HY-P70903 | IDI2, Human (His) | Reference compound | |
| HY-P70905 | EPT1, Human (GST) | Reference compound | |
| HY-P70966 | PCSK9, Macaca nemestrina (HEK293, His) | Reference compound | |
| HY-P702185 | DDX41, Human (His, Strep, Flag) | Reference compound | |
| HY-P70226 | Coagulation factor XIII A/F13A, Human (HEK293, His) | Reference compound | |
| HY-P70239 | GLP-1/GCG, Human (HEK293, His) | Reference compound | |
| HY-P702620 | PKC iota, Human (Sf9, His) | Reference compound | |
| HY-P702835 | STAT6, Human (Phosphorylated, 536a.a, His) | Reference compound | |
| HY-P702915 | LOXL4, Human (His) | Reference compound | |
| HY-P70300 | Glucosamine (N-acetyl)-6-Sulfatase/GNS, Human (HEK293, His) | Reference compound | |
| HY-P701421 | USP47, Human (Sf9, FLAG) | Reference compound | |
| HY-P701447 | USP28, Human (Sf9, His) | Reference compound | |
| HY-P701450 | USP30, Human (Sf9) | Reference compound | |
| HY-P701466 | OTUD7B, Human (Sf9, His, Strep) | Reference compound | |
| HY-P70149 | ISG15/UCRP, Human (His) | Reference compound | |
| HY-P701526 | HACE1, Human (His) | Reference compound | |
| HY-P701606 | EIF4A1, Human (His, Strep) | Reference compound | |
| HY-P70139 | Stromelysin-1/MMP-3, Human (HEK293, His) | Reference compound | |
| HY-P701429 | USP6, Human (Sf9, GST) | Reference compound | |
| HY-P701443 | USP22, Human (Sf9) | Reference compound | |
| HY-P70145 | MMP-9, Human (HEK293, His, solution) | Reference compound | |
| HY-P701465 | OTUD7B, Human (Sf9) | Dye Reagents | |
| HY-P701492 | UFC1, Human (Sf9, His, Strep) | Dye Reagents | |
| HY-P70150 | GSTP1, Human | Reference compound | |
| HY-P702739 | NEK2, Human (Active) | Reference compound | |
| HY-P70274 | HMGB1/HMG-1, Human (HEK293, His, solution) | Reference compound | |
| HY-P70288 | MIF, Human (His, solution) | Reference compound | |
| HY-P70299 | NME1/NDPKA, Human (His) | Reference compound | |
| HY-P703100 | CENPE, Human | Reference compound | |
| HY-P70324 | KEL/Kelch-like 41, Human (HEK293, His, solution) | Reference compound | |
| HY-P703246 | CUL4A-RBX1, Human (Sf9) | Reference compound | |
| HY-P703326 | PUS7, Human (Sf9, His, Strep) | Reference compound | |
| HY-P70349 | MDH1, Human (His) | Reference compound | |
| HY-P703597 | CDC7, Human (His) | Reference compound | |
| HY-P70364 | METAP2/Methionine aminopeptidase 2, Human (Sf9, His) | Reference compound | |
| HY-P703885 | CEACAM6, Human (HEK293, His) | Reference compound | |
| HY-P703938 | MMP-7, Human (HEK293, His) | Reference compound | |
| HY-P704038 | FASN, Human (His) | Reference compound | |
| HY-P70509 | PRTN3, Human (HEK293, His) | Reference compound | |
| HY-P70679 | IDO-1, Human (His) | Reference compound | |
| HY-P70840 | KARS, Human (HEK293, His) | Reference compound | |
| HY-P70867 | GALNT7, Human (HEK293, His) | Reference compound | |
| HY-P70884 | Hemopexin, Mouse (HEK293, His, solution) | Reference compound | |
| HY-P7092Y | EGF, Rat (Tag Free, Solution) | Reference compound | |
| HY-P70933 | HSPB8, Human (His) | Reference compound | |
| HY-P70977 | SULT1B1, Human (His) | Natural Products | |
| HY-P701381 | KIFC1, Human (His) | Natural Products | |
| HY-P701401 | RORa, Human (Sf9, His) | Natural Products | |
| HY-P701431 | USP9X, Human (GST) | Natural Products | |
| HY-P701444 | USP25, Human | Natural Products | |
| HY-P701584 | KLHL21, Human (Sf9, His, Strep) | Natural Products | |
| HY-P701596 | NEDD4L, Human (His) | Reference compound | |
| HY-P701640 | TAB1, Human | Reference compound | |
| HY-P701727 | Wee1, Human (Sf9, His) | Reference compound | |
| HY-P701739 | PDPK1, Human (Sf9, His) | Reference compound | |
| HY-P701766 | RIOK2, Human (Sf9, His, GST) | Reference compound | |
| HY-P701770 | ROCK1, Human (Sf9, His) | Reference compound | |
| HY-P701786 | IKKβ, Human (Sf9, GST) | Reference compound | |
| HY-P701863 | TKT, Human (His) | Reference compound | |
| HY-P701915 | GLUD1, Human (His) | Reference compound | |
| HY-P701922 | ACSS2, Human | Reference compound | |
| HY-P701970 | PTPRG, Human | Reference compound | |
| HY-P70303 | Beta-galactosidase/GLB1, Human (HEK293, His) | Reference compound | |
| HY-P703199 | GLUT1, Human (Sf9, His) | Reference compound | |
| HY-P70320 | GPD1, Human (HEK293, His) | Reference compound | |
| HY-P703200 | GLUT3, Human (Sf9, His) | Natural Products | |
| HY-P703229 | TRPC6, Human (HEK293, Flag, His, Strep) | Natural Products | |
| HY-P703234 | KAT6A, Human (Biotinylated) | Natural Products | |
| HY-P703270 | DCAF1, Human (Sf9) | Natural Products | |
| HY-P703374 | AIFM2, Human (Strep) | Natural Products | |
| HY-P703384 | SLC15A4, Human (HEK293, StrepⅡ, His) | Natural Products | |
| HY-P703401 | cGAS, MOUSE | Natural Products | |
| HY-P703417 | TRIm72, Human | Reference compound | |
| HY-P70351 | MMP-9, Mouse (HEK293, His) | Reference compound | |
| HY-P703591 | TAK1, Human (Sf9) | Reference compound | |
| HY-P70360 | Glutathione synthetase/GSS, Human (His) | Reference compound | |
| HY-P704104 | HSP90AA1, Human (sf9, His) | Natural Products | |
| HY-P70411 | Hyaluronidase-1/HYAL1, Human (HEK293, His) | Natural Products | |
| HY-P70417 | GAMT, Human (His) | Natural Products | |
| HY-P70606 | Kallikrein-3/PSA Protein, Human (237a.a, HEK293, His) | Natural Products | |
| HY-P70723 | LAG-3, Human (HEK293, Fc) | Natural Products | |
| HY-P70737 | FGL1, Human (HEK293, His, solution) | Natural Products | |
| HY-P70888 | GCDH, Human (His) | Natural Products | |
| HY-P70932 | HAO1, Human (Trx-His) | Natural Products | |
| HY-P71048 | SOD1, Human (His) | Natural Products | |
| HY-P71096 | UCHL1 Protein, Human (His) | Natural Products | |
| HY-P71109 | ODC1, Human (HEK293, His-T7) | Natural Products | |
| HY-P71113 | PDIA4, Human (HEK293, His) | Natural Products | |
| HY-P71128 | TAC1, Human (His) | Natural Products | |
| HY-P71131 | Tryptase beta-2, Mouse (HEK293, His) | Natural Products | |
| HY-P71145 | PRDX6, Human (His) | Natural Products | |
| HY-P71193 | PDIA6, Human (HEK293, His) | Reference compound | |
| HY-P701653 | TTK, Human (Sf9, GST, FLAG) | Reference compound | |
| HY-P701678 | ERK1, Human (GST) | Reference compound | |
| HY-P701690 | GSK3α, Human (Sf9, GST) | Reference compound | |
| HY-P701729 | WEE2, Human (Sf9, His, GST) | Reference compound | |
| HY-P701773 | RSK2, Human | Reference compound | |
| HY-P701813 | MKNK1, Human (Sf9, GST) | Natural Products | |
| HY-P701815 | MKNK2, Human (His) | Natural Products | |
| HY-P701821 | MST2, Human (Sf9, GST) | Natural Products | |
| HY-P701873 | DPP8, Human (Sf9) | Natural Products | |
| HY-P701964 | Phospholipase C, Bacillus cereus | Natural Products | |
| HY-P701985 | MGLL, Human (His) | Natural Products | |
| HY-P701996 | IFI16, Human (FLAG) | Natural Products | |
| HY-P702089 | Menin, Human | Natural Products | |
| HY-P702188 | NLRP1, Human | Natural Products | |
| HY-P70221 | Acyl-protein thioesterase 2/LYPLA2, Human (His) | Natural Products | |
| HY-P70227 | HGPRT, Human (His) | Natural Products | |
| HY-P70367 | Glypican-3/GPC3, Human (HEK293, Fc, solution) | Natural Products | |
| HY-P703672 | USP14, Human (399a.a, His) | Natural Products | |
| HY-P704018 | Cathepsin C/DPPI, Mouse (Active, HEK293, His) | Natural Products | |
| HY-P70531 | S100A8, Human (C-His) | Natural Products | |
| HY-P70538 | Rnase 3, Human (HEK293, His) | Natural Products | |
| HY-P70584 | Serpin F1, Mouse (375a.a) | Natural Products | |
| HY-P70599 | PKM2, Human (530a.a, His) | Natural Products | |
| HY-P71041 | ACAT2, Human (Trx-His) | Natural Products | |
| HY-P71186 | PAP, Human (His) | Natural Products | |
| HY-P71223 | PPIC, Human (Trx-His) | Natural Products | |
| HY-P71241 | PSP, Human (His) | Natural Products | |
| HY-P71253 | RCN3, Human (HEK293, His) | Natural Products | |
| HY-P71255 | REG-3 gamma/REG3G, Human (HEK293, Fc) | Natural Products | |
| HY-P71258 | RELT, Human (HEK293, Fc) | Natural Products | |
| HY-P71272A | S100A15A, Mouse (solution) | Natural Products | |
| HY-P71282 | Semaphorin-3C/SEMA3C, Human (HEK293, His, solution) | Natural Products | |
| HY-P71302 | Serpin A3N, Mouse (HEK293, His) | Natural Products | |
| HY-P71332 | ST6GALNAC2, Human (HEK293, His) | Reference compound | |
| HY-P71341 | SULT1A3, Human (His) | Reference compound | |
| HY-P71347 | SWSAP1, Human (His) | Reference compound | |
| HY-P71406 | UBE2M, Human | Reference compound | |
| HY-P72427 | VSIG8, Mouse (HEK293, His, solution) | Reference compound | |
| HY-P72637 | Galectin-9/LGALS9, Mouse (GST) | Reference compound | |
| HY-P72825 | Aminopeptidase A, Mouse (sf9, His) | Reference compound | |
| HY-P73116 | ICAM-2/CD102, Human (HEK293, His, solution) | Reference compound | |
| HY-P73146 | IL-1 beta, Canine | Reference compound | |
| HY-P73176 | IL-17A, Rabbit (sf9, His) | Reference compound | |
| HY-P73221 | IL-6R, Canine (HEK293, His) | Reference compound | |
| HY-P73283 | Lyn, Human (sf9, GST) | Reference compound | |
| HY-P70998 | UBE2D3, Human | Reference compound | |
| HY-P71012 | SULT1C2, Human (His) | Reference compound | |
| HY-P71014 | Syntenin-1, Human (C-His) | Natural Products | |
| HY-P71053 | SPINK1, Human (HEK293, His) | Natural Products | |
| HY-P71098 | Tryptophan Synthase, E.coli (His) | Natural Products | |
| HY-P71125 | TPSB2, Human (HEK293, His) | Natural Products | |
| HY-P71137 | TIMP-2, Mouse (HEK293, His) | Natural Products | |
| HY-P7115 | TPO/Thrombopoietin, Human (CHO, His) | Natural Products | |
| HY-P71189 | PCSK9, Mouse (HEK293, His, solution) | Natural Products | |
| HY-P71199 | PFKFB3, Human (His) | Natural Products | |
| HY-P71234 | PRKG1, Human (HEK293, His) | Natural Products | |
| HY-P71242 | PTGDS, Human (His, solution) | Natural Products | |
| HY-P71295 | Alpha-2-Antiplasmin/Serpin F2, Mouse (HEK293, His) | Natural Products | |
| HY-P71309 | SIAE, Human (HEK293, His) | Reference compound | |
| HY-P71345 | SUMF1, Human (HEK293, His) | Reference compound | |
| HY-P71385 | TRIM5, Human (His) | Reference compound | |
| HY-P71405 | UBE2K, Human (GST) | Reference compound | |
| HY-P71420 | VCP, Human (His) | Reference compound | |
| HY-P71721Y | Calreticulin/CALR, Mouse (P.pastoris, His, solution) | ||
| HY-P71742Y | HSPA5/GRP-78, Mouse (P.pastoris, His, solution) | ||
| HY-P71850Y | KCIP-1 , Mouse (P.pastoris, His, solution) | ||
| HY-P71986 | CTLA-4, Guinea pig (P.pastoris, His) | ||
| HY-P70701 | Claudin-18/CLDN18.2, Human (His) | ||
| HY-P70769 | ACE2, Human (Biotinylated, HEK293, His-Avi) | ||
| HY-P70780 | GAS6, Human (HEK293, His, solution) | ||
| HY-P70810 | Carbonic Anhydrase 14, Mouse (HEK293, His) | ||
| HY-P70845 | MOG, Human (HEK293, His) | ||
| HY-P70848 | IA2, Human (His) | ||
| HY-P70865 | IMPA3, Mouse (HEK293, His) | ||
| HY-P72338A | OGG1, Human (N-His) | ||
| HY-P72426A | BMP-15, Human (His, Myc, soluition) | ||
| HY-P7248 | MDC/CCL22, Mouse (His) | ||
| HY-P72489Y | BDNF, Human (R125A, R127A, R128A, solution) | ||
| HY-P72561 | IL-20R beta Protein, Human (HEK293, Fc) | ||
| HY-P72639 | GABARAP, Human (His, Fc) | ||
| HY-P72732 | CD38, Mouse (HEK293, His) | ||
| HY-P72922 | CD6, Human (HEK293, Fc) | ||
| HY-P73061 | FGFR-4, Rat (HEK293, Fc, Solution) | ||
| HY-P73065 | VEGFR-1, Human (328a.a, HEK293, His) | ||
| HY-P73141 | IGFBP-6, Human (HEK293, His) | ||
| HY-P73153 | IL-10, Human (HEK293, His) | ||
| HY-P73177 | IL-17A, Rhesus macaque (sf9) | ||
| HY-P73252 | IFN-gamma, Mouse (HEK293, Fc) | ||
| HY-P70939 | Kallikrein-5, Human (HEK293, His) | ||
| HY-P70959 | NANS, Human (His) | ||
| HY-P70980 | TPP1, Human (HEK293, His) | ||
| HY-P71025 | YKT6, Human (His) | ||
| HY-P71070 | TDT, Human (His) | ||
| HY-P71071 | PLA2G1B, Human (HEK293, His) | ||
| HY-P71076 | S100A8-S100A9 Heterodimer, Human (His, solution) | ||
| HY-P71089Y | Rnase 1, Human (HEK293, His, solution) | ||
| HY-P701548 | RNF114, Human | ||
| HY-P701559 | RNF14, Human (His) | ||
| HY-P701668 | DYRK1A, Human (His) | ||
| HY-P701745 | PIM1, Human | ||
| HY-P70175 | LRG1, Human (HEK293, Fc-His) | ||
| HY-P701768 | RIPK1, Human (Sf9, His, GST) | ||
| HY-P701861 | SPR, Human (His) | ||
| HY-P701881 | FASN, Human (Sf9) | ||
| HY-P701945 | CHAC1, Human (Strep) | ||
| HY-P702030 | SLC29A2, Human (Sf9, His, MBP, FLAG) | ||
| HY-P702048 | CRKL, Human | ||
| HY-P702090 | Menin, Human (His) | ||
| HY-P70228 | Kanamycin kinase type II/NEO, Klebsiella pneumoniae | ||
| HY-P70249 | Plasma kallikrein/KLKB1, Human (HEK293, His, solution) | ||
| HY-P70260 | Enolase 1/ENO1, Human (His, solution) | ||
| HY-P70231 | Coagulation factor IX/F9, Human (HEK293, His) | ||
| HY-P702498 | ADAM10, Human (HEK293, His) | ||
| HY-P702527 | MMP-13, Human (HEK293) | ||
| HY-P70253 | Granzyme B/GZMB, Mouse (HEK293, His, solution) | ||
| HY-P70258 | Beta-glucuronidase/GUSB, E.coli (N-His, solution) | ||
| HY-P70259 | LDHA, Mouse (HEK293, His) | ||
| HY-P702743 | MAP4K4, Human (sf9, GST) | ||
| HY-P73374 | Peroxiredoxin-2/PRDX2, Human (sf9, His) | ||
| HY-P73430 | TGFBR2/TGF-beta RII, Rat (HEK293, Fc) | ||
| HY-P73521 | Erythropoietin receptor/EpoR, Human (HEK293 , Fc) | ||
| HY-P73540 | WARS, Human (sf9, His) | ||
| HY-P73543 | Vitamin D Receptor/VDR, Human (sf9, His) | ||
| HY-P73628Y | STAT1, Human (sf9, His-GST, solution) | ||
| HY-P73677 | RFK, Human (His) | ||
| HY-P73690 | P-Selectin, Human (HEK293, Fc) | ||
| HY-P73718 | PDK1, Human (sf9, His) | ||
| HY-P73865 | Integrin alpha V beta 8 Protein, Human (HEK293, His, solution) | ||
| HY-P73914 | I-309/CCL1, Human (HEK293, Fc) | ||
| HY-P73919 | HRAS, Human (sf9, His) | ||
| HY-P74196 | E/Envelope, Dengue virus 2 (102a.a, P.pastoris, His) | ||
| HY-P73305 | DKK-1, Rat (HEK293, His, solution) | ||
| HY-P73344 | PD-1, Human (HEK293, Fc) | ||
| HY-P73378 | Podoplanin, Human (HEK293, His-Fc) | ||
| HY-P73506 | CD84/SLAMF5, Mouse (HEK293, His, solution) | ||
| HY-P73523 | G-CSF, Human (HEK293) | ||
| HY-P73566 | Tryptophan Hydroxylase 1/TPH-1, Human (His) | ||
| HY-P73613 | TGF beta 2/TGFB2, Rhesus Macaque (HEK293, His) | ||
| HY-P74201 | Dectin-2/CLEC6A, Human (HEK293, Fc) | ||
| HY-P74212 | Cyclophilin A, Mouse (His) | ||
| HY-P7435 | SARS-CoV-2 S1 (HEK293, Fc) | ||
| HY-P74372 | C7/Complement component C7, Human (HEK293, Fc) | ||
| HY-P7439 | Nucleocapsid CTD domain, Virus (His) | ||
| HY-P74525 | TGFBI, Human (HEK293, His, solution) | ||
| HY-P7470 | AKR1C4, Human (His) | ||
| HY-P74704 | Neuroligin-1/NLGN1, Mouse (HEK293, His) | ||
| HY-P74754 | MERS-CoV Nucleoprotein/NP (sf9, His) | ||
| HY-P74826 | IL-17RA Protein, Rat (HEK293, hFc) | ||
| HY-P74887 | Histone H1, Human (His) | ||
| HY-P7497 | ABP1/AOC1, Human (HEK293, His) | ||
| HY-P7514 | Annexin A13/ANXA13, Human | ||
| HY-P75152 | GSTM2, Human (His, solution) | ||
| HY-P75226 | Epiregulin, Mouse (HEK293, hFc) | ||
| HY-P7523 | APE, Human | ||
| HY-P75286 | DLAT, Human (sf9, His) | ||
| HY-P75296 | Dectin-1/CLEC7A, Mouse (HEK293, His, solution) | ||
| HY-P75324 | CSF1R, Human (430a.a, sf9, His-GST) | ||
| HY-P7537 | BCL2, Human (His) | ||
| HY-P75381 | CD8 alpha, Cynomolgus (HEK293, Fc) | ||
| HY-P71222A | PPC-DC, Human (His, solution) | ||
| HY-P71227 | PPM1A, Human (His) | ||
| HY-P71300 | Vaspin, Human (HEK293, His) | ||
| HY-P71336 | STAT5B, Human (His) | ||
| HY-P71344 | SULT4A1, Human | ||
| HY-P71351 | TALDO1, Human (HEK293, His) | ||
| HY-P71416 | UPP1, Human (His) | ||
| HY-P71601Y | IL-1F10/IL-38, Mouse (His-SUMO, solution) | ||
| HY-P702600 | USP21, Human (356a.a) | ||
| HY-P702641 | PRKCA, Human (sf9, GST) | ||
| HY-P70277 | Leukotriene A4 Hydrolase/LTA4H, Human (HEK293, His) | ||
| HY-P70283 | G6PD, Human (HEK293, His) | ||
| HY-P702830 | CCR5, Human (HEK293, Flag, His, Strep) | ||
| HY-P70291 | Insulysin/IDE, Human (HEK293, His) | ||
| HY-P70294 | Glutamine synthetase/GLUL, Human (His) | ||
| HY-P73837A | LIGHT/TNFSF14, Mouse (sf9, His, solution) | ||
| HY-P73894 | IL-1RA/IL-1RN, Rat (His, solution) | ||
| HY-P73901 | IgG1, Mouse (HEK293, C102S) | ||
| HY-P73957 | HA/Hemagglutinin, Influenza B (A4D5Q0, sf9, His) | ||
| HY-P74032 | HA/Hemagglutinin, H1N1 (QEM24663, sf9, His) | ||
| HY-P74171 | EphB4, Human (HEK293, Fc) | ||
| HY-P74252 | Chymase/CMA1, Human (sf9, His) | ||
| HY-P74263 | CD81, Mouse (HEK293, Fc) | ||
| HY-P7429 | SARS-CoV-2 3C-likease (His) | ||
| HY-P7431 | SARS-CoV-2 S RBD (194a.a, HEK293, His) | ||
| HY-P74371 | C7/Complement component C7, Human (HEK293, His) | ||
| HY-P74381 | beta-Catenin, Mouse (sf9, His-GST) | ||
| HY-P74404 | B2M/Beta-2 microglobulin, Human (HEK293, His, solution) | ||
| HY-P71672 | ZP3, Human (HEK293, His) | ||
| HY-P72053 | PKM2, Mouse (Baculovirus, His) | ||
| HY-P72405 | PCSK9, Human (Biotinylated, V474I, G670E, HEK293, Avi) | ||
| HY-P72477 | Serpin A8/Angiotensinogen, Human (HEK293, His, solution) | ||
| HY-P72860 | Carbonic Anhydrase 2, Human (C-His, Solution) | ||
| HY-P72861 | Carbonic Anhydrase 2, Mouse (His) | ||
| HY-P74419 | Aldolase B, Human (GST) | ||
| HY-P7443 | ACE2, Human (HEK293, mFc) | ||
| HY-P74444 | SARS-CoV-2 S (Omicron, B.1.1.529, His) | ||
| HY-P74445 | SARS-CoV-2 S1 (Omicron, B.1.1.529, His, solution) | ||
| HY-P74456 | Zika virus E/Envelope (HEK293, His) | ||
| HY-P7448 | CD73/5'-Nucleotidase, Mouse (HEK293, His) | ||
| HY-P74602 | RANTES/CCL5, Rat (P.pastoris, His) | ||
| HY-P74617 | Progranulin/PGRN, Mouse (HEK293, His, solution) | ||
| HY-P74618 | Progranulin/PGRN, Human (HEK293, His) | ||
| HY-P74655 | p67phox, Human (sf9, His-GST) | ||
| HY-P74682 | Neuregulin-2/NRG2, Human (HEK293, His) | ||
| HY-P74684 | Non-structural 1/NS1, H1N1 (His) | ||
| HY-P7469 | AKR1C2, Human | ||
| HY-P74741 | MST4/STK26, Human (sf9, GST) | ||
| HY-P72959 | CTLA-4, Human (HEK293) | ||
| HY-P72970 | Delta-like 1/DLL1, Mouse (HEK293, His) | ||
| HY-P72989 | EGFR, Mouse (HEK293, His) | ||
| HY-P73081 | GM-CSF, Human (HEK293, Fc) | ||
| HY-P73175 | IL-17A, Rabbit (solution) | ||
| HY-P73200 | IL-27, Mouse (228a.a, HEK293, His) | ||
| HY-P73244 | Insulin R/CD220, Human (sf9, His-GST) | ||
| HY-P73464 | TrkC, Human (HEK293, His-Fc) | ||
| HY-P73563 | Tyrosine Hydroxylase, Mouse (sf9, His) | ||
| HY-P73589 | TLR2, Rat (sf9, His) | ||
| HY-P73664 | SARS-CoV-2 S RBD (sf9, His) | ||
| HY-P73719 | PDGF-CC, Mouse (P.pastoris, His) | ||
| HY-P73743 | Neurotensin, Human (HEK293, Fc) | ||
| HY-P73873 | Insulin R/CD220, Human (HEK293, His, solution) | ||
| HY-P70276 | HO-1, Human | ||
| HY-P702821 | SARS-COV-2 S trimer (XBB.1.16, HEK293, His) | ||
| HY-P702845 | PKM2, Human | ||
| HY-P702860 | CDK4 Protein, Human (His, Avi) | ||
| HY-P70295 | Ezrin/EZR, Human | ||
| HY-P703112 | DHX9, Human (Sf9, His) | ||
| HY-P703117 | DRD3, Human (sf9, Flag, His) | ||
| HY-P703151 | IMPDH1, Human | ||
| HY-P70319A | MAG/Siglec-4a, Mouse (HEK293, His, solution) | ||
| HY-P703226 | HSP90B1, Human (His, Strep) | ||
| HY-P703310 | KLHDC2, Human (Sf9, His, GST) | ||
| HY-P703434 | srtA, Staphylococcus aureus (His) | ||
| HY-P703615 | WDR5, Human | ||
| HY-P70390 | Lysozyme C/LYZ, Human (HEK293, His) | ||
| HY-P704021 | Dihydroorotate Dehydrogenase, Human (C-His) | ||
| HY-P7476 | ALDH1A3, Human (His) | ||
| HY-P74767 | L-selectin/CD62L, Human (CHO, His) | ||
| HY-P74852 | IFN-gamma R2, Mouse (HEK293, His) | ||
| HY-P74860 | IFN-alpha/beta R2, Human (HEK293, hFc) | ||
| HY-P74890 | HEXB/Hexosaminidase B, Human (HEK293, His) | ||
| HY-P7500 | AMY2B, Human (HEK293, His) | ||
| HY-P75043 | HA/Hemagglutinin, H5N1 (ACO07033, sf9, His) | ||
| HY-P73916 | HSP60, Mouse (His, solution) | ||
| HY-P73967 | HA/Hemagglutinin, H7N9 (AGI60301, sf9, His) | ||
| HY-P74059 | HA/Hemagglutinin, H1N1 (ACR08536,sf9, His) | ||
| HY-P74112 | HA1/Hemagglutinin, H1N1 (ABD77675, HEK293, His) | ||
| HY-P74125 | GIP, Human (HEK293, hFc, solution) | ||
| HY-P74190 | E/Envelope, Dengue virus 4 (395a.a, sf9, His) | ||
| HY-P75894 | ITCH/AIP4, Human (solution) | ||
| HY-P75992 | PTMA, Human (GST) | ||
| HY-P76006 | RNASET2, Human (sf9, His) | ||
| HY-P76013 | RSPO2/R-spondin-2, Mouse (Fc) | ||
| HY-P76134 | SMPD1, Mouse (sf9, His) | ||
| HY-P7620 | ATG5, Human | ||
| HY-P76219 | CD299, Human (HEK293, Fc) | ||
| HY-P76261 | CIRBP, Human (His) | ||
| HY-P70418 | UDP-glucose 4-epimerase/GALE, Human (His) | ||
| HY-P70453B | Wnt3a Surrogate, Human (HEK293, Fc) | ||
| HY-P70492 | CD73/5'-Nucleotidase, Human (T376A, M379T, HEK293, His) | ||
| HY-P70573 | IRF5, Human | ||
| HY-P70718 | IL-2, Rat (HEK293, His) | ||
| HY-P70731 | CD38, Human (HEK293, His, solution) | ||
| HY-P70834 | INPP5A, Human (HEK293, His) | ||
| HY-P701987 | MMP-13, Human (His) | ||
| HY-P702057 | MYD88, Human (His, GST) | ||
| HY-P702082 | KDM6B, Human (Sf9) | ||
| HY-P702167 | LCC, Unknown prokaryotic organism (His) | ||
| HY-P702584 | USP10, Human (Sf9, His, GST) | ||
| HY-P702601 | CDK6, Human (Sf9, His-Avi) | ||
| HY-P702631 | AKT1, Human (Active, sf9, GST) | ||
| HY-P74266 | CD8 beta, Human (HEK293) | ||
| HY-P74310 | CD28, Rat (HEK293, Fc) | ||
| HY-P7434 | SARS-CoV-2 S1 (HEK293, mFc) | ||
| HY-P74344 | Cathepsin E, Rat (HEK293, His) | ||
| HY-P74408 | ATF2, Human (sf9, His-GST) | ||
| HY-P7442 | ACE2, Human (HEK293, hFc, solution) | ||
| HY-P74446 | SARS-CoV-2 S RBD (Biotinylated, Omicron, B.1.1.529, His-Avi) | ||
| HY-P702975 | PFKFB2, Human (sf9, GST) | ||
| HY-P703152 | IRF1, Human (His, Strep) | ||
| HY-P703165 | Menin, Human (His, T349M) | ||
| HY-P703219 | SLC15A1, Human (HEK293, Strep, His) | ||
| HY-P703252 | SLC4A4, Human (HEK293, His, Strep, GFP) | ||
| HY-P703605 | FXR, Human | ||
| HY-P703940 | Granzyme B/GZMB, Human (227a.a, HEK293, His) | ||
| HY-P70887 | Kallikrein-6, Human (HEK293, His) | ||
| HY-P70968 | OGG1, Human | ||
| HY-P70969 | SULT1A1, Human (His) | ||
| HY-P70984 | PSG9, Human (HEK293, His) | ||
| HY-P71015 | RNASET2, Human (HEK293, His) | ||
| HY-P71020 | UBE2L6, Human (His) | ||
| HY-P71029 | PPIH, Human (His) | ||
| HY-P71036 | HPGDS, Human | ||
| HY-P70400 | Hepcidin/HAMP, Human (GST) | ||
| HY-P704017 | Cathepsin C/DPPI, Mouse (HEK293, His) | ||
| HY-P704031 | ECM1, Human (HEK293, His) | ||
| HY-P704037 | KAT7, Human (Active, sf9, GST) | ||
| HY-P70700 | TMEM173, Human (Sumo-His) | ||
| HY-P70724 | Thrombomodulin, Human (HEK293, His, solution) | ||
| HY-P70851 | LGALSL, Human (His) | ||
| HY-P70934 | Kallikrein-13, Human (HEK293, His) | ||
| HY-P70971 | QPRTase, Human (His) | ||
| HY-P71038 | SH2D1A, Human (His) | ||
| HY-P71073 | SOD2/Mn-SOD, Human (HEK293, His) | ||
| HY-P71111 | Pentraxin 2/SAP, Mouse (HEK293, His) | ||
| HY-P71115 | UCHL3, Human (His) | ||
| HY-P71224 | PPID, Human (His, solution) | ||
| HY-P71228 | PPP1CC, Human (His) | ||
| HY-P71231 | PRDX1, Human (His) | ||
| HY-P71288 | SENP2, Human | ||
| HY-P71323 | SMAD3, Human (Flag-His) | ||
| HY-P71369 | TINAGL1, Human (HEK293, His) | ||
| HY-P71671 | Transthyretin/TTR, Cynomolgus (HEK293, His, Myc) | ||
| HY-P72209A | GOLM1, Human (His, Solution) | ||
| HY-P72451 | Thrombomodulin, Mouse (HEK293, His) | ||
| HY-P70264A | FABP1/L-FABP, Human (His, solution) | ||
| HY-P70265 | LDHB, Human (His) | ||
| HY-P702676 | CDK2-CCND1, Human (sf9, GST, Flag, His) | ||
| HY-P702682 | CDK4-CCND1, Human (sf9, GST, Flag, His) | ||
| HY-P70279 | Esterase D/FGH, Human (His) | ||
| HY-P702832 | EGFR, Human (T790M, L858R, sf9, Strep, GST, His) | ||
| HY-P70298 | Histatin-3/HTN3, Human | ||
| HY-P71082 | S100A6, Human (His) | ||
| HY-P71089 | Rnase 1, Human (HEK293, His) | ||
| HY-P71090 | PFKM, Human (HEK293, His) | ||
| HY-P71118 | PFKFB1, Human (HEK293, His) | ||
| HY-P71132 | TGM2/Transglutaminase 2, Mouse (HEK293, His) | ||
| HY-P71210 | PKLR, Human (HEK293, His) | ||
| HY-P71230 | PPT1, Human (HEK293, His) | ||
| HY-P70306 | MGMT, Human (His) | ||
| HY-P703075 | FASN, Human (Sf9, His, Strep, Flag) | ||
| HY-P703116 | DRD2, Human (Sf9, Flag, His) | ||
| HY-P703141 | GSPT1, Human (Sf9, Biotinylated) | ||
| HY-P70316 | Elafin/Trappin-2, Human (HEK293, His) | ||
| HY-P70322 | HER3, Human (HEK293, Fc) | ||
| HY-P703299 | CPEB3, Human (His, Strep) | ||
| HY-P72580 | IL-17RC, Human (HEK293, Fc) | ||
| HY-P72612 | IFN-gamma R1/CD119, Human (HEK293, His, solution) | ||
| HY-P72826 | Aminopeptidase A, Rat (sf9, His) | ||
| HY-P72846 | Bcl-XL, Mouse (His) | ||
| HY-P72871 | Cardiotrophin-1/CTF1, Human (HEK293, Fc) | ||
| HY-P72884 | 4-1BB/TNFRSF9, Mouse (HEK293, His) | ||
| HY-P72933 | CLPS, Human (sf9, His) | ||
| HY-P76325 | EXOSC9, Human (sf9, His) | ||
| HY-P76444 | HA1/Hemagglutinin, H13N6 (AAV91213, sf9, His) | ||
| HY-P76484 | MAGOH, Human (His) | ||
| HY-P76554 | PSME3, Human (His) | ||
| HY-P7658 | BDH1, Human (His) | ||
| HY-P7659 | BDH2, Human (His) | ||
| HY-P76664 | STAT4, Human (sf9, His) | ||
| HY-P7668 | PRCP, Human (HEK293, His) | ||
| HY-P71232 | PRDX4, Human (His) | ||
| HY-P71264 | RPE, Human (His) | ||
| HY-P71343 | SULT2A1, Human (His) | ||
| HY-P71359 | THOP1, Human (His) | ||
| HY-P71372 | Troponin C/TNNC1, Human (His) | ||
| HY-P71395 | UBA5, Human (His) | ||
| HY-P71399 | UBE2D1, Human (GST) | ||
| HY-P72616 | IDO-1, Mouse (His) | ||
| HY-P703315 | DCAF4, Human (Sf9, His, Strep) | ||
| HY-P703383 | SLC15A4, Human (HEK293, His) | ||
| HY-P703486 | aerA | ||
| HY-P703593 | TNFAIP3, Human (GST, His) | ||
| HY-P70365 | Galactokinase/GALK1, Human (His) | ||
| HY-P70586 | IL-1beta, Human (solution) | ||
| HY-P70708 | Fc gamma RIII/CD16, Mouse (HEK293, His) | ||
| HY-P74466 | VEGFR-3/FLT4, Mouse (HEK293, His) | ||
| HY-P7453 | ACTB, Human (His) | ||
| HY-P74568 | SCG3/Secretogranin-3, Human (HEK293, His, solution) | ||
| HY-P7460 | ADAMDEC1, Human (HEK293, His) | ||
| HY-P74605 | AGER, Human (HEK293) | ||
| HY-P74649 | PCBP1, Human (His) | ||
| HY-P7465 | AG-2, Human (HEK293, His, solution) | ||
| HY-P72625A | HER3, Human (HEK293, His, solution) | ||
| HY-P72730 | CD39L1/ENTPD2, Human (HEK293, His) | ||
| HY-P72757 | MCP-1/CCL2, Mouse (HEK293, His) | ||
| HY-P72823 | Alpha-2-macroglobulin, Human (sf9, His) | ||
| HY-P72845 | BCAM, Rat (HEK293, His) | ||
| HY-P72850 | BCMA/TNFRSF17, Mouse (HEK293, His-Fc) | ||
| HY-P72867 | Carbonic Anhydrase 14, Human (HEK293, His) | ||
| HY-P76761 | CaMKII alpha/CAMK2A, Human (sf9, GST) | ||
| HY-P76858 | DAPK1, Human (sf9, His-GST) | ||
| HY-P76924 | FCRL2, Human (HEK293, His) | ||
| HY-P77015 | HA/Hemagglutinin, H11N2 (ADD21478, sf9, His) | ||
| HY-P77019 | HA/Hemagglutinin, H12N1 (ABB88099, sf9, His) | ||
| HY-P77020 | HA/Hemagglutinin, H14N5 (P26136, sf9, His) | ||
| HY-P72947 | Contactin-3/CNTN3, Human (N708D, HEK293, Fc) | ||
| HY-P72995 | EphA4, Mouse (HEK293, Fc) | ||
| HY-P73015 | Ephrin-B2/EFNB2, Human (HEK293) | ||
| HY-P73114 | ICAM-1/CD54, Rat (HEK293, His) | ||
| HY-P73129 | IFN-beta, Human (HEK293, Fc) | ||
| HY-P73243 | Insulin, Human (P.pastoris) | ||
| HY-P73280 | LIF, Mouse (HEK293, His) | ||
| HY-P7508 | ANGPTL4/Angiopoietin-related 4, Mouse (HEK293, Fc, solution) | ||
| HY-P75141 | HA/Hemagglutinin, H10N8 (EPI497477, sf9, His) | ||
| HY-P75187 | FHIT, Human (His) | ||
| HY-P75225 | Epstein-Barr virus Glycoprotein gp350/GP350 (HEK293, His) | ||
| HY-P75253 | Enolase 1/ENO1, Rat (His) | ||
| HY-P75309 | DARS, Human (His) | ||
| HY-P75349 | CHEK2, Human (sf9, GST) | ||
| HY-P77059 | LIFR, Human (HEK293, His) | ||
| HY-P77065 | Livin/BIRC7, Human (His) | ||
| HY-P77163 | CD162/PSGL-1, Human (HEK293, His) | ||
| HY-P77336 | CLEC4E, Rhesus Macaque (HEK293, Fc) | ||
| HY-P77347 | PD-L1, Cynomolgus/Rhesus Macaque (HEK293, His) | ||
| HY-P7735 | Carboxypeptidase B2/CPB2, Human (HEK293, His) | ||
| HY-P7736 | Carboxypeptidase E/CPE, Human (HEK293 His) | ||
| HY-P70837 | KPNB1, Human (His) | ||
| HY-P70878 | EDIL3, Human (HEK293, His, solution) | ||
| HY-P70931 | MAPKSP1, Human (His) | ||
| HY-P70957 | MAN1B1, Human (HEK293, His) | ||
| HY-P71022 | PP1MG, Human (His) | ||
| HY-P71072 | TFF1, Human (HEK293, His) | ||
| HY-P71074 | Thymidine kinase 1/TK1, Human (HEK293, His) | ||
| HY-P71087 | P4HB, Human (HEK293, His) | ||
| HY-P73322 | Noggin, Human (HEK293, His) | ||
| HY-P73324 | NOTCH1, Mouse (sf9, His) | ||
| HY-P73381 | Prolactin, Mouse (Sf9, His) | ||
| HY-P73425 | TFPI, Mouse (HEK293, His) | ||
| HY-P73477 | VEGFR-2, Human (208a.a, HEK293, Fc) | ||
| HY-P73556 | VEGF145, Human (HEK293, solution) | ||
| HY-P73640 | Siglec-3/CD33, Mouse (HEK293, Fc) | ||
| HY-P72943 | CNTF, Human (His) | ||
| HY-P72955 | CSF1R, Rat (HEK293, His) | ||
| HY-P73038 | Erythropoietin/EPO, Mouse (HEK293, solution) | ||
| HY-P73053 | FGF-9, Human (HEK293, Fc, solution) | ||
| HY-P73174 | IL-17A, Mouse | ||
| HY-P73219 | IL-5, Mouse (sf9, His) | ||
| HY-P73255 | IRAK4, Human (sf9, His) | ||
| HY-P73282 | LOK, Human (His) | ||
| HY-P71119 | NPPB, Human (His, solution) | ||
| HY-P71185 | PAFAHB, Human (His) | ||
| HY-P71252 | RCN2, Human (HEK293, His) | ||
| HY-P71277 | SAA4, Human (His) | ||
| HY-P71310 | Sialidase-1, Human (HEK293, His) | ||
| HY-P71328 | SORD, Human (HEK293, His) | ||
| HY-P71403 | UBE2I, Human (GST) | ||
| HY-P71409 | UBE2T, Human (His) | ||
| HY-P74743 | MRAP, Human (HEK293, hFc) | ||
| HY-P74774 | Lipocalin-2/NGAL, Rat (sf9, His) | ||
| HY-P74804 | IL-31 Protein, Mouse (HEK293, His) | ||
| HY-P74845 | IGFBP-4, Mouse (HEK293, His) | ||
| HY-P74867 | IdeS, Streptococcus pyogenes (His, solution) | ||
| HY-P7491 | Serpin A1a, Mouse (HEK293, His) | ||
| HY-P75012 | HA/Hemagglutinin, H9N2 (ADC41863, sf9, His) | ||
| HY-P75182 | Fusion glycoprotein F0/F, HRSV (sf9, His) | ||
| HY-P75229 | Ephrin B3, Mouse (HEK293, hFc) | ||
| HY-P75399 | CD52, Human (HEK293, hFc) | ||
| HY-P7540 | ARC, Human | ||
| HY-P7541 | Arginase-1/ARG1, Human (C-His) | ||
| HY-P75417 | CD39, Human (sf9, His) | ||
| HY-P75672 | Chk1, Human (sf9, GST) | ||
| HY-P71699A | HLA-B, Human (N-His) | ||
| HY-P72044 | TMPRSS2, Human (R255Q, HEK293, His) | ||
| HY-P72338 | OGG1, Human (His) | ||
| HY-P72824 | Aminopeptidase A, Human (sf9, His) | ||
| HY-P72889 | CD200, Mouse (HEK293, His) | ||
| HY-P72907 | CD40L/CD154/TRAP, Human (His) | ||
| HY-P73200Y | IL-27, Mouse (HEK293, His, solution) | ||
| HY-P75706 | DERP1, Dermatophagoides pteronyssinus (C132A, N150E, HEK293, His) | ||
| HY-P75790 | Glucokinase/GCK, Human | ||
| HY-P75903 | KYNU/Kynureninase, Human (sf9, His) | ||
| HY-P75935 | NEK7, Human (sf9, His-GST) | ||
| HY-P75944 | Neuregulin-3/NRG3, Human (61a.a, HEK293, His) | ||
| HY-P7602 | Arginase-1/ARG1, Human (HEK293, His) | ||
| HY-P76058 | Serglycin/SRGN, Human (HEK293, His-Myc) | ||
| HY-P76101 | Syndecan-1/CD138, Mouse (HEK293, His) | ||
| HY-P76103 | TCPTP, Human (sf9, solution) | ||
| HY-P76142 | AMPK gamma 1/beta 1/alpha 2 Heterotrimer, Human (sf9, His-GST) | ||
| HY-P76143 | AMPK gamma 1/beta 2/alpha 1 Heterotrimer, Human (sf9, His-GST) | ||
| HY-P76144 | AMPK gamma 1/beta 2/alpha 2 Heterotrimer, Human (sf9, His-GST) | ||
| HY-P7617 | ATG3, Human | ||
| HY-P76174 | BMPRIB/ALK-6, Human (sf9, His-GST) | ||
| HY-P76192A | CES2/carboxylesterase 2 , Human (HEK293,C-His,Solution) | ||
| HY-P76301 | DSC2/Desmocollin-2, Human (HEK293, His) | ||
| HY-P76345 | FKBP12, Human (His) | ||
| HY-P76462 | IFN-alpha 5/IFNA5, Rat (HEK293, His) | ||
| HY-P7647 | BAG-2, Human (His) | ||
| HY-P76478 | LRPAP1, Human (HEK293, His) | ||
| HY-P76479 | LRPAP1, Mouse (HEK293, His, Solution) | ||
| HY-P76530 | Osteomodulin, Mouse (HEK293, His) | ||
| HY-P76578 | RIOK1, Human (sf9, His-GST) | ||
| HY-P76583 | S100A13, Mouse (His) | ||
| HY-P7664 | Biliverdin Reductase A/BLVRA, Human (C-His) | ||
| HY-P76688A | UBE2F, Human (His, Solution) | ||
| HY-P76800 | Fc gamma RIIB/CD32b, Cynomolgus (HEK293, His) | ||
| HY-P76834 | CLEC4D, Human (HEK293, His) | ||
| HY-P76869 | DDR2, Human (HEK293, His) | ||
| HY-P7688 | BUP-1, Human (His) | ||
| HY-P77021 | HA/Hemagglutinin, H15N2 (ABB90704, sf9, His) | ||
| HY-P77064 | LILRB3/CD85a, Mouse (HEK293, His) | ||
| HY-P77196 | SERPINB10, Mouse (sf9, His) | ||
| HY-P73248 | IFN-alpha 2/IFNA2, Mouse (HEK293, Fc) | ||
| HY-P73387 | RANKL/TNFSF11, Human (HEK293, hFc) | ||
| HY-P73431 | Thioredoxin/TXN, Human (Solution) | ||
| HY-P7352 | FGF-9, Mouse (His, solution) | ||
| HY-P73526 | Serpin G1, Human (HEK293, His) | ||
| HY-P73829 | M-CSF, Human (HEK293, Fc) | ||
| HY-P73846 | Ku70-Ku80 Heterodimer, Human (sf9, His) | ||
| HY-P77207 | SLITRK4, Human (HEK293, His) | ||
| HY-P77211 | Sorcin/SRI, Human (sf9, His-GST) | ||
| HY-P77258 | TRXR1/TXNRD1, Human (His) | ||
| HY-P77273 | UMP-CMP kinase/CMPK1, Human (sf9, His, solution) | ||
| HY-P77308 | ABL1, Human (sf9, GST) | ||
| HY-P7737 | Carboxypeptidase M/CPM, Human (HEK293, His) | ||
| HY-P7744 | Catalase, Human | ||
| HY-P77366 | FGL1, Cynomolgus (HEK293, Fc) | ||
| HY-P77514 | C-Reactive, Human (Biotinylated, HEK293) | ||
| HY-P77727 | Cas9, S. pyogenes (His) | ||
| HY-P77936 | FOLR4, Human (HEK293, His) | ||
| HY-P77973 | Plasma kallikrein/KLKB1, Mouse (HEK293, His, solution) | ||
| HY-P78164 | KGF/FGF-7, Human (Biotinylated, His) | ||
| HY-P78248 | CCL24/Eotaxin-2, Mouse (HEK293, His) | ||
| HY-P7828 | ACE2, Rhesus macaque (HEK293, His) | ||
| HY-P7829 | Cutinase, Thermobifida Fusca (His) | ||
| HY-P78329 | Lipocalin-2/NGAL, Mouse (HEK293, Fc) | ||
| HY-P7836 | CD73/5'-Nucleotidase, Cynomolgus (HEK293, His) | ||
| HY-P78368 | Claudin-18/CLDN18.2-VLP, Human (HEK293) | ||
| HY-P78542 | Apolipoprotein E/APOE4, Human (C130R, HEK293, Fc, solution) | ||
| HY-P71141 | SHP-1, Human (His) | ||
| HY-P71147 | PRDX3, Human | ||
| HY-P71150 | DUSP3, Human (His) | ||
| HY-P71192 | PDIA5, Human (HEK293, His) | ||
| HY-P71209 | PKI-beta, Human (His) | ||
| HY-P71320 | SLP-76, Human (His-T7) | ||
| HY-P71331 | SPINK7, Human (HEK293, His) | ||
| HY-P71364 | TIM, Human (His) | ||
| HY-P71379 | TRAT1, Human (His) | ||
| HY-P71397 | UBE2A, Human (GST-His) | ||
| HY-P71402 | UBE2H, Human (GST) | ||
| HY-P71418 | USP14, Human (His) | ||
| HY-P72356 | CD38, Human (Biotinylated, HEK293, His-Avi) | ||
| HY-P72655 | FCRL1, Human (HEK293, His) | ||
| HY-P72658 | Fas Ligand, Human (HEK293, His) | ||
| HY-P72659 | FAP, Human (HEK293, His) | ||
| HY-P72819 | ACVRL1/ALK1, Mouse (HEK293, His-Fc) | ||
| HY-P72839 | B7-H6, Human (HEK293, Fc) | ||
| HY-P72910 | CD40, Human (HEK293, Fc) | ||
| HY-P72927 | CD64, Mouse (HEK293, His-Avi) | ||
| HY-P72938 | HGFR, Human (sf9, His-GST) | ||
| HY-P72980 | EGF, Canine (P.pastoris) | ||
| HY-P72982 | EGF, Human (HEK293, N-hFc, solution) | ||
| HY-P75392 | CD58, Human (HEK293, Fc) | ||
| HY-P75504 | Apolipoprotein L/APOL1, Human (sf9, His) | ||
| HY-P75519 | AKT3, Human (sf9, GST) | ||
| HY-P75542 | ACK1, Human (sf9, GST) | ||
| HY-P75567Y | AARS1, Mouse (sf9, His, solution) | ||
| HY-P75584 | Artemin, Mouse (HEK293, Fc) | ||
| HY-P75608 | CD131, Human (HEK293, His) | ||
| HY-P72987 | EGFR, Human (sf9, His-GST) | ||
| HY-P73004 | EphB4, Mouse (HEK293, Fc) | ||
| HY-P73104 | HMGB1/HMG-1, Mouse (HEK293, Fc, solution) | ||
| HY-P73138 | IGFBP-3, Human (HEK293, His) | ||
| HY-P73148 | IL-1 beta, Feline | ||
| HY-P73156 | GMP IL-12, Human (HEK293, His) | ||
| HY-P73181 | IL-18, Mouse (solution) | ||
| HY-P75760 | FCGRT-B2M Heterodimer, Rat (HEK293, His, solution) | ||
| HY-P75765 | FGFR-1 beta (IIIb), Human (HEK293, Fc) | ||
| HY-P75800 | GSTK1, Human | ||
| HY-P75892 | IFN-alpha 5/IFNA5, Human (HEK293, Fc) | ||
| HY-P75897Y | KEAP1, Human (sf9, solution) | ||
| HY-P75936 | NELL2, Human (sf9, His) | ||
| HY-P75966 | PDGF-BB, Cynomolgus (HEK293, Fc) | ||
| HY-P7896 | CD20/MS4A1, Human (Trx-His, Solution) | ||
| HY-P79018 | TYR, Human (HEK293, His) | ||
| HY-P79211 | Heparinase III, P. heparinus (His) | ||
| HY-P990020 | Eglatoprutug | 2518200-21-8 | |
| HY-P990023 | Bempikibart | 2622254-57-1 | |
| HY-P990059 | Puxitatug | 2760250-47-1 | |
| HY-P990068 | Perenostobart | 2643331-31-9 | |
| HY-P990081 | Oloctinebart | 2669063-84-5 | |
| HY-P990094 | Trabikibart | 2643974-98-3 | |
| HY-P99010 | Bemarituzumab | 1952272-74-0 | |
| HY-P73197 | IL-23R, Rat (HEK293, Fc) | ||
| HY-P73230 | IL-9, Rat (sf9, His) | ||
| HY-P73249 | IFN-alpha B/IFNA8, Cynomolgus (HEK293, Fc) | ||
| HY-P73256 | IRE1, Human (sf9, His-GST) | ||
| HY-P73309 | Neuropilin-1, Human (Biotinylated, HEK293, His-Avi, solution) | ||
| HY-P73332 | TNFRSF11B/OPG, Human (HEK293, His, solution) | ||
| HY-P73422 | Src, Human (sf9, His-GST) | ||
| HY-P77458 | OX40 Ligand/TNFSF4, Human (HEK293, Fc) | ||
| HY-P77543 | TNF-alpha/TNFSF2, Cynomolgus (Biotinylated) | ||
| HY-P77872 | Apolipoprotein A-V/APOA5, Mouse (His) | ||
| HY-P78149 | IL-21, Mouse (Biotinylated, His-Avi) | ||
| HY-P78155 | IL-5, Mouse (Biotinylated, HEK293, His-Avi) | ||
| HY-P7827 | Creatine kinase M-type/CKM, Human (HEK293, His) | ||
| HY-P73848 | JNK1, Human (sf9, GST) | ||
| HY-P73886 | IL-23R, Human (HEK293, His) | ||
| HY-P73898 | IL-12, Human (HEK293, His) | ||
| HY-P74034 | HA/Hemagglutinin, H1N1 (P03452, sf9, His) | ||
| HY-P74067 | HA/Hemagglutinin, H1N1 (ACF41933, sf9, His) | ||
| HY-P74120 | envelope glycoprotein gp120, HIV-1 (AAC57427, HEK293 , His) | ||
| HY-P74194 | E/Envelope, Dengue virus 2 (429a.a, sf9, His) | ||
| HY-P73335 | p38 alpha/MAPK14, Human (Activated, sf9, His) | ||
| HY-P73337 | PARP, Mouse (sf9, His) | ||
| HY-P73414A | SLPI, Human (107a.a, sf9, His, solution) | ||
| HY-P73423 | Src, Mouse (sf9, His-GST) | ||
| HY-P73486 | YES1, Human (sf9, His-GST) | ||
| HY-P73565 | Tubulin cofactor A, Human | ||
| HY-P74128 | GARS, Human (sf9, His) | ||
| HY-P76009 | ROBO4, Human (HEK293, His) | ||
| HY-P76021 | SARS-CoV-2 Plpro/Papain-like protease (His) | ||
| HY-P76055 | Semaphorin-4A/SEMA4A, Human (HEK293, Fc) | ||
| HY-P76086 | SR-BI/SCARB1, Mouse (HEK293, His-Fc) | ||
| HY-P76126 | VNN1/Vanin-1, Mouse (HEK293, Fc) | ||
| HY-P7613 | ASS1, Human (His) | ||
| HY-P76145 | Angiopoietin-1, Cynomolgus (HEK293, Fc) | ||
| HY-P99016A | Enfortumab vedotin-ejfv | 1346452-25-2 | |
| HY-P99018 | Etokimab | 2022981-44-6 | |
| HY-P99026 | Lemzoparlimab | 2377483-71-9 | |
| HY-P990314 | AFM24 | ||
| HY-P99044 | Sabatolimab | 2252262-24-9 | |
| HY-P99046 | Selicrelumab | 1622140-49-1 | |
| HY-P99050 | Sutimlimab | 2049079-64-1 | |
| HY-P99058 | Zolbetuximab | 1496553-00-4 | |
| HY-P990638 | NI-0701 | ||
| HY-P990646 | Anti-TPBG Antibody (PF-06263507) | ||
| HY-P990670 | TTX-030 | 2935496-38-9 | |
| HY-P990688 | Xaluritamig | 2559056-68-5 | |
| HY-P9906A | Bevacizumab (PBS) | 216974-75-3 | |
| HY-P990715 | Ozekibart | 2539847-03-3 | |
| HY-P990747 | Lumrotatug | 2760318-99-6 | |
| HY-P991040 | hu14.18 (K322A) | ||
| HY-P991041 | Anti-SEZ6 Antibody (SC17) | ||
| HY-P991045 | Donanemab (Mouse IgG2a) | ||
| HY-P991049 | Atrosimab | ||
| HY-P991089 | GEN-1044 | ||
| HY-P99152 | Muromonab | 140608-64-6 | |
| HY-P9916 | Sarilumab | 1189541-98-7 | |
| HY-P99164 | Zagotenemab | 2019133-28-7 | |
| HY-P9917 | Tocilizumab | 375823-41-9 | |
| HY-P99183 | Abituzumab | 1105038-73-0 | |
| HY-P99184 | Abrilumab | 1342290-43-0 | |
| HY-P73678 | RET, Human (sf9, His-GST) | ||
| HY-P73811 | MKK6, Human (S207D, T211D, sf9, His-GST) | ||
| HY-P73861 | IFN-alpha B/IFNA8, Human (HEK293) | ||
| HY-P73915 | HSPA8/HSC70, Human (His, Solution) | ||
| HY-P74092 | HA/Hemagglutinin, H1N1 (AAD17229, HEK293, His) | ||
| HY-P74126 | GFER, Human (HEK293, His, solution) | ||
| HY-P74132 | Galanin, Human (HEK293, Fc) | ||
| HY-P74138 | Frizzled-5, Human (HEK293, His) | ||
| HY-P74289 | CD47, Mouse (HEK293, solution) | ||
| HY-P74394 | B7-H4, Mouse (HEK293, His) | ||
| HY-P74412 | Angiopoietin-1, Mouse (HEK293, His, solution) | ||
| HY-P74420 | AKT2, Human (sf9, His-GST) | ||
| HY-P7444 | MASP1, Human (HEK293, His) | ||
| HY-P74447 | SARS-CoV-2 S RBD (Omicron, B.1.1.529, His) | ||
| HY-P78338 | PGLYRP1/PGRP-S, Mouse (HEK293, Fc) | ||
| HY-P78543 | CD20/MS4A1-VLP, Human (HEK293) | ||
| HY-P78739 | JAK1, Human (sf9, His) | ||
| HY-P78747 | Furin/PCSK3, Human (HEK293, His) | ||
| HY-P7897 | Creatine kinase B-type/CKB, Human (His) | ||
| HY-P7899 | Aminopeptidase N/APN, Human (HEK293, His, solution) | ||
| HY-P79126 | HO-2/HMOX2, Human (His) | ||
| HY-P990009 | Nisevokitug | 2649854-92-0 | |
| HY-P990019 | Epacmarstobart | 2518200-89-8 | |
| HY-P99002 | Human IgG2 kappa, Isotype Control | ||
| HY-P990040 | Exlinkibart | 2642171-64-8 | |
| HY-P990045 | Lixudebart | 2749515-10-2 | |
| HY-P990049 | Becotatug | 2648260-93-7 | |
| HY-P99009 | Batoclimab | 2187430-05-1 | |
| HY-P99027 | Ieramilimab | 2137049-37-5 | |
| HY-P99028 | Ibalizumab | 680188-33-4 | |
| HY-P990328 | Anti-AGER/RAGE Antibody (XT-M4) | ||
| HY-P99034 | Moxetumomab | 1622075-65-3 | |
| HY-P73428 | TGFBR2/TGF-beta RII, Human (sf9, His) | ||
| HY-P73449 | TNF RI/TNFRSF1A, Mouse (HEK293, Fc) | ||
| HY-P73574 | TrkB, Rat (HEK293, His, solution) | ||
| HY-P73585 | TOP1, Human (575a.a, sf9, His) | ||
| HY-P73618 | Fetal-tau/0N3R, Human (His, solution) | ||
| HY-P73729 | PCNA, Human (sf9, His) | ||
| HY-P73741 | NRAS, Human (His, solution) | ||
| HY-P74204 | DDC, Mouse (sf9, His) | ||
| HY-P74211 | Cyclophilin F/PPIF, Human (HEK293, His, solution) | ||
| HY-P74221 | C-Reactive, Human (HEK293, solution) | ||
| HY-P74257 | CDK1-CCNE1 Heterodimer, Human (sf9, His-GST) | ||
| HY-P74382 | beta-Catenin, Human (sf9, His-GST) | ||
| HY-P74442 | IGF-I R, Human (HEK293, His, solution) | ||
| HY-P74471 | VEGFR-2, Mouse (HEK293, His) | ||
| HY-P74472 | VEGFR-2, Mouse (Biotinylated, HEK293, His) | ||
| HY-P74491 | TRIB3, Human (sf9, GST) | ||
| HY-P74546 | SIRP alpha/CD172a, Human (G75A, HEK293, His) | ||
| HY-P74563 | Semaphorin-4D/SEMA4D, Mouse (HEK293, His) | ||
| HY-P74565 | Semaphorin-4D/SEMA4D, Human (HEK293, hFc) | ||
| HY-P74589 | S100A1, Human | ||
| HY-P74620 | PRC1, Human (sf9, His) | ||
| HY-P74621 | PRAK/MAPKAPK5, Human (sf9, His-GST) | ||
| HY-P7468 | AGR3, Mouse (HEK293, His) | ||
| HY-P74766 | L-selectin/CD62L, Mouse (3332a.a, HEK293, His) | ||
| HY-P7478 | Aldolase C, Human (HEK293, His) | ||
| HY-P74781 | LAMP2/CD107b, Mouse (HEK293, His) | ||
| HY-P74797 | IP-10/CXCL10, Rat (P.pastoris, His) | ||
| HY-P74279 | CD68, Human (sf9, His) | ||
| HY-P74342 | CCL4, Human (P.pastoris, His) | ||
| HY-P7436 | SARS-CoV-2 S1 (HEK293) | ||
| HY-P7438 | Nucleocapsid NTD domain, Virus (His) | ||
| HY-P74402 | B2M/Beta-2 microglobulin, Rat (HEK293, His, solution) | ||
| HY-P7441 | ACE2, Human (HEK293, His, solution) | ||
| HY-P74423Y | AGO2/Argonaute-2, Mouse (sf9, His, solution) | ||
| HY-P74455 | Zika virus NS1 (HEK293, His) | ||
| HY-P7447 | 4-1BB/TNFRSF9, Mouse (HEK293, Fc, solution) | ||
| HY-P7450 | PGD, Human (HEK293, His) | ||
| HY-P74625 | PLTP, Human (HEK293, His) | ||
| HY-P74639 | PDK4, Mouse (sf9, His-GST) | ||
| HY-P74652 | PARP1, Human (sf9, His) | ||
| HY-P74742 | MST1/STK4, Human (sf9, His) | ||
| HY-P99035 | Naptumomab | 1412892-09-1 | |
| HY-P99038 | Odronextamab | 1801338-64-6 | |
| HY-P990394 | Anti-CXCR3/GPR9/CD183 Antibody | ||
| HY-P990396 | Anti-CYR61/CCN1 Antibody | ||
| HY-P990465 | Anti-Meflin Antibody | ||
| HY-P990498 | Anti-RGMC/HFE2 Antibody (DISC-0974) | ||
| HY-P990534 | Anti-TSHR Antibody (K1-70) | ||
| HY-P990537 | Anti-VCAM1/CD106 Antibody | ||
| HY-P99054 | Tusamitamab | 2349294-95-5 | |
| HY-P990552 | ATN-658 | ||
| HY-P990569 | CM-24 | 1783801-93-3 | |
| HY-P990598 | Adakitug | 2231258-73-2 | |
| HY-P990620 | LY3022856 | ||
| HY-P990624 | MEDI-2045 | ||
| HY-P990645 | PF-03732010 | 2070913-84-5 | |
| HY-P990687 | Luveltamab | ||
| HY-P990706 | Povetacicept | 2490217-42-8 | |
| HY-P990756 | Pemivibart | 2858673-18-2 | |
| HY-P990766 | Sipavibart | 2768288-97-5 | |
| HY-P990774 | Verekitug | 2768386-15-6 | |
| HY-P990918 | Emiltatug | 2855971-15-0 | |
| HY-P990984 | Eclutatug | 2922054-25-7 | |
| HY-P99102 | Zinlirvimab | 2417213-75-1 | |
| HY-P99103 | Bebtelovimab | 2578319-11-4 | |
| HY-P99112 | Satralizumab | 1535963-91-7 | |
| HY-P99132 | Anti-Mouse CTLA-4 Antibody (9D9) | ||
| HY-P99144 | Anti-Mouse PD-1 Antibody (RMP1-14) | ||
| HY-P99144A | Anti-Mouse PD-1 Antibody (S-5001) | ||
| HY-P99163 | Tilavonemab | 2096513-89-0 | |
| HY-P99179 | CTX-2026 | ||
| HY-P99196 | Ficlatuzumab | 1174900-84-5 | |
| HY-P99202 | Vibostolimab | 2231305-30-7 | |
| HY-P99215 | Parsatuzumab | 1312797-14-0 | |
| HY-P99227 | Caplacizumab | 915810-67-2 | |
| HY-P99231 | Edrecolomab | 156586-89-9 | |
| HY-P99233 | Camidanlumab | 921618-45-3 | |
| HY-P99244 | Fezakinumab | 1007106-86-6 | |
| HY-P99246 | Bermekimab | 1401965-15-8 | |
| HY-P99253 | Mogamulizumab | 1159266-37-1 | |
| HY-P99254 | Racotumomab | 946832-34-4 | |
| HY-P99258 | Brontictuzumab | 1447814-75-6 | |
| HY-P76264 | CKMT1A, Human (sf9, His) | ||
| HY-P76279 | CL-P1/COLEC12, Rat (sf9, His) | ||
| HY-P76379 | HAPLN1, Human (HEK293, His) | ||
| HY-P76401 | IFN-alpha 14/IFNA14, Mouse (HEK293, His) | ||
| HY-P76506 | OCAM/NCAM2, Human (HEK293, His) | ||
| HY-P76532 | p38 gamma/MAPK12, Human (sf9) | ||
| HY-P76582 | RSPO2/R-Spondin 2, Human (HEK293, Fc) | ||
| HY-P73750 | N-Cadherin, Mouse (HEK293) | ||
| HY-P73811A | MKK6, Human (S207D, T211D, sf9, His) | ||
| HY-P73824 | Mer, Human (HEK293) | ||
| HY-P73904 | IgG, Rabbit (T185A, N284S, HEK293) | ||
| HY-P74039 | HA/Hemagglutinin, H1N1 (Biotinylated, ACP41105, sf9, His) | ||
| HY-P74141 | Frizzled-4/CD344, Human (HEK293, Fc) | ||
| HY-P74383 | BDNF, Mouse (R129A, R130A, HEK293, His, Solution)) | ||
| HY-P74388 | Basigin/CD147, Human (HEK293) | ||
| HY-P74441 | Lymphocyte antigen 86/MD-1, Mouse (HEK293, His) | ||
| HY-P74478 | USP7, Human (sf9) | ||
| HY-P7451 | MCAD, Human (His) | ||
| HY-P74522 | TGFBR1/ALK-5, Human (sf9, His-GST) | ||
| HY-P74537 | SRP54, Human (sf9, His) | ||
| HY-P74552 | SFRP4, Human (CHO, His) | ||
| HY-P74608 | RAC1, Human (sf9, GST) | ||
| HY-P74636 | PFKFB3, Human (sf9, His-GST) | ||
| HY-P74638 | Periostin, Human (781a.a, HEK293, His) | ||
| HY-P74680 | Nucleophosmin/Npm1, Human (193a.a, His, soultion) | ||
| HY-P7474 | ALDH1A1, Human (His) | ||
| HY-P74762 | Matrix 1/M1, H1N1 (NP_040978, His) | ||
| HY-P74791 | L1CAM, Human (HEK293, His) | ||
| HY-P74427 | Adenylate Kinase 1/AK1, Rat (His) | ||
| HY-P74428 | Adenylate Kinase 1/AK1, Human (His) | ||
| HY-P74432 | Aconitase 2/ACO2, Human (sf9, His-GST) | ||
| HY-P74468 | VEGFR-3/FLT4, Human (HEK293, His) | ||
| HY-P74523 | TGFBR1/ALK-5, Human (HEK293, His-Fc) | ||
| HY-P74581 | SARS-CoV Plpro/papain-like protease (His) | ||
| HY-P74619 | PRNP/CD230, Human (HEK293, Fc) | ||
| HY-P74706 | Neurofascin, Human (HEK293, His) | ||
| HY-P74864 | IFN-alpha 1/IFNA1, Rat (HEK293, His) | ||
| HY-P7498 | Aminopeptidase P1, Human (His) | ||
| HY-P75047 | HA/Hemagglutinin, H5N1 (ACL11932, HEK293, His) | ||
| HY-P75075 | HA/Hemagglutinin, H4N2 (ADN78261, sf9, His) | ||
| HY-P75161 | HCMV Glycoprotein B/gB (HEK293, Fc) | ||
| HY-P7517 | Annexin A5/ANXA5, Human (solution) | ||
| HY-P74796 | ITK, Human (sf9, GST) | ||
| HY-P75081 | HA/Hemagglutinin, H3N2 (EPI552125, sf9, His) | ||
| HY-P75135 | HA/Hemagglutinin, H18N11 (AGX84934, sf9, His) | ||
| HY-P75172 | GBP1, Human (HEK293, His) | ||
| HY-P75223 | MAPK1/ERK2, Human (sf9, His) | ||
| HY-P75227 | EPHX2, Human (sf9, His) | ||
| HY-P7524 | Apolipoprotein B-100/APOB, Human (His, solution) | ||
| HY-P99190 | Eldelumab | 946414-98-8 | |
| HY-P9920A | Ramucirumab (anti-VEGFR) | 947687-13-0 | |
| HY-P99220 | Tabalumab | 1143503-67-6 | |
| HY-P99237 | Sofituzumab | 1615692-28-8 | |
| HY-P99265 | Mapatumumab | 658052-09-6 | |
| HY-P99270 | Tigatuzumab | 918127-53-4 | |
| HY-P99286 | Drozitumab | 912628-39-8 | |
| HY-P99288 | FG-3019 | 946415-13-0 | |
| HY-P99289 | Epratuzumab | 205923-57-5 | |
| HY-P7479 | Aldose 1-epimerase/GALM, Human (His) | ||
| HY-P74833 | IL-17A, Cynomolgus (sf9) | ||
| HY-P74839 | IL-10R beta, Human (HEK293, His-hFc) | ||
| HY-P74866 | IFN-alpha 1/IFNA1, Mouse (P.pastoris, His) | ||
| HY-P74900 | Hendra virus Glycoprotein/GP (HEK293, Fc) | ||
| HY-P75027 | HA/Hemagglutinin, H5N6 (AKS48023, sf9, His) | ||
| HY-P7493 | PARVA/alpha-Parvin, Human (His) | ||
| HY-P75176 | Galectin-9/LGALS9, Human (HEK293, hFc) | ||
| HY-P75217 | FABP4, Mouse (HEK293, His) | ||
| HY-P75281 | DPP10, Human (HEK293, His) | ||
| HY-P75302 | DDR1, Mouse (HEK293, His, solution) | ||
| HY-P75328 | Cas9, S. pyogenes (sf9, NLS, His) | ||
| HY-P7539 | APT-1/LYPLA1, Human (His) | ||
| HY-P75428 | CD26/Dipeptidyl Peptidase 4, Mouse (HEK293, His) | ||
| HY-P75437 | CD1D, Mouse (HEK293, His) | ||
| HY-P75472 | BMP-5, Human (HEK293, hFc) | ||
| HY-P75481 | Basigin/CD147, Mouse (HEK293, His) | ||
| HY-P75503 | Apolipoprotein A-I/APOA1, Mouse (HEK293, His, solution) | ||
| HY-P75675A | CIB2, Human (N-His) | ||
| HY-P75772 | FGG/Fibrinogen gamma chain, Human (P.pastoris) | ||
| HY-P75178 | GAD2/GAD65, Mouse (sf9) | ||
| HY-P75179 | GAD2/GAD65, Human (sf9, GST) | ||
| HY-P75346 | CHL1, Mouse (HEK293) | ||
| HY-P75356 | CEACAM5, Human (HEK293, His, solution) | ||
| HY-P75463 | C1s-A subcomponent, Mouse (HEK293, His) | ||
| HY-P75571 | Activin RIB/ALK-4, Human (HEK293, Fc) | ||
| HY-P75611 | CD146/MCAM, Human (HEK293, Fc) | ||
| HY-P75174 | GAS6, Mouse (HEK293, His, solution) | ||
| HY-P75181 | FUT8, Human (sf9, His) | ||
| HY-P75242 | EphA1, Human (HEK293, hFc) | ||
| HY-P75259 | EGFR, Cynomolgus (sf9, His) | ||
| HY-P7529 | APOC2, Human (His, solution) | ||
| HY-P75336 | CLEC1B/CLEC-2, Human (HEK293, His) | ||
| HY-P75366 | CD99, Mouse (HEK293, Fc) | ||
| HY-P75517 | Alanyl-tRNA synthetase, Human (sf9, His) | ||
| HY-P75554 | Chemerin/RARRES2, Mouse (HEK293, His) | ||
| HY-P75560 | Aconitase 1/ACO1, Human (sf9, His) | ||
| HY-P75614 | PVR/CD155, Human (HEK293) | ||
| HY-P75709 | DLST, Human (sf9, His) | ||
| HY-P75756 | ERAP2, Human (HEK293, His) | ||
| HY-P7603 | Arginase-2/ARG2, Human (His) | ||
| HY-P7608 | Arylsulfatase A/ARSA, Human (HEK293, His, solution) | ||
| HY-P76122 | VEGF164, Rat (sf9) | ||
| HY-P76155 | APOA1BP, Human (HEK293, His) | ||
| HY-P76163 | BBOX1, Human (sf9, His-GST) | ||
| HY-P76170 | BLMH/Bleomycin Hydrolase, Mouse (His) | ||
| HY-P76381 | HIST2H2BE, Human | ||
| HY-P76429 | IL-20R beta, Mouse (HEK293, His) | ||
| HY-P76798 | TCblR/CD320, Mouse (HEK293, His) | ||
| HY-P76904 | ENTPD3, Human (sf9, His) | ||
| HY-P7692 | HABP1/C1QBP, Human (His) | ||
| HY-P77026 | HA/Hemagglutinin, H3N2 (ACN50256, sf9) | ||
| HY-P77120 | ADCYAP1R1, Human (HEK293, Fc) | ||
| HY-P7715 | CAMKI delta/CAMK1D, Human (GST) | ||
| HY-P7722 | Carbonic Anhydrase 7, Human (His) | ||
| HY-P7734 | Carboxypeptidase B1/CPB1, Human (HEK293, His) | ||
| HY-P7740 | Carnosine Dipeptidase 1/CNDP1, Human (HEK293, His) | ||
| HY-P7748 | Cathepsin D, Human (HEK293, His, solution) | ||
| HY-P77510 | IL-4, Human (Biotinylated) | ||
| HY-P77527 | CD19, Mouse (Biotinylated, HEK293, His) | ||
| HY-P77911 | BCA-1/CXCL13, Mouse (HEK293, His) | ||
| HY-P99264 | Inotuzumab | 1660159-36-3 | |
| HY-P99267 | Rontalizumab | 948570-30-7 | |
| HY-P99272 | Ulocuplumab | 1375830-34-4 | |
| HY-P9927A | Secukinumab (Anti-Human IL-17A) | 1229022-83-6 | |
| HY-P9932 | Obiltoxaximab | 1351337-07-9 | |
| HY-P99339 | Tebentafusp | 1874157-95-5 | |
| HY-P99346 | Regdanvimab | 2444308-95-4 | |
| HY-P99382 | Vopratelimab | 2039148-04-2 | |
| HY-P9939 | Burosumab | 1610833-03-8 | |
| HY-P99393 | Tavolixizumab | 1635395-25-3 | |
| HY-P76584A | S100A14 Protein, Human (His) | ||
| HY-P76710 | SMPD1, Human (sf9, His) | ||
| HY-P76733 | ARP3/ACTR3, Human (sf9, His-GST) | ||
| HY-P76837 | CNDP2, Human (sf9, His) | ||
| HY-P7690 | Butyrylcholinesterase/BCHE, Human (HEK293, His) | ||
| HY-P77023 | HA/Hemagglutinin, H17N10 (AFC35418, sf9, His) | ||
| HY-P7711 | Calnexin, Human (HEK293, His) | ||
| HY-P7718 | Carbonic Anhydrase 1, Human (His) | ||
| HY-P77180 | RON/MSPR, Human (HEK293, His) | ||
| HY-P77293 | ADAM8, Rhesus Macaque (HEK293, His) | ||
| HY-P77381 | HPRG, Rat (HEK293, His) | ||
| HY-P77548 | Glypican-3/GPC3, Human (Biotinylated, HEK293, His) | ||
| HY-P77643 | EMAP-II, Mouse (His) | ||
| HY-P77816 | SARS-CoV-2 NSP7-NSP8 Heterodimer (His) | ||
| HY-P77867 | ADAM9, Human (HEK293, His, solution) | ||
| HY-P77899 | Claudin-6/CLDN6-VLP, Human (HEK293, solution) | ||
| HY-P77958 | GPRC5D-VLP, Human (HEK293) | ||
| HY-P7846 | BRD4, Human (His-Flag) | ||
| HY-P78549 | GMP IL-4, Human | ||
| HY-P7883 | DNA polymerase beta, Human (His) | ||
| HY-P7886 | Collagen alpha-1(III) chain/COL3A, Mouse (HEK293, His) | ||
| HY-P7894 | SARS-CoV-2 PP1ab (His-MBP) | ||
| HY-P79221 | Heparinase II, P. heparinus (His) | ||
| HY-P79244 | Chondroitinase ABC, P. vulgaris (His) | ||
| HY-P9807 | Anti-SARS-CoV-2 Spike mAb (CR3022) | ||
| HY-P990007 | Tulisokibart | 2648504-55-4 | |
| HY-P99003 | Human IgG4 (S228P) kappa, Isotype Control | ||
| HY-P990069 | Linavonkibart | 2640981-30-0 | |
| HY-P990084 | Veligrotug | 2728655-31-8 | |
| HY-P990110 | Lecanemab (Mouse IGG2a) | ||
| HY-P75268 | Ebola virus Glycoprotein/GP (QDA39862, HEK293, His) | ||
| HY-P75306 | DcR3/TNFRSF6B, Human (sf9, hFc) | ||
| HY-P75434 | CD2, Cynomolgus/Rhesus Macaque (HEK293, His, solution) | ||
| HY-P75435 | CD2, Cynomolgus/Rhesus Macaque (HEK293, hFc) | ||
| HY-P75464 | C1QB, Human (sf9, His) | ||
| HY-P75530 | ADK/Adenosine Kinase, Human (HEK293) | ||
| HY-P75533 | ADAM15, Human (HEK293, His) | ||
| HY-P75621 | Fc gamma RIIIA/CD16a, Rat (HEK293, His, solution) | ||
| HY-P75644 | Fc gamma RIIA/CD32a, Human (H167R, HEK293, Fc) | ||
| HY-P75655 | CD55/DAF, Mouse (HEK293, His) | ||
| HY-P75683 | COL4A3, Rat (HEK293, Fc) | ||
| HY-P75781 | Follistatin-like 1/FSTL1, Rat (HEK293, His, solution) | ||
| HY-P75961 | PDE3A, Human (sf9, His-GST) | ||
| HY-P75792 | gp130/IL6ST, Human (HEK293) | ||
| HY-P75929 | MMP-19, Human | ||
| HY-P75933 | NCAM-1/CD56, Human (HEK293, His, solution) | ||
| HY-P75998 | RAB7A, Rat (His, solution) | ||
| HY-P7611 | GOT1, Human (His) | ||
| HY-P76119A | UCHL3, Mouse (His, solution) | ||
| HY-P76141 | AMPK gamma 1/beta 1/alpha 1 Heterotrimer, Human (sf9, His-GST) | ||
| HY-P99292 | Fontolizumab | 326859-36-3 | |
| HY-P99299 | Lexatumumab | 845816-02-6 | |
| HY-P99309 | Pagibaximab | 595566-61-3 | |
| HY-P99313 | Quilizumab | 1228538-47-3 | |
| HY-P99321 | Teneliximab | 299423-37-3 | |
| HY-P99328 | Tucotuzumab | ||
| HY-P9933 | Dinutuximab | 1363687-32-4 | |
| HY-P99333 | Volociximab | 558480-40-3 | |
| HY-P99343 | Atoltivimab | 2135632-29-8 | |
| HY-P99352 | Anetumab | 1954758-84-9 | |
| HY-P77912 | BCA-1/CXCL13, Mouse (HEK293, Fc) | ||
| HY-P78014 | PGLYRP1/PGRP-S, Human (HEK293, Fc) | ||
| HY-P78024 | WFDC1/PS20, Human (His) | ||
| HY-P7813 | Complement Factor B/CFB, Human (HEK293, His) | ||
| HY-P78369 | FITC-Labeled Mesothelin, Human (HEK293, Fc) | ||
| HY-P7853 | Cystatin F/CST7, Mouse (HEK293, His) | ||
| HY-P78544 | CD24-VLP, Human (HEK293) | ||
| HY-P99359 | Elezanumab | 1791416-49-3 | |
| HY-P99360 | Enapotamab | 1912423-61-0 | |
| HY-P99361 | Enavatuzumab | 1062149-33-0 | |
| HY-P99400 | Samalizumab | 1073059-33-2 | |
| HY-P99407 | Pepinemab | 2097151-87-4 | |
| HY-P99408 | Oxelumab | 1186098-83-8 | |
| HY-P99480 | Bintrafusp alfa | 1918149-01-5 | |
| HY-P99486 | Briakinumab | 339308-60-0 | |
| HY-P99490 | Burfiralimab | 2460809-80-5 | |
| HY-P75926 | METTL1, Human (His) | ||
| HY-P75975 | PHPT1, Human (His) | ||
| HY-P76012 | RSPO1/R-spondin-1, Mouse (CHO, His) | ||
| HY-P76270 | CLEC9A, Mouse (HEK293, Fc) | ||
| HY-P76432 | IL-23 alpha, Human (HEK293, Fc) | ||
| HY-P76445 | HA/Hemagglutinin, H16N3 (AAV91217, sf9, His) | ||
| HY-P7650 | Bcl-2-like 1, Human (His) | ||
| HY-P99496 | Cendakimab | 2151032-62-9 | |
| HY-P99517 | Voxalatamab | 2411871-58-2 | |
| HY-P99518 | Taldefgrobep alfa | 1580555-26-5 | |
| HY-P99519 | Vixarelimab | 2243320-83-2 | |
| HY-P99524 | Vatelizumab | 1238217-55-4 | |
| HY-P9954 | Catumaxomab | 509077-98-9 | |
| HY-P99546 | Trebananib | 894356-79-7 | |
| HY-P99559 | Tilogotamab | 2109731-10-2 | |
| HY-P99590 | Sotatercept | 1001080-50-7 | |
| HY-P99594 | Socazolimab | 2305043-30-3 | |
| HY-P99613 | Favezelimab | 2231068-83-8 | |
| HY-P99620 | Firivumab | 1443004-15-6 | |
| HY-P99623 | Flotetuzumab | 1664355-28-5 | |
| HY-P99627 | Frunevetmab | 1708936-80-4 | |
| HY-P99648 | Gosuranemab | 1788032-39-2 | |
| HY-P99656 | Iladatuzumab | 1906205-76-2 | |
| HY-P99673 | Itepekimab | 2226742-52-3 | |
| HY-P99676 | Izalontamab | 2559704-24-2 | |
| HY-P99680 | Keliximab | 174722-30-6 | |
| HY-P99683 | Ladiratuzumab vedotin | 1629760-29-7 | |
| HY-P99687 | Latikafusp | 2552814-07-8 | |
| HY-P76545 | PILR-alpha, Mouse (HEK293, His) | ||
| HY-P76557 | PTPN12, Human | ||
| HY-P76665 | Statherin, Human (HEK293, Fc) | ||
| HY-P76729 | APEG1, Human (His) | ||
| HY-P76965 | Nucleocapsid/NP, HTNV (sf9, His) | ||
| HY-P76968 | HER3, Rhesus Macaque (HEK293, Fc) | ||
| HY-P77076 | SCGB2A1, Human (HEK293, Fc) | ||
| HY-P9902 | Pembrolizumab | 1374853-91-4 | |
| HY-P99036 | Nesvacumab | 1296818-77-3 | |
| HY-P990369 | Anti-CLDN6 Antibody (AB3-7) | ||
| HY-P99040 | Onvatilimab | 1969313-51-6 | |
| HY-P990401 | Anti-DLL3 Antibody | ||
| HY-P99042 | Polatuzumab | 2279068-37-8 | |
| HY-P990447 | Anti-IL-20 Antibody | ||
| HY-P990555 | BI-765063 | ||
| HY-P990568 | CLN-619 | ||
| HY-P990575 | DFRF4539A (RG-7598) | ||
| HY-P99057A | Varlilumab (anti-CD27) | 1393344-72-3 | |
| HY-P990587 | FR104 | ||
| HY-P990607 | Indatuximab | ||
| HY-P990656 | RG-6125 | ||
| HY-P990704 | Rilvegostomig | 2640305-01-5 | |
| HY-P7628 | B4GALT1, Human (HEK293, Y285L, His) | ||
| HY-P76316 | EGFL6, Mouse (HEK293, His) | ||
| HY-P76356 | Gastrokine 1, Human (sf9, His) | ||
| HY-P76411 | IGSF11, Human (HEK293, His) | ||
| HY-P76510 | Neuroligin-3/NLGN3, Human (HEK293, His) | ||
| HY-P7653 | Bcl-2-like 2, Human (His) | ||
| HY-P76585 | S100A3, Human (His-MBP) | ||
| HY-P79097 | MMP-16, Human (I152N, His) | ||
| HY-P79356 | PNGase F, F. meningosepticum (His) | ||
| HY-P990053 | Nelistotug | 2645437-82-5 | |
| HY-P990071 | Fepixnebart | 2489584-93-0 | |
| HY-P990073 | Davutamig | 2648058-48-2 | |
| HY-P990083 | Tegoprubart | 2628092-47-5 | |
| HY-P990095 | Vonsetamig | 2408319-33-3 | |
| HY-P9901 | Ipilimumab | 477202-00-9 | |
| HY-P990100 | Human IgG1(E356D/M358L) kappa, Isotype Control | ||
| HY-P990124 | Anti-Mouse GITR Antibody (DTA-1) | ||
| HY-P99022 | Gantenerumab | 1043556-46-2 | |
| HY-P99025 | Lebrikizumab | 953400-68-5 | |
| HY-P99030 | Margetuximab | 1350624-75-7 | |
| HY-P99031 | Mavrilimumab | 1085337-57-0 | |
| HY-P990315 | Anti-ENPP3/CD203c Antibody (AGS-16C3F antibody) | ||
| HY-P990335 | Anti-ANGPTL4 Antibody | ||
| HY-P990354 | Anti-CD48 Antibody | ||
| HY-P990366 | Anti-CHI3L1 Antibody | ||
| HY-P990387 | Anti-CTSS/Cathepsin S Antibody (Fsn0503h) | ||
| HY-P99043 | Rovalpituzumab | 1613313-01-1 | |
| HY-P99045 | Sacituzumab | 1796566-95-4 | |
| HY-P990464 | Anti-Matriptase Antibody | ||
| HY-P99051 | Tinurilimab | 2226224-30-0 | |
| HY-P990536 | Anti-TSPAN8 Antibody | ||
| HY-P7708 | Calcitonin/CALCA, Human (His, solution) | ||
| HY-P77124 | PDGF R beta, Human (HEK293, Fc) | ||
| HY-P7720 | Carbonic Anhydrase 4, Human (His) | ||
| HY-P77257 | Transglutaminase 3/TGM3, Human (sf9, His) | ||
| HY-P7729 | Carbonic Anhydrase 11, Human (HEK293, His) | ||
| HY-P77395 | IGFL2, Human (HEK293, Fc) | ||
| HY-P7756 | Cathepsin S, Human (HEK293, His) | ||
| HY-P76094 | ST6GAL1, Mouse (HEK293, His) | ||
| HY-P76095 | STC2/Stanniocalcin-2, Human (HEK293, Fc) | ||
| HY-P76114Y | TGM2/Transglutaminase 2, Human (sf9, His, solution) | ||
| HY-P76138 | ALDH4A1, Human (sf9) | ||
| HY-P7618 | ATG4A, Human (His) | ||
| HY-P76196 | CD133/PROM1, Rat (HEK293, His) | ||
| HY-P76363 | Gliomedin, Human (HEK293, Fc, solution) | ||
| HY-P77757 | HLA-A*0201 NY-ESO-1 Complex Tetramer, Human (HEK293, His-Avi) | ||
| HY-P77830 | S100A9, Canine (His) | ||
| HY-P77896 | Chordin-like 1/CHRDL1, Human (His, solution) | ||
| HY-P78105 | Claudin-18/CLDN18.2-VLP, Human (Biotinylated, HEK293) | ||
| HY-P7824 | Complement C8G, Human (His) | ||
| HY-P78275 | SARS-CoV-2 3CLpro/3C-like protease | ||
| HY-P990561 | BT-063 | ||
| HY-P990615 | Anti-c-Kit Antibody (LMJ729) | ||
| HY-P990619 | LY3022855 | ||
| HY-P990631 | Mibavademab | 2305770-44-7 | |
| HY-P990635 | NGM-120 | ||
| HY-P990641 | NTX-1088 | ||
| HY-P990642 | Oportuzumab | ||
| HY-P990659 | Anti-LY6E Antibody (MLYE4489A) | ||
| HY-P990672 | U3-1784 | ||
| HY-P990712 | Ersodetug | 2410976-61-1 | |
| HY-P990773 | Venanprubart | 2635407-50-8 | |
| HY-P9908 | Adalimumab | 331731-18-1 | |
| HY-P9909 | Ustekinumab | 815610-63-0 | |
| HY-P990907 | Brivekimig | 2834733-45-6 | |
| HY-P990911 | Crebankitug | 2893793-17-2 | |
| HY-P76450 | HA/Hemagglutinin, H6N2 (AFJ19048, sf9, His) | ||
| HY-P76546 | PIN1, Human | ||
| HY-P76550 | PLK1, Human (sf9, His) | ||
| HY-P7662 | BID, Human | ||
| HY-P76712 | envelope glycoprotein gp64, AcmNPV (sf9, His) | ||
| HY-P77208 | SLITRK6, Human (HEK293, His) | ||
| HY-P77212 | SPG21, Human (sf9, His) | ||
| HY-P99113A | Inebilizumab (FUT8-KO) | ||
| HY-P9913 | Rituximab | 174722-31-7 | |
| HY-P9914 | Eculizumab | 219685-50-4 | |
| HY-P99140 | Anti-Mouse IL-1R Antibody (JAMA-147) | ||
| HY-P99148 | Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) | ||
| HY-P99155 | Zalutumumab | 667901-13-5 | |
| HY-P99166 | Vudalimab | 2329669-72-7 | |
| HY-P99178 | CTX-471 | 2377152-49-1 | |
| HY-P99193 | Enokizumab | 909875-08-7 | |
| HY-P99198 | Fletikumab | 1357158-22-5 | |
| HY-P99199 | Foralumab | 946415-64-1 | |
| HY-P99200 | Fulranumab | 902141-80-4 | |
| HY-P78558 | IL-15R alpha & IL-15, Mouse (HEK293, His) | ||
| HY-P7857 | CLIC3, Human (His) | ||
| HY-P78736 | CD206/MMR, Human (HEK293, His) | ||
| HY-P7877 | Fructose-bisphosphate aldolase A/ALDOA, Human (His, solution) | ||
| HY-P7880 | Alkaline Phosphatase/ALPL, Human (HEK293, His) | ||
| HY-P79286 | Nicotinamide N-Methyltransferase/NNMT, Human (His) | ||
| HY-P7726 | Carbonic Anhydrase 13, Human (His) | ||
| HY-P7730 | Carboxylesterase 1, Human (HEK293, His) | ||
| HY-P7732 | Carboxypeptidase A1/CPA1, Human (HEK293, His) | ||
| HY-P7755A | Cathepsin L2, Human (HEK293, His, solution) | ||
| HY-P7758 | Cathepsin Z/CTSZ, Human (HEK293, His, solution) | ||
| HY-P77835 | SFRP2, Human (HEK293, His, solution) | ||
| HY-P99210 | Olokizumab | 1007223-17-7 | |
| HY-P99216 | Ponezumab | 1178862-65-1 | |
| HY-P99218 | Robatumumab | 934235-44-6 | |
| HY-P99225 | Mirvetuximab | 1453084-36-0 | |
| HY-P99226 | Daxdilimab | 2245966-28-1 | |
| HY-P99234 | Pivekimab | 2234335-84-1 | |
| HY-P99242 | Alsevalimab | 2254029-91-7 | |
| HY-P99249 | Vonlerolizumab | 1638935-72-4 | |
| HY-P99259 | Cabiralizumab | 1613144-80-1 | |
| HY-P99269 | Sibrotuzumab | 216669-97-5 | |
| HY-P78035 | Semaphorin-7A/SEMA7A, Mouse (HEK293, His) | ||
| HY-P7817 | Prostatic acid phosphatase/ACPP, Human (354a.a, HEK293, His, solution) | ||
| HY-P78344 | RSPO1/R-spondin-1, Mouse (HEK293, His) | ||
| HY-P78551 | GMP IL-2 Protein, Human (solution) | ||
| HY-P7861A | Complement Factor D/Adipsin, Human (HEK293, His, Solution) | ||
| HY-P79001 | Crlf1, Mouse ( HEK293, His, solution) | ||
| HY-P990006 | Duvakitug | 2750005-84-4 | |
| HY-P990008 | Atrosab | 1365659-05-7 | |
| HY-P990015 | Tobevibart | 2645440-65-7 | |
| HY-P990016 | Temtokibart | 2639874-57-8 | |
| HY-P990027 | Izeltabart | 2642078-60-0 | |
| HY-P990033 | Anzurstobart | 2543693-10-1 | |
| HY-P990037 | Erzotabart | 2430792-01-9 | |
| HY-P990057 | Picankibart | 2622900-74-5 | |
| HY-P990078 | Remternetug | 2571940-41-3 | |
| HY-P990096 | Human IgG1 lambda2, Isotype Control | ||
| HY-P990111 | BMS-986325 (anti-CD40) | ||
| HY-P99017 | Eptinezumab | 1644539-04-7 | |
| HY-P99271 | Tisotumab | 1418628-81-5 | |
| HY-P99274 | Xentuzumab | 1417158-65-6 | |
| HY-P99276 | Abagovomab | 792921-10-9 | |
| HY-P99277 | Actoxumab | 1245634-25-6 | |
| HY-P99280 | Bimekizumab | 1418205-77-2 | |
| HY-P99293 | Galiximab | 357613-77-5 | |
| HY-P99325 | Toralizumab | 252662-47-8 | |
| HY-P99327 | Tregalizumab | 1207446-68-1 | |
| HY-P9934 | Abciximab | 143653-53-6 | |
| HY-P99401 | Rosmantuzumab | 1684393-04-1 | |
| HY-P99404 | Quetmolimab | 2084037-83-0 | |
| HY-P99428 | Aldafermin | 1616639-03-2 | |
| HY-P99431 | KY-1044 | 2489390-15-8 | |
| HY-P9944 | Palivizumab | 188039-54-5 | |
| HY-P99446 | Atacicept | 845264-92-8 | |
| HY-P99454 | Azintuxizumab vedotin | 1826819-58-2 | |
| HY-P99455 | Bafisontamab | 2437210-79-0 | |
| HY-P99457 | Balstilimab | 2148321-77-9 | |
| HY-P99461 | Barecetamab | 2275727-74-5 | |
| HY-P99470 | Benufutamab | 2109730-69-8 | |
| HY-P76667 | TARC/CCL17, Rhesus Macaque (sf9, His) | ||
| HY-P76853 | PF-4/CXCL4, Human | ||
| HY-P76866 | DCUN1D2, Human (His) | ||
| HY-P77033 | HA/Hemagglutinin, H8N4 (ABB87729, sf9, His) | ||
| HY-P77048 | Kallikrein-15, Human (HEK293, His) | ||
| HY-P77053 | LAMTOR2, Human (His) | ||
| HY-P77057 | LDLRAD3, Human (HEK293, Fc) | ||
| HY-P99341 | Casirivimab | 2415933-42-3 | |
| HY-P99355 | Bimagrumab | 1356922-05-8 | |
| HY-P99356 | Cinpanemab | 2094516-02-4 | |
| HY-P99362 | Ensituximab | 1092658-06-4 | |
| HY-P99364 | Icrucumab | 1024603-92-6 | |
| HY-P99371 | Lirentelimab | 2283348-97-8 | |
| HY-P99372 | Lorvotuzumab | 339306-30-8 | |
| HY-P99379 | Nidanilimab (Nadunolimab) | 2171061-85-9 | |
| HY-P99473 | Bersanlimab | 1987854-08-9 | |
| HY-P99520 | Vilobelimab | 2250440-41-4 | |
| HY-P99529 | Valziflocept | 1804910-11-9 | |
| HY-P99540 | Tuvonralimab | 2417649-44-4 | |
| HY-P99556 | Tixagevimab | 2420564-02-7 | |
| HY-P99557 | Tirnovetmab | 2364504-80-1 | |
| HY-P99566 | Tenatumomab | 1412891-40-7 | |
| HY-P9957 | Raxibacumab | 565451-13-0 | |
| HY-P99575 | Tarlatamab | 2307488-83-9 | |
| HY-P99586 | Suptavumab | 1629615-23-1 | |
| HY-P99608 | Exbivirumab | 569658-80-6 | |
| HY-P79168 | Hyaluronan Lyase, S. agActiae (His) | ||
| HY-P79454 | ISG15 E1/UBE1L, Human (sf9, His, Strep) | ||
| HY-P7989 | Janus kinase 2/JAK2, Human (His) | ||
| HY-P7991 | IFN-lambda 2/IL-28A, Mouse (HEK293, His, solution) | ||
| HY-P9803 | Anti-SARS-80R mAb | ||
| HY-P99001 | Human IgG1 kappa, Isotype Control | ||
| HY-P990025 | Empasiprubart | 2579031-19-7 | |
| HY-P990028 | Raludotatug | 2610074-56-9 | |
| HY-P7719 | Carbonic Anhydrase 3, Human (His) | ||
| HY-P77213 | SPG21, Mouse (sf9, His) | ||
| HY-P77270 | TXNL4B, Human (His) | ||
| HY-P77363 | FCAMR/CD351, Mouse (HEK293, His) | ||
| HY-P7745 | Cathepsin A, Human (HEK293, His, solution) | ||
| HY-P77484 | Serpina1d, Mouse (HEK293) | ||
| HY-P77507 | WWP2, Human (sf9, His-GST) | ||
| HY-P990748 | Lunsekimig | 2770858-49-4 | |
| HY-P990760 | Rezorstobart | 2762201-86-3 | |
| HY-P990767 | Solrikitug | 2768721-24-8 | |
| HY-P990788 | Anti-Mouse PD-1 Antibody (29F.1A12) | ||
| HY-P9907A | Trastuzumab (anti-HER2) | 180288-69-1 | |
| HY-P990941 | Rinatabart | 2853518-94-0 | |
| HY-P99107A | Brentuximab vedotin (solution) | 914088-09-8 | |
| HY-P99115 | Envafolimab | 2102192-68-5 | |
| HY-P99126 | Anti-Mouse CD44 Antibody (IM7) | ||
| HY-P99128 | Anti-Mouse CD8 beta Antibody (53-5.8) | ||
| HY-P99145 | Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) | ||
| HY-P99151 | Brentuximab | 2088770-90-3 | |
| HY-P99161 | Tilvestamab | 2226775-26-2 | |
| HY-P99614 | Fazpilodemab | 2517935-02-1 | |
| HY-P99658 | Imaprelimab | 2014343-04-3 | |
| HY-P99659 | Imsidolimab | 2102543-86-0 | |
| HY-P99675 | Ivonescimab | 2428381-53-5 | |
| HY-P99722 | Maftivimab | 2135632-36-7 | |
| HY-P99746 | Murlentamab | 2058047-65-5 | |
| HY-P99757 | Nivatrotamab | 2278244-14-5 | |
| HY-P99780 | Opicinumab | 1422268-07-2 | |
| HY-P99793 | Orticumab | 1314241-10-5 | |
| HY-P99822 | Recaticimab | 2361290-85-7 | |
| HY-P99830 | Conbercept | 1227158-72-6 | |
| HY-P990183 | Mouse IgG2a (D265A) kappa, isotype control | ||
| HY-P99020 | Fresolimumab | 948564-73-6 | |
| HY-P99032 | Monalizumab | 1228763-95-8 | |
| HY-P99033 | Mosunetuzumab | 1905409-39-3 | |
| HY-P990402 | Anti-DLL4 Antibody | ||
| HY-P990500 | Anti-ROBO1 Antibody | ||
| HY-P990554 | BHQ-880 | ||
| HY-P990586 | FG-3246 (FOR46) | ||
| HY-P990608 | Alpitatug | 2921676-05-1 | |
| HY-P990613 | LIV-1205 (CBA-1205) | ||
| HY-P990623 | MDX-1105 | ||
| HY-P990625 | MEDI-3617 | 1415642-51-1 | |
| HY-P990643 | OS-2966 | ||
| HY-P990651 | PY314 | ||
| HY-P990667 | STX-100 | 1439902-67-6 | |
| HY-P990673 | Vandortuzumab | ||
| HY-P990726 | Abiprubart | 2765071-95-0 | |
| HY-P990764 | Sigvotatug | 2764774-90-3 | |
| HY-P990781 | Suciraslimab | 2415439-63-1 | |
| HY-P99100 | Visugromab | 2556646-63-8 | |
| HY-P991042 | Anti-IGFBP2 Antibody (M14) | ||
| HY-P99105 | Anselamimab | 2414866-63-8 | |
| HY-P99109 | Zimberelimab | 2259860-24-5 | |
| HY-P9911 | Vedolizumab | 943609-66-3 | |
| HY-P99113 | Inebilizumab | 1299440-37-1 | |
| HY-P99117 | Cadonilimab | 2394841-59-7 | |
| HY-P9912A | Pertuzumab (anti-HER2) | 380610-27-5 | |
| HY-P990031 | Dargistotug | 2649362-29-6 | |
| HY-P990034 | Pateclizumab | 1202526-59-7 | |
| HY-P990039 | Falbikitug | 2740565-02-8 | |
| HY-P990042 | Gotistobart | 2226344-78-9 | |
| HY-P990043 | Iluzanebart | 2733621-19-5 | |
| HY-P990048 | Muzastotug | 2750031-18-4 | |
| HY-P990067 | Evunzekibart | 2639688-77-8 | |
| HY-P990093 | Stapokibart | 2734715-10-5 | |
| HY-P99013 | Codrituzumab | 1365267-33-9 | |
| HY-P99014 | Cusatuzumab | 1864871-20-4 | |
| HY-P99015 | Dacetuzumab | 880486-59-9 | |
| HY-P9903 | Nivolumab | 946414-94-4 | |
| HY-P99153 | Farletuzumab | 896723-44-7 | |
| HY-P9915A | Daratumumab (PBS) | 945721-28-8 | |
| HY-P99162 | Nemolizumab | 1476039-58-3 | |
| HY-P99167 | Lucatumumab | 903512-50-5 | |
| HY-P99168 | Anifrolumab | 1326232-46-5 | |
| HY-P99172 | CC-90002 | 2085844-54-6 | |
| HY-P99186 | Blosozumab | 1132758-87-2 | |
| HY-P99195 | Fasinumab | 1190239-42-9 | |
| HY-P9919A | Durvalumab (anti-PD-L1) | 1428935-60-7 | |
| HY-P99201 | Zilovertamab | 2485779-13-1 | |
| HY-P99203 | Cemiplimab | 1801342-60-8 | |
| HY-P99835 | Crenezumab | 1095207-05-8 | |
| HY-P9986 | Tiragolumab | 1918185-84-8 | |
| HY-P99866 | Duligotuzumab | 1314238-96-4 | |
| HY-P99867 | Dusigitumab | 1204390-13-5 | |
| HY-P9988 | Mecbotamab | 2460400-28-4 | |
| HY-P99901 | Sibeprenlimab | 2382896-07-1 | |
| HY-P99936 | Elgemtumab | 1512559-37-3 | |
| HY-P99940 | Remtolumab | 1791410-27-9 | |
| HY-P99953 | Rivabazumab | 1627519-84-9 | |
| HY-P99955 | Rocatinlimab | 2431972-52-8 | |
| HY-P99961 | Tifcemalimab | 2236068-83-8 | |
| HY-P9997 | Rosnilimab | 2412764-40-8 | |
| HY-P990319 | ALT-100 (Human IgG4) | ||
| HY-P990360 | Anti-CD9 Antibody | ||
| HY-P990363 | Anti-CDH17/Cadherin-17 Antibody (PTA001_A4) | ||
| HY-P990384 | Anti-CSF3R/G-CSFR Antibody | ||
| HY-P99039 | Oleclumab | 1803176-05-7 | |
| HY-P99049 | Sotigalimab | 2305607-45-6 | |
| HY-P990496 | Anti-PVRIG Antibody (COM701) | ||
| HY-P99053 | Tralokinumab | 1044515-88-9 | |
| HY-P990591 | GSK-1070806 | ||
| HY-P990636 | NGM-313 | ||
| HY-P990637 | NGM-621 | ||
| HY-P990650 | PY159 | ||
| HY-P990657 | RG-7212 (RO5458640) | ||
| HY-P990675 | VGX-100 | ||
| HY-P990676 | VIB-9600 | ||
| HY-P990682 | Rat IgG2b kappa, Isotype Control | ||
| HY-P99169 | Uliledlimab | 2378407-27-1 | |
| HY-P99176 | ATG-031 | ||
| HY-P99177 | Enibarcimab | 2305638-98-4 | |
| HY-P99181 | Mupadolimab | 2451856-97-4 | |
| HY-P99189 | Cixutumumab | 947687-12-9 | |
| HY-P99191 | Emapalumab | 1709815-23-5 | |
| HY-P99208 | Lirilumab | 1000676-41-4 | |
| HY-P99217 | Rilotumumab | 872514-65-3 | |
| HY-P9921A | Trastuzumab emtansine (solution) | 1018448-65-1 | |
| HY-P99239 | Rosopatamab | 2260767-49-3 | |
| HY-P99245 | Emactuzumab | 1448221-67-7 | |
| HY-P99979 | Rat IgG1 kappa, Isotype Control | ||
| HY-P99980 | Rabbit IgG1 kappa, Isotype Control | ||
| HY-P99993 | Human IgG1 (S239D/I332E) kappa, Isotype Control | ||
| HY-W210476 | Somantadine | 79594-24-4 | |
| HY-P9938 | Erenumab | 1582205-90-0 | |
| HY-P99385 | Vobarilizumab | 1628814-88-9 | |
| HY-P99394 | Talquetamab | 2226212-40-2 | |
| HY-P99418 | Acapatamab | 2314491-93-3 | |
| HY-P99429 | Alefacept | 222535-22-0 | |
| HY-P99435 | Amubarvimab | 2509447-07-6 | |
| HY-P99437 | Anbenitamab | 2367012-88-0 | |
| HY-P99443 | Aselizumab | 395639-53-9 | |
| HY-P99450 | Avdoralimab | 2226393-85-5 | |
| HY-P99453 | Azintuxizumab | 1826819-57-1 | |
| HY-P99459 | Baminercept | 909110-25-4 | |
| HY-P99261 | Demcizumab | 1243262-17-0 | |
| HY-P99263 | Inclacumab | 1256258-86-2 | |
| HY-P99275 | Patritumab | 1262787-83-6 | |
| HY-P99284 | Dalotuzumab | 1005389-60-5 | |
| HY-P99285 | Denintuzumab | 1630074-14-4 | |
| HY-P9928A | Alirocumab (anti-PCSK9) | 1245916-14-6 | |
| HY-P99294 | Ganitumab | 905703-97-1 | |
| HY-P99297 | Bedinvetmab | 2171034-69-6 | |
| HY-P99301 | Lokivetmab | 1533403-95-0 | |
| HY-P77589 | CCR2b-VLP, Human (HEK293) | ||
| HY-P77731A | Kallikrein-5, Mouse (271a.a, HEK293, His) | ||
| HY-P77849 | ST3GAL4, Human (HEK293, His-HA) | ||
| HY-P77900 | Claudin-6/CLDN6-VLP, Human (Biotinylated, HEK293) | ||
| HY-P78005 | MASP2, Human (His) | ||
| HY-P7803 | PKM2, Human (420 a.a, His) | ||
| HY-P78552 | GMP IFN-gamma, Human | ||
| HY-P99693 | Lenvervimab | 2055006-79-4 | |
| HY-P99721 | Lutikizumab | 1791411-57-8 | |
| HY-P99737 | Mirikizumab | 1884201-71-1 | |
| HY-P99778 | Ontuxizumab | 946415-62-9 | |
| HY-P99784 | Porgaviximab | 1792982-55-8 | |
| HY-P99797 | Pabinafusp alfa | 2140211-48-7 | |
| HY-P99801 | Pascolizumab | 331243-22-2 | |
| HY-P99809 | Quavonlimab | 2254059-25-9 | |
| HY-P99827 | Cobolimab | 2022215-65-0 | |
| HY-P99832 | Cosfroviximab | 1792982-57-0 | |
| HY-P99836 | Cudarolimab | 2244739-29-3 | |
| HY-P99499 | Cetrelimab | 2050478-92-5 | |
| HY-P99509 | Zelminemab | 2225850-33-7 | |
| HY-P99590A | Sotatercept (mIgG2a) | ||
| HY-P99593 | Sofituzumab vedotin | 1418200-58-4 | |
| HY-P99603 | Cifurtilimab | 1629760-27-5 | |
| HY-P99634 | Gatipotuzumab | 1264737-26-9 | |
| HY-P99641 | Gilvetmab | 1808081-43-7 | |
| HY-P9965 | Elotuzumab | 915296-00-3 | |
| HY-P99667 | Ipafricept | 1391727-24-4 | |
| HY-P99670 | Iscalimab | 2031153-61-2 | |
| HY-P99686 | Larcaviximab | 1792982-56-9 | |
| HY-P99841 | Dalutrafusp alfa | 2419918-89-9 | |
| HY-P99845 | Dazodalibep | 2245953-10-8 | |
| HY-P99854 | Disitamab | 2185868-98-6 | |
| HY-P99859 | Donanemab | 1931944-80-7 | |
| HY-P99872 | Ecleralimab | 2415207-91-7 | |
| HY-P99888 | Pimurutamab | 2251771-76-1 | |
| HY-P99891 | Rovelizumab | 339086-79-2 | |
| HY-P99895 | Rulonilimab | 2417124-95-7 | |
| HY-P99904 | Siplizumab | 288392-69-8 | |
| HY-P99919 | Efmarodocokin alfa | 2247840-74-8 | |
| HY-P99933 | Eftilagimod alfa | 1800476-36-1 | |
| HY-P99302 | Lulizumab | 2235419-62-0 | |
| HY-P99304 | Lumretuzumab | 1448327-63-6 | |
| HY-P9931 | Guselkumab | 1350289-85-8 | |
| HY-P99315 | Ruplizumab | 220651-94-5 | |
| HY-P99317 | Solanezumab | 955085-14-0 | |
| HY-P99329 | Vadastuximab | 1436390-64-5 | |
| HY-P99344 | Bamlanivimab | 2423943-37-5 | |
| HY-P99350 | Gresonitamab | 2413817-97-5 | |
| HY-P99389 | Tesnatilimab | 2242758-08-1 | |
| HY-P99402 | Rinucumab | 1569263-06-4 | |
| HY-P7859 | Beta-galactosidase/GLB1, E.coli | ||
| HY-P78653 | FITC-Labeled CLEC12A/MICL, Human (HEK293, His, solution) | ||
| HY-P7898 | D-amino-acid oxidase/DAO, Human (His) | ||
| HY-P78999 | PSAT1, Human (His) | ||
| HY-P79219 | Toxin B/TcdB, C. difficile (His) | ||
| HY-P990012 | Vamikibart | 2744320-12-3 | |
| HY-P990024 | Casdozokitug | 2643331-37-5 | |
| HY-P990026 | Ulviprubart | 2569434-60-0 | |
| HY-P99938 | Pucotenlimab | 2403647-03-8 | |
| HY-P99943 | Erfonrilimab | 2367013-69-0 | |
| HY-P99949 | Etigilimab | 2044984-83-8 | |
| HY-P99950 | Evorpacept | 2484949-51-9 | |
| HY-P99956 | Zilovertamab vedotin | ||
| HY-P99977 | Mouse IgG1 kappa, Isotype Control | ||
| HY-P99987 | Human IgG4 (S228P) lambda1, Isotype Control | ||
| HY-P9S0008 | Cetuximab (PBS) | ||
| HY-P99703 | Libivirumab | 569658-79-3 | |
| HY-P99708 | Livmoniplimab | 2412004-88-5 | |
| HY-P99731 | Milatuzumab | 899796-83-9 | |
| HY-P99732 | Minretumomab | 195189-17-4 | |
| HY-P9974 | Vantictumab | 1345009-45-1 | |
| HY-P9975 | Theralizumab | 906068-56-2 | |
| HY-P99763 | Ociperlimab | 2342597-93-5 | |
| HY-P9976A | Isatuximab (anti-CD38) | 1461640-62-9 | |
| HY-P9977 | Amivantamab | 2171511-58-1 | |
| HY-P99770 | Omodenbamab | 2241724-48-9 | |
| HY-P99776 | Plamotamab | 2138442-31-4 | |
| HY-P99788 | Praluzatamab | 2145109-70-0 | |
| HY-P99806 | Pritumumab | 499212-74-7 | |
| HY-P99813 | Patritumab deruxtecan | 2227102-46-5 | |
| HY-P99821 | Ravagalimab | 2050816-56-1 | |
| HY-P99850 | Depemokimab | 2243274-14-6 | |
| HY-P99852 | Dilpacimab | 1791420-09-1 | |
| HY-P99877 | Efavaleukin alfa | 2049067-94-7 | |
| HY-P9989 | Linvoseltamab | 2408319-25-3 | |
| HY-P99902 | Simlukafusp alfa | 1776942-10-9 | |
| HY-P99908 | Efineptakin alfa | 2026634-47-7 | |
| HY-P99909 | Elranatamab | 2408850-14-4 | |
| HY-P99006 | Amatuximab | 931402-35-6 | |
| HY-P990061 | Polzastobart | 2640981-19-5 | |
| HY-P990070 | Zigakibart | 2642175-46-8 | |
| HY-P990074 | Enlonstobart | 2651230-53-2 | |
| HY-P99008 | Atibuclimab | 2417175-94-9 | |
| HY-P990092 | Rolistobart | 2723442-10-0 | |
| HY-P99016 | Enfortumab | 1448664-46-7 | |
| HY-P99016B | Enfortumab vedotin-ejfv (solution) | 1346452-25-2 | |
| HY-P99024 | Glofitamab | 2229047-91-8 | |
| HY-P99029 | Magrolimab | 2169232-81-7 | |
| HY-P990461 | Anti-LIF Antibody (MSC-1) | ||
| HY-P99047 | Simtuzumab | 1318075-13-6 | |
| HY-P990489 | Anti-PDGFRB/CD140b Antibody (IMC-2C5) | ||
| HY-P990996 | Felmetatug | 2924808-29-5 | |
| HY-P99110 | Lanadelumab | 1426055-14-2 | |
| HY-P99116 | Faricimab | 1607793-29-2 | |
| HY-P99136 | Anti-Mouse IFN gamma Antibody (H22) | ||
| HY-P99149 | Anti-Mouse TNFR2 Antibody (TR75-54.7) | ||
| HY-P99159 | Ivuxolimab | 2128729-41-7 | |
| HY-P99160 | Labetuzumab | 219649-07-7 | |
| HY-P99175 | KWAR 23 | 2243227-60-1 | |
| HY-P99185 | Bapineuzumab | 648895-38-9 | |
| HY-P99188 | Carlumab | 915404-94-3 | |
| HY-P99230 | Pinatuzumab | 1639820-81-7 | |
| HY-P99232 | Indusatumab | 1497400-26-6 | |
| HY-P99241 | Ponsegromab | 2368950-15-4 | |
| HY-P99415 | Abelacimab | 2098724-83-3 | |
| HY-P99422 | Adebrelimab | 2247114-85-6 | |
| HY-P99434 | Amlitelimab | 2378692-15-8 | |
| HY-P99466 | Begelomab | 1403744-56-8 | |
| HY-P99507 | Zenocutuzumab | 1969309-56-5 | |
| HY-P99512 | Zampilimab | 2098280-42-1 | |
| HY-P99523 | Vepsitamab | 2413453-53-7 | |
| HY-P99533 | Urabrelimab | 2249722-58-3 | |
| HY-P99538 | Ublituximab | 1174014-05-1 | |
| HY-P99542 | Tusamitamab ravtansine | 2254086-60-5 | |
| HY-P99550 | Tozorakimab | 2376858-66-9 | |
| HY-P9956 | Siltuximab | 541502-14-1 | |
| HY-P99571 | Tefibazumab | 521079-87-8 | |
| HY-P99576 | Tarcocimab | 2408661-40-3 | |
| HY-P9958A | Denosumab (anti-TNFSF11) | 615258-40-7 | |
| HY-P9961 | Ofatumumab | 679818-59-8 | |
| HY-P99622 | Flanvotumab | 1188277-05-5 | |
| HY-P99624 | Foravirumab | 944548-38-3 | |
| HY-P99639 | Geptanolimab | 2348469-43-0 | |
| HY-P99644 | ACT017 | 2101829-58-5 | |
| HY-P99645 | Goflikicept | 2416984-26-2 | |
| HY-P99646 | Golocdacimab | 2418540-63-1 | |
| HY-P99056 | Utomilumab | 1417318-27-4 | |
| HY-P990601 | ICT-01 | ||
| HY-P990604 | Anti-ADAM9 Antibody (MGA021) | ||
| HY-P990614 | LK-1 | ||
| HY-P990634 | NEO-201 | ||
| HY-P990662 | Sapelizumab | 1535963-91-7 | |
| HY-P990669 | Torudokimab | 2241728-76-5 | |
| HY-P990685 | Romiplostim | 267639-76-9 | |
| HY-P990762 | Seniprutug | 2484772-72-5 | |
| HY-P990775 | Vilastobart | 2760549-50-4 | |
| HY-P990896 | FZ-A038 | ||
| HY-P990993 | Emugrobart | 2922218-19-5 | |
| HY-P99101 | Vobramitamab | 2490556-50-6 | |
| HY-P991080 | Anti-SLC44A4 Antibody | ||
| HY-P991192 | BI-1808 | ||
| HY-P99129 | Anti-Mouse CD8a Antibody (53-6.7) | ||
| HY-P99248 | Risankizumab | 1612838-76-2 | |
| HY-P99250 | Onartuzumab | 1133766-06-9 | |
| HY-P99268 | Seribantumab | 1334296-12-6 | |
| HY-P99279 | Bavituximab | 648904-28-3 | |
| HY-P99295 | Imgatuzumab | 959963-46-3 | |
| HY-P99303 | Lumiliximab | 357613-86-6 | |
| HY-P99335 | Vunakizumab | 1792181-33-9 | |
| HY-P99336 | Enlimomab | 142864-19-5 | |
| HY-P99342 | Imdevimab | 2415933-40-1 | |
| HY-P99958 | Vixtimotamab | 2243775-32-6 | |
| HY-P99959 | Unasnemab | 2379805-59-9 | |
| HY-P99962 | Surzebiclimab | 2342597-90-2 | |
| HY-P99978 | Mouse IgG2a kappa, Isotype Control | ||
| HY-P99996 | Human IgG1 (D265A) kappa, Isotype Control | ||
| HY-W392209A | Copovidone (50% in ethanol) | 25086-89-9 | |
| HY-P99661 | Inbakicept | 2135939-52-3 | |
| HY-P99665 | Insulin efsitora alfa | 2131038-11-2 | |
| HY-P99700 | Letaplimab | 2283356-07-8 | |
| HY-P99733 | Mipasetamab | 2361055-48-1 | |
| HY-P99744 | Modakafusp alfa | 2254522-19-3 | |
| HY-P99754 | Netakimab | 1796570-08-5 | |
| HY-P99761 | Obexelimab | 1690307-05-1 | |
| HY-P99764 | Odesivimab | 2135632-30-1 | |
| HY-P99795 | Otilimab | 1638332-55-4 | |
| HY-P99796 | Ozoralizumab | 1167985-17-2 | |
| HY-P99812 | Ragifilimab | 2207590-51-8 | |
| HY-P99833 | Cosibelimab | 2216751-26-5 | |
| HY-P99365 | Ravulizumab | 1803171-55-2 | |
| HY-P99366A | Tezepelumab (anti-TSLP) | 1572943-04-4 | |
| HY-P99374 | Naratuximab | 1622327-39-2 | |
| HY-P99380 | Zanidatamab | 2169946-15-8 | |
| HY-P99383 | Volagidemab | 1233956-13-2 | |
| HY-P99386 | Vesencumab | 1205533-60-3 | |
| HY-P99392 | Teclistamab | 2119595-80-9 | |
| HY-P99398 | Setrusumab | 1847394-95-9 | |
| HY-P99403 | Refanezumab | 1233953-61-1 | |
| HY-P99413 | IMAB027 | 1650599-68-0 | |
| HY-P9918 | Tremelimumab | 745013-59-6 | |
| HY-P99187 | Bococizumab | 1407495-02-6 | |
| HY-P99194 | Evinacumab | 1446419-85-7 | |
| HY-P99197 | Figitumumab | 943453-46-1 | |
| HY-P9921 | Trastuzumab emtansine | 1018448-65-1 | |
| HY-P99214 | Panobacumab | 885053-97-4 | |
| HY-P99222 | Teplizumab | 876387-05-2 | |
| HY-P99223 | Tovetumab | 1243266-04-7 | |
| HY-P99229 | Upifitamab | 2254118-43-7 | |
| HY-P9925 | Brodalumab | 1174395-19-7 | |
| HY-P99256 | Tildrakizumab | 1326244-10-3 | |
| HY-P99425 | Afelimomab | 156227-98-4 | |
| HY-P99444 | Astegolimab | 2173054-79-8 | |
| HY-P9945A | Mepolizumab (anti-IL5) | 196078-29-2 | |
| HY-P9947 | Efalizumab | 214745-43-4 | |
| HY-P99471 | Bepranemab | 2244960-75-4 | |
| HY-P99485 | Brazikumab | 1610353-18-8 | |
| HY-P99489 | Budigalimab | 2098225-93-3 | |
| HY-P99498 | Cergutuzumab amunaleukin | 1509916-03-3 | |
| HY-P99530 | Valanafusp alfa | 1815583-32-4 | |
| HY-P99539 | Ubamatamab | 2305629-50-7 | |
| HY-P99544 | Tagitanlimab | 2417649-97-7 | |
| HY-P99206 | Naxitamab | 1879925-92-4 | |
| HY-P99219 | Sifalimumab | 1006877-41-3 | |
| HY-P9922 | Olaratumab | 1024603-93-7 | |
| HY-P99236 | Bexmarilimab | 2259301-27-2 | |
| HY-P9923A | Benralizumab (anti-IL5RA ) | 1044511-01-4 | |
| HY-P99252 | Itolizumab | 1116433-11-4 | |
| HY-P99262 | Imalumab | 1430205-07-4 | |
| HY-P99281 | Bivatuzumab | 214559-60-1 | |
| HY-P99296 | Intetumumab | 725735-28-4 | |
| HY-P99306 | Modotuximab | 1310460-86-6 | |
| HY-P99307 | Namilumab | 1206681-39-1 | |
| HY-P99316 | Sirukumab | 1194585-53-9 | |
| HY-P99323 | Timolumab | 1073538-99-4 | |
| HY-P99345 | Dostarlimab | 2022215-59-2 | |
| HY-P99347 | Etesevimab | 2423948-94-9 | |
| HY-P99349 | Loncastuximab tesirine | 1879918-31-6 | |
| HY-P99358 | Dezamizumab | 1662664-56-3 | |
| HY-P99367 | Ifinatamab | 2484870-90-6 | |
| HY-P99368 | Lacnotuzumab | 1831128-32-5 | |
| HY-P99257 | Bleselumab | 1453067-91-8 | |
| HY-P99266 | Zanolimumab | 652153-01-0 | |
| HY-P99273 | Vorsetuzumab | 1165740-62-4 | |
| HY-P99278 | Adecatumumab | 503605-66-1 | |
| HY-P99291 | Etaracizumab | 892553-42-3 | |
| HY-P99298 | Lampalizumab | 1278466-20-8 | |
| HY-P99300 | Ligelizumab | 1322627-61-1 | |
| HY-P99305 | Metelimumab | 272780-74-2 | |
| HY-P99310 | Perakizumab | 89957-37-9 | |
| HY-P99378 | Neihulizumab | 2158362-38-8 | |
| HY-P99390 | Tepoditamab | 2044679-53-8 | |
| HY-P99399 | Semorinemab | 2159141-27-0 | |
| HY-P99405 | Prasinezumab | 1960462-19-4 | |
| HY-P99414 | Prezalumab | 1523164-68-2 | |
| HY-P99419 | Acasunlimab | 2253937-12-9 | |
| HY-P99424 | Afasevikumab | 1589503-30-9 | |
| HY-P99430 | Alnuctamab | 2296827-07-9 | |
| HY-P99438 | Anivovetmab | 2370896-63-0 | |
| HY-P99439 | Anrukinzumab | 910649-32-0 | |
| HY-P99552 | Tafolecimab | 2225109-03-3 | |
| HY-P99628 | Futuximab | 1310460-85-5 | |
| HY-P99631 | Garadacimab | 2162134-62-3 | |
| HY-P99637 | Gedivumab | 1807954-17-1 | |
| HY-P9964 | Necitumumab | 906805-06-9 | |
| HY-P99654 | Idactamab | 2245205-37-0 | |
| HY-P9966 | Enoblituzumab | 1353485-38-7 | |
| HY-P99663 | Inezetamab | 2568264-76-4 | |
| HY-P99671 | Isecarosmab | 2254082-79-4 | |
| HY-P9969 | Matuzumab | 339186-68-4 | |
| HY-P99699 | Lesofavumab | 1807960-57-1 | |
| HY-P9970A | Infliximab (Anti-TNF-α) | ||
| HY-P9984 | Etrolizumab | 1044758-60-2 | |
| HY-P99842A | Dapirolizumab | 1416147-64-2 | |
| HY-P99849 | Depatuxizumab | 1471999-69-5 | |
| HY-P99853 | Diridavumab | 1393659-46-5 | |
| HY-P99879 | Efbemalenograstim alfa | 2200269-79-8 | |
| HY-P99880 | Roledumab | 1174008-79-7 | |
| HY-P99899 | Samrotamab | 2052591-32-7 | |
| HY-P9992 | Pelgifatamab | 2414550-93-7 | |
| HY-P99925 | Enoticumab | 1192578-27-0 | |
| HY-P99935 | Elarekibep | 2485020-60-6 | |
| HY-P99969 | Inetetamab | ||
| HY-P99320 | Tarextumab | 1359940-55-8 | |
| HY-P99322 | Tesidolumab | 1531594-08-7 | |
| HY-P99326 | Tositumomab | 192391-48-3 | |
| HY-P99340 | Sotrovimab | 2423014-07-5 | |
| HY-P99351 | Andecaliximab | 1518996-49-0 | |
| HY-P99369 | Lacutamab | 2187368-16-5 | |
| HY-P99375 | Narnatumab | 1188275-92-4 | |
| HY-P99376 | Narsoplimab | 2108782-45-0 | |
| HY-P99711 | Loncastuximab | 1875032-68-0 | |
| HY-P99728 | Melredableukin alfa | 2056881-92-4 | |
| HY-P99748 | Nadecnemab | 2377679-19-9 | |
| HY-P99750 | Navivumab | 1443004-16-7 | |
| HY-P99756 | Nirsevimab | 1989556-22-0 | |
| HY-P99760 | Nurulimab | 2168561-20-2 | |
| HY-P99768 | Olinvacimab | 2095504-49-5 | |
| HY-P99777 | Ontorpacept | 2131089-46-6 | |
| HY-P99786 | Pozelimab | 2096328-94-6 | |
| HY-P99791 | Orilanolimab | 2066544-85-0 | |
| HY-P99799 | Pacmilimab | 2145091-51-4 | |
| HY-P99388 | Trevogrumab | 1429201-24-0 | |
| HY-P99391 | Telisotuzumab | 1781223-80-0 | |
| HY-P99397 | Sonelokimab | 1414386-05-2 | |
| HY-P99406 | Petosemtamab | 2213450-26-9 | |
| HY-P99410 | Ordesekimab | 879293-15-9 | |
| HY-P99412 | Lusvertikimab | 2375835-91-7 | |
| HY-P99462 | Barzolvolimab | 2438203-51-9 | |
| HY-P99463 | Batiraxcept | 2268717-61-7 | |
| HY-P99481 | Birtamimab | 1608108-91-3 | |
| HY-P99493 | Cantuzumab ravtansine | 868747-45-9 | |
| HY-P99506 | Tamrintamab | 2148325-59-9 | |
| HY-P99807 | Prolgolimab | 2093956-19-3 | |
| HY-P9981 | Tafasitamab | 1422527-84-1 | |
| HY-P99811 | Rafivirumab | 944548-37-2 | |
| HY-P99814 | Pavurutamab | 2250292-39-6 | |
| HY-P99823 | Recifercept | 2226238-09-9 | |
| HY-P99828 | Cofetuzumab | 1869928-62-0 | |
| HY-P99858 | Domvanalimab | 2368219-35-4 | |
| HY-P99869 | Ebdarokimab | 2393651-11-9 | |
| HY-P99910 | Eluvixtamab | 1679391-73-1 | |
| HY-P99937 | Elipovimab | 2101210-43-7 | |
| HY-P9996 | Reozalimab | 2445259-99-2 | |
| HY-P99521 | Vibecotamab | 2138442-13-2 | |
| HY-P99537 | Ulenistamab | 2415259-90-2 | |
| HY-P99551 | Tosatoxumab | 1374419-41-6 | |
| HY-P99572 | Tecaginlimab | 2253891-70-0 | |
| HY-P99573 | Tebotelimab | 2245725-04-4 | |
| HY-P99583 | Suvratoxumab | 1629620-18-3 | |
| HY-P99588 | Stamulumab | 705287-60-1 | |
| HY-P99589 | Sotevtamab | 2411526-47-9 | |
| HY-P99591 | Sontuzumab | 372075-37-1 | |
| HY-P99617 | Fianlimab | 2126132-98-5 | |
| HY-P9963 | Blinatumomab | 853426-35-4 | |
| HY-P99632 | Garetosmab | 2097125-54-5 | |
| HY-P99638 | Gefurulimab | 2456407-94-4 | |
| HY-P99649 | Gremubamab | 1800381-36-5 | |
| HY-P99650 | Grisnilimab | 2367001-70-3 | |
| HY-P99672 | Istiratumab | 1509928-04-4 | |
| HY-P99688 | Latozinemab | 2376132-27-1 | |
| HY-P99697 | Leronlimab | 674782-26-4 | |
| HY-P9970 | Infliximab | 170277-31-3 | |
| HY-P99707 | Lilotomab | 1453362-55-4 | |
| HY-P99729 | Melrilimab | 2222865-46-3 | |
| HY-P99742 | Mitazalimab | 2055640-86-1 | |
| HY-135849B | Catalase, Human Erythrocyte | ||
| HY-136562 | N-Arachidonyl maleimide | 876305-42-9 | |
| HY-14190 | Valategrast | 220847-86-9 | |
| HY-152963 | Tisotumab vedotin | 1418731-10-8 | |
| HY-15870A | (6E)-SR 11302 | 1386982-70-2 | |
| HY-160719 | NHS-activated 2-octynoic acid-BSA | ||
| HY-16466 | Spliceostatin A | 391611-36-2 | |
| HY-164789 | Sacituzumab tirumotecan | 2768350-77-0 | |
| HY-170554 | ABBV-706 | ||
| HY-32349S | Ercalcidiol-d3 | 1217467-39-4 | |
| HY-B1342S2 | Vitamin A-d4 | 118063-12-0 | |
| HY-P99982 | Mouse IgG2b kappa, Isotype Control | ||
| HY-P99992 | Human IgG1 lambda1, Isotype Control | ||
| HY-U00449G | AGN 193109 (GMP) | 171746-21-7 | |
| HY-W010861 | 2'-Deoxycytidine-5'-diphosphate (trisodium) | 151151-32-5 | |
| HY-W013063 | 1,2-Dilinoleoyl-sn-glycero-3-phosphocholine | 998-06-1 | |
| HY-Y1977 | 100mM Pro-Ac, 20 mM Arg, pH 5.0 buffer | ||
| HY-P99994 | Human IgG1 (N297A) kappa, Isotype Control | ||
| HY-W087187 | DOTAGA-anhydride | 1375475-53-8 | |
| HY-P99762 | Obrindatamab | 2069959-72-2 | |
| HY-P99794 | Osocimab | 2056878-75-0 | |
| HY-P99810 | Quisovalimab | 2427667-03-4 | |
| HY-P9982 | Romosozumab | 909395-70-6 | |
| HY-P99855 | Divozilimab | 2254061-60-2 | |
| HY-P99857 | Domagrozumab | 1629605-31-7 | |
| HY-P99865 | Dresbuxelimab | 2550560-20-6 | |
| HY-P99868 | Duvortuxizumab | 1831098-91-9 | |
| HY-P99889 | Romlusevimab | 2509447-08-7 | |
| HY-P9991 | Osemitamab | 2460539-61-9 | |
| HY-P99930 | Efruxifermin | 2375240-92-7 | |
| HY-P99440 | Anumigilimab | 2416593-08-1 | |
| HY-P99441 | Apitegromab | 2278276-46-1 | |
| HY-P99445 | Asunercept | 1450882-18-4 | |
| HY-P99483 | Blontuvetmab | 1608112-78-2 | |
| HY-P99487 | Briobacept | 869881-54-9 | |
| HY-P99488 | Briquilimab | 2574591-89-0 | |
| HY-P99491 | Camoteskimab | 2492472-82-7 | |
| HY-P99508 | Tamgiblimab | 2411914-36-6 | |
| HY-P99514 | Zalifrelimab | 2148321-69-9 | |
| HY-P99547 | Trastuzumab duocarmazine | 1642152-40-6 | |
| HY-P99555 | Tomaralimab | 1449294-76-1 | |
| HY-E70373 | λ Protein phosphatase | 401941-75-1 | |
| HY-K0553 | Mycoplasma Detection Kit (qPCR) | ||
| HY-K6002 | Basement Membrane Matrix | ||
| HY-K6003 | Basement Membrane Matrix GFR (Phenol Red) | ||
| HY-K6008 | Basement Membrane Matrix HC | ||
| HY-K6009 | Basement Membrane Matrix GFR&HC | ||
| HY-N7686 | Paeoniflorgenin | 697300-41-7 | |
| HY-P1363B | β-Amyloid (1-42), human, HFIP-treated | 107761-42-2 | |
| HY-P2799D | Creatine Kinase MB (rCK-MB), Recombinant Human | 9001-15-4 | |
| HY-P700002A | Tenascin/Tnc, Mouse (His-Myc, Solution) | ||
| HY-P70003 | DPEP1, Human (HEK293, His) | ||
| HY-P70014 | CDK2, Human (His) | ||
| HY-P700977 | C-MPL, Cynomolgus (HEK293, His) | ||
| HY-P700984 | TAFA5/FAM19A5, Human (His) | ||
| HY-P701027 | NLRP3, Human (GST) | ||
| HY-P70103 | CNDP2, Mouse (HEK293, His) | ||
| HY-P701135 | PICALM Recombinant,Human(HEK293,C-His) | ||
| HY-P70127 | SARS-CoV-2 NSP1 (His) | ||
| HY-P701284 | FITC-Labeled NKG2D/CD314, Human (HEK293, Fc) | ||
| HY-P99579 | Tamtuvetmab | 1608122-71-9 | |
| HY-P99584 | Suvizumab | 914257-21-9 | |
| HY-P99625 | Frexalimab | 2515463-86-0 | |
| HY-P99640 | Giloralimab | 2226292-20-0 | |
| HY-P99643 | Ginisortamab | 2390147-17-6 | |
| HY-P99653 | Ianalumab | 1929549-92-7 | |
| HY-P99664 | Inolimomab | 152981-31-2 | |
| HY-P99669 | Iratumumab | 640735-09-7 | |
| HY-P9967 | Aducanumab | 1384260-65-4 | |
| HY-P99681 | Labetuzumab govitecan | 1469876-18-3 | |
| HY-P99682 | Ladiratuzumab | 1629760-28-6 | |
| HY-P701311 | Laminin 521, Human | ||
| HY-P701341 | Caspase-3/CASP3, Human | ||
| HY-P701379 | KIF11, Human (His) | ||
| HY-P701404 | LXR-α, Human | ||
| HY-P701632 | TNKS1, Human | ||
| HY-P701676 | EEF2K, Human (GST) | ||
| HY-P701705 | ASK1, Human (His) | ||
| HY-P701811 | MELK, Human (His) | ||
| HY-P701839 | ubiquitin, Human (His) | ||
| HY-P99701 | Letolizumab | 1450981-87-9 | |
| HY-P99712 | Lonigutamab | 2362015-67-4 | |
| HY-P99715 | Losatuxizumab | 1801544-27-3 | |
| HY-P99718 | Lupartumab | 1640971-88-5 | |
| HY-P9972 | Spartalizumab | 1935694-88-4 | |
| HY-P99720 | Luspatercept | 1373715-00-4 | |
| HY-P99724 | Manfidokimab | 2428381-56-8 | |
| HY-P99725 | Marstacimab | 1985638-39-8 | |
| HY-P99730 | Mezagitamab | 2227490-52-8 | |
| HY-P99758 | Nofazinlimab | 2377845-98-0 | |
| HY-P99802 | Pasotuxizumab | 1442657-12-6 | |
| HY-P99931 | Epcoritamab | 2134641-34-0 | |
| HY-P99934 | Eftozanermin alfa | 1820660-69-2 | |
| HY-P99965 | Crovalimab | 1917321-26-6 | |
| HY-P99986 | Mouse lgG2a (D265A) kappa, Isotype Control | ||
| HY-P9999 | Trontinemab | 2568868-35-7 | |
| HY-P99990 | Human IgG3 kappa, Isotype Control | ||
| HY-P99998 | Human IgG1 (F405L) kappa, Isotype Control | ||
| HY-Y1968A | Sterile 10 mM Histidine, pH 5.5 buffer | ||
| HY-P701874 | DPP8, Human (Sf9, His) | ||
| HY-P701889 | Galactokinase, Thermus thermophilus | ||
| HY-P701914 | GLUD1, Human | ||
| HY-P701983 | metK, Shigella sonnei (His) | ||
| HY-P702061 | p30, African swine fever virus | ||
| HY-P70222Y | GDF-11/BMP-11, Human (HEK293, solution) | ||
| HY-P70250 | MMP-1, Human (HEK293, His) | ||
| HY-P70267 | Fumarate hydratase/FH, Human | ||
| HY-P70269Y | HMBS/Porphobilinogen deaminase, Human (HEK293, His, solution) | ||
| HY-P702775 | Envelop VLP Control (HEK293) | ||
| HY-P702823 | ADH5, Human | ||
| HY-P702858 | HDAC8, Human (sf9) | ||
| HY-P70297 | 15-PGDH/HPGD, Human (HEK293, His) | ||
| HY-P703031 | KDM5B, Mouse (sf9, GST) | ||
| HY-P70335 | IMPA1, Human (His) | ||
| HY-P703357 | NOD2, Human (Sf9, Strep, Flag) | ||
| HY-P703526 | ACVR2B, Human | ||
| HY-P703579 | STAT6, Human (sf9, His, Strep) | ||
| HY-P703584 | PREP, Human | ||
| HY-P70371 | Importin alpha-1/KPNA2, Human (His) | ||
| HY-P70380 | METAP1/Methionine aminopeptidase 1, Human | ||
| HY-P703829 | AGR-2, Human (His) | ||
| HY-P70548 | PSMA, Human (HEK293, His, solution) | ||
| HY-P70600 | FGF basic/bFGF, Human (K128N, solution) | ||
| HY-P70831 | GALNT3, Human (HEK293, His) | ||
| HY-P70890 | FAM3D, Human (HEK293, His) | ||
| HY-P70929 | HSPB7, Human (His) | ||
| HY-P70990 | PADI4, Human (His) | ||
| HY-P70992 | PEPD, Human | ||
| HY-P70993 | PLA2G7, Human (HEK293, His) | ||
| HY-P71049 | PGK1, Human (HEK293, His) | ||
| HY-P71050 | PLAU/uPA, Human (411a.a, HEK293, His, solution) | ||
| HY-P71085 | Serpin E2, Human (HEK293, His) | ||
| HY-P71116 | ST6GAL1, Human (HEK293, His) | ||
| HY-P71138 | S100P, Human (His) | ||
| HY-P71156 | Lipocalin-2/NGAL, Human (HEK293, His) | ||
| HY-P71211 | PLA2G16, Human (His) | ||
| HY-P71212 | PLA2G1B, Mouse (HEK293, His) | ||
| HY-P71225 | PPIE, Human (His) | ||
| HY-P71226 | PPIL1, Human (His) | ||
| HY-P71246 | PTX3, Mouse (HEK293, His) | ||
| HY-P71340 | STUB1, Human | ||
| HY-P71401 | UBE2G2, Human (GST) | ||
| HY-P71805Y | Insulin-1/Ins1 Protein, Mouse (P.pastoris, Myc, His, solution) | ||
| HY-P72337 | cGAS, Human (His) | ||
| HY-P72729 | CD39L1/ENTPD2, Mouse (HEK293, His) | ||
| HY-P72876 | MME, Human (HEK293) | ||
| HY-P72914 | CD45, Mouse (sf9) | ||
| HY-P72929 | CD70, Rat (HEK293, Fc) | ||
| HY-P72991 | EphA2, Human (sf9, His-GST) | ||
| HY-P73006 | Ephrin-A3/EFNA3, Human (HEK293) | ||
| HY-P73045 | Coagulation Factor VII/F7, Mouse (CHO, His) | ||
| HY-P73090 | GSK-3 beta, Mouse (sf9, His) | ||
| HY-P73198 | IL-25/IL-17E, Mouse (His) | ||
| HY-P73246 | IFN-alpha 2b/IFNA2, Human (P.pastoris) | ||
| HY-P73269 | Lck, Human (sf9, GST) | ||
| HY-P73315 | Neuropilin-2, Mouse (HEK293, His) | ||
| HY-P73342 | PD-1, Canine (HEK293, His) | ||
| HY-P73352 | PDGF-BB, Mouse (P.pastoris, His) | ||
| HY-P73390 | ROR1, Human (sf9, His) | ||
| HY-P73397 | SARS-CoV-2 S RBD (HEK293, Fc) | ||
| HY-P73466 | UCHL1, Mouse (His) | ||
| HY-P73537 | XIAP, Human (His) | ||
| HY-P73584 | TOP1, Human (765a.a, sf9, His) | ||
| HY-P73634 | SNAP25, Human (His) | ||
| HY-P73636 | SMAD3, Human/Mouse/Rat (sf9, His-GST) | ||
| HY-P99870 | Eblasakimab | 2445460-16-0 | |
| HY-P99873 | Ecromeximab | 292819-64-8 | |
| HY-P99906 | Sirexatamab | 2414962-49-3 | |
| HY-P9993 | Peresolimab | 2411580-63-5 | |
| HY-P99944 | SHR-1701 | 2891860-17-4 | |
| HY-P99945 | Revdofilimab | 2230138-89-1 | |
| HY-P99967 | Cantuzumab | 1204740-23-7 | |
| HY-P99968 | Clivatuzumab | 1622075-09-5 | |
| HY-P99970 | Lifastuzumab | 1615697-16-9 | |
| HY-P73671 | S100A8, Mouse (sf9, His) | ||
| HY-P73685 | PTP1B, Human (His) | ||
| HY-P73701 | PPAR gamma, Human (sf9, His-GST) | ||
| HY-P73713 | PRDX1, Mouse (His) | ||
| HY-P73740 | NS1, Dengue virus 2 (HEK293, His) | ||
| HY-P73858 | IRE1, Human (sf9) | ||
| HY-P73868 | Integrin alpha V beta 3 Protein, Human (HEK293, His, solution) | ||
| HY-P73934 | Haptoglobin, Rat (HEK293, His) | ||
| HY-P73935 | HA/Hemagglutinin, Influenza B (EPI529345, sf9, His) | ||
| HY-P73947 | HA/Hemagglutinin, Influenza B (ACN29380, sf9) | ||
| HY-P74008 | HA/Hemagglutinin, H5N1 (AAT76166, sf9, His) | ||
| HY-P74114 | GSK-3 beta, Human (sf9, His) | ||
| HY-P74239 | Coagulation Factor VII/F7, Human (HEK293, His) | ||
| HY-P7437 | Nucleocapsid (His) | ||
| HY-P74443 | SARS-CoV-2 Nucleocapsid (Omicron, B.1.1.529, His) | ||
| HY-P74458 | Zika virus E/Envelope (438a.a, sf9, His) | ||
| HY-P7449 | CD73/5'-Nucleotidase, Rat (HEK293, His) | ||
| HY-P74517 | Thy1/CD90, Human (HEK293, Fc) | ||
| HY-P7455 | ACVR2A/Activin RIIA, Human (HEK293, His, solution) | ||
| HY-P74569 | SDF-1, Canine | ||
| HY-P74601 | RBBP4, Human (sf9, His) | ||
| HY-P74623 | PON3, Human (S50N, sf9, His) | ||
| HY-P74739 | MVK, Human (sf9, His-GST) | ||
| HY-P7475 | ALDH1A2, Human (His) | ||
| HY-P74751 | MERS-CoV Spike/S1 (HEK293, His) | ||
| HY-P74780 | LAP3, Human (HEK293, His) | ||
| HY-P74862A | IFN-alpha/beta R2 Protein, Human (HEK293, His, solution) | ||
| HY-P7487 | Alkaline Phosphatase/ALPP, Human (HEK293, His) | ||
| HY-P74876 | HTRA2/OMI, Human (His) | ||
| HY-P74879 | HOXA1, Human (His) | ||
| HY-P74885 | envelope glycoprotein gp160, HIV-1 (AAT67478, HEK293, His) | ||
| HY-P7492 | Alpha-Galactosidase A, Human (HEK293, His) | ||
| HY-P75153 | GSTA1, Human (HEK293, His, solution) | ||
| HY-P75200 | FCGRT-B2M Heterodimer, Mouse (Biotinylated, HEK293, His) | ||
| HY-P75263 | EDAR, Human (HEK293, Fc) | ||
| HY-P75370 | CD97, Human (HEK293, hFc) | ||
| HY-P75446 | CD105/Endoglin, Mouse (HEK293, His) | ||
| HY-P75541 | ACOX1, Human (sf9, His) | ||
| HY-P75640 | CD30 Ligand/TNFSF8, Rat (HEK293, Fc) | ||
| HY-P75664 | CD98, Rat (HEK293, His) | ||
| HY-P75739 | EphA3, Mouse (sf9, His-GST) | ||
| HY-P75825 | IL-10R alpha, Mouse (HEK293, Fc) | ||
| HY-P75899 | KEAP1, Human (sf9, His-GST) | ||
| HY-P76078 | SLITRK1, Human (HEK293, His) | ||
| HY-P76099 | SULT1E1, Human (His) | ||
| HY-P76185 | HABP1/C1QBP, Mouse (His) | ||
| HY-P76254 | CHIT1/Chitotriosidase-1, Human (HEK293, His) | ||
| HY-P76263 | CSNK2A1, Human (sf9, GST) | ||
| HY-P76284 | CREB3L1, Human (HEK293, His) | ||
| HY-P76352 | FTCD, Human (sf9, His) | ||
| HY-P76403 | IFN-alpha 4/IFNA4, Mouse (HEK293, His) | ||
| HY-P76744 | BAFFR/TNFRSF13C, Rat (HEK293, Fc) | ||
| HY-P76827A | CKMT2, Rat (His, Solution) | ||
| HY-P76948 | GFRA1/GDNFR-alpha-1, Rat (HEK293, Fc) | ||
| HY-P76966 | USH1C, Human (His) | ||
| HY-P76974 | HS3ST1, Human (sf9, His) | ||
| HY-P76987 | IL-10R alpha, Rhesus Macaque (HEK293, Fc) | ||
| HY-P77197 | Serpin B12, Mouse (sf9, His) | ||
| HY-P7721 | Carbonic Anhydrase 5B, Human (His) | ||
| HY-P77214 | SPG3A/ATL1, Human (sf9, His) | ||
| HY-P77215 | SRFBP1, Human (sf9, His-GST) | ||
| HY-P77222 | TAOK3, Human (sf9, His) | ||
| HY-P7723 | Carbonic Anhydrase 8, Human (His) | ||
| HY-P77286 | DAPK3/ZIPK, Human (sf9, GST) | ||
| HY-P77398 | IL-11R alpha, Canine (HEK293, Fc) | ||
| HY-P77523 | B7-1/CD80, Mouse (Biotinylated, HEK293, His) | ||
| HY-P7754 | Cathepsin L1, Human (HEK293, His, solution) | ||
| HY-P7776 | CD105/Endoglin, Human (Trx-His) | ||
| HY-P77995 | MBP, Mouse (His) | ||
| HY-P78041 | SLPI, Mouse (HEK293, Fc) | ||
| HY-P7814 | DFF45/ICAD, Human (His) | ||
| HY-P78455 | HLA-G, Human (C66S, His-Avi) | ||
| HY-P7890 | Complement factor H/CFH, Human (431a.a, HEK293, His) | ||
| HY-P78955 | NucA, S. marcescens | ||
| HY-P79310 | PPA1, S. cerevisiae (His) | ||
| HY-P79459 | SENP1 Catalytic Domain, Human (His) | ||
| HY-P9801 | Anti-Spike-RBD mAb | ||
| HY-P990018 | Boserolimab | 2444297-08-7 | |
| HY-P990032 | Belrestotug | 2574438-65-4 | |
| HY-P990036 | Dazukibart | 2639474-65-8 | |
| HY-P990044 | Dalnicastobart | 2642171-59-1 | |
| HY-P990047 | Maridebart | 2761478-99-1 | |
| HY-P990051 | Delpacibart | 2653183-66-3 | |
| HY-P99007 | Aprutumab | 1634620-63-5 | |
| HY-P990090 | Rademikibart | 2648260-80-2 | |
| HY-P990091 | Riliprubart | 2756228-76-7 | |
| HY-P990104 | Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) | ||
| HY-P99010A | Bemarituzumab (FUT8-KO) | ||
| HY-P99011 | Cibisatamab | 1855925-27-7 | |
| HY-P99023 | Girentuximab | 916138-87-9 | |
| HY-P990317 | AGS-67E | ||
| HY-P990341 | Anti-B7-H4/VTCN1 Antibody | ||
| HY-P990351 | Anti-CD34 Antibody | ||
| HY-P99037 | Nipocalimab | 2211985-36-1 | |
| HY-P9904 | Atezolizumab | 1380723-44-3 | |
| HY-P99041 | Panitumumab | 339177-26-3 | |
| HY-P990426 | Anti-GREM1/Gremlin Antibody | ||
| HY-P990545 | ANX005 | ||
| HY-P99055 | Urelumab | 934823-49-1 | |
| HY-P99057 | Varlilumab | 1393344-72-3 | |
| HY-P990579 | Anti-CLDN6 Antibody (DS-9606A antibody) | ||
| HY-P990627 | Anti-EphA2 Antibody (1C1) | ||
| HY-P990647 | PF-06342674 | ||
| HY-P990770 | Ucenprubart | 2414559-57-0 | |
| HY-P990785 | Etentamig | 2490552-52-6 | |
| HY-P990876 | Afimkibart | 2911580-96-4 | |
| HY-P991047 | Anti-CD71/TfR1 Antibody | ||
| HY-P99118 | Serplulimab | 2231029-82-4 | |
| HY-P99122 | Anti-Mouse CD209b Antibody (22D1) | ||
| HY-P99156 | Relatlimab | 1673516-98-7 | |
| HY-P99157 | Omburtamab | 1895083-75-6 | |
| HY-P99165 | Teprotumumab | 1036734-93-6 | |
| HY-P99171 | Gevokizumab | 1129435-60-4 | |
| HY-P99192 | Emibetuzumab | 1365287-97-3 | |
| HY-P99205 | Glembatumumab | 1020264-78-1 | |
| HY-P99207 | Lenzilumab | 1229575-09-0 | |
| HY-P99209 | Motavizumab | 677010-34-3 | |
| HY-P99211 | Otelixizumab | 881191-44-2 | |
| HY-P99212 | Otlertuzumab | 1372645-37-8 | |
| HY-P99221 | Tanezumab | 880266-57-9 | |
| HY-P99224 | Veltuzumab | 728917-18-8 | |
| HY-P99238 | Rolinsatamab | 2095467-30-2 | |
| HY-P99260 | Conatumumab | 896731-82-1 | |
| HY-P99283 | Concizumab | 1312299-39-0 | |
| HY-P99287 | Elsilimomab | 468715-71-1 | |
| HY-P99318 | Sonepcizumab | 1031360-18-5 | |
| HY-P99319 | Talizumab | 380610-22-0 | |
| HY-P99330 | Vanucizumab | 1448221-05-3 | |
| HY-P99332 | Visilizumab | 219716-33-3 | |
| HY-P99337 | Ansuvimab | 2375952-29-5 | |
| HY-P99353 | Ascrinvacumab | 1463459-96-2 | |
| HY-P99357 | Crotedumab | 1452387-69-7 | |
| HY-P99363 | Feladilimab | 2252518-85-5 | |
| HY-P99370 | Landogrozumab | 1391726-30-9 | |
| HY-P99381 | XmAb 5592 | 1221901-33-2 | |
| HY-P99384 | Vofatamab | 1312305-12-6 | |
| HY-P99395 | Talacotuzumab | 1826831-79-1 | |
| HY-P99396 | Spesolimab | 2097104-58-8 | |
| HY-P99417 | Abrezekimab | 2043952-59-4 | |
| HY-P99420 | Acazicolcept | 2797026-97-0 | |
| HY-P99423 | Adintrevimab | 2516243-54-0 | |
| HY-P99451 | Avizakimab | 2229685-51-0 | |
| HY-P99452 | Axatilimab | 2155851-88-8 | |
| HY-P99460 | Bapotulimab | 2359413-58-2 | |
| HY-P9948 | Alemtuzumab | 216503-57-0 | |
| HY-P99484 | Botensilimab | 2408310-37-0 | |
| HY-P99492 | Cantuzumab mertansine | 400010-39-1 | |
| HY-P99494 | Carotuximab | 1268714-50-6 | |
| HY-P99505 | Ziltivekimab | 2226654-05-1 | |
| HY-P99510 | Zansecimab | 2415205-37-5 | |
| HY-P99515 | Xeligekimab | 2382921-73-3 | |
| HY-P9951A | Ranibizumab (anti-VEGF) | 347396-82-1 | |
| HY-P99564 | Teropavimab | 2417213-72-8 | |
| HY-P99570 | Telazorlimab | 2126777-87-3 | |
| HY-P99592 | Solitomab | 1005198-65-1 | |
| HY-P9960 | Ocrelizumab | 637334-45-3 | |
| HY-P99601 | Cevostamab | 2249888-53-5 | |
| HY-P99604 | Cilgavimab | 2420563-99-9 | |
| HY-P99605 | Cinrebafusp alfa | 2218515-90-1 | |
| HY-P99610 | Ezabenlimab | 2249882-54-8 | |
| HY-P99611 | Faralimomab | 167816-91-3 | |
| HY-P99612 | Farletuzumab ecteribulin | 2407465-18-1 | |
| HY-P99616 | Felzartamab | 2197112-39-1 | |
| HY-P99618 | Fidasimtamab | 2377419-89-9 | |
| HY-P99621 | Fiztasovimab | 2467411-25-0 | |
| HY-P99629 | Galegenimab | 2403683-24-7 | |
| HY-P99635 | Gatralimab | 1826020-80-7 | |
| HY-P99652 | Gumokimab | 2428381-52-4 | |
| HY-P99677 | Izenivetmab | 2447755-72-6 | |
| HY-P99684 | Laprituximab | 1622327-38-1 | |
| HY-P99698 | Lesabelimab | 2475402-56-1 | |
| HY-P99704 | Licaminlimab | 1688648-13-6 | |
| HY-P99706 | Ligufalimab | 2428381-55-7 | |
| HY-P9973 | Brolucizumab | 1531589-13-5 | |
| HY-P99740 | Mirzotamab | 2229859-11-2 | |
| HY-P99752 | Nemvaleukin alfa | 2315268-27-8 | |
| HY-P99781 | Plozalizumab | 1610761-46-0 | |
| HY-P9979 | Rozanolixizumab | 1584645-37-3 | |
| HY-P99798 | Pacanalotamab | 2251756-52-0 | |
| HY-P9980 | Belantamab | 2061894-48-0 | |
| HY-P99804 | Clesrovimab | 2429913-18-6 | |
| HY-P99818 | Ramatercept | 1169766-01-1 | |
| HY-P99829 | Cofetuzumab pelidotin | 1869937-48-3 | |
| HY-P9983 | Lintuzumab | 166089-32-3 | |
| HY-P99843 | Datopotamab | 2267989-53-5 | |
| HY-P9985 | Disitamab vedotin | 2136633-23-1 | |
| HY-P99892 | Serclutamab | 2140172-41-2 | |
| HY-P99896 | Runimotamab | 2361325-98-4 | |
| HY-P9990 | Litifilimab | 2407378-48-5 | |
| HY-P99911 | Efizonerimod alfa | 1635395-27-5 | |
| HY-P99917 | Eflepedocokin alfa | 2200269-84-5 | |
| HY-P99922 | Encelimab | 2173096-82-5 | |
| HY-P99941 | Retifanlimab | 2079108-44-2 | |
| HY-P99947 | Rimteravimab | 2540797-21-3 | |
| HY-P9995 | Posdinemab | 2517973-04-3 | |
| HY-P99964 | Sirtratumab | 1824663-82-2 | |
| HY-P99971 | Gemtuzumab | 220578-59-6 | |
| HY-P9998 | Semzuvolimab | 2409099-32-5 | |
| HY-P99995 | Human IgG1 (K214R) kappa, Isotype Control | ||
| HY-T1000 | Fetal Bovine Serum (Superfine), Uruguay | ||
| HY-W017464 | NAPQI | 50700-49-7 |
|
Life Technologies (India) Pvt Ltd. 306, Agarwal City Mall, opposite M2K Pitampura, Delhi-110034 (India) Tel # +91-11-4220-8000; 4220-8111; 4220-8222 Fax# +91-11-4220-8444, Mobile# +91-98105-21400 Email# customerservice@lifetechindia.com |